Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A1BG		ENSG00000121410	"Alpha-1-B glycoprotein"	P04217	19	58345178-58353499	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	180	"liver: 299.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.0;Hep G2: 4.8;REH: 6.4;U-266/70: 4.8"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB016673, HPA044252"	Supported				"Secreted to blood"	200000000000	49000000000			"CAB016673: AB_1611892, HPA044252: "	"unprognostic (9.95e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.67e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (3.97e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.19e-5)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.72e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	299.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.1	0.0	1.0	0.7	0.0	0.7	0.1	1.3	0.0	0.3	0.6	1.9	0.0	0.0	0.0	0.2	0.0	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.9	5.0	2.6	0.0	4.8	0.0	1.0	0.4	0.2	0.4	0.0	0.0	0.0	0.8	0.0	0.0	1.8	0.9	1.6	0.3	0.4	6.4	3.1	1.3	0.0	0.0	0.0	0.4	0.7	0.2	0.8	1.0	1.1	0.0	1.8	0.3	0.0	0.0	4.8	2.1	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.4	0.5	0.5	0.6	0.0	0.3	0.0	0.0	0.0	1.6	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 231.0;lung: 227.4"	"Group enriched"	"Detected in some"	5	"AF22: 111.0;ASC diff: 33.0;Hep G2: 89.4;SK-MEL-30: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.4;T-cells: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	2900000000000	220000000000			"CAB017621: AB_1118894, HPA002265: AB_1078142"	"unprognostic (1.73e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.32e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.03e-3)"	77.4	20.5	12.5	14.7	16.8	0.3	39.6	6.1	16.1	41.8	27.3	25.3	10.5	15.0	54.6	28.2	39.5	30.6	49.7	68.0	12.4	10.2	50.0	231.0	227.4	14.9	16.9	8.0	40.8	13.0	20.9	20.4	48.0	20.5	77.3	35.9	47.5	20.5	26.3	26.0	10.2	23.1	57.7	20.9	42.3	25.8	26.2	13.0	4.0	29.5	17.0	8.6	68.9	59.0	0.2	1.4	0.0	0.4	0.0	4.4	0.3	0.0	0.0	111.0	0.0	33.0	2.4	0.3	13.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	89.4	0.0	0.1	0.1	5.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	32.1	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	2.1	0.0	0.4	0.0	4.4	0.2	2.6	0.2	0.5	1.2	0.3	0.0	0.1	0.7	0.0	0.0	0.0	1.4	0.0	0.3	12.5	16.8	6.1	16.1	12.4	10.2	16.9	8.0	20.5	13.0
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264123-218270257	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol				Microtubules	Cytosol	"CAB017717: , HPA031868: "	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	36.3	40.4	41.2	35.5	49.1	15.9	36.7	40.8	48.5	36.5	48.5	30.8	48.3	38.7	38.2	34.1	50.0	40.1	50.2	39.7	37.3	35.7	38.2	49.8	28.8	29.0	39.0	51.4	53.1	59.2	44.0	37.9	40.4	40.8	39.3	37.2	28.7	43.9	41.4	47.8	42.6	39.0	42.8	32.8	32.2	51.4	50.9	36.5	27.8	46.6	33.6	32.1	39.9	34.6	30.2	50.9	15.7	53.2	27.2	31.6	41.8	32.1	27.1	19.2	26.4	29.9	20.8	36.9	22.4	35.7	43.4	32.3	57.9	25.3	16.0	33.1	28.6	24.4	39.0	34.1	34.4	26.3	49.4	36.7	27.8	65.6	41.5	34.3	24.3	26.2	39.9	45.4	39.8	25.2	49.5	21.2	28.5	47.4	30.0	58.2	32.0	19.0	22.4	25.5	28.7	26.7	41.3	25.1	23.8	15.0	33.7	32.8	26.7	26.8	21.7	32.1	21.2	20.8	26.9	27.5	49.3	27.3	30.3	22.4	20.8	15.7	44.2	14.9	28.8	53.2	29.3	27.3	25.4	26.1	50.9	30.2	31.6	28.8	7.0	27.2	50.2	29.7	27.2	41.8	41.2	49.1	40.8	48.5	37.3	35.7	39.0	51.4	40.8	36.5
AARS	"AlaRS, CMT2N"	ENSG00000090861	"Alanyl-tRNA synthetase"	P49588	16	70252295-70289543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034261, HPA040870, HPA044223"	Supported		Enhanced	Cytosol			700000	Cytosol		"CAB034261: AB_1562673, HPA040870: AB_10794995, HPA044223: AB_2678862"	"unprognostic (1.98e-2)"	"unprognostic (6.87e-2)"	"unprognostic (8.02e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.42e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.05e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.83e-3)"	22.8	25.3	28.0	19.6	34.8	5.9	22.6	36.4	54.0	22.3	18.4	30.6	21.4	16.8	22.0	33.9	14.5	20.4	14.1	20.9	29.5	31.7	25.5	36.4	19.5	17.9	40.3	40.5	18.7	45.4	61.2	23.1	21.0	37.5	23.2	17.5	17.3	30.1	30.0	25.2	14.1	14.4	28.4	33.2	16.7	21.1	12.2	32.7	10.3	42.1	10.6	20.9	17.7	26.9	13.4	11.6	3.9	13.3	21.3	13.4	11.6	22.9	38.7	10.7	39.6	25.0	22.7	25.8	18.2	25.3	23.0	29.1	31.7	31.0	26.1	24.5	18.3	26.9	30.9	24.8	32.4	11.8	11.1	25.7	16.4	28.1	66.2	15.4	15.4	26.8	37.5	44.2	99.0	22.8	32.7	34.5	17.2	52.0	16.5	18.1	20.0	22.3	31.6	6.7	57.0	15.7	11.8	13.3	11.4	50.6	11.9	44.8	37.3	33.9	15.0	17.0	16.5	16.8	15.1	48.7	31.9	48.1	29.1	24.1	33.2	3.9	8.6	3.9	12.6	12.7	12.8	13.4	10.9	12.1	11.6	11.4	13.1	13.4	1.3	21.3	13.3	7.9	8.4	11.6	28.0	34.8	36.4	54.0	29.5	31.7	40.3	40.5	37.5	32.7
ABAT	GABAT	ENSG00000183044	"4-aminobutyrate aminotransferase"	P80404	16	8674565-8784575	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Neurotransmitter degradation"	"Aminotransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 53.3;liver: 136.5;pancreas: 54.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 44.3;MCF7: 28.5;RH-30: 25.1;T-47d: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041528, HPA041690"	Enhanced	Supported	Supported	Mitochondria			1500000	Mitochondria		"HPA041528: AB_10795690, HPA041690: AB_10794674"	"unprognostic (1.77e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.05e-1)"	"prognostic favourable (5.36e-5)"	"prognostic favourable (5.93e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (5.44e-8)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.50e-2)"	2.1	12.6	26.1	2.7	39.3	1.7	3.2	19.9	43.3	2.2	5.2	10.9	0.1	17.5	2.1	5.0	3.0	2.8	2.7	6.2	20.4	30.9	53.3	136.5	2.8	2.8	24.5	26.1	5.3	54.2	4.0	22.1	2.3	14.3	9.9	4.2	2.6	2.6	2.5	1.4	2.1	8.4	2.1	14.1	2.5	3.9	6.3	11.8	1.0	12.7	0.4	3.3	6.4	1.1	2.2	1.9	8.8	5.8	1.6	2.5	1.8	0.2	0.0	11.8	6.7	1.9	0.6	0.5	1.4	0.8	0.7	0.2	4.4	0.3	1.4	0.5	0.8	3.0	0.7	2.8	0.9	0.8	0.6	1.9	0.0	44.3	3.1	0.4	3.0	2.5	1.2	1.2	0.5	0.2	0.3	1.0	0.2	28.5	0.7	0.2	1.0	0.1	3.4	25.1	0.6	0.4	7.0	1.9	5.7	0.6	0.4	0.0	15.6	1.2	0.2	0.2	2.0	0.9	0.0	1.1	0.1	0.3	0.3	2.0	1.4	1.1	3.1	4.1	2.5	3.6	1.1	0.8	1.7	1.7	1.9	2.2	1.1	1.8	8.8	1.6	5.8	0.3	1.6	1.8	26.1	39.3	19.9	35.1	20.4	30.9	24.5	26.1	14.3	11.8
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 16.9;U-87 MG: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: "	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.6	2.2	0.0	6.5	2.4	2.0	2.8	10.8	0.9	1.0	0.4	0.3	3.8	3.1	2.8	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.4	11.7	0.0	6.7	16.9	0.7	11.0	0.2	1.0	0.0	9.7	0.2	0.3	2.3	5.1	3.1	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	0.0	1.9	0.9	2.9	0.2	3.8	3.1	3.8	1.8	2.3	38.7	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.0;SK-BR-3: 13.1;T-47d: 6.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: "	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.0	0.0	2.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.1	0.0	6.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007227-137028922	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 84.3"	"Cell line enhanced"	"Detected in many"		"T-47d: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2"	"Low region specificity"	"Detected in all"							HPA042886	Approved									"HPA042886: "	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	7.8	6.1	20.0	3.9	42.4	5.7	2.6	16.7	54.2	4.0	4.5	84.3	0.9	3.2	2.8	4.7	3.5	6.3	5.7	7.1	32.2	17.6	4.8	3.8	4.1	4.1	57.5	21.9	2.5	8.6	8.1	7.8	3.3	31.1	5.2	2.5	3.8	8.0	5.1	5.7	6.3	4.1	2.7	70.5	8.3	6.1	3.0	47.7	0.2	9.5	0.1	2.2	3.3	1.8	0.4	2.7	0.4	0.3	1.2	2.2	1.1	4.3	4.8	2.4	9.5	6.0	6.4	4.1	4.8	1.9	2.2	0.8	1.4	5.3	0.2	13.8	5.2	7.4	1.5	3.6	0.4	3.2	3.0	0.4	13.7	1.7	2.9	6.8	7.6	2.7	3.3	1.5	0.4	1.2	1.1	0.8	2.7	13.0	0.0	14.7	1.2	4.8	6.7	2.4	6.4	1.5	1.0	9.1	10.5	5.2	10.2	3.7	34.6	8.9	6.2	6.0	3.3	8.5	2.0	0.1	0.1	0.0	10.1	1.3	3.0	0.0	0.3	0.0	2.2	0.2	1.3	0.4	0.2	0.7	0.3	0.2	0.0	0.9	0.4	1.2	0.0	2.7	1.0	1.1	20.0	42.4	16.7	30.7	32.2	17.6	57.5	21.9	31.1	47.7
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 20.8;T-47d: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.5	1.8	14.8	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.1	0.2	8.5	0.1	0.3	14.9	5.7	0.9	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	14.4	10.2	0.0	0.0	12.7	0.0	1.0	2.0	4.6	2.3	0.3	1.6	8.5	0.3	20.8	14.9	1.8	10.5	0.2	34.2	0.9	4.1	0.1	0.5	4.0	4.2	2.8	1.2	0.0	2.1	5.1	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078826	Enhanced									"HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favourable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	1.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.2	0.4	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"									"CAB001716, HPA002199"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"		"CAB001716: , HPA002199: AB_1844428"	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favourable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	9.0	16.3	1.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.3	0.0	0.4	36.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558695	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain									"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: "	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	13.2	6.4	5.5	6.7	6.0	37.1	14.0	15.1	6.1	7.9	18.8	5.4	3.7	12.6	9.9	6.9	10.7	6.1	11.9	8.3	5.5	5.4	10.9	24.7	9.8	15.5	5.2	3.8	6.3	8.2	9.0	4.2	11.4	4.9	9.9	8.6	5.3	7.1	5.9	13.9	6.0	30.1	14.7	5.0	15.0	7.8	4.0	4.2	9.4	9.6	8.3	12.1	10.0	9.1	2.4	3.2	2.9	2.7	1.3	4.1	1.3	10.4	6.2	5.2	4.2	8.9	7.7	22.6	9.6	7.3	8.8	8.0	6.4	8.0	11.5	8.8	8.8	9.1	11.1	8.0	8.9	7.8	14.0	12.6	5.5	8.1	6.3	42.2	7.0	5.3	6.9	5.3	6.2	9.4	26.8	26.5	9.0	3.3	10.7	24.2	6.9	5.3	9.8	10.2	12.2	7.1	6.8	3.8	5.8	7.5	8.4	11.8	6.5	14.8	7.2	9.5	6.0	5.9	13.1	6.5	4.8	10.0	5.0	7.4	5.9	1.7	2.4	2.9	2.8	2.7	3.6	1.8	3.3	4.1	2.8	2.4	3.0	4.0	0.4	1.3	1.9	3.2	2.7	1.3	5.5	6.0	15.1	6.1	5.5	5.4	5.2	3.8	4.9	4.2
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 11.7;WM-115: 22.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"				"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: , HPA053288: "	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	11.7	0.0	0.5	2.2	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.7	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Supported	Mitochondria				Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.4	11.2	11.5	14.5	7.6	18.9	5.5	8.1	9.1	7.4	12.7	13.9	17.0	18.0	15.6	6.6	12.0	22.2	10.3	12.6	19.3	18.4	12.1	22.5	10.3	6.3	19.6	10.5	13.4	9.8	10.0	13.1	16.0	13.1	23.3	8.0	6.9	14.8	14.4	19.5	15.7	15.0	22.1	21.0	9.6	11.4	13.8	9.1	19.1	17.5	10.9	7.8	13.8	8.3	7.6	14.8	15.8	7.8	7.6	19.3	16.3	7.4	23.6	8.0	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Hydrolase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Low region specificity"	"Detected in all"							HPA002380	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA002380: AB_1844432"	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.2	24.2	0.1	6.3	5.6	3.5	1.3	7.1	8.7	6.2	6.4	3.8	17.5	6.6	38.2	13.7	6.5	2.0	7.0	4.7	11.5	2.2	8.1	14.2	14.0	16.7	2.9	21.1	7.3	4.7	1.8	1.0	6.8	8.2	3.4	1.9	4.5	5.2	2.7	3.8	3.6	18.5	3.6	3.2	2.3	8.2	3.5	5.8	9.0	9.8	2.4	3.4	1.5	0.6	0.4	1.4	5.1	5.7	6.3	3.2	2.2	3.2	3.0	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Group enriched"	"Detected in some"	5	"A549: 59.0;Hep G2: 58.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004860, CAB037271"	Enhanced									"CAB037271: AB_2221326, HPA004860: AB_1844433"	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	59.0	0.9	2.9	4.5	3.5	1.0	0.1	0.3	0.1	0.2	12.6	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	58.8	0.1	0.0	0.2	0.5	4.1	0.4	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.3	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.0	4.8	0.9	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Group enriched"	"Detected in many"	4	"HEL: 60.4;HMC-1: 66.1;RPTEC TERT1: 17.8"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"				"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favourable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.4	7.8	1.3	2.3	2.4	3.2	0.3	3.6	3.6	3.2	2.8	10.8	3.3	2.5	2.3	4.8	6.0	2.0	1.7	4.0	7.3	3.0	60.4	2.4	2.1	5.0	6.9	66.1	2.4	0.8	2.3	4.7	4.1	6.2	0.1	4.3	1.4	1.2	1.1	1.5	1.9	1.8	3.6	6.5	17.8	10.0	3.2	2.3	1.2	0.2	2.5	0.0	3.7	6.7	3.4	2.2	2.8	4.2	0.0	0.0	1.0	6.5	3.9	1.6	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 37.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Plasma membrane"				"Plasma membrane"		"HPA038105: "	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.5	0.9	3.7	1.4	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	37.7	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.0	0.4	0.1	4.8	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2										
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	5	"A549: 4.6;AN3-CA: 3.7;SCLC-21H: 6.5"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: "	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285423-74303056	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved									"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	17.1	13.0	17.2	13.6	21.9	11.8	15.1	23.4	21.3	13.3	16.7	22.7	15.1	23.4	18.3	17.0	13.6	23.8	21.4	16.6	15.7	15.7	18.6	22.2	16.3	16.4	20.9	11.7	22.2	17.1	12.4	19.7	19.9	17.7	13.4	11.5	15.7	12.7	15.7	11.3	11.7	22.8	14.7	21.7	17.8	13.1	15.7	17.9	13.3	20.0	8.6	13.5	16.4	14.7	3.1	6.7	9.6	2.5	4.0	7.6	2.7	2.7	3.2	8.2	6.3	6.8	4.5	10.0	4.2	5.7	5.9	6.3	6.5	13.9	4.6	7.8	6.1	9.1	6.1	5.6	3.2	3.9	3.8	2.3	4.3	5.1	2.4	2.8	4.7	10.8	2.5	4.1	2.8	9.8	4.2	2.0	4.7	4.6	7.8	5.7	3.0	6.0	9.5	11.6	6.4	9.1	8.7	3.9	7.5	5.5	5.7	5.9	12.5	1.7	10.0	3.8	7.6	3.2	2.5	4.6	4.4	3.3	5.4	4.3	4.6	9.6	2.5	2.7	5.0	1.9	3.1	2.9	4.4	5.7	3.9	3.1	2.5	3.5	1.7	4.0	1.5	6.7	7.6	2.7	17.2	21.9	23.4	21.3	15.7	15.7	20.9	11.7	17.7	17.9
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol				Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.0	5.4	7.1	9.6	7.9	5.2	3.2	10.2	5.3	7.1	9.8	17.9	3.0	10.1	11.2	6.4	8.7	10.4	5.9	13.7	7.2	9.0	12.3	7.5	5.6	2.5	12.5	4.0	4.6	6.2	11.0	2.8	2.2	22.5	3.7	7.8	2.6	6.5	2.8	4.9	3.3	20.6	7.0	10.6	5.4	11.0	6.5	13.3	5.6	15.5	3.0	3.9	3.4	7.1	13.8	4.2	3.2	5.5	13.5	21.8	17.6	1.5	14.6	10.0	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2
ABHD14B	"CIB, MGC15429"	ENSG00000114779	"Abhydrolase domain containing 14B"	Q96IU4	3	51968510-51983409	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036444, HPA036642"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol			2600000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA036444: AB_10672221, HPA036642: AB_10672225"	"unprognostic (8.97e-2)"	"prognostic favourable (6.92e-5)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.42e-5)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.35e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.95e-2)"	"prognostic favourable (2.93e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.55e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.70e-2)"	40.0	34.2	6.2	19.8	7.5	11.4	25.2	10.7	7.0	21.9	33.6	8.6	32.1	30.3	19.6	21.7	27.7	22.0	32.9	12.2	6.2	5.8	42.6	78.4	21.5	35.1	7.8	7.3	29.5	45.0	14.2	15.2	11.4	6.7	30.9	20.2	29.1	39.4	35.0	11.7	16.0	58.7	22.6	8.9	23.3	18.7	11.2	6.2	26.0	35.3	15.2	32.5	24.6	16.9	24.9	15.5	12.5	9.4	9.9	27.2	14.0	10.1	8.7	0.7	10.2	28.4	25.3	2.6	4.0	4.8	7.5	8.7	6.4	20.2	11.5	3.2	14.1	5.1	6.3	5.8	5.7	15.6	6.8	18.0	7.5	25.1	15.3	10.1	18.6	32.7	20.1	7.6	10.3	9.1	10.4	18.3	14.4	9.9	4.4	7.7	0.9	22.2	11.4	1.4	51.6	13.6	4.2	4.3	4.6	10.2	19.1	32.6	27.5	6.9	8.5	4.0	18.8	9.0	2.4	23.4	10.9	4.7	8.6	32.3	6.9	12.5	9.4	4.2	18.3	7.6	27.2	24.9	23.0	22.4	15.5	18.7	23.4	21.3	0.8	9.9	4.8	11.3	16.3	14.0	6.2	7.5	10.7	7.0	6.2	5.8	7.8	7.3	6.7	6.2
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.3;PC-3: 16.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059272	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA059272: "																		4.3	3.6	3.0	5.3	3.8	2.0	1.1	0.6	3.0	1.3	1.9			4.1	2.3	0.0	2.9	2.2	0.9	2.2	1.9	2.0	2.6	2.0	2.2	3.4	1.5		2.3	4.8	0.0	3.2	1.3		2.9	0.0		3.6	0.0	3.1	2.4	3.4	0.0	1.2	7.4	5.0	9.0			2.0		0.0	1.4	1.5	1.8	1.6	6.3	1.8	0.4	2.0	1.6	4.0	2.7	0.5	1.1	0.0	0.0	6.2	4.8	0.0	0.0	0.0	13.3	5.3	3.7	4.0	0.0	10.5	0.0	0.0	0.0	2.5	3.2	2.4	4.6	9.6	0.0	1.4	6.8	0.0	0.0	0.0	0.0	0.0	4.5	4.4	0.0	6.9	2.2	3.9	1.1	16.0	4.7	0.6	1.4	0.0	2.8	1.9	1.6	4.5	2.6	0.6	5.3	0.6	1.6	2.9	5.0	1.5	2.0	3.6	2.1	2.5	2.1	1.5	2.0	0.3	1.8	6.3	1.9	1.2	1.2	0.8	0.7	1.5	1.5	1.8	1.5	1.1	0.8	0.4	0.8	1.6	2.0	1.6										
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 47.3;hTEC/SVTERT24-B: 84.1;hTERT-HME1: 85.4;TIME: 182.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 4.0;basal ganglia: 15.3;cerebellum: 5.8;cerebral cortex: 13.1;olfactory region: 13.7"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"		570000000			"HPA044127: "	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favourable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	35.3	5.2	2.7	24.7	9.0	0.0	16.1	1.2	3.3	45.0	15.8	9.7	6.9	1.7	29.4	23.6	23.4	16.9	44.1	28.1	4.2	2.9	6.6	2.2	34.5	8.2	4.4	3.6	33.5	3.8	0.5	4.3	45.8	4.7	23.0	19.4	80.6	10.5	4.2	8.7	9.8	10.2	39.2	8.0	3.8	22.3	12.3	5.3	0.2	23.2	23.7	25.3	38.5	19.1	0.7	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	4.4	47.3	0.0	9.7	9.4	17.8	8.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.1	28.3	0.0	0.0	0.2	0.1	0.0	2.5	0.0	0.0	2.8	0.1	84.1	85.4	34.7	0.0	0.1	15.5	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	182.9	3.8	0.0	32.2	1.9	0.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	9.0	1.2	2.4	4.2	2.9	4.4	3.6	4.7	5.3
ABLIM3	KIAA0843	ENSG00000173210	"Actin binding LIM protein family member 3"	O94929	5	149141483-149260542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 58.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 25.2;HHSteC: 25.8;HSkMC: 29.7;hTERT-HME1: 29.7;TIME: 32.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003245	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003245: AB_1078083"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.74e-2)"	"unprognostic (4.19e-2)"	"unprognostic (9.48e-3)"	"unprognostic (4.37e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (3.12e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.20e-1)"	45.9	6.0	7.9	3.5	9.8	1.2	35.0	29.7	12.5	9.1	4.7	11.6	7.0	2.9	4.9	8.9	15.6	5.8	6.1	58.4	8.5	10.2	17.0	48.1	9.1	4.8	9.9	5.9	2.6	2.4	39.3	3.1	26.1	14.3	6.5	4.7	7.7	3.0	9.9	24.3	3.5	3.7	8.7	14.0	5.0	2.7	2.3	3.3	0.1	4.2	8.9	4.5	8.8	14.6	0.0	0.6	2.2	0.3	0.0	0.0	6.8	7.3	1.5	0.0	0.0	13.1	25.2	0.0	5.1	14.3	2.9	5.2	0.0	5.1	0.0	0.8	6.4	0.1	0.0	6.0	5.8	0.0	0.0	0.0	0.3	0.1	25.8	0.0	0.0	29.7	1.6	10.5	29.7	13.1	0.0	2.3	17.1	2.8	0.0	0.0	0.0	20.2	0.0	0.0	0.0	16.4	5.0	2.0	0.0	1.0	0.3	2.8	0.4	0.0	32.9	6.2	1.4	6.4	8.6	0.0	0.0	0.0	10.8	0.0	17.6	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	6.8	7.9	9.8	29.7	12.5	8.5	10.2	9.9	5.9	14.3	3.3
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028682-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Cell line enhanced"	"Detected in many"		"HL-60: 71.8;NB-4: 76.3;U-937: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol			7400000	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favourable (1.65e-6)"	12.2	4.2	12.0	25.5	10.1	23.1	22.1	1.8	19.0	6.5	28.4	2.4	10.6	22.6	10.3	43.8	23.5	6.0	10.9	7.9	15.1	7.1	29.0	26.8	14.0	39.0	5.5	10.3	5.1	9.5	10.3	9.3	12.9	4.8	8.2	26.9	4.3	19.9	9.7	2.3	12.8	35.5	7.1	5.1	45.6	13.7	20.1	5.0	60.2	13.2	19.2	26.0	23.0	9.0	17.1	37.2	30.5	82.9	24.6	48.8	51.8	11.0	5.9	15.2	14.2	6.0	9.5	16.6	8.8	6.3	6.6	13.7	13.1	12.9	0.0	16.1	8.7	16.8	13.3	19.0	7.8	29.3	24.6	43.1	3.3	4.5	8.8	71.8	19.8	8.5	16.0	8.9	7.4	34.8	5.4	15.1	19.0	23.2	44.7	76.3	18.2	11.6	28.9	9.4	3.4	17.9	32.7	34.0	3.7	6.0	16.8	27.5	6.7	53.9	25.8	4.3	3.6	8.8	15.6	8.2	23.4	3.0	5.4	74.2	12.5	30.5	31.7	18.9	29.8	55.8	46.1	15.3	48.8	38.1	33.8	17.1	47.7	44.3	8.6	24.6	82.9	37.2	43.5	51.8	12.0	10.1	1.8	19.0	15.1	7.1	5.5	10.3	4.8	5.0
ACAA1		ENSG00000060971	"Acetyl-CoA acyltransferase 1"	P09110	3	38103129-38137242	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006764, HPA007244"	Enhanced		Enhanced	Peroxisomes			4300000	Peroxisomes		"HPA006764: AB_1078085, HPA007244: AB_1078084"	"prognostic favourable (3.00e-4)"	"unprognostic (5.57e-2)"	"unprognostic (4.54e-2)"	"prognostic favourable (7.53e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (9.35e-3)"	"unprognostic (2.91e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.90e-1)"	"prognostic favourable (6.99e-9)"	"unprognostic (1.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.65e-2)"	9.5	12.7	11.0	5.6	11.9	9.6	10.2	8.1	14.3	6.7	16.1	12.5	10.6	23.4	4.9	13.3	12.1	4.6	16.0	17.7	10.2	8.9	48.7	152.1	8.2	5.9	14.0	9.4	5.0	19.2	7.4	5.9	6.8	11.0	13.4	12.4	7.3	11.5	9.4	9.8	6.2	23.8	4.8	12.7	10.0	8.5	4.4	10.9	5.7	9.3	10.1	10.2	9.4	7.0	9.2	47.0	32.8	45.2	17.8	19.3	18.8	8.4	9.2	3.1	9.9	13.6	7.9	10.9	7.8	11.3	8.9	8.5	12.3	9.5	5.0	5.6	12.4	5.6	8.5	13.1	4.9	7.3	8.8	6.5	8.1	34.8	8.8	14.8	14.5	14.7	9.4	7.6	5.5	12.0	6.0	5.9	9.9	11.0	14.3	10.6	3.3	11.2	3.3	6.0	8.4	25.1	25.1	2.7	4.2	7.6	85.3	5.4	8.8	11.9	8.7	5.4	5.2	10.7	10.6	7.8	5.0	3.9	8.8	12.9	8.5	15.3	29.9	32.8	13.6	40.7	11.4	9.2	13.1	13.3	47.0	8.7	13.0	12.1	20.4	17.8	45.2	27.7	19.3	18.8	11.0	11.9	8.1	14.3	10.2	8.9	14.0	9.4	11.0	10.9
ACAA2	DSAEC	ENSG00000167315	"Acetyl-CoA acyltransferase 2"	P42765	18	49782167-49813960	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 245.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042303	Approved		Supported	Mitochondria			3200000	Mitochondria		"HPA042303: AB_10794046"	"unprognostic (7.94e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (8.53e-4)"	"unprognostic (2.92e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-1)"	"prognostic favourable (1.36e-10)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.26e-3)"	"unprognostic (3.41e-1)"	22.7	12.9	9.4	6.9	10.7	4.4	13.0	3.6	7.0	4.1	27.2	8.0	7.8	25.9	5.1	5.1	7.1	4.1	9.2	38.9	6.8	7.0	60.3	245.7	7.9	7.5	10.7	6.1	6.4	13.6	6.3	7.1	7.5	6.7	7.9	18.4	9.5	3.3	6.2	22.9	4.2	37.0	11.3	9.7	6.9	6.0	6.5	7.5	8.4	15.7	8.8	5.0	8.1	4.9	13.0	31.8	27.5	33.0	35.5	40.9	28.6	0.7	13.9	23.2	21.2	30.7	16.2	11.8	7.1	11.6	12.0	9.3	29.5	12.0	12.4	15.2	26.1	0.9	38.6	4.5	11.9	37.9	9.1	8.8	18.1	34.9	14.5	0.1	16.6	21.4	1.5	19.4	6.1	19.6	7.6	11.7	33.2	16.0	0.5	19.1	21.0	5.6	30.4	49.6	45.4	40.5	0.6	33.3	26.4	0.5	16.3	1.1	9.2	12.8	9.3	10.2	12.9	15.4	7.7	23.8	27.4	31.6	7.3	17.9	9.3	13.1	25.9	27.5	32.1	33.0	40.9	13.0	19.2	28.6	31.8	9.7	16.4	24.3	2.5	35.5	31.1	14.9	22.6	28.6	9.4	10.7	3.6	7.0	6.8	7.0	10.7	6.1	6.7	7.5
ACACB	"ACC2, ACCB, HACC275"	ENSG00000076555	"Acetyl-CoA carboxylase beta"	O00763	12	109116595-109268226	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Allosteric enzyme, Ligase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 104.5;breast: 67.4;liver: 42.0;skeletal muscle: 154.2"	"Cell line enriched"	"Detected in many"	18	"ASC diff: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006554	Enhanced				"Intracellular and membrane"					"HPA006554: AB_1844495"	"unprognostic (2.24e-1)"	"unprognostic (4.66e-1)"	"unprognostic (3.97e-2)"	"unprognostic (4.54e-6)"	"unprognostic (2.82e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.62e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (1.93e-4)"	"unprognostic (6.63e-2)"	"prognostic favourable (1.15e-5)"	"unprognostic (2.36e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.58e-2)"	104.5	8.2	4.3	10.6	4.0	1.6	67.4	3.3	3.5	3.5	19.3	3.2	6.2	3.8	4.6	4.3	4.9	3.9	10.5	12.1	4.5	2.0	5.4	42.0	3.1	4.0	6.4	2.7	6.8	8.5	8.9	7.1	1.3	3.7	3.6	3.9	4.0	5.8	9.0	154.2	2.8	4.8	7.5	6.5	2.5	5.6	1.6	4.9	0.4	6.2	12.5	1.7	7.3	6.3	2.5	0.2	15.5	0.4	0.1	1.7	0.1	0.2	1.7	1.1	2.1	71.5	0.5	0.8	0.2	0.4	0.3	0.2	1.2	0.3	0.8	0.5	0.3	1.4	0.9	0.4	0.2	1.1	1.6	2.0	1.8	1.2	0.3	1.7	0.5	0.8	0.4	0.7	0.1	0.1	0.2	0.1	0.2	0.5	1.2	1.6	1.2	3.8	0.6	1.5	0.4	0.5	0.6	0.7	1.7	1.8	0.8	1.1	0.8	1.7	0.1	0.7	0.4	0.8	0.6	2.7	1.5	1.2	1.7	1.3	0.5	4.1	0.4	15.5	1.1	0.1	0.6	1.7	1.0	0.3	0.2	2.5	1.7	0.9	0.6	0.1	0.2	0.2	0.6	0.1	4.3	4.0	3.3	3.5	4.5	2.0	6.4	2.7	3.7	4.9
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Mitochondria			15000	Mitochondria	Nucleoplasm	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favourable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favourable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.3	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	3.3	4.3	1.3	0.5	10.5	5.3	5.2	2.2	12.0	6.2	0.4	23.7	10.3	2.0	1.7	0.1	4.0	4.2	0.0	1.7	4.2	7.2	12.0	1.3	3.0	5.4	2.7	1.4	7.3	11.6	0.7	4.0	6.2	0.0	9.9	5.0	8.2	4.4	0.1	3.1	3.0	0.6	10.1	5.7	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4
ACADSB	"ACAD7, SBCAD"	ENSG00000196177	"Acyl-CoA dehydrogenase short/branched chain"	P45954	10	123008979-123058311	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 28.9;liver: 114.2"	"Cell line enhanced"	"Detected in all"		"Hep G2: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041458	Enhanced		Supported	Mitochondria			63000	Mitochondria		"HPA041458: "	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.91e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.67e-1)"	"prognostic favourable (3.40e-4)"	"unprognostic (9.37e-3)"	"prognostic favourable (6.37e-12)"	"unprognostic (2.69e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.60e-3)"	"unprognostic (7.14e-2)"	4.6	9.4	6.7	2.4	9.0	1.4	8.3	10.3	8.3	3.9	5.3	5.5	6.4	16.8	4.1	3.3	4.4	4.1	3.1	13.7	8.5	4.8	28.9	114.2	4.3	2.7	5.1	8.2	5.0	5.3	8.0	4.9	1.9	7.5	7.9	5.8	4.9	5.6	6.0	12.7	4.7	5.5	5.2	4.8	2.7	4.8	2.9	5.4	3.6	4.3	7.9	3.9	5.0	4.1	6.3	6.8	13.5	5.0	9.0	11.7	6.0	9.5	6.8	5.1	9.3	7.0	8.7	4.5	5.9	12.0	5.9	6.0	6.0	3.1	10.0	4.1	5.0	4.0	7.9	4.1	9.9	6.5	8.2	5.2	2.1	34.6	4.9	7.3	5.0	6.4	4.2	3.7	3.4	5.7	5.0	7.4	7.4	4.4	7.0	6.1	3.1	4.3	8.3	10.7	3.1	8.5	10.6	1.0	5.9	9.1	2.7	9.3	8.3	3.6	6.0	3.2	2.9	7.4	7.1	8.3	9.4	5.3	5.0	7.0	2.4	13.5	5.0	12.3	10.0	5.0	11.7	5.9	9.4	8.6	6.8	6.3	8.9	9.9	3.2	9.0	3.0	4.1	7.6	6.0	6.7	9.0	10.3	8.3	8.5	4.8	5.1	8.2	7.5	5.4
ACAP1	"CENTB1, KIAA0050"	ENSG00000072818	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 1"	Q15027	17	7336529-7351478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 29.4;bone marrow: 30.3;lymphoid tissue: 51.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 18.5;HDLM-2: 24.4;Karpas-707: 24.1;NB-4: 29.8;REH: 11.9;U-937: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075570	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA075570: "	"unprognostic (1.20e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (2.49e-1)"	"prognostic favourable (2.97e-5)"	"unprognostic (4.43e-4)"	"prognostic favourable (4.17e-5)"	"unprognostic (5.66e-3)"	"unprognostic (1.11e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.65e-10)"	"unprognostic (1.14e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.90e-1)"	"unprognostic (8.61e-3)"	2.6	0.6	0.6	31.4	1.3	30.3	1.1	1.0	1.2	1.4	4.5	0.4	0.4	3.2	0.9	1.5	3.3	2.0	3.1	1.4	0.6	0.6	2.9	2.3	7.3	29.3	2.7	0.1	1.0	0.7	0.0	0.8	0.5	1.2	1.8	1.5	1.7	9.6	1.3	0.5	1.2	19.2	0.8	1.3	44.9	3.7	1.4	0.9	51.5	2.5	1.0	33.9	3.7	1.8	17.8	13.3	22.4	5.9	23.7	29.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	18.5	0.1	0.0	0.0	0.0	0.0	0.0	24.4	0.0	7.0	0.1	0.0	0.0	9.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	11.2	29.8	0.3	0.0	11.9	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	0.0	0.0	7.5	6.3	8.4	0.1	19.7	0.0	17.0	5.9	22.4	24.6	1.8	27.5	16.6	25.8	26.1	10.5	17.8	22.7	22.4	17.7	23.7	0.2	13.3	29.4	16.1	0.6	1.3	1.0	1.2	0.6	0.6	2.7	0.1	1.2	0.9
ACAP2	"CENTB2, CNT-B2, KIAA0041"	ENSG00000114331	"ArfGAP with coiled-coil, ankyrin repeat and PH domains 2"	Q15057	3	195274736-195443078	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 59.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034807, HPA034808"	Supported		Approved	Endosomes			9300	Endosomes		"HPA034807: AB_10669896, HPA034808: AB_10673103"	"unprognostic (9.13e-2)"	"unprognostic (1.75e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.54e-2)"	25.8	11.7	16.3	26.8	14.4	35.7	19.1	27.0	15.1	22.2	19.4	13.1	12.1	14.3	18.2	13.6	28.3	14.8	14.8	11.5	14.1	11.8	14.2	14.3	18.2	25.8	13.9	11.4	20.9	11.8	16.6	24.2	15.7	16.1	14.5	17.6	15.3	16.7	16.9	10.6	21.1	18.6	15.2	15.3	32.9	13.9	14.9	13.5	30.6	22.2	16.1	27.0	17.4	20.6	12.5	9.2	59.4	15.7	4.5	7.7	5.9	14.7	5.6	9.3	9.2	15.5	19.3	14.0	12.2	16.6	9.2	9.5	8.0	8.6	16.2	29.8	11.2	9.4	7.0	6.0	13.4	18.5	4.3	16.4	6.2	3.3	15.4	22.6	12.0	15.0	10.2	9.1	20.5	9.9	8.0	16.7	13.1	8.5	14.1	8.2	5.7	8.1	16.8	11.3	11.9	6.4	13.7	10.4	5.1	13.2	12.1	14.4	22.7	13.3	17.4	11.6	6.6	15.2	14.1	9.8	20.8	36.9	8.7	23.9	12.2	13.1	15.7	14.3	7.7	13.3	6.1	10.1	7.5	6.0	8.7	12.5	6.3	6.4	59.4	4.5	15.1	9.2	6.6	5.9	16.3	14.4	27.0	14.2	14.1	11.8	13.9	11.4	16.1	13.5
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria			870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	15.8	13.0	10.3	29.6	33.3	29.5	5.7	15.2	16.3	16.5	19.3	35.8	16.4	8.8	26.2	17.0	16.8	29.8	14.4	18.0	17.5	24.4	25.3	14.8	32.5	23.0	23.9	15.0	26.7	16.0	14.4	27.0	17.5	35.1	13.1	26.3	9.1	14.1	22.3	10.1	29.1	19.7	20.3	85.2	22.6	10.4	16.5	19.6	24.8	32.2	16.6	27.5	19.6	19.5	17.8	10.4	16.2	18.3	4.4	12.9	16.5	7.9	47.9	12.6	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159760328-159779055	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 20.4;liver: 31.0"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 48.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Supported	Nucleoplasm,Cytosol			16000000	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favourable (1.12e-4)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	1.6	2.6	2.7	1.5	1.7	1.6	2.2	2.2	6.3	2.1	4.3			3.2	1.4	4.8	5.7	1.0	0.7	0.7	2.9	3.6	3.0	31.0	1.8	2.5	2.9		2.1	0.7	1.3	1.2	0.9		4.2	3.9		2.3	0.5	0.1	2.4	1.6	1.4	5.1	1.1	1.7	6.6			0.9		4.2	1.1	2.6	13.3	9.5	12.3	8.4	10.0	20.4	12.2	6.9	6.5	44.3	16.9	6.3	11.8	1.5	6.2	7.3	14.7	25.4	25.4	8.9	5.9	3.1	4.8	6.7	18.3	48.0	17.4	3.5	18.8	13.6	10.6	42.2	6.4	7.8	3.7	6.4	3.5	24.2	10.4	7.1	14.6	9.9	8.9	12.4	13.5	12.5	14.9	4.8	8.4	9.9	18.0	34.2	9.1	11.9	6.7	7.1	4.6	2.4	8.9	15.7	4.4	5.4	4.7	7.6	15.8	4.7	8.7	14.4	1.6	15.5	8.1	6.1	7.1	12.3	13.9	8.4	13.7	13.3	15.9	13.8	9.5	13.3	16.0	12.3	3.2	10.0	5.6	8.7	20.4	12.2										
ACBD3	"GCP60, GOCAP1, GOLPH1, PAP7"	ENSG00000182827	"Acyl-CoA binding domain containing 3"	Q9H3P7	1	226144679-226186730	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015594	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA015594: AB_1844491"	"unprognostic (1.82e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.66e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.54e-3)"	38.0	19.7	17.6	21.4	21.3	22.3	27.9	23.0	20.5	30.1	22.7	19.1	25.4	17.2	25.8	28.5	39.8	23.0	23.9	23.8	19.2	18.8	26.3	30.6	25.3	19.1	20.6	18.4	31.6	27.5	31.1	35.4	45.0	25.9	25.9	25.9	14.2	31.2	30.8	29.0	28.9	21.0	23.4	20.0	22.4	30.8	19.2	23.4	21.8	29.3	26.2	28.5	34.7	31.8	8.4	2.5	3.2	3.0	1.7	2.9	1.1	18.8	12.9	11.0	6.8	34.0	30.5	21.3	23.8	24.9	14.3	18.4	16.6	23.6	20.2	21.9	30.6	14.9	15.4	15.5	20.1	8.4	18.0	9.8	13.5	15.1	21.9	15.6	12.1	22.5	20.9	17.7	23.4	16.3	18.1	14.3	22.9	9.5	11.5	12.3	16.2	17.0	10.8	24.1	20.3	13.4	17.2	12.5	18.1	21.1	23.7	22.5	24.3	18.1	20.4	14.3	10.1	34.6	22.4	27.4	28.4	25.3	17.0	10.6	23.5	3.2	2.4	2.3	1.8	3.0	2.9	8.4	2.4	1.7	1.8	7.9	2.8	2.5	2.6	1.7	2.6	2.5	2.9	1.1	17.6	21.3	23.0	20.5	19.2	18.8	20.6	18.4	25.9	23.4
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 35.9;HUVEC TERT2: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	121920000	92000000	Vesicles		"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: "	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	35.9	0.4	1.3	2.6	0.0	0.0	0.5	3.1	0.7	1.0	6.1	0.0	1.7	0.0	0.0	0.0	0.7	3.4	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	18.3	3.0	0.0	0.0	0.6	0.0	0.7	0.2	0.3	0.1	0.2	0.5	0.0	0.0	4.5	3.2	0.0	0.0	0.0	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	32.4	44.4	34.6	46.6	36.2	57.6	32.5	45.7	41.8	36.6	30.1	39.1	35.2	28.5	52.9	32.2	39.3	34.6	33.3	29.7	33.1	28.3	34.9	35.5	28.8	41.1	34.4	27.7	43.9	34.5	51.1	48.3	37.0	33.7	35.4	34.6	31.5	33.0	38.3	43.8	38.1	35.1	40.1	35.0	52.9	34.0	34.5	40.6	44.2	38.5	27.1	45.9	30.5	47.8	6.9	6.8	13.4	4.9	9.7	5.5	2.7	23.2	24.0	37.9	30.7	23.7	19.1	38.1	26.0	18.4	31.4	25.7	31.8	27.4	43.2	15.4	21.5	25.7	52.4	29.7	32.3	30.3	23.2	38.0	25.4	43.7	13.6	41.2	33.8	22.3	18.4	32.2	27.1	27.4	35.0	17.3	23.7	29.1	46.7	40.7	42.6	23.0	42.4	29.5	23.0	26.1	41.1	25.3	18.6	34.5	22.6	20.5	18.6	33.4	28.0	21.5	21.6	20.4	24.0	18.4	20.7	44.8	19.2	31.3	23.3	4.1	4.9	5.6	5.5	4.5	4.4	4.4	3.7	4.2	4.1	6.9	5.1	4.6	13.4	9.7	3.7	6.8	3.8	2.7	34.6	36.2	45.7	41.8	33.1	28.3	34.4	27.7	33.7	40.6
ACLY	"ACL, ATPCL, CLATP"	ENSG00000131473	"ATP citrate lyase"	P53396	17	41866908-41930542	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007783, HPA022434, HPA022953, HPA022959, HPA028758"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			2100000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB007783: AB_562242, HPA022434: AB_1844513, HPA022953: AB_1844514, HPA022959: AB_1844515, HPA028758: AB_10603575"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.94e-3)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (3.38e-3)"	"unprognostic (4.11e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.67e-3)"	38.3	24.0	16.7	26.2	22.9	19.1	35.7	21.5	29.1	22.9	22.2	25.1	18.0	30.7	27.0	24.9	23.2	23.7	28.2	18.4	18.3	33.7	37.8	22.2	23.3	27.4	23.1	17.9	19.0	30.6	27.1	19.5	26.7	49.0	41.3	23.2	15.6	25.4	19.6	10.9	19.6	29.6	27.2	26.2	24.5	24.6	20.7	21.4	32.0	21.3	18.2	24.6	20.3	21.3	16.1	23.9	25.2	26.3	16.0	23.9	21.4	23.2	79.1	37.4	32.2	57.8	54.3	34.4	32.7	35.8	41.2	51.8	40.1	26.8	37.8	21.0	45.8	37.0	48.2	56.0	34.5	34.0	46.1	21.6	45.6	41.7	26.9	34.9	28.3	43.1	16.9	72.4	14.6	43.4	26.6	30.2	34.1	23.7	57.4	19.6	24.3	14.4	37.7	45.2	48.4	42.2	41.4	70.4	38.7	23.3	73.0	25.0	43.5	33.4	46.6	32.2	26.5	32.3	53.6	17.7	22.5	35.9	54.4	27.1	26.1	18.9	20.7	25.2	23.8	22.1	22.5	16.1	19.0	21.3	23.9	13.8	14.6	16.1	10.7	16.0	26.3	13.9	23.9	21.4	16.7	22.9	21.5	27.7	18.3	33.7	23.1	17.9	49.0	21.4
ACO1	"IREB1, IREBP, IRP1"	ENSG00000122729	"Aconitase 1"	P21399	9	32384603-32454769	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	"Lyase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019371, HPA024157"	Enhanced		Supported	Mitochondria,Cytosol			8000000	"Mitochondria, Cytosol"		"HPA019371: AB_1844519, HPA024157: AB_1844520"	"unprognostic (2.11e-1)"	"unprognostic (5.61e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.08e-1)"	"prognostic favourable (5.73e-5)"	"unprognostic (2.54e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.23e-2)"	41.4	27.2	9.6	7.1	9.4	1.5	30.1	8.9	8.1	9.3	19.7	6.2	6.4	21.9	12.8	14.6	12.8	7.2	8.9	15.1	6.5	7.6	40.5	80.9	9.2	9.4	6.1	6.2	14.1	27.9	8.9	8.7	11.3	7.7	10.7	9.8	11.7	11.7	9.5	11.2	5.5	28.4	14.5	6.0	6.4	13.5	11.4	5.9	6.0	18.4	7.2	5.1	13.9	11.7	4.7	7.1	21.4	8.8	4.7	7.4	6.2	9.4	8.7	6.7	10.6	52.5	28.5	3.0	17.9	44.1	8.2	6.5	9.1	2.9	1.9	5.7	18.7	1.3	13.3	17.1	16.6	6.0	3.6	13.8	9.4	9.9	26.4	1.3	5.6	24.8	5.3	21.2	15.0	21.3	4.9	4.1	23.4	2.4	7.3	6.6	7.0	9.2	5.7	10.0	1.9	31.4	8.7	0.8	2.8	18.6	0.7	1.9	4.3	3.4	23.0	30.1	10.2	10.0	4.6	2.0	3.8	3.7	21.0	4.6	2.6	21.4	8.7	2.4	7.4	8.8	6.4	4.7	5.2	5.7	7.1	4.2	6.8	7.0	1.0	4.7	7.2	3.4	2.8	6.2	9.6	9.4	8.9	8.1	6.5	7.6	6.1	6.2	7.7	5.9
ACO2	ACONM	ENSG00000100412	"Aconitase 2"	Q99798	22	41469125-41528989	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 121.0;skeletal muscle: 157.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001097	Enhanced	Approved	Approved	Mitochondria			4000000	Mitochondria		"HPA001097: AB_1078092"	"unprognostic (1.95e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.07e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.46e-2)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.12e-2)"	22.8	18.5	41.4	11.1	38.2	9.8	12.2	21.0	43.5	12.2	25.4	27.7	12.3	45.1	9.5	9.9	17.5	15.7	11.1	121.0	33.8	24.2	37.9	22.2	10.0	11.1	27.6	32.7	8.6	17.2	48.5	7.6	9.1	24.9	12.5	20.0	14.7	20.1	15.2	157.9	9.8	46.6	12.5	28.6	10.0	21.0	9.6	23.1	9.5	16.0	42.7	12.0	12.3	8.8	22.9	28.1	7.3	36.6	15.8	16.4	19.4	16.1	18.8	18.9	39.0	32.6	21.3	26.5	14.9	18.8	25.1	23.5	27.7	21.1	37.1	24.4	22.1	37.1	35.1	27.2	13.2	24.5	25.0	18.0	26.3	29.4	28.5	47.9	27.6	37.8	21.9	26.0	27.7	24.8	23.2	40.5	19.7	30.3	24.4	16.2	12.9	37.7	33.2	13.0	51.4	32.3	32.1	13.6	11.6	36.6	43.3	27.6	25.1	25.6	17.6	21.4	24.0	19.5	16.3	24.1	29.9	25.9	34.6	20.9	23.1	4.5	21.1	7.3	14.7	31.3	14.0	22.9	12.5	15.8	28.1	20.2	14.2	14.6	5.3	15.8	36.6	11.2	16.4	19.4	41.4	38.2	21.0	43.5	33.8	24.2	27.6	32.7	24.9	23.1
ACOT2	"Mte1, ZAP128"	ENSG00000119673	"Acyl-CoA thioesterase 2"	P49753	14	73567620-73575658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 60.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA043705, HPA060170"	Enhanced		Approved	Mitochondria				Mitochondria		"HPA043705: , HPA060170: "	"unprognostic (4.44e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.10e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (2.28e-6)"	"unprognostic (1.66e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.35e-1)"	41.4	16.5	5.9	6.4	5.3	2.7	13.4	3.3	8.7	7.8	11.9	4.6	4.0	12.8	13.9	10.6	9.4	8.3	8.8	35.1	4.5	4.0	25.0	60.5	6.2	4.4	4.3	5.4	6.2	8.1	6.4	2.7	7.9	4.3	8.5	6.2	6.9	7.3	6.8	50.7	3.9	12.0	16.3	3.2	4.3	7.4	5.7	3.7	5.3	7.4	11.6	3.9	11.3	4.6	9.7	13.8	1.8	4.4	9.0	19.0	8.1	11.1	10.9	2.3	9.6	10.2	4.0	0.4	6.0	13.8	9.7	12.9	7.7	7.4	0.0	4.3	3.2	6.1	0.0	0.6	5.1	14.0	13.8	6.7	4.4	26.5	6.6	0.0	19.1	9.0	0.0	3.6	0.0	4.2	0.0	0.0	8.3	4.6	1.0	7.6	3.3	16.5	15.9	9.7	0.1	3.5	4.7	10.0	12.1	14.6	11.4	11.9	27.3	5.4	7.5	8.6	21.4	5.5	5.6	0.0	0.0	4.0	7.1	0.0	8.0	1.5	3.7	1.8	14.6	4.4	10.7	9.7	13.7	11.1	13.8	7.9	12.4	13.5	0.1	9.0	3.9	8.5	19.0	8.1	5.9	5.3	3.3	8.7	4.5	4.0	4.3	5.4	4.3	3.7
ACOT8	"hACTE-III, hTE, NAP1, PTE-2, PTE1"	ENSG00000101473	"Acyl-CoA thioesterase 8"	O14734	20	45841721-45857406	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Host-virus interaction, Lipid metabolism, Peroxisome biogenesis"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010261	Approved		Supported	Vesicles,Mitochondria				Vesicles	Mitochondria	"CAB010261: AB_2221664"	"unprognostic (2.36e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (3.18e-4)"	"unprognostic (2.79e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.61e-2)"	"unprognostic (2.98e-1)"	7.0	22.6	23.5	10.9	24.3	16.5	8.7	14.4	32.6	6.8	17.1	13.5	9.9	23.3	6.5	13.1	15.8	12.2	10.1	27.0	22.8	19.3	15.3	19.0	9.7	12.1	22.1	19.0	8.3	17.4	5.9	11.4	8.1	19.5	9.6	14.3	10.4	14.4	7.3	21.7	16.7	22.2	7.3	14.6	9.1	16.7	12.8	11.1	17.1	12.4	8.6	12.2	10.9	7.2	20.5	27.0	31.0	26.2	11.2	22.5	18.8	7.6	9.2	3.1	6.3	8.9	5.4	5.5	5.2	4.2	7.3	6.8	13.4	10.7	9.6	23.6	7.1	15.0	6.0	13.0	2.5	7.1	10.6	9.6	12.4	12.8	8.0	9.1	9.0	6.3	9.9	7.0	5.0	4.5	8.5	11.9	5.1	21.5	13.0	11.9	5.6	24.5	6.3	5.8	17.1	7.7	8.7	10.9	5.1	11.5	29.4	17.8	16.1	22.5	5.1	18.1	4.0	9.3	8.6	10.1	15.0	6.0	22.4	9.6	9.6	20.0	26.2	31.0	18.8	25.0	17.1	20.5	18.1	17.0	27.0	19.3	16.1	17.3	18.7	11.2	23.4	17.0	22.5	18.8	23.5	24.3	14.4	32.6	22.8	19.3	22.1	19.0	19.5	11.1
ACP1	"HAAP, LMW-PTP, LMWPTP"	ENSG00000143727	"Acid phosphatase 1"	P24666	2	264140-278283	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016754	Approved		Approved	Nucleoplasm,Cytosol			3700000	Nucleoplasm	Cytosol	"HPA016754: AB_1844505"	"unprognostic (1.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (6.67e-6)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (3.04e-4)"	"unprognostic (9.72e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.88e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.44e-2)"	22.3	59.7	38.0	20.8	40.3	38.0	33.0	27.9	43.7	23.1	29.7	27.4	24.4	31.1	25.2	36.2	24.8	29.5	26.9	27.4	34.6	33.7	42.1	54.8	24.7	29.4	31.5	34.6	33.7	53.0	28.4	43.9	39.7	39.7	27.0	32.8	28.5	46.0	23.8	35.4	21.6	34.5	24.2	28.6	28.1	34.2	38.3	21.2	33.0	32.5	32.8	29.8	22.7	20.3	33.9	20.3	17.3	23.0	35.3	41.0	33.1	17.6	26.4	41.1	22.6	18.7	18.7	33.5	21.5	22.9	21.5	19.1	36.1	17.8	11.1	16.8	20.1	17.4	39.9	23.3	19.4	27.0	40.7	32.5	23.9	79.1	25.9	36.9	18.7	19.0	21.3	20.1	24.9	24.4	32.8	21.7	25.4	24.0	39.7	35.7	49.7	29.8	26.3	41.8	25.4	33.6	25.3	44.9	44.5	13.4	31.7	43.0	18.8	19.8	20.1	23.7	15.8	19.5	32.4	29.5	58.6	34.7	28.1	32.0	27.9	17.3	19.8	17.1	30.1	22.7	39.7	33.9	34.3	34.4	17.7	31.1	41.0	39.7	3.5	35.3	23.0	20.3	35.6	33.1	38.0	40.3	27.9	43.7	34.6	33.7	31.5	34.6	39.7	21.2
ACP5	"HPAP, TRAP"	ENSG00000102575	"Acid phosphatase 5, tartrate resistant"	P13686	19	11574660-11579008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 117.9;lung: 151.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.3;RPMI-8226: 13.6;SK-MEL-30: 40.4;U-138 MG: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 51.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002584, HPA057655, HPA059463"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		3700000	Cytosol		"CAB002584: AB_564039, HPA057655: , HPA059463: "	"unprognostic (4.27e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.93e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.17e-3)"	"unprognostic (5.13e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.66e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	117.9	2.8	0.9	21.1	1.1	1.4	7.7	0.7	1.0	11.9	10.2	1.2	2.1	7.7	7.7	6.5	12.1	3.5	9.1	6.8	0.9	0.4	28.0	16.3	151.9	30.8	1.0	1.0	13.2	8.7	0.2	1.6	9.2	1.2	6.4	8.7	19.1	8.6	2.8	3.0	10.4	15.6	3.3	1.9	20.7	15.0	3.5	0.7	9.2	2.2	8.2	18.4	11.4	10.1	51.4	13.9	16.8	9.4	2.6	16.0	8.1	3.2	0.4	0.0	0.0	0.2	0.0	14.3	0.4	9.6	0.0	0.0	0.0	0.1	0.4	0.6	2.8	0.1	0.0	1.4	0.0	3.6	0.3	0.1	0.0	1.7	0.5	0.0	0.2	0.0	1.1	0.1	0.0	0.0	10.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.1	0.7	13.6	0.0	0.1	0.2	0.3	0.0	0.0	40.4	0.0	0.1	0.3	38.0	0.4	0.7	0.1	0.2	1.8	0.2	7.8	0.0	1.2	0.0	9.4	16.8	4.1	9.1	2.1	51.4	6.4	4.7	1.7	23.5	8.3	4.7	2.6	2.6	8.7	13.9	16.0	8.1	0.9	1.1	0.7	1.0	0.9	0.4	1.0	1.0	1.2	0.7
ACPP	"ACP-3, ACP3, PAP"	ENSG00000014257	"Acid phosphatase, prostate"	P15309	3	132317367-132368298	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"prostate: 345.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.2;NB-4: 7.7;RPMI-8226: 32.3;U-698: 9.4;U-87 MG: 9.0"	"Cancer enriched"	"Detected in many"	275	"prostate cancer: 1227.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 43.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							"CAB000071, HPA004335, HPA063916"	Enhanced				"Secreted to blood"		9200			"CAB000071: , HPA004335: AB_1079684, HPA063916: "	"unprognostic (6.67e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.78e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.71e-1)"	0.4	0.6	0.4	0.7	1.6	1.4	0.8	0.3	0.7	3.9	0.4	0.2	0.0	0.4	0.3	2.5	14.7	0.6	0.2	0.9	0.3	0.3	6.2	0.3	2.0	2.7	0.6	0.8	0.4	0.8	0.5	0.3	5.3	0.7	345.2	0.7	0.8	9.1	0.2	0.3	2.5	0.4	0.4	2.2	1.0	0.5	1.0	0.6	0.2	1.3	6.6	6.8	0.5	1.5	0.2	11.2	43.1	9.7	0.9	0.0	2.9	0.2	0.0	0.0	0.0	0.1	0.6	7.0	0.1	10.2	0.0	0.0	0.2	0.2	5.7	0.4	0.0	2.9	0.0	0.0	0.0	0.0	0.3	1.1	0.2	0.1	0.1	4.1	0.1	0.6	0.8	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.0	7.7	0.4	1.2	0.0	0.0	32.3	3.1	3.8	0.0	2.5	0.0	1.2	0.3	0.2	3.7	0.0	0.0	0.1	1.5	0.0	0.4	0.2	9.4	9.0	7.3	0.1	0.0	9.7	43.1	0.0	8.6	0.0	0.2	0.0	0.0	11.2	0.0	0.0	0.0	8.5	0.9	7.7	0.8	0.0	2.9	0.4	1.6	0.3	0.7	0.3	0.3	0.6	0.8	0.7	0.6
ACSL1	"ACS1, FACL1, FACL2, LACS, LACS1, LACS2"	ENSG00000151726	"Acyl-CoA synthetase long chain family member 1"	P33121	4	184755595-184826818	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.0;liver: 190.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 147.8;ASC TERT1: 35.9;HSkMC: 78.5;RPTEC TERT1: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"neutrophil: 80.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 80.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011316, HPA011964"	Enhanced		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA011316: AB_1844536, HPA011964: AB_1844537"	"unprognostic (1.10e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.89e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.15e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (2.77e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (3.13e-2)"	105.0	6.7	4.2	14.1	13.5	46.0	54.4	3.2	9.6	7.2	12.2	16.4	5.5	4.9	5.7	12.7	8.8	6.4	5.7	24.3	6.4	4.1	32.8	190.9	20.7	18.9	24.0	3.8	4.2	7.3	5.9	8.7	4.4	11.6	14.2	2.6	9.1	17.9	4.8	89.1	20.4	4.5	6.4	18.2	16.9	6.5	6.4	15.9	2.1	8.3	10.1	5.8	7.6	11.0	0.5	2.2	80.2	8.9	0.7	0.7	2.9	5.9	1.8	1.1	3.1	147.8	35.9	1.0	3.3	1.6	2.0	1.4	0.4	1.7	2.5	0.3	3.9	3.7	5.3	2.1	1.6	12.1	1.9	1.8	1.6	4.9	23.8	4.8	4.5	78.5	18.2	1.6	8.5	2.6	0.8	7.6	9.6	3.1	0.3	6.7	0.2	2.6	0.9	1.0	3.1	46.8	17.1	4.5	4.2	3.0	9.1	10.2	3.4	4.9	2.8	1.7	2.0	4.2	1.0	2.9	1.5	1.1	5.7	6.7	2.7	2.3	8.9	2.8	0.5	5.2	0.5	0.5	0.4	0.2	2.2	0.5	0.4	0.3	80.2	0.7	3.6	0.4	0.7	2.9	4.2	13.5	3.2	9.6	6.4	4.1	24.0	3.8	11.6	15.9
ACSL4	"ACS4, FACL4, LACS4, MRX63, MRX68"	ENSG00000068366	"Acyl-CoA synthetase long chain family member 4"	O60488	X	109624244-109733403	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase	"Alport syndrome, Deafness, Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000286, HPA005552"	Supported		Approved	"Golgi apparatus,Mitochondria"			100000	"Golgi apparatus"	Mitochondria	"HPA000286: , HPA005552: AB_1078774"	"unprognostic (9.13e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.94e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.29e-2)"	"prognostic favourable (5.73e-4)"	29.5	31.1	16.3	25.5	18.0	9.2	30.0	13.9	22.8	34.7	10.5	8.8	4.6	10.0	13.7	11.7	11.2	10.7	20.1	20.3	27.6	20.3	31.2	9.6	27.8	29.6	15.2	19.0	13.1	8.8	16.7	12.9	33.9	21.1	9.7	9.7	8.0	10.7	11.0	42.5	9.1	9.0	15.8	24.6	17.0	12.9	17.7	9.7	9.5	12.8	8.5	11.9	19.5	21.0	2.2	6.5	20.3	10.9	2.2	4.0	3.8	13.7	4.4	5.5	5.9	20.7	13.0	4.3	20.1	22.3	19.7	20.5	4.3	9.6	9.8	7.8	14.5	3.9	4.7	19.4	31.0	3.4	4.9	38.7	6.3	45.8	9.5	9.2	80.3	11.2	7.6	22.5	16.4	14.7	1.1	12.1	22.5	0.9	8.0	12.1	6.9	8.0	5.8	10.1	8.1	28.2	4.4	3.6	2.8	24.0	0.0	12.4	0.3	9.8	27.2	18.0	5.1	28.4	18.4	6.0	6.9	9.2	31.7	20.6	11.4	15.5	7.0	20.3	2.8	9.8	2.0	2.2	2.5	2.2	6.5	2.2	2.0	2.4	19.8	2.2	10.9	2.6	4.0	3.8	16.3	18.0	13.9	22.6	27.6	20.3	15.2	19.0	21.1	9.7
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria			22000	Mitochondria	Nucleoplasm	"CAB035986: AB_941506, CAB062546: , HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favourable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.4	0.2	0.2	0.0	0.8	0.1	1.0	0.3	2.2	0.0	0.1	10.4	42.4	14.0	2.6	0.5	0.1	0.0	0.0	0.2	11.6	0.0	10.9	0.4	18.1	2.8	16.9	18.5	1.9	0.0	0.2	0.0	0.8	0.0	6.3	0.0	0.0	0.0	7.8	0.0	0.4	3.8	0.0	8.5	1.1	43.4	0.0	0.2	16.9	6.5	0.0	0.0	9.5	12.3	0.1	0.1	0.7	0.7	4.6	0.0	6.8	0.3	21.2	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5
ACTA1	"ACTA, NEM3"	ENSG00000143632	"Actin, alpha 1, skeletal muscle"	P68133	1	229431245-229434098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 1935.3;tongue: 523.6"	"Cell line enriched"	"Detected in some"	22	"BEWO: 102.2"	"Group enriched"	"Detected in many"	18	"head and neck cancer: 133.1;prostate cancer: 34.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000045, HPA041264, HPA041271"	Enhanced						6100000000			"CAB000045: AB_2242301, HPA041264: , HPA041271: "	"unprognostic (5.59e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-4)"	"unprognostic (5.75e-3)"	"unprognostic (3.84e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.64e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.56e-3)"	"unprognostic (9.40e-4)"	"unprognostic (2.61e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.01e-1)"	29.6	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.3	0.2	0.2	0.0	0.8	0.2	0.2	48.6	30.0	0.2	0.2	122.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.1	0.2	0.0	2.7	0.2	0.0	40.4	0.2	1935.3	0.5	0.2	1.2	0.4	0.2	0.2	0.2	0.0	0.0	5.3	523.6	39.9	0.2	0.1	4.4	14.7	20.5	15.5	5.1	9.7	20.8	0.0	0.0	0.0	0.0	0.0	0.0	102.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.4	0.0	0.1	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	8.9	9.3	20.5	7.6	15.5	5.7	4.4	6.4	7.4	14.7	4.3	5.0	7.7	12.1	5.1	14.0	4.7	9.7	20.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.0	0.0
ACTA2	ACTSA	ENSG00000107796	"Actin, alpha 2, smooth muscle, aorta"	P62736	10	88935074-88991339	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 59.5;fHDF/TERT166: 92.0;HHSteC: 94.7;HSkMC: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 143.1"	"CAB000002, CAB003761, CAB013531, HPA041264, HPA041271"	Enhanced		Supported	"Actin filaments"				"Actin filaments"		"CAB000002: AB_2223500, CAB003761: AB_562031, CAB013531: , HPA041264: , HPA041271: "	"unprognostic (7.05e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.30e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.33e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (1.37e-8)"	"unprognostic (1.87e-3)"	"unprognostic (2.30e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.09e-3)"	48.1	9.5	1.6	76.4	5.2	0.0	40.0	1.2	7.5	264.5	121.9	5.4	120.3	9.4	332.1	158.2	209.0	151.1	204.3	51.7	1.7	1.8	38.1	12.8	36.5	19.1	3.6	6.4	136.5	3.9	1.9	2.8	52.8	11.8	188.5	35.9	55.2	31.8	251.1	19.9	16.3	32.1	378.4	3.3	44.0	82.3	84.9	1.5	2.2	17.8	24.9	12.8	354.7	71.3	3.3	5.5	10.5	6.7	1.8	29.5	5.0	0.5	2.7	7.2	15.0	29.9	59.5	1.4	15.8	19.9	1.7	6.7	0.0	1.2	1.0	1.7	92.0	0.2	0.2	3.6	1.6	8.5	1.6	0.0	0.8	16.8	94.7	0.1	0.4	52.1	6.6	10.9	4.2	1.6	0.0	1.0	18.7	1.5	0.1	4.0	0.3	0.1	0.2	0.0	0.6	3.9	0.7	0.1	1.1	1.4	1.1	0.1	4.7	0.1	4.0	3.5	0.5	4.4	1.3	3.1	0.2	0.0	4.4	1.4	3.7	10.5	6.5	8.7	9.6	4.4	7.6	3.3	7.9	10.8	5.5	1.0	0.9	6.1	5.7	1.8	6.7	0.2	29.5	5.0	1.6	5.2	1.2	7.5	1.7	1.8	3.6	6.4	11.8	1.5
ACTB		ENSG00000075624	"Actin beta"	P60709	7	5527147-5563784	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB002621, HPA041264, HPA041271"	Supported									"CAB002621: , HPA041264: , HPA041271: "	"unprognostic (1.66e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (9.80e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (2.68e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.88e-3)"	209.6	84.4	88.8	260.7	97.2	204.1	152.2	50.8	143.4	172.0	392.7	135.4	95.7	107.9	333.6	113.6	296.2	196.4	168.5	79.3	99.3	73.7	132.4	148.1	183.0	295.5	90.7	79.4	211.9	49.7	41.0	52.5	139.9	103.8	183.7	142.0	78.3	101.5	182.5	70.4	96.8	190.2	371.8	135.5	238.9	216.9	102.1	61.9	358.3	83.1	100.4	279.2	346.2	146.3	113.6	386.3	575.1	443.8	122.3	233.8	559.5	250.8	150.4	182.7	152.0	74.1	96.0	232.1	199.0	111.6	134.3	105.2	253.6	141.5	151.4	153.0	265.3	160.3	97.2	248.0	158.0	175.8	57.6	132.3	145.3	143.7	104.1	145.1	337.4	119.3	81.7	178.6	52.4	131.7	71.9	114.8	206.7	234.3	127.8	385.8	223.3	120.7	183.6	108.4	112.2	193.0	93.7	55.6	92.4	195.4	183.8	67.1	194.9	167.1	272.0	353.6	226.9	232.2	286.4	66.0	73.5	164.9	193.7	213.2	407.8	250.3	323.7	575.1	227.2	395.9	185.1	113.6	169.8	205.2	386.3	107.3	128.1	177.5	383.7	122.3	443.8	151.0	233.8	559.5	88.8	97.2	50.8	143.4	99.3	73.7	90.7	79.4	103.8	61.9
ACTBL2	DKFZp686D0972	ENSG00000169067	"Actin, beta like 2"	Q562R1	5	57480016-57482809	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 2.4;placenta: 4.2;skin 1: 3.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.2;HaCaT: 1.7;RPTEC TERT1: 3.9;SiHa: 6.8;U-2 OS: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041264, HPA041271"	Uncertain						2600000000			"HPA041264: , HPA041271: "	"unprognostic (7.83e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.96e-1)"	"unprognostic (8.66e-2)"		"unprognostic (2.57e-2)"		"unprognostic (2.39e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.60e-2)"		"unprognostic (2.04e-2)"	"unprognostic (1.92e-2)"	0.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.8	0.0	0.0	1.2	0.1	0.1	3.4	0.0	0.6	0.0	0.0	0.2	1.2	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.3	0.0	2.2	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.9	0.0	0.0	0.0	6.8	0.6	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACTC1	"ACTC, CMD1R"	ENSG00000159251	"Actin, alpha, cardiac muscle 1"	P68032	15	34788096-34796139	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Atrial septal defect, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"heart muscle: 243.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 36.4;LHCN-M2: 147.6;RH-30: 70.7"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 20.7;prostate cancer: 5.1;testis cancer: 6.9;urothelial cancer: 7.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB037330, HPA041264, HPA041271"	Enhanced						6200000000			"CAB037330: , HPA041264: , HPA041271: "	"unprognostic (8.18e-3)"	"unprognostic (3.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"prognostic unfavourable (3.72e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.26e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-3)"	"unprognostic (5.68e-4)"	"unprognostic (8.79e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (9.32e-4)"	1.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0			0.0	0.1	0.0	0.2	0.0	0.0	243.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.9	0.0		0.6	12.5	8.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0			0.0		0.0	9.5	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	147.6	0.0	0.0	0.0	0.1	0.0	0.0	70.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4										
ACTG1	"ACTG, DFNA20, DFNA26"	ENSG00000184009	"Actin gamma 1"	P63261	17	81509971-81523847	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Mental retardation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041264, HPA041271"	Approved									"HPA041264: , HPA041271: "	"unprognostic (3.95e-2)"	"unprognostic (3.38e-1)"	"prognostic favourable (2.41e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-3)"	129.9	96.9	72.0	137.6	93.5	118.7	118.8	40.5	125.3	137.6	135.1	84.9	115.8	109.9	168.0	96.7	234.4	123.0	154.5	67.6	67.4	73.3	103.2	126.1	145.1	196.0	77.1	95.1	312.6	206.5	61.1	87.1	152.3	86.2	120.3	76.9	109.9	138.1	95.7	74.1	136.9	142.9	84.9	98.1	140.8	129.6	76.4	42.1	344.3	167.2	235.1	219.1	163.5	146.0	99.9	223.0	256.5	195.1	94.0	205.2	282.2	165.5	184.6	196.7	101.3	37.1	122.3	69.5	224.8	135.1	152.1	115.0	155.4	72.1	99.7	142.8	180.5	94.0	75.4	141.8	78.2	189.5	112.4	87.3	92.6	145.1	95.0	82.8	95.2	158.0	58.4	155.6	42.8	228.6	15.7	121.3	142.5	110.8	338.9	89.8	89.0	107.9	170.0	71.4	72.6	144.1	122.7	67.8	56.1	247.4	40.9	217.1	96.5	76.9	274.7	228.0	94.6	130.3	310.1	42.6	44.0	79.7	172.3	83.9	130.5	256.5	129.7	216.4	165.2	168.0	157.9	99.9	146.5	157.2	223.0	68.3	107.8	139.9	118.3	94.0	195.1	116.7	205.2	282.2	72.0	93.5	40.5	125.3	67.4	73.3	77.1	95.1	86.2	42.1
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavourable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.1	14.0	34.9	18.4	13.3	14.6	27.4	18.6	14.5	34.8	29.5	31.5	22.7	36.1	33.5	17.5	21.3	30.4	22.9	43.4	35.8	25.4	29.6	15.5	23.8	15.3	36.7	18.5	10.2	23.5	22.5	19.0	19.8	23.0	20.7	25.0	31.6	32.1	22.7	30.9	31.4	30.2	29.2	66.8	27.5	18.7	28.7	20.5	28.7	28.8	28.8	56.1	30.2	14.9	24.9	21.5	25.5	56.2	13.5	20.1	55.5	13.8	39.0	27.3	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0
ACTN1		ENSG00000072110	"Actinin alpha 1"	P12814	14	68874143-68979440	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 71.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004303, HPA006035"	Approved		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"			780000000	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB004303: AB_626633, HPA006035: AB_1078095"	"unprognostic (4.40e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (6.19e-3)"	"prognostic unfavourable (7.63e-5)"	"unprognostic (3.62e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (9.08e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.05e-3)"	"prognostic unfavourable (8.00e-4)"	27.6	10.8	18.7	33.1	28.4	31.0	38.8	4.1	20.0	30.5	101.8	3.1	43.7	11.6	80.3	24.6	48.3	38.7	53.3	31.2	9.9	6.2	11.2	20.3	23.9	23.1	4.7	15.0	27.8	12.4	2.3	7.9	22.0	8.7	43.2	26.4	11.1	30.1	72.7	7.1	14.6	25.9	135.4	10.3	19.4	52.3	9.5	9.6	7.0	9.3	9.9	11.3	81.1	53.1	0.0	8.8	71.8	12.5	0.7	22.0	14.9	83.8	25.9	16.0	12.1	28.4	18.8	60.0	74.2	71.1	78.1	58.4	20.7	19.6	0.0	26.1	73.2	36.6	12.6	78.3	98.8	0.4	3.8	11.4	13.6	17.3	51.2	8.2	1.4	23.9	15.4	48.5	55.2	42.8	5.4	0.1	61.2	23.9	0.9	17.4	12.5	19.8	5.7	29.7	3.1	29.7	22.2	5.7	6.9	64.4	9.7	17.9	14.6	16.6	53.9	111.0	44.2	12.8	64.5	11.5	4.4	0.3	32.1	11.3	58.3	11.2	12.5	25.6	1.1	5.7	1.4	0.0	4.6	2.5	8.8	0.0	22.0	18.7	71.8	0.7	1.6	0.4	1.8	14.9	18.7	28.4	4.1	20.0	9.9	6.2	4.7	15.0	8.7	9.6
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.0;HSkMC: 11.9;hTEC/SVTERT24-B: 7.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in all"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"			69000000	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.7	11.9	0.0	7.5	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3
ACTN3		ENSG00000248746	"Actinin alpha 3 (gene/pseudogene)"	Q08043	11	66546395-66563329	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"skeletal muscle: 185.5"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 16.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"					"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA006035	Uncertain		Uncertain	"Actin filaments"			29000000	"Actin filaments"		"HPA006035: AB_1078095"	"unprognostic (2.54e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.35e-4)"	"unprognostic (1.40e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.09e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.71e-9)"	"unprognostic (2.06e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.48e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	1.0	0.0	0.0	0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	185.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.7	1.9	0.1	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1										
ACTN4	FSGS1	ENSG00000130402	"Actinin alpha 4"	O43707	19	38647649-38731583	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 90.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001873, HPA006035"	Supported		Approved	"Nuclear bodies,Actin filaments,Cytosol"			230000000	"Nuclear bodies, Actin filaments"	Cytosol	"HPA001873: AB_1078096, HPA006035: AB_1078095"	"unprognostic (1.03e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (2.99e-1)"	"prognostic favourable (5.25e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.52e-2)"	38.3	39.2	19.2	30.1	24.4	28.1	34.1	16.6	26.6	45.2	47.9	31.8	23.4	51.0	70.1	22.2	61.4	37.9	41.5	25.0	19.6	16.2	48.4	34.1	39.5	17.7	27.8	18.7	33.6	34.1	17.8	21.0	65.9	21.8	33.7	22.4	29.2	41.4	35.4	16.0	40.4	69.4	54.0	32.9	40.8	34.3	13.4	24.6	11.6	29.2	30.5	42.9	40.3	41.1	2.6	8.5	12.9	5.7	17.5	9.7	5.6	44.3	90.6	13.3	6.3	7.7	9.4	26.4	20.2	27.2	30.1	24.2	32.5	34.5	9.8	48.6	45.1	21.3	8.0	31.9	9.0	24.2	8.4	13.9	41.8	28.1	16.9	10.2	17.3	15.5	10.6	26.2	17.6	18.5	16.2	10.6	22.9	23.2	3.3	6.8	9.4	21.5	9.9	12.4	5.2	32.5	46.5	9.9	5.8	36.6	29.2	13.3	12.0	12.2	31.5	34.4	16.7	16.4	67.1	4.8	10.8	8.1	30.4	10.8	61.5	4.5	5.1	10.9	9.7	5.7	7.8	2.4	4.5	9.7	4.6	2.6	0.8	3.3	12.9	17.5	4.6	8.5	7.1	5.6	19.2	24.4	16.6	26.6	19.6	16.2	27.8	18.7	21.8	24.6
ACTR1A	"ARP1, Arp1A"	ENSG00000138107	"ARP1 actin related protein 1 homolog A"	P61163	10	102461881-102502711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037193, HPA047443"	Approved		Approved	Microtubules			4900000	Microtubules		"CAB037193: AB_258253, HPA047443: "	"unprognostic (9.64e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (4.13e-1)"	32.1	28.7	35.6	23.3	42.2	19.6	20.5	28.3	62.5	26.3	33.1	40.0	12.0	23.3	26.6	24.7	27.6	20.1	22.7	44.9	36.4	40.6	23.6	23.1	28.1	18.8	41.1	32.9	18.9	22.4	38.4	23.4	29.9	55.3	26.2	26.9	23.2	19.4	34.9	65.7	26.0	23.1	43.2	36.9	20.6	23.8	29.5	25.7	33.6	18.6	24.7	25.3	28.9	20.2	10.5	22.7	23.4	29.7	12.9	18.5	18.9	20.7	25.4	30.8	31.5	38.4	30.6	12.3	26.6	47.6	42.1	39.2	13.7	16.9	14.2	20.5	39.5	20.9	29.5	32.9	29.3	18.3	20.3	19.0	14.9	20.2	27.8	14.6	17.7	31.3	24.3	38.4	27.7	54.1	15.4	14.4	41.5	17.4	26.4	25.3	12.2	23.2	20.4	39.7	9.0	33.9	11.6	11.0	24.2	15.9	9.5	19.1	35.0	10.1	39.0	20.5	19.8	22.6	26.6	14.7	14.9	16.6	21.6	25.8	12.3	15.9	22.1	23.4	18.5	28.5	15.3	10.5	13.3	17.9	22.7	9.6	11.1	12.5	17.8	12.9	29.7	11.7	18.1	18.9	35.6	42.2	28.3	62.5	36.4	40.6	41.1	32.9	55.3	25.7
ACTR1B	"Arp1B, CTRN2"	ENSG00000115073	"ARP1 actin related protein 1 homolog B"	P42025	2	97655963-97664107	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047443			Approved	Microtubules			1500000	Microtubules		"HPA047443: "	"unprognostic (5.26e-2)"	"unprognostic (8.91e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.67e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (8.21e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.58e-2)"	"prognostic favourable (4.69e-4)"	15.4	26.3	22.3	13.1	28.3	19.1	15.7	31.6	57.6	17.2	17.8	18.1	17.7	20.3	19.5	15.3	19.1	23.6	21.4	32.6	22.9	18.6	18.0	20.6	16.3	15.6	19.2	24.5	23.0	29.6	31.5	16.3	11.7	18.8	17.4	12.8	16.8	24.8	23.1	43.9	21.1	19.4	22.2	14.1	22.8	18.9	10.1	16.2	14.2	20.3	16.2	13.6	17.6	13.6	11.7	16.2	14.1	14.2	10.7	22.1	11.6	21.1	11.7	11.4	14.9	21.1	17.3	32.9	20.3	31.0	14.6	12.3	9.1	11.6	15.4	19.2	20.7	11.7	9.1	23.3	6.2	30.8	15.3	11.4	11.0	25.0	16.6	9.1	18.2	17.1	17.5	9.2	28.9	16.2	7.9	18.7	21.7	23.6	17.5	11.5	11.5	15.9	9.9	16.7	25.3	23.1	16.8	13.4	10.0	9.8	20.1	14.7	15.9	14.6	16.9	9.8	15.3	10.3	8.4	24.4	10.6	5.5	29.2	13.2	8.8	6.6	11.4	14.1	15.6	10.1	12.1	11.7	17.1	15.6	16.2	11.5	14.5	15.5	4.5	10.7	14.2	6.5	22.1	11.6	22.3	28.3	31.6	57.6	22.9	18.6	19.2	24.5	18.8	16.2
ACTR2	ARP2	ENSG00000138071	"ARP2 actin related protein 2 homolog"	P61160	2	65227753-65271253	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005083, HPA015050"	Approved		Approved	Cytosol			76000000	Cytosol		"CAB005083: AB_2221848, HPA015050: AB_1844556"	"unprognostic (2.23e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (4.50e-4)"	"unprognostic (3.88e-2)"	"unprognostic (3.16e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.18e-2)"	"unprognostic (4.35e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.03e-2)"	31.7	22.3	40.0	58.1	46.1	41.0	24.9	38.5	53.8	24.9	39.3	19.2	16.1	29.1	23.9	18.9	39.5	17.8	26.0	28.9	39.5	35.6	25.8	30.3	32.0	63.1	36.8	39.4	20.9	19.3	19.8	19.6	31.2	30.2	21.1	40.2	16.0	26.7	19.3	28.8	21.2	33.1	29.7	42.6	56.6	29.6	13.7	28.1	59.6	20.9	19.4	69.2	31.9	25.2	21.2	44.9	54.9	53.2	21.3	25.2	59.3	35.8	30.2	28.8	30.8	30.7	41.8	30.1	50.8	39.1	39.2	27.3	33.8	29.4	79.5	26.0	55.3	27.1	24.8	35.2	64.2	45.9	20.8	87.9	21.4	31.7	35.0	82.4	102.8	36.0	27.6	43.7	42.2	48.1	37.3	29.0	64.9	26.5	43.0	43.1	24.0	21.8	46.7	37.4	33.1	44.8	46.8	14.8	24.2	33.0	37.6	34.8	23.2	55.2	64.2	43.3	26.4	28.3	55.4	22.4	20.5	113.1	37.2	80.7	48.9	54.3	38.9	45.3	23.6	51.5	25.2	21.2	21.2	22.1	44.9	18.0	16.7	23.3	54.9	21.3	53.2	16.8	23.5	59.3	40.0	46.1	38.5	53.8	39.5	35.6	36.8	39.4	30.2	28.1
ACTR3	ARP3	ENSG00000115091	"ARP3 actin related protein 3 homolog"	P61158	2	113889960-113962596	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005085, HPA047016, HPA051683"	Approved						100000000			"CAB005085: AB_2289106, HPA047016: , HPA051683: "	"unprognostic (7.28e-2)"	"prognostic unfavourable (6.52e-5)"	"unprognostic (2.03e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (7.76e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (4.44e-1)"	48.3	46.1	19.4	74.5	20.9	48.6	28.6	20.1	21.5	27.5	31.2	17.9	26.1	26.0	35.0	24.8	63.1	23.2	29.7	25.1	21.8	20.7	41.9	34.1	38.6	65.9	21.3	11.4	29.8	17.6	13.8	15.7	34.9	18.1	27.5	31.9	13.2	30.0	26.4	19.6	26.9	45.7	33.7	24.6	77.0	26.5	20.5	20.5	73.1	22.1	43.5	79.1	44.0	30.0	57.0	78.0	124.9	100.1	55.4	68.8	123.3	47.8	21.8	32.6	22.3	24.8	35.4	35.1	68.2	52.7	49.4	47.5	46.4	30.5	70.1	79.9	64.4	26.0	34.8	36.8	67.2	103.1	17.2	65.1	27.2	35.9	43.4	60.3	118.9	31.0	29.7	63.5	43.5	45.9	34.4	52.1	66.1	18.0	54.3	25.9	24.4	38.2	41.8	32.5	35.1	51.8	44.3	16.5	16.5	34.5	35.1	42.4	14.8	49.3	67.9	59.9	38.8	27.5	57.6	27.8	55.6	83.3	51.5	39.7	54.7	72.8	57.5	124.9	60.4	88.2	49.4	57.0	56.2	59.5	78.0	45.1	50.3	58.4	95.9	55.4	100.1	23.6	68.8	123.3	19.4	20.9	20.1	21.5	21.8	20.7	21.3	11.4	18.1	20.5
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003695, HPA036174, HPA036175"	Enhanced						28000000			"CAB003695: AB_425286, HPA036174: , HPA036175: "	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.9	9.0	12.2	12.9	4.2	7.9	9.3	5.1	12.5	20.9	2.5	3.6	7.3	4.9	4.0	25.7	3.7	7.0	5.1	9.0	4.6	38.5	16.7	6.0	5.8	14.0	21.3	8.2	22.2	3.5	13.5	8.0	9.1	11.2	0.0	11.0	5.7	13.6	3.1	3.3	22.6	24.4	15.1	5.5	5.0	5.3	17.6	9.3	14.2	7.9	1.7	6.7	6.4	8.3	5.0	21.0	4.9	3.8	7.9	12.6	8.1	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Nucleotide metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell line enriched"	"Detected in many"	8	"MOLT-4: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"			650000	"Plasma membrane"	Cytosol	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (6.77e-5)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	3.9	2.0	1.3	3.9	5.4	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.8	0.2	1.4	5.8	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.1	26.1	2.5	0.5	0.9	5.4	2.0	3.3	0.6	3.4	197.1	2.9	0.5	1.4	10.6	2.8	9.8	0.2	0.0	0.0	0.9	2.1	0.4	2.5	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1
ADA2	"ADGF, CECR1, IDGFL"	ENSG00000093072	"Adenosine deaminase 2"	Q9NZK5	22	17178790-17221989	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 63.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.0;EFO-21: 11.5;HUVEC TERT2: 12.4;Karpas-707: 22.1;MOLT-4: 20.5;U-266/70: 12.6;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA007888	Uncertain				"Secreted to blood"		50000000			"HPA007888: AB_1078495"	"unprognostic (1.03e-3)"	"unprognostic (2.00e-3)"	"unprognostic (6.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.01e-3)"	"unprognostic (4.48e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.80e-2)"	"prognostic favourable (9.26e-4)"	"prognostic favourable (8.91e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.51e-1)"	24.7	6.6	6.9	15.3	7.5	8.7	6.3	9.7	9.2	7.8	9.8	17.3	3.9	7.0	9.6	7.0	6.9	18.2	12.4	15.9	6.4	8.8	15.2	8.5	28.6	24.3	9.2	5.8	8.9	6.7	0.6	13.7	8.4	14.5	7.4	12.3	15.3	6.9	6.3	2.5	2.5	12.6	7.9	18.2	45.0	7.2	9.7	5.3	63.0	7.5	2.9	22.6	18.0	4.1	6.1	29.8	2.6	46.4	9.5	7.9	28.3	0.0	0.0	3.4	0.0	0.0	0.6	0.1	1.2	0.1	0.0	0.0	0.0	13.0	2.9	11.5	3.6	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.2	0.1	6.2	0.0	0.1	0.0	12.4	0.1	22.1	0.5	0.0	20.5	1.5	10.2	0.0	0.4	0.0	3.2	0.0	3.9	5.8	0.1	0.0	0.1	0.0	0.0	5.8	1.4	0.0	0.1	0.1	0.0	12.6	1.1	0.7	0.1	20.7	0.1	2.6	44.1	2.4	7.9	46.4	6.3	6.1	6.4	7.9	29.8	5.0	7.6	7.8	2.1	9.5	35.2	14.7	3.6	28.3	6.9	7.5	9.7	9.2	6.4	8.8	9.2	5.8	14.5	5.3
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 76.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	11.8	26.9	7.3	8.0	9.4	13.6	18.5	10.2	30.4	7.5	10.5	12.4	15.7	5.5	31.6	9.1	24.3	4.4	10.8	10.0	8.2	5.6	9.4	9.8	11.5	10.5	6.6	27.2	11.9	8.0	5.2	7.7	14.6	5.9	15.0	13.2	4.4	21.9	7.6	10.0	3.8	9.1	24.0	14.1	17.5	32.1	8.0	5.2	11.1	12.9	17.6	7.7	13.3	10.3	9.9	11.0	76.0	9.8	8.4	18.1	6.0	13.8	12.9	17.3	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9
ADAM19	MLTNB	ENSG00000135074	"ADAM metallopeptidase domain 19"	Q9H013	5	157395534-157575775	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 49.4;smooth muscle: 46.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.1;U-251 MG: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 32.3;eosinophil: 37.5;memory B-cell: 14.1;naive B-cell: 15.8;neutrophil: 20.1;plasmacytoid DC: 18.5"	"Group enriched"	"Detected in many"	5	"B-cells: 15.8;dendritic cells: 18.5;granulocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055537			Approved	Vesicles				Vesicles		"HPA055537: "	"unprognostic (4.71e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.63e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.90e-12)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.11e-2)"	3.7	2.5	1.3	49.4	1.5	4.8	2.8	6.9	2.4	4.4	15.1	1.1	3.6	3.9	8.6	5.9	4.6	5.9	14.7	18.9	1.6	1.7	1.6	4.3	9.1	19.2	1.6	1.0	3.0	0.5	0.0	1.4	33.0	3.4	5.9	4.9	5.0	6.8	4.6	3.9	0.8	14.0	46.1	2.8	16.8	7.7	1.3	0.5	5.6	3.1	3.3	29.4	17.0	3.9	15.8	18.5	37.5	3.9	0.1	4.4	2.2	10.9	1.7	3.4	0.0	0.2	0.2	21.9	13.1	4.7	8.2	6.1	5.7	9.0	5.7	0.7	6.7	9.3	0.5	0.8	7.5	31.1	0.3	0.0	0.9	0.7	2.0	0.0	0.0	1.5	0.0	6.4	1.3	9.2	1.6	0.8	17.4	0.0	0.0	0.0	3.6	5.7	0.1	19.6	4.8	0.8	0.1	1.5	1.0	0.0	4.7	0.6	0.0	0.1	14.1	8.9	9.6	2.0	59.2	3.5	0.1	20.5	2.0	0.0	3.9	32.3	3.9	37.5	0.4	0.3	1.0	14.1	4.4	1.0	1.1	15.8	0.1	0.1	20.1	0.1	0.0	18.5	4.4	2.2	1.3	1.5	6.9	2.3	1.6	1.7	1.6	1.0	3.4	0.5
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell line enriched"	"Detected in some"	8	"CAPAN-2: 24.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"			"Plasma membrane"	Mitochondria	"HPA074034: "	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.7	0.2	0.7	0.0	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1
ADAM30	svph4	ENSG00000134249	"ADAM metallopeptidase domain 30"	Q9UKF2	1	119893533-119896495	"Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026080	Uncertain									"HPA026080: AB_1844581"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADAM7	"EAPI, GP-83"	ENSG00000069206	"ADAM metallopeptidase domain 7"	Q9H2U9	8	24440930-24526970	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"epididymis: 309.9"	"Group enriched"	"Detected in some"	31	"BEWO: 4.3;NB-4: 10.8;RPMI-8226: 2.8;SH-SY5Y: 3.3"	"Group enriched"	"Detected in some"	16	"prostate cancer: 1.0;renal cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA008879	Enhanced				"Intracellular and membrane"					"HPA008879: AB_10601789"												"unprognostic (1.03e-3)"	"unprognostic (3.96e-4)"					0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	21.7	0.0	0.1	309.9	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	1.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	6.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ADAM8	"CD156, CD156a, MS2"	ENSG00000151651	"ADAM metallopeptidase domain 8"	P78325	10	133262403-133276868	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 56.8;bone marrow: 37.1;lymphoid tissue: 28.3"	"Cell line enhanced"	"Detected in some"		"A-431: 22.3;BEWO: 32.2;CAPAN-2: 27.3;HaCaT: 26.8;HDLM-2: 17.2;U-87 MG: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 20.7;eosinophil: 56.8;neutrophil: 32.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 56.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064637	Approved				"Intracellular and membrane"					"HPA064637: "	"unprognostic (8.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.27e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.26e-2)"	"unprognostic (6.47e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-3)"	"unprognostic (3.37e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (3.99e-10)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.32e-2)"	4.8	1.0	0.7	18.0	1.6	37.1	3.1	1.7	1.2	3.8	4.8	0.9	0.2	3.5	1.8	1.6	2.8	3.6	10.1	4.1	0.8	1.1	2.8	4.3	13.0	25.0	1.0	0.2	1.7	2.4	0.1	2.0	7.5	1.6	2.9	0.9	2.9	5.5	0.7	1.5	1.9	6.0	1.6	1.5	28.3	6.9	2.3	0.5	6.6	2.0	1.8	19.7	12.0	2.8	2.5	8.6	56.8	5.4	5.5	5.5	4.6	22.3	0.6	0.2	0.3	0.1	0.0	32.2	0.2	0.5	0.1	0.1	1.7	27.3	0.4	0.6	0.0	26.8	0.0	4.6	0.0	17.2	0.3	0.3	0.1	0.0	0.2	1.3	6.3	0.1	0.4	0.2	0.4	0.0	1.2	0.9	0.0	1.8	0.0	7.6	0.1	0.6	0.1	0.2	2.4	0.3	0.5	0.0	0.3	0.1	0.1	0.4	0.4	0.7	0.6	0.0	0.6	0.2	0.3	1.3	0.8	0.2	13.7	0.7	0.1	20.7	5.4	56.8	5.5	2.1	4.0	2.5	3.7	5.2	8.6	1.5	1.4	2.0	32.9	5.5	2.0	0.1	3.8	4.6	0.7	1.6	1.7	1.2	0.8	1.1	1.0	0.2	1.6	0.5
ADAM9	"CORD9, KIAA0021, MCMP, MDC9, Mltng"	ENSG00000168615	"ADAM metallopeptidase domain 9"	Q13443	8	38996869-39105144	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Cone-rod dystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004000			Approved	"Endoplasmic reticulum,Vesicles"	"Secreted - unknown location"		640000	Vesicles	"Endoplasmic reticulum"	"HPA004000: AB_1844584"	"prognostic unfavourable (1.14e-4)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (7.21e-6)"	"unprognostic (5.77e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (5.83e-2)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (2.80e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.23e-2)"	36.7	25.0	14.7	21.7	13.6	10.4	17.1	20.9	14.4	21.8	24.4	13.2	21.8	19.4	24.9	19.8	24.1	15.5	31.7	28.5	12.5	10.1	29.4	11.6	39.2	20.3	19.2	12.9	17.6	11.1	37.5	10.4	30.1	15.8	23.8	23.8	15.4	44.5	21.4	18.3	12.8	25.4	32.8	22.0	25.7	33.2	13.7	12.7	2.4	24.0	14.9	11.7	34.8	19.2	0.6	8.1	3.4	11.4	3.1	0.8	2.8	41.1	29.8	11.8	7.2	19.1	61.6	15.3	55.9	61.1	31.4	29.4	14.1	29.9	2.1	21.1	38.4	17.6	5.0	39.5	60.9	2.0	5.1	2.2	20.7	12.2	38.7	1.6	4.8	47.4	23.5	30.9	35.2	42.7	4.3	14.0	65.3	4.0	1.6	1.0	1.7	9.6	1.4	21.3	7.1	51.0	11.8	1.6	2.4	14.9	17.9	13.6	14.5	3.0	73.4	24.0	23.1	45.3	25.6	4.5	6.9	2.3	39.8	2.7	16.3	1.4	11.4	2.2	0.6	6.1	0.3	0.1	0.3	0.8	8.1	0.6	0.1	0.6	3.4	3.1	2.6	2.7	0.4	2.8	14.7	13.6	20.9	14.4	12.5	10.1	19.2	12.9	15.8	12.7
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 126.7;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 15.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.5"	"Group enriched"	"Detected in many"	7	"B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"		22000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.6	0.3	46.3	0.3	0.0	0.4	0.3	0.3	0.4	57.4	0.1	0.1	30.4	0.3	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.5	0.4	1.4	30.0	0.3	0.1	0.4	0.4	0.0	0.4	0.9	0.1	0.4	52.2	0.2	0.8	0.1	0.3	0.5	126.7	1.7	0.4	5.2	0.8	0.4	0.1	1.9	0.5	0.5	5.4	5.0	0.4	2.7	0.4	4.5	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	15.2	3.6	0.0	0.0	0.0	0.0	0.0	2.0	4.5	0.0	2.1	0.0	2.7	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Uncertain		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: "	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	60.9	15.1	3.7	71.0	24.8	12.3	8.1	0.0	0.0	0.0	4.9	22.5	1.3	0.8	3.6	21.7	0.0	22.6	0.0	7.4	0.0	11.7	2.8	0.0	16.9	0.0	49.0	44.6	5.0	1.2	0.0	36.4	0.0	0.3	0.0	4.0	2.8	0.0	28.1	0.2	41.6	4.0	0.0	5.5	3.3	0.0	0.3	0.1	0.7	5.1	17.5	0.9	27.2	10.5	0.1	0.0	0.0	14.4	0.0	5.3	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4
ADAMTS12		ENSG00000151388	"ADAM metallopeptidase with thrombospondin type 1 motif 12"	P58397	5	33523535-33892192	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.3;BJ hTERT+: 15.7;hTEC/SVTERT24-B: 22.6;U-2 OS: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035973, HPA075079"	Uncertain		Approved	Nucleoli,Mitochondria	"Secreted to extracellular matrix"			Nucleoli	Mitochondria	"HPA035973: AB_10669663, HPA075079: "	"unprognostic (6.18e-3)"	"unprognostic (3.12e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.78e-3)"	"unprognostic (3.39e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.27e-7)"	"unprognostic (4.45e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.85e-2)"	"prognostic unfavourable (6.78e-4)"	13.7	5.4	0.2	2.5	0.8	0.0	17.6	0.3	1.0	6.0	3.0	2.3	2.6	0.6	13.0	4.4	1.4	3.1	5.9	1.4	0.3	0.6	2.0	2.1	9.4	4.2	1.2	0.2	4.9	8.7	1.2	0.9	5.5	2.1	6.7	1.4	2.7	4.4	4.2	4.1	2.0	1.6	9.4	6.5	0.6	1.8	5.0	0.3	0.1	2.6	4.1	1.6	4.3	7.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.9	0.4	11.7	0.0	17.3	8.3	0.0	6.0	15.7	8.0	9.8	0.0	0.0	0.0	0.0	4.2	0.4	0.3	7.9	11.2	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	6.5	0.0	22.6	5.9	0.0	0.0	0.0	12.9	0.0	0.0	0.0	2.4	0.0	0.0	13.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	17.5	0.1	3.6	2.0	1.5	0.0	12.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.3	1.0	0.3	0.6	1.2	0.2	2.1	0.3
ADAMTS13	"C9orf8, DKFZp434C2322, FLJ42993, MGC118899, MGC118900, TTP, vWF-CP, VWFCP"	ENSG00000160323	"ADAM metallopeptidase with thrombospondin type 1 motif 13"	Q76LX8	9	133414358-133459402	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 53.7"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042014, HPA042844, HPA052077"	Approved		Approved	Vesicles	"Secreted to blood"	1301000000	38000000	Vesicles		"HPA042014: , HPA042844: , HPA052077: "	"unprognostic (1.09e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.75e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.52e-5)"	"unprognostic (1.11e-1)"	"unprognostic (9.91e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.30e-3)"	1.4	1.0	3.1	1.4	3.7	0.5	1.4	6.6	4.2	1.4	1.4	1.4	1.4	4.1	1.6	4.0	1.4	2.1	1.5	1.7	3.4	2.2	1.8	53.7	4.8	1.4	2.1	1.4	2.3	1.8	2.2	4.2	1.7	1.6	1.6	1.1	1.6	2.5	2.0	2.6	2.9	4.4	1.4	2.0	1.4	5.5	3.8	1.4	1.4	1.7	1.4	1.4	1.7	1.4	0.3	0.0	2.3	0.0	0.0	0.5	0.1	0.0	1.4	3.4	4.7	2.7	2.5	1.2	1.1	0.9	0.5	0.7	0.5	3.7	0.4	1.5	0.8	0.6	0.3	0.6	0.1	2.0	3.1	0.4	1.4	0.7	2.0	0.1	1.1	6.6	1.7	0.5	1.3	0.3	0.1	1.4	0.5	5.6	0.1	1.5	3.6	2.0	0.4	0.4	1.6	1.5	1.4	2.2	6.9	2.4	1.3	1.8	5.9	0.6	0.8	2.5	1.4	1.6	0.0	2.5	0.6	0.5	2.1	0.4	2.8	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.1	3.7	6.6	4.2	3.4	2.2	2.1	1.4	1.6	1.4
ADAMTS14		ENSG00000138316	"ADAM metallopeptidase with thrombospondin type 1 motif 14"	Q8WXS8	10	70672803-70762441	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;gallbladder: 12.3;placenta: 13.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;K-562: 11.4;RH-30: 6.2;U-138 MG: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.1"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.4"	"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.98e-3)"	"unprognostic (3.54e-3)"	"unprognostic (2.17e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.98e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.84e-13)"	"unprognostic (3.90e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.16e-2)"	1.7	0.5	4.6	5.4	10.7	1.1	0.6	1.0	4.7	1.3	3.3	13.4	1.0	4.1	1.4	1.0	1.8	1.1	12.3	2.8	7.2	3.0	0.7	0.5	2.7	2.0	8.1	5.7	0.7	0.5	0.2	0.4	13.5	4.0	1.1	3.6	2.6	1.6	0.4	0.4	2.5	5.7	3.9	4.6	0.8	2.6	0.9	5.9	0.5	0.4	2.3	2.3	6.7	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	4.7	0.0	1.2	3.6	0.3	2.0	0.0	10.2	0.0	0.8	1.8	0.8	0.0	0.0	0.1	3.9	0.0	0.4	0.0	0.3	0.0	0.0	2.7	0.4	0.1	0.9	0.2	0.0	11.4	0.0	1.4	0.0	0.0	1.0	0.4	0.0	0.0	6.2	0.2	0.0	0.0	3.9	0.6	0.0	0.1	0.3	0.0	0.0	0.0	10.3	0.1	0.8	0.5	0.9	0.0	0.0	0.5	1.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	10.7	1.0	4.7	7.2	3.0	8.1	5.7	4.0	5.9
ADAMTS2	"ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP"	ENSG00000087116	"ADAM metallopeptidase with thrombospondin type 1 motif 2"	O95450	5	179110851-179345430	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.7;ASC TERT1: 13.7;BJ: 12.1;fHDF/TERT166: 14.2;HHSteC: 44.5;HSkMC: 35.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA028363, HPA028444"	Uncertain		Approved	"Vesicles,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	Vesicles	"HPA028363: , HPA028444: AB_10601964"	"unprognostic (6.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (8.85e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (1.71e-8)"	"unprognostic (1.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.48e-2)"	24.2	4.3	0.9	5.8	0.7	0.7	29.1	0.9	2.3	16.3	10.1	0.4	3.9	2.7	12.0	9.5	6.0	7.2	9.5	10.1	0.7	1.2	4.2	7.4	13.1	25.9	1.0	1.3	6.3	2.7	1.0	8.7	15.1	2.4	6.0	2.6	3.8	2.5	3.8	3.8	4.6	4.6	13.8	0.7	16.5	4.2	4.3	0.5	0.8	3.2	5.9	1.2	8.8	14.7	1.4	1.3	2.1	0.3	0.8	0.6	0.1	0.0	0.0	0.0	0.3	13.7	13.7	0.0	12.1	2.0	4.6	4.9	0.0	0.0	0.0	0.1	14.2	0.0	0.7	0.0	2.0	0.0	0.6	0.0	0.0	0.9	44.5	0.0	0.0	35.5	0.0	1.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.5	0.0	0.0	0.1	0.0	3.9	0.0	7.7	1.2	10.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	1.5	0.3	0.4	0.6	0.2	0.3	0.6	0.5	0.4	1.3	1.4	0.5	0.5	2.1	0.8	0.1	0.8	0.5	0.1	0.9	0.7	0.9	2.3	0.7	1.2	1.0	1.3	2.4	0.5
ADAMTS7	"ADAM-TS7, DKFZp434H204"	ENSG00000136378	"ADAM metallopeptidase with thrombospondin type 1 motif 7"	Q9UKP4	15	78759203-78811431	"Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 31.9"	"Cell line enriched"	"Detected in some"	9	"HMC-1: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA045284, HPA048453"	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA045284: , HPA048453: "	"unprognostic (5.94e-3)"	"unprognostic (9.94e-3)"	"unprognostic (2.76e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.88e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.53e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.86e-2)"	6.0	4.1	0.7	4.1	2.5	0.3	2.8	1.5	1.8	4.3	2.9	1.7	1.4	2.2	8.6	1.9	2.2	1.6	9.9	31.9	1.7	0.6	1.5	0.8	5.3	3.2	1.2	0.7	8.7	1.0	0.4	0.7	4.0	2.3	1.5	0.6	4.4	0.9	1.1	1.8	1.4	2.8	4.5	1.3	4.1	1.7	3.5	2.6	0.3	1.6	1.1	1.4	3.1	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.8	2.1	2.0	2.4	6.1	1.0	0.3	0.3	0.1	0.0	0.0	0.0	1.4	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.5	0.1	0.0	2.0	0.0	76.1	0.9	0.6	0.5	0.3	6.9	0.0	0.2	1.6	0.0	0.0	1.3	1.3	0.4	4.8	2.2	0.0	0.1	0.2	0.0	7.0	1.3	0.0	0.1	0.9	0.1	8.5	2.8	0.3	0.9	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	2.5	1.5	1.8	1.7	0.6	1.2	0.7	2.3	2.6
ADAMTS8	"ADAM-TS8, FLJ41712, METH2"	ENSG00000134917	"ADAM metallopeptidase with thrombospondin type 1 motif 8"	Q9UP79	11	130404925-130428993	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 13.0;lung: 21.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.9;HMC-1: 5.7;NTERA-2: 2.8;U-2 OS: 12.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 5.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 6.4;cerebral cortex: 7.6;hippocampal formation: 7.3;olfactory region: 5.2"	HPA066349	Approved				"Secreted to extracellular matrix"		2200000			"HPA066349: "	"unprognostic (4.76e-6)"	"unprognostic (3.92e-2)"	"unprognostic (6.13e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.09e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.03e-3)"	"unprognostic (5.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-1)"	2.1	0.1	1.5	10.2	2.5	0.0	0.5	0.6	4.4	1.3	5.3	0.5	0.2	1.1	2.6	1.5	3.1	1.7	13.0	3.9	1.6	0.6	2.1	0.2	21.0	0.2	0.7	0.2	1.0	0.7	0.0	0.8	2.7	0.9	2.9	0.5	0.7	0.3	5.7	0.4	0.1	1.6	7.4	0.8	0.9	5.6	0.2	0.4	0.2	0.4	0.2	0.4	3.8	3.4	0.0	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.8	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.5	0.6	3.2	1.6	0.6	0.7	0.2	0.9	0.4
ADAMTS9	KIAA1312	ENSG00000163638	"ADAM metallopeptidase with thrombospondin type 1 motif 9"	Q9P2N4	3	64515654-64688000	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 51.4"	"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028567, HPA028577, HPA028601"	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	"Endoplasmic reticulum"	"HPA028567: AB_10599275, HPA028577: AB_10600330, HPA028601: "	"unprognostic (2.21e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.80e-3)"	"unprognostic (5.85e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.46e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.00e-3)"	51.4	4.7	5.6	12.0	11.5	0.5	15.2	3.9	8.0	10.4	10.4	2.8	7.2	1.6	13.9	5.6	6.8	7.7	8.2	29.6	5.7	2.7	9.0	3.1	11.5	7.7	6.8	0.3	17.4	9.9	17.2	2.4	30.5	12.4	7.4	3.2	0.7	3.5	4.3	10.8	2.6	3.2	12.2	12.6	4.4	4.6	3.1	5.9	0.0	6.4	3.7	1.6	19.6	29.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	5.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	3.5	1.0	0.0	0.0	0.2	9.4	0.2	0.0	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.9	0.0	11.2	0.1	0.0	52.2	0.0	0.0	0.0	0.0	0.2	2.1	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	11.5	3.9	8.0	5.7	2.7	6.8	0.3	12.4	5.9
ADAMTSL2	KIAA0605	ENSG00000197859	"ADAMTS like 2"	Q86TH1	9	133532164-133575519	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.4;heart muscle: 36.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.8;RPMI-8226: 8.0;SH-SY5Y: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045634, HPA053812"	Approved		Approved	Vesicles	"Secreted in other tissues"		67000000	Vesicles		"HPA045634: , HPA053812: "	"unprognostic (5.10e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (6.70e-4)"	"unprognostic (5.17e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	3.6	30.4	5.5	1.8	5.4	0.7	0.9	6.4	9.3	1.6	1.6	8.8	0.9	2.4	1.9	4.9	1.8	1.8	11.0	36.4	4.7	4.0	15.1	24.8	11.3	6.8	5.7	4.9	6.9	7.9	1.4	8.6	2.6	9.9	4.3	1.1	4.5	5.4	3.8	5.5	0.9	2.6	1.8	5.1	3.5	2.3	3.2	6.8	0.0	6.5	1.3	1.3	2.2	6.0	0.3	0.2	1.0	0.2	0.4	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.8	0.6	8.0	0.0	0.0	1.2	25.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	0.7	0.3	0.8	0.4	0.0	0.2	0.0	0.3	5.5	5.4	6.4	9.3	4.7	4.0	5.7	4.9	9.9	6.8
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"CAB056157: , HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.1	30.3	26.0	32.0	26.3	27.3	31.0	18.0	36.3	60.5	52.6	26.1	25.8	47.2	29.2	28.8	25.5	33.2	34.3	30.8	45.8	16.7	24.6	21.5	14.8	28.7	34.7	27.3	26.5	25.1	31.0	31.8	31.0	23.2	36.3	21.1	32.0	41.9	17.9	43.0	22.9	40.1	21.4	37.9	20.8	29.2	25.9	30.9	31.2	50.4	37.0	33.9	42.7	28.2	21.8	21.4	17.9	20.9	43.1	47.1	50.7	21.1	22.9	24.5	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9
ADARB1	"ADAR2, ADAR2a, ADAR2a-L1, ADAR2a-L2, ADAR2a-L3, ADAR2b, ADAR2c, ADAR2d, ADAR2g, DRABA2, DRADA2, hRED1, RED1"	ENSG00000197381	"Adenosine deaminase, RNA specific B1"	P78563	21	45073853-45226560	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 59.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.3;HHSteC: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029645			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029645: AB_10602106"	"unprognostic (2.69e-1)"	"unprognostic (7.65e-2)"	"prognostic unfavourable (8.16e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (4.57e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.38e-2)"	12.2	5.3	7.1	10.4	8.4	4.5	8.9	33.1	11.6	11.7	17.2	2.5	5.6	2.9	13.4	6.6	14.0	8.8	11.1	6.7	7.3	8.1	4.6	4.0	19.9	11.8	7.4	8.1	5.3	4.7	19.0	3.7	12.0	13.6	14.7	5.0	11.0	4.6	8.7	11.8	10.8	5.9	59.9	3.5	10.5	11.7	3.8	4.0	3.9	3.8	4.5	8.4	34.6	20.3	6.1	2.1	4.8	0.6	0.5	2.6	0.5	3.1	0.4	2.4	2.9	3.0	2.1	3.3	2.1	3.5	6.7	4.3	4.9	0.5	1.0	5.7	10.3	0.3	3.6	8.7	7.5	0.7	3.2	6.8	27.3	3.2	31.7	4.6	3.3	11.3	3.8	2.4	7.1	7.1	1.5	0.4	19.6	2.3	3.0	4.4	4.0	4.7	0.9	2.3	3.1	1.5	1.0	14.4	3.8	16.7	0.7	5.3	1.6	3.7	7.4	2.2	2.7	9.0	7.8	3.1	1.4	0.8	2.0	10.9	11.9	1.3	0.2	4.8	1.1	0.6	1.8	2.4	2.6	1.6	0.0	6.1	1.8	1.4	0.2	0.5	0.3	2.1	1.6	0.5	7.1	8.4	33.1	11.6	7.3	8.1	7.4	8.1	13.6	4.0
ADCY3	AC3	ENSG00000138031	"Adenylate cyclase 3"	O60266	2	24819169-24919839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis, Olfaction, Sensory transduction"	"Calmodulin-binding, Lyase"	Obesity	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010223	Approved									"CAB010223: AB_630839"	"unprognostic (3.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.01e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.06e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (1.32e-9)"	"unprognostic (3.74e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.55e-3)"	35.8	8.2	14.4	11.7	26.0	13.2	41.2	15.0	21.7	22.5	15.1	16.5	6.5	7.6	23.3	15.6	17.4	21.4	18.2	18.2	13.7	13.1	9.5	4.6	15.3	13.7	29.6	14.1	29.5	7.7	15.4	16.2	58.6	16.3	15.1	11.7	11.3	8.7	24.9	7.9	14.8	12.3	25.1	12.4	11.7	9.8	11.3	18.2	4.3	14.4	13.9	12.8	13.5	24.2	7.2	11.0	3.2	1.8	1.1	3.1	1.2	28.0	19.3	6.3	10.6	32.0	25.5	12.2	14.1	20.7	12.3	11.3	15.6	9.7	9.8	3.2	20.6	20.6	15.4	19.2	8.6	22.3	20.5	16.0	21.2	2.0	24.3	9.1	10.1	21.3	16.3	12.3	18.7	11.3	8.0	17.2	7.2	20.1	8.8	2.1	6.8	8.4	15.6	32.9	20.3	5.3	16.8	10.2	7.5	17.6	21.0	12.1	5.4	7.6	10.8	21.6	15.5	12.5	21.2	17.9	41.6	38.3	7.0	14.4	13.4	3.2	1.8	0.0	0.6	1.8	0.3	6.4	1.4	0.5	11.0	7.2	0.7	0.6	0.0	1.1	0.4	10.1	3.1	1.2	14.4	26.0	15.0	21.7	13.7	13.1	29.6	14.1	16.3	18.2
ADCY4	AC4	ENSG00000129467	"Adenylate cyclase 4"	Q8NFM4	14	24318349-24335093	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 9.7;TIME: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005070, HPA048344"	Approved									"CAB005070: AB_2273639, HPA048344: "	"unprognostic (5.59e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-4)"	"prognostic favourable (8.20e-4)"	"unprognostic (4.06e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.75e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.87e-2)"	"prognostic unfavourable (7.01e-4)"	"unprognostic (8.02e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	15.8	2.7	2.3	4.6	2.0	1.5	14.2	1.1	2.4	13.3	4.4	1.6	6.3	1.7	16.8	10.0	6.0	7.7	10.9	10.3	1.6	1.4	6.3	2.0	14.7	8.4	2.3	1.5	3.2	2.1	4.7	1.8	17.8	2.7	4.8	2.3	5.8	3.6	8.0	6.2	4.4	3.9	7.0	1.9	9.3	3.4	2.6	1.6	0.0	7.4	7.3	3.3	5.9	12.6	0.0	1.1	5.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.9	0.4	1.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.8	0.0	0.2	0.0	9.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	4.0	0.3	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	5.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.3	2.0	1.1	2.4	1.6	1.4	2.3	1.5	2.7	1.6
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"			1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favourable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favourable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.3	15.4	36.7	18.9	54.4	40.7	13.8	31.2	37.5	32.6	27.6	22.6	23.4	9.6	16.4	53.4	11.8	27.4	26.2	27.3	12.3	12.6	27.2	13.4	21.8	26.6	16.1	19.4	40.1	24.6	28.6	11.5	40.5	28.2	23.4	37.0	10.8	49.6	22.6	20.6	21.9	22.0	20.3	11.3	23.8	40.8	22.0	28.6	22.5	9.2	19.3	21.6	15.4	48.8	26.7	13.8	21.8	25.7	18.8	15.2	12.3	25.7	20.1	25.7	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0
ADGRB1	BAI1	ENSG00000181790	"Adhesion G protein-coupled receptor B1"	O14514	8	142449430-142545009	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity, Myogenesis, Neurogenesis, Phagocytosis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 27.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 11.5;MCF7: 4.2;NB-4: 5.6;RPMI-8226: 15.9;U-2 OS: 10.9"	"Cancer enhanced"	"Detected in many"		"glioma: 11.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (9.57e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.87e-3)"	"unprognostic (8.50e-3)"	"unprognostic (9.98e-2)"	"unprognostic (5.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.30e-11)"	"unprognostic (6.27e-2)"	"unprognostic (7.42e-2)"	"unprognostic (4.52e-3)"	"unprognostic (3.29e-2)"	1.0	3.4	13.6	1.4	18.1	0.9	1.1	5.4	27.4	2.0	1.0	3.1	0.1	1.4	1.8	2.3	0.9	1.4	0.9	0.9	11.0	11.9	1.1	0.8	1.2	1.6	8.7	9.2	1.6	1.1	0.9	2.7	2.5	9.1	1.3	0.9	0.9	2.6	1.9	0.7	3.1	1.4	1.0	2.3	3.7	1.5	2.1	3.2	0.0	0.9	0.0	1.0	0.9	0.4	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	5.6	1.8	0.0	0.1	0.0	15.9	0.0	0.0	3.1	3.1	0.0	0.0	0.2	0.1	0.3	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	18.1	5.4	19.5	11.0	11.9	8.7	9.2	9.1	3.2
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635367-69389511	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 55.0;pituitary gland: 17.1"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 9.1;SH-SY5Y: 19.6"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										9200				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	2.7	8.0	20.0	2.8	22.5	1.5	2.1	46.9	55.0	3.1	3.4	6.2	0.0	2.2	5.2	3.1	2.7	2.4	3.0	3.2	17.6	15.2	2.4	2.4	3.6	1.6	9.0	22.7	4.3	1.9	1.8	17.1	1.8	9.6	2.6	3.6	1.2	3.2	3.9	1.9	1.9	3.2	6.7	10.1	2.4	1.9	4.4	11.1	0.0	2.1	0.0	1.6	2.9	1.8	0.0	2.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.0	0.0	1.2	1.0	0.0	0.0	9.1	19.6	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	20.0	22.5	46.9	25.1	17.6	15.2	9.0	22.7	9.6	11.1
ADGRF3	"GPR113, hGPCR37, PGR23"	ENSG00000173567	"Adhesion G protein-coupled receptor F3"	Q8IZF5	2	26308173-26346817	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 7.6"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 3.9;U-937: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044500	Uncertain									"HPA044500: AB_10794290"	"unprognostic (9.58e-3)"	"unprognostic (2.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.68e-4)"	"unprognostic (8.98e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.66e-4)"	"unprognostic (2.29e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.70e-5)"	0.4	0.5	0.4	1.1	0.9	1.4	0.5	2.1	1.2	1.0	1.2	0.1	0.1	2.0	0.8	0.1	0.8	0.5	0.5	1.3	3.3	0.3	3.4	0.7	2.6	1.8	0.3	0.1	0.8	3.2	0.0	0.8	0.7	1.5	0.6	0.4	0.1	2.7	2.6	0.4	0.8	0.7	0.1	1.5	1.4	0.8	2.8	0.7	2.0	0.9	0.1	0.5	0.7	7.6	1.3	0.0	2.0	0.8	0.5	1.5	0.0	0.5	0.2	0.4	1.4	0.1	0.3	2.1	0.2	0.2	0.0	0.3	0.7	0.0	2.4	1.6	0.2	0.9	0.0	0.0	0.0	0.5	0.5	1.0	1.6	0.2	0.0	0.8	1.0	0.3	0.0	0.1	0.0	0.6	0.1	1.0	0.1	0.1	3.9	1.1	2.7	0.0	2.3	2.2	1.0	0.2	3.1	1.9	0.9	0.0	1.0	0.0	0.1	0.2	0.4	0.1	0.5	0.9	0.3	1.8	1.4	2.7	0.1	3.5	0.4	0.0	0.0	2.0	1.1	0.8	0.8	1.3	0.5	0.6	0.0	0.3	0.7	1.5	0.1	0.5	0.3	0.0	1.5	0.0	0.4	0.9	2.1	1.2	3.3	0.3	0.3	0.1	1.5	0.7
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852512-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 54.6"	"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 13.1;TIME: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														23000000				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favourable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	32.6	11.9	5.0	3.4	7.1	0.2	27.5	2.1	5.8	6.6	5.3	4.2	7.0	2.9	10.4	8.9	5.9	6.7	8.5	34.3	6.4	4.9	33.6	8.7	54.6	6.1	7.3	4.7	6.5	3.3	7.0	5.2	25.1	5.9	5.5	3.1	7.5	3.5	5.0	19.4	3.8	4.0	11.1	6.1	26.2	3.8	3.1	3.0	0.1	16.1	8.8	1.7	8.1	13.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.0	7.1	2.1	5.8	6.4	4.9	7.3	4.7	5.9	3.0
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989309-19122637	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 202.4"	"Cell line enhanced"	"Detected in some"		"A549: 6.1;BEWO: 7.7;HeLa: 6.4;NTERA-2: 6.7;SH-SY5Y: 7.0;U-2197: 15.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"			7900000	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	4.4	0.3	0.4	0.9	0.2	0.2	2.8	0.1	0.2	0.8	1.0	0.1	6.6	0.2	0.5	202.4	0.9	6.9	1.4	1.8	0.6	0.6	0.7	0.9	1.7	3.1	0.2	0.2	0.9	0.9	24.8	1.9	0.6	0.3	3.2	0.2	1.6	9.6	0.8	0.6	0.3	1.4	0.6	0.2	1.2	3.5	4.7	0.2	2.7	1.8	0.6	1.9	1.1	1.5	0.1	0.2	0.9	0.6	0.0	0.2	0.0	0.2	6.1	0.0	0.0	0.1	0.9	7.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	6.4	0.2	0.9	0.0	0.0	0.1	0.1	0.0	1.2	0.0	0.0	0.2	0.0	1.0	0.0	2.3	6.7	2.0	0.0	0.1	4.4	0.0	1.2	2.3	7.0	1.5	0.1	0.0	0.1	0.1	0.1	0.2	0.4	15.3	2.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.9	0.1	0.4	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.7	0.0	0.6	0.1	0.0	0.0	0.4	0.2	0.1	0.2	0.6	0.6	0.2	0.2	0.3	0.2
ADGRG3	"GPR97, Pb99, PGR26"	ENSG00000182885	"Adhesion G protein-coupled receptor G3"	Q86Y34	16	57668187-57689378	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 42.8;bone marrow: 62.7;lymphoid tissue: 26.4"	"Group enriched"	"Detected in some"	6	"NB-4: 8.5;SK-MEL-30: 4.7;U-937: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"eosinophil: 33.3;neutrophil: 42.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 42.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040469	Uncertain									"HPA040469: AB_10794032"	"unprognostic (4.41e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-4)"	"unprognostic (5.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.67e-3)"	"unprognostic (4.75e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.90e-1)"	4.6	0.4	0.3	7.2	0.9	62.7	1.6	0.2	0.5	1.1	4.1	0.0	0.0	1.4	1.4	2.0	2.9	3.4	1.6	7.7	0.2	0.3	0.7	2.7	11.0	26.4	2.0	0.0	1.7	0.6	0.2	0.3	1.7	0.6	1.6	0.9	1.2	0.4	0.3	2.3	0.7	3.9	1.5	0.3	25.4	1.2	1.7	0.3	1.1	6.5	1.2	0.8	3.4	7.2	0.0	0.0	42.8	0.0	8.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	15.6	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.8	8.8	0.0	0.0	0.0	0.1	0.3	0.9	0.2	0.5	0.2	0.3	2.0	0.0	0.6	0.3
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416888	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"intestine: 23.6"	"Cell line enhanced"	"Detected in single"		"TIME: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035324	Uncertain									"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.9	0.0	0.0	7.1	0.7	1.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	23.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"liver: 51.9;placenta: 104.9"	"Cell line enhanced"	"Detected in many"		"A549: 25.2;Hep G2: 23.5;hTERT-HME1: 23.9;HUVEC TERT2: 46.1;MCF7: 43.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 3.5"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 3.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved						70000000			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.6	1.4	1.1	4.1	1.0	0.0	6.1	0.5	1.1	4.1	14.0	1.0	2.7	8.9	2.2	2.8	9.1	2.6	8.8	4.4	1.4	1.1	5.3	51.9	12.0	2.6	1.9	0.8	1.4	3.1	0.3	0.7	104.9	1.3	7.2	3.3	3.3	6.3	3.6	1.5	7.8	17.5	5.0	2.3	6.1	6.6	1.5	0.9	2.2	2.1	3.9	4.7	11.3	9.2	0.0	3.5	0.0	0.2	0.0	0.1	0.0	4.7	25.2	0.5	2.6	0.1	0.0	0.0	6.5	1.2	5.0	3.1	20.1	14.6	0.0	5.9	3.7	11.8	0.7	6.3	8.3	0.0	1.9	1.0	4.3	23.5	4.9	4.0	0.0	0.0	10.2	0.1	23.9	46.1	0.1	0.0	2.0	43.2	0.0	0.0	0.2	5.7	0.0	2.2	4.9	2.6	10.7	0.0	0.0	1.9	8.9	4.1	4.8	0.0	1.5	0.0	2.2	2.2	3.2	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	1.0	0.5	1.1	1.4	1.1	1.9	0.8	1.3	0.9
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5;parathyroid gland: 23.1"	"Group enriched"	"Detected in some"	4	"AF22: 29.6;EFO-21: 7.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain									"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	4.9	7.6	19.7	1.6	19.0	0.4	2.7	11.3	30.5	7.3	4.8	5.0	0.4	3.3	4.9	2.6	1.6	3.3	2.3	3.2	13.1	12.3	2.4	0.9	3.4	0.8	11.8	11.9	1.8	0.7	23.1	0.9	4.9	9.8	2.0	5.0	0.4	0.8	5.6	0.8	2.6	4.4	3.9	8.5	0.8	3.9	4.8	6.1	0.0	0.9	0.6	0.6	2.2	2.9	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.7	0.0	0.0	4.1	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.3	0.0	0.0	0.7	0.0	2.8	0.1	0.1	0.0	3.2	0.1	0.0	4.5	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.1	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	19.7	19.0	11.3	23.3	13.1	12.3	11.8	11.9	9.8	6.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79006718	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.9"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 63.2;TIME: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported						1800000			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	98.9	4.7	3.6	5.6	5.7	0.0	43.8	3.2	6.1	14.6	7.8	1.5	6.6	2.8	12.9	7.1	12.4	6.8	12.3	12.3	4.3	3.7	11.3	8.8	16.2	8.5	5.4	1.4	9.3	3.0	5.7	7.8	12.8	6.2	12.2	3.6	5.9	4.8	5.7	16.1	5.3	4.8	16.0	4.7	34.8	4.9	6.8	4.3	1.1	13.9	8.0	3.9	16.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	1.6	5.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	3.8	0.0	10.9	0.0	63.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	77.1	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.7	3.2	6.1	4.3	3.7	5.4	1.4	6.2	4.3
ADH1A	ADH1	ENSG00000187758	"Alcohol dehydrogenase 1A (class I), alpha polypeptide"	P07327	4	99276367-99291028	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	322	"liver: 250.3"	"Cell line enriched"	"Detected in some"	5	"ASC diff: 10.9"	"Cancer enriched"	"Detected in some"	251	"liver cancer: 165.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009562, HPA047814, HPA060902"	Enhanced		Approved	"Plasma membrane,Cytosol"			12000000	"Plasma membrane, Cytosol"		"CAB009562: AB_2257984, HPA047814: , HPA060902: "	"unprognostic (5.89e-2)"	"unprognostic (6.16e-2)"		"unprognostic (1.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (2.78e-3)"		"unprognostic (4.25e-1)"	"unprognostic (4.79e-3)"	"unprognostic (6.21e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.40e-1)"		"unprognostic (2.86e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	250.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
ADH1B	ADH2	ENSG00000196616	"Alcohol dehydrogenase 1B (class I), beta polypeptide"	P00325	4	99304964-99352760	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 253.5;liver: 466.3"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 385.0"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 223.1"	"Group enriched"	"Detected in some"	5	"midbrain: 2.3;pons and medulla: 1.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"											"HPA047814, HPA060902"	Supported		Approved	"Plasma membrane,Cytosol"			16000000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (5.13e-2)"	"unprognostic (9.80e-3)"	"unprognostic (6.59e-2)"	"unprognostic (5.56e-2)"	"unprognostic (9.49e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.73e-2)"	"unprognostic (7.47e-3)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.33e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.60e-2)"	253.5	12.3	0.2	21.8	0.0	0.4	78.7	0.2	0.4	18.3	60.0	0.4	5.7	3.5	12.8	14.4	33.5	22.3	31.9	24.2	0.3	0.0	9.2	466.3	43.8	17.5	2.3	0.1	18.0	8.7	0.8	5.3	0.9	1.6	30.7	10.1	2.3	11.2	3.9	20.5	11.9	25.4	30.8	2.4	5.9	10.9	18.0	0.2	0.2	16.1	9.7	2.0	42.3	76.0	0.6	0.2	1.2	0.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	385.0	56.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.3	0.2	0.1	0.1	0.2	0.4	0.1	0.0	0.6	0.3	0.4	1.2	0.8	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.3	0.0	2.3	0.1	1.6	0.2
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.1;HSkMC: 15.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"HPA047814: , HPA060902: "	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.55e-4)"	"prognostic favourable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.1	1.7	5.1	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.5	1.4	0.3	15.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.9	0.4	0.1	0.1	0.9	2.1	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1										
ADH4	ADH-2	ENSG00000198099	"Alcohol dehydrogenase 4 (class II), pi polypeptide"	P08319	4	99123657-99157792	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 345.2"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 21.9"	"Cancer enriched"	"Detected in some"	60	"liver cancer: 230.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020525	Enhanced		Uncertain	Nucleoplasm,Cytosol			5300000	"Nucleoplasm, Cytosol"		"HPA020525: AB_1844609"	"unprognostic (2.75e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.33e-2)"	"prognostic favourable (7.08e-6)"	"unprognostic (1.49e-1)"		"unprognostic (1.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.20e-1)"		"unprognostic (5.89e-3)"	0.3	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	3.6	0.0	0.1	11.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	345.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.1	4.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.1	0.1	0.5	1.2	0.7	2.8	0.5	0.4	0.9	0.1	0.3	0.3	0.2	0.3	0.4	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.2	0.5	0.3	0.0	0.3	0.0	0.2	0.4	0.2	0.1	0.5	0.8	21.9	0.1	1.8	0.5	0.3	0.0	0.2	0.2	0.1	0.4	1.0	0.1	0.3	0.3	0.6	0.3	0.2	0.2	1.8	0.5	0.2	0.4	0.2	0.3	2.0	0.3	0.0	0.5	0.0	0.4	0.5	0.2	0.4	0.1	0.6	0.4	0.7	0.1	0.7	0.1	2.8	0.4	0.5	0.9	0.5	0.8	0.4	0.5	0.5	0.1	1.2	0.8	0.8	1.0	0.4	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0
ADH5	"ADH-3, ADHX, FDH, GSNOR"	ENSG00000197894	"Alcohol dehydrogenase 5 (class III), chi polypeptide"	P11766	4	99070978-99088801	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044578, HPA061919"	Approved						6800000			"HPA044578: , HPA061919: AB_2684638"	"unprognostic (1.05e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.14e-3)"	"prognostic favourable (9.90e-5)"	"unprognostic (2.63e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.48e-2)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (4.58e-10)"	"unprognostic (1.79e-3)"	"unprognostic (9.05e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-1)"	35.6	19.8	17.3	18.5	18.5	6.3	28.6	11.2	22.3	34.1	39.4	19.8	17.0	24.9	53.8	40.3	43.5	28.6	20.8	31.9	13.7	16.6	46.6	69.7	19.9	15.3	15.7	16.1	39.1	12.8	10.5	15.1	19.9	18.6	45.0	27.7	28.7	17.3	35.9	20.7	13.8	28.5	43.6	13.5	20.5	27.0	27.2	10.0	35.2	30.4	18.4	18.6	60.0	22.0	13.9	12.5	18.2	11.1	26.2	25.3	17.0	15.7	12.9	38.1	21.4	69.2	64.4	22.9	26.2	46.3	28.5	24.9	14.7	18.7	18.2	15.3	37.8	13.5	26.2	36.4	27.5	13.1	11.0	12.6	17.5	57.9	67.1	22.0	10.3	57.9	28.3	21.3	16.9	21.9	23.3	10.4	37.5	17.9	29.6	19.8	30.6	15.5	21.7	21.3	9.6	45.0	18.4	14.6	19.1	15.8	18.8	28.6	15.2	15.5	16.4	26.0	16.5	16.9	18.0	11.0	13.6	25.3	26.7	14.6	26.3	9.8	11.1	18.2	18.4	9.8	16.7	13.9	20.3	17.1	12.5	13.1	19.9	18.3	1.6	26.2	7.1	10.8	25.3	17.0	17.3	18.5	11.2	22.3	13.7	16.6	15.7	16.1	18.6	10.0
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell line enriched"	"Detected in single"	670	"ASC diff: 84.1"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	11285000000	1000000000			"CAB046467: AB_1078104, HPA051767: "	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	84.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIRF	"AFRO, APM2, C10orf116"	ENSG00000148671	"Adipogenesis regulatory factor"	Q15847	10	86968192-86983934	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 25.2;HaCaT: 65.1;PC-3: 35.5;RT4: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.9;naive CD8 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 3.9"					"Low region specificity"	"Detected in many"			HPA026810	Approved		Supported	Nucleoplasm,Cytosol			580000	"Nucleoplasm, Cytosol"		"HPA026810: "																		123.4	9.5	15.7	21.4	6.1	1.5	109.7	1.6	8.4	44.3	65.3	6.8	21.6	66.2	25.3	34.6	24.3	34.7	29.9	24.8	17.3	6.1	20.3	10.3	32.5	5.4	10.5	9.3	54.7	12.6	7.2	11.7	8.7	7.2	38.6	7.0	23.6	41.5	38.8	30.5	23.7	69.5	19.8	9.6	10.0	12.2	12.5	9.9	1.2	29.7	38.6	8.3	39.5	41.6	0.0	0.3	0.0	0.3	0.0	3.9	0.6	25.2	0.3	0.0	0.0	2.1	12.4	1.7	8.8	9.5	0.0	0.0	0.9	3.2	0.0	0.3	10.8	65.1	0.0	2.1	0.1	0.9	0.0	0.0	2.7	0.2	1.2	0.0	0.4	0.3	4.1	0.0	5.8	3.6	0.1	3.5	0.3	3.1	0.1	0.6	0.1	35.5	0.1	0.0	0.3	0.4	45.2	1.6	0.1	3.0	13.5	0.1	16.7	0.3	9.6	0.3	2.0	1.7	0.0	0.5	0.4	0.0	0.7	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.3	0.0	3.9	2.8	0.0	0.0	0.0	0.0	0.2	0.6	15.7	6.1	1.6	7.9	17.3	6.1	10.5	9.3	7.2	9.9
ADM	AM	ENSG00000148926	Adrenomedullin	P35318	11	10304680-10307397	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 133.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 107.9;fHDF/TERT166: 53.9;HSkMC: 65.9;U-138 MG: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 62.3"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016075	Approved				"Secreted to blood"	31000	46000			"CAB016075: AB_628693"	"unprognostic (1.67e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.55e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (1.78e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.83e-1)"	"unprognostic (8.13e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (9.70e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.62e-2)"	65.2	18.3	6.8	18.3	12.4	21.1	52.1	2.5	15.0	28.3	23.3	5.9	1.6	4.8	11.6	8.0	26.5	7.9	18.7	28.3	4.7	3.5	17.3	26.1	34.3	15.2	8.0	2.0	19.0	16.0	10.8	8.4	133.1	14.2	13.8	7.0	23.5	9.6	2.1	92.3	28.7	8.0	11.8	12.7	14.6	10.7	11.6	9.9	0.3	15.9	13.3	10.1	76.1	32.4	0.1	0.6	62.3	3.2	0.0	0.0	0.4	5.3	4.2	5.1	1.4	107.9	46.3	8.0	40.8	38.2	38.6	26.6	21.4	6.5	0.0	1.8	53.9	7.6	1.4	6.3	32.5	0.1	1.6	0.1	2.0	2.5	13.7	0.2	0.1	65.9	5.1	4.4	7.1	8.7	0.0	0.0	9.6	0.1	0.0	1.2	9.6	1.6	0.1	0.1	7.6	2.3	7.3	0.1	0.4	15.5	3.4	0.0	4.7	0.0	2.5	56.8	0.8	35.5	5.9	0.4	4.3	1.4	17.0	0.0	16.9	0.0	1.7	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	62.3	0.0	3.2	0.0	0.0	0.4	6.8	12.4	2.5	15.0	4.7	3.5	8.0	2.0	14.2	9.9
ADRA1B		ENSG00000170214	"Adrenoceptor alpha 1B"	P35368	5	159865080-159972544	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.6;liver: 20.3;lymphoid tissue: 17.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074416			Supported	"Plasma membrane"				"Plasma membrane"		"HPA074416: "	"unprognostic (4.93e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.00e-5)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (4.08e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.68e-1)"	"unprognostic (6.12e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (1.40e-6)"	"unprognostic (5.24e-4)"	"unprognostic (2.54e-1)"	"prognostic favourable (3.19e-5)"	"unprognostic (1.59e-2)"	5.3	2.9	5.3	0.9	9.0	0.4	2.3	1.3	21.6	0.9	1.2	0.7	0.8	1.2	1.5	3.6	1.1	3.6	1.3	3.3	6.2	5.8	7.4	20.3	4.7	2.3	1.2	13.9	6.2	0.8	1.0	0.8	1.1	5.2	1.6	1.1	0.9	1.0	1.9	1.6	1.3	1.7	1.2	0.9	17.4	0.9	0.8	0.5	0.0	2.0	0.0	1.1	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.3	0.0	2.4	0.9	0.1	0.5	0.2	0.6	0.3	0.0	4.2	0.0	13.0	3.8	6.6	0.0	0.5	0.3	0.0	0.3	0.0	1.6	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.6	0.0	0.7	0.0	4.5	0.0	0.4	0.0	0.0	0.3	0.4	0.1	0.0	11.0	0.1	9.2	0.0	7.0	0.0	0.0	0.0	3.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	9.0	1.3	21.6	6.2	5.8	1.2	13.9	5.2	0.5
ADRA1D	"ADRA1, ADRA1A, ADRA1R"	ENSG00000171873	"Adrenoceptor alpha 1D"	P25100	20	4220631-4249074	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 17.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;BJ: 11.7;CAPAN-2: 5.3;fHDF/TERT166: 6.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.4;hippocampal formation: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 23.5;hippocampal formation: 31.8;olfactory region: 11.0"	"Low region specificity"	"Detected in many"			HPA038789	Uncertain									"HPA038789: AB_10673475"	"unprognostic (5.37e-2)"	"unprognostic (4.65e-1)"	"unprognostic (8.73e-2)"	"unprognostic (7.75e-11)"	"unprognostic (7.83e-3)"	"unprognostic (1.54e-2)"	"unprognostic (7.62e-2)"	"unprognostic (7.82e-4)"	"unprognostic (4.41e-3)"	"unprognostic (8.37e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.71e-7)"	"unprognostic (5.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.32e-5)"	2.5	1.1	1.9	0.5	2.8	0.3	1.0	0.1	7.4	9.1	2.4	1.4	1.1	0.6	4.7	1.8	0.9	3.5	1.2	0.4	17.7	1.7	0.5	0.4	2.9	1.5	0.5	1.1	1.0	1.2	0.4	0.0	0.7	2.9	8.8	1.0	0.0	0.8	6.0	1.2	0.4	0.8	1.6	0.5	3.6	2.5	1.5	0.0	0.0	0.9	0.0	0.4	3.3	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.0	0.0	0.0	0.0	11.7	2.1	0.8	0.2	0.5	5.3	0.0	0.0	6.9	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.8	0.1	7.4	17.7	1.7	0.5	1.1	2.9	0.0
ADSS		ENSG00000035687	"Adenylosuccinate synthase"	P30520	1	244408494-244452134	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024400	Supported		Supported	"Plasma membrane,Cytosol"			620000	Cytosol	"Plasma membrane"	"HPA024400: AB_1844623"	"unprognostic (4.24e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-2)"	19.4	17.8	23.2	23.8	31.2	29.2	26.3	18.3	26.3	20.9	20.9	35.9	27.1	21.1	18.9	23.3	27.7	18.3	15.8	9.8	24.9	23.4	25.1	19.3	19.2	21.2	42.5	16.6	20.9	21.2	26.6	17.7	21.0	34.9	19.8	22.7	13.1	25.0	21.7	11.0	26.5	23.2	22.9	29.3	24.9	24.7	48.9	36.7	26.7	26.3	17.9	24.8	26.5	21.8	10.9	13.6	24.6	21.3	15.5	16.0	11.9	25.4	14.1	12.3	10.8	14.4	20.7	22.7	25.8	21.7	18.5	14.1	18.5	24.7	22.8	17.1	19.8	19.3	13.4	16.8	20.8	16.9	23.7	15.2	14.1	14.0	17.4	35.8	19.6	14.1	20.4	17.2	17.5	66.0	26.3	17.0	18.4	6.1	23.0	24.1	32.7	15.6	21.3	11.7	24.6	30.7	15.9	16.7	14.7	21.9	20.4	25.7	14.1	19.1	28.8	17.2	9.4	19.8	26.7	20.6	27.0	17.2	14.2	42.1	25.3	24.6	15.8	13.0	15.0	20.5	16.0	10.9	13.7	12.8	13.6	8.6	11.8	13.3	11.9	15.5	21.3	5.5	14.7	11.9	23.2	31.2	18.3	26.3	24.9	23.4	42.5	16.6	34.9	36.7
ADSSL1	FLJ38602	ENSG00000185100	"Adenylosuccinate synthase like 1"	Q8N142	14	104724186-104747325	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 200.5;tongue: 53.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 12.7;MCF7: 11.3;SiHa: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										220000				"unprognostic (2.23e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.72e-3)"	"unprognostic (5.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (2.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.78e-2)"	2.5	1.1	0.8	0.5	1.8	0.4	0.9	0.3	1.2	0.8	0.7	3.4	0.3	0.8	0.9	3.5	3.9	1.5	2.2	27.8	1.2	1.5	2.9	7.2	0.7	0.5	3.3	0.4	0.8	1.7	1.9	2.2	1.6	2.0	1.9	0.6	4.6	3.2	1.1	200.5	1.3	0.8	1.0	2.1	0.5	1.2	3.4	2.0	0.0	1.7	53.2	2.8	6.1	3.8	0.0	0.4	1.2	2.1	0.0	0.5	0.0	0.1	2.6	2.0	5.8	1.4	0.9	0.6	0.7	1.1	0.2	0.6	0.2	2.0	0.0	12.7	0.6	1.0	0.2	0.4	0.5	0.8	0.4	0.0	6.2	0.9	1.5	0.0	5.0	2.8	1.9	0.0	2.1	0.4	2.3	0.1	1.0	11.3	0.0	0.6	1.7	1.1	0.1	0.3	0.7	0.4	1.4	1.7	3.5	19.0	0.8	2.5	5.9	1.6	0.6	0.1	0.5	1.3	0.0	3.7	2.7	0.0	1.8	0.8	1.2	0.0	0.1	1.2	0.5	2.1	0.0	0.0	0.1	0.4	0.4	0.0	0.4	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.8	1.8	0.3	1.2	1.2	1.5	3.3	0.4	2.0	2.0
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: "	"prognostic unfavourable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	17.0	7.4	14.9	13.0	17.2	1.8	23.5	17.8	19.3	19.6	26.3	16.1	25.5	22.2	15.8	17.7	59.5	27.9	18.2	13.9	15.6	7.2	20.6	29.3	26.3	5.1	17.1	12.5	16.2	29.7	16.4	27.4	18.7	16.1	20.9	27.2	15.3	38.6	18.6	12.7	24.8	42.3	17.4	13.0	13.5	21.1	16.3	15.2	2.1	25.7	13.7	24.5	16.3	27.9	3.5	0.6	2.9	0.5	0.0	1.2	0.0	19.4	6.1	42.4	15.1	4.1	3.5	31.6	7.9	4.0	6.8	8.5	25.9	12.1	3.4	14.7	4.7	9.4	17.6	16.2	12.3	21.9	18.2	0.1	2.6	19.6	6.2	2.1	9.3	2.4	10.9	11.5	27.1	12.6	38.9	13.6	4.4	8.3	0.2	0.1	10.4	2.8	12.5	11.1	14.7	12.5	9.5	19.7	12.0	8.0	30.5	12.0	3.6	0.8	18.5	3.2	15.4	13.7	13.0	0.2	16.5	7.1	9.5	4.5	27.8	0.0	0.5	0.0	1.0	0.5	0.6	3.5	1.2	0.4	0.6	2.7	0.0	0.5	2.9	0.0	0.3	0.0	0.6	0.0	14.9	17.2	17.8	19.3	15.6	7.2	17.1	12.5	16.1	15.2
AFF2	"FMR2, FRAXE"	ENSG00000155966	"AF4/FMR2 family member 2"	P51816	X	148500619-149000663	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.6;brain: 13.6;epididymis: 15.1;pituitary gland: 17.4;placenta: 17.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 29.6;HL-60: 12.5;U-698: 43.2;U-937: 9.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"basophil: 1.7;eosinophil: 2.5;neutrophil: 4.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003139	Approved									"HPA003139: AB_1078107"	"unprognostic (5.68e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.00e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.80e-2)"	"unprognostic (9.78e-5)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.34e-2)"	1.9	0.6	4.2	5.3	3.7	13.6	1.1	13.6	5.9	4.8	0.4	0.2	1.2	0.2	0.8	15.1	0.5	0.6	2.9	1.3	10.7	5.2	0.7	0.3	3.6	6.3	2.3	5.9	2.0	0.5	0.2	17.4	17.4	3.9	1.0	0.3	0.2	0.8	2.1	0.4	1.3	0.5	0.3	2.4	0.8	0.4	2.8	0.0	5.5	1.1	0.0	7.3	1.0	0.7	0.1	0.0	4.5	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.6	0.0	1.7	0.0	4.6	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	12.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.6	3.8	1.1	0.0	3.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.5	0.0	1.3	0.1	0.1	43.2	0.0	9.2	0.0	1.7	0.1	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	4.2	3.7	13.6	5.9	10.7	5.2	2.3	5.9	3.9	0.0
AFG3L2	"SCA28, SPAX5"	ENSG00000141385	"AFG3 like matrix AAA peptidase subunit 2"	Q9Y4W6	18	12328944-12377314	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004479, HPA004480"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA004479: AB_1078109, HPA004480: AB_1078108"	"unprognostic (1.11e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (1.31e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.00e-2)"	"prognostic favourable (6.05e-14)"	"unprognostic (5.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.22e-1)"	11.5	15.8	11.8	14.3	14.0	11.7	19.9	17.2	30.3	11.2	25.7	9.5	12.7	33.1	11.4	10.1	18.3	10.4	11.2	77.4	13.2	13.1	27.2	22.9	16.3	23.7	12.0	13.2	12.0	23.1	34.3	12.6	9.9	16.9	10.8	23.5	12.2	14.9	14.8	61.0	17.5	35.0	15.1	14.0	9.9	16.0	8.9	7.1	10.7	16.9	22.4	13.2	14.0	11.6	10.1	15.8	8.5	12.3	19.9	15.2	8.4	16.9	17.4	12.4	14.0	14.4	15.7	16.6	19.0	19.0	27.3	20.0	26.9	10.5	48.9	21.0	17.3	17.1	31.4	21.9	22.3	11.4	13.4	14.6	19.0	25.1	19.7	55.1	22.0	17.4	24.0	25.8	34.2	19.8	32.9	29.0	13.3	26.9	19.7	16.9	17.3	12.8	22.2	39.3	40.8	23.4	37.8	23.2	16.2	29.9	32.4	26.7	14.9	25.0	15.0	32.5	28.0	30.9	24.8	20.4	23.5	31.4	17.8	21.7	14.9	2.6	11.5	8.5	8.7	12.3	10.7	10.1	10.4	13.7	15.8	7.7	13.3	15.2	0.8	19.9	10.8	8.1	6.4	8.4	11.8	14.0	17.2	30.3	13.2	13.1	12.0	13.2	16.9	7.1
AFM	"ALB2, ALBA"	ENSG00000079557	Afamin	P43652	4	73481683-73504001	"Plasma proteins, Predicted secreted proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 169.0"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 5.8"	"Cancer enriched"	"Detected in single"	167	"liver cancer: 62.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA017006, HPA052437"	Enhanced				"Secreted to blood"	54865000000	5000000000			"HPA017006: AB_1844635, HPA052437: AB_2732575"							"prognostic favourable (1.80e-4)"				"unprognostic (5.73e-2)"		"unprognostic (4.24e-2)"					0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	169.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AFP	"FETA, HPAFP"	ENSG00000081051	"Alpha fetoprotein"	P02771	4	73431138-73456174	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"heart muscle: 4.3;liver: 9.6;lung: 2.9"	"Cell line enriched"	"Detected in some"	190	"Hep G2: 214.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 208.8;testis cancer: 49.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Not detected"	"Not detected"			"HPA010607, HPA023600, CAB024283, CAB025339"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	6000000	930000	"Golgi apparatus"	Cytosol	"CAB024283: AB_2650473, CAB025339: , HPA010607: AB_1078141, HPA023600: AB_1844769"	"unprognostic (4.69e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.54e-1)"		"unprognostic (3.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-6)"	"unprognostic (1.98e-2)"	"unprognostic (5.80e-2)"		"unprognostic (1.14e-1)"	0.0	0.4	0.1	0.0	1.0	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.3	0.3	0.0	0.0	9.6	2.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0
AGA	ASRG	ENSG00000038002	Aspartylglucosaminidase	P20933	4	177430770-177442503	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 31.5;Karpas-707: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031415, HPA031417"	Enhanced				"Intracellular and membrane"		28000000			"HPA031415: AB_10603578, HPA031417: AB_10670967"	"unprognostic (8.76e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.11e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (8.61e-4)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (3.79e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.49e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.47e-2)"	12.8	15.1	11.2	11.2	11.9	10.9	18.5	4.4	13.7	13.5	12.1	24.2	8.0	8.0	9.8	26.4	18.8	7.1	15.1	8.4	13.0	9.4	20.5	26.5	12.4	12.3	14.0	11.0	10.2	14.7	19.2	9.0	9.3	15.0	10.1	11.1	24.0	27.1	10.8	6.7	16.9	14.4	8.1	22.3	14.9	13.0	13.3	10.0	13.4	14.0	14.3	18.3	9.0	10.2	10.0	11.1	16.3	23.8	8.9	16.3	10.3	2.0	4.6	5.3	7.6	6.3	5.6	3.6	15.5	31.5	8.0	10.2	2.4	10.3	10.3	2.9	11.9	2.5	4.5	5.1	16.3	6.6	2.9	4.3	5.1	6.7	4.1	7.5	3.0	4.0	8.9	5.9	2.7	7.6	3.8	44.6	3.3	5.7	6.0	4.7	2.0	4.8	1.9	2.2	1.5	8.5	5.2	2.9	6.7	4.6	4.0	12.3	9.1	15.4	2.3	5.6	5.0	2.6	5.9	8.6	6.6	5.5	9.0	8.5	6.2	15.0	10.7	16.3	11.7	18.9	13.4	10.0	12.8	14.0	10.5	8.1	11.4	16.3	2.4	8.9	23.8	11.1	12.0	10.3	11.2	11.9	4.4	13.7	13.0	9.4	14.0	11.0	15.0	10.0
AGAP1	"CENTG2, GGAP1, KIAA1099"	ENSG00000157985	"ArfGAP with GTPase domain, ankyrin repeat and PH domain 1"	Q9UPQ3	2	235494089-236131800	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1;MAIT T-cell: 4.2"	"Lineage enriched"	"Detected in single"	42	"T-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051405	Uncertain									"HPA051405: "	"unprognostic (1.69e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (1.36e-1)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (6.52e-5)"	"unprognostic (5.56e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.32e-2)"	5.7	6.1	28.3	4.1	28.0	2.2	10.3	16.5	29.6	7.8	13.4	31.7	8.2	8.5	6.6	11.3	8.4	8.6	7.0	7.2	25.6	20.6	9.7	3.4	6.9	2.2	29.3	15.1	7.5	8.1	9.3	6.5	8.2	20.1	6.2	14.0	11.9	4.8	6.9	9.0	4.7	10.3	13.0	19.9	2.5	6.8	8.1	30.2	0.0	11.3	3.1	2.5	8.0	8.6	0.0	0.0	0.0	0.0	0.0	4.2	0.2	8.3	6.7	10.6	5.0	7.8	5.1	6.5	4.3	4.6	5.0	3.9	6.9	15.6	0.0	1.8	7.3	2.2	7.8	10.2	6.2	0.1	4.0	12.9	6.4	5.0	3.1	0.0	8.9	7.4	10.0	10.3	8.2	3.4	6.6	0.5	6.3	10.8	0.2	1.4	4.6	3.0	1.8	5.4	8.0	5.5	10.0	40.2	10.2	3.6	8.7	4.9	4.8	2.0	3.3	6.0	6.1	5.0	5.8	2.9	0.0	0.4	9.4	0.1	6.4	0.0	0.0	0.0	2.1	0.0	4.2	0.0	0.6	1.2	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.2	28.3	28.0	16.5	22.4	25.6	20.6	29.3	15.1	20.1	30.2
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184324	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lung: 178.6"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.3;MCF7: 4.5;RPTEC TERT1: 5.5;U-266/70: 6.6"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"		140000	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: , HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favourable (2.74e-6)"	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.6	0.4	0.4	0.2	0.2	0.2	0.0	0.5	0.2	178.6	0.2	0.2	0.2	0.5	0.3	0.1	0.7	0.4	0.4	0.5	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.2	22.6	0.2	0.2	0.2	0.3	0.7	0.7	1.0	0.3	0.1	0.5	0.1	0.2	0.2	0.0	0.6	0.3	2.1	2.9	0.1	0.3	0.1	0.2	0.1	0.5	0.2	2.3	0.5	2.3	0.2	1.2	0.4	0.4	5.3	1.4	0.1	0.0	0.0	0.6	2.4	0.3	0.3	0.1	0.2	0.4	0.0	0.8	0.3	4.5	0.3	1.7	0.0	0.0	0.1	0.3	0.3	5.5	0.1	0.1	0.5	0.1	0.0	2.0	1.3	0.1	0.3	0.0	1.6	1.6	0.2	6.6	3.4	2.4	2.3	0.5	0.6	0.0	0.3	0.0	0.5	0.0	0.1	0.0	0.3	0.2	0.0	0.7	0.4	0.3	1.0	0.1	0.2	0.7	0.0	0.1	0.2	0.2	0.9	0.2	0.2	0.0	0.2	0.2	0.4	0.2
AGL		ENSG00000162688	"Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase"	P35573	1	99850084-99924023	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Glycogen biosynthesis"	"Glycosidase, Glycosyltransferase, Hydrolase, Multifunctional enzyme, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 23.1;skeletal muscle: 85.6;tongue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028498, HPA054340"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			16000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA028498: AB_10600975, HPA054340: "	"unprognostic (2.90e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.18e-2)"	"unprognostic (6.46e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.10e-3)"	"unprognostic (7.61e-2)"	"prognostic favourable (1.73e-10)"	"unprognostic (6.38e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.13e-2)"	5.0	4.5	2.5	4.7	3.6	2.0	4.2	5.4	6.1	3.4	4.5	2.1	5.4	3.3	4.8	4.2	9.1	4.1	2.6	8.2	2.2	2.3	5.8	23.1	4.2	5.3	2.4	4.2	3.8	3.6	8.7	4.7	4.8	2.9	5.5	4.2	3.9	5.1	8.7	85.6	3.7	4.0	5.4	2.8	4.8	4.4	2.9	1.2	7.1	4.3	34.4	3.4	6.7	3.6	3.0	2.3	3.5	1.6	6.1	4.3	2.1	11.8	3.5	4.2	6.9	7.0	6.6	14.2	3.8	5.6	3.3	5.9	13.3	4.0	15.6	7.3	6.4	6.7	24.6	7.4	6.3	8.3	7.8	9.1	12.2	7.4	4.6	8.0	5.5	8.1	4.8	4.6	3.9	5.2	14.9	1.1	3.4	3.7	9.4	2.5	6.7	4.6	0.0	1.4	0.8	10.1	16.1	10.5	7.3	10.9	10.5	5.8	7.5	5.4	5.3	4.0	5.8	5.4	3.7	4.5	3.5	18.1	7.1	2.1	2.1	0.1	1.3	3.5	4.3	1.6	4.1	3.0	3.2	2.9	2.3	2.9	3.2	3.2	1.5	6.1	0.9	2.1	3.3	2.1	2.5	3.6	5.4	6.1	2.2	2.3	2.4	4.2	2.9	1.2
AGO2	"CASC7, EIF2C2, hAGO2, LINC00980, Q10"	ENSG00000123908	"Argonaute 2, RISC catalytic component"	Q9UKV8	8	140520156-140635619	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Endonuclease, Hydrolase, Nuclease, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019309, HPA058075"	Approved		Supported	"Nucleoplasm,Cell Junctions"			35000000	"Nucleoplasm, Cell Junctions"		"CAB019309: , HPA058075: "	"unprognostic (2.75e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.50e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.02e-1)"	11.2	6.6	7.7	9.9	13.1	16.2	25.0	9.9	11.4	7.5	9.2	12.1	12.8	5.3	10.2	10.4	10.6	8.6	8.8	12.4	8.8	5.3	6.9	7.4	13.2	12.5	13.4	5.0	11.8	8.4	13.2	8.8	9.9	10.7	7.5	6.9	5.6	8.1	12.6	37.1	14.1	7.5	15.0	11.7	6.9	10.0	5.9	12.7	11.1	8.6	8.2	8.9	10.4	18.4	2.5	2.1	6.4	2.6	2.4	3.0	1.5	12.6	10.5	10.8	12.3	7.1	8.4	9.1	8.0	5.8	3.6	4.5	11.6	3.8	14.6	10.1	7.7	8.6	18.2	8.6	8.0	8.2	9.5	17.1	18.0	7.4	6.4	7.0	5.8	5.7	7.8	10.0	10.4	8.3	17.8	9.2	11.7	19.2	12.1	5.6	8.0	18.3	12.5	9.1	6.6	4.6	13.2	12.7	9.2	12.5	4.3	8.9	11.0	10.3	11.6	6.3	17.5	9.8	12.8	8.2	2.6	10.3	4.6	12.8	9.2	1.8	2.6	0.7	2.7	2.3	3.0	1.3	2.6	2.3	2.1	2.5	2.7	2.7	6.4	2.4	2.3	1.5	2.1	1.5	7.7	13.1	9.9	11.4	8.8	5.3	13.4	5.0	10.7	12.7
AGPS	"ADAP-S, ADAS, ADHAPS, ADPS, ALDHPSY"	ENSG00000018510	"Alkylglycerone phosphate synthase"	O00116	2	177392644-177559299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Cataract, Disease mutation, Dwarfism, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030209, HPA030210, HPA030211"	Supported		Enhanced	Peroxisomes	"Intracellular and membrane"		9300	Peroxisomes		"HPA030209: AB_10600634, HPA030210: AB_10600202, HPA030211: AB_10602195"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (8.62e-6)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.41e-2)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (7.74e-2)"	"prognostic favourable (9.45e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.46e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.92e-2)"	22.9	17.7	13.5	21.2	14.9	28.3	17.1	14.9	13.4	16.0	23.5	17.2	14.1	14.1	22.4	10.5	18.4	12.5	16.0	23.9	14.2	13.5	20.8	21.2	15.2	14.7	17.4	11.8	16.4	21.2	37.0	11.7	14.7	15.0	14.7	24.0	8.0	18.2	10.8	23.2	9.6	17.6	21.3	31.8	17.1	14.5	19.1	13.7	29.5	14.2	14.4	14.5	16.9	20.7	3.4	7.6	11.2	6.8	5.6	6.4	3.0	17.7	11.4	8.1	8.3	10.4	11.4	19.3	13.9	6.9	11.9	11.8	21.2	12.4	20.0	30.4	14.4	19.4	21.8	14.2	15.6	26.4	7.4	27.8	19.8	24.9	10.6	30.1	29.6	9.9	9.0	19.1	15.2	23.8	19.0	12.5	14.3	0.0	24.3	10.2	13.8	18.9	19.5	24.2	12.1	20.3	21.3	10.0	12.1	26.4	2.3	16.4	0.1	12.5	24.4	10.7	36.7	10.9	24.3	16.2	28.0	10.0	9.8	13.5	4.1	3.8	6.1	11.2	4.3	6.7	6.4	3.4	5.5	5.3	7.6	2.1	5.3	3.1	1.3	5.6	6.8	0.7	6.2	3.0	13.5	14.9	14.9	13.4	14.2	13.5	17.4	11.8	15.0	13.7
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020123-1056118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 45.6;EFO-21: 53.1;HaCaT: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		15000000	"Plasma membrane, Cytosol"		"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	10.2	2.8	13.0	5.3	12.4	2.9	8.3	2.3	24.0	11.3	8.5	20.5	8.9	9.8	8.2	14.5	8.8	11.4	37.2	8.1	10.9	8.3	36.0	9.3	18.1	2.3	9.3	7.0	7.6	25.2	5.7	5.0	11.0	12.7	8.7	2.5	13.6	26.5	10.8	4.7	18.6	11.2	3.9	7.7	7.2	14.1	7.5	8.1	6.4	27.0	9.5	7.6	13.7	6.2	0.0	0.1	0.0	0.5	0.0	1.1	0.1	26.5	16.5	3.2	10.7	0.5	0.7	28.8	13.4	4.3	9.0	5.5	13.9	45.6	0.5	53.1	2.0	46.2	1.1	16.5	1.0	1.0	6.3	0.0	21.6	14.5	3.9	0.3	5.4	2.4	7.2	2.8	6.2	1.5	5.5	0.1	0.7	21.8	0.2	3.8	6.9	12.0	4.2	6.3	4.0	15.8	11.8	0.8	6.4	27.3	29.6	26.0	26.0	2.0	23.5	11.1	39.3	1.5	10.8	0.3	0.2	0.9	7.0	2.4	2.9	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	13.0	12.4	2.3	22.0	10.9	8.3	9.3	7.0	12.7	8.1
AGRP	"Agrt, ART, ASIP2"	ENSG00000159723	"Agouti related neuropeptide"	O00253	16	67482571-67483813	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.4;epididymis: 49.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.6;CAPAN-2: 2.7;HeLa: 1.5;Hep G2: 2.1;HMC-1: 1.8"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	13	"hypothalamus: 19.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"hypothalamus: 18.9"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.9"	HPA041017	Enhanced	Supported			"Secreted in other tissues"					"HPA041017: AB_10795498"	"unprognostic (1.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-2)"	0.1	9.6	0.1	0.1	1.4	0.0	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.1	49.8	0.1	0.0	0.1	0.1	0.1	19.4	0.5	0.1	2.1	0.3	0.1	0.3	0.1	0.1	0.0	0.4	0.1	0.2	0.1	0.0	0.3	0.5	0.1	0.1	0.4	0.1	0.1	0.3	0.3	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.2	2.1	1.4	3.8	0.3	3.2	1.0	0.1	0.0	0.4	1.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	2.7	0.8	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	1.5	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.2	0.0	0.1	1.0	0.5	0.9	0.0	0.4	0.3	0.0	3.8	1.4	3.2	2.3	1.6	2.2	0.8	1.1	1.5	1.9	2.1	2.2	0.6	0.3	1.2	2.1	1.3	1.0	0.1	1.4	0.1	0.2	0.1	19.4	0.1	0.3	0.2	0.1
AGT	SERPINA8	ENSG00000135744	Angiotensinogen	P01019	1	230702523-230714297	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 309.0"	"Group enriched"	"Detected in some"	6	"Hep G2: 108.5;THP-1: 41.4"	"Group enriched"	"Detected in all"	10	"glioma: 275.3;liver cancer: 1163.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025798	Supported				"Secreted to blood"	2420000	110000000000			"CAB025798: "	"unprognostic (7.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.32e-3)"	"unprognostic (6.70e-2)"	"unprognostic (9.28e-2)"	"unprognostic (4.42e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.38e-1)"	2.8	3.2	23.6	1.9	25.0	1.4	1.6	17.1	37.0	3.8	2.1	24.2	0.0	1.9	1.7	1.8	2.0	2.3	22.5	30.9	18.0	11.9	9.3	309.0	1.6	1.5	19.5	15.0	1.8	2.3	1.8	2.6	1.5	23.8	2.5	2.2	0.0	1.5	1.9	7.8	1.4	2.2	2.6	29.8	1.4	2.4	2.0	15.9	0.0	1.9	0.5	1.4	3.2	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	108.5	0.3	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.9	0.0	41.4	0.0	0.0	0.2	0.0	0.1	0.5	7.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	25.0	17.1	20.0	18.0	11.9	19.5	15.0	23.8	15.9
AGXT	"AGT, AGT1, AGXT1, PH1, SPAT, SPT"	ENSG00000172482	"Alanine-glyoxylate aminotransferase"	P21549	2	240868479-240880502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	172	"liver: 247.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 13.1"	"Cancer enriched"	"Detected in some"	425	"liver cancer: 253.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035370, HPA035371"	Enhanced		Supported	Vesicles			5200000	Vesicles		"HPA035370: AB_10673218, HPA035371: AB_2674593"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.56e-2)"	"prognostic favourable (5.92e-5)"	"unprognostic (8.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.57e-3)"	"unprognostic (2.54e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.37e-1)"		"unprognostic (3.26e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	247.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	13.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.2	0.0	0.0	0.0	0.1	0.0	0.8	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AHCY	SAHH	ENSG00000101444	Adenosylhomocysteinase	P23526	20	34280268-34311802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA041225, HPA044675"	Approved		Supported	Cytosol			3900000	Cytosol		"HPA041225: AB_2677371, HPA044675: AB_2679041"	"unprognostic (3.35e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.32e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.93e-3)"	15.3	18.6	11.7	15.4	15.0	17.0	24.3	6.3	16.4	25.1	30.0	14.7	18.4	24.6	20.2	23.9	43.4	26.6	22.4	26.0	12.0	12.8	52.2	99.8	19.1	18.1	16.0	10.6	39.1	72.0	15.7	15.0	44.5	13.2	26.9	20.2	14.4	32.4	18.3	48.2	14.8	20.4	18.8	15.7	17.9	22.2	33.3	13.4	25.0	52.8	31.0	29.2	18.2	20.5	9.1	24.1	2.3	26.0	4.6	7.4	11.4	36.8	48.4	20.5	36.2	24.0	25.8	23.6	15.2	21.8	33.9	27.0	130.7	31.9	57.5	27.1	19.4	42.4	48.3	85.2	21.8	7.6	29.3	69.4	24.1	84.1	25.8	32.3	22.8	53.4	38.8	21.0	33.9	23.1	33.7	14.6	17.9	39.1	42.2	30.6	26.3	47.2	31.7	52.2	40.4	30.3	26.3	35.6	23.7	30.3	36.0	50.4	54.1	30.1	14.6	29.5	31.4	14.8	28.6	21.8	31.9	34.6	21.7	20.0	15.7	2.3	13.7	0.4	4.1	26.0	6.7	9.1	6.0	5.3	21.1	7.8	6.6	7.4	1.1	4.6	16.5	24.1	6.7	11.4	11.7	15.0	6.3	16.4	12.0	12.8	16.0	10.6	13.2	13.4
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 84.9;fHDF/TERT166: 79.0;TIME: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"			950000	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.47e-6)"	85.2	8.2	15.3	35.3	9.3	10.0	91.1	9.3	10.8	69.7	66.3	16.8	36.4	13.0	52.2	47.4	96.9	39.4	59.2	55.8	20.9	6.0	18.4	16.0	54.9	16.6	16.2	13.4	40.2	8.9	8.0	5.3	39.8	15.9	42.6	26.8	29.6	35.5	36.8	64.8	88.4	38.2	101.5	16.1	16.9	38.3	16.9	16.2	5.8	18.4	72.9	44.0	54.3	86.1	8.2	28.9	15.3	30.1	11.1	16.7	12.2	26.0	15.4	1.4	6.4	63.3	84.9	10.2	23.7	29.1	15.1	8.5	13.2	9.3	0.0	9.0	79.0	34.8	5.9	29.2	19.4	21.1	0.9	3.1	22.9	3.9	12.1	4.3	20.8	30.6	34.3	29.7	27.2	31.1	2.9	20.2	30.6	10.1	0.0	8.4	0.4	23.4	0.0	6.5	15.6	33.6	17.1	0.0	1.3	23.9	10.1	10.1	19.4	4.0	82.6	27.0	17.6	33.5	10.4	3.6	0.7	0.0	20.5	1.4	8.8	15.3	30.1	0.1	16.7	17.5	11.0	8.2	10.7	13.1	28.9	5.2	1.4	7.6	0.4	11.1	14.0	7.9	7.9	12.2	15.3	9.3	9.3	10.8	20.9	6.0	16.2	13.4	15.9	16.2
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469474	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 177.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol			28000	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	23.7	39.3	37.8	26.9	44.4	20.7	58.9	33.1	52.1	25.7	27.9	22.6	28.9	21.0	31.7	34.9	27.2	56.4	18.6	47.8	38.2	38.2	31.5	28.4	21.9	29.4	61.8	29.7	30.3	25.4	32.0	37.0	34.9	50.1	32.0	34.9	11.5	24.7	35.3	48.5	20.8	20.7	40.0	42.5	21.5	22.8	40.5	54.3	26.0	37.6	24.5	40.3	24.8	177.1	44.3	36.6	34.5	45.1	42.3	42.3	26.9	33.4	66.2	18.1	23.7	28.1	20.3	31.9	25.0	19.8	39.3	29.5	49.6	29.0	62.4	19.6	24.4	38.4	65.4	32.0	43.8	24.8	38.9	29.4	33.0	59.8	20.8	18.6	42.5	17.9	42.8	26.4	12.9	37.0	36.3	20.1	24.5	92.1	45.6	35.3	31.5	69.8	36.8	21.5	31.1	30.9	34.9	28.0	30.8	23.1	51.8	21.4	31.6	25.6	19.2	21.3	30.3	23.8	35.5	20.3	40.8	47.9	30.9	37.2	23.4	32.6	28.2	34.5	37.8	39.0	42.3	44.3	34.8	38.7	36.6	34.3	40.0	40.1	20.2	42.3	45.1	34.1	40.0	26.9	37.8	44.4	33.1	52.1	38.2	38.2	61.8	29.7	50.1	54.3
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 210.3"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	225100000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	210.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
AHSP	"EDRF, ERAF"	ENSG00000169877	"Alpha hemoglobin stabilizing protein"	Q9NZD4	16	31527864-31528803	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 189.3"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 7.5;K-562: 3.2;MOLT-4: 2.1;NTERA-2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA040940	Enhanced						8400000			"HPA040940: AB_10796231"		"unprognostic (3.00e-1)"			"unprognostic (2.01e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.53e-1)"		"unprognostic (3.10e-1)"	"unprognostic (2.16e-1)"		"unprognostic (3.70e-3)"	"unprognostic (2.04e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.25e-2)"		0.6	0.1	0.3	0.3	0.4	189.3	0.9	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.3	0.1	0.2	0.1	0.1	4.0	0.2	0.2	1.0	3.5	20.0	0.1	0.7	0.0	0.8	1.1	0.1	1.1	30.2	0.2	0.5	0.1	1.0	0.1	0.1	0.7	0.3	0.1	0.1	0.3	18.9	0.1	2.8	0.1	1.1	2.1	0.0	0.1	1.5	0.8	0.3	0.2	0.8	0.1	0.0	0.2	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	9.2	0.3	0.4	0.0	0.1	0.2	0.2	0.7	0.0	0.2	0.1
AIFM1	"AIF, CMTX4, NAMSD, PDCD8"	ENSG00000156709	"Apoptosis inducing factor mitochondria associated 1"	O95831	X	130129362-130165887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"DNA-binding, Oxidoreductase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003764, HPA030611"	Enhanced						160000			"CAB003764: AB_289587, HPA030611: "	"unprognostic (3.00e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.81e-3)"	"prognostic favourable (4.42e-10)"	"unprognostic (1.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.11e-2)"	9.9	28.9	7.1	11.3	8.6	5.3	7.1	7.5	8.9	10.4	14.2	8.4	10.0	19.6	9.9	11.7	8.6	13.0	11.4	34.2	7.2	7.0	66.8	50.5	5.8	9.8	8.2	7.1	7.3	14.6	16.8	7.7	6.1	8.8	6.9	14.2	12.3	13.1	9.4	35.7	5.8	23.2	8.9	6.4	8.7	14.9	14.9	7.2	19.5	7.9	16.1	9.7	8.4	6.0	10.8	22.0	9.8	18.3	15.8	12.8	8.0	16.7	31.0	12.7	31.8	14.5	10.4	16.8	10.6	9.2	16.4	13.3	22.0	12.4	36.2	37.1	9.7	16.2	39.2	13.8	17.5	13.8	23.9	22.9	23.4	29.9	18.5	20.1	24.2	12.8	13.6	17.4	14.9	13.8	19.7	16.8	11.5	40.4	20.4	31.6	9.1	24.1	18.5	14.3	41.9	37.1	17.0	16.4	9.6	12.4	28.8	27.7	14.8	18.2	10.0	7.8	7.5	21.3	20.2	9.0	14.5	16.9	10.1	33.7	11.7	2.9	14.8	9.8	9.1	18.3	9.6	10.8	9.7	11.2	22.0	8.1	9.6	9.7	2.1	15.8	15.5	10.6	12.8	8.0	7.1	8.6	7.5	8.9	7.2	7.0	8.2	7.1	8.8	7.2
AIMP2	"JTV-1, JTV1, p38, PRO0992"	ENSG00000106305	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 2"	Q13155	7	6009245-6023834	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Protein biosynthesis"	"Developmental protein"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019098, HPA020057"	Supported		Approved	Cytosol			8200	Cytosol		"HPA019098: AB_1852040, HPA020057: AB_1852042"	"unprognostic (1.24e-3)"	"unprognostic (1.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (9.29e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.13e-2)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.38e-5)"	"unprognostic (7.44e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (3.09e-4)"	10.2	11.2	6.3	6.9	7.3	5.3	11.2	5.3	11.0	5.6	14.9	10.2	7.1	22.8	8.9	10.8	11.2	7.7	8.7	17.7	6.5	5.8	18.6	30.7	6.8	15.1	6.8	8.2	7.5	9.6	12.3	4.5	9.0	7.6	6.1	12.2	6.6	13.6	9.0	66.1	10.3	21.0	9.8	7.2	9.4	7.5	20.4	5.1	9.3	12.9	28.4	9.1	8.2	6.6	19.0	37.3	13.8	30.0	17.8	17.7	16.1	26.2	29.8	10.1	14.5	10.7	11.8	34.6	14.9	10.0	24.6	18.3	32.6	17.5	32.4	14.1	15.3	29.3	34.2	22.4	15.3	10.4	26.0	17.9	17.6	24.3	33.3	25.1	16.2	18.1	33.2	22.1	36.3	18.2	25.0	10.7	17.8	41.7	10.9	45.7	41.2	21.7	24.4	22.5	27.3	35.8	12.3	20.3	19.2	15.0	30.5	20.4	28.5	20.5	15.3	14.1	35.0	23.3	32.5	13.7	20.8	27.9	11.8	35.9	22.7	13.8	25.0	7.6	17.7	30.0	15.0	19.0	12.2	14.0	37.3	13.3	12.2	12.8	2.5	17.8	22.1	23.9	13.0	16.1	6.3	7.3	5.3	11.0	6.5	5.8	6.8	8.2	7.6	5.1
AIP	"ARA9, FKBP16, XAP2"	ENSG00000110711	"Aryl hydrocarbon receptor interacting protein"	O00170	11	67483041-67491103	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cushing syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033674, HPA050217, CAB069477"	Approved		Supported	Cytosol				Cytosol		"CAB033674: AB_2224981, CAB069477: AB_10002466, HPA050217: "	"unprognostic (2.59e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (8.15e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (9.45e-2)"	23.1	30.5	30.7	31.1	32.6	25.1	29.0	30.3	34.2	27.8	38.5	26.6	24.2	23.7	30.6	24.2	30.8	25.0	28.6	34.7	28.0	25.4	28.0	20.7	24.7	55.2	34.2	24.6	45.5	23.0	18.2	22.0	23.6	27.1	36.2	14.6	21.4	25.0	28.1	26.5	15.9	25.0	29.8	30.2	37.9	22.9	18.2	30.4	34.6	38.0	16.6	33.5	33.1	60.6	56.5	49.8	36.9	38.0	37.6	80.0	41.7	20.5	23.9	13.8	13.2	17.7	17.8	10.5	13.0	16.3	22.5	16.5	37.4	20.5	36.7	31.8	14.3	16.7	15.5	13.6	8.6	53.6	16.8	22.2	26.1	22.2	18.4	22.2	39.0	21.2	12.9	19.9	13.0	11.4	12.6	22.1	14.6	39.4	47.2	54.8	13.0	30.7	21.0	20.9	32.4	15.6	12.3	21.8	21.8	16.8	12.0	51.2	16.2	22.6	18.8	19.8	19.3	29.0	11.9	18.1	24.8	28.7	27.1	17.4	15.2	36.9	28.9	31.0	49.5	33.4	53.5	56.5	58.5	57.9	43.1	48.7	53.2	50.8	19.0	37.6	38.0	49.8	80.0	41.7	30.7	32.6	30.3	34.2	28.0	25.4	34.2	24.6	27.1	30.4
AK1		ENSG00000106992	"Adenylate kinase 1"	P00568	9	127866480-127877743	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 84.5;skeletal muscle: 279.0"	"Cell line enhanced"	"Detected in many"		"U-2197: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006456, CAB009893"	Enhanced		Supported	Cytosol			32000000	Cytosol		"CAB009893: AB_2225151, HPA006456: AB_1078116"	"unprognostic (6.07e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.74e-2)"	"unprognostic (6.65e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (2.62e-1)"	"unprognostic (8.40e-3)"	"unprognostic (6.99e-3)"	7.7	9.2	19.6	3.7	18.8	6.5	3.9	9.8	17.3	10.5	8.6	18.1	12.2	5.2	3.4	17.3	9.0	84.5	12.0	60.4	17.6	18.5	6.3	10.7	18.7	2.2	16.4	15.3	12.3	4.6	5.6	7.1	2.9	17.5	5.2	10.8	7.0	13.4	15.7	279.0	3.4	2.6	6.3	11.5	5.6	5.8	9.8	11.1	0.0	10.5	61.5	4.0	4.4	4.4	1.2	3.4	2.8	0.4	1.4	1.5	1.2	15.2	6.6	8.4	11.5	20.5	41.8	7.7	10.6	10.7	18.9	11.5	4.8	9.7	0.4	11.6	21.8	22.0	0.0	11.8	7.6	2.4	7.3	2.2	18.9	8.4	11.5	0.0	0.3	31.7	23.0	14.0	10.2	25.2	8.9	0.6	21.4	14.5	0.0	0.3	3.0	20.4	0.4	8.5	3.3	12.6	1.1	13.7	8.5	28.0	16.1	8.1	12.9	9.1	20.8	13.2	5.4	46.5	10.1	1.0	0.1	0.0	16.6	0.0	9.2	0.9	0.4	0.4	1.5	0.3	1.1	0.3	0.6	1.1	0.1	1.2	0.3	1.1	2.8	1.4	0.4	3.4	0.3	1.2	19.6	18.8	9.8	17.3	17.6	18.5	16.4	15.3	17.5	11.1
AK2		ENSG00000004455	"Adenylate kinase 2"	P54819	1	33007940-33080996	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018479	Approved						5500000			"HPA018479: AB_1844676"	"prognostic favourable (4.37e-4)"	"unprognostic (3.25e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (8.65e-4)"	"unprognostic (3.16e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (7.86e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (6.40e-4)"	"unprognostic (4.95e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.56e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-3)"	24.9	27.1	16.0	27.6	20.3	18.3	24.2	19.1	17.6	21.4	31.3	24.6	22.4	36.6	20.6	22.8	31.6	17.6	25.0	33.9	15.1	14.5	51.2	46.5	17.9	18.2	23.1	9.9	24.3	23.2	27.2	16.2	18.6	19.7	22.4	31.8	20.4	31.4	21.5	73.8	20.6	37.1	18.7	25.9	24.7	24.0	29.3	25.0	40.2	37.4	34.4	28.7	26.7	23.3	31.7	51.9	50.9	41.2	27.4	24.4	43.1	44.8	20.0	18.9	21.9	13.1	16.4	19.2	25.4	19.6	38.2	40.2	38.3	40.8	83.7	30.1	18.8	32.6	43.8	43.1	41.2	36.5	32.0	55.4	38.4	29.1	30.6	98.6	31.4	16.2	32.6	32.7	66.1	26.1	58.8	31.5	22.6	22.6	37.3	54.5	26.4	30.7	43.5	32.1	55.1	37.6	27.1	27.8	16.3	29.0	32.2	80.9	26.2	70.1	19.0	23.2	28.0	35.6	47.4	32.9	43.0	78.0	31.5	93.3	26.7	11.0	41.2	50.9	22.0	37.4	23.0	31.7	20.6	20.6	51.9	27.7	21.2	19.8	11.3	27.4	31.5	39.1	24.4	43.1	16.0	20.3	19.1	17.6	15.1	14.5	23.1	9.9	19.7	25.0
AK3	"AK3L1, AK6, AKL3L1"	ENSG00000147853	"Adenylate kinase 3"	Q9UIJ7	9	4709559-4742043	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 85.0;HEL: 54.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063324	Enhanced		Supported	Mitochondria			68000	Mitochondria		"HPA063324: "	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.76e-2)"	"prognostic favourable (6.07e-9)"	"unprognostic (1.24e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-3)"	24.6	25.1	20.9	9.8	22.4	6.8	24.0	14.6	17.5	17.7	23.7	15.3	16.0	24.4	18.9	17.5	28.3	14.0	16.1	90.0	22.4	16.4	37.7	75.1	16.4	13.1	25.2	15.2	22.4	15.7	16.9	14.1	13.0	22.9	19.0	23.0	17.4	14.5	19.1	72.0	18.1	22.0	21.2	24.1	12.1	22.5	9.3	24.9	15.2	20.8	32.8	14.9	20.1	17.1	7.0	14.4	17.0	5.6	14.7	17.1	10.2	8.7	7.3	12.5	5.1	17.5	12.9	0.9	11.0	26.0	6.9	10.4	1.2	9.7	8.1	3.8	14.0	5.6	9.1	10.6	11.8	85.0	6.9	54.4	13.0	22.0	13.8	5.7	2.8	20.4	9.5	5.9	8.2	20.3	4.1	11.1	20.7	5.2	5.5	16.5	11.2	2.7	7.4	4.5	4.0	20.2	12.2	20.7	13.0	12.9	4.2	7.4	5.8	11.4	12.6	5.8	5.9	15.2	8.6	2.8	1.8	10.0	10.6	4.3	4.1	6.8	5.6	17.0	16.2	4.4	14.7	7.0	12.5	14.8	10.5	6.9	16.6	17.1	1.9	14.7	3.4	14.4	16.7	10.2	20.9	22.4	14.6	17.5	22.4	16.4	25.2	15.2	22.9	24.9
AKAP10	"D-AKAP2, MGC9414, PRKA10"	ENSG00000108599	"A-kinase anchoring protein 10"	O43572	17	19904302-19978343	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028901	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028901: AB_10602227"	"unprognostic (2.17e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.33e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.16e-2)"	"unprognostic (5.20e-2)"	20.5	24.2	22.5	19.4	25.5	16.1	21.2	22.8	27.9	21.2	19.4	17.4	13.4	16.1	22.3	15.9	18.5	19.2	18.4	14.4	20.1	17.9	22.7	14.9	18.5	24.3	22.4	23.2	24.3	16.2	28.0	20.3	20.3	19.2	19.5	20.3	16.1	17.8	21.3	13.7	17.5	18.5	22.9	19.0	28.6	20.2	22.9	24.2	25.9	26.0	9.1	20.5	22.2	22.7	7.3	6.1	24.4	10.3	5.1	7.9	3.0	11.0	13.3	8.9	6.2	11.8	14.9	16.4	12.9	13.9	14.4	17.4	14.4	6.7	9.5	8.8	10.2	11.8	11.4	10.8	19.7	7.8	9.8	8.1	13.0	6.9	11.2	5.9	13.4	12.5	13.6	13.1	16.3	11.6	5.2	4.8	15.0	8.0	10.9	8.8	5.8	4.6	7.3	29.2	4.9	12.0	7.0	3.0	9.1	14.9	7.0	12.3	17.0	6.6	10.1	11.2	9.3	9.5	11.9	6.0	6.4	11.6	14.8	7.1	10.7	3.6	7.3	8.8	6.7	10.3	6.1	6.0	6.5	7.2	6.1	7.3	7.9	7.0	24.4	5.1	9.3	4.6	4.9	3.0	22.5	25.5	22.8	27.9	20.1	17.9	22.4	23.2	19.2	24.2
AKAP11	"AKAP220, DKFZp781I12161, FLJ11304, KIAA0629, PPP1R44, PRKA11"	ENSG00000023516	"A-kinase anchoring protein 11"	Q9UKA4	13	42272153-42323267	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039089	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA039089: AB_10674279"	"unprognostic (6.43e-2)"	"prognostic unfavourable (9.26e-4)"	"unprognostic (4.91e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.49e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.10e-1)"	11.2	13.6	21.7	10.0	42.3	3.0	11.0	19.9	30.7	17.1	9.1	9.0	5.9	6.9	13.0	15.2	10.2	10.2	9.7	10.4	18.3	17.9	12.9	9.9	10.2	13.4	16.4	22.8	14.6	6.4	11.6	14.5	7.2	20.3	11.1	10.1	6.7	7.6	12.4	5.7	9.1	8.1	13.4	21.4	11.7	9.5	18.1	16.0	5.6	13.3	4.6	12.6	10.4	9.4	3.0	1.6	4.2	1.4	4.8	2.7	0.7	9.2	9.5	11.7	6.9	15.4	18.9	5.1	12.6	10.5	7.6	7.2	10.4	7.7	19.1	4.9	14.1	11.1	10.1	10.5	14.7	20.3	4.7	5.4	6.6	5.1	12.1	13.4	13.3	13.8	10.9	15.5	13.6	11.1	17.7	7.8	15.3	7.0	7.8	4.3	6.9	4.5	6.5	8.2	9.2	7.6	6.9	5.0	7.2	9.6	6.4	4.5	5.5	7.3	15.4	12.9	6.7	19.5	9.5	3.0	3.7	9.9	16.5	6.9	9.0	4.2	0.9	1.2	1.7	1.1	2.1	2.7	2.4	1.6	1.0	3.0	2.1	2.1	0.3	4.8	1.4	1.6	2.7	0.7	21.7	42.3	19.9	24.6	18.3	17.9	16.4	22.8	20.3	16.0
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239999-151358557	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 43.1;TIME: 42.9;U-251 MG: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	184	"basophil: 20.4"	"Lineage enriched"	"Detected in single"	184	"granulocytes: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			6400000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavourable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	52.5	11.2	11.5	11.0	18.1	2.0	38.5	31.3	21.2	11.5	23.4	1.9	5.9	6.1	20.5	13.6	12.8	15.6	32.3	22.8	9.8	17.4	14.9	20.6	18.2	6.9	11.4	9.9	49.0	7.6	2.0	11.1	24.1	28.7	13.5	9.4	26.6	3.3	14.7	11.3	4.1	10.6	27.9	14.1	8.1	12.4	62.0	6.6	0.3	11.4	6.6	2.8	34.5	24.7	0.0	0.0	20.4	0.0	0.0	0.1	0.0	1.7	8.6	12.4	0.0	23.4	35.1	4.3	10.0	5.4	4.5	4.5	0.2	32.5	0.0	4.0	7.5	0.2	23.5	7.4	4.0	11.1	8.6	0.1	9.6	7.9	2.6	0.0	2.2	24.8	0.0	19.1	1.0	29.4	2.1	0.2	16.3	0.1	0.0	0.0	7.7	10.1	43.1	0.5	0.0	26.1	1.4	8.8	5.1	3.2	0.1	5.7	0.6	0.1	42.9	0.6	8.0	25.6	45.9	0.0	0.0	0.0	14.9	0.0	8.6	20.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.1	31.3	19.1	9.8	17.4	11.4	9.9	28.7	6.6
AKAP13	"AKAP-Lbc, ARHGEF13, BRX, c-lbc, HA-3, Ht31, LBC, PROTO-LB"	ENSG00000170776	"A-kinase anchoring protein 13"	Q12802	15	85380571-85749358	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019773	Approved		Supported	Cytosol				Cytosol		"HPA019773: AB_1844686"	"unprognostic (4.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.69e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.81e-3)"	35.9	11.1	7.2	32.5	9.3	23.7	17.1	1.9	7.8	24.6	13.6	8.4	23.0	7.8	57.8	24.5	16.1	16.3	22.1	40.5	8.8	6.1	10.9	14.0	54.9	40.1	9.0	5.5	20.0	26.4	8.0	40.5	22.5	12.4	16.7	10.4	17.2	17.8	26.5	35.8	17.0	21.0	37.4	13.7	42.9	17.8	15.0	7.1	36.0	26.0	18.7	38.6	24.6	18.2	19.3	27.1	61.4	19.4	27.7	35.4	11.0	4.6	10.2	7.4	2.7	11.2	12.5	4.1	3.8	8.1	3.3	3.2	3.9	3.8	21.4	5.4	6.5	9.5	8.1	3.4	3.2	15.7	4.1	28.1	6.9	2.9	6.2	5.6	56.6	9.1	9.1	4.1	14.0	8.8	1.8	10.2	5.0	2.2	8.1	4.3	4.7	4.2	5.8	7.4	7.8	5.3	9.4	4.7	8.5	10.1	2.9	5.2	2.1	4.8	10.0	4.0	2.8	2.4	3.7	16.1	10.1	17.1	2.4	18.7	3.1	61.4	17.8	46.3	35.4	14.9	19.7	19.3	23.7	26.2	10.3	19.2	20.1	22.1	29.0	27.7	19.4	27.1	18.8	11.0	7.2	9.3	1.9	7.8	8.8	6.1	9.0	5.5	12.4	7.1
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 39.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"basophil: 5.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.7"					"Group enriched"	"Detected in many"	5	"amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm				Nucleoplasm		"CAB004308: AB_626655, HPA053891: "	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.7	0.8	17.3	2.2	39.1	1.0	1.1	2.9	21.8	0.7	5.9	0.2	0.0	1.1	2.3	0.6	1.0	0.8	1.6	0.6	9.9	1.4	2.4	1.2	3.0	2.9	1.3	9.2	0.7	0.5	1.5	1.3	1.8	0.9	1.0	6.1	0.0	0.7	1.0	0.6	1.0	2.4	2.2	0.7	2.0	1.1	0.7	1.3	0.1	1.1	0.0	2.5	1.4	0.7	0.7	0.4	5.7	0.3	0.9	1.0	0.2	1.7	1.4	1.7	1.0	0.6	0.1	5.7	1.3	0.6	1.6	2.1	14.0	4.3	1.3	2.7	1.0	0.6	3.7	0.3	1.6	2.6	3.1	4.2	2.6	1.2	0.1	0.5	0.6	0.6	0.1	1.1	0.0	0.6	0.5	1.0	1.0	1.0	3.3	0.3	1.3	0.7	4.2	0.8	0.3	2.6	1.6	4.4	2.0	1.5	0.1	0.3	1.3	0.3	0.8	1.9	5.8	0.2	2.1	2.9	3.2	3.2	1.3	0.5	0.3	5.7	0.3	0.2	1.0	0.1	0.2	0.5	0.3	0.9	0.2	0.7	0.4	0.5	0.7	0.9	0.1	0.4	0.1	0.2	17.3	39.1	2.9	19.9	9.9	1.4	1.3	9.2	0.9	1.3
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135666-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 39.4;pancreas: 37.5"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 19.0;RPTEC TERT1: 16.6;RT4: 18.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles				Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favourable (2.56e-4)"	5.7	39.4	16.1	6.2	11.2	6.3	4.7	16.6	15.4	6.0	12.9	4.9	4.1	19.9	4.5	4.1	3.0	4.9	6.8	4.4	12.0	9.9	5.6	15.7	6.2	11.6	8.1	11.7	7.2	37.5	3.1	3.5	2.8	7.2	10.0	13.3	2.9	3.4	4.8	9.8	2.3	12.4	5.2	6.2	6.2	3.7	5.8	6.4	18.9	4.2	2.1	5.5	8.6	4.3	4.4	1.8	9.5	3.4	3.2	14.9	5.0	0.8	1.5	5.5	2.6	3.1	6.6	3.8	2.3	3.7	3.9	5.2	1.8	1.5	0.1	4.3	3.9	0.0	1.5	2.4	2.9	0.0	2.3	5.4	1.8	8.2	4.4	0.2	1.8	5.6	1.7	2.5	3.3	4.0	0.9	7.9	3.7	1.4	2.4	1.4	19.0	2.1	4.9	3.6	0.1	16.6	18.4	0.0	1.9	3.1	0.3	7.4	1.2	11.5	1.3	1.8	2.5	5.2	5.6	7.4	0.0	1.3	4.4	5.5	4.1	9.5	1.5	0.2	6.8	2.9	10.5	2.6	9.4	9.1	1.8	4.4	14.9	9.3	0.4	3.2	3.4	0.1	3.2	5.0	16.1	11.2	16.6	15.4	12.0	9.9	8.1	11.7	7.2	6.4
AKAP8	"AKAP95, DKFZp586B1222"	ENSG00000105127	"A-kinase anchoring protein 8"	O43823	19	15353385-15379798	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Protein transport, Transcription, Transcription regulation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004776	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004776: AB_1078122"	"unprognostic (9.04e-3)"	"unprognostic (3.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.78e-3)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.57e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.83e-2)"	17.7	12.1	7.0	14.0	11.9	32.8	13.9	15.7	10.9	14.8	11.5	11.6	7.9	18.0	14.9	14.9	13.4	12.9	10.9	10.8	7.6	5.8	12.9	14.2	11.7	12.9	10.9	5.9	13.5	13.7	11.4	9.4	17.8	9.3	11.8	7.7	13.7	13.5	15.8	25.7	16.1	14.5	14.9	9.3	16.0	13.3	12.4	11.1	15.2	12.3	12.1	16.0	13.6	11.4	7.2	9.7	2.3	9.3	5.6	7.9	4.9	14.5	10.5	10.5	9.6	3.6	5.3	12.8	8.8	7.6	9.0	8.1	15.8	18.1	14.4	9.3	8.7	11.0	7.8	11.0	5.8	13.8	11.5	16.4	12.0	14.5	4.2	22.1	13.5	7.5	5.9	7.7	2.5	7.6	11.8	9.8	6.0	18.5	13.4	10.0	15.7	13.9	14.2	9.5	15.4	4.6	18.8	9.7	10.2	9.4	13.6	10.4	7.7	9.4	14.7	13.4	8.2	12.9	17.1	13.0	10.5	16.7	9.9	15.4	10.8	0.0	6.7	2.3	7.6	7.3	7.9	7.2	6.5	7.8	9.7	6.4	5.9	6.2	0.9	5.6	9.3	7.8	7.9	4.9	7.0	11.9	15.7	10.9	7.6	5.8	10.9	5.9	9.3	11.1
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"				"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.2	7.0	10.4	6.6	14.9	11.0	7.4	8.4	5.7	4.3	5.5	11.9	9.8	10.2	12.2	7.4	10.4	10.0	5.5	8.1	9.2	8.5	11.2	12.2	7.8	6.1	18.5	11.9	6.9	8.8	8.9	10.2	9.3	16.6	16.7	7.3	16.3	12.6	7.3	8.0	8.7	7.7	17.4	8.2	5.9	12.4	17.0	11.9	17.8	20.0	8.6	5.2	9.0	17.1	8.7	11.2	15.2	11.4	12.0	13.2	13.7	7.7	9.4	9.8	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4
AKR1A1	"ALR, DD3"	ENSG00000117448	"Aldo-keto reductase family 1 member A1"	P14550	1	45550543-45570049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006246, HPA017919, HPA019649, HPA027734"	Approved		Supported	Nucleoplasm,Cytosol			8100000	Cytosol	Nucleoplasm	"CAB006246: AB_425840, HPA017919: AB_1844695, HPA019649: AB_1844696, HPA027734: AB_10600976"	"unprognostic (1.73e-1)"	"prognostic favourable (2.66e-6)"	"unprognostic (4.03e-1)"	"prognostic favourable (2.92e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.57e-2)"	20.0	20.4	12.0	27.9	13.9	9.7	31.8	11.5	23.6	21.7	39.6	18.7	20.0	43.6	18.5	31.7	39.0	21.8	31.7	18.5	11.2	12.0	79.6	80.4	26.0	33.8	15.0	13.9	18.3	44.2	11.3	27.5	20.2	13.1	19.4	28.9	16.7	59.8	24.1	13.4	18.2	69.7	19.4	16.3	25.6	27.7	10.5	13.1	24.8	24.6	31.3	33.2	17.4	18.6	23.3	46.8	26.8	56.3	13.8	18.7	38.4	16.4	23.8	21.8	16.8	47.4	34.5	15.4	19.6	45.7	17.1	34.5	9.9	12.7	40.7	15.7	22.3	21.1	22.9	28.5	16.1	16.4	20.6	23.5	20.2	43.4	39.6	30.3	26.4	38.0	25.8	21.6	40.2	39.5	12.0	32.6	20.0	11.9	32.4	13.2	23.7	16.4	37.4	26.2	47.1	48.6	22.5	26.0	15.0	16.9	67.6	24.7	18.9	17.4	24.0	7.9	17.6	27.4	11.6	22.5	29.9	19.1	15.5	39.6	6.8	26.8	56.3	10.5	16.3	51.8	17.8	23.3	15.3	16.0	46.8	22.7	13.1	13.5	2.6	13.8	38.1	40.8	18.7	38.4	12.0	13.9	11.5	23.6	11.2	12.0	15.0	13.9	13.1	13.1
AKR1B1	"ALDR1, AR"	ENSG00000085662	"Aldo-keto reductase family 1 member B"	P15121	7	134442350-134459284	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adrenal gland: 302.2;seminal vesicle: 109.3"	"Cell line enhanced"	"Detected in many"		"A549: 121.0;BJ hTERT+: 222.0;RPTEC TERT1: 105.0;U-87 MG: 99.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026425, CAB027391, CAB047353, HPA052751"	Enhanced		Supported	Nucleoplasm,Cytosol			1700000	Cytosol	Nucleoplasm	"CAB027391: , CAB047353: , HPA026425: AB_10601563, HPA052751: "	"unprognostic (2.76e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (2.44e-5)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (7.00e-4)"	5.9	302.2	7.5	4.7	13.7	2.5	9.5	6.9	10.9	4.4	3.9	8.2	50.4	2.7	4.6	6.1	4.2	4.6	5.2	24.2	7.3	8.4	17.7	2.5	6.9	10.0	9.5	9.0	8.2	7.2	9.4	8.0	24.8	11.9	5.5	4.1	5.8	4.4	109.3	37.6	2.8	4.8	5.6	7.9	6.7	5.0	5.2	5.9	7.3	6.0	10.3	7.6	7.1	3.7	31.4	34.8	22.5	26.0	26.3	42.7	47.2	13.3	121.0	13.6	19.3	58.9	16.0	36.3	13.0	222.0	19.1	24.8	5.6	12.3	0.0	6.0	21.7	5.7	14.8	12.9	15.2	4.8	13.6	6.8	18.2	16.4	84.4	0.0	0.0	14.9	9.7	27.3	7.3	26.9	0.0	4.5	21.1	0.2	20.0	9.2	22.7	0.1	20.9	8.7	10.1	105.0	65.4	10.2	22.7	90.9	0.1	9.5	0.0	10.2	21.2	18.9	8.8	1.7	14.1	12.5	13.7	33.8	99.9	0.0	11.3	22.5	26.0	1.2	37.9	17.0	34.0	31.4	32.4	36.7	34.8	28.5	42.7	41.1	2.1	26.3	8.9	4.9	22.0	47.2	7.5	13.7	6.9	10.9	7.3	8.4	9.5	9.0	11.9	5.9
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell line enhanced"	"Detected in many"		"A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdT-cell: 26.7"	"Low lineage specificity"	"Detected in many"											"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			11000000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"CAB010874: AB_476751, HPA068265: "	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	149.2	0.1	43.6	85.8	30.9	0.0	0.0	2.1	0.0	0.1	4.4	2.5	0.0	8.1	2.0	1.2	0.1	2.9	0.0	0.3	0.0	0.2	46.2	62.6	0.4	0.0	0.0	17.1	6.1	2.0	0.0	2.8	0.9	0.0	3.9	0.3	1.0	0.2	0.0	0.4	0.3	0.9	4.4	14.7	58.9	0.0	0.3	21.4	0.0	0.0	0.0	0.0	20.8	0.5	0.4	9.0	0.3	0.0	0.0	0.0	5.0	5.9	0.4	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2
AKR1C4	"3-alpha-HSD, C11, CDR, CHDR, DD4, HAKRA, MGC22581"	ENSG00000198610	"Aldo-keto reductase family 1 member C4"	P17516	10	5195462-5218949	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"liver: 127.0"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 11.8"	"Cancer enriched"	"Detected in some"	86	"liver cancer: 108.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basophil: 1.2;gdT-cell: 1.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.2;T-cells: 1.1"									"HPA044720, HPA068265"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			1800000	"Nucleoplasm, Cytosol"	"Nucleoli fibrillar center, Endoplasmic reticulum"	"HPA044720: , HPA068265: "	"unprognostic (2.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"		"unprognostic (5.99e-2)"	"unprognostic (9.40e-2)"	"unprognostic (2.32e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.52e-2)"		"unprognostic (1.29e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.34e-2)"		"unprognostic (1.45e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	1.1	0.1	0.0	1.5	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.5	0.3	1.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AKR7A2	AFAR	ENSG00000053371	"Aldo-keto reductase family 7 member A2"	O43488	1	19303965-19312146	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB032587, CAB032841, HPA064638"	Enhanced		Supported	Cytosol			2700000	Cytosol		"CAB032587: AB_673379, CAB032841: AB_2224545, HPA064638: "	"unprognostic (1.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.50e-2)"	"unprognostic (5.11e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (8.59e-4)"	21.2	39.0	25.2	14.0	26.9	15.2	22.0	19.8	26.2	32.9	38.5	28.1	28.7	56.0	20.2	23.0	25.7	35.1	31.9	31.2	22.0	19.4	49.3	32.4	14.4	21.9	24.9	26.2	31.6	60.8	14.8	19.0	17.2	23.6	19.9	19.5	25.8	21.4	24.9	33.8	18.8	43.1	20.8	20.0	16.3	22.3	21.6	21.4	24.7	22.9	20.2	18.3	16.7	21.6	23.0	40.1	13.7	29.0	22.2	27.1	23.5	24.2	15.3	16.8	15.5	26.7	26.0	11.2	18.1	22.2	25.5	22.9	19.4	20.5	17.6	19.4	24.3	19.4	18.8	27.3	12.1	14.0	29.8	11.0	14.8	31.0	20.8	12.1	8.9	25.8	21.6	19.5	12.0	21.5	16.0	16.5	26.0	24.2	23.6	11.8	4.8	19.3	24.9	21.0	31.0	24.8	10.7	31.7	11.8	19.8	17.9	30.5	35.6	42.4	16.8	16.0	16.9	17.1	13.5	20.1	12.6	21.4	34.5	27.9	22.5	0.1	29.0	13.7	23.0	23.7	26.8	23.0	20.7	20.3	40.1	21.4	23.9	20.6	3.4	22.2	17.8	35.0	27.1	23.5	25.2	26.9	19.8	26.2	22.0	19.4	24.9	26.2	23.6	21.4
AKT3	"PKBG, PRKBG, RAC-gamma"	ENSG00000117020	"AKT serine/threonine kinase 3"	Q9Y243	1	243488233-243851079	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013090, HPA026441"	Approved		Supported	Cytosol				Cytosol		"CAB013090: AB_2533692, HPA026441: AB_1844711"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.71e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (9.27e-4)"	15.4	17.0	16.0	7.8	15.2	2.2	11.0	39.9	33.4	16.9	16.1	12.4	17.4	4.1	19.7	12.3	10.0	11.8	12.1	9.8	15.5	13.6	12.8	4.0	11.3	7.9	14.2	15.8	29.8	4.4	15.1	14.6	17.0	18.4	19.4	6.6	8.9	4.1	23.9	4.8	4.7	8.1	20.4	12.1	9.9	8.7	10.4	14.8	2.9	17.7	5.0	6.2	17.2	18.6	1.9	0.8	1.2	0.9	3.8	3.6	0.6	23.5	2.4	14.9	0.0	11.0	12.6	7.9	13.3	12.2	8.6	7.6	0.1	9.7	0.0	0.0	16.8	0.3	8.2	5.3	11.4	5.9	6.4	0.3	0.0	0.0	5.7	0.1	2.6	6.5	0.0	10.7	9.7	17.6	0.0	0.1	3.9	0.0	5.0	1.1	6.3	3.7	2.7	9.1	0.1	2.9	0.8	19.1	25.3	0.1	0.0	23.8	0.0	8.0	13.8	15.3	11.8	0.1	11.0	1.3	0.4	2.8	11.2	1.2	12.8	1.2	0.9	0.5	2.3	0.3	3.6	1.0	2.2	2.5	0.8	1.9	1.9	1.7	0.2	3.8	0.7	0.6	0.7	0.6	16.0	15.2	39.9	22.9	15.5	13.6	14.2	15.8	18.4	14.8
AKTIP	"FLJ13258, FTS"	ENSG00000166971	"AKT interacting protein"	Q9H8T0	16	53491040-53504411	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041794, HPA046300"	Approved									"HPA041794: AB_2677677, HPA046300: "	"unprognostic (2.08e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"prognostic favourable (1.18e-14)"	"unprognostic (2.39e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.31e-1)"	13.4	11.2	29.6	8.0	22.7	14.9	10.7	19.3	27.2	11.2	11.9	13.4	15.2	8.1	11.9	17.2	17.7	11.0	9.2	31.6	26.0	25.7	19.7	20.3	12.7	10.5	29.6	14.7	16.9	8.5	28.2	14.5	45.2	24.8	13.5	9.6	13.9	13.0	17.4	62.4	12.3	16.7	13.6	27.5	8.4	9.0	21.7	15.2	7.2	16.9	19.5	13.2	12.8	10.6	5.4	1.4	13.1	2.0	11.6	23.7	8.8	18.8	12.3	8.5	11.1	11.5	8.7	24.9	12.0	9.1	10.7	2.7	16.7	10.0	3.1	7.4	12.2	16.4	7.2	9.7	14.4	4.6	11.1	0.9	6.4	13.0	15.0	4.3	8.5	7.4	27.4	10.6	9.2	18.1	1.7	6.9	9.4	14.6	3.7	6.4	5.8	11.6	4.5	14.1	14.1	13.9	15.9	6.6	8.3	7.0	25.6	10.5	22.8	2.7	16.8	11.5	12.5	7.4	11.6	10.2	8.9	6.6	12.3	3.8	7.3	7.9	2.0	4.8	15.8	1.5	9.5	3.8	15.4	16.4	0.9	5.4	23.7	19.0	13.1	11.6	1.4	1.4	20.6	8.8	29.6	22.7	19.3	27.2	26.0	25.7	29.6	14.7	24.8	15.2
ALAD	"ALADH, PBGS"	ENSG00000148218	"Aminolevulinate dehydratase"	P13716	9	113386317-113401333	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021023, HPA022124"	Enhanced						44000000			"HPA021023: AB_1844716, HPA022124: AB_1844717"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"prognostic unfavourable (7.33e-5)"	"prognostic favourable (5.64e-4)"	"unprognostic (4.16e-2)"	"unprognostic (9.49e-2)"	"prognostic favourable (8.80e-5)"	"unprognostic (2.87e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.31e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-2)"	19.9	70.3	24.1	6.4	26.3	27.3	13.7	14.0	24.8	8.3	10.5	28.3	8.8	11.6	7.5	11.5	14.6	6.8	13.0	23.3	24.6	20.8	29.9	84.2	8.4	5.9	37.5	20.6	12.3	18.8	24.1	7.2	10.2	27.9	14.5	10.2	9.8	37.2	15.1	10.6	15.6	10.7	8.9	40.1	5.9	18.1	5.4	28.6	4.7	10.9	6.6	7.5	9.0	8.0	7.6	12.1	19.1	13.1	5.5	9.7	7.6	3.4	6.0	4.7	6.6	32.9	22.7	30.0	9.3	15.7	6.2	7.8	8.3	7.2	4.8	5.7	13.2	12.7	3.4	6.4	3.6	12.0	4.3	9.6	7.5	10.9	7.5	8.7	8.2	19.1	4.8	5.6	2.5	12.1	3.6	7.2	10.1	25.1	10.0	8.7	2.4	11.9	7.9	8.2	8.3	9.6	7.2	4.3	4.1	11.8	14.4	8.5	15.2	10.0	13.1	5.5	4.2	10.8	5.2	10.7	10.0	3.8	15.5	8.1	5.9	7.2	11.5	19.1	9.7	13.1	5.4	5.9	8.4	5.4	12.1	7.6	8.1	8.9	5.6	5.5	12.7	4.9	8.5	7.6	24.1	26.3	14.0	24.8	24.6	20.8	37.5	20.6	27.9	28.6
ALAS1	"ALAS, ALAS3"	ENSG00000023330	"5'-aminolevulinate synthase 1"	P13196	3	52198086-52214327	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Heme biosynthesis"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 167.6;liver: 136.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 55.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017498, HPA035860"	Enhanced		Enhanced	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB017498: AB_2225629, HPA035860: AB_10672992"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.21e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (3.98e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.64e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (8.45e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.75e-2)"	9.2	167.6	7.8	6.7	10.6	39.1	8.9	17.0	15.4	6.0	11.0	12.0	15.3	11.4	6.3	11.8	10.5	4.7	8.7	24.8	8.8	7.0	14.1	136.4	13.5	10.0	7.6	9.9	5.8	6.1	8.5	5.8	13.4	12.2	7.3	11.1	8.3	15.7	16.9	24.6	6.8	17.4	6.5	7.3	6.3	12.2	9.7	5.0	7.5	7.4	11.4	9.6	12.1	7.6	6.8	8.4	55.0	12.2	8.8	11.3	6.3	10.4	16.2	11.5	10.6	18.0	13.4	31.4	15.4	14.3	20.6	20.0	21.6	19.8	9.8	3.9	10.7	6.2	16.5	12.6	16.9	19.0	6.4	12.6	12.8	16.4	25.5	20.4	25.3	16.7	11.9	32.7	10.9	18.8	7.4	8.1	18.7	8.5	9.6	31.0	9.9	28.2	5.8	7.2	15.5	18.1	63.4	6.1	4.0	24.9	12.3	13.9	7.0	29.0	13.5	11.5	11.4	23.7	22.2	12.0	20.8	14.8	12.9	22.1	18.3	55.0	9.2	27.8	6.9	12.2	11.3	6.8	7.2	7.7	8.4	6.0	6.5	7.0	14.2	8.8	10.2	4.8	9.7	6.3	7.8	10.6	17.0	15.4	8.8	7.0	7.6	9.9	12.2	5.0
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 308.4"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.1	308.4	0.0	7.9	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	6.8	0.0	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 122.5"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 64.6;U-138 MG: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 20.7"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced				"Intracellular and membrane"		1800000000			"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	16.6	14.1	23.6	5.2	31.1	4.2	34.2	4.2	25.3	12.9	8.2	25.0	13.9	7.2	7.0	15.4	4.0	20.6	9.9	4.7	23.2	24.3	9.6	19.4	29.6	4.2	45.1	19.7	24.6	15.3	122.5	11.9	5.3	31.5	14.0	6.6	3.0	17.9	17.5	0.9	5.9	7.3	10.8	35.3	3.0	14.2	2.3	43.8	2.2	25.6	2.7	6.2	9.9	5.5	3.5	20.7	3.7	3.2	0.4	1.6	2.0	38.4	14.8	10.7	5.4	16.2	7.1	0.1	31.5	18.4	20.3	28.6	0.1	8.0	2.7	13.1	44.3	29.8	1.7	25.0	60.2	2.5	2.6	0.3	11.4	0.7	18.2	15.6	0.1	12.6	18.7	26.0	64.6	22.3	0.0	4.6	26.6	2.6	2.2	5.7	2.2	16.8	1.4	0.9	0.1	30.8	4.3	7.7	21.5	3.2	3.1	2.0	6.0	10.3	46.2	77.9	26.6	3.4	37.2	0.0	0.0	0.2	17.7	3.3	33.2	0.0	3.2	2.4	0.4	1.5	1.4	3.5	1.1	0.7	20.7	2.2	0.2	0.2	3.7	0.4	0.8	7.4	1.6	2.0	23.6	31.1	4.2	24.6	23.2	24.3	45.1	19.7	31.5	43.8
ALDH16A1	MGC10204	ENSG00000161618	"Aldehyde dehydrogenase 16 family member A1"	Q8IZ83	19	49453169-49471048	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059488	Approved		Approved	Mitochondria			910000	Mitochondria		"HPA059488: "	"unprognostic (2.39e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.92e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.28e-2)"	"unprognostic (1.91e-3)"	"unprognostic (2.94e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.23e-3)"	13.3	11.0	6.9	16.9	9.6	13.3	10.5	6.0	8.2	12.3	14.2	6.6	7.4	21.0	12.5	7.7	11.4	9.9	15.3	6.2	4.8	3.0	10.5	22.0	8.7	14.2	12.1	3.1	8.9	15.1	6.5	6.0	10.8	8.5	7.8	4.0	6.2	8.0	9.6	6.5	15.2	19.9	5.6	5.2	21.8	12.4	4.5	9.6	16.8	9.4	10.6	14.6	9.6	9.9	13.2	12.0	12.0	19.8	5.8	7.4	4.5	11.4	15.6	3.7	8.8	1.7	1.2	12.3	7.4	2.3	5.8	6.0	8.0	4.4	17.3	11.8	1.0	7.9	1.5	4.2	0.7	10.8	9.0	13.4	5.6	11.4	2.5	8.2	30.1	2.1	2.5	2.8	2.2	3.7	9.3	18.0	1.4	11.6	5.8	23.3	8.1	0.0	9.8	5.3	12.9	2.7	13.6	6.7	7.6	6.6	7.4	6.1	6.8	9.4	8.3	8.5	5.6	3.8	8.1	15.0	17.3	5.0	2.1	11.6	5.9	7.6	7.1	12.0	6.8	17.7	7.4	12.5	6.8	7.4	11.3	13.2	6.3	6.4	1.3	5.8	19.8	12.0	5.4	4.5	6.9	9.6	6.0	8.2	4.8	3.0	12.1	3.1	8.5	9.6
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Supported	Mitochondria			23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favourable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.2	17.3	16.6	43.6	22.4	21.7	17.9	21.3	32.1	21.7	27.3	34.6	14.6	62.1	20.0	33.5	24.2	33.3	21.9	24.7	17.6	26.2	19.7	12.3	49.1	14.7	34.3	22.0	22.7	13.5	17.7	34.7	22.7	18.3	13.1	16.2	26.2	31.0	22.1	19.6	17.3	29.2	19.1	21.3	25.3	13.9	16.6	16.5	16.9	13.5	15.7	20.1	16.0	18.8	9.0	14.4	23.2	24.4	15.1	11.2	38.0	17.6	39.8	11.5	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell line enhanced"	"Detected in some"		"A549: 287.9;Hep G2: 88.6;RPTEC TERT1: 51.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"					"Region enriched"	"Detected in many"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Approved	Approved	Enhanced	Cytosol			62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favourable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	287.9	0.0	0.0	1.6	0.0	0.1	10.0	0.0	0.0	0.0	9.6	0.0	0.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.3	0.0	88.6	1.0	0.0	0.0	0.5	0.0	0.0	0.0	10.3	1.1	0.0	11.0	0.4	0.0	0.1	0.0	0.0	0.0	3.2	0.1	51.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Cell line enhanced"	"Detected in some"		"Hep G2: 23.4;Karpas-707: 24.1;RPMI-8226: 12.6;RT4: 64.5;U-266/70: 13.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol			640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favourable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.6	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.1	0.0	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.4	3.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	24.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.6	0.3	64.5	0.1	0.1	0.3	3.1	0.0	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.3	4.1	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2
ALDH2		ENSG00000111275	"Aldehyde dehydrogenase 2 family (mitochondrial)"	P05091	12	111766887-111817529	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 279.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.2;HHSteC: 29.4;SK-BR-3: 59.1;THP-1: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.8;myeloid DC: 46.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 46.6;monocytes: 45.8"									HPA051065	Approved						1400000			"HPA051065: "	"unprognostic (9.22e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.14e-3)"	"prognostic favourable (2.63e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-3)"	"prognostic favourable (3.95e-7)"	"unprognostic (5.62e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.51e-1)"	"prognostic favourable (5.24e-6)"	"unprognostic (9.70e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (7.71e-4)"	88.9	34.0	42.1	17.0	44.6	9.9	39.6	14.3	30.9	10.4	25.3	17.5	16.8	25.6	9.0	11.6	26.4	10.3	28.5	45.0	30.9	24.2	59.0	279.7	38.1	13.3	34.1	32.6	16.1	14.0	2.2	7.6	4.0	30.6	13.5	26.2	13.1	17.9	30.7	40.1	43.5	25.5	29.4	26.6	8.0	34.9	9.5	23.8	3.3	12.0	28.1	18.2	17.0	22.9	1.4	46.6	10.8	45.8	0.7	0.2	21.7	2.4	3.8	5.5	9.4	26.2	3.9	18.0	2.6	4.9	1.2	0.9	6.7	3.5	0.1	13.5	5.9	4.7	0.0	1.3	0.8	0.1	1.8	0.2	2.4	18.2	29.4	0.2	0.2	7.2	6.7	4.4	0.1	7.8	4.9	0.8	1.2	0.1	0.2	6.6	7.3	0.6	0.1	0.1	0.5	9.1	0.1	2.2	6.8	6.6	59.1	0.0	5.9	26.3	0.3	0.1	5.0	0.1	0.1	1.6	0.8	7.1	6.5	0.2	0.1	0.9	45.8	10.8	0.1	20.1	0.2	1.4	0.0	0.1	46.6	1.2	0.1	0.1	2.3	0.7	5.0	15.5	0.1	21.7	42.1	44.6	14.3	30.9	30.9	24.2	34.1	32.6	30.6	23.8
ALDH4A1	"ALDH4, P5CDh"	ENSG00000159423	"Aldehyde dehydrogenase 4 family member A1"	P30038	1	18871430-18902781	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Proline metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 73.7;liver: 92.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.9;SK-BR-3: 35.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 72.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004645, HPA006401"	Enhanced						40000			"CAB004645: AB_425775, HPA006401: AB_1844731"	"unprognostic (1.17e-1)"	"prognostic favourable (5.06e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.34e-2)"	22.9	4.1	14.4	2.0	18.0	4.6	6.6	3.1	16.8	3.8	2.4	8.6	18.9	1.3	2.5	5.2	11.4	2.7	3.0	12.6	8.6	7.1	73.7	92.6	2.4	1.7	15.9	11.2	2.9	2.2	9.4	2.4	8.3	8.5	12.1	1.6	9.7	2.4	12.1	25.6	8.0	1.3	3.3	2.7	2.1	3.4	1.4	6.6	2.8	3.0	8.9	2.9	8.3	3.6	1.5	7.2	2.6	5.6	0.3	1.4	2.2	5.0	7.9	4.0	11.9	17.0	2.5	9.8	4.8	3.0	5.0	4.0	5.7	3.8	3.4	6.5	6.2	13.5	6.8	14.4	1.8	1.9	6.0	1.9	1.8	33.9	5.3	1.6	6.1	6.6	8.1	2.8	2.7	5.6	7.5	2.5	3.4	12.9	1.6	8.2	1.9	4.0	10.5	3.3	3.9	5.2	12.8	7.9	3.0	8.5	35.0	6.3	15.9	2.6	4.6	4.3	5.7	5.2	1.7	2.7	6.5	0.9	1.5	13.2	5.7	0.0	4.1	2.6	1.1	5.6	0.9	1.5	0.7	1.4	7.2	1.1	0.3	0.9	0.6	0.3	3.1	2.4	1.0	2.2	14.4	18.0	3.1	16.8	8.6	7.1	15.9	11.2	8.5	6.6
ALDH7A1	"ATQ1, EPD, PDE"	ENSG00000164904	"Aldehyde dehydrogenase 7 family member A1"	P49419	5	126531200-126595418	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 64.4"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023296	Enhanced		Supported	Mitochondria,Cytosol			140000	Mitochondria	Cytosol	"HPA023296: AB_1844738"	"unprognostic (1.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.58e-3)"	"unprognostic (9.49e-3)"	"unprognostic (7.61e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (3.08e-4)"	"unprognostic (1.51e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.93e-2)"	9.0	14.2	46.0	3.4	39.1	0.8	18.8	11.0	22.5	14.0	11.5	23.1	7.2	9.5	10.5	7.5	13.5	11.9	7.8	10.8	35.0	17.3	46.5	64.4	6.4	3.1	28.7	18.5	27.6	10.8	17.7	5.9	17.7	16.9	17.6	11.2	13.7	15.0	12.2	4.5	11.9	8.1	9.8	20.2	2.8	9.0	4.9	28.4	4.0	19.4	10.1	7.4	7.2	7.1	1.3	9.7	0.7	0.3	0.1	1.8	0.6	14.8	9.8	27.8	46.0	23.2	13.8	35.5	17.8	22.0	20.7	26.8	27.6	14.3	0.0	18.2	13.9	11.1	8.6	60.2	19.1	0.0	10.4	2.8	14.7	23.4	11.3	0.0	0.0	16.9	14.2	16.1	11.6	16.5	0.0	0.0	18.2	9.7	0.6	0.0	18.8	8.3	8.9	31.6	0.0	19.7	11.3	9.5	11.3	0.0	9.8	10.3	17.7	0.6	20.0	6.0	18.6	6.9	12.2	0.0	0.0	0.0	3.2	0.0	9.6	0.7	0.3	0.1	0.2	0.0	0.3	1.3	0.3	0.2	2.7	1.1	1.8	1.0	0.3	0.1	0.0	9.7	0.1	0.6	46.0	39.1	11.0	22.5	35.0	17.3	28.7	18.5	16.9	28.4
ALDH9A1	"ALDH4, ALDH7, ALDH9, E3"	ENSG00000143149	"Aldehyde dehydrogenase 9 family member A1"	P49189	1	165662216-165698863	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006077, HPA010873"	Approved		Approved	Cytosol	"Intracellular and membrane"		1100000	Cytosol		"HPA006077: , HPA010873: AB_1078126"	"unprognostic (2.24e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.83e-1)"	"prognostic favourable (4.56e-4)"	"unprognostic (5.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.15e-1)"	39.1	52.7	30.8	17.4	25.4	7.7	39.6	16.2	26.6	20.3	18.0	22.7	17.1	19.5	15.5	35.5	47.0	18.8	22.2	22.2	24.8	21.1	50.5	73.5	20.7	20.4	23.7	18.4	20.6	17.8	31.2	19.2	14.1	22.8	24.6	18.7	27.2	52.2	23.2	29.9	22.6	23.9	19.2	21.9	18.8	14.7	37.3	21.5	12.4	45.1	24.2	27.9	18.5	19.1	29.6	20.2	29.4	24.5	23.1	39.0	24.4	17.4	17.1	16.0	14.3	51.2	45.1	13.4	23.2	32.9	23.3	20.3	10.6	13.2	0.0	22.2	20.7	13.8	12.9	22.6	27.7	8.1	16.4	11.1	12.3	11.5	26.4	17.5	11.9	28.9	11.5	24.7	20.8	20.2	17.6	15.8	36.3	10.5	11.6	18.0	23.3	21.1	10.0	20.4	23.4	30.3	16.6	19.0	13.1	16.5	18.6	21.2	35.5	26.6	19.9	14.1	13.8	17.2	11.7	14.7	19.2	17.5	15.9	16.7	13.5	26.8	20.3	28.1	28.3	21.5	30.1	29.6	27.7	30.6	20.2	26.0	28.1	32.0	29.4	23.1	24.5	12.6	39.0	24.4	30.8	25.4	16.2	26.6	24.8	21.1	23.7	18.4	22.8	21.5
ALDOA		ENSG00000149925	"Aldolase, fructose-bisphosphate A"	P04075	16	30064164-30070457	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 1296.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA004177, CAB006252"	Enhanced		Supported	Cytosol			1200000000	Cytosol		"CAB006252: AB_437007, HPA004177: AB_1078128"	"unprognostic (2.63e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.74e-3)"	"unprognostic (4.28e-3)"	"prognostic unfavourable (5.79e-5)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.19e-3)"	"unprognostic (4.48e-2)"	27.9	30.9	34.7	24.2	42.3	36.0	25.3	31.2	59.7	21.0	32.8	16.3	25.9	29.4	21.9	33.9	73.5	22.1	24.4	109.3	31.6	33.4	28.2	11.1	17.9	34.0	35.0	49.6	23.4	19.4	51.0	25.2	19.9	38.0	23.6	23.5	24.6	37.9	36.9	1296.2	28.4	21.5	30.1	22.7	17.4	24.4	9.2	18.9	18.5	26.6	189.8	29.0	36.8	27.7	61.1	142.9	165.7	166.3	50.5	93.2	217.0	138.7	104.6	31.5	101.2	48.3	55.1	100.7	84.0	87.6	85.7	107.2	73.9	107.0	94.6	137.8	84.8	106.0	63.1	183.2	62.9	41.6	83.0	77.4	83.9	163.2	75.4	112.5	83.1	75.5	64.7	96.2	64.7	63.1	66.6	62.5	90.8	197.9	68.4	93.0	78.3	88.2	102.1	50.6	211.5	106.7	79.0	63.1	44.4	52.4	221.1	78.4	94.0	76.3	75.0	126.6	50.5	69.0	90.8	123.5	84.3	86.6	235.6	109.3	99.9	106.7	164.0	130.3	70.2	156.8	79.1	61.1	76.8	72.5	142.9	55.5	73.8	70.3	165.7	50.5	166.3	53.8	93.2	217.0	34.7	42.3	31.2	59.7	31.6	33.4	35.0	49.6	38.0	18.9
ALDOA		ENSG00000285043	"Aldolase, fructose-bisphosphate A"	P04075	16	30053090-30070420	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation, Glycogen storage disease, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004177	Uncertain		Supported	Cytosol			1200000000	Cytosol		"HPA004177: AB_1078128"																		1.8	0.9	2.7	1.1	5.0	2.1	7.2	0.7	7.7	4.9	1.5	2.0	2.4	0.0	2.5	3.9	0.9	3.6	1.6	5.3	2.3		1.3	0.0	2.3	2.0	0.8	4.4	2.2	0.8	0.8	3.0	1.4	4.0	2.4	0.5	2.8	1.6	7.5	10.6	0.6	0.1	1.9	0.4	1.7	1.3	11.6	0.8	1.2	4.7	0.2	2.7	1.2	1.0	7.0	6.6	0.9	6.2	4.2	8.5	12.5	3.7	8.8	1.9	6.2	1.5	5.2	1.5	4.0	6.9	5.4	21.6	3.6	5.0	24.5	5.9	6.8	6.3	14.0	10.9	3.8	4.3	7.9	6.0	8.2	5.9	11.5	10.5	2.3	5.1	0.5	10.7	12.2	7.7	1.2	7.1	13.4	3.9	4.9	8.0	2.1	5.5	7.6	4.0	22.4	15.1	0.7	6.1	5.0	1.0	1.6	1.5	5.1	4.0	1.7	8.0	2.4	3.7	5.3	7.3	5.5	8.0	7.6	11.4	3.5	0.1	6.2	0.1	5.3	2.6	7.4	7.0	7.0	5.7	6.6	6.2	8.5	6.6	0.9	4.2	2.3	5.6	5.4	12.5										
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.1;NB-4: 13.2;RPMI-8226: 15.2;SH-SY5Y: 13.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA002198, CAB020827"	Enhanced						930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.3	0.0	2.9	1.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.2	0.2	0.0	0.2	3.1	15.2	0.0	0.0	2.5	13.2	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.3	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1
ALDOC		ENSG00000109107	"Aldolase, fructose-bisphosphate C"	P09972	17	28573115-28577264	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 166.7;heart muscle: 56.9"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 62.2;U-266/70: 42.9"	"Cancer enriched"	"Detected in all"	6	"glioma: 128.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003282, CAB020828, HPA067442"	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center,Vesicles,Cytosol"			280000000	"Nucleoplasm, Nucleoli fibrillar center"	"Vesicles, Cytosol"	"CAB020828: , HPA003282: AB_1078130, HPA067442: "	"unprognostic (2.90e-1)"	"unprognostic (4.45e-3)"	"unprognostic (5.69e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.56e-1)"	"prognostic unfavourable (9.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.90e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavourable (1.29e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.23e-1)"	26.0	9.4	86.7	4.8	78.9	7.5	9.8	100.1	166.7	3.8	5.3	17.4	0.3	7.0	4.4	4.6	7.1	3.9	4.4	56.9	64.6	54.3	3.3	26.2	4.6	6.5	69.9	51.4	12.8	1.6	4.7	2.3	2.1	98.1	6.0	5.6	16.5	4.2	6.1	1.7	12.5	15.0	4.6	34.4	6.7	8.7	4.6	23.4	0.0	2.1	0.5	10.0	3.4	3.5	12.2	4.6	8.8	4.1	13.7	20.5	8.8	7.4	0.5	3.5	14.4	7.2	7.4	0.7	3.8	8.6	2.9	18.1	4.3	0.7	3.5	4.6	3.4	9.7	2.3	23.6	5.5	3.0	2.2	6.7	2.7	7.4	6.8	2.4	7.8	6.8	3.3	0.3	5.9	1.3	4.6	18.8	2.5	3.5	2.8	8.1	5.4	3.9	2.4	0.4	62.2	0.4	1.0	9.2	16.4	2.2	17.7	0.1	9.6	5.5	0.9	0.3	1.4	0.5	0.6	42.9	12.3	2.6	28.1	7.0	0.5	0.1	3.5	1.4	11.4	4.1	16.2	12.2	15.6	9.2	4.6	11.5	20.5	15.1	8.8	13.7	2.3	2.2	19.5	8.8	86.7	78.9	100.1	78.5	64.6	54.3	69.9	51.4	98.1	23.4
ALK	CD246	ENSG00000171094	"ALK receptor tyrosine kinase"	Q9UM73	2	29192774-29921566	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1;pituitary gland: 17.9"	"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 26.4"	"Group enriched"	"Detected in some"	5	"glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010694	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010694: AB_1078133"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.56e-7)"	"unprognostic (7.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.07e-3)"	"unprognostic (6.29e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-4)"	"unprognostic (3.70e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.61e-2)"	1.8	3.1	3.6	1.2	4.4	0.3	1.1	0.5	8.1	0.7	2.1	2.0	0.0	0.7	0.5	0.5	0.6	0.5	1.2	0.4	3.4	4.9	0.4	0.5	1.1	0.5	2.7	4.2	0.6	0.4	0.4	17.9	0.5	5.5	0.5	1.2	2.4	0.9	0.8	0.3	0.9	1.5	0.9	2.1	0.5	0.8	4.9	0.9	0.0	1.6	0.0	0.3	0.6	1.2	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	3.5	0.0	0.0	0.1	0.3	26.4	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	4.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	4.4	0.5	5.9	3.4	4.9	2.7	4.2	5.5	0.9
ALKBH1	"ABH, alkB, ALKBH, hABH"	ENSG00000100601	"AlkB homolog 1, histone H2A dioxygenase"	Q13686	14	77672404-77708020	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, RNA repair, Translation regulation"	"Dioxygenase, Lyase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044087, HPA060061"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Intracellular and membrane"			Nucleoplasm	"Endoplasmic reticulum"	"HPA044087: , HPA060061: "	"unprognostic (1.92e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.74e-3)"	"unprognostic (7.45e-3)"	"unprognostic (2.68e-2)"	"unprognostic (3.95e-2)"	"unprognostic (5.05e-3)"	"unprognostic (2.16e-2)"	"prognostic favourable (1.80e-4)"	"unprognostic (1.65e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.44e-2)"	8.2	8.5	6.2	6.7	8.6	2.7	9.7	9.6	8.8	9.7	9.1	8.2	4.5	6.5	7.0	5.9	7.1	8.0	5.8	11.1	5.4	5.7	7.9	9.4	5.9	8.3	6.5	3.7	8.3	7.9	8.4	11.2	10.2	6.4	9.3	9.1	9.9	7.2	8.7	16.5	8.2	6.7	7.8	5.5	8.3	7.8	9.9	6.6	12.7	8.8	6.5	10.3	8.5	9.4	5.4	4.9	11.4	5.7	5.2	5.3	3.2	5.2	7.8	6.4	4.3	6.9	7.5	8.0	5.5	7.2	12.2	13.7	7.9	3.2	8.1	3.1	5.0	4.8	13.9	5.9	14.4	5.5	5.4	4.3	4.6	6.6	9.7	4.5	2.8	6.4	9.9	7.1	11.3	9.9	6.6	4.7	6.5	8.3	6.0	5.9	7.0	10.1	6.1	6.5	5.4	7.0	4.7	8.2	6.1	4.5	4.7	5.9	11.6	4.7	4.5	5.1	5.2	5.6	4.4	5.9	9.3	7.9	3.4	6.5	5.0	11.4	5.0	2.2	5.0	5.7	4.3	5.4	4.7	5.0	4.9	4.9	5.0	3.9	1.4	5.2	3.8	2.6	5.3	3.2	6.2	8.6	9.6	8.8	5.4	5.7	6.5	3.7	6.4	6.6
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Biomineralization	Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	6	"HaCaT: 86.1;SiHa: 23.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB026327: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	9.7	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.7	8.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALPPL2		ENSG00000163286	"Alkaline phosphatase, placental like 2"	P10696	2	232406843-232410714	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.2;lung: 9.4"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 24.5;HaCaT: 18.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 49.1;testis cancer: 64.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB020698, HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB020698: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (1.39e-1)"	"unprognostic (6.63e-3)"	"unprognostic (1.27e-2)"		"unprognostic (2.89e-1)"		"unprognostic (1.46e-1)"		"unprognostic (1.26e-1)"	"unprognostic (1.69e-3)"			"unprognostic (1.65e-1)"	"unprognostic (2.67e-1)"		"unprognostic (6.72e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	0.2	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.5	24.5	0.0	0.0	0.0	18.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ALS2CR12		ENSG00000155749	"Amyotrophic lateral sclerosis 2 chromosome region 12"	Q96Q35	2	201288271-201357398	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.3;epididymis: 14.4;testis: 29.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 6.9;U-2197: 9.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 14.3"	"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA035793			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035793: AB_10602429"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.72e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.40e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.25e-2)"	0.8	0.9	1.5	0.7	3.6	4.3	0.5	0.7	1.1	0.9	0.6	7.6	0.4	0.3	0.7	14.4	1.1	9.9	0.9	4.7	2.1	2.6	1.3	0.7	3.7	1.4	1.0	1.3	5.3	0.7	1.2	1.3	0.9	14.3	0.4	0.9	0.5	0.7	0.7	1.4	1.1	0.9	0.9	0.9	0.8	0.5	29.9	1.3	0.4	1.7	0.4	0.5	0.6	0.4	1.8	0.5	7.3	1.1	2.8	1.5	0.4	0.3	0.4	2.0	1.4	5.6	2.2	0.1	1.5	0.5	1.2	0.8	0.0	0.4	0.7	1.2	2.1	2.0	0.7	0.2	0.6	1.2	0.2	0.3	2.5	0.7	1.1	2.1	1.8	1.0	0.5	1.3	0.3	0.2	1.0	2.9	1.2	0.0	1.1	1.8	0.6	1.2	0.5	1.0	1.3	0.7	0.5	0.5	1.3	1.6	0.0	6.9	1.5	2.4	1.5	2.8	1.7	9.4	1.0	1.6	3.0	1.0	2.7	1.0	1.3	5.4	1.1	1.0	1.5	0.5	0.7	0.6	1.0	0.9	0.5	1.8	1.2	1.4	7.3	2.8	0.6	0.4	0.6	0.4	1.5	3.6	0.7	1.0	2.1	2.6	1.0	1.3	14.3	1.3
AMACR	"P504S, RACE"	ENSG00000242110	"Alpha-methylacyl-CoA racemase"	Q9UHK6	5	33986178-34008108	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 68.0;liver: 63.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 58.5;U-266/84: 30.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 34.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001809, HPA019527, HPA020912"	Enhanced		Supported	"Vesicles,Plasma membrane"			65000	"Vesicles, Plasma membrane"		"CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034"	"unprognostic (8.96e-2)"	"unprognostic (5.20e-3)"	"prognostic favourable (7.11e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.59e-5)"	"unprognostic (1.95e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.32e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.50e-1)"	2.8	8.3	5.2	2.7	8.2	0.9	2.8	4.7	7.8	4.4	14.1	4.3	6.5	6.2	4.0	3.6	8.2	2.3	11.0	3.5	4.5	6.8	68.0	63.6	3.3	2.0	4.5	4.5	2.9	5.1	5.4	4.3	3.2	7.0	13.9	15.5	5.5	25.4	5.4	6.0	2.6	7.4	3.7	3.8	2.9	15.9	2.1	2.1	3.8	3.3	3.4	3.3	5.7	4.5	7.8	10.2	11.2	14.2	9.9	10.0	6.8	4.0	6.5	3.7	4.7	2.6	4.0	6.3	5.4	4.0	2.5	1.9	21.1	4.9	1.3	2.9	7.6	1.9	0.9	3.9	2.6	4.0	3.4	3.1	4.7	6.1	1.8	1.9	1.0	6.1	1.9	3.2	1.2	2.8	1.1	4.8	7.3	2.9	1.5	2.4	3.3	10.6	1.9	6.1	2.0	11.1	20.3	2.0	2.8	8.9	6.4	5.4	4.9	1.9	5.0	8.3	1.8	2.0	4.3	58.5	30.5	2.3	2.3	3.9	6.1	0.3	7.1	10.2	10.0	8.8	8.4	7.8	8.7	7.8	10.2	7.0	8.1	6.1	11.2	9.9	14.2	5.3	8.9	6.8	5.2	8.2	4.7	7.8	4.5	6.8	4.5	4.5	7.0	2.1
AMBP	"EDC1, HCP, HI30, IATIL, ITI, ITIL, ITILC, UTI"	ENSG00000106927	"Alpha-1-microglobulin/bikunin precursor"	P02760	9	114060127-114078472	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"liver: 592.2"	"Cell line enriched"	"Detected in some"	154	"Hep G2: 164.4"	"Cancer enriched"	"Detected in many"	115	"liver cancer: 2620.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001497, CAB069436, HPA075585"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"		71000000000	"Golgi apparatus"	Cytosol	"CAB069436: AB_1611916, HPA001497: AB_1078144, HPA075585: "	"unprognostic (6.92e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.95e-3)"	"prognostic favourable (1.20e-4)"	"unprognostic (9.79e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.89e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.97e-3)"	"unprognostic (9.45e-3)"	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.8	0.1	0.0	0.0	1.7	592.2	0.1	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	164.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.8	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AMPD3		ENSG00000133805	"Adenosine monophosphate deaminase 3"	Q01432	11	10308313-10507579	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.2;skeletal muscle: 61.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.3;CAPAN-2: 19.0;HMC-1: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038662, HPA047408"	Uncertain		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA038662: , HPA047408: "	"unprognostic (2.24e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.44e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (1.89e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.25e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.68e-1)"	"unprognostic (3.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.12e-2)"	2.9	13.7	5.3	13.8	14.0	39.2	2.3	2.3	7.8	3.3	3.4	19.6	0.7	4.7	3.1	4.2	5.2	8.0	4.6	2.1	7.4	7.1	4.2	1.5	4.5	12.7	15.2	5.7	2.3	2.5	24.9	14.5	3.7	11.2	5.5	4.9	4.3	4.7	2.8	61.0	10.8	5.0	3.1	12.8	8.3	4.6	1.4	12.6	14.8	2.7	7.6	14.2	6.1	5.1	7.6	3.9	17.0	6.0	3.3	5.3	2.3	7.4	1.1	0.3	0.1	4.0	2.9	0.4	6.8	24.3	1.7	1.7	3.7	19.0	2.7	0.6	3.1	4.7	0.1	6.4	5.0	6.7	0.2	6.7	0.9	0.5	1.3	9.1	20.2	10.6	10.0	3.3	4.3	0.7	10.1	2.9	5.5	0.2	5.3	11.9	0.9	6.7	2.0	8.8	9.8	0.3	6.3	2.8	1.5	1.5	0.2	0.4	0.2	3.1	1.8	7.7	0.1	5.3	0.2	2.7	1.5	2.9	8.9	9.1	0.2	6.6	6.0	17.0	2.3	3.8	5.3	7.6	3.3	2.5	3.9	5.8	3.7	2.5	8.3	3.3	1.6	2.5	1.9	2.3	5.3	14.0	2.3	7.8	7.4	7.1	15.2	5.7	11.2	12.6
AMT	"GCST, NKH"	ENSG00000145020	Aminomethyltransferase	P48728	3	49416775-49422753	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 10.2;Hep G2: 29.5;NTERA-2: 5.3;SH-SY5Y: 7.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005566	Supported		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005566: AB_1844811"	"unprognostic (2.10e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.14e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.29e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.90e-8)"	"unprognostic (4.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.98e-3)"	4.7	10.9	6.6	8.0	8.8	6.0	6.6	16.7	10.4	8.4	10.0	7.4	21.3	10.9	9.2	11.1	3.4	9.7	13.0	16.6	7.4	2.0	21.4	41.2	5.6	2.3	7.6	8.3	14.5	18.5	16.3	10.4	2.5	10.7	9.1	10.1	12.2	9.8	20.0	3.8	5.4	11.0	7.1	5.8	7.9	8.1	2.6	7.4	1.7	8.7	0.4	1.8	6.2	8.1	0.7	5.4	4.7	3.2	8.9	1.6	2.3	0.1	0.5	0.7	0.1	0.4	0.0	10.2	0.0	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.2	0.1	0.0	0.3	29.5	1.1	0.0	0.1	0.3	0.7	0.0	0.4	0.1	0.0	0.0	0.1	0.2	0.2	0.2	5.3	0.1	0.0	0.1	0.2	0.7	0.2	0.0	7.8	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	3.2	4.7	0.0	1.9	0.1	0.6	0.0	0.0	5.4	0.7	1.6	1.5	0.3	8.9	0.7	0.5	0.0	2.3	6.6	8.8	16.7	10.4	7.4	2.0	7.6	8.3	10.7	7.4
AMY2B	AMY2	ENSG00000240038	"Amylase, alpha 2B (pancreatic)"	P19961	1	103553815-103579534	"Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pancreas: 939.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 11.3;EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	15	"pancreatic cancer: 25.1"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 8.5"	"Low lineage specificity"	"Detected in many"											"HPA045394, HPA045399, HPA046980"	Supported				"Secreted to digestive system"		75000000			"HPA045394: , HPA045399: , HPA046980: "	"unprognostic (8.69e-4)"	"unprognostic (3.71e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.51e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.55e-2)"	"unprognostic (5.74e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.12e-4)"	1.7	0.5	0.8	0.8	1.5	0.4	1.0	2.6	0.8	0.9	0.9	0.8	0.8	0.5	0.8	1.0	0.8	1.5	0.9	1.1	0.8	0.5	1.5	1.1	1.0	1.1	1.0	0.9	1.2	939.9	0.8	1.1	0.8	0.8	0.9	0.4	0.9	145.7	1.0	1.7	1.3	0.9	0.8	0.8	1.0	0.4	0.8	0.8	0.8	2.4	1.1	0.8	0.8	0.8	1.8	2.6	1.9	8.5	0.1	1.1	1.9	0.0	0.6	1.2	0.0	6.3	11.3	1.2	0.9	0.9	0.7	1.7	0.0	0.2	1.1	11.6	0.3	1.3	0.1	1.4	1.6	1.4	1.7	2.0	4.3	0.8	0.9	2.6	2.8	7.7	7.5	0.8	1.3	0.2	0.0	3.4	0.9	0.0	2.0	0.5	0.1	1.6	0.6	0.0	5.0	6.5	2.1	3.1	0.5	2.6	1.2	0.8	0.1	1.5	0.9	0.4	1.0	0.5	0.7	3.9	0.1	0.3	2.1	1.9	0.2	0.0	8.5	1.7	0.8	3.9	0.6	1.7	0.3	0.4	2.6	1.8	1.1	0.4	1.9	0.1	3.6	0.8	0.3	1.9	0.8	1.5	2.6	0.8	0.8	0.5	1.0	0.9	0.8	0.8
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	15.6	20.3	17.8	14.7	25.1	12.2	19.9	24.8	25.1	20.6	16.2	16.8	12.2	11.9	21.4	19.8	34.2	20.9	15.6	18.8	19.1	18.5	21.4	16.8	16.6	20.8	16.2	22.1	18.1	16.7	26.6	14.9	9.6	17.6	21.8	18.9	16.4	19.7	21.3	29.7	16.0	13.3	24.0	17.1	16.8	14.9	36.3	16.3	25.8	23.2	24.5	22.2	19.2	22.5	14.9	17.7	17.6	15.1	20.1	22.4	12.5	18.3	25.3	18.6	15.8	19.5	9.9	10.6	12.9	11.8	23.9	16.6	25.8	11.8	29.4	13.2	17.3	18.7	27.6	17.7	24.4	15.6	22.3	26.0	18.8	21.3	14.2	23.2	12.3	10.7	12.8	20.7	13.8	23.1	40.7	6.0	18.7	19.7	35.1	17.3	16.1	22.1	27.2	18.4	35.0	16.2	23.6	24.2	13.9	20.2	15.9	21.2	33.7	21.1	14.5	14.3	13.4	12.7	15.2	10.6	21.7	39.6	15.9	19.9	16.5	14.3	10.5	17.6	17.2	15.1	20.2	13.3	18.5	16.5	17.7	14.9	15.5	16.5	8.3	20.1	13.1	9.7	22.4	12.5	17.8	25.1	24.8	25.1	19.1	18.5	16.2	22.1	17.6	16.3
ANG	"RAA1, RNASE5"	ENSG00000214274	Angiogenin	P03950	14	20684177-20698971	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Stress response"	"Developmental protein, DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein synthesis inhibitor"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 371.4"	"Cell line enriched"	"Detected in many"	5	"Hep G2: 56.6"	"Cancer enriched"	"Detected in all"	17	"liver cancer: 279.2"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 18.1;myeloid DC: 10.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA055896			Approved	"Nucleoli,Actin filaments"	"Secreted to blood"	307535000	230000000	Nucleoli	"Actin filaments"	"HPA055896: "	"unprognostic (2.50e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (6.85e-4)"	"unprognostic (5.71e-3)"	"unprognostic (6.99e-2)"	"prognostic favourable (7.83e-5)"	"unprognostic (1.16e-1)"	"unprognostic (3.20e-3)"	"unprognostic (9.19e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.09e-1)"	17.0	0.9	0.7	2.6	0.7	0.7	16.4	0.5	0.7	14.4	9.0	0.7	6.6	3.5	10.7	10.3	8.0	3.8	13.3	3.8	0.8	0.7	10.6	371.4	6.9	2.3	1.0	0.1	17.7	9.0	1.3	1.1	1.9	0.8	17.5	6.5	5.5	20.2	7.7	3.5	4.0	7.4	9.7	1.5	1.5	7.9	7.1	0.4	0.0	4.2	5.5	3.6	14.3	15.0	4.5	10.4	0.3	18.1	0.0	0.9	4.8	1.4	3.7	0.9	0.0	9.3	11.2	0.1	1.6	3.2	0.4	1.5	2.2	1.9	0.1	0.4	4.5	1.4	1.0	1.1	0.5	6.2	1.4	0.3	2.0	56.6	2.0	1.4	0.2	9.0	0.9	0.5	1.9	2.1	0.0	10.4	1.3	0.2	0.3	0.4	0.2	4.1	0.2	1.5	4.2	0.9	1.1	0.0	0.1	1.6	0.6	2.5	1.5	0.2	1.8	0.6	1.1	0.5	0.2	2.2	1.7	0.2	1.1	0.7	1.8	0.0	18.1	0.0	0.3	2.1	0.2	4.5	0.9	0.8	10.4	2.4	0.2	0.2	0.3	0.0	0.1	1.6	0.4	4.8	0.7	0.7	0.5	0.6	0.8	0.7	1.0	0.1	0.8	0.4
ANGEL2	"Ccr4d, FLJ12793, KIAA0759L"	ENSG00000174606	"Angel homolog 2"	Q5VTE6	1	212992182-213015826	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030795, HPA030796"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria"				Nucleoplasm	"Nuclear bodies, Mitochondria"	"HPA030795: , HPA030796: AB_10600979"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.70e-3)"	"unprognostic (6.46e-2)"	"prognostic unfavourable (8.39e-6)"	"unprognostic (9.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.20e-4)"	11.4	11.7	18.0	10.8	32.6	9.5	17.8	21.6	22.7	14.5	9.3	16.9	8.6	8.6	14.8	14.2	10.2	12.2	10.4	9.2	17.4	13.8	13.3	13.0	11.0	15.8	17.0	13.9	19.1	10.5	15.5	14.8	10.8	13.8	14.5	11.0	12.3	9.8	11.2	11.0	15.1	10.7	12.2	14.9	15.5	10.5	9.0	15.9	19.5	14.0	7.9	14.9	10.8	9.7	7.8	7.2	7.6	5.9	14.1	11.3	6.7	8.6	6.9	11.3	9.6	8.6	12.7	10.1	7.1	11.9	11.4	11.4	4.6	6.4	8.4	6.5	7.0	6.8	12.9	6.8	11.5	15.7	7.8	8.4	5.5	4.5	9.5	8.3	10.1	7.8	8.8	8.9	9.1	9.6	9.7	8.7	13.0	2.8	9.5	5.6	26.5	5.0	4.8	20.2	8.7	8.9	5.8	5.5	16.1	8.5	11.6	13.1	8.9	6.1	7.1	9.4	5.0	11.5	10.7	6.4	6.1	5.6	10.5	6.2	8.6	7.4	5.9	7.6	7.4	5.5	9.1	7.8	9.2	7.6	7.2	5.3	9.8	8.1	4.0	14.1	4.4	4.4	11.3	6.7	18.0	32.6	21.6	22.7	17.4	13.8	17.0	13.9	13.8	15.9
ANGPT1	"Ang1, KIAA0003"	ENSG00000154188	"Angiopoietin 1"	Q15389	8	107249482-107498055	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.2;HEL: 16.9;HSkMC: 50.2;U-138 MG: 24.2;WM-115: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017815, HPA018793, HPA018816"	Approved				"Secreted to blood"	32019377				"CAB017815: , HPA018793: AB_1844820, HPA018816: AB_1844821"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.22e-3)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.54e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-1)"	"prognostic favourable (4.40e-4)"	"unprognostic (4.56e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	23.3	3.9	3.4	5.4	2.3	0.4	5.9	14.2	2.6	9.1	3.8	5.1	22.3	1.4	2.9	8.0	7.3	3.2	11.2	5.8	8.5	2.1	8.0	1.4	25.1	0.8	2.4	4.3	7.3	1.5	1.2	35.0	14.2	6.2	23.8	2.3	13.0	7.6	28.5	14.1	1.9	2.6	5.2	4.7	7.4	5.2	2.3	4.7	0.7	5.2	3.1	0.7	5.8	5.6	0.3	0.5	9.3	2.2	0.3	0.4	1.1	0.0	0.8	3.1	1.8	30.2	10.5	2.3	10.0	8.5	2.7	4.0	2.0	0.0	0.0	0.0	5.2	0.0	1.3	0.0	3.5	0.0	0.4	16.9	0.2	0.0	8.6	0.2	0.0	50.2	0.0	1.7	0.2	0.2	9.0	1.8	3.5	0.0	0.3	2.5	3.2	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.7	0.0	0.1	24.2	0.3	0.8	0.2	0.1	1.0	0.0	3.4	0.3	15.8	0.3	2.0	0.0	0.3	2.2	0.4	0.1	0.3	0.3	0.5	0.3	0.1	0.1	9.3	0.3	0.9	0.5	0.1	1.1	3.4	2.3	14.2	2.6	8.5	2.1	2.4	4.3	6.2	4.7
ANGPT2	Ang2	ENSG00000091879	"Angiopoietin 2"	O15123	8	6499651-6563409	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"HMC-1: 9.9;HSkMC: 23.6;HUVEC TERT2: 36.5;WM-115: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB011437, CAB017626"	Approved				"Secreted to blood"	4244467	31000			"CAB011437: , CAB017626: AB_1118956"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.99e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.36e-5)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (4.48e-4)"	"unprognostic (2.94e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (1.52e-7)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.44e-2)"	15.8	0.8	5.3	5.0	20.6	0.6	17.9	10.4	19.5	9.3	3.5	0.5	2.2	1.6	6.2	2.8	3.8	5.8	7.2	10.1	6.1	5.9	3.0	4.1	4.6	8.3	13.1	1.0	3.0	1.2	1.9	1.1	20.0	20.8	4.3	2.7	0.5	2.8	4.4	17.7	3.3	2.6	9.9	9.4	2.3	2.3	1.4	12.4	2.9	10.5	2.2	3.9	14.8	8.1	1.9	1.1	5.4	0.7	0.8	1.2	0.2	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.5	0.0	9.9	23.6	0.0	0.0	0.0	36.5	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.9	5.4	0.7	0.6	0.9	0.4	0.9	0.7	0.8	0.8	0.1	1.9	0.9	1.2	0.8	0.8	0.4	1.1	0.2	0.2	5.3	20.6	10.4	19.5	6.1	5.9	13.1	1.0	20.8	12.4
ANGPTL3	ANGPT5	ENSG00000132855	"Angiopoietin like 3"	Q9Y5C1	1	62597487-62606159	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Lipid metabolism"	Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 276.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.1;HL-60: 2.1"	"Cancer enriched"	"Detected in some"	39	"liver cancer: 94.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038097	Approved				"Secreted to blood"	224800000	45000000			"HPA038097: AB_10675628"	"unprognostic (2.29e-1)"	"unprognostic (8.01e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-3)"	"unprognostic (6.85e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.62e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.7	276.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.2	1.1	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.7	0.2	0.0	0.6	0.1	0.0	0.1	0.0	0.2	0.7	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ANGPTL4	"ARP4, FIAF, HFARP, NL2, PGAR, pp1158"	ENSG00000167772	"Angiopoietin like 4"	Q9BY76	19	8363289-8374373	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 55.5;liver: 68.4;pancreas: 51.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.1;HBEC3-KT: 64.0;LHCN-M2: 17.3;TIME: 32.2;U-138 MG: 19.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 212.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 5.8;neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA007879, CAB033770"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted to blood"	7750000	1500000	"Nucleoplasm, Vesicles"		"CAB033770: AB_2057427, HPA007879: AB_1078158"	"unprognostic (1.26e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (1.88e-2)"	"unprognostic (7.68e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (3.18e-1)"	"unprognostic (3.90e-3)"	"unprognostic (9.69e-3)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.00e-2)"	55.5	9.6	23.3	13.5	24.7	2.3	33.0	5.1	37.6	3.3	11.8	9.2	0.3	10.6	5.9	1.5	11.8	3.2	8.8	11.4	17.1	5.5	9.4	68.4	9.0	2.7	21.4	3.1	2.9	51.7	2.3	3.3	21.4	36.8	6.7	2.1	2.5	3.9	3.7	5.9	6.5	23.5	6.0	20.6	2.5	4.4	3.7	27.7	0.0	7.1	2.5	3.5	10.7	6.0	0.5	0.3	5.8	0.4	0.8	0.6	0.2	0.0	0.6	0.3	0.9	16.1	3.5	0.1	1.2	0.1	0.2	0.0	0.0	5.9	0.0	8.8	2.4	0.8	0.0	64.0	0.1	0.5	0.1	0.1	0.2	0.1	0.3	0.0	0.0	1.6	0.2	9.8	0.2	4.9	0.3	0.2	17.3	0.5	0.0	0.5	0.1	0.5	0.3	0.0	0.2	3.2	1.1	0.0	0.1	7.4	0.7	1.1	1.9	0.1	32.2	19.0	0.1	9.5	0.0	0.0	0.0	0.0	13.0	0.0	3.5	5.8	0.4	0.9	0.4	0.2	0.3	0.5	0.5	0.4	0.2	0.4	0.3	0.3	2.3	0.8	0.2	0.3	0.6	0.2	23.3	24.7	5.1	37.6	17.1	5.5	21.4	3.1	36.8	27.7
ANGPTL6	"AGF, ARP5"	ENSG00000130812	"Angiopoietin like 6"	Q8NI99	19	10092338-10102796	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 31.8"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 36.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"	450310	550000				"unprognostic (1.28e-1)"	"unprognostic (2.18e-6)"	"unprognostic (1.42e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.26e-10)"	"unprognostic (8.96e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.32e-1)"	0.3	0.3	0.7	2.1	1.6	2.6	0.3	0.7	2.7	0.2	0.5	0.7	0.5	0.7	0.1	0.2	0.7	0.7	0.9	0.7	0.6	0.7	0.9	31.8	0.5	3.3	1.6	0.2	0.4	1.2	0.0	0.4	2.3	1.4	0.2	0.4	0.1	0.5	0.0	0.1	0.3	2.9	0.2	0.9	3.0	1.6	1.3	0.5	0.3	0.3	0.0	3.4	0.6	0.9	2.9	0.6	0.0	1.4	1.3	2.6	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.1	0.0	0.3	36.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.7	2.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	2.9	0.0	0.0	0.0	0.0	0.0	3.1	0.7	1.7	0.1	0.4	0.4	0.0	1.3	0.0	2.6	1.4	1.8	2.9	1.6	1.8	0.6	2.8	1.0	1.6	0.0	1.3	0.7	0.4	2.0	0.9	0.7	1.6	0.7	2.7	0.6	0.7	1.6	0.2	1.4	0.5
ANGPTL8	"C19orf80, RIFL, TD26"	ENSG00000130173	"Angiopoietin like 8"	Q6UXH0	19	11237450-11241943	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid metabolism"	Hormone	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 81.0"	"Group enriched"	"Detected in some"	27	"Hep G2: 26.2;MCF7: 15.2"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 84.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042131			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	835950	320000	"Golgi apparatus"	Nucleoplasm	"HPA042131: AB_10794413"	"unprognostic (2.37e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.84e-6)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.75e-2)"	8.0	0.1	0.0	0.6	0.0	0.0	5.1	0.0	0.1	0.1	5.7	0.0	0.0	0.2	0.1	0.8	0.1	0.1	1.0	0.6	0.0	0.0	1.5	81.0	0.1	3.0	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4.8	0.1	0.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.7	26.2	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.2	0.0	0.5	0.1	0.0	0.1	0.3	0.7	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in some"	4	"HEL: 37.1;K-562: 39.0;RH-30: 49.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"		33000000			"HPA004842: AB_1844827, HPA056953: "	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.0	0.1	0.0	0.0	0.9	0.0	1.4	10.0	0.4	0.2	0.0	0.0	2.3	0.4	1.0	0.8	0.2	0.1	0.2	0.9	0.0	37.1	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.0	39.0	0.8	0.6	0.1	0.0	0.4	0.5	0.0	0.2	49.4	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	0.6	0.9	0.2	0.1	0.2	8.5	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"				"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: , HPA035970: "	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavourable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.2	4.2	16.1	22.5	0.0	1.0	1.8	0.7	2.0	4.0	0.0	4.2	1.4	3.6	0.0	7.5	0.4	0.6	1.9	6.2	2.4	0.0	1.7	1.0	1.0	0.7	9.6	1.6	0.9	3.9	0.0	0.0	6.9	3.4	0.1	0.2	0.0	5.3	1.7	0.5	30.8	0.0	0.1	0.0	8.3	15.5	0.1	0.3	5.3	0.1	0.6	0.0	3.2	1.7	0.2	1.9	4.1	1.1	0.6	12.7	0.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2
ANK3		ENSG00000151150	"Ankyrin 3"	Q12955	10	60026298-60733490	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism spectrum disorder, Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 95.4;parathyroid gland: 74.4"	"Cell line enhanced"	"Detected in many"		"RT4: 24.3;SK-BR-3: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"CAB013249, CAB015179, HPA038455"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: "	"unprognostic (1.91e-1)"	"unprognostic (5.33e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (8.88e-16)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.83e-2)"	2.7	3.1	21.1	3.1	24.8	1.1	9.1	95.4	29.1	5.5	10.5	21.5	19.4	15.7	9.7	52.9	7.1	8.2	8.9	31.2	24.4	16.4	38.9	6.6	10.1	2.5	26.8	19.8	5.2	5.0	74.4	10.5	31.9	31.9	8.6	8.8	6.5	16.1	19.4	29.2	16.0	10.6	5.9	16.5	5.9	6.3	3.4	30.0	0.6	17.2	4.6	3.4	5.6	6.6	6.2	3.5	1.7	0.4	2.1	7.7	1.3	4.1	2.4	15.0	0.2	0.0	0.9	11.6	0.3	0.2	0.0	0.3	10.7	8.1	0.2	4.9	0.3	5.9	8.0	7.2	0.2	0.2	5.4	0.1	4.6	0.0	3.1	0.0	0.2	7.4	4.6	3.8	0.2	1.7	2.0	10.1	3.4	13.8	0.0	0.4	6.8	13.0	0.0	10.8	2.0	2.7	24.3	7.8	1.4	0.3	24.4	0.0	14.2	0.0	4.9	0.4	1.5	6.6	0.7	0.4	0.0	0.0	2.7	0.1	9.3	1.7	0.4	0.6	4.1	0.3	3.7	6.2	7.0	2.2	0.2	1.9	7.7	1.9	1.1	2.1	0.4	3.5	1.0	1.3	21.1	24.8	95.4	29.1	24.4	16.4	26.8	19.8	31.9	30.0
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163907-4263977	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes			5600	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: "	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	14.7	19.3	16.5	15.6	21.9	15.8	14.1	20.1	25.6	15.9	25.2	33.7	9.4	12.4	27.0	12.3	15.3	17.5	13.3	11.3	19.6	14.2	13.0	15.3	16.7	13.9	21.3	17.2	23.3	13.7	27.1	16.4	15.4	23.2	14.1	15.8	16.0	16.2	14.5	15.3	21.6	15.0	16.6	20.7	16.1	14.7	12.2	26.6	15.4	16.1	8.4	16.5	17.6	15.4	1.6	3.8	2.3	9.7	1.3	4.0	2.6	11.1	25.7	17.8	11.9	24.1	18.4	11.5	12.4	13.1	20.3	20.1	11.4	7.6	9.7	10.2	18.7	17.6	16.2	13.2	17.8	5.1	16.6	9.5	18.4	10.6	13.4	5.6	11.5	19.2	14.0	14.4	10.7	11.8	9.1	9.4	13.7	8.6	8.4	6.1	7.5	9.1	12.8	11.8	5.3	10.5	15.1	6.0	9.3	17.9	8.4	11.0	9.7	7.4	15.0	12.7	6.7	17.4	16.4	3.1	2.4	3.3	15.6	11.6	15.2	1.6	5.0	2.2	4.0	9.7	3.8	1.3	2.6	2.9	3.8	1.6	2.7	2.6	2.3	1.3	9.3	1.5	2.6	2.6	16.5	21.9	20.1	24.7	19.6	14.2	21.3	17.2	23.2	26.6
ANKRD17	"FLJ22206, GTAR, KIAA0697, MASK2, NY-BR-16"	ENSG00000132466	"Ankyrin repeat domain 17"	O75179	4	73073376-73258798	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045024, HPA063731"	Approved		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA045024: AB_10964778, HPA063731: "	"unprognostic (3.86e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.06e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.00e-2)"	"unprognostic (4.07e-1)"	19.6	20.2	28.9	23.2	32.4	10.3	24.8	41.2	29.9	22.8	19.4	21.2	19.5	18.2	19.3	24.2	22.2	23.5	18.8	20.4	23.4	21.6	25.3	25.3	18.0	17.4	22.3	19.4	23.4	22.8	40.2	34.6	23.2	31.8	19.7	24.2	21.5	23.1	23.1	32.7	22.2	18.5	20.7	18.0	17.7	19.2	13.5	25.1	22.3	22.7	15.9	21.1	21.1	18.9	4.5	7.6	3.2	2.8	9.3	5.3	1.7	12.1	13.4	21.5	16.9	24.1	21.3	11.7	18.0	21.2	16.2	15.7	16.3	16.1	33.2	15.0	18.4	10.3	26.7	15.9	22.5	12.9	11.4	22.5	14.6	23.6	13.0	29.4	14.0	17.9	17.4	23.2	18.6	21.5	31.5	12.3	19.4	11.3	24.1	10.5	13.9	13.6	19.3	23.6	13.7	17.3	18.5	20.8	14.1	17.4	19.7	9.4	10.5	11.7	25.9	17.1	16.4	15.3	14.1	10.2	5.2	25.4	13.9	13.0	17.5	2.3	2.8	3.0	5.3	1.8	2.7	3.0	3.3	3.6	2.3	4.5	3.2	3.6	3.2	9.3	2.1	7.6	2.0	1.7	28.9	32.4	41.2	29.9	23.4	21.6	22.3	19.4	31.8	25.1
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Group enriched"	"Detected in some"	5	"A-431: 33.8;CAPAN-2: 52.0;HaCaT: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA032148: , HPA057356: "	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favourable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	33.8	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.0	0.0	0.6	0.0	63.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.2	4.9	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.8	0.2	4.1	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: , HPA067561: "	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.0	32.0	42.1	36.3	14.8	13.0	28.0	13.7	18.5	27.0	22.8	26.4	49.1	84.6	25.8	15.5	38.3	97.4	28.1	32.5	38.1	33.1	64.0	27.1	33.0	9.2	50.3	34.6	10.4	19.9	14.8	29.6	39.2	46.5	33.1	23.1	18.2	50.5	41.3	37.4	16.2	70.9	39.1	50.2	23.8	41.2	55.9	34.7	20.9	23.6	38.7	31.4	66.0	17.5	28.0	44.6	19.3	36.7	20.1	55.7	98.0	18.6	84.7	25.6	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol			290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: , HPA067561: , HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	70.9	38.4	42.8	35.7	24.1	42.7	39.0	36.9	32.7	39.7	33.5	48.1	34.9	87.1	22.1	24.7	47.0	57.7	41.6	45.6	56.5	32.5	75.3	33.0	51.9	31.0	129.1	43.9	32.3	30.5	31.8	65.8	34.4	144.9	61.7	30.5	94.8	97.4	114.8	16.7	38.2	58.2	66.8	41.4	25.9	29.8	34.6	30.2	43.3	42.3	37.8	23.9	48.3	41.7	25.9	42.0	32.5	38.7	56.0	63.2	52.6	24.0	51.8	48.2	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"			1500000000	"Plasma membrane"		"CAB002417: AB_563491, HPA004625: "	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	4.9	0.0	0.0	60.1	77.0	0.5	76.7	109.7	9.4	8.3	0.5	0.0	0.0	0.9	65.8	0.0	0.5	0.0	3.7	0.0	0.0	14.5	0.4	11.4	35.4	1.0	69.8	67.4	0.1	29.7	0.0	85.8	0.4	0.1	3.6	0.0	0.0	34.1	0.2	5.2	0.0	0.0	0.8	42.9	0.0	0.1	0.7	0.0	0.1	0.0	0.0	6.7	85.8	41.4	0.0	93.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2
ANTXR1	"ATR, FLJ10601, FLJ21776, TEM8"	ENSG00000169604	"Anthrax toxin receptor 1"	Q9H6X2	2	69013178-69249327	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	Hypotrichosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 72.6;RH-30: 39.4;TIME: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054785			Uncertain	Vesicles	"Intracellular and membrane"		4100000	Vesicles		"HPA054785: "	"unprognostic (1.44e-1)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.15e-3)"	"unprognostic (9.05e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (2.26e-3)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (2.09e-2)"	27.5	25.8	10.0	10.1	14.9	0.1	21.1	11.0	9.6	33.4	14.2	23.6	8.5	4.9	35.7	13.5	14.0	20.7	51.5	18.8	17.0	10.1	6.1	3.1	20.1	4.4	19.4	6.5	45.5	3.1	30.5	10.4	32.3	23.6	21.7	8.8	37.2	13.8	23.0	12.4	17.9	8.9	30.4	21.4	11.7	7.4	6.6	16.7	2.6	17.5	10.4	6.7	29.1	24.5	0.0	0.1	0.1	0.0	0.2	0.4	0.0	6.8	8.6	7.6	4.8	35.4	17.3	0.1	11.2	23.0	12.0	9.6	0.0	0.6	0.0	6.6	29.7	6.5	5.3	6.7	11.3	0.0	4.3	1.8	19.2	2.2	15.7	1.5	1.0	28.1	2.7	11.8	7.4	3.3	1.1	0.0	72.6	3.1	4.2	0.1	7.2	5.6	0.0	39.4	0.1	2.9	6.0	4.3	19.4	21.9	0.1	7.7	2.2	0.4	49.3	15.2	12.8	15.3	11.9	0.0	0.0	0.0	7.9	1.3	6.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	10.0	14.9	11.0	9.0	17.0	10.1	19.4	6.5	23.6	16.7
ANTXR2	"CMG-2, CMG2, FLJ31074"	ENSG00000163297	"Anthrax toxin receptor 2"	P58335	4	79901149-80125454	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 43.1;HHSteC: 37.0;LHCN-M2: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		6600000				"unprognostic (3.01e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.95e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (3.34e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.78e-1)"	18.6	8.8	1.7	14.4	2.0	4.3	16.8	1.0	1.8	30.7	24.6	2.4	10.2	4.1	36.3	11.1	20.1	14.6	22.9	10.0	2.9	1.5	4.1	10.4	9.8	10.1	1.9	2.0	23.5	3.1	16.7	2.5	23.1	2.8	40.2	11.1	6.2	4.6	22.2	8.9	4.8	17.3	56.5	3.9	9.1	19.5	11.1	2.1	4.3	4.3	5.0	8.2	38.0	20.3	9.2	12.4	22.1	6.8	1.5	14.1	5.0	2.6	0.2	6.4	1.1	43.1	25.4	0.6	8.6	25.7	3.8	4.4	0.1	2.1	0.0	0.1	15.8	0.8	0.9	10.2	14.8	0.3	0.8	2.0	0.1	0.8	37.0	8.9	5.6	30.2	2.9	27.1	14.3	11.2	4.8	6.5	43.6	0.0	0.1	4.9	0.8	12.3	0.4	3.8	1.6	2.1	2.7	6.1	8.3	0.9	0.1	1.0	0.1	1.8	12.4	28.0	1.5	31.0	15.8	0.3	0.0	0.0	15.7	6.8	8.5	22.1	6.8	21.1	5.1	3.6	5.6	9.2	8.1	5.0	12.4	3.8	4.6	2.0	20.2	1.5	6.8	10.3	14.1	5.0	1.7	2.0	1.0	1.8	2.9	1.5	1.9	2.0	2.8	2.1
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: , HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favourable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favourable (4.57e-5)"	"prognostic unfavourable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	65.9	104.2	4.7	4.9	66.5	63.3	0.3	114.3	71.4	47.3	32.1	3.0	59.7	0.1	37.8	99.7	81.2	10.1	69.2	37.5	37.3	0.7	5.0	31.0	0.1	53.1	11.0	2.5	36.4	57.4	47.8	94.0	67.0	20.9	2.8	58.3	0.2	19.4	6.0	5.9	42.4	0.0	26.6	0.2	106.4	14.0	0.0	0.0	39.3	1.0	26.4	0.2	1.7	82.7	55.5	34.9	76.2	58.6	0.4	0.1	0.2	128.1	10.2	83.4	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol			530000	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favourable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	44.1	7.3	19.4	27.8	23.8	37.0	61.1	22.8	24.4	26.4	34.4	8.6	18.4	28.6	20.2	36.4	49.5	23.9	47.5	57.1	17.2	8.3	39.1	21.9	35.1	38.1	10.8	14.2	27.3	24.0	26.2	9.7	35.0	7.5	28.9	27.6	16.7	20.2	27.8	39.5	18.6	44.1	28.1	11.2	22.9	29.3	15.1	6.6	45.7	18.9	39.2	31.8	34.9	39.6	12.7	14.4	77.9	12.1	11.6	21.9	13.0	34.7	30.5	1.8	9.0	39.1	38.6	19.5	26.0	67.0	16.2	16.8	27.6	54.4	2.3	18.8	38.9	45.5	7.8	21.7	9.8	59.1	13.9	14.2	18.1	21.4	22.9	15.6	35.3	40.7	13.2	9.0	6.9	23.0	13.9	26.4	12.8	20.7	19.0	34.5	3.3	64.7	14.5	2.7	52.6	27.4	32.3	0.8	6.3	11.2	45.0	25.4	13.3	19.2	27.7	11.4	17.1	26.0	13.6	16.1	21.9	15.1	11.9	26.1	7.5	22.6	12.1	77.9	14.5	9.6	15.3	12.7	18.3	20.3	9.1	10.9	17.3	14.9	43.8	11.6	10.7	14.4	21.9	13.0	19.4	23.8	22.8	24.4	17.2	8.3	10.8	14.2	7.5	6.6
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Group enriched"	"Detected in some"	13	"A549: 23.3;HDLM-2: 12.0"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavourable (2.54e-5)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	142.1	158.7	8.4	3.7	114.7	184.1	36.5	169.9	109.6	108.0	94.8	75.2	68.6	0.3	139.9	219.8	152.1	37.3	319.1	118.4	30.3	3.9	2.8	76.4	29.2	69.2	0.1	2.1	89.8	87.1	76.7	165.4	201.2	11.3	16.6	230.6	16.5	0.6	8.4	18.2	123.6	1.6	46.1	7.9	191.4	86.7	11.0	6.2	67.2	15.3	66.7	32.8	5.9	229.5	92.1	125.5	308.8	166.8	6.2	20.3	2.7	86.8	1.6	183.2	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell line enhanced"	"Detected in many"		"A-431: 52.0;CACO-2: 53.3;CAPAN-2: 72.2;EFO-21: 44.2;hTERT-HME1: 73.6;RPTEC TERT1: 62.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	Cytosol			7400000	Cytosol		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favourable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	52.0	9.9	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	53.3	72.2	0.0	44.2	1.8	20.6	0.0	38.1	2.3	0.2	0.4	4.6	21.3	3.2	6.1	0.6	0.0	0.3	33.8	0.5	73.6	15.1	0.1	0.0	0.2	2.0	0.2	0.0	1.6	7.3	0.0	0.1	0.0	62.0	6.0	0.0	0.0	30.7	7.6	2.2	1.3	0.6	19.1	0.1	6.9	0.0	11.7	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"			6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favourable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (3.01e-5)"	"prognostic unfavourable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavourable (9.29e-7)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.4	22.6	30.8	17.0	148.6	113.4	33.6	108.3	96.6	56.2	50.4	16.4	13.3	2.3	19.6	148.5	10.8	19.6	47.9	52.8	21.7	11.3	6.8	21.3	44.7	85.2	14.7	11.8	65.4	23.3	47.8	47.2	74.1	6.6	18.4	141.8	20.1	14.9	5.0	15.9	47.4	0.5	70.5	4.6	94.3	4.5	7.9	9.6	39.0	15.3	98.6	13.4	17.6	54.6	89.4	43.8	63.9	32.1	16.5	20.0	5.1	57.3	8.0	105.1	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100712-151157882	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol			970000	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	78.3	38.2	22.2	44.7	38.3	28.6	109.1	22.0	70.0	37.4	50.2	13.3	34.1	12.5	52.2	34.2	27.0	39.5	39.0	53.0	28.7	37.8	22.1	54.7	33.7	66.7	38.6	30.0	54.9	27.6	8.2	41.4	47.4	62.5	39.3	24.0	36.7	19.7	60.7	85.4	16.6	30.7	82.8	16.8	41.4	31.3	16.8	7.2	44.6	25.5	34.7	50.1	53.0	51.4	36.4	22.4	15.0	15.3	47.0	58.1	50.1	0.3	3.8	24.3	35.9	104.9	47.9	6.6	48.9	58.1	36.8	51.2	12.9	1.9	3.3	17.2	62.3	0.0	18.8	23.0	37.4	13.2	6.7	1.9	7.7	24.1	35.3	11.9	11.9	59.4	0.1	31.3	5.1	46.8	2.6	45.6	86.7	11.7	21.8	18.3	6.8	10.9	14.3	75.1	3.6	5.4	0.0	1.4	6.3	5.1	34.7	21.0	59.4	22.5	41.0	34.6	10.5	2.5	12.7	25.5	34.7	0.5	18.8	55.6	5.5	13.8	15.3	15.0	58.1	10.3	38.6	35.0	43.4	52.6	22.4	36.4	30.4	36.9	3.3	47.0	4.6	5.5	34.8	50.1	22.2	38.3	22.0	70.0	28.7	37.8	38.6	30.0	62.5	7.2
AOC3	"HPAO, VAP-1, VAP1"	ENSG00000131471	"Amine oxidase, copper containing 3"	Q16853	17	42851184-42858130	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	18	"ASC diff: 83.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"							"HPA000980, CAB025797"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted - unknown location"		240000000	Cytosol	"Golgi apparatus"	"CAB025797: , HPA000980: AB_1078170"	"unprognostic (2.20e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.79e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (6.98e-4)"	97.0	11.5	0.4	18.7	1.0	0.0	67.7	0.5	1.3	26.9	44.3	1.0	16.3	3.6	44.7	34.8	36.1	18.5	50.9	12.1	0.4	0.4	5.8	8.3	48.0	7.9	0.5	1.2	23.8	2.4	2.2	1.3	10.8	2.0	36.5	9.4	32.1	8.0	24.7	7.7	5.5	15.0	79.2	0.6	7.5	17.7	16.2	0.3	1.0	6.6	11.6	2.6	75.9	20.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	83.5	0.1	1.3	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.2	0.3	1.4	0.1	0.1	4.6	0.2	0.0	0.2	0.9	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.3	0.1	1.2	1.3	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.5	1.3	0.4	0.4	0.5	1.2	2.0	0.3
AOX1	"AO, AOH1"	ENSG00000138356	"Aldehyde oxidase 1"	Q06278	2	200585868-200677064	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 228.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 83.9;ASC TERT1: 43.1;HSkMC: 17.3;hTERT-HME1: 17.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 122.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040199, HPA040215"	Enhanced						410000			"HPA040199: AB_10795273, HPA040215: AB_10795360"	"unprognostic (4.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.17e-4)"	"unprognostic (1.92e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.00e-2)"	"prognostic favourable (6.05e-5)"	"unprognostic (1.33e-2)"	"unprognostic (8.16e-3)"	"unprognostic (3.38e-2)"	"unprognostic (4.99e-3)"	12.8	55.6	0.1	1.8	0.4	0.2	10.5	0.3	0.2	2.9	3.2	1.3	18.6	0.3	2.0	11.1	3.9	8.1	4.0	3.5	0.3	0.0	20.8	228.8	3.6	7.5	0.2	0.2	12.2	28.5	0.2	0.8	1.9	0.6	4.4	1.0	1.6	2.7	20.1	2.5	3.2	1.7	6.9	0.4	1.7	2.4	10.8	0.2	0.1	4.8	2.7	0.6	7.1	10.6	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	83.9	43.1	0.0	1.3	2.5	1.1	2.1	0.0	0.0	0.0	0.1	1.7	0.0	0.0	3.8	4.7	0.0	0.1	0.0	1.0	4.2	5.6	0.1	0.0	17.3	1.0	5.5	17.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	1.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	6.6	2.9	2.3	0.0	0.5	0.0	0.0	0.5	2.3	0.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.2	0.3	0.0	0.2	0.2	0.6	0.2
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			1000000	"Golgi apparatus, Vesicles"	Cytosol	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.9	15.4	16.0	17.0	12.3	9.0	20.0	19.0	21.2	23.4	22.4	23.5	11.1	14.9	12.6	21.6	24.3	22.9	32.0	14.9	19.1	33.4	24.7	20.0	13.3	13.7	35.2	34.2	12.9	11.9	22.3	18.0	32.4	16.9	18.2	15.4	29.5	14.8	11.7	12.4	17.5	28.4	17.6	39.6	16.5	61.4	25.4	18.0	23.5	27.6	11.8	22.4	16.1	27.9	27.0	16.7	15.4	19.8	19.8	10.3	27.3	19.2	15.3	15.7	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7
AP1M1	"AP47, CLAPM2"	ENSG00000072958	"Adaptor related protein complex 1 mu 1 subunit"	Q9BXS5	19	16197578-16245907	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045256	Uncertain						58000			"HPA045256: AB_10960697"	"unprognostic (5.10e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (1.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.56e-1)"	26.7	24.9	22.8	21.4	27.8	38.1	20.6	20.6	43.5	15.4	17.5	22.8	9.7	23.5	20.2	9.4	17.0	15.6	15.9	25.6	20.0	26.5	23.2	41.0	22.1	24.2	23.8	27.0	21.2	10.8	13.7	13.4	20.1	25.5	15.3	9.7	17.8	12.0	19.8	20.7	15.1	16.2	26.2	19.4	20.7	14.5	40.7	16.6	29.1	12.6	8.6	20.2	20.5	14.9	30.6	37.6	67.2	62.1	36.0	45.5	43.2	18.6	21.1	21.3	19.9	26.1	25.7	12.0	21.0	22.6	30.8	32.2	25.0	14.7	14.4	24.4	22.9	10.6	16.5	17.1	34.7	25.1	37.0	23.8	19.8	33.7	21.2	25.9	30.0	26.3	12.9	27.5	18.6	29.1	11.6	30.1	33.3	22.3	38.0	16.2	17.4	49.4	25.9	17.4	19.9	17.0	13.5	13.7	30.7	17.1	10.5	19.1	12.5	21.8	25.0	34.9	14.3	46.6	39.8	32.3	40.0	15.9	39.1	33.4	26.9	23.4	40.7	67.2	32.1	51.2	32.3	30.6	31.9	33.7	34.9	27.9	36.3	45.5	29.1	36.0	62.1	37.6	44.4	43.2	22.8	27.8	20.6	43.5	20.0	26.5	23.8	27.0	25.5	16.6
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA060945: "	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.2	21.3	14.3	27.1	10.6	17.5	31.1	17.6	11.9	12.0	12.8	11.4	33.5	5.9	30.8	19.2	13.0	8.2	27.1	10.7	13.3	13.3	4.0	13.4	14.2	13.1	10.7	19.9	19.5	20.7	11.8	5.1	17.7	12.8	23.7	29.6	65.4	8.9	23.1	22.9	43.0	5.6	6.5	12.3	28.8	22.4	11.3	37.0	10.0	26.6	32.1	11.7	10.0	18.3	17.3	30.2	6.5	12.1	5.3	11.2	11.3	44.0	11.9	34.8	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 alpha 2 subunit"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles			93000	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: "	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	21.9	11.1	20.2	8.7	20.7	18.4	23.2	50.9	32.4	17.5	13.9	9.5	10.4	16.8	16.3	8.5	12.2	21.5	10.1	14.7	22.6	20.0	19.4	16.3	13.3	18.1	16.1	21.1	11.2	14.7	7.8	15.5	16.3	16.9	15.5	16.3	11.5	21.7	14.7	13.3	16.5	12.0	18.5	18.1	34.5	17.0	16.4	6.7	12.4	12.1	5.0	9.1	10.5	10.5	3.4	3.7	6.8	4.6	3.4	5.4	1.7	5.5	2.5	3.0	8.7	11.3	11.6	7.3	7.9	2.7	4.9	4.0	0.9	6.0	5.8	6.9	9.4	7.3	7.0	4.4	3.1	4.2	18.1	1.7	7.7	3.0	4.4	2.2	4.1	13.7	4.8	2.4	4.9	6.7	5.8	4.5	4.9	0.5	2.0	2.5	1.7	14.1	3.5	2.0	6.3	7.4	5.0	9.4	8.0	8.9	7.3	1.1	4.2	0.8	10.5	1.6	1.9	2.2	4.0	3.6	2.9	4.3	3.0	2.8	2.4	3.3	4.6	3.8	3.1	4.6	1.8	1.7	3.2	1.8	3.7	3.4	3.4	3.5	6.8	3.4	3.8	3.7	5.4	1.7	20.2	20.7	50.9	32.4	22.6	20.0	16.1	21.1	16.9	6.7
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 mu 1 subunit"	Q96CW1	3	184174689-184184091	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"			340000	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: "	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	37.6	78.2	58.6	38.3	78.2	47.7	32.5	64.2	111.9	52.4	42.7	33.5	35.4	40.7	46.7	27.0	54.9	39.1	41.2	86.8	62.5	64.6	39.7	36.8	35.8	35.2	57.5	83.0	49.8	26.0	53.6	48.2	59.0	79.8	40.0	35.6	44.4	40.2	61.3	33.9	38.1	36.1	60.3	41.5	34.1	32.9	27.8	32.1	30.5	35.3	34.5	37.1	49.5	38.8	26.4	59.3	51.4	62.6	34.9	39.5	77.6	47.9	36.9	31.8	35.7	51.1	53.8	32.9	80.9	47.1	91.5	64.4	39.7	35.2	22.0	99.0	121.0	54.6	42.9	54.7	75.8	45.2	53.6	56.9	42.4	35.1	60.4	27.9	36.2	68.2	31.1	57.9	37.2	67.9	27.2	43.3	85.6	109.9	35.9	16.6	77.4	55.4	33.5	40.6	43.6	56.7	43.8	33.9	24.7	63.5	80.0	37.5	107.1	34.1	72.8	58.1	47.2	56.7	106.6	39.1	34.2	49.2	109.5	41.3	37.8	37.5	62.6	51.4	32.5	52.7	32.0	26.4	30.3	31.1	59.3	25.5	26.1	26.7	28.5	34.9	42.2	29.7	39.5	77.6	58.6	78.2	64.2	111.9	62.5	64.6	57.5	83.0	79.8	32.1
AP3B1	"ADTB3A, HPS2"	ENSG00000132842	"Adaptor related protein complex 3 beta 1 subunit"	O00203	5	78000525-78294755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038737, HPA045458"	Approved		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA038737: AB_10670788, HPA045458: "	"unprognostic (9.14e-2)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.37e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.47e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.97e-2)"	"prognostic favourable (7.97e-6)"	"unprognostic (1.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.39e-2)"	30.1	19.9	16.5	23.1	20.7	16.5	19.0	15.2	16.6	21.7	20.8	17.4	21.1	17.0	21.2	50.3	26.5	14.6	14.2	16.6	15.6	15.1	28.3	13.7	16.1	27.1	22.2	11.4	18.3	22.0	29.4	36.1	20.1	17.4	18.8	25.6	15.0	23.3	18.8	12.9	18.9	24.8	18.1	20.2	25.5	19.1	13.0	20.9	38.0	24.0	18.6	22.9	19.4	18.2	26.2	10.1	9.0	9.2	5.2	6.7	4.5	20.0	16.2	18.8	25.7	22.5	27.2	16.4	22.7	26.6	20.5	27.9	12.4	17.8	21.2	13.4	27.9	14.8	18.1	38.1	26.4	24.1	12.8	14.8	14.8	22.5	13.2	13.0	19.4	19.7	14.2	17.3	17.6	26.0	10.4	13.9	35.6	12.4	16.8	21.2	9.9	9.7	17.6	32.9	29.3	30.5	19.2	6.5	10.6	20.9	13.7	19.5	16.6	22.3	26.1	15.5	12.2	18.6	22.8	10.8	16.6	14.5	20.1	19.4	19.5	8.5	7.3	6.3	6.0	7.5	6.7	18.5	5.1	6.2	10.1	26.2	4.4	5.6	9.0	5.2	9.2	8.6	6.0	4.5	16.5	20.7	15.2	16.6	15.6	15.1	22.2	11.4	17.4	20.9
AP3D1	ADTD	ENSG00000065000	"Adaptor related protein complex 3 delta 1 subunit"	O14617	19	2100988-2164468	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Albinism, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA074408			Approved	Cytosol			10000	Cytosol		"HPA074408: "	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.35e-2)"	"prognostic unfavourable (9.23e-4)"	"unprognostic (4.24e-2)"	"unprognostic (8.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.37e-2)"	"prognostic favourable (2.61e-6)"	"unprognostic (8.11e-3)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.73e-2)"	22.4	30.3	27.6	26.0	31.5	18.6	27.1	38.1	41.5	24.8	23.1	22.3	30.1	27.1	27.9	23.9	28.1	26.3	22.6	32.6	25.6	23.6	28.6	45.5	23.5	29.7	19.7	29.8	24.4	55.3	32.1	39.8	26.8	25.1	23.1	18.0	25.9	35.1	28.6	42.6	21.2	26.2	25.7	16.5	25.0	25.9	33.2	21.2	23.6	34.6	19.3	22.5	27.8	23.5	4.1	11.0	5.1	5.0	7.8	8.4	2.9	32.0	33.4	20.1	30.4	25.8	21.9	24.5	26.1	25.7	27.9	25.4	37.9	17.8	17.5	15.1	38.6	21.9	29.0	31.6	18.4	25.3	27.5	22.7	21.7	29.6	44.9	24.4	30.3	26.9	21.3	28.9	42.5	27.0	23.2	61.4	24.5	23.4	23.7	13.3	30.0	21.6	25.4	21.9	23.4	21.0	46.3	28.6	23.8	23.5	24.9	43.9	24.1	28.6	34.9	26.6	11.3	35.9	30.2	52.0	50.1	22.5	36.3	16.2	26.4	0.3	4.9	3.9	5.3	5.0	8.4	3.5	5.2	6.3	5.6	4.1	4.3	5.3	5.1	7.8	4.1	11.0	3.0	2.9	27.6	31.5	38.1	41.5	25.6	23.6	19.7	29.8	25.1	21.2
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 epsilon 1 subunit"	Q9UPM8	15	50908672-51005900	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved									"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	8.7	7.8	7.6	11.4	8.4	6.0	14.3	10.2	11.0	7.4	8.0	7.0	7.9	6.6	11.1	8.1	11.3	7.7	6.8	8.4	6.3	5.7	6.7	6.7	6.8	11.1	8.5	5.8	7.7	5.6	17.3	17.7	12.9	7.3	6.4	7.8	5.2	8.6	7.3	25.8	12.4	9.0	10.7	8.2	9.6	6.7	8.4	8.5	15.6	8.6	7.3	10.2	10.2	16.4	2.0	1.9	5.3	3.0	2.0	3.1	1.2	9.1	7.1	5.0	5.9	6.8	10.4	9.8	9.2	7.4	9.0	9.4	8.7	1.5	9.0	3.6	10.1	11.3	7.4	7.9	10.5	9.8	3.8	7.9	11.7	3.5	9.5	9.6	6.9	10.5	9.8	11.2	17.8	5.9	7.2	5.3	12.2	12.3	5.6	5.5	3.2	3.6	7.8	7.1	5.5	6.6	8.5	3.4	5.6	9.7	7.0	7.1	6.3	9.4	8.2	13.3	4.9	7.9	12.8	8.1	9.2	11.6	10.4	21.2	6.0	5.3	2.0	1.1	2.7	3.0	1.8	2.0	2.0	2.5	1.9	1.2	1.5	3.1	0.4	2.0	1.7	1.3	1.2	1.2	7.6	8.4	10.2	11.0	6.3	5.7	8.5	5.8	7.3	8.5
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645141-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"				"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	10.5	4.7	10.3	11.0	11.0	36.1	8.8	13.4	11.5	10.8	11.6	8.2	5.5	7.0	10.6	7.5	6.2	6.3	11.6	5.8	10.2	8.6	5.8	6.8	11.8	11.2	8.8	6.7	10.8	7.4	5.7	6.2	10.1	8.2	9.1	12.9	8.5	8.2	6.4	6.0	7.5	14.9	7.2	10.9	15.9	8.6	6.1	9.3	15.7	7.0	3.9	14.2	9.5	9.0	2.8	6.3	33.0	8.7	1.1	1.9	1.5	4.3	6.6	20.2	7.7	6.9	12.2	5.6	11.0	8.3	8.4	8.5	4.2	3.2	6.6	3.1	9.2	7.3	14.1	8.0	10.6	4.6	5.7	12.0	6.3	5.2	2.4	11.7	15.5	5.0	2.5	8.5	4.4	14.4	5.6	3.4	12.3	1.2	6.2	12.3	5.5	3.8	7.8	16.1	2.1	4.9	7.8	2.9	5.0	8.6	3.6	3.2	6.3	17.6	11.1	5.7	4.5	6.5	3.5	2.3	4.3	7.3	2.2	16.5	7.5	6.2	8.7	7.2	1.9	3.6	1.5	2.4	1.4	1.1	6.3	2.8	1.4	0.9	33.0	1.1	3.6	4.6	0.9	1.5	10.3	11.0	13.4	11.5	10.2	8.6	8.8	6.7	8.2	9.3
APBB1	"Fe65, RIR"	ENSG00000166313	"Amyloid beta precursor protein binding family B member 1"	O00213	11	6395124-6419414	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 34.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038521, HPA038522"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA038521: , HPA038522: "	"unprognostic (4.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.36e-1)"	"prognostic favourable (1.86e-5)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-13)"	"unprognostic (1.32e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.09e-2)"	7.9	14.0	26.0	6.9	26.0	1.9	5.5	54.3	84.6	11.5	9.6	31.1	3.7	4.5	15.7	3.2	9.2	19.7	7.0	21.8	29.5	23.9	9.2	2.3	9.4	7.5	27.0	30.7	21.3	9.5	14.8	15.7	5.4	25.8	10.9	3.3	5.5	8.0	16.5	21.5	4.6	5.2	19.5	36.4	5.9	5.7	7.2	24.7	6.0	7.7	2.5	6.6	7.7	5.8	6.3	0.6	3.0	0.6	5.5	34.4	11.3	0.0	5.9	20.6	9.2	11.2	11.5	0.0	9.6	16.8	16.8	21.2	10.7	4.1	0.0	1.5	17.6	0.2	17.9	3.0	8.0	10.7	13.5	0.1	3.8	0.3	8.0	0.0	4.0	10.3	0.7	7.8	1.2	20.8	0.4	0.3	6.1	0.2	0.2	0.0	7.4	6.3	0.1	0.8	0.0	0.7	0.0	28.3	16.0	1.4	1.2	6.4	0.8	1.3	9.1	1.7	10.4	11.1	1.9	5.6	2.6	0.7	8.7	0.0	5.7	3.0	0.6	0.1	9.1	0.5	9.8	2.6	12.7	11.7	0.6	6.3	34.4	20.0	0.5	5.5	0.2	0.1	17.0	11.3	26.0	26.0	54.3	49.3	29.5	23.9	27.0	30.7	25.8	24.7
APC	"DP2, DP2.5, DP3, PPP1R46"	ENSG00000134982	"APC, WNT signaling pathway regulator"	P25054	5	112707498-112846239	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013349	Supported									"HPA013349: AB_1844913"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.62e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	7.2	5.4	40.9	6.4	21.7	8.5	6.3	19.1	39.7	6.8	7.1	10.3	2.0	6.6	6.3	3.9	8.4	5.0	5.5	7.4	37.9	12.9	6.9	6.2	6.7	5.6	23.6	20.7	7.6	4.6	13.8	7.2	5.5	39.1	5.9	6.9	4.0	4.0	4.9	7.0	6.1	8.8	8.1	19.1	6.2	5.4	5.3	20.6	3.6	6.5	2.7	6.2	6.2	3.9	3.8	3.0	12.9	2.9	3.0	3.4	1.1	8.3	7.7	12.8	9.3	10.6	8.8	5.2	13.5	6.4	7.5	8.9	6.1	6.8	16.1	13.1	17.2	6.8	13.1	11.0	12.4	9.6	8.9	12.2	11.1	4.6	5.2	6.1	6.7	7.4	7.6	12.7	8.4	10.4	15.0	5.6	10.9	5.8	7.0	3.1	4.6	2.7	6.0	15.9	7.8	6.9	10.6	13.0	7.8	12.8	5.0	5.5	6.9	5.0	16.6	15.3	7.4	15.0	10.2	4.4	6.6	6.3	8.5	11.4	8.5	10.4	2.9	5.0	3.4	1.4	2.9	3.1	1.8	2.1	2.3	3.8	2.9	2.8	12.9	3.0	2.5	3.0	1.6	1.1	40.9	21.7	19.1	31.4	37.9	12.9	23.6	20.7	39.1	20.6
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.2;SiHa: 2.1"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	27700000000	76000000000			"CAB007817: AB_598185, HPA053294: "							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.7	4.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol			1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.4	20.8	22.8	29.6	19.9	13.4	30.2	16.6	21.4	23.4	25.1	33.4	27.6	32.6	18.7	18.9	23.6	25.4	38.5	17.8	15.5	10.5	35.1	34.7	27.3	19.8	37.6	54.7	15.2	29.2	13.4	27.8	21.1	21.7	16.2	23.2	23.5	26.5	19.1	13.5	19.0	10.1	19.6	42.3	46.3	60.4	10.9	18.9	18.8	45.7	20.7	30.1	20.1	9.6	14.5	25.4	22.6	22.4	18.6	13.2	19.4	25.0	26.6	20.8	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7
APEX1	"APE, APE-1, APEN, APEX, APX, HAP1, REF-1, REF1"	ENSG00000100823	"Apurinic/apyrimidinic endodeoxyribonuclease 1"	P27695	14	20455191-20457772	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	"Activator, DNA-binding, Endonuclease, Exonuclease, Hydrolase, Lyase, Nuclease, Repressor, RNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000956, HPA002564, CAB004294, CAB047307"	Supported		Supported	Nucleoplasm			98000	Nucleoplasm		"CAB004294: AB_626685, CAB047307: , HPA000956: , HPA002564: AB_1078174"	"unprognostic (2.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavourable (7.82e-5)"	"unprognostic (4.21e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.08e-2)"	43.9	52.8	30.6	33.2	32.5	55.6	43.6	24.1	44.9	38.5	41.9	37.3	28.4	44.1	53.2	30.1	40.7	42.9	46.4	34.4	28.0	27.4	44.4	61.3	31.8	44.5	30.2	31.1	64.7	48.4	31.8	21.7	29.4	34.4	36.1	39.8	36.0	35.5	38.9	53.2	41.2	37.6	40.9	30.1	51.0	41.7	20.9	28.3	73.2	51.2	38.5	48.4	41.8	32.7	35.0	53.0	1.5	23.7	20.6	32.5	38.4	43.9	54.1	48.5	44.7	34.1	49.3	41.8	41.3	44.5	61.6	53.5	39.4	43.7	84.9	36.9	31.5	47.2	57.7	43.7	57.2	37.9	24.6	34.4	32.0	65.6	35.9	109.2	35.8	50.9	48.3	40.1	39.8	51.4	39.9	28.0	49.3	42.8	69.9	46.0	47.8	48.9	77.8	54.5	35.6	51.7	59.3	58.5	37.3	44.8	55.9	44.4	34.0	49.4	33.1	32.5	54.5	32.7	38.5	37.6	65.1	57.3	14.5	69.4	41.0	0.1	23.7	1.5	19.0	20.5	25.9	35.0	23.8	22.6	46.8	31.4	32.5	28.3	1.5	20.6	12.4	53.0	14.1	38.4	30.6	32.5	24.1	44.9	28.0	27.4	30.2	31.1	34.4	28.3
APLP1	APLP	ENSG00000105290	"Amyloid beta precursor like protein 1"	P51693	19	35867899-35879791	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Endocytosis"	Heparin-binding	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 147.5"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;AN3-CA: 46.0;EFO-21: 24.4;HMC-1: 23.8;SCLC-21H: 26.8;SH-SY5Y: 27.2"	"Cancer enhanced"	"Detected in many"		"glioma: 63.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028970, HPA028971"	Enhanced						3900000			"HPA028970: AB_2672847, HPA028971: AB_10601334"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.36e-3)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (7.32e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.57e-11)"	"unprognostic (1.38e-3)"	"unprognostic (7.12e-2)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (2.65e-5)"	2.6	15.6	37.0	2.9	47.9	1.6	1.6	13.1	147.5	2.4	2.6	91.6	0.0	2.0	2.3	2.1	2.2	2.3	4.3	6.0	53.2	37.4	2.4	1.5	2.4	2.1	54.6	24.6	1.9	32.1	5.6	17.6	1.9	38.4	2.3	2.6	3.3	2.4	2.4	1.5	2.0	2.4	2.9	118.2	1.7	9.6	5.7	36.9	0.0	2.2	0.0	2.2	2.1	0.1	1.5	0.4	2.2	0.7	3.0	0.6	0.2	1.4	10.4	24.8	46.0	2.4	1.0	3.2	2.1	1.1	2.4	0.3	2.4	1.4	0.2	24.4	5.3	0.7	7.7	0.5	1.6	17.3	0.9	0.1	3.1	1.4	0.7	0.0	23.8	1.1	0.6	1.0	0.0	0.8	0.9	0.4	7.0	2.3	0.0	0.0	1.2	6.1	2.4	0.1	0.3	0.4	0.3	26.8	27.2	8.0	1.1	0.3	6.0	1.3	0.6	16.7	9.6	9.4	1.3	1.1	0.4	0.1	11.0	0.3	8.4	2.2	0.7	0.4	0.4	0.5	0.3	0.7	0.4	0.6	0.2	1.5	0.5	0.6	2.1	3.0	0.7	0.4	0.2	0.2	37.0	47.9	13.1	54.6	53.2	37.4	54.6	24.6	38.4	36.9
APLP2	"APPH, APPL2"	ENSG00000084234	"Amyloid beta precursor like protein 2"	Q06481	11	130069837-130144811	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 52.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039319	Approved		Approved	Vesicles			480000	Vesicles		"HPA039319: AB_10673141"	"unprognostic (2.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (3.86e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.44e-2)"	"prognostic favourable (1.33e-9)"	"unprognostic (3.20e-3)"	"unprognostic (4.95e-2)"	"prognostic favourable (2.90e-4)"	"unprognostic (4.42e-2)"	72.4	32.9	41.4	29.8	48.5	35.2	43.9	106.0	61.4	39.8	44.9	29.0	31.8	56.6	48.7	42.4	36.2	37.9	51.1	55.6	35.6	49.7	79.2	73.8	82.2	27.3	39.7	43.0	42.0	28.4	76.9	22.3	67.6	48.2	63.4	39.0	105.5	35.4	65.9	17.3	27.3	52.1	46.0	40.9	24.3	33.2	18.2	26.0	12.5	128.7	21.0	17.0	51.0	46.7	12.3	26.0	36.5	52.5	3.6	4.7	25.8	17.8	15.0	27.1	24.3	113.6	74.9	33.9	51.0	62.2	25.5	21.7	111.7	130.7	8.9	133.9	124.2	46.2	20.8	48.5	14.5	13.9	17.3	15.3	11.0	42.8	17.5	46.1	31.2	50.2	31.8	22.4	42.9	78.3	14.6	19.1	42.0	17.7	2.3	20.7	15.8	25.3	5.9	6.3	8.6	68.0	49.9	9.5	20.8	61.5	32.6	7.9	49.8	42.7	134.8	27.5	18.8	42.8	24.6	3.0	4.2	20.9	31.0	42.3	19.5	8.7	52.5	14.3	4.5	28.8	3.4	3.4	3.3	4.2	26.0	12.3	2.5	3.3	36.5	3.6	20.8	2.4	4.7	25.8	41.4	48.5	106.0	61.4	35.6	49.7	39.7	43.0	48.2	26.0
APMAP	"BSCv, C20orf3"	ENSG00000101474	"Adipocyte plasma membrane associated protein"	Q9HDC9	20	24962925-24992979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.8;liver: 100.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012863, HPA064700"	Uncertain		Approved	"Plasma membrane"			80000000	"Plasma membrane"		"HPA012863: AB_1845683, HPA064700: "	"unprognostic (4.07e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.99e-3)"	"unprognostic (8.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.51e-2)"	43.5	13.0	14.8	12.4	16.1	44.5	23.1	47.3	22.7	11.7	12.3	15.7	17.9	8.9	14.8	31.8	7.5	13.0	13.4	10.2	18.2	20.9	12.9	100.5	14.4	15.9	15.4	17.2	12.3	12.2	18.9	20.2	28.3	17.0	12.5	12.4	11.6	10.6	18.7	9.8	14.0	9.3	13.8	13.7	16.9	10.2	19.9	15.4	10.6	57.9	5.7	9.2	13.0	10.6	5.2	13.9	93.8	13.9	43.2	53.4	40.1	23.0	40.0	20.6	30.8	40.0	21.9	20.9	30.1	33.0	29.1	30.2	23.6	40.9	9.5	35.2	36.2	42.5	18.8	35.0	34.2	12.7	14.7	10.5	14.4	47.9	31.5	20.6	25.4	29.6	49.6	34.1	24.5	41.4	12.4	43.0	28.2	34.6	14.1	23.2	12.9	36.4	11.8	68.3	19.9	31.0	21.1	33.7	13.0	31.0	53.7	33.3	19.0	17.3	36.2	35.0	31.4	29.6	44.8	24.5	27.1	10.6	18.4	31.3	33.2	7.4	13.9	26.1	53.4	13.4	33.0	5.1	15.1	38.8	13.9	5.2	11.9	30.9	93.8	43.2	9.0	6.8	9.9	40.1	14.8	16.1	47.3	22.7	18.2	20.9	15.4	17.2	17.0	15.4
APOA1		ENSG00000118137	"Apolipoprotein A1"	P02647	11	116835751-116837950	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Amyloidosis, Atherosclerosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 573.5"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 247.4"	"Cancer enriched"	"Detected in many"	48	"liver cancer: 4515.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 3.6;T-cells: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB016778, HPA046715"	Supported		Approved	Vesicles,Cytosol	"Secreted to blood"	2185000000000	220000000000	Vesicles	Cytosol	"CAB016778: , HPA046715: "	"unprognostic (1.88e-3)"	"unprognostic (4.53e-2)"	"unprognostic (7.46e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (5.05e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.60e-3)"	"unprognostic (1.59e-3)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (1.67e-8)"	"unprognostic (3.46e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.54e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	24.6	0.2	0.2	55.6	0.2	0.3	0.2	0.1	0.3	1.3	0.2	0.0	0.2	573.5	0.2	0.2	0.2	0.2	0.7	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.0	127.9	0.2	0.2	0.4	0.3	11.8	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.5	3.6	0.0	0.7	0.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	13.8	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	247.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	1.2	1.5	0.0	0.2	0.4	1.7	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.2	0.0	2.4	0.7	0.3	0.0	0.2	1.8	0.8	0.5	0.8	1.7	0.0	0.7	0.0	3.6	2.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
APOA2		ENSG00000158874	"Apolipoprotein A2"	P02652	1	161222292-161223631	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction, Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	321	"liver: 932.2"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 596.2"	"Cancer enriched"	"Detected in many"	329	"liver cancer: 11230.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.1;neutrophil: 2.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.0;granulocytes: 2.9;monocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB025885	Supported				"Secreted to blood"	229315000000	210000000000			"CAB025885: "		"unprognostic (2.05e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.99e-1)"		"unprognostic (9.82e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.16e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-2)"		"unprognostic (4.40e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.09e-2)"	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	932.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.0	2.9	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	65.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	596.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	1.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.9	0.0	0.8	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	148500000000	140000000000	Vesicles		"CAB068250: , CAB068251: , CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	3.2	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOA5	"APOA-V, RAP3"	ENSG00000110243	"Apolipoprotein A5"	Q6Q788	11	116789367-116792420	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	209	"liver: 112.2"	"Cell line enriched"	"Detected in single"	65	"Hep G2: 35.8"	"Cancer enriched"	"Detected in single"	489	"liver cancer: 112.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	113600000	15000000				"unprognostic (1.57e-4)"						"unprognostic (4.67e-3)"	"unprognostic (5.57e-2)"		"unprognostic (2.60e-3)"		"unprognostic (2.40e-1)"		"unprognostic (2.31e-4)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	112.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	35.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	1290000000000	89000000000	"Vesicles, Cytosol"		"CAB016070: AB_626690, HPA049793: "	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
APOC1		ENSG00000130208	"Apolipoprotein C1"	P02654	19	44914247-44919349	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 702.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 98.0;HSkMC: 60.7;K-562: 25.5;SK-MEL-30: 45.2"	"Cancer enriched"	"Detected in all"	21	"liver cancer: 3253.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"myeloid DC: 8.9"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"							HPA051518	Supported				"Secreted to blood"	60000000000	26000000000			"HPA051518: "	"unprognostic (3.51e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"prognostic favourable (1.15e-7)"	"unprognostic (9.51e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.48e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.65e-1)"	1.5	58.9	6.6	1.6	30.0	2.4	3.6	0.6	4.4	1.5	1.8	4.9	0.3	0.9	0.6	2.5	0.4	0.8	1.8	0.4	4.1	7.8	0.6	702.7	12.6	6.1	20.2	1.0	4.1	1.1	0.4	2.6	2.3	6.6	0.6	1.1	1.3	2.0	0.4	1.2	1.4	1.0	0.5	11.7	9.6	1.3	1.0	5.2	1.0	0.7	0.5	1.9	1.2	0.3	0.2	8.9	0.0	0.6	0.2	0.0	0.6	0.4	4.6	2.1	0.8	6.7	7.0	19.8	0.2	0.3	0.8	1.3	9.7	8.7	1.4	1.7	0.1	0.3	2.7	0.3	0.4	0.0	11.2	6.2	0.6	98.0	6.0	4.6	3.2	60.7	0.5	0.8	0.3	0.2	25.5	0.1	0.3	0.6	0.2	0.3	20.0	0.9	1.0	2.8	0.1	1.2	0.3	0.9	0.5	3.3	0.0	45.2	0.4	17.0	0.7	0.0	0.3	0.0	0.2	0.8	0.8	1.5	0.1	1.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.9	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.6	6.6	30.0	0.6	3.1	4.1	7.8	20.2	1.0	6.6	5.2
APOC2		ENSG00000234906	"Apolipoprotein C2"	P02655	19	44945982-44949565	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Disease mutation, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	78	"liver: 506.5"	"Group enriched"	"Detected in some"	4	"Hep G2: 82.9;THP-1: 153.3"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 49.7"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	21	"NK-cell: 6.5"	"Lineage enriched"	"Detected in single"	21	"NK-cells: 6.5"					"Not detected"	"Not detected"			HPA055877	Supported				"Secreted to blood"	43000000000	110000000000			"HPA055877: "	"unprognostic (4.28e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.66e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.14e-8)"	"unprognostic (1.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.80e-3)"	0.2	0.4	2.8	0.3	3.7	0.2	0.5	0.4	1.6	0.4	2.1	3.7	0.0	2.8	0.2	0.5	0.3	0.4	0.4	0.2	2.3	2.2	1.2	506.5	2.2	0.8	4.7	0.5	0.2	0.2	0.3	0.2	0.3	2.2	0.2	0.4	0.0	0.3	0.3	0.3	0.4	6.3	0.2	4.7	0.3	0.3	0.2	2.1	0.0	0.2	0.0	0.7	0.3	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	14.4	0.2	82.9	0.0	1.7	28.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.1	13.8	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.8	0.0	153.3	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	3.7	0.4	1.6	2.3	2.2	4.7	0.5	2.2	2.1
APOC3		ENSG00000110245	"Apolipoprotein C3"	P02656	11	116829706-116833072	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Lipid transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 714.1"	"Group enriched"	"Detected in some"	19	"CACO-2: 27.8;Hep G2: 75.2"	"Cancer enriched"	"Detected in many"	643	"liver cancer: 4021.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA065365, HPA073918"	Supported		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"	"Secreted to blood"	88520000000	97000000000	Nucleoplasm	"Nucleoli, Cell Junctions"	"HPA065365: , HPA073918: "							"prognostic favourable (3.77e-4)"				"unprognostic (2.33e-1)"		"prognostic unfavourable (6.87e-5)"	"unprognostic (1.60e-2)"	"unprognostic (5.21e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	38.7	0.1	0.1	31.7	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.4	714.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	91.3	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	27.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	75.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.3	1.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
APOC4		ENSG00000267467	"Apolipoprotein C4"	P55056	19	44942238-44945496	"Plasma proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"liver: 126.0"	"Cell line enhanced"	"Detected in some"		"HEL: 4.2;SK-MEL-30: 6.4"	"Cancer enriched"	"Detected in single"	15	"liver cancer: 0.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062671	Approved				"Secreted to blood"	1000000000	1500000000			"HPA062671: "							"unprognostic (1.82e-3)"											0.0	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	126.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	3.1	4.3	1.7	0.8	1.2	0.1	0.8	0.0	0.0	0.8	0.0	0.9	1.6	0.0	0.0	1.1	0.2	0.0	0.2	1.1	0.1	0.0	0.1	0.6	0.4	0.3	0.2	0.4	4.2	0.0	2.6	0.0	0.3	1.2	2.4	0.3	0.0	0.4	0.0	1.2	1.9	0.7	1.0	0.3	0.0	0.0	0.5	0.0	0.5	0.8	0.0	1.4	0.5	0.2	0.7	0.8	6.4	1.3	0.0	3.0	0.6	0.3	0.4	0.0	0.8	0.8	2.0	0.2	1.3	0.0	2.1	0.8	1.9	0.9	1.7	0.4	0.6	0.9	1.2	0.4	1.4	0.6	0.6	4.3	0.8	0.8	3.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.0
APOD		ENSG00000189058	"Apolipoprotein D"	P05090	3	195568702-195584205	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"breast: 840.7"	"Group enriched"	"Detected in some"	7	"ASC diff: 233.9;ASC TERT1: 126.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 925.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"memory B-cell: 6.7"	"Lineage enriched"	"Detected in single"	10	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040520	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	27730000	220000000000	"Plasma membrane"		"HPA040520: "	"prognostic favourable (5.51e-4)"	"unprognostic (7.62e-3)"	"unprognostic (7.85e-3)"	"unprognostic (3.34e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.90e-3)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.12e-4)"	"unprognostic (1.71e-3)"	134.4	15.2	39.7	5.7	39.9	3.4	840.7	14.7	66.1	75.0	16.4	79.7	10.9	12.9	36.6	30.0	46.1	42.9	36.4	124.7	45.5	29.2	8.5	3.5	11.8	6.5	96.9	28.2	19.4	28.3	9.0	14.3	59.6	50.9	39.7	13.1	99.1	152.5	35.1	110.4	66.0	7.2	30.4	81.6	3.6	28.7	32.0	56.5	0.0	87.7	42.2	6.6	62.1	95.7	6.7	0.1	0.4	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	233.9	126.0	0.3	2.0	0.5	0.0	0.0	12.9	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	6.4	1.4	0.0	1.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	2.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	25.3	0.4	0.1	0.0	0.1	0.1	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.1	39.7	39.9	14.7	39.5	45.5	29.2	96.9	28.2	50.9	56.5
APOE	AD2	ENSG00000130203	"Apolipoprotein E"	P02649	19	44905754-44909393	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	Heparin-binding	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Hyperlipidemia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 226.8;liver: 508.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 163.3;Hep G2: 75.9;HSkMC: 119.7;SK-MEL-30: 151.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 3183.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008363, HPA065539, HPA068768, CAB069921"	Enhanced		Approved	Vesicles	"Secreted to blood"	37650000000	63000000000	Vesicles		"CAB008363: AB_590560, CAB069921: AB_920623, HPA065539: AB_2685509, HPA068768: AB_2686029"	"unprognostic (8.98e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (7.25e-2)"	"unprognostic (5.22e-3)"	"unprognostic (6.13e-2)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.13e-2)"	76.8	226.8	78.4	14.6	106.8	9.7	12.8	26.6	109.8	13.6	15.1	40.3	0.8	7.7	9.4	10.9	2.6	4.3	17.1	6.9	41.4	57.9	121.8	508.1	21.5	46.0	104.0	34.5	23.5	5.2	2.7	4.9	17.2	54.1	6.6	5.2	11.2	8.5	3.4	5.7	33.0	10.2	3.6	35.1	89.2	13.4	12.6	33.9	4.9	6.0	1.3	8.6	11.8	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.2	163.3	6.7	5.9	0.1	0.3	0.7	0.1	38.7	0.2	0.1	0.8	0.0	0.5	1.0	0.1	0.0	0.1	0.3	0.2	0.1	75.9	16.8	0.5	0.1	119.7	0.2	1.2	0.1	0.0	9.9	0.2	0.1	0.2	0.1	0.2	20.4	0.1	0.2	0.6	0.1	0.2	0.0	0.4	0.2	0.3	0.1	151.8	14.0	4.3	0.2	1.1	0.2	0.1	0.1	0.4	0.6	0.3	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	78.4	106.8	26.6	53.4	41.4	57.9	104.0	34.5	54.1	33.9
APOF		ENSG00000175336	"Apolipoprotein F"	Q13790	12	56360569-56362823	"Plasma proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"liver: 114.0"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 9.7"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 34.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"												"Secreted to blood"	18000000000	4000000000				"unprognostic (3.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.55e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.43e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.9	1.8	0.5	1.1	1.4	0.1	0.2	0.2	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.7	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.3	0.6	0.9	9.7	0.0	0.9	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.3	0.1	0.3	0.2	0.1	0.5	0.4	0.3	0.4	0.6	0.5	0.4	0.3	0.1	0.4	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.4	0.2	0.4	0.3	1.8	0.5	0.3	0.5	0.2	0.8	1.6	0.7	0.6	0.1	2.1	1.4	1.1	1.3	1.1	0.4	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APOH	"B2G1, BG"	ENSG00000091583	"Apolipoprotein H"	P02749	17	66212033-66256525	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	550	"liver: 823.7"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 162.9"	"Cancer enriched"	"Detected in many"	232	"liver cancer: 2878.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001654, HPA003732, CAB022214"	Enhanced		Supported	"Golgi apparatus"	"Secreted to blood"	171400000000	44000000000	"Golgi apparatus"		"CAB022214: , HPA001654: AB_1078181, HPA003732: AB_1078183"			"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"		"prognostic favourable (2.39e-7)"	"unprognostic (1.26e-1)"		"unprognostic (5.99e-2)"	"unprognostic (2.88e-3)"		"prognostic unfavourable (1.10e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.76e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	823.7	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.7	0.9	1.3	1.0	1.3	0.2	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	162.9	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	0.3	0.0	0.0	1.3	0.4	1.3	0.5	1.3	0.8	0.8	0.6	0.7	1.4	0.9	0.8	0.9	1.0	0.4	0.5	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253010-36267530	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 62.5;HDLM-2: 40.3;HHSteC: 30.8;RPTEC TERT1: 23.9;RT4: 37.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA018885, CAB056156"	Supported				"Secreted to blood"	1637000000	19000000000			"CAB056156: , HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavourable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favourable (2.01e-5)"	22.4	7.1	2.5	16.5	3.2	0.7	11.8	1.7	2.6	16.6	13.0	1.8	11.6	9.1	19.9	15.6	15.9	11.5	25.8	11.5	3.5	2.4	22.8	66.4	23.8	9.9	3.6	2.0	21.6	7.8	1.3	6.5	39.3	4.7	26.4	7.8	13.0	9.5	24.1	6.5	3.1	22.9	17.9	4.6	23.1	17.5	6.1	2.4	9.6	21.9	10.0	9.7	25.9	46.3	2.0	3.3	12.7	7.1	17.2	10.9	4.9	5.1	1.1	0.0	0.1	12.0	11.6	3.5	0.5	2.2	3.4	9.7	0.1	8.4	1.7	62.5	5.8	1.2	0.0	4.8	0.9	40.3	0.0	1.4	0.8	9.8	30.8	0.6	5.1	2.0	0.4	9.8	0.2	6.7	6.0	21.4	0.6	0.0	1.9	0.4	0.1	0.0	3.3	0.5	0.7	23.9	37.0	0.5	0.0	2.5	1.4	0.5	0.1	1.8	6.1	7.3	3.2	0.7	0.3	1.6	0.9	0.3	4.1	2.9	1.1	9.8	4.6	3.9	10.9	5.2	8.7	2.0	6.7	9.0	3.3	1.2	4.0	5.4	12.7	17.2	7.1	0.4	4.1	4.9	2.5	3.2	1.7	2.6	3.5	2.4	3.6	2.0	4.7	2.4
APOL2	APOL-II	ENSG00000128335	"Apolipoprotein L2"	Q9BQE5	22	36226203-36239954	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA001078	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			10000000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA001078: AB_10602432"	"unprognostic (4.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.26e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.22e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (5.06e-6)"	21.5	14.2	17.4	25.3	12.0	6.9	20.3	26.5	30.1	16.7	15.6	11.1	11.1	25.0	20.3	17.9	10.2	15.3	25.6	17.3	15.1	19.3	18.2	39.7	23.6	22.0	20.2	11.9	12.6	10.1	11.2	57.1	14.6	28.7	19.0	16.1	15.9	15.2	18.8	16.5	9.6	21.7	22.2	16.2	26.2	22.7	7.2	12.0	14.9	23.0	12.7	17.0	25.8	19.4	6.2	6.0	43.0	17.0	9.9	15.5	4.6	7.4	5.5	5.4	4.1	21.2	16.5	10.3	10.1	23.7	27.6	37.5	2.2	6.1	9.0	17.2	18.2	3.5	5.9	8.1	13.7	30.4	6.7	4.2	11.7	10.4	35.8	9.0	8.2	20.8	5.5	19.3	5.1	17.9	7.5	25.6	17.2	2.7	9.1	4.0	2.0	5.1	9.4	7.0	5.3	27.8	19.7	9.8	2.8	6.9	13.2	5.4	4.1	1.3	17.3	16.7	8.3	3.4	5.6	15.5	7.7	2.8	14.4	4.7	6.3	8.9	8.6	5.8	15.5	17.0	14.1	6.2	11.2	12.7	6.0	4.1	6.5	10.9	43.0	9.9	11.4	3.7	10.5	4.6	17.4	12.0	26.5	30.1	15.1	19.3	20.2	11.9	28.7	12.0
APOL4	APOLIV	ENSG00000100336	"Apolipoprotein L4"	Q9BPW4	22	36189124-36204840	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.1;HDLM-2: 45.5;HSkMC: 7.4;K-562: 9.7;SCLC-21H: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 4.3;intermediate monocyte: 2.3;myeloid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;monocytes: 4.3"									"HPA049797, HPA055435"	Uncertain		Supported	Vesicles	"Secreted to blood"			Vesicles		"HPA049797: , HPA055435: "	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.31e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (3.45e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (2.00e-5)"	"unprognostic (4.26e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.18e-2)"	"prognostic favourable (2.40e-6)"	2.3	0.8	1.1	2.7	1.3	0.0	2.3	0.9	1.0	2.4	1.2	0.7	0.7	2.2	2.0	0.7	2.4	3.1	3.2	2.8	0.8	1.0	10.3	1.1	7.3	1.7	1.0	0.7	4.2	0.9	0.0	1.9	3.0	1.2	9.0	1.5	1.8	2.9	1.6	1.0	1.6	5.4	2.1	2.3	1.1	2.3	0.7	1.2	7.1	1.1	0.7	2.3	7.4	1.4	0.4	3.8	0.6	4.3	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.9	8.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	45.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.3	9.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	20.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	4.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	3.8	0.3	0.0	0.0	0.2	0.8	0.2	0.0	0.0	1.2	1.1	1.3	0.9	1.0	0.8	1.0	1.0	0.7	1.2	1.2
APOL5	APOLV	ENSG00000128313	"Apolipoprotein L5"	Q9BWW9	22	35717872-35729483	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"liver: 1.8;skeletal muscle: 5.4;testis: 2.6"	"Cell line enriched"	"Detected in single"	13	"U-698: 6.1"	"Cancer enriched"	"Detected in single"	7	"liver cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040968	Uncertain									"HPA040968: AB_10963933"	"unprognostic (2.23e-1)"				"unprognostic (7.61e-4)"	"unprognostic (9.34e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.23e-1)"			"unprognostic (4.18e-2)"		"unprognostic (4.37e-5)"	"unprognostic (3.23e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-1)"	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
APOM	"ApoM, G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 94.6"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.3"	"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	7404315000	18000000000	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: "	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	1.3	1.5	1.8	1.5	1.6	6.8	1.9	1.3	2.0	1.3	1.8	2.2	1.9	2.4	2.3	3.0	1.6	1.5	1.4	1.5	1.5	1.3	15.2	94.6	1.0	3.6	1.7	1.9	3.7	3.3	1.4	1.9	0.7	1.6	1.1	0.9	2.1	3.1	1.6	2.2	2.4	2.4	1.5	2.4	1.3	1.4	6.6	1.1	3.6	2.7	1.7	3.1	1.1	1.0	3.3	1.6	5.8	2.1	1.0	2.2	1.0	2.1	1.1	2.5	4.1	2.0	2.5	0.5	1.5	2.7	1.0	2.4	1.5	3.2	3.4	0.8	2.6	3.5	1.4	1.6	2.1	2.1	2.5	2.4	1.8	3.1	3.3	4.2	1.1	3.3	1.6	1.0	3.0	0.9	4.2	2.2	2.7	3.2	3.6	4.1	2.1	0.5	2.2	1.8	3.8	2.8	3.2	2.2	1.0	2.1	0.2	1.8	4.5	3.0	0.4	1.4	0.5	2.8	0.6	3.9	3.4	4.1	1.3	6.5	0.6	5.8	1.9	1.7	1.1	0.9	1.7	3.3	1.3	1.1	1.6	1.9	1.7	1.8	1.7	1.0	2.1	1.4	2.2	1.0	1.8	1.6	1.3	1.8	1.5	1.3	1.7	1.9	1.6	1.1
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 24.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"			15000000	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favourable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	44.8	92.5	89.9	26.3	109.3	21.2	79.9	64.5	139.1	51.7	63.4	86.9	72.0	39.7	52.2	57.2	33.0	57.6	63.4	69.1	104.6	97.7	102.2	54.5	50.2	12.9	97.4	95.8	58.9	57.1	36.4	34.1	79.7	83.2	49.2	59.6	48.9	47.2	66.6	17.2	38.2	34.9	69.3	109.0	26.3	37.9	32.2	67.5	13.9	85.0	21.5	16.7	52.5	58.4	1.5	24.0	0.9	3.9	0.3	1.5	1.8	31.5	40.8	44.8	37.3	61.1	75.8	48.4	64.1	85.6	32.5	38.3	23.4	77.6	0.0	74.7	50.1	21.6	27.3	75.3	27.5	1.2	22.0	0.0	24.6	16.4	59.6	29.9	1.6	68.3	83.3	38.1	70.0	145.5	0.0	3.3	51.0	35.4	0.5	0.3	35.2	36.5	19.6	43.2	26.3	110.1	22.2	22.8	33.3	68.8	45.3	32.2	40.1	32.6	155.5	72.4	30.7	26.3	30.3	19.9	0.2	0.3	58.9	0.1	69.5	0.4	3.9	0.0	0.1	1.2	0.2	0.5	1.4	0.5	3.4	1.5	1.5	0.4	0.9	0.3	0.9	24.0	0.3	1.8	89.9	109.3	64.5	124.6	104.6	97.7	97.4	95.8	83.2	67.5
APRT		ENSG00000198931	"Adenine phosphoribosyltransferase"	P07741	16	88809339-88811944	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026681	Approved		Supported	Nucleoplasm,Cytosol			1200000	"Nucleoplasm, Cytosol"		"HPA026681: AB_1844964"	"unprognostic (5.87e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.48e-2)"	22.9	37.1	10.9	33.6	13.2	32.9	31.6	10.1	15.3	22.7	31.1	10.7	33.6	27.1	19.9	28.3	50.7	21.0	30.4	22.5	9.1	8.2	27.7	60.4	30.6	94.2	14.8	10.7	17.9	58.2	19.4	15.6	19.3	11.0	25.1	15.1	13.9	48.2	37.4	26.2	49.8	24.3	18.4	12.1	30.4	27.5	16.0	12.2	37.9	29.5	49.7	35.8	18.5	32.8	65.4	92.1	24.2	70.2	58.2	83.7	104.7	25.4	37.4	7.3	33.0	9.0	17.9	39.1	19.3	17.2	22.8	8.9	38.5	30.9	23.7	37.8	10.9	27.3	12.0	31.7	4.6	16.7	71.6	20.2	17.7	40.2	28.6	13.8	16.5	19.1	34.3	18.1	23.0	28.4	42.4	17.8	11.5	93.8	39.0	40.8	28.2	49.0	42.0	11.4	56.1	25.1	17.3	36.5	22.4	36.8	21.5	20.8	71.0	27.5	18.3	20.6	18.0	16.6	18.9	35.0	29.3	65.2	30.3	36.8	18.1	8.5	70.2	24.2	63.0	57.7	83.7	63.2	81.9	67.5	71.6	65.4	75.9	64.3	4.3	58.2	37.1	92.1	66.1	104.7	10.9	13.2	10.1	15.3	9.1	8.2	14.8	10.7	11.0	12.2
AQP3	GIL	ENSG00000165272	"Aquaporin 3 (Gill blood group)"	Q92482	9	33441154-33447633	"Blood group antigen proteins, Plasma proteins, Predicted membrane proteins"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 28.0;HeLa: 50.9;RT4: 47.4;SK-BR-3: 32.8;U-266/70: 34.0;U-266/84: 44.0"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"hippocampal formation: 2.1;pons and medulla: 6.7"	"Group enriched"	"Detected in many"	6	"MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1"	"Lineage enriched"	"Detected in many"	16	"T-cells: 42.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014924	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA014924: "	"unprognostic (4.29e-2)"	"prognostic favourable (5.31e-4)"	"unprognostic (1.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.51e-2)"	1.3	0.4	0.4	2.7	0.2	1.9	5.2	0.9	0.3	29.7	26.7	0.1	1.7	9.9	5.5	3.2	179.6	3.3	2.0	6.0	2.1	0.4	23.9	44.0	16.5	5.7	0.5	0.3	3.6	5.7	0.0	0.7	5.3	6.7	15.5	1.2	0.4	194.2	5.5	0.9	65.2	33.2	5.1	0.3	17.2	3.9	1.2	0.0	70.6	0.6	132.4	156.1	37.6	60.2	2.6	2.4	0.5	0.1	0.5	42.1	10.3	0.1	8.4	0.4	0.0	15.5	2.8	0.2	0.0	0.2	0.2	0.2	4.4	2.6	0.1	2.0	0.0	28.0	1.3	0.1	0.0	13.3	1.3	0.9	50.9	0.4	0.0	0.2	0.3	0.4	1.4	0.1	0.0	0.1	14.3	13.0	1.5	6.2	12.7	4.9	1.1	0.1	0.2	21.2	2.3	0.2	47.4	0.4	1.0	7.1	32.8	0.0	0.2	2.2	0.2	0.0	0.2	0.0	0.0	34.0	44.0	3.1	0.1	0.0	0.0	0.3	0.1	0.0	4.5	0.0	41.1	2.6	39.2	12.0	0.0	0.5	22.7	10.8	0.5	0.5	0.1	2.4	42.1	10.3	0.4	0.2	0.9	0.3	2.1	0.4	0.5	0.3	6.7	0.0
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA040624: , HPA055647: "	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	15.5	15.8	8.0	14.0	12.4	9.7	16.1	11.2	14.3	16.6	11.2	11.8	8.7	9.2	18.5	11.8	18.3	12.3	8.7	9.9	8.4	7.5	14.4	11.2	10.7	12.6	8.7	6.9	15.5	13.6	16.8	13.2	15.3	13.2	12.0	11.8	12.4	15.1	11.3	8.7	14.2	13.0	14.3	8.3	16.8	12.9	15.8	9.2	27.9	14.8	8.5	16.5	15.7	14.9	5.9	5.5	7.1	5.1	4.5	6.5	2.9	5.0	13.0	8.7	9.1	11.8	11.0	4.5	6.2	7.9	8.2	7.4	5.9	3.1	4.1	4.0	10.4	8.0	14.5	8.8	9.2	5.8	5.9	13.2	11.5	5.4	6.7	10.7	6.2	8.5	5.9	6.5	6.9	7.0	9.3	4.1	8.1	3.4	6.1	7.1	8.6	5.4	8.4	14.9	4.1	8.3	8.9	9.5	7.4	10.1	9.6	2.2	6.8	8.3	9.1	6.2	3.4	4.2	5.4	5.0	6.1	8.3	7.7	9.3	6.2	7.1	4.7	2.7	6.5	5.1	5.7	4.0	5.7	6.2	3.8	5.9	5.8	6.4	2.3	4.5	3.0	5.5	4.6	2.9	8.0	12.4	11.2	13.4	8.4	7.5	8.7	6.9	13.2	9.2
AR	"AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1"	ENSG00000169083	"Androgen receptor"	P10275	X	67544032-67730619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.0"	"Cell line enhanced"	"Detected in some"		"AF22: 11.0;BJ hTERT+: 9.6;HAP1: 14.1;LHCN-M2: 12.4;RH-30: 20.5;T-47d: 8.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000001, HPA065701, CAB065764"	Enhanced		Approved	Mitochondria				Mitochondria		"CAB000001: AB_2060174, CAB065764: AB_10620739, HPA065701: "	"unprognostic (1.34e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (8.77e-4)"	"unprognostic (4.99e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.29e-1)"	"prognostic favourable (1.03e-8)"	"unprognostic (8.23e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.23e-2)"	"unprognostic (7.97e-2)"	10.1	1.2	0.9	1.6	0.9	0.1	10.7	0.4	1.6	34.4	1.9	2.4	25.4	0.2	20.5	20.5	2.2	17.5	4.3	5.7	0.9	1.5	6.3	49.0	1.5	0.2	1.2	0.7	14.4	1.0	0.1	2.3	0.3	1.9	28.0	0.5	3.8	1.6	36.1	8.1	3.9	1.1	7.6	1.9	0.9	1.6	9.3	1.2	5.4	3.1	2.0	1.2	6.3	13.1	0.0	5.4	0.3	0.0	0.1	0.0	0.1	0.0	4.6	11.0	0.0	0.0	0.1	0.0	5.8	9.6	0.4	0.1	0.2	0.0	0.0	0.0	0.7	0.0	14.1	0.0	0.1	0.0	1.8	0.0	1.1	0.0	0.6	0.0	0.0	4.5	0.0	1.6	0.0	3.4	4.0	1.8	12.4	1.2	0.0	0.0	4.4	0.0	0.0	20.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	8.6	5.2	0.2	0.2	2.0	0.1	2.9	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	5.4	0.0	0.1	0.9	0.9	0.4	1.6	0.9	1.5	1.2	0.7	1.9	1.2
ARAF	ARAF1	ENSG00000078061	"A-Raf proto-oncogene, serine/threonine kinase"	P10398	X	47561100-47571920	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046188, HPA066326"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA046188: AB_2679578, HPA066326: AB_2685659"	"unprognostic (1.21e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.63e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.75e-2)"	"unprognostic (8.65e-2)"	"prognostic favourable (1.45e-6)"	"unprognostic (1.97e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.71e-2)"	22.2	24.2	10.9	16.5	15.5	41.9	19.5	16.0	13.7	18.0	23.2	21.1	24.1	17.8	21.3	18.4	19.4	18.7	21.0	28.6	12.8	7.3	28.0	49.6	21.8	20.2	16.4	9.5	23.4	35.1	28.1	16.9	25.3	13.5	23.5	15.8	25.4	22.1	18.5	60.8	18.9	23.8	18.6	11.2	27.4	24.2	10.2	16.3	27.7	23.1	23.9	27.3	20.2	16.9	23.9	34.3	36.1	38.4	22.4	29.1	27.5	19.9	28.8	12.3	19.9	18.8	15.0	16.7	16.8	17.8	25.2	23.3	23.4	24.5	11.9	13.9	22.6	28.2	21.8	23.3	14.5	21.8	25.6	11.9	30.5	12.1	26.5	23.6	36.5	19.7	23.7	24.0	21.1	19.4	22.0	23.5	17.0	33.8	17.1	25.4	17.7	32.2	15.9	16.1	26.8	14.4	19.1	14.0	10.8	18.2	16.8	9.9	31.6	17.8	18.4	16.4	18.4	32.7	17.0	30.5	19.5	9.2	21.8	26.7	13.0	23.9	29.0	36.1	29.1	35.4	26.9	21.4	25.5	26.7	34.3	23.9	22.7	26.7	23.6	22.4	38.4	24.7	25.1	27.5	10.9	15.5	16.0	13.7	12.8	7.3	16.4	9.5	13.5	16.3
ARCN1	COPD	ENSG00000095139	"Archain 1"	P48444	11	118572390-118603033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037573, HPA044874"	Approved		Enhanced	"Golgi apparatus,Vesicles"			340000	Vesicles	"Golgi apparatus"	"HPA037573: AB_10696938, HPA044874: "	"unprognostic (1.46e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (2.97e-5)"	"unprognostic (3.10e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.67e-3)"	"unprognostic (9.39e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.20e-2)"	"unprognostic (4.14e-3)"	"unprognostic (5.56e-3)"	46.9	37.4	26.7	30.3	32.9	15.0	35.7	34.4	38.8	48.8	36.7	37.3	39.9	36.0	39.8	61.6	38.6	32.6	38.0	39.5	28.7	30.6	39.1	61.4	34.0	27.3	30.4	24.7	45.1	65.2	49.7	64.7	46.0	38.3	42.4	39.6	29.3	62.0	46.9	25.8	31.9	47.1	41.9	34.3	34.9	38.1	37.9	29.7	39.0	44.1	29.3	39.2	46.9	42.1	22.7	29.1	46.2	33.0	34.1	39.5	26.7	24.3	20.4	35.8	26.1	44.1	47.1	19.3	61.5	54.7	27.9	33.3	64.4	32.3	25.7	52.8	68.6	33.0	40.0	36.2	38.9	35.3	18.7	55.1	14.8	35.0	50.1	33.8	32.3	41.1	30.1	46.0	42.9	42.2	28.4	36.1	52.4	39.1	30.4	30.1	22.5	27.3	26.5	34.8	39.1	33.7	26.5	24.6	24.7	34.2	33.4	17.3	42.5	30.3	38.5	35.2	17.3	33.2	28.4	21.2	18.8	37.4	20.7	31.7	41.8	46.2	26.4	26.3	30.5	33.0	39.5	22.7	30.2	29.3	29.1	20.7	29.1	26.6	23.1	34.1	32.1	24.4	28.3	26.7	26.7	32.9	34.4	38.8	28.7	30.6	30.4	24.7	38.3	29.7
ARF3		ENSG00000134287	"ADP ribosylation factor 3"	P61204	12	48935723-48957551	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.99e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.95e-1)"	20.4	23.0	60.9	24.5	84.1	18.7	17.4	29.2	92.1	23.3	31.1	24.6	12.9	18.5	17.4	23.9	23.3	19.9	16.0	13.0	58.4	45.8	28.7	16.7	22.6	14.8	37.6	48.1	16.3	14.9	43.1	21.4	18.8	38.3	18.6	29.5	15.7	16.8	20.8	4.7	21.5	20.7	23.6	32.1	18.4	17.6	15.5	18.3	15.1	23.0	11.9	21.6	17.2	13.7	5.8	24.7	26.0	18.2	8.2	8.4	8.8	42.4	63.0	27.5	24.3	22.9	16.7	26.2	28.4	35.9	33.4	29.0	83.3	56.3	34.1	42.7	30.9	35.4	37.9	38.4	30.2	41.6	19.5	55.4	51.7	23.8	14.3	42.2	45.1	18.7	30.5	36.3	21.7	35.4	33.7	18.6	28.4	52.0	31.3	23.0	38.8	33.9	30.3	15.7	22.5	36.0	54.5	28.4	26.0	30.6	35.8	26.7	60.5	33.9	49.0	25.0	40.2	15.6	17.7	18.2	41.1	25.0	32.8	33.0	14.1	2.6	18.2	12.5	6.7	11.7	5.5	5.8	7.9	8.4	24.7	5.3	4.3	4.9	26.0	8.2	7.7	19.1	6.1	8.8	60.9	84.1	29.2	92.1	58.4	45.8	37.6	48.1	38.3	18.3
ARF4	ARF2	ENSG00000168374	"ADP ribosylation factor 4"	P18085	3	57571363-57598220	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										4000000				"unprognostic (1.75e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (7.29e-7)"	"unprognostic (4.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (9.30e-4)"	"unprognostic (4.98e-3)"	52.8	60.2	26.3	29.0	30.1	17.5	55.8	21.6	38.5	64.6	44.2	25.1	59.2	34.7	40.6	70.4	43.5	33.6	46.7	42.9	26.5	32.2	52.1	164.0	52.5	52.6	25.9	16.1	52.7	105.9	32.2	46.4	89.2	26.2	41.8	57.0	35.5	105.0	66.7	21.7	23.4	60.3	49.0	28.7	34.3	38.7	45.2	17.5	19.8	54.5	39.4	45.3	47.4	32.2	17.9	36.2	62.6	28.4	17.6	25.9	27.6	30.6	12.3	27.7	23.7	69.5	71.2	27.4	77.1	75.2	48.9	62.7	33.7	29.5	11.5	14.3	98.3	12.1	30.9	45.1	62.5	14.2	10.5	22.9	27.6	43.5	86.5	14.7	16.3	68.9	39.1	47.3	56.8	61.1	16.5	22.2	84.2	15.0	9.2	18.7	34.0	41.9	5.2	23.0	20.8	57.9	22.0	9.4	21.6	32.2	29.6	38.5	21.0	24.9	47.3	38.8	22.5	56.7	45.5	16.4	14.1	15.9	43.3	29.4	49.5	62.6	28.4	29.7	14.8	23.9	25.1	17.9	20.8	18.9	23.8	15.6	25.9	19.6	33.4	17.6	20.2	36.2	18.9	27.6	26.3	30.1	21.6	38.5	26.5	32.2	25.9	16.1	26.2	17.5
ARF5		ENSG00000004059	"ADP ribosylation factor 5"	P84085	7	127588345-127591705	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										4600000				"unprognostic (6.72e-3)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.81e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.46e-2)"	24.3	24.7	43.7	30.0	49.0	46.4	29.6	40.5	63.6	34.0	31.1	18.0	35.6	33.2	28.9	50.7	64.1	38.1	39.1	40.2	41.2	33.0	31.6	34.7	28.6	46.7	29.2	47.0	21.7	61.4	23.8	27.1	31.7	25.0	27.7	22.4	18.6	33.8	29.9	43.5	62.1	35.0	26.4	23.1	28.7	32.1	28.7	19.5	35.7	29.0	56.2	31.2	34.2	29.9	23.8	73.1	80.1	57.3	26.1	31.9	56.7	24.7	25.0	19.2	62.0	16.7	26.4	26.9	6.9	20.7	19.2	22.4	38.4	33.5	18.6	10.7	20.8	18.8	14.7	31.3	6.1	16.8	39.8	7.0	23.4	25.9	25.4	10.8	16.2	27.1	32.3	12.6	12.2	28.8	16.5	19.9	18.5	87.0	38.5	50.4	29.0	34.3	23.7	12.1	39.3	32.2	25.3	57.4	37.3	23.1	74.0	17.9	19.8	17.7	16.7	29.0	12.7	20.6	15.9	19.0	11.9	23.6	29.5	22.6	24.8	41.3	57.3	47.6	27.6	46.7	27.9	23.8	29.3	28.4	73.1	21.8	22.3	24.2	80.1	26.1	36.1	47.5	31.9	56.7	43.7	49.0	40.5	63.6	41.2	33.0	29.2	47.0	25.0	19.5
ARFGAP1	"ARF1GAP, bA261N11.3, FLJ10767"	ENSG00000101199	"ADP ribosylation factor GTPase activating protein 1"	Q8N6T3	20	63272785-63289793	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051019, HPA056273"	Approved		Supported	"Nuclear membrane,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Nuclear membrane"	"HPA051019: AB_2681313, HPA056273: AB_2683084"	"unprognostic (1.81e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.57e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.86e-3)"	"unprognostic (8.62e-2)"	"prognostic favourable (4.57e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (3.48e-7)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.86e-1)"	12.3	13.8	17.8	16.7	21.8	12.4	10.4	29.2	28.9	16.0	16.6	27.1	15.3	14.8	17.3	17.9	13.4	16.0	20.0	14.3	17.5	17.2	13.7	14.8	13.1	16.6	26.0	19.9	16.7	32.8	13.7	40.9	17.9	19.2	16.2	11.7	20.1	21.3	18.1	10.4	21.9	15.7	14.8	15.9	17.2	21.1	19.9	22.7	11.2	15.0	10.3	15.5	16.0	11.9	7.4	8.2	8.3	12.6	6.6	9.9	7.0	11.0	21.0	9.2	10.9	11.0	12.5	18.0	16.2	13.4	33.0	16.6	50.0	12.4	8.4	14.9	19.4	15.3	8.3	26.2	10.3	5.5	9.3	6.5	20.3	42.1	16.9	9.8	13.6	10.7	16.9	15.9	9.0	11.6	11.7	9.8	8.8	18.2	17.6	9.2	12.2	18.1	9.9	13.2	8.1	8.1	13.5	9.8	10.8	19.4	20.7	20.2	15.2	12.6	15.0	20.2	27.4	12.2	12.8	10.1	6.5	9.2	20.5	6.9	12.5	6.9	7.6	8.3	8.8	10.5	9.9	4.8	4.8	8.0	8.2	7.4	4.9	4.6	3.6	6.6	12.6	6.2	5.9	7.0	17.8	21.8	29.2	28.9	17.5	17.2	26.0	19.9	19.2	22.7
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131573144-131584332	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 284.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;HL-60: 3.9;RH-30: 1.6;SiHa: 1.8;U-698: 2.2"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 24.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 24.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.7"	"Low region specificity"	"Detected in single"			"HPA003595, CAB009434, HPA024006, CAB056159"	Enhanced						15000000			"CAB009434: AB_2058955, CAB056159: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	1.0	0.0	0.1	0.1	0.1	34.3	0.6	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	0.3	0.1	3.0	0.2	0.0	0.1	284.1	5.1	0.8	0.2	0.1	0.4	0.2	0.0	0.1	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	14.6	0.1	0.1	0.1	3.5	0.0	0.3	0.1	0.5	0.3	1.7	0.3	0.3	0.7	0.1	0.1	24.4	0.4	0.0	4.7	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.1	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.3	0.2	1.6	0.0	3.9	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.5	0.1	0.3	0.1	0.0	0.0	1.6	0.4	0.0	0.3	0.2	0.1	1.8	0.4	0.2	0.1	0.5	0.0	0.0	0.2	0.3	0.1	1.0	0.1	2.2	0.1	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.1	24.4	0.0	0.4	0.1	4.7	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.1
ARHGAP1	"CDC42GAP, p50rhoGAP, RhoGAP"	ENSG00000175220	"Rho GTPase activating protein 1"	Q07960	11	46677080-46700615	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004689, HPA008285"	Approved	Approved	Supported	Vesicles			16000000	Vesicles		"HPA004689: AB_1078194, HPA008285: AB_1078195"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.19e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (2.14e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.94e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.24e-2)"	39.9	23.0	17.5	21.3	24.0	17.5	25.8	9.5	30.1	35.6	23.9	42.9	13.1	15.2	43.0	23.9	36.8	31.0	40.2	63.3	23.0	14.8	19.8	19.4	17.9	22.0	17.5	17.7	32.6	17.0	18.6	16.7	32.0	17.1	36.3	20.0	33.8	21.6	39.3	15.1	26.9	19.5	58.5	18.1	29.0	21.4	21.4	24.1	21.0	20.0	16.2	27.2	59.5	27.1	7.9	17.1	18.8	33.4	11.6	14.3	10.3	7.0	17.7	8.9	12.6	44.6	32.9	10.6	15.6	16.0	14.5	13.3	10.6	9.4	10.3	8.6	32.0	17.7	7.0	23.9	10.9	7.1	7.7	11.3	9.1	12.5	14.7	9.6	17.0	43.4	15.0	11.1	13.9	12.4	7.3	9.7	17.6	25.6	6.4	9.5	23.0	9.3	7.7	12.8	15.2	13.7	26.7	3.2	10.2	14.4	22.4	6.0	28.2	11.0	15.4	26.8	8.4	31.6	15.7	10.3	11.3	7.7	25.1	16.2	12.5	12.0	16.3	15.6	14.3	28.2	10.2	7.7	11.3	12.1	16.1	7.9	9.9	11.2	18.8	11.6	33.4	17.1	13.4	10.3	17.5	24.0	9.5	30.1	23.0	14.8	17.5	17.7	17.1	24.1
ARHGAP25	KIAA0053	ENSG00000163219	"Rho GTPase activating protein 25"	P42331	2	68679601-68826833	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 94.2;lymphoid tissue: 48.7"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 94.2"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 3.2;basal ganglia: 7.8;cerebral cortex: 8.5;hippocampal formation: 6.4"	"Low region specificity"	"Detected in all"			"HPA035346, HPA061395"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA035346: AB_10601116, HPA061395: AB_2684501"	"unprognostic (1.13e-3)"	"prognostic favourable (7.72e-4)"	"unprognostic (2.45e-2)"	"unprognostic (4.44e-3)"	"unprognostic (8.07e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (3.10e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.61e-1)"	"unprognostic (4.49e-2)"	7.4	3.5	2.6	33.1	3.6	14.6	5.7	0.9	3.2	3.1	4.9	6.7	1.6	2.5	4.0	10.5	3.5	3.5	7.2	4.3	2.8	2.3	5.7	4.6	12.9	39.0	5.9	1.9	8.1	2.2	0.6	3.1	4.5	4.2	3.7	4.2	3.1	5.7	1.5	2.0	3.3	14.3	3.5	6.3	48.7	3.4	2.2	3.3	20.9	4.0	2.3	40.6	6.1	4.7	23.6	7.5	94.2	12.5	22.8	26.3	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.7	0.0	5.7	0.0	0.6	0.0	18.3	0.0	0.0	0.2	4.0	73.6	0.0	0.7	0.1	2.3	0.0	0.1	6.7	0.0	0.0	4.6	12.9	0.3	0.0	5.1	1.2	0.2	0.0	1.5	1.1	0.1	0.0	0.0	0.4	0.0	3.4	0.9	0.0	0.2	0.0	0.1	14.5	7.7	4.6	0.0	9.1	0.1	27.5	8.7	72.8	26.3	10.9	16.4	23.6	11.8	22.7	5.3	14.5	8.5	15.0	94.2	22.8	12.5	7.5	14.2	15.7	2.6	3.6	0.9	3.2	2.8	2.3	5.9	1.9	4.2	3.3
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.7;THP-1: 27.4;U-266/70: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019816	Enhanced						2200000			"HPA019816: AB_1853923"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	4.9	2.8	2.8	28.3	3.8	35.2	4.3	0.9	2.2	2.1	4.8	3.8	0.6	4.4	2.1	2.6	3.2	3.3	5.4	2.7	3.0	2.2	4.6	3.5	17.5	42.2	5.4	1.2	1.2	1.5	0.5	2.5	5.8	3.9	3.2	1.7	3.2	6.7	1.5	1.2	2.0	23.4	2.0	4.9	50.4	6.1	1.7	4.6	45.0	4.3	1.8	38.4	4.3	4.3	9.3	9.4	15.7	9.2	11.3	32.1	21.0	3.2	0.6	0.0	3.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	8.7	4.2	21.9	0.9	0.0	2.9	0.6	0.1	0.0	16.0	0.3	2.9	6.0	1.0	0.1	14.2	17.3	0.0	0.9	0.0	0.0	0.0	1.9	30.7	0.0	0.2	15.8	12.7	2.3	1.6	15.3	0.1	21.7	0.0	0.0	0.1	0.0	5.0	0.0	1.3	1.0	27.4	1.4	0.0	0.6	0.0	0.0	40.4	17.3	17.5	0.1	21.4	1.6	2.7	9.2	9.8	20.4	9.0	17.8	7.3	23.2	24.2	9.4	9.3	32.1	23.3	15.7	11.3	8.4	5.6	18.2	21.0	2.8	3.8	0.9	2.2	3.0	2.2	5.4	1.2	3.9	4.6
ARHGAP5	"GFI2, p190-B, p190BRhoGAP, RhoGAP5"	ENSG00000100852	"Rho GTPase activating protein 5"	Q13017	14	32076114-32159728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046993, HPA056507"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA046993: , HPA056507: "	"unprognostic (1.79e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.28e-2)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.97e-8)"	"unprognostic (9.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.00e-2)"	11.3	13.1	29.8	8.4	26.1	4.0	13.0	39.1	29.2	14.2	14.6	11.5	7.9	16.0	13.2	11.9	31.5	11.1	15.3	28.0	29.5	19.6	20.8	14.5	12.8	5.9	26.8	23.4	23.3	13.5	21.8	27.6	16.9	24.2	14.7	12.3	9.2	26.0	14.5	11.5	14.0	17.3	13.4	26.6	18.7	13.3	20.4	30.6	8.8	32.5	7.7	8.0	15.6	25.8	7.3	9.0	1.5	1.8	6.8	7.4	2.3	18.6	15.2	15.2	22.2	20.0	14.1	8.7	11.6	14.4	7.1	10.7	19.3	18.3	5.5	10.4	14.7	19.9	14.5	12.5	13.9	5.5	8.4	8.3	9.4	28.2	13.6	5.0	5.0	15.6	25.5	6.6	25.0	8.7	7.3	16.5	11.5	9.8	10.9	0.2	7.5	18.3	11.9	18.7	1.0	15.6	49.9	23.6	9.2	31.3	16.8	23.7	17.4	0.3	13.9	13.2	19.9	10.9	8.5	6.3	12.3	0.8	6.6	5.4	35.9	1.5	1.8	0.0	4.0	0.8	4.8	7.3	7.0	3.7	6.1	7.1	7.4	4.3	0.6	6.8	1.3	9.0	5.7	2.3	29.8	26.1	39.1	29.2	29.5	19.6	26.8	23.4	24.2	30.6
ARHGAP6	rhoGAPX-1	ENSG00000047648	"Rho GTPase activating protein 6"	O43182	X	11137543-11665701	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 57.3;seminal vesicle: 58.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.8;ASC TERT1: 19.2;HEL: 18.9;HMC-1: 13.3;HSkMC: 18.9;K-562: 13.7;RT4: 10.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001798, HPA036779, HPA064390"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		920000	Cytosol		"HPA001798: , HPA036779: AB_10672229, HPA064390: "	"unprognostic (2.36e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.31e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.46e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.55e-8)"	"unprognostic (1.60e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.28e-2)"	"unprognostic (7.99e-4)"	9.4	1.2	16.7	2.6	10.0	0.7	6.3	0.6	2.9	9.5	11.7	4.1	57.3	2.0	10.2	9.0	4.1	7.6	5.4	3.6	5.6	4.3	6.0	1.1	8.7	1.2	2.3	3.6	15.1	1.9	1.1	6.6	6.2	2.7	24.8	3.7	3.2	2.5	58.8	8.0	2.3	4.2	12.1	3.1	5.0	4.1	2.2	3.3	0.0	25.9	3.1	1.4	14.3	8.0	1.3	0.2	1.0	0.9	0.0	0.1	2.7	0.0	0.0	1.3	0.0	14.8	19.2	0.3	0.1	0.3	0.7	0.5	0.1	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.7	0.0	0.2	18.9	0.0	0.0	5.4	0.0	13.3	18.9	0.0	1.3	0.0	0.3	13.7	6.4	0.8	0.0	0.0	0.0	0.3	0.2	0.0	6.3	8.0	4.5	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	3.8	0.1	0.3	0.0	0.0	0.1	0.0	2.0	1.0	0.3	0.5	0.0	0.9	0.0	1.3	0.0	0.1	0.2	0.4	0.0	0.0	1.0	0.0	0.7	0.2	0.0	2.7	16.7	10.0	0.6	2.9	5.6	4.3	2.3	3.6	2.7	3.3
ARHGDIA	"GDIA1, RHOGDI"	ENSG00000141522	"Rho GDP dissociation inhibitor alpha"	P52565	17	81867721-81871406	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010005, HPA021407"	Approved		Supported	Cytosol			49000000	Cytosol		"CAB010005: AB_2227516, HPA021407: AB_1856267"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (5.32e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.88e-3)"	67.9	52.5	43.8	71.8	59.5	91.1	57.2	20.4	65.7	41.2	55.4	44.6	29.7	85.9	50.0	34.1	55.0	40.9	46.2	36.7	41.5	44.6	50.9	64.9	56.0	68.2	39.9	43.4	49.7	65.9	30.6	42.9	52.8	39.0	44.1	27.2	39.9	52.7	43.2	36.7	41.0	88.8	35.7	41.7	57.1	68.4	26.3	35.4	67.1	41.2	41.4	49.9	42.2	44.8	17.0	24.0	35.0	41.0	18.4	29.9	22.8	64.7	64.0	20.8	33.3	19.3	24.2	23.8	55.7	35.9	41.9	31.2	31.4	24.7	34.3	23.8	42.1	35.7	23.0	42.0	17.7	26.6	58.9	36.2	38.2	40.7	39.3	57.0	53.2	30.6	19.5	30.3	26.4	63.7	29.8	48.3	33.6	39.0	82.7	58.1	24.7	56.6	37.9	26.7	27.4	27.5	40.1	27.7	81.5	29.3	75.4	52.2	35.4	46.9	70.1	83.7	71.5	77.1	94.5	42.6	22.2	35.4	72.6	34.4	56.7	15.7	20.5	35.0	29.9	31.3	28.5	17.0	25.0	28.5	21.2	13.2	16.8	19.7	13.3	18.4	41.0	24.0	23.9	22.8	43.8	59.5	20.4	65.7	41.5	44.6	39.9	43.4	39.0	35.4
ARHGDIB	"GDIA2, GDID4, Ly-GDI, RAP1GN1, RhoGDI2"	ENSG00000111348	"Rho GDP dissociation inhibitor beta"	P52566	12	14942017-14961728	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"blood: 333.1;bone marrow: 150.7;lymphoid tissue: 221.4"	"Cell line enhanced"	"Detected in many"		"HEL: 101.6;HL-60: 118.9;HMC-1: 134.6;MOLT-4: 140.7;REH: 118.4;U-698: 108.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018584, HPA051235"	Enhanced		Supported	Cytosol			120000000	Cytosol		"CAB018584: AB_647972, HPA051235: "	"unprognostic (2.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.42e-4)"	40.3	13.4	9.0	66.1	18.4	150.7	27.9	1.8	8.9	14.6	14.5	13.9	3.6	8.5	14.7	13.2	16.9	18.2	18.3	20.5	8.3	7.8	24.5	20.0	41.3	93.9	17.0	3.9	11.7	7.1	3.9	8.1	35.6	11.4	18.0	16.1	20.4	22.4	7.6	13.3	14.7	38.3	15.7	17.9	157.8	11.1	11.2	15.8	221.4	22.7	12.4	108.1	31.2	13.5	114.0	95.5	267.1	151.9	96.3	231.1	333.1	9.3	0.3	0.3	20.8	1.4	1.1	0.1	0.3	0.1	0.1	0.1	1.2	10.3	75.4	4.8	1.7	10.3	0.0	16.7	1.1	0.1	0.0	101.6	0.2	0.0	0.3	118.9	134.6	0.1	2.1	0.0	1.5	58.5	0.5	28.9	1.8	0.0	140.7	85.6	0.4	0.1	118.4	1.3	33.7	3.3	52.2	0.1	0.0	0.1	13.5	0.1	0.7	86.6	74.1	0.3	0.7	0.1	2.2	4.8	0.7	108.9	0.3	83.4	0.1	206.0	109.9	267.1	125.6	130.8	123.3	114.0	144.4	140.7	95.5	103.2	141.1	146.5	237.7	96.3	151.9	41.4	231.1	333.1	9.0	18.4	1.8	8.9	8.3	7.8	17.0	3.9	11.4	15.8
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favourable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	19.9	24.3	5.6	7.0	8.0	8.4	6.6	10.6	16.2	13.4	11.8	7.4	17.3	26.8	19.5	9.6	11.8	7.2	16.4	4.2	25.1	8.3	21.6	10.5	9.7	11.7	23.1	35.7	10.1	10.9	13.0	8.5	12.8	8.5	16.5	7.7	13.8	16.1	17.9	6.4	18.9	24.4	10.5	15.8	8.2	11.0	3.7	15.7	14.8	6.6	12.1	7.7	39.5	17.2	17.9	12.0	9.5	16.3	22.5	14.3	23.2	14.6	36.7	28.2	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6
ARHGEF2	"GEF-H1, KIAA0651, LFP40, P40"	ENSG00000116584	"Rho/Rac guanine nucleotide exchange factor 2"	Q92974	1	155946851-156007070	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Immunity, Innate immunity, Mitosis, Neurogenesis"	"Developmental protein, Guanine-nucleotide releasing factor"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043437	Approved									"HPA043437: "	"unprognostic (2.27e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.24e-3)"	"unprognostic (1.90e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (9.20e-6)"	"unprognostic (5.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (7.17e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.85e-3)"	"unprognostic (7.98e-2)"	19.8	6.2	20.6	24.5	33.2	36.2	19.1	36.2	42.8	14.3	19.6	44.8	8.3	12.5	17.6	10.8	12.8	19.1	20.6	19.2	26.4	13.9	10.9	5.9	41.4	28.9	30.2	23.7	14.2	6.4	12.8	7.4	21.1	19.8	11.2	19.4	10.4	12.2	10.9	8.6	7.2	17.1	20.1	46.2	30.0	23.4	11.4	26.0	32.5	19.0	7.1	21.6	18.4	14.8	11.7	13.9	24.7	15.7	8.4	12.8	16.4	7.3	6.1	10.7	7.3	10.2	13.0	11.0	16.6	21.5	16.4	17.6	5.4	5.6	18.5	10.2	12.7	10.9	6.4	5.2	12.5	7.5	5.5	24.4	9.4	3.2	40.4	31.9	21.4	15.1	21.9	24.3	29.9	13.3	13.5	22.7	23.0	4.1	16.0	43.4	11.8	4.0	17.5	14.9	31.3	6.8	4.4	17.6	8.0	7.1	10.5	57.1	10.9	44.1	17.5	14.1	8.1	12.3	21.0	37.8	38.4	13.1	20.1	16.1	34.6	10.0	14.7	12.2	12.8	13.9	8.9	11.7	8.1	9.1	13.9	11.1	8.1	9.0	24.7	8.4	15.7	6.7	7.5	16.4	20.6	33.2	36.2	42.8	26.4	13.9	30.2	23.7	19.8	26.0
ARHGEF4	"ASEF, KIAA1112, STM6"	ENSG00000136002	"Rho guanine nucleotide exchange factor 4"	Q9NR80	2	130836916-131047263	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.3;skin 1: 35.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 17.3;hTCEpi: 35.9;SCLC-21H: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 4.3"	"Group enriched"	"Detected in many"	35	"dendritic cells: 2.6;T-cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018267	Approved									"HPA018267: AB_1845006"	"unprognostic (2.30e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.68e-2)"	"prognostic favourable (7.00e-4)"	"unprognostic (3.93e-3)"	"unprognostic (9.71e-3)"	5.4	5.5	24.0	1.5	25.7	0.7	2.0	8.9	37.3	3.5	1.9	14.7	0.5	0.8	2.9	2.1	13.2	8.8	3.4	1.5	28.5	12.7	0.9	1.2	3.6	0.9	15.0	16.5	8.3	13.6	2.4	5.2	0.8	14.9	5.4	1.4	0.6	3.2	9.0	8.0	35.1	1.6	4.5	23.5	0.7	1.5	4.4	20.5	0.0	5.2	10.1	4.0	4.2	6.1	0.0	2.6	0.0	0.0	0.0	4.3	0.6	1.6	1.0	0.3	7.9	0.0	0.0	0.1	2.5	0.1	0.1	0.0	0.3	0.5	0.0	0.1	1.0	17.3	1.1	4.0	0.0	0.0	0.9	0.0	2.7	0.0	0.3	0.0	0.0	0.0	35.9	0.8	3.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.2	2.9	7.8	0.1	0.3	1.2	0.0	22.0	3.3	0.2	3.2	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.5	0.0	0.8	1.6	0.0	0.0	1.6	4.3	0.0	0.0	0.0	2.6	1.3	0.6	24.0	25.7	8.9	26.6	28.5	12.7	15.0	16.5	14.9	20.5
ARPC1A	"Arc40, SOP2Hs, SOP2L"	ENSG00000241685	"Actin related protein 2/3 complex subunit 1A"	Q92747	7	99325910-99366262	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA004334	Approved		Approved	"Cell Junctions,Cytosol"			2400000	"Cell Junctions"	Cytosol	"HPA004334: AB_1078215"	"unprognostic (1.31e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.22e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (4.70e-4)"	"unprognostic (2.52e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.88e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.83e-1)"	36.6	39.8	40.2	25.2	41.0	18.7	49.1	32.3	55.9	40.0	43.6	32.3	37.9	50.1	30.4	45.9	58.3	43.3	32.1	65.3	45.9	43.5	30.6	41.2	29.6	32.2	38.6	39.7	47.2	41.9	30.9	31.4	31.8	40.6	28.2	44.2	33.9	31.7	36.7	20.9	46.1	55.0	31.9	27.9	26.8	53.1	28.6	25.1	23.7	44.4	41.8	31.6	31.5	33.9	11.1	16.1	33.2	29.1	10.9	12.6	9.9	45.4	24.8	28.2	12.9	26.3	44.8	24.0	32.7	38.4	33.4	33.3	27.8	52.5	15.9	48.4	39.7	19.3	36.9	47.5	40.4	7.9	31.1	8.5	18.5	22.4	29.0	10.0	11.2	41.6	26.6	43.0	46.0	54.6	21.3	18.5	51.2	66.5	16.7	13.4	26.4	56.1	9.9	19.5	19.5	24.8	27.6	29.1	24.9	32.0	46.0	43.6	23.0	14.8	42.3	42.8	38.4	75.4	52.1	7.2	13.2	22.6	37.0	22.5	56.1	33.2	18.9	31.9	9.8	28.6	7.6	11.0	9.3	12.6	16.1	11.1	12.1	9.1	23.8	10.9	29.1	11.7	12.1	9.9	40.2	41.0	32.3	55.9	45.9	43.5	38.6	39.7	40.6	25.1
ARPC1B	"ARC41, p40-ARC, p41-ARC"	ENSG00000130429	"Actin related protein 2/3 complex subunit 1B"	O15143	7	99374249-99394814	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 213.6"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 110.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004832	Approved		Supported	Vesicles,Cytosol			53000000	"Vesicles, Cytosol"		"HPA004832: AB_1845044"	"unprognostic (5.94e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (2.57e-4)"	"unprognostic (4.37e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.86e-1)"	"prognostic unfavourable (1.62e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.27e-2)"	31.8	17.8	8.7	50.7	14.4	56.4	35.4	1.9	7.7	17.9	30.7	8.4	18.1	32.6	17.4	21.8	16.0	18.3	23.4	24.4	5.7	7.0	27.9	34.8	40.0	92.8	10.7	3.7	11.6	13.0	3.8	13.1	36.2	9.4	15.6	10.5	20.6	18.3	15.1	10.6	10.0	42.3	12.1	10.2	81.8	16.3	10.8	9.3	31.0	23.0	13.7	37.2	19.0	21.1	53.5	133.7	127.2	154.4	38.9	83.4	213.6	15.7	28.6	2.2	6.2	8.3	30.2	21.9	21.9	22.1	8.8	7.8	18.6	61.4	27.3	41.0	23.8	11.9	2.8	19.3	3.6	22.2	10.3	19.9	8.3	12.8	24.0	19.9	67.8	16.8	10.0	12.4	12.4	23.2	22.1	66.0	12.8	72.7	22.0	43.6	7.8	62.4	17.8	1.9	67.0	18.2	7.8	1.8	5.8	14.9	65.8	110.1	15.5	40.6	34.0	25.2	20.9	44.4	27.5	12.3	24.4	33.5	25.1	52.0	45.1	53.7	153.2	121.6	53.8	154.4	50.2	53.5	62.8	59.6	133.7	42.8	37.0	49.3	127.2	38.9	142.0	77.9	83.4	213.6	8.7	14.4	1.9	7.7	5.7	7.0	10.7	3.7	9.4	9.3
ARPC2	"ARC34, p34-Arc"	ENSG00000163466	"Actin related protein 2/3 complex subunit 2"	O15144	2	218217094-218254356	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001994, HPA008352"	Approved		Supported	"Golgi apparatus,Cytosol"			24000000	Cytosol	"Golgi apparatus"	"CAB001994: , HPA008352: AB_1854887"	"unprognostic (7.42e-2)"	"unprognostic (4.07e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.23e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.41e-2)"	46.9	28.8	32.6	78.6	37.9	79.5	67.1	19.3	31.4	34.1	42.5	19.9	26.3	34.0	37.2	35.8	103.4	30.2	51.2	52.3	40.7	25.0	38.2	35.1	71.8	118.3	26.4	27.8	30.7	31.2	18.9	23.0	67.1	26.8	35.6	48.6	23.7	39.0	32.7	60.1	56.2	59.2	69.1	23.9	73.7	43.8	36.5	22.3	59.0	27.2	72.7	102.5	58.5	49.7	60.6	101.2	167.7	145.0	50.0	76.2	149.4	46.7	20.5	29.5	21.9	39.6	53.3	54.9	73.1	70.6	61.8	62.2	63.5	49.8	38.2	39.9	83.1	54.5	39.9	108.1	72.9	31.8	28.4	38.8	31.0	34.8	44.4	80.9	109.7	35.4	87.5	61.8	51.3	80.6	18.3	75.6	94.7	32.4	43.9	94.9	35.1	20.0	33.5	26.1	52.0	62.2	85.3	17.4	31.7	26.6	29.6	62.8	21.4	74.5	70.1	80.5	30.8	36.1	54.7	41.2	43.6	66.7	58.3	50.9	60.5	106.1	97.2	143.7	75.0	131.3	50.2	60.6	58.9	72.7	101.2	47.6	42.1	62.0	167.7	50.0	145.0	56.1	76.2	149.4	32.6	37.9	19.3	31.4	40.7	25.0	26.4	27.8	26.8	22.3
ARPC3	"ARC21, p21-Arc"	ENSG00000111229	"Actin related protein 2/3 complex subunit 3"	O15145	12	110434825-110450422	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006550	Approved		Uncertain	Nucleoplasm			38000000	Nucleoplasm		"HPA006550: AB_1854869"	"unprognostic (1.83e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.15e-1)"	"unprognostic (4.26e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (9.96e-2)"	"prognostic unfavourable (2.22e-11)"	"unprognostic (3.00e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-3)"	47.9	50.5	47.4	65.2	50.0	123.1	65.3	21.3	61.0	40.2	58.9	29.4	31.4	47.2	35.9	56.9	88.1	32.4	49.4	39.7	44.6	39.1	64.3	54.0	86.0	143.3	41.1	38.0	27.6	51.5	23.8	41.9	58.4	34.4	34.4	63.9	23.1	51.2	37.6	23.9	35.5	52.2	40.1	49.6	93.9	47.8	29.3	35.0	65.7	38.6	49.8	99.3	61.6	47.2	59.7	83.9	136.8	111.0	33.9	50.9	102.9	48.0	38.5	34.5	21.6	35.9	68.5	45.7	54.7	59.7	65.6	64.5	41.4	38.4	69.7	40.9	60.1	37.7	37.2	56.0	71.6	40.3	45.3	60.3	17.1	40.0	58.9	59.5	94.7	47.9	60.9	41.5	38.6	81.5	38.2	19.1	80.9	38.0	71.0	146.8	33.6	46.6	55.5	20.0	59.1	113.8	61.6	38.5	38.3	36.8	51.8	45.4	83.7	100.7	68.6	39.5	22.3	34.8	37.3	37.8	54.5	98.0	51.8	60.4	46.5	89.4	83.8	134.8	32.1	97.9	29.0	59.7	32.9	35.7	83.9	52.2	24.8	32.1	136.8	33.9	111.0	53.8	50.9	102.9	47.4	50.0	21.3	61.0	44.6	39.1	41.1	38.0	34.4	35.0
ARPC4	"ARC20, p20-Arc"	ENSG00000241553	"Actin related protein 2/3 complex subunit 4"	P59998	3	9792495-9807726	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										22000000				"unprognostic (2.54e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.79e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.20e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.34e-4)"	49.1	37.1	38.3	48.8	35.9	49.2	46.0	20.1	48.4	27.5	45.2	31.6	33.8	36.0	40.6	35.5	48.3	29.5	39.3	25.7	42.5	32.3	39.6	38.8	34.3	72.2	31.9	34.3	28.4	33.8	20.5	23.6	36.5	24.1	31.1	44.7	24.5	35.3	28.6	28.5	36.4	39.1	40.8	27.3	59.8	30.8	28.2	20.3	55.4	35.0	45.0	72.1	34.1	38.6	27.6	53.3	79.4	56.3	26.3	37.9	52.1	23.9	31.1	26.5	17.6	32.9	27.4	65.6	37.2	32.2	28.4	25.4	19.4	35.9	16.2	21.1	50.1	15.7	16.7	29.7	34.1	31.8	10.4	51.8	32.1	21.6	34.5	49.9	73.5	29.6	27.3	38.0	23.7	40.2	24.5	15.5	53.5	50.7	43.0	29.7	51.0	28.9	35.7	18.0	28.6	40.3	36.9	10.9	37.1	21.7	29.1	27.3	34.3	74.6	40.8	34.7	14.5	34.3	52.4	10.4	30.4	47.6	51.3	37.8	53.8	30.4	48.9	51.7	37.9	56.3	31.4	27.6	31.7	31.2	41.2	26.2	22.7	29.8	79.4	26.3	55.1	53.3	33.5	52.1	38.3	35.9	20.1	48.4	42.5	32.3	31.9	34.3	24.1	20.3
ARPC5	"ARC16, dJ127C7.3, p16-Arc"	ENSG00000162704	"Actin related protein 2/3 complex subunit 5"	O15511	1	183620846-183635757	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 154.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022013, HPA031972"	Approved		Approved	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"			15000000	"Vesicles, Plasma membrane, Cell Junctions, Cytosol"		"HPA022013: AB_1845045, HPA031972: "	"unprognostic (3.82e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (5.90e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (1.21e-10)"	"unprognostic (3.03e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	46.6	25.1	24.9	57.5	24.3	25.2	28.9	13.8	24.8	26.6	42.3	26.5	18.6	40.8	39.0	26.7	44.5	29.3	24.6	36.8	28.2	22.3	28.8	29.7	52.3	58.3	28.4	18.7	27.3	21.5	12.4	18.2	84.8	20.0	23.2	29.2	17.0	25.4	16.5	16.4	25.2	47.3	32.8	46.0	79.9	35.6	21.7	23.5	61.2	27.5	22.7	52.8	30.6	30.8	27.4	68.9	154.0	96.6	30.7	40.7	124.3	50.8	28.2	24.3	16.7	20.1	28.7	58.2	69.9	53.9	30.5	24.9	25.5	36.1	46.8	79.6	40.2	35.4	17.1	23.8	16.1	67.4	15.3	28.3	38.4	22.0	32.7	41.0	55.2	34.7	25.4	36.9	29.4	35.7	21.5	38.8	39.5	20.9	38.2	11.0	23.2	10.8	35.6	21.6	45.2	17.1	26.4	10.5	28.3	72.9	31.5	27.0	31.6	36.7	79.5	44.6	23.2	49.8	67.3	46.3	51.1	32.0	35.1	29.6	34.2	79.3	80.0	124.1	34.8	89.8	27.7	27.4	34.2	35.5	68.9	24.4	37.1	37.6	154.0	30.7	96.6	32.5	40.7	124.3	24.9	24.3	13.8	21.1	28.2	22.3	28.4	18.7	20.0	23.5
ARSB		ENSG00000113273	"Arylsulfatase B"	P15848	5	78777209-78986087	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation, Ichthyosis, Leukodystrophy, Metachromatic leukodystrophy, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 17.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.2;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037770, HPA037771"	Approved		Approved	"Golgi apparatus"	"Intracellular and membrane"			"Golgi apparatus"		"HPA037770: AB_10671719, HPA037771: AB_10671720"	"unprognostic (1.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.57e-3)"	"unprognostic (9.88e-2)"	"unprognostic (6.54e-3)"	"prognostic unfavourable (3.42e-4)"	15.2	8.4	7.7	9.9	8.9	9.4	11.4	6.2	10.4	7.8	8.7	10.8	2.6	4.0	14.1	6.7	8.6	6.7	12.0	13.0	7.7	5.8	23.2	9.3	10.8	17.2	7.1	6.1	6.1	9.6	10.7	6.1	14.7	7.1	7.5	10.5	12.1	5.2	9.3	5.3	3.4	6.0	18.0	8.3	10.9	7.9	4.1	5.6	7.2	6.4	4.0	6.2	10.3	5.6	1.2	5.5	17.2	5.7	0.1	0.6	1.6	2.3	5.5	9.0	2.9	22.0	8.7	8.3	13.0	11.5	9.7	11.9	4.8	4.2	2.7	14.1	12.7	1.9	3.4	3.7	9.6	23.2	2.6	4.4	5.9	18.6	5.0	4.9	5.2	10.1	1.2	10.2	3.4	11.3	0.9	6.4	9.8	4.5	2.3	9.2	2.7	2.9	3.4	5.3	2.9	6.1	3.0	3.2	7.3	9.7	3.1	5.7	3.4	12.7	7.5	8.7	5.0	3.9	11.6	5.5	9.9	3.6	10.5	10.5	19.7	10.5	5.7	17.2	0.6	4.6	0.4	1.2	0.3	0.3	5.5	1.1	0.2	0.4	3.3	0.1	3.7	4.0	0.5	1.6	7.7	8.9	6.2	10.4	7.7	5.8	7.1	6.1	7.1	5.6
ARSK	"DKFZp313G1735, TSULF"	ENSG00000164291	"Arylsulfatase family member K"	Q6UWY0	5	95555074-95605064	"Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042384	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"			Vesicles	Nucleoplasm	"HPA042384: AB_10795703"	"unprognostic (9.50e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.59e-4)"	"unprognostic (3.39e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.19e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-2)"	8.5	10.2	6.9	4.8	7.6	4.7	7.6	14.2	12.3	8.9	8.6	4.3	9.6	5.1	8.5	9.6	6.7	7.4	6.9	8.5	7.9	7.1	11.5	9.7	7.4	5.6	8.4	9.9	12.8	11.7	29.3	14.5	11.2	7.2	10.7	5.9	7.3	6.7	11.2	5.5	8.4	5.4	6.7	8.8	5.5	9.7	4.5	7.5	10.6	15.8	2.8	4.5	9.2	14.0	6.7	2.7	10.0	1.6	3.9	9.2	2.3	3.3	2.1	4.6	4.6	22.8	11.9	6.6	10.7	6.2	4.2	8.7	2.7	5.3	4.6	5.6	3.6	3.2	4.0	6.8	9.3	4.9	5.8	3.7	5.5	4.4	6.6	2.0	3.0	8.7	6.1	6.4	4.1	6.8	3.7	5.0	9.3	1.6	5.5	3.9	5.9	10.4	3.4	7.3	7.2	9.7	0.8	3.2	3.3	6.6	2.2	6.4	6.1	2.1	12.2	6.7	5.4	10.3	6.5	4.3	7.3	5.5	6.6	5.4	24.8	10.0	1.6	2.5	5.3	1.5	6.1	5.3	6.0	6.7	0.8	6.7	9.2	6.9	1.5	3.9	1.0	2.7	4.5	2.3	6.9	7.6	14.2	12.3	7.9	7.1	8.4	9.9	7.2	7.5
ARX	"CT121, EIEE1, ISSX, MRX29, MRX32, MRX33, MRX36, MRX38, MRX43, MRX54, MRX76, MRX87, MRXS1, PRTS"	ENSG00000004848	"Aristaless related homeobox"	Q96QS3	X	25003694-25016420	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Epilepsy, Lissencephaly, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 25.2;ovary: 58.7;skeletal muscle: 16.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.9;PC-3: 6.0;THP-1: 2.5;U-266/70: 12.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 9.5;basal ganglia: 6.7;cerebral cortex: 25.2;hippocampal formation: 10.4;olfactory region: 17.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (8.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.54e-7)"	"unprognostic (9.85e-2)"	"unprognostic (7.96e-3)"		"unprognostic (1.18e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-6)"	"unprognostic (6.01e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.91e-1)"	0.5	0.5	9.5	0.5	6.7	0.5	0.7	0.3	25.2	0.5	1.1	1.9	0.0	2.9	0.5	1.8	0.5	1.1	0.5	0.5	10.4	2.6	0.6	0.5	0.8	0.5	0.9	17.1	58.7	2.7	4.4	0.5	0.5	0.0	0.7	1.1	0.0	0.5	0.5	16.9	0.5	1.0	0.5	0.3	0.6	4.9	13.6	3.1	0.0	0.5	0.5	0.8	0.5	0.5	0.0	0.1	0.6	0.4	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	6.0	0.6	0.0	0.1	0.1	1.7	0.0	0.0	0.0	0.0	0.1	0.5	2.5	0.0	0.0	0.2	0.0	0.0	12.8	0.4	0.0	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	9.5	6.7	0.3	25.2	10.4	2.6	0.9	17.1	0.0	3.1
ASB17		ENSG00000154007	"Ankyrin repeat and SOCS box containing 17"	Q8WXJ9	1	75918873-75932431	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 33.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (7.27e-2)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASCC1	"ASC1p50, CGI-18, Em:AC022392.3"	ENSG00000138303	"Activating signal cointegrator 1 complex subunit 1"	Q8N9N2	10	72096032-72217134	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038038, HPA057567"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038038: AB_10674544, HPA057567: "	"unprognostic (1.96e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.34e-2)"	"prognostic unfavourable (3.52e-4)"	"unprognostic (1.22e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-1)"	"unprognostic (6.64e-2)"	17.2	23.3	23.2	13.3	25.9	10.9	20.9	27.4	23.8	21.2	12.4	25.7	19.6	9.5	16.9	21.3	16.4	17.2	16.0	26.4	24.7	21.6	18.6	24.3	12.7	19.8	35.2	14.9	21.9	24.8	19.3	22.0	14.5	28.2	15.4	12.9	13.1	11.9	19.5	25.7	14.8	12.5	18.0	35.4	16.9	13.7	20.9	34.5	20.8	17.8	9.4	20.9	18.0	15.7	24.9	22.9	25.4	14.9	19.7	24.2	14.6	13.2	17.4	13.3	25.1	18.4	19.3	10.2	8.1	17.3	13.8	17.0	18.9	47.8	17.9	16.6	11.7	17.2	10.6	16.2	14.9	12.6	9.4	11.3	14.4	17.4	16.6	12.3	11.9	18.1	35.6	14.8	20.8	16.8	15.5	22.4	14.7	12.6	16.1	17.0	7.0	4.2	9.1	10.7	13.1	23.7	8.9	12.6	9.0	11.2	28.9	21.8	9.9	8.4	16.0	7.0	13.3	5.5	8.5	13.9	17.9	21.7	11.3	28.1	5.4	16.5	14.9	25.4	14.5	14.7	14.4	24.3	17.2	15.2	15.1	24.9	24.2	21.9	9.4	19.7	11.5	22.9	21.6	14.6	23.2	25.9	27.4	23.8	24.7	21.6	35.2	14.9	28.2	34.5
ASGR2	CLEC4H2	ENSG00000161944	"Asialoglycoprotein receptor 2"	P07307	17	7101322-7115700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 154.1"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 105.4"	"Cancer enriched"	"Detected in many"	66	"liver cancer: 214.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 36.9;myeloid DC: 21.7"	"Group enriched"	"Detected in many"	52	"dendritic cells: 21.7;monocytes: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014899, HPA015998"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"			4700000	"Endoplasmic reticulum, Plasma membrane"		"HPA014899: AB_1845085, HPA015998: AB_1845084"	"unprognostic (6.76e-2)"	"unprognostic (7.45e-7)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.35e-4)"	"unprognostic (1.54e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.31e-2)"	0.2	0.0	0.3	1.4	0.1	1.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.1	3.4	0.2	0.2	0.0	0.2	154.1	0.5	4.1	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.9	0.1	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.0	21.7	0.5	36.9	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	36.9	0.2	0.0	3.8	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	9.5	0.3	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1
ASIC2	"ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG"	ENSG00000108684	"Acid sensing ion channel subunit 2"	Q16515	17	33013087-34174964	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 13.1;cervix, uterine: 6.8;endometrium 1: 9.5;smooth muscle: 3.9"	"Group enriched"	"Detected in some"	4	"NTERA-2: 4.2;PC-3: 1.1;RPTEC TERT1: 3.8"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052112	Enhanced									"HPA052112: AB_2681733"	"unprognostic (3.40e-1)"	"unprognostic (2.45e-2)"	"unprognostic (8.50e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.88e-3)"	"unprognostic (5.29e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	0.4	1.9	8.1	0.4	6.3	0.3	0.7	8.7	13.1	6.8	0.7	1.1	0.0	1.2	9.5	0.5	0.4	1.5	0.5	0.4	7.7	10.0	1.2	0.4	0.5	0.4	4.6	5.5	0.4	0.4	0.3	0.5	0.5	3.7	0.6	0.8	0.2	0.3	1.7	0.3	0.6	1.2	3.9	2.3	0.4	0.5	1.1	0.8	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	1.1	0.0	0.0	0.5	3.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.3	8.7	9.6	7.7	10.0	4.6	5.5	3.7	0.8
ASL		ENSG00000126522	"Argininosuccinate lyase"	P04424	7	66075798-66093558	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB003696, HPA016646"	Enhanced		Approved	Cytosol			10000000	Cytosol		"CAB003696: AB_425316, HPA016646: AB_1845096"	"unprognostic (2.95e-2)"	"prognostic unfavourable (4.05e-6)"	"unprognostic (4.83e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.25e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.40e-3)"	5.6	4.8	4.0	8.0	4.3	7.3	5.9	7.2	7.4	5.5	17.2	3.7	7.8	20.8	5.0	7.1	7.7	4.9	19.5	4.3	3.7	4.3	16.0	99.5	8.1	4.5	4.4	6.2	5.9	10.4	3.3	5.8	3.3	7.2	5.4	12.4	5.8	7.1	5.7	2.4	4.1	16.6	3.4	3.2	8.6	12.6	2.1	3.5	1.2	7.1	7.9	5.9	5.2	5.9	8.6	19.3	20.7	18.4	30.4	9.2	10.7	18.2	7.5	4.1	14.8	9.4	7.3	9.0	12.8	11.2	18.3	16.7	16.8	22.6	5.6	20.5	16.8	5.0	2.6	21.7	5.3	4.6	3.4	7.4	7.3	26.1	17.7	8.4	21.7	13.7	7.9	12.8	20.5	18.0	13.1	10.7	10.1	13.0	1.7	11.6	6.2	9.7	4.5	4.3	19.2	13.3	11.0	7.1	9.7	11.7	40.8	4.4	17.8	7.6	20.4	23.2	12.0	9.2	16.5	11.7	6.1	7.3	21.9	16.0	18.7	12.1	18.1	20.7	7.7	18.4	6.5	8.6	5.2	6.1	19.3	5.6	3.7	4.0	4.0	30.4	13.8	1.2	9.2	10.7	4.0	4.3	7.2	7.4	3.7	4.3	4.4	6.2	7.2	3.5
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"			900000	"Endoplasmic reticulum"		"HPA055161: , HPA059303: "	"unprognostic (8.07e-2)"	"prognostic unfavourable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	50.0	72.7	10.2	6.2	45.8	43.5	3.5	89.8	83.5	38.5	40.4	12.4	66.7	3.8	6.2	52.6	18.7	6.3	31.3	65.8	1.4	6.4	8.9	44.2	34.0	29.4	1.3	1.4	35.7	7.1	21.4	27.3	16.2	2.4	3.6	33.8	10.6	0.3	1.8	5.8	42.9	2.4	11.0	0.8	23.5	41.5	10.6	3.7	27.9	13.2	11.1	5.4	2.4	50.8	39.0	20.0	35.6	31.6	2.3	2.9	0.1	102.6	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6
ASPM	"ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5"	ENSG00000066279	"Abnormal spindle microtubule assembly"	Q8IZT6	1	197084128-197146694	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 62.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"plasmacytoid DC: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;T-cells: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB017816			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017816: "	"unprognostic (3.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (3.67e-1)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.25e-4)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.67e-3)"	"unprognostic (9.29e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (0.00e+0)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.66e-2)"	0.7	0.7	0.2	12.4	0.4	13.8	1.5	0.2	0.4	1.2	2.8	0.2	0.2	2.8	0.3	1.5	8.7	0.2	0.4	0.6	0.2	0.2	0.5	1.3	1.9	7.0	0.3	0.2	0.5	0.3	0.0	0.2	1.8	0.5	0.4	2.8	0.3	1.5	0.2	0.5	4.6	3.1	0.8	0.5	4.3	1.7	6.3	0.2	62.8	0.3	5.0	6.9	1.2	2.3	0.0	1.5	0.0	0.0	0.3	2.4	0.0	19.8	11.1	18.1	11.0	1.0	2.5	6.8	15.9	11.2	15.8	12.5	7.7	15.5	20.3	5.7	12.4	20.1	15.5	6.3	19.7	18.2	11.8	14.2	26.2	7.4	0.2	21.2	10.1	0.2	0.6	12.7	8.9	16.6	17.8	24.1	16.2	7.8	17.0	9.9	8.2	3.0	13.0	24.8	14.9	5.7	5.5	9.5	13.5	22.6	11.7	5.1	13.0	8.8	12.6	9.8	9.5	16.8	28.9	6.9	9.4	11.7	7.7	5.8	19.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	2.4	0.0	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.2	0.5	0.2
ASPN	"FLJ20129, PLAP-1, SLRR1C"	ENSG00000106819	Asporin	Q9BXN1	9	92456205-92482506	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Biomineralization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 62.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.4;BJ hTERT+: 4.9;HHSteC: 20.5;HSkMC: 4.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008435, HPA024230"	Approved				"Secreted to extracellular matrix"		33000			"HPA008435: AB_1845112, HPA024230: AB_1845113"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.13e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.50e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.70e-2)"	"prognostic unfavourable (1.64e-7)"	"unprognostic (1.42e-3)"	"unprognostic (3.04e-2)"	"unprognostic (6.27e-3)"	"unprognostic (2.48e-2)"	13.4	2.2	0.5	5.2	1.7	0.0	4.8	0.4	0.7	40.2	14.6	0.6	8.1	2.8	62.1	26.7	15.3	9.9	26.4	31.6	0.6	0.6	3.5	21.9	10.3	0.7	0.9	1.4	7.8	4.7	0.8	1.9	3.7	1.0	12.2	3.6	1.6	2.0	3.6	10.8	3.7	19.7	37.1	0.8	0.8	8.8	6.7	0.4	1.5	7.1	27.7	2.2	24.2	3.8	0.4	0.2	1.9	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.3	14.4	0.0	1.9	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	4.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.2	0.1	0.7	0.2	0.0	0.0	0.5	1.7	0.4	0.7	0.6	0.6	0.9	1.4	1.0	0.4
ASPRV1	"FLJ25084, SASPase, Taps"	ENSG00000244617	"Aspartic peptidase retroviral like 1"	Q53RT3	2	69960089-69962265	"Plasma proteins, Predicted membrane proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 75.3"	"Cell line enhanced"	"Detected in many"		"REH: 8.8"	"Group enriched"	"Detected in many"	8	"head and neck cancer: 23.1;melanoma: 35.1"					"Cell type enriched"	"Detected in some"	6	"neutrophil: 11.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034809, HPA034810"	Enhanced						83000			"HPA034809: AB_2674343, HPA034810: AB_10601456"	"unprognostic (4.75e-4)"	"unprognostic (1.90e-3)"	"unprognostic (2.34e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.43e-2)"	0.2	0.2	0.5	0.1	0.6	0.0	5.5	0.8	0.4	0.3	0.0			0.3	0.3	0.6	0.0	0.4	0.1	0.1	0.6	0.7	0.2	0.0	0.1	0.1	0.7		0.9	0.0	0.0	0.5	0.1		0.1	0.0		0.0	0.2	1.0	75.3	0.2	0.2	1.0	0.4	0.1	0.4			0.0		0.1	0.0	0.6	0.1	1.2	11.2	0.1	0.3	0.9	0.5	0.1	0.7	1.8	3.5	2.3	0.8	0.5	0.4	0.7	0.4	0.3	1.2	0.1	1.3	0.3	0.3	0.5	1.6	0.2	0.4	2.4	4.6	2.7	0.4	1.2	0.9	2.3	2.0	1.1	0.7	0.4	0.7	0.4	1.0	3.6	0.4	0.5	1.9	5.2	1.8	0.4	8.8	1.0	0.5	0.1	0.1	2.0	0.5	0.2	1.4	1.4	0.1	1.0	0.2	0.1	1.8	0.1	0.3	3.9	2.3	2.7	0.2	1.6	2.0	0.0	0.1	1.9	0.7	0.1	0.7	0.0	0.3	0.6	0.1	0.1	0.2	0.6	11.2	0.3	0.1	1.2	0.9	0.5										
ASS1	"ASS, CTLN1"	ENSG00000130707	"Argininosuccinate synthase 1"	P00966	9	130444929-130501274	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 121.5;liver: 309.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 86.6;HaCaT: 82.0;hTCEpi: 79.7;RPMI-8226: 132.8;THP-1: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020896, HPA020934"	Enhanced		Approved	Nucleoplasm,Cytosol			4500000	Cytosol	Nucleoplasm	"HPA020896: AB_1845117, HPA020934: AB_1845118"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (8.14e-9)"	"unprognostic (3.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.14e-1)"	"unprognostic (4.72e-3)"	20.6	15.4	4.6	7.1	4.1	0.0	15.7	2.3	5.4	8.3	18.5	3.5	33.9	11.9	12.0	12.6	9.4	16.6	14.0	11.4	3.8	5.7	121.5	309.9	8.0	2.2	3.2	4.3	11.4	7.9	0.5	4.6	8.7	4.5	12.1	16.8	10.7	26.3	40.6	7.4	12.5	26.8	5.9	3.4	2.7	5.2	8.7	2.2	0.8	17.5	7.0	4.5	17.7	8.6	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.6	1.1	1.3	2.2	8.8	22.5	4.2	13.9	86.6	2.7	8.4	4.9	3.2	0.0	9.4	28.6	82.0	5.7	0.5	1.9	2.0	2.6	0.0	1.8	12.7	30.7	1.7	0.1	14.8	79.7	4.4	8.0	0.1	0.4	51.7	2.7	57.6	0.6	24.3	1.8	2.5	0.1	1.5	132.8	7.6	5.8	33.4	0.5	49.5	52.2	3.9	35.8	99.5	0.0	1.1	6.9	0.2	1.2	8.6	8.2	2.9	21.8	12.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	4.6	4.1	2.3	5.4	3.8	5.7	3.2	4.3	4.5	2.2
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 19.9;brain: 52.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.9;NTERA-2: 4.5;SCLC-21H: 2.8;U-2 OS: 3.6;U-266/84: 20.1"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA074112: "	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	1.4	19.9	21.5	1.6	23.8	1.1	1.7	15.0	52.5	1.3	1.5	7.4	1.9	1.5	2.3	5.4	1.2	3.2	1.9	1.7	17.4	13.7	1.3	1.4	1.4	1.2	8.5	18.8	8.9	1.7	1.2	8.2	1.6	9.8	2.4	1.6	2.2	2.0	3.3	1.3	1.1	1.5	2.2	5.8	3.6	1.2	1.9	7.2	0.0	1.2	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	20.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	23.8	15.0	27.2	17.4	13.7	8.5	18.8	9.8	7.2
ATAD2B	KIAA1240	ENSG00000119778	"ATPase family, AAA domain containing 2B"	Q9ULI0	2	23748664-23927114	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034555	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA034555: AB_10601665"	"unprognostic (2.40e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.93e-3)"	"unprognostic (5.57e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.14e-2)"	"unprognostic (7.56e-3)"	"prognostic unfavourable (2.35e-5)"	"unprognostic (2.46e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.98e-1)"	9.5	6.0	10.8	13.9	11.7	16.7	12.2	17.1	8.1	8.9	6.8	7.0	7.5	9.8	10.1	5.6	11.3	8.1	7.8	7.2	9.2	4.9	6.2	8.0	13.9	13.0	8.7	5.2	11.9	8.8	10.6	14.0	7.9	7.9	8.5	8.7	8.8	9.5	5.1	17.1	15.9	9.6	13.4	8.0	9.4	7.6	8.1	10.5	25.3	10.5	6.1	12.5	7.5	13.3	7.6	11.5	13.2	8.8	6.0	5.9	1.8	3.7	3.2	10.3	4.7	3.0	3.3	8.0	2.5	2.0	3.3	2.3	5.0	1.8	12.2	2.3	2.3	4.9	7.9	2.7	2.7	7.9	3.8	10.2	3.9	5.9	3.3	9.1	7.6	2.6	4.9	2.0	3.3	4.5	10.8	5.4	2.5	6.3	8.4	10.7	6.1	1.8	9.7	11.1	2.7	3.6	8.3	4.8	7.9	6.8	8.4	3.6	4.1	9.1	4.2	3.3	3.8	2.8	2.9	5.7	2.5	9.2	1.8	10.4	3.0	12.4	8.8	5.1	4.5	5.1	4.9	7.6	4.1	3.9	7.9	7.6	5.9	4.8	13.2	6.0	6.1	11.5	3.5	1.8	10.8	11.7	17.1	8.1	9.2	4.9	8.7	5.2	7.9	10.5
ATF6	ATF6A	ENSG00000118217	"Activating transcription factor 6"	P18850	1	161766294-161964070	"Disease related genes, Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005935	Approved						26000000			"HPA005935: "	"unprognostic (1.31e-1)"	"unprognostic (5.15e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.57e-3)"	21.6	14.9	10.6	13.8	12.7	8.6	16.0	14.6	14.5	14.2	14.5	14.7	18.9	9.9	16.0	22.9	14.0	12.5	11.9	13.5	10.5	11.0	20.1	43.1	18.5	19.6	16.3	9.1	17.5	37.4	30.7	18.3	28.9	12.4	14.4	15.2	18.1	17.5	15.7	14.4	18.1	13.2	15.9	16.0	20.5	15.0	13.4	14.2	18.5	18.5	12.1	17.2	17.0	13.1	4.9	7.1	19.6	10.2	4.2	5.6	5.2	10.4	6.5	7.6	8.4	11.7	10.7	10.3	12.3	17.5	11.8	11.8	4.7	13.5	7.1	16.2	18.6	12.4	7.1	10.4	12.8	9.4	5.3	8.8	8.9	4.7	22.9	15.2	14.7	11.0	16.8	11.9	29.6	25.8	14.8	9.1	10.6	5.5	6.2	5.2	6.3	7.9	5.5	10.5	15.3	11.5	6.5	4.3	7.6	12.7	9.1	18.1	9.0	15.5	26.4	10.6	7.5	4.4	13.8	13.0	12.5	10.3	15.4	2.5	11.5	5.3	9.5	6.2	5.3	10.1	5.1	4.4	5.1	4.3	7.1	4.9	5.6	5.4	19.6	4.2	10.2	2.6	4.5	5.2	10.6	12.7	14.6	13.2	10.5	11.0	16.3	9.1	12.4	14.2
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli			31000000	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	11.7	19.4	23.1	13.7	29.4	24.9	14.3	20.2	19.1	17.8	20.2	15.4	9.8	11.2	19.2	32.7	20.0	27.7	15.4	11.0	19.4	11.4	13.5	14.0	15.6	17.0	20.6	16.5	22.6	18.4	38.1	16.1	21.1	16.9	16.8	18.8	14.1	16.2	14.0	7.1	17.8	15.9	9.4	12.8	22.8	20.2	19.5	17.0	21.7	21.2	11.8	21.0	18.0	16.4	4.4	5.7	6.6	4.1	5.6	4.9	4.4	0.8	2.9	8.1	3.0	6.1	6.9	3.0	3.3	3.2	7.3	9.2	9.5	15.9	14.5	11.7	29.4	4.7	11.0	22.1	5.4	2.9	12.1	1.1	15.3	10.1	20.1	1.1	17.6	11.5	9.8	1.3	20.4	19.9	19.1	19.3	18.7	7.5	10.1	7.1	2.4	0.5	0.7	3.5	6.4	6.6	1.4	0.5	0.8	14.3	7.8	19.4	24.4	1.8	8.6	4.0	4.5	6.5	9.9	19.3	8.3	6.8	9.3	6.7	9.9	6.6	2.2	1.9	4.9	4.1	4.7	4.4	2.8	2.3	5.7	3.4	1.8	3.5	2.5	5.6	3.7	3.8	4.5	4.4	23.1	29.4	20.2	19.1	19.4	11.4	20.6	16.5	16.9	17.0
ATIC	"AICARFT, IMPCHASE, PURH"	ENSG00000138363	"5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase"	P31939	2	215311817-215349773	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Hydrolase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013462, HPA021012"	Supported		Enhanced	"Plasma membrane,Cytosol"			3400000	"Plasma membrane, Cytosol"		"CAB013462: , HPA021012: AB_1845169"	"unprognostic (1.41e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.81e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (1.86e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.31e-3)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (1.00e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.39e-3)"	19.4	27.4	21.1	23.0	28.4	16.9	24.8	12.1	32.3	20.6	26.7	29.1	18.1	23.4	27.9	15.6	19.1	21.9	19.1	18.2	20.3	21.1	23.1	35.6	17.3	36.1	29.7	19.9	23.4	32.9	25.1	21.1	31.1	24.4	21.9	35.9	19.5	14.4	29.4	35.5	17.0	20.6	26.7	21.7	29.0	20.4	15.0	28.0	46.3	16.1	13.5	35.3	27.6	18.0	21.7	13.4	2.9	8.9	19.6	22.8	10.0	20.2	30.7	17.1	29.1	23.0	23.3	8.6	20.7	18.0	23.7	27.2	59.1	31.8	29.5	25.7	21.6	21.3	37.6	31.2	34.0	21.9	36.4	35.9	26.3	53.0	29.8	44.9	18.4	19.7	24.0	31.6	38.2	15.8	46.3	24.6	32.5	29.9	39.1	21.8	65.9	17.2	36.4	24.7	26.4	25.1	32.7	26.9	18.6	16.6	20.5	23.4	33.6	16.0	13.9	20.1	20.8	25.9	13.0	31.1	40.6	61.2	17.5	25.1	29.0	2.9	6.0	0.1	13.2	8.9	22.8	21.7	18.6	20.0	13.4	13.2	18.9	17.5	0.7	19.6	7.4	11.7	17.7	10.0	21.1	28.4	12.1	32.3	20.3	21.1	29.7	19.9	24.4	28.0
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB000102: , HPA067142: "	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.6	3.8	7.5	4.0	9.8	14.3	1.9	6.0	6.7	3.5	5.8	4.7	6.3	9.4	8.9	4.8	4.0	5.7	5.0	5.4	7.5	3.3	8.5	4.7	4.7	5.1	10.2	9.2	9.2	3.1	5.2	10.2	7.2	8.2	6.4	6.8	1.9	7.0	9.4	6.1	3.8	5.5	5.2	14.8	3.9	5.4	5.1	6.3	6.9	3.2	10.3	4.9	5.8	11.3	8.6	4.8	4.9	5.6	4.3	4.5	47.4	5.7	11.3	9.6	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	37.6	38.6	34.6	20.1	28.1	4.3	25.9	57.5	45.5	33.7	30.5	27.0	38.3	22.8	35.7	17.2	21.2	34.7	28.0	25.6	32.8	22.4	21.6	8.8	26.3	11.9	24.4	33.8	72.0	28.7	37.4	43.8	27.6	29.2	28.9	14.2	29.2	44.0	40.9	26.5	28.3	20.5	33.4	29.5	19.3	22.3	8.8	29.4	2.3	42.0	7.3	9.1	30.0	57.6	2.6	2.1	2.5	0.5	0.5	2.5	0.7	15.4	20.2	21.8	44.0	20.7	18.7	36.5	18.5	16.0	19.0	13.6	20.4	18.5	4.2	5.9	22.8	10.4	13.3	18.1	10.1	49.1	13.3	19.7	18.7	9.6	32.1	3.9	30.0	30.2	13.4	23.8	18.7	18.6	16.6	8.5	16.8	22.2	8.6	3.6	44.7	8.6	18.1	11.8	3.1	13.9	21.9	6.8	21.8	18.9	22.0	13.2	8.4	11.1	24.0	22.4	28.9	17.6	28.3	6.5	2.2	2.9	17.4	5.2	23.4	1.9	0.5	2.5	2.5	0.3	2.2	2.6	1.1	1.4	0.6	2.3	1.4	1.9	0.0	0.5	0.1	2.1	1.2	0.7	34.6	28.1	57.5	45.5	32.8	22.4	24.4	33.8	29.2	29.4
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.6;HL-60: 2.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																"prognostic favourable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles				Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	13.8	7.1	9.0	10.6	4.6	6.2	16.1	6.6	3.9	5.7	4.6	22.3	16.1	7.0	8.1	5.6	11.8	8.1	5.5	5.5	7.0	7.6	8.1	5.9	11.6	7.3	15.2	13.3	4.2	4.2	6.8	4.2	14.8	5.6	1.2	3.9	5.2	6.9	9.6	3.9	5.1	6.0	3.6	4.0	30.9	3.2	14.5	4.0	6.4	8.4	5.5	3.2	20.3	9.7	0.0	12.3	7.3	5.0	3.8	7.5	2.9	2.5	14.3	6.2	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved									"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.8	7.0	4.8	7.6	10.6	4.6	9.6	8.0	5.8	13.1	8.8	5.3	30.2	4.8	12.0	9.5	7.3	9.1	7.4	5.2	6.7	4.5	10.8	41.4	6.7	11.2	9.6	3.2	13.1	4.6	6.8	4.2	4.6	9.5	11.5	6.4	10.7	5.8	21.4	6.6	5.6	7.8	11.3	6.3	14.4	7.1	7.9	9.7	14.9	6.1	4.0	7.4	12.7	12.2	2.8	2.1	5.1	1.7	3.5	2.5	0.5	9.4	4.0	8.3	13.5	12.4	16.9	10.6	11.3	15.2	9.2	12.8	3.5	7.7	13.6	25.6	16.0	7.9	20.0	5.1	14.5	12.4	11.7	6.8	8.9	6.9	13.8	11.9	4.4	11.1	3.4	9.9	8.5	15.8	7.7	10.4	12.1	5.1	10.9	8.1	14.1	7.7	10.9	9.0	11.3	7.7	15.7	6.5	10.8	4.4	0.5	5.9	3.4	6.6	17.7	12.6	4.1	15.2	15.4	3.0	2.9	10.7	5.7	14.9	6.2	5.1	1.5	0.4	1.2	1.0	2.5	2.8	1.4	1.1	1.2	2.7	1.4	2.2	2.8	3.5	1.7	2.1	1.0	0.5	4.8	10.6	8.0	5.8	6.7	4.5	9.6	3.2	9.5	9.7
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.2;HEL: 3.2;NTERA-2: 1.0;U-266/84: 2.8;U-937: 1.6"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved									"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.3	0.0	0.5	1.2	3.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	2.8	0.1	0.0	1.6	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663693	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles				Vesicles		"HPA031798: , HPA049717: "	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	13.7	20.8	18.6	22.6	20.4	16.0	15.4	19.9	22.4	16.6	15.3	18.9	11.7	20.5	19.1	13.3	17.5	17.4	15.8	11.4	14.4	11.5	17.6	22.9	15.6	23.9	21.6	14.5	24.6	23.4	38.1	21.0	15.4	15.7	16.8	15.0	18.4	18.9	16.8	13.5	17.0	23.2	13.2	16.1	29.9	18.1	16.7	20.7	24.7	23.1	11.0	22.2	15.4	15.6	3.1	8.1	4.1	10.8	1.8	4.5	2.6	12.2	17.3	9.5	20.6	15.4	10.2	26.0	11.1	15.6	9.7	9.9	16.5	21.0	17.0	19.2	13.1	6.8	14.4	14.2	5.3	6.1	30.0	9.3	17.3	12.9	15.8	17.5	27.7	14.7	13.5	10.4	12.6	6.9	15.9	38.1	9.6	20.3	11.7	12.7	17.4	21.2	9.3	6.8	37.8	10.2	17.1	13.2	22.3	10.3	16.6	11.5	10.5	19.2	11.0	20.5	3.1	23.2	13.3	31.0	18.5	10.2	14.3	22.6	15.3	0.0	4.2	4.1	3.9	7.4	4.2	3.1	4.5	4.1	8.1	2.7	3.0	3.7	0.1	1.8	10.8	6.3	3.7	2.6	18.6	20.4	19.9	22.4	14.4	11.5	21.6	14.5	15.7	20.7
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 17.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced									"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: , HPA054717: "	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	9.6	12.3	21.9	16.3	25.8	8.7	6.7	25.5	45.3	6.0	12.5	12.0	4.7	10.4	5.3	6.1	8.9	7.1	7.6	4.5	23.8	34.6	6.5	2.5	9.6	13.2	28.4	20.3	5.3	30.1	7.8	22.2	10.5	52.2	7.2	8.3	9.6	15.6	7.2	7.5	10.0	11.1	7.3	10.9	16.1	10.7	6.2	9.9	5.2	8.6	2.9	8.1	9.2	5.2	2.1	17.9	0.4	2.9	2.2	2.5	1.1	10.2	10.8	5.9	23.0	5.5	4.8	15.7	5.9	5.7	6.5	6.9	19.0	11.9	4.6	25.5	9.9	16.2	11.8	21.7	2.3	6.2	22.7	15.9	10.2	9.8	7.2	5.8	7.5	3.8	12.1	18.4	13.5	12.8	10.2	8.8	26.7	8.4	6.7	3.2	8.7	7.4	7.4	22.4	18.1	7.4	15.7	15.9	10.3	26.9	35.0	22.7	11.7	7.0	12.8	7.3	13.7	12.2	11.9	1.8	2.1	4.8	13.7	31.6	11.6	0.0	1.3	0.3	2.4	2.9	2.5	1.2	1.9	2.0	0.4	2.1	1.0	1.4	0.4	2.2	2.7	17.9	1.5	1.1	21.9	25.8	25.5	45.3	23.8	34.6	28.4	20.3	52.2	9.9
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 248.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced						380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	32.9	12.2	12.7	6.3	25.5	24.7	65.2	19.8	39.4	24.4	34.7	48.7	23.7	26.1	28.0	23.4	43.1	25.0	41.7	35.5	9.6	27.7	15.2	23.0	41.1	19.5	38.1	21.4	27.5	69.9	28.4	37.5	29.9	25.0	25.3	21.6	65.6	15.4	13.8	29.8	24.5	14.9	29.6	23.1	88.1	34.0	12.5	11.0	30.7	58.4	248.8	15.3	22.1	26.3	13.9	19.5	35.9	40.0	12.2	9.5	20.1	42.7	22.0	81.6	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell line enhanced"	"Detected in some"		"AF22: 32.2;HHSteC: 9.4;RH-30: 10.5;U-87 MG: 6.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced									"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.8	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3
ATP2A1	"ATP2A, SERCA1"	ENSG00000196296	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1"	O14983	16	28878405-28904509	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"skeletal muscle: 456.3;tongue: 209.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 19.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"thalamus: 14.3"	"Low region specificity"	"Detected in all"			"CAB002310, CAB032706"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB002310: AB_564139, CAB032706: AB_2061286"	"unprognostic (2.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.23e-5)"	"unprognostic (5.35e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.72e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-2)"	7.6	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.1	1.1	5.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.6	0.1	12.6	7.0	0.3	456.3	0.2	0.2	0.1	0.1	0.1	0.1	0.9	0.0	0.0	4.2	209.0	6.5	0.2	0.1	1.6	3.1	0.7	0.2	4.7	1.5	0.6	4.8	5.2	9.6	5.7	0.4	1.6	8.9	2.3	1.3	0.4	0.4	2.9	4.4	7.6	2.7	0.4	5.1	2.4	0.1	0.7	3.8	19.8	2.7	11.8	9.0	0.2	1.1	2.5	4.1	1.1	0.6	0.5	0.2	5.1	6.5	0.3	9.7	10.9	6.1	9.6	7.4	16.8	6.8	5.7	0.0	0.6	6.1	4.9	3.3	4.5	3.4	3.4	2.7	2.0	3.0	6.3	5.6	2.8	9.5	5.7	7.4	5.9	15.0	2.9	0.0	0.1	0.7	1.0	0.0	1.3	1.6	1.1	1.0	0.0	0.8	1.4	1.3	0.0	4.7	0.2	3.1	1.5	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced						38000000			"HPA062605: "	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	34.9	69.8	35.4	28.4	23.5	30.2	51.0	43.7	55.0	44.3	29.9	50.5	37.3	43.2	37.0	41.5	51.2	58.5	69.0	50.4	35.7	29.3	37.7	28.0	29.5	40.0	43.0	36.5	31.7	48.6	56.3	54.6	34.2	43.9	21.2	36.0	33.6	23.2	26.7	40.3	35.3	24.6	31.8	35.7	21.8	72.3	37.4	28.1	54.9	45.2	25.5	60.7	23.2	36.7	41.1	22.1	27.3	33.3	43.6	53.0	48.5	37.4	18.6	46.5	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1
ATP2A3	SERCA3	ENSG00000074370	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3"	Q93084	17	3923870-3964464	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.4;salivary gland: 88.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 39.1;HMC-1: 57.9;Karpas-707: 25.3;MOLT-4: 51.8;SK-BR-3: 42.1"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"cerebellum: 10.9;midbrain: 4.1"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in some"	15	"cerebellum: 75.4"	"Low region specificity"	"Detected in many"			"HPA007180, CAB010882"	Approved						100000000			"CAB010882: AB_258368, HPA007180: AB_1845177"	"unprognostic (4.14e-2)"	"prognostic favourable (4.69e-5)"	"unprognostic (1.21e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.02e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (8.83e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.29e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-3)"	2.1	4.9	0.9	36.9	1.6	24.3	2.7	10.9	1.7	2.3	15.4	1.8	48.8	8.1	3.4	2.8	4.5	2.2	16.0	2.6	0.9	0.7	3.4	1.6	7.8	25.6	4.1	1.4	2.1	20.2	0.0	0.8	1.7	1.4	7.4	9.0	8.7	88.1	47.3	0.9	9.4	26.1	3.0	1.0	36.4	25.5	1.6	1.2	82.4	4.2	6.0	47.5	5.4	2.6	8.3	10.8	21.1	1.0	2.5	7.8	3.9	0.0	1.6	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.3	39.1	2.4	0.1	0.1	0.6	0.0	0.0	4.8	0.4	20.4	1.2	0.0	0.3	22.2	57.9	0.0	0.0	0.1	0.0	0.0	4.1	25.3	0.0	24.3	51.8	23.9	0.2	0.3	5.7	0.0	9.0	0.0	0.7	2.5	0.7	0.3	42.1	0.0	2.6	5.5	0.1	0.0	0.4	0.1	0.0	9.4	2.8	13.8	0.5	15.9	0.0	9.1	1.0	21.1	7.8	0.6	6.1	6.9	4.8	7.2	1.0	8.3	3.6	4.4	9.0	2.5	0.3	10.8	4.2	3.9	0.9	1.6	10.9	1.7	0.9	0.7	4.1	1.4	1.4	1.2
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 53.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 58.4;LHCN-M2: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	8.7	5.1	23.4	12.5	53.8	40.5	8.8	30.9	44.1	9.0	14.0	4.1	4.0	17.8	8.2	5.8	6.5	8.4	11.3	5.2	29.0	11.8	7.4	10.0	9.2	11.8	7.8	31.5	7.6	7.4	13.7	8.7	11.7	9.2	6.4	14.8	2.9	5.6	6.9	10.9	11.3	12.8	8.7	6.1	12.7	12.4	9.8	16.4	5.7	6.3	6.0	12.3	9.9	7.4	27.1	16.2	41.5	25.6	8.4	16.3	6.2	4.1	21.1	8.3	4.0	12.1	19.3	3.8	12.8	41.9	12.4	19.8	8.4	3.9	8.2	0.9	17.7	3.7	7.3	3.5	34.7	2.8	8.5	2.9	7.4	7.4	39.5	12.2	4.9	15.9	6.7	38.6	58.4	3.1	4.8	3.0	90.7	6.6	3.8	5.2	6.5	10.1	5.4	26.8	3.4	11.8	19.3	7.9	4.3	14.8	4.2	3.5	6.1	1.4	2.2	33.7	5.5	12.3	13.9	2.3	3.5	8.8	15.3	3.5	7.4	2.7	13.0	6.7	7.1	13.6	9.0	27.1	12.4	9.0	16.2	27.0	4.6	5.7	41.5	8.4	25.6	2.9	16.3	6.2	23.4	53.8	30.9	44.1	29.0	11.8	7.8	31.5	9.2	16.4
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	4	"EFO-21: 5.3;RPMI-8226: 15.0;SCLC-21H: 5.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced									"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	15.0	0.0	0.0	5.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2
ATP2B3	"CFAP39, CLA2, PMCA3, SCAX1"	ENSG00000067842	"ATPase plasma membrane Ca2+ transporting 3"	Q16720	X	153517676-153582939	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	Calmodulin-binding	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 18.6;brain: 23.2"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.3;SH-SY5Y: 4.2;THP-1: 3.5;U-937: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001583	Enhanced									"HPA001583: AB_1079641"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.71e-12)"	"unprognostic (1.44e-3)"	"unprognostic (2.04e-1)"		"unprognostic (2.42e-2)"	0.8	18.6	5.4	0.9	11.3	0.8	0.8	16.1	23.2	0.8	0.9	3.9	0.0	0.9	0.9	2.6	0.8	3.1	0.8	0.8	7.8	5.5	1.0	0.8	0.8	0.8	4.3	11.5	0.8	0.9	0.8	1.2	1.7	13.6	0.8	0.8	1.4	1.3	1.3	0.8	0.9	0.9	0.9	1.4	0.8	0.8	1.1	0.9	0.0	0.8	0.0	0.8	0.8	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.3	4.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.4	11.3	16.1	20.7	7.8	5.5	4.3	11.5	13.6	0.9
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting alpha subunit"	P20648	19	35550043-35563658	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 120.1"	"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-138 MG: 1.5"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA039154	Enhanced						790000			"HPA039154: AB_10672772"	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.1	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.6	0.1	0.1	3.4	0.1	0.0	0.1	0.1	4.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	120.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.1	0.0	1.5	0.3	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
ATP5F1A	"ATP5A, ATP5A1, ATP5AL2, ATPM, hATP1, OMR, ORM"	ENSG00000152234	"ATP synthase F1 subunit alpha"	P25705	18	46080248-46104334	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013067, HPA040622, HPA044202"	Enhanced		Supported	Mitochondria			51000000	Mitochondria		"CAB013067: AB_221511, HPA040622: AB_2677048, HPA044202: AB_2678855"	"unprognostic (3.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.79e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (4.60e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.87e-3)"	30.1	60.0	34.7	30.3	45.8	22.4	33.9	52.6	65.0	27.0	52.1	20.5	39.3	55.6	25.2	30.5	44.4	30.0	27.9	196.2	31.4	36.1	94.0	64.8	25.2	40.2	42.3	31.8	28.6	49.0	73.2	35.9	25.7	41.5	28.3	54.9	37.6	42.6	42.8	182.2	34.0	50.4	36.6	22.6	32.1	46.7	24.0	19.9	45.6	35.1	99.7	41.1	31.5	26.4	58.7	110.9	17.9	64.5	44.2	63.6	124.8	42.5	43.4	57.8	54.2	70.4	78.2	64.1	49.3	69.9	76.0	66.7	64.9	33.7	100.9	30.3	59.7	79.4	99.5	75.7	71.0	44.9	55.9	66.7	56.0	80.4	46.1	141.1	63.4	72.1	53.2	54.8	57.1	78.3	53.8	59.7	64.9	44.3	72.5	69.4	54.1	45.8	71.8	67.2	136.5	103.0	104.2	58.8	54.9	36.1	45.2	60.5	58.2	82.4	45.5	41.9	36.2	21.9	42.9	68.6	58.7	65.0	41.7	84.9	44.5	11.8	64.5	17.9	43.5	58.2	55.8	58.7	52.4	47.5	110.9	44.0	63.6	52.8	6.7	44.2	52.2	54.0	58.9	124.8	34.7	45.8	52.6	65.0	31.4	36.1	42.3	31.8	41.5	19.9
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria			100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavourable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favourable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	65.7	80.0	63.6	98.1	57.4	61.4	112.4	66.9	62.5	115.7	65.9	129.9	73.4	117.0	72.5	82.4	88.2	134.0	81.1	104.8	54.8	92.8	128.3	74.7	79.6	71.1	143.5	90.9	75.2	81.9	90.4	116.8	95.0	115.5	134.9	97.0	61.0	106.3	84.4	107.0	154.1	102.4	71.2	149.1	126.0	117.2	72.8	64.7	102.2	146.4	113.7	137.4	108.5	64.4	45.6	50.8	66.5	72.2	65.1	80.9	121.0	68.6	96.0	69.8	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3
ATP5F1C	"ATP5C, ATP5C1, ATP5CL1"	ENSG00000165629	"ATP synthase F1 subunit gamma"	P36542	10	7788129-7807815	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060949	Approved						2600000			"HPA060949: "	"unprognostic (1.81e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.62e-1)"	"unprognostic (4.12e-1)"	"prognostic favourable (9.26e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.30e-2)"	"unprognostic (4.08e-2)"	35.3	75.5	30.9	24.4	33.5	23.1	31.4	27.8	38.7	26.1	48.5	20.3	25.7	45.3	27.6	30.4	48.2	22.2	30.5	138.0	29.5	28.5	98.2	70.9	21.6	21.4	30.3	28.1	22.9	46.9	43.3	23.3	38.8	43.6	26.7	52.1	26.9	46.2	29.2	98.1	24.9	64.5	33.6	23.2	30.4	38.1	18.0	18.7	45.8	35.7	97.9	34.1	39.7	23.1	42.0	75.7	57.5	75.5	41.0	51.3	59.2	44.1	40.5	40.6	33.9	36.9	49.0	38.0	31.9	29.4	59.8	58.8	79.9	43.7	49.0	24.5	40.6	49.9	47.9	52.8	52.7	33.3	58.9	52.4	27.8	70.0	28.5	28.3	38.3	38.8	37.1	36.1	19.7	70.0	41.3	34.6	58.6	65.2	66.7	32.7	26.1	32.8	43.4	30.5	67.0	101.4	43.8	21.8	26.6	29.2	62.8	56.5	67.1	46.8	33.5	25.3	31.9	54.7	33.9	23.0	28.6	39.8	36.5	42.8	20.3	57.5	55.4	46.0	33.6	71.9	38.5	42.0	38.2	36.2	75.7	32.1	31.8	34.6	17.7	41.0	75.5	50.8	51.3	59.2	30.9	33.5	27.8	38.7	29.5	28.5	30.3	28.1	43.6	18.7
ATP5PF	"ATP5, ATP5A, ATP5J, ATPM, CF6"	ENSG00000154723	"ATP synthase peripheral stalk subunit F6"	P18859	21	25716503-25735673	"Plasma proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031069	Supported		Supported	Mitochondria			720000	Mitochondria		"HPA031069: AB_10603676"	"unprognostic (3.52e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.83e-2)"	"prognostic favourable (2.37e-5)"	"unprognostic (1.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.15e-2)"	39.8	46.8	49.0	20.3	43.6	23.0	32.6	30.8	46.6	25.9	48.6	26.1	22.4	43.0	24.0	57.4	45.2	21.6	19.2	148.9	41.1	37.1	72.8	111.0	18.7	22.2	47.0	27.0	23.9	37.4	31.2	37.5	33.9	45.7	32.6	47.9	33.9	47.1	37.5	164.7	18.7	57.9	46.9	32.8	25.0	37.6	21.0	25.8	31.4	32.1	69.9	29.9	42.0	23.1	87.8	102.4	80.9	91.5	69.1	95.2	112.2	41.6	30.0	38.3	43.0	41.2	38.0	47.5	36.9	42.9	36.1	35.3	68.9	32.9	51.4	24.5	36.4	22.9	51.2	44.2	39.8	44.9	54.4	107.1	61.0	68.4	46.6	78.2	35.1	37.1	54.6	34.5	31.0	41.9	66.8	63.2	52.6	46.6	54.1	79.2	68.8	54.5	42.3	74.4	97.0	77.0	57.0	43.7	48.6	62.0	62.7	56.8	45.3	70.4	31.6	27.6	33.1	25.7	31.7	63.1	103.1	65.0	42.4	81.8	34.5	69.2	88.8	80.9	60.3	91.5	64.0	87.8	80.2	74.6	102.4	71.6	79.6	78.0	56.9	69.1	89.7	96.4	95.2	112.2	49.0	43.6	30.8	46.6	41.1	37.1	47.0	27.0	45.7	25.8
ATP5PO	"ATP5O, ATPO, OSCP"	ENSG00000241837	"ATP synthase peripheral stalk subunit OSCP"	P48047	21	33903453-33915980	"Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB016209, HPA041394"	Enhanced		Enhanced	Mitochondria			4000000	Mitochondria		"CAB016209: AB_631361, HPA041394: "	"unprognostic (2.08e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.30e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.81e-1)"	"prognostic favourable (9.34e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.26e-2)"	"unprognostic (7.89e-3)"	32.6	26.8	49.3	27.7	43.5	34.9	37.8	35.0	44.8	28.7	45.0	21.6	24.2	48.2	25.1	34.3	44.2	28.9	30.3	139.4	40.8	36.7	61.3	57.5	20.6	31.5	45.6	38.4	38.0	40.1	29.5	19.2	25.1	46.4	32.5	52.4	27.2	38.8	28.6	130.6	28.7	57.5	34.8	29.3	27.3	43.2	25.4	20.1	42.7	37.4	98.0	36.2	39.4	26.5	71.9	94.0	48.5	71.5	46.8	73.3	112.2	41.9	19.7	54.9	53.8	37.7	48.4	61.1	24.0	42.2	40.4	39.7	57.7	40.7	56.2	20.7	36.4	23.8	59.1	82.0	47.9	41.9	58.9	84.3	31.5	57.3	43.5	63.8	29.2	49.2	50.2	39.1	64.3	55.6	67.6	73.0	51.9	43.2	48.7	62.7	62.6	58.3	50.3	54.2	106.1	110.7	37.3	44.4	25.7	41.2	61.7	54.6	62.2	70.5	31.3	26.6	31.7	47.4	27.2	48.2	52.6	58.9	49.1	109.6	38.3	33.4	69.9	48.5	44.5	71.5	53.0	71.9	58.8	52.9	94.0	59.0	73.3	61.5	17.2	46.8	62.6	55.9	70.1	112.2	49.3	43.5	35.0	44.8	40.8	36.7	45.6	38.4	46.4	20.1
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428632-154436516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"			160000	"Plasma membrane, Microtubules, Cytosol"		"CAB015218: "	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favourable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	29.8	37.8	36.6	20.0	50.3	27.5	22.1	59.2	82.7	28.4	26.5	39.4	27.4	24.0	20.6	43.2	29.1	29.6	23.0	35.1	40.8	47.5	42.4	26.9	37.9	21.8	36.5	40.5	24.4	42.6	67.1	41.5	66.1	60.1	41.6	24.7	29.8	35.9	29.4	18.4	30.2	24.2	22.9	39.4	36.4	27.6	21.2	24.2	22.1	39.7	20.9	21.4	27.3	21.1	20.1	68.4	64.0	56.6	23.7	28.9	33.8	22.4	21.4	18.3	31.1	29.7	16.4	34.4	16.6	23.6	25.9	37.8	20.2	28.1	13.3	70.4	35.6	24.1	26.9	15.4	14.3	12.1	27.8	7.6	27.5	20.0	37.4	12.3	56.5	21.8	26.4	24.3	14.0	35.9	9.1	37.6	16.9	32.9	8.9	18.6	6.8	21.9	13.8	12.2	34.5	27.4	18.8	18.3	19.0	14.5	59.3	31.1	26.1	30.4	27.7	18.9	17.1	32.2	27.0	54.3	58.3	15.7	22.6	26.7	19.0	37.4	53.9	64.0	28.6	56.6	28.9	17.5	23.7	24.7	68.4	20.1	21.4	23.5	60.0	23.7	43.4	39.0	26.9	33.8	36.6	50.3	59.2	82.7	40.8	47.5	36.5	40.5	60.1	24.2
ATP6V0A2	"a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1"	ENSG00000185344	"ATPase H+ transporting V0 subunit a2"	Q9Y487	12	123712318-123761755	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044279	Approved		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA044279: AB_10961274"	"unprognostic (2.60e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.58e-1)"	13.5	9.4	7.2	13.0	9.9	15.5	11.5	16.2	9.8	8.9	13.1	13.0	9.0	16.0	13.4	8.8	9.1	10.4	10.4	13.6	8.0	7.9	8.9	13.7	13.1	16.6	12.8	6.9	9.7	18.1	8.1	10.4	10.2	9.1	9.8	12.0	9.8	24.5	10.0	13.0	20.5	15.8	12.3	9.4	13.1	15.9	15.9	10.8	24.0	10.3	8.6	17.5	11.0	10.3	2.3	3.4	13.1	1.5	2.1	2.7	0.9	3.2	8.3	8.6	11.6	5.1	4.9	5.3	3.9	4.6	5.1	5.6	6.1	2.6	12.5	2.8	5.3	7.0	11.2	4.1	3.8	8.5	6.3	18.0	6.6	3.5	8.1	11.4	37.1	4.4	3.6	6.0	6.5	4.4	10.9	2.3	5.6	9.0	10.8	14.1	9.0	5.5	10.4	7.5	4.0	4.9	8.1	5.2	8.8	6.6	4.6	5.8	4.8	8.4	6.4	6.5	2.5	7.9	6.5	7.5	8.2	11.7	5.4	6.9	5.5	6.4	0.9	13.1	2.1	0.9	1.5	1.3	2.1	1.8	1.1	2.3	1.9	2.7	2.4	2.1	1.5	3.4	1.4	0.9	7.2	9.9	16.2	9.8	8.0	7.9	12.8	6.9	9.1	10.8
ATP6V0C	"ATP6C, ATP6L, ATPL, VATL, Vma3"	ENSG00000185883	"ATPase H+ transporting V0 subunit c"	P27449	16	2513870-2520218	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA065100			Approved	Cytosol				Cytosol		"HPA065100: "	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.96e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.78e-2)"	"prognostic favourable (1.07e-6)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.04e-2)"	56.5	68.2	61.2	53.6	83.5	87.2	24.1	76.0	156.7	27.7	42.9	39.2	25.2	55.2	28.0	21.9	48.7	25.6	23.0	32.5	64.3	70.1	78.0	37.3	40.5	37.1	55.4	74.2	27.2	42.7	41.9	52.3	35.1	70.4	35.7	19.5	40.1	54.3	30.3	108.8	38.7	52.8	18.3	41.9	48.3	59.0	30.4	29.4	25.1	25.7	34.7	29.2	20.8	29.6	15.9	28.2	50.6	42.5	13.0	16.1	18.2	29.4	31.7	17.1	24.4	21.7	10.8	40.9	43.7	13.8	18.3	17.6	29.4	38.2	14.9	40.2	20.9	35.9	18.2	25.9	9.3	37.9	54.3	17.0	25.5	36.0	30.8	26.9	52.5	19.5	19.4	23.1	12.2	13.1	40.3	28.6	15.9	57.5	27.1	70.5	33.2	38.8	43.6	14.9	46.6	32.2	17.6	55.8	45.4	36.8	42.7	35.0	41.1	34.5	31.2	29.5	35.2	44.4	31.2	53.2	64.9	27.2	25.9	19.9	29.9	22.1	32.6	50.6	14.8	36.3	15.1	15.9	13.4	16.1	20.4	15.4	15.6	13.5	43.7	13.0	42.5	28.2	13.2	18.2	61.2	83.5	76.0	123.3	64.3	70.1	55.4	74.2	70.4	29.4
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481237	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain									"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favourable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	24.2	41.4	32.0	28.2	58.8	31.0	19.8	41.1	89.9	27.9	36.7	35.3	17.1	30.5	26.8	27.4	33.0	26.3	24.7	27.0	40.4	48.5	34.3	30.6	34.5	29.7	39.6	39.1	17.9	25.7	42.5	40.7	30.1	66.6	23.8	33.0	26.6	23.7	26.3	42.5	30.1	29.6	36.0	24.8	37.0	26.9	40.6	18.9	27.6	35.2	21.3	27.4	26.9	22.0	21.1	53.8	106.5	79.7	16.8	16.0	66.3	17.9	25.6	15.9	20.5	40.5	22.0	15.3	21.5	35.3	44.5	53.6	26.6	19.4	7.5	18.1	31.0	21.6	23.4	27.0	26.7	9.1	21.5	13.9	15.0	22.1	38.3	13.8	58.5	34.1	26.8	44.8	10.7	27.6	15.6	10.0	35.9	43.1	10.2	31.4	15.4	18.4	18.3	18.6	20.9	27.0	30.1	31.1	14.5	56.1	15.3	23.2	24.8	21.2	26.5	22.4	9.2	27.4	11.3	16.9	23.8	22.0	31.5	14.8	13.2	29.6	79.7	58.7	16.0	56.9	11.0	21.1	12.0	14.7	53.8	18.9	9.3	11.5	106.5	16.8	51.1	19.3	14.4	66.3	32.0	58.8	41.1	89.9	40.4	48.5	39.6	39.1	66.6	18.9
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035083, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			2700000	"Nucleoplasm, Vesicles"	Cytosol	"CAB006910: , HPA035083: AB_2674453, HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favourable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.0	11.4	14.4	12.5	30.3	13.6	15.3	13.6	20.8	14.3	19.8	21.5	20.2	20.5	32.3	19.8	16.3	32.4	17.9	18.8	9.3	8.9	18.2	17.7	16.5	25.1	13.3	21.3	18.3	12.4	18.5	12.9	23.2	20.8	15.6	21.2	16.4	9.7	6.0	18.0	14.3	8.4	10.4	23.3	39.1	23.9	27.9	10.3	23.8	16.2	17.8	24.6	10.8	21.3	13.3	10.0	9.1	8.1	16.3	17.5	19.0	26.2	16.9	14.8	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628818	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm			61000	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: "	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favourable (4.18e-4)"	"prognostic favourable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	32.8	45.9	59.5	20.4	69.0	24.9	31.5	48.9	90.3	30.2	26.7	34.5	25.2	17.6	27.7	44.4	37.5	26.7	26.7	67.4	58.9	55.4	71.7	26.1	31.7	24.5	54.5	52.3	27.0	15.8	48.3	29.6	46.2	69.8	31.1	32.0	24.1	21.5	42.1	48.5	26.9	19.1	38.1	53.7	23.9	23.8	20.2	32.4	17.5	31.9	26.1	32.5	32.1	22.0	24.2	26.3	55.3	34.8	22.6	29.4	30.1	21.5	19.7	17.8	17.3	59.5	32.2	19.6	28.9	38.6	36.8	42.7	24.4	17.9	13.5	24.9	38.6	34.3	27.8	25.3	32.9	25.9	31.5	24.4	19.7	32.7	87.1	28.0	42.3	40.3	49.7	35.4	25.9	31.0	30.4	27.8	62.6	22.5	24.2	20.3	13.1	27.8	14.2	26.1	8.0	61.0	34.2	13.1	22.8	26.5	18.8	62.2	18.2	32.5	26.4	25.9	13.7	32.3	21.4	27.3	47.8	17.1	41.7	13.7	34.7	45.2	32.9	55.3	21.4	30.8	20.8	24.2	21.9	20.5	26.3	19.0	20.8	21.5	44.3	22.6	34.8	25.4	29.4	30.1	59.5	69.0	48.9	90.3	58.9	55.4	54.5	52.3	69.8	32.4
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli			150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: "	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	17.9	17.3	35.7	8.7	29.6	21.5	33.1	28.1	22.3	23.3	16.7	23.2	21.7	17.4	24.6	20.0	40.8	26.6	21.2	19.6	13.8	18.3	16.7	21.9	33.7	41.5	37.2	31.0	27.4	57.1	18.6	23.2	22.0	32.0	37.0	31.8	39.0	35.9	23.5	42.2	32.7	34.9	22.9	27.9	47.6	30.9	26.9	34.4	37.8	66.1	99.7	53.6	44.2	29.3	19.0	15.1	29.5	31.4	49.9	97.9	30.4	24.5	22.4	26.0	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA012887: AB_1845205, HPA048107: "	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.5	6.7	4.5	4.6	4.3	4.5	0.8	3.9	5.4	2.3	4.8	0.9	3.0	3.7	5.8	3.8	3.1	5.8	3.1	4.4	5.5	4.0	1.9	6.5	0.7	5.4	3.3	3.5	4.8	1.3	5.0	1.5	6.1	15.3	14.4	4.3	2.2	3.5	1.1	1.3	1.4	2.9	7.5	12.6	3.9	7.2	1.4	17.1	9.6	2.4	4.9	1.8	1.1	7.7	3.1	3.1	4.3	1.5	4.7	8.3	4.3	5.1	2.0	4.7	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.8;Daudi: 27.6;HEL: 9.7;REH: 9.5;SH-SY5Y: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles			20000	Vesicles		"HPA052935: "	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favourable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.2	16.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	27.6	7.8	0.1	1.4	4.0	0.0	0.0	4.4	2.7	9.7	0.9	0.4	0.0	2.3	0.2	0.3	0.0	0.0	0.0	0.1	0.0	3.1	0.0	1.2	3.5	0.8	1.2	0.3	9.5	0.0	3.1	6.0	0.3	3.0	9.2	0.2	5.8	0.0	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.6	0.4	3.3	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9
ATP8B4	"ATPIM, KIAA1939"	ENSG00000104043	"ATPase phospholipid transporting 8B4 (putative)"	Q8TF62	15	49858238-50182817	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.1;cervix, uterine: 26.0;endometrium 1: 18.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 18.6;NB-4: 7.1;THP-1: 12.0;U-937: 37.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 6.9;NK-cell: 10.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040254	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA040254: AB_10673028"	"unprognostic (6.45e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.08e-1)"	2.3	1.2	1.6	1.5	2.1	28.1	1.0	0.6	0.9	26.0	1.5	1.7	1.6	0.4	18.2	3.5	0.6	9.5	3.1	0.8	2.5	0.9	1.0	1.2	3.2	0.7	2.7	0.1	3.9	0.4	0.2	1.1	2.9	2.1	0.7	1.2	0.8	0.9	0.6	0.4	0.5	1.1	2.7	3.1	2.3	0.6	0.9	4.6	0.8	0.5	0.8	2.1	1.3	1.5	0.0	2.2	6.9	1.7	10.6	0.5	0.8	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.1	0.0	3.0	0.6	0.0	0.0	5.2	18.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	12.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.4	37.6	0.0	6.9	1.7	2.4	0.5	0.8	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.8	10.6	0.3	0.0	0.0	0.8	1.6	2.1	0.6	0.9	2.5	0.9	2.7	0.1	2.1	4.6
ATRN	"DPPT-L, MGCA"	ENSG00000088812	Attractin	O75882	20	3471040-3651122	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008853	Approved		Approved	Cytosol	"Secreted to blood"		39000000000	Cytosol		"HPA008853: AB_1078248"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.99e-2)"	"unprognostic (4.28e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (2.19e-6)"	"unprognostic (3.71e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.91e-2)"	12.1	22.8	14.9	7.4	20.7	5.7	13.0	18.4	29.3	13.5	22.8	18.3	7.4	39.9	12.2	12.2	9.3	9.2	12.4	14.8	13.6	14.7	18.4	45.2	10.6	7.1	12.8	18.9	11.5	17.7	40.3	13.4	16.5	16.1	10.1	9.5	12.2	14.0	10.7	11.7	13.6	31.1	11.3	15.2	9.7	17.1	16.2	12.3	5.4	24.1	7.5	7.1	12.0	9.8	3.6	5.7	5.7	6.5	3.0	4.8	1.9	17.7	16.7	9.9	8.3	17.7	28.9	12.8	11.9	16.9	12.5	10.6	7.2	12.2	0.0	8.0	16.6	24.9	6.7	25.9	16.8	1.9	5.7	5.5	4.6	15.4	10.6	11.7	3.8	15.4	21.0	13.2	12.8	16.2	8.7	8.7	12.1	5.1	4.7	4.5	6.7	10.1	4.0	23.2	13.3	11.4	12.6	5.9	9.2	11.9	22.2	16.2	11.8	11.2	19.9	13.4	7.9	14.0	11.7	6.1	8.6	0.0	8.2	7.9	13.3	5.7	6.5	3.6	4.8	5.6	2.3	2.8	2.7	3.0	5.7	3.6	4.4	3.7	0.0	3.0	5.7	5.3	3.4	1.9	14.9	20.7	18.4	29.3	13.6	14.7	12.8	18.9	16.1	12.3
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol				Cytosol		"HPA041506: , HPA043391: , HPA071955: "	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	24.7	31.1	32.5	38.7	30.4	56.8	44.9	57.9	42.5	27.4	24.6	28.0	22.8	35.1	28.4	22.9	29.5	26.2	25.8	24.8	31.1	22.2	30.9	32.9	37.1	46.2	33.8	36.1	31.7	34.8	39.9	44.8	31.2	28.9	29.2	22.8	22.5	30.9	34.2	27.9	31.7	31.9	27.8	33.6	44.0	30.2	77.2	33.1	45.2	31.4	19.5	36.8	25.5	38.8	6.8	9.5	4.2	3.7	3.0	4.0	1.4	17.8	22.9	23.8	26.8	14.7	15.2	28.0	18.0	17.5	19.8	22.2	28.9	21.3	41.5	23.1	12.7	26.0	22.3	18.1	22.0	32.4	19.8	27.6	27.2	29.3	26.5	31.0	39.0	19.4	21.8	28.0	40.4	17.4	36.0	52.6	16.2	25.4	37.7	52.7	24.1	16.0	49.9	16.5	28.8	11.8	18.5	24.8	19.8	10.5	20.0	21.7	21.8	32.8	20.7	24.7	20.5	15.8	24.6	75.4	52.3	37.2	18.6	29.8	28.4	0.7	3.7	2.2	2.9	3.3	3.0	6.8	3.5	3.5	2.7	5.7	3.3	4.0	4.2	3.0	2.6	9.5	2.8	1.4	32.5	30.4	57.9	42.5	31.1	22.2	33.8	36.1	28.9	33.1
ATXN3	"ATX3, JOS, MJD, SCA3"	ENSG00000066427	"Ataxin 3"	P54252	14	92044496-92106625	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB021976, HPA024123, HPA069338"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"				"Nucleoplasm, Nucleoli"	"Plasma membrane"	"CAB021976: , HPA024123: AB_1845133, HPA069338: "	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.94e-3)"	"unprognostic (4.22e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.11e-1)"	17.8	10.3	10.2	9.1	11.6	14.3	12.8	18.7	12.1	16.0	11.8	12.2	11.9	6.4	17.9	12.4	17.7	9.5	11.2	10.4	9.0	9.9	9.9	16.0	12.3	11.6	16.3	9.5	14.0	10.3	11.9	17.2	11.7	13.8	15.8	11.7	8.6	11.4	10.2	6.1	21.0	8.7	20.6	16.5	12.6	9.0	14.8	14.3	16.2	11.5	12.0	15.6	15.4	13.6	9.8	14.5	11.4	18.8	7.0	8.5	5.3	5.6	11.1	10.0	9.3	14.6	14.3	19.6	6.4	10.4	8.2	11.4	8.0	15.7	11.5	12.8	10.5	9.8	7.7	14.0	18.1	13.1	2.3	4.9	5.4	11.7	12.1	8.6	8.8	11.6	12.5	14.3	15.0	12.6	6.5	8.6	12.4	21.9	9.0	7.8	7.1	9.2	7.2	18.5	6.5	10.5	12.8	3.4	6.0	15.5	6.6	8.8	12.3	6.0	6.7	8.1	11.9	5.2	3.4	7.5	12.5	10.6	6.0	8.5	4.7	11.4	13.4	9.4	5.9	14.5	7.0	7.1	6.9	6.5	14.5	9.8	7.6	8.5	11.3	7.0	18.8	8.4	6.8	5.3	10.2	11.6	18.7	12.1	9.0	9.9	16.3	9.5	13.8	14.3
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000163635	"Ataxin 7"	O15265	3	63898399-64003453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.1"	"Low lineage specificity"	"Detected in many"											HPA034989			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA034989: AB_10602596"	"unprognostic (1.51e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.92e-1)"	"prognostic favourable (1.22e-4)"	"unprognostic (9.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.77e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.45e-2)"	8.8	6.4	4.9	14.5	7.4	19.7	8.9	10.2	6.5	9.5	10.7	4.9	6.7	8.0	10.9	9.2	9.2	7.5	11.4	7.5	5.0	4.3	6.3	8.2	10.2	19.9	6.1	3.1	12.4	21.7	15.3	10.9	15.1	6.0	8.2	8.1	15.1	12.2	7.8	9.6	10.6	12.5	9.2	5.7	11.1	7.2	14.6	6.7	55.4	8.8	8.5	24.2	8.4	10.2	0.9	0.5	11.1	0.5	2.6	5.9	1.1	5.9	4.8	5.0	4.0	5.7	6.5	6.5	3.5	6.4	7.4	6.0	6.8	5.8	5.7	2.1	6.7	3.9	6.3	6.5	7.9	15.0	2.6	10.0	5.7	2.0	2.9	4.2	12.1	6.2	3.5	11.0	12.2	5.5	3.7	17.5	4.6	14.2	8.8	3.4	3.4	2.2	3.8	4.5	6.9	3.6	7.1	2.0	3.7	7.7	5.2	7.0	3.6	6.0	7.6	6.4	8.7	9.3	8.0	7.9	7.9	6.4	7.6	7.0	6.1	11.1	0.3	0.9	3.2	0.5	2.6	0.0	5.9	3.4	0.1	0.9	5.7	3.7	1.2	2.6	0.1	0.5	4.7	1.1	4.9	7.4	10.2	6.5	5.0	4.3	6.1	3.1	6.0	6.7
ATXN7	"ADCAII, OPCA3, SCA7"	ENSG00000285258	"Ataxin 7"	O15265	3	63864557-64003462	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.9"	"Low cell line specificity"	"Detected in many"											"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA034989			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034989: AB_10602596"																		0.4	0.0		1.5		2.8	1.3		0.0	2.0	0.7			0.0	2.0	2.0	0.0	0.9	0.8	0.0			1.0	0.9	0.9	2.1			0.5	1.0	3.0		1.9		0.9	0.9		0.5	0.6	0.3	3.1	0.8	0.3		1.5	1.0	0.0			0.8		1.8	0.1		4.9	3.6	8.9	1.9	2.5	4.3	0.7	2.4	0.1	3.4	3.2	3.2	6.0	3.3	3.0	2.5	4.0	5.5	1.4	3.2	6.8	1.1	2.0	2.7	3.3	2.3	4.8	6.5	2.5	6.2	4.2	2.4	4.5	4.5	5.7	1.8	6.8	5.1	6.7	2.9	2.3	9.7	2.8	13.0	2.9	3.9	2.2	0.8	5.7	2.9	2.4	2.5	3.3	1.1	1.7	5.9	4.8	3.8	1.4	6.6	4.0	6.0	3.3	3.6	4.6	5.3	4.7	4.2	2.3	4.7	3.5	5.7	1.9	2.7	2.5	1.2	2.9	4.9	2.9	2.4	1.6	4.3	3.5	2.5	8.9	2.5	1.4	3.6	4.3	0.7										
ATXN7L1	"ATXN7L4, KIAA1218, MGC33190"	ENSG00000146776	"Ataxin 7 like 1"	Q9ULK2	7	105605067-105876604	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021448	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021448: AB_1845213"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.20e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.01e-1)"	10.8	10.7	10.3	12.1	16.6	7.7	10.6	24.7	13.4	13.3	11.7	9.7	12.3	7.9	9.2	9.1	9.6	11.7	8.4	6.4	8.5	6.2	14.1	12.3	7.8	15.6	7.1	7.3	13.3	7.2	11.2	17.8	10.8	6.9	10.1	11.6	8.3	11.4	12.1	5.2	12.2	10.9	9.7	6.9	10.4	9.8	20.8	9.9	12.4	11.8	4.6	17.9	11.3	11.7	3.9	3.1	4.3	4.8	4.2	14.5	3.4	2.8	3.8	8.3	3.9	5.1	6.0	2.6	5.1	5.1	4.6	4.3	3.7	5.5	1.1	4.0	5.4	2.7	4.6	5.3	3.4	15.9	3.1	3.8	2.8	3.6	3.0	6.2	12.8	4.1	4.3	3.1	3.1	4.1	4.5	2.6	3.8	6.8	3.4	3.5	15.3	3.9	3.4	2.8	0.8	3.5	2.9	5.2	3.4	3.6	7.3	7.2	3.8	6.4	10.4	7.3	3.3	5.9	2.0	0.5	0.0	0.1	4.5	9.7	7.2	2.3	4.2	4.3	2.9	4.8	2.1	3.9	7.5	6.4	3.1	3.6	8.2	4.7	1.4	4.2	2.8	2.1	14.5	3.4	10.3	16.6	24.7	13.4	8.5	6.2	7.1	7.3	6.9	9.9
AUH		ENSG00000148090	"AU RNA binding methylglutaconyl-CoA hydratase"	Q13825	9	91213815-91361913	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	"Lyase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004171	Enhanced				"Intracellular and membrane"					"HPA004171: AB_1845215"	"unprognostic (4.10e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (8.23e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	13.0	39.6	14.3	15.6	20.1	3.8	15.2	22.5	20.7	14.1	19.8	10.5	25.3	19.2	11.1	16.0	8.9	10.7	11.4	30.4	15.4	19.7	50.4	21.3	9.7	6.7	19.1	9.0	11.8	20.7	27.0	10.1	13.1	16.3	23.8	14.4	10.6	20.1	35.4	31.0	6.7	16.0	10.4	15.2	7.7	17.7	6.1	12.1	9.1	17.5	11.8	8.9	10.2	10.5	8.7	5.8	16.1	4.6	9.9	10.0	5.3	4.5	4.4	6.3	3.2	7.8	8.4	9.7	4.1	5.2	3.2	3.7	2.5	5.9	5.4	4.3	4.3	6.7	9.3	5.2	4.6	41.3	7.9	3.6	4.9	14.8	5.9	5.3	3.8	7.0	6.6	2.6	8.9	3.9	5.1	8.1	3.7	4.4	7.2	11.9	7.8	6.5	4.3	5.0	9.2	14.0	2.4	6.4	4.6	6.1	14.7	7.7	2.7	3.5	4.0	3.2	4.0	4.7	3.9	9.3	7.8	1.8	5.1	4.3	2.1	15.2	4.6	16.1	6.9	3.2	7.9	7.8	7.6	10.0	4.2	8.7	9.6	8.8	7.1	9.9	2.1	5.8	9.3	5.3	14.3	20.1	22.5	20.7	15.4	19.7	19.1	9.0	16.3	12.1
AURKA	"AIK, ARK1, AurA, BTAK, PPP1R47, STK15, STK6, STK7"	ENSG00000087586	"Aurora kinase A"	O14965	20	56369389-56392337	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 32.3;testis: 41.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"CAB001454, HPA002636"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"CAB001454: AB_563420, HPA002636: AB_1845217"	"unprognostic (7.73e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (9.40e-5)"	"unprognostic (1.92e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (4.69e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.47e-8)"	"unprognostic (1.67e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (5.14e-2)"	3.7	2.3	1.5	12.7	1.3	8.3	3.0	1.3	1.8	1.4	6.7	1.3	0.8	7.3	1.8	1.2	7.7	1.1	3.7	4.1	1.1	1.1	2.4	5.1	2.9	12.3	1.6	0.9	8.3	1.4	0.3	0.7	6.1	1.5	1.0	8.3	1.5	2.7	0.5	6.9	2.1	7.2	2.7	1.3	7.4	4.3	41.1	1.1	32.3	1.2	5.9	13.3	2.4	2.4	3.9	5.2	6.0	8.7	2.0	6.6	2.6	32.5	24.0	16.1	11.3	0.9	2.1	20.4	26.7	12.5	64.7	27.3	67.2	22.8	10.7	18.4	10.9	26.3	28.5	17.9	69.0	9.6	10.9	19.0	24.6	41.8	0.5	25.4	26.8	1.0	1.9	22.4	20.1	15.1	21.5	8.5	27.5	33.2	15.2	19.7	14.7	24.8	11.6	31.1	11.8	10.3	8.6	13.9	7.5	37.3	43.0	17.9	25.5	15.9	8.6	28.1	27.9	15.5	37.6	11.9	13.8	18.5	15.2	14.8	23.2	0.2	5.3	6.0	1.9	8.7	2.9	3.9	3.3	1.9	5.2	1.4	1.5	1.5	3.7	2.0	4.8	1.2	6.6	2.6	1.5	1.3	1.3	1.8	1.1	1.1	1.6	0.9	1.5	1.1
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
AUTS2	"FBRSL2, KIAA0442"	ENSG00000158321	"AUTS2, activator of transcription and developmental regulator"	Q8WXX7	7	69598296-70793495	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Autism, Autism spectrum disorder, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 27.5;REH: 26.9;SCLC-21H: 37.8;T-47d: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.6;naive B-cell: 11.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000390	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000390: AB_1845218"	"unprognostic (8.73e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.62e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (7.33e-2)"	10.3	7.3	29.3	11.6	30.3	9.3	20.3	14.3	19.1	10.5	14.0	17.3	4.1	8.9	10.5	12.4	13.7	8.0	16.6	5.6	22.2	12.9	14.6	19.7	14.7	6.1	14.8	12.3	17.2	6.0	9.9	17.4	5.7	18.9	14.6	13.1	9.9	52.1	8.3	14.9	23.3	18.8	13.6	10.2	8.2	11.3	10.0	20.6	10.5	6.7	7.9	8.9	13.0	10.8	11.6	3.2	0.8	0.2	1.5	2.2	0.7	0.1	2.4	27.5	1.4	1.8	1.1	0.3	1.7	0.0	0.1	0.1	9.3	0.1	4.0	0.6	1.6	8.9	3.3	3.7	0.7	18.3	7.4	2.0	2.6	0.1	0.8	0.0	0.1	2.9	5.1	4.1	1.0	0.0	0.1	2.2	2.3	1.5	0.4	0.7	19.6	0.0	26.9	13.4	11.4	0.0	4.1	37.8	20.6	1.7	3.0	0.0	25.9	0.0	0.0	0.1	9.3	2.9	16.9	0.0	0.0	13.9	0.0	0.0	0.0	0.8	0.2	0.2	1.6	0.1	2.2	8.6	1.1	1.5	0.7	11.6	0.2	0.9	0.5	1.5	0.1	3.2	0.2	0.7	29.3	30.3	14.3	19.1	22.2	12.9	14.8	12.3	18.9	20.6
AVIL	"ADVIL, DOC6, FLJ12386, p92"	ENSG00000135407	Advillin	O75366	12	57797376-57818704	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;RH-30: 12.6"	"Cancer enhanced"	"Detected in all"		"glioma: 9.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 9.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058864	Approved									"HPA058864: "	"unprognostic (3.86e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.79e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-4)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.71e-4)"	1.0	4.0	0.9	1.9	1.4	0.2	1.1	9.8	1.2	0.9	13.6	0.9	0.9	3.0	0.9	3.4	0.9	1.3	2.6	1.2	0.9	0.6	1.4	1.3	2.2	0.9	0.9	0.9	2.0	3.9	0.0	2.1	1.0	1.9	1.6	1.3	1.4	1.4	1.0	9.3	6.0	21.4	0.9	1.5	1.1	1.0	0.9	1.3	0.9	3.4	0.9	0.9	1.7	1.1	2.3	1.3	9.0	1.4	0.6	2.0	0.1	0.5	0.6	4.3	3.0	1.1	2.0	0.3	0.4	0.2	0.0	0.3	0.1	1.5	6.6	0.6	0.6	2.3	0.1	0.0	0.5	0.0	2.0	0.7	1.4	1.3	0.4	2.7	0.1	1.4	1.1	0.2	0.6	0.6	0.5	2.8	0.0	0.6	0.0	2.8	0.3	1.4	0.1	12.6	0.4	0.2	1.2	0.9	0.1	0.5	0.4	1.5	0.9	0.0	0.3	1.9	0.2	1.4	0.0	1.3	4.7	0.8	0.7	0.5	0.5	0.4	1.4	2.3	1.2	0.6	1.3	1.2	2.0	1.0	0.6	2.3	1.9	1.4	9.0	0.6	1.0	1.3	0.6	0.1	0.9	1.4	9.8	1.2	0.9	0.6	0.9	0.9	1.9	1.3
AVPR1A	AVPR1	ENSG00000166148	"Arginine vasopressin receptor 1A"	P37288	12	63142759-63150942	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 34.9;liver: 71.2"	"Group enriched"	"Detected in some"	12	"ASC diff: 6.8;Karpas-707: 15.1;U-266/84: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 7.1;hypothalamus: 4.4"	"Low region specificity"	"Detected in all"														"unprognostic (1.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.90e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.43e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.58e-6)"	"unprognostic (1.45e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.66e-4)"	26.4	34.9	0.3	2.8	0.3	0.0	6.3	0.2	0.4	9.7	4.2	0.5	1.1	0.2	16.5	2.1	2.5	3.7	3.4	2.5	0.3	0.3	4.2	71.2	0.7	1.5	0.3	0.0	3.8	1.5	1.1	1.0	1.2	0.6	3.2	0.5	0.5	1.1	2.4	4.4	1.3	0.8	7.5	0.3	0.5	1.5	1.8	0.0	0.6	6.1	3.0	0.4	6.2	2.6	0.0	0.0	0.9	0.0	0.0	0.0	1.2	0.2	0.2	0.7	0.0	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.2	0.3	0.3	0.2	0.4	0.3	0.3	0.3	0.0	0.6	0.0
AXIN1	PPP1R49	ENSG00000103126	"Axin 1"	O15169	16	287440-352673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012987	Approved		Supported	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"CAB012987: AB_2533178"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (3.38e-5)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-1)"	10.8	8.3	13.7	18.9	17.1	28.1	21.0	26.4	13.6	10.4	15.8	12.7	9.4	17.3	12.6	8.5	14.1	10.7	12.7	11.0	11.5	7.7	9.8	9.6	13.6	13.4	15.6	10.6	13.3	17.7	11.1	11.9	8.4	13.9	11.4	10.2	9.6	13.9	9.5	17.7	16.9	17.6	18.9	9.6	15.1	15.2	9.6	14.6	17.5	12.7	7.5	14.5	11.9	22.9	1.8	1.4	5.5	1.1	3.6	10.4	2.4	9.4	13.8	7.3	12.9	5.5	5.1	15.5	6.4	5.9	8.9	7.7	20.2	11.1	14.7	9.9	6.6	13.7	11.5	10.0	4.0	14.4	18.8	9.5	11.5	14.7	9.4	10.9	10.6	5.0	17.5	9.2	11.3	5.8	23.7	8.1	4.0	25.4	11.7	7.6	16.8	8.4	22.2	6.7	20.4	6.7	5.6	16.8	10.3	12.2	13.7	20.1	9.0	13.9	6.6	8.9	9.5	10.2	9.2	9.4	9.2	18.0	4.2	7.3	8.7	1.4	1.1	5.5	10.4	0.9	9.5	1.8	3.0	7.0	0.8	1.6	3.2	4.3	3.2	3.6	0.7	1.4	3.0	2.4	13.7	17.1	26.4	13.6	11.5	7.7	15.6	10.6	13.9	14.6
AXIN2	"DKFZp781B0869, MGC126582"	ENSG00000168646	"Axin 2"	Q9Y2T1	17	65528563-65561647	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.3;CACO-2: 24.7;Hep G2: 36.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 33.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012283, CAB017783"	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane"	Cytosol	"CAB012283: AB_2290204, CAB017783: "	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.48e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.84e-3)"	"prognostic favourable (6.58e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.25e-1)"	7.4	10.1	9.0	7.0	8.9	0.9	5.2	8.2	13.1	16.5	12.2	8.7	10.5	7.2	29.0	7.7	6.5	18.6	6.9	7.3	7.9	5.7	3.5	2.5	15.2	3.4	5.3	10.3	14.7	3.9	3.2	5.8	18.2	10.6	14.8	15.2	7.8	4.6	9.8	12.4	14.9	7.5	18.0	4.8	6.9	14.6	6.8	9.0	27.6	11.3	3.6	3.8	11.8	8.7	4.1	0.0	4.4	0.0	1.9	5.1	0.8	0.0	6.6	13.3	0.2	4.8	2.0	5.9	0.2	0.6	0.4	0.8	24.7	2.4	0.4	0.8	3.8	0.2	2.7	0.0	0.9	1.1	1.5	0.0	1.1	36.9	0.5	0.0	0.0	1.2	1.0	1.0	0.3	1.1	0.1	0.6	0.6	0.1	6.4	0.0	2.6	0.3	4.6	0.7	0.0	1.2	0.1	4.1	2.7	0.2	0.1	2.3	0.4	0.1	3.0	2.6	4.8	3.7	0.8	0.0	1.3	1.7	1.2	0.3	1.2	4.4	0.0	0.0	0.3	0.0	0.8	1.0	2.3	0.4	0.0	4.1	5.1	0.8	0.0	1.9	0.0	0.0	0.0	0.8	9.0	8.9	8.2	13.1	7.9	5.7	5.3	10.3	10.6	9.0
AXL	"ARK, JTK11, Tyro7, UFO"	ENSG00000167601	"AXL receptor tyrosine kinase"	P30530	19	41219203-41261766	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Oncogene, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 66.1;U-251 MG: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 8.8;plasmacytoid DC: 18.3"	"Group enriched"	"Detected in many"	14	"dendritic cells: 18.3;NK-cells: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032501, HPA037422, HPA037423, HPA075217"	Uncertain		Supported	"Vesicles,Plasma membrane,Actin filaments"			61000000	"Plasma membrane"	"Vesicles, Actin filaments"	"CAB032501: AB_2062572, HPA037422: AB_10672347, HPA037423: , HPA075217: "	"unprognostic (2.20e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.79e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.57e-3)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (1.16e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.83e-3)"	38.0	15.4	10.6	11.7	12.7	1.3	27.1	6.3	12.1	26.2	26.8	13.4	8.1	9.1	28.0	19.4	21.8	17.4	17.8	18.5	11.5	6.1	7.8	13.0	20.0	7.6	10.6	9.3	20.9	5.1	9.6	5.6	26.6	10.1	19.5	10.2	16.8	7.8	20.4	14.1	13.8	12.8	29.4	10.7	27.3	16.2	22.4	10.4	3.4	12.0	8.4	5.8	35.6	18.3	0.1	18.3	0.9	0.2	8.8	0.3	0.2	52.5	21.2	1.3	0.1	4.8	4.8	0.0	41.8	37.6	61.4	38.1	1.1	24.7	0.0	17.0	66.1	4.4	0.0	28.1	52.9	0.0	0.0	0.0	14.0	0.8	17.4	0.0	0.0	3.6	0.5	36.2	56.2	22.7	2.0	0.0	38.0	0.0	0.0	0.0	0.5	10.2	0.0	22.4	0.0	27.4	0.0	0.0	0.0	10.8	0.0	0.2	0.1	0.9	46.6	43.5	29.7	41.5	70.8	0.0	0.1	0.1	29.0	0.0	32.3	0.9	0.2	0.1	0.1	0.2	0.2	0.1	0.3	0.1	4.2	0.1	0.2	0.2	0.3	8.8	0.1	18.3	0.2	0.2	10.6	12.7	6.3	12.1	11.5	6.1	10.6	9.3	10.1	10.4
AZGP1	"ZA2G, ZAG"	ENSG00000160862	"Alpha-2-glycoprotein 1, zinc-binding"	P25311	7	99966720-99976157	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 158.8;salivary gland: 270.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 19.8;Karpas-707: 11.3;RPMI-8226: 45.9;SK-BR-3: 9.3;T-47d: 15.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 412.6;liver cancer: 273.6;prostate cancer: 469.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 0.9"					"HPA012582, CAB016087, CAB032276"	Enhanced				"Secreted to blood"	55210000000	160000000000			"CAB016087: AB_667849, CAB032276: AB_2062580, HPA012582: AB_1845226"	"unprognostic (8.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (5.42e-3)"	"unprognostic (4.98e-2)"	"unprognostic (5.74e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (1.53e-4)"	"unprognostic (2.18e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-3)"	6.4	0.0	1.1	1.3	1.7	0.0	64.1	1.1	1.4	1.1	1.4	1.5	0.9	1.4	0.9	1.2	1.3	0.0	2.2	9.0	1.2	0.4	18.0	158.8	3.0	0.9	2.7	1.2	1.0	55.3	0.0	0.9	1.0	1.3	62.4	0.0	1.6	270.5	2.5	1.0	11.5	1.5	0.9	1.1	0.9	14.4	1.2	1.7	0.9	1.0	3.0	3.2	1.0	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.4	5.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	1.9	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	11.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	45.9	0.0	0.0	0.0	0.7	0.3	9.3	4.5	15.4	0.0	0.0	0.1	0.0	0.7	0.3	0.7	0.3	0.1	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.1	1.4	1.2	0.4	2.7	1.2	1.3	1.7
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Cell line enriched"	"Detected in some"	7	"THP-1: 150.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"		290000	Vesicles		"HPA055851: , HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	150.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711477-44718877	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Immunity		"Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"		3200000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	127.2	50.9	24.2	109.2	29.8	131.1	85.2	11.8	23.1	70.5	111.4	29.1	43.3	79.1	72.7	74.7	80.5	36.8	112.8	73.6	26.0	23.1	109.7	140.3	191.2	172.1	42.2	18.8	54.8	42.7	7.8	40.5	91.9	33.1	78.7	128.9	53.5	121.5	40.9	45.7	94.1	178.5	55.1	56.7	272.8	52.5	30.0	29.5	108.0	97.7	71.5	131.6	135.9	73.5	138.9	74.9	341.3	132.8	128.8	215.8	323.7	33.1	14.7	1.4	8.3	54.6	73.6	52.1	22.0	44.9	35.8	60.9	19.1	77.4	15.8	31.1	21.4	29.3	5.5	9.8	17.2	110.7	13.0	60.2	89.2	22.1	41.6	33.7	36.1	37.2	9.1	11.0	11.8	24.4	15.3	2.2	39.6	17.7	13.8	89.0	2.4	31.4	16.8	36.0	100.3	31.2	137.5	5.8	2.1	23.0	18.7	25.9	6.2	175.3	48.5	70.3	7.8	92.6	42.9	41.0	93.8	29.5	68.5	111.3	33.6	221.2	90.4	210.9	126.8	132.8	125.9	138.9	171.7	141.1	58.9	109.4	137.0	167.5	341.3	128.8	106.5	74.9	215.8	323.7	24.2	29.8	11.8	23.1	26.0	23.1	42.2	18.8	33.1	29.5
B3GALNT1	"B3GALT3, beta3Gal-T3, galT3, GLOB, P1"	ENSG00000169255	"Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)"	O75752	3	161083883-161105384	"Blood group antigen proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Blood group antigen, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 36.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 16.9;RT4: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 4.9;NK-cell: 16.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 4.9;NK-cells: 16.7"	"Low region specificity"	"Detected in all"							HPA041204			Approved	Vesicles			290000	Vesicles		"HPA041204: AB_10795585"	"unprognostic (3.85e-2)"	"unprognostic (5.11e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.06e-2)"	"unprognostic (7.83e-2)"	"unprognostic (4.07e-2)"	"unprognostic (9.26e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.19e-3)"	3.8	5.4	14.0	3.0	24.5	3.1	7.4	17.2	24.7	15.5	2.3	5.5	2.6	1.5	8.3	6.9	5.4	10.4	7.1	36.8	15.4	21.6	14.3	1.0	10.8	3.5	11.3	16.2	13.8	7.8	6.5	8.5	10.0	17.7	8.9	2.0	7.5	14.8	6.7	1.1	2.2	1.9	7.2	7.6	4.2	7.5	6.2	5.0	1.1	19.5	2.3	3.9	10.5	4.7	1.4	1.4	4.9	0.2	16.7	0.7	0.5	6.6	0.2	3.1	0.1	0.3	1.0	0.1	3.7	3.2	8.1	2.8	4.4	5.0	0.0	14.8	3.0	1.5	0.0	6.4	2.6	0.1	0.0	3.6	2.8	0.0	4.7	0.1	0.1	9.9	1.9	2.2	0.5	11.8	0.0	0.0	3.3	10.7	0.0	0.0	7.4	16.9	0.1	0.0	0.1	3.8	51.5	6.2	0.0	9.3	3.4	2.7	14.2	5.4	0.0	0.1	6.5	0.2	0.1	1.5	0.0	0.0	5.7	0.0	0.0	4.9	0.2	0.0	0.4	0.1	0.4	1.4	0.2	0.4	1.4	0.3	0.5	0.7	0.4	16.7	0.0	1.0	0.0	0.5	14.0	24.5	17.2	24.7	15.4	21.6	11.3	16.2	17.7	5.0
B3GNT2	"B3GN-T1, B3GN-T2, B3GNT-2, B3GNT1, BETA3GNT"	ENSG00000170340	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2"	Q9NY97	2	62196113-62224731	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005997	Approved		Approved	Vesicles			43000000	Vesicles		"HPA005997: AB_1845234"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.25e-1)"	18.9	14.3	8.6	10.8	23.0	41.6	17.5	3.1	14.1	18.4	17.9	7.4	5.6	17.9	19.8	8.0	24.5	8.7	18.1	20.9	7.6	11.5	24.4	14.2	23.9	13.9	9.7	7.1	9.0	43.2	5.4	25.9	22.8	9.5	7.5	16.3	14.4	17.2	6.0	5.2	13.0	21.7	16.3	7.6	14.6	12.0	7.0	10.6	27.0	15.6	8.5	18.5	11.8	14.7	8.4	6.8	28.3	5.6	20.3	19.3	8.2	7.6	5.3	8.1	3.5	8.9	4.0	23.3	7.5	8.3	6.0	8.0	10.9	12.4	8.3	6.9	6.9	7.4	5.1	6.3	10.4	17.3	4.1	20.5	2.5	6.4	6.7	12.2	9.2	4.9	11.9	11.5	4.1	8.9	11.1	5.2	7.2	5.8	23.2	18.3	7.7	2.2	42.6	5.6	4.5	11.4	7.5	7.8	5.8	5.3	11.5	8.6	3.3	14.4	10.1	7.3	6.4	12.2	7.4	14.8	5.2	35.9	5.7	21.2	7.0	7.2	4.5	28.3	11.0	4.4	15.6	7.6	8.2	19.3	5.5	8.4	9.9	14.4	11.3	20.3	5.6	6.8	13.2	8.2	8.6	23.0	3.1	14.1	7.6	11.5	9.7	7.1	9.5	10.6
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.7;SiHa: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favourable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	15.9	11.8	2.2	3.0	11.2	19.8	39.9	16.6	20.9	10.0	10.0	7.2	18.6	6.1	10.6	24.2	8.6	2.2	20.6	10.1	55.7	2.2	3.5	49.2	5.5	22.1	2.8	5.9	22.1	36.9	11.4	14.0	10.6	3.9	7.6	9.5	13.9	2.5	5.7	1.3	3.6	3.4	2.0	4.0	30.1	13.9	1.6	2.1	105.0	20.5	4.1	25.9	5.2	9.8	7.2	8.5	23.1	6.4	1.2	2.8	3.8	22.3	3.9	2.6	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6
B4GAT1	"B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT"	ENSG00000174684	"Beta-1,4-glucuronyltransferase 1"	O43505	11	66345372-66347692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015484	Uncertain				"Intracellular and membrane"		48000000			"HPA015484: AB_1845235"	"unprognostic (1.80e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.43e-3)"	"prognostic favourable (3.55e-5)"	"unprognostic (2.20e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.76e-3)"	8.3	24.8	29.3	3.6	47.1	1.0	5.4	28.5	69.5	7.8	6.5	11.8	4.2	9.5	10.0	9.5	5.2	10.5	6.0	19.6	33.3	57.9	15.0	9.7	9.7	3.7	24.7	32.0	18.9	12.8	11.9	15.6	12.9	31.0	10.2	4.9	10.1	9.1	14.2	12.9	5.8	7.2	8.5	13.2	5.1	7.7	4.4	11.6	1.1	10.7	1.7	2.8	5.5	4.1	5.6	6.8	0.4	1.1	3.9	9.7	4.2	4.2	10.7	12.3	14.9	13.8	12.4	16.3	7.4	17.4	11.6	9.5	8.0	6.0	3.5	31.7	6.8	6.8	13.0	8.3	5.6	6.9	23.7	0.5	8.8	30.5	8.2	2.7	1.1	12.1	6.4	7.2	3.0	13.7	3.3	5.6	5.5	7.1	6.5	7.5	8.3	11.4	9.5	9.6	6.2	12.0	1.1	7.4	14.0	6.4	4.3	28.8	17.4	2.7	7.9	9.1	6.7	11.5	3.8	10.8	7.4	2.0	15.4	2.3	10.6	0.0	1.1	0.0	7.1	0.4	9.7	5.6	7.8	7.6	2.8	3.5	9.2	8.4	0.4	3.9	0.2	6.8	5.3	4.2	29.3	47.1	28.5	59.9	33.3	57.9	24.7	32.0	31.0	11.6
BACH1	"BACH-1, BTBD24"	ENSG00000156273	"BTB domain and CNC homolog 1"	O14867	21	29194071-29630751	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 46.7"	"Group enriched"	"Detected in all"	4	"granulocytes: 46.7;monocytes: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034949	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034949: "	"unprognostic (1.57e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.99e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.76e-2)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.19e-2)"	"unprognostic (8.70e-2)"	23.3	7.8	7.9	15.5	13.1	44.7	10.3	4.7	8.8	13.5	12.8	9.6	6.7	9.9	16.0	10.0	18.6	8.9	15.6	10.7	8.0	5.8	11.7	17.6	25.2	21.9	10.8	5.5	9.5	12.5	5.3	9.2	28.8	11.1	14.9	7.8	9.2	12.2	5.3	30.7	22.9	17.9	15.9	16.0	22.9	9.5	20.6	11.1	14.3	11.3	12.6	14.0	19.4	15.8	4.0	7.6	46.7	15.2	2.1	4.4	4.0	7.4	3.0	9.5	2.4	7.5	21.8	5.9	8.2	19.7	8.0	9.0	6.3	10.4	8.9	6.6	7.5	3.9	5.7	11.0	14.2	7.4	4.7	27.5	6.4	6.5	10.0	7.9	10.3	11.2	16.9	15.6	23.3	4.2	13.9	47.2	10.9	2.6	6.7	4.6	14.7	3.1	6.9	22.6	11.5	4.2	5.9	3.9	4.6	4.5	8.5	10.4	6.2	9.6	10.5	7.8	10.9	8.5	4.1	27.4	17.5	9.6	6.4	9.8	23.4	17.9	15.2	11.3	1.6	12.4	1.3	3.2	2.7	1.4	7.6	4.0	3.9	1.9	46.7	2.1	13.3	1.8	4.4	4.0	7.9	13.1	4.7	8.8	8.0	5.8	10.8	5.5	11.1	11.1
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926529-90296908	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 29.8"	"Group enriched"	"Detected in some"	6	"Daudi: 51.5;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"naive B-cell: 15.4"	"Lineage enriched"	"Detected in many"	4	"B-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA051384: , HPA058384: "	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	2.9	2.1	5.3	29.8	5.6	18.5	4.1	11.4	6.9	5.4	2.2	6.3	1.0	1.3	6.8	2.1	1.9	3.0	2.3	2.6	5.2	2.9	1.7	5.8	5.8	26.7	5.2	4.0	6.3	4.0	5.8	1.9	2.4	4.9	3.7	1.7	0.9	5.2	2.2	7.9	5.4	6.5	2.8	5.2	7.6	1.8	3.4	6.9	26.9	2.0	2.4	20.6	4.8	3.3	15.4	0.2	1.8	0.0	1.5	3.7	0.4	0.3	0.0	1.9	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	51.5	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	1.1	0.0	2.0	4.5	0.0	0.1	1.0	0.0	0.5	0.4	7.0	1.3	0.9	0.0	0.1	1.7	4.8	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.4	0.1	30.2	0.2	0.5	0.3	1.8	0.0	0.7	0.4	0.0	0.8	2.1	0.8	0.7	0.2	15.4	3.7	2.4	0.0	1.5	0.0	0.2	0.1	0.4	5.3	5.6	11.4	6.9	5.2	2.9	5.2	4.0	4.9	6.9
BAG2		ENSG00000112208	"BCL2 associated athanogene 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 67.0;urinary bladder: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavourable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (6.24e-3)"	3.4	3.5	3.7	8.7	2.8	1.2	4.6	4.1	3.4	18.4	24.5	0.8	14.8	1.9	29.4	9.5	13.4	5.9	6.9	17.2	3.3	3.5	3.7	3.8	4.1	2.3	3.3	2.3	15.4	1.5	0.6	4.5	6.7	3.4	23.7	4.3	2.6	1.5	15.1	9.9	1.7	5.7	67.0	3.4	1.3	7.4	6.7	2.6	1.6	7.6	6.0	1.9	51.0	17.1	5.9	1.4	0.9	0.4	3.3	6.1	1.9	9.3	5.2	2.2	7.8	5.5	15.9	6.2	15.2	14.5	11.0	10.5	6.7	4.8	3.1	14.6	24.0	1.7	12.6	1.3	10.6	9.9	9.3	9.1	7.8	15.1	8.5	8.0	2.1	7.7	0.7	9.0	8.5	8.5	18.4	4.5	10.8	0.7	5.6	6.7	8.4	5.4	5.2	6.2	6.3	13.1	1.5	2.8	2.5	6.8	0.5	5.5	1.2	7.0	11.6	6.3	10.3	13.2	15.0	3.0	2.9	6.9	5.6	3.2	0.6	0.1	0.3	0.9	3.3	0.4	3.9	5.9	3.1	3.3	1.4	4.3	6.1	5.1	0.3	3.3	0.1	0.5	3.2	1.9	3.7	2.8	4.1	3.4	3.3	3.5	3.3	2.3	3.4	2.6
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			890000	"Plasma membrane, Cytosol"		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.1	29.8	8.3	10.8	21.6	15.2	15.6	23.9	20.3	18.3	15.8	12.6	12.8	1.0	11.4	20.5	39.1	8.5	42.2	12.7	12.8	14.0	1.4	8.0	15.7	18.3	0.0	6.1	15.3	24.4	13.3	21.1	20.4	11.2	6.5	18.2	37.4	1.4	5.8	3.2	34.1	0.0	11.8	4.5	13.8	5.9	1.5	1.4	9.5	16.9	12.4	10.5	3.5	25.4	9.7	8.4	13.1	34.1	6.0	3.5	0.6	18.1	0.4	7.3	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6
BAIAP2	"BAP2, IRSp53"	ENSG00000175866	"BAI1 associated protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (7.58e-6)"	10.1	10.9	29.0	4.1	37.4	1.7	11.5	19.6	45.3	14.6	11.8	11.4	18.0	4.3	10.1	26.0	45.9	20.6	17.6	8.7	22.1	10.6	20.6	26.3	20.0	3.6	7.3	24.3	5.1	7.6	8.4	19.2	17.0	9.8	25.7	7.1	11.8	17.0	17.1	3.9	52.6	4.9	10.8	5.4	6.2	20.1	9.2	12.3	2.1	10.2	20.1	20.2	11.1	20.5	0.1	15.4	4.8	7.8	1.3	2.7	2.3	29.9	13.8	8.9	11.5	7.1	9.5	10.3	12.4	8.1	11.2	5.0	18.7	15.2	0.1	9.0	10.9	29.2	8.1	14.2	4.3	0.1	10.2	6.1	12.2	13.9	6.6	0.0	8.9	4.0	16.8	9.2	4.9	6.0	7.8	0.2	6.4	15.9	1.2	6.7	3.7	12.2	1.8	2.2	24.6	34.3	10.5	11.7	12.8	19.8	28.7	33.3	25.2	6.9	7.3	26.2	24.9	4.3	13.1	0.4	0.1	0.4	22.8	1.0	5.6	0.0	5.9	0.4	2.7	7.8	0.9	0.1	1.0	0.9	8.3	0.1	1.2	1.5	4.8	1.3	7.2	15.4	0.4	2.3	29.0	37.4	19.6	45.3	22.1	10.6	7.3	24.3	9.8	12.3
BAMBI	NMA	ENSG00000095739	"BMP and activin membrane bound inhibitor"	Q13145	10	28677342-28682939	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 46.8;seminal vesicle: 52.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 42.8;SK-MEL-30: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA010819, HPA010866"	Approved		Approved	"Nucleoli fibrillar center,Vesicles,Lipid droplets"				Vesicles	"Nucleoli fibrillar center, Lipid droplets"	"HPA010819: , HPA010866: AB_10601686"	"unprognostic (7.02e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (9.42e-6)"	"unprognostic (1.09e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-3)"	"unprognostic (9.29e-2)"	"prognostic favourable (5.25e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.10e-2)"	2.0	24.7	6.7	1.8	6.9	3.0	13.6	2.2	6.3	3.9	2.3	12.9	15.5	1.1	10.1	2.0	1.1	2.8	3.0	22.8	6.7	6.4	11.2	12.9	5.7	3.1	12.0	2.9	46.8	3.9	7.4	4.5	20.9	10.5	6.5	2.8	30.4	3.8	52.4	1.2	2.7	1.1	12.7	10.8	9.0	2.3	4.8	7.9	0.1	0.6	2.1	1.3	13.8	11.6	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.2	10.8	1.1	0.6	1.3	0.0	6.5	2.6	0.9	4.2	2.7	42.8	4.5	0.1	1.6	1.9	3.2	2.6	0.4	1.9	2.6	6.0	10.1	1.6	16.2	1.5	0.6	13.4	1.0	0.6	2.8	0.4	0.6	5.7	4.9	0.8	17.8	0.0	0.7	19.6	2.7	0.1	2.0	0.9	3.4	10.4	1.8	1.4	3.5	20.8	51.1	6.1	0.7	0.0	2.8	2.1	4.5	1.3	0.1	3.7	0.0	0.2	2.3	17.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.7	6.9	2.2	4.8	6.7	6.4	12.0	2.9	10.5	7.9
BANF1	BAF	ENSG00000175334	"Barrier to autointegration factor 1"	O75531	11	66002079-66004149	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB032896, HPA039242"	Enhanced		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB032896: AB_2061090, HPA039242: "	"unprognostic (1.69e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.04e-1)"	"unprognostic (9.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.16e-3)"	"unprognostic (8.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.76e-2)"	"unprognostic (4.57e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	31.2	39.7	38.2	31.6	33.9	24.0	33.5	30.8	38.1	40.7	32.4	33.2	26.5	25.0	38.8	44.4	43.8	58.4	33.4	51.0	35.4	32.5	38.6	61.0	24.6	35.7	33.8	24.7	60.0	40.8	33.5	27.3	40.1	27.5	52.6	33.1	31.1	38.0	38.8	112.7	25.5	29.9	38.9	35.8	39.7	26.8	44.2	27.8	57.6	71.5	54.5	43.8	36.4	45.8	40.0	44.6	14.7	42.8	32.5	30.4	43.8	62.7	63.5	42.8	41.5	21.9	29.1	21.6	34.9	32.6	65.2	41.3	36.8	50.6	54.4	64.5	46.1	44.2	56.2	58.2	47.9	42.7	33.6	63.2	40.2	45.7	26.8	45.7	48.8	27.0	37.5	41.6	36.7	47.5	50.3	43.7	62.9	101.7	51.2	89.9	48.4	44.5	48.1	42.4	123.3	58.6	31.9	34.6	44.6	37.8	62.6	43.3	69.7	35.3	32.9	50.0	55.5	56.5	48.7	32.1	57.9	68.1	43.9	39.1	45.4	14.7	41.6	13.9	29.2	41.7	27.6	40.0	24.5	28.3	44.6	37.8	28.3	30.4	4.4	32.5	42.8	40.0	20.6	43.8	38.2	33.9	30.8	38.1	35.4	32.5	33.8	24.7	27.5	27.8
BARD1		ENSG00000138376	"BRCA1 associated RING domain 1"	Q99728	2	214725646-214809711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB034106, HPA035354, HPA044864"	Enhanced		Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"CAB034106: AB_2061237, HPA035354: , HPA044864: "	"unprognostic (4.85e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.80e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.94e-8)"	"unprognostic (3.94e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	4.4	1.9	3.2	11.8	4.8	16.1	4.9	1.2	5.8	7.3	5.4	5.4	3.6	3.7	6.8	5.0	10.0	4.1	3.9	3.6	3.4	2.8	2.2	2.1	5.3	8.2	5.1	1.9	5.8	3.7	3.6	6.3	3.8	4.5	5.7	6.1	1.9	4.7	6.5	12.4	16.3	4.5	7.5	5.3	4.7	3.8	9.5	3.9	25.8	4.0	8.0	9.9	8.3	7.8	9.7	6.6	6.0	3.4	6.1	16.0	2.0	7.7	4.3	11.7	6.0	1.6	2.0	8.0	9.4	5.5	9.3	10.7	5.4	7.7	8.3	4.5	3.9	8.5	8.4	5.5	13.3	6.6	4.4	8.3	7.9	5.7	0.6	9.2	8.4	2.7	0.8	8.2	4.5	3.1	4.6	23.5	8.9	6.4	16.5	9.6	9.2	2.2	14.3	11.8	7.5	2.7	6.5	3.7	5.9	8.6	9.9	3.4	10.2	9.2	2.7	12.0	8.4	7.0	8.5	7.1	7.9	16.9	4.8	7.0	8.0	2.9	1.7	6.0	4.8	3.4	3.1	8.9	5.3	5.2	3.0	9.7	2.5	3.6	0.5	6.1	2.9	6.6	16.0	2.0	3.2	4.8	1.2	5.8	3.4	2.8	5.1	1.9	4.5	3.9
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.3;epididymis: 126.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 113.7;SiHa: 109.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 42.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 42.4"	"Low region specificity"	"Detected in many"							"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"			85000000	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: "	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	9.2	6.7	64.3	28.4	37.4	31.1	4.8	37.2	107.3	16.2	5.2	4.0	15.1	3.8	15.5	126.9	4.0	3.6	12.7	4.4	65.0	55.8	4.2	7.7	9.1	30.2	30.1	56.6	11.7	2.5	3.6	6.4	36.4	21.9	32.2	5.5	7.9	3.8	11.5	1.6	6.0	5.7	14.2	11.0	21.9	9.2	2.2	4.3	3.7	3.6	1.3	35.4	17.6	13.0	2.5	1.6	42.4	1.1	0.6	0.1	0.2	0.0	17.0	21.2	0.0	10.2	10.9	30.4	21.2	7.0	17.9	19.0	0.8	0.0	6.6	3.0	15.2	1.4	13.5	14.8	23.3	2.7	7.6	0.0	113.7	0.0	22.7	13.1	0.1	18.7	18.5	20.2	17.0	19.3	0.0	0.0	19.0	24.4	0.0	12.0	15.6	5.2	0.0	0.0	3.6	6.4	4.2	13.6	2.8	109.2	10.0	0.0	0.0	13.6	24.6	23.7	0.0	1.9	3.4	0.2	0.0	3.5	23.9	16.3	3.1	6.2	1.1	7.8	0.0	0.4	0.0	1.8	0.0	0.0	1.6	2.5	0.0	0.0	42.4	0.6	0.6	0.1	0.1	0.2	64.3	37.4	37.2	107.3	65.0	55.8	30.1	56.6	21.9	4.3
BAZ1B	"WBSCR10, WBSCR9, WSTF"	ENSG00000009954	"Bromodomain adjacent to zinc finger domain 1B"	Q9UIG0	7	73440398-73522278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037081, CAB037158, HPA067010"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB037081: AB_477637, CAB037158: AB_477636, HPA067010: "	"unprognostic (1.17e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.12e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	23.3	22.3	21.4	26.4	23.9	20.7	24.6	32.4	23.4	24.6	24.2	21.1	34.1	15.3	26.3	19.8	18.1	20.6	16.5	19.8	22.4	21.4	17.1	23.4	19.4	24.7	29.3	19.4	31.8	20.2	34.9	27.0	23.1	22.3	23.1	20.5	16.4	18.0	30.8	28.9	14.6	19.2	28.7	22.9	22.2	18.8	16.2	27.3	46.5	23.5	17.9	27.7	24.7	24.4	5.3	6.2	6.1	3.1	5.6	6.3	1.7	20.6	21.3	29.4	32.8	15.2	16.3	9.8	20.1	15.5	19.4	20.5	17.3	15.7	39.1	4.7	17.9	14.6	35.7	13.4	29.3	22.0	18.1	23.3	25.3	14.9	17.0	35.1	19.7	11.6	13.1	23.9	29.5	15.4	40.5	24.6	21.7	19.6	35.9	16.2	19.0	16.0	36.6	25.8	26.0	11.0	16.3	29.5	25.2	28.7	32.1	16.8	19.7	17.6	18.0	33.7	19.4	20.2	34.2	14.3	22.7	67.1	19.1	33.3	30.5	6.1	3.1	1.9	6.3	2.2	5.5	2.5	4.8	4.6	2.1	5.3	3.8	4.1	2.2	5.6	1.7	6.2	4.7	1.7	21.4	23.9	32.4	23.4	22.4	21.4	29.3	19.4	22.3	27.3
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: "	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	25.5	22.8	18.2	25.5	22.4	45.5	25.5	39.0	26.0	25.6	23.2	24.6	23.2	20.1	25.2	21.8	28.0	21.5	24.1	19.1	18.7	11.6	19.9	19.7	31.5	25.0	23.1	13.5	32.6	26.2	33.8	36.1	29.0	19.4	21.9	22.1	27.6	24.0	34.5	24.7	26.0	27.6	19.4	19.2	32.9	20.9	34.1	24.4	46.1	26.4	19.6	30.3	27.3	30.5	5.1	8.6	20.1	9.0	12.6	3.6	1.7	20.4	20.8	27.0	22.5	15.7	16.0	27.2	14.2	19.6	20.2	14.9	24.5	24.8	30.3	21.1	16.6	17.7	31.9	18.8	18.7	19.4	17.1	34.3	12.8	12.4	17.4	19.7	25.9	14.1	19.5	17.5	25.5	20.2	36.4	36.7	11.6	13.1	16.3	13.2	24.6	15.9	13.9	20.0	20.6	14.6	20.2	18.3	15.1	23.8	25.0	13.1	27.6	18.1	27.8	10.2	20.4	13.3	10.0	20.5	19.2	28.1	9.8	14.3	15.3	6.5	5.1	3.7	3.6	4.5	3.0	4.3	2.8	2.7	1.8	5.1	2.4	2.1	20.1	12.6	9.0	8.6	2.5	1.7	18.2	22.4	39.0	26.0	18.7	11.6	23.1	13.5	19.4	24.4
BBC3	"JFY1, PUMA"	ENSG00000105327	"BCL2 binding component 3"	"Q96PG8, Q9BXH1"	19	47220822-47232766	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.6;NB-4: 21.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.1;neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.4"									"CAB007752, HPA070403"	Approved		Approved	Cytosol				Cytosol		"CAB007752: AB_562336, HPA070403: "	"unprognostic (4.39e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (1.31e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.38e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.57e-1)"	"prognostic favourable (2.62e-5)"	6.8	5.4	4.0	4.7	2.9	9.4	6.5	14.0	7.2	6.3	8.9	1.4	2.3	5.9	5.4	3.7	8.2	5.0	8.0	5.8	4.9	3.9	4.6	5.9	19.0	11.8	3.6	4.3	5.2	11.8	1.6	2.5	5.6	3.4	9.8	4.9	4.5	9.2	4.2	28.6	9.4	6.6	5.7	2.8	7.4	7.9	3.2	3.0	13.3	6.2	1.7	3.2	8.2	3.0	0.2	0.4	6.4	1.0	1.0	1.1	0.3	2.3	5.2	5.7	1.2	1.4	2.7	14.1	3.7	5.1	0.9	2.3	1.5	3.9	9.1	1.6	0.9	0.7	0.8	3.3	0.1	5.8	10.1	2.6	1.8	10.0	18.6	0.4	8.6	6.4	5.4	1.9	1.8	6.5	6.6	5.7	0.6	5.2	0.9	21.3	3.6	0.7	2.5	0.8	10.5	0.2	0.8	0.9	8.7	1.7	3.6	11.2	1.2	7.2	4.3	1.1	7.2	0.1	1.2	9.4	2.0	5.7	1.7	1.3	3.9	6.1	0.9	0.5	0.9	1.0	0.8	0.2	0.2	0.6	0.4	0.0	1.1	0.7	6.4	1.0	0.8	0.1	0.5	0.3	4.0	2.9	14.0	5.7	4.9	3.9	3.6	4.3	3.4	3.0
BBS7	"BBS2L1, FLJ10715"	ENSG00000138686	"Bardet-Biedl syndrome 7"	Q8IWZ6	4	121824440-121870497	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Sensory transduction, Transport, Vision"		"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044592	Approved									"HPA044592: AB_10795882"	"unprognostic (6.36e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.15e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.33e-1)"	9.2	9.6	10.4	7.2	15.7	2.8	10.7	19.6	27.4	11.6	8.6	7.0	5.7	7.2	15.1	7.5	9.2	11.8	8.6	6.9	11.9	13.8	9.9	3.6	7.7	6.5	10.7	14.5	18.5	5.3	16.6	21.9	6.8	22.3	10.3	9.3	8.4	6.9	10.2	5.0	9.6	7.3	14.8	9.4	6.3	6.8	12.2	9.0	7.0	8.1	6.9	6.7	8.4	10.3	2.8	3.3	4.2	3.0	4.7	5.6	2.8	9.6	4.7	10.9	8.0	14.2	20.7	4.0	13.2	10.6	11.5	10.6	3.7	5.4	10.7	3.7	15.5	5.1	11.2	10.7	13.2	10.0	9.0	6.3	7.5	4.4	12.6	8.8	5.9	10.6	7.9	13.1	9.8	12.2	4.2	10.8	16.1	3.0	14.7	4.3	5.8	6.0	6.8	14.0	3.2	11.5	3.5	12.1	5.2	12.6	5.6	9.7	4.7	3.4	12.1	8.7	9.4	11.9	8.4	10.2	7.0	9.4	10.0	7.1	8.3	1.7	2.8	4.2	5.6	2.9	4.4	2.7	4.3	5.1	3.2	2.8	3.7	4.7	0.7	4.7	3.0	3.3	4.1	2.8	10.4	15.7	19.6	27.4	11.9	13.8	10.7	14.5	22.3	9.0
BCAM	"CD239, LU"	ENSG00000187244	"Basal cell adhesion molecule (Lutheran blood group)"	P50895	19	44809059-44821421	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Blood group antigen, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 101.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 30.8;HaCaT: 62.8;SK-BR-3: 58.9;T-47d: 33.4;U-2 OS: 28.9"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 493.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005654	Uncertain		Approved	"Nucleoli fibrillar center"			16000000	"Nucleoli fibrillar center"		"HPA005654: "	"unprognostic (5.63e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.31e-4)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.41e-1)"	"prognostic favourable (5.94e-6)"	"unprognostic (1.83e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.97e-3)"	28.9	7.2	4.9	8.1	5.4	1.4	33.1	3.4	8.7	33.5	8.5	4.4	17.8	5.7	24.8	26.5	15.6	46.3	23.2	23.8	4.5	4.2	101.8	13.2	41.6	5.8	4.4	6.5	30.4	17.8	5.8	9.8	28.7	7.0	42.7	2.4	21.4	17.8	27.3	16.7	12.7	7.4	12.5	3.8	14.2	9.6	13.6	2.6	5.7	93.0	23.7	8.5	14.2	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	9.2	0.2	25.6	0.1	0.1	30.8	2.8	1.3	2.3	1.5	13.8	17.6	0.0	14.2	0.3	62.8	2.2	15.7	0.7	0.0	1.6	0.0	1.9	19.1	5.2	0.0	3.4	2.5	6.1	0.8	0.9	1.4	1.4	0.1	0.3	3.6	0.0	0.2	2.9	3.2	0.1	3.0	0.7	19.2	4.5	0.0	0.1	11.4	58.9	0.6	33.4	1.0	3.7	0.6	28.9	0.7	1.3	0.1	0.2	0.0	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.9	5.4	3.4	8.7	4.5	4.2	4.4	6.5	7.0	2.6
BCAN	"BEHAB, CSPG7, MGC13038"	ENSG00000132692	Brevican	Q96GW7	1	156641390-156659532	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"brain: 144.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 24.2;K-562: 34.1;U-266/70: 20.5;U-266/84: 39.4"	"Group enriched"	"Detected in many"	77	"glioma: 348.5;melanoma: 75.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 8.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007865, CAB025862"	Enhanced	Supported			"Secreted in brain"		98000			"CAB025862: , HPA007865: AB_1078299"	"unprognostic (7.14e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.54e-2)"	"unprognostic (5.40e-1)"	"unprognostic (1.90e-1)"	1.4	5.8	51.8	1.6	35.9	1.3	1.4	10.4	144.2	2.3	2.4	30.5	1.3	4.6	2.7	9.5	1.6	2.4	3.1	1.5	40.8	22.9	1.4	1.3	1.5	1.5	26.6	21.5	1.4	1.3	1.3	0.7	1.7	15.1	1.4	1.3	4.3	2.0	2.4	1.6	9.0	5.0	2.4	13.0	1.6	2.4	2.0	26.7	0.0	1.4	0.0	1.3	2.3	0.3	0.6	0.0	8.2	0.4	0.0	0.0	0.0	13.7	9.5	0.0	2.6	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.3	6.8	0.0	14.7	0.0	9.7	0.1	0.0	0.0	24.2	0.8	2.4	6.3	7.8	0.0	0.9	2.4	0.0	0.0	0.0	0.0	0.0	34.1	6.7	0.0	4.0	0.0	0.0	0.7	1.4	0.0	15.8	0.0	0.0	1.7	0.0	0.2	0.0	0.0	14.3	0.0	0.9	2.9	0.0	7.8	2.8	3.7	20.5	39.4	0.0	2.9	6.4	1.1	8.2	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	35.9	10.4	33.3	40.8	22.9	26.6	21.5	15.1	26.7
BCAR1	"CAS, CASS1, Crkas, P130Cas"	ENSG00000050820	"BCAR1, Cas family scaffolding protein"	P56945	16	75228187-75268053	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000443, HPA042282"	Approved	Approved	Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB000443: , HPA042282: "	"unprognostic (5.44e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.43e-3)"	"prognostic unfavourable (9.11e-5)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.38e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.20e-1)"	16.6	12.3	14.3	8.4	19.5	1.8	11.5	29.1	26.7	16.7	22.7	31.5	9.1	28.6	17.5	11.0	9.6	10.8	20.4	17.8	14.2	9.4	21.3	17.3	15.9	4.9	18.9	13.5	11.3	31.0	9.2	13.2	28.1	13.9	10.9	7.9	14.6	25.7	12.5	37.4	7.2	25.7	8.6	10.4	28.9	28.7	17.3	20.1	0.2	11.8	9.7	6.3	13.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	16.2	7.9	2.6	3.0	2.8	15.2	12.8	7.4	9.4	7.4	20.7	13.9	0.8	17.0	14.2	7.9	2.6	14.6	2.7	0.0	9.1	0.0	9.8	17.2	7.7	0.0	6.6	8.6	7.3	11.1	5.5	25.4	8.2	0.4	5.5	22.0	0.0	0.5	10.4	10.8	0.3	3.5	3.3	8.6	12.0	9.7	13.9	12.2	2.8	4.9	6.6	2.2	22.8	15.8	13.7	3.9	18.8	3.5	1.9	0.2	9.9	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	19.5	29.1	26.7	14.2	9.4	18.9	13.5	13.9	20.1
BCAS3	FLJ20128	ENSG00000141376	"BCAS3, microtubule associated cell migration factor"	Q9H6U6	17	60677453-61392838	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Transcription, Transcription regulation"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052409, HPA057289"	Approved		Approved	Nucleoli				Nucleoli		"HPA052409: , HPA057289: "	"unprognostic (2.84e-2)"	"prognostic favourable (2.04e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-1)"	"unprognostic (5.52e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.47e-1)"	"prognostic favourable (1.23e-5)"	"unprognostic (2.55e-1)"	"prognostic favourable (1.73e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	12.1	15.9	13.9	8.3	24.1	8.8	11.6	21.5	30.8	12.9	11.4	32.2	12.6	7.1	20.6	18.6	14.3	21.1	11.3	11.7	15.8	14.3	17.1	18.3	13.6	8.5	19.2	18.6	11.9	13.5	26.5	16.9	14.7	24.3	17.1	9.3	16.1	13.6	14.3	20.3	17.0	8.4	13.6	16.3	10.8	11.7	20.2	20.0	16.6	13.7	7.6	13.9	17.0	11.9	9.1	6.9	26.8	8.0	11.7	12.9	6.4	3.3	8.1	4.2	14.0	8.6	7.3	4.9	3.5	4.8	3.6	4.6	5.5	7.4	1.3	6.0	5.8	2.6	2.4	2.9	4.7	3.0	9.4	3.2	4.6	4.9	4.8	1.6	2.7	8.6	3.4	3.0	5.5	4.2	2.7	6.6	3.2	43.2	4.6	1.2	4.4	9.3	5.7	5.7	6.0	3.0	12.6	6.2	5.3	7.1	2.1	5.0	7.7	2.4	3.9	4.8	4.1	2.0	1.6	15.4	12.7	5.6	5.7	1.2	3.7	15.8	7.8	11.7	12.1	6.7	9.8	9.1	8.4	9.2	6.9	8.4	9.3	7.5	26.8	11.7	8.0	4.9	12.9	6.4	13.9	24.1	21.5	30.8	15.8	14.3	19.2	18.6	24.3	20.0
BCHE	"CHE1, CHE2, E1"	ENSG00000114200	Butyrylcholinesterase	P06276	3	165772904-165837472	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Serine esterase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 145.4"	"Cell line enriched"	"Detected in some"	9	"Karpas-707: 128.6"	"Group enriched"	"Detected in many"	6	"glioma: 24.0;liver cancer: 13.7;melanoma: 18.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA001560	Approved				"Secreted to blood"		13000000000			"HPA001560: AB_1078271"	"unprognostic (4.74e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.21e-4)"	"unprognostic (8.19e-8)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.04e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.59e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.46e-5)"	"unprognostic (2.17e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.26e-4)"	14.0	3.9	6.7	6.2	4.3	0.4	1.9	3.6	9.1	24.4	15.5	4.7	8.3	1.8	20.2	13.4	20.0	18.0	2.2	7.8	6.1	4.4	2.8	145.4	3.7	0.7	5.5	2.7	10.3	1.1	0.4	1.2	0.5	4.7	4.7	5.3	0.7	1.0	10.5	1.1	2.8	6.4	13.9	3.4	3.7	1.9	1.8	6.1	1.0	0.8	0.4	0.5	9.7	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	5.3	0.0	0.0	0.9	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	4.1	0.2	0.0	1.3	0.6	0.0	128.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	4.7	10.7	0.1	0.0	0.0	0.1	0.0	0.0	7.4	5.7	0.0	0.0	3.2	0.0	0.0	1.3	0.5	0.0	0.2	1.3	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	4.3	3.6	4.3	6.1	4.4	5.5	2.7	4.7	6.1
BCKDHA	"MSU, OVD1A"	ENSG00000248098	"Branched chain keto acid dehydrogenase E1, alpha polypeptide"	P12694	19	41397460-41425005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA036640	Supported									"HPA036640: AB_10671964"	"unprognostic (4.50e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (9.37e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (5.33e-10)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.27e-5)"	"unprognostic (9.66e-2)"	18.4	36.1	11.5	9.2	14.9	11.4	12.9	9.3	19.3	12.5	11.2	16.6	25.0	11.2	11.0	11.2	31.0	15.0	12.4	41.1	10.8	9.5	23.4	47.6	12.3	17.0	16.0	17.6	13.8	28.2	15.7	12.6	13.4	12.7	12.6	8.8	15.0	23.1	31.1	61.7	15.6	10.4	10.8	11.2	13.2	22.0	21.2	13.5	15.8	21.8	25.3	15.9	14.0	15.1	16.5	45.9	17.6	38.0	25.9	19.7	27.1	14.2	26.2	2.3	14.0	6.6	4.0	6.0	3.5	6.7	6.9	8.8	6.0	9.9	11.5	7.9	3.7	5.7	4.4	7.1	3.6	12.0	12.6	8.0	13.7	5.6	14.1	8.4	5.9	7.3	10.2	4.6	10.2	13.3	8.0	21.8	6.2	12.9	7.2	5.1	3.9	6.5	8.7	7.8	27.4	9.7	6.7	10.2	12.2	12.4	28.2	8.6	14.5	22.6	10.0	7.4	7.6	4.3	7.5	48.8	19.7	11.3	26.8	15.7	8.6	13.5	36.9	17.6	15.8	38.0	18.2	16.5	15.9	16.1	45.9	16.4	13.4	15.3	10.9	25.9	26.1	17.6	19.7	27.1	11.5	14.9	9.3	19.3	10.8	9.5	16.0	17.6	12.7	13.5
BCL11A	"BCL11A-L, BCL11A-S, BCL11A-XL, CTIP1, EVI9, HBFQTL5, ZNF856"	ENSG00000119866	"B cell CLL/lymphoma 11A"	Q9H165	2	60450520-60555154	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 107.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.3;MOLT-4: 18.7;REH: 19.1;U-698: 41.8;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 39.6;naive B-cell: 53.7;plasmacytoid DC: 107.1"	"Group enriched"	"Detected in many"	16	"B-cells: 53.7;dendritic cells: 107.1"	"Group enriched"	"Detected in all"	5	"amygdala: 42.3;basal ganglia: 57.1;cerebral cortex: 62.7;hippocampal formation: 65.3;olfactory region: 101.8"	"Group enriched"	"Detected in all"	4	"basal ganglia: 58.3;cerebral cortex: 93.2;hippocampal formation: 97.2;olfactory region: 128.9"	"CAB014891, HPA029003"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB014891: , HPA029003: "	"unprognostic (4.10e-3)"	"unprognostic (6.72e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.41e-3)"	"unprognostic (2.37e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.27e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.99e-2)"	1.5	2.4	6.6	13.9	14.6	17.0	5.5	1.8	34.5	3.9	8.6	0.2	0.1	7.6	1.8	1.4	13.6	4.8	2.2	4.7	14.5	3.4	1.7	1.5	3.0	21.2	3.5	14.4	1.6	11.3	1.2	3.9	0.9	9.6	4.8	5.1	0.0	11.4	2.0	1.4	24.9	11.4	2.9	2.0	13.5	3.3	2.0	2.6	20.9	2.4	4.0	30.4	3.6	7.8	53.7	107.1	1.3	5.1	1.0	0.1	1.2	0.2	0.0	1.7	0.0	0.3	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	20.3	0.1	0.0	4.1	6.3	3.0	0.0	0.3	6.0	0.0	0.2	0.1	0.0	7.3	0.0	0.7	1.6	0.0	1.0	1.0	0.3	0.1	0.0	0.0	18.7	7.4	11.5	0.1	19.1	0.5	7.7	0.0	0.3	8.2	2.0	0.1	0.1	0.1	0.1	3.5	0.5	0.1	4.8	0.1	0.0	0.3	0.0	41.8	0.0	13.4	0.6	0.4	2.9	0.5	0.0	5.1	0.1	39.6	0.0	0.0	10.7	53.7	0.1	0.1	1.3	1.0	3.7	107.1	0.1	1.2	6.6	14.6	1.8	34.5	14.5	3.4	3.5	14.4	9.6	2.6
BCL11B	"CTIP-2, CTIP2, hRIT1-alpha, ZNF856B"	ENSG00000127152	"B cell CLL/lymphoma 11B"	Q9C0K0	14	99169287-99271524	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Mental retardation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.7;lymphoid tissue: 25.4;skin 1: 17.6"	"Cell line enriched"	"Detected in some"	6	"MOLT-4: 32.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 13.7"	"Group enriched"	"Detected in many"	8	"gdT-cell: 3.3;MAIT T-cell: 3.0;memory CD4 T-cell: 4.5;memory CD8 T-cell: 3.7;naive CD4 T-cell: 7.4;naive CD8 T-cell: 4.9;T-reg: 3.0"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049117	Enhanced	Supported	Approved	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"HPA049117: AB_2680639"	"unprognostic (1.64e-5)"	"unprognostic (4.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.87e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.75e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.60e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.31e-3)"	"prognostic favourable (7.48e-4)"	0.3	0.4	4.4	6.6	13.7	5.2	1.3	0.3	3.8	0.8	1.3	0.1	0.0	2.3	1.9	0.8	3.9	0.3	3.0	0.8	4.8	1.0	0.3	0.5	1.1	10.8	0.8	2.6	0.2	0.1	0.0	0.1	0.0	0.6	0.6	1.7	0.3	5.0	0.7	0.1	17.6	3.0	0.2	0.7	4.9	2.1	0.4	1.6	25.4	0.9	1.5	8.8	2.0	2.3	0.0	0.0	0.1	0.0	0.5	7.4	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.2	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.1	0.0	0.0	3.0	0.0	1.8	32.6	0.5	0.3	0.0	5.1	0.0	0.0	0.0	1.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	2.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.1	3.3	0.0	3.0	0.0	4.5	3.7	0.0	0.0	7.4	4.9	0.0	0.5	0.0	0.0	3.0	1.1	4.4	13.7	0.3	3.8	4.8	1.0	0.8	2.6	0.6	1.6
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2, apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 22.3;U-266/70: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.3;MAIT T-cell: 7.6;memory B-cell: 5.2;memory CD4 T-cell: 6.3;memory CD8 T-cell: 3.8;naive B-cell: 4.1;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.5;T-reg: 6.7"	"Group enriched"	"Detected in many"	8	"B-cells: 5.2;T-cells: 7.6"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: "	"unprognostic (1.11e-3)"	"prognostic favourable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favourable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.47e-4)"	"unprognostic (2.63e-1)"	12.9	3.0	10.1	15.7	9.4	5.3	24.6	4.7	8.4	14.8	7.8	7.4	9.1	5.0	17.1	9.3	4.7	12.2	9.2	6.5	10.0	8.1	8.5	2.3	5.0	14.6	10.8	5.6	18.2	2.9	19.6	7.0	22.4	9.2	8.4	5.9	10.8	5.4	15.7	20.0	6.3	10.5	8.6	9.3	17.8	5.4	3.5	10.5	21.0	35.6	2.9	13.4	7.9	16.4	5.2	0.3	0.7	0.2	0.7	7.6	1.9	0.4	0.1	2.3	1.8	2.7	0.4	0.8	0.2	0.2	0.7	0.5	1.1	0.1	0.0	0.4	0.2	0.1	2.0	0.3	0.4	13.3	0.4	0.0	0.6	0.2	0.5	12.1	1.8	0.5	0.2	0.9	1.9	0.2	0.2	22.3	0.4	0.4	2.5	5.2	0.5	0.4	11.4	0.5	8.6	3.8	1.8	1.9	1.8	0.0	0.0	2.7	0.1	10.2	0.1	3.0	1.0	0.3	1.5	77.6	10.2	0.8	0.5	8.6	1.7	0.7	0.0	0.0	2.3	0.0	7.6	5.2	6.3	3.8	0.1	4.1	5.1	4.5	0.1	0.7	0.2	0.3	6.7	1.9	10.1	9.4	4.7	8.4	10.0	8.1	10.8	5.6	9.2	10.5
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria				Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: "	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	15.3	17.4	13.3	7.6	14.2	10.9	17.3	13.0	17.4	9.2	11.9	14.8	8.8	8.3	10.5	10.7	14.5	11.7	10.0	18.9	12.7	12.2	18.9	20.9	10.6	9.3	14.4	13.4	10.4	22.0	25.8	12.3	14.1	12.2	11.1	14.1	15.2	12.4	9.5	61.2	15.5	12.4	11.7	13.0	8.3	11.2	22.9	11.5	12.1	13.5	14.5	12.3	14.6	10.2	6.5	11.3	4.7	17.3	10.4	8.3	9.5	14.0	6.3	10.1	9.6	16.8	16.2	13.4	10.1	17.7	15.0	17.1	7.1	9.4	12.2	7.3	14.4	19.3	11.6	15.5	15.7	11.7	8.8	11.5	5.7	3.7	21.0	16.0	10.0	13.1	18.2	12.8	34.7	13.1	28.5	11.5	16.3	9.5	8.1	5.1	8.0	7.9	8.6	15.6	4.5	15.6	9.7	14.3	9.0	13.3	13.5	24.1	9.2	15.8	13.0	8.9	4.6	12.7	9.6	9.9	8.9	10.5	13.3	12.3	15.2	3.8	17.3	4.7	4.6	15.6	5.7	6.5	6.2	5.7	11.3	5.4	5.5	4.5	4.4	10.4	11.0	5.7	8.3	9.5	13.3	14.2	13.0	17.4	12.7	12.2	14.4	13.4	12.2	11.5
BCL3	"BCL4, D19S37"	ENSG00000069399	"B cell CLL/lymphoma 3"	P20749	19	44747705-44760044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;Karpas-707: 22.0;SiHa: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002051, HPA047514"	Approved		Supported	Nucleoplasm,Vesicles,Midbody				Nucleoplasm	"Vesicles, Midbody"	"CAB002051: AB_563428, HPA047514: "	"prognostic favourable (9.67e-4)"	"unprognostic (8.82e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (2.09e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.13e-14)"	"unprognostic (8.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-2)"	"unprognostic (3.04e-2)"	17.7	13.0	4.0	21.1	5.6	35.2	18.7	1.4	4.7	11.7	14.9	2.4	5.9	24.5	10.4	9.7	27.1	12.5	22.7	20.1	3.9	2.0	17.8	52.1	36.4	20.5	4.3	0.5	26.5	13.2	2.4	9.2	9.5	5.6	16.0	8.0	8.8	13.7	13.7	20.2	9.0	35.5	11.5	6.5	41.6	15.0	8.3	4.0	6.5	13.9	22.9	37.0	18.7	11.9	1.3	2.6	16.5	2.4	1.8	1.5	0.7	3.8	13.4	0.3	7.1	2.6	5.4	0.6	2.4	2.6	1.5	2.2	2.8	7.1	3.8	5.5	4.7	4.3	0.9	4.0	0.9	26.5	0.2	0.4	7.0	3.6	6.2	0.3	11.4	9.4	3.2	3.3	4.2	4.0	0.5	22.0	0.9	3.2	0.0	2.9	0.3	5.6	1.7	2.7	1.4	6.8	8.1	0.0	0.4	28.2	14.4	0.7	5.0	2.9	6.7	4.8	5.0	7.5	0.9	20.9	8.2	3.9	8.9	0.5	3.6	0.2	2.4	4.2	0.7	1.6	1.0	1.3	0.9	1.1	2.1	1.1	0.5	0.6	16.5	1.8	0.9	2.6	1.5	0.7	4.0	5.6	1.4	4.7	3.9	2.0	4.3	0.5	5.6	4.0
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"			190000	"Nuclear speckles"		"HPA006484: , HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavourable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favourable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	22.6	20.9	19.3	20.6	33.6	93.9	26.8	56.9	31.0	27.6	23.2	13.3	18.1	15.2	25.8	21.3	22.7	22.9	12.4	17.0	20.4	19.0	19.3	22.0	19.9	22.7	24.4	19.5	33.5	20.5	34.8	50.2	25.5	27.8	21.4	23.7	14.2	23.5	18.2	26.8	22.2	20.8	23.1	22.4	22.7	22.2	16.7	27.2	38.6	24.7	21.5	25.4	24.0	23.2	22.2	25.2	35.7	20.4	29.1	24.9	13.4	18.2	15.9	37.7	31.4	12.0	10.2	19.2	34.9	21.7	23.5	25.1	22.6	12.4	38.5	21.8	26.7	17.8	42.2	23.0	29.6	21.2	26.2	47.9	22.9	24.5	13.9	80.1	30.5	13.9	11.5	33.2	20.8	20.8	42.5	19.1	24.6	21.8	31.9	9.1	27.7	16.6	29.0	47.4	17.1	17.6	35.1	32.1	22.2	34.2	16.5	13.3	15.4	16.2	28.6	18.7	27.4	22.3	34.0	16.2	29.2	53.1	11.1	25.8	21.6	15.4	16.4	24.2	21.1	20.4	21.0	22.2	19.4	17.6	25.2	19.8	24.9	22.3	35.7	29.1	19.7	14.9	14.7	13.4	19.3	33.6	56.9	31.0	20.4	19.0	24.4	19.5	27.8	27.2
BDNF		ENSG00000176697	"Brain derived neurotrophic factor"	P23560	11	27654893-27722058	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.5;smooth muscle: 10.5"	"Cell line enhanced"	"Detected in many"		"BJ: 22.4;BJ hTERT+ SV40 Large T+: 17.2;BJ hTERT+ SV40 Large T+ RasG12V: 13.1;HBF TERT88: 16.5;U-138 MG: 24.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009564, HPA031440, HPA056104"	Enhanced		Supported	"Nuclear speckles,Mitochondria"	"Secreted to blood"	19244000		"Nuclear speckles, Mitochondria"		"CAB009564: AB_2064213, HPA031440: , HPA056104: "	"unprognostic (1.25e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.84e-3)"	0.9	1.3	5.0	0.6	4.5	0.5	0.6	9.4	14.5	1.6	0.8	0.6	0.7	0.8	0.7	8.2	1.4	0.5	2.1	5.8	8.5	5.7	0.9	0.5	4.1	0.4	2.5	4.7	1.2	1.0	0.2	2.3	3.7	12.7	4.9	0.4	3.0	0.9	4.2	1.3	2.1	0.5	10.5	1.0	0.6	0.9	1.3	0.0	0.0	2.3	0.0	0.4	3.2	1.2	0.1	0.4	0.0	0.2	0.1	1.0	0.1	1.6	6.6	0.2	0.0	2.3	1.9	0.0	22.4	4.3	17.2	13.1	0.0	2.6	0.0	2.1	8.1	1.0	0.1	0.2	16.5	0.1	0.1	0.0	2.2	0.0	10.0	0.1	0.1	5.8	2.2	3.8	2.2	0.7	0.0	0.0	2.7	0.0	0.0	0.0	2.1	1.8	0.0	1.3	0.0	2.5	0.0	0.1	0.6	4.3	0.0	0.0	0.1	0.0	7.4	24.1	4.0	9.3	5.0	0.3	0.0	0.0	9.3	0.6	1.3	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.6	0.2	0.1	0.7	0.4	0.0	0.1	0.0	0.4	1.0	0.1	5.0	4.5	9.4	9.4	8.5	5.7	2.5	4.7	12.7	0.0
BHMT	BHMT1	ENSG00000145692	"Betaine--homocysteine S-methyltransferase"	Q93088	5	79111779-79132290	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	39	"kidney: 105.9;liver: 216.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.2;NTERA-2: 3.5;SCLC-21H: 2.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 90.6;renal cancer: 50.4"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA038285, HPA058310"	Enhanced		Supported	Cytosol			9200000	Cytosol		"HPA038285: AB_10675791, HPA058310: AB_2683675"	"unprognostic (2.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.45e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.14e-1)"	"prognostic favourable (7.32e-4)"	"unprognostic (5.33e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.66e-4)"	"unprognostic (6.42e-2)"	"unprognostic (8.26e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.30e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.1	1.5	0.0	105.9	216.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	4.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.2	0.0	1.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	3.5	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.6	0.1	0.0
BIN3		ENSG00000147439	"Bridging integrator 3"	Q9NQY0	8	22620418-22669148	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Septation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023769	Approved									"HPA023769: AB_1845361"	"unprognostic (4.93e-3)"	"unprognostic (4.42e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	21.8	26.3	15.5	12.2	13.7	43.6	16.7	16.3	17.6	11.8	14.4	9.2	18.6	9.0	12.3	13.1	14.9	19.8	23.3	10.3	10.5	8.4	14.2	13.0	11.4	11.8	8.8	8.5	12.1	10.5	15.9	17.8	13.2	10.3	15.3	13.1	14.1	12.8	24.3	15.5	13.5	12.8	10.8	8.8	13.3	15.4	15.0	9.8	13.5	13.8	11.1	14.2	11.0	12.7	11.7	11.5	40.5	15.2	15.0	16.3	14.5	9.1	8.0	3.6	7.7	9.5	8.9	4.0	8.3	14.3	13.3	11.0	3.2	3.6	7.5	3.7	9.2	10.4	6.8	8.7	9.2	5.6	4.6	6.2	3.9	6.1	8.0	6.4	6.9	9.1	10.4	9.8	5.2	8.5	12.1	4.8	6.8	4.4	10.0	14.3	6.8	3.5	5.1	3.8	3.6	13.3	7.4	1.9	4.1	4.0	2.9	42.5	2.9	5.7	8.1	4.1	5.1	8.5	6.2	3.2	2.6	6.7	11.9	4.6	27.0	20.1	15.2	31.2	12.7	13.5	13.0	10.4	13.5	9.7	11.5	11.7	13.2	10.6	40.5	15.0	9.9	10.4	16.3	14.5	15.5	13.7	16.3	17.6	10.5	8.4	8.8	8.5	10.3	9.8
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BIRC6	BRUCE	ENSG00000115760	"Baculoviral IAP repeat containing 6"	Q9NR09	2	32357028-32618899	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074409, HPA074738"			Supported	"Golgi apparatus,Vesicles,Mitotic spindle"				"Golgi apparatus, Vesicles"	"Mitotic spindle"	"HPA074409: , HPA074738: "	"unprognostic (3.38e-2)"	"unprognostic (8.13e-3)"	"unprognostic (8.88e-2)"	"unprognostic (7.06e-3)"	"unprognostic (6.69e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.49e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.32e-2)"	"unprognostic (3.37e-1)"	15.0	16.7	10.3	20.7	14.4	18.4	16.1	21.9	13.7	16.2	13.0	15.3	15.6	8.7	17.2	13.9	13.2	13.1	11.7	11.4	9.8	7.3	14.1	14.8	12.5	16.1	13.9	11.8	23.6	24.8	32.5	17.4	14.1	14.8	11.3	13.6	11.5	14.7	17.1	20.9	14.9	16.0	12.5	13.3	16.1	13.9	13.0	14.4	23.1	21.5	9.2	17.2	16.2	12.0	3.8	2.8	10.6	2.4	2.3	3.4	0.7	15.1	12.7	11.8	5.1	9.3	13.2	7.1	6.7	9.5	8.3	7.9	8.7	3.6	16.3	5.4	12.6	7.0	16.5	10.0	10.3	13.0	7.5	22.0	8.0	7.2	5.1	20.4	7.8	8.8	4.9	13.0	11.6	12.3	17.8	7.0	7.7	5.8	10.2	4.7	7.9	7.5	10.4	19.0	5.5	6.0	15.6	8.8	13.5	13.3	6.9	6.1	4.6	7.3	19.2	8.7	9.8	5.9	10.2	9.4	13.1	21.8	6.3	10.1	5.7	10.6	1.6	0.9	2.7	1.2	3.4	1.7	2.1	2.3	1.3	3.8	2.3	2.6	2.7	2.3	2.4	2.8	1.6	0.7	10.3	14.4	21.9	13.7	9.8	7.3	13.9	11.8	14.8	14.4
BIRC8	"hILP2, ILP-2, RNF136"	ENSG00000163098	"Baculoviral IAP repeat containing 8"	Q96P09	19	53289601-53291626	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	246	"testis: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BLM	"BS, RECQ2, RECQL3"	ENSG00000197299	"Bloom syndrome RecQ like helicase"	P54132	15	90717327-90816165	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005689	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA005689: AB_1845372"	"unprognostic (2.77e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.89e-2)"	"unprognostic (6.12e-5)"	"unprognostic (2.82e-2)"	"unprognostic (4.55e-3)"	"unprognostic (5.24e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.55e-15)"	"unprognostic (6.53e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-2)"	1.8	0.4	3.1	11.4	1.5	5.5	0.6	4.7	2.6	0.7	1.9	0.9	0.5	1.4	1.2	1.1	2.9	0.4	1.3	1.0	2.3	2.4	0.9	0.5	2.0	7.7	2.8	0.2	0.9	0.4	0.0	1.2	3.6	0.5	0.7	2.5	0.7	7.8	0.0	1.7	0.6	2.8	0.5	1.9	6.7	1.4	4.9	0.5	36.7	0.6	3.1	9.3	1.4	0.7	7.4	1.2	4.3	1.6	4.6	5.0	1.6	5.4	7.8	8.7	5.1	0.0	0.4	5.5	4.1	1.2	4.7	5.1	6.8	3.8	14.1	2.6	1.1	9.1	13.4	3.7	6.1	8.5	9.9	14.7	8.4	2.2	0.0	14.1	7.3	0.0	0.0	4.7	2.4	3.3	12.7	4.4	4.9	3.4	10.6	7.8	9.3	1.7	10.8	16.4	5.4	1.1	9.8	6.5	6.1	3.3	4.4	2.6	3.1	11.6	1.8	3.4	6.3	3.5	8.7	3.2	13.1	14.7	1.9	10.0	5.8	2.5	1.0	4.3	3.1	1.2	4.8	7.4	2.8	3.8	1.2	4.3	2.0	2.2	0.8	4.6	1.6	1.2	5.0	1.6	3.1	1.5	4.7	1.7	2.3	2.4	2.8	0.2	0.5	0.5
BLMH	BH	ENSG00000108578	"Bleomycin hydrolase"	Q13867	17	30248195-30292056	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA039548, HPA064307"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			59000000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA039548: AB_10805479, HPA064307: AB_2685241"	"unprognostic (6.85e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.54e-2)"	"unprognostic (3.91e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.05e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.95e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-1)"	11.2	8.3	9.0	17.1	10.2	8.5	14.2	12.1	14.5	10.5	9.8	8.5	9.6	6.7	13.1	12.2	15.7	8.4	10.1	9.7	7.5	7.2	13.6	7.5	13.6	20.3	9.5	8.5	8.8	15.3	15.0	8.3	14.6	9.2	8.4	8.5	7.3	12.8	9.5	15.0	67.5	10.0	15.7	11.1	13.2	9.2	12.4	8.6	24.7	9.3	15.5	13.6	10.8	11.7	4.6	6.6	0.9	5.7	9.8	17.3	6.3	10.1	16.1	15.6	10.8	10.7	11.5	7.5	9.5	5.9	15.0	13.0	23.6	3.0	30.3	17.0	7.6	7.1	33.7	13.0	12.7	8.0	26.5	18.6	14.5	20.0	15.6	33.8	11.5	13.5	0.9	11.7	6.8	22.0	39.6	12.4	6.2	7.7	41.8	24.7	14.9	7.5	36.3	40.5	20.0	12.0	9.1	36.0	12.9	8.4	16.4	10.3	11.2	17.5	14.0	9.3	18.7	4.1	16.8	15.0	30.8	40.9	7.1	0.0	12.4	0.0	5.7	0.9	10.5	3.9	17.3	4.6	12.6	13.7	6.5	4.2	11.6	12.3	0.7	9.8	1.9	6.6	12.4	6.3	9.0	10.2	12.1	14.5	7.5	7.2	9.5	8.5	9.2	8.6
BLOC1S4	"BCAS4L, CNO, FLJ11230"	ENSG00000186222	"Biogenesis of lysosomal organelles complex 1 subunit 4"	Q9NUP1	4	6716055-6717671	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043840	Approved		Approved	Vesicles,Cytosol				Vesicles	Cytosol	"HPA043840: AB_10965701"	"unprognostic (3.09e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.24e-3)"	"unprognostic (5.62e-3)"	14.6	15.5	9.2	11.8	11.5	13.6	11.4	10.7	14.4	15.4	15.2	9.5	10.1	14.6	13.8	14.3	14.1	12.3	15.7	9.6	9.3	7.7	13.6	13.8	8.7	16.9	8.6	9.4	19.1	18.4	8.4	9.8	23.2	9.8	13.7	9.4	13.3	10.8	11.2	16.6	10.7	15.8	8.2	7.4	17.7	13.3	14.0	8.9	20.9	16.8	10.1	15.5	12.3	10.9	6.1	3.8	13.7	4.8	2.5	9.6	1.8	9.9	6.8	10.4	10.6	8.1	10.5	21.0	8.1	8.9	7.6	6.7	6.1	10.8	9.5	8.8	7.2	6.8	5.8	9.3	5.9	7.6	9.5	14.5	6.5	15.0	10.0	7.0	13.6	9.9	9.3	6.0	5.2	6.9	19.0	8.7	7.8	9.9	11.4	24.4	13.6	13.7	11.9	11.5	8.5	10.4	8.9	9.0	12.1	6.8	4.9	14.4	15.4	13.7	7.7	7.1	6.2	8.1	10.2	13.0	12.6	12.6	7.8	12.9	11.1	2.5	3.1	13.7	5.1	4.8	5.2	6.1	6.2	5.5	3.8	4.9	9.6	5.3	1.8	2.5	3.1	3.7	5.1	1.8	9.2	11.5	10.7	14.4	9.3	7.7	8.6	9.4	9.8	8.9
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064414	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB025613, HPA077525"	Uncertain		Supported	Vesicles				Vesicles		"CAB025613: , HPA077525: "	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavourable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	12.2	13.9	10.1	11.0	11.1	4.8	14.1	8.8	8.9	12.0	9.7	9.0	6.4	5.9	14.3	10.5	10.7	9.2	8.2	9.7	7.6	7.0	23.2	14.7	8.0	11.8	10.3	6.0	14.2	8.8	17.2	8.6	9.2	7.4	12.0	7.8	10.6	9.6	13.6	11.3	10.3	10.0	13.4	12.4	12.0	9.2	8.2	9.2	24.1	14.6	7.2	13.8	12.1	10.4	15.7	14.8	16.9	11.2	15.1	15.2	11.4	3.6	3.9	8.6	11.1	9.5	11.9	5.8	3.9	5.5	5.7	5.6	8.0	3.5	12.5	27.1	5.0	3.3	6.3	3.0	8.1	12.5	6.8	7.5	3.0	14.5	8.5	12.8	8.7	5.2	8.0	5.7	8.6	10.1	15.3	2.3	8.0	4.0	14.9	8.5	4.7	5.5	12.3	9.9	19.8	10.7	3.1	8.1	4.3	4.0	6.1	12.1	7.7	6.8	4.4	9.0	6.5	5.3	3.4	10.2	20.3	11.4	3.6	10.6	9.2	13.6	9.0	16.9	11.5	11.2	14.8	15.7	14.8	14.6	14.8	14.8	15.2	15.1	2.1	15.1	6.1	6.0	13.0	11.4	10.1	11.1	8.8	8.9	7.6	7.0	10.3	6.0	7.4	9.2
BLVRA	BLVR	ENSG00000106605	"Biliverdin reductase A"	P53004	7	43758680-43807342	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019709, HPA042865, HPA054322"	Approved		Supported	Cytosol			1600000	Cytosol		"HPA019709: , HPA042865: AB_10797024, HPA054322: "	"unprognostic (2.47e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.79e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.45e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (8.65e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.93e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.13e-3)"	"unprognostic (4.56e-2)"	31.7	13.1	14.5	16.2	14.7	23.8	22.5	13.3	21.9	22.7	25.9	9.1	12.6	5.2	19.3	58.7	35.8	18.7	17.5	21.7	11.9	16.2	26.8	6.0	27.7	25.1	15.8	15.4	26.4	14.8	19.3	13.1	12.2	20.5	21.8	8.8	17.2	17.9	21.1	23.0	15.1	12.2	26.4	10.6	40.9	17.7	9.3	6.7	12.1	19.0	21.3	21.5	28.5	18.9	4.9	23.2	27.5	61.6	3.4	14.0	30.7	11.4	22.3	6.5	27.1	13.9	18.6	0.3	7.8	24.3	13.4	16.4	5.3	6.9	0.0	15.1	12.4	15.1	19.9	19.8	11.5	53.8	13.9	24.7	20.5	32.6	35.5	2.7	9.3	12.6	33.6	14.1	9.4	22.7	16.4	13.7	10.1	12.4	8.6	1.5	8.8	25.7	19.0	11.3	62.2	29.7	6.4	8.4	25.9	16.0	16.0	13.0	36.0	18.5	13.8	12.3	13.7	5.4	13.3	18.5	14.6	0.0	20.1	11.2	19.1	7.8	50.5	27.5	7.0	61.6	6.6	4.9	14.0	11.7	23.2	2.4	7.5	5.8	4.5	3.4	57.7	3.4	13.6	30.7	14.5	14.7	13.3	21.9	11.9	16.2	15.8	15.4	20.5	6.7
BLVRB	"FLR, SDR43U1"	ENSG00000090013	"Biliverdin reductase B"	P30043	19	40447765-40465840	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 137.6"	"Cell line enhanced"	"Detected in many"		"A549: 82.6;K-562: 75.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"classical monocyte: 73.4"	"Group enriched"	"Detected in all"	7	"dendritic cells: 54.8;monocytes: 73.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041698, HPA041937"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			440000000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA041698: AB_10796781, HPA041937: AB_10794308"	"unprognostic (1.86e-1)"	"unprognostic (1.14e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.92e-2)"	36.9	17.9	10.9	12.8	12.2	137.6	28.9	3.5	10.9	17.0	26.7	7.7	18.5	20.9	14.1	19.6	45.3	14.6	19.0	31.0	8.2	8.6	31.8	72.4	37.3	30.0	11.7	9.6	21.3	19.4	5.7	5.6	32.2	13.8	22.9	7.7	17.5	27.1	22.1	43.4	16.7	26.4	22.1	9.7	47.1	31.1	7.6	7.9	6.6	24.3	42.9	24.4	29.9	22.1	8.6	54.8	9.1	73.4	4.0	5.3	34.4	34.8	82.6	1.1	12.3	11.5	11.1	9.8	4.4	12.9	6.0	11.7	16.2	31.7	11.7	34.0	7.9	11.1	4.2	9.6	1.2	19.8	3.6	17.8	12.5	9.8	26.5	0.2	5.2	10.8	18.2	8.0	4.4	6.3	75.0	21.3	7.0	54.2	0.9	1.0	0.3	23.1	8.2	3.9	18.9	7.5	23.5	0.0	1.8	13.4	35.2	13.5	34.3	2.7	6.8	16.0	17.2	24.6	2.3	11.6	13.6	4.4	41.8	7.0	6.2	5.0	73.4	2.6	4.6	33.7	4.4	8.6	4.0	4.0	54.8	5.4	4.2	3.3	9.1	4.0	16.9	11.5	5.3	34.4	10.9	12.2	3.5	10.9	8.2	8.6	11.7	9.6	13.8	7.9
BMP1	PCOLC	ENSG00000168487	"Bone morphogenetic protein 1"	P13497	8	22164736-22212326	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor, Hydrolase, Metalloprotease, Protease"	"Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"lung: 72.2;placenta: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014572	Enhanced				"Secreted to extracellular matrix"		2100000			"HPA014572: AB_1845390"	"unprognostic (1.24e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.34e-2)"	"unprognostic (6.76e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.64e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.75e-3)"	"unprognostic (7.05e-3)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (3.37e-9)"	"unprognostic (2.11e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.34e-2)"	6.9	11.7	2.7	3.6	4.6	1.1	5.9	7.8	4.2	8.1	5.8	3.1	3.7	4.4	9.4	5.2	4.8	7.7	5.4	3.4	2.6	1.3	4.9	9.2	72.2	3.2	3.4	1.5	5.2	3.7	2.8	2.2	106.2	3.5	6.5	4.7	4.6	2.4	4.6	2.4	6.8	5.7	11.0	3.6	3.2	2.9	2.2	3.6	1.0	7.1	2.4	2.9	9.9	9.5	0.0	0.9	0.1	1.4	0.8	2.2	0.4	4.6	4.8	1.3	6.2	15.3	11.3	6.8	20.3	16.9	10.4	9.6	2.5	3.0	1.1	12.7	18.6	10.2	1.6	5.4	2.0	1.0	2.1	1.7	7.3	2.9	12.5	0.7	3.5	12.9	8.5	8.1	2.6	10.0	2.2	2.1	5.6	1.7	0.5	1.0	0.8	2.6	1.1	3.3	4.9	9.0	0.7	0.8	3.3	14.6	0.8	3.3	0.9	2.0	12.7	2.7	6.0	6.5	6.0	1.0	0.6	0.2	5.3	2.7	7.5	0.0	1.4	0.0	2.2	0.7	1.4	0.0	0.4	1.0	0.0	0.0	0.3	1.7	0.1	0.8	0.5	0.9	0.0	0.4	2.7	4.6	7.8	4.2	2.6	1.3	3.4	1.5	3.5	3.6
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 15.7;RT4: 13.1;SK-BR-3: 5.9"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0
BMPER	"CRIM3, Cv2"	ENSG00000164619	"BMP binding endothelial regulator"	Q8N8U9	7	33904911-34155872	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.5;BJ: 11.0;fHDF/TERT166: 14.2;HBF TERT88: 15.6;HSkMC: 11.7;hTEC/SVTERT24-B: 10.3;U-138 MG: 16.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (4.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.96e-4)"	"unprognostic (5.34e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.01e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.67e-5)"	"unprognostic (2.54e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.47e-3)"	7.0	1.1	2.2	8.5	6.3	0.3	2.2	9.5	9.7	5.0	2.4	0.6	0.0	1.3	3.4	6.7	1.6	1.6	2.0	2.7	2.4	1.9	1.1	12.9	5.7	7.8	1.6	4.7	3.3	1.0	0.4	5.3	11.3	6.0	9.5	2.0	1.8	1.9	0.9	3.7	1.0	3.8	2.0	1.7	1.0	4.2	1.4	0.0	0.0	1.1	2.0	0.3	1.6	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	11.5	6.2	0.0	11.0	2.7	6.9	6.1	0.0	0.0	0.1	0.0	14.2	5.2	0.0	0.0	15.6	0.0	0.5	0.0	0.5	0.0	1.2	0.0	0.0	11.7	0.0	10.3	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.9	0.0	0.0	16.2	1.4	8.0	0.0	1.3	0.0	0.0	5.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	6.3	9.5	9.7	2.4	1.9	1.6	4.7	6.0	0.0
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.4;testis: 27.5;tongue: 20.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 15.9;HBEC3-KT: 36.3;hTCEpi: 40.8;hTERT-HME1: 39.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA063183: , HPA066947: , HPA077428: "	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	12.7	0.1	0.0	1.6	0.1	0.0	0.9	0.0	0.4	2.7	1.5	0.1	0.0	0.0	0.4	10.8	13.4	0.8	0.1	1.4	0.1	0.0	0.1	0.1	0.7	1.3	0.2	0.2	0.6	0.0	0.0	0.0	1.9	0.5	0.4	0.0	0.7	1.7	0.2	0.1	7.9	0.2	0.3	0.3	0.1	0.0	27.5	0.0	6.0	0.2	20.2	3.7	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	1.3	2.1	0.0	0.6	0.1	6.9	9.7	0.0	0.1	0.0	0.3	4.2	15.9	0.8	36.3	12.6	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.8	40.8	6.2	39.8	6.8	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0
BOK	"BCL2L9, BOKL, MGC4631"	ENSG00000176720	"BOK, BCL2 family apoptosis regulator"	Q9UMX3	2	241551424-241574138	"Plasma proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.0;brain: 64.1"	"Cell line enhanced"	"Detected in many"		"TIME: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.30e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.09e-9)"	"unprognostic (9.48e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"	56.0	5.4	15.0	4.5	44.5	0.8	25.6	8.6	24.7	10.5	13.7	45.2	3.3	5.9	15.4	12.0	20.1	13.2	15.5	4.4	19.8	16.0	10.9	46.2	13.8	2.6	64.1	12.8	5.5	11.0	2.9	2.0	4.3	38.6	14.7	4.0	3.0	7.7	19.1	2.1	12.9	4.9	14.1	44.8	3.7	8.5	4.4	56.2	0.0	5.4	3.0	2.7	13.2	13.8	0.0	0.0	0.0	0.0	1.4	5.7	1.5	14.0	3.5	6.4	14.7	11.0	6.6	1.8	11.5	4.6	15.2	15.8	6.4	5.9	0.0	4.0	20.4	13.2	0.7	11.6	5.7	0.0	0.1	0.0	3.6	16.5	9.2	0.1	0.5	6.7	12.0	6.4	1.8	18.1	2.5	0.0	14.8	18.1	0.0	0.1	4.0	10.9	0.1	10.6	0.0	9.8	0.3	5.8	2.2	5.3	3.5	9.2	9.9	0.5	26.1	0.0	22.2	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	5.7	0.0	0.6	0.0	1.7	2.3	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.0	1.5	15.0	44.5	8.6	24.7	19.8	16.0	64.1	12.8	38.6	56.2
BPGM		ENSG00000172331	"Bisphosphoglycerate mutase"	P07738	7	134646808-134679813	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Congenital erythrocytosis, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 184.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.1;RT4: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016493, HPA028735"	Enhanced		Approved	Nucleoplasm,Nucleoli			69000000	Nucleoli	Nucleoplasm	"HPA016493: AB_1845414, HPA028735: AB_10600791"	"unprognostic (2.56e-1)"	"prognostic favourable (7.95e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.96e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.67e-3)"	"unprognostic (7.42e-2)"	"unprognostic (5.69e-2)"	"prognostic favourable (1.54e-8)"	"unprognostic (2.18e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.78e-2)"	6.1	7.3	13.6	4.5	11.1	37.7	6.9	11.7	11.6	7.1	6.9	9.1	6.1	4.3	5.4	10.2	14.6	4.7	6.9	7.3	12.5	14.2	19.1	8.1	8.0	5.2	13.9	7.8	5.7	5.4	16.5	14.4	184.7	12.4	7.5	5.4	6.7	10.6	10.3	17.7	5.5	6.0	6.6	15.9	8.6	6.8	7.4	8.8	8.5	7.5	22.2	13.3	24.9	9.5	11.6	10.2	28.2	12.8	9.8	14.5	12.8	4.4	5.4	7.2	9.7	8.3	4.9	7.2	13.4	16.2	5.2	7.8	2.1	6.0	5.4	4.0	7.5	3.6	7.6	7.4	9.2	37.1	6.7	3.1	5.0	2.5	5.7	5.9	4.1	4.8	6.7	9.8	5.3	18.9	9.0	6.8	12.3	2.1	9.6	8.2	7.4	5.2	7.3	5.1	3.9	11.8	59.6	6.2	10.4	6.2	7.5	6.7	4.9	3.8	14.3	8.3	2.0	11.1	10.8	11.3	12.9	6.8	14.4	5.7	14.2	28.2	9.8	27.6	14.5	12.8	10.4	11.6	9.5	12.7	10.2	10.5	13.2	13.4	18.0	9.8	12.5	6.7	12.0	12.8	13.6	11.1	11.7	11.6	12.5	14.2	13.9	7.8	12.4	8.8
BPIFA1	"bA49G10.5, LUNX, PLUNC, SPLUNC1"	ENSG00000198183	"BPI fold containing family A member 1"	Q9NP55	20	33235995-33243311	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 8.0;lung: 20.2;lymphoid tissue: 25.2;pituitary gland: 16.9;tongue: 11.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 1.3;NTERA-2: 2.2;REH: 1.2;U-266/70: 1.6"	"Cancer enriched"	"Detected in many"	27	"lung cancer: 262.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			CAB025669	Supported				"Secreted in other tissues"		1200000			"CAB025669: "						"unprognostic (1.06e-1)"		"unprognostic (1.53e-1)"						"unprognostic (3.65e-1)"		"unprognostic (1.80e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	11.9	25.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB1	"bA49G10.6, C20orf114, dJ1187J4.1, LPLUNC1, MGC14597, VEMSGP"	ENSG00000125999	"BPI fold containing family B member 1"	Q8TDL5	20	33273480-33309878	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 100.1;lung: 101.0;lymphoid tissue: 115.1;stomach 1: 76.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.2;HMC-1: 2.0;RT4: 4.1;SK-BR-3: 8.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 75.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 6.2"	"Low region specificity"	"Detected in all"			HPA024256	Enhanced				"Secreted in other tissues"		7500000			"HPA024256: AB_1845664"	"unprognostic (2.42e-1)"	"unprognostic (5.41e-2)"		"unprognostic (3.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.00e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.36e-7)"	"unprognostic (3.30e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.55e-2)"	0.1	0.0	0.2	0.2	0.2	0.0	0.2	0.1	0.2	100.1	0.1	0.3	0.1	3.7	0.5	0.2	23.3	0.0	0.3	0.3	0.2	0.0	0.1	0.1	101.0	0.1	0.1	0.1	0.1	0.1	0.0	4.7	0.1	0.1	0.9	0.0	0.1	38.8	0.8	1.0	0.0	0.1	0.1	0.1	0.1	76.9	1.1	0.1	0.2	0.2	29.6	115.1	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.1	0.0	0.7	0.0	0.3	0.0	4.1	0.0	0.0	0.0	8.4	0.0	0.6	0.0	0.6	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell line enriched"	"Detected in single"	552	"Hep G2: 67.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"		68000	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favourable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BPIFB3	"C20orf185, dJ726C3.4, LPLUNC3, RYA3"	ENSG00000186190	"BPI fold containing family B member 3"	P59826	20	33055424-33073628	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"blood: 1.2;pituitary gland: 2.8;salivary gland: 3.1;testis: 3.0"	"Group enriched"	"Detected in some"	27	"HEL: 8.1;HMC-1: 5.8"	"Cancer enriched"	"Detected in single"	7	"ovarian cancer: 1.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045741	Uncertain				"Intracellular and membrane"					"HPA045741: "										"unprognostic (4.33e-2)"					"unprognostic (1.06e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.8	0.0		0.0	0.0		3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0			0.2		0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2										
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825524-67984378	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA029069: AB_10602597, HPA048289: "	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	16.1	16.2	28.0	28.6	28.7	22.3	19.5	61.9	35.3	20.7	18.5	18.9	17.0	12.1	20.1	24.0	17.9	17.8	17.4	13.9	26.6	17.7	17.1	14.7	24.1	31.7	31.6	22.2	27.1	16.3	31.3	29.7	17.2	26.0	17.3	18.0	14.5	16.9	18.4	17.9	29.5	18.2	16.5	18.4	21.1	17.4	23.6	33.5	41.4	19.0	12.3	30.1	16.7	32.5	12.6	10.4	15.1	4.8	9.7	7.3	1.4	13.2	17.4	25.6	12.9	14.3	13.6	14.0	10.4	9.8	12.6	10.9	16.0	9.6	54.6	7.7	11.7	10.4	25.0	11.2	20.5	7.6	24.1	20.9	16.8	21.9	6.8	30.5	16.9	9.9	12.7	12.5	9.6	23.5	23.7	15.7	10.9	20.4	31.1	15.2	19.5	15.9	22.5	30.9	10.7	11.0	16.7	19.2	22.1	14.3	38.7	14.7	16.3	17.7	16.4	19.2	15.0	7.0	12.8	12.9	13.0	32.5	9.0	14.9	7.4	15.1	3.9	7.5	7.3	2.2	5.9	5.7	5.9	5.7	2.8	12.6	6.2	6.4	8.9	9.7	4.8	10.4	4.2	1.4	28.0	28.7	61.9	35.3	26.6	17.7	31.6	22.2	26.0	33.5
BRCA1	"BRCC1, FANCS, PPP1R53, RNF53"	ENSG00000012048	"BRCA1, DNA repair associated"	P38398	17	43044295-43170245	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Fanconi anemia, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 9.1;granulocytes: 9.7;monocytes: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001946, HPA004840, HPA034966, HPA057371"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: "	"unprognostic (7.87e-3)"	"unprognostic (6.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.39e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.56e-3)"	"unprognostic (4.14e-3)"	"unprognostic (9.62e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.31e-2)"	4.8	4.3	6.0	9.6	11.3	15.3	5.1	12.9	10.6	5.4	9.2	3.4	6.8	4.3	5.4	5.5	9.1	5.5	3.3	6.5	6.6	5.3	4.2	7.7	4.9	13.0	7.5	5.9	5.1	4.7	4.2	11.0	5.3	10.5	4.1	10.4	3.7	5.4	7.4	7.3	8.3	6.7	5.5	9.2	5.9	5.1	17.6	7.0	10.9	15.6	7.3	14.6	5.5	5.6	2.0	9.1	9.7	12.7	1.4	1.3	10.7	15.5	25.2	13.9	11.1	2.3	5.2	13.6	18.3	7.9	15.4	14.7	15.3	12.1	35.9	3.4	7.0	18.0	18.9	10.2	25.9	16.4	13.8	16.9	19.8	13.2	0.5	30.1	14.7	1.4	1.7	23.2	7.4	7.9	25.4	15.4	14.5	10.3	25.2	9.9	7.6	6.7	17.4	29.3	14.7	5.7	15.1	9.6	10.3	14.1	4.7	6.9	12.4	13.9	5.2	13.8	11.2	17.8	19.1	7.2	17.6	27.6	11.1	17.9	14.4	4.6	12.7	1.8	1.3	4.0	1.3	1.1	1.3	1.0	9.1	2.0	1.2	1.3	9.7	1.4	1.5	1.4	0.4	10.7	6.0	11.3	12.9	10.6	6.6	5.3	7.5	5.9	10.5	7.0
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039614: AB_10963698"	"prognostic unfavourable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favourable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.7	14.5	14.9	20.5	6.5	9.2	29.4	18.2	12.9	24.6	15.7	19.8	19.5	32.5	9.4	10.8	12.3	26.0	18.8	28.0	17.4	25.7	21.7	34.9	17.7	17.8	34.5	15.0	11.1	12.2	22.7	20.5	11.3	37.9	10.0	16.0	16.0	23.9	37.8	24.0	21.4	21.5	27.0	13.9	14.1	17.2	18.0	16.1	37.7	26.4	16.9	16.5	21.3	6.7	18.9	20.7	13.6	34.8	9.0	19.2	41.3	16.4	39.7	23.5	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9
BRPF1	BR140	ENSG00000156983	"Bromodomain and PHD finger containing 1"	P55201	3	9731729-9748018	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003359	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003359: AB_1078217"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.20e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (5.28e-4)"	"unprognostic (1.51e-3)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.67e-3)"	10.5	7.7	6.2	10.4	8.1	29.2	10.7	16.5	13.1	10.7	9.5	10.4	5.0	6.8	14.4	8.9	10.7	12.9	10.7	7.0	5.4	4.2	8.2	5.3	10.7	12.3	8.3	7.0	12.5	9.2	11.3	9.5	9.9	7.5	9.0	6.3	9.6	12.1	8.5	11.1	14.2	10.5	8.3	5.1	12.2	9.2	23.7	11.4	24.3	12.0	7.8	11.4	11.5	9.4	1.2	3.5	2.3	1.8	9.3	4.2	1.3	5.3	8.3	8.3	4.0	5.2	4.4	42.4	6.6	4.4	7.8	5.8	7.4	4.6	9.2	3.1	6.6	4.5	8.4	6.7	5.6	9.7	8.9	11.9	16.6	4.9	6.1	16.9	11.1	5.6	5.6	11.5	6.9	6.0	12.6	9.3	4.9	12.9	10.5	13.9	10.5	7.8	14.2	5.8	6.4	4.1	8.5	4.9	7.6	7.1	5.2	6.0	5.2	16.4	7.6	9.2	7.8	7.9	12.1	7.5	8.4	17.1	7.2	13.9	7.9	2.2	1.8	2.3	2.7	1.6	4.2	1.1	2.1	2.5	1.5	1.2	2.5	2.9	1.3	9.3	1.5	3.5	1.3	1.3	6.2	8.1	16.5	13.1	5.4	4.2	8.3	7.0	7.5	11.4
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	9.6	21.8	11.9	12.3	11.7	12.3	25.8	22.4	16.7	11.9	15.2	10.9	28.3	13.5	16.0	13.4	9.5	10.8	10.6	10.9	10.3	9.1	15.9	16.5	9.6	7.7	10.4	11.7	15.2	20.8	18.1	18.8	8.7	7.4	15.2	15.3	8.0	16.5	31.0	22.9	14.5	17.0	12.2	9.8	9.8	12.4	22.9	11.8	11.8	18.3	4.4	7.1	13.9	22.3	0.8	0.5	3.0	0.2	0.1	2.0	0.6	6.7	6.5	16.3	12.8	9.0	7.7	14.0	10.2	10.8	14.4	11.4	19.0	6.4	10.5	11.0	9.9	6.6	14.3	7.3	12.6	9.9	8.9	7.4	6.0	11.2	9.6	5.7	10.3	9.8	6.3	17.1	8.6	10.7	15.3	9.6	7.8	9.6	6.5	2.5	8.2	5.6	19.0	6.7	3.2	4.7	13.9	23.4	7.3	8.3	9.1	8.7	10.2	15.8	11.2	15.0	12.9	4.1	11.7	8.0	10.3	7.9	2.5	9.1	17.7	3.0	0.2	1.4	1.9	0.2	2.0	0.8	0.5	0.6	0.2	0.4	0.9	0.6	1.5	0.1	0.1	0.5	1.2	0.6	11.9	11.7	22.4	16.7	10.3	9.1	10.4	11.7	7.4	11.8
BRS3	"BB3, BB3R"	ENSG00000102239	"Bombesin receptor subtype 3"	P32247	X	136487887-136493780	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"epididymis: 27.4"	"Cell line enhanced"	"Detected in single"		"U-266/70: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"basal ganglia: 3.6;hypothalamus: 2.8"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.2;naive CD8 T-cell: 1.0"	"Group enriched"	"Detected in many"	11	"B-cells: 1.2;T-cells: 1.0"	"Group enriched"	"Detected in some"	9	"basal ganglia: 1.6;hypothalamus: 7.1"	"Low region specificity"	"Detected in all"															"unprognostic (1.49e-1)"			"unprognostic (1.31e-1)"					"unprognostic (2.07e-1)"	"unprognostic (1.79e-2)"		"unprognostic (3.73e-6)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-1)"		"unprognostic (5.59e-2)"	0.1	0.1	0.1	0.1	3.6	0.0	0.5	0.4	0.4	0.3	0.1	0.1	0.1	0.0	0.2	27.4	0.1	2.4	0.1	0.1	0.1	2.8	0.1	0.1	0.1	0.1	0.1	0.1	2.9	0.3	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.1	0.1	0.2	0.1	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.4	0.4	0.1	2.8	0.1	0.1	0.3	0.1
BRSK1	KIAA1811	ENSG00000160469	"BR serine/threonine kinase 1"	Q8TDC3	19	55282072-55312533	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 65.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 25.9;SH-SY5Y: 23.2;WM-115: 21.1"	"Cancer enhanced"	"Detected in all"		"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021212, HPA061719"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA021212: AB_1845455, HPA061719: "	"unprognostic (1.42e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.69e-3)"	"unprognostic (2.71e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.06e-6)"	"unprognostic (4.24e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.04e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (1.16e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.09e-1)"	1.4	9.8	28.6	3.2	23.6	1.0	1.6	26.7	65.0	1.8	2.2	7.9	0.1	3.3	5.4	3.7	3.0	2.3	3.9	6.5	33.4	20.0	1.4	0.8	1.7	2.4	20.4	14.8	2.4	2.6	12.4	11.0	1.5	13.3	3.8	1.9	2.8	2.5	4.6	1.0	1.1	2.6	4.9	9.2	1.5	1.9	4.4	7.2	0.0	3.0	0.0	1.6	3.2	0.7	0.0	0.3	0.0	0.9	0.1	0.8	0.2	0.3	1.2	15.3	8.0	0.0	0.6	0.1	2.4	3.4	3.3	4.8	5.9	2.7	3.1	1.7	2.7	0.1	3.2	0.1	3.1	14.4	12.6	2.0	1.6	0.6	3.3	0.6	5.9	2.1	0.3	3.3	0.0	0.1	2.8	18.8	2.9	0.8	3.6	0.7	11.1	1.0	8.3	3.8	0.5	0.2	0.0	25.9	23.2	0.0	0.4	5.6	1.3	1.7	0.0	6.3	6.7	3.5	4.6	15.6	11.4	7.0	6.5	1.4	21.1	0.0	0.9	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.2	28.6	23.6	26.7	40.2	33.4	20.0	20.4	14.8	13.3	7.2
BRWD1	"C21orf107, DCAF19, FLJ11315, N143, WDR9"	ENSG00000185658	"Bromodomain and WD repeat domain containing 1"	Q9NSI6	21	39184176-39321559	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030943, HPA030944, HPA030945, CAB034184"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"CAB034184: AB_2243666, HPA030943: , HPA030944: , HPA030945: AB_10670161"	"unprognostic (6.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.39e-3)"	"unprognostic (4.94e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.82e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.56e-2)"	10.9	16.7	33.0	15.4	36.8	13.4	16.3	15.5	40.2	12.3	12.0	14.3	10.5	8.8	13.0	21.1	10.2	11.8	9.9	12.9	29.1	32.9	13.9	21.8	10.0	12.9	24.3	17.7	16.2	17.2	12.8	12.0	15.2	13.4	13.2	11.5	13.0	9.3	11.8	14.6	11.9	9.6	13.1	16.1	9.6	9.9	17.2	10.5	22.4	17.7	9.3	13.2	12.1	11.6	8.5	7.2	11.6	6.1	10.2	11.1	3.8	10.2	4.1	10.1	5.6	6.5	9.8	10.4	5.9	7.0	4.6	5.4	3.9	7.0	33.0	6.2	8.0	5.1	9.4	6.8	7.3	7.6	7.8	22.4	7.2	7.1	8.2	12.3	6.3	6.7	11.3	6.3	16.0	6.8	16.5	16.6	6.4	7.9	8.4	14.6	10.6	5.8	14.9	7.9	10.4	5.6	6.6	8.0	10.3	12.6	15.3	8.8	12.9	17.3	7.5	6.1	2.9	3.5	4.4	18.5	12.7	16.1	7.3	13.2	4.8	4.4	5.2	11.6	10.7	6.1	8.3	8.5	9.2	11.0	7.2	6.3	11.1	9.0	5.7	10.2	3.8	6.8	10.3	3.8	33.0	36.8	15.5	40.0	29.1	32.9	24.3	17.7	13.4	10.5
BSN	ZNF231	ENSG00000164061	"Bassoon presynaptic cytomatrix protein"	Q9UPA5	3	49554489-49671545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 36.9"	"Cell line enhanced"	"Detected in some"		"K-562: 3.8;SCLC-21H: 8.9;SH-SY5Y: 5.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034757	Enhanced									"HPA034757: AB_10671233"	"unprognostic (8.57e-2)"	"unprognostic (3.45e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.50e-4)"	"unprognostic (7.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.21e-5)"	"unprognostic (2.50e-3)"	"unprognostic (5.38e-5)"	"unprognostic (9.33e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.34e-2)"	1.2	3.9	23.0	1.3	22.4	1.1	1.2	25.4	36.9	1.3	1.2	1.8	0.0	1.3	1.5	7.0	1.2	1.4	1.2	1.3	13.1	5.1	1.4	1.3	1.3	1.2	3.9	19.1	1.6	2.1	1.7	4.4	1.3	7.9	1.3	1.2	0.7	1.3	1.4	1.4	1.3	1.3	1.3	1.6	1.3	1.7	5.1	4.0	0.0	1.4	0.0	1.1	1.1	0.3	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.2	0.4	2.1	1.4	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.5	0.4	2.4	0.5	0.0	0.3	0.3	0.0	0.1	0.4	1.0	0.3	0.6	1.1	0.0	0.4	0.9	0.1	0.0	0.0	0.4	0.0	3.8	0.4	0.1	0.8	0.4	0.2	1.7	1.0	0.0	0.2	0.4	0.0	0.4	8.9	5.5	0.8	0.1	0.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.3	1.0	0.2	0.2	0.1	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.1	0.0	23.0	22.4	25.4	36.9	13.1	5.1	3.9	19.1	7.9	4.0
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.3;TIME: 20.0;U-937: 23.7;WM-115: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"		170000000			"HPA050121: "	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.4	0.5	0.4	13.2	3.1	0.7	10.3	0.9	9.4	10.6	0.1	5.6	0.3	0.9	5.2	0.1	1.5	0.2	8.0	0.3	0.2	2.4	0.3	0.2	3.4	3.2	7.1	2.7	0.7	6.0	0.5	1.4	0.3	0.2	5.5	0.1	1.0	1.9	1.2	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.0	0.2	0.3	6.8	0.2	36.3	20.0	0.3	0.4	3.7	0.4	0.2	0.0	0.2	1.3	23.7	21.6	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405648	"CD markers, Plasma proteins, Predicted membrane proteins"	"Antiviral defense, B-cell activation, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 101.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 78.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA017060	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017060: AB_1845467"	"prognostic favourable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	29.6	72.2	8.4	31.1	9.8	13.6	27.9	2.5	7.6	14.4	12.0	5.6	24.8	6.9	13.4	36.7	8.6	26.8	30.1	13.9	7.9	4.9	24.7	30.8	44.9	16.6	10.0	5.2	101.0	6.9	0.3	8.6	31.5	8.8	15.6	4.8	8.4	11.4	17.5	6.0	3.2	14.0	11.3	9.0	32.9	12.3	8.5	9.4	10.3	10.3	5.9	12.3	14.0	42.4	26.2	74.1	35.8	66.4	57.9	32.6	54.5	39.2	0.0	0.1	18.1	0.0	0.1	6.2	0.1	3.0	58.0	78.1	18.4	35.4	30.4	42.9	24.2	0.1	26.4	2.9	1.8	33.5	0.2	0.4	63.6	17.9	33.2	14.3	38.6	0.1	0.0	19.1	0.0	14.7	17.3	75.8	0.0	10.7	6.8	25.1	19.9	50.8	12.8	0.1	63.5	13.8	0.1	0.0	0.1	40.1	1.5	48.2	30.4	20.3	0.1	0.2	1.4	0.0	0.4	39.1	51.0	20.1	0.1	56.7	0.2	35.8	61.6	21.0	32.6	66.4	30.8	21.0	27.5	30.2	50.7	26.2	22.5	25.6	20.3	57.9	59.3	74.1	24.8	54.5	8.4	9.8	2.5	7.6	7.9	4.9	10.0	5.2	8.8	9.4
BTAF1	"MOT1, TAF-172, TAF(II)170, TAF172, TAFII170"	ENSG00000095564	"B-TFIID TATA-box binding protein associated factor 1"	O14981	10	91923769-92030325	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070682			Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA070682: "	"unprognostic (2.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.92e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (2.72e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (4.04e-5)"	"unprognostic (6.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.98e-1)"	21.8	13.7	15.1	20.2	23.1	26.7	20.8	19.9	21.6	20.8	19.7	18.3	17.4	15.9	24.3	22.0	19.4	26.2	15.5	15.9	16.0	7.0	13.8	15.5	20.1	29.3	22.2	13.4	30.4	19.7	21.1	22.3	13.8	16.5	18.2	16.4	18.1	21.0	18.3	15.8	48.6	23.4	22.1	22.4	22.4	19.6	21.2	23.8	29.0	19.5	10.8	25.8	24.3	21.2	6.9	9.6	6.8	6.3	4.4	5.3	2.6	17.0	8.3	19.6	23.8	10.4	16.5	9.8	10.0	11.9	9.9	14.9	11.4	10.5	18.4	6.5	9.8	18.5	13.1	8.9	14.9	12.5	14.2	13.0	19.5	11.9	10.7	19.5	13.7	11.6	11.5	15.1	22.0	9.5	10.6	21.2	10.1	7.4	15.0	12.4	8.9	6.6	12.2	12.2	8.5	9.3	10.6	7.6	8.9	9.6	4.9	12.3	9.9	13.1	10.2	9.0	7.2	12.0	14.2	24.7	11.3	15.2	14.1	18.1	2.3	6.8	5.5	2.9	5.3	3.7	4.6	5.1	3.9	3.6	4.0	6.9	4.9	3.7	3.9	4.4	6.3	9.6	3.1	2.6	15.1	23.1	19.9	21.6	16.0	7.0	22.2	13.4	16.5	23.8
BTD		ENSG00000169814	Biotinidase	P43251	3	15601341-15647640	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052275	Uncertain				"Secreted to blood"		2900000000			"HPA052275: "	"unprognostic (6.04e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.37e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.37e-3)"	"unprognostic (4.26e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (2.60e-9)"	"unprognostic (2.44e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.73e-2)"	18.5	17.9	7.5	3.9	10.2	4.4	13.5	17.0	11.8	11.2	28.1	19.6	12.2	25.3	12.3	34.1	7.1	10.3	10.4	6.9	8.0	6.8	20.0	50.7	8.2	5.2	12.3	9.5	17.2	26.6	19.6	11.1	10.7	9.3	10.7	9.4	20.0	11.6	12.1	6.9	6.5	40.5	7.9	8.8	7.6	12.9	15.0	12.6	5.9	14.8	3.8	6.2	11.7	9.1	8.4	13.7	31.0	11.9	7.5	15.6	8.7	3.8	10.8	3.3	3.2	28.2	7.8	19.6	7.0	9.4	8.3	15.0	3.8	10.3	1.0	8.4	16.1	4.3	2.6	8.3	9.7	3.3	5.5	5.9	14.5	11.6	6.8	2.9	6.9	9.5	8.6	21.8	2.2	15.9	3.8	13.7	23.3	4.6	1.6	3.4	3.6	6.0	2.1	8.2	13.0	8.0	7.8	2.3	5.7	8.3	2.0	11.0	10.2	5.6	10.8	9.0	6.9	8.3	4.4	3.2	4.8	1.2	10.5	3.5	6.5	31.0	11.9	25.2	13.2	11.1	12.3	8.4	14.1	11.3	12.1	7.8	12.2	9.2	10.8	7.5	8.4	13.7	15.6	8.7	7.5	10.2	17.0	11.8	8.0	6.8	12.3	9.5	9.3	12.6
BTF3	"BTF3a, BTF3b, NACB"	ENSG00000145741	"Basic transcription factor 3"	P20290	5	73498408-73505635	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013007, HPA056420"	Approved		Supported	Cytosol			100000	Cytosol		"CAB013007: , HPA056420: "	"unprognostic (3.48e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.20e-3)"	"unprognostic (5.18e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.16e-1)"	98.4	64.4	44.7	67.6	40.8	98.2	105.6	38.2	49.0	111.8	87.3	45.8	69.7	62.2	107.5	67.3	141.3	75.1	68.7	69.1	40.7	41.3	74.4	107.7	66.6	100.6	46.7	41.6	172.4	111.0	44.3	44.5	90.8	44.8	110.9	75.1	53.0	102.7	76.0	157.9	107.7	87.7	95.7	53.2	84.4	76.9	56.5	41.0	132.6	123.5	131.7	113.4	135.1	88.0	89.0	104.4	19.3	77.0	75.6	102.1	159.0	96.7	65.0	70.6	100.8	70.9	119.5	110.8	67.7	95.4	118.5	114.2	83.6	110.9	146.8	107.1	70.5	68.5	102.7	175.1	136.2	60.7	131.7	83.0	62.4	109.0	103.4	78.5	67.1	103.5	139.9	76.2	141.5	107.6	77.2	95.6	99.6	88.0	117.7	147.4	89.7	65.4	90.0	83.9	182.1	124.5	97.8	82.9	110.7	66.5	76.0	136.1	97.7	162.0	77.2	51.4	69.9	61.2	182.7	90.0	91.6	136.7	68.0	120.4	75.5	19.3	77.0	19.3	52.5	60.9	88.6	89.0	89.8	73.3	104.4	71.3	99.5	87.1	10.8	75.6	47.8	58.7	102.1	159.0	44.7	40.8	38.2	49.0	40.7	41.3	46.7	41.6	44.8	41.0
BTK	"AGMX1, ATK, IMD1, PSCTK1, XLA"	ENSG00000010671	"Bruton tyrosine kinase"	Q06187	X	101349447-101390796	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 77.5;lymphoid tissue: 37.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 28.8;HEL: 40.0;HMC-1: 144.1;U-937: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 77.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001198, HPA002028, CAB016689"	Enhanced		Supported	"Plasma membrane,Cytosol"			610000	"Plasma membrane, Cytosol"		"CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306"	"unprognostic (3.19e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.58e-3)"	"unprognostic (6.02e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.14e-2)"	7.3	2.4	3.3	23.5	5.6	14.0	2.6	0.8	3.6	2.3	3.0	4.7	0.3	2.2	1.9	2.6	2.4	2.0	3.7	3.3	3.3	2.5	2.2	2.5	10.7	25.1	5.4	1.2	1.2	1.5	0.2	1.4	3.2	4.1	2.5	4.5	1.5	3.2	1.0	1.0	2.5	12.9	3.3	10.8	37.0	3.1	1.3	6.3	4.0	1.7	1.8	36.7	5.8	2.0	13.7	13.2	77.5	20.7	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.0	0.0	0.0	16.0	144.1	0.0	0.0	0.0	0.0	0.0	8.4	0.3	0.0	0.0	0.0	11.2	0.2	0.0	12.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	13.7	0.0	20.9	0.0	77.5	11.3	19.3	0.0	18.1	0.0	13.7	0.0	0.0	13.2	13.7	0.0	0.0	4.5	0.0	20.7	6.0	0.0	6.1	3.3	5.6	0.8	3.6	3.3	2.5	5.4	1.2	4.1	6.3
C14orf39	SIX6OS1	ENSG00000179008	"Chromosome 14 open reading frame 39"	Q8N1H7	14	60396469-60515543	"Plasma proteins, Predicted intracellular proteins"	"DNA recombination, Meiosis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pituitary gland: 16.9;salivary gland: 6.7;testis: 14.9"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;HSkMC: 4.2;MOLT-4: 20.4;RH-30: 5.6;U-2 OS: 11.5"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA059518	Uncertain		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA059518: "	"unprognostic (6.17e-2)"	"unprognostic (1.73e-3)"		"unprognostic (3.00e-6)"	"unprognostic (2.78e-1)"	"unprognostic (6.97e-2)"		"unprognostic (7.55e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.78e-1)"		"unprognostic (7.46e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	1.0	2.7	0.0	0.6	0.2	0.0	0.1	0.0	0.5	0.5	0.8	0.0	0.0	0.3	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4	1.7	0.0	0.6	16.9	0.0	0.2	1.6	0.0	1.6	6.7	0.1	3.8	0.0	0.3	0.1	0.5	0.0	0.6	14.9	0.0	0.0	0.4	1.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.0	0.0	0.3	4.2	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	20.4	0.2	2.7	1.3	0.0	5.6	0.0	0.3	1.5	0.1	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	1.4	0.1	0.4	0.2	0.0
C17orf75	"NJMU-R1, SRI2"	ENSG00000108666	"Chromosome 17 open reading frame 75"	Q9HAS0	17	32324565-32350023	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004061, HPA075333"	Approved	Approved	Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA004061: AB_1078337, HPA075333: "	"unprognostic (4.21e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.92e-2)"	"unprognostic (7.80e-2)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.09e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.27e-2)"	"unprognostic (5.60e-2)"	6.9	17.3	16.6	8.2	21.2	5.7	13.1	25.8	23.9	8.7	10.1	12.7	10.9	10.5	12.7	15.6	9.9	14.7	6.9	18.6	13.4	14.8	19.6	12.7	8.0	10.8	13.8	14.1	16.0	11.3	16.6	17.2	9.3	21.1	11.8	11.3	11.7	11.8	11.8	15.0	8.0	9.2	11.0	11.3	10.8	10.9	20.4	13.3	11.7	16.4	8.3	11.3	9.7	8.9	15.0	13.7	18.4	12.3	13.7	16.4	13.0	13.2	14.4	20.9	7.4	6.1	8.1	10.9	9.6	10.6	15.5	13.8	7.2	5.2	9.1	11.2	8.8	14.9	17.2	13.1	22.2	6.4	16.7	7.3	13.3	13.3	13.2	10.4	6.1	6.4	15.9	11.1	8.0	11.7	14.3	13.2	10.1	10.9	29.1	9.0	13.3	7.9	18.4	13.8	15.9	9.2	7.4	20.4	16.8	8.5	7.5	20.2	19.1	6.4	7.3	8.1	12.8	3.8	14.9	15.8	17.8	31.4	6.2	9.1	2.4	18.4	10.6	13.2	16.0	8.8	16.4	14.5	14.6	15.4	13.7	15.0	16.1	15.1	3.5	13.7	12.3	10.4	15.0	13.0	16.6	21.2	25.8	23.9	13.4	14.8	13.8	14.1	21.1	13.3
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22636506-22639608	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 204.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 3.8;NB-4: 2.2;RPMI-8226: 11.5;SCLC-21H: 5.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"intermediate monocyte: 50.3;non-classical monocyte: 37.5"	"Lineage enriched"	"Detected in single"	57	"monocytes: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"		1100000000			"CAB009823: AB_2228238, HPA002350: AB_1078552"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.07e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.75e-2)"	"unprognostic (7.30e-2)"	51.4	33.0	12.4	19.3	21.0	5.3	40.6	1.9	10.9	10.8	20.3	8.0	2.1	22.1	8.2	25.9	11.3	15.5	22.6	43.9	9.2	10.4	14.4	27.6	60.7	94.4	17.2	4.6	9.5	11.9	2.4	9.6	33.6	15.8	16.0	15.9	12.2	9.4	7.5	7.9	4.3	24.7	24.8	26.8	204.0	11.6	12.3	16.6	7.5	10.9	5.4	8.4	24.1	12.8	0.0	0.8	0.1	50.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	2.2	0.5	0.0	0.8	0.5	11.5	0.0	0.0	5.1	1.6	0.1	0.0	0.0	0.9	0.1	0.4	0.0	0.3	0.6	0.2	1.5	0.0	0.1	0.2	0.2	0.1	0.0	1.2	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	37.5	0.0	0.0	2.1	12.4	21.0	1.9	10.9	9.2	10.4	17.2	4.6	15.8	16.6
C1QB		ENSG00000173369	"Complement C1q B chain"	P02746	1	22652762-22661538	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 262.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 2.7;NB-4: 2.5;SH-SY5Y: 2.9;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	66	"intermediate monocyte: 41.9;non-classical monocyte: 26.9"	"Lineage enriched"	"Detected in single"	83	"monocytes: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"		4700000000			"HPA052116: "	"unprognostic (1.42e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.20e-2)"	"unprognostic (5.93e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (9.58e-6)"	"unprognostic (4.14e-2)"	"unprognostic (7.76e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.35e-2)"	76.7	42.3	30.3	22.0	54.5	7.1	17.6	3.3	27.8	12.1	28.2	27.6	1.4	30.0	9.0	25.5	10.8	21.5	33.2	19.8	19.8	17.0	21.8	51.5	87.9	84.1	45.7	6.8	9.8	11.2	4.2	14.4	41.2	35.7	15.0	24.6	17.2	13.9	9.3	9.2	4.3	30.5	41.9	52.2	262.8	14.4	11.7	38.1	7.4	9.8	3.7	9.5	36.8	6.6	0.0	0.5	0.1	41.9	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.2	2.5	1.6	0.0	1.6	1.1	1.9	0.0	0.0	1.9	2.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.3	2.9	0.1	0.5	0.5	0.3	0.6	0.0	0.5	0.0	0.0	41.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.2	26.9	0.0	0.0	1.4	30.3	54.5	3.3	27.8	19.8	17.0	45.7	6.8	35.7	38.1
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"		930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	48.8	76.0	26.9	43.4	20.1	24.8	36.4	37.5	30.7	87.4	53.8	72.7	16.4	105.0	37.1	28.3	43.8	86.4	50.9	80.9	24.0	148.7	48.3	39.5	84.5	32.1	58.9	38.5	27.4	46.8	48.0	69.5	44.5	57.4	26.9	33.9	34.1	83.6	42.6	60.6	45.5	66.7	38.1	57.3	50.4	37.0	21.6	40.5	30.8	39.6	52.2	25.0	29.8	26.1	28.1	25.6	31.9	81.4	14.1	21.5	46.2	26.8	56.7	43.0	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643630-22648110	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 192.2"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.6;RPMI-8226: 6.6;SH-SY5Y: 2.0;U-266/70: 2.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"intermediate monocyte: 28.4"	"Lineage enriched"	"Detected in single"	284	"monocytes: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	513300000	1300000000			"CAB009828: AB_2067541, HPA001471: AB_1078553"	"unprognostic (2.97e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.21e-2)"	"unprognostic (3.73e-2)"	50.5	35.7	24.2	24.6	39.2	5.9	15.6	2.5	18.3	9.8	21.8	19.9	1.2	30.0	8.5	23.4	9.7	17.0	26.8	22.6	17.5	13.6	14.4	41.2	48.2	75.1	34.8	6.1	8.5	7.8	2.6	10.2	34.8	30.2	15.0	15.7	14.8	13.2	8.3	8.0	4.6	33.1	27.1	34.5	192.2	15.5	10.3	29.1	10.7	8.3	4.0	9.5	28.3	6.0	0.0	0.0	0.0	28.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.8	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.7	2.6	0.7	0.0	1.5	0.8	6.6	0.0	0.0	1.2	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.3	0.3	2.9	0.0	0.3	0.3	0.4	0.0	0.0	0.7	0.0	0.0	28.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.5	24.2	39.2	2.5	18.3	17.5	13.6	34.8	6.1	30.2	29.1
C1QL1	"C1QRF, C1QTNF14, CRF"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968071	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 17.8;SH-SY5Y: 12.7;U-2 OS: 44.5;U-251 MG: 13.4;U-87 MG: 14.4"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in brain"						"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	2.5	2.3	20.2	2.0	9.7	1.3	1.5	4.9	42.5	1.6	2.9	12.7	0.0	5.2	5.0	2.0	2.5	1.8	1.8	1.8	14.4	16.3	6.4	1.4	1.3	1.3	13.3	10.4	1.3	4.3	1.2	0.7	1.3	35.2	11.6	1.8	10.3	1.4	1.4	1.2	1.6	3.9	2.5	12.8	1.3	4.4	1.6	8.5	0.0	1.4	0.0	1.2	2.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.5	0.6	9.0	0.2	0.0	0.2	0.3	0.3	0.3	0.8	0.3	0.3	0.1	1.4	0.2	0.2	1.4	0.1	0.1	5.7	3.8	0.0	4.1	0.0	1.1	0.0	1.1	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.2	0.5	1.9	0.0	1.5	5.4	3.2	0.1	0.1	0.0	0.2	17.8	12.7	7.6	0.6	0.5	2.1	0.1	0.0	0.7	44.5	0.5	13.4	0.5	0.0	0.0	14.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	9.7	4.9	13.9	14.4	16.3	13.3	10.4	35.2	8.5
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34019448-34043832	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"salivary gland: 171.5"	"Cell line enriched"	"Detected in single"	199	"U-266/84: 129.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	44100000	27000000	"Golgi apparatus"		"HPA064996: , HPA066011: "	"unprognostic (7.71e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.83e-2)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.80e-1)"	"unprognostic (9.38e-3)"	"unprognostic (2.35e-1)"	4.4	0.3	5.7	2.7	6.4	0.2	4.5	9.6	3.4	2.4	7.9	1.8	4.8	2.1	2.5	3.9	22.5	2.0	3.6	0.9	4.2	3.1	4.0	0.5	2.6	0.5	4.3	1.4	1.1	1.0	0.3	0.7	0.8	3.7	30.2	6.6	2.4	171.5	3.2	1.3	1.4	5.5	14.4	5.6	0.5	8.4	7.9	2.6	0.6	1.0	3.6	0.7	13.1	3.2	0.4	0.1	0.4	0.0	0.0	1.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.1	0.0	0.1	0.1	129.4	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.4	5.7	6.4	9.6	2.8	4.2	3.1	4.3	1.4	3.7	2.6
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446166	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 39.6"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.0;ASC TERT1: 6.2;HSkMC: 3.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	14	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	238000000		Vesicles		"CAB007055: , HPA051797: , HPA055392: "	"unprognostic (6.61e-2)"	"unprognostic (4.50e-2)"	"unprognostic (6.16e-2)"	"unprognostic (6.50e-4)"	"unprognostic (1.24e-1)"	"unprognostic (4.98e-3)"	"unprognostic (2.31e-2)"	"unprognostic (7.69e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.97e-4)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (7.56e-3)"	"unprognostic (7.28e-3)"	16.0	0.9	0.6	24.7	0.8	0.0	7.4	0.3	0.7	39.6	12.0	0.5	3.3	0.6	24.6	10.1	17.3	6.2	20.3	5.4	0.6	0.6	4.0	1.0	7.9	0.5	0.8	0.5	15.9	1.3	0.0	1.4	5.4	0.8	22.0	3.2	5.4	2.7	2.4	2.2	3.5	4.1	22.1	0.7	10.2	10.4	4.4	0.1	0.3	4.2	13.0	2.0	16.3	15.8	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.3	0.7	0.6	0.6	0.8	0.5	0.8	0.1
C1R		ENSG00000159403	"Complement C1r"	P00736	12	7080209-7092607	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 370.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 177.7;ASC TERT1: 90.7;BJ hTERT+: 78.2;BJ hTERT+ SV40 Large T+ RasG12V: 48.2;HSkMC: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 2.0;gdT-cell: 1.6;MAIT T-cell: 2.0;memory CD4 T-cell: 1.4;memory CD8 T-cell: 3.4;naive CD4 T-cell: 2.8;naive CD8 T-cell: 2.9;neutrophil: 2.5;NK-cell: 3.2;T-reg: 1.4"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.5;NK-cells: 3.2;T-cells: 3.4"					"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol	"Secreted to blood"		14000000000	"Nucleoplasm, Cytosol"		"HPA001251: , HPA001551: AB_10754818"	"unprognostic (1.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (1.94e-14)"	"unprognostic (3.54e-2)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.59e-2)"	45.8	17.4	2.6	18.1	3.8	0.0	82.0	1.4	2.8	36.7	24.5	2.4	11.2	5.0	27.2	66.8	38.1	33.3	46.7	49.5	1.9	1.8	27.5	370.2	25.3	46.8	3.5	2.0	103.5	11.4	1.4	6.3	10.3	4.6	47.8	15.3	17.7	12.8	13.2	16.0	10.7	14.4	53.2	6.2	35.1	19.8	39.3	1.9	2.3	30.6	20.7	15.1	46.8	83.8	0.4	0.0	2.5	0.4	3.2	3.4	0.8	0.1	1.5	0.1	1.3	177.7	90.7	0.1	19.9	78.2	23.7	48.2	0.2	0.3	0.0	0.6	15.6	0.2	1.7	0.8	3.3	1.8	0.1	0.0	0.6	0.6	34.2	0.1	0.2	105.0	0.5	10.8	0.8	0.4	0.0	2.5	3.1	0.0	0.8	0.1	0.8	0.1	1.1	0.5	0.1	0.1	0.9	0.0	0.3	14.4	0.4	0.4	0.0	0.0	0.0	5.6	0.9	26.1	0.1	0.1	0.4	0.0	8.1	0.1	0.8	0.0	0.4	2.0	1.6	0.1	2.0	0.0	1.4	3.4	0.0	0.4	2.8	2.9	2.5	3.2	0.0	0.0	1.4	0.8	2.6	3.8	1.4	2.8	1.9	1.8	3.5	2.0	4.6	1.9
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109273	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.6;HSkMC: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA011338, CAB026172"	Supported		Approved	Microtubules,Cytosol	"Secreted to blood"	5500000000	20000000000	Microtubules	Cytosol	"CAB026172: , HPA011338: AB_1847111"	"prognostic favourable (7.92e-4)"	"unprognostic (7.76e-2)"	"unprognostic (3.91e-3)"	"unprognostic (5.25e-3)"	"unprognostic (2.92e-3)"	"unprognostic (9.60e-2)"	"unprognostic (2.75e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.34e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (1.52e-7)"	"unprognostic (1.75e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.26e-3)"	16.5	31.2	3.8	10.0	5.5	6.1	14.2	1.2	4.9	12.1	13.5	3.2	10.5	6.0	12.4	14.9	13.3	14.5	14.7	10.0	2.5	1.6	21.4	96.1	14.2	13.1	4.5	2.7	21.3	23.8	5.2	15.7	4.2	6.4	16.5	7.2	11.3	16.9	11.5	11.1	7.8	9.5	15.4	9.3	12.7	11.1	7.2	4.7	2.8	14.4	8.1	7.0	15.5	16.4	2.2	1.7	11.7	2.5	0.6	1.4	0.9	2.2	5.9	0.6	5.9	18.4	31.6	4.2	3.7	17.2	3.6	11.3	3.8	10.3	0.9	3.2	2.9	5.0	1.6	6.4	1.5	9.3	0.3	3.5	5.9	8.8	14.9	0.7	17.2	35.0	12.0	2.3	7.4	3.9	2.8	2.2	2.3	0.1	0.5	0.7	1.1	0.1	2.0	0.0	0.7	10.5	10.0	0.4	1.3	12.6	1.5	2.2	1.5	3.1	3.3	3.4	6.3	3.9	0.6	1.7	0.7	0.1	6.4	2.5	1.5	7.2	1.5	8.0	1.4	2.3	0.6	2.2	1.4	1.0	1.7	1.1	0.9	0.8	11.7	0.6	2.5	0.9	0.8	0.9	3.8	5.5	1.2	4.9	2.5	1.6	4.5	2.7	6.4	4.7
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 351.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 97.0;ASC TERT1: 129.2;BJ hTERT+: 41.1;HSkMC: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 6.2"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 6.2"					"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	93000000000	13000000000	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: AB_1847112"	"unprognostic (2.72e-3)"	"unprognostic (7.31e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.63e-2)"	"prognostic favourable (7.73e-4)"	"unprognostic (6.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (7.44e-15)"	"unprognostic (2.02e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.19e-2)"	"unprognostic (5.39e-2)"	48.7	16.6	3.3	18.7	4.1	0.0	55.7	1.9	3.1	35.3	31.1	2.9	12.7	6.8	32.2	50.0	38.3	46.4	47.2	34.4	2.5	1.1	18.0	351.6	31.4	21.1	6.3	3.2	98.8	15.5	1.9	6.0	8.5	6.5	52.1	18.6	26.1	14.6	12.4	18.2	14.7	19.2	47.6	8.8	32.5	24.6	37.2	2.3	3.2	30.5	22.7	18.8	48.6	73.0	0.2	0.1	6.2	0.3	0.2	0.1	0.0	0.0	2.2	0.1	1.2	97.0	129.2	0.4	17.5	41.1	9.3	17.0	0.0	0.2	0.0	2.4	21.7	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.6	4.6	29.2	0.2	0.1	68.6	0.3	7.5	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.1	0.3	0.3	0.0	0.1	10.6	0.2	0.2	0.0	0.0	0.0	4.3	0.3	16.5	0.0	0.0	0.0	0.1	9.3	0.1	0.2	0.6	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.1	6.2	0.2	0.1	0.1	0.0	0.0	3.3	4.1	1.9	3.1	2.5	1.1	6.3	3.2	6.5	2.3
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 132.7"	"Group enriched"	"Detected in some"	5	"Hep G2: 16.9;Karpas-707: 52.8"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"classical monocyte: 2.9;intermediate monocyte: 6.4;non-classical monocyte: 6.5"	"Lineage enriched"	"Detected in single"	8	"monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016775	Supported				"Secreted to blood"		52000000000			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavourable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	9.2	3.2	0.9	4.8	1.5	0.8	5.0	1.2	1.3	2.0	5.3	1.8	1.6	2.5	2.0	4.8	1.9	3.3	3.2	5.4	0.8	0.8	13.1	132.7	19.4	13.1	1.2	0.3	2.7	2.1	0.8	2.8	7.6	1.7	1.8	4.3	2.9	2.4	1.5	0.7	1.6	6.6	3.5	1.8	12.1	1.9	2.0	1.0	1.8	1.2	0.8	3.4	2.7	1.5	0.2	0.5	0.8	6.5	0.1	0.3	1.2	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.6	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	16.9	0.3	0.0	0.2	0.9	0.1	0.2	0.0	0.0	0.1	52.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	1.3	0.6	0.0	0.0	0.1	0.1	1.0	0.1	0.0	0.1	2.3	0.1	0.1	0.2	0.2	0.0	0.2	6.6	1.0	0.2	0.3	0.0	0.1	2.9	0.0	0.1	6.4	0.1	0.1	0.1	0.1	0.5	0.2	0.3	0.2	0.8	0.1	6.5	0.0	0.1	1.2	0.9	1.5	1.2	1.2	0.8	0.8	1.2	0.3	1.7	1.0
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"liver: 611.7"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.4;EFO-21: 99.9;Hep G2: 103.2;HSkMC: 73.7;SiHa: 27.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 1213.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.2;monocytes: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	1003333333333	250000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	59.7	34.1	9.3	20.0	19.6	1.0	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7.0	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3.0	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2.0	0.4	0.8	8.3	3.0	0.0	0.0	1.5	5.0	10.0	0.6	47.4	0.9	1.7	0.5	6.5	0.2	99.9	0.0	6.1	0.0	5.7	0.9	3.0	0.0	0.4	4.4	103.2	2.2	0.8	1.2	73.7	1.7	8.2	3.7	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.0	4.3	0.8	0.0	0.0	27.6	0.0	0.0	2.3	1.1	0.4	0.7	0.9	0.6	0.4	0.2	0.5	0.5	10.2	0.6	0.0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2.0	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7.0	4.1	12.3	2.2	12.8	10.7
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982024-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease mutation, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 49.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 24.8;HSkMC: 35.2;U-266/70: 8.2;U-266/84: 15.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	342400000	98000000000			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: , HPA048287: , HPA050103: "	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	2.7	17.5	1.3	4.3	1.1	0.0	3.3	0.0	0.1	0.4	3.0			2.9	1.6	5.8	0.7	3.5	0.8	2.7	0.7	0.9	12.8	49.5	6.7	1.4	0.9		8.0	2.6	0.0	2.2	0.0		1.5	1.7		1.3	0.0	0.0	0.1	1.2	0.0	0.7	2.9	4.1	0.3			8.1		1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	24.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	35.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	8.2	15.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014762-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 30.7;liver: 52.4"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 52.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"		97000000000			"HPA046356: , HPA048287: , HPA050103: "	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	3.7	30.7	0.9	0.0	0.7	0.0	1.3	0.0	0.9	0.7	2.3			0.9	1.4	0.0	0.0	4.7	2.4	2.6	0.4	0.9	7.2	52.4	2.0	0.7	0.7		7.2	2.7	1.0	1.8	0.5		0.5	2.7		2.0	0.4	0.0	0.0	1.0	3.8	0.6	1.4	0.8	0.7			5.7		1.6	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	3.3	0.2	0.0	10.2	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104262-207144972	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 377.2"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 28.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 434.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	153	"neutrophil: 21.6"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 21.6"									"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	30800000000	34000000000			"HPA000926: AB_1078355, HPA001578: AB_1078354"	"unprognostic (3.85e-4)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (6.37e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.94e-1)"	"unprognostic (5.90e-4)"	"unprognostic (4.47e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.51e-7)"	"unprognostic (9.74e-2)"	"unprognostic (2.52e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-1)"	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.6	0.2	0.1	0.1	0.0	0.6	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	377.2	26.0	0.1	0.1	0.1	0.3	1.8	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	21.6	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088842-207099993	"Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 156.5"	"Group enriched"	"Detected in some"	18	"CACO-2: 38.3;HeLa: 15.9;Hep G2: 49.8"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 83.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5;plasmacytoid DC: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.6;T-cells: 2.5"					"Low region specificity"	"Detected in all"			HPA051620	Approved				"Secreted to blood"	265000000000	1300000000			"HPA051620: "	"unprognostic (1.73e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.58e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.25e-2)"	0.5	0.0	0.1	0.5	0.1	0.0	0.3	0.1	0.1	0.5	2.0	0.1	0.1	0.6	0.1	0.9	0.2	0.1	1.0	0.6	0.1	0.0	0.2	156.5	0.6	0.1	0.1	0.1	9.9	2.2	0.0	0.1	1.3	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.9	0.2	0.1	0.1	1.5	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	3.6	0.0	0.0	0.0	2.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	49.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.5	0.8	0.0	0.0	0.0	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120952335-121050276	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"liver: 259.9"	"Cell line enhanced"	"Detected in many"		"A549: 20.1;Hep G2: 21.1"	"Cancer enriched"	"Detected in many"	17	"liver cancer: 73.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	113184500000	46000000000			"HPA029339: AB_10601125"	"unprognostic (2.51e-1)"	"unprognostic (5.88e-3)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.52e-3)"	"prognostic favourable (9.43e-4)"	"unprognostic (1.83e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.46e-5)"	"unprognostic (5.91e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.75e-1)"	0.5	0.3	0.4	0.3	0.5	0.3	0.4	0.3	0.3	0.4	1.1	0.3	0.3	0.7	0.5	0.7	0.3	0.6	0.4	0.3	0.4	0.3	1.1	259.9	2.3	0.3	0.4	0.3	0.7	4.7	0.8	0.7	0.3	0.4	0.6	0.2	0.3	0.3	0.4	0.3	0.7	3.2	0.3	0.5	0.3	1.2	0.4	0.3	0.3	0.3	0.3	0.3	0.5	0.4	1.8	2.1	1.8	1.6	0.1	1.2	0.5	1.1	20.1	4.6	8.1	6.0	6.9	0.2	2.4	2.5	0.7	1.4	0.6	1.9	2.9	0.1	1.2	7.9	0.2	0.2	1.1	0.6	0.0	1.2	1.0	21.1	1.1	0.7	0.5	3.1	0.4	1.4	2.7	0.7	0.5	2.8	1.5	3.9	0.3	0.1	1.2	7.8	1.7	2.0	0.3	1.2	0.6	1.2	4.8	1.1	0.0	2.0	1.6	2.6	0.9	2.0	0.1	5.4	2.4	1.6	1.2	1.2	1.6	2.7	4.9	0.0	1.6	1.8	0.3	0.4	1.2	1.8	0.6	0.5	2.1	1.0	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.5	0.4	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.4	0.3
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	13	"ASC diff: 5.1;ASC TERT1: 7.1;HSkMC: 18.8"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"		7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favourable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	7.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	18.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1
C7		ENSG00000112936	"Complement C7"	P10643	5	40909252-40982939	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 199.9"	"Group enriched"	"Detected in some"	9	"ASC diff: 37.6;HHSteC: 49.7;HSkMC: 68.4;SH-SY5Y: 46.4"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA001465	Approved				"Secreted to blood"		67000000000			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favourable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	54.4	99.5	0.8	7.4	1.6	0.0	10.5	1.1	1.0	30.2	34.7	3.1	14.8	2.5	36.8	48.6	55.3	47.7	48.2	79.7	0.9	0.3	81.3	41.0	29.1	69.0	3.9	1.5	199.9	32.4	3.0	5.2	55.4	3.7	52.5	4.8	1.4	5.1	17.5	1.9	1.8	17.0	43.3	3.2	33.6	17.9	44.6	0.7	3.1	32.4	1.1	7.2	39.9	29.6	0.7	0.4	1.6	0.3	1.5	0.4	0.0	0.0	0.0	0.0	0.0	37.6	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.2	0.0	0.7	0.3	0.4	1.1	1.5	0.3	0.4	0.0	0.0	0.8	1.6	1.1	1.0	0.9	0.3	3.9	1.5	3.7	0.7
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"		3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929210-56966140	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"liver: 240.9"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.7"	"Cancer enriched"	"Detected in some"	181	"liver cancer: 107.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	47	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	47	"granulocytes: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023694	Supported				"Secreted to blood"		3600000000			"HPA023694: AB_1847128"				"unprognostic (6.65e-2)"			"prognostic favourable (9.31e-5)"	"unprognostic (2.37e-1)"			"unprognostic (2.37e-1)"			"unprognostic (1.29e-2)"	"unprognostic (6.57e-2)"	"unprognostic (5.12e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	240.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	5.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945246-136946974	"Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 165.8"	"Cell line enriched"	"Detected in some"	13	"HMC-1: 59.5"	"Cancer enriched"	"Detected in all"	58	"liver cancer: 260.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 1.5;T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA046269	Approved				"Secreted to blood"		1500000000			"HPA046269: "	"unprognostic (5.00e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (2.99e-4)"	"unprognostic (3.94e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.16e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.05e-2)"	0.2	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	6.0	0.2	0.2	14.6	0.2	0.2	0.2	0.2	2.7	0.2	0.2	0.1	0.4	165.8	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	0.3	12.1	0.2	0.2	0.6	0.6	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.5	0.0	0.1	0.0	3.4	0.3	0.1	0.8	0.1	0.2	0.1	0.0	0.6	0.3	0.0	0.0	0.0	1.1	0.6	1.1	0.7	0.0	0.9	0.0	0.1	0.0	1.1	0.1	0.3	1.6	4.5	0.0	0.0	59.5	0.0	0.2	0.2	0.0	0.2	0.1	0.6	0.2	0.8	0.1	0.5	0.0	0.2	0.1	0.2	0.8	0.2	0.5	0.2	0.2	0.2	1.7	0.3	1.5	0.4	0.6	0.3	0.1	0.1	0.2	0.3	0.5	0.0	0.2	0.5	0.2	0.0	0.1	0.0	3.4	0.0	0.4	0.0	0.7	1.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
C9		ENSG00000113600	"Complement C9"	P02748	5	39284262-39424868	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	577	"liver: 419.5"	"Cell line enhanced"	"Detected in some"		"HL-60: 2.5;RH-30: 1.6;SiHa: 1.0;U-698: 6.3"	"Cancer enriched"	"Detected in single"	244	"liver cancer: 90.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	69605000000	97000000000			"CAB002151: AB_563670, HPA029577: AB_10603779"	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.50e-1)"		"unprognostic (2.01e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.49e-3)"		"unprognostic (1.91e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (9.43e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.04e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	419.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C9orf3	"AOPEP, AP-O, APO, C90RF3, FLJ14675"	ENSG00000148120	"Chromosome 9 open reading frame 3"	Q8N6M6	9	94726701-95087218	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004633, HPA072729"	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA004633: AB_1078362, HPA072729: "	"unprognostic (4.25e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (6.33e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.37e-2)"	6.2	8.5	6.8	9.1	12.7	2.4	11.3	10.5	10.3	14.0	17.8	24.6	24.1	5.1	28.8	15.0	20.2	16.0	17.9	29.9	8.9	5.9	12.7	28.1	10.9	3.1	11.3	6.1	11.7	24.7	25.0	11.1	24.4	11.3	22.1	6.8	11.4	13.1	17.6	29.8	39.1	8.1	32.2	11.6	6.8	10.8	6.4	11.4	3.3	11.6	23.7	7.8	12.9	25.1	5.4	5.8	2.1	3.6	3.4	3.6	1.8	4.5	20.4	2.2	3.8	2.3	3.0	8.7	4.4	2.0	4.6	2.8	4.3	6.0	1.3	3.7	7.4	18.0	4.1	4.2	2.3	9.5	3.2	1.3	18.5	3.8	4.7	1.2	1.0	3.1	17.5	4.0	2.7	2.6	2.1	1.9	8.4	6.7	1.7	1.4	2.9	8.5	2.7	7.1	1.7	8.1	4.1	4.5	6.8	7.4	6.9	1.6	7.6	0.9	2.0	2.0	2.0	8.3	2.3	1.6	2.1	0.7	6.9	1.0	3.6	0.3	3.6	2.1	3.6	2.5	2.3	2.4	3.0	3.3	5.8	5.4	2.3	2.7	1.3	3.4	1.7	5.2	1.9	1.8	6.8	12.7	10.5	10.3	8.9	5.9	11.3	6.1	11.3	11.4
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 156.0;intestine: 203.6"	"Cell line enriched"	"Detected in single"	1206	"HEL: 165.2"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006558, CAB025790"	Enhanced						7800000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.8	0.4	0.5	11.5	0.5	156.0	0.4	0.3	0.4	0.3	95.4	1.5	0.0	0.0	0.3	0.0	0.6	0.7	0.0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0.0	0.8	0.5	0.0	1.0	24.0	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0.0	0.2	7.5	0.0	0.2	4.5	16.0	0.7	0.7	0.0	0.3	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0.0	0.6	0.0
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463852-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"Disease mutation, FDA approved drug targets, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.1;stomach 1: 171.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 33.1;HEK 293: 139.1;THP-1: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001550, CAB010102"	Enhanced						790000000			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	1.6	2.2	24.4	21.5	32.6	32.4	6.9	4.3	23.2	1.3	108.1	28.9	42.0	46.9	0.9	2.2	5.6	0.9	33.0	4.3	29.1	14.5	53.5	43.0	10.2	1.3	49.0	14.2	0.5	9.1	3.1	2.0	3.5	65.0	0.8	105.6	7.0	14.0	54.2	9.2	13.3	7.6	6.0	27.5	2.5	171.5	5.1	58.3	0.0	3.8	2.4	1.1	1.0	1.4	1.9	8.0	20.3	8.2	0.0	4.4	17.5	0.5	0.3	1.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.2	0.0	33.1	4.8	1.6	0.0	0.0	139.1	4.3	2.4	0.0	0.0	3.0	0.6	0.0	8.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.4	0.0	2.7	0.1	0.0	0.4	1.1	0.0	0.0	0.7	0.0	0.0	0.0	58.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	20.3	3.1	4.4	0.1	8.2	4.4	0.6	0.0	0.4	8.0	1.9	0.0	0.0	6.8	0.0	7.1	0.8	0.0	17.5	24.4	32.6	4.3	23.2	29.1	14.5	49.0	14.2	65.0	58.3
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"skeletal muscle: 347.5"	"Group enriched"	"Detected in some"	32	"HEL: 23.3;RH-30: 39.2"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced						31000000			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favourable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	18.0	0.4	0.2	0.1	0.2	0.5	0.6	0.2	0.1	0.5	0.3	0.0	0.1	0.1	0.6	29.0	9.5	1.0	0.2	1.3	0.2	0.1	0.2	0.2	4.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	6.6	0.0	0.0	5.5	0.2	347.5	0.3	0.4	1.4	0.1	0.1	0.3	0.5	0.0	0.0	0.3	14.1	3.4	0.7	0.5	0.5	1.8	0.0	0.0	0.0	0.8	0.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	23.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	1.8	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.0
CAB39	"CGI-66, MO25"	ENSG00000135932	"Calcium binding protein 39"	Q9Y376	2	230712845-230821075	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037112	Supported		Approved	"Nucleoli fibrillar center,Cytosol"			130000	"Nucleoli fibrillar center"	Cytosol	"CAB037112: AB_1078367"	"unprognostic (4.36e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.84e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (8.33e-4)"	"unprognostic (1.04e-1)"	"prognostic favourable (9.05e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.92e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.36e-1)"	28.8	16.7	24.5	25.8	24.0	22.1	22.2	22.4	35.0	16.5	26.1	16.8	14.0	23.4	19.3	18.3	28.3	15.5	20.8	34.2	25.4	26.0	27.4	18.9	20.9	25.8	28.4	27.6	17.0	16.3	22.3	15.2	21.0	32.8	20.9	28.4	13.9	22.4	16.7	82.2	21.8	28.8	26.3	28.0	21.5	22.6	19.6	17.8	20.9	22.0	26.6	28.1	22.9	30.8	3.6	3.6	12.4	5.1	11.6	8.4	2.6	37.4	8.7	11.9	10.1	14.7	18.5	13.6	21.6	27.1	13.6	14.3	10.6	41.2	9.7	17.0	18.7	17.3	13.2	40.5	27.8	40.5	10.4	26.0	11.2	11.3	12.5	35.9	30.3	13.0	23.7	17.5	38.8	16.8	43.3	9.0	12.9	13.0	16.6	22.2	11.8	15.4	19.4	17.7	9.5	25.3	30.5	13.0	7.9	16.1	20.3	17.2	5.0	20.9	21.3	19.3	7.3	20.3	17.6	11.7	8.8	15.7	13.7	20.9	15.7	4.5	4.5	6.9	6.0	5.1	6.2	3.6	7.5	7.7	3.6	3.1	6.0	8.4	12.4	11.6	4.7	2.7	7.1	2.6	24.5	24.0	22.4	35.0	25.4	26.0	28.4	27.6	32.8	17.8
CAB39L	"bA103J18.3, FLJ12577, MO2L"	ENSG00000102547	"Calcium binding protein 39 like"	Q9H9S4	13	49308650-49444126	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 23.9;RT4: 25.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 28.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003686, HPA045954"	Uncertain		Approved	Vesicles				Vesicles		"CAB003686: AB_426084, HPA045954: "	"unprognostic (3.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (3.08e-2)"	"prognostic favourable (7.91e-4)"	"prognostic favourable (1.94e-13)"	"unprognostic (6.59e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.96e-2)"	"unprognostic (8.05e-3)"	19.6	32.1	18.4	5.6	18.2	2.1	32.6	17.6	22.6	12.9	33.2	13.1	19.0	5.5	11.5	14.8	25.6	12.5	13.6	14.5	22.2	16.3	12.8	5.0	12.2	3.7	29.6	19.5	17.6	10.2	17.9	10.7	10.3	26.4	35.8	10.2	7.6	13.8	20.7	4.9	10.6	8.0	21.1	23.3	3.8	18.8	24.1	24.9	2.5	8.9	9.1	4.6	21.3	13.0	3.8	3.9	9.9	3.8	2.7	5.3	3.2	0.9	1.0	6.6	1.9	6.4	6.5	9.0	5.8	12.5	3.6	2.9	23.9	3.4	8.1	0.8	3.9	1.8	3.4	4.3	6.8	2.8	3.2	2.1	1.4	1.6	3.4	1.7	1.0	4.8	3.7	2.9	4.6	4.6	0.3	1.9	5.6	1.6	1.9	1.6	5.1	1.6	1.6	0.9	1.2	5.7	25.0	0.8	2.6	3.1	7.1	7.6	11.0	3.4	4.7	1.7	1.7	3.3	4.8	1.5	1.4	9.4	1.8	1.7	4.0	9.9	3.8	7.9	4.4	3.5	3.2	3.8	5.2	5.3	3.9	2.9	4.0	3.7	8.4	2.7	2.9	0.5	5.2	3.2	18.4	18.2	17.6	22.2	22.2	16.3	29.6	19.5	26.4	24.9
CABIN1	"KIAA0330, PPP3IN"	ENSG00000099991	"Calcineurin binding protein 1"	Q9Y6J0	22	24011192-24178628	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043296	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA043296: AB_10794657"	"unprognostic (8.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.74e-2)"	"prognostic favourable (9.57e-5)"	"unprognostic (3.43e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.04e-2)"	"unprognostic (2.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (2.94e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.50e-3)"	"unprognostic (7.79e-2)"	14.4	14.6	15.9	18.5	22.9	34.2	13.4	47.2	29.2	17.5	17.3	23.3	22.6	17.6	24.9	17.2	12.4	23.7	16.9	15.4	14.7	13.2	18.2	13.7	19.7	22.4	12.7	17.4	16.6	18.2	24.4	24.9	12.0	17.8	17.6	11.4	19.0	18.6	24.2	10.2	20.7	16.7	18.0	10.9	21.2	18.6	24.4	10.8	22.5	27.0	10.6	19.3	14.1	14.2	4.1	2.7	15.9	3.7	4.8	7.0	2.0	12.3	9.0	12.3	10.8	11.2	13.0	17.3	10.4	9.1	8.4	9.6	11.1	6.1	14.4	5.8	10.4	11.8	14.6	9.5	7.5	24.0	14.3	12.4	10.2	23.2	5.3	28.4	13.4	11.0	6.2	10.3	7.8	14.0	25.6	7.9	4.8	15.9	13.4	30.9	7.6	6.5	13.1	9.1	18.0	7.6	12.6	15.9	13.6	12.9	9.1	13.2	8.1	12.9	11.4	19.6	15.3	7.5	7.5	13.9	8.3	8.7	9.1	13.7	8.1	5.9	3.7	12.9	5.5	2.5	6.2	2.5	4.2	7.0	2.3	4.1	5.0	4.6	15.9	4.8	1.7	2.7	3.2	2.0	15.9	22.9	47.2	29.2	14.7	13.2	12.7	17.4	17.8	10.8
CABLES1	"FLJ35924, HsT2563"	ENSG00000134508	"Cdk5 and Abl enzyme substrate 1"	Q8TDN4	18	23134564-23260467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 40.6"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 42.2;U-266/70: 61.0"	"Cancer enriched"	"Detected in all"	5	"melanoma: 38.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"NK-cell: 4.2"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073649			Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"		"HPA073649: "	"unprognostic (1.27e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.56e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (4.71e-6)"	"unprognostic (1.00e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.81e-2)"	12.0	2.9	22.3	1.6	31.5	1.8	40.6	8.6	23.4	4.7	4.1	3.0	0.0	6.0	7.7	2.7	5.6	9.2	4.2	3.2	13.9	11.9	10.8	8.0	17.0	2.0	17.2	12.9	3.3	2.0	31.3	2.6	8.4	13.6	2.8	4.2	17.1	17.0	3.9	1.1	13.5	5.1	5.7	3.8	2.6	11.6	2.8	9.2	0.3	12.2	0.2	1.8	5.4	7.1	0.3	0.5	0.0	0.2	4.2	0.4	0.0	3.5	3.9	3.3	0.2	2.0	0.1	5.7	0.8	4.8	1.1	0.7	2.6	6.3	0.1	3.7	4.0	3.1	2.5	0.6	0.9	0.1	5.4	0.2	10.8	10.0	1.7	0.6	0.2	1.2	0.5	1.4	1.7	13.1	0.1	4.5	3.2	8.1	0.0	2.3	2.1	13.0	0.8	11.8	13.4	5.9	8.6	3.1	2.3	7.2	9.1	42.2	14.6	1.9	21.8	13.6	0.1	0.4	1.0	61.0	23.2	7.4	0.0	5.2	4.6	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.1	0.3	0.3	0.0	0.4	0.0	4.2	0.2	0.5	0.1	0.0	22.3	31.5	8.6	23.4	13.9	11.9	17.2	12.9	13.6	9.2
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 30.5;U-87 MG: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA064258: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.8	0.1	0.3	0.0	1.6	1.5	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.0	0.0	1.2	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.1	0.9	0.2	0.4	0.0	0.1	0.0	0.1	30.5	0.0	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	17.2	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8
CACNA1B	"CACNL1A5, CACNN, Cav2.2"	ENSG00000148408	"Calcium voltage-gated channel subunit alpha1 B"	Q00975	9	137877789-138124624	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 6.2;brain: 18.9;fallopian tube: 6.6;pituitary gland: 4.8;testis: 8.1"	"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 20.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA044347	Uncertain									"HPA044347: AB_10960837"	"unprognostic (1.34e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.51e-7)"	"unprognostic (8.10e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.73e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.63e-6)"	"unprognostic (4.25e-2)"	"unprognostic (4.72e-1)"	"unprognostic (7.77e-3)"	"unprognostic (8.69e-2)"	0.5	6.2	5.7	0.7	8.7	0.5	0.5	18.7	18.9	1.2	0.8	0.2	0.0	0.6	0.6	1.7	0.4	6.6	1.4	1.0	4.5	7.3	0.4	1.2	0.5	0.5	2.9	9.1	0.5	1.2	0.4	4.8	0.4	3.6	1.6	0.8	0.4	0.4	1.3	0.4	0.9	0.7	0.8	4.5	0.6	0.6	8.1	1.4	0.0	0.9	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	20.7	3.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	8.7	18.7	10.9	4.5	7.3	2.9	9.1	3.6	1.4
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 14.1;RPMI-8226: 32.8;SK-BR-3: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"				"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.5	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.1	32.8	0.3	2.2	3.0	1.3	0.2	6.2	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 55.8"	"Cell line enhanced"	"Detected in some"		"A549: 2.5;BEWO: 2.5;MCF7: 2.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced									"HPA068379: "	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.7	0.8	1.8	0.7	1.5	4.0	1.8	5.3	2.0	0.7	1.0	0.7	0.7	1.9	0.7	2.7	0.7	1.0	0.7	0.7	0.8	0.6	0.7	0.7	1.4	2.7	0.7	0.7	0.7	1.4	0.0	0.7	0.7	0.7	0.7	1.5	55.8	1.2	0.9	0.7	2.4	3.7	0.7	0.7	1.8	1.0	0.7	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.4	4.6	2.0	0.9	0.5	1.0	0.2	0.2	2.5	0.2	0.0	0.6	0.0	2.5	0.4	0.2	0.0	0.0	0.1	0.9	1.4	0.5	0.5	0.1	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.5	0.1	0.8	0.6	0.0	0.4	0.0	0.7	1.0	0.3	0.0	2.8	1.3	1.5	1.1	0.0	0.1	0.0	0.5	0.4	1.5	0.6	0.0	0.0	0.1	0.0	0.9	1.5	1.0	0.2	0.3	0.2	0.1	4.6	1.6	0.0	0.8	0.4	0.0	0.9	0.7	0.6	0.6	0.5	0.5	0.7	0.8	0.4	0.8	1.4	0.5	1.0	2.0	0.5	0.9	4.6	0.7	0.2	1.8	1.5	5.3	2.0	0.8	0.6	0.7	0.7	0.7	0.7
CACNA1G	"Cav3.1, NBR13"	ENSG00000006283	"Calcium voltage-gated channel subunit alpha1 G"	O43497	17	50561068-50627474	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.8;cervix, uterine: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 13.3;HeLa: 4.6;SCLC-21H: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004714	Uncertain									"HPA004714: AB_1078368"	"unprognostic (1.90e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.02e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.76e-2)"	"unprognostic (4.87e-12)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.63e-2)"	1.7	1.0	3.5	0.9	5.2	1.3	2.1	22.8	17.1	13.6	1.0	2.7	0.0	0.9	7.4	1.0	1.6	5.7	1.2	3.8	2.4	8.8	0.7	1.1	0.9	1.2	5.3	7.9	7.1	0.6	0.6	0.4	1.4	6.1	2.5	0.8	4.3	1.1	1.6	0.8	3.9	0.8	2.1	5.9	0.9	0.9	1.7	2.3	0.0	1.2	0.0	1.0	1.0	3.9	1.3	1.3	2.7	0.8	0.7	1.4	0.0	0.0	13.3	3.1	3.5	0.9	0.1	0.2	0.1	0.0	0.1	0.1	2.8	0.5	0.0	1.0	0.1	0.5	1.6	0.0	0.3	1.8	0.6	0.9	4.6	0.7	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.0	0.0	1.2	0.8	1.4	1.1	0.0	0.0	0.2	4.1	1.8	2.8	0.1	0.0	0.2	0.1	0.3	1.4	3.9	0.5	0.1	1.0	0.1	0.0	0.5	0.1	0.5	0.5	0.8	0.6	1.4	0.4	0.7	0.8	0.7	0.8	0.2	1.3	0.9	1.0	2.7	0.7	0.4	1.3	0.5	0.0	3.5	5.2	22.8	17.1	2.4	8.8	5.3	7.9	6.1	2.3
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689737	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 4.6;brain: 8.1;lymphoid tissue: 4.3;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	5	"SK-BR-3: 6.0;T-47d: 3.6"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 2.1"					"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.0	4.6	3.4	1.9	5.8	1.3	0.2	8.1	7.5	0.0	0.2			0.2	0.0	0.0	0.1	0.0	0.4	0.0	5.0	3.6	0.0	0.0	0.2	4.3	0.7		0.0	0.0	0.0	0.0	0.0		0.0	0.1		0.0	0.0	0.0	0.1	0.9	0.0	0.4	1.3	0.5	1.1			4.1		1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	6.0	0.0	3.6	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.5	0.0	0.0	1.9	0.7	0.0	0.0	0.0	0.0	0.8	0.1										
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443798	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.0"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.1;HUVEC TERT2: 24.7;SH-SY5Y: 28.7;TIME: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"		310000000			"HPA008213: AB_1845862, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	9.9	13.4	15.7	4.2	18.1	0.7	4.3	8.8	20.8	5.7	11.3	7.3	1.0	5.0	7.1	2.9	5.4	4.1	6.3	25.8	12.7	14.9	8.0	1.8	3.6	2.2	6.3	15.6	7.8	2.0	1.9	8.3	4.2	8.6	12.8	5.3	1.9	3.3	6.6	59.0	4.7	3.5	13.0	5.6	4.3	5.5	3.7	8.0	0.0	16.9	14.6	3.3	6.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	4.8	0.0	8.5	10.8	0.0	10.5	6.8	5.2	5.1	0.0	1.5	0.0	0.0	9.1	0.0	5.0	0.0	6.9	0.0	6.8	0.3	6.8	0.0	5.6	2.3	0.0	6.3	0.0	18.1	0.0	24.7	0.0	0.1	11.6	0.0	0.0	0.0	5.7	2.2	1.0	0.9	0.0	0.4	0.4	9.7	28.7	2.0	0.0	0.0	0.0	0.0	17.7	9.3	7.0	9.2	0.0	0.0	0.0	0.0	7.8	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	18.1	8.8	20.8	12.7	14.9	6.3	15.6	8.6	8.0
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832768-152099475	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.7"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 20.7"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"									HPA015601	Approved									"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	1.6	1.7	5.2	1.3	28.0	1.7	3.2	35.7	28.0	1.4	1.2	2.6	0.0	1.2	1.4	1.7	3.1	1.1	2.1	1.1	4.5	4.4	2.8	0.9	3.9	1.1	4.3	10.9	1.3	1.2	1.0	3.8	2.1	9.8	3.9	1.4	0.9	2.1	3.9	0.8	11.7	1.1	4.2	3.0	1.2	1.6	4.1	3.4	0.0	3.1	0.0	2.2	3.5	0.8	0.4	1.3	7.0	0.6	0.2	0.1	0.1	0.0	0.0	0.7	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.1	4.0	0.0	0.2	20.7	0.2	0.1	0.4	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.6	1.8	0.2	0.6	1.2	0.6	1.4	0.7	0.0	0.0	0.0	3.3	0.8	0.0	1.9	2.1	0.6	0.4	0.4	0.0	0.0	0.5	4.8	0.1	1.2	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.4	0.1	0.1	7.0	0.2	0.0	1.3	0.0	0.1	5.2	28.0	35.7	21.7	4.5	4.4	4.3	10.9	9.8	3.4
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Approved		Enhanced	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: "	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.4	21.1	31.1	13.3	10.4	11.7	20.0	23.4	13.9	30.4	22.2	21.7	19.1	32.2	24.5	16.6	16.7	38.7	17.1	31.5	17.0	23.6	24.1	20.8	23.3	7.9	32.4	15.1	7.8	10.6	24.9	15.1	21.3	48.3	18.1	21.8	11.3	49.8	29.6	29.5	9.8	22.5	22.1	37.1	21.6	24.4	21.4	20.6	15.9	27.9	24.1	21.6	28.4	11.0	17.3	18.5	24.1	37.5	17.5	50.2	71.4	14.5	28.5	20.1	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5
CAD	GATD4	ENSG00000084774	"Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase"	P27708	2	27217390-27243943	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Allosteric enzyme, Hydrolase, Ligase, Multifunctional enzyme, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007781, HPA057266, HPA069341"	Supported		Supported	Nucleoplasm			26000	Nucleoplasm		"CAB007781: AB_562057, HPA057266: AB_2683387, HPA069341: AB_2686125"	"unprognostic (1.69e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (1.72e-11)"	"unprognostic (1.25e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.93e-3)"	12.0	11.9	10.1	23.1	12.4	11.1	18.9	13.3	13.1	14.6	12.4	10.9	9.7	12.1	21.0	18.0	16.3	16.6	15.8	9.8	8.6	8.8	13.1	22.9	13.0	27.9	11.8	9.5	24.4	18.1	10.7	16.4	10.6	10.1	12.5	11.6	12.9	11.7	18.3	12.3	26.0	13.2	17.3	12.5	18.7	11.4	21.3	10.8	35.2	13.8	14.1	18.5	12.7	13.1	5.1	4.9	0.8	2.3	3.7	7.9	2.6	25.2	22.9	10.2	20.4	16.6	13.7	8.1	10.7	7.5	13.6	9.7	25.9	10.1	22.6	9.7	9.8	14.3	30.0	14.2	10.2	14.8	24.2	32.3	17.4	13.5	8.3	25.4	16.3	10.4	11.7	19.7	22.5	14.5	22.7	12.6	11.9	25.4	16.2	37.8	24.5	17.4	28.4	30.6	23.5	10.0	12.9	20.5	10.3	15.0	10.7	12.5	8.3	10.7	13.0	20.6	17.0	16.0	21.5	26.2	16.9	46.2	8.3	24.5	17.7	0.0	1.2	0.5	4.7	2.3	4.0	5.1	6.5	7.7	2.7	5.0	4.3	4.3	0.8	3.7	1.2	4.9	7.9	2.6	10.1	12.4	13.3	13.1	8.6	8.8	11.8	9.5	10.1	10.8
CADM1	"BL2, IGSF4, IGSF4A, Necl-2, NECL2, RA175, ST17, SYNCAM, SYNCAM1, TSLC1"	ENSG00000182985	"Cell adhesion molecule 1"	Q9BY67	11	115169218-115504957	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Differentiation, Host-virus interaction, Immunity, Spermatogenesis"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 69.0;WM-115: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.6;myeloid DC: 10.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 10.2;T-cells: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037266	Enhanced		Supported	"Cell Junctions"			200000000	"Cell Junctions"		"CAB037266: AB_532287"	"unprognostic (1.50e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (1.32e-4)"	"unprognostic (4.11e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.75e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.61e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.77e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.40e-2)"	3.5	15.2	31.3	3.0	33.7	0.5	8.3	53.7	24.8	11.5	7.1	16.9	22.9	4.0	9.1	53.1	6.5	11.4	6.2	12.2	21.5	26.5	15.2	31.3	34.3	6.3	14.2	19.0	6.6	8.0	47.6	24.0	18.1	27.8	7.9	4.4	32.9	17.8	15.1	3.9	5.5	4.4	4.5	11.5	3.9	6.6	23.3	17.1	1.0	34.5	1.3	6.9	6.6	3.6	1.8	10.2	0.1	0.0	0.5	10.6	1.8	0.0	5.4	6.1	0.0	0.0	0.0	0.0	5.7	9.7	0.7	0.0	69.0	6.2	0.0	18.4	8.6	1.1	1.1	6.4	0.4	0.2	9.5	0.0	2.0	26.3	0.0	0.0	13.6	0.0	9.3	0.0	15.4	0.2	0.0	0.6	1.0	4.6	4.5	0.1	5.7	0.0	0.0	0.1	14.0	10.8	0.2	12.1	26.0	0.0	6.1	4.9	22.0	0.3	0.0	0.5	11.2	5.6	3.0	15.6	22.4	4.4	8.8	0.0	44.5	0.1	0.0	0.0	10.6	0.0	4.7	1.8	3.9	2.8	10.2	0.3	0.1	2.7	0.0	0.5	0.0	0.0	6.3	1.8	31.3	33.7	53.7	24.8	21.5	26.5	14.2	19.0	27.8	17.1
CADPS	"CAPS, CAPS1, KIAA1121, UNC-31"	ENSG00000163618	"Calcium dependent secretion activator"	Q9ULU8	3	62398346-62875389	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.0"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 16.5;SK-MEL-30: 7.3;U-698: 10.5;U-87 MG: 17.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"memory B-cell: 1.3"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059328	Enhanced		Approved	Vesicles				Vesicles		"HPA059328: "	"unprognostic (3.46e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.08e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.20e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.91e-3)"	"unprognostic (5.35e-3)"	1.2	17.2	18.2	2.8	16.0	1.0	1.6	22.4	58.0	4.0	3.5	2.4	0.0	3.9	1.5	3.4	1.1	1.1	3.2	11.6	21.9	24.7	1.1	1.1	1.6	1.4	33.7	18.4	2.8	13.5	0.9	19.6	1.1	43.6	4.5	3.3	5.3	1.3	3.8	1.0	2.2	4.0	1.7	7.1	1.4	4.1	3.2	2.7	0.0	1.1	0.0	1.6	1.2	0.6	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	16.5	1.2	0.0	0.0	7.3	0.0	0.0	0.0	1.4	0.1	2.7	0.7	0.0	1.4	10.5	17.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.2	16.0	22.4	32.0	21.9	24.7	33.7	18.4	43.6	2.7
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;HEL: 23.4;HMC-1: 51.0;U-2 OS: 14.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol			6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.7	6.5	0.0	0.2	0.0	1.2	0.2	0.1	0.2	0.0	0.0	8.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.2	0.0	0.0	51.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	14.6	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.8;hTERT-HME1: 1.7;Karpas-707: 1.8;SCLC-21H: 3.4"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					HPA059886		Supported			"Secreted to blood"	96005				"HPA059886: "			"unprognostic (1.97e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0
CALCB	"CALC2, CGRP-II, FLJ30166"	ENSG00000175868	"Calcitonin related polypeptide beta"	P10092	11	14904997-15082342	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 14.3;pancreas: 7.9;thyroid gland: 26.0"	"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;Karpas-707: 11.0;SH-SY5Y: 3.8;U-266/70: 16.6"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Group enriched"	"Detected in many"	8	"hypothalamus: 13.5;pons and medulla: 14.3"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"pons and medulla: 10.1"					HPA059886		Supported			"Secreted to blood"					"HPA059886: "	"unprognostic (7.84e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (3.42e-5)"	"unprognostic (2.02e-1)"	"unprognostic (8.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.33e-1)"	0.5	0.2	0.0	1.6	1.6	0.3	1.5	1.5	0.8	0.3	1.5	0.0	0.0	0.9	0.4	0.3	0.3	0.2	0.3	0.9	0.0	13.5	0.4	1.1	1.3	1.0	0.7	0.2	0.2	7.9	0.3	2.7	0.4	14.3	0.4	0.5	1.8	0.7	0.2	1.2	0.3	0.8	0.4	3.9	0.9	0.3	1.4	0.3	0.6	26.0	0.0	0.3	0.3	0.0	0.2	0.3	1.1	0.2	1.8	1.2	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.3	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	2.0	0.4	0.0	11.0	0.0	0.0	0.0	0.6	3.0	0.1	0.5	0.0	0.2	0.0	0.0	1.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	16.6	0.6	0.4	2.2	0.0	0.0	0.0	0.2	1.1	0.8	0.1	1.2	0.0	0.5	0.7	0.3	0.2	1.2	1.1	0.6	1.8	0.0	0.0	0.1	0.4	0.0	1.6	1.5	0.8	0.0	13.5	0.7	0.2	14.3	0.3
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187343129-187448460	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.0"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 61.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.2;monocytes: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: "	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	42.4	5.2	4.9	6.4	3.8	0.2	19.6	7.3	9.4	21.2	12.6	2.6	4.0	3.1	17.9	6.8	16.3	6.5	13.4	15.1	4.5	3.8	16.5	12.5	91.0	16.9	4.7	3.5	15.2	3.7	8.2	5.3	6.4	7.5	10.7	5.3	7.5	8.4	4.4	5.0	4.2	5.6	14.5	18.1	9.1	5.0	7.9	2.8	2.3	16.9	11.8	4.7	10.6	14.0	0.2	11.2	0.1	3.3	1.2	1.1	1.1	0.0	0.0	3.1	0.0	2.3	0.5	0.0	0.2	0.4	0.0	0.3	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	1.7	0.0	0.0	1.6	0.1	0.1	0.7	61.0	0.0	0.8	0.4	0.0	0.2	0.0	0.1	0.0	0.0	1.1	0.1	14.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	8.8	0.2	0.0	0.0	0.1	2.2	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	11.2	0.0	1.1	0.2	0.1	1.2	1.2	3.3	0.0	1.1	4.9	3.8	7.3	3.7	4.5	3.8	4.7	3.5	7.5	2.8
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970728	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 224.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 78.6;fHDF/TERT166: 127.8;U-138 MG: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"			110000000	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	38.6	17.4	6.7	33.4	11.1	0.0	26.6	11.9	9.1	83.1	141.0	6.0	111.4	12.6	82.3	59.8	122.8	45.8	46.3	20.1	7.7	5.0	33.5	39.6	26.1	12.9	8.7	8.5	76.3	6.9	4.1	17.8	57.4	8.9	87.8	25.1	10.9	12.4	133.3	15.3	12.9	39.2	224.5	8.5	35.9	64.5	29.7	9.7	2.1	20.3	14.1	5.3	205.3	70.4	0.1	0.2	4.3	0.2	0.4	0.2	5.9	12.0	7.9	17.9	15.7	62.2	50.4	17.7	70.9	78.6	24.4	27.1	14.4	0.3	0.0	16.9	127.8	2.8	11.4	21.1	33.2	0.1	3.8	0.4	9.4	9.7	40.9	0.0	0.0	38.7	15.7	27.3	15.4	20.5	0.0	0.1	36.4	0.0	0.0	0.2	21.4	2.7	0.1	15.9	0.0	5.0	3.2	3.1	7.8	24.9	3.3	9.5	0.7	0.1	54.7	82.0	14.3	15.5	24.1	0.0	0.0	0.0	28.5	0.0	61.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	4.3	0.4	0.0	0.0	0.0	5.9	6.7	11.1	11.9	9.1	7.7	5.0	8.7	8.5	8.9	9.7
CALML3	CLP	ENSG00000178363	"Calmodulin like 3"	P27482	10	5524009-5526771	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 108.7;skin 1: 40.8;vagina: 42.4"	"Group enriched"	"Detected in some"	6	"A-431: 16.5;hTCEpi: 6.5;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	15	"cervical cancer: 150.9;head and neck cancer: 196.3;lung cancer: 59.9;melanoma: 47.8;urothelial cancer: 43.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB010070, HPA044999"	Approved						500000			"CAB010070: , HPA044999: "	"unprognostic (1.02e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"		"unprognostic (1.29e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.43e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	24.5	0.0			0.0	0.0	0.0	108.7	0.2	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.2	0.0		29.8	0.0	0.1	40.8	0.0	0.0	0.0	0.0	0.0	0.0			0.0		9.0	0.0	42.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CALML5	CLSP	ENSG00000178372	"Calmodulin like 5"	Q9NZT1	10	5498697-5499555	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"salivary gland: 129.5;skin 1: 212.5"	"Cell line enriched"	"Detected in some"	21	"A-431: 92.9"	"Group enriched"	"Detected in many"	6	"breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA040725	Enhanced		Approved	"Plasma membrane,Cytosol"			75000000	"Plasma membrane, Cytosol"		"HPA040725: AB_10793863"	"unprognostic (7.68e-3)"	"unprognostic (5.06e-3)"		"unprognostic (5.64e-2)"		"prognostic favourable (2.59e-5)"		"unprognostic (4.82e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.27e-2)"	"unprognostic (1.14e-1)"		"unprognostic (2.79e-1)"	"unprognostic (1.71e-1)"		"unprognostic (4.99e-2)"	0.2	0.0	0.2	0.2	0.2	0.0	8.0	0.3	0.2	6.7	0.2	0.2	0.2	0.0	1.0	0.2	4.8	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	129.5	0.2	1.8	212.5	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.1	0.2	10.9	8.2	0.2	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		450000000	"Endoplasmic reticulum"		"CAB001513: , CAB019952: AB_2069792, CAB079775: AB_303403, HPA002242: AB_1078384"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.93e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.10e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.37e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.27e-2)"	67.5	55.5	31.9	58.9	36.1	86.4	64.6	20.9	38.9	50.2	52.3	42.5	65.7	44.1	61.6	108.4	65.2	49.1	67.5	62.5	31.6	35.2	81.9	302.6	61.8	83.6	33.5	33.4	59.6	124.3	56.4	60.3	98.0	35.7	53.1	60.0	43.2	121.0	68.6	25.1	34.2	53.8	56.9	42.1	66.6	49.7	65.0	32.7	61.6	250.6	55.0	65.2	39.4	68.0	25.1	57.2	16.1	38.6	26.3	48.4	16.2	116.3	46.0	63.2	137.7	79.9	72.1	57.9	155.6	127.8	93.8	136.6	70.3	93.7	74.7	143.7	180.5	46.4	69.1	99.2	95.0	55.5	39.4	62.2	56.0	106.9	188.8	249.7	84.4	66.8	46.0	86.9	73.6	112.8	53.2	37.9	76.1	80.4	69.3	163.3	56.2	65.3	53.6	53.6	90.4	82.4	66.7	24.0	51.4	96.5	53.1	31.8	71.0	103.6	97.6	78.4	49.4	111.4	69.5	47.3	42.2	75.1	110.4	109.0	86.1	16.1	19.5	10.1	48.4	38.6	34.3	25.1	29.2	36.7	20.4	22.4	21.6	39.2	6.6	26.3	30.8	57.2	21.5	16.2	31.9	36.1	20.9	38.9	31.6	35.2	33.5	33.4	35.7	32.7
CALR3	"CRT2, CT93, FLJ25355, MGC26577"	ENSG00000269058	"Calreticulin 3"	Q96L12	19	16479057-16496192	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	Chaperone	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"testis: 43.6"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025749, HPA043355, HPA048460"	Enhanced				"Intracellular and membrane"					"CAB025749: , HPA043355: AB_2678442, HPA048460: AB_2680403"	"unprognostic (1.19e-1)"	"unprognostic (3.84e-1)"		"unprognostic (7.17e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.18e-2)"	"unprognostic (6.69e-7)"	"unprognostic (1.60e-1)"	"unprognostic (2.78e-1)"	"unprognostic (6.28e-3)"	"unprognostic (6.34e-3)"	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	43.6	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.3	0.8	2.2	0.1	0.0	0.6	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.7	0.2	0.0	1.1	0.0	1.0	0.9	0.6	0.1	0.0	0.2	1.1	0.2	0.0	1.3	1.3	0.9	0.0	0.0	0.5	0.0	1.1	0.0	3.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.4	1.3	0.0	0.0	0.0	0.0	0.9	1.1	1.0	0.1	0.7	0.7	0.5	0.1	0.1	0.0	0.0	0.1	0.0	0.1	1.4	1.7	1.1	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.2	1.2	0.2	0.0	0.2	1.3	0.6	0.1	2.2	0.0	0.0	0.8	0.0	0.1	0.5	0.4	0.8	0.8	0.4	0.0	0.4	0.0	0.3	0.3
CALU		ENSG00000128595	Calumenin	O43852	7	128739292-128771807	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006018	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		15000000	"Endoplasmic reticulum"		"HPA006018: AB_1845934"	"unprognostic (7.22e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.52e-3)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.30e-11)"	"unprognostic (3.80e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.60e-5)"	33.6	20.7	10.2	30.8	13.6	6.2	27.6	7.8	13.0	33.6	35.0	13.9	34.0	8.4	57.0	29.4	29.7	27.3	24.0	60.0	10.5	9.0	23.6	38.3	31.4	17.0	14.0	9.8	28.5	21.5	18.6	19.7	104.6	14.4	29.9	21.1	18.7	26.9	40.2	26.5	12.5	16.6	78.1	17.4	26.6	25.6	14.3	10.8	8.1	25.5	16.7	13.4	57.0	27.6	14.0	19.5	13.4	22.9	13.7	18.5	16.4	16.2	13.7	32.0	10.2	89.4	86.8	17.6	112.0	97.7	41.2	54.4	17.7	25.1	8.0	20.3	154.3	9.5	16.5	21.9	62.2	4.9	11.5	8.9	20.4	19.6	40.9	12.6	16.5	58.5	16.3	56.7	22.2	37.3	15.1	11.7	79.8	9.2	9.2	7.4	21.5	13.8	7.6	23.1	12.6	17.1	9.0	3.3	19.2	36.1	33.3	45.1	7.1	10.0	50.0	114.2	14.7	95.2	49.5	18.9	23.3	15.0	118.9	16.0	116.4	11.2	21.7	13.4	18.5	22.9	17.0	14.0	12.7	13.8	18.6	10.0	11.3	13.4	2.8	13.7	18.2	19.5	13.6	16.4	10.2	13.6	7.8	13.0	10.5	9.0	14.0	9.8	14.4	10.8
CAMK1	CaMKI	ENSG00000134072	"Calcium/calmodulin dependent protein kinase I"	Q14012	3	9757342-9769992	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Differentiation, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 60.5;blood: 59.4"	"Cell line enriched"	"Detected in many"	4	"HMC-1: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 59.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031904, HPA051409"	Approved		Approved	Cytosol			550000	Cytosol		"CAB031904: AB_630964, HPA051409: "	"unprognostic (4.43e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (7.52e-4)"	"unprognostic (5.53e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.01e-1)"	27.1	60.5	28.0	11.7	26.0	3.5	34.1	12.4	31.2	9.5	10.7	4.4	5.8	6.8	12.6	10.5	7.1	12.6	8.9	10.2	21.4	14.0	13.1	20.7	9.2	10.4	10.3	19.9	21.5	4.5	7.4	7.9	5.1	10.1	18.6	8.1	6.8	5.1	15.1	4.7	3.3	8.3	18.4	7.2	7.1	8.1	13.4	5.6	0.6	7.0	3.7	10.4	9.5	10.3	0.0	3.2	59.4	9.2	0.7	0.4	0.9	0.1	3.6	2.9	0.0	15.1	5.6	7.3	8.6	4.8	9.9	9.4	5.3	0.6	0.2	2.0	5.8	0.6	0.0	1.1	6.2	0.1	21.1	11.6	6.9	7.4	8.4	1.0	92.0	5.9	0.9	13.9	1.5	8.3	1.5	0.2	3.7	2.2	0.0	8.5	2.0	5.7	0.0	0.1	0.2	5.9	0.6	0.9	3.7	1.5	0.1	0.8	0.9	14.9	4.3	4.5	5.6	6.4	10.8	0.0	0.0	0.2	9.6	3.3	0.6	3.3	4.8	59.4	0.0	9.2	0.0	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.2	0.7	9.2	0.1	0.4	0.9	28.0	26.0	12.4	31.2	21.4	14.0	10.3	19.9	10.1	5.6
CAMK1D	CKLiK	ENSG00000183049	"Calcium/calmodulin dependent protein kinase ID"	Q8IU85	10	12349482-12835545	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Inflammatory response, Neurogenesis"	"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 46.7;U-266/70: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 31.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007266	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA007266: AB_1078389"	"unprognostic (1.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (6.90e-3)"	"prognostic favourable (1.67e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.56e-3)"	5.1	5.3	20.9	10.5	22.1	6.6	4.0	23.4	33.5	8.3	11.5	4.6	10.0	3.8	3.3	3.3	8.7	4.3	6.8	13.8	18.6	7.2	2.2	11.5	7.6	9.3	5.8	17.8	2.6	17.0	1.3	2.5	3.2	5.0	4.9	12.9	11.9	4.5	15.4	1.7	18.5	5.5	5.6	4.9	10.5	3.4	6.2	6.8	20.8	13.6	2.9	12.5	8.1	7.0	7.1	4.2	31.8	3.7	1.4	2.3	1.3	0.1	2.5	2.9	0.1	1.8	0.6	0.2	0.4	0.9	0.6	0.9	3.5	2.0	1.4	0.3	0.2	1.3	3.5	0.5	0.5	46.7	1.8	5.6	8.3	0.2	0.5	0.1	5.1	0.1	2.3	1.2	0.1	0.3	0.1	0.2	0.7	2.9	10.9	2.2	1.9	1.1	8.3	1.6	2.6	0.1	2.7	4.5	2.0	5.5	2.0	0.0	1.5	1.3	0.1	2.4	3.6	7.7	1.6	21.5	6.7	4.7	3.6	3.6	0.0	8.3	2.2	31.8	1.8	3.1	1.9	5.6	1.6	2.3	4.2	7.1	1.9	1.3	13.9	1.4	3.7	1.4	0.5	1.3	20.9	22.1	23.4	33.5	18.6	7.2	5.8	17.8	5.0	6.8
CAMK1G	"CLICKIII, dJ272L16.1, VWS1"	ENSG00000008118	"Calcium/calmodulin dependent protein kinase IG"	Q96NX5	1	209583717-209613938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Allosteric enzyme, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 34.4;ovary: 29.2"	"Cell line enhanced"	"Detected in some"		"BJ: 2.0;hTEC/SVTERT24-B: 12.1;NTERA-2: 1.9;SK-MEL-30: 3.6;U-138 MG: 2.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.17e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.79e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.59e-3)"	"unprognostic (8.55e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.43e-2)"	0.7	3.5	7.5	0.9	34.4	1.0	0.7	1.3	27.8	1.1	0.8	0.7	1.2	0.8	1.8	6.1	0.6	0.9	1.5	0.6	10.9	9.2	6.9	0.9	1.2	0.8	3.6	17.7	29.2	1.3	0.6	2.0	2.8	3.9	4.6	0.8	0.6	0.6	7.4	0.6	0.6	0.8	2.3	0.9	6.1	0.7	1.4	2.7	0.0	0.7	0.0	0.8	1.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	2.0	0.3	0.8	0.3	0.0	0.2	0.0	0.0	0.8	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	12.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.2	2.1	0.2	0.0	0.1	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	34.4	1.3	27.8	10.9	9.2	3.6	17.7	3.9	2.7
CAMK2A	"CAMKA, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"brain: 105.7;skeletal muscle: 50.1"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.6;SCLC-21H: 9.5;U-87 MG: 8.0"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Group enriched"	"Detected in all"	6	"amygdala: 60.7;basal ganglia: 50.6;cerebral cortex: 99.6;hippocampal formation: 74.6;olfactory region: 39.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"amygdala: 1311.6;basal ganglia: 698.1;cerebral cortex: 1576.4;hippocampal formation: 1569.1"	"Low region specificity"	"Detected in all"			"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"			21000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	1.3	1.7	60.7	1.3	50.6	1.3	1.1	1.4	105.7	1.8	1.3	3.7	0.0	1.2	2.1	1.4	1.9	1.7	1.3	3.7	74.6	10.5	1.6	1.2	1.5	1.2	5.1	39.8	1.3	1.1	1.1	0.4	1.3	2.4	1.6	1.3	0.0	1.2	1.4	50.1	1.6	1.3	2.5	1.7	1.2	1.3	1.2	2.3	0.0	1.2	0.0	1.1	1.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.6	0.0	0.5	1.3	0.8	0.7	0.0	0.1	0.0	0.2	0.6	2.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.2	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	9.5	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.2	0.1	0.0	8.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	60.7	50.6	1.4	99.6	74.6	10.5	5.1	39.8	2.4	2.3
CAMK2B	"CAM2, CAMK2, CAMKB"	ENSG00000058404	"Calcium/calmodulin dependent protein kinase II beta"	Q13554	7	44217150-44334577	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.9;heart muscle: 39.2;skeletal muscle: 70.7"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 41.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006849, HPA026307, HPA051783, HPA051785, HPA053973"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions,Cytosol"			680000	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB006849: , HPA026307: AB_1845941, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (1.88e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.23e-7)"	"unprognostic (7.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.95e-2)"	1.4	8.1	20.6	1.4	46.7	1.2	2.0	60.1	81.9	1.2	1.4	4.0	0.7	1.7	1.3	18.8	2.0	1.8	1.2	39.2	36.5	18.0	1.7	3.5	1.2	1.8	10.3	21.3	1.1	3.3	5.6	9.9	1.1	13.4	3.0	1.4	2.7	1.8	2.2	70.7	1.8	1.6	1.2	4.1	1.3	2.4	2.3	4.8	0.0	7.7	2.4	2.0	1.1	0.0	1.3	1.0	3.2	1.2	3.2	1.2	0.8	0.0	0.3	0.2	0.3	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.2	0.1	0.2	0.7	0.0	1.0	2.4	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	5.2	0.0	0.2	0.1	2.3	0.1	0.9	0.1	0.0	0.0	41.0	2.2	0.2	0.0	0.0	1.9	0.1	0.2	0.2	0.3	0.2	0.0	0.5	0.4	0.1	0.1	0.0	0.2	3.2	0.7	1.0	0.8	0.9	1.2	1.1	1.0	0.5	0.5	1.3	1.2	1.1	2.0	3.2	1.2	1.0	0.9	0.8	20.6	46.7	60.1	42.4	36.5	18.0	10.3	21.3	13.4	4.8
CAMK2D	CAMKD	ENSG00000145349	"Calcium/calmodulin dependent protein kinase II delta"	Q13557	4	113451032-113761927	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026281, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			140000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA026281: AB_1845944, HPA051783: , HPA051785: , HPA053973: "	"unprognostic (2.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.90e-2)"	22.8	12.9	47.7	18.3	13.0	2.8	23.5	50.2	30.6	11.0	18.2	7.4	28.6	13.6	11.6	9.4	15.6	9.6	14.8	77.1	17.9	21.4	9.6	17.6	14.7	17.5	14.0	23.8	12.9	7.4	33.7	7.0	9.3	12.5	16.3	19.0	9.9	9.4	48.3	48.5	10.8	19.2	26.2	16.0	8.4	17.6	9.4	8.5	11.2	11.6	9.8	14.5	21.5	22.6	18.5	11.2	0.6	8.8	6.4	9.7	5.2	1.0	14.3	15.8	5.3	34.6	66.2	5.6	33.5	22.4	13.2	11.4	9.6	4.0	20.5	4.9	23.3	0.5	9.8	5.2	13.5	7.8	2.5	0.0	5.2	11.0	17.5	0.0	0.0	42.3	7.2	10.2	25.3	11.7	0.8	9.2	24.8	3.8	2.0	0.8	2.2	5.3	4.0	18.5	0.1	13.5	9.7	4.3	4.3	4.5	6.8	4.5	0.1	5.5	7.0	34.9	8.2	14.8	6.6	7.1	3.6	17.6	18.0	1.2	16.4	0.0	8.8	0.0	5.1	5.1	9.7	8.0	5.0	5.6	11.2	18.5	5.8	4.9	0.6	6.4	1.7	0.0	9.3	5.2	47.7	13.0	50.2	25.6	17.9	21.4	14.0	23.8	12.5	8.5
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 73.0"	"Cell line enhanced"	"Detected in all"		"PC-3: 45.4;SK-BR-3: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"granulocytes: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"			170000	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: , HPA051783: , HPA051785: , HPA053973: "	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	9.1	8.8	27.4	9.4	20.7	17.4	6.8	22.2	53.8	9.0	37.3	13.3	9.7	19.7	20.1	9.1	20.6	13.2	10.6	6.7	22.8	24.4	11.6	5.9	10.7	8.9	26.8	31.2	6.4	5.7	8.0	6.0	15.8	38.6	18.5	15.5	8.5	12.4	29.8	73.0	9.1	18.1	29.6	29.8	11.0	14.2	3.8	13.4	4.4	6.4	7.6	8.7	26.5	10.8	4.2	7.1	39.8	5.6	9.8	9.2	5.0	10.9	7.9	7.1	13.6	5.2	8.6	8.4	7.5	12.9	10.4	8.5	12.2	11.8	8.1	7.9	9.7	17.0	5.6	6.4	8.3	7.3	6.7	5.5	6.1	5.5	2.6	7.5	9.3	4.5	5.8	10.3	7.2	8.8	6.0	12.1	5.7	7.6	12.5	11.2	5.2	45.4	11.4	7.5	4.3	5.4	15.9	3.7	8.6	4.3	57.2	3.7	10.7	4.7	10.8	7.7	12.4	4.2	10.1	3.7	4.4	7.5	8.3	21.5	2.7	8.5	5.6	39.8	7.5	2.3	9.2	4.2	8.4	8.0	7.1	3.9	8.1	7.9	36.4	9.8	4.0	2.4	8.1	5.0	27.4	20.7	22.2	53.8	22.8	24.4	26.8	31.2	38.6	13.4
CAMSAP3	"KIAA1543, Nezha, PPP1R80"	ENSG00000076826	"Calmodulin regulated spectrin associated protein family member 3"	Q9P1Y5	19	7595902-7618304	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 33.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;Hep G2: 11.2;SK-BR-3: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043830, HPA062149"	Enhanced		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA043830: AB_10795879, HPA062149: "	"unprognostic (3.83e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (3.87e-3)"	"unprognostic (7.00e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"prognostic favourable (7.55e-7)"	"unprognostic (2.16e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.59e-3)"	0.8	2.8	8.0	1.9	9.2	0.9	4.1	12.0	15.5	4.5	11.4	0.8	13.5	20.9	1.5	8.0	14.7	4.8	7.6	0.9	5.2	4.8	9.7	14.2	4.5	1.1	2.6	6.5	1.0	15.7	4.2	6.2	3.6	7.0	6.7	4.1	8.8	22.1	16.0	1.1	33.9	17.7	1.0	1.0	1.1	14.5	9.1	1.1	0.9	9.6	2.5	5.7	4.1	6.9	0.0	0.1	0.0	0.0	0.0	0.6	0.0	8.3	1.3	0.2	0.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	19.7	4.4	2.3	3.6	0.0	7.4	3.2	2.1	0.0	1.5	7.6	0.0	0.3	11.2	0.0	0.0	3.4	0.0	4.2	0.0	0.3	0.0	0.7	0.0	0.0	9.4	0.1	0.1	5.1	3.6	0.5	0.0	2.7	1.5	4.4	6.4	6.8	1.0	9.7	0.0	8.0	1.3	0.0	0.0	1.6	0.0	0.3	3.9	0.7	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.0	9.2	12.0	15.5	5.2	4.8	2.6	6.5	7.0	1.1
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269281-67319951	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"			4200000	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	21.3	26.7	28.7	19.1	38.3	19.6	27.0	34.6	32.6	23.9	20.0	17.5	17.0	19.7	22.8	29.9	26.6	20.6	19.0	15.2	24.8	27.0	25.4	27.7	18.7	25.4	23.3	29.0	29.0	22.1	33.2	27.1	23.3	33.2	24.1	21.7	15.8	19.6	22.0	11.1	29.5	19.5	22.4	21.5	20.2	19.3	26.9	23.8	39.4	27.0	17.0	30.2	21.1	22.1	11.9	7.8	6.1	10.1	14.7	15.2	4.3	22.2	23.0	35.1	24.9	26.9	21.1	23.5	22.2	19.2	23.4	20.7	21.3	12.8	48.2	19.4	22.2	21.4	37.6	25.2	26.9	18.3	22.5	27.2	18.5	20.1	17.7	31.9	15.5	19.8	19.2	21.4	19.8	21.8	21.4	27.1	25.2	21.9	28.9	21.7	37.1	16.1	28.3	30.0	20.4	21.6	38.1	36.0	17.9	27.6	25.5	17.9	27.3	14.7	18.5	18.7	12.1	12.8	16.7	8.9	10.9	41.1	22.2	19.0	19.1	6.1	5.0	5.5	11.6	5.9	14.1	8.6	14.2	12.7	7.8	11.9	15.2	12.7	2.2	14.7	10.1	6.6	14.7	4.3	28.7	38.3	34.6	31.8	24.8	27.0	23.3	29.0	33.2	23.8
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179730925	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"			82000000	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (2.15e-1)"	49.3	35.4	40.0	35.8	40.9	57.6	37.8	27.3	49.1	93.0	33.6	37.1	48.3	44.0	42.7	115.4	31.6	31.7	30.0	51.3	36.9	50.9	61.6	120.8	34.7	30.1	47.5	27.9	41.0	78.2	13.7	33.0	70.5	44.9	33.5	55.1	32.2	121.5	48.5	28.5	23.4	68.5	60.5	48.8	38.2	31.7	34.3	30.0	31.0	113.4	25.9	29.9	41.4	47.6	10.1	26.3	25.9	28.9	18.7	22.6	30.0	8.2	23.4	19.9	12.1	42.8	31.8	10.1	42.8	47.0	49.4	42.0	20.3	19.2	62.9	60.1	34.3	5.7	31.2	23.3	56.5	16.1	9.5	10.1	58.4	13.2	58.3	19.3	9.6	6.2	42.9	26.5	77.2	20.4	7.9	24.5	5.4	7.7	9.7	0.3	4.0	1.4	10.1	14.4	6.8	36.4	24.5	10.0	2.4	12.0	5.2	107.2	40.5	8.5	38.0	11.3	18.9	12.8	33.2	7.4	25.8	15.9	17.1	12.6	11.0	25.9	28.9	8.8	17.7	21.2	22.6	10.1	13.9	16.3	26.3	7.7	9.5	10.6	6.1	18.7	18.0	25.3	10.1	30.0	40.0	40.9	27.3	33.3	36.9	50.9	47.5	27.9	44.9	30.0
CAP1	CAP	ENSG00000131236	"Cyclase associated actin cytoskeleton regulatory protein 1"	Q01518	1	40040233-40072649	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 201.2"	"Cell line enhanced"	"Detected in all"		"THP-1: 199.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030124	Approved		Supported	Cytosol			270000000	Cytosol		"HPA030124: AB_10600799"	"unprognostic (1.80e-3)"	"unprognostic (1.23e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (1.44e-6)"	"unprognostic (5.37e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	70.0	31.8	33.3	68.7	41.0	74.6	42.4	16.6	37.4	40.1	58.2	42.7	25.2	37.9	69.4	28.9	60.9	44.6	36.9	27.2	28.6	26.6	56.6	52.0	58.2	63.7	37.2	26.9	44.5	22.6	29.7	22.5	74.4	39.5	42.0	57.7	31.3	39.8	39.7	20.6	37.1	58.9	62.9	42.7	79.9	44.6	39.0	30.0	62.4	40.2	32.6	83.1	53.3	40.8	27.4	70.6	201.2	106.1	37.2	57.6	115.5	44.0	19.1	24.2	14.3	34.4	32.3	36.1	78.1	47.2	44.1	44.5	27.5	46.8	34.2	31.9	64.3	27.7	28.9	57.2	60.8	45.7	17.1	53.7	21.1	21.6	31.7	33.1	153.1	32.9	29.5	67.3	38.1	37.2	20.0	23.0	65.9	13.0	26.3	18.2	39.2	21.5	19.9	32.1	21.0	46.7	46.6	11.5	24.1	33.2	38.5	53.0	17.8	199.4	66.1	37.7	34.3	19.7	66.1	18.8	36.9	31.4	49.6	37.0	49.4	95.4	60.2	201.2	57.6	88.9	45.3	27.4	41.7	55.1	70.6	26.3	35.4	47.9	128.3	37.2	106.1	27.7	55.1	115.5	33.3	41.0	16.6	37.4	28.6	26.6	37.2	26.9	39.5	30.0
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394748-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 121.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 79.6;HMC-1: 114.2;SK-MEL-30: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"		6700000	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	44.3	4.9	10.1	18.3	10.8	32.4	17.6	3.3	7.6	19.9	13.8	17.6	17.7	6.8	14.0	16.0	52.3	12.9	25.2	4.1	8.5	6.5	35.4	2.9	44.3	26.9	14.7	4.8	10.6	8.9	40.3	5.2	15.6	11.9	15.0	11.0	7.6	22.5	19.3	2.6	39.2	11.5	9.9	17.6	10.9	25.9	8.4	10.0	21.2	31.5	28.1	40.2	27.0	31.1	50.1	121.1	79.0	97.4	48.3	9.7	67.5	22.3	10.8	0.0	1.0	7.6	16.6	11.6	8.6	0.9	8.4	8.3	1.3	79.6	2.8	12.1	16.0	26.1	0.0	16.8	3.6	17.2	0.6	8.0	19.8	4.7	6.0	4.5	114.2	14.4	13.0	7.6	9.5	5.5	0.9	6.6	5.8	18.9	12.0	53.2	3.3	14.3	12.0	1.3	1.3	32.0	11.2	0.1	0.1	10.7	14.4	83.0	5.9	56.7	21.2	18.0	3.9	0.6	0.3	0.1	0.6	1.2	40.8	60.6	0.2	79.0	97.4	58.2	1.1	36.4	3.4	50.1	9.7	3.7	121.1	37.1	2.8	1.3	14.1	48.3	10.3	84.1	9.6	67.5	10.1	10.8	3.3	7.6	8.5	6.5	14.7	4.8	11.9	10.0
CAPN1	"CANP, CANPL1, muCANP, muCL"	ENSG00000014216	"Calpain 1"	P07384	11	65180566-65212006	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 88.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005992	Enhanced		Supported	Cytosol			28000000	Cytosol		"HPA005992: AB_1845924"	"unprognostic (2.07e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.33e-1)"	"prognostic favourable (7.06e-8)"	"unprognostic (5.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.98e-1)"	22.0	15.6	9.6	23.8	11.6	18.2	18.8	17.7	20.1	25.8	33.3	8.4	23.0	25.4	19.3	30.2	86.9	28.1	39.1	21.4	8.8	11.2	27.8	21.3	19.4	19.5	10.8	9.7	21.4	24.9	13.3	14.1	38.1	16.8	27.3	17.0	15.8	39.7	24.3	24.2	38.9	49.9	16.5	7.7	21.3	20.7	8.3	6.7	32.1	37.5	50.2	53.7	33.7	35.2	16.7	22.8	34.5	24.8	15.7	19.6	28.5	47.4	25.3	7.2	16.1	13.2	16.7	22.0	14.1	22.5	16.6	12.7	16.1	42.7	11.9	23.6	26.8	70.2	9.4	59.6	5.3	12.6	7.5	28.3	14.6	15.7	13.1	6.6	39.8	18.4	32.1	14.1	6.9	28.5	16.8	9.6	13.6	30.5	13.1	21.0	20.9	22.9	13.0	7.4	7.2	22.6	88.3	13.0	9.6	14.9	57.7	13.6	24.8	13.1	24.7	13.0	8.9	27.6	6.3	5.9	4.3	14.1	22.6	8.1	14.0	34.3	24.8	34.5	19.6	23.7	15.7	15.6	15.5	17.7	22.8	16.7	9.1	12.5	15.8	15.7	14.0	17.9	16.6	28.5	9.6	11.6	17.7	20.1	8.8	11.2	10.8	9.7	16.8	6.7
CAPN2	"CANPL2, CANPml, mCANP"	ENSG00000162909	"Calpain 2"	P17655	1	223701593-223776018	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024470	Approved	Approved	Supported	Cytosol			1500000	Cytosol		"HPA024470: AB_1845925"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.21e-1)"	"prognostic favourable (2.19e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (6.21e-4)"	56.2	41.0	23.8	20.7	22.2	11.1	61.1	26.1	20.9	40.3	44.8	18.3	23.3	14.5	29.1	44.5	56.3	40.1	58.9	33.0	26.5	13.1	41.6	13.3	58.6	18.2	27.4	18.2	32.4	26.8	53.7	12.7	26.4	23.8	27.2	44.4	16.5	62.5	31.9	48.1	16.5	22.7	35.7	32.3	15.9	48.2	17.2	24.7	5.0	29.9	39.7	35.9	28.3	38.8	9.0	41.6	1.7	29.1	6.0	28.7	28.2	45.7	29.3	9.4	6.3	31.4	43.6	9.0	43.3	62.9	31.5	17.9	23.2	36.8	0.0	14.3	48.0	28.6	10.1	68.4	29.3	11.7	10.5	0.8	15.0	2.9	28.2	2.4	1.5	23.3	22.2	49.0	26.2	62.4	13.1	12.2	92.6	0.9	0.1	2.1	5.2	38.3	3.8	30.7	0.7	54.3	2.7	2.0	10.9	22.3	60.9	13.5	9.2	11.0	95.9	29.5	24.5	25.4	55.5	3.6	6.9	0.1	73.9	5.1	32.4	1.7	29.1	1.7	28.7	19.5	24.5	9.0	20.0	27.7	41.6	3.6	6.4	17.4	1.5	6.0	17.5	1.9	19.9	28.2	23.8	22.2	26.1	20.9	26.5	13.1	27.4	18.2	23.8	24.7
CAPNS1	"30K, CANP, CANPS, CAPN4, CDPS"	ENSG00000126247	"Calpain small subunit 1"	P04632	19	36139575-36150353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006872	Approved		Approved	Nucleoplasm,Cytosol			50000000	"Nucleoplasm, Cytosol"		"HPA006872: AB_1078382"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.25e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (7.10e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-2)"	67.8	59.4	58.7	49.6	53.1	47.1	54.4	29.9	92.0	74.8	87.8	50.8	45.3	61.3	50.1	48.8	111.9	74.9	70.6	137.2	55.7	61.0	104.0	67.5	70.7	74.0	56.6	52.0	63.0	45.1	72.3	48.6	48.1	71.5	59.8	69.6	62.8	61.4	71.8	95.7	30.9	95.6	69.2	47.4	63.6	50.4	49.2	27.8	45.4	71.4	65.9	87.3	56.7	57.9	13.4	25.7	11.3	33.2	9.6	20.3	8.1	40.5	101.8	25.5	36.4	61.6	75.5	5.1	33.2	71.0	67.8	52.6	23.0	60.3	14.6	49.3	110.6	21.7	30.5	81.4	57.6	61.4	15.0	16.9	30.7	38.8	71.6	16.8	42.8	80.7	50.8	43.8	62.3	73.6	20.4	58.9	103.0	53.3	30.0	30.5	14.7	51.6	15.9	20.7	27.0	127.2	40.9	17.3	21.8	40.0	56.8	15.8	33.1	27.6	47.5	60.2	45.8	20.1	33.3	21.0	27.9	13.0	68.3	23.0	51.5	8.8	22.5	9.3	20.3	31.4	13.0	12.9	14.3	16.2	19.8	13.4	8.8	11.8	11.3	9.6	33.2	25.7	14.0	8.1	58.7	53.1	29.9	92.0	55.7	61.0	56.6	52.0	71.5	27.8
CAPZA1		ENSG00000116489	"Capping actin protein of muscle Z-line alpha subunit 1"	P52907	1	112619173-112671619	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB045963	Approved						45000000			"CAB045963: AB_11126023"	"unprognostic (7.06e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (1.17e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-3)"	"unprognostic (4.59e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-1)"	16.0	13.3	12.1	22.1	20.1	26.7	11.7	16.3	19.2	10.7	17.0	14.5	17.4	13.6	18.8	21.7	32.9	9.9	11.9	9.4	20.6	12.9	15.3	15.7	17.8	28.7	16.3	17.3	10.6	12.3	6.4	15.7	17.3	15.2	14.8	20.3	17.2	13.9	20.1	8.2	18.7	16.9	13.0	17.7	28.3	13.8	35.9	15.2	6.2	25.0	9.8	37.7	15.1	17.1	31.7	32.6	82.9	62.7	22.1	38.9	47.9	43.1	12.9	22.6	18.6	29.1	33.4	28.3	34.9	37.2	36.6	32.8	17.0	18.7	48.7	25.4	42.5	20.9	31.0	38.1	46.0	33.6	15.9	42.4	22.1	21.6	34.5	75.3	56.2	36.4	29.4	35.9	34.6	41.6	42.9	28.9	52.3	25.5	36.0	33.7	22.1	28.0	27.0	46.0	23.7	32.5	30.5	15.9	17.0	42.1	38.7	28.3	19.9	67.3	47.0	29.8	29.1	48.0	42.6	19.7	18.0	52.9	50.9	58.1	67.0	49.8	40.5	48.0	29.3	59.4	32.3	31.7	32.5	35.1	32.6	23.8	18.4	29.6	82.9	22.1	62.7	25.7	38.9	47.9	12.1	20.1	16.3	19.2	20.6	12.9	16.3	17.3	15.2	15.2
CAPZA2	"CAPPA2, CAPZ"	ENSG00000198898	"Capping actin protein of muscle Z-line alpha subunit 2"	P47755	7	116811070-116922049	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007470, HPA007643"	Uncertain		Approved	"Endoplasmic reticulum,Cytosol"			19000000	"Endoplasmic reticulum"	Cytosol	"HPA007470: AB_1845985, HPA007643: "	"unprognostic (1.37e-2)"	"unprognostic (2.25e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.63e-3)"	"prognostic unfavourable (9.34e-5)"	"unprognostic (1.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.08e-3)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.65e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.58e-2)"	32.4	17.7	23.6	15.8	22.6	33.6	18.5	17.6	30.2	17.7	26.3	10.7	13.5	16.9	20.6	16.4	25.9	14.9	17.6	36.4	26.7	20.6	40.9	29.2	23.2	16.6	22.1	15.9	17.3	13.8	12.9	16.4	26.1	27.1	21.8	20.6	11.8	14.4	18.3	47.1	11.6	30.6	30.3	19.6	26.0	17.8	12.4	13.7	17.7	24.5	21.0	14.0	31.5	15.0	6.6	14.8	32.0	22.8	7.1	7.8	17.7	12.9	8.8	8.5	11.1	16.3	17.3	4.7	12.8	18.1	12.9	14.8	6.4	16.6	8.8	21.0	18.1	8.1	8.8	10.5	20.0	9.6	7.0	13.2	8.7	10.7	10.1	8.8	17.9	13.9	11.8	10.5	9.9	27.1	8.8	15.3	25.3	6.3	11.4	14.8	12.6	7.6	8.1	11.5	17.4	30.0	11.1	9.1	10.4	11.9	44.9	12.2	6.3	10.2	10.0	20.7	6.6	16.3	12.0	12.1	8.8	16.8	12.3	12.5	14.7	19.9	16.4	19.2	5.5	20.1	6.1	6.6	6.5	5.7	14.8	6.0	6.4	6.5	32.0	7.1	22.8	8.2	7.8	17.7	23.6	22.6	17.6	30.2	26.7	20.6	22.1	15.9	27.1	13.7
CAPZB		ENSG00000077549	"Capping actin protein of muscle Z-line beta subunit"	P47756	1	19338776-19485539	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031531	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			35000000	"Nucleoplasm, Cytosol"	Vesicles	"HPA031531: AB_10603556"	"unprognostic (7.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (4.55e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (3.57e-4)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.78e-1)"	29.6	24.8	57.1	38.4	47.3	27.9	28.1	23.0	39.7	34.8	84.1	34.3	19.3	29.2	40.3	28.2	41.8	29.2	29.3	80.3	53.8	40.7	29.3	37.5	29.7	50.4	53.5	33.6	38.6	24.9	23.7	18.1	36.9	29.5	42.2	43.5	30.4	23.7	35.9	160.5	27.0	43.7	49.5	72.0	42.1	32.6	70.5	22.3	51.2	34.2	35.3	54.3	56.9	32.3	39.8	55.6	155.9	96.3	27.1	57.2	78.0	47.7	28.4	51.2	36.8	70.3	90.5	36.0	81.3	84.9	72.1	74.2	35.4	67.4	33.0	35.5	101.6	40.6	43.9	56.1	81.2	51.9	31.1	64.6	38.1	55.2	72.1	42.8	106.8	83.4	46.7	61.7	58.4	65.6	22.9	47.2	72.0	33.9	47.4	49.8	38.4	30.8	42.9	36.0	43.3	90.9	27.5	31.1	24.1	47.8	40.0	53.8	43.9	37.5	67.6	48.6	39.9	79.5	38.7	29.2	35.1	41.6	63.7	56.4	52.3	53.8	54.4	155.9	49.1	79.4	41.8	39.8	51.1	52.3	55.6	29.1	43.1	46.1	87.8	27.1	96.3	30.2	57.2	78.0	57.1	47.3	23.0	39.7	53.8	40.7	53.5	33.6	29.5	22.3
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.6;U-2197: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"				"Vesicles, Intermediate filaments"	Cytosol	"HPA029359: AB_10601354, HPA055612: "	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	8.1	6.8	3.5	4.5	2.3	0.0	10.2	1.5	2.7	5.7	16.4	2.4	4.1	23.7	9.8	6.4	6.8	5.9	14.1	7.6	1.7	1.1	14.0	10.5	7.0	2.4	1.6	1.3	6.8	8.9	1.6	1.7	4.9	3.8	5.6	6.2	5.6	12.6	3.2	8.0	7.3	33.6	4.1	1.3	3.3	7.0	11.1	1.3	0.7	5.6	13.5	3.9	4.9	9.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	12.8	9.4	1.7	1.3	0.0	3.8	8.5	1.2	2.8	5.5	4.3	5.8	9.2	0.0	4.6	2.2	18.2	2.1	23.6	1.7	0.0	5.1	0.3	5.9	9.0	2.3	0.2	0.8	1.3	4.9	10.5	13.5	11.0	1.3	0.0	4.1	4.4	0.0	0.8	3.1	5.7	0.0	16.9	1.3	8.2	2.2	0.6	1.0	9.0	4.0	0.9	4.3	0.7	14.6	4.1	12.1	35.4	6.7	0.0	0.0	0.0	13.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	3.5	2.3	1.5	2.7	1.7	1.1	1.6	1.3	3.8	1.3
CARD6	CINCIN1	ENSG00000132357	"Caspase recruitment domain family member 6"	Q9BX69	5	40841184-40860175	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 12.8;HUVEC TERT2: 20.1;TIME: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 5.5;granulocytes: 17.0;monocytes: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036438	Uncertain									"HPA036438: AB_10670105"	"unprognostic (8.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.12e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.88e-3)"	23.5	14.3	2.8	5.0	4.6	2.5	7.4	1.5	5.1	6.0	5.6	1.6	8.8	7.0	4.0	3.5	13.5	4.8	10.7	5.7	2.1	2.0	8.3	8.1	11.3	7.2	4.4	0.4	3.9	4.0	2.3	6.1	7.7	6.0	5.9	2.6	3.8	9.9	5.4	5.1	3.3	12.0	4.5	6.3	23.6	11.0	3.0	3.0	3.8	8.1	6.8	7.8	9.9	11.0	1.4	5.5	17.0	9.3	1.2	2.5	3.0	1.8	3.3	0.5	0.0	8.3	12.8	0.1	1.0	1.9	0.1	0.4	0.3	0.7	3.9	6.5	2.4	1.2	0.2	4.9	0.4	0.4	0.9	3.7	6.8	0.4	2.4	3.6	8.4	8.3	4.2	4.4	1.0	20.1	3.9	0.7	1.8	0.0	0.0	3.6	0.0	1.1	0.0	0.1	3.9	7.8	4.1	0.0	0.0	5.5	1.8	0.8	0.1	6.9	21.4	1.0	0.8	0.3	1.3	0.2	0.0	0.5	1.8	7.9	3.5	17.0	8.0	2.9	1.0	8.1	0.8	0.8	1.3	0.8	5.5	1.4	1.3	0.9	7.8	1.2	9.3	2.2	2.5	3.0	2.8	4.6	1.5	5.1	2.1	2.0	4.4	0.4	6.0	3.0
CASKIN1	"ANKS5A, KIAA1306"	ENSG00000167971	"CASK interacting protein 1"	Q8WXD9	16	2177180-2196525	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 30.4"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 4.5;HDLM-2: 16.6;HEK 293: 3.7;SCLC-21H: 7.7;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055990, CAB079050"	Enhanced	Supported	Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB079050: , HPA055990: "	"unprognostic (4.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.21e-4)"	"unprognostic (2.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.34e-3)"	"unprognostic (3.39e-1)"	1.1	1.8	17.7	1.2	18.1	1.1	1.4	15.0	30.4	1.5	1.2	2.3	0.0	1.2	1.5	1.3	1.2	1.4	1.2	2.5	16.4	12.8	1.3	1.1	1.1	1.1	12.4	11.7	1.2	1.5	1.9	1.4	1.2	11.1	1.8	1.2	1.8	2.5	1.4	1.3	2.2	1.3	1.2	2.8	1.1	1.3	1.8	4.0	0.0	1.6	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.0	4.5	0.0	0.0	2.2	0.0	0.0	0.1	0.0	1.5	0.1	0.0	0.9	0.0	0.0	1.2	0.3	0.0	16.6	3.7	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.3	0.0	0.9	0.7	0.0	0.9	0.0	0.4	0.2	0.0	7.7	3.7	0.1	0.2	0.2	1.0	0.5	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	18.1	15.0	21.7	16.4	12.8	12.4	11.7	11.1	4.0
CASP14	"MGC119078, MGC119079, MICE"	ENSG00000105141	"Caspase 14"	P31944	19	15049384-15058293	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Hydrolase, Protease, Thiol protease"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 109.4"	"Cell line enriched"	"Detected in some"	7	"hTCEpi: 32.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 62.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010059, HPA027062"	Enhanced		Approved	Nucleoplasm,Mitochondria,Cytosol			2200000	"Nucleoplasm, Cytosol"	Mitochondria	"CAB010059: AB_626800, HPA027062: "	"unprognostic (1.17e-2)"	"unprognostic (6.44e-3)"		"unprognostic (6.22e-2)"		"unprognostic (2.77e-1)"		"prognostic unfavourable (7.59e-4)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (2.68e-1)"		"unprognostic (4.30e-2)"	"unprognostic (1.99e-1)"		"unprognostic (1.97e-1)"	0.2	0.2	0.2	0.0	0.3	0.0	1.9	0.2	0.3	17.9	0.2	0.0	0.8	0.0	1.1	0.3	1.2	0.1	0.0	0.2	0.3	0.2	0.4	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.2	0.5	0.0	7.7	0.0	0.0	0.8	2.7	0.3	109.4	0.2	0.0	0.2	0.1	0.2	1.6	0.0	2.3	0.2	0.9	0.0	0.6	4.0	0.8	0.5	2.3	0.6	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.6	0.4	0.4	0.2	0.4	0.3	0.6	0.4	0.1	0.8	0.5	0.4	2.3	0.1	0.2	0.5	0.6	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.0	0.0	0.0
CASP2	"ICH1, MGC2181, NEDD2, PPP1R57"	ENSG00000106144	"Caspase 2"	P42575	7	143288215-143307696	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 45.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012175, HPA050678"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB012175: , HPA050678: "	"unprognostic (6.96e-2)"	"prognostic favourable (7.38e-4)"	"unprognostic (2.74e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (2.34e-4)"	"unprognostic (1.74e-2)"	"unprognostic (1.34e-2)"	"prognostic favourable (2.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.64e-1)"	10.5	6.5	6.6	10.7	6.7	26.8	10.2	9.6	10.9	9.6	8.5	9.0	8.2	8.2	10.8	7.8	14.1	8.4	5.7	6.1	5.7	4.1	7.3	5.8	9.8	15.8	6.9	6.1	8.7	8.1	12.1	6.6	11.3	7.3	7.6	10.2	10.1	11.6	5.8	4.3	14.2	14.0	7.4	6.3	18.6	7.5	8.6	6.9	45.7	8.9	8.0	23.0	7.4	10.2	18.5	11.8	33.2	17.7	13.4	21.4	7.6	10.7	10.1	11.4	20.2	6.4	7.6	6.1	11.1	5.0	10.2	11.2	10.1	12.3	20.5	10.5	7.0	10.6	11.4	8.7	13.6	17.9	8.8	12.1	16.0	6.9	3.4	23.6	15.2	5.2	7.2	12.3	4.4	8.7	10.1	13.1	10.8	10.6	41.0	24.9	14.3	10.3	30.2	5.9	12.5	6.0	9.2	12.5	14.1	22.0	9.6	7.0	10.5	9.0	9.7	9.0	6.3	16.2	11.0	10.9	10.7	23.8	10.2	28.1	16.4	33.2	10.8	9.3	14.9	11.9	14.6	15.8	20.6	15.4	9.8	18.5	15.4	17.8	12.3	13.4	17.7	11.8	21.4	7.6	6.6	6.7	9.6	10.9	5.7	4.1	6.9	6.1	7.3	6.9
CASP3	"apopain, CPP32, CPP32B, Yama"	ENSG00000164305	"Caspase 3"	P42574	4	184627696-184649509	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 76.7"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 72.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 76.7;eosinophil: 62.8"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000091, HPA002643, CAB008381"	Enhanced		Supported	Nucleoplasm,Mitochondria			310000	"Nucleoplasm, Mitochondria"		"CAB000091: , CAB008381: AB_590737, HPA002643: AB_1846048"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (2.29e-3)"	"unprognostic (3.58e-2)"	"unprognostic (9.57e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (1.41e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-3)"	20.7	11.6	10.8	16.9	10.5	16.7	10.0	22.3	9.2	10.4	25.4	12.8	12.5	32.3	13.9	11.5	22.8	8.9	12.0	8.8	10.0	8.8	10.6	18.7	12.4	23.6	10.2	8.5	8.3	10.0	4.6	13.6	29.4	9.7	8.8	20.9	8.2	13.0	10.0	12.6	9.5	49.7	9.3	12.6	26.5	18.7	6.4	10.9	44.7	7.8	13.5	24.3	16.2	11.0	4.2	5.2	76.7	10.6	9.2	9.9	7.0	8.2	4.6	18.3	8.7	11.4	15.2	10.6	24.8	18.8	17.4	10.1	8.3	6.9	11.5	3.9	12.1	7.0	14.5	8.8	19.9	29.4	7.9	18.3	3.6	19.3	13.6	14.9	17.5	20.7	10.8	11.0	9.0	21.5	15.1	72.7	17.9	3.5	23.5	13.9	18.1	5.8	17.0	8.6	11.0	15.0	13.5	10.5	11.4	10.7	9.8	13.9	5.3	9.7	14.6	8.0	7.3	5.9	11.4	33.8	31.7	7.9	9.7	10.4	11.3	76.7	4.2	62.8	5.5	6.8	5.7	4.2	5.1	7.8	5.2	3.1	3.9	5.8	5.8	9.2	10.6	4.1	9.9	7.0	10.8	10.5	22.3	9.2	10.0	8.8	10.2	8.5	9.7	10.9
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 22.3;intestine: 31.0;lymphoid tissue: 12.3"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 9.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 10.5;neutrophil: 7.8;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 7.8;monocytes: 22.3"																				"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.6	0.3	0.3	11.8	1.0	0.0	0.3	0.2	0.8	0.2	13.3	0.2	0.0	8.2	0.2	0.2	0.3	0.5	0.1	0.4	2.9	0.3	0.4	1.2	2.7	10.5	0.4	0.2	0.2	0.3	0.0	0.9	0.5	2.0	0.4	11.3	0.2	0.3	0.0	0.8	0.2	31.0	1.4	2.1	12.3	0.4	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	1.0	7.8	22.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	10.5	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.8	0.0	22.3	0.3	0.0	0.6	0.3	1.0	0.2	0.8	2.9	0.3	0.4	0.2	2.0	0.3
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183683-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 155.3"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.0"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA039686, HPA050335"	Enhanced									"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	21.0	0.0	0.1	0.2	18.1	0.5	0.0	0.0	0.1	0.0	0.6	12.1	155.3	0.6	0.0	0.2	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.5	0.3	0.0	0.1	1.6	0.0	0.1	0.7	0.0	1.4	0.5	1.1	0.3	0.8	1.1	0.2	0.6	1.3	0.7	1.1	0.3	0.3	0.7	0.7	0.0	0.0	0.1	0.6	0.8	1.1	0.9	0.4	0.5	0.2	0.2	0.3	0.8	0.1	1.4	1.1	1.1	0.0	0.7	0.8	0.4	0.4	0.4	0.2	0.2	0.6	2.0	0.3	0.7	0.5	0.9	1.4	0.6	0.6	0.5	0.6	4.0	1.5	0.6	0.8	0.9	0.5	0.3	0.9	0.3	1.3	1.0	1.8	1.0	0.3	1.6	1.1	0.5	0.7	0.6	1.0	1.0	0.3	0.1	0.9	0.2	0.9	0.7	0.9	0.9	0.1	1.4	0.7	0.6	1.1	0.8	0.2	0.5	1.1	0.2	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0
CASS4	"C20orf32, HEFL, HEPL"	ENSG00000087589	"Cas scaffolding protein family member 4"	Q9NQ75	20	56412112-56460387	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.8;lung: 16.7"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.4;HEL: 10.5;HMC-1: 32.0;K-562: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"eosinophil: 10.8;neutrophil: 33.8"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 33.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB034217	Approved						890000			"CAB034217: AB_2071598"	"unprognostic (9.55e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.28e-2)"	"unprognostic (6.19e-2)"	"unprognostic (7.27e-4)"	"unprognostic (5.33e-2)"	"unprognostic (3.65e-2)"	"unprognostic (6.50e-2)"	"unprognostic (8.16e-2)"	3.3	1.7	2.0	13.0	2.2	2.4	1.7	1.3	4.5	1.7	1.4	6.1	0.0	1.8	2.5	0.9	1.4	1.6	3.5	1.6	2.4	1.5	1.6	2.2	16.7	12.1	1.9	3.1	2.4	1.5	0.4	1.3	6.6	3.4	1.4	1.3	2.7	1.8	2.5	1.3	1.5	2.9	1.8	2.9	9.2	1.5	1.1	2.2	4.1	1.3	1.1	4.3	3.0	1.4	0.0	3.4	33.8	1.9	1.4	2.3	1.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.6	0.2	0.1	0.3	0.1	2.2	0.1	0.1	6.4	0.1	0.1	0.0	0.4	0.1	0.1	10.5	0.1	0.6	0.2	0.3	32.0	0.7	0.2	0.1	0.0	0.0	12.9	0.1	0.3	0.1	0.2	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	1.3	0.1	0.2	1.9	10.8	0.7	0.4	1.0	0.0	1.2	1.3	3.4	0.0	2.3	2.0	33.8	1.4	0.0	1.2	0.6	1.1	2.0	2.2	1.3	4.5	2.4	1.5	1.9	3.1	3.4	2.2
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			18000000	"Endoplasmic reticulum, Cytosol"		"CAB009491: AB_2259755, HPA036881: , HPA036882: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavourable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	47.9	39.6	6.7	17.5	40.6	75.7	23.7	34.2	48.4	27.4	35.7	9.7	29.3	6.9	32.4	46.3	81.7	12.7	46.5	33.2	44.6	12.0	8.9	41.9	11.6	31.2	5.8	15.5	34.2	43.1	39.3	64.1	30.6	7.5	22.4	33.3	15.1	2.8	0.2	5.2	14.7	2.7	22.7	11.8	54.4	20.3	28.4	6.8	34.9	19.2	22.3	11.7	6.3	40.6	37.4	15.9	24.9	34.5	7.5	20.0	3.2	42.4	3.1	10.3	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 75.2;THP-1: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles			960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favourable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favourable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.1	6.8	5.0	7.8	48.4	21.1	10.6	7.8	9.9	8.8	9.7	3.8	6.2	15.2	7.6	15.5	14.7	8.4	8.5	9.8	13.2	7.7	12.8	7.3	21.9	5.7	75.2	6.4	11.3	5.9	2.6	1.0	10.6	26.5	6.3	11.1	5.8	15.4	13.4	0.0	16.6	10.9	23.8	12.4	24.1	23.3	2.6	4.0	8.8	14.2	11.6	20.3	62.8	7.5	5.3	5.2	13.2	4.6	5.1	2.9	3.2	10.4	51.8	3.8	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 43.7"	"Cell line enhanced"	"Detected in many"		"HeLa: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 9.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																						"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.1	0.9	1.1	1.1	1.4	3.2	1.3	9.0	1.1	1.1	1.7	1.1	1.1	2.7	1.1	5.2	1.9	1.1	1.1	1.1	1.1	1.3	1.1	1.1	1.1	1.3	1.1	1.1	1.4	1.1	4.0	3.0	1.1	1.1	1.3	1.9	1.1	1.1	1.9	1.1	4.8	3.1	1.1	1.6	1.1	1.3	43.7	1.1	1.1	1.7	1.1	1.1	1.2	1.1	3.3	1.8	2.3	1.2	1.8	2.9	0.2	2.4	3.5	1.5	5.5	0.0	0.0	2.5	0.9	2.1	1.5	3.7	0.8	1.3	2.9	1.3	0.6	5.4	1.4	4.8	1.5	2.5	6.7	8.4	12.6	1.2	2.3	1.9	2.8	0.3	3.8	2.1	5.4	1.9	3.3	3.1	0.5	0.6	1.6	3.4	0.5	1.5	2.3	1.7	1.4	3.1	3.9	3.3	1.1	1.4	2.1	0.1	4.1	1.9	0.5	3.9	1.6	0.0	2.3	0.6	0.3	5.8	2.7	6.0	1.4	0.4	1.2	0.5	1.3	0.5	1.6	3.3	1.1	1.8	0.8	1.7	1.5	2.9	2.3	1.8	1.2	1.8	0.5	0.2	1.1	1.4	9.0	1.1	1.1	1.3	1.1	1.1	1.1	1.1
CAVIN1	"cavin-1, CGL4, PTRF"	ENSG00000177469	"Caveolae associated protein 1"	Q6NZI2	17	42402452-42423517	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	"RNA-binding, rRNA-binding"	"Congenital generalized lipodystrophy, Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 110.3;TIME: 91.5;U-138 MG: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049838, HPA074213"	Supported		Supported	"Vesicles,Plasma membrane"			29000	"Plasma membrane"	Vesicles	"HPA049838: AB_2680907, HPA074213: "	"unprognostic (1.59e-1)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.76e-3)"	"unprognostic (6.33e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (7.18e-3)"	"unprognostic (2.36e-1)"	"unprognostic (3.44e-3)"	"unprognostic (4.24e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (5.87e-4)"	105.6	12.7	4.7	26.4	5.4	0.7	111.2	4.5	7.6	68.6	52.0	15.3	31.9	7.1	65.6	45.6	60.3	37.1	74.0	37.3	6.4	4.6	12.1	6.6	47.0	15.6	7.7	6.1	57.8	6.8	7.5	6.9	47.7	13.6	51.8	12.4	34.0	17.4	53.8	45.4	28.6	18.6	115.4	14.7	23.9	27.0	24.3	5.2	3.3	30.4	47.9	12.6	80.6	57.9	0.9	0.6	2.7	0.5	0.7	1.2	0.2	30.6	26.3	0.5	7.0	35.6	42.9	0.7	110.3	48.1	44.1	35.0	13.2	2.0	0.0	22.1	78.8	50.7	4.7	33.0	36.1	0.1	0.9	13.4	16.1	6.4	22.5	0.0	0.1	29.4	12.2	34.6	11.9	59.4	9.1	0.1	18.8	0.4	0.7	0.1	2.6	0.1	0.0	17.6	0.0	18.8	0.1	0.0	0.2	37.0	0.6	8.8	3.0	0.2	91.5	93.8	44.1	33.5	40.0	0.0	0.0	0.1	27.8	0.0	10.5	2.7	0.5	0.3	0.5	0.4	0.3	0.3	1.2	0.3	0.2	0.9	0.6	0.3	2.3	0.7	0.4	0.6	0.3	0.2	4.7	5.4	4.5	7.6	6.4	4.6	7.7	6.1	13.6	5.2
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834302-191847255	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 27.6;HEL: 20.1;HUVEC TERT2: 62.5;LHCN-M2: 96.9;TIME: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 9.9;neutrophil: 8.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			160000000	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: "	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.45e-5)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	60.3	8.9	4.9	10.1	8.3	1.8	37.8	2.8	6.1	26.1	32.6	2.8	14.5	3.9	23.9	17.4	18.2	19.5	45.3	46.5	7.1	5.3	15.9	10.4	57.9	20.1	8.9	5.6	20.4	7.6	3.2	4.3	11.6	5.8	19.3	8.9	9.8	6.9	11.2	35.7	3.8	10.6	39.3	7.1	52.9	8.8	7.2	4.4	0.3	34.5	20.1	2.8	33.2	34.5	0.1	1.0	9.9	0.8	0.4	0.1	39.0	0.0	3.4	1.2	0.0	0.1	0.6	0.0	0.7	0.6	0.1	0.2	0.0	0.0	0.0	4.4	27.6	0.6	0.0	5.4	0.4	0.0	0.0	20.1	0.2	7.6	7.8	0.0	0.0	1.5	3.6	0.5	1.7	62.5	7.2	0.0	96.9	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.8	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	8.9	0.4	0.4	1.0	0.1	39.0	4.9	8.3	2.8	6.1	7.1	5.3	8.9	5.6	5.8	4.4
CBLN4	"CBLNL1, dJ885A10.1"	ENSG00000054803	"Cerebellin 4 precursor"	Q9NTU7	20	55997440-56005472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.5;brain: 16.8;epididymis: 11.8"	"Cell line enriched"	"Detected in single"	49	"SH-SY5Y: 14.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074497		Supported			"Secreted in brain"		10000000			"HPA074497: "	"unprognostic (3.61e-1)"	"unprognostic (8.43e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.22e-4)"	"unprognostic (7.50e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.79e-3)"	1.3	23.5	11.9	0.3	8.9	0.2	1.8	0.1	16.8	2.8	0.3	0.5	0.8	0.3	1.2	11.8	0.3	5.4	0.9	0.2	5.9	14.8	1.0	1.3	1.1	0.2	1.6	5.0	2.2	1.2	0.4	0.1	0.5	2.4	0.4	0.2	0.1	0.3	0.7	0.5	0.3	0.3	0.6	0.4	0.2	0.7	2.7	0.0	0.0	1.3	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	8.9	0.1	16.8	5.9	14.8	1.6	5.0	2.4	0.0
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018433	Enhanced		Approved	Nucleoplasm,Cytosol			12000000	Nucleoplasm	Cytosol	"HPA018433: AB_1846109"	"prognostic favourable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favourable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.4	39.2	4.8	12.4	25.2	25.5	0.2	28.5	20.5	15.6	18.7	14.4	15.0	6.4	18.8	26.6	18.7	9.8	28.0	12.0	31.6	23.2	19.2	22.8	9.8	14.4	10.6	17.7	12.4	35.3	15.1	6.6	16.6	0.0	4.7	14.3	25.2	5.3	11.1	0.0	28.6	0.0	0.1	17.7	41.5	12.7	14.0	12.6	27.6	40.1	32.4	19.0	14.8	16.7	17.5	7.4	44.5	20.6	32.1	58.1	0.1	32.2	10.6	25.4	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9
CBS	HIP4	ENSG00000160200	Cystathionine-beta-synthase	P35520	21	43053191-43076943	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Cysteine biosynthesis"	"Allosteric enzyme, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 55.7;pancreas: 43.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 40.2;HAP1: 38.3;HHSteC: 51.8;MCF7: 44.3;RPMI-8226: 42.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	84	"neutrophil: 8.3"	"Lineage enriched"	"Detected in single"	84	"granulocytes: 8.3"									HPA001223	Supported		Approved	Nucleoli,Vesicles				Vesicles	Nucleoli	"HPA001223: AB_1846112"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.68e-4)"	"unprognostic (3.62e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.73e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	1.3	1.5	6.5	2.4	5.1	0.4	1.0	12.3	6.7	4.8	1.3	2.0	0.8	1.6	0.9	0.8	0.8	2.0	2.1	2.0	5.6	5.5	1.3	55.7	1.7	1.4	4.8	2.8	13.9	43.0	0.3	1.4	1.4	2.3	4.0	0.7	2.8	9.3	3.4	0.8	0.6	2.9	1.4	3.7	0.8	2.7	2.2	3.3	0.8	5.0	0.8	0.9	2.6	0.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	6.3	3.8	5.0	19.6	11.3	7.3	40.2	7.8	2.0	3.2	3.3	11.8	0.3	0.0	4.2	14.7	0.4	38.3	2.7	0.6	0.0	4.8	2.6	15.3	14.2	51.8	1.6	3.8	4.4	0.4	3.5	3.1	8.6	29.6	22.3	2.4	44.3	2.7	0.0	4.7	6.7	0.0	0.0	42.4	0.1	3.5	10.4	15.3	17.2	1.0	7.4	6.1	20.0	1.1	0.2	9.9	0.1	0.8	7.8	6.2	8.8	3.6	2.3	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	6.5	5.1	12.3	5.2	5.6	5.5	4.8	2.8	2.3	3.3
CBX3	HP1Hs-gamma	ENSG00000122565	"Chromobox 3"	Q13185	7	26201162-26213356	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001973, HPA004902"	Supported		Supported	"Nucleoplasm,Nuclear bodies"			40000	Nucleoplasm	"Nuclear bodies"	"CAB001973: , HPA004902: AB_1850635"	"prognostic unfavourable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.25e-3)"	"prognostic unfavourable (2.20e-8)"	"unprognostic (2.13e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.71e-3)"	"prognostic unfavourable (4.00e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.56e-7)"	"unprognostic (7.79e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.78e-2)"	40.7	49.4	41.2	54.3	38.8	65.8	69.4	37.4	45.9	33.9	38.4	20.3	39.0	49.8	39.5	42.1	36.4	33.9	28.6	43.3	39.0	40.8	51.1	45.8	37.0	68.6	44.9	37.2	45.3	31.8	22.4	27.5	45.4	51.1	30.7	43.7	23.7	35.0	45.6	60.4	27.1	56.4	46.7	66.9	54.0	29.3	45.1	33.7	92.3	32.1	38.2	65.0	39.8	38.1	38.8	37.4	55.2	48.4	39.5	60.7	35.1	49.3	21.8	46.7	46.2	16.8	30.6	36.8	38.8	29.6	29.6	30.1	25.8	41.7	75.1	31.3	25.6	39.5	39.0	32.4	48.5	20.7	29.1	42.8	28.8	28.7	18.5	67.6	41.6	22.4	28.4	23.4	33.5	39.9	68.5	37.2	50.0	28.2	65.1	81.6	59.5	31.6	42.7	43.5	61.9	43.1	27.7	57.2	63.5	32.1	68.4	35.6	58.1	61.4	29.6	26.9	48.9	31.4	51.4	55.2	79.5	127.7	23.5	58.3	121.5	47.8	38.4	55.2	34.6	47.6	42.8	38.8	51.7	42.7	37.4	35.8	55.0	54.0	39.3	39.5	48.4	30.5	60.7	35.1	41.2	38.8	37.4	45.9	39.0	40.8	44.9	37.2	51.1	33.7
CCBE1	"FLJ30681, KIAA1983"	ENSG00000183287	"Collagen and calcium binding EGF domains 1"	Q6UXH8	18	59430940-59697380	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 28.0"	"Cell line enhanced"	"Detected in some"		"BJ: 26.2;BJ hTERT+: 26.9;BJ hTERT+ SV40 Large T+ RasG12V: 25.2;HBF TERT88: 30.2;hTERT-HME1: 40.9;LHCN-M2: 45.9;TIME: 24.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 10.0"	"Group enriched"	"Detected in some"	7	"basophil: 9.6;neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 9.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA041361, HPA041374"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"			"Plasma membrane, Cytosol"		"HPA041361: AB_10796667, HPA041374: AB_10794515"	"unprognostic (3.09e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.54e-5)"	"unprognostic (1.66e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.68e-5)"	"unprognostic (2.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.62e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.02e-2)"	10.0	12.6	2.4	3.8	1.1	0.4	3.5	0.4	2.0	16.8	15.8	0.6	8.2	0.8	12.1	2.8	2.3	6.9	6.9	2.1	10.0	0.5	3.1	4.3	16.5	3.6	0.4	2.1	28.0	0.8	0.4	2.6	0.3	1.7	3.0	2.3	9.1	1.0	3.5	10.6	3.3	3.0	4.9	0.3	0.3	1.7	2.1	1.3	0.2	1.0	0.0	0.7	2.9	5.1	0.8	0.4	9.6	0.3	0.8	0.3	0.2	5.1	0.4	0.0	0.0	4.1	12.9	8.0	26.2	26.9	19.1	25.2	0.0	0.1	0.1	0.0	10.4	0.5	0.0	16.9	30.2	0.1	0.1	0.0	0.1	0.1	9.5	0.1	0.0	8.6	0.7	14.9	40.9	0.9	0.0	0.1	45.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.5	0.1	0.2	0.0	0.0	0.2	0.0	0.1	24.7	0.0	2.6	3.9	0.0	0.1	0.0	0.0	1.3	0.1	0.6	9.6	0.3	0.8	0.3	0.2	0.2	0.4	0.2	0.2	0.1	0.8	0.3	0.3	2.7	0.8	0.2	0.4	0.2	0.2	2.4	1.1	0.4	2.0	10.0	0.5	0.4	2.1	1.7	1.3
CCDC33	"CT61, FLJ32855"	ENSG00000140481	"Coiled-coil domain containing 33"	Q8N5R6	15	74202705-74336472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	10	"fallopian tube: 35.9;testis: 41.5"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 12.1;SCLC-21H: 6.8;SH-SY5Y: 8.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (2.16e-1)"		"unprognostic (3.16e-3)"		"unprognostic (3.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.05e-2)"		"unprognostic (4.46e-1)"	"unprognostic (4.18e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.37e-2)"	0.0	0.2	0.8	0.0	2.6	0.0	0.0	0.0	0.2	0.9	0.3	2.7	0.7	0.0	0.5	3.0	0.0	35.9	0.5	0.0	1.1	1.4	0.0	0.0	3.4	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.2	3.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.2	0.0	0.3	41.5	0.8	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.1	0.0	1.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	6.8	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.6	0.0	0.1	1.1	1.4	0.0	0.0	3.3	0.8
CCDC88C	"DAPLE, HkRP2, KIAA1509, SCA40"	ENSG00000015133	"Coiled-coil domain containing 88C"	Q9P219	14	91271323-91417844	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Guanine-nucleotide releasing factor"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 23.9;U-266/70: 21.0;U-266/84: 29.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 18.7"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005832	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA005832: AB_1079202"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-3)"	"unprognostic (7.23e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.47e-4)"	"unprognostic (3.07e-2)"	"prognostic favourable (2.90e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (7.48e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.35e-2)"	3.6	0.9	2.7	31.1	18.7	15.0	6.9	0.9	2.3	3.0	8.9	1.8	15.5	9.6	4.7	4.0	8.9	9.7	11.8	2.2	2.0	2.4	5.0	2.6	11.1	34.5	2.0	0.3	2.0	14.8	6.7	4.0	1.8	1.6	6.4	4.7	4.1	12.1	11.7	1.5	4.5	9.6	6.0	2.9	14.5	8.1	4.8	3.7	18.5	2.5	6.0	27.6	7.1	5.3	2.3	1.8	5.2	3.2	3.1	11.0	2.8	3.1	2.9	3.4	3.9	0.0	0.0	15.1	0.0	0.0	0.0	0.0	3.0	4.7	13.5	2.5	0.0	0.1	4.8	2.7	0.0	11.4	1.8	3.6	2.0	4.2	0.3	7.0	3.0	0.0	4.0	0.0	0.0	3.7	4.1	17.0	0.0	10.3	7.1	9.3	3.3	4.4	5.9	0.1	4.5	0.8	4.5	23.9	5.3	2.0	6.9	1.6	3.8	6.5	1.1	0.0	0.0	0.0	0.0	21.0	29.5	6.9	0.0	6.4	0.0	5.2	3.2	1.3	9.0	1.8	8.7	2.3	6.1	9.3	1.8	1.9	3.9	5.8	2.6	3.1	2.5	1.5	11.0	2.8	2.7	18.7	0.9	2.3	2.0	2.4	2.0	0.3	1.6	3.7
CCDC9	DKFZP586M1019	ENSG00000105321	"Coiled-coil domain containing 9"	Q9Y3X0	19	47255980-47273701	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045624, HPA072007"	Approved		Approved	Cytosol				Cytosol		"HPA045624: AB_10961402, HPA072007: "	"unprognostic (4.53e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.70e-3)"	"unprognostic (8.22e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (4.02e-1)"	17.4	16.9	10.1	18.4	13.5	38.3	16.0	14.9	15.0	18.0	16.1	13.0	20.6	14.8	31.2	19.6	15.0	16.2	17.4	15.6	10.6	7.1	14.3	16.0	18.0	14.3	14.7	10.4	23.4	35.1	16.2	14.9	21.8	13.2	19.3	9.8	17.9	14.7	19.8	23.2	23.5	14.0	28.2	9.3	16.8	17.3	23.3	15.6	11.1	19.0	13.1	13.3	21.8	23.2	2.3	2.9	7.8	2.7	2.0	3.6	0.8	11.4	11.7	9.3	10.3	2.9	8.1	10.5	16.0	7.1	9.8	10.9	12.4	9.1	5.3	4.4	10.6	10.8	8.5	6.8	5.4	13.9	5.2	13.5	10.7	9.4	9.5	5.4	14.1	8.6	10.1	9.3	8.8	6.5	18.3	26.9	6.5	13.8	6.3	47.9	10.2	4.6	11.2	8.8	5.9	4.4	8.4	3.6	9.2	21.7	15.8	8.5	13.1	11.2	8.9	11.4	10.3	6.8	13.5	9.0	15.5	7.9	10.7	7.4	8.7	0.8	2.5	3.8	2.9	2.7	1.5	1.4	2.3	2.4	1.9	2.3	2.4	1.7	7.8	2.0	1.7	2.9	3.6	0.8	10.1	13.5	14.9	15.0	10.6	7.1	14.7	10.4	13.2	15.6
CCDC96	FLJ90575	ENSG00000173013	"Coiled-coil domain containing 96"	Q2M329	4	7040849-7042939	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 52.9"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 9.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047546	Enhanced									"HPA047546: "	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"unprognostic (7.95e-2)"	"prognostic favourable (4.05e-4)"	"unprognostic (1.22e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.77e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.92e-1)"	"prognostic favourable (4.87e-4)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.80e-5)"	"unprognostic (4.37e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	0.8	1.4	1.7	0.5	3.9	1.1	1.2	1.1	2.6	0.8	0.6	2.4	0.6	0.9	0.9	3.3	0.8	10.5	1.0	0.5	2.4	2.7	1.2	0.5	1.7	0.7	1.5	2.4	3.0	1.3	1.1	3.0	0.5	4.0	0.9	0.6	0.8	0.9	1.2	0.6	1.6	0.6	0.7	1.2	0.8	1.0	52.9	1.5	0.0	1.5	0.5	0.6	0.6	1.0	0.6	1.6	0.5	3.8	0.4	1.6	0.6	1.6	4.6	2.5	2.0	3.3	2.3	0.5	4.7	2.8	5.2	3.2	1.6	4.1	1.0	1.3	2.6	2.1	0.9	2.1	1.6	0.1	0.7	1.0	2.1	1.1	1.6	1.3	2.6	2.0	2.2	3.2	0.4	2.1	0.7	0.4	3.3	4.0	2.7	1.7	1.0	2.8	1.1	1.7	0.3	9.2	1.7	6.8	1.5	3.7	1.7	0.8	1.8	2.4	2.3	4.4	1.2	2.7	3.5	0.0	0.1	0.9	3.5	0.1	1.4	0.0	1.6	0.0	0.3	3.8	0.7	0.6	0.4	0.0	1.6	0.0	0.3	1.6	0.5	0.4	2.9	0.0	0.0	0.6	1.7	3.9	1.1	2.6	2.4	2.7	1.5	2.4	4.0	1.5
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.7;RPTEC TERT1: 22.7"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"					"HPA045039: , HPA069515: "	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	22.7	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5
CCL14	"CKb1, HCC-1, HCC-3, MCIF, NCC-2, SCYA14, SCYL2"	ENSG00000276409	"C-C motif chemokine ligand 14"	Q16627	17	35983291-35987004	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 80.7;lymphoid tissue: 98.4"	"Cell line enriched"	"Detected in single"	52	"HUVEC TERT2: 35.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB004423, HPA030268"	Uncertain				"Secreted to blood"	5200000	19000000			"CAB004423: AB_627716, HPA030268: AB_10603782"	"unprognostic (4.13e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.55e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.79e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.33e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	56.3	5.1	0.0	5.9	0.0	0.0	80.7	0.0	0.0	37.6	8.4	0.0	16.6	0.0	37.6	11.1	20.9	9.1	17.3	27.5	0.0		8.7	34.2	26.4	39.1	0.0	0.0	12.4	0.8	2.0	6.5	0.0	0.0	23.5	0.7	4.1	6.5	11.4	21.9	7.5	3.9	19.1	0.0	98.4	0.2	15.0	0.0	1.3	17.6	16.7	6.2	25.3	45.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36002038	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 36.4;liver: 17.9"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 26.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"		7900000	"Golgi apparatus"	Vesicles	"HPA058608: "	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favourable (3.02e-4)"	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.1	18.0	0.0	0.0	11.6	0.0	0.4	0.0	1.1	7.4	0.8	0.0		6.4	17.9	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	15.8	0.0	0.0	0.0	0.0	0.4	36.4	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	1.0	2.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.7	0.4	0.2	2.2	0.9	0.1	1.0	0.3	0.0										
CCL16	"CKb12, HCC-4, LCC-1, LEC, LMC, Mtn-1, NCC-4, SCYA16, SCYL4"	ENSG00000275152	"C-C motif chemokine ligand 16"	O15467	17	35976493-35981496	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 79.1"	"Cell line enriched"	"Detected in single"	23	"Hep G2: 14.6"	"Cancer enriched"	"Detected in single"	154	"liver cancer: 49.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"								"Secreted to blood"	749700	20000000				"unprognostic (3.85e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.75e-2)"		"unprognostic (2.72e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.66e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	79.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2										
CCL18	"AMAC-1, CKb7, DC-CK1, DCCK1, MIP-4, PARC, SCYA18"	ENSG00000275385	"C-C motif chemokine ligand 18"	P55774	17	36064280-36072032	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.4;lung: 77.9;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in single"		"SK-MEL-30: 1.5"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	36566667	940000				"unprognostic (8.91e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.87e-2)"	18.2	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.2	0.0	3.1	0.0	0.0	1.6	0.0	5.8	3.2	0.0	0.4	41.4	0.0		0.0	1.3	77.9	61.9	0.0	0.0	3.7	0.3	0.0	0.0	5.9	0.0	0.2	2.5	0.0	0.2	0.0	0.0	0.3	3.4	4.1	0.0	3.7	0.3	1.6	0.0	43.8	2.2	4.3	16.7	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL2	"GDCF-2, HC11, MCAF, MCP-1, MCP1, MGC9434, SCYA2, SMC-CF"	ENSG00000108691	"C-C motif chemokine ligand 2"	P13500	17	34255218-34257203	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"BJ hTERT+: 159.2;HMC-1: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 10.3;eosinophil: 3.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 3.9;monocytes: 10.3"					"Low region specificity"	"Detected in many"			"CAB013676, HPA019163"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	342420		"Golgi apparatus"	Vesicles	"CAB013676: , HPA019163: AB_1846179"	"unprognostic (6.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.37e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.33e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (4.51e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	78.1	31.2	10.3	52.3	50.6	19.1	19.0	1.5	23.3	9.7	41.9	28.6	3.0	9.4	7.2	7.6	14.4	25.8	62.0	76.9	45.1	6.7	32.5	38.4	105.2	16.9	16.0	2.0	28.6	32.8	15.2	17.3	22.8	63.6	42.0	25.3	22.3	13.5	13.4	17.8	10.5	16.7	34.6	85.4	16.1	30.2	4.6	8.6	4.8	20.8	21.6	19.1	27.2	9.0	0.0	1.1	3.9	10.3	0.0	0.1	2.3	0.0	1.2	3.4	0.0	9.6	8.2	0.0	9.7	159.2	20.7	44.4	0.5	0.0	0.0	7.7	2.2	5.3	0.3	0.0	10.5	0.0	0.0	0.0	1.1	0.0	0.3	0.0	207.5	9.1	0.0	4.3	0.2	9.4	0.5	1.7	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.2	1.7	29.6	0.0	0.0	0.6	0.0	0.5	0.2	0.3	0.2	0.5	11.1	0.4	0.3	0.0	0.1	0.0	0.0	6.5	3.0	7.0	0.0	10.3	3.9	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	0.0	2.3	10.3	50.6	1.5	23.3	45.1	6.7	16.0	2.0	63.6	8.6
CCL21	"6Ckine, CKb9, ECL, exodus-2, SCYA21, SLC, TCA4"	ENSG00000137077	"C-C motif chemokine ligand 21"	O00585	9	34709005-34710124	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 430.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.6;HL-60: 2.3;K-562: 3.8;RH-30: 2.4;U-937: 1.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005067, HPA051210"	Enhanced				"Secreted to blood"	197877	770000			"CAB005067: AB_2071925, HPA051210: "	"unprognostic (3.06e-3)"	"unprognostic (7.19e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.50e-2)"		"unprognostic (4.51e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.66e-2)"	"unprognostic (8.91e-2)"	24.4	6.5	0.3	83.5	0.4	0.0	18.0	0.3	0.4	13.6	25.5	0.4	5.9	3.7	26.8	23.7	80.1	23.0	23.2	18.8	0.3	0.0	19.6	11.0	30.5	430.9	0.3	0.3	13.8	3.3	0.0	0.4	7.4	0.5	9.4	11.9	0.7	96.9	4.1	4.7	7.6	71.2	10.6	0.3	35.9	10.7	5.5	0.3	2.3	91.0	44.8	181.2	15.7	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.7	2.3	0.3	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.8	0.0	0.9	2.4	0.6	0.0	0.0	0.3	0.5	1.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.5	0.0	0.8	0.0	0.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
CCL23	"Ckb-8, CKb8, MIP-3, MPIF-1, SCYA23"	ENSG00000274736	"C-C motif chemokine ligand 23"	P55773	17	36013056-36017968	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3"	"Group enriched"	"Detected in some"	4	"HEL: 12.6;THP-1: 26.9"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in single"	173	"eosinophil: 50.3"	"Lineage enriched"	"Detected in single"	173	"granulocytes: 50.3"									HPA042015	Uncertain				"Secreted to blood"	91400	57000			"HPA042015: AB_10794039"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.05e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.35e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.95e-1)"	5.8	0.5	0.0	13.1	0.0	2.1	3.7	0.0	0.5	2.1	2.0	0.0	1.0	0.0	1.8	3.0	1.3	1.5	2.2	4.6	0.0		3.0	5.9	7.9	8.0	0.3	0.0	1.2	0.0	0.0	0.5	1.5	0.2	1.7	7.2	0.7	0.0	1.1	0.5	0.4	1.0	8.4	0.0	2.0	0.0	0.1	0.0	0.4	1.1	0.6	0.5	3.0	0.0	0.2	0.1	50.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.2	50.3	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0										
CCL5	"D17S136E, MGC17164, RANTES, SCYA5, SISd, TCP228"	ENSG00000271503	"C-C motif chemokine ligand 5"	P13501	17	35871491-35880793	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 169.0"	"Cell line enriched"	"Detected in some"	4	"NB-4: 71.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"gdT-cell: 157.7;memory CD8 T-cell: 169.0"	"Lineage enriched"	"Detected in many"	4	"T-cells: 169.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"								"Secreted to blood"	21766000	8200000				"unprognostic (3.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (8.63e-2)"	"prognostic favourable (1.34e-5)"	"unprognostic (1.36e-3)"	"unprognostic (6.37e-3)"	"unprognostic (8.70e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (2.42e-4)"	"unprognostic (3.26e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (3.61e-7)"	"unprognostic (1.70e-2)"	"unprognostic (7.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (3.73e-2)"	3.6	2.4	0.0	28.8	0.1	17.1	2.6	0.0	0.2	6.0	14.7	1.0	0.6	7.1	5.0	7.2	5.2	1.7	20.5	7.5	0.0		2.7	4.7	29.8	33.5	2.8	0.0	5.9	2.3	0.0	0.1	4.8	1.7	7.8	4.0	8.0	5.5	6.4	2.8	0.0	38.7	2.3	2.2	38.8	6.9	1.9	0.0	12.2	1.6	5.5	27.9	11.5	0.0	1.2	1.1	9.9	0.6	40.8	169.0	106.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	2.4	2.8	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.1	11.3	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.6	0.0	0.0	0.0	71.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.1	1.7	0.0	16.7	0.0	0.0	0.0	0.1	0.0	2.1	0.7	0.1	0.0	15.3	0.1	9.9	0.6	0.7	157.7	0.4	103.8	1.2	36.7	169.0	1.1	0.7	8.8	99.3	4.6	40.8	0.5	0.9	0.5	106.5										
CCM2L	"C20orf160, dJ310O13.5"	ENSG00000101331	"CCM2 like scaffolding protein"	Q9NUG4	20	32010450-32032180	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 10.4;HUVEC TERT2: 12.2;NTERA-2: 6.6;RH-30: 4.6;SCLC-21H: 11.3;TIME: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008434, HPA071063"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA008434: AB_1845671, HPA071063: "	"unprognostic (1.71e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.27e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.00e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.66e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	7.2	1.8	2.1	1.8	2.0	0.2	15.0	2.1	2.2	4.4	1.4	1.7	2.1	1.2	7.1	2.3	1.9	2.6	2.4	5.4	2.0	1.7	3.1	1.0	15.1	1.3	2.3	1.5	1.8	1.0	1.4	1.4	6.7	2.5	1.9	1.2	4.9	1.4	2.0	3.5	1.5	1.6	3.2	1.4	53.0	1.4	1.6	1.6	0.2	3.0	5.2	1.0	2.0	4.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	3.5	0.0	0.0	6.6	0.0	0.8	4.6	0.2	0.0	0.0	11.3	1.3	0.3	0.0	0.0	3.6	0.0	6.2	0.1	2.0	0.0	0.0	0.2	0.0	0.2	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	2.1	2.0	2.1	2.2	2.0	1.7	2.3	1.5	2.5	1.6
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: , HPA061448: "	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (1.54e-7)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.7	40.7	55.8	49.6	2.9	5.0	131.9	26.0	19.5	68.7	58.1	60.1	55.4	36.1	31.7	24.0	37.1	56.1	56.9	77.1	35.4	27.8	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.4	27.5	36.6	27.7	28.7	55.9	55.9	27.3	23.8	31.1	25.8	28.7	40.3	37.0	25.1	21.7	28.4	17.9	44.8	21.1	19.3	40.3	20.9	15.4	15.3	49.8	27.6	65.0	14.4	26.6	50.4	21.2	35.0	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (2.83e-4)"	"prognostic unfavourable (4.63e-4)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.4	25.1	41.3	10.2	1.8	3.8	21.9	23.6	15.2	36.6	30.1	40.6	17.6	26.5	17.1	15.2	35.2	39.0	20.1	34.6	27.5	20.9	34.3	29.4	23.0	0.5	25.5	22.1	1.4	2.7	15.7	20.1	24.8	34.6	42.6	27.6	20.7	29.1	37.2	30.5	14.9	34.0	58.4	26.9	11.5	20.2	25.7	17.4	32.4	17.6	21.3	30.5	25.5	12.9	18.2	31.0	20.1	44.9	19.0	28.4	47.1	11.9	58.4	25.7	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2
CCNG1	CCNG	ENSG00000113328	"Cyclin G1"	P51959	5	163437569-163446151	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB000350	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB000350: "	"unprognostic (2.49e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (7.00e-4)"	"unprognostic (2.92e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.26e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.89e-2)"	32.3	24.8	11.1	16.0	14.6	9.6	20.5	9.0	9.7	27.9	43.5	11.0	14.1	41.4	22.3	23.6	24.7	19.4	25.8	29.8	11.5	10.3	40.4	46.6	20.7	26.0	22.5	9.1	44.1	42.5	13.5	12.6	17.9	17.0	39.3	26.9	12.6	25.6	18.1	51.7	10.2	68.7	35.8	27.1	22.7	24.6	17.0	15.8	26.5	38.3	29.7	15.6	48.1	21.4	23.2	23.3	15.9	14.0	15.4	36.5	22.8	9.5	10.7	44.6	25.0	38.6	74.4	47.0	13.2	32.4	13.5	30.5	23.1	19.5	23.4	13.5	17.6	3.9	24.6	33.0	19.9	11.2	31.1	18.5	14.2	40.1	42.2	8.5	12.5	80.7	19.1	13.3	13.7	43.2	15.8	16.7	45.6	5.9	14.9	11.5	20.4	9.7	13.0	21.9	12.9	32.7	37.0	10.6	12.0	0.0	5.5	26.9	20.9	27.4	25.1	8.7	18.8	7.3	11.5	14.9	5.8	15.8	15.5	14.4	14.5	15.9	10.3	11.8	15.1	14.0	22.3	23.2	26.6	20.6	23.3	14.5	36.5	29.8	4.2	15.4	13.0	8.9	31.3	22.8	11.1	14.6	9.0	9.7	11.5	10.3	22.5	9.1	17.0	15.8
CCNO	"CCNU, FLJ22422, UDG2, UNG2"	ENSG00000152669	"Cyclin O"	P22674	5	55231152-55233680	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation"	Cyclin	"Ciliopathy, Disease mutation, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 28.1;epididymis: 18.2;seminal vesicle: 23.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.5;T-47d: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA050090	Uncertain									"HPA050090: "	"unprognostic (3.44e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-2)"	"prognostic favourable (6.78e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.18e-3)"	"prognostic favourable (7.60e-4)"	"unprognostic (3.54e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (5.10e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.49e-2)"	"unprognostic (8.88e-3)"	0.7	0.8	1.3	0.8	7.2	0.6	0.7	1.7	4.5	1.9	1.2	1.3	28.1	1.4	1.1	18.2	0.9	4.0	3.5	0.6	1.3	2.0	2.2	0.7	1.3	0.8	0.1	1.6	1.4	9.5	3.0	5.4	0.8	4.3	1.8	0.5	1.6	6.5	23.2	0.5	3.1	2.1	0.6	0.1	0.6	5.3	12.2	0.1	0.0	7.4	0.8	0.9	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.3	3.8	0.0	1.4	0.3	0.0	6.5	0.0	0.0	0.5	0.6	0.0	3.9	0.0	2.7	0.0	3.0	0.1	0.0	0.0	0.0	5.0	0.1	2.8	0.4	0.0	0.4	1.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.1	0.5	5.4	1.9	0.4	0.1	1.3	0.9	2.9	0.0	4.6	1.2	1.0	8.8	0.5	0.3	0.0	3.1	3.6	1.6	3.4	1.8	0.0	2.3	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	7.2	1.7	4.5	1.3	2.0	0.1	1.6	4.3	0.1
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607"	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	16.6	14.9	13.1	12.9	17.4	38.1	15.7	20.9	17.7	13.4	12.6	16.5	10.9	9.9	19.9	13.0	13.8	15.8	10.5	11.8	13.5	8.5	13.0	14.1	15.6	14.9	14.3	13.2	21.5	15.9	18.4	19.6	18.5	14.5	12.8	12.4	12.8	12.6	11.2	18.8	16.4	14.6	13.3	12.1	16.8	13.8	22.6	15.7	22.4	16.5	10.9	15.9	15.3	13.2	5.5	4.4	14.8	2.8	3.7	4.9	0.9	7.5	10.5	10.3	10.3	8.3	9.7	12.6	10.2	8.0	7.7	6.3	13.0	9.3	20.6	13.4	6.5	9.5	16.6	7.2	11.5	11.4	10.6	21.4	16.9	5.9	9.8	23.5	10.9	7.7	10.8	9.7	13.3	6.4	20.5	8.9	9.3	4.8	10.9	11.0	11.3	8.6	10.7	16.6	8.8	7.7	13.9	11.0	12.6	15.6	8.5	12.4	11.3	13.6	6.5	8.9	9.1	6.3	8.9	13.8	18.5	18.4	10.1	33.6	5.1	6.8	2.8	7.9	3.6	1.8	4.9	4.3	3.1	3.5	1.7	5.5	4.5	4.0	14.8	3.7	2.0	4.4	1.8	0.9	13.1	17.4	20.9	17.7	13.5	8.5	14.3	13.2	14.5	15.7
CCNT2		ENSG00000082258	"Cyclin T2"	O60583	2	134918235-134959342	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA005559	Supported		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA005559: AB_1078608"	"unprognostic (2.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (2.44e-4)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.33e-1)"	"unprognostic (8.51e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (3.28e-4)"	15.8	14.1	21.0	15.2	19.9	32.5	21.1	30.5	22.2	16.4	14.2	16.9	17.8	17.6	22.6	20.9	15.4	16.1	12.9	14.2	16.1	14.3	12.9	20.8	17.5	18.9	18.6	16.2	22.8	24.0	25.1	29.6	17.9	20.0	18.0	16.7	11.5	16.9	19.4	14.5	20.3	17.2	18.0	17.1	19.8	18.9	15.8	19.1	23.0	18.7	9.4	18.2	18.9	19.5	3.8	4.9	6.9	4.5	6.2	8.4	3.4	6.8	3.4	22.3	8.3	11.1	11.3	17.0	9.4	7.8	8.9	11.2	9.1	7.9	11.2	7.1	7.7	8.9	13.3	7.1	13.1	6.0	9.0	12.0	8.7	12.9	10.8	10.8	10.7	10.3	14.1	8.8	10.9	13.1	10.0	11.5	10.3	4.6	11.9	16.2	18.1	7.1	11.6	8.0	8.9	13.9	18.9	15.3	12.6	6.9	8.1	10.7	8.5	13.2	11.9	11.6	12.8	4.9	6.9	8.1	5.0	11.7	7.2	8.6	9.8	6.9	3.7	4.5	4.3	4.5	5.3	3.8	4.8	5.1	4.9	3.1	8.4	6.4	4.8	6.2	2.3	4.5	5.9	3.4	21.0	19.9	30.5	22.2	16.1	14.3	18.6	16.2	20.0	19.1
CCP110	"CP110, KIAA0419"	ENSG00000103540	"Centriolar coiled-coil protein 110"	O43303	16	19523811-19553408	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039402	Approved		Supported	Centrosome				Centrosome		"HPA039402: AB_10671041"	"unprognostic (2.83e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (9.68e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.37e-1)"	5.2	5.9	19.0	6.0	39.1	12.6	9.0	19.1	28.4	7.6	4.5	13.2	4.6	3.7	8.9	7.3	6.4	13.0	5.7	4.4	23.6	15.0	4.5	3.4	8.1	7.1	40.0	13.3	10.6	3.7	9.6	17.2	4.6	20.6	7.3	5.5	2.1	4.8	7.1	4.3	5.5	4.5	7.6	16.0	5.8	6.1	31.6	36.6	10.9	6.9	1.9	7.1	5.7	6.6	4.5	4.0	13.0	5.3	2.3	5.6	2.5	11.2	5.2	12.9	12.5	6.5	5.8	6.7	12.0	7.0	10.7	12.1	4.2	6.0	16.5	7.6	5.9	7.9	13.2	3.8	18.1	7.5	6.0	8.2	7.2	7.2	3.2	21.1	10.6	2.8	5.3	12.0	7.4	8.2	8.6	8.3	12.5	8.7	21.6	8.2	9.9	3.9	27.6	24.1	5.8	4.9	4.7	25.5	12.9	13.0	6.2	3.9	11.3	12.9	4.8	12.5	8.3	8.4	9.8	9.3	8.6	12.0	8.0	9.1	7.3	13.0	3.8	6.7	5.5	3.6	3.5	3.3	4.9	5.2	4.0	4.5	5.6	3.2	7.7	2.3	5.3	2.6	3.9	2.5	19.0	39.1	19.1	28.4	23.6	15.0	40.0	13.3	20.6	36.6
CCR10	GPR2	ENSG00000184451	"C-C motif chemokine receptor 10"	P46092	17	42678889-42683917	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.6;RPMI-8226: 6.2;U-266/70: 17.7;U-266/84: 8.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 31.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.9;T-cells: 31.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB011684, HPA048007, HPA069188"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB011684: AB_731502, HPA048007: , HPA069188: "	"unprognostic (3.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.25e-2)"	"unprognostic (2.23e-3)"	"unprognostic (5.18e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.32e-11)"	"unprognostic (2.84e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-1)"	10.0	5.4	5.7	4.8	5.3	0.7	3.0	7.3	7.3	3.9	9.7	0.9	1.5	5.1	5.8	1.4	1.5	4.5	1.5	2.5	3.5	5.0	1.6	0.5	2.2	12.5	1.9	5.0	5.2	2.6	0.4	14.0	2.3	4.1	2.1	1.0	1.1	4.0	2.0	9.1	1.1	8.7	1.8	4.4	4.3	5.0	2.2	1.2	0.5	1.5	0.3	3.6	1.0	2.0	2.3	10.9	0.1	0.3	0.0	31.1	0.7	0.5	0.8	1.1	4.9	0.3	0.8	1.1	2.4	0.5	0.2	0.4	0.7	0.3	0.1	0.3	0.3	0.9	0.0	0.1	0.1	2.3	1.2	0.0	3.1	0.4	0.7	0.0	0.3	0.8	0.0	0.4	0.0	0.1	2.6	8.6	0.0	0.3	0.1	2.3	0.6	1.2	0.6	0.2	6.2	1.1	0.0	0.8	1.1	0.7	0.0	0.2	0.8	0.9	2.4	2.9	0.6	0.9	0.3	17.7	8.0	2.5	1.4	0.7	0.9	0.0	0.3	0.1	0.2	0.0	0.1	2.3	5.2	2.6	0.2	2.1	0.6	0.8	0.0	0.0	0.1	10.9	31.1	0.7	5.7	5.3	7.3	7.3	3.5	5.0	1.9	5.0	4.1	1.2
CCS		ENSG00000173992	"Copper chaperone for superoxide dismutase"	O14618	11	66592821-66606019	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008672, HPA040026, HPA044090"	Approved						480000			"CAB008672: AB_1623300, HPA040026: , HPA044090: "	"unprognostic (1.19e-1)"	"unprognostic (8.46e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.25e-3)"	13.2	21.1	14.2	26.2	15.6	17.2	12.0	14.0	16.8	13.6	19.4	13.7	20.2	16.8	18.8	20.4	13.3	13.1	23.7	16.7	11.7	13.9	15.0	37.7	9.4	14.0	15.6	16.7	20.8	17.4	17.4	14.9	12.0	11.7	16.4	10.9	23.0	21.3	23.9	16.4	14.9	15.7	18.4	11.5	16.0	13.2	15.6	12.1	14.0	18.0	11.6	13.3	13.7	12.4	12.3	31.8	23.2	10.7	6.2	7.7	6.5	8.4	12.7	9.5	7.9	8.7	9.2	9.6	6.0	9.4	6.7	5.0	12.2	7.5	4.1	7.6	9.9	9.2	2.2	11.0	2.7	7.5	4.9	5.1	10.4	17.3	20.9	0.9	4.7	13.3	7.6	5.6	5.9	13.9	3.6	6.2	6.9	19.4	1.9	6.9	7.8	10.9	4.1	8.7	8.4	11.7	9.3	6.4	4.2	12.3	7.6	11.1	13.2	4.3	5.5	4.3	5.3	9.5	2.9	10.1	5.9	1.2	10.0	3.4	8.8	7.8	10.7	23.2	7.5	8.0	7.3	12.3	7.3	7.2	13.8	9.7	7.6	7.7	7.9	6.2	4.7	31.8	7.5	6.5	14.2	15.6	14.0	16.8	11.7	13.9	15.6	16.7	11.7	12.1
CCT2	Cctb	ENSG00000166226	"Chaperonin containing TCP1 subunit 2"	P78371	12	69585334-69601570	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003197, HPA003198"	Enhanced		Supported	Cytosol			9100000	Cytosol		"HPA003197: AB_1078425, HPA003198: AB_1078424"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.42e-2)"	"prognostic unfavourable (8.38e-4)"	"prognostic unfavourable (3.61e-9)"	"unprognostic (5.28e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.34e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (6.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.21e-2)"	29.4	32.1	25.7	28.3	31.4	45.8	33.8	39.2	37.0	25.0	27.0	23.1	21.0	20.7	27.8	18.0	32.1	28.0	21.9	30.8	25.0	29.9	46.0	39.7	22.5	33.6	24.7	22.2	30.7	28.6	29.1	28.2	29.5	45.3	27.5	34.8	19.6	21.6	22.1	46.6	22.6	22.2	32.8	23.1	33.3	25.1	81.7	20.3	55.7	34.8	41.2	40.5	31.4	32.0	29.7	28.2	10.3	25.3	23.2	29.5	24.5	37.9	59.1	52.7	50.3	24.4	27.7	60.2	41.4	30.5	68.2	42.2	79.4	18.5	83.6	40.2	33.5	37.5	82.0	47.3	83.5	45.9	60.2	60.8	46.3	48.8	27.3	74.6	39.4	24.2	30.3	65.8	38.7	45.0	73.7	25.0	62.7	56.0	69.6	65.1	73.5	61.3	56.2	57.4	55.4	56.9	71.2	50.9	43.3	43.1	48.1	42.5	62.1	55.7	28.9	35.9	43.8	42.0	62.1	30.4	57.3	88.2	31.2	52.5	43.6	10.3	15.4	4.4	19.1	25.3	29.5	29.7	22.4	24.9	28.2	24.2	26.6	27.9	1.5	23.2	22.0	25.8	23.8	24.5	25.7	31.4	39.2	37.0	25.0	29.9	24.7	22.2	45.3	20.3
CCT3	"Cctg, TRIC5"	ENSG00000163468	"Chaperonin containing TCP1 subunit 3"	P49368	1	156308968-156367873	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006543	Approved		Supported	"Plasma membrane,Cytosol"			4000000	"Plasma membrane, Cytosol"		"HPA006543: AB_1078426"	"unprognostic (2.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.00e-3)"	"unprognostic (8.39e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavourable (3.87e-7)"	"unprognostic (4.43e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.34e-4)"	"unprognostic (7.16e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.10e-1)"	38.8	68.8	37.6	41.8	43.2	26.9	51.2	54.5	51.4	35.1	42.1	46.2	33.8	37.9	50.4	34.8	56.1	52.2	29.2	41.5	36.7	41.6	60.8	61.9	30.9	48.1	43.5	32.8	53.0	59.0	56.7	55.9	39.2	43.0	38.1	50.0	35.3	34.4	41.4	66.4	38.2	39.5	59.7	41.2	41.6	41.9	49.8	47.6	62.1	60.0	49.9	60.7	44.8	82.4	34.8	39.3	14.2	30.5	30.8	45.1	43.9	50.2	57.4	39.2	37.5	43.5	32.4	51.1	47.1	37.4	74.5	45.8	56.8	46.7	83.1	54.8	39.4	47.4	124.0	61.2	63.7	44.5	78.0	52.7	46.7	44.8	32.1	65.1	44.4	41.1	36.7	66.8	62.3	63.0	90.4	30.0	44.2	46.8	85.7	40.0	79.3	83.2	69.0	39.7	89.9	54.6	31.8	53.1	54.8	43.3	76.4	41.9	67.6	79.8	43.5	30.3	45.2	31.7	83.8	55.9	99.2	123.6	35.3	41.6	49.1	14.2	25.3	11.2	31.2	30.5	41.6	34.1	34.7	34.2	39.3	34.8	45.1	37.8	3.6	30.8	30.2	25.5	35.5	43.9	37.6	43.2	54.5	51.4	36.7	41.6	43.5	32.8	43.0	47.6
CCT4	Cctd	ENSG00000115484	"Chaperonin containing TCP1 subunit 4"	P50991	2	61868089-61888804	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029349	Supported		Supported	Nucleoplasm,Cytosol			3400000	Cytosol	Nucleoplasm	"HPA029349: AB_10600800"	"prognostic unfavourable (2.03e-4)"	"unprognostic (2.80e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (9.37e-12)"	"unprognostic (1.28e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.96e-1)"	"unprognostic (2.14e-2)"	35.1	42.3	34.8	33.3	38.7	32.4	63.3	41.2	40.6	37.7	36.2	26.0	34.4	26.7	43.1	32.6	47.9	44.6	25.3	49.0	31.4	33.7	43.1	37.6	28.7	54.1	42.1	33.9	66.4	65.9	39.7	32.8	37.7	40.0	37.6	35.4	21.5	32.1	35.9	52.5	37.5	28.1	42.5	39.7	36.2	38.1	49.4	37.7	55.6	50.0	40.8	50.9	39.3	93.4	30.3	31.4	13.7	29.8	31.6	39.1	34.6	41.7	48.7	32.6	30.1	27.1	41.3	54.7	38.2	27.4	55.3	37.1	84.8	30.4	67.3	38.9	27.3	30.2	63.8	49.0	58.4	33.0	62.7	43.0	25.2	53.2	24.4	52.8	28.8	35.0	34.2	44.5	46.3	46.1	61.0	21.8	47.0	37.5	45.5	72.6	58.5	43.5	51.7	50.9	45.5	38.4	28.8	28.4	23.9	27.7	35.4	49.3	25.6	39.1	28.9	30.7	44.7	22.8	61.9	33.3	44.5	114.2	30.4	61.1	40.2	13.7	19.0	7.5	27.8	27.2	35.7	30.3	29.6	33.3	31.4	27.5	39.1	38.0	2.7	31.6	29.8	20.3	30.7	34.6	34.8	38.7	41.2	40.6	31.4	33.7	42.1	33.9	40.0	37.7
CCT5	KIAA0098	ENSG00000150753	"Chaperonin containing TCP1 subunit 5"	P48643	5	10249921-10266412	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002238, HPA005958, CAB006271"	Enhanced						4000000			"CAB006271: AB_425898, HPA002238: AB_1078427, HPA005958: AB_1846209"	"unprognostic (7.02e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-3)"	"prognostic unfavourable (6.57e-11)"	"unprognostic (6.40e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (8.23e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.82e-2)"	45.0	42.7	26.1	40.9	38.1	31.4	34.2	26.2	36.8	28.4	38.1	28.8	18.7	30.1	35.9	25.3	51.4	35.8	23.9	33.5	29.9	37.9	51.8	52.1	30.1	44.9	34.1	25.0	40.8	38.9	39.3	34.7	46.7	44.3	26.0	45.6	17.2	30.8	25.6	61.0	29.0	34.5	40.6	29.5	41.2	30.5	58.0	27.4	62.5	52.2	49.4	51.0	27.7	53.9	39.8	49.1	34.5	68.6	36.1	42.8	56.1	40.9	58.3	49.5	56.4	31.6	23.9	70.1	54.5	35.0	86.6	61.1	77.8	45.0	63.6	60.8	38.7	40.1	92.6	59.2	96.3	59.1	63.9	51.9	136.0	60.1	37.0	78.0	37.5	27.8	37.0	67.9	45.5	51.2	69.3	23.0	55.1	57.8	55.7	77.6	52.6	70.5	51.6	37.4	32.6	54.6	42.8	37.6	41.4	114.5	51.8	39.2	39.9	58.2	34.2	71.5	64.4	26.2	81.3	23.7	37.1	68.5	40.1	113.9	57.1	27.3	46.9	34.5	32.3	62.7	42.8	39.8	36.6	35.8	49.1	31.6	34.7	35.0	26.3	36.1	68.6	18.0	37.7	56.1	26.1	38.1	26.2	36.8	29.9	37.9	34.1	25.0	44.3	27.4
CCT6A	"CCT6, Cctz, HTR3, TCP20, TCPZ, TTCP20"	ENSG00000146731	"Chaperonin containing TCP1 subunit 6A"	P40227	7	56051630-56063989	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042996, HPA045576, HPA049949"	Supported		Approved	Cytosol			7400000	Cytosol		"HPA042996: , HPA045576: , HPA049949: "	"prognostic unfavourable (4.04e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (8.45e-4)"	"prognostic unfavourable (9.00e-10)"	"unprognostic (1.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.24e-2)"	"unprognostic (4.82e-2)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.44e-3)"	32.9	36.5	35.3	35.8	36.1	32.0	62.4	43.7	40.4	26.2	29.1	19.6	28.4	29.8	31.7	23.7	39.5	29.7	22.9	49.3	34.7	39.8	43.2	45.7	22.6	42.0	36.8	26.8	33.4	42.9	48.3	33.7	33.9	34.9	30.2	35.4	16.4	27.3	32.2	72.3	32.6	28.6	35.3	35.8	36.7	32.3	27.0	26.5	41.1	38.2	41.4	44.0	37.1	83.7	24.0	35.3	11.8	34.2	26.6	29.9	25.8	176.1	40.4	24.3	36.6	17.1	21.5	28.0	33.3	18.9	32.8	26.5	45.4	22.2	54.6	25.9	21.4	37.5	49.7	38.2	45.5	30.7	37.7	34.1	39.1	39.9	18.5	48.9	27.7	18.4	21.9	33.1	33.0	32.2	74.6	13.8	37.0	21.8	37.6	42.7	51.4	53.8	34.6	24.8	31.4	36.9	33.8	32.5	32.6	29.5	50.3	29.4	37.0	37.7	27.0	22.5	43.3	74.8	68.5	16.9	34.8	67.4	22.5	43.4	74.6	6.9	25.0	11.8	22.4	31.6	29.9	24.0	23.5	24.4	35.3	17.8	24.0	25.4	3.1	26.6	34.2	19.6	24.2	25.8	35.3	36.1	43.7	40.4	34.7	39.8	36.8	26.8	34.9	26.5
CCT7	"Ccth, Nip7-1"	ENSG00000135624	"Chaperonin containing TCP1 subunit 7"	Q99832	2	73233420-73253021	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008425	Approved		Approved	Cytosol			5900000	Cytosol		"HPA008425: AB_1078428"	"unprognostic (5.02e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (4.60e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (4.37e-3)"	"unprognostic (8.76e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.12e-2)"	35.1	55.7	33.5	34.6	46.3	27.0	54.2	52.2	46.9	34.9	36.3	32.4	29.5	28.7	46.5	42.3	43.6	47.4	32.7	56.5	36.4	36.1	38.9	48.0	29.4	47.0	35.8	37.1	51.3	56.1	45.3	34.9	34.3	36.1	41.2	43.7	27.6	33.2	41.2	82.1	32.7	28.9	51.0	33.5	36.1	36.9	80.6	28.6	49.0	44.0	52.5	51.5	37.5	61.6	53.1	49.4	29.1	45.6	42.7	54.8	62.6	46.0	77.0	44.2	48.0	32.5	27.0	56.7	40.0	38.0	70.8	44.6	125.6	32.8	88.2	26.7	43.3	39.5	98.7	64.0	78.4	48.9	87.7	58.1	49.1	89.7	36.5	67.6	45.4	41.6	36.5	69.0	85.0	63.4	74.8	32.1	59.5	73.7	78.8	94.4	62.7	55.5	72.0	108.2	63.2	51.0	44.7	63.0	38.3	34.7	50.3	47.9	28.6	39.3	39.0	48.3	57.7	29.7	79.1	36.9	38.0	81.5	39.4	80.1	52.8	29.1	31.5	17.9	48.5	42.3	53.8	53.1	50.1	48.5	48.4	49.5	54.8	51.0	9.6	42.7	45.6	49.4	43.3	62.6	33.5	46.3	52.2	46.9	36.4	36.1	35.8	37.1	36.1	28.6
CCT8	"C21orf112, Cctq, PRED71"	ENSG00000156261	"Chaperonin containing TCP1 subunit 8"	P50990	21	29055805-29073797	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018520, HPA021051, HPA029426"	Enhanced		Approved	"Nucleoplasm,Intermediate filaments,Cytosol"			2700000	"Intermediate filaments"	"Nucleoplasm, Cytosol"	"HPA018520: AB_1846204, HPA021051: AB_1846205, HPA029426: AB_10601796"	"unprognostic (3.41e-3)"	"unprognostic (2.75e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.25e-3)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	33.5	62.5	28.9	36.1	43.8	28.2	39.7	47.9	46.4	34.5	33.7	15.7	41.9	29.6	37.4	36.4	47.6	33.6	23.6	43.9	33.0	36.0	43.6	42.1	33.2	48.8	28.8	39.2	39.3	47.2	35.4	42.6	41.0	39.6	30.9	38.3	17.0	34.7	38.6	68.4	35.5	30.1	38.3	29.5	39.8	35.2	30.2	30.2	66.6	36.1	52.0	57.6	38.5	47.8	25.6	41.7	17.5	38.1	22.8	27.2	33.9	49.0	27.9	35.7	25.7	26.4	36.4	39.8	39.4	25.1	44.7	37.4	59.1	30.4	97.1	26.5	27.2	19.9	73.6	45.5	50.9	41.0	38.3	134.3	33.6	26.4	27.4	66.3	37.6	27.7	28.1	52.6	43.8	42.7	103.5	56.8	45.6	25.5	49.9	26.0	64.3	34.8	44.9	70.3	60.3	45.7	25.8	35.8	25.8	38.6	40.8	33.8	36.5	58.1	30.8	25.4	71.9	23.9	49.0	36.9	71.3	76.5	29.8	75.5	38.8	17.5	33.7	16.7	18.5	36.9	25.5	25.6	24.0	24.3	41.7	19.2	27.2	24.5	3.7	22.8	38.1	24.6	26.6	33.9	28.9	43.8	47.9	46.4	33.0	36.0	28.8	39.2	39.6	30.2
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"parathyroid gland: 203.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 61.6;BJ hTERT+: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane"			120000000	"Plasma membrane"		"HPA008992: , HPA015723: "	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (2.65e-4)"	"prognostic unfavourable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (4.68e-4)"	27.4	1.5	1.6	1.9	2.2	1.9	6.5	0.4	1.9	15.0	7.1	3.4	2.0	1.5	22.5	8.5	22.4	3.4	2.4	8.2	1.8	1.4	3.5	1.4	14.5	1.4	1.7	1.4	2.8	1.2	203.4	0.6	5.0	3.0	7.1	2.1	0.6	4.2	2.2	4.1	12.4	2.4	12.6	4.5	1.7	1.5	3.3	2.8	6.3	1.7	16.8	4.7	8.7	8.0	0.3	2.6	1.4	0.4	0.6	0.4	0.3	9.2	8.3	0.5	0.0	12.7	61.6	0.0	8.4	37.8	2.8	6.1	0.0	5.4	0.0	5.2	17.3	26.1	0.9	16.9	3.7	2.5	1.4	3.3	6.8	1.4	2.7	0.0	0.0	16.9	13.4	5.2	21.1	20.0	0.0	0.0	12.6	0.2	0.2	0.0	0.6	5.4	0.7	2.4	11.4	1.2	1.0	0.0	0.0	19.1	0.1	8.3	0.2	1.5	18.5	26.4	3.7	4.7	7.2	0.1	5.2	0.0	10.6	0.0	23.4	0.6	0.4	0.3	0.2	0.2	0.1	0.2	0.3	0.2	2.6	0.3	0.4	0.2	1.4	0.6	0.2	1.4	0.1	0.3	1.6	2.2	0.4	1.9	1.8	1.4	1.7	1.4	3.0	2.8
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Plasma proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 189.4;liver: 165.8"	"Cell line enhanced"	"Detected in many"		"A549: 8.9;CACO-2: 13.6;SiHa: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 189.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 52.3;monocytes: 189.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Supported	Vesicles	"Secreted to blood"	2752500000	15000000000	Vesicles		"CAB033631: AB_781932, CAB072865: , CAB072866: , HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	27.9	44.1	9.0	42.7	25.2	9.8	11.7	3.5	8.9	5.6	10.0	6.0	1.8	5.4	5.6	24.0	4.5	12.0	14.6	18.9	11.7	7.4	12.7	165.8	23.8	34.7	21.6	2.9	14.2	5.3	4.3	10.1	37.3	18.9	8.5	9.2	14.6	28.5	5.8	10.2	3.5	12.1	21.4	18.2	35.5	6.6	6.5	17.3	2.2	7.9	5.8	6.6	15.9	3.8	0.5	23.6	52.3	189.4	0.2	0.4	124.2	0.1	8.9	0.1	0.5	1.2	0.3	0.4	0.8	4.1	1.3	1.6	13.6	2.1	0.4	0.6	4.9	3.8	0.0	1.6	0.2	0.1	0.9	0.3	0.5	1.8	4.8	1.0	0.4	3.9	0.2	0.2	1.3	0.0	0.2	0.2	1.2	0.3	0.0	0.5	0.2	0.3	0.3	0.4	1.1	0.2	0.0	2.4	1.0	16.3	0.4	0.5	0.3	1.7	0.6	0.2	0.3	1.5	1.2	0.7	0.9	0.5	0.4	0.4	0.1	0.4	189.4	1.0	0.3	36.6	0.4	0.5	0.2	0.2	23.6	0.1	0.3	0.2	52.3	0.2	4.8	1.3	0.1	124.2	9.0	25.2	3.5	8.9	11.7	7.4	21.6	2.9	18.9	17.3
CD163	"M130, MM130, SCARI1"	ENSG00000177575	"CD163 molecule"	Q86VB7	12	7470813-7503893	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Acute phase, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 113.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.1;CACO-2: 1.9;HSkMC: 5.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 28.2;myeloid DC: 25.3"	"Group enriched"	"Detected in many"	40	"dendritic cells: 25.3;monocytes: 28.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB002432, HPA046404, HPA051974"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"	903333333	1600000000	"Plasma membrane"		"CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678"	"unprognostic (1.13e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (7.27e-4)"	"unprognostic (1.04e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.20e-2)"	66.7	23.8	2.1	44.6	7.2	4.1	23.2	2.8	4.9	11.3	25.3	1.6	1.4	3.5	7.2	16.8	11.3	20.1	13.2	15.7	2.8	1.8	43.9	38.9	81.0	99.8	6.9	0.5	10.3	6.7	3.1	11.7	31.9	9.9	6.8	6.5	9.8	8.6	2.2	15.2	4.0	12.5	37.2	5.7	113.6	10.2	19.6	4.3	3.4	15.5	2.9	3.5	20.1	8.3	0.0	25.3	0.6	28.2	0.0	0.0	6.3	0.0	0.0	0.0	0.0	2.1	1.1	0.4	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.3	5.9	0.0	0.4	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.6	0.0	0.1	1.0	0.1	0.0	0.0	0.3	0.6	0.1	0.2	0.0	0.0	0.3	0.0	1.1	0.3	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.5	28.2	0.1	0.0	2.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	6.3	2.1	7.2	2.8	2.4	2.8	1.8	6.9	0.5	9.9	4.3
CD22	"SIGLEC-2, SIGLEC2"	ENSG00000012124	"CD22 molecule"	P20273	19	35319261-35347355	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.3;lymphoid tissue: 77.8;ovary: 35.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 68.2;REH: 20.2;U-698: 54.2;WM-115: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"memory B-cell: 29.8;naive B-cell: 39.3"	"Lineage enriched"	"Detected in many"	28	"B-cells: 39.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002418, HPA024353"	Enhanced									"CAB002418: AB_563529, HPA024353: AB_10600695"	"unprognostic (2.80e-3)"	"unprognostic (3.99e-2)"	"unprognostic (6.79e-3)"	"unprognostic (9.17e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.45e-3)"	"unprognostic (3.79e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	2.1	1.0	5.5	57.9	6.8	3.1	0.5	0.7	3.2	1.4	1.0	0.9	0.5	0.4	1.4	0.9	4.4	7.9	2.9	0.8	9.9	4.2	1.4	0.6	5.5	52.6	9.8	0.5	35.4	0.5	0.0	0.7	1.0	0.9	2.8	1.5	1.1	5.9	1.1	0.5	0.0	11.6	2.0	13.5	64.1	1.4	1.2	0.6	5.0	1.1	2.3	77.8	4.3	0.9	39.3	1.3	0.3	0.3	0.0	0.0	1.4	0.2	0.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.2	68.2	1.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	3.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	20.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	54.2	0.5	0.2	12.4	0.0	0.0	0.0	0.0	0.3	0.0	29.8	0.0	0.0	1.3	39.3	0.0	0.0	0.3	0.0	0.2	1.1	0.0	1.4	5.5	6.8	0.7	3.2	9.9	4.2	9.8	0.5	0.9	0.6
CD244	"2B4, NAIL, NKR2B4, Nmrk, SLAMF4"	ENSG00000122223	"CD244 molecule"	Q9BZW8	1	160830160-160862855	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 75.8;lymphoid tissue: 22.1"	"Cell line enhanced"	"Detected in some"		"HEL: 10.6;HMC-1: 37.4;NB-4: 7.4;U-937: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 75.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 75.8"					"Not detected"	"Not detected"														"unprognostic (6.11e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.85e-2)"	"unprognostic (6.95e-6)"	"unprognostic (5.79e-2)"	"unprognostic (1.43e-4)"	"unprognostic (1.93e-2)"	"unprognostic (7.36e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.79e-1)"	2.9	0.4	0.5	3.3	0.5	8.6	0.6	0.3	0.7	0.9	3.1	0.4	1.6	2.8	1.4	0.7	1.0	0.7	1.7	2.0	0.5	0.5	0.7	4.1	5.3	7.4	1.7	0.0	1.6	0.5	0.0	0.5	1.8	1.1	1.6	1.2	1.0	1.6	0.9	1.1	0.5	6.0	2.6	1.5	22.1	0.8	2.8	0.6	0.7	0.6	0.0	4.0	1.5	0.8	0.0	7.9	75.8	13.2	14.0	14.8	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.2	3.4	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	14.9	0.0	75.8	8.2	20.1	14.8	11.2	7.3	0.0	0.8	8.1	7.9	0.0	1.1	7.8	0.6	14.0	13.2	0.4	0.0	11.3	0.5	0.5	0.3	0.7	0.5	0.5	1.7	0.0	1.1	0.6
CD27	"S152, TNFRSF7, Tp55"	ENSG00000139193	"CD27 molecule"	P26842	12	6444867-6451718	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 82.3;lymphoid tissue: 60.4"	"Group enriched"	"Detected in some"	141	"Daudi: 63.7;U-698: 35.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 82.3"	"Group enriched"	"Detected in many"	7	"B-cells: 41.8;T-cells: 82.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002420, HPA038936"	Enhanced						28000			"CAB002420: AB_563539, HPA038936: "	"unprognostic (2.75e-3)"	"prognostic favourable (3.77e-5)"	"unprognostic (8.87e-3)"	"prognostic favourable (2.90e-4)"	"unprognostic (2.35e-1)"	"prognostic favourable (6.65e-7)"	"unprognostic (3.56e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (5.50e-4)"	"unprognostic (1.31e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (1.19e-6)"	"unprognostic (2.80e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.35e-2)"	1.1	0.6	0.4	40.8	0.5	2.0	1.2	0.4	0.4	1.7	10.0	0.2	0.5	5.3	0.8	0.6	4.9	1.6	3.7	0.9	0.4	0.4	1.7	1.0	2.9	49.5	0.4	0.1	1.0	0.5	0.0	0.6	0.4	0.2	1.3	2.9	1.2	10.7	1.4	0.4	0.6	19.4	0.2	0.6	45.7	3.7	0.5	0.1	33.5	3.1	2.3	60.4	9.1	1.2	41.8	0.3	0.8	0.1	8.3	82.3	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.8	0.1	0.1	16.7	0.1	28.7	41.8	40.1	37.5	0.1	10.5	55.6	39.1	0.8	8.3	0.1	0.3	82.3	22.1	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.1	0.2	0.1
CD300A	"CMRF-35-H9, CMRF35H, IGSF12, IRC1, IRC2, Irp60"	ENSG00000167851	"CD300a molecule"	Q9UGN4	17	74466416-74484796	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 81.1;brain: 28.7;lymphoid tissue: 57.8"	"Group enriched"	"Detected in some"	5	"HMC-1: 41.3;NB-4: 16.8;RPMI-8226: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA011645	Approved				"Intracellular and membrane"		2800000			"HPA011645: AB_1846988"	"unprognostic (1.99e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.17e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (5.97e-2)"	"unprognostic (5.45e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	8.6	4.5	9.8	16.0	17.7	11.9	4.4	2.2	11.5	2.0	4.8	3.7	0.0	6.0	1.9	1.3	2.1	2.1	7.7	3.4	7.3	4.2	3.0	7.5	10.6	19.0	20.1	0.3	1.5	2.1	0.3	3.0	6.9	12.6	2.8	4.7	2.3	3.0	1.3	1.1	2.3	7.4	6.0	28.7	57.8	2.4	1.5	17.4	4.1	1.9	0.5	6.0	5.4	2.1	2.2	19.4	81.1	45.7	52.1	29.5	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.9	41.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.5	16.8	0.0	0.0	0.0	0.0	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.3	0.0	81.1	20.4	57.3	29.5	45.7	6.2	2.2	6.1	8.7	19.4	0.6	2.3	7.1	71.6	52.1	44.2	18.1	0.3	19.2	9.8	17.7	2.2	11.5	7.3	4.2	20.1	0.3	12.6	17.4
CD33	"FLJ00391, p67, SIGLEC-3, SIGLEC3"	ENSG00000105383	"CD33 molecule"	P20138	19	51225064-51243860	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.3;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 37.1;HMC-1: 27.8;NB-4: 17.7;RPMI-8226: 20.0;THP-1: 21.8;U-937: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6"	"Group enriched"	"Detected in many"	9	"dendritic cells: 49.3;monocytes: 37.6"									"CAB011442, HPA035832, HPA064807"	Approved		Supported	"Nucleoplasm,Plasma membrane"			1400000	"Nucleoplasm, Plasma membrane"		"CAB011442: , HPA035832: , HPA064807: "	"unprognostic (1.18e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (5.90e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.28e-2)"	"unprognostic (6.88e-4)"	"unprognostic (7.79e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.67e-1)"	10.2	4.3	3.6	8.4	6.0	23.0	6.5	0.8	3.5	2.6	2.7	4.4	0.3	2.5	2.3	5.2	1.7	3.9	5.3	7.5	3.1	2.5	4.1	6.4	11.6	45.4	6.4	1.8	1.9	1.9	0.5	1.7	5.4	5.2	2.6	3.4	2.6	2.9	2.1	1.2	2.5	4.0	5.6	9.9	31.6	2.8	1.5	5.8	2.5	1.7	0.2	2.7	4.7	2.3	0.1	49.3	4.6	37.6	3.3	0.2	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	27.9	0.1	0.0	0.0	37.1	27.8	0.0	0.0	0.0	0.0	0.0	5.1	7.0	0.0	0.0	0.0	17.7	0.0	8.5	0.0	1.4	20.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.8	0.2	4.8	0.4	0.6	0.0	0.1	2.4	0.0	3.2	27.4	0.1	3.3	37.6	2.3	0.0	27.3	0.1	0.0	0.0	0.1	49.3	0.1	0.0	0.0	4.6	3.3	12.6	1.4	0.2	14.7	3.6	6.0	0.8	3.5	3.1	2.5	6.4	1.8	5.2	5.8
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Group enriched"	"Detected in some"	5	"ASC diff: 80.8;HEL: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"			92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: "	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	80.8	0.8	0.1	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	1.0	0.1	0.0	0.1	0.1	38.4	0.1	6.1	0.0	0.0	0.0	7.8	3.1	0.0	0.0	0.2	1.3	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	2.7	4.4	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.2	10.2	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5
CD3G		ENSG00000160654	"CD3g molecule"	P09693	11	118344344-118355161	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 187.6"	"Cell line enriched"	"Detected in single"	78	"MOLT-4: 64.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	30	"gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2"	"Lineage enriched"	"Detected in many"	37	"T-cells: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017520, HPA038494"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB017520: AB_831094, HPA038494: "	"prognostic favourable (6.33e-4)"	"prognostic favourable (2.61e-4)"	"unprognostic (4.58e-3)"	"unprognostic (3.12e-5)"	"unprognostic (6.30e-2)"	"prognostic favourable (3.00e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.10e-3)"	1.1	0.6	0.4	7.1	0.4	0.5	0.8	0.3	0.3	0.7	2.3	0.4	0.4	2.0	0.9	0.6	1.5	1.1	1.9	0.6	0.4	0.4	1.2	0.9	2.4	17.2	0.5	0.2	0.7	0.7	0.0	0.5	0.4	0.3	1.0	1.6	0.9	2.9	0.3	5.9	0.6	8.1	0.2	0.8	11.5	2.4	0.5	0.2	187.6	1.4	1.7	19.2	2.5	1.1	0.1	0.2	1.2	0.2	0.2	46.7	14.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	64.9	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.6	0.2	0.2	43.5	0.1	25.6	0.1	36.1	37.1	0.1	0.1	37.6	46.7	1.2	0.2	0.1	0.2	34.2	14.1	0.4	0.4	0.3	0.3	0.4	0.4	0.5	0.2	0.3	0.2
CD44	"CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1"	ENSG00000026508	"CD44 molecule (Indian blood group)"	P16070	11	35138870-35232402	"Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Blood group antigen, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000112, CAB000316, HPA005785"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane"	"Secreted - unknown location"		2400000000	"Plasma membrane"	"Golgi apparatus"	"CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467"	"unprognostic (5.33e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.97e-2)"	"unprognostic (9.90e-3)"	"unprognostic (3.50e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.51e-3)"	"unprognostic (4.63e-2)"	"prognostic unfavourable (1.78e-8)"	"unprognostic (6.41e-2)"	"unprognostic (4.14e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.98e-2)"	45.5	9.0	10.5	42.5	21.7	53.0	35.6	4.7	13.4	43.2	19.5	26.3	8.3	10.6	80.5	20.3	66.5	18.6	48.0	11.7	14.9	9.3	12.4	9.1	43.4	48.4	31.5	6.1	12.8	83.9	0.8	3.8	19.4	40.7	30.1	24.5	30.2	148.2	22.4	15.9	107.7	18.9	44.5	100.5	30.9	19.9	7.2	20.3	17.9	20.6	53.9	53.7	55.0	54.2	22.7	41.0	19.1	65.2	54.6	53.1	59.9	41.5	37.6	0.3	0.1	22.7	62.8	0.1	81.5	63.8	45.4	25.3	2.5	13.1	0.0	10.9	115.5	71.7	0.8	88.6	62.4	8.9	0.4	1.5	18.5	0.0	22.4	21.1	97.8	28.3	70.0	61.1	49.6	15.9	0.3	13.6	43.5	0.2	1.9	13.9	0.8	11.1	0.1	7.7	0.6	66.5	12.0	0.1	0.1	15.4	0.4	36.9	2.2	1.2	45.6	56.6	10.2	69.4	83.7	23.6	25.4	0.2	85.9	11.9	82.2	19.1	65.2	6.0	26.2	45.7	37.0	22.7	39.8	34.9	41.0	16.2	34.5	28.7	16.4	54.6	59.3	14.2	53.1	59.9	10.5	21.7	4.7	13.4	14.9	9.3	31.5	6.1	40.7	20.3
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752057-207795513	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 69.8"									"CAB010401, HPA016903"	Enhanced		Uncertain	"Plasma membrane"			1000000	"Plasma membrane"		"CAB010401: AB_2291289, HPA016903: AB_1846309"	"unprognostic (1.42e-2)"	"prognostic unfavourable (8.54e-5)"	"unprognostic (3.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.74e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.78e-3)"	"prognostic favourable (2.38e-4)"	"unprognostic (1.76e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.49e-2)"	38.0	78.0	13.0	22.9	20.5	18.5	57.0	12.9	17.8	27.5	35.4	25.3	64.3	32.9	39.7	32.6	43.2	30.4	25.2	20.6	16.1	15.5	50.8	57.8	43.6	25.0	21.4	13.2	27.6	47.9	86.6	32.7	119.6	29.1	47.0	28.5	26.7	68.4	60.5	18.8	18.4	39.8	25.0	21.8	26.9	33.9	16.5	20.7	20.3	25.3	21.8	30.3	37.2	27.0	7.7	8.1	69.8	14.1	7.5	13.5	14.9	26.2	14.8	13.9	6.4	44.0	43.5	21.2	19.7	28.7	13.0	17.7	14.6	69.9	4.0	20.1	19.6	35.6	10.4	27.0	19.9	20.2	14.8	8.7	16.3	26.1	28.0	19.0	30.4	37.4	40.3	19.6	15.5	36.4	18.3	17.5	20.0	12.3	9.0	16.7	15.9	14.8	6.1	22.1	24.7	53.3	52.0	14.1	9.6	24.9	56.1	32.3	44.1	16.3	31.2	14.0	12.5	29.4	22.4	23.6	28.5	12.1	20.5	12.5	13.1	41.7	13.5	63.7	9.2	14.0	12.5	7.7	11.7	10.1	8.1	6.0	13.5	11.2	69.8	7.5	14.1	4.2	10.1	14.9	13.0	20.5	12.9	17.8	16.1	15.5	21.4	13.2	29.1	20.7
CD48	"BCM1, BLAST, hCD48, mCD48, SLAMF2"	ENSG00000117091	"CD48 molecule"	P09326	1	160678746-160711851	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.3;lymphoid tissue: 86.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.0;HMC-1: 42.5;U-266/70: 90.0;U-266/84: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB002497, HPA055146"	Enhanced		Supported	"Nucleoli fibrillar center,Plasma membrane,Cytosol"	"Intracellular and membrane"		2600000	"Plasma membrane"	"Nucleoli fibrillar center, Cytosol"	"CAB002497: AB_563586, HPA055146: "	"prognostic favourable (3.91e-4)"	"unprognostic (1.72e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.58e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (3.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.38e-2)"	"unprognostic (8.51e-2)"	5.5	1.4	1.0	44.6	0.9	23.1	2.8	0.6	0.7	3.2	5.0	0.5	1.1	3.2	1.9	2.5	7.3	2.1	4.8	1.8	1.0	1.0	3.6	3.1	15.4	86.3	1.6	0.3	2.3	1.5	0.0	1.3	2.2	0.8	2.8	5.7	2.4	13.9	1.5	1.3	1.2	21.2	1.7	3.8	66.6	5.0	1.3	0.2	50.8	2.9	3.6	58.0	8.6	2.6	34.6	53.6	35.8	74.1	24.9	57.9	81.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	4.5	42.5	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	13.2	6.5	0.0	0.0	0.8	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.0	60.1	15.4	0.0	11.4	0.0	28.2	52.2	35.8	42.4	74.1	57.9	34.6	48.3	48.8	53.6	27.9	49.7	52.5	13.4	24.9	73.5	9.4	36.4	81.3	1.0	0.9	0.6	0.7	1.0	1.0	1.6	0.3	0.8	0.2
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321376-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 77.5;HMC-1: 103.6;PC-3: 61.7;U-2197: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.4"	"Low lineage specificity"	"Detected in all"											"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	32300000	310000000			"CAB010454: AB_2075970, HPA002190: AB_1078472, HPA024386: AB_1846319"	"unprognostic (4.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (9.36e-4)"	"unprognostic (3.41e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.33e-2)"	21.8	63.2	5.8	27.2	20.2	31.9	17.9	4.6	10.5	34.0	14.8	13.8	7.8	12.8	16.3	11.9	36.1	10.4	18.0	32.0	7.5	10.1	9.6	16.7	114.6	41.1	16.7	4.7	31.3	9.1	8.1	12.8	107.0	11.9	9.7	12.4	8.2	82.3	12.8	108.8	37.5	26.0	23.5	11.4	30.4	17.7	10.2	18.8	4.2	13.2	31.4	19.1	39.3	19.1	18.6	18.3	101.4	31.6	19.0	16.9	20.3	4.7	6.5	0.0	2.1	8.3	8.9	33.9	9.0	15.8	5.2	5.6	20.4	6.8	9.2	7.5	5.3	2.7	10.4	2.0	4.8	4.2	3.8	11.9	77.5	3.3	27.0	7.2	103.6	4.2	24.4	6.4	28.1	26.8	12.8	4.4	2.9	5.1	0.7	5.0	6.6	61.7	1.0	6.4	7.2	8.6	4.5	2.6	0.0	48.7	9.9	7.8	8.4	6.1	11.7	2.6	5.0	62.8	3.4	3.7	4.3	6.2	7.1	2.9	11.9	39.3	26.9	35.9	5.5	26.3	8.2	16.9	7.4	5.8	18.3	18.6	16.9	16.4	101.4	19.0	31.6	9.8	5.0	20.3	5.8	20.2	4.6	10.5	7.5	10.1	16.7	4.7	11.9	18.8
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736491	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 285.5"	"Cell line enhanced"	"Detected in many"		"TIME: 213.3;U-2197: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		98000000	"Golgi apparatus, Vesicles"		"CAB001448: AB_563604, HPA026494: AB_1846321"	"unprognostic (2.07e-2)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (7.40e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (3.10e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (1.66e-2)"	"prognostic favourable (1.39e-10)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.09e-1)"	96.7	41.0	36.7	26.3	44.3	23.8	76.0	25.9	32.7	44.8	36.9	24.0	57.9	16.5	45.4	132.8	68.4	53.2	67.6	90.5	35.6	38.4	100.0	61.0	86.4	39.8	39.7	25.8	39.3	52.3	60.6	48.0	285.5	68.7	47.4	37.7	51.4	114.8	62.6	70.6	43.4	25.0	52.4	32.9	26.2	54.7	28.1	23.1	16.1	85.9	57.7	40.0	51.2	63.4	13.5	20.5	42.8	4.8	17.7	60.4	11.1	16.5	15.5	4.6	13.5	107.8	84.5	2.7	94.2	105.1	23.6	27.7	7.2	49.8	1.2	16.8	101.4	18.7	8.5	93.9	33.2	26.3	12.9	1.7	54.9	10.8	29.4	9.9	5.7	39.2	23.8	20.0	96.4	144.0	11.6	38.3	148.6	15.1	4.6	4.1	2.5	80.9	1.7	14.4	13.3	71.3	28.3	3.2	4.3	32.8	15.2	17.3	11.6	1.0	213.3	54.3	13.0	176.7	32.6	17.0	33.2	1.6	46.7	0.0	94.3	30.5	4.8	42.8	11.3	1.6	14.4	13.5	24.0	12.7	20.5	10.6	15.7	9.3	28.4	17.7	0.9	10.5	60.4	11.1	36.7	44.3	25.9	32.7	35.6	38.4	39.7	25.8	68.7	23.1
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830914-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 178.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.1;Karpas-707: 1.9;REH: 2.0;RH-30: 1.2;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	5	"liver cancer: 4.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.2"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.2"	"Not detected"	"Not detected"							"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	5525000000	6800000000			"HPA065686: AB_2685532, HPA068384: AB_2685979"		"unprognostic (2.96e-1)"		"unprognostic (2.90e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.94e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.56e-1)"		"unprognostic (5.95e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.63e-1)"		0.2	0.0	0.1	0.1	0.1	2.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	21.3	0.2	2.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	178.3	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.8	0.0	2.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.2	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 272.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356"	Supported		Supported	Vesicles	"Intracellular and membrane"			Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323"	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	115.3	88.2	42.5	44.9	37.2	67.4	106.3	13.7	33.1	80.6	84.7	34.4	71.5	39.9	99.7	177.9	70.9	60.4	102.7	154.4	36.9	39.0	106.6	92.5	109.6	113.8	49.8	27.2	93.8	187.1	33.3	49.3	176.9	50.8	82.9	81.8	102.1	105.0	83.7	92.7	38.5	72.4	88.2	43.6	107.7	74.8	52.1	30.5	17.6	108.1	50.7	47.4	96.3	82.2	9.6	40.3	147.4	50.8	58.4	29.8	56.6	21.9	38.3	21.0	20.4	272.1	170.6	27.7	89.3	163.9	52.9	57.7	42.7	44.3	6.3	28.5	133.0	20.4	15.2	37.0	68.1	17.8	14.3	34.5	29.9	23.5	108.3	15.3	82.2	125.6	36.8	58.8	53.9	58.3	19.4	44.2	168.3	35.1	3.1	20.8	19.1	44.5	6.9	46.1	15.8	89.5	74.8	8.2	21.0	24.5	18.5	160.6	26.1	51.2	43.3	34.2	25.0	47.2	29.9	18.1	11.2	4.4	98.1	9.9	62.5	89.6	50.8	147.4	29.8	38.5	21.8	9.6	11.9	23.7	40.3	6.5	5.3	18.1	55.7	58.4	26.1	27.0	10.0	56.6	42.5	37.2	13.7	33.1	36.9	39.0	49.8	27.2	50.8	30.5
CD68	"DKFZp686M18236, GP110, LAMP4, macrosialin, SCARD1"	ENSG00000129226	"CD68 molecule"	P34810	17	7579467-7582113	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 179.1;lymphoid tissue: 139.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 73.3;U-87 MG: 115.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 155.1;intermediate monocyte: 179.1;non-classical monocyte: 170.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 68.4;monocytes: 179.1"	"Low region specificity"	"Detected in all"							"CAB000051, CAB000066, HPA048982, CAB072861, CAB072862"	Enhanced		Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"CAB000051: AB_2314148, CAB000066: AB_2074844, CAB072861: , CAB072862: , HPA048982: "	"unprognostic (2.16e-2)"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.75e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (1.58e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.65e-2)"	118.4	28.5	12.5	46.8	21.6	46.8	40.9	2.9	11.2	27.1	38.1	15.5	2.1	57.0	9.6	24.1	26.9	17.3	33.7	39.0	10.1	6.9	20.9	43.1	84.4	102.5	21.1	4.4	15.8	7.5	2.1	8.5	34.7	15.7	12.1	18.5	12.8	22.2	4.4	16.1	9.4	58.3	15.6	26.0	139.1	17.6	9.4	16.3	13.3	8.8	12.3	21.1	31.4	19.1	3.7	68.4	11.0	179.1	0.9	0.5	125.6	35.1	7.1	0.4	0.5	73.3	28.0	0.3	11.2	30.7	14.9	17.4	1.5	10.6	0.4	12.8	32.6	1.5	0.1	7.1	10.1	0.3	1.3	5.6	1.7	8.5	6.2	2.7	31.7	8.8	1.4	31.2	23.0	3.9	2.2	3.6	14.4	0.2	0.2	2.4	0.4	5.2	0.4	0.6	20.7	3.0	1.5	0.2	0.4	9.3	4.7	10.9	0.2	21.6	12.2	19.0	1.1	19.0	14.6	0.2	0.2	0.2	115.5	6.9	9.6	10.1	155.1	0.9	0.4	179.1	0.5	3.7	0.2	0.3	40.9	2.0	0.3	0.2	11.0	0.9	170.1	68.4	0.3	125.6	12.5	21.6	2.9	11.2	10.1	6.9	21.1	4.4	15.7	16.3
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 231.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"			1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavourable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavourable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	24.5	25.5	20.5	31.3	231.4	131.6	17.2	46.5	103.0	37.6	38.0	23.9	0.1	21.0	16.8	130.3	32.3	12.6	33.1	15.5	9.9	38.9	3.2	9.7	0.0	76.6	13.6	27.6	95.6	47.3	15.3	23.3	35.9	14.3	36.9	52.5	18.8	11.5	17.4	24.6	20.7	23.7	10.3	13.4	40.4	16.6	22.1	24.5	14.8	39.0	28.0	12.9	24.9	47.8	19.2	14.2	35.9	15.9	27.3	6.2	38.3	27.9	8.1	32.8	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3
CD82	"IA4, KAI1, R2, ST6, TSPAN27"	ENSG00000085117	"CD82 molecule"	P27701	11	44564427-44620363	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 77.3;LHCN-M2: 45.7;U-87 MG: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 80.5"	"Group enriched"	"Detected in all"	6	"B-cells: 51.1;granulocytes: 80.5;T-cells: 25.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002508, HPA028900, HPA061418"	Supported		Approved	Vesicles				Vesicles		"CAB002508: AB_563640, HPA028900: AB_10603558, HPA061418: "	"unprognostic (5.31e-2)"	"unprognostic (4.62e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.29e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.88e-2)"	"unprognostic (6.30e-2)"	14.7	4.9	16.3	21.6	23.1	43.6	13.8	6.3	13.6	17.5	20.7	23.0	53.0	25.9	4.8	13.5	58.3	19.8	21.7	12.7	16.9	13.3	10.2	18.8	38.8	22.8	17.9	9.2	9.0	11.6	2.8	3.9	20.7	14.0	14.3	6.8	18.6	29.8	55.2	10.5	34.6	36.0	8.9	10.2	21.9	22.5	4.5	12.6	23.9	8.3	23.5	33.5	16.3	28.1	51.1	6.7	80.5	9.1	7.2	25.6	9.5	5.0	0.7	6.6	1.3	4.5	17.2	0.2	2.9	23.6	5.1	13.0	0.3	3.4	5.2	3.5	1.4	19.2	0.9	15.0	11.8	23.2	0.4	32.5	1.5	0.1	3.3	8.9	77.3	23.7	17.6	21.4	11.4	9.0	0.2	1.6	45.7	3.6	8.6	16.7	0.2	0.3	0.2	27.6	7.3	3.0	4.9	0.2	0.3	1.8	27.6	3.8	26.3	8.8	5.0	16.2	2.1	0.3	27.5	0.6	0.0	0.1	54.7	4.9	8.6	48.4	9.1	16.0	4.9	4.8	8.5	51.1	24.9	11.6	2.2	30.9	8.6	3.8	80.5	7.2	3.4	6.7	25.6	9.5	16.3	23.1	6.3	13.6	16.9	13.3	17.9	9.2	14.0	12.6
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 127.8;HUVEC TERT2: 82.6;RT4: 94.7;TIME: 188.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"basophil: 137.8;eosinophil: 98.3"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 137.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"			68000000	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favourable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (8.93e-5)"	"unprognostic (9.26e-2)"	38.1	44.5	20.0	24.1	36.2	3.1	48.2	6.8	29.6	55.0	68.3	63.1	151.6	19.5	36.2	43.4	139.8	38.4	23.2	39.2	30.3	15.6	39.9	12.2	61.1	8.2	43.3	23.3	14.1	23.3	89.5	15.2	13.0	28.7	77.9	73.5	25.5	91.6	180.4	11.3	60.1	29.6	62.2	48.9	12.2	27.7	10.4	47.7	6.0	63.6	112.3	85.8	54.5	76.0	1.9	0.9	137.8	5.6	0.2	1.1	5.6	33.9	14.9	0.3	9.2	14.7	15.1	12.9	20.1	40.2	6.9	10.6	10.9	127.8	0.1	5.0	4.3	74.5	7.8	40.2	5.3	1.7	5.5	0.1	11.3	2.3	6.3	0.1	42.8	0.0	29.9	12.6	10.9	82.6	1.5	0.1	4.3	48.6	0.1	3.7	11.6	15.0	0.3	24.6	43.2	67.6	94.7	0.0	2.9	20.0	16.6	17.2	7.7	3.5	188.9	0.7	18.9	0.7	2.4	0.1	0.1	5.1	11.8	0.0	18.6	137.8	5.6	98.3	0.1	1.8	0.2	0.5	0.1	0.1	0.9	1.9	0.4	1.1	2.6	0.2	0.0	0.3	0.0	5.6	20.0	36.2	6.8	29.6	30.3	15.6	43.3	23.3	28.7	47.7
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079349-23086340	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 57.0;TIME: 72.2;U-937: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 14.4;neutrophil: 17.4"	"Group enriched"	"Detected in many"	40	"dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"			440000000	"Vesicles, Plasma membrane"		"HPA009300: AB_1846342, HPA012368: AB_1846341"	"unprognostic (2.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (8.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.11e-2)"	50.5	6.1	2.4	15.0	3.4	4.7	31.4	1.0	3.0	13.6	8.1	1.7	3.9	3.2	14.3	12.5	10.0	13.6	14.2	33.3	2.4	2.2	10.8	10.9	34.8	25.3	4.1	1.2	11.6	5.9	5.1	4.3	48.9	5.3	9.7	4.3	4.9	5.9	3.9	16.2	6.8	7.7	15.4	4.3	17.5	7.5	6.9	3.3	6.9	12.3	9.3	4.5	15.6	12.2	0.0	5.5	17.4	14.4	0.0	0.3	4.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	72.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.6	0.0	0.0	14.4	0.2	0.2	10.3	0.0	0.0	0.1	0.0	5.5	0.0	0.0	0.0	17.4	0.0	4.2	0.7	0.3	4.7	2.4	3.4	1.0	3.0	2.4	2.2	4.1	1.2	5.3	3.3
CD99	MIC2	ENSG00000002586	"CD99 molecule (Xg blood group)"	P14209	X	2691133-2741309	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 359.1;breast: 433.0;heart muscle: 347.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB000020, HPA035304"	Supported		Approved	"Golgi apparatus"			34000000	"Golgi apparatus"		"CAB000020: AB_2076419, HPA035304: AB_10672861"	"unprognostic (3.71e-3)"	"unprognostic (2.90e-1)"	"unprognostic (5.97e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (2.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.61e-2)"	45.7	14.1	85.8	14.4	100.5	11.1	433.0	45.7	60.9	243.9	31.8	4.5	4.5	19.9	258.4	18.3	26.1	22.2	35.2	347.0	103.4	14.7	66.4	24.6	24.5	16.6	161.0	56.6	187.4	28.9	3.3	67.0	138.7	185.5	30.5	20.6	4.5	18.1	37.7	18.9	28.0	23.8	31.1	359.1	18.5	21.7	23.3	101.3	4.5	15.2	4.5	16.1	24.7	208.8	32.7	62.6	4.3	47.1	32.1	107.1	103.6	23.8	27.4	30.6	41.4	124.2	94.2	18.4	64.0	100.3	40.2	58.6	39.5	16.8	1.6	12.5	88.7	9.3	12.2	16.1	33.4	32.4	30.8	4.6	19.1	34.3	39.4	7.3	36.5	58.5	19.9	22.0	15.5	73.3	5.7	0.0	37.9	18.7	63.6	24.9	10.0	29.9	10.8	25.6	45.2	23.2	16.4	0.1	13.5	15.4	13.8	38.4	12.2	22.8	67.6	49.6	8.4	47.3	21.5	0.1	0.0	10.4	33.2	18.3	30.9	1.8	47.1	1.5	107.1	11.6	60.4	32.7	72.6	94.6	44.6	20.2	26.8	57.1	4.3	32.1	2.6	62.6	74.3	103.6	85.8	100.5	45.7	60.9	103.4	14.7	161.0	56.6	185.5	101.3
CDA	CDD	ENSG00000158825	"Cytidine deaminase"	P32320	1	20588948-20618908	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.5;bone marrow: 68.0"	"Cell line enhanced"	"Detected in many"		"A-431: 41.9;CAPAN-2: 28.0;HeLa: 39.7;PC-3: 20.0;SiHa: 49.8;U-937: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 126.5"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 126.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA064202	Enhanced		Approved	Nucleoplasm			3700000	Nucleoplasm		"HPA064202: "	"unprognostic (2.38e-1)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (2.94e-2)"	"unprognostic (5.03e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.89e-3)"	4.0	1.4	1.5	4.0	1.5	68.0	2.2	1.1	2.4	19.0	8.6	1.7	2.0	2.6	6.7	3.5	38.3	2.9	1.8	5.9	1.7	1.6	12.5	42.1	8.4	9.1	2.0	1.3	2.9	0.8	1.2	0.7	30.8	3.5	4.2	10.2	4.5	6.9	1.5	3.2	7.0	24.7	4.3	1.9	11.8	1.2	2.9	0.9	0.9	3.0	23.3	10.5	3.1	16.5	0.0	1.3	126.5	21.7	0.0	0.1	7.1	41.9	4.1	0.0	0.0	0.0	1.2	0.0	3.2	0.8	0.8	3.3	0.2	28.0	0.0	1.6	6.7	14.7	0.8	11.0	2.2	0.0	0.8	0.0	39.7	5.3	0.3	0.0	0.0	1.8	1.8	7.9	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	49.8	0.0	0.0	0.0	1.2	0.7	0.0	1.7	3.8	0.2	0.0	0.0	0.0	0.5	17.6	0.0	16.3	21.7	43.3	0.0	11.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	126.5	0.0	9.3	0.2	0.0	7.1	1.5	1.5	1.1	2.4	1.7	1.6	2.0	1.3	3.5	0.9
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	6.5	9.0	8.4	9.8	8.1	14.4	9.8	16.2	9.7	11.8	6.8	8.7	9.4	6.0	11.0	9.6	7.1	9.1	7.2	5.2	6.4	4.4	6.3	6.7	6.6	8.0	8.3	7.4	21.7	9.6	9.1	9.5	6.7	5.8	11.4	5.5	9.3	10.6	10.1	6.6	10.1	6.9	9.3	5.1	8.1	8.0	14.7	8.6	14.7	9.0	3.3	8.2	10.2	12.2	0.3	0.8	3.7	0.3	0.0	0.6	0.1	6.8	4.7	6.4	9.2	5.7	4.9	7.7	9.1	3.8	8.9	6.5	11.7	3.6	3.3	10.1	5.0	13.6	6.8	4.1	2.6	8.4	6.3	12.4	8.4	4.5	4.2	9.1	11.7	6.7	4.6	5.6	4.1	6.7	15.8	5.0	7.2	3.8	7.0	12.1	3.2	7.5	10.1	8.0	2.9	2.8	6.8	5.2	6.1	7.1	10.0	1.5	7.6	13.7	4.8	9.3	8.4	7.6	10.3	10.0	10.4	7.5	4.9	13.6	7.6	3.7	0.3	1.7	0.5	0.1	0.6	0.1	0.4	0.5	0.0	0.3	0.4	0.3	0.4	0.0	0.0	0.8	0.1	0.1	8.4	8.1	16.2	9.7	6.4	4.4	8.3	7.4	5.8	8.6
CDC14A	"cdc14, Cdc14A1, Cdc14A2, DFNB105"	ENSG00000079335	"Cell division cycle 14A"	Q9UNH5	1	100345001-100520278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Hearing"	"Hydrolase, Protein phosphatase"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 38.2"	"Cell line enhanced"	"Detected in many"		"K-562: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA023783	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA023783: AB_1846352"	"unprognostic (3.72e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-4)"	"unprognostic (4.88e-3)"	"unprognostic (6.30e-2)"	"unprognostic (3.97e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.66e-2)"	6.2	2.4	5.8	6.5	5.5	13.7	12.2	1.8	6.2	7.7	11.8	4.8	2.2	7.2	15.1	4.8	3.4	13.7	3.6	4.1	8.8	3.5	6.6	2.4	12.3	15.4	3.8	5.4	5.8	6.7	9.8	8.1	7.6	4.6	10.0	6.3	8.3	7.7	3.9	4.3	5.6	22.6	5.0	3.2	9.6	6.0	38.2	4.7	12.0	6.1	3.4	11.3	5.8	8.4	4.8	6.1	11.6	3.7	3.9	13.0	4.1	2.2	1.8	5.8	6.5	2.1	1.6	4.0	2.8	1.9	2.8	2.3	6.1	1.9	1.1	2.1	1.7	1.7	3.9	1.6	2.9	2.2	9.7	3.9	1.7	1.9	0.8	5.2	7.0	1.3	0.4	3.0	1.0	4.9	30.0	3.4	4.1	0.9	4.2	5.9	3.5	2.3	4.6	7.5	1.1	1.9	5.0	1.0	1.8	3.0	2.9	3.9	1.3	6.8	2.1	1.6	3.5	2.6	1.6	1.7	0.6	1.7	1.9	4.9	0.9	11.6	3.7	8.4	7.3	3.3	13.0	4.8	11.3	8.4	3.5	3.1	11.0	5.8	5.5	3.9	2.3	6.1	5.6	4.1	5.8	5.5	1.8	6.2	8.8	3.5	3.8	5.4	4.6	4.7
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: , HPA055288: "	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	51.7	25.3	35.3	23.0	1.2	3.1	33.9	24.0	21.6	70.1	37.4	39.6	43.2	30.0	14.1	22.0	36.5	38.6	45.8	58.5	23.5	28.5	43.9	25.0	24.5	0.3	30.6	16.0	1.0	2.1	48.6	44.1	29.7	19.8	20.6	31.7	20.0	29.4	18.8	44.7	34.1	42.8	48.5	19.0	17.1	13.8	20.9	10.3	42.5	28.7	13.3	20.1	38.8	15.4	21.0	49.2	23.3	74.5	15.9	14.0	31.1	15.0	38.2	31.2	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7
CDC25A		ENSG00000164045	"Cell division cycle 25A"	P30304	3	48157146-48188402	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 13.0;lymphoid tissue: 23.0;testis: 19.4"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"testis cancer: 19.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005855			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA005855: AB_1846364"	"unprognostic (1.49e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (7.05e-7)"	"unprognostic (1.35e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.92e-3)"	"unprognostic (4.41e-2)"	"unprognostic (9.09e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	0.8	1.2	1.1	5.5	1.1	13.0	0.8	0.7	1.2	1.1	3.3	0.6	1.0	1.8	0.6	0.9	3.9	0.4	2.2	0.7	1.3	2.4	1.2	0.9	0.7	4.1	1.4	0.2	2.1	3.6	0.4	2.3	4.2	1.2	1.0	4.0	1.5	1.8	0.5	0.7	0.8	2.1	0.8	0.7	3.6	1.3	19.4	0.2	23.0	1.6	8.8	7.4	0.8	1.3	1.7	0.9	0.5	0.1	0.0	1.0	0.1	7.5	3.7	17.8	9.6	0.6	1.2	12.3	10.5	4.0	13.2	10.7	16.1	3.9	22.4	4.1	2.7	5.7	30.5	7.2	13.9	7.3	16.0	28.7	6.8	7.9	0.6	20.2	8.3	0.6	1.1	16.4	7.1	5.0	22.8	11.9	7.1	4.0	25.2	15.7	26.0	8.5	11.3	11.7	12.2	3.3	7.1	8.4	10.4	6.5	7.6	3.3	4.0	14.3	2.5	6.5	10.0	7.2	14.2	6.0	17.9	35.2	4.8	22.5	5.4	0.0	0.0	0.5	0.4	0.0	0.0	1.7	0.6	0.2	0.9	0.0	0.0	1.0	0.0	0.0	0.1	0.5	0.0	0.1	1.1	1.1	0.7	1.2	1.3	2.4	1.4	0.2	1.2	0.2
CDC25B		ENSG00000101224	"Cell division cycle 25B"	P30305	20	3786772-3806121	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 4.5;NK-cells: 9.3;T-cells: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038892, HPA038893, HPA075215"	Enhanced		Supported	"Vesicles,Mitotic spindle"				Vesicles	"Mitotic spindle"	"HPA038892: , HPA038893: , HPA075215: "	"unprognostic (4.69e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.93e-2)"	"prognostic unfavourable (4.76e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-1)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.92e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.03e-2)"	"prognostic unfavourable (2.94e-13)"	"unprognostic (1.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.94e-1)"	"unprognostic (9.46e-2)"	12.1	8.7	15.1	27.7	23.3	26.0	28.8	49.6	21.1	13.0	14.7	12.8	4.6	14.9	17.0	10.3	11.7	13.0	18.6	7.5	15.7	12.5	13.3	11.0	33.0	42.8	21.9	12.5	17.3	5.7	7.5	21.0	30.3	13.8	11.0	12.0	7.7	7.4	10.2	6.2	19.8	16.8	14.8	14.7	24.5	14.1	6.3	22.3	33.3	18.7	20.8	31.6	15.3	16.3	4.5	1.3	1.5	1.8	9.3	15.5	5.9	29.8	64.5	8.6	14.3	10.6	10.4	4.3	14.8	22.2	24.8	18.5	11.2	43.3	20.8	6.4	15.1	43.7	11.7	24.6	11.7	8.0	12.6	11.2	20.7	13.5	42.3	8.7	5.8	10.2	19.8	23.0	27.2	13.7	7.2	55.1	14.6	24.0	27.1	12.7	6.4	27.6	14.2	24.4	14.9	16.9	2.8	6.2	13.5	35.1	33.5	17.2	11.3	4.5	11.3	13.3	16.1	24.1	19.6	13.4	21.2	8.4	6.8	8.6	12.8	1.5	1.4	0.0	13.6	1.8	12.7	3.5	13.6	13.7	1.3	4.5	11.4	13.2	0.1	9.3	0.9	0.7	15.5	5.9	15.1	23.3	49.6	21.1	15.7	12.5	21.9	12.5	13.8	22.3
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: , HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favourable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavourable (4.38e-4)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	29.2	18.9	19.4	18.7	25.2	23.0	23.3	26.0	33.0	23.7	17.2	14.8	13.8	14.4	23.2	19.6	17.6	17.6	18.6	22.8	18.3	22.6	16.8	23.8	20.4	21.3	19.4	23.9	19.5	14.3	27.8	26.8	25.0	31.5	17.6	18.2	14.6	15.7	16.5	31.6	15.5	15.3	24.4	17.7	24.2	16.1	23.5	17.4	25.2	42.8	15.5	22.9	23.6	17.3	9.0	7.7	9.6	10.3	12.8	11.6	5.4	23.2	24.9	20.9	16.9	14.1	22.5	12.4	32.9	29.7	31.5	32.3	15.9	12.3	31.3	22.2	27.6	11.2	22.5	18.6	43.4	45.0	23.1	36.4	26.4	14.1	15.3	21.4	16.6	16.3	9.2	28.3	22.4	32.5	29.0	17.5	25.6	19.8	26.2	9.7	9.9	20.4	14.1	53.8	13.9	18.9	14.7	13.9	17.0	16.5	5.8	18.3	17.6	15.1	34.5	32.9	28.6	20.8	24.3	17.9	31.0	28.5	18.2	12.8	22.7	9.6	4.4	6.2	8.1	10.3	7.8	6.0	6.8	8.5	6.0	9.0	6.7	7.6	5.7	12.8	7.4	7.7	11.6	5.4	19.4	25.2	26.0	33.0	18.3	22.6	19.4	23.9	31.5	17.4
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22052627-22092946	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"			42000000	"Microtubules, Cytokinetic bridge"		"CAB004360: AB_627233, HPA069590: "	"unprognostic (9.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.72e-2)"	"prognostic unfavourable (5.28e-5)"	"unprognostic (1.09e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.90e-2)"	"unprognostic (9.41e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	76.4	42.0	42.2	45.8	45.9	103.1	44.1	48.8	51.3	46.4	56.1	63.0	27.7	42.1	93.6	33.5	62.0	40.5	42.9	36.3	43.7	56.8	66.3	67.2	55.0	60.3	48.5	33.9	59.0	35.2	30.7	33.0	83.6	55.7	44.1	56.6	40.5	72.9	35.3	38.8	50.1	61.7	52.0	61.7	66.9	45.4	34.6	24.8	60.3	44.4	48.8	60.1	50.8	45.8	25.3	36.0	67.9	71.4	29.4	36.3	48.6	54.8	26.2	45.9	39.7	54.8	57.9	49.2	59.3	56.8	66.1	61.5	31.4	66.9	44.5	46.7	73.2	35.8	42.9	65.6	79.5	58.9	33.1	77.2	35.9	37.0	48.2	66.2	64.1	53.3	71.7	61.5	36.1	95.7	43.1	49.2	77.5	23.1	41.5	53.2	30.3	32.2	34.9	53.7	41.5	57.4	51.1	33.4	30.4	53.0	41.3	43.9	43.7	38.2	83.4	48.8	46.2	62.8	35.2	27.3	54.8	50.9	42.9	72.3	49.8	46.3	45.6	52.3	33.9	60.0	33.0	25.3	36.3	34.5	36.0	24.1	26.6	35.0	67.9	29.4	71.4	23.5	33.7	48.6	42.2	45.9	48.8	51.3	43.7	56.8	48.5	33.9	55.7	24.8
CDC42EP1	"Borg5, CEP1, MSE55"	ENSG00000128283	"CDC42 effector protein 1"	Q00587	22	37560447-37569405	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 9.4;intermediate monocyte: 2.9;myeloid DC: 3.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.5;monocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006379	Approved		Supported	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA006379: AB_1078486"	"unprognostic (1.32e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.79e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.06e-2)"	"unprognostic (4.38e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.09e-3)"	19.1	26.2	12.1	10.6	29.4	1.9	21.9	2.9	27.3	17.2	13.0	68.7	7.2	19.7	21.0	6.2	25.0	20.4	31.9	12.2	18.3	10.1	14.6	57.4	18.6	6.9	41.4	13.1	31.7	80.8	7.4	5.7	24.9	28.7	11.5	9.9	12.0	36.5	16.9	7.2	22.4	13.8	13.2	34.5	9.7	69.5	8.8	34.2	0.4	9.7	14.2	14.2	10.3	19.2	0.6	3.5	0.4	9.4	0.6	0.3	3.5	30.2	8.8	3.8	17.1	6.1	10.5	18.6	17.4	10.3	20.1	13.9	21.5	3.9	0.0	6.1	20.1	23.6	4.5	8.7	6.7	3.7	15.2	0.1	8.5	12.9	43.8	0.0	0.1	19.5	13.2	16.5	15.8	14.9	18.9	0.1	8.2	10.3	0.0	0.1	3.4	19.9	0.1	6.9	0.6	7.0	0.4	0.1	0.7	12.7	28.4	27.2	12.6	2.7	22.7	42.2	25.2	20.2	24.0	0.0	0.1	0.0	16.7	0.1	33.9	0.4	9.4	0.0	0.2	2.9	0.2	0.0	0.1	0.1	3.5	0.6	0.1	0.3	0.3	0.6	0.2	0.4	0.0	3.5	12.1	29.4	2.9	27.3	18.3	10.1	41.4	13.1	28.7	34.2
CDC45	"CDC45L, CDC45L2"	ENSG00000093009	"Cell division cycle 45"	O75419	22	19479459-19520612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.7;lymphoid tissue: 25.4;testis: 43.5"	"Cell line enhanced"	"Detected in many"		"K-562: 86.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000614, CAB009459"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB009459: AB_2078507, HPA000614: AB_1078487"	"unprognostic (5.56e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.17e-3)"	"unprognostic (3.42e-3)"	"unprognostic (3.57e-1)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (6.95e-6)"	"unprognostic (6.01e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (7.28e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.62e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.10e-1)"	0.9	0.9	0.3	8.4	0.5	15.7	0.9	0.3	0.6	1.3	3.4	0.3	0.2	2.2	0.6	1.4	6.2	0.4	0.8	1.6	0.7	0.3	0.8	1.4	1.3	7.5	0.4	0.2	0.7	0.5	0.1	0.4	3.5	0.4	0.7	4.3	0.2	1.3	0.2	0.4	2.1	3.1	1.1	0.4	4.2	1.8	43.5	0.2	25.4	0.5	7.2	10.2	1.3	1.9	0.7	0.9	1.6	0.5	1.8	3.2	1.9	13.1	11.0	13.7	10.7	0.6	1.3	5.8	16.2	7.6	18.7	18.6	8.4	7.3	14.6	5.7	4.8	12.6	14.6	10.7	16.8	17.8	24.7	19.5	12.4	9.2	0.7	28.3	10.7	0.4	0.5	14.3	6.4	9.4	86.6	18.4	10.9	17.5	22.9	13.4	4.1	8.3	19.1	22.8	6.4	4.3	12.6	17.7	9.3	8.8	9.7	2.8	6.3	12.6	3.6	14.6	23.4	11.0	14.7	6.3	11.6	17.0	7.7	14.2	19.5	0.0	0.2	0.0	2.2	0.0	0.0	0.7	1.4	2.3	0.6	0.0	1.0	0.7	1.6	1.8	0.5	0.9	3.2	1.9	0.3	0.5	0.3	0.6	0.7	0.3	0.4	0.2	0.4	0.2
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387525-44450426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	21.3	18.6	17.1	17.4	17.6	24.5	18.3	30.3	22.1	19.4	16.1	12.2	13.9	12.6	18.2	20.5	20.4	15.1	12.0	18.0	17.4	15.3	16.4	24.7	12.8	16.3	16.6	15.0	21.8	15.0	32.4	26.1	20.8	19.2	19.6	15.6	8.6	16.8	13.6	30.8	14.8	15.9	23.2	18.1	17.6	14.3	16.9	19.1	28.4	16.0	17.4	18.1	26.0	16.6	11.5	13.6	21.1	17.6	14.8	14.8	8.2	20.4	8.0	19.7	16.0	8.1	10.6	11.2	14.9	11.7	18.9	20.9	10.4	7.0	19.5	12.5	11.9	13.0	20.5	11.8	28.4	16.4	18.5	26.0	8.0	13.4	7.4	19.5	14.1	8.1	10.4	18.4	16.0	12.2	19.9	11.5	17.0	13.7	18.0	13.4	13.9	7.4	14.1	22.7	12.6	10.7	12.2	21.9	19.1	12.0	8.1	15.9	11.5	19.0	11.2	16.3	16.6	12.6	21.0	9.9	12.0	35.8	10.5	17.0	16.3	16.7	13.9	17.4	11.7	16.6	13.3	10.7	11.4	12.9	13.6	11.5	12.2	11.8	21.1	14.8	17.6	11.8	14.8	8.2	17.1	17.6	30.3	22.1	17.4	15.3	16.6	15.0	19.2	19.1
CDC6	CDC18L	ENSG00000094804	"Cell division cycle 6"	Q99741	17	40287633-40304657	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.2;NK-cells: 2.2;T-cells: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA050114, HPA065070"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge, Mitotic spindle"	"HPA050114: , HPA065070: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.97e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (5.96e-8)"	"unprognostic (2.31e-3)"	"unprognostic (1.46e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (5.47e-2)"	"unprognostic (3.00e-15)"	"unprognostic (1.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (3.88e-2)"	1.8	2.9	3.1	10.8	2.6	16.8	1.5	2.3	6.0	2.7	5.8	0.8	2.7	5.3	1.9	1.6	9.0	1.3	5.4	1.6	1.9	1.4	1.8	5.1	2.8	10.6	1.0	1.5	1.5	3.6	1.1	1.2	9.4	0.8	1.4	5.6	0.2	3.2	4.1	0.9	2.3	7.9	2.4	1.6	7.7	2.7	14.8	1.2	30.0	1.3	5.0	10.1	4.1	3.0	0.7	6.2	0.2	0.3	2.2	3.4	1.2	25.0	17.3	21.0	14.9	1.1	2.3	19.1	27.3	8.2	23.9	29.0	19.6	11.2	20.2	17.1	5.8	36.4	18.1	12.4	23.8	10.7	14.2	16.4	20.7	17.6	0.7	22.4	10.1	0.5	0.9	27.7	16.7	7.2	29.9	19.0	11.6	13.1	32.5	5.4	17.2	6.4	24.0	51.0	19.1	4.0	28.2	14.4	12.9	24.8	85.2	8.4	17.3	19.4	6.0	17.3	24.7	28.3	32.3	7.9	17.2	39.0	15.0	14.8	18.9	0.1	0.3	0.0	1.3	0.0	0.9	0.7	1.2	2.1	1.4	0.7	0.9	2.1	0.2	2.2	0.0	6.2	3.4	1.2	3.1	2.6	2.3	6.0	1.9	1.4	1.0	1.5	0.8	1.2
CDC7	"CDC7L1, HsCdc7, Hsk1, huCdc7"	ENSG00000097046	"Cell division cycle 7"	O00311	1	91500893-91525764	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002669, HPA035831"	Enhanced		Supported	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle"				Nucleoplasm	"Cytokinetic bridge, Mitotic spindle"	"CAB002669: , HPA035831: "	"unprognostic (6.84e-2)"	"unprognostic (6.01e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.02e-3)"	"unprognostic (5.57e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (3.15e-6)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.89e-15)"	"unprognostic (9.44e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-2)"	2.5	3.7	5.7	7.6	8.9	15.4	4.3	19.4	10.3	2.5	4.2	1.4	0.9	4.2	2.8	2.6	4.7	1.7	2.6	1.9	6.8	5.2	3.6	2.3	5.1	11.7	4.0	4.7	3.7	2.4	2.2	12.3	7.9	5.2	2.7	6.8	2.3	2.5	2.3	1.0	6.8	4.9	3.3	5.9	15.1	2.6	21.2	4.7	18.7	2.5	4.5	12.0	4.2	3.0	1.6	3.5	0.1	1.6	2.4	6.5	2.1	14.0	4.2	27.1	7.7	0.6	3.6	8.6	5.3	4.2	10.5	11.5	8.7	5.0	9.7	7.5	3.3	6.1	17.8	6.0	14.6	16.1	15.3	14.8	12.0	4.1	1.0	16.1	5.4	1.9	1.8	9.6	5.5	4.0	19.5	14.2	7.2	5.1	13.7	14.4	22.5	9.9	17.1	22.5	6.2	4.6	10.6	21.6	8.5	16.9	4.7	9.4	4.4	7.9	3.3	12.0	10.6	9.2	8.0	5.2	6.6	26.1	4.3	15.6	4.4	0.0	1.6	0.0	5.9	1.2	5.2	1.5	4.5	5.6	3.5	1.6	2.5	5.1	0.1	2.4	0.3	2.1	6.5	2.1	5.7	8.9	19.4	10.3	6.8	5.2	4.0	4.7	5.2	4.7
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737225-68835548	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 125.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 105.6;CACO-2: 35.5;CAPAN-2: 49.6;HaCaT: 47.9;hTCEpi: 33.8;MCF7: 29.3;RT4: 36.5;T-47d: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"myeloid DC: 2.8;plasmacytoid DC: 8.5"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"			22000000	"Plasma membrane, Cell Junctions"	"Golgi apparatus"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: , CAB072856: , CAB072857: , HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.1	0.7	1.3	14.8	1.5	0.5	15.3	0.8	1.1	14.4	63.8	1.8	42.4	25.5	4.7	18.6	48.5	9.7	48.9	0.8	1.5	1.0	24.2	64.9	24.4	0.5	1.8	0.9	5.6	71.5	62.2	13.2	55.2	2.8	28.9	25.9	11.8	66.6	43.7	0.8	30.5	125.5	1.5	1.1	3.5	21.6	2.1	1.8	11.7	83.0	26.2	32.6	16.8	21.7	0.0	8.5	0.0	0.0	0.3	0.4	0.1	21.3	2.2	0.0	0.0	0.0	0.0	105.6	0.0	0.0	0.0	0.0	35.5	49.6	0.0	0.4	0.0	47.9	0.0	23.8	0.0	4.1	0.6	0.0	0.1	7.6	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.1	0.8	0.1	0.0	0.0	0.3	8.7	36.5	1.3	0.1	0.2	0.0	9.0	31.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.8	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.1	0.1	1.3	1.5	0.8	1.1	1.5	1.0	1.8	0.9	2.8	1.8
CDH12	"Br-cadherin, CDHB"	ENSG00000154162	"Cadherin 12"	P55289	5	21750673-22853622	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;cervix, uterine: 9.3;pituitary gland: 8.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;PC-3: 5.1;SCLC-21H: 7.4;U-2 OS: 3.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029325	Uncertain		Uncertain	Vesicles				Vesicles		"HPA029325: "	"unprognostic (2.38e-1)"	"unprognostic (3.21e-1)"		"unprognostic (4.95e-2)"	"unprognostic (8.61e-2)"	"unprognostic (3.31e-2)"		"unprognostic (3.91e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.25e-4)"	"unprognostic (7.35e-2)"	"unprognostic (3.48e-2)"		"unprognostic (5.19e-2)"	0.5	5.2	5.8	0.3	17.7	0.4	1.7	2.0	13.8	9.3	0.5	0.0	0.0	0.5	1.3	1.0	0.4	6.7	0.3	0.5	6.3	3.4	0.7	0.5	0.8	0.3	1.4	4.8	0.5	0.5	0.6	8.6	0.7	4.2	0.5	0.6	1.4	3.1	0.9	0.5	2.5	0.4	0.9	2.5	0.3	0.4	2.9	0.5	0.0	0.4	0.0	0.5	1.5	0.2	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	1.0	0.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	5.1	0.2	0.0	0.1	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.0	5.8	17.7	2.0	13.8	6.3	3.4	1.4	4.8	4.2	0.5
CDH13	CDHH	ENSG00000140945	"Cadherin 13"	P55290	16	82626803-83800640	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 47.5;U-138 MG: 61.3;U-87 MG: 53.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.9;monocytes: 7.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001380, CAB025863"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		230000000	"Plasma membrane"		"CAB025863: , HPA001380: AB_1078371"	"unprognostic (2.50e-2)"	"unprognostic (2.75e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.06e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.30e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (5.16e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-1)"	14.0	2.3	13.9	2.7	14.8	0.7	7.6	0.6	32.5	32.7	3.6	2.0	2.8	1.3	36.1	8.9	6.4	6.1	3.6	34.6	5.2	9.9	3.7	1.4	10.8	1.2	4.2	13.3	3.2	0.8	1.1	0.7	4.0	3.8	2.8	4.2	0.9	4.0	5.0	37.2	14.3	1.8	19.5	3.4	1.6	1.7	3.6	1.6	0.0	4.1	21.3	2.7	4.6	14.6	1.0	0.9	2.9	7.2	0.1	0.1	0.3	2.2	0.0	0.8	0.1	14.0	13.5	0.0	10.0	11.0	11.6	5.0	0.0	0.0	0.0	1.9	29.1	18.9	0.2	14.9	17.5	0.0	0.1	0.0	7.4	0.0	8.1	0.1	0.1	1.7	13.0	23.3	28.5	5.7	0.0	0.1	47.5	0.1	0.0	0.1	2.3	4.1	0.0	12.5	0.0	10.0	0.1	0.0	0.0	17.9	0.1	0.0	0.2	0.0	9.1	61.3	5.0	0.4	9.0	0.0	0.0	0.0	53.4	0.1	15.0	2.9	1.0	2.4	0.1	3.8	0.1	0.9	0.1	0.0	0.9	1.0	0.1	0.1	2.0	0.1	7.2	0.6	0.1	0.3	13.9	14.8	0.6	32.5	5.2	9.9	4.2	13.3	3.8	1.6
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"			3400000	"Cell Junctions"	Nucleoplasm	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
CDH2	"CD325, CDHN, NCAD"	ENSG00000170558	"Cadherin 2"	P19022	18	27950966-28177446	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.6;parathyroid gland: 35.4"	"Cell line enhanced"	"Detected in many"		"AF22: 56.4;BJ: 40.7;fHDF/TERT166: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 4.4;neutrophil: 4.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000141, CAB018580, HPA058574, CAB078686"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			160000000	"Plasma membrane, Cell Junctions"		"CAB000141: , CAB018580: AB_626778, CAB078686: , HPA058574: "	"unprognostic (9.42e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.07e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.53e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.00e-2)"	"unprognostic (7.53e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.59e-3)"	0.6	29.6	9.8	1.5	9.4	0.5	0.5	5.7	16.1	3.2	2.0	8.0	0.2	0.8	3.1	1.9	0.6	4.7	1.7	77.6	9.9	9.6	9.2	23.3	0.7	1.1	6.0	9.1	3.4	0.7	35.4	5.4	0.5	5.9	1.4	0.8	6.8	0.5	4.6	0.4	0.5	0.9	3.2	6.7	5.9	2.5	19.6	7.4	0.9	2.8	0.0	1.0	1.0	1.3	0.0	0.0	4.4	0.0	0.7	0.9	0.0	0.0	4.5	56.4	0.0	8.9	1.8	0.0	40.7	12.4	16.6	15.2	0.0	0.0	0.0	21.9	84.2	6.0	9.2	0.0	23.6	0.1	5.9	0.0	15.2	14.0	8.5	0.0	0.0	0.8	0.1	38.1	6.7	14.5	0.0	0.0	12.9	0.0	10.2	0.0	7.5	4.9	0.0	6.7	7.7	0.0	1.8	14.7	25.5	0.0	0.0	4.5	0.0	0.0	2.2	36.0	11.5	0.5	29.4	0.0	0.0	0.0	6.9	0.0	27.7	4.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	0.0	0.0	9.8	9.4	5.7	10.1	9.9	9.6	6.0	9.1	5.9	7.4
CDH26	VR20	ENSG00000124215	"Cadherin 26"	Q8IXH8	20	59958427-60034011	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 16.1;prostate: 15.3"	"Cell line enriched"	"Detected in some"	6	"RT4: 33.9"	"Group enriched"	"Detected in some"	6	"cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.4;eosinophil: 1.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA015722, HPA047578"	Uncertain		Supported	"Plasma membrane,Microtubules"				"Plasma membrane"	Microtubules	"HPA015722: AB_2077659, HPA047578: "	"unprognostic (2.42e-1)"	"prognostic favourable (7.62e-4)"	"unprognostic (4.71e-4)"	"unprognostic (8.17e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.26e-4)"	"unprognostic (8.24e-3)"	"unprognostic (9.96e-7)"	"unprognostic (1.85e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	0.8	0.5	0.8	0.7	1.2	1.3	0.8	2.0	1.1	3.8	0.7	0.7	0.7	0.5	1.3	0.7	3.8	2.5	0.7	0.7	1.2	1.0	0.7	0.7	2.9	0.7	1.3	0.7	2.0	0.7	0.7	1.9	0.7	1.4	15.3	0.4	1.4	2.8	0.7	1.0	0.4	0.7	0.7	1.6	0.7	1.9	0.7	0.7	4.2	0.7	0.7	16.1	6.2	1.3	0.0	0.9	1.6	1.4	0.0	0.2	0.4	0.0	0.5	0.1	0.0	0.4	0.2	0.3	0.1	0.0	0.1	0.0	0.6	0.6	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.2	0.2	0.1	1.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.4	0.4	0.1	0.0	0.0	0.6	0.0	33.9	0.7	0.1	0.3	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.8	0.0	0.0	1.4	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.2	2.0	1.1	1.2	1.0	1.3	0.7	1.4	0.7
CDH5	"7B4, CD144"	ENSG00000179776	"Cadherin 5"	P33151	16	66366622-66404786	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 96.6"	"Group enriched"	"Detected in some"	6	"HUVEC TERT2: 111.2;TIME: 95.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB028366, HPA075875"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"			1000000000	"Plasma membrane"	"Nucleoplasm, Nuclear membrane"	"CAB028366: AB_2276033, HPA075875: "	"unprognostic (1.05e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.96e-2)"	"unprognostic (5.50e-3)"	"unprognostic (9.38e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (9.49e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.15e-2)"	48.7	5.6	4.0	6.2	5.8	0.6	28.1	2.6	4.8	11.1	6.6	3.4	5.5	3.7	18.7	11.2	8.4	7.2	12.6	21.7	4.5	4.3	7.8	12.7	43.7	9.7	6.5	2.8	7.7	3.6	5.0	3.5	96.6	7.6	9.0	4.8	8.5	5.2	4.4	19.0	7.0	6.8	12.1	5.4	10.8	5.7	6.7	3.3	1.2	16.6	15.7	4.5	11.7	11.3	0.0	0.6	0.4	0.8	0.1	0.1	1.1	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	111.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	95.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.6	0.1	1.1	4.0	5.8	2.6	4.8	4.5	4.3	6.5	2.8	7.6	3.3
CDH6		ENSG00000113361	"Cadherin 6"	P55285	5	31193750-31329146	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 73.8"	"Cell line enriched"	"Detected in some"	8	"EFO-21: 104.0"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 15.0;renal cancer: 28.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA007047, HPA007403, HPA007456, CAB025274"	Enhanced		Supported	"Cell Junctions"			1200000	"Cell Junctions"		"CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373"	"unprognostic (3.87e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.58e-2)"	"unprognostic (7.61e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.22e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.22e-2)"	"unprognostic (2.09e-2)"	6.7	1.9	3.4	2.2	7.5	0.6	3.9	1.1	8.4	7.0	2.1	2.4	1.0	2.1	4.5	8.4	3.8	10.0	13.4	3.0	3.3	4.3	73.8	1.4	6.5	1.1	5.0	4.8	3.5	1.3	2.5	2.1	5.3	5.6	2.4	1.7	20.4	1.4	2.9	1.9	1.8	2.0	4.0	6.3	1.4	1.8	0.9	5.5	0.0	3.5	3.3	1.3	4.4	3.4	0.6	0.5	1.7	0.5	0.7	0.4	0.3	0.0	0.4	13.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	104.0	0.0	0.0	10.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	3.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.3	0.0	0.0	0.1	0.0	0.0	0.3	1.5	0.4	0.4	0.4	0.3	0.3	0.4	0.3	0.3	0.2	0.6	0.3	0.4	1.7	0.7	0.5	0.5	0.3	0.3	3.4	7.5	1.1	6.7	3.3	4.3	5.0	4.8	5.6	5.5
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 179.8"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 21.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hypothalamus: 2.5"	"Low region specificity"	"Detected in many"			"HPA012569, HPA017053"	Enhanced						3600000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	2.5	0.3	0.0	0.1	0.1	0.3	0.1	80.0	0.1	0.1	67.2	0.1	0.8	0.1	0.2	7.1	0.1	0.1	0.4	3.0	26.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	2.9	0.5	0.1	0.1	0.1	0.1	179.8	0.1	0.1	0.1	2.8	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.3	0.0	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.5	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.1	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616565-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 296.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;CACO-2: 6.6;RPMI-8226: 3.7"	"Group enriched"	"Detected in many"	17	"colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"		170000000			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.3	0.1	8.1	0.1	0.0	0.1	0.1	0.1	0.1	118.7	0.4	0.0	34.3	0.1	0.8	0.1	0.2	12.1	0.1	0.2	0.1	10.9	43.8	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	1.6	0.1	21.3	5.1	0.1	0.0	0.1	0.1	296.7	0.8	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.6	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	1.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.7	0.8	0.0	0.1	0.1	3.7	0.0	0.3	0.0	1.6	0.0	0.2	0.0	0.0	0.2	0.6	0.1	0.1	0.3	1.1	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.6	0.0
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favourable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (1.10e-6)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.2	18.4	48.9	19.3	3.2	4.9	20.1	36.5	26.6	44.5	42.9	43.0	42.7	44.2	14.2	10.0	30.0	33.2	21.2	46.4	31.4	24.2	23.2	18.1	24.9	0.5	35.5	24.0	0.9	2.1	28.8	28.1	26.7	35.3	54.5	49.5	12.8	44.6	25.5	21.5	38.7	38.8	45.5	21.7	17.0	16.0	22.9	20.1	24.5	37.3	18.9	40.2	21.8	11.0	19.0	40.6	20.0	49.8	21.4	34.3	39.9	16.4	39.8	23.6	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 105.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: "	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic unfavourable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.5	8.9	19.6	10.9	4.0	5.2	36.2	20.6	10.8	25.6	24.0	18.7	15.9	15.7	15.5	7.6	10.6	14.9	9.0	26.1	18.5	14.6	18.1	14.8	7.1	1.3	14.3	13.1	2.7	2.3	17.3	6.0	12.9	17.2	14.3	17.8	12.7	29.6	12.1	7.8	13.3	29.0	18.9	11.8	7.4	16.2	8.1	10.5	23.5	8.6	105.5	18.6	10.5	7.2	17.7	17.2	13.6	15.0	8.2	9.4	19.6	10.0	10.5	15.2	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1
CDK4	PSK-J3	ENSG00000135446	"Cyclin dependent kinase 4"	P11802	12	57747727-57756013	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	10	"HBEC3-KT: 125.1;LHCN-M2: 138.1;RH-30: 434.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006024, CAB013116, CAB069405"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"				Cytosol	"Nucleoplasm, Nuclear membrane, Nucleoli"	"CAB013116: AB_2536376, CAB069405: AB_1613464, HPA006024: "	"unprognostic (8.88e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.27e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (7.39e-2)"	"unprognostic (3.23e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.15e-5)"	"unprognostic (3.32e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.57e-2)"	32.2	43.1	13.8	22.2	15.7	24.0	45.0	13.1	17.9	36.3	28.2	20.1	22.8	15.2	51.4	28.1	29.9	31.0	32.3	27.4	14.5	12.1	24.0	36.9	26.8	26.4	18.3	13.7	61.4	54.4	18.9	34.2	25.0	16.0	37.2	26.9	26.2	29.3	24.1	27.8	25.6	20.7	34.1	13.5	27.2	23.9	24.6	17.5	29.2	54.3	32.1	27.5	33.6	30.9	29.6	25.5	2.6	19.9	15.8	32.1	22.2	9.3	10.8	14.3	12.7	13.1	11.5	9.5	5.4	17.6	23.8	19.8	15.4	8.9	13.6	9.7	8.4	7.2	19.7	125.1	18.1	6.7	9.1	12.7	7.3	10.8	15.4	14.4	8.8	11.3	9.2	14.6	16.8	15.3	13.5	11.7	138.1	13.5	13.7	11.7	16.8	11.0	12.4	434.6	12.6	7.4	14.7	12.9	12.1	9.5	7.2	14.4	9.6	17.5	6.9	11.2	10.5	12.6	10.9	5.8	9.5	20.9	10.3	13.3	13.4	1.7	14.3	2.6	26.2	19.9	27.0	29.6	23.1	23.7	21.0	28.1	32.1	28.5	1.2	15.8	12.0	25.5	16.6	22.2	13.8	15.7	13.1	17.9	14.5	12.1	18.3	13.7	16.0	17.5
CDK5	PSSALRE	ENSG00000164885	"Cyclin dependent kinase 5"	Q00535	7	151053812-151058530	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Lissencephaly, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 36.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008909, HPA064535"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB008909: , HPA064535: "	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.25e-3)"	"unprognostic (3.35e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.11e-1)"	4.5	11.3	24.4	6.9	30.4	6.1	5.3	13.6	36.1	5.3	6.1	6.7	4.5	7.9	4.5	17.4	6.5	5.0	6.2	5.8	25.0	19.7	9.0	7.7	5.3	6.0	15.4	15.4	3.2	5.8	8.9	7.9	5.3	20.8	5.8	6.3	3.2	6.0	6.3	5.7	6.5	6.2	6.0	8.6	5.2	5.7	3.1	7.7	6.8	6.0	3.6	6.9	6.7	3.1	6.6	21.5	9.0	21.7	9.5	14.9	10.6	11.6	14.0	13.1	21.3	14.5	10.7	6.5	7.7	12.8	15.2	12.6	9.9	10.9	11.5	27.7	9.5	8.3	21.0	11.8	7.0	9.1	12.5	12.6	12.3	9.8	9.6	10.2	23.7	11.5	8.8	12.5	3.9	10.2	12.8	8.4	15.2	22.6	27.4	20.8	14.4	22.1	13.4	5.4	12.8	13.2	8.8	8.3	35.7	11.1	13.7	14.6	6.4	9.0	8.6	15.0	3.9	11.2	14.4	19.6	21.4	4.5	23.6	14.7	26.8	7.8	19.0	9.0	6.9	21.7	5.4	6.6	6.8	6.8	21.5	5.9	5.1	6.2	2.8	9.5	16.4	12.8	14.9	10.6	24.4	30.4	13.6	36.1	25.0	19.7	15.4	15.4	20.8	7.7
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"				Centrosome	"Cell Junctions"	"CAB079753: , HPA035820: AB_10671939, HPA046529: "	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.8	23.3	14.0	10.1	14.9	12.5	12.3	9.5	14.0	13.1	13.2	12.6	17.8	5.7	12.0	21.0	18.4	14.1	13.5	14.2	7.4	15.2	30.8	23.3	9.5	18.7	10.2	26.8	9.4	12.4	16.4	12.1	14.0	15.5	18.3	21.5	20.0	12.0	21.6	12.7	19.7	27.9	8.4	10.0	7.6	15.3	17.6	21.4	11.8	14.2	27.6	12.9	8.1	12.2	13.3	14.2	13.9	11.3	15.7	20.0	12.7	12.0	25.5	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7
CDK5RAP3	"C53, FLJ13660, HSF-27, IC53, LZAP, MST016, OK/SW-cl.114"	ENSG00000108465	"CDK5 regulatory subunit associated protein 3"	Q96JB5	17	47967810-47981774	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022141, HPA022882, HPA027883"	Supported		Supported	Nucleoli,Vesicles,Cytosol				Cytosol	"Nucleoli, Vesicles"	"HPA022141: AB_1846426, HPA022882: AB_1846428, HPA027883: AB_10602797"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-3)"	"unprognostic (9.95e-3)"	"unprognostic (6.65e-2)"	"unprognostic (5.98e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.84e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (3.61e-5)"	"unprognostic (8.35e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.58e-2)"	"prognostic favourable (7.31e-5)"	15.5	19.7	20.8	30.0	38.3	21.2	22.5	35.7	31.9	21.1	21.2	27.1	39.4	24.1	26.2	45.4	20.8	26.1	22.0	14.4	23.2	16.7	23.2	31.0	18.8	22.0	31.3	25.8	28.9	51.9	29.4	41.3	15.4	27.3	24.2	25.5	25.1	44.0	26.4	10.7	16.8	25.8	18.4	18.2	32.3	28.6	40.1	29.5	32.3	29.7	16.5	24.6	20.0	18.5	22.8	26.9	27.2	33.5	22.4	22.3	21.0	22.3	36.0	19.9	35.6	16.7	16.8	35.7	16.3	19.8	16.5	15.2	28.2	21.7	26.9	33.8	17.0	21.9	12.9	18.3	18.5	39.7	17.0	12.8	42.9	38.2	18.7	15.1	14.3	19.1	15.5	14.8	29.1	15.9	15.1	25.0	16.7	42.8	41.1	24.5	12.0	15.6	22.0	33.5	30.5	16.4	28.1	13.6	32.6	12.6	11.3	16.4	25.7	19.8	12.7	13.7	12.2	16.5	20.8	32.9	31.0	16.6	17.1	21.0	16.6	9.1	33.5	27.2	20.9	32.7	22.3	22.1	20.0	18.5	26.9	22.8	18.1	19.9	15.7	22.4	32.5	24.4	19.0	21.0	20.8	38.3	35.7	31.9	23.2	16.7	31.3	25.8	27.3	29.5
CDK6	PLSTIRE	ENSG00000105810	"Cyclin dependent kinase 6"	Q00534	7	92604921-92836594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 91.7;REH: 44.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA002637, CAB004363"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004363: AB_627242, HPA002637: AB_1846432"	"unprognostic (1.29e-1)"	"unprognostic (5.98e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.19e-2)"	"unprognostic (7.78e-3)"	"prognostic unfavourable (3.86e-6)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (2.33e-5)"	6.6	11.3	6.0	9.1	7.5	22.5	5.9	2.4	6.0	7.8	10.0	9.6	5.7	7.5	6.0	5.9	8.5	4.6	7.8	6.6	6.9	4.2	6.5	7.5	7.3	7.4	7.0	5.2	5.0	10.0	25.7	4.2	20.5	7.5	6.1	9.2	4.4	10.9	6.1	2.0	11.6	9.4	9.8	7.5	6.3	10.8	5.4	8.0	74.6	4.3	9.2	10.3	6.7	9.0	3.6	5.6	6.5	4.8	3.9	7.1	2.3	6.0	2.8	7.8	5.0	2.3	2.6	1.6	6.3	3.9	3.1	3.0	7.7	4.7	4.7	3.6	4.2	3.8	4.3	9.0	7.4	10.3	3.0	11.8	5.4	7.4	1.4	7.3	0.5	2.5	4.9	4.2	20.0	1.2	11.2	13.0	5.6	1.2	91.7	0.7	2.4	2.6	44.8	27.6	7.9	4.3	0.1	4.1	26.8	0.7	2.1	3.7	0.1	12.0	4.6	10.3	16.1	4.0	12.6	7.0	0.1	6.3	1.5	25.0	13.6	4.9	1.9	6.5	5.2	3.9	5.9	2.0	5.5	5.6	4.0	3.6	7.1	4.0	1.1	3.9	4.8	5.6	2.8	2.3	6.0	7.5	2.4	6.0	6.9	4.2	7.0	5.2	7.5	8.0
CDK7	"CAK, CAK1, CDKN7, MO15, STK1"	ENSG00000134058	"Cyclin dependent kinase 7"	P50613	5	69234795-69277430	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004364, HPA007932"	Enhanced									"CAB004364: AB_627243, HPA007932: AB_1078492"	"unprognostic (3.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (9.42e-7)"	"unprognostic (2.61e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.55e-2)"	7.9	12.9	10.9	6.2	15.2	44.1	14.0	10.8	14.7	9.4	12.7	6.0	6.3	15.8	9.4	8.6	23.4	18.5	16.5	8.1	11.5	9.3	13.8	10.6	10.1	8.8	7.6	9.7	7.7	9.1	3.3	16.2	22.9	11.2	11.2	14.8	6.6	13.2	6.5	15.9	15.4	9.8	12.1	9.2	7.9	13.9	29.0	7.8	12.1	20.0	15.6	15.5	10.7	11.7	15.6	15.0	22.4	11.3	12.4	15.3	7.8	3.7	7.8	1.8	0.5	2.4	11.6	14.7	6.5	7.7	10.8	17.5	16.7	1.9	2.8	10.2	1.7	2.5	1.4	2.8	5.9	1.3	7.0	0.4	8.2	7.9	0.4	6.7	3.2	14.3	13.9	9.0	2.8	13.6	10.4	4.5	4.9	0.7	4.1	14.8	1.7	7.5	6.7	0.4	1.1	1.6	1.0	0.6	6.5	1.5	5.8	3.4	11.6	0.6	2.6	0.1	3.2	0.9	5.1	4.8	8.4	3.7	0.8	4.0	0.8	7.3	10.9	22.4	8.6	11.3	14.8	12.4	12.9	15.3	15.0	15.6	11.1	13.2	10.0	12.4	8.0	11.2	12.8	7.8	10.9	15.2	10.8	12.7	11.5	9.3	7.6	9.7	11.2	7.8
CDK8	K35	ENSG00000132964	"Cyclin dependent kinase 8"	P49336	13	26254104-26405238	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044721			Approved	Nucleoplasm				Nucleoplasm		"HPA044721: "	"unprognostic (3.28e-3)"	"unprognostic (2.25e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.12e-1)"	"prognostic favourable (9.23e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.37e-2)"	7.6	8.8	10.1	10.4	8.5	5.2	5.6	26.9	11.3	5.9	24.0	6.0	13.8	13.8	11.2	6.5	10.0	7.0	11.2	7.6	8.3	7.3	9.4	10.4	6.7	5.2	7.8	7.9	6.1	12.7	8.4	10.2	10.6	8.2	7.8	11.2	4.6	9.0	19.2	9.7	6.1	15.0	12.7	6.0	6.4	11.7	16.3	9.9	12.8	6.4	6.9	7.2	15.5	11.0	1.9	1.7	3.4	1.6	1.0	2.1	1.3	6.8	5.6	11.4	11.6	6.0	7.5	7.0	13.2	9.1	9.8	7.1	16.3	9.6	7.3	5.8	6.8	8.4	13.1	8.9	12.4	16.8	7.2	13.8	4.6	5.6	4.2	21.6	7.9	5.4	8.5	7.4	12.4	7.1	21.4	0.0	8.8	7.3	16.5	10.2	9.1	7.0	10.4	11.3	5.0	5.7	6.4	9.7	5.7	5.6	10.7	9.7	3.8	9.9	7.3	6.3	8.0	11.5	7.1	5.6	9.9	13.4	3.9	9.1	7.4	0.4	0.9	3.4	1.1	1.6	1.9	1.0	1.5	2.1	1.7	1.9	2.1	1.7	0.0	1.0	1.2	1.0	0.6	1.3	10.1	8.5	26.9	11.3	8.3	7.3	7.8	7.9	8.2	9.9
CDK9	"C-2k, CDC2L4, PITALRE, TAK"	ENSG00000136807	"Cyclin dependent kinase 9"	P50750	9	127785679-127790787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004216, HPA006738"	Supported		Approved	"Nucleoplasm,Cytoplasmic bodies"				Nucleoplasm	"Cytoplasmic bodies"	"CAB004216: AB_627245, HPA006738: AB_1078493"	"unprognostic (3.60e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.24e-3)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.52e-2)"	"unprognostic (8.78e-3)"	26.2	27.0	22.8	18.9	22.4	33.9	17.4	31.0	26.8	23.1	21.9	22.9	24.7	16.6	22.5	20.1	22.7	29.1	21.5	22.9	26.3	23.4	18.5	48.7	23.3	26.6	23.4	18.8	43.7	29.1	15.5	28.4	19.8	20.6	20.7	10.8	18.7	20.6	21.6	14.6	26.6	21.4	21.0	17.9	29.0	17.7	22.3	16.1	29.3	25.8	18.3	24.2	17.0	17.6	6.0	8.9	5.1	6.4	18.6	9.9	2.9	8.8	16.1	10.1	11.1	11.5	9.0	13.2	9.1	13.4	9.5	8.6	11.9	10.0	15.5	10.7	10.3	17.9	6.6	14.9	3.6	13.9	8.0	14.5	17.4	9.8	16.8	14.0	23.3	15.8	18.2	10.1	11.4	19.6	12.5	20.9	8.5	23.3	15.3	21.1	22.3	17.2	44.3	8.6	22.3	13.8	9.9	10.0	11.9	13.7	14.5	8.2	18.2	13.3	22.4	11.4	12.9	9.8	8.8	38.1	29.2	13.9	10.7	9.6	10.4	3.7	3.4	4.9	9.9	4.5	9.9	3.5	5.6	7.9	4.4	6.0	6.3	7.7	5.1	18.6	6.4	8.9	3.8	2.9	22.8	22.4	31.0	26.8	26.3	23.4	23.4	18.8	20.6	16.1
CDKL5	"CFAP247, EIEE2, STK9"	ENSG00000008086	"Cyclin dependent kinase like 5"	O76039	X	18425583-18653629	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0"	"Cell line enhanced"	"Detected in many"		"A549: 12.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 7.7;eosinophil: 2.1;neutrophil: 4.7"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002847, CAB011577"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB011577: AB_727019, HPA002847: AB_1080107"	"unprognostic (7.01e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.63e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.66e-1)"	"prognostic favourable (5.54e-4)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.99e-1)"	3.3	3.2	8.0	1.8	24.7	3.2	4.3	3.9	28.0	5.4	2.7	7.7	1.8	1.5	4.5	2.8	5.2	2.8	3.1	5.0	8.0	3.7	6.3	2.2	6.9	1.4	3.5	13.2	6.7	4.5	6.2	5.0	5.4	5.9	6.7	2.2	2.0	3.9	4.4	3.0	3.5	1.9	4.0	5.7	2.3	4.9	14.0	5.7	1.6	5.1	0.8	2.1	5.6	4.6	0.7	1.0	7.7	1.0	0.5	0.6	0.2	1.7	12.3	3.5	3.1	3.3	4.5	2.5	2.0	3.8	2.8	3.2	4.0	2.3	1.9	0.4	1.3	0.5	4.0	3.0	5.9	0.5	2.6	0.0	7.1	3.1	1.6	0.1	0.8	2.6	3.1	6.8	7.1	1.3	0.1	1.9	4.2	1.7	0.8	0.8	7.1	3.0	0.7	3.8	0.1	2.4	8.9	0.7	4.4	4.5	1.1	2.2	1.6	0.7	7.3	4.3	1.9	7.9	1.5	0.3	0.1	0.3	2.4	0.5	4.2	7.7	1.0	2.1	0.6	0.6	0.3	0.2	0.4	0.3	0.3	0.7	0.6	0.6	4.7	0.5	0.6	1.0	0.2	0.2	8.0	24.7	3.9	28.0	8.0	3.7	3.5	13.2	5.9	5.7
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"					"Low region specificity"	"Detected in many"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli				Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: "	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favourable (5.19e-4)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.6	34.9	3.5	50.0	7.2	32.2	1.6	6.0	5.9	36.4	15.8	30.9	56.7	0.0	53.1	2.3	1.5	3.5	3.0	3.8	0.0	19.8	11.0	2.0	0.0	32.9	17.9	0.1	0.3	0.0	0.4	29.2	0.0	13.3	26.4	4.0	0.0	33.0	2.3	38.0	6.3	53.0	7.5	0.1	6.5	0.1	0.4	0.0	0.1	14.7	8.3	29.4	0.0	9.4	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9
CDKN2C	"INK4C, p18"	ENSG00000123080	"Cyclin dependent kinase inhibitor 2C"	P42773	1	50960745-50974633	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005303, CAB018398, HPA019057, HPA019764"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB005303: AB_2078729, CAB018398: AB_2078731, HPA019057: AB_1854865, HPA019764: AB_1854866"	"unprognostic (4.07e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.76e-3)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.38e-1)"	"prognostic unfavourable (1.70e-10)"	"unprognostic (2.55e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.24e-1)"	42.1	12.6	5.9	10.7	7.9	14.9	31.7	4.3	5.7	13.1	13.0	8.7	7.7	6.6	17.1	13.9	11.5	8.4	13.7	20.1	5.7	3.1	7.4	3.3	7.9	11.0	13.7	5.3	22.5	9.4	23.1	5.7	3.1	3.9	10.3	5.7	6.0	5.4	12.2	9.2	8.5	7.9	15.1	7.5	8.5	5.3	5.3	8.9	54.2	8.0	4.9	9.8	17.4	21.7	3.4	7.4	12.2	2.5	6.0	14.1	3.8	13.8	5.7	1.0	19.1	19.7	2.8	0.2	13.2	13.4	22.2	19.5	0.3	4.7	27.2	11.9	11.2	1.7	12.9	1.7	10.9	16.4	17.3	20.6	43.6	3.5	1.0	14.3	9.4	1.0	0.3	6.0	2.6	5.8	9.2	0.0	12.9	3.4	18.4	6.9	0.0	14.0	22.0	18.0	0.0	7.0	5.8	9.7	22.7	18.0	12.7	4.2	6.3	48.6	4.6	25.5	9.8	15.4	0.2	27.9	26.5	22.4	0.0	52.3	22.4	12.2	2.5	11.0	5.2	1.4	6.0	3.4	7.7	6.8	6.1	1.9	4.3	4.1	0.2	6.0	0.6	7.4	14.1	3.8	5.9	7.9	4.3	5.7	5.7	3.1	13.7	5.3	3.9	8.9
CDS2		ENSG00000101290	"CDP-diacylglycerol synthase 2"	O95674	20	5126786-5197887	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"U-266/84: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019698	Approved		Approved	"Endoplasmic reticulum,Cytosol"			200000	"Endoplasmic reticulum"	Cytosol	"HPA019698: AB_1846464"	"unprognostic (4.59e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.53e-9)"	"unprognostic (8.89e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.44e-1)"	14.8	16.1	22.2	9.9	25.5	12.1	12.1	36.0	34.5	12.7	11.8	21.4	6.7	5.9	12.9	9.8	10.5	12.5	10.0	26.6	22.0	34.0	16.9	14.2	14.5	10.9	26.7	24.0	10.9	7.2	20.6	15.6	11.1	28.3	15.9	12.3	19.8	8.0	19.7	9.4	6.2	9.9	20.2	16.2	9.8	10.6	13.0	12.5	8.1	14.2	4.6	13.6	11.6	8.2	7.6	7.9	28.3	9.7	6.5	11.1	11.7	9.4	10.6	10.6	5.5	6.3	5.8	4.9	5.2	10.7	8.6	12.5	6.5	9.3	7.2	2.6	9.7	13.6	8.6	10.9	9.2	7.6	3.0	8.3	3.0	10.0	5.9	5.4	3.1	5.0	6.1	11.3	4.4	11.5	4.0	9.3	8.0	1.6	10.6	2.0	5.1	3.2	9.2	8.6	3.3	5.5	9.2	4.4	6.2	5.8	9.9	13.4	6.1	2.5	8.4	6.2	4.9	5.5	5.2	8.1	59.6	6.0	2.8	4.2	3.7	24.1	9.7	11.5	10.0	8.0	10.6	7.6	10.2	11.1	7.9	7.4	8.0	7.8	28.3	6.5	7.3	6.3	11.1	11.7	22.2	25.5	36.0	31.6	22.0	34.0	26.7	24.0	28.3	12.5
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"			220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	49.7	11.6	20.5	13.5	23.7	29.3	24.3	27.5	35.9	27.6	27.4	28.7	20.1	63.7	41.9	30.8	21.5	29.3	27.5	51.8	40.7	11.0	37.6	12.8	17.6	36.9	41.8	24.2	27.8	28.9	24.6	66.5	34.8	27.0	42.8	39.9	14.3	34.2	24.2	20.7	14.9	20.9	27.3	51.0	29.0	20.3	16.3	12.3	26.1	19.5	32.7	63.0	25.7	43.1	29.5	27.9	23.4	27.2	62.5	46.8	150.0	16.5	25.4	17.1	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"Carcinoembryonic antigen related cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 12.5;Hep G2: 35.4;RT4: 23.3;SK-MEL-30: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.6;neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.6"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"		180000000			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favourable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	5.3	5.0	0.4	30.2	0.7	15.8	5.3	0.5	0.5	7.7	58.7	0.9	2.5	11.8	3.5	1.5	35.6	1.7	4.3	3.8	0.5	0.5	24.0	46.1	5.4	8.6	1.8	0.0	2.5	1.0	0.0	3.7	16.8	1.0	8.8	35.6	1.7	20.7	5.4	0.9	1.7	54.9	3.0	1.5	5.5	3.6	1.3	0.7	1.2	2.3	18.5	46.5	7.8	12.7	1.9	0.1	20.6	1.8	0.0	1.5	0.3	0.1	2.3	0.1	0.1	0.0	0.0	6.0	0.0	0.1	0.4	0.2	0.9	12.5	0.7	5.0	0.0	0.3	0.0	3.4	0.1	0.0	0.2	0.1	0.1	35.4	0.7	0.0	5.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.1	0.0	0.1	0.7	0.7	0.0	0.5	0.2	23.3	0.1	0.0	0.0	0.0	26.2	0.1	0.0	0.8	0.1	0.2	0.1	0.1	0.7	0.0	1.3	0.0	0.1	0.1	0.4	0.0	20.6	0.0	0.9	0.2	1.9	0.5	0.2	0.1	0.3	0.4	0.1	12.7	0.0	1.8	0.0	1.5	0.3	0.4	0.7	0.5	0.5	0.5	0.5	1.8	0.0	1.0	0.7
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell adhesion"		"Cancer-related genes, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 17.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		19000000	"Plasma membrane"		"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.4	1.4	0.3	0.0	0.1	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CEACAM8	"CD66b, CGM6"	ENSG00000124469	"Carcinoembryonic antigen related cell adhesion molecule 8"	P31997	19	42580241-42595055	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 71.0;placenta: 35.6"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 4.2;monocytes: 3.0"									CAB033676	Approved				"Intracellular and membrane"		15000000			"CAB033676: AB_1125678"		"unprognostic (2.01e-1)"	"unprognostic (4.52e-2)"		"unprognostic (3.31e-1)"			"unprognostic (6.30e-2)"		"unprognostic (2.68e-1)"	"unprognostic (1.62e-1)"		"unprognostic (1.71e-2)"	"unprognostic (7.77e-2)"		"unprognostic (9.62e-2)"		0.2	0.0	0.1	0.0	0.1	71.0	0.1	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.6	0.1	0.1	0.1	0.4	4.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	35.6	0.1	0.0	0.1	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.1	10.1	0.0	0.1	0.1	1.9	0.1	0.0	0.0	0.0	0.7	0.5	0.1	4.2	3.0	0.6	0.4	4.1	0.8	0.2	1.1	2.1	0.0	0.5	0.3	1.3	0.0	0.0	0.1	0.2	0.4	1.2	0.3	0.5	0.5	0.0	0.3	0.0	0.2	0.3	0.5	0.7	0.7	0.1	0.8	0.6	0.0	0.1	0.1	0.1	0.0	0.7	1.5	0.0	0.3	0.4	0.9	0.5	0.1	0.5	0.5	1.3	0.4	0.5	0.7	0.8	0.1	0.3	1.2	1.3	0.9	0.8	1.4	0.3	1.5	0.5	1.5	1.3	0.7	0.8	1.3	0.7	0.6	0.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.5	0.3	0.4	4.2	0.6	3.0	0.1	0.1	4.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: "	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavourable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	18.4	22.8	28.3	19.9	30.8	25.8	22.7	49.5	29.8	17.8	20.7	16.6	22.9	14.7	22.9	20.1	21.5	19.0	16.5	19.3	18.7	14.1	18.5	36.5	21.0	24.0	12.8	20.2	18.9	19.2	54.3	19.6	18.2	14.6	16.3	17.7	18.4	18.0	19.7	45.4	20.1	20.1	31.4	11.9	22.3	17.9	20.4	17.7	15.8	19.5	17.0	24.6	20.6	23.8	15.4	12.4	20.6	15.5	7.0	16.1	8.0	17.6	31.4	26.2	26.8	20.6	22.0	22.3	19.0	19.7	24.0	25.2	26.7	21.0	46.7	13.3	20.4	26.5	40.4	27.0	40.5	19.5	17.7	14.3	41.3	19.0	20.0	22.4	15.9	16.9	16.6	26.1	31.8	21.9	26.9	19.1	15.3	23.6	23.1	18.0	36.6	18.6	23.9	20.9	18.3	20.7	31.7	24.6	20.8	25.3	23.5	15.4	33.2	14.9	25.1	27.5	27.1	26.2	25.7	16.4	14.9	37.2	22.2	10.8	22.3	10.9	10.8	20.6	12.8	9.6	16.1	14.6	13.5	14.5	12.4	15.4	14.7	12.1	14.6	7.0	15.5	7.7	9.2	8.0	28.3	30.8	49.5	29.8	18.7	14.1	12.8	20.2	14.6	17.7
CELSR3	"ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2"	ENSG00000008300	"Cadherin EGF LAG seven-pass G-type receptor 3"	Q9NYQ7	3	48636469-48662915	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.7;pituitary gland: 11.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 12.9;SH-SY5Y: 14.7;SiHa: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062866	Approved									"HPA062866: "	"unprognostic (7.80e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.89e-1)"	"unprognostic (9.12e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-6)"	"unprognostic (3.61e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.46e-3)"	"unprognostic (5.07e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.87e-3)"	"unprognostic (3.26e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.73e-1)"	0.7	4.0	10.9	1.2	8.3	1.7	0.8	19.7	11.1	0.6	1.3	0.0	0.0	1.2	0.8	1.2	0.6	0.7	0.7	0.5	7.1	1.4	0.6	0.6	0.8	1.4	2.0	10.4	0.9	2.6	1.4	11.2	1.0	3.6	0.7	1.2	1.4	0.6	0.8	0.5	1.2	1.3	0.8	3.3	1.0	2.1	5.4	1.4	0.0	0.9	0.0	1.0	0.7	0.7	0.3	0.1	0.0	0.1	0.2	1.5	0.4	3.8	2.9	4.8	2.8	0.6	0.9	1.2	0.2	0.5	0.6	0.9	5.4	2.9	0.8	0.7	0.2	0.4	1.5	0.2	0.3	12.9	0.8	1.3	11.1	1.9	0.9	1.2	2.1	0.4	3.8	0.3	6.9	0.0	0.5	3.9	0.9	4.1	0.1	0.0	2.7	1.3	0.3	0.7	4.0	0.0	2.6	10.8	14.7	12.9	0.3	0.5	6.4	2.5	0.0	4.8	4.6	6.2	2.3	0.3	7.0	3.4	3.4	0.9	7.4	0.0	0.1	0.0	1.0	0.0	0.2	0.3	0.2	0.2	0.1	0.0	0.3	1.5	0.0	0.2	0.0	0.0	1.1	0.4	10.9	8.3	19.7	11.1	7.1	1.4	2.0	10.4	3.6	1.4
CEMIP	"HYBID, IR2155535, KIAA1199, TMEM2L"	ENSG00000103888	"Cell migration inducing hyaluronan binding protein"	Q8WUJ3	15	80779343-80951776	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"endometrium 1: 33.9;lymphoid tissue: 116.9"	"Group enriched"	"Detected in some"	5	"BJ: 43.3;BJ hTERT+: 68.5;fHDF/TERT166: 54.4;HSkMC: 37.4;U-138 MG: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"		560000				"unprognostic (1.14e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.49e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.27e-10)"	"unprognostic (1.82e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (2.65e-4)"	6.7	2.1	1.7	11.6	5.0	1.7	1.0	6.8	8.9	2.4	6.9	6.4	2.6	1.2	33.9	7.8	7.1	7.0	2.8	6.4	2.2	2.8	1.1	1.0	16.6	116.9	14.1	9.4	5.3	1.4	0.7	9.1	2.9	15.6	2.5	2.4	15.4	5.9	3.2	4.3	6.2	1.6	0.9	13.6	2.0	1.3	3.3	1.1	0.0	4.4	0.7	5.0	6.5	3.1	0.9	1.5	0.6	0.5	0.2	1.3	0.2	0.1	1.6	0.3	0.2	0.1	0.6	0.2	43.3	68.5	1.1	0.9	0.5	0.2	0.2	0.1	54.4	1.0	0.0	0.1	0.2	0.1	0.4	0.1	0.2	3.5	0.4	0.1	0.2	37.4	0.0	8.5	0.0	0.0	0.2	0.1	1.0	0.9	0.1	0.1	0.2	1.9	0.2	0.0	0.1	0.0	0.7	2.7	0.1	0.7	0.1	3.6	0.2	0.0	0.2	19.8	0.2	1.4	0.7	0.1	0.1	0.2	2.1	0.3	1.3	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.2	0.0	0.9	0.0	0.7	0.6	0.2	0.5	1.5	1.3	0.2	1.7	5.0	6.8	8.9	2.2	2.8	14.1	9.4	15.6	1.1
CENPE	"KIF10, PPP1R61"	ENSG00000138778	"Centromere protein E"	Q02224	4	103105806-103198409	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Developmental protein, Motor protein"	"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.3;lymphoid tissue: 25.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA042294	Enhanced		Approved	Nucleoplasm,Microtubules,Cytosol				"Microtubules, Cytosol"	Nucleoplasm	"HPA042294: AB_10797386"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.64e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.40e-8)"	"unprognostic (2.49e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.88e-5)"	"unprognostic (1.15e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.95e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-1)"	2.7	0.9	0.6	9.4	1.5	11.3	0.7	0.2	1.3	1.0	2.1	0.5	0.0	1.9	0.7	1.9	5.9	0.5	0.8	2.5	2.0	0.8	1.3	0.6	1.4	7.3	1.9	0.6	0.7	0.5	0.1	0.4	3.1	1.4	0.7	2.7	0.2	2.2	0.8	0.4	2.2	2.4	1.4	1.3	3.3	1.6	6.6	0.6	25.1	0.6	5.9	6.4	1.5	1.9	0.6	0.5	5.7	3.0	0.8	1.4	0.2	20.6	5.9	21.6	10.4	1.5	3.3	4.2	18.8	9.4	14.0	9.4	9.3	11.2	14.0	4.8	6.9	9.2	15.4	7.6	22.2	17.5	5.7	16.5	12.4	6.7	0.2	19.5	9.6	1.0	0.5	11.3	9.5	11.8	17.0	16.8	18.1	7.5	15.3	8.8	6.9	9.3	10.3	20.2	4.6	3.9	4.1	10.0	5.9	16.7	11.6	4.5	6.6	6.9	12.8	13.6	14.3	14.1	19.2	8.2	14.0	14.5	7.5	10.9	14.4	5.7	0.1	0.7	0.2	0.6	0.0	0.6	0.4	0.4	0.2	0.2	0.1	0.3	0.1	0.8	3.0	0.5	1.4	0.2	0.6	1.5	0.2	1.3	2.0	0.8	1.9	0.6	1.4	0.6
CENPF	hcp-1	ENSG00000117724	"Centromere protein F"	P49454	1	214603195-214664588	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, DNA synthesis, Mitosis, Myogenesis"	"Developmental protein"	"Cancer-related genes, Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 19.5;lymphoid tissue: 67.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA052382, HPA064308, CAB070134"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB070134: AB_2229328, HPA052382: , HPA064308: "	"unprognostic (2.80e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (2.29e-5)"	"unprognostic (1.13e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.89e-2)"	"unprognostic (4.12e-1)"	1.6	1.5	1.0	10.7	1.3	19.5	1.1	0.4	0.9	2.1	5.6	0.3	0.0	4.6	1.2	1.7	9.4	0.8	0.4	1.7	0.6	0.6	1.0	0.8	3.2	6.2	0.6	0.5	1.4	0.6	0.0	0.4	6.4	0.8	0.7	4.5	0.4	1.9	0.0	0.5	4.7	6.4	1.6	1.5	3.8	2.3	9.4	0.6	67.5	0.6	7.6	7.6	1.4	2.9	0.3	0.3	0.0	0.0	0.7	1.9	0.2	32.2	18.3	39.5	20.6	1.5	2.0	15.4	20.0	8.2	12.0	11.9	14.5	20.0	30.8	11.9	11.1	20.1	24.3	13.1	20.5	26.8	15.3	25.3	28.1	20.7	0.2	35.7	13.8	0.7	1.0	17.3	20.0	12.6	22.7	18.4	21.5	12.3	21.1	14.3	35.0	8.1	22.5	55.8	10.1	11.8	8.0	18.5	25.2	27.0	18.0	10.4	21.5	13.7	16.5	21.9	25.8	18.1	41.3	14.2	15.3	29.6	9.5	25.8	19.3	0.0	0.0	0.0	0.4	0.0	0.1	0.2	1.4	0.4	0.3	0.3	1.9	0.8	0.0	0.7	0.0	0.3	1.7	0.2	1.0	1.3	0.4	0.9	0.6	0.6	0.6	0.5	0.8	0.6
CEP104	"CFAP256, GlyBP, JBTS25, KIAA0562, ROC22, RP1-286D6.4"	ENSG00000116198	"Centrosomal protein 104"	O60308	1	3812081-3857214	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010126	Approved									"HPA010126: AB_10601583"	"unprognostic (3.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.49e-3)"	"unprognostic (8.35e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.90e-1)"	"unprognostic (2.89e-1)"	"prognostic favourable (1.70e-5)"	"unprognostic (7.06e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-1)"	15.9	20.2	15.5	11.3	22.7	8.9	13.2	21.9	18.8	14.0	13.6	28.5	14.6	11.3	14.4	17.7	17.0	15.8	10.5	14.6	17.5	14.9	21.1	17.9	15.6	14.8	26.4	8.8	16.8	19.4	29.6	25.1	12.4	21.6	14.5	13.7	23.5	14.8	19.6	18.4	16.1	14.2	16.6	23.6	13.4	14.3	24.2	23.2	19.8	17.9	7.9	16.9	17.3	15.7	4.6	4.0	8.8	2.6	3.2	4.2	0.8	13.1	13.5	7.9	12.8	20.8	13.6	6.2	10.9	8.8	14.8	10.5	10.3	12.6	13.1	15.7	11.9	12.9	16.7	14.3	18.9	16.4	16.2	12.1	17.8	16.7	16.4	13.6	12.8	9.4	14.0	17.0	24.9	14.7	15.1	15.9	14.0	12.2	18.7	7.3	4.8	16.4	13.4	13.4	15.2	9.5	9.3	21.1	5.6	16.8	20.7	13.2	9.3	4.1	11.6	11.9	5.5	22.4	8.8	15.5	17.3	16.7	6.4	13.9	4.4	8.8	2.6	5.2	4.2	2.3	3.3	2.8	3.0	2.9	1.5	4.6	2.6	2.3	3.8	3.2	1.5	4.0	2.9	0.8	15.5	22.7	21.9	18.8	17.5	14.9	26.4	8.8	21.6	23.2
CEP131	"AZ1, AZI1, KIAA1118"	ENSG00000141577	"Centrosomal protein 131"	Q9UPN4	17	81189593-81222999	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation, Differentiation, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024019	Approved		Supported	"Microtubules,Cytokinetic bridge,Centriolar satellite"				"Microtubules, Cytokinetic bridge, Centriolar satellite"		"HPA024019: AB_1845227"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavourable (9.68e-5)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (7.04e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.32e-3)"	8.4	8.3	8.9	15.7	9.2	18.8	7.7	23.5	11.7	7.0	6.1	10.7	5.6	10.4	10.6	9.0	7.2	7.9	11.1	8.5	9.0	7.8	8.0	4.4	8.9	15.2	6.9	8.4	10.0	9.1	4.6	11.6	9.4	8.3	8.1	2.7	9.7	12.5	5.7	18.0	15.4	9.1	9.5	7.8	18.2	10.7	23.7	9.3	15.6	9.0	4.5	10.4	7.0	7.8	5.1	3.8	4.0	7.4	1.9	2.6	1.3	11.0	10.8	5.8	10.5	1.0	1.5	18.4	7.7	1.3	5.7	4.4	12.7	5.6	7.9	4.4	1.9	8.0	1.7	3.8	1.3	3.2	14.8	7.6	16.6	21.6	1.6	6.5	16.9	1.3	2.6	4.1	1.1	4.0	5.4	4.7	1.4	12.5	15.0	12.7	5.1	9.6	15.3	6.7	3.3	2.1	9.8	13.3	15.0	9.9	6.2	9.4	9.4	6.5	5.3	10.3	17.9	9.1	10.1	12.1	2.0	5.9	5.3	5.7	7.3	4.0	1.6	1.0	2.6	4.3	0.8	5.1	1.5	2.1	3.5	3.7	2.2	1.6	2.5	1.9	7.4	3.8	0.2	1.3	8.9	9.2	23.5	11.7	9.0	7.8	6.9	8.4	8.3	9.3
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073950			Uncertain	"Focal adhesion sites"				"Focal adhesion sites"		"HPA073950: "	"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (6.11e-5)"	5.5	3.0	2.9	13.8	6.0	12.8	5.2	5.1	5.3	8.5	4.6	3.1	7.5	4.3	12.8	4.5	4.7	7.4	4.5	3.4	5.3	3.4	5.7	2.9	7.0	13.0	5.8	3.9	9.6	4.5	4.1	6.9	8.1	4.5	4.4	4.6	2.5	3.7	5.9	2.3	5.4	6.2	7.1	5.5	11.1	3.6	9.3	4.6	27.1	5.0	4.5	10.1	4.8	5.6	9.2	8.7	11.9	4.4	7.1	7.5	2.0	6.9	3.8	10.6	9.9	2.2	4.2	4.5	6.9	4.8	6.3	7.4	4.2	7.2	18.6	5.2	3.1	3.3	11.0	4.3	12.0	5.1	7.0	6.5	5.6	3.7	2.4	11.7	10.3	3.2	3.3	8.0	5.7	5.2	11.9	9.0	6.4	4.1	16.4	7.3	6.7	4.1	12.0	5.0	3.8	4.5	5.1	7.7	8.0	6.1	4.2	5.0	5.6	7.6	5.1	8.6	14.1	10.2	12.0	4.9	3.4	12.7	4.3	9.3	10.5	11.9	3.4	4.2	4.7	4.1	4.3	4.6	6.0	4.5	2.1	9.2	7.5	4.8	7.0	7.1	4.4	8.7	3.7	2.0	2.9	6.0	5.1	5.3	5.3	3.4	5.8	3.9	4.5	4.6
CEP152	"KIAA0912, MCPH9, SCKL5"	ENSG00000103995	"Centrosomal protein 152"	O94986	15	48712928-48811146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Disease mutation, Dwarfism, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039408	Approved		Supported	Centrosome				Centrosome		"HPA039408: AB_10795288"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.87e-4)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-2)"	"unprognostic (6.24e-3)"	"unprognostic (5.29e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.25e-1)"	4.0	3.0	3.5	10.1	5.5	21.4	4.8	9.9	10.3	3.7	6.9	0.9	5.4	4.7	3.3	3.4	5.5	3.3	3.0	4.4	4.5	1.5	7.1	2.4	4.4	6.3	3.3	1.6	5.5	6.0	2.4	5.8	9.0	4.7	3.5	5.1	1.8	5.1	6.9	1.7	4.7	7.9	3.3	9.0	6.1	4.1	15.8	4.8	18.4	6.2	2.4	7.1	3.7	7.6	5.3	4.4	6.0	4.1	3.6	3.3	1.4	4.7	3.6	7.5	9.1	1.3	2.5	4.8	8.3	3.5	6.2	7.6	7.8	4.0	10.9	3.6	2.4	11.2	8.4	3.0	9.1	9.6	5.1	17.6	18.5	4.2	0.9	14.7	8.3	0.9	2.4	6.8	4.0	4.5	10.6	13.3	5.2	2.6	10.8	13.8	4.7	3.7	13.3	10.1	13.5	2.2	4.6	9.0	6.0	6.5	5.4	2.5	4.1	7.2	3.6	15.2	8.0	11.7	9.2	5.6	6.2	12.8	4.9	21.5	10.6	4.5	3.2	5.3	2.7	4.1	2.3	2.9	3.0	2.8	2.4	5.3	3.3	3.3	6.0	3.6	4.1	4.4	3.1	1.4	3.5	5.5	9.9	10.3	4.5	1.5	3.3	1.6	4.7	4.8
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227635	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	5.9	4.3	4.2	5.3	6.0	3.8	5.4	9.4	7.8	6.4	6.3	4.8	6.6	2.1	9.1	4.4	4.1	7.2	5.2	4.0	4.5	2.6	7.7	2.6	5.3	4.6	4.8	3.2	7.9	4.1	9.6	19.1	4.5	5.8	4.7	4.9	2.7	5.5	4.6	4.1	4.1	4.2	6.4	7.6	5.8	4.9	14.4	6.4	11.6	7.7	2.1	4.2	7.3	5.4	2.5	1.8	2.2	1.3	0.1	2.6	0.8	2.9	1.3	8.7	9.5	5.2	7.8	5.5	3.3	3.2	4.7	5.8	3.8	4.0	3.2	3.2	2.6	4.6	5.1	3.1	7.5	8.0	3.5	5.8	5.9	2.8	2.9	6.2	5.6	3.6	2.3	4.8	1.8	5.2	11.7	3.7	3.4	1.5	1.6	4.0	5.7	2.0	8.9	11.2	1.7	3.5	2.7	6.0	7.5	2.3	1.4	2.5	3.1	4.6	4.2	4.7	4.2	4.1	3.7	2.9	3.9	1.9	2.9	3.4	5.8	0.0	1.3	1.5	1.9	1.2	2.6	2.5	1.5	1.7	0.7	1.6	1.2	2.0	2.2	0.1	1.0	1.8	0.3	0.8	4.2	6.0	9.4	7.8	4.5	2.6	4.8	3.2	5.8	6.4
CEP250	"C-NAP1, CEP2"	ENSG00000126001	"Centrosomal protein 250"	Q9BV73	20	35455164-35519280	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cilium biogenesis/degradation"		"Cone-rod dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064875			Supported	Centrosome				Centrosome		"HPA064875: "	"unprognostic (6.35e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.60e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (9.27e-6)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (1.30e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.57e-2)"	7.2	8.3	15.2	12.9	23.6	20.0	6.3	35.1	19.7	9.9	8.3	12.0	13.1	7.2	11.4	9.8	9.8	12.8	7.7	6.5	10.8	12.7	6.0	5.3	7.3	21.7	10.6	11.3	15.6	7.7	19.0	17.8	6.7	11.5	11.9	8.9	11.2	10.3	9.8	8.8	13.4	9.6	10.3	11.8	17.4	7.9	18.5	14.7	12.2	8.3	6.2	14.1	10.2	9.4	6.0	12.7	14.8	2.2	6.4	10.0	4.0	13.2	15.4	7.5	14.0	11.4	10.4	11.5	6.6	7.3	10.5	8.3	20.6	10.9	14.2	8.9	9.4	14.7	8.1	20.0	11.8	2.6	3.2	26.7	11.5	18.9	6.9	13.0	14.8	7.4	12.2	17.8	25.3	10.7	9.2	13.6	17.8	6.8	15.9	13.2	5.2	17.5	9.3	21.8	3.9	10.0	15.1	10.4	11.3	18.0	12.5	8.6	8.6	11.4	17.2	47.5	12.4	17.6	9.6	4.8	5.2	13.2	25.8	8.8	8.0	14.8	1.7	4.5	10.0	2.2	6.3	5.4	4.3	8.0	3.7	6.0	5.2	5.7	0.7	6.4	1.4	12.7	4.5	4.0	15.2	23.6	35.1	19.7	10.8	12.7	10.6	11.3	11.5	14.7
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome				Centrosome		"CAB079754: , HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: "	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.7	9.3	12.0	4.2	10.2	9.5	11.2	8.7	11.7	7.5	8.3	10.3	7.7	14.2	9.5	7.8	15.8	9.0	5.0	9.9	13.7	6.2	10.1	11.7	6.4	11.2	19.9	9.5	9.4	7.9	9.8	12.9	9.2	19.5	10.8	8.1	9.4	11.6	5.6	11.2	2.3	10.1	13.2	10.9	5.3	26.7	8.4	9.0	14.5	9.8	16.6	10.6	17.9	9.3	10.7	7.5	9.4	9.2	18.9	23.8	27.8	5.0	8.6	15.9	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5
CEP57	"KIAA0092, Translokin, TSP57"	ENSG00000166037	"Centrosomal protein 57"	Q86XR8	11	95789965-95832693	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018315	Approved		Supported	Microtubules,Cytosol	"Intracellular and membrane"			Microtubules	Cytosol	"HPA018315: AB_1846537"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (7.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.04e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.69e-3)"	"unprognostic (3.25e-1)"	16.8	13.7	12.9	25.9	20.6	21.6	17.4	27.9	16.2	25.6	33.8	6.9	19.2	27.0	18.5	18.8	18.2	16.5	22.9	14.0	13.3	14.1	14.9	34.4	19.0	28.9	12.6	15.2	27.2	24.5	13.6	26.1	13.3	15.0	21.5	15.6	10.5	14.1	22.3	12.6	15.8	28.8	22.2	14.6	19.8	15.3	24.3	12.7	46.5	23.4	15.7	23.9	27.5	18.3	17.2	15.5	17.6	11.0	18.6	25.3	13.0	11.2	5.6	19.4	14.4	8.3	17.1	15.4	12.8	20.6	17.7	20.1	20.1	24.2	20.3	17.9	9.5	19.0	14.6	12.7	18.8	15.9	9.7	27.9	16.3	16.7	15.3	28.3	16.9	11.5	18.1	18.1	34.9	14.7	18.0	11.2	14.1	5.5	30.6	37.4	9.9	12.8	19.1	23.2	17.0	14.9	12.5	9.3	13.5	15.2	15.1	16.1	15.4	18.4	8.2	15.5	12.5	22.7	12.2	8.2	16.0	22.7	6.4	31.6	13.4	11.3	9.1	17.6	16.5	11.0	21.2	17.2	21.0	18.8	11.9	16.2	20.2	19.2	8.5	18.6	9.1	15.5	25.3	13.0	12.9	20.6	27.9	16.2	13.3	14.1	12.6	15.2	15.0	12.7
CEP70	"BITE, FLJ13036"	ENSG00000114107	"Centrosomal protein 70"	Q8NHQ1	3	138494344-138594538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"gdT-cell: 4.2;MAIT T-cell: 5.0;memory B-cell: 2.9;memory CD4 T-cell: 3.4;memory CD8 T-cell: 3.7;naive B-cell: 2.0;naive CD4 T-cell: 5.9;naive CD8 T-cell: 6.4;NK-cell: 3.6;T-reg: 2.0"	"Group enriched"	"Detected in many"	8	"B-cells: 2.9;NK-cells: 3.6;T-cells: 6.4"	"Low region specificity"	"Detected in all"							"HPA036941, HPA036942"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"HPA036941: AB_10670567, HPA036942: AB_10670957"	"unprognostic (1.61e-1)"	"prognostic favourable (2.93e-4)"	"unprognostic (2.27e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.95e-2)"	"unprognostic (9.92e-3)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (5.01e-3)"	"prognostic unfavourable (9.60e-5)"	"unprognostic (8.90e-3)"	"unprognostic (8.07e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.71e-3)"	"unprognostic (6.43e-2)"	5.5	8.3	11.0	5.7	15.8	3.5	9.0	14.7	15.6	20.8	12.2	7.1	22.8	35.7	14.0	14.8	10.2	20.3	8.9	11.3	10.9	15.9	17.0	18.8	11.5	4.2	12.6	10.2	14.4	17.4	16.6	27.8	2.7	14.4	14.3	12.1	12.6	6.1	28.7	10.6	4.6	11.5	14.0	19.1	3.9	8.6	41.5	15.3	24.2	26.2	6.7	4.5	13.3	9.1	2.9	0.2	0.5	0.1	3.6	6.4	2.0	21.5	4.5	10.6	13.0	6.6	7.5	10.0	4.2	8.1	5.9	8.8	6.3	11.7	5.1	10.2	8.0	9.5	9.7	8.5	13.5	8.9	6.3	14.6	10.5	8.2	10.5	0.7	5.4	40.2	5.0	4.5	11.2	8.6	10.6	17.1	9.7	8.1	15.3	0.8	6.3	10.2	16.9	13.8	13.1	11.4	9.6	13.0	8.4	22.5	5.4	25.4	27.0	7.0	5.0	4.4	8.4	9.0	5.2	15.9	8.7	17.3	9.8	1.4	14.9	0.4	0.1	0.2	4.2	0.1	5.0	2.9	3.4	3.7	0.1	2.0	5.9	6.4	0.5	3.6	0.0	0.2	2.0	2.0	11.0	15.8	14.7	15.6	10.9	15.9	12.6	10.2	14.4	15.3
CES1	"CEH, CES1A1, CES1A2, CES2, HMSE, HMSE1, SES1"	ENSG00000198848	"Carboxylesterase 1"	P23141	16	55802851-55833337	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 355.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 93.9;THP-1: 101.2"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 711.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	18	"classical monocyte: 32.6;myeloid DC: 32.9"	"Group enriched"	"Detected in many"	20	"dendritic cells: 32.9;monocytes: 32.6"	"Not detected"	"Not detected"							"HPA012023, HPA046717"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		40000000	"Endoplasmic reticulum"		"HPA012023: AB_1846554, HPA046717: AB_2679770"	"unprognostic (1.04e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.51e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.62e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (9.92e-4)"	27.1	1.7	0.3	0.5	0.4	2.1	24.7	0.4	0.6	3.1	8.9	0.5	1.5	2.4	7.3	2.1	4.5	6.7	57.7	8.1	0.3	0.0	0.7	355.0	19.8	2.3	0.3	0.6	3.9	1.3	0.0	0.8	1.1	0.6	11.2	1.0	3.8	3.9	4.0	1.6	1.4	3.5	10.2	0.7	4.4	7.0	1.0	0.3	0.4	1.7	2.3	1.5	8.2	16.1	0.2	32.9	0.2	32.6	0.1	1.6	12.1	0.0	0.6	0.0	0.0	14.1	0.0	0.4	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	101.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	20.3	0.0	0.0	32.6	0.1	1.3	1.8	0.5	0.2	0.2	1.6	32.9	0.2	0.2	0.4	0.2	0.1	0.4	1.7	0.1	12.1	0.3	0.4	0.4	0.6	0.3	0.0	0.3	0.6	0.6	0.3
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Cell line enhanced"	"Detected in some"		"HEL: 5.1;HUVEC TERT2: 8.6;TIME: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	2470000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	0.9	1.0	1.6	0.0	0.1	0.0	0.1	0.0	0.0	8.6	0.0	0.8	0.1	0.0	0.0	1.7	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"liver: 461.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.0;ASC TERT1: 5.8;CAPAN-2: 6.9;fHDF/TERT166: 11.3;HSkMC: 18.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	878700000	180000000000	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: , HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favourable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	9.3	1.0	0.3	4.1	0.4	0.3	2.4	0.2	0.4	1.3	9.0	0.4	0.9	3.2	0.5	3.7	2.2	4.0	8.9	3.3	0.2	0.0	16.1	461.5	2.5	2.1	0.7	0.1	2.8	5.8	0.4	1.0	4.0	1.0	4.0	1.6	2.6	3.1	0.3	0.5	0.5	4.7	2.6	0.6	0.8	4.1	1.4	0.3	0.3	1.8	0.5	1.7	1.6	0.4	0.1	1.6	0.0	0.8	0.0	0.2	0.0	0.0	1.8	0.1	0.1	6.0	5.8	0.0	0.0	0.3	1.5	0.6	0.0	6.9	0.1	5.1	11.3	0.0	0.0	1.9	1.4	0.4	0.3	0.4	0.3	0.5	0.0	0.7	0.1	18.7	0.1	0.9	0.6	0.2	0.2	0.7	0.1	0.1	0.1	0.4	0.3	0.1	0.2	0.4	0.2	1.6	0.0	0.0	0.0	0.5	1.2	0.2	0.0	0.2	0.0	0.2	0.5	0.3	0.3	0.5	1.9	0.5	3.1	0.5	0.5	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.3	0.4	0.2	0.3	0.2	0.0	0.7	0.1	1.0	0.3
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859643-863630	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"ASC diff: 39.8;THP-1: 56.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 125.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	731723333	8000000000				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	161.3	4.6	0.0	16.4	0.0	5.6	96.7	0.0	1.7	44.2	35.2	0.2	42.2	10.9	8.9	89.8	54.1	15.6	59.0	102.0	0.0	0.0	1.9	2.3	34.0	6.2	0.0	0.0	13.7	6.0	1.7	0.1	20.2	0.1	102.0	4.3	3.4	22.7	15.1	40.5	35.8	16.5	97.3	0.1	3.7	19.7	33.6	0.0	0.8	52.6	55.6	9.0	83.7	130.3	0.6	5.6	125.0	25.8	0.1	1.0	10.4	0.7	1.9	0.0	0.3	39.8	6.2	2.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.5	0.2	0.0	0.0	1.1	2.8	0.0	1.7	0.6	0.6	0.3	1.0	6.3	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.9	0.0	8.9	0.1	2.8	0.2	0.0	0.9	0.0	0.1	0.3	0.3	0.8	0.2	0.0	1.1	56.5	0.0	0.0	0.9	0.4	0.1	1.7	0.7	0.0	0.0	3.3	0.0	125.0	18.2	58.8	0.7	20.1	1.0	0.6	0.5	0.9	5.6	0.2	0.7	0.8	43.2	0.1	25.8	0.5	0.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651878-196747504	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 295.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 25.2;HHSteC: 31.8;HSkMC: 31.0;RH-30: 23.2;RT4: 56.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 151.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 16.5"	"Lineage enriched"	"Detected in single"	27	"T-cells: 16.5"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	395836666667	110000000000	Vesicles		"CAB016385: AB_627572, CAB016769: , HPA038922: , HPA049176: , HPA053326: "	"unprognostic (2.40e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-3)"	"unprognostic (7.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.92e-6)"	"unprognostic (6.50e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-1)"	28.6	5.5	1.6	3.7	3.8	0.1	8.8	2.6	2.7	10.4	9.1	1.0	3.9	3.7	2.5	8.7	15.2	3.4	17.0	47.3	2.0	1.2	7.0	295.2	11.0	10.3	5.3	1.7	40.9	1.9	1.7	4.3	5.1	5.3	10.3	10.4	6.3	19.0	3.3	10.0	11.5	8.1	12.6	4.2	3.3	5.8	6.4	2.9	0.7	22.0	22.8	5.8	17.2	16.8	0.0	0.1	0.6	0.1	0.0	16.5	1.0	0.0	16.1	0.0	0.0	25.2	14.3	0.0	6.5	15.9	0.9	3.5	0.0	3.0	0.0	2.4	0.0	0.5	0.0	5.9	0.6	0.3	0.0	4.8	19.1	0.0	31.8	0.2	0.0	31.0	0.1	4.7	2.0	19.8	18.1	0.6	22.5	0.0	0.1	0.0	0.1	0.0	0.0	23.2	5.1	0.0	56.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	19.2	0.2	0.2	0.2	0.2	0.0	0.0	3.4	0.0	1.4	0.0	0.1	0.0	1.8	0.0	16.5	0.0	6.0	3.5	0.1	0.0	0.4	1.4	0.6	0.0	0.0	0.0	0.0	1.0	1.6	3.8	2.6	2.7	2.0	1.2	5.3	1.7	5.3	2.9
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819757-196832189	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	174	"liver: 218.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.6;HeLa: 3.1;HL-60: 4.7;U-266/70: 6.2"	"Cancer enriched"	"Detected in single"	798	"liver cancer: 182.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"		15000000000	Vesicles		"HPA038915: , HPA038922: , HPA040726: "	"unprognostic (2.28e-1)"	"unprognostic (3.18e-1)"			"unprognostic (3.50e-2)"	"unprognostic (1.88e-2)"	"prognostic favourable (8.71e-6)"	"unprognostic (3.02e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.48e-2)"		"unprognostic (7.21e-4)"	"unprognostic (7.01e-4)"	"unprognostic (1.13e-1)"		"unprognostic (6.41e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	218.9	0.0	0.5	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.3	0.2	2.6	1.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	1.6	3.1	0.2	0.2	4.7	0.8	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.8	0.0	1.4	0.0	0.8	0.0	0.8	2.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.2	0.4	0.0	1.4	0.9	0.4	0.2	0.2	6.2	0.0	1.1	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1										
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943772-196959226	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1462	"liver: 146.2"	"Cell line enhanced"	"Detected in some"		"HEL: 2.8;TIME: 1.2"	"Cancer enriched"	"Detected in single"	175	"liver cancer: 8.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"		5700000000			"HPA038915: , HPA040726: , HPA049813: "							"unprognostic (1.25e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	146.2	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774795-196795406	"Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	171	"liver: 121.9"	"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;T-47d: 6.8;U-266/70: 12.4"	"Cancer enriched"	"Detected in single"	80	"liver cancer: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"	582000000	3800000000				"unprognostic (1.73e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.77e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.20e-3)"	"prognostic favourable (2.86e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.11e-3)"	"unprognostic (2.06e-10)"	"unprognostic (2.67e-4)"	"unprognostic (3.00e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.32e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	121.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.4	0.0	0.6	0.2	0.1	1.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.5	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	3.3	0.0	0.0	0.4	0.5	0.0	1.3	0.0	0.0	0.0	0.7	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	12.4	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.2	0.3	0.4	0.6	0.1	0.5	0.3	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196850241-196918972	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	188	"liver: 61.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;RPMI-8226: 2.0;U-2197: 2.5;U-266/70: 4.9;U-266/84: 2.0"	"Cancer enriched"	"Detected in single"	145	"liver cancer: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to blood"		180000000									"unprognostic (5.97e-1)"	"prognostic favourable (1.57e-6)"	"unprognostic (1.89e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.26e-1)"				"unprognostic (1.68e-2)"			"unprognostic (4.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	61.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	2.5	0.0	4.9	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196977556-197009674	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	241	"liver: 85.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	396	"liver cancer: 57.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038915, HPA040726"	Supported				"Secreted to blood"		1700000000			"HPA038915: , HPA040726: "							"unprognostic (9.12e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.6	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109740694-109802179	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 90.7;liver: 198.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 28.9;Hep G2: 45.8;HSkMC: 19.0;RPTEC TERT1: 51.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"		11000000000			"CAB016777: , HPA001143: AB_1078555, HPA024061: AB_1847129"	"unprognostic (1.04e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.61e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (6.06e-4)"	9.5	13.2	1.5	2.3	1.4	0.0	3.9	0.9	2.5	5.0	4.1	1.1	2.9	4.9	5.0	12.0	4.4	9.7	9.3	6.2	1.6	0.8	90.7	198.4	7.2	3.1	1.8	0.7	10.6	7.6	0.5	3.8	3.2	2.6	3.9	0.7	6.8	3.6	3.6	1.4	0.5	4.6	3.0	3.0	7.8	1.7	3.6	1.6	0.5	5.3	2.3	1.4	3.8	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.0	0.0	0.0	28.9	0.0	9.2	0.0	0.0	0.0	0.0	0.0	9.7	0.3	0.0	0.1	45.8	2.0	0.0	0.0	19.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.2	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	0.9	2.5	1.6	0.8	1.8	0.7	2.6	1.6
CFL1	CFL	ENSG00000172757	"Cofilin 1"	P23528	11	65823022-65862026	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033687, CAB037077, HPA053761"	Approved						470000000			"CAB033687: AB_1121774, CAB037077: AB_1078547, HPA053761: "	"unprognostic (1.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (1.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.57e-3)"	"unprognostic (2.09e-1)"	"unprognostic (6.19e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.06e-1)"	95.5	58.2	107.4	126.1	98.4	164.2	64.2	88.0	157.9	60.6	162.4	100.1	42.3	167.5	95.9	54.2	89.3	63.7	90.1	60.0	112.0	88.7	98.3	136.6	86.3	128.0	93.3	66.0	57.0	35.0	49.5	47.2	86.0	94.3	56.6	146.0	54.6	60.7	73.0	37.3	63.1	194.0	119.7	104.7	148.2	90.3	43.7	66.6	185.1	54.1	70.8	150.2	78.9	59.0	93.6	199.7	167.7	182.9	108.6	160.6	310.0	147.5	119.6	135.8	105.7	83.8	86.5	72.0	152.5	140.1	179.7	107.8	68.2	127.5	109.4	120.9	202.4	113.9	98.3	146.0	134.7	114.1	45.2	141.5	92.3	76.5	89.1	122.4	203.4	95.2	103.0	152.4	79.4	191.3	62.6	116.1	189.3	140.3	183.6	201.2	145.2	91.7	136.5	62.8	147.3	134.0	96.6	64.5	143.7	81.3	123.1	114.9	147.0	97.7	153.5	149.0	114.0	188.2	144.8	83.8	128.8	148.0	154.0	77.8	139.3	85.0	154.1	165.2	160.6	172.7	125.1	93.6	128.8	144.9	199.7	88.9	96.6	126.1	167.7	108.6	182.9	152.3	155.9	310.0	107.4	98.4	88.0	157.9	112.0	88.7	93.3	66.0	94.3	66.6
CFL2	NEM7	ENSG00000165410	"Cofilin 2"	Q9Y281	14	34706769-34714823	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 88.5;skeletal muscle: 185.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037078, HPA045599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			90000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB037078: AB_259128, HPA045599: "	"unprognostic (1.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.59e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (2.16e-5)"	14.0	16.5	15.9	8.8	17.7	5.0	6.7	13.6	16.6	13.7	23.2	25.8	9.2	4.7	21.3	10.2	20.7	11.2	7.2	88.5	19.0	14.5	8.7	33.0	7.8	3.7	22.7	10.6	12.9	3.0	9.3	4.5	10.3	28.9	22.4	8.6	7.8	5.4	31.8	185.9	2.6	6.7	38.1	24.6	4.2	11.9	6.9	20.1	0.5	9.0	30.8	3.4	34.7	9.3	8.5	2.9	3.6	1.8	3.2	5.8	1.6	17.6	15.9	10.2	6.6	10.4	39.0	5.8	30.8	35.5	29.5	31.5	11.9	7.6	6.3	12.6	49.1	3.5	21.8	6.5	52.0	0.8	9.0	1.3	18.8	28.2	17.0	1.6	1.0	29.5	2.3	25.1	13.9	29.2	1.9	5.0	36.2	5.0	1.2	0.8	3.3	24.4	1.1	32.5	0.9	10.7	3.6	2.1	8.8	20.1	4.3	10.4	9.6	1.5	25.6	29.4	19.6	13.8	14.7	7.0	4.5	2.4	10.8	2.3	6.9	3.6	1.8	2.1	3.7	1.8	5.8	8.5	4.3	4.0	2.9	5.0	3.4	3.5	0.7	3.2	0.8	2.8	3.6	1.6	15.9	17.7	13.6	16.6	19.0	14.5	22.7	10.6	28.9	20.1
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 106.7;bone marrow: 39.4;lymphoid tissue: 41.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 20.7;HEL: 4.5;HMC-1: 5.1;NB-4: 9.9;U-937: 6.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"classical monocyte: 102.4;intermediate monocyte: 106.7;myeloid DC: 86.2;neutrophil: 64.3;non-classical monocyte: 70.6"	"Group enriched"	"Detected in many"	40	"dendritic cells: 86.2;granulocytes: 64.3;monocytes: 106.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"		8500000000				"unprognostic (2.77e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.15e-2)"	"unprognostic (9.66e-5)"	"unprognostic (9.90e-3)"	"unprognostic (1.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.17e-1)"	3.3	1.0	0.7	10.3	0.9	39.4	1.6	0.7	0.6	0.6	2.0	0.2	0.6	0.5	0.7	3.1	1.8	2.5	2.1	4.3	0.6	0.6	1.3	21.6	8.7	41.3	0.4	0.0	0.7	0.4	0.0	0.7	1.6	0.3	0.8	0.4	1.2	3.1	0.6	1.4	1.0	2.1	2.6	0.4	39.3	1.1	0.8	0.0	6.0	0.9	1.3	5.6	2.1	0.9	0.4	86.2	64.3	106.7	1.1	2.1	70.7	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.7	0.0	0.1	0.1	0.0	0.0	0.0	0.2	4.5	0.1	0.0	0.1	1.1	5.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	9.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.5	0.1	0.4	0.3	0.1	0.1	6.9	0.0	9.0	102.4	3.2	0.2	106.7	0.2	0.4	1.4	0.1	86.2	0.1	2.1	0.7	64.3	1.1	70.6	2.7	1.1	70.7	0.7	0.9	0.7	0.6	0.6	0.6	0.4	0.0	0.3	0.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"Cystic fibrosis transmembrane conductance regulator"	P13569	7	117465784-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 103.0"	"Group enriched"	"Detected in some"	22	"CACO-2: 12.5;MOLT-4: 47.0;U-266/70: 25.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"olfactory region: 6.3"	"CAB001951, HPA021939"	Enhanced									"CAB001951: , HPA021939: AB_1846578"	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.2	0.4	10.5	0.4	0.0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103.0	0.0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1
CGA	"FSHA, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095406	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"pituitary gland: 398.8;placenta: 489.3"	"Cell line enriched"	"Detected in some"	19	"BEWO: 105.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hypothalamus: 69.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"					"CAB023350: AB_617281, HPA029698: "	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	398.8	489.3	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.6	0.0	0.1	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	1.9	3.5	1.5	1.1	2.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	105.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.3	1.1	1.0	1.7	0.5	0.7	1.3	0.8	1.4	0.6	2.2	1.2	2.1	3.5	1.1	1.5	1.9	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.0;CACO-2: 37.3;CAPAN-2: 24.6;RT4: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			24000000	"Plasma membrane, Cell Junctions"		"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favourable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.7	1.3	1.1	1.9	0.0	0.0	15.0	0.0	0.0	0.3	0.4	37.3	24.6	0.5	4.0	0.0	11.2	3.6	2.1	0.2	7.0	2.5	1.0	0.5	0.8	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.1	0.5	3.6	0.0	10.8	2.0	0.2	9.6	1.0	2.2	1.2	1.7	7.9	18.1	3.8	1.9	0.7	11.4	0.4	14.1	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.3	2.1	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3
CGREF1	CGR11	ENSG00000138028	"Cell growth regulator with EF-hand domain 1"	Q99674	2	27098889-27119115	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 38.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008241, HPA071103"	Uncertain		Approved	"Golgi apparatus"	"Secreted in brain"		22000	"Golgi apparatus"		"HPA008241: AB_1846605, HPA071103: "	"unprognostic (1.39e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.18e-4)"	"unprognostic (8.45e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (5.22e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.30e-2)"	"unprognostic (7.24e-4)"	"unprognostic (1.20e-2)"	5.0	3.0	15.7	1.4	28.8	2.2	7.1	14.8	31.6	2.1	3.2	2.8	0.2	4.6	5.6	2.0	3.4	5.9	4.6	2.8	16.1	13.8	3.4	10.3	0.9	0.8	8.5	15.9	11.0	3.8	0.4	1.4	0.7	10.3	5.1	4.6	0.8	13.7	1.4	3.1	2.1	6.3	6.4	2.6	1.0	13.4	4.0	3.6	0.0	0.7	1.6	2.8	4.0	0.5	1.0	0.9	0.9	1.0	0.9	1.1	0.6	3.5	3.0	0.1	3.9	9.1	3.4	0.2	4.3	0.0	0.4	0.2	0.8	3.0	0.0	1.2	8.5	0.2	0.6	0.9	0.2	0.0	1.8	0.1	5.2	7.6	8.4	2.3	0.3	2.3	8.7	1.2	1.0	0.3	0.1	0.1	0.5	11.2	1.7	3.1	1.0	8.3	0.1	0.0	0.2	0.0	0.1	8.7	13.1	8.5	38.3	4.3	12.3	6.4	0.0	0.0	3.5	0.0	0.3	1.1	0.3	0.3	0.0	0.1	4.9	0.9	1.0	0.0	0.7	0.8	0.5	1.0	1.0	0.7	0.5	0.7	0.6	1.1	0.6	0.9	0.4	0.9	0.7	0.6	15.7	28.8	14.8	20.5	16.1	13.8	8.5	15.9	10.3	3.6
CHAD	SLRR4A	ENSG00000136457	Chondroadherin	O15335	17	50464496-50468966	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 6.2;SCLC-21H: 12.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 23.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	52	"memory B-cell: 17.9;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	83	"B-cells: 17.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA018241	Enhanced				"Secreted to extracellular matrix"		15000000			"HPA018241: AB_1846612"	"prognostic favourable (7.68e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.06e-3)"	"prognostic favourable (1.59e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.75e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.41e-3)"	4.5	10.0	11.3	0.8	10.9	0.4	9.5	19.2	8.5	21.0	3.2	4.2	0.1	7.7	0.7	0.9	1.8	0.4	1.5	1.0	11.6	2.7	1.5	18.4	3.7	0.7	2.2	2.9	3.0	17.9	0.1	0.8	0.6	4.9	1.0	3.7	0.3	9.0	0.4	15.4	8.1	9.1	0.2	5.0	1.2	4.7	2.0	3.5	0.6	2.5	3.4	20.6	0.8	0.5	17.9	0.1	0.0	0.0	0.0	0.2	0.5	1.5	1.1	1.1	1.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	2.2	1.2	0.1	0.3	0.0	2.2	0.0	0.0	0.0	0.9	1.2	1.7	0.9	2.1	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.7	0.0	1.1	0.1	1.2	1.4	0.2	2.4	0.0	6.2	12.8	0.4	0.2	0.5	0.0	0.6	0.3	1.4	3.4	0.7	0.2	0.0	2.5	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	11.3	10.9	19.2	8.5	11.6	2.7	2.2	2.9	4.9	3.5
CHAF1B	"CAF-1, CAF1, CAF1A, CAF1P60, MPHOSPH7, MPP7"	ENSG00000159259	"Chromatin assembly factor 1 subunit B"	Q13112	21	36385378-36419015	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021679, CAB033604"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB033604: AB_2229411, HPA021679: AB_1846621"	"unprognostic (2.28e-2)"	"prognostic favourable (5.44e-5)"	"prognostic favourable (7.92e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (6.14e-6)"	"unprognostic (2.14e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.27e-2)"	"unprognostic (7.66e-6)"	"unprognostic (5.89e-2)"	"unprognostic (5.00e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.36e-1)"	2.4	1.4	2.8	3.7	5.9	9.3	4.1	7.2	9.4	2.4	3.0	2.0	1.2	2.8	3.9	2.8	4.4	2.3	1.6	2.9	2.0	2.7	1.7	1.4	2.1	4.5	1.8	4.1	2.7	6.9	3.1	2.1	2.1	3.8	2.9	3.6	4.6	5.2	1.6	20.7	4.4	3.1	2.4	1.5	2.5	2.1	6.2	0.2	12.3	1.7	3.6	7.3	1.8	2.6	2.8	1.3	3.7	0.8	4.4	5.1	1.7	14.7	8.9	15.3	8.7	1.1	3.1	8.4	10.5	6.0	13.0	13.7	10.1	7.9	11.6	4.7	5.4	4.9	15.7	6.9	10.6	11.7	12.3	18.0	9.6	7.1	0.8	11.4	8.8	1.9	1.7	12.1	5.3	6.1	15.6	10.9	6.6	10.3	17.7	6.7	10.7	6.5	26.1	8.3	6.6	4.5	7.3	9.3	7.7	16.0	12.3	5.7	9.6	7.8	3.7	10.6	5.3	9.4	12.1	8.0	14.8	13.6	6.7	12.6	13.4	3.1	0.8	1.0	3.7	0.4	3.3	2.6	2.9	2.8	0.7	2.8	1.9	3.0	3.7	4.4	0.7	1.3	5.1	1.7	2.8	5.9	7.2	9.4	2.0	2.7	1.8	4.1	3.8	0.2
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93028005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA060744: , HPA060960: "	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	23.7	16.6	18.7	23.6	21.1	66.7	21.8	35.1	22.8	24.1	19.9	19.7	17.6	15.7	26.1	31.9	20.3	18.4	16.8	15.3	18.5	15.7	17.7	17.6	30.4	25.2	22.1	13.9	26.3	20.9	27.5	41.9	33.1	19.1	22.4	16.1	22.1	21.2	19.9	24.3	25.2	24.3	20.3	30.8	26.9	20.8	20.4	22.4	39.5	28.8	11.3	37.4	34.7	19.0	25.5	17.2	34.5	6.3	8.0	17.5	4.6	10.7	5.8	15.9	7.0	9.9	24.5	12.2	10.1	10.3	6.8	8.5	7.4	14.1	2.6	8.5	8.7	16.0	9.2	9.9	9.6	0.0	5.4	12.7	11.7	6.4	13.4	13.4	10.0	15.4	12.2	8.1	16.5	11.5	13.2	30.3	10.3	6.6	6.9	7.0	10.1	6.6	10.0	14.5	14.5	7.1	14.5	8.8	9.5	17.5	6.4	13.1	7.2	11.4	18.4	5.6	7.4	4.8	6.4	28.9	11.6	11.0	8.6	8.1	4.8	14.9	6.3	15.0	12.9	3.3	11.8	25.5	12.6	10.1	3.3	23.4	17.5	12.5	34.5	8.0	5.8	17.2	12.3	4.6	18.7	21.1	35.1	22.8	18.5	15.7	22.1	13.9	19.1	22.4
CHD3	"Mi-2a, Mi2-ALPHA, ZFH"	ENSG00000170004	"Chromodomain helicase DNA binding protein 3"	Q12873	17	7884806-7912760	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043368, HPA076524"	Supported		Approved	"Nucleoplasm,Nucleoli,Centriolar satellite"				"Nucleoplasm, Nucleoli, Centriolar satellite"		"HPA043368: , HPA076524: "	"unprognostic (1.77e-2)"	"unprognostic (8.01e-2)"	"prognostic unfavourable (2.43e-4)"	"prognostic favourable (7.68e-5)"	"unprognostic (1.53e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.83e-2)"	"unprognostic (5.25e-3)"	"prognostic favourable (8.36e-4)"	"unprognostic (9.11e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.90e-3)"	"unprognostic (2.20e-3)"	10.4	12.9	31.7	24.3	26.0	18.7	12.5	12.1	28.3	41.1	21.1	4.1	22.5	8.2	46.3	16.1	15.1	25.0	20.0	8.7	30.4	14.2	15.2	2.3	13.1	19.0	8.4	28.4	27.3	15.1	28.5	21.0	8.0	10.7	32.9	11.1	20.7	19.4	23.0	3.3	16.2	14.0	23.3	6.9	14.6	15.8	11.3	5.1	40.6	19.7	7.5	17.7	20.6	28.9	1.6	4.0	4.1	3.5	2.7	7.8	3.6	12.1	30.4	17.8	23.6	21.7	18.2	9.5	14.2	19.1	12.1	12.9	5.9	10.3	34.3	10.8	20.9	16.5	33.4	15.0	15.2	17.4	19.4	16.6	39.4	0.7	11.6	4.7	32.7	24.0	8.0	16.2	10.9	22.3	11.1	0.5	11.2	12.0	13.1	5.5	2.8	11.2	38.4	21.7	5.2	12.0	29.7	12.1	16.4	35.3	13.8	6.9	15.8	7.8	27.9	26.2	20.6	6.3	20.4	2.5	0.4	19.4	13.3	13.5	22.3	0.6	2.7	4.1	7.0	1.7	5.5	1.5	6.7	6.6	2.1	1.6	7.8	5.1	2.1	2.7	3.5	4.0	3.6	3.6	31.7	26.0	12.1	28.3	30.4	14.2	8.4	28.4	10.7	5.1
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.5	18.7	46.5	17.4	19.1	21.5	27.3	22.8	22.2	25.2	23.2	31.2	16.0	44.2	9.1	25.7	18.4	43.6	25.1	34.0	33.0	22.4	61.7	29.1	19.5	16.6	48.4	29.6	20.7	12.5	24.3	17.1	29.3	48.5	22.1	23.9	25.7	45.9	15.8	44.5	17.7	39.4	28.6	24.1	15.9	24.3	22.0	28.3	29.3	32.6	22.6	14.9	27.6	27.2	25.7	54.8	18.8	26.6	35.8	21.3	56.4	17.0	29.6	18.8	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9
CHD6	"CHD5, dJ620E11.1, FLJ22369, KIAA1335, RIGB"	ENSG00000124177	"Chromodomain helicase DNA binding protein 6"	Q8TD26	20	41402101-41618494	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015543			Approved	Nucleoplasm				Nucleoplasm		"HPA015543: "	"unprognostic (5.13e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.72e-3)"	"prognostic favourable (3.42e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.12e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-2)"	12.1	12.6	16.5	12.7	16.2	18.1	19.4	34.1	24.9	17.4	11.3	16.6	15.4	6.5	20.4	19.9	11.0	16.3	11.7	12.1	15.8	13.9	11.8	10.7	11.7	12.1	14.7	16.8	26.1	12.5	31.4	30.3	12.9	24.3	19.7	10.0	14.2	14.5	17.0	9.4	14.4	10.5	14.4	17.3	12.0	12.3	11.1	18.2	21.4	21.4	6.7	15.3	16.9	15.0	12.0	11.5	15.1	9.3	10.4	10.4	2.3	6.4	7.6	16.4	7.2	9.3	9.6	10.9	5.6	11.6	10.0	12.3	10.4	5.3	7.7	10.2	9.5	9.5	10.2	9.6	11.5	2.4	4.9	10.5	6.9	10.0	5.2	8.2	5.2	9.6	9.0	7.3	8.1	8.6	8.2	8.7	7.7	17.6	12.9	8.9	5.3	12.7	10.0	19.4	5.4	6.2	14.8	14.8	10.2	17.1	4.6	11.4	7.8	6.2	9.9	15.8	7.8	8.4	4.8	7.9	6.3	9.9	7.1	4.0	4.9	15.1	6.5	7.1	8.9	6.2	8.9	8.8	7.7	7.3	5.1	12.0	10.4	8.7	0.9	10.4	9.3	11.5	5.9	2.3	16.5	16.2	34.1	24.9	15.8	13.9	14.7	16.8	24.3	18.2
CHD7	"CRG, FLJ20357, FLJ20361, KIAA1416"	ENSG00000171316	"Chromodomain helicase DNA binding protein 7"	Q9P2D1	8	60678778-60868028	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.1"	"Cell line enhanced"	"Detected in many"		"AF22: 25.8;SCLC-21H: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	15	"B-cells: 12.2;granulocytes: 12.6;T-cells: 5.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 110.3"	HPA053075			Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA053075: "	"unprognostic (3.77e-2)"	"unprognostic (3.28e-3)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (9.59e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.41e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.09e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.17e-1)"	3.9	2.2	7.0	7.9	11.2	25.1	4.1	47.1	9.0	2.3	5.7	13.4	3.1	5.9	2.6	3.2	5.1	3.2	3.1	4.1	8.1	4.3	3.6	3.6	4.7	7.0	8.1	3.3	1.4	6.4	12.4	9.9	5.6	9.9	2.9	5.5	6.4	5.7	2.8	10.3	5.7	6.6	2.4	7.5	6.1	4.5	4.3	12.2	1.6	5.4	2.2	7.3	2.9	5.9	12.2	0.6	12.6	0.6	0.0	5.5	0.4	3.8	1.9	25.8	4.5	0.0	0.0	8.1	0.2	0.0	0.9	0.8	4.8	3.6	7.5	0.4	0.0	2.3	13.2	3.8	0.8	2.8	7.1	17.6	3.2	6.3	1.1	5.3	3.3	0.5	2.9	0.0	4.3	3.8	1.3	6.7	0.6	3.9	8.3	6.0	17.7	0.9	17.3	6.1	2.4	2.0	4.4	23.6	11.7	0.7	2.9	7.2	5.2	5.0	4.4	0.2	4.2	0.2	2.1	7.1	4.1	11.7	1.5	0.6	6.6	10.4	0.3	12.6	2.6	0.1	3.3	8.0	2.9	0.9	0.1	12.2	5.5	2.0	7.1	0.0	0.6	0.6	0.2	0.4	7.0	11.2	47.1	6.5	8.1	4.3	8.1	3.3	9.9	12.2
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA052186: , HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.2	21.3	23.6	11.0	15.1	13.1	13.4	12.9	14.9	19.7	19.7	18.5	14.1	26.9	8.2	17.3	20.0	28.9	18.2	25.0	20.6	13.2	23.6	14.3	22.4	14.0	32.6	22.5	17.6	14.8	22.1	15.9	17.5	16.4	14.4	14.9	17.5	23.4	13.3	18.0	18.1	22.0	17.9	9.1	14.6	30.1	17.3	16.6	20.3	15.8	11.2	11.1	15.8	20.5	16.4	12.6	9.6	15.3	16.4	19.5	26.9	6.6	12.1	16.3	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1
CHD9	"BC022889, FLJ12178, KIAA0308"	ENSG00000177200	"Chromodomain helicase DNA binding protein 9"	Q3L8U1	16	53055033-53329150	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 42.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042053, HPA049420"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042053: , HPA049420: "	"unprognostic (3.57e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.34e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.75e-3)"	"unprognostic (2.87e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.35e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.96e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.87e-1)"	18.0	12.6	14.5	12.5	17.3	30.3	15.7	49.3	19.6	18.5	13.8	6.6	17.4	8.0	14.2	15.0	14.4	13.5	11.6	12.2	15.9	8.2	16.8	12.3	12.3	9.2	16.0	12.3	18.8	12.9	28.1	39.9	12.3	15.1	13.7	11.5	8.9	17.8	15.3	17.1	14.4	11.1	11.6	20.1	11.6	13.4	7.0	18.7	15.6	17.7	11.2	9.4	13.9	15.1	16.4	42.9	23.7	12.7	12.1	8.8	1.7	5.7	6.7	15.0	12.2	11.2	16.4	2.6	10.6	7.8	5.6	2.5	3.7	5.2	7.7	6.9	8.7	7.0	7.8	5.5	7.9	2.7	5.8	10.9	6.4	2.3	7.8	15.1	9.1	11.3	5.6	8.2	10.4	8.3	12.7	2.6	7.0	2.2	7.5	3.4	5.4	5.1	26.5	18.0	3.3	3.4	5.4	6.4	7.1	9.4	3.1	7.8	3.4	7.0	16.0	10.6	5.4	3.9	7.1	8.0	5.5	13.5	7.5	6.5	10.4	23.7	9.2	8.9	5.7	7.6	8.8	12.5	3.9	6.2	5.4	16.4	3.1	4.4	3.0	12.1	12.7	42.9	1.9	1.7	14.5	17.3	49.3	19.6	15.9	8.2	16.0	12.3	15.1	18.7
CHEK1	CHK1	ENSG00000149554	"Checkpoint kinase 1"	O14757	11	125625136-125676255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 80.0;seminal vesicle: 66.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 11.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 11.7"	"Low region specificity"	"Detected in single"							HPA044364			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA044364: "	"unprognostic (6.74e-2)"	"unprognostic (3.63e-1)"	"prognostic favourable (3.62e-4)"	"unprognostic (5.54e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.70e-6)"	"unprognostic (3.95e-3)"	"unprognostic (1.26e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (1.04e-8)"	"unprognostic (2.89e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.33e-1)"	3.0	2.5	2.5	9.0	2.8	14.9	2.1	1.1	2.2	2.5	5.2	1.3	80.0	5.0	1.9	10.2	6.5	1.7	3.6	1.5	2.4	2.4	3.7	2.0	1.8	9.6	3.0	1.2	3.8	4.0	25.5	3.5	3.8	1.5	2.9	6.3	1.6	2.6	66.8	1.2	2.9	5.2	2.3	3.0	3.6	2.8	7.2	1.5	22.4	1.8	4.5	8.8	3.8	3.3	1.9	1.8	1.9	0.7	1.2	11.7	1.0	12.7	10.4	23.4	14.2	4.8	10.3	10.2	17.9	8.6	11.5	12.4	25.4	28.3	33.4	18.5	7.0	15.4	14.3	9.4	14.2	20.9	6.6	61.9	8.7	13.0	1.5	31.6	11.8	5.3	2.0	14.5	10.3	13.6	31.3	29.4	15.1	6.6	46.9	15.5	23.7	9.4	28.6	21.9	17.5	10.6	17.0	14.8	15.7	14.7	10.2	4.3	27.5	10.3	9.1	16.6	14.1	8.0	16.4	6.6	11.8	47.6	6.1	23.8	19.4	1.9	0.5	0.3	1.3	0.7	1.2	1.9	3.5	1.6	1.1	1.5	3.3	2.0	0.4	1.2	0.4	1.8	11.7	1.0	2.5	2.8	1.1	2.2	2.4	2.4	3.0	1.2	1.5	1.5
CHEK2	"bA444G7, CDS1, CHK2, HuCds1, PP1425, RAD53"	ENSG00000183765	"Checkpoint kinase 2"	O96017	22	28687743-28742422	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001878, CAB002030"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB002030: AB_563660, HPA001878: AB_1078514"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.08e-3)"	"unprognostic (3.33e-3)"	"unprognostic (9.62e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (7.80e-9)"	"unprognostic (2.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.27e-2)"	"unprognostic (6.79e-3)"	5.6	8.3	2.5	13.0	7.0	13.7	5.6	0.7	5.6	6.6	9.8	2.5	4.8	6.8	4.8	10.9	10.0	4.3	6.0	6.0	4.1	2.3	5.3	6.5	7.9	10.1	6.7	1.6	12.9	6.7	1.2	4.2	10.1	5.1	8.3	10.6	8.7	7.0	5.8	2.2	6.3	8.5	5.4	5.0	9.8	5.8	9.7	3.6	13.1	7.5	4.8	13.7	6.2	6.7	11.8	8.7	6.5	8.4	2.9	4.4	3.7	14.7	4.7	13.5	16.7	3.8	19.2	8.7	7.3	8.6	9.7	14.2	12.0	10.1	17.4	6.2	5.1	14.2	20.5	13.4	11.3	12.4	15.7	22.9	9.0	19.8	3.8	14.5	16.8	8.1	6.2	12.4	11.0	10.7	13.8	15.2	9.0	20.7	11.6	23.3	19.0	12.0	25.3	9.2	20.3	6.0	6.1	7.9	4.5	8.1	14.5	8.0	9.9	13.4	3.7	7.8	9.3	6.8	3.8	9.2	16.2	34.0	7.4	15.2	9.9	6.5	3.7	1.2	1.1	8.4	2.3	11.8	2.2	2.1	8.7	8.4	4.4	2.8	0.3	2.9	4.1	7.0	2.8	3.7	2.5	7.0	0.7	5.6	4.1	2.3	6.7	1.6	5.1	3.6
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"				"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: "	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavourable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	13.7	11.4	14.1	19.0	15.0	25.8	12.5	20.0	16.9	12.1	15.2	16.5	13.4	19.0	15.6	16.7	21.6	12.6	14.3	13.7	12.5	9.8	12.8	13.4	17.0	21.7	15.1	12.6	9.6	16.8	9.6	20.6	22.9	13.0	14.3	12.8	15.5	13.9	14.7	21.0	16.7	18.7	17.8	15.1	24.9	16.8	19.2	14.2	22.3	13.5	12.7	18.4	18.6	14.2	6.6	12.1	19.7	17.0	12.3	12.5	10.1	4.4	10.8	9.1	0.8	8.0	10.7	17.0	9.1	7.6	9.7	10.1	8.5	3.8	0.1	8.8	10.6	7.1	1.1	9.2	5.6	0.6	9.6	14.4	7.4	8.6	17.5	0.6	25.0	14.4	8.4	8.8	6.6	11.8	6.1	0.0	6.7	14.8	10.4	11.2	10.9	8.6	1.4	1.3	4.4	6.4	20.9	8.9	11.4	7.5	7.7	7.0	13.8	14.9	13.2	0.6	2.2	5.0	3.3	15.9	0.0	2.1	0.0	3.0	8.7	17.6	14.2	19.7	10.8	16.9	10.0	6.6	8.7	11.6	12.1	4.5	8.3	9.1	18.9	12.3	17.0	6.6	12.5	10.1	14.1	15.0	20.0	16.9	12.5	9.8	15.1	12.6	13.0	14.2
CHGA		ENSG00000100604	"Chromogranin A"	P10645	14	92923080-92935293	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 577.6"	"Group enriched"	"Detected in some"	134	"SCLC-21H: 43.3;SH-SY5Y: 117.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 114.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 97.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000023, HPA017369, CAB040544, CAB055506, CAB058688"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		78000000	Vesicles		"CAB000023: , CAB040544: , CAB055506: AB_2081135, CAB058688: , HPA017369: AB_1846698"	"prognostic favourable (7.85e-5)"	"unprognostic (4.89e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (2.40e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.81e-13)"	"unprognostic (1.07e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (3.99e-4)"	2.0	81.9	6.6	3.1	18.7	1.3	1.3	0.5	97.9	1.9	36.1	4.0	0.0	15.8	1.3	1.3	1.2	1.3	1.3	1.2	11.2	14.0	1.3	1.2	1.4	1.2	8.0	36.1	1.2	15.9	577.6	81.1	1.2	17.1	2.0	7.9	0.4	1.3	1.3	1.2	1.3	38.8	1.3	2.5	1.3	51.9	32.5	0.7	0.0	5.9	0.0	1.2	1.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	43.3	117.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.6	18.7	0.5	97.9	11.2	14.0	8.0	36.1	17.1	0.7
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 65.1;SH-SY5Y: 99.7"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favourable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	65.1	99.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8
CHI3L1	"GP39, YKL40"	ENSG00000133048	"Chitinase 3 like 1"	P36222	1	203178931-203186749	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Inflammatory response"	Antimicrobial	"Asthma, Cancer-related genes, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 336.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 39.8;ASC TERT1: 88.7;HSkMC: 78.7;THP-1: 125.5;U-138 MG: 37.2;U-87 MG: 37.1"	"Cancer enriched"	"Detected in all"	8	"glioma: 1313.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	490	"neutrophil: 81.3"	"Lineage enriched"	"Detected in single"	490	"granulocytes: 81.3"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in single"	13	"olfactory region: 10.7"	HPA077365			Approved	"Golgi apparatus"	"Secreted to blood"	25100000	230000000	"Golgi apparatus"		"HPA077365: "	"unprognostic (2.11e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.01e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.39e-3)"	19.0	0.8	20.3	53.4	58.0	81.6	23.9	1.2	69.4	4.3	2.1	5.0	0.0	0.9	4.3	25.5	3.5	10.2	1.9	2.6	9.1	17.8	11.9	336.4	10.0	12.4	32.3	3.6	4.5	2.5	0.8	22.9	4.7	66.4	1.5	1.6	9.1	19.3	1.1	10.5	10.0	2.2	3.3	23.5	2.9	1.7	3.4	6.5	0.9	2.0	1.7	14.6	61.5	4.0	0.0	0.0	81.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	39.8	88.7	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	78.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	125.5	0.0	37.2	0.1	0.0	0.0	0.2	4.7	0.0	37.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.3	0.0	0.1	0.0	0.0	0.1	20.3	58.0	1.2	28.9	9.1	17.8	32.3	3.6	66.4	6.5
CHI3L2	"YKL-39, YKL39"	ENSG00000064886	"Chitinase 3 like 2"	Q15782	1	111200771-111243440	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 86.7;salivary gland: 47.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 23.5;MOLT-4: 83.0;U-698: 18.5"	"Cancer enriched"	"Detected in many"	8	"glioma: 104.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 36.0"	"Group enriched"	"Detected in many"	4	"B-cells: 16.8;T-cells: 36.0"					"Low region specificity"	"Detected in all"			HPA005443	Approved				"Secreted to blood"		480000			"HPA005443: AB_1078510"	"unprognostic (1.02e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (9.10e-5)"	"prognostic favourable (2.19e-4)"	"unprognostic (7.12e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (8.59e-7)"	"unprognostic (7.15e-3)"	"unprognostic (7.68e-2)"	"unprognostic (1.39e-3)"	"unprognostic (1.20e-1)"	8.3	0.9	3.9	38.7	11.9	0.9	13.4	0.3	11.9	0.7	2.5	5.9	0.3	0.4	0.6	3.7	2.2	0.7	4.4	20.8	8.3	8.3	3.0	0.3	21.0	19.1	5.6	1.2	1.4	0.3	0.1	1.6	5.8	7.3	3.9	1.0	4.2	47.2	0.3	3.0	3.2	2.6	1.2	28.4	18.4	2.5	4.4	2.1	86.7	4.2	4.2	39.4	19.3	1.7	16.8	0.5	0.9	1.2	6.4	36.0	10.1	0.0	0.0	0.1	0.1	23.5	4.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	6.8	0.0	0.0	0.1	0.3	0.3	0.0	0.4	5.6	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	83.0	0.1	0.0	0.0	0.4	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	1.8	0.3	0.0	0.1	1.3	0.1	18.5	5.8	0.1	0.5	0.3	1.2	0.1	8.7	0.3	2.2	14.3	6.1	14.3	0.3	16.8	36.0	13.6	0.9	6.4	0.2	0.5	3.6	10.1	3.9	11.9	0.3	5.4	8.3	8.3	5.6	1.2	7.3	2.1
CHIT1	"CHI3, CHIT"	ENSG00000133063	"Chitinase 1"	Q13231	1	203212827-203273641	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Carbohydrate metabolism, Chitin degradation, Polysaccharide degradation"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 99.9;lymphoid tissue: 106.5"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.7;LHCN-M2: 1.7;RH-30: 1.7;U-266/70: 2.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 31.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"neutrophil: 2.9;non-classical monocyte: 1.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;monocytes: 1.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA010575, HPA074844"	Supported				"Secreted to blood"	26410000	58000000			"HPA010575: AB_1078512, HPA074844: "	"unprognostic (5.80e-3)"	"prognostic favourable (2.02e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.55e-2)"	"unprognostic (6.36e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	99.9	0.2	0.2	0.4	0.3	26.7	5.5	0.1	0.3	5.9	0.6	0.5	0.1	0.0	2.5	0.2	0.3	0.1	0.2	0.6	0.2	0.1	0.1	0.4	22.1	106.5	0.4	0.1	1.4	1.1	0.0	0.2	0.4	0.5	0.6	0.5	0.3	0.3	0.1	0.1	0.3	0.7	0.2	9.4	4.3	0.1	0.1	0.1	2.3	0.9	0.2	0.5	0.1	0.3	0.5	0.2	2.9	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	2.7	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.2	0.0	0.0	0.1	0.2	0.0	1.7	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	2.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.9	0.0	1.1	0.2	0.0	1.3	0.2	0.3	0.1	0.3	0.2	0.1	0.4	0.1	0.5	0.1
CHKB	"CHETK, CHKL"	ENSG00000100288	"Choline kinase beta"	Q9Y259	22	50578949-50601455	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Kinase, Transferase"	"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 14.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018797	Approved		Approved	Cytosol				Cytosol		"HPA018797: AB_1846666"	"unprognostic (6.03e-4)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.70e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.84e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.54e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-3)"	14.1	13.6	12.7	18.9	14.4	14.8	13.0	21.3	13.4	12.9	15.1	13.8	10.4	9.8	10.1	12.5	10.7	16.2	13.6	10.6	10.7	6.8	14.3	9.3	12.6	8.7	14.7	6.1	9.1	8.4	21.9	19.2	12.3	12.7	11.7	6.9	12.8	13.4	12.5	7.8	10.5	16.9	8.0	9.5	18.5	14.8	19.9	15.8	8.5	14.5	6.6	16.5	12.1	10.9	13.6	21.2	15.0	23.9	20.6	18.6	19.5	3.6	1.0	3.0	1.1	3.1	2.1	10.1	4.3	8.6	1.8	2.4	0.0	1.4	1.8	3.3	0.0	1.7	1.5	0.9	0.3	1.5	4.3	2.4	2.2	0.8	14.4	2.9	6.1	0.9	5.3	0.7	3.6	9.0	1.2	4.7	4.8	3.3	2.6	8.2	0.5	0.6	3.3	0.4	10.1	3.9	2.5	1.4	4.2	3.4	3.4	3.0	1.2	1.8	2.7	1.7	3.6	1.6	1.2	7.7	0.7	2.3	2.9	2.2	1.7	5.7	23.9	15.0	16.3	21.9	15.5	12.9	15.2	17.3	21.2	13.6	14.4	13.3	5.7	20.6	14.2	19.5	18.6	19.5	12.7	14.4	21.3	13.4	10.7	6.8	14.7	6.1	12.7	15.8
CHL1	"CALL, FLJ44930, L1CAM2, MGC132578"	ENSG00000134121	"Cell adhesion molecule L1 like"	O00533	3	196596-409417	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.9"	"Group enriched"	"Detected in some"	5	"SK-MEL-30: 44.1;WM-115: 14.0"	"Cancer enhanced"	"Detected in many"		"glioma: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	56	"memory B-cell: 4.5;naive B-cell: 6.7"	"Lineage enriched"	"Detected in single"	67	"B-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003345, CAB026120"	Enhanced				"Intracellular and membrane"		6900000000			"CAB026120: , HPA003345: AB_1078516"	"unprognostic (5.54e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.45e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.51e-1)"	"prognostic favourable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.66e-3)"	12.8	4.7	17.8	7.9	32.1	1.1	8.4	7.3	62.9	2.9	10.8	5.0	0.9	4.6	3.9	2.4	8.8	2.8	5.1	10.0	21.2	19.0	17.2	1.5	5.3	5.8	11.1	28.7	16.5	2.4	2.0	3.7	0.8	17.8	3.1	8.1	2.3	7.1	6.9	0.9	12.1	6.1	5.5	9.9	3.3	3.9	2.2	7.5	0.0	1.7	0.0	3.3	2.4	5.3	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	32.1	7.3	36.1	21.2	19.0	11.1	28.7	17.8	7.5
CHMP5	"C9orf83, CGI-34, HSPC177, SNF7DC2, Vps60"	ENSG00000086065	"Charged multivesicular body protein 5"	Q9NZZ3	9	33264879-33282069	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033874, HPA042883, HPA056437"	Enhanced		Supported	Microtubules,Midbody,Cytosol				"Microtubules, Cytosol"	Midbody	"CAB033874: AB_10608611, HPA042883: AB_2678212, HPA056437: AB_2683133"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.66e-1)"	"prognostic favourable (2.87e-7)"	"unprognostic (2.22e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.31e-2)"	29.7	37.5	48.0	24.3	48.6	18.8	36.2	39.9	49.4	28.3	39.0	28.1	28.4	38.1	28.2	36.3	39.2	31.4	30.6	35.1	45.1	45.2	55.6	39.2	35.6	26.1	44.1	47.5	26.5	19.9	36.4	34.8	55.7	47.4	40.8	40.9	19.8	26.0	30.2	27.1	25.6	51.9	27.5	49.2	33.0	37.3	21.2	37.0	24.9	42.0	26.1	26.0	33.7	33.5	12.4	27.8	51.2	24.6	18.1	16.6	18.1	30.8	23.0	23.4	15.1	35.9	32.7	21.9	30.9	35.0	49.3	54.8	17.5	19.6	16.7	34.2	29.0	13.4	24.5	25.2	40.1	34.5	17.3	14.0	46.5	19.0	31.2	17.7	27.6	34.7	46.7	33.1	30.9	25.6	15.0	22.1	38.8	14.1	18.4	54.9	21.5	28.4	11.3	20.8	11.0	40.5	16.9	11.5	29.6	31.4	18.5	28.3	18.9	28.0	25.5	24.7	25.8	21.1	27.3	14.7	29.1	19.2	35.6	12.3	15.8	31.5	20.1	40.2	10.7	21.6	11.5	12.4	14.3	14.0	18.3	10.6	13.2	12.5	51.2	18.1	24.6	27.8	16.6	18.1	48.0	48.6	39.9	49.4	45.1	45.2	44.1	47.5	47.4	37.0
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174799363-175005369	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 145.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.9;BJ hTERT+ SV40 Large T+ RasG12V: 29.7"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 9.0;memory CD8 T-cell: 2.9;T-reg: 10.0"	"Lineage enriched"	"Detected in single"	35	"T-cells: 10.0"	"Low region specificity"	"Detected in all"							HPA036111			Approved	Cytosol				Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	3.8	5.2	63.4	3.4	60.8	1.0	2.4	9.1	145.3	4.7	2.5	4.4	0.2	1.7	3.9	15.1	3.2	2.9	4.7	5.2	74.0	21.4	2.1	1.4	7.1	7.4	21.4	51.7	2.8	1.9	31.7	5.2	14.4	23.0	7.2	2.6	3.1	1.4	4.6	1.2	1.9	1.8	5.5	5.1	2.7	2.1	7.5	9.1	0.0	4.0	0.0	7.2	4.5	1.2	0.2	0.2	0.0	0.0	0.1	10.0	1.1	0.0	3.3	14.6	4.2	4.5	20.7	0.1	14.1	58.9	20.3	29.7	0.1	1.9	0.1	0.4	21.2	0.5	18.6	0.4	8.2	0.2	8.1	2.5	4.8	1.4	10.0	1.3	0.3	18.4	0.5	9.8	3.1	7.5	0.1	0.6	14.9	2.7	6.7	0.6	17.3	5.0	2.1	20.6	0.1	0.2	0.1	18.0	19.5	11.2	0.1	1.7	0.6	0.3	2.3	8.6	1.3	2.8	5.1	1.6	7.8	0.2	1.9	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.7	0.2	9.0	2.9	0.0	0.0	1.3	0.3	0.0	0.1	0.0	0.2	10.0	1.1	63.4	60.8	9.1	135.3	74.0	21.4	21.4	51.7	23.0	9.1
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;intestine: 44.3"	"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA018989	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA018989: AB_1846681"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	2.7	4.4	7.9	3.3	21.8	1.4	2.1	89.2	14.7	6.6	14.1	19.2	0.3	44.3	2.7	2.1	1.9	5.0	4.8	6.9	10.5	7.0	8.2	22.0	3.7	2.0	34.7	6.9	13.4	13.9	0.5	1.9	6.4	16.5	5.3	5.9	4.6	1.6	2.9	2.7	1.5	36.3	3.0	16.5	5.1	4.2	2.3	29.2	0.8	4.7	0.0	1.7	3.5	4.0	0.3	8.5	3.9	11.2	9.3	2.5	2.6	0.1	0.4	1.6	0.0	0.0	0.0	9.4	0.0	0.0	0.4	0.0	5.0	1.5	0.5	3.1	0.1	2.6	5.0	0.0	0.0	8.9	1.6	18.2	0.8	9.7	0.1	0.0	35.5	0.0	3.3	0.0	0.7	1.9	0.7	0.2	0.1	0.2	4.9	0.2	0.6	1.7	0.4	0.0	0.9	9.2	6.2	9.5	0.7	2.2	3.3	5.8	0.3	1.0	0.2	0.5	0.1	0.0	0.2	1.8	7.0	0.0	0.1	1.1	0.7	3.9	10.5	0.1	2.5	11.2	1.8	0.3	0.4	2.2	8.5	0.2	0.5	1.0	0.6	9.3	6.4	1.0	0.0	2.6	7.9	21.8	89.2	14.7	10.5	7.0	34.7	6.9	16.5	29.2
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281890	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles				Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favourable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favourable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	39.4	32.5	21.2	17.0	21.5	25.7	32.3	13.5	34.1	17.0	51.0	19.0	18.9	41.0	13.4	16.4	39.1	11.2	38.8	27.3	22.7	23.8	35.6	82.3	31.6	14.4	22.4	15.6	13.6	31.1	27.1	13.9	12.2	32.1	16.8	37.6	15.2	28.7	23.1	42.2	24.2	55.6	15.8	19.0	12.6	52.5	7.5	11.3	10.3	23.6	34.2	24.7	21.7	22.5	8.6	30.5	52.5	47.4	11.0	11.8	19.4	21.4	21.0	8.1	31.1	34.5	32.8	12.7	16.7	21.0	13.1	14.1	18.6	41.5	3.6	18.7	21.9	26.4	15.7	25.3	14.6	15.2	5.9	14.4	17.4	28.8	26.9	19.0	22.8	33.6	27.6	15.1	15.1	23.5	23.3	23.7	14.4	11.8	7.9	19.4	8.8	11.3	11.3	13.3	10.3	25.6	39.4	5.5	13.7	28.4	52.5	13.9	31.0	18.0	33.6	14.8	16.0	23.2	10.9	13.9	36.8	17.6	26.5	11.7	13.4	42.9	47.4	52.5	10.7	40.0	11.0	8.6	10.1	10.7	30.5	6.8	6.5	9.3	35.6	11.0	38.5	19.2	11.8	19.4	21.2	21.5	13.5	34.1	22.7	23.8	22.4	15.6	32.1	11.3
CHRD		ENSG00000090539	Chordin	Q9H2X0	3	184380073-184390736	"Plasma proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.8;liver: 48.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.6;Hep G2: 15.0;MCF7: 3.2;U-2 OS: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035827	Approved				"Secreted in other tissues"		120000			"HPA035827: AB_10669657"	"unprognostic (2.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.55e-2)"	"prognostic unfavourable (6.09e-7)"	"unprognostic (5.53e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.84e-2)"	"unprognostic (7.99e-3)"	8.9	6.2	8.9	3.1	6.4	0.4	4.2	32.8	15.9	13.0	2.9	2.4	1.8	2.7	14.9	6.4	3.2	5.7	3.9	4.6	6.5	1.1	10.1	48.3	3.0	2.2	1.8	7.0	7.9	13.9	0.8	2.5	3.8	4.7	4.2	1.6	2.6	2.0	8.3	4.9	3.2	3.0	7.0	2.9	4.6	3.4	1.2	1.8	0.0	3.2	2.3	0.9	3.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.1	0.1	1.9	0.5	0.0	0.3	0.2	3.6	0.0	0.0	1.4	0.4	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.1	15.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.9	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	6.4	32.8	15.9	6.5	1.1	1.8	7.0	4.7	1.8
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: "	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.69e-4)"	22.1	26.5	34.6	33.0	41.1	42.5	32.8	40.6	51.0	25.1	22.7	29.1	29.7	23.4	29.9	30.0	28.5	30.0	22.1	35.3	32.3	24.9	26.0	29.9	32.3	33.6	42.6	32.8	34.6	37.9	31.9	29.2	31.0	32.3	27.0	26.5	20.8	25.0	30.5	83.6	31.5	25.4	29.1	47.1	37.7	25.9	35.0	39.8	34.5	32.8	30.6	33.3	21.6	33.1	29.2	34.8	43.0	28.2	20.5	31.9	27.4	26.3	23.3	39.6	24.0	17.2	12.7	31.5	18.6	17.3	26.7	23.1	25.9	26.8	29.8	28.4	17.4	24.4	38.0	27.3	17.7	34.8	35.1	23.4	35.5	21.4	21.4	35.9	29.6	14.7	31.7	25.7	36.7	21.3	28.8	23.1	19.9	33.4	38.5	36.4	45.9	29.2	24.0	24.2	33.0	25.8	36.5	24.1	27.9	19.9	28.9	31.1	31.0	49.8	18.2	18.0	26.7	22.6	30.0	32.3	27.0	34.6	18.9	29.5	20.9	43.0	28.0	25.2	31.7	28.2	31.5	29.2	31.2	30.7	34.8	27.4	31.9	28.4	19.8	20.5	25.5	26.8	31.8	27.4	34.6	41.1	40.6	51.0	32.3	24.9	42.6	32.8	32.3	39.8
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 22.8;REH: 40.0;U-698: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.5	5.0	0.8	0.0	0.9	0.0	0.0	0.1	22.8	0.2	2.9	1.0	0.6	0.0	0.4	0.4	1.0	0.0	0.1	0.0	0.0	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.1	40.0	0.3	3.5	0.0	1.6	0.9	0.1	0.9	0.3	0.9	0.5	1.6	0.3	2.1	0.3	0.6	0.2	8.4	0.6	11.8	7.5	0.5	6.8	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4
CIRBP	CIRP	ENSG00000099622	"Cold inducible RNA binding protein"	Q14011	19	1259384-1274880	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060537			Supported	Nucleoplasm			33000	Nucleoplasm		"HPA060537: "	"unprognostic (2.77e-3)"	"prognostic favourable (3.63e-4)"	"unprognostic (9.80e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (2.50e-4)"	"unprognostic (6.43e-2)"	"unprognostic (2.29e-2)"	"prognostic favourable (2.69e-4)"	"unprognostic (1.82e-1)"	"prognostic favourable (3.65e-7)"	"unprognostic (1.04e-1)"	"unprognostic (5.76e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.49e-2)"	57.0	64.6	54.3	54.4	63.7	55.9	72.7	92.0	88.7	78.6	55.7	98.9	75.2	33.2	82.9	86.4	38.5	89.5	75.1	62.4	47.8	57.1	51.7	34.7	51.4	66.6	45.3	95.9	154.5	115.1	101.0	92.2	48.9	61.6	67.8	40.1	115.4	91.5	100.1	119.1	68.5	48.9	93.0	50.0	56.7	60.7	67.4	37.5	33.7	73.7	65.1	63.7	58.5	49.1	70.6	67.4	48.3	54.6	52.3	58.6	40.5	37.0	8.0	58.5	29.6	26.1	29.4	15.2	40.8	57.6	32.1	28.8	14.6	14.4	74.6	22.1	42.1	17.6	24.5	36.9	24.9	33.4	7.1	44.4	8.4	18.8	95.5	68.7	32.4	72.1	33.3	20.7	90.8	28.9	29.1	60.3	33.2	26.3	35.2	18.6	23.1	13.6	44.0	47.1	36.7	36.3	31.2	27.8	50.5	43.1	19.7	32.4	41.0	19.4	35.0	23.6	14.5	56.2	35.5	80.1	86.3	62.6	20.3	28.5	30.8	43.5	21.4	48.3	56.1	36.7	57.3	62.5	50.2	50.3	23.9	70.6	57.6	54.1	36.8	52.3	54.6	67.4	58.6	40.5	54.3	63.7	92.0	88.7	47.8	57.1	45.3	95.9	61.6	37.5
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374620	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 76.8;fHDF/TERT166: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.40e-4)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	42.8	34.5	6.8	27.1	11.2	71.7	35.4	24.2	27.9	22.2	23.6	6.0	19.0	9.3	53.3	26.5	24.1	58.1	27.0	37.7	4.7	6.6	24.9	55.2	40.6	14.3	3.7	7.2	84.0	35.3	58.5	6.0	75.7	17.4	23.3	11.4	26.1	31.4	44.6	44.5	34.8	19.6	23.3	3.7	40.6	21.4	17.7	3.0	11.2	99.7	18.7	16.6	17.6	24.4	1.9	2.9	20.0	6.6	2.3	4.7	2.2	2.8	1.7	5.9	17.4	25.2	27.0	22.3	76.8	57.2	35.1	33.1	15.2	4.3	2.0	11.3	133.5	3.4	1.8	1.7	25.0	56.7	5.7	42.1	9.6	1.2	20.6	12.4	4.6	21.5	8.3	15.3	11.8	6.4	15.7	10.1	45.5	6.3	2.1	15.5	5.5	2.6	3.0	4.3	18.2	16.8	6.5	6.5	0.1	5.5	21.1	2.4	9.1	42.7	35.0	28.2	9.0	8.3	4.3	3.0	2.6	3.1	8.7	10.7	1.9	2.1	6.6	20.0	3.0	3.7	4.3	1.0	4.7	4.3	2.9	1.9	4.1	2.1	3.3	2.3	4.9	1.3	2.7	2.2	6.8	11.2	24.2	27.9	4.7	6.6	3.7	7.2	17.4	3.0
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128166064-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA020380: , HPA020387: "	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	31.9	24.3	33.6	23.8	36.0	36.7	36.7	39.4	40.4	31.5	35.7	28.0	21.3	26.8	33.6	20.9	30.3	33.5	26.7	25.5	30.5	19.9	19.7	12.1	22.2	24.8	29.4	27.5	56.3	41.7	23.1	21.1	21.9	23.4	30.1	21.8	23.3	31.3	28.8	51.4	49.6	26.1	40.0	27.3	22.5	28.9	35.4	37.0	30.3	22.8	24.2	27.0	35.2	39.3	6.7	4.6	4.9	5.8	8.1	8.3	3.2	22.9	27.8	23.8	22.4	24.6	29.8	23.3	18.1	27.3	33.4	19.0	25.4	20.2	27.1	15.5	30.5	33.5	18.3	19.5	18.3	24.5	20.9	25.8	34.9	16.3	28.4	23.9	30.8	28.8	35.0	36.5	31.1	22.5	62.4	23.4	20.0	53.7	31.3	24.3	20.6	28.6	26.6	25.1	27.8	15.1	15.8	29.7	23.0	40.3	28.6	24.0	29.7	31.2	23.9	35.7	25.4	40.4	34.0	27.2	30.7	26.1	25.3	16.1	38.2	4.6	4.3	4.9	5.0	5.8	4.5	5.7	6.1	6.4	4.6	6.7	6.1	5.5	0.7	8.1	4.3	4.6	8.3	3.2	33.6	36.0	39.4	40.4	30.5	19.9	29.4	27.5	23.4	37.0
CKAP5	"ch-TOG, KIAA0097, TOG, TOGp"	ENSG00000175216	"Cytoskeleton associated protein 5"	Q14008	11	46743048-46846308	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039377, HPA040375"	Supported		Approved	"Nucleoli,Plasma membrane,Centrosome"			460000	"Plasma membrane, Centrosome"	Nucleoli	"HPA039377: AB_10805477, HPA040375: AB_10794739"	"unprognostic (8.00e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (6.09e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.30e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.69e-2)"	13.7	25.5	20.6	11.5	25.7	18.6	12.5	34.6	32.9	11.3	14.6	16.5	7.3	10.2	13.7	10.4	11.7	9.5	10.1	16.6	19.2	19.3	9.7	37.7	8.5	14.1	18.8	21.1	23.8	7.9	20.0	20.8	13.8	33.0	13.5	15.0	9.1	8.7	12.0	26.3	10.7	9.9	16.1	22.5	8.8	12.9	25.4	22.2	28.6	8.0	10.8	14.7	12.6	9.7	8.6	8.4	6.0	8.7	11.7	10.0	3.6	25.9	25.1	53.9	23.1	12.8	20.1	12.5	29.8	18.1	28.4	30.2	20.4	8.8	28.3	10.5	20.0	29.5	38.6	16.9	35.7	25.5	29.5	47.2	20.1	19.6	9.5	36.0	19.8	10.2	9.0	15.9	34.5	21.4	33.3	26.6	23.4	17.9	30.6	9.3	29.0	20.2	32.5	57.4	24.8	9.1	16.0	25.1	21.4	40.5	14.5	14.8	26.7	9.8	18.4	27.6	24.4	46.7	43.9	15.1	32.6	40.8	17.3	17.1	27.0	5.4	5.7	6.0	9.0	8.7	8.8	8.6	6.7	10.0	8.4	8.0	8.2	8.5	0.9	11.7	7.8	5.4	7.5	3.6	20.6	25.7	34.6	31.2	19.2	19.3	18.8	21.1	33.0	22.2
CKB	CKBB	ENSG00000166165	"Creatine kinase B"	P12277	14	103519659-103523111	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 158.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 53.1;HEK 293: 135.1;SCLC-21H: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"non-classical monocyte: 50.0"	"Lineage enriched"	"Detected in many"	17	"monocytes: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001254, CAB047313"	Enhanced		Supported	Cytosol			50000000	Cytosol		"CAB047313: , HPA001254: AB_1078528"	"unprognostic (9.97e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.10e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.68e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (4.02e-8)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.13e-1)"	32.4	27.3	75.4	10.4	114.6	3.1	5.3	94.3	158.5	29.1	121.5	51.4	23.8	17.6	37.3	8.9	28.6	35.7	17.8	36.4	60.7	43.2	26.7	3.4	12.8	3.6	63.4	93.3	15.8	10.2	20.3	9.7	3.7	63.3	107.5	55.0	43.9	18.3	92.1	19.1	14.4	17.5	53.2	31.9	3.6	66.7	22.1	50.9	0.0	19.8	7.8	3.9	43.0	13.0	0.0	2.9	1.4	50.0	0.0	0.1	0.9	0.3	6.7	26.9	1.4	0.2	0.2	0.5	2.9	0.0	0.3	0.1	53.1	0.8	0.0	3.2	2.0	5.9	7.8	0.1	0.0	1.2	135.1	10.0	29.7	18.2	1.1	0.0	8.2	1.0	0.0	0.2	0.1	0.0	17.4	0.4	0.4	2.2	0.2	0.3	10.5	21.0	1.7	0.5	27.6	4.9	0.2	76.9	31.6	5.7	0.9	2.1	2.5	4.1	0.1	0.1	5.2	0.5	12.6	1.3	0.3	0.9	0.7	0.2	0.9	0.3	0.1	1.4	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.1	0.0	50.0	0.0	0.1	0.9	75.4	114.6	94.3	152.7	60.7	43.2	63.4	93.3	63.3	50.9
CKM	CKMM	ENSG00000104879	"Creatine kinase, M-type"	P06732	19	45306414-45322977	"Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 1374.7;tongue: 354.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 36.8"	"Group enriched"	"Detected in many"	33	"head and neck cancer: 64.4;prostate cancer: 14.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 2.8;intermediate monocyte: 1.1;myeloid DC: 2.1"	"Group enriched"	"Detected in many"	25	"dendritic cells: 2.1;monocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047859	Enhanced						190000000			"HPA047859: "	"unprognostic (3.51e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.04e-3)"	"unprognostic (1.85e-2)"	"unprognostic (4.23e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.00e-1)"	"unprognostic (9.46e-3)"	"unprognostic (9.67e-8)"	"unprognostic (3.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.95e-1)"	13.9	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	23.5	21.1	0.1	0.1	187.9	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	2.8	0.1	0.8	17.6	0.2	1374.7	0.2	0.2	0.2	0.3	0.1	0.5	0.3	0.0	0.0	11.1	354.9	24.8	0.2	0.1	0.0	2.1	0.0	2.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.9	0.0	0.1	8.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	3.3	0.1	0.1	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
CKMT2	SMTCK	ENSG00000131730	"Creatine kinase, mitochondrial 2"	P17540	5	81233285-81266397	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"heart muscle: 153.2;skeletal muscle: 182.4;tongue: 103.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;BEWO: 5.9;Hep G2: 5.1;HHSteC: 3.9;T-47d: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 3.8"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051880	Enhanced						3200000			"HPA051880: "	"unprognostic (3.64e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.75e-3)"	2.5	5.0	1.3	0.3	1.9	0.2	0.8	0.4	1.2	1.2	0.5	1.2	2.5	0.3	1.3	11.5	3.0	1.2	1.5	153.2	1.5	0.9	2.7	0.3	0.4	0.3	2.3	1.4	1.6	1.3	1.1	0.7	0.3	4.1	2.0	0.3	2.5	9.1	2.1	182.4	0.5	0.6	1.4	2.8	0.4	2.1	0.9	1.5	0.0	3.3	103.6	2.9	1.0	0.6	0.4	0.1	0.0	0.4	3.8	0.3	0.0	0.1	0.9	0.0	0.9	3.6	0.7	5.9	0.1	0.0	0.0	0.0	0.3	0.3	0.6	0.4	0.0	0.1	0.0	0.0	0.0	0.5	3.1	0.0	0.7	5.1	3.9	0.4	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.2	0.1	0.7	0.4	0.8	0.9	0.0	0.0	0.1	0.7	0.7	0.5	0.4	0.8	9.5	0.4	0.8	0.5	0.9	0.5	0.3	0.1	0.1	0.8	0.4	0.5	0.9	0.0	0.2	0.0	0.1	0.4	0.0	0.1	0.3	0.0	0.0	0.4	0.1	0.2	0.0	3.8	0.0	0.1	0.2	0.0	1.3	1.9	0.4	1.2	1.5	0.9	2.3	1.4	4.1	1.5
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol				Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.9	2.8	2.3	6.1	2.1	1.8	5.3	2.8	1.6	2.8	1.8	14.9	2.7	2.8	7.9	1.4	13.8	3.3	3.1	0.8	2.5	4.0	2.5	5.8	6.3	1.3	1.0	2.5	3.4	2.5	2.4	2.8	2.7	0.9	1.4	0.9	4.4	0.8	1.3	3.4	4.3	4.9	2.2	9.5	3.5	6.0	3.8	2.3	2.9	10.4	4.7	8.4	1.1	1.3	1.4	4.3	7.0	6.9	3.7	4.8	1.7	2.5	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8
CLCN5	"ClC-5, CLC5, DENTS, hCIC-K2, hClC-K2, NPHL1, NPHL2, XLRH, XRN"	ENSG00000171365	"Chloride voltage-gated channel 5"	P51795	X	49922615-50099235	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 24.9;RH-30: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	8	"dendritic cells: 6.6;monocytes: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000401, HPA003213"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"				"Golgi apparatus, Plasma membrane"	Cytosol	"HPA000401: AB_1078531, HPA003213: "	"unprognostic (3.33e-2)"	"unprognostic (6.15e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.21e-2)"	"prognostic favourable (5.20e-4)"	"unprognostic (3.59e-2)"	"prognostic favourable (2.05e-8)"	"unprognostic (7.87e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.60e-2)"	4.4	4.1	2.5	2.4	2.9	2.1	3.4	9.4	3.4	2.3	3.1	2.6	4.7	5.0	9.8	26.7	3.7	4.6	7.6	2.2	3.1	2.8	46.1	15.8	4.7	3.0	2.6	2.5	10.8	6.7	2.6	8.3	7.3	5.9	2.7	3.7	7.6	4.0	3.5	5.6	6.2	6.4	3.8	4.3	3.0	4.0	5.9	2.3	1.2	3.6	4.0	2.3	2.4	3.1	0.2	6.6	0.5	1.8	0.3	0.4	0.5	1.7	2.8	2.1	3.3	8.3	5.2	4.6	1.5	0.7	0.9	1.2	24.9	1.7	1.8	0.8	1.7	1.4	6.7	0.8	1.5	0.7	4.6	1.7	1.4	6.5	3.9	2.3	3.3	3.1	1.1	2.5	3.7	3.6	2.7	2.7	2.9	1.8	0.8	0.6	3.1	1.3	1.0	38.6	2.7	3.7	2.8	3.7	2.7	2.1	2.1	3.1	1.9	1.1	1.8	1.0	2.1	7.6	0.9	2.2	6.7	4.1	1.6	3.7	5.0	0.1	1.8	0.0	0.2	1.5	0.3	0.2	0.4	0.4	3.8	0.2	0.1	0.1	0.5	0.3	0.3	6.6	0.0	0.5	2.5	2.9	9.4	3.4	3.1	2.8	2.6	2.5	5.9	2.3
CLCN6	"CLC-6, KIAA0046"	ENSG00000011021	"Chloride voltage-gated channel 6"	P51797	1	11806096-11843144	"Plasma proteins, Predicted membrane proteins"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032097	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA032097: AB_10670827"	"unprognostic (3.14e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.84e-3)"	"unprognostic (1.51e-3)"	"unprognostic (6.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.71e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.65e-2)"	11.2	14.6	18.9	11.5	18.7	12.2	8.6	18.0	27.9	9.2	8.7	22.4	8.6	9.6	12.8	14.2	6.3	10.7	8.1	15.7	15.0	20.6	10.0	9.1	10.6	11.1	16.4	17.8	21.4	6.6	8.4	14.8	9.6	32.4	11.3	7.8	13.1	6.7	8.7	11.2	10.0	9.1	10.8	15.9	10.6	8.5	16.1	14.5	4.3	10.7	5.0	9.5	7.7	8.2	10.1	3.2	4.2	4.6	2.0	3.2	1.1	5.7	5.3	12.1	10.1	13.0	13.5	3.8	4.8	9.2	6.6	10.4	8.2	13.9	8.1	4.0	4.4	8.5	7.9	8.9	5.9	3.6	4.3	8.4	10.6	10.8	16.8	4.7	7.9	9.2	5.3	12.5	7.0	5.9	10.7	11.8	6.7	3.1	4.9	12.8	8.1	4.2	6.1	6.6	7.4	8.8	4.7	5.3	8.4	3.2	5.1	11.1	4.5	8.5	7.2	6.2	7.0	10.6	3.3	7.1	4.3	21.0	7.7	9.5	4.5	4.2	4.6	1.5	2.6	3.7	1.5	8.0	2.1	3.2	2.7	10.1	2.3	2.1	3.9	2.0	4.6	3.2	1.4	1.1	18.9	18.7	18.0	27.9	15.0	20.6	16.4	17.8	32.4	14.5
CLEC11A	"CLECSF3, LSLCL, P47, SCGF"	ENSG00000105472	"C-type lectin domain containing 11A"	Q9Y240	19	50723329-50725718	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.1"	"Group enriched"	"Detected in many"	4	"HEL: 44.4;HMC-1: 82.3;NB-4: 109.3;THP-1: 88.3;U-937: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.0;monocytes: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042690	Approved		Approved	Centrosome	"Secreted in other tissues"		45000	Centrosome		"HPA042690: AB_10795511"	"unprognostic (9.33e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (6.09e-2)"	"unprognostic (8.66e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.57e-2)"	5.5	5.4	3.0	5.6	3.1	77.1	4.5	4.5	3.6	33.6	6.5	1.2	6.7	3.9	26.6	27.8	6.7	13.5	10.7	5.6	2.6	3.4	7.4	5.4	7.5	3.5	2.9	1.3	16.1	2.6	2.0	7.5	6.9	4.0	18.9	2.1	8.9	2.9	10.2	3.4	5.0	5.2	8.5	3.4	4.9	3.1	4.9	0.8	4.0	3.8	4.5	2.6	8.4	10.1	0.3	12.0	1.2	17.2	3.4	3.2	6.7	0.3	0.4	0.0	0.3	4.3	5.9	10.1	17.3	4.7	2.0	1.9	0.0	0.0	0.0	0.2	8.6	0.2	0.0	0.0	1.3	0.0	2.8	44.4	0.0	0.0	2.7	0.0	82.3	4.3	0.0	0.2	0.2	2.2	0.5	0.2	3.7	0.3	0.3	109.3	0.2	0.5	3.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	6.7	0.1	88.3	12.4	0.1	5.4	0.0	0.1	0.2	0.2	0.0	6.3	45.8	5.7	1.0	17.2	0.2	0.6	7.2	0.0	0.3	0.2	0.1	12.0	0.3	1.5	3.2	1.2	3.4	3.3	3.2	0.1	6.7	3.0	3.1	4.5	3.6	2.6	3.4	2.9	1.3	4.0	0.8
CLEC3B	"TN, TNA"	ENSG00000163815	"C-type lectin domain family 3 member B"	P05452	3	45001548-45036071	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 185.2;lung: 216.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 50.0;ASC TERT1: 99.6;U-2197: 20.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002582, HPA034794"	Approved				"Secreted to blood"	6540000000	46000000000			"CAB002582: AB_564027, HPA034794: "	"unprognostic (2.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.57e-2)"	"unprognostic (7.75e-2)"	"prognostic favourable (1.53e-4)"	"prognostic favourable (9.99e-9)"	"unprognostic (1.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.02e-1)"	"prognostic favourable (5.68e-4)"	"unprognostic (9.33e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.21e-2)"	70.8	11.5	6.6	16.9	8.9	0.5	185.2	5.9	10.2	17.4	20.3	4.8	39.0	8.4	15.7	54.2	17.2	6.9	38.8	72.8	8.1	6.8	20.6	7.0	216.5	8.3	8.8	7.4	5.1	6.1	2.1	5.0	37.7	13.2	7.4	10.1	17.7	9.7	19.2	26.5	27.6	16.3	90.3	10.0	65.5	8.3	24.9	1.5	2.3	15.8	40.8	5.4	28.0	24.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	50.0	99.6	0.0	6.5	10.3	0.2	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	20.1	0.0	0.2	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.6	8.9	5.9	10.2	8.1	6.8	8.8	7.4	13.2	1.5
CLIC1	"G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020825, CAB040557"	Enhanced		Supported	Cytosol			78000000	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavourable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	64.5	22.9	7.4	33.7	11.3	35.3	41.1	2.5	8.3	38.7	50.3	9.0	27.1	24.5	30.0	29.2	59.0	26.3	60.8	35.5	7.9	7.7	70.8	28.3	58.6	59.6	13.9	3.7	34.8	30.3	11.1	17.0	72.3	12.1	42.2	43.5	20.0	37.7	33.6	18.3	45.0	54.9	31.5	13.6	79.9	34.8	16.7	9.2	52.9	46.1	37.4	58.5	49.2	40.0	39.0	30.5	70.9	39.4	33.5	37.2	67.9	26.7	12.4	20.4	10.6	13.6	28.8	10.2	11.9	24.5	21.9	18.4	28.5	20.1	11.0	17.4	42.5	16.2	15.2	35.7	29.6	8.7	8.0	21.0	10.7	24.6	17.6	36.6	29.7	17.8	18.9	36.9	35.3	36.6	24.2	34.9	42.0	17.8	17.0	47.7	1.8	18.2	3.0	11.2	25.9	49.2	16.7	3.9	4.6	9.9	11.4	16.6	7.8	51.9	24.2	30.5	21.5	9.5	37.6	11.4	21.3	14.8	14.7	27.6	31.3	45.8	36.5	48.1	37.2	39.4	30.3	39.0	22.5	34.5	30.5	30.4	7.0	21.9	70.9	33.5	33.8	17.2	31.0	67.9	7.4	11.3	2.5	8.3	7.9	7.7	13.9	3.7	12.1	9.2
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 66.8;MCF7: 30.4;SK-BR-3: 12.7;T-47d: 29.0;TIME: 23.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA005963	Enhanced		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.4	0.0	0.0	0.0	0.1	0.3	66.8	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.4	4.7	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.1	12.7	0.0	29.0	0.0	23.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859175	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 95.0;eosinophil: 27.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles			340000	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favourable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (3.56e-1)"	22.0	23.3	12.6	27.1	18.8	38.1	18.8	13.6	14.7	22.0	27.9	10.0	43.8	28.8	19.1	30.3	56.4	17.1	40.3	23.4	14.0	12.7	40.8	48.6	22.3	19.2	11.7	11.7	20.1	25.3	47.9	25.9	30.1	14.3	21.5	23.7	11.3	39.9	47.1	38.7	26.0	34.6	30.9	13.0	19.0	29.4	12.1	13.0	23.6	30.3	23.3	32.8	37.1	33.8	7.8	9.9	95.0	7.8	8.8	12.7	7.5	22.7	32.9	23.5	21.8	32.7	27.6	33.7	32.1	33.3	31.8	44.9	45.8	36.0	42.9	36.9	30.5	34.4	31.8	37.1	45.4	20.2	25.7	28.6	29.6	22.9	33.4	39.0	38.8	20.5	27.9	35.6	40.2	29.7	24.4	23.9	25.5	20.0	30.6	21.7	24.6	34.1	27.6	35.2	36.2	31.8	41.0	20.7	22.5	23.2	40.2	31.6	27.7	27.6	29.8	27.8	20.6	25.3	31.4	27.9	26.5	55.0	22.5	44.7	24.3	95.0	7.4	27.6	7.4	7.8	12.7	7.8	7.1	7.3	9.9	7.0	6.2	6.6	2.8	8.8	7.8	7.8	10.1	7.5	12.6	18.8	13.6	14.7	14.0	12.7	11.7	11.7	14.3	13.0
CLIP1	"CLIP, CLIP-170, CLIP170, CYLN1, RSN"	ENSG00000130779	"CAP-Gly domain containing linker protein 1"	P30622	12	122271432-122422632	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004399, HPA026678"	Approved		Supported	"Microtubule ends,Cytosol"			7700	"Microtubule ends, Cytosol"		"CAB004399: AB_671001, HPA026678: AB_1846954"	"unprognostic (1.18e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.52e-3)"	14.4	12.6	9.8	9.1	10.9	6.4	11.7	44.5	11.5	11.6	19.5	4.3	13.9	5.7	14.3	10.1	24.8	7.5	7.7	11.8	9.3	7.5	10.0	15.2	10.0	5.8	6.5	9.5	6.3	9.1	37.8	10.9	36.5	8.7	13.2	7.1	6.7	11.8	15.1	96.5	16.8	9.1	31.1	7.2	5.9	9.6	6.1	6.9	3.7	24.1	25.9	10.1	22.2	16.6	5.3	5.4	18.2	10.6	3.9	7.2	3.7	15.3	19.4	12.0	12.1	10.3	15.9	20.9	21.9	20.9	14.9	9.3	9.0	7.6	6.9	14.8	28.4	19.7	7.6	9.0	16.9	28.9	5.5	2.3	12.9	9.5	20.5	7.9	12.7	10.5	31.0	17.1	25.9	14.9	8.6	4.7	14.9	8.9	4.9	2.8	4.5	17.2	4.6	9.3	3.4	13.4	17.6	4.6	2.9	47.0	11.5	19.2	9.9	4.7	28.8	11.3	12.2	26.5	14.3	5.3	4.1	4.1	19.4	4.0	7.8	3.6	6.5	5.2	7.2	10.6	5.4	5.3	6.7	6.5	5.4	3.6	5.0	3.7	18.2	3.9	8.6	3.5	5.8	3.7	9.8	10.9	44.5	11.5	9.3	7.5	6.5	9.5	8.7	6.9
CLIP2	"CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4"	ENSG00000106665	"CAP-Gly domain containing linker protein 2"	Q9UDT6	7	74289475-74405943	"Plasma proteins, Predicted intracellular proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 44.0"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 43.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA020430, CAB020767"	Enhanced						960000			"CAB020767: , HPA020430: AB_1846958"	"unprognostic (7.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.38e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.96e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.38e-1)"	6.3	7.1	27.8	9.3	24.1	3.7	2.9	16.0	44.0	8.6	15.3	28.2	3.3	10.5	8.9	2.6	6.3	4.8	10.3	4.7	28.3	24.9	4.9	2.3	6.0	4.8	30.9	17.9	16.7	11.9	6.3	5.6	8.3	19.3	5.4	9.5	4.0	3.7	9.5	2.2	9.0	12.7	8.0	34.7	6.0	11.1	3.0	18.3	2.0	1.9	1.0	6.8	7.4	10.5	2.8	0.7	2.9	2.1	0.1	0.6	0.9	3.2	11.6	9.1	9.8	10.7	12.1	0.1	8.5	16.9	4.9	5.4	2.5	15.2	0.5	1.7	15.1	12.5	1.7	9.3	2.1	22.5	0.8	2.6	1.6	6.4	10.5	0.5	3.2	13.5	4.2	14.9	12.4	7.2	0.6	0.2	9.4	1.0	0.3	17.3	4.1	11.4	17.7	3.5	0.7	6.4	11.7	1.9	10.3	4.7	1.4	16.7	1.0	2.0	8.6	13.3	8.2	18.3	5.1	0.5	0.1	0.0	15.5	4.8	11.3	2.9	1.2	0.0	0.1	2.1	0.6	2.8	0.0	0.0	0.7	0.9	0.0	0.4	0.8	0.1	0.9	0.0	0.0	0.9	27.8	24.1	16.0	27.6	28.3	24.9	30.9	17.9	19.3	18.3
CLMN	"FLJ12383, KIAA0500, KIAA1188"	ENSG00000165959	Calmin	Q96JQ2	14	95181940-95319906	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 38.1"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 13.9;T-47d: 11.6;WM-115: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012634	Enhanced		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies"	Cytosol	"HPA012634: AB_1846973"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (8.88e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.09e-2)"	"prognostic favourable (2.68e-7)"	"unprognostic (8.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.91e-3)"	14.1	2.3	11.0	5.9	36.3	2.0	13.0	3.1	20.1	7.8	15.3	31.6	5.6	4.6	5.6	11.0	4.3	8.2	8.3	3.7	13.0	5.6	18.9	18.8	5.2	2.3	38.1	8.0	3.5	18.1	4.7	3.4	9.2	17.2	8.0	17.6	7.1	9.4	7.9	4.6	3.5	6.9	4.5	14.5	3.6	10.0	33.4	34.0	0.0	6.6	1.8	2.9	7.3	7.1	3.8	3.0	7.2	8.4	0.0	0.1	2.1	5.2	7.1	1.1	0.2	4.4	2.0	0.4	0.1	0.0	0.3	0.2	0.6	9.0	0.0	0.8	0.0	4.7	0.5	3.2	0.0	3.6	1.3	0.1	0.2	4.2	0.4	0.0	0.1	2.1	3.2	1.4	5.1	3.6	0.0	1.0	2.6	4.6	0.2	0.4	0.4	1.7	4.0	3.8	2.3	3.4	8.7	1.4	1.4	1.8	13.9	7.1	11.6	0.3	1.0	0.1	3.2	0.0	0.2	1.4	0.1	4.9	2.5	2.1	13.2	6.0	8.4	0.7	0.0	3.0	0.0	3.8	0.0	0.0	1.8	2.2	0.0	0.1	7.2	0.0	1.8	3.0	0.0	2.1	11.0	36.3	3.1	20.1	13.0	5.6	38.1	8.0	17.2	34.0
CLPB	"ANKCLB, FLJ13152, HSP78, SKD3"	ENSG00000162129	"ClpB homolog, mitochondrial AAA ATPase chaperonin"	Q9H078	11	72285495-72434680	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cataract, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 87.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039005, HPA039006, HPA064571"	Enhanced									"HPA039005: AB_2676305, HPA039006: AB_10672767, HPA064571: "	"unprognostic (9.36e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (8.36e-8)"	"unprognostic (9.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.28e-2)"	4.4	6.1	5.7	4.8	7.2	7.9	3.4	5.6	10.5	3.1	3.1	6.7	2.5	3.2	3.8	3.1	3.7	2.9	2.9	4.1	4.9	4.1	6.7	8.5	3.7	3.0	5.7	5.9	3.2	5.5	8.6	3.4	6.5	7.9	2.7	3.1	3.1	4.2	3.3	6.5	2.8	2.9	4.5	3.9	3.9	3.7	87.9	6.4	2.7	4.7	1.8	2.9	3.7	3.0	1.6	18.3	4.0	11.7	1.8	2.4	5.2	6.4	18.5	5.8	11.9	7.9	5.8	15.0	7.0	4.3	10.5	7.9	24.7	9.8	16.7	16.1	6.6	13.8	15.5	15.3	12.9	15.1	11.6	14.1	19.2	14.7	6.8	14.1	25.1	7.7	5.1	18.6	18.8	11.8	19.1	11.8	7.5	17.1	12.7	13.4	6.1	18.5	11.6	8.7	7.2	6.1	11.1	14.6	11.1	9.5	21.9	16.3	11.3	12.3	9.2	15.0	9.7	15.1	13.5	5.7	8.1	9.5	8.0	12.0	11.4	4.0	11.7	0.6	2.4	9.3	2.4	1.5	1.4	2.1	18.3	1.6	1.8	1.4	1.0	1.8	5.2	3.3	0.8	5.2	5.7	7.2	5.6	10.5	4.9	4.1	5.7	5.9	7.9	6.4
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1551	"pancreas: 4260.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.6;HDLM-2: 1.3;T-47d: 3.3;U-2 OS: 3.0;U-266/84: 2.4"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA010512	Enhanced				"Secreted to digestive system"		1100000			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	4260.9	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.4	2.7	0.4	1.3	1.1	0.1	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	3.0	0.0	1.0	0.0	2.4	1.0	0.0	0.9	0.0	0.5	0.4	1.3	0.1	0.2	0.0	0.3	1.1	0.1	0.4	0.5	0.3	0.0	2.7	1.3	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
CLSTN1	"CDHR12, CSTN1, KIAA0911"	ENSG00000171603	"Calsyntenin 1"	O94985	1	9729026-9824526	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 102.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012412	Enhanced						70000000			"HPA012412: AB_1846981"	"unprognostic (4.63e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.07e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-1)"	"prognostic favourable (4.10e-7)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.72e-2)"	13.6	20.1	38.2	15.0	51.2	5.2	15.4	90.5	102.0	24.2	28.6	25.1	11.7	16.7	35.9	14.2	21.0	35.1	25.6	16.3	32.1	31.2	23.3	4.7	16.0	16.4	25.8	53.8	33.6	31.1	27.8	21.0	22.8	32.3	33.6	26.1	29.8	30.0	24.9	10.3	45.6	18.6	28.8	22.0	14.4	15.1	8.1	21.6	15.3	20.9	12.9	16.1	18.0	23.6	2.5	2.7	8.5	1.7	0.9	6.3	2.5	27.2	16.2	23.4	21.8	25.0	16.6	7.7	17.4	19.5	22.3	20.4	11.4	65.8	21.5	45.6	34.3	39.0	13.7	61.5	17.9	24.4	16.7	6.4	20.4	12.0	34.7	12.0	10.4	16.9	42.4	28.8	19.6	31.1	2.9	16.8	10.9	12.7	13.3	6.2	9.8	13.0	20.1	8.6	10.3	27.6	7.9	25.0	15.8	25.1	48.4	19.4	9.8	20.6	46.3	26.4	21.0	17.6	28.8	17.1	15.8	31.1	22.6	19.3	29.8	8.5	1.4	4.3	6.3	1.7	3.3	2.3	4.0	4.7	2.7	2.5	2.9	2.6	0.8	0.9	1.7	1.7	3.6	2.5	38.2	51.2	90.5	99.9	32.1	31.2	25.8	53.8	32.3	21.6
CLSTN3	"CDHR14, CSTN3, KIAA0726"	ENSG00000139182	"Calsyntenin 3"	Q9BQT9	12	7129698-7158945	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 12.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										50000				"prognostic favourable (5.08e-4)"	"unprognostic (2.84e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.73e-3)"	"unprognostic (6.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (1.19e-5)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (4.49e-5)"	"unprognostic (2.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (8.07e-4)"	11.0	16.2	22.1	14.9	37.1	14.4	6.8	51.4	64.0	5.9	6.0	5.7	1.7	8.1	8.1	4.2	4.9	7.2	12.2	4.1	19.2	33.3	14.1	14.6	7.8	15.4	13.3	31.6	13.2	6.9	14.4	15.0	4.1	37.6	5.8	6.0	7.6	8.1	5.7	1.4	11.1	7.1	8.9	6.0	14.1	6.1	3.5	4.0	6.7	6.5	1.0	11.3	12.0	5.6	0.3	0.2	2.6	0.0	12.4	7.2	1.9	6.9	11.7	4.0	9.7	4.9	7.1	18.0	4.1	9.7	7.1	11.7	16.9	11.0	11.2	3.1	8.1	9.1	7.2	8.0	4.3	11.4	6.9	18.6	18.2	15.9	6.7	2.9	33.8	21.1	8.0	9.2	11.2	8.6	17.3	6.9	1.6	2.1	7.2	3.0	11.4	0.7	4.9	0.0	3.3	10.9	13.0	5.2	8.6	9.8	2.4	1.6	4.8	6.8	5.1	4.5	13.6	10.3	2.2	8.5	2.0	1.5	8.0	3.9	2.7	2.6	0.0	0.0	7.2	0.0	4.1	0.3	3.2	6.1	0.2	0.3	1.1	2.5	0.5	12.4	0.0	0.1	3.3	1.9	22.1	37.1	51.4	64.0	19.2	33.3	13.3	31.6	37.6	4.0
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes			2100000	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: , HPA054667: "	"prognostic favourable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (1.01e-4)"	"unprognostic (4.98e-2)"	60.0	64.8	65.0	46.9	60.8	35.4	55.5	68.6	86.3	58.1	71.4	55.5	35.8	65.6	58.1	64.5	63.8	65.2	56.4	31.4	62.6	62.0	72.2	60.0	48.7	53.1	67.1	67.0	78.1	52.8	42.8	47.0	78.2	67.9	53.3	67.6	48.1	58.8	47.6	33.2	47.5	58.3	52.4	71.5	59.6	56.3	48.3	41.9	58.2	77.1	49.4	54.5	46.2	60.5	31.3	57.3	29.1	59.5	22.6	40.5	45.9	60.3	48.5	36.6	27.8	53.5	53.9	59.0	62.7	47.8	50.5	59.5	36.3	27.2	45.7	34.8	41.7	25.8	45.8	43.6	46.5	30.9	37.0	35.0	49.4	37.1	71.9	37.1	32.5	59.2	48.4	57.9	46.0	62.3	30.4	24.1	76.0	21.0	33.3	47.3	58.4	69.5	32.2	24.3	25.9	68.2	43.3	28.4	47.8	26.2	30.8	51.5	27.8	45.9	79.6	40.8	45.9	46.6	65.2	16.2	38.0	48.5	50.3	52.2	35.9	29.1	56.6	28.0	26.5	59.5	27.8	31.3	28.9	27.2	57.3	30.6	26.4	22.8	22.2	22.6	45.6	49.5	40.5	45.9	65.0	60.8	68.6	86.3	62.6	62.0	67.1	67.0	67.9	41.9
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392455-176416569	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 103.7;MCF7: 92.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"			350000	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	20.4	24.1	29.7	18.7	26.7	13.5	16.0	27.5	47.9	27.7	34.7	14.2	11.4	35.4	15.0	15.7	94.2	12.7	28.4	65.7	26.4	26.9	20.3	15.0	15.6	12.2	25.9	22.7	24.3	19.7	17.9	19.8	61.2	28.7	16.8	18.1	19.4	22.2	19.3	93.7	81.8	41.1	27.1	15.4	14.2	39.6	9.9	10.1	14.3	17.2	55.4	31.2	26.1	45.3	4.3	9.9	28.0	9.9	7.4	11.6	3.6	32.8	15.8	4.5	19.1	10.1	7.6	36.8	42.4	16.5	26.9	19.3	20.3	15.4	7.2	25.0	19.0	31.4	7.6	103.7	10.5	49.2	14.1	4.8	23.4	12.5	15.9	7.6	12.9	8.0	36.1	14.7	17.4	12.6	9.2	18.5	14.8	92.2	12.0	11.6	3.6	23.5	13.1	7.9	23.6	14.2	13.4	19.3	6.6	20.1	22.2	14.4	9.0	14.8	27.2	9.7	14.5	17.6	23.9	14.7	10.1	9.7	7.8	16.3	11.0	2.8	9.9	28.0	7.2	7.5	3.7	3.1	6.4	7.0	9.9	4.3	5.2	5.5	18.7	7.4	9.7	8.0	11.6	3.6	29.7	26.7	27.5	47.9	26.4	26.9	25.9	22.7	28.7	10.1
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"			51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: "	"unprognostic (1.56e-1)"	"prognostic unfavourable (7.35e-4)"	"prognostic favourable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavourable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	46.9	71.1	35.1	34.7	59.3	48.3	40.1	50.5	53.3	45.3	47.3	43.5	28.9	32.7	58.0	71.7	31.0	52.2	42.0	60.5	35.1	28.1	53.6	45.0	67.5	45.2	36.6	31.0	45.7	25.7	68.8	44.4	50.0	53.3	46.3	70.5	83.7	21.7	10.9	30.2	41.5	19.3	58.8	39.6	50.7	66.7	31.5	37.5	31.3	20.5	29.9	48.7	23.1	63.9	83.1	49.6	39.6	51.7	36.5	51.2	30.2	60.9	24.8	50.7	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291716	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 53.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 34.3;K-562: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 3.3;neutrophil: 8.4"	"Group enriched"	"Detected in many"	15	"granulocytes: 8.4;monocytes: 3.3"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles				Vesicles		"HPA075327: , HPA075795: "	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	2.9	3.3	1.1	0.9	2.0	9.7	1.6	3.4	1.8	1.3	1.0	3.7	1.2	0.4	2.3	3.1	2.2	1.4	0.9	5.6	1.3	1.7	1.0	1.7	1.2	0.6	2.7	1.4	1.4	0.9	2.1	14.9	1.1	4.1	1.8	0.8	4.2	1.5	1.1	53.0	2.1	0.9	2.4	3.6	0.9	1.0	17.2	1.2	1.3	2.7	10.4	0.7	1.2	1.3	0.2	0.3	8.4	3.3	0.0	0.3	0.6	2.2	2.3	1.5	2.5	5.8	3.2	0.7	1.6	1.7	2.3	3.4	0.8	0.7	0.9	0.2	3.6	0.8	2.4	4.5	1.8	0.1	2.4	0.1	2.2	2.7	2.9	3.2	34.3	13.7	3.7	4.1	5.8	1.4	16.0	0.9	5.2	1.8	0.4	11.4	2.0	1.9	1.2	13.1	0.0	1.7	0.9	3.7	0.6	3.4	2.1	0.2	4.6	13.8	0.4	4.0	8.6	2.2	2.6	1.8	4.2	0.4	2.4	8.8	0.8	0.0	3.3	0.3	0.1	0.7	0.0	0.0	0.1	0.3	0.3	0.2	0.3	0.0	8.4	0.0	0.0	0.1	0.0	0.6	1.1	2.0	3.4	1.8	1.3	1.7	2.7	1.4	4.1	1.2
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27615031	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 580.4;liver: 590.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 233.1;SK-BR-3: 203.8;T-47d: 148.7;U-2 OS: 133.0"	"Cancer enhanced"	"Detected in all"		"glioma: 1485.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 69.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 69.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253"	Enhanced				"Secreted to blood"	131033333333	36000000000			"CAB016253: AB_673562, HPA000572: AB_1078539"	"unprognostic (1.10e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.74e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.72e-1)"	"prognostic favourable (7.66e-5)"	"unprognostic (5.29e-2)"	82.5	217.4	233.5	50.2	280.3	3.4	90.4	141.2	414.7	78.3	47.9	139.5	184.6	19.9	55.4	580.4	48.3	217.2	172.7	24.6	176.2	154.7	69.8	590.5	30.5	127.3	209.0	173.1	49.6	134.8	220.4	34.3	8.5	189.0	63.4	18.0	125.4	62.2	359.2	7.7	12.8	24.0	87.9	255.2	17.2	56.6	161.5	113.5	5.3	106.6	11.8	134.8	72.2	54.7	0.1	1.3	69.2	2.1	0.9	2.7	110.6	0.7	96.0	4.2	4.9	23.8	32.8	13.4	17.0	33.6	4.5	2.3	18.4	15.2	0.3	68.3	15.1	32.2	18.2	2.7	2.9	70.8	17.6	41.6	233.1	22.6	20.8	1.0	111.1	54.9	11.0	19.4	5.6	59.1	0.5	49.0	1.5	16.1	0.3	3.1	35.0	11.4	0.3	16.1	13.3	44.4	69.3	3.9	2.4	23.6	203.8	1.0	148.7	0.6	8.7	1.3	133.0	7.6	5.7	6.3	22.4	0.7	107.0	6.9	0.6	69.2	2.1	0.9	2.3	0.6	0.8	0.0	2.7	2.5	0.7	0.1	0.3	0.8	9.6	0.9	0.1	1.3	0.7	110.6	233.5	280.3	141.2	223.1	176.2	154.7	209.0	173.1	189.0	113.5
CMA1		ENSG00000092009	"Chymase 1"	P23946	14	24505353-24508265	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;BEWO: 1.5;HL-60: 1.7;TIME: 1.5;U-937: 3.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.5"	"Low region specificity"	"Detected in single"							"CAB000363, HPA052634"	Enhanced				"Secreted to blood"	3000000				"CAB000363: AB_2083616, HPA052634: "	"unprognostic (1.37e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.04e-1)"			"unprognostic (7.07e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.91e-3)"	"unprognostic (4.19e-3)"	"unprognostic (1.29e-4)"	"unprognostic (2.52e-3)"	"unprognostic (7.78e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.98e-3)"	12.3	0.2	0.2	2.9	0.2	0.0	15.9	0.2	0.2	7.3	6.2	0.2	1.2	0.1	2.9	6.0	8.3	1.0	10.0	10.3	0.2	0.2	2.0	0.8	1.1	1.6	0.2	0.2	0.6	0.9	0.5	0.5	0.7	0.3	6.0	6.9	3.0	5.9	1.3	1.2	13.0	5.3	6.2	0.2	0.5	2.4	2.7	0.2	1.0	0.4	7.9	3.9	4.1	2.0	0.3	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	1.6	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.4	0.9	1.1	1.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.8	0.0	0.8	1.5	0.0	0.3	0.3	0.3	0.9	1.0	0.3	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2
CMAS		ENSG00000111726	"Cytidine monophosphate N-acetylneuraminic acid synthetase"	Q8NFW8	12	22046174-22065674	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039905	Supported		Uncertain	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA039905: AB_10795237"	"unprognostic (5.54e-2)"	"unprognostic (4.10e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.91e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.03e-1)"	8.1	28.2	28.1	9.6	31.6	17.6	14.9	16.3	39.3	12.1	34.3	14.5	17.1	29.4	12.8	32.0	33.2	10.0	11.0	18.1	28.8	33.4	12.8	31.9	7.9	9.8	33.9	27.3	11.9	18.6	14.6	14.3	20.2	34.3	17.0	33.1	10.2	14.8	12.9	18.2	12.9	32.9	13.3	18.0	8.5	12.9	30.2	14.8	6.4	10.9	11.9	12.4	11.8	17.2	12.2	19.5	19.4	18.9	22.8	19.9	15.0	19.5	15.8	19.5	9.2	15.3	19.2	28.4	13.7	15.0	14.9	15.7	35.4	22.7	17.4	13.4	11.7	16.0	11.5	19.0	20.1	22.9	14.4	52.4	12.9	17.8	14.3	13.8	27.8	12.9	18.1	18.9	28.3	19.7	32.9	8.9	26.3	25.8	15.8	32.1	47.1	22.1	11.3	20.4	16.5	17.7	21.5	7.8	13.7	10.8	19.1	15.3	26.3	18.9	14.3	16.8	13.9	14.7	25.1	6.1	7.8	23.1	27.3	10.8	16.9	10.3	17.9	19.4	13.7	18.9	17.8	12.2	18.6	18.1	19.5	12.1	16.8	17.4	1.8	22.8	16.5	12.3	19.9	15.0	28.1	31.6	16.3	39.3	28.8	33.4	33.9	27.3	34.3	14.8
CMPK1	"CMPK, UMP-CMPK"	ENSG00000162368	"Cytidine/uridine monophosphate kinase 1"	P30085	1	47333797-47378839	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Pyrimidine biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053730, HPA058604"	Approved		Supported	Nucleoplasm	"Intracellular and membrane"		2100000	Nucleoplasm		"HPA053730: AB_2682244, HPA058604: AB_2683773"	"unprognostic (2.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.02e-3)"	"unprognostic (7.36e-2)"	35.0	17.0	28.5	30.4	24.4	14.8	72.2	18.0	35.8	26.8	44.8	17.8	20.9	53.7	16.5	19.3	42.2	13.5	39.2	28.6	28.0	31.4	26.2	88.2	36.8	46.2	35.1	16.8	16.2	42.3	19.3	16.6	16.0	25.4	32.8	48.1	16.2	50.8	18.3	30.4	22.2	64.9	46.9	33.1	21.6	35.9	8.6	18.2	25.6	31.7	26.7	28.0	34.0	39.0	11.2	10.6	23.1	12.4	15.0	17.5	12.1	30.3	17.0	22.0	19.7	40.3	47.2	31.3	54.1	32.6	32.9	33.5	15.1	21.1	45.0	27.9	36.7	20.7	16.3	28.0	45.1	68.1	13.3	35.0	23.5	26.1	26.3	49.8	25.6	26.4	33.9	27.4	30.8	34.0	32.9	36.4	42.8	11.1	40.4	23.5	14.0	23.6	25.2	38.2	33.8	32.0	33.5	20.0	10.6	38.7	45.0	31.0	11.2	29.8	31.8	41.2	23.8	39.3	44.4	26.5	36.6	30.7	32.5	30.9	28.1	23.1	10.2	18.2	13.6	10.7	17.5	11.2	15.5	16.7	10.6	10.2	14.7	14.0	4.2	15.0	12.4	8.9	16.0	12.1	28.5	24.4	18.0	35.8	28.0	31.4	35.1	16.8	25.4	18.2
CNBP	"CNBP1, DM2, RNF163, ZCCHC22, ZNF9"	ENSG00000169714	"CCHC-type zinc finger nucleic acid binding protein"	P62633	3	129169484-129183922	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063097			Supported	Nucleoplasm,Cytosol			43000	"Nucleoplasm, Cytosol"		"HPA063097: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-2)"	"unprognostic (4.84e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (7.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (4.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (1.89e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.58e-1)"	54.2	52.8	36.4	33.6	33.7	35.9	46.6	43.5	35.6	58.1	47.1	34.5	40.5	32.4	54.5	49.4	55.6	40.9	48.5	78.2	33.0	32.0	38.0	71.6	47.5	40.6	39.7	30.3	67.4	65.4	39.3	33.5	41.5	33.3	62.3	37.1	41.3	48.9	50.9	182.1	46.7	40.6	71.9	38.0	43.2	43.1	32.1	33.1	39.0	67.3	81.1	41.2	76.1	63.5	74.3	60.3	120.1	84.1	61.7	83.4	172.9	61.2	36.3	53.0	42.0	53.0	45.5	41.8	48.2	76.5	52.6	60.5	53.2	43.2	81.5	41.4	44.8	46.1	69.2	55.9	71.3	54.7	50.4	78.7	37.5	57.2	52.8	84.4	45.3	43.9	65.6	36.8	133.0	46.4	58.9	56.1	55.0	73.3	78.2	62.1	64.6	61.4	68.8	49.2	97.1	54.4	59.1	72.2	57.8	38.0	37.6	102.2	43.3	58.1	48.8	39.0	38.4	53.5	48.7	52.8	48.0	128.2	40.1	57.9	51.4	93.4	84.1	96.8	64.1	63.8	80.6	74.3	77.4	68.9	60.3	62.7	83.4	72.0	120.1	61.7	48.9	35.1	73.9	172.9	36.4	33.7	43.5	35.6	33.0	32.0	39.7	30.3	33.3	33.1
CNDP1	"CN1, CPGL2, HsT2308, MGC10825"	ENSG00000150656	"Carnosine dipeptidase 1"	Q96KN2	18	74534440-74587212	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 60.3;liver: 41.4"	"Cell line enriched"	"Detected in single"	69	"U-266/84: 41.2"	"Group enriched"	"Detected in some"	10	"glioma: 4.4;liver cancer: 1.0;melanoma: 1.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008933	Enhanced				"Secreted in brain"		1900000000			"HPA008933: AB_1847033"	"unprognostic (7.43e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	1.1	1.2	14.9	1.2	28.2	1.3	1.1	4.5	60.3	1.1	1.1	54.9	0.0	5.7	1.1	2.1	1.1	1.1	1.3	1.1	28.9	15.1	1.9	41.4	1.1	1.2	44.1	12.9	1.1	1.2	1.1	0.1	1.1	50.0	1.2	1.1	0.5	1.1	1.3	2.2	1.1	1.9	1.1	51.1	1.1	1.2	1.4	28.8	0.0	1.3	0.0	1.1	1.1	0.0	0.7	0.7	1.9	0.5	1.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	41.2	0.0	0.0	0.0	0.0	1.3	0.5	0.4	0.4	0.2	0.2	0.3	0.3	0.2	0.1	0.7	0.4	0.4	1.9	1.0	0.2	0.7	0.2	0.2	14.9	28.2	4.5	22.5	28.9	15.1	44.1	12.9	50.0	28.8
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 75.1;RPMI-8226: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol			2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.0	13.6	9.9	9.3	12.1	7.2	41.6	10.6	10.0	14.5	14.5	7.9	10.8	12.7	13.5	11.5	15.3	15.0	20.1	10.4	19.0	5.9	12.6	6.9	12.5	17.6	24.7	19.7	10.8	15.5	12.5	22.7	12.7	13.3	75.1	9.6	11.3	13.1	11.8	14.9	8.1	14.3	11.4	96.6	57.1	42.2	10.7	5.6	8.3	59.0	14.1	24.7	10.2	13.2	15.6	13.3	3.4	7.1	14.1	57.6	17.0	10.5	18.1	13.0	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;RPMI-8226: 3.3;SCLC-21H: 9.4;SiHa: 5.4"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol				Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.6	1.7	0.9	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.2	0.1	0.0	3.3	0.0	1.2	9.4	0.1	5.4	2.7	0.0	0.1	0.1	0.7	0.3	0.4	0.4	0.1	0.2	0.5	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0
CNMD	"BRICD3, CHM-I, CHM1, LECT1, MYETS1"	ENSG00000136110	Chondromodulin	O75829	13	52703264-52739812	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.1;salivary gland: 15.1;thyroid gland: 8.0"	"Cell line enriched"	"Detected in single"	137	"NTERA-2: 32.4"	"Group enriched"	"Detected in many"	5	"glioma: 1.5;lung cancer: 6.0;testis cancer: 5.8;thyroid cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010510	Uncertain				"Secreted to extracellular matrix"					"HPA010510: AB_10602021"	"unprognostic (7.52e-3)"		"unprognostic (1.34e-1)"		"unprognostic (7.36e-2)"			"unprognostic (1.45e-2)"		"unprognostic (1.15e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-1)"		0.3	0.3	3.1	0.3	11.1	0.3	0.4	0.9	2.5	0.3	0.5	4.3	0.0	0.3	0.3	0.3	0.6	0.4	0.3	0.4	3.0	2.6	0.3	0.3	3.9	0.3	3.7	0.9	0.4	1.1	0.3	2.5	0.5	3.1	1.6	0.5	6.1	15.1	0.4	0.5	0.5	0.4	0.3	4.4	1.0	0.4	4.2	4.1	0.0	8.0	0.0	0.6	0.3	0.0	0.0	0.6	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	3.1	11.1	0.9	2.3	3.0	2.6	3.7	0.9	3.1	4.1
CNN2		ENSG00000064666	"Calponin 2"	Q99439	19	1026581-1039068	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA049095	Approved		Approved	"Nucleoplasm,Actin filaments,Cytosol"			39000000	Cytosol	"Nucleoplasm, Actin filaments"	"HPA049095: "	"unprognostic (2.52e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.58e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (4.70e-7)"	"unprognostic (1.28e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.54e-1)"	36.6	6.5	1.3	46.2	2.5	44.2	29.2	2.0	3.0	38.2	16.9	5.4	22.2	5.5	35.5	24.5	39.4	25.0	40.1	18.7	1.5	1.5	24.6	15.8	54.7	61.5	3.5	1.5	81.1	26.8	1.9	6.9	21.5	4.8	35.6	7.8	26.3	40.9	34.4	6.1	21.3	17.7	28.2	2.9	59.4	21.1	15.9	2.1	37.0	68.1	27.3	78.6	37.9	51.2	33.6	29.3	115.7	26.3	27.1	57.0	43.1	37.2	12.6	35.1	43.7	18.1	34.5	27.3	33.7	37.4	42.6	33.1	43.3	32.2	24.5	34.6	60.9	36.7	20.8	53.9	28.4	17.0	1.7	17.0	20.2	33.8	72.6	15.9	39.2	58.7	25.7	26.9	20.4	23.9	10.1	38.2	34.6	7.1	1.4	14.6	43.3	5.5	8.4	12.4	27.7	41.8	44.8	0.0	2.5	42.7	5.8	4.8	42.4	26.8	58.7	23.3	24.2	35.6	34.3	17.8	13.5	48.9	13.7	19.1	37.2	61.3	18.6	81.0	34.8	24.2	57.0	33.6	43.7	46.4	29.3	30.8	37.3	36.3	115.7	27.1	26.3	13.0	45.6	43.1	1.3	2.5	2.0	3.0	1.5	1.5	3.5	1.5	4.8	2.1
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927278	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 95.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.7;naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	14	"B-cells: 9.7;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"			320000	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: "	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.99e-4)"	49.3	78.5	53.4	27.9	53.9	1.2	82.7	25.3	44.7	55.1	36.3	30.8	20.8	45.4	74.0	31.4	53.6	39.4	55.3	33.0	46.8	40.3	74.2	50.6	59.0	28.6	45.3	27.0	61.5	28.0	21.6	33.5	88.5	67.8	38.8	30.2	47.5	32.9	48.9	16.1	16.6	33.4	68.6	78.2	30.8	30.6	21.1	41.9	9.3	44.3	18.4	17.2	48.7	74.5	9.7	0.1	0.4	0.1	0.7	11.1	2.6	44.8	8.7	49.6	43.7	35.5	31.9	22.0	21.7	43.0	36.6	58.1	40.2	4.0	0.0	50.1	28.0	12.9	36.2	19.3	53.0	0.1	12.8	2.0	6.1	30.4	66.0	0.0	0.0	29.8	3.0	45.2	10.5	32.8	0.4	4.1	95.4	0.0	2.1	0.1	38.1	4.7	0.0	59.2	0.2	47.7	18.7	3.0	30.4	18.1	7.7	30.6	13.9	4.5	20.1	24.5	42.0	9.0	70.6	5.0	2.9	0.1	5.3	0.0	36.7	0.1	0.0	0.0	1.9	0.1	3.1	3.9	2.0	1.1	0.1	9.7	11.1	7.6	0.4	0.7	0.1	0.0	0.0	2.6	53.4	53.9	25.3	43.6	46.8	40.3	45.3	27.0	67.8	41.9
CNOT1	"AD-005, CDC39, KIAA1007, NOT1, NOT1H"	ENSG00000125107	"CCR4-NOT transcription complex subunit 1"	A5YKK6	16	58519951-58629886	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046577, HPA049664"	Approved		Supported	Cytosol			210000	Cytosol		"HPA046577: , HPA049664: "	"unprognostic (1.30e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.39e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.52e-1)"	20.4	26.5	14.9	31.5	16.5	18.2	18.8	24.2	16.8	21.3	26.6	16.7	26.6	24.3	22.2	19.1	45.6	19.0	15.4	15.5	14.2	9.0	18.8	20.9	19.6	24.1	19.0	12.3	22.6	21.8	39.6	25.4	23.2	16.1	15.9	26.6	17.3	28.3	27.2	32.6	27.4	31.4	20.0	13.6	25.8	22.7	53.9	18.1	45.1	20.2	22.6	32.6	26.9	26.0	15.4	14.6	18.8	20.9	14.6	19.2	10.6	25.9	30.6	23.3	18.7	11.3	14.5	26.8	20.6	18.0	23.7	17.6	34.6	15.7	39.6	9.9	15.7	25.6	37.4	21.0	32.1	14.7	20.4	30.8	25.2	39.5	15.4	47.4	34.5	13.9	14.4	27.5	32.4	18.4	36.0	11.6	16.0	10.6	36.6	12.4	24.1	26.6	46.7	40.3	25.1	13.4	36.6	19.3	12.5	69.9	23.7	11.7	14.2	24.8	20.6	17.4	17.3	13.1	18.0	26.5	26.7	80.4	18.4	20.2	16.1	18.3	11.6	13.0	14.6	15.9	19.2	15.4	14.1	14.6	14.6	14.2	12.6	13.5	18.8	14.6	20.9	7.4	14.8	10.6	14.9	16.5	24.2	16.8	14.2	9.0	19.0	12.3	16.1	18.1
CNOT8	"CAF1, CALIF, hCAF1, POP2"	ENSG00000155508	"CCR4-NOT transcription complex subunit 8"	Q9UFF9	5	154857553-154876793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Exonuclease, Hydrolase, Nuclease, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051398	Approved									"HPA051398: "	"unprognostic (2.51e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.66e-2)"	"prognostic favourable (6.41e-4)"	40.5	28.0	23.6	20.9	23.8	60.1	30.3	20.3	29.2	26.0	23.5	21.3	19.5	19.0	21.1	22.5	18.2	18.2	17.5	17.2	23.2	16.1	17.1	16.6	33.5	30.5	33.0	18.3	20.0	16.2	20.1	17.8	23.9	24.4	17.4	27.5	16.5	24.1	17.5	14.3	28.0	23.7	23.2	25.9	30.7	19.1	24.4	26.2	41.5	36.0	11.3	29.5	24.6	22.8	20.5	33.4	65.4	31.9	20.9	31.5	36.6	12.0	13.9	24.2	26.6	23.2	21.2	18.4	18.6	20.7	20.5	31.9	17.8	27.0	21.2	23.5	15.9	13.3	16.7	23.1	23.4	10.5	17.3	17.7	21.6	15.7	14.7	40.7	33.0	14.4	20.3	18.3	15.9	25.2	15.6	16.0	21.4	14.4	35.9	42.6	13.1	8.2	30.2	20.5	22.0	16.2	16.7	19.0	28.4	24.9	20.1	23.1	18.8	33.5	19.5	21.8	13.7	11.9	12.2	15.5	19.9	32.6	15.3	32.5	13.5	55.0	31.9	65.4	19.3	22.6	21.4	20.5	24.0	23.1	33.4	20.4	31.5	22.7	32.2	20.9	17.7	18.0	26.0	36.6	23.6	23.8	20.3	29.2	23.2	16.1	33.0	18.3	24.4	26.2
CNP		ENSG00000173786	"2',3'-cyclic nucleotide 3' phosphodiesterase"	P09543	17	41966741-41977731	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 211.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 49.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002672, HPA023266, HPA023278, HPA023280, HPA023338"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol			730000	Nucleoplasm	Cytosol	"CAB002672: , HPA023266: AB_1847058, HPA023278: AB_1847060, HPA023280: AB_1847061, HPA023338: AB_1847062"	"unprognostic (2.17e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.10e-3)"	9.1	8.9	51.4	9.5	72.8	6.7	8.1	13.4	125.3	10.3	7.5	211.7	2.3	7.1	8.0	12.7	15.0	9.3	10.8	7.6	78.4	40.7	14.7	9.6	6.7	10.5	86.7	49.0	11.2	9.2	5.8	4.4	7.8	66.7	11.7	6.4	3.6	15.1	13.2	7.6	11.1	6.4	10.1	160.2	7.1	7.4	4.6	63.5	2.1	7.2	2.2	11.2	9.8	5.7	9.9	49.1	7.3	13.1	7.3	7.5	9.1	13.7	23.5	22.3	27.5	19.1	18.0	9.6	17.2	26.5	44.8	50.6	18.4	12.6	14.6	13.9	22.4	23.7	15.0	11.4	15.6	14.5	19.0	14.2	16.2	31.9	20.6	13.8	12.9	29.7	8.2	24.5	6.0	20.4	10.0	12.0	15.6	8.7	35.4	12.5	5.2	16.8	22.1	32.8	14.2	11.9	14.1	13.1	17.7	21.8	32.9	38.3	14.7	20.7	20.4	17.5	19.2	23.7	20.3	13.5	15.3	11.7	17.3	10.7	68.2	4.9	12.1	7.3	7.5	13.1	5.9	9.9	6.5	6.0	11.1	7.0	5.9	6.9	2.6	7.3	10.3	49.1	7.2	9.1	51.4	72.8	13.4	93.8	78.4	40.7	86.7	49.0	66.7	63.5
CNPY2	"Cnpy2, HP10390, TMEM4, ZSIG9"	ENSG00000257727	"Canopy FGF signaling regulator 2"	Q9Y2B0	12	56309842-56316336	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038465, HPA038466"	Supported		Supported	Cytosol	"Intracellular and membrane"		62000	Cytosol		"HPA038465: AB_10967609, HPA038466: AB_10672646"	"unprognostic (3.83e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (8.37e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavourable (2.32e-8)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.06e-2)"	17.8	31.4	19.0	16.1	23.8	14.0	27.3	17.3	24.1	29.9	23.7	23.3	40.1	23.0	21.1	46.4	19.1	26.1	19.9	16.9	19.0	20.4	26.7	53.2	17.3	14.9	21.2	21.8	25.7	59.9	19.9	39.3	39.7	21.6	23.4	24.2	18.9	46.2	33.4	10.9	12.3	26.4	16.8	22.5	20.2	23.6	13.7	20.4	13.0	38.0	15.5	16.2	19.7	17.4	33.1	35.3	22.2	36.4	30.1	38.7	33.7	16.3	29.4	21.1	19.3	57.5	22.5	42.7	18.6	37.0	34.7	24.7	39.2	29.2	15.2	32.1	40.0	23.8	26.3	20.8	20.2	18.3	24.6	14.6	31.0	34.5	28.6	27.4	22.3	26.1	31.6	28.5	32.2	28.0	23.3	39.2	23.8	26.8	16.8	32.5	21.5	41.9	19.8	17.3	32.1	26.9	12.6	22.7	13.4	27.3	27.3	27.3	25.8	60.3	15.1	15.2	11.5	16.4	22.2	19.3	25.6	11.4	28.1	26.8	24.2	22.2	36.4	18.3	33.4	26.1	38.7	33.1	37.2	35.2	35.3	27.6	37.9	34.3	5.2	30.1	15.9	34.3	31.2	33.7	19.0	23.8	17.3	24.1	19.0	20.4	21.2	21.8	21.6	20.4
CNTF	HCNTF	ENSG00000242689	"Ciliary neurotrophic factor"	P26441	11	58622673-58625733	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 47.5"	"Cell line enhanced"	"Detected in many"		"U-2197: 12.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"midbrain: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA019654	Approved		Approved	Vesicles				Vesicles		"HPA019654: AB_1859050"	"unprognostic (1.88e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.24e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.25e-4)"	"unprognostic (5.42e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.50e-2)"	"unprognostic (9.67e-2)"	2.0	0.7	1.4	0.9	4.8	10.0	0.8	1.2	1.6	0.3	0.9	2.5	1.1	1.4	0.3	1.4	0.9	8.3	0.8	2.5	1.8	1.6	0.9	0.9	0.8	0.6	47.5	0.9	0.3	0.5	1.2	0.5	0.6	9.3	0.6	1.3	3.1	1.3	0.4	3.7	0.9	0.9	0.6	22.8	0.6	0.5	0.7	1.2	0.2	1.0	3.7	0.6	0.6	0.3	0.4	0.0	0.0	0.3	0.0	0.7	0.2	2.1	0.8	3.4	3.5	1.0	0.3	1.7	1.6	2.2	1.6	1.2	2.9	2.9	4.3	1.2	2.2	3.8	3.6	3.9	3.2	3.0	2.1	2.3	4.3	1.6	0.4	3.3	4.2	1.0	1.3	5.3	1.7	1.7	3.4	1.0	2.0	0.9	3.2	3.1	2.1	1.5	2.2	2.4	3.0	1.9	2.5	1.5	4.2	2.2	2.3	5.8	2.9	2.4	1.2	2.5	1.9	12.7	4.0	2.4	4.9	3.7	6.6	1.7	2.9	0.0	0.3	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.4	4.8	1.2	1.4	1.8	1.6	47.5	0.9	9.3	1.2
CNTFR		ENSG00000122756	"Ciliary neurotrophic factor receptor"	P26992	9	34551432-34590140	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 44.7;skeletal muscle: 33.6"	"Group enriched"	"Detected in some"	6	"AF22: 46.8;SH-SY5Y: 22.4"	"Cancer enhanced"	"Detected in many"		"glioma: 22.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB025310	Approved						36000000			"CAB025310: "	"unprognostic (1.39e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.72e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.99e-3)"	"unprognostic (7.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	44.7	9.4	17.0	2.2	27.9	0.7	17.3	30.6	28.7	11.1	5.8	8.2	1.1	3.4	2.6	2.9	3.9	5.6	5.7	10.1	18.6	11.7	1.9	6.5	2.2	1.5	15.5	9.8	4.5	2.4	0.8	2.5	4.8	12.0	5.3	2.5	7.5	9.0	7.6	33.6	4.4	6.0	1.8	6.3	16.1	3.0	4.9	10.9	0.2	3.2	3.8	1.0	1.4	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	22.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	27.9	30.6	22.0	18.6	11.7	15.5	9.8	12.0	10.9
CNTN1	"F3, GP135"	ENSG00000018236	"Contactin 1"	Q12860	12	40692442-41072418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.2"	"Cell line enhanced"	"Detected in some"		"A549: 70.2;HaCaT: 12.7;SCLC-21H: 21.6;SH-SY5Y: 13.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025200, HPA070467"	Enhanced				"Intracellular and membrane"		490000000			"CAB025200: , HPA070467: "	"unprognostic (3.18e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.66e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.32e-2)"	"unprognostic (8.15e-4)"	"unprognostic (6.98e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (3.75e-4)"	2.9	21.0	27.8	2.1	21.5	0.8	5.7	47.1	81.2	9.9	2.5	14.3	0.7	1.8	7.9	2.2	6.5	2.1	8.2	1.1	27.5	22.1	8.2	1.4	3.3	3.1	23.0	27.7	32.3	4.5	0.8	7.7	0.8	27.0	18.4	3.0	6.9	3.8	18.1	1.1	8.3	2.5	14.4	32.2	5.3	3.0	5.9	17.8	0.0	1.4	0.5	2.9	11.8	3.6	1.6	2.2	6.4	1.4	1.9	1.3	0.2	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	12.7	1.9	3.3	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	21.6	13.1	0.0	0.7	0.8	0.0	0.1	0.0	0.0	1.3	0.0	2.9	0.9	0.0	0.0	0.1	0.0	0.2	6.4	1.4	1.9	1.1	0.8	1.0	1.3	0.9	0.6	0.2	1.6	1.3	0.9	4.1	1.9	0.9	2.2	0.7	0.2	27.8	21.5	47.1	32.6	27.5	22.1	23.0	27.7	27.0	17.8
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	7	"NTERA-2: 5.6;SCLC-21H: 14.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"		13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3
CNTN3	"BIG-1, PANG"	ENSG00000113805	"Contactin 3"	Q9P232	3	74262568-74521140	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.9;fallopian tube: 8.7"	"Group enriched"	"Detected in some"	5	"BJ: 7.3;fHDF/TERT166: 19.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003341	Approved				"Intracellular and membrane"		54000000			"HPA003341: AB_1078556"	"unprognostic (1.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.86e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.94e-5)"	"unprognostic (4.25e-2)"	"unprognostic (2.13e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.30e-7)"	"unprognostic (4.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	2.2	3.3	5.3	0.0	3.0	0.0	1.2	1.2	8.9	2.6	3.3			0.1	0.7	1.7	0.1	8.7	2.1	1.7	4.4	3.9	4.1	3.2	0.6	0.0	1.4		0.9	1.6	0.0	3.7	0.0		6.9	3.0		0.3	5.1	0.0	0.3	0.2	0.1	0.5	1.7	1.0	0.4			1.5		0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	7.3	0.0	1.2	0.4	0.0	0.0	0.0	0.0	19.9	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.3	2.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057956	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 29.2"	"Group enriched"	"Detected in some"	6	"BEWO: 8.5;CACO-2: 9.0;HEK 293: 5.6;SH-SY5Y: 17.2;WM-115: 5.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		89000000				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favourable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.7	1.2	5.8	1.5	8.6	0.1	2.9	20.6	14.6	9.2	4.3	0.7	2.0	1.7	7.9	3.1	3.0	4.1	4.8	3.1	2.4	3.2	4.2	2.6	3.4	3.1	3.4	6.8	1.9	1.9	29.2	16.6	7.4	3.1	4.4	3.2	7.6	2.1	5.7	1.4	1.6	3.9	4.4	2.1	0.9	3.2	15.7	0.4	0.4	21.6	1.3	2.4	3.7	4.1	1.0	0.6	1.8	0.5	0.4	0.6	0.1	0.0	0.0	1.2	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.2	17.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	1.8	0.5	0.6	0.5	0.2	0.4	0.7	0.5	0.5	0.0	1.0	0.6	0.6	1.0	0.4	0.3	0.6	0.3	0.1	5.8	8.6	20.6	14.6	2.4	3.2	3.4	6.8	3.1	0.4
CNTN5	"hNB-2, NB-2"	ENSG00000149972	"Contactin 5"	O94779	11	99020953-100358885	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.9;pituitary gland: 12.0;salivary gland: 28.4"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.2;TIME: 2.1;U-138 MG: 1.0;U-266/70: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA039492, HPA041223"	Approved				"Intracellular and membrane"		100000			"HPA039492: AB_10795108, HPA041223: AB_10794549"	"unprognostic (2.09e-2)"	"unprognostic (3.40e-1)"		"unprognostic (8.99e-3)"	"unprognostic (4.20e-2)"	"unprognostic (6.51e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"		"unprognostic (6.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.72e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	0.3	0.5	6.5	0.3	4.0	0.2	0.2	0.6	10.9	0.7	0.4	0.5	0.0	0.3	0.6	0.3	0.3	3.8	0.3	0.4	5.0	3.4	1.4	0.5	0.7	0.3	1.4	2.0	0.4	0.9	0.2	12.0	7.4	3.9	0.5	0.3	0.0	28.4	1.1	0.2	0.2	0.3	0.4	0.5	0.2	0.5	0.8	0.3	0.0	5.9	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.8	0.2	2.1	1.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.0	0.6	10.9	5.0	3.4	1.4	2.0	3.9	0.3
CNTNAP2	"Caspr2, KIAA0868, NRXN4"	ENSG00000174469	"Contactin associated protein like 2"	Q9UHC6	7	146116002-148420998	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Autism, Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8"	"Group enriched"	"Detected in some"	4	"AF22: 7.3;CACO-2: 6.1;NTERA-2: 10.9;SCLC-21H: 19.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	31	"memory B-cell: 1.8;naive B-cell: 6.1"	"Lineage enriched"	"Detected in single"	48	"B-cells: 6.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002739	Enhanced									"HPA002739: AB_1078545"	"unprognostic (2.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.05e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.00e-3)"	0.9	2.0	14.0	1.2	16.6	0.9	2.2	4.4	25.8	0.7	2.3	1.2	0.0	0.7	0.9	0.7	1.4	2.2	0.8	1.0	9.6	6.4	1.0	3.5	0.8	1.6	7.5	16.2	1.7	1.1	0.7	2.7	1.9	17.0	8.7	1.6	2.5	0.9	1.0	0.7	0.8	2.0	0.8	18.1	1.7	1.2	1.4	0.5	2.4	1.5	0.0	1.3	0.8	0.5	6.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.3	1.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.0	0.2	1.8	1.6	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	2.0	0.0	0.0	19.7	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	14.0	16.6	4.4	25.8	9.6	6.4	7.5	16.2	17.0	0.5
CNTRL	"CEP1, CEP110"	ENSG00000119397	Centriolin	Q7Z7A1	9	121074863-121177610	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020468, HPA020480, HPA051583"	Approved		Supported	Centrosome,Cytosol				Centrosome	Cytosol	"HPA020468: , HPA020480: , HPA051583: "	"unprognostic (4.33e-3)"	"unprognostic (2.89e-3)"	"unprognostic (2.09e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.21e-5)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.60e-3)"	"unprognostic (9.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.13e-2)"	7.7	4.7	5.5	22.2	11.7	24.0	6.8	10.9	8.7	8.4	5.5	4.9	5.9	3.8	7.3	6.4	5.6	8.4	5.1	4.4	6.6	4.3	4.0	3.8	9.3	20.3	8.1	4.1	10.6	5.2	4.0	17.3	5.8	7.0	7.2	5.5	4.4	6.3	8.6	2.8	5.2	8.8	5.7	9.7	14.8	7.1	30.2	9.8	26.7	6.2	4.2	19.2	8.6	7.1	12.7	10.5	15.0	6.9	4.8	10.4	2.5	5.3	3.6	10.0	7.2	1.5	2.3	1.7	3.7	2.8	2.9	2.5	2.1	5.9	24.6	1.4	2.7	11.3	3.3	2.2	4.8	14.9	2.6	12.8	6.5	2.5	2.1	34.8	15.6	1.4	1.7	3.1	7.5	6.4	8.3	14.1	2.8	3.4	13.6	11.9	3.4	2.9	12.9	15.1	7.0	1.4	2.5	3.8	5.7	12.7	2.3	2.9	4.9	16.7	4.7	3.1	5.4	4.8	6.8	9.8	10.7	16.7	2.6	14.4	7.1	12.2	6.9	15.0	7.5	4.5	5.7	10.8	7.7	5.5	3.4	12.7	9.3	6.6	2.7	4.8	5.8	10.5	10.4	2.5	5.5	11.7	10.9	8.7	6.6	4.3	8.1	4.1	7.0	9.8
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.1;Hep G2: 19.7;K-562: 38.7;NB-4: 32.1;SCLC-21H: 35.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.0	1.0	0.0	0.2	0.0	6.9	0.0	0.0	2.0	5.5	6.5	0.3	0.1	0.5	0.0	0.0	6.9	0.0	3.4	0.0	30.1	5.5	2.5	19.7	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.1	38.7	1.6	0.5	0.2	2.7	32.1	3.7	1.1	8.1	0.0	0.2	0.3	1.0	35.7	9.6	0.8	0.1	0.0	0.0	15.0	0.2	0.0	0.0	0.1	0.0	1.8	4.7	3.4	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9
COG2	LDLC	ENSG00000135775	"Component of oligomeric golgi complex 2"	Q14746	1	230642489-230693982	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076994			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA076994: "	"unprognostic (2.21e-1)"	"unprognostic (7.35e-2)"	"prognostic favourable (9.76e-4)"	"unprognostic (2.91e-1)"	"unprognostic (1.32e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.62e-2)"	11.6	27.5	11.4	12.7	12.5	8.0	13.2	24.9	13.7	14.1	18.5	15.4	13.4	13.3	14.3	14.6	10.9	14.5	13.9	17.7	11.4	8.6	17.3	12.7	11.0	14.7	14.5	9.6	12.7	17.0	49.1	17.6	11.1	12.3	13.0	23.0	14.0	14.6	13.6	25.5	13.5	18.0	11.9	11.1	18.5	15.8	13.9	13.4	21.6	16.8	10.7	17.2	13.7	15.9	11.6	13.8	15.0	20.2	16.2	18.1	13.4	8.2	9.7	11.8	11.3	11.8	9.2	17.2	7.2	11.2	12.0	10.5	13.2	12.8	25.6	11.3	9.8	12.6	11.0	12.9	11.4	20.6	21.9	9.0	9.7	13.8	14.6	23.1	14.1	12.4	14.3	7.6	11.0	9.9	15.5	14.5	9.6	6.6	20.9	11.6	16.9	18.3	18.1	18.9	30.2	12.4	12.4	12.2	16.7	8.5	15.5	16.3	18.6	22.7	8.4	5.8	5.4	7.1	14.0	17.8	14.8	20.4	9.7	9.6	12.2	10.9	11.8	15.0	13.1	15.0	15.2	11.6	12.5	12.5	13.8	11.0	18.1	15.7	0.5	16.2	20.2	6.9	9.9	13.4	11.4	12.5	24.9	13.7	11.4	8.6	14.5	9.6	12.3	13.4
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201555-107564514	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: "	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (1.15e-1)"	17.2	15.8	15.2	13.7	14.9	16.5	13.9	16.1	17.7	24.8	12.1	15.0	18.3	8.8	28.4	14.0	16.4	10.9	20.3	25.7	13.3	10.3	12.7	8.9	12.9	9.5	14.7	12.5	16.7	18.9	40.3	28.4	14.4	13.4	25.6	14.1	10.5	34.0	20.6	16.5	15.8	12.5	23.8	17.5	10.8	13.1	12.6	15.3	14.0	26.3	11.5	17.3	13.9	21.4	9.8	8.6	10.1	12.9	7.0	12.3	8.9	16.2	7.5	6.8	2.6	2.0	1.8	6.7	12.0	14.3	6.4	10.2	4.8	7.5	2.3	4.6	11.8	8.4	2.8	2.1	9.3	11.3	2.1	1.8	3.1	8.0	1.5	4.6	10.7	6.1	1.1	12.5	14.0	18.4	5.2	8.9	12.3	8.0	4.8	0.0	0.9	8.1	2.1	3.0	4.2	5.5	7.8	1.5	10.1	4.1	12.4	13.1	1.2	3.0	20.9	3.9	6.6	19.8	7.0	2.9	6.7	5.0	10.5	6.4	18.9	9.9	10.8	10.1	9.6	12.5	12.3	9.8	12.0	10.3	8.6	8.2	10.2	10.1	5.1	7.0	12.9	5.5	9.5	8.9	15.2	14.9	16.1	17.7	13.3	10.3	14.7	12.5	13.4	15.3
COG8		ENSG00000272617	"Component of oligomeric golgi complex 8"	Q96MW5	16	69326913-69339667	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041406, HPA049429"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA041406: , HPA049429: "																		9.3	13.7	11.4	10.5	12.7	5.8	10.8	13.1	16.1	11.6	10.7	17.9	10.3	10.9	8.8	13.1	10.2	9.8	10.4	8.5	12.4	11.5	23.8	25.2	9.7	9.3	14.4	8.0	11.4	11.7	21.1	10.5	8.0	10.7	9.7	12.7	12.4	9.9	9.5	15.2	12.3	11.0	11.1	8.0	10.5	8.5	40.2	13.5	17.4	11.6	7.4	13.0	7.3	9.4	9.6	10.0	7.7	8.0	13.9	12.8	6.6	7.6	16.4	15.5	17.6	19.2	12.6	7.4	9.6	13.4	17.5	17.5	10.5	15.7	11.3	3.7	14.2	13.4	22.6	16.5	18.1	3.6	6.7	7.7	13.7	21.6	13.9	16.1	8.2	11.6	17.0	18.5	15.2	10.9	11.2	7.7	13.8	22.2	14.8	17.6	17.4	2.3	22.1	7.0	22.2	25.8	9.3	15.2	13.3	17.8	9.8	10.4	29.1	17.4	6.3	12.4	8.2	10.0	10.0	7.2	9.8	24.6	11.8	10.3	14.0	4.1	8.0	7.7	8.0	7.1	8.1	7.1	10.5	12.8	10.0	9.6	9.9	10.9	5.0	13.9	7.9	4.9	7.9	6.6	11.4	12.7	13.1	16.1	12.4	11.5	14.4	8.0	10.7	13.5
COL11A1	"CO11A1, COLL6, STL2"	ENSG00000060718	"Collagen type XI alpha 1 chain"	P12107	1	102876467-103108872	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Cataract, Deafness, Disease mutation, Dwarfism, Ectodermal dysplasia, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 33.3"	"Cell line enhanced"	"Detected in some"		"AF22: 38.3;BJ: 13.5;BJ hTERT+ SV40 Large T+ RasG12V: 28.6;HBF TERT88: 16.2;HSkMC: 48.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA058335			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		270000	"Endoplasmic reticulum"		"HPA058335: "	"unprognostic (2.60e-3)"	"unprognostic (6.61e-4)"	"unprognostic (9.58e-2)"	"unprognostic (5.06e-5)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.23e-3)"	"unprognostic (9.08e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.01e-12)"	"unprognostic (1.27e-2)"	"unprognostic (3.53e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.32e-2)"	1.2	1.8	8.6	1.3	9.1	0.8	1.5	2.0	7.9	2.3	1.1	4.1	0.0	1.0	1.8	1.0	0.8	0.8	5.9	0.8	8.3	8.6	1.0	0.8	1.2	0.9	8.1	5.9	1.2	1.9	1.0	5.5	33.3	11.1	1.1	1.4	5.9	3.3	2.2	0.9	2.4	0.9	1.3	9.0	2.2	0.9	4.7	5.8	0.0	0.9	0.6	0.8	1.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	38.3	0.0	1.5	2.0	0.0	13.5	5.1	7.7	28.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	48.2	0.0	0.3	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	2.7	0.0	0.0	2.3	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.9	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.6	9.1	2.0	7.9	8.3	8.6	8.1	5.9	11.1	5.8
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pituitary gland: 28.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;HMC-1: 2.1;U-266/70: 2.3;U-698: 2.9"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"		720000				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.6	0.7	0.8	0.6	1.5	0.2	0.4	6.6	2.8	1.2	0.4	2.5	0.1	1.2	0.6	1.2	0.4	0.3	0.5	1.6	1.1	0.9	0.4	0.8	0.7	0.3	2.7	0.1	0.5	1.7	0.2	28.8	0.5	1.7	0.8	0.2	2.6	2.2	0.6	2.5	1.6	1.5	0.9	2.2	0.8	3.5	4.5	1.8	1.1	2.1	0.9	0.6	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.1	0.2	0.1	2.0	0.3	1.6	0.9	0.2	0.2	0.0	0.0	0.5	0.3	0.2	0.4	0.0	0.0	0.0	0.3	2.1	0.3	0.0	0.1	0.1	0.1	0.5	0.8	0.1	0.3	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.4	1.2	0.4	0.2	0.8	1.5	0.0	0.1	2.3	1.7	2.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.4	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.8	1.5	6.6	1.2	1.1	0.9	2.7	0.1	1.7	1.8
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206051	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 136.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 161.0;SiHa: 95.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA009143, HPA070695"	Uncertain		Approved	Nucleoplasm	"Secreted to extracellular matrix"		4300000	Nucleoplasm		"HPA009143: AB_1847095, HPA070695: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	53.1	5.6	0.9	33.1	1.3	0.0	136.8	0.4	2.0	65.0	23.0	0.5	14.8	4.2	64.6	18.1	29.2	14.9	16.3	17.1	1.1	1.1	7.6	1.5	22.2	23.5	2.0	1.5	52.0	4.1	1.5	1.9	2.6	1.6	12.3	8.7	2.4	5.9	21.4	21.6	16.8	14.1	32.4	1.4	5.0	6.9	10.6	0.4	1.0	8.2	15.0	4.4	24.8	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	34.5	19.3	3.2	31.3	26.1	21.6	30.1	3.1	0.0	0.0	3.2	161.0	6.9	0.0	3.3	20.4	0.0	0.1	0.0	11.6	0.0	12.9	0.0	0.0	28.9	0.5	4.8	5.9	3.6	0.0	0.0	3.5	0.0	0.0	0.0	0.8	1.7	0.0	2.7	0.0	1.1	1.6	0.0	0.0	95.7	2.5	0.0	15.2	0.0	0.0	9.3	11.5	4.9	10.4	0.0	0.0	0.0	3.1	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.3	0.4	2.0	1.1	1.1	2.0	1.5	1.6	0.4
COL14A1	UND	ENSG00000187955	"Collagen type XIV alpha 1 chain"	Q05707	8	120059780-120372036	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 87.4"	"Group enriched"	"Detected in some"	6	"ASC TERT1: 18.0;RH-30: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023781	Uncertain		Approved	Vesicles	"Secreted to extracellular matrix"		2000000	Vesicles		"HPA023781: AB_1847098"	"unprognostic (1.10e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.07e-2)"	"prognostic unfavourable (5.79e-5)"	"unprognostic (1.07e-2)"	"unprognostic (8.21e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (1.01e-4)"	20.0	3.3	0.8	20.8	0.9	0.0	21.6	0.7	0.9	87.4	13.9	1.0	9.6	1.3	64.6	39.2	20.0	15.6	38.6	27.8	0.8	1.0	8.3	5.0	8.8	4.5	1.1	1.1	62.1	4.4	1.1	1.8	30.8	3.0	41.7	10.5	4.2	21.8	5.8	7.6	5.4	12.2	45.2	6.5	15.4	10.1	13.3	0.4	1.1	15.7	32.5	9.9	30.4	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.9	18.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.6	2.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	5.2	0.1	0.0	4.6	0.1	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.4	0.0	0.0	47.8	0.1	2.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.7	0.9	0.8	1.0	1.1	1.1	3.0	0.4
COL15A1		ENSG00000204291	"Collagen type XV alpha 1 chain"	P39059	9	98943179-99070792	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;BJ hTERT+: 27.2;HDLM-2: 11.5;U-2197: 22.5;U-87 MG: 10.3;WM-115: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.7;NK-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017913, HPA017915"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		23000000	"Endoplasmic reticulum"		"HPA017913: AB_1847099, HPA017915: AB_1847100"	"unprognostic (4.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.09e-2)"	"prognostic favourable (5.47e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.20e-3)"	"unprognostic (3.66e-3)"	"unprognostic (8.98e-2)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (3.08e-4)"	36.1	17.6	0.5	12.7	0.7	0.0	21.4	0.4	0.7	22.4	19.7	1.4	5.0	3.0	42.4	22.0	26.6	9.0	25.2	41.2	0.5	0.7	8.7	1.0	5.6	11.7	1.6	0.8	28.9	13.7	4.5	3.4	66.9	2.1	16.6	4.0	11.4	23.4	6.2	12.8	6.7	11.1	27.3	1.3	3.9	14.8	22.8	0.4	5.1	10.5	21.7	8.6	21.3	8.8	0.6	0.1	0.0	0.4	1.7	1.7	0.2	0.0	0.0	0.0	0.0	2.3	1.3	0.0	13.0	27.2	0.7	0.2	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.1	11.5	0.0	0.1	6.6	0.0	0.5	0.1	1.2	3.8	0.0	3.0	0.1	0.0	8.8	0.0	1.0	0.0	0.0	0.2	0.1	0.0	0.0	7.3	0.1	0.0	0.0	0.0	0.0	0.4	1.9	3.5	0.1	0.2	0.0	0.0	0.3	22.5	0.2	0.1	0.0	0.0	10.3	0.1	15.2	0.0	0.3	0.0	1.7	0.4	0.1	0.6	0.4	0.5	0.1	0.1	0.1	0.3	0.0	1.7	0.2	0.0	0.4	0.2	0.5	0.7	0.4	0.7	0.5	0.7	1.6	0.8	2.1	0.4
COL17A1	"BP180, BPAG2"	ENSG00000065618	"Collagen type XVII alpha 1 chain"	Q9UMD9	10	104031286-104086002	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 85.8;skin 1: 123.2;tongue: 64.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 55.3;HBEC3-KT: 88.6;hTCEpi: 115.1;hTERT-HME1: 98.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 227.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 1.2"	"Cell type enriched"	"Detected in single"	15	"neutrophil: 3.7"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 3.7"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Not detected"	"Not detected"			"HPA043673, HPA052963"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to extracellular matrix"			"Plasma membrane"	"Golgi apparatus"	"HPA043673: AB_10960893, HPA052963: "	"prognostic favourable (1.38e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.85e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.35e-2)"	0.2	0.0	0.2	4.4	1.2	7.5	8.1	0.2	0.2	15.2	9.3	0.2	0.9	2.0	0.6	2.6	31.5	0.1	1.2	0.2	0.2	0.1	0.4	0.2	0.7	0.2	0.2	0.2	0.2	0.2	0.0	0.6	85.8	0.2	5.0	5.4	0.2	15.5	7.3	0.5	123.2	23.2	0.8	0.2	0.3	3.9	4.0	0.2	18.1	2.0	64.0	24.7	3.0	17.3	0.0	0.0	3.7	0.2	0.0	0.0	0.8	3.1	0.0	0.1	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.7	0.0	55.3	0.0	88.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	115.1	0.0	98.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	5.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.8	0.2	1.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
COL18A1	"KNO, KNO1, KS"	ENSG00000182871	"Collagen type XVIII alpha 1 chain"	P39060	21	45405137-45513720	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 273.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 31.2;EFO-21: 70.3;NTERA-2: 39.1;TIME: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.3"	"Region enriched"	"Detected in many"	6	"cerebellum: 24.8"	"Low region specificity"	"Detected in all"			"CAB001961, HPA011025, HPA036104"	Approved		Approved	"Golgi apparatus"	"Secreted to extracellular matrix"		250000000	"Golgi apparatus"		"CAB001961: , HPA011025: AB_1078551, HPA036104: "	"unprognostic (4.32e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (5.55e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (4.23e-3)"	"unprognostic (9.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.10e-3)"	"unprognostic (2.25e-3)"	25.5	14.4	2.2	12.7	13.0	5.6	17.7	3.4	8.5	40.4	12.7	26.0	19.6	12.6	22.2	72.5	12.0	18.8	25.3	18.5	3.5	5.3	36.2	273.2	11.9	7.6	35.5	3.5	43.3	21.8	2.6	17.8	16.5	20.8	13.9	2.3	17.3	8.8	20.2	8.1	23.1	10.6	33.4	31.9	14.5	7.1	11.0	23.6	2.3	16.0	12.0	6.7	28.7	18.2	0.4	0.4	7.3	0.4	0.0	1.2	0.2	2.5	19.1	4.8	4.3	8.9	7.4	1.0	18.4	31.2	8.8	2.4	11.9	6.8	0.5	70.3	18.2	8.6	1.0	1.1	1.7	0.2	5.3	11.0	0.3	16.2	8.6	0.4	1.1	8.7	0.7	0.8	1.0	27.1	11.1	0.1	3.2	4.4	0.4	1.1	39.1	7.1	0.5	3.0	1.1	29.7	0.4	5.4	4.1	1.8	2.0	5.8	1.8	3.0	41.3	0.2	2.8	0.1	4.3	0.1	0.2	0.3	0.0	0.9	7.6	1.0	0.4	1.5	0.1	0.4	0.2	0.4	0.4	0.0	0.1	0.1	1.2	0.6	7.3	0.0	0.3	0.4	0.0	0.2	2.2	13.0	3.4	8.5	3.5	5.3	35.5	3.5	20.8	23.6
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866571-70209976	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 23.1;brain: 14.4;lymphoid tissue: 18.8;smooth muscle: 37.8;urinary bladder: 12.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.5;RH-30: 14.2;SCLC-21H: 4.0;SK-MEL-30: 11.9;WM-115: 10.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 14.4"	"Group enriched"	"Detected in some"	156	"memory B-cell: 7.9;naive B-cell: 23.1"	"Lineage enriched"	"Detected in single"	232	"B-cells: 23.1"	"Low region specificity"	"Detected in many"							HPA042422	Uncertain				"Secreted to extracellular matrix"					"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	4.2	0.7	1.1	18.8	2.7	1.1	0.5	14.4	4.1	0.5	1.6	0.0	0.0	0.8	0.5	0.2	0.6	0.7	0.6	2.6	6.0	1.0	4.5	0.6	0.6	7.3	0.7	1.1	0.5	0.9	0.2	4.2	0.4	0.7	5.2	2.2	0.0	0.8	0.4	3.7	0.5	2.3	37.8	0.6	4.2	4.4	1.5	0.0	1.3	0.6	0.0	8.8	12.4	2.3	23.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.2	0.0	0.0	0.0	4.0	2.9	0.0	0.0	11.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	2.7	14.4	4.1	6.0	1.0	0.7	1.1	0.7	0.0
COL1A1	OI4	ENSG00000108821	"Collagen type I alpha 1 chain"	P02452	17	50183289-50201632	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, FDA approved drug targets, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 415.7"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 89.7;BJ: 172.4;fHDF/TERT166: 260.2;HSkMC: 131.8;U-138 MG: 140.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA011795	Approved		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"		58000000	Cytosol	Vesicles	"HPA011795: AB_1847088"	"unprognostic (1.61e-1)"	"unprognostic (3.60e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-2)"	"unprognostic (8.53e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavourable (7.19e-12)"	"unprognostic (2.74e-2)"	"unprognostic (4.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.87e-3)"	30.2	5.7	0.7	28.2	4.0	0.1	31.7	0.6	0.9	415.7	25.7	1.6	23.9	3.0	121.8	70.9	17.4	33.0	110.3	43.9	0.7	0.1	7.5	4.6	18.8	38.5	0.7	1.2	73.6	10.5	1.0	10.7	89.1	2.2	31.5	4.0	9.2	9.1	21.0	11.0	35.5	10.6	88.0	1.3	13.7	15.0	44.6	0.7	7.7	6.7	15.5	8.7	67.3	49.7	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.2	0.9	0.1	36.9	89.7	1.5	172.4	46.8	43.0	27.0	3.4	0.8	0.0	0.4	260.2	0.5	0.4	0.1	7.7	0.2	0.3	0.0	4.3	0.2	70.3	0.0	0.0	131.8	2.5	52.5	0.2	0.0	0.1	0.0	21.6	0.4	0.0	0.0	0.9	0.5	0.3	0.1	0.1	0.2	0.0	0.1	0.4	0.3	0.2	0.0	2.2	0.0	0.0	140.1	30.6	20.9	0.8	0.1	0.3	0.0	10.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.6	0.9	0.7	0.1	0.7	1.2	2.2	0.7
COL1A2	OI4	ENSG00000164692	"Collagen type I alpha 2 chain"	P08123	7	94394561-94431232	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Ehlers-Danlos syndrome, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 244.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 150.8;ASC TERT1: 181.0;BJ: 148.1;BJ hTERT+: 108.7;fHDF/TERT166: 501.0;HSkMC: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB032650, HPA059738"	Approved		Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		21000000	"Endoplasmic reticulum"		"CAB032650: AB_2082039, HPA059738: "	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.35e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.31e-3)"	44.7	9.8	1.2	34.9	4.3	0.0	33.4	1.7	2.4	244.6	26.5	2.1	54.1	3.8	166.9	139.1	28.2	36.6	101.4	45.1	1.3	0.8	10.2	4.1	37.1	20.4	1.8	2.8	68.3	10.9	1.8	6.0	70.6	3.8	40.3	10.1	23.0	17.5	28.0	12.1	35.6	15.2	100.7	3.2	16.4	16.1	49.7	1.1	5.6	14.7	42.7	12.6	62.4	55.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	55.8	150.8	181.0	0.0	148.1	108.7	24.4	32.5	0.0	0.1	0.0	0.1	501.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	157.1	0.0	19.2	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	62.2	0.0	38.5	4.2	0.0	0.0	0.0	15.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.3	1.7	2.4	1.3	0.8	1.8	2.8	3.8	1.1
COL3A1	EDS4A	ENSG00000168542	"Collagen type III alpha 1 chain"	P02461	2	188974320-189012746	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 304.2;endometrium 1: 208.0"	"Cell line enhanced"	"Detected in some"		"AF22: 80.2;ASC diff: 148.6;ASC TERT1: 258.7;fHDF/TERT166: 104.0;HHSteC: 102.2;HSkMC: 192.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA007583, CAB016766, CAB059993"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		16000000	"Endoplasmic reticulum"		"CAB016766: , CAB059993: AB_2314211, HPA007583: AB_1078548"	"unprognostic (1.12e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.94e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (3.59e-10)"	"unprognostic (1.70e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.17e-3)"	41.7	9.7	0.7	34.1	3.4	0.0	29.7	0.8	1.2	304.2	41.3	1.3	23.8	3.9	208.0	82.0	31.3	32.3	116.3	41.0	1.0	0.3	14.4	12.1	32.9	39.3	1.3	1.1	54.9	14.4	1.7	2.3	161.2	3.2	27.4	18.3	32.0	15.1	22.4	14.5	28.3	24.2	114.1	1.7	29.5	25.3	45.5	0.7	9.5	12.8	44.8	15.4	64.8	51.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.2	3.1	148.6	258.7	0.0	32.2	28.8	14.1	12.7	0.4	0.0	0.0	0.0	104.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	13.6	0.0	102.2	0.1	0.0	192.4	0.0	17.1	2.8	0.7	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.4	0.0	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	1.7	6.8	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.4	0.8	1.2	1.0	0.3	1.3	1.1	3.2	0.7
COL4A2	"DKFZp686I14213, FLJ22259"	ENSG00000134871	"Collagen type IV alpha 2 chain"	P08572	13	110305812-110513027	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 125.7"	"Cell line enhanced"	"Detected in many"		"EFO-21: 142.4;WM-115: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010751, HPA029118"	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"		1900000	Vesicles		"CAB010751: AB_476828, HPA029118: "	"unprognostic (2.43e-1)"	"unprognostic (4.13e-3)"	"unprognostic (8.04e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (3.49e-5)"	"unprognostic (1.33e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.95e-2)"	"prognostic unfavourable (9.25e-4)"	87.2	9.5	4.6	26.1	3.3	0.1	50.1	2.0	3.0	37.2	53.1	1.9	30.3	7.6	48.4	25.5	23.0	26.3	52.4	26.6	3.6	1.4	18.4	5.7	35.9	17.5	3.8	1.7	25.7	8.3	7.3	3.8	125.7	5.0	26.9	5.5	12.2	7.6	29.3	26.3	9.2	16.9	84.1	2.8	58.5	23.4	11.0	1.9	4.2	16.0	8.0	5.7	65.3	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.4	6.5	29.5	0.0	38.5	16.0	46.5	40.1	14.5	23.9	11.2	0.7	0.0	0.0	142.4	9.3	11.2	0.0	12.0	4.6	1.5	6.1	0.0	11.0	0.3	28.4	0.0	0.1	7.2	0.7	16.7	11.5	24.9	0.0	0.0	3.9	0.2	0.0	1.0	4.6	2.3	0.0	12.2	0.0	26.3	0.2	0.9	4.8	0.0	0.1	12.5	0.0	0.5	42.8	13.1	33.4	0.3	21.7	0.0	0.2	0.5	0.3	0.0	60.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.6	3.3	2.0	3.0	3.6	1.4	3.8	1.7	5.0	1.9
COL4A3		ENSG00000169031	"Collagen type IV alpha 3 chain"	Q01955	2	227164565-227314792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 27.9"	"Cell line enhanced"	"Detected in some"		"HeLa: 16.1;Karpas-707: 9.5;RPTEC TERT1: 10.7;U-266/70: 8.8"	"Group enriched"	"Detected in some"	6	"lung cancer: 1.7;renal cancer: 3.0;thyroid cancer: 5.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 3.8;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.8"	"Not detected"	"Not detected"							HPA042064	Approved		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to extracellular matrix"			Vesicles	"Endoplasmic reticulum"	"HPA042064: AB_10794410"	"unprognostic (4.81e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.28e-6)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.30e-1)"	"unprognostic (9.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (3.02e-2)"	"prognostic favourable (2.51e-7)"	"unprognostic (1.78e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	0.7	9.5	0.9	5.4	2.9	0.3	0.9	1.4	2.9	0.7	0.7	1.7	12.0	0.7	1.5	15.3	1.1	1.5	5.3	6.7	1.6	1.2	27.9	0.7	15.0	3.6	2.4	0.0	3.6	4.4	0.2	16.7	0.2	7.5	4.9	1.0	20.9	1.1	11.2	17.8	0.6	5.0	2.9	3.1	6.1	1.5	1.5	3.4	0.0	16.2	9.4	5.8	1.8	1.2	3.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.4	0.0	0.1	1.3	0.0	0.0	0.0	2.9	10.7	2.1	0.5	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	8.8	3.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.5	3.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.9	1.4	2.9	1.6	1.2	2.4	0.0	7.5	3.4
COL4A4	CA44	ENSG00000081052	"Collagen type IV alpha 4 chain"	P53420	2	227002711-227164453	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Alport syndrome, Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.7"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.0;Karpas-707: 6.9;RPTEC TERT1: 11.4;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"memory B-cell: 8.0"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to extracellular matrix"						"unprognostic (7.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (6.65e-2)"	"unprognostic (4.88e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-2)"	"unprognostic (8.50e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"prognostic favourable (2.30e-13)"	"unprognostic (1.53e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.15e-2)"	1.6	8.8	1.2	7.2	2.4	0.2	1.3	1.0	1.8	1.0	1.1	0.7	16.1	1.2	4.8	12.7	2.4	3.0	13.7	11.5	1.4	1.5	28.7	1.9	15.8	13.0	2.4	0.0	3.2	6.6	0.5	15.3	0.7	7.4	7.2	1.2	8.3	1.4	10.9	7.5	0.9	3.3	12.0	4.6	3.7	1.9	1.9	1.5	0.9	12.1	6.6	6.2	3.9	3.7	8.0	0.0	0.1	0.0	1.1	0.5	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.5	0.0	0.5	0.0	1.3	0.0	0.1	2.3	0.8	0.2	0.0	2.6	0.0	25.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	2.1	11.4	4.2	0.6	0.0	1.6	0.1	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.2	5.2	3.8	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.5	0.0	0.0	8.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	2.4	1.0	1.8	1.4	1.5	2.4	0.0	7.4	1.5
COL5A1		ENSG00000130635	"Collagen type V alpha 1 chain"	P20908	9	134641774-134844843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding	"Cancer-related genes, Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 110.7"	"Cell line enhanced"	"Detected in many"		"BJ: 71.5;fHDF/TERT166: 66.4;HeLa: 47.4;HHSteC: 45.1;SiHa: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA030769	Approved		Approved	Vesicles	"Secreted to extracellular matrix"		12000000	Vesicles		"HPA030769: "	"unprognostic (7.77e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (8.07e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.54e-2)"	"unprognostic (5.03e-3)"	"unprognostic (5.05e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (2.07e-12)"	"unprognostic (2.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.50e-3)"	11.5	4.2	1.5	13.7	1.4	0.0	9.5	3.0	1.2	110.7	20.9	1.4	11.8	3.6	42.1	24.1	12.3	20.5	31.8	12.2	1.8	0.9	4.3	3.4	13.4	7.8	3.0	1.3	19.5	3.7	3.7	2.6	53.8	2.2	23.3	4.7	9.1	5.1	9.9	5.0	6.9	8.7	26.7	1.5	6.5	12.5	9.5	1.1	2.7	4.1	10.1	4.0	21.8	22.9	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	2.1	3.4	32.1	34.6	1.3	71.5	14.4	12.2	13.1	0.0	0.0	0.0	15.8	66.4	0.9	0.0	0.0	3.5	0.0	0.1	0.0	47.4	0.0	45.1	0.0	0.4	33.9	0.0	11.8	0.9	14.5	0.0	0.2	6.4	0.6	0.0	0.1	1.2	1.3	2.5	8.3	0.2	0.0	0.0	0.9	0.4	47.1	0.3	0.0	0.1	0.0	24.7	25.7	10.6	31.4	14.9	0.0	0.0	0.0	20.4	0.0	4.3	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.4	3.0	1.2	1.8	0.9	3.0	1.3	2.2	1.1
COL5A2		ENSG00000204262	"Collagen type V alpha 2 chain"	P05997	2	189031896-189179879	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 44.6;BJ hTERT+ SV40 Large T+: 68.6;BJ hTERT+ SV40 Large T+ RasG12V: 59.0;fHDF/TERT166: 63.9;HHSteC: 44.4;HSkMC: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"		230000				"unprognostic (7.45e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.31e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (5.97e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.53e-10)"	"unprognostic (4.57e-3)"	"unprognostic (3.76e-2)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (3.58e-4)"	31.8	2.9	1.8	14.9	4.7	0.0	18.1	0.6	8.8	51.7	25.9	0.9	5.0	3.5	42.6	19.1	11.5	13.2	30.6	11.3	5.6	1.7	3.5	4.2	15.1	9.2	1.1	4.3	13.6	3.9	2.5	4.6	40.3	1.9	13.5	9.4	4.4	4.9	5.3	3.7	7.8	12.9	35.1	2.3	8.8	13.6	10.1	0.4	1.3	6.2	18.7	5.8	19.7	18.8	0.0	0.1	0.0	0.1	0.0	0.7	0.0	0.0	11.1	21.7	9.7	32.9	44.6	0.0	31.9	36.4	68.6	59.0	9.1	0.0	0.0	0.3	63.9	0.2	0.4	0.2	23.5	0.0	0.1	0.1	0.1	0.0	44.4	0.0	0.0	52.7	0.8	19.5	6.8	16.2	0.0	0.0	16.0	0.2	0.0	0.0	3.1	10.8	0.0	4.7	0.0	0.0	2.7	0.1	0.1	0.4	0.3	0.7	0.2	0.0	13.5	32.7	3.5	7.7	6.4	0.0	0.0	0.0	4.8	0.0	35.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	4.7	0.6	8.8	5.6	1.7	1.1	4.3	1.9	0.4
COL6A1		ENSG00000142156	"Collagen type VI alpha 1 chain"	P12109	21	45981737-46005050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 92.0;ASC TERT1: 187.3;BJ: 70.3;HHSteC: 81.7;HSkMC: 136.9;U-138 MG: 102.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.0;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"							"HPA019142, HPA029401"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"		250000000	Cytosol		"HPA019142: AB_1847093, HPA029401: AB_10601361"	"unprognostic (3.45e-1)"	"unprognostic (4.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.12e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.86e-1)"	"prognostic unfavourable (1.07e-8)"	"unprognostic (5.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavourable (4.54e-4)"	73.4	10.8	6.8	45.5	7.1	0.1	85.4	31.9	9.1	100.7	111.6	5.1	34.7	17.1	98.8	75.0	54.5	64.7	89.7	39.7	6.0	5.6	10.2	9.9	21.6	24.7	4.8	5.4	83.0	13.5	6.2	19.8	65.7	9.2	59.6	9.9	18.6	23.1	36.4	20.0	28.2	33.8	147.8	4.7	15.9	40.9	20.2	5.5	9.4	15.9	23.4	12.8	86.9	49.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	1.5	2.4	7.7	92.0	187.3	0.3	70.3	45.4	18.1	6.3	1.2	4.8	0.0	5.8	39.5	0.3	1.0	0.1	1.5	0.0	1.0	0.0	0.2	0.3	81.7	0.0	0.1	136.9	0.0	45.0	0.6	0.4	0.0	0.0	4.6	0.1	0.0	0.2	1.7	19.7	0.0	1.4	0.3	0.1	0.8	0.0	3.0	6.5	0.0	1.3	0.3	0.3	0.0	102.6	6.8	28.1	26.8	0.0	0.0	0.0	36.6	0.5	8.9	0.0	0.0	0.0	0.7	0.0	1.0	0.0	0.3	1.7	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	7.1	31.9	9.1	6.0	5.6	4.8	5.4	9.2	5.5
COL6A2		ENSG00000142173	"Collagen type VI alpha 2 chain"	P12110	21	46098097-46132849	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.7;ASC TERT1: 173.4;BJ: 83.4;BJ hTERT+: 77.6;HHSteC: 92.0;HSkMC: 123.8;U-138 MG: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	14	"T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA007029, HPA030920, HPA038799"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		8900000	Cytosol	"Plasma membrane"	"HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214"	"unprognostic (3.53e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.28e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (8.72e-14)"	"unprognostic (2.13e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.22e-3)"	81.2	8.7	1.5	65.0	2.7	0.2	116.7	1.8	2.7	103.5	112.6	4.7	75.0	15.3	127.2	160.3	55.5	66.5	179.8	90.6	2.1	1.3	9.6	9.1	38.7	38.3	3.2	3.8	76.1	14.8	2.7	11.8	52.6	8.8	81.0	9.8	23.5	33.4	81.4	30.6	37.8	38.1	231.3	5.8	23.6	49.0	33.2	1.8	9.8	19.9	58.5	17.2	107.2	76.1	0.0	0.0	0.0	0.0	0.5	7.6	0.7	0.7	0.9	2.7	2.4	93.7	173.4	0.7	83.4	77.6	21.1	9.7	0.1	3.3	0.0	6.3	59.8	0.0	0.6	0.0	1.7	0.0	0.9	0.0	0.0	0.0	92.0	0.0	0.3	123.8	0.0	39.9	0.8	0.0	0.0	0.0	8.5	0.3	0.0	0.1	1.5	10.2	0.0	5.3	0.1	0.0	0.0	0.0	4.3	3.2	0.0	0.0	0.0	0.5	0.0	90.5	10.6	33.3	20.6	0.0	0.0	0.0	46.3	0.0	12.8	0.0	0.0	0.0	7.6	0.0	5.1	0.0	0.7	3.8	0.0	0.0	0.8	2.1	0.0	0.5	0.0	0.0	0.1	0.7	1.5	2.7	1.8	2.7	2.1	1.3	3.2	3.8	8.8	1.8
COL6A3		ENSG00000163359	"Collagen type VI alpha 3 chain"	P12111	2	237324003-237414375	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Protease inhibitor, Serine protease inhibitor"	"Congenital muscular dystrophy, Disease mutation, Dystonia, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 201.8;ASC TERT1: 259.8;BJ hTERT+: 75.3;HSkMC: 164.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA010080	Supported				"Secreted to extracellular matrix"		990000000			"HPA010080: AB_1078550"	"unprognostic (8.94e-2)"	"unprognostic (7.24e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.20e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (5.57e-11)"	"unprognostic (1.54e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.84e-3)"	95.3	2.7	0.4	22.2	1.2	0.0	48.6	0.4	0.6	104.9	29.9	1.0	27.6	3.9	101.6	70.1	31.9	33.2	47.9	33.0	0.6	0.4	6.8	3.0	24.8	32.7	0.8	0.3	61.9	12.9	2.5	1.3	35.6	1.7	47.2	9.9	1.0	17.1	16.3	31.8	10.8	17.7	73.0	0.7	17.2	16.5	25.8	0.1	4.2	18.5	22.5	8.3	74.8	39.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	201.8	259.8	3.6	47.6	75.3	9.9	11.3	0.0	0.0	0.2	0.0	47.4	0.0	0.0	0.0	5.9	0.1	0.0	0.0	0.0	0.0	40.9	0.0	0.0	164.9	0.0	35.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.7	1.6	8.1	0.0	0.0	0.0	51.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.8	0.3	1.7	0.1
COL8A1	"C3orf7, MGC9568"	ENSG00000144810	"Collagen type VIII alpha 1 chain"	P27658	3	99638475-99799226	"Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 56.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 36.4;fHDF/TERT166: 149.5;LHCN-M2: 43.9;TIME: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA053107	Enhanced		Supported	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA053107: "	"unprognostic (3.13e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (9.39e-8)"	"unprognostic (2.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-3)"	20.5	4.7	1.0	6.1	3.0	0.1	7.5	2.4	0.9	5.8	16.9	1.8	11.8	0.6	5.9	16.8	15.3	6.4	6.8	26.7	1.2	1.4	9.4	1.9	36.5	0.5	1.8	2.1	7.7	0.9	32.3	9.4	5.5	2.9	13.1	4.8	38.7	5.2	8.8	5.0	2.3	2.7	18.8	3.0	0.9	4.2	6.4	0.6	0.0	56.0	6.4	0.8	21.3	12.1	0.4	0.1	0.9	0.2	0.3	0.4	0.1	0.0	0.0	0.4	0.0	22.0	36.4	0.0	8.9	5.8	9.0	18.1	0.0	0.0	0.0	0.8	149.5	0.0	0.0	11.6	23.5	0.0	0.0	0.0	1.2	0.0	4.0	0.0	0.0	20.7	0.4	7.0	11.8	17.5	0.0	0.0	43.9	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.1	4.2	3.3	0.2	4.7	0.0	0.0	0.0	8.3	0.0	32.1	0.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.4	0.4	0.4	0.7	0.3	0.1	0.1	0.1	0.1	1.0	3.0	2.4	0.9	1.2	1.4	1.8	2.1	2.9	0.6
COL9A2	"EDM2, MED"	ENSG00000049089	"Collagen type IX alpha 2 chain"	Q14055	1	40300487-40317813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Deafness, Disease mutation, Dwarfism, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;pituitary gland: 32.1;retina: 40.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 34.6;HMC-1: 33.4;THP-1: 37.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 68.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 6.4;myeloid DC: 2.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.7;granulocytes: 6.4"	"Low region specificity"	"Detected in all"							"HPA056316, HPA075286"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			Vesicles	Nucleoplasm	"HPA056316: , HPA075286: "	"unprognostic (1.42e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.06e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.71e-2)"	0.7	2.3	17.2	2.6	19.5	7.6	3.1	2.3	12.1	10.0	3.6	32.0	17.4	4.6	3.9	1.5	0.7	3.7	6.5	1.0	20.8	14.5	4.3	0.6	2.8	4.2	29.8	10.5	0.6	1.7	28.3	32.1	0.9	16.3	8.8	2.6	40.8	13.7	21.3	0.3	2.0	3.3	1.3	35.3	3.2	12.8	0.8	19.7	0.2	4.3	0.9	2.5	4.0	0.5	0.7	2.7	6.4	0.7	0.4	0.3	0.1	4.2	0.1	0.6	0.3	0.9	0.5	2.9	0.0	0.0	0.2	0.5	0.1	2.4	1.2	3.7	0.1	0.7	0.0	0.0	0.1	34.6	0.5	0.7	0.3	9.7	0.6	0.3	33.4	1.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.9	0.4	0.7	0.8	0.4	0.8	0.0	2.4	0.0	5.1	0.5	0.8	0.0	4.3	0.4	5.4	37.4	0.0	0.0	4.4	0.0	0.1	0.5	0.0	1.1	0.3	4.4	0.2	0.0	0.2	6.4	0.0	0.5	0.0	0.5	0.2	0.0	2.7	0.7	0.1	0.0	1.1	0.4	0.7	0.3	0.3	0.1	17.2	19.5	2.3	10.8	20.8	14.5	29.8	10.5	16.3	19.7
COLEC10	CL-L1	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119106582	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 47.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HHSteC: 3.4;SK-BR-3: 14.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"		5700000				"unprognostic (1.28e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.79e-4)"	"unprognostic (6.25e-3)"	"unprognostic (1.80e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (5.79e-4)"	"unprognostic (1.05e-1)"		"unprognostic (1.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.25e-2)"	"unprognostic (9.02e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-5)"	"unprognostic (7.12e-2)"	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.1	0.1	0.3	47.4	0.7	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.5	0.1	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	8.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	1.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
COLEC11	"CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 61.9;liver: 57.4"	"Group enriched"	"Detected in some"	7	"HHSteC: 52.5;SH-SY5Y: 47.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035241	Uncertain				"Secreted to blood"		30000000			"HPA035241: AB_10600701"	"unprognostic (3.35e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.95e-3)"	"unprognostic (5.85e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (9.27e-3)"	"unprognostic (7.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.60e-1)"	3.7	13.2	0.5	0.5	1.2	0.6	1.7	0.7	1.4	0.5	1.7	1.3	0.8	1.7	0.7	1.0	1.2	1.4	61.9	14.8	0.9	0.1	7.9	57.4	0.9	1.8	0.6	0.5	15.8	6.5	0.2	2.0	2.8	3.6	1.6	0.1	1.0	0.8	0.5	1.0	0.4	3.0	1.6	0.7	1.4	0.7	2.5	0.5	0.7	5.5	0.6	0.5	1.8	1.5	1.2	0.8	4.0	0.8	1.2	1.8	0.2	0.0	0.4	0.2	0.8	0.0	0.0	4.4	0.2	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.4	1.5	52.5	0.0	0.3	0.5	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.6	47.4	0.5	0.3	0.2	0.1	0.3	0.0	0.0	0.2	0.2	0.1	1.0	7.6	0.4	0.1	0.4	0.2	1.9	0.8	1.2	0.6	0.2	0.5	0.6	0.3	0.3	0.3	1.2	1.8	1.0	4.0	1.2	0.4	0.8	0.3	0.2	0.5	1.2	0.7	1.4	0.9	0.1	0.6	0.5	3.6	0.5
COMP	"EDM1, EPD1, MED, PSACH, THBS5"	ENSG00000105664	"Cartilage oligomeric matrix protein"	P49747	19	18782773-18791314	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cell adhesion"	Heparin-binding	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 39.1;skeletal muscle: 59.6"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 134.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA077555			Approved	"Golgi apparatus"	"Secreted to extracellular matrix"		1100000000	"Golgi apparatus"		"HPA077555: "	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (9.08e-5)"	"prognostic unfavourable (2.04e-4)"	"unprognostic (8.05e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavourable (1.52e-6)"	"unprognostic (5.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (6.95e-4)"	39.1	0.2	0.0	1.0	0.0	0.0	4.1	1.8	0.2	2.7	2.0	0.1	2.5	0.0	3.0	24.2	4.7	0.4	16.2	21.6	0.2	0.0	4.5	0.4	2.9	2.7	0.0	0.6	0.9	3.3	0.1	0.1	8.2	0.2	8.7	0.0	0.1	6.0	7.4	59.6	31.8	0.3	13.0	0.2	0.1	0.9	11.5	0.0	0.3	8.9	27.6	0.9	10.8	11.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.2	0.0	0.0	0.6	0.2	0.0
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"			560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favourable (5.67e-4)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.0	19.6	2.2	19.4	22.1	19.7	0.8	21.6	27.3	18.5	21.3	16.6	22.2	7.7	9.6	30.9	26.1	3.7	23.2	4.9	16.6	24.7	13.7	10.5	38.7	41.3	22.8	5.5	25.0	28.7	16.1	16.0	17.4	55.4	16.4	15.0	118.0	8.9	41.0	4.8	6.6	13.5	19.4	10.6	19.6	60.5	9.5	8.3	7.2	61.3	17.8	13.2	64.3	20.8	33.2	12.7	10.9	16.2	6.0	2.5	6.3	35.8	30.9	22.8	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7
COPA	HEP-COP	ENSG00000122218	"Coatomer protein complex subunit alpha"	P53621	1	160289273-160343400	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"ER-Golgi transport, Protein transport, Transport"	Hormone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028024	Supported		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"		260000	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA028024: AB_10603787"	"unprognostic (1.59e-2)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.42e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.39e-1)"	38.3	32.7	29.2	28.9	41.0	22.9	32.4	43.1	48.4	46.3	34.3	53.2	24.5	38.4	37.0	33.1	28.4	31.5	28.6	38.4	33.3	35.2	36.3	64.3	33.8	26.6	42.7	29.3	36.8	47.8	49.1	57.4	45.1	56.2	35.3	39.9	28.8	42.1	33.9	40.5	28.7	50.3	40.4	42.8	36.6	32.8	21.2	35.8	36.0	42.8	21.0	34.1	30.3	27.5	15.4	31.4	25.1	29.1	18.1	21.2	25.3	28.1	22.1	23.4	22.7	60.4	49.8	27.5	38.7	46.0	33.0	39.0	28.8	19.2	20.7	25.1	58.7	28.3	27.1	27.9	38.0	23.5	18.3	23.8	30.4	30.2	45.4	28.9	24.9	46.5	17.0	44.0	41.1	38.6	21.9	23.2	39.3	20.6	18.6	12.6	25.7	25.8	16.7	27.0	31.8	27.0	26.6	19.5	24.6	43.7	38.4	40.9	42.8	39.1	45.5	24.9	19.4	33.3	25.4	38.2	26.5	31.8	32.4	15.1	37.0	25.1	29.1	20.1	17.1	27.3	21.2	15.4	14.3	18.3	31.4	12.1	13.2	15.2	10.8	18.1	27.9	13.3	17.5	25.3	29.2	41.0	43.1	48.4	33.3	35.2	42.7	29.3	56.2	35.8
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"			400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: , HPA064403: "	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.91e-4)"	"prognostic unfavourable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.2	26.8	28.7	21.5	48.0	55.7	23.2	47.4	49.8	42.3	49.7	20.7	48.7	30.4	21.3	59.8	34.5	32.3	31.8	52.3	28.4	26.8	32.3	19.2	31.5	42.6	29.6	32.8	38.8	42.0	28.2	53.6	44.2	23.9	25.0	53.2	23.5	26.9	18.2	14.9	29.2	22.1	39.6	20.7	38.1	28.9	18.4	19.8	36.7	29.7	24.3	27.0	25.9	44.8	40.7	21.1	43.8	25.7	13.4	22.6	33.5	30.7	18.5	37.9	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6
COPB2	"beta'-COP, betaprime-COP"	ENSG00000184432	"Coatomer protein complex subunit beta 2"	P35606	3	139355600-139389732	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036867, HPA058180"	Approved		Approved	Cytosol			1000000	Cytosol		"HPA036867: AB_10672271, HPA058180: "	"unprognostic (3.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.38e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (2.41e-7)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (8.11e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.95e-2)"	28.7	40.8	21.9	22.3	26.2	12.1	28.7	31.7	29.0	39.5	32.4	22.6	40.3	26.1	33.0	44.7	35.9	28.9	26.2	31.4	21.6	18.9	42.1	67.5	29.1	20.1	26.0	16.6	36.0	65.5	41.2	72.2	51.7	28.7	35.5	33.8	20.5	46.5	28.6	20.6	23.5	37.1	30.0	21.1	31.3	29.9	21.1	25.7	33.1	40.4	27.4	31.2	30.0	26.5	22.6	36.4	35.9	34.4	27.4	23.5	22.6	53.1	21.4	31.4	28.3	63.1	58.1	27.5	63.7	60.6	41.2	50.9	40.0	20.3	21.5	59.0	67.5	28.3	35.6	34.1	51.7	37.2	24.4	32.3	33.8	38.2	37.8	28.8	37.1	40.7	31.0	32.4	33.6	39.7	21.1	26.2	48.8	32.2	14.4	17.7	28.5	23.5	19.5	25.5	37.0	37.8	38.5	22.3	20.4	62.6	56.8	35.1	45.3	31.1	46.3	23.2	18.7	34.1	22.4	40.8	24.3	38.0	38.8	16.4	35.8	35.9	28.4	30.1	22.9	34.4	23.2	22.6	20.4	23.5	36.4	16.3	15.9	20.0	26.9	27.4	32.3	17.0	21.9	22.6	21.9	26.2	31.7	29.0	21.6	18.9	26.0	16.6	28.7	25.7
COPG1	COPG	ENSG00000181789	"Coatomer protein complex subunit gamma 1"	Q9Y678	3	129249606-129277773	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037866, HPA037867, HPA045712"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"			110000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA037866: AB_2675710, HPA037867: AB_10697085, HPA045712: "	"unprognostic (8.86e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.17e-2)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (6.66e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.23e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.60e-1)"	25.2	39.4	21.1	22.2	28.0	20.1	37.3	23.6	50.3	43.3	42.1	24.3	50.6	34.2	27.6	66.5	29.5	24.4	34.5	33.4	24.2	26.7	32.4	72.1	36.5	39.4	23.0	21.6	28.6	75.6	47.6	49.7	49.3	34.9	45.1	45.1	22.4	59.9	45.5	24.1	24.3	32.4	29.1	20.7	29.0	36.3	23.6	16.2	26.9	33.0	22.0	27.7	19.9	24.1	15.7	31.9	34.9	33.0	31.1	31.8	26.0	32.4	16.5	24.1	20.9	56.6	45.9	25.8	52.9	50.6	36.5	46.2	30.3	20.2	17.8	30.8	75.2	19.6	19.9	31.2	39.8	21.7	8.2	29.6	21.8	48.9	51.6	22.4	31.8	47.9	27.5	29.2	48.2	32.8	10.3	43.1	43.9	49.3	13.1	22.8	14.4	20.2	14.2	22.7	34.5	45.5	27.0	15.1	17.6	40.6	30.4	48.5	33.6	32.8	44.4	19.9	18.9	42.0	20.4	33.7	16.1	31.2	48.6	17.1	38.1	34.9	26.8	20.2	26.2	33.0	31.8	15.0	23.7	25.7	31.9	15.7	18.5	21.6	21.3	31.1	29.7	29.4	23.6	26.0	21.1	28.0	23.6	50.3	24.2	26.7	23.0	21.6	34.9	16.2
COPG2	2-COP	ENSG00000158623	"Coatomer protein complex subunit gamma 2"	Q9UBF2	7	130506238-130668748	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045712	Approved						40000			"HPA045712: "	"unprognostic (9.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.40e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.23e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.23e-1)"	12.0	26.6	13.5	8.9	22.1	10.7	20.4	21.1	22.9	15.5	12.0	18.1	11.5	9.3	21.1	17.7	17.3	19.6	12.8	15.2	12.9	18.4	12.9	9.1	9.8	11.5	14.8	15.8	40.4	12.2	29.0	27.0	15.6	20.0	13.9	14.1	16.8	13.2	15.3	17.5	20.3	8.6	19.2	14.4	11.7	9.7	31.8	9.8	20.0	18.5	10.7	14.6	12.7	14.0	4.3	4.4	6.0	4.5	1.9	2.0	1.7	20.9	12.0	22.2	11.1	9.8	17.6	5.8	9.9	15.0	16.6	16.2	7.4	11.6	14.5	8.3	12.7	10.7	7.4	18.5	21.8	15.7	15.3	14.8	6.3	10.5	15.6	19.3	13.8	14.0	9.4	13.4	20.7	15.6	23.6	4.3	20.9	21.0	18.5	15.1	28.0	9.8	18.1	29.3	8.6	20.0	28.1	17.2	24.7	20.5	19.3	15.6	12.5	6.3	13.7	15.0	7.9	12.4	14.4	9.7	11.8	17.1	16.7	16.1	12.9	2.9	3.7	6.0	2.0	3.6	1.7	4.3	1.8	1.5	4.4	2.3	2.0	1.8	1.1	1.9	4.5	1.9	2.0	1.7	13.5	22.1	21.1	22.9	12.9	18.4	14.8	15.8	20.0	9.8
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593998-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"epididymis: 11.6;heart muscle: 39.5"	"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 31.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Low region specificity"	"Detected in single"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"			"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: "	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.3	0.1	0.3	0.0	0.1	0.0	0.8	0.1	0.1	3.1	0.1	0.1	2.6	0.0	3.4	11.6	0.7	1.2	4.5	39.5	0.0	0.2	2.0	0.0	1.3	0.0	0.2	0.0	0.6	0.1	0.0	1.5	0.6	1.6	1.7	0.0	0.4	0.3	4.6	0.2	5.3	0.4	0.5	0.0	3.5	0.3	3.7	0.0	0.2	0.1	1.7	0.4	0.8	3.2	0.2	0.0	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.2	7.3	31.8	0.0	1.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.0	0.2	0.2	0.0	1.6	0.0
CORO1A	"coronin-1, HCORO1, p57"	ENSG00000102879	"Coronin 1A"	P31146	16	30182827-30189076	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 204.4;bone marrow: 94.9;lymphoid tissue: 99.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 85.3;HL-60: 59.6;HMC-1: 103.1;MOLT-4: 57.6;NB-4: 68.1;RPMI-8226: 89.9;U-698: 55.7;U-937: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046473, HPA051132"	Enhanced		Approved	Cytosol			130000000	Cytosol		"CAB046473: AB_10602363, HPA051132: "	"unprognostic (4.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (3.86e-2)"	"prognostic favourable (6.91e-4)"	"unprognostic (2.41e-1)"	"prognostic favourable (4.42e-4)"	"unprognostic (1.99e-2)"	"unprognostic (8.27e-3)"	"unprognostic (8.26e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (5.74e-7)"	"unprognostic (2.55e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.01e-1)"	6.4	4.9	12.7	58.9	10.8	94.9	4.4	7.8	13.6	2.9	5.0	6.0	0.2	8.3	3.0	3.0	4.7	5.9	8.6	4.8	10.4	7.8	4.9	3.8	13.7	99.8	9.6	8.2	2.2	2.7	0.6	3.0	4.8	7.3	3.3	2.9	2.2	12.3	1.6	1.3	3.4	28.7	4.1	9.0	92.0	8.5	1.1	7.5	86.0	3.6	3.2	64.8	15.8	3.1	41.6	67.7	204.4	67.5	39.1	66.4	101.2	0.2	0.3	1.0	2.0	0.0	0.0	0.5	0.2	0.0	0.5	0.2	0.0	0.6	85.3	0.5	0.0	0.4	0.4	1.0	0.1	27.3	0.2	9.0	0.0	1.3	0.1	59.6	103.1	0.3	0.0	0.4	0.0	0.1	0.1	43.9	0.3	7.2	57.6	68.1	0.4	0.6	31.3	1.6	89.9	0.1	0.4	1.6	1.2	0.2	10.3	0.2	0.1	34.7	0.1	0.4	0.8	0.2	0.2	34.1	45.0	55.7	0.3	75.5	0.6	52.5	58.3	204.4	53.7	67.5	50.5	41.6	48.4	52.2	67.7	41.6	46.6	48.1	105.8	39.1	66.3	38.2	66.4	101.2	12.7	10.8	7.8	13.6	10.4	7.8	9.6	8.2	7.3	7.5
CORO1B	coronin-2	ENSG00000172725	"Coronin 1B"	Q9BR76	11	67435510-67443821	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017616, HPA040113, HPA070456"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			200000000	"Plasma membrane, Cytosol"		"CAB017616: AB_2087018, HPA040113: , HPA070456: "	"unprognostic (1.94e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.21e-1)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.02e-1)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.64e-3)"	26.0	24.0	12.6	20.6	16.1	9.7	21.6	9.7	19.0	25.8	37.0	20.3	23.1	35.0	28.7	34.0	31.2	25.6	35.3	15.2	12.6	11.0	27.5	36.4	21.6	23.3	15.9	10.7	21.2	24.2	15.4	16.1	29.2	14.3	31.4	19.1	20.5	42.5	27.4	9.2	16.7	44.7	20.5	14.8	34.7	29.8	13.9	16.5	16.1	31.6	23.3	20.0	25.8	20.8	4.2	17.5	10.9	47.1	2.4	12.3	11.7	18.9	18.6	9.0	18.4	23.4	20.4	13.5	13.4	28.5	23.1	17.5	31.1	28.1	0.6	28.1	19.0	16.4	10.1	17.9	4.1	4.3	8.8	13.3	12.2	13.3	37.3	0.2	28.7	27.6	16.0	19.5	9.0	29.1	9.8	2.0	13.1	54.0	2.9	1.5	11.6	17.6	2.6	9.4	3.3	15.5	23.7	10.2	12.7	12.7	34.6	41.7	43.3	15.2	23.0	15.8	11.4	21.3	8.3	0.3	0.6	3.0	25.4	1.8	15.9	10.9	22.9	1.7	1.9	47.1	1.4	4.2	9.3	3.0	17.5	1.4	5.3	2.3	10.9	2.4	45.8	13.5	12.3	11.7	12.6	16.1	9.7	19.0	12.6	11.0	15.9	10.7	14.3	16.5
CORO1C	"coronin-3, HCRNN4"	ENSG00000110880	"Coronin 1C"	Q9ULV4	12	108645109-108731596	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041737	Approved						96000000			"HPA041737: AB_10804115"	"unprognostic (2.86e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.96e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.32e-2)"	"prognostic unfavourable (5.59e-5)"	"unprognostic (2.49e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.93e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.90e-3)"	39.3	13.9	17.1	20.7	18.2	19.3	22.8	16.0	19.5	25.1	50.7	25.8	14.3	12.2	55.1	16.5	30.8	27.8	27.0	16.4	17.6	14.4	12.3	21.0	32.6	12.8	20.6	12.2	22.2	6.5	19.0	13.6	25.0	16.4	21.2	24.3	12.8	13.5	31.4	14.0	23.7	20.2	67.1	16.7	13.1	24.6	11.1	19.1	15.5	7.4	18.9	14.5	41.9	22.0	8.5	25.6	27.5	26.5	4.0	2.6	12.2	26.5	30.3	40.0	20.3	20.5	28.1	17.8	49.8	54.2	65.4	52.4	35.7	11.8	1.5	13.4	78.7	12.4	22.3	37.0	82.5	11.8	10.4	44.6	14.7	27.4	18.5	10.5	23.1	26.0	17.6	74.0	56.3	33.9	22.5	14.7	68.5	9.8	4.9	12.3	10.3	29.6	7.5	23.3	16.9	25.5	17.6	11.2	9.7	17.4	2.3	21.9	12.0	8.0	37.6	46.9	24.2	43.2	42.2	14.4	33.6	32.7	35.9	9.0	31.2	9.4	22.2	10.2	2.6	26.5	1.2	8.5	1.0	1.6	25.4	6.3	0.3	1.2	27.5	4.0	24.1	25.6	2.5	12.2	17.1	18.2	16.0	17.6	17.6	14.4	20.6	12.2	16.4	19.1
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578969-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.5;fallopian tube: 27.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 12.7;ASC TERT1: 27.4;HSkMC: 19.7;hTEC/SVTERT24-B: 16.0;U-87 MG: 27.3"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.2;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	21	"B-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	4.4	15.7	3.2	30.1	1.9	4.8	33.7	53.5	6.5	3.4	27.3	0.8	2.4	7.5	3.9	2.7	27.4	6.3	7.2	23.0	15.1	5.5	2.0	5.8	3.5	20.9	18.8	18.4	2.9	1.6	1.5	4.7	23.6	3.2	2.9	11.8	3.4	6.9	3.8	5.6	3.3	8.4	35.0	3.6	2.0	2.2	17.5	0.0	4.6	0.6	1.9	3.0	1.6	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	12.1	1.0	12.7	27.4	0.0	6.1	6.8	1.0	1.5	0.1	1.3	1.4	0.7	1.0	0.0	0.4	0.1	4.4	0.0	0.5	0.0	0.0	0.6	4.6	0.0	0.1	19.7	0.1	16.0	0.9	0.4	0.0	0.0	11.2	0.0	0.0	0.0	2.9	0.0	0.9	0.0	0.5	1.7	0.0	7.0	0.1	0.1	0.0	3.6	0.0	1.4	0.1	3.6	4.1	0.7	8.1	0.0	0.0	1.4	27.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	30.1	33.7	29.3	23.0	15.1	20.9	18.8	23.6	17.5
COTL1	CLP	ENSG00000103187	"Coactosin like F-actin binding protein 1"	Q14019	16	84565594-84618077	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Chaperone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 206.6;lymphoid tissue: 103.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 127.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 110.8;eosinophil: 160.2;intermediate monocyte: 190.1;myeloid DC: 117.3;neutrophil: 86.8;non-classical monocyte: 206.6"	"Group enriched"	"Detected in all"	5	"dendritic cells: 117.3;granulocytes: 160.2;monocytes: 206.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008918, CAB062328"	Enhanced		Supported	Cytosol			28000000	Cytosol		"CAB062328: AB_2084785, HPA008918: "	"unprognostic (2.93e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.70e-2)"	"unprognostic (5.99e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (5.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.48e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.35e-3)"	28.6	9.9	20.4	68.1	19.5	57.7	13.7	12.4	18.1	7.6	16.5	25.3	2.4	22.0	13.2	8.4	8.2	13.2	18.7	7.2	19.6	24.9	34.3	12.4	26.6	103.0	28.9	8.1	10.8	7.5	5.1	13.1	29.4	23.2	11.8	16.7	30.8	7.7	7.6	5.1	5.1	26.1	16.2	27.8	92.3	29.6	8.0	13.4	33.0	10.1	5.2	62.0	29.3	7.6	28.5	117.3	160.2	206.6	30.8	32.5	108.3	52.7	44.1	101.0	106.6	11.6	32.0	30.5	46.0	29.7	36.3	14.0	59.8	82.0	14.6	14.1	34.5	26.6	6.1	36.2	36.6	0.1	7.8	27.5	9.3	15.8	32.7	30.8	109.2	25.5	5.8	35.0	31.3	17.3	2.5	6.1	21.6	8.5	9.4	18.6	12.4	45.2	1.0	3.4	0.9	53.3	22.5	16.0	0.8	42.9	10.3	22.9	7.7	25.1	44.3	52.3	29.8	16.8	33.4	1.1	5.5	12.0	40.9	15.0	127.4	29.6	110.8	160.2	3.6	190.1	4.8	28.5	23.0	21.7	117.3	13.2	10.3	12.1	86.8	30.8	206.6	6.0	32.5	108.3	20.4	19.5	12.4	18.1	19.6	24.9	28.9	8.1	23.2	13.4
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported						5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favourable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favourable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	34.5	38.5	47.7	41.6	29.4	34.0	52.5	31.5	27.9	40.4	37.8	42.8	43.9	79.3	38.8	27.1	68.5	112.6	45.8	33.9	44.8	105.1	65.8	40.1	53.2	36.9	75.1	41.4	34.5	49.7	25.2	57.1	47.2	60.4	54.0	40.3	27.2	62.7	57.8	50.6	57.0	58.5	45.7	92.1	59.0	58.6	69.9	30.0	47.7	71.7	98.6	35.9	61.3	31.9	30.6	28.9	38.2	49.9	61.9	113.5	87.9	32.8	99.8	27.8	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2
COX6B1	"COX6B, COXG"	ENSG00000126267	"Cytochrome c oxidase subunit 6B1"	P14854	19	35648223-35658861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004192	Supported		Supported	Mitochondria			1200000	Mitochondria		"HPA004192: AB_1847180"	"unprognostic (5.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.88e-1)"	"prognostic favourable (5.42e-4)"	"unprognostic (2.10e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.48e-3)"	37.2	32.2	62.1	32.1	58.7	46.2	42.8	31.1	57.6	34.1	65.0	25.2	41.2	52.7	27.1	70.2	52.4	36.3	39.8	132.5	51.5	52.2	61.1	68.9	24.7	40.4	57.4	60.2	29.2	41.1	41.4	28.8	30.2	39.2	30.2	77.1	31.8	54.9	44.2	168.4	35.1	63.2	37.6	38.7	30.7	42.0	21.0	29.0	42.7	37.6	110.6	52.7	33.8	31.6	110.6	115.5	111.1	116.1	61.2	107.9	167.5	42.8	102.5	44.5	59.3	58.5	59.9	41.3	34.9	53.0	57.7	58.4	83.6	43.2	48.4	61.9	55.0	31.5	71.3	59.3	56.8	56.2	48.9	82.8	54.8	81.9	46.2	74.4	43.2	70.3	74.4	53.9	31.3	56.0	51.6	72.5	58.0	83.0	52.2	54.9	33.0	69.1	45.3	48.9	80.0	131.6	85.7	39.1	44.7	56.2	96.9	34.5	38.4	80.8	33.4	33.4	38.3	35.4	54.3	43.5	52.2	65.7	44.1	57.7	42.9	87.7	108.6	94.7	65.5	116.1	62.4	110.6	90.5	76.1	111.8	92.7	89.6	79.4	111.1	61.2	107.8	115.5	107.9	167.5	62.1	58.7	31.1	57.6	51.5	52.2	57.4	60.2	39.2	29.0
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149222055	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"liver: 311.1"	"Cell line enriched"	"Detected in some"	9	"EFO-21: 80.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	160000000000	830000000000			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	1.8	0.7	2.6	0.6	5.7	0.4	3.5	2.6	3.5	10.5	2.0	2.5	0.0	1.7	2.3	0.3	1.1	1.5	0.5	6.6	3.6	1.7	1.6	311.1	2.1	2.4	4.2	0.9	0.4	1.2	1.4	5.3	1.9	9.4	2.1	2.7	15.5	6.9	0.4	1.2	2.0	2.6	0.7	4.8	3.5	0.7	0.5	4.4	0.0	2.8	0.4	3.0	3.2	2.9	1.3	0.8	0.6	1.0	0.3	1.3	0.4	0.0	4.7	4.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.7	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	1.0	0.5	0.8	0.6	0.8	0.9	0.4	0.5	0.6	1.3	0.4	1.3	0.4	0.3	0.4	0.8	0.4	0.4	2.6	5.7	2.6	3.5	3.6	1.7	4.2	0.9	9.4	4.4
CPA3		ENSG00000163751	"Carboxypeptidase A3"	P15088	3	148865256-148897196	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 111.7"	"Cell line enriched"	"Detected in some"	43	"HEL: 79.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1118	"basophil: 111.7"	"Lineage enriched"	"Detected in single"	1118	"granulocytes: 111.7"	"Low region specificity"	"Detected in single"							"HPA006479, HPA008689, CAB020712"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	Nucleoplasm	"CAB020712: , HPA006479: AB_1078396, HPA008689: AB_1846009"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.66e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.30e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.69e-3)"	12.4	0.6	0.4	12.0	0.4	5.6	6.2	0.4	0.5	25.4	14.1	0.8	4.4	7.1	14.1	21.2	16.5	3.7	50.9	4.5	0.4	0.2	5.8	2.8	37.3	15.2	0.4	0.4	2.0	7.2	0.7	0.8	1.3	0.5	37.3	16.4	8.5	8.8	5.8	1.4	12.7	20.2	24.3	0.4	1.0	13.7	7.1	0.4	3.6	1.4	9.9	7.1	14.0	8.9	0.0	0.0	111.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	79.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.5	0.4
CPA4	CPA3	ENSG00000128510	"Carboxypeptidase A4"	Q9UI42	7	130293134-130324180	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.0;skin 1: 41.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.8;LHCN-M2: 62.5;U-2 OS: 34.2;U-87 MG: 61.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 10.0;head and neck cancer: 9.8"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							HPA021030			Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in other tissues"		480000	Nucleoplasm	"Centrosome, Cytosol"	"HPA021030: AB_1846010"	"unprognostic (7.60e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.36e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.49e-2)"	"unprognostic (6.21e-10)"	"unprognostic (2.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.56e-2)"	"prognostic unfavourable (1.31e-4)"	2.7	2.3	0.1	0.4	0.4	0.2	2.8	0.1	0.4	8.1	1.1	0.3	0.1	0.1	1.1	1.2	18.0	0.2	0.2	4.4	0.1	1.2	1.2	0.2	0.8	0.3	0.1	0.1	1.8	6.9	0.1	1.1	8.8	0.9	0.3	0.1	0.6	4.4	0.1	0.3	41.0	0.5	0.7	0.7	1.7	0.2	2.2	0.1	0.8	0.1	12.3	2.3	1.7	6.7	0.4	0.4	1.6	0.4	1.5	0.4	0.1	20.2	1.1	0.0	0.0	0.1	0.3	0.0	16.2	30.8	16.6	4.1	0.1	1.7	0.0	3.2	6.9	1.2	0.0	8.9	17.2	0.1	0.0	0.0	6.5	0.4	0.4	0.0	0.0	0.2	14.5	1.5	2.1	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.1	2.4	0.0	16.7	0.0	7.8	0.8	0.0	0.0	10.7	5.1	0.1	0.1	0.0	12.4	4.0	34.2	1.3	1.6	0.0	0.0	0.0	61.4	0.0	0.1	1.0	0.4	0.4	0.4	0.1	0.2	0.3	0.2	0.3	0.0	0.4	0.3	0.3	1.6	1.5	0.2	0.4	0.3	0.1	0.1	0.4	0.1	0.3	0.1	1.2	0.1	0.1	0.9	0.1
CPB1		ENSG00000153002	"Carboxypeptidase B1"	P15086	3	148791102-148860187	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	590	"pancreas: 3628.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.7;EFO-21: 2.9;HDLM-2: 3.0;U-2 OS: 5.1;U-251 MG: 1.5;U-266/84: 2.4"	"Group enriched"	"Detected in some"	312	"breast cancer: 293.8;pancreatic cancer: 641.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB026158, HPA038069, HPA046340"	Enhanced				"Secreted to digestive system"		6600000			"CAB026158: , HPA038069: , HPA046340: "	"unprognostic (6.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.59e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.50e-8)"	"unprognostic (3.08e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.93e-2)"	0.2	1.7	0.1	0.1	0.2	0.0	0.7	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.2	3628.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.7	0.2	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	1.8	1.1	6.1	1.0	3.1	3.5	0.9	0.0	0.0	0.0	0.0	2.7	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	2.9	0.0	0.0	0.0	0.0	0.1	3.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	5.1	0.0	1.5	0.0	2.4	0.6	0.0	0.0	0.0	6.1	0.7	1.1	3.0	0.9	2.2	0.9	1.3	2.6	0.3	1.8	0.9	3.5	4.5	3.1	1.0	1.1	0.6	0.9	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2
CPB2	"CPU, PCPB, TAFI"	ENSG00000080618	"Carboxypeptidase B2"	Q96IY4	13	46053195-46105033	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	82	"liver: 246.8"	"Cell line enriched"	"Detected in single"	76	"Hep G2: 61.1"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 268.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA004146	Approved				"Secreted to blood"		14000000000			"HPA004146: AB_1078397"	"unprognostic (3.44e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.17e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.61e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	246.8	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	61.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.4	0.2	0.5	0.4	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CPE		ENSG00000109472	"Carboxypeptidase E"	P16870	4	165361194-165498320	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 203.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 49.9;SCLC-21H: 70.2;SiHa: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003819, CAB024907"	Supported		Approved	Nucleoplasm,Vesicles,Centrosome	"Intracellular and membrane"		470000	Centrosome	"Nucleoplasm, Vesicles"	"CAB024907: , HPA003819: "	"unprognostic (1.84e-1)"	"unprognostic (5.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.52e-2)"	"unprognostic (2.91e-3)"	"unprognostic (9.01e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.56e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (4.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (2.12e-4)"	27.7	33.8	123.1	4.4	135.5	0.9	21.5	82.9	203.7	10.7	9.6	31.6	5.3	5.0	13.3	94.3	16.4	15.7	14.0	19.6	116.9	56.3	12.0	6.3	11.0	7.6	56.9	70.7	23.4	35.5	33.9	40.0	2.2	53.0	66.5	8.8	13.2	12.0	20.1	11.0	5.5	6.2	18.5	40.5	2.8	19.2	30.4	53.3	0.9	40.7	4.3	7.7	6.3	9.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.3	9.0	1.7	7.2	0.8	0.4	0.0	3.6	1.3	2.9	0.0	0.0	0.0	2.6	0.0	0.2	3.4	0.7	0.8	0.0	13.2	0.0	3.7	49.9	0.5	0.0	0.0	17.6	3.7	0.0	0.0	0.0	0.0	0.3	1.8	2.5	0.0	0.4	5.7	2.0	0.0	0.0	0.1	0.1	0.5	70.2	23.2	103.0	12.9	0.0	7.7	0.3	0.0	2.8	7.2	0.2	0.2	3.9	0.0	0.3	2.6	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	123.1	135.5	82.9	82.2	116.9	56.3	56.9	70.7	53.0	53.3
CPM		ENSG00000135678	"Carboxypeptidase M"	P14384	12	68842197-68971570	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 56.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.8;ASC TERT1: 20.5;HSkMC: 37.0;SiHa: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 15.5;myeloid DC: 11.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.9;monocytes: 15.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002657, HPA077243"	Enhanced		Uncertain	Vesicles			5000000	Vesicles		"HPA002657: AB_1078398, HPA077243: "	"unprognostic (1.74e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.58e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.06e-1)"	56.1	6.6	3.8	5.4	7.0	1.1	37.2	1.2	4.9	6.5	12.9	13.2	0.9	1.6	10.7	6.1	4.1	6.4	6.5	2.9	5.3	3.0	22.1	11.6	24.1	13.0	10.9	4.3	7.5	7.8	3.2	1.0	27.9	5.5	6.2	10.8	2.7	3.2	1.7	8.2	13.0	3.7	2.5	6.7	11.4	5.9	5.8	9.3	1.1	5.1	3.5	4.5	4.4	4.4	2.8	11.9	1.3	15.5	0.3	1.3	4.7	0.0	1.5	0.0	0.0	28.8	20.5	0.3	3.8	0.4	0.6	0.9	1.2	1.6	0.2	3.8	0.5	0.0	0.5	1.0	1.6	0.0	1.0	0.0	6.2	0.1	0.1	0.4	0.7	37.0	0.2	0.4	0.8	0.0	0.0	0.0	2.9	0.6	0.0	0.2	0.6	2.0	1.1	0.2	0.0	2.9	2.2	0.1	0.0	27.1	4.2	3.2	0.4	10.1	0.1	0.5	3.1	0.2	0.0	0.1	0.1	4.9	1.7	5.1	2.3	0.3	15.5	0.1	0.1	10.2	0.0	1.4	1.2	0.0	11.9	2.8	0.7	0.1	1.3	0.3	4.7	0.8	1.3	4.7	3.8	7.0	1.2	4.9	5.3	3.0	10.9	4.3	5.5	9.3
CPN1		ENSG00000120054	"Carboxypeptidase N subunit 1"	P15169	10	100042193-100081877	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"liver: 76.8"	"Cell line enriched"	"Detected in some"	17	"SK-MEL-30: 55.2"	"Group enriched"	"Detected in some"	12	"liver cancer: 26.6;melanoma: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"		22000000000						"unprognostic (2.97e-2)"	"unprognostic (2.23e-2)"			"unprognostic (3.93e-2)"		"unprognostic (1.64e-1)"		"unprognostic (6.75e-2)"		"unprognostic (2.93e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.63e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CPN2	ACBP	ENSG00000178772	"Carboxypeptidase N subunit 2"	P22792	3	194339765-194351328	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 225.5"	"Cell line enriched"	"Detected in some"	25	"Hep G2: 36.3"	"Cancer enriched"	"Detected in some"	32	"liver cancer: 72.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA004732	Uncertain				"Secreted to blood"		42000000000			"HPA004732: AB_1078561"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.42e-1)"			"unprognostic (4.12e-2)"	"prognostic favourable (2.05e-4)"	"unprognostic (1.27e-1)"	"unprognostic (8.65e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.64e-1)"		"prognostic unfavourable (4.59e-4)"	"unprognostic (2.91e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.90e-5)"	"unprognostic (8.42e-2)"	0.2	1.1	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	8.5	225.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.3	0.2	0.6	0.0	0.1	0.0	0.1	0.2	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.3	36.3	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.8	1.1	0.1	1.4	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.3	0.5	0.5	0.2	0.4	0.2	0.5	0.4	0.0	0.6	0.3	0.6	2.5	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
CPNE1	CPN1	ENSG00000214078	"Copine 1"	Q99829	20	35626031-35664956	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047259, HPA072634"	Approved		Supported	"Nucleoplasm,Nuclear membrane"			160000	"Nucleoplasm, Nuclear membrane"		"HPA047259: , HPA072634: "	"unprognostic (5.94e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-3)"	"unprognostic (7.49e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.06e-2)"	"prognostic unfavourable (2.74e-10)"	"unprognostic (3.10e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.35e-1)"	32.0	25.3	23.1	32.9	25.6	36.5	31.8	34.0	24.7	35.5	31.5	23.9	26.3	18.4	38.8	35.1	30.8	34.3	27.8	22.1	22.1	16.0	25.4	23.2	33.3	28.7	22.0	24.8	41.6	27.5	21.5	33.3	39.3	19.4	30.0	27.6	27.4	27.9	25.9	23.9	32.9	31.9	40.5	19.2	42.4	26.3	25.6	23.1	64.8	36.3	27.1	44.4	34.9	33.7	39.4	43.9	52.1	31.0	60.1	53.8	44.7	41.0	32.5	18.5	7.7	2.3	3.1	14.1	19.9	35.6	48.4	32.0	97.7	18.1	28.9	19.2	29.5	15.9	14.3	37.6	30.0	5.4	10.9	72.9	25.6	70.7	22.3	23.6	10.2	20.7	38.8	19.5	23.2	30.5	9.5	14.8	23.5	22.6	35.0	31.7	4.5	31.5	25.0	55.4	19.7	19.7	29.7	13.0	14.6	44.9	21.4	30.4	22.2	23.6	19.9	51.4	9.4	16.7	20.9	10.0	10.1	20.0	37.0	13.0	11.3	13.6	31.0	52.1	39.6	30.4	53.8	39.4	38.0	36.6	43.9	37.0	37.7	37.4	42.9	60.1	28.9	24.0	46.0	44.7	23.1	25.6	34.0	24.7	22.1	16.0	22.0	24.8	19.4	23.1
CPNE3		ENSG00000085719	"Copine 3"	O75131	8	86514427-86561498	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029552	Uncertain		Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol			52000	"Nucleoplasm, Cytosol"	"Nucleoli, Mitochondria"	"HPA029552: AB_10600703"	"unprognostic (5.63e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.40e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.64e-3)"	"unprognostic (2.77e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.13e-2)"	26.5	16.6	21.3	9.8	18.0	35.1	20.6	18.8	13.5	26.0	16.4	20.9	13.2	15.1	28.6	12.6	40.5	15.9	14.6	24.4	17.6	19.7	29.8	25.5	16.9	22.6	19.7	10.5	26.7	24.1	25.4	28.9	16.1	17.0	22.4	16.5	21.0	20.6	15.3	10.4	18.7	19.5	20.9	18.7	18.3	16.9	9.7	14.1	30.5	33.6	21.8	29.7	25.4	20.0	14.6	31.4	28.2	24.3	15.0	18.3	14.4	34.3	12.1	8.4	10.9	32.4	25.3	6.9	16.5	24.6	13.8	15.7	7.8	11.8	9.4	11.0	20.1	26.6	18.0	17.6	24.9	10.0	14.1	1.5	8.9	9.3	11.2	0.8	0.8	17.1	19.0	15.3	20.4	16.9	8.4	18.2	17.1	13.3	16.5	0.5	3.2	17.6	7.9	7.7	44.0	17.9	24.7	17.8	14.0	14.4	66.0	10.4	25.1	2.6	18.0	12.4	12.1	16.4	12.8	13.0	15.6	2.6	17.8	3.5	11.4	10.8	16.7	26.4	18.3	19.1	14.2	14.6	14.8	12.8	30.8	14.1	13.3	14.3	28.2	15.0	24.3	31.4	10.5	14.4	21.3	18.0	18.8	13.5	17.6	19.7	19.7	10.5	17.0	14.1
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36840002	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.1;brain: 50.3;heart muscle: 28.6"	"Group enriched"	"Detected in some"	4	"Daudi: 32.3;HUVEC TERT2: 13.3;U-266/70: 11.1;U-266/84: 8.9;U-698: 15.2"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.3"	"Group enriched"	"Detected in some"	82	"memory B-cell: 27.1;naive B-cell: 12.9"	"Lineage enriched"	"Detected in single"	111	"B-cells: 27.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 100.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 166.9"	HPA031369	Enhanced		Approved	Cytosol				Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	1.8	1.1	8.1	12.5	50.3	1.1	1.7	1.9	49.4	1.8	4.2	1.3	0.0	3.9	3.7	1.0	1.8	11.3	1.7	28.6	3.7	4.9	1.3	0.5	1.5	14.3	3.6	12.8	2.3	1.0	0.8	3.6	1.3	3.3	2.9	3.6	4.1	2.0	2.2	0.5	1.0	2.9	3.6	3.0	7.1	3.4	11.8	6.2	0.1	1.4	0.0	20.3	5.5	1.9	27.1	0.1	0.2	0.1	0.0	0.1	2.2	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.0	0.1	32.3	0.3	0.4	0.3	0.1	0.2	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	13.3	0.1	0.9	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.5	0.0	0.5	3.0	0.2	0.4	0.0	1.3	11.1	8.9	15.2	0.2	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	27.1	0.1	0.0	0.0	12.9	0.0	0.0	0.2	0.0	0.1	0.1	0.0	2.2	8.1	50.3	1.9	20.4	3.7	4.9	3.6	12.8	3.3	6.2
CPNE6		ENSG00000100884	"Copine 6"	O95741	14	24070837-24078100	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;seminal vesicle: 20.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;SK-MEL-30: 1.1;U-266/84: 4.1"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031636, HPA076665"	Enhanced									"HPA031636: AB_10601203, HPA076665: "	"unprognostic (1.02e-2)"	"unprognostic (3.26e-4)"	"unprognostic (1.64e-1)"	"unprognostic (5.66e-5)"	"unprognostic (3.51e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.79e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.71e-1)"	1.3	1.5	36.3	1.4	25.1	1.4	1.1	19.1	41.8	1.2	1.5	8.6	1.2	4.8	1.2	2.6	3.7	1.3	1.2	1.4	34.8	16.0	7.9	4.7	1.2	1.2	11.4	20.5	1.3	1.1	1.1	2.7	1.1	20.1	3.5	1.9	2.4	1.2	20.8	1.1	1.2	5.8	1.6	5.1	1.2	1.2	1.3	5.6	0.0	1.2	0.0	1.1	1.5	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	36.3	25.1	19.1	33.2	34.8	16.0	11.4	20.5	20.1	5.6
CPQ	"LDP, PGCP"	ENSG00000104324	"Carboxypeptidase Q"	Q9Y646	8	96645227-97149654	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 94.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 37.7;ASC TERT1: 43.3;Karpas-707: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023235, HPA024490"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"		51000000	"Golgi apparatus, Vesicles"		"HPA023235: AB_1855257, HPA024490: AB_1855258"	"unprognostic (4.04e-2)"	"unprognostic (5.46e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-3)"	"unprognostic (3.98e-3)"	"unprognostic (5.24e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.16e-3)"	"prognostic favourable (5.40e-5)"	"unprognostic (6.74e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.75e-1)"	17.4	12.6	12.5	10.1	18.3	9.5	15.4	8.3	11.3	26.3	16.5	19.4	21.1	9.4	24.5	19.5	9.1	16.8	20.0	24.1	14.0	9.2	26.4	22.1	13.9	12.3	27.6	8.8	35.3	18.8	20.7	14.2	12.4	16.6	18.1	10.9	19.8	10.9	18.6	5.0	9.1	14.1	30.8	15.3	12.9	14.5	7.3	24.5	1.3	94.4	8.1	7.2	16.9	19.3	1.8	12.8	62.6	17.5	6.3	7.3	8.4	0.6	1.9	1.6	0.4	37.7	43.3	0.5	11.5	17.5	4.1	8.5	1.3	0.8	1.1	9.4	18.2	0.6	0.7	0.8	3.9	10.4	1.5	9.8	1.8	5.7	8.3	2.3	12.7	22.6	2.1	4.7	1.2	1.8	9.5	31.5	9.2	0.6	0.3	4.8	1.2	1.9	2.2	0.3	0.5	8.5	4.4	1.2	0.8	4.1	0.4	8.9	4.4	9.5	8.2	18.0	2.1	0.8	4.2	3.1	0.7	0.4	11.4	7.8	11.9	5.4	17.5	10.8	7.3	12.0	7.3	1.5	5.5	6.3	12.8	1.8	5.0	6.7	62.6	6.3	11.0	3.7	5.7	8.4	12.5	18.3	8.3	11.3	14.0	9.2	27.6	8.8	16.6	24.5
CPS1		ENSG00000021826	"Carbamoyl-phosphate synthase 1"	P31327	2	210477682-210679107	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Urea cycle"	"Allosteric enzyme, Ligase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 298.3"	"Cell line enhanced"	"Detected in many"		"HeLa: 88.4;SK-BR-3: 26.7"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 136.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB003781, HPA021400"	Enhanced		Supported	Nucleoli			2100000	Nucleoli		"CAB003781: , HPA021400: AB_1847197"	"unprognostic (1.67e-2)"	"unprognostic (3.72e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.21e-7)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (6.93e-5)"	"unprognostic (1.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.38e-4)"	"unprognostic (5.90e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.14e-2)"	"unprognostic (3.74e-2)"	0.4	0.1	0.5	0.3	1.6	0.0	0.8	0.3	0.7	0.4	0.2	0.7	0.3	31.5	0.3	0.7	0.5	0.2	0.4	0.3	0.5	0.4	0.6	298.3	0.2	0.3	1.5	0.8	0.7	0.2	0.0	0.4	1.1	1.4	0.3	0.0	0.6	0.2	0.2	0.3	0.3	17.2	0.4	2.3	0.3	0.2	1.3	0.5	0.0	0.4	0.4	0.1	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	2.3	6.2	4.2	4.1	7.2	6.6	2.2	2.7	2.6	4.1	0.6	0.0	1.0	0.1	2.4	1.1	0.2	3.7	6.6	0.0	1.9	3.9	88.4	5.5	1.3	2.0	0.0	3.7	2.8	5.2	5.3	0.2	3.9	0.3	4.3	1.1	0.1	0.2	2.4	0.6	0.2	5.7	0.5	5.6	0.0	0.1	0.4	15.5	26.7	3.0	0.0	0.6	2.9	6.8	2.1	2.0	4.8	0.0	0.3	0.0	4.5	4.3	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.3	0.7	0.5	0.4	1.5	0.8	1.4	0.5
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409349	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA065167: , HPA068906: "	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	11.9	13.5	13.4	18.6	17.2	27.0	14.3	28.5	18.0	11.7	15.1	16.3	14.9	40.7	17.8	8.9	13.0	16.2	14.3	10.3	13.0	8.2	13.0	15.0	13.7	17.4	16.6	11.5	19.8	22.4	7.3	21.6	11.1	15.4	18.4	7.6	14.9	26.9	13.8	14.7	25.2	29.8	11.7	11.0	21.2	16.3	27.9	16.1	27.1	17.7	10.6	16.0	13.1	13.4	7.5	8.8	4.9	9.3	5.7	10.0	5.8	9.3	13.2	12.1	12.6	6.4	5.2	11.8	8.8	5.6	7.3	7.6	13.3	12.2	10.9	8.6	6.6	8.6	6.7	7.5	2.0	9.7	19.6	21.3	14.8	21.3	5.5	8.1	13.2	5.7	3.2	6.6	3.9	9.6	17.8	9.3	3.6	40.1	21.1	17.0	7.3	18.7	15.2	4.8	8.7	7.7	13.9	9.8	9.7	11.4	7.1	6.4	12.6	9.0	8.2	5.0	19.3	10.9	9.8	5.5	4.3	10.2	6.7	13.7	5.9	4.9	7.8	4.9	8.0	9.3	8.4	6.9	8.5	8.4	8.8	7.5	7.5	7.1	1.5	5.7	8.6	4.1	10.0	5.8	13.4	17.2	28.5	18.0	13.0	8.2	16.6	11.5	15.4	16.1
CPSF2	"CPSF100, KIAA1367"	ENSG00000165934	"Cleavage and polyadenylation specific factor 2"	Q9P2I0	14	92121937-92172145	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024238	Supported		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA024238: AB_1847200"	"unprognostic (2.31e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.77e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.14e-2)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.78e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.90e-2)"	20.5	24.0	14.6	24.1	16.3	10.6	16.7	14.5	16.5	18.3	16.4	19.3	21.5	15.1	19.3	16.5	25.7	15.4	15.9	16.3	14.9	13.6	16.8	22.2	17.3	20.1	20.8	11.8	21.5	16.5	24.9	28.9	19.6	16.0	17.1	18.1	14.7	18.5	25.3	36.6	14.9	19.0	18.8	19.7	23.8	17.8	25.7	18.1	44.0	22.6	19.4	25.0	19.7	17.7	9.3	13.0	15.0	14.4	12.8	13.4	9.7	18.4	18.4	18.8	19.4	9.8	8.7	28.0	23.9	23.4	22.2	22.1	15.9	25.7	19.8	15.7	25.4	27.4	25.9	21.7	32.2	32.0	8.9	29.0	19.0	15.3	29.1	29.1	24.5	14.2	18.6	21.1	38.1	20.7	26.0	25.1	24.7	26.9	33.5	10.3	21.3	16.8	33.1	29.2	17.8	15.1	26.2	20.8	14.0	28.1	15.9	20.3	33.0	18.3	22.1	17.9	11.3	13.4	20.3	15.2	24.7	40.4	21.5	23.0	27.7	15.0	14.4	10.4	9.6	13.6	12.9	9.3	8.6	10.2	13.0	5.3	7.8	10.5	5.2	12.8	10.7	8.4	13.4	9.7	14.6	16.3	14.5	16.5	14.9	13.6	20.8	11.8	16.0	18.1
CPSF4	"CPSF30, NAR"	ENSG00000160917	"Cleavage and polyadenylation specific factor 4"	O95639	7	99438922-99457371	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049094, HPA066470"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA049094: , HPA066470: "	"unprognostic (4.03e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (5.87e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.23e-2)"	15.2	11.6	19.3	11.8	19.0	15.7	11.8	20.9	25.6	9.3	9.8	19.8	13.1	12.4	11.1	11.4	13.6	11.2	10.3	10.0	21.5	16.0	10.0	11.7	9.3	20.3	16.8	17.4	13.4	25.4	7.3	12.7	15.1	21.9	11.6	10.2	9.9	17.3	12.2	21.2	18.4	9.6	10.5	20.3	13.9	11.5	38.4	14.6	8.7	11.0	10.7	17.8	10.5	10.4	10.2	6.4	3.1	4.1	5.0	9.7	3.9	14.6	12.8	22.0	17.4	9.0	10.3	26.0	9.7	12.2	15.1	20.0	21.1	19.7	21.1	13.2	9.5	12.8	15.1	15.2	14.6	15.4	16.1	10.0	14.7	20.3	47.1	18.0	12.9	18.7	13.2	16.0	24.4	13.8	25.9	25.1	14.3	36.1	37.1	33.2	20.0	18.2	15.1	14.7	24.9	9.5	13.8	17.4	20.1	11.2	23.3	22.9	9.7	19.4	7.5	14.2	19.8	24.3	18.4	23.4	24.6	30.7	10.9	18.0	16.8	1.4	4.1	3.1	4.4	3.3	5.8	10.2	6.7	7.9	5.2	8.5	8.5	7.6	1.6	5.0	2.6	6.4	9.7	3.9	19.3	19.0	20.9	25.6	21.5	16.0	16.8	17.4	21.9	14.6
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239537-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"			500000	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	22.3	26.4	29.4	28.1	32.6	52.0	23.1	49.1	32.2	24.8	20.7	24.3	21.3	21.8	27.4	34.5	27.1	23.2	17.0	21.8	24.3	16.4	20.0	19.7	21.6	36.1	23.6	26.8	42.2	23.5	28.6	36.4	21.0	24.9	21.5	21.5	22.2	25.6	21.4	25.4	23.3	23.1	22.3	20.7	24.7	21.9	22.1	25.8	42.8	25.5	10.5	32.9	21.3	24.2	22.0	25.5	21.0	21.5	19.3	30.2	12.4	28.4	24.0	35.5	24.8	13.8	15.7	26.7	18.8	22.4	26.8	25.4	24.9	19.6	45.4	19.3	19.0	26.9	34.7	22.2	28.7	29.6	23.7	36.6	24.8	28.5	20.6	49.4	26.8	18.8	17.6	21.6	8.9	20.6	37.6	48.8	22.2	33.1	46.2	32.3	34.2	20.5	46.9	28.0	31.8	21.1	33.9	29.9	26.3	25.2	23.7	25.6	28.4	35.0	23.6	20.3	24.9	19.1	30.7	31.4	25.3	56.8	16.4	28.9	26.0	21.0	17.1	18.7	19.7	21.5	20.9	22.0	22.0	20.2	25.5	19.0	17.0	20.1	5.2	19.3	17.8	18.3	30.2	12.4	29.4	32.6	49.1	32.2	24.3	16.4	23.6	26.8	24.9	25.8
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria			790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.3	14.8	2.1	14.5	9.5	8.6	0.6	6.7	5.5	5.3	1.1	0.5	28.3	0.0	24.8	17.6	27.5	18.8	4.0	1.6	13.4	1.8	20.5	16.2	6.8	14.2	11.9	24.9	8.9	1.9	10.6	6.4	18.8	2.1	16.9	4.8	24.0	9.7	21.1	0.2	15.8	27.1	0.3	36.5	12.5	20.9	0.3	9.5	18.5	35.7	5.9	31.9	11.6	18.8	11.6	0.2	23.2	9.6	13.2	16.8	8.5	12.2	8.8	12.6	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0
CPT2	"CPT1, CPTASE"	ENSG00000157184	"Carnitine palmitoyltransferase 2"	P23786	1	53196429-53214197	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028201, HPA028202, HPA028214"	Enhanced		Supported	Nucleoplasm,Nucleoli,Mitochondria				"Nucleoplasm, Nucleoli, Mitochondria"		"HPA028201: AB_10599177, HPA028202: AB_10599942, HPA028214: AB_10601958"	"unprognostic (2.43e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (5.27e-4)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.34e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.97e-2)"	"prognostic favourable (1.46e-12)"	"unprognostic (4.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.95e-2)"	7.5	15.5	5.3	6.8	6.1	2.3	6.5	4.0	7.2	5.1	15.4	9.4	10.7	16.6	5.1	7.6	10.5	5.4	11.3	21.4	4.3	4.5	19.8	69.0	6.9	8.3	5.7	3.7	5.3	15.9	10.7	11.5	18.1	6.4	6.0	15.6	13.8	11.8	12.2	13.6	6.0	18.9	5.5	5.2	10.3	10.1	11.2	4.7	9.7	8.3	7.2	10.3	8.0	4.9	5.9	12.4	10.0	13.1	4.8	8.0	6.5	7.8	3.3	7.7	7.5	6.6	3.9	8.8	4.9	5.0	7.1	6.6	1.6	6.7	13.5	7.5	2.3	7.9	14.3	11.3	6.0	7.4	8.4	7.7	4.5	1.3	9.8	7.3	7.4	8.4	9.7	5.1	4.4	4.8	9.8	4.8	4.4	4.6	5.7	6.0	14.4	8.8	6.6	7.3	14.3	8.8	7.4	11.5	7.7	9.8	12.5	18.5	14.5	15.6	4.7	4.0	3.2	7.0	4.0	14.9	9.1	8.3	5.1	8.4	5.8	4.1	8.4	10.0	5.1	12.6	6.2	4.5	4.9	5.9	12.4	5.9	8.0	5.5	5.1	4.8	13.1	6.4	7.0	6.5	5.3	6.1	4.0	7.2	4.3	4.5	5.7	3.7	6.4	4.7
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.2;lymphoid tissue: 42.3"	"Group enriched"	"Detected in some"	9	"HL-60: 8.8;HMC-1: 20.6;NB-4: 8.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"basophil: 23.2;eosinophil: 9.4;neutrophil: 9.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.2"									"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced						27000000			"CAB002491: AB_563553, CAB016271: AB_627040, HPA042455: , HPA043579: , HPA049348: "	"unprognostic (1.74e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.75e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.29e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.50e-3)"	9.0	1.1	0.6	17.0	0.6	5.8	1.5	0.4	0.5	0.6	1.7	0.2	0.0	0.5	0.7	5.6	1.4	2.2	1.1	8.0	0.6	0.5	2.3	3.8	4.0	42.3	0.6	0.0	1.7	1.2	0.0	0.6	5.5	1.0	1.7	0.7	0.5	1.9	0.0	0.8	0.5	5.1	3.6	0.7	42.0	1.1	0.9	0.1	1.3	0.7	0.0	11.1	3.2	1.3	2.8	0.2	23.2	2.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	8.8	20.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	23.2	2.3	9.4	0.0	1.4	0.4	2.8	0.6	0.3	0.2	1.4	0.1	0.1	9.1	0.0	1.2	0.0	0.0	0.6	0.6	0.6	0.4	0.5	0.6	0.5	0.6	0.0	1.0	0.1
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207454230-207489895	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 97.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 21.1;MOLT-4: 11.5;RPMI-8226: 4.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 13.3;naive B-cell: 16.2"	"Lineage enriched"	"Detected in many"	9	"B-cells: 16.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB002659, HPA052942, HPA060715"	Enhanced						150000000			"CAB002659: , HPA052942: AB_2681994, HPA060715: AB_2684349"	"prognostic favourable (6.90e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.35e-2)"	0.5	0.3	0.4	97.2	0.3	0.0	0.4	0.3	0.3	0.3	1.2	0.0	0.0	0.0	0.3	0.0	2.8	0.3	0.3	0.3	0.4	0.4	1.4	0.4	2.0	72.8	0.4	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.0	6.0	0.0	0.4	0.3	11.5	0.0	0.4	63.4	1.4	0.5	0.0	6.5	0.7	0.3	56.3	0.6	0.3	16.2	0.0	0.2	0.0	0.0	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.5	0.0	1.9	0.2	0.0	0.2	4.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	13.3	0.7	0.5	0.0	16.2	1.8	1.6	0.2	0.0	0.0	0.0	0.0	1.1	0.4	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.0	0.0
CRABP1	"CRABP, CRABP-I, CRABPI, RBP5"	ENSG00000166426	"Cellular retinoic acid binding protein 1"	P29762	15	78340324-78348230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.1;retina: 73.2;thyroid gland: 80.6"	"Group enriched"	"Detected in some"	8	"AF22: 143.3;NTERA-2: 42.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 117.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"myeloid DC: 1.2"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 1.2"	"Group enriched"	"Detected in many"	5	"amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8"	"Low region specificity"	"Detected in some"			HPA017203	Enhanced	Supported								"HPA017203: AB_1846512"	"unprognostic (1.23e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (2.01e-1)"	"unprognostic (4.35e-2)"		"unprognostic (1.05e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.37e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.69e-1)"	0.7	1.3	6.3	1.8	25.6	0.6	24.8	2.8	12.4	1.2	1.9	3.3	0.3	0.9	1.5	1.9	0.7	0.5	1.2	0.7	1.1	21.9	4.2	0.5	0.8	0.6	16.9	4.5	0.7	0.7	0.5	6.3	7.0	40.1	1.0	1.3	73.2	0.6	24.8	0.5	12.3	2.3	1.3	7.3	21.1	1.9	0.6	2.4	0.4	80.6	2.4	1.0	0.7	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	7.6	0.0	42.9	0.1	0.0	0.0	0.0	0.0	0.2	12.0	8.1	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	25.6	2.8	12.4	1.1	21.9	16.9	4.5	40.1	2.4
CRB1	"LCA8, RP12"	ENSG00000134376	"Crumbs 1, cell polarity complex component"	P82279	1	197268204-197478455	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell line enriched"	"Detected in some"	8	"HeLa: 17.1"	"Cancer enriched"	"Detected in single"	12	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"basophil: 9.4"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 9.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA061250, HPA063127"	Approved		Uncertain	Vesicles	"Intracellular and membrane"			Vesicles		"HPA061250: , HPA063127: "	"unprognostic (1.96e-1)"	"unprognostic (5.38e-3)"		"unprognostic (2.92e-3)"	"unprognostic (1.50e-2)"	"unprognostic (5.13e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.48e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.96e-1)"	1.1	1.1	11.9	0.9	11.0	1.8	1.2	31.4	20.4	0.9	0.9	10.4	0.0	0.9	0.8	1.2	1.1	2.0	1.0	1.2	11.4	6.2	1.1	0.9	1.0	1.0	4.0	8.9	2.6	1.7	0.7	1.9	0.9	14.1	1.0	0.9	9.0	0.8	0.9	2.4	0.9	0.9	0.8	8.7	0.9	1.5	7.3	9.6	0.0	1.3	0.0	0.8	0.9	0.1	0.1	0.0	9.4	0.0	0.1	0.4	0.0	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	17.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	2.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.3	0.1	0.0	0.0	0.0	0.0	11.9	11.0	31.4	10.5	11.4	6.2	4.0	8.9	14.1	9.6
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: "	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.5	14.3	18.6	8.2	11.4	11.3	9.6	8.0	13.5	13.9	13.5	12.9	10.5	15.4	9.6	15.3	10.8	21.4	6.6	15.8	26.0	8.6	12.1	13.2	8.2	12.6	12.1	17.4	10.0	6.7	15.4	18.6	10.4	13.7	21.1	7.5	19.1	8.0	5.8	15.2	5.9	37.8	14.7	11.8	5.4	7.5	15.5	10.2	13.7	13.5	8.1	12.0	11.9	16.1	17.0	16.9	8.7	7.3	9.9	10.6	29.9	3.4	7.3	11.9	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2
CRH	"CRF, CRH1"	ENSG00000147571	"Corticotropin releasing hormone"	P06850	8	66176382-66178725	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"placenta: 209.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;SCLC-21H: 2.5"	"Cancer enriched"	"Detected in some"	28	"urothelial cancer: 34.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 28.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062111	Uncertain				"Secreted to blood"	10000				"HPA062111: "					"unprognostic (1.62e-1)"						"unprognostic (9.68e-2)"				"unprognostic (1.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.22e-3)"	2.7	0.2	4.1	0.2	2.1	0.3	0.2	0.0	6.7	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	2.7	28.4	0.2	0.2	0.3	0.2	0.4	1.1	0.2	1.3	0.2	0.1	209.9	13.8	0.2	0.2	0.0	0.2	0.2	0.3	0.2	0.2	0.5	0.1	0.2	0.4	0.9	0.0	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	2.1	0.0	6.7	2.7	28.4	0.4	1.1	13.8	0.0
CRHBP	"CRF-BP, CRFBP"	ENSG00000145708	"Corticotropin releasing hormone binding protein"	P24387	5	76952713-76981158	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;liver: 99.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 4.9;BJ hTERT+ SV40 Large T+ RasG12V: 4.8;HBF TERT88: 8.7;U-698: 9.5;U-87 MG: 5.2;WM-115: 4.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 24.9"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036234, HPA046120"	Approved	Supported			"Secreted to blood"		43000000			"HPA036234: , HPA046120: AB_10959760"	"unprognostic (1.41e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.36e-3)"	"unprognostic (4.44e-5)"	"unprognostic (2.16e-1)"	"unprognostic (7.08e-2)"	"unprognostic (4.98e-4)"	"unprognostic (1.09e-1)"	"unprognostic (6.63e-5)"	"unprognostic (2.76e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-2)"	8.4	5.6	3.5	0.4	5.4	1.2	2.6	0.0	7.8	1.6	0.3	3.2	1.8	0.4	1.2	0.7	0.2	0.9	0.5	3.2	4.0	24.9	16.1	99.9	0.3	0.4	2.7	5.4	0.8	0.2	0.4	0.0	18.1	1.8	0.6	0.3	1.5	0.6	1.9	0.5	0.2	0.3	0.8	2.2	13.9	0.3	0.5	1.2	0.0	1.9	0.9	0.4	0.5	0.2	0.0	0.0	1.2	0.1	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	4.9	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.7	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	9.5	5.2	0.0	4.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	3.5	5.4	0.0	7.8	4.0	24.9	2.7	5.4	1.8	1.2
CRIP1	CRIP	ENSG00000213145	"Cysteine rich protein 1"	P50238	14	105486317-105488947	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 129.0;CAPAN-2: 71.9;HaCaT: 77.9;HDLM-2: 55.1;HeLa: 63.2;T-47d: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042462	Approved		Approved	"Nuclear speckles,Plasma membrane,Centrosome,Cytosol"				"Nuclear speckles, Cytosol"	"Plasma membrane, Centrosome"	"HPA042462: AB_10794277"	"unprognostic (2.97e-3)"	"unprognostic (1.27e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.33e-1)"	"unprognostic (3.33e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.26e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.14e-1)"	44.3	3.3	3.8	37.5	4.9	5.5	97.2	3.2	4.0	37.7	44.0	4.5	65.3	25.7	20.0	83.0	28.4	23.7	33.8	45.5	4.5	4.7	20.4	2.6	56.7	53.0	4.7	4.5	11.2	4.2	1.1	7.3	38.5	4.8	11.7	13.2	9.9	21.8	71.0	12.9	48.8	106.3	25.9	5.1	16.6	20.3	7.5	1.9	24.2	32.0	83.4	58.3	18.4	18.9	111.4	79.3	56.3	49.4	56.9	121.1	75.8	0.0	129.0	0.8	0.1	2.3	1.6	12.0	0.2	0.0	1.7	0.0	4.0	71.9	38.9	0.7	34.4	77.9	0.0	0.0	0.1	55.1	0.0	3.0	63.2	21.7	0.4	0.0	0.0	0.7	0.0	4.2	0.0	0.1	0.1	0.1	0.0	1.0	1.9	0.3	1.2	6.7	30.5	0.0	8.1	0.0	0.0	3.4	0.2	0.4	0.2	0.0	101.1	18.5	0.2	0.0	0.1	0.9	0.0	0.0	0.0	3.2	0.0	0.0	0.1	19.4	43.3	56.3	47.7	38.5	32.7	111.4	92.1	51.4	79.3	43.6	21.9	25.7	2.9	56.9	49.4	62.1	121.1	75.8	3.8	4.9	3.2	4.0	4.5	4.7	4.7	4.5	4.8	1.9
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727384-49744437	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 156.3;fallopian tube: 117.6;salivary gland: 233.3"	"Group enriched"	"Detected in some"	65	"HEL: 14.2;RT4: 4.8;SK-BR-3: 10.8;T-47d: 5.3"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	45	"neutrophil: 6.0;non-classical monocyte: 2.9"	"Group enriched"	"Detected in many"	45	"granulocytes: 6.0;monocytes: 2.9"					"Low region specificity"	"Detected in many"			HPA054392	Supported				"Secreted in other tissues"		390000000			"HPA054392: "	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.2	0.2	0.2	0.0	0.2	33.5	0.2	0.2	0.2	11.1	0.2	0.0	156.3	0.0	0.7	0.0	45.3	117.6	2.0	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.2	0.0	15.9	1.7	0.0	0.2	0.0	0.0	3.0	0.0	0.0	233.3	17.7	0.2	0.6	0.2	0.0	0.2	0.4	0.2	0.2	0.0	0.0	0.2	56.7	14.8	1.2	14.4	0.0	0.0	6.0	2.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	10.8	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	2.9	0.0	0.0	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984515-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.4"	"Group enriched"	"Detected in some"	5	"AF22: 51.1;SH-SY5Y: 27.6"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	32	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	32	"dendritic cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"					"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	3.2	1.0	5.3	1.7	24.7	1.0	22.4	0.7	8.2	5.4	3.8	15.9	0.0	0.5	7.1	4.0	4.0	5.9	7.8	8.4	10.2	6.4	1.6	1.6	2.2	1.8	7.8	4.7	4.7	1.8	12.1	1.9	5.7	34.4	20.0	1.2	3.1	15.1	2.2	0.7	3.2	1.7	5.4	29.6	1.4	1.7	3.2	9.3	6.0	12.9	1.6	1.1	2.4	1.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	51.1	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.3	0.0	0.0	7.3	0.0	0.0	4.2	0.0	0.0	0.0	1.9	0.0	1.9	0.0	1.1	0.0	0.4	2.8	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	5.2	1.8	0.0	7.0	0.0	0.0	0.0	0.3	27.6	0.0	0.0	2.9	3.9	2.3	0.0	1.4	7.7	0.0	0.2	0.9	0.3	0.0	1.7	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.3	24.7	0.7	8.2	10.2	6.4	7.8	4.7	34.4	9.3
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol			1500000	Nucleoplasm	Cytosol	"HPA000532: , HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavourable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.2	6.7	15.2	11.9	10.3	6.6	16.4	7.6	9.4	11.8	13.4	11.1	5.1	14.5	6.2	8.0	14.5	17.8	12.2	14.1	12.3	17.4	20.1	7.4	12.2	10.3	21.3	10.3	6.7	16.3	10.2	17.6	10.4	87.6	12.0	9.5	10.6	12.4	10.0	12.0	7.4	16.2	24.2	3.5	7.9	9.9	9.9	12.7	12.8	11.3	9.3	9.7	11.9	8.4	18.8	21.4	7.0	9.6	11.5	11.1	16.9	13.9	9.1	11.5	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8
CRLF3	"CREME9, CYTOR4"	ENSG00000176390	"Cytokine receptor like factor 3"	Q8IUI8	17	30769388-30824776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 43.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007596	Enhanced		Supported	"Plasma membrane,Cytosol"			830000	"Plasma membrane, Cytosol"		"HPA007596: AB_1847241"	"unprognostic (1.02e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.52e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.31e-7)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.51e-2)"	8.7	4.8	8.8	22.7	8.3	16.7	7.3	12.4	9.4	6.9	7.0	5.9	3.9	5.5	6.3	3.6	15.4	6.1	7.0	5.8	7.5	6.6	5.3	5.4	9.7	28.6	6.6	9.3	5.8	5.5	5.1	6.9	12.3	7.3	6.6	7.4	4.4	7.5	3.9	3.8	10.7	11.3	6.1	8.7	22.0	5.9	9.6	6.7	26.7	5.7	4.5	27.8	10.3	9.3	15.9	13.9	43.6	21.8	12.9	35.7	25.2	6.2	6.9	4.3	9.0	7.9	6.2	6.5	5.9	5.8	11.5	12.1	9.1	4.3	20.9	8.9	7.3	11.0	7.3	4.9	13.9	9.7	13.4	8.7	6.1	6.0	4.4	11.5	6.5	3.6	6.9	9.3	7.9	11.2	22.1	22.2	7.2	3.8	25.4	12.7	8.6	4.6	11.3	14.0	12.2	7.6	5.3	3.1	7.3	6.3	9.4	6.5	7.2	5.8	5.9	6.7	8.3	10.7	14.4	9.3	7.7	14.0	6.4	9.4	7.4	15.5	18.8	43.6	13.0	19.2	13.7	15.9	18.3	14.6	13.9	14.9	35.7	26.4	38.3	12.9	21.8	7.2	20.1	25.2	8.8	8.3	12.4	9.4	7.5	6.6	6.6	9.3	7.3	6.7
CRNKL1	"CLF, Clf1, CRN, SYF3"	ENSG00000101343	"Crooked neck pre-mRNA splicing factor 1"	Q9BZJ0	20	20034368-20056046	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.43e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (8.06e-6)"	"unprognostic (1.18e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-2)"	15.9	14.5	14.3	12.6	17.1	29.5	21.2	27.8	19.2	17.7	14.9	12.4	16.8	13.0	20.7	14.8	17.5	13.8	11.2	15.3	13.8	11.4	15.6	19.0	12.1	15.9	18.0	13.1	20.2	13.8	22.6	17.1	16.4	13.8	18.4	16.0	8.6	16.9	16.0	33.0	15.6	15.3	16.1	16.7	18.1	13.9	16.1	18.9	23.5	17.3	11.1	15.8	16.8	19.2	10.1	7.2	25.5	14.2	14.3	11.6	7.5	11.9	15.0	11.4	14.0	11.1	11.9	16.0	10.9	10.1	14.0	13.5	10.1	11.4	11.8	8.2	11.2	16.9	12.9	14.5	17.0	5.9	7.1	11.7	4.5	20.7	8.7	13.8	27.6	9.5	8.2	15.1	9.0	10.6	12.3	14.4	12.0	18.2	15.2	10.2	10.7	15.1	13.5	28.2	15.5	8.2	8.2	17.7	12.9	14.9	23.4	15.3	20.3	9.9	9.8	11.2	9.1	10.8	12.0	20.0	19.6	12.5	5.5	7.7	9.7	19.7	9.4	20.3	9.9	10.1	11.6	10.1	11.4	10.7	7.2	9.1	10.8	9.5	25.5	14.3	14.2	6.5	11.0	7.5	14.3	17.1	27.8	19.2	13.8	11.4	18.0	13.1	13.8	18.9
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 34.6;RT4: 33.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles				Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favourable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.0	5.2	6.5	2.2	6.2	5.7	4.8	7.5	7.1	4.6	5.0	2.8	3.7	3.0	6.7	6.3	8.9	1.0	10.0	6.5	4.2	4.5	6.5	3.7	3.5	4.0	4.0	4.0	4.6	34.6	3.7	2.9	6.5	0.3	4.3	12.0	6.9	5.0	4.0	1.4	7.9	2.3	8.9	0.5	5.9	33.8	1.0	5.1	9.2	10.6	4.8	6.7	1.4	3.4	10.7	4.6	14.4	7.1	6.6	9.4	4.1	7.2	0.0	6.3	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	66	"liver: 1139.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;HDLM-2: 7.6;U-2 OS: 5.4;U-266/84: 12.8"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 1010.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	1832500000	5400000000	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: AB_562362, HPA027367: AB_1847216, HPA027396: AB_1847217"	"unprognostic (3.74e-1)"	"unprognostic (5.31e-2)"				"unprognostic (2.97e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.57e-2)"			"unprognostic (1.33e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (4.17e-10)"	"unprognostic (3.39e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.61e-2)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.0	17.2	0.1	0.1	0.0	0.1	1139.7	0.1	0.1	0.1	0.1	0.1	7.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.3	0.0	0.0	0.0	7.6	0.0	0.3	0.0	0.0	0.0	0.3	0.1	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.1	0.9	0.0	12.8	2.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 34.0;lung: 42.1;retina: 31.6;seminal vesicle: 31.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.5;HUVEC TERT2: 8.7;SCLC-21H: 5.8;SK-MEL-30: 9.6;TIME: 11.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008175	Enhanced				"Secreted to extracellular matrix"		360000000			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favourable (1.51e-4)"	4.5	1.4	6.2	1.6	7.2	0.8	2.0	7.2	27.3	3.9	6.0	3.8	4.5	1.2	1.2	4.8	7.9	34.0	1.1	6.2	5.5	7.0	3.1	1.1	42.1	1.1	9.2	5.8	2.2	1.8	1.4	3.2	0.8	27.5	3.3	1.1	31.6	3.4	31.1	1.4	2.9	1.2	3.6	6.8	0.8	1.0	4.0	2.7	0.0	4.4	0.7	1.0	25.5	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.7	0.0	3.5	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.2	5.8	1.3	0.7	0.0	9.6	0.1	0.0	11.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.2	7.2	18.7	5.5	7.0	9.2	5.8	27.5	2.7
CRYAA	"CRYA1, HSPB4"	ENSG00000160202	"Crystallin alpha A"	P02489	21	43169008-43172805	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Chaperone, Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 45.5"	"Cell line enriched"	"Detected in single"	140	"Hep G2: 28.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037737, HPA038430"	Supported		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA037737: , HPA038430: "							"unprognostic (3.68e-3)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	8.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0										
CRYBA1	CRYB1	ENSG00000108255	"Crystallin beta A1"	P05813	17	29246863-29254494	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.4;bone marrow: 1.4;brain: 2.8;lymphoid tissue: 1.5"	"Group enriched"	"Detected in some"	8	"AF22: 6.7;BEWO: 8.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA022016	Supported									"HPA022016: "	"unprognostic (2.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.60e-2)"	"unprognostic (2.52e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.09e-6)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.31e-2)"	"unprognostic (6.84e-3)"	0.0	0.0	0.2	1.5	0.3	1.4	0.0	0.0	2.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.4	0.6	0.0	0.0	0.0	1.3	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.4	0.0	0.7	0.1	0.0	0.0	6.7	0.1	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.3	1.4	0.4	0.4	0.7	0.1	0.8	1.0	0.3	0.1	0.4	0.0	0.0	0.4	0.0	0.1	0.2	0.3	0.0	2.8	0.2	0.2	0.5	0.0	0.0	0.0
CRYBB1		ENSG00000100122	"Crystallin beta B1"	P53674	22	26599278-26618088	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Eye lens protein"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;epididymis: 17.4"	"Group enriched"	"Detected in some"	5	"Karpas-707: 21.0;RPMI-8226: 37.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 10.6;non-classical monocyte: 7.5"	"Lineage enriched"	"Detected in many"	6	"monocytes: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003448, CAB010058"	Supported						93000			"CAB010058: AB_668166, HPA003448: "	"unprognostic (1.31e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.89e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.88e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-2)"	3.0	3.0	2.5	2.1	2.2	1.1	2.0	0.3	4.4	1.2	1.1	5.6	0.0	1.1	1.1	17.4	1.4	1.5	2.3	2.8	2.4	1.9	1.1	1.0	2.9	3.1	3.8	0.3	1.2	2.6	0.7	1.7	8.3	1.9	2.7	0.8	1.7	1.3	1.1	1.1	0.4	0.9	1.6	3.6	5.7	1.0	1.0	1.0	0.8	0.6	0.0	1.0	2.3	0.7	0.3	1.7	0.5	10.6	0.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	5.8	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	37.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.8	0.0	1.0	0.0	0.0	1.0	0.0	0.0	10.6	0.0	0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.5	0.4	7.5	0.0	0.0	0.6	2.5	2.2	0.3	4.4	2.4	1.9	3.8	0.3	1.9	1.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"	Q9Y4K1	6	106360808-106571978	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.7;placenta: 96.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 31.7;HBEC3-KT: 39.6;hTERT-HME1: 30.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	9	"pons and medulla: 10.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.1"	"Not detected"	"Not detected"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: , HPA030949: "	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	4.6	0.8	0.6	6.8	0.7	6.5	11.3	0.6	0.9	7.4	7.4	1.6	2.5	7.6	1.5	10.8	61.7	2.0	2.0	0.9	1.1	0.6	9.8	3.6	4.0	5.6	0.7	0.7	2.0	5.5	5.0	0.9	96.6	10.3	12.6	5.9	16.0	10.2	4.3	0.8	16.6	7.6	4.4	0.8	6.5	2.5	1.8	0.5	2.3	1.8	24.6	35.8	11.5	13.1	6.8	8.7	3.1	4.4	5.7	10.9	3.9	10.4	0.0	0.0	0.0	8.8	31.7	3.2	1.5	11.6	3.4	3.2	0.7	3.7	16.4	0.7	7.2	16.9	0.1	39.6	1.6	22.3	0.7	0.0	0.4	5.1	4.2	10.0	0.0	15.8	23.1	6.4	30.7	14.4	0.5	2.3	9.1	1.2	2.8	4.0	0.1	6.9	4.9	0.1	0.1	5.3	24.9	0.7	0.0	6.4	11.0	0.1	5.4	7.6	4.2	3.8	0.5	0.0	10.5	1.8	1.4	17.9	18.1	12.6	8.2	0.3	3.8	0.4	8.1	4.4	10.9	6.8	10.5	8.9	8.7	3.8	6.7	6.3	3.1	5.7	4.4	1.0	9.9	3.9	0.6	0.7	0.6	0.9	1.1	0.6	0.7	0.7	10.3	0.5
CRYL1	"GDH, lambda-CRY, MGC149525, MGC149526"	ENSG00000165475	"Crystallin lambda 1"	Q9Y2S2	13	20403666-20525873	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 104.0;liver: 80.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040403	Enhanced		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Plasma membrane"			210000	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Plasma membrane"	"HPA040403: AB_10795632"	"unprognostic (1.84e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.25e-2)"	"prognostic favourable (1.76e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.75e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.80e-2)"	"prognostic favourable (2.30e-9)"	"unprognostic (9.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.11e-1)"	9.8	8.9	21.5	8.8	22.9	3.5	7.0	10.4	17.4	11.8	35.1	26.7	18.9	61.0	9.2	18.0	7.4	9.3	16.1	9.3	18.8	19.8	104.0	80.8	6.8	5.9	24.5	12.3	7.3	15.4	5.3	10.4	5.6	16.8	11.2	16.5	17.2	13.1	20.1	5.4	4.1	45.7	8.0	32.0	6.5	12.0	2.7	16.4	3.2	11.9	5.6	5.5	8.6	5.9	9.3	25.7	1.8	24.3	6.0	15.6	17.5	3.4	3.0	2.6	19.0	14.5	16.8	2.6	4.9	8.8	2.1	1.7	1.1	3.2	0.0	9.3	6.7	0.8	2.5	4.4	2.2	8.3	2.1	6.1	0.3	23.7	8.3	1.9	5.5	9.9	2.8	1.6	10.0	23.0	0.4	2.4	5.6	12.5	5.2	3.1	0.1	4.6	2.7	1.7	0.4	18.3	7.4	1.8	2.2	2.9	1.4	21.8	9.4	7.8	22.0	2.7	1.2	6.5	3.0	3.4	0.7	0.0	5.1	3.4	10.9	1.8	21.8	1.4	10.5	24.3	8.5	9.3	14.0	10.0	25.7	9.1	11.0	10.2	0.7	6.0	20.1	2.8	15.6	17.5	21.5	22.9	10.4	17.4	18.8	19.8	24.5	12.3	16.8	16.4
CRYZ		ENSG00000116791	"Crystallin zeta"	Q08257	1	74705482-74733408	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.0;liver: 79.8"	"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 96.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021921, HPA023290"	Approved		Supported	Cytosol			7200000	Cytosol		"HPA021921: AB_1847262, HPA023290: AB_1847263"	"unprognostic (3.64e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.79e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.12e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.32e-2)"	6.0	13.4	7.5	4.6	5.4	0.2	8.8	4.2	5.9	19.8	12.6	3.9	27.1	11.3	11.9	29.1	9.7	11.5	15.7	10.4	6.0	9.0	100.0	79.8	7.1	4.8	6.5	3.5	9.4	26.1	13.2	17.2	3.7	11.1	13.8	4.9	9.4	5.9	21.9	5.6	5.6	19.8	14.1	6.8	5.4	9.5	4.9	5.9	7.1	17.1	7.9	5.8	14.8	15.8	18.2	8.9	4.7	8.6	14.4	21.7	9.0	2.5	24.3	12.6	3.6	14.5	15.9	8.5	7.8	12.4	11.4	12.8	19.0	10.0	13.6	13.8	15.2	6.7	10.2	9.9	18.6	15.7	4.1	5.6	7.6	38.0	7.6	4.8	11.7	7.3	8.8	18.2	3.3	9.5	17.8	4.9	23.7	5.6	8.7	8.1	9.4	15.8	5.6	11.8	5.0	96.4	7.8	3.5	6.2	1.8	13.2	8.6	11.8	1.6	4.6	2.7	6.8	8.6	11.8	3.5	6.8	6.7	22.3	1.9	7.8	4.7	5.2	0.9	18.2	7.7	14.7	18.2	17.9	16.7	8.9	13.7	15.7	16.7	0.8	14.4	8.6	7.5	21.7	9.0	7.5	5.4	4.2	5.9	6.0	9.0	6.5	3.5	11.1	5.9
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria			4400000	Mitochondria		"CAB075750: , CAB075751: , CAB075752: , CAB075753: , CAB075754: , HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.4	38.4	31.3	40.7	41.7	38.8	20.4	29.6	29.1	52.1	36.5	54.1	34.9	69.4	29.1	37.3	38.5	86.6	44.5	49.9	24.1	44.0	47.7	27.9	39.0	23.4	58.3	34.3	42.7	42.6	40.9	49.6	58.6	49.3	41.7	45.5	28.5	48.2	18.0	24.9	55.5	47.0	36.8	52.4	32.3	36.1	41.2	27.0	38.3	45.6	30.0	63.5	34.0	38.8	26.3	36.9	37.1	31.2	27.5	41.9	45.2	24.3	42.9	24.7	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1
CSAD	"CSD, PCAP"	ENSG00000139631	"Cysteine sulfinic acid decarboxylase"	Q9Y600	12	53157663-53180909	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 38.7;T-47d: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 16.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039487	Approved				"Intracellular and membrane"					"HPA039487: AB_10672776"	"unprognostic (1.00e-1)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (1.57e-1)"	"unprognostic (7.99e-2)"	"prognostic favourable (6.33e-4)"	"prognostic favourable (1.37e-4)"	"unprognostic (2.46e-2)"	"unprognostic (7.87e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.39e-4)"	"unprognostic (3.48e-2)"	"prognostic unfavourable (1.93e-6)"	"unprognostic (4.59e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (6.81e-6)"	30.3	11.4	23.4	12.4	17.8	24.8	26.0	26.4	20.8	17.8	13.1	23.5	24.7	12.4	27.7	39.4	12.3	16.5	14.6	9.9	19.3	10.2	14.9	39.5	12.7	12.5	18.3	22.4	24.6	15.3	16.4	18.4	9.5	17.6	24.8	12.1	19.5	23.2	19.6	12.9	41.9	12.0	14.8	18.9	16.5	12.4	18.5	18.9	12.1	16.0	9.9	10.2	10.5	16.2	2.1	2.2	16.3	2.0	1.5	3.0	0.4	1.6	2.9	7.1	3.0	38.7	16.0	2.6	6.3	1.4	2.7	2.2	1.8	3.9	2.1	4.8	3.4	5.6	3.1	4.9	1.6	2.8	3.8	3.4	7.2	3.7	3.5	1.3	2.2	19.6	6.2	4.0	5.1	2.4	3.5	19.1	2.5	13.4	0.7	4.0	1.4	2.8	2.8	0.4	4.9	3.5	4.2	3.6	2.8	6.2	9.0	2.3	23.5	2.8	5.5	7.9	1.6	2.3	1.8	5.5	1.3	1.1	6.6	3.6	3.1	3.5	2.0	2.2	1.3	1.1	0.8	1.2	1.9	0.8	0.9	2.1	2.5	1.4	16.3	1.5	1.2	2.2	3.0	0.4	23.4	17.8	26.4	20.8	19.3	10.2	18.3	22.4	17.6	18.9
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 222.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"			13000	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: "	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	60.6	21.4	38.1	38.0	43.5	56.6	53.3	53.6	40.1	36.1	29.4	31.3	18.4	47.8	45.3	51.1	25.8	42.2	41.6	52.7	58.4	28.8	46.9	39.0	27.7	38.5	34.8	28.0	41.0	45.3	43.2	57.1	41.3	47.5	31.4	44.1	222.4	46.7	22.2	72.6	28.9	35.0	118.0	22.5	28.7	47.8	47.1	31.3	52.5	43.8	40.6	22.5	55.7	49.7	42.7	58.9	56.0	58.8	48.0	52.2	53.6	55.2	39.6	130.2	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol			64000	"Nucleoplasm, Cytosol"		"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavourable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavourable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	35.5	24.8	30.3	23.3	11.8	15.2	32.9	28.1	14.9	88.5	37.5	81.0	28.8	36.5	37.7	17.8	41.3	44.5	52.8	84.5	5.9	21.6	25.3	29.1	39.2	7.2	27.8	13.9	8.5	19.8	43.2	25.1	29.2	35.7	14.4	33.1	12.2	33.5	14.4	25.5	37.0	21.4	49.9	28.4	19.4	24.9	26.7	15.5	44.9	48.7	16.0	40.6	18.2	18.8	47.1	39.6	27.7	39.8	8.4	20.4	34.2	28.1	22.5	25.0	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0
CSF1	"M-CSF, MCSF, MGC31930"	ENSG00000184371	"Colony stimulating factor 1"	P09603	1	109910242-109930992	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.6;ASC TERT1: 29.3;BJ hTERT+: 30.7;HHSteC: 70.9;HSkMC: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"basophil: 7.0;eosinophil: 16.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA076624			Supported	"Nuclear bodies,Plasma membrane"	"Secreted to blood"	423300	17000000	"Plasma membrane"	"Nuclear bodies"	"HPA076624: "	"unprognostic (2.35e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavourable (1.00e-11)"	"unprognostic (2.03e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.01e-1)"	"unprognostic (3.16e-2)"	38.1	21.4	11.5	14.6	16.7	10.1	36.5	4.3	14.6	13.8	12.8	28.2	3.6	8.5	12.0	10.1	11.3	15.7	20.6	16.0	11.4	5.8	10.7	10.3	23.5	16.9	24.3	5.4	16.9	11.3	6.7	5.2	26.0	19.2	16.3	11.0	12.2	12.4	11.6	12.7	10.4	12.7	16.0	21.9	25.8	11.9	7.5	20.3	2.9	12.4	7.8	11.0	20.6	29.2	0.0	0.0	16.5	0.0	0.0	1.0	0.1	1.5	5.7	2.9	1.1	46.6	29.3	1.0	6.7	30.7	5.3	4.9	0.2	0.8	0.0	8.4	16.4	1.2	1.2	2.2	2.0	18.6	0.9	2.0	3.3	1.9	70.9	0.0	2.6	45.3	0.6	11.7	7.1	1.0	0.4	1.1	6.3	0.1	0.0	0.3	1.0	0.5	0.2	1.5	0.1	2.2	1.5	0.1	0.3	1.9	0.5	2.3	0.4	0.2	3.5	5.6	1.9	24.5	3.7	0.5	0.2	0.0	14.1	0.0	20.7	7.0	0.0	16.5	0.2	0.0	0.5	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	11.5	16.7	4.3	14.6	11.4	5.8	24.3	5.4	19.2	20.3
CSF1R	"C-FMS, CD115, CSFR, FMS"	ENSG00000182578	"Colony stimulating factor 1 receptor"	P07333	5	150053291-150113372	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Immunity, Inflammatory response, Innate immunity"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.5;lymphoid tissue: 82.6"	"Group enriched"	"Detected in some"	5	"BEWO: 50.6;SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 60.7;non-classical monocyte: 82.5"	"Lineage enriched"	"Detected in many"	4	"monocytes: 82.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008970, HPA012323"	Uncertain		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"		1500000000	"Vesicles, Plasma membrane"		"CAB008970: , HPA012323: AB_1848977"	"unprognostic (3.82e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.83e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (3.67e-2)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (1.72e-2)"	"unprognostic (4.61e-2)"	20.9	12.4	18.2	28.1	18.9	1.8	7.7	2.8	13.5	9.3	8.3	25.4	1.1	9.2	5.9	13.1	8.4	7.9	16.1	8.7	16.4	13.7	7.8	15.1	13.7	25.4	21.3	6.0	5.3	5.2	5.9	6.4	52.1	17.1	8.5	8.4	16.8	8.0	8.7	3.0	5.8	14.5	16.2	25.8	82.6	9.0	4.9	23.0	3.1	4.2	2.9	8.2	16.4	4.7	0.0	19.1	2.9	82.5	0.0	0.1	13.9	1.7	0.0	0.0	0.0	0.8	0.2	50.6	0.1	0.0	0.0	0.0	1.5	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	19.3	0.0	0.0	7.2	0.0	0.3	0.0	0.0	1.3	0.0	0.1	0.0	2.6	0.9	0.0	0.4	18.1	0.5	0.1	60.7	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	2.9	0.0	82.5	1.4	0.0	13.9	18.2	18.9	2.8	13.4	16.4	13.7	21.3	6.0	17.1	23.0
CSF2RB	"betaGMR, CD131, IL3RB, IL5RB"	ENSG00000100368	"Colony stimulating factor 2 receptor beta common subunit"	P32927	22	36913628-36940449	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.1;placenta: 73.6"	"Group enriched"	"Detected in some"	6	"HEL: 26.3;HMC-1: 82.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 53.1;neutrophil: 20.1"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 53.1"					"Low region specificity"	"Detected in all"			HPA078677			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA078677: "	"unprognostic (1.67e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (7.47e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.82e-3)"	"unprognostic (5.76e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.52e-2)"	8.5	1.8	1.5	28.9	1.5	21.7	6.0	0.6	1.0	3.0	5.9	2.0	0.4	4.5	2.2	2.8	4.0	3.6	5.5	4.2	1.4	1.4	2.4	3.5	12.6	34.1	2.9	0.2	2.5	1.9	0.3	1.2	73.6	2.4	3.5	3.8	2.8	9.7	1.0	2.6	3.8	10.2	3.0	2.9	25.2	3.9	2.1	1.9	8.2	3.4	4.8	30.5	8.2	4.3	0.4	3.8	53.1	2.1	0.0	0.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	26.3	0.0	0.0	0.0	0.4	82.6	0.0	0.0	0.0	0.0	4.6	0.0	3.2	0.0	0.0	0.0	2.7	0.0	0.0	2.6	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.2	0.0	0.0	0.0	0.4	0.2	1.6	0.0	3.8	0.0	53.1	1.9	5.8	0.0	2.1	0.0	0.4	0.0	0.0	1.2	0.3	0.0	0.0	20.1	0.0	1.7	3.8	0.6	1.8	1.5	1.5	0.6	1.0	1.4	1.4	2.9	0.2	2.4	1.9
CSF3	"C17orf33, G-CSF, GCSF, MGC45931"	ENSG00000108342	"Colony stimulating factor 3"	P09919	17	40015361-40017813	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 27.9;lung: 60.9"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 19.5;U-87 MG: 76.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"						"unprognostic (3.59e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.45e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"		"unprognostic (1.10e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.80e-3)"	12.4	1.5	1.0	13.8	1.3	3.0	2.8	0.8	1.6	27.9	3.0	1.4	0.0	0.2	2.3	2.2	5.9	2.9	2.1	6.9	1.1	1.0	0.2	0.5	60.9	0.5	1.2	0.1	3.3	4.1	0.2	3.8	2.6	7.4	4.3	0.7	1.6	0.6	0.3	20.6	0.4	1.4	1.6	2.6	1.0	2.0	1.1	1.2	0.1	0.7	8.8	7.0	7.2	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	3.1	2.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.3	0.8	1.6	1.1	1.0	1.2	0.1	7.4	1.2
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Approved	Vesicles,Cytosol			1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favourable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favourable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavourable (1.74e-4)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.7	18.0	8.8	14.5	8.4	6.5	7.6	8.6	8.2	16.3	11.6	16.4	11.8	57.1	11.4	7.7	13.3	18.5	17.3	4.6	27.6	22.8	48.3	6.6	16.5	11.7	25.2	61.6	9.2	8.5	11.6	10.4	12.3	13.9	19.9	9.7	21.5	18.1	14.9	10.9	12.9	20.1	7.6	41.6	7.5	28.4	14.7	10.2	11.1	23.4	14.8	16.1	37.2	10.6	19.8	10.4	15.5	14.8	10.7	21.5	58.3	10.2	48.2	13.3	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8"	"Cell line enhanced"	"Detected in some"		"BJ: 4.8;fHDF/TERT166: 5.8;HEL: 8.8;NTERA-2: 7.1;PC-3: 7.3;U-87 MG: 20.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008622	Uncertain									"HPA008622: AB_1078579"	"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	2.1	2.3	9.0	2.0	10.6	0.7	0.9	5.9	15.8	1.2	1.1	6.2	1.6	1.7	1.4	1.3	1.1	0.9	6.6	1.5	10.4	7.5	1.0	0.9	1.0	1.9	4.7	9.3	0.9	1.9	0.8	0.8	0.9	10.4	1.4	1.4	2.7	0.9	1.8	0.8	1.6	1.4	2.5	7.4	1.5	1.2	3.4	5.2	0.0	1.3	0.0	2.9	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	7.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	2.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	10.6	5.9	15.8	10.4	7.5	4.7	9.3	10.4	5.2
CSNK1A1	"CK1, CK1a, CK1alpha, CKIa, CKIalpha"	ENSG00000113712	"Casein kinase 1 alpha 1"	P48729	5	149492197-149551552	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016680, HPA051334"	Uncertain		Supported	Cytosol				Cytosol		"CAB016680: AB_1614518, HPA051334: "	"unprognostic (4.27e-3)"	"unprognostic (5.85e-3)"	"prognostic favourable (1.15e-4)"	"unprognostic (7.39e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.56e-2)"	"unprognostic (4.38e-1)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (5.47e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.28e-3)"	"unprognostic (6.92e-2)"	33.5	35.8	26.0	26.9	35.2	71.0	40.2	32.0	39.3	33.8	38.2	28.2	40.5	23.2	41.0	29.4	66.1	31.8	36.0	45.7	24.4	26.1	24.0	30.1	37.5	27.3	28.0	29.8	31.7	23.9	46.9	30.9	28.7	38.0	38.1	31.4	25.5	38.5	39.3	51.4	48.4	31.8	45.8	33.9	23.6	34.2	28.6	24.1	38.6	32.0	53.1	41.1	45.0	40.0	28.6	40.6	47.4	39.6	34.2	41.9	40.8	36.1	24.1	40.7	38.5	42.0	51.5	43.5	51.6	49.1	40.2	42.4	47.0	49.0	19.3	57.1	54.8	37.0	28.7	69.5	61.6	27.9	17.3	26.1	28.0	21.6	37.8	40.8	42.0	42.1	72.1	45.2	72.8	46.3	22.0	29.1	45.3	22.6	37.5	16.5	21.4	58.8	28.0	32.2	21.9	28.0	63.0	31.4	28.2	38.3	51.4	62.8	48.2	35.6	45.9	47.4	24.9	31.4	49.1	27.0	34.5	29.7	44.2	29.7	57.2	47.4	36.6	35.4	29.0	38.7	33.1	28.6	36.7	32.9	40.6	23.4	39.9	34.0	31.1	34.2	39.6	24.2	41.9	40.8	26.0	35.2	32.0	39.3	24.4	26.1	28.0	29.8	38.0	24.1
CSNK1D	"CKID, CKIdelta, HCKID"	ENSG00000141551	"Casein kinase 1 delta"	P48730	17	82239023-82273731	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Wnt signaling pathway"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015410	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"CAB015410: AB_831049"	"unprognostic (1.07e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (2.38e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (2.38e-6)"	"unprognostic (8.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.00e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (2.23e-3)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.52e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.74e-2)"	30.1	36.3	30.8	25.9	30.8	21.0	26.3	36.3	42.8	30.9	33.0	27.7	32.9	32.6	37.9	29.8	31.3	38.0	34.9	28.5	26.2	26.9	32.0	33.5	30.1	25.8	27.2	27.8	31.4	42.8	34.2	35.9	32.8	30.3	35.3	19.3	28.4	38.0	37.7	52.3	26.7	42.3	34.1	21.4	36.4	32.5	48.3	24.6	29.2	33.0	31.8	33.7	31.4	26.1	6.4	11.4	29.6	12.1	8.7	7.6	7.1	21.3	25.4	14.5	19.9	19.1	20.4	29.1	31.4	19.8	22.5	21.1	20.8	18.4	19.5	24.8	22.3	20.7	13.6	31.8	18.2	16.5	32.9	24.2	20.2	22.3	55.5	19.9	18.5	30.9	22.6	15.3	22.8	32.8	27.2	10.4	21.2	24.9	25.5	20.8	15.5	40.0	22.0	17.9	17.3	23.7	33.5	17.9	32.3	37.5	31.3	35.1	22.4	26.1	34.5	32.4	29.1	28.1	23.8	22.7	11.0	20.9	26.0	17.1	23.5	4.7	11.0	14.6	7.6	12.1	7.4	6.4	5.9	7.3	11.4	5.6	5.0	5.3	29.6	8.7	11.1	5.5	5.2	7.1	30.8	30.8	36.3	42.8	26.2	26.9	27.2	27.8	30.3	24.6
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665236-31670343	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved									"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	28.1	30.5	26.6	28.8	28.0	30.3	27.6	26.9	42.9	29.9	32.7	30.8	24.0	13.9	26.2	101.7	51.5	30.1	32.0	43.8	24.4	23.1	41.1	49.8	34.4	33.8	25.4	24.6	32.9	42.1	3.5	26.4	39.6	23.6	34.3	26.0	30.4	30.3	32.5	40.8	58.3	31.6	32.2	26.6	33.3	26.9	66.0	20.8	60.2	38.5	41.8	33.4	28.3	25.9	20.6	24.9	21.3	22.8	16.3	20.2	16.0	0.0	6.5	0.0	10.7	6.5	10.9	8.0	15.0	26.0	30.7	29.0	0.0	9.4	23.1	8.1	11.0	0.0	0.0	26.5	30.1	11.2	26.9	0.0	0.0	0.0	16.6	25.3	0.0	21.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.4	0.0	7.7	0.0	11.7	0.0	14.7	14.7	8.7	0.0	18.3	0.1	0.0	11.5	0.1	0.0	7.4	12.8	15.6	14.6	0.0	9.5	14.8	14.7	9.1	0.0	11.6	16.5	22.8	21.3	16.2	22.3	16.0	20.6	16.7	16.7	21.1	16.4	14.4	12.7	18.4	16.3	14.1	24.9	20.2	16.0	26.6	28.0	26.9	42.9	24.4	23.1	25.4	24.6	23.6	20.8
CSRP1	"CSRP, CYRP, D1S181E"	ENSG00000159176	"Cysteine and glycine rich protein 1"	P21291	1	201483530-201509456	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 338.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045617	Uncertain						25000000			"HPA045617: "	"unprognostic (7.08e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (2.87e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.58e-2)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.96e-3)"	33.9	17.1	39.0	27.3	53.5	5.1	39.6	12.0	56.6	75.6	200.1	92.2	63.2	23.2	159.3	48.5	116.7	81.5	49.4	15.5	41.9	29.6	15.5	14.4	31.1	7.8	55.6	29.8	46.1	14.0	30.9	10.1	26.8	42.2	123.0	56.5	13.9	30.9	338.6	6.7	17.0	41.2	247.1	41.7	15.0	73.6	17.1	62.2	1.6	20.7	8.9	8.5	214.4	40.4	11.0	27.0	26.2	20.9	12.6	21.8	16.4	9.8	26.5	6.7	15.0	11.1	14.2	35.2	74.9	65.8	59.1	47.1	28.0	7.4	9.5	4.6	40.8	18.1	4.2	15.4	44.1	20.9	3.9	11.0	31.8	3.9	51.3	8.7	1.5	13.1	13.5	47.8	21.8	65.0	0.5	9.6	38.6	28.7	5.8	1.4	0.1	9.2	2.2	39.0	33.1	27.3	17.3	3.5	3.1	30.1	65.2	20.4	11.2	9.3	75.3	39.8	25.3	26.9	31.0	5.3	10.0	3.8	39.9	17.1	26.1	25.5	19.8	26.2	16.2	19.8	16.2	11.0	15.9	15.2	27.0	7.3	9.2	11.3	2.2	12.6	20.9	2.1	21.8	16.4	39.0	53.5	12.0	56.6	41.9	29.6	55.6	29.8	42.2	62.2
CSRP3	"CLP, CMD1M, MLP"	ENSG00000129170	"Cysteine and glycine rich protein 3"	P50461	11	19182030-19210573	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Actin-binding, Developmental protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"heart muscle: 223.9;skeletal muscle: 156.7"	"Cell line enhanced"	"Detected in some"		"HSkMC: 3.5;RH-30: 1.5;U-2 OS: 2.7"	"Cancer enriched"	"Detected in some"	6	"head and neck cancer: 18.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA042581	Enhanced						240000			"HPA042581: "				"unprognostic (1.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-2)"				"unprognostic (4.72e-2)"				"unprognostic (5.99e-2)"	"unprognostic (1.08e-1)"			0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	3.4	0.0	0.0	223.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	4.5	0.0	156.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	46.9	2.3	0.0	0.0	0.4	0.0	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.6	3.5	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.2	2.7	0.5	0.7	0.0	0.2	0.4	0.8	0.9	0.1	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST1		ENSG00000170373	"Cystatin SN"	P01037	20	23747553-23751268	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	46	"salivary gland: 704.2"	"Cell line enriched"	"Detected in some"	5	"RT4: 153.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB026769, HPA043706, HPA044763"	Enhanced				"Secreted to digestive system"		6600000			"CAB026769: , HPA043706: , HPA044763: "	"prognostic favourable (4.00e-4)"	"unprognostic (2.47e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.58e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.91e-3)"	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	4.8	0.1	0.1	0.3	7.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.1	0.1	15.2	0.0	0.1	704.2	0.1	0.1	4.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.3	1.6	0.1	0.0	0.2	0.0	0.7	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	153.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CST3		ENSG00000101439	"Cystatin C"	P01034	20	23626706-23638473	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Age-related macular degeneration, Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 160.1;ASC TERT1: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 163.9;intermediate monocyte: 211.0;myeloid DC: 269.6;non-classical monocyte: 135.1;plasmacytoid DC: 153.5"	"Group enriched"	"Detected in many"	9	"dendritic cells: 269.6;monocytes: 211.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000118, HPA013143"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"		4100000000	"Golgi apparatus, Vesicles"		"CAB000118: , HPA013143: AB_1847417"	"unprognostic (3.89e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (8.53e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.97e-1)"	"unprognostic (5.01e-2)"	"prognostic favourable (8.77e-4)"	95.8	72.6	229.0	37.9	254.7	22.2	68.6	61.4	196.7	76.6	78.2	75.4	39.5	59.4	47.6	143.6	73.8	64.9	89.4	79.7	157.4	96.2	35.9	67.3	58.0	91.2	148.3	90.6	51.4	142.1	34.5	45.6	25.8	69.9	55.2	66.1	195.0	338.2	74.2	44.2	44.9	77.9	57.3	73.3	85.5	105.5	57.4	68.4	40.7	43.2	40.1	31.9	49.4	50.2	0.6	269.6	27.4	211.0	6.4	2.4	106.7	12.6	28.8	6.7	15.5	160.1	109.6	12.6	22.1	30.8	15.2	12.3	54.7	19.6	0.0	20.8	30.1	43.0	6.2	44.1	4.7	0.0	21.3	13.0	5.7	93.0	57.3	0.6	21.9	84.8	37.2	20.4	21.9	23.7	11.8	0.3	21.1	20.2	0.1	13.8	9.0	63.2	0.4	8.2	17.5	62.4	28.7	7.4	8.5	16.1	4.8	27.4	13.6	47.7	59.8	14.4	10.4	20.1	8.2	13.6	0.4	0.1	12.3	28.6	16.2	1.4	163.9	1.0	2.4	211.0	0.9	0.6	0.6	1.6	269.6	0.5	0.6	1.2	27.4	6.4	135.1	153.5	0.4	106.7	229.0	254.7	61.4	196.7	157.4	96.2	148.3	90.6	69.9	68.4
CST5		ENSG00000170367	"Cystatin D"	P28325	20	23875935-23879750	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	268	"salivary gland: 1065.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;RPTEC TERT1: 3.7;RT4: 1.9;U-2 OS: 1.6"	"Cancer enriched"	"Detected in many"	5	"breast cancer: 17.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB024944, HPA061449"	Enhanced				"Secreted to digestive system"					"CAB024944: , HPA061449: "	"unprognostic (2.43e-1)"		"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (3.19e-1)"			"unprognostic (1.51e-2)"	"unprognostic (4.73e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.83e-3)"		"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.8	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1065.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.9	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.8	0.0	0.6	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CST6		ENSG00000175315	"Cystatin E/M"	Q15828	11	66011841-66013505	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 124.5"	"Group enriched"	"Detected in some"	6	"A-431: 26.2;CAPAN-2: 73.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 171.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB019316, HPA044963"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted in other tissues"		110000000	"Plasma membrane"	Cytosol	"CAB019316: , HPA044963: "	"unprognostic (3.01e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (5.02e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (5.89e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.59e-2)"	0.6	0.2	0.1	1.5	0.1	0.2	8.7	0.4	0.2	5.5	0.2	0.0	1.4	0.1	0.3	0.8	11.3	4.3	0.7	2.4	0.1	0.2	1.0	0.1	27.2	1.2	0.1	0.0	1.3	0.2	0.5	0.4	26.5	0.2	0.9	0.1	1.1	1.3	26.5	0.7	124.5	0.2	0.2	0.2	0.2	0.2	1.0	0.0	2.8	14.6	13.6	4.4	0.5	3.7	0.4	0.9	0.0	1.6	0.0	0.2	0.7	26.2	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.1	73.1	0.0	0.4	0.9	0.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	7.3	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.7	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.0
CST7		ENSG00000077984	"Cystatin F"	O76096	20	24949230-24959928	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Thiol protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 120.9;bone marrow: 160.2;lymphoid tissue: 51.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 15.7;HMC-1: 44.0;NB-4: 43.2;U-937: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 120.9"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"olfactory region: 2.3"	"Low region specificity"	"Detected in all"			HPA040442	Enhanced				"Secreted to blood"		12000			"HPA040442: "	"prognostic favourable (6.55e-4)"	"prognostic favourable (7.90e-4)"	"unprognostic (9.37e-2)"	"prognostic favourable (9.17e-6)"	"unprognostic (2.38e-2)"	"prognostic favourable (5.85e-5)"	"unprognostic (1.00e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.84e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavourable (4.37e-6)"	"unprognostic (7.64e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.45e-1)"	"unprognostic (7.62e-2)"	4.9	0.9	0.8	9.7	0.9	160.2	1.4	0.9	1.0	2.5	1.9	0.1	0.5	1.1	2.2	1.8	2.4	4.6	10.7	6.2	0.9	0.8	1.6	3.5	23.0	30.4	4.0	0.0	2.2	1.1	0.2	0.9	1.6	0.7	3.5	1.0	3.2	1.3	0.7	1.9	1.2	3.7	1.0	1.2	51.3	1.6	1.7	0.2	6.6	1.6	2.5	15.4	6.0	11.8	0.3	2.5	29.8	0.2	53.9	120.9	42.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	15.7	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	43.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	77.6	0.0	5.0	0.2	0.8	120.9	0.2	67.5	0.3	18.3	84.3	2.5	0.3	4.0	52.3	29.8	53.9	0.2	0.6	10.5	42.2	0.8	0.9	0.9	1.0	0.9	0.8	4.0	0.0	0.7	0.2
CSTA	"STF1, STFA"	ENSG00000121552	"Cystatin A"	P01040	3	122325244-122341972	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 312.4;tongue: 421.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 33.1;hTCEpi: 146.6;THP-1: 91.6;U-698: 58.3;U-937: 29.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 405.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	20	"classical monocyte: 74.6;intermediate monocyte: 37.5;myeloid DC: 54.6;neutrophil: 36.0;non-classical monocyte: 21.6"	"Group enriched"	"Detected in many"	193	"dendritic cells: 54.6;granulocytes: 36.0;monocytes: 74.6"									"CAB000469, HPA001031, CAB047315"	Enhanced		Approved	Nucleoplasm,Cytosol			39000000	"Nucleoplasm, Cytosol"		"CAB000469: , CAB047315: , HPA001031: AB_1078610"	"unprognostic (5.22e-3)"	"unprognostic (6.10e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.79e-3)"	"prognostic favourable (5.86e-4)"	"unprognostic (4.46e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (2.60e-6)"	"unprognostic (8.89e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.99e-1)"	2.0	0.2	0.3	4.4	0.8	19.8	4.5	0.2	0.5	55.4	0.4	0.2	1.1	0.0	4.7	1.7	312.4	0.2	0.7	1.0	0.3	0.0	0.4	3.4	6.8	4.8	1.1	0.2	1.8	0.2	0.0	0.3	1.3	0.5	1.3	0.1	0.3	57.4	0.7	0.7	28.2	0.3	0.4	0.7	2.0	2.2	0.3	0.6	2.2	0.3	421.9	99.0	1.5	93.5	0.1	54.6	36.0	74.6	0.2	0.2	32.0	1.6	0.1	0.0	0.3	3.8	7.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.6	10.2	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	13.3	0.2	3.7	146.6	0.3	14.4	0.0	0.0	3.5	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.1	0.0	0.0	16.4	0.0	0.0	1.6	0.8	1.1	0.1	91.6	0.0	0.2	2.4	0.0	0.1	0.0	0.1	58.3	3.2	29.1	0.0	0.7	74.6	2.2	0.0	37.5	0.2	0.1	0.1	0.1	54.6	0.0	0.0	0.1	36.0	0.2	21.6	1.0	0.1	32.0	0.3	0.8	0.2	0.5	0.3	0.0	1.1	0.2	0.5	0.6
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell line enhanced"	"Detected in all"		"RT4: 90.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol			6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: "	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	57.8	17.5	5.8	7.3	30.9	25.4	14.4	12.5	14.5	7.9	7.9	13.5	32.5	4.7	9.7	19.5	10.4	13.3	14.0	5.0	19.4	15.8	13.1	13.5	15.6	27.6	3.2	10.9	26.9	14.6	21.8	10.8	11.0	9.7	25.8	11.6	14.6	4.1	10.1	14.0	30.2	6.8	3.3	53.1	22.7	90.4	5.5	4.9	16.5	8.8	35.2	8.2	8.1	16.9	13.2	6.9	12.3	7.9	6.4	11.2	8.7	57.4	15.2	9.2	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100840932	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	8.6	11.1	10.1	14.1	14.6	12.2	10.5	18.8	14.5	10.0	14.9	9.1	15.8	11.4	11.9	11.8	30.1	11.3	8.8	7.8	12.7	10.5	10.3	7.9	9.1	14.7	11.2	11.6	9.8	8.1	11.9	12.7	9.5	10.8	10.3	16.5	9.7	13.0	16.8	7.2	11.8	12.7	10.7	12.5	11.8	9.1	18.9	11.2	20.6	9.0	9.4	24.2	11.3	12.8	15.8	19.6	14.6	20.9	19.1	21.2	12.7	17.1	20.2	12.8	12.6	7.4	6.3	18.8	13.7	12.2	22.8	34.2	22.2	15.2	16.8	16.9	8.8	17.6	31.6	17.3	26.0	15.8	20.4	15.3	19.2	15.2	10.5	20.2	17.1	6.0	8.5	24.6	15.4	13.7	24.4	16.9	13.4	20.7	16.8	15.4	37.2	19.9	17.5	22.2	20.2	8.9	15.7	11.7	15.0	21.9	10.2	9.6	10.3	11.3	11.3	13.5	22.0	17.4	17.6	10.9	22.2	20.8	11.5	24.4	16.3	14.6	14.6	10.1	21.2	16.5	16.6	15.8	18.7	20.0	19.6	13.4	16.4	16.2	2.4	19.1	20.9	13.5	20.3	12.7	10.1	14.6	18.8	14.5	12.7	10.5	11.2	11.6	10.8	11.2
CTAGE5	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, MEA6, MGEA, MGEA11, MGEA6"	ENSG00000150527	"CTAGE family member 5, ER export factor"	"O15320, Q96PC5"	14	39230231-39388513	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 43.9;Hep G2: 36.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"			"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: , HPA055459: "	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	9.3	16.9	7.3	11.4	7.3	7.3	7.9	5.1	7.9	12.1	22.8	5.8	13.5	28.5	8.5	17.9	18.5	8.4	15.1	7.5	6.4	5.9	34.7	52.2	10.6	9.0	7.8	6.5	8.6	20.6	22.9	20.6	6.0	21.1	8.9	12.6	6.0	22.3	17.0	17.4	6.4	52.4	6.9	9.7	9.7	16.0	8.7	8.6	10.1	17.0	15.9	7.0	8.3	10.9	8.7	12.5	24.5	13.5	9.8	11.6	8.4	7.8	8.7	3.7	6.5	7.5	8.5	5.1	4.6	4.8	3.3	3.4	6.7	43.9	9.4	14.4	5.2	12.0	4.4	5.2	3.9	7.3	3.7	5.9	4.2	36.3	17.6	7.9	11.0	5.2	29.8	3.3	24.9	5.4	5.5	24.2	4.9	7.5	5.0	6.4	4.2	7.3	5.2	6.5	11.7	15.3	8.5	3.1	1.8	10.8	11.5	7.0	11.0	8.5	8.4	5.1	3.3	3.7	3.0	13.8	11.9	9.3	2.9	5.0	4.2	22.5	11.8	17.6	11.6	12.3	10.5	8.5	8.9	10.8	12.5	8.7	11.0	10.2	24.5	9.8	13.5	8.7	8.1	8.4	7.3	7.3	5.1	7.9	6.4	5.9	7.8	6.5	21.1	8.6
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: "	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favourable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.5	33.3	25.8	31.6	18.1	13.1	22.2	17.8	16.6	22.2	22.6	28.5	54.7	27.6	20.7	20.7	18.1	15.6	23.4	6.7	20.9	18.8	25.0	37.7	36.4	30.2	22.4	35.7	22.5	18.0	18.8	10.9	16.5	28.3	47.5	12.2	37.2	72.1	70.7	30.5	32.2	51.1	15.5	36.0	14.2	28.7	48.5	30.4	17.0	18.4	23.5	40.3	34.6	21.1	37.1	20.9	21.2	38.0	34.6	33.0	31.9	29.3	35.0	29.1	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2
CTBP2	ribeye	ENSG00000175029	"C-terminal binding protein 2"	P56545	10	124984317-125161170	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA023559, HPA023564, CAB031916, HPA044971, CAB079018"	Approved	Approved	Approved	Cytosol				Cytosol		"CAB031916: AB_2086774, CAB079018: , HPA023559: AB_1847309, HPA023564: AB_1847310, HPA044971: "	"unprognostic (8.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.99e-3)"	"prognostic favourable (1.70e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.62e-1)"	13.9	13.1	14.5	9.6	16.3	9.0	29.8	23.5	11.8	31.1	20.9	22.5	17.8	19.8	29.0	21.2	16.3	23.3	17.4	10.9	16.1	12.3	15.4	3.1	17.3	6.5	19.2	11.8	24.1	24.5	12.9	13.6	14.9	15.6	22.9	17.9	28.6	19.9	18.5	11.4	8.6	19.4	23.7	15.1	12.1	19.9	14.5	16.8	3.1	43.3	11.6	6.1	16.7	23.8	0.3	6.5	15.4	11.6	19.7	5.3	2.6	25.1	28.6	25.3	21.0	13.6	13.4	14.0	19.7	23.0	18.6	21.2	17.7	29.7	0.0	10.2	19.7	19.9	25.1	31.6	14.0	0.1	19.0	18.5	18.8	0.4	28.5	7.8	14.8	11.5	25.1	19.2	38.4	23.6	0.7	0.1	11.6	27.9	0.8	8.0	19.0	18.4	22.4	10.6	0.2	21.9	11.4	7.7	22.2	19.1	16.8	25.3	11.9	12.9	19.0	11.2	14.3	16.0	16.8	0.4	1.4	0.0	14.1	0.1	11.0	15.4	5.1	9.2	5.3	5.0	0.6	0.3	0.2	1.4	6.5	0.2	0.3	2.3	8.5	19.7	11.6	5.5	0.1	2.6	14.5	16.3	23.5	11.8	16.1	12.3	19.2	11.8	15.6	16.8
CTBS	CTB	ENSG00000117151	Chitobiase	Q01459	1	84549606-84574480	"Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"basal ganglia: 7.6"	"CAB017043, HPA023594, HPA048810"	Approved		Uncertain	Cytosol	"Intracellular and membrane"		380000000	Cytosol		"CAB017043: , HPA023594: AB_1847311, HPA048810: "	"unprognostic (7.76e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.36e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.04e-2)"	6.4	6.9	4.0	8.8	4.4	9.7	15.3	4.4	3.5	5.3	5.8	3.3	8.1	3.7	6.2	16.4	4.8	5.2	8.0	13.1	4.5	4.4	10.4	22.3	15.6	28.1	5.8	2.3	5.1	15.0	6.5	10.4	6.9	8.1	8.1	5.1	4.7	18.5	12.5	4.3	8.4	7.2	6.7	10.0	12.6	6.1	3.5	4.4	5.5	5.9	4.9	5.1	5.5	5.2	0.8	0.4	3.2	1.6	0.7	0.6	0.2	1.8	0.6	0.4	0.4	5.5	6.6	1.4	1.3	4.5	0.6	1.7	0.2	2.2	2.4	0.5	2.7	0.8	0.1	1.7	1.9	2.2	0.6	1.5	0.3	0.3	3.4	1.6	0.8	4.9	3.3	1.6	2.4	1.9	1.4	4.4	1.3	0.1	1.0	1.8	0.4	0.6	0.5	0.7	1.6	4.0	0.9	0.3	0.8	0.5	1.8	2.1	1.0	1.7	2.9	2.3	0.2	3.1	1.4	1.3	0.4	0.7	1.6	2.2	1.6	1.8	0.8	1.5	0.2	0.9	0.4	0.5	0.4	0.3	0.4	0.8	0.3	0.6	3.2	0.7	1.6	0.4	0.4	0.2	4.0	4.4	4.4	3.5	4.5	4.4	5.8	2.3	8.1	4.4
CTDSP1	"NLIIF, SCP1"	ENSG00000144579	"CTD small phosphatase 1"	Q9GZU7	2	218398256-218405941	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062654			Supported	Nucleoplasm				Nucleoplasm		"HPA062654: "	"unprognostic (1.97e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.69e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.57e-1)"	32.9	22.5	15.9	21.9	13.9	19.9	41.1	12.2	16.4	34.8	30.7	27.6	31.8	24.2	34.5	30.7	31.3	30.9	43.4	25.9	15.5	8.6	34.1	47.5	30.2	33.2	15.0	13.1	44.9	50.8	28.8	12.6	71.3	15.9	41.5	19.8	35.4	34.3	31.5	23.2	30.5	41.3	33.7	12.4	39.1	34.2	15.1	16.1	33.2	41.0	27.2	29.9	32.5	28.4	3.4	6.6	29.3	12.4	6.7	11.0	7.5	10.1	13.1	7.8	25.5	21.1	19.7	29.3	13.7	19.8	13.3	11.5	17.1	25.5	6.2	11.9	24.2	20.9	11.5	16.5	6.8	22.0	9.0	23.5	16.1	22.9	25.4	14.4	32.9	22.4	20.2	10.1	11.4	19.5	19.0	22.1	14.0	28.5	12.6	42.1	5.4	13.5	17.5	10.9	13.3	16.9	12.6	5.2	12.9	12.0	26.1	12.9	14.4	34.7	17.0	21.2	12.9	16.1	6.0	14.2	9.2	14.5	18.8	13.7	11.7	20.3	12.4	29.3	11.0	10.2	7.1	3.4	6.7	7.0	6.6	3.2	4.3	5.7	24.5	6.7	10.4	2.3	5.6	7.5	15.9	13.9	12.2	16.4	15.5	8.6	15.0	13.1	15.9	16.1
CTDSPL	"C3orf8, HYA22, PSR1, RBSP3, SCP3"	ENSG00000144677	"CTD small phosphatase like"	O15194	3	37861960-37984469	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048325	Approved		Approved	Nucleoplasm,Vesicles			10000	Vesicles	Nucleoplasm	"HPA048325: "	"unprognostic (7.35e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (6.22e-14)"	"unprognostic (3.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.67e-2)"	12.8	6.3	11.1	7.8	12.4	5.6	22.0	30.2	14.1	15.5	19.9	8.0	25.7	9.3	14.5	18.3	16.8	12.2	37.2	18.9	13.1	5.9	26.7	13.3	19.0	4.9	7.8	9.9	13.7	10.2	8.3	9.4	20.6	6.9	17.5	20.3	15.6	45.5	22.4	12.5	34.8	11.2	21.3	8.1	11.3	19.7	8.1	8.3	2.9	10.0	13.9	6.9	19.6	21.7	0.0	0.2	1.1	0.5	0.0	0.5	5.6	15.5	6.8	2.8	8.8	11.0	15.9	20.9	10.7	13.5	7.4	8.8	9.8	12.8	0.0	6.6	13.2	13.0	6.9	20.3	6.0	0.0	5.4	9.5	7.2	22.1	10.1	0.0	2.3	8.2	49.9	7.8	9.4	10.4	3.0	0.0	12.3	4.9	3.9	0.0	11.5	1.0	4.3	5.4	0.1	23.8	10.4	2.3	7.4	5.9	10.6	11.9	10.2	2.6	8.2	5.4	7.5	10.0	6.7	0.2	0.0	0.0	6.0	5.3	9.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.1	1.1	0.0	0.0	0.0	0.0	5.6	11.1	12.4	30.2	14.1	13.1	5.9	7.8	9.9	6.9	8.3
CTGF	"CCN2, IGFBP8"	ENSG00000118523	"Connective tissue growth factor"	P29279	6	131948176-131951373	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 128.3;HUVEC TERT2: 107.9;TIME: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"naive B-cell: 11.6"	"Lineage enriched"	"Detected in single"	117	"B-cells: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"		5200000	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	51.9	15.5	3.5	48.2	7.6	0.0	39.2	1.6	7.1	84.0	26.9	7.2	27.5	5.8	84.9	50.1	38.9	56.3	82.5	73.6	8.8	3.6	83.5	18.8	45.8	53.3	4.7	9.4	30.7	26.3	4.7	9.7	44.0	13.8	54.5	19.7	55.0	28.2	45.3	29.4	30.1	28.7	123.4	12.0	169.8	41.6	24.4	2.3	5.9	66.9	46.9	9.8	48.5	23.3	11.6	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.5	10.0	0.2	22.7	12.9	0.1	29.0	13.9	18.0	9.6	0.0	0.9	0.0	128.3	37.2	0.4	0.3	2.0	17.0	0.1	0.2	0.0	4.1	10.4	8.9	0.0	0.0	18.8	0.4	13.0	3.2	107.9	0.0	0.0	51.0	0.1	0.0	0.0	4.8	1.7	2.4	0.4	0.0	6.5	0.0	0.0	0.0	2.9	4.9	1.3	0.4	0.2	222.6	25.0	19.5	31.4	53.4	0.9	0.1	0.2	3.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.5	7.6	1.6	7.1	8.8	3.6	4.7	9.4	13.8	2.3
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"			5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: , HPA063535: "	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favourable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.5	23.8	36.0	53.3	31.4	34.5	54.9	33.0	41.6	31.6	40.1	49.5	44.3	0.1	28.0	49.2	25.0	24.7	54.3	36.8	18.7	21.5	13.7	39.1	30.0	37.9	0.2	13.4	21.7	43.5	37.7	41.5	59.5	7.5	14.2	34.0	28.8	0.3	4.2	14.5	0.5	12.9	21.0	19.6	66.7	43.6	14.4	19.0	60.9	85.7	49.8	30.3	9.4	50.4	33.3	18.0	20.6	22.8	5.1	9.6	1.9	31.7	5.9	42.9	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6
CTNNA2	"CAP-R, CT114"	ENSG00000066032	"Catenin alpha 2"	P26232	2	79185231-80648861	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Differentiation"	"Developmental protein"	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.1;brain: 58.4;epididymis: 58.1"	"Cell line enhanced"	"Detected in some"		"AF22: 8.2;Karpas-707: 9.4;NTERA-2: 7.7;SCLC-21H: 4.4;SH-SY5Y: 12.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.9;glioma: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	66	"basophil: 25.1"	"Lineage enriched"	"Detected in single"	252	"granulocytes: 25.1"	"Low region specificity"	"Detected in all"							CAB037175	Enhanced									"CAB037175: AB_476883"	"unprognostic (9.15e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.31e-2)"	"unprognostic (4.04e-1)"	"unprognostic (3.17e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.96e-3)"	"unprognostic (8.76e-2)"	"unprognostic (2.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (8.44e-4)"	"unprognostic (1.73e-4)"	"unprognostic (2.83e-1)"	1.2	5.1	34.7	1.6	24.1	1.2	1.2	10.1	58.4	1.2	1.9	8.7	0.0	1.4	3.8	58.1	1.3	2.7	1.3	1.1	23.6	16.1	1.2	1.2	1.1	1.1	12.5	28.3	1.1	1.7	1.1	9.3	1.1	12.7	1.9	1.8	5.1	1.3	1.8	1.3	1.2	1.7	1.5	4.3	1.1	2.1	14.4	10.4	0.0	1.1	0.0	1.1	1.1	0.3	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.8	0.0	4.4	12.4	0.0	0.0	0.5	0.1	0.7	0.0	0.5	0.8	0.2	0.0	2.7	0.0	0.0	3.2	0.0	2.2	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	34.7	24.1	10.1	35.8	23.6	16.1	12.5	28.3	12.7	10.4
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"			1000000	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	52.9	54.5	38.8	33.5	45.9	46.3	70.5	78.8	59.3	71.7	49.6	57.3	34.2	48.7	79.2	42.5	46.3	49.8	45.0	42.1	38.6	41.5	46.9	53.2	53.6	31.6	37.0	47.0	84.2	38.6	59.2	44.0	82.6	41.5	50.8	50.1	75.9	53.9	49.7	31.2	44.7	70.4	66.5	39.4	41.0	37.3	29.0	39.3	40.1	62.3	44.5	36.6	46.9	54.2	10.1	13.5	7.5	14.5	11.1	13.5	4.8	22.6	30.2	63.7	35.6	34.4	28.2	48.9	25.6	36.4	42.8	42.5	20.8	32.4	18.6	23.4	45.2	17.0	46.1	73.9	45.9	17.2	31.4	30.0	40.1	74.3	25.7	17.0	14.4	41.0	33.5	51.1	31.1	37.6	21.2	11.6	47.4	23.0	11.9	9.2	58.0	23.5	9.0	41.5	12.4	26.5	70.9	15.2	25.8	42.4	21.6	113.7	35.4	35.4	48.4	32.2	24.7	20.6	37.5	7.2	11.2	19.8	33.0	21.5	53.7	4.3	8.1	6.9	11.2	14.5	13.5	9.6	10.5	12.1	13.5	10.1	10.7	10.8	7.5	11.1	13.7	11.7	12.6	4.8	38.8	45.9	78.8	59.3	38.6	41.5	37.0	47.0	41.5	39.3
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.5;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 10.2;monocytes: 12.5"					"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"			15000	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	39.7	19.9	15.1	20.4	17.0	3.2	31.4	15.0	20.5	28.8	41.9	25.7	49.2	37.5	32.7	32.7	76.3	22.9	28.8	18.2	15.6	10.3	30.6	31.2	34.0	11.6	14.4	12.8	23.3	50.4	41.9	34.5	49.8	16.4	29.7	39.8	34.4	46.4	39.1	11.8	48.7	82.0	22.8	17.2	25.9	39.4	27.8	14.7	7.1	38.4	34.9	45.6	32.3	38.9	1.4	10.2	0.4	12.5	0.4	0.5	2.3	37.4	28.1	25.1	16.8	13.6	18.6	35.6	17.2	19.4	15.6	14.9	21.8	41.6	0.7	30.4	21.3	49.2	20.2	26.1	20.0	0.4	6.6	9.3	11.0	24.6	14.1	2.0	14.7	20.5	31.6	19.7	20.2	47.4	14.0	0.4	17.2	12.1	0.7	3.5	17.9	15.1	0.7	21.2	0.8	23.3	40.0	2.3	11.2	24.3	33.3	25.4	35.0	2.5	40.1	15.0	12.9	14.7	9.7	1.3	0.8	1.1	14.0	1.2	26.4	0.0	6.9	0.2	0.2	12.5	0.5	1.0	0.1	0.4	10.2	1.4	0.2	0.3	0.4	0.4	11.9	3.1	0.2	2.3	15.1	17.0	15.0	20.5	15.6	10.3	14.4	12.8	16.4	14.7
CTSB		ENSG00000164733	"Cathepsin B"	P07858	8	11842524-11869448	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 297.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 237.0;fHDF/TERT166: 137.7"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 1446.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 53.1;classical monocyte: 127.4;intermediate monocyte: 97.0;myeloid DC: 68.0;non-classical monocyte: 54.7;plasmacytoid DC: 95.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 95.4;granulocytes: 53.1;monocytes: 127.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000457, HPA018156, HPA048998"	Enhanced		Supported	Nucleoli,Vesicles	"Secreted to blood"		130000000	Vesicles	Nucleoli	"CAB000457: , HPA018156: AB_1846069, HPA048998: "	"unprognostic (5.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.98e-3)"	"unprognostic (5.96e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.61e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.12e-2)"	"prognostic favourable (5.76e-4)"	"prognostic unfavourable (9.02e-4)"	227.9	42.1	19.6	67.2	24.4	14.7	67.6	14.9	31.4	76.7	49.1	30.1	22.7	29.9	53.2	44.8	54.2	52.4	43.6	120.7	18.3	23.7	95.6	167.8	94.3	175.1	29.1	16.5	44.2	31.6	13.8	21.6	68.7	24.8	42.6	27.9	33.8	63.7	33.6	41.3	22.8	51.2	51.1	35.9	116.4	26.7	21.5	20.4	18.1	297.0	25.9	38.4	56.8	62.2	7.9	95.4	53.1	127.4	5.3	17.1	108.5	6.4	29.1	3.7	16.0	65.8	74.1	11.6	121.4	237.0	42.5	50.4	13.9	37.9	0.1	17.6	137.7	35.4	5.1	33.5	26.9	3.1	5.0	9.4	3.4	34.1	67.0	2.1	7.0	81.1	45.7	38.4	34.4	83.1	7.8	21.5	35.3	5.1	0.8	3.4	3.1	9.8	3.3	3.8	16.4	12.9	10.1	1.6	9.5	14.0	7.6	63.3	12.3	6.3	115.1	72.3	24.5	23.1	22.6	21.4	15.5	0.5	82.9	8.1	33.8	53.1	127.4	16.3	5.2	97.0	7.2	7.9	17.1	5.8	68.0	6.1	9.6	4.1	18.5	5.3	54.7	95.4	13.4	108.5	19.6	24.4	14.9	28.0	18.3	23.7	29.1	16.5	24.8	20.4
CTSC	"DPP1, PALS, PLS"	ENSG00000109861	"Cathepsin C"	P53634	11	88293592-88337787	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 218.6"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025364, HPA066610, HPA068434"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		19000000	Vesicles		"CAB025364: , HPA066610: , HPA068434: "	"unprognostic (4.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.45e-2)"	"prognostic unfavourable (9.30e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (2.93e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.07e-2)"	40.7	20.5	6.7	44.5	10.6	12.0	35.3	1.5	5.6	14.0	25.3	7.1	6.2	20.4	16.1	24.0	21.8	16.7	36.6	53.3	6.8	6.5	62.7	18.1	110.1	218.6	12.5	3.6	11.0	24.8	3.8	17.3	43.4	9.4	13.8	33.1	27.0	35.1	5.8	10.0	11.7	28.5	14.2	14.6	86.6	13.5	10.8	9.2	19.5	17.7	25.3	30.0	30.2	16.9	8.5	75.9	52.5	92.6	34.7	42.4	31.2	11.2	11.5	4.5	9.4	12.2	33.0	30.2	77.1	112.0	44.0	31.8	31.2	51.8	17.5	41.0	41.8	18.2	7.0	32.6	35.2	30.8	12.7	22.8	31.9	35.1	16.2	28.9	15.4	45.9	23.1	33.9	69.6	43.2	20.7	21.1	5.3	2.1	13.0	40.0	23.6	35.7	17.0	4.7	31.0	56.6	18.9	1.2	9.5	13.0	17.2	10.1	3.8	19.8	21.0	3.0	27.3	20.9	48.9	9.0	12.8	17.7	8.0	61.1	16.7	12.5	32.5	52.5	42.4	69.3	36.5	8.5	19.5	37.8	35.1	4.6	9.9	23.8	37.2	34.7	92.6	75.9	28.4	31.2	6.7	10.6	1.5	5.6	6.8	6.5	12.5	3.6	9.4	9.2
CTSD	"CLN10, CPSD"	ENSG00000117984	"Cathepsin D"	P07339	11	1752752-1764573	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"	"Alzheimer disease, Cancer-related genes, Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 215.7;SK-BR-3: 206.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB000109, HPA003001"	Supported				"Secreted to blood"		540000000			"CAB000109: , HPA003001: AB_1078404"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.65e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"prognostic favourable (4.93e-5)"	"unprognostic (8.98e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.60e-1)"	151.9	148.7	21.4	32.8	27.0	83.7	67.7	18.6	47.4	56.3	59.3	41.4	41.9	61.6	25.9	48.2	46.2	34.2	90.0	86.0	25.3	27.6	150.5	163.5	102.6	81.1	49.6	25.7	41.2	62.3	21.3	24.9	56.1	42.8	33.9	33.7	234.4	64.1	42.3	76.2	50.8	90.9	23.3	36.7	87.6	47.0	29.8	29.7	21.1	36.3	42.9	41.4	64.6	43.5	4.9	22.7	51.1	83.8	28.4	26.1	58.7	15.6	42.4	4.9	20.4	62.1	21.2	7.9	11.6	36.2	15.6	18.5	10.5	215.7	3.8	30.1	29.9	84.4	7.1	13.0	4.3	16.1	15.4	5.8	8.0	13.2	65.5	13.3	61.6	34.2	57.0	8.4	15.5	11.4	6.9	23.2	27.6	57.7	3.4	7.5	11.6	17.0	4.9	6.0	14.1	55.0	49.0	6.8	6.7	13.8	206.2	39.1	80.7	18.4	14.3	47.5	7.3	6.5	18.6	32.0	40.1	2.4	69.2	36.1	39.8	29.0	83.8	25.2	26.1	47.6	15.1	4.9	12.2	18.3	22.7	3.2	14.3	18.3	51.1	28.4	38.5	19.2	13.5	58.7	21.4	27.0	18.6	47.4	25.3	27.6	49.6	25.7	42.8	29.7
CTSF	"CATSF, CLN13"	ENSG00000174080	"Cathepsin F"	Q9UBX1	11	66563463-66568841	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 28.2;SK-MEL-30: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"NK-cells: 7.5;T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002141, HPA031431, HPA055610"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"		3600000	Cytosol	"Vesicles, Plasma membrane"	"CAB002141: AB_563471, HPA031431: , HPA055610: "	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.12e-2)"	"prognostic favourable (8.92e-7)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.42e-1)"	28.1	29.4	24.7	8.0	29.0	1.8	31.1	38.4	47.1	37.3	23.8	32.6	25.2	5.8	38.1	29.8	12.9	34.3	37.3	34.5	25.3	20.5	29.8	45.4	17.3	8.5	28.0	26.0	68.2	23.1	42.6	15.9	20.2	25.4	32.3	8.1	35.0	35.5	37.8	35.8	19.7	9.4	34.6	22.4	10.4	17.8	37.1	30.1	0.8	18.6	14.2	6.3	22.2	21.5	2.1	1.1	0.5	0.7	7.5	9.7	2.4	0.1	9.2	5.0	12.9	21.3	8.6	3.6	6.5	16.5	6.8	4.8	0.0	8.2	0.0	11.0	14.2	0.9	8.5	2.8	3.6	2.2	0.0	0.3	3.8	0.0	11.9	0.1	5.0	28.2	9.6	1.5	1.1	4.3	2.8	1.5	8.5	1.9	0.1	1.1	0.6	3.4	0.0	1.9	1.6	6.1	0.2	6.0	6.4	17.4	2.0	52.3	13.2	0.8	2.8	2.7	2.7	3.2	0.6	8.8	0.1	0.0	6.5	0.1	4.1	0.0	0.7	0.4	6.5	0.7	7.0	2.0	5.6	7.3	0.8	2.1	9.7	5.5	0.5	7.5	0.3	1.1	1.7	2.4	24.7	29.0	38.4	47.1	25.3	20.5	28.0	26.0	25.4	30.1
CTSG	CG	ENSG00000100448	"Cathepsin G"	P08311	14	24573522-24576260	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"bone marrow: 450.3"	"Cell line enriched"	"Detected in some"	7	"THP-1: 437.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.5;memory CD8 T-cell: 3.5;myeloid DC: 5.1;naive CD8 T-cell: 1.8;neutrophil: 7.1;NK-cell: 5.2;plasmacytoid DC: 5.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB000110, HPA047737"	Enhanced				"Intracellular and membrane"		67000			"CAB000110: , HPA047737: "	"unprognostic (1.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.08e-1)"		"prognostic favourable (1.57e-4)"	"unprognostic (4.05e-2)"	"unprognostic (4.13e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.91e-4)"	15.1	0.5	0.0	6.0	0.0	450.3	6.0	0.0	0.6	10.0	5.1	0.0	2.8	1.1	6.2	19.7	6.4	0.8	16.7	23.4	0.0	0.0	2.1	2.0	9.2	3.7	0.0	0.0	1.5	3.4	0.8	0.5	3.0	0.0	8.2	3.2	2.6	6.3	6.9	1.1	19.5	8.9	14.9	0.0	10.7	3.2	2.8	0.0	15.6	0.5	12.0	5.1	2.9	3.3	0.0	5.7	7.1	6.5	5.2	3.5	12.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	437.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	64.9	0.0	0.0	6.5	0.0	1.1	1.0	0.0	0.0	1.0	3.5	5.1	0.0	0.0	1.8	7.1	5.2	0.0	5.7	0.0	12.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
CTSH	"ACC-4, ACC-5, ACC4, ACC5, CPSB"	ENSG00000103811	"Cathepsin H"	P09668	15	78921058-78949574	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 82.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.5;HaCaT: 31.0;RT4: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 42.8"	"Group enriched"	"Detected in all"	5	"B-cells: 20.6;dendritic cells: 41.2;monocytes: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000458, HPA003524"	Enhanced		Supported	"Vesicles,Cytosol,Cytoplasmic bodies"	"Intracellular and membrane"		10000000	"Vesicles, Cytosol, Cytoplasmic bodies"		"CAB000458: , HPA003524: AB_1846075"	"unprognostic (6.47e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.90e-4)"	"unprognostic (4.37e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.96e-2)"	"unprognostic (4.10e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.79e-3)"	16.7	10.6	9.5	24.2	7.0	5.4	23.9	4.5	9.8	25.1	11.4	17.7	14.7	10.6	10.3	17.1	7.8	13.1	29.2	16.5	14.8	6.7	66.7	18.7	82.6	65.4	12.1	11.6	14.6	25.8	12.3	6.5	7.7	9.4	18.6	6.6	6.7	15.4	15.9	7.0	13.5	16.6	9.8	10.8	20.3	15.6	6.7	15.7	6.6	8.5	4.8	34.8	39.6	13.5	20.6	41.2	1.4	42.8	1.3	7.6	27.3	16.0	1.1	0.4	4.7	1.1	0.0	5.2	1.6	0.6	2.8	1.5	7.0	42.5	5.6	1.7	0.1	31.0	2.0	7.7	2.3	23.6	0.1	0.1	0.2	16.2	1.6	0.0	1.0	0.8	2.2	0.0	0.0	0.2	11.4	0.0	3.8	1.7	3.6	9.8	1.2	0.3	0.0	0.3	0.9	9.8	118.0	0.5	1.1	6.9	3.9	9.6	1.5	5.3	2.2	0.0	1.0	0.0	0.7	0.1	12.2	3.1	0.0	10.3	1.7	0.0	42.8	0.4	1.4	28.3	7.6	20.6	4.1	2.1	41.2	12.0	0.4	0.7	1.4	1.3	17.0	4.2	3.1	27.3	9.5	7.0	4.5	9.8	14.8	6.7	12.1	11.6	9.4	15.7
CTSK	"CTSO, CTSO2, PKND, PYCD"	ENSG00000143387	"Cathepsin K"	P43235	1	150796208-150808323	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Thiol protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 104.1"	"Group enriched"	"Detected in some"	8	"ASC diff: 200.2;ASC TERT1: 73.3;BJ hTERT+: 161.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 6.7"	"Low region specificity"	"Detected in all"							HPA050346			Supported	Vesicles	"Intracellular and membrane"			Vesicles		"HPA050346: "	"unprognostic (1.48e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.61e-3)"	"unprognostic (5.08e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.54e-2)"	"prognostic unfavourable (7.12e-5)"	"unprognostic (6.07e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.93e-3)"	"unprognostic (6.41e-2)"	104.1	2.4	1.2	6.5	1.6	1.3	79.3	2.4	2.3	70.6	23.6	2.2	10.1	2.7	72.5	25.9	26.5	12.5	53.4	14.7	1.1	1.1	3.4	1.8	8.7	10.4	1.1	1.7	25.4	2.9	0.3	3.0	30.6	2.6	24.2	11.5	56.0	10.9	6.8	19.9	44.0	11.0	26.9	2.0	5.6	8.6	24.1	0.9	1.1	7.1	13.2	10.7	38.0	48.2	0.1	1.0	1.0	6.7	0.5	1.2	1.8	0.1	0.1	0.3	0.3	200.2	73.3	0.2	5.7	161.8	0.4	0.8	0.0	0.1	0.1	0.2	11.1	0.2	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.0	1.0	0.1	0.4	14.6	0.5	4.5	0.1	0.6	0.0	0.5	0.4	0.3	0.0	0.7	1.1	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.6	0.3	0.0	3.0	0.2	0.2	0.4	0.2	0.1	0.2	0.2	0.6	0.5	1.1	17.0	0.0	0.9	0.0	6.7	1.0	0.7	3.4	0.2	0.0	0.6	0.2	0.4	0.1	0.3	0.5	0.6	0.5	2.0	1.0	1.2	1.8	1.2	1.6	2.4	2.3	1.1	1.1	1.1	1.7	2.6	0.9
CTSL	"CTSL1, FLJ31037"	ENSG00000135047	"Cathepsin L"	P07711	9	87725519-87731393	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 237.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 198.5;HSkMC: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 31.0;non-classical monocyte: 44.3"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.3"									"CAB000459, HPA070413"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		17000000	"Golgi apparatus"	Vesicles	"CAB000459: AB_2292484, HPA070413: "	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (1.19e-3)"	"unprognostic (8.12e-3)"	"prognostic unfavourable (5.15e-5)"	"unprognostic (2.09e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.21e-1)"	"prognostic favourable (4.34e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.26e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.11e-3)"	60.3	21.5	10.4	27.2	24.6	18.4	23.3	6.9	12.3	14.8	23.2	14.1	13.7	9.0	24.1	22.3	11.4	25.7	20.7	37.7	10.7	11.4	65.4	98.0	53.1	80.5	18.9	7.7	25.0	14.3	18.8	18.0	237.0	18.4	19.4	13.0	23.2	22.0	23.5	29.3	9.1	12.0	36.6	16.1	108.1	17.5	14.1	15.7	6.8	19.2	9.4	10.1	41.3	26.5	0.0	1.7	0.1	44.3	0.0	4.3	2.4	6.3	36.8	2.5	4.3	46.3	198.5	15.4	20.5	59.7	17.6	22.1	3.5	5.9	0.0	9.6	26.5	5.4	3.3	6.6	14.5	0.1	3.2	1.1	10.4	8.6	30.0	0.0	4.4	91.8	11.2	28.8	11.2	13.8	11.9	0.0	25.3	10.6	0.0	0.7	4.9	7.0	1.5	1.5	0.0	12.3	3.3	3.7	4.5	4.3	9.6	23.5	1.1	7.3	21.7	15.8	8.6	57.5	8.6	1.6	5.9	0.0	57.8	0.0	5.2	0.1	3.5	0.1	0.0	31.0	0.0	0.0	1.8	0.0	1.7	0.0	4.3	0.3	0.1	0.0	44.3	0.1	0.3	2.4	10.4	24.6	6.9	11.7	10.7	11.4	18.9	7.7	18.4	15.7
CTSS		ENSG00000163131	"Cathepsin S"	P25774	1	150730196-150765957	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 171.4;lymphoid tissue: 111.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.1;HMC-1: 50.3;U-698: 106.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 171.4;intermediate monocyte: 151.2;myeloid DC: 43.5;neutrophil: 94.5;non-classical monocyte: 138.5"	"Group enriched"	"Detected in all"	9	"dendritic cells: 43.5;granulocytes: 94.5;monocytes: 171.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000460, HPA002988"	Supported		Approved	Vesicles	"Intracellular and membrane"		19000000	Vesicles		"CAB000460: , HPA002988: AB_1078409"	"unprognostic (7.81e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.47e-3)"	41.6	9.3	6.8	32.3	10.3	30.3	9.7	1.9	6.2	4.7	32.9	6.6	5.6	19.6	3.7	12.9	8.8	10.7	15.9	17.3	6.4	5.1	9.6	21.5	55.8	99.5	12.6	2.3	7.6	6.4	0.4	3.4	14.4	9.3	7.5	33.4	6.5	12.9	3.3	3.5	3.8	38.0	6.8	17.1	111.4	13.8	3.8	9.5	12.9	7.6	4.6	22.8	21.5	5.3	11.1	43.5	94.5	171.4	3.3	5.6	145.4	1.0	3.2	0.0	0.0	0.4	0.3	0.3	0.0	3.2	0.2	0.6	0.0	21.1	14.5	1.6	0.1	0.4	0.0	0.1	0.0	8.1	0.0	6.4	0.1	0.0	0.0	8.7	50.3	0.6	0.0	1.8	0.1	1.2	0.6	12.7	0.4	0.0	0.0	6.2	0.0	0.0	3.6	1.2	17.8	3.9	3.1	0.0	0.1	0.2	0.9	0.3	0.0	17.8	1.7	1.3	0.2	0.0	0.2	8.8	0.8	106.9	7.4	9.4	0.8	1.2	171.4	16.5	3.2	151.2	3.9	11.1	3.9	3.8	43.5	10.2	3.9	3.6	94.5	3.3	138.5	9.4	5.6	145.4	6.8	10.3	1.9	6.2	6.4	5.1	12.6	2.3	9.3	9.5
CTSW		ENSG00000172543	"Cathepsin W"	P56202	11	65879809-65883741	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.2;bone marrow: 41.4"	"Group enriched"	"Detected in some"	23	"HEL: 37.9;NB-4: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 106.6;MAIT T-cell: 67.7;memory CD8 T-cell: 68.3;naive CD8 T-cell: 51.4;NK-cell: 157.2"	"Group enriched"	"Detected in many"	48	"NK-cells: 157.2;T-cells: 106.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			CAB016345	Enhanced				"Secreted to blood"		340000			"CAB016345: AB_626813"	"prognostic favourable (3.06e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.71e-2)"	"prognostic favourable (8.36e-6)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (8.84e-6)"	"unprognostic (3.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.01e-3)"	5.2	1.2	0.9	4.9	1.0	41.4	2.3	0.6	0.7	3.9	4.9	0.8	0.5	2.4	8.4	4.0	2.1	2.1	2.5	9.0	0.9	1.0	2.5	6.8	12.7	36.0	1.1	0.6	3.0	1.1	0.0	1.4	10.7	1.4	7.4	2.5	6.3	10.9	1.5	1.9	1.5	5.9	1.7	2.1	33.1	3.3	3.4	0.4	11.1	3.1	1.3	18.2	4.5	2.6	0.4	2.7	2.3	0.3	157.2	106.6	45.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	37.9	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.4	86.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	2.3	0.0	2.3	0.2	0.3	106.6	0.2	67.7	0.4	11.7	68.3	2.7	0.3	7.0	51.4	2.0	157.2	0.3	1.7	1.6	45.7	0.9	1.0	0.6	0.7	0.9	1.0	1.1	0.6	1.4	0.4
CTSZ	CTSX	ENSG00000101160	"Cathepsin Z"	Q9UBR2	20	58995185-59007247	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.7;memory B-cell: 1.0;myeloid DC: 3.9;naive B-cell: 1.9;neutrophil: 3.5;non-classical monocyte: 2.9;plasmacytoid DC: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025114, HPA049876, HPA053504"	Supported		Supported	Vesicles	"Intracellular and membrane"		85000000	Vesicles		"CAB025114: , HPA049876: , HPA053504: "	"unprognostic (7.30e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.11e-3)"	"unprognostic (8.25e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (5.72e-5)"	"unprognostic (1.96e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	70.7	27.9	12.4	40.8	20.4	20.7	51.2	14.6	13.5	25.4	52.8	16.0	19.9	40.8	20.6	25.5	20.1	20.7	22.3	50.1	9.8	13.3	34.9	83.7	54.3	61.2	18.8	10.5	29.7	29.0	30.6	27.6	38.6	19.2	28.8	37.8	31.5	40.3	17.7	20.7	12.9	63.6	26.4	22.1	56.5	19.2	13.8	14.9	18.4	42.4	17.5	35.8	29.8	21.5	1.9	3.9	3.5	3.2	0.3	0.6	0.8	27.2	21.2	0.0	0.0	25.0	28.8	15.0	44.9	49.7	34.4	30.8	41.0	45.9	15.0	29.7	118.0	21.8	13.5	42.5	23.6	47.9	1.8	13.7	34.4	0.0	26.2	1.6	47.7	24.5	25.7	15.0	18.0	54.4	9.9	7.6	23.0	0.0	0.1	14.8	1.7	21.2	0.3	0.1	18.0	25.1	6.4	0.4	0.3	34.9	40.4	0.1	18.7	23.2	59.8	0.0	23.2	30.2	0.2	36.2	22.0	2.8	0.4	33.1	0.0	0.0	3.2	0.3	0.6	2.7	0.0	1.0	0.4	0.1	3.9	1.9	0.4	0.1	3.5	0.3	2.9	2.2	0.2	0.8	12.4	20.4	14.6	13.5	9.8	13.3	18.8	10.5	19.2	14.9
CTTN	EMS1	ENSG00000085733	Cortactin	Q14247	11	70398404-70436584	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 128.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011235, HPA057242"	Supported		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"			34000000	"Plasma membrane, Cytosol"	"Golgi apparatus, Vesicles"	"CAB011235: , HPA057242: "	"unprognostic (6.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.81e-2)"	"prognostic unfavourable (2.19e-6)"	"prognostic unfavourable (4.45e-4)"	"unprognostic (6.10e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.94e-1)"	37.5	53.6	33.0	19.7	36.7	5.7	32.0	33.3	41.1	41.3	35.3	42.3	33.7	37.1	48.8	40.2	49.4	35.5	56.2	37.3	28.5	23.5	47.2	24.9	30.5	13.7	45.0	32.0	46.3	40.0	28.9	38.3	32.3	37.2	38.9	32.4	24.4	38.0	38.5	31.5	52.9	39.2	43.1	36.0	21.4	51.3	30.2	38.6	7.7	36.0	44.5	26.7	33.2	38.2	0.1	0.8	4.6	0.2	0.0	0.4	13.9	128.4	28.3	9.6	11.0	16.2	25.3	15.8	27.5	27.5	24.3	19.2	37.4	32.4	5.0	27.3	35.2	28.6	11.4	28.9	17.8	10.1	11.5	0.5	21.1	17.5	35.0	0.1	6.8	35.7	20.4	26.8	15.2	20.3	14.4	0.9	23.9	35.1	0.2	1.8	10.4	17.3	0.0	11.8	4.0	27.1	41.9	7.9	13.5	20.1	27.6	45.7	22.5	0.5	25.3	21.4	13.7	33.2	18.3	2.2	1.4	0.3	42.7	0.1	29.2	1.4	0.2	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.4	0.0	4.6	0.0	0.2	0.8	0.0	13.9	33.0	36.7	33.3	41.1	28.5	23.5	45.0	32.0	37.2	38.6
CTTNBP2	"C7orf8, CORTBP2, KIAA1758, Orf4"	ENSG00000077063	"Cortactin binding protein 2"	Q8WZ74	7	117710651-117874139	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HEL: 26.9;HMC-1: 35.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"non-classical monocyte: 9.6"	"Lineage enriched"	"Detected in single"	22	"monocytes: 9.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009151, HPA044654"	Enhanced		Approved	"Midbody ring,Cytosol"				"Midbody ring, Cytosol"		"CAB009151: AB_2088281, HPA044654: "	"unprognostic (6.28e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.64e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.28e-4)"	"unprognostic (3.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.71e-5)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.45e-3)"	11.2	3.9	10.7	1.8	17.6	0.7	4.7	8.3	15.5	10.7	3.9	22.1	2.0	3.3	11.4	9.4	14.0	7.2	6.6	2.4	13.5	9.1	11.5	3.8	3.2	1.0	16.2	9.9	5.4	13.1	21.9	5.8	3.4	15.5	6.6	5.0	5.0	5.2	4.0	1.1	2.5	3.3	9.5	14.3	4.2	1.8	2.2	16.8	0.0	9.8	1.7	2.1	4.8	4.9	0.0	0.4	0.0	9.6	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	3.8	0.0	0.0	0.0	1.0	26.9	0.2	0.0	0.1	0.0	35.8	0.1	0.2	0.0	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	5.0	0.1	0.0	0.0	0.1	5.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.3	0.0	0.0	2.4	0.0	0.5	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	10.7	17.6	8.3	15.3	13.5	9.1	16.2	9.9	15.5	16.8
CUL1		ENSG00000055130	"Cullin 1"	Q13616	7	148697914-148801036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002676, HPA064584"	Supported		Supported	Nucleoplasm,Nucleoli			190000	Nucleoplasm	Nucleoli	"CAB002676: , HPA064584: "	"unprognostic (3.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.06e-3)"	"unprognostic (9.45e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.24e-3)"	26.0	20.9	21.2	20.4	22.4	22.3	27.5	27.5	26.2	23.9	25.8	19.5	22.5	16.7	30.2	23.7	22.7	21.2	18.7	25.7	21.1	21.8	16.9	35.2	20.5	26.5	21.7	16.7	25.0	17.9	24.9	30.7	32.0	21.0	23.9	18.8	22.7	19.6	25.0	58.9	20.5	21.2	37.7	26.3	21.9	22.4	65.6	23.7	16.9	24.5	24.6	24.5	26.1	28.8	16.8	24.1	13.4	17.1	22.1	20.8	16.1	30.7	23.9	23.5	36.3	18.5	20.8	29.8	25.4	30.0	25.7	24.5	25.4	21.5	42.2	20.4	25.1	20.8	33.5	23.7	30.3	27.5	28.5	24.9	16.9	24.6	21.7	28.2	23.7	17.0	23.3	18.8	19.1	28.0	38.4	32.6	28.0	29.4	24.5	32.3	44.0	22.9	29.8	20.7	40.6	21.1	22.5	33.8	24.8	29.6	35.3	20.0	11.6	22.4	21.5	18.4	6.4	37.2	29.2	30.6	21.2	41.8	37.4	31.5	27.1	13.4	15.2	12.0	16.1	17.1	18.6	16.8	16.7	18.6	24.1	14.4	20.8	16.7	2.1	22.1	14.5	5.5	15.9	16.1	21.2	22.4	27.5	26.2	21.1	21.8	21.7	16.7	21.0	23.7
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120524609-120575794	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: "	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	20.9	24.0	19.0	19.2	28.1	12.2	25.3	28.9	25.7	32.6	20.5	12.1	25.7	14.0	24.2	47.2	29.3	19.6	18.5	19.4	18.5	20.2	19.1	20.4	23.8	23.5	17.3	20.4	30.1	18.8	34.4	48.3	17.0	18.4	30.8	17.2	15.7	17.3	27.3	10.8	17.7	16.3	36.0	20.5	19.9	17.0	34.0	17.3	29.8	18.8	13.9	24.1	40.4	22.5	7.6	12.5	15.4	4.3	5.5	8.3	4.9	12.0	10.2	8.5	9.0	37.5	19.0	6.9	27.3	32.8	22.6	23.7	9.2	34.2	12.1	9.4	62.8	9.0	17.4	8.0	25.8	7.0	9.0	5.9	14.8	6.5	16.2	6.3	8.4	21.3	6.1	13.0	11.3	40.4	9.1	9.4	21.8	6.4	8.3	6.6	12.9	10.3	7.0	8.4	12.3	7.5	6.0	9.7	8.1	20.2	9.9	10.0	8.4	5.8	53.2	16.3	9.0	21.7	24.4	6.0	10.4	15.1	17.6	8.6	14.6	5.8	4.3	9.0	7.2	3.8	7.7	7.6	7.0	6.6	5.1	5.7	7.9	8.3	15.4	5.5	2.7	12.5	8.2	4.9	19.0	28.1	28.9	25.7	18.5	20.2	17.3	20.4	18.4	17.3
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182175-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol				Cytosol		"HPA016434: AB_1848125, HPA052004: "	"prognostic favourable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favourable (4.87e-4)"	6.2	9.2	11.7	9.5	13.9	12.8	6.9	12.5	13.8	7.4	8.5	12.9	7.3	8.2	11.2	6.5	11.5	10.7	8.5	5.5	10.0	6.4	7.7	5.6	7.5	11.7	10.0	9.8	9.5	8.6	13.2	15.9	5.0	9.2	8.3	5.1	11.2	8.7	9.3	6.0	16.1	10.2	7.7	6.9	10.1	8.7	12.5	10.4	10.8	10.9	4.9	10.8	12.0	7.0	1.1	1.1	0.5	0.9	0.3	2.6	1.0	7.8	5.8	3.2	7.6	9.1	5.4	4.3	3.2	5.5	5.0	4.7	1.9	3.3	6.6	6.1	5.0	5.7	2.7	6.6	2.4	7.9	2.5	7.2	6.2	2.9	5.9	4.4	11.8	7.3	13.9	4.2	3.8	7.4	3.7	8.7	4.4	7.2	9.1	6.5	0.6	3.7	13.3	2.2	6.4	3.8	8.2	5.5	7.9	4.2	5.0	7.0	8.6	10.1	6.7	12.7	8.8	3.7	5.9	8.3	7.8	5.3	3.2	8.0	5.7	0.0	0.9	0.3	1.2	0.5	1.3	1.1	0.7	2.6	1.1	0.8	0.6	1.4	0.5	0.3	0.4	0.9	2.5	1.0	11.7	13.9	12.5	13.8	10.0	6.4	10.0	9.8	9.2	10.4
CUX2	"CDP2, CUTL2, KIAA0293"	ENSG00000111249	"Cut like homeobox 2"	O14529	12	111034024-111350554	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.9;brain: 13.2;liver: 21.5;prostate: 13.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.3;HDLM-2: 3.1;hTERT-HME1: 4.0;SCLC-21H: 7.4;SH-SY5Y: 15.9"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 11.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	100	"plasmacytoid DC: 9.9"	"Lineage enriched"	"Detected in single"	100	"dendritic cells: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.87e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.83e-5)"	"unprognostic (2.67e-1)"	"unprognostic (3.54e-3)"	"unprognostic (4.31e-2)"	"unprognostic (9.03e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.90e-2)"	0.2	0.2	2.9	0.4	4.8	0.3	2.3	1.2	13.2	1.1	0.3	0.3	2.8	0.3	0.3	0.5	0.3	0.2	0.2	0.2	1.9	2.1	0.2	21.5	0.2	0.6	2.7	3.1	0.1	0.2	0.1	1.9	0.2	1.0	13.6	0.2	0.6	0.1	5.4	0.2	0.2	0.3	0.1	0.4	0.4	1.2	0.6	0.4	0.0	4.9	0.0	0.7	0.3	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.3	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.4	0.0	0.2	0.0	0.1	0.0	0.1	7.4	15.9	0.0	0.0	0.0	0.3	0.2	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	2.9	4.8	1.2	13.2	1.9	2.1	2.7	3.1	1.0	0.4
CX3CL1	"ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1"	ENSG00000006210	"C-X3-C motif chemokine ligand 1"	P78423	16	57372458-57385048	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"EFO-21: 13.4;HDLM-2: 36.5;Hep G2: 27.2;RPTEC TERT1: 16.2;SK-BR-3: 9.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026192, HPA040361"	Approved		Supported	"Plasma membrane"	"Secreted to blood"	1867500		"Plasma membrane"		"CAB026192: , HPA040361: AB_10796453"	"unprognostic (6.89e-3)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.52e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.06e-2)"	"prognostic favourable (8.52e-7)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	24.3	3.6	13.4	4.7	26.6	0.7	42.5	3.8	45.1	12.4	5.9	6.9	8.7	4.2	12.1	7.0	10.7	11.7	14.9	12.0	16.4	13.8	14.5	11.2	35.3	6.0	9.2	18.0	5.2	9.6	3.8	4.5	3.4	11.7	22.3	4.5	12.2	39.9	34.4	9.2	9.9	5.0	21.7	6.6	1.5	5.0	3.8	3.9	0.8	12.0	5.7	4.9	19.7	6.7	1.0	0.8	2.1	0.7	0.8	0.6	0.2	0.0	0.3	3.5	3.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.0	0.0	13.4	0.0	0.1	0.0	0.0	0.0	36.5	0.2	0.0	0.0	27.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	0.0	16.2	0.0	0.1	3.1	0.0	9.5	0.8	0.0	0.1	0.0	0.1	2.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	1.4	0.7	0.5	0.6	0.4	0.3	0.6	0.4	0.3	0.2	1.0	0.4	0.6	2.1	0.8	0.4	0.8	0.2	0.2	13.4	26.6	3.8	37.3	16.4	13.8	9.2	18.0	11.7	3.9
CX3CR1	"CCRL1, CMKBRL1, CMKDR1, GPR13, V28"	ENSG00000168329	"C-X3-C motif chemokine receptor 1"	P49238	3	39263494-39281735	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Host-virus interaction"	"G-protein coupled receptor, Receptor, Transducer"	"Age-related macular degeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 69.2;brain: 51.6"	"Cell line enriched"	"Detected in some"	20	"RPMI-8226: 112.1"	"Cancer enhanced"	"Detected in many"		"glioma: 21.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 69.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032478, HPA046587"	Approved									"CAB032478: AB_638830, HPA046587: "	"unprognostic (2.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.12e-1)"	2.3	3.8	14.9	6.0	17.3	0.9	4.8	2.5	34.1	2.7	1.2	51.6	0.0	1.2	2.7	4.2	1.4	5.9	2.5	2.2	12.4	11.9	2.5	1.9	9.0	1.8	21.8	7.4	1.8	1.8	5.2	2.5	4.3	21.8	3.7	1.2	3.5	6.4	7.0	5.2	2.4	1.2	3.3	33.5	10.3	1.5	1.8	16.3	0.8	2.4	0.7	4.7	2.8	1.3	0.1	15.7	3.5	69.2	6.5	46.5	29.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	112.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	5.5	0.0	1.2	15.9	0.2	46.5	43.3	0.5	0.1	10.4	25.2	15.7	0.1	3.7	22.7	3.5	6.5	69.2	1.1	0.2	29.8	14.9	17.3	2.5	19.9	12.4	11.9	21.8	7.4	21.8	16.3
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 78.9;EFO-21: 201.6;RPTEC TERT1: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"														"Secreted to blood"	232113					"prognostic favourable (7.83e-4)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.1	78.9	1.9	2.0	0.0	1.4	0.0	201.6	0.1	4.0	0.0	0.3	10.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	14.2	1.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	72.8	1.7	0.0	0.0	0.1	0.0	3.9	0.0	0.1	18.2	0.0	0.6	3.9	0.1	0.0	0.1	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7
CXCL10	"C7, crg-2, gIP-10, IFI10, INP10, IP-10, mob-1, SCYB10"	ENSG00000169245	"C-X-C motif chemokine ligand 10"	P02778	4	76021117-76023497	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 36.2;lymphoid tissue: 34.8;prostate: 34.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;BJ hTERT+ SV40 Large T+: 3.6;BJ hTERT+ SV40 Large T+ RasG12V: 3.5;Daudi: 3.1;RPMI-8226: 6.6;RT4: 3.7;THP-1: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 10.6;intermediate monocyte: 25.5;non-classical monocyte: 15.9"	"Lineage enriched"	"Detected in many"	15	"monocytes: 25.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	189803					"unprognostic (1.94e-1)"	"unprognostic (5.32e-2)"	"unprognostic (9.98e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.59e-2)"	"prognostic favourable (1.12e-5)"	"prognostic unfavourable (4.61e-4)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (1.03e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.66e-2)"	4.3	2.1	2.7	34.8	2.5	0.0	7.3	1.8	4.8	8.1	3.5	0.9	0.2	3.8	2.3	6.7	4.7	1.2	3.8	7.6	1.2	1.2	7.5	10.6	36.2	21.7	3.2	1.6	3.9	1.2	0.0	2.3	5.6	3.0	34.6	6.0	2.6	9.1	2.1	7.3	2.1	4.1	5.5	11.3	15.8	6.4	1.3	0.9	15.0	25.7	5.4	9.2	9.2	2.2	0.5	1.6	0.6	25.5	0.0	0.1	3.7	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.6	3.6	3.5	0.3	0.1	3.1	0.4	0.0	0.0	0.0	0.2	0.2	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	6.6	0.1	3.7	0.0	0.0	0.0	0.7	2.1	0.2	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.9	0.0	0.0	10.6	0.0	0.0	25.5	0.0	0.5	0.1	0.0	1.6	0.0	0.0	0.0	0.6	0.0	15.9	0.0	0.0	3.7	2.7	2.5	1.8	4.8	1.2	1.2	3.2	1.6	3.0	0.9
CXCL2	"CINC-2a, GRO2, GROb, MGSA-b, MIP-2a, SCYB2"	ENSG00000081041	"C-X-C motif chemokine ligand 2"	P19875	4	74097035-74099293	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 113.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 24.4;HHSteC: 17.2;hTCEpi: 18.1;hTEC/SVTERT24-B: 12.9;hTERT-HME1: 17.6;RPTEC TERT1: 12.3;U-87 MG: 14.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.0;non-classical monocyte: 3.5"	"Group enriched"	"Detected in many"	25	"granulocytes: 1.4;monocytes: 3.5"														"Secreted to blood"						"prognostic favourable (5.93e-5)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.49e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.07e-6)"	"unprognostic (1.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	22.8	3.8	2.4	19.9	4.3	20.7	10.9	0.8	1.7	20.4	5.7	2.3	0.9	0.9	4.4	3.8	6.2	5.8	15.2	14.2	1.7	2.0	3.2	113.1	22.4	35.0	2.8	0.5	5.8	24.9	0.6	2.3	1.4	4.3	5.1	6.4	5.1	4.8	3.6	30.9	1.3	3.8	4.1	4.6	3.7	7.5	3.1	1.6	0.0	2.1	18.5	1.8	11.7	4.1	0.0	0.0	1.4	3.5	0.0	0.0	0.1	0.6	1.7	0.1	0.0	0.6	2.1	0.0	1.9	24.4	1.0	2.9	0.1	3.8	0.0	3.4	0.1	0.0	0.1	5.3	4.0	0.0	0.0	1.5	2.0	0.0	17.2	0.6	0.0	1.9	18.1	12.9	17.6	2.1	0.1	0.0	0.5	0.0	0.2	0.3	0.0	0.6	0.0	0.0	0.0	12.3	0.0	0.0	0.0	1.1	0.1	0.5	0.0	0.1	3.2	0.9	0.3	3.8	1.8	0.0	0.0	0.0	14.9	4.0	0.1	1.4	0.6	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	3.5	0.0	0.0	0.1	2.4	4.3	0.8	1.7	1.7	2.0	2.8	0.5	4.3	1.6
CXCL3	"CINC-2b, GRO3, GROg, MIP-2b, SCYB3"	ENSG00000163734	"C-X-C motif chemokine ligand 3"	P19876	4	74036589-74038807	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 28.5"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 22.8;hTEC/SVTERT24-B: 35.8;RPTEC TERT1: 20.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"																"Secreted to blood"	28710					"unprognostic (2.12e-3)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (1.08e-3)"	"unprognostic (6.97e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.80e-4)"	"unprognostic (2.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.89e-6)"	"unprognostic (2.61e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.20e-1)"	18.8	0.6	1.7	16.5	1.2	10.3	4.3	0.2	1.2	19.6	3.3	1.0	0.4	0.5	0.7	2.2	1.3	1.7	9.2	7.2	1.3	0.8	1.7	3.2	28.5	1.8	2.0	1.0	4.9	3.1	0.0	0.6	1.5	3.0	2.3	7.9	0.8	4.4	0.9	2.3	0.6	2.8	1.2	2.2	5.3	10.3	1.6	0.6	2.7	0.8	2.7	1.9	11.7	0.5	0.0	0.5	0.4	1.0	0.0	0.4	2.4	0.2	1.7	0.7	0.0	0.4	0.6	0.0	2.5	22.8	0.6	1.4	0.0	2.7	0.0	2.5	0.0	0.1	0.1	0.8	5.0	0.0	0.0	1.8	0.2	0.0	2.8	0.2	0.0	0.5	0.6	35.8	3.5	0.5	0.4	0.0	1.0	0.0	0.5	0.1	0.3	0.7	0.0	0.8	0.0	20.6	0.6	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.9	5.1	0.2	2.5	6.3	0.0	0.0	0.0	5.7	0.1	0.3	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.0	0.5	0.0	2.4	1.7	1.2	0.2	1.2	1.3	0.8	2.0	1.0	3.0	0.6
CXCL5	"ENA-78, SCYB5"	ENSG00000163735	"C-X-C motif chemokine ligand 5"	P42830	4	73995642-73998779	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.0;lymphoid tissue: 28.0;salivary gland: 31.2"	"Cell line enhanced"	"Detected in some"		"A549: 33.7;EFO-21: 28.4;HSkMC: 20.5;hTEC/SVTERT24-B: 14.7;RPTEC TERT1: 108.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 74.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.1"									HPA065474	Approved				"Secreted to blood"	513680				"HPA065474: "	"unprognostic (5.56e-3)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (2.23e-4)"	"unprognostic (7.99e-2)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (3.72e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.30e-2)"	1.7	0.3	1.6	28.0	6.0	0.7	2.4	0.4	1.4	10.5	0.7	1.5	0.2	0.6	0.3	0.0	0.6	0.4	3.9	1.4	4.3	2.8	0.4	2.1	20.0	13.6	1.2	0.1	0.3	0.8	0.0	0.3	1.5	7.4	1.5	0.2	0.0	31.2	0.5	0.3	0.3	1.8	0.1	2.6	5.2	6.4	5.4	0.2	1.0	0.3	10.8	0.8	10.9	0.3	0.0	0.0	1.1	0.1	0.0	0.2	5.5	0.0	33.7	0.1	0.0	0.0	1.2	0.0	0.6	0.5	0.2	0.5	0.1	0.3	0.0	28.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	20.5	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	5.5	1.6	6.0	0.4	1.0	4.3	2.8	1.2	0.1	7.4	0.2
CXCL8	"3-10C, AMCF-I, b-ENAP, GCP-1, GCP1, IL-8, IL8, K60, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1, SCYB8, TSG-1"	ENSG00000169429	"C-X-C motif chemokine ligand 8"	P10145	4	73740506-73743716	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 79.4;bone marrow: 300.7;lung: 106.1"	"Cell line enriched"	"Detected in many"	7	"BJ hTERT+: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	428	"neutrophil: 79.4"	"Lineage enriched"	"Detected in single"	794	"granulocytes: 79.4"					"Not detected"	"Not detected"			HPA057179	Supported				"Secreted to blood"	6307				"HPA057179: "	"unprognostic (3.42e-1)"	"prognostic unfavourable (1.18e-5)"	"unprognostic (3.91e-3)"	"unprognostic (8.49e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.03e-3)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (1.37e-3)"	"unprognostic (3.19e-1)"	"unprognostic (4.46e-1)"	"unprognostic (7.19e-3)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (4.73e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.15e-2)"	13.4	1.6	1.8	21.9	1.9	300.7	1.7	0.4	1.5	6.5	1.4	0.8	0.0	0.5	4.5	0.9	6.7	3.9	18.9	17.7	1.3	1.1	2.4	8.4	106.1	2.3	2.4	0.9	4.4	4.3	0.3	1.1	9.6	7.8	4.3	1.0	1.9	7.4	0.3	2.9	0.5	1.6	1.4	5.5	1.6	2.8	13.5	1.1	1.0	1.1	9.3	7.7	27.9	1.5	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.4	0.0	1.8	288.7	2.6	8.5	0.0	0.9	0.0	39.6	0.0	3.4	0.0	0.0	41.2	0.1	0.0	0.0	0.0	0.4	0.5	2.6	0.1	0.9	0.1	8.6	0.2	8.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.4	0.0	0.0	0.0	22.9	1.2	0.0	0.0	0.1	0.0	3.9	0.0	0.3	22.2	4.1	0.3	1.1	3.7	0.0	0.0	0.1	18.6	2.1	6.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.4	1.5	1.3	1.1	2.4	0.9	7.8	1.1
CXCL9	"CMK, crg-10, Humig, MIG, SCYB9"	ENSG00000138755	"C-X-C motif chemokine ligand 9"	Q07325	4	76001275-76007488	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.6;thyroid gland: 28.6"	"Cell line enriched"	"Detected in single"	8	"RPMI-8226: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.2;non-classical monocyte: 2.6"	"Lineage enriched"	"Detected in single"	27	"monocytes: 2.6"	"Region enhanced"	"Detected in single"		"olfactory region: 0.6"	"Low region specificity"	"Detected in many"								"Secreted to blood"	548803					"prognostic favourable (6.36e-4)"	"unprognostic (6.86e-3)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (2.97e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (8.06e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (5.15e-6)"	"unprognostic (4.76e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.54e-2)"	6.3	0.4	0.5	30.8	0.8	0.0	4.4	0.4	0.4	6.0	2.4	0.4	1.0	0.5	1.1	3.6	2.5	0.5	2.1	5.3	0.5	0.4	9.9	5.9	16.4	70.6	0.3	0.5	4.5	1.0	0.0	1.5	2.1	1.3	5.0	7.3	2.9	4.9	0.6	7.0	2.2	6.6	3.4	2.6	18.6	4.1	1.9	0.4	17.3	28.6	3.5	15.7	4.3	1.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	4.8	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.5	0.8	0.4	0.4	0.5	0.4	0.3	0.5	1.3	0.4
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250847-74292016	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 266.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 151.3;RT4: 66.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol			780000	"Vesicles, Cytosol"		"CAB006333: , HPA047548: , HPA058547: "	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	25.0	13.2	4.3	11.0	5.8	1.5	39.4	6.9	5.9	7.5	68.2	4.3	38.5	37.7	4.9	16.0	8.3	7.0	34.8	14.5	4.1	3.7	76.2	266.8	67.0	9.2	6.5	3.4	25.1	75.3	10.1	6.5	7.2	5.2	13.5	9.0	6.2	7.6	54.9	4.3	11.4	70.7	21.2	11.5	10.3	18.0	12.2	5.5	4.6	4.6	7.9	4.3	21.6	18.8	34.9	16.9	2.1	12.9	10.2	38.0	13.5	9.8	16.8	8.8	0.0	151.3	26.9	11.7	6.8	14.7	14.5	21.8	19.8	10.7	12.0	4.8	12.4	22.0	0.0	9.3	11.6	22.4	11.7	4.4	9.2	52.5	23.5	8.4	5.8	45.0	7.4	8.2	4.2	7.9	7.1	4.5	12.1	17.7	4.7	10.0	3.9	10.9	11.7	2.8	0.2	14.4	66.0	25.1	10.4	6.6	18.0	8.0	35.6	8.0	7.4	0.0	11.4	3.5	8.6	3.2	13.0	3.7	8.9	2.3	8.4	1.1	9.6	2.1	16.7	10.8	38.0	28.5	18.7	19.6	16.9	34.9	18.4	23.1	1.1	10.2	12.9	14.8	14.4	13.5	4.3	5.8	6.9	5.9	4.1	3.7	6.5	3.4	5.2	5.5
CYB5B	CYB5-M	ENSG00000103018	"Cytochrome b5 type B"	O43169	16	69424525-69466266	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 130.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007893	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite,Cytosol"			1600000	"Endoplasmic reticulum"	"Centriolar satellite, Cytosol"	"HPA007893: AB_1847369"	"unprognostic (1.13e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.51e-4)"	"unprognostic (2.87e-3)"	"unprognostic (4.35e-3)"	"unprognostic (3.87e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.10e-1)"	"prognostic favourable (6.38e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.30e-2)"	21.3	130.7	29.6	15.4	33.1	5.9	17.1	12.0	37.9	16.6	29.0	22.8	12.6	21.9	20.5	24.6	21.4	19.2	14.7	18.0	23.1	22.0	26.9	26.5	18.3	20.1	21.6	24.4	19.9	12.8	26.3	16.2	24.6	34.3	17.1	38.2	20.2	14.8	16.7	19.9	16.0	31.2	19.9	20.8	20.7	15.4	14.0	16.0	26.0	19.9	17.6	23.5	24.3	16.0	24.8	44.2	35.8	28.3	32.3	46.0	32.4	29.0	92.5	38.1	23.5	17.6	23.6	16.3	26.0	36.3	43.7	41.3	64.5	35.7	26.5	26.3	25.2	34.6	36.3	37.7	49.7	14.1	13.8	12.8	16.7	75.1	26.0	26.2	28.4	20.2	19.1	51.8	24.8	41.2	20.6	12.8	26.7	37.8	43.0	32.0	28.2	12.7	40.8	21.1	29.1	58.3	33.3	22.3	11.4	69.4	13.3	22.0	25.8	21.1	18.5	25.2	20.8	16.7	22.9	15.6	34.4	81.3	26.0	21.9	29.1	35.8	20.3	24.3	39.3	28.3	32.2	24.8	29.6	30.8	24.8	22.6	24.6	29.2	6.1	32.3	20.1	44.2	46.0	32.4	29.6	33.1	12.0	37.9	23.1	22.0	21.6	24.4	34.3	16.0
CYC1	UQCR4	ENSG00000179091	"Cytochrome c1"	P08574	8	144095027-144097525	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.2"	"Cell line enhanced"	"Detected in all"		"PC-3: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001247	Supported		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"			110000	Mitochondria	"Nucleoplasm, Nuclear bodies, Cytosol"	"HPA001247: AB_1078602"	"unprognostic (3.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.92e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (5.89e-6)"	"unprognostic (6.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.13e-2)"	16.0	31.3	16.2	13.2	20.1	19.5	12.1	19.1	32.1	13.0	33.3	13.4	14.4	38.1	13.9	10.1	36.2	15.5	13.1	92.1	16.6	14.1	44.8	55.9	11.2	16.5	18.0	18.6	15.0	21.4	17.9	10.6	16.0	17.7	16.5	25.3	13.3	23.3	17.2	145.2	17.7	42.6	16.3	11.8	18.3	22.4	13.9	11.5	21.5	21.7	43.8	18.5	19.9	14.4	34.9	76.7	22.1	60.0	30.2	26.1	58.5	22.2	50.4	13.4	28.0	11.1	12.3	25.8	12.8	15.6	32.7	21.5	35.2	27.8	31.5	28.9	17.1	33.0	29.2	25.4	12.3	19.3	38.7	33.8	42.5	32.2	19.9	19.9	22.1	17.9	31.8	20.8	41.3	18.9	30.7	28.2	17.0	79.8	37.3	18.5	15.5	151.2	33.0	17.9	55.2	26.8	35.8	36.0	15.9	35.7	49.4	26.2	40.6	30.6	14.4	20.8	44.4	23.0	38.9	31.3	22.7	23.4	26.5	34.1	26.6	22.1	59.7	15.9	24.1	60.0	25.4	34.9	20.1	25.8	76.7	29.4	19.7	25.4	5.8	30.2	44.8	42.9	26.1	58.5	16.2	20.1	19.1	32.1	16.6	14.1	18.0	18.6	17.7	11.5
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria			190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	43.0	24.1	26.1	36.3	15.0	11.6	26.9	41.5	17.1	31.1	36.2	39.9	29.5	49.6	20.4	18.1	51.2	53.0	39.1	55.0	14.7	23.8	41.3	28.6	28.3	23.6	94.3	36.8	15.4	35.0	31.1	67.5	27.8	75.6	52.6	33.0	19.9	51.5	36.7	48.9	45.7	36.3	31.4	47.4	48.4	42.3	53.0	25.2	21.6	92.4	33.4	47.9	56.5	20.1	28.6	52.1	44.1	76.6	54.4	63.0	110.8	38.1	68.7	79.2	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1
CYP17A1	"CPT7, CYP17, P450C17, S17AH"	ENSG00000148795	"Cytochrome P450 family 17 subfamily A member 1"	P05093	10	102830531-102837533	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Steroidogenesis	"Lyase, Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"adrenal gland: 425.4"	"Group enriched"	"Detected in some"	4	"HMC-1: 7.8;SCLC-21H: 3.1"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 22.7"	"Region enriched"	"Detected in single"	103	"basal ganglia: 19.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048533	Enhanced				"Intracellular and membrane"					"HPA048533: "	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.39e-4)"	"unprognostic (8.26e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.43e-7)"	"unprognostic (1.07e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.94e-4)"	0.0	425.4	0.0	0.1	19.7	0.0	0.0	0.1	0.1	0.1	0.0	78.5	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	6.4	1.7	0.1	0.0	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	82.3	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	7.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	19.7	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
CYP1A1	"CP11, CYP1, P1-450, P450-C, P450DX"	ENSG00000140465	"Cytochrome P450 family 1 subfamily A member 1"	P04798	15	74719542-74725610	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	"Lyase, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 38.3;lung: 144.1;urinary bladder: 40.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 24.0;hTCEpi: 13.1;HUVEC TERT2: 12.6;SK-BR-3: 9.8"	"Group enriched"	"Detected in some"	24	"liver cancer: 18.6;urothelial cancer: 54.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB018654	Uncertain									"CAB018654: AB_2088699"	"unprognostic (1.71e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.45e-3)"	"unprognostic (6.34e-2)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-1)"	"unprognostic (1.28e-1)"	9.3	0.4	0.1	0.4	0.2	0.2	7.7	0.2	0.5	2.3	0.7	0.4	3.9	0.5	3.8	4.4	1.2	0.2	11.3	3.0	0.1	0.0	0.7	38.3	144.1	0.2	0.1	0.1	0.5	0.5	0.2	0.1	3.5	0.3	0.2	0.2	0.8	2.1	0.5	1.5	8.1	10.7	5.9	0.2	0.2	0.4	0.3	0.1	0.1	0.8	0.8	8.0	40.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.4	0.1	0.0	0.3	0.0	7.8	0.0	0.1	0.4	0.2	24.0	1.0	0.2	6.5	0.0	7.5	0.5	4.8	0.2	0.0	0.7	0.3	1.7	3.5	0.1	0.2	7.7	0.0	13.1	0.2	1.0	12.6	1.4	0.2	0.0	0.5	0.0	0.2	0.1	1.9	0.7	0.0	0.3	0.0	1.6	0.4	0.2	1.1	9.8	2.5	0.3	0.1	0.6	1.1	0.3	3.5	0.0	0.5	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.3	0.1	0.0	0.1	0.1	0.3	0.1
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038265-32041670	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"adrenal gland: 170.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.5;Hep G2: 1.8;Karpas-707: 3.1"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA048979, HPA053371"	Enhanced				"Intracellular and membrane"					"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	0.1	170.9	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	6.7	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.3	7.4	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	3.6	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.5	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2A6	"CPA6, CYP2A, CYP2A3"	ENSG00000255974	"Cytochrome P450 family 2 subfamily A member 6"	P11509	19	40843538-40850447	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	165	"liver: 199.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.2;HL-60: 2.8;K-562: 1.4;RH-30: 4.3;SiHa: 2.2;U-937: 1.0"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 281.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046713, HPA047262"	Supported				"Intracellular and membrane"					"HPA046713: , HPA047262: "	"unprognostic (5.40e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.64e-2)"	"prognostic favourable (5.38e-5)"	"unprognostic (4.98e-3)"	"unprognostic (4.86e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.55e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	199.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
CYP2B6	"CPB6, CYP2B, CYPIIB6"	ENSG00000197408	"Cytochrome P450 family 2 subfamily B member 6"	P20813	19	40991250-41018398	"Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 137.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 7.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 28.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB033866, HPA048124, HPA062973"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"			"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB033866: AB_2292644, HPA048124: , HPA062973: "	"unprognostic (1.86e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.13e-2)"	"unprognostic (6.13e-2)"		"unprognostic (4.59e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"		"unprognostic (5.78e-2)"		"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (9.43e-2)"		"unprognostic (5.44e-1)"	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.9	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.0	3.0	137.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	1.8	3.1	0.8	0.7	0.9	0.1	0.4	0.4	0.5	0.4	0.1	0.0	0.4	0.2	0.4	0.0	0.2	1.6	0.0	0.4	0.3	0.3	7.4	0.4	0.1	0.1	0.3	0.6	0.4	0.8	0.5	0.4	0.4	0.4	0.0	0.5	0.3	0.1	0.6	0.4	0.1	0.2	0.1	0.8	1.9	0.7	0.5	0.2	0.5	0.5	1.8	0.1	0.9	0.2	0.3	0.1	0.5	0.8	1.1	0.9	0.6	0.3	0.8	0.6	0.3	0.8	0.9	0.2	1.2	0.3	3.1	0.8	0.4	0.4	0.5	0.4	0.6	0.6	0.4	0.1	1.9	0.5	0.8	2.7	0.7	0.3	1.8	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;EFO-21: 1.5;hTCEpi: 2.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"														"Intracellular and membrane"						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015066	Supported				"Intracellular and membrane"					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CYP2C8	CPC8	ENSG00000138115	"Cytochrome P450 family 2 subfamily C member 8"	P10632	10	95036772-95069497	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	131	"liver: 247.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;HL-60: 2.7;SiHa: 2.9;U-266/70: 2.9;U-266/84: 2.2"	"Cancer enriched"	"Detected in some"	82	"liver cancer: 102.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"gdT-cell: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"									"HPA013547, HPA013970, HPA015066"	Enhanced				"Intracellular and membrane"					"HPA013547: AB_1847435, HPA013970: AB_1847434, HPA015066: AB_1847433"	"unprognostic (3.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.38e-1)"	"prognostic favourable (9.82e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.63e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.05e-4)"	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.3	247.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	1.1	0.2	0.0	0.2	0.0	0.7	1.0	0.0	1.0	0.5	2.7	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	2.9	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.9	2.2	1.1	0.0	0.9	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;NB-4: 4.4;RPMI-8226: 6.6;SCLC-21H: 2.5;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033671, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol		"CAB033671: AB_782375, HPA072245: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.1	4.4	0.3	0.0	0.0	2.1	6.6	0.0	0.4	2.5	4.9	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	0.0	0.7	0.0	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP3A43		ENSG00000021461	"Cytochrome P450 family 3 subfamily A member 43"	Q9HB55	7	99828013-99866102	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"liver: 32.5"	"Low cell line specificity"	"Detected in some"			"Cancer enriched"	"Detected in single"	18	"liver cancer: 1.4"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"HPA066463, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol		"HPA066463: , HPA072245: "	"unprognostic (1.20e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.64e-3)"		"unprognostic (7.24e-2)"	"unprognostic (2.52e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.46e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.37e-4)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.9	0.1	0.0	0.1	0.1	0.1	0.0	0.2	32.5	0.1	0.1	0.1	0.1	0.1	8.0	0.0	2.2	0.1	0.1	1.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.5	1.6	0.6	0.3	0.6	0.2	0.1	0.0	0.9	0.3	1.1	0.2	0.2	0.0	0.1	0.2	0.2	1.2	0.7	1.5	0.2	0.3	1.3	0.2	0.0	0.7	0.2	0.5	0.9	1.4	1.3	0.3	0.9	1.3	0.0	0.7	0.0	0.0	0.5	1.0	1.0	0.0	0.0	0.0	0.6	0.4	0.0	0.9	0.0	0.2	0.7	1.6	0.5	0.4	0.6	1.7	0.0	0.5	0.0	1.6	0.5	0.2	1.1	0.7	1.1	1.2	0.1	0.8	0.4	0.2	1.5	0.6	0.4	0.6	0.2	0.3	0.3	0.3	0.2	0.1	0.6	0.5	0.5	1.6	0.3	0.2	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP4F11		ENSG00000171903	"Cytochrome P450 family 4 subfamily F member 11"	Q9HBI6	19	15912367-15934867	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 88.6"	"Cell line enhanced"	"Detected in some"		"A-431: 7.5;CAPAN-2: 29.9;EFO-21: 11.2;Hep G2: 14.4;RPMI-8226: 7.8;RT4: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.2"	"Low lineage specificity"	"Detected in single"											"HPA017265, CAB033648, HPA058960"	Enhanced				"Intracellular and membrane"					"CAB033648: AB_2088410, HPA017265: AB_1847451, HPA058960: "	"prognostic favourable (4.05e-4)"	"unprognostic (4.12e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.99e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (4.44e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.78e-2)"	"unprognostic (4.64e-2)"	0.4	2.2	3.6	0.5	4.4	0.5	1.7	1.8	5.4	1.1	2.5	4.4	0.0	7.5	0.5	11.8	7.9	2.2	12.9	0.4	3.9	1.4	4.9	88.6	2.4	0.4	2.1	3.8	0.3	3.5	0.2	0.6	0.2	8.3	2.4	1.9	0.6	2.6	3.4	0.5	0.8	15.7	0.2	9.7	0.9	2.7	1.0	3.0	0.0	2.2	2.8	1.8	4.8	2.0	0.1	0.1	0.8	1.2	0.0	0.2	0.1	7.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.1	11.2	0.0	0.9	0.0	3.9	0.0	0.0	0.0	0.0	2.3	14.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	6.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.1	7.8	2.0	8.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.1	0.1	0.1	0.3	0.1	0.2	0.9	0.0	0.8	0.5	0.0	0.1	1.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.7	0.1	0.0	0.1	3.6	4.4	1.8	5.4	3.9	1.4	2.1	3.8	8.3	3.0
CYTH1	"B2-1, cytohesin-1, D17S811E, PSCD1"	ENSG00000108669	"Cytohesin 1"	Q15438	17	78674048-78782297	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047498			Uncertain	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA047498: "	"unprognostic (3.82e-3)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.63e-1)"	"prognostic favourable (6.48e-4)"	"unprognostic (6.60e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.69e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.10e-1)"	17.4	12.4	20.7	28.5	36.0	34.4	12.0	17.7	27.5	10.1	17.4	64.1	5.0	13.2	7.7	6.5	25.9	10.2	15.5	10.3	21.5	16.0	11.5	16.0	25.7	42.3	44.4	27.4	5.9	16.0	7.5	8.4	15.8	32.1	15.2	19.9	10.1	17.3	5.3	17.5	15.9	21.4	10.0	31.2	31.8	24.8	7.9	45.2	19.3	15.2	9.2	50.1	14.4	12.1	24.7	19.1	45.9	20.0	21.8	39.4	31.3	9.1	6.4	6.4	5.5	4.4	5.6	6.2	4.3	3.8	5.3	6.2	4.0	10.2	6.8	4.3	5.6	8.1	3.1	11.2	4.3	14.2	8.6	2.7	8.1	7.3	3.1	5.6	27.5	2.7	9.3	6.0	6.2	17.0	4.5	26.3	6.2	4.6	36.2	5.0	1.6	5.7	9.6	7.1	23.8	5.8	6.4	3.7	13.5	7.6	14.8	6.0	7.2	6.6	8.0	4.2	6.2	6.6	4.4	30.6	14.0	24.9	3.1	5.6	4.4	45.9	16.2	31.4	39.4	20.0	28.6	24.7	32.8	31.8	13.7	23.0	36.5	30.7	33.8	21.8	17.6	19.1	24.5	31.3	20.7	36.0	17.7	27.5	21.5	16.0	44.4	27.4	32.1	45.2
CYTH2	"ARNO, CTS18.1, cytohesin-2, PSCD2, PSCD2L, Sec7p-L, Sec7p-like"	ENSG00000105443	"Cytohesin 2"	Q99418	19	48469032-48482314	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB014872, HPA060662"	Uncertain		Supported	"Golgi apparatus,Plasma membrane,Cytosol"			11000	Cytosol	"Golgi apparatus, Plasma membrane"	"CAB014872: , HPA060662: "	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.33e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (3.21e-4)"	13.5	14.2	12.7	14.1	13.6	8.0	19.5	11.4	24.4	21.9	11.7	12.9	14.8	23.2	15.4	15.9	18.8	15.0	25.5	8.3	12.4	7.4	19.2	8.9	15.2	10.0	13.2	18.9	14.4	17.3	35.1	21.0	21.1	12.4	18.0	9.7	13.5	24.2	14.4	7.4	19.9	23.0	12.2	8.7	13.0	19.2	42.0	13.5	18.4	46.2	15.1	10.6	15.6	15.9	4.1	5.6	11.1	4.0	1.8	6.1	3.2	9.2	14.1	42.8	9.6	6.5	5.6	7.8	7.3	6.7	7.8	7.4	7.7	12.7	6.1	7.7	6.3	11.7	8.2	8.9	5.0	9.3	11.2	8.6	17.6	8.3	5.8	5.2	11.8	7.2	15.3	9.7	6.2	10.1	8.6	21.5	10.3	7.5	8.7	38.3	4.6	5.8	11.2	6.4	4.2	13.3	20.3	12.6	12.4	8.0	22.5	6.2	10.6	7.0	10.9	17.0	8.6	4.0	10.4	21.4	11.3	4.0	6.2	10.4	11.8	4.1	4.0	3.3	4.1	3.0	2.7	4.1	5.3	6.1	3.3	2.7	4.9	3.4	11.1	1.8	3.9	5.6	5.3	3.2	12.7	13.6	11.4	24.4	12.4	7.4	13.2	18.9	12.4	13.5
CYTL1	"C17, C4orf4"	ENSG00000170891	"Cytokine like 1"	Q9NRR1	4	5014586-5019472	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 42.2"	"Cell line enhanced"	"Detected in some"		"HEL: 41.7;HUVEC TERT2: 33.5;NB-4: 81.5;WM-115: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 21.0;melanoma: 20.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"NK-cell: 18.8"	"Lineage enriched"	"Detected in many"	10	"NK-cells: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067201			Supported	"Nuclear membrane,Endoplasmic reticulum"	"Secreted in other tissues"			"Nuclear membrane, Endoplasmic reticulum"		"HPA067201: "	"unprognostic (2.35e-2)"	"unprognostic (9.01e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.10e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (7.43e-4)"	"prognostic unfavourable (3.00e-5)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.25e-4)"	5.2	2.3	6.5	2.0	6.0	10.8	6.4	0.7	4.2	11.0	4.9	9.2	4.9	1.0	10.1	2.8	5.3	7.3	4.6	4.4	5.4	4.4	1.2	0.8	17.1	9.4	6.2	2.1	2.5	1.1	1.7	1.6	42.2	4.7	10.5	1.8	4.5	4.0	14.2	0.8	3.3	2.1	4.2	11.0	1.1	4.9	2.2	8.4	0.5	5.7	3.6	4.8	13.2	7.4	0.0	0.3	1.9	1.0	18.8	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.6	0.0	33.5	0.0	1.7	0.0	0.0	0.0	81.5	0.1	0.0	1.2	1.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	5.1	0.0	0.0	11.4	0.0	7.9	0.0	0.0	0.2	0.0	0.0	0.0	1.0	19.7	1.9	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.6	0.1	18.8	0.0	0.3	0.0	0.6	6.5	6.0	0.7	4.2	5.4	4.4	6.2	2.1	4.7	8.4
DAAM1	KIAA0666	ENSG00000100592	"Dishevelled associated activator of morphogenesis 1"	Q9Y4D1	14	59188646-59371405	"Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 18.3"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026605, HPA064789"	Uncertain		Approved	"Plasma membrane,Cytosol"			450000	"Plasma membrane, Cytosol"		"HPA026605: AB_1847464, HPA064789: "	"unprognostic (2.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.15e-2)"	13.8	8.0	13.8	9.4	9.3	3.7	9.3	17.3	13.3	14.6	11.4	6.3	7.4	4.5	16.9	7.0	19.2	8.4	6.0	17.3	10.2	6.7	6.0	10.7	9.7	8.8	5.6	13.6	8.6	8.2	25.6	9.6	12.4	8.7	10.9	7.8	16.9	12.0	10.5	6.0	25.6	7.7	19.5	10.0	10.2	9.1	5.8	7.2	4.1	7.1	14.1	13.8	15.3	13.1	10.7	18.3	4.9	3.1	6.9	3.8	1.9	12.8	1.3	8.8	2.3	5.8	4.1	11.6	1.6	1.6	3.4	3.6	6.6	10.7	13.3	3.4	4.0	26.5	8.3	6.4	2.8	5.8	2.9	5.0	3.3	7.9	3.6	5.6	2.6	2.7	6.5	2.9	2.9	7.5	8.1	6.6	2.1	11.0	4.7	2.7	4.8	3.8	4.4	7.5	1.3	4.4	10.1	13.8	3.1	11.2	16.4	10.0	21.8	1.2	7.5	2.6	5.1	5.9	1.5	1.4	1.6	15.6	3.6	1.0	6.3	4.9	2.1	2.5	2.6	2.4	3.1	10.7	3.3	2.4	2.4	4.7	2.7	2.7	2.6	6.9	3.1	18.3	3.8	1.9	13.8	9.3	17.3	13.3	10.2	6.7	5.6	13.6	8.7	7.2
DAB2	DOC-2	ENSG00000153071	"DAB2, clathrin adaptor protein"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 194.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.2;ASC TERT1: 45.4;fHDF/TERT166: 65.6;TIME: 39.5;U-138 MG: 46.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"plasmacytoid DC: 26.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: "	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	51.6	44.2	2.6	12.2	3.5	0.6	21.8	6.1	2.6	16.6	14.0	4.1	4.5	3.3	16.6	34.8	10.8	9.6	13.3	25.1	2.9	3.0	75.2	6.9	22.4	31.8	4.0	2.1	12.7	11.3	3.2	3.9	194.4	4.7	11.6	14.6	14.6	12.9	5.3	12.7	9.3	10.4	16.0	5.2	21.1	7.2	8.7	2.5	7.3	10.9	8.4	7.4	17.8	14.7	0.1	26.6	2.2	2.5	0.9	1.3	7.0	0.0	1.5	2.4	5.3	42.2	45.4	3.0	27.2	27.9	10.7	17.7	19.9	0.0	0.0	1.7	65.6	0.0	0.3	0.9	15.1	0.0	0.8	3.6	36.2	6.5	10.2	0.0	4.7	28.2	0.0	17.5	3.1	32.2	0.0	0.9	17.7	0.1	0.3	0.0	1.6	3.0	0.9	6.2	0.0	7.1	0.5	0.0	0.0	3.2	1.7	15.2	0.1	0.9	39.5	46.0	5.1	5.3	2.2	0.0	0.0	0.0	16.0	3.4	5.9	2.2	1.2	0.2	1.3	2.5	0.0	0.1	0.2	0.7	3.4	0.1	0.1	1.0	1.8	0.9	0.6	26.6	0.2	7.0	2.6	3.5	6.1	2.6	2.9	3.0	4.0	2.1	4.7	2.5
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		70000000	Vesicles		"CAB001960: , CAB016353: AB_627292"	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.0	22.5	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.2	2.8	2.1	6.4	15.7	2.0	1.6	14.5	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	38.6	4.8	11.0	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.2	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.3	21.0	17.2	27.2	25.4	32.1	42.3	27.3	28.9	28.1	24.6	38.7	39.8	46.2	55.7	22.2	33.1	25.5	23.8	30.7	28.9	18.6	28.1	18.8	35.1	34.8	38.4	25.1	26.9	34.2	35.8	47.4	27.6	60.7	32.9	29.2	43.0	33.7	45.0	30.4	34.4	27.9	21.6	49.0	33.4	31.0	20.0	35.5	26.2	77.4	47.1	48.0	63.3	23.6	23.9	25.2	29.5	45.8	36.0	53.7	53.2	23.8	34.5	30.7	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol			160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.1	19.4	16.6	17.5	18.5	23.2	38.0	23.6	26.5	25.9	25.4	41.8	20.6	55.1	37.0	19.4	27.2	25.4	30.6	47.1	25.2	22.7	33.5	19.2	43.4	23.9	44.8	22.3	22.3	24.7	28.9	26.1	14.2	35.9	17.6	21.4	22.2	34.3	38.6	19.5	18.5	42.0	36.1	38.5	31.1	18.4	11.8	22.5	18.1	16.4	18.4	18.0	32.0	10.7	22.7	22.7	16.7	23.4	48.5	26.4	59.3	35.7	34.2	14.0	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol			1700000	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	22.1	15.0	11.4	33.1	14.2	37.1	32.9	16.1	19.4	15.2	21.4	22.2	17.2	28.3	17.8	11.0	30.9	16.0	13.5	26.7	11.5	9.2	17.1	38.1	18.7	29.2	16.8	12.4	20.7	28.3	11.9	11.4	22.2	13.3	15.9	15.6	16.8	17.0	12.0	31.4	20.2	28.7	17.7	10.9	28.5	22.0	46.8	15.0	43.8	15.9	22.6	21.0	21.4	27.7	7.1	6.1	4.3	7.5	6.5	7.1	3.1	52.7	19.2	12.9	23.5	5.7	7.0	37.0	23.8	11.9	19.5	16.1	19.1	26.2	62.2	14.6	11.5	29.8	17.0	22.7	16.5	43.5	27.0	32.0	18.4	19.4	13.3	38.7	27.5	7.0	15.0	13.2	24.3	17.0	47.6	32.8	12.1	21.6	67.8	34.5	39.8	19.4	49.0	20.6	38.3	14.6	17.9	25.7	23.0	15.7	24.8	28.7	22.5	51.7	18.4	16.1	21.8	28.0	51.9	38.9	39.9	49.4	19.4	37.8	24.5	3.2	5.5	4.3	6.5	7.5	7.1	7.1	6.0	6.9	4.9	5.5	6.0	6.4	2.4	6.5	5.2	6.1	6.1	3.1	11.4	14.2	16.1	19.4	11.5	9.2	16.8	12.4	13.3	15.0
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 201.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	37	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.2	201.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0
DBI	"ACBD1, ACBP"	ENSG00000155368	"Diazepam binding inhibitor, acyl-CoA binding protein"	P07108	2	119366921-119372560	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 222.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051428	Approved						7100000			"HPA051428: "	"unprognostic (1.24e-1)"	"prognostic favourable (5.77e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.45e-1)"	55.3	22.5	87.5	25.0	53.9	17.1	122.9	47.3	55.4	27.9	52.5	55.2	108.2	50.8	11.2	113.8	90.5	14.0	33.0	78.6	79.8	52.4	90.5	157.2	41.0	27.4	74.1	45.5	12.7	25.3	71.8	11.5	19.0	61.9	77.5	50.1	16.7	53.3	113.7	39.8	57.5	39.1	16.3	87.7	18.3	29.6	24.6	68.8	11.9	22.4	101.0	50.9	18.6	41.6	66.2	99.6	129.8	60.0	53.1	74.9	82.8	46.1	24.2	49.7	22.7	122.4	104.4	31.3	24.6	62.6	34.7	67.4	50.3	37.6	64.3	28.1	38.2	24.3	34.9	51.4	31.2	42.5	23.1	55.0	24.7	66.3	30.7	17.4	222.3	59.1	33.6	53.2	20.0	40.9	6.4	60.3	49.3	47.7	36.7	49.9	32.9	37.9	13.4	48.3	55.9	83.9	71.0	23.6	18.9	20.6	48.6	52.5	29.9	82.2	29.0	23.4	29.9	25.7	29.7	19.8	14.0	52.4	33.0	31.5	27.7	116.9	57.6	129.8	63.9	60.0	46.3	55.9	50.5	61.9	94.2	66.2	38.8	58.3	36.7	53.1	47.2	99.6	74.9	82.8	87.5	53.9	47.3	50.6	79.8	52.4	74.1	45.5	61.9	68.8
DBN1	D0S117E	ENSG00000113758	"Drebrin 1"	Q16643	5	177456608-177474401	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051452, HPA056940"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"			17000000	"Plasma membrane, Actin filaments"		"HPA051452: AB_2681489, HPA056940: AB_2683279"	"unprognostic (3.81e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.57e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (8.28e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-3)"	21.4	9.0	21.7	15.0	42.4	5.4	13.5	12.0	46.0	25.7	21.7	8.8	8.7	8.6	37.4	15.0	19.2	16.2	21.5	13.9	24.2	20.9	15.1	2.7	12.1	7.3	11.9	22.1	20.2	13.2	9.1	17.1	6.7	20.3	14.9	5.8	9.3	24.8	23.0	21.3	12.7	10.0	29.5	8.6	7.8	17.0	14.4	9.4	19.8	20.0	11.0	4.4	20.6	12.0	0.2	5.1	6.0	0.9	0.1	12.7	1.5	2.9	10.1	33.8	58.9	8.0	12.7	10.5	36.1	9.3	21.2	17.8	34.9	10.6	0.0	25.8	28.0	4.7	14.9	26.2	10.0	0.8	12.9	19.6	13.2	14.5	28.5	7.3	3.6	16.6	6.9	23.7	7.1	34.9	9.0	4.7	15.4	4.2	20.1	11.2	48.9	22.7	60.2	36.6	5.9	15.8	4.2	39.8	54.1	11.8	5.2	20.0	14.4	7.6	53.9	23.7	32.2	5.2	16.7	1.1	0.5	31.6	9.9	6.9	14.5	6.0	0.9	0.7	9.2	0.5	12.7	0.1	0.2	6.6	1.4	0.2	0.3	4.5	2.5	0.1	0.4	5.1	0.0	1.5	21.7	42.4	12.0	40.8	24.2	20.9	11.9	22.1	20.3	9.4
DBNL	"ABP1, HIP-55, SH3P7"	ENSG00000136279	"Drebrin like"	Q9UJU6	7	44044640-44069456	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Endocytosis, Immunity, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020265, HPA027735"	Enhanced		Supported	Nucleoplasm,Cytosol			15000000	Cytosol	Nucleoplasm	"HPA020265: AB_1850723, HPA027735: AB_10603790"	"unprognostic (9.57e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (2.25e-1)"	"unprognostic (6.18e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.88e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.51e-2)"	23.9	19.6	21.2	45.4	17.4	34.1	20.5	11.4	24.0	23.9	21.0	19.6	23.5	17.9	22.0	21.8	65.6	19.1	32.7	18.0	18.3	18.8	18.9	18.4	23.6	49.8	19.1	23.8	15.2	19.2	16.7	18.5	25.8	16.1	21.0	15.2	17.2	23.4	22.3	15.9	26.2	23.2	25.2	19.8	46.8	24.7	13.0	15.8	31.0	18.2	32.0	52.3	23.6	31.6	46.7	66.0	64.1	73.7	31.6	35.4	80.5	19.4	28.4	17.8	19.3	22.2	14.3	16.5	32.1	26.8	32.0	26.9	28.4	27.2	43.7	23.3	34.9	34.6	10.3	37.5	12.0	23.3	12.0	14.8	21.3	16.2	22.5	22.1	27.6	13.5	15.0	30.4	10.6	21.9	18.6	15.2	30.3	28.3	39.6	24.9	14.5	24.0	22.0	14.5	21.7	20.7	27.2	21.6	28.7	21.9	43.0	6.8	31.7	30.9	35.1	26.3	23.8	15.2	37.1	35.6	15.3	24.5	24.7	25.1	62.2	39.2	66.3	50.2	35.4	73.7	28.0	46.7	26.7	28.8	63.9	45.8	27.0	28.2	64.1	31.6	71.0	66.0	31.3	80.5	21.2	17.4	11.4	24.0	18.3	18.8	19.1	23.8	16.1	15.8
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.5	5.7	5.2	10.6	11.6	10.1	12.2	7.9	6.4	7.1	8.6	11.8	4.4	10.5	11.6	4.7	10.4	11.6	8.4	8.9	11.1	6.7	7.6	10.9	5.8	9.9	10.0	3.6	9.8	9.3	5.8	9.1	6.6	12.2	11.5	5.6	2.6	8.3	3.2	11.0	11.4	8.1	19.2	7.9	7.8	10.5	9.2	5.7	17.5	15.6	13.2	12.3	6.2	7.6	7.0	4.7	8.9	7.1	8.1	8.2	5.4	8.3	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA036142: AB_10669666, HPA052445: , HPA053203: "	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favourable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.7	13.2	12.9	11.6	11.6	9.3	12.2	12.1	9.1	13.1	12.9	14.4	10.5	26.2	6.7	9.5	9.5	24.2	10.8	17.0	18.2	12.0	22.4	18.1	12.4	8.5	29.2	16.3	6.1	12.6	16.9	12.4	10.1	13.1	17.1	10.2	10.9	22.3	11.9	13.5	14.6	9.5	13.8	17.3	10.2	16.8	6.7	11.9	13.3	12.4	7.3	8.4	12.4	12.6	10.8	14.5	17.7	18.5	11.6	15.7	27.0	12.5	20.1	8.8	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9
DCC	"IGDCC1, NTN1R1"	ENSG00000187323	"DCC netrin 1 receptor"	P43146	18	52340172-53535903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.0;testis: 16.5"	"Group enriched"	"Detected in some"	4	"AF22: 15.1;U-266/70: 46.8;U-266/84: 22.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055376, HPA069552"	Enhanced		Supported	"Golgi apparatus"			25000	"Golgi apparatus"		"HPA055376: , HPA069552: "	"unprognostic (1.96e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.22e-4)"	"unprognostic (4.14e-2)"	"unprognostic (1.27e-4)"	"unprognostic (7.21e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-3)"	0.5	1.9	6.3	0.8	22.0	0.4	0.6	0.7	10.1	0.8	0.9	1.3	0.0	0.5	0.4	1.0	0.7	0.7	0.5	0.5	18.4	2.0	0.9	0.5	3.8	0.4	1.5	9.9	0.7	1.2	0.6	1.1	0.4	5.3	1.3	0.8	0.0	0.8	3.5	0.4	0.8	0.7	0.5	2.4	0.8	0.8	16.5	6.5	0.7	0.5	0.0	1.1	0.8	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	46.8	22.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	22.0	0.7	10.1	18.4	2.0	1.5	9.9	5.3	6.5
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063967	Enhanced				"Secreted in other tissues"		370000000			"HPA063967: "	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.5	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.3	0.7	0.4	0.0	0.0	0.4	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 19.7;EFO-21: 13.8;Hep G2: 22.3;RPTEC TERT1: 72.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"				"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: , HPA031584: "	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.5	0.0	1.5	0.1	0.0	0.3	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2
DCHS1	"CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16"	ENSG00000166341	"Dachsous cadherin-related 1"	Q96JQ0	11	6621323-6655854	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.8;HUVEC TERT2: 26.1;REH: 12.6;SH-SY5Y: 18.2;TIME: 11.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017970, HPA050246"	Approved		Approved	"Plasma membrane"			75000	"Plasma membrane"		"HPA017970: , HPA050246: "	"unprognostic (2.42e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.38e-3)"	"unprognostic (2.52e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.96e-2)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (5.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-3)"	9.0	2.0	4.1	7.7	4.7	0.5	6.8	5.2	4.4	26.1	12.9	4.4	9.0	3.8	23.9	4.7	5.0	10.4	9.1	8.0	4.0	4.5	3.4	5.6	7.7	3.9	2.5	3.4	13.7	3.3	1.6	2.7	9.7	3.3	12.0	3.4	9.7	3.3	12.0	3.5	3.4	6.0	16.0	1.6	10.2	6.8	2.6	2.5	5.8	3.3	2.6	2.6	10.9	11.9	0.0	1.4	0.1	0.0	0.0	0.9	0.4	0.0	0.0	18.8	0.1	0.0	0.0	0.1	0.6	4.8	3.0	3.4	0.1	0.0	0.1	2.9	5.4	0.0	1.5	0.0	2.1	0.0	0.5	0.3	0.0	0.0	0.2	0.1	0.0	0.6	0.1	1.4	0.0	26.1	0.1	0.0	1.1	0.0	0.6	0.3	2.8	0.0	12.6	0.0	0.0	0.0	0.0	1.4	18.2	0.0	0.1	0.1	0.0	0.7	11.1	0.0	5.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.8	0.9	0.1	0.0	0.0	1.4	0.0	0.4	4.1	4.7	5.2	4.4	4.0	4.5	2.5	3.4	3.3	2.5
DCLK1	"DCAMKL1, DCDC3A, DCLK, KIAA0369"	ENSG00000133083	"Doublecortin like kinase 1"	O15075	13	35768652-36131306	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 17.3;ASC TERT1: 16.4;fHDF/TERT166: 13.3;HAP1: 10.3;HSkMC: 15.1;NTERA-2: 21.4"	"Cancer enhanced"	"Detected in many"		"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012405, HPA015040, HPA015655"	Enhanced		Approved	Nucleoplasm,Cytosol			11000	Nucleoplasm	Cytosol	"CAB012405: , HPA015040: , HPA015655: "	"unprognostic (2.29e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.14e-4)"	13.9	3.3	14.3	4.2	25.0	1.1	8.6	8.6	76.5	12.2	3.5	8.6	0.5	2.0	6.4	5.8	5.8	3.3	7.1	5.8	21.9	21.9	1.9	1.2	3.0	4.3	11.9	22.5	6.4	2.1	1.5	7.4	1.1	13.9	4.7	4.4	0.5	2.5	4.7	1.9	4.7	2.7	17.0	10.4	4.6	2.5	2.2	8.5	0.0	2.1	1.4	2.9	5.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	17.3	16.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	13.3	0.0	10.3	0.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	0.0	15.1	7.5	0.3	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	21.4	0.2	0.0	1.2	0.0	0.6	0.0	4.3	2.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	3.5	4.4	0.7	0.1	0.0	0.0	1.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	25.0	8.6	45.8	21.9	21.9	11.9	22.5	13.9	8.5
DCN	"DSPG2, SLRR1B"	ENSG00000011465	Decorin	P07585	12	91140484-91183123	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Corneal dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 227.5;ASC TERT1: 175.3;BJ hTERT+: 175.9;HSkMC: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"basophil: 18.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA003315, CAB017118, HPA064736, CAB068930"	Enhanced				"Secreted to extracellular matrix"		1300000			"CAB017118: , CAB068930: AB_425394, HPA003315: AB_1078639, HPA064736: AB_2685340"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.22e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (3.06e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.56e-3)"	152.8	64.6	4.8	52.8	8.3	0.0	137.1	4.5	5.8	177.7	60.6	5.1	105.8	7.8	124.0	266.8	142.9	113.6	94.3	190.2	5.2	4.0	35.4	35.1	107.0	27.5	16.7	9.1	265.5	25.7	1.5	12.7	192.0	12.4	130.7	28.3	40.7	32.7	51.8	77.2	76.0	34.9	222.4	24.9	1.8	47.5	116.5	6.0	3.3	74.2	99.4	29.3	187.8	113.8	0.8	0.6	18.7	0.3	0.5	0.4	0.0	0.0	0.0	0.2	0.0	227.5	175.3	0.3	40.3	175.9	1.9	2.0	0.0	0.0	0.0	0.0	34.3	0.1	0.0	0.1	0.3	0.0	0.0	0.0	1.3	0.0	48.6	0.0	0.0	159.5	0.4	5.1	2.4	0.0	0.0	0.0	3.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.7	0.5	0.0	0.0	0.0	0.0	0.0	9.1	0.0	32.4	0.0	0.1	0.1	0.1	0.5	0.1	0.0	18.7	0.3	0.6	0.4	0.2	0.3	0.4	0.3	0.3	0.1	0.8	0.4	0.4	2.7	0.5	0.2	0.6	0.3	0.0	4.8	8.3	4.5	5.8	5.2	4.0	16.7	9.1	12.4	6.0
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283428-53347610	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 30.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"				"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favourable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	8.0	5.7	4.8	5.4	6.9	18.5	6.1	11.1	8.8	7.2	4.7	6.8	2.1	3.9	8.4	5.8	5.5	6.5	5.5	5.4	4.3		4.6	4.9	5.1	6.3	5.1	3.7	11.2	6.9	8.5	10.0	9.9	5.8	5.8	5.8	7.0	3.8	5.0	5.0	4.9	6.4	7.6	5.8	6.5	4.1	4.9	6.0	11.4	6.1	4.0	10.0	8.2	5.8	26.7	17.4	23.6	25.8	29.4	30.3	19.0	5.7	6.0	14.2	11.4	9.8	10.2	19.0	6.8	9.0	15.1	14.2	17.5	10.5	13.4	2.8	8.6	4.9	18.3	7.0	13.2	11.9	8.2	13.0	8.2	9.1	8.5	15.4	17.8	8.0	6.8	13.6	11.1	10.9	10.9	14.5	7.3	3.5	21.2	7.8	9.0	8.8	9.8	9.5	9.2	6.3	13.0	7.4	12.1	11.7	7.7	10.1	5.0	12.0	11.6	7.3	10.4	7.4	10.1	9.1	7.9	15.5	8.8	9.0	12.8	23.6	13.6	22.4	24.3	14.4	30.1	21.7	24.8	28.1	15.0	26.7	30.3	28.1	13.9	29.4	25.8	17.4	16.9	19.0										
DCTN1		ENSG00000204843	"Dynactin subunit 1"	Q14203	2	74361154-74392087	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"		"Amyotrophic lateral sclerosis, Cancer-related genes, Neurodegeneration, Neuropathy, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009108, HPA034635, HPA071875"	Approved		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"			220000	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB009108: AB_2090601, HPA034635: , HPA071875: "	"unprognostic (1.14e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.11e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (2.34e-7)"	"unprognostic (5.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.12e-3)"	20.7	21.1	36.0	13.7	54.6	11.1	14.0	45.9	70.9	23.5	17.1	37.8	8.9	11.8	18.5	9.8	22.9	19.7	15.1	37.7	39.5	35.8	13.5	10.0	18.9	10.9	37.7	40.3	21.9	15.2	70.2	21.6	17.2	54.6	16.5	14.0	13.2	23.5	21.7	39.5	19.9	13.7	26.5	32.2	12.4	16.0	25.5	26.7	9.4	17.0	9.5	12.8	17.2	18.0	11.6	12.1	12.9	15.8	9.8	16.7	15.5	18.7	22.0	20.7	21.6	38.0	28.3	16.7	30.3	31.6	38.6	27.6	29.2	14.5	25.9	12.4	62.8	18.8	25.2	38.4	29.5	32.1	25.4	26.8	17.7	24.5	29.3	14.6	33.2	34.0	18.8	41.9	25.1	33.0	11.5	18.5	29.1	16.1	26.5	15.1	22.3	23.4	23.8	36.4	18.5	21.4	11.6	25.5	22.6	16.9	20.4	18.2	13.1	10.6	24.9	35.2	25.6	15.1	22.4	11.5	9.1	23.5	32.9	23.8	24.6	7.3	11.4	12.9	16.7	14.2	13.5	11.6	9.5	12.4	12.1	8.6	6.8	7.5	9.8	9.8	15.8	9.6	8.1	15.5	36.0	54.6	45.9	70.9	39.5	35.8	37.7	40.3	54.6	26.7
DCXR	"DCR, KIDCR, SDR20C1"	ENSG00000169738	"Dicarbonyl and L-xylulose reductase"	Q7Z4W1	17	82035136-82037732	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism, Xylose metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 293.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 64.9;MCF7: 79.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 305.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023371, HPA023863"	Enhanced		Uncertain	Nucleoli,Microtubules			2700000	"Nucleoli, Microtubules"		"HPA023371: AB_1847530, HPA023863: AB_1847531"	"unprognostic (3.33e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.70e-4)"	"unprognostic (1.72e-1)"	"prognostic favourable (2.13e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.10e-2)"	12.7	6.1	12.8	4.3	12.1	5.7	12.2	9.0	15.1	9.9	9.5	8.4	18.1	7.8	4.4	62.7	11.7	6.1	4.8	11.8	9.8	9.7	50.8	293.8	10.5	5.3	14.4	7.3	8.1	13.0	6.7	7.2	9.0	13.4	22.3	5.4	7.8	19.3	14.0	22.5	8.6	6.8	3.6	8.4	4.4	14.9	8.7	9.7	8.3	15.6	12.6	9.1	7.5	6.4	32.8	52.7	25.3	33.1	35.2	43.7	35.8	8.9	12.3	5.7	10.3	23.0	5.8	15.2	4.6	6.0	12.7	8.7	21.8	3.9	18.5	9.0	6.4	10.6	10.4	9.2	4.4	3.9	26.7	17.7	9.2	64.9	24.7	13.6	21.8	8.4	11.5	4.0	14.6	7.1	20.2	13.5	6.7	79.8	11.4	32.7	6.6	13.1	10.5	7.7	24.2	9.4	12.7	15.9	9.4	6.4	55.0	8.0	41.2	13.5	3.6	6.7	8.4	9.0	8.6	13.9	10.2	8.7	5.7	15.0	4.9	13.9	33.1	25.3	24.7	30.6	23.6	28.6	30.8	23.6	52.7	32.8	43.7	31.9	16.5	35.2	28.0	42.5	33.1	35.8	12.8	12.1	9.0	15.1	9.8	9.7	14.4	7.3	13.4	9.7
DDAH1	DDAH	ENSG00000153904	"Dimethylarginine dimethylaminohydrolase 1"	O94760	1	85318481-85578363	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 61.6"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.3;naive B-cell: 1.0"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006308	Enhanced		Approved	"Nucleoli,Plasma membrane,Cytosol"			140000	"Plasma membrane, Cytosol"	Nucleoli	"HPA006308: AB_1847532"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (5.99e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.37e-2)"	"unprognostic (9.06e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.56e-2)"	4.3	14.3	43.9	5.8	44.9	0.7	6.6	14.4	37.2	7.7	22.1	20.7	4.3	21.1	6.0	33.8	4.9	18.4	12.2	6.4	29.5	24.1	61.6	39.9	11.8	1.1	24.9	37.0	3.4	13.8	13.0	7.2	3.1	13.8	13.1	21.4	4.1	8.5	6.2	13.8	2.8	19.9	7.4	8.1	4.1	15.6	9.3	11.0	0.0	14.1	1.0	1.2	6.0	3.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	18.7	2.3	6.6	1.2	11.1	9.4	0.8	22.1	13.4	7.9	8.4	26.6	5.0	0.0	9.2	25.0	5.4	23.9	4.6	10.1	0.0	9.2	0.0	6.3	9.2	4.0	17.0	1.0	7.8	0.4	6.6	4.2	12.5	0.0	1.9	20.2	1.5	0.9	0.0	7.9	6.9	0.0	15.5	0.2	33.7	14.0	18.7	36.3	2.9	16.8	2.7	9.1	1.3	24.4	6.9	5.6	1.7	15.4	0.0	0.0	0.0	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	43.9	44.9	14.4	37.2	29.5	24.1	24.9	37.0	13.8	11.0
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 10.6;ASC TERT1: 13.2;EFO-21: 16.9;fHDF/TERT166: 10.5;SK-MEL-30: 10.6;U-2 OS: 12.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012509	Uncertain		Supported	"Centriolar satellite,Cytosol"			1800000	Cytosol	"Centriolar satellite"	"HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	24.3	7.8	12.5	11.1	10.3	5.5	22.7	3.1	7.8	32.1	17.0	7.9	12.9	2.6	34.6	22.0	18.4	18.1	26.7	20.7	11.8	10.8	16.9	12.9	37.4	16.5	10.6	6.6	22.5	4.3	3.0	6.2	13.7	13.1	19.8	5.4	13.0	18.1	13.2	6.8	15.1	22.3	27.1	18.9	21.4	11.4	7.3	9.9	14.1	35.4	17.1	8.9	16.3	23.4	2.9	5.5	8.0	2.7	2.3	0.5	0.3	0.4	6.6	0.2	1.4	10.6	13.2	0.7	0.6	0.3	0.4	0.1	4.3	0.7	0.2	16.9	10.5	0.8	0.0	6.2	0.0	0.1	8.9	0.5	0.5	0.1	0.3	0.9	0.0	8.5	0.1	0.8	0.1	0.1	0.2	2.2	0.0	3.6	0.5	2.5	0.1	0.2	0.3	0.5	0.0	7.5	0.7	0.4	0.9	0.3	0.0	10.6	0.7	0.9	1.1	0.8	12.6	0.2	0.1	2.7	9.2	2.5	7.3	1.5	0.2	8.0	0.8	7.7	0.5	2.6	0.3	2.9	0.2	0.3	1.5	2.5	0.1	0.1	1.3	2.3	2.7	5.5	0.4	0.3	12.5	10.3	3.1	7.8	11.8	10.8	10.6	6.6	13.1	9.9
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm			170000	Nucleoplasm		"CAB032821: AB_639050, HPA045174: , HPA068456: "	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	19.3	83.3	19.9	14.1	24.9	16.1	19.7	22.9	33.8	21.3	16.2	24.9	33.3	18.4	23.9	30.6	19.8	26.2	17.4	21.1	18.1	20.8	21.7	26.8	16.0	21.7	18.3	23.4	31.1	23.5	107.3	22.0	80.3	27.3	19.4	17.8	33.0	23.9	27.2	57.1	24.1	19.7	20.7	16.7	17.5	19.7	36.1	14.4	33.3	22.1	20.4	21.0	22.6	17.9	19.6	30.5	17.8	23.5	22.0	32.5	23.8	39.4	42.6	41.4	36.2	39.4	37.2	62.2	37.1	48.1	45.1	34.2	46.1	33.4	59.7	33.0	50.8	36.9	60.7	44.2	48.7	30.1	32.8	34.3	40.9	47.6	27.6	48.9	29.8	43.8	30.4	44.6	38.5	48.4	68.9	32.7	39.6	47.9	60.4	23.0	54.9	36.8	49.8	52.5	62.4	31.5	43.8	36.9	37.6	40.1	46.9	36.9	58.1	20.8	39.9	32.1	30.3	36.6	26.2	37.7	39.8	53.0	35.4	26.2	31.0	17.8	20.9	17.7	24.8	23.5	32.5	19.6	22.4	24.8	30.5	17.9	20.7	23.1	2.5	22.0	21.0	16.8	24.4	23.8	19.9	24.9	22.9	33.8	18.1	20.8	18.3	23.4	27.3	14.4
DDHD1	"KIAA1705, PA-PLA1, SPG28"	ENSG00000100523	"DDHD domain containing 1"	Q8NEL9	14	53036745-53153282	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049870	Enhanced									"HPA049870: "	"unprognostic (2.48e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (8.14e-3)"	"unprognostic (9.40e-2)"	"unprognostic (4.91e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.67e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	6.5	6.1	10.7	8.4	11.3	10.4	6.4	15.6	12.2	8.1	5.6	10.1	1.3	4.1	7.8	4.1	3.9	5.2	6.4	6.0	11.7	10.9	4.1	4.0	7.3	11.7	13.9	9.9	7.7	4.4	8.7	7.8	10.9	12.1	5.6	7.3	8.1	4.0	5.8	4.8	6.1	5.5	6.8	15.8	8.2	5.6	28.1	10.8	10.2	5.3	2.8	10.0	7.4	7.3	4.4	2.4	2.0	4.3	6.6	6.7	1.8	6.0	6.2	18.2	8.0	9.3	8.1	5.6	7.4	5.5	5.9	6.1	1.9	1.2	15.0	4.7	6.0	2.4	8.9	2.5	8.1	7.4	4.8	1.9	5.6	3.3	7.8	6.6	6.1	4.2	2.9	6.1	5.9	4.6	3.7	12.8	7.0	6.3	6.6	4.2	3.9	6.1	6.3	21.1	2.9	3.2	7.4	9.5	7.5	10.0	3.0	2.7	3.8	4.5	6.5	6.1	9.0	9.6	6.5	6.5	3.7	10.2	3.4	6.8	3.3	1.9	1.9	1.6	6.3	3.1	6.0	4.4	5.0	6.7	2.4	4.4	4.7	5.4	2.0	6.6	4.3	2.3	5.7	1.8	10.7	11.3	15.6	12.2	11.7	10.9	13.9	9.9	12.1	10.8
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol			170000	"Nucleoplasm, Cytosol"		"HPA043119: , HPA043225: "	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.4	4.3	7.9	8.2	10.9	8.6	7.7	4.7	3.6	4.1	3.6	10.6	6.8	18.8	5.5	5.1	8.0	17.2	7.6	7.0	8.6	11.5	14.7	7.3	10.4	4.7	19.4	7.4	8.5	9.0	7.7	8.3	8.4	23.5	7.0	5.0	5.0	11.2	6.4	7.6	3.6	10.6	11.2	11.1	5.8	6.2	9.7	5.4	8.8	14.2	13.0	7.4	5.1	7.3	6.0	5.1	6.7	5.7	6.6	7.9	15.2	4.7	14.2	4.6	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"			3300000	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: , HPA052867: "	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favourable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (4.88e-4)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavourable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	25.7	42.7	17.0	28.7	21.6	37.1	42.5	13.9	26.7	32.8	35.3	16.4	52.0	27.3	37.1	54.7	33.2	32.7	40.0	53.2	13.9	15.7	36.0	59.8	37.2	84.7	16.5	18.3	42.4	146.9	25.4	37.2	71.6	16.1	24.9	39.1	29.5	51.3	58.3	25.5	25.1	35.6	32.2	12.8	49.8	36.5	35.1	15.0	32.5	51.5	28.7	34.5	26.7	30.0	45.6	80.1	50.1	57.1	49.7	58.9	80.7	46.3	29.8	26.0	77.0	51.7	54.1	54.3	39.1	78.7	63.7	65.8	39.6	97.2	38.5	65.2	63.3	40.2	35.8	47.9	47.2	30.5	36.8	33.3	19.4	52.0	77.1	51.7	86.2	55.4	53.4	53.3	64.4	72.7	16.1	64.3	38.2	35.4	24.5	42.8	26.7	31.6	21.6	34.9	68.4	52.0	20.5	18.9	32.9	42.2	43.0	58.1	34.4	80.2	37.3	36.7	38.7	63.4	36.0	76.3	82.0	25.9	60.5	69.2	49.3	44.7	55.7	50.1	55.7	57.1	58.9	45.6	48.2	51.3	80.1	39.6	44.1	46.6	14.2	49.7	48.5	65.4	49.2	80.7	17.0	21.6	13.9	26.7	13.9	15.7	16.5	18.3	16.1	15.0
DDT	DDCT	ENSG00000099977	"D-dopachrome tautomerase"	P30046	22	23971365-23980469	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Melanin biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.8;liver: 58.4"	"Cell line enhanced"	"Detected in all"		"HEK 293: 67.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA049871	Approved		Approved	Mitochondria				Mitochondria		"HPA049871: "	"unprognostic (1.77e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.00e-3)"	"unprognostic (2.02e-3)"	"unprognostic (6.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.61e-3)"	9.7	6.6	5.4	3.4	4.8	8.8	4.5	2.1	4.4	3.0	9.8			11.8	2.7	4.3	5.8	2.8	1.4	7.7	4.2	4.0	11.3	58.4	3.2	2.9	5.4		4.1	14.4	1.3	1.8	2.5		5.8	6.4		7.1	4.4	10.4	3.7	11.6	2.0	4.6	3.2	8.2	1.2			3.7		2.7	4.3	3.2	30.4	52.8	27.8	38.0	23.8	29.0	28.6	26.7	11.4	4.0	9.3	7.6	6.7	24.2	7.8	5.3	6.8	7.1	10.1	7.7	25.6	7.3	4.1	22.2	9.8	9.7	4.5	10.8	67.6	15.4	15.6	21.9	7.7	33.8	15.5	6.7	7.4	6.8	6.0	7.3	13.9	10.4	6.8	13.1	7.4	30.6	12.0	34.5	16.3	7.4	36.6	12.1	9.9	13.5	13.0	16.1	30.4	22.9	7.7	10.6	8.4	7.1	15.8	7.2	8.1	32.0	10.6	16.1	13.9	12.6	13.6	20.7	38.0	27.8	19.9	32.4	20.3	30.4	24.1	21.1	35.7	28.4	21.9	21.3	24.2	23.8	29.6	52.8	29.0	28.6										
DDX1	DBP-RB	ENSG00000079785	"DEAD-box helicase 1"	Q92499	2	15591178-15631111	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, mRNA processing, Transcription, Transcription regulation, tRNA processing"	"Activator, DNA-binding, Exonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012280, HPA034502, HPA034503"	Enhanced		Enhanced	Nucleoplasm,Cytosol			46000	Nucleoplasm	Cytosol	"CAB012280: , HPA034502: AB_10794321, HPA034503: AB_10795025"	"unprognostic (9.94e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (8.36e-3)"	"unprognostic (9.28e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.09e-9)"	"unprognostic (2.55e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.89e-2)"	"unprognostic (2.03e-1)"	"prognostic favourable (9.69e-4)"	"unprognostic (3.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.20e-3)"	23.8	28.2	29.3	17.6	35.0	17.1	30.1	35.3	37.2	25.1	24.5	15.0	20.5	21.0	24.3	25.6	27.7	21.0	15.8	47.6	34.7	25.3	35.8	35.2	17.8	16.0	24.5	36.9	23.6	27.6	42.1	41.2	28.1	35.1	22.2	28.1	14.8	23.9	24.5	67.5	24.5	25.9	31.0	21.0	17.1	24.1	19.2	23.0	23.0	29.6	24.8	21.5	26.1	19.8	18.7	22.8	19.2	25.1	23.0	26.6	19.9	19.1	29.4	41.8	31.2	36.3	31.9	48.2	40.3	33.8	39.7	33.4	46.9	19.8	49.7	19.6	46.4	29.2	57.1	38.6	42.0	21.1	37.1	54.5	39.3	59.1	27.3	44.5	25.7	24.7	26.7	33.0	31.8	35.7	55.5	16.4	39.1	26.8	24.3	33.6	53.8	24.8	29.4	63.3	36.0	45.4	38.6	33.7	42.2	27.5	29.0	36.6	20.2	18.9	28.8	33.3	34.5	20.9	45.4	21.5	37.3	67.1	30.0	35.7	31.0	19.2	20.0	11.5	20.2	25.1	21.3	18.7	23.4	23.4	22.8	18.0	26.6	23.6	3.1	23.0	23.2	19.5	21.6	19.9	29.3	35.0	35.3	37.2	34.7	25.3	24.5	36.9	35.1	23.0
DDX17	P72	ENSG00000100201	"DEAD-box helicase 17"	Q92841	22	38483440-38507660	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, mRNA processing, mRNA splicing, RNA-mediated gene silencing, rRNA processing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024908, HPA063142"	Supported		Supported	"Nuclear speckles"	"Intracellular and membrane"		90000	"Nuclear speckles"		"CAB024908: , HPA063142: "	"unprognostic (1.46e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.24e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (6.06e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.51e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.19e-3)"	49.7	43.1	46.3	49.2	54.5	19.8	50.8	69.7	52.0	47.7	53.3	56.5	54.4	33.1	58.5	82.9	37.5	52.2	46.1	39.9	47.0	31.2	34.3	41.9	41.5	52.6	64.0	37.7	67.8	41.5	68.5	83.7	49.4	46.0	46.2	36.8	51.4	43.9	51.8	89.2	60.3	38.7	52.7	47.1	54.1	39.7	24.6	63.1	69.3	59.8	29.2	47.7	54.5	52.9	10.3	12.4	23.7	9.5	4.0	9.9	6.1	29.6	28.8	58.8	35.3	39.0	44.9	30.7	25.3	25.3	37.0	36.0	27.5	24.8	57.6	17.5	33.1	32.8	64.3	35.9	41.4	56.7	36.7	35.8	48.2	32.9	41.8	45.7	42.6	31.3	47.1	24.1	41.7	42.2	36.9	65.2	29.3	19.3	32.1	38.9	37.8	14.0	58.3	32.8	35.3	35.1	39.7	34.0	20.0	39.7	31.4	41.9	27.1	35.3	34.2	31.6	19.7	20.1	19.0	50.4	34.8	49.6	40.8	29.6	38.8	8.5	9.5	11.0	9.9	7.3	9.4	9.0	8.0	7.1	6.8	10.3	5.8	7.5	23.7	4.0	6.8	12.4	7.9	6.1	46.3	54.5	69.7	52.0	47.0	31.2	64.0	37.7	46.0	63.1
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Supported	Nucleoli				Nucleoli		"HPA035400: AB_10672091, HPA041056: "	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	21.5	9.8	14.7	13.2	8.7	7.9	24.2	12.8	10.1	17.7	15.7	24.1	14.3	31.8	21.0	10.6	16.8	28.5	16.6	26.2	16.2	19.9	30.4	9.2	24.2	12.2	40.5	15.9	8.2	15.3	22.5	22.8	10.6	33.1	13.8	13.5	13.4	22.1	21.2	36.8	14.8	19.3	22.9	27.9	11.7	12.8	14.1	24.0	14.9	16.4	16.6	10.4	22.4	8.1	15.9	23.4	11.1	23.0	15.9	19.8	88.2	11.7	19.2	7.1	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335283	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm				Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: , HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	22.2	18.6	8.8	16.6	12.7	19.4	20.1	30.4	16.3	13.1	16.7	14.6	13.8	14.4	15.0	13.9	16.0	13.2	15.2	15.0	8.3	8.3	15.9	33.9	16.6	15.3	10.5	10.7	14.6	21.6	20.3	17.9	12.0	13.2	13.8	18.2	19.3	16.8	15.2	24.8	26.9	16.6	15.7	10.1	17.8	18.5	64.3	12.3	17.4	18.0	16.9	20.8	16.2	13.9	21.1	21.1	27.0	28.6	22.1	35.4	22.5	2.0	12.3	17.5	15.9	9.7	12.9	15.2	9.9	14.1	21.8	22.8	26.1	15.1	16.1	9.4	12.4	12.1	0.1	5.7	22.6	6.6	11.1	9.5	8.0	21.4	20.8	20.3	9.2	15.9	11.2	16.5	12.6	16.7	9.6	7.0	13.3	14.1	0.0	29.3	10.9	5.1	28.1	9.5	23.2	13.0	11.4	11.5	15.1	23.4	5.3	12.6	11.9	18.1	10.1	10.3	9.2	8.5	9.1	15.0	7.8	37.3	3.4	16.6	13.2	27.0	22.1	19.0	23.2	28.6	22.3	21.1	20.9	25.3	21.1	19.0	19.0	18.0	4.1	22.1	17.7	6.5	35.4	22.5	8.8	12.7	30.4	16.3	8.3	8.3	10.5	10.7	13.2	12.3
DDX20	"DP103, GEMIN3"	ENSG00000064703	"DEAD-box helicase 20"	Q9UHI6	1	111755245-111768016	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005516, CAB015427"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB015427: AB_629518, HPA005516: AB_1849612"	"unprognostic (3.71e-2)"	"unprognostic (5.25e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (6.35e-6)"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.46e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.30e-2)"	3.1	2.8	2.9	2.7	4.3	5.9	9.8	5.8	5.1	2.7	2.6	1.8	2.6	2.0	4.0	2.9	2.6	3.7	1.7	2.0	4.3	1.6	2.7	2.4	4.1	3.8	2.4	1.9	3.9	2.9	4.0	3.9	2.7	3.4	2.9	2.6	1.2	2.6	2.7	5.1	2.5	3.5	2.9	5.6	4.5	2.8	81.7	3.3	5.1	3.2	1.7	4.1	2.9	5.0	11.9	7.4	12.7	7.4	10.5	14.1	7.8	11.4	4.7	12.2	11.0	8.8	7.0	11.4	11.2	8.7	16.1	15.7	7.0	4.0	26.8	8.8	7.6	9.2	14.4	11.3	18.0	12.2	13.0	13.0	9.2	7.2	8.8	12.8	9.6	7.0	9.9	13.7	13.9	11.1	12.4	9.8	12.2	10.8	15.7	13.0	15.3	9.6	15.4	20.1	6.7	10.5	9.0	12.7	11.5	10.8	13.5	18.0	8.4	13.6	9.8	9.8	14.5	17.5	13.0	4.9	6.9	20.5	10.2	13.2	22.1	12.7	7.0	6.9	10.0	7.3	13.3	11.9	11.7	11.8	7.4	10.1	14.1	12.3	5.0	10.5	7.4	5.2	11.7	7.8	2.9	4.3	5.8	5.1	4.3	1.6	2.4	1.9	3.4	3.3
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			14000	Nucleoli	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	32.8	19.5	11.4	35.2	10.3	13.6	24.1	22.6	18.3	29.2	24.9	63.1	22.5	49.6	13.9	18.7	29.3	43.9	28.2	39.2	15.4	30.9	34.7	13.9	26.2	22.1	82.5	33.0	14.0	36.7	34.9	58.4	21.2	66.0	24.8	20.5	15.0	32.3	18.0	31.2	41.7	28.9	18.7	24.3	19.4	17.7	23.6	25.3	20.3	45.1	26.3	25.5	17.3	21.8	17.2	24.3	23.0	39.6	28.6	37.8	73.2	14.3	62.6	11.6	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3
DDX24		ENSG00000089737	"DEAD-box helicase 24"	Q9GZR7	14	94048291-94081245	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 103.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002554	Uncertain		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA002554: AB_1078631"	"unprognostic (7.48e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.81e-2)"	"unprognostic (2.66e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.13e-2)"	"prognostic favourable (3.06e-9)"	"prognostic unfavourable (2.89e-4)"	"unprognostic (6.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.66e-2)"	18.0	45.5	19.7	13.7	41.3	53.3	18.5	31.4	40.8	17.4	20.9	21.9	14.3	13.6	23.2	103.0	20.1	18.9	21.3	28.6	25.0	31.3	36.3	30.1	16.4	27.4	22.0	29.0	21.4	12.5	8.3	32.0	11.2	38.7	16.0	14.6	17.4	15.9	17.7	28.5	23.4	12.6	17.9	21.8	18.1	15.0	38.5	17.4	14.3	25.3	11.8	25.8	21.7	14.9	4.1	3.1	10.6	3.3	6.2	5.3	5.0	3.8	1.0	7.1	4.6	4.3	5.6	1.7	10.7	8.9	13.9	12.5	1.3	2.4	17.7	4.0	2.3	2.5	7.3	0.6	15.2	7.7	0.4	9.4	2.0	5.7	3.5	13.5	4.2	0.9	4.0	2.5	2.4	2.3	4.9	5.2	5.9	10.6	4.0	11.5	4.7	0.1	5.4	16.5	2.0	10.1	1.4	5.6	5.2	10.5	2.6	4.9	4.1	4.8	6.8	4.0	2.6	5.1	3.2	2.1	13.6	19.0	5.7	7.4	3.1	10.6	3.3	2.5	5.0	2.6	1.4	2.9	2.9	3.0	2.0	4.1	5.3	5.3	2.6	6.2	2.5	3.1	3.3	5.0	19.7	41.3	31.4	40.8	25.0	31.3	22.0	29.0	38.7	17.4
DDX25	GRTH	ENSG00000109832	"DEAD-box helicase 25"	Q9UHL0	11	125903348-125943702	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, mRNA transport, Spermatogenesis, Translation regulation, Transport"	"Developmental protein, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 17.3;testis: 64.2"	"Group enriched"	"Detected in some"	4	"NTERA-2: 13.6;SCLC-21H: 11.0"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020137	Enhanced									"HPA020137: AB_1847552"	"unprognostic (5.78e-3)"	"unprognostic (9.75e-3)"	"unprognostic (7.93e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.91e-3)"	"unprognostic (6.24e-5)"	"unprognostic (2.57e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.69e-1)"	0.7	2.8	8.7	0.8	13.2	0.9	0.8	7.9	17.3	0.8	0.8	2.0	0.0	1.0	0.9	0.9	0.8	0.9	0.8	0.7	8.4	7.1	2.7	0.8	0.8	0.8	4.8	8.9	1.2	1.8	2.6	7.1	0.9	5.9	0.9	0.8	2.3	0.8	1.0	0.8	1.6	0.8	0.7	3.4	0.9	1.0	64.2	3.0	0.0	4.3	0.0	0.8	0.7	0.2	0.6	0.5	3.3	0.3	1.3	0.5	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.2	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.6	2.0	0.1	13.6	0.0	0.5	0.0	0.0	0.0	0.1	11.0	2.5	0.2	0.0	1.9	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.8	2.1	0.3	0.6	0.3	0.2	0.2	0.4	0.5	0.2	0.1	0.6	0.4	0.3	3.3	1.3	0.2	0.5	0.1	0.1	8.7	13.2	7.9	12.5	8.4	7.1	4.8	8.9	5.9	3.0
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"			120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: , HPA058450: "	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavourable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favourable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.1	13.3	6.5	13.5	11.6	7.7	3.4	3.9	10.0	9.0	4.0	4.0	3.1	11.7	16.7	5.6	15.1	25.6	9.4	2.7	40.3	5.5	4.7	9.6	4.5	7.4	6.0	17.9	15.4	10.1	31.7	6.3	23.8	2.5	8.3	2.1	6.5	27.0	5.6	2.8	5.5	5.9	3.6	20.2	3.9	6.1	17.0	6.8	3.1	3.9	2.3	6.4	3.5	1.3	4.8	1.2	8.9	10.2	12.6	25.0	0.8	10.4	5.3	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: "	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.4	50.5	47.2	25.9	55.6	47.2	28.8	33.1	46.6	34.0	27.4	51.9	30.6	0.5	23.7	37.1	30.7	57.7	46.6	56.7	26.9	45.0	28.9	50.3	31.2	28.9	54.1	52.0	34.1	33.1	57.3	55.4	53.3	53.0	28.6	31.6	34.4	34.1	16.9	45.4	20.4	40.0	50.3	37.0	32.0	61.2	32.3	48.9	75.0	38.5	39.7	34.6	36.8	48.1	35.1	37.6	37.5	39.3	33.4	39.6	44.9	35.4	32.8	33.2	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3, Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 40.6;HEL: 41.4;U-266/84: 34.4;U-698: 30.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059583: "			"unprognostic (3.89e-2)"		"unprognostic (1.70e-1)"	"prognostic favourable (4.70e-5)"	"unprognostic (6.50e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.22e-2)"		"unprognostic (4.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.87e-2)"	12.0	10.5	4.9	29.5	14.1	46.1	8.7	17.0	16.3	0.4	24.4	12.6	31.5	7.6	0.4	29.7	12.2	0.4	14.2	10.8	5.6	7.1	8.9	26.5	20.0	17.7	5.7	0.0	0.4	14.5	0.4	12.2	14.0	20.2	26.7	15.8	15.1	20.4	32.6	17.7	8.4	16.0	40.7	6.2	34.3	8.9	41.9	0.0	26.9	10.8	21.4	19.3	14.4	0.0	6.1	8.8	6.5	7.1	6.5	8.4	3.8	0.1	7.5	0.0	0.0	0.0	0.0	5.5	18.6	13.3	9.8	12.1	0.0	0.0	40.6	0.0	18.3	0.0	0.0	0.0	17.3	10.2	0.0	41.4	0.0	12.2	9.7	0.0	0.0	10.3	11.6	0.0	0.0	0.0	0.0	0.0	11.6	0.0	16.0	0.0	7.4	0.0	0.0	4.9	7.4	10.5	11.2	12.2	0.0	0.0	0.0	13.6	0.0	9.7	13.3	15.3	0.0	0.0	12.2	21.9	34.4	30.2	1.8	0.0	0.0	1.6	6.2	5.7	8.4	7.1	7.7	6.1	6.4	7.1	8.8	5.9	7.8	6.5	6.5	6.5	4.6	2.5	5.7	3.8	4.9	14.1	17.0	16.3	5.6	7.1	5.7	0.0	20.2	0.0
DDX41	"ABS, MGC8828"	ENSG00000183258	"DEAD-box helicase 41"	Q9UJV9	5	177511577-177517469	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017911, HPA048803"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA017911: AB_1847558, HPA048803: "	"unprognostic (2.52e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavourable (2.21e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.75e-1)"	17.9	22.7	27.0	25.1	30.7	17.2	16.5	22.8	39.2	19.1	21.2	16.9	18.5	25.5	19.5	16.5	23.0	22.1	17.1	15.3	29.3	20.1	23.7	29.3	16.8	19.9	22.1	24.8	21.2	18.0	22.2	15.1	22.1	27.4	16.3	15.4	19.0	19.0	17.5	36.6	21.7	26.8	16.7	14.8	21.9	19.7	16.8	15.4	24.9	22.9	18.2	23.5	19.6	18.4	15.9	22.5	16.4	22.8	18.6	20.6	18.0	21.0	24.1	13.2	15.5	13.6	16.1	44.5	18.9	11.5	13.9	10.3	39.2	19.7	23.6	28.8	17.8	17.3	17.2	43.3	9.5	56.4	21.6	30.0	24.5	23.2	18.0	31.0	31.9	15.8	15.3	13.2	17.8	17.7	26.0	16.9	16.4	45.4	25.8	15.2	23.2	19.5	28.1	16.0	27.8	15.5	24.5	15.7	17.2	20.1	26.8	22.6	18.7	45.3	18.9	25.5	15.1	16.2	29.4	20.3	23.8	40.3	27.9	34.2	16.7	10.6	22.8	16.4	16.1	21.5	20.6	15.9	16.0	15.3	22.5	14.1	14.8	15.5	7.7	18.6	21.4	10.2	15.6	18.0	27.0	30.7	22.8	39.2	29.3	20.1	22.1	24.8	27.4	15.4
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavourable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	32.4	28.2	27.1	26.3	39.4	24.2	32.5	34.1	40.7	39.1	31.2	33.7	20.9	23.0	39.2	30.7	26.1	34.4	35.1	25.6	25.6	26.7	23.0	25.7	26.4	27.5	29.6	35.8	43.5	41.8	36.8	26.2	30.7	34.1	39.0	28.0	28.8	34.0	35.6	44.7	29.2	26.7	37.7	27.3	26.9	30.5	28.6	21.5	33.2	26.1	21.8	33.7	42.6	25.4	7.6	5.0	8.4	4.4	6.7	6.6	2.8	30.8	32.5	29.3	30.0	29.7	24.1	31.6	30.5	27.4	27.9	27.4	30.5	20.5	43.2	11.9	34.0	24.8	33.0	27.0	37.0	12.7	21.7	32.5	31.5	37.0	29.3	37.6	22.3	30.6	25.8	25.2	30.7	27.6	36.1	18.3	28.3	25.2	35.9	21.0	27.9	17.4	31.4	50.3	22.1	25.5	36.5	18.5	35.0	23.0	41.5	25.9	28.4	31.1	29.3	41.3	25.2	16.7	35.7	20.6	16.4	39.8	21.2	20.9	21.6	2.6	3.9	8.4	6.2	3.2	6.6	4.1	5.2	6.1	5.0	7.6	6.6	6.4	2.9	6.7	4.4	3.0	3.1	2.8	27.1	39.4	34.1	40.7	25.6	26.7	29.6	35.8	34.1	21.5
DDX46	"FLJ25329, KIAA0801, Prp5, PRPF5"	ENSG00000145833	"DEAD-box helicase 46"	Q7L014	5	134758771-134855133	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036554, HPA057501"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA036554: AB_10673621, HPA057501: AB_2683449"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (9.01e-6)"	"unprognostic (7.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.50e-2)"	22.2	21.8	18.8	29.4	23.8	22.7	22.7	39.0	24.8	25.1	21.4	17.5	18.6	19.0	26.8	19.8	23.7	21.0	15.8	18.3	17.7	13.0	22.9	22.7	21.6	26.6	22.9	15.1	25.8	24.2	27.2	37.5	22.1	21.7	19.0	24.2	12.8	23.9	23.3	46.6	26.3	23.0	24.6	27.8	30.0	22.2	17.8	25.9	40.4	22.1	21.0	29.1	23.1	28.9	27.0	23.5	34.6	19.9	19.4	20.4	9.7	25.7	23.6	16.8	21.9	6.6	7.4	23.3	17.2	13.4	18.3	20.6	35.7	18.8	32.5	14.9	11.5	16.0	24.7	16.4	21.6	21.8	22.5	39.1	25.8	14.4	5.7	35.4	21.1	6.6	9.0	19.2	10.9	14.4	33.2	14.0	13.5	12.3	30.4	13.8	23.2	10.7	26.6	44.0	16.4	10.0	22.3	20.0	19.1	24.1	11.5	12.5	17.9	20.3	17.9	19.4	13.5	14.8	34.1	11.0	29.9	43.1	13.4	33.8	12.2	25.7	19.9	27.6	20.0	17.5	18.0	22.0	19.6	19.8	15.2	27.0	20.4	20.3	34.6	19.4	15.7	23.5	17.1	9.7	18.8	23.8	39.0	24.8	17.7	13.0	22.9	15.1	21.7	25.9
DDX47	"DKFZp564O176, FLJ30012, HQ0256, RRP3"	ENSG00000213782	"DEAD-box helicase 47"	Q9H0S4	12	12813316-12829981	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014855	Approved		Supported	Nucleoli				Nucleoli		"HPA014855: AB_1847567"	"unprognostic (3.14e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.91e-2)"	"unprognostic (5.84e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.49e-3)"	"unprognostic (6.55e-9)"	"unprognostic (1.68e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.20e-6)"	29.3	24.1	19.9	21.6	25.6	31.0	29.1	27.4	26.9	26.7	26.2	28.2	21.4	16.0	33.7	21.0	28.9	27.5	17.9	22.6	20.0	19.4	29.6	38.1	23.2	26.1	28.2	19.9	33.7	31.0	25.8	23.8	27.6	25.1	29.2	24.2	25.5	27.1	27.7	40.6	28.1	20.4	34.1	21.4	25.6	28.0	26.8	29.8	29.7	39.4	27.9	33.7	35.7	26.7	22.0	25.0	3.5	19.1	16.6	26.0	14.0	39.6	17.2	16.9	13.7	16.6	16.4	28.8	17.1	19.6	36.5	34.2	25.9	25.6	20.4	6.7	23.1	25.9	24.2	19.7	41.1	28.8	17.3	18.7	12.8	14.7	14.1	21.2	12.0	15.8	18.7	21.6	17.9	28.0	18.0	4.6	19.9	14.2	17.2	14.7	74.0	10.5	19.1	32.8	12.3	22.2	28.6	7.4	18.8	20.7	13.3	17.0	5.4	16.1	12.5	14.7	35.8	9.4	25.6	6.5	11.8	37.0	15.7	11.1	16.9	3.3	14.4	3.5	21.8	19.1	26.0	22.0	19.4	20.1	25.0	21.2	25.8	24.2	1.7	16.6	18.2	14.7	18.7	14.0	19.9	25.6	27.4	26.9	20.0	19.4	28.2	19.9	25.1	29.8
DDX5	"G17P1, HLR1, p68"	ENSG00000108654	"DEAD-box helicase 5"	P17844	17	64499616-64508199	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005868, HPA020043"	Supported		Enhanced	Nucleoplasm			150000	Nucleoplasm		"CAB005868: AB_446484, HPA020043: AB_1847572"	"unprognostic (6.64e-2)"	"unprognostic (6.98e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.94e-2)"	"unprognostic (5.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.28e-3)"	91.6	61.4	46.9	80.0	68.0	108.3	94.7	61.6	58.9	81.6	81.1	53.3	104.2	27.4	106.7	94.5	64.5	96.9	101.4	53.9	48.5	30.6	53.1	68.0	84.8	70.9	62.8	44.1	74.0	49.3	88.9	110.5	56.6	73.1	59.5	55.4	50.9	62.2	103.6	77.6	59.7	54.7	113.1	71.0	67.6	69.0	39.7	57.8	82.1	81.1	77.7	69.3	91.0	63.9	46.9	59.6	66.4	66.2	40.3	60.8	109.8	54.0	20.4	61.8	39.1	57.2	53.9	39.3	53.6	69.2	65.7	65.9	22.1	33.1	79.3	30.7	70.4	32.2	66.5	61.7	74.4	28.1	47.7	51.6	15.5	16.9	41.9	65.6	55.0	60.7	53.3	60.1	46.9	70.2	40.8	67.8	50.6	32.2	137.1	19.1	36.0	63.0	85.9	65.2	55.8	40.3	25.9	43.4	72.9	52.0	50.5	65.3	47.3	36.9	49.3	40.0	44.7	43.1	55.5	37.9	74.6	140.0	42.4	32.3	47.1	66.4	62.5	66.4	53.7	56.9	60.8	46.9	42.9	51.7	59.6	46.8	44.5	43.1	37.8	40.3	66.2	37.0	50.2	109.8	46.9	68.0	61.6	58.9	48.5	30.6	62.8	44.1	73.1	57.8
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli				Nucleoli		"HPA037388: AB_10671752, HPA037389: , HPA058196: "	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.7	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	17.4	21.5	15.2	23.4	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	15.0	24.1	15.4	23.0	15.5	26.8	27.0	12.9	28.1	23.3	25.3	4.5	14.7	11.6	15.5	21.4	15.2	17.8	22.8	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3
DDX54	"APR-5, DP97, MGC2835"	ENSG00000123064	"DEAD-box helicase 54"	Q8TDD1	12	113157174-113185479	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028244, HPA070786"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli, Golgi apparatus"		"HPA028244: AB_10603885, HPA070786: "	"unprognostic (1.61e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-1)"	17.2	17.6	9.2	20.7	12.8	25.4	17.2	9.9	13.6	17.9	16.4	12.4	18.1	20.3	18.0	19.4	19.5	17.2	17.9	20.1	8.8	7.9	22.3	28.6	14.0	19.9	8.1	9.4	22.4	27.0	18.3	7.4	22.6	10.0	16.6	9.0	13.4	17.4	13.9	45.4	18.7	19.4	14.8	8.1	22.2	16.1	11.4	8.6	26.6	23.1	21.6	22.2	16.7	17.5	12.1	13.3	8.0	15.2	11.9	13.0	10.0	26.4	27.7	10.3	19.0	6.9	8.3	26.7	14.4	13.4	19.7	10.8	28.5	12.9	34.3	16.9	12.0	19.7	18.3	18.7	7.5	19.7	22.5	20.6	14.9	19.4	12.2	34.3	24.4	13.7	14.8	19.0	11.8	16.1	29.8	12.3	10.1	24.5	29.5	49.0	24.1	19.7	21.9	15.3	35.0	10.7	27.7	13.4	12.2	20.4	31.3	13.0	26.8	26.9	11.9	16.7	18.7	19.8	30.0	18.0	20.5	38.6	14.7	19.2	17.5	8.0	10.0	2.3	12.4	15.2	13.0	11.6	11.4	12.2	13.3	12.1	11.8	12.5	0.6	11.9	9.8	10.0	9.4	10.0	9.2	12.8	9.9	13.6	8.8	7.9	8.1	9.4	10.0	8.6
DDX6	"HLR2, RCK"	ENSG00000110367	"DEAD-box helicase 6"	P26196	11	118747766-118791149	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004668, HPA024201, HPA026644"	Approved		Supported	"Cytosol,Cytoplasmic bodies"				"Cytoplasmic bodies"	Cytosol	"CAB004668: AB_436960, HPA024201: AB_10603562, HPA026644: AB_1847582"	"unprognostic (1.26e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.82e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (3.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.58e-2)"	"unprognostic (4.55e-2)"	29.8	23.0	25.0	24.1	41.0	43.3	25.1	41.9	39.2	26.9	23.2	29.4	14.5	17.1	30.1	22.9	31.8	23.4	17.5	26.8	25.5	25.1	22.8	24.6	23.4	32.2	21.9	27.1	38.2	27.9	30.9	43.2	26.1	29.6	24.9	20.8	25.4	26.8	22.9	43.8	23.9	24.1	27.8	30.4	30.6	21.2	19.9	24.0	46.0	27.9	19.4	42.8	33.0	25.7	12.2	6.5	17.8	10.3	7.2	12.6	5.7	11.7	16.0	25.8	25.4	22.6	23.3	16.9	15.9	20.9	14.8	14.1	23.3	18.1	26.9	16.7	26.0	18.8	30.1	23.2	23.9	20.2	6.0	51.8	10.3	18.9	15.0	37.1	20.0	24.6	17.1	21.9	35.7	23.6	23.8	39.1	20.9	32.0	27.0	17.2	18.3	11.8	29.8	20.8	21.5	17.3	30.4	17.1	23.6	30.0	24.1	9.5	28.2	14.6	26.9	24.6	13.5	14.0	16.0	12.2	15.8	32.1	9.8	17.9	21.0	10.5	4.1	11.6	10.1	5.7	12.6	11.4	9.9	10.4	4.7	12.2	12.4	10.8	17.8	7.2	10.3	6.5	8.9	5.7	25.0	41.0	41.9	39.2	25.5	25.1	21.9	27.1	29.6	24.0
DECR1	"DECR, SDR18C1"	ENSG00000104325	"2,4-dienoyl-CoA reductase 1"	Q16698	8	90001405-90052092	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 120.2"	"Cell line enriched"	"Detected in many"	4	"SK-BR-3: 129.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023160, HPA023162, HPA023238"	Enhanced		Supported	Mitochondria,Cytosol			740000	Mitochondria	Cytosol	"HPA023160: AB_1847585, HPA023162: AB_1847586, HPA023238: AB_1847587"	"prognostic unfavourable (1.49e-4)"	"unprognostic (5.76e-3)"	"unprognostic (8.37e-3)"	"unprognostic (6.13e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.79e-7)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (6.06e-4)"	26.9	45.7	13.2	18.1	17.6	9.2	15.6	10.3	14.5	13.0	29.0	10.4	11.8	32.4	11.9	13.7	16.2	8.5	12.6	70.0	15.4	9.0	44.8	120.2	12.9	14.0	12.5	12.8	12.7	14.4	22.2	16.8	5.8	13.6	11.0	22.9	9.5	15.7	9.9	37.9	12.5	42.7	11.5	11.9	20.1	12.7	17.0	14.5	20.3	15.0	32.1	15.3	11.6	10.6	23.4	52.3	37.2	42.8	19.8	31.3	27.8	10.3	5.9	17.4	19.7	12.2	19.9	3.7	9.1	15.7	5.9	9.3	2.3	10.3	7.9	7.2	10.9	7.8	6.4	9.2	9.9	11.9	0.7	19.0	5.3	9.4	15.3	4.1	3.9	15.7	7.1	4.7	8.0	17.7	19.7	15.7	28.5	11.9	11.8	6.1	1.1	17.8	10.0	4.6	14.1	29.2	26.0	0.7	6.6	13.8	129.9	10.9	16.6	10.7	15.9	10.1	4.8	13.3	5.4	7.9	6.0	9.3	9.6	9.4	12.8	15.0	31.5	10.2	21.4	42.8	22.6	23.4	20.1	21.8	52.3	19.2	21.3	21.0	37.2	19.8	37.2	20.4	31.3	27.8	13.2	17.6	10.3	14.5	15.4	9.0	12.5	12.8	13.6	14.5
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 825.5"	"Cell line enriched"	"Detected in single"	17	"NB-4: 6.6"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"CAB032548, HPA052517"	Enhanced				"Intracellular and membrane"					"CAB032548: AB_2277258, HPA052517: "																		1.3	0.1	0.2	0.1	0.6	825.5	0.6	0.0	0.4	0.1	0.1			0.1	0.4	0.1	0.1	0.1	0.1	2.3	0.2	0.2	0.2	6.0	41.9	0.3	0.3		0.1	0.1	0.1	1.0	0.6		0.1	0.1		0.6	0.1	0.5	1.8	0.1	0.1	0.0	115.5	0.1	0.1			0.6		0.1	0.1	0.0	0.1	0.3	0.5	0.7	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.3	0.0										
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"bone marrow: 734.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"											HPA052517	Supported				"Intracellular and membrane"					"HPA052517: "																		0.4	0.0	0.0	0.0	0.0	734.0	0.1	0.0	0.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	16.0	0.0	0.0		0.0	0.0	0.0	0.3	0.5		0.0	0.0		1.8	0.0	0.0	0.5	0.0	0.0	0.0	49.1	0.0	0.0			0.2		0.0	0.0	0.0	1.8	1.2	0.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.8	0.5	1.1	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0										
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	8	"BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"			Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favourable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	1.7	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924693-6926076	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"intestine: 316.3"	"Group enriched"	"Detected in some"	12	"BEWO: 12.5;NB-4: 13.1;RPMI-8226: 15.4;SH-SY5Y: 10.6;U-2197: 4.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"									HPA019462	Enhanced				"Secreted to digestive system"					"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	262.3	0.0	0.0	181.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	316.3	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.9	10.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223868-18264823	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015226, HPA054505, HPA057799"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB015226: , HPA054505: , HPA057799: "	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	30.9	20.0	22.9	41.8	29.5	50.8	28.9	41.5	30.2	31.0	35.8	11.4	24.0	28.2	32.9	19.7	31.0	23.8	19.2	33.5	26.8	14.1	19.3	23.8	29.2	42.7	30.7	17.6	28.3	19.3	20.5	27.8	24.3	27.7	33.9	29.9	11.0	26.8	21.4	40.2	23.2	35.9	51.3	28.1	29.8	24.2	12.6	32.9	58.8	44.9	33.9	38.4	45.1	43.3	40.0	40.2	57.7	49.3	34.0	46.3	35.0	59.7	17.6	46.7	38.9	9.4	16.4	27.1	55.1	30.5	49.8	67.5	28.8	22.5	68.1	58.5	24.8	35.9	34.5	27.3	83.8	45.8	33.0	42.1	31.7	33.6	9.2	64.1	34.3	8.1	13.6	34.3	27.1	23.8	51.1	0.0	31.7	21.5	46.2	28.8	28.6	19.7	61.6	62.0	39.9	24.0	34.6	28.6	26.3	49.7	43.2	30.1	38.9	26.4	24.1	58.4	32.4	32.5	68.6	4.2	10.0	71.8	13.9	32.7	54.0	51.1	49.3	21.9	41.4	39.3	46.3	40.0	42.1	42.5	40.2	33.2	33.5	32.0	57.7	34.0	43.9	31.0	40.6	35.0	22.9	29.5	41.5	30.2	26.8	14.1	30.7	17.6	27.7	32.9
DENND1A	"FAM31A, FLJ21129, KIAA1608"	ENSG00000119522	"DENN domain containing 1A"	Q8TEH3	9	123379654-123930152	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.4;granulocytes: 11.2;monocytes: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020481			Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA020481: AB_2092106"	"unprognostic (1.35e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (5.63e-2)"	"prognostic favourable (4.11e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.31e-2)"	11.4	12.2	17.4	13.9	19.8	32.5	10.0	18.6	21.2	10.9	14.8	12.8	10.3	15.8	13.3	9.0	11.3	13.0	10.5	10.3	15.9	12.8	16.4	14.5	9.4	11.6	11.8	14.9	12.0	8.9	20.1	19.0	23.9	13.9	11.0	14.1	14.5	8.5	11.8	11.0	9.3	17.2	14.4	10.1	20.2	9.9	12.1	13.2	10.6	15.5	5.6	9.5	10.6	17.4	1.5	8.4	11.2	15.2	0.5	1.3	3.2	14.7	8.7	7.9	14.9	5.4	8.5	36.6	14.4	21.7	12.3	10.6	11.9	6.6	11.9	3.0	11.6	8.4	6.7	10.4	12.0	5.0	5.1	5.6	21.2	8.7	7.2	6.7	3.8	7.8	9.4	10.1	17.4	10.9	15.3	9.1	9.9	8.4	8.0	9.7	15.7	13.3	12.4	7.7	10.1	6.1	5.2	16.8	13.6	11.6	7.7	8.9	10.5	17.0	5.0	13.3	5.1	15.4	7.5	14.0	10.8	8.2	11.1	13.4	8.7	11.2	15.2	2.8	1.3	10.1	0.7	1.1	0.9	0.6	8.4	1.5	0.6	0.7	9.3	0.5	8.2	1.3	0.4	3.2	17.4	19.8	18.6	21.2	15.9	12.8	11.8	14.9	13.9	13.2
DENR	"DRP, DRP1, SMAP-3"	ENSG00000139726	"Density regulated re-initiation and release factor"	O43583	12	122752774-122771064	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021783	Approved		Approved	Cytosol			120000	Cytosol		"HPA021783: "	"unprognostic (3.65e-2)"	"unprognostic (7.00e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (6.62e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (2.23e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.02e-3)"	"prognostic unfavourable (8.57e-6)"	"unprognostic (1.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.35e-1)"	19.5	23.2	23.3	28.3	23.8	19.3	27.1	21.7	36.8	19.1	20.8	12.0	24.8	20.9	20.8	23.6	33.6	17.8	23.1	20.1	22.5	26.1	22.4	26.2	16.8	28.6	24.9	30.3	19.2	21.6	56.5	23.7	27.9	23.2	23.6	21.2	13.2	24.5	24.9	42.5	23.1	21.8	30.4	16.4	24.5	19.0	11.7	14.8	35.5	24.0	28.4	26.9	22.6	22.2	15.5	15.5	57.7	20.8	14.8	17.7	13.7	34.0	19.3	24.6	24.9	15.4	23.0	21.3	31.1	17.2	27.3	19.0	26.7	12.7	30.5	33.0	21.9	26.1	28.7	27.2	36.9	27.5	20.6	37.3	11.4	19.0	20.2	41.8	31.0	19.9	27.0	25.0	33.7	26.4	38.7	11.3	29.1	22.4	41.1	39.8	49.7	39.5	36.6	28.8	19.4	26.5	30.2	28.1	20.2	43.1	12.7	31.6	40.6	23.4	25.6	25.7	30.8	29.0	30.9	18.6	42.9	49.3	24.4	30.4	28.4	57.7	11.7	18.5	13.8	17.2	16.0	15.5	15.0	13.8	15.5	14.0	17.7	15.5	13.9	14.8	20.8	13.8	15.7	13.7	23.3	23.8	21.7	36.8	22.5	26.1	24.9	30.3	23.2	14.8
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013164-123042423	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 133.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavourable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	31.2	34.3	12.7	24.5	14.6	43.4	31.6	18.6	19.5	17.3	23.9	16.6	21.4	22.9	21.3	17.0	23.4	17.5	20.2	23.8	11.7	12.4	25.4	73.3	23.4	42.3	14.1	11.5	23.5	33.6	11.7	23.0	25.0	14.9	16.4	21.5	17.9	21.9	24.4	48.0	16.3	32.6	16.9	14.4	35.3	18.1	22.4	13.0	17.9	25.2	20.9	31.2	23.3	18.3	34.0	26.6	32.8	35.1	34.6	47.3	35.1	20.1	15.0	9.0	11.7	16.3	12.3	7.4	17.0	11.6	11.3	14.0	9.5	20.3	23.3	21.3	14.0	17.0	8.4	11.0	16.1	27.1	9.4	24.3	10.4	7.9	14.9	9.4	18.2	11.1	14.4	12.3	14.9	10.0	14.4	31.1	12.6	40.2	10.3	5.9	6.8	13.5	10.7	7.4	39.1	28.7	14.5	9.8	14.4	17.2	133.0	10.8	15.6	8.6	11.5	13.5	25.4	11.9	15.8	39.3	65.7	21.0	22.3	11.8	12.6	27.3	28.8	32.8	45.1	35.1	47.3	34.0	30.6	37.1	23.4	26.2	21.6	33.3	19.8	34.6	34.2	26.6	36.6	35.1	12.7	14.6	18.6	19.5	11.7	12.4	14.1	11.5	14.9	13.0
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;pancreas: 80.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 33.1;RPMI-8226: 19.4;U-266/70: 35.6;U-698: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 77.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles				Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favourable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favourable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	1.3	1.8	1.2	27.3	2.1	4.1	2.8	1.7	1.6	3.7	21.5	1.1	20.2	18.7	1.9	2.9	4.1	3.4	5.7	3.9	1.2	1.9	2.9	4.7	7.2	25.5	1.3	1.2	1.1	80.8	0.6	4.0	7.9	2.4	1.6	6.9	1.9	44.8	29.3	1.3	0.4	14.9	0.3	1.0	28.5	21.8	12.6	1.6	1.0	9.5	3.4	36.1	15.5	1.2	8.4	77.7	0.1	0.0	0.0	0.1	1.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.0	3.4	0.6	0.0	0.0	0.3	0.6	0.0	0.7	1.8	0.1	2.0	0.0	0.4	3.7	0.9	0.0	0.1	0.2	0.0	0.1	0.5	33.1	0.0	0.0	0.5	2.0	0.5	0.1	2.6	0.0	19.4	0.7	0.1	0.3	0.0	0.1	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.0	35.6	4.3	8.4	0.4	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	8.4	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.0	0.0	77.7	0.0	1.3	1.2	2.1	1.7	1.6	1.2	1.9	1.3	1.2	2.4	1.6
DES	"CMD1I, CSM1, CSM2"	ENSG00000175084	Desmin	P17661	2	219418377-219426739	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cancer-related genes, Cardiomyopathy, Desmin-related myopathy, Disease mutation, Limb-girdle muscular dystrophy, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 531.0;skeletal muscle: 600.8;smooth muscle: 439.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 17.6;LHCN-M2: 35.2;RH-30: 81.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 562.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 1.9;non-classical monocyte: 1.4"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 45.7"	"CAB000034, HPA018803"	Enhanced		Supported	"Intermediate filaments"			1300000	"Intermediate filaments"		"CAB000034: , HPA018803: AB_1847616"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.76e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.61e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.72e-2)"	"unprognostic (4.67e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-3)"	9.1	2.5	0.1	35.1	0.2	0.1	1.9	0.1	0.3	41.3	238.3	0.4	69.1	12.6	95.6	80.2	209.7	33.0	149.8	531.0	0.1	0.1	2.1	0.3	4.8	3.0	0.3	0.8	20.3	0.7	0.0	0.1	2.4	0.8	101.0	11.2	3.8	11.9	104.2	600.8	4.2	43.2	439.9	0.3	0.6	72.6	10.9	0.0	0.0	9.4	161.2	12.5	343.7	34.4	0.0	0.2	0.4	2.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.3	17.6	0.0	0.0	0.0	0.0	0.6	0.0	35.2	0.0	0.0	9.2	0.1	0.0	0.0	81.8	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.7	0.1	0.2	0.1	0.3	0.1	0.1	0.3	0.8	0.8	0.0
DFFA	"DFF-45, DFF1, DFF45, ICAD"	ENSG00000160049	"DNA fragmentation factor subunit alpha"	O00273	1	10456522-10472526	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002679, HPA018859, HPA019938, HPA025230"	Supported		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623"	"unprognostic (1.23e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (9.46e-4)"	"unprognostic (1.55e-1)"	"unprognostic (9.24e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.57e-9)"	"unprognostic (1.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.88e-1)"	17.8	19.9	22.9	15.6	23.0	7.9	20.9	20.4	20.7	16.6	15.1	22.5	19.1	16.5	18.4	14.4	24.2	18.6	15.3	17.2	20.7	19.9	23.7	18.9	15.5	15.6	26.4	18.9	22.5	19.8	25.7	17.2	27.2	26.1	17.0	17.3	15.0	16.3	18.4	16.8	14.8	14.7	22.4	24.1	14.8	16.8	13.4	21.9	16.7	18.0	13.0	21.4	18.7	26.1	14.1	10.7	7.2	9.9	14.1	14.4	8.9	14.3	14.4	12.4	14.1	10.5	10.0	6.0	20.6	13.3	21.5	16.0	34.3	19.1	30.8	13.3	17.3	11.9	23.9	24.4	21.8	12.2	16.5	15.3	14.9	13.7	17.2	18.7	10.2	12.5	12.3	33.8	27.3	16.3	27.4	7.0	15.2	18.3	18.4	8.5	10.9	16.8	15.9	14.8	15.5	19.3	11.1	14.7	14.3	19.1	16.8	22.6	10.7	6.5	17.0	10.1	13.8	18.5	13.5	8.7	12.1	44.9	10.7	17.8	15.2	1.3	9.9	7.2	14.4	8.0	10.9	14.1	9.7	12.4	9.2	13.7	10.2	12.3	1.5	14.1	9.7	10.7	13.5	8.9	22.9	23.0	20.4	20.7	20.7	19.9	26.4	18.9	26.1	21.9
DGCR8	"C22orf12, DGCRK6, Gy1, pasha"	ENSG00000128191	"DGCR8, microprocessor complex subunit"	Q8WYQ5	22	20080232-20111877	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.34e-2)"	"unprognostic (2.75e-3)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.34e-1)"	"unprognostic (5.72e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.62e-2)"	"prognostic unfavourable (5.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.26e-2)"	7.9	7.8	9.9	10.3	10.1	10.1	9.4	29.8	14.1	9.7	10.3	11.8	13.4	7.6	14.5	8.1	11.7	11.5	10.5	7.8	10.0	6.9	7.9	7.9	8.1	8.9	10.6	9.7	13.9	15.2	11.6	16.8	17.9	10.4	9.5	7.9	11.3	10.5	10.3	19.9	11.3	10.1	12.6	7.4	10.3	10.0	22.4	10.9	11.1	9.8	11.9	9.0	11.5	12.6	1.7	3.3	1.2	6.8	3.2	4.6	2.7	11.9	8.5	11.0	6.5	4.3	7.0	14.1	11.5	6.9	7.8	5.5	9.0	6.1	10.6	6.4	10.7	11.5	10.0	9.6	6.8	10.4	14.8	11.6	8.9	7.3	11.5	21.3	9.6	5.6	12.0	8.2	6.0	6.8	40.9	7.7	9.0	7.6	12.8	6.3	10.7	6.4	15.3	11.6	3.6	4.7	11.2	12.3	7.9	10.5	6.2	6.7	5.9	9.2	10.1	11.4	9.6	7.1	11.6	4.3	5.9	10.7	8.5	9.7	11.0	0.0	2.1	1.2	4.5	1.9	3.5	1.7	2.2	4.6	2.9	1.5	2.3	2.6	0.4	3.2	6.8	3.3	2.7	2.7	9.9	10.1	29.8	14.1	10.0	6.9	10.6	9.7	10.4	10.9
DGKB	"DAGK2, DGK, DGK-BETA, KIAA0718"	ENSG00000136267	"Diacylglycerol kinase beta"	Q9Y6T7	7	14145049-14974777	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;fHDF/TERT166: 5.5;hTEC/SVTERT24-B: 2.1;SCLC-21H: 2.8;SH-SY5Y: 2.1;U-266/70: 7.4"	"Cancer enriched"	"Detected in single"	11	"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020321		Supported								"HPA020321: "	"unprognostic (9.89e-2)"	"unprognostic (9.72e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.34e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.37e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-4)"	1.1	5.2	11.5	1.1	37.7	0.8	0.8	1.3	34.0	4.9	1.6	1.4	0.0	0.9	6.1	0.9	1.6	2.7	1.3	1.4	10.5	4.3	2.6	1.1	0.8	0.8	2.2	11.3	0.8	0.9	0.8	1.8	0.7	4.8	1.1	1.7	0.0	0.9	0.9	1.2	0.9	1.2	3.1	3.5	0.8	0.8	0.9	7.9	0.0	0.9	0.0	0.8	1.5	0.6	0.7	0.6	1.3	0.3	0.6	0.5	0.1	0.1	0.0	2.7	0.1	0.0	0.2	0.1	0.0	1.2	0.0	0.3	0.2	0.0	0.1	0.0	5.5	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	2.8	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.1	0.7	0.3	0.3	0.5	0.2	0.4	0.3	0.5	0.2	0.1	0.7	0.5	0.4	1.3	0.6	0.2	0.6	0.2	0.1	11.5	37.7	1.3	19.1	10.5	4.3	2.2	11.3	4.8	7.9
DGKD	"DGKdelta, KIAA0145"	ENSG00000077044	"Diacylglycerol kinase delta"	Q16760	2	233354507-233472104	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 22.1;U-698: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027530, HPA049101"	Approved		Supported	Cytosol				Cytosol		"HPA027530: , HPA049101: "	"unprognostic (1.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.69e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (1.69e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.03e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (4.07e-8)"	"unprognostic (1.78e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.94e-3)"	5.9	3.6	10.0	10.9	12.4	26.3	5.3	34.3	7.9	3.7	7.8	8.9	12.4	8.1	5.8	12.6	2.7	5.5	8.0	6.4	9.6	4.3	3.1	3.3	9.3	14.0	11.7	4.3	8.6	3.0	2.3	3.7	8.9	7.2	6.0	8.4	6.2	4.9	8.0	25.4	2.9	10.9	7.3	11.1	10.3	19.4	17.4	8.3	4.5	7.6	1.3	13.5	5.6	10.1	6.6	1.0	5.9	2.0	1.8	3.4	2.5	3.2	8.0	4.7	3.0	2.2	2.2	7.2	1.9	1.7	1.8	1.9	13.8	3.2	5.8	1.0	3.0	3.2	5.1	2.3	3.0	8.7	4.8	8.1	22.1	4.7	2.8	7.0	8.8	3.1	4.9	2.3	4.4	2.0	5.7	1.3	1.9	3.1	5.7	7.3	2.5	4.5	11.4	8.7	4.7	1.4	3.8	7.2	5.2	6.5	3.5	3.4	1.5	12.5	1.9	3.9	7.2	2.3	5.8	4.7	2.9	22.4	3.4	10.9	3.0	1.7	2.0	5.9	3.3	0.8	1.6	6.3	1.0	2.9	1.0	6.6	2.3	3.4	2.0	1.8	1.4	0.6	0.5	2.5	10.0	12.4	34.3	7.9	9.6	4.3	11.7	4.3	7.2	8.3
DGKG	DAGK3	ENSG00000058866	"Diacylglycerol kinase gamma"	P49619	3	186105668-186362237	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 19.8;HL-60: 6.3;U-266/84: 7.5;U-87 MG: 12.5;U-937: 5.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036577	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA036577: AB_10672358"	"unprognostic (2.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.24e-5)"	"unprognostic (2.70e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.21e-3)"	"unprognostic (3.80e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.05e-7)"	"unprognostic (3.47e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.16e-3)"	3.1	6.9	13.4	3.1	7.1	14.5	1.9	53.4	23.1	2.7	3.5	6.2	1.1	3.0	1.9	14.6	8.5	7.7	2.2	15.0	15.3	7.4	3.1	2.1	4.3	2.1	7.4	11.3	2.0	1.6	4.7	7.5	13.5	25.2	3.1	2.1	7.8	1.9	4.0	2.4	1.4	2.7	5.3	5.6	2.0	3.3	1.2	7.1	0.0	2.5	0.0	2.1	4.8	2.4	0.6	2.9	5.3	4.2	0.0	0.0	1.3	2.6	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	2.3	0.0	0.2	0.0	0.0	0.0	19.8	0.0	2.6	0.0	2.9	0.0	6.3	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.1	0.1	2.2	0.4	1.2	1.4	0.0	2.2	0.0	0.0	0.5	0.0	0.8	0.0	1.6	0.1	4.1	0.0	0.0	0.7	2.0	2.4	0.0	7.5	0.0	12.5	5.9	2.3	0.0	4.2	2.4	0.0	2.4	0.0	0.6	0.0	0.0	2.9	0.3	0.0	0.0	5.3	0.0	2.8	0.5	0.0	1.3	13.4	7.1	53.4	14.7	15.3	7.4	7.4	11.3	25.2	7.1
DGKQ	"DAGK, DAGK4, DAGK7"	ENSG00000145214	"Diacylglycerol kinase theta"	P52824	4	958887-986895	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026797, CAB033835"	Uncertain									"CAB033835: AB_2091307, HPA026797: AB_10600902"	"unprognostic (7.39e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-3)"	6.4	9.3	15.9	10.7	13.8	10.4	6.9	21.6	17.4	5.4	14.7	7.9	6.9	27.0	6.3	3.8	7.9	5.3	10.3	4.5	15.0	12.1	8.4	8.9	6.9	12.3	9.7	12.3	5.1	9.8	5.5	8.2	4.4	10.2	7.0	8.4	6.7	12.1	5.8	3.7	13.0	28.0	5.9	5.2	12.7	8.6	6.8	7.7	9.1	6.7	3.8	8.7	6.6	7.0	1.3	1.9	4.0	1.4	5.3	5.0	1.8	4.2	6.8	3.0	10.1	3.6	3.0	11.2	8.1	4.6	4.6	4.6	4.9	8.4	5.7	6.8	5.1	4.9	1.7	5.6	1.1	4.4	5.3	8.7	6.3	8.5	6.3	3.7	11.7	5.7	9.6	3.8	1.8	5.6	6.6	0.7	3.5	6.3	7.7	21.7	5.3	11.7	12.5	0.9	0.6	5.0	5.9	1.9	5.1	2.8	3.2	8.4	7.5	9.2	8.1	8.0	3.8	9.0	5.3	15.6	6.6	4.3	6.9	8.1	7.2	4.0	1.4	2.9	5.0	1.1	2.3	1.1	1.8	4.1	0.9	1.3	1.9	3.4	0.9	5.3	1.1	1.9	1.1	1.8	15.9	13.8	21.6	17.4	15.0	12.1	9.7	12.3	10.2	7.7
DGKZ	"DAGK5, DAGK6, DGK-ZETA, hDGKzeta"	ENSG00000149091	"Diacylglycerol kinase zeta"	Q13574	11	46332905-46380554	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051336	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA051336: "	"unprognostic (2.85e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.66e-3)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.48e-3)"	"unprognostic (7.75e-2)"	"unprognostic (3.61e-2)"	"unprognostic (7.84e-3)"	8.6	6.7	34.5	11.8	27.4	28.0	6.8	22.6	50.7	7.5	7.4	8.5	2.5	21.0	6.1	4.3	7.1	6.3	6.7	16.0	48.0	9.2	5.3	3.3	8.3	20.7	9.4	26.7	5.0	17.3	7.0	18.6	8.4	7.5	5.9	4.2	4.8	24.1	7.0	42.8	8.3	23.2	5.6	7.2	15.6	9.9	5.0	7.5	14.2	4.1	9.1	9.9	7.6	5.0	0.9	12.3	11.2	11.8	7.7	7.5	8.1	11.7	10.5	7.1	10.7	3.8	4.2	33.2	9.2	6.9	9.8	8.6	12.5	5.5	15.1	6.7	9.5	13.7	8.6	13.3	3.5	15.1	20.0	9.9	7.7	9.1	6.8	18.6	19.9	5.7	6.3	5.3	7.3	10.7	13.8	9.4	6.9	31.0	17.9	29.2	20.8	16.2	21.4	12.4	6.4	3.0	11.6	49.0	8.3	10.5	35.3	7.2	25.4	23.5	12.0	12.9	14.0	20.3	16.5	6.2	7.0	12.4	17.6	16.9	11.9	11.2	11.8	5.8	7.5	6.1	4.5	0.4	4.7	6.3	12.3	0.9	4.9	5.0	9.8	7.7	5.9	5.9	4.5	8.1	34.5	27.4	22.6	50.7	48.0	9.2	9.4	26.7	7.5	7.5
DHPS	MIG13	ENSG00000095059	"Deoxyhypusine synthase"	P49366	19	12675717-12681902	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Hypusine biosynthesis"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014461, HPA029413"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA014461: AB_1847651, HPA029413: AB_10602217"	"unprognostic (4.17e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.83e-2)"	16.4	30.3	26.9	18.6	31.2	17.0	24.8	43.3	38.8	20.7	25.7	27.5	25.3	23.1	20.9	16.9	21.3	32.3	18.2	26.0	26.3	28.0	23.4	30.3	18.9	24.2	27.5	28.0	34.8	32.0	28.8	32.6	23.2	22.4	24.1	24.5	20.2	24.8	24.6	65.1	25.6	21.5	24.5	29.1	19.5	24.2	13.3	26.3	31.9	24.9	22.9	26.9	23.5	19.2	39.6	29.5	35.8	30.5	27.8	38.1	29.7	20.7	15.3	24.9	13.2	11.2	18.5	5.8	13.3	19.6	25.5	25.7	10.9	10.1	21.5	15.1	14.5	12.6	17.0	18.9	17.6	18.8	12.0	14.3	16.7	14.3	13.8	17.1	22.9	14.9	23.3	15.4	26.6	17.8	13.0	15.3	18.6	41.2	30.5	24.8	19.5	26.1	20.3	9.3	31.0	19.6	11.2	32.4	44.0	13.4	19.5	22.6	18.1	28.7	8.9	30.0	12.2	29.3	20.2	48.9	52.7	14.6	18.4	21.1	28.3	14.5	27.0	35.8	24.7	24.2	25.9	39.6	28.9	25.6	29.0	36.9	38.1	28.1	9.7	27.8	30.5	29.5	34.3	29.7	26.9	31.2	43.3	38.8	26.3	28.0	27.5	28.0	22.4	26.3
DHTKD1	"CMT2Q, DKFZP762M115, KIAA1630, MGC3090"	ENSG00000181192	"Dehydrogenase E1 and transketolase domain containing 1"	Q96HY7	10	12068972-12123225	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.5"	"Cell line enhanced"	"Detected in all"		"T-47d: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037949, HPA037950, HPA066098"	Approved		Supported	Mitochondria				Mitochondria		"HPA037949: , HPA037950: AB_10673650, HPA066098: "	"unprognostic (3.76e-2)"	"unprognostic (8.08e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.04e-3)"	"unprognostic (3.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.02e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.43e-4)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.88e-3)"	5.7	6.3	6.5	4.7	6.6	2.2	5.0	5.7	7.2	5.5	5.7	9.8	5.0	4.5	4.7	5.0	5.1	4.2	4.5	7.7	5.3	4.8	23.8	69.5	4.2	6.9	7.5	5.2	7.1	16.6	5.4	4.1	4.7	6.2	7.6	6.3	7.2	9.7	7.1	10.5	3.6	4.3	3.5	6.1	5.1	6.1	4.4	6.6	10.1	6.8	6.7	8.0	5.2	4.1	9.5	12.5	16.8	11.0	10.2	4.1	3.3	11.2	8.7	13.0	10.3	8.1	4.8	15.7	5.7	3.7	10.2	9.1	5.5	6.7	8.1	1.9	3.5	16.1	13.6	4.4	11.7	4.5	6.1	4.4	3.4	4.2	7.9	1.7	1.7	5.9	3.5	5.9	2.4	5.5	6.9	6.6	2.7	21.8	5.9	3.2	7.2	2.0	10.1	4.2	6.8	6.6	2.7	3.4	15.3	11.2	20.1	6.7	44.2	6.4	2.4	3.3	2.4	6.9	4.1	5.9	4.1	5.2	4.3	3.1	5.5	16.8	4.8	10.7	3.2	6.8	3.4	9.5	2.5	2.1	8.6	7.8	2.5	3.3	14.0	10.2	11.0	12.5	4.1	3.3	6.5	6.6	5.7	7.2	5.3	4.8	7.5	5.2	6.2	6.6
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"			30000	"Nuclear speckles"		"HPA047047: "	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favourable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	29.6	29.1	48.3	23.9	23.7	23.2	28.8	34.6	30.5	36.6	36.4	29.5	36.0	54.5	21.4	28.3	24.9	62.0	41.6	57.0	20.0	29.4	47.3	31.9	23.8	14.0	48.7	32.7	19.4	25.1	35.6	24.1	30.5	44.3	22.1	41.4	22.4	63.8	32.6	52.5	26.5	42.1	56.7	25.5	43.6	42.7	41.5	26.0	26.8	25.9	24.3	28.3	25.3	27.8	31.0	20.4	23.4	40.3	16.7	28.1	65.2	20.8	39.8	36.9	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9
DHX29	DDX29	ENSG00000067248	"DExH-box helicase 29"	Q7Z478	5	55256245-55307722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038317, HPA038318"	Approved		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA038317: AB_10673169, HPA038318: AB_10672589"	"unprognostic (3.43e-2)"	"unprognostic (5.09e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.57e-3)"	"unprognostic (4.01e-1)"	"unprognostic (3.85e-1)"	"unprognostic (4.78e-3)"	"unprognostic (9.40e-2)"	14.6	16.2	15.1	12.2	16.6	9.8	16.3	22.0	16.9	17.3	18.4	9.2	20.2	11.3	17.4	12.8	18.5	13.6	11.7	22.1	12.8	9.6	22.4	20.6	15.2	11.8	13.7	11.9	13.8	15.3	30.3	30.7	17.7	16.3	18.9	13.3	7.8	15.2	24.3	31.8	15.9	14.7	18.5	13.1	14.3	14.8	10.2	16.6	15.6	20.9	12.0	11.9	19.9	14.4	18.5	25.9	32.4	19.6	16.0	18.8	6.3	22.2	15.7	13.1	17.3	21.6	18.2	16.1	23.8	18.8	17.5	18.2	12.8	14.6	13.0	21.7	26.7	16.5	20.6	23.1	25.2	5.3	11.6	12.0	14.6	8.9	12.4	8.0	12.8	15.9	14.3	18.7	11.3	23.0	14.6	10.0	20.9	15.4	14.0	8.0	11.1	17.6	6.8	20.6	21.5	15.2	15.4	12.2	8.3	23.6	13.0	11.8	18.4	14.8	20.1	16.1	13.6	14.4	17.3	9.6	14.4	17.7	19.8	13.9	18.1	32.4	16.3	15.9	13.5	16.4	15.1	18.5	16.9	15.0	12.1	17.6	18.8	15.8	15.2	16.0	19.6	25.9	13.9	6.3	15.1	16.6	22.0	16.9	12.8	9.6	13.7	11.9	16.3	16.6
DHX35	"C20orf15, DDX35, FLJ22759, KAIA0875"	ENSG00000101452	"DEAH-box helicase 35"	Q9H5Z1	20	38962299-39039723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054451, HPA062700"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Centrosome"				"Nuclear bodies"	"Nucleoplasm, Centrosome"	"HPA054451: , HPA062700: "	"unprognostic (8.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (1.29e-2)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (5.63e-6)"	"unprognostic (9.83e-2)"	"unprognostic (2.21e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.47e-2)"	"unprognostic (5.67e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.31e-1)"	10.4	7.3	9.7	6.9	14.6	13.9	9.8	9.7	14.3	12.2	23.2	14.8	10.7	9.9	19.7	13.9	13.9	12.5	9.2	16.9	9.0	5.8	10.4	7.5	8.7	12.6	8.2	6.7	13.9	6.5	12.1	13.5	8.4	10.9	13.3	14.3	12.4	10.4	12.6	12.5	11.1	12.4	14.7	9.9	8.4	13.4	12.5	9.4	12.1	8.5	7.6	11.2	15.9	11.8	4.6	6.7	2.0	4.9	5.8	8.2	4.4	7.3	4.4	11.9	4.9	4.6	6.0	8.4	4.4	7.8	10.1	7.8	21.0	7.2	8.4	7.8	8.4	11.7	8.2	12.9	10.1	2.1	4.0	11.2	10.0	11.9	5.5	13.0	5.9	7.0	8.3	8.9	8.4	4.5	11.3	4.8	5.4	6.0	21.3	10.0	6.8	9.9	10.4	17.4	6.8	3.7	8.4	10.5	8.2	12.1	7.3	11.1	9.9	10.8	4.4	14.6	8.0	5.7	9.1	4.8	6.4	8.8	8.6	5.9	7.6	0.0	4.9	2.0	5.3	4.5	5.2	4.6	4.5	5.6	6.7	4.3	8.2	4.3	1.0	5.8	3.8	2.4	2.8	4.4	9.7	14.6	9.7	14.3	9.0	5.8	8.2	6.7	10.9	9.4
DHX38	"DDX38, hPrp16, KIAA0224, PRP16, PRPF16"	ENSG00000140829	"DEAH-box helicase 38"	Q92620	16	72093562-72112912	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041347, HPA041604"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA041347: AB_10796571, HPA041604: "	"unprognostic (2.38e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.32e-3)"	"unprognostic (8.50e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-2)"	21.8	16.5	21.1	22.2	25.0	35.1	20.5	36.0	29.4	18.6	19.5	23.5	19.4	20.1	24.1	13.5	21.1	19.9	18.1	19.2	24.1	13.7	17.3	20.8	20.6	26.1	24.1	20.7	29.0	17.3	36.6	18.7	19.3	20.9	18.3	17.2	17.9	20.4	16.4	33.0	27.2	23.0	23.5	22.5	27.3	19.4	17.5	27.8	24.6	20.8	23.2	23.1	20.5	21.4	10.4	8.1	8.3	10.6	11.8	14.9	6.3	14.4	21.5	15.7	8.7	13.7	10.6	20.6	13.1	12.8	19.6	15.1	26.1	14.5	19.3	11.8	19.7	19.1	18.1	18.0	15.2	9.6	19.5	14.8	18.3	35.5	12.7	17.4	26.9	14.7	16.6	26.4	19.1	16.9	21.9	9.2	12.0	44.6	16.6	19.7	19.7	12.4	21.5	10.8	19.1	9.4	13.8	14.1	15.5	16.8	8.0	9.3	14.6	14.5	19.1	18.9	16.8	13.7	14.3	22.7	17.9	37.1	17.8	12.1	14.7	7.4	7.9	8.3	14.9	10.6	13.7	10.4	9.3	10.7	8.1	8.2	10.4	10.8	8.2	11.8	6.6	7.4	10.9	6.3	21.1	25.0	36.0	29.4	24.1	13.7	24.1	20.7	20.9	27.8
DHX8	"DDX8, Dhr2, HRH1, PRP22, PRPF22"	ENSG00000067596	"DEAH-box helicase 8"	Q14562	17	43483865-43544463	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049285	Approved		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	"Nuclear bodies"	"HPA049285: "	"unprognostic (2.99e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.28e-2)"	21.9	18.6	17.5	17.0	22.9	47.8	22.3	21.6	29.8	20.3	21.0	25.3	17.2	17.1	26.1	28.4	26.6	17.9	16.7	18.5	18.1	18.7	18.5	20.1	19.8	21.0	20.8	19.7	19.5	17.4	35.4	23.0	21.7	22.7	22.1	24.6	20.1	21.7	21.7	25.2	32.9	22.0	24.6	19.2	27.3	19.5	34.6	20.6	40.8	20.5	17.8	28.9	19.4	22.6	11.5	16.3	23.3	20.4	9.5	14.9	9.8	12.3	35.1	19.1	23.7	19.0	19.5	10.6	13.0	27.5	28.8	27.7	16.0	12.6	17.1	12.1	25.5	16.8	28.6	22.9	33.8	17.9	22.6	14.5	26.8	24.7	16.3	25.1	22.0	9.7	19.4	23.6	26.0	25.4	16.1	16.9	22.2	13.4	31.8	22.4	15.5	13.4	19.4	36.4	17.6	19.5	25.9	16.5	24.9	14.6	8.4	11.7	19.5	24.8	17.3	22.4	12.2	16.1	19.4	12.7	15.1	19.4	18.6	15.7	17.9	23.3	15.2	17.2	13.7	20.4	13.6	11.5	11.4	14.9	16.3	10.6	11.2	10.9	19.2	9.5	19.6	8.4	11.7	9.8	17.5	22.9	21.6	29.8	18.1	18.7	20.8	19.7	22.7	20.6
DHX9	"DDX9, LKP, RHA"	ENSG00000135829	"DExH-box helicase 9"	Q08211	1	182839369-182887751	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA replication, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, mRNA processing, mRNA splicing, mRNA transport, RNA-mediated gene silencing, Transcription, Transcription regulation, Transcription termination, Translation regulation, Transport"	"Activator, DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011819, HPA028050"	Supported		Supported	Nucleoplasm			97000	Nucleoplasm		"CAB011819: AB_777725, HPA028050: AB_10603564"	"unprognostic (8.14e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (9.98e-2)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.53e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.99e-1)"	30.2	25.9	25.7	28.5	28.6	68.9	32.9	42.5	33.1	31.9	24.5	23.3	25.2	19.8	38.2	24.2	27.7	30.6	19.7	22.9	24.4	22.6	36.2	31.4	27.8	32.0	34.2	23.1	37.5	24.9	51.8	35.8	28.5	28.0	25.7	30.1	21.1	28.2	29.4	27.6	26.6	27.0	31.6	25.3	32.8	26.5	29.4	37.4	68.3	30.1	31.6	41.2	32.4	31.9	16.8	22.9	12.0	17.4	14.7	21.9	15.0	35.1	34.5	49.5	27.2	25.9	20.1	48.9	31.2	28.6	45.4	30.8	38.5	27.2	56.5	30.5	28.0	30.5	75.1	33.8	50.8	22.9	37.3	37.6	28.2	26.0	14.6	54.4	25.8	17.9	17.0	44.5	12.1	35.4	59.0	20.3	36.3	30.9	55.0	13.4	62.7	21.3	50.2	46.2	32.3	29.3	40.9	35.7	41.0	44.2	28.0	18.2	32.7	30.8	27.6	28.2	31.5	28.6	42.2	21.3	34.8	67.1	17.7	29.9	38.2	5.6	16.0	12.0	19.2	17.4	21.9	16.8	16.8	17.6	22.9	14.6	18.4	19.9	6.5	14.7	14.3	11.1	15.4	15.0	25.7	28.6	42.5	33.1	24.4	22.6	34.2	23.1	28.0	37.4
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122226568	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria			21000	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	17.2	29.7	21.9	15.5	24.0	26.7	24.8	21.9	30.1	20.4	25.9	29.0	14.3	20.6	22.2	36.6	23.5	21.8	19.2	20.3	21.2	26.8	31.7	37.2	15.8	20.9	28.3	23.6	22.4	32.6	22.9	30.6	28.5	27.0	21.1	24.2	22.4	22.2	20.2	25.8	18.2	21.3	21.8	29.2	18.5	19.8	62.7	21.8	23.2	26.9	23.0	22.8	20.5	17.9	32.8	35.0	27.5	29.1	29.9	32.1	26.8	19.0	37.8	26.7	18.1	19.2	18.8	20.5	19.8	19.5	23.3	21.0	32.6	10.0	23.3	18.7	17.9	19.0	29.0	23.7	27.7	20.1	22.7	25.5	15.6	29.9	27.4	27.4	10.6	26.0	16.9	27.5	41.3	26.9	29.2	9.9	22.6	28.4	22.4	40.3	21.5	35.5	20.4	26.6	25.6	26.3	29.7	25.3	25.8	26.5	10.6	21.5	35.8	19.3	18.3	18.0	22.2	20.4	17.8	21.6	36.1	33.4	23.0	21.1	23.6	23.6	28.9	27.5	30.4	29.1	29.1	32.8	28.4	28.4	35.0	26.0	27.9	28.2	12.7	29.9	26.5	26.8	32.1	26.8	21.9	24.0	21.9	30.1	21.2	26.8	28.3	23.6	27.0	21.8
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000284934	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207662-122227534	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 20.8"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001825	Uncertain		Approved	Mitochondria			21000	Mitochondria		"HPA001825: AB_1857247"																		0.1	8.7	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.2	5.3	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.9	2.4	0.0	1.2	0.6	1.1	0.6	0.6	2.3	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.1	0.7	0.0	0.4	1.8	20.8	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.5	0.3	1.4	0.6	1.0	0.3	1.0	2.3	0.6	1.2	0.3	1.3	1.1	0.6	0.2	0.4	2.2	0.5										
DIAPH1	"DFNA1, hDIA1, LFHL1"	ENSG00000131504	"Diaphanous related formin 1"	O60610	5	141515016-141619055	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	Actin-binding	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.8"	"Cell line enhanced"	"Detected in all"		"HMC-1: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004916, HPA076913"	Approved		Approved	"Plasma membrane"			10000000	"Plasma membrane"		"HPA004916: AB_1847668, HPA076913: "	"unprognostic (6.79e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.54e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (7.81e-5)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.29e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.65e-1)"	14.5	10.0	5.2	22.3	10.4	27.9	10.6	8.8	7.8	11.6	17.1	3.9	11.4	14.2	9.9	16.8	26.5	9.1	15.7	21.3	5.1	6.3	30.1	48.7	22.4	21.7	3.8	4.3	9.7	20.2	17.6	22.1	28.2	7.2	7.8	11.0	8.8	18.0	13.8	79.8	19.1	24.1	9.6	3.4	20.2	15.5	12.1	2.9	44.2	14.9	23.8	34.1	12.3	13.3	5.9	8.6	19.2	9.3	8.2	22.7	9.3	25.5	16.6	9.6	12.6	7.7	10.4	13.3	10.5	11.2	12.3	12.9	56.6	24.5	28.6	16.1	15.4	28.5	21.4	35.8	15.6	15.4	11.9	49.3	21.9	18.4	7.3	34.3	105.8	6.6	19.0	17.7	17.9	16.1	17.3	20.2	12.1	24.9	38.1	44.8	9.5	11.0	42.8	15.8	15.8	23.6	28.2	12.8	6.8	26.0	34.7	10.4	14.5	16.6	9.3	17.3	9.2	9.5	21.4	10.1	16.0	19.8	9.4	27.5	10.7	12.7	8.6	19.2	22.7	9.2	15.2	5.9	14.4	17.6	8.6	5.0	10.5	17.3	9.4	8.2	9.3	6.6	11.9	9.3	5.2	10.4	8.8	7.8	5.1	6.3	3.8	4.3	7.2	2.9
DIAPH2	"DIA, DIA2, POF, POF2"	ENSG00000147202	"Diaphanous related formin 2"	O60879	X	96684663-97604997	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Oogenesis"	"Developmental protein"	"Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005647, CAB015461, CAB068183, CAB068184"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Vesicles"				"Endoplasmic reticulum, Vesicles"	Nucleoli	"CAB015461: AB_831223, CAB068183: , CAB068184: , HPA005647: AB_1078657"	"unprognostic (5.75e-2)"	"unprognostic (4.13e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.16e-5)"	"unprognostic (1.58e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (6.44e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.99e-3)"	"unprognostic (6.08e-3)"	25.3	5.7	8.2	16.5	13.6	19.9	12.0	1.6	4.6	17.8	18.5	2.9	15.1	5.5	10.7	9.1	16.3	10.4	12.6	13.0	6.6	3.0	6.1	15.7	16.8	6.9	4.1	4.4	14.2	6.6	8.7	5.5	37.2	7.1	16.0	11.4	4.7	9.4	17.2	19.9	9.3	12.0	18.5	7.3	9.8	9.9	12.3	5.1	9.4	7.5	12.0	4.9	19.8	26.9	2.7	4.3	5.7	5.8	1.4	2.8	1.0	0.0	4.0	1.9	3.9	11.0	18.4	0.0	6.9	7.3	3.7	7.9	3.3	7.6	11.3	5.5	5.9	0.0	10.3	1.1	4.9	0.3	5.9	0.0	4.8	3.5	9.2	14.5	5.2	9.2	3.7	5.0	15.7	7.2	0.0	9.3	6.9	3.2	5.4	5.9	15.3	5.9	0.0	10.4	0.0	2.1	6.0	0.0	4.0	0.0	2.0	5.5	1.7	8.0	9.1	8.1	3.7	6.6	4.4	0.1	0.0	9.5	6.8	14.8	4.7	0.0	5.8	5.7	2.3	5.4	1.8	2.7	2.4	2.8	4.3	2.4	1.6	1.5	0.6	1.4	4.5	4.1	1.3	1.0	8.2	13.6	1.6	4.6	6.6	3.0	4.1	4.4	7.1	5.1
DIAPH3	"AN, AUNA1, DRF3, FLJ34705, NSDAN"	ENSG00000139734	"Diaphanous related formin 3"	Q9NSV4	13	59665583-60163987	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.2;testis: 19.6"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	4	"dendritic cells: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA032151			Supported	"Plasma membrane,Microtubules"				"Plasma membrane, Microtubules"		"HPA032151: "	"unprognostic (3.78e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (9.04e-4)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (2.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.27e-4)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.22e-5)"	"unprognostic (3.59e-3)"	"unprognostic (5.31e-5)"	"unprognostic (4.30e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.74e-3)"	1.8	0.4	1.7	11.5	1.8	6.7	1.6	0.1	1.4	0.9	4.7	0.2	0.4	2.0	1.4	1.1	7.1	0.3	2.5	1.1	1.0	1.6	1.7	0.4	4.1	2.9	1.0	0.0	0.4	0.4	0.5	0.2	9.4	0.2	0.4	2.3	0.0	1.6	0.0	0.1	1.8	4.3	2.7	0.3	2.5	3.1	19.6	0.0	35.2	0.2	5.3	5.9	0.8	1.5	0.4	2.0	0.4	0.2	0.0	0.5	0.2	17.9	6.0	6.2	3.5	1.1	2.9	10.6	25.2	11.2	25.5	22.3	15.9	12.2	6.0	2.0	12.9	12.3	10.1	9.9	38.9	6.8	7.0	8.6	15.4	3.6	1.6	11.7	6.9	1.1	0.2	15.5	10.5	11.4	6.6	8.6	24.2	2.6	10.4	5.0	5.8	3.5	7.1	15.4	4.9	8.3	3.7	3.3	5.7	12.8	8.9	3.9	6.5	6.4	11.3	16.2	10.4	5.4	20.8	5.8	6.3	9.4	4.3	5.8	12.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	2.0	0.5	0.2	1.7	1.8	0.1	1.4	1.0	1.6	1.0	0.0	0.2	0.0
DICER1	"Dicer, HERNA, K12H4.8-LIKE, KIAA0928, MNG1"	ENSG00000100697	"Dicer 1, ribonuclease III"	Q9UPY3	14	95086228-95158010	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"RNA-mediated gene silencing"	"Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000694, CAB068185"	Approved		Supported	Cytosol				Cytosol		"CAB068185: , HPA000694: AB_1078661"	"unprognostic (2.97e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.52e-3)"	"unprognostic (5.73e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.74e-2)"	23.2	12.5	18.4	22.4	33.3	20.5	23.2	28.5	29.9	19.0	18.1	31.4	22.4	13.0	20.8	20.6	23.4	18.5	16.2	15.3	22.0	14.1	19.5	23.6	22.4	20.3	29.7	19.6	23.8	19.8	26.9	30.9	29.9	23.2	20.3	19.7	14.5	19.5	18.9	28.0	20.7	17.3	19.0	26.8	20.7	17.1	20.6	32.0	17.0	23.8	14.7	20.3	20.7	24.1	2.5	1.8	10.7	7.2	1.2	3.3	1.0	12.8	13.4	25.1	9.3	6.5	9.8	19.9	10.6	6.4	6.8	8.2	17.0	9.9	14.5	11.5	9.8	15.2	19.9	10.0	14.2	22.5	8.9	21.9	7.4	12.2	6.6	13.4	13.5	9.1	8.3	9.1	13.9	10.1	9.2	12.9	11.4	18.0	15.0	8.9	7.1	6.6	12.0	20.5	8.0	9.0	20.5	20.8	11.8	10.7	11.0	12.0	12.4	9.9	10.0	5.2	10.3	10.1	11.9	14.8	21.1	20.6	5.4	10.9	9.3	3.1	3.0	1.2	1.6	3.1	3.3	1.9	1.5	1.2	1.8	2.5	1.5	1.3	10.7	1.2	7.2	1.6	1.6	1.0	18.4	33.3	28.5	29.9	22.0	14.1	29.7	19.6	23.2	32.0
DIDO1	"BYE1, C20orf158, DATF1, DIO-1, DIO1, dJ885L7.8, FLJ11265, KIAA0333"	ENSG00000101191	"Death inducer-obliterator 1"	Q9BTC0	20	62877738-62937952	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004374, HPA049904"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"CAB004374: AB_2093108, HPA049904: "	"unprognostic (9.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.68e-1)"	"prognostic favourable (5.13e-4)"	"unprognostic (9.92e-3)"	"unprognostic (4.57e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"prognostic favourable (3.88e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.50e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.64e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.82e-2)"	25.1	15.9	19.7	21.5	21.3	22.8	26.9	38.1	23.2	29.7	24.0	27.0	26.7	18.4	33.2	26.9	20.7	29.2	27.0	23.2	17.9	14.7	18.2	18.3	22.9	27.5	22.9	18.8	37.4	21.4	28.0	25.1	30.6	17.6	24.3	19.2	27.0	26.3	25.5	27.6	34.0	25.2	27.5	17.5	25.8	21.2	24.1	23.1	35.1	25.1	20.5	29.6	26.1	35.6	9.7	8.6	20.9	7.6	10.1	15.3	7.1	11.6	9.0	15.2	8.6	7.8	9.6	8.1	8.8	7.5	32.9	9.5	38.6	12.1	11.5	12.2	10.8	18.3	13.8	17.1	21.4	6.3	9.3	16.6	14.9	27.5	9.9	14.8	17.2	9.8	23.6	11.4	6.4	9.0	16.2	10.6	8.3	11.3	30.0	13.1	12.1	13.2	21.3	19.4	7.3	5.4	10.4	18.7	11.1	17.7	17.2	11.6	17.1	17.0	11.2	26.9	18.8	8.9	12.5	7.1	4.6	15.4	12.2	7.5	9.7	20.9	5.6	15.1	12.9	7.6	13.3	9.7	11.3	12.3	4.1	8.2	15.3	14.1	8.6	10.1	5.8	8.6	9.0	7.1	19.7	21.3	38.1	23.2	17.9	14.7	22.9	18.8	17.6	23.1
DIP2C	KIAA0934	ENSG00000151240	"Disco interacting protein 2 homolog C"	Q9Y2E4	10	274190-689668	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-2197: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.8;T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030264, HPA059325"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	Vesicles	"HPA030264: AB_10600903, HPA059325: "	"unprognostic (1.72e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.00e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (8.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.94e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (2.46e-6)"	"unprognostic (8.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.10e-3)"	15.4	8.1	19.9	5.0	25.0	0.9	9.9	23.0	24.7	12.6	20.8	21.2	6.4	6.2	14.1	7.8	12.2	9.1	11.3	17.3	16.3	10.1	19.2	11.5	6.7	3.4	21.7	14.4	18.1	10.4	10.4	7.4	6.3	16.5	11.5	6.3	13.0	5.6	12.7	38.2	5.5	7.3	16.1	14.9	4.5	8.3	9.4	23.1	0.0	7.3	2.9	2.5	11.6	13.0	3.8	0.5	0.1	0.3	0.3	1.3	0.4	0.4	4.0	7.4	3.9	12.6	13.7	6.1	8.8	5.5	6.8	5.6	1.1	1.2	0.3	2.4	14.1	0.1	4.5	0.7	4.2	0.2	4.0	0.1	2.7	1.2	6.1	0.0	5.5	11.1	3.6	4.3	0.0	1.5	0.0	0.7	5.1	10.8	0.4	0.0	1.9	1.6	6.1	3.1	1.2	4.8	4.5	3.7	5.3	1.5	3.2	12.7	4.2	0.0	0.1	7.2	1.9	21.5	2.9	0.5	8.5	4.6	9.1	0.2	4.1	0.0	0.3	0.0	0.4	0.0	0.4	2.6	0.8	1.0	0.0	3.8	1.2	1.3	0.1	0.3	0.0	0.5	0.5	0.4	19.9	25.0	23.0	24.7	16.3	10.1	21.7	14.4	16.5	23.1
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA039281: AB_10795583, HPA058762: "	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	25.5	14.7	11.7	17.6	24.8	23.8	22.4	23.4	19.4	20.3	18.8	11.6	17.0	11.8	18.0	19.3	23.1	17.8	16.0	21.6	12.4	13.6	20.2	25.6	19.3	22.2	13.9	17.0	23.4	15.3	15.8	22.8	26.3	18.7	18.0	15.6	9.8	17.4	19.3	19.9	17.3	17.9	17.5	12.9	22.8	16.2	27.7	14.6	23.7	21.3	19.1	23.0	26.7	19.3	6.9	6.8	11.1	9.7	10.3	10.0	5.0	15.6	7.3	14.4	12.1	15.4	18.4	9.5	14.0	17.1	14.3	17.6	11.2	13.1	19.1	12.2	14.3	13.1	19.7	16.1	23.2	15.6	14.5	22.4	15.7	10.1	19.2	37.8	13.0	19.1	11.3	16.2	21.4	15.3	14.9	8.0	17.4	5.5	16.0	18.6	13.5	8.6	13.0	11.0	8.6	14.4	12.6	13.1	17.2	11.5	9.6	13.5	9.3	17.3	14.3	8.7	7.0	9.7	14.8	15.5	17.4	15.3	24.2	18.0	12.5	11.1	5.5	7.8	6.5	9.7	9.4	6.9	8.5	7.3	6.8	6.0	8.1	7.6	3.4	10.3	7.6	4.3	10.0	5.0	11.7	24.8	23.4	19.4	12.4	13.6	13.9	17.0	18.7	14.6
DISC1		ENSG00000162946	"Disrupted in schizophrenia 1"	Q9NRI5	1	231626815-232041272	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"THP-1: 12.2;TIME: 9.5;WM-115: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA048911			Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA048911: "	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	5.3	3.3	9.1	6.4	10.6	5.3	7.6	2.5	7.6	4.9	3.1	11.6	0.0	2.6	4.2	1.6	3.1	2.9	5.6	19.2	9.2	5.9	2.7	3.1	3.9	11.3	10.5	4.8	9.6	2.1	2.7	2.8	14.3	9.2	3.9	2.9	13.1	4.0	2.4	3.2	2.9	3.1	3.4	10.2	6.1	2.4	2.2	9.3	4.2	4.1	2.5	3.9	4.5	7.2	0.5	3.3	2.6	2.9	0.7	1.6	0.7	0.0	0.5	4.4	0.1	0.1	0.4	3.2	1.7	4.0	4.7	3.9	1.5	0.9	0.1	5.3	1.5	0.0	0.4	0.1	4.1	2.8	1.8	2.4	0.4	4.4	0.6	3.9	5.8	2.5	0.8	1.5	1.3	4.1	0.0	1.8	5.1	0.4	1.1	5.9	2.2	1.6	2.9	1.2	0.5	0.2	0.0	0.8	2.5	1.5	0.0	2.7	0.0	12.2	9.5	2.4	2.6	1.1	1.0	1.1	0.8	0.0	1.9	6.1	9.7	0.3	2.7	0.1	0.9	2.9	0.5	0.1	1.4	0.3	3.3	0.5	1.6	0.5	2.6	0.7	1.2	1.9	0.5	0.7	9.1	10.6	2.5	6.3	9.2	5.9	10.5	4.8	9.2	9.3
DKC1	"Cbf5, DKC, dyskerin, NAP57, NOLA4, XAP101"	ENSG00000130826	"Dyskerin pseudouridine synthase 1"	O60832	X	154762742-154777689	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Isomerase, Ribonucleoprotein, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000166, HPA000447, HPA001022, CAB033086"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			40000	"Nucleoli fibrillar center"	Nucleoplasm	"CAB033086: AB_2091314, HPA000166: AB_1078669, HPA000447: AB_1078667, HPA001022: "	"unprognostic (9.87e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (2.66e-5)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (2.94e-4)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (7.02e-2)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (2.53e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (1.46e-9)"	"unprognostic (5.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.55e-1)"	17.6	18.1	17.2	22.5	17.3	42.3	25.8	19.6	20.7	16.6	20.3	14.8	20.7	17.4	19.7	17.1	33.6	18.5	15.9	16.9	15.4	16.3	15.2	22.5	15.2	26.8	15.6	16.6	23.9	38.7	22.6	24.6	19.1	17.0	17.1	26.2	13.7	20.8	18.7	40.8	25.5	18.5	18.3	20.9	25.8	17.6	33.1	16.7	31.3	26.6	28.7	33.2	16.4	20.8	23.5	18.5	16.7	15.5	20.8	26.8	14.8	36.1	20.2	12.5	17.8	7.8	8.0	18.5	13.8	9.8	20.7	19.6	25.4	18.1	69.3	36.4	11.6	19.5	38.0	22.8	31.2	16.7	21.1	35.3	21.2	22.0	11.0	46.4	21.3	7.6	21.9	22.8	52.1	14.3	31.8	17.4	14.0	21.0	31.2	35.7	20.8	25.3	27.2	28.0	35.8	13.0	20.6	27.5	13.6	12.2	21.4	18.8	10.8	18.7	11.4	14.9	22.4	19.1	45.6	32.2	44.5	113.1	10.2	49.2	16.1	4.8	13.1	16.7	21.4	15.5	26.8	23.5	17.6	22.7	18.5	17.1	23.3	22.2	4.0	20.8	14.9	13.4	13.4	14.8	17.2	17.3	19.6	20.7	15.4	16.3	15.6	16.6	17.0	16.7
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11963106-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 94.7;heart muscle: 297.4"	"Cell line enhanced"	"Detected in many"		"BJ: 60.0;BJ hTERT+: 92.8;fHDF/TERT166: 86.9;TIME: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 8.9;memory CD8 T-cell: 5.5;naive CD8 T-cell: 2.2"	"Lineage enriched"	"Detected in single"	90	"T-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"		15000000	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	4.8	21.7	44.9	3.5	94.7	1.3	6.8	32.5	60.3	25.8	7.3	12.1	4.1	4.9	7.8	5.6	8.8	4.9	17.9	297.4	49.6	23.5	5.1	2.7	17.8	3.1	19.1	45.8	10.8	5.7	10.9	6.6	7.5	24.7	16.8	4.6	10.7	9.1	22.3	2.7	8.3	7.3	12.0	32.9	9.0	7.0	8.9	25.5	0.0	4.7	2.5	2.6	10.5	7.8	0.0	0.0	0.0	0.0	0.0	8.9	0.6	0.2	1.8	2.6	0.0	2.2	4.4	0.0	60.0	92.8	26.6	30.2	1.3	0.4	0.0	6.6	86.9	9.2	0.2	25.9	10.2	0.0	0.0	0.0	0.2	0.0	16.9	0.0	0.0	6.7	8.7	9.0	22.2	28.1	0.0	0.0	36.7	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	9.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	49.8	15.8	12.4	1.6	15.5	0.0	0.0	0.0	2.6	0.0	14.8	0.0	0.0	0.0	0.8	0.0	8.9	0.0	0.8	5.5	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.6	44.9	94.7	32.5	46.5	49.6	23.5	19.1	45.8	24.7	25.5
DLC1	"ARHGAP7, DLC-1, HP, p122-RhoGAP, STARD12"	ENSG00000164741	"DLC1 Rho GTPase activating protein"	Q96QB1	8	13083361-13604610	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.7;hTERT-HME1: 13.8;HUVEC TERT2: 18.8;U-2197: 18.6;WM-115: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 6.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017753	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA017753: AB_10600805"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.11e-4)"	"unprognostic (7.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.56e-3)"	"unprognostic (2.79e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.67e-1)"	33.9	8.0	8.5	8.8	15.4	4.9	31.9	3.1	11.4	13.6	13.1	16.0	2.0	6.1	12.4	7.4	8.6	10.4	13.1	15.1	10.0	7.3	9.2	24.1	32.4	5.6	18.0	6.8	8.0	6.3	6.3	4.4	22.3	16.2	5.7	4.5	13.6	4.9	4.1	7.6	5.4	8.5	18.7	15.0	16.6	11.1	5.5	16.5	0.0	12.0	6.1	2.9	17.1	17.2	0.0	0.2	6.5	1.3	0.0	0.1	0.0	0.0	0.1	1.6	0.0	12.3	7.0	5.9	0.6	0.1	0.2	0.5	3.9	2.4	0.0	0.2	11.7	2.0	1.0	1.6	1.1	0.0	0.9	0.3	0.0	4.1	6.4	0.0	3.5	5.4	0.1	18.7	13.8	18.8	1.0	0.0	5.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	5.9	0.0	0.8	0.0	0.2	6.2	0.0	0.0	1.9	13.5	7.3	18.6	4.4	0.0	0.0	0.0	10.4	0.0	13.7	6.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	8.5	15.4	3.1	11.0	10.0	7.3	18.0	6.8	16.2	16.5
DLD	"DLDH, GCSL, LAD"	ENSG00000091140	"Dihydrolipoamide dehydrogenase"	P09622	7	107890970-107931730	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044849	Supported		Supported	Mitochondria			16000000	Mitochondria		"HPA044849: "	"unprognostic (2.01e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.43e-2)"	"unprognostic (7.35e-2)"	"prognostic favourable (7.58e-9)"	"unprognostic (4.08e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.18e-1)"	25.7	37.9	14.5	12.7	25.4	12.0	15.2	16.6	27.2	13.2	28.0	10.6	12.2	20.9	13.6	9.6	25.6	11.6	12.7	69.1	16.4	14.4	40.7	37.9	11.0	13.0	16.7	20.1	15.1	14.8	24.6	22.4	15.4	29.3	14.7	26.8	12.8	19.4	14.4	71.5	13.8	29.5	23.7	10.6	17.4	23.0	10.6	10.7	18.7	17.0	31.8	16.9	20.1	11.7	13.5	30.4	45.8	37.8	22.9	19.4	20.2	39.9	32.4	18.0	31.0	25.9	22.9	20.4	23.0	19.4	26.8	20.8	37.9	22.4	39.1	39.7	24.4	26.6	36.2	32.4	40.5	26.1	21.5	27.5	43.0	27.0	19.9	45.2	28.4	26.1	23.6	28.4	15.5	32.1	68.6	29.2	29.0	44.9	36.9	32.8	21.4	23.5	26.6	28.8	53.0	36.6	59.8	22.4	23.7	37.7	63.7	33.8	24.2	38.7	20.3	29.6	24.3	57.6	34.9	22.1	42.1	26.3	27.9	48.3	30.6	36.5	22.3	45.8	17.5	28.2	18.5	13.5	17.7	17.3	30.4	12.3	18.7	19.4	14.0	22.9	37.8	10.5	16.8	20.2	14.5	25.4	16.6	27.2	16.4	14.4	16.7	20.1	29.3	10.7
DLEC1	"CFAP81, DLC1"	ENSG00000008226	"Deleted in lung and esophageal cancer 1"	Q9Y238	3	38039205-38124025	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 21.1;fallopian tube: 23.2;testis: 28.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.4;RT4: 2.8;SK-BR-3: 1.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA019077	Enhanced		Supported	Cytosol				Cytosol		"HPA019077: AB_1847724"	"unprognostic (1.24e-4)"	"unprognostic (3.60e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.50e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.62e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.94e-4)"	0.8	0.3	1.3	0.7	8.3	1.1	0.5	0.0	0.6	3.3	0.6	6.1	3.5	0.7	1.1	21.1	0.3	23.2	1.3	0.3	1.7	2.5	0.3	0.3	10.0	1.7	0.5	0.2	6.3	0.2	0.6	14.2	0.3	9.8	0.8	0.6	0.8	0.6	1.8	0.2	0.7	0.7	0.3	0.6	0.7	0.6	28.9	1.7	0.0	0.8	0.0	0.6	0.4	0.1	0.2	0.1	0.9	0.4	0.1	1.1	0.1	0.1	0.0	1.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.2	0.2	0.5	0.0	0.2	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.2	0.1	3.4	0.0	0.0	0.0	0.2	0.1	2.8	0.5	0.2	0.3	1.7	0.5	0.1	0.3	0.0	0.0	0.4	0.3	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.8	0.2	0.4	0.2	1.1	0.0	0.1	0.1	0.2	0.0	0.9	0.1	0.1	0.1	0.2	0.1	1.3	8.3	0.0	0.6	1.7	2.5	0.5	0.2	9.8	1.7
DLG3	"KIAA1232, MRX90, NE-Dlg, NEDLG, PPP1R82, SAP-102, SAP102"	ENSG00000082458	"Discs large MAGUK scaffold protein 3"	Q92796	X	70444861-70505490	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 20.6;SK-BR-3: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.1;MAIT T-cell: 1.8;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.4;naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.8;NK-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001733, HPA078130"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA001733: AB_1078675, HPA078130: "	"prognostic unfavourable (1.69e-4)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.98e-2)"	"prognostic favourable (1.72e-10)"	"unprognostic (3.36e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-3)"	2.7	3.3	12.5	6.5	17.6	0.7	10.8	16.4	25.2	9.2	16.0	4.3	14.7	11.7	7.6	23.7	14.5	17.4	16.3	6.0	15.2	10.0	10.8	1.4	7.8	3.1	6.5	10.2	11.2	27.1	21.2	8.9	5.5	8.0	9.6	17.1	10.2	21.0	10.4	1.1	8.4	20.8	11.3	3.4	14.6	13.8	1.9	3.5	3.2	13.8	2.6	8.0	11.2	9.9	0.4	0.0	0.0	0.0	1.7	2.4	0.3	3.6	1.7	10.6	4.5	2.7	3.4	7.4	2.2	2.5	1.2	1.2	10.5	8.7	0.0	5.1	2.2	8.0	20.6	4.8	0.8	4.3	6.2	0.0	9.4	5.7	5.4	0.1	1.4	3.5	3.2	1.5	3.4	0.4	2.0	14.7	1.1	12.9	8.3	0.0	17.8	12.4	7.8	5.2	1.6	7.2	11.3	5.0	0.3	1.7	20.6	3.9	10.8	0.0	0.8	1.4	1.4	1.3	1.6	9.7	7.3	4.6	2.1	0.0	2.0	0.0	0.0	0.0	2.1	0.0	1.8	0.4	1.7	2.4	0.0	0.0	1.1	1.8	0.0	1.7	0.0	0.0	2.4	0.3	12.5	17.6	16.4	25.2	15.2	10.0	6.5	10.2	8.0	3.5
DLGAP5	"DLG1, DLG7, HURP, KIAA0008"	ENSG00000126787	"DLG associated protein 5"	Q15398	14	55148112-55191678	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 65.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 8.3"	"Lineage enriched"	"Detected in many"	6	"T-cells: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA005546	Enhanced		Supported	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA005546: AB_1078677"	"unprognostic (2.24e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.19e-3)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.52e-6)"	"prognostic unfavourable (7.85e-4)"	"unprognostic (6.15e-3)"	"unprognostic (3.55e-1)"	"prognostic unfavourable (9.94e-6)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.06e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-2)"	1.4	0.9	0.3	11.4	0.4	16.2	0.5	0.3	0.5	1.3	3.3	0.2	0.2	2.9	0.9	1.0	8.7	0.3	1.3	0.7	0.2	0.3	1.1	0.8	2.1	10.6	0.3	0.2	0.7	0.4	0.0	0.3	3.3	0.3	0.5	4.1	0.3	1.5	0.2	0.5	1.9	4.1	1.3	0.3	6.6	2.2	13.0	0.2	65.1	0.4	6.4	11.4	1.7	2.4	1.1	0.4	0.4	0.0	1.3	8.3	1.2	37.0	14.7	38.8	17.4	0.9	3.9	12.0	21.5	14.2	31.9	30.4	12.0	20.5	21.6	11.9	12.5	23.1	24.8	17.3	41.9	25.9	12.2	22.1	13.8	10.3	0.1	21.6	13.6	0.7	0.6	14.9	7.2	35.1	17.9	21.6	29.6	17.8	27.3	11.1	20.0	15.4	21.3	37.5	9.9	10.4	12.1	19.8	11.1	22.9	8.6	8.5	19.3	8.1	13.6	14.3	37.4	13.8	24.7	5.3	11.5	28.6	10.0	15.4	22.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.1	2.3	0.4	0.1	0.5	0.2	0.4	1.3	0.0	0.0	8.3	1.2	0.3	0.4	0.3	0.5	0.2	0.3	0.3	0.2	0.3	0.2
DLL3	SCDO1	ENSG00000090932	"Delta like canonical Notch ligand 3"	Q9NYJ7	19	39498895-39508481	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 38.5"	"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 41.1"	"Group enriched"	"Detected in many"	11	"glioma: 29.2;melanoma: 15.5;testis cancer: 8.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 5.4;naive CD8 T-cell: 3.3"	"Group enriched"	"Detected in many"	13	"B-cells: 5.4;T-cells: 3.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA056533			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA056533: "	"unprognostic (2.52e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.82e-4)"	"unprognostic (4.94e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.97e-1)"	0.6	0.6	8.9	0.7	10.1	0.6	0.6	1.4	38.5	0.5	0.6	10.3	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.6	6.5	6.8	0.5	0.6	0.6	0.7	4.5	1.9	0.6	0.5	0.6	3.2	0.5	4.3	0.6	0.5	0.0	0.6	0.5	0.5	0.6	0.6	0.5	3.6	0.6	0.6	1.2	2.3	0.0	0.7	0.0	0.6	0.6	0.0	5.4	0.3	0.0	0.0	0.0	3.3	0.4	0.0	1.9	0.4	1.0	0.0	0.0	0.3	0.5	0.0	0.3	0.1	0.3	0.4	0.0	1.9	0.0	0.0	1.2	0.5	0.1	0.5	3.0	0.1	0.0	0.1	0.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.4	3.1	0.3	0.1	0.1	0.1	0.1	7.3	7.4	1.4	0.0	41.1	0.0	0.1	0.0	0.0	1.3	0.1	0.5	0.7	0.0	0.4	0.0	0.2	1.2	0.0	0.0	0.0	0.9	0.0	0.4	5.4	0.2	1.3	0.3	1.2	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.4	8.9	10.1	1.4	4.8	6.5	6.8	4.5	1.9	4.3	2.3
DMAP1	"DNMAP1, DNMTAP1, EAF2, FLJ11543, KIAA1425, MEAF2, SWC4"	ENSG00000178028	"DNA methyltransferase 1 associated protein 1"	Q9NPF5	1	44213455-44220681	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028419, CAB033018"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB033018: AB_2230431, HPA028419: "	"unprognostic (1.91e-3)"	"unprognostic (2.79e-3)"	"unprognostic (4.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.72e-2)"	"unprognostic (7.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.04e-2)"	12.7	31.7	21.5	17.6	22.4	12.5	12.6	21.3	31.5	12.8	13.8	20.4	15.6	13.5	14.0	14.9	12.9	19.8	11.7	20.3	20.7	18.3	14.9	16.1	12.9	17.2	18.0	19.4	23.3	19.9	25.3	15.7	14.3	17.9	13.9	11.9	19.2	21.1	15.2	30.5	18.0	12.7	17.0	15.8	16.7	13.8	13.8	17.0	15.2	18.1	14.3	13.6	12.7	11.4	18.6	15.4	23.2	14.8	26.5	23.1	15.0	12.4	13.3	18.8	9.9	9.8	9.3	21.7	11.1	14.9	26.8	23.2	21.7	15.7	18.7	15.1	17.8	10.3	16.7	14.3	14.3	15.0	27.0	17.2	23.7	21.4	17.7	16.8	13.1	14.5	15.9	22.1	12.8	17.2	11.9	17.2	15.6	14.5	23.5	21.2	26.7	17.0	23.9	19.0	20.4	14.1	15.8	17.5	14.4	20.8	14.9	21.1	12.3	19.5	16.5	7.6	23.0	17.4	22.3	21.0	12.5	15.0	14.4	16.8	12.5	23.2	14.8	14.1	21.2	13.1	21.6	18.6	21.4	21.8	15.4	18.6	19.6	19.3	6.4	26.5	10.5	12.4	23.1	15.0	21.5	22.4	21.3	31.5	20.7	18.3	18.0	19.4	17.9	17.0
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339441	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Hep G2: 14.7;RH-30: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.6;naive B-cell: 4.9;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	18	"B-cells: 4.9;dendritic cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced									"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	19.8	11.8	12.5	11.6	11.1	0.7	11.8	15.6	11.6	18.9	25.6	6.8	30.3	4.5	22.2	10.0	13.1	12.5	22.3	27.5	10.0	7.6	4.4	36.2	5.9	3.7	8.5	9.8	11.7	34.5	4.9	4.1	10.3	7.8	14.5	6.8	10.7	19.7	31.6	57.7	8.5	7.4	48.2	6.1	1.9	11.9	4.6	7.4	0.0	6.2	34.5	4.7	32.6	7.9	4.9	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	16.1	0.0	0.1	0.1	4.8	3.2	0.3	1.7	1.9	8.0	0.0	0.2	0.0	8.8	5.4	6.4	8.2	2.7	4.7	5.1	0.2	7.3	14.7	9.3	0.0	1.5	2.1	6.0	3.0	11.3	4.3	0.6	0.1	4.6	0.3	2.5	0.0	8.1	7.4	0.1	20.3	0.0	0.1	1.3	0.3	4.5	0.0	1.2	2.3	1.1	0.0	0.5	0.1	0.0	0.2	3.3	0.1	6.6	0.3	0.4	0.0	8.8	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.5	11.1	15.6	11.6	10.0	7.6	8.5	9.8	7.8	7.4
DMGDH		ENSG00000132837	"Dimethylglycine dehydrogenase"	Q9UI17	5	78997606-79236038	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"kidney: 50.2;liver: 81.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 5.6;Hep G2: 11.3;hTEC/SVTERT24-B: 3.5;Karpas-707: 3.6"	"Group enriched"	"Detected in some"	12	"liver cancer: 15.6;renal cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036441, HPA036442, HPA077849"	Enhanced		Supported	Mitochondria			440000	Mitochondria		"HPA036441: AB_2675124, HPA036442: AB_10669792, HPA077849: "	"unprognostic (3.11e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.52e-3)"	"prognostic favourable (5.32e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.07e-4)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.17e-5)"	"unprognostic (2.03e-2)"	"unprognostic (9.75e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.26e-1)"	2.8	2.2	0.8	0.8	1.3	0.0	1.5	0.4	0.6	0.5	0.5	0.7	1.9	0.1	0.9	5.9	0.4	0.4	0.6	1.3	0.8	0.8	50.2	81.8	0.1	0.1	0.8	0.3	1.0	0.5	0.3	2.1	0.0	1.1	0.9	0.1	2.7	0.4	1.1	0.6	0.2	0.3	2.0	1.7	0.0	0.4	1.2	0.2	0.0	1.5	0.8	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.5	0.5	1.4	0.4	0.3	5.6	1.3	2.3	0.0	0.1	0.0	0.4	1.7	0.0	0.1	0.0	1.8	0.3	0.0	0.0	0.0	11.3	3.1	0.0	0.0	2.7	3.3	3.5	2.5	0.0	0.0	3.6	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.2	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.8	1.3	0.4	0.6	0.8	0.8	0.8	0.3	1.1	0.2
DMKN	ZD52F10	ENSG00000161249	Dermokine	Q6E0U4	19	35497220-35513658	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skin 1: 365.3"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CACO-2: 39.0;CAPAN-2: 33.5;HBEC3-KT: 51.1;RPTEC TERT1: 50.5"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 9.5"	"Cell type enhanced"	"Detected in many"		"NK-cell: 11.1"	"Group enriched"	"Detected in many"	5	"NK-cells: 11.1;T-cells: 7.0"									HPA029406	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted in other tissues"		29000000	"Nucleoplasm, Cytosol"		"HPA029406: AB_10603661"	"unprognostic (5.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.82e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.93e-2)"	"prognostic favourable (5.37e-6)"	"unprognostic (3.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.08e-1)"	1.4	1.1	0.6	0.5	4.7	0.6	23.9	0.7	2.0	54.8	1.2	1.1	2.5	1.0	5.6	9.2	25.3	8.7	0.6	1.4	0.7	1.1	11.3	0.8	8.8	0.5	0.9	0.6	11.7	29.5	4.7	13.3	1.7	9.5	5.0	1.0	9.5	8.2	9.1	2.4	365.3	1.2	0.9	0.9	0.6	1.8	0.8	2.3	3.1	25.9	62.9	16.9	3.5	27.5	1.7	0.2	0.0	0.0	11.1	7.0	1.2	31.5	5.1	0.0	0.0	1.2	1.9	8.9	0.1	4.2	0.2	0.3	39.0	33.5	0.0	12.8	0.3	17.7	9.6	51.1	0.4	0.1	9.3	0.0	0.0	8.7	1.5	0.0	0.1	17.5	13.8	0.9	29.7	0.0	0.1	0.0	0.1	27.6	0.0	0.0	28.3	2.1	0.0	0.0	1.2	50.5	20.9	0.1	0.0	7.7	0.0	3.1	12.8	0.0	0.0	4.9	15.0	0.1	0.1	0.2	0.0	0.2	4.2	0.0	0.3	0.0	0.0	0.0	7.0	0.0	6.1	1.7	0.6	3.4	0.0	0.2	0.1	2.4	0.0	11.1	0.0	0.2	0.0	1.2	0.6	4.7	0.7	2.0	0.7	1.1	0.9	0.6	9.5	2.3
DMTN	"DMT, EPB49"	ENSG00000158856	"Dematin actin binding protein"	Q08495	8	22048995-22082527	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.6"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;HEL: 64.4;HMC-1: 19.5;RPTEC TERT1: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"gdT-cell: 2.1;MAIT T-cell: 2.1;memory CD4 T-cell: 4.7;memory CD8 T-cell: 2.0;naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.0;neutrophil: 1.5;T-reg: 3.8"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.5;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024290	Uncertain						6700000			"HPA024290: AB_1847601"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-3)"	"prognostic unfavourable (7.92e-5)"	"unprognostic (2.88e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (3.85e-9)"	"unprognostic (3.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.07e-2)"	15.0	14.7	49.7	2.8	60.0	51.1	5.8	24.9	88.6	5.2	9.6	5.2	4.3	4.5	5.9	7.3	9.1	14.8	6.5	31.7	36.6	28.0	18.4	5.8	8.5	1.7	19.2	39.9	1.8	13.4	20.4	23.5	3.7	31.8	9.4	7.4	6.0	10.2	10.4	27.2	10.2	5.4	6.9	6.0	4.5	8.0	3.1	9.0	0.0	16.1	3.1	1.9	3.9	3.0	0.0	0.4	1.5	0.1	0.0	4.7	11.4	12.4	19.9	0.1	0.4	0.3	0.1	1.6	1.3	1.2	4.3	1.3	8.6	7.7	0.1	13.0	0.2	4.3	0.6	0.7	1.9	0.1	3.8	64.4	1.5	18.0	0.4	0.0	19.5	0.2	8.7	0.0	0.0	4.3	6.0	0.6	0.0	5.4	1.5	0.1	0.5	1.8	0.0	0.1	0.8	25.8	3.5	4.6	6.5	2.1	0.2	0.9	3.2	0.6	7.5	0.0	6.7	0.1	6.8	0.0	0.0	0.2	0.1	0.0	4.5	0.0	0.1	0.2	2.1	0.0	2.1	0.0	4.7	2.0	0.1	0.0	2.0	2.0	1.5	0.0	0.0	0.4	3.8	11.4	49.7	60.0	24.9	88.6	36.6	28.0	19.2	39.9	31.8	9.0
DNA2	"DNA2L, KIAA0083"	ENSG00000138346	"DNA replication helicase/nuclease 2"	P51530	10	68414064-68472121	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Disease mutation, Dwarfism, Mental retardation, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"lymphoid tissue: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 5.5"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037487, HPA057526"	Approved		Supported	Mitochondria				Mitochondria		"HPA037487: AB_10672493, HPA057526: "	"unprognostic (1.79e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.37e-3)"	"unprognostic (4.60e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.50e-5)"	"unprognostic (3.36e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.09e-10)"	"unprognostic (3.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.23e-2)"	1.6	1.2	2.0	13.7	2.4	7.0	3.0	6.2	3.8	1.6	4.5	1.1	0.8	3.5	3.0	1.8	3.2	1.0	2.4	2.0	2.5	2.2	3.4	6.2	3.3	8.4	2.9	5.0	1.9	2.4	1.1	2.3	4.0	1.7	3.0	5.0	0.9	2.3	0.8	2.3	2.9	5.2	1.9	3.0	5.2	2.6	7.0	1.4	49.1	1.5	5.1	10.8	2.3	2.0	0.4	0.1	0.9	0.1	5.5	0.6	0.1	13.7	7.1	16.3	11.5	1.8	1.3	11.5	6.8	5.7	9.8	12.1	17.0	9.0	14.1	2.6	2.1	8.5	9.3	3.6	11.8	8.7	7.0	8.6	4.4	6.5	0.5	14.7	9.3	1.0	1.4	7.0	2.0	4.4	12.5	12.8	5.6	4.8	22.7	10.7	11.5	13.4	17.8	11.3	4.5	4.2	6.4	7.4	8.9	9.4	11.9	2.2	9.2	6.3	1.8	3.8	11.7	4.8	12.9	6.5	7.3	21.1	3.2	14.1	4.9	0.0	0.0	0.9	0.2	0.0	0.2	0.4	0.2	0.6	0.1	0.4	0.3	0.3	0.1	5.5	0.1	0.0	0.4	0.1	2.0	2.4	6.2	3.8	2.5	2.2	2.9	5.0	1.7	1.4
DNAAF5	"CILD18, FLJ20397, FLJ25564, FLJ31671, FLJ39381, HEATR2"	ENSG00000164818	"Dynein axonemal assembly factor 5"	Q86Y56	7	726701-786475	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020243	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA020243: AB_1848750"	"unprognostic (9.77e-2)"	"unprognostic (9.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.57e-1)"	"unprognostic (8.22e-3)"	"prognostic unfavourable (8.42e-4)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (8.07e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.59e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.70e-3)"	11.5	13.0	9.3	13.5	11.4	10.7	12.3	17.4	14.2	15.5	16.3	14.7	10.3	12.0	18.4	13.9	16.7	23.4	15.4	18.8	11.6	8.6	15.0	18.2	9.9	11.8	9.5	7.6	20.6	22.5	14.4	21.1	12.1	10.4	16.1	9.9	14.0	17.6	14.3	33.9	12.0	13.6	13.9	9.2	12.5	13.0	14.8	9.4	20.7	15.9	11.2	14.2	15.6	12.4	3.3	4.6	1.4	2.8	3.0	4.7	1.9	30.3	24.0	7.2	16.7	4.7	5.2	18.1	6.3	6.1	7.9	7.5	23.9	16.1	18.6	9.2	6.6	18.5	13.3	15.8	6.1	3.1	22.5	4.6	14.3	17.3	6.5	13.8	8.3	6.3	6.8	9.9	7.3	10.7	28.9	3.9	5.7	29.8	8.2	12.4	26.4	19.1	15.2	2.3	12.8	9.2	12.9	15.1	25.1	10.3	25.5	7.3	22.5	11.6	8.8	4.4	15.7	15.0	14.1	7.6	9.1	10.8	9.7	14.6	23.0	0.0	1.9	1.4	2.2	2.8	3.3	1.6	3.5	4.7	2.7	3.3	3.3	2.5	0.0	3.0	2.0	4.6	0.8	1.9	9.3	11.4	17.4	14.2	11.6	8.6	9.5	7.6	10.4	9.4
DNAH3	"DKFZp434N074, DLP3, Dnahc3b, Hsadhc3"	ENSG00000158486	"Dynein axonemal heavy chain 3"	Q8TD57	16	20933111-21159441	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 10.4;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.1;CACO-2: 1.0;CAPAN-2: 1.1;hTEC/SVTERT24-B: 1.3;U-698: 1.2"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA062493			Approved	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane"	"Intermediate filaments"	"HPA062493: "	"unprognostic (1.68e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-5)"	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.15e-1)"	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2			0.0	0.2	0.0	0.0	10.4	0.0	0.0	0.5	0.7	0.0	0.0	1.8	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.3		0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	1.0	1.1	0.1	0.4	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.3	1.3	0.0	0.0	0.4	0.3	0.1	0.0	0.1	0.0	0.6	0.1	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.7	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAH5	"CILD3, Dnahc5, HL1, KTGNR, PCD"	ENSG00000039139	"Dynein axonemal heavy chain 5"	Q8TE73	5	13690331-13944543	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.1;LHCN-M2: 2.7;PC-3: 6.6;RPTEC TERT1: 3.6;TIME: 2.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 3.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037469, HPA037470"	Enhanced									"HPA037469: AB_10672791, HPA037470: AB_10672348"	"unprognostic (3.85e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (6.23e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.86e-2)"	"unprognostic (9.94e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (9.97e-3)"	"unprognostic (8.87e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	0.0	0.1	0.5	0.0	1.1	0.0	3.7	0.0	0.4	0.7	0.0			0.0	0.3	0.2	0.0	8.9	0.2	0.0	0.8	1.1	1.9	1.6	3.8	0.0	0.2		0.0	1.7	0.0	3.3	0.0		1.6	0.0		0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7			2.4		0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	0.2	0.1	0.0	0.2	0.1	0.9	4.1	0.2	0.3	0.0	1.4	0.0	1.4	0.6	0.3	0.0	0.9	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.7	0.0	0.0	2.7	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	3.6	1.0	0.7	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
DNAH6	"Dnahc6, DNHL1, FLJ37357, HL-2"	ENSG00000115423	"Dynein axonemal heavy chain 6"	Q9C0G6	2	84516455-84819589	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;fallopian tube: 15.3;pituitary gland: 17.4"	"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.5;SK-MEL-30: 2.9;U-266/70: 1.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 3.8;naive CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.8"	"Low region specificity"	"Detected in many"							HPA036391	Enhanced									"HPA036391: AB_10672220"	"unprognostic (4.87e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-8)"	"unprognostic (2.04e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.97e-2)"	1.4	1.2	7.7	0.8	17.7	0.7	1.7	0.6	10.0	1.8	1.0	3.2	0.7	0.7	2.0	11.0	0.6	15.3	0.8	0.6	7.9	3.5	1.9	3.6	4.8	1.0	0.9	7.2	5.1	1.2	6.2	17.4	0.7	23.7	1.1	1.1	0.5	0.6	1.3	0.5	0.7	0.8	0.8	1.6	0.8	2.0	7.2	3.0	0.0	3.9	0.0	0.8	0.7	0.6	0.0	0.2	0.1	0.0	0.0	3.8	0.4	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.0	0.9	0.0	2.9	0.0	0.5	0.0	0.5	0.5	0.4	0.2	1.6	0.1	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	3.8	1.2	0.0	0.0	0.0	0.2	0.0	0.4	7.7	17.7	0.6	10.0	7.9	3.5	0.9	7.2	23.7	3.0
DNAH7	KIAA0944	ENSG00000118997	"Dynein axonemal heavy chain 7"	Q8WXX0	2	195737703-196068812	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.7;fallopian tube: 19.4;pituitary gland: 25.2"	"Cell line enhanced"	"Detected in some"		"PC-3: 10.5;RPTEC TERT1: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"neutrophil: 2.0;plasmacytoid DC: 2.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.0;granulocytes: 2.0"					"Low region specificity"	"Detected in many"			"HPA034724, HPA044070"	Approved		Supported	Cytosol				Cytosol		"HPA034724: AB_10670977, HPA044070: "	"unprognostic (1.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.58e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.24e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.98e-2)"	1.0	2.6	6.8	1.4	9.9	0.7	1.9	0.6	6.4	3.3	1.9	4.6	4.3	0.9	2.2	12.9	1.1	19.4	1.9	1.4	7.1	5.8	4.5	1.2	9.5	0.9	3.4	3.5	3.9	4.2	3.6	25.2	0.9	21.7	1.9	1.6	1.8	1.8	2.5	0.6	0.9	1.9	1.2	2.1	0.8	1.5	18.3	2.3	0.0	5.9	0.0	1.0	1.3	0.5	0.3	2.0	2.0	0.0	0.1	0.2	0.2	0.6	2.4	0.5	0.2	1.3	0.9	0.1	0.2	1.4	0.5	0.5	0.5	1.7	0.0	0.7	0.5	0.1	0.0	0.3	0.4	0.0	1.4	0.0	2.9	0.7	0.2	0.1	0.2	0.3	0.4	2.1	0.4	0.0	0.6	3.3	0.9	2.4	0.0	0.1	0.5	10.5	0.1	0.6	0.8	4.9	0.3	1.1	1.9	0.6	0.4	0.2	0.9	0.2	0.0	1.3	0.4	2.0	0.6	2.6	2.3	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.1	2.0	0.1	0.0	2.0	0.0	0.2	6.8	9.9	0.6	6.4	7.1	5.8	3.4	3.5	21.7	2.3
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715341-39030529	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 36.0"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 32.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028447	Uncertain									"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.0	3.5	0.0	0.0	0.0	0.1	0.0	2.6	0.2	0.0	0.1	5.0	0.0	36.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.7	0.0	5.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	32.3	0.0	0.0	0.0	0.0	4.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
DNAH9	"DNAH17L, Dnahc9, DNAL1, DYH9, HL-20, HL20, KIAA0357"	ENSG00000007174	"Dynein axonemal heavy chain 9"	Q9NYC9	17	11598431-11969748	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.8;fallopian tube: 41.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.2;Karpas-707: 1.6;NTERA-2: 2.3;SH-SY5Y: 1.9;WM-115: 4.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA052641	Enhanced									"HPA052641: "	"unprognostic (4.16e-3)"	"unprognostic (3.67e-2)"	"unprognostic (9.31e-2)"	"prognostic favourable (6.79e-5)"	"unprognostic (8.37e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-3)"	"unprognostic (5.31e-2)"	2.8	1.4	8.1	0.9	8.3	0.6	1.1	0.8	5.2	2.0	0.7	13.1	2.1	0.6	2.3	9.6	0.8	41.2	1.0	0.6	11.4	10.4	1.7	0.7	5.5	0.6	8.4	2.2	8.2	2.7	2.8	3.0	1.0	18.8	1.5	0.7	0.8	0.6	3.1	0.9	1.0	0.6	1.2	8.5	0.7	0.7	7.1	3.6	0.0	1.5	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.1	8.3	0.8	5.2	11.4	10.4	8.4	2.2	18.8	3.6
DNAI1	"CILD1, DIC1, PCD"	ENSG00000122735	"Dynein axonemal intermediate chain 1"	Q9UI46	9	34457414-34520989	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Motor protein"	"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 14.6;fallopian tube: 32.2;pituitary gland: 36.4;testis: 47.0"	"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 5.6;HDLM-2: 4.0;RPTEC TERT1: 2.1;SK-BR-3: 2.9;T-47d: 1.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA021649, HPA021843"	Enhanced									"HPA021649: AB_1847913, HPA021843: AB_1847914"	"unprognostic (9.61e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.39e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.16e-3)"	"unprognostic (8.14e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.13e-1)"	0.4	0.4	2.3	0.4	8.0	0.4	0.9	0.3	3.1	2.2	0.4	3.6	0.0	0.4	1.3	6.8	0.4	32.2	0.5	0.4	2.7	3.3	0.9	0.5	4.3	0.4	1.0	0.2	3.5	1.2	1.9	36.4	0.4	14.6	0.5	0.4	1.3	0.4	0.5	0.4	0.4	0.4	0.4	0.6	0.4	0.6	47.0	1.5	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	1.8	0.7	0.2	0.0	5.6	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	2.1	0.0	0.4	0.3	0.0	2.9	0.8	1.9	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	8.0	0.3	3.1	2.7	3.3	1.0	0.2	14.6	1.5
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 42.5;LHCN-M2: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.7	3.5	2.0	15.0	28.0	1.6	27.2	6.9	12.1	13.7	0.9	1.8	2.0	4.6	12.9	2.1	4.4	2.4	20.7	2.3	1.2	1.0	8.2	6.6	20.3	0.5	0.5	11.6	6.6	15.7	4.5	42.5	4.4	1.4	72.3	0.1	0.6	1.5	2.1	1.3	1.1	6.0	1.3	2.9	0.7	2.5	0.8	3.1	2.3	2.6	0.9	0.8	20.3	17.1	4.2	12.1	3.5	1.2	0.4	1.8	2.3	1.2	2.9	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5
DNAJC2	"MPHOSPH11, MPP11, ZRF1, ZUO1, zuotin"	ENSG00000105821	"DnaJ heat shock protein family (Hsp40) member C2"	Q99543	7	103312474-103344873	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chaperone, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020454	Approved		Supported	Cytosol				Cytosol		"HPA020454: AB_1859492"	"unprognostic (1.07e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.28e-1)"	12.8	12.5	12.8	21.5	14.2	37.0	13.6	12.9	16.8	13.3	15.0	5.1	10.7	14.3	13.4	12.5	13.6	11.8	11.5	13.6	11.4	11.0	16.2	25.2	10.7	15.5	13.3	12.7	16.4	13.2	12.2	28.5	13.8	16.1	12.0	13.0	5.6	12.6	9.1	29.4	12.7	18.6	13.1	12.2	19.7	12.8	30.6	15.7	17.6	13.0	12.0	13.6	16.6	16.5	9.1	7.1	28.6	9.1	10.0	8.8	3.7	17.3	12.6	7.2	13.8	5.8	8.1	14.8	12.0	8.7	13.4	10.0	18.7	12.8	24.6	19.3	8.2	11.8	19.5	8.7	20.5	13.1	16.1	18.2	11.9	15.8	10.5	32.0	14.5	7.0	7.6	15.6	14.0	8.7	42.1	16.1	10.9	29.1	30.5	33.1	25.8	19.5	19.6	14.9	22.9	7.9	8.3	14.2	13.2	16.2	22.6	12.5	9.6	16.3	10.3	13.3	21.3	28.7	23.4	17.1	22.5	49.3	9.5	33.4	16.6	28.6	6.0	5.5	7.6	6.5	8.4	7.8	7.6	7.9	5.9	9.1	8.8	8.8	2.4	10.0	9.1	7.1	8.1	3.7	12.8	14.2	12.9	16.8	11.4	11.0	13.3	12.7	16.1	15.7
DNM1	DNM	ENSG00000106976	"Dynamin 1"	Q05193	9	128191655-128255248	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 133.5"	"Cell line enhanced"	"Detected in many"		"A549: 48.8;U-87 MG: 18.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005920, HPA049910, HPA061801"	Enhanced		Supported	Nucleoplasm			440000	Nucleoplasm		"CAB005920: , HPA049910: , HPA061801: "	"unprognostic (3.25e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.34e-3)"	"unprognostic (3.95e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.60e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.62e-3)"	"unprognostic (6.30e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-3)"	5.9	6.1	31.5	3.3	36.9	2.3	4.6	57.7	133.5	11.7	3.0	2.5	0.0	2.4	4.6	2.7	3.3	6.3	9.0	2.7	33.4	24.0	2.9	1.8	2.5	2.5	18.3	33.0	1.6	4.7	3.2	5.5	2.7	33.0	2.9	2.9	4.3	2.6	3.1	2.3	4.6	3.3	4.4	5.1	1.6	2.6	4.0	1.8	0.0	1.9	0.4	2.3	3.6	3.7	0.3	0.4	0.5	0.3	0.0	0.3	0.7	3.2	48.8	4.4	1.0	1.4	14.9	0.2	3.0	7.3	6.2	2.6	0.6	1.0	0.0	4.2	6.3	5.8	0.7	0.3	3.4	0.0	4.7	3.1	7.0	0.2	1.0	0.4	2.2	3.9	0.1	4.8	0.0	0.0	1.1	0.2	0.0	1.3	0.2	1.0	4.7	8.9	5.8	0.1	1.5	0.9	0.0	6.3	10.6	10.4	0.3	0.4	0.1	4.2	0.2	0.2	14.1	14.2	6.2	0.4	0.1	0.3	18.6	0.1	1.0	0.0	0.3	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.4	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.7	31.5	36.9	57.7	71.8	33.4	24.0	18.3	33.0	33.0	1.8
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Supported		Enhanced	Vesicles,Cytosol			10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: "	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	22.1	22.1	23.2	23.8	18.8	19.3	44.9	24.9	19.2	23.5	21.8	31.0	17.0	29.8	17.5	22.5	19.9	24.4	28.6	28.3	15.7	19.9	33.9	21.3	17.0	15.5	24.0	17.9	17.4	14.5	24.9	25.7	28.4	24.5	12.9	26.9	8.6	9.6	20.2	48.9	10.8	16.2	43.7	20.3	19.8	30.5	20.3	20.8	26.5	18.2	19.4	20.9	16.4	25.6	20.1	20.2	47.1	23.1	9.1	24.6	31.1	19.5	16.1	15.2	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"			500000	"Golgi apparatus, Cytosol"		"HPA054246: "	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (8.91e-4)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	34.9	28.9	21.2	16.9	21.9	21.5	27.2	23.4	22.2	34.7	29.5	28.8	23.1	25.4	42.2	25.2	30.7	28.9	25.4	29.1	31.1	23.0	48.7	25.8	32.2	27.0	26.7	46.3	22.0	19.6	26.5	25.0	33.7	39.1	43.7	21.3	42.3	37.2	25.5	24.1	35.0	37.8	23.0	28.6	22.8	52.7	30.6	20.0	26.7	22.9	16.7	18.4	31.8	30.5	38.1	12.9	53.5	30.9	36.2	36.9	23.4	28.5	40.9	18.8	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4
DNM3	KIAA0820	ENSG00000197959	"Dynamin 3"	Q9UQ16	1	171841498-172418466	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Hydrolase, Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell line enhanced"	"Detected in many"		"HEL: 17.9;HMC-1: 8.3;RH-30: 8.1;RPTEC TERT1: 15.5;U-251 MG: 11.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064121			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA064121: "	"unprognostic (8.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.70e-3)"	5.0	19.3	14.1	2.3	28.3	2.6	3.4	41.4	39.7	6.8	2.7	26.8	0.0	1.9	5.9	3.1	3.0	6.0	5.1	3.0	14.3	16.3	5.8	1.4	7.5	2.5	19.6	17.7	4.6	2.6	3.5	10.3	1.6	47.3	3.6	2.7	2.9	3.7	3.6	2.5	4.0	2.4	5.7	16.4	3.6	5.3	5.4	22.1	0.0	3.4	0.0	2.2	4.3	3.6	0.7	0.7	1.1	0.4	1.0	4.0	3.8	0.6	2.0	1.6	0.3	1.2	0.8	0.0	0.4	1.0	0.8	1.0	0.0	2.9	0.0	6.2	0.9	0.2	1.2	2.3	0.7	0.8	2.3	17.9	3.0	0.0	0.1	0.3	8.3	0.6	0.4	0.9	0.5	0.4	0.0	0.2	0.3	0.0	1.1	0.1	4.7	1.4	1.1	8.1	0.0	15.5	0.1	3.2	0.6	2.1	0.6	0.2	0.0	0.7	0.2	2.3	3.1	1.9	11.1	3.1	0.5	0.1	2.2	0.9	0.8	0.0	0.4	0.0	0.7	0.0	0.9	0.7	1.0	0.5	0.7	0.0	1.2	1.5	1.1	1.0	0.3	0.0	4.0	3.8	14.1	28.3	41.4	31.6	14.3	16.3	19.6	17.7	47.3	22.1
DNMT1	"CXXC9, DNMT, MCMT"	ENSG00000130816	"DNA methyltransferase 1"	P26358	19	10133345-10231286	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Deafness, Disease mutation, FDA approved drug targets, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002694, CAB005876"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB005876: AB_731983, HPA002694: AB_1847810"	"unprognostic (3.51e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.62e-1)"	"unprognostic (7.59e-3)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.73e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.46e-1)"	12.1	7.6	9.8	20.2	10.8	31.9	11.5	27.1	14.4	12.0	8.6	10.0	4.3	8.1	12.1	8.0	12.0	11.5	7.8	8.0	9.3	8.1	6.9	9.2	11.8	29.7	12.5	7.9	11.1	6.2	10.2	8.8	32.5	8.7	8.3	10.7	7.8	9.3	6.5	6.8	10.8	11.3	11.2	9.1	11.0	9.0	19.9	12.6	31.4	9.5	8.8	28.8	11.4	9.7	12.6	19.0	10.2	13.4	25.0	18.2	6.8	24.0	15.2	19.5	16.5	7.3	7.5	41.8	16.3	13.0	23.5	23.6	14.7	13.1	40.3	10.2	10.0	15.9	21.4	12.7	24.1	15.8	31.9	58.4	13.6	7.6	3.1	23.8	23.7	5.0	2.4	20.5	8.1	12.7	23.1	24.9	17.5	16.0	34.7	32.4	25.5	22.2	35.2	20.4	22.2	7.4	15.3	20.8	16.1	19.8	8.9	6.4	9.3	12.1	9.6	39.5	13.5	23.9	24.1	20.4	21.2	47.7	11.5	22.2	30.6	10.2	13.4	3.3	18.2	13.2	15.9	7.9	14.6	12.5	11.3	12.6	16.6	12.3	3.1	25.0	7.9	19.0	12.9	6.8	9.8	10.8	27.1	14.4	9.3	8.1	12.5	7.9	8.7	12.6
DNMT3A		ENSG00000119772	"DNA methyltransferase 3 alpha"	Q9Y6K1	2	25227855-25342590	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 25.5;REH: 25.1;SH-SY5Y: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009469, HPA026588"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009469: AB_2093990, HPA026588: AB_1847812"	"unprognostic (2.38e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (8.38e-2)"	"unprognostic (7.27e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.18e-4)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-2)"	7.8	12.4	13.7	12.7	15.5	10.8	8.6	21.6	20.1	9.0	12.7	14.5	7.6	9.1	13.0	12.2	8.0	9.6	8.9	8.2	12.3	6.7	9.4	6.9	9.5	13.6	15.3	10.1	18.3	12.1	6.3	12.6	20.8	10.7	9.3	9.2	12.0	8.5	9.2	29.1	6.6	11.4	11.3	7.9	17.5	11.6	6.6	15.2	20.8	9.1	10.5	11.8	9.8	8.4	3.0	4.1	4.9	4.1	8.7	8.3	2.3	1.0	3.5	14.7	3.6	1.6	1.2	19.4	1.0	0.9	2.0	1.6	8.7	5.7	0.0	2.2	1.9	0.9	1.6	2.2	1.2	3.6	2.5	6.3	5.3	10.4	3.8	1.3	4.1	3.6	1.1	2.6	0.9	8.2	7.3	1.3	1.5	8.4	13.8	14.9	25.5	1.9	25.1	16.2	2.1	1.2	1.5	8.8	31.0	1.2	8.4	2.6	0.9	6.7	2.8	2.5	3.2	0.6	1.3	3.1	2.2	8.5	0.9	3.8	2.6	4.7	1.8	3.1	5.2	3.0	7.0	2.3	3.4	4.9	2.0	3.0	8.3	6.6	4.9	8.7	4.1	4.1	2.8	2.3	13.7	15.5	21.6	20.1	12.3	6.7	15.3	10.1	10.7	15.2
DNPEP	"ASPEP, DAP"	ENSG00000123992	"Aspartyl aminopeptidase"	Q9ULA0	2	219373527-219400022	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036398, HPA044860"	Enhanced		Supported	Cytosol			6200000	Cytosol		"HPA036398: AB_10970915, HPA044860: AB_10961275"	"unprognostic (3.71e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.54e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.85e-3)"	20.1	12.3	8.8	15.5	10.4	7.2	20.0	7.2	9.3	16.5	30.4	8.6	13.8	27.9	15.1	13.3	16.9	15.3	16.6	22.9	10.4	6.8	21.2	33.5	15.5	11.7	10.5	7.2	19.4	19.0	9.7	11.0	28.5	9.4	21.0	15.8	15.9	18.7	14.7	36.6	14.6	50.3	12.9	6.8	17.5	15.2	33.7	9.3	11.3	15.0	20.0	17.4	20.7	13.1	11.6	16.1	5.8	15.0	15.7	15.7	10.9	16.0	8.8	5.4	16.1	14.4	11.9	43.0	8.0	16.2	20.9	22.1	24.3	21.2	9.8	17.3	16.6	15.8	6.5	18.3	7.6	19.2	4.6	15.9	9.0	26.4	38.2	13.1	11.4	19.3	19.5	21.5	18.0	14.3	17.9	15.8	10.7	34.9	20.0	14.6	8.9	5.5	26.0	12.4	12.9	11.6	25.0	6.8	9.2	9.3	30.8	11.3	9.0	14.5	7.9	20.1	16.6	10.5	11.5	17.7	10.3	7.0	28.6	12.6	8.5	5.8	13.2	5.4	13.6	15.0	15.4	10.2	11.0	15.0	16.1	11.6	12.0	15.7	1.0	15.7	12.2	5.8	12.6	10.9	8.8	10.4	7.2	9.3	10.4	6.8	10.5	7.2	9.4	9.3
DNTT	TDT	ENSG00000107447	"DNA nucleotidylexotransferase"	P04053	10	96304396-96338564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Terminal addition"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"lymphoid tissue: 171.0"	"Group enriched"	"Detected in some"	420	"MOLT-4: 48.7;REH: 168.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"naive B-cell: 1.2;naive CD4 T-cell: 4.5"	"Group enriched"	"Detected in many"	15	"B-cells: 1.2;T-cells: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036532, HPA044194"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA036532: , HPA044194: AB_10960525"								"unprognostic (4.24e-1)"					"unprognostic (1.00e-1)"		"unprognostic (2.60e-2)"	"unprognostic (1.86e-2)"		0.0	0.0	0.1	0.1	0.3	24.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	2.7	0.0	171.0	0.6	0.0	2.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	168.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0
DNTTIP1	"C20orf167, dJ447F3.4, Tdif1"	ENSG00000101457	"Deoxynucleotidyltransferase terminal interacting protein 1"	Q9H147	20	45791937-45811427	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 74.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Group enriched"	"Detected in all"	7	"dendritic cells: 14.2;granulocytes: 41.0;monocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045496			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA045496: "	"unprognostic (7.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (1.79e-5)"	"unprognostic (6.29e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.81e-3)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (1.90e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	15.2	16.3	15.8	19.0	18.0	31.6	16.0	15.5	19.9	16.4	24.2	15.4	20.5	14.0	23.3	21.3	18.8	20.6	18.6	20.6	14.6	15.3	15.6	18.7	18.2	17.7	14.5	17.6	20.1	24.1	18.2	17.8	18.3	15.1	23.5	32.0	16.1	21.0	21.6	45.0	21.8	19.6	32.6	13.8	21.2	20.7	36.9	11.8	25.2	21.1	19.4	21.7	30.1	16.1	3.2	14.2	41.0	16.6	1.0	3.4	4.5	20.4	10.9	11.3	10.7	8.7	9.4	11.8	7.7	12.5	25.0	22.7	34.6	33.6	8.5	25.3	11.2	15.5	9.9	16.5	16.7	4.6	12.4	9.2	11.5	22.0	17.7	18.0	15.4	9.4	15.6	16.3	15.8	14.6	8.5	8.7	14.8	27.2	14.7	27.9	7.6	74.6	11.9	14.0	8.8	12.5	9.8	10.6	9.6	15.7	12.8	16.1	12.7	28.9	8.5	15.0	11.2	14.5	18.4	9.5	6.1	10.5	32.8	11.6	12.8	4.8	16.6	21.6	1.4	6.9	1.4	3.2	1.9	2.4	14.2	2.7	3.4	1.6	41.0	1.0	4.2	5.5	2.7	4.5	15.8	18.0	15.5	19.9	14.6	15.3	14.5	17.6	15.1	11.8
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004378: AB_2094604, HPA048692: , HPA053277: "	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	17.1	7.7	27.4	8.1	36.8	1.0	17.4	6.9	25.4	23.5	12.5	27.4	14.3	12.2	18.3	18.0	13.8	17.6	16.2	12.9	24.4	17.8	18.9	9.0	12.8	8.0	34.5	11.4	24.2	12.1	38.6	5.3	17.9	25.0	16.1	13.0	9.4	15.4	18.3	9.7	30.0	13.6	21.2	25.4	8.7	11.0	6.6	32.3	2.2	25.1	9.1	5.5	14.5	18.5	0.0	2.3	0.0	0.7	0.8	0.0	0.0	6.4	12.3	24.2	17.1	12.4	16.7	5.3	12.9	27.4	9.3	9.8	7.7	7.4	0.0	4.3	19.1	7.4	7.6	9.6	10.9	0.1	7.4	4.0	8.1	8.9	12.2	0.0	6.0	13.4	2.9	9.6	20.8	21.1	0.0	0.0	13.9	6.5	0.0	0.0	5.9	5.6	0.0	15.8	0.1	9.2	7.1	1.4	10.2	13.5	7.7	12.0	1.9	0.0	22.1	16.7	6.7	4.2	12.3	0.0	0.0	0.0	13.3	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	27.4	36.8	6.9	25.4	24.4	17.8	34.5	11.4	25.0	32.3
DOCK10	"KIAA0694, ZIZ3"	ENSG00000135905	"Dedicator of cytokinesis 10"	Q96BY6	2	224765090-225042445	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;lymphoid tissue: 27.6"	"Cell line enhanced"	"Detected in many"		"BJ: 20.0;HDLM-2: 22.7;TIME: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058106	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA058106: "	"unprognostic (6.95e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (3.22e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (7.72e-2)"	4.2	7.6	17.1	16.7	28.8	8.8	4.0	3.0	18.4	9.5	5.9	27.6	0.0	4.1	3.4	1.4	3.4	2.5	6.4	1.8	24.3	14.7	2.9	5.4	7.3	23.9	33.3	9.6	15.9	1.8	1.9	1.4	2.5	23.2	2.0	6.7	1.1	4.1	2.0	1.3	5.0	8.5	4.4	37.7	26.5	6.1	2.3	35.5	27.6	2.7	1.3	18.4	6.6	3.7	6.8	6.2	2.6	9.6	12.8	10.5	4.0	0.0	9.4	3.0	0.0	3.9	8.3	0.0	20.0	16.4	9.6	7.2	0.0	0.0	0.2	0.0	12.6	0.2	0.0	0.0	7.7	22.7	0.0	0.2	2.0	0.0	0.1	1.9	0.9	1.9	0.2	13.9	5.4	9.5	0.0	18.8	16.2	0.9	3.4	2.6	1.1	2.2	4.5	4.4	2.7	0.5	0.0	0.1	2.5	0.0	0.0	2.0	0.6	8.7	21.2	10.4	2.5	4.9	6.8	0.0	0.0	0.0	14.7	12.9	4.5	2.6	2.8	0.2	6.2	8.2	6.4	6.8	10.5	8.8	6.2	3.8	10.4	9.0	0.1	12.8	9.6	2.6	7.5	4.0	17.1	28.8	3.0	18.4	24.3	14.7	33.3	9.6	23.2	35.5
DOCK2	KIAA0209	ENSG00000134516	"Dedicator of cytokinesis 2"	Q92608	5	169637247-170083382	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.0;bone marrow: 29.8;lymphoid tissue: 50.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.9;HDLM-2: 40.1;HL-60: 31.8;HMC-1: 37.0;MOLT-4: 24.2;U-698: 28.2;U-937: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036469	Enhanced									"HPA036469: "	"unprognostic (3.45e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.92e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.24e-2)"	7.3	3.1	2.9	30.7	4.8	29.8	4.1	1.0	2.7	2.2	3.5	5.8	1.2	2.6	2.9	2.7	2.4	2.9	4.9	2.7	3.4	2.5	3.1	2.9	12.6	22.6	4.8	1.3	1.9	1.9	0.7	2.2	3.8	4.1	3.3	4.5	2.6	6.6	1.2	1.3	2.0	13.7	3.6	8.5	28.0	3.6	1.8	3.7	50.3	2.8	1.7	31.5	6.2	2.5	6.4	14.0	12.7	31.0	6.6	6.6	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	3.2	0.0	0.0	31.9	0.6	2.5	0.0	0.0	0.0	4.0	40.1	0.0	17.7	0.3	0.0	0.0	31.8	37.0	0.0	0.0	0.7	0.0	0.0	0.3	16.0	0.8	0.0	24.2	8.2	0.0	0.0	15.1	0.5	12.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.1	0.3	1.0	0.4	0.7	5.0	7.8	28.2	0.6	22.1	0.0	6.2	12.7	10.0	6.4	23.0	6.6	6.4	5.9	6.3	14.0	5.3	4.3	5.0	12.7	6.6	31.0	4.8	5.3	9.4	2.9	4.8	1.0	2.7	3.4	2.5	4.8	1.3	4.1	3.7
DOCK4	"FLJ34238, KIAA0716"	ENSG00000128512	"Dedicator of cytokinesis 4"	Q8N1I0	7	111726110-112206411	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.7;HUVEC TERT2: 35.6;TIME: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071516			Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				"Nucleoli, Plasma membrane"	"Golgi apparatus, Cytosol"	"HPA071516: "	"unprognostic (1.37e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.48e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	10.7	6.5	16.5	10.0	28.2	2.3	6.8	11.7	28.2	9.1	4.4	21.0	2.0	2.8	7.9	4.4	4.4	8.7	7.9	6.9	22.2	10.1	7.3	13.9	25.5	3.7	18.2	12.4	14.2	5.0	4.7	4.0	10.8	12.2	6.5	4.9	1.7	4.4	3.9	6.7	3.5	3.2	10.7	20.3	3.2	3.1	3.5	21.8	0.0	5.8	2.7	3.6	5.7	5.2	0.2	0.3	6.4	1.2	0.1	0.1	0.2	0.0	1.6	4.0	3.2	3.3	4.9	2.3	0.4	4.4	0.8	1.3	0.0	0.0	0.3	3.3	1.0	0.1	0.6	3.8	3.4	1.2	6.6	0.1	2.7	5.6	2.4	0.5	0.2	2.6	0.4	18.7	9.7	35.6	0.0	10.1	1.7	0.4	0.8	0.2	2.1	6.9	0.2	2.9	1.6	2.7	0.1	0.9	3.1	2.5	2.0	2.4	0.3	0.1	30.7	3.1	1.5	6.0	1.3	0.4	0.1	0.3	0.3	0.7	6.9	0.2	0.7	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.1	6.4	0.1	0.2	0.3	0.0	0.2	16.5	28.2	11.7	18.2	22.2	10.1	18.2	12.4	12.2	21.8
DOCK9	"KIAA1058, ZIZ1"	ENSG00000088387	"Dedicator of cytokinesis 9"	Q9BZ29	13	98793429-99086625	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.8;hTERT-HME1: 90.8;HUVEC TERT2: 36.7;TIME: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 2.4;MAIT T-cell: 5.7;memory CD4 T-cell: 6.3;memory CD8 T-cell: 2.6;naive CD4 T-cell: 7.6;naive CD8 T-cell: 4.7;NK-cell: 8.5;T-reg: 2.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 8.5;T-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034061, CAB034065, HPA043940"	Uncertain									"CAB034061: AB_2277513, CAB034065: AB_2094798, HPA043940: "	"unprognostic (5.31e-2)"	"unprognostic (3.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.38e-3)"	"unprognostic (2.79e-1)"	"unprognostic (7.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.31e-2)"	48.8	8.7	24.7	10.1	42.0	2.9	26.4	20.0	33.4	17.2	15.1	54.5	10.5	8.0	13.7	19.3	41.7	15.5	18.5	19.3	29.1	19.9	12.0	8.0	37.1	15.7	40.9	18.2	13.1	10.5	20.8	8.8	49.1	40.5	12.2	11.0	17.7	20.1	12.3	10.2	38.5	12.8	19.0	34.0	8.2	9.7	7.9	43.5	2.2	31.9	13.1	19.8	14.3	23.2	0.7	0.0	0.1	0.0	8.5	7.6	1.8	12.3	3.9	2.2	2.9	2.2	1.7	40.8	3.5	2.8	2.5	2.2	25.4	9.6	10.5	8.2	3.3	12.2	5.6	11.1	4.5	10.3	3.0	0.0	7.6	0.4	2.9	0.0	0.6	1.9	7.8	2.5	90.8	36.7	2.1	2.4	10.7	4.0	7.1	0.0	1.0	2.9	0.4	8.0	0.5	7.9	10.2	4.9	5.5	5.3	13.3	3.2	3.6	0.0	36.1	2.1	2.4	1.4	5.6	3.7	2.8	1.6	3.5	0.0	3.2	0.0	0.0	0.0	2.4	0.0	5.7	0.7	6.3	2.6	0.0	0.4	7.6	4.7	0.1	8.5	0.0	0.0	2.7	1.8	24.7	42.0	20.0	33.4	29.1	19.9	40.9	18.2	40.5	43.5
DOK1	p62dok	ENSG00000115325	"Docking protein 1"	Q99704	2	74549026-74557554	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004224, HPA048561"	Approved		Supported	Cytosol			74000	Cytosol		"CAB004224: AB_627447, HPA048561: "	"unprognostic (2.40e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.60e-1)"	"prognostic favourable (8.42e-4)"	"unprognostic (9.86e-3)"	"unprognostic (1.28e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (4.64e-4)"	"unprognostic (7.57e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (3.16e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.20e-2)"	13.2	4.9	4.7	11.2	6.0	15.7	13.3	1.3	3.3	6.2	5.9	5.3	2.6	4.3	7.0	3.6	3.4	5.5	8.0	5.0	4.9	4.2	4.7	2.3	8.0	9.5	6.9	2.8	6.7	10.9	5.5	3.1	5.0	5.4	5.6	5.1	3.1	4.1	5.0	2.0	2.2	7.2	4.7	6.7	15.5	6.6	4.5	5.2	14.5	8.8	1.3	10.8	5.0	7.7	6.9	13.9	17.9	16.1	7.4	5.6	9.9	2.1	0.6	2.0	1.5	4.3	4.7	1.9	4.3	2.7	1.3	2.1	0.7	2.2	1.0	6.8	4.1	0.3	2.9	1.2	0.7	31.2	2.9	13.3	1.9	0.1	3.6	7.6	14.3	4.5	0.0	10.7	4.9	1.7	4.1	2.8	3.1	2.2	6.1	16.6	4.1	0.9	4.9	3.9	1.6	1.0	1.9	0.9	3.7	1.4	0.2	3.4	1.5	11.1	3.4	10.5	6.1	5.7	1.0	4.4	3.2	0.0	10.1	10.8	1.8	10.8	15.1	11.3	4.9	14.3	4.1	6.7	3.9	4.2	13.9	6.9	3.6	3.6	17.9	7.4	16.1	2.9	5.6	9.9	4.7	6.0	1.3	2.8	4.9	4.2	6.9	2.8	5.4	5.2
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA059449: , HPA062780: "	"prognostic favourable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favourable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	1.0	0.0	3.4	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.3	27.1	0.0	1.1	0.2	0.1	0.0	5.3	0.2	1.8	2.3	0.4	0.1	2.2	0.0	0.0	6.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4
DONSON	"B17, C21orf60, C2TA, DKFZP434M035"	ENSG00000159147	"Downstream neighbor of SON"	Q9NYP3	21	33559542-33588708	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039558, HPA049033"	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Nucleoplasm, Cell Junctions"	Cytosol	"HPA039558: , HPA049033: "	"unprognostic (9.90e-3)"	"unprognostic (1.01e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (8.22e-4)"	"unprognostic (4.00e-2)"	"unprognostic (5.93e-3)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.77e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.83e-2)"	6.4	3.5	4.1	9.2	8.0	9.4	10.2	7.8	5.6	6.8	7.1	3.3	3.5	6.1	6.7	5.8	8.3	6.3	5.9	7.5	5.5	4.4	5.6	16.2	5.2	11.1	4.7	4.0	13.5	5.7	11.7	6.9	12.2	8.1	5.7	7.4	4.4	4.8	4.3	5.9	9.1	9.3	5.4	5.2	8.2	5.8	24.0	3.0	26.4	5.0	8.1	10.7	4.5	9.7	0.7	0.5	0.1	0.9	0.4	1.4	0.3	27.0	6.3	13.3	11.6	4.2	7.7	10.4	21.6	9.3	16.6	18.8	17.8	7.4	14.7	5.6	10.7	8.1	17.9	7.7	18.2	14.7	15.5	27.6	13.9	16.1	3.0	14.6	6.7	5.5	2.5	18.7	4.6	10.6	26.3	25.7	14.2	5.5	13.3	5.2	13.8	7.8	12.0	27.6	15.7	7.4	7.3	14.5	6.0	32.4	10.4	9.5	13.6	7.4	6.1	15.8	11.0	11.5	15.2	23.3	22.9	24.2	8.8	19.5	17.8	0.0	0.3	0.1	1.4	0.9	0.7	0.2	1.4	0.6	0.2	0.7	0.8	0.1	0.0	0.4	0.0	0.5	0.6	0.3	4.1	8.0	7.8	5.6	5.5	4.4	4.7	4.0	8.1	3.0
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA011875: , HPA071217: , HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favourable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.0	6.5	22.1	12.1	1.6	2.4	29.1	6.9	1.5	3.8	3.0	8.3	4.5	14.2	3.3	4.4	10.9	7.3	3.8	1.8	7.2	9.2	13.1	10.6	8.1	2.7	18.6	24.1	2.4	2.9	7.3	3.7	3.1	15.8	14.9	2.9	6.9	14.9	20.6	17.1	11.6	15.4	6.3	9.7	2.1	5.7	14.8	11.4	4.8	14.4	9.1	6.6	14.3	4.4	10.6	9.6	15.6	13.2	13.8	18.0	9.8	10.5	12.9	6.1	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7
DPEP2		ENSG00000167261	"Dipeptidase 2"	Q9H4A9	16	67987394-68000586	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Dipeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 105.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HMC-1: 19.5;NB-4: 4.2;U-937: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 43.5;eosinophil: 105.1;neutrophil: 47.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 105.1"					"Low region specificity"	"Detected in many"			HPA035644	Approved						260000000			"HPA035644: AB_10670164"	"unprognostic (8.81e-2)"	"unprognostic (7.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.66e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.91e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (7.78e-3)"	"unprognostic (3.91e-2)"	7.8	0.9	1.3	7.1	2.4	13.0	3.5	0.7	2.5	1.5	2.6	2.4	1.1	1.7	4.1	4.1	1.8	2.0	6.8	2.4	1.6	1.3	2.0	2.0	11.4	10.4	2.1	2.0	0.7	0.9	0.1	0.9	19.4	2.7	2.4	2.4	5.1	2.8	0.4	1.6	1.2	10.1	2.3	3.3	26.4	1.6	2.5	1.6	3.5	2.5	3.8	11.1	6.3	1.5	5.0	4.3	105.1	15.3	5.6	4.9	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	1.3	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	4.3	0.0	0.1	0.0	0.1	19.5	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	4.2	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.3	0.0	6.5	0.0	43.5	10.7	105.1	2.3	13.0	2.7	4.1	4.0	1.9	4.3	5.0	4.9	2.5	47.3	5.6	15.3	0.6	4.0	5.7	1.3	2.4	0.7	2.5	1.6	1.3	2.1	2.0	2.7	1.6
DPF2	"BAF45d, REQ, ubi-d4"	ENSG00000133884	"Double PHD fingers 2"	Q92785	11	65333754-65353249	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020880, HPA056786"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020880: AB_1847845, HPA056786: "	"unprognostic (2.06e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.40e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.34e-1)"	18.5	16.3	22.5	14.3	26.4	23.0	17.0	29.4	28.6	26.3	24.8	41.7	16.9	14.1	31.5	25.5	19.5	34.9	20.8	27.1	21.4	20.4	14.7	12.2	17.3	21.4	30.4	18.6	46.3	18.1	21.9	17.7	19.8	23.2	22.9	15.9	21.7	19.7	30.5	27.6	14.2	17.9	31.2	27.3	23.3	18.9	27.0	30.3	40.6	26.1	10.8	25.8	25.2	21.3	36.9	26.4	56.1	26.5	41.8	35.2	33.7	13.3	17.0	21.5	18.7	19.4	19.7	12.0	11.6	16.5	25.8	18.6	16.6	16.2	18.2	19.3	15.9	14.3	24.7	14.9	18.5	21.5	10.8	23.1	12.1	16.9	30.0	21.1	17.1	17.2	14.5	22.9	42.0	20.5	21.7	23.8	16.8	21.6	26.5	21.6	23.9	17.3	29.0	14.1	21.1	15.9	11.1	14.0	12.8	15.0	21.2	20.3	27.6	11.6	12.0	16.7	14.8	18.2	11.7	29.3	34.5	23.3	10.2	13.9	18.6	53.0	26.5	46.9	29.4	23.9	31.7	36.7	28.6	28.5	26.4	36.9	30.0	27.1	56.1	41.8	26.1	24.2	35.2	33.7	22.5	26.4	29.4	28.6	21.4	20.4	30.4	18.6	23.2	30.3
DPM1	"CDGIE, MPDS"	ENSG00000000419	"Dolichyl-phosphate mannosyltransferase subunit 1, catalytic"	O60762	20	50934867-50958555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA051818	Approved									"HPA051818: "	"unprognostic (2.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.49e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.74e-1)"	32.3	39.7	20.2	23.3	30.0	32.9	29.0	22.5	35.1	31.1	28.1	21.3	28.9	24.0	29.9	32.9	36.0	25.6	24.0	38.7	22.2	21.5	41.7	54.0	24.2	33.0	21.6	17.2	30.8	38.9	21.2	35.1	43.9	31.4	29.8	28.9	22.8	35.9	31.5	44.7	27.1	35.6	24.9	21.1	38.6	30.4	25.6	21.7	36.1	34.5	49.1	36.4	35.3	28.3	20.7	25.0	22.2	19.6	20.3	25.1	15.7	34.6	14.1	21.8	13.0	19.0	21.6	23.9	13.8	15.8	26.7	21.1	63.5	28.2	21.2	30.1	17.8	39.9	17.4	32.7	27.2	10.1	13.9	22.0	18.3	42.7	27.1	34.8	13.2	18.5	48.3	18.5	19.3	20.3	33.1	26.9	26.5	15.3	31.5	36.8	22.3	32.2	17.5	31.9	28.0	26.6	21.1	16.4	17.9	35.6	52.6	46.0	35.8	41.3	16.8	34.3	28.5	20.1	28.3	19.2	24.3	30.4	37.8	23.3	15.5	12.2	16.8	18.6	19.0	19.6	23.0	20.7	21.8	20.3	21.9	19.3	23.7	25.1	22.2	20.3	18.9	25.0	21.0	15.7	20.2	30.0	22.5	35.1	22.2	21.5	21.6	17.2	31.4	21.7
DPP3		ENSG00000254986	"Dipeptidyl peptidase 3"	Q9NY33	11	66480013-66509657	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035780, HPA035781"	Approved		Supported	Cytosol			2600000	Cytosol		"HPA035780: AB_2674778, HPA035781: AB_10669529"	"unprognostic (5.74e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.62e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.67e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.73e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.85e-2)"	"prognostic favourable (1.34e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.66e-2)"	10.4	13.0	5.2	16.8	12.1	10.9	16.9	13.7	11.5	7.3	18.5	9.1	10.3	15.3	10.5	6.8	15.6	7.1	15.7	8.4	9.3	5.9	18.4	31.1	9.8	20.0	9.5	10.6	5.1	11.6	11.2	6.9	10.9	7.4	10.3	16.9	5.7	17.6	8.5	15.8	9.4	15.5	10.0	10.6	12.5	11.8	15.5	6.7	16.1	10.5	10.8	14.0	11.4	8.6	7.5	19.7	12.2	24.4	18.2	17.9	9.9	28.5	24.8	11.5	12.8	9.6	10.4	17.9	16.2	21.8	21.9	14.6	31.2	24.0	16.6	55.2	18.3	25.7	18.3	19.8	14.1	31.5	8.3	21.6	11.6	18.3	14.8	26.1	36.1	14.7	19.4	16.4	8.2	16.7	15.1	9.9	19.9	32.4	30.4	26.6	19.6	15.2	21.5	11.6	27.2	18.8	24.6	21.8	18.7	13.8	16.1	21.6	25.0	15.3	17.4	13.1	14.3	14.4	15.8	8.3	15.1	18.9	17.4	12.5	16.1	9.6	11.3	12.2	13.7	24.4	8.4	7.5	10.3	11.4	19.7	7.2	6.3	9.2	2.0	18.2	16.0	13.7	17.9	9.9	5.2	12.1	13.7	11.5	9.3	5.9	9.5	10.6	7.4	6.7
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Aminopeptidase, Hydrolase, Protease, Receptor, Serine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.8;ASC TERT1: 42.4;BJ hTERT+: 38.9;RPTEC TERT1: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB045970	Enhanced				"Secreted in other tissues"		170000000			"CAB045970: AB_11140529"	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.98e-4)"	"prognostic favourable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favourable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	41.8	42.4	0.1	7.7	38.9	2.1	7.6	7.8	0.2	0.0	2.9	13.4	0.2	0.1	0.0	1.3	2.4	0.1	0.0	0.0	11.7	17.1	0.0	0.0	4.8	0.0	13.1	0.1	1.2	0.0	0.0	0.7	0.0	0.7	0.1	0.4	16.0	0.0	0.0	0.1	56.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	4.5	0.2	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 56.7;THP-1: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Supported		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: "	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavourable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favourable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.8	10.9	0.9	0.9	13.5	10.8	1.4	10.4	17.0	6.9	4.5	10.3	5.7	13.6	11.4	6.8	14.9	8.0	2.0	0.3	13.3	0.5	6.2	15.0	0.3	30.2	16.8	34.9	13.3	8.3	3.0	6.2	9.0	13.6	10.6	4.6	19.0	8.4	16.0	3.7	10.7	12.4	0.1	56.7	11.0	7.7	17.4	12.1	12.0	31.6	29.4	11.3	54.5	10.9	17.7	6.0	11.2	7.2	13.0	7.4	3.6	21.2	10.2	7.9	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8
DPP8	"DP8, DPRP1, FLJ14920, FLJ20283, MGC26191, MSTP141"	ENSG00000074603	"Dipeptidyl peptidase 8"	Q6V1X1	15	65442463-65517704	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008706	Approved		Supported	Cytosol				Cytosol		"HPA008706: AB_1078665"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.59e-1)"	15.6	16.1	16.4	14.9	18.8	16.2	13.9	22.9	24.9	15.5	14.5	15.0	12.7	18.0	15.9	13.9	13.1	11.1	12.4	18.8	15.1	14.6	16.0	9.9	13.3	16.0	15.4	11.8	16.2	11.7	22.2	14.5	15.9	21.7	13.5	15.8	13.9	15.6	20.8	30.5	14.2	16.5	16.2	17.5	17.2	13.2	29.9	15.8	22.5	17.4	12.5	16.0	16.2	13.2	10.7	8.1	20.0	10.8	6.1	10.3	5.3	9.4	15.3	10.1	10.1	11.4	16.4	8.6	15.3	18.1	13.7	13.2	6.6	8.2	16.7	12.1	19.1	17.7	19.5	11.0	16.8	14.1	12.1	16.1	11.8	6.3	11.9	20.7	15.9	12.2	10.5	11.1	10.5	15.0	10.9	15.6	16.8	7.6	11.0	7.6	6.9	7.9	14.7	18.7	16.2	11.3	20.6	7.2	12.7	9.9	10.1	15.4	9.3	12.4	18.9	18.4	12.9	8.7	16.3	20.2	26.4	17.0	13.9	20.9	13.2	20.0	9.1	11.1	9.9	9.2	10.3	9.2	8.6	9.5	8.1	10.7	8.6	9.2	18.3	6.1	10.8	7.5	8.9	5.3	16.4	18.8	22.9	24.4	15.1	14.6	15.4	11.8	21.7	15.8
DPYSL2	"CRMP2, DHPRP2, DRP-2, DRP2"	ENSG00000092964	"Dihydropyrimidinase like 2"	Q16555	8	26514022-26658178	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 137.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 60.4;Karpas-707: 62.2"	"Cancer enhanced"	"Detected in all"		"glioma: 89.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 25.5;monocytes: 26.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002381, CAB018719"	Supported		Supported	"Plasma membrane,Cytosol"			3900000	Cytosol	"Plasma membrane"	"CAB018719: AB_2085366, HPA002381: AB_1847244"	"unprognostic (2.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.32e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (5.41e-5)"	31.6	21.7	53.5	13.4	48.1	3.0	21.3	51.8	137.0	14.6	12.2	54.7	3.9	7.1	14.2	8.1	12.0	14.7	18.0	27.2	52.9	48.6	12.1	11.2	45.3	9.9	56.5	45.4	25.8	7.5	5.1	7.2	25.6	46.9	9.8	12.4	8.2	6.5	10.3	10.9	10.2	9.7	19.9	70.1	19.0	8.5	7.5	44.9	5.8	7.7	5.2	12.3	14.0	13.1	3.2	25.5	0.6	26.7	4.0	4.6	8.8	4.7	22.7	22.4	11.9	60.4	27.9	2.2	9.2	21.4	8.8	11.5	8.8	6.8	7.0	6.7	28.7	4.6	23.5	9.2	8.4	15.8	2.0	7.9	8.6	12.4	38.7	1.7	3.2	34.5	13.3	24.0	14.0	17.6	0.2	62.2	8.8	3.0	13.5	1.7	17.5	4.4	18.0	9.0	4.6	14.7	5.4	10.2	21.5	11.2	0.1	6.0	1.7	3.2	31.7	20.0	8.1	16.5	4.0	8.8	9.0	5.5	28.9	10.4	10.1	0.4	24.0	0.2	3.5	26.7	1.2	3.2	3.1	2.3	25.5	1.7	1.6	2.1	0.6	4.0	16.2	15.1	4.6	8.8	53.5	48.1	51.8	68.4	52.9	48.6	56.5	45.4	46.9	44.9
DPYSL4	"DRP-4, ULIP4"	ENSG00000151640	"Dihydropyrimidinase like 4"	O14531	10	132186900-132205776	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.0;heart muscle: 19.0"	"Cell line enhanced"	"Detected in many"		"AF22: 23.2;AN3-CA: 30.4;SH-SY5Y: 31.6"	"Cancer enhanced"	"Detected in many"		"glioma: 13.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049066	Approved		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"		"HPA049066: "	"unprognostic (6.27e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.95e-1)"	"unprognostic (5.99e-2)"	"unprognostic (8.36e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.81e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.47e-6)"	"unprognostic (3.04e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (3.11e-4)"	1.5	4.4	11.8	2.0	12.3	1.1	1.5	8.9	32.0	1.7	1.4	6.5	0.2	1.1	6.4	2.2	1.4	1.4	2.1	19.0	13.6	9.6	1.0	1.0	1.5	1.4	9.0	9.1	3.0	1.9	1.0	5.0	1.3	6.0	4.8	1.0	4.6	1.5	4.2	2.5	1.6	1.2	2.7	8.1	2.5	1.8	6.7	4.8	0.0	1.0	0.0	1.3	1.4	0.4	0.7	0.0	0.0	0.6	1.1	2.5	0.8	0.0	6.5	23.2	30.4	0.0	0.2	0.0	1.9	0.2	1.2	0.3	0.0	0.2	0.0	0.8	1.0	0.0	4.5	4.4	0.1	0.0	0.8	0.0	0.0	2.4	4.1	0.0	4.6	2.1	2.1	0.7	0.1	2.3	0.0	0.2	3.3	1.9	0.0	0.0	4.0	2.2	0.0	0.0	3.6	0.0	0.4	3.6	31.6	0.7	0.0	4.0	0.1	0.0	3.8	5.8	9.7	0.0	5.4	0.0	1.5	0.0	9.7	0.0	0.6	0.0	0.1	0.0	1.4	0.6	0.0	0.0	1.1	0.1	0.0	0.7	2.5	0.7	0.0	1.1	0.5	0.0	0.0	0.8	11.8	12.3	8.9	18.7	13.6	9.6	9.0	9.1	6.0	4.8
DPYSL5	"CRAM, CRMP-5, CRMP5, Ulip6"	ENSG00000157851	"Dihydropyrimidinase like 5"	Q9BPU6	2	26847747-26950351	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 47.1"	"Group enriched"	"Detected in some"	4	"AF22: 41.0;HAP1: 34.1;SCLC-21H: 48.9;SH-SY5Y: 28.9"	"Group enriched"	"Detected in some"	15	"glioma: 17.7;testis cancer: 8.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034544, HPA072387"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034544: AB_10671228, HPA072387: "	"unprognostic (1.07e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.64e-6)"	"unprognostic (3.94e-1)"	"unprognostic (6.21e-2)"		"unprognostic (6.12e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.43e-1)"	1.2	4.7	6.1	1.6	18.4	1.1	1.1	7.8	36.6	1.4	1.6	43.5	0.0	1.7	1.2	1.1	1.3	1.2	1.1	1.1	10.3	11.3	1.2	1.1	1.1	1.1	24.3	8.8	1.1	1.1	1.1	2.8	1.2	21.9	1.3	1.5	1.6	1.1	1.1	1.2	1.2	1.7	1.6	47.1	1.1	1.1	10.3	19.7	0.0	1.1	0.0	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	41.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	34.1	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	48.9	28.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	18.4	7.8	11.8	10.3	11.3	24.3	8.8	21.9	19.7
DRG1	NEDD3	ENSG00000185721	"Developmentally regulated GTP binding protein 1"	Q9Y295	22	31399523-31530634	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 86.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001218	Enhanced		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA001218: AB_1078704"	"unprognostic (4.94e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.26e-2)"	"unprognostic (4.66e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (7.71e-4)"	"unprognostic (3.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.69e-3)"	"unprognostic (1.55e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.25e-1)"	14.5	18.1	12.3	10.6	18.1	11.9	15.3	14.1	20.9	12.7	10.5	13.3	11.7	9.3	13.6	17.6	13.4	14.7	8.4	18.5	11.2	12.7	15.3	15.7	9.4	11.1	12.6	14.9	15.7	16.4	14.2	11.9	19.6	17.2	13.5	13.3	14.3	17.0	13.3	47.0	11.9	10.1	14.9	10.9	11.7	12.4	86.8	9.9	23.6	17.8	12.1	15.7	15.0	10.5	29.4	25.2	25.1	27.1	25.0	27.6	24.8	22.0	18.2	22.6	18.6	20.3	24.0	18.1	20.7	25.2	38.9	32.7	29.7	11.3	32.5	11.2	25.9	18.9	38.9	25.1	42.5	15.1	47.2	20.9	20.9	29.9	29.2	50.3	19.7	20.4	18.8	31.5	47.8	26.9	26.9	14.0	29.8	25.9	20.1	25.8	18.0	20.3	27.7	36.0	28.4	25.5	20.3	24.1	15.1	23.2	23.2	29.5	17.4	22.2	15.0	17.5	23.3	17.6	23.2	19.0	21.4	31.3	17.1	22.2	22.5	13.7	23.9	25.1	20.5	27.1	23.8	29.4	22.1	25.2	25.2	21.7	24.7	23.9	5.4	25.0	19.9	22.1	27.6	24.8	12.3	18.1	14.1	20.9	11.2	12.7	12.6	14.9	17.2	9.9
DRG2		ENSG00000108591	"Developmentally regulated GTP binding protein 2"	P55039	17	18087886-18107971	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007716	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Vesicles, Cytosol"	Nucleoplasm	"HPA007716: AB_1078705"	"unprognostic (7.47e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"prognostic favourable (1.56e-4)"	"unprognostic (1.26e-3)"	"unprognostic (7.86e-2)"	"unprognostic (8.85e-2)"	"unprognostic (5.72e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (3.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	19.9	19.9	16.1	17.5	21.8	17.4	19.3	14.7	30.8	19.3	19.3	22.9	16.6	19.2	23.5	22.8	21.6	25.2	18.2	22.4	15.7	17.0	19.1	31.9	15.7	21.2	17.6	16.1	27.6	23.9	20.6	18.8	22.4	17.9	21.1	13.4	18.4	21.7	21.7	33.3	19.4	17.9	18.3	17.1	20.7	17.6	14.6	17.2	21.6	23.6	21.2	25.6	20.5	18.0	12.6	18.4	17.0	20.9	20.0	19.8	14.0	16.8	24.1	8.2	8.1	15.3	16.3	15.7	11.9	11.8	19.3	18.0	25.5	10.1	16.3	15.5	13.7	17.8	13.5	16.5	13.1	14.4	36.9	7.1	12.8	14.2	16.6	6.5	11.4	18.1	14.7	19.3	16.3	18.4	12.5	6.4	11.2	19.0	17.3	11.0	6.1	17.7	18.6	19.9	30.2	11.5	9.9	4.7	13.3	11.8	7.0	14.6	13.9	9.9	13.8	9.3	8.9	10.9	19.5	7.3	8.9	9.2	13.4	11.9	17.1	11.6	15.9	17.0	19.8	17.2	16.4	12.2	14.7	15.8	18.4	12.6	14.0	15.3	2.1	20.0	20.9	10.3	18.3	14.0	16.1	21.8	14.7	30.8	15.7	17.0	17.6	16.1	17.9	17.2
DSC1	CDHF1	ENSG00000134765	"Desmocollin 1"	Q08554	18	31129236-31162856	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 78.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 1.0;HaCaT: 1.0;HEL: 1.5;hTCEpi: 1.0;MCF7: 1.0"	"Group enriched"	"Detected in some"	17	"head and neck cancer: 7.3;melanoma: 4.1"	"Region enriched"	"Detected in single"	13	"cerebral cortex: 7.0"	"Group enriched"	"Detected in some"	8	"naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075379	Enhanced						18000000			"HPA075379: "	"unprognostic (1.41e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.19e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-6)"	"unprognostic (5.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.74e-5)"	0.2	0.1	0.1	0.3	0.5	0.0	3.5	0.1	7.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	2.8	0.1	0.0	9.1	0.1	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.4	0.1	1.3	0.0	0.1	0.0	1.3	1.2	0.0	0.2	78.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.1	0.1	16.6	1.5	0.1	0.2	0.0	0.0	0.7	0.0	0.0	5.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.0	0.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	5.7	5.2	0.7	0.0	0.0	0.0	0.0	0.9	0.1	0.5	0.1	7.0	0.1	0.1	0.1	0.1	0.0	0.0
DSC2	"CDHF2, DSC3"	ENSG00000134755	"Desmocollin 2"	Q02487	18	31058840-31102415	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 127.5;lymphoid tissue: 68.2;tongue: 163.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.8;CAPAN-2: 20.5;HaCaT: 29.6;hTCEpi: 32.0;SK-BR-3: 18.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 48.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.4;neutrophil: 5.7"	"Lineage enriched"	"Detected in many"	14	"granulocytes: 20.4"	"Not detected"	"Not detected"							"HPA011911, HPA012615"	Enhanced						14000000			"HPA011911: AB_1847618, HPA012615: AB_1847619"	"unprognostic (3.28e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (7.66e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (3.01e-4)"	3.3	1.1	1.1	9.8	1.1	0.0	6.3	0.7	0.9	38.1	23.6	0.6	0.2	12.1	3.0	2.4	127.5	1.5	1.1	9.5	1.0	0.9	4.7	4.3	3.3	6.3	1.1	0.6	1.0	3.8	11.8	0.7	20.0	1.1	4.5	13.3	1.3	22.4	0.0	0.7	4.4	33.5	0.8	1.7	6.1	12.6	0.9	0.7	4.8	2.5	163.9	68.2	1.0	39.6	0.0	0.0	20.4	1.5	0.0	0.0	0.3	7.3	0.7	1.2	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	3.8	20.5	0.0	0.3	0.0	29.6	4.9	2.1	0.0	0.0	2.9	11.0	3.6	6.6	0.1	0.0	0.2	0.1	32.0	0.0	3.1	0.0	5.3	0.0	0.0	5.9	0.0	0.4	4.8	7.3	5.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	18.8	0.0	5.0	7.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	20.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.3	1.1	1.1	0.7	0.9	1.0	0.9	1.1	0.6	1.1	0.7
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 69.4;HBEC3-KT: 16.0;hTCEpi: 41.1;hTERT-HME1: 30.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Not detected"	"Not detected"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			2700000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: , HPA073937: "	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.4	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.4	0.0	16.0	0.0	0.0	3.8	0.2	1.3	0.1	2.6	0.0	0.0	2.7	41.1	0.0	30.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.7	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
DSCAM	"CHD2-42, CHD2-52"	ENSG00000171587	"DS cell adhesion molecule"	O60469	21	40010999-40847139	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 22.2;pituitary gland: 9.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.4;MCF7: 12.0;NTERA-2: 3.3;SCLC-21H: 5.0;T-47d: 3.3"	"Cancer enriched"	"Detected in single"	14	"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019324	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA019324: "	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.98e-2)"	"unprognostic (5.49e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.58e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.12e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.75e-2)"	"unprognostic (5.46e-3)"	0.9	1.1	12.7	0.9	10.3	0.9	1.2	3.0	22.2	0.9	1.0	8.2	0.0	1.0	0.9	2.8	0.9	1.1	1.0	0.9	10.1	8.6	0.9	1.4	1.0	0.9	6.8	10.1	0.9	1.2	0.9	9.1	2.9	9.5	1.0	1.0	0.7	0.9	1.0	0.9	0.9	1.0	0.9	3.7	2.9	0.9	2.0	6.9	0.0	0.9	0.0	0.9	1.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.7	10.3	3.0	14.7	10.1	8.6	6.8	10.1	9.5	6.9
DSG1	"CDHF4, DSG"	ENSG00000134760	"Desmoglein 1"	Q02413	18	31318089-31357029	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 124.8;tongue: 117.4"	"Cell line enriched"	"Detected in single"	18	"hTCEpi: 14.2"	"Group enriched"	"Detected in many"	10	"head and neck cancer: 57.0;melanoma: 16.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"CAB009394, HPA022128"	Enhanced						140000000			"CAB009394: AB_2293011, HPA022128: AB_1847620"	"unprognostic (2.55e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (4.13e-1)"	"unprognostic (5.22e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.15e-2)"	"unprognostic (4.24e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.44e-1)"		"prognostic unfavourable (2.99e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	30.9	0.0	0.0	0.0	0.0	1.3	0.0	18.5	0.0	0.0	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	4.2	0.0	0.3	124.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.0	0.0	117.4	2.3	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.2;HaCaT: 58.0;HBEC3-KT: 43.0;hTERT-HME1: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"			94000000	"Cell Junctions"		"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavourable (8.22e-4)"	"prognostic favourable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.8	9.6	0.8	0.0	0.1	1.6	31.3	0.0	0.0	0.0	0.0	6.7	37.2	0.0	14.1	0.0	58.0	11.8	43.0	0.0	0.0	7.3	0.0	11.1	7.5	4.5	3.1	0.0	2.2	29.9	0.9	46.9	0.0	9.8	0.0	0.0	6.5	6.6	0.4	12.0	5.0	11.0	0.0	15.9	14.4	12.4	5.2	0.0	18.9	13.4	0.0	9.6	2.7	0.0	0.0	5.6	0.0	6.1	1.2	0.0	0.0	4.4	0.0	5.4	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5
DSG3	CDHF6	ENSG00000134757	"Desmoglein 3"	P32926	18	31447795-31478702	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 156.7;lymphoid tissue: 50.7;tongue: 158.9"	"Group enriched"	"Detected in some"	7	"HaCaT: 41.1;hTCEpi: 101.8"	"Group enriched"	"Detected in many"	5	"cervical cancer: 104.0;head and neck cancer: 183.9;lung cancer: 36.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 9.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046864, HPA056863, CAB069880"	Enhanced									"CAB069880: AB_2093604, HPA046864: AB_2679846, HPA056863: AB_2683260"	"unprognostic (5.76e-3)"	"unprognostic (6.99e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.79e-2)"		"unprognostic (1.00e-2)"		"unprognostic (4.08e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.21e-2)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.26e-2)"	"unprognostic (8.35e-7)"	"unprognostic (8.85e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (9.90e-4)"	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.1	35.9	1.1	0.0	0.0	1.6	2.3	0.0	156.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	10.6	0.0	0.0	10.2	1.8	0.1	0.0	0.0	0.0	0.1	0.0	3.2	0.0	158.9	50.7	0.4	24.8	0.2	0.1	9.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.8	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DSN1	"C20orf172, dJ469A13.2, hKNL-3, KNL3, MIS13"	ENSG00000149636	"DSN1 homolog, MIS12 kinetochore complex component"	Q9H410	20	36751791-36773818	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002813, HPA030627"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear bodies,Cytosol"				Nucleoplasm	"Nucleoli fibrillar center, Nuclear bodies, Cytosol"	"HPA002813: AB_1078343, HPA030627: "	"unprognostic (3.60e-2)"	"prognostic favourable (4.49e-4)"	"unprognostic (5.22e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (4.16e-5)"	"unprognostic (3.93e-1)"	"unprognostic (9.35e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (6.92e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.84e-1)"	6.7	10.4	5.6	15.6	7.4	11.6	8.2	5.4	7.2	5.1	8.6	4.1	9.5	6.3	9.5	12.0	9.1	5.0	8.1	6.2	5.1	4.7	5.8	8.6	6.1	11.0	4.8	3.9	5.3	5.4	3.6	7.6	12.9	5.1	6.5	10.3	10.1	9.7	8.1	4.6	7.3	8.8	5.9	4.1	11.6	7.0	27.2	4.1	21.2	6.3	11.4	13.8	5.8	5.5	10.9	25.4	21.7	5.9	5.6	6.5	3.7	13.1	11.9	14.0	11.1	5.5	7.2	9.2	16.1	13.6	24.7	27.9	20.6	17.0	15.1	10.7	8.7	17.3	13.0	12.6	23.6	6.7	8.3	29.5	11.4	13.8	1.2	16.9	13.0	2.8	3.6	17.1	5.4	12.0	11.5	12.6	16.2	9.4	21.6	13.0	6.5	21.0	17.0	42.6	10.1	6.2	7.8	14.3	6.5	20.0	20.6	9.7	21.0	11.4	6.3	22.6	13.8	22.1	17.3	10.6	14.2	17.2	19.0	15.3	16.1	21.7	3.6	7.5	4.4	5.9	4.9	8.8	4.8	5.8	3.9	10.9	5.9	5.5	6.5	5.6	5.0	25.4	6.5	3.7	5.6	7.4	5.4	7.2	5.1	4.7	4.8	3.9	5.1	4.1
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541575-7586717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 138.3;skin 1: 136.5;tongue: 189.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.5;HaCaT: 49.1;HBEC3-KT: 35.3;hTCEpi: 111.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	19	"naive B-cell: 5.8"	"Lineage enriched"	"Detected in single"	59	"B-cells: 5.8"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 12.8"	"Low region specificity"	"Detected in all"			"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"			110000000	"Cell Junctions"		"CAB037324: , HPA045840: , HPA054950: "	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favourable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavourable (1.82e-4)"	1.3	2.7	0.9	9.6	0.7	0.0	12.5	0.6	0.8	27.5	19.4	0.2	9.1	8.1	2.8	11.2	138.3	2.5	8.7	71.8	0.7	0.6	8.7	21.9	8.0	1.4	0.6	0.9	1.4	23.0	8.1	2.7	25.7	2.5	9.0	7.0	3.4	25.6	8.5	0.6	136.5	28.2	1.1	1.4	1.0	7.4	0.8	0.1	15.0	17.1	189.6	48.7	3.1	46.9	5.8	0.0	0.0	0.0	0.0	0.0	0.0	20.6	6.2	0.0	0.0	0.9	1.4	45.5	4.0	3.5	2.0	2.0	17.7	5.4	0.0	5.8	6.5	49.1	7.5	35.3	0.3	0.0	8.7	0.0	3.5	23.8	0.0	0.1	0.1	0.3	111.4	1.8	20.4	0.0	0.0	0.0	3.6	9.7	0.0	0.1	0.9	3.1	0.0	0.0	5.2	7.5	5.6	2.1	0.0	4.6	9.8	0.0	11.6	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.6	0.8	0.7	0.6	0.6	0.9	2.5	0.1
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954628	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 92.5;hTERT-HME1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.3;monocytes: 1.7;NK-cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	26.5	29.2	43.4	11.7	57.1	2.5	59.2	43.6	52.4	53.8	31.5	32.1	11.5	15.1	53.6	21.7	37.1	19.4	16.8	28.1	41.2	36.2	18.0	26.6	29.4	5.4	56.5	28.9	30.3	14.0	32.1	28.2	15.1	53.9	22.6	17.4	8.4	23.6	25.3	57.5	81.8	16.9	53.6	54.9	12.8	14.8	11.7	66.5	6.1	7.6	33.6	7.7	19.7	23.7	0.6	5.3	0.3	1.7	2.1	0.4	0.3	11.9	5.7	7.7	4.4	12.8	20.2	4.4	16.1	15.4	6.7	7.5	3.3	3.2	1.8	6.7	36.4	8.4	6.5	28.4	13.2	11.4	9.7	3.4	10.4	6.1	11.5	3.2	0.0	8.9	92.5	16.2	68.5	12.6	2.7	7.9	17.3	3.3	0.9	1.3	5.9	4.2	0.0	6.0	2.7	20.2	15.4	10.3	7.7	6.9	2.4	11.0	3.7	5.2	33.8	14.8	12.4	7.0	13.3	8.9	6.3	0.9	10.5	1.7	7.0	0.3	1.7	0.0	0.3	1.3	0.1	0.2	0.4	0.0	3.2	0.6	0.1	0.2	0.1	2.1	1.0	5.3	0.0	0.3	43.4	57.1	43.6	52.4	41.2	36.2	56.5	28.9	53.9	66.5
DSTN	"ACTDP, ADF"	ENSG00000125868	"Destrin, actin depolymerizing factor"	P60981	20	17569863-17609919	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 158.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB037094	Approved						16000000			"CAB037094: AB_476911"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.89e-3)"	"unprognostic (6.05e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-3)"	44.6	40.9	32.4	31.3	35.5	7.5	55.0	30.4	50.5	56.1	156.6	15.6	62.7	23.1	101.2	55.3	98.5	60.6	77.3	67.0	35.7	30.6	46.1	25.0	46.8	15.3	34.6	40.5	46.7	77.1	30.3	25.4	30.0	41.6	100.4	54.2	31.3	49.6	138.0	20.9	33.5	41.9	225.7	46.4	13.9	82.6	25.0	16.8	9.1	47.4	46.1	17.5	134.4	75.0	5.4	22.3	24.5	19.0	20.9	26.9	17.7	34.3	47.0	18.0	17.7	45.7	45.2	34.0	43.6	68.0	27.8	25.1	21.7	38.4	5.3	11.0	63.9	33.6	16.4	66.4	31.9	2.9	13.8	14.1	29.4	31.6	48.9	10.9	9.7	40.9	63.1	26.7	31.2	39.8	6.6	7.3	51.8	26.8	4.4	12.9	12.2	35.7	3.0	27.7	11.0	76.3	31.7	27.4	8.2	39.7	158.2	45.8	72.6	6.0	37.7	33.4	10.5	36.1	29.8	4.4	5.4	14.5	15.8	4.7	27.6	12.4	7.6	24.5	25.8	13.5	21.7	5.4	26.9	24.0	9.5	3.9	17.9	22.5	5.1	20.9	19.0	22.3	19.8	17.7	32.4	35.5	30.4	50.5	35.7	30.6	34.6	40.5	41.6	16.8
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 106.3;heart muscle: 82.8;skeletal muscle: 90.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 17.5;NTERA-2: 19.5;SCLC-21H: 27.5;U-87 MG: 28.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;T-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"				"Nucleoplasm, Cell Junctions, Intermediate filaments"		"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favourable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	9.3	5.3	51.5	4.0	47.6	1.6	7.3	37.7	69.1	4.5	5.4	38.7	0.9	3.4	4.3	13.9	13.9	7.6	7.1	82.8	42.3	46.5	2.7	2.5	4.8	2.3	44.7	21.0	5.4	12.3	1.4	6.1	3.6	51.0	14.6	5.6	3.4	5.7	15.9	90.2	1.8	3.9	15.2	106.3	3.9	3.6	4.7	39.5	0.0	9.3	6.5	2.4	12.8	1.7	1.4	7.0	0.4	1.3	1.0	6.7	1.7	0.2	0.1	7.5	0.0	4.8	13.4	1.2	2.0	7.3	0.3	0.9	1.7	0.0	0.0	4.4	0.8	0.6	0.9	3.9	0.7	0.0	5.2	0.0	0.4	3.5	3.9	0.1	0.1	10.2	0.8	6.3	2.2	3.2	1.1	0.9	2.1	17.5	0.1	0.0	19.5	4.0	0.0	3.7	11.9	0.3	0.1	27.5	3.2	0.0	0.7	2.0	10.7	2.6	0.1	8.7	4.7	0.1	2.7	0.6	0.9	0.4	28.1	0.0	3.7	0.4	1.3	0.0	1.4	0.0	1.9	1.4	2.7	1.9	7.0	1.1	2.8	2.0	0.1	1.0	0.0	0.2	6.7	1.7	51.5	47.6	37.7	35.7	42.3	46.5	44.7	21.0	51.0	39.5
DTNB		ENSG00000138101	"Dystrobrevin beta"	O60941	2	25377198-25673647	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 49.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA061357	Uncertain		Approved	Mitochondria				Mitochondria		"HPA061357: "	"unprognostic (1.14e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.78e-2)"	"unprognostic (3.67e-3)"	"unprognostic (3.98e-2)"	"unprognostic (9.45e-2)"	"unprognostic (4.67e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.49e-2)"	3.6	3.5	19.1	5.2	21.3	4.7	13.9	14.5	24.6	7.7	2.7	9.5	13.6	2.2	4.7	14.0	4.6	7.3	5.9	3.4	20.6	12.6	6.3	5.1	6.6	4.6	12.4	11.7	7.2	10.3	12.2	9.6	5.4	13.2	10.5	2.4	4.2	49.4	13.9	2.7	4.6	2.3	3.1	13.1	4.4	7.7	9.0	7.3	6.3	15.7	1.0	5.4	5.2	4.3	7.4	1.1	7.2	2.2	5.1	7.4	2.8	8.8	7.5	6.2	6.8	3.6	4.5	0.2	2.7	3.7	3.4	4.8	2.9	2.3	4.7	1.1	2.2	3.2	4.3	11.6	1.9	7.1	9.9	3.7	2.3	8.8	2.5	4.7	3.6	3.6	9.9	3.6	6.2	4.6	0.3	7.2	2.5	8.9	7.6	3.9	7.0	5.1	6.1	9.9	8.8	6.4	8.3	8.1	11.8	8.8	15.6	10.8	8.2	2.7	1.9	1.3	6.4	2.0	4.8	12.6	5.5	8.4	4.0	8.5	5.0	0.5	2.2	7.2	5.8	1.1	6.6	5.7	7.4	5.2	0.7	7.4	7.3	5.0	4.3	5.1	0.6	1.1	6.4	2.8	19.1	21.3	14.5	24.6	20.6	12.6	12.4	11.7	13.2	7.3
DUSP14	"MKP-L, MKP6"	ENSG00000276023	"Dual specificity phosphatase 14"	O95147	17	37489831-37513501	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 12.5;HBF TERT88: 17.9;WM-115: 10.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in single"		"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019911	Approved		Approved	Nucleoplasm,Cytosol			44000	"Nucleoplasm, Cytosol"		"HPA019911: AB_1847888"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.60e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.43e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.02e-3)"	"unprognostic (3.81e-1)"	"prognostic unfavourable (6.97e-9)"	"unprognostic (7.93e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.41e-3)"	4.7	3.7	3.3	2.1	6.6	1.1	3.9	1.8	8.0	3.3	1.0	1.5	0.1	0.7	2.7	1.2	7.2	11.7	5.1	2.6	2.3		2.1	6.5	2.4	1.0	1.9	2.5	3.0	2.9	1.7	3.3	11.6	2.6	1.4	1.4	1.6	2.8	1.1	1.7	8.4	0.9	3.5	2.7	1.7	1.0	3.5	0.8	2.3	8.3	6.1	4.3	1.9	1.0	0.5	0.0	3.2	0.0	0.4	0.4	0.5	1.7	0.1	0.4	0.8	0.0	0.5	1.5	8.0	6.1	10.7	12.5	0.9	1.8	0.1	0.7	5.8	1.3	0.1	4.7	17.9	0.1	0.5	0.0	1.0	2.0	0.8	0.4	1.2	4.7	2.9	3.8	2.0	0.2	0.4	0.0	7.9	0.3	0.8	0.2	0.2	0.0	0.7	0.5	0.2	2.6	0.7	1.3	0.1	0.4	0.7	1.1	0.6	1.0	0.7	8.6	2.0	0.1	4.0	0.0	0.2	0.1	0.0	0.0	10.3	0.0	0.0	0.9	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.3	0.2	3.2	0.4	0.0	0.0	0.0	0.5										
DUSP3	VHR	ENSG00000108861	"Dual specificity phosphatase 3"	P51452	17	43766121-43778988	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 19.5;granulocytes: 5.2;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063616			Supported	Nucleoplasm,Cytosol			1300000	Nucleoplasm	Cytosol	"HPA063616: "	"unprognostic (1.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (4.83e-2)"	"unprognostic (8.98e-2)"	"unprognostic (5.13e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.40e-3)"	"prognostic favourable (5.49e-5)"	"unprognostic (2.67e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.37e-2)"	17.1	17.8	23.1	10.2	20.8	4.6	22.0	14.3	28.6	12.8	28.4	11.1	16.7	13.4	17.5	18.7	23.6	10.6	19.3	64.0	21.5	18.1	27.1	39.9	17.2	9.0	17.6	19.1	9.1	19.2	27.5	11.4	15.0	17.1	22.6	13.1	14.3	11.1	36.6	106.9	8.9	15.2	31.1	12.7	14.5	19.6	8.0	10.8	1.2	13.9	22.8	6.5	20.7	24.1	1.7	19.5	5.2	17.0	0.9	1.7	5.8	10.9	19.8	7.6	8.1	22.3	12.0	6.5	8.3	19.9	19.4	23.5	19.0	7.4	1.7	13.2	15.5	9.5	11.8	10.2	20.5	3.7	9.0	5.5	9.1	15.5	27.3	0.6	5.7	11.1	18.4	14.9	13.1	13.5	4.9	1.9	22.6	7.8	2.8	2.8	3.5	14.5	3.6	23.0	4.1	26.9	11.5	4.3	7.7	9.7	6.5	24.4	29.1	15.4	14.0	22.0	14.9	31.2	13.7	10.2	13.4	0.4	26.1	7.7	7.3	5.2	17.0	3.5	1.0	8.9	1.7	1.7	1.5	1.2	19.5	1.6	1.2	1.1	4.1	0.9	10.8	8.2	0.9	5.8	23.1	20.8	14.3	28.6	21.5	18.1	17.6	19.1	17.1	10.8
DUSP4	"HVH2, MKP-2, TYP"	ENSG00000120875	"Dual specificity phosphatase 4"	Q13115	8	29333064-29350668	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 46.7;pancreas: 78.6;seminal vesicle: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 30.0;SK-MEL-30: 46.2;WM-115: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"T-reg: 9.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061967			Supported	Nucleoplasm				Nucleoplasm		"HPA061967: "	"unprognostic (1.92e-1)"	"unprognostic (5.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.66e-3)"	"unprognostic (7.30e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.73e-3)"	"unprognostic (9.60e-3)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (6.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (6.07e-2)"	10.9	3.4	1.2	3.6	1.1	3.4	17.1	4.8	2.7	4.6	1.7	1.0	46.7	0.8	3.2	0.7	1.6	1.3	13.1	1.5	4.6	0.8	0.7	0.4	3.7	1.8	0.8	0.8	1.2	78.6	0.1	3.7	17.7	0.7	4.3	0.9	17.1	8.9	63.5	2.7	3.5	1.3	1.5	1.1	0.6	20.6	1.7	0.2	3.9	1.2	2.0	4.7	7.4	3.0	0.0	0.5	0.0	0.0	0.2	9.6	0.1	11.1	30.0	17.8	0.8	2.3	0.0	1.5	2.3	12.8	7.0	3.1	0.3	5.7	0.0	6.3	1.0	3.6	0.2	7.7	4.2	0.3	0.6	0.0	1.0	0.2	0.0	0.1	14.6	1.4	5.1	2.2	13.1	5.7	0.1	1.3	14.0	12.6	0.0	2.1	3.1	18.4	0.3	0.6	2.3	16.1	5.9	0.1	9.9	3.2	15.2	46.2	3.2	0.3	16.0	5.2	0.0	0.0	1.6	3.6	0.4	0.0	15.6	2.6	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	9.6	0.1	1.2	1.1	4.8	2.7	4.6	0.8	0.8	0.8	0.7	0.2
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 80.6;NB-4: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favourable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.0	80.6	20.8	17.7	0.0	8.7	11.1	1.7	1.3	7.0	1.2	0.0	2.0	3.7	9.3	0.1	21.6	2.5	0.1	0.1	3.6	0.2	11.2	14.7	15.5	39.5	3.4	7.6	15.3	14.3	40.1	0.0	3.8	5.5	0.5	0.5	57.8	14.6	19.7	39.3	3.0	1.5	24.8	23.3	0.4	17.1	0.2	0.1	45.9	1.2	8.6	10.7	5.9	0.1	1.1	4.1	0.6	3.1	0.0	24.5	10.9	37.4	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4
DVL1		ENSG00000107404	"Dishevelled segment polarity protein 1"	O14640	1	1335276-1349350	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 120.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011538	Approved									"CAB011538: AB_2093326"	"unprognostic (2.67e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.05e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.81e-3)"	"unprognostic (5.03e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.35e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (3.33e-4)"	"unprognostic (2.34e-2)"	"unprognostic (2.55e-2)"	13.2	14.1	18.8	7.7	17.1	5.9	12.5	13.9	25.7	8.4	10.4	13.3	12.2	17.9	9.4	8.0	15.4	11.6	8.0	21.4	18.1	11.9	8.0	12.2	9.6	6.2	12.7	17.3	12.5	34.3	10.3	10.6	10.0	13.5	10.8	4.7	7.3	36.5	10.4	120.4	17.0	16.1	12.7	11.8	9.3	18.3	15.0	12.2	2.8	9.0	13.9	6.8	9.8	17.5	2.1	2.0	0.9	2.1	0.8	1.6	0.6	25.3	13.2	5.4	11.5	5.3	6.5	13.3	15.6	7.5	12.4	6.2	10.2	32.2	8.1	23.6	6.9	15.8	4.3	15.8	1.9	9.9	24.8	4.6	23.6	18.3	11.3	7.0	7.2	5.5	9.8	16.5	11.4	4.2	17.6	5.7	5.0	10.3	6.8	11.7	8.6	50.5	11.6	4.3	13.9	9.0	4.0	21.1	14.5	7.5	20.5	20.7	11.3	11.9	8.3	7.0	18.2	27.1	26.0	9.1	3.6	9.8	20.7	9.9	4.4	0.9	2.1	0.1	1.6	1.8	1.5	2.1	1.3	1.3	0.7	0.3	1.4	0.7	0.8	0.8	1.2	2.0	0.9	0.6	18.8	17.1	13.9	25.7	18.1	11.9	12.7	17.3	13.5	12.2
DYNC1H1	"CMT2O, DHC1, DNCH1, Dnchc1, DNCL, DNECL, HL-3, p22"	ENSG00000197102	"Dynein cytoplasmic 1 heavy chain 1"	Q14204	14	101964510-102056443	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Mental retardation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003742, CAB010443"	Enhanced		Supported	Centrosome,Cytosol			120000	"Centrosome, Cytosol"		"CAB010443: AB_2093483, HPA003742: AB_1078713"	"unprognostic (2.58e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.65e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.49e-2)"	"prognostic unfavourable (3.03e-7)"	"unprognostic (8.93e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.09e-6)"	"unprognostic (1.63e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-3)"	23.3	17.2	24.3	13.9	42.9	21.1	12.7	43.9	53.4	16.9	18.4	35.0	10.2	13.9	18.6	12.5	18.3	15.5	16.1	26.6	26.1	26.6	11.2	9.4	14.6	14.0	29.1	23.4	24.7	15.4	28.1	16.4	14.8	51.5	16.7	11.9	15.5	18.0	18.6	44.5	42.0	13.8	17.7	30.3	15.4	15.5	17.2	12.6	15.1	18.1	11.1	12.9	19.1	12.8	2.7	6.3	4.5	6.0	7.8	4.7	3.3	23.8	35.7	19.7	15.1	44.1	28.8	12.0	20.7	19.3	24.4	21.5	15.2	12.1	13.7	17.0	28.2	21.8	19.2	23.1	8.9	11.8	11.6	9.8	23.3	24.6	20.1	14.4	10.2	18.7	12.2	57.6	43.0	26.7	8.4	15.7	27.7	23.4	9.4	3.6	11.9	44.2	8.9	20.7	7.8	19.7	38.0	22.4	18.1	27.3	13.9	18.0	11.5	6.1	58.6	29.0	12.4	40.0	28.2	10.8	10.9	9.2	39.9	8.6	17.8	3.6	3.4	2.5	4.6	6.0	4.7	2.2	3.0	4.0	6.3	2.7	3.6	4.2	4.5	7.8	3.9	3.3	3.0	3.3	24.3	42.9	43.9	53.4	26.1	26.6	29.1	23.4	51.5	12.6
DYNLL1	"DLC1, DLC8, DNCL1, hdlc1, LC8, PIN"	ENSG00000088986	"Dynein light chain LC8-type 1"	P63167	12	120469850-120498493	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation, Transport"	"Activator, Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039954			Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			650000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA039954: "	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.09e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (4.41e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.61e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (7.97e-7)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.62e-1)"	45.5	48.5	128.5	34.4	97.8	21.9	54.3	48.4	120.5	50.6	61.8	61.9	31.1	31.6	47.2	64.9	113.7	107.1	46.7	44.2	124.1	105.2	49.7	40.7	40.3	41.2	92.9	90.7	49.0	45.7	30.4	46.4	49.8	67.4	39.9	64.5	24.8	34.0	54.9	15.0	117.3	38.9	75.2	93.6	30.4	45.1	59.4	56.8	35.4	37.1	84.3	65.6	59.0	63.0	55.0	80.6	73.6	55.0	46.7	63.4	50.8	78.4	89.7	89.0	68.2	78.2	83.0	28.6	108.6	50.2	88.7	53.2	84.5	52.9	44.0	58.7	103.7	70.8	105.7	90.8	88.7	58.3	69.2	43.0	64.3	114.3	79.0	44.8	71.5	50.4	97.2	66.5	54.6	92.1	53.9	50.7	117.0	103.9	58.5	97.6	73.0	104.7	59.8	46.1	54.6	126.7	72.7	61.2	45.2	88.5	76.9	98.6	76.2	65.6	70.8	68.3	58.3	60.2	93.5	30.6	58.7	43.7	75.7	70.1	87.4	73.6	49.5	63.6	37.7	51.4	28.7	55.0	39.0	39.0	49.1	36.5	25.2	31.5	9.1	46.7	55.0	80.6	63.4	50.8	128.5	97.8	48.4	120.5	124.1	105.2	92.9	90.7	67.4	56.8
DYNLRB1	"DNCL2A, DNLC2A, ROBLD1"	ENSG00000125971	"Dynein light chain roadblock-type 1"	Q9NP97	20	34516409-34540958	"Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009845	Approved									"CAB009845: AB_2093671"	"unprognostic (2.23e-1)"	"unprognostic (7.60e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (9.10e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.00e-1)"	43.8	57.2	99.7	30.4	95.2	32.3	45.5	74.4	129.5	51.6	48.5	51.3	28.6	37.3	46.6	71.2	48.2	68.3	38.7	86.7	86.2	89.4	71.0	39.7	49.8	35.8	79.5	83.5	48.9	37.0	49.1	49.1	50.4	82.1	58.8	44.0	45.7	45.6	61.6	56.2	65.4	41.6	54.0	61.3	36.5	42.2	19.3	46.9	33.0	59.1	33.2	43.3	45.6	54.2	45.5	49.4	67.7	42.0	39.2	72.9	39.5	34.2	46.6	38.0	29.3	45.8	44.6	25.5	38.2	56.9	59.8	51.0	124.0	32.3	19.1	48.4	58.6	30.5	41.3	56.2	39.9	23.1	28.6	65.5	44.5	95.5	52.3	30.6	36.1	38.3	36.7	48.2	37.0	41.6	27.0	35.2	59.7	44.7	42.6	59.0	21.0	50.7	21.6	52.6	30.3	89.6	23.9	38.0	39.9	55.1	89.6	48.5	51.1	33.9	35.6	72.2	18.1	50.6	41.7	30.3	42.2	21.8	61.7	26.7	31.5	57.3	37.4	67.7	29.8	37.9	29.7	45.5	49.3	39.1	41.3	37.9	35.0	34.4	36.6	39.2	42.0	49.4	72.9	39.5	99.7	95.2	74.4	129.5	86.2	89.4	79.5	83.5	82.1	46.9
DYRK2		ENSG00000127334	"Dual specificity tyrosine phosphorylation regulated kinase 2"	Q92630	12	67648338-67665406	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027230, HPA056902"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027230: AB_1847925, HPA056902: "	"unprognostic (5.86e-3)"	"unprognostic (4.18e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-1)"	12.2	5.3	4.5	20.1	4.8	8.6	8.1	4.4	6.6	10.1	21.3	4.1	8.3	13.7	14.6	9.6	9.6	9.1	16.9	26.1	4.7	3.2	6.3	4.6	10.1	17.9	4.0	3.3	7.6	8.5	3.6	4.4	13.0	5.0	7.1	15.3	6.6	7.2	6.6	23.7	9.4	26.0	11.2	5.3	10.3	14.0	4.4	3.9	34.3	7.6	12.5	17.2	11.1	12.2	2.7	1.9	5.9	1.3	6.9	6.8	1.6	13.5	7.7	11.5	8.3	5.8	7.9	9.2	13.8	9.0	6.8	3.9	10.1	7.5	25.4	17.1	20.0	15.9	9.2	5.4	7.3	10.9	12.0	4.1	5.1	3.8	2.2	9.2	8.9	6.5	7.8	18.2	14.6	3.8	5.0	13.3	8.6	7.8	7.9	4.5	10.0	12.4	21.1	11.4	11.2	7.9	17.1	15.2	18.0	5.8	7.8	8.0	5.3	7.8	5.6	10.8	10.2	7.4	10.9	6.3	1.0	14.1	10.4	6.3	11.1	3.2	0.5	5.9	5.2	1.3	4.0	2.7	3.9	6.8	1.9	2.7	3.3	6.1	0.7	6.9	1.3	0.8	3.1	1.6	4.5	4.8	4.4	6.6	4.7	3.2	4.0	3.3	5.0	3.9
E2F1	"RBBP3, RBP3"	ENSG00000101412	"E2F transcription factor 1"	Q01094	20	33675683-33686404	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.5;lymphoid tissue: 21.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000329, HPA008003, CAB019308, HPA029735"	Enhanced		Enhanced	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"CAB000329: AB_627476, CAB019308: , HPA008003: AB_1847936, HPA029735: "	"unprognostic (7.46e-2)"	"prognostic favourable (9.22e-6)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (4.33e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (4.18e-4)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (8.99e-5)"	"unprognostic (1.05e-2)"	"unprognostic (7.50e-2)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.91e-1)"	2.4	5.3	6.8	12.7	9.7	32.5	2.1	1.1	6.4	1.2	4.4	5.1	0.7	3.9	1.4	0.8	5.1	1.5	4.1	2.0	7.1	3.6	0.9	1.7	8.1	9.3	6.2	2.9	3.4	1.2	2.3	0.3	3.3	5.9	1.7	4.8	0.3	1.6	1.4	1.4	5.4	4.9	3.3	6.2	4.8	3.4	12.1	6.0	21.9	1.0	4.9	7.7	1.9	3.1	2.2	0.6	0.7	3.7	1.4	1.2	0.6	15.9	15.5	18.0	14.0	1.8	1.3	13.7	15.3	7.4	19.6	16.5	27.4	16.5	29.4	15.5	6.8	12.0	8.7	8.1	8.8	8.8	12.5	24.0	23.1	15.9	0.1	11.2	15.2	1.0	0.5	10.7	1.9	5.0	6.3	20.8	12.1	14.1	23.8	23.8	5.4	22.3	23.8	49.1	12.1	3.3	9.8	26.9	18.9	18.6	13.0	7.6	16.3	14.2	2.7	22.9	13.4	15.8	21.7	20.3	13.7	24.2	19.0	6.7	13.5	0.0	0.0	0.7	0.1	0.9	0.0	2.2	0.6	0.4	0.2	0.2	0.2	1.2	0.3	1.4	3.7	0.6	0.8	0.6	6.8	9.7	1.1	6.4	7.1	3.6	6.2	2.9	5.9	6.0
E2F2	E2F-2	ENSG00000007968	"E2F transcription factor 2"	Q14209	1	23506430-23531220	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 22.8;lymphoid tissue: 69.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 23.6;Karpas-707: 20.3;U-266/84: 18.1;U-698: 19.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 6.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			CAB016313	Uncertain									"CAB016313: AB_2096794"	"unprognostic (3.14e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.18e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.70e-3)"	"unprognostic (6.43e-6)"	"unprognostic (7.83e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.86e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.00e-3)"	"unprognostic (2.82e-1)"	"unprognostic (8.67e-3)"	"unprognostic (1.84e-1)"	0.4	0.2	0.1	6.1	0.2	22.8	1.0	0.1	0.2	1.1	3.5	0.2	0.0	1.6	0.1	0.2	11.2	0.1	0.2	1.5	0.0	0.0	0.4	0.7	1.2	3.3	0.2	0.0	0.2	0.6	0.0	0.0	2.2	0.2	0.3	2.3	0.3	1.2	0.0	0.0	4.4	3.4	0.4	0.2	6.8	0.9	4.4	0.1	69.7	0.3	3.9	6.1	0.5	2.3	0.9	1.1	6.7	2.0	0.2	2.8	0.4	2.7	2.0	3.3	5.3	0.1	0.1	2.3	1.3	0.6	1.2	1.6	1.2	1.6	23.6	1.6	0.6	5.5	6.7	0.3	1.1	5.9	2.1	3.7	5.0	1.4	0.0	2.7	4.9	0.0	0.0	0.9	0.1	0.4	2.8	20.3	0.5	1.6	12.0	2.5	0.7	1.0	13.3	7.2	8.0	0.5	0.7	4.4	6.1	2.2	2.8	0.6	2.1	2.0	0.2	1.1	3.3	3.6	1.8	15.0	18.1	19.5	1.1	2.9	2.2	6.7	0.6	1.7	0.2	1.5	0.1	0.9	0.7	0.5	1.1	0.6	0.1	0.2	0.4	0.2	2.0	0.9	2.8	0.4	0.1	0.2	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1
E2F6	E2F-6	ENSG00000169016	"E2F transcription factor 6"	O75461	2	11444375-11466177	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 8.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075185			Supported	Nucleoplasm				Nucleoplasm		"HPA075185: "	"unprognostic (7.13e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (4.18e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.90e-1)"	"unprognostic (3.05e-3)"	"unprognostic (7.58e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.64e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	8.4	6.6	4.4	5.0	5.9	5.0	6.2	7.8	8.0	4.1	4.9	7.4	4.7	4.2	8.4	6.6	3.6	7.4	5.0	8.9	4.3	4.9	4.0	6.2	4.5	3.3	5.6	3.8	6.7	5.3	3.9	12.4	5.4	5.0	5.3	3.5	4.7	4.7	6.5	17.7	3.9	4.8	10.6	9.0	5.0	5.7	4.2	7.3	2.9	6.7	4.4	3.7	6.3	4.9	0.0	0.3	8.3	0.3	0.0	0.8	0.2	3.1	3.9	8.3	4.6	3.8	3.1	6.3	3.0	5.5	3.6	3.3	7.7	4.6	7.0	3.5	3.5	2.3	5.8	4.5	3.8	7.8	8.4	11.1	3.0	9.7	7.5	11.4	11.4	5.3	4.2	3.9	4.6	3.2	8.3	11.8	2.8	7.4	6.5	12.5	11.8	5.2	11.6	9.4	6.2	3.9	2.8	7.1	15.0	3.5	5.2	13.6	4.7	5.8	2.7	5.2	6.6	3.3	6.8	17.1	12.6	15.1	5.7	10.8	7.9	8.3	0.3	0.1	0.2	0.0	0.8	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	4.4	5.9	7.8	8.0	4.3	4.9	5.6	3.8	5.0	7.3
ECE1	ECE	ENSG00000117298	"Endothelin converting enzyme 1"	P42892	1	21217247-21345504	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Hirschsprung disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 114.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 101.6;TIME: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001490, HPA013616"	Enhanced						2100000			"HPA001490: AB_1078718, HPA013616: AB_1847963"	"unprognostic (7.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.97e-2)"	44.0	49.9	10.3	18.7	14.5	17.3	33.7	3.6	15.6	29.5	27.5	19.2	11.2	12.4	24.0	10.5	15.6	19.1	23.0	30.9	12.4	8.0	14.9	41.8	30.1	14.4	13.9	13.4	34.2	42.1	114.4	21.6	27.0	14.6	27.9	14.6	26.5	14.7	11.4	15.2	14.8	23.2	24.1	13.2	23.5	18.9	19.1	14.7	9.5	23.2	10.7	19.1	34.2	37.0	4.6	2.0	21.5	7.5	1.0	6.1	4.2	13.6	9.2	11.8	5.9	17.1	18.2	6.8	20.3	35.5	11.1	10.2	6.6	42.0	4.9	51.2	20.5	5.8	4.8	9.7	9.7	12.4	4.0	7.1	14.2	5.3	22.8	1.0	1.8	9.5	11.4	17.1	8.5	101.6	1.4	2.6	9.4	2.8	2.0	1.6	3.6	7.2	2.5	6.8	7.1	17.3	2.5	4.0	9.8	20.2	11.9	8.8	8.5	2.9	90.1	25.0	12.2	11.0	11.7	4.1	6.9	5.7	52.0	2.4	30.2	0.1	5.8	2.2	2.2	7.5	3.3	4.6	4.6	3.5	0.5	3.1	3.1	1.9	21.5	1.0	5.2	2.0	6.1	4.2	10.3	14.5	3.6	15.6	12.4	8.0	13.9	13.4	14.6	14.7
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288710-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles				Vesicles		"HPA035445: AB_10669860, HPA035446: "	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	40.1	16.8	20.8	16.5	23.1	6.8	21.9	16.6	21.4	18.6	27.2	12.0	12.8	21.9	13.7	15.5	20.6	11.4	16.1	20.0	19.4	18.0	44.4	44.3	26.8	17.8	27.3	16.5	11.9	14.2	14.5	16.1	17.0	23.1	19.8	26.3	15.1	22.2	14.5	22.0	13.3	25.8	30.1	27.3	14.1	18.1	8.3	20.9	20.7	42.4	14.2	19.4	24.2	22.6	13.2	29.6	13.4	31.2	6.4	11.6	16.9	15.8	12.6	18.1	16.7	27.0	25.7	15.4	25.8	31.5	22.3	28.5	21.9	12.1	24.0	22.3	24.5	13.1	0.0	19.4	28.3	14.2	12.1	31.9	17.0	34.8	24.1	42.6	18.0	28.9	23.4	20.8	17.7	20.1	39.5	14.6	29.7	14.9	28.1	19.8	15.0	15.7	13.3	22.4	19.6	40.6	19.6	20.9	20.3	14.5	0.5	35.5	0.5	49.9	20.8	13.7	22.0	34.6	28.8	18.7	37.6	31.6	25.1	37.4	32.2	6.2	31.2	10.0	11.0	25.6	11.6	12.8	9.5	10.8	29.6	13.2	11.6	11.6	13.4	6.4	17.9	22.6	9.6	16.9	20.8	23.1	16.6	21.4	19.4	18.0	27.3	16.5	23.1	20.9
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria			1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.7	36.1	19.7	49.1	28.6	18.4	18.0	21.2	28.0	29.6	25.1	79.2	28.0	21.7	18.4	23.8	27.0	25.5	21.5	21.4	16.6	44.8	21.6	21.8	56.3	24.0	28.0	15.4	20.5	18.6	19.6	25.1	26.2	19.5	19.1	28.8	68.2	13.9	54.7	13.7	43.4	24.0	23.9	11.6	36.5	36.9	12.7	20.2	21.9	36.4	27.5	28.3	27.0	21.0	13.4	19.4	27.7	27.9	14.4	8.8	24.6	31.7	15.3	11.0	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria			11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favourable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favourable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.5	6.7	27.6	2.6	3.6	25.3	7.4	5.1	6.1	9.0	30.9	22.5	10.6	18.6	4.6	18.1	7.9	7.0	0.8	18.4	40.4	3.2	16.4	38.1	23.6	9.5	1.5	6.8	16.7	5.0	11.0	6.1	17.6	22.6	2.0	30.2	0.9	14.3	15.6	17.8	33.4	7.3	51.1	11.6	8.3	23.2	14.7	17.9	33.9	22.4	21.8	17.0	5.0	4.8	18.0	5.1	8.2	25.0	14.7	17.3	6.3	8.9	6.7	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6
ECM1		ENSG00000143369	"Extracellular matrix protein 1"	Q16610	1	150508062-150513789	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Biomineralization, Mineral balance, Osteogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.2;esophagus: 257.1;lymphoid tissue: 107.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 76.4;BJ hTERT+: 53.2;fHDF/TERT166: 50.1;hTEC/SVTERT24-B: 36.0;LHCN-M2: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;myeloid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA027241	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"		12000000000	Cytosol	Nucleoplasm	"HPA027241: AB_1847976"	"unprognostic (2.89e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.33e-2)"	"prognostic unfavourable (1.51e-9)"	"unprognostic (1.23e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.20e-5)"	16.1	2.5	0.9	1.8	1.3	0.1	11.0	0.9	4.2	37.9	2.8	0.1	7.4	1.5	10.5	133.2	257.1	3.3	30.7	11.6	0.9	1.0	2.5	16.7	3.8	0.2	1.0	1.7	3.0	0.8	0.3	2.0	20.2	4.2	2.6	3.1	1.6	28.7	2.9	3.5	11.5	2.0	5.3	0.8	3.6	2.1	5.9	0.0	0.0	1.8	45.5	107.2	6.0	46.6	0.0	1.8	0.0	1.2	0.0	0.4	1.3	6.1	0.6	2.3	0.0	13.8	76.4	2.1	22.4	53.2	14.0	18.3	0.3	3.4	0.1	0.2	50.1	12.9	0.0	2.6	14.7	0.1	0.1	0.9	0.7	0.1	3.8	0.0	23.2	6.7	0.1	36.0	1.3	3.9	4.8	0.1	39.0	0.0	0.0	0.7	0.2	0.7	0.3	16.8	0.1	0.5	0.0	0.1	0.0	5.2	0.1	19.1	0.0	5.9	1.0	29.7	4.4	3.3	4.8	0.1	0.1	0.2	15.6	2.0	4.0	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.9	1.3	0.9	4.2	0.9	1.0	1.0	1.7	4.2	0.0
ECM2		ENSG00000106823	"Extracellular matrix protein 2"	O94769	9	92493554-92536655	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"ASC diff: 11.1;ASC TERT1: 20.3;HSkMC: 21.4;hTCEpi: 24.4;hTERT-HME1: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035347	Approved				"Secreted to extracellular matrix"		5500000			"HPA035347: AB_10669856"	"unprognostic (2.48e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.50e-5)"	"unprognostic (6.14e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (4.09e-6)"	"unprognostic (1.12e-3)"	"unprognostic (2.39e-2)"	"unprognostic (3.80e-2)"	"unprognostic (6.63e-3)"	43.3	5.0	5.4	7.2	4.3	0.0	18.6	9.5	1.9	20.9	6.5	5.4	11.6	2.9	14.7	27.5	8.4	11.6	11.2	13.8	9.3	3.6	10.1	28.2	8.8	2.3	11.0	4.2	34.6	1.9	4.9	4.7	1.4	17.8	16.4	2.4	5.8	3.4	8.1	6.0	5.8	5.4	10.1	15.8	0.5	2.8	15.4	7.4	1.1	8.3	15.5	2.4	13.7	8.8	0.3	0.6	0.0	0.5	0.1	0.5	0.0	0.4	0.0	0.2	0.0	11.1	20.3	0.7	0.4	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.3	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.0	1.9	0.1	0.0	21.4	24.4	0.5	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.1	0.1	0.6	0.0	0.0	5.4	4.3	9.5	1.9	9.3	3.6	11.0	4.2	17.8	7.4
EDAR	"DL, ED1R, ED3, ED5, EDA1R, EDA3, Edar"	ENSG00000135960	"Ectodysplasin A receptor"	Q9UNE0	2	108894471-108989372	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein, Receptor"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.2;esophagus: 9.2;lymphoid tissue: 11.3"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 6.5;HaCaT: 14.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"naive CD4 T-cell: 10.2;naive CD8 T-cell: 4.8"	"Lineage enriched"	"Detected in single"	102	"T-cells: 10.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042292	Approved									"HPA042292: AB_10794648"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.83e-7)"	"unprognostic (9.21e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.03e-3)"	0.3	0.2	0.3	1.9	0.4	0.5	1.8	0.4	0.3	2.8	2.9	0.1	0.0	2.2	1.1	2.6	9.2	0.4	6.8	0.5	0.3	0.4	1.9	1.9	2.4	6.6	0.3	0.0	0.3	0.5	0.0	0.2	0.2	0.3	1.6	4.5	0.1	3.2	0.1	0.3	3.5	2.5	1.3	1.2	0.5	1.8	0.6	0.2	3.2	0.3	1.7	11.3	4.6	3.5	0.0	0.0	0.0	0.0	0.0	10.2	1.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	6.5	0.0	0.5	0.0	14.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	10.2	4.8	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.4	0.4	0.3	0.3	0.4	0.3	0.0	0.3	0.2
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9;U-698: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"				"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	3.8	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	10.7	2.2	35.3	6.6	2.8	20.5	3.9	1.5	3.6	29.9	5.4	23.5	6.2	10.0	0.4	4.0	5.6	8.1	11.5	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290363-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 107.5;HUVEC TERT2: 71.2;T-47d: 22.0;TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	1085		"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	35.7	1.5	8.4	6.2	30.8	3.6	19.2	3.2	22.0	8.2	9.2	4.2	1.1	9.0	7.2	15.3	10.8	8.6	11.9	5.2	19.0	6.2	5.7	2.8	25.1	6.7	10.9	5.5	4.3	8.2	1.6	1.0	16.0	25.1	5.4	12.9	6.9	9.7	8.5	25.6	8.2	6.7	9.7	13.5	10.2	6.8	4.8	5.6	0.2	2.9	3.8	2.1	5.3	4.1	0.2	0.2	1.2	7.9	0.0	0.2	0.0	1.5	9.0	0.1	0.0	0.0	0.0	0.0	2.8	2.5	2.4	2.0	11.6	1.3	0.0	107.5	1.1	0.8	0.0	1.6	1.7	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.4	0.3	71.2	0.0	0.0	9.0	0.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	5.6	1.4	0.1	0.0	0.2	8.5	0.0	22.0	0.1	52.7	6.0	4.8	0.1	3.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	7.9	0.1	0.0	0.0	8.4	30.8	3.2	22.0	19.0	6.2	10.9	5.5	25.1	5.6
EEA1	ZFYVE2	ENSG00000102189	"Early endosome antigen 1"	Q15075	12	92770637-92929331	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB005861, CAB018782, HPA038158, HPA038159"	Supported		Supported	Vesicles				Vesicles		"CAB005861: AB_2262056, CAB018782: AB_2277714, HPA038158: AB_10966710, HPA038159: AB_10962356"	"unprognostic (5.38e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.75e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.68e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.65e-1)"	26.4	11.1	10.9	14.9	13.5	5.3	13.7	20.5	12.4	18.4	12.2	7.7	8.3	10.2	14.4	9.5	20.9	11.0	11.4	13.4	12.0	9.8	10.6	14.7	12.9	8.0	12.5	11.8	17.6	9.3	16.9	14.3	23.6	16.7	14.2	11.0	7.3	13.7	12.3	23.1	16.7	10.3	15.7	14.3	15.3	10.7	7.8	12.5	6.9	12.6	15.2	8.2	19.2	17.9	2.2	2.0	2.2	3.3	0.7	3.4	0.9	8.9	3.0	4.4	3.1	19.2	19.4	10.4	17.7	10.2	9.4	6.7	10.3	2.4	9.1	3.2	12.4	10.9	9.9	5.0	14.6	6.2	4.9	9.7	3.5	9.4	10.7	6.9	4.6	12.6	7.4	10.0	15.2	16.5	7.3	3.1	9.7	4.1	4.9	4.7	4.5	6.8	5.6	11.4	6.1	4.9	12.4	3.8	2.9	13.0	8.6	7.9	11.3	6.1	21.0	13.3	5.1	10.6	6.7	3.4	5.8	6.4	4.9	6.1	7.2	0.1	2.5	0.7	1.7	1.8	1.8	2.2	2.0	1.8	2.0	2.0	3.4	2.4	2.2	0.7	3.3	2.0	0.7	0.9	10.9	13.5	20.5	12.4	12.0	9.8	12.5	11.8	16.7	12.5
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73515750-73523797	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol				Cytosol		"HPA051759: , HPA053862: , HPA056990: "	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	134.1	124.1	80.2	136.0	75.6	140.9	182.0	103.3	106.2	149.6	133.3	94.9	93.7	81.7	152.0	127.3	136.4	143.1	102.4	88.2	71.5	58.0	130.9	123.1	169.6	135.6	74.3	93.2	240.8	227.6	106.3	111.2	89.1	79.7	115.0	114.7	105.0	133.3	123.6	51.3	139.8	101.6	121.6	108.6	111.3	121.5	129.9	71.6	125.1	132.4	143.1	169.7	151.1	134.8	258.9	209.7	54.6	187.6	184.6	366.8	517.5	111.1	141.0	200.2	273.4	410.7	679.5	159.4	166.6	430.1	213.7	205.1	218.7	153.9	454.1	222.8	281.5	118.0	244.5	318.4	206.0	79.2	153.0	169.5	115.0	243.6	356.6	315.0	185.1	587.0	541.5	157.3	530.9	289.4	313.2	143.7	258.2	148.2	134.8	330.2	214.2	98.0	268.8	337.3	509.0	274.5	235.6	164.3	182.4	83.5	196.4	329.6	133.5	509.2	240.4	91.3	130.0	67.6	189.1	161.4	143.4	106.6	94.8	261.3	143.4	54.6	187.6	20.8	198.7	165.4	366.8	258.9	288.8	250.9	209.7	199.5	323.8	277.8	17.0	184.6	169.0	161.7	202.9	517.5	80.2	75.6	103.3	106.2	71.5	58.0	74.3	93.2	79.7	71.6
EEF1A2	"EEF1AL, HS1, STN, STNL"	ENSG00000101210	"Eukaryotic translation elongation factor 1 alpha 2"	Q05639	20	63488012-63499322	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Autism spectrum disorder, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 298.6"	"Cell line enhanced"	"Detected in many"		"HAP1: 55.3;HBF TERT88: 27.8;MCF7: 45.7;SCLC-21H: 29.1;T-47d: 23.7;U-2 OS: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034019, HPA051759, HPA053862, HPA056990"	Approved		Supported	Cytosol			55000000	Cytosol		"CAB034019: AB_1562672, HPA051759: , HPA053862: , HPA056990: "	"unprognostic (1.40e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.07e-1)"	2.2	8.0	21.3	2.3	23.5	1.9	2.2	41.1	51.3	1.9	2.3	2.3	0.1	2.2	2.0	2.3	4.1	2.1	2.6	51.9	23.0	21.0	2.0	2.0	2.0	2.1	13.9	31.0	2.0	3.5	6.1	16.6	2.0	23.1	3.7	2.1	1.8	3.4	2.2	298.6	2.2	2.3	2.1	4.8	2.0	3.6	2.3	3.6	0.0	2.0	23.9	2.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.3	0.1	10.6	0.2	2.5	0.0	0.1	1.3	2.1	0.3	10.5	3.5	1.4	7.0	0.0	18.6	0.1	5.0	55.3	0.1	27.8	0.1	2.5	0.0	4.0	0.4	0.6	0.0	2.5	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.1	45.7	0.1	0.1	1.9	17.8	1.3	0.0	1.7	0.4	0.5	29.1	17.7	16.8	1.9	0.1	23.7	0.6	0.0	0.0	32.4	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	21.3	23.5	41.1	51.3	23.0	21.0	13.9	31.0	23.1	3.6
EEF1B2		ENSG00000114942	"Eukaryotic translation elongation factor 1 beta 2"	P24534	2	206159585-206162928	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012477, HPA035029"	Supported		Approved	"Nucleoli fibrillar center,Cytosol"			640000	"Nucleoli fibrillar center, Cytosol"		"CAB012477: AB_732078, HPA035029: "	"prognostic favourable (2.60e-4)"	"unprognostic (3.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (9.95e-4)"	"unprognostic (2.70e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.62e-6)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-2)"	42.9	33.9	37.6	72.1	32.6	93.8	78.8	18.8	37.1	46.7	80.3	23.3	37.8	55.8	41.4	43.9	71.7	42.1	54.1	40.7	30.2	26.4	36.9	72.4	41.9	171.3	35.9	20.7	73.2	252.4	9.1	19.4	34.6	35.3	41.6	49.1	19.3	93.2	60.0	122.3	59.4	58.3	59.7	36.1	58.7	40.4	27.3	22.4	58.3	44.2	101.5	69.2	63.1	79.0	88.9	55.0	6.2	29.4	46.5	95.3	121.3	27.3	34.0	40.0	37.3	57.1	96.7	85.1	55.0	56.5	58.2	38.7	74.9	46.8	78.3	37.0	64.9	35.5	53.0	65.5	53.0	24.2	48.7	55.6	48.1	101.0	76.2	110.1	49.7	97.6	77.8	43.2	98.2	61.1	76.5	65.3	64.4	56.9	97.7	91.5	55.5	57.9	73.1	78.0	99.2	63.0	53.8	40.3	41.2	22.0	47.9	53.5	29.3	136.3	43.1	30.7	41.0	40.0	52.1	70.5	57.8	89.2	35.7	74.9	23.3	6.2	28.2	3.5	37.2	29.4	68.4	88.9	66.4	49.4	55.0	69.7	95.3	76.8	4.1	46.5	23.1	53.5	35.1	121.3	37.6	32.6	18.8	37.1	30.2	26.4	35.9	20.7	35.3	22.4
EEF1D	"EF-1D, FLJ20897"	ENSG00000104529	"Eukaryotic translation elongation factor 1 delta"	P29692	8	143579697-143599541	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"DNA-binding, Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045101, HPA051002"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"			900000	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045101: AB_10963077, HPA051002: "	"unprognostic (9.34e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (8.56e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (3.99e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.14e-1)"	58.0	47.7	25.2	48.0	23.6	67.6	61.7	20.1	25.9	56.4	54.7	35.0	50.8	33.8	57.2	50.8	63.0	39.5	68.6	58.5	24.5	20.5	43.0	89.4	49.1	123.8	27.3	18.7	95.0	258.8	23.3	27.8	34.6	22.3	70.7	25.3	50.2	98.6	48.3	95.1	56.2	45.4	65.7	31.2	60.1	49.9	33.4	23.3	73.4	76.4	82.3	77.4	57.8	94.6	122.6	75.1	35.9	46.3	69.1	128.4	143.7	46.8	68.5	30.6	26.4	27.7	34.2	34.0	36.4	46.9	58.1	46.3	93.5	44.7	36.0	38.5	40.6	46.8	31.6	58.8	25.3	28.4	52.0	35.3	120.8	91.0	41.4	21.9	30.0	65.6	86.0	35.1	40.0	38.8	33.0	53.5	32.9	151.4	85.4	55.8	32.3	90.9	38.0	22.0	70.5	49.7	79.7	30.4	32.9	31.8	78.1	76.2	58.4	56.2	30.1	33.9	99.6	50.3	78.3	36.4	14.0	37.5	38.1	44.9	29.4	19.5	46.3	21.3	80.0	41.6	103.1	114.0	102.4	83.8	53.3	122.6	128.4	103.5	35.9	69.1	36.6	75.1	96.2	143.7	25.2	23.6	20.1	25.9	24.5	20.5	27.3	18.7	22.3	23.3
EEF1G	EF1G	ENSG00000254772	"Eukaryotic translation elongation factor 1 gamma"	P26641	11	62559601-62574086	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 334.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040688, HPA055316"	Enhanced		Approved	Mitochondria			4600000	Mitochondria		"HPA040688: AB_10961632, HPA055316: AB_2732593"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.22e-4)"	"unprognostic (1.14e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.86e-1)"	"unprognostic (8.59e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.04e-2)"	46.5	38.1	33.0	41.3	40.0	60.6	84.9	30.4	56.5	53.8	45.4	30.6	29.7	40.9	48.6	43.0	71.1	61.0	35.1	62.2	34.6	24.7	49.4	64.5	41.7	98.8	29.1	31.8	105.3	103.9	29.9	31.7	41.4	51.4	50.4	49.2	29.0	58.9	35.5	207.2	88.5	45.0	38.2	39.6	48.4	45.8	236.9	28.8	43.9	41.1	118.6	70.9	47.7	66.1	203.5	136.9	27.4	83.9	114.5	251.4	334.5	88.4	94.3	98.5	139.5	148.6	192.7	98.9	77.5	140.7	97.3	74.6	104.8	112.7	263.5	123.7	123.3	104.9	116.5	114.2	89.2	84.6	108.4	68.6	106.1	107.1	161.7	138.3	81.1	220.1	207.0	96.2	236.7	133.8	137.4	127.3	114.5	182.8	150.2	247.5	118.7	82.6	125.8	126.8	250.5	129.7	117.2	85.5	106.4	46.7	158.6	210.7	181.7	154.4	90.1	56.6	79.4	109.2	67.0	89.1	86.3	131.7	64.3	102.6	79.2	27.4	83.9	21.0	87.3	78.5	173.5	203.5	167.7	112.9	136.9	187.5	251.4	169.1	12.3	114.5	64.0	108.5	119.2	334.5	33.0	40.0	30.4	56.5	34.6	24.7	29.1	31.8	51.4	28.8
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985469	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			9700000	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favourable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	104.2	84.9	64.0	66.7	57.1	92.7	77.5	55.7	96.2	93.4	91.3	55.8	80.8	95.4	100.1	75.1	115.1	83.4	88.6	104.1	51.6	44.4	65.5	161.0	67.7	108.9	51.4	38.3	167.1	395.7	45.1	72.3	63.7	47.5	105.6	41.3	67.7	191.3	64.4	260.8	87.2	100.9	112.3	46.8	85.4	98.5	70.9	32.4	123.4	127.1	112.5	108.3	111.8	94.7	84.9	60.0	10.0	58.4	48.3	76.3	83.7	95.2	68.4	39.8	105.1	106.7	192.3	57.3	74.9	101.4	71.7	70.6	107.8	44.2	199.0	44.6	69.1	72.3	62.8	116.0	38.0	49.6	104.2	50.8	65.7	110.7	156.0	109.1	88.4	248.2	122.7	63.1	97.7	74.2	99.1	146.7	43.6	138.2	97.9	83.7	105.3	69.2	109.1	59.2	126.5	59.0	85.2	109.0	101.3	47.1	94.3	135.0	91.9	132.7	88.9	51.4	53.7	104.4	115.2	157.4	105.6	99.0	76.6	137.2	67.0	10.0	58.4	8.3	38.6	45.8	68.7	84.9	67.7	50.8	60.0	70.7	76.3	59.4	6.1	48.3	43.8	50.5	58.4	83.7	64.0	57.1	55.7	96.2	51.6	44.4	51.4	38.3	47.5	32.4
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.8;HUVEC TERT2: 263.9;TIME: 233.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: , HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	0.2	0.4	0.0	20.1	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	21.0	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.1	0.0	0.0	64.8	6.9	1.5	17.3	263.9	0.0	0.0	5.6	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.4	6.5	0.0	20.2	0.0	233.7	0.1	7.0	25.9	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 24.1;BJ: 27.7;BJ hTERT+: 34.5;fHDF/TERT166: 49.8;HSkMC: 33.5;LHCN-M2: 30.0;U-138 MG: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.5;gdT-cell: 4.4;NK-cell: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.5;NK-cells: 2.3;T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"		1100000			"HPA023270: AB_1848019"	"unprognostic (3.13e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.89e-2)"	"unprognostic (9.12e-2)"	"prognostic unfavourable (3.94e-5)"	"unprognostic (8.33e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.58e-2)"	22.1	10.5	9.4	10.1	9.9	1.6	13.4	6.2	7.3	38.9	16.4	7.7	19.8	4.8	29.3	28.4	13.0	16.3	29.7	29.4	7.0	6.0	14.7	5.4	14.5	15.1	8.4	5.7	39.7	12.2	14.1	7.6	21.9	6.5	26.5	4.0	24.5	9.6	22.1	11.9	6.9	6.9	23.6	7.6	8.4	10.4	19.9	4.8	2.8	25.3	11.3	4.8	23.1	15.2	0.1	0.3	1.5	0.2	2.3	4.4	0.5	0.1	0.0	0.5	9.2	11.9	24.1	0.2	27.7	34.5	10.9	9.8	0.0	0.9	0.1	2.3	49.8	0.2	0.0	0.3	2.7	1.4	0.0	0.2	0.7	1.8	18.9	0.0	0.0	33.5	0.0	4.2	0.2	6.2	0.0	1.7	30.0	0.1	0.0	4.2	0.3	0.1	0.1	0.1	0.7	0.3	0.1	0.1	2.9	0.0	0.3	0.3	0.3	2.2	13.8	24.0	5.8	11.5	0.1	3.0	0.1	0.0	9.2	0.2	4.2	0.0	0.2	1.5	4.4	0.1	0.1	0.1	0.5	0.0	0.3	0.0	0.1	0.5	0.6	2.3	0.2	0.0	0.0	0.5	9.4	9.9	6.2	7.3	7.0	6.0	8.4	5.7	6.5	4.8
EFNB1	"CFNS, Elk-L, EPLG2, LERK2"	ENSG00000090776	"Ephrin B1"	P98172	X	68828997-68842147	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Cancer-related genes, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.4;hTCEpi: 27.6;PC-3: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB031489, HPA067188"	Uncertain		Supported	"Plasma membrane"			790000	"Plasma membrane"		"CAB031489: AB_631414, HPA067188: "	"unprognostic (2.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.32e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.05e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.86e-2)"	36.5	13.2	5.0	11.5	4.5	1.3	26.5	2.3	4.7	19.5	21.1	4.7	13.1	14.0	15.2	14.9	17.4	15.2	33.7	16.0	3.6	2.7	25.5	15.3	23.0	5.2	4.7	3.5	21.6	4.5	15.0	6.4	34.3	3.9	15.9	10.1	14.9	7.0	13.2	9.1	26.4	24.0	12.3	2.6	15.3	13.3	7.4	4.2	4.8	11.9	22.0	11.2	16.7	14.8	0.5	7.1	0.6	3.4	1.3	1.0	1.0	3.7	1.9	15.6	5.7	8.3	5.1	8.2	3.2	3.5	1.4	1.0	1.7	6.9	0.9	21.2	1.2	19.8	14.7	35.4	0.8	1.5	3.7	0.9	0.8	3.0	7.6	0.7	8.0	9.5	27.6	3.5	16.0	10.8	1.0	0.0	1.2	3.0	1.5	0.7	10.8	26.2	6.6	1.6	5.9	5.9	13.1	5.8	2.8	2.4	0.7	0.9	0.6	1.3	18.1	2.7	3.3	7.2	1.2	0.0	0.8	0.9	1.3	4.0	1.7	0.0	1.3	0.6	1.0	3.4	0.6	0.5	0.9	0.9	7.1	0.4	0.8	0.4	0.3	1.3	2.1	1.0	0.4	1.0	5.0	4.5	2.3	4.7	3.6	2.7	4.7	3.5	3.9	4.2
EFNB2	"EPLG5, Htk-L, HTKL, LERK5, MGC126226, MGC126227, MGC126228"	ENSG00000125266	"Ephrin B2"	P52799	13	106489731-106535662	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 49.4;SH-SY5Y: 24.8;U-87 MG: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008999, CAB009368"	Supported		Supported	Nucleoplasm,Cytosol			760000	Nucleoplasm	Cytosol	"CAB009368: AB_2095700, HPA008999: AB_1078721"	"unprognostic (1.70e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.52e-3)"	"prognostic unfavourable (3.11e-6)"	"unprognostic (2.32e-2)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (8.70e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.27e-3)"	15.7	4.9	11.2	8.2	11.0	0.8	21.8	8.3	14.0	13.2	23.1	5.8	13.1	13.9	10.8	5.2	11.4	13.6	11.2	11.8	10.4	6.5	9.3	11.8	50.1	7.8	6.2	11.5	8.4	3.7	5.7	6.1	27.7	5.2	11.8	18.4	15.2	12.7	20.6	6.6	14.3	20.6	10.5	5.0	9.3	21.3	7.2	5.9	7.3	11.2	8.8	5.9	7.7	12.4	0.2	0.0	0.4	0.0	1.5	0.0	0.0	11.8	1.1	49.4	0.0	0.1	0.4	0.2	5.4	3.4	5.3	3.1	11.9	18.1	0.0	5.2	1.6	14.1	1.8	6.9	5.8	0.0	10.6	0.0	4.1	0.0	1.0	3.9	0.3	2.3	12.4	0.2	10.6	6.7	0.0	0.0	5.8	2.0	0.1	0.0	2.6	2.4	9.9	2.0	0.0	7.6	1.5	3.5	24.8	2.0	1.0	0.0	0.6	0.1	5.2	10.6	0.0	0.3	12.1	0.1	0.0	0.0	22.2	0.2	2.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	11.2	11.0	8.3	14.0	10.4	6.5	6.2	11.5	5.2	5.9
EFS	"CASS3, EFS1, EFS2, HEFS, SIN"	ENSG00000100842	"Embryonal Fyn-associated substrate"	O43281	14	23356402-23365752	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.7;AN3-CA: 15.1;BEWO: 23.2;SH-SY5Y: 26.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001581, HPA001790"	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA001581: , HPA001790: "	"unprognostic (9.58e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.85e-2)"	"unprognostic (7.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (4.09e-5)"	"unprognostic (3.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.29e-1)"	12.0	10.2	11.7	4.4	15.7	0.6	13.1	9.4	21.2	17.9	8.5	29.4	8.0	2.8	17.0	9.8	18.3	10.0	6.7	5.5	14.3	8.3	3.2	1.2	5.7	2.8	14.9	8.2	23.7	1.5	25.0	3.2	33.1	15.6	17.9	3.1	8.3	15.6	18.6	3.8	42.3	3.9	13.0	25.7	4.5	4.7	4.4	16.0	0.4	6.8	15.5	10.0	11.8	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	27.7	15.1	6.9	8.0	23.2	2.0	4.2	0.7	0.3	0.0	0.0	0.0	0.0	11.4	10.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	4.5	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	8.8	0.0	0.0	8.8	3.0	26.5	5.9	0.9	0.0	6.6	0.0	0.0	2.9	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	15.7	9.4	11.8	14.3	8.3	14.9	8.2	15.6	16.0
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849943-44899662	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	22.5	26.5	16.0	23.1	27.0	25.0	17.7	13.4	34.9	14.8	20.3	22.0	10.4	16.6	22.1	15.4	27.0	20.2	12.7	22.6	16.6	16.7	21.5	27.7	17.3	25.2	15.8	19.8	15.3	20.0	21.2	15.3	27.5	22.6	14.9	23.2	19.1	27.2	15.7	49.6	22.0	20.3	18.5	15.7	25.9	18.5	30.2	13.1	36.9	18.6	17.9	34.9	18.6	16.0	12.8	31.8	31.6	31.5	15.6	16.9	23.3	22.8	45.8	22.3	36.2	17.1	17.0	26.3	18.2	24.4	46.0	40.0	35.2	19.6	39.6	21.5	22.9	26.2	48.5	31.8	53.8	39.7	40.2	39.2	28.6	37.4	18.9	46.2	29.2	18.4	18.2	42.5	23.2	39.8	48.3	15.4	26.1	22.8	46.2	30.5	23.0	38.3	32.6	45.4	34.3	26.2	25.7	36.8	22.0	17.9	13.3	18.8	35.2	29.2	24.1	34.6	26.7	20.9	45.8	16.3	20.5	39.8	27.8	25.7	35.2	12.3	31.5	31.6	15.2	31.0	16.9	12.8	13.5	14.6	31.8	12.5	12.0	13.3	5.1	15.6	29.7	13.7	13.2	23.3	16.0	27.0	13.4	34.9	16.6	16.7	15.8	19.8	22.6	13.1
EGF		ENSG00000138798	"Epidermal growth factor"	P01133	4	109912884-110012266	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Growth factor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 48.4;pancreas: 41.2;skeletal muscle: 19.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 8.0;SK-BR-3: 14.6;U-251 MG: 4.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"										25000				"unprognostic (2.83e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.88e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.64e-3)"	"unprognostic (5.06e-4)"	"unprognostic (8.30e-2)"	"unprognostic (2.21e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.72e-3)"	"unprognostic (4.64e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.80e-5)"	"unprognostic (3.92e-3)"	0.8	0.1	0.4	0.0	0.4	0.0	5.9	0.1	0.9	0.2	0.2	0.3	0.3	0.0	0.3	2.6	0.9	0.2	0.3	2.3	0.8	0.3	48.4	0.0	0.6	0.0	1.2	0.7	0.0	41.2	0.0	0.4	0.0	1.4	0.6	0.4	3.9	8.4	0.1	19.8	0.5	0.2	1.9	0.6	0.2	0.0	0.2	0.2	0.0	1.2	4.5	0.4	0.4	0.5	0.0	0.4	1.7	0.0	0.0	0.0	2.6	0.2	0.3	2.4	0.1	0.0	0.1	0.0	0.6	1.5	0.8	0.5	0.1	0.0	0.0	8.0	0.8	0.0	0.3	0.0	0.6	0.1	0.4	0.1	0.9	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.2	0.8	0.1	0.0	0.0	2.9	0.5	0.2	0.1	0.6	0.6	0.2	0.0	0.0	0.0	14.6	0.5	3.5	0.0	0.0	1.2	2.0	0.0	4.6	0.0	0.0	0.0	1.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	2.6	0.4	0.4	0.1	0.9	0.8	0.3	1.2	0.7	1.4	0.2
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell line enriched"	"Detected in many"	12	"A-431: 337.7"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"		93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: , CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavourable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	337.7	4.3	1.1	1.5	6.9	4.3	1.1	3.3	4.5	2.0	1.6	0.8	3.7	0.2	0.8	2.8	13.5	0.0	14.9	2.5	0.1	0.2	0.0	1.8	0.2	1.8	0.0	0.0	2.1	13.7	5.2	27.9	0.2	0.0	0.0	4.4	0.2	0.0	0.0	0.3	2.2	0.0	0.6	0.0	2.5	3.6	0.0	1.3	2.8	3.4	0.6	0.3	0.7	1.0	1.9	0.5	14.6	3.1	0.0	0.3	0.1	2.5	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9
EGLN1	"C1orf12, HIFPH2, PHD2, SM-20, ZMYND6"	ENSG00000135766	"Egl-9 family hypoxia inducible factor 1"	Q9GZT9	1	231363751-231425044	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 14.9;skeletal muscle: 46.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 14.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022129	Approved									"HPA022129: AB_1848046"	"unprognostic (4.20e-1)"	"prognostic unfavourable (2.99e-7)"	"unprognostic (8.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.87e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.81e-2)"	4.9	4.2	4.4	1.4	4.5	0.8	3.5	3.6	4.3	3.0	3.3			3.9	3.1	2.6	3.5	2.3	2.9	7.0	4.4	3.5	5.2	7.2	1.6	1.6	4.1		4.1	4.4	5.5	2.1	4.4		2.6	2.8		2.3	3.5	46.9	5.6	3.9	2.8	4.1	3.0	2.0	1.3			2.8		1.8	2.5	2.7	0.6	0.7	14.9	1.4	0.7	1.1	0.3	13.4	12.9	4.1	7.9	10.9	7.6	4.6	6.6	9.7	9.2	12.7	9.4	10.7	4.0	11.6	9.4	6.8	5.8	7.7	16.4	5.8	14.7	1.9	5.3	8.0	7.8	9.5	2.7	6.0	7.1	6.2	7.7	12.0	9.1	7.6	8.7	2.6	2.3	3.5	4.9	7.2	5.0	5.7	4.9	11.7	4.8	4.2	11.2	8.2	10.7	21.8	5.7	27.3	14.2	10.8	5.9	10.7	12.4	18.9	11.5	3.6	15.0	3.6	15.0	4.1	0.6	2.5	0.7	0.9	0.5	0.6	0.8	0.6	0.7	0.6	0.9	1.1	14.9	0.7	1.4	0.6	0.6	0.3										
EGLN2	"HIFPH1, PHD1"	ENSG00000269858	"Egl-9 family hypoxia inducible factor 2"	Q96KS0	19	40798996-40808433	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056649			Supported	Nucleoplasm				Nucleoplasm		"HPA056649: "	"unprognostic (1.11e-2)"	"prognostic favourable (2.88e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.51e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (7.10e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.38e-3)"	27.4	24.3	24.8	24.7	28.5	23.3	33.5	22.6	28.9	22.2	21.2	21.9	26.4	17.8	24.2	17.8	16.7	18.6	23.4	18.6	25.5	18.7	18.4	19.1	31.6	29.0	21.8	25.7	22.8	16.6	10.6	16.9	42.5	16.9	20.9	15.3	16.5	19.4	25.7	15.5	13.4	16.8	28.1	15.0	42.4	18.0	74.1	18.0	14.4	29.7	17.2	22.7	19.6	25.1	25.1	16.3	68.2	21.5	15.1	30.2	26.5	16.3	44.5	20.7	20.0	26.9	19.7	13.5	17.9	15.0	25.6	28.2	36.7	16.6	14.6	15.3	21.4	10.6	26.0	20.4	13.8	18.2	14.7	19.4	26.0	13.9	28.9	14.9	26.6	24.2	21.8	24.4	14.1	31.5	27.5	13.7	26.9	11.6	27.5	24.7	17.9	15.5	25.7	10.2	9.9	27.6	25.2	19.1	17.4	29.3	23.2	23.6	30.6	40.8	29.0	32.2	23.2	13.2	21.1	6.9	10.0	25.7	23.5	21.8	23.7	20.9	19.1	46.8	24.1	21.5	25.3	23.2	28.5	24.9	16.3	25.1	30.2	25.2	68.2	15.1	19.9	11.9	25.6	26.5	24.8	28.5	22.6	28.9	25.5	18.7	21.8	25.7	16.9	18.0
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465490-138469315	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.2;hTCEpi: 57.1;U-266/84: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 9.9;monocytes: 5.1"	"Group enriched"	"Detected in all"	6	"amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1"	"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB019427: AB_2097038, HPA029937: , HPA029938: "	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	78.7	47.9	5.5	114.3	23.3	18.3	28.7	23.7	25.0	61.8	40.5	31.6	8.0	6.8	51.7	15.6	47.2	187.3	158.4	42.9	7.0	8.1	22.0	68.8	39.7	18.6	4.9	7.0	130.9	23.0	15.8	43.3	24.3	17.8	45.2	21.7	56.1	18.7	100.5	19.4	54.2	29.8	60.8	4.4	8.8	46.1	14.7	2.8	19.4	76.6	67.5	26.6	43.2	20.3	0.9	0.9	9.9	5.1	0.1	0.2	0.4	4.1	0.1	8.9	13.2	24.2	39.2	1.0	7.1	4.4	9.6	7.8	5.0	3.6	0.2	1.1	15.4	1.9	0.5	14.4	4.4	0.2	0.6	0.5	1.7	1.4	3.1	1.5	11.4	3.0	57.1	8.5	1.9	0.8	20.9	5.1	2.8	20.5	0.6	6.4	0.8	0.0	0.1	1.3	0.7	7.3	2.5	11.2	1.2	8.6	23.9	18.5	0.3	1.2	0.3	3.5	4.5	1.7	2.7	11.9	86.2	1.7	4.0	19.6	1.0	0.0	3.5	0.4	0.2	5.1	0.0	0.9	0.1	0.1	0.9	0.3	0.2	0.2	9.9	0.1	1.4	0.0	0.2	0.4	5.5	23.3	23.7	25.0	7.0	8.1	4.9	7.0	17.8	2.8
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (1.95e-8)"	19.6	12.6	19.8	10.2	15.4	4.0	12.0	27.5	22.5	22.5	22.3	8.0	7.5	6.8	22.3	6.0	20.9	12.7	18.2	7.8	16.0	15.9	12.3	36.9	8.1	5.7	17.1	13.0	35.1	10.9	9.7	14.5	8.2	12.8	12.6	10.4	8.6	10.2	14.0	5.4	7.4	8.5	21.4	9.3	5.4	11.1	24.1	9.8	5.4	10.4	7.5	7.0	12.3	12.7	8.4	5.4	3.5	3.6	4.7	6.8	2.8	18.3	25.4	10.4	6.2	18.2	35.2	10.5	16.4	16.1	12.1	10.0	30.2	13.8	12.7	6.0	30.0	11.2	13.4	11.6	20.1	13.5	6.3	10.9	9.0	35.6	12.5	6.3	8.4	16.2	21.0	12.3	24.1	7.7	7.5	7.3	19.4	7.1	7.3	4.0	10.1	9.9	6.6	13.0	5.4	8.1	6.0	11.3	9.2	13.5	10.0	16.3	4.8	6.3	5.6	13.1	13.6	21.5	8.6	8.4	5.7	12.1	13.0	9.9	26.1	0.2	3.4	3.5	6.3	3.6	6.3	8.4	6.8	6.0	5.4	7.3	6.7	5.7	1.3	4.7	1.9	3.5	3.7	2.8	19.8	15.4	27.5	22.5	16.0	15.9	17.1	13.0	12.8	9.8
EHD1	"FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1"	ENSG00000110047	"EH domain containing 1"	Q9H4M9	11	64851642-64888296	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751, HPA067747"	Approved		Supported	"Plasma membrane"			19000000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA066751: , HPA067747: "	"unprognostic (1.51e-1)"	"unprognostic (3.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.81e-5)"	"unprognostic (1.46e-3)"	"unprognostic (9.10e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.37e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.59e-2)"	17.5	10.4	7.3	33.3	7.4	57.5	12.3	27.2	11.3	11.1	13.5	18.2	8.0	14.7	13.1	10.8	15.5	12.5	15.2	11.3	8.2	9.4	14.5	9.3	18.7	41.1	13.8	5.9	10.0	5.2	5.1	3.4	34.8	16.7	9.0	6.6	8.0	11.9	10.0	13.2	14.1	22.9	12.4	13.1	43.1	12.7	65.8	10.4	21.3	12.3	13.6	33.6	13.5	10.3	10.6	3.5	38.0	13.1	10.2	17.2	10.2	26.4	18.4	6.6	7.3	8.1	13.2	3.9	27.0	24.5	22.9	13.4	23.8	16.6	34.9	9.7	32.2	21.6	6.9	27.2	8.9	21.8	3.8	23.2	9.6	12.0	9.6	7.5	6.3	5.9	5.8	35.4	11.1	22.6	9.5	62.0	17.3	14.1	15.0	12.5	4.4	24.1	6.0	21.3	12.1	21.7	8.8	4.7	4.2	15.1	27.8	12.3	37.8	5.4	31.8	10.2	9.1	27.0	12.9	25.5	11.2	26.8	26.6	9.8	5.5	6.7	5.0	38.0	16.9	6.7	17.2	10.6	11.9	14.6	2.9	8.2	7.2	9.8	23.6	10.2	13.1	3.5	12.9	10.2	7.3	7.4	27.2	11.3	8.2	9.4	13.8	5.9	16.7	10.4
EHD3	PAST3	ENSG00000013016	"EH domain containing 3"	Q9NZN3	2	31234337-31269447	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.4;esophagus: 29.1"	"Cell line enhanced"	"Detected in many"		"BJ: 25.1;BJ hTERT+: 62.1;HEL: 24.1;U-266/70: 15.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 17.8;naive B-cell: 4.4"	"Lineage enriched"	"Detected in many"	9	"B-cells: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA066751"	Approved		Approved	"Plasma membrane"			41000000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA066751: "	"unprognostic (3.44e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.79e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (4.88e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (4.92e-3)"	2.7	7.1	15.0	5.6	16.3	2.0	3.3	10.6	37.4	5.6	2.2	7.3	0.0	1.9	3.9	3.4	29.1	4.9	3.6	14.8	16.7	8.9	15.0	10.8	4.8	6.3	9.6	21.6	2.9	1.4	8.7	6.0	11.3	13.3	5.7	2.1	2.8	4.8	4.9	2.3	3.0	2.9	4.8	9.4	5.8	1.9	1.6	6.6	1.2	2.5	1.5	10.4	7.8	4.2	17.8	0.4	1.0	1.9	0.6	1.7	7.8	0.5	2.6	1.4	1.2	2.5	3.8	0.2	25.1	62.1	2.4	2.2	0.0	0.3	0.1	0.9	8.2	0.2	0.0	1.6	1.7	1.0	2.2	24.1	0.1	0.0	8.6	0.0	0.0	6.0	0.7	2.4	1.0	0.0	0.0	0.1	1.8	3.9	0.3	0.0	5.6	1.3	0.8	0.1	0.5	1.9	2.8	0.7	3.9	0.2	0.4	0.0	0.3	0.0	0.0	1.8	1.7	0.1	2.0	15.6	1.9	0.0	4.8	0.0	3.9	0.4	0.4	0.3	1.7	0.8	0.9	17.8	0.9	1.1	0.4	4.4	0.8	0.4	1.0	0.6	1.9	0.0	0.4	7.8	15.0	16.3	10.6	32.7	16.7	8.9	9.6	21.6	13.3	6.6
EHD4	PAST4	ENSG00000103966	"EH domain containing 4"	Q9H223	15	41895939-41972578	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 33.6;TIME: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049890, HPA049986, HPA052729, HPA066751"	Approved		Approved	"Plasma membrane"			410000	"Plasma membrane"		"HPA049890: , HPA049986: , HPA052729: , HPA066751: "	"unprognostic (1.45e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.72e-1)"	26.1	5.0	3.3	12.9	5.0	8.0	17.9	1.9	5.6	11.4	11.4	4.7	11.3	4.7	20.8	16.4	18.1	10.5	17.4	35.4	4.3	2.6	14.5	22.8	19.9	24.3	7.2	2.0	14.1	14.1	13.9	6.5	14.4	7.5	14.1	9.3	17.4	11.1	12.0	10.5	16.1	16.0	11.6	7.1	11.1	10.0	7.5	4.3	5.3	19.1	9.0	13.7	14.4	10.1	2.6	13.3	7.7	12.7	3.6	6.8	6.2	8.9	3.1	3.0	3.1	1.5	2.2	2.6	4.8	10.1	8.5	12.0	13.1	5.2	1.8	12.9	6.0	9.1	4.5	10.4	6.3	11.1	3.8	2.7	4.6	2.2	3.8	1.2	8.0	1.8	4.1	8.6	9.5	33.6	2.8	2.1	6.8	3.8	1.2	1.4	2.3	10.8	0.0	8.0	2.9	7.6	18.2	5.0	2.1	3.5	7.5	5.4	7.4	1.7	55.3	2.7	5.2	9.9	23.1	5.9	9.4	3.9	3.4	3.0	23.1	0.9	12.7	7.7	3.8	11.2	5.8	2.0	6.0	4.8	13.3	2.6	2.6	3.7	2.1	3.6	4.4	2.2	6.8	6.2	3.3	5.0	1.9	5.6	4.3	2.6	7.2	2.0	7.5	4.3
EHHADH	ECHD	ENSG00000113790	"Enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenase"	Q08426	3	185190624-185281990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 37.1;liver: 91.2"	"Low cell line specificity"	"Detected in many"			"Group enriched"	"Detected in all"	7	"liver cancer: 42.2;renal cancer: 25.4"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036401, HPA042021"	Enhanced									"HPA036401: AB_10670165, HPA042021: "	"unprognostic (1.20e-1)"	"unprognostic (5.99e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-5)"	"unprognostic (1.93e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.80e-1)"	4.1	1.2	1.2	1.7	1.4	0.1	1.5	0.5	1.2	1.7	6.4	0.8	0.4	5.2	1.0	2.0	2.9	0.8	3.0	3.2	1.2	0.9	37.1	91.2	1.9	1.0	1.7	0.7	0.8	2.5	2.7	0.9	1.3	2.1	1.7	2.6	8.3	2.7	0.4	0.7	1.1	9.9	1.0	1.4	1.7	2.4	0.9	0.9	1.4	2.1	1.7	1.2	1.8	1.0	1.5	6.0	0.2	2.2	2.7	2.7	1.1	8.2	3.5	1.0	0.0	5.2	4.5	1.1	4.0	1.2	2.6	2.9	15.1	5.2	0.0	15.7	3.9	4.0	0.0	3.3	5.5	11.0	3.7	5.8	0.9	15.2	3.4	0.7	0.1	6.3	4.3	2.6	2.4	3.8	3.8	4.3	5.0	4.3	0.1	3.4	2.1	4.4	0.0	7.0	0.3	10.8	4.7	3.1	4.5	7.8	4.5	7.2	16.6	6.8	1.8	1.7	2.6	1.3	0.3	1.2	3.7	0.3	0.5	2.6	2.8	0.2	2.2	0.0	1.6	2.1	1.0	1.5	1.1	2.4	6.0	0.2	1.6	2.7	0.1	2.7	2.0	2.4	1.4	1.1	1.2	1.4	0.5	1.2	1.2	0.9	1.7	0.7	2.1	0.9
EHMT1	"bA188C12.1, EHMT1-IT1, Eu-HMTase1, FLJ12879, FLJ40292, KIAA1876, KMT1D"	ENSG00000181090	"Euchromatic histone lysine methyltransferase 1"	Q9H9B1	9	137618963-137870016	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060022			Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA060022: "	"unprognostic (1.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-2)"	"prognostic favourable (6.56e-4)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.91e-4)"	"unprognostic (5.87e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.55e-3)"	"unprognostic (2.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (4.24e-1)"	"unprognostic (7.12e-3)"	"unprognostic (7.75e-2)"	16.6	18.3	16.4	23.2	22.3	24.9	17.1	23.7	20.4	16.3	20.7	21.6	20.4	17.1	22.0	13.0	17.9	18.5	20.0	12.1	12.8	9.6	12.7	14.9	14.9	25.0	27.8	12.1	21.4	13.6	15.1	16.2	17.9	18.6	16.9	12.4	19.1	16.5	18.0	23.1	17.3	17.9	21.5	12.5	22.1	16.4	30.8	21.5	22.3	18.9	11.0	22.2	19.2	15.7	20.0	19.0	25.0	13.7	13.1	15.6	6.9	11.0	22.1	24.8	22.9	10.5	10.9	20.7	14.6	9.2	10.7	8.7	14.4	13.8	33.8	14.2	11.0	23.7	14.8	15.9	8.5	18.9	10.5	14.3	22.1	9.2	9.2	21.7	17.1	9.8	11.2	12.9	12.6	17.5	21.4	11.7	7.6	25.5	25.4	10.8	24.1	14.7	32.7	21.3	19.5	8.9	20.3	21.9	17.8	27.7	19.5	6.3	21.9	17.5	16.4	12.6	13.1	19.3	13.8	7.5	20.8	27.8	9.3	11.6	13.6	13.6	13.7	16.3	15.6	11.7	10.0	13.3	13.5	13.3	10.4	20.0	13.3	11.8	25.0	13.1	12.0	19.0	11.1	6.9	16.4	22.3	23.7	20.4	12.8	9.6	27.8	12.1	18.6	21.5
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 10.2;NTERA-2: 15.5;U-266/84: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"			"Nuclear speckles"	Nucleoplasm	"HPA050550: , HPA060259: "	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	9.4	12.2	13.1	9.6	21.4	7.6	6.3	17.1	17.5	8.0	7.7	12.3	8.4	14.6	15.0	11.7	18.0	7.6	8.1	7.6	12.3	12.4	5.3	4.4	8.5	6.9	12.6	10.6	10.6	13.2	2.2	8.1	6.0	10.3	10.4	4.3	7.2	5.6	9.6	5.2	5.5	10.1	9.6	8.4	9.1	9.8	7.6	14.9	14.6	9.5	4.8	7.2	8.7	7.6	0.3	0.6	0.0	0.7	0.1	1.1	1.3	0.0	3.5	6.3	0.0	2.8	1.5	4.0	2.7	2.2	3.1	2.6	0.0	0.0	0.0	6.2	4.5	0.0	0.0	6.8	1.5	4.1	9.4	0.0	0.0	0.0	0.0	10.2	0.0	3.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	15.5	0.0	6.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.8	5.2	0.0	0.0	3.0	3.3	2.6	5.6	0.0	9.0	12.2	2.9	3.8	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.1	0.8	0.6	0.3	0.3	1.1	1.1	0.0	0.1	0.7	0.6	0.2	1.3	13.1	21.4	17.1	16.5	12.3	12.4	12.6	10.6	10.3	14.9
EIF1	"A121, EIF-1, EIF1A, ISO1, SUI1"	ENSG00000173812	"Eukaryotic translation initiation factor 1"	P41567	17	41688885-41692668	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 310.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (1.43e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (9.45e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.63e-3)"	82.5	56.0	51.7	44.2	59.6	197.5	80.3	43.2	63.7	53.0	55.1	54.5	43.6	54.6	54.7	33.1	55.5	46.0	46.9	86.0	48.2	41.8	51.4	70.8	51.3	72.4	87.8	55.0	68.1	104.6	35.3	51.6	44.0	67.8	44.8	32.3	43.7	92.7	45.9	310.6	54.2	47.2	67.3	63.5	52.8	61.2	54.7	68.3	44.4	46.2	78.7	41.4	60.3	80.6	48.0	42.4	138.7	61.5	30.3	60.0	68.8	38.4	20.2	23.4	22.0	47.3	44.0	22.5	51.5	36.9	28.3	27.9	11.8	27.7	52.2	40.9	38.8	48.7	31.3	34.9	27.5	55.2	26.6	27.3	10.5	17.3	98.4	43.2	54.5	52.9	67.7	38.5	94.8	27.7	43.3	80.5	26.5	10.7	50.8	27.6	20.1	38.9	25.8	50.4	51.5	24.8	18.4	29.0	37.2	31.0	58.0	112.2	40.7	31.5	43.4	27.9	42.8	57.9	51.0	119.7	99.1	42.2	39.6	27.2	35.1	138.7	50.8	63.8	38.9	61.4	48.1	48.0	52.9	45.3	42.4	45.2	55.7	47.7	52.8	30.3	61.5	42.3	60.0	68.8	51.7	59.6	43.2	63.7	48.2	41.8	87.8	55.0	67.8	68.3
EIF2A	EIF-2A	ENSG00000144895	"Eukaryotic translation initiation factor 2A"	Q9BY44	3	150546678-150584242	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036256	Approved		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA036256: AB_10611961"	"unprognostic (1.72e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.36e-2)"	"unprognostic (3.96e-3)"	"unprognostic (7.05e-3)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (2.11e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.57e-6)"	"unprognostic (6.30e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.39e-1)"	33.5	23.7	12.6	21.4	22.8	27.2	34.3	38.3	23.8	35.1	29.4	12.6	17.3	23.1	31.5	19.9	37.2	20.6	19.0	24.9	11.3	11.9	27.0	44.5	24.7	32.8	16.5	11.7	35.6	39.4	22.6	36.4	26.2	22.7	32.9	23.8	15.4	29.8	23.9	53.3	26.8	33.1	25.0	16.9	28.9	26.5	16.3	17.9	38.5	41.8	33.8	25.8	44.0	26.1	17.0	27.7	7.9	24.6	20.5	26.9	19.0	38.1	13.9	19.5	20.6	25.1	50.0	27.0	23.6	32.7	30.3	32.8	38.5	42.2	50.4	36.2	28.1	31.1	32.4	32.7	43.1	19.0	21.7	29.6	16.7	29.7	24.1	36.8	28.3	33.3	37.2	22.2	49.6	37.5	24.3	30.0	24.4	26.9	26.8	19.5	27.7	22.0	23.6	25.6	58.5	31.7	23.7	24.8	26.5	14.2	22.7	36.9	33.3	34.3	21.9	19.2	18.3	27.1	45.3	52.1	27.4	46.4	24.3	32.3	9.5	7.9	22.6	4.7	14.9	23.5	23.3	17.0	21.2	18.2	27.7	14.9	26.9	21.0	1.8	20.5	24.6	13.1	17.3	19.0	12.6	22.8	38.3	23.8	11.3	11.9	16.5	11.7	22.7	17.9
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184145311	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB015412: AB_831253, HPA064370: , HPA069303: "	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavourable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	15.2	20.1	15.3	15.4	20.2	10.6	21.5	24.5	25.8	15.1	18.8	17.8	24.3	17.3	16.3	14.9	24.3	15.4	14.0	21.5	13.0	16.1	17.5	27.5	15.6	20.1	20.8	15.1	16.0	19.1	27.0	21.2	20.6	17.7	20.4	23.7	15.3	23.2	21.0	47.2	22.8	18.2	17.5	14.7	21.1	19.6	11.9	17.3	20.9	17.4	16.9	26.9	19.1	18.3	12.7	10.3	10.9	8.4	11.2	17.2	6.5	24.5	11.3	13.9	15.1	14.0	11.5	15.0	14.7	15.7	21.5	18.3	18.5	12.4	22.4	17.0	14.4	19.0	24.9	17.2	22.1	20.1	20.4	36.6	11.5	16.2	10.9	27.6	19.4	9.6	15.5	13.0	13.5	15.4	19.7	19.6	15.2	20.6	20.2	19.3	18.7	20.9	21.9	16.7	25.2	19.6	21.7	15.0	16.6	12.6	39.9	16.3	37.0	27.3	14.3	13.1	15.3	12.4	28.2	16.9	23.3	28.5	15.6	29.6	16.3	7.2	8.4	10.9	7.6	7.4	10.5	12.0	11.9	12.7	10.3	12.7	17.2	10.7	1.6	11.2	7.7	5.0	9.5	6.5	15.3	20.2	24.5	25.8	13.0	16.1	20.8	15.1	17.7	17.3
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67359997-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol			52000	Cytosol		"CAB011663: AB_2096478, HPA064885: "	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavourable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavourable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (7.11e-4)"	35.5	26.2	18.7	24.8	26.3	18.9	22.5	18.9	30.6	17.8	25.7	16.3	16.1	18.5	22.9	18.0	34.8	18.4	19.1	27.9	21.9	17.0	23.8	45.0	21.1	24.1	19.9	20.8	22.9	27.8	21.3	16.3	28.0	24.1	24.4	24.2	12.6	19.9	21.0	52.0	23.8	18.4	30.9	18.9	22.8	22.9	29.1	15.1	27.3	29.0	29.9	28.0	31.1	23.1	26.6	32.9	17.3	32.7	25.7	29.2	30.2	67.2	22.5	15.8	24.3	15.3	17.4	34.0	30.1	18.0	34.0	29.8	26.2	24.1	30.4	15.3	22.6	26.1	36.5	28.7	51.9	22.1	13.6	19.6	21.9	17.9	16.1	20.8	19.2	14.0	16.7	30.3	46.4	27.6	33.2	23.6	33.5	33.4	28.4	16.4	16.1	37.6	21.8	26.3	21.6	20.9	31.0	22.9	16.2	21.6	25.5	23.2	43.4	18.1	21.0	45.1	48.6	21.7	31.8	20.5	22.3	45.9	26.1	37.3	28.9	17.3	24.2	14.8	23.9	32.7	29.1	26.6	27.9	25.7	32.9	21.3	26.0	26.5	3.3	25.7	27.4	22.5	29.2	30.2	18.7	26.3	18.9	30.6	21.9	17.0	19.9	20.8	24.1	15.1
EIF2S2	"EIF2, EIF2beta, PPP1R67"	ENSG00000125977	"Eukaryotic translation initiation factor 2 subunit beta"	P20042	20	34088298-34112332	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034415, HPA041262, HPA041332"	Approved		Supported	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"CAB034415: AB_2095998, HPA041262: , HPA041332: "	"unprognostic (5.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.47e-3)"	"prognostic unfavourable (3.23e-5)"	"unprognostic (9.36e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavourable (9.64e-10)"	"unprognostic (2.52e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.12e-2)"	25.9	30.1	32.8	23.3	40.7	21.4	38.1	20.2	37.7	21.1	24.3	10.9	27.1	21.2	21.2	22.4	36.3	17.0	18.3	36.3	30.1	20.4	22.0	40.1	27.2	37.7	40.0	26.2	19.9	45.4	18.7	22.4	29.9	35.8	20.4	24.7	7.4	26.3	25.5	101.8	21.2	20.4	37.0	50.2	23.0	28.1	19.6	35.6	18.2	24.1	32.7	30.1	25.0	30.7	38.8	48.5	28.1	39.3	32.4	42.4	27.3	38.9	26.2	19.9	24.0	19.5	29.7	38.0	35.7	34.3	35.6	36.0	92.0	27.4	35.0	26.3	32.2	36.9	32.3	58.7	43.3	11.2	17.6	69.3	21.6	47.0	50.4	44.3	22.6	30.3	50.1	35.2	52.7	37.2	40.6	33.5	29.2	25.0	41.0	37.0	19.3	47.9	23.7	33.9	32.3	28.1	32.7	20.3	13.8	39.5	24.0	73.2	36.3	52.5	25.0	40.8	25.1	25.5	33.4	31.5	27.7	36.5	38.3	34.5	29.5	21.2	37.0	28.1	26.9	39.3	32.9	38.8	38.2	37.6	34.7	31.8	36.4	36.5	21.9	32.4	35.6	48.5	42.4	27.3	32.8	40.7	20.2	37.7	30.1	20.4	40.0	26.2	35.8	35.6
EIF2S3	"EIF2, EIF2G, EIF2gamma"	ENSG00000130741	"Eukaryotic translation initiation factor 2 subunit gamma"	P41091	X	24054716-24077971	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Epilepsy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB012471	Approved									"CAB012471: AB_873547"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.46e-3)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.66e-3)"	"unprognostic (6.94e-3)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (5.44e-6)"	"unprognostic (4.88e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-1)"	37.3	27.0	20.6	24.6	26.0	23.7	30.3	24.9	26.1	39.9	29.8	18.2	15.0	23.7	35.2	17.0	33.7	31.8	20.1	21.5	22.2	13.0	30.6	33.6	23.4	37.8	27.1	17.6	60.6	56.0	21.0	22.2	23.2	24.8	28.4	25.5	22.1	26.8	16.5	31.4	26.5	28.7	38.5	27.0	31.2	30.4	15.9	25.1	40.5	40.3	19.4	41.0	47.8	31.5	44.0	31.7	14.1	37.7	25.2	55.7	34.0	47.0	46.1	22.7	36.0	23.8	49.5	15.5	26.2	25.6	23.4	26.9	51.8	35.5	81.4	27.8	20.8	32.6	70.2	55.0	28.9	26.5	41.8	32.5	88.3	31.1	25.5	53.7	43.3	43.5	35.0	27.0	55.8	33.5	50.2	35.4	25.0	22.9	32.5	48.2	53.2	30.2	31.9	42.1	51.9	29.4	43.4	12.3	26.1	43.7	43.4	44.1	58.0	38.7	25.2	19.5	13.4	34.5	23.3	30.4	56.6	46.7	24.0	36.4	22.6	14.1	37.6	7.0	24.1	37.7	41.0	44.0	42.9	32.3	31.7	35.2	55.7	45.3	13.7	25.2	31.3	24.1	32.1	34.0	20.6	26.0	24.9	26.1	22.2	13.0	27.1	17.6	24.8	25.1
EIF3B	"eIF3b, EIF3S9, PRT1"	ENSG00000106263	"Eukaryotic translation initiation factor 3 subunit B"	P55884	7	2354086-2380745	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017562, HPA048983"	Approved		Approved	Nucleoplasm,Cytosol			22000	Nucleoplasm	Cytosol	"CAB017562: AB_2246341, HPA048983: "	"unprognostic (1.50e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (2.20e-4)"	"prognostic unfavourable (4.41e-9)"	"unprognostic (4.64e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavourable (9.66e-6)"	"unprognostic (2.38e-1)"	"unprognostic (7.54e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.18e-3)"	27.5	27.3	16.5	28.9	21.8	38.7	28.8	20.0	26.2	23.5	33.3	22.4	25.7	20.3	29.6	24.1	38.8	28.6	26.2	32.1	15.8	16.5	24.3	51.4	21.7	29.6	22.2	19.4	31.2	66.6	24.2	20.3	34.6	21.1	26.0	24.0	18.0	34.1	24.2	72.3	39.8	23.9	33.0	16.5	31.6	29.7	45.2	19.0	44.9	23.1	34.3	35.9	32.9	29.7	6.5	8.0	3.7	7.3	16.5	9.5	4.4	85.0	43.5	18.0	48.8	20.4	18.5	44.7	29.9	22.5	34.1	32.0	56.8	33.3	49.7	24.7	31.7	46.4	49.6	39.4	37.7	14.8	58.2	37.8	42.2	38.3	28.8	46.0	28.1	23.0	26.0	36.9	38.9	27.4	96.1	23.2	31.1	60.4	22.2	51.8	56.3	39.2	27.4	36.5	51.2	21.8	39.0	41.2	30.8	31.6	70.5	17.1	46.9	51.1	28.9	26.4	58.3	40.4	54.0	25.6	34.4	50.4	29.9	51.7	64.4	1.8	7.3	3.7	7.6	6.8	9.5	6.3	7.4	8.4	7.8	6.5	8.8	8.9	0.6	16.5	5.8	8.0	8.7	4.4	16.5	21.8	20.0	26.2	15.8	16.5	22.2	19.4	21.1	19.0
EIF3C	"eIF3-p110, eIF3c, EIF3S8"	ENSG00000184110	"Eukaryotic translation initiation factor 3 subunit C"	Q99613	16	28688558-28735730	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB034045, HPA047097, HPA049495, HPA050112"	Supported		Supported	Cytosol				Cytosol		"CAB034045: AB_1122487, HPA047097: , HPA049495: , HPA050112: "	"unprognostic (2.42e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.53e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"unprognostic (1.10e-3)"	30.0	24.4	22.2	20.9	33.5	21.2	30.2	24.3	34.8	24.4	31.8	18.1	14.5	23.6	41.5	26.5	30.1	31.0	32.0	32.3	35.9	20.8	30.1	51.7	22.8	21.8	20.9	33.4	42.3	38.1	63.8	21.4	20.0	26.9	20.3	29.3	18.8	54.7	27.9	114.0	32.3	25.0	33.3	19.8	20.7	25.4	47.2	17.5	25.6	32.8	46.4	29.3	24.9	23.6	28.5	50.5	20.6	49.1	37.9	36.1	52.5	25.7	40.8	56.7	68.5	50.7	62.1	87.5	65.4	48.9	77.5	55.6	81.5	48.8	60.7	85.9	41.8	31.8	47.8	80.6	87.5	26.4	48.3	69.6	66.4	105.5	62.9	107.6	53.7	71.3	48.8	49.3	79.4	88.6	75.4	57.6	41.6	94.9	85.8	31.3	94.6	63.9	87.5	87.0	59.8	41.0	56.7	53.5	82.1	55.3	76.7	63.4	76.5	44.3	78.4	55.1	54.7	25.9	42.6	50.0	38.1	122.3	58.3	42.6	56.2	10.7	44.9	20.6	31.1	47.8	36.1	28.5	32.9	33.0	50.5	27.4	33.3	30.3	3.8	37.9	49.1	23.7	34.0	52.5	22.2	33.5	24.3	34.8	35.9	20.8	20.9	33.4	26.9	17.5
EIF3D	"eIF3-p66, eIF3-zeta, eIF3d, EIF3S7"	ENSG00000100353	"Eukaryotic translation initiation factor 3 subunit D"	O15371	22	36510850-36529436	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045882, HPA063330, HPA066216"	Approved		Supported	Cytosol				Cytosol		"HPA045882: , HPA063330: , HPA066216: "	"unprognostic (4.98e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.10e-5)"	"unprognostic (1.47e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.98e-2)"	"unprognostic (5.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.78e-2)"	49.5	28.2	15.7	30.2	21.3	38.1	47.9	22.6	23.6	51.6	43.1	25.7	27.6	27.0	46.1	32.7	57.8	42.1	30.1	27.2	15.0	13.4	35.3	36.6	29.8	55.0	19.6	17.6	60.7	87.2	32.7	20.9	42.3	18.0	50.3	35.7	27.7	40.7	28.8	55.5	49.1	41.1	46.7	19.8	51.3	39.7	28.9	20.7	65.9	55.4	41.2	61.9	52.7	38.6	70.5	72.2	19.2	51.5	51.6	82.8	93.2	51.1	29.4	31.5	34.5	42.1	82.8	49.3	39.6	53.8	55.6	54.1	45.7	29.1	67.2	29.5	45.6	39.7	54.8	64.1	58.4	36.2	52.6	37.3	27.5	34.8	75.0	86.7	38.0	74.0	74.7	61.6	88.6	60.0	40.5	33.8	63.4	31.6	29.9	44.6	33.6	23.3	54.3	51.1	51.0	55.9	37.4	25.3	33.9	26.9	54.6	54.6	35.0	78.1	41.4	44.6	39.1	33.6	55.4	42.2	28.5	55.5	44.5	54.1	42.0	19.2	51.5	18.7	46.8	47.2	74.9	70.5	67.3	55.4	72.2	68.4	82.8	66.9	13.5	51.6	44.5	41.6	79.7	93.2	15.7	21.3	22.6	23.6	15.0	13.4	19.6	17.6	18.0	20.7
EIF3G	"eIF3-delta, eIF3-p44, eIF3g, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115017-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol			12000	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	41.6	29.0	20.2	34.2	21.5	34.1	36.1	18.1	28.4	41.1	41.2	27.0	30.3	29.8	40.2	34.6	37.7	34.1	47.0	52.3	19.0	18.4	30.5	45.0	28.2	40.1	22.6	18.5	63.6	88.6	30.9	24.8	34.9	19.3	41.9	17.6	25.6	57.1	35.5	141.1	40.2	30.1	39.1	24.3	36.7	38.9	51.0	23.4	46.4	42.3	49.7	40.3	46.2	48.7	47.1	58.4	31.4	60.6	80.3	70.8	74.7	25.1	21.4	16.4	21.6	21.8	28.0	21.1	21.5	30.2	34.0	31.6	35.0	13.6	25.9	30.9	25.7	19.3	19.9	32.4	14.1	23.3	60.6	45.9	21.6	34.9	36.4	36.0	24.2	33.6	24.0	23.9	23.0	24.2	41.1	30.8	20.3	33.7	39.2	175.1	40.1	46.1	31.7	16.1	34.1	21.6	22.1	21.3	41.3	14.3	18.8	33.7	16.5	31.9	23.8	29.4	16.7	31.9	40.8	91.1	66.2	28.9	22.1	39.5	28.0	31.4	60.6	25.3	54.6	44.4	70.8	46.7	59.0	59.1	58.4	47.1	60.3	54.1	11.7	80.3	35.6	45.9	64.9	74.7	20.2	21.5	18.1	28.4	19.0	18.4	22.6	18.5	19.3	23.4
EIF3J	"eIF3-alpha, eIF3-p35, eIF3j, EIF3S1"	ENSG00000104131	"Eukaryotic translation initiation factor 3 subunit J"	O75822	15	44537057-44563029	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA050977	Approved		Enhanced	Cytosol			8600	Cytosol		"HPA050977: "	"unprognostic (4.47e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.47e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.01e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.52e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.76e-1)"	"prognostic unfavourable (4.96e-5)"	23.7	17.8	24.7	21.0	21.9	16.4	22.8	16.6	23.1	15.6	18.4	13.2	20.5	17.7	15.8	17.2	28.0	11.9	14.8	36.8	22.8	23.7	23.3	46.3	14.7	18.3	26.3	19.2	15.0	35.1	17.3	22.9	22.9	31.6	17.1	20.0	6.9	27.0	25.4	134.3	18.9	16.6	18.6	29.0	20.9	18.4	14.7	20.9	17.0	19.2	27.3	24.9	23.0	20.6	26.7	33.2	22.6	19.2	28.2	23.9	6.4	22.3	11.9	19.5	12.2	13.9	14.1	23.9	35.4	10.5	24.7	16.8	37.7	13.7	20.7	41.7	14.8	42.4	31.3	22.6	30.3	23.1	15.9	47.1	29.4	23.9	26.2	50.4	21.0	12.5	30.3	17.0	33.4	26.5	61.2	27.3	22.1	15.7	25.3	34.4	11.9	19.5	29.6	33.5	30.7	28.1	26.8	26.4	16.2	32.7	31.1	19.6	26.1	41.9	31.2	26.9	31.9	28.8	47.6	32.5	61.1	52.2	18.7	55.1	25.3	22.6	19.2	16.8	17.4	18.3	21.0	26.7	23.2	22.3	22.2	24.7	22.8	23.9	7.7	28.2	16.3	33.2	23.6	6.4	24.7	21.9	16.6	23.1	22.8	23.7	26.3	19.2	31.6	20.9
EIF4A1	"DDX2A, EIF-4A, EIF4A"	ENSG00000161960	"Eukaryotic translation initiation factor 4A1"	P60842	17	7572706-7579005	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011689, HPA068286"	Uncertain		Approved	Cytosol			2300000	Cytosol		"CAB011689: AB_732122, HPA068286: "	"unprognostic (1.49e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.12e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.19e-3)"	"prognostic unfavourable (1.76e-8)"	"unprognostic (1.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.13e-2)"	56.5	49.0	19.3	41.4	19.8	51.4	80.2	13.6	26.6	40.4	45.6	28.5	26.4	28.7	45.9	30.2	76.4	43.4	39.2	33.5	18.5	17.1	34.2	58.0	46.3	135.7	27.7	12.9	55.2	77.0	19.8	28.8	45.2	21.8	36.2	44.0	33.0	65.8	30.7	36.5	48.4	30.9	46.5	33.4	46.8	42.2	31.6	21.8	91.5	34.7	73.8	67.7	42.5	40.8	35.1	143.6	29.1	115.7	47.1	60.3	170.1	84.2	115.6	77.5	70.2	69.7	81.7	72.4	81.4	92.6	150.9	116.7	116.6	38.2	115.4	62.7	85.3	75.7	164.4	125.3	162.7	37.3	121.9	65.0	75.2	129.6	106.9	66.4	65.8	108.2	64.8	126.8	129.7	113.2	66.3	23.9	108.6	88.6	68.9	57.0	66.4	80.1	65.1	58.5	55.4	105.5	77.5	41.0	79.6	73.3	49.4	102.0	54.8	51.1	80.9	79.8	55.7	51.0	163.6	23.5	32.8	75.6	85.8	81.8	87.4	19.6	115.7	29.1	37.0	102.6	60.3	35.1	40.0	39.5	143.6	28.9	39.4	39.6	12.1	47.1	75.7	54.8	49.2	170.1	19.3	19.8	13.6	26.6	18.5	17.1	27.7	12.9	21.8	21.8
EIF4A2	"BM-010, DDX2B, EIF4A, EIF4F"	ENSG00000156976	"Eukaryotic translation initiation factor 4A2"	Q14240	3	186783205-186789900	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Helicase, Hydrolase, Initiation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011690, HPA068286"	Uncertain		Approved	Cytosol			1000000	Cytosol		"CAB011690: AB_732123, HPA068286: "	"unprognostic (1.49e-1)"	"unprognostic (9.62e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.50e-3)"	"unprognostic (2.82e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.00e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.03e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.62e-2)"	34.6	66.1	61.2	27.7	79.9	1.9	53.5	121.1	111.5	65.1	52.1	26.5	30.1	30.3	73.1	45.5	44.5	73.9	45.1	83.7	58.4	71.9	63.9	43.5	33.7	36.1	48.9	61.7	142.0	59.0	30.9	84.1	47.3	69.6	57.9	40.1	31.8	43.7	62.8	126.7	19.8	35.6	57.1	41.9	32.5	39.0	32.9	39.5	23.9	67.8	36.4	35.4	61.1	51.7	55.1	19.3	39.4	24.8	33.0	63.4	51.3	10.5	5.3	22.3	3.6	85.9	81.0	6.8	19.0	17.2	20.2	26.6	19.6	3.8	23.6	106.5	27.3	17.8	32.7	8.0	35.6	22.0	17.2	38.0	7.1	26.3	33.7	8.0	26.7	54.2	38.5	5.8	48.6	35.8	12.8	39.8	65.6	1.8	12.7	3.9	22.1	25.5	16.3	15.8	14.3	40.0	12.9	43.9	8.8	30.9	21.3	40.4	33.2	29.3	26.1	16.0	8.0	15.4	11.6	31.7	44.8	10.8	11.0	8.4	7.5	39.4	16.0	18.5	28.5	18.2	45.3	55.1	41.9	34.8	19.3	46.1	63.4	50.2	11.0	33.0	24.8	17.4	38.6	51.3	61.2	79.9	121.1	111.5	58.4	71.9	48.9	61.7	69.6	39.5
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80135214-80147183	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm			73000	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favourable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.68e-5)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	27.3	37.0	19.6	23.6	21.5	71.7	22.0	20.3	19.8	24.2	23.8	16.9	19.2	16.2	24.9	18.0	41.5	29.4	17.1	24.2	17.8	12.3	24.5	20.3	21.6	25.4	16.8	19.7	37.5	16.8	17.1	21.9	38.3	13.1	24.7	20.9	14.7	22.1	31.2	19.8	31.2	18.6	18.5	13.7	25.5	20.4	35.1	19.3	30.7	26.9	26.4	30.6	28.9	25.8	38.7	80.4	33.1	41.9	30.2	38.9	48.3	47.5	42.7	28.2	20.9	21.7	13.3	24.7	25.3	18.0	35.9	28.9	45.5	22.3	43.6	17.0	22.1	31.8	38.7	27.0	40.0	16.1	40.5	27.3	33.8	49.0	21.4	49.1	28.6	20.3	13.9	30.0	24.4	29.3	36.3	28.3	21.2	36.4	44.3	25.0	30.3	39.6	36.7	57.2	34.4	17.5	40.8	39.4	21.5	34.8	68.1	29.2	44.5	33.1	20.1	22.3	28.6	32.8	39.8	24.8	21.4	80.5	18.0	31.1	22.8	25.7	41.1	33.1	26.7	41.9	34.5	38.7	34.5	30.8	50.3	31.6	32.0	30.7	24.4	30.2	32.9	80.4	38.9	48.3	19.6	21.5	20.3	19.8	17.8	12.3	16.8	19.7	13.1	19.3
EIF4E	"EIF4E1, EIF4EL1, EIF4F"	ENSG00000151247	"Eukaryotic translation initiation factor 4E"	P06730	4	98871684-98930637	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"	"Autism, Autism spectrum disorder, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004077, CAB016316, HPA051311"	Supported		Enhanced	"Cytosol,Cytoplasmic bodies"			580000	"Cytosol, Cytoplasmic bodies"		"CAB004077: AB_823488, CAB016316: AB_627502, HPA051311: "	"unprognostic (3.07e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-3)"	"unprognostic (7.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.03e-5)"	"unprognostic (6.55e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.28e-1)"	22.3	26.8	25.7	20.1	35.3	25.2	23.1	40.8	38.4	21.4	27.2	23.3	19.1	19.8	21.7	21.4	39.6	19.9	18.8	23.0	26.0	29.9	29.3	26.2	18.8	24.4	27.7	28.4	18.8	16.1	24.7	25.6	21.8	35.3	19.9	33.2	15.4	23.2	21.0	29.8	19.1	19.5	24.8	31.0	19.4	20.6	39.1	23.4	22.4	33.4	27.1	34.2	22.1	24.2	31.3	25.4	36.6	32.0	32.6	32.2	30.0	25.6	22.5	38.4	25.5	21.9	23.0	23.0	48.9	30.7	40.5	30.5	30.2	32.5	52.0	15.8	30.0	13.0	52.8	36.8	49.5	34.3	15.3	35.4	15.7	27.5	18.8	50.8	26.8	16.4	23.5	31.2	24.7	31.1	58.8	24.3	35.8	22.0	47.0	19.7	30.2	21.0	29.7	26.0	23.1	35.7	22.9	32.5	21.4	22.8	48.4	15.8	23.6	20.1	22.8	29.3	31.5	26.3	39.4	18.2	46.1	47.0	26.1	26.1	33.1	23.3	22.3	36.6	26.3	25.9	30.5	31.3	29.2	27.0	25.4	26.9	32.2	31.9	16.2	32.6	32.0	21.4	28.7	30.0	25.7	35.3	40.8	38.4	26.0	29.9	27.7	28.4	35.3	23.4
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles				Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favourable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	10.9	10.9	18.8	13.4	18.9	12.6	10.8	19.4	20.8	11.9	15.9	14.4	12.3	11.8	14.9	14.5	12.6	13.3	8.6	13.2	16.3	11.8	11.9	7.6	10.7	12.3	12.5	15.7	16.9	10.9	18.1	12.2	14.3	16.2	12.5	12.6	12.7	11.2	15.2	17.4	13.7	10.3	13.8	11.8	11.4	11.3	43.6	14.8	8.8	13.3	7.7	15.3	14.1	12.9	6.6	6.5	3.1	10.7	1.7	5.7	3.0	13.3	8.2	20.9	11.3	11.8	10.5	8.4	9.7	11.8	15.3	14.3	9.3	4.8	17.4	5.7	14.4	13.2	18.8	8.7	14.1	13.6	19.4	7.1	13.2	10.6	12.3	27.6	12.7	12.4	12.0	11.4	12.9	12.8	17.1	18.7	14.3	15.8	18.1	13.4	9.6	6.8	21.2	17.5	17.9	15.5	10.1	16.2	15.1	13.4	10.8	10.0	11.6	10.9	14.2	10.2	13.4	10.1	10.7	13.8	13.3	17.0	9.8	10.1	11.9	2.0	3.5	1.6	5.4	4.2	5.7	6.6	3.0	5.1	3.2	3.3	3.1	5.1	3.1	1.7	10.7	6.5	2.0	3.0	18.8	18.9	19.4	20.8	16.3	11.8	12.5	15.7	16.2	14.8
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol			17000	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: "	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	30.2	33.1	18.3	26.4	18.9	26.3	30.3	18.0	23.2	24.1	25.2	19.6	33.6	21.9	24.5	30.5	45.2	20.9	31.1	33.0	16.9	16.9	40.6	108.0	26.0	21.0	19.4	15.9	29.3	46.4	47.5	21.9	34.6	18.3	24.0	21.8	19.9	31.4	34.1	103.7	39.0	31.6	26.8	15.7	33.1	27.1	30.8	18.0	25.8	30.0	46.2	34.3	28.6	27.6	8.8	15.9	5.5	17.0	8.1	11.4	9.1	90.2	37.9	31.8	36.1	35.5	35.1	55.1	49.8	35.2	55.4	42.2	80.3	29.5	57.8	66.4	61.8	48.9	54.9	61.1	43.2	61.0	57.7	52.2	38.8	35.5	30.8	52.2	36.6	35.4	35.6	50.4	48.2	48.3	37.9	45.8	36.6	67.1	35.4	18.8	62.6	30.7	36.4	31.3	46.3	29.3	55.1	33.4	29.7	42.5	70.4	33.8	75.0	37.4	60.4	39.4	39.8	51.5	93.3	35.7	43.1	106.8	44.3	45.9	43.0	4.8	13.6	5.5	11.4	13.9	11.0	7.6	7.7	9.2	12.2	8.8	7.1	7.0	5.1	8.1	17.0	15.9	5.4	9.1	18.3	18.9	18.0	23.2	16.9	16.9	19.4	15.9	18.3	18.0
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10809110	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol			25000	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavourable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	86.2	86.5	81.0	73.8	78.4	124.4	122.8	76.8	84.8	94.3	102.2	64.5	70.2	57.5	108.8	85.3	125.4	83.5	82.4	199.1	83.8	85.7	121.2	115.8	84.6	71.3	92.0	66.4	81.3	76.1	117.7	118.9	187.1	96.8	90.8	90.2	69.5	84.4	97.1	162.7	84.2	102.0	113.1	104.8	120.0	83.9	60.5	65.5	110.6	110.0	81.9	96.5	107.8	98.9	48.4	57.5	87.4	72.2	44.5	52.7	114.7	104.7	85.7	116.0	63.1	79.0	87.9	78.5	97.3	104.8	91.4	61.1	90.3	124.9	60.2	58.5	120.8	62.8	126.6	90.9	119.0	97.7	53.2	76.6	54.3	66.0	67.5	117.1	65.9	70.8	68.4	54.0	69.0	98.0	59.2	67.8	109.0	52.0	87.3	40.1	81.0	83.7	80.6	67.8	38.5	71.8	158.5	43.3	69.8	113.8	76.0	58.7	66.8	51.1	94.6	110.8	72.7	93.7	81.4	32.7	99.7	92.3	64.2	67.3	117.3	50.2	60.0	87.4	42.3	70.9	52.7	48.4	45.7	47.8	57.5	40.6	40.4	41.6	42.9	44.5	72.2	28.5	50.3	114.7	81.0	78.4	76.8	84.8	83.8	85.7	92.0	66.4	96.8	65.5
EIF4G3	eIF4GII	ENSG00000075151	"Eukaryotic translation initiation factor 4 gamma 3"	O43432	1	20806292-21176888	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025031, HPA025039, HPA025041"	Enhanced		Approved	Cytosol				Cytosol		"HPA025031: AB_1848102, HPA025039: AB_1848103, HPA025041: AB_1848104"	"unprognostic (1.29e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (9.60e-7)"	"unprognostic (1.02e-1)"	"unprognostic (6.95e-3)"	"unprognostic (8.36e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	17.8	19.2	24.8	19.0	28.6	24.1	14.3	24.8	33.8	17.2	17.9	24.5	18.6	12.2	19.7	17.5	16.8	17.1	17.0	16.6	25.9	24.8	14.8	13.6	12.9	14.8	23.1	24.8	15.7	10.6	44.5	30.3	13.8	36.3	16.1	21.0	17.4	11.3	18.5	29.1	17.7	14.0	23.8	25.0	16.1	14.2	67.1	23.1	13.9	30.5	9.7	16.1	18.0	15.7	3.6	5.6	4.2	2.6	1.4	3.7	1.5	11.1	9.0	30.1	11.9	31.5	31.3	6.2	24.3	26.2	17.0	17.6	9.8	12.3	22.4	15.7	26.3	12.5	18.5	19.7	24.1	19.5	17.5	11.1	18.0	6.9	15.9	18.4	20.7	32.8	16.0	17.9	23.2	21.9	8.4	15.7	25.2	9.8	5.7	9.6	8.5	8.2	11.1	11.1	7.4	18.8	6.1	17.1	13.3	25.2	10.9	14.8	7.9	21.4	22.4	19.3	7.2	27.4	11.0	7.2	7.7	0.1	24.7	29.4	17.9	2.0	2.6	3.0	3.7	0.5	1.6	2.6	1.5	1.8	3.4	3.6	1.0	2.8	4.2	1.4	1.0	5.6	1.7	1.5	24.8	28.6	24.8	33.8	25.9	24.8	23.1	24.8	36.3	23.1
EIF4H	"KIAA0038, WBSCR1, WSCR1"	ENSG00000106682	"Eukaryotic translation initiation factor 4H"	Q15056	7	74174245-74197101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Initiation factor, RNA-binding"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030542	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			520000	"Nucleoplasm, Nuclear bodies, Cytosol"		"HPA030542: AB_10601368"	"unprognostic (2.83e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (3.89e-4)"	"prognostic unfavourable (2.15e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.27e-2)"	46.8	42.7	47.6	37.6	52.8	82.3	42.8	56.0	89.5	39.8	44.5	46.6	36.2	43.1	48.1	37.9	58.6	44.4	40.7	47.4	45.6	41.4	34.5	50.7	37.4	42.8	45.4	54.6	54.2	74.3	54.3	30.1	72.2	47.6	44.8	35.1	35.6	60.3	45.4	89.6	53.0	41.5	43.4	59.9	34.6	45.4	52.5	32.1	46.8	43.5	57.9	44.2	43.4	41.4	38.4	57.6	60.2	64.2	46.7	52.0	80.6	86.2	57.5	43.9	53.2	39.1	41.7	49.9	61.7	46.9	51.1	50.3	70.4	66.5	74.1	16.9	56.9	45.8	48.3	82.0	48.4	49.8	56.6	41.3	54.0	56.5	44.8	69.6	41.7	48.7	52.1	56.7	80.8	55.9	72.5	32.2	52.3	73.6	54.9	82.6	58.5	56.9	64.4	58.8	66.9	42.5	55.2	44.6	56.4	57.5	72.7	48.9	82.2	45.1	58.2	73.3	49.8	61.2	77.5	38.3	45.7	126.5	57.3	73.1	75.2	45.7	58.4	60.2	43.5	64.2	44.9	38.4	44.7	43.0	57.6	35.3	52.0	42.4	39.0	46.7	63.6	24.4	47.6	80.6	47.6	52.8	56.0	89.5	45.6	41.4	45.4	54.6	47.6	32.1
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005042, HPA061298"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB005042: AB_562281, HPA061298: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavourable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	69.0	55.6	37.9	57.0	40.4	83.1	44.5	35.0	59.8	44.6	54.8	37.5	39.8	47.4	47.2	45.5	107.0	38.1	52.9	55.8	35.6	33.6	58.5	192.9	46.6	67.2	34.3	35.9	50.3	126.0	26.0	34.1	73.9	34.0	38.0	57.2	40.7	87.7	40.7	100.6	71.1	49.0	45.4	29.5	65.5	42.9	56.8	24.2	77.9	57.9	105.4	79.0	48.6	50.7	64.7	87.7	44.4	75.7	75.2	79.3	64.3	133.0	166.1	51.2	102.5	39.6	51.0	72.0	100.5	66.3	135.9	95.1	99.3	56.8	129.0	65.1	77.2	91.0	111.3	129.5	123.7	71.7	161.6	77.6	137.6	127.2	70.2	58.9	80.3	54.1	68.0	100.3	136.3	87.2	106.7	36.1	91.9	82.5	69.2	85.2	97.2	82.0	68.5	62.3	118.9	82.0	74.0	59.6	77.5	64.4	78.5	62.2	62.1	45.4	81.7	95.8	69.0	63.6	158.7	30.4	41.5	83.4	90.6	88.7	109.1	44.4	56.0	38.9	65.1	75.7	79.3	64.7	67.1	57.7	85.8	62.6	62.3	62.6	25.1	75.2	68.6	87.7	58.9	64.3	37.9	40.4	35.0	59.8	35.6	33.6	34.3	35.9	34.0	24.2
EIF5B	"DKFZp434I036, FLJ10524, IF2, KIAA0741"	ENSG00000158417	"Eukaryotic translation initiation factor 5B"	O60841	2	99337353-99401326	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Hydrolase, Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034648, HPA040095"	Approved		Approved	"Plasma membrane,Cytosol"			11000	Cytosol	"Plasma membrane"	"HPA034648: AB_10601902, HPA040095: "	"unprognostic (1.23e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.88e-3)"	"prognostic unfavourable (7.15e-10)"	"unprognostic (6.80e-2)"	"unprognostic (9.84e-3)"	"prognostic favourable (8.99e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.42e-6)"	"unprognostic (6.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.93e-3)"	24.5	16.0	25.2	22.4	32.6	11.5	22.6	27.7	26.0	23.7	25.1	10.5	19.9	14.8	19.4	28.7	30.8	14.5	15.0	61.7	26.0	22.3	28.8	32.1	17.9	19.2	26.9	23.0	22.3	24.6	26.8	27.5	26.4	28.5	26.0	20.3	7.1	22.3	29.1	105.8	25.3	19.3	31.5	37.6	27.0	20.7	22.6	33.8	17.8	18.2	29.2	22.8	40.1	31.9	15.9	20.2	11.6	12.1	14.1	14.9	4.5	33.7	16.9	19.3	25.1	23.4	27.8	32.0	29.8	18.8	19.9	19.8	38.9	24.2	38.7	25.9	22.2	19.4	33.7	28.9	35.2	23.4	20.2	46.5	17.3	51.1	18.6	45.5	28.8	18.7	20.4	27.6	28.3	28.9	51.3	19.4	28.5	27.4	28.8	42.2	30.1	24.9	25.2	28.7	31.6	40.7	28.4	16.4	15.5	16.2	37.4	24.0	15.2	30.1	31.7	30.9	30.3	16.1	26.5	14.4	20.4	31.6	22.5	50.5	22.7	11.6	8.8	9.8	12.7	9.5	14.9	15.3	13.4	12.5	6.4	15.9	13.2	14.0	2.3	14.1	12.1	20.2	9.0	4.5	25.2	32.6	27.7	26.0	26.0	22.3	26.9	23.0	28.5	33.8
EIF6	"b(2)gcn, EIF3A, ITGB4BP, p27BBP"	ENSG00000242372	"Eukaryotic translation initiation factor 6"	P56537	20	35278911-35284985	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Ribosome biogenesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA040873	Enhanced		Supported	Nucleoplasm			150000	Nucleoplasm		"HPA040873: "	"unprognostic (9.00e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (7.25e-5)"	"unprognostic (9.94e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (9.18e-2)"	"unprognostic (8.15e-2)"	21.5	24.9	13.7	21.7	13.1	14.3	21.4	12.4	20.3	26.9	29.5	13.4	15.7	33.7	22.5	19.4	59.9	25.2	29.7	14.4	13.1	14.3	39.9	63.7	18.3	27.9	13.1	15.8	22.1	35.6	17.7	15.6	30.8	13.7	21.2	29.0	14.7	27.0	22.7	14.9	40.6	43.2	22.8	11.1	21.4	20.6	24.1	10.9	31.0	30.7	49.7	43.8	24.1	29.8	51.3	64.0	70.4	60.4	47.4	39.3	60.5	36.7	54.0	13.5	15.4	16.9	20.3	17.4	24.5	29.5	51.9	39.4	100.1	34.6	26.5	28.9	30.2	29.1	27.8	78.3	32.9	6.3	18.5	42.9	21.3	72.0	32.0	22.6	20.9	20.4	50.7	40.4	79.4	35.5	27.8	13.1	54.6	36.1	13.1	30.0	16.2	45.3	18.3	22.3	23.1	67.0	26.1	22.7	19.2	18.8	74.8	26.7	36.3	17.7	27.9	56.6	24.1	28.7	32.8	14.3	15.3	21.9	27.9	24.2	31.3	70.4	55.8	46.1	36.7	55.8	39.2	51.3	35.6	39.3	64.0	49.7	29.1	34.2	18.8	47.4	60.4	59.6	38.1	60.5	13.7	13.1	12.4	20.3	13.1	14.3	13.1	15.8	13.7	10.9
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12992391-13018187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	20.3	35.9	15.2	17.2	23.5	13.8	18.6	16.9	30.0	17.5	21.2	24.6	17.9	15.8	22.1	13.1	25.9	19.5	19.6	28.1	14.2	14.3	23.5	34.8	14.2	19.4	18.2	19.5	20.3	24.5	27.5	14.0	21.2	20.5	20.7	25.1	19.4	19.1	26.2	49.2	20.7	18.7	26.6	15.6	25.5	22.8	29.5	17.1	28.1	20.7	20.1	25.9	23.0	16.3	19.9	23.5	9.4	20.4	24.0	25.1	20.9	20.2	32.2	22.4	24.9	17.9	17.5	13.6	22.2	17.9	36.3	24.4	25.9	10.8	36.7	24.2	21.1	27.4	40.5	25.7	36.3	19.0	40.8	21.4	25.2	17.0	13.3	18.3	29.7	15.6	21.9	28.2	26.3	25.4	29.3	11.2	27.5	18.0	32.3	18.3	18.5	21.6	22.7	38.2	23.0	20.5	18.2	11.5	16.8	28.2	18.4	11.4	18.3	8.0	24.7	44.9	14.9	17.7	32.6	7.0	13.0	14.8	17.8	19.6	16.3	9.4	14.7	9.3	21.4	20.1	23.0	19.9	20.7	21.3	23.5	17.4	21.5	19.2	2.2	24.0	20.4	13.3	25.1	20.9	15.2	23.5	16.9	30.0	14.2	14.3	18.2	19.5	20.5	17.1
ELANE	"ELA2, HLE, HNE, NE"	ENSG00000197561	"Elastase, neutrophil expressed"	P08246	19	851014-856247	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"bone marrow: 244.3"	"Cell line enriched"	"Detected in some"	65	"THP-1: 193.2"	"Group enriched"	"Detected in some"	7	"pancreatic cancer: 3.5;stomach cancer: 3.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"classical monocyte: 3.2;neutrophil: 6.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.9;monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB015409, HPA066836"	Enhanced				"Secreted to blood"		59000			"CAB015409: AB_831596, HPA066836: "	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.42e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.80e-3)"	"unprognostic (3.43e-2)"	"unprognostic (3.92e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.19e-10)"	"unprognostic (6.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.75e-3)"	1.5	0.3	0.1	0.3	0.1	244.3	1.6	0.2	0.6	0.3	0.6	0.7	0.0	0.3	0.3	0.7	0.5	0.6	0.8	31.2	0.0	0.0	0.3	1.5	17.8	1.6	0.0	0.0	0.3	1.8	0.3	0.4	4.7	0.5	1.4	0.3	1.0	0.7	0.3	1.1	2.1	0.5	0.5	0.0	22.5	0.5	0.3	0.0	23.0	2.3	0.9	0.3	1.0	0.2	0.0	0.0	6.9	3.2	0.0	0.5	11.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.2	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	11.2	0.1	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0
ELAVL1	"Hua, HuR, MelG"	ENSG00000066044	"ELAV like RNA binding protein 1"	Q15717	19	7958579-8005659	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005256, HPA046298"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			210000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB005256: AB_2096342, HPA046298: "	"unprognostic (1.19e-1)"	"unprognostic (9.66e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.81e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.75e-2)"	"prognostic favourable (4.93e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (7.23e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-2)"	19.7	23.8	28.0	22.4	34.1	17.2	22.4	35.4	28.0	23.1	21.4	21.2	19.6	17.9	27.5	19.7	24.4	25.7	16.9	25.2	23.6	17.6	20.8	21.4	19.4	26.5	27.5	22.2	25.7	20.4	29.4	25.4	23.3	26.5	20.4	20.2	19.7	21.2	23.0	27.6	19.2	18.4	30.4	17.7	21.9	19.7	46.7	26.5	40.4	20.6	18.7	30.7	23.4	32.2	17.1	17.6	24.3	14.7	23.2	19.6	9.4	35.6	23.7	39.8	29.9	15.6	15.7	22.4	26.6	22.4	39.7	31.1	34.2	20.8	43.0	37.5	29.2	24.9	44.3	30.5	33.6	38.4	41.2	37.7	17.4	31.8	22.9	35.7	30.2	19.4	18.3	27.6	16.8	30.3	38.7	32.3	27.3	26.5	59.6	28.8	35.5	30.2	67.1	26.0	28.3	25.2	26.4	28.6	20.9	25.2	25.5	20.1	29.1	28.2	22.7	37.2	26.1	34.4	45.8	33.0	31.8	45.2	20.8	43.0	32.0	16.4	13.0	24.3	12.2	11.7	12.9	14.0	17.8	19.6	17.6	17.1	16.1	12.4	3.8	23.2	14.7	8.8	13.5	9.4	28.0	34.1	35.4	28.0	23.6	17.6	27.5	22.2	26.5	26.5
ELK3	"ERP, NET, SAP2"	ENSG00000111145	"ELK3, ETS transcription factor"	P41970	12	96194382-96269835	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001600	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA001600: AB_1078752"	"unprognostic (3.11e-1)"	"unprognostic (8.81e-3)"	"unprognostic (6.38e-2)"	"unprognostic (5.77e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-3)"	"unprognostic (7.39e-2)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.90e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.05e-2)"	36.9	9.3	5.0	20.9	6.7	8.3	23.5	12.9	4.5	29.2	12.6	7.3	12.0	4.6	45.2	15.6	25.7	15.0	16.3	15.5	4.8	5.1	13.3	8.2	17.1	20.6	6.1	2.8	13.3	5.8	6.6	6.0	15.9	8.9	18.1	7.5	15.7	14.1	8.6	10.5	8.7	11.1	20.8	13.1	32.7	9.1	8.6	6.3	17.4	19.7	25.1	32.1	15.9	20.9	11.3	9.4	4.1	12.8	10.5	24.1	6.3	12.8	7.7	7.9	4.2	20.2	38.0	2.0	16.4	31.4	13.1	10.1	0.4	9.6	2.0	5.6	18.3	4.6	0.8	26.2	23.1	5.6	3.0	0.6	3.2	2.9	6.1	6.2	1.5	22.3	4.9	26.9	20.4	31.2	1.5	8.6	44.1	1.9	1.2	4.2	9.7	10.3	10.2	13.4	2.3	11.2	3.4	0.4	8.4	5.3	2.4	8.2	1.3	3.4	19.2	36.0	14.1	22.1	14.2	16.6	13.7	0.5	12.7	7.3	24.9	3.3	12.8	0.3	6.2	6.9	24.1	11.3	14.7	8.4	9.4	9.9	8.9	6.5	4.1	10.5	5.9	3.8	23.4	6.3	5.0	6.7	12.9	4.5	4.8	5.1	6.1	2.8	8.9	6.3
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 16.5;BJ: 22.9;fHDF/TERT166: 32.8;U-2197: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		2900000	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: "	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (1.62e-3)"	35.0	8.8	4.3	14.9	3.6	0.0	24.8	27.8	5.8	23.3	12.1	12.9	9.1	3.2	22.3	26.0	30.1	17.1	30.8	41.5	5.4	3.0	8.3	3.7	49.7	7.5	4.4	9.2	10.6	35.3	0.7	6.1	22.5	13.7	25.1	4.6	34.3	16.8	14.5	6.0	23.6	9.2	34.7	9.9	10.7	16.0	8.1	6.4	0.9	11.9	10.3	4.4	34.0	21.7	0.4	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.3	0.1	0.0	16.5	0.1	0.1	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	1.3	0.1	0.0	8.8	0.1	0.0	0.0	4.5	10.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	130.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.3	3.6	27.8	5.8	5.4	3.0	4.4	9.2	13.7	6.4
ELOA	"SIII, TCEB3, TCEB3A"	ENSG00000011007	"Elongin A"	Q14241	1	23743155-23762059	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005910	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA005910: AB_1080227"	"unprognostic (6.90e-2)"	"unprognostic (5.99e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (1.72e-1)"	"unprognostic (8.84e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.90e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	25.6	13.7	10.0	14.2	16.1	22.9	16.3	16.0	17.2	13.7	12.2	15.2	15.1	9.8	15.0	9.0	23.6	13.3	15.7	12.9	9.9	9.8	18.1	41.7	20.3	24.1	10.3	12.5	16.0	41.5	19.1	17.1	19.6	12.7	13.6	13.5	13.0	18.6	13.4	26.0	18.3	14.1	14.0	10.9	20.5	24.6	14.4	10.0	19.3	18.4	22.4	21.8	15.6	14.5	20.7	18.8	18.3	20.9	11.0	14.8	13.2	20.0	11.2	16.2	13.9	19.2	12.0	10.3	20.8	18.8	31.0	27.1	13.7	17.6	10.5	25.6	21.0	19.3	33.2	21.9	34.7	30.1	16.4	23.7	17.6	15.9	17.0	24.8	14.4	12.7	17.7	33.8	25.9	18.5	35.1	18.3	24.7	15.2	12.8	10.1	18.8	17.0	19.3	20.6	20.0	14.6	13.7	31.0	17.5	18.9	19.1	23.1	13.8	9.2	19.6	24.4	21.6	43.2	24.4	19.0	21.2	23.2	21.4	24.8	24.3	18.3	19.8	15.4	14.8	20.9	14.6	20.7	12.4	13.3	18.8	16.6	10.2	13.4	5.5	11.0	18.4	15.5	14.0	13.2	10.0	16.1	16.0	17.2	9.9	9.8	10.3	12.5	12.7	10.0
ELOA3	"ELOA3A, HsT829, TCEB3C, TCEB3L2"	ENSG00000183791	"Elongin A3"	Q8NG57	18	47028202-47030078	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048971, HPA049178, HPA050086"	Uncertain									"HPA048971: , HPA049178: , HPA050086: "																		0.1	0.1	0.3	0.1	0.8	0.1	0.1	0.6	0.3	0.4	0.1			0.1	0.6	0.1	0.1	0.6	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.2		0.1	0.1	0.1	0.1	0.1		0.2	0.1		0.1	0.1	0.1	0.8	0.1	0.1	0.2	0.1	0.6	0.9			0.6		0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ELOC	"SIII, TCEB1"	ENSG00000154582	"Elongin C"	Q15369	8	73939169-73972287	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078113			Approved	"Nucleoli,Vesicles,Cell Junctions"			250000	Vesicles	"Nucleoli, Cell Junctions"	"HPA078113: "	"prognostic unfavourable (6.48e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.46e-2)"	"unprognostic (8.02e-3)"	"unprognostic (5.84e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.99e-3)"	"unprognostic (4.02e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.77e-3)"	"unprognostic (3.84e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.95e-2)"	27.0	29.5	39.1	19.2	37.6	35.4	24.2	25.6	43.3	17.5	19.6	12.2	21.0	13.4	18.2	31.7	24.5	17.2	17.9	50.1	33.9	29.5	28.2	36.1	21.2	35.2	32.5	28.4	17.9	25.5	17.6	20.0	25.7	27.3	19.2	20.6	12.1	16.3	21.0	62.5	16.6	14.5	24.4	33.9	18.7	18.5	51.0	18.8	19.7	19.6	31.9	27.9	19.3	16.7	38.9	55.3	51.7	35.4	32.5	44.9	26.4	44.6	36.6	33.6	24.3	25.7	33.6	24.1	44.4	36.3	43.6	44.8	32.5	39.0	22.8	36.0	39.3	32.1	37.0	44.3	57.7	26.2	30.7	39.7	39.1	51.5	33.6	25.4	29.8	34.0	35.6	39.4	51.0	40.5	34.9	30.6	57.2	33.1	65.3	45.7	30.5	59.3	23.8	21.1	21.6	47.5	39.2	31.7	30.0	18.6	101.5	41.4	37.4	27.4	30.9	31.7	35.8	34.6	44.5	34.8	42.4	42.0	38.1	27.8	38.4	51.7	32.2	38.2	31.2	35.4	34.0	38.9	37.5	34.8	34.2	34.0	34.3	34.4	37.7	32.5	33.8	55.3	44.9	26.4	39.1	37.6	25.6	43.3	33.9	29.5	32.5	28.4	27.3	18.8
ELP1	"DYS, IKAP, IKBKAP, IKI3, TOT1"	ENSG00000070061	"Elongator complex protein 1"	O95163	9	108867517-108934116	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, tRNA processing"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 26.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 26.9"	"Low region specificity"	"Detected in all"							"CAB021340, HPA049677, HPA050686"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB021340: , HPA049677: , HPA050686: "	"prognostic unfavourable (1.57e-4)"	"unprognostic (8.71e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.98e-2)"	10.4	33.0	18.7	10.6	22.9	10.8	13.1	37.6	19.9	13.0	11.5	17.2	11.4	8.2	15.7	17.3	9.8	15.1	10.3	15.3	14.8	15.2	13.0	14.7	11.2	12.8	20.9	17.3	26.4	12.9	41.3	42.3	11.2	20.5	13.1	12.6	15.0	12.0	12.8	11.6	15.7	11.2	14.4	16.7	13.3	11.3	11.7	19.3	12.1	15.4	8.3	13.2	10.4	13.4	2.1	2.7	26.9	2.6	4.0	4.2	1.9	9.1	17.6	15.2	9.8	16.7	16.1	12.5	15.0	10.4	15.3	12.2	16.6	6.7	16.8	6.8	13.4	23.6	23.3	18.7	16.9	15.8	14.6	9.8	27.4	44.9	12.5	19.1	8.8	12.3	13.2	21.3	20.1	13.1	23.1	11.8	14.0	15.6	16.3	11.8	19.4	17.7	14.2	20.5	10.5	11.6	11.8	18.4	14.8	16.5	16.5	10.2	21.4	8.6	12.5	8.8	10.1	19.6	14.9	11.2	25.2	8.5	14.7	12.7	11.9	26.9	1.7	2.5	3.1	2.0	4.2	2.1	3.0	4.0	2.7	1.4	2.9	3.6	0.3	4.0	2.6	1.3	2.4	1.9	18.7	22.9	37.6	19.9	14.8	15.2	20.9	17.3	20.5	19.3
EMG1		ENSG00000126749	"EMG1, N1-specific pseudouridine methyltransferase"	Q92979	12	6970893-6979941	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, rRNA-binding, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA039304, HPA039666"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039304: , HPA039666: AB_10672891"	"unprognostic (1.23e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (3.69e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (2.83e-6)"	"unprognostic (2.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.62e-1)"	8.1	10.1	4.9	12.4	6.6	7.3	8.8	3.6	6.3	5.8	7.5	4.8	11.5	7.5	6.9	9.9	8.1	5.8	7.4	11.6	5.0		7.2	8.3	6.4	8.8	6.4	4.2	8.9	9.4	2.7	5.6	12.6	6.2	7.2	6.8	5.1	8.6	11.4	14.9	5.6	6.7	6.3	5.5	7.7	6.0	4.8	6.1	9.0	8.7	9.5	10.8	7.5	8.7	33.3	20.5	7.7	29.6	20.8	30.1	28.5	16.8	16.8	6.5	8.0	5.1	3.7	27.1	12.6	5.6	10.0	6.8	33.0	18.1	17.0	4.7	7.7	12.4	5.9	14.4	11.3	12.3	9.6	23.6	16.6	30.4	6.6	23.9	15.3	6.0	8.6	14.5	16.6	4.3	11.6	3.8	9.4	19.9	12.4	14.7	53.9	8.8	17.2	13.2	13.5	6.3	21.4	3.8	11.4	13.2	13.9	12.0	3.8	17.8	9.1	10.5	13.6	8.5	28.5	4.6	5.2	29.6	11.2	10.4	16.6	4.4	16.6	7.7	24.0	23.8	24.8	30.7	25.5	26.3	18.8	33.3	30.1	27.7	2.3	20.8	29.6	20.5	24.1	28.5										
EMILIN1	"DKFZp586M121, gp115"	ENSG00000138080	"Elastin microfibril interfacer 1"	Q9Y6C2	2	27078567-27086408	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 29.3;BJ hTERT+: 19.7;HHSteC: 31.0;HSkMC: 34.2;SH-SY5Y: 39.5;U-138 MG: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA002822	Supported				"Secreted to extracellular matrix"		20000000			"HPA002822: AB_1078738"	"unprognostic (3.14e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.92e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.85e-1)"	"unprognostic (7.97e-2)"	"prognostic unfavourable (8.13e-9)"	"unprognostic (8.96e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.70e-3)"	13.8	12.7	2.8	25.2	4.2	1.0	17.9	0.6	2.7	56.7	45.2	2.8	35.5	14.1	56.2	34.2	22.5	29.2	66.8	16.9	2.3	1.1	14.6	9.4	21.2	18.4	3.1	2.2	75.0	4.8	0.6	6.4	9.2	3.8	42.9	4.8	13.6	4.1	34.5	6.5	4.2	18.3	80.2	7.2	26.2	21.4	14.1	3.0	1.3	6.8	5.0	4.5	58.2	37.3	0.6	2.5	1.8	0.3	0.0	1.1	0.1	0.2	0.2	1.8	0.2	11.1	15.3	0.3	29.3	19.7	6.3	9.1	0.1	0.2	0.2	0.2	16.7	0.2	0.0	0.0	1.1	0.9	0.4	0.5	0.1	12.9	31.0	0.4	8.3	34.2	0.0	4.3	0.0	0.0	0.2	0.2	1.3	0.3	0.2	8.4	0.9	0.2	4.5	0.4	0.3	0.0	0.1	0.5	39.5	0.0	0.1	0.3	0.1	0.7	3.5	19.6	0.6	2.3	0.1	0.5	0.5	0.3	0.2	0.3	5.2	0.0	0.3	1.8	0.4	0.3	0.5	0.2	0.2	0.5	0.2	0.6	0.8	0.1	0.0	0.0	0.0	2.5	1.1	0.1	2.8	4.2	0.6	2.7	2.3	1.1	3.1	2.2	3.8	3.0
EMILIN2	"FLJ33200, FOAP-10"	ENSG00000132205	"Elastin microfibril interfacer 2"	Q9BXX0	18	2847030-2915993	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 83.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 22.4;BEWO: 17.2;HL-60: 16.2;HMC-1: 27.6;HSkMC: 12.1;THP-1: 16.1;U-2197: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"midbrain: 9.1;pons and medulla: 16.9;thalamus: 6.3"	HPA064576	Supported				"Secreted to extracellular matrix"		600000			"HPA064576: "	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.91e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.98e-3)"	"unprognostic (9.91e-3)"	"prognostic unfavourable (6.30e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (1.49e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.96e-1)"	32.3	1.4	0.9	8.4	0.7	4.9	14.5	0.3	0.8	5.8	3.9	1.1	2.2	1.1	6.8	6.7	3.9	5.2	4.3	9.6	1.0	1.1	2.0	1.3	10.9	24.4	3.1	0.0	11.0	1.8	83.7	0.6	34.9	3.7	4.6	2.0	2.4	2.9	1.0	3.9	3.0	2.4	5.7	16.4	6.9	1.9	2.8	0.3	2.8	3.0	4.1	1.8	7.9	6.6	0.5	2.1	8.0	2.3	3.1	0.9	0.6	0.1	0.1	1.3	0.0	22.4	9.3	17.2	3.5	0.0	0.6	1.1	2.4	0.0	0.0	0.2	8.5	0.0	0.4	0.0	1.2	0.0	1.2	0.2	0.0	0.1	0.7	16.2	27.6	12.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	2.2	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.6	0.0	16.1	0.2	0.0	2.4	21.1	0.2	0.0	0.0	0.0	1.4	4.0	0.4	8.0	2.3	0.6	0.9	1.6	0.7	0.4	0.9	0.6	2.1	0.5	0.5	0.9	2.3	3.1	1.4	1.4	0.6	0.6	0.9	0.7	0.3	0.8	1.0	1.1	3.1	0.0	3.7	0.3
EMSY	C11orf30	ENSG00000158636	"EMSY, BRCA2 interacting transcriptional repressor"	Q7Z589	11	76444923-76553025	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012234, HPA050777"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB012234: AB_449325, HPA050777: "	"unprognostic (1.69e-2)"	"unprognostic (8.15e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.74e-2)"	14.5	12.1	13.7	12.8	22.7	19.7	15.6	39.4	22.2	17.7	14.3	17.2	12.6	9.0	21.7	14.0	11.5	15.8	11.4	17.2	13.6	10.6	13.1	10.7	17.8	14.3	23.8	10.8	20.9	15.3	23.2	23.1	25.8	16.2	14.6	15.7	14.7	14.0	14.4	18.3	11.6	13.5	18.0	24.8	14.7	13.9	14.4	26.7	22.6	15.1	8.5	14.3	14.2	17.1	7.0	6.2	11.8	5.1	5.0	8.4	4.4	4.9	6.9	16.0	9.8	6.0	6.0	7.0	7.9	7.8	10.3	11.4	11.7	6.8	6.7	7.6	8.5	9.8	12.9	7.6	16.1	10.7	4.8	10.5	10.2	5.0	3.8	11.3	9.4	5.4	5.1	11.8	9.9	9.3	7.2	11.9	8.3	13.1	15.1	6.8	6.9	9.2	9.7	29.4	9.4	7.1	5.8	10.0	4.3	11.1	7.6	2.4	15.3	7.0	6.9	9.8	13.3	25.0	5.5	6.6	7.1	19.3	3.2	6.9	7.1	11.8	5.1	10.3	7.2	4.8	6.7	6.4	6.7	8.4	3.8	7.0	6.3	5.8	10.8	5.0	3.8	6.2	6.5	4.4	13.7	22.7	39.4	22.2	13.6	10.6	23.8	10.8	16.2	26.7
ENDOD1	KIAA0830	ENSG00000149218	"Endonuclease domain containing 1"	O94919	11	95089810-95132645	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008932, HPA010517"	Enhanced		Approved	"Nuclear membrane"	"Secreted - unknown location"		19000000	"Nuclear membrane"		"HPA008932: AB_2262252, HPA010517: AB_1852351"	"unprognostic (8.81e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.65e-1)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.64e-7)"	"unprognostic (5.92e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.62e-3)"	"prognostic unfavourable (3.27e-4)"	14.9	13.8	20.3	7.9	27.9	4.1	15.0	14.3	31.0	17.6	25.4	52.6	9.7	8.4	13.7	12.2	19.0	13.1	12.2	14.4	24.0	22.3	18.9	4.9	10.6	7.3	33.5	20.1	12.0	4.7	48.8	11.8	12.1	40.6	36.5	29.4	15.5	12.5	22.9	34.4	20.6	14.5	16.2	40.4	22.9	8.3	9.3	25.5	0.5	12.6	12.3	6.7	9.0	16.5	7.3	2.9	1.3	5.4	3.1	5.9	6.1	1.1	1.7	2.1	1.3	61.3	19.7	9.0	8.2	1.8	2.2	2.3	8.4	14.8	7.8	10.1	6.5	10.9	2.1	11.2	0.8	6.2	1.5	17.0	0.8	3.5	6.7	3.1	21.9	17.7	14.7	1.2	4.1	7.5	3.4	5.1	8.1	2.9	1.3	0.1	0.5	5.5	5.7	0.0	3.2	6.5	9.2	1.1	0.9	3.4	3.4	6.1	3.5	0.8	5.4	12.0	3.5	8.0	3.4	4.3	3.1	0.6	3.6	1.7	26.7	1.3	1.3	0.9	5.9	3.2	5.5	7.2	3.9	5.0	2.9	7.3	3.2	3.8	0.6	3.1	5.4	1.3	2.2	6.1	20.3	27.9	14.3	31.0	24.0	22.3	33.5	20.1	40.6	25.5
ENDOG		ENSG00000167136	"Endonuclease G"	Q14249	9	128818474-128822677	"Plasma proteins, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021335, HPA021830"	Approved				"Intracellular and membrane"					"HPA021335: AB_1848151, HPA021830: AB_1848152"	"unprognostic (1.35e-1)"	"unprognostic (3.41e-1)"	"unprognostic (4.86e-2)"	"prognostic favourable (5.12e-4)"	"unprognostic (2.51e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.90e-1)"	"unprognostic (6.97e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.06e-7)"	"unprognostic (1.69e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	5.8	6.4	8.6	3.2	9.1	3.9	8.1	8.1	15.0	4.4	8.4	5.3	8.8	10.3	3.1	2.6	5.7	7.7	4.3	19.9	8.0	8.3	9.9	18.5	3.8	5.7	7.2	7.2	3.5	8.4	8.0	4.8	3.9	6.0	6.9	5.5	4.8	5.9	7.0	91.2	5.2	7.6	3.4	4.1	3.4	7.6	6.1	6.5	5.2	8.1	18.1	3.7	4.3	7.1	3.9	6.9	1.5	3.8	2.3	3.1	1.3	6.6	7.2	1.9	9.9	5.0	4.3	8.5	6.4	3.4	6.1	4.2	4.4	5.3	2.1	5.8	4.2	18.8	6.0	5.6	1.1	4.2	10.7	3.7	7.0	7.7	2.3	11.5	14.3	4.5	6.9	3.6	2.5	4.6	11.6	3.4	3.8	9.6	8.9	23.7	4.7	27.2	10.7	2.1	22.3	9.0	2.4	16.6	16.5	14.3	13.2	3.2	12.6	5.7	4.7	4.3	2.5	6.1	4.7	10.9	1.5	4.1	8.6	8.3	4.4	0.0	2.3	1.5	2.8	3.8	2.5	3.2	2.8	1.3	3.6	3.9	2.7	3.1	0.0	2.3	1.7	6.9	1.1	1.3	8.6	9.1	8.1	15.0	8.0	8.3	7.2	7.2	6.0	6.5
ENG	"CD105, END, HHT1, ORW, ORW1"	ENSG00000106991	Endoglin	P17813	9	127815012-127854756	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 66.9;TIME: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0"	"Group enriched"	"Detected in many"	4	"dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000096, HPA011862, HPA067440, CAB072873"	Enhanced		Supported	"Nuclear bodies,Plasma membrane"			260000000	"Plasma membrane"	"Nuclear bodies"	"CAB000096: AB_563482, CAB072873: , HPA011862: AB_1846217, HPA067440: "	"unprognostic (2.28e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"prognostic favourable (6.61e-4)"	"prognostic favourable (5.62e-6)"	"unprognostic (2.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.98e-2)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (3.33e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	40.3	19.3	6.4	26.6	10.5	5.5	52.7	3.9	8.6	26.3	14.0	7.6	18.5	11.2	27.0	25.2	17.2	23.2	28.3	105.4	8.0	5.0	40.8	26.8	66.7	44.1	10.6	7.0	66.4	9.6	8.6	12.5	60.2	10.1	23.1	6.4	35.5	9.9	51.7	24.1	10.1	14.5	23.1	8.7	52.4	11.6	37.2	7.7	6.7	35.4	19.3	11.0	20.3	44.8	1.1	6.4	0.3	17.7	4.6	2.3	4.6	0.1	0.1	0.9	0.0	16.8	11.5	29.6	19.5	14.0	10.4	6.1	0.0	0.1	0.1	9.5	35.8	0.3	0.0	3.1	3.4	0.0	0.0	5.5	11.0	0.6	13.1	2.6	0.0	19.7	0.7	13.5	4.9	66.9	0.0	0.1	12.1	0.1	0.0	0.2	0.2	0.5	8.7	1.7	0.1	0.0	0.0	0.1	0.2	10.3	9.0	2.6	1.8	3.9	136.5	34.1	1.8	22.2	0.0	0.7	0.1	0.1	9.2	6.8	11.2	0.0	12.2	0.3	1.3	17.7	0.4	0.4	2.1	2.3	6.4	1.1	1.3	2.0	0.3	4.6	13.0	2.4	0.8	4.6	6.4	10.5	3.9	8.6	8.0	5.0	10.6	7.0	10.1	7.7
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"			490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: "	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavourable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavourable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	180.7	158.0	76.2	65.2	63.8	71.3	69.1	98.3	109.0	211.8	199.1	101.1	105.0	130.3	131.2	118.2	89.2	129.4	262.3	216.0	88.9	136.7	110.0	160.5	125.6	95.9	219.2	67.8	73.6	79.6	167.7	255.0	135.6	120.5	51.0	137.3	89.5	82.6	117.4	83.1	158.6	85.6	113.6	212.8	250.7	43.1	103.1	63.7	115.3	167.9	121.2	84.1	65.7	123.9	146.7	129.9	125.1	167.1	145.5	103.2	197.7	227.8	179.8	123.1	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8
ENO2		ENSG00000111674	"Enolase 2"	P09104	12	6913745-6923698	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 119.2"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5"	"Group enriched"	"Detected in many"	7	"B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000063, HPA068284, HPA068721, CAB073539, CAB079023"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			89000000	"Plasma membrane, Cytosol"		"CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: "	"unprognostic (8.96e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.28e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (7.89e-11)"	"unprognostic (7.61e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.24e-1)"	4.2	20.7	31.2	8.3	48.0	4.0	4.9	115.2	119.2	7.6	7.9	10.9	2.6	4.9	11.7	6.3	5.9	9.4	8.0	10.3	30.2	39.2	3.5	2.0	10.1	10.5	29.6	47.4	3.7	4.1	19.1	15.5	4.8	47.7	8.0	7.4	28.6	3.1	15.3	2.1	5.8	6.0	15.2	15.7	5.8	6.4	3.2	13.3	1.7	14.2	0.3	10.3	7.1	5.0	5.6	1.0	6.2	0.2	0.4	10.8	4.5	14.0	8.9	3.2	0.1	4.8	5.2	0.2	10.9	7.0	16.2	25.0	1.7	1.1	19.8	1.8	4.7	2.1	33.7	3.0	24.6	39.6	3.1	27.3	9.1	11.8	3.5	1.6	32.9	2.6	0.1	11.9	2.4	3.4	1.8	0.2	10.8	1.9	12.8	1.7	17.1	5.0	14.2	2.7	4.3	7.9	1.9	25.9	18.2	2.8	0.2	18.6	0.9	0.8	4.3	14.2	15.0	19.1	14.1	14.5	14.5	2.9	81.3	0.0	2.9	1.3	0.0	0.1	8.2	0.0	9.7	5.6	10.8	9.6	0.0	3.3	7.1	7.4	6.2	0.4	0.2	1.0	5.5	4.5	31.2	48.0	115.2	91.3	30.2	39.2	29.6	47.4	47.7	13.3
ENO3		ENSG00000108515	"Enolase 3"	P13929	17	4948092-4957131	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	Lyase	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"skeletal muscle: 638.2;tongue: 320.3"	"Group enriched"	"Detected in many"	4	"HDLM-2: 70.1;HeLa: 30.0;HMC-1: 29.6;RH-30: 48.2;RPMI-8226: 25.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000793, HPA068284, HPA068721"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000000	"Plasma membrane, Cytosol"		"HPA000793: AB_1078742, HPA068284: , HPA068721: "	"unprognostic (7.35e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (7.33e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.21e-2)"	"unprognostic (4.63e-2)"	"unprognostic (5.34e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.50e-2)"	7.6	0.3	0.2	0.6	0.2	0.7	0.5	0.6	0.2	0.2	0.4	0.0	0.1	0.8	0.4	8.5	8.6	0.4	0.1	38.3	0.2	0.1	0.5	5.0	0.4	0.5	0.2	0.0	0.4	0.3	0.3	0.5	0.2	0.1	2.1	0.1	1.2	11.8	0.1	638.2	0.3	0.7	0.4	0.2	0.8	0.4	0.5	0.0	0.6	4.8	320.3	10.5	0.3	0.3	13.3	21.0	27.1	24.8	18.5	23.3	36.0	2.8	6.2	2.8	2.6	2.4	0.6	6.8	5.0	0.6	0.3	0.3	3.0	1.9	5.2	6.8	0.4	3.6	1.0	0.4	0.2	70.1	5.7	5.1	30.0	4.4	0.9	1.5	29.6	4.1	1.0	0.5	1.0	0.3	2.3	9.7	1.5	1.5	1.8	6.2	3.6	2.6	8.3	48.2	25.2	0.7	1.9	1.8	6.8	3.2	2.8	3.6	2.5	1.6	1.5	3.0	5.5	1.3	3.7	6.9	3.8	4.3	1.7	5.0	2.9	13.5	15.6	27.1	21.8	22.5	14.7	13.3	18.7	20.3	21.0	11.1	12.3	19.7	19.7	18.5	24.8	16.6	23.3	36.0	0.2	0.2	0.6	0.2	0.2	0.1	0.2	0.0	0.1	0.0
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEK 293: 12.1;MOLT-4: 2.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced						37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.1	0.3	4.5	0.6	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.9	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4
ENPP2	"ATX, PD-IALPHA, PDNP2"	ENSG00000136960	"Ectonucleotide pyrophosphatase/phosphodiesterase 2"	Q13822	8	119557086-119673453	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Lipid degradation, Lipid metabolism"	Hydrolase	"Cancer-related genes, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.7;placenta: 79.0"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;ASC diff: 33.8;ASC TERT1: 72.2;BJ hTERT+: 41.5;fHDF/TERT166: 26.8;HSkMC: 33.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 46.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 26.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 26.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023700, HPA053652"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Intracellular and membrane"		1100000000	"Nucleoplasm, Golgi apparatus"	"Actin filaments"	"HPA023700: AB_1848170, HPA053652: "	"unprognostic (1.17e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.07e-5)"	"unprognostic (5.54e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.37e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	29.9	15.4	24.0	18.2	42.0	0.7	26.2	4.4	33.3	19.6	8.1	103.7	1.7	20.8	44.8	6.4	2.9	18.7	12.7	3.6	39.8	21.5	24.9	8.9	13.5	31.0	71.5	20.9	5.3	5.2	0.9	4.1	79.0	59.7	8.5	10.6	67.6	3.4	9.2	3.0	5.4	12.1	28.9	102.4	17.3	8.3	9.7	63.9	3.6	3.7	0.8	26.1	13.4	5.7	0.2	3.8	26.8	0.1	0.2	1.8	0.3	0.0	0.0	24.7	0.0	33.8	72.2	0.0	22.7	41.5	9.8	9.4	0.0	0.0	0.0	0.3	26.8	0.0	0.5	0.0	6.9	1.8	0.7	0.0	0.0	0.6	15.1	0.0	0.1	33.1	0.2	20.0	1.0	0.1	0.0	4.0	0.5	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	19.9	0.4	23.9	0.1	0.2	0.0	0.0	16.8	0.1	0.5	26.8	0.1	5.2	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	1.8	0.6	0.3	0.2	0.0	3.8	0.0	0.3	24.0	42.0	4.4	33.3	39.8	21.5	71.5	20.9	59.7	63.9
ENSA	"ARPP-19e, MGC4319, MGC78563, MGC8394"	ENSG00000143420	"Endosulfine alpha"	O43768	1	150600851-150629612	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	13	"U-698: 419.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051294	Uncertain		Approved	Nucleoplasm,Nucleoli,Microtubules,Cytosol			22000	"Nucleoplasm, Nucleoli"	"Microtubules, Cytosol"	"HPA051294: "	"unprognostic (6.27e-2)"	"prognostic favourable (8.24e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.64e-2)"	"unprognostic (8.07e-3)"	30.3	26.4	48.9	26.9	48.9	46.8	33.0	33.8	69.3	31.7	31.8	28.0	26.8	34.4	29.7	45.4	66.3	26.3	28.5	30.0	42.4	37.9	31.7	32.3	28.6	30.0	42.0	39.0	27.7	30.5	33.0	25.2	37.5	34.6	23.9	30.4	28.5	29.4	22.8	67.7	49.8	34.0	27.3	38.3	23.8	28.7	12.8	27.3	25.8	35.2	42.9	35.5	31.7	36.3	34.4	39.5	49.5	33.6	33.0	33.2	38.4	14.3	7.6	10.5	10.1	6.7	5.6	11.4	6.5	6.6	9.7	8.2	8.5	10.9	12.9	10.8	5.2	11.6	8.5	14.4	7.2	22.3	11.9	18.5	10.7	6.4	4.5	14.9	23.9	4.4	8.9	10.0	12.8	9.1	14.1	27.2	6.5	31.1	14.6	12.1	21.1	9.3	14.3	8.7	16.1	12.7	12.6	15.8	10.0	9.2	19.4	10.0	26.5	21.9	9.6	7.2	13.4	8.6	16.7	15.3	22.2	419.6	10.0	17.3	9.5	28.7	30.7	49.5	32.2	33.6	28.9	34.4	27.0	33.2	39.5	31.8	22.3	32.9	29.0	33.0	31.9	30.2	29.8	38.4	48.9	48.9	33.8	69.3	42.4	37.9	42.0	39.0	34.6	27.3
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell line enhanced"	"Detected in all"		"RT4: 33.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced		Approved	Cytosol	"Secreted to blood"		5000000	Cytosol		"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.3	4.3	4.9	9.1	9.8	9.3	5.7	5.6	4.6	3.7	4.3	3.3	6.4	6.0	2.8	7.6	6.3	4.9	8.1	4.2	5.1	2.3	4.5	3.2	17.8	9.5	2.7	5.3	7.6	8.2	5.3	11.0	7.5	5.0	9.3	5.5	7.6	3.0	3.3	1.5	9.4	3.5	4.7	2.9	6.6	33.8	3.5	3.7	9.5	7.5	5.4	10.9	2.4	6.2	7.6	7.9	4.5	4.1	6.0	9.4	4.9	4.8	5.0	6.8	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5
EP400	"CAGH32, DKFZP434I225, KIAA1498, KIAA1818, P400, TNRC12"	ENSG00000183495	"E1A binding protein p400"	Q96L91	12	131949920-132081102	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 6.7;dendritic cells: 7.3;T-cells: 2.8"	"Low region specificity"	"Detected in all"							"HPA016704, HPA049013"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA016704: AB_1854888, HPA049013: "	"unprognostic (2.28e-1)"	"unprognostic (4.04e-1)"	"unprognostic (4.33e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.24e-1)"	14.1	15.5	19.3	23.9	21.9	20.0	16.5	27.4	24.0	17.3	15.6	17.6	13.4	11.4	19.2	25.8	14.0	17.1	18.0	11.1	16.6	12.6	12.3	11.9	13.9	18.9	15.6	17.6	24.6	14.0	24.6	17.9	13.3	13.7	15.6	13.2	14.4	16.1	22.6	19.2	27.9	14.7	16.3	12.0	19.4	13.4	27.0	16.8	22.5	18.0	11.8	16.9	16.0	20.9	6.7	7.3	1.0	1.2	0.8	2.8	0.9	14.5	19.3	18.3	9.1	11.0	10.9	14.4	8.2	6.3	6.3	5.5	11.5	4.5	12.4	7.7	10.2	11.1	8.8	8.3	8.6	5.1	13.1	17.7	6.6	12.9	9.1	19.0	13.9	9.3	7.9	11.7	10.6	10.8	17.2	3.5	9.1	18.3	14.3	26.0	14.6	16.8	15.2	12.2	4.9	8.5	17.8	14.8	12.5	9.5	6.7	9.2	11.2	15.0	16.0	10.2	15.9	11.4	11.8	9.1	7.0	12.7	10.6	10.6	10.2	1.0	1.2	0.9	1.9	0.9	2.0	6.7	1.7	1.5	0.9	6.4	2.0	2.8	1.0	0.8	0.8	7.3	1.1	0.9	19.3	21.9	27.4	24.0	16.6	12.6	15.6	17.6	13.7	16.8
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 45.9;HHSteC: 57.5;RT4: 56.9;TIME: 56.7;U-138 MG: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA031200: , HPA069697: "	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favourable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.2	5.6	0.3	0.4	27.0	17.4	45.9	16.6	45.2	9.5	10.4	0.9	0.9	0.0	4.1	31.5	2.5	0.1	13.3	7.1	0.1	0.2	0.0	1.8	11.7	57.5	0.0	3.4	25.5	18.3	18.6	13.1	32.7	0.5	0.0	5.8	4.5	0.1	0.1	0.2	3.1	0.1	0.6	1.7	5.9	56.9	0.2	11.8	13.0	29.9	3.6	2.0	2.3	56.7	49.3	1.4	6.5	1.3	0.0	0.0	0.0	36.0	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell line enhanced"	"Detected in many"		"HEL: 39.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"			3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: , HPA028096: , HPA028412: , HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.3	1.7	18.3	8.6	1.5	0.2	6.1	1.8	2.8	2.3	2.9	4.9	8.8	13.6	4.9	2.5	3.3	22.8	1.7	2.5	24.5	7.0	39.0	5.5	7.9	2.8	13.2	26.0	0.5	5.4	2.2	3.9	4.0	36.7	10.8	0.0	2.5	21.4	8.6	19.2	2.8	32.9	8.0	19.5	2.2	9.3	24.7	18.3	5.7	5.4	12.4	4.1	5.1	0.3	0.1	3.8	3.6	3.8	16.3	21.1	24.3	3.5	13.6	2.0	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"			170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.7	19.8	27.2	13.8	22.1	6.1	14.1	17.8	14.4	20.1	16.6	11.8	10.1	26.5	19.3	4.3	7.6	13.0	28.8	43.0	17.5	18.1	10.4	9.5	8.1	0.0	22.2	10.8	0.2	25.4	9.8	22.1	49.1	29.1	9.1	2.1	14.1	3.1	18.3	9.5	22.1	23.8	0.9	24.2	7.9	2.1	0.0	5.9	0.1	11.4	3.0	18.9	26.7	17.0	32.0	28.6	42.3	24.1	0.4	9.5	11.6	0.1	25.8	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;ASC TERT1: 20.5;HUVEC TERT2: 18.5;SCLC-21H: 20.7;TIME: 50.8;U-2 OS: 18.5;U-2197: 18.0;U-251 MG: 21.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	4	"monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"			140000	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	17.1	19.4	12.0	16.4	32.1	2.5	8.9	35.9	36.3	5.1	10.6	36.2	1.4	29.8	5.8	7.1	6.8	8.8	6.0	6.0	11.3	16.6	21.0	3.1	8.8	8.8	46.4	15.9	7.8	4.4	14.7	9.0	12.7	46.8	4.0	8.4	3.8	3.6	5.0	4.6	3.5	27.9	8.3	27.2	10.5	3.2	35.9	36.6	0.9	4.0	1.5	2.6	5.6	5.8	0.0	2.5	0.7	11.6	0.0	0.6	0.7	0.0	0.3	1.2	0.0	17.6	20.5	13.8	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	12.0	0.0	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	1.4	10.7	0.0	3.8	0.0	18.5	0.1	0.1	0.0	0.0	0.1	0.2	2.5	3.9	0.0	0.0	0.0	0.1	1.4	20.7	0.1	0.0	0.1	8.2	0.2	1.4	50.8	0.1	18.5	18.0	21.8	0.0	0.0	0.0	0.0	1.6	2.1	0.0	4.5	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.7	0.0	11.6	0.0	0.0	0.7	12.0	32.1	35.9	27.7	11.3	16.6	46.4	15.9	46.8	36.6
EPB42	"MGC116735, MGC116737, PA"	ENSG00000166947	"Erythrocyte membrane protein band 4.2"	P16452	15	43197227-43221125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape, Erythrocyte maturation"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 54.8;placenta: 16.1"	"Cell line enriched"	"Detected in single"	92	"HEL: 42.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"cerebellum: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040261	Supported		Uncertain	Nucleoplasm,Cytosol			7500000	"Nucleoplasm, Cytosol"		"HPA040261: AB_10673441"	"unprognostic (8.45e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.95e-1)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.48e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.88e-2)"	"unprognostic (3.47e-3)"	7.5	0.4	0.4	0.4	0.9	54.8	1.3	4.3	1.0	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.4	0.5	0.6	1.9	0.4	0.9	0.5	0.9	5.5	0.3	0.5	0.3	0.8	0.3	0.3	0.3	16.1	0.7	0.5	0.3	0.3	0.3	0.3	1.3	1.1	1.0	0.3	0.3	5.3	0.5	2.4	0.3	0.5	1.2	0.3	0.5	1.6	4.5	0.0	0.3	0.2	0.0	0.0	0.1	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	4.2	0.4	0.9	4.3	1.0	0.4	0.9	0.5	0.3	0.7	0.3
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Tumor antigen"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 303.2"	"Cell line enhanced"	"Detected in many"		"A-431: 58.3;CACO-2: 75.6;CAPAN-2: 106.4;RPTEC TERT1: 45.4;SCLC-21H: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"		"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: "	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	0.4	2.1	1.8	49.8	3.0	0.2	8.9	0.6	1.0	10.8	155.8	0.7	31.5	66.8	4.4	35.2	2.8	10.2	41.6	0.4	1.7	2.7	60.2	1.2	22.6	0.4	1.2	0.4	3.8	54.1	19.8	38.7	2.2	0.9	9.0	70.5	0.7	47.2	25.0	0.5	2.0	303.2	1.7	1.4	0.5	15.3	5.5	0.9	1.7	83.6	4.2	4.1	4.1	2.1	0.2	1.9	0.4	0.2	0.0	0.0	0.6	58.3	0.6	0.0	0.1	0.0	0.0	37.0	0.0	0.0	0.0	0.0	75.6	106.4	0.0	16.4	0.1	27.5	0.5	6.9	0.2	0.0	6.7	0.0	0.3	29.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	17.4	0.0	0.0	29.8	0.0	2.8	19.1	3.8	0.0	0.0	14.8	45.4	25.8	41.1	0.3	0.4	21.7	0.0	18.3	0.1	0.0	0.0	0.7	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.6	1.8	3.0	0.6	1.0	1.7	2.7	1.2	0.4	0.9	0.9
EPHA1	"EPH, EPHT, EPHT1"	ENSG00000146904	"EPH receptor A1"	P21709	7	143390289-143408892	"Cancer-related genes, Enzymes, Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 104.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;HaCaT: 9.6;HBEC3-KT: 7.8;MCF7: 8.5;NTERA-2: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 3.4;naive CD4 T-cell: 6.9;naive CD8 T-cell: 5.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.9"	"Not detected"	"Not detected"							CAB026144	Uncertain						24000000			"CAB026144: "	"unprognostic (1.54e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.58e-3)"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.09e-1)"	"unprognostic (7.59e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.24e-3)"	"prognostic favourable (1.14e-6)"	"unprognostic (3.73e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	0.4	0.4	0.0	2.0	0.1	0.5	1.2	0.9	0.3	5.7	7.9	0.0	3.3	3.3	0.9	1.4	29.3	1.6	7.9	0.4	0.0	0.0	2.8	10.6	2.9	5.8	0.0	0.0	1.2	2.9	104.4	1.3	5.5	1.1	2.1	0.9	1.3	5.8	3.9	0.3	9.5	12.3	0.4	0.2	0.5	1.8	0.8	0.0	5.1	6.0	16.4	17.2	1.6	11.8	0.0	0.7	0.2	0.1	0.2	6.9	1.6	4.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	10.3	4.1	0.0	0.0	0.0	9.6	0.0	7.8	0.0	0.0	0.0	1.0	0.0	0.9	0.0	0.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	1.0	32.1	0.0	0.0	0.0	0.0	0.6	3.9	0.1	0.0	0.0	4.8	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	3.4	0.9	0.4	0.0	6.9	5.1	0.2	0.2	0.0	0.7	0.2	1.6	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	0.0
EPHA4	"Hek8, TYRO1"	ENSG00000116106	"EPH receptor A4"	P54764	2	221418027-221574202	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.6"	"Cell line enhanced"	"Detected in many"		"AF22: 35.0;ASC diff: 15.5;CACO-2: 25.6;U-2197: 17.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 3.0;gdT-cell: 3.4;MAIT T-cell: 3.4;memory B-cell: 2.5;memory CD4 T-cell: 5.0;memory CD8 T-cell: 3.3;naive B-cell: 1.8;naive CD4 T-cell: 1.9;NK-cell: 6.0;T-reg: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB028368	Enhanced						8400000			"CAB028368: AB_2099353"	"unprognostic (1.28e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.05e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavourable (9.56e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (5.67e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.66e-2)"	7.1	1.8	8.1	1.9	18.3	3.5	5.2	14.7	29.6	4.9	5.9	3.1	3.2	1.1	6.5	3.1	5.0	6.6	3.3	16.7	19.9	4.4	5.2	0.9	3.7	2.5	2.4	16.4	11.7	1.2	2.0	1.2	1.7	4.9	5.9	4.7	0.8	3.7	6.7	3.1	12.8	4.1	8.2	2.1	3.3	4.0	11.4	2.6	0.5	9.8	3.7	3.2	4.6	4.9	2.5	0.2	3.0	0.0	6.0	5.0	0.7	1.1	1.0	35.0	0.0	15.5	9.6	0.0	8.3	3.6	7.5	2.8	25.6	0.4	0.0	0.0	11.6	3.0	5.4	0.0	3.2	4.1	3.0	0.0	0.3	0.0	0.4	0.0	0.6	3.8	1.9	2.3	0.0	7.1	0.0	0.0	1.9	4.1	0.1	0.0	2.5	0.7	0.0	3.8	0.0	11.7	1.8	6.2	0.0	2.7	0.5	0.6	1.3	0.0	0.0	0.8	1.4	17.1	0.4	0.0	0.0	0.0	3.1	0.0	1.5	3.0	0.0	0.0	3.4	0.0	3.4	2.5	5.0	3.3	0.0	1.8	1.9	0.3	0.2	6.0	0.0	0.2	2.1	0.7	8.1	18.3	14.7	29.6	19.9	4.4	2.4	16.4	4.9	2.6
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419547	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 110.4"	"Group enriched"	"Detected in some"	4	"AF22: 8.7;HEK 293: 25.0;RH-30: 23.8;THP-1: 20.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"		340000			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	1.3	1.3	6.0	1.7	24.6	1.2	2.2	21.6	8.6	2.4	24.6	0.0	0.1	2.5	2.0	7.5	14.7	1.7	3.1	4.2	13.8	2.9	6.9	1.3	1.5	1.3	2.4	5.8	3.0	1.3	110.4	5.6	1.6	6.7	17.9	3.6	0.4	8.2	1.9	1.3	1.4	6.5	20.2	4.8	4.7	14.9	2.1	4.4	0.0	1.3	0.0	1.3	9.7	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	25.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	3.6	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.5	0.6	4.4	23.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	24.6	21.6	8.6	13.8	2.9	2.4	5.8	6.7	4.4
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		290000	"Plasma membrane"	Nucleoplasm	"CAB013647: , HPA071200: "	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (4.98e-4)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	16.7	7.1	6.8	10.9	0.6	0.6	0.0	3.9	0.2	11.8	2.5	2.4	6.7	0.2	8.4	1.7	15.8	4.6	22.8	3.1	0.0	1.6	0.0	0.7	0.0	7.1	0.0	1.7	2.3	7.3	21.1	0.1	31.1	0.6	0.0	2.3	2.5	0.3	0.1	1.6	4.6	2.0	7.0	0.3	5.8	1.6	7.4	7.8	6.8	0.2	0.1	0.4	0.2	30.7	4.7	12.4	11.9	26.8	0.0	0.1	0.0	8.8	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827521	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.6;neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013537	Uncertain						1000000			"CAB013537: "	"prognostic unfavourable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (8.84e-4)"	14.0	20.7	1.8	4.2	2.9	2.2	17.1	1.9	3.0	29.1	9.5	2.9	14.6	4.1	28.8	10.3	11.0	13.1	35.0	19.0	3.4	1.1	16.8	29.8	16.5	12.0	2.2	0.9	24.6	11.6	5.6	3.1	35.5	3.2	13.7	5.4	11.6	10.8	14.7	5.1	14.2	7.0	12.4	2.2	50.5	8.6	12.2	2.1	2.3	10.2	13.1	7.0	7.7	21.5	0.0	1.6	7.4	3.6	0.0	0.0	1.2	12.5	11.1	11.1	32.2	7.1	4.6	32.9	4.9	10.7	7.7	10.1	9.1	9.6	1.6	22.4	5.0	13.1	4.8	12.9	4.1	2.0	8.9	0.4	6.4	14.1	4.1	0.2	0.3	5.4	19.5	4.9	11.4	28.7	23.6	0.6	6.2	21.8	0.2	4.9	19.0	16.7	17.0	5.5	2.9	9.8	6.6	0.0	9.6	7.5	3.5	7.3	8.9	2.2	24.1	9.6	15.3	17.7	7.2	0.1	0.2	0.5	1.4	4.1	17.4	0.0	3.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	7.4	0.0	0.2	0.3	0.0	1.2	1.8	2.9	1.9	3.0	3.4	1.1	2.2	0.9	3.2	2.1
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell line enhanced"	"Detected in many"		"K-562: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Approved		Enhanced	Cytosol			720000	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favourable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	8.4	5.7	3.6	4.7	0.2	0.0	2.7	0.7	0.5	0.4	0.1	4.5	5.8	0.0	3.4	2.1	6.1	0.6	1.4	0.3	0.0	2.7	12.5	0.6	13.7	2.0	0.0	2.6	5.1	6.2	0.0	0.7	0.3	28.2	0.1	0.0	2.6	8.1	0.3	5.8	9.9	0.0	0.0	0.2	5.1	1.2	3.0	9.4	6.9	8.2	8.2	12.5	2.3	0.1	0.0	2.3	1.0	0.1	7.3	5.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9
EPN1		ENSG00000063245	"Epsin 1"	Q9Y6I3	19	55675226-55709858	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 70.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB009729, HPA061136"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB009729: AB_2277865, HPA061136: "	"unprognostic (6.93e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.94e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.16e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.78e-3)"	"unprognostic (7.92e-3)"	26.7	23.4	34.2	20.6	31.4	15.7	31.4	26.3	47.1	13.5	32.7	17.2	18.1	67.7	13.7	19.8	21.3	15.4	28.2	56.0	28.0	18.6	23.1	36.0	16.5	25.5	17.5	25.9	23.2	54.5	12.1	14.3	15.0	15.8	19.3	13.8	13.5	24.8	22.7	84.7	22.2	59.7	12.2	14.3	26.9	55.1	20.2	13.1	11.2	15.3	26.3	14.6	13.1	16.2	2.2	3.6	4.6	6.9	0.7	2.0	2.4	24.6	34.1	8.5	17.4	9.8	9.4	17.5	18.4	10.5	13.1	13.1	14.2	15.6	15.2	12.5	14.7	18.9	7.4	14.0	4.7	5.2	70.5	11.1	18.2	16.8	13.6	7.1	10.7	12.2	12.4	11.3	8.2	12.5	16.5	12.9	8.6	13.9	11.3	11.7	19.5	48.2	7.6	11.6	26.6	9.9	14.6	12.3	29.9	17.0	18.5	12.1	13.9	25.0	20.8	36.5	17.6	13.1	26.5	14.2	12.9	10.9	26.8	14.4	18.0	2.4	3.5	4.4	1.4	4.5	1.0	2.2	1.4	1.3	2.4	2.0	1.4	1.3	4.6	0.7	6.9	3.6	2.0	2.4	34.2	31.4	26.3	47.1	28.0	18.6	17.5	25.9	15.8	13.1
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol			29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavourable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	37.9	29.6	32.8	34.8	39.4	27.6	25.7	28.8	22.7	24.3	57.8	22.0	41.5	32.2	34.8	31.8	34.6	28.3	22.1	31.4	25.9	19.3	32.3	52.1	26.9	23.6	40.8	32.7	41.0	28.0	54.0	45.6	25.0	14.8	22.3	12.7	26.8	39.7	23.7	24.5	56.5	23.5	13.2	33.1	26.0	23.0	38.2	40.2	35.3	56.9	24.9	12.2	22.6	37.5	36.7	30.9	35.1	48.9	28.3	37.5	38.7	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519328	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		67000	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: "	"unprognostic (1.45e-2)"	"prognostic unfavourable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	39.0	26.9	35.5	25.3	27.8	13.2	19.3	22.2	41.0	25.7	16.7	35.7	16.2	11.4	21.8	21.3	19.6	14.1	19.3	18.9	40.7	26.0	21.0	19.1	24.4	30.7	36.2	11.2	22.4	10.9	17.0	14.6	22.8	20.3	22.5	15.5	25.7	24.3	16.4	30.9	18.1	19.3	18.2	36.8	33.8	15.2	32.4	33.1	25.0	20.3	23.4	32.1	25.3	17.0	16.1	10.8	14.9	12.2	10.7	18.7	8.0	14.7	4.4	9.6	9.0	22.2	22.2	23.9	10.3	16.4	8.5	12.6	6.0	8.2	30.2	10.7	16.2	14.1	12.4	9.9	12.9	34.1	7.8	26.9	7.6	7.2	20.9	15.2	24.8	18.0	9.2	14.8	20.2	15.8	16.6	13.8	12.9	7.2	12.2	8.3	13.1	7.2	10.0	14.5	6.6	11.2	18.4	6.6	9.2	12.3	21.9	17.9	8.9	10.8	21.8	7.9	8.5	15.8	8.6	16.5	16.7	20.4	11.7	17.3	6.9	14.9	10.1	11.6	10.1	10.7	15.3	16.1	12.2	15.6	10.8	10.0	7.3	10.5	7.8	10.7	12.2	7.1	18.7	8.0	35.5	27.8	22.2	41.0	40.7	26.0	36.2	11.2	20.3	33.1
EPS15L1	eps15R	ENSG00000127527	"Epidermal growth factor receptor pathway substrate 15 like 1"	Q9UBC2	19	16355239-16472085	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019237, HPA055309"	Uncertain		Approved	Vesicles			8900	Vesicles		"HPA019237: AB_1848223, HPA055309: "	"unprognostic (3.06e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.35e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.12e-2)"	"unprognostic (1.07e-3)"	"unprognostic (7.54e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.81e-2)"	"prognostic favourable (8.10e-5)"	"unprognostic (2.47e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.32e-1)"	14.1	12.2	16.4	12.4	22.9	22.7	10.2	34.2	31.6	15.3	10.8	19.9	11.4	8.7	14.1	7.4	18.5	15.4	11.0	26.4	16.8	15.5	13.0	11.5	10.8	14.1	15.4	17.2	16.1	12.8	19.8	18.2	15.6	20.5	13.9	11.1	16.4	14.4	16.0	44.0	20.6	11.2	16.7	11.8	14.3	11.9	14.7	15.2	14.2	12.9	13.9	16.5	11.6	14.4	11.1	4.4	26.4	6.2	8.7	5.9	4.2	13.3	6.4	13.9	9.2	15.0	11.7	20.6	8.9	7.8	15.7	13.7	6.9	9.6	14.5	16.3	13.7	13.6	19.6	10.9	13.7	7.2	18.4	12.4	8.9	14.8	15.2	10.8	13.4	9.6	11.2	17.2	12.0	12.6	9.7	16.0	13.1	27.2	12.3	16.1	8.7	22.1	15.9	5.9	12.4	10.8	14.5	12.4	7.6	9.7	8.6	9.2	29.9	10.6	13.0	9.5	6.1	30.4	15.0	4.4	9.1	14.0	10.1	16.1	13.0	23.5	5.8	16.1	5.8	5.7	5.5	11.1	5.0	5.9	4.4	9.7	5.6	4.1	26.4	8.7	6.2	4.2	4.9	4.2	16.4	22.9	34.2	31.6	16.8	15.5	15.4	17.2	20.5	15.2
EPS8		ENSG00000151491	"Epidermal growth factor receptor pathway substrate 8"	Q12929	12	15620158-15882329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 56.1;HHSteC: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 16.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003897	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA003897: AB_1848224"	"unprognostic (6.16e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (3.33e-7)"	"unprognostic (2.68e-1)"	"prognostic favourable (1.45e-7)"	"unprognostic (7.47e-3)"	"unprognostic (7.20e-2)"	"prognostic favourable (5.11e-4)"	"unprognostic (1.79e-2)"	52.6	5.9	7.9	7.4	10.7	0.1	37.3	7.9	7.6	28.7	24.9	9.5	13.5	16.6	39.1	28.5	12.2	16.9	25.4	16.3	8.4	6.8	25.4	16.3	12.7	7.0	12.6	6.6	23.4	6.6	6.4	4.4	23.4	10.9	24.4	24.2	23.3	12.0	19.0	12.7	9.8	26.2	36.0	13.5	11.1	14.2	12.1	11.8	0.1	15.9	9.5	2.8	33.5	40.1	1.0	4.4	3.6	16.7	0.7	0.9	1.2	13.4	8.2	8.2	0.3	56.1	39.9	11.5	15.7	12.8	7.5	10.0	7.0	20.7	0.0	0.5	29.5	3.5	2.4	2.0	11.3	0.0	2.7	1.2	2.5	7.2	48.5	0.8	0.0	35.1	9.1	19.8	25.4	3.8	0.0	0.0	36.0	3.6	0.0	0.6	1.1	6.6	0.0	23.7	0.1	21.4	19.4	0.6	1.0	4.5	2.6	19.3	7.3	0.9	6.1	12.0	3.1	6.9	6.4	0.7	0.0	0.0	7.0	2.2	34.1	0.0	2.2	0.2	0.2	8.7	0.1	1.0	0.8	0.3	4.4	0.3	0.9	0.4	3.6	0.7	16.7	0.3	0.1	1.2	7.9	10.7	7.9	7.6	8.4	6.8	12.6	6.6	10.9	11.8
EPYC	"DSPG3, Pg-Lb, SLRR3B"	ENSG00000083782	Epiphycan	Q99645	12	90963679-91005026	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"placenta: 67.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;U-266/70: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 3.8;basal ganglia: 3.8;cerebral cortex: 6.2;hippocampal formation: 4.4"	"HPA038212, HPA045455"	Approved				"Secreted to extracellular matrix"					"HPA038212: AB_10672739, HPA045455: "	"unprognostic (2.25e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.28e-2)"		"unprognostic (1.81e-2)"		"unprognostic (4.07e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.77e-2)"	"unprognostic (6.44e-9)"	"unprognostic (2.83e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.20e-1)"	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.4	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.0	0.0	0.0	67.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.0	3.9	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ERAP1	"A-LAP, ARTS-1, ERAAP1, KIAA0525, PILS-AP"	ENSG00000164307	"Endoplasmic reticulum aminopeptidase 1"	Q9NZ08	5	96760810-96808100	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025095, HPA042317"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		27000000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB025095: , HPA042317: "	"unprognostic (2.33e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.84e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.14e-2)"	23.8	13.6	9.3	22.7	11.9	11.6	23.3	14.2	14.6	14.5	23.8	10.1	11.2	30.8	14.7	13.4	12.3	14.3	19.9	16.1	9.7	6.8	13.3	23.7	17.8	16.4	13.5	7.6	15.5	16.5	11.1	39.4	28.2	11.4	13.4	21.9	8.5	13.9	15.2	23.1	17.7	39.7	10.6	17.1	19.5	16.5	5.4	13.8	55.5	13.5	9.8	17.8	15.9	14.1	14.9	15.2	19.8	17.5	19.8	21.8	10.7	7.3	4.7	6.3	5.9	35.0	34.3	18.4	5.4	17.5	13.1	23.0	5.9	26.7	22.0	11.3	10.4	7.6	5.2	11.1	8.2	39.8	2.2	7.1	3.1	4.0	40.1	3.4	13.2	14.2	4.8	15.0	4.6	18.0	3.7	21.4	7.8	3.4	31.6	3.5	3.1	3.0	23.5	8.6	10.9	9.8	11.4	2.3	1.6	8.6	5.8	8.4	5.1	16.4	14.3	11.3	3.8	1.9	8.9	8.0	15.0	17.1	12.1	11.6	6.6	19.8	13.2	15.6	21.2	11.4	19.7	13.0	18.5	18.2	9.5	14.9	21.8	17.4	14.4	19.8	17.5	15.2	12.3	10.7	9.3	11.9	14.2	14.6	9.7	6.8	13.5	7.6	11.4	13.8
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	27	"SK-BR-3: 263.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Supported	"Plasma membrane,Cytosol"			430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: , HPA001060: , HPA001338: , HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavourable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favourable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	3.1	3.8	4.2	2.7	5.1	3.6	5.7	2.2	3.7	4.9	4.2	2.8	8.6	0.2	4.6	5.1	9.8	0.2	5.1	2.3	0.4	3.2	0.1	3.0	4.5	3.0	0.0	0.0	3.5	4.8	3.0	1.8	2.0	0.4	0.1	3.6	4.8	0.5	0.2	7.6	0.9	0.3	1.7	0.4	5.0	9.8	0.8	0.2	4.2	263.9	1.3	7.4	0.1	0.2	2.5	3.3	3.2	1.4	0.4	0.2	0.2	0.2	0.0	8.2	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7
ERBB3	"HER3, LCCS2"	ENSG00000065361	"Erb-b2 receptor tyrosine kinase 3"	P21860	12	56076799-56103505	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 31.1;MCF7: 20.3;RT4: 24.3;SK-BR-3: 28.6;SK-MEL-30: 38.1;T-47d: 31.7;WM-115: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.3"	"Low region specificity"	"Detected in many"							"CAB025331, HPA045396"	Uncertain		Approved	"Plasma membrane,Actin filaments"	"Secreted - unknown location"		420000	"Actin filaments"	"Plasma membrane"	"CAB025331: , HPA045396: "	"unprognostic (2.97e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.31e-3)"	"unprognostic (2.66e-2)"	"unprognostic (9.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.76e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.07e-2)"	1.1	1.4	11.6	12.6	16.5	0.6	26.8	2.0	16.7	6.8	40.5	40.3	12.0	37.7	2.8	7.5	29.4	5.7	22.9	3.4	18.6	9.0	16.5	33.9	13.4	0.5	23.5	9.3	0.9	21.5	11.4	1.0	15.4	14.9	16.8	29.7	5.5	36.8	22.3	1.1	30.7	41.3	3.2	27.4	0.5	32.9	1.2	23.8	0.0	4.5	7.4	8.5	11.8	14.4	0.9	0.7	5.3	0.6	1.2	1.2	0.2	10.1	0.6	0.8	0.3	0.0	0.0	16.5	0.8	1.9	1.1	1.1	5.5	18.3	0.0	0.2	0.2	8.6	1.2	1.9	0.6	0.2	0.8	0.0	0.3	31.1	0.0	0.0	0.1	0.4	2.5	0.2	0.0	0.0	0.7	0.3	0.1	20.3	0.1	0.3	2.8	0.4	0.1	1.9	0.5	2.1	24.3	0.9	0.3	0.7	28.6	38.1	31.7	0.1	0.0	0.1	1.1	0.6	0.1	0.3	0.1	0.1	0.1	0.0	40.5	5.3	0.4	0.8	0.9	0.4	0.4	0.4	0.7	0.3	0.3	0.9	0.6	1.2	3.3	1.2	0.6	0.7	0.8	0.2	11.6	16.5	2.0	16.7	18.6	9.0	23.5	9.3	14.9	23.8
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.4;EFO-21: 7.0;HEK 293: 5.2;RPTEC TERT1: 7.7;SCLC-21H: 4.3;T-47d: 6.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced						140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	1.6	1.9	15.1	1.2	15.0	1.0	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7.0	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2.0	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12.0	0.0	4.5	1.1	1.2	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	7.0	1.0	0.4	0.2	0.0	0.0	0.1	5.2	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	7.7	0.4	4.3	0.2	0.0	0.1	0.1	6.9	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12.0
ERC2	"CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110"	ENSG00000187672	"ELKS/RAB6-interacting/CAST family member 2"	O15083	3	55508308-56468363	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 30.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.7;HUVEC TERT2: 3.6;Karpas-707: 12.0;SH-SY5Y: 3.0;U-266/70: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073739	Enhanced									"HPA073739: "	"unprognostic (2.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.09e-2)"	0.9	1.6	13.4	1.0	9.5	0.9	1.1	11.5	30.5	1.0	1.0	0.7	1.3	1.0	1.2	0.9	1.0	1.0	1.1	2.2	9.4	5.3	1.4	0.9	1.1	0.9	3.8	12.6	2.9	1.3	0.9	7.4	1.3	8.8	1.5	1.0	1.1	1.0	3.1	0.9	0.9	1.1	1.1	2.3	0.9	1.2	1.5	1.5	0.0	1.3	0.0	0.9	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.0	12.0	0.0	1.5	0.0	0.0	2.6	0.3	0.0	0.2	0.0	2.7	0.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.3	8.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	13.4	9.5	11.5	16.8	9.4	5.3	3.8	12.6	8.8	1.5
ERCC3	"BTF2, GTF2H, RAD25, TFIIH, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294176	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB037153: AB_796181, HPA046077: "	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavourable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	17.4	20.0	26.1	23.8	28.9	20.5	21.0	35.9	32.0	22.1	19.4	19.7	17.1	11.5	21.6	15.7	19.1	23.6	20.4	20.4	23.2	18.8	17.5	17.4	19.4	23.1	19.7	25.8	23.3	22.4	32.0	26.4	16.3	21.5	20.1	17.1	18.3	18.0	21.8	30.1	19.7	17.3	26.1	16.0	24.5	17.4	39.5	20.1	24.1	19.3	15.8	25.9	22.4	20.8	11.8	13.9	7.2	9.7	18.8	16.2	11.7	21.8	15.1	18.6	19.7	20.8	14.2	23.1	20.1	26.2	32.6	31.6	22.9	16.0	16.6	16.7	18.3	19.6	28.4	21.2	28.4	25.9	25.4	20.8	18.4	24.2	15.4	18.1	22.7	14.7	19.9	37.7	16.1	20.9	20.2	10.9	20.5	21.6	25.7	19.5	27.1	23.5	21.2	21.4	13.7	18.2	20.4	22.6	24.4	17.2	26.2	26.3	14.1	20.8	16.6	19.6	22.5	17.8	23.9	19.5	38.1	26.0	17.3	8.7	20.9	6.6	9.5	7.2	16.0	9.7	16.2	11.5	11.8	13.5	13.9	11.8	15.8	10.9	3.1	18.8	7.9	11.3	16.1	11.7	26.1	28.9	35.9	32.0	23.2	18.8	19.7	25.8	21.5	20.1
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920157-13952345	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease mutation, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cell Junctions"				"Nucleoplasm, Nuclear bodies"	"Cell Junctions"	"CAB000156: , HPA045828: "	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.41e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.49e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.30e-2)"	"unprognostic (5.88e-4)"	8.4	12.7	8.6	7.0	11.3	5.3	6.4	8.9	9.7	8.1	6.7	9.9	6.0	4.1	8.5	6.8	6.7	8.5	6.8	7.8	7.2	7.1	6.9	7.2	6.9	6.8	10.5	8.8	9.9	7.6	13.3	13.0	5.9	9.6	8.3	5.4	7.1	6.4	7.0	31.3	6.9	5.7	8.5	10.3	7.7	6.6	14.2	8.9	13.7	9.7	5.6	6.4	9.1	7.8	8.4	7.9	8.3	6.8	8.9	7.4	2.6	5.4	7.0	6.4	9.2	10.7	10.1	5.0	7.2	7.7	6.5	8.3	2.4	5.4	9.1	10.4	6.3	6.9	9.5	4.9	10.1	12.3	5.6	4.5	7.8	6.0	9.8	6.0	5.1	7.6	6.9	8.6	7.3	8.6	7.0	10.7	9.1	4.5	8.0	4.1	4.7	3.7	9.2	13.0	11.2	4.0	3.7	5.3	6.3	8.8	7.2	6.7	9.1	4.6	9.7	9.6	7.1	8.6	6.3	9.5	11.1	6.3	9.2	7.3	9.7	8.3	6.2	5.4	6.8	6.8	7.4	6.2	6.4	5.1	5.5	8.4	6.4	6.9	7.2	8.9	5.7	7.9	5.8	2.6	8.6	11.3	8.9	9.7	7.2	7.1	10.5	8.8	9.6	8.9
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102807146-102876001	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045845, HPA050126, HPA050374"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA045845: , HPA050126: , HPA050374: "	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavourable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (6.82e-4)"	22.3	19.1	15.9	16.1	17.8	23.7	20.1	26.4	20.8	19.7	27.0	17.9	27.0	25.0	22.1	25.7	21.0	15.1	21.1	15.4	14.6	13.1	18.7	28.1	19.9	26.4	17.1	16.2	22.9	22.3	15.7	25.6	17.9	19.0	20.1	23.1	15.9	20.5	24.7	14.6	25.8	31.1	17.0	19.4	30.6	21.9	14.0	17.8	40.8	21.8	16.6	26.0	22.4	19.6	10.1	10.8	23.4	17.4	17.7	17.5	12.0	14.7	5.4	10.8	6.7	21.5	20.2	6.5	14.9	19.9	8.7	11.3	8.2	20.6	9.3	7.5	15.1	15.4	9.5	13.7	9.1	14.0	5.3	13.8	15.6	7.2	10.5	28.0	18.0	19.2	13.2	10.0	15.6	15.1	6.4	8.5	15.2	4.0	15.1	19.5	4.6	7.5	8.2	8.0	9.3	17.9	8.2	7.2	10.7	7.8	13.2	8.0	11.8	26.2	15.2	6.7	3.4	5.6	9.4	12.4	3.7	4.7	26.2	11.4	8.4	23.4	9.8	18.3	16.7	12.3	15.5	9.6	15.5	17.5	10.8	10.1	16.6	16.1	7.2	17.7	17.4	7.7	16.6	12.0	15.9	17.8	26.4	20.8	14.6	13.1	17.1	16.2	19.0	17.8
ERCC6	"ARMD5, CKN2, CSB, RAD26"	ENSG00000225830	"ERCC excision repair 6, chromatin remodeling factor"	"Q03468, P0DP91, Q8N328"	10	49455368-49539538	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Age-related macular degeneration, Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Mental retardation, Premature ovarian failure, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 34.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071297			Approved	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA071297: "	"unprognostic (1.92e-2)"	"unprognostic (1.85e-1)"	"unprognostic (9.79e-3)"	"unprognostic (7.26e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.05e-2)"	7.9	6.9	11.5	6.0	12.3	13.9	11.1	21.0	13.9	9.8	7.0	8.9	10.6	6.4	9.3	8.6	13.5	8.1	7.7	9.1	12.7	6.5	10.1	10.0	8.0	7.9	9.2	11.4	12.5	13.1	20.3	14.2	9.7	10.1	10.5	8.8	9.2	10.5	13.7	9.6	14.4	9.1	7.9	11.8	9.2	7.6	7.8	12.4	7.8	13.6	8.2	9.6	9.9	11.6	7.9	5.1	10.9	8.1	1.6	5.3	2.1	6.6	3.5	2.6	1.6	4.5	7.6	2.1	11.9	16.5	8.2	5.8	3.6	4.1	2.9	2.2	10.7	6.2	3.7	9.4	8.3	4.6	2.4	2.2	13.1	2.0	2.6	3.0	2.3	2.6	12.9	8.0	34.2	11.9	4.3	0.8	10.6	4.9	2.1	1.7	2.4	6.2	2.0	3.8	1.7	2.8	4.7	3.5	3.6	8.8	3.2	5.3	5.8	1.7	22.8	4.6	3.8	5.5	3.0	3.2	3.0	2.8	5.6	3.3	3.4	10.9	4.1	9.7	5.3	3.7	4.2	7.9	3.1	2.9	5.1	6.3	3.8	1.8	9.8	1.6	8.1	2.8	4.0	2.1	11.5	12.3	21.0	13.9	12.7	6.5	9.2	11.4	10.1	12.4
ERGIC2	"Erv41, PTX1"	ENSG00000087502	"ERGIC and golgi 2"	Q96RQ1	12	29337352-29381189	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049695	Approved		Supported	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoli	"HPA049695: "	"unprognostic (1.62e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.53e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.19e-3)"	"prognostic unfavourable (8.06e-6)"	"unprognostic (3.70e-2)"	"unprognostic (2.32e-2)"	"prognostic favourable (8.18e-4)"	"prognostic unfavourable (7.02e-6)"	"unprognostic (2.67e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (6.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.64e-1)"	26.6	21.0	24.4	21.9	32.8	5.5	29.9	28.1	36.1	25.4	22.7	14.6	25.8	21.2	23.1	33.1	32.5	16.6	21.2	33.7	25.3	22.6	27.7	36.2	18.6	18.9	29.8	24.2	24.9	32.6	27.3	40.1	40.9	31.2	29.5	21.4	12.1	28.8	23.8	29.2	15.6	24.3	31.4	31.0	25.6	21.1	32.8	30.7	25.7	28.6	21.6	25.8	33.4	20.6	27.0	39.0	59.2	30.1	22.1	40.8	27.5	24.6	22.7	18.6	12.5	26.9	31.7	45.4	40.2	33.9	25.2	27.3	29.9	41.7	13.6	40.1	31.9	25.9	17.7	26.6	40.4	29.1	19.1	22.1	32.5	17.3	15.8	30.7	18.7	22.4	21.4	31.8	32.2	19.5	18.0	38.7	33.6	13.3	15.3	33.3	26.2	64.2	14.2	51.3	27.6	21.4	36.2	7.1	11.6	20.5	23.3	23.8	45.0	25.2	21.6	34.4	29.3	45.4	43.3	28.5	36.0	27.2	28.7	23.0	27.8	24.2	17.0	22.1	29.7	25.3	35.8	27.0	38.1	34.8	17.8	22.3	38.4	32.3	59.2	22.1	30.1	39.0	40.8	27.5	24.4	32.8	28.1	36.1	25.3	22.6	29.8	24.2	31.2	30.7
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039142-64130819	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 40.4;RPMI-8226: 18.1;U-266/70: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 12.9;MAIT T-cell: 12.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported									"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	5.5	24.9	2.2	10.6	1.6	8.0	7.7	2.3	1.8	15.8	10.0	3.5	36.1	5.1	11.9	15.0	7.4	7.9	10.6	4.1	1.9	1.7	6.4	21.5	12.3	12.6	2.1	1.6	14.7	44.1	2.9	32.8	10.1	1.8	6.6	3.9	5.0	23.2	34.9	4.2	6.6	11.5	4.1	2.2	9.9	8.8	2.8	1.6	11.6	7.5	5.9	16.7	10.0	7.7	0.1	5.7	12.9	0.7	3.0	12.2	1.0	2.2	1.7	0.9	2.3	2.2	1.8	4.4	1.9	4.2	1.3	1.1	1.2	1.2	2.8	1.3	1.4	1.4	1.2	1.8	3.2	0.8	1.0	2.6	0.9	1.8	13.5	1.2	0.9	2.0	5.1	3.6	11.5	2.4	1.8	40.4	1.1	1.5	1.8	0.5	0.3	1.6	1.9	1.9	18.1	1.1	2.9	3.2	1.9	1.8	3.0	4.4	1.6	2.6	2.3	1.1	2.6	2.5	1.1	38.1	10.0	2.2	2.1	1.3	1.8	12.9	0.7	0.2	4.6	0.4	12.2	0.1	3.0	3.2	0.3	0.1	0.7	1.3	3.3	3.0	0.2	5.7	0.7	1.0	2.2	1.6	2.3	1.8	1.9	1.7	2.1	1.6	1.8	1.6
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639916-52695900	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 98.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"		75000			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavourable (7.59e-4)"	"prognostic unfavourable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	12.4	3.9	4.7	8.2	5.7	18.1	6.8	6.3	7.4	27.8	8.1	3.6	8.2	7.6	5.3	6.9	98.4	4.4	8.3	6.9	4.3	5.8	6.6	16.2	8.3	8.9	4.0	5.5	7.0	9.0	6.1	5.8	20.0	5.8	7.1	7.9	7.0	20.3	7.3	4.1	7.1	10.0	5.9	5.4	8.2	12.2	3.3	3.7	4.4	6.7	31.0	28.2	27.5	28.3	4.5	4.2	14.9	7.5	6.1	10.5	2.1	32.1	7.5	6.4	7.0	17.9	20.7	11.8	14.0	16.7	11.0	18.5	10.5	50.3	8.5	17.3	8.8	20.0	8.5	26.5	27.8	7.1	4.3	1.1	7.6	13.0	15.5	18.9	23.3	18.0	17.7	14.1	14.5	15.2	5.2	16.3	14.6	4.9	11.3	11.6	3.7	5.2	6.9	20.1	11.3	17.0	30.7	5.7	15.4	9.4	5.7	12.5	7.9	7.0	13.2	20.0	9.9	16.3	12.1	8.4	9.0	7.2	29.1	9.7	9.2	14.9	5.5	9.6	4.8	6.1	10.4	4.5	9.2	6.1	4.2	3.1	5.5	5.4	13.4	6.1	7.5	3.3	10.5	2.1	4.7	5.7	6.3	7.4	4.3	5.8	4.0	5.5	5.8	3.7
ERP29	"C12orf8, ERp28, ERp29, ERp31, PDI-DB, PDIA9"	ENSG00000089248	"Endoplasmic reticulum protein 29"	P30040	12	112013316-112023451	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039363, HPA039456"	Enhanced		Uncertain	Nucleoplasm,Microtubules	"Intracellular and membrane"		4900000	Microtubules	Nucleoplasm	"HPA039363: AB_10673422, HPA039456: AB_10672963"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.96e-1)"	"prognostic favourable (7.43e-5)"	"unprognostic (1.13e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.58e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.74e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.26e-2)"	19.1	37.1	20.2	32.4	19.8	55.1	39.7	29.5	30.8	23.3	45.8	16.8	66.5	32.0	23.1	38.3	30.6	24.6	39.0	24.2	18.6	24.9	34.9	67.5	33.8	61.2	22.5	19.7	28.5	111.2	33.3	35.9	46.1	23.4	30.9	29.6	23.2	61.5	58.8	13.0	37.0	35.6	27.2	21.4	41.6	39.5	31.7	16.3	35.8	53.8	28.3	37.6	24.4	30.9	49.2	83.9	60.6	43.3	14.8	37.7	46.6	20.3	19.9	14.7	28.5	55.6	22.3	31.3	20.1	24.7	16.4	21.1	31.0	23.8	21.9	15.8	34.9	25.5	27.3	26.0	13.4	18.7	15.2	24.8	22.7	34.8	37.7	60.5	24.3	31.7	34.1	26.4	30.8	22.7	28.2	40.8	12.3	23.6	19.8	110.0	23.8	15.0	16.5	17.8	70.3	33.5	31.5	13.3	17.9	25.0	20.7	60.3	26.0	83.5	16.9	13.8	21.5	13.2	14.9	45.3	51.9	18.4	23.4	38.2	10.7	14.8	43.3	60.6	25.5	32.0	27.6	47.9	33.8	31.6	41.9	49.2	37.7	30.7	8.7	14.8	29.0	83.9	31.5	46.6	20.2	19.8	29.5	30.8	18.6	24.9	22.5	19.7	23.4	16.3
ERP44	"KIAA0573, PDIA10, TXNDC4"	ENSG00000023318	"Endoplasmic reticulum protein 44"	Q9BS26	9	99979179-100099040	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001318	Supported				"Intracellular and membrane"		10000000			"HPA001318: AB_1080427"	"unprognostic (8.28e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.56e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.31e-1)"	18.1	18.7	14.1	18.5	13.7	15.3	26.7	22.4	17.1	17.6	17.9	10.3	28.8	18.2	17.2	34.3	21.8	15.3	14.9	20.0	13.0	10.9	20.7	57.1	22.1	29.9	14.3	9.5	15.7	41.8	16.5	19.0	30.3	12.6	16.4	20.0	10.0	25.9	39.5	13.5	14.5	25.6	16.8	12.4	18.4	20.4	10.5	11.7	15.5	23.7	18.1	18.4	15.2	16.8	15.0	20.0	22.4	30.5	14.1	12.5	17.1	8.1	6.6	9.6	10.8	34.9	16.7	17.5	18.2	24.8	12.8	17.1	14.0	23.9	21.1	12.0	20.5	30.1	11.8	12.7	11.7	10.8	6.6	7.9	6.9	10.1	30.6	14.2	12.6	18.7	19.3	11.2	16.3	15.6	15.2	16.5	10.4	12.7	9.6	10.0	9.9	8.7	8.5	16.1	14.4	16.5	9.4	7.5	8.8	14.9	18.5	12.5	6.9	14.7	10.8	9.6	9.1	12.7	7.9	9.5	8.3	7.1	14.7	9.4	12.9	14.7	24.6	21.9	11.6	25.8	11.1	15.0	11.6	12.5	20.0	14.2	8.9	10.4	22.4	14.1	30.5	12.6	12.3	17.1	14.1	13.7	22.4	17.1	13.0	10.9	14.3	9.5	12.6	11.7
ESAM	W117m	ENSG00000149564	"Endothelial cell adhesion molecule"	Q96AP7	11	124752583-124762290	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 93.0"	"Group enriched"	"Detected in some"	13	"HEL: 52.2;HUVEC TERT2: 67.9;TIME: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 6.7;neutrophil: 5.5"	"Group enriched"	"Detected in many"	9	"B-cells: 6.7;granulocytes: 5.5;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051043, HPA056293"	Uncertain		Approved	Microtubules			64000000	Microtubules		"HPA051043: , HPA056293: "	"unprognostic (1.52e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.06e-2)"	37.1	6.0	6.6	5.3	9.6	1.3	44.6	3.8	8.2	11.8	6.1	5.4	3.7	4.3	14.5	9.5	10.7	10.3	11.5	20.1	7.5	6.6	15.5	10.2	38.4	6.9	9.1	3.9	8.4	6.4	5.4	5.5	93.0	9.0	10.9	5.0	12.4	5.1	9.8	14.6	5.9	6.4	17.2	7.2	8.2	7.6	5.4	5.9	0.9	44.9	10.9	5.0	11.4	25.4	6.7	0.3	5.5	0.5	0.0	1.8	19.4	0.2	0.4	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.6	3.4	0.2	0.7	0.0	0.0	0.9	0.0	0.0	0.4	0.3	52.2	0.0	1.8	0.1	0.1	0.9	0.0	0.0	0.0	0.0	67.9	0.0	1.5	0.1	0.4	0.0	0.0	0.1	0.5	0.0	0.2	0.2	0.0	0.5	0.0	0.2	0.0	3.9	0.0	0.8	0.2	34.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.5	0.0	0.1	0.2	0.0	1.4	1.3	0.1	0.3	6.7	1.8	0.6	5.5	0.0	0.0	0.3	0.4	19.4	6.6	9.6	3.8	8.2	7.5	6.6	9.1	3.9	9.0	5.9
ESCO1	"EFO1, ESO1, KIAA1911"	ENSG00000141446	"Establishment of sister chromatid cohesion N-acetyltransferase 1"	Q5FWF5	18	21529281-21600884	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042497	Approved									"HPA042497: AB_10794278"	"unprognostic (8.12e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.81e-3)"	"unprognostic (1.72e-3)"	"unprognostic (6.80e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.72e-2)"	8.7	7.8	10.2	15.1	9.7	18.1	14.0	22.2	13.3	11.5	13.1	4.7	11.5	7.7	10.0	13.7	11.9	7.9	6.8	7.7	10.4	8.2	9.4	11.0	8.8	11.9	9.4	9.1	10.7	9.0	16.4	29.0	14.6	10.8	9.6	7.9	5.7	11.9	13.8	15.1	10.1	17.2	8.0	12.9	14.1	8.7	24.3	9.9	16.6	11.7	8.4	12.6	11.7	9.5	4.6	2.7	8.8	2.0	4.2	7.4	2.2	6.2	3.0	6.7	3.2	6.4	7.0	6.9	3.9	8.0	5.8	7.9	6.1	4.2	11.4	9.1	5.2	9.1	8.4	5.5	7.9	11.6	5.5	8.4	4.5	10.2	10.0	14.2	8.7	5.8	11.8	4.3	11.5	7.5	11.9	11.5	7.8	7.3	10.6	15.0	13.5	7.4	7.1	8.1	12.4	11.1	10.0	10.2	7.5	7.6	9.6	16.0	6.7	10.0	3.9	7.1	7.2	5.3	4.9	28.5	16.1	13.1	7.1	8.3	7.0	6.6	1.2	7.9	6.9	2.0	6.0	4.1	6.0	6.2	2.4	4.6	7.3	7.4	8.8	4.2	1.7	2.7	5.9	2.2	10.2	9.7	22.2	13.3	10.4	8.2	9.4	9.1	10.8	9.9
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Golgi apparatus,Cytosol"			16000000	"Golgi apparatus"	Cytosol	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	21.8	12.7	38.6	26.5	45.3	74.8	10.3	31.5	45.7	43.9	34.2	21.5	26.8	24.9	9.5	37.7	22.4	42.4	37.2	56.2	28.4	44.0	32.1	12.8	33.1	37.1	62.8	13.8	51.1	34.6	28.3	38.1	41.1	31.4	6.7	72.6	21.4	55.6	41.7	10.0	24.2	44.3	22.7	16.8	62.3	8.9	19.1	21.7	14.0	11.9	25.2	22.9	36.0	27.4	16.2	19.1	31.0	29.0	4.6	9.7	21.5	35.0	36.0	21.6	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol			130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.0	17.4	5.6	5.9	18.8	21.9	18.6	13.7	14.1	10.9	12.4	9.7	38.2	8.9	15.9	24.6	14.5	8.0	14.4	10.6	9.2	8.2	7.4	13.9	10.3	19.2	26.4	16.9	15.8	18.0	12.4	16.6	13.0	15.8	30.2	17.9	24.4	27.3	19.1	8.9	16.8	23.3	10.8	10.9	18.7	12.4	16.4	9.0	43.7	35.3	19.9	12.9	28.9	20.0	12.1	6.4	53.6	17.4	20.6	5.3	8.7	30.1	27.4	35.7	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1
ETF1	"ERF, eRF1, RF1, SUP45L1, TB3-1"	ENSG00000120705	"Eukaryotic translation termination factor 1"	P62495	5	138506095-138543300	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011686, HPA037511"	Approved						24000			"CAB011686: AB_732263, HPA037511: "	"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"prognostic favourable (9.33e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.63e-2)"	31.9	26.9	22.2	22.9	24.4	69.2	25.0	15.0	21.0	21.4	26.7	19.3	27.9	15.8	25.2	27.7	42.7	21.9	24.9	29.1	17.6	17.6	26.6	27.7	29.3	17.4	23.1	19.7	30.4	26.6	28.2	28.0	39.0	22.2	21.9	22.4	17.9	29.7	28.7	58.8	35.3	19.1	27.9	18.1	21.8	27.0	28.1	20.9	23.0	30.7	33.7	26.2	26.8	32.1	15.8	21.8	14.1	24.1	14.7	19.4	15.1	31.1	30.6	21.9	35.7	29.3	27.6	38.5	34.4	35.8	41.2	48.2	74.0	28.9	39.3	30.0	35.0	26.2	51.2	64.7	62.3	22.0	27.4	31.3	35.1	29.4	39.6	26.4	26.3	28.7	37.9	42.0	55.7	33.2	40.4	24.1	42.1	23.4	32.8	23.3	26.8	17.8	28.1	36.2	31.9	28.3	44.4	28.5	28.8	38.2	26.1	60.9	30.5	31.5	27.3	32.7	18.7	25.7	50.1	50.4	47.3	57.8	29.4	39.9	30.8	13.7	20.8	12.6	16.7	24.1	19.4	15.8	17.3	19.1	21.8	10.8	12.5	16.3	14.1	14.7	21.5	15.4	17.7	15.1	22.2	24.4	15.0	21.0	17.6	17.6	23.1	19.7	22.2	20.9
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria			6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favourable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.8	28.6	37.5	26.3	30.5	34.2	30.7	31.7	40.7	36.5	26.5	26.1	55.9	92.3	36.6	39.9	43.8	18.0	39.7	26.1	36.6	21.9	37.9	29.7	21.4	34.7	17.3	28.9	34.5	37.5	38.0	35.0	34.3	7.8	31.7	18.5	10.8	34.3	29.6	48.8	37.6	70.1	24.9	12.6	39.9	91.2	36.1	46.8	40.2	20.2	33.4	22.7	29.2	31.7	18.5	38.0	45.0	24.0	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell line enriched"	"Detected in all"	4	"Hep G2: 185.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria			640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favourable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favourable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.2	34.2	4.7	13.0	15.2	17.8	7.5	9.0	6.9	7.3	7.3	28.7	21.8	13.2	9.2	14.5	11.7	9.4	19.2	2.2	19.7	36.6	10.4	20.9	185.6	16.7	9.9	7.8	27.6	5.7	9.9	10.2	6.2	15.6	14.9	9.4	26.8	10.3	9.4	3.0	42.3	11.5	12.8	24.7	10.0	15.2	10.6	5.1	19.9	5.7	10.3	14.9	9.6	8.7	7.6	8.0	8.2	8.2	22.9	13.9	11.8	39.0	14.8	19.6	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9
ETFDH	ETFQO	ENSG00000171503	"Electron transfer flavoprotein dehydrogenase"	Q16134	4	158672125-158709623	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"	Oxidoreductase	"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 72.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041978	Enhanced									"HPA041978: AB_10795605"	"unprognostic (7.19e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.92e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-2)"	"prognostic favourable (5.76e-10)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.74e-1)"	11.3	20.1	7.0	3.9	8.6	2.8	12.9	10.3	8.2	5.1	12.5	6.5	6.1	23.0	5.7	6.4	10.9	4.3	5.2	47.8	7.2	5.0	17.3	72.8	4.3	2.9	8.0	5.3	5.0	8.9	11.4	8.8	9.0	8.5	5.2	10.5	7.4	7.2	5.6	33.7	7.7	20.4	8.5	4.8	4.8	9.2	4.1	8.4	4.9	6.0	17.5	5.4	5.8	6.1	5.8	11.0	24.5	13.5	6.2	9.2	5.4	5.6	3.5	5.9	10.7	25.6	15.3	2.8	10.0	10.0	7.4	7.2	1.9	12.5	13.8	2.1	12.1	6.6	11.4	9.9	10.4	21.9	8.3	12.7	8.1	3.3	11.2	10.9	12.1	14.1	12.5	8.0	6.8	14.4	7.0	26.1	11.8	5.8	10.5	5.5	2.3	8.6	8.5	2.0	9.7	11.1	4.9	9.0	3.5	10.0	19.9	9.4	13.5	8.4	6.4	6.0	3.1	8.8	5.1	14.7	18.3	9.4	12.4	9.2	6.4	2.5	13.5	24.5	6.7	13.3	8.1	5.8	6.3	6.8	11.0	5.4	7.8	6.6	4.6	6.2	11.7	8.4	9.2	5.4	7.0	8.6	10.3	8.2	7.2	5.0	8.0	5.3	8.5	8.4
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 122.5"	"Cell line enhanced"	"Detected in many"		"HEL: 60.8;U-698: 81.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002575: AB_563721, HPA063230: "	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	33.2	6.3	4.1	45.9	4.7	6.4	24.0	1.6	3.3	13.3	15.0	3.1	4.9	5.3	18.0	9.3	12.6	8.1	13.6	19.1	4.2	3.7	12.4	9.9	36.7	53.9	4.7	2.9	14.1	6.2	6.7	4.1	11.6	4.2	11.7	6.6	12.7	11.7	5.7	12.9	7.5	19.1	7.9	4.3	68.0	8.8	6.0	2.3	122.5	16.7	9.2	51.4	17.5	18.8	6.0	3.0	20.5	0.4	12.5	17.3	4.7	14.9	2.7	13.0	0.0	5.6	9.1	0.0	11.5	24.8	14.5	14.0	0.8	16.2	53.9	11.8	19.1	5.2	1.2	33.3	30.7	11.4	0.2	60.8	1.1	0.0	15.1	6.2	0.7	17.8	2.7	12.4	45.8	12.0	0.1	11.2	17.4	0.0	31.3	4.6	4.8	9.7	8.6	21.2	4.2	11.5	16.7	0.1	0.9	6.0	0.1	12.7	0.0	3.0	22.0	32.7	10.2	6.3	18.9	8.4	1.5	81.3	5.8	11.8	28.7	20.5	0.0	3.0	10.4	0.1	14.6	6.0	14.0	12.6	0.1	4.9	17.3	13.5	0.5	12.5	0.4	3.0	15.5	4.7	4.1	4.7	1.6	3.3	4.2	3.7	4.7	2.9	4.2	2.3
ETV3	PE-1	ENSG00000117036	"ETS variant 3"	P41162	1	157121191-157138474	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004794	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA004794: AB_1078761"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.78e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.02e-2)"	"unprognostic (7.26e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.97e-2)"	"unprognostic (6.65e-2)"	15.2	7.0	8.9	9.2	10.1	17.8	10.9	9.0	9.3	14.2	12.7	10.2	13.1	13.0	13.1	10.6	20.8	10.8	11.3	9.4	8.6	7.7	6.4	7.4	13.0	8.1	8.9	5.7	11.8	7.2	25.9	7.5	19.5	9.9	12.7	8.6	9.7	11.0	8.1	9.9	37.2	15.1	13.2	7.1	10.7	10.4	8.9	11.0	14.4	8.4	13.6	17.0	14.0	14.3	4.4	7.4	8.9	8.1	6.6	10.8	3.8	6.9	6.8	7.1	6.0	10.7	7.1	6.0	6.4	6.8	6.5	6.1	7.2	6.8	8.3	8.3	7.9	10.7	7.8	9.9	8.5	18.1	4.9	6.9	7.1	3.8	6.4	10.9	11.0	7.9	11.8	9.7	8.1	6.6	8.0	6.1	7.2	9.1	3.3	6.1	23.1	5.3	5.0	8.4	9.5	4.9	25.9	5.9	11.6	7.0	16.8	17.1	8.5	12.0	11.1	8.2	7.3	7.9	8.1	15.0	7.8	10.1	9.5	6.4	27.0	8.3	8.1	5.4	7.9	6.7	10.8	3.8	6.9	7.8	7.4	4.4	7.2	6.3	8.9	6.6	6.2	2.2	5.2	3.8	8.9	10.1	9.0	9.3	8.6	7.7	8.9	5.7	9.9	11.0
EVL	RNB6	ENSG00000196405	Enah/Vasp-like	Q9UI08	14	99971449-100144236	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 98.2"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 70.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018849, HPA019536, CAB033987"	Enhanced		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB033987: AB_2101264, HPA018849: AB_1848310, HPA019536: AB_2670180"	"unprognostic (1.12e-3)"	"unprognostic (5.03e-3)"	"unprognostic (6.46e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.27e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.35e-3)"	"prognostic favourable (4.07e-6)"	"unprognostic (3.50e-3)"	"prognostic unfavourable (4.14e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.69e-3)"	"unprognostic (2.43e-1)"	14.5	15.0	50.9	37.0	57.8	19.9	28.5	57.4	66.2	11.8	12.4	20.7	10.7	12.7	23.6	25.1	11.2	18.0	20.1	19.7	42.4	43.3	12.4	24.4	28.4	63.5	34.8	31.4	23.3	17.1	9.8	28.6	13.5	26.2	16.4	12.0	24.2	20.0	16.5	12.8	15.6	18.7	29.4	23.1	44.2	15.2	13.2	20.3	98.2	11.0	7.5	55.8	18.3	9.3	7.8	2.5	14.2	8.7	9.3	20.6	5.4	4.0	3.6	27.4	8.2	5.5	15.9	15.8	5.4	6.8	3.5	4.8	0.2	2.8	7.7	7.1	4.9	0.1	12.9	9.3	4.4	8.3	8.2	12.7	2.9	2.1	4.6	3.8	30.2	8.4	4.8	2.4	9.3	9.5	6.3	0.5	3.8	5.6	70.9	20.3	5.7	5.4	17.1	14.2	1.3	4.5	0.1	33.3	19.5	3.8	5.9	1.6	4.5	11.2	5.8	2.9	4.6	17.9	2.9	14.5	10.9	21.8	3.8	6.4	4.7	1.5	1.5	14.2	11.6	7.6	8.9	6.2	13.6	11.0	2.5	7.8	16.5	14.6	0.3	9.3	8.7	0.4	20.6	5.4	50.9	57.8	57.4	66.2	42.4	43.3	34.8	31.4	26.2	20.3
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	35.3	43.2	45.3	41.3	51.3	67.5	32.1	58.2	48.6	32.4	39.8	43.2	31.3	41.0	45.1	38.5	40.8	37.6	25.9	40.7	40.1	32.8	33.0	48.5	33.4	50.5	32.7	49.9	38.4	32.0	47.2	44.3	34.0	41.7	35.0	39.9	41.5	32.3	38.2	52.8	34.8	36.6	40.5	33.8	44.1	34.5	85.6	32.5	39.9	32.5	30.9	55.4	36.4	34.5	52.0	65.8	50.6	81.1	58.4	67.8	76.1	56.4	44.0	60.5	47.0	30.9	25.6	41.6	34.4	55.0	57.1	49.0	50.1	29.3	77.2	21.8	52.7	44.4	86.2	70.4	58.8	52.5	61.5	58.3	39.0	47.9	46.2	89.6	41.7	39.1	29.7	47.6	77.3	44.1	43.6	34.9	42.2	56.7	90.0	34.4	42.5	33.5	63.2	58.3	46.6	52.5	60.0	49.6	47.4	42.8	50.2	37.1	32.2	48.8	45.0	34.9	38.8	21.9	49.9	45.4	36.4	71.6	33.2	39.9	42.4	48.4	57.9	50.6	60.2	81.1	60.7	50.4	56.6	59.6	65.8	52.0	55.8	53.6	43.3	58.4	78.6	35.3	67.8	76.1	45.3	51.3	58.2	48.6	40.1	32.8	32.7	49.9	41.7	32.5
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: "	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favourable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.7	14.6	20.2	19.9	23.7	24.7	7.0	13.0	21.7	11.8	15.6	8.4	25.0	13.3	9.4	24.4	11.3	10.8	17.7	19.7	20.2	12.9	10.7	15.4	8.9	26.1	14.0	11.7	24.0	22.2	16.8	31.2	20.1	15.4	13.3	21.9	11.6	25.5	15.5	15.1	13.7	11.4	17.9	23.9	19.1	15.9	15.8	24.9	19.5	18.0	20.8	11.9	13.2	21.8	13.2	6.9	13.9	14.1	21.1	12.8	12.8	38.9	16.5	20.1	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: "	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favourable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.4	10.6	11.3	7.4	0.6	0.7	4.0	3.9	10.8	3.5	4.4	3.9	7.2	9.6	8.2	1.8	5.4	9.1	2.4	4.5	8.5	9.2	13.9	3.7	5.0	4.4	15.1	12.5	1.0	1.3	3.2	2.1	46.2	11.7	6.4	1.7	4.5	6.3	9.8	1.5	3.1	9.6	4.9	5.0	7.7	5.7	3.8	5.3	4.0	4.1	5.0	8.0	8.0	9.4	0.2	3.7	3.3	6.3	4.8	5.1	7.8	1.2	17.0	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1
EXOSC1	"CGI-108, CSL4, Csl4p, hCsl4p, p13, SKI4, Ski4p"	ENSG00000171311	"Exosome component 1"	Q9Y3B2	10	97436142-97446017	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038370	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA038370: AB_10672515"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.88e-9)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.41e-2)"	18.2	23.3	22.3	28.8	26.2	24.8	23.4	22.8	26.6	19.9	21.9	21.4	23.4	21.9	22.9	45.6	25.1	20.2	19.2	19.4	21.6	23.2	20.5	24.6	18.3	30.1	24.2	19.8	22.3	35.0	21.0	33.6	22.8	21.8	21.5	26.2	20.6	32.5	27.7	23.6	22.1	20.7	24.2	22.4	27.4	26.2	15.6	20.8	36.6	23.4	21.1	34.1	23.5	19.9	37.3	32.2	30.9	43.0	18.5	47.2	28.4	18.8	19.0	12.1	20.1	16.9	18.1	15.9	16.8	29.0	22.7	26.5	30.7	20.8	21.1	16.8	18.7	21.1	19.2	22.6	22.3	22.4	23.6	13.0	16.4	23.2	29.5	29.0	14.3	18.6	29.8	25.8	39.1	26.4	15.7	35.1	17.6	24.0	27.5	48.2	18.8	16.4	20.0	14.2	36.4	15.1	10.8	6.9	12.1	11.8	9.9	25.0	23.4	32.9	13.0	11.3	12.9	17.1	35.0	22.1	27.0	36.8	18.5	36.8	8.6	24.3	31.6	30.9	28.1	43.0	35.3	37.3	35.5	31.9	32.2	29.4	34.2	29.6	13.0	18.5	39.0	28.1	47.2	28.4	22.3	26.2	22.8	26.6	21.6	23.2	24.2	19.8	21.8	20.8
EXOSC2	"hRrp4p, p7, RRP4, Rrp4p"	ENSG00000130713	"Exosome component 2"	Q13868	9	130693721-130704894	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Deafness, Disease mutation, Dwarfism, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021756, HPA021790"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA021756: , HPA021790: AB_1848320"	"unprognostic (8.19e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (8.33e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.73e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.41e-1)"	13.0	14.2	14.4	18.6	17.0	12.7	17.9	22.7	18.0	16.1	14.3	15.8	13.6	11.0	18.7	10.1	16.6	19.0	11.7	12.5	15.8	12.5	14.3	18.4	11.1	16.7	18.5	17.3	22.1	25.0	19.6	12.6	13.1	13.9	13.9	17.4	14.6	14.1	13.7	22.3	13.1	11.5	18.7	12.3	14.0	13.4	8.4	17.6	17.3	14.2	15.7	21.3	15.8	13.9	11.0	10.4	5.6	7.9	16.8	11.7	7.7	13.7	28.2	16.9	14.9	6.1	6.9	12.3	20.7	10.0	20.8	16.1	22.7	12.0	27.4	11.4	11.1	25.2	26.9	20.7	23.0	16.2	13.1	21.9	27.6	15.8	11.5	33.0	14.5	8.8	7.8	29.1	34.1	14.7	23.8	11.9	14.4	24.5	23.2	9.2	20.9	18.3	18.3	31.0	29.9	9.7	12.8	10.4	11.6	24.2	18.5	10.9	19.2	11.9	8.9	20.5	15.9	18.2	29.2	6.1	24.0	41.6	14.6	19.3	16.0	1.5	7.7	5.6	10.9	7.9	11.2	11.0	11.0	9.2	10.4	10.4	11.7	10.0	2.0	16.8	5.4	6.8	9.9	7.7	14.4	17.0	22.7	18.0	15.8	12.5	18.5	17.3	13.9	17.6
EXOSC4	"FLJ20591, hRrp41p, p12A, RRP41, RRP41A, Rrp41p, SKI6, Ski6p"	ENSG00000178896	"Exosome component 4"	Q9NPD3	8	144078626-144080647	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024792	Approved		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA024792: AB_1848325"	"unprognostic (2.32e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.36e-2)"	"prognostic favourable (2.23e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.11e-2)"	12.3	16.7	12.8	11.4	17.6	13.8	8.9	13.9	20.6	8.1	12.0	10.5	13.6	15.8	9.8	10.4	14.5	10.0	9.3	16.5	11.4	11.2	14.9	21.5	8.7	11.4	11.5	13.0	10.3	15.0	8.0	10.2	11.5	12.0	12.1	6.5	11.6	28.0	14.7	12.1	12.7	11.1	6.7	9.3	13.4	13.9	45.0	9.7	14.8	10.8	10.4	11.1	8.7	7.8	24.7	38.2	19.0	31.8	17.1	16.1	18.8	10.2	22.5	4.0	9.6	3.5	2.6	11.0	8.0	3.3	6.3	6.4	15.7	7.2	6.2	11.7	3.3	8.4	7.4	8.8	1.8	8.1	25.0	8.9	16.8	17.4	5.8	6.6	10.6	3.8	9.0	7.3	5.8	3.2	13.9	4.2	5.1	37.2	10.2	13.1	10.4	90.3	4.5	6.6	16.0	6.0	10.4	12.6	16.7	10.0	13.0	18.5	14.7	10.0	3.2	6.5	14.2	15.5	13.6	11.2	13.4	7.7	9.4	10.6	10.1	19.0	31.8	12.5	15.9	29.4	16.1	22.0	12.4	15.4	29.8	24.7	15.9	15.4	9.2	17.1	16.1	38.2	13.7	18.8	12.8	17.6	13.9	20.6	11.4	11.2	11.5	13.0	12.0	9.7
EXT2	SOTV	ENSG00000151348	"Exostosin glycosyltransferase 2"	Q93063	11	44095549-44245429	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, Hereditary multiple exostoses, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078409			Supported	"Golgi apparatus"			20000000	"Golgi apparatus"		"HPA078409: "	"unprognostic (5.87e-2)"	"unprognostic (3.05e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (1.77e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (5.36e-6)"	"unprognostic (7.07e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.36e-2)"	24.5	19.5	11.6	17.2	18.5	6.6	25.8	14.5	23.0	26.8	25.0	15.5	17.5	17.6	37.1	25.5	16.7	26.0	23.4	22.7	11.7	13.0	19.2	36.3	22.3	16.8	11.8	12.3	29.3	21.8	25.7	17.3	58.0	16.2	23.7	20.6	22.9	24.7	22.8	16.9	20.2	34.0	35.0	12.2	18.7	19.3	20.0	11.4	16.2	24.7	16.7	13.0	20.2	23.2	6.7	14.9	13.0	12.0	17.8	17.6	9.8	12.9	17.9	9.7	30.2	44.8	33.0	13.4	40.2	50.3	23.8	32.4	12.7	8.9	8.9	18.3	47.0	20.6	10.4	28.5	28.8	17.9	14.3	8.2	9.4	9.7	17.7	8.2	17.8	25.6	18.9	14.4	22.5	33.8	11.0	16.2	17.3	9.9	5.7	5.0	10.4	12.8	7.2	27.8	4.5	13.7	12.3	7.0	7.8	25.4	10.4	6.7	17.3	8.8	30.5	32.2	21.1	31.5	25.7	7.3	9.5	6.5	21.2	6.4	34.3	9.3	11.9	13.0	15.6	12.0	17.6	6.4	12.5	14.4	14.9	6.7	11.9	11.7	2.6	17.8	8.5	5.1	9.6	9.8	11.6	18.5	14.5	23.0	11.7	13.0	11.8	12.3	16.2	11.4
EXTL2		ENSG00000162694	"Exostosin like glycosyltransferase 2"	Q9UBQ6	1	100872372-100895998	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020716, HPA068921"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		83000000	Nucleoplasm	Cytosol	"CAB020716: , HPA068921: "	"unprognostic (3.14e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.20e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.64e-5)"	"unprognostic (7.81e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.84e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.34e-2)"	7.5	23.0	9.8	4.1	19.9	1.7	10.4	14.7	22.8	13.4	8.7	8.1	9.9	4.5	16.7	13.1	6.0	10.1	10.3	8.2	9.5	13.3	11.2	10.0	7.6	3.4	14.0	12.0	18.8	7.7	17.5	18.7	21.8	20.1	12.3	7.1	8.6	6.0	11.4	5.3	5.9	4.6	15.4	11.4	5.4	6.2	9.7	16.3	6.4	9.3	5.0	3.4	9.0	6.2	2.1	7.4	3.3	1.1	5.3	5.6	1.9	5.1	2.7	19.8	20.7	22.0	16.2	12.6	8.9	14.6	7.0	15.7	2.5	3.9	5.7	8.6	8.1	5.0	7.2	7.6	14.2	11.6	5.0	7.0	9.6	7.1	7.2	10.9	3.7	19.2	2.7	14.0	2.7	25.5	8.8	0.7	17.6	2.6	5.7	6.0	24.9	6.0	4.2	20.4	4.7	7.5	3.9	8.2	23.3	6.8	1.7	15.9	4.3	4.9	10.7	17.5	10.3	11.2	9.3	6.1	5.4	3.5	27.9	11.3	5.7	3.3	0.8	0.0	5.6	1.1	2.8	1.9	1.9	3.7	2.5	2.1	2.1	4.8	0.2	5.3	0.9	7.4	0.0	1.9	9.8	19.9	14.7	22.8	9.5	13.3	14.0	12.0	20.1	16.3
EYA2	EAB1	ENSG00000064655	"EYA transcriptional coactivator and phosphatase 2"	O00167	20	46894624-47188844	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 47.4"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 13.4;SCLC-21H: 20.4;U-266/70: 38.0;U-266/84: 46.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 69.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"memory B-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"B-cells: 2.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027024, HPA059291"	Uncertain		Supported	Cytosol				Cytosol		"HPA027024: AB_1848334, HPA059291: "	"unprognostic (1.08e-1)"	"unprognostic (5.71e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.30e-5)"	"unprognostic (3.32e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.56e-1)"	10.5	2.0	6.5	2.6	7.4	0.8	13.4	2.4	6.5	47.4	6.4	3.8	21.0	1.0	15.7	10.7	25.9	28.2	2.2	4.3	7.0	4.1	5.2	1.8	2.3	1.3	6.3	4.9	5.2	2.4	11.5	4.7	5.9	9.1	18.5	3.2	15.4	28.6	27.3	2.1	4.2	1.1	2.3	7.2	1.1	8.2	4.9	5.1	14.3	21.4	3.6	14.0	5.5	17.3	2.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.6	0.1	13.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	1.3	0.0	0.0	0.0	0.0	0.1	0.4	2.4	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	20.4	0.0	0.0	9.1	0.0	1.8	0.0	0.0	0.0	1.6	0.1	3.0	38.0	46.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.5	7.4	2.4	6.5	7.0	4.1	6.3	4.9	9.1	5.1
EZH2	"ENX-1, EZH1, KMT6, KMT6A"	ENSG00000106462	"Enhancer of zeste 2 polycomb repressive complex 2 subunit"	Q15910	7	148807383-148884321	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.5;lymphoid tissue: 44.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009589	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB009589: "	"unprognostic (2.42e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.69e-3)"	"prognostic unfavourable (8.18e-12)"	"prognostic favourable (6.97e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.67e-2)"	2.0	1.7	1.8	10.6	1.6	25.5	1.4	4.9	2.7	2.6	4.8	1.1	0.1	3.8	1.7	2.8	11.0	0.9	3.0	0.9	0.8	0.6	1.7	3.3	2.3	12.6	1.3	0.3	2.2	3.8	0.6	1.7	3.4	1.4	1.4	5.1	1.8	3.2	1.6	3.7	6.4	4.8	1.5	1.2	5.8	2.7	19.6	1.3	44.1	0.9	5.5	12.4	2.6	3.5	1.5	4.7	1.3	3.9	8.5	10.3	1.7	16.9	7.9	27.1	18.0	0.8	1.4	14.8	13.2	5.3	10.9	11.0	11.9	19.6	29.9	6.4	4.9	10.4	13.9	4.5	13.9	42.8	13.9	12.7	9.8	9.2	2.2	28.4	10.5	1.2	2.6	8.1	4.3	6.4	27.1	19.9	9.7	19.2	55.1	23.7	21.5	10.7	34.1	15.2	18.5	5.0	8.1	25.9	16.5	16.6	12.6	4.3	9.2	12.2	3.9	11.6	5.4	23.1	23.6	17.9	19.4	30.1	10.6	19.4	22.7	0.5	2.2	1.3	1.7	1.5	1.3	1.5	3.4	2.9	4.7	0.8	1.9	1.2	0.2	8.5	3.9	1.0	10.3	1.7	1.8	1.6	4.9	2.7	0.8	0.6	1.3	0.3	1.4	1.3
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819412	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"			75000000	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: , HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favourable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	22.8	56.4	30.9	31.2	31.4	24.7	13.3	4.0	21.5	18.0	45.5	28.2	35.2	33.8	9.8	25.8	71.8	25.1	30.2	34.3	37.6	13.9	53.5	16.2	44.3	36.7	14.8	19.0	20.7	33.0	77.1	14.6	125.1	23.5	21.7	22.8	37.0	27.4	32.0	13.6	47.5	87.9	22.8	12.8	26.0	55.4	21.4	22.2	41.6	37.1	34.4	75.6	38.2	25.3	81.7	30.0	24.3	31.2	20.7	61.7	41.1	87.0	47.6	11.8	16.9	1.3	1.4	68.9	27.4	9.0	30.9	26.1	55.7	48.3	87.7	27.2	31.3	66.8	23.2	30.5	35.9	30.6	15.0	1.8	28.9	24.6	31.4	21.7	13.5	2.3	23.7	29.1	28.3	20.2	17.3	43.0	17.9	22.9	30.7	26.2	19.6	15.9	23.1	5.5	19.9	63.5	26.5	21.4	17.5	47.9	69.1	5.2	16.8	28.7	26.1	10.0	32.1	13.7	42.1	29.7	27.0	75.2	6.2	11.2	11.9	24.3	14.0	16.4	34.8	31.2	41.0	81.7	36.7	42.9	30.0	67.5	19.9	26.5	6.1	20.7	30.6	14.0	61.7	41.1	30.9	31.4	4.0	21.5	37.6	13.9	14.8	19.0	23.5	22.2
F10		ENSG00000126218	"Coagulation factor X"	P00742	13	113122814-113149529	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 116.7"	"Cell line enhanced"	"Detected in some"		"BJ: 8.3;CACO-2: 7.1;fHDF/TERT166: 7.4;Hep G2: 32.8;HHSteC: 6.8;SH-SY5Y: 16.2"	"Cancer enriched"	"Detected in many"	11	"liver cancer: 95.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"		16000000000				"unprognostic (4.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.88e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.82e-5)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (5.14e-5)"	"unprognostic (6.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.23e-3)"	8.1	3.7	0.3	2.9	0.7	0.0	5.4	0.4	0.8	20.3	5.9	0.6	7.6	4.5	12.6	21.4	4.5	9.9	10.0	18.4	0.5	0.5	2.3	116.7	4.9	1.6	0.5	0.7	18.2	3.0	0.0	1.7	3.6	1.0	18.1	0.7	6.9	2.0	6.1	2.6	7.8	7.6	11.7	0.6	1.3	3.2	9.5	0.6	0.6	3.1	5.6	1.8	7.8	10.3	0.0	0.0	0.0	0.0	0.9	1.0	0.3	0.0	0.0	1.4	0.2	4.8	4.9	0.0	8.3	6.6	0.5	0.2	7.1	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	32.8	6.8	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.6	16.2	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.8	0.5	0.5	0.5	0.7	1.0	0.6
F11	FXI	ENSG00000088926	"Coagulation factor XI"	P03951	4	186265945-186288806	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 88.9"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 13.7"	"Cancer enriched"	"Detected in some"	13	"liver cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039808			Approved	Vesicles	"Secreted to blood"		4400000000	Vesicles		"HPA039808: "			"unprognostic (1.28e-1)"		"unprognostic (3.15e-1)"		"prognostic favourable (3.29e-5)"	"unprognostic (1.88e-1)"			"unprognostic (2.08e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.91e-2)"	"unprognostic (7.65e-2)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	2.7	0.1	0.1	5.5	0.2	0.3	0.1	0.1	4.8	0.1	0.1	0.1	10.2	88.9	2.8	0.1	0.1	0.1	0.1	19.0	0.0	0.2	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.1	0.1	6.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2
F11R	"CD321, JAM-1, JAM-A, JAM1, JAMA, JCAM, PAM-1"	ENSG00000158769	"F11 receptor"	Q9Y624	1	160995211-161021348	"CD markers, Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.7;HaCaT: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 44.5;neutrophil: 32.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004671, HPA043616, HPA061700"	Enhanced		Supported	"Cell Junctions,Microtubules"			41000000	Microtubules	"Cell Junctions"	"CAB004671: AB_425964, HPA043616: , HPA061700: "	"unprognostic (1.60e-2)"	"unprognostic (5.78e-3)"	"unprognostic (1.78e-3)"	"unprognostic (2.24e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.72e-3)"	"unprognostic (5.01e-2)"	20.7	13.3	3.0	9.6	3.6	6.4	11.8	2.0	3.5	14.5	36.3	3.9	21.4	20.5	8.6	11.2	41.5	12.3	30.5	10.0	3.4	3.2	35.9	69.8	55.0	10.4	3.6	1.8	10.9	37.9	18.5	16.3	61.8	5.3	17.8	19.5	5.7	59.3	23.7	9.0	22.0	59.8	4.9	4.0	27.0	18.8	11.0	3.3	8.1	52.2	25.8	29.9	16.8	19.7	1.3	7.0	44.5	8.9	2.2	3.8	6.6	28.5	3.7	1.1	0.3	0.8	0.0	23.3	0.1	0.0	1.0	1.0	26.4	37.7	2.1	19.4	0.0	49.4	5.8	24.5	1.5	1.6	4.3	6.0	1.5	12.0	1.1	5.6	17.8	0.3	31.0	0.1	8.2	23.2	8.1	0.6	0.1	12.3	1.7	3.2	19.7	5.3	2.6	0.0	9.2	16.6	21.7	8.2	2.1	6.9	29.7	6.1	32.3	10.0	13.9	0.1	0.7	0.1	0.2	6.9	13.6	0.7	4.4	5.5	1.8	7.6	8.9	44.5	3.8	4.5	2.0	1.3	3.5	2.3	7.0	0.9	3.4	2.7	32.2	2.2	3.4	5.3	1.5	6.6	3.0	3.6	2.0	3.5	3.4	3.2	3.6	1.8	5.3	3.3
F12		ENSG00000131187	"Coagulation factor XII"	P00748	5	177402140-177409576	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"liver: 180.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.6;MCF7: 10.9;PC-3: 8.1;SH-SY5Y: 5.5;U-937: 5.6"	"Cancer enriched"	"Detected in many"	21	"liver cancer: 171.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.5;eosinophil: 6.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.9;monocytes: 2.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA003825	Approved				"Secreted to blood"	1040000	6600000000			"HPA003825: AB_1078790"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-1)"	"prognostic favourable (4.63e-5)"	"unprognostic (6.97e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (4.41e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (7.09e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.40e-6)"	"unprognostic (6.48e-2)"	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	180.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	1.0	6.9	2.5	0.7	0.3	1.0	0.8	2.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.3	1.3	0.0	0.4	0.0	1.4	0.7	0.4	0.0	8.6	1.8	1.3	0.3	0.9	0.2	0.7	3.0	0.2	1.3	0.1	0.4	0.2	0.4	3.2	0.0	10.9	0.1	2.6	0.0	8.1	0.6	0.2	1.8	1.1	0.0	2.5	5.5	0.3	1.0	0.7	0.4	0.0	0.0	0.2	1.1	0.0	0.3	0.5	0.0	0.1	0.1	5.6	0.6	0.0	2.5	6.9	0.3	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.0	0.1	0.9	0.7	0.9	1.0	0.0	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144085-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.1"	"Cell line enhanced"	"Detected in some"		"AF22: 15.3;LHCN-M2: 5.7;RH-30: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 27.6;myeloid DC: 33.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 33.7;monocytes: 27.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"		1400000000			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	56.6	19.4	2.2	11.4	6.5	3.1	57.9	2.2	1.8	13.3	21.8	2.6	2.5	2.2	4.7	35.6	13.4	16.8	12.6	55.4	2.0	2.2	17.5	1.3	14.5	52.7	5.8	1.4	10.2	8.9	5.3	9.3	110.1	7.5	16.4	15.1	11.6	11.5	3.3	18.5	10.4	10.6	20.1	5.0	5.1	11.5	16.7	2.5	2.7	22.4	8.3	6.1	23.7	6.5	0.0	33.7	6.6	27.6	0.0	0.1	63.5	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	28.9	0.5	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	27.6	0.2	0.1	4.9	0.1	0.0	0.0	0.0	33.7	0.0	0.0	0.0	6.6	0.0	0.1	2.4	0.0	63.5	2.2	6.5	2.2	1.8	2.0	2.2	5.8	1.4	7.5	2.5
F13B	FXIIIB	ENSG00000143278	"Coagulation factor XIII B chain"	P05160	1	197039191-197067267	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	95	"liver: 76.3"	"Cell line enhanced"	"Detected in some"		"A549: 1.8;Hep G2: 2.2"	"Cancer enriched"	"Detected in single"	816	"liver cancer: 46.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003827, HPA052139"	Supported				"Secreted to blood"		3400000000			"HPA003827: AB_1078794, HPA052139: "					"unprognostic (1.46e-1)"		"prognostic favourable (6.78e-5)"							"unprognostic (1.21e-2)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	76.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F2		ENSG00000180210	"Coagulation factor II, thrombin"	P00734	11	46719180-46739506	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	593	"liver: 324.8"	"Cell line enriched"	"Detected in some"	21	"Hep G2: 76.5"	"Cancer enriched"	"Detected in some"	110	"liver cancer: 508.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB016780, CAB018650, HPA051476, HPA054698"	Enhanced				"Secreted to blood"	107500000000	43000000000			"CAB016780: , CAB018650: AB_2246689, HPA051476: , HPA054698: "	"unprognostic (1.98e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.94e-2)"		"unprognostic (5.79e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavourable (6.75e-12)"	"unprognostic (5.65e-3)"	"unprognostic (5.80e-2)"		"unprognostic (1.54e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	324.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	76.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
F2RL3	PAR4	ENSG00000127533	"F2R like thrombin or trypsin receptor 3"	Q96RI0	19	16888860-16892606	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.4;breast: 30.7;lung: 33.0"	"Group enriched"	"Detected in some"	7	"HEL: 24.3;HMC-1: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031401, HPA042340"			Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA031401: , HPA042340: "	"unprognostic (6.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.64e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.31e-3)"	"unprognostic (2.97e-1)"	"unprognostic (3.28e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-3)"	"prognostic favourable (6.25e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.11e-2)"	69.4	3.3	0.2	2.6	0.4	1.3	30.7	0.2	0.6	1.3	16.9	0.4	0.5	1.9	1.3	1.9	4.3	1.0	4.5	9.7	0.5	0.2	5.0	0.8	33.0	2.6	0.2	0.3	3.9	12.3	0.5	2.3	1.1	1.4	1.4	1.5	1.3	1.0	0.8	6.5	2.2	4.4	1.1	0.2	3.0	5.4	2.5	0.2	0.3	27.1	2.3	1.5	3.4	1.9	5.3	4.3	5.8	2.5	3.9	3.3	3.2	0.2	0.2	0.7	0.3	0.1	0.2	0.7	0.4	0.0	0.2	0.1	0.4	0.7	0.5	0.5	0.2	0.6	0.1	0.2	0.2	0.3	0.3	24.3	0.9	0.4	0.2	0.3	9.8	0.0	0.1	0.3	0.2	0.8	1.9	1.0	0.1	0.3	0.3	2.4	0.3	0.2	0.2	0.2	0.7	0.2	0.5	0.4	0.2	0.2	0.1	0.1	0.5	1.6	0.9	0.5	0.5	0.3	0.3	0.5	0.3	0.5	0.2	0.4	0.4	5.8	2.5	1.6	2.2	1.4	2.1	3.9	2.4	1.9	0.8	5.3	3.3	3.1	5.3	3.9	1.8	4.3	1.7	3.2	0.2	0.4	0.2	0.6	0.5	0.2	0.2	0.3	1.4	0.2
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529225-94541800	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 115.2;HaCaT: 54.6;HBEC3-KT: 141.7;U-2197: 53.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	7733431000		Vesicles		"CAB009438: AB_668005, HPA049292: , HPA069132: "	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	45.5	9.8	27.0	14.1	42.9	2.1	55.1	3.4	27.9	14.8	18.7	20.9	18.7	18.3	30.5	23.7	21.3	25.4	30.9	18.8	26.9	14.5	6.6	2.8	31.4	5.8	14.1	20.3	41.6	35.0	6.1	28.8	65.4	39.2	29.7	22.2	49.9	29.2	33.0	2.4	17.7	19.2	5.9	46.3	2.9	18.2	16.4	16.0	0.0	21.8	17.3	11.9	24.7	22.3	0.5	0.9	2.8	0.8	0.7	0.4	0.2	115.2	0.2	0.2	0.0	12.6	6.2	6.5	16.4	9.8	17.8	19.4	2.0	24.7	0.0	8.4	20.3	54.6	1.4	141.7	29.3	0.1	0.1	0.0	3.5	0.3	4.2	0.0	0.0	10.7	3.2	8.4	41.1	0.1	0.1	0.1	12.4	0.2	0.1	2.4	1.1	0.2	0.1	1.1	0.0	2.2	0.3	0.1	0.3	13.1	5.4	0.4	0.1	1.5	0.0	10.8	0.3	53.8	4.9	0.1	0.1	0.0	8.2	0.6	0.4	1.7	0.8	0.1	0.3	0.3	0.4	0.2	0.3	0.2	0.2	0.5	0.3	0.3	2.8	0.7	0.2	0.9	0.2	0.2	27.0	42.9	3.4	27.1	26.9	14.5	14.1	20.3	39.2	16.0
F5		ENSG00000198734	"Coagulation factor V"	P12259	1	169514166-169586588	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;liver: 88.8;placenta: 32.2"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 26.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 69.6"	"Region enriched"	"Detected in many"	11	"pons and medulla: 27.9"	"Cell type enhanced"	"Detected in some"		"eosinophil: 8.7;neutrophil: 8.0"	"Group enriched"	"Detected in many"	13	"granulocytes: 8.7;monocytes: 4.2;T-cells: 7.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 2.8;hippocampal formation: 7.4;pons and medulla: 4.6;thalamus: 5.8"	"Group enriched"	"Detected in many"	7	"amygdala: 59.9;basal ganglia: 33.8;cerebral cortex: 88.3;hippocampal formation: 79.2;olfactory region: 58.9"	HPA002036			Approved	"Golgi apparatus"	"Secreted to blood"	7667000000	13000000000	"Golgi apparatus"		"HPA002036: AB_1078787"	"unprognostic (3.67e-2)"	"unprognostic (2.77e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.56e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.39e-4)"	"unprognostic (3.46e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (3.39e-4)"	"unprognostic (7.15e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.31e-1)"	1.1	0.4	0.4	1.4	0.5	1.5	0.8	1.0	0.4	0.4	0.4	6.7	0.0	0.5	0.4	2.2	0.4	1.6	14.1	13.9	2.5	0.5	1.2	88.8	1.1	1.1	1.4	0.1	0.4	1.3	0.1	2.0	32.2	27.9	1.0	0.4	17.8	4.4	0.1	0.4	1.3	0.5	0.5	2.6	1.9	2.2	0.7	1.1	0.0	0.7	0.2	2.6	1.5	0.4	0.0	0.5	8.7	4.2	0.0	7.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.2	8.7	0.0	0.2	0.0	0.0	1.7	0.2	0.5	0.0	0.3	0.0	8.0	0.0	0.0	0.0	7.0	1.1	0.4	0.5	1.0	0.4	2.5	0.5	1.4	0.1	27.9	1.1
F7		ENSG00000057593	"Coagulation factor VII"	P08709	13	113105788-113120681	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	39	"liver: 68.0"	"Group enriched"	"Detected in some"	9	"CACO-2: 16.2;Hep G2: 10.1"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 41.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"gdT-cell: 1.7;MAIT T-cell: 1.2;memory CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004826			Approved	Mitochondria	"Secreted to blood"	3600000	1500000000	Mitochondria		"HPA004826: AB_10602805"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.50e-3)"	"unprognostic (3.81e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.36e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	68.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.1
F8	"DXS1253E, F8C, FVIII, HEMA"	ENSG00000185010	"Coagulation factor VIII"	P00451	X	154835788-155026940	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"		"Disease mutation, FDA approved drug targets, Hemophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB018777	Enhanced				"Secreted to blood"		6400000			"CAB018777: AB_640320"	"unprognostic (2.09e-1)"	"unprognostic (5.66e-4)"	"unprognostic (4.94e-2)"	"unprognostic (8.32e-5)"	"unprognostic (1.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.44e-2)"	48.9	9.4	6.8	3.1	7.2	1.5	32.2	1.5	8.6	11.9	10.3	2.2	6.1	2.3	11.1	8.5	18.4	5.4	4.4	38.0	4.9	4.4	17.1	31.3	24.4	25.6	5.6	1.2	18.8	7.2	6.0	14.0	2.8	5.1	20.5	3.5	8.8	4.0	7.1	30.3	2.0	4.3	12.8	3.3	39.0	3.2	17.2	1.8	1.1	15.8	15.0	3.0	17.5	20.2	2.3	3.0	5.2	3.3	4.0	12.9	2.7	4.7	3.9	0.8	1.7	6.0	9.4	0.2	2.6	1.6	1.8	3.1	0.1	5.7	10.2	7.2	2.6	0.5	0.9	0.9	1.6	4.1	1.5	2.1	2.0	0.0	2.8	1.6	4.9	6.7	0.5	1.6	2.2	1.1	0.8	7.9	8.9	2.3	1.4	1.5	1.2	3.9	1.1	1.3	1.4	1.6	1.1	3.1	2.4	6.2	0.6	3.2	1.4	4.2	1.1	9.3	4.7	14.7	2.7	4.6	3.8	4.9	8.6	10.6	4.9	3.7	3.3	0.5	6.5	2.8	12.9	2.3	3.9	6.8	3.0	1.6	2.0	5.1	5.2	4.0	2.6	0.4	5.2	2.7	6.8	7.2	1.5	8.6	4.9	4.4	5.6	1.2	5.1	1.8
F9	FIX	ENSG00000101981	"Coagulation factor IX"	P00740	X	139530758-139563458	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets, Hemophilia, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2334	"liver: 233.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.7;RH-30: 1.9;SiHa: 1.5;U-698: 1.1"	"Cancer enriched"	"Detected in single"	1354	"liver cancer: 67.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"		11000000000										"prognostic favourable (6.69e-4)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	233.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in some"	7	"CACO-2: 25.6;Hep G2: 81.3"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol			32000000	"Nucleoplasm, Cytosol"		"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	25.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	81.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.0	1.4	7.5	0.0	0.1	0.8	5.6	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			46000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.4	2.4	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.1	0.4	3.8	0.2	0.5	0.3	0.2	3.2	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.3	0.1	0.9	0.4	0.4	1.4	0.1	0.7	0.2	0.6	0.3	0.2	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FABP3	"FABP11, H-FABP, MDGI, O-FABP"	ENSG00000121769	"Fatty acid binding protein 3"	P05413	1	31365625-31376850	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 420.9;skeletal muscle: 129.4"	"Cell line enriched"	"Detected in some"	5	"ASC TERT1: 117.9"	"Cancer enhanced"	"Detected in all"		"renal cancer: 92.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							"CAB017830, HPA055754"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Focal adhesion sites"			4400000	"Focal adhesion sites"	"Golgi apparatus, Plasma membrane"	"CAB017830: , HPA055754: "	"unprognostic (2.07e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.54e-7)"	"unprognostic (5.80e-3)"	"unprognostic (3.45e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.76e-3)"	2.3	5.2	8.1	0.7	6.0	0.5	22.7	1.4	14.6	3.9	1.3	0.8	3.4	0.7	6.8	5.3	3.1	2.8	1.1	420.9	11.0	5.3	21.3	1.9	4.3	1.3	9.8	6.0	2.2	0.4	0.3	0.7	1.1	13.7	5.0	1.5	3.0	4.4	14.0	129.4	0.9	0.6	13.0	3.4	3.9	3.6	2.0	1.3	0.1	1.7	31.6	2.2	2.5	2.5	1.4	0.5	0.0	0.9	0.2	0.9	0.6	0.1	0.0	3.2	0.2	22.6	117.9	1.1	0.9	8.7	0.1	3.1	0.2	0.8	0.2	12.5	2.4	0.3	0.9	0.0	0.1	0.1	0.5	0.3	1.1	2.3	1.5	0.2	0.0	10.4	0.0	2.3	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.2	6.0	0.4	0.1	1.2	0.0	2.8	0.0	0.3	0.0	0.5	0.0	13.5	0.1	1.4	0.3	0.2	0.1	2.1	0.1	0.1	0.4	0.1	0.5	0.1	0.2	0.0	0.4	0.0	0.9	0.9	0.6	0.2	0.5	0.5	0.5	1.4	0.0	0.9	0.0	0.2	0.1	0.4	0.6	0.6	8.1	6.0	1.4	13.3	11.0	5.3	9.8	6.0	13.7	1.3
FABP4	"A-FABP, aP2"	ENSG00000170323	"Fatty acid binding protein 4"	P15090	8	81478419-81483263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"adipose tissue: 492.7;breast: 545.8"	"Group enriched"	"Detected in some"	325	"ASC diff: 275.5;RT4: 136.3"	"Group enriched"	"Detected in all"	7	"breast cancer: 42.1;cervical cancer: 141.7;head and neck cancer: 133.8;urothelial cancer: 65.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002188, CAB024961"	Enhanced						30000000			"CAB024961: , HPA002188: AB_1078822"	"unprognostic (4.81e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.70e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.39e-1)"	492.7	3.5	0.3	16.1	0.3	0.1	545.8	0.2	0.2	0.9	42.2	0.0	1.8	0.2	0.6	2.9	4.8	1.0	7.6	15.6	0.3	0.3	1.2	0.4	9.3	4.7	0.3	0.0	0.7	1.3	2.2	0.3	15.9	0.3	7.7	2.9	0.1	7.6	1.7	13.0	5.5	4.5	3.3	0.3	0.7	2.2	6.1	0.0	0.7	7.4	7.3	0.1	15.4	60.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	275.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	136.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.3	0.3	0.3	0.0	0.3	0.0
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 92.9;MOLT-4: 90.8"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: "	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.7	16.5	10.1	0.0	48.4	4.5	0.0	11.8	0.6	9.2	11.7	0.1	7.9	92.9	6.8	2.9	5.4	24.6	18.9	7.9	47.2	53.4	33.5	11.8	25.0	4.3	32.0	8.7	3.5	38.9	11.4	23.5	53.0	9.6	10.1	5.5	5.6	90.8	16.4	13.4	64.3	40.5	0.0	9.8	14.8	71.8	42.0	15.9	5.7	1.9	4.4	0.0	16.5	7.5	0.0	26.3	0.1	0.1	12.5	4.9	66.2	4.2	30.7	14.8	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6
FAF1	"CGI-03, hFAF1, HFAF1s, UBXD12, UBXN3A"	ENSG00000185104	"Fas associated factor 1"	Q9UNN5	1	50437028-50960263	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018253, CAB072814"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB072814: , HPA018253: AB_1848351"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (1.87e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-3)"	"unprognostic (6.42e-3)"	16.0	13.6	11.6	18.0	13.4	17.4	16.7	20.0	16.3	14.1	14.6	19.1	14.5	12.2	17.2	12.9	16.9	13.3	12.2	22.3	11.1	10.8	13.2	14.7	13.3	14.9	16.4	13.3	17.0	21.3	22.8	21.5	12.0	13.1	13.9	13.0	12.5	18.0	17.3	58.4	19.0	15.8	17.3	13.1	10.6	14.5	29.7	15.7	29.6	15.6	19.6	17.8	19.4	14.0	5.6	5.4	7.3	5.0	6.1	9.1	2.4	14.3	10.6	9.2	15.6	9.2	8.8	13.6	14.0	12.7	21.8	19.9	11.8	10.3	23.2	10.4	11.9	10.7	14.8	13.0	18.7	15.4	13.3	19.3	14.1	12.2	15.0	20.7	11.5	8.1	11.8	22.9	28.2	11.7	22.4	0.0	11.1	5.7	21.4	16.5	12.2	7.6	20.1	20.4	0.0	21.9	12.9	0.1	11.5	12.7	26.0	21.3	8.1	24.8	7.1	12.3	15.1	15.1	0.1	18.2	19.0	27.0	0.0	30.2	14.1	1.4	3.4	7.3	6.6	4.1	8.7	4.0	5.9	6.4	5.4	5.6	7.0	4.7	1.2	6.1	5.0	4.5	9.1	2.4	11.6	13.4	20.0	16.3	11.1	10.8	16.4	13.3	13.1	15.7
FAH		ENSG00000103876	"Fumarylacetoacetate hydrolase"	P16930	15	80152490-80186946	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 109.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041370, HPA044093"	Enhanced		Approved	Cytosol			230000000	Cytosol		"HPA041370: AB_2677438, HPA044093: AB_2678806"	"unprognostic (3.15e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.19e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.93e-1)"	"unprognostic (8.98e-2)"	32.1	17.8	4.6	6.1	3.6	4.7	22.8	2.3	3.3	4.7	8.6	3.1	8.3	4.1	5.1	14.8	4.4	6.8	7.1	6.8	4.1	2.8	18.9	109.4	7.9	6.2	4.0	2.1	7.2	6.5	4.8	4.4	2.3	3.5	4.9	3.4	2.4	5.3	5.4	7.7	2.4	7.6	4.4	5.9	6.0	3.3	9.7	3.0	2.3	4.2	4.9	3.9	4.1	6.1	0.1	16.0	16.9	11.7	3.6	5.8	6.1	4.4	7.5	3.1	3.8	14.5	14.8	7.6	5.7	13.1	6.0	5.2	4.5	8.2	0.0	9.4	12.0	6.6	11.0	13.6	5.9	2.8	6.2	38.1	4.4	23.3	75.2	18.0	21.1	25.6	8.5	5.2	9.4	8.4	15.9	8.1	11.3	6.7	4.9	9.0	2.2	8.6	2.7	4.4	28.5	17.5	5.4	0.1	1.9	6.4	17.7	17.8	13.5	12.3	29.3	11.1	7.0	5.9	9.6	7.4	15.2	3.0	23.1	42.2	6.2	16.9	11.7	1.9	5.8	4.9	1.5	0.1	1.6	3.9	16.0	0.0	2.0	1.8	0.7	3.6	4.8	1.2	1.5	6.1	4.6	3.6	2.3	3.3	4.1	2.8	4.0	2.1	3.5	3.0
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451722-93566107	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol				Cytosol		"HPA019734: AB_1848369, HPA055800: "	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favourable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	25.7	35.1	23.3	28.6	19.1	15.7	23.0	22.1	21.8	26.1	27.0	14.9	32.2	21.3	33.2	17.2	26.0	24.2	24.1	22.1	20.5	11.0	21.2	33.2	25.7	26.4	18.4	12.6	25.5	34.4	40.6	16.8	24.6	20.0	17.4	26.0	15.9	27.7	22.4	71.5	17.6	23.6	23.3	17.7	21.7	25.3	7.5	17.7	19.5	19.8	23.8	17.6	46.5	33.1	4.7	6.6	15.2	9.2	4.2	7.5	3.5	48.3	39.7	9.0	25.9	27.1	34.0	28.3	34.0	30.1	26.2	19.3	12.8	30.1	31.6	19.5	42.9	52.3	24.0	39.8	20.4	31.4	17.5	17.2	35.5	20.3	30.4	29.2	23.6	33.0	24.8	29.7	47.6	37.3	19.7	26.5	28.3	54.2	28.6	16.6	11.5	37.2	16.7	24.1	26.4	31.8	29.2	24.2	14.9	38.4	46.8	23.2	25.4	19.2	38.5	28.5	20.5	34.8	37.1	21.0	20.5	12.2	30.8	26.4	25.2	3.0	7.1	5.0	5.4	8.1	5.1	4.7	5.2	5.6	6.6	4.1	3.6	5.1	15.2	4.2	9.2	4.6	7.5	3.5	23.3	19.1	22.1	21.8	20.5	11.0	18.4	12.6	20.0	17.7
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.5	30.3	24.0	44.0	40.9	24.3	15.1	8.0	24.5	0.0	17.5	49.7	36.9	4.4	32.6	8.0	4.2	4.7	3.7	37.5	8.3	30.7	0.1	10.8	33.2	20.5	40.0	14.1	36.6	7.1	0.2	46.1	26.1	0.2	6.2	5.3	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	35.9	25.6	15.6	16.8	1.2	47.3	25.0	10.9	31.4	36.3	0.4	0.8	0.0	70.5	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2
FAM13A	"ARHGAP48, FAM13A1, KIAA0914"	ENSG00000138640	"Family with sequence similarity 13 member A"	O94988	4	88725955-89111398	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 6.5;T-cells: 5.2"	"Low region specificity"	"Detected in all"							"HPA038108, HPA038109"	Uncertain		Approved	"Nucleoli,Cell Junctions,Cytosol"				"Cell Junctions, Cytosol"	Nucleoli	"HPA038108: , HPA038109: AB_10672619"	"unprognostic (1.14e-1)"	"unprognostic (1.53e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.71e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.90e-2)"	"unprognostic (7.44e-2)"	"prognostic favourable (4.28e-4)"	58.6	10.8	9.1	11.0	9.3	6.5	19.0	17.9	18.5	15.5	41.0	3.7	7.4	30.5	10.9	12.0	9.3	14.8	10.7	8.8	9.6	5.7	14.0	22.9	13.3	5.3	10.0	6.8	17.8	23.5	45.5	11.2	20.7	11.4	15.9	9.3	11.5	13.3	8.0	8.4	17.5	30.5	15.6	19.4	4.9	13.4	11.1	12.9	3.2	20.4	16.1	4.0	30.4	23.8	0.1	5.7	1.4	6.5	0.7	5.2	2.6	2.4	3.7	5.5	7.2	32.2	13.3	9.1	5.7	6.9	2.2	2.1	3.1	5.7	0.1	2.3	4.0	1.5	8.1	4.1	5.1	0.3	5.6	4.0	5.1	0.4	9.4	3.3	0.5	12.7	3.3	5.7	2.1	3.8	10.5	0.4	4.9	0.1	0.3	1.5	6.8	3.8	5.5	9.4	2.1	4.2	12.0	14.0	3.7	1.4	4.4	5.4	3.1	0.1	1.4	6.4	3.5	3.1	3.2	1.9	1.1	0.0	9.5	0.3	3.3	0.1	6.5	0.1	1.8	3.2	1.3	0.1	4.7	0.6	5.7	0.1	5.2	1.3	1.4	0.7	1.0	1.9	2.5	2.6	9.1	9.3	17.9	18.5	9.6	5.7	10.0	6.8	11.4	12.9
FAM206A	"C9orf6, CG-8, FLJ20457, Simiate"	ENSG00000119328	"Family with sequence similarity 206 member A"	Q9NX38	9	108934181-108950744	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035917, HPA035918"	Uncertain		Supported	"Nucleoplasm,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cytosol"	"Cytokinetic bridge"	"HPA035917: AB_2674860, HPA035918: AB_10670593"	"unprognostic (4.89e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.05e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	12.0	11.4	16.8	9.0	28.8	12.9	17.8	12.3	19.2	11.6	13.3	12.8	10.3	13.8	12.6	22.9	16.0	18.9	9.9	13.3	16.2	16.0	14.1	12.6	12.0	9.9	16.7	20.0	13.7	13.7	23.3	28.5	10.6	16.0	11.9	15.1	7.6	16.9	13.5	12.2	22.9	15.1	14.4	16.6	7.5	13.0	16.7	14.8	8.4	20.9	10.2	10.6	10.5	11.7	10.6	23.6	24.4	20.7	12.4	16.1	11.9	8.7	9.5	10.4	11.4	18.5	25.7	13.9	9.0	9.7	8.4	6.9	14.1	4.8	8.6	5.0	8.0	21.4	8.3	8.7	8.4	5.2	8.6	5.2	12.9	13.2	15.5	18.8	7.4	13.5	16.6	10.2	23.6	11.4	18.4	8.9	9.9	24.8	13.4	7.6	11.7	13.9	6.7	16.8	9.0	10.9	9.8	13.4	7.3	12.9	11.3	14.1	15.4	10.2	7.4	4.7	8.6	20.8	10.6	7.3	18.9	6.3	15.0	7.5	6.8	19.9	20.6	19.0	9.9	20.6	15.2	10.6	15.8	13.1	22.6	6.9	16.1	12.1	24.4	12.4	20.7	23.6	13.0	11.9	16.8	28.8	12.3	19.2	16.2	16.0	16.7	20.0	16.0	14.8
FAM20C	"DKFZp547D065, DMP4, G-CK, IMAGE:4942737"	ENSG00000177706	"FAM20C, golgi associated secretory pathway kinase"	Q8IXL6	7	192969-260745	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	Biomineralization	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 80.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 52.0;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019823			Approved	"Nucleoplasm,Golgi apparatus"	"Secreted in other tissues"		160000000	"Golgi apparatus"	Nucleoplasm	"HPA019823: AB_1848389"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.47e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (9.40e-6)"	"unprognostic (1.97e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.83e-3)"	27.5	10.2	10.8	19.3	16.6	3.3	25.6	7.4	14.9	8.3	20.1	13.5	15.1	12.9	9.5	6.9	11.1	9.7	15.0	15.0	8.8	7.2	31.8	31.6	12.7	5.1	16.9	5.6	11.8	14.8	2.6	9.2	7.2	15.8	15.0	4.6	8.8	80.6	11.8	20.4	6.8	16.5	17.0	17.0	6.9	20.0	5.9	14.8	0.4	9.6	8.4	4.4	20.5	17.5	0.0	0.6	0.0	1.6	0.2	0.0	0.0	13.8	6.7	0.2	9.6	12.3	20.4	0.0	12.3	20.9	6.7	5.4	0.8	8.5	0.0	6.8	18.4	12.0	1.0	0.6	1.7	2.9	0.6	0.0	3.2	3.7	9.3	0.0	0.9	52.0	1.5	0.2	0.7	4.6	0.0	0.1	1.7	1.8	0.0	0.7	6.5	0.4	1.5	0.4	0.0	5.0	0.0	3.2	0.1	12.8	0.0	1.9	9.1	6.3	12.9	8.4	4.2	7.1	3.7	0.0	0.0	0.0	32.0	0.8	23.8	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.8	16.6	7.4	14.9	8.8	7.2	16.9	5.6	15.8	14.8
FAM3C	"GS3876, ILEI"	ENSG00000196937	"Family with sequence similarity 3 member C"	Q92520	7	121348851-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 13.9;naive B-cell: 11.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"		59000000	"Golgi apparatus"		"HPA043376: , HPA050548: "	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	18.1	18.0	38.0	13.7	29.8	3.2	16.3	26.5	46.6	38.6	27.1	8.2	12.8	65.6	20.9	23.0	15.5	14.3	13.7	24.6	23.4	20.0	24.3	20.7	15.9	15.3	20.6	42.0	15.7	35.5	20.6	15.8	21.7	30.6	12.3	21.2	11.1	20.4	13.2	9.0	14.5	60.8	16.9	14.1	16.8	21.9	9.0	12.7	6.4	42.8	11.4	16.2	17.3	15.9	13.9	1.1	0.6	0.9	2.3	1.8	0.7	16.5	4.2	7.9	8.3	13.3	22.1	7.1	17.8	7.9	5.4	6.9	3.3	163.3	15.7	8.4	9.2	10.9	4.5	9.9	11.5	1.9	8.9	4.3	2.6	3.4	9.7	7.2	8.2	22.1	6.8	7.6	7.5	9.6	2.8	19.8	42.1	2.7	2.7	5.6	14.1	5.9	4.3	8.0	6.4	33.5	9.6	5.1	5.0	5.3	21.8	9.7	3.1	4.0	22.9	14.1	4.5	30.6	12.1	19.0	8.4	6.2	15.2	7.5	25.2	0.0	0.9	0.6	1.8	0.9	1.7	13.9	0.8	1.4	0.8	11.9	1.0	0.8	0.2	2.3	0.7	1.1	0.4	0.7	38.0	29.8	26.5	46.6	23.4	20.0	20.6	42.0	30.6	12.7
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849386-3851317	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.7;MCF7: 13.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067817	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"				"Nucleoplasm, Cytokinetic bridge"		"HPA067817: "	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favourable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	7.2	9.5	13.4	5.7	20.6	3.1	5.7	18.7	16.7	6.7	6.8	11.0	8.4	10.1	8.3	6.7	5.5	11.2	8.1	16.0	12.8	14.2	12.9	12.0	6.2	7.1	11.4	14.9	14.4	12.7	5.8	7.7	3.4	9.7	8.2	3.0	5.9	15.2	9.8	41.1	7.9	6.9	10.2	10.8	7.7	7.9	10.2	9.9	5.8	11.8	5.7	5.5	7.5	13.3	14.9	10.1	3.4	9.1	19.4	20.5	5.6	3.1	4.2	0.0	0.0	2.5	2.4	0.2	3.7	1.8	2.5	3.2	0.0	5.7	3.3	4.0	2.7	2.4	0.0	1.5	1.9	41.7	2.2	0.0	10.0	0.0	2.6	0.0	0.0	2.6	2.9	2.0	0.5	2.5	0.0	0.0	2.2	13.1	0.0	4.6	0.9	2.0	0.0	0.0	0.0	1.2	0.0	5.9	5.2	6.0	3.8	0.2	4.1	3.7	3.5	0.0	0.4	5.0	0.0	0.0	9.0	0.0	1.4	0.3	6.9	3.4	4.7	2.4	7.1	6.1	16.8	14.9	13.6	9.2	6.1	12.9	11.3	7.1	1.9	19.4	9.1	10.1	20.5	5.6	13.4	20.6	18.7	16.7	12.8	14.2	11.4	14.9	9.7	9.9
FAM83C	"C20orf128, dJ614O4.7"	ENSG00000125998	"Family with sequence similarity 83 member C"	Q9BQN1	20	35285731-35292401	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 24.0;lymphoid tissue: 12.1;skin 1: 29.7;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.0;Hep G2: 1.0;U-87 MG: 1.2"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB034227, HPA049978"	Uncertain									"CAB034227: AB_1562876, HPA049978: "		"unprognostic (3.76e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.02e-1)"		"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.11e-1)"	"unprognostic (9.17e-5)"	"unprognostic (9.89e-3)"	"unprognostic (1.71e-1)"		"unprognostic (5.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.5	0.0	0.1	29.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	22.3	12.1	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.4	0.2	0.3	2.0	0.0	0.5	0.0	0.0	0.4	0.2	0.5	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.8	0.1	1.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FAM98B	FLJ38426	ENSG00000171262	"Family with sequence similarity 98 member B"	Q52LJ0	15	38454127-38487710	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008320, HPA008502"	Enhanced		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA008320: AB_1848419, HPA008502: AB_1848420"	"unprognostic (1.05e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-1)"	15.6	15.6	20.4	16.9	21.0	10.8	17.0	27.3	24.4	13.7	19.3	12.7	8.7	12.5	17.9	12.9	14.9	14.5	11.0	15.8	20.1	19.6	17.7	10.1	10.6	16.3	18.6	20.3	15.6	10.6	27.5	18.3	20.1	17.7	16.5	15.7	9.3	11.2	14.2	16.2	11.5	12.8	17.4	21.0	13.8	12.0	13.0	14.0	27.4	15.7	12.3	16.8	14.8	13.4	3.5	2.5	3.7	1.1	3.8	6.6	0.7	13.5	7.2	35.8	18.3	6.6	12.2	17.5	17.4	12.8	17.2	17.4	16.0	6.6	9.4	19.3	14.4	14.4	21.5	17.8	24.3	9.6	11.7	27.6	16.7	12.3	9.6	26.1	16.0	11.2	11.2	15.4	17.9	17.7	19.8	11.8	16.4	6.1	22.0	14.0	19.2	10.1	23.5	19.3	7.8	14.9	17.9	22.1	22.7	19.2	12.3	8.4	15.1	16.2	14.7	19.7	24.0	13.0	19.5	22.0	19.7	34.1	10.7	17.3	20.4	3.7	0.9	2.5	5.3	0.8	4.6	2.8	5.4	4.4	1.1	3.5	6.6	5.1	0.8	3.8	1.1	2.5	3.3	0.7	20.4	21.0	27.3	24.4	20.1	19.6	18.6	20.3	17.7	14.0
FAM9B	TEX39B	ENSG00000177138	"Family with sequence similarity 9 member B"	Q8IZU0	X	9024232-9164639	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.4;liver: 3.7;testis: 11.4"	"Group enriched"	"Detected in some"	49	"U-266/70: 20.7;U-266/84: 22.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"									HPA035135	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA035135: AB_10669999"		"unprognostic (3.95e-1)"			"unprognostic (4.49e-1)"		"unprognostic (3.76e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"		"unprognostic (1.40e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.08e-10)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.54e-2)"		0.1	0.1	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.2			0.1	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.1	0.0		0.6	0.2	0.0	0.0	0.0		0.4	0.0		0.0	0.2	0.2	0.5	0.5	0.1	0.0	1.1	0.2	11.4			0.1		0.0	0.2	0.6	0.8	0.7	3.4	0.7	0.7	0.4	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.7	22.2	0.1	0.0	0.1	0.0	1.0	0.7	0.4	0.3	0.3	0.3	0.5	0.4	0.3	0.2	0.8	0.4	0.4	3.4	0.7	0.4	0.7	0.3	0.4										
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"Fanconi anemia complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 29.7"	"Cell line enhanced"	"Detected in all"		"RH-30: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 10.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB017793: , HPA030771: "	"unprognostic (1.48e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.26e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.00e-3)"	"unprognostic (3.19e-2)"	"prognostic favourable (6.03e-6)"	"unprognostic (2.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.71e-2)"	4.9	2.7	4.3	8.6	7.0	3.6	4.6	29.7	7.7	4.6	6.4	4.9	5.1	7.1	6.3	4.1	4.5	3.6	5.2	3.2	4.0	2.7	10.0	25.7	6.7	3.7	7.3	1.6	3.3	5.4	2.9	12.1	4.3	6.7	4.4	6.1	4.0	4.0	4.2	4.5	7.7	8.1	2.9	6.4	3.4	4.4	19.6	7.3	7.9	4.3	3.2	6.0	3.5	4.0	1.0	1.3	10.4	1.7	0.3	1.5	0.7	13.4	9.1	12.0	10.5	1.2	3.2	7.6	5.9	3.8	9.4	8.7	10.4	5.7	7.7	4.1	4.3	16.5	12.2	5.1	5.1	7.3	5.7	6.0	10.2	5.3	2.0	6.0	6.8	2.7	2.1	7.5	3.3	5.2	9.0	3.4	6.7	9.5	5.6	3.5	5.8	5.2	12.1	31.2	3.6	3.9	3.5	17.5	9.3	11.1	4.0	3.4	4.1	5.1	2.5	8.3	12.0	9.0	8.3	3.5	6.5	4.0	4.4	5.5	9.7	10.4	0.4	0.0	1.3	0.8	1.3	1.0	0.7	1.5	0.4	1.0	1.2	1.0	0.1	0.3	1.7	1.3	1.3	0.7	4.3	7.0	29.7	7.7	4.0	2.7	7.3	1.6	6.7	7.3
FANCE	"FACE, FAE"	ENSG00000112039	"Fanconi anemia complementation group E"	Q9HB96	6	35452361-35467103	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											CAB014893	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	7.2	2.1	2.6	7.0	3.8	7.2	8.5	5.5	3.9	6.7	4.1	4.8	1.5	3.1	6.1	4.7	10.0	4.9	5.4	4.1	2.8	3.2	2.4	1.7	5.5	5.4	2.4	1.8	10.8	6.9	2.7	4.0	21.3	3.9	6.7	4.1	3.7	5.3	4.0	20.8	16.8	4.7	4.1	3.7	4.6	3.8	12.1	3.5	3.0	5.9	10.1	8.5	6.7	15.0	2.4	1.8	1.0	1.0	2.6	3.6	0.9	5.6	2.8	7.7	17.3	5.6	10.0	20.7	6.8	5.8	8.9	7.8	6.6	3.2	19.3	4.5	4.2	4.2	8.6	5.8	8.6	6.5	7.5	13.5	6.7	4.3	3.0	7.9	5.5	6.3	17.5	10.9	16.8	5.2	12.4	7.2	7.4	6.6	3.7	9.9	3.2	4.4	10.9	7.3	7.2	2.0	6.2	7.7	7.2	3.9	5.5	6.1	5.4	25.8	3.2	10.8	9.0	6.9	10.6	4.8	16.6	7.0	2.4	14.6	10.1	0.7	1.0	1.0	2.2	0.6	3.0	0.7	2.8	3.6	0.6	2.4	1.9	1.9	0.6	2.6	0.6	1.8	1.7	0.9	2.6	3.8	5.5	3.9	2.8	3.2	2.4	1.8	3.9	3.5
FAP	DPPIV	ENSG00000078098	"Fibroblast activation protein alpha"	Q12884	2	162170684-162245151	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 30.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 47.0;ASC TERT1: 49.9;BJ hTERT+: 39.4;TIME: 19.7;U-138 MG: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059739	Uncertain				"Secreted to blood"		34000000			"HPA059739: "	"unprognostic (7.48e-3)"	"unprognostic (7.87e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.30e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.52e-1)"	"unprognostic (7.32e-11)"	"unprognostic (1.72e-3)"	"unprognostic (9.84e-3)"	"unprognostic (7.97e-2)"	"unprognostic (4.49e-3)"	19.8	0.7	2.6	3.2	1.2	0.0	7.5	0.6	3.7	17.6	4.5	0.4	4.0	0.1	30.0	13.7	4.1	5.1	14.9	5.2	3.1	0.9	2.0	0.9	4.7	0.8	2.6	1.2	4.1	2.3	0.5	1.0	17.0	1.9	4.1	1.5	2.4	5.3	3.9	8.1	2.9	1.4	17.9	2.2	0.9	1.7	9.8	3.4	0.0	3.5	9.0	0.8	12.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	49.9	0.0	19.2	39.4	4.0	6.1	0.0	0.0	0.0	0.1	7.3	0.0	0.0	1.2	1.9	0.0	0.0	0.0	0.2	0.0	4.7	0.0	0.0	16.1	0.3	6.7	1.2	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	2.0	0.0	0.0	19.7	40.1	0.8	9.7	0.0	0.0	0.0	0.0	9.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.2	0.6	3.7	3.1	0.9	2.6	1.2	1.9	3.4
FASLG	"APT1LG1, CD178, FasL, TNFSF6"	ENSG00000117560	"Fas ligand"	P48023	1	172659018-172666874	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Apoptosis, Transcription, Transcription regulation"	"Cytokine, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.6;lymphoid tissue: 13.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.0;LHCN-M2: 2.4;NB-4: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 25.6"	"Group enriched"	"Detected in many"	12	"NK-cells: 16.0;T-cells: 25.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054959	Approved				"Secreted to blood"	34930061667				"HPA054959: "	"unprognostic (1.09e-3)"	"unprognostic (1.41e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.54e-7)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.67e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.59e-6)"	"unprognostic (3.49e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.82e-3)"	0.9	1.1	0.5	1.9	0.7	3.6	1.8	0.5	0.8	0.7	2.6	0.6	0.0	3.0	3.9	1.2	1.0	0.8	1.6	1.2	0.5	0.5	1.2	2.2	6.8	7.7	1.4	0.0	1.5	0.6	0.0	0.7	2.4	0.6	4.7	1.2	2.8	1.9	0.3	0.4	0.5	3.8	1.9	1.7	13.4	2.1	0.4	0.0	1.2	1.1	0.0	10.1	1.4	0.9	0.0	0.0	1.6	0.0	16.0	25.6	5.5	0.0	0.0	0.3	0.1	1.0	0.0	0.5	0.2	0.0	0.0	0.1	0.0	0.5	0.5	0.1	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.4	0.7	0.0	0.2	0.6	2.4	0.0	0.0	1.2	0.4	0.0	0.0	0.0	0.1	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.3	0.7	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	25.6	0.0	15.8	0.0	5.4	13.7	0.0	0.0	1.1	11.7	0.8	16.0	0.0	0.0	0.1	5.5	0.5	0.7	0.5	0.8	0.5	0.5	1.4	0.0	0.6	0.0
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 152.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavourable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.1	24.3	11.3	7.8	18.3	12.4	24.2	4.6	6.0	4.9	9.0	25.4	15.8	7.7	3.8	3.5	19.4	10.9	21.3	0.9	3.6	47.4	16.0	18.2	33.9	5.2	8.6	2.4	11.9	5.6	12.5	2.9	5.5	24.1	6.9	1.7	40.1	9.4	13.7	21.9	14.2	8.3	6.4	15.3	5.5	29.7	28.1	15.6	6.8	152.8	12.4	27.2	16.5	9.6	7.2	14.8	5.9	11.0	9.3	2.0	8.0	4.3	9.4	10.6	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8
FAT2	"CDHF8, CDHR9, HFAT2, MEGF1"	ENSG00000086570	"FAT atypical cadherin 2"	Q9NYQ8	5	151504093-151568944	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 61.0;skin 1: 35.1"	"Group enriched"	"Detected in some"	9	"BEWO: 16.9;EFO-21: 10.1;HaCaT: 24.4;HBEC3-KT: 11.1;hTCEpi: 33.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 13.9;head and neck cancer: 21.4;lung cancer: 6.1;urothelial cancer: 5.6"	"Region enriched"	"Detected in some"	34	"cerebellum: 61.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"cerebellum: 35.9"	"Region enriched"	"Detected in single"	67	"cerebellum: 442.8"	CAB033680	Enhanced									"CAB033680: AB_2100956"	"unprognostic (8.06e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.43e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-7)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.77e-2)"	"unprognostic (3.64e-3)"	0.4	0.0	0.4	0.4	1.7	0.0	2.2	61.0	0.4	2.4	0.4	0.4	0.4	0.0	0.4	1.0	11.8	0.5	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.4	0.0	0.4	0.4	0.9	0.9	0.0	0.4	3.8	3.2	0.4	35.1	0.4	0.4	0.4	0.4	0.0	2.7	0.4	0.4	0.4	0.4	1.9	1.0	4.9	0.2	0.6	0.1	0.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	24.4	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.9	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	1.7	61.0	0.4	0.4	0.0	0.4	0.4	0.9	0.4
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: "	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.1	51.5	45.5	72.1	44.6	66.6	62.4	44.6	43.5	62.6	39.7	58.2	78.5	93.1	121.2	38.4	69.1	42.2	59.5	26.1	68.3	64.6	75.1	54.1	79.9	82.0	89.0	82.8	82.1	99.1	53.7	73.2	48.2	70.0	110.4	33.1	97.7	102.7	179.6	125.2	85.8	100.0	36.4	182.7	57.6	44.2	63.4	63.6	34.7	100.3	139.4	89.7	123.4	45.6	56.6	65.3	87.3	71.3	120.1	114.1	158.5	68.6	69.3	64.0	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2
FBL	"FIB, FLRN, Nop1, RNU3IP1"	ENSG00000105202	Fibrillarin	P22087	19	39834458-39846414	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001514, HPA049546"	Supported		Supported	"Nucleoli fibrillar center"			190000	"Nucleoli fibrillar center"		"CAB001514: AB_367009, HPA049546: "	"prognostic favourable (1.65e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.09e-3)"	"unprognostic (4.69e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavourable (4.52e-6)"	"unprognostic (4.04e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	29.1	20.3	16.3	50.3	15.9	40.0	43.2	15.1	18.0	46.3	42.7	13.9	24.7	20.2	34.7	24.7	50.0	43.2	38.0	32.6	13.7	11.8	20.3	25.0	29.7	82.7	15.5	13.6	70.5	67.8	19.9	16.7	24.8	11.8	37.7	34.2	17.9	27.3	40.1	47.7	49.0	25.4	36.2	16.5	42.5	24.5	28.3	14.5	56.3	35.4	52.9	58.2	43.8	54.5	26.9	23.9	1.8	13.0	26.5	33.7	20.9	37.9	79.2	33.3	37.3	13.4	23.3	20.1	21.9	19.3	37.8	36.1	45.5	22.3	86.8	20.3	18.7	15.4	48.8	46.5	47.3	15.6	61.3	34.9	28.8	41.7	17.4	81.3	27.0	18.7	17.0	30.6	64.3	29.2	54.7	36.0	21.1	50.0	70.4	35.0	32.7	23.7	39.1	33.8	43.2	20.7	44.0	45.0	26.3	21.0	33.1	13.2	16.9	29.6	15.6	18.1	28.7	24.9	50.1	25.0	26.1	58.5	18.2	53.2	16.5	0.5	13.0	1.8	23.2	10.8	33.2	26.1	24.5	22.7	23.1	26.9	33.7	31.8	1.0	26.5	11.4	23.9	17.1	20.9	16.3	15.9	15.1	18.0	13.7	11.8	15.5	13.6	11.8	14.5
FBLN1	FBLN	ENSG00000077942	"Fibulin 1"	P23142	22	45502238-45601135	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 287.9;vagina: 228.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 154.6;ASC TERT1: 68.6;BJ: 82.9;BJ hTERT+: 131.8;HSkMC: 113.1;RT4: 118.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"pons and medulla: 29.1"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 2.9;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001612, HPA001613, CAB004393, CAB068187"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		34000000000	"Endoplasmic reticulum"		"CAB004393: AB_671972, CAB068187: , HPA001612: AB_1078825, HPA001613: AB_1078824"	"unprognostic (6.62e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.64e-1)"	"prognostic favourable (9.28e-4)"	"unprognostic (1.26e-3)"	"unprognostic (4.82e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (6.30e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.02e-10)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-2)"	"unprognostic (3.64e-2)"	42.3	14.9	2.6	16.9	3.7	0.0	101.2	2.9	6.0	141.6	20.5	11.6	30.3	8.6	62.4	69.7	48.3	47.1	123.7	86.4	6.6	1.3	8.1	2.9	42.5	9.2	3.8	4.2	46.6	12.3	30.0	10.0	287.9	29.1	99.0	10.0	35.3	12.8	21.8	11.5	33.1	16.9	136.1	6.1	2.7	30.3	20.7	2.8	1.1	21.6	18.9	5.3	67.1	228.2	0.4	2.9	0.9	5.7	0.1	0.3	0.2	1.3	3.3	10.0	21.0	154.6	68.6	46.0	82.9	131.8	7.4	2.8	14.2	0.4	0.0	3.5	3.0	7.3	6.3	0.2	0.9	0.0	1.7	0.0	18.1	9.5	20.5	0.0	0.0	113.1	1.3	7.3	2.7	0.0	0.0	0.1	5.1	0.1	0.0	0.2	14.1	1.2	0.1	0.0	0.1	3.3	118.6	0.7	13.4	10.2	48.3	0.0	0.3	0.4	0.6	1.4	9.2	38.1	0.0	0.1	0.0	0.1	0.1	0.0	3.5	0.9	0.1	0.0	0.2	0.7	0.2	0.1	0.2	0.1	1.2	0.4	0.3	0.2	0.6	0.1	5.7	2.9	0.2	0.2	2.6	3.7	2.9	6.0	6.6	1.3	3.8	4.2	29.1	2.8
FBLN2		ENSG00000163520	"Fibulin 2"	P98095	3	13549131-13638422	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 80.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 73.8;fHDF/TERT166: 48.4;HMC-1: 58.9;HSkMC: 42.8;U-2197: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.2;naive CD8 T-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	7	"olfactory region: 15.4"	"Low region specificity"	"Detected in all"			"HPA001934, CAB018622"	Enhanced		Supported	"Plasma membrane"	"Secreted to extracellular matrix"		28000000	"Plasma membrane"		"CAB018622: AB_2294196, HPA001934: AB_1078827"	"unprognostic (1.19e-1)"	"unprognostic (7.76e-2)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (2.82e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (3.17e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	58.5	2.7	1.8	8.0	2.2	0.1	34.3	0.8	3.2	21.4	11.5	1.3	9.5	2.1	11.6	23.6	32.7	7.2	21.9	80.5	1.6	1.7	2.1	1.2	7.8	5.1	2.4	1.4	6.3	3.2	1.1	0.9	31.8	2.3	22.1	4.2	7.9	10.8	3.3	20.1	20.8	6.1	42.9	1.5	2.3	6.9	41.8	0.5	4.8	20.7	23.8	8.5	34.2	36.3	2.2	9.2	0.0	0.0	0.4	5.4	1.1	0.0	0.2	9.5	0.0	73.8	10.0	4.5	23.0	18.4	23.1	15.3	1.4	0.0	0.0	1.1	48.4	0.0	0.0	0.1	4.3	0.0	0.0	18.2	0.4	0.0	5.0	0.0	58.9	42.8	0.3	3.6	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.1	2.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.4	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.7	0.0	0.3	9.2	2.2	0.0	5.4	0.0	0.4	0.0	0.7	0.0	1.1	1.8	2.2	0.8	3.2	1.6	1.7	2.4	1.4	2.3	0.5
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869412-91947987	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 85.9;ASC TERT1: 44.9;BJ: 40.2;BJ hTERT+: 37.7;fHDF/TERT166: 71.8;HSkMC: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Group enriched"	"Detected in many"	19	"granulocytes: 8.5;T-cells: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Supported	"Plasma membrane"	"Secreted to extracellular matrix"		4500000	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favourable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	48.3	23.5	3.4	11.5	9.5	1.8	49.5	2.2	5.6	52.4	26.6	5.3	20.3	6.0	51.7	36.0	22.6	32.2	97.4	54.5	2.5	2.6	38.9	12.1	50.5	8.6	7.0	4.1	36.5	14.6	7.6	3.9	21.0	9.4	41.2	6.4	40.6	18.3	23.8	24.7	17.5	12.8	51.8	6.8	48.2	18.8	43.9	2.1	1.2	30.3	15.1	9.4	56.4	51.1	0.2	0.1	8.5	0.3	0.0	2.8	0.6	0.0	0.2	0.0	0.0	85.9	44.9	4.5	40.2	37.7	1.1	0.8	0.7	0.0	0.0	0.8	71.8	0.0	1.8	0.1	0.2	0.0	0.4	0.0	0.8	0.0	14.3	0.0	0.0	41.2	0.0	0.7	2.6	1.8	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.2	0.0	0.0	0.0	2.2	0.1	0.5	0.5	0.0	0.3	0.5	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	3.5	1.2	0.2	0.7	0.1	0.5	0.1	0.0	0.2	1.7	2.8	4.1	0.0	0.3	0.1	0.1	0.6	3.4	9.5	2.2	5.6	2.5	2.6	7.0	4.1	9.4	2.1
FBN1	"FBN, MASS, MFS1, OCTD, SGS, WMS"	ENSG00000166147	"Fibrillin 1"	P35555	15	48408306-48645849	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Heparin-binding, Hormone"	"Aortic aneurysm, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 69.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 36.6;ASC TERT1: 79.0;fHDF/TERT166: 67.8;HSkMC: 42.7;U-138 MG: 34.8;U-2197: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002670, HPA017759, HPA021057, CAB058696, CAB068188"	Enhanced		Approved	Cytosol	"Secreted to blood"		540000000	Cytosol		"CAB002670: , CAB058696: , CAB068188: , HPA017759: AB_1848584, HPA021057: AB_1848586"	"unprognostic (3.97e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.40e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (7.44e-5)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.69e-3)"	"prognostic unfavourable (5.11e-4)"	34.2	5.4	2.1	7.8	2.7	1.8	10.9	1.0	2.8	24.6	11.1	3.5	10.7	2.2	18.4	25.6	22.1	12.1	15.5	24.3	2.5	2.3	2.9	1.9	10.7	5.8	2.8	2.6	20.4	2.5	2.6	3.3	69.8	3.1	11.8	6.9	13.4	5.7	7.8	15.4	6.6	6.9	21.5	3.8	11.3	7.2	13.6	1.6	1.9	17.9	16.3	4.9	22.8	11.2	0.8	0.8	1.8	0.6	1.1	0.6	0.2	0.0	0.8	3.3	3.7	36.6	79.0	0.0	28.5	10.3	8.5	5.4	0.0	0.0	0.0	1.3	67.8	0.1	0.6	0.1	7.7	3.2	0.2	0.3	14.5	0.0	20.6	0.1	0.0	42.7	0.0	22.5	2.6	9.1	0.0	0.0	9.1	0.0	0.2	0.0	0.6	1.1	0.0	2.8	0.0	1.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.2	17.2	34.8	1.0	50.5	6.0	0.2	0.1	0.0	23.3	0.0	2.2	1.1	0.5	0.7	0.5	0.3	0.4	0.5	0.4	0.4	0.2	0.8	0.5	0.6	1.8	1.1	0.6	0.8	0.3	0.2	2.1	2.7	1.0	2.8	2.5	2.3	2.8	2.6	3.1	1.6
FBN2	"CCA, DA9"	ENSG00000138829	"Fibrillin 2"	P35556	5	128257909-128659185	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"placenta: 175.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 37.3;HSkMC: 26.6;hTERT-HME1: 58.9;HUVEC TERT2: 33.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;non-classical monocyte: 5.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.6"	"Low region specificity"	"Detected in some"			"HPA012853, CAB026401"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"		4600000	Cytosol	Nucleoplasm	"CAB026401: , HPA012853: AB_1848588"	"unprognostic (2.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.79e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.69e-2)"	"unprognostic (8.60e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (7.41e-5)"	0.3	7.9	0.3	1.0	0.3	1.6	0.1	0.2	0.3	1.5	0.7	0.4	1.0	0.2	2.9	0.6	1.1	0.6	0.2	6.7	0.2	0.5	0.2	0.2	0.2	1.3	0.2	0.4	0.9	0.1	0.0	1.3	175.9	0.4	1.0	0.8	6.2	0.4	0.9	0.2	0.3	0.5	0.8	0.4	0.6	0.5	4.6	0.2	0.3	0.9	0.4	0.7	0.4	1.2	0.0	1.1	0.6	5.0	0.0	0.0	0.4	0.0	4.4	16.1	0.0	2.6	4.6	3.3	17.6	0.0	15.6	11.7	0.0	0.0	0.0	0.0	23.5	2.6	10.4	2.6	14.7	0.0	4.2	0.0	7.4	0.0	37.3	2.3	0.0	26.6	1.4	6.6	58.9	33.1	0.0	0.0	9.6	0.0	0.0	0.8	6.9	5.3	5.1	5.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	4.9	0.0	6.3	12.0	17.9	0.0	0.0	0.0	0.0	1.8	0.0	6.6	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	5.0	0.0	0.0	0.4	0.3	0.3	0.2	0.3	0.2	0.5	0.2	0.4	0.4	0.2
FBP1	FBP	ENSG00000165140	"Fructose-bisphosphatase 1"	P09467	9	94603133-94640249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 248.1;lung: 87.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 20.1;MCF7: 62.8;RT4: 41.2;SK-BR-3: 12.0;U-698: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"eosinophil: 73.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005857, HPA012513, CAB033869"	Enhanced		Uncertain	Mitochondria			23000000	Mitochondria		"CAB033869: AB_1121520, HPA005857: AB_1848445, HPA012513: AB_1848446"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (1.79e-4)"	"unprognostic (6.94e-3)"	"unprognostic (4.52e-2)"	"unprognostic (7.79e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (6.86e-7)"	"unprognostic (6.91e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.64e-5)"	19.3	5.8	0.6	2.3	0.9	1.1	7.0	0.4	0.8	2.2	48.8	0.7	17.6	40.7	0.6	2.5	0.7	0.9	9.7	1.3	0.8	0.5	34.6	248.1	87.8	8.9	0.9	0.7	1.0	8.1	17.1	1.9	1.0	1.0	6.4	3.0	1.5	9.1	17.7	0.5	1.7	60.4	3.1	1.2	2.8	10.4	1.0	0.8	0.5	4.3	1.0	1.1	22.4	9.6	0.6	17.1	73.5	30.7	2.8	3.3	5.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	20.1	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	62.8	0.0	1.1	0.2	2.2	0.0	0.2	0.4	0.0	41.2	0.2	1.2	0.1	12.0	0.0	7.2	1.7	0.0	0.0	0.2	0.2	0.0	0.0	0.1	29.9	0.0	0.3	0.0	10.6	13.0	73.5	1.5	30.7	2.3	0.6	0.9	0.9	17.1	0.6	3.3	1.6	2.3	2.8	16.3	6.1	0.4	5.2	0.6	0.9	0.4	0.8	0.8	0.5	0.9	0.7	1.0	0.8
FBP2		ENSG00000130957	"Fructose-bisphosphatase 2"	O00757	9	94558720-94593793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Gluconeogenesis"	"Allosteric enzyme, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 33.7;skeletal muscle: 134.7;tongue: 45.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.2;CACO-2: 3.7;HMC-1: 4.0;MCF7: 5.3;PC-3: 3.7;SiHa: 5.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	36	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA012513, HPA055286, HPA077371"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA012513: AB_1848446, HPA055286: , HPA077371: "	"unprognostic (3.88e-2)"	"unprognostic (3.54e-4)"	"unprognostic (2.38e-1)"	"unprognostic (6.03e-2)"		"unprognostic (2.21e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.40e-4)"	"unprognostic (3.95e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.39e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.48e-4)"	2.0	0.4	0.1	0.0	0.1	0.0	0.2	0.1	0.9	0.1	0.1	3.8	4.4	1.0	0.1	1.0	1.6	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	1.2	4.1	0.1	0.0	33.7	0.2	0.0	5.0	1.4	1.8	134.7	0.1	0.1	0.1	0.2	0.1	9.0	0.4	0.0	0.0	0.2	45.6	2.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.3	0.0	2.5	0.0	0.0	7.2	0.0	0.0	0.1	0.0	3.7	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.9	2.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	2.4	0.6	0.1	5.0	1.2	0.0	0.4	0.1	0.0	0.0	2.3	2.2	0.0	0.0	0.1	1.0	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.7	0.1	0.1	0.0	33.7	0.0
FBXL20	"Fbl2, Fbl20, MGC15482"	ENSG00000108306	"F-box and leucine rich repeat protein 20"	Q96IG2	17	39252644-39402523	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044748, HPA050397"	Uncertain		Supported	Microtubules				Microtubules		"HPA044748: , HPA050397: "	"unprognostic (7.21e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (9.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.90e-2)"	9.1	12.9	12.7	11.0	13.3	15.4	9.9	23.6	13.9	10.3	10.4	11.1	9.3	7.6	9.6	8.0	9.8	9.2	8.1	8.0	12.7	11.7	9.4	9.9	8.7	7.4	10.1	10.2	11.0	9.4	12.2	12.3	11.6	10.1	8.5	9.2	8.7	8.2	10.2	10.8	11.7	8.0	11.0	10.7	9.1	8.2	25.1	11.3	15.2	8.7	4.2	8.5	9.4	9.8	4.2	3.6	18.7	4.2	5.4	5.3	1.5	2.3	4.8	4.8	5.0	6.2	4.4	2.7	3.2	4.4	3.8	4.6	1.5	5.4	3.6	7.3	4.2	5.4	5.5	3.8	5.5	6.8	7.3	3.8	4.2	4.5	4.5	5.3	4.9	3.7	4.5	3.7	4.3	4.5	7.5	2.7	3.6	3.4	5.3	3.8	1.2	2.0	2.6	9.5	2.4	1.9	3.6	3.0	2.3	6.2	39.2	4.1	6.1	5.2	3.4	4.2	4.2	3.1	3.0	4.7	4.9	3.0	5.3	2.5	3.3	15.4	3.8	11.8	3.0	3.1	2.7	2.5	2.9	2.7	2.8	4.2	2.6	2.6	18.7	5.4	4.2	3.6	5.3	1.5	12.7	13.3	23.6	13.9	12.7	11.7	10.1	10.2	10.1	11.3
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500196-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA055464	Uncertain									"HPA055464: "	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.69e-4)"	"unprognostic (1.94e-3)"	13.8	23.3	11.5	6.2	13.6	0.8	10.6	4.0	11.9	16.5	12.1	24.2	9.4	3.0	28.1	12.9	11.9	11.8	10.2	18.4	13.2	4.7	4.5	3.1	7.3	3.3	14.1	9.3	26.8	2.0	1.8	4.1	8.1	11.1	11.9	6.8	12.3	4.4	24.0	3.1	3.9	5.0	28.9	10.1	5.5	8.8	5.7	16.8	0.0	6.6	5.7	3.1	12.2	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	10.1	14.6	8.4	6.4	0.0	8.6	10.5	6.2	6.5	0.0	0.0	0.0	0.0	13.2	0.0	5.0	3.2	6.2	0.0	0.7	0.0	0.0	0.0	3.3	0.0	0.0	7.6	0.0	5.0	0.4	14.3	0.0	3.8	4.6	0.0	0.0	0.0	3.4	1.6	0.0	7.1	0.0	0.0	0.0	2.9	10.0	0.0	3.0	9.1	0.0	0.0	14.0	13.0	2.6	7.3	3.8	0.0	0.0	0.0	7.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.6	4.0	11.9	13.2	4.7	14.1	9.3	11.1	16.8
FBXO11	"FBX11, UBR6"	ENSG00000138081	"F-box protein 11"	Q86XK2	2	47789316-47905793	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002690			Supported	Nucleoplasm				Nucleoplasm		"HPA002690: AB_1848448"	"unprognostic (1.18e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.20e-2)"	18.0	13.8	18.6	15.7	18.8	17.5	26.1	42.2	31.7	21.3	15.3	12.7	15.1	10.4	28.9	16.8	14.5	16.3	15.0	14.1	16.9	13.6	14.3	17.0	22.3	15.0	17.4	21.7	28.9	12.4	25.2	14.4	14.5	19.7	15.3	13.3	12.0	15.6	16.5	22.9	14.5	13.5	19.9	16.4	14.5	13.3	25.1	16.0	14.6	17.3	9.8	17.2	19.3	21.9	4.7	4.3	8.2	2.7	4.8	6.6	2.0	25.5	13.3	32.0	27.2	22.5	21.2	19.1	17.9	24.7	16.8	16.6	11.2	13.1	16.6	23.5	25.2	12.8	21.8	18.9	24.8	11.0	10.9	15.4	11.0	17.8	21.5	16.0	16.4	20.6	21.4	14.9	25.3	21.5	15.0	17.2	20.5	12.3	15.4	15.7	19.5	13.2	20.1	29.7	12.3	24.0	20.9	22.6	26.7	17.0	15.9	26.2	7.4	13.7	23.1	20.8	19.2	14.0	19.6	14.9	7.7	30.2	14.1	15.1	21.2	8.2	2.3	4.3	3.8	2.7	3.8	4.7	3.4	4.1	3.1	3.6	6.6	4.1	4.1	4.8	2.4	4.3	3.6	2.0	18.6	18.8	42.2	31.7	16.9	13.6	17.4	21.7	19.7	16.0
FBXO18	"FBH1, Fbx18, FLJ14590"	ENSG00000134452	"F-box protein, helicase, 18"	Q8NFZ0	10	5890203-5937594	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002844	Supported									"HPA002844: AB_1078829"	"unprognostic (3.14e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (7.73e-7)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.54e-2)"	21.3	30.6	21.0	22.4	28.2	18.8	32.7	23.0	21.8	23.5	21.9	18.1	26.3	21.7	30.6	21.2	23.8	28.7	22.8	35.1	21.0	13.4	20.4	23.2	22.5	24.2	19.4	18.0	27.5	26.2	23.3	24.5	23.6	22.5	23.9	22.1	23.1	21.0	24.8	23.6	26.2	23.4	27.5	13.5	29.7	22.4	27.1	20.1	36.8	22.8	14.9	23.3	23.8	33.8	6.1	6.1	4.8	3.2	7.2	9.2	2.5	14.4	15.8	14.9	16.3	34.4	22.8	13.4	16.8	11.6	16.7	18.8	18.7	13.3	13.6	11.1	24.4	21.7	20.1	17.9	15.2	14.7	14.8	13.0	12.5	15.9	23.7	6.4	12.7	28.5	17.4	21.1	9.4	28.2	22.9	14.4	17.6	22.0	15.5	9.5	6.8	9.0	17.2	7.1	22.6	16.3	11.8	8.5	12.8	17.2	15.7	23.3	16.0	13.1	17.6	10.7	12.0	28.2	12.9	14.8	11.6	7.6	14.4	9.5	7.4	0.0	3.2	4.8	3.2	2.5	2.1	4.9	3.3	4.1	3.0	6.1	4.0	2.9	2.1	7.2	1.9	6.1	9.2	2.5	21.0	28.2	23.0	21.8	21.0	13.4	19.4	18.0	22.5	20.1
FBXO28	"CENP-30, Fbx28, FLJ10766, KIAA0483"	ENSG00000143756	"F-box protein 28"	Q9NVF7	1	224114087-224162047	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003289			Supported	"Nucleoplasm,Focal adhesion sites"				Nucleoplasm	"Focal adhesion sites"	"HPA003289: "	"unprognostic (4.91e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.09e-2)"	"unprognostic (5.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.46e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.61e-1)"	17.4	13.1	16.4	14.9	19.7	12.1	19.6	22.5	21.6	18.7	15.9	15.0	13.1	13.3	16.2	13.3	22.2	14.1	15.1	15.0	15.3	15.6	21.4	26.6	14.0	14.9	15.9	13.6	18.7	13.4	25.7	16.2	15.8	20.2	16.5	17.1	11.9	16.6	14.9	24.6	32.3	14.4	15.7	15.6	16.1	13.7	11.9	15.5	19.4	15.7	13.1	16.1	17.5	20.0	10.3	10.0	14.7	8.9	10.9	11.0	5.7	14.0	6.2	9.7	10.4	10.2	11.8	16.0	14.2	11.7	9.7	9.2	8.6	11.1	6.8	14.8	13.0	12.4	14.3	13.8	16.7	9.6	16.0	8.6	7.9	6.2	12.7	16.2	11.4	11.4	16.7	14.0	25.5	16.0	14.0	9.8	17.3	4.6	8.4	8.2	23.2	13.4	9.0	13.9	12.8	18.2	9.4	15.8	17.0	14.8	22.8	15.8	12.0	16.3	18.3	12.0	9.1	15.0	26.8	10.6	12.5	10.6	14.9	7.9	23.3	8.9	8.7	14.7	7.8	8.1	10.1	10.3	8.2	9.6	10.0	10.2	8.3	9.1	5.3	10.9	8.9	4.7	11.0	5.7	16.4	19.7	22.5	21.6	15.3	15.6	15.9	13.6	20.2	15.5
FBXO3	"FBA, FBX3"	ENSG00000110429	"F-box protein 3"	Q9UK99	11	33740939-33774543	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002467			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA002467: "	"unprognostic (1.87e-1)"	"unprognostic (2.81e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.36e-2)"	"prognostic favourable (2.46e-9)"	"unprognostic (6.96e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-2)"	18.2	16.0	18.4	8.7	33.9	14.1	17.4	27.7	30.3	16.1	13.3	17.1	11.5	11.2	16.4	15.8	21.1	15.0	13.5	28.1	17.3	19.3	29.3	25.3	12.2	10.3	15.2	15.4	18.8	16.5	35.9	21.8	15.3	27.8	16.6	15.0	16.7	17.0	16.9	67.6	18.4	16.3	19.0	12.4	12.6	14.6	15.1	15.2	18.6	21.6	24.2	16.6	15.9	16.6	11.1	8.4	13.0	9.2	15.7	22.8	10.4	11.6	10.5	14.3	15.2	17.3	13.6	8.6	14.0	14.1	11.4	14.3	11.9	11.8	7.8	9.9	15.2	20.3	19.1	18.5	19.2	7.8	26.4	4.0	16.4	9.7	11.0	9.2	9.4	13.8	18.8	7.8	12.5	15.0	13.6	15.7	12.8	7.9	6.8	5.4	7.2	16.1	5.2	32.0	11.0	16.5	14.8	20.3	11.2	19.8	13.7	10.3	19.7	7.1	13.7	14.1	12.4	19.9	11.7	8.8	11.4	13.3	12.6	7.2	13.9	13.0	7.8	11.1	15.1	7.5	16.6	10.9	17.9	17.0	8.4	11.1	22.8	15.9	8.4	15.7	9.2	4.3	21.4	10.4	18.4	33.9	27.7	30.3	17.3	19.3	15.2	15.4	27.8	15.2
FBXO33	Fbx33	ENSG00000165355	"F-box protein 33"	Q7Z6M2	14	39397669-39432500	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 49.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046657	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA046657: AB_10960398"	"unprognostic (8.84e-3)"	"unprognostic (6.72e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.19e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"prognostic favourable (4.58e-4)"	"unprognostic (9.61e-2)"	"unprognostic (4.54e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.58e-3)"	8.9	13.3	8.9	8.9	12.1	49.1	8.4	12.3	19.7	10.1	7.0	7.1	10.0	8.2	8.5	12.0	7.5	8.8	8.6	6.1	10.4	11.7	8.5	8.8	9.0	12.8	9.1	11.0	9.4	7.8	18.4	19.0	8.8	9.3	9.1	6.9	9.4	10.8	12.0	4.4	6.7	8.0	7.7	7.2	10.4	8.2	12.8	7.5	16.6	14.9	5.7	10.6	8.6	8.7	2.5	1.6	7.8	2.2	5.5	4.8	1.3	9.5	6.0	5.5	8.4	19.9	9.3	9.1	9.6	13.1	5.4	6.4	3.5	8.6	10.8	12.0	15.0	5.0	14.1	9.5	9.8	10.3	9.1	4.3	8.8	9.2	5.6	16.1	16.4	8.6	10.4	9.2	3.0	4.5	3.7	9.8	10.6	10.2	14.3	10.1	5.6	9.0	12.5	8.9	9.8	10.3	12.3	9.5	4.3	8.7	9.2	10.5	6.7	10.4	5.7	9.2	8.3	13.6	7.6	13.4	15.7	17.0	7.1	7.7	6.8	1.6	1.7	3.7	3.4	2.1	3.2	2.5	3.4	3.7	1.6	2.3	4.8	4.5	7.8	5.5	2.2	1.5	3.4	1.3	8.9	12.1	12.3	19.7	10.4	11.7	9.1	11.0	9.3	7.5
FBXO40	"Fbx40, KIAA1195"	ENSG00000163833	"F-box protein 40"	Q9UH90	3	121593119-121630295	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 48.3;skeletal muscle: 58.2;tongue: 38.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4;U-266/70: 3.0;U-266/84: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"pons and medulla: 1.8"	"Low region specificity"	"Detected in many"														"unprognostic (1.67e-2)"	"unprognostic (1.23e-4)"			"unprognostic (9.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-1)"		"unprognostic (4.30e-2)"	1.0	0.1	0.2	0.0	0.1	0.3	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	0.6	1.1	0.1	0.1	48.3	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.5	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	1.3	2.3	0.0	58.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.9	38.0	3.9	0.1	0.1	0.5	0.6	2.8	0.8	0.2	0.9	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.4	0.1	0.0	0.4	0.6	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.1	0.2	0.2	0.0	0.2	0.0	0.6	0.1	0.3	0.0	0.1	0.2	0.2	0.0	0.1	0.3	0.5	0.4	0.0	0.0	0.0	3.0	1.9	0.8	0.2	0.1	0.0	0.2	0.8	0.8	0.9	0.6	0.3	0.2	0.8	0.2	0.2	0.5	0.4	0.6	2.8	0.2	0.4	0.6	0.9	0.1	0.2	0.1	0.1	1.0	0.1	0.1	0.2	0.5	0.2	0.0
FBXW11	"BTRC2, BTRCP2, Fbw11, Fbw1b, FBXW1B, Hos, KIAA0696"	ENSG00000072803	"F-box and WD repeat domain containing 11"	Q9UKB1	5	171861549-172006873	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062578, HPA072204"	Approved		Approved	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA062578: , HPA072204: "	"unprognostic (4.04e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.69e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.87e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.14e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.76e-1)"	15.0	17.1	28.1	11.5	29.4	7.9	17.2	29.7	34.4	17.5	11.2	24.7	9.4	10.2	19.2	10.7	20.0	22.7	14.5	30.3	28.9	26.3	19.5	16.5	14.0	14.0	28.8	20.1	21.8	24.1	37.8	15.8	11.2	23.3	16.2	13.3	12.4	11.6	18.1	24.5	11.0	10.3	21.6	30.6	13.6	15.8	11.3	21.2	12.0	17.5	7.0	17.0	12.9	16.0	9.0	8.2	19.1	7.0	12.9	6.2	5.5	16.2	16.7	24.9	21.7	19.6	19.9	12.7	17.5	25.1	21.9	27.6	17.0	11.0	14.9	21.6	22.4	10.7	17.9	26.4	36.6	19.7	17.7	12.1	17.4	13.1	17.8	13.4	17.3	14.4	18.4	17.6	28.9	18.3	7.5	15.1	26.6	12.2	9.3	7.0	9.5	18.6	13.8	20.9	10.1	16.9	13.8	10.4	18.4	15.4	13.1	32.3	16.4	14.4	15.8	21.7	10.8	13.1	17.2	15.4	17.4	10.4	15.2	12.9	16.5	19.1	7.0	6.5	5.7	4.7	6.2	8.7	4.9	5.7	6.9	9.0	4.7	5.8	6.7	12.9	5.1	8.2	5.3	5.5	28.1	29.4	29.7	29.9	28.9	26.3	28.8	20.1	23.3	21.2
FBXW12	"Fbw12, FBXO35"	ENSG00000164049	"F-box and WD repeat domain containing 12"	Q6X9E4	3	48372219-48401259	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"pancreas: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HEK 293: 1.7;SH-SY5Y: 1.0;THP-1: 1.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA037491, HPA037492"	Uncertain									"HPA037491: , HPA037492: "	"unprognostic (5.38e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-3)"	"unprognostic (6.96e-3)"	"unprognostic (2.36e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.81e-3)"	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.9	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1		0.1	12.4	0.0	0.1	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.9	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.8	1.0	0.0	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.3	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"			55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: "	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.2	0.0	0.3	4.0	28.2	0.3	0.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.2	7.9	0.0	0.6	0.1	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.9	3.5	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2
FCGR3A	"CD16, CD16a, FCG3, FCGR3"	ENSG00000203747	"Fc fragment of IgG receptor IIIa"	P08637	1	161541759-161550737	"CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 223.6;lymphoid tissue: 60.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;SH-SY5Y: 1.3;U-2197: 1.1;U-266/70: 1.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 109.4;non-classical monocyte: 223.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 73.0;monocytes: 223.6"									"CAB032435, HPA055431"	Supported				"Secreted to blood"		2500000000			"CAB032435: AB_626925, HPA055431: "	"unprognostic (5.27e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.98e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (3.22e-6)"	"unprognostic (1.14e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.51e-2)"	11.9	9.7	7.5	20.5	12.4	4.4	4.1	1.6	7.0	1.9	2.1	5.5	0.8	0.8	1.1	2.4	1.0	2.4	5.1	6.4	6.3	7.3	2.6	22.5	43.2	8.0	12.7	1.9	1.4	2.9	1.8	3.9	14.6	6.8	2.6	2.3	2.2	2.7	1.3	1.3	0.3	1.2	14.3	25.7	60.8	1.3	1.2	8.0	1.4	1.8	1.3	1.3	6.3	2.3	0.1	11.7	73.0	223.6	7.9	33.9	35.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.5	0.5	0.0	0.8	0.5	0.4	0.0	0.0	0.5	1.3	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	1.7	0.0	0.4	0.0	0.0	0.0	0.3	1.6	0.5	33.9	109.4	0.3	0.1	0.3	13.2	11.7	0.0	0.2	12.2	73.0	7.9	223.6	0.2	0.1	35.8	7.5	12.4	1.6	7.0	6.3	7.3	12.7	1.9	6.8	8.0
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"IgG-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"														"Secreted to blood"						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134905890-134917963	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 318.5;bone marrow: 135.4"	"Group enriched"	"Detected in some"	7	"NB-4: 15.3;U-937: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 318.5;intermediate monocyte: 218.1"	"Lineage enhanced"	"Detected in many"		"monocytes: 318.5"									"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	1064333333	63000000			"CAB016760: , HPA000685: AB_1078840, HPA001295: AB_1078842"	"unprognostic (1.57e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.34e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.62e-3)"	"unprognostic (3.66e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.73e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.28e-1)"	6.6	0.9	0.6	35.2	0.7	135.4	2.2	0.4	1.0	1.8	2.0	0.4	0.0	0.1	1.6	7.8	1.0	3.6	2.9	7.6	0.5	0.6	2.3	4.6	24.9	23.5	2.3	0.1	3.5	1.6	0.0	0.7	9.2	0.9	1.6	1.0	3.0	1.7	0.3	2.7	0.7	1.3	8.1	1.2	47.3	2.2	1.0	0.5	6.8	1.6	1.1	3.6	8.5	1.6	0.8	93.9	53.7	318.5	0.4	0.6	273.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.3	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.1	0.0	0.2	0.0	22.8	0.0	1.2	318.5	3.0	0.5	218.1	0.6	0.8	0.2	0.3	93.9	0.2	0.3	0.3	53.7	0.4	99.0	2.5	0.3	273.0	0.6	0.7	0.4	1.0	0.5	0.6	2.3	0.1	0.9	0.5
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880812-134887520	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 77.4"	"Cell line enhanced"	"Detected in some"		"RH-30: 1.3;SCLC-21H: 1.1;T-47d: 1.3;U-698: 1.2"	"Group enriched"	"Detected in some"	8	"breast cancer: 1.0;liver cancer: 2.0;prostate cancer: 1.1;renal cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 6.0;intermediate monocyte: 5.6"	"Low lineage specificity"	"Detected in many"																"Secreted to blood"	8100000000	1800000000				"unprognostic (1.91e-1)"	"unprognostic (1.07e-1)"			"unprognostic (6.96e-4)"		"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"		"unprognostic (3.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"		"unprognostic (1.05e-1)"	"unprognostic (3.07e-1)"		2.0	11.4	0.2	0.2	0.2	0.0	4.0	0.2	0.3	0.2	0.3	0.3	0.5	0.0	0.3	0.6	0.2	0.0	0.2	0.5	0.2	0.0	2.2	77.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.5	0.2	0.3	1.5	0.0	0.2	1.4	0.2	0.2	0.0	0.2	0.2	0.2	1.4	0.0	0.3	0.2	0.2	0.9	0.2	0.2	0.3	0.2	0.0	3.3	1.3	6.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.9	0.0	0.0	6.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	7.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.3	0.2
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369112-27374824	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"liver: 83.2;lung: 153.7"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.7;MCF7: 2.2;U-2197: 2.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB025945	Approved				"Secreted to blood"	22766000000	33000000000			"CAB025945: "	"unprognostic (1.59e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (6.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.87e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.61e-2)"	7.2	5.0	0.1	1.7	0.2	0.0	21.2	0.1	0.3	0.3	0.6	0.4	0.1	0.2	0.3	0.1	1.0	0.5	0.5	25.0	0.4	0.0	13.0	83.2	153.7	1.0	0.1	0.1	0.3	2.3	0.7	2.1	6.7	1.1	0.5	0.2	0.8	0.4	0.2	1.0	0.3	0.7	0.6	0.2	2.7	0.8	0.5	0.2	0.1	9.1	0.3	0.3	1.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.1	0.8	0.0	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.8	0.4	0.6	0.0	1.0	0.0	0.4	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.4	0.3	2.2	0.2	0.3	0.1	0.5	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.0	0.1	0.1	1.1	0.2
FDPS		ENSG00000160752	"Farnesyl diphosphate synthase"	P14324	1	155308748-155320666	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Host-virus interaction, Isoprene biosynthesis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 147.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028200	Approved		Approved	Nucleoplasm,Cytosol			2000000	Cytosol	Nucleoplasm	"HPA028200: AB_10612109"	"unprognostic (1.23e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavourable (7.35e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.64e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.44e-2)"	21.0	57.8	19.3	17.6	26.5	16.5	19.8	12.8	32.2	19.0	25.0	22.6	14.5	45.9	18.0	21.7	41.4	16.7	18.8	19.6	18.6	23.4	23.7	100.8	25.7	19.2	19.5	24.3	15.2	27.5	15.6	12.3	20.2	47.3	16.5	29.7	20.5	29.2	12.9	15.7	29.3	32.3	18.9	23.0	17.7	23.4	15.1	16.5	25.1	19.5	41.7	27.3	13.7	20.8	41.1	39.7	49.4	37.1	45.3	45.5	48.3	35.6	19.4	71.3	25.7	16.7	61.3	25.4	17.0	33.7	27.2	44.3	31.4	84.9	27.2	41.4	14.9	39.8	42.4	147.8	25.5	14.8	30.4	15.8	34.6	37.8	27.5	25.5	18.1	43.6	23.4	43.2	21.7	47.3	28.1	73.3	28.3	38.3	32.6	24.8	42.8	28.4	28.2	30.9	75.4	71.6	23.8	27.7	23.7	17.5	31.9	29.4	23.0	69.4	34.4	15.2	18.7	9.4	31.1	31.1	23.9	48.5	14.8	27.2	23.9	30.5	36.0	49.4	39.4	37.1	35.0	41.1	34.8	39.8	39.7	34.2	31.5	39.3	16.5	45.3	27.2	31.4	45.5	48.3	19.3	26.5	12.8	32.2	18.6	23.4	19.5	24.3	47.3	16.5
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli			38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favourable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavourable (5.73e-6)"	"prognostic favourable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.0	28.6	31.4	16.9	3.1	3.9	20.0	27.5	15.7	33.7	38.4	25.0	23.4	44.9	21.5	11.7	32.9	44.2	24.1	34.6	23.6	24.3	23.7	39.1	25.4	2.4	36.8	24.5	2.7	3.3	31.1	8.3	13.1	35.8	32.5	28.0	39.1	51.2	33.1	34.5	28.1	35.2	36.4	46.3	13.4	29.5	35.8	29.7	18.3	24.1	15.8	34.9	25.9	8.8	30.0	37.9	38.2	27.7	25.7	39.9	46.6	20.9	24.7	25.8	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9
FER	"PPP1R74, TYK3"	ENSG00000151422	"FER tyrosine kinase"	P16591	5	108747822-109196841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RPMI-8226: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007641, CAB022464"	Approved		Supported	Cytosol				Cytosol		"CAB022464: , HPA007641: AB_1078845"	"unprognostic (1.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.46e-3)"	"unprognostic (4.72e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (5.55e-4)"	"unprognostic (3.83e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.99e-3)"	13.4	5.7	5.5	6.1	13.4	1.8	5.2	6.0	5.0	9.7	6.7	1.4	16.8	2.5	6.5	19.3	8.2	4.6	5.3	4.6	4.8	4.8	7.2	3.6	12.2	1.9	4.9	2.2	7.2	3.0	18.5	15.9	5.7	3.1	6.8	3.6	5.0	4.5	21.9	5.0	6.6	3.5	7.2	6.2	8.1	4.1	15.9	2.6	3.9	10.2	12.8	2.8	7.7	9.0	10.5	5.4	8.0	5.1	1.2	2.8	1.1	4.6	1.6	5.7	9.0	3.4	5.2	3.6	5.6	5.5	3.3	3.9	9.5	2.9	7.5	3.5	6.7	3.3	3.1	7.0	7.5	3.1	4.2	4.9	7.2	3.4	2.3	2.7	4.2	3.1	3.9	7.9	9.0	4.9	6.1	5.6	4.2	1.3	2.1	0.8	0.8	3.3	1.7	5.5	44.2	3.2	1.6	1.9	2.8	9.2	0.5	6.0	2.2	1.2	7.2	6.4	4.9	3.2	4.4	4.8	7.1	2.9	4.0	0.8	3.0	8.0	5.1	5.4	1.7	3.1	2.8	10.5	1.0	1.8	2.8	3.8	1.6	2.0	0.4	1.2	2.4	5.4	2.1	1.1	5.5	13.4	6.0	4.2	4.8	4.8	4.9	2.2	3.1	2.6
FER1L6	C8ORFK23	ENSG00000214814	"Fer-1 like family member 6"	Q2WGJ9	8	123851987-124120061	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"stomach 1: 29.3"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;ASC TERT1: 4.9;BJ hTERT+: 3.2;PC-3: 4.4;U-87 MG: 4.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 4.2;stomach cancer: 5.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054117	Enhanced									"HPA054117: "	"unprognostic (1.90e-1)"	"unprognostic (3.08e-3)"	"unprognostic (2.06e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.09e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.23e-6)"	"unprognostic (7.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.39e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	3.1			1.7	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	7.3		0.0	0.0	0.4	0.0	3.8	0.0	0.0	0.0	29.3	3.8			1.3		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.2	4.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.9	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.3	4.4	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FERMT3	"KIND3, MGC10966, MIG-2, MIG2B, UNC112C, URP2"	ENSG00000149781	"Fermitin family member 3"	Q86UX7	11	64206678-64223886	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.4;bone marrow: 57.6;lymphoid tissue: 52.7"	"Cell line enhanced"	"Detected in many"		"HEL: 61.5;HL-60: 26.9;HMC-1: 65.8;Karpas-707: 26.5;NB-4: 34.6;U-937: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065231			Approved	Vesicles			450000000	Vesicles		"HPA065231: "	"unprognostic (1.96e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.38e-3)"	"prognostic favourable (9.89e-4)"	"unprognostic (8.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.20e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (2.12e-5)"	"unprognostic (3.08e-3)"	"unprognostic (5.25e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.75e-1)"	20.0	5.6	3.1	29.4	5.5	57.6	5.6	0.9	3.2	3.4	8.8	3.4	0.7	8.1	3.4	6.0	3.6	5.8	6.5	7.2	2.2	2.4	5.3	5.5	17.8	39.1	6.3	0.8	4.9	2.8	0.2	2.6	7.5	3.7	4.2	3.0	5.6	8.9	2.9	3.2	2.8	12.4	3.3	4.8	52.7	10.6	2.5	4.3	51.2	4.0	2.4	29.6	6.2	2.9	13.7	47.3	54.7	49.5	22.6	30.6	59.4	0.2	0.3	0.1	0.1	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.4	6.5	0.6	1.2	0.5	0.2	0.1	0.1	16.7	0.1	61.5	0.2	0.0	2.3	26.9	65.8	0.2	0.2	1.0	0.0	16.7	1.4	26.5	1.7	0.7	23.9	34.6	0.2	0.4	14.5	1.8	0.1	0.0	0.1	0.3	0.1	0.1	0.9	0.3	0.4	18.7	1.5	0.2	0.5	0.3	0.1	0.3	0.6	11.8	4.1	27.9	17.7	40.6	49.5	54.7	30.6	46.3	29.4	13.7	24.4	28.4	39.0	13.4	16.1	21.1	45.0	22.6	33.5	47.3	28.3	59.4	3.1	5.5	0.9	3.2	2.2	2.4	6.3	0.8	3.7	4.3
FETUB		ENSG00000090512	"Fetuin B"	Q9UGM5	3	186635969-186653141	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Fertilization	"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 76.1"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.5;Hep G2: 4.4;NTERA-2: 1.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 44.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035132	Supported				"Secreted to blood"	47505000000	4500000000			"HPA035132: AB_10601650"		"unprognostic (9.01e-2)"		"unprognostic (1.95e-1)"	"unprognostic (4.62e-1)"	"unprognostic (8.74e-2)"	"unprognostic (6.28e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.73e-2)"			"unprognostic (9.18e-2)"	"unprognostic (1.79e-1)"	"unprognostic (8.39e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	76.1	0.0	0.0	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	2.6	11.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.5	0.0	0.9	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.6	0.4	0.2	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1
FEZ2		ENSG00000171055	"Fasciculation and elongation protein zeta 2"	Q9UHY8	2	36531805-36646087	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035978	Uncertain		Approved	"Nucleoli,Golgi apparatus,Cytosol"				Nucleoli	"Golgi apparatus, Cytosol"	"HPA035978: AB_10672235"	"unprognostic (1.42e-1)"	"unprognostic (5.02e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.94e-3)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.09e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	31.7	23.4	28.7	12.0	25.3	8.1	18.6	20.1	31.2	18.3	17.2	28.0	6.0	13.1	20.4	13.1	20.4	13.1	14.6	28.5	26.1	22.6	21.4	18.4	16.5	13.1	27.6	21.6	18.3	6.8	14.2	8.5	29.6	29.3	15.6	18.4	19.0	9.7	22.1	51.0	9.1	18.7	26.9	33.8	17.8	12.2	12.6	25.4	9.4	14.8	12.2	12.1	15.5	13.5	1.7	13.6	4.7	3.5	3.1	1.5	0.7	15.3	9.2	12.6	5.3	24.9	33.0	9.9	39.1	20.0	24.0	15.2	6.4	5.0	9.5	24.0	50.6	6.1	10.6	13.5	26.2	2.2	5.8	7.7	3.3	10.6	11.9	7.7	1.9	31.6	11.6	14.8	17.8	34.2	8.3	3.0	44.2	5.4	4.7	6.7	6.6	14.5	3.1	11.4	3.2	19.0	15.0	0.3	11.4	9.6	7.9	9.3	2.8	9.7	39.7	15.0	8.0	8.2	22.7	2.2	2.6	6.5	14.9	5.4	21.1	2.4	3.5	4.7	1.5	3.3	1.0	1.7	1.1	0.8	3.6	1.0	1.3	0.5	4.0	3.1	1.9	13.6	1.3	0.7	28.7	25.3	20.1	28.8	26.1	22.6	27.6	21.6	29.3	25.4
FGA		ENSG00000171560	"Fibrinogen alpha chain"	P02671	4	154583126-154590766	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	740	"liver: 2009.3"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 94.6"	"Cancer enriched"	"Detected in many"	43	"liver cancer: 2431.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB016776, HPA051370, HPA064755"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	406800000	170000000000	"Endoplasmic reticulum"		"CAB016776: , HPA051370: , HPA064755: "		"unprognostic (5.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.02e-1)"		"unprognostic (5.68e-2)"	"prognostic favourable (7.33e-4)"	"unprognostic (1.29e-3)"			"unprognostic (1.84e-1)"		"prognostic unfavourable (4.23e-6)"	"unprognostic (4.20e-1)"	"unprognostic (1.41e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	2.7	2009.3	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	94.6	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 75.9"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavourable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	75.9	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FGD1	"FGDY, ZFYVE3"	ENSG00000102302	"FYVE, RhoGEF and PH domain containing 1"	P98174	X	54445454-54496166	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000911	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA000911: AB_1078853"	"unprognostic (2.49e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.41e-2)"	"unprognostic (9.40e-3)"	5.9	7.7	15.6	5.9	10.9	1.6	7.1	16.3	15.6	12.3	7.2	3.7	3.4	4.5	12.4	4.4	9.3	7.6	7.8	9.2	9.6	7.1	5.1	1.9	4.6	4.0	4.8	11.2	13.7	6.9	6.9	5.4	9.4	5.7	6.5	3.8	6.8	7.7	7.9	3.3	11.8	5.5	11.9	3.7	5.8	5.2	4.6	4.8	0.0	5.6	7.3	4.3	7.6	7.8	1.6	0.6	0.5	2.6	1.2	3.2	1.1	13.8	5.9	11.4	14.9	5.3	9.5	5.5	8.3	8.4	7.0	5.7	1.8	1.2	0.8	6.8	12.8	5.4	9.6	5.9	3.9	1.4	8.4	0.5	4.5	2.1	5.7	0.7	0.5	7.7	3.7	10.7	5.1	6.3	2.2	0.5	5.5	2.9	1.6	1.5	11.2	9.3	8.0	6.5	0.5	6.0	0.8	10.6	10.0	9.1	0.8	13.7	10.0	1.2	6.1	8.8	7.8	19.3	7.6	1.0	2.0	1.5	9.7	1.6	4.8	0.0	0.6	0.5	2.0	1.3	2.0	1.5	1.6	2.2	0.6	1.6	3.2	1.8	0.0	1.2	2.6	0.2	1.4	1.1	15.6	10.9	16.3	15.6	9.6	7.1	4.8	11.2	5.7	4.8
FGD3	"FLJ00004, ZFYVE5"	ENSG00000127084	"FYVE, RhoGEF and PH domain containing 3"	Q5JSP0	9	92947451-93036236	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 49.2;lymphoid tissue: 48.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;Karpas-707: 28.7;RT4: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA020963, HPA021018"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA020963: , HPA021018: "	"unprognostic (5.66e-3)"	"prognostic favourable (5.51e-4)"	"unprognostic (5.05e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (2.23e-7)"	"unprognostic (2.26e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.56e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.22e-2)"	3.1	1.5	2.3	20.5	2.5	23.4	3.5	0.5	1.6	1.8	3.1	3.1	1.6	1.9	2.8	2.5	2.8	2.5	3.1	1.5	2.2	2.0	4.6	2.1	7.5	30.5	3.3	1.0	1.1	5.7	0.1	1.0	2.6	2.6	3.2	1.4	2.2	6.6	1.0	0.7	3.1	10.1	1.5	6.3	28.1	2.6	3.9	2.5	48.1	3.5	2.1	25.8	7.7	3.2	11.3	10.3	49.2	24.7	10.5	15.7	17.1	6.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.9	4.4	5.1	0.2	0.0	4.1	0.3	0.0	0.0	8.8	0.0	8.1	0.0	0.3	0.0	2.1	20.7	0.0	0.1	0.0	0.0	0.0	0.3	28.7	0.0	10.6	9.4	9.0	0.2	0.5	9.4	0.0	7.2	0.0	16.3	0.6	0.2	0.0	7.0	0.2	2.7	9.5	0.0	0.0	0.3	0.0	0.0	2.9	2.9	2.4	1.5	4.5	0.0	34.0	13.4	36.7	15.1	17.3	15.5	8.5	15.6	14.1	10.3	11.3	15.7	13.3	49.2	10.5	24.7	4.7	13.5	17.1	2.3	2.5	0.5	1.6	2.2	2.0	3.3	1.0	2.6	2.5
FGF20		ENSG00000078579	"Fibroblast growth factor 20"	Q9NP95	8	16992169-17002181	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.0"	"Group enriched"	"Detected in some"	4	"BJ hTERT+: 3.3;CAPAN-2: 10.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"B-cells: 1.0"	"Region enhanced"	"Detected in some"		"midbrain: 0.7"	"Region enriched"	"Detected in single"	5	"cerebellum: 3.4"						"Secreted in other tissues"						"unprognostic (1.93e-2)"		"unprognostic (2.19e-1)"	"unprognostic (5.57e-3)"	"unprognostic (3.95e-2)"			"unprognostic (1.59e-3)"		"unprognostic (1.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.92e-1)"	"unprognostic (4.08e-2)"		0.2	2.0	1.9	0.2	1.6	0.0	1.1	9.0	3.7	3.9	0.1	4.0	0.1	0.4	0.1	2.5	0.1	0.8	1.2	0.3	2.3	2.1	0.1	0.1	0.1	0.5	2.9	2.4	2.5	0.2	0.0	0.9	0.5	2.7	0.6	0.2	0.8	3.8	0.6	0.1	0.0	0.2	0.1	4.2	3.6	2.2	0.8	1.1	0.1	0.5	0.1	1.6	0.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.4	0.0	1.2	3.3	0.5	1.6	0.0	10.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	9.0	3.7	2.3	2.1	2.9	2.4	2.7	1.1
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Cell line enhanced"	"Detected in many"		"AF22: 5.4;HBEC3-KT: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	56750								"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.4	1.8	2.8	0.6	0.8	0.1	0.1	0.0	0.2	1.0	1.9	0.3	0.2	0.9	1.2	0.8	3.9	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.1	0.5	1.6	0.1	2.5	3.2	0.4	0.5	2.3	0.1	0.0	0.7	1.3	1.4	0.2	0.9	0.1	0.8	0.6	1.1	1.2	1.1	0.0	1.8	0.2	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
FGFBP2	KSP37	ENSG00000137441	"Fibroblast growth factor binding protein 2"	Q9BYJ0	4	15960243-15969309	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.8"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 10.9;T-47d: 5.4;WM-115: 2.2"	"Group enriched"	"Detected in many"	9	"glioma: 4.8;head and neck cancer: 13.1;lung cancer: 16.7;melanoma: 16.9"	"Region enriched"	"Detected in many"	6	"midbrain: 16.0"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.8"	"Lineage enriched"	"Detected in many"	10	"T-cells: 79.8"														"Secreted to blood"	345500000	6900000				"unprognostic (3.51e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.49e-2)"	21.0	1.4	0.3	0.4	1.0	33.4	19.4	0.0	0.9	1.1	7.1	0.2	0.9	0.2	0.6	6.0	3.4	0.7	0.8	16.1	0.4	0.2	0.5	0.8	6.7	1.9	16.0	1.0	0.9	0.2	0.1	0.2	0.8	2.8	3.1	0.8	30.7	5.7	0.9	6.7	14.4	1.8	5.3	5.0	10.4	1.2	11.3	0.0	5.8	0.7	3.8	1.9	1.5	3.7	0.1	0.2	1.2	0.2	8.3	79.8	39.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	10.9	5.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.0	2.2	0.4	0.1	0.3	79.8	0.1	0.7	0.1	19.7	47.0	0.1	0.0	7.6	47.5	1.2	8.3	0.2	0.2	0.1	39.3	0.3	1.0	0.0	0.9	0.4	0.2	16.0	1.0	2.8	0.0
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38411138-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 109.2;BJ hTERT+: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved						120000000			"CAB033614: AB_783377, HPA056402: "	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	41.1	8.6	12.5	14.5	12.2	7.2	39.5	45.0	10.5	36.0	31.5	10.1	11.6	5.5	29.3	20.6	22.9	29.4	32.4	31.7	12.8	10.1	11.8	5.4	18.6	9.7	11.4	14.3	42.0	51.2	11.5	22.3	28.4	20.0	28.2	10.8	35.8	14.0	31.6	12.0	12.9	14.4	52.4	15.6	4.5	16.4	16.4	8.5	11.3	12.6	13.0	9.8	39.6	41.2	1.6	0.7	1.8	1.1	0.8	5.7	0.7	2.4	9.3	40.3	109.2	25.1	17.9	26.6	24.8	49.8	17.3	18.0	6.0	1.4	0.3	6.9	23.8	0.0	19.1	1.2	20.0	6.5	4.2	0.0	1.5	5.9	14.1	5.8	0.1	16.2	0.1	14.0	2.8	16.6	2.2	0.1	8.1	2.8	17.0	1.9	28.4	3.9	15.7	4.2	0.0	8.4	0.0	1.6	3.6	4.4	0.2	1.0	2.2	1.1	10.4	11.3	6.2	31.2	5.9	0.4	0.7	0.0	13.4	0.3	5.9	1.4	1.1	0.4	5.7	0.3	3.9	0.7	2.7	3.7	0.1	1.6	1.5	4.1	1.8	0.8	0.5	0.7	2.2	0.7	12.5	12.2	45.0	10.5	12.8	10.1	11.4	14.3	20.0	8.5
FGFR2	"BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25"	ENSG00000066468	"Fibroblast growth factor receptor 2"	P21802	10	121478334-121598458	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Apoptosis	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Lacrimo-auriculo-dento-digital syndrome, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 74.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 57.8;BEWO: 19.4;CACO-2: 15.1;HaCaT: 17.4;HAP1: 18.7;NTERA-2: 18.5;T-47d: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	15	"basophil: 10.8;eosinophil: 4.6"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010886, HPA035305"	Uncertain		Supported	"Nucleoplasm,Vesicles,Cell Junctions"	"Secreted - unknown location"		500000	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB010886: AB_259379, HPA035305: AB_10672862"	"unprognostic (5.53e-2)"	"prognostic favourable (8.79e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (9.32e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.25e-1)"	2.1	8.8	16.4	3.0	30.3	0.0	9.9	15.8	21.3	6.8	14.1	55.7	5.6	4.2	22.0	6.6	10.2	12.5	12.5	1.4	20.6	11.1	11.4	16.1	13.1	1.0	41.2	13.3	7.4	12.8	25.5	2.5	6.2	30.2	11.7	8.7	16.4	23.8	24.3	0.4	45.4	4.7	18.3	74.8	0.5	9.3	2.9	32.1	0.8	23.4	1.6	3.4	6.9	8.5	0.1	0.1	10.8	0.1	0.1	0.3	0.0	2.2	0.1	9.0	57.8	0.0	0.0	19.4	0.1	0.0	0.0	0.0	15.1	0.3	0.0	4.1	0.9	17.4	18.7	4.0	0.0	0.0	4.0	0.0	0.0	0.3	0.4	0.0	3.8	0.0	8.4	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.0	0.0	18.5	0.0	0.0	0.0	2.2	5.6	4.9	0.1	0.1	0.1	10.6	0.0	15.5	0.0	0.0	0.1	2.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	10.8	0.1	4.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	16.4	30.3	15.8	21.3	20.6	11.1	41.2	13.3	30.2	32.1
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Group enriched"	"Detected in many"	4	"CACO-2: 42.0;Hep G2: 42.0;RH-30: 67.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"		4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	11.8	0.2	2.9	0.0	0.0	5.8	0.0	0.0	0.0	0.0	42.0	1.6	1.2	5.5	0.0	0.6	2.3	0.4	0.0	0.7	2.8	0.1	0.6	42.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	3.9	0.1	0.9	9.6	0.0	0.8	7.1	1.0	1.9	67.6	7.1	5.7	0.1	0.4	0.7	0.4	3.0	1.4	2.9	0.6	0.2	0.0	5.7	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4
FGG		ENSG00000171557	"Fibrinogen gamma chain"	P02679	4	154604134-154612967	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	495	"liver: 2225.7"	"Cell line enriched"	"Detected in some"	55	"Hep G2: 125.7"	"Cancer enriched"	"Detected in many"	19	"liver cancer: 1503.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027529, CAB033120, HPA074638"	Supported		Approved	"Endoplasmic reticulum"	"Secreted to blood"	267000000000	68000000000	"Endoplasmic reticulum"		"CAB033120: AB_2103818, HPA027529: AB_10601322, HPA074638: "	"unprognostic (1.26e-2)"				"unprognostic (4.77e-3)"	"unprognostic (6.33e-3)"	"unprognostic (3.69e-3)"	"unprognostic (2.18e-3)"		"unprognostic (9.63e-2)"	"unprognostic (7.57e-3)"		"prognostic unfavourable (1.00e-6)"	"unprognostic (1.75e-3)"	"unprognostic (3.21e-1)"		"unprognostic (1.14e-1)"	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	2.7	2225.7	4.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	125.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
FGL1	HFREP-1	ENSG00000104760	"Fibrinogen like 1"	Q08830	8	17864380-17910365	"Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 450.7"	"Group enriched"	"Detected in some"	15	"A549: 21.7;Hep G2: 51.0"	"Cancer enriched"	"Detected in some"	40	"liver cancer: 399.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted to blood"		1800000				"unprognostic (3.62e-2)"	"unprognostic (1.14e-2)"		"unprognostic (1.75e-5)"	"unprognostic (3.00e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.62e-1)"		"unprognostic (2.71e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.86e-7)"	"prognostic unfavourable (5.38e-4)"	"unprognostic (3.62e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	450.7	0.2	0.1	0.1	0.1	0.1	71.3	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	21.7	0.0	2.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	51.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
FGL2	"pT49, T49"	ENSG00000127951	"Fibrinogen like 2"	Q14314	7	77193371-77199848	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.0;Karpas-707: 3.7;LHCN-M2: 4.1;NB-4: 4.5;RPTEC TERT1: 7.8;U-937: 8.2;WM-115: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	50	"classical monocyte: 59.3;eosinophil: 52.6;intermediate monocyte: 82.0;myeloid DC: 38.1;neutrophil: 68.4;non-classical monocyte: 73.5"	"Group enriched"	"Detected in many"	56	"dendritic cells: 38.1;granulocytes: 68.4;monocytes: 82.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021011, HPA026682"	Enhanced				"Secreted to blood"	38783333	6400000			"HPA021011: AB_1848532, HPA026682: AB_1848533"	"unprognostic (9.80e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.01e-2)"	30.0	8.7	6.0	28.7	10.7	1.5	18.0	5.7	4.7	8.0	29.5	5.0	7.7	14.2	7.6	18.4	41.4	13.8	16.2	17.8	5.1	5.5	23.3	14.3	17.0	28.1	10.3	4.1	6.4	3.0	1.8	8.0	7.0	11.4	17.9	20.3	6.8	11.7	4.4	6.2	8.6	40.9	73.7	18.4	63.4	16.9	3.4	8.6	12.0	19.2	18.3	9.1	55.8	7.7	1.0	38.1	68.4	82.0	0.7	1.1	34.6	0.0	0.0	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	3.7	4.1	0.1	0.0	4.5	0.3	0.2	0.2	0.5	0.4	7.8	1.0	0.1	0.3	0.1	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.3	8.2	8.8	0.6	59.3	52.6	1.1	82.0	0.5	1.0	0.7	1.0	38.1	0.5	0.4	0.8	68.4	0.7	73.5	1.2	1.1	34.6	6.0	10.7	5.7	4.7	5.1	5.5	10.3	4.1	11.4	8.6
FGR	"c-fgr, p55c-fgr, SRC2"	ENSG00000000938	"FGR proto-oncogene, Src family tyrosine kinase"	P09769	1	27612064-27635277	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3"	"Group enriched"	"Detected in some"	4	"Daudi: 29.4;U-266/70: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA002024	Enhanced		Approved	"Plasma membrane,Aggresome"				"Plasma membrane"	Aggresome	"HPA002024: AB_1078503"	"unprognostic (2.66e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.32e-2)"	"unprognostic (9.74e-3)"	"unprognostic (6.66e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.12e-3)"	20.8	2.6	2.2	23.6	4.5	73.6	5.6	1.1	4.2	2.9	2.8	1.5	4.2	1.6	4.0	2.3	2.2	6.3	5.3	8.5	2.6	2.3	3.0	4.2	30.9	34.1	6.6	1.7	1.9	2.4	0.4	1.2	3.3	4.2	2.5	1.8	2.1	2.9	2.6	4.4	1.7	3.7	6.4	4.8	54.3	2.5	2.6	4.1	1.9	2.9	2.5	7.8	5.1	6.1	13.3	28.9	40.8	68.0	36.3	29.6	55.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.5	10.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	54.6	0.7	2.2	0.0	6.7	0.0	3.1	52.4	32.3	29.6	68.0	1.7	7.7	2.6	13.6	28.9	13.3	1.3	12.8	40.8	36.3	55.6	1.3	0.1	55.0	2.2	4.5	1.1	4.2	2.6	2.3	6.6	1.7	4.2	4.1
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria			2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favourable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.2	24.5	23.3	21.0	22.9	27.0	36.9	36.3	28.5	41.0	25.8	35.1	18.3	18.6	24.1	27.8	41.7	35.6	27.0	35.8	21.2	11.5	17.4	26.0	29.9	20.5	40.7	15.9	19.5	16.8	23.0	26.0	25.2	53.0	24.1	29.8	14.6	35.1	27.2	24.7	52.7	29.0	25.5	83.5	39.5	24.9	30.0	25.9	30.6	36.3	23.2	27.6	27.7	24.7	18.4	23.8	32.5	60.5	21.6	23.1	22.6	20.6	46.8	26.4	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7
FHL1	"bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA"	ENSG00000022267	"Four and a half LIM domains 1"	Q13642	X	136146702-136211359	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Differentiation	"Developmental protein"	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 557.6;tongue: 239.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.7;fHDF/TERT166: 52.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 20.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4"	"Low region specificity"	"Detected in all"							"HPA001040, HPA001391, CAB020817"	Enhanced		Supported	"Plasma membrane,Cytosol"			18000000	Cytosol	"Plasma membrane"	"CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542"	"unprognostic (2.16e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.34e-2)"	"unprognostic (7.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.17e-3)"	"unprognostic (4.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.05e-3)"	"prognostic unfavourable (2.11e-4)"	61.9	4.1	7.6	11.0	9.5	0.7	30.6	6.3	7.2	31.5	30.6	3.9	10.0	5.0	25.5	27.7	43.2	14.2	11.7	79.0	6.1	8.1	3.3	2.5	13.7	2.5	5.5	8.1	6.7	2.4	13.4	5.0	13.5	4.4	23.4	10.0	13.5	16.5	30.1	557.6	4.9	11.4	77.7	4.3	2.5	22.1	5.7	3.0	0.6	18.2	239.4	22.1	47.0	14.3	3.4	12.5	0.7	0.4	20.6	11.4	6.2	0.0	9.4	13.1	12.3	28.5	11.5	0.2	36.7	57.7	7.3	17.8	0.0	2.7	0.1	12.8	52.2	0.1	25.3	31.3	6.2	0.1	29.2	0.1	7.8	0.0	26.7	0.0	6.1	21.4	5.1	8.9	28.1	7.7	0.0	5.5	17.2	0.4	5.1	0.3	4.0	11.1	14.4	0.5	7.8	0.2	0.0	9.2	13.8	1.3	0.0	2.6	0.0	0.5	21.6	34.1	15.8	1.3	9.2	1.4	3.2	0.2	2.5	0.2	3.8	0.0	0.4	0.0	3.2	0.0	8.6	3.4	11.4	4.5	1.8	2.3	7.6	2.3	0.7	20.6	0.0	12.5	1.2	6.2	7.6	9.5	6.3	7.2	6.1	8.1	5.5	8.1	4.4	3.0
FHOD1	FHOS	ENSG00000135723	"Formin homology 2 domain containing 1"	Q9Y613	16	67229387-67247658	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.0;skeletal muscle: 61.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024468	Approved		Supported	Cytosol			2500000	Cytosol		"HPA024468: AB_1848568"	"unprognostic (6.53e-3)"	"prognostic unfavourable (9.57e-4)"	"unprognostic (5.42e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-2)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (1.90e-8)"	"unprognostic (1.72e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-3)"	"unprognostic (4.70e-2)"	8.3	7.5	2.5	5.1	4.4	2.9	7.9	4.7	2.8	4.2	5.3	2.5	3.8	3.3	3.9	4.7	2.5	3.4	5.6	3.7	2.3	1.3	4.8	2.3	12.5	4.4	4.0	0.7	12.9	3.4	2.5	2.5	5.8	4.2	4.2	2.6	4.0	5.7	4.0	61.1	2.5	3.9	3.5	5.6	38.0	2.9	2.2	3.0	2.7	8.2	11.1	5.8	2.6	3.5	0.5	2.0	2.2	3.0	1.3	1.4	2.1	4.3	11.9	4.4	3.6	18.1	10.9	15.0	9.2	7.6	10.6	10.3	8.2	5.7	5.2	6.7	6.7	5.3	5.2	7.5	5.3	4.1	8.3	23.2	4.6	8.9	4.8	9.5	42.6	13.5	0.9	16.2	1.5	16.4	12.0	3.2	6.6	14.9	6.4	17.1	6.7	3.8	7.4	10.0	12.3	3.3	1.7	1.4	7.4	14.5	8.3	8.4	8.9	7.6	19.0	14.4	8.4	8.8	7.4	11.1	11.3	7.6	29.6	9.0	13.1	1.5	3.0	0.5	1.1	1.2	1.4	0.1	1.3	1.0	2.0	0.5	0.8	0.6	2.2	1.3	1.0	1.2	1.2	2.1	2.5	4.4	4.7	2.8	2.3	1.3	4.0	0.7	4.2	3.0
FIS1	"CGI-135, Fis1, H_NH0132A01.6, TTC11"	ENSG00000214253	"Fission, mitochondrial 1"	Q9Y3D6	7	101239458-101252316	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017430	Approved		Supported	Mitochondria			590000	Mitochondria		"HPA017430: AB_1848608"	"unprognostic (1.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.73e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.08e-7)"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-1)"	35.1	46.8	53.4	22.3	49.9	32.7	35.8	26.0	60.0	30.3	34.4	57.9	38.0	30.0	31.1	42.7	35.6	47.0	39.4	78.6	52.6	44.8	39.6	58.3	27.8	23.6	65.3	37.8	41.2	56.6	39.5	37.1	34.0	45.1	29.3	26.3	28.8	45.2	43.8	120.5	29.7	29.2	32.4	87.9	28.1	31.1	30.4	44.1	21.3	47.1	48.8	22.6	30.5	29.3	73.0	73.4	63.6	67.4	55.6	72.8	87.9	24.7	29.2	21.9	31.4	25.3	33.9	15.0	26.9	32.8	24.6	21.2	20.1	40.8	24.3	36.0	36.9	14.6	15.3	43.5	13.8	18.8	22.2	11.0	42.5	26.6	30.2	20.5	17.1	32.2	41.0	17.2	26.4	44.5	23.1	33.4	37.0	113.9	31.9	37.0	24.3	28.4	15.6	12.3	53.2	37.2	28.7	28.4	33.3	12.8	61.9	18.2	20.6	23.3	36.4	28.9	18.6	29.9	28.6	28.3	21.6	14.0	26.8	23.3	37.7	58.9	67.4	63.6	63.2	65.5	65.1	72.2	61.0	59.7	73.4	73.0	60.7	63.5	51.4	55.6	59.0	61.4	72.8	87.9	53.4	49.9	26.0	60.0	52.6	44.8	65.3	37.8	45.1	44.1
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FK506 binding protein 1A"	P62942	20	1368978-1393172	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 149.0;TIME: 172.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3"									"CAB004639, HPA051798"	Uncertain						16000000			"CAB004639: AB_425434, HPA051798: "	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavourable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavourable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	106.0	42.4	67.3	55.0	114.8	44.4	63.5	15.8	55.8	33.2	39.7	22.1	33.8	32.7	45.5	45.9	42.7	33.8	32.0	36.4	51.7	30.6	41.9	41.7	59.2	84.1	26.0	36.5	41.7	57.7	20.6	21.7	65.0	22.5	34.4	49.4	21.4	30.8	40.6	38.9	31.5	37.1	56.0	23.3	68.0	33.0	21.1	28.4	47.4	62.2	39.7	48.3	48.1	37.0	13.3	63.6	88.4	94.3	14.5	18.6	84.3	69.9	19.4	15.5	22.4	52.4	65.7	20.4	44.5	30.2	35.7	33.1	19.3	27.2	28.6	14.3	41.4	32.2	19.9	81.3	46.9	8.2	21.7	29.4	9.1	36.8	32.2	34.1	16.3	38.2	26.0	32.9	34.0	149.0	26.9	14.7	41.9	8.7	33.3	47.0	33.2	38.0	28.6	27.0	34.7	46.0	17.7	25.8	19.5	22.0	44.3	73.6	17.4	29.1	172.6	132.5	22.2	28.2	32.8	7.4	15.9	30.0	22.8	34.6	29.3	23.9	79.4	88.4	11.5	94.3	10.2	12.8	13.9	13.2	63.6	13.3	14.8	14.2	77.9	14.5	90.3	31.6	18.6	84.3	67.3	114.8	15.8	55.8	51.7	30.6	26.0	36.5	22.5	28.4
FKBP3	"FKBP-25, PPIase"	ENSG00000100442	"FK506 binding protein 3"	Q00688	14	45115600-45135319	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 113.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000864, CAB012232, CAB012520"	Supported		Supported	Cytosol			980000	Cytosol		"CAB012232: , CAB012520: AB_873554, HPA000864: AB_1078873"	"unprognostic (7.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.82e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.22e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.47e-1)"	11.7	13.2	28.1	10.2	40.7	9.8	15.5	25.1	32.1	12.0	14.6	11.4	8.3	13.2	9.9	20.4	14.6	8.8	9.1	31.3	26.0	24.4	16.5	20.5	8.0	14.6	23.2	23.8	9.9	10.9	15.0	17.1	14.0	22.9	17.9	15.2	6.6	10.7	12.2	113.3	11.3	13.9	12.8	19.6	9.9	10.6	13.5	22.4	12.7	12.4	24.2	16.5	12.7	9.3	19.5	27.5	13.5	17.4	15.4	19.4	13.0	36.9	41.2	60.0	31.5	26.7	29.2	23.7	22.7	26.1	36.0	39.7	36.0	31.8	19.7	24.0	25.6	30.8	44.5	29.3	51.3	28.5	26.6	16.2	32.0	46.5	26.4	28.0	17.6	27.5	30.6	20.9	19.5	46.8	23.4	14.9	42.6	45.2	44.8	37.5	30.4	39.1	43.2	44.2	23.9	57.5	42.8	36.6	14.3	36.4	22.7	34.8	53.1	21.0	30.1	27.5	47.6	14.4	17.4	25.1	44.6	30.7	16.6	19.3	25.6	11.6	14.6	13.5	13.0	17.2	15.7	19.5	17.5	17.6	21.8	13.6	16.8	18.8	2.3	15.4	17.4	27.5	19.4	13.0	28.1	40.7	25.1	32.1	26.0	24.4	23.2	23.8	22.9	22.4
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Approved		Enhanced	Nucleoplasm,Cytosol			110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: "	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.12e-5)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.5	34.6	10.0	16.8	12.5	7.4	48.1	15.3	5.5	25.3	17.2	34.4	19.0	20.8	4.4	9.8	21.3	62.3	20.7	30.5	38.0	39.9	22.9	25.5	12.2	9.6	17.9	6.2	6.7	19.0	29.9	30.0	14.7	21.0	29.7	10.1	44.7	31.3	16.2	85.5	25.0	18.8	17.6	12.4	21.3	19.9	14.5	20.8	17.7	48.4	7.7	65.3	12.1	7.8	12.5	39.3	14.0	38.5	7.4	11.3	30.7	11.1	26.7	12.7	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 101.4;ASC TERT1: 63.1;HHSteC: 79.4;HSkMC: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: "	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	4.9	2.1	9.5	14.2	101.4	63.1	0.1	2.7	0.1	1.7	4.1	3.7	0.8	24.5	2.5	0.5	0.0	5.6	11.9	4.2	9.6	5.3	10.5	1.8	5.2	79.4	6.6	1.0	95.9	48.2	3.1	29.1	10.3	11.2	10.0	18.6	3.1	27.3	12.4	2.4	1.6	12.2	2.4	11.9	7.9	3.0	3.6	2.2	2.2	2.5	0.5	14.0	7.8	22.7	2.5	2.2	0.3	3.7	4.5	5.2	31.1	0.8	12.9	0.9	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4
FKBP8	"FKBP38, FKBPr38"	ENSG00000105701	"FK506 binding protein 8"	Q14318	19	18531751-18544077	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 32.5;neutrophil: 31.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 32.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025346, HPA045177"	Supported		Supported	"Endoplasmic reticulum,Mitochondria,Cytosol"				Mitochondria	"Endoplasmic reticulum, Cytosol"	"CAB025346: , HPA045177: "	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (7.76e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.32e-1)"	44.3	38.1	75.9	27.5	82.1	82.5	26.5	43.4	113.7	35.2	31.9	41.2	34.6	31.1	31.4	27.2	48.7	39.3	34.5	43.4	69.6	62.1	28.9	42.7	34.3	31.1	55.3	54.3	56.1	60.4	28.8	42.2	36.6	51.2	36.5	12.9	31.9	73.1	46.1	56.7	35.1	31.6	34.6	46.3	36.7	31.9	49.5	26.9	32.1	38.8	24.2	30.7	36.3	45.8	4.3	4.3	32.5	6.9	3.1	6.6	9.1	36.6	26.3	20.6	39.1	21.3	33.5	51.7	29.7	31.6	22.7	31.5	24.9	50.0	21.0	48.3	36.4	19.9	12.7	41.3	6.4	25.6	60.3	19.6	34.3	29.9	36.7	19.4	43.2	43.7	39.9	20.4	13.0	23.3	41.1	50.0	19.7	61.0	35.2	58.1	42.1	38.2	37.0	17.1	71.8	30.5	24.0	22.9	41.7	20.8	17.2	37.0	20.2	56.7	27.1	28.4	26.0	55.4	22.5	38.3	21.9	24.4	64.3	31.2	25.2	6.3	5.6	32.5	6.0	5.8	5.5	4.1	6.1	6.6	4.3	4.3	4.7	5.3	31.0	3.1	6.9	4.3	6.0	9.1	75.9	82.1	43.4	113.7	69.6	62.1	55.3	54.3	51.2	26.9
FKBP9	"FKBP60, FKBP63"	ENSG00000122642	"FK506 binding protein 9"	O95302	7	32957404-33006931	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.5;fHDF/TERT166: 70.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012595, HPA055256"	Approved		Approved	"Golgi apparatus,Vesicles,Mitochondria"	"Intracellular and membrane"			"Golgi apparatus, Mitochondria"	Vesicles	"HPA012595: AB_1848629, HPA055256: "	"unprognostic (1.23e-2)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (6.94e-2)"	"unprognostic (6.25e-3)"	"prognostic unfavourable (5.80e-4)"	"prognostic unfavourable (2.02e-4)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (3.40e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.90e-3)"	"prognostic unfavourable (7.02e-6)"	35.4	21.1	9.7	12.5	13.6	0.9	43.7	4.5	16.3	33.6	18.3	9.3	16.8	8.8	31.3	30.9	23.7	24.1	28.8	44.4	9.7	11.9	18.2	10.1	30.6	17.5	10.8	9.7	25.9	26.0	12.9	16.0	35.2	13.2	23.7	21.2	30.4	16.0	25.6	17.1	28.0	13.4	37.0	12.8	10.7	17.4	16.3	6.4	2.9	18.9	19.4	11.1	23.7	23.6	0.4	1.4	7.4	4.1	0.3	0.1	0.9	7.0	13.4	5.2	21.6	49.7	57.5	7.0	38.1	39.7	12.6	20.1	5.8	16.8	0.0	15.6	70.8	13.8	7.7	18.6	14.5	0.0	2.3	1.2	14.4	5.8	20.7	0.0	2.0	37.3	11.3	11.2	10.9	15.8	2.7	1.4	25.6	6.8	0.0	3.5	1.1	7.1	0.0	14.1	0.0	14.1	2.4	4.9	12.0	21.7	11.1	13.5	7.8	3.4	21.2	20.7	19.9	12.8	8.7	4.6	8.8	0.0	20.2	0.0	41.1	1.5	4.1	0.9	0.1	2.6	0.1	0.4	0.1	0.0	1.4	0.3	0.1	0.1	7.4	0.3	0.7	0.3	0.0	0.9	9.7	13.6	4.5	16.3	9.7	11.9	10.8	9.7	13.2	6.4
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell line enhanced"	"Detected in some"		"HaCaT: 14.0;NTERA-2: 4.4;TIME: 3.0;U-2 OS: 3.4;U-2197: 3.6"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"			500000	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	14.0	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	3.0	1.2	3.4	3.6	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
FLG2	IFPS	ENSG00000143520	"Filaggrin family member 2"	Q5D862	1	152348735-152360006	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 107.4"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.7"	"Cancer enriched"	"Detected in some"	8	"melanoma: 7.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in single"			HPA028699	Approved						19000000			"HPA028699: AB_10601905"		"unprognostic (2.58e-1)"				"unprognostic (2.33e-1)"		"unprognostic (3.08e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.96e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	7.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.3	107.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.9	0.1	19.6	0.4	0.1	0.2	0.3	0.3	1.2	0.2	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.7	0.2	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.9	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII, actin remodeling protein"	Q13045	17	18244836-18258916	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Approved		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"			1800000	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	21.2	16.8	8.6	16.9	12.4	16.6	21.7	11.7	11.4	17.5	18.5	12.8	14.3	14.6	17.3	16.3	25.9	13.7	15.6	28.3	9.3	7.4	19.0	18.8	17.3	13.4	15.0	6.1	15.3	20.0	15.4	13.5	15.8	13.6	17.2	10.7	11.0	21.3	17.0	78.4	14.4	18.9	19.1	11.1	20.0	15.4	15.6	11.9	21.2	15.1	25.4	17.5	21.5	16.3	5.3	16.0	12.9	24.9	5.2	7.2	10.3	58.9	21.3	6.0	9.3	14.0	12.7	9.1	16.4	19.9	18.5	11.5	27.1	13.5	11.5	17.2	18.8	26.3	8.1	27.3	10.9	9.6	12.6	6.3	15.7	10.7	15.8	7.0	13.4	11.4	16.7	15.1	22.8	17.9	5.1	4.7	10.8	17.6	10.3	5.8	6.3	11.2	10.1	27.2	14.3	13.8	16.7	2.1	3.2	19.1	16.3	8.8	27.7	5.5	21.9	16.5	17.0	31.7	19.3	4.9	3.6	3.5	15.6	6.8	8.9	4.8	13.6	12.9	7.0	21.4	7.2	5.3	5.8	7.2	16.0	3.6	4.3	4.6	12.0	5.2	24.9	4.7	6.6	10.3	8.6	12.4	11.7	11.4	9.3	7.4	15.0	6.1	13.6	11.9
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"			2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: , HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.2	67.8	23.9	30.8	20.9	27.7	39.4	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.6	90.7	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.7	15.2	38.5	28.6	31.8	26.5	12.4	79.8	31.9	39.8	6.8	52.3	38.3	20.0	13.6	9.9	25.2	45.1	13.7	21.7	6.7	20.8	18.2	5.3	12.1	48.8	7.9	39.3	7.6	9.0	95.2	61.2	59.0	62.0	107.6	32.8	19.2	15.2	56.9	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 70.2;TIME: 79.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"			37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	19.8	34.0	3.4	5.0	2.3	4.0	59.9	7.4	6.0	16.5	16.9	34.0	34.0	3.2	2.8	26.0	32.7	6.4	47.2	16.1	17.9	3.1	2.7	28.9	16.5	17.1	2.3	9.8	6.3	20.5	22.9	70.2	55.8	4.5	1.0	10.2	4.3	7.2	5.7	5.3	29.4	3.2	0.9	2.8	22.1	33.9	3.8	3.6	37.5	20.6	4.1	17.0	6.6	79.1	4.3	13.5	51.5	26.3	0.7	0.2	2.6	16.0	4.3	4.5	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell line enhanced"	"Detected in many"		"BJ: 78.6;fHDF/TERT166: 35.8;hTEC/SVTERT24-B: 38.9;U-2 OS: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006135	Enhanced		Supported	"Plasma membrane,Cytosol"			54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavourable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.1	8.6	0.8	78.6	14.9	22.4	10.8	24.4	0.2	0.0	13.3	35.8	0.0	4.8	0.1	13.3	0.0	2.6	0.0	4.0	0.0	9.0	0.0	0.0	16.3	0.0	38.9	0.0	13.9	9.4	0.0	15.2	0.0	0.0	0.3	13.1	4.5	0.0	26.0	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	0.1	0.3	28.8	7.8	33.6	2.0	0.0	0.0	0.0	0.0	26.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742733	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 29.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"			1500000	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	25.7	43.8	32.1	22.6	26.1	22.4	45.9	27.8	37.4	32.9	23.3	14.3	18.8	16.7	19.3	16.7	15.8	27.6	18.8	46.4	29.5	25.7	26.6	26.0	22.9	34.1	29.2	31.9	16.5	24.7	28.7	17.9	25.9	27.2	23.1	18.4	13.0	25.5	32.9	46.1	8.2	16.7	29.0	30.4	22.8	16.7	11.7	18.7	7.8	28.7	13.8	17.1	21.3	36.9	2.9	6.0	29.1	7.3	7.2	3.5	4.7	7.2	2.9	7.0	8.3	7.2	11.1	3.7	7.4	10.1	13.1	11.7	3.8	3.6	4.9	8.1	16.8	5.4	6.9	2.8	8.0	15.1	6.6	6.4	2.8	3.8	17.1	1.2	8.4	11.9	4.2	7.8	15.1	9.1	4.6	7.9	13.7	2.4	4.2	1.7	2.3	8.4	5.4	7.9	6.7	5.1	2.1	6.7	6.4	5.5	3.9	27.8	6.3	1.3	6.1	25.1	8.2	4.4	20.7	5.4	5.3	4.9	3.4	5.3	15.9	12.8	7.3	12.2	3.5	3.4	2.3	2.9	2.2	2.9	5.5	2.2	2.5	2.9	29.1	7.2	2.2	6.0	0.3	4.7	32.1	26.1	27.8	37.4	29.5	25.7	29.2	31.9	27.2	18.7
FLOT2	"ECS-1, ECS1, ESA, ESA1, M17S1"	ENSG00000132589	"Flotillin 2"	Q14254	17	28879335-28897679	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001396, CAB004395, HPA071038"	Supported		Supported	"Vesicles,Plasma membrane"			1900000	"Plasma membrane"	Vesicles	"CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: "	"unprognostic (6.04e-2)"	"unprognostic (8.76e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.15e-3)"	"unprognostic (2.17e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.20e-2)"	26.1	19.5	21.5	28.3	21.9	47.8	21.1	17.3	35.9	17.3	20.7	14.4	13.7	11.1	15.7	14.3	25.9	21.0	15.0	24.5	17.3	18.7	36.4	52.5	24.7	40.1	15.3	17.8	19.8	18.5	18.8	9.1	30.4	31.9	27.6	14.8	20.9	24.3	29.5	21.1	17.7	19.2	25.5	12.8	49.6	17.5	8.4	12.3	17.4	21.8	14.5	33.1	36.7	34.4	25.7	29.4	84.8	21.3	14.8	21.4	24.1	14.7	25.2	19.6	16.8	10.0	12.7	21.2	11.5	15.9	17.0	20.1	26.0	12.7	20.6	22.4	12.8	17.5	21.1	19.1	7.3	65.3	24.9	25.0	23.7	18.7	13.2	20.3	4.2	15.4	14.8	14.1	18.9	26.9	23.5	18.1	7.8	22.3	5.6	15.3	17.2	6.7	8.7	19.7	50.4	30.0	46.3	17.3	29.0	27.0	19.3	20.9	20.1	36.6	21.9	6.1	11.0	9.8	17.4	10.3	17.7	10.6	17.0	19.6	11.3	28.0	21.3	41.2	21.4	19.5	15.8	21.4	16.4	18.1	29.4	25.7	12.3	15.2	84.8	14.8	20.8	8.0	19.3	24.1	21.5	21.9	17.3	35.9	17.3	18.7	15.3	17.8	31.9	12.3
FLT1	"FLT, VEGFR1"	ENSG00000102755	"Fms related tyrosine kinase 1"	P17948	13	28300344-28495145	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"placenta: 155.3"	"Cell line enhanced"	"Detected in some"		"BJ: 17.0;BJ hTERT+: 13.5;HMC-1: 84.6;HUVEC TERT2: 15.3;WM-115: 30.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1"	"Group enriched"	"Detected in many"	5	"B-cells: 3.7;granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011740, HPA014290, CAB068189, CAB068190"	Enhanced		Supported	"Plasma membrane,Actin filaments"	"Secreted to blood"	875697	54000	"Plasma membrane, Actin filaments"		"CAB068189: , CAB068190: , HPA011740: AB_1858737, HPA014290: AB_1858738"	"unprognostic (3.33e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.13e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.03e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.27e-3)"	"unprognostic (9.91e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (4.20e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	18.9	4.0	9.9	4.0	14.3	1.2	13.5	8.0	15.9	7.1	4.6	3.5	1.7	3.5	7.2	2.2	3.4	4.0	6.9	18.3	11.4	7.3	10.3	7.6	12.3	2.5	10.3	3.2	5.1	5.4	13.4	3.7	155.3	13.8	5.1	3.1	9.1	3.0	5.0	12.5	2.6	3.4	7.3	9.6	7.2	4.6	6.8	10.2	0.0	19.1	3.8	2.8	7.6	9.2	3.7	0.5	2.1	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.0	17.0	13.5	6.2	3.6	0.0	0.0	0.0	0.0	2.2	0.0	1.6	0.0	11.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	84.6	0.1	0.0	0.0	0.2	15.3	0.4	0.0	0.0	0.0	1.0	0.8	9.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.1	0.0	30.3	0.2	0.1	0.1	0.1	0.1	0.0	1.1	0.1	0.1	0.0	3.7	0.4	0.4	2.1	0.2	0.1	0.5	0.2	0.2	9.9	14.3	8.0	15.9	11.4	7.3	10.3	3.2	13.8	10.2
FLT4	"PCL, VEGFR3"	ENSG00000037280	"Fms related tyrosine kinase 4"	P35916	5	180601506-180649624	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 8.3;BEWO: 10.2;HEK 293: 12.6;HL-60: 7.4;HUVEC TERT2: 8.1;T-47d: 12.0;TIME: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.7"	"Lineage enriched"	"Detected in single"	35	"T-cells: 7.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000099, HPA046519, HPA067906"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Secreted to blood"		270000000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"CAB000099: , HPA046519: , HPA067906: "	"unprognostic (7.35e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.45e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.88e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.83e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.32e-1)"	14.8	7.1	1.6	4.9	6.0	0.7	28.5	1.3	2.7	6.3	7.3	1.9	2.1	3.1	7.3	6.2	5.7	9.2	5.3	6.4	1.7	0.9	11.7	10.2	14.1	23.6	2.0	0.8	5.8	2.3	2.3	6.2	56.3	2.1	4.9	1.4	6.7	3.3	4.4	4.8	2.8	4.7	4.7	1.5	14.5	2.4	3.5	2.0	0.3	19.4	4.4	2.3	6.1	14.7	0.0	0.1	0.2	0.0	0.0	7.7	0.2	0.1	2.0	2.7	8.3	0.0	0.0	10.2	0.2	0.1	0.0	0.0	0.3	0.3	0.2	0.8	0.1	0.3	2.8	0.1	0.2	0.1	12.6	1.0	0.4	0.4	0.1	7.4	0.2	0.2	0.0	0.1	0.3	8.1	0.3	0.3	1.7	4.5	0.1	0.4	5.8	0.5	6.5	0.0	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.0	12.0	0.2	12.7	0.1	5.9	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.9	0.0	7.7	0.0	0.4	1.6	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.2	1.6	6.0	1.3	2.7	1.7	0.9	2.0	0.8	2.1	2.0
FN1	"CIG, FINC, GFND2, LETS, MSF"	ENSG00000115414	"Fibronectin 1"	P02751	2	215360440-215436172	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Angiogenesis, Cell adhesion, Cell shape"	Heparin-binding	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 235.4;placenta: 433.0"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 837.5;HSkMC: 391.7;hTERT-HME1: 230.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 833.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000126, HPA027066"	Enhanced				"Secreted to blood"		47000000000			"CAB000126: , HPA027066: AB_10602500"	"unprognostic (8.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.36e-2)"	"unprognostic (5.91e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (3.44e-8)"	"prognostic unfavourable (8.82e-5)"	"unprognostic (7.88e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (3.33e-4)"	20.2	4.5	3.1	13.0	5.2	0.2	13.1	2.2	4.3	21.9	57.1	4.4	235.4	3.5	25.1	27.5	37.4	26.5	20.9	57.3	3.9	2.9	5.8	166.3	81.5	7.9	4.6	5.0	16.9	3.3	1.7	3.5	433.0	6.1	17.1	25.1	5.1	10.4	141.2	9.8	7.0	13.5	114.9	4.6	1.9	21.8	9.0	2.7	9.4	5.4	17.4	2.6	64.7	16.9	0.2	0.8	0.0	0.6	0.0	0.3	0.0	0.2	1.9	2.6	0.5	106.3	837.5	0.1	43.2	28.8	43.7	31.2	26.1	1.0	0.0	0.2	143.6	4.4	0.4	98.4	23.6	0.0	0.1	0.0	0.6	81.5	76.9	0.0	0.1	391.7	0.6	103.4	230.4	50.7	0.1	0.1	87.2	0.3	0.0	0.0	1.2	0.3	0.0	0.0	0.1	1.1	0.3	0.1	0.6	5.1	2.7	28.0	0.4	0.0	97.2	63.4	6.7	69.3	8.0	0.1	0.0	0.0	75.3	0.0	16.4	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	3.1	5.2	2.2	4.3	3.9	2.9	4.6	5.0	6.1	2.7
FN3K		ENSG00000167363	"Fructosamine 3 kinase"	Q9H479	17	82735575-82751197	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 17.4;Hep G2: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059151, HPA061358"	Supported		Approved	Mitochondria			1400000	Mitochondria		"HPA059151: , HPA061358: "	"unprognostic (4.74e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.22e-2)"	"prognostic favourable (1.10e-4)"	"unprognostic (6.10e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (2.40e-4)"	"unprognostic (6.66e-2)"	"prognostic favourable (1.39e-6)"	"unprognostic (2.68e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.22e-2)"	12.0	29.4	25.7	3.1	32.7	8.9	5.0	24.8	48.1	10.0	11.0	44.8	6.4	19.4	7.8	7.0	4.7	11.9	6.6	38.1	24.7	22.8	41.7	34.7	7.4	2.6	28.9	25.3	14.0	14.9	17.9	11.9	5.2	34.2	10.4	8.8	11.4	24.6	11.9	14.8	5.0	12.4	6.6	30.8	4.4	10.7	4.6	25.3	0.0	8.2	3.5	2.7	5.6	4.5	0.2	0.0	0.0	0.0	0.9	0.4	0.2	0.6	8.0	2.2	11.8	3.6	3.0	1.5	1.4	1.1	2.8	1.4	10.4	1.7	0.1	2.0	1.3	0.3	17.4	1.3	1.0	0.5	1.2	6.1	6.7	32.3	9.9	0.1	5.2	2.5	4.6	1.1	0.0	5.4	10.9	0.3	0.5	0.9	0.1	0.1	1.4	6.6	1.0	0.1	0.0	5.8	2.2	3.6	11.7	2.7	0.6	7.5	7.8	2.2	1.2	0.2	0.8	2.9	2.1	0.6	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.2	25.7	32.7	24.8	48.1	24.7	22.8	28.9	25.3	34.2	25.3
FN3KRP	"FLJ12171, FN3KL"	ENSG00000141560	"Fructosamine 3 kinase related protein"	Q9HA64	17	82716683-82730328	"Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056172, HPA065831"	Approved		Approved	Nucleoplasm			14000	Nucleoplasm		"HPA056172: , HPA065831: "	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.71e-2)"	17.6	18.3	27.9	10.8	26.3	12.3	15.7	19.5	27.3	15.3	17.4	27.4	10.0	11.8	18.4	16.7	16.4	16.6	13.0	12.7	26.1	20.8	18.8	23.1	12.8	12.9	25.7	23.0	21.9	15.3	10.8	11.4	17.1	22.2	17.1	14.4	13.2	17.2	20.0	7.3	16.1	13.6	20.3	30.7	13.7	12.6	8.8	21.6	8.2	15.1	9.8	17.5	12.1	12.9	16.5	23.2	18.5	15.5	18.5	23.0	17.1	10.7	43.6	11.9	15.7	5.8	11.1	9.9	20.2	11.3	19.6	16.0	23.0	7.6	8.9	13.6	16.3	12.4	10.8	15.3	17.7	5.9	19.2	14.9	24.3	26.5	10.4	10.3	8.3	10.2	18.2	18.6	10.2	14.0	14.3	5.6	25.0	20.4	20.2	15.4	5.4	19.0	15.2	30.3	13.8	13.9	20.7	10.0	21.1	33.4	15.1	16.3	25.2	15.1	12.4	38.1	13.1	26.9	29.8	11.5	12.6	22.0	17.7	13.1	17.5	17.0	14.2	18.5	20.4	15.5	20.0	15.7	19.9	19.5	11.7	16.5	23.0	16.7	2.1	18.5	8.4	23.2	18.6	17.1	27.9	26.3	19.5	27.3	26.1	20.8	25.7	23.0	22.2	21.6
FNBP1	"FBP17, KIAA0554"	ENSG00000187239	"Formin binding protein 1"	Q96RU3	9	129887187-130043194	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.9;MOLT-4: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019635, HPA019691, HPA022119"	Enhanced									"HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897"	"unprognostic (2.86e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.30e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.90e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (8.45e-5)"	"unprognostic (6.84e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	11.5	6.5	20.7	30.5	27.3	20.0	10.1	56.0	21.3	16.9	42.5	30.1	12.2	8.5	23.6	10.2	23.0	15.6	15.9	8.7	22.3	18.6	7.8	10.4	14.1	39.8	25.1	14.5	13.4	5.5	6.2	8.6	9.2	22.8	20.8	17.4	11.4	7.7	26.7	12.2	13.4	15.7	64.7	29.9	32.1	15.3	9.1	27.3	52.1	15.7	5.7	40.4	34.6	12.4	13.5	8.2	12.3	6.9	6.5	13.4	4.9	13.8	6.4	11.9	13.8	7.3	9.1	10.0	7.9	6.8	6.0	5.1	6.7	5.4	27.2	7.0	14.8	7.0	11.1	7.2	6.0	44.9	3.3	7.4	7.8	4.5	12.5	20.1	25.8	6.5	3.1	11.1	6.7	8.7	1.7	0.4	5.5	11.0	45.1	19.8	9.3	11.0	10.4	9.6	7.8	7.5	7.6	1.9	6.0	14.4	14.5	5.5	10.1	9.3	10.6	5.7	7.2	10.3	4.9	5.6	20.6	1.2	6.8	13.9	8.4	12.3	6.0	10.5	13.4	6.6	11.7	13.5	12.2	12.7	6.8	9.0	11.3	10.9	11.4	6.5	6.9	8.2	12.3	4.9	20.7	27.3	56.0	21.3	22.3	18.6	25.1	14.5	22.8	27.3
FNDC3A	"bA203I16.5, FNDC3, KIAA0970"	ENSG00000102531	"Fibronectin type III domain containing 3A"	Q9Y2H6	13	48975912-49209779	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008927, HPA012825"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA008927: AB_1078899, HPA012825: AB_1848985"	"unprognostic (1.54e-1)"	"unprognostic (1.34e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.91e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.03e-2)"	"prognostic favourable (4.25e-4)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.14e-2)"	13.9	27.2	16.9	14.8	24.9	10.0	17.4	19.4	15.0	25.3	22.3	14.6	32.0	17.8	22.4	32.2	10.6	18.2	17.9	14.0	15.0	23.1	20.4	43.0	18.1	12.0	14.6	14.8	25.0	37.4	14.1	59.0	79.8	15.7	15.6	16.2	15.1	22.5	31.6	9.1	9.2	24.7	17.5	14.8	16.2	18.5	18.8	16.6	13.2	34.2	11.6	12.7	17.8	15.4	6.6	7.6	8.7	6.9	3.9	7.9	3.2	4.4	5.1	18.9	4.9	24.0	30.3	3.7	21.0	28.1	20.3	14.8	6.9	10.9	3.4	3.9	15.8	4.9	11.2	7.1	29.6	8.4	8.7	5.5	14.8	12.8	14.5	5.1	0.9	15.5	10.0	17.9	20.9	20.8	6.8	8.3	22.0	1.8	5.0	10.2	9.3	4.3	4.8	7.5	6.2	17.1	8.3	7.2	11.9	7.9	7.1	14.9	3.8	10.1	16.4	10.6	7.3	9.7	14.8	10.2	5.3	3.1	7.9	6.6	10.8	3.4	5.7	3.6	5.2	4.0	7.5	6.6	6.1	4.4	3.6	4.9	7.9	6.7	8.7	3.9	6.9	7.6	4.7	3.2	16.9	24.9	19.4	14.5	15.0	23.1	14.6	14.8	15.7	16.6
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49146635-49208670	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Carboxypeptidase, Dipeptidase, Hydrolase, Metalloprotease, Multifunctional enzyme, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;intestine: 111.2;prostate: 33.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;RPMI-8226: 3.7;SK-BR-3: 4.4;TIME: 2.8;WM-115: 5.3"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced									"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favourable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.2	1.0	10.4	0.9	16.4	0.8	2.5	1.4	12.7	1.4	67.6	37.7	0.0	111.2	1.3	0.8	1.2	2.1	5.0	0.7	16.9	8.7	6.1	15.7	1.1	0.9	19.0	9.1	1.0	0.7	0.7	0.4	0.7	17.7	33.8	0.8	0.6	20.7	0.8	0.6	1.2	61.1	1.0	33.0	1.5	1.0	0.9	16.2	0.0	1.0	0.0	0.8	1.2	0.5	0.9	0.1	0.3	0.8	1.4	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.6	0.0	0.2	5.3	0.5	0.0	1.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.0	0.0	0.3	0.3	3.7	0.0	0.0	0.4	1.6	0.0	4.4	1.0	1.0	0.0	2.8	0.2	2.7	0.4	0.3	0.1	0.5	0.1	0.0	0.9	5.3	0.1	0.8	0.3	0.9	0.6	0.2	0.6	1.2	0.5	0.0	0.9	0.7	0.3	0.2	1.4	0.5	0.1	0.4	0.0	10.4	16.4	1.4	12.7	16.9	8.7	19.0	9.1	17.7	16.2
FOSL1	fra-1	ENSG00000175592	"FOS like 1, AP-1 transcription factor subunit"	P15407	11	65892049-65900573	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.2;tongue: 46.8"	"Cell line enhanced"	"Detected in many"		"PC-3: 92.9;U-2197: 62.3;WM-115: 140.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 6.9"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004396, HPA030728"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004396: AB_627632, HPA030728: "	"unprognostic (2.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.80e-4)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.26e-5)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (6.40e-6)"	"unprognostic (2.23e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.82e-2)"	22.4	3.7	1.5	8.2	3.1	17.9	3.6	1.1	2.8	5.4	2.8	1.5	0.2	0.8	2.1	2.0	35.2	4.4	24.4	5.8	2.3	1.3	2.2	4.4	7.7	1.7	2.6	0.5	2.6	9.9	0.4	2.0	3.2	6.5	3.1	1.7	0.6	5.4	1.0	6.6	9.2	2.0	3.6	3.5	1.6	8.7	1.5	2.3	0.3	2.1	46.8	16.5	16.6	4.6	0.0	6.9	1.0	1.6	0.0	0.6	1.1	36.0	5.3	0.6	2.4	5.4	5.4	5.2	33.8	31.0	29.3	16.4	1.6	30.1	0.0	7.4	23.4	6.8	2.2	27.2	25.2	1.1	0.0	2.2	0.5	4.0	6.8	1.4	0.8	2.3	2.7	22.9	34.7	9.4	5.2	0.2	38.4	1.5	0.0	3.0	2.5	92.9	0.1	2.9	0.1	13.6	2.4	0.0	0.0	2.0	0.0	25.4	0.1	1.3	23.3	34.7	7.1	62.3	49.5	0.0	0.1	0.1	48.8	0.6	140.9	0.0	1.6	0.0	0.3	1.1	0.2	0.0	0.6	0.3	6.9	0.0	0.6	0.0	1.0	0.0	0.5	0.8	0.0	1.1	1.5	3.1	1.1	2.7	2.3	1.3	2.6	0.5	6.5	2.3
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609972-1613897	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"retina: 32.7;salivary gland: 86.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 38.9;HEK 293: 37.9;RPTEC TERT1: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 1.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA040670	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	7.7	4.4	2.6	1.3	3.4	1.0	9.4	2.3	3.4	6.6	1.4	2.8	3.2	1.2	2.4	3.8	3.8	3.4	9.8	9.5	3.2	2.1	12.9	1.4	3.8	1.6	4.5	2.3	4.8	2.8	2.2	6.5	3.1	6.5	6.0	1.3	32.7	86.6	4.9	3.6	7.1	1.2	2.1	3.9	0.9	1.1	4.6	2.6	2.8	3.7	4.2	2.9	5.7	4.6	0.0	0.0	0.2	0.1	1.4	0.0	0.0	7.2	0.8	0.2	38.9	1.8	2.0	1.2	3.6	4.3	2.3	1.8	2.7	1.5	0.0	4.2	2.1	8.2	3.7	2.7	1.9	2.2	37.9	1.5	2.2	1.3	1.2	0.5	2.5	6.8	3.7	3.1	3.6	3.3	1.0	0.0	0.9	1.5	0.0	0.8	0.1	3.1	0.0	1.6	0.2	15.2	5.5	1.4	3.4	4.5	0.0	2.6	1.1	0.6	0.8	4.9	3.0	2.5	3.8	0.1	0.3	0.0	1.4	1.8	4.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.0	2.6	3.4	2.3	3.4	3.2	2.1	4.5	2.3	6.5	2.6
FOXD4L1	FOXD5	ENSG00000184492	"Forkhead box D4 like 1"	Q9NU39	2	113498665-113501155	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 2.2;bone marrow: 3.0;brain: 3.3;lymphoid tissue: 1.2;testis: 3.1"	"Cell line enhanced"	"Detected in some"		"RH-30: 5.2;THP-1: 3.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	22	"naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"B-cells: 2.2"									HPA012836	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA012836: AB_2105429"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.02e-2)"	"unprognostic (6.61e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.41e-4)"	"unprognostic (2.54e-1)"	"unprognostic (5.77e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.54e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.18e-8)"	"unprognostic (1.57e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.91e-4)"	0.2	0.5	0.4	1.2	1.2	3.0	0.1	3.3	0.8	0.0	0.0			0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.6	0.6	0.4	0.1	0.4	0.4	0.3		0.0	0.2	0.0	0.4	0.1		0.2	0.1		0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.6	0.2	3.1			0.2		0.0	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.6	1.0	0.0	1.5	0.0	0.6	0.0	0.1	0.3	0.0	2.0	0.9	0.1	0.1	0.6	0.0	0.1	1.9	1.3	0.7	1.0	0.9	0.0	2.1	1.6	0.0	0.7	0.2	0.0	0.0	1.2	1.7	0.3	0.1	0.3	0.9	0.0	0.7	0.6	5.2	0.7	0.1	0.6	0.7	0.4	0.5	0.1	0.2	0.4	3.7	0.4	1.7	1.5	0.6	1.3	1.3	1.3	0.7	0.3	1.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FOXI1	"FKHL10, FREAC6"	ENSG00000168269	"Forkhead box I1"	Q12951	5	170105897-170109725	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 37.0;salivary gland: 12.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.4;HaCaT: 1.4;MCF7: 5.3;SCLC-21H: 1.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 5.8;renal cancer: 23.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	48	"eosinophil: 4.7"	"Lineage enriched"	"Detected in single"	48	"granulocytes: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071469	Enhanced		Uncertain	Nucleoli,Vesicles				"Nucleoli, Vesicles"		"HPA071469: "	"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.48e-2)"		"unprognostic (8.06e-2)"		"unprognostic (7.47e-2)"		"unprognostic (2.73e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.71e-3)"	"unprognostic (4.88e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.34e-2)"		"unprognostic (2.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	7.5	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	37.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.3	0.0	0.0	12.4	3.7	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	1.4	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70952817-71583993	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 39.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003876, CAB011501"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	24.6	5.1	7.0	30.2	19.2	32.7	21.9	7.2	13.1	16.3	29.3	8.7	10.3	10.1	19.8	9.9	19.6	13.1	19.3	15.5	8.4	5.9	7.6	12.9	26.1	34.0	7.6	10.2	30.3	14.7	7.2	25.7	11.4	7.4	21.6	21.6	11.3	24.6	11.2	12.7	12.2	16.7	34.3	7.9	18.6	20.4	11.7	10.1	38.1	19.8	13.1	27.0	28.5	31.8	29.9	8.4	14.4	9.9	9.2	29.6	11.2	3.7	2.8	7.0	4.7	3.3	9.4	3.3	11.2	12.9	9.8	7.2	20.9	4.4	10.1	1.7	5.0	2.6	12.9	9.6	16.6	3.1	5.3	5.2	7.0	19.7	8.1	9.8	12.8	9.6	4.0	39.5	17.5	14.6	5.2	14.9	4.4	16.5	4.8	3.9	8.6	18.3	14.6	12.0	1.8	8.0	11.9	5.9	10.7	11.7	3.2	0.7	2.3	7.2	18.4	13.6	5.9	19.0	15.5	3.7	2.8	14.3	8.7	12.5	2.9	14.4	5.7	6.0	8.3	5.7	9.3	25.8	18.3	10.3	5.3	29.9	29.6	18.9	8.3	9.2	9.9	8.4	15.9	11.2	7.0	19.2	7.2	13.1	8.4	5.9	7.6	10.2	7.4	10.1
FPGT	GFPP	ENSG00000254685	"Fucose-1-phosphate guanylyltransferase"	O14772	1	74198212-74234086	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072331			Uncertain	Vesicles				Vesicles		"HPA072331: "	"unprognostic (1.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.18e-3)"	"unprognostic (4.32e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.86e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.88e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.91e-1)"	14.6	11.6	10.9	9.1	12.6	3.4	13.0	19.0	15.8	15.9	11.7	13.0	7.5	11.5	17.7	11.1	15.7	15.4	13.3	12.8	10.9	7.1	15.9	13.7	10.8	8.0	15.5	10.6	14.1	10.2	14.2	27.7	10.6	14.4	11.1	11.3	10.6	11.7	9.1	15.7	12.0	12.0	11.8	16.3	11.0	12.3	8.7	13.9	6.6	20.0	6.8	9.2	17.9	12.9	4.3	9.2	15.2	14.9	3.8	5.4	7.4	9.2	7.7	5.8	8.5	13.5	12.7	8.7	12.2	8.1	8.4	10.0	4.3	7.0	5.7	15.1	7.2	7.8	10.4	11.1	13.4	11.5	4.4	12.9	9.3	7.2	11.3	9.8	9.9	10.4	14.5	8.4	4.0	8.7	13.2	6.8	13.2	2.4	5.4	2.0	6.3	7.0	5.8	13.6	8.0	7.4	6.7	6.1	6.1	9.0	13.2	14.0	15.9	11.2	7.8	3.7	7.1	20.2	9.2	7.5	5.3	7.6	15.0	9.7	12.5	12.0	14.9	15.2	4.3	14.5	5.0	3.6	4.4	3.9	9.2	4.3	4.9	4.4	4.4	3.8	12.5	0.9	5.4	7.4	10.9	12.6	19.0	15.8	10.9	7.1	15.5	10.6	14.4	13.9
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"RT4: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025217, HPA030479"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025217: , HPA030479: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favourable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	3.2	5.3	0.8	1.3	0.4	0.4	1.0	0.8	0.2	0.1	0.1	4.1	5.1	1.3	4.9	0.8	7.7	0.4	1.5	0.2	4.4	0.5	1.8	4.6	3.5	0.3	1.2	1.1	0.3	2.2	0.5	0.6	0.3	0.9	3.3	1.3	1.8	1.0	0.8	1.4	0.9	1.5	4.6	1.6	6.5	10.1	1.1	1.2	1.1	6.8	0.7	2.1	1.0	1.3	1.5	1.6	1.2	0.8	5.0	3.5	2.3	1.5	0.8	1.0	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5
FRMD4B	"GRSP1, KIAA1013"	ENSG00000114541	"FERM domain containing 4B"	Q9Y2L6	3	69169990-69542583	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.4;hTERT-HME1: 22.0;HUVEC TERT2: 23.9;TIME: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA009705	Uncertain	Supported					7400			"HPA009705: AB_1849147"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.59e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.23e-2)"	"prognostic favourable (5.01e-4)"	"unprognostic (1.49e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.39e-3)"	10.0	3.7	10.0	7.8	32.0	9.3	11.1	2.3	16.6	17.4	8.4	47.9	3.3	5.9	7.8	9.7	25.9	9.2	13.3	11.6	14.9	8.1	11.6	23.7	16.7	9.3	27.1	11.1	7.7	5.8	1.5	4.8	16.9	21.2	12.0	8.9	11.5	23.8	6.8	2.8	22.1	8.2	7.0	21.3	20.0	10.0	2.8	30.2	9.4	27.4	10.2	8.4	7.9	15.0	1.4	11.0	8.3	18.9	2.4	9.9	4.5	3.0	0.8	4.9	0.1	0.1	0.7	5.4	0.2	0.7	0.4	0.4	18.4	5.3	0.3	1.7	0.2	12.0	1.9	14.1	0.6	1.0	1.4	7.8	0.6	1.0	0.3	2.0	4.1	0.7	16.5	0.5	22.0	23.9	0.7	2.7	1.4	3.4	0.2	0.4	2.6	3.5	12.8	1.2	0.5	7.2	2.1	5.4	7.0	0.8	5.8	15.2	2.1	3.1	18.7	0.2	2.0	0.2	0.7	0.2	0.1	0.4	0.1	6.1	6.2	8.3	18.9	1.5	1.4	9.2	5.0	1.1	4.6	1.9	10.8	1.4	1.4	1.3	4.9	2.4	1.5	11.0	9.9	4.5	10.0	32.0	2.3	16.6	14.9	8.1	27.1	11.1	21.2	30.2
FSCN1	"FLJ38511, p55, SNL"	ENSG00000075618	"Fascin actin-bundling protein 1"	Q16658	7	5592823-5606655	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 80.6;K-562: 67.5;NB-4: 76.7;PC-3: 67.5;SH-SY5Y: 64.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000121, HPA005723, CAB035991, HPA050654"	Enhanced		Supported	"Plasma membrane,Cytosol"			4500000	Cytosol	"Plasma membrane"	"CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: "	"unprognostic (1.91e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.12e-2)"	"unprognostic (5.00e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (2.16e-3)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (8.15e-7)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.93e-3)"	26.3	13.3	23.7	29.6	30.1	6.3	8.1	5.5	56.9	9.9	5.5	35.1	0.0	5.4	11.7	2.3	22.3	5.9	8.9	10.6	27.7	16.8	5.5	7.1	11.3	15.2	26.9	23.6	21.8	5.1	2.3	7.0	29.4	20.1	4.1	3.0	8.1	11.0	3.9	7.8	17.3	6.6	7.0	29.6	39.3	7.6	15.9	28.3	9.3	8.5	15.9	11.4	14.7	12.3	0.2	5.4	1.0	1.9	0.0	0.1	1.4	7.8	18.3	12.2	43.7	4.7	9.1	80.6	18.9	8.4	3.2	3.5	12.7	2.0	0.1	23.2	8.3	30.0	7.0	30.4	0.2	9.0	3.8	0.5	19.4	59.7	2.5	0.0	1.5	5.6	9.0	6.1	5.0	15.9	67.5	0.1	4.2	0.8	0.2	76.7	31.9	67.5	17.8	2.9	0.3	4.7	0.7	9.8	64.8	15.9	0.2	0.6	0.4	4.8	32.3	22.5	39.6	13.0	19.4	0.1	0.1	0.0	14.5	0.0	42.2	0.0	1.9	0.1	0.0	0.5	0.0	0.2	0.1	0.0	5.4	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	1.4	23.7	30.1	5.5	41.3	27.7	16.8	26.9	23.6	20.1	28.3
FST	FS	ENSG00000134363	Follistatin	P19883	5	53480409-53487134	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 58.2;HaCaT: 49.3;HBEC3-KT: 31.5;HMC-1: 35.4;PC-3: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.0;naive CD4 T-cell: 2.0;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	5	"monocytes: 1.0;T-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB026025	Approved				"Secreted to blood"		1800000			"CAB026025: "	"unprognostic (1.43e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (4.44e-5)"	"unprognostic (1.21e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-1)"	12.4	3.2	2.0	3.1	0.8	0.1	7.1	0.2	0.7	3.5	5.2	0.3	1.1	0.9	2.3	9.5	3.6	4.9	4.1	5.6	1.0	1.0	1.7	42.7	4.3	0.8	0.4	0.6	20.7	19.4	0.0	2.9	13.5	1.0	9.3	1.7	5.7	5.5	6.5	12.6	9.0	4.3	3.7	0.4	0.2	4.8	4.9	0.5	1.2	2.0	6.7	7.1	6.2	13.8	0.1	0.2	0.0	1.0	0.0	2.0	0.1	3.2	0.3	5.8	0.0	6.6	2.3	9.6	12.7	58.2	7.8	7.7	0.0	0.0	0.0	0.1	3.3	49.3	0.0	31.5	5.6	0.1	0.0	0.6	0.2	5.2	3.5	0.0	35.4	5.4	0.0	14.4	9.4	6.6	0.0	0.1	4.9	0.0	0.0	0.2	8.9	95.2	0.6	7.4	0.0	0.0	5.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	21.6	6.2	2.2	1.8	0.0	0.0	0.0	2.5	0.6	19.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.2	0.1	2.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.8	0.2	0.7	1.0	1.0	0.4	0.6	1.0	0.5
FSTL1	"FRP, FSL1, OCC-1, OCC1, tsc36"	ENSG00000163430	"Follistatin like 1"	Q12841	3	120392293-120451253	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 127.1;BJ: 147.5;fHDF/TERT166: 182.0;HBF TERT88: 121.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035251, HPA040815"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		32000000	"Vesicles, Cytosol"		"HPA035251: AB_10601906, HPA040815: "	"unprognostic (2.60e-1)"	"unprognostic (1.59e-3)"	"unprognostic (8.84e-2)"	"unprognostic (4.54e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.88e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (4.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.47e-3)"	72.3	28.6	4.8	23.1	5.8	0.0	104.0	2.5	6.7	52.1	39.1	7.3	28.7	5.8	41.6	58.1	39.2	42.6	45.6	69.4	5.9	3.2	15.1	5.5	33.6	44.4	4.3	4.3	26.9	8.7	5.5	7.9	110.0	13.2	36.3	15.4	26.2	17.5	32.5	23.6	18.4	18.6	90.2	9.4	16.7	22.1	19.8	4.9	4.7	23.8	29.1	11.1	67.1	65.8	0.1	1.2	10.2	0.1	0.0	0.0	3.6	5.3	1.4	15.3	6.3	92.4	127.1	0.0	147.5	82.8	95.5	84.8	0.0	12.3	0.0	12.5	182.0	1.4	4.7	18.3	121.8	0.0	2.2	0.0	11.6	0.0	20.3	0.0	0.0	96.6	0.5	61.7	13.5	55.3	0.0	0.0	15.5	0.0	1.4	0.1	12.6	12.3	0.0	6.4	0.0	10.2	0.1	2.7	6.5	52.4	0.9	5.3	1.6	0.4	67.5	35.9	34.5	18.7	21.8	0.0	0.0	0.1	12.5	0.0	4.6	10.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	1.2	0.0	3.6	4.8	5.8	2.5	6.7	5.9	3.2	4.3	4.3	13.2	4.9
FTH1	"FHC, FTH, FTHL6, PIG15, PLIF"	ENSG00000167996	"Ferritin heavy chain 1"	P02794	11	61959718-61967660	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 756.2"	"Cell line enhanced"	"Detected in all"		"ASC diff: 547.1;HHSteC: 570.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 756.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB008623	Approved		Approved	Microtubules			9000000	Microtubules		"CAB008623: "	"unprognostic (7.15e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (7.56e-5)"	"prognostic unfavourable (6.18e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.44e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (2.99e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.83e-2)"	155.1	118.0	177.6	138.9	92.6	162.0	302.9	38.5	163.7	104.2	142.4	97.8	72.0	72.2	81.6	102.4	88.8	70.6	83.5	236.1	124.7	91.2	113.5	128.2	297.3	394.0	118.5	110.6	81.7	150.8	49.7	46.7	70.1	77.5	60.9	138.5	79.5	180.5	65.1	124.1	42.5	110.0	140.0	182.1	84.4	81.0	67.8	88.2	58.5	100.3	64.1	48.9	106.7	94.0	69.5	163.3	756.2	424.5	30.7	69.2	284.2	64.4	181.0	27.6	73.0	547.1	265.0	152.3	59.1	254.1	60.4	61.0	21.9	89.5	7.5	375.8	170.2	110.4	24.6	48.9	39.2	30.7	12.1	37.5	250.9	142.9	570.0	17.6	59.0	358.9	240.3	120.5	226.6	75.5	55.9	86.0	210.8	87.2	19.7	28.8	47.2	306.1	19.6	34.1	53.6	308.6	175.5	23.5	29.7	203.3	22.4	96.2	39.8	23.7	84.1	188.8	45.2	83.5	37.1	14.9	51.2	23.1	257.4	7.8	44.9	401.9	297.7	247.4	40.8	367.6	40.2	68.6	58.3	40.4	163.3	69.5	49.3	38.2	756.2	30.7	424.5	121.2	69.2	284.2	177.6	92.6	38.5	163.7	124.7	91.2	118.5	110.6	77.5	88.2
FTL	"MGC71996, NBIA3"	ENSG00000087086	"Ferritin light chain"	P02792	19	48965301-48966878	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Iron storage"		"Cancer-related genes, Cataract, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 1149.4"	"Cell line enhanced"	"Detected in all"		"HHSteC: 570.4;HSkMC: 477.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"granulocytes: 1149.4;monocytes: 890.5"									"CAB020769, HPA041602"	Enhanced		Approved	Cytosol			240000000	Cytosol		"CAB020769: , HPA041602: "	"unprognostic (2.95e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.56e-3)"	"unprognostic (7.48e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (6.17e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (4.40e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.87e-2)"	326.0	111.3	147.1	113.6	130.9	179.8	321.8	25.8	101.3	105.7	107.5	134.7	58.2	120.5	54.9	85.4	85.0	71.3	214.6	140.8	111.7	88.2	295.2	526.9	391.6	444.6	139.4	49.6	126.8	108.0	27.0	63.6	166.3	89.0	108.0	92.3	114.4	59.4	75.4	75.6	48.3	159.4	149.2	194.5	317.9	105.2	53.9	74.5	45.1	130.0	57.5	67.5	159.8	172.1	147.8	231.2	1149.4	890.5	41.5	86.1	674.1	18.5	282.8	21.2	32.4	367.1	381.0	38.0	48.2	283.8	69.5	156.5	61.9	75.4	14.1	92.8	287.8	11.1	17.4	28.5	62.8	190.6	11.2	37.5	73.8	404.9	570.4	88.0	126.2	477.2	38.7	118.2	52.1	100.6	69.3	29.6	137.1	4.5	24.3	51.4	38.5	28.9	20.3	14.4	145.7	44.1	11.8	27.2	15.8	126.6	6.9	26.3	4.0	184.1	75.2	76.1	40.0	97.6	65.9	128.1	282.4	13.2	80.7	92.8	133.0	488.0	642.5	675.8	63.9	890.5	72.6	147.8	71.3	68.3	231.2	132.2	86.1	74.8	1149.4	41.5	768.3	97.2	83.8	674.1	147.1	130.9	25.8	101.3	111.7	88.2	139.4	49.6	89.0	74.5
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm			200000	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavourable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	23.9	35.5	21.8	42.4	26.9	56.8	27.0	34.0	31.8	24.3	19.6	18.1	23.0	21.8	29.4	35.0	23.5	25.2	18.4	27.5	22.0	22.3	26.6	16.3	27.2	37.6	17.5	28.8	44.4	31.6	36.0	41.5	27.3	26.3	22.4	28.3	22.0	28.2	35.6	27.4	21.3	24.0	22.7	31.3	28.6	22.6	17.6	19.9	64.9	35.0	26.2	40.3	24.0	29.1	16.1	11.3	10.8	16.1	23.5	22.2	12.8	21.8	19.2	45.6	18.1	7.1	8.9	37.4	22.6	13.5	21.7	15.8	19.5	24.4	39.1	10.6	16.8	21.8	30.5	24.9	29.1	43.0	15.5	25.0	32.0	28.6	15.3	42.8	10.5	11.7	20.6	23.2	18.4	17.3	28.6	17.4	17.1	22.1	34.0	20.7	35.6	13.8	41.7	36.1	15.0	22.5	21.5	24.1	22.7	21.0	19.9	17.8	24.3	15.5	22.2	21.0	30.7	5.9	27.0	16.7	18.0	50.7	9.1	18.9	21.4	3.8	9.6	10.8	18.7	15.7	22.2	16.1	18.3	19.4	8.7	13.1	17.9	20.9	4.0	23.5	16.1	11.3	21.3	12.8	21.8	26.9	34.0	31.8	22.0	22.3	17.5	28.8	26.3	19.9
FUCA1		ENSG00000179163	"Alpha-L-fucosidase 1"	P04066	1	23845077-23868294	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046542, HPA056371"	Enhanced				"Intracellular and membrane"		65000000			"HPA046542: AB_2679691, HPA056371: AB_2683108"	"unprognostic (6.94e-3)"	"unprognostic (6.53e-2)"	"unprognostic (2.68e-3)"	"prognostic favourable (2.45e-4)"	"unprognostic (5.64e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.99e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (5.70e-13)"	"unprognostic (3.75e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.13e-3)"	15.8	18.0	4.6	24.1	7.1	0.9	8.9	4.2	8.1	13.1	30.2	6.9	28.4	20.4	9.9	35.7	8.7	12.7	22.6	15.0	4.7	6.4	28.9	39.3	20.7	66.7	4.8	4.7	19.4	15.5	12.2	10.9	31.9	8.0	15.2	33.5	13.8	22.6	18.5	6.9	6.6	42.3	7.4	7.1	32.3	14.8	15.6	2.9	11.6	27.3	8.0	25.1	23.6	7.8	8.3	15.2	16.8	34.8	14.4	9.9	19.0	5.2	3.6	0.7	10.9	1.4	0.1	3.8	5.6	11.7	5.9	11.1	4.8	56.3	7.9	14.2	7.1	3.2	5.2	12.0	7.8	5.6	8.7	6.5	3.2	10.8	5.0	0.6	21.8	5.4	6.8	2.1	2.8	2.3	3.0	0.1	7.0	5.7	1.6	5.8	1.8	5.7	8.9	0.0	8.6	22.0	13.6	3.7	3.6	16.2	6.3	8.5	4.7	2.6	0.6	2.0	3.2	13.4	1.9	9.9	10.0	2.8	5.0	19.7	3.2	13.7	34.8	16.8	9.9	34.5	8.5	8.3	7.2	8.4	15.2	4.7	7.0	8.2	4.3	14.4	28.7	8.8	7.0	19.0	4.6	7.1	4.2	8.1	4.7	6.4	4.8	4.7	8.0	2.9
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494811-143511690	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"		53000000			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	22.6	32.6	10.3	14.2	16.2	11.6	24.1	6.2	11.4	18.5	21.2	17.6	23.1	22.0	17.9	24.8	11.9	17.2	25.0	25.6	11.6	11.8	34.1	45.7	21.7	30.0	20.4	8.7	21.9	32.6	52.3	14.4	40.7	16.9	12.0	28.4	21.4	18.9	24.5	6.7	9.3	29.5	14.6	18.5	20.3	20.4	11.0	16.1	3.6	17.9	8.7	10.3	16.7	15.0	4.1	22.9	9.3	29.3	9.7	6.7	14.9	23.1	13.6	11.9	21.5	17.6	34.7	22.5	21.9	23.6	27.1	46.1	25.9	23.3	0.0	16.4	29.4	0.1	5.9	2.9	37.7	20.8	22.8	7.8	25.4	39.1	25.5	0.0	4.0	18.5	17.4	24.2	10.5	27.5	27.6	12.2	30.5	27.4	0.0	18.1	15.4	18.8	0.0	24.9	17.1	32.2	14.5	9.0	5.9	24.1	16.2	19.7	7.9	19.1	16.1	16.2	13.7	40.3	42.1	4.5	4.9	0.1	18.7	14.3	5.5	9.3	29.3	8.7	4.9	28.8	5.6	4.1	3.6	4.1	22.9	2.5	1.6	3.0	2.0	9.7	20.0	3.5	6.7	14.9	10.3	16.2	6.2	11.4	11.6	11.8	20.4	8.7	16.9	16.1
FURIN	"FUR, PACE, PCSK3, SPC1"	ENSG00000140564	"Furin, paired basic amino acid cleaving enzyme"	P09958	15	90868592-90883458	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"liver: 118.4;placenta: 158.9;salivary gland: 337.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009499	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"		41000	"Golgi apparatus"	Nucleoplasm	"CAB009499: AB_2105095"	"unprognostic (2.46e-1)"	"unprognostic (2.73e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.11e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.52e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.46e-2)"	"unprognostic (4.27e-3)"	"unprognostic (8.20e-2)"	8.3	3.3	3.0	7.5	3.6	16.6	5.9	5.0	4.4	4.1	6.6	2.8	3.5	5.7	4.9	10.8	4.7	4.4	3.9	6.9	3.1	1.8	6.4	118.4	9.5	3.1	2.8	2.7	4.2	22.5	3.8	7.2	158.9	3.5	9.3	2.2	3.0	337.9	4.7	8.7	9.0	5.9	3.1	3.0	8.2	6.0	5.3	2.9	4.8	8.9	5.5	4.1	4.4	4.3	1.5	3.3	10.3	3.3	3.1	1.9	2.0	14.1	8.6	1.9	8.7	14.3	9.2	22.2	17.8	13.6	7.4	5.2	12.6	15.5	0.5	45.9	12.9	25.5	3.9	9.2	1.6	40.7	10.1	24.8	15.5	16.5	7.6	3.4	40.9	10.4	10.4	8.4	3.8	23.6	18.9	2.5	4.9	9.7	1.3	11.2	6.2	2.5	2.2	7.5	3.2	11.5	10.8	3.9	2.6	15.1	8.2	12.6	2.9	9.1	34.7	8.3	17.8	12.7	26.1	4.4	25.1	1.1	15.9	11.2	16.8	7.5	3.3	10.3	1.9	1.1	1.4	1.5	1.2	1.2	2.1	1.0	0.6	0.8	7.4	3.1	0.7	3.3	0.9	2.0	3.0	3.6	5.0	4.4	3.1	1.8	2.8	2.7	3.5	2.9
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180110-31194871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Enhanced	Nucleoplasm			190000	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: , HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavourable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	44.0	24.2	35.0	47.1	43.3	41.7	29.9	64.1	59.0	39.7	32.4	48.6	22.6	28.0	54.5	44.7	29.6	48.6	35.9	32.0	32.7	34.6	30.3	24.4	27.7	51.3	31.1	39.0	66.7	28.8	41.7	24.8	44.1	39.2	29.1	30.2	39.3	27.6	30.5	43.6	24.3	28.7	46.5	33.7	36.2	27.7	40.7	30.7	66.3	29.1	40.1	49.6	30.3	31.4	16.4	22.3	24.2	29.0	14.2	24.8	9.4	47.8	41.5	54.7	35.5	13.5	11.5	58.2	64.4	23.4	29.5	22.5	56.0	32.2	73.7	46.0	32.5	20.9	54.5	41.7	28.2	43.8	35.4	62.3	31.4	56.4	22.5	66.2	42.9	23.2	11.5	42.5	28.9	28.1	66.0	25.1	36.6	58.6	48.1	58.6	83.3	45.6	79.0	72.8	42.2	32.9	35.1	35.7	64.0	42.3	29.9	31.9	36.0	73.7	34.8	47.2	47.4	31.1	68.1	23.4	44.7	103.8	26.4	45.1	57.0	5.6	17.5	24.2	24.8	29.0	24.0	12.8	17.4	21.8	19.3	16.4	20.3	21.1	14.9	14.2	25.1	22.3	13.9	9.4	35.0	43.3	64.1	59.0	32.7	34.6	31.1	39.0	39.2	30.7
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol				Cytosol		"HPA018246: AB_1849204, HPA055475: "	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	37.8	17.6	38.1	29.6	29.3	33.5	17.2	30.1	30.8	33.9	33.6	25.9	19.1	19.3	49.9	20.7	18.3	30.7	18.5	47.5	25.5	20.7	19.7	23.3	29.5	31.3	12.2	16.3	35.3	21.2	17.1	41.0	34.1	15.7	23.5	42.6	13.7	23.2	20.5	43.0	19.4	16.1	48.7	20.6	26.1	11.9	16.1	20.6	26.1	30.4	38.9	42.2	23.5	27.2	25.6	28.6	16.0	59.2	22.0	27.5	23.0	26.7	17.6	32.5	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavourable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	99.5	23.8	0.0	0.1	35.6	45.2	24.0	57.3	76.4	40.9	30.6	6.7	29.2	22.9	15.7	69.1	23.5	14.7	35.3	26.4	28.3	9.6	42.8	13.2	0.0	28.1	24.4	42.7	26.8	15.8	29.7	51.4	38.6	40.2	111.0	25.5	0.1	2.9	10.2	7.4	13.8	13.7	5.0	29.0	15.0	0.5	4.3	0.0	31.6	16.6	33.4	8.7	19.6	54.4	50.6	19.3	54.8	4.3	0.1	1.7	5.8	77.1	56.7	77.2	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"			2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: "	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favourable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.2	34.2	5.7	26.2	16.1	0.6	5.4	17.1	4.6	8.3	0.2	0.3	3.8	3.5	10.4	0.2	4.8	7.5	9.1	0.1	12.6	10.5	2.5	0.5	15.5	3.5	3.6	15.4	11.3	17.4	14.9	18.8	0.8	26.8	16.4	0.2	16.7	3.2	4.9	3.4	5.3	4.6	0.2	0.0	1.7	24.0	9.7	1.0	0.4	22.8	0.2	10.6	11.9	14.0	2.6	103.1	3.4	3.8	3.5	5.9	26.4	8.2	24.3	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell line enhanced"	"Detected in many"		"AF22: 16.3;HSkMC: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favourable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.3	1.7	13.3	11.5	3.0	5.9	3.8	2.2	1.5	0.7	2.8	0.0	1.4	3.8	3.0	2.5	1.3	1.4	0.0	3.2	0.1	3.1	0.8	0.9	2.6	0.7	21.8	2.3	5.0	1.6	0.5	0.9	2.3	6.3	3.9	0.4	0.7	4.2	2.7	3.2	10.0	0.2	3.5	7.6	2.2	4.3	4.5	3.7	0.9	1.9	2.4	2.4	9.3	7.0	9.8	2.4	2.2	1.5	0.2	10.0	2.2	10.7	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5
FZD8		ENSG00000177283	"Frizzled class receptor 8"	Q9H461	10	35638249-35642278	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 27.3;U-138 MG: 10.3;U-251 MG: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA045025, HPA071142"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045025: AB_10795888, HPA071142: "	"unprognostic (1.20e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.85e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.21e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.19e-1)"	8.9	2.6	7.4	2.7	5.1	0.7	4.9	0.5	8.5	5.2	10.4	4.9	0.6	1.8	3.4	2.2	2.1	7.9	3.9	12.5	12.0	1.7	13.1	5.0	9.5	4.3	2.7	3.8	4.9	9.5	6.0	4.0	1.8	7.1	3.4	4.6	14.2	4.5	3.5	5.8	4.6	2.6	3.6	1.4	21.3	10.4	4.1	5.5	3.3	14.7	2.4	3.0	2.8	5.4	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	2.9	0.5	0.0	1.2	0.0	1.8	3.2	0.1	0.1	0.1	0.3	0.5	0.0	0.5	1.4	1.0	0.3	1.0	0.0	0.0	8.4	0.0	0.3	0.1	0.6	0.0	0.2	1.0	4.1	6.7	2.6	2.3	0.1	0.0	0.9	1.2	0.0	0.0	2.7	27.3	2.6	1.7	0.0	5.2	0.2	8.2	0.2	0.6	0.1	0.0	0.0	0.4	5.4	10.3	1.6	5.0	8.8	0.0	0.0	0.0	5.9	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.4	5.1	0.5	8.5	12.0	1.7	2.7	3.8	7.1	5.5
G3BP1	"G3BP, HDH-VIII"	ENSG00000145907	"G3BP stress granule assembly factor 1"	Q13283	5	151771045-151812785	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Transport"	"DNA-binding, Endonuclease, Helicase, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004052, CAB037068"	Supported		Supported	Cytosol			150000	Cytosol		"CAB037068: AB_1840864, HPA004052: AB_1849348"	"unprognostic (1.31e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.88e-2)"	36.7	27.5	21.1	29.1	23.7	12.2	29.7	24.3	21.4	28.5	23.4	27.7	19.6	18.1	29.9	19.3	40.7	26.5	20.7	24.8	21.7	21.2	30.7	44.1	25.9	36.8	31.8	16.7	38.2	30.6	29.9	29.9	27.9	24.9	24.5	27.2	22.6	24.1	19.7	66.4	25.3	22.8	27.0	27.4	28.9	20.6	27.4	25.8	57.1	28.9	37.0	42.3	27.7	34.8	25.6	19.9	19.5	19.1	29.4	40.0	32.1	37.4	29.3	36.1	15.8	46.0	24.9	41.7	37.2	33.8	48.0	57.0	53.8	48.6	69.9	54.7	34.5	35.6	54.5	72.2	63.0	19.3	26.2	43.2	27.1	36.0	26.2	54.1	28.6	24.9	39.4	41.7	41.4	39.5	33.8	34.5	47.0	20.1	45.6	24.0	40.3	30.0	41.8	45.6	33.3	31.5	37.2	34.1	24.7	35.2	51.3	53.8	41.0	30.1	43.1	34.7	40.4	32.8	67.5	21.5	29.6	55.0	26.1	41.6	62.6	19.5	13.9	13.0	25.7	19.1	40.0	25.6	34.4	28.7	18.0	21.9	33.0	32.9	6.1	29.4	16.8	19.9	34.0	32.1	21.1	23.7	24.3	21.4	21.7	21.2	31.8	16.7	24.9	25.8
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell line enhanced"	"Detected in all"		"A549: 225.5;MCF7: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"			12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.4	225.5	4.6	17.8	19.5	26.7	4.1	10.8	31.0	11.0	19.1	10.3	5.8	10.0	16.8	24.7	13.8	7.2	18.3	5.7	10.2	5.0	10.6	51.0	23.2	38.2	10.6	36.4	12.9	5.4	21.6	4.6	22.9	6.3	4.4	19.9	85.5	6.8	7.6	3.3	16.7	6.7	2.6	10.9	33.2	19.3	4.7	5.9	10.8	42.1	9.0	6.3	8.9	27.2	7.0	24.7	9.7	16.6	5.3	6.9	17.1	19.4	7.0	14.3	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5
GAA		ENSG00000171298	"Glucosidase alpha, acid"	P10253	17	80101556-80119879	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 23.8;eosinophil: 8.4;intermediate monocyte: 20.0;myeloid DC: 15.6;neutrophil: 10.8;non-classical monocyte: 24.7"	"Group enriched"	"Detected in all"	9	"dendritic cells: 15.6;granulocytes: 10.8;monocytes: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026970, HPA029126"	Enhanced						3000000			"HPA026970: AB_2672065, HPA029126: AB_2672918"	"unprognostic (1.13e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (7.66e-4)"	"unprognostic (2.94e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.18e-1)"	27.5	19.6	13.8	17.0	14.8	11.3	18.6	14.3	23.0	14.9	16.5	23.4	21.7	19.4	20.1	50.9	13.9	18.2	23.5	21.4	13.5	17.6	27.9	44.2	34.0	30.2	18.1	16.1	14.6	29.4	28.8	24.7	84.1	14.9	22.3	7.2	21.9	27.5	22.1	26.3	18.3	15.4	17.2	16.6	35.8	17.4	30.7	14.6	13.9	21.9	14.9	13.5	24.0	13.4	1.4	15.6	10.8	24.7	1.1	1.8	9.8	11.3	22.1	4.4	14.3	13.7	13.8	28.5	7.1	13.1	5.4	4.4	6.5	18.5	4.1	18.9	5.6	4.8	1.3	8.2	1.3	5.2	16.5	0.0	3.7	23.4	23.9	0.5	13.5	29.6	11.8	10.2	3.5	9.6	4.0	17.1	4.0	26.1	1.8	2.6	9.0	15.5	9.8	15.0	6.9	4.4	11.9	5.0	14.5	9.3	10.4	12.7	29.6	16.2	6.1	20.1	10.8	14.5	2.6	40.8	11.3	1.2	6.4	10.5	12.6	0.1	23.8	8.4	1.5	20.0	1.8	1.3	1.2	1.6	15.6	1.4	1.4	0.9	10.8	1.1	24.7	3.8	0.8	9.8	13.8	14.8	14.3	23.0	13.5	17.6	18.1	16.1	14.9	14.6
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.0;HEL: 7.7;U-2 OS: 8.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 1.8;plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"			Centrosome		"HPA050483: , HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favourable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavourable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	14.0	7.4	33.6	7.0	47.2	8.2	4.2	29.1	53.8	6.9	5.6	17.3	3.0	2.3	18.1	1.9	2.9	7.9	4.1	4.6	24.8	21.4	2.9	2.0	6.9	6.6	15.6	33.7	7.8	5.1	1.8	5.8	5.0	22.3	12.8	3.2	4.4	13.0	13.3	8.5	18.3	6.1	5.5	14.9	24.2	6.1	4.3	15.4	0.0	3.9	0.1	5.2	4.0	5.9	1.8	1.7	0.0	0.5	0.0	0.4	0.3	2.9	0.0	1.9	8.0	0.9	2.1	2.1	2.0	0.8	1.8	0.5	2.3	0.1	1.4	2.0	0.0	2.4	0.9	0.0	0.0	7.2	3.4	7.7	3.4	0.0	1.2	0.3	4.0	0.0	0.0	1.6	0.0	1.0	6.6	0.0	0.3	1.9	0.7	0.1	0.6	1.1	3.5	0.7	0.1	0.3	0.0	0.5	1.3	0.5	0.0	3.3	1.5	1.1	4.5	3.2	8.3	0.3	3.7	7.0	0.7	0.0	1.8	3.5	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.3	33.6	47.2	29.1	53.8	24.8	21.4	15.6	33.7	22.3	15.4
GADD45G	"CR6, DDIT2, GADD45gamma, GRP17"	ENSG00000130222	"Growth arrest and DNA damage inducible gamma"	O95257	9	89605013-89606555	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"placenta: 65.6"	"Group enriched"	"Detected in some"	4	"HDLM-2: 46.7;SCLC-21H: 24.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 79.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023606	Approved									"HPA023606: AB_1849409"	"unprognostic (5.84e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.06e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.75e-2)"	"unprognostic (7.65e-3)"	"unprognostic (4.16e-3)"	"prognostic favourable (3.80e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.95e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.22e-1)"	7.0	23.6	4.6	4.4	7.7	8.4	6.7	4.8	5.4	23.3	7.4	2.8	12.0	4.2	21.3	6.5	6.1	6.4	5.9	53.4	4.1	3.8	6.7	48.4	4.6	1.5	5.3	3.7	14.1	28.7	4.9	25.4	65.6	7.4	12.7	1.6	3.0	14.7	10.2	58.0	5.5	6.0	5.5	6.7	1.3	6.5	13.0	3.0	0.8	8.4	26.8	2.6	5.1	6.2	0.0	0.2	8.0	0.3	0.0	0.1	0.1	1.2	0.0	6.7	0.0	0.0	0.0	8.8	0.4	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.9	2.2	0.0	0.0	46.7	0.4	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.8	0.0	0.0	0.1	0.1	0.0	0.0	1.9	0.1	0.4	6.1	0.1	0.5	1.9	0.4	0.0	0.3	24.6	5.6	0.4	2.6	0.0	1.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.1	0.1	4.6	7.7	4.8	5.4	4.1	3.8	5.3	3.7	7.4	3.0
GAL	"GAL-GMAP, GALN, GLNN, GMAP"	ENSG00000069482	"Galanin and GMAP prepropeptide"	P22466	11	68683779-68691175	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Neuropeptide"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"pituitary gland: 149.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 46.9;HEK 293: 21.9;K-562: 24.3;NB-4: 86.7;SH-SY5Y: 35.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"hypothalamus: 18.8"	"Cell type enriched"	"Detected in single"	15	"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	15	"monocytes: 1.5"	"Region enhanced"	"Detected in many"		"hypothalamus: 111.6"	"Low region specificity"	"Detected in all"			"HPA049864, CAB079779"	Enhanced	Supported	Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	60030		"Golgi apparatus"	Vesicles	"CAB079779: , HPA049864: "	"unprognostic (8.56e-2)"	"unprognostic (1.45e-2)"	"unprognostic (7.50e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.70e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.07e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.85e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-2)"	2.8	0.2	0.1	14.8	0.5	0.4	4.5	0.6	2.0	0.2	6.0	0.1	0.4	1.7	0.2	0.7	0.7	0.2	0.3	0.6	1.3	18.8	0.3	0.2	0.2	0.1	0.2	0.6	0.2	2.9	0.0	149.9	0.9	2.2	0.7	4.1	0.6	0.5	1.8	0.3	4.5	2.2	9.7	0.3	0.2	1.5	0.5	0.4	0.7	0.2	0.4	0.3	1.5	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	4.4	6.6	0.0	0.1	0.0	46.9	1.7	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	21.9	1.1	14.1	0.0	0.2	0.6	0.0	0.3	0.7	0.0	0.0	1.1	24.3	0.0	0.0	13.3	0.0	86.7	11.2	4.2	0.0	0.0	8.9	0.1	0.0	9.1	35.0	4.6	0.2	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.7	1.3	18.8	0.2	0.6	2.2	0.4
GALC		ENSG00000054983	Galactosylceramidase	P54803	14	87837820-87993665	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid degradation, Lipid metabolism, Sphingolipid metabolism"	"Glycosidase, Hydrolase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 35.1;HMC-1: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022196	Approved				"Intracellular and membrane"		16000			"CAB022196: "	"unprognostic (1.27e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.44e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.72e-2)"	13.8	17.7	21.2	13.2	32.2	18.9	15.4	16.3	25.5	12.3	15.8	28.8	9.6	30.3	10.7	12.1	6.5	20.1	17.4	19.6	22.0	19.5	20.5	11.1	23.0	18.0	30.7	20.1	17.3	13.6	14.4	12.6	15.6	24.9	14.1	16.9	13.3	8.9	10.1	9.3	9.4	30.2	9.3	33.8	14.3	14.9	21.6	26.1	8.6	23.5	5.8	7.3	12.6	11.4	1.7	5.7	20.8	10.5	9.4	16.3	6.4	0.0	8.2	3.0	0.0	10.2	9.2	0.0	3.7	7.6	3.6	4.3	4.5	35.1	2.1	11.4	3.6	0.5	0.0	0.4	4.4	1.1	0.2	12.1	0.3	0.0	8.4	0.0	33.2	9.0	2.8	2.4	0.0	9.6	4.0	1.6	6.0	0.8	0.0	1.8	2.7	0.9	0.0	0.2	0.1	5.7	3.3	2.8	6.7	10.3	1.7	0.0	8.5	8.3	8.1	0.0	5.6	2.3	0.0	1.7	3.2	0.0	1.0	2.8	8.0	12.8	9.5	20.8	7.5	10.5	16.3	1.7	5.7	7.2	5.7	0.8	4.2	4.9	7.8	9.4	8.0	1.0	3.2	6.4	21.2	32.2	16.3	25.5	22.0	19.5	30.7	20.1	24.9	26.1
GALK1	GALK	ENSG00000108479	"Galactokinase 1"	P51570	17	75751594-75765711	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Galactose metabolism"	"Kinase, Transferase"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 36.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007094, HPA016960"	Approved		Approved	"Golgi apparatus,Cytosol"			8600	Cytosol	"Golgi apparatus"	"HPA007094: AB_1078939, HPA016960: AB_1849430"	"unprognostic (1.16e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (1.55e-6)"	"unprognostic (3.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.62e-5)"	6.4	3.3	3.8	6.2	4.4	3.6	14.2	4.6	5.1	4.7	9.3	3.7	3.5	15.9	4.7	5.0	9.0	4.8	3.8	7.2	3.6	3.6	12.3	31.6	4.7	11.7	4.3	3.8	5.2	16.0	1.9	2.6	4.6	3.2	4.7	1.3	3.6	14.9	4.7	5.4	6.2	17.3	3.7	4.0	7.2	5.3	5.7	3.3	7.6	3.3	5.1	4.8	3.6	5.0	10.6	36.7	20.7	30.2	5.7	9.4	14.6	8.0	30.3	1.8	8.5	2.7	6.8	7.1	6.5	5.4	6.7	6.3	16.8	1.6	12.5	8.2	3.4	4.7	2.0	1.9	0.7	5.4	19.0	7.8	11.5	28.1	9.2	5.2	17.3	6.0	2.6	3.3	1.4	15.6	6.2	7.7	4.1	34.4	14.4	19.7	2.1	15.7	17.3	21.1	20.8	3.7	3.3	4.1	11.4	5.6	14.4	14.2	11.7	8.6	13.7	10.0	9.6	9.5	5.7	19.5	4.8	3.2	11.2	12.2	7.7	2.6	30.2	8.3	9.4	25.5	8.5	10.6	7.8	8.6	27.2	6.8	4.2	6.2	20.7	5.7	20.2	36.7	8.7	14.6	3.8	4.4	4.6	5.1	3.6	3.6	4.3	3.8	3.2	3.3
GALNT1	GalNAc-T1	ENSG00000141429	"Polypeptide N-acetylgalactosaminyltransferase 1"	Q10472	18	35581117-35711834	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012628	Uncertain				"Intracellular and membrane"		1600000			"HPA012628: AB_1849439"	"unprognostic (9.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.96e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.07e-2)"	"unprognostic (8.60e-2)"	15.0	14.2	11.3	11.4	16.0	9.7	24.2	14.3	12.3	15.1	18.7	11.3	8.3	18.9	10.3	13.7	31.8	8.9	13.0	18.4	15.3	9.7	12.9	21.8	12.0	27.4	14.9	13.3	10.5	22.2	4.6	15.0	22.9	12.5	11.7	18.7	15.7	28.3	8.4	19.9	27.6	24.7	15.8	13.7	17.9	11.9	9.8	12.6	13.8	13.5	16.0	17.3	32.3	19.3	6.2	6.7	11.1	9.1	6.6	5.8	2.0	7.7	8.5	10.1	9.3	20.2	19.2	13.4	8.2	8.8	7.6	7.0	5.1	15.3	9.2	8.8	8.8	6.0	5.0	15.7	12.2	10.8	4.6	11.7	16.7	11.7	10.1	25.4	15.7	13.0	15.0	11.9	13.2	82.2	3.5	12.3	29.6	6.2	7.4	9.7	10.4	4.1	9.3	13.3	4.4	31.4	36.4	5.5	10.8	14.6	10.7	8.6	8.2	20.0	28.5	14.1	5.7	9.2	9.0	17.7	8.4	17.7	9.9	17.4	7.3	8.4	5.4	11.1	5.1	6.7	5.8	6.2	3.6	4.7	6.1	3.8	3.4	4.9	6.4	6.6	9.1	6.7	3.6	2.0	11.3	16.0	14.3	12.3	15.3	9.7	14.9	13.3	12.5	12.6
GALNT2	GalNAc-T2	ENSG00000143641	"Polypeptide N-acetylgalactosaminyltransferase 2"	Q10471	1	230057990-230282124	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 140.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 89.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA011222	Supported		Supported	"Golgi apparatus"	"Intracellular and membrane"		11000000	"Golgi apparatus"		"HPA011222: AB_1849446"	"unprognostic (1.26e-1)"	"prognostic unfavourable (1.22e-6)"	"unprognostic (1.15e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.70e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (8.48e-8)"	"unprognostic (2.93e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.79e-13)"	"unprognostic (3.79e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.89e-1)"	19.5	25.6	11.1	19.6	10.1	6.9	20.4	7.7	12.5	11.7	12.7	9.1	10.5	11.3	13.7	11.5	11.5	13.2	17.0	13.9	12.5	8.5	17.5	140.3	13.2	20.4	8.4	9.0	24.8	35.9	4.3	7.3	16.6	12.6	10.8	7.5	10.5	11.1	9.6	42.2	8.4	11.3	14.6	13.6	9.5	18.0	12.7	8.2	28.4	10.7	10.7	7.0	14.9	13.1	6.7	13.5	3.5	10.1	2.7	5.3	6.3	15.9	21.3	12.6	14.9	24.2	20.7	26.0	30.3	18.8	12.3	11.8	9.2	30.4	4.0	22.5	15.9	31.2	8.3	25.4	10.4	40.3	10.8	12.3	47.7	10.2	13.2	4.7	24.2	29.6	12.6	16.4	6.6	14.4	15.3	6.2	13.6	4.4	24.3	4.7	17.2	20.4	27.1	18.0	12.4	12.1	19.0	4.0	14.9	30.7	1.6	18.4	9.7	8.8	34.1	12.1	23.3	27.2	24.0	20.7	11.9	9.0	31.2	9.4	89.5	1.1	10.1	3.5	4.7	9.6	3.6	3.8	2.9	4.7	7.9	6.7	2.8	5.3	3.2	2.7	9.6	13.5	3.4	6.3	11.1	10.1	7.7	11.8	12.5	8.5	8.4	9.0	12.6	8.2
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074794-76077541	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.1;NTERA-2: 4.6;THP-1: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Approved									"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.3	0.1	0.0	9.8	0.1	3.5	0.0	0.0	0.3	0.3	13.1	0.0	0.0	0.6	0.0	0.0	1.1	0.1	0.5	0.1	1.4	0.8	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	9.0	6.4	1.4	0.2	0.4	0.3	0.0	0.0	0.0	1.1	1.2	1.0	0.2	0.0	1.1	1.4	0.9	0.5	0.4	0.7	0.2	1.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.0	2.1	0.4	0.6	0.3	0.0	3.1	0.0	0.1	0.0	0.3	2.5	0.0	1.5	2.8	0.3	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.1	1.1	0.2	0.3	4.6	2.9	0.1	0.6	0.8	0.0	0.2	0.2	0.1	1.7	0.7	0.3	0.6	6.8	0.2	0.2	0.6	0.2	0.4	0.7	0.4	2.6	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.4	1.1	0.0	0.7	0.0	0.1	0.0	0.3	1.4	0.8	0.2	0.0	0.6	0.0
GAMT	"PIG2, TP53I2"	ENSG00000130005	"Guanidinoacetate N-methyltransferase"	Q14353	19	1397026-1401570	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 73.0;skeletal muscle: 222.2"	"Cell line enhanced"	"Detected in many"		"Hep G2: 51.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 173.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051806	Approved						38000			"HPA051806: "	"unprognostic (3.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (3.22e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.36e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.54e-2)"	5.1	4.6	9.1	1.5	8.7	2.2	3.2	5.1	11.4	2.3	1.4	15.1	5.1	1.3	2.0	31.3	5.3	3.8	2.6	10.8	9.2	7.7	8.0	73.0	1.5	2.0	8.7	5.2	3.8	47.0	5.4	4.9	1.6	5.9	5.6	1.1	4.5	9.1	4.7	222.2	6.0	1.4	2.1	8.8	2.1	3.2	7.7	4.5	5.6	3.3	26.7	2.8	1.9	1.7	15.7	23.0	6.9	2.6	8.0	21.6	7.7	6.2	7.1	7.6	17.2	9.6	11.7	10.4	7.5	12.5	9.7	8.8	16.0	4.5	3.3	5.3	8.9	2.7	12.0	4.6	2.6	23.8	13.7	10.2	5.9	51.2	5.7	0.2	3.5	13.0	1.6	10.3	0.0	2.1	14.5	8.0	15.8	6.4	29.8	3.5	8.6	22.6	29.9	6.8	23.8	11.4	5.8	2.5	17.9	0.5	4.3	9.2	19.8	14.2	3.6	10.7	11.1	0.6	3.4	36.3	7.0	5.6	9.9	13.5	12.2	1.6	1.2	6.9	9.9	1.6	13.9	10.6	13.7	12.2	5.4	15.7	21.6	16.1	0.8	8.0	2.6	23.0	7.5	7.7	9.1	8.7	5.1	11.4	9.2	7.7	8.7	5.2	5.9	4.5
GAN	"GAN1, KLHL16"	ENSG00000261609	Gigaxonin	Q9H2C0	16	81314952-81390884	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skin 1: 46.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011825, HPA049473"	Approved		Supported	Microtubules				Microtubules		"CAB011825: AB_732515, HPA049473: "	"unprognostic (1.78e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.23e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.42e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.22e-3)"	"unprognostic (5.91e-3)"	"unprognostic (3.12e-3)"	"unprognostic (5.93e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.86e-2)"	3.1	2.8	7.5	2.9	7.6	2.8	6.2	8.0	7.8	3.9	4.0	10.9	3.2	3.0	3.3	3.7	8.4	2.6	2.8	2.9	10.8	5.0	2.5	2.5	3.0	2.8	5.5	7.5	3.0	3.5	4.1	2.9	3.1	7.5	3.9	3.9	2.7	4.1	3.0	4.0	46.9	3.0	4.3	8.1	3.0	4.2	3.2	7.7	2.0	3.1	6.2	4.0	3.3	6.6	2.2	3.3	2.4	1.6	3.2	3.7	0.6	2.1	3.1	2.0	2.6	2.6	1.3	13.2	1.8	1.2	1.4	0.7	6.3	2.4	3.3	2.1	2.1	3.9	4.1	1.7	3.0	0.9	1.8	2.9	2.5	4.9	2.5	2.7	3.2	1.5	4.8	1.9	4.6	2.4	3.7	1.5	1.5	11.1	2.4	3.5	5.1	1.1	4.6	2.0	1.3	2.1	6.9	2.3	1.3	6.3	5.3	1.7	3.8	2.4	3.3	3.0	3.9	1.2	2.4	2.8	3.6	8.1	1.6	2.9	2.4	2.4	1.6	0.8	3.1	1.4	2.8	1.7	3.1	2.5	0.9	2.2	2.9	3.7	1.3	3.2	1.3	3.3	2.2	0.6	7.5	7.6	8.0	7.8	10.8	5.0	5.5	7.5	7.5	7.7
GANAB	"G2AN, GIIA, GluII, KIAA0088"	ENSG00000089597	"Glucosidase II alpha subunit"	Q14697	11	62624826-62646726	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026874, HPA061426"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"		37000000	"Endoplasmic reticulum"		"HPA026874: AB_1849745, HPA061426: AB_2684516"	"unprognostic (2.12e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.65e-2)"	"prognostic unfavourable (1.27e-5)"	"unprognostic (5.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (9.54e-4)"	33.6	34.6	16.2	23.3	20.7	17.9	30.1	19.9	31.0	38.9	31.5	29.8	43.4	26.0	44.0	38.6	29.2	34.2	33.8	32.6	17.2	16.5	35.9	91.5	31.4	30.2	21.7	19.5	49.0	51.4	56.6	27.3	61.1	20.0	29.4	32.6	33.7	43.5	40.7	28.2	24.5	39.8	37.4	19.5	37.4	31.2	27.7	20.2	41.8	45.6	25.2	34.0	36.0	29.4	14.6	17.5	16.5	18.8	22.5	20.0	17.6	42.3	37.2	46.5	84.3	71.9	62.8	50.4	47.8	71.8	66.2	57.2	31.0	78.9	29.0	96.8	84.4	58.0	56.1	53.7	68.7	23.4	24.2	28.7	51.0	12.9	53.0	44.5	36.1	60.9	34.8	65.8	69.2	61.3	40.6	52.5	59.5	37.2	23.1	14.5	39.4	30.2	30.8	55.7	73.0	32.5	34.7	24.6	33.4	68.3	44.4	50.8	58.1	37.9	46.1	66.3	42.4	52.0	44.4	52.7	60.9	22.2	72.8	23.9	64.5	16.5	15.0	14.4	20.0	18.8	20.0	14.6	13.8	15.9	17.5	13.1	17.9	16.3	7.0	22.5	16.4	11.6	13.0	17.6	16.2	20.7	19.9	31.0	17.2	16.5	21.7	19.5	20.0	20.2
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"				"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	34.8	0.0	0.0	0.0	0.0	0.0	0.0	22.4	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7
GAPDH	GAPD	ENSG00000111640	"Glyceraldehyde-3-phosphate dehydrogenase"	P04406	12	6533927-6538374	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Glycolysis, Translation regulation"	"Oxidoreductase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 1236.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005197, CAB016392, HPA040067, HPA061280"	Supported		Supported	"Nuclear membrane,Vesicles,Plasma membrane,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Nuclear membrane, Vesicles"	"CAB005197: AB_641107, CAB016392: AB_627678, HPA040067: AB_10965903, HPA061280: AB_2684463"	"unprognostic (3.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.77e-3)"	"prognostic unfavourable (1.79e-6)"	"unprognostic (2.89e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (9.50e-3)"	"unprognostic (4.52e-1)"	"prognostic unfavourable (6.25e-10)"	"unprognostic (2.33e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.26e-2)"	50.0	59.4	104.1	57.6	101.0	195.5	38.4	58.0	151.3	49.4	73.3	80.7	24.0	75.8	37.3	46.8	146.9	50.2	58.0	215.1	95.0	95.5	88.4	221.0	41.3	90.1	111.8	58.0	62.0	27.0	66.1	46.1	98.2	115.9	48.3	76.7	74.5	60.8	63.2	1236.8	54.4	74.4	68.0	95.6	50.7	41.1	36.4	35.9	101.9	38.3	238.7	105.3	89.5	50.5	57.9	171.0	110.0	201.6	60.5	108.8	271.9	196.0	345.9	99.8	155.5	97.4	160.6	217.5	149.0	212.2	218.1	227.7	244.1	134.6	229.2	29.5	175.6	111.7	92.7	345.6	151.4	201.0	100.7	126.8	217.1	207.3	131.3	204.9	102.1	134.3	112.9	214.3	242.1	240.0	68.1	48.3	247.7	391.1	233.5	107.9	368.8	115.3	189.9	177.7	109.1	248.1	239.9	70.7	113.5	131.5	343.1	197.9	53.6	144.8	149.7	170.2	205.7	87.8	257.4	109.8	79.8	295.4	360.8	129.9	266.3	110.0	201.6	37.0	74.1	103.2	65.3	57.9	77.9	74.4	171.0	32.2	44.1	51.2	106.5	60.5	92.3	25.2	108.8	271.9	104.1	101.0	58.0	151.3	95.0	95.5	111.8	58.0	115.9	35.9
GAPDHS	"GAPD2, GAPDH-2, GAPDS"	ENSG00000105679	"Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic"	O14556	19	35533412-35545316	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 154.6"	"Cell line enhanced"	"Detected in many"		"A549: 16.2"	"Cancer enriched"	"Detected in single"	97	"melanoma: 13.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042666	Enhanced		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA042666: "	"unprognostic (3.74e-1)"	"unprognostic (1.59e-1)"			"unprognostic (7.41e-2)"			"unprognostic (1.56e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.81e-2)"			"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.37e-1)"	0.3	0.5	0.3	0.8	0.3	0.2	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.6	0.5	1.6	0.6	0.2	0.8	0.8	0.3	0.3	0.3	0.3	0.3	1.6	0.3	0.3	0.7	1.3	0.0	0.3	0.3	0.3	0.3	0.0	4.2	1.3	0.3	0.3	4.4	0.6	0.3	0.3	1.2	0.4	154.6	0.3	0.3	3.6	0.3	0.3	0.6	0.3	2.1	1.0	1.2	0.8	1.4	2.0	0.8	4.4	16.2	4.5	6.8	0.0	0.0	3.8	1.3	0.0	0.0	0.0	9.8	7.4	7.4	2.1	0.0	5.4	0.0	0.0	0.0	7.2	7.9	4.9	10.3	5.0	0.1	4.4	5.9	0.0	0.0	0.0	0.0	0.0	11.8	4.4	0.0	13.8	1.7	2.1	6.1	2.2	5.2	3.2	5.7	0.0	4.4	8.1	3.7	1.6	4.1	4.8	3.4	1.9	1.5	5.2	5.8	1.3	1.8	12.1	3.2	4.3	2.8	8.0	1.9	0.0	0.8	1.2	1.1	0.6	2.0	1.1	0.4	1.9	1.0	2.1	1.1	1.2	0.0	1.4	0.3	0.8	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
GAR1	NOLA1	ENSG00000109534	"GAR1 ribonucleoprotein"	Q9NY12	4	109815510-109824740	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059098	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA059098: "	"unprognostic (9.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (1.01e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.17e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.17e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.08e-3)"	16.6	18.9	15.2	19.5	19.9	34.7	22.4	11.0	16.5	14.6	20.9	12.4	15.5	17.0	24.3	14.8	26.6	17.2	17.8	11.6	14.2	13.3	15.6	20.0	13.7	17.2	15.5	17.1	20.2	24.1	15.7	19.1	24.8	13.8	17.3	21.0	14.5	23.3	17.5	13.8	25.4	16.3	19.0	18.1	18.8	15.1	27.7	16.3	29.5	17.3	27.6	22.4	15.5	15.5	11.3	9.3	7.4	9.3	9.5	10.7	4.3	15.6	18.2	12.5	16.9	6.7	9.6	10.9	16.3	8.8	13.5	10.9	28.4	19.9	38.3	10.7	12.3	7.5	23.0	16.2	22.5	11.3	22.6	22.8	16.4	31.0	16.3	48.8	12.1	8.7	17.0	16.7	12.0	16.3	54.4	11.7	16.6	33.5	30.1	33.7	20.4	22.1	20.4	20.5	14.2	17.8	22.1	18.5	18.9	10.3	26.8	14.5	9.5	14.5	14.1	13.5	18.9	9.9	20.8	14.9	24.2	47.3	9.6	23.9	14.6	7.4	5.9	3.3	9.7	9.3	10.3	11.3	9.2	9.8	9.3	10.0	10.7	9.9	1.0	9.5	8.0	9.2	9.6	4.3	15.2	19.9	11.0	16.5	14.2	13.3	15.5	17.1	13.8	16.3
GARS	"CMT2D, DSMAV, GlyRS, SMAD1"	ENSG00000106105	"Glycyl-tRNA synthetase"	P41250	7	30594681-30634033	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Hydrolase, Ligase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017896, HPA019097"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		660000	Cytosol		"HPA017896: AB_1849478, HPA019097: AB_1849480"	"prognostic unfavourable (1.02e-4)"	"unprognostic (2.46e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (8.48e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-3)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (7.31e-3)"	"unprognostic (4.76e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.45e-2)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (3.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.32e-2)"	"prognostic unfavourable (3.04e-5)"	25.8	27.3	24.5	26.2	28.5	24.6	32.4	31.1	44.7	21.5	23.7	17.0	11.5	17.2	24.1	23.3	43.7	18.6	18.4	25.7	21.1	26.8	27.6	57.2	27.9	28.0	22.9	28.4	35.4	49.4	44.4	33.3	24.3	37.6	17.2	30.2	14.1	28.7	21.6	35.6	33.2	18.1	30.1	17.6	23.5	30.5	29.7	14.9	28.6	31.4	33.9	38.4	22.8	25.7	22.5	26.4	21.2	27.2	15.3	27.6	21.2	33.0	16.4	14.5	51.5	27.2	40.9	27.6	49.5	44.8	25.5	51.7	21.8	16.5	55.7	14.9	60.2	26.2	36.2	31.4	44.9	13.3	16.9	25.7	13.4	18.3	86.4	37.8	22.8	38.9	55.2	36.6	43.5	32.7	50.9	64.9	40.4	20.3	32.9	26.2	39.2	31.4	16.7	12.8	43.2	29.2	14.9	17.6	29.4	13.2	37.0	70.3	33.0	58.0	30.0	12.1	40.7	24.3	31.2	64.2	53.8	65.5	42.3	57.3	56.9	21.2	19.0	17.7	23.2	25.8	23.7	22.5	23.7	25.1	26.4	19.3	25.5	27.6	5.6	15.3	27.2	18.0	25.9	21.2	24.5	28.5	31.1	44.7	21.1	26.8	22.9	28.4	37.6	14.9
GART	"GARS-AIRS-GART, PGFT, PRGS"	ENSG00000159131	"Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase"	P22102	21	33503931-33543491	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Ligase, Multifunctional enzyme, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002119, HPA005779"	Approved		Uncertain	Nucleoplasm,Mitochondria,Cytosol			1300000	"Nucleoplasm, Mitochondria, Cytosol"		"HPA002119: AB_1849482, HPA005779: AB_1849484"	"unprognostic (3.77e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (5.05e-5)"	"prognostic unfavourable (9.82e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (1.98e-3)"	"prognostic unfavourable (3.95e-6)"	"unprognostic (1.36e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.57e-1)"	24.9	24.7	16.0	20.0	22.3	14.2	22.2	14.5	20.3	16.2	20.1	20.5	13.3	18.9	21.7	15.9	28.1	19.9	14.3	19.3	16.4	14.9	19.2	33.6	18.3	24.4	21.9	14.6	21.0	30.6	21.6	22.9	23.1	21.0	16.4	26.9	19.5	18.6	16.1	33.2	17.6	19.1	23.5	17.9	21.4	21.9	47.0	21.7	40.8	20.0	19.4	32.8	21.6	17.6	18.7	19.5	9.7	20.9	27.1	21.1	13.3	30.0	14.3	21.2	23.5	15.6	16.1	23.8	19.5	16.5	22.8	24.2	27.1	25.6	40.0	11.6	13.0	15.9	44.4	30.6	33.3	21.0	26.4	60.3	17.1	17.7	21.3	33.5	15.9	14.2	21.4	26.9	39.6	21.5	70.1	25.7	20.6	14.4	35.3	22.5	46.2	16.9	29.5	39.5	56.6	18.3	16.1	22.6	20.3	27.0	21.3	25.2	27.0	21.5	15.8	15.5	18.6	13.4	20.8	25.6	35.4	43.7	16.3	39.5	22.9	5.3	15.2	9.7	17.3	20.9	21.1	18.7	16.9	17.9	19.5	14.4	17.7	17.4	7.0	27.1	17.7	14.7	20.6	13.3	16.0	22.3	14.5	20.3	16.4	14.9	21.9	14.6	21.0	21.7
GAS2L1	GAR22	ENSG00000185340	"Growth arrest specific 2 like 1"	Q99501	22	29306582-29312785	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ductus deferens: 40.5"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.0;eosinophil: 3.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019858	Approved		Approved	"Plasma membrane,Cell Junctions"				"Plasma membrane"	"Cell Junctions"	"HPA019858: AB_1849486"	"unprognostic (3.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.95e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (4.23e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-2)"	15.1	10.7	15.2	5.3	13.4	5.4	7.6	10.5	19.8	4.5	5.6	6.8	40.5	17.9	5.1	8.4	8.6	4.6	4.3	7.0	12.9	8.1	6.0	6.6	7.5	2.2	11.3	10.2	2.9	10.0	4.6	6.8	4.3	9.5	7.1	2.2	3.2	12.7	22.9	4.9	22.4	13.0	4.5	10.0	11.5	8.3	16.6	8.8	0.0	4.5	9.2	3.5	3.9	4.7	0.0	1.1	3.1	2.0	0.0	0.2	1.2	8.2	9.6	1.5	6.1	2.4	2.3	9.6	12.3	3.8	5.2	2.7	4.3	5.9	0.0	5.6	6.5	25.1	2.5	7.0	0.9	11.2	1.2	10.8	7.6	3.0	3.0	0.1	7.6	2.4	4.8	5.0	2.0	6.9	5.1	1.7	3.7	7.0	0.2	6.0	2.2	21.7	0.2	4.3	0.7	3.1	5.3	0.5	8.1	9.5	12.8	6.8	12.7	1.7	14.7	33.1	22.8	14.7	12.3	0.1	0.1	0.1	14.6	0.4	8.1	0.0	2.0	3.1	0.0	0.3	0.0	0.0	0.1	0.0	1.1	0.0	0.2	0.0	0.5	0.0	1.4	0.0	0.0	1.2	15.2	13.4	10.5	19.8	12.9	8.1	11.3	10.2	9.5	8.8
GAS8	"DRC4, GAS11"	ENSG00000141013	"Growth arrest specific 8"	O95995	16	90019629-90044975	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 25.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041311, HPA048238"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041311: , HPA048238: "	"unprognostic (2.23e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.47e-1)"	"prognostic favourable (7.67e-4)"	"unprognostic (3.06e-2)"	"prognostic favourable (1.09e-7)"	"unprognostic (1.98e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.19e-2)"	7.1	11.1	8.5	6.5	13.2	2.3	7.6	13.5	12.2	11.7	6.8	10.0	10.8	4.1	12.7	16.2	7.8	26.5	11.6	21.0	8.7	9.8	12.4	6.3	9.9	4.0	8.9	8.9	12.8	12.9	23.2	22.0	3.5	10.1	8.9	4.6	11.0	16.2	12.6	18.8	4.2	4.2	8.4	7.5	4.2	7.6	16.1	6.4	1.7	15.5	5.5	5.2	6.6	5.1	2.5	4.8	4.3	5.0	0.0	3.7	2.3	10.6	8.6	1.1	5.4	5.1	3.9	9.2	2.1	5.4	8.8	2.6	8.6	8.1	0.6	5.9	4.4	10.6	3.6	6.3	1.9	0.0	6.4	2.2	5.5	9.8	5.7	1.2	1.8	5.2	3.6	6.6	3.0	5.2	8.5	1.2	3.7	25.6	1.5	5.4	7.2	4.5	0.4	10.1	0.6	11.0	5.2	9.1	6.6	11.3	6.1	12.9	11.5	5.0	3.6	5.4	6.3	2.9	5.1	2.0	3.2	0.0	13.8	1.7	9.4	4.3	3.1	3.7	1.8	5.0	1.8	1.2	2.8	3.7	4.4	2.5	2.3	2.0	4.0	0.0	3.1	4.8	3.5	2.3	8.5	13.2	13.5	12.2	8.7	9.8	8.9	8.9	10.1	6.4
GATA3	HDR	ENSG00000107485	"GATA binding protein 3"	P23771	10	8045378-8075203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 97.8;skin 1: 61.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 32.6;MCF7: 77.8;RT4: 31.8;SH-SY5Y: 27.3;T-47d: 101.3"	"Group enriched"	"Detected in many"	24	"breast cancer: 190.0;urothelial cancer: 87.0"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	42	"gdT-cell: 9.7;MAIT T-cell: 13.3;memory CD4 T-cell: 18.2;memory CD8 T-cell: 14.1;naive CD4 T-cell: 10.0;naive CD8 T-cell: 9.0;NK-cell: 16.6;T-reg: 18.9"	"Group enriched"	"Detected in many"	54	"NK-cells: 16.6;T-cells: 18.9"	"Region enriched"	"Detected in single"	6	"midbrain: 7.3"	"Group enriched"	"Detected in some"	46	"midbrain: 25.5;pons and medulla: 17.5;thalamus: 20.0"	"CAB016217, HPA029730"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"CAB016217: AB_2108591, HPA029730: AB_10601907"	"unprognostic (1.70e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.68e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.82e-3)"	2.0	2.0	0.3	3.4	0.3	0.9	17.8	0.3	0.3	1.8	0.5	0.1	44.4	0.1	0.4	13.5	0.8	0.4	0.4	0.9	0.3	0.4	12.9	0.7	1.6	2.7	0.8	0.0	0.3	0.4	55.0	3.8	53.4	1.4	8.1	0.0	1.8	8.9	97.8	0.8	61.7	1.2	3.4	0.4	2.7	0.5	0.8	0.1	42.4	3.3	0.6	3.4	26.9	16.4	0.2	0.0	0.3	0.0	16.6	18.9	3.0	5.4	1.3	0.0	0.0	0.0	0.0	32.6	0.1	0.0	0.0	0.0	2.0	4.9	0.0	0.0	0.0	4.7	0.5	0.1	0.0	15.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.3	2.5	0.0	0.0	0.0	77.8	8.5	0.0	0.5	0.7	0.4	0.4	0.1	0.0	31.8	1.6	27.3	0.0	4.4	0.0	101.3	0.0	0.0	0.4	1.0	0.2	0.6	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	9.7	0.0	13.3	0.2	18.2	14.1	0.0	0.0	10.0	9.0	0.3	16.6	0.0	0.0	18.9	3.0	0.3	0.3	0.3	0.3	0.3	0.4	0.8	0.0	1.4	0.1
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	19.2	16.1	14.7	24.4	15.3	30.5	25.9	11.1	14.2	12.9	22.2	12.2	20.4	24.8	16.7	16.1	23.3	13.1	17.4	16.3	16.2	11.3	21.2	28.7	22.3	29.9	12.8	10.1	16.0	28.5	13.8	16.2	26.9	15.3	11.7	13.0	18.1	16.7	20.2	17.9	29.9	26.4	13.1	14.8	28.1	19.5	42.0	11.4	34.1	16.1	15.3	24.6	16.3	23.0	3.2	4.9	12.3	4.9	3.7	5.2	2.7	18.5	16.0	14.9	22.1	6.2	6.5	31.4	14.7	10.1	15.4	14.7	28.9	19.8	36.5	22.5	14.7	15.6	13.9	13.0	9.0	12.5	15.1	26.9	16.0	15.9	15.2	29.8	23.3	10.2	9.7	16.0	13.0	15.3	42.7	11.9	8.9	21.1	35.1	11.8	31.4	14.6	37.5	15.0	17.0	8.0	24.7	28.3	15.8	12.7	15.5	18.6	14.0	12.5	29.8	29.3	14.1	34.2	27.4	14.8	18.5	39.1	18.2	25.2	17.0	5.6	4.9	4.5	5.2	2.3	3.1	3.1	3.1	4.2	2.1	3.2	2.3	2.6	12.3	3.7	4.5	4.9	2.1	2.7	14.7	15.3	11.1	14.2	16.2	11.3	12.8	10.1	15.3	11.4
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	12.9	9.6	16.5	16.2	19.8	22.2	13.6	33.2	24.4	12.0	12.4	22.2	10.5	10.7	15.7	9.0	14.6	13.1	9.6	19.3	16.3	11.0	8.8	10.5	15.9	18.4	15.1	12.3	17.1	16.0	19.4	11.1	14.4	14.7	10.8	9.6	12.3	10.7	14.6	20.2	17.2	11.9	17.6	13.9	14.6	11.6	24.6	17.9	29.5	19.1	7.6	17.7	12.1	14.4	1.3	2.9	6.7	1.1	1.5	1.4	0.7	4.7	9.1	8.1	8.9	1.7	5.3	4.9	2.9	7.2	9.5	11.2	4.4	7.5	9.4	7.1	6.7	9.7	11.2	5.8	7.8	8.5	7.8	9.2	9.9	1.8	5.5	5.5	13.1	4.2	4.1	10.6	21.1	9.0	6.8	13.0	1.9	8.9	19.9	1.5	3.5	4.5	20.3	4.1	10.3	1.9	6.7	9.4	9.9	11.1	13.7	5.9	12.6	4.7	8.0	9.3	8.3	5.1	6.3	17.6	11.9	14.5	5.2	3.7	8.0	6.7	1.1	0.9	1.3	0.5	1.3	0.7	0.6	1.4	0.3	1.3	0.5	0.6	6.4	1.5	0.5	2.9	1.1	0.7	16.5	19.8	33.2	24.4	16.3	11.0	15.1	12.3	14.7	17.9
GATM	AGAT	ENSG00000171766	"Glycine amidinotransferase"	P50440	15	45361124-45402327	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"kidney: 186.3;liver: 252.2;pancreas: 286.1"	"Group enriched"	"Detected in some"	4	"RH-30: 55.9;RT4: 14.7;U-266/70: 34.5;U-266/84: 43.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 135.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 12.8;myeloid DC: 6.9;naive B-cell: 5.9;plasmacytoid DC: 6.8"	"Group enriched"	"Detected in many"	6	"B-cells: 12.8;dendritic cells: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026077	Enhanced		Supported	Mitochondria			620000	Mitochondria		"HPA026077: AB_1849528"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.77e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.67e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.07e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.80e-1)"	1.8	2.5	18.5	1.6	14.7	0.6	2.9	11.4	16.2	1.5	3.1	24.9	0.3	17.8	1.3	2.2	3.0	1.7	5.0	5.5	15.2	10.3	186.3	252.2	1.2	2.1	20.6	14.3	17.6	286.1	0.7	1.2	7.8	14.5	1.7	1.7	1.5	5.5	2.1	13.5	13.9	10.8	2.7	26.1	3.5	10.0	8.0	18.4	0.7	6.6	2.5	3.1	2.2	2.0	12.8	6.9	0.3	1.5	0.1	1.5	0.8	3.4	1.7	1.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	5.7	8.8	0.3	0.0	0.6	4.4	0.1	0.1	0.4	0.0	0.7	0.0	0.0	0.2	5.1	0.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.6	0.1	3.1	0.0	0.1	55.9	0.4	0.9	14.7	6.5	1.1	1.8	0.1	0.3	0.7	5.8	0.0	0.0	0.1	0.0	1.7	34.5	43.6	0.2	0.4	0.1	0.3	0.0	1.1	0.3	0.3	1.5	0.0	12.8	0.0	0.3	6.9	5.9	0.0	1.5	0.0	0.1	0.6	6.8	0.0	0.8	18.5	14.7	11.4	16.2	15.2	10.3	20.6	14.3	14.5	18.4
GBE1		ENSG00000114480	"1,4-alpha-glucan branching enzyme 1"	Q04446	3	81489699-81762161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038073, HPA038074, HPA038075"	Enhanced		Approved	Nucleoplasm,Cytosol			5900000	"Nucleoplasm, Cytosol"		"HPA038073: AB_10673040, HPA038074: AB_10672403, HPA038075: AB_10674545"	"unprognostic (3.10e-1)"	"unprognostic (1.02e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.36e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.83e-3)"	"unprognostic (3.78e-3)"	23.1	22.4	2.2	7.8	4.2	5.6	19.2	4.2	4.6	6.4	7.7	5.2	5.2	4.1	8.4	4.9	7.5	4.9	11.5	19.7	3.6	4.3	14.0	36.3	11.3	7.5	7.9	3.4	8.2	5.7	8.2	11.6	11.4	8.4	5.7	4.5	9.9	8.0	10.1	56.9	5.9	6.3	7.2	6.1	8.0	4.5	4.6	4.1	5.4	6.5	11.2	4.5	9.6	10.0	11.6	13.6	14.5	11.4	13.0	7.2	6.1	12.0	7.3	2.4	34.6	60.9	46.3	4.4	20.0	28.6	12.0	20.4	1.4	3.1	13.5	8.8	24.6	1.4	2.0	9.2	28.3	6.3	1.1	4.2	15.1	4.5	41.9	14.1	3.7	34.1	6.9	19.3	19.9	26.6	3.2	7.8	39.0	3.5	2.3	16.8	2.4	11.1	4.4	11.0	15.8	8.5	4.1	1.2	1.6	13.0	3.8	4.1	2.7	11.7	37.0	24.9	5.8	17.4	18.5	35.7	4.1	4.9	40.5	9.5	10.1	6.3	11.4	14.5	5.6	10.4	5.4	11.0	6.0	5.9	13.6	11.6	7.0	7.2	11.0	13.0	10.8	4.5	5.0	6.1	2.2	4.2	4.2	4.6	3.6	4.3	7.9	3.4	8.4	4.1
GBF1	"ARF1GEF, KIAA0248"	ENSG00000107862	"Golgi brefeldin A resistant guanine nucleotide exchange factor 1"	Q92538	10	102245532-102382899	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037759, HPA037760"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA037759: AB_10671884, HPA037760: "	"unprognostic (5.97e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.74e-3)"	"unprognostic (7.02e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.78e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.34e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.09e-2)"	19.8	21.8	15.8	19.5	27.2	27.4	19.2	32.6	35.8	22.0	22.7	21.0	29.6	21.2	26.4	21.7	21.7	20.0	18.9	24.0	15.8	15.6	21.7	29.1	20.3	16.6	16.3	17.3	23.2	24.7	43.2	39.0	31.2	22.3	24.2	26.1	26.1	36.7	23.4	43.0	25.9	24.8	25.4	17.4	22.3	20.6	34.8	14.7	24.9	26.2	21.3	28.4	21.4	20.1	4.9	7.0	7.3	8.0	3.9	7.7	4.2	7.7	17.1	14.1	12.1	31.4	22.0	10.5	18.0	25.6	19.9	23.8	17.9	16.3	9.1	11.6	26.2	16.4	20.7	23.2	20.8	15.1	15.3	13.9	17.6	13.0	11.7	16.5	22.3	19.2	12.7	27.1	27.0	19.0	8.8	24.1	18.4	13.1	10.5	10.8	5.8	11.5	13.9	33.7	7.2	18.1	12.4	6.1	6.7	12.8	8.1	8.6	23.3	9.1	26.5	13.1	11.3	16.0	20.4	14.5	11.1	10.1	13.8	16.0	7.9	7.3	5.5	4.0	7.7	8.0	6.6	4.9	5.3	7.3	7.0	4.0	4.8	5.7	4.1	3.9	5.1	3.4	6.9	4.2	15.8	27.2	32.6	35.8	15.8	15.6	16.3	17.3	22.3	14.7
GBP1		ENSG00000117228	"Guanylate binding protein 1"	P32455	1	89052319-89065360	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.8;BJ hTERT+ SV40 Large T+ RasG12V: 50.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											CAB015450	Approved				"Intracellular and membrane"					"CAB015450: AB_2109333"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-2)"	"prognostic favourable (8.32e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.67e-2)"	"prognostic favourable (5.04e-4)"	"unprognostic (8.36e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.01e-3)"	32.2	4.9	4.2	30.8	8.8	2.1	12.5	3.1	4.3	18.3	14.7	5.9	4.8	7.3	17.3	11.5	9.4	11.0	19.7	7.1	4.2	4.6	15.5	35.4	38.6	21.6	6.7	3.0	16.5	2.3	8.4	4.2	20.9	20.1	21.4	7.2	5.4	5.9	9.3	17.0	6.3	21.4	18.0	9.0	32.3	9.4	4.6	4.5	12.5	51.3	7.7	12.6	19.2	9.8	4.0	10.8	26.0	30.6	14.1	39.1	18.7	3.7	0.0	0.0	0.0	3.5	6.4	10.9	10.1	20.2	36.8	50.2	1.1	2.6	3.5	6.3	11.9	0.8	0.0	4.6	17.0	10.9	0.0	0.8	3.4	0.1	21.8	0.0	0.5	15.4	1.8	16.2	2.9	8.9	0.0	3.3	12.3	0.0	8.4	0.0	0.1	0.4	12.3	11.6	0.2	2.4	6.1	0.2	0.0	11.0	2.7	1.0	0.3	0.0	11.8	10.9	0.4	3.3	8.1	0.1	0.0	0.0	4.2	0.0	1.1	0.1	9.3	1.2	23.4	30.6	22.3	4.0	23.7	24.9	10.8	2.7	18.1	20.8	26.0	14.1	29.3	0.0	39.1	18.7	4.2	8.8	3.1	4.3	4.2	4.6	6.7	3.0	20.1	4.5
GBP4	Mpa2	ENSG00000162654	"Guanylate binding protein 4"	Q96PP9	1	89181148-89198932	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.8;HDLM-2: 7.9;HEL: 10.4;REH: 8.8;RT4: 14.8;U-266/70: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030101, HPA062039"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"				"Golgi apparatus"	"Plasma membrane"	"HPA030101: AB_10601654, HPA062039: "	"unprognostic (1.32e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.22e-1)"	"unprognostic (9.93e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (9.29e-5)"	"unprognostic (1.91e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.30e-5)"	"unprognostic (1.22e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.02e-3)"	25.4	4.4	3.9	18.4	5.9	3.6	9.4	2.1	5.0	7.8	5.8	4.4	2.9	8.0	10.5	7.4	7.9	6.3	5.7	9.2	4.6	4.4	8.5	9.8	34.7	20.5	5.8	4.4	12.8	2.4	9.3	4.8	9.1	6.9	12.7	4.8	17.4	4.8	4.8	12.0	3.2	11.0	5.1	7.4	23.4	7.4	2.6	2.7	8.1	23.3	5.7	15.2	9.3	7.7	3.3	2.0	5.1	12.6	12.2	7.6	4.4	0.6	0.0	0.1	0.2	0.1	0.1	0.5	1.5	6.2	6.7	6.1	0.1	9.8	0.5	0.8	1.8	0.7	0.0	0.3	0.3	7.9	0.1	10.4	0.3	0.3	0.9	0.2	0.3	0.3	0.0	0.1	0.0	1.5	0.3	1.9	0.0	0.1	5.1	0.3	0.4	0.1	8.8	0.2	0.3	0.1	14.8	0.2	0.5	0.2	0.5	0.2	0.5	1.1	0.4	0.2	1.4	0.2	0.1	13.3	0.2	0.3	0.3	0.1	1.8	0.4	3.8	0.4	6.6	12.6	5.8	2.3	7.3	7.3	2.0	3.3	5.5	5.1	5.1	12.2	11.5	0.7	7.6	4.4	3.9	5.9	2.1	5.0	4.6	4.4	5.8	4.4	6.9	2.7
GC	"DBP, hDBP, VDBP"	ENSG00000145321	"GC, vitamin D binding protein"	P02774	4	71741693-71804041	"Plasma proteins, Predicted secreted proteins"	Transport	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 552.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 4.1;RH-30: 6.4;SiHa: 3.1;U-698: 2.3"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 1016.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001526, CAB008596, HPA019855"	Supported				"Secreted to blood"	142606666667	69000000000			"CAB008596: AB_1622398, HPA001526: AB_1078959, HPA019855: AB_1849545"							"prognostic favourable (8.08e-4)"				"unprognostic (1.06e-3)"		"prognostic unfavourable (5.81e-5)"	"unprognostic (1.55e-1)"	"unprognostic (2.15e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.0	0.0	2.6	0.1	0.2	0.1	0.1	43.7	0.1	0.1	0.1	2.0	552.1	0.1	0.0	0.1	0.0	0.1	6.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.0	0.0	0.1	0.4	2.6	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	4.1	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.3	3.1	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.8	0.0	2.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
GCA	GCL	ENSG00000115271	Grancalcin	P28676	2	162318840-162371595	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 41.1;neutrophil: 112.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 112.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA035033, HPA035034"	Enhanced		Supported	"Plasma membrane,Cytosol"			890000	Cytosol	"Plasma membrane"	"HPA035033: AB_10669854, HPA035034: AB_10669900"	"unprognostic (9.62e-2)"	"unprognostic (9.76e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.82e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.56e-2)"	"unprognostic (5.80e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.32e-2)"	13.1	6.8	13.4	24.8	21.3	116.0	7.8	6.9	15.8	6.0	7.7	15.3	3.2	8.2	4.6	11.0	5.0	7.2	9.7	11.2	15.9	13.0	8.5	7.6	15.6	51.8	26.0	9.7	4.4	11.5	4.8	8.1	10.6	24.6	5.7	8.6	3.7	6.9	4.9	2.2	3.7	7.8	7.7	30.2	50.0	10.3	10.7	20.8	5.8	7.4	2.5	10.3	10.0	6.3	3.1	8.9	112.7	18.2	0.3	1.3	8.4	1.3	2.1	5.8	0.0	1.4	1.2	0.2	2.1	6.1	3.4	6.2	4.8	16.3	1.9	15.0	0.1	0.8	2.2	6.9	4.2	9.1	9.2	17.1	1.5	9.1	1.7	21.4	5.0	1.5	2.4	3.1	0.7	0.4	0.3	6.6	0.2	16.8	0.4	12.4	3.7	8.3	7.4	1.4	9.6	17.9	9.6	3.8	6.5	2.8	12.6	10.6	8.6	9.6	0.4	0.8	6.2	9.7	3.2	6.3	11.7	0.3	5.3	8.4	4.0	4.4	18.2	41.1	0.4	10.7	0.5	3.0	0.6	0.6	8.9	3.1	1.1	0.7	112.7	0.3	8.0	2.2	1.3	8.4	13.4	21.3	6.9	15.8	15.9	13.0	26.0	9.7	24.6	20.8
GCAT	KBL	ENSG00000100116	"Glycine C-acetyltransferase"	O75600	22	37807905-37817176	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 81.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA020460	Uncertain		Supported	"Nucleoplasm,Nuclear speckles,Mitochondria"				Nucleoplasm	"Nuclear speckles, Mitochondria"	"HPA020460: AB_1849548"	"unprognostic (1.61e-1)"	"unprognostic (1.80e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.56e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.73e-3)"	"unprognostic (3.99e-1)"	2.9	6.0	8.9	2.4	8.8	8.1	4.2	8.3	12.3	4.5	4.7	5.2	8.0	3.5	3.0	4.0	6.3	3.9	6.0	21.5	8.6	8.4	8.1	19.1	2.3	2.1	10.1	7.4	4.0	81.6	3.5	3.7	2.2	7.4	12.2	3.5	4.3	12.0	5.0	10.3	3.2	3.2	3.1	6.3	1.1	4.4	5.9	4.3	2.8	10.7	9.3	4.3	3.3	2.2	0.3	2.5	0.8	1.3	2.3	7.1	2.8	8.7	2.3	5.9	33.6	12.2	9.9	4.1	12.6	13.3	9.6	8.2	5.1	1.0	2.7	5.9	5.6	5.1	5.9	8.9	2.2	1.2	10.7	6.1	7.3	20.1	19.9	10.8	8.0	11.6	5.4	6.3	14.0	7.8	15.6	3.2	4.5	7.7	11.3	20.0	2.5	9.4	11.9	1.2	16.1	12.1	6.9	12.2	8.3	9.8	15.9	6.7	12.8	5.3	5.9	9.7	5.3	6.4	4.3	10.7	5.2	5.7	6.7	10.1	10.1	0.2	1.3	0.8	1.5	1.2	0.6	0.3	3.4	1.0	2.4	0.1	7.1	2.9	0.6	2.3	0.8	2.5	3.3	2.8	8.9	8.8	8.3	12.3	8.6	8.4	10.1	7.4	7.4	4.3
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108448561-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: "	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	10.9	10.6	12.0	15.2	21.6	20.5	13.1	5.0	16.8	11.9	13.6	3.9	26.7	13.4	10.9	32.0	9.5	12.4	13.2	8.0	9.3	5.8	12.8	8.3	14.2	13.0	7.8	15.6	17.6	13.1	11.5	24.3	8.6	15.0	14.6	13.6	4.3	14.9	32.3	9.6	9.3	18.1	8.4	11.4	11.7	18.1	15.5	10.5	11.1	13.8	6.1	10.0	16.3	11.3	14.3	17.6	20.3	8.8	7.9	23.0	4.5	7.5	5.8	7.6	2.7	5.6	13.5	13.2	10.5	12.4	4.0	6.7	11.2	9.3	8.8	12.5	7.2	6.2	4.3	7.4	8.5	10.7	7.5	11.9	9.8	7.4	6.2	15.4	8.7	14.2	7.1	10.4	8.8	6.9	15.2	7.2	7.5	4.6	6.4	8.0	12.2	7.6	6.5	8.9	8.2	4.6	12.6	7.9	9.0	11.8	8.7	9.0	4.4	5.0	11.9	8.2	12.4	7.8	4.0	9.5	16.7	10.5	9.2	3.9	5.1	20.1	5.2	13.7	15.4	4.6	14.9	14.3	16.9	16.0	4.0	13.6	23.0	19.7	20.3	7.9	8.8	17.6	12.3	4.5	12.0	21.6	5.0	16.8	9.3	5.8	7.8	15.6	15.0	10.5
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814013	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 68.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;MCF7: 6.0;SK-BR-3: 5.2;U-87 MG: 6.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			HPA071228			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA071228: "	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	3.9	0.1	0.6	0.3	0.0	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.1	0.0	11.4	68.8	0.1	0.1	0.1	0.1	0.1	0.5	3.9	0.1	0.1	0.5	0.2	0.0	1.4	0.3	0.1	0.1	0.9	0.2	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.2	0.6	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.5	0.0	5.2	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.5	0.1
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 69.2"	"Cell line enhanced"	"Detected in all"		"A549: 54.7;Hep G2: 46.7;RT4: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			3600000	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favourable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavourable (8.24e-4)"	"unprognostic (2.30e-2)"	15.8	11.1	12.9	9.0	16.0	14.4	13.0	5.4	15.1	6.8	16.2	21.6	8.2	18.9	9.2	5.3	20.0	29.1	14.9	7.4	13.1	10.6	15.4	69.2	12.9	10.1	21.6	12.2	6.2	12.4	6.6	5.4	6.2	13.0	13.0	12.2	5.2	11.2	10.1	7.0	8.6	14.8	11.9	13.6	16.8	14.8	5.2	17.5	3.1	14.1	32.4	10.6	34.4	12.3	1.6	4.2	2.2	1.9	8.0	2.3	0.6	8.1	54.7	4.5	10.6	5.4	2.4	6.0	4.1	6.7	3.1	3.7	8.0	19.0	15.5	7.9	3.7	11.6	13.7	30.1	4.2	12.2	8.4	10.4	10.6	46.7	6.2	13.6	6.4	3.8	12.8	3.5	15.7	4.7	5.7	4.9	1.5	8.6	11.7	5.4	8.3	5.1	3.9	2.7	13.7	10.1	50.4	13.0	6.4	6.9	11.1	7.2	7.6	6.5	6.5	2.8	9.8	7.1	6.1	6.6	10.1	9.0	7.0	9.8	4.7	2.2	1.1	0.6	1.2	1.9	0.8	1.6	1.0	2.3	4.2	1.0	0.6	1.3	0.5	8.0	1.8	3.0	1.6	0.6	12.9	16.0	5.4	11.9	13.1	10.6	21.6	12.2	13.0	17.5
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1, eIF2 alpha kinase activator homolog"	Q92616	12	120127203-120194710	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol			40000	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavourable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	23.1	14.6	7.9	14.3	14.4	15.7	14.4	18.3	20.6	15.3	15.2	22.3	9.7	11.5	31.2	10.2	20.2	14.8	11.3	12.6	7.7	7.8	14.7	19.1	14.0	16.0	11.5	6.8	18.9	19.9	23.8	21.4	24.4	14.9	15.1	12.2	16.8	33.3	13.2	36.0	20.9	15.5	14.4	9.7	18.3	17.2	16.0	10.3	22.2	20.6	14.3	27.4	15.9	15.1	4.3	4.9	2.2	6.5	3.1	7.8	3.1	16.7	33.1	12.0	13.4	19.0	11.5	42.0	15.0	13.2	15.7	12.9	28.3	11.6	22.3	17.1	21.5	16.6	27.7	21.3	9.8	14.8	22.6	27.6	21.6	19.6	12.4	25.4	17.7	14.1	12.4	18.5	17.6	14.3	32.3	5.7	13.1	16.9	16.0	19.3	21.2	20.3	19.5	12.3	22.1	10.8	57.5	19.7	19.7	24.7	10.8	8.9	22.9	14.4	19.5	12.9	14.3	8.4	15.5	22.7	20.8	22.6	12.3	13.4	12.9	1.2	3.1	2.2	6.4	3.2	7.8	3.9	5.0	5.3	4.1	4.3	3.8	4.0	0.1	3.1	6.5	4.9	4.6	3.1	7.9	14.4	18.3	20.6	7.7	7.8	11.5	6.8	14.9	10.3
GCSH		ENSG00000140905	"Glycine cleavage system protein H"	P23434	16	81081938-81096425	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA041368	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA041368: AB_10804001"	"unprognostic (4.09e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.55e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.80e-2)"	"prognostic favourable (6.26e-6)"	"unprognostic (1.12e-2)"	"unprognostic (2.59e-1)"	"unprognostic (6.31e-2)"	"unprognostic (6.47e-2)"	10.9	10.0	28.9	3.7	26.8	3.0	11.4	8.1	21.8	9.9	6.4	15.0	14.2	3.8	9.4	35.9	6.0	10.4	6.3	11.7	23.5	20.6	37.3	55.9	4.0	5.8	30.8	15.8	8.9	10.2	19.4	7.2	12.9	18.7	9.9	7.0	10.4	9.4	9.3	18.1	4.3	3.1	6.9	27.6	2.6	5.2	3.5	17.9	6.7	48.7	5.9	4.8	6.6	4.9	4.4	12.2	2.8	2.6	7.9	7.3	2.9	17.8	7.9	24.9	10.8	12.2	9.4	50.8	10.4	7.7	12.7	6.2	10.5	16.7	4.7	9.4	4.5	9.2	19.0	10.5	21.3	1.3	24.8	6.0	10.5	32.4	13.9	19.7	7.1	9.6	14.2	7.9	16.2	6.4	23.6	1.0	12.6	18.8	12.8	39.9	32.8	16.5	20.0	13.1	7.1	28.7	16.4	12.9	13.4	14.9	9.7	19.7	14.2	9.5	5.6	8.2	14.4	13.1	10.7	4.0	8.6	28.6	5.5	11.8	6.6	2.8	1.7	1.7	3.4	2.6	5.7	4.4	3.3	4.9	4.5	3.3	5.8	7.3	2.2	7.9	2.0	12.2	2.6	2.9	28.9	26.8	8.1	21.8	23.5	20.6	30.8	15.8	18.7	17.9
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;BJ hTERT+: 9.2;EFO-21: 50.3;HeLa: 17.6;hTCEpi: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm			1300000	Nucleoplasm		"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	12.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	9.2	0.0	0.0	1.1	7.1	0.0	50.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	2.9	0.0	0.2	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2
GDF10	BMP-3b	ENSG00000266524	"Growth differentiation factor 10"	P55107	10	47300386-47313547	"Plasma proteins, Predicted secreted proteins"	Osteogenesis	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 15.8;tongue: 14.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.3;MOLT-4: 3.7;SH-SY5Y: 7.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.3;naive CD4 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Region enriched"	"Detected in many"	8	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA015498	Uncertain		Approved	Vesicles	"Secreted in other tissues"			Vesicles		"HPA015498: AB_1849584"	"unprognostic (4.34e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.09e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-7)"	"unprognostic (3.49e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.59e-3)"	"unprognostic (2.63e-1)"	6.8	4.4	1.4	0.3	2.8	0.0	10.8	7.6	5.2	1.9	0.4	1.7	0.0	0.0	2.3	2.4	5.4	0.5	2.9	2.1	3.0		0.0	0.0	15.8	0.9	0.0	5.0	0.1	11.6	0.2	0.0	0.0	0.9	2.8	0.3	6.8	3.0	0.3	2.5	0.3	0.1	0.6	0.8	0.1	0.1	10.5	0.8	0.0	3.7	14.8	2.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1										
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 70.7;Hep G2: 36.4;HHSteC: 98.3;TIME: 35.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	1258667	890000	"Golgi apparatus"		"CAB062554: , HPA011191: AB_1078962, HPA070957: "	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	15.8	1.5	0.5	3.8	3.2	70.7	5.5	3.0	0.2	3.2	0.7	4.9	0.0	10.0	0.4	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	36.4	98.3	0.0	6.1	8.4	23.8	15.4	10.0	16.7	24.3	0.1	3.8	3.8	0.0	0.1	0.9	8.9	0.0	0.6	0.0	11.7	15.6	0.1	0.1	0.0	0.9	19.8	0.4	0.0	35.3	0.0	1.3	0.3	0.2	0.2	0.6	0.0	8.9	0.0	4.6	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4
GDF2	"BMP-9, BMP9"	ENSG00000263761	"Growth differentiation factor 2"	Q9UK05	10	47322490-47326270	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Angiogenesis	"Cytokine, Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	273	"liver: 27.3"	"Cell line enhanced"	"Detected in single"		"K-562: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB023357	Uncertain				"Secreted to blood"	2207333	300000			"CAB023357: AB_2111086"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	27.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GDF5	"BMP14, CDMP1"	ENSG00000125965	"Growth differentiation factor 5"	P43026	20	35433347-35454746	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Chondrogenesis	"Cytokine, Growth factor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"salivary gland: 16.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 16.9;BJ hTERT+: 5.0;fHDF/TERT166: 4.0;HHSteC: 5.5;HSkMC: 13.7;U-87 MG: 6.4"	"Cancer enriched"	"Detected in single"	7	"endometrial cancer: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA015648	Uncertain				"Secreted to blood"					"HPA015648: AB_1849589"	"unprognostic (4.59e-3)"	"unprognostic (3.48e-2)"	"unprognostic (5.53e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.53e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.17e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.96e-3)"	1.3	0.2	0.6	0.2	1.9	0.2	0.9	0.2	1.3	0.7	2.3	0.1	1.0	0.1	0.9	0.2	0.2	0.2	0.5	0.9	0.3	0.1	0.8	0.1	3.3	0.1	0.7	0.0	0.4	0.1	0.1	4.1	0.2	0.6	1.6	0.2	0.5	16.4	2.4	0.2	0.2	0.1	1.1	1.0	0.1	0.3	0.7	0.0	1.0	0.5	1.1	0.1	0.5	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	16.9	0.1	2.6	5.0	0.4	0.9	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	13.7	0.1	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.2	0.0	0.1	0.6	1.9	0.2	1.3	0.3	0.1	0.7	0.0	0.6	0.0
GDI1	"FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4"	ENSG00000203879	"GDP dissociation inhibitor 1"	P31150	X	154436913-154443467	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 122.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012979, HPA049290, HPA057668"	Enhanced		Approved	Vesicles			70000000	Vesicles		"CAB012979: AB_2533970, HPA049290: , HPA057668: "	"prognostic unfavourable (6.84e-4)"	"unprognostic (1.13e-2)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.31e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.98e-3)"	"unprognostic (3.86e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.72e-1)"	19.8	27.1	51.7	16.2	65.3	10.5	12.0	61.3	122.3	16.7	13.6	46.2	6.5	11.5	20.1	15.7	14.4	23.0	15.2	25.7	53.7	54.3	13.7	10.3	16.9	15.1	45.1	49.6	27.7	16.2	18.8	26.9	19.0	65.3	19.6	13.9	13.8	13.6	24.0	14.3	17.2	13.1	25.6	46.4	17.1	13.5	12.9	31.3	6.8	12.7	6.2	15.7	13.9	11.8	7.6	8.3	20.6	13.4	5.6	13.0	4.9	20.3	18.9	42.7	35.2	17.5	20.7	13.4	29.5	19.8	31.1	32.5	11.0	10.8	16.3	30.9	29.9	16.1	37.4	18.0	21.6	29.4	18.4	5.1	27.7	7.3	25.8	4.9	18.6	21.2	22.3	36.0	22.1	20.0	6.2	25.9	36.9	20.6	15.6	12.4	11.3	34.5	15.6	11.1	9.3	21.7	9.6	59.1	45.7	14.2	18.5	22.4	11.0	8.9	22.6	28.7	24.9	29.7	43.1	36.7	38.9	25.9	31.2	11.1	35.2	14.9	5.7	17.2	8.9	8.6	13.0	7.3	9.6	8.6	4.7	7.6	7.6	7.5	20.6	5.6	13.4	8.3	10.8	4.9	51.7	65.3	61.3	96.6	53.7	54.3	45.1	49.6	65.3	31.3
GDI2	RABGDIB	ENSG00000057608	"GDP dissociation inhibitor 2"	P50395	10	5765223-5842132	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049290, HPA057668"	Supported						89000000			"HPA049290: , HPA057668: "	"unprognostic (1.08e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (9.26e-4)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (7.56e-7)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.68e-2)"	65.9	53.8	31.2	46.0	31.6	35.3	64.3	26.8	43.5	41.8	50.3	35.6	41.7	55.7	40.6	43.3	54.8	34.8	36.5	43.2	29.8	32.3	51.3	88.4	44.8	77.7	37.8	28.5	50.3	74.2	29.2	45.7	42.7	38.7	43.0	52.8	27.2	44.7	42.9	51.9	45.6	71.9	43.8	53.7	54.1	42.4	32.4	33.0	64.2	58.3	46.6	73.3	55.5	40.9	40.3	62.3	30.5	77.4	31.7	32.8	64.2	55.9	40.8	58.7	40.9	51.6	60.7	32.7	54.7	28.8	49.4	54.1	57.9	48.3	90.9	34.3	56.6	54.1	62.3	48.4	49.7	34.8	29.3	62.7	28.2	69.6	48.4	40.9	39.9	50.7	40.1	42.8	25.6	67.3	64.4	34.6	55.5	47.2	64.1	33.6	41.3	26.7	76.6	31.1	64.0	55.9	41.4	23.7	36.2	43.0	79.3	58.0	65.2	49.2	57.1	24.7	42.7	71.7	46.8	31.0	52.1	89.0	36.7	45.3	22.0	21.1	50.1	30.5	21.9	63.3	26.8	40.3	27.2	24.1	62.3	38.3	25.6	23.6	25.6	31.7	77.4	26.4	32.8	64.2	31.2	31.6	26.8	43.5	29.8	32.3	37.8	28.5	38.7	33.0
GEMIN4	"DKFZP434B131, DKFZP434D174, HC56, HCAP1, HHRF-1, p97"	ENSG00000179409	"Gem nuclear organelle associated protein 4"	P57678	17	744414-753999	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065699, HPA067891"	Uncertain		Supported	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA065699: , HPA067891: "	"unprognostic (1.85e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.00e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.89e-2)"	"unprognostic (8.67e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.74e-2)"	"unprognostic (8.56e-3)"	10.8	6.5	6.4	5.9	5.1	10.5	10.1	15.0	7.2	11.1	6.9	5.4	11.3	6.1	10.5	5.9	12.0	9.5	9.9	9.1	5.5	3.3	5.4	9.9	8.0	12.8	5.8	4.0	13.5	8.5	4.1	5.2	7.6	5.4	11.2	5.0	6.8	9.1	8.8	10.5	29.5	7.6	8.7	4.2	11.4	10.7	36.7	6.5	20.5	20.1	8.7	11.4	10.4	9.9	11.7	8.3	1.5	9.6	6.9	13.4	8.4	18.6	33.1	11.1	16.6	7.1	8.9	13.8	10.7	7.5	19.4	17.3	18.8	10.1	32.8	14.3	9.2	23.7	20.9	20.1	15.6	12.3	31.1	11.8	17.6	10.5	5.0	12.4	16.2	8.6	10.2	15.9	11.3	10.9	16.3	13.8	10.3	13.2	20.4	7.0	10.7	14.3	22.2	5.3	15.4	8.3	13.8	11.5	9.3	11.0	11.3	5.0	12.0	9.1	8.6	12.0	10.9	15.5	25.8	2.3	5.0	18.8	10.3	17.6	13.7	1.5	6.1	0.3	7.6	8.5	13.4	11.6	8.2	8.0	8.3	11.7	10.0	9.8	0.8	6.9	9.6	4.8	5.5	8.4	6.4	5.1	15.0	7.2	5.5	3.3	5.8	4.0	5.4	6.5
GFAP	FLJ45472	ENSG00000131095	"Glial fibrillary acidic protein"	P14136	17	44903161-44916937	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	61	"brain: 595.5"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 9.5"	"Cancer enriched"	"Detected in some"	368	"glioma: 2468.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000039, HPA056030, HPA063513"	Enhanced	Supported	Supported	"Intermediate filaments"			220000000	"Intermediate filaments"		"CAB000039: AB_10013382, HPA056030: , HPA063513: "	"unprognostic (1.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.12e-5)"	"unprognostic (4.08e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.57e-3)"	"unprognostic (7.35e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.75e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	3.0	2.9	122.2	3.2	105.4	5.8	3.0	33.9	595.5	2.7	3.0	171.0	0.0	2.8	2.9	3.0	3.6	3.2	3.1	4.0	143.0	175.1	3.0	2.8	3.0	3.1	227.0	67.3	3.0	3.0	3.4	1.3	2.8	212.7	3.0	2.9	0.0	3.1	2.9	3.2	3.3	2.8	2.9	482.0	3.0	3.0	2.9	119.0	0.0	3.0	0.0	2.9	3.4	0.0	1.1	0.8	9.8	1.2	2.9	0.8	0.3	1.7	1.1	2.0	3.8	0.0	0.8	0.5	1.7	2.0	2.4	2.0	2.1	2.4	3.5	3.1	0.9	4.3	2.2	0.7	3.0	4.3	1.9	2.8	2.9	1.4	0.1	0.8	4.2	0.2	1.3	1.7	0.0	0.0	1.3	8.3	0.6	2.2	2.9	4.1	2.7	5.2	1.2	1.2	2.8	1.1	1.5	2.7	2.9	0.5	3.4	0.3	2.2	2.2	1.2	2.1	1.6	1.9	2.5	1.2	2.3	2.7	9.5	3.4	3.3	1.9	1.2	0.5	0.5	1.1	0.4	0.4	0.5	0.7	0.3	1.1	0.6	0.8	9.8	2.9	0.7	0.8	0.4	0.3	122.2	105.4	33.9	69.4	143.0	175.1	227.0	67.3	212.7	119.0
GGCT	"C7orf24, CRF21, GCTG, Ggc, MGC3077"	ENSG00000006625	Gamma-glutamylcyclotransferase	O75223	7	30496621-30504844	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA020735, HPA029914"	Approved						2400000			"HPA020735: AB_1845754, HPA029914: AB_10602321"	"prognostic unfavourable (7.68e-4)"	"unprognostic (2.66e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (1.33e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.42e-3)"	"unprognostic (2.66e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.12e-3)"	"unprognostic (2.00e-3)"	"unprognostic (9.92e-2)"	30.8	18.6	15.5	14.5	15.9	10.2	26.4	10.8	25.6	12.6	20.2	7.3	19.3	16.7	10.4	59.6	33.4	13.5	22.5	12.2	14.6	12.4	22.0	18.7	14.6	13.6	11.6	14.4	15.2	17.2	14.9	11.4	18.5	15.0	14.3	21.9	8.0	23.9	19.2	12.6	29.8	16.8	14.2	9.9	13.2	13.3	8.1	5.8	11.0	28.7	32.1	18.9	17.4	19.1	14.8	21.7	5.6	12.8	15.3	16.4	10.1	40.2	10.6	17.2	23.2	7.3	13.3	20.1	13.8	5.4	13.3	16.1	14.0	14.1	26.0	9.1	5.1	51.4	18.1	14.4	17.4	4.9	20.0	18.4	21.4	18.4	9.5	30.9	14.3	12.9	11.6	13.8	17.9	13.4	26.1	15.0	10.4	22.2	18.7	41.8	24.9	17.1	18.8	20.0	25.9	12.7	36.8	21.9	22.1	12.3	77.4	14.7	49.6	29.3	8.0	8.7	16.4	16.5	26.8	11.1	26.1	20.1	6.8	42.0	16.2	5.6	12.8	4.2	9.6	12.5	13.3	14.8	12.7	12.3	21.7	11.7	12.3	11.9	0.7	15.3	7.3	19.1	16.4	10.1	15.5	15.9	10.8	25.6	14.6	12.4	11.6	14.4	15.0	5.8
GGH		ENSG00000137563	"Gamma-glutamyl hydrolase"	Q92820	8	63015079-63039171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 42.5;liver: 59.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019296, HPA025226"	Approved				"Intracellular and membrane"		1400000000			"CAB019296: , HPA025226: AB_1849645"	"unprognostic (9.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (3.99e-7)"	"unprognostic (5.57e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.50e-2)"	3.5	3.6	7.4	4.7	8.6	12.3	11.8	15.5	9.9	3.5	17.6	1.5	1.0	3.7	2.6	3.7	11.0	1.6	2.8	5.9	7.9	7.6	42.5	59.5	3.5	5.0	4.7	7.0	1.9	4.2	1.0	1.6	17.7	14.8	1.9	26.4	2.2	6.5	1.8	1.7	11.1	3.6	4.2	7.6	3.7	3.2	14.0	3.8	5.2	1.4	14.5	7.6	3.9	6.6	4.1	18.2	2.1	1.9	2.9	1.4	1.4	20.4	19.7	20.2	3.1	19.9	8.4	14.9	12.6	21.6	20.0	29.1	27.5	36.3	14.0	3.6	15.6	17.1	20.0	21.1	29.8	28.4	15.1	23.0	10.6	18.6	3.8	10.7	13.8	6.1	6.0	20.2	9.7	24.2	12.2	51.3	37.5	11.6	5.2	10.7	9.5	18.6	15.6	19.7	18.8	15.5	7.2	8.1	13.8	18.4	20.1	19.1	22.2	11.9	12.8	21.6	24.2	20.7	22.7	24.0	24.4	16.4	33.4	0.0	38.1	0.0	1.9	2.1	1.1	1.1	0.5	4.1	1.3	1.3	0.6	1.9	1.0	1.3	1.8	2.9	1.2	18.2	1.4	1.4	7.4	8.6	15.5	9.9	7.9	7.6	4.7	7.0	14.8	3.8
GGPS1	GGPPS1	ENSG00000152904	"Geranylgeranyl diphosphate synthase 1"	O95749	1	235327350-235344532	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Isoprene biosynthesis"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029472	Enhanced									"HPA029472: AB_10696206"	"unprognostic (7.45e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.10e-3)"	"prognostic unfavourable (6.69e-4)"	"unprognostic (4.50e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (2.66e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.70e-2)"	24.5	24.8	26.8	16.2	25.7	6.8	33.4	30.1	28.7	24.9	23.1	19.9	21.8	19.8	22.8	30.3	24.1	20.9	19.2	21.8	25.4	25.8	26.4	20.0	18.9	18.3	24.4	22.0	23.5	16.0	19.0	29.3	24.2	25.8	29.0	23.2	15.9	27.8	21.9	26.8	19.0	20.6	24.9	28.3	20.4	20.1	42.5	25.6	22.6	27.9	21.2	20.0	26.9	17.9	28.5	22.2	33.9	35.9	22.1	31.3	26.0	17.6	9.6	24.0	18.1	18.7	27.1	9.4	15.7	22.0	10.4	14.7	7.4	28.2	12.0	22.9	17.3	14.4	12.7	16.2	13.8	12.1	23.7	10.1	9.1	12.5	21.1	12.4	8.7	17.6	29.3	14.1	19.1	18.4	24.2	10.8	13.7	10.3	15.5	14.9	20.5	5.0	9.6	7.5	13.6	29.0	9.6	19.3	26.7	11.8	27.1	22.6	33.8	19.9	15.5	12.5	9.4	21.1	14.7	18.9	22.8	14.6	15.8	14.1	22.4	26.6	22.8	33.9	24.8	26.8	24.9	28.5	31.3	26.4	22.2	23.4	29.2	26.5	20.6	22.1	35.9	18.4	30.0	26.0	26.8	25.7	30.1	28.7	25.4	25.8	24.4	22.0	25.8	25.6
GGT1	"CD224, D22S672, D22S732, GGT"	ENSG00000100031	"Gamma-glutamyltransferase 1"	P19440	22	24583750-24629005	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Glutathione biosynthesis"	"Acyltransferase, Hydrolase, Protease, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 54.1;seminal vesicle: 41.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.8;Karpas-707: 52.7;RPMI-8226: 51.8;RPTEC TERT1: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA045635, HPA047534, HPA065444"	Supported		Approved	Vesicles	"Intracellular and membrane"		4600000	Vesicles		"HPA045635: , HPA047534: , HPA065444: "	"unprognostic (8.13e-3)"	"unprognostic (4.76e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.21e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (4.55e-2)"	"unprognostic (2.55e-2)"	"prognostic favourable (4.83e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.10e-2)"	1.6	0.5	1.7	1.7	2.2	2.7	8.2	2.3	2.6	7.3	7.9	1.6	23.7	22.3	1.4	19.9	1.2	0.8	12.2	2.0	1.8	1.2	54.1	29.2	14.3	3.2	1.7	1.6	1.3	17.3	0.0	1.6	1.4	2.2	14.7	2.4	1.4	8.7	41.7	0.9	1.1	20.9	1.7	1.9	4.7	6.6	5.0	2.1	2.4	4.8	1.6	5.5	2.1	1.1	3.3	7.5	15.9	14.6	6.6	8.6	6.6	0.2	19.4	0.2	0.0	0.0	0.1	0.5	0.1	0.6	0.2	0.2	2.6	4.3	0.2	4.3	0.0	2.8	1.4	0.2	0.1	35.8	2.9	0.1	8.6	14.1	1.5	0.3	12.0	0.4	0.2	0.6	0.4	0.1	2.0	52.7	0.2	0.4	0.3	14.6	1.4	0.2	0.2	2.2	51.8	48.2	0.6	0.2	0.3	0.1	9.4	0.2	9.4	11.1	2.2	3.5	2.3	10.9	0.3	15.8	6.0	0.2	7.4	15.1	0.1	5.2	14.6	0.4	1.4	6.8	5.2	3.3	7.7	3.4	7.5	0.3	1.0	1.9	15.9	6.6	5.5	0.1	8.6	6.6	1.7	2.2	2.3	2.6	1.8	1.2	1.7	1.6	2.2	2.1
GHDC	LGP1	ENSG00000167925	"GH3 domain containing"	Q8N2G8	17	42188799-42194532	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031650	Uncertain				"Intracellular and membrane"					"HPA031650: AB_10601014"	"unprognostic (2.30e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.60e-1)"	"prognostic favourable (3.21e-4)"	"prognostic unfavourable (6.81e-5)"	"unprognostic (5.13e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (5.20e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.18e-2)"	"prognostic favourable (2.00e-6)"	"unprognostic (2.08e-1)"	"unprognostic (7.93e-2)"	"unprognostic (9.66e-2)"	"unprognostic (4.02e-2)"	14.8	22.4	6.6	10.3	8.3	9.8	10.2	11.5	12.2	12.6	13.7	13.0	28.4	15.1	10.5	11.7	10.2	10.8	15.5	9.2	6.5	9.4	21.5	20.0	10.3	14.8	11.8	5.9	15.7	17.2	10.9	11.5	10.1	10.0	14.5	5.2	15.9	22.4	17.2	5.5	6.1	17.2	8.8	8.4	21.6	13.3	8.4	8.0	8.5	30.0	6.5	12.7	10.6	8.8	7.7	5.3	3.3	7.3	2.1	4.7	4.0	3.2	11.4	0.8	9.1	3.1	2.7	7.2	4.3	3.4	2.2	2.9	3.6	15.6	4.9	15.7	4.0	0.3	2.6	0.1	0.5	8.0	9.3	7.4	5.1	7.6	8.1	5.9	31.8	4.1	2.3	6.1	1.9	3.4	7.1	22.4	1.1	3.9	3.8	11.6	2.0	0.0	3.7	4.2	21.2	6.1	2.6	1.8	6.2	0.1	20.6	14.7	14.2	9.5	2.9	10.6	4.2	9.2	2.0	16.8	13.0	3.3	8.9	7.5	4.2	1.4	5.9	3.3	4.7	5.9	2.2	5.3	3.2	4.7	5.3	7.7	3.3	3.6	3.3	2.1	7.3	4.7	2.8	4.0	6.6	8.3	11.5	12.2	6.5	9.4	11.8	5.9	10.0	8.0
GHRL	"ghrelin, MTLRP, obestatin"	ENSG00000157017	"Ghrelin and obestatin prepropeptide"	Q9UBU3	3	10285675-10292947	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.8;stomach 1: 64.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 6.2;classical monocyte: 6.0;eosinophil: 6.0;myeloid DC: 21.8;neutrophil: 13.5;plasmacytoid DC: 15.0"	"Group enriched"	"Detected in many"	7	"dendritic cells: 21.8;granulocytes: 13.5;monocytes: 6.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014246, CAB022731"	Enhanced				"Secreted to blood"	2584407	69000			"CAB022731: , HPA014246: AB_1849659"	"unprognostic (1.74e-2)"	"unprognostic (3.01e-4)"	"unprognostic (3.75e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.52e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.79e-4)"	1.2	0.6	1.8	4.2	1.7	1.5	0.6	0.7	1.5	0.6	1.2	1.8	2.2	7.4	0.9	2.3	1.1	1.0	1.7	1.3	1.6	0.7	0.8	0.8	1.8	14.5	0.9	0.4	1.0	1.7	0.2	0.8	0.2	1.1	1.2	0.2	0.7	3.2	0.1	0.7	0.8	1.4	0.3	0.9	4.9	64.9	0.7	1.3	1.7	1.2	0.0	4.3	0.7	0.5	0.8	21.8	13.5	6.0	2.1	0.1	2.0	0.7	0.3	3.0	2.2	2.1	0.0	5.4	2.7	0.0	0.8	0.2	3.1	0.5	1.6	1.0	0.1	0.4	0.0	0.7	0.0	0.5	3.2	3.3	1.7	6.7	0.0	3.4	6.0	0.4	0.0	0.1	0.1	0.6	1.4	16.2	0.0	0.7	1.3	4.7	1.4	5.9	0.9	0.3	0.9	0.0	3.5	2.1	0.3	1.8	1.2	0.1	1.7	4.2	2.8	1.4	0.8	1.2	1.8	1.9	2.7	3.4	0.4	3.9	0.6	6.2	6.0	6.0	0.1	2.8	0.0	0.8	0.1	0.0	21.8	0.5	0.1	0.0	13.5	2.1	0.2	15.0	0.1	2.0	1.8	1.7	0.7	1.5	1.6	0.7	0.9	0.4	1.1	1.3
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"intestine: 87.5"	"Group enriched"	"Detected in some"	4	"A549: 8.6;BEWO: 7.8;Hep G2: 12.3"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016729, HPA021612"	Enhanced				"Secreted to blood"	33915				"CAB016729: , HPA021612: AB_1849506"										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	87.5	0.0	0.0	75.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	61.7	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.4	0.7	7.8	0.3	0.0	0.1	0.0	2.2	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.5	12.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
GIT1		ENSG00000108262	"GIT ArfGAP 1"	Q9Y2X7	17	29573469-29594054	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004059, HPA004186"	Enhanced		Supported	"Focal adhesion sites,Mitochondria,Cytosol"			53000	"Focal adhesion sites, Cytosol"	Mitochondria	"HPA004059: AB_1078966, HPA004186: AB_1078967"	"unprognostic (3.66e-1)"	"unprognostic (4.46e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (2.54e-6)"	"unprognostic (3.00e-3)"	"unprognostic (2.79e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.69e-1)"	13.0	8.5	34.0	11.1	38.1	8.0	9.4	18.9	43.4	7.8	9.8	15.6	2.2	11.6	10.0	5.3	13.2	14.0	10.2	12.2	41.5	16.4	7.0	3.7	12.0	12.6	19.2	21.8	13.6	14.3	10.2	8.1	13.8	15.0	8.4	6.9	7.8	11.9	10.3	10.0	20.2	10.9	8.7	11.9	11.1	9.5	42.9	19.8	10.8	11.0	4.5	9.7	9.8	7.5	1.8	4.7	3.0	6.0	5.6	4.9	3.6	17.1	28.8	14.2	25.2	11.3	7.2	16.5	8.5	8.4	10.3	9.2	11.6	6.4	13.0	13.7	11.1	28.4	14.9	21.9	5.3	16.8	17.8	9.4	14.1	10.4	13.8	11.8	7.7	8.7	25.2	11.8	18.5	19.0	7.6	11.3	7.3	17.7	37.3	16.0	10.5	6.9	28.4	19.0	19.5	9.3	9.5	29.9	25.6	12.0	28.0	42.0	13.7	15.8	23.5	9.8	14.2	21.5	17.1	9.4	12.9	14.2	16.1	10.2	16.5	0.3	3.6	3.0	4.7	6.0	2.2	1.8	4.5	4.9	4.7	1.7	3.7	2.7	1.2	5.6	3.7	4.0	2.9	3.6	34.0	38.1	18.9	43.4	41.5	16.4	19.2	21.8	15.0	19.8
GIT2	"KIAA0148, PKL"	ENSG00000139436	"GIT ArfGAP 2"	Q14161	12	109929792-109996389	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004681	Approved		Approved	Microtubules				Microtubules		"CAB004681: AB_425820"	"unprognostic (1.07e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.67e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.87e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.90e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.41e-2)"	13.5	16.4	16.1	19.6	22.6	43.1	15.4	35.5	17.2	10.6	10.5	13.8	9.2	9.1	15.9	9.5	9.9	9.8	12.9	14.0	14.9	12.1	9.7	10.0	14.9	24.7	11.4	13.6	16.3	16.9	13.3	13.5	18.8	14.2	10.8	11.8	11.3	11.6	11.5	11.2	11.4	16.3	16.6	15.1	30.8	9.5	12.6	15.4	31.7	14.0	5.6	25.3	14.0	10.8	14.2	21.5	48.3	21.6	13.3	13.3	16.1	9.3	11.5	7.8	8.7	13.9	12.9	5.6	20.2	19.2	17.7	11.3	5.5	5.0	22.6	7.9	23.9	7.0	6.6	8.6	18.2	18.8	6.9	14.5	6.7	6.6	8.9	20.7	23.6	10.8	8.2	16.6	8.8	18.6	7.6	5.7	21.7	5.5	18.4	29.8	5.5	8.9	15.4	19.7	12.7	8.7	7.8	4.7	6.8	12.4	5.8	7.9	8.4	17.7	17.4	11.8	6.2	9.3	10.1	11.8	10.0	22.2	10.4	15.5	10.1	19.7	21.6	48.3	13.0	20.6	12.7	12.7	13.0	13.3	21.5	14.2	11.4	10.1	48.1	13.3	18.9	8.9	13.2	16.1	16.1	22.6	35.5	17.2	14.9	12.1	11.4	13.6	14.2	15.4
GK2	"GKP2, GKTA"	ENSG00000196475	"Glycerol kinase 2"	Q14410	4	79406352-79408293	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Glycerol metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	90	"testis: 61.0"	"Cell line enriched"	"Detected in single"	52	"SCLC-21H: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 2.0"	HPA060687	Uncertain									"HPA060687: "															"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GKN1	"AMP18, BRICD1, CA11"	ENSG00000169605	"Gastrokine 1"	Q9NS71	2	68974573-68980974	"Plasma proteins, Predicted secreted proteins"		Mitogen		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"stomach 1: 918.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.1;HMC-1: 13.9;MOLT-4: 9.7;NTERA-2: 13.2;REH: 5.6;U-2 OS: 8.6;U-266/70: 8.6"	"Cancer enriched"	"Detected in some"	116	"stomach cancer: 255.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047684	Enhanced				"Secreted to digestive system"		26000000			"HPA047684: "						"unprognostic (5.40e-2)"					"prognostic unfavourable (1.54e-4)"			"unprognostic (4.54e-1)"			"prognostic favourable (4.53e-4)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	22.4	0.0	2.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	918.9	0.0	0.0	1.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.7	0.0	13.2	0.0	5.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	8.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
GLB1	"EBP, ELNR1"	ENSG00000170266	"Galactosidase beta 1"	P16278	3	32996608-33097230	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008382, HPA040610, HPA069503"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"		1700000	Vesicles	"Golgi apparatus"	"CAB008382: AB_590642, HPA040610: , HPA069503: "	"unprognostic (1.51e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.02e-3)"	"unprognostic (9.66e-3)"	"unprognostic (9.61e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (5.85e-2)"	17.3	33.1	9.6	14.9	14.7	9.5	18.4	8.9	19.8	18.3	21.9	12.1	19.8	21.2	18.3	55.0	12.7	15.2	25.8	13.7	9.7	10.0	35.0	33.2	24.3	25.0	9.2	9.7	18.3	25.3	28.4	16.4	26.5	14.0	13.6	23.7	23.5	21.1	17.7	6.1	12.9	28.3	15.6	9.8	21.4	22.7	10.0	8.0	8.3	26.9	7.7	19.5	18.4	13.6	11.1	45.2	22.7	39.2	6.8	20.9	20.9	5.6	9.8	6.3	7.6	39.1	20.3	136.7	9.1	24.7	11.7	15.1	13.9	13.6	2.8	8.1	18.6	5.5	6.0	11.6	8.7	16.0	5.0	10.9	5.9	7.1	20.1	7.6	11.2	23.4	11.2	10.6	6.3	18.0	9.8	10.6	12.8	6.6	4.5	5.0	4.3	4.3	3.9	4.2	13.0	12.6	8.4	1.9	6.6	11.7	19.0	11.4	12.6	19.9	10.5	7.5	5.2	10.3	7.7	8.4	13.4	0.9	15.9	11.0	5.7	10.5	39.2	22.7	8.3	34.6	11.8	11.1	10.2	9.1	45.2	10.0	5.4	6.5	15.5	6.8	23.7	9.5	20.9	20.9	9.6	14.7	8.9	19.8	9.7	10.0	9.2	9.7	14.0	8.0
GLCE	"HSEPI, KIAA0836"	ENSG00000138604	"Glucuronic acid epimerase"	O94923	15	69160584-69272217	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 49.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 58.4"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 4.0;monocytes: 4.4;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040481, HPA048216"	Uncertain		Approved	Mitochondria	"Intracellular and membrane"		78000	Mitochondria		"HPA040481: , HPA048216: "	"unprognostic (1.30e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.00e-2)"	"unprognostic (5.23e-1)"	"unprognostic (4.07e-2)"	8.3	12.2	6.5	4.9	14.2	0.6	8.8	58.4	12.1	8.4	12.1	12.4	7.8	13.5	6.3	6.9	10.2	5.9	7.2	5.5	5.8	8.5	13.3	16.0	8.4	5.3	9.4	8.1	12.9	5.9	9.0	12.0	12.6	14.4	5.7	14.0	10.8	11.7	8.9	4.1	9.8	11.2	6.8	10.2	4.0	8.8	6.1	7.6	5.4	4.1	8.4	5.8	6.3	5.6	0.6	4.0	0.1	4.4	0.5	4.0	1.9	3.9	3.5	2.3	4.1	8.0	7.7	0.8	7.3	9.7	5.6	10.8	2.9	9.8	2.3	3.6	5.9	5.8	5.0	4.7	11.6	0.9	5.6	3.9	6.6	2.9	7.8	1.7	8.1	5.2	3.3	7.0	8.0	49.9	1.5	2.5	10.6	2.3	1.0	2.9	1.1	2.4	2.3	9.6	2.9	5.2	4.1	7.6	1.6	7.4	4.6	15.4	3.3	2.4	17.3	5.5	6.8	6.0	6.4	1.0	1.5	0.5	5.5	2.8	7.9	0.0	4.4	0.1	0.7	3.4	1.2	0.6	1.8	0.8	3.6	0.5	1.2	1.5	0.1	0.5	4.4	4.0	4.0	1.9	6.5	14.2	58.4	12.1	5.8	8.5	9.4	8.1	14.4	7.6
GLIPR2	"C9orf19, GAPR-1"	ENSG00000122694	"GLI pathogenesis related 2"	Q9H4G4	9	36136536-36163913	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.4;HDLM-2: 25.2;TIME: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029478	Approved		Uncertain	Vesicles,Microtubules			18000000	Vesicles	Microtubules	"HPA029478: AB_10670038"	"unprognostic (1.57e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.87e-2)"	"prognostic unfavourable (6.54e-7)"	"unprognostic (6.57e-3)"	"unprognostic (4.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-2)"	28.5	10.8	8.1	25.5	12.1	32.5	15.6	5.7	11.2	19.9	32.4	23.3	9.1	7.5	40.3	16.8	16.3	18.7	13.0	11.7	9.4	7.1	4.9	3.5	31.2	26.5	14.7	6.5	13.4	2.8	0.4	2.9	4.7	12.3	20.1	17.1	11.6	7.9	21.3	4.8	6.1	14.9	35.5	21.8	21.1	13.8	5.0	13.2	10.1	10.6	7.4	9.4	19.2	14.2	3.3	28.8	92.9	48.6	15.8	24.8	45.5	1.2	1.0	7.5	7.9	26.4	12.6	0.8	12.0	7.2	2.8	5.1	0.4	0.1	0.0	3.7	10.8	0.0	2.7	0.4	1.7	25.2	2.3	3.0	2.4	0.1	10.5	1.9	10.3	8.5	0.3	16.1	2.8	22.2	0.1	1.8	6.4	2.8	9.4	5.2	7.2	3.8	6.5	15.9	0.3	0.6	0.6	2.0	4.1	1.5	0.7	1.2	0.8	8.3	44.7	3.9	9.1	3.5	9.7	2.8	0.7	4.3	4.0	12.2	0.9	30.1	48.6	71.9	24.8	22.3	13.1	3.2	17.2	15.8	28.8	3.3	7.3	11.5	92.9	15.8	16.2	2.5	17.6	45.5	8.1	12.1	5.7	9.8	9.4	7.1	14.7	6.5	12.3	13.2
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703141	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 244.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			1600000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: "	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	22.2	30.5	42.1	19.5	42.3	11.4	32.0	25.4	42.3	27.1	42.1	19.7	22.9	48.1	25.3	49.2	28.2	31.5	17.8	39.2	37.8	37.7	37.1	65.3	30.7	31.6	38.9	29.7	37.6	25.9	33.2	12.6	26.7	40.6	74.0	22.7	21.7	21.7	28.2	57.5	31.3	64.3	28.9	37.6	25.6	21.3	12.9	21.4	19.8	32.6	42.5	24.3	28.6	24.7	25.9	28.6	8.5	15.6	10.8	24.4	14.7	18.1	8.4	24.2	24.0	11.5	20.8	21.4	15.8	15.0	22.3	23.2	20.5	7.0	20.2	12.5	12.6	12.0	20.7	20.4	28.3	18.3	32.0	29.9	10.9	19.1	17.3	11.3	244.2	17.7	12.6	21.1	15.1	24.0	23.5	13.4	20.8	15.3	17.7	14.4	17.4	16.5	15.4	29.3	13.2	20.3	13.7	18.9	19.1	11.1	15.5	29.8	18.0	57.1	9.9	17.4	16.0	15.0	25.0	10.6	20.0	55.5	6.3	29.4	27.9	8.5	9.8	6.9	18.0	15.6	24.4	24.7	18.1	18.3	18.3	25.9	17.1	17.9	1.2	10.8	12.1	28.6	15.7	14.7	42.1	42.3	25.4	42.3	37.8	37.7	38.9	29.7	40.6	21.4
GLRX	"GRX, GRX1"	ENSG00000173221	Glutaredoxin	P35754	5	95751319-95823005	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 94.4;skeletal muscle: 141.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.5;U-87 MG: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB008634, HPA046431, CAB069419"	Approved		Approved	"Plasma membrane,Cytosol"			13000000	"Plasma membrane, Cytosol"		"CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: "	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.62e-3)"	"unprognostic (9.31e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.11e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.61e-1)"	17.7	20.7	6.2	15.0	6.6	30.6	10.5	15.5	15.5	5.4	22.6	3.1	4.0	40.2	2.9	4.6	3.1	3.7	9.5	25.2	12.1	7.8	45.9	46.9	23.1	21.5	7.8	5.9	3.5	2.6	9.5	6.4	63.9	7.6	5.7	8.8	2.4	17.9	5.5	141.6	7.3	42.5	4.5	7.3	15.2	8.2	2.2	4.0	14.4	6.3	6.4	14.3	11.6	5.8	16.0	52.2	94.4	81.6	11.2	48.9	71.1	3.2	14.7	1.1	2.4	31.8	45.8	0.2	49.2	83.5	5.3	8.9	3.6	1.5	12.8	7.0	14.8	1.2	1.8	23.4	14.8	11.1	3.7	9.3	9.7	33.8	60.6	9.8	27.5	28.5	2.8	33.7	3.3	10.1	1.2	7.7	33.4	1.1	16.9	17.4	3.2	16.8	27.4	10.1	15.8	63.9	2.4	3.3	1.8	12.9	6.4	5.6	1.7	9.7	11.7	14.0	15.8	11.1	2.0	5.5	28.2	10.2	68.6	24.7	2.9	3.8	81.6	94.4	26.2	51.0	35.7	16.0	24.1	19.5	52.2	10.7	24.1	22.1	85.7	11.2	40.5	18.0	48.9	71.1	6.2	6.6	15.5	15.5	12.1	7.8	7.8	5.9	7.6	4.0
GLUD1	"GDH, GLUD"	ENSG00000148672	"Glutamate dehydrogenase 1"	P00367	10	87050486-87094866	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 182.4"	"Cell line enhanced"	"Detected in all"		"Hep G2: 106.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042492, HPA044839, HPA061369"	Approved		Supported	Mitochondria	"Intracellular and membrane"		26000000	Mitochondria		"HPA042492: , HPA044839: , HPA061369: "	"unprognostic (1.48e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.81e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavourable (1.76e-5)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.44e-6)"	"unprognostic (2.29e-1)"	"unprognostic (4.23e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.27e-2)"	15.5	21.5	57.8	9.9	54.5	5.9	23.2	13.4	37.9	12.1	14.5	19.9	5.5	18.4	10.9	7.5	17.0	11.5	12.6	16.7	44.1	35.3	56.2	182.4	13.1	11.5	40.6	30.8	17.5	15.2	8.7	6.6	13.5	31.1	26.5	14.6	8.1	10.0	13.3	9.2	15.3	19.8	14.0	22.7	10.2	12.2	6.4	33.2	12.6	16.1	8.7	13.1	14.0	9.5	9.2	15.8	9.2	14.6	13.7	11.9	5.9	24.0	19.5	15.3	25.9	29.1	35.9	16.7	19.0	33.0	18.5	20.3	44.9	23.6	27.1	15.6	27.7	38.0	19.9	19.2	19.8	19.5	15.7	13.1	11.7	106.0	65.0	30.7	19.1	24.7	36.2	20.5	61.4	22.0	13.2	24.5	19.9	17.5	27.6	27.6	17.4	15.7	21.0	19.5	17.6	53.1	19.7	7.9	14.8	17.1	13.6	24.3	18.6	21.6	21.8	9.6	8.5	19.4	19.3	14.7	15.1	32.4	23.2	35.2	5.7	5.5	13.8	9.2	8.7	11.1	10.9	9.2	11.8	10.6	15.8	8.8	10.6	8.5	1.3	13.7	14.6	5.9	11.9	5.9	57.8	54.5	13.4	37.9	44.1	35.3	40.6	30.8	31.1	33.2
GLUL	GLNS	ENSG00000135821	"Glutamate-ammonia ligase"	P15104	1	182381704-182392206	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Ligase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 138.5;ASC TERT1: 97.9;HSkMC: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 92.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 92.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007316, HPA007571, CAB008636"	Approved		Supported	Mitochondria,Cytosol			28000	"Mitochondria, Cytosol"		"CAB008636: AB_1616669, HPA007316: AB_1078981, HPA007571: AB_1078980"	"prognostic favourable (4.81e-4)"	"unprognostic (1.52e-3)"	"unprognostic (3.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.52e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.55e-2)"	"unprognostic (4.53e-3)"	173.3	19.2	83.7	37.2	91.0	47.6	63.1	48.5	80.7	41.9	20.4	49.9	9.4	6.2	20.5	29.7	54.0	31.6	26.2	23.5	74.0	48.7	15.6	64.9	39.5	36.9	71.0	48.8	66.2	49.0	7.4	8.9	41.8	70.6	17.4	23.3	39.3	30.4	25.5	159.8	27.9	16.4	30.5	51.3	36.1	71.4	24.0	55.2	8.6	63.9	15.5	24.2	34.7	32.2	2.5	11.0	92.2	21.1	3.4	6.3	18.6	2.9	1.2	13.7	0.0	138.5	97.9	10.1	5.0	16.2	3.0	2.7	7.2	3.0	2.5	5.4	9.7	6.8	5.9	35.6	2.5	6.8	16.6	33.5	5.7	14.0	7.3	14.7	26.8	84.6	42.8	3.8	45.4	6.1	28.2	1.5	10.7	1.6	22.9	14.1	10.1	6.4	8.3	3.6	4.3	5.3	13.0	9.4	6.2	1.4	18.3	1.9	17.8	18.7	4.5	0.1	0.2	0.0	1.1	0.5	0.3	0.0	2.6	8.4	0.5	43.6	21.1	54.9	6.3	20.5	2.6	1.6	4.5	5.2	11.0	2.5	2.3	3.9	92.2	3.4	17.1	6.1	1.7	18.6	83.7	91.0	48.5	80.7	74.0	48.7	71.0	48.8	70.6	55.2
GM2A	SAP-3	ENSG00000196743	"GM2 ganglioside activator"	P17900	5	151212150-151270440	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase	"Disease mutation, Gangliosidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 108.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.6;HBEC3-KT: 60.2;hTCEpi: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 15.9;dendritic cells: 19.0;monocytes: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008063	Enhanced				"Intracellular and membrane"		23000000			"HPA008063: AB_1849842"	"unprognostic (4.33e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.77e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.33e-3)"	"unprognostic (9.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	55.8	16.1	17.8	15.5	18.8	9.6	15.2	8.1	15.2	20.5	10.3	31.7	6.4	8.4	9.5	17.3	39.5	8.8	12.6	13.8	18.0	12.6	7.5	13.2	24.8	30.2	22.4	13.0	12.2	9.3	11.7	5.6	108.7	18.9	11.9	14.5	14.1	13.3	10.4	3.9	42.8	11.2	10.9	35.9	28.5	8.2	8.9	15.3	21.9	7.1	25.9	39.7	21.0	32.0	15.9	19.0	4.2	19.4	1.9	3.3	8.0	4.5	3.0	3.2	15.0	20.9	10.4	43.6	7.2	15.5	4.0	5.4	6.1	5.3	14.7	7.5	5.5	12.5	3.5	60.2	5.7	8.2	2.1	2.3	3.7	7.6	5.1	3.8	24.7	13.9	60.1	5.1	3.4	5.7	2.3	6.4	6.2	1.9	8.0	3.6	2.1	6.7	3.6	1.5	9.2	3.8	8.9	0.8	2.8	5.9	27.9	11.8	6.3	4.5	5.0	9.8	3.8	8.0	2.1	15.9	18.9	40.3	11.2	6.1	4.0	3.5	19.4	1.1	1.9	6.5	1.4	14.9	2.3	2.0	19.0	15.9	3.3	2.5	4.2	1.9	1.4	13.7	2.4	8.0	17.8	18.8	8.1	13.9	18.0	12.6	22.4	13.0	18.9	15.3
GMCL1	"BTBD13, FLJ13057, GCL1, SPATA29"	ENSG00000087338	"Germ cell-less, spermatogenesis associated 1"	Q96IK5	2	69829642-69881396	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 33.6"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.6;NK-cells: 11.7;T-cells: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039579	Approved									"HPA039579: AB_10805480"	"unprognostic (1.89e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.27e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	12.7	9.1	11.6	16.6	12.2	15.0	13.7	17.3	15.2	12.6	18.1	11.2	16.1	19.8	11.5	11.8	14.5	10.3	20.5	8.1	12.8	11.8	15.0	14.5	10.6	13.7	12.6	13.8	13.4	17.0	22.4	17.5	19.3	13.7	14.6	15.7	12.2	13.9	14.9	5.7	12.5	19.5	9.4	12.1	11.7	10.6	35.4	11.6	32.8	11.8	8.1	14.8	13.6	12.7	4.1	3.5	33.6	4.2	11.7	9.1	4.4	8.3	6.0	10.2	10.8	9.1	8.0	10.9	7.0	4.6	4.8	8.2	5.7	7.9	17.5	5.8	4.6	8.2	11.8	6.1	8.4	8.0	12.4	27.3	6.8	12.9	6.0	20.3	19.3	4.4	6.8	3.8	8.9	8.5	10.9	12.9	7.6	7.1	20.6	19.1	10.8	5.6	14.8	13.4	13.3	7.1	12.8	16.1	13.4	7.6	11.3	8.3	7.4	12.7	5.2	7.5	9.3	11.5	8.4	13.1	15.8	10.8	7.6	16.8	7.6	33.6	3.6	17.1	5.3	2.8	9.1	4.1	5.3	6.5	3.3	3.6	7.7	7.5	11.9	11.7	4.2	3.5	6.7	4.4	11.6	12.2	17.3	15.2	12.8	11.8	12.6	13.8	13.7	11.6
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668732-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044811: AB_10959666, HPA052975: "	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	8.3	6.6	8.0	14.0	6.5	21.1	8.7	13.5	9.0	8.8	8.0	8.4	6.4	5.4	10.9	8.0	10.4	8.5	8.0	6.8	7.8	4.9	6.6	7.3	8.7	11.3	5.8	7.0	12.1	7.5	8.6	8.8	16.4	5.8	7.2	8.4	8.0	7.4	6.8	10.3	9.3	8.6	9.1	6.3	11.5	7.4	11.4	6.4	25.3	7.5	7.0	14.1	7.9	12.4	10.8	9.7	14.4	12.7	10.6	12.8	6.3	9.2	6.7	11.4	10.3	3.8	7.0	8.1	9.9	7.2	6.4	9.6	2.1	7.4	17.0	5.2	9.2	3.6	10.1	7.7	8.4	19.4	6.2	15.9	7.0	4.1	5.7	13.1	8.2	5.6	5.5	15.5	10.1	8.8	9.5	13.8	7.7	8.1	8.2	4.4	15.2	4.5	5.5	7.8	7.9	4.8	7.6	8.4	6.9	9.4	6.4	6.4	4.9	6.8	8.8	4.4	10.6	7.5	13.3	6.1	10.4	9.6	5.3	12.3	6.9	10.0	8.2	14.4	11.1	10.2	8.4	6.6	10.6	12.8	9.7	10.8	8.8	9.3	11.8	10.6	12.7	7.2	8.9	6.3	8.0	6.5	13.5	9.0	7.8	4.9	5.8	7.0	5.8	6.4
GMFB	GMF	ENSG00000197045	"Glia maturation factor beta"	P60983	14	54474484-54489196	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Approved	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			1000000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (7.93e-2)"	"unprognostic (7.69e-3)"	"unprognostic (4.81e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.48e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.29e-2)"	"prognostic favourable (9.48e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.09e-2)"	14.2	13.2	37.9	12.9	26.7	14.2	15.3	25.1	41.6	11.8	19.8	23.9	6.1	19.1	11.6	8.5	9.3	8.4	9.7	9.6	36.7	30.1	19.9	14.7	13.8	13.3	36.9	28.3	9.8	7.3	10.1	13.6	17.9	25.6	9.0	20.7	6.6	7.0	8.0	4.1	7.8	17.5	10.5	54.4	10.1	10.7	6.2	21.7	6.4	12.8	6.1	13.5	10.0	7.4	9.1	12.8	16.4	14.5	9.0	8.8	6.8	30.4	12.3	24.7	18.0	26.7	33.4	18.5	31.2	23.0	22.7	28.4	14.2	27.0	28.0	14.8	30.7	11.3	24.9	21.6	36.0	10.1	8.6	14.0	13.9	13.1	22.8	19.5	12.3	25.3	20.3	19.7	19.5	20.4	10.2	9.9	35.9	15.1	11.9	7.6	15.9	13.1	12.1	29.0	8.1	29.0	29.0	14.7	22.8	21.7	18.5	23.6	20.4	15.5	16.1	33.0	25.1	16.7	19.3	3.5	6.2	17.5	27.8	12.1	20.8	8.7	11.0	9.2	6.1	13.5	8.5	7.6	7.2	6.0	12.8	9.1	7.8	8.2	16.4	9.0	14.5	5.2	8.8	6.8	37.9	26.7	25.1	33.5	36.7	30.1	36.9	28.3	25.6	21.7
GMFG		ENSG00000130755	"Glia maturation factor gamma"	O60234	19	39328353-39342372	"Plasma proteins, Predicted intracellular proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 276.5;bone marrow: 80.9;lymphoid tissue: 109.5"	"Cell line enhanced"	"Detected in some"		"HMC-1: 77.0;Karpas-707: 59.8;NB-4: 43.6;REH: 49.0;THP-1: 76.8;U-937: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002954	Uncertain	Approved	Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			1500000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA002954: AB_1078997"	"unprognostic (1.22e-2)"	"prognostic favourable (7.35e-4)"	"unprognostic (2.37e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.93e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.11e-6)"	"unprognostic (3.01e-1)"	"unprognostic (8.76e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.27e-3)"	22.6	6.1	7.3	29.6	7.4	80.9	16.8	2.2	4.8	6.0	8.8	4.0	1.7	5.3	4.4	9.4	6.4	7.3	8.7	7.5	6.0	4.9	9.4	9.7	28.5	42.2	8.6	2.3	4.7	3.6	1.1	3.1	18.0	5.8	6.1	7.9	4.9	8.1	2.3	5.4	4.2	17.8	6.8	8.2	86.0	5.9	2.9	5.6	109.5	9.8	7.0	37.1	11.1	7.5	39.1	57.2	276.5	79.4	41.6	88.0	106.7	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.8	33.5	0.3	0.0	0.2	0.0	0.1	0.1	11.3	0.0	36.5	0.0	0.5	0.6	39.0	77.0	0.1	0.0	0.0	0.1	2.0	1.3	59.8	0.3	0.0	35.5	43.6	0.0	0.0	49.0	0.4	21.9	0.0	5.2	0.1	0.0	0.1	0.2	0.2	0.1	76.8	20.0	0.0	0.4	0.1	0.1	3.4	11.6	38.3	0.2	52.7	0.3	185.2	79.4	178.1	37.7	72.3	40.0	39.1	56.7	46.6	57.2	35.0	55.9	46.4	276.5	41.6	78.9	22.2	88.0	106.7	7.3	7.4	2.2	4.8	6.0	4.9	8.6	2.3	5.8	5.6
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238580-16295549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.3"	"Cell line enhanced"	"Detected in many"		"HEL: 45.2;HMC-1: 77.1;SK-MEL-30: 17.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.8;NK-cell: 8.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.8;monocytes: 4.2;NK-cells: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain						3800000			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favourable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	2.8	7.3	14.6	1.4	11.0	9.6	6.5	3.8	6.9	2.7	3.7	9.1	2.0	1.5	4.2	7.9	2.5	22.4	1.9	31.5	13.3	11.5	10.3	2.7	3.7	2.5	14.0	5.7	15.7	7.4	4.4	6.8	3.4	21.3	25.5	1.8	22.0	5.2	4.2	103.3	4.3	1.5	4.3	11.8	3.3	8.3	25.1	10.9	1.4	2.7	16.2	1.5	2.0	1.2	0.7	1.3	7.8	4.2	8.3	1.0	14.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.9	3.7	6.6	13.6	0.3	0.1	0.0	2.1	1.4	0.0	1.6	0.2	1.1	0.0	1.2	45.2	0.0	0.0	2.9	0.2	77.1	0.9	0.7	2.0	0.0	11.9	10.0	0.0	1.1	0.8	0.0	0.9	0.4	1.8	0.0	10.2	0.0	8.8	1.2	2.3	0.3	0.4	0.7	17.2	0.7	0.3	2.9	0.1	0.0	0.3	1.7	0.5	0.0	0.0	0.2	4.8	5.2	7.8	2.9	0.4	0.6	4.2	1.0	0.2	0.1	0.4	1.3	0.7	0.0	0.2	3.0	8.3	1.3	1.2	0.0	14.1	14.6	11.0	3.8	6.9	13.3	11.5	14.0	5.7	21.3	10.9
GMPR2		ENSG00000100938	"Guanosine monophosphate reductase 2"	Q9P2T1	14	24232422-24239242	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA067884, HPA068782"	Uncertain		Approved	Nucleoplasm,Nucleoli			160000	Nucleoplasm	Nucleoli	"HPA000904: AB_1078998, HPA067884: , HPA068782: "	"unprognostic (1.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.86e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.21e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.12e-2)"	18.9	44.2	19.6	14.6	24.2	11.5	26.2	13.6	31.7	22.5	21.1	25.1	20.3	21.3	18.8	26.3	17.8	28.7	23.4	15.0	20.1	21.9	39.1	26.3	19.0	18.1	23.0	21.2	26.1	26.9	49.1	22.4	22.7	26.0	20.3	21.6	21.9	22.6	23.7	16.1	14.4	21.7	18.2	20.3	25.5	21.2	10.6	19.1	21.6	43.0	11.2	21.0	21.8	17.6	7.5	14.4	32.3	14.0	7.6	14.9	11.0	9.0	10.4	14.1	9.2	16.3	23.1	12.8	10.7	19.1	15.1	19.3	12.2	7.2	12.1	9.8	15.7	12.6	15.5	23.2	21.5	11.4	11.4	9.5	6.5	44.5	15.3	15.6	15.0	21.7	16.7	7.9	16.5	24.4	5.5	11.5	15.2	16.9	15.4	14.0	10.9	13.5	11.7	9.5	10.0	20.7	15.0	10.0	14.1	7.7	16.9	14.4	14.7	12.5	12.5	7.1	5.7	9.4	7.8	25.5	24.4	7.9	5.9	11.9	6.9	9.0	14.0	7.2	10.1	11.2	10.7	7.5	10.2	11.2	14.4	7.1	9.1	10.2	32.3	7.6	11.3	6.5	14.9	11.0	19.6	24.2	13.6	31.7	20.1	21.9	23.0	21.2	26.0	19.1
GMPS	GATD7	ENSG00000163655	"Guanine monophosphate synthase"	P49915	3	155870536-155944026	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	Ligase	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046630			Approved	Cytosol				Cytosol		"HPA046630: "	"unprognostic (3.89e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavourable (5.54e-5)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (8.73e-7)"	"unprognostic (1.71e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.58e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.79e-2)"	15.9	18.3	10.4	19.7	14.0	24.6	22.4	22.1	24.9	16.1	13.9	9.8	15.3	10.3	17.5	15.4	19.5	14.0	10.8	15.3	9.2	7.7	11.0	14.7	15.8	19.5	9.3	12.1	15.7	23.5	19.1	14.1	13.5	14.8	13.0	15.3	9.0	21.6	18.6	16.6	21.0	12.6	16.1	8.9	14.6	15.4	60.9	10.5	28.3	13.6	12.5	18.4	15.9	18.5	11.1	17.2	10.9	18.1	19.0	20.7	10.8	55.8	22.1	30.1	24.5	12.2	19.4	29.0	23.8	22.1	31.5	31.9	40.3	37.7	40.4	28.5	18.3	27.5	25.5	25.0	43.4	23.4	19.6	43.0	16.2	21.8	14.0	43.7	16.8	14.3	15.4	24.3	37.3	19.3	30.2	15.5	23.4	37.5	35.4	23.1	28.8	16.4	34.9	35.6	48.7	16.2	24.6	18.0	16.7	26.5	38.0	23.8	39.7	28.8	13.5	20.9	16.9	29.5	48.0	21.7	13.3	69.1	21.0	32.6	18.6	10.9	10.4	7.2	17.3	13.1	20.7	11.1	16.8	15.7	17.2	8.8	16.8	15.8	1.4	19.0	18.1	9.5	17.6	10.8	10.4	14.0	22.1	24.9	9.2	7.7	9.3	12.1	14.8	10.5
GNA13	"G13, MGC46138"	ENSG00000120063	"G protein subunit alpha 13"	Q14344	17	65010715-65056839	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010087	Approved		Supported	Cytosol			4000000	Cytosol		"HPA010087: AB_10601478"	"unprognostic (2.55e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.23e-3)"	"unprognostic (8.21e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.77e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.59e-1)"	28.2	17.4	16.4	25.3	17.5	75.6	15.1	15.1	15.0	14.2	19.1	23.0	13.0	14.0	12.9	12.1	13.2	12.1	17.7	15.4	16.8	13.3	12.4	17.4	27.6	27.5	18.5	9.4	16.3	10.0	12.1	10.0	25.0	14.8	16.8	17.3	10.7	10.5	13.9	35.0	11.4	17.5	15.9	32.1	22.5	13.6	11.3	20.4	34.9	11.9	9.0	27.5	28.3	26.0	5.7	5.5	15.8	13.4	7.8	11.2	4.4	11.6	13.2	12.1	8.2	12.6	11.4	12.5	9.1	10.6	12.5	14.3	7.4	7.8	47.6	6.0	9.8	8.1	12.9	11.1	19.3	12.3	7.5	24.8	8.0	14.5	18.2	18.5	16.5	9.6	17.0	12.0	16.6	18.8	10.0	29.7	14.4	11.0	28.4	6.7	7.5	9.8	16.5	24.3	17.3	12.6	19.1	8.9	18.8	6.6	13.8	15.6	14.2	18.1	13.4	20.8	18.3	8.9	11.9	22.0	26.1	54.0	7.6	12.0	11.0	7.1	6.4	8.5	7.2	13.4	7.3	5.7	8.9	8.5	5.5	4.8	5.2	5.7	15.8	7.8	8.3	2.5	11.2	4.4	16.4	17.5	15.1	15.0	16.8	13.3	18.5	9.4	14.8	20.4
GNA15	GNA16	ENSG00000060558	"G protein subunit alpha 15"	P30679	19	3136193-3163769	"Plasma proteins, Predicted intracellular proteins"		Transducer		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.4;esophagus: 46.0;lymphoid tissue: 42.2"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.4;HMC-1: 45.9;MOLT-4: 45.9;NB-4: 17.2;REH: 34.3;THP-1: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043113	Approved									"HPA043113: AB_10967343"	"prognostic favourable (7.57e-5)"	"unprognostic (6.06e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (2.01e-4)"	"unprognostic (4.34e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (4.26e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.07e-1)"	4.9	1.7	1.6	7.2	2.3	37.4	3.9	1.1	2.0	7.9	1.3	1.6	1.0	1.0	0.8	1.8	46.0	1.3	2.8	2.6	1.6	1.1	1.3	1.2	7.6	3.7	3.1	1.3	1.0	0.7	0.2	0.8	4.5	2.7	5.9	1.1	1.3	9.2	1.7	0.8	20.0	1.1	1.8	2.8	5.6	2.5	1.1	2.2	42.2	0.7	29.0	25.3	10.4	16.2	0.0	31.0	6.2	12.6	2.1	3.9	5.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	10.7	0.0	19.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	7.8	45.9	0.0	12.1	0.0	8.0	0.0	0.0	0.1	0.0	0.0	45.9	17.2	0.0	0.0	34.3	0.0	0.0	0.0	6.9	0.0	0.0	1.3	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	5.8	12.6	6.2	0.0	9.7	0.5	0.0	1.0	0.1	13.0	0.0	0.0	0.0	3.1	2.1	6.5	31.0	3.9	5.1	1.6	2.3	1.1	2.0	1.6	1.1	3.1	1.3	2.7	2.2
GNAI1		ENSG00000127955	"G protein subunit alpha i1"	P63096	7	80133955-80219402	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"NK-cell: 20.0"	"Lineage enriched"	"Detected in many"	5	"NK-cells: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022449, HPA042141"	Approved		Supported	Nucleoplasm,Nucleoli,Centrosome			9000000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022449: , HPA042141: "	"unprognostic (2.29e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.48e-1)"	"unprognostic (9.41e-3)"	"prognostic unfavourable (6.47e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.53e-1)"	33.2	23.4	17.2	5.4	26.2	1.5	14.4	14.4	33.7	9.4	10.5	36.9	3.0	6.9	10.0	3.0	16.6	9.0	8.6	5.7	23.8	18.3	25.9	13.1	10.3	3.4	40.3	21.9	14.3	5.4	2.5	7.3	30.4	26.2	10.1	9.0	2.8	4.9	9.5	4.2	32.4	5.3	12.2	49.7	5.7	8.3	11.1	32.0	0.9	11.1	3.2	4.6	15.5	9.0	0.1	3.7	2.1	1.5	20.0	2.3	0.7	2.9	20.5	18.8	0.1	23.4	15.0	8.6	12.5	15.1	11.1	13.7	0.0	3.2	0.1	4.0	13.4	3.0	10.4	12.8	14.7	0.1	9.6	17.6	18.1	1.2	23.7	2.2	3.8	16.1	32.4	5.9	17.1	7.4	1.4	0.0	20.7	0.5	0.1	0.1	5.4	7.4	8.2	7.2	8.8	33.1	9.9	13.8	9.5	13.4	0.2	10.6	2.5	0.4	13.1	24.8	17.5	5.7	4.7	0.1	0.0	0.1	6.5	1.3	11.0	2.1	0.7	0.7	0.1	0.7	0.0	0.0	0.3	0.2	3.7	0.1	2.3	0.9	0.3	20.0	1.5	0.3	0.2	0.7	17.2	26.2	14.4	25.5	23.8	18.3	40.3	21.9	26.2	32.0
GNAI3	87U6	ENSG00000065135	"G protein subunit alpha i3"	P08754	1	109548611-109618321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"	Transducer	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022099, HPA042141"	Approved		Approved	Nucleoplasm,Nucleoli,Centrosome			8400000	Centrosome	"Nucleoplasm, Nucleoli"	"CAB022099: , HPA042141: "	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (1.62e-4)"	"unprognostic (1.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.45e-3)"	"prognostic unfavourable (5.30e-6)"	"unprognostic (2.56e-3)"	"unprognostic (2.18e-2)"	"prognostic favourable (4.59e-4)"	"unprognostic (1.83e-3)"	"unprognostic (6.91e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.66e-2)"	25.2	13.0	12.3	15.5	11.3	26.4	15.8	12.8	10.7	19.0	14.7	10.3	14.3	12.1	19.7	15.7	34.8	12.5	13.2	9.3	12.3	9.4	18.1	25.8	13.2	23.8	13.1	8.3	18.4	13.7	10.7	11.0	22.4	11.5	17.2	13.8	8.0	16.2	14.4	8.6	27.9	17.0	15.9	12.9	21.6	12.1	14.0	12.0	22.2	12.9	25.2	20.6	20.0	20.4	6.1	9.6	16.8	13.1	5.8	7.2	9.3	13.9	4.9	9.5	5.6	9.1	10.9	7.8	10.6	8.5	10.8	10.8	7.5	4.9	7.5	7.1	11.3	7.4	8.9	10.8	15.1	8.4	5.5	6.5	8.5	6.4	7.8	10.2	6.0	8.1	9.2	12.4	8.6	12.9	8.5	7.4	10.7	9.5	7.8	8.3	9.5	5.8	5.6	22.4	4.8	12.0	10.7	6.1	10.7	7.4	8.4	11.6	6.5	9.0	11.7	9.1	12.5	13.6	12.0	7.9	8.9	8.7	15.1	10.1	14.1	8.5	9.1	16.6	6.8	13.1	7.2	6.1	6.7	6.5	9.6	5.0	5.6	6.4	16.8	5.8	12.3	4.3	6.9	9.3	12.3	11.3	12.8	10.7	12.3	9.4	13.1	8.3	11.5	12.0
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"			60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: "	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.0	51.2	60.8	42.4	34.8	38.3	23.5	76.8	51.3	69.8	54.8	41.7	54.2	56.5	56.6	77.4	28.6	60.9	55.7	63.8	86.6	30.0	54.8	48.5	47.4	43.8	32.9	60.2	33.8	39.3	66.6	62.0	56.6	33.9	51.1	66.5	33.7	72.1	25.9	35.0	41.5	70.4	47.0	44.6	47.8	33.7	74.8	85.3	71.2	46.4	62.3	32.4	45.2	86.2	61.5	41.3	47.8	55.7	34.7	60.4	129.3	52.6	69.5	34.6	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2
GNB3		ENSG00000111664	"G protein subunit beta 3"	P16520	12	6839954-6847393	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"pituitary gland: 27.0;retina: 79.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 8.4;NTERA-2: 10.1;U-698: 25.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040736	Uncertain		Approved	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"HPA040736: "	"unprognostic (3.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.96e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.74e-3)"	"unprognostic (5.98e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.25e-5)"	"unprognostic (3.21e-2)"	"unprognostic (4.77e-11)"	"unprognostic (2.43e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.07e-2)"	0.8	1.6	0.9	1.4	2.0	0.5	0.8	6.9	1.6	1.1	1.0	0.8	0.8	2.3	2.7	0.8	0.8	1.0	1.1	5.4	1.0	1.3	0.8	0.8	0.8	1.4	1.1	0.8	3.5	0.8	3.2	27.0	0.8	1.6	1.6	0.4	79.9	2.6	1.8	1.5	0.6	1.6	4.1	0.9	0.9	0.9	0.8	0.8	0.8	1.2	1.0	1.8	2.1	0.8	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	4.9	0.8	0.6	0.8	0.5	2.9	0.6	1.6	1.1	1.0	0.2	8.4	0.0	3.1	0.3	4.8	0.2	1.5	0.7	1.1	2.1	2.6	0.7	0.5	0.6	1.4	1.2	0.2	1.5	2.1	1.3	0.8	0.7	0.4	0.4	0.4	0.4	10.1	0.3	0.3	1.7	0.5	0.3	0.2	0.8	1.2	0.2	0.0	0.6	0.0	0.5	2.6	1.3	2.0	2.4	3.8	0.7	0.5	25.4	0.6	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.0	6.9	1.5	1.0	1.3	1.1	0.8	1.6	0.8
GNB5	GB5	ENSG00000069966	"G protein subunit beta 5"	O14775	15	52115105-52191369	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		Transducer	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032353, HPA041942, HPA044198"	Uncertain		Approved	"Nuclear speckles,Centrosome,Rods & Rings"			11000	"Nuclear speckles"	"Centrosome, Rods & Rings"	"CAB032353: AB_2263274, HPA041942: AB_10794309, HPA044198: "	"unprognostic (2.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.97e-3)"	"prognostic favourable (1.47e-6)"	"unprognostic (6.15e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.10e-1)"	"prognostic favourable (3.32e-11)"	"unprognostic (1.40e-3)"	"unprognostic (8.12e-3)"	"unprognostic (3.55e-3)"	"unprognostic (1.52e-1)"	6.2	11.2	17.7	8.2	25.6	3.7	8.9	42.5	30.7	15.2	9.2	4.0	9.6	4.6	21.2	13.4	9.0	20.4	15.4	17.3	13.0	18.6	26.9	10.3	5.8	14.7	13.6	21.9	38.1	13.7	35.5	14.7	4.4	21.3	12.9	4.5	20.4	6.5	20.3	1.7	4.8	7.0	13.3	5.9	8.3	7.5	11.7	9.2	7.0	16.2	1.9	14.1	14.6	14.0	21.6	9.9	3.6	1.9	10.8	19.7	9.3	8.0	20.8	5.8	10.2	9.9	12.4	5.6	15.8	15.4	14.1	15.4	5.8	6.1	14.1	5.0	12.9	11.9	10.2	15.0	10.7	10.9	7.7	9.4	28.1	6.7	11.8	4.7	34.1	11.4	12.7	11.3	4.2	8.8	0.7	13.3	15.4	14.4	7.4	13.4	5.3	9.2	10.0	20.1	17.1	10.0	24.7	9.3	8.1	15.1	1.4	12.3	4.9	14.7	21.6	12.7	13.9	14.4	15.9	8.5	16.3	15.4	26.7	11.5	20.4	3.6	1.9	0.2	10.7	1.7	8.9	21.0	14.0	12.8	4.8	21.6	13.2	11.3	1.0	10.8	1.4	9.9	19.7	9.3	17.7	25.6	42.5	30.7	13.0	18.6	13.6	21.9	21.3	9.2
GNPTG	"C16orf27, c316G12.3, CAB56184, GNPTAG"	ENSG00000090581	"N-acetylglucosamine-1-phosphate transferase gamma subunit"	Q9UJJ9	16	1351923-1364113	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004055	Approved		Approved	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		420000000	"Endoplasmic reticulum"	Cytosol	"HPA004055: AB_1079006"	"unprognostic (4.37e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.07e-2)"	23.1	67.3	38.0	16.9	35.7	19.9	20.2	22.0	38.8	19.6	23.5	41.7	22.2	16.5	18.9	28.4	17.3	19.1	22.2	17.8	38.5	31.7	29.9	41.1	21.7	22.6	39.3	28.6	22.3	34.6	33.7	25.1	27.2	28.9	21.1	15.6	20.5	37.8	22.2	28.1	33.4	19.5	15.1	43.3	26.3	21.2	18.0	31.0	11.1	24.0	13.2	13.2	20.0	17.8	15.5	29.3	25.8	37.1	14.6	21.7	20.9	4.7	7.6	5.6	9.8	51.7	19.2	7.2	13.9	18.2	5.5	10.6	6.8	13.4	3.0	16.1	18.7	8.7	3.4	8.1	2.8	9.5	7.4	3.9	23.7	11.6	21.9	6.4	16.0	25.6	14.2	5.3	7.6	10.1	4.7	17.9	9.1	10.8	3.0	6.4	5.2	4.3	10.8	4.8	13.6	13.7	6.2	4.4	5.8	14.0	14.5	10.0	13.4	9.7	9.8	11.1	9.5	9.1	6.7	18.9	13.7	6.2	9.1	5.6	7.3	25.8	37.1	22.2	21.7	34.0	19.9	15.5	18.7	20.5	29.3	14.6	17.3	15.8	15.0	14.6	31.9	24.7	21.3	20.9	38.0	35.7	22.0	38.8	38.5	31.7	39.3	28.6	28.9	31.0
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878357-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"				"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: , HPA050555: "	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favourable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	13.2	16.2	11.2	13.6	16.0	7.7	12.1	11.0	15.3	11.8	15.1	22.0	16.9	15.0	19.3	9.6	15.2	12.3	11.5	14.9	13.6	9.1	11.8	16.0	12.0	11.5	17.3	13.2	13.6	15.8	16.8	15.1	14.2	16.6	13.1	14.5	19.3	13.4	13.4	20.0	16.4	14.7	21.4	16.9	13.7	13.5	30.0	15.7	8.7	12.5	11.2	12.9	18.2	12.5	5.5	6.7	11.5	5.2	4.1	6.9	1.8	6.3	11.4	6.9	7.3	12.1	10.6	8.8	10.4	11.3	11.2	8.3	7.5	7.6	4.2	5.2	11.7	16.7	5.5	8.9	8.2	6.1	5.5	4.6	14.7	9.9	13.9	5.3	10.8	7.2	6.6	10.8	13.2	10.0	7.3	7.4	7.9	13.3	3.8	6.2	2.5	10.7	2.4	10.1	9.2	5.7	8.7	4.0	7.6	12.7	10.5	6.9	19.9	3.8	11.5	10.4	5.8	13.3	9.6	9.3	14.3	4.9	13.2	5.7	10.9	10.4	5.2	6.1	6.4	5.0	5.2	4.6	4.0	6.9	4.7	5.5	4.2	3.9	11.5	4.1	3.9	6.7	3.7	1.8	11.2	16.0	11.0	15.3	13.6	9.1	17.3	13.2	16.6	15.7
GOLGA4	"GCP2, GOLG, golgin-240, p230"	ENSG00000144674	"Golgin A4"	Q13439	3	37243177-37366751	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035102, HPA040675"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA035102: AB_10601472, HPA040675: "	"unprognostic (9.46e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.18e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.79e-3)"	"unprognostic (3.90e-2)"	"unprognostic (5.62e-2)"	"unprognostic (8.55e-2)"	"prognostic favourable (3.62e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.33e-1)"	22.3	20.6	16.7	14.0	29.0	11.4	30.6	26.9	27.1	19.1	25.1	14.5	29.1	23.9	12.8	18.4	22.0	11.3	16.7	34.3	18.1	12.3	22.1	32.7	15.2	12.2	30.5	12.8	14.8	27.7	27.1	42.8	34.5	18.9	21.1	18.1	20.2	24.8	24.4	64.6	29.8	29.1	19.0	23.9	14.8	21.2	26.0	24.9	10.3	29.9	22.6	11.8	20.5	24.8	10.0	9.9	19.8	11.0	13.0	14.9	3.2	23.4	16.2	8.4	10.6	22.2	19.2	21.4	30.2	25.3	11.9	14.4	13.9	13.1	8.1	7.9	25.6	13.8	13.3	21.4	24.8	10.3	9.8	10.9	14.4	22.1	22.3	11.5	8.0	10.2	20.5	18.8	36.6	17.2	13.3	12.7	19.1	10.0	8.8	5.0	9.1	15.5	2.0	25.5	8.5	14.8	24.7	5.4	7.1	18.7	20.2	23.1	29.7	8.4	20.7	12.2	14.2	23.5	21.5	15.7	11.0	7.1	21.7	10.1	14.3	19.8	5.5	12.0	14.9	6.4	12.5	8.1	9.2	10.3	4.5	10.0	9.6	7.2	7.7	13.0	11.0	9.9	6.0	3.2	16.7	29.0	26.9	27.1	18.1	12.3	30.5	12.8	18.9	24.9
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"			35000	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	16.7	22.3	17.6	12.5	24.0	12.8	25.7	22.3	28.0	24.6	16.8	8.2	27.1	12.7	16.5	35.0	15.9	14.0	14.0	16.6	16.8	10.3	19.7	17.2	13.4	8.5	26.1	14.5	20.9	23.4	26.2	39.4	24.4	17.7	28.0	18.4	12.5	21.5	29.3	11.7	20.5	20.6	21.3	30.6	14.8	16.6	12.1	20.7	9.0	19.3	12.9	10.1	17.2	13.6	3.6	5.8	16.4	4.4	3.9	5.0	1.5	12.4	10.0	10.0	6.5	19.3	21.0	6.3	8.1	17.9	7.9	8.9	8.8	4.6	2.7	6.8	15.1	5.8	5.9	8.8	9.3	3.9	11.3	7.7	12.1	12.1	11.5	8.5	10.6	17.1	21.0	4.9	12.4	9.9	3.5	6.2	8.2	8.9	2.5	6.2	6.5	10.6	3.4	7.9	6.4	11.7	12.9	7.1	7.9	10.0	7.1	10.5	8.8	9.6	13.7	7.5	4.6	3.3	5.8	11.7	6.9	4.6	10.2	4.2	2.8	1.7	4.4	4.3	5.0	2.2	4.0	3.6	4.0	3.6	2.7	3.2	3.7	4.0	16.4	3.9	1.7	5.8	3.8	1.5	17.6	24.0	22.3	28.0	16.8	10.3	26.1	14.5	17.7	20.7
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 83.7;stomach 1: 114.2"	"Cell line enhanced"	"Detected in many"		"U-266/70: 78.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"		70000000	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	6.1	53.6	23.3	15.6	18.2	1.9	11.6	23.1	27.7	21.0	53.1	16.5	6.0	62.8	11.9	9.3	4.2	11.1	83.7	4.0	24.7	26.3	22.0	6.6	4.4	2.8	17.4	20.4	11.1	19.5	7.8	15.1	5.3	22.3	39.9	45.5	10.9	43.0	3.5	2.6	4.6	16.5	8.4	25.5	11.3	114.2	5.0	16.4	5.0	19.5	7.9	36.6	11.6	11.0	1.2	2.2	7.2	5.9	1.2	5.7	2.5	29.3	28.7	21.6	24.4	27.9	16.2	22.8	13.4	9.7	21.1	17.2	14.1	58.8	0.6	13.3	25.9	22.7	13.2	13.2	15.3	1.0	21.0	9.1	19.2	0.7	16.6	13.4	7.4	24.4	7.2	19.8	7.2	36.0	5.7	0.9	11.9	13.8	1.6	10.1	34.0	20.8	8.6	24.6	4.4	35.2	12.6	24.4	15.3	18.2	39.6	15.0	22.3	13.8	22.9	5.5	15.5	16.7	15.8	78.9	7.4	0.2	23.9	6.0	12.0	2.1	5.5	0.8	5.7	3.9	0.7	1.1	0.5	0.8	0.7	1.2	0.7	1.3	7.2	1.2	5.9	2.2	0.3	2.5	23.3	18.2	23.1	20.8	24.7	26.3	17.4	20.4	22.3	16.4
GOT1	AST1	ENSG00000120053	"Glutamic-oxaloacetic transaminase 1"	P17174	10	99396870-99430624	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 116.9;liver: 82.9;skeletal muscle: 102.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064532, HPA072629"	Enhanced		Supported	Nucleoplasm,Cytosol			130000000	Nucleoplasm	Cytosol	"HPA064532: AB_2685279, HPA072629: AB_2686540"	"unprognostic (6.40e-2)"	"prognostic favourable (6.23e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.96e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.72e-13)"	"unprognostic (1.93e-2)"	"unprognostic (4.23e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.00e-1)"	3.3	14.0	15.7	3.6	32.1	2.0	5.9	22.9	56.4	13.5	12.0	9.7	5.9	14.7	3.4	7.0	10.3	4.6	12.2	116.9	19.4	19.0	34.6	82.9	3.5	3.4	17.8	16.4	3.8	8.2	15.9	4.9	3.7	49.9	5.9	14.7	9.0	12.4	7.2	102.1	4.5	12.7	5.4	7.7	3.6	10.1	9.3	4.7	3.3	11.7	31.3	7.1	4.9	4.0	10.6	21.4	3.9	16.8	11.4	15.6	8.8	16.9	9.4	11.1	28.0	8.6	7.4	31.4	13.9	25.6	24.3	26.5	21.3	13.8	16.6	4.8	11.7	21.3	25.3	18.3	26.8	5.7	10.8	6.3	12.1	27.7	45.6	18.0	10.8	11.6	19.8	20.6	55.9	11.7	16.2	26.0	15.5	15.3	9.6	13.5	7.1	13.1	10.5	10.6	17.3	42.4	9.3	4.8	7.1	10.5	14.9	51.9	28.5	6.2	5.4	6.2	13.8	6.7	15.9	18.6	21.9	16.9	16.3	9.4	8.2	2.4	5.3	3.9	12.4	14.7	11.4	10.6	13.5	12.9	12.9	10.2	10.2	14.5	0.5	11.4	16.8	21.4	15.6	8.8	15.7	32.1	22.9	56.4	19.4	19.0	17.8	16.4	49.9	4.7
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"		7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavourable (1.61e-4)"	"prognostic favourable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favourable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.1	36.9	19.5	23.6	14.1	12.8	25.5	20.9	22.3	41.2	22.6	31.9	24.6	60.8	24.9	23.1	40.2	41.6	40.6	52.6	16.7	38.2	16.4	20.1	35.6	17.9	26.2	15.1	12.3	23.1	25.9	22.7	41.3	32.8	6.3	20.9	24.3	32.6	25.4	26.4	71.7	35.8	29.7	58.3	38.9	40.0	31.1	22.6	40.0	43.1	15.0	21.8	8.6	16.6	15.0	27.5	11.7	26.5	14.6	13.5	49.8	16.1	26.3	15.1	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9
GP1BA	"CD42b, GP1B, GPIbalpha"	ENSG00000185245	"Glycoprotein Ib platelet alpha subunit"	P07359	17	4932297-4935030	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Bernard Soulier syndrome, Disease mutation, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 37.8"	"Cell line enriched"	"Detected in some"	24	"HEL: 39.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	7	"basophil: 7.5"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002496, HPA013316"	Supported						2000000000			"CAB002496: AB_563748, HPA013316: AB_1855459"	"unprognostic (4.87e-4)"	"unprognostic (8.21e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.59e-3)"	"unprognostic (7.30e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.54e-4)"	"unprognostic (1.27e-1)"	"unprognostic (4.85e-3)"	"unprognostic (4.58e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.53e-4)"	"unprognostic (8.35e-2)"	0.7	0.1	0.4	15.8	1.2	5.3	0.7	1.9	0.7	0.7	1.0	0.2	0.2	1.5	0.6	0.7	5.7	0.8	0.3	4.2	0.5	0.4	1.0	1.6	3.5	37.8	0.4	0.2	0.7	0.4	0.0	0.4	1.1	0.4	0.7	0.6	0.3	7.7	0.2	3.0	4.6	3.7	0.2	0.4	13.0	0.9	0.6	0.2	2.0	0.8	0.8	17.6	0.9	1.1	0.0	0.3	7.5	0.2	0.0	0.2	3.6	0.0	1.3	0.3	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	1.1	0.1	1.2	0.4	0.0	1.3	0.0	0.0	0.0	0.4	1.0	39.3	0.5	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	0.3	0.2	0.1	0.2	0.6	0.3	0.2	0.0	0.7	0.0	0.2	0.5	0.0	0.2	1.6	0.7	0.1	0.2	0.2	0.8	0.1	0.7	0.2	0.9	0.6	0.6	0.4	7.5	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.0	0.1	0.3	0.0	3.6	0.4	1.2	1.9	0.4	0.5	0.4	0.4	0.2	0.4	0.2
GP5	CD42d	ENSG00000178732	"Glycoprotein V platelet"	P40197	3	194394821-194398354	"CD markers, Plasma proteins, Predicted membrane proteins"	"Blood coagulation, Cell adhesion, Hemostasis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.7"	"Cell line enriched"	"Detected in some"	9	"HEL: 18.6"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;naive CD8 T-cell: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.1;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA072646			Uncertain	Cytosol			400000000	Cytosol		"HPA072646: "	"unprognostic (3.74e-2)"	"unprognostic (3.40e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	0.3	0.0	0.4	2.1	0.5	1.6	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	2.5	0.3	0.3	0.4	0.6	0.3	0.6	0.9	3.7	0.3	0.3	0.8	0.3	0.0	0.4	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.3	1.7	0.2	0.3	0.3	0.3	1.0	0.3	1.9	0.3	0.5	0.1	1.1	0.2	0.0	0.0	2.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.4	0.1	0.1	2.0	2.2	0.1	0.0	0.0	1.1	0.0	0.4	0.4	0.5	0.3	0.3	0.4	0.6	0.3	0.3	0.3	0.3
GP6	GPVI	ENSG00000088053	"Glycoprotein VI platelet"	Q9HCN6	19	55013705-55038264	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.9"	"Group enriched"	"Detected in some"	12	"HEL: 13.5;K-562: 5.8;U-2 OS: 3.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"											HPA066482	Approved		Approved	Nucleoplasm	"Intracellular and membrane"		28000000	Nucleoplasm		"HPA066482: "	"unprognostic (3.06e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.74e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.50e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.44e-3)"	"unprognostic (2.70e-2)"	0.3	0.3	0.8	0.4	1.4	4.4	0.9	4.6	1.6	1.3	0.4	0.3	0.3	0.1	1.1	0.3	2.1	0.5	0.5	5.4	0.7	0.9	0.4	1.5	1.4	0.3	0.3	0.3	0.6	0.3	0.6	0.3	2.8	0.3	0.6	0.4	2.0	0.7	3.0	0.3	3.2	0.3	0.3	0.3	8.9	0.1	4.2	1.0	0.3	0.6	0.3	0.3	0.7	1.8	0.0	0.3	1.3	0.2	0.0	0.1	4.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.6	0.2	0.0	0.2	0.2	0.5	13.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	5.8	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.4	0.2	0.2	0.1	3.9	0.1	0.0	0.3	0.0	0.4	0.1	0.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	4.0	0.8	1.4	4.6	1.6	0.7	0.9	0.3	0.3	0.3	1.0
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 101.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;MOLT-4: 2.3;NB-4: 1.1;NTERA-2: 4.0;RPMI-8226: 2.9;THP-1: 1.1"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.8;T-reg: 13.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced									"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.2	0.2	0.2	12.1	0.2	0.0	0.2	0.2	0.2	0.2	46.9	0.2	0.1	31.6	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.3	0.2	0.2	43.5	0.2	0.3	0.1	0.2	0.2	101.1	1.4	0.2	0.6	0.2	0.2	0.1	0.6	0.2	0.1	0.6	0.2	0.2	1.7	1.7	0.1	2.5	0.1	17.8	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	4.0	0.1	0.0	0.0	2.9	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	2.5	1.1	0.1	7.6	3.9	1.7	1.7	17.8	2.4	0.1	0.1	1.6	0.0	13.0	4.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661229-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favourable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	8.6	8.0	8.4	9.8	9.0	8.1	11.3	9.8	11.9	8.8	17.5	12.3	4.3	5.6	10.8	10.8	9.3	14.4	8.8	14.6	7.7	6.9	11.7	10.4	11.1	12.1	9.0	6.8	20.8	10.6	1.1	11.5	13.8	9.0	10.8	9.4	11.6	13.7	8.4	16.9	12.2	11.6	7.2	8.8	12.0	9.8	26.7	10.2	40.3	13.8	9.3	10.1	10.7	10.0	3.9	4.8	11.4	3.7	4.7	5.4	2.8	3.2	3.3	1.6	4.9	8.4	6.5	4.7	3.1	4.8	3.8	4.5	0.4	4.9	10.4	5.4	3.3	4.7	0.0	8.3	2.1	5.8	5.1	11.1	0.0	3.3	5.5	3.1	3.8	2.9	3.7	10.2	7.2	3.7	2.6	9.2	3.9	2.5	10.6	3.7	0.0	1.1	3.9	6.8	6.4	5.1	2.4	13.1	7.9	4.0	1.8	4.5	4.8	7.9	3.9	6.4	6.8	0.0	0.0	5.9	8.4	3.3	7.3	7.2	4.0	10.9	3.7	11.4	5.4	3.0	5.1	2.4	4.1	3.2	3.8	3.9	5.2	4.3	10.6	4.7	3.1	4.8	5.2	2.8	8.4	9.0	9.8	11.9	7.7	6.9	9.0	6.8	9.0	10.2
GPATCH2	"CT110, FLJ10252, GPATC2, Pfa1, PPP1R30"	ENSG00000092978	"G-patch domain containing 2"	Q9NW75	1	217426992-217631082	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027181, HPA027322"	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA027181: AB_10602601, HPA027322: AB_1848645"	"unprognostic (3.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (9.99e-6)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.41e-2)"	11.0	10.4	14.6	13.7	19.0	6.7	17.1	12.2	19.9	15.1	12.4	10.6	19.4	11.4	15.9	19.2	13.4	12.2	14.8	11.6	12.9	13.7	12.7	11.4	10.4	11.0	11.0	13.4	13.6	12.5	18.2	27.7	14.6	12.8	17.0	11.2	8.5	12.2	19.5	13.0	12.0	13.8	12.3	11.5	11.7	11.2	16.6	12.2	20.6	16.5	11.7	12.7	12.2	13.3	5.2	9.0	6.6	6.0	4.8	6.0	2.7	6.9	7.9	8.6	6.7	7.6	7.7	7.1	6.5	8.0	9.1	8.6	6.9	9.1	7.4	6.7	5.6	8.2	9.6	7.7	10.7	5.5	5.5	4.9	6.5	4.4	9.4	7.4	5.8	6.8	11.3	10.6	17.5	6.2	11.9	0.1	6.6	6.5	9.9	5.3	15.5	8.7	4.9	19.6	8.9	6.4	15.1	10.1	14.4	11.6	10.7	8.5	10.0	7.3	6.4	8.6	6.0	12.0	6.0	7.8	5.5	7.1	6.5	4.9	6.1	6.6	6.0	1.9	5.1	3.4	3.5	4.6	6.0	3.5	6.1	5.2	5.3	4.8	0.9	4.8	4.9	9.0	5.1	2.7	14.6	19.0	12.2	19.9	12.9	13.7	11.0	13.4	12.8	12.2
GPATCH8	"GPATC8, KIAA0553"	ENSG00000186566	"G-patch domain containing 8"	Q9UKJ3	17	44395284-44503430	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044380	Approved		Approved	"Nuclear speckles,Mitochondria"				"Nuclear speckles"	Mitochondria	"HPA044380: AB_10965696"	"unprognostic (3.37e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.07e-3)"	"unprognostic (2.13e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.84e-3)"	"unprognostic (8.47e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.49e-1)"	8.6	8.5	7.1	12.0	9.3	11.9	7.7	22.2	11.7	8.3	6.5	9.9	6.4	6.9	10.2	4.7	8.5	7.4	6.7	8.1	7.8	5.6	6.4	4.8	7.5	10.0	8.7	6.8	11.2	7.7	14.7	18.1	11.0	9.0	7.1	7.5	9.2	9.1	5.8	21.0	8.3	8.6	8.0	8.3	9.3	6.5	7.6	10.1	9.6	7.7	3.8	9.5	11.6	12.8	10.1	9.6	10.3	16.0	12.4	13.2	6.1	10.2	7.3	8.8	8.5	5.7	7.8	8.7	8.5	10.1	10.6	11.2	10.2	6.9	12.9	5.0	10.5	6.8	11.8	8.0	13.0	15.2	7.6	15.2	6.9	5.6	4.1	12.5	10.3	8.0	4.4	11.1	10.5	8.6	10.4	11.0	6.3	3.2	16.0	1.1	5.9	7.3	14.3	11.4	9.1	1.4	7.5	8.2	6.4	9.9	4.3	5.8	6.1	6.9	6.9	6.6	6.0	9.8	10.0	11.3	10.0	14.0	7.3	4.9	6.6	10.3	8.2	6.7	13.2	7.9	12.4	10.1	10.4	9.4	7.9	9.7	9.7	9.7	6.4	12.4	16.0	9.6	5.2	6.1	7.1	9.3	22.2	11.7	7.8	5.6	8.7	6.8	9.0	10.1
GPC4	K-glypican	ENSG00000076716	"Glypican 4"	O75487	X	133300103-133415490	"Plasma proteins, Predicted membrane proteins"			"Deafness, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 50.7;EFO-21: 17.4;HAP1: 29.1;NTERA-2: 26.6;RPTEC TERT1: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030834, HPA030836"	Approved		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		170000	"Plasma membrane"	Nucleoplasm	"HPA030834: , HPA030836: AB_10601327"	"unprognostic (9.60e-2)"	"unprognostic (8.67e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.21e-2)"	"unprognostic (8.51e-3)"	"unprognostic (5.90e-3)"	"unprognostic (5.68e-2)"	"prognostic favourable (3.51e-4)"	"unprognostic (2.54e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.30e-1)"	"prognostic favourable (1.25e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.72e-1)"	39.7	9.9	16.3	10.7	5.3	0.3	6.8	3.7	4.9	14.6	21.6	8.2	3.4	10.0	11.7	16.3	18.6	11.2	23.7	9.6	9.5	5.0	39.6	2.4	25.6	7.1	5.1	6.6	12.4	12.5	9.4	20.4	26.9	9.5	10.3	10.7	9.3	12.2	11.6	20.3	4.3	11.3	16.9	7.9	6.5	19.8	7.2	6.4	5.2	12.4	11.6	2.0	17.1	11.7	0.9	0.6	0.1	0.7	0.0	0.0	0.2	0.0	0.0	50.7	2.0	2.2	0.3	6.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	17.4	0.2	0.0	29.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	26.6	0.7	0.1	4.6	0.0	66.9	1.9	0.0	0.3	0.2	0.0	0.0	0.7	0.7	0.0	5.2	6.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	16.3	5.3	3.7	4.9	9.5	5.0	5.1	6.6	9.5	6.4
GPD1		ENSG00000167588	"Glycerol-3-phosphate dehydrogenase 1"	P21695	12	50103819-50111319	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.3;skeletal muscle: 106.9"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 52.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044620	Enhanced						3800000			"HPA044620: AB_10796803"	"unprognostic (2.65e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (7.19e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-2)"	116.3	1.2	2.4	3.6	3.0	0.3	44.9	1.6	3.9	0.3	13.4	12.2	0.4	16.2	0.3	3.0	1.2	0.3	8.1	3.9	4.3	2.7	30.6	31.4	4.0	1.6	6.8	1.2	0.2	1.8	2.3	0.3	0.2	13.5	0.5	0.9	0.1	17.7	0.5	106.9	2.0	23.5	0.5	24.7	0.2	0.8	0.3	2.0	0.0	0.7	14.1	0.3	1.1	0.3	0.7	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	52.2	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	9.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.2	0.0	0.0	0.6	0.3	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.4	3.0	1.6	3.9	4.3	2.7	6.8	1.2	13.5	2.0
GPD2		ENSG00000115159	"Glycerol-3-phosphate dehydrogenase 2"	P43304	2	156435290-156613735	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 6.5;eosinophil: 3.1;intermediate monocyte: 3.3;myeloid DC: 5.1;neutrophil: 2.3;non-classical monocyte: 4.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.1;granulocytes: 3.1;monocytes: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008012, HPA045506"	Enhanced				"Intracellular and membrane"		7600000			"HPA008012: AB_1079013, HPA045506: AB_2679355"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.79e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.60e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.01e-2)"	12.7	5.5	19.6	12.4	21.4	11.4	15.2	23.1	16.3	10.9	17.6	8.8	8.1	13.7	9.1	5.0	23.1	18.4	8.6	6.2	18.7	12.7	7.7	3.4	11.4	9.0	11.3	11.8	9.0	7.4	26.6	11.0	7.9	10.3	10.8	17.8	6.8	21.5	7.5	21.2	12.0	24.9	5.9	9.4	10.6	17.1	9.5	8.3	6.7	11.8	17.6	14.0	10.1	10.5	0.5	5.1	3.1	6.5	0.7	0.9	2.7	17.2	11.1	7.0	10.5	14.7	18.7	0.0	22.2	13.6	14.2	17.1	21.9	15.8	3.1	14.4	11.5	19.9	12.8	19.8	18.2	10.7	4.5	2.5	20.3	0.0	5.1	4.7	5.8	8.9	6.3	24.5	12.2	10.8	5.4	0.8	17.8	10.2	0.1	0.4	12.6	14.7	5.4	4.4	4.0	16.6	21.7	12.4	4.4	19.8	14.8	13.0	5.0	12.5	10.4	2.7	11.8	12.1	15.6	0.6	0.1	0.1	15.3	1.3	21.2	0.6	6.5	3.1	0.5	3.3	0.9	0.3	0.3	0.9	5.1	0.5	0.7	0.5	2.3	0.7	4.3	0.5	0.9	2.7	19.6	21.4	23.1	16.3	18.7	12.7	11.3	11.8	10.3	8.3
GPI	"AMF, NLK"	ENSG00000105220	"Glucose-6-phosphate isomerase"	P06744	19	34359480-34402413	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Gluconeogenesis, Glycolysis"	"Cytokine, Growth factor, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB018655, HPA024305, CAB040563, HPA052171"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		140000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748"	"unprognostic (1.03e-1)"	"unprognostic (8.39e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.95e-2)"	"unprognostic (8.52e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.60e-3)"	"unprognostic (2.88e-2)"	62.1	66.6	43.4	27.6	58.2	83.3	34.8	62.6	88.7	20.6	36.6	20.8	23.7	48.2	21.1	20.6	45.3	24.2	33.5	107.2	42.0	45.6	51.3	77.9	19.6	29.6	39.3	64.3	22.5	21.4	66.9	33.7	20.4	50.2	23.7	37.2	36.2	34.6	33.9	144.7	29.4	44.3	34.2	22.8	23.1	26.7	19.7	19.0	23.8	26.1	68.5	32.6	32.5	25.2	16.2	26.3	74.8	40.9	14.5	27.5	24.6	76.1	107.4	9.4	73.5	30.9	23.0	22.5	29.4	23.2	37.1	44.8	60.5	27.0	50.2	43.7	28.8	53.1	56.8	63.9	42.2	55.8	22.9	64.5	51.8	63.6	20.0	83.5	42.0	31.5	26.4	43.9	22.8	34.6	32.8	39.8	26.1	64.6	36.3	29.2	25.4	38.0	34.0	24.9	94.8	46.5	51.3	51.4	29.9	59.3	104.6	21.4	23.7	26.6	29.8	14.0	30.9	39.8	45.3	73.5	41.7	45.5	46.8	63.5	28.4	38.5	22.9	74.8	22.5	35.2	27.5	16.2	20.7	25.5	26.3	13.3	17.5	20.7	1.6	14.5	40.9	8.7	21.6	24.6	43.4	58.2	62.6	88.7	42.0	45.6	39.3	64.3	50.2	19.0
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 61.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 10.2;U-698: 10.4"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Region enriched"	"Detected in many"	4	"cerebellum: 8.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	102626666667	3700000000			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	2.2	0.4	0.8	0.6	1.2	0.3	0.6	8.5	1.8	0.6	0.6	0.6	0.6	0.1	0.8	0.6	0.6	0.4	0.6	0.6	0.6	1.9	0.6	61.6	0.6	0.6	0.7	0.6	0.7	0.6	1.5	1.3	0.6	0.6	1.0	0.1	0.6	0.6	3.3	0.7	4.8	0.6	0.8	0.6	0.6	0.3	0.8	0.6	6.6	1.6	0.6	0.7	1.0	1.0	1.1	1.6	0.4	0.2	0.1	1.8	0.0	0.7	1.3	1.2	1.8	0.0	0.1	3.0	0.1	0.3	0.4	0.3	5.2	0.1	10.2	1.2	0.2	0.0	1.7	0.3	0.2	1.3	3.4	1.4	1.3	4.3	0.0	1.8	0.2	0.1	0.2	0.1	0.0	0.0	0.6	0.5	0.3	0.7	1.0	0.6	3.9	0.5	2.0	0.3	0.1	0.4	5.1	3.3	3.4	1.1	0.1	0.5	0.5	0.5	0.1	1.2	1.3	0.1	1.4	3.0	4.7	10.4	0.1	0.5	0.5	0.4	0.2	0.1	0.4	0.1	1.4	0.6	0.3	0.2	0.0	1.1	0.3	1.8	0.4	0.1	0.1	1.6	0.2	0.0	0.8	1.2	8.5	1.8	0.6	1.9	0.7	0.6	0.6	0.6
GPNMB	"HGFIN, NMB"	ENSG00000136235	"Glycoprotein nmb"	Q14956	7	23235967-23275108	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 137.7"	"Cell line enriched"	"Detected in many"	5	"ASC diff: 322.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 354.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.8;intermediate monocyte: 7.1"	"Lineage enriched"	"Detected in many"	6	"monocytes: 7.1"	"Region enhanced"	"Detected in some"		"olfactory region: 12.1"	"Low region specificity"	"Detected in some"								"Intracellular and membrane"		41000000				"unprognostic (3.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.40e-2)"	"unprognostic (2.08e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.82e-1)"	"unprognostic (6.95e-2)"	137.7	4.3	7.7	9.5	5.9	0.7	33.8	1.0	5.5	56.0	20.7	7.9	9.2	3.5	56.5	34.6	32.6	17.3	45.8	50.0	5.5	2.8	10.8	8.9	58.7	24.1	4.4	5.0	39.7	4.0	0.3	3.7	52.7	18.2	24.8	15.7	115.7	18.1	9.8	11.3	97.2	12.1	26.2	15.7	8.4	11.2	19.8	1.5	20.6	14.0	31.7	26.7	33.4	41.9	0.4	0.8	1.2	7.1	0.3	0.2	0.8	1.1	0.0	0.0	0.0	322.8	58.8	0.0	2.0	35.0	1.7	7.4	0.0	0.0	0.0	0.0	6.6	7.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	40.4	8.4	2.9	0.3	0.0	0.0	0.0	9.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.4	27.3	0.1	0.0	0.0	10.9	50.3	0.1	0.1	0.0	10.3	1.1	18.7	0.3	0.3	0.5	0.0	3.6	0.1	10.3	0.9	3.8	0.1	0.2	7.1	0.1	0.2	0.0	0.0	0.8	0.4	0.2	0.1	1.2	0.3	0.3	0.8	0.1	0.8	7.7	5.9	1.0	5.5	5.5	2.8	4.4	5.0	18.2	1.5
GPR50	"H9, Mel1c"	ENSG00000102195	"G protein-coupled receptor 50"	Q13585	X	151176653-151181465	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"pituitary gland: 64.9"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 10.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"hypothalamus: 16.8"	"Region enriched"	"Detected in single"	9	"hypothalamus: 6.4"	"HPA049862, HPA054678"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA049862: , HPA054678: "						"unprognostic (8.84e-3)"		"unprognostic (5.59e-2)"							"unprognostic (1.15e-1)"			0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.3	1.4	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	64.9	3.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0
GPR83	GPR72	ENSG00000123901	"G protein-coupled receptor 83"	Q9NYM4	11	94377311-94401419	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"brain: 20.0;thyroid gland: 9.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"														"unprognostic (6.74e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.88e-1)"	"unprognostic (6.36e-3)"	"unprognostic (6.89e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"unprognostic (6.17e-2)"	"unprognostic (1.47e-12)"	"unprognostic (3.16e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-2)"	"unprognostic (8.28e-3)"	0.6	2.6	3.3	0.8	6.1	2.0	0.6	20.0	11.7	0.8	0.7	0.9	0.0	0.7	0.8	1.2	0.5	0.8	0.8	1.2	19.8	6.7	1.2	1.2	0.7	1.1	1.0	3.7	0.7	0.7	0.5	0.6	0.5	1.7	0.5	0.6	0.3	0.6	0.6	1.3	1.4	0.8	0.6	1.8	1.1	0.8	1.1	1.0	0.0	9.3	0.0	0.7	0.5	0.3	0.7	0.5	2.6	0.6	1.6	0.6	0.2	0.3	0.4	0.8	1.1	0.0	0.2	0.9	0.7	0.1	0.1	0.2	5.6	1.0	1.1	0.5	0.1	1.2	0.3	0.2	0.1	0.8	0.5	1.2	1.2	0.7	0.0	1.6	2.9	0.1	0.5	0.4	0.2	0.0	1.1	1.3	0.1	0.8	0.4	2.4	1.1	0.7	1.0	0.2	0.8	0.1	0.9	0.7	0.7	0.5	0.8	0.2	0.9	0.1	0.4	0.8	1.3	0.8	0.8	1.2	1.5	0.5	0.5	1.0	1.1	2.6	0.6	0.5	0.5	0.3	0.4	0.4	0.5	0.6	0.2	0.7	0.4	0.4	1.4	1.6	0.6	0.5	0.3	0.2	3.3	6.1	20.0	11.7	19.8	6.7	1.0	3.7	1.7	1.0
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	26.7	50.1	18.7	24.3	13.2	12.8	26.4	18.0	14.5	28.7	23.8	43.8	16.7	13.3	16.2	18.0	20.4	17.7	23.1	9.8	8.8	63.3	22.4	28.1	48.5	21.9	24.4	21.8	18.2	16.9	25.3	15.1	29.8	21.0	15.4	15.8	52.9	41.6	27.7	23.7	37.5	25.6	25.6	21.5	17.6	27.9	32.0	50.2	18.3	34.0	26.6	38.5	22.1	16.9	28.7	34.0	22.1	28.9	28.3	11.8	14.0	22.4	15.8	25.7	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2
GPT	"ALT1, GPT1"	ENSG00000167701	"Glutamic--pyruvic transaminase"	P24298	8	144502973-144507174	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminotransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 56.8;skeletal muscle: 27.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 4.7;Karpas-707: 5.6;U-266/70: 6.0"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 38.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 2.3;non-classical monocyte: 2.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.9"	"Low region specificity"	"Detected in all"							"HPA031059, HPA031060, CAB032997, CAB032999"	Enhanced						15000000			"CAB032997: AB_2261949, CAB032999: AB_2095427, HPA031059: AB_10600214, HPA031060: AB_10602178"	"unprognostic (8.22e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.37e-2)"	"prognostic favourable (1.47e-5)"	"unprognostic (9.42e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.22e-2)"	"prognostic favourable (2.19e-4)"	"unprognostic (2.83e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-2)"	9.0	0.8	1.7	8.7	2.2	1.1	3.9	1.5	2.3	0.2	17.4	2.0	4.6	10.9	0.2	1.7	0.9	0.5	19.8	16.9	1.7	0.9	8.7	56.8	0.2	0.2	1.3	2.2	0.4	3.6	0.5	1.1	0.1	2.0	0.7	3.5	1.6	17.0	2.7	27.0	6.1	19.2	0.2	0.7	0.4	8.6	0.8	1.6	0.0	0.6	13.9	3.3	0.3	0.5	0.0	0.5	0.0	2.9	0.0	0.0	0.0	0.5	1.5	0.4	1.1	0.9	0.0	1.3	0.8	0.0	0.0	0.0	0.4	1.9	0.8	0.7	0.0	4.3	0.0	0.0	0.0	1.5	2.7	0.7	2.5	4.7	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.5	5.6	0.0	2.6	0.9	0.9	0.6	1.0	0.9	0.3	3.0	0.0	1.8	1.2	1.7	0.5	1.4	0.2	3.8	0.2	0.4	0.3	1.3	1.3	0.2	6.0	0.4	0.4	0.8	1.9	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	1.7	2.2	1.5	2.3	1.7	0.9	1.3	2.2	2.0	1.6
GPX3		ENSG00000211445	"Glutathione peroxidase 3"	P22352	5	151020438-151028993	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 844.2;thyroid gland: 424.1"	"Cell line enriched"	"Detected in some"	12	"ASC diff: 417.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 856.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 16.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 279.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 67.2;hypothalamus: 176.5;midbrain: 58.6;pons and medulla: 52.3"	CAB069456	Approved				"Secreted to blood"	5092600000	10000000000			"CAB069456: AB_1616682"	"unprognostic (4.03e-1)"	"unprognostic (7.35e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.70e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (1.65e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.26e-1)"	177.5	21.9	1.2	6.6	5.5	1.6	310.9	3.1	6.3	26.2	33.9	5.1	6.5	7.5	11.8	16.8	44.4	27.0	17.3	108.1	2.7	5.0	844.2	64.1	88.2	43.8	3.9	1.8	28.8	13.0	5.5	32.3	44.8	17.6	41.3	8.3	160.8	14.8	12.4	56.7	18.7	18.5	48.5	3.5	29.6	19.5	23.6	1.2	0.5	424.1	19.0	9.8	58.8	164.2	0.0	3.5	16.7	3.6	0.0	0.2	1.2	0.1	0.5	0.4	0.1	417.4	0.3	0.4	0.1	0.0	0.4	0.1	8.9	0.2	0.0	11.4	0.2	0.1	2.0	22.5	0.3	0.3	0.1	0.0	0.2	9.7	16.0	0.0	0.2	35.3	2.1	0.0	0.0	0.5	0.0	0.0	0.5	1.5	0.0	0.0	0.7	0.0	0.0	0.2	0.0	3.9	0.2	0.6	0.6	0.0	1.6	0.1	2.2	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.7	0.1	0.3	0.1	0.0	0.0	3.6	0.1	0.0	1.4	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	1.2	1.2	5.5	3.1	3.6	2.7	5.0	3.9	1.8	17.6	1.2
GPX4	"MCSP, PHGPx"	ENSG00000167468	"Glutathione peroxidase 4"	P36969	19	1103926-1106791	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Developmental protein, Oxidoreductase, Peroxidase"	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008630, HPA047224, HPA058546"	Enhanced		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"		220000	"Nucleoplasm, Mitochondria"		"CAB008630: AB_1616685, HPA047224: , HPA058546: "	"unprognostic (8.42e-3)"	"prognostic favourable (7.18e-4)"	"unprognostic (8.14e-3)"	"prognostic favourable (1.84e-5)"	"unprognostic (1.00e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.49e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (1.29e-1)"	"prognostic favourable (8.61e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.96e-2)"	163.0	76.4	63.3	27.1	73.7	33.3	102.3	33.5	83.7	53.3	49.1	42.4	33.8	56.9	27.2	74.7	35.6	38.4	46.9	64.4	54.2	60.2	75.3	119.0	44.7	41.7	74.6	47.3	47.1	35.1	33.1	54.7	46.4	49.3	44.7	25.5	82.3	61.6	46.9	98.2	36.3	58.5	43.6	46.5	32.4	27.7	170.4	36.5	29.9	52.8	49.8	39.2	51.2	47.0	56.7	64.0	85.2	85.2	28.4	58.5	110.5	28.3	32.3	46.7	98.7	141.7	84.0	52.0	22.5	81.3	42.9	43.8	65.9	38.5	10.3	24.6	45.5	32.0	27.3	32.6	21.0	57.6	49.3	19.4	29.0	92.9	82.4	22.7	31.1	83.3	49.7	21.7	36.6	60.0	27.1	25.9	35.4	72.9	38.4	39.0	44.2	52.1	53.3	6.3	29.7	46.6	70.6	40.3	25.5	44.1	41.9	45.8	40.9	55.6	50.8	45.7	30.4	78.3	28.2	91.1	61.7	24.0	43.0	45.6	26.2	75.6	85.2	85.2	37.0	62.0	43.0	56.7	54.3	38.6	64.0	47.8	58.5	41.7	42.4	28.4	68.3	44.1	46.8	110.5	63.3	73.7	33.5	83.7	54.2	60.2	74.6	47.3	49.3	36.5
GRAMD1A	"FLJ90346, KIAA1533"	ENSG00000089351	"GRAM domain containing 1A"	Q96CP6	19	34994784-35026471	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008852, HPA012570"	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane"	Cytosol	"HPA008852: AB_1079203, HPA012570: AB_2112577"	"unprognostic (3.09e-2)"	"unprognostic (4.62e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.42e-3)"	"unprognostic (5.96e-2)"	"unprognostic (4.54e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (7.95e-12)"	"unprognostic (2.04e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.36e-2)"	15.6	19.1	14.6	21.4	14.0	17.1	19.4	13.8	18.1	16.8	13.2	10.4	17.4	13.0	16.9	12.9	7.8	17.2	13.8	17.2	15.9	12.0	13.3	11.0	27.5	42.0	13.7	12.2	21.8	44.1	11.5	14.9	14.1	16.6	15.6	7.5	11.5	45.3	17.2	35.7	6.8	10.9	21.3	12.8	21.1	16.1	11.7	12.1	17.9	12.7	11.5	12.1	17.3	21.4	1.1	4.1	13.1	14.9	3.8	5.5	2.5	5.4	42.3	8.3	16.4	9.7	11.1	6.9	6.6	10.9	8.9	8.8	16.0	4.7	3.1	13.2	9.9	3.6	8.6	13.0	3.4	13.1	15.0	9.1	10.5	14.7	19.5	6.4	14.5	19.6	8.1	6.3	10.8	28.8	9.9	2.1	6.1	5.2	14.6	7.9	13.0	4.7	13.9	2.6	3.8	9.5	1.0	12.5	25.2	6.7	5.1	10.9	7.7	7.1	15.6	14.3	7.4	2.9	9.4	2.3	7.8	7.5	9.4	7.1	10.5	13.1	4.5	3.6	2.9	7.3	5.5	0.5	3.9	2.1	4.1	1.1	2.9	4.2	9.8	3.8	14.9	1.4	3.1	2.5	14.6	14.0	13.8	18.1	15.9	12.0	13.7	12.2	16.6	12.1
GRAP		ENSG00000154016	"GRB2-related adaptor protein"	Q13588	17	19020673-19047637	"Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 37.3;lymphoid tissue: 20.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 31.7;HUVEC TERT2: 13.1;REH: 16.6;TIME: 25.7;U-698: 22.3"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 28.2;T-cells: 37.3"									"HPA046595, HPA066654"	Uncertain		Approved	Centrosome				Centrosome		"HPA046595: AB_10966385, HPA066654: "	"unprognostic (3.02e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.86e-6)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-5)"	"unprognostic (2.25e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.77e-3)"	2.8	1.4	0.7	5.7	0.9	2.4	2.8	0.1	0.4	1.4	0.6			0.3	1.4	0.0	0.5	1.9	2.1	0.6	0.8	0.6	2.2	2.7	3.5	15.8	1.0		0.6	0.1	0.0	0.7	2.5		1.0	0.4		0.4	1.6	0.3	0.8	7.7	1.1	1.0	20.9	0.5	2.5			2.7		14.2	1.7	0.8	28.2	2.7	5.6	2.5	4.9	37.3	13.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	6.5	0.5	0.3	0.0	16.6	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	25.7	0.0	0.0	3.1	0.0	0.0	0.0	22.3	0.0	0.0	0.1	5.6	2.5	0.3	5.9	1.3	5.9	28.2	18.5	7.7	2.7	22.8	37.3	17.9	0.7	4.9	0.1	2.0	15.4	13.0										
GRAP2	"GADS, GRBLG, GrbX, Grf40, Mona"	ENSG00000100351	"GRB2-related adaptor protein 2"	O75791	22	39901082-39973721	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 138.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.4;HEL: 18.1;K-562: 17.3;MOLT-4: 47.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"gdT-cell: 19.5;MAIT T-cell: 14.4;memory CD4 T-cell: 14.4;memory CD8 T-cell: 21.1;naive CD4 T-cell: 12.2;naive CD8 T-cell: 22.5;T-reg: 12.0"	"Lineage enriched"	"Detected in many"	9	"T-cells: 22.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005788, CAB022073"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			260000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB022073: , HPA005788: AB_1079021"	"unprognostic (1.96e-4)"	"unprognostic (1.82e-4)"	"unprognostic (4.19e-2)"	"unprognostic (8.91e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.56e-5)"	"unprognostic (1.27e-2)"	"unprognostic (8.41e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.17e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.06e-2)"	1.6	0.4	0.3	7.7	0.7	7.6	1.5	0.3	0.4	1.1	2.3	0.6	0.4	2.9	2.3	1.6	1.6	1.2	3.5	2.8	0.6	0.4	1.2	1.8	6.4	12.6	0.9	0.4	1.0	0.8	0.0	0.6	1.1	0.6	2.4	1.9	1.2	2.4	1.2	0.5	1.4	6.2	2.0	2.2	13.2	2.9	2.4	0.3	138.0	1.3	1.5	11.3	3.0	1.9	2.1	0.4	2.5	0.2	1.7	22.5	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	18.1	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	47.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.2	0.0	19.5	0.1	14.4	1.0	14.4	21.1	0.4	2.1	12.2	22.5	2.5	1.7	0.1	0.3	12.0	25.9	0.3	0.7	0.3	0.4	0.6	0.4	0.9	0.4	0.6	0.3
GRB2	NCKAP2	ENSG00000177885	"Growth factor receptor bound protein 2"	P62993	17	75318076-75405709	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002589, HPA030749, HPA030750"	Approved		Enhanced	Nucleoplasm			1900000	Nucleoplasm		"CAB002589: AB_10693935, HPA030749: AB_2673590, HPA030750: AB_2673591"	"unprognostic (4.83e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.04e-7)"	"unprognostic (1.01e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.58e-1)"	29.0	29.2	36.1	48.2	40.3	56.3	23.6	42.2	41.6	18.5	27.8	28.2	19.1	29.2	28.3	19.4	27.0	22.1	22.5	32.2	34.7	33.9	24.9	32.2	33.7	54.8	30.9	29.2	21.8	16.7	21.8	21.8	33.1	26.9	21.4	27.9	21.8	21.2	25.6	27.8	18.6	30.5	30.6	42.6	56.7	22.8	10.8	27.1	45.8	20.4	15.6	53.1	29.8	19.2	24.7	25.0	64.9	42.8	12.0	13.4	20.7	24.8	21.7	14.9	18.0	16.5	15.5	34.0	26.3	21.4	27.7	26.6	18.6	16.7	32.5	15.6	24.0	14.9	21.5	18.9	28.8	16.0	19.7	34.8	14.3	27.1	14.9	40.0	68.0	14.3	19.8	28.9	14.5	33.2	23.5	22.6	20.1	31.0	46.8	38.7	10.3	22.1	28.1	32.0	23.5	21.1	18.6	18.0	26.0	22.2	21.7	27.7	24.0	64.7	21.1	26.6	20.2	21.0	26.7	41.5	31.9	52.2	20.5	31.3	19.0	25.1	32.1	38.5	13.4	38.4	11.7	23.7	12.1	13.2	25.0	24.7	12.7	12.0	64.9	12.0	42.8	16.7	13.2	20.7	36.1	40.3	42.2	41.6	34.7	33.9	30.9	29.2	26.9	27.1
GRHPR	"GLXR, PH2"	ENSG00000137106	"Glyoxylate and hydroxypyruvate reductase"	Q9UBQ7	9	37422666-37436990	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022971	Uncertain		Approved	Nucleoplasm,Cytosol			1400000	Cytosol	Nucleoplasm	"HPA022971: AB_1849975"	"prognostic favourable (7.00e-5)"	"unprognostic (6.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-3)"	"unprognostic (5.78e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.36e-1)"	"prognostic favourable (5.39e-9)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.79e-1)"	12.8	33.7	16.3	13.8	17.4	9.9	12.3	9.5	22.3	12.1	17.6	27.5	11.6	17.2	14.3	18.1	17.6	12.9	18.1	29.2	15.8	14.7	41.9	172.0	9.7	13.8	20.0	16.5	17.0	15.5	9.5	8.8	13.2	15.5	14.2	10.2	13.5	21.6	14.0	40.0	14.8	14.6	14.2	19.4	10.0	13.3	13.0	18.7	9.5	15.1	25.2	13.6	13.4	11.7	30.6	33.2	17.8	30.3	28.9	25.9	22.4	31.3	45.2	25.6	23.4	23.6	26.2	26.0	25.1	33.3	34.2	37.2	17.1	13.6	30.1	14.8	29.4	14.2	14.7	32.7	20.5	40.2	18.4	17.6	42.1	30.3	37.3	16.7	18.3	31.3	28.7	19.8	25.5	29.6	32.2	12.4	30.0	24.0	16.3	17.2	15.6	19.7	16.1	18.8	16.7	45.6	17.8	10.7	19.2	21.6	41.2	23.4	23.2	21.6	32.2	18.8	30.2	13.0	21.6	9.8	7.6	20.1	26.7	9.6	27.5	17.8	30.2	15.0	19.4	30.3	16.2	28.6	20.7	22.0	33.2	30.6	20.4	17.3	7.0	28.9	24.7	29.8	25.9	22.4	16.3	17.4	9.5	22.3	15.8	14.7	20.0	16.5	15.5	18.7
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"AF22: 13.4;ASC diff: 4.1;BJ: 6.4;LHCN-M2: 9.4;U-266/70: 6.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001965, HPA035202"	Enhanced									"CAB001965: , HPA035202: "	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.8	1.6	44.9	1.2	23.1	1.0	1.5	23.6	52.6	1.4	1.2	3.7	0.0	1.3	1.2	2.0	1.2	1.2	1.1	2.0	50.4	13.4	1.1	1.1	9.5	1.0	4.8	20.0	1.3	1.4	1.2	0.5	1.1	4.6	1.1	1.2	0.7	1.1	1.7	1.1	1.1	1.3	2.3	2.3	1.1	1.2	2.1	5.2	0.0	1.1	0.0	1.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	4.1	2.8	0.0	6.4	3.3	0.4	0.1	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	23.1	23.6	24.3	50.4	13.4	4.8	20.0	4.6	5.2
GRIK3	"GluK3, GLUR7"	ENSG00000163873	"Glutamate ionotropic receptor kainate type subunit 3"	Q13003	1	36795527-37034129	"Plasma proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;pituitary gland: 13.1"	"Cell line enriched"	"Detected in some"	4	"T-47d: 29.1"	"Cancer enhanced"	"Detected in some"		"glioma: 13.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.60e-3)"	"unprognostic (9.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.08e-2)"	1.7	4.6	5.4	1.8	9.4	0.6	5.4	5.7	24.7	2.1	8.4	3.3	1.5	2.1	0.8	4.5	3.1	1.2	2.2	1.9	3.8	9.6	0.8	0.7	0.9	0.9	9.1	10.4	1.3	1.6	1.5	13.1	0.6	13.1	1.9	3.3	9.0	2.2	5.8	0.7	1.1	2.9	1.8	3.6	1.0	2.1	2.0	2.7	0.0	1.0	0.2	1.4	1.1	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.4	5.7	14.2	3.8	9.6	9.1	10.4	13.1	2.7
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138390-137168762	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"brain: 97.5"	"Cell line enhanced"	"Detected in some"		"REH: 3.0;RPMI-8226: 4.3;SCLC-21H: 9.8;SH-SY5Y: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced									"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	1.7	2.0	23.6	2.0	47.5	1.7	1.8	28.1	97.5	1.8	2.0	3.2	0.0	2.2	1.7	1.8	1.7	1.7	1.7	1.7	29.1	26.4	1.8	1.7	1.8	1.8	15.4	37.9	1.7	1.8	1.8	0.0	1.7	22.0	2.2	1.8	0.7	2.5	1.8	1.7	1.8	2.2	1.8	4.7	1.8	1.8	1.9	6.3	0.0	1.7	0.0	1.8	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	1.5	0.1	0.0	0.2	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	0.0	3.0	0.0	4.3	0.0	0.0	9.8	6.8	0.1	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	23.6	47.5	28.1	87.9	29.1	26.4	15.4	37.9	22.0	6.3
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182754	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.2"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.7;RPMI-8226: 2.9;U-138 MG: 8.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced									"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.9	1.0	5.4	0.5	5.9	0.4	0.6	8.5	25.2	0.6	0.7	1.5	0.0	0.9	0.8	4.5	2.1	4.1	0.5	4.0	8.0	1.9	0.9	0.4	1.0	0.5	1.7	10.3	0.5	0.6	0.4	0.3	0.4	1.4	0.5	0.7	1.4	0.7	1.0	0.5	1.2	0.7	0.9	1.2	0.4	1.1	5.2	0.8	0.0	0.8	0.0	0.7	0.6	0.5	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.8	0.5	1.4	0.0	0.1	0.0	0.0	7.7	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.8	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.4	5.9	8.5	17.9	8.0	1.9	1.7	10.3	1.4	0.8
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;RPMI-8226: 3.9;SCLC-21H: 5.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"												"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.1	0.0	0.0	0.0	0.0	1.3	0.2	0.5	0.1	0.0	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.2	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.3	0.9	3.9	0.0	0.3	5.0	0.3	2.1	0.2	0.8	0.7	0.1	0.2	0.4	2.0	0.4	0.1	1.1	0.1	0.2	0.4	0.6	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9
GRK1	"GPRK1, RHOK, RK"	ENSG00000185974	"G protein-coupled receptor kinase 1"	Q15835	13	113667155-113737735	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"retina: 51.5"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.2"	"Cancer enhanced"	"Detected in single"		"thyroid cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035200, HPA059376"	Enhanced									"HPA035200: AB_2674515, HPA059376: AB_2683996"	"unprognostic (7.93e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.24e-5)"	"unprognostic (1.76e-3)"	"unprognostic (1.53e-1)"		"unprognostic (3.59e-2)"		"unprognostic (2.21e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.00e-2)"	"unprognostic (4.02e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.18e-2)"	"unprognostic (6.11e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0
GRK2	"ADRBK1, BARK1"	ENSG00000173020	"G protein-coupled receptor kinase 2"	P25098	11	67266410-67286556	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 78.2"	"Cell line enhanced"	"Detected in all"		"NB-4: 55.2;REH: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005021, CAB037248, HPA048330"	Approved		Approved	Vesicles				Vesicles		"CAB005021: AB_562360, CAB037248: AB_1078280, HPA048330: "	"unprognostic (5.58e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.01e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.31e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (3.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.19e-3)"	13.1	10.7	24.5	35.8	17.0	78.2	17.0	32.9	35.3	12.8	17.2	12.2	12.6	17.5	11.4	9.9	20.2	12.6	17.6	13.6	21.9	17.4	13.0	14.1	19.1	42.8	13.4	19.0	9.8	10.4	9.7	12.2	12.7	15.7	17.8	16.2	9.3	17.4	20.8	20.8	23.5	26.3	12.2	12.5	59.6	17.4	6.8	11.1	35.9	10.1	13.6	37.5	17.1	15.5	4.1	6.0	21.0	18.3	3.8	5.3	7.4	7.5	5.3	5.2	8.8	4.2	3.8	5.2	4.5	4.3	6.2	5.1	11.8	12.5	38.8	7.3	4.2	10.2	7.6	6.1	3.2	47.2	4.7	22.0	6.1	5.3	5.2	46.1	44.2	3.4	7.1	4.9	6.6	7.9	7.9	19.9	5.3	14.0	25.6	55.2	6.5	8.0	73.3	10.3	11.5	6.3	9.9	10.5	5.7	6.7	9.8	16.0	9.1	50.2	4.3	4.9	6.5	6.2	5.0	12.7	11.6	34.8	6.4	27.3	4.5	6.9	10.3	10.5	5.3	15.9	4.0	3.8	4.0	4.3	6.0	4.1	3.2	3.1	21.0	3.8	18.3	5.3	2.6	7.4	24.5	17.0	32.9	35.3	21.9	17.4	13.4	19.0	15.7	11.1
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.6;HeLa: 1.4;Karpas-707: 1.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles				Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	1.5	0.1	0.0	0.0	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	1.1	0.6	0.1	0.1	0.5	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.2	0.1	0.1	0.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345086-44353102	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 138.4;intermediate monocyte: 80.4;myeloid DC: 109.8;neutrophil: 61.8;non-classical monocyte: 36.4;plasmacytoid DC: 95.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 109.8;granulocytes: 61.8;monocytes: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	"Endoplasmic reticulum,Endosomes,Lysosomes"	"Secreted to blood"		91000000	"Endoplasmic reticulum, Endosomes, Lysosomes"		"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	66.8	27.1	8.2	31.2	10.2	76.4	30.1	5.2	13.9	29.1	45.0	16.6	46.2	23.2	29.8	76.5	104.7	18.8	51.4	46.9	7.8	9.5	39.3	43.2	74.9	81.1	10.5	9.3	20.7	21.6	11.6	18.0	116.4	11.4	28.7	25.1	23.8	54.5	42.1	15.2	37.3	42.9	21.1	13.4	76.3	25.6	21.0	9.7	23.5	31.4	46.3	52.1	34.8	38.5	13.0	109.8	61.8	138.4	2.1	3.8	83.8	17.2	28.2	8.6	23.2	70.5	37.1	26.4	21.2	67.6	35.0	46.5	12.2	42.6	51.1	45.5	34.2	26.9	12.3	49.5	15.8	8.4	26.6	5.4	14.8	25.7	35.8	8.8	72.0	49.1	65.7	29.1	19.2	39.8	10.4	7.7	23.7	25.6	5.0	25.4	6.5	47.7	14.3	26.9	60.1	39.1	20.6	8.2	10.9	28.4	13.4	52.3	30.6	33.4	47.7	65.6	15.8	44.8	14.6	17.0	46.4	17.4	39.6	20.9	18.1	12.5	138.4	11.9	2.7	80.4	2.1	13.0	2.9	2.4	109.8	8.2	2.2	2.1	61.8	2.1	36.4	95.5	3.8	83.8	8.2	10.2	5.2	13.9	7.8	9.5	10.5	9.3	11.4	9.7
GSN	DKFZp313L0718	ENSG00000148180	Gelsolin	P06396	9	121207794-121332843	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cilium biogenesis/degradation"	"Actin capping, Actin-binding"	"Amyloidosis, Cancer-related genes, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.4;HaCaT: 66.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010823, CAB016728, CAB036009, HPA054026"	Supported		Supported	"Actin filaments"	"Secreted to blood"	111500000000	510000000000	"Actin filaments"		"CAB010823: , CAB016728: , CAB036009: , HPA054026: "	"unprognostic (3.25e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.10e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.06e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.79e-5)"	187.8	23.1	14.1	23.7	21.4	26.6	186.2	7.3	20.0	81.9	69.6	53.7	48.0	22.3	88.1	64.7	99.6	57.8	59.6	235.1	17.6	11.9	14.8	3.9	30.6	12.9	42.8	16.5	40.8	20.4	7.4	25.7	17.5	33.4	74.0	29.0	83.0	44.8	63.2	48.1	55.6	32.7	154.8	33.4	12.4	45.0	32.5	29.9	5.6	67.7	46.4	20.9	113.5	109.0	2.2	43.3	133.9	15.2	24.4	0.4	11.8	5.8	8.0	5.9	16.9	167.4	55.1	3.8	19.5	43.1	4.7	9.5	8.1	17.5	0.4	5.3	25.7	66.5	0.4	13.4	2.7	1.0	1.0	4.7	7.4	18.4	4.6	1.0	22.9	20.5	12.8	7.8	4.9	17.0	1.4	0.6	21.0	10.5	0.0	34.3	2.0	6.2	1.1	2.0	0.5	22.2	9.0	0.9	1.5	8.8	9.5	25.6	37.7	20.9	30.9	13.7	4.8	1.2	1.9	0.2	0.2	0.4	15.2	2.3	37.7	30.2	15.2	133.9	0.2	10.2	0.1	2.2	0.1	0.1	43.3	0.6	0.0	0.0	37.0	24.4	2.6	28.7	0.4	11.8	14.1	21.4	7.3	20.0	17.6	11.9	42.8	16.5	33.4	29.9
GSPT1	"eRF3a, ETF3A, GST1"	ENSG00000103342	"G1 to S phase transition 1"	P15170	16	11868128-11916082	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052488, HPA074588"	Approved		Approved	Vesicles,Cytosol			150000	Cytosol	Vesicles	"HPA052488: , HPA074588: "	"unprognostic (4.13e-2)"	"unprognostic (1.66e-1)"	"prognostic favourable (2.10e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (7.94e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.06e-5)"	"unprognostic (3.47e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.61e-3)"	"unprognostic (3.13e-2)"	28.5	36.5	27.0	31.2	25.0	30.1	52.5	18.1	33.9	21.7	25.8	18.5	23.3	15.6	20.8	23.1	42.8	18.7	20.1	35.6	22.4	15.3	26.2	46.0	31.3	38.1	26.4	21.6	20.8	48.2	40.9	18.5	23.1	24.1	24.3	29.1	12.6	26.4	30.8	74.1	25.3	20.5	25.6	27.4	26.3	28.1	30.6	23.2	34.8	27.7	24.8	37.0	23.9	30.1	8.8	7.8	7.9	12.0	7.3	11.4	4.6	45.1	44.8	25.0	34.4	36.2	37.7	36.2	50.3	52.3	40.5	40.5	31.9	42.0	61.3	66.1	43.5	34.8	63.3	46.5	68.3	29.3	32.8	41.8	36.4	67.3	30.5	52.9	22.4	29.4	36.7	45.7	62.9	44.7	67.4	31.8	46.9	43.5	44.6	27.5	49.9	25.6	52.9	43.2	71.6	40.0	39.7	40.4	21.6	72.2	54.9	29.4	47.6	25.5	34.4	45.1	28.4	32.6	39.5	31.7	46.8	53.5	31.7	54.0	27.3	1.5	6.5	7.9	7.6	12.0	10.6	8.8	9.8	9.0	7.8	6.4	9.9	9.5	2.2	7.3	10.1	4.3	11.4	4.6	27.0	25.0	18.1	33.9	22.4	15.3	26.4	21.6	24.1	23.2
GSR		ENSG00000104687	"Glutathione-disulfide reductase"	P00390	8	30678061-30727999	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001538, CAB008632"	Approved		Supported	"Plasma membrane,Cytosol"			110000000	Cytosol	"Plasma membrane"	"CAB008632: AB_1616690, HPA001538: AB_1078986"	"unprognostic (1.23e-1)"	"prognostic favourable (3.37e-4)"	"prognostic favourable (4.08e-5)"	"unprognostic (2.89e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (3.61e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (6.92e-3)"	"prognostic favourable (1.80e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	8.9	14.4	6.8	10.7	9.1	7.9	6.2	9.1	11.8	18.6	18.7	7.1	18.4	20.4	13.2	12.0	19.4	8.8	17.3	11.9	5.0	5.7	27.9	17.8	10.8	9.7	4.9	6.0	11.8	17.6	22.9	7.2	8.9	6.8	16.4	17.2	10.9	12.0	17.4	14.7	6.5	31.8	9.3	4.5	13.6	17.7	7.9	4.2	17.0	9.2	11.8	12.0	23.9	14.5	2.5	4.7	19.0	5.7	2.6	7.3	2.1	12.0	51.0	8.3	6.4	8.9	10.0	8.0	5.4	11.8	7.7	10.3	15.0	6.4	23.6	26.7	6.9	13.6	12.5	11.7	8.4	6.1	11.6	23.7	17.6	50.1	24.0	7.2	38.3	16.6	7.4	11.5	4.6	10.9	19.6	10.5	17.3	11.0	25.5	8.5	14.7	9.1	9.8	9.5	11.4	15.2	30.6	6.3	8.1	7.4	17.3	12.9	7.5	8.2	14.7	3.2	8.9	7.6	8.0	5.8	6.4	15.1	10.2	10.2	10.5	19.0	4.6	11.5	4.2	4.2	7.3	2.5	3.8	4.6	4.7	2.0	2.4	3.1	6.5	2.6	5.7	2.9	3.2	2.1	6.8	9.1	9.1	11.8	5.0	5.7	4.9	6.0	6.8	4.2
GSS		ENSG00000100983	"Glutathione synthetase"	P48637	20	34928433-34956027	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054508, HPA059315"	Enhanced		Supported	Nucleoplasm			23000000	Nucleoplasm		"HPA054508: AB_2682509, HPA059315: AB_2683976"	"unprognostic (5.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (7.21e-5)"	"unprognostic (2.90e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.64e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (7.31e-6)"	"unprognostic (3.35e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.52e-1)"	12.9	29.8	14.7	13.2	21.0	16.0	16.2	9.2	27.6	12.7	26.9	17.2	28.9	20.0	11.5	47.5	25.6	18.5	18.3	14.6	15.0	15.9	30.5	30.9	12.1	11.7	15.1	15.1	11.6	10.3	17.5	15.6	27.2	15.3	18.6	27.6	15.4	19.1	19.4	10.7	19.1	21.4	12.9	13.3	13.3	15.7	16.8	9.2	17.0	18.0	12.0	21.0	14.4	13.9	7.3	24.3	7.9	21.3	15.2	18.3	14.9	18.0	21.9	10.8	15.1	12.6	13.1	15.4	15.4	14.3	24.3	20.2	40.3	22.1	12.8	20.6	15.8	17.2	15.7	39.3	20.6	5.9	8.9	50.4	14.0	40.0	17.7	12.7	17.8	13.7	42.1	22.9	38.7	17.2	24.4	10.5	29.5	19.9	20.2	18.0	6.4	28.4	18.6	21.7	30.4	34.8	18.5	21.2	12.4	27.2	25.5	20.3	31.3	11.6	13.5	28.0	15.9	18.4	13.3	10.7	9.9	14.1	23.8	14.0	16.6	7.9	20.3	4.6	18.0	21.3	16.1	7.3	14.5	18.3	24.3	5.2	16.9	14.3	5.3	15.2	19.0	13.5	17.5	14.9	14.7	21.0	9.2	27.6	15.0	15.9	15.1	15.1	15.3	9.2
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol		"HPA004342: AB_1078987, HPA048934: , HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
GSTK1	GST13	ENSG00000197448	"Glutathione S-transferase kappa 1"	Q9Y2Q3	7	143244093-143270854	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006311, HPA022904"	Supported		Supported	Peroxisomes			1300000	Peroxisomes		"HPA006311: AB_1849786, HPA022904: AB_1849787"	"prognostic favourable (4.41e-6)"	"unprognostic (2.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-3)"	"unprognostic (1.99e-2)"	"unprognostic (7.27e-2)"	"prognostic favourable (2.10e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.94e-1)"	"unprognostic (9.13e-2)"	"unprognostic (2.15e-2)"	38.0	45.3	14.0	45.3	19.9	29.0	43.0	5.6	19.6	30.4	69.0	19.9	35.7	58.0	24.8	39.8	37.8	27.4	55.2	56.4	15.0	13.1	67.6	97.1	35.4	52.2	24.3	16.3	22.7	39.9	46.2	20.7	41.5	23.9	28.0	43.5	34.4	72.9	35.8	38.9	30.0	91.0	22.2	17.5	58.5	34.8	18.9	20.8	27.1	48.0	56.6	50.3	29.4	26.6	32.8	57.1	35.7	75.4	22.3	99.0	95.2	27.1	19.6	2.7	24.4	43.3	62.2	13.0	16.1	27.6	14.4	28.8	11.8	69.8	15.5	23.0	23.2	41.2	10.7	25.2	12.6	29.8	11.6	12.6	14.7	18.5	29.8	15.2	20.6	56.1	31.0	16.6	11.8	38.2	17.6	18.9	38.5	20.9	15.5	27.6	6.5	29.7	13.4	0.4	30.6	49.9	15.0	11.3	15.4	29.5	48.1	24.4	23.1	21.3	22.5	7.8	7.3	20.5	13.6	32.4	15.2	3.5	28.3	61.3	16.1	35.7	67.9	25.8	41.1	74.8	39.6	32.8	76.4	52.4	57.1	21.9	39.5	38.1	21.2	22.3	75.4	23.9	99.0	95.2	14.0	19.9	5.6	19.6	15.0	13.1	24.3	16.3	23.9	20.8
GSTM1	"GST1, H-B, MU"	ENSG00000134184	"Glutathione S-transferase mu 1"	P09488	1	109687814-109709039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 163.2;seminal vesicle: 101.4"	"Cell line enhanced"	"Detected in some"		"HEL: 26.6;HeLa: 31.8;HHSteC: 25.4;hTEC/SVTERT24-B: 23.0;HUVEC TERT2: 19.5;MOLT-4: 34.3"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 63.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022669, CAB047357, HPA048652, HPA055972, HPA055973"	Approved		Approved	Cytosol				Cytosol		"CAB022669: , CAB047357: , HPA048652: , HPA055972: , HPA055973: "	"unprognostic (2.22e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.20e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.45e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.72e-3)"	14.5	25.4	15.2	6.9	15.6	2.9	8.2	5.6	19.2	22.0	7.8	16.9	0.0	7.7	9.8	20.2	22.5	13.8	8.2	6.4	14.4	6.8	14.1	163.2	7.7	1.0	7.8	32.1	29.0	18.2	41.4	5.3	2.9	8.2	38.1	6.6	25.7	11.8	101.4	25.1	18.8	17.7	18.2	6.8	21.7	7.5	15.1	11.2	10.9	7.6	1.6	14.5	30.8	19.5	14.6	34.9	14.1	18.9	13.3	17.3	10.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	2.2	8.2	0.0	12.7	0.4	0.0	0.1	0.2	0.0	0.1	26.6	31.8	0.5	25.4	0.0	0.2	0.0	0.0	23.0	0.1	19.5	0.0	17.8	0.7	0.0	34.3	0.2	17.1	0.0	0.1	0.1	3.3	2.8	0.0	1.6	0.2	0.0	0.1	0.1	0.3	14.0	0.0	11.4	0.6	0.2	0.0	14.3	18.8	1.1	9.8	0.3	0.6	0.7	12.2	14.1	14.8	18.9	15.7	14.6	15.8	13.7	34.9	14.6	16.5	15.6	1.0	13.3	7.4	19.2	17.3	10.0	15.2	15.6	5.6	19.2	14.4	6.8	7.8	32.1	8.2	11.2
GSTO1	"GSTTLp28, P28"	ENSG00000148834	"Glutathione S-transferase omega 1"	P78417	10	104235356-104267459	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Oxidoreductase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 137.3"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037603, HPA037604"	Enhanced		Approved	Nucleoplasm,Cytosol			200000000	Cytosol	Nucleoplasm	"HPA037603: AB_2675574, HPA037604: AB_10672283"	"prognostic favourable (6.95e-4)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.23e-3)"	"unprognostic (4.57e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (1.86e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.51e-3)"	"unprognostic (5.82e-2)"	29.6	31.9	19.9	21.8	24.4	35.8	20.0	15.0	24.3	17.8	29.7	16.8	17.8	36.3	16.5	21.4	22.6	15.2	24.7	67.9	19.7	21.5	32.7	137.3	32.0	35.7	23.2	23.1	19.7	21.2	18.6	23.2	26.3	17.0	18.2	20.8	18.0	25.3	21.2	42.7	13.3	41.0	21.4	18.9	26.8	19.8	7.0	14.2	30.8	32.9	24.0	16.8	28.0	18.8	18.7	55.4	85.5	68.3	21.8	25.5	68.0	31.0	21.3	16.5	28.2	23.2	44.3	7.2	40.6	72.1	26.9	29.4	26.7	33.2	27.7	17.6	26.9	17.9	10.8	36.0	28.4	13.8	25.9	20.4	15.2	58.3	41.5	26.1	34.3	33.6	15.4	39.1	47.3	51.5	41.9	17.3	56.4	16.9	20.3	36.8	15.2	14.9	14.9	10.8	11.7	40.0	20.0	8.2	10.3	13.1	9.4	121.1	10.3	21.1	47.5	32.0	16.8	49.7	36.1	0.3	0.4	0.2	59.9	45.5	12.6	85.5	68.3	19.2	18.3	57.2	22.0	18.7	22.6	23.4	55.4	15.0	19.7	19.8	19.5	21.8	43.9	25.7	25.5	68.0	19.9	24.4	15.0	24.3	19.7	21.5	23.2	23.1	17.0	14.2
GSTP1	"FAEES3, GST3, GSTP"	ENSG00000084207	"Glutathione S-transferase pi 1"	P09211	11	67583595-67586656	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019779, HPA019869"	Enhanced		Supported	Mitochondria,Cytosol			120000000	"Mitochondria, Cytosol"		"HPA019779: AB_1849799, HPA019869: AB_1849801"	"unprognostic (9.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-3)"	"unprognostic (3.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.14e-3)"	"unprognostic (9.37e-2)"	"unprognostic (5.72e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.48e-1)"	24.2	25.3	20.2	23.8	21.7	46.2	39.5	15.5	19.8	51.8	51.9	23.5	125.4	35.2	43.5	41.9	181.6	60.8	51.1	45.3	18.3	23.5	44.2	5.9	61.0	39.4	25.5	19.9	33.4	60.7	44.1	33.8	57.9	46.0	37.0	17.9	59.9	50.2	110.8	33.7	58.5	34.0	30.1	22.8	25.1	48.5	15.4	15.4	29.8	91.6	131.5	75.6	40.8	79.5	25.3	191.4	12.4	168.2	70.1	40.7	167.2	68.1	93.0	45.3	70.5	35.1	39.6	41.9	29.8	40.0	45.6	35.5	170.8	71.7	0.1	68.4	47.1	99.7	122.4	131.2	12.9	47.5	44.5	3.3	67.7	0.0	52.1	22.4	39.9	49.1	298.4	36.3	35.1	68.3	73.9	19.0	35.6	0.2	51.3	62.5	86.7	39.9	47.9	7.6	0.2	72.5	0.2	15.4	44.0	41.8	13.6	135.0	0.2	37.7	36.8	21.0	53.4	44.0	21.6	11.8	73.8	25.0	23.9	37.1	43.6	2.3	168.2	12.4	40.7	125.7	15.0	25.3	18.4	33.3	191.4	24.3	15.3	27.3	7.0	70.1	79.4	76.2	18.3	167.2	20.2	21.7	15.5	19.8	18.3	23.5	25.5	19.9	46.0	15.4
GTF2B	TFIIB	ENSG00000137947	"General transcription factor IIB"	Q00403	1	88852932-88891944	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061626	Supported		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA061626: "	"prognostic favourable (4.81e-4)"	"unprognostic (5.21e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.74e-2)"	23.7	27.0	22.2	27.1	29.8	54.9	30.2	25.7	30.0	24.2	21.9	12.5	19.2	18.8	23.4	32.9	26.4	23.0	24.6	16.0	22.0	21.7	23.7	34.8	22.8	30.6	24.3	17.9	28.2	23.8	21.6	25.9	30.2	23.8	19.2	24.7	13.8	24.9	20.8	21.6	26.4	29.3	21.6	20.6	30.0	22.5	15.2	23.5	44.4	27.6	24.0	30.8	22.6	22.7	28.6	31.6	51.1	28.2	25.8	34.4	23.8	19.6	7.4	18.9	9.3	28.6	20.1	22.8	16.6	22.0	24.9	26.6	9.7	13.6	22.7	18.9	15.5	11.8	20.0	17.8	21.9	22.4	18.7	23.9	12.2	16.2	18.6	27.6	14.7	17.7	18.2	21.8	12.6	13.1	21.3	19.7	26.1	6.9	28.1	25.0	14.5	16.1	18.0	23.2	17.3	26.5	21.9	14.2	12.5	15.8	19.7	29.0	8.4	27.3	11.6	10.6	13.0	18.4	19.9	19.3	13.3	30.2	7.0	23.4	8.9	37.9	25.5	39.3	25.6	28.2	29.1	28.6	28.5	27.2	31.6	24.2	34.4	29.5	51.1	25.8	28.1	21.3	34.2	23.8	22.2	29.8	25.7	30.0	22.0	21.7	24.3	17.9	23.8	23.5
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009884: AB_2279381, HPA056359: , HPA066881: "	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	11.1	18.0	8.6	10.7	9.9	6.6	10.0	9.1	9.9	9.2	8.5	11.6	7.3	7.8	13.3	8.1	9.4	7.6	6.4	8.5	8.8	8.3	12.9	12.7	8.4	14.0	9.3	7.6	10.5	14.5	8.4	12.9	11.9	9.1	8.2	10.4	7.9	18.7	10.2	12.8	7.8	9.8	10.0	11.9	14.0	7.8	16.3	8.9	25.6	9.6	10.0	14.9	9.2	9.5	10.9	10.5	16.8	12.9	11.9	12.0	8.7	9.1	12.8	16.1	9.8	12.2	5.7	14.1	6.2	5.6	9.7	10.5	15.3	6.7	15.1	10.8	4.6	11.1	14.9	8.1	13.6	10.4	3.4	19.4	9.4	12.7	9.5	17.4	11.8	7.4	8.8	7.2	10.3	14.8	13.5	7.9	10.2	10.5	14.3	8.8	15.3	12.0	11.9	19.0	11.2	9.6	5.9	3.4	10.7	9.3	8.1	8.3	10.3	13.5	12.9	9.1	10.0	2.9	6.9	7.0	7.7	21.6	9.6	17.7	8.7	16.8	8.5	13.0	8.5	12.9	11.1	10.9	10.1	12.0	10.5	9.1	11.1	10.7	6.2	11.9	11.7	4.9	11.4	8.7	8.6	9.9	9.1	9.9	8.8	8.3	9.3	7.6	9.1	8.9
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: , HPA070752: "	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favourable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favourable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.0	28.1	20.4	32.5	13.8	22.4	16.1	26.8	25.2	33.5	32.0	29.4	15.1	23.3	37.7	17.5	34.7	19.2	17.0	16.4	35.4	24.4	32.2	20.9	26.1	24.0	37.4	26.2	23.5	22.8	23.9	18.2	19.7	39.4	31.6	18.5	26.5	37.1	21.3	37.0	35.8	34.3	22.7	29.7	18.6	21.9	25.1	34.5	27.7	21.3	29.5	27.0	29.8	27.8	26.3	22.2	45.3	37.7	56.1	63.0	25.1	32.7	39.2	29.4	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74657667-74760692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favourable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	10.2	14.3	12.6	10.2	14.3	4.0	11.5	13.1	15.2	11.3	8.6	15.4	6.0	9.1	10.5	9.6	9.9	12.5	10.8	8.6	12.8		13.5	10.2	10.2	8.8	18.1	9.7	12.1	8.5	29.0	12.4	9.8	12.9	12.1	6.9	12.1	11.7	10.3	13.4	10.9	7.9	11.1	8.8	7.5	12.0	4.3	16.0	21.2	22.3	6.3	11.6	10.3	7.1	16.8	14.8	10.9	6.9	14.2	13.2	5.8	30.3	25.1	52.0	51.0	28.8	25.7	10.8	19.3	17.7	21.3	21.2	17.4	37.1	36.7	7.8	23.6	26.7	51.0	23.2	27.6	27.6	26.9	18.7	29.8	24.2	17.4	35.3	28.0	23.7	19.9	16.1	16.6	28.5	36.4	17.6	25.6	28.3	29.4	31.7	55.7	15.7	32.3	18.1	30.0	28.0	52.9	43.6	55.8	35.1	52.7	17.6	27.0	23.4	25.4	29.3	15.8	14.6	24.5	20.7	18.2	58.3	16.7	21.4	29.2	5.1	6.9	10.9	8.3	5.1	13.2	14.6	11.3	12.9	10.5	16.8	13.1	12.9	2.8	14.2	4.2	14.8	5.7	5.8										
GTSE1	"B99, GTSE-1"	ENSG00000075218	"G2 and S-phase expressed 1"	Q9NYZ3	22	46296741-46330810	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 20.0;testis: 22.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029457			Approved	"Plasma membrane,Centrosome"				Centrosome	"Plasma membrane"	"HPA029457: "	"unprognostic (1.97e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.59e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (1.90e-10)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.09e-1)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.49e-3)"	"unprognostic (0.00e+0)"	"unprognostic (6.52e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-2)"	1.1	1.3	0.3	10.4	0.8	10.2	1.3	1.0	1.1	1.2	2.5	0.7	0.1	4.1	1.1	1.3	6.6	0.4	0.4	0.8	1.0	0.3	0.9	0.9	1.3	9.0	0.6	0.4	0.9	0.5	0.0	0.9	2.8	1.8	0.6	2.6	0.7	1.5	0.1	0.3	2.4	3.3	1.0	0.6	4.6	2.4	22.3	0.3	20.0	0.5	5.8	8.8	1.1	2.1	1.4	1.9	3.0	0.2	1.8	1.6	0.9	21.5	10.2	20.2	15.9	0.4	1.2	9.7	18.7	8.8	27.4	22.6	10.7	8.2	20.4	5.0	7.2	11.3	18.1	4.7	17.6	12.2	19.5	13.6	14.4	8.2	0.0	24.4	16.7	0.2	0.3	11.7	6.0	11.8	10.4	25.7	16.3	12.0	21.8	12.0	14.1	11.6	21.7	22.7	13.4	4.5	3.9	10.5	14.3	17.9	11.7	8.2	9.9	9.4	9.3	15.6	29.6	12.7	19.6	14.7	7.0	20.7	9.9	11.8	22.7	0.1	0.2	1.5	1.3	0.1	0.4	1.4	0.6	0.6	0.3	0.6	0.4	0.3	3.0	1.8	0.1	1.9	1.6	0.9	0.3	0.8	1.0	1.1	1.0	0.3	0.6	0.4	1.8	0.3
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 11.3;NB-4: 3.7;U-2197: 3.2"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"amygdala: 0.2"	HPA018215	Enhanced				"Secreted to blood"		26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 8.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 0.8;hippocampal formation: 0.5"						"Secreted to blood"		740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GUCY1A1	"GC-SA3, GUC1A3, GUCY1A3"	ENSG00000164116	"Guanylate cyclase 1 soluble subunit alpha 1"	Q02108	4	155666711-155732349	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 55.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 6.0;Karpas-707: 8.5;MOLT-4: 15.6;RPTEC TERT1: 10.7;RT4: 12.5;SH-SY5Y: 7.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.6;non-classical monocyte: 9.2;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	27	"dendritic cells: 11.6;monocytes: 9.2;NK-cells: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010887, HPA056004, HPA058617"	Uncertain		Supported	Nucleoplasm			6100	Nucleoplasm		"CAB010887: AB_259901, HPA056004: , HPA058617: "	"unprognostic (4.81e-3)"	"unprognostic (2.60e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.99e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.38e-4)"	"unprognostic (1.85e-3)"	"unprognostic (6.46e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.59e-4)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-3)"	10.9	5.3	12.4	10.2	19.9	0.9	11.1	3.4	11.6	13.7	31.2	7.3	2.8	5.6	14.7	6.0	7.0	6.8	8.3	21.0	9.0	7.2	11.6	5.1	13.2	7.3	4.7	12.5	5.4	8.5	55.2	5.8	16.3	6.3	17.2	6.9	39.7	7.0	9.8	4.5	3.6	10.1	18.8	6.6	8.5	12.9	2.1	8.5	4.5	8.1	7.3	5.9	6.4	10.6	0.1	11.6	0.3	9.2	7.6	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	6.0	0.0	0.0	0.0	4.8	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	8.5	0.0	0.0	15.6	0.0	0.0	0.2	3.5	0.0	2.6	10.7	12.5	2.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.3	0.0	2.3	0.1	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	7.6	9.2	11.6	0.0	1.0	12.4	19.9	3.4	11.6	9.0	7.2	4.7	12.5	6.3	8.5
GUCY1B1	"GC-S-beta-1, GC-SB3, GUC1B3, GUCY1B3"	ENSG00000061918	"Guanylate cyclase 1 soluble subunit beta 1"	Q02153	4	155758992-155807591	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"cGMP biosynthesis"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.8;Karpas-707: 13.1;MOLT-4: 15.6;RPTEC TERT1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 5.6;non-classical monocyte: 17.8"	"Lineage enriched"	"Detected in many"	12	"monocytes: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010890, HPA020870"	Approved		Approved	Cytosol			5200	Cytosol		"CAB010890: AB_259911, HPA020870: AB_1850444"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.55e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.69e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.84e-1)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (7.35e-3)"	"prognostic unfavourable (3.23e-4)"	"unprognostic (2.14e-1)"	"unprognostic (6.36e-3)"	8.8	5.4	18.7	9.8	42.0	1.8	5.5	12.2	36.8	8.1	14.9	5.7	0.4	4.2	11.3	4.7	5.9	9.5	9.2	12.2	16.1	25.0	9.2	5.4	9.4	6.6	14.5	23.2	3.7	7.4	71.6	3.8	28.0	20.6	9.8	6.2	5.8	3.2	8.7	3.8	2.2	5.9	16.3	6.7	7.2	8.9	2.1	5.5	2.6	4.6	2.4	5.1	8.0	6.8	0.2	1.4	1.1	17.8	0.9	0.0	4.8	0.0	0.2	3.5	0.0	1.2	6.6	0.0	1.1	1.9	0.1	0.0	0.0	0.0	0.0	1.7	0.6	0.0	7.3	0.1	0.4	0.0	2.6	24.8	0.0	0.0	0.7	0.0	0.0	2.9	0.2	0.0	0.1	0.0	0.0	13.1	1.7	1.1	15.6	0.0	0.2	1.8	1.8	0.5	0.4	25.2	2.3	0.4	4.4	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.9	7.1	5.2	0.1	0.0	0.0	9.0	0.0	0.0	1.1	0.4	0.3	0.0	5.6	0.0	0.1	0.0	0.0	1.4	0.2	0.0	0.0	0.4	0.9	17.8	1.2	0.0	4.8	18.7	42.0	12.2	36.8	16.1	25.0	14.5	23.2	20.6	5.5
GUCY2F	"CYGF, GC-F, GUC2DL, RetGC-2, ROS-GC2"	ENSG00000101890	"Guanylate cyclase 2F, retinal"	P51841	X	109372906-109482072	"Enzymes, Plasma proteins, Predicted membrane proteins"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"retina: 23.1"	"Group enriched"	"Detected in some"	5	"THP-1: 4.4;U-266/70: 1.6;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	"unprognostic (1.91e-1)"	"unprognostic (4.45e-2)"									"unprognostic (2.96e-1)"	"unprognostic (2.23e-1)"			0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
GULP1	"CED-6, CED6, GULP"	ENSG00000144366	"GULP, engulfment adaptor PTB domain containing 1"	Q9UBP9	2	188291669-188595931	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Lipid transport, Phagocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 86.0"	"Cell line enhanced"	"Detected in many"		"AF22: 32.1;SH-SY5Y: 24.2;WM-115: 69.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA020587	Enhanced		Approved	Vesicles				Vesicles		"HPA020587: AB_1850452"	"unprognostic (1.95e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.23e-1)"	"prognostic favourable (4.25e-6)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.04e-4)"	8.0	15.0	3.1	7.6	9.8	0.0	9.7	0.7	8.0	22.6	11.8	2.2	14.4	6.5	23.3	40.6	11.5	10.4	8.9	5.1	2.5	4.8	11.4	1.0	9.0	1.2	2.4	4.5	17.9	32.3	23.9	3.7	86.0	14.3	14.3	3.8	19.4	10.7	16.1	5.9	5.0	10.5	15.1	2.8	3.2	11.9	17.0	2.2	0.3	8.0	6.1	3.1	11.3	20.2	0.6	0.4	1.5	1.9	0.6	0.2	0.3	3.7	9.3	32.1	7.1	5.0	4.9	6.0	5.2	8.8	8.5	6.9	5.8	18.5	0.0	3.9	4.2	2.5	6.4	0.4	6.2	0.0	4.3	7.9	6.9	0.0	4.6	0.0	0.0	3.0	1.1	4.0	4.3	3.9	6.6	0.1	5.8	0.5	0.0	0.1	8.1	14.4	0.0	7.6	3.8	17.0	1.6	0.1	24.2	0.0	4.3	11.1	1.4	0.0	1.9	2.6	1.2	8.6	2.9	0.0	0.0	0.0	1.4	0.0	69.9	1.3	1.9	0.4	0.2	1.1	0.1	0.3	0.1	0.1	0.4	0.6	0.2	0.2	1.5	0.6	0.7	0.2	0.1	0.3	3.1	9.8	0.7	8.0	2.5	4.8	2.4	4.5	14.3	2.2
GUSB		ENSG00000169919	"Glucuronidase beta"	P08236	7	65960684-65982314	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036322, HPA036323"	Approved		Supported	Vesicles	"Intracellular and membrane"		48000	Vesicles		"HPA036322: AB_10670796, HPA036323: "	"unprognostic (1.54e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.98e-1)"	"unprognostic (5.06e-1)"	"unprognostic (1.45e-1)"	23.5	12.0	3.7	7.9	5.5	20.7	25.4	5.7	4.4	10.4	14.6	7.7	22.0	10.0	10.4	12.2	9.3	7.6	11.1	8.0	3.7	2.9	11.8	50.4	15.3	12.3	6.3	3.1	8.6	17.1	9.0	7.3	30.0	4.5	12.1	11.4	9.9	17.2	11.8	5.9	10.0	16.1	8.3	3.9	17.5	11.0	7.9	5.8	14.7	17.7	5.9	13.0	9.2	7.4	9.7	27.7	22.1	36.0	15.2	11.5	15.8	16.8	6.5	6.4	14.3	21.9	13.1	9.3	5.3	14.9	11.8	10.9	9.3	17.4	7.7	8.4	6.8	6.9	4.1	6.4	7.0	7.2	8.4	10.5	9.8	6.4	10.7	22.4	17.5	9.0	6.9	6.8	8.9	10.2	15.9	55.9	7.6	12.2	8.2	24.1	4.3	5.5	8.5	14.8	43.7	7.4	10.2	9.4	8.3	14.3	33.6	18.7	18.7	22.4	7.2	14.4	13.1	5.4	13.3	31.8	38.1	13.0	10.8	29.9	17.5	7.4	28.1	22.1	11.5	36.0	10.3	9.7	9.0	10.2	27.7	7.8	6.2	7.3	4.5	15.2	30.0	11.3	11.3	15.8	3.7	5.5	5.7	4.4	3.7	2.9	6.3	3.1	4.5	5.8
GYS1	"GSY, GYS"	ENSG00000104812	"Glycogen synthase 1"	P13807	19	48968125-48993310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycogen biosynthesis"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 106.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007793, HPA041598"	Enhanced		Approved	Microtubules,Cytosol			10000	"Microtubules, Cytosol"		"CAB007793: AB_562291, HPA041598: "	"unprognostic (3.37e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (6.83e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (4.04e-2)"	"unprognostic (6.76e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.81e-2)"	9.7	7.3	5.1	6.1	6.5	16.0	10.6	11.3	6.2	5.3	7.3	6.2	5.8	6.1	6.2	6.9	11.5	5.9	6.1	37.3	6.8	4.0	7.2	4.3	5.0	6.3	5.3	5.5	6.8	4.4	6.4	5.1	5.0	5.9	8.7	6.1	12.4	7.2	7.6	106.1	8.1	6.1	6.8	6.0	5.8	7.3	2.2	5.5	6.4	5.2	42.6	9.0	7.9	6.9	6.7	15.9	8.2	10.5	12.8	10.9	7.3	28.3	11.3	8.4	11.5	19.6	7.7	16.7	19.7	13.9	20.8	24.4	11.0	9.3	11.8	12.0	19.2	20.3	14.0	25.0	18.2	7.3	20.3	9.8	14.5	9.7	11.0	10.7	7.3	19.0	12.0	13.4	11.4	17.4	6.8	15.9	26.0	10.8	13.2	9.3	4.5	13.1	11.2	14.7	11.6	20.6	30.4	5.2	7.3	17.5	22.9	4.6	12.1	11.1	13.4	25.6	9.9	11.5	21.3	13.2	13.6	5.8	26.1	9.4	5.7	8.2	10.5	7.5	8.8	6.3	10.9	6.7	7.6	8.2	15.9	5.5	6.3	5.6	4.4	12.8	8.5	8.6	10.1	7.3	5.1	6.5	11.3	6.2	6.8	4.0	5.3	5.5	5.9	5.5
GZMB	"CCPI, CGL-1, CGL1, CSP-B, CSPB, CTLA1, CTSGL1, HLP, SECT"	ENSG00000100453	"Granzyme B"	P10144	14	24630954-24634267	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"blood: 298.5"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 298.5"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 298.5"									"CAB000376, HPA003418"	Enhanced				"Secreted to blood"					"CAB000376: AB_323716, HPA003418: AB_1079020"	"prognostic favourable (7.27e-4)"	"unprognostic (2.82e-3)"	"unprognostic (8.54e-2)"	"prognostic favourable (1.58e-5)"	"unprognostic (2.07e-3)"	"unprognostic (1.48e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (1.10e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-3)"	6.4	0.7	0.8	8.0	1.1	26.4	3.2	0.7	0.7	1.6	3.0	0.5	1.3	0.8	3.9	1.5	4.0	1.0	3.1	4.8	0.7	2.4	2.1	5.7	21.7	16.7	1.1	0.0	1.4	0.7	0.0	1.0	7.5	0.8	2.6	0.9	4.0	2.7	2.3	3.5	0.6	2.9	1.8	1.5	33.0	3.5	0.9	0.4	6.1	4.4	5.3	16.8	6.0	1.5	0.2	298.5	2.0	0.2	19.9	60.5	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	2.9	0.3	0.1	0.2	60.5	0.1	0.7	0.2	4.6	28.4	0.2	0.1	1.4	28.7	2.0	19.9	0.2	298.5	0.1	53.6	0.8	1.1	0.7	0.7	0.7	2.4	1.1	0.0	0.8	0.4
GZMM	"LMET1, MET1"	ENSG00000197540	"Granzyme M"	P51124	19	544034-549924	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Cytolysis, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 79.2;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.2;HDLM-2: 4.2;HMC-1: 5.3;MOLT-4: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 79.2"	"Group enriched"	"Detected in many"	31	"NK-cells: 22.7;T-cells: 79.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015624	Enhanced				"Secreted to blood"					"HPA015624: "	"unprognostic (2.97e-3)"	"unprognostic (2.29e-3)"	"unprognostic (7.53e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (1.07e-1)"	"prognostic favourable (1.87e-7)"	"unprognostic (2.35e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (7.94e-2)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (1.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.94e-2)"	1.8	1.0	0.7	13.6	0.9	15.6	1.0	4.3	1.4	1.0	3.5	0.2	0.1	1.8	1.0	2.9	2.0	1.1	4.7	1.6	0.7	0.6	1.1	2.6	4.8	15.1	0.7	0.4	0.8	0.4	0.0	0.9	1.6	0.5	1.7	0.1	1.5	12.0	0.3	0.8	0.7	5.1	0.5	1.1	21.1	3.0	1.5	0.4	28.6	1.4	1.1	10.9	1.1	1.2	0.4	0.4	1.6	0.2	22.7	79.2	27.0	0.1	0.7	0.1	0.3	0.2	0.0	0.7	0.0	0.1	0.1	0.0	0.6	0.2	0.1	5.2	0.0	0.1	0.0	0.0	0.0	4.2	0.4	0.0	0.6	0.2	0.6	0.4	5.3	0.2	0.0	0.1	0.0	0.1	1.6	0.3	0.0	1.2	3.4	1.4	0.9	0.8	0.3	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.8	0.9	0.0	1.1	0.4	1.1	0.3	0.8	0.3	0.8	0.1	0.1	79.2	0.2	49.8	0.1	26.4	63.6	0.1	0.4	25.8	53.1	1.6	22.7	0.2	0.4	12.2	27.0	0.7	0.9	4.3	1.4	0.7	0.6	0.7	0.4	0.5	0.4
H1F0	"H10, H1FV"	ENSG00000189060	"H1 histone family member 0"	P07305	22	37805093-37807436	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 158.1"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000843	Supported		Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Actin filaments"				"Nucleoplasm, Nuclear bodies"	"Golgi apparatus, Actin filaments"	"HPA000843: AB_1079062"	"unprognostic (1.29e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.85e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (5.95e-3)"	"unprognostic (4.86e-3)"	"prognostic favourable (7.68e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.73e-1)"	21.7	13.6	27.5	14.7	24.9	158.1	32.3	35.7	41.7	48.2	37.9	20.4	11.3	35.8	42.7	18.5	66.0	31.7	38.5	30.3	23.5	17.6	33.2	90.6	22.8	15.0	16.0	23.8	48.5	43.5	20.2	25.6	33.6	23.5	43.7	34.0	28.3	43.2	12.4	53.5	53.2	59.2	28.0	18.6	16.3	34.6	15.2	18.8	56.3	36.1	33.4	32.0	24.9	45.2	0.1	6.3	12.5	9.0	0.1	2.4	4.7	20.7	9.0	28.0	12.4	7.4	6.8	39.8	16.9	35.3	49.5	70.7	36.6	33.1	0.0	4.2	14.0	40.6	0.0	11.6	35.3	0.1	2.0	35.1	3.3	24.4	25.9	0.0	0.1	6.3	20.8	24.8	28.0	13.1	0.0	0.0	3.8	34.3	5.8	3.4	10.8	44.5	9.7	16.7	7.1	7.8	5.6	6.4	36.1	46.6	31.8	61.5	24.8	21.9	8.7	3.7	113.0	16.6	3.4	0.0	2.3	0.1	4.6	12.6	10.7	12.5	7.6	11.3	0.1	9.0	0.1	0.0	0.8	0.2	6.3	0.1	2.4	0.3	4.2	0.1	7.7	5.7	0.2	4.7	27.5	24.9	35.7	41.7	23.5	17.6	16.0	23.8	23.5	18.8
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell line enhanced"	"Detected in all"		"U-266/70: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099"	Supported		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB012235: , HPA040099: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.6	10.4	19.8	8.5	2.0	2.4	18.8	8.6	6.3	10.3	10.9	6.2	10.8	2.5	9.6	3.0	19.8	8.3	5.5	1.6	18.0	16.1	7.5	8.1	8.5	8.5	8.6	2.0	4.8	7.6	4.1	9.5	5.9	11.5	44.8	1.4	20.6	40.1	17.2	18.5	11.8	28.9	8.4	23.4	3.1	4.1	31.6	36.6	9.1	4.6	26.2	17.9	17.6	5.8	8.0	41.9	7.8	7.2	137.4	52.5	21.2	6.5	8.2	8.7	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3
H2AFJ	"FLJ10903, MGC921"	ENSG00000246705	"H2A histone family member J"	Q9BTM1	12	14774383-14778002	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 148.5"	"Cell line enhanced"	"Detected in many"		"A549: 51.1;MCF7: 66.0;RT4: 47.4"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 151.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported									"HPA041189: "	"unprognostic (9.38e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.92e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.66e-3)"	"unprognostic (5.22e-3)"	"unprognostic (3.87e-3)"	37.8	27.6	3.6	15.0	11.6	14.6	36.7	2.2	5.2	19.1	27.3	9.9	21.7	16.0	15.4	26.7	29.9	13.9	34.0	24.8	4.3	3.8	22.2	16.7	22.7	16.9	9.0	5.1	12.7	47.7	4.8	5.0	25.5	6.8	49.2	8.6	18.2	67.6	25.7	20.4	26.8	18.7	18.6	11.8	15.7	17.8	148.5	5.8	14.4	19.3	25.3	17.4	26.5	29.3	7.2	39.1	23.8	44.5	19.8	25.1	24.2	20.9	51.1	2.0	0.0	23.3	15.5	33.3	15.7	8.8	6.4	6.2	10.0	34.5	0.0	10.0	7.6	20.1	1.2	11.9	1.7	1.1	0.9	0.8	18.1	8.4	33.5	0.0	7.9	20.2	13.1	8.8	8.2	12.7	0.0	0.0	3.1	66.0	0.1	5.6	3.2	11.7	8.2	0.0	4.0	10.1	47.4	0.6	0.2	19.9	24.7	0.0	37.7	6.4	12.5	0.0	6.1	9.3	3.0	5.1	7.4	0.0	1.7	0.0	5.1	23.8	44.5	9.3	18.0	24.5	16.3	5.8	17.8	13.4	39.1	7.2	12.7	13.7	15.4	19.8	21.4	19.4	25.1	24.2	3.6	11.6	2.2	5.2	4.3	3.8	9.0	5.1	6.8	5.8
H2AFX	H2AX	ENSG00000188486	"H2A histone family member X"	P16104	11	119093854-119095467	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 135.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB012264, HPA041189, HPA051647"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"CAB012264: AB_297215, HPA041189: , HPA051647: "	"unprognostic (1.44e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (2.32e-3)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.31e-2)"	"prognostic unfavourable (5.47e-9)"	"unprognostic (1.21e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-2)"	5.9	10.1	10.7	17.9	9.4	24.0	4.2	9.4	13.9	5.0	12.0	15.2	2.5	15.4	5.7	2.8	9.8	5.5	4.0	4.7	10.6	10.1	6.4	5.0	7.1	17.0	13.3	5.3	8.0	9.2	3.8	8.1	12.8	9.3	6.4	5.4	6.3	5.8	6.3	7.2	10.8	13.7	4.2	13.6	11.1	12.6	28.3	9.5	135.1	5.9	11.3	23.2	4.8	6.6	2.0	3.4	7.4	2.4	3.8	3.4	1.8	26.1	15.8	25.0	14.9	2.3	1.7	26.4	29.8	9.1	16.8	14.8	25.0	11.3	18.0	18.0	6.8	27.2	11.8	8.5	4.5	26.5	33.1	36.4	4.3	25.7	2.4	17.9	22.7	1.4	1.8	7.1	4.4	8.4	29.4	29.6	8.0	66.7	40.9	53.6	18.2	33.5	40.0	29.5	8.4	7.6	11.4	26.7	31.7	23.6	13.8	4.1	20.6	13.6	10.3	16.3	43.1	13.2	22.1	8.1	7.9	18.2	3.7	29.2	31.8	7.0	2.4	7.4	3.4	1.1	1.8	2.0	3.4	3.4	3.4	1.8	2.3	2.0	1.2	3.8	1.5	1.5	2.8	1.8	10.7	9.4	9.4	13.9	10.6	10.1	13.3	5.3	9.3	9.5
H2AFY	macroH2A1.2	ENSG00000113648	"H2A histone family member Y"	O75367	5	135333900-135399914	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041189, HPA050962"	Supported		Supported	Nucleoplasm			4700000	Nucleoplasm		"HPA041189: , HPA050962: "	"unprognostic (1.05e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (3.17e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.53e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.89e-3)"	"unprognostic (8.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	34.9	26.0	24.8	32.2	27.2	75.1	21.7	37.6	27.6	22.5	40.0	19.7	14.0	40.2	22.0	21.8	60.7	22.4	38.8	41.9	21.4	28.8	23.8	24.1	36.7	39.4	24.1	26.5	21.8	16.6	24.2	25.8	30.0	21.0	20.2	43.2	24.4	28.3	14.0	34.9	33.4	52.0	21.9	21.8	33.8	28.5	21.4	16.9	76.9	22.2	40.7	47.2	28.7	29.6	16.0	51.8	23.8	45.6	21.5	15.9	30.1	44.8	31.7	48.9	33.5	23.0	13.7	44.0	18.9	20.4	33.6	23.9	49.9	45.2	53.4	32.3	15.3	30.7	36.6	80.1	25.3	28.8	36.5	63.6	37.4	33.5	16.8	30.2	28.0	14.5	21.7	28.0	30.2	21.5	22.1	22.0	19.1	39.3	86.8	57.6	19.1	17.0	78.6	27.8	37.7	41.7	51.3	68.9	43.4	36.8	35.9	30.3	42.5	83.7	17.4	29.6	24.9	21.7	38.5	10.6	42.8	50.0	24.6	68.2	20.7	4.1	45.6	20.5	10.8	30.1	9.1	11.7	14.0	13.4	51.8	16.0	13.6	11.2	23.8	21.5	19.0	37.3	15.9	30.1	24.8	27.2	37.6	27.6	21.4	28.8	24.1	26.5	21.0	16.9
H2AFZ	"H2A.Z, H2AZ"	ENSG00000164032	"H2A histone family member Z"	P0C0S5	4	99948086-99950388	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022549, HPA057236"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022549: , HPA057236: "	"unprognostic (1.21e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.03e-3)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.74e-3)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (2.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (4.99e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (3.02e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.52e-1)"	23.5	22.5	28.9	40.7	40.4	113.9	31.1	39.5	38.0	26.3	45.0	13.9	26.9	33.2	40.4	23.1	53.5	24.0	27.9	32.1	28.6	28.1	37.1	26.9	32.4	70.6	32.9	26.2	32.6	19.8	14.5	30.3	32.0	26.1	30.2	43.2	29.5	29.4	27.2	28.3	30.1	34.0	46.2	26.7	46.1	37.4	32.2	31.3	139.8	29.7	47.9	81.0	51.6	29.9	46.7	54.1	139.3	87.0	41.3	80.9	120.4	86.1	60.7	126.6	65.2	26.1	22.1	41.7	91.5	66.0	94.6	89.1	62.3	100.8	153.4	33.3	46.5	31.4	110.6	89.2	102.7	67.3	77.0	78.6	71.8	70.6	15.8	140.0	66.3	17.4	39.1	72.8	40.9	93.2	77.3	93.5	107.9	119.7	115.9	116.5	73.1	58.2	100.1	92.7	64.1	52.6	52.4	82.6	63.7	56.5	108.0	105.5	55.1	108.4	48.7	61.1	116.5	41.7	116.8	54.0	79.9	183.1	68.4	93.7	95.6	61.8	63.2	120.2	38.1	68.7	42.2	46.7	60.5	49.8	54.1	39.3	56.9	47.2	139.3	41.3	87.0	36.1	80.9	120.4	28.9	40.4	39.5	38.0	28.6	28.1	32.9	26.2	26.1	31.3
H6PD	GDH	ENSG00000049239	"Hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase"	O95479	1	9234775-9271337	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Hydrolase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 116.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.8;HSkMC: 32.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004824, HPA005440"	Approved		Uncertain	Cytosol	"Intracellular and membrane"		91000000	Cytosol		"HPA004824: AB_1079037, HPA005440: AB_1079036"	"unprognostic (4.83e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.73e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.16e-2)"	"unprognostic (7.35e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.95e-1)"	18.3	16.1	4.1	10.7	5.5	4.8	12.2	4.1	6.3	16.6	11.9	10.5	8.2	6.3	22.0	18.0	11.1	15.6	11.9	11.9	3.7	3.0	7.0	116.9	12.2	11.1	6.8	2.6	38.3	10.6	8.0	8.7	14.9	6.0	11.6	5.3	11.8	29.8	8.1	24.7	20.7	10.4	10.2	6.6	10.7	9.9	12.4	5.5	16.2	12.6	12.9	14.1	12.2	10.1	4.5	3.7	4.1	6.3	3.1	4.7	3.0	3.8	3.1	2.7	10.2	28.6	32.8	2.6	3.9	9.6	2.9	4.5	0.6	7.9	4.2	4.5	6.0	4.0	0.7	1.9	4.2	12.6	0.9	0.0	1.0	2.6	16.0	1.3	1.6	32.2	3.7	6.9	4.5	13.1	1.1	7.3	5.6	2.2	1.5	3.2	1.5	1.8	0.4	0.3	3.5	3.7	1.6	0.9	4.9	5.1	4.0	4.8	3.0	6.8	13.0	9.9	1.6	2.5	1.0	9.8	2.9	1.0	16.6	6.1	6.2	3.5	6.2	0.9	4.7	6.3	3.7	3.5	3.5	4.1	2.8	4.5	3.4	3.2	4.1	3.1	5.8	3.7	2.8	3.0	4.1	5.5	4.1	6.3	3.7	3.0	6.8	2.6	6.0	5.5
HAAO		ENSG00000162882	"3-hydroxyanthranilate 3,4-dioxygenase"	P46952	2	42767089-42792593	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 78.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;Hep G2: 31.1;REH: 6.5;THP-1: 5.9"	"Group enriched"	"Detected in all"	5	"liver cancer: 46.5;renal cancer: 13.9"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 15.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 15.7;granulocytes: 12.6;monocytes: 11.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036394, HPA042024"	Enhanced						150000			"HPA036394: AB_10673131, HPA042024: AB_2677803"	"unprognostic (6.97e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.23e-3)"	"prognostic favourable (5.77e-4)"	"unprognostic (6.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.03e-1)"	2.9	1.8	1.6	6.8	1.2	0.7	3.5	0.4	1.1	5.8	11.9	1.9	3.5	5.8	3.6	6.2	2.7	3.2	2.7	2.2	0.9	0.8	10.9	78.7	1.8	2.1	1.4	1.6	5.0	8.6	1.7	1.6	3.8	1.4	6.5	2.9	12.1	1.4	3.1	0.9	1.6	24.5	6.5	1.5	1.8	2.4	1.7	0.9	1.6	2.0	1.3	1.9	4.3	3.2	2.8	15.7	12.6	11.8	0.5	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	3.0	8.8	0.1	0.0	0.1	0.3	0.0	3.1	0.0	0.5	0.0	1.0	3.5	0.0	31.1	0.3	1.2	0.1	1.5	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	1.8	0.0	6.5	0.7	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.7	11.8	12.6	0.0	7.0	0.0	2.2	0.0	0.0	15.7	2.8	0.0	0.0	3.7	0.5	1.8	5.1	0.0	3.5	1.6	1.2	0.4	1.1	0.9	0.8	1.4	1.6	1.4	0.9
HABP2	"FSAP, HABP, HGFAL, PHBP"	ENSG00000148702	"Hyaluronan binding protein 2"	Q14520	10	113550837-113589602	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 135.4"	"Cell line enriched"	"Detected in some"	6	"RPTEC TERT1: 33.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 92.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019518	Uncertain				"Secreted to blood"	20206666667	3200000000			"HPA019518: AB_1850467"	"unprognostic (3.89e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.78e-2)"	"unprognostic (5.10e-2)"	"unprognostic (4.77e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.05e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.6	0.6	0.3	0.0	0.4	26.4	0.4	0.0	0.0	20.9	135.4	0.2	0.0	0.0	0.0	0.8	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria			2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: "	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.3	20.8	13.7	22.4	54.5	34.1	11.7	18.3	19.8	18.9	16.4	26.3	22.7	15.4	12.0	32.1	14.9	24.0	35.5	17.1	34.5	29.4	23.1	22.1	43.8	18.8	29.1	17.0	34.8	23.3	26.8	26.9	31.6	31.4	31.3	24.3	28.6	12.7	32.6	11.7	40.2	11.7	29.6	33.1	21.6	28.2	9.7	19.3	21.5	22.4	24.8	11.9	28.2	28.9	11.0	16.3	16.4	13.4	10.3	20.3	27.4	17.1	34.5	13.2	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0
HAGH	"GLO2, GLXII, HAGH1"	ENSG00000063854	"Hydroxyacylglutathione hydrolase"	Q16775	16	1795620-1827194	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 91.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043041, HPA061143"	Approved						3000000			"HPA043041: , HPA061143: "	"unprognostic (3.11e-1)"	"prognostic favourable (5.82e-5)"	"unprognostic (2.54e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (5.33e-6)"	"unprognostic (5.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (7.69e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.81e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.24e-2)"	"unprognostic (7.18e-3)"	"prognostic favourable (5.19e-4)"	14.8	36.9	24.9	7.8	26.7	26.2	16.4	26.8	35.3	9.7	12.9	13.6	19.6	17.6	6.8	13.0	11.7	11.8	9.9	50.9	28.0	24.5	38.8	91.4	14.5	8.5	23.2	24.5	6.3	24.6	17.1	19.7	9.2	18.5	12.4	9.5	11.9	12.5	16.2	67.1	11.0	17.1	11.7	20.7	10.1	13.1	33.8	13.7	7.4	14.1	18.3	7.2	9.7	18.2	13.7	28.9	27.7	36.5	10.9	18.3	12.5	11.4	17.4	15.8	17.8	13.8	5.5	14.2	14.4	13.4	22.3	18.0	8.9	10.0	2.4	29.7	12.3	12.6	14.9	14.4	6.7	23.8	24.0	4.4	17.8	25.5	19.9	5.8	24.2	6.7	31.1	11.1	7.6	19.1	5.8	21.6	7.0	18.9	14.9	12.5	6.0	16.1	12.6	9.9	27.0	28.6	5.2	21.2	18.3	15.8	20.3	31.0	14.9	19.4	14.5	6.8	8.4	14.2	16.5	24.5	23.1	7.1	11.6	5.4	10.8	14.4	15.3	27.7	12.6	25.8	9.2	13.7	16.2	12.9	13.7	12.4	15.8	13.2	13.5	10.9	36.5	28.9	18.3	12.5	24.9	26.7	26.8	35.3	28.0	24.5	23.2	24.5	18.5	13.7
HAL	HIS	ENSG00000084110	"Histidine ammonia-lyase"	P42357	12	95972662-95996365	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 29.5;liver: 96.8;skin 1: 26.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;NB-4: 3.9;THP-1: 15.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 23.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"basophil: 20.1;neutrophil: 29.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 29.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038547, HPA038548"	Enhanced		Approved	Cytosol			67000	Cytosol		"HPA038547: AB_10669541, HPA038548: AB_10673175"	"unprognostic (3.39e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.74e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.87e-2)"	0.5	0.0	0.1	1.1	0.3	4.4	0.9	0.1	0.3	0.3	0.2	0.1	0.1	0.1	1.1	0.3	0.5	0.2	0.3	0.2	0.1	0.0	0.2	96.8	1.7	2.3	0.5	0.1	0.3	0.5	0.0	7.4	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.2	26.9	0.2	0.2	0.3	2.7	0.1	0.2	0.2	0.1	0.2	0.9	1.3	0.2	0.5	0.0	1.4	29.5	6.3	0.3	0.1	1.6	0.5	0.0	0.2	0.1	0.0	0.0	3.1	0.0	0.2	0.1	0.2	0.0	0.1	0.9	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.5	0.4	0.2	0.0	0.0	0.6	0.6	0.0	0.9	0.4	0.4	0.3	0.0	0.2	0.1	0.0	0.2	3.9	1.3	0.6	0.2	0.1	0.1	0.1	0.8	0.2	0.4	0.4	0.1	0.0	0.0	15.1	0.2	0.1	0.2	0.2	0.2	0.6	0.7	0.2	0.0	2.4	0.0	20.1	6.3	0.9	0.0	2.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	29.5	0.3	5.1	0.1	0.1	1.6	0.1	0.3	0.1	0.3	0.1	0.0	0.5	0.1	0.2	0.2
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol			52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.5	30.0	18.1	39.5	23.1	25.1	19.1	33.1	23.9	38.3	35.9	54.7	17.4	27.4	29.2	37.1	21.6	27.5	53.3	36.1	23.2	34.0	19.7	39.0	34.6	28.7	30.9	16.9	26.6	16.7	41.7	23.8	38.4	17.2	22.7	39.8	35.3	22.0	28.8	14.2	19.8	20.3	26.3	22.3	30.8	26.2	28.5	27.5	27.4	40.0	26.1	29.5	17.4	32.0	36.0	13.8	20.2	44.6	22.9	27.2	27.7	27.3	26.0	24.5	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5
HAUS7	"UCHL5IP, UIP1"	ENSG00000213397	"HAUS augmin like complex subunit 7"	Q99871	X	153447666-153495516	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003614			Approved	"Nucleoli,Plasma membrane,Centrosome,Cytosol"				"Plasma membrane, Centrosome, Cytosol"	Nucleoli	"HPA003614: AB_1080368"	"unprognostic (2.06e-1)"	"prognostic favourable (6.12e-4)"	"unprognostic (3.81e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.84e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.65e-3)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.09e-2)"	13.1	9.4	16.1	10.3	16.4	9.4	7.9	9.1	19.3	12.7	9.3	8.9	20.3	7.9	10.8	17.1	7.0	9.9	15.1	11.9	20.3	9.1	13.3	11.9	9.4	12.1	12.0	16.5	9.3	4.3	3.1	6.4	12.6	11.1	11.8	6.2	7.8	8.5	17.4	7.2	46.9	7.4	12.1	8.9	16.4	8.8	6.1	18.4	14.2	10.8	8.8	9.8	7.5	11.8	20.2	22.3	10.1	31.1	16.7	18.5	15.8	13.7	22.2	9.8	19.1	3.5	4.8	13.7	9.5	5.4	11.0	19.7	16.1	7.7	13.2	30.7	6.5	11.7	14.1	9.6	8.6	15.8	23.2	9.6	20.6	12.0	3.1	15.8	13.9	7.3	2.5	9.8	6.2	7.8	12.0	6.8	6.5	26.5	14.8	19.1	6.1	22.2	13.9	16.2	19.9	3.5	8.7	10.9	8.3	5.2	11.3	3.9	4.5	7.6	5.0	9.5	19.0	22.2	17.4	9.9	26.2	51.5	5.1	28.4	13.1	4.7	26.2	10.1	17.0	31.1	17.8	20.2	18.5	17.1	22.3	16.6	18.4	16.7	3.4	16.7	27.1	12.6	15.5	15.8	16.1	16.4	9.1	19.3	20.3	9.1	12.0	16.5	11.1	18.4
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 1020.7"	"Group enriched"	"Detected in some"	37	"HEL: 243.0;K-562: 171.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 11.7;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 11.7"									"CAB032534, HPA043780"	Enhanced						17000000000			"CAB032534: AB_2294993, HPA043780: "	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	12.6	8.8	7.1	5.0	6.6	1020.7	5.0	7.9	10.0	2.2	3.2	3.0	2.2	1.3	2.2	4.1	2.8	4.8	4.0	16.9	5.2	5.1	20.6	15.7	30.3	8.1	10.1	5.8	4.9	2.2	0.9	7.5	104.1	3.3	4.8	1.4	4.5	6.7	3.3	9.4	1.9	2.2	5.1	7.9	101.4	1.6	6.7	2.2	2.2	9.3	2.2	2.2	3.4	9.4	0.6	7.4	11.7	0.5	0.9	2.1	186.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	243.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	3.3	1.9	0.0	0.0	0.6	0.2	0.7	0.7	0.4	0.7	2.1	11.7	0.9	0.0	7.4	0.0	186.1	7.1	6.6	7.9	10.0	5.2	5.1	10.1	5.8	3.3	2.2
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 427.1;bone marrow: 1094.2"	"Group enriched"	"Detected in some"	18	"HEL: 157.4;K-562: 42.2"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 15.7;granulocytes: 33.6"									"CAB038417, HPA043780"	Enhanced						17000000000			"CAB038417: , HPA043780: "	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	15.4	11.8	7.2	6.9	7.3	1094.2	7.6	4.1	4.1	4.1	4.1	4.1	4.1	1.1	4.1	4.1	4.1	7.7	5.8	19.5	5.8	6.2	24.3	17.7	38.4	4.1	11.2	4.1	4.1	4.1	0.5	8.9	128.7	4.1	4.1	1.3	4.1	9.2	5.6	17.7	0.9	4.1	4.1	9.3	98.3	1.9	4.1	4.1	4.1	12.5	4.1	4.1	4.1	20.1	1.4	15.7	33.6	0.9	1.5	3.0	427.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.1	1.6	1.3	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	9.8	3.0	0.0	0.1	1.4	0.3	0.2	1.4	0.8	0.8	2.6	33.6	1.5	0.0	15.7	0.0	427.1	7.2	7.3	4.1	4.1	5.8	6.2	11.2	4.1	4.1	4.1
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"bone marrow: 3646.7"	"Cell line enhanced"	"Detected in some"		"HEL: 5.4;SCLC-21H: 4.7;SH-SY5Y: 5.9;U-266/70: 21.8;U-266/84: 3.6"	"Cancer enhanced"	"Detected in all"		"glioma: 244.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"neutrophil: 19.3;plasmacytoid DC: 9.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 9.9;granulocytes: 19.3"									"CAB009526, HPA043234"	Enhanced						15000000000			"CAB009526: AB_2143058, HPA043234: "	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	32.7	20.0	20.9	10.1	21.0	3646.7	43.4	6.5	10.7	9.2	11.3	7.2	3.4	3.2	7.3	11.1	36.6	28.4	30.4	38.9	17.9	17.4	45.0	37.6	305.8	7.0	31.6	10.8	82.6	28.4	2.9	18.6	236.8	23.7	23.1	7.5	32.0	17.4	12.8	29.5	3.8	3.9	12.0	26.5	216.8	4.0	9.3	3.8	5.6	46.4	20.2	7.6	124.5	256.7	0.6	9.9	19.3	0.6	1.2	1.1	523.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.1	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.3	0.3	0.0	0.0	4.7	5.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	21.8	3.6	0.0	0.0	0.0	0.0	2.2	0.6	1.9	0.9	0.0	0.1	0.6	0.2	0.0	0.9	0.4	0.4	1.1	19.3	1.2	0.1	9.9	0.0	523.2	20.9	21.0	6.5	10.7	17.9	17.4	31.6	10.8	23.7	3.8
HBD		ENSG00000223609	"Hemoglobin subunit delta"	P02042	11	5232678-5243657	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"bone marrow: 233.7"	"Group enriched"	"Detected in some"	5	"HEL: 30.6;U-266/70: 41.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB037087, HPA043234"	Supported						11000000000			"CAB037087: AB_260051, HPA043234: "	"unprognostic (1.32e-2)"		"unprognostic (4.87e-2)"		"unprognostic (4.14e-2)"	"unprognostic (2.26e-3)"		"unprognostic (1.52e-1)"		"unprognostic (3.56e-2)"	"unprognostic (1.04e-1)"		"unprognostic (8.67e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.17e-1)"	1.6	0.2	0.4	0.3	0.6	233.7	0.8	0.1	0.5	0.2	0.2	1.5	0.0	0.2	0.4	0.2	0.9	0.5	0.2	4.3	1.3	0.4	1.4	3.9	22.5	0.2	1.0	0.0	1.1	0.2	0.2	1.3	12.0	0.8	0.5	0.2	1.0	0.9	0.2	1.0	0.2	0.2	0.2	0.4	29.6	0.2	0.2	0.0	1.2	4.4	0.0	0.4	1.7	11.9	0.0	0.5	0.8	0.0	0.0	0.0	31.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	30.6	0.0	0.0	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.6	7.3	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	31.6	0.4	0.6	0.1	0.5	1.3	0.4	1.0	0.0	0.8	0.0
HBE1	HBE	ENSG00000213931	"Hemoglobin subunit epsilon 1"	P02100	11	5268345-5505652	"Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 7.7;liver: 6.7"	"Cell line enriched"	"Detected in some"	15	"K-562: 461.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043234	Approved									"HPA043234: "	"unprognostic (7.59e-2)"			"unprognostic (6.70e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.25e-1)"		"unprognostic (1.64e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.02e-3)"		"unprognostic (2.14e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.34e-2)"	1.8	1.1	1.1	0.4	1.0	1.3	0.9	1.0	1.9	0.7	0.4	0.4	0.4	0.1	0.6	2.0	0.4	1.0	0.6	0.4	1.4	0.8	0.9	6.7	0.6	0.4	7.7	5.1	1.9	0.5	0.1	0.6	3.6	3.2	1.1	0.3	0.4	0.7	0.6	1.5	0.6	0.4	1.2	0.5	1.0	0.4	2.2	0.4	1.6	0.6	0.4	0.4	0.4	0.7	0.0	0.0	2.1	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	461.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.7	1.1	1.0	1.0	1.9	1.4	0.8	7.7	5.1	3.2	0.4
HBG2	HBG-T1	ENSG00000196565	"Hemoglobin subunit gamma 2"	P69892	11	5253190-5505605	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Oxygen transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	41	"placenta: 553.0"	"Group enriched"	"Detected in some"	175	"HEL: 313.8;K-562: 326.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB016143, HPA043234"	Approved									"CAB016143: AB_2295004, HPA043234: "	"unprognostic (4.48e-3)"	"unprognostic (2.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.94e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.29e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.70e-5)"	"unprognostic (1.64e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	2.6	0.3	1.4	0.7	1.2	3.7	0.7	0.9	0.8	0.7	0.7	0.7	0.7	0.4	0.7	0.7	0.7	0.3	0.7	2.3	1.0	1.0	2.3	2.2	5.5	0.7	1.7	0.7	0.7	0.8	0.3	1.0	553.0	0.7	0.7	0.3	0.8	0.7	0.7	1.3	0.3	0.7	0.7	2.3	13.3	0.5	1.1	0.7	0.7	1.7	0.7	0.7	0.7	0.8	0.0	0.1	0.4	0.7	0.0	0.1	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	326.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	9.5	1.4	1.2	0.9	0.8	1.0	1.0	1.7	0.7	0.7	0.7
HCFC1	"CFF, HCF-1, HCF1, HFC1, MGC70925, MRX3, PPP1R89, VCAF"	ENSG00000172534	"Host cell factor C1"	P51610	X	153947553-153971807	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018312			Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA018312: AB_1850522"	"unprognostic (2.05e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.80e-1)"	16.0	19.2	18.2	23.7	18.5	48.3	14.2	24.4	23.3	13.9	20.0	17.3	14.1	16.8	26.3	13.6	18.2	18.8	20.8	14.7	17.0	12.7	15.6	17.2	19.0	24.9	14.6	16.1	20.4	15.6	21.9	26.4	13.8	15.8	17.7	11.2	13.8	21.5	20.6	27.8	18.2	18.3	19.7	20.0	25.2	18.0	15.3	17.9	52.3	16.4	15.6	17.6	17.4	18.3	4.8	8.0	1.7	5.6	2.8	6.7	3.5	15.2	19.9	13.5	17.1	5.7	4.1	19.9	6.3	4.9	7.5	6.8	21.0	10.3	27.8	16.2	8.1	12.6	14.6	10.3	3.9	14.7	17.2	16.6	15.9	16.5	3.9	20.4	27.6	6.3	6.7	13.0	5.7	7.9	23.1	17.6	5.2	21.4	28.2	26.4	17.6	12.2	33.0	11.1	16.8	5.6	14.2	15.1	16.4	11.6	12.1	6.4	11.1	18.5	10.4	14.3	17.6	12.3	20.2	28.1	38.3	34.8	11.6	19.9	13.4	1.7	4.0	1.7	6.0	5.6	4.3	4.8	4.8	4.6	4.5	4.4	4.9	6.7	0.8	2.8	4.0	8.0	3.2	3.5	18.2	18.5	24.4	23.3	17.0	12.7	14.6	16.1	15.8	17.9
HCLS1	"CTTNL, HS1"	ENSG00000180353	"Hematopoietic cell-specific Lyn substrate 1"	P14317	3	121631399-121660927	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 149.7;lymphoid tissue: 110.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 42.3;HMC-1: 60.1;THP-1: 41.9;U-266/70: 59.5;U-698: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019143	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"HPA019143: AB_1850532"	"unprognostic (2.27e-2)"	"unprognostic (1.79e-3)"	"unprognostic (5.38e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.02e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.93e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.01e-1)"	24.7	10.7	7.8	44.9	14.7	35.5	9.1	1.3	7.4	6.3	10.4	8.5	2.2	5.5	5.6	8.2	4.8	9.1	10.1	7.5	6.7	5.0	10.5	10.1	18.7	59.4	12.9	3.2	4.6	5.1	1.4	6.1	15.4	10.9	6.1	8.6	4.9	7.4	3.1	7.0	4.6	23.0	8.9	15.1	110.1	7.1	3.6	11.6	41.0	6.1	4.4	61.5	12.5	5.6	33.4	59.6	149.7	84.9	24.3	44.1	103.5	0.1	0.0	0.0	0.0	3.5	1.9	0.9	0.6	0.6	0.1	0.2	0.0	0.0	42.3	20.6	0.0	0.0	1.1	1.6	0.1	18.8	0.0	27.4	0.0	0.0	1.9	30.1	60.1	0.3	0.0	0.0	0.3	24.9	5.4	39.1	0.0	0.0	21.3	25.4	0.0	0.7	21.6	0.0	40.2	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.0	41.9	32.5	0.0	0.3	0.0	0.1	59.5	18.1	59.5	0.3	29.0	0.0	26.6	64.1	104.2	40.2	80.6	32.9	33.4	33.3	36.8	59.6	29.4	28.5	33.0	149.7	24.3	84.9	18.5	44.1	103.5	7.8	14.7	1.3	7.4	6.7	5.0	12.9	3.2	10.9	11.6
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254950-45696498	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.4;retina: 16.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.6;WM-115: 4.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced									"HPA019195: "	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		1.0	2.8	6.0	1.0	13.0	1.3	1.2	9.8	26.4	0.9	1.0	0.5	0.0	0.9	1.1	0.9	1.1	1.0	1.0	4.6	8.1	4.5	0.9	1.0	1.0	1.0	2.6	11.1	1.1	1.7	0.9	4.0	0.9	9.2	1.0	1.0	16.1	1.0	0.9	3.6	1.6	1.1	0.9	1.2	1.1	1.1	1.2	0.0	0.0	1.1	0.0	0.9	0.9	0.3	0.6	0.2	0.6	0.2	0.3	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.1	0.3	1.6	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	4.6	0.5	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.6	0.2	0.3	0.6	0.3	0.1	0.2	0.0	0.0	6.0	13.0	9.8	26.4	8.1	4.5	2.6	11.1	9.2	0.0
HCN3	KIAA1535	ENSG00000143630	"Hyperpolarization activated cyclic nucleotide gated potassium channel 3"	Q9P1Z3	1	155277583-155289848	"Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026584	Approved									"HPA026584: AB_1850534"	"unprognostic (1.04e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (7.49e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.90e-2)"	"prognostic favourable (6.93e-4)"	1.6	3.5	4.5	2.0	7.5	1.5	2.1	20.3	9.5	3.6	4.4	3.3	3.6	7.7	4.5	2.1	3.9	2.2	3.0	1.6	4.0	8.2	4.4	10.2	1.9	2.3	4.1	8.5	4.7	4.7	6.4	12.6	2.4	9.5	2.7	5.0	4.0	4.4	3.6	1.1	9.2	6.6	2.8	3.0	1.9	3.2	1.7	2.1	1.6	2.6	1.3	3.0	2.3	3.6	0.3	0.0	0.0	0.1	0.0	0.6	0.0	1.6	1.8	7.8	3.1	1.2	1.5	1.9	1.3	1.1	1.6	1.9	2.7	5.4	1.5	1.0	0.9	6.8	2.2	1.0	0.8	2.1	2.7	0.6	5.0	1.8	0.5	0.6	1.6	0.9	1.0	1.1	0.2	0.3	3.6	4.3	1.9	2.2	1.1	0.6	2.6	2.1	3.9	1.9	2.8	2.1	1.7	6.4	4.5	1.2	1.6	0.5	2.8	1.3	0.1	1.9	1.6	3.9	1.2	1.4	0.6	1.3	1.4	1.1	1.7	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	7.5	20.3	9.5	4.0	8.2	4.1	8.5	9.5	2.1
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005017: AB_2248344, CAB068191: , HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.5	18.0	11.6	23.1	6.8	8.1	24.2	20.9	23.5	28.1	26.0	33.0	53.3	45.6	38.9	23.1	34.6	35.7	28.5	31.2	42.6	35.5	31.4	21.7	25.3	16.1	55.6	45.6	14.7	15.7	21.7	14.4	21.3	41.1	18.2	12.3	22.5	63.3	31.3	26.9	46.2	43.8	27.6	20.3	30.4	42.8	9.1	11.5	35.0	23.6	44.0	27.8	43.3	24.6	18.7	22.0	5.7	51.0	11.1	23.8	62.5	15.4	46.2	24.3	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7
HDAC2	"RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavourable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavourable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	25.8	33.8	25.8	30.1	31.3	34.9	58.7	32.8	36.5	32.1	30.7	25.6	32.2	22.0	38.7	36.7	36.3	32.7	23.3	27.6	26.5	26.9	31.6	22.2	29.9	41.5	29.6	26.5	39.2	31.5	31.7	45.1	38.1	27.9	32.1	36.1	17.5	29.3	39.0	33.9	30.8	26.1	36.1	31.1	30.7	29.9	47.4	27.4	64.0	35.1	31.3	32.5	33.1	47.3	27.0	35.7	28.2	32.6	26.3	32.6	24.3	24.2	16.7	78.2	44.9	20.2	23.0	32.8	28.9	23.7	34.2	41.0	44.3	17.9	20.0	24.2	26.0	19.1	53.0	29.3	57.6	28.5	36.6	48.2	21.7	25.6	26.9	48.9	21.8	18.6	19.7	36.4	34.2	39.8	62.0	20.4	56.5	20.3	43.8	44.3	44.2	23.1	29.8	39.0	18.4	35.3	29.3	52.3	44.4	22.9	21.6	24.1	15.7	57.1	32.1	21.8	25.1	22.8	47.9	16.2	21.3	47.9	18.5	47.2	36.9	23.1	27.6	28.2	21.1	26.6	28.1	27.0	25.9	22.7	35.7	22.3	32.6	29.7	16.3	26.3	32.6	30.9	24.5	24.3	25.8	31.3	32.8	36.5	26.5	26.9	29.6	26.5	27.9	27.4
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol		"HPA004775: AB_1850548"	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HDAC9	"HD7, HDAC, HDAC7B, KIAA0744, MITR"	ENSG00000048052	"Histone deacetylase 9"	Q9UKV0	7	18086949-19002416	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 54.3;hTERT-HME1: 26.0;SH-SY5Y: 21.7;U-698: 21.5;WM-115: 22.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 29.5"	"Group enriched"	"Detected in many"	9	"B-cells: 21.8;dendritic cells: 29.5;monocytes: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028926	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA028926: AB_10602327"	"unprognostic (2.06e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.01e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	10.7	13.5	12.6	10.7	16.2	5.9	8.4	19.1	16.9	11.6	7.4	11.3	7.5	3.8	17.8	6.7	4.7	10.5	7.5	14.9	13.1	12.0	3.9	3.1	5.7	18.9	13.9	14.9	3.0	2.7	3.0	17.7	6.8	11.2	12.5	6.2	9.7	6.9	16.5	15.5	3.8	8.4	14.4	17.6	17.4	9.1	8.7	18.2	2.9	5.5	5.4	19.3	7.1	9.6	21.8	29.5	0.5	9.7	2.0	2.1	4.5	12.3	0.0	2.0	0.0	0.3	2.8	0.0	0.7	7.3	3.1	5.3	0.1	4.0	5.3	13.7	8.2	1.8	54.3	1.0	8.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	1.0	1.0	9.6	26.0	0.1	0.0	8.3	4.2	0.0	0.5	1.0	6.6	1.2	1.5	0.8	3.1	1.7	3.3	3.9	21.7	0.1	0.1	3.9	0.2	4.9	0.5	11.3	3.6	0.6	7.0	9.6	4.1	21.5	2.9	0.5	22.2	0.1	9.7	0.0	1.7	6.7	1.7	21.8	0.6	0.8	29.5	16.3	0.0	0.9	0.5	2.0	3.8	6.4	2.1	4.5	12.6	16.2	19.1	16.9	13.1	12.0	13.9	14.9	11.2	18.2
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742107-156766925	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm			300000	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favourable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	27.6	24.0	24.4	26.4	24.6	78.7	51.5	26.7	22.1	29.7	57.9	22.4	23.9	40.6	22.1	22.9	53.0	34.9	38.1	41.7	23.5	18.3	64.5	92.6	38.0	32.6	23.7	12.9	29.0	35.3	25.6	19.0	49.1	20.4	21.3	37.5	15.9	26.5	30.6	57.2	39.2	83.1	21.7	25.5	30.0	25.6	11.8	22.4	79.0	38.3	64.8	44.0	30.9	29.6	7.5	14.5	10.4	12.3	6.1	9.7	7.8	76.0	37.7	43.4	20.6	25.1	34.6	47.9	25.2	64.5	59.2	38.8	42.6	81.2	51.4	49.9	50.2	53.8	64.4	56.7	58.9	41.6	45.7	44.0	54.8	37.2	33.5	64.4	37.2	24.8	54.3	46.3	90.4	43.5	57.5	43.1	48.1	55.9	53.0	71.4	76.5	53.5	59.9	25.9	68.7	65.0	25.7	64.7	70.4	60.2	79.7	30.4	63.6	100.1	38.4	29.9	46.5	37.9	64.0	58.2	72.3	89.5	39.9	51.2	38.1	6.0	12.3	10.4	8.5	10.4	6.3	6.7	7.3	7.5	14.1	7.5	6.6	6.2	7.1	6.1	11.4	14.5	9.7	7.8	24.4	24.6	26.7	22.1	23.5	18.3	23.7	12.9	20.4	22.4
HDLBP	"HBP, VGL"	ENSG00000115677	"High density lipoprotein binding protein"	Q00341	2	241227264-241317061	"Plasma proteins, Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 210.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004189, CAB026457"	Enhanced		Supported	Cytosol				Cytosol		"CAB026457: , HPA004189: AB_1079044"	"unprognostic (2.57e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.58e-5)"	"unprognostic (1.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.92e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (6.39e-5)"	"prognostic unfavourable (4.12e-4)"	38.2	38.7	18.1	18.1	27.7	15.9	37.4	18.1	27.0	39.6	30.4	24.7	38.2	22.5	34.8	43.2	35.3	38.7	30.9	37.5	17.9	15.9	33.9	92.0	29.9	20.9	19.8	16.6	40.1	210.4	40.5	40.0	44.4	22.5	35.9	29.4	26.1	105.2	34.3	80.2	27.6	36.1	29.9	18.5	23.0	39.2	39.6	19.3	20.8	39.0	45.7	34.7	31.9	31.0	10.9	22.4	11.6	28.8	10.1	12.3	12.4	33.8	27.3	28.6	45.5	73.0	89.6	40.6	84.6	86.8	38.5	55.0	24.4	34.7	10.3	10.3	122.4	27.2	42.5	55.4	63.1	16.4	26.3	32.9	34.4	59.5	71.5	23.5	28.8	66.2	45.0	55.9	63.0	52.4	31.3	13.9	60.0	35.3	13.5	12.3	27.6	18.1	12.6	55.5	20.5	31.4	40.4	23.8	27.3	36.9	38.9	33.0	30.7	23.0	65.8	47.1	30.0	65.0	35.4	16.4	13.5	18.3	59.7	17.6	43.1	11.6	20.0	9.1	9.3	21.9	12.3	10.9	10.6	11.1	22.4	7.4	9.6	8.9	11.5	10.1	28.8	14.7	9.8	12.4	18.1	27.7	18.1	27.0	17.9	15.9	19.8	16.6	22.5	19.3
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065941-50106387	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: "	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavourable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	14.7	13.6	8.8	17.8	16.1	10.1	9.3	19.5	14.0	10.2	11.5	12.4	11.1	10.1	9.2	10.3	13.0	8.5	9.4	9.9	9.4	9.6	10.7	20.7	10.5	14.6	10.9	8.1	7.1	19.2	14.8	13.3	12.1	8.7	8.4	13.8	7.8	12.4	7.8	19.6	13.3	10.9	11.3	10.5	21.6	11.4	15.6	11.1	14.5	6.4	10.7	12.9	9.2	8.0	2.4	4.2	2.2	7.0	2.0	2.9	2.2	10.7	11.1	10.2	16.2	6.4	8.6	11.0	13.2	8.7	13.2	5.3	13.5	8.2	20.4	9.6	12.5	13.0	12.3	9.8	15.4	5.2	13.3	10.1	7.7	17.1	9.1	17.4	20.5	6.7	6.8	9.3	5.7	10.6	12.8	3.5	12.9	6.6	13.3	21.8	12.1	11.5	14.8	13.9	16.5	7.3	8.9	13.3	7.0	12.7	16.6	8.3	7.5	12.8	13.8	10.6	7.2	8.1	10.0	8.7	6.8	18.3	10.5	17.6	10.4	1.3	6.2	1.4	2.6	7.0	2.8	1.6	1.6	2.9	4.2	2.4	2.3	2.4	2.2	2.0	6.1	3.7	2.6	2.2	8.8	16.1	19.5	14.0	9.4	9.6	10.9	8.1	8.7	11.1
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593692	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HUVEC TERT2: 15.0;SCLC-21H: 17.4;TIME: 19.7;U-138 MG: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.7;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 7.7;monocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034609	Enhanced									"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0.0	1.1	3.0	1.0	5.5	6.3	4.8	14.0	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0.0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0.0	0.1	0.1	0.0	0.7	1.2	0.0	0.7	2.3	0.9	1.5	3.9	1.2	1.4	0.1	0.0	0.7	0.3	7.2	1.7	0.5	0.1	2.5	26.6	0.9	0.0	1.1	0.1	0.1	0.2	0.2	0.5	0.7	8.9	3.1	15.0	0.1	0.0	3.6	0.9	0.0	0.3	1.4	0.6	0.0	0.3	0.0	0.0	0.0	17.4	1.4	1.1	0.2	0.0	0.0	0.1	19.7	12.0	0.8	2.6	0.3	0.1	0.0	0.7	3.0	0.0	0.1	0.2	0.5	1.3	0.0	1.9	0.0	0.5	0.1	0.0	0.7	0.6	0.1	0.0	7.7	0.0	5.2	0.0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8
HEG1	"HEG, KIAA1237"	ENSG00000173706	"Heart development protein with EGF like domains 1"	Q9ULI3	3	124965710-125055958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.1;HHSteC: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010952, HPA011559"	Approved		Approved	Vesicles	"Intracellular and membrane"		360000000	Vesicles		"HPA010952: , HPA011559: AB_1850580"	"unprognostic (1.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.33e-2)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (1.11e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.20e-3)"	"prognostic unfavourable (1.16e-4)"	23.6	8.2	5.8	12.1	8.4	0.7	16.4	2.6	8.9	12.2	9.6	14.7	8.0	3.9	12.0	7.3	9.0	11.4	29.6	36.3	6.9	5.5	8.9	5.5	42.4	7.7	9.7	4.7	8.1	16.6	14.2	4.0	17.4	11.6	7.2	6.5	26.2	7.1	7.4	6.2	4.3	7.9	14.4	11.9	11.5	7.5	11.3	6.5	3.0	29.1	10.8	8.7	13.0	15.6	1.0	0.9	1.2	3.9	7.3	4.0	1.1	2.0	2.1	14.7	1.2	18.2	16.2	5.5	17.3	22.6	19.2	21.1	15.0	0.2	0.6	11.8	46.1	3.6	2.2	8.4	23.2	1.6	1.1	0.3	11.1	1.8	56.0	0.4	22.4	19.7	2.4	25.0	5.9	18.7	0.0	0.2	5.8	0.3	0.9	0.0	2.5	1.3	1.3	11.1	0.0	3.3	0.3	0.2	1.3	38.3	2.6	1.5	6.2	0.9	28.9	10.8	12.1	38.9	7.3	1.5	4.7	0.0	20.4	1.6	21.1	1.2	0.3	0.0	4.0	3.6	2.7	0.9	1.6	3.6	0.7	1.0	2.4	1.5	0.0	7.3	3.9	0.9	0.5	1.1	5.8	8.4	2.6	8.9	6.9	5.5	9.7	4.7	11.6	6.5
HELZ	"DHRC, HUMORF5, KIAA0054"	ENSG00000198265	"Helicase with zinc finger"	P42694	17	67070438-67245989	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028276	Approved		Approved	"Nucleoli,Plasma membrane,Actin filaments"				Nucleoli	"Plasma membrane, Actin filaments"	"HPA028276: AB_10601814"	"unprognostic (3.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.83e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.85e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.31e-1)"	17.9	12.9	11.2	14.3	14.3	17.7	12.6	24.3	17.7	14.4	14.0	11.6	12.9	7.9	17.0	13.0	9.1	11.1	11.5	11.1	12.0	9.7	11.8	17.3	14.8	14.6	10.7	6.2	20.5	13.9	34.1	33.5	19.2	16.5	11.9	10.9	12.2	12.4	10.9	18.9	9.0	15.6	12.2	13.5	17.3	11.7	16.4	12.7	34.1	15.3	8.8	13.9	15.3	11.9	4.8	4.4	4.3	4.9	4.0	11.0	3.2	7.5	7.6	9.2	9.5	11.7	6.5	14.2	6.7	6.7	8.8	9.7	11.0	6.0	15.6	5.6	9.0	8.0	17.6	8.5	14.2	6.0	5.5	19.9	8.3	9.0	5.6	16.4	12.2	7.7	8.2	8.7	11.1	13.6	13.8	10.0	7.4	9.6	21.1	5.7	5.6	7.3	14.3	16.8	6.8	7.1	10.7	9.3	8.5	10.6	8.9	11.6	10.5	10.2	12.2	11.4	13.1	6.2	6.0	8.2	9.6	11.8	5.6	10.2	11.8	3.6	4.9	4.3	8.8	4.5	11.0	2.9	5.4	5.3	4.4	4.8	3.3	4.5	3.7	4.0	2.9	3.6	4.8	3.2	11.2	14.3	24.3	17.7	12.0	9.7	10.7	6.2	16.5	12.7
HELZ2	"KIAA1769, PDIP1, PRIC285"	ENSG00000130589	"Helicase with zinc finger 2"	Q9BYK8	20	63558086-63574239	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 33.8;SK-MEL-30: 13.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051267	Uncertain									"HPA051267: "	"unprognostic (1.86e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (9.76e-2)"	"unprognostic (1.16e-1)"	3.2	2.1	0.7	4.6	0.9	13.3	3.1	0.0	0.7	2.4	2.4			3.1	2.3	0.3	4.2	2.9	2.5	2.7	0.3	0.7	3.5	4.6	5.8	3.6	0.7		2.2	3.7	0.7	3.1	1.8		2.4	0.4		10.4	0.7	1.1	2.4	3.4	0.6	0.6	9.5	5.6	0.5			3.5		1.3	2.2	1.9	0.9	0.4	2.7	0.8	0.3	0.8	0.8	5.3	2.0	0.6	2.0	1.2	1.6	4.0	1.9	2.9	33.8	13.2	5.5	6.9	0.1	4.2	0.7	8.4	0.4	2.0	1.3	2.0	0.9	0.1	2.2	1.9	2.8	0.1	13.3	2.0	1.4	2.4	0.4	1.6	0.9	2.3	0.4	5.3	0.6	5.5	1.1	6.4	1.2	1.1	2.0	0.9	6.2	0.5	1.9	6.0	0.4	13.7	1.9	1.6	2.5	3.2	4.9	2.6	2.0	2.9	0.3	0.1	3.5	0.9	2.9	0.4	0.8	1.9	0.8	0.6	0.3	0.4	0.5	0.6	0.4	0.9	0.3	0.5	2.7	0.3	0.4	0.0	0.5	0.8										
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.1;fHDF/TERT166: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: "	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.4	8.0	5.1	8.5	13.2	18.1	4.6	55.1	34.1	20.7	13.4	4.5	10.6	7.9	4.3	61.8	11.9	5.6	8.1	28.0	5.2	2.7	3.6	13.3	3.5	7.0	4.4	6.5	8.9	9.5	11.0	9.8	12.8	3.8	4.0	31.9	9.6	3.1	5.2	3.0	14.0	4.2	2.1	2.8	9.4	6.4	2.4	2.8	17.9	7.7	7.8	4.8	5.6	17.4	10.9	6.1	26.8	9.4	2.8	3.3	5.0	20.0	8.6	3.7	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6
HERPUD1	"HERP, KIAA0025, Mif1, SUP"	ENSG00000051108	"Homocysteine inducible ER protein with ubiquitin like domain 1"	Q15011	16	56932048-56944863	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 61.2;RPMI-8226: 76.8;U-266/70: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037041, CAB037104, HPA040754, HPA041219"	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268"	"unprognostic (1.92e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.93e-3)"	"unprognostic (3.39e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.69e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.50e-1)"	"prognostic favourable (1.41e-9)"	"unprognostic (1.06e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.27e-3)"	22.7	38.8	16.2	35.6	20.7	21.6	39.4	17.7	20.0	30.1	32.1	20.0	48.8	21.4	21.6	51.6	15.0	20.2	32.5	28.8	15.8	15.5	42.9	57.7	30.4	40.0	25.6	12.5	44.8	148.6	37.6	26.7	26.2	25.6	49.5	32.3	35.3	108.6	76.1	34.6	18.3	24.7	17.6	24.2	38.3	37.2	10.6	20.8	9.6	64.2	20.4	53.8	24.4	25.9	50.8	121.9	29.0	39.5	22.4	33.4	46.5	4.4	4.9	4.8	10.0	11.2	14.6	17.2	10.6	16.9	13.7	10.7	6.8	10.2	18.1	13.6	10.2	7.7	8.2	3.7	13.6	10.4	4.9	1.5	8.2	24.5	61.2	3.2	8.1	17.7	35.8	6.2	19.7	10.4	2.4	25.9	38.2	3.7	6.1	6.7	3.1	11.1	4.2	12.2	76.8	29.4	5.0	5.3	6.1	9.2	45.4	46.9	5.0	12.2	6.3	5.7	5.7	5.0	4.2	87.6	28.5	28.3	8.1	4.5	7.4	23.9	39.5	18.0	16.1	31.0	17.4	50.8	17.5	21.1	30.6	37.8	11.4	17.4	29.0	22.4	21.5	121.9	33.4	46.5	16.2	20.7	17.7	20.0	15.8	15.5	25.6	12.5	25.6	20.8
HES1	"bHLHb39, FLJ20408, HES-1, Hes1, HRY"	ENSG00000114315	"Hes family bHLH transcription factor 1"	Q14469	3	194136145-194138732	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 26.7;hTCEpi: 33.5;SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 19.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066929			Supported	Nucleoplasm				Nucleoplasm		"HPA066929: "	"unprognostic (1.79e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.64e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.04e-5)"	31.0	10.9	8.4	7.9	9.3	0.6	30.1	5.5	8.1	28.4	18.9	14.1	36.1	17.2	21.2	15.9	47.8	9.9	11.5	21.2	9.5	6.0	22.1	27.4	37.9	3.7	6.3	8.8	15.7	21.2	19.7	15.1	23.5	8.8	35.1	20.5	58.7	31.0	89.6	32.8	56.0	12.6	9.7	8.4	10.7	23.9	11.7	8.0	2.3	36.3	29.7	40.3	26.3	39.8	0.5	0.1	19.5	4.8	0.0	0.0	0.1	3.1	0.9	7.4	9.5	2.2	0.0	1.8	1.5	4.2	0.3	0.1	12.5	9.1	0.4	26.7	0.5	18.0	1.4	8.4	0.1	2.6	15.5	11.3	1.2	3.2	0.0	0.0	10.8	0.8	33.5	0.3	3.9	10.1	5.4	0.4	0.0	14.9	15.9	15.5	6.9	6.2	0.0	0.5	0.3	9.9	24.6	0.4	0.5	7.3	28.0	12.5	7.8	0.8	7.7	0.8	8.0	0.1	10.7	0.0	0.0	0.0	0.6	0.0	15.3	0.0	0.1	19.5	0.0	3.1	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	4.8	0.0	0.0	0.1	8.4	9.3	5.5	8.1	9.5	6.0	6.3	8.8	8.8	8.0
HEXA		ENSG00000213614	"Hexosaminidase subunit alpha"	P06865	15	72340919-72376476	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054583	Supported				"Intracellular and membrane"		20000000			"HPA054583: AB_2682531"	"unprognostic (1.51e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.41e-1)"	"prognostic favourable (5.63e-8)"	"unprognostic (6.58e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (9.98e-2)"	"unprognostic (3.98e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.02e-2)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	30.1	37.4	23.1	18.0	22.9	35.5	37.8	23.3	28.1	30.6	20.5	19.4	30.1	18.5	25.9	65.7	11.7	21.8	29.2	33.8	23.4	12.8	34.6	29.5	43.9	31.4	24.9	21.1	20.9	22.2	18.1	22.9	37.9	18.8	18.1	26.0	26.9	24.8	22.0	17.7	17.9	24.6	23.4	21.4	31.5	22.6	18.0	22.9	12.1	31.2	11.1	16.4	26.7	17.1	16.1	37.9	22.4	32.7	17.8	18.1	21.3	7.4	12.7	5.5	10.5	45.0	51.4	7.8	10.5	53.3	22.8	36.5	6.7	54.8	6.2	10.1	21.0	15.0	14.4	6.7	14.5	5.0	5.8	7.8	12.6	11.5	34.9	18.7	22.4	43.7	20.0	9.9	17.8	20.8	12.1	38.8	30.3	6.4	4.0	9.4	3.1	0.1	4.2	11.9	14.0	25.5	11.8	4.7	5.2	26.3	24.8	59.3	4.6	23.6	10.4	34.2	14.3	31.4	11.1	20.7	27.9	6.5	12.4	25.0	16.5	8.9	32.7	22.4	18.1	13.7	15.8	16.1	12.0	15.8	37.9	15.6	9.5	14.0	3.1	17.8	4.8	14.4	10.7	21.3	23.1	22.9	23.3	28.1	23.4	12.8	24.9	21.1	18.8	22.9
HEXB		ENSG00000049860	"Hexosaminidase subunit beta"	P07686	5	74640023-74722647	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Gangliosidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 174.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 112.8;BJ hTERT+: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055409, HPA056010"	Enhanced				"Intracellular and membrane"		43000000			"HPA055409: AB_2682808, HPA056010: AB_2683008"	"unprognostic (3.45e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.85e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.44e-3)"	"prognostic unfavourable (3.36e-8)"	"unprognostic (2.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.45e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.64e-2)"	48.0	21.9	7.7	13.6	11.6	11.1	26.1	7.4	11.2	25.8	34.2	9.5	18.0	21.6	22.1	77.3	20.6	17.3	28.1	46.3	7.1	9.1	30.4	44.5	40.9	19.3	8.5	6.7	22.7	30.4	21.8	14.3	174.3	9.3	22.6	26.3	21.0	34.6	13.3	21.0	15.3	33.6	21.0	8.7	20.5	20.7	16.2	6.1	10.8	33.7	15.2	15.4	24.0	19.7	8.9	59.8	23.8	65.9	7.6	16.4	42.9	21.1	16.7	5.8	19.2	112.8	34.8	19.0	26.0	84.4	25.4	55.2	19.5	27.7	0.0	20.7	21.3	17.0	6.2	26.5	33.6	11.8	11.2	2.8	16.2	14.7	33.1	2.3	22.9	30.7	15.6	26.7	17.9	29.1	7.8	34.7	27.8	21.5	2.7	5.3	5.4	7.5	6.4	8.5	27.6	17.5	19.4	3.8	4.7	20.2	13.7	25.1	14.5	15.7	17.2	16.8	4.2	30.8	24.0	16.1	27.6	0.1	38.2	20.8	30.4	14.5	65.9	18.6	14.2	24.5	16.4	8.9	11.7	13.1	59.8	5.5	11.2	10.9	23.8	7.6	14.6	18.0	13.7	42.9	7.7	11.6	7.4	11.2	7.1	9.1	8.5	6.7	9.3	6.1
HGD	"AKU, HGO"	ENSG00000113924	"Homogentisate 1,2-dioxygenase"	Q93099	3	120628173-120682571	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 176.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.1;EFO-21: 23.3;Hep G2: 44.9;RPTEC TERT1: 58.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 119.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047374, HPA052359"	Enhanced		Approved	"Golgi apparatus"			210000	"Golgi apparatus"		"HPA047374: AB_2680019, HPA052359: AB_2681798"	"unprognostic (1.36e-1)"	"unprognostic (9.89e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.65e-3)"	"unprognostic (7.20e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.29e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.43e-1)"	0.2	0.2	0.2	0.6	0.6	0.0	1.8	0.2	0.5	3.7	7.2	0.3	1.4	4.7	0.6	4.0	0.2	0.4	11.5	0.3	0.2	0.1	33.3	176.7	0.7	0.3	0.2	0.2	0.3	6.9	0.0	0.4	0.3	0.3	6.7	2.7	5.9	3.3	1.0	0.4	0.3	15.0	0.3	0.4	0.3	3.9	0.3	0.2	0.2	8.1	0.3	0.3	0.2	0.2	0.0	0.3	2.8	0.4	0.0	0.0	5.1	0.0	2.9	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.1	3.0	0.0	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	44.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.4	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	5.1	0.2	0.6	0.2	0.5	0.2	0.1	0.2	0.2	0.3	0.2
HGF	"DFNB39, F-TCF, HGFB, HPTA, SF"	ENSG00000019991	"Hepatocyte growth factor"	P14210	7	81699008-81770438	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Serine protease homolog"	"Cancer-related genes, Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 116.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 44.8;HHSteC: 35.1;HL-60: 19.6;hTEC/SVTERT24-B: 22.0;Karpas-707: 60.7;U-87 MG: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"basophil: 33.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 33.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010333, HPA040360, HPA044088"	Approved		Approved	Centrosome,Cytosol	"Secreted to blood"			Cytosol	Centrosome	"CAB010333: AB_647965, HPA040360: , HPA044088: "	"unprognostic (5.24e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.45e-5)"	"unprognostic (1.66e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.28e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.29e-2)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (7.90e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.06e-2)"	6.2	10.6	1.4	2.9	1.2	4.6	4.8	0.5	4.5	5.1	4.0	0.4	2.9	1.5	5.2	3.1	2.9	4.0	7.1	9.3	3.6	1.3	7.3	27.5	15.8	2.0	1.3	1.4	3.2	1.4	1.6	4.3	116.9	1.9	10.8	1.9	2.0	2.2	3.2	1.4	0.9	1.8	15.1	6.0	6.6	2.3	2.0	0.9	0.5	5.3	1.4	1.4	10.5	21.5	0.0	2.0	33.5	7.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.5	44.8	0.0	0.1	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	35.1	19.6	0.1	10.6	0.0	22.0	0.0	0.5	0.0	60.7	0.1	0.0	0.0	13.6	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	16.1	4.1	0.0	33.5	6.6	1.6	0.0	7.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.3	0.0	6.7	0.4	0.0	1.5	1.4	1.2	0.5	4.5	3.6	1.3	1.3	1.4	1.9	0.9
HGFAC	"HGFA, HGFAP"	ENSG00000109758	"HGF activator"	Q04756	4	3441887-3449495	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	141	"liver: 128.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 10.7"	"Cancer enriched"	"Detected in some"	22	"liver cancer: 26.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058279, HPA059076"	Enhanced				"Secreted to blood"	7586667	11000000000			"HPA058279: AB_2683665, HPA059076: AB_2683898"	"unprognostic (2.70e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.37e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.54e-3)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (9.31e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.74e-4)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.2	1.2	0.7	0.4	0.1	0.0	0.0	0.6	1.1	0.0	0.0	0.3	0.1	0.0	0.0	0.5	0.7	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol			250000	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	26.8	33.5	34.7	31.9	44.7	66.5	28.9	35.7	45.6	25.4	31.1	35.2	24.5	33.2	27.3	37.2	42.1	32.8	29.1	25.4	32.7	30.4	34.2	31.3	29.4	34.3	39.8	44.2	33.2	39.7	21.8	31.7	32.4	40.7	31.9	31.1	23.6	38.2	27.9	36.3	57.5	32.5	32.6	28.5	38.5	35.6	53.1	38.1	22.2	26.2	25.9	32.5	24.9	34.6	12.2	14.6	28.9	20.2	17.2	18.7	18.8	33.2	27.1	20.5	25.4	18.5	20.9	22.5	25.0	24.3	29.3	22.6	22.8	23.8	9.3	17.1	33.8	28.3	17.3	27.4	20.7	7.9	28.9	20.0	34.1	28.7	27.9	17.2	26.4	23.3	30.0	32.7	46.6	36.7	21.8	17.1	30.8	20.1	18.9	39.8	14.8	28.8	20.6	16.4	14.7	28.7	25.2	29.3	34.9	19.0	48.4	22.2	29.7	33.4	30.5	57.1	33.6	28.2	46.4	21.9	7.7	11.8	35.1	22.5	30.0	25.2	17.4	22.3	18.7	20.2	12.4	11.4	13.5	13.0	14.6	12.2	10.1	11.7	28.9	17.2	19.1	12.4	14.9	18.8	34.7	44.7	35.7	45.6	32.7	30.4	39.8	44.2	40.7	38.1
HIBADH	NS5ATP1	ENSG00000106049	"3-hydroxyisobutyrate dehydrogenase"	P31937	7	27525442-27662995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019522, HPA021002"	Enhanced						780000			"HPA019522: AB_1850690, HPA021002: AB_1850692"	"unprognostic (6.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.28e-3)"	"unprognostic (7.22e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (5.56e-11)"	"unprognostic (2.49e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.39e-2)"	17.7	40.3	8.4	9.4	10.0	2.1	23.8	9.3	9.2	13.7	16.5	8.7	8.3	10.0	15.3	12.0	8.8	14.0	11.9	36.2	6.7	7.4	45.8	56.5	8.3	8.3	9.8	7.0	12.6	20.2	24.8	12.5	27.7	10.6	15.8	10.3	19.6	15.5	14.8	31.4	7.5	17.2	19.6	7.5	6.6	11.6	14.5	7.2	8.1	26.3	17.7	5.6	15.2	10.8	12.5	12.9	5.4	14.7	14.0	17.2	11.1	19.3	12.5	7.7	13.1	21.3	31.2	8.8	13.3	22.5	12.9	14.5	6.8	20.8	8.0	10.9	21.6	17.2	9.3	17.7	17.2	5.6	11.1	4.5	17.8	25.8	19.4	5.4	4.4	29.4	14.5	9.6	29.4	18.6	16.0	7.8	30.7	7.7	5.7	8.0	8.3	17.9	5.9	8.7	8.2	26.5	12.6	8.6	8.7	25.6	41.3	18.0	20.0	10.9	11.1	7.7	15.8	12.7	7.7	15.2	10.5	4.8	11.7	17.1	21.9	2.3	11.7	5.4	12.0	14.7	16.1	12.5	13.4	13.7	12.9	11.4	17.2	13.9	2.1	14.0	13.4	5.9	8.4	11.1	8.4	10.0	9.3	9.2	6.7	7.4	9.8	7.0	10.6	7.2
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 alpha subunit"	Q16665	14	61695513-61748259	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 47.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"				"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB017442: AB_10621732, HPA000907: , HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	31.9	62.0	15.6	45.2	17.8	125.2	24.9	22.7	18.5	45.7	15.3	12.3	23.5	10.8	17.7	31.3	31.2	21.7	50.0	19.4	17.5	16.5	76.4	42.7	42.8	27.3	18.3	11.0	34.5	12.7	13.7	26.8	24.2	25.1	17.6	13.9	14.0	24.6	36.2	8.0	17.4	16.9	18.7	27.2	57.3	16.0	21.1	12.4	24.7	26.9	18.4	28.8	37.8	21.5	6.6	6.0	47.8	6.8	6.2	7.9	5.1	37.6	15.0	15.1	43.2	24.0	38.7	20.5	31.3	37.8	39.5	35.6	6.5	12.5	9.2	23.6	38.7	8.9	9.7	51.5	49.4	4.0	5.0	5.6	13.8	11.2	53.6	2.3	6.2	67.6	16.3	28.9	31.0	24.8	3.8	0.0	117.8	7.8	7.3	2.9	13.6	19.8	0.5	34.0	2.7	50.9	25.1	12.7	14.1	58.8	8.4	20.7	8.8	4.5	14.7	89.7	20.1	29.7	26.3	4.9	7.2	10.4	47.3	4.7	24.2	11.2	6.8	47.8	3.8	5.5	4.9	6.5	5.0	4.4	6.0	6.6	7.9	5.1	18.2	6.2	5.6	2.9	3.4	5.1	15.6	17.8	22.7	13.2	17.5	16.5	18.3	11.0	25.1	12.4
HINT1	"HINT, PKCI-1, PRKCNH1"	ENSG00000169567	"Histidine triad nucleotide binding protein 1"	P49773	5	131159027-131171735	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044577	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3600000	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA044577: AB_10795618"	"unprognostic (2.00e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.30e-2)"	"unprognostic (6.49e-2)"	"unprognostic (6.50e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.39e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.68e-1)"	28.5	46.5	56.6	46.2	51.6	50.5	64.7	42.9	78.4	29.8	53.3	20.4	49.1	36.5	30.6	43.8	44.3	42.3	36.7	61.4	47.3	43.9	65.4	124.4	38.9	54.7	48.7	50.6	32.2	62.9	43.9	39.6	24.6	40.8	41.3	50.0	22.6	44.4	41.8	84.0	38.3	41.3	37.9	37.5	32.5	32.5	30.5	25.1	29.4	47.5	56.6	39.4	29.1	45.1	26.6	46.5	19.2	25.3	20.9	40.3	52.9	37.5	55.0	43.2	88.5	30.8	33.4	39.9	28.6	26.8	28.9	33.6	53.7	52.7	51.7	57.1	36.7	23.2	34.4	75.4	26.8	45.2	63.3	19.9	77.9	68.7	64.5	31.0	6.4	44.6	66.6	34.7	58.3	36.2	30.2	113.2	37.1	41.4	52.4	78.1	41.9	43.9	37.9	43.2	93.5	54.3	48.5	53.0	33.2	37.9	25.9	45.1	31.4	45.4	39.7	38.2	21.7	30.3	58.1	32.6	41.6	44.9	53.6	50.2	35.2	19.2	25.3	9.6	21.7	12.8	29.7	26.6	40.3	28.6	39.2	25.7	32.0	25.3	5.0	20.9	12.9	46.5	27.0	52.9	56.6	51.6	42.9	78.4	47.3	43.9	48.7	50.6	40.8	25.1
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: "	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favourable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	11.0	9.2	13.8	15.1	16.7	17.6	10.9	12.7	10.7	8.8	9.8	7.6	14.4	16.0	27.7	13.8	13.9	23.4	15.8	24.8	7.8	14.0	10.0	13.2	14.4	23.5	11.7	8.1	41.5	12.0	20.8	19.5	9.8	7.4	46.2	19.7	11.1	17.5	21.6	7.6	13.3	15.9	12.0	14.9	16.0	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.1	40.1	18.3	18.0	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2
HIPK1	"KIAA0630, MGC26642, MGC33446, MGC33548, Myak, Nbak2"	ENSG00000163349	"Homeodomain interacting protein kinase 1"	Q86Z02	1	113929192-113977869	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 90.1"	"Cell line enhanced"	"Detected in all"		"MCF7: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016664	Approved		Approved	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Centrosome, Cytosol"		"HPA016664: AB_1850725"	"unprognostic (2.98e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.89e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.47e-2)"	"unprognostic (9.84e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.22e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.99e-2)"	15.1	16.8	21.2	14.7	23.0	90.1	13.6	38.1	20.4	20.4	14.4	20.7	14.5	10.2	15.5	14.2	18.7	27.3	17.5	27.9	22.9	17.2	14.8	13.8	19.3	14.7	15.0	16.4	18.7	16.8	20.7	23.8	13.8	21.3	14.4	15.2	20.7	13.0	14.9	19.7	18.5	13.4	15.1	18.3	15.9	14.8	33.5	21.3	47.2	23.3	13.1	15.5	17.3	26.7	2.3	6.2	9.8	4.2	4.3	6.0	2.3	8.1	6.6	9.2	7.0	10.8	5.7	6.2	5.6	6.8	8.0	7.7	7.6	3.1	10.9	7.7	8.9	5.5	11.8	6.6	11.6	7.9	6.0	15.9	8.3	8.0	9.0	12.7	19.7	6.1	9.6	10.2	10.5	11.8	10.8	11.8	11.5	61.5	16.6	7.2	9.4	5.9	10.1	27.0	3.8	7.2	7.0	4.1	5.4	10.2	11.0	7.2	6.4	18.3	11.5	7.9	10.7	12.8	8.5	7.4	5.8	9.5	8.8	10.3	17.9	3.4	4.2	8.2	5.5	3.7	5.2	1.7	4.9	4.9	3.1	2.3	5.0	6.0	9.8	4.3	2.6	6.2	3.6	2.3	21.2	23.0	38.1	20.4	22.9	17.2	15.0	16.4	21.3	21.3
HIPK2		ENSG00000064393	"Homeodomain interacting protein kinase 2"	Q9H2X6	7	139561570-139777778	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, DNA damage, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 17.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007611	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA007611: AB_1850730"	"unprognostic (1.35e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.42e-3)"	"unprognostic (4.58e-2)"	"prognostic favourable (9.99e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.03e-2)"	19.6	9.8	58.8	7.4	53.6	14.4	12.6	8.5	39.8	5.5	7.4	54.5	5.2	8.2	4.7	5.2	10.2	9.9	5.5	30.5	60.0	39.9	28.2	17.5	8.6	5.3	66.1	16.4	6.6	12.3	17.2	7.6	10.8	26.4	10.7	5.8	9.4	11.5	7.1	21.6	3.2	6.2	4.8	56.2	7.3	15.4	2.6	38.6	1.7	10.4	2.8	4.9	6.8	7.4	0.6	0.5	17.8	2.9	0.2	1.4	0.5	4.1	18.2	8.4	5.2	20.7	14.8	1.0	2.2	2.2	2.5	2.6	1.3	2.2	0.0	5.3	4.2	0.2	3.8	5.9	6.4	42.0	1.6	18.7	3.0	6.5	11.6	5.1	5.1	22.6	3.9	11.7	17.6	6.3	10.8	5.2	19.5	3.1	6.4	3.7	2.1	12.5	7.7	4.6	0.5	11.6	0.7	5.1	4.7	5.1	0.1	2.6	2.9	2.1	21.2	8.9	4.3	10.3	11.1	25.4	15.1	3.7	18.3	2.7	4.8	17.8	1.1	2.7	0.2	0.9	0.3	0.6	0.5	0.1	0.5	0.3	1.4	0.4	1.5	0.2	2.9	0.2	0.0	0.5	58.8	53.6	8.5	25.2	60.0	39.9	66.1	16.4	26.4	38.6
HIST1H1B	"H1.5, H1b, H1F5, H1s-3"	ENSG00000184357	"Histone cluster 1 H1 family member b"	P16401	6	27866849-27867529	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lymphoid tissue: 342.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.7;NB-4: 7.5;U-698: 5.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 13.0;dendritic cells: 12.7;T-cells: 3.4"									"CAB012241, HPA055907"	Approved		Supported	Nucleoplasm			510000	Nucleoplasm		"CAB012241: , HPA055907: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	1.1	0.4	0.4	22.9	0.5	18.2	2.1	0.5	0.4	1.7	7.3	0.0	0.0	0.3	0.5	1.0	10.2	0.3	1.9	0.6	0.5	0.5	0.4	0.6	3.9	10.7	0.5	0.0	0.4	0.4	0.3	0.4	6.4	0.0	0.4	0.5	0.0	0.8	0.3	0.4	1.4	7.0	0.3	1.7	14.4	1.3	1.7	0.0	342.6	0.6	10.5	26.0	2.0	0.7	13.0	12.7	0.7	1.1	1.8	3.4	2.1	2.2	0.0	0.8	0.0	0.0	0.0	1.7	0.7	0.6	1.0	0.6	0.7	1.5	2.6	0.4	0.8	0.8	0.0	0.0	0.1	0.8	0.9	3.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.2	0.0	0.9	2.6	1.9	0.1	0.4	13.7	7.5	2.1	0.0	4.2	0.0	0.0	0.4	0.0	1.9	1.1	2.3	0.3	0.0	1.0	2.4	0.8	1.4	0.1	1.3	1.0	2.8	0.0	5.8	1.9	0.9	1.3	0.0	0.9	0.0	3.3	0.9	1.7	4.8	3.1	3.4	5.1	13.0	1.7	1.8	0.7	1.8	1.1	12.7	3.4	2.1	0.4	0.5	0.5	0.4	0.5	0.5	0.5	0.0	0.0	0.0
HIST1H1C	"H1.2, H1c, H1F2, H1s-1"	ENSG00000187837	"Histone cluster 1 H1 family member c"	P16403	6	26055787-26056428	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 353.5"	"Cell line enhanced"	"Detected in many"		"K-562: 48.9;SiHa: 46.5;U-2 OS: 91.7;U-266/70: 101.7;U-266/84: 96.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 79.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 79.7"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	Nucleoplasm,Nucleoli			1800000	"Nucleoplasm, Nucleoli"		"CAB011507: AB_2117984, HPA055907: "	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (8.06e-5)"	25.1	17.4	10.1	32.1	10.2	94.7	36.0	23.8	12.8	29.8	23.3	8.1	14.3	15.0	24.7	21.0	48.6	16.6	27.4	37.6	9.3	7.3	23.8	43.1	31.4	37.2	8.2	8.7	34.4	46.6	2.3	5.8	29.1	6.9	44.3	21.2	26.5	22.0	9.5	69.1	21.0	21.1	22.9	12.5	28.4	25.6	33.7	5.4	353.5	21.7	28.5	39.7	38.8	28.0	14.9	5.9	79.7	3.2	3.3	8.6	4.2	5.7	4.2	3.1	3.3	8.0	1.6	0.1	2.9	4.8	13.8	14.7	2.2	4.2	0.4	16.8	3.8	2.5	1.0	2.2	3.9	5.6	3.6	2.4	4.6	2.5	2.3	1.1	5.8	11.2	3.1	1.8	3.0	2.1	48.9	36.8	6.8	2.6	2.9	2.6	1.7	6.4	1.5	1.4	18.7	8.1	4.2	8.0	2.7	46.5	8.0	3.2	9.9	1.7	0.9	6.3	91.7	1.8	1.3	101.7	96.6	4.4	4.6	38.1	2.1	35.8	2.6	79.7	3.8	2.6	4.8	9.8	6.3	4.1	5.6	14.9	5.8	4.4	43.0	3.3	3.2	5.9	8.6	4.2	10.1	10.2	23.8	12.8	9.3	7.3	8.2	8.7	6.9	5.4
HIST1H2AA	"bA317E16.2, H2AFR"	ENSG00000164508	"Histone cluster 1 H2A family member a"	Q96QV6	6	25726132-25726527	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	518	"testis: 453.1"	"Cell line enriched"	"Detected in single"	29	"HEK 293: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA041189	Supported									"HPA041189: "													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	2.9	1.7	0.9	0.9	0.9	0.5	1.1	2.9	1.1	2.0	1.6	2.4	1.8	1.1	5.6	1.0	2.2	1.2	1.2	1.0	2.6	1.0	0.9	2.7	4.1	1.1	1.4	3.7	12.3	0.7	0.8	0.5	0.7	16.6	9.3	3.8	3.3	3.1	3.0	0.9	5.4	1.4	1.3	6.9	3.4	0.7	4.2	1.3	32.9	2.5	1.1	14.0	1.3	2.4	2.4	23.0	1.5	1.2	19.0	23.3	5.5	1.0	3.6	1.6	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5
HIST1H2BE	"H2B.h, H2B/h, H2BFH"	ENSG00000274290	"Histone cluster 1 H2B family member e"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	26	"lymphoid tissue: 165.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 8.0;REH: 7.8"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.7	1.1	0.4	12.2	0.8	5.9	1.8	0.6	1.7	2.5	2.9	0.1	1.8	1.1	1.5	2.9	5.5	1.6	1.6	1.9	0.5		1.7	0.3	1.5	6.7	0.0	1.2	2.1	1.2	0.7	0.0	2.4	0.2	5.2	1.5	0.7	4.0	2.2	2.1	1.9	2.0	1.8	1.6	4.5	2.5	5.4	0.0	165.1	1.2	6.4	7.1	1.8	0.0	3.6	3.1	5.5	1.7	1.6	2.9	0.8	0.5	3.6	2.9	0.9	2.9	0.4	0.4	3.0	1.0	0.5	0.3	0.8	2.1	0.6	1.4	0.5	4.2	0.5	1.1	0.6	1.5	0.9	0.5	1.4	0.1	0.2	0.3	2.4	0.6	0.2	0.6	0.2	0.3	2.3	1.8	0.1	1.6	4.5	8.0	2.4	0.9	7.8	0.2	2.5	1.4	1.8	2.7	3.6	3.9	1.4	0.9	2.7	1.6	0.8	1.5	2.6	1.0	1.9	2.3	4.4	0.6	0.6	1.4	0.5	5.2	1.7	2.4	2.0	1.3	1.6	2.1	2.0	2.5	0.7	3.6	1.8	1.7	5.5	1.6	1.5	3.1	2.9	0.8										
HIST1H2BF	"H2B/g, H2BFG"	ENSG00000277224	"Histone cluster 1 H2B family member f"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	25	"lymphoid tissue: 252.2"	"Group enriched"	"Detected in some"	4	"U-266/70: 21.3;U-266/84: 15.0"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.2"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.4	1.2	0.0	17.3	0.1	3.8	5.7	0.3	0.7	2.7	3.3	0.4	1.0	0.5	1.6	1.3	9.9	1.3	1.2	0.6	0.0		0.5	0.4	2.5	7.0	0.0	0.2	0.8	0.6	0.4	0.0	3.2	0.2	5.4	1.1	0.5	1.4	1.3	0.2	0.4	3.0	0.3	0.9	8.3	1.3	2.2	0.1	252.2	0.4	3.3	14.6	2.4	0.0	3.0	0.7	6.2	0.7	0.4	1.5	1.2	0.4	0.2	0.2	0.4	0.2	0.0	0.2	0.1	0.1	0.6	0.1	0.5	0.0	0.5	0.9	0.0	0.8	0.4	0.1	0.3	0.6	0.2	0.3	1.4	0.1	0.1	0.1	0.7	0.2	0.0	0.1	0.1	0.1	1.6	3.8	0.0	0.1	3.2	1.3	0.5	0.5	1.2	0.6	2.4	0.1	0.1	2.1	0.3	4.1	0.8	0.0	3.7	0.2	0.1	0.3	1.9	0.0	0.5	21.3	15.0	1.2	0.1	0.9	0.4	0.0	0.2	1.4	0.7	0.3	1.5	0.7	0.7	0.8	0.4	3.0	0.6	1.2	6.2	0.4	0.7	0.7	0.6	1.2										
HIST1H2BG	"H2B.1A, H2B/a, H2BFA"	ENSG00000273802	"Histone cluster 1 H2B family member g"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 8.8;T-47d: 17.8;U-266/70: 16.7"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	0.4	1.5	0.7	16.5	1.2	8.9	20.2	5.1	3.4	4.3	2.9	0.5	5.1	1.8	2.8	4.0	6.6	2.1	1.8	1.7	0.2		1.2	0.6	2.0	7.2	0.1	2.0	1.3	1.9	0.4	0.5	1.6	0.7	10.3	3.0	1.2	5.0	5.8	0.3	1.6	2.2	2.8	4.7	3.1	2.9	6.7	0.3	75.2	1.0	6.9	8.3	4.3	0.0	5.8	14.6	12.0	1.6	1.3	6.2	2.0	2.4	0.1	1.2	0.0	3.8	0.2	0.3	3.1	0.2	2.0	0.8	0.3	2.1	0.0	3.1	0.3	2.6	1.1	1.0	1.1	2.1	1.3	0.7	1.2	1.1	0.6	0.2	2.0	1.4	0.5	0.6	0.0	0.4	7.6	0.1	0.0	1.8	2.2	1.7	1.2	1.6	1.4	0.7	4.3	1.1	0.6	7.2	1.1	8.8	3.2	1.0	17.8	0.8	0.2	0.0	1.0	0.3	0.4	16.7	0.1	0.0	0.3	1.0	0.5	12.0	1.2	2.5	2.0	0.9	6.2	3.7	3.1	3.8	4.4	5.8	1.5	1.3	5.6	1.3	1.6	14.6	2.7	2.0										
HIST1H2BI	"H2B/k, H2BFK"	ENSG00000278588	"Histone cluster 1 H2B family member i"	P62807	6	26272976-26273356	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 150.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 5.3;MOLT-4: 14.8;THP-1: 6.2"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.5	0.1	0.0	19.0	0.0	8.9	1.2	0.4	0.1	1.3	3.1	0.0	0.5	0.1	0.7	2.1	6.6	0.4	2.0	1.3	0.0		0.3	0.1	2.0	6.3	0.0	0.0	0.7	0.1	0.1	0.0	2.8	0.0	0.1	0.3	0.0	1.3	0.3	0.1	1.2	1.9	0.1	0.1	11.1	0.4	1.9	0.0	150.8	0.4	8.2	14.5	2.2	0.0	4.7	0.7	0.9	1.3	0.4	4.6	0.2	1.8	0.8	1.2	0.0	0.0	0.0	0.2	0.7	0.7	2.0	5.3	0.8	0.0	0.9	0.4	0.4	0.9	1.8	0.5	0.8	2.6	0.0	0.4	0.8	0.6	0.0	0.0	0.4	0.0	0.4	0.0	0.0	1.8	0.0	3.8	0.0	0.7	14.8	2.5	2.8	0.0	4.0	0.0	4.9	0.0	0.4	0.3	0.9	1.1	1.0	0.0	0.0	6.2	0.9	0.8	0.0	0.6	3.0	3.1	0.4	0.0	1.1	0.5	2.2	0.2	0.5	0.0	3.4	1.3	2.2	2.2	3.2	4.6	0.7	4.7	1.4	0.8	0.9	0.4	0.1	0.3	1.5	0.2										
HIST1H2BL	"dJ97D16.4, H2B/c, H2BFC"	ENSG00000185130	"Histone cluster 1 H2B family member l"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	16	"lymphoid tissue: 217.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.9;U-266/84: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Low lineage specificity"	"Detected in many"											"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: , HPA043013: , HPA048671: "	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	1.2	1.0	0.2	13.9	1.0	13.7	1.6	1.4	0.6	1.8	5.1	0.0	0.3	0.6	0.8	0.6	7.4	0.9	0.9	1.3	0.9	0.7	0.3	0.6	1.5	3.5	0.5	0.0	1.3	1.2	1.2	0.2	1.9	0.0	1.2	1.1	0.0	0.7	0.2	0.2	0.9	3.9	0.7	2.8	4.8	0.8	1.5	0.0	217.6	1.2	5.9	15.6	1.1	1.2	1.9	1.2	7.7	0.6	0.4	2.0	0.9	2.4	2.2	0.7	2.3	0.0	0.0	0.1	1.4	0.4	1.2	3.2	1.0	1.7	0.9	0.5	0.3	1.5	0.0	0.2	0.4	1.1	3.2	1.7	3.1	3.8	0.0	2.8	2.3	1.0	0.0	0.0	0.0	0.7	2.2	5.7	0.0	6.0	12.9	4.8	2.1	3.3	3.0	0.0	1.4	0.0	2.2	3.0	1.1	3.9	1.6	0.2	1.4	0.9	0.5	0.1	1.6	1.3	1.0	3.3	12.7	4.2	0.4	5.0	0.5	0.6	0.5	4.0	1.1	0.2	1.3	1.9	0.6	1.1	1.2	1.3	0.4	0.6	7.7	0.4	0.6	0.7	2.0	0.9	0.2	1.0	1.4	0.5	0.9	0.7	0.5	0.0	0.0	0.0
HIST3H2A	MGC3165	ENSG00000181218	"Histone cluster 3 H2A"	Q7L7L0	1	228456979-228457873	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"brain: 35.8;lymphoid tissue: 62.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 18.4;U-266/70: 18.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 35.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041189	Supported									"HPA041189: "	"unprognostic (3.65e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (3.73e-4)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.67e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.76e-2)"	2.5	20.5	4.3	7.0	8.3	11.1	5.8	35.8	8.1	9.9	3.8	2.4	2.0	7.7	5.0	4.4	7.0	4.2	3.8	4.9	5.4	4.6	1.6	1.0	2.5	5.1	5.6	5.3	8.3	4.5	3.5	5.0	3.4	6.5	7.0	2.8	13.9	6.6	3.9	1.0	6.4	4.2	1.5	5.2	6.6	4.7	3.5	4.8	62.3	1.9	5.6	9.3	2.9	9.3	3.4	3.4	5.1	7.1	6.8	11.7	4.3	3.5	1.9	2.5	3.4	2.1	2.1	3.0	1.7	1.7	5.1	3.6	1.8	2.9	1.6	2.1	0.4	8.7	1.8	0.8	1.2	2.5	18.4	2.5	2.5	0.0	4.9	1.7	5.1	4.7	5.2	0.9	2.2	2.1	8.8	0.0	0.0	5.0	2.3	0.0	3.8	4.7	0.0	0.0	13.3	0.8	2.1	15.5	10.9	6.2	5.5	11.9	9.8	1.3	0.8	0.0	0.0	6.8	1.5	18.5	13.1	0.0	1.8	1.8	1.3	5.1	1.7	0.0	7.1	3.1	5.1	3.4	6.8	5.3	3.4	2.0	5.3	5.2	0.7	6.8	7.1	0.6	11.7	4.3	4.3	8.3	35.8	5.9	5.4	4.6	5.6	5.3	6.5	4.8
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"Human immunodeficiency virus type I enhancer binding protein 2"	P31629	6	142751467-142956698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm				Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	11.3	9.7	13.9	13.6	17.4	4.2	9.2	29.8	30.1	6.3	7.2	5.9	3.8	6.1	8.6	7.3	11.7	15.9	13.5	10.5	15.7	10.4	8.5	7.7	10.6	14.9	9.3	12.8	18.5	13.4	19.0	8.7	9.6	12.7	7.3	6.3	7.1	10.9	8.6	24.3	10.6	8.0	10.1	13.5	10.4	6.5	2.7	8.5	18.6	11.2	9.6	15.5	12.5	12.0	2.1	1.1	2.3	0.6	1.7	3.9	1.2	3.6	0.7	0.8	3.2	7.2	8.1	2.6	5.3	13.6	3.3	4.0	0.3	3.0	5.8	3.3	23.3	2.3	1.4	10.8	8.2	2.2	1.7	1.5	2.4	1.4	5.4	5.0	0.0	7.4	10.8	13.6	15.6	1.8	0.1	5.3	5.6	4.1	6.6	2.1	0.8	5.3	8.7	5.9	0.5	3.0	6.4	8.9	3.8	7.0	5.8	3.9	1.0	3.0	1.9	11.2	2.8	9.4	4.6	11.1	1.8	12.5	3.1	3.9	5.2	0.0	0.3	0.0	1.6	0.6	3.6	2.1	3.9	3.2	1.1	1.3	3.9	3.0	2.3	1.7	0.5	0.5	2.9	1.2	13.9	17.4	29.8	30.1	15.7	10.4	9.3	12.8	12.7	8.5
HK1		ENSG00000156515	"Hexokinase 1"	P19367	10	69269984-69401884	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glycolysis, Immunity, Inflammatory response, Innate immunity"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007043, HPA007044, CAB010052, HPA011956"	Supported		Supported	Mitochondria			16000000	Mitochondria		"CAB010052: AB_627721, HPA007043: AB_1850652, HPA007044: AB_1079049, HPA011956: AB_1850758"	"unprognostic (8.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (3.39e-6)"	"unprognostic (1.23e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.86e-2)"	17.5	10.5	21.1	19.9	30.4	23.5	15.8	40.0	48.6	16.6	16.9	10.1	7.6	6.3	13.5	9.4	44.8	15.2	12.6	61.6	19.8	23.3	10.8	4.4	17.2	14.3	19.8	31.3	9.0	4.6	12.5	14.7	22.6	31.3	25.5	15.4	21.2	21.5	26.8	62.1	30.7	8.6	25.6	9.7	13.3	20.3	28.9	10.6	18.9	33.6	32.6	23.0	25.8	23.1	11.4	25.5	17.8	39.3	8.9	23.0	29.6	17.4	9.9	13.3	12.7	14.9	11.2	8.5	17.4	45.8	23.3	25.2	2.9	1.9	1.2	13.8	29.1	15.3	12.4	38.9	22.3	11.6	9.7	43.4	10.6	0.2	17.0	0.8	32.9	16.9	22.7	33.3	74.5	24.1	72.3	9.2	31.9	28.9	5.0	2.2	20.4	44.3	7.7	8.1	0.1	16.1	20.6	13.7	16.1	19.9	38.7	11.5	21.1	2.8	24.7	34.8	15.9	19.1	24.2	11.0	7.2	3.0	45.1	22.8	10.0	17.8	27.3	13.4	14.0	39.3	23.0	11.4	16.2	15.8	25.5	6.8	14.5	11.5	6.6	8.9	39.3	2.9	17.8	29.6	21.1	30.4	40.0	48.6	19.8	23.3	19.8	31.3	31.3	10.6
HK2		ENSG00000159399	"Hexokinase 2"	P52789	2	74833981-74893359	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 26.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028587	Enhanced									"HPA028587: AB_10602605"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (2.85e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.67e-2)"	27.0	2.2	4.4	9.5	5.0	20.4	10.8	0.7	4.5	5.3	23.2	7.3	5.7	1.3	2.6	40.1	13.6	4.8	9.1	8.3	2.8	2.3	2.1	1.4	16.5	5.0	8.5	1.1	14.9	3.5	1.1	1.7	13.2	5.4	4.0	19.2	9.6	10.3	0.5	29.3	9.7	8.9	1.7	10.9	7.4	8.7	24.8	7.4	4.3	7.1	22.3	9.2	29.0	8.3	0.8	6.2	26.2	7.1	0.0	0.8	2.0	16.2	0.1	3.8	13.7	32.3	3.4	14.0	6.3	9.2	7.1	10.3	13.0	2.9	11.8	6.1	2.9	5.6	17.2	13.3	20.8	3.3	3.7	16.0	3.7	17.8	10.2	23.3	26.3	5.6	14.5	13.6	23.8	3.4	13.9	0.0	2.0	11.5	5.6	23.9	13.6	11.3	9.2	7.9	9.2	4.3	22.9	2.7	13.4	4.0	20.4	8.0	1.0	3.7	2.7	22.8	4.0	9.4	11.4	8.1	2.3	5.9	53.2	17.1	5.8	6.6	7.1	26.2	0.1	5.7	0.3	0.6	0.4	0.1	6.2	0.8	0.7	0.7	5.9	0.0	3.7	0.1	0.8	2.0	4.4	5.0	0.7	4.5	2.8	2.3	8.5	1.1	5.4	7.4
HK3		ENSG00000160883	"Hexokinase 3"	P52790	5	176880869-176899332	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 76.2;bone marrow: 55.0;lymphoid tissue: 40.6"	"Cell line enriched"	"Detected in some"	4	"U-937: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"basophil: 76.2"	"Group enriched"	"Detected in many"	11	"granulocytes: 76.2;monocytes: 31.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056743	Enhanced						1700000			"HPA056743: "	"unprognostic (4.22e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.69e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.82e-1)"	"prognostic unfavourable (3.84e-8)"	"unprognostic (7.02e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.42e-2)"	9.2	2.6	0.6	8.5	1.0	55.0	1.3	0.3	1.2	0.4	1.7	0.3	0.0	0.9	0.8	2.6	1.9	3.0	0.9	5.4	0.6	0.3	1.6	4.1	16.3	24.1	1.2	0.5	1.2	1.0	0.0	0.4	2.9	0.5	0.9	0.6	0.9	0.9	0.1	0.8	0.3	1.6	3.4	0.6	40.6	1.2	0.6	0.2	1.3	1.5	0.2	1.2	1.8	5.3	0.0	5.1	76.2	31.4	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.1	0.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	20.8	0.0	76.2	15.4	32.9	0.0	29.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	5.4	0.0	31.4	0.2	0.0	6.0	0.6	1.0	0.3	1.2	0.6	0.3	1.2	0.5	0.5	0.2
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	"P16188, P04439, P13746"	6	29941260-29945884	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 154.8;fHDF/TERT166: 41.4;HBEC3-KT: 42.5;RPMI-8226: 40.3;U-266/70: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB078470			Supported	"Golgi apparatus,Plasma membrane"				"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favourable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favourable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	69.4	57.5	16.0	69.1	18.2	41.2	40.8	9.1	20.7	54.4	92.6	20.4	28.6	105.7	38.4	76.2	48.4	27.8	92.3	59.1	14.6	16.6	80.5	47.6	112.0	90.5	19.5	8.9	57.2	30.0	22.5	33.3	38.7	22.7	64.1	38.5	52.4	28.3	19.2	44.0	110.4	129.4	30.3	22.8	150.0	115.9	26.6	12.3	71.1	62.3	38.5	97.7	86.4	41.0	23.0	10.9	65.8	25.2	25.9	46.7	45.4	154.8	3.9	0.0	0.0	25.0	23.6	0.1	0.1	0.3	0.2	0.2	0.0	0.0	0.4	0.0	41.4	3.8	0.0	42.5	0.0	0.3	1.5	27.0	1.2	0.8	1.4	0.0	1.8	0.2	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.4	0.3	0.4	3.3	0.3	40.3	29.0	31.8	0.0	1.4	3.5	0.0	1.4	0.1	3.6	0.5	2.3	0.1	0.7	0.4	41.3	10.5	8.7	0.0	22.8	0.0	65.8	25.2	35.4	38.3	17.9	28.8	23.0	29.6	34.4	4.1	14.9	21.7	29.7	47.9	25.9	19.8	10.9	46.7	45.4	16.0	18.2	9.1	20.7	14.6	16.6	19.5	8.9	22.7	12.3
HLA-C	"D6S204, HLA-JY3, PSORS1"	ENSG00000204525	"Major histocompatibility complex, class I, C"	P10321	6	31268749-31272130	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 93.9;EFO-21: 103.9;RPTEC TERT1: 59.4;U-266/70: 62.7;U-266/84: 48.8;U-698: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (2.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.16e-2)"	48.6	34.7	14.8	87.9	17.9	38.3	32.9	7.8	14.3	33.1	51.3	11.7	8.7	1.8	36.4	92.7	25.1	49.7	37.6	62.2	13.9	9.9	41.4	92.2	165.9	100.3	21.5	2.8	47.5	16.6	1.4	21.1	34.5	19.5	35.8	11.2	29.2	25.9	20.5	25.0	42.3	117.4	18.2	18.0	142.8	40.1	20.3	17.0	36.5	33.5	12.7	58.9	64.2	42.8	0.2	0.2	2.0	1.2	0.5	0.6	22.3	93.9	0.1	0.0	0.0	15.9	12.6	0.2	0.4	0.1	0.1	0.3	0.1	0.0	0.0	103.9	24.1	0.0	0.0	23.9	0.0	0.1	21.8	0.1	1.1	0.0	0.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.2	0.0	0.2	59.4	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.4	0.0	25.8	8.7	0.3	0.3	62.7	48.8	35.6	0.0	1.0	0.0	1.0	1.2	1.5	0.5	0.5	0.4	0.2	0.3	0.4	0.2	0.2	0.3	0.3	2.0	0.5	0.2	0.1	0.6	22.3	14.8	17.9	7.8	14.3	13.9	9.9	21.5	2.8	19.5	17.0
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004178-33009612	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.3;HDLM-2: 4.5;REH: 20.2;U-698: 4.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 9.1;naive B-cell: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 11.2;dendritic cells: 9.1;monocytes: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045038	Enhanced									"HPA045038: AB_10959457"	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	5.7	5.7	2.2	18.4	3.9	2.0	5.1	1.5	2.1	4.5	4.0	8.3	2.2	5.1	4.6	6.0	2.7	4.6	4.8	9.3	2.8	3.1	10.0	3.4	18.1	24.7	5.5	2.0	5.7	2.9	3.3	3.3	1.0	5.4	5.4	4.7	4.0	4.5	3.2	1.2	2.5	12.3	2.4	9.6	25.5	4.5	1.2	3.9	14.7	3.8	3.2	30.6	3.4	3.1	11.2	9.1	0.3	4.4	0.1	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.4	0.0	7.4	0.0	0.3	9.1	11.2	0.1	0.9	0.3	0.1	2.0	2.8	0.7	1.4	2.2	3.9	1.5	2.1	2.8	3.1	5.5	2.0	5.4	3.9
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439842-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 211.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 55.4;HDLM-2: 98.7;REH: 40.2;U-266/70: 24.3;U-698: 56.9;U-87 MG: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 29.8;intermediate monocyte: 46.8;memory B-cell: 59.4;naive B-cell: 61.7;non-classical monocyte: 28.0;plasmacytoid DC: 29.6"	"Group enriched"	"Detected in all"	5	"B-cells: 61.7;dendritic cells: 29.6;monocytes: 46.8"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced						1600000			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favourable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	51.8	33.5	14.1	79.1	20.2	1.8	37.3	2.3	10.1	21.1	38.9	21.5	10.9	30.8	16.5	76.8	15.9	33.9	21.8	34.7	13.1	16.2	60.9	17.8	147.2	211.6	27.3	7.4	14.7	10.0	1.7	14.7	9.7	23.5	21.9	33.8	23.5	21.6	12.6	12.9	27.6	86.2	9.0	52.8	127.3	68.7	7.2	21.6	53.7	18.6	25.9	151.6	53.5	15.1	61.7	29.6	9.3	46.8	1.8	2.7	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	55.4	0.4	0.0	0.0	0.0	0.0	0.0	98.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	24.3	0.0	56.9	39.6	0.0	0.0	0.6	29.8	9.3	0.3	46.8	0.1	59.4	0.3	1.7	0.5	61.7	0.2	0.3	2.2	1.8	28.0	29.6	2.7	29.9	14.1	20.2	2.3	10.1	13.1	16.2	27.3	7.4	23.5	21.6
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	"P04229, Q29974, Q9GIY3, P01911"	6	32578769-32589848	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.6;lung: 95.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 154.0;HMC-1: 21.9;U-266/70: 20.5;U-698: 26.5;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 95.6"	"Group enriched"	"Detected in all"	10	"B-cells: 41.3;dendritic cells: 95.6;monocytes: 52.5"									"CAB015400, CAB034021, HPA043151"	Enhanced									"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: "	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	36.8	18.7	9.7	32.2	15.9	8.7	24.9	3.6	10.0	14.2	18.2	11.5	11.2	0.2	10.5	27.2	12.1	13.3	12.0	11.9	8.5	6.9	50.0	15.6	95.9	80.8	18.9	5.4	6.9	8.0	0.0	9.4	5.7	14.8	9.5	23.7	16.1	11.3	2.4	8.2	13.3	42.1	3.8	19.7	62.1	38.1	5.6	13.2	33.6	14.1	3.8	44.7	29.7	17.0	41.3	95.6	6.3	52.5	2.7	4.7	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.2	0.0	0.6	0.0	154.0	1.7	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	3.7	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	3.4	0.6	18.5	0.0	0.0	0.1	0.2	0.0	20.5	0.5	26.5	42.5	0.7	0.0	0.2	34.6	6.3	1.8	52.5	0.3	32.7	1.2	3.7	95.6	41.3	0.1	1.6	1.2	2.7	26.9	20.4	4.7	37.7	9.7	15.9	3.6	10.0	8.5	6.9	18.9	5.4	14.8	13.2
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 25.4;HEK 293: 9.0;HEL: 6.2;HHSteC: 7.7;U-266/70: 6.3;U-937: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"																		27000000				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"	12.2	8.0	3.9	33.3	6.5	3.1	10.8	2.6	3.6	8.2	15.7	2.3	5.2	33.2	9.4	10.7	7.5	7.5	24.8	10.7	2.9	2.8	8.2	7.7	24.0	39.4	4.2	2.6	3.9	4.4	1.5	5.3	2.8	3.9	6.2	4.1	8.9	16.2	5.3	6.7	28.0	21.7	6.4	4.1	43.9	36.5	4.9	3.7	9.7	8.9	11.0	18.7	11.4	8.7	11.6	3.2	28.5	13.8	15.3	20.4	14.8	25.4	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	9.0	6.2	0.2	0.0	7.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.3	1.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.1	0.1	0.9	0.1	6.3	1.3	0.0	0.0	9.6	0.1	28.5	9.4	20.6	20.4	9.8	13.5	11.6	13.4	16.8	0.6	9.6	13.4	13.3	14.5	15.3	13.8	3.2	13.2	14.8	3.9	6.5	2.6	3.6	2.9	2.8	4.2	2.6	3.9	3.7
HM13	"dJ324O17.1, H13, IMP1, IMPAS, PSENL3, PSL3, SPP, SPPL1"	ENSG00000101294	"Histocompatibility minor 13"	Q8TCT9	20	31514428-31577923	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045089, HPA056062"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA045089: AB_10962054, HPA056062: "	"unprognostic (8.03e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.87e-3)"	"prognostic unfavourable (1.95e-5)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.10e-2)"	"prognostic unfavourable (4.64e-12)"	"unprognostic (3.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.17e-2)"	25.2	34.3	9.2	20.1	11.1	19.8	36.4	10.2	17.5	37.9	17.0	13.2	64.7	18.1	23.3	40.7	39.2	21.4	24.1	17.9	9.3	13.0	30.2	121.3	25.5	38.7	10.8	9.8	20.8	132.3	24.4	28.6	45.9	14.5	22.4	16.3	15.4	149.6	84.3	13.1	15.0	17.8	17.9	11.0	22.0	25.3	11.7	9.0	15.5	33.5	21.5	30.5	18.1	21.4	16.7	48.2	50.1	65.3	19.4	29.8	52.6	24.6	26.0	10.5	15.5	47.9	30.8	36.2	42.2	39.5	28.9	29.8	51.6	29.7	15.9	56.9	46.0	45.1	14.7	28.4	19.0	8.0	19.9	35.2	19.0	31.0	53.3	20.0	14.1	28.1	18.5	24.4	33.4	22.3	15.5	63.3	26.7	29.1	17.1	14.4	12.1	44.6	10.9	49.5	74.2	27.8	13.2	13.8	16.7	43.2	41.6	34.1	32.3	19.1	27.0	43.9	23.4	44.2	23.7	40.9	24.3	12.6	59.9	72.2	38.7	18.4	65.3	31.8	21.7	64.0	29.8	16.7	20.5	20.9	46.0	12.6	13.8	16.2	50.1	19.4	58.6	48.2	18.1	52.6	9.2	11.1	10.2	17.5	9.3	13.0	10.8	9.8	14.5	9.0
HMBS	"PBGD, PORC, UPS"	ENSG00000256269	"Hydroxymethylbilane synthase"	P08397	11	119084866-119093549	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 75.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006114, HPA050659"	Supported		Approved	"Lipid droplets"			28000000	"Lipid droplets"		"HPA006114: AB_1079067, HPA050659: "	"unprognostic (6.24e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.42e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.90e-3)"	"unprognostic (3.91e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.11e-2)"	5.5	11.0	5.3	6.2	9.3	75.2	8.6	5.2	8.0	5.5	8.3	6.0	6.0	7.9	6.9	7.9	9.4	5.5	6.4	11.5	5.9	5.5	9.9	22.2	5.8	14.5	8.8	4.5	3.7	21.2	7.9	5.9	9.7	8.4	5.5	9.2	4.1	10.1	7.2	17.4	6.0	7.9	6.8	9.7	10.4	7.1	7.4	7.5	6.0	8.4	13.0	9.3	5.7	4.8	7.7	19.1	12.0	14.0	3.8	7.4	9.4	9.1	14.0	6.7	11.9	5.4	6.7	10.1	7.3	8.3	10.8	9.3	17.3	14.5	14.2	16.4	9.3	13.0	10.0	14.2	6.9	9.7	10.2	23.3	5.6	12.6	9.9	8.7	7.6	7.3	9.1	17.0	13.0	5.0	34.5	6.3	8.5	36.8	8.4	16.8	7.5	8.9	9.7	6.6	13.8	10.8	8.4	7.4	10.1	5.9	9.2	6.4	15.7	12.1	4.6	8.2	6.2	8.0	8.5	3.4	4.0	8.4	5.4	11.5	9.7	12.0	14.0	1.4	5.1	12.2	6.7	7.7	4.8	5.7	19.1	7.2	7.4	5.6	0.4	3.8	7.3	12.3	4.9	9.4	5.3	9.3	5.2	8.0	5.9	5.5	8.8	4.5	8.4	7.5
HMGA2	"BABL, HMGIC, LIPO"	ENSG00000149948	"High mobility group AT-hook 2"	P52926	12	65824131-65966295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, DNA condensation, Growth regulation, Mitosis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.3"	"Cell line enhanced"	"Detected in many"		"AF22: 66.0;NTERA-2: 38.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"CAB017809, HPA039076"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB017809: , HPA039076: "	"unprognostic (2.39e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.21e-3)"	"prognostic unfavourable (4.79e-4)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.33e-2)"	"unprognostic (4.55e-5)"	"unprognostic (4.22e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (2.86e-4)"	6.5	0.3	0.5	3.8	0.8	8.1	2.1	0.2	0.6	2.5	7.6	0.4	0.0	2.4	2.7	0.1	1.1	2.4	3.3	0.5	0.3	0.4	1.0	0.4	0.5	0.1	0.3	1.3	2.1	1.7	0.0	1.7	0.3	0.6	0.5	4.6	0.4	0.5	1.8	2.0	0.7	5.1	0.7	1.7	0.8	2.1	25.3	0.0	0.8	1.1	3.0	0.1	0.8	2.8	0.7	0.3	3.8	2.1	1.3	0.7	0.1	9.5	4.2	66.0	9.4	3.1	17.3	0.0	30.5	13.9	5.4	5.4	5.4	4.0	0.0	19.8	1.4	4.2	10.9	26.2	25.7	0.0	11.4	0.0	0.1	33.0	1.7	0.9	0.1	13.1	1.6	11.5	20.8	21.1	0.0	0.1	30.5	0.0	0.1	5.4	38.7	19.0	2.6	3.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	16.7	0.1	0.1	24.6	19.4	5.8	14.8	9.1	0.0	0.0	0.0	23.4	0.0	4.4	3.8	1.0	0.7	0.5	0.6	0.3	0.3	0.4	0.5	0.2	0.7	0.4	0.7	2.5	1.3	2.1	0.3	0.3	0.1	0.5	0.8	0.2	0.6	0.3	0.4	0.3	1.3	0.6	0.0
HMGB1	"DKFZp686A04236, HMG1, HMG3, SBP-1"	ENSG00000189403	"High mobility group box 1"	P09429	13	30456704-30617597	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Autophagy, Chemotaxis, DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Inflammatory response, Innate immunity"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003506, CAB005873"	Supported		Supported	Nucleoplasm	"Intracellular and membrane"		2000000	Nucleoplasm		"CAB005873: AB_444360, HPA003506: AB_1079070"	"unprognostic (9.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.44e-2)"	"unprognostic (4.29e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.28e-3)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-1)"	"unprognostic (9.13e-3)"	"unprognostic (1.97e-2)"	52.0	40.0	71.2	57.0	86.8	147.8	57.6	69.6	66.1	56.0	55.0	59.6	45.1	47.6	69.7	48.8	58.5	50.2	39.4	40.3	71.2	58.7	42.4	61.1	43.6	104.8	90.3	57.3	56.1	34.5	28.4	53.3	42.7	70.6	47.5	67.3	40.0	43.0	51.7	62.6	41.2	51.6	70.3	85.8	53.8	44.8	27.1	91.2	68.8	48.9	48.3	120.9	51.0	79.5	90.8	78.1	133.2	74.8	87.6	102.9	132.3	50.7	39.4	91.6	68.4	25.7	25.6	36.1	64.9	35.4	62.8	42.6	62.3	85.6	103.4	33.9	58.7	56.9	95.7	52.3	108.6	54.3	40.1	108.6	28.7	57.1	14.1	155.8	66.3	16.9	27.9	46.6	43.4	83.9	71.9	37.2	55.3	94.3	198.6	167.4	77.1	44.2	167.4	126.1	60.8	58.8	50.5	83.0	75.0	59.5	44.3	33.0	43.4	117.1	52.0	42.2	61.1	45.0	75.2	33.7	43.4	221.7	17.2	103.3	88.3	127.3	74.8	133.2	75.5	60.7	84.2	87.9	86.6	84.5	78.1	90.8	78.6	74.9	96.4	87.6	57.4	77.3	102.9	132.3	71.2	86.8	69.6	66.1	71.2	58.7	90.3	57.3	70.6	91.2
HMGB2	HMG2	ENSG00000164104	"High mobility group box 2"	P26583	4	173331695-173335125	"Plasma proteins, Predicted intracellular proteins"	"Chemotaxis, DNA recombination, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 95.9;bone marrow: 325.8;lymphoid tissue: 187.1"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003506, CAB037206, HPA053314"	Enhanced		Supported	Nucleoplasm,Nucleoli	"Intracellular and membrane"		380000	Nucleoplasm	Nucleoli	"CAB037206: AB_1079071, HPA003506: AB_1079070, HPA053314: "	"unprognostic (2.82e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (8.37e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.04e-4)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (7.60e-12)"	"unprognostic (1.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.21e-2)"	18.8	5.9	10.3	48.9	13.2	325.8	19.9	6.6	9.5	17.1	24.0	8.6	7.9	15.7	18.6	16.2	28.6	15.4	13.8	23.4	9.5	10.2	13.2	6.9	25.4	59.8	12.5	8.2	29.0	5.8	2.9	8.0	18.5	9.3	19.0	21.2	12.2	13.8	8.6	46.2	15.5	21.5	25.3	13.3	36.7	13.0	26.7	10.6	187.1	18.7	23.0	61.6	27.1	18.5	11.6	16.8	95.9	20.5	11.9	39.9	14.3	34.3	8.2	70.9	31.6	8.8	8.8	27.2	25.6	19.5	28.2	25.3	23.3	48.0	116.2	5.8	14.3	13.4	46.5	14.0	44.2	71.1	21.7	127.7	20.9	34.1	8.6	112.9	49.3	8.5	4.3	14.1	32.2	29.0	48.1	163.7	25.9	28.7	168.3	104.8	25.8	14.3	85.1	36.4	43.1	16.3	14.7	61.4	55.4	25.9	15.0	11.5	20.8	82.4	16.6	12.7	37.6	15.7	38.4	52.9	29.6	133.0	10.8	82.6	33.0	95.9	20.5	57.6	15.6	8.5	14.1	11.6	22.7	21.2	16.8	8.8	15.0	14.3	47.8	11.9	6.8	6.8	39.9	14.3	10.3	13.2	6.6	9.5	9.5	10.2	12.5	8.2	9.3	10.6
HMGB3	"HMG2A, HMG4, MGC90319"	ENSG00000029993	"High mobility group box 3"	O15347	X	150980509-150990775	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	DNA-binding	Microphthalmia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 54.3"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 107.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA062583	Enhanced		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA062583: "	"unprognostic (2.85e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.66e-3)"	"unprognostic (4.54e-3)"	"unprognostic (2.70e-2)"	"prognostic favourable (9.85e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.96e-2)"	"prognostic favourable (6.15e-4)"	"unprognostic (2.58e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	4.4	5.4	7.9	4.8	7.1	20.3	4.1	2.8	10.3	10.8	12.0	4.7	3.9	7.3	6.3	13.4	10.2	4.4	3.2	4.5	9.8	7.6	9.0	41.6	5.9	6.3	6.1	7.3	3.1	7.1	18.7	1.6	54.3	9.7	3.7	9.2	5.3	9.7	4.3	20.5	6.8	7.6	3.6	5.0	8.4	4.0	26.0	3.2	18.2	6.2	5.1	9.5	4.9	3.7	3.1	6.5	11.8	5.3	0.9	6.2	2.3	37.1	16.5	52.0	27.0	2.2	6.5	64.7	16.3	10.8	19.0	9.9	13.0	15.4	26.0	52.6	12.5	17.9	47.3	107.0	21.4	17.7	13.8	22.6	15.9	20.4	3.2	34.0	11.5	5.1	25.3	7.7	19.6	24.5	11.7	15.5	22.5	28.5	37.5	26.2	30.8	20.2	46.0	42.3	14.7	13.9	17.8	37.5	24.5	24.2	26.2	8.1	23.1	22.6	18.4	7.9	18.7	25.1	35.9	14.1	17.5	96.4	9.4	17.4	16.0	0.0	4.8	11.8	0.5	3.2	0.1	3.1	2.4	3.3	6.5	0.6	0.0	0.2	0.6	0.9	5.3	3.3	6.2	2.3	7.9	7.1	2.8	10.3	9.8	7.6	6.1	7.3	9.7	3.2
HMGCL	HL	ENSG00000117305	"3-hydroxymethyl-3-methylglutaryl-CoA lyase"	P35914	1	23801885-23838620	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004727	Enhanced				"Intracellular and membrane"		120000			"HPA004727: AB_1079074"	"unprognostic (8.24e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (7.67e-4)"	"unprognostic (1.23e-3)"	"unprognostic (5.47e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.05e-1)"	"unprognostic (8.24e-2)"	"prognostic favourable (5.07e-8)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.39e-3)"	7.4	18.5	6.4	8.2	6.6	1.6	14.3	4.3	7.7	7.6	13.9	9.0	12.0	12.0	6.2	13.2	9.1	9.7	12.8	11.2	5.9	6.0	30.3	81.4	8.8	11.1	7.5	7.1	6.1	15.2	13.1	7.8	8.5	7.9	8.7	14.2	10.0	8.9	11.5	15.2	7.0	15.4	11.7	9.3	8.6	10.8	7.2	6.1	8.3	14.5	8.1	8.3	8.8	6.7	24.1	27.7	40.8	33.8	24.5	21.2	26.8	10.7	6.2	7.0	5.2	28.5	21.8	2.7	8.5	15.0	9.3	11.3	3.9	20.9	5.6	17.6	13.3	8.7	8.3	13.8	10.1	11.5	6.3	7.5	5.5	8.8	36.9	2.9	5.0	25.2	20.6	12.2	23.4	12.6	7.6	8.0	16.9	11.0	4.5	5.8	1.8	8.6	6.5	5.7	10.4	21.8	5.6	5.9	5.2	11.1	4.2	18.8	13.3	7.3	9.3	7.7	4.7	14.0	3.6	11.4	5.6	5.0	19.1	10.9	8.9	40.8	32.4	30.1	18.4	30.4	20.1	21.9	20.0	21.2	27.7	24.1	20.3	19.4	12.2	24.5	33.8	20.6	20.8	26.8	6.4	6.6	4.3	7.7	5.9	6.0	7.5	7.1	7.9	6.1
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75362104	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797"	Approved									"CAB016797: , HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	5.6	28.9	12.4	8.7	31.1	12.1	16.4	14.4	36.3	13.9	23.0	10.9	7.1	18.9	9.0	14.4	35.0	6.5	8.2	4.0	21.8	16.5	12.1	53.5	12.1	7.0	9.8	19.4	15.2	8.4	16.2	11.4	9.2	29.6	12.4	19.7	7.8	12.4	4.5	3.4	36.1	19.0	6.8	17.0	7.9	14.6	14.0	8.8	13.9	12.5	23.2	12.4	6.2	18.1	4.3	12.5	23.2	11.0	9.5	6.5	5.1	15.8	6.3	63.7	21.9	13.5	26.1	16.0	4.6	12.8	9.4	20.9	23.5	39.2	14.2	16.7	7.4	20.1	33.0	53.7	9.9	4.8	12.1	10.8	9.5	18.1	19.9	9.0	8.0	16.9	31.6	32.6	16.2	7.5	11.6	21.8	14.7	10.4	16.6	9.1	27.2	4.7	11.7	19.0	20.3	38.5	37.2	22.1	10.0	10.1	10.5	9.1	10.3	23.8	8.7	5.1	7.6	5.4	7.8	7.0	8.8	19.6	7.4	17.7	10.5	6.7	11.0	6.3	6.1	6.9	5.1	4.3	4.6	6.4	12.5	4.2	4.5	6.2	23.2	9.5	7.4	3.9	6.5	5.1	12.4	31.1	14.4	36.3	21.8	16.5	9.8	19.4	29.6	8.8
HMGCS1	HMGCS	ENSG00000112972	"3-hydroxy-3-methylglutaryl-CoA synthase 1"	Q01581	5	43289395-43313512	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 117.0"	"Cell line enhanced"	"Detected in all"		"AF22: 123.5;HBEC3-KT: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032907, HPA036913, HPA036914"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			310000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB032907: AB_2118319, HPA036913: , HPA036914: AB_10671751"	"unprognostic (1.31e-1)"	"unprognostic (5.12e-3)"	"unprognostic (6.82e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.40e-3)"	"unprognostic (9.15e-2)"	"prognostic favourable (3.87e-6)"	"unprognostic (1.09e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.37e-2)"	6.0	16.5	13.3	8.1	24.4	4.3	12.8	8.4	38.2	16.9	15.5	16.9	9.5	27.8	6.8	11.5	53.0	4.1	7.5	5.1	19.4	18.8	10.5	117.0	26.9	6.2	10.4	20.7	15.4	8.4	10.8	5.0	6.9	59.3	12.9	14.2	13.0	18.5	7.7	5.0	25.2	17.1	6.3	25.8	4.4	13.4	9.8	8.1	3.3	7.5	58.1	23.3	6.1	21.4	9.3	7.8	6.9	7.7	6.7	7.9	3.3	15.3	7.4	123.5	14.2	7.2	28.7	8.4	2.4	9.7	3.5	7.0	12.8	22.2	16.3	5.5	3.5	12.1	30.7	71.2	3.7	3.4	36.9	6.0	6.8	17.3	11.3	13.1	4.3	15.6	8.6	18.5	7.4	3.6	10.7	44.6	2.9	7.1	11.8	16.0	22.1	3.9	8.5	17.3	18.0	54.7	23.8	10.6	5.1	12.6	6.3	3.7	9.9	17.5	4.3	2.6	13.3	2.8	2.3	6.0	9.1	22.2	2.3	15.8	2.3	5.5	4.0	3.7	5.6	7.4	5.6	9.3	6.2	7.9	7.8	7.5	5.3	7.3	6.9	6.7	7.7	6.5	5.7	3.3	13.3	24.4	8.4	32.1	19.4	18.8	10.4	20.7	59.3	8.1
HMGCS2		ENSG00000134240	"3-hydroxy-3-methylglutaryl-CoA synthase 2"	P54868	1	119747996-119768905	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 257.0"	"Cell line enriched"	"Detected in some"	16	"RT4: 66.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 441.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA027423, HPA027442, CAB032906"	Enhanced		Supported	Mitochondria			820000	Mitochondria		"CAB032906: AB_2118322, HPA027423: AB_2672266, HPA027442: AB_2672277"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	"unprognostic (7.62e-2)"		"unprognostic (1.49e-2)"	"prognostic favourable (2.43e-7)"	"unprognostic (9.68e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (9.57e-2)"	"unprognostic (2.31e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.54e-3)"	0.3	0.1	0.3	8.7	0.3	0.0	20.6	0.3	0.3	0.3	30.8	0.4	0.3	13.8	0.3	0.3	0.7	0.1	4.4	42.0	0.4	0.0	7.4	257.0	0.8	0.3	0.3	0.3	0.3	1.4	0.0	0.3	0.8	0.7	3.8	19.8	18.9	5.1	0.3	1.4	1.8	12.2	1.9	0.3	0.3	8.1	6.1	0.3	0.4	0.3	0.6	2.1	7.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	66.2	0.0	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.4	0.0	0.3	0.3	0.7	0.3
HMGN5	NSBP1	ENSG00000198157	"High mobility group nucleosome binding domain 5"	P82970	X	81113701-81201942	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.6"	"Cell line enhanced"	"Detected in many"		"Daudi: 44.5;Karpas-707: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000511, HPA076238"	Approved		Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA000511: AB_1079505, HPA076238: "	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.63e-3)"	"prognostic favourable (6.60e-4)"	"unprognostic (2.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.32e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.08e-1)"	5.2	11.4	14.7	3.1	15.6	12.5	6.5	6.0	12.0	8.6	10.6	5.1	12.3	10.2	7.7	30.9	9.8	7.5	4.8	5.4	16.1	14.3	16.2	9.9	3.9	2.0	13.2	10.1	9.5	5.6	11.9	39.8	2.0	10.4	7.0	7.9	3.5	5.6	9.3	3.6	5.2	10.8	7.3	22.1	8.2	5.9	48.6	19.6	10.9	8.1	8.6	2.7	7.8	6.0	6.5	11.0	2.8	3.1	3.4	10.2	3.4	0.2	2.2	5.8	28.5	5.0	1.5	1.2	1.6	2.5	0.4	0.7	0.7	10.8	44.5	5.0	0.7	1.9	34.4	4.1	1.0	26.0	13.7	18.6	21.0	0.3	0.5	30.9	18.4	1.2	1.1	1.7	1.7	2.2	24.5	65.6	2.9	1.0	28.1	11.0	25.9	7.5	1.0	24.3	21.0	7.0	0.8	0.2	0.6	0.2	0.6	1.9	3.5	7.3	2.6	0.9	7.6	4.5	6.0	4.6	1.9	7.2	2.7	12.2	1.6	2.0	3.1	1.4	8.5	1.6	7.7	3.6	5.2	4.6	5.3	6.5	10.2	8.7	2.8	3.4	2.5	11.0	1.7	3.4	14.7	15.6	6.0	12.0	16.1	14.3	13.2	10.1	10.4	19.6
HMGXB3	"HMGX3, KIAA0194, SMF"	ENSG00000113716	"HMG-box containing 3"	Q12766	5	150000046-150053142	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"parathyroid gland: 151.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005967			Approved	Nucleoli				Nucleoli		"HPA005967: AB_1080044"	"unprognostic (3.66e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (3.37e-5)"	"unprognostic (9.72e-2)"	"unprognostic (3.36e-1)"	"unprognostic (3.89e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-2)"	12.0	14.2	8.2	14.5	14.4	15.3	16.1	14.5	17.4	11.3	10.3	15.0	15.4	8.3	13.9	20.0	9.3	13.5	12.1	9.4	8.6	8.3	11.6	11.7	14.7	10.3	10.1	11.0	15.0	13.8	151.8	15.3	11.8	12.9	17.6	10.8	16.8	12.4	18.4	12.5	13.1	9.9	12.8	8.9	14.4	12.0	17.7	7.3	15.3	14.7	10.1	12.0	11.2	10.1	5.8	6.2	5.1	5.9	2.2	8.1	3.7	12.2	14.4	10.2	16.1	14.7	12.5	17.8	11.9	22.0	17.9	22.6	20.2	15.0	11.7	14.0	16.2	9.1	19.4	20.4	15.5	10.9	13.9	10.3	15.2	9.8	20.4	19.6	23.4	16.3	15.3	26.2	20.7	12.7	13.4	12.3	18.8	9.7	12.2	10.2	7.7	21.7	10.6	14.2	11.3	10.7	15.4	13.2	13.3	10.4	25.5	26.4	11.9	12.8	10.9	26.8	11.4	12.9	21.9	14.6	13.7	16.7	31.3	15.1	13.8	5.1	4.7	4.0	7.0	5.9	5.5	5.8	5.7	4.9	6.2	5.0	4.4	4.6	0.5	2.2	3.9	4.6	8.1	3.7	8.2	14.4	14.5	17.4	8.6	8.3	10.1	11.0	12.9	7.3
HMOX2	HO-2	ENSG00000103415	"Heme oxygenase 2"	P30519	16	4474690-4510347	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025464, HPA040611"	Supported		Approved	Vesicles,Cytosol			1200000	"Vesicles, Cytosol"		"CAB025464: , HPA040611: AB_10961034"	"unprognostic (3.33e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.91e-4)"	"unprognostic (2.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (6.23e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.74e-3)"	"unprognostic (9.87e-2)"	"prognostic favourable (8.98e-6)"	"unprognostic (3.51e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.64e-1)"	19.4	19.2	32.1	15.7	50.7	13.6	16.6	19.7	38.6	13.3	17.9	22.9	12.2	23.5	11.9	18.7	36.6	15.6	19.7	57.2	29.3	22.0	32.2	39.7	15.8	20.8	27.3	35.1	12.5	22.4	20.6	14.7	12.5	36.5	12.1	19.9	8.6	16.0	10.0	20.1	16.6	19.3	16.6	27.2	23.3	29.7	48.1	28.2	8.7	13.8	16.7	25.3	16.5	15.0	14.5	14.5	48.7	8.9	18.7	35.8	25.8	24.6	10.5	6.3	13.6	18.8	9.7	10.5	17.0	8.4	14.5	12.6	13.3	16.8	11.4	19.2	15.6	14.9	19.7	36.5	16.5	14.6	13.4	8.3	10.1	18.0	12.7	18.0	14.2	15.1	12.3	16.8	12.3	26.6	13.4	5.8	13.3	30.5	14.8	14.1	9.6	10.0	15.7	11.0	24.0	20.1	16.2	10.6	6.2	13.6	28.9	18.3	18.0	10.1	25.9	8.2	12.2	35.1	8.7	7.2	8.9	25.2	5.2	14.9	10.4	13.7	7.4	48.7	35.2	8.9	29.9	14.5	32.7	35.8	14.5	13.0	31.7	32.7	26.1	18.7	6.5	8.2	30.0	25.8	32.1	50.7	19.7	38.6	29.3	22.0	27.3	35.1	36.5	28.2
HNRNPA0	"hnRNPA0, HNRPA0"	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754376	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm			110000	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: "	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	25.6	30.9	18.1	31.8	21.4	40.7	62.9	35.2	43.8	27.0	21.2	11.5	17.2	21.0	38.1	26.3	25.7	29.3	29.5	29.1	15.7	18.0	17.4	18.5	40.4	61.2	16.5	22.5	42.7	34.8	15.1	20.4	30.7	16.6	22.1	17.2	20.0	18.6	20.8	38.1	23.2	23.1	33.4	16.8	24.2	24.3	25.7	13.6	50.1	26.2	22.5	21.6	24.8	24.2	5.2	6.1	8.0	4.4	7.8	7.1	1.5	14.6	14.7	28.6	28.8	14.1	9.0	29.4	11.3	9.4	10.2	11.7	27.4	11.6	26.7	16.4	9.6	13.5	15.4	17.5	12.4	13.4	21.5	17.2	9.4	16.6	13.0	15.8	18.4	14.6	12.4	8.0	9.3	14.0	14.0	17.9	10.2	19.0	29.5	21.2	22.3	10.8	35.4	20.9	13.4	10.0	16.9	36.4	29.6	14.5	10.2	19.1	12.8	18.3	13.6	16.3	13.9	9.0	21.4	18.2	14.6	18.9	10.5	18.3	16.0	4.2	2.4	8.0	5.9	4.1	7.1	4.2	5.6	5.9	4.2	5.2	6.1	6.0	2.6	7.8	4.4	6.1	3.2	1.5	18.1	21.4	35.2	43.8	15.7	18.0	16.5	22.5	16.6	13.6
HNRNPA1	"ALS20, hnRNP-A1, hnRNPA1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm			10000000	Nucleoplasm		"CAB010894: AB_261962, HPA001609: , HPA001666: AB_1850836, HPA005812: , HPA007185: "	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	36.4	33.3	31.7	55.6	37.4	99.5	45.1	48.3	43.0	52.2	38.9	38.4	33.9	35.2	54.1	41.6	41.3	39.5	20.4	31.9	29.7	28.5	40.5	76.2	29.7	51.7	33.1	23.1	123.6	46.1	34.4	36.7	49.9	42.6	35.3	38.7	28.1	33.4	31.5	40.5	37.3	35.6	34.9	40.1	59.5	34.1	69.6	33.3	88.7	42.1	62.0	62.7	37.5	45.8	61.6	72.5	17.9	51.1	86.6	98.1	105.8	83.6	77.1	164.9	130.5	51.0	81.6	89.7	77.2	88.6	85.6	72.6	115.4	92.4	221.1	75.9	53.5	75.6	110.1	110.7	104.1	86.4	83.9	122.8	110.6	198.7	27.1	174.6	80.8	72.6	42.9	56.5	84.4	93.7	135.8	93.3	71.3	108.6	190.0	188.8	173.7	54.7	185.4	131.6	107.7	92.8	126.5	92.6	127.0	57.2	117.9	85.5	73.6	109.5	79.1	63.9	85.8	64.3	98.8	83.7	84.7	148.2	41.9	110.1	55.9	12.0	39.5	17.9	61.9	51.1	96.1	61.6	82.7	72.3	72.5	55.2	98.1	89.4	4.2	86.6	41.3	55.9	70.9	105.8	31.7	37.4	48.3	43.0	29.7	28.5	33.1	23.1	42.6	33.3
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26189927-26201529	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"		11000000	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: , HPA065537: "	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (5.12e-4)"	"prognostic unfavourable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	82.2	97.4	85.1	105.3	106.3	90.9	74.4	123.3	87.4	77.1	85.7	89.4	68.7	87.5	92.6	71.9	90.4	75.1	51.7	87.9	82.4	71.8	113.4	103.7	76.2	127.7	118.6	57.0	121.0	75.7	107.2	121.2	100.7	96.3	75.5	98.6	64.4	71.4	66.5	167.2	58.7	94.8	73.7	139.7	116.5	74.1	73.1	135.4	180.3	81.9	104.4	140.7	74.2	128.8	33.7	46.5	35.1	52.4	32.1	42.5	36.0	122.0	104.2	151.7	113.7	39.0	35.7	70.2	78.3	61.1	86.5	78.4	96.2	88.9	223.1	74.9	72.5	85.2	162.2	102.3	122.0	69.4	98.9	135.2	125.7	115.0	32.8	145.5	92.7	33.7	53.6	82.3	75.1	89.3	159.0	73.0	87.4	98.7	155.7	170.3	134.3	80.3	144.7	123.3	93.5	99.9	106.8	88.6	108.7	94.1	92.7	57.2	103.9	126.8	77.1	48.7	100.8	65.9	133.6	97.0	192.2	212.4	62.7	166.0	91.7	17.4	38.7	35.1	42.5	52.4	38.6	33.7	35.5	36.6	46.5	29.2	35.6	35.6	13.0	32.1	48.4	43.6	36.1	36.0	85.1	106.3	123.3	87.4	82.4	71.8	118.6	57.0	96.3	135.4
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm			1500000	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: , HPA066381: "	"unprognostic (2.85e-2)"	"prognostic favourable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	22.9	17.6	24.7	29.5	28.0	29.8	19.5	22.3	29.3	24.3	24.8	16.1	13.7	18.0	26.5	26.9	33.8	20.8	20.9	16.7	20.8	14.2	23.9	20.3	23.7	29.9	40.4	17.7	35.6	19.3	20.6	20.1	27.0	26.5	19.0	28.7	14.9	20.0	28.4	28.0	23.2	23.5	23.4	35.0	24.8	19.7	22.2	27.3	23.0	30.7	18.4	40.6	20.5	28.2	15.2	26.4	7.4	15.8	15.6	18.7	9.3	62.7	42.4	93.0	47.5	24.6	21.9	71.4	48.1	22.7	37.9	36.1	84.2	32.4	126.6	36.7	37.1	36.2	91.8	60.2	71.4	58.1	56.0	94.3	64.2	166.5	26.5	101.3	58.7	24.5	27.0	56.5	42.1	51.6	67.4	43.6	48.1	84.5	70.6	40.8	50.8	39.9	90.5	79.0	39.6	52.9	124.1	54.5	49.1	71.6	22.3	29.0	32.3	63.7	57.2	48.7	54.3	33.7	69.3	39.7	70.4	108.3	29.0	67.4	31.4	4.9	15.3	7.4	18.7	15.8	15.0	13.9	15.0	16.5	16.4	15.2	13.8	13.9	6.6	15.6	14.9	26.4	17.3	9.3	24.7	28.0	22.3	29.3	20.8	14.2	40.4	17.7	26.5	27.3
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204507-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046688	Approved		Enhanced	Nucleoplasm			380000	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favourable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavourable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	34.9	41.7	16.5	47.8	18.4	44.6	32.5	17.9	19.1	30.0	54.0	20.4	24.9	37.0	33.9	23.0	50.9	27.3	38.6	44.4	15.4	17.8	50.0	72.4	29.8	36.5	20.6	12.4	39.1	39.1	25.5	20.5	36.7	16.8	26.8	47.1	19.4	31.3	26.7	53.3	43.4	55.0	38.7	18.9	53.5	31.9	26.5	15.9	75.6	34.6	46.3	41.3	38.7	36.8	5.9	11.4	15.1	7.2	5.7	6.6	2.2	45.5	38.0	58.7	56.8	21.7	19.2	84.9	51.4	23.8	41.2	44.4	70.1	34.3	73.9	47.4	27.5	30.2	50.8	69.8	51.1	114.3	59.9	46.5	30.6	42.8	21.8	58.7	39.6	18.9	33.0	36.9	37.2	36.8	37.8	33.8	41.2	122.8	70.7	56.7	53.8	54.8	57.8	35.4	43.7	34.7	49.0	54.1	42.1	40.0	56.0	36.2	33.5	36.0	33.0	50.3	42.5	35.4	70.2	39.7	46.3	86.9	20.3	65.1	40.8	2.8	4.8	15.1	5.5	7.2	6.2	5.9	4.6	6.6	4.6	5.0	4.5	5.3	0.9	5.7	7.1	11.4	4.8	2.2	16.5	18.4	17.9	19.1	15.4	17.8	20.6	12.4	16.8	15.9
HNRNPC	"hnRNPC, HNRPC"	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C (C1/C2)"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm			1400000	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: , CAB075756: , HPA051075: "	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavourable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favourable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavourable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	41.1	53.9	51.8	51.1	64.0	71.6	55.1	72.1	65.5	49.6	41.9	45.3	47.3	35.3	51.0	51.1	53.4	54.3	38.0	41.1	47.9	45.1	50.0	51.9	43.0	76.7	54.8	42.1	72.8	57.8	38.3	63.3	54.7	43.7	45.2	47.8	43.9	36.0	44.5	44.5	39.8	39.5	57.6	54.8	55.8	37.4	62.4	52.4	49.3	53.0	37.9	75.6	45.3	45.9	78.3	104.6	119.0	73.3	64.8	89.1	142.9	92.8	77.7	117.1	66.7	77.8	72.0	82.5	59.3	72.1	100.2	85.5	73.2	70.6	165.1	37.7	74.6	70.2	161.0	100.4	136.7	107.5	85.9	82.8	61.3	109.1	88.5	126.6	69.2	74.6	82.1	73.9	176.6	105.2	127.1	70.5	79.2	89.3	151.0	120.5	121.8	72.4	121.1	93.4	81.3	106.8	84.4	64.9	60.4	72.0	69.6	65.6	65.4	113.7	68.0	36.0	65.1	42.8	85.2	64.0	95.8	161.1	33.6	103.2	70.6	57.8	73.3	71.2	65.9	63.5	86.1	78.3	78.0	70.2	104.6	68.7	89.1	75.0	119.0	64.8	59.7	67.5	80.3	142.9	51.8	64.0	72.1	65.5	47.9	45.1	54.8	42.1	43.7	52.4
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm			550000	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	45.5	40.0	35.4	58.8	46.1	88.0	49.4	49.1	40.6	55.2	49.8	37.2	40.5	45.1	56.2	39.1	55.5	47.9	48.5	40.8	28.4	27.4	36.4	40.6	43.2	72.2	26.5	37.1	64.5	48.9	51.6	38.7	51.9	32.9	44.9	45.8	41.5	52.9	48.6	51.6	49.5	49.9	53.1	27.9	61.4	46.7	30.4	30.7	136.1	41.5	53.7	80.4	58.2	49.9	17.8	21.8	18.0	11.9	12.4	17.5	5.9	59.0	23.4	101.2	32.1	13.4	17.4	47.8	46.5	35.9	53.7	46.3	41.9	52.5	121.0	33.8	31.5	29.3	80.4	34.8	84.4	22.5	41.5	86.7	32.3	56.8	27.3	114.8	44.7	21.3	15.6	43.3	43.9	48.5	95.3	41.9	45.5	22.8	139.8	79.8	84.1	21.8	103.5	102.8	50.2	44.8	36.2	51.1	55.2	45.9	39.9	23.2	29.8	45.8	40.9	41.5	56.7	31.9	59.8	44.5	35.0	140.8	31.9	59.4	47.2	18.0	10.8	10.8	13.2	11.3	14.5	17.8	15.9	16.5	12.3	14.4	17.5	14.5	13.1	12.4	11.9	21.8	17.2	5.9	35.4	46.1	49.1	40.6	28.4	27.4	26.5	37.1	32.9	30.7
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm			2500000	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: "	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	48.1	34.0	19.9	41.2	34.9	43.3	56.1	23.2	22.3	31.1	44.5	31.6	26.9	41.1	34.9	32.6	50.4	39.2	35.7	26.2	21.7	18.3	42.3	68.3	40.4	55.9	33.7	13.9	54.2	39.7	22.5	28.1	37.5	32.5	35.4	37.8	26.2	36.9	25.0	40.0	40.6	57.5	41.6	27.5	58.7	39.2	66.4	31.2	77.5	40.6	42.3	56.9	46.2	57.4	58.3	59.7	52.0	62.5	63.2	75.8	89.4	46.1	49.2	30.6	46.2	37.5	41.1	44.8	36.2	61.0	51.0	60.3	45.9	64.6	93.1	23.3	39.1	65.6	81.5	59.2	42.0	39.0	48.8	59.3	30.5	59.0	46.3	86.8	60.3	49.9	47.0	39.5	73.1	43.7	59.8	42.3	38.5	72.1	84.8	47.6	23.1	41.5	71.5	28.7	44.2	52.1	71.7	37.7	37.9	36.9	67.8	54.9	75.5	42.5	32.5	23.6	44.7	38.4	57.1	38.1	64.3	56.5	38.2	83.6	22.9	38.5	54.4	52.0	62.3	62.5	75.8	58.3	65.5	68.6	59.7	48.1	55.7	52.5	36.5	63.2	55.5	33.4	72.6	89.4	19.9	34.9	23.2	22.3	21.7	18.3	33.7	13.9	32.5	31.2
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm			2100000	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: , HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (7.85e-4)"	"prognostic unfavourable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	40.1	36.2	26.8	86.3	31.0	90.5	45.4	73.4	33.2	55.6	38.2	26.6	54.7	30.2	52.4	44.3	41.7	37.7	45.3	30.3	25.6	23.3	36.5	42.3	37.0	59.8	33.0	30.3	60.1	41.3	24.4	46.1	43.6	28.9	40.8	34.7	34.4	53.5	60.3	51.3	44.3	43.0	61.6	31.3	65.2	34.4	42.5	34.3	113.2	47.5	61.5	62.0	57.3	54.4	26.3	34.7	18.4	27.7	24.3	36.8	13.8	51.0	38.9	61.6	40.3	22.1	12.2	49.9	30.4	15.8	39.8	26.3	52.7	33.9	84.9	27.5	22.1	32.7	57.4	35.8	35.8	71.1	41.2	46.2	64.2	66.2	26.0	60.3	44.5	12.7	26.1	38.8	24.5	21.6	57.9	44.9	23.6	35.0	91.8	56.2	71.4	28.6	81.8	70.1	50.3	20.4	60.8	58.8	50.1	59.0	40.4	53.1	38.4	78.3	35.4	58.3	41.5	26.6	68.7	36.9	79.8	89.0	31.6	57.7	68.1	18.4	18.0	17.5	26.0	27.7	34.3	26.3	27.8	27.9	26.6	22.7	35.5	36.8	3.5	24.3	20.8	34.7	31.7	13.8	26.8	31.0	73.4	33.2	25.6	23.3	33.0	30.3	28.9	34.3
HNRNPH3	"2H9, HNRPH3"	ENSG00000096746	"Heterogeneous nuclear ribonucleoprotein H3"	P31942	10	68331174-68343191	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038264			Supported	Nucleoplasm			560000	Nucleoplasm		"HPA038264: AB_10697246"	"unprognostic (1.72e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-5)"	"unprognostic (6.17e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.06e-3)"	44.9	41.8	47.1	37.9	53.2	51.3	42.8	57.3	48.1	45.1	39.2	49.8	33.2	33.4	58.2	29.2	38.2	42.4	27.8	40.3	45.0	42.3	42.7	34.4	34.6	43.7	57.3	42.2	71.4	27.0	41.2	61.5	50.4	45.6	53.1	40.4	30.4	28.1	39.7	50.4	38.5	41.9	61.1	81.9	38.0	33.7	40.5	65.3	48.9	60.5	31.6	45.8	55.4	78.7	13.6	17.4	29.0	19.3	17.5	22.7	10.6	41.5	40.4	64.7	20.1	25.4	15.7	41.7	36.7	19.3	34.5	28.6	68.9	36.9	65.9	20.2	24.2	28.0	51.9	35.4	53.4	40.5	27.5	51.1	36.5	41.6	22.3	58.3	28.2	10.3	32.5	39.2	69.9	26.1	63.1	22.9	38.1	57.7	51.5	63.3	42.9	48.0	43.2	54.2	21.4	27.7	34.6	29.2	31.8	39.0	27.0	38.3	28.7	29.8	28.4	31.8	53.8	16.8	49.4	27.9	37.5	67.3	17.8	28.9	25.0	14.7	15.3	29.0	15.0	17.0	15.5	13.2	17.8	17.2	17.4	13.6	22.7	18.6	19.8	17.5	19.3	14.3	15.8	10.6	47.1	53.2	57.3	48.1	45.0	42.3	57.3	42.2	45.6	65.3
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm			5000000	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: "	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavourable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	79.0	92.0	70.0	80.7	81.7	146.9	97.2	88.0	104.8	77.9	70.0	68.8	80.9	74.5	96.3	69.0	95.8	79.6	67.5	80.4	68.2	71.5	76.0	90.9	77.7	125.0	80.9	72.9	96.5	102.8	91.4	74.5	92.3	67.3	69.4	75.2	58.6	76.5	104.6	101.4	78.7	76.7	100.9	86.3	96.1	72.5	60.3	78.6	162.5	79.9	80.8	106.9	81.0	77.1	59.7	76.1	92.7	71.0	75.6	73.2	136.4	120.8	83.6	143.7	85.1	69.1	76.5	115.4	85.5	106.3	107.2	100.9	69.9	86.6	143.6	58.9	89.5	93.0	143.6	103.8	130.9	98.7	84.6	100.8	73.3	99.1	91.5	124.8	100.1	77.8	79.4	91.3	121.6	109.1	102.4	73.8	105.4	106.0	154.7	85.6	127.6	81.4	135.3	114.5	95.7	103.8	99.8	93.3	110.7	89.9	96.0	85.2	95.1	106.2	89.2	74.7	88.0	75.6	111.4	77.7	101.7	104.3	71.3	101.2	105.5	77.4	71.0	90.1	53.9	69.2	67.3	59.7	62.5	61.2	76.1	56.8	65.1	59.3	92.7	75.6	65.8	45.2	73.2	136.4	70.0	81.7	88.0	104.8	68.2	71.5	80.9	72.9	67.3	78.6
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836388-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm			130000	Nucleoplasm		"CAB016326: AB_627736, HPA051748: , HPA052661: "	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	44.1	43.3	32.8	47.1	37.1	102.7	40.6	48.9	47.6	38.9	46.2	42.5	35.9	43.7	47.8	34.8	50.1	36.2	42.0	39.7	31.8	31.9	39.9	52.9	43.2	48.0	36.2	32.5	41.6	41.6	36.1	28.1	47.9	34.7	34.6	49.1	35.6	37.5	39.8	44.7	50.7	48.1	49.4	34.3	44.8	38.2	34.9	39.4	102.8	53.0	36.8	67.6	37.9	40.5	3.1	6.2	3.5	3.8	2.2	3.6	1.9	45.7	36.2	46.0	29.6	18.3	21.6	43.5	38.1	26.3	35.4	33.7	38.8	35.2	72.6	31.2	24.4	28.1	56.6	42.7	52.7	55.9	30.8	60.0	23.1	34.5	19.5	55.4	40.7	23.5	20.2	35.7	35.3	39.1	58.1	37.7	36.9	36.2	57.3	34.2	54.1	25.1	74.4	52.6	45.7	39.7	34.4	38.6	35.8	38.2	30.0	15.4	39.4	30.8	34.9	35.5	40.5	31.2	54.7	36.2	48.5	81.8	22.9	49.0	38.7	1.1	2.6	1.7	3.5	3.8	2.7	2.2	2.5	2.1	3.5	3.1	2.7	2.2	3.5	2.2	2.8	6.2	3.6	1.9	32.8	37.1	48.9	47.6	31.8	31.9	36.2	32.5	34.7	39.4
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm			170000	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	41.1	38.3	43.2	57.1	44.8	83.6	39.3	66.1	56.7	41.0	45.8	32.8	45.7	42.0	51.5	35.5	54.5	40.7	41.2	38.3	40.4	29.0	38.9	53.9	37.9	55.7	36.4	35.5	56.3	36.0	57.6	42.2	44.8	37.5	37.9	41.1	35.7	40.4	52.4	98.8	43.4	40.8	48.7	39.6	50.1	38.3	41.0	45.4	91.7	41.4	40.0	64.7	37.9	64.3	26.0	32.4	16.5	35.0	30.6	36.6	28.2	61.4	41.8	79.3	31.7	18.2	20.3	50.5	37.1	27.9	46.4	35.3	59.5	18.9	90.9	49.6	33.5	37.9	80.8	46.4	58.4	56.7	66.7	80.6	42.5	56.9	18.9	82.3	43.1	20.9	23.6	39.2	16.4	41.5	80.8	26.1	36.7	41.8	79.0	71.3	68.2	50.9	89.2	68.8	43.0	24.4	59.7	43.6	48.5	62.5	33.7	34.8	40.1	49.1	48.1	40.5	49.0	42.5	69.3	38.4	70.7	105.4	30.3	67.2	43.9	6.9	28.2	16.5	36.0	35.0	36.6	26.0	31.4	35.9	32.2	24.6	34.0	33.0	7.7	30.6	25.7	32.4	31.6	28.2	43.2	44.8	66.1	56.7	40.4	29.0	36.4	35.5	37.5	45.4
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm			50000	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	27.1	30.4	31.2	36.1	34.7	33.8	31.2	41.0	32.2	32.4	27.4	34.3	29.5	26.5	42.2	23.7	33.2	32.7	20.3	25.6	29.1	27.9	25.1	25.1	28.1	39.6	35.0	27.9	44.3	32.8	40.5	40.9	40.9	27.5	27.3	31.3	26.5	28.1	27.7	31.1	27.8	26.8	41.0	34.1	28.8	24.9	20.3	40.0	68.3	29.9	29.7	40.9	29.0	29.4	21.9	23.6	20.8	23.2	26.1	28.5	19.8	36.1	22.6	46.3	27.3	16.5	16.6	21.8	24.6	25.1	34.7	25.1	15.5	25.1	44.3	12.1	29.9	20.9	47.7	31.9	45.6	30.7	32.4	42.3	29.8	27.8	16.7	52.3	28.5	18.4	19.7	32.5	26.4	25.7	38.0	30.9	26.7	20.8	59.8	15.2	26.1	20.8	42.8	45.2	31.2	23.5	17.7	29.6	30.8	32.2	27.4	19.9	21.9	23.4	26.1	23.3	31.9	28.6	29.1	19.6	29.2	59.7	17.6	44.8	25.4	8.7	18.5	20.8	25.4	22.5	27.7	21.9	24.3	25.2	23.6	20.1	26.3	24.4	6.6	26.1	23.2	13.9	28.5	19.8	31.2	34.7	41.0	32.2	29.1	27.9	35.0	27.9	27.5	40.0
HNRNPU	"C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm			840000	Nucleoplasm		"CAB011532: AB_732983, HPA041057: , HPA058707: "	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	55.6	57.5	55.3	55.3	68.1	87.3	60.9	80.2	61.7	53.4	47.9	57.7	49.6	38.9	61.4	74.9	53.3	55.9	48.0	47.4	53.3	51.5	68.5	61.2	45.1	52.2	60.5	51.8	76.0	51.7	85.9	48.6	55.4	47.2	56.5	51.1	43.9	49.0	54.3	69.7	43.9	50.3	58.0	55.4	62.3	49.4	47.8	64.5	121.5	61.7	41.5	64.3	57.5	97.9	17.3	25.1	17.0	11.7	15.1	21.7	7.3	47.2	38.0	50.5	39.6	26.5	22.9	49.6	33.9	21.9	31.2	27.8	36.4	31.5	74.7	31.7	28.6	37.2	67.6	38.4	49.5	31.4	45.3	64.4	33.7	55.4	27.9	73.6	39.2	25.8	23.2	33.9	36.0	31.8	83.8	27.8	41.9	33.8	78.3	76.6	87.6	34.6	78.6	63.0	40.6	50.1	34.8	42.3	41.6	53.3	35.3	40.9	48.6	83.1	38.3	31.2	46.0	33.2	59.7	45.9	50.0	72.9	25.6	63.2	44.6	14.1	11.7	15.5	15.3	10.1	16.2	17.3	18.6	18.4	12.4	17.0	21.7	18.3	17.0	15.1	11.0	25.1	15.8	7.3	55.3	68.1	80.2	50.4	53.3	51.5	60.5	51.8	47.2	64.5
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307598	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm			20000	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	44.8	37.1	31.0	40.7	32.2	72.3	40.4	35.9	40.3	48.9	48.0	47.3	38.1	38.6	50.3	33.3	43.6	41.4	43.6	52.9	28.9	24.6	29.1	28.4	39.0	45.5	30.8	26.7	58.8	44.9	34.3	33.7	27.9	28.8	38.3	35.8	40.8	45.4	44.7	50.9	48.4	40.1	55.5	29.7	41.2	39.6	54.3	34.5	85.2	39.6	45.9	50.2	52.7	44.1	9.4	13.0	13.2	6.7	11.5	19.3	4.8	57.5	76.5	45.5	41.9	22.5	26.8	17.4	35.1	40.3	43.8	40.1	44.5	44.3	51.6	24.0	42.0	18.9	42.9	39.6	49.7	50.4	37.3	57.0	35.4	34.6	26.2	53.2	52.9	28.6	25.0	39.0	36.3	40.6	40.7	48.9	38.7	43.9	67.6	31.3	34.7	28.0	44.1	36.9	28.6	32.1	60.9	36.3	33.2	77.5	44.6	20.0	34.2	59.2	40.3	49.3	48.0	22.4	65.0	57.5	37.0	48.5	31.3	43.3	64.9	9.0	5.9	9.4	12.3	6.2	19.3	8.6	14.9	12.6	6.7	9.4	10.1	8.0	13.2	11.5	6.7	13.0	9.8	4.8	31.0	32.2	35.9	40.3	28.9	24.6	30.8	26.7	28.8	34.5
HOXA4	"HOX1, HOX1D"	ENSG00000197576	"Homeobox A4"	Q00056	7	27128507-27130799	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 18.7;HEK 293: 14.3;REH: 13.1;WM-115: 18.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	18	"pons and medulla: 26.7"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	47	"pons and medulla: 11.9"	"Region enriched"	"Detected in single"	60	"pons and medulla: 24.6"	HPA060088	Approved		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA060088: "	"unprognostic (3.37e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.59e-4)"	"unprognostic (3.93e-2)"	8.9	6.2	0.4	2.2	0.3	0.2	11.6	0.3	1.2	2.7	7.5	0.4	8.2	3.5	3.9	10.3	27.5	18.1	5.7	4.8	0.3	0.0	9.6	2.0	10.5	3.0	1.4	0.3	8.8	1.1	17.6	0.3	0.5	26.7	4.1	1.7	0.3	0.7	5.6	29.8	3.5	5.2	4.9	25.8	5.5	9.3	1.6	0.4	0.3	2.3	3.4	1.2	5.5	10.9	0.9	1.4	0.1	0.5	0.1	0.3	0.2	5.8	2.0	0.0	18.7	0.0	0.0	1.2	0.5	0.6	1.9	2.0	3.7	1.2	1.5	0.1	1.8	2.5	0.7	0.3	1.5	0.0	14.3	0.0	0.6	8.5	2.2	2.0	3.5	2.1	1.6	6.6	0.5	6.6	0.0	0.0	6.4	1.6	0.0	7.0	0.0	4.6	13.1	2.9	0.1	9.4	1.4	0.9	0.0	1.8	0.0	6.9	0.4	1.0	8.6	0.0	3.0	4.9	0.1	0.0	0.0	0.7	4.0	3.2	18.7	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.2	0.0	0.3	0.0	0.0	0.1	0.5	1.4	0.0	0.2	0.4	0.3	0.3	1.2	0.3	0.0	1.4	0.3	26.7	0.4
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162435-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 42.7;PC-3: 14.9;RPTEC TERT1: 14.7;SCLC-21H: 39.7;U-937: 14.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7"									HPA061982	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA061982: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	3.2	3.4	0.2	8.8	0.1	2.4	8.7	0.1	0.2	15.5	12.8	0.2	4.1	0.0	10.4	16.8	1.4	12.2	0.3	0.1	0.1	0.0	35.1	0.1	0.8	0.7	0.1	0.1	2.0	0.1	0.0	0.1	1.4	0.4	16.6	4.5	0.2	0.5	5.6	21.0	13.3	8.2	13.1	0.7	1.0	0.0	2.4	0.1	2.6	0.3	0.3	0.3	16.2	11.4	0.5	6.0	5.4	1.0	11.7	1.5	0.5	12.4	0.0	0.0	6.3	2.1	1.6	0.0	5.0	4.0	0.4	0.4	0.8	0.5	0.1	0.5	2.7	11.7	8.1	0.0	0.4	0.0	42.7	0.1	0.3	0.0	0.2	0.0	0.1	2.1	0.0	0.0	0.0	10.5	0.0	0.0	0.4	0.0	0.0	0.3	0.0	14.9	2.7	0.0	0.0	14.7	0.2	39.7	0.0	5.3	0.0	0.1	0.0	10.5	0.4	0.0	4.0	4.8	0.0	0.0	0.0	0.0	0.0	14.2	0.0	5.4	1.0	0.0	1.5	0.2	0.2	0.2	0.0	0.1	6.0	0.5	0.3	0.1	0.9	11.7	0.4	1.9	0.2	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.1
HOXB3	"HOX2, HOX2G"	ENSG00000120093	"Homeobox B3"	P14651	17	48548870-48604912	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 56.7;epididymis: 44.9;seminal vesicle: 68.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.2;EFO-21: 17.7;HEK 293: 21.4;RPTEC TERT1: 16.6;U-251 MG: 19.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	40	"pons and medulla: 9.3"	"Region enriched"	"Detected in single"	29	"pons and medulla: 12.9"	"CAB009860, HPA064990"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009860: AB_2119262, HPA064990: "	"unprognostic (5.88e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.39e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.14e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.60e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.45e-6)"	8.3	4.5	1.0	7.3	1.1	0.2	8.0	1.0	1.0	11.3	16.4	1.0	56.7	2.3	10.1	44.9	5.5	17.7	3.6	1.7	1.0	0.0	16.3	1.6	4.8	1.6	1.0	1.0	2.8	1.7	6.7	1.0	3.8	2.6	4.1	4.9	1.0	1.0	68.4	4.0	2.9	11.3	3.5	4.8	6.5	7.8	3.7	1.0	1.0	1.8	1.0	1.1	6.4	5.2	0.1	2.8	1.7	0.9	1.4	1.1	0.4	3.2	6.8	4.6	2.1	3.8	5.4	1.2	0.1	0.0	0.1	0.1	3.2	20.2	1.6	17.7	14.5	0.1	0.9	0.3	0.0	5.2	21.4	5.0	3.0	0.0	6.3	0.0	13.3	6.2	0.0	6.0	0.4	6.3	6.8	0.1	3.7	0.1	0.3	0.1	0.1	0.7	0.0	3.3	0.6	16.6	3.0	0.0	0.0	0.7	0.0	3.3	6.5	1.4	7.0	2.2	7.0	1.2	19.1	1.7	2.0	0.1	4.5	0.0	3.7	1.7	0.1	0.0	0.9	0.1	0.4	0.0	0.5	1.1	0.3	0.1	0.8	1.0	0.0	1.4	0.9	2.8	1.1	0.4	1.0	1.1	1.0	1.0	1.0	0.0	1.0	1.0	2.6	1.0
HOXC11	HOX3H	ENSG00000123388	"Homeobox C11"	O43248	12	53973126-53977643	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 7.0;skin 1: 9.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 23.0;BJ hTERT+: 11.6;HaCaT: 10.1;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038291	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038291: AB_10674552"	"unprognostic (1.50e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"		"unprognostic (6.90e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.41e-3)"	"unprognostic (4.46e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-1)"		"unprognostic (1.82e-1)"	4.8	0.0	0.1	0.1	0.1	0.0	1.2	0.1	0.1	2.5	0.1	0.1	0.1	0.8	2.0	1.0	0.1	0.7	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.7	0.1	0.1	0.5	0.1	0.0	0.1	0.6	0.3	0.5	0.0	0.1	0.1	2.0	7.0	9.2	2.7	0.4	0.1	0.1	0.0	1.6	0.1	0.5	0.1	0.1	0.1	1.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.7	0.0	23.0	2.2	3.3	0.0	3.3	11.6	4.9	3.6	0.2	0.9	0.0	0.2	3.1	10.1	4.4	0.0	2.2	0.6	0.1	0.1	7.5	0.0	0.0	0.1	0.1	0.6	0.9	0.0	0.3	0.0	0.9	0.0	3.1	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.8	0.0	0.1	2.1	5.2	2.0	18.1	0.0	0.0	0.0	4.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
HOXC12	"HOC3F, HOX3, HOX3F"	ENSG00000123407	"Homeobox C12"	P31275	12	53954834-53958956	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.0;lymphoid tissue: 8.1;skin 1: 6.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 21.8;K-562: 6.0;SiHa: 4.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055632	Uncertain									"HPA055632: "	"unprognostic (6.95e-2)"	"unprognostic (2.34e-2)"				"unprognostic (1.10e-1)"		"unprognostic (4.37e-2)"	"unprognostic (5.98e-2)"			"unprognostic (1.45e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.84e-2)"	"unprognostic (2.55e-1)"			3.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.5	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	21.8	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HP		ENSG00000257017	Haptoglobin	P00738	16	72054592-72061055	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Immunity"	"Antibiotic, Antimicrobial, Antioxidant, Serine protease homolog"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	37	"liver: 1156.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 64.7;HSkMC: 37.1"	"Cancer enriched"	"Detected in many"	81	"liver cancer: 1297.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 20.0;eosinophil: 30.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 30.9;monocytes: 20.0"									"CAB003787, HPA047750"	Enhanced		Approved	Vesicles	"Secreted to blood"	181000000	140000000000	Vesicles		"CAB003787: , HPA047750: "	"unprognostic (6.38e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (6.94e-13)"	"unprognostic (4.34e-4)"	"unprognostic (1.80e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.49e-2)"	9.8	0.0	0.3	0.4	0.3	4.4	0.3	0.3	0.3	1.5	0.4	0.3	0.3	0.0	0.3	0.5	0.3	1.1	0.3	3.0	0.3	0.0	0.4	1156.9	1.4	0.4	0.3	0.3	0.3	0.5	0.0	0.5	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	1.4	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.0	3.5	30.9	20.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	64.7	0.1	9.2	1.7	37.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.5	0.1	0.7	0.0	0.3	6.9	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	2.1	1.4	0.0	0.2	0.0	0.0	1.2	0.0	4.4	0.0	3.6	0.0	2.6	20.0	30.9	0.0	0.8	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	5.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
HPCA		ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"brain: 118.9"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 10.0"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Group enriched"	"Detected in many"	5	"basal ganglia: 118.9;cerebral cortex: 40.4;hippocampal formation: 42.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 1321.6;hippocampal formation: 1344.5"	"CAB012340, HPA043245"	Enhanced									"CAB012340: AB_2120209, HPA043245: "	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	1.2	1.5	13.5	1.2	118.9	1.1	1.2	4.8	82.2	1.4	1.5	2.2	0.0	1.2	1.4	1.2	1.1	1.4	1.3	1.2	42.5	2.8	1.3	1.1	1.1	1.2	3.7	14.5	1.5	1.2	1.1	0.0	1.2	0.0	1.3	1.5	0.6	1.3	1.3	1.1	1.2	1.4	1.3	0.8	1.2	1.2	2.5	12.2	0.0	1.3	0.0	1.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.6	1.4	0.3	0.4	0.0	0.1	0.1	0.3	0.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.6	0.0	0.0	10.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	1.0	0.8	0.0	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	13.5	118.9	4.8	40.4	42.5	2.8	3.7	14.5	0.0	12.2
HPCAL1	"BDR1, HLP2, VILIP-3"	ENSG00000115756	"Hippocalcin like 1"	P37235	2	10302889-10427617	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 103.3"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 62.1;PC-3: 68.4;U-87 MG: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043245	Approved						35000			"HPA043245: "	"unprognostic (3.22e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (4.11e-5)"	"unprognostic (2.73e-1)"	"unprognostic (6.76e-3)"	"unprognostic (5.26e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (4.06e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.55e-1)"	11.8	20.7	30.5	13.8	17.7	7.5	19.7	103.3	42.2	9.8	16.8	8.6	5.4	20.5	22.6	10.3	4.8	12.1	9.7	10.9	18.0	41.0	16.3	13.4	31.9	14.4	17.9	31.1	6.1	26.5	2.9	15.3	14.8	17.6	5.7	12.8	14.0	10.6	5.9	6.2	6.1	35.3	17.1	14.5	14.6	28.1	13.2	6.0	10.0	10.2	3.8	10.0	6.7	8.3	13.6	21.0	33.8	23.9	11.0	24.3	12.4	9.8	17.2	1.2	5.0	2.8	7.2	12.0	8.0	21.8	11.6	12.8	6.0	25.2	3.8	9.5	5.9	3.6	3.2	11.0	5.2	62.1	5.5	8.5	19.3	13.1	12.5	5.2	17.3	3.9	5.1	27.7	8.6	15.3	7.9	25.5	20.7	13.4	4.3	32.0	6.5	68.4	5.7	4.8	16.7	16.7	2.8	4.5	30.5	8.4	10.2	19.4	3.2	13.9	18.3	14.6	4.5	15.4	13.4	7.7	8.3	1.9	67.4	12.9	34.1	10.8	23.9	28.5	11.1	19.0	12.5	13.6	19.9	14.3	21.0	11.3	24.3	15.5	33.8	11.0	16.6	7.6	15.9	12.4	30.5	17.7	103.3	42.2	18.0	41.0	17.9	31.1	17.6	6.0
HPD	"4-HPPD, 4HPPD, GLOD3, PPD"	ENSG00000158104	"4-hydroxyphenylpyruvate dioxygenase"	P32754	12	121839527-121863596	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Dioxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 267.5"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 104.7"	"Cancer enriched"	"Detected in many"	100	"liver cancer: 540.9"	"Region enriched"	"Detected in single"	29	"pons and medulla: 13.7"	"Group enriched"	"Detected in many"	4	"eosinophil: 9.8;neutrophil: 4.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.0;granulocytes: 9.8"	"Region enriched"	"Detected in single"	8	"amygdala: 0.4"	"Low region specificity"	"Detected in many"			"HPA038321, HPA038322"	Enhanced		Uncertain	"Nuclear speckles"			23000000	"Nuclear speckles"		"HPA038321: AB_2675957, HPA038322: AB_10670778"	"unprognostic (3.01e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.13e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.14e-3)"	"unprognostic (9.72e-3)"	"unprognostic (8.61e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.34e-1)"	0.1	0.5	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.2	0.1	2.1	0.3	0.0	0.3	0.4	0.1	0.7	0.2	0.3	0.4	0.0	51.3	267.5	0.2	0.4	0.1	0.0	0.7	0.7	0.0	0.1	0.0	13.7	0.5	0.0	3.8	0.0	0.8	0.2	0.0	0.1	0.4	0.2	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.6	0.2	0.1	5.0	9.8	1.4	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	104.7	2.5	0.3	3.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	2.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.8	9.8	0.0	1.0	0.1	0.1	0.1	0.1	1.3	0.1	0.3	0.2	4.8	0.0	1.4	5.0	0.0	0.3	0.0	0.1	0.1	0.3	0.4	0.0	0.1	0.0	13.7	0.1
HPR		ENSG00000261701	"Haptoglobin-related protein"	P00739	16	72063224-72077246	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"liver: 151.4"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 32.8"	"Cancer enriched"	"Detected in some"	53	"liver cancer: 185.1"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA047750	Supported		Approved	Vesicles	"Secreted to blood"	49000000000	77000000000	Vesicles		"HPA047750: "	"unprognostic (2.43e-1)"		"unprognostic (4.69e-2)"	"unprognostic (5.97e-3)"	"unprognostic (2.42e-1)"		"unprognostic (2.32e-3)"	"unprognostic (2.36e-1)"		"unprognostic (1.66e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.44e-6)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.29e-1)"		0.2	0.0	1.3	0.0	1.6	0.0	0.0	0.0	0.6	0.1	0.0			0.1	0.0	0.1	0.0	0.0	0.1	15.2	0.7	0.8	0.1	151.4	0.0	0.1	2.1		0.4	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2			0.0		0.0	0.0	0.0	1.1	2.9	1.1	1.0	0.4	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	1.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.3	1.0	0.1	0.5	0.4	0.4	0.3	1.1	2.0	1.1	0.3	0.4	0.3	2.9	2.3	0.3										
HPRT1	"HGPRT, HPRT"	ENSG00000165704	"Hypoxanthine phosphoribosyltransferase 1"	P00492	X	134460153-134520513	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets, Gout"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006360, CAB012200"	Enhanced		Supported	Cytosol			15000000	Cytosol		"CAB012200: AB_297217, HPA006360: AB_1079082"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.32e-3)"	"unprognostic (8.55e-2)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (1.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.93e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.00e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-1)"	7.9	14.9	31.0	12.6	30.2	25.3	11.3	24.2	49.8	7.5	13.7	5.8	9.8	11.0	7.9	36.2	10.3	9.4	8.1	12.8	27.6	37.3	18.4	24.7	7.3	15.9	23.5	28.9	9.8	20.2	9.9	18.6	8.8	34.4	8.8	13.2	9.7	7.1	9.5	10.7	8.0	14.2	9.5	9.8	8.7	17.1	39.7	4.9	13.7	12.3	8.6	15.9	10.8	7.5	13.5	19.7	10.1	18.5	19.9	29.3	12.6	31.0	15.0	4.2	8.7	9.5	13.7	12.8	16.6	16.0	21.3	28.0	13.4	19.9	35.2	37.9	10.8	19.1	27.4	22.8	36.8	29.2	51.3	19.1	21.3	13.6	9.4	41.0	17.6	10.1	8.6	18.9	30.3	24.5	14.6	0.9	16.6	31.7	31.6	35.6	8.7	40.3	19.0	21.6	36.1	25.6	15.1	26.9	14.7	12.0	9.7	11.3	8.3	17.2	12.1	14.5	10.9	41.4	41.2	13.4	23.2	0.2	17.8	45.6	7.9	2.2	11.6	10.1	11.6	18.5	16.7	12.3	17.3	15.3	19.7	13.5	14.3	15.1	2.9	19.9	17.2	8.2	29.3	12.6	31.0	30.2	24.2	49.8	27.6	37.3	23.5	28.9	34.4	4.9
HPS5	"AIBP63, BLOC2S2, RU2"	ENSG00000110756	"HPS5, biogenesis of lysosomal organelles complex 2 subunit 2"	Q9UPZ3	11	18278668-18322198	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Albinism, Disease mutation, Hermansky-Pudlak syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA077851	Approved									"HPA077851: "	"unprognostic (2.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.85e-3)"	"unprognostic (5.89e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (2.05e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.72e-1)"	7.1	9.0	6.7	8.4	7.7	4.5	15.2	6.9	6.1	6.0	8.6	8.0	3.2	8.7	5.5	4.2	7.5	5.5	5.7	6.2	6.5	6.0	8.9	35.7	12.5	11.9	8.1	4.3	7.7	9.9	8.1	18.0	13.5	7.9	5.1	4.8	15.9	20.7	7.1	5.5	6.1	18.6	5.9	11.6	15.1	4.8	17.5	7.8	9.2	7.7	4.3	15.3	6.2	5.5	10.0	14.7	15.7	9.8	4.5	5.0	4.2	6.1	9.1	9.7	9.7	13.1	7.4	10.6	16.2	13.4	10.7	11.4	5.6	1.9	14.9	6.3	14.0	8.8	11.3	10.7	13.3	12.4	8.2	7.2	7.5	6.9	12.5	15.6	13.4	11.8	10.9	6.5	14.1	8.5	9.4	8.7	17.2	5.0	8.2	11.4	4.9	10.1	12.2	13.9	6.2	10.4	5.5	3.2	6.4	20.4	7.3	24.0	5.5	9.1	6.4	12.3	6.7	15.9	7.4	3.7	12.1	17.1	6.9	8.1	34.7	15.7	6.2	4.9	4.1	9.6	5.0	10.0	5.0	4.1	14.7	8.6	5.0	4.9	1.8	4.5	9.8	5.7	4.4	4.2	6.7	7.7	6.9	6.1	6.5	6.0	8.1	4.3	7.9	7.8
HPX		ENSG00000110169	Hemopexin	P02790	11	6431049-6442617	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	949	"liver: 528.6"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 20.8"	"Cancer enriched"	"Detected in many"	79	"liver cancer: 571.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB016725	Supported				"Secreted to blood"	425000000000	230000000000			"CAB016725: "	"unprognostic (3.39e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.88e-1)"	"unprognostic (6.19e-4)"	"unprognostic (2.05e-2)"	"unprognostic (2.41e-1)"	"prognostic favourable (2.26e-4)"	"unprognostic (6.33e-2)"	"unprognostic (5.67e-3)"	"unprognostic (3.88e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-12)"	"unprognostic (2.01e-1)"	"unprognostic (4.48e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.14e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	528.6	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.3	1.4	0.0	0.8	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.2	0.6	0.1	20.8	0.0	2.9	0.0	0.8	0.6	0.1	0.0	0.1	0.4	0.1	0.1	0.4	0.0	0.0	0.3	0.0	0.1	1.3	0.2	0.0	0.1	0.2	0.0	1.0	3.0	0.2	1.1	0.0	0.4	0.3	0.2	1.0	0.1	0.3	0.2	0.9	0.2	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
HRAS	HRAS1	ENSG00000174775	"HRas proto-oncogene, GTPase"	P01112	11	532242-537287	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002015, HPA049830, HPA070222"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB002015: , HPA049830: , HPA070222: "	"unprognostic (3.06e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.49e-3)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (2.32e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.38e-1)"	12.3	11.4	25.2	9.1	34.5	5.0	16.2	16.1	25.3	7.9	9.5	8.1	10.8	8.9	6.2	9.2	22.3	8.3	10.9	28.7	22.2	22.4	8.2	6.5	8.9	8.0	23.2	12.9	7.7	9.7	11.7	10.3	10.1	15.0	10.0	6.2	8.2	10.1	12.7	51.8	32.0	8.2	8.4	17.0	6.5	7.2	6.1	11.0	5.9	8.1	24.5	9.3	9.9	19.8	2.1	1.1	0.7	4.6	0.1	2.0	0.3	21.8	19.4	9.3	8.3	5.8	4.1	12.0	10.9	5.8	17.1	14.6	9.8	8.7	8.4	3.4	14.8	17.4	9.9	26.5	4.8	6.9	22.1	4.3	7.8	8.5	8.8	3.4	3.3	6.2	29.6	9.2	10.0	8.5	8.8	12.3	9.6	17.9	12.7	12.1	9.4	19.3	10.2	11.8	7.5	9.6	5.4	36.3	14.4	10.1	18.1	7.8	14.8	6.7	13.5	15.3	12.1	5.6	14.0	4.6	6.1	6.5	14.4	6.3	14.3	0.0	0.6	0.7	1.4	1.2	1.6	0.8	1.4	1.3	0.7	2.1	2.0	0.6	0.0	0.1	4.6	1.1	2.0	0.3	25.2	34.5	16.1	21.1	22.2	22.4	23.2	12.9	15.0	11.0
HRG	"HPRG, HRGP"	ENSG00000113905	"Histidine rich glycoprotein"	P04196	3	186660216-186678240	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Angiogenesis, Blood coagulation, Chemotaxis, Fibrinolysis, Hemostasis"	Heparin-binding	"Disease mutation, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"liver: 425.4"	"Cell line enhanced"	"Detected in some"		"HEL: 1.7;HL-60: 5.7;RH-30: 6.8;SiHa: 2.4"	"Cancer enriched"	"Detected in some"	262	"liver cancer: 406.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA050269, HPA054598"	Supported				"Secreted to blood"	120050000000	30000000000			"HPA050269: , HPA054598: "		"unprognostic (2.67e-1)"		"unprognostic (1.74e-2)"		"unprognostic (7.58e-5)"	"prognostic favourable (9.64e-5)"	"unprognostic (1.44e-1)"		"unprognostic (2.98e-3)"	"unprognostic (2.22e-1)"		"unprognostic (1.55e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	425.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.2	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	1.6	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.7	0.0	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HRNR	"FLG3, S100A16, S100a18"	ENSG00000197915	Hornerin	Q86YZ3	1	152212082-152224193	"Plasma proteins, Predicted intracellular proteins"	Keratinization	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 4.0"	"Cell line enhanced"	"Detected in some"		"A549: 1.5;HaCaT: 1.5;HDLM-2: 1.3;NTERA-2: 6.1;U-2 OS: 1.5;U-2197: 1.4"	"Cancer enhanced"	"Detected in single"		"melanoma: 1.0"					"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 1.5"									HPA031469	Uncertain		Approved	Mitochondria			210000000	Mitochondria		"HPA031469: AB_10603771"	"unprognostic (1.34e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.72e-4)"	"unprognostic (1.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.09e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.64e-2)"	0.3	0.4	0.0	0.1	0.2	0.1	0.3	0.0	1.3	0.7	0.1			0.1	0.5	0.0	1.8	0.8	0.6	0.5	0.1	0.1	1.0	0.0	0.1	0.4	0.0		1.6	1.5	0.0	0.4	0.1		0.6	0.0		0.2	0.0	0.1	4.0	0.2	0.0	0.1	0.1	0.1	1.3			1.6		0.0	0.4	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.6	1.2	0.1	1.5	1.4	0.3	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0										
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 13.1;seminal vesicle: 9.4;skeletal muscle: 10.1"	"Cell line enhanced"	"Detected in some"		"PC-3: 4.9;RT4: 9.0;SCLC-21H: 17.5;U-266/70: 4.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved									"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.5	1.9	3.3	0.9	13.1	1.3	0.5	0.6	11.9	0.8	1.0	9.1	3.5	0.7	0.8	0.5	0.6	0.6	0.7	0.5	4.2	3.5	0.9	0.5	1.1	0.5	6.1	2.7	0.6	1.3	0.5	0.3	0.6	7.8	0.7	0.9	0.6	0.7	9.4	10.1	1.3	1.2	0.9	7.5	0.5	1.2	0.9	8.0	0.0	0.6	0.0	0.5	2.5	0.2	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	4.9	0.0	1.0	0.0	0.0	9.0	17.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	4.4	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.3	13.1	0.6	5.7	4.2	3.5	6.1	2.7	7.8	8.0
HSD17B10	"17b-HSD10, ABAD, CAMR, ERAB, HADH2, MHBD, MRPP2, MRXS10, SDR5C1"	ENSG00000072506	"Hydroxysteroid 17-beta dehydrogenase 10"	Q99714	X	53431258-53434373	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	Oxidoreductase	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001432	Approved						1800000			"HPA001432: AB_1078740"	"unprognostic (1.27e-1)"	"prognostic favourable (2.80e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.37e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.92e-1)"	"unprognostic (9.51e-2)"	20.9	29.8	13.2	19.1	14.5	16.4	15.9	7.9	14.0	16.9	20.6	16.2	20.2	17.2	17.1	19.0	31.3	14.8	19.6	42.6	11.9	14.0	33.9	96.7	12.7	21.6	16.1	9.7	21.0	32.7	12.5	18.4	25.0	14.9	15.3	19.4	13.0	23.2	17.8	35.4	22.9	17.4	18.6	14.8	19.7	17.4	8.6	14.0	25.6	28.4	39.0	26.0	16.1	17.9	30.4	53.2	12.8	38.2	27.7	33.3	32.9	22.0	37.8	18.5	34.2	18.2	8.0	27.9	13.7	13.7	36.6	24.1	38.8	19.1	37.7	12.5	15.7	23.2	59.4	27.7	20.1	29.9	33.3	17.7	54.2	32.1	30.5	33.5	27.8	17.0	26.4	28.3	15.9	26.7	25.4	29.9	16.9	77.9	29.6	50.3	51.1	48.9	30.3	34.1	66.7	28.1	24.5	32.7	43.1	39.5	47.3	25.0	49.8	31.2	11.9	15.7	25.0	32.7	20.7	24.5	34.1	46.6	21.8	70.5	23.1	12.8	38.2	11.4	27.0	36.7	27.8	30.0	25.1	26.7	53.2	30.4	21.1	22.2	3.2	27.7	26.8	29.0	33.3	32.9	13.2	14.5	7.9	14.0	11.9	14.0	16.1	9.7	14.9	14.0
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.7;Hep G2: 18.8;hTERT-HME1: 11.3;RT4: 38.9;TIME: 21.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA021826: AB_10961148, HPA050235: "	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	23.7	0.0	0.0	4.3	0.7	0.0	4.7	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.1	18.8	0.1	0.1	0.1	0.0	1.2	0.0	11.3	0.3	0.0	0.2	3.5	0.1	0.0	0.4	0.1	8.6	0.0	0.0	0.5	0.4	38.9	0.2	0.6	0.0	1.1	0.1	0.0	0.0	21.8	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes			6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.7	15.3	28.8	38.1	71.9	33.8	15.2	17.3	23.3	16.4	29.9	12.6	29.5	23.7	35.6	18.7	17.8	21.1	37.6	25.6	25.9	19.5	31.2	16.6	24.1	18.3	9.8	48.9	29.4	15.8	17.6	16.5	28.0	10.6	13.8	17.8	15.4	15.0	6.4	21.3	10.8	19.2	28.8	25.6	26.2	49.0	21.7	18.7	40.6	6.4	18.9	23.6	16.6	19.9	16.1	11.0	17.7	14.1	7.0	14.7	8.7	18.3	26.3	15.8	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria				Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favourable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favourable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.2	13.7	10.3	5.2	17.9	17.8	11.9	10.5	6.5	7.5	6.3	26.3	17.2	9.8	5.8	15.3	17.6	11.1	14.7	9.3	41.2	7.3	10.2	22.2	25.7	11.2	5.7	6.6	18.9	10.7	11.2	8.1	8.7	14.1	6.6	20.4	10.1	14.2	5.3	6.0	17.8	9.2	31.2	14.4	15.9	13.9	7.4	5.3	26.3	17.5	8.8	24.7	7.0	9.8	10.8	10.1	30.2	10.2	7.8	19.2	4.6	13.4	8.5	6.3	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5
HSF1	HSTF1	ENSG00000185122	"Heat shock transcription factor 1"	Q00613	8	144291591-144314722	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, Host-virus interaction, mRNA processing, mRNA transport, Stress response, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004239, HPA008888"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004239: AB_627753, HPA008888: AB_1079088"	"unprognostic (7.08e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.07e-2)"	"prognostic unfavourable (8.93e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.63e-2)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (5.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.12e-1)"	24.7	22.9	17.4	21.0	20.9	20.8	30.8	24.4	23.6	21.3	26.9	18.3	17.7	18.9	23.3	16.7	25.5	28.5	22.9	42.8	17.0	17.5	21.2	19.5	20.3	23.6	17.4	15.9	32.4	36.8	25.8	21.8	22.8	17.8	26.7	15.2	20.7	26.4	24.6	55.2	20.3	17.8	35.1	14.4	20.3	23.6	42.6	17.8	23.2	29.9	24.2	19.8	30.3	33.9	16.9	20.3	20.3	24.2	12.9	18.4	14.2	14.6	19.9	8.6	7.3	14.5	13.6	14.3	11.0	10.0	10.9	9.5	13.3	12.9	16.9	16.2	15.2	10.7	13.1	15.8	7.0	10.7	15.1	21.2	20.4	18.1	22.9	6.1	16.4	13.2	14.9	15.3	28.3	14.7	14.0	10.2	10.9	29.7	20.6	9.4	11.0	57.4	13.4	7.5	21.4	7.8	14.9	13.0	10.5	16.8	13.5	19.4	15.2	12.6	14.8	11.2	25.4	17.6	18.0	7.1	5.4	14.5	16.0	11.5	10.7	10.6	18.9	20.3	14.5	19.9	15.2	16.9	15.7	18.4	20.3	15.5	15.6	13.9	8.1	12.9	24.2	10.3	18.1	14.2	17.4	20.9	24.4	23.6	17.0	17.5	17.4	15.9	17.8	17.8
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399546-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.6	13.7	9.0	6.7	14.7	20.6	11.4	17.8	19.4	12.7	9.3	9.9	9.2	6.3	14.4	9.8	8.7	11.1	6.9	20.3	9.2	11.3	6.4	4.9	7.7	11.5	9.7	15.5	14.3	5.9	13.5	18.5	7.3	18.0	10.4	6.5	9.7	7.7	12.1	37.9	10.2	7.8	12.6	9.2	8.5	8.5	31.7	9.3	14.3	8.3	15.9	10.7	13.1	8.6	6.6	3.8	4.0	4.2	7.0	21.3	7.7	4.2	4.5	23.3	19.0	10.5	8.4	6.5	7.7	18.4	14.2	22.3	6.6	3.6	16.5	6.8	9.6	5.5	15.6	7.4	20.0	16.5	19.0	16.0	4.3	13.6	10.7	11.8	8.3	10.6	11.4	11.7	13.5	8.5	17.2	8.2	13.3	5.7	19.3	15.5	7.2	6.5	17.9	9.5	5.3	10.7	4.9	25.0	16.8	8.0	6.6	7.4	5.6	12.9	5.1	7.7	8.9	8.5	11.6	12.0	11.4	21.0	8.3	7.8	10.0	3.4	2.7	4.0	8.5	3.2	9.1	6.6	8.1	7.4	3.8	5.4	21.3	16.0	0.4	7.0	4.2	2.6	8.8	7.7	9.0	14.7	17.8	19.4	9.2	11.3	9.7	15.5	18.0	9.3
HSF4	CTM	ENSG00000102878	"Heat shock transcription factor 4"	Q9ULV5	16	67164681-67169945	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 11.6;U-266/70: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048584			Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA048584: "	"unprognostic (1.90e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (9.20e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.26e-3)"	"prognostic unfavourable (2.19e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.48e-2)"	"unprognostic (8.74e-3)"	6.9	16.8	11.8	2.5	14.7	2.6	5.5	16.4	20.2	7.1	4.6	2.6	16.0	6.4	6.5	13.7	7.5	7.9	5.3	8.7	11.6	5.5	6.4	8.3	6.0	2.6	19.3	16.9	7.1	17.4	10.2	12.3	5.0	11.5	12.2	3.4	19.1	16.4	4.3	36.8	13.2	6.3	26.8	11.7	3.4	16.1	3.4	15.1	0.3	7.4	10.6	1.9	10.9	8.4	0.0	0.5	0.0	0.9	0.0	0.4	0.2	1.4	0.9	0.0	1.1	0.5	2.8	5.1	0.6	0.5	0.2	0.0	2.1	2.6	0.0	2.3	1.0	5.0	0.4	0.6	0.2	1.6	2.0	0.8	1.9	3.0	2.1	0.3	3.6	1.5	4.3	0.3	2.3	0.8	1.4	4.8	2.0	1.3	0.6	1.3	0.1	1.8	2.4	1.8	5.9	3.8	2.2	2.8	5.9	4.1	2.7	6.2	11.6	4.0	1.2	1.5	1.7	5.6	1.6	21.2	3.0	1.3	3.1	1.5	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	11.8	14.7	16.4	20.2	11.6	5.5	19.3	16.9	11.5	15.1
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080738-102139699	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 519.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol			94000000	Cytosol		"CAB002058: "	"prognostic unfavourable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavourable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	50.8	75.3	96.1	46.7	106.8	64.1	118.6	81.3	113.4	51.0	47.3	50.7	43.0	31.0	40.7	55.5	40.9	94.7	61.0	70.9	99.6	113.3	75.6	62.5	51.7	48.1	134.4	58.6	53.4	40.1	94.9	121.6	67.2	143.6	63.2	53.3	23.4	57.0	57.0	65.2	35.6	38.9	51.0	139.7	35.7	41.3	84.6	132.7	53.5	91.5	34.3	59.5	54.2	519.3	30.7	46.9	31.8	29.9	57.7	63.1	21.9	86.3	118.1	75.4	52.0	45.8	38.8	100.2	96.1	46.2	117.9	66.5	71.7	81.2	106.2	90.5	61.8	95.9	216.5	94.0	215.1	80.3	71.3	82.0	67.5	91.5	22.7	122.0	63.3	36.4	40.0	75.3	27.8	65.0	113.2	54.6	106.6	116.8	130.4	56.1	78.4	111.7	125.8	102.5	45.8	68.4	111.7	99.4	71.7	121.5	91.5	53.6	117.6	48.7	46.0	82.5	53.4	122.6	182.5	51.7	161.1	157.1	78.1	75.4	99.4	31.8	19.9	24.0	47.8	29.9	63.1	29.6	40.5	49.0	23.9	30.7	30.1	43.5	13.5	57.7	27.5	46.9	39.2	21.9	96.1	106.8	81.3	102.7	99.6	113.3	134.4	58.6	143.6	132.7
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"		62000000	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	79.9	116.1	88.0	65.9	105.0	74.6	107.8	92.1	118.2	92.3	60.4	61.7	80.9	40.6	113.3	107.6	71.6	138.4	63.8	115.0	89.0	110.5	72.0	70.7	76.2	73.8	109.7	94.4	238.4	113.9	151.6	95.3	83.6	133.7	93.5	76.4	52.7	64.8	100.3	197.1	67.9	49.0	102.1	93.9	57.5	77.3	45.9	100.2	58.3	133.8	89.8	102.5	86.2	223.4	75.9	50.5	7.2	45.7	55.7	82.5	74.9	138.6	89.0	79.1	97.1	54.3	56.9	82.8	62.7	61.5	116.1	81.8	133.0	42.5	177.7	68.0	65.2	80.9	192.3	93.3	143.7	58.8	77.8	138.3	50.4	173.8	39.3	138.0	95.8	52.5	63.2	91.2	78.8	111.1	184.5	66.3	78.9	140.0	114.9	83.3	92.2	68.2	110.9	80.8	97.5	78.5	84.4	115.8	70.8	48.7	70.6	87.9	91.8	69.1	69.6	69.3	116.0	56.6	143.1	76.8	120.4	321.0	75.3	101.5	78.9	7.2	30.2	6.8	49.3	45.7	82.5	75.9	55.2	56.4	50.5	63.2	75.2	71.3	3.7	55.7	43.3	31.4	42.6	74.9	88.0	105.0	92.1	118.2	89.0	110.5	109.7	94.4	133.7	100.2
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		410000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: , HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	79.2	43.0	86.8	89.1	88.9	84.0	117.8	133.6	101.0	71.2	95.1	76.6	74.3	23.2	106.3	140.2	55.4	85.4	143.5	96.1	54.8	32.6	62.3	48.5	79.0	137.1	62.8	48.9	49.2	64.0	87.6	125.8	136.9	49.8	88.2	94.0	28.5	37.7	70.3	71.3	51.8	34.4	56.0	96.9	95.2	50.0	25.8	61.8	83.4	86.3	84.3	70.2	93.3	78.7	53.9	46.2	43.8	55.7	90.3	84.5	42.9	107.4	46.5	83.4	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9
HSPA12B	"C20orf60, dJ1009E24.2"	ENSG00000132622	"Heat shock protein family A (Hsp70) member 12B"	Q96MM6	20	3732667-3753111	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;EFO-21: 6.6;HUVEC TERT2: 12.5;TIME: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"non-classical monocyte: 3.1"	"Lineage enriched"	"Detected in single"	11	"monocytes: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013659, HPA015639"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA013659: AB_1851195, HPA015639: AB_1851192"	"unprognostic (1.00e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.66e-2)"	22.7	3.4	2.6	4.6	4.9	1.8	19.4	1.5	5.5	11.0	4.3	3.9	4.3	2.6	11.7	8.1	6.2	6.2	10.7	14.6	3.1	2.7	5.7	3.0	26.8	2.3	4.1	2.8	6.4	4.8	2.1	1.8	13.9	5.1	5.1	2.0	7.2	5.3	5.4	13.5	4.8	3.6	6.1	2.8	21.2	3.2	5.2	1.8	0.4	6.1	9.6	2.1	4.7	7.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.6	2.2	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	6.3	0.2	0.2	6.6	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.1	0.0	3.4	0.2	0.1	0.1	0.2	0.0	0.1	0.0	12.5	0.4	0.2	0.0	1.3	0.5	1.1	1.4	1.1	2.2	0.3	0.6	0.0	0.0	1.2	1.0	0.4	0.2	0.1	0.2	0.7	6.9	0.2	2.9	1.0	0.5	0.5	0.4	0.6	0.2	1.1	0.6	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	2.6	4.9	1.5	5.5	3.1	2.7	4.1	2.8	5.1	1.8
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815065	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"testis: 29.1;vagina: 17.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;EFO-21: 2.1;HEK 293: 6.7;U-266/70: 2.8;U-266/84: 2.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Lineage enriched"	"Detected in single"	4	"T-cells: 1.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles			49000000	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: "	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favourable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	0.4	0.5	1.8	0.5	2.2	0.5	1.2	1.4	3.1	0.5	0.7	1.5	0.0	0.3	0.8	3.0	0.8	1.5	0.3	0.5	2.0	1.1	0.9	0.7	1.7	0.7	4.5	0.8	1.1	1.5	0.3	0.7	1.0	2.6	1.2	0.6	0.2	0.4	1.5	3.9	0.6	0.8	0.5	4.6	1.1	0.8	29.1	3.2	0.0	2.0	0.0	0.7	0.5	17.0	0.3	0.0	0.4	0.1	0.0	1.7	1.1	0.0	1.7	0.0	0.0	1.9	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.9	0.0	0.0	6.7	0.0	0.0	0.2	0.2	1.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	2.8	2.4	0.0	1.7	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	1.0	1.3	0.0	0.3	1.5	1.6	0.3	0.0	0.0	0.0	1.7	1.1	1.8	2.2	1.4	3.1	2.0	1.1	4.5	0.8	2.6	3.2
HSPA2		ENSG00000126803	"Heat shock protein family A (Hsp70) member 2"	P54652	14	64535905-64546173	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0;skeletal muscle: 90.5"	"Cell line enhanced"	"Detected in many"		"A549: 24.6;BEWO: 38.4;BJ hTERT+: 32.8;SCLC-21H: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000798, HPA052504"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles			77000000	Vesicles	Nucleoplasm	"HPA000798: AB_1079090, HPA052504: "	"prognostic favourable (1.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.25e-1)"	5.2	3.3	21.1	5.2	45.3	1.5	5.2	3.7	37.6	3.3	23.3	87.0	0.1	4.4	13.8	12.8	25.2	7.2	4.2	22.8	33.2	18.7	26.6	2.6	4.5	3.2	71.0	20.6	2.4	3.8	7.5	4.3	37.6	37.7	3.8	6.9	3.5	10.2	4.0	90.5	14.8	7.8	17.9	83.8	8.5	5.7	58.8	65.2	0.0	2.3	8.2	3.9	12.4	4.0	0.7	0.3	2.4	0.6	0.9	3.7	0.5	9.6	24.6	3.8	0.0	2.7	0.2	38.4	13.9	32.8	5.6	9.2	0.9	17.4	2.4	5.6	15.1	11.0	0.0	0.7	3.4	1.3	1.9	0.0	1.4	0.0	2.7	0.0	3.3	1.2	0.5	0.8	0.0	0.3	0.0	2.0	2.7	4.3	0.1	0.1	2.8	3.0	1.9	0.0	0.0	8.6	1.5	34.1	1.9	0.6	1.2	0.0	0.9	1.0	0.5	0.1	0.0	1.2	0.0	2.5	0.0	0.0	3.1	0.0	3.7	0.9	0.2	0.1	1.8	0.4	0.1	0.7	1.7	0.8	0.0	0.5	0.6	0.6	2.4	0.9	0.6	0.3	3.7	0.5	21.1	45.3	3.7	28.3	33.2	18.7	71.0	20.6	37.7	65.2
HSPA4	"HS24/P52, HSPH2"	ENSG00000170606	"Heat shock protein family A (Hsp70) member 4"	P34932	5	133051962-133106449	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010023, CAB025529"	Uncertain		Supported	Nucleoplasm,Cytosol			10000000	"Nucleoplasm, Cytosol"		"CAB025529: , HPA010023: AB_1851206"	"unprognostic (2.54e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.62e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-3)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (2.31e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.41e-1)"	20.6	35.0	26.6	25.6	27.6	20.5	39.0	25.9	35.6	19.4	20.5	18.7	19.9	17.4	23.3	20.2	42.0	19.2	18.9	32.9	26.4	31.9	30.3	31.1	17.2	28.9	30.9	24.5	23.2	19.5	37.1	32.8	24.5	34.3	18.9	23.9	16.0	20.3	19.2	48.3	19.6	18.5	23.6	25.9	20.0	20.9	39.8	29.5	27.3	26.8	24.8	38.6	24.5	77.1	27.7	17.9	15.5	23.0	14.1	14.9	11.5	34.2	47.2	33.0	53.7	31.4	26.5	59.9	37.6	28.3	36.5	45.3	88.6	36.0	57.0	39.6	36.1	30.6	57.2	62.2	52.9	26.3	32.8	42.0	31.7	48.5	25.1	26.0	36.9	26.3	26.3	47.0	30.9	34.8	43.9	17.7	39.8	30.2	36.6	19.4	45.2	21.9	33.6	40.4	30.3	33.0	45.2	26.3	21.6	35.8	18.8	50.0	27.6	25.6	30.4	33.3	47.9	28.4	44.5	20.3	45.0	43.8	28.5	43.3	33.0	14.8	14.4	15.5	12.6	23.0	14.9	22.6	11.6	13.0	17.9	27.7	12.1	11.2	9.6	14.1	16.4	6.8	11.3	11.5	26.6	27.6	25.9	35.6	26.4	31.9	30.9	24.5	34.3	29.5
HSPA4L	"APG-1, HSPH3, Osp94"	ENSG00000164070	"Heat shock protein family A (Hsp70) member 4 like"	O95757	4	127781821-127840733	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.0;vagina: 32.0"	"Cell line enhanced"	"Detected in many"		"HAP1: 37.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034450, HPA039149, HPA061446"	Enhanced		Approved	Centrosome,Cytosol				"Centrosome, Cytosol"		"CAB034450: AB_2119823, HPA039149: , HPA061446: "	"unprognostic (6.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.40e-2)"	"unprognostic (3.28e-1)"	"prognostic favourable (3.80e-9)"	"unprognostic (8.53e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (6.78e-4)"	1.6	9.3	7.4	1.4	9.0	2.8	5.5	16.6	11.4	2.9	2.5	1.7	1.6	2.5	1.5	1.7	10.9	5.9	3.5	5.3	6.1	10.1	10.6	5.9	1.9	1.0	6.6	6.6	3.5	3.6	12.2	23.2	2.8	20.1	3.9	3.5	3.5	4.6	4.7	1.5	6.5	1.6	3.8	5.0	1.4	2.1	73.0	5.2	1.0	3.7	4.1	4.0	2.8	32.0	0.7	0.5	3.9	0.4	0.5	0.4	0.1	8.9	11.8	6.4	10.1	4.4	4.5	7.4	4.1	1.7	4.0	4.4	8.6	4.1	0.0	7.5	1.1	2.1	37.3	14.7	5.5	16.7	11.1	4.8	16.2	10.4	1.6	18.5	8.2	4.1	13.7	2.6	9.4	5.1	8.5	5.5	4.9	6.5	5.8	1.6	1.5	9.8	0.0	0.7	0.9	13.5	4.1	11.8	4.3	7.4	12.9	0.6	9.8	3.1	1.4	1.4	0.0	1.7	9.8	10.8	12.4	2.8	5.4	12.6	4.2	1.6	0.4	3.9	0.4	0.2	0.2	0.4	0.3	0.3	0.5	0.7	0.4	0.4	1.3	0.5	0.3	0.4	0.3	0.1	7.4	9.0	16.6	11.4	6.1	10.1	6.6	6.6	20.1	5.2
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.1	31.7	41.9	38.0	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.2	41.1	40.1	46.8	45.5	28.3	57.3	51.3	23.8	14.3	24.6	30.1	67.2	200.7	33.5	46.6	27.0	112.5	38.3	167.9	74.1	18.2	57.5	34.7	26.3	14.8	23.7	35.8	24.2	14.0	32.3	66.7	46.2	23.6	16.4	29.2	40.8	43.7	65.4	45.0	24.5	49.7	29.1	28.4	29.7	29.8	60.2	57.5	34.8	70.7	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5
HSPA6	HSP70B'	ENSG00000173110	"Heat shock protein family A (Hsp70) member 6"	P17066	1	161524540-161526910	"Plasma proteins, Predicted intracellular proteins"	"Stress response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.6;vagina: 99.8"	"Cell line enriched"	"Detected in some"	7	"Karpas-707: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 67.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 67.6"									"CAB017452, HPA028549, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"CAB017452: AB_10618032, HPA028549: AB_10601817, HPA052504: "	"unprognostic (3.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.36e-3)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (4.61e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.98e-5)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	6.8	11.9	9.4	10.3	12.4	3.5	43.0	3.5	6.0	1.4	1.9	2.2	1.7	1.9	2.2	1.3	3.2	1.1	9.6	4.5	4.5	9.3	3.1	14.6	13.5	2.1	13.7	1.3	9.3	5.4	0.9	5.4	20.8	5.7	3.3	1.9	1.7	2.9	5.8	1.4	4.4	1.7	4.2	13.2	11.2	3.6	1.4	5.0	1.3	5.8	1.8	2.8	3.1	99.8	0.0	2.5	67.6	9.0	1.6	1.4	2.1	0.5	0.9	0.0	0.2	0.0	0.8	0.7	0.4	0.3	0.1	0.3	0.3	0.5	0.1	1.5	0.1	0.2	0.3	0.2	0.2	0.3	0.0	0.2	0.9	0.0	0.0	0.1	2.2	0.1	0.7	0.3	0.0	0.0	0.4	33.3	0.0	0.0	0.1	0.8	0.0	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	1.9	0.2	0.4	0.1	0.1	0.3	0.2	2.2	4.5	0.2	0.0	0.8	0.8	1.5	0.8	7.5	2.7	1.4	9.0	0.2	0.0	0.1	0.7	2.5	0.0	0.0	0.3	67.6	1.6	7.3	0.0	0.0	2.1	9.4	12.4	3.5	6.0	4.5	9.3	13.7	1.3	5.7	5.0
HSPA8	"HSC70, HSC71, HSP73, HSPA10"	ENSG00000109971	"Heat shock protein family A (Hsp70) member 8"	P11142	11	123057489-123063230	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Stress response, Transcription, Transcription regulation"	"Chaperone, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002056, HPA052504"	Uncertain		Approved	Nucleoplasm,Vesicles			210000000	Nucleoplasm	Vesicles	"CAB002056: , HPA052504: "	"unprognostic (2.28e-3)"	"unprognostic (1.19e-3)"	"prognostic favourable (6.14e-6)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.70e-2)"	"prognostic unfavourable (1.93e-4)"	"unprognostic (9.65e-3)"	"unprognostic (3.82e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (3.81e-4)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.16e-2)"	70.0	96.8	93.7	78.1	102.8	58.1	73.8	119.5	125.1	52.8	64.1	72.0	77.3	77.7	59.9	98.3	83.4	76.2	76.7	106.4	83.1	102.4	128.6	114.2	68.9	93.3	105.7	72.4	66.7	191.1	97.2	98.3	71.6	169.2	65.3	81.0	53.1	62.4	69.9	224.6	31.2	74.4	75.4	91.8	79.7	92.7	58.3	98.1	92.9	90.9	98.3	124.4	76.1	123.2	77.4	47.5	41.1	84.2	76.1	124.3	200.0	82.8	125.6	83.4	72.0	77.2	82.8	110.5	164.7	91.3	201.5	121.3	188.4	109.0	134.9	104.0	91.6	112.9	238.2	59.7	201.2	116.6	36.2	146.4	59.0	91.8	21.1	142.2	112.5	44.1	96.6	61.9	19.3	107.8	158.4	70.2	161.4	73.8	147.8	105.6	131.9	111.9	133.4	59.5	76.3	104.4	60.6	85.6	64.9	120.0	130.3	45.4	113.6	55.7	105.9	101.2	81.3	87.0	145.9	47.4	116.9	115.8	112.8	203.3	122.1	30.3	41.5	41.1	96.5	82.9	115.9	77.4	113.4	105.2	47.5	53.7	109.6	105.1	14.9	76.1	84.2	34.4	124.3	200.0	93.7	102.8	119.5	125.1	83.1	102.4	105.7	72.4	169.2	98.1
HSPA9	"GRP75, HSPA9B, mot-2, mthsp75, PBP74"	ENSG00000113013	"Heat shock protein family A (Hsp70) member 9"	P38646	5	138554882-138575444	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000898, CAB005219"	Supported		Supported	Mitochondria			3100000	Mitochondria		"CAB005219: AB_647720, HPA000898: AB_1079032"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.86e-1)"	"prognostic favourable (4.53e-4)"	"unprognostic (3.73e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.06e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.29e-1)"	26.4	76.4	30.9	22.1	33.2	39.8	27.7	24.3	39.5	20.0	28.7	30.4	24.0	27.8	23.1	29.7	28.5	19.1	19.3	55.0	28.2	32.5	59.9	117.7	20.5	22.8	35.5	31.3	28.9	31.9	56.7	25.5	24.6	43.7	25.3	32.7	20.6	26.0	26.4	84.2	24.0	25.7	24.0	29.3	24.6	27.7	18.6	32.0	21.1	41.0	32.8	29.1	23.7	33.1	19.3	24.1	6.6	20.9	20.5	28.3	23.3	32.7	41.5	23.7	45.4	24.9	16.3	48.8	34.8	30.9	39.1	42.6	79.1	35.0	62.8	47.8	25.8	27.8	63.1	46.6	54.3	31.5	30.9	34.6	37.3	52.7	67.3	34.8	38.5	27.7	70.8	43.1	97.4	18.5	43.2	54.1	30.8	40.2	36.5	30.0	34.7	34.5	41.0	34.3	48.6	43.9	47.3	28.5	21.7	40.3	64.2	131.7	36.9	40.9	17.7	38.4	24.3	32.0	55.1	66.8	47.8	63.2	47.3	61.5	38.2	6.6	16.9	6.5	24.0	20.9	28.3	19.3	20.6	23.0	24.1	14.1	23.0	22.8	3.9	20.5	20.6	14.1	18.2	23.3	30.9	33.2	24.3	39.5	28.2	32.5	35.5	31.3	43.7	32.0
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 162.0;MCF7: 227.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavourable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	72.6	54.0	5.8	43.1	35.1	31.1	0.3	30.9	16.3	16.8	21.1	4.8	42.6	0.6	23.9	40.0	66.7	25.3	18.1	5.4	40.5	8.5	3.3	41.7	22.8	18.8	4.9	30.5	38.6	162.0	25.3	3.7	55.4	26.4	74.3	19.2	227.6	8.3	33.6	29.6	47.3	25.7	11.9	59.0	24.9	27.7	0.4	33.1	21.7	88.6	27.6	104.4	34.8	29.9	50.5	75.3	15.7	77.9	5.2	8.6	0.7	36.9	15.2	36.7	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria			53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavourable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	40.4	49.8	41.8	37.5	28.7	30.0	60.8	42.2	22.3	50.8	37.3	167.0	24.4	123.1	55.1	22.0	41.4	163.6	46.5	72.1	30.2	65.6	87.4	80.6	193.3	27.0	96.8	27.5	33.9	54.0	45.0	79.4	39.8	107.6	48.3	37.3	51.8	60.1	98.0	82.6	104.2	72.3	51.6	88.9	53.4	42.3	54.8	31.0	42.3	45.8	54.1	31.7	57.5	17.7	31.6	43.8	40.6	66.6	27.1	59.6	102.2	37.1	58.5	33.9	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8
HSPE1	"CPN10, EPF, GroES, HSP10"	ENSG00000115541	"Heat shock protein family E (Hsp10) member 1"	P61604	2	197499994-197503457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 196.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017366, HPA038755, HPA048272"	Supported						9000000			"CAB017366: AB_10998950, HPA038755: , HPA048272: "	"unprognostic (2.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.83e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.39e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.08e-3)"	24.9	134.7	38.4	25.0	35.0	17.8	50.6	17.1	41.2	19.1	39.9	16.3	20.3	30.8	15.8	31.7	24.3	21.1	16.7	33.8	33.7	37.3	62.5	120.9	18.6	23.8	51.5	26.8	22.7	35.9	14.9	27.2	26.0	48.3	21.9	39.0	9.1	25.1	27.6	39.1	13.0	27.7	17.9	46.7	18.6	21.7	9.4	45.7	10.4	30.6	31.5	30.8	20.2	116.3	50.8	44.9	3.6	29.0	31.5	48.1	28.0	34.4	45.7	42.3	31.2	29.3	14.7	52.4	37.8	16.9	32.9	30.8	138.0	29.2	64.9	48.7	17.9	29.8	106.4	36.6	38.4	31.2	45.5	69.5	91.6	196.9	12.9	93.7	30.2	20.1	25.0	33.1	16.4	29.2	87.0	21.6	22.1	49.7	70.3	91.5	61.8	84.1	43.0	37.7	76.6	44.9	51.8	33.2	21.4	35.8	42.2	29.8	16.4	49.8	22.6	27.2	38.7	30.0	61.1	25.7	58.5	111.3	30.5	42.5	36.8	3.6	16.7	3.3	30.2	29.0	38.4	50.8	40.3	37.1	27.0	37.1	45.8	48.1	1.8	31.5	22.1	44.9	32.0	28.0	38.4	35.0	17.1	41.2	33.7	37.3	51.5	26.8	48.3	45.7
HSPG2	"perlecan, PRCAN, SJS1"	ENSG00000142798	"Heparan sulfate proteoglycan 2"	P98160	1	21822245-21937297	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 104.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 45.8;HUVEC TERT2: 101.1;TIME: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 3.0"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009820, HPA018892, CAB020718"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		1700000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB009820: AB_2119229, CAB020718: , HPA018892: AB_1850597"	"unprognostic (1.61e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.90e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (2.82e-4)"	54.8	12.8	1.1	22.9	1.5	0.2	19.8	0.8	1.5	37.3	32.3	2.4	37.2	6.2	62.8	37.6	32.7	20.6	60.0	30.2	1.2	1.2	15.7	8.9	12.5	7.8	2.5	1.2	19.8	9.4	4.6	3.4	24.6	3.8	32.0	2.5	24.6	15.5	22.3	20.8	12.2	13.7	104.4	1.8	16.4	18.9	11.4	0.7	3.4	16.9	20.1	8.5	66.2	28.2	0.2	3.0	0.0	0.0	0.0	0.2	0.0	6.8	6.4	2.1	7.5	22.1	16.8	8.5	10.4	2.7	3.0	2.8	7.7	14.1	0.5	45.8	16.1	4.3	0.5	5.1	0.7	0.1	0.7	2.3	6.8	5.6	4.6	0.0	0.6	10.1	1.5	3.1	0.9	101.1	3.1	0.9	4.1	1.9	0.0	3.1	1.9	2.9	1.0	9.0	0.9	5.8	0.9	0.2	0.6	7.9	3.3	4.6	1.3	1.1	80.7	6.0	7.8	4.6	0.3	0.0	1.0	0.3	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	3.0	0.0	0.0	1.1	1.5	0.8	1.5	1.2	1.2	2.5	1.2	3.8	0.7
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937306-87016683	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 16.4;ovary: 13.3"	"Group enriched"	"Detected in some"	22	"PC-3: 2.9;SH-SY5Y: 11.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA004931	Approved									"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.5	0.6	8.9	0.6	13.3	0.5	0.5	5.4	16.4	1.6	0.5	0.0	0.0	0.5	5.1	1.1	0.6	0.5	0.8	0.5	4.1	2.8	0.5	0.5	0.5	0.5	1.8	11.4	13.3	0.8	0.5	0.3	0.5	2.2	1.1	0.5	0.0	0.5	1.2	0.5	0.5	0.5	2.9	0.6	0.5	3.6	1.4	1.5	0.0	2.7	0.0	0.5	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	13.3	5.4	16.4	4.1	2.8	1.8	11.4	2.2	1.5
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122461525-122514908	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 198.9;ASC TERT1: 73.9;fHDF/TERT166: 67.4;HSkMC: 129.7;LHCN-M2: 98.6;U-87 MG: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	20	"monocytes: 2.4;T-cells: 1.6"	"Low region specificity"	"Detected in all"							HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	24800000	2600000	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (5.62e-6)"	40.8	21.8	64.5	9.1	79.0	0.5	48.2	16.2	62.8	50.4	19.3	60.8	7.2	5.6	47.6	67.0	15.6	19.5	78.7	28.7	50.8	35.4	34.7	60.4	14.6	9.1	62.7	32.5	111.3	14.5	37.6	26.9	114.1	41.9	19.5	14.0	20.7	19.3	31.5	7.5	29.6	9.3	40.5	46.5	10.5	12.9	9.8	49.5	1.7	13.3	8.5	7.1	41.5	27.3	0.0	0.0	0.0	2.4	0.0	1.6	0.7	0.0	3.4	1.5	0.4	198.9	73.9	0.0	8.5	15.6	3.5	1.9	0.0	0.0	0.0	2.3	67.4	1.0	0.6	9.7	0.5	0.0	0.3	0.0	5.7	0.0	10.1	0.0	0.0	129.7	35.7	2.0	16.6	16.3	0.0	0.1	98.6	1.7	0.0	0.0	1.6	5.4	0.0	0.1	0.0	22.5	0.1	0.1	0.3	21.4	0.0	9.2	0.6	0.0	10.7	25.1	0.3	11.3	7.2	0.0	0.0	0.0	81.4	0.0	11.7	0.0	2.4	0.0	0.6	0.0	0.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	64.5	79.0	16.2	54.6	50.8	35.4	62.7	32.5	41.9	49.5
HTRA2	"OMI, PARK13, PRSS25"	ENSG00000115317	"HtrA serine peptidase 2"	O43464	2	74529377-74533348	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Apoptosis	"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004004, HPA006602, HPA027366"	Uncertain		Supported	Mitochondria				Mitochondria		"CAB004004: AB_326421, HPA006602: , HPA027366: AB_1851301"	"unprognostic (3.09e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (7.77e-8)"	"unprognostic (2.12e-3)"	"unprognostic (4.18e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.15e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-2)"	16.4	12.7	10.6	14.9	11.3	18.9	12.9	10.7	17.7	12.3	12.8	12.6	9.7	12.6	12.9	6.9	10.7	10.6	9.0	12.9	11.6	8.7	13.1	11.4	11.3	13.2	10.8	11.9	18.7	12.9	10.5	9.0	10.4	13.5	11.6	5.5	10.2	13.1	9.2	17.6	9.0	12.6	11.8	9.1	17.3	11.8	13.9	12.6	12.2	16.8	12.6	9.3	10.4	15.2	12.9	9.4	5.9	8.1	5.5	7.8	7.0	7.9	4.9	5.7	4.9	7.9	3.2	15.2	6.9	3.6	4.2	2.4	9.1	3.5	7.2	5.4	3.9	9.0	6.7	7.9	1.1	16.2	13.4	14.4	4.7	8.0	7.4	6.7	10.6	3.8	5.3	7.9	6.7	5.2	18.9	10.7	3.1	5.2	12.4	14.2	4.7	14.2	8.5	16.1	7.9	3.4	3.2	6.6	7.9	3.7	8.5	13.2	3.9	6.6	3.7	7.3	9.0	14.7	15.4	13.1	4.3	4.7	6.3	10.7	5.8	5.9	8.1	4.8	7.3	6.2	7.8	12.9	7.3	6.2	9.4	11.6	6.3	6.4	3.2	5.5	4.7	6.6	7.4	7.0	10.6	11.3	10.7	17.7	11.6	8.7	10.8	11.9	13.5	12.6
HTT	"HD, IT15"	ENSG00000197386	Huntingtin	P42858	4	3074681-3243960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002756, HPA026114"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB002756: , HPA026114: AB_1851330"	"unprognostic (2.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.52e-2)"	"unprognostic (8.33e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.04e-2)"	"prognostic favourable (2.41e-12)"	"unprognostic (9.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.84e-2)"	12.9	13.8	19.4	16.6	18.3	14.1	12.3	24.7	32.3	10.0	13.6	11.6	11.0	10.5	11.5	15.9	16.3	11.6	9.4	8.9	19.7	12.1	11.3	13.1	21.5	18.1	11.8	19.5	13.0	27.0	29.5	13.0	12.0	12.8	10.5	11.4	13.3	10.2	11.4	19.1	25.4	12.8	12.0	10.4	17.4	12.0	14.9	10.4	17.4	13.3	7.3	15.6	11.7	9.6	2.9	3.5	2.8	4.5	2.9	4.3	1.9	12.3	8.6	12.1	7.1	22.3	12.7	12.3	5.8	7.1	8.7	8.3	11.4	8.1	19.0	6.2	13.9	7.1	14.3	10.5	8.8	5.0	10.5	18.1	12.3	12.2	5.2	12.1	26.5	8.8	6.5	17.1	8.0	10.1	11.8	6.8	7.7	11.9	12.9	11.5	14.8	14.0	11.6	11.6	3.7	9.3	12.8	13.3	9.4	10.3	3.9	10.1	10.7	7.6	14.0	12.2	7.7	8.4	12.9	5.3	6.2	15.1	9.1	11.2	8.7	0.0	2.6	2.8	3.5	3.4	2.4	2.9	2.7	4.3	3.5	2.4	2.0	2.4	0.4	2.9	4.5	2.6	3.5	1.9	19.4	18.3	24.7	32.3	19.7	12.1	11.8	19.5	12.8	10.4
HYAL1	"FUS2, HYAL-1, LUCA1, NAT6"	ENSG00000114378	"Hyaluronoglucosaminidase 1"	Q12794	3	50299889-50312381	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 105.8"	"Group enriched"	"Detected in some"	4	"Hep G2: 44.8;SK-BR-3: 13.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 37.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002112	Uncertain				"Secreted to blood"		15000			"HPA002112: AB_1857412"	"unprognostic (1.39e-1)"	"unprognostic (8.68e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.56e-11)"	"unprognostic (4.51e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.90e-2)"	4.9	6.3	1.0	0.9	1.3	0.0	8.4	0.9	1.4	2.9	1.8	1.7	1.3	1.2	3.5	3.5	5.8	1.9	19.3	18.2	1.1	0.5	25.0	105.8	11.3	2.5	1.2	0.9	1.9	3.1	8.0	0.8	1.3	2.9	1.4	1.0	3.1	3.6	1.2	5.2	5.8	1.4	2.7	1.2	28.0	7.2	1.7	0.8	0.2	3.1	4.2	1.0	1.3	4.3	1.2	1.1	7.3	0.9	0.7	1.5	0.2	1.3	0.8	0.1	0.4	0.2	0.3	0.2	0.0	0.1	0.0	0.2	5.1	1.3	0.0	0.3	0.2	3.1	0.1	0.2	0.0	0.0	0.0	0.1	3.8	44.8	2.1	0.3	0.3	1.8	6.5	0.0	0.2	1.3	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.1	2.7	0.1	0.0	1.0	0.0	13.0	0.1	0.9	0.1	0.8	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.2	0.9	2.9	0.7	0.3	1.5	0.9	0.7	1.0	0.4	1.2	1.5	0.8	7.3	0.7	0.7	1.1	0.9	0.2	1.0	1.3	0.9	1.4	1.1	0.5	1.2	0.9	2.9	0.8
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044189-119057202	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 97.5"	"Cell line enhanced"	"Detected in all"		"EFO-21: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"		140000000			"HPA049296: "	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favourable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (5.00e-4)"	"unprognostic (1.38e-2)"	10.8	13.1	10.7	18.1	18.1	11.0	13.4	11.9	20.2	16.7	15.0	10.5	22.9	12.3	14.1	36.7	12.6	13.2	11.2	16.4	11.2	18.1	21.6	97.5	14.4	10.9	12.0	14.3	11.2	75.1	15.3	22.8	17.4	16.6	15.0	15.5	8.8	43.5	16.1	5.8	6.5	13.5	13.5	9.7	13.5	15.2	24.3	11.3	14.7	49.9	5.1	14.1	12.2	15.7	4.0	24.1	2.8	4.3	4.9	9.4	2.7	8.4	7.5	16.7	48.8	9.4	4.4	23.4	12.7	8.1	14.0	10.5	22.3	22.1	18.0	93.2	8.7	12.9	15.6	15.3	11.9	19.4	5.9	32.5	7.6	15.9	42.6	18.8	16.4	5.5	19.8	12.3	41.4	21.8	11.3	29.7	7.4	20.5	12.2	10.0	12.0	7.6	13.3	12.6	29.9	10.5	14.9	10.1	15.2	17.6	22.8	11.3	17.0	17.5	16.6	13.3	10.6	6.0	16.6	19.1	13.6	13.1	11.9	16.3	29.3	2.8	3.1	1.4	8.5	4.3	9.4	4.0	4.7	6.1	3.6	2.7	3.0	4.4	0.9	4.9	2.9	24.1	3.5	2.7	10.7	18.1	11.9	20.2	11.2	18.1	12.0	14.3	16.6	11.3
IARS	"IARS1, ILRS"	ENSG00000196305	"Isoleucyl-tRNA synthetase"	P41252	9	92210207-92293756	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029806	Approved		Supported	Cytosol				Cytosol		"HPA029806: AB_10601818"	"unprognostic (1.32e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavourable (4.98e-7)"	"unprognostic (2.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.76e-3)"	20.6	31.0	19.1	21.1	28.5	13.8	24.8	24.5	32.1	22.8	23.7	17.5	25.8	13.6	31.9	24.8	29.7	23.8	15.1	26.0	21.4	18.5	24.5	29.9	24.4	24.1	21.6	20.6	28.4	42.8	57.4	29.0	21.1	31.6	23.6	26.7	17.1	25.2	27.7	47.4	25.4	18.8	32.6	20.0	23.1	29.0	18.7	16.9	25.1	52.3	26.7	28.8	22.1	20.5	14.5	15.3	1.9	7.3	18.6	18.6	9.7	35.9	37.3	20.9	32.8	34.4	38.8	33.0	38.2	36.5	30.3	37.1	13.1	23.2	48.9	15.0	58.9	45.0	64.3	49.7	38.3	30.7	23.9	29.8	32.1	23.2	72.7	40.6	22.0	37.8	55.9	52.8	87.4	31.8	52.5	44.5	42.5	26.2	37.5	15.8	33.8	34.5	26.3	31.7	23.5	25.0	18.1	26.7	22.1	25.9	28.5	36.0	22.8	25.4	23.4	22.4	28.0	36.9	31.0	32.6	41.6	25.9	52.4	31.3	41.3	1.9	6.7	0.5	14.7	7.3	18.6	14.5	14.5	14.9	15.3	10.7	14.7	15.3	0.8	18.6	6.2	6.2	12.9	9.7	19.1	28.5	24.5	32.1	21.4	18.5	21.6	20.6	31.6	16.9
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10270835-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 68.3;lung: 91.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 31.1;Karpas-707: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002126, CAB002142, HPA004877"	Enhanced		Uncertain	"Plasma membrane,Cytosol"			3100000000	"Plasma membrane, Cytosol"		"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favourable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	26.1	8.6	4.0	41.0	4.1	36.5	15.0	1.0	4.5	5.6	10.0	2.7	1.6	6.1	8.5	7.7	7.9	10.7	19.8	16.3	2.6	2.1	10.9	68.3	91.3	32.8	5.4	1.7	12.4	7.2	2.5	4.0	9.3	6.8	10.4	6.6	10.6	7.2	3.6	13.9	6.9	7.9	8.0	7.8	42.2	7.3	6.5	3.6	8.3	11.6	13.7	13.4	14.8	17.1	2.2	13.3	22.2	14.2	7.9	5.6	8.9	8.2	0.1	1.5	0.0	0.4	0.9	2.1	1.7	18.5	4.1	12.5	2.7	9.3	7.6	25.8	0.7	1.7	0.3	0.0	8.7	22.7	0.0	0.7	0.2	11.3	31.1	0.2	4.5	10.9	0.7	2.6	4.0	2.1	2.8	88.5	0.3	0.6	0.1	6.4	0.5	4.7	0.2	0.0	28.1	7.0	0.0	0.0	0.2	11.4	0.6	18.1	1.4	0.5	6.4	4.2	0.4	2.3	0.1	27.0	27.8	4.7	6.8	4.9	6.2	2.2	13.9	2.6	3.0	14.2	5.6	2.2	2.4	3.6	13.3	0.9	1.0	2.2	22.2	7.9	7.9	7.5	3.4	8.9	4.0	4.1	1.0	4.5	2.6	2.1	5.4	1.7	6.8	3.6
ICAM2	CD102	ENSG00000108622	"Intercellular adhesion molecule 2"	P13598	17	64002594-64020634	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 74.5;lymphoid tissue: 63.9"	"Group enriched"	"Detected in many"	6	"HUVEC TERT2: 163.3;TIME: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071155			Approved	"Plasma membrane,Cytosol"			1200000000	"Plasma membrane"	Cytosol	"HPA071155: "	"unprognostic (9.43e-3)"	"unprognostic (3.31e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.93e-2)"	"unprognostic (6.04e-2)"	"unprognostic (2.29e-1)"	36.0	3.6	8.4	13.0	11.5	8.3	34.1	3.5	7.7	9.4	9.7	5.6	2.8	6.4	9.8	5.2	9.5	7.4	8.8	22.8	9.5	8.9	10.5	8.7	27.9	24.0	12.3	3.1	6.3	7.4	3.1	4.5	36.8	9.1	7.9	8.5	8.1	8.8	4.3	17.1	5.5	10.8	13.9	10.5	63.9	8.0	4.0	7.4	14.3	11.6	9.0	18.0	12.8	23.6	49.0	30.9	56.5	74.5	26.0	65.3	67.5	0.0	0.0	0.0	0.0	1.3	1.5	0.4	0.1	0.1	0.0	0.1	0.3	6.8	11.5	2.1	0.0	0.0	0.1	0.0	0.2	2.5	0.0	10.3	0.6	1.2	0.2	1.7	0.0	0.0	0.0	0.1	0.0	163.3	8.4	6.7	0.0	0.0	12.8	1.5	0.0	0.0	7.8	0.0	15.9	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	41.2	0.0	0.1	0.8	0.0	6.4	2.2	10.2	0.0	2.1	0.0	56.5	30.0	8.9	45.8	66.5	52.8	36.5	60.1	42.8	30.9	49.0	65.3	40.7	3.6	26.0	74.5	10.0	64.5	67.5	8.4	11.5	3.5	7.7	9.5	8.9	12.3	3.1	9.1	7.4
ICAM3	"CD50, CDW50, ICAM-R"	ENSG00000076662	"Intercellular adhesion molecule 3"	P32942	19	10333776-10339823	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 172.3;bone marrow: 51.5;lymphoid tissue: 68.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 64.3;NB-4: 41.4;RPMI-8226: 48.2;U-266/84: 34.1;U-937: 33.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 172.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 172.3"									"CAB002498, HPA049820"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"			370000000	Mitochondria	"Nucleoplasm, Nuclear membrane"	"CAB002498: AB_563593, HPA049820: "	"unprognostic (6.85e-4)"	"unprognostic (5.28e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (5.34e-3)"	"unprognostic (5.79e-6)"	"unprognostic (5.05e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.62e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.84e-1)"	6.8	2.8	1.7	23.5	1.9	51.5	5.5	0.6	1.5	3.0	6.8	1.1	1.2	4.3	1.7	3.0	4.0	2.9	7.2	6.4	1.1	0.9	5.1	28.7	13.2	68.5	1.8	1.4	1.7	6.8	0.2	0.4	4.8	1.5	2.8	3.3	2.4	10.3	1.3	5.0	1.6	11.9	1.8	1.0	39.4	5.4	1.4	1.0	47.6	3.0	5.7	38.4	4.5	4.9	25.5	28.4	172.3	33.5	31.0	41.0	43.1	2.6	1.3	0.9	2.9	1.6	1.3	1.6	1.6	1.1	1.4	1.2	1.1	1.8	0.0	5.7	1.4	1.1	0.0	1.2	0.4	19.8	0.8	5.0	1.2	5.0	0.8	18.3	20.7	1.1	1.0	1.6	0.5	0.6	2.7	64.3	1.5	5.4	2.4	41.4	0.7	9.0	1.5	0.6	48.2	1.4	2.3	0.3	1.2	1.4	4.5	3.6	3.9	5.2	1.1	6.3	0.5	7.0	1.6	3.1	34.1	7.6	4.5	33.8	4.9	15.3	33.1	72.0	33.8	24.4	41.0	25.5	32.7	31.2	28.4	23.9	29.3	27.4	172.3	31.0	33.5	4.8	36.9	43.1	1.7	1.9	0.6	1.5	1.1	0.9	1.8	1.4	1.5	1.0
ICAM5	"TLCN, TLN"	ENSG00000105376	"Intercellular adhesion molecule 5"	Q9UMF0	19	10289981-10296778	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 32.6"	"Cell line enhanced"	"Detected in some"		"HEL: 13.2;K-562: 10.5;RPMI-8226: 12.0;U-266/70: 14.5;U-87 MG: 8.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 4.8"	"Group enriched"	"Detected in many"	15	"amygdala: 22.5;basal ganglia: 24.3;cerebral cortex: 32.6;hippocampal formation: 23.0;olfactory region: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	9	"amygdala: 111.1;basal ganglia: 75.7;cerebral cortex: 76.7;hippocampal formation: 105.7;olfactory region: 63.4"	"Group enriched"	"Detected in many"	14	"amygdala: 58.8;basal ganglia: 55.2;cerebral cortex: 67.5;hippocampal formation: 103.7;olfactory region: 57.5"	"HPA008943, HPA009083, CAB025178"	Enhanced						2400000			"CAB025178: , HPA008943: AB_1079095, HPA009083: AB_1079094"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.58e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.99e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.89e-3)"	"unprognostic (5.29e-5)"	"unprognostic (6.47e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.44e-3)"	"unprognostic (6.28e-3)"	0.8	0.9	22.5	0.8	24.3	2.0	0.9	0.0	32.6	0.8	0.8	1.0	0.0	0.8	0.8	0.8	0.8	0.9	0.8	1.0	23.0	1.4	1.1	0.8	3.6	1.2	0.9	15.9	1.4	0.8	0.8	0.1	1.1	0.0	0.9	0.8	0.0	0.8	0.9	0.8	0.8	1.0	0.8	0.1	1.0	1.0	1.9	1.6	0.0	0.8	0.0	0.9	0.8	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.0	2.8	0.0	0.0	6.1	0.0	0.0	0.1	4.3	0.7	0.1	0.4	0.0	0.1	4.6	1.9	0.0	5.3	0.2	0.0	0.0	0.1	0.9	13.2	4.2	0.4	0.1	0.0	2.6	0.0	0.5	0.1	0.0	0.0	10.5	0.1	0.0	0.6	0.0	1.8	0.0	4.3	0.1	0.0	12.0	0.2	0.0	0.8	0.1	1.9	0.1	0.3	2.2	0.0	0.0	1.3	0.0	0.6	0.0	14.5	2.3	2.6	8.6	0.0	1.3	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	24.3	0.0	32.6	23.0	1.4	0.9	15.9	0.0	1.6
ICMT	"HSTE14, PCCMT, PPMT"	ENSG00000116237	"Isoprenylcysteine carboxyl methyltransferase"	O60725	1	6221193-6235972	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 126.5"	"Low region specificity"	"Detected in all"			"HPA032024, HPA032025"	Uncertain									"HPA032024: AB_2674115, HPA032025: AB_10601819"	"unprognostic (1.95e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.53e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (2.30e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.27e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.99e-3)"	19.0	20.9	11.2	11.4	22.6	3.2	37.4	20.1	19.8	19.8	16.6	12.9	13.3	17.3	18.0	19.7	19.0	15.1	17.7	28.5	11.5	10.3	23.5	14.5	17.2	13.9	13.9	8.4	8.7	20.2	26.2	24.0	20.3	12.7	16.2	16.0	21.5	15.4	18.2	41.3	16.9	22.8	19.8	11.1	11.3	13.5	9.1	7.8	13.0	18.1	30.3	17.2	15.4	13.6	4.1	6.2	4.1	5.1	4.6	7.4	3.9	12.5	11.7	16.1	15.7	49.4	19.7	6.9	30.3	20.4	18.0	13.8	12.5	10.2	13.8	11.6	23.9	17.1	18.3	12.8	19.2	27.4	17.7	9.4	17.2	9.5	9.7	14.8	13.4	12.6	8.6	18.9	7.2	14.0	9.1	10.9	20.3	7.9	14.8	10.3	10.8	16.3	12.5	22.7	8.0	21.7	9.3	21.9	10.7	14.9	35.3	12.9	9.2	12.5	17.3	20.6	8.1	24.0	21.7	10.2	19.7	11.0	10.1	34.4	10.6	4.1	4.2	3.6	7.4	5.1	6.5	2.7	6.0	7.3	3.9	4.1	5.4	4.5	1.8	4.6	4.0	6.2	3.4	3.9	11.2	22.6	20.1	19.8	11.5	10.3	13.9	8.4	12.7	7.8
ICOSLG	"B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653"	ENSG00000160223	"Inducible T cell costimulator ligand"	O75144	21	44217014-44240966	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, B-cell activation, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 6.5"	"Low lineage specificity"	"Detected in many"											"CAB026037, HPA029179"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"			150000000	"Plasma membrane, Cytoplasmic bodies"		"CAB026037: , HPA029179: "	"unprognostic (3.03e-2)"	"unprognostic (1.40e-4)"	"unprognostic (3.52e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.40e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.84e-1)"	2.3	3.0	5.3	3.9	7.1	14.1	2.3	2.3	5.9	2.9	2.3	2.3	2.3	1.8	2.3	2.3	4.0	2.7	3.5	3.7	8.8	3.7	5.3	2.7	2.3	6.5	6.5	2.3	2.3	2.3	0.0	2.3	2.3	2.3	2.3	1.2	2.3	2.3	2.3	2.3	5.5	2.9	2.3	8.4	3.2	4.2	2.3	2.3	2.3	2.3	2.3	4.5	2.4	2.6	6.5	1.6	1.0	0.8	0.5	1.1	0.4	0.3	3.3	0.1	2.8	0.8	1.1	7.7	0.7	0.6	0.4	0.2	5.6	0.4	14.0	2.1	0.3	4.2	1.9	1.3	0.2	1.4	1.4	0.4	2.7	1.6	0.7	6.0	10.3	1.1	1.9	0.9	0.9	0.8	2.3	1.3	0.2	3.6	0.3	7.9	2.0	3.5	11.9	0.9	8.2	0.6	7.4	1.4	0.0	9.3	13.2	0.3	3.8	8.6	0.8	0.4	3.3	0.3	0.2	12.1	8.2	11.7	4.3	5.6	1.8	0.6	0.8	0.4	0.3	0.8	0.3	3.7	0.8	0.5	0.5	6.5	0.8	1.1	1.0	0.5	0.5	1.6	0.4	0.4	5.3	7.1	2.3	2.3	8.8	3.7	6.5	2.3	2.3	2.3
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 163.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 75.1;HaCaT: 71.6;Hep G2: 59.5;PC-3: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"CAB025915: , HPA051456: , HPA058518: "	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	28.6	12.3	8.2	15.2	9.1	4.4	33.2	5.6	13.8	36.3	33.3	15.4	38.5	36.4	25.9	11.6	78.0	25.1	19.0	33.5	8.7	8.4	22.3	23.4	57.4	17.9	10.0	7.9	12.3	5.8	4.0	25.7	22.1	14.3	56.4	13.1	34.9	10.5	163.1	23.0	16.5	40.6	16.9	8.1	15.3	48.6	7.8	4.0	2.4	78.8	36.2	21.0	80.0	26.4	0.4	0.7	3.9	0.7	0.3	0.5	0.5	10.5	35.1	0.4	7.1	4.6	2.1	27.4	45.0	1.8	8.3	0.9	18.5	16.0	0.0	75.1	12.0	71.6	5.8	2.5	1.3	0.8	3.7	5.8	30.4	59.5	6.3	0.1	0.3	8.6	10.2	0.0	0.6	5.0	12.9	0.3	15.9	13.8	1.5	0.2	25.2	74.9	0.1	29.3	0.5	1.6	29.4	13.7	12.8	37.4	13.4	0.3	8.2	1.0	26.8	22.3	43.5	7.1	30.2	0.8	0.8	0.6	26.0	5.6	3.0	0.0	0.6	0.9	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.4	0.0	0.5	3.9	0.3	0.7	0.0	0.0	0.5	8.2	9.1	5.6	13.8	8.7	8.4	10.0	7.9	14.3	4.0
IDE		ENSG00000119912	"Insulin degrading enzyme"	P14735	10	92451684-92574076	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Allosteric enzyme, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063478	Approved				"Intracellular and membrane"		140000			"HPA063478: "	"unprognostic (1.70e-1)"	"unprognostic (6.40e-2)"	"prognostic favourable (3.69e-4)"	"prognostic favourable (3.53e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.81e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.91e-1)"	9.8	13.1	6.9	11.7	8.8	6.0	19.8	8.6	9.4	10.5	9.9	6.5	17.5	7.4	10.2	15.9	13.0	8.4	9.6	13.6	5.8	5.3	13.3	21.3	7.9	9.2	8.9	5.1	7.7	15.7	19.4	11.1	9.4	7.6	11.6	10.0	10.5	11.0	17.2	31.1	45.2	10.7	14.3	8.8	9.9	10.3	18.1	7.5	13.5	12.0	13.9	10.7	11.5	9.8	7.4	11.3	3.8	13.7	7.7	10.6	5.5	12.2	18.1	14.1	29.0	13.8	11.6	7.8	10.8	25.7	11.4	9.7	18.4	14.5	17.3	16.0	15.8	15.8	18.6	11.9	7.5	20.7	11.4	8.6	15.1	16.1	12.1	26.2	13.6	8.2	11.6	13.4	19.4	19.2	16.0	12.3	12.9	8.2	8.7	10.3	11.2	7.2	12.1	13.2	11.0	16.8	22.9	6.6	9.2	14.6	10.5	9.5	15.0	7.4	17.8	7.4	8.4	7.7	13.9	11.3	14.1	18.5	10.8	21.0	5.1	2.3	8.2	3.8	6.7	11.4	5.9	7.4	7.9	6.5	11.3	5.3	6.0	6.4	0.5	7.7	13.7	4.4	10.6	5.5	6.9	8.8	8.6	9.4	5.8	5.3	8.9	5.1	7.6	7.5
IDH1		ENSG00000138413	"Isocitrate dehydrogenase (NADP(+)) 1, cytosolic"	O75874	2	208236227-208266074	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 108.5;RT4: 75.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033218, HPA035248, HPA057936, CAB062556"	Enhanced		Approved	"Nuclear bodies,Cytosol"			16000000	"Nuclear bodies, Cytosol"		"CAB033218: AB_2123166, CAB062556: , HPA035248: AB_10600714, HPA057936: "	"unprognostic (2.79e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"prognostic unfavourable (6.93e-5)"	"unprognostic (3.32e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.03e-2)"	"unprognostic (5.54e-2)"	"unprognostic (4.18e-3)"	"prognostic unfavourable (2.45e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-2)"	41.3	82.3	6.2	8.8	7.0	1.3	20.9	6.5	8.3	12.6	35.2	8.7	38.0	30.6	8.0	29.9	30.3	8.8	18.7	10.8	6.3	6.2	20.5	91.0	19.8	14.3	8.1	4.7	19.4	21.5	4.8	6.2	24.1	8.7	38.5	23.1	15.4	18.7	39.0	4.7	7.4	54.1	10.1	9.3	21.3	20.4	15.6	8.4	3.5	7.9	11.0	11.9	43.4	12.1	4.9	22.8	6.4	31.6	7.4	6.6	12.0	9.6	16.2	23.2	9.4	42.2	30.1	13.2	4.0	18.4	6.8	16.6	25.6	23.6	1.9	25.6	12.5	14.9	16.7	19.4	6.6	1.3	6.3	8.3	13.4	108.5	56.2	5.4	8.3	25.9	41.3	15.5	11.3	18.7	8.3	6.7	10.4	6.1	3.8	9.3	42.4	6.7	3.7	8.4	5.4	30.6	75.8	4.0	6.9	15.3	14.8	50.1	5.7	15.8	12.3	6.9	7.0	9.8	4.3	3.2	5.0	2.5	22.4	32.8	5.5	5.7	31.6	4.8	4.5	14.5	5.1	4.9	4.0	5.3	22.8	4.9	3.3	3.9	6.4	7.4	6.5	8.4	6.6	12.0	6.2	7.0	6.5	8.3	6.3	6.2	8.1	4.7	8.7	8.4
IDH2		ENSG00000182054	"Isocitrate dehydrogenase (NADP(+)) 2, mitochondrial"	P48735	15	90083045-90102504	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Glyoxylate bypass, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 126.2;skeletal muscle: 190.7"	"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007831	Enhanced		Supported	Mitochondria			53000000	Mitochondria		"HPA007831: AB_1851397"	"unprognostic (2.45e-2)"	"prognostic favourable (5.15e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.53e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.76e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.92e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-2)"	5.4	2.0	14.9	10.1	16.6	22.6	8.8	4.9	19.1	6.4	16.2	13.8	12.4	16.1	5.9	15.3	23.7	6.0	9.4	126.2	10.2	9.3	25.0	93.2	6.9	15.8	14.4	12.0	3.0	25.1	8.4	3.3	15.1	11.9	13.3	14.5	6.0	28.0	21.9	190.7	11.0	13.9	15.8	11.0	7.5	27.9	1.2	7.6	28.2	3.4	69.0	13.6	11.0	8.6	16.8	32.8	17.2	56.3	22.2	29.5	31.2	10.2	5.8	30.2	30.0	4.2	5.2	25.7	12.8	19.5	12.1	13.0	2.7	8.9	12.2	3.6	10.6	3.5	4.4	3.9	5.8	23.9	2.9	20.8	2.2	20.3	5.1	14.2	21.1	10.8	2.2	2.9	2.3	24.8	3.1	10.5	9.3	29.8	68.3	22.1	9.0	2.4	57.9	21.7	36.3	18.7	12.3	43.6	22.1	15.9	63.6	5.1	51.3	43.9	5.9	21.7	3.1	2.8	5.9	17.3	3.2	1.4	6.9	30.0	12.5	9.0	26.4	17.2	26.1	48.0	12.4	16.8	18.7	29.5	32.8	9.8	10.2	18.2	5.1	22.2	56.3	17.8	15.9	31.2	14.9	16.6	4.9	19.1	10.2	9.3	14.4	12.0	11.9	7.6
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria			2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favourable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	15.9	21.9	4.0	13.9	10.0	10.2	8.7	19.0	9.3	15.5	11.8	15.5	9.7	34.0	14.1	11.1	24.1	36.9	14.7	14.4	14.9	12.2	13.1	23.7	7.0	8.5	25.4	18.8	7.7	9.1	15.1	15.9	9.7	16.8	14.0	9.8	15.2	18.6	6.8	4.9	8.2	10.8	17.0	10.6	12.9	21.7	15.9	6.1	21.8	31.2	17.6	12.4	13.8	10.0	18.3	17.0	24.1	30.6	16.0	35.6	18.1	12.9	24.3	14.3	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase 3 (NAD(+)) beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favourable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	19.5	20.0	19.4	15.5	31.7	20.6	18.5	32.1	30.5	16.4	23.9	16.9	14.5	30.5	19.2	16.7	20.7	17.9	19.2	57.3	19.8	20.0	29.7	25.2	15.1	17.6	24.0	29.4	20.2	15.2	27.6	12.2	17.0	31.2	15.4	25.6	16.2	19.3	19.5	75.5	20.9	24.9	21.5	17.1	19.2	19.9	19.6	16.0	19.7	19.1	37.7	22.5	16.7	17.4	34.7	49.4	25.8	44.7	29.5	38.6	33.9	26.1	35.5	16.2	14.1	18.0	14.2	18.8	14.1	18.0	33.3	26.6	45.7	27.6	29.6	12.9	19.3	37.0	29.9	45.7	30.6	8.1	23.5	35.9	13.8	47.3	17.6	39.0	7.8	18.8	17.6	31.1	16.4	19.6	45.3	16.6	20.2	14.4	33.9	44.8	31.5	33.7	27.8	29.6	33.2	19.1	24.6	29.3	21.2	17.3	57.7	29.7	28.9	17.4	17.4	26.0	16.4	8.8	32.3	22.6	51.6	31.2	12.2	40.4	24.6	22.2	41.7	25.8	33.9	44.7	25.6	34.7	29.4	30.7	49.4	30.6	34.4	29.8	11.9	29.5	38.3	22.9	38.6	33.9	19.4	31.7	32.1	30.5	19.8	20.0	24.0	29.4	31.2	16.0
IDH3G		ENSG00000067829	"Isocitrate dehydrogenase 3 (NAD(+)) gamma"	P51553	X	153785766-153794523	"Citric acid cycle related proteins, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000425, HPA002017"	Supported		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA000425: AB_1079097, HPA002017: AB_1079096"	"unprognostic (4.24e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (5.73e-6)"	"unprognostic (1.50e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.46e-1)"	24.5	34.0	27.7	26.8	47.2	37.1	24.1	37.2	61.5	25.0	28.8	25.7	24.6	34.7	26.6	21.3	31.8	29.4	25.6	50.8	35.0	25.2	40.6	29.5	20.9	25.6	27.3	35.6	31.8	40.5	29.1	24.9	22.5	40.5	21.4	25.2	26.0	34.5	29.8	54.9	36.3	34.9	24.8	20.1	26.9	24.8	16.0	23.3	31.2	24.3	37.1	28.2	24.4	21.1	20.6	45.5	43.7	44.4	23.7	28.8	33.6	28.9	26.7	15.8	22.2	24.8	20.5	19.4	15.1	21.3	26.8	28.5	22.1	22.1	36.9	26.2	24.2	21.7	23.9	20.6	9.9	12.1	30.5	13.8	36.3	17.7	28.1	19.2	29.2	23.1	14.9	20.7	22.6	20.5	7.6	20.3	21.6	40.5	21.8	22.6	7.1	35.4	19.3	13.5	32.2	29.9	18.0	20.2	13.8	9.4	32.0	15.0	13.3	16.6	18.1	17.0	10.7	25.0	35.7	27.9	6.9	47.0	27.8	23.9	18.8	42.5	43.9	43.7	21.5	44.4	19.9	19.1	22.0	20.9	45.5	20.6	17.6	19.2	16.3	23.7	43.1	27.9	28.8	33.6	27.7	47.2	37.2	61.5	35.0	25.2	27.3	35.6	40.5	23.3
IDUA	MPS1	ENSG00000127415	"Iduronidase, alpha-L-"	P35475	4	986997-1004506	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mucopolysaccharidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025901, HPA046979, HPA054254"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		130000	Vesicles		"CAB025901: , HPA046979: , HPA054254: "	"unprognostic (3.62e-2)"	"unprognostic (9.08e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.89e-3)"	"unprognostic (2.64e-2)"	"unprognostic (4.61e-3)"	"prognostic unfavourable (7.87e-5)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"prognostic favourable (8.04e-5)"	11.0	15.0	14.7	12.0	15.3	10.8	12.9	36.5	15.7	12.4	9.2	10.9	16.9	17.1	13.0	13.4	7.7	12.1	15.9	8.9	13.4	6.5	13.4	10.7	12.8	11.2	11.6	10.0	14.6	22.6	13.0	15.2	4.0	12.8	14.5	6.0	14.1	20.2	15.8	6.2	16.8	11.8	7.3	9.0	15.3	21.3	4.7	12.6	7.6	14.0	3.4	10.0	10.4	11.2	0.8	4.1	0.0	3.8	3.1	4.5	1.1	3.0	5.7	0.0	2.4	13.2	4.7	8.7	8.3	7.3	2.8	1.7	2.0	9.8	1.3	9.3	5.6	1.9	0.3	1.1	0.6	8.3	0.4	4.9	5.9	0.7	5.5	4.0	13.2	9.0	4.1	2.3	0.0	2.0	2.4	0.1	2.7	3.3	2.7	4.2	1.9	5.4	7.5	0.0	1.4	4.6	6.1	0.1	3.8	0.9	0.0	4.7	6.7	3.4	8.6	15.4	1.7	8.6	2.2	32.0	3.6	1.6	7.5	5.4	3.7	0.0	3.5	0.0	3.3	2.7	4.5	0.6	2.7	2.6	4.1	0.8	3.4	2.0	0.0	3.1	3.8	2.5	1.3	1.1	14.7	15.3	36.5	15.7	13.4	6.5	11.6	10.0	12.8	12.6
IFI16	"IFNGIP1, PYHIN2"	ENSG00000163565	"Interferon gamma inducible protein 16"	Q16666	1	158999968-159055155	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Autophagy, Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA002134, CAB016293"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016293: AB_627775, HPA002134: AB_1079099"	"unprognostic (7.23e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.70e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (7.62e-2)"	"prognostic unfavourable (1.11e-16)"	"unprognostic (5.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.14e-1)"	64.2	21.0	10.9	42.5	18.0	10.2	34.8	6.7	11.4	28.5	18.6	9.6	7.8	7.5	32.5	21.8	32.8	25.0	33.4	24.8	16.5	7.5	13.3	10.2	32.1	51.0	19.5	6.3	32.6	5.5	3.2	7.0	21.4	18.0	23.0	15.2	10.9	33.6	11.2	14.6	23.7	21.6	29.1	32.2	63.2	11.8	14.2	16.0	81.8	19.1	24.2	41.8	30.9	27.6	28.9	20.8	51.2	21.0	27.9	24.6	16.9	6.9	0.5	2.4	0.1	16.8	55.6	0.0	14.8	39.7	41.7	55.5	0.0	8.9	40.9	12.8	9.0	20.3	0.3	15.0	16.7	12.6	0.1	10.5	3.1	0.0	31.4	3.6	0.7	52.3	26.9	21.3	30.4	43.8	0.2	30.0	23.1	0.0	48.0	3.3	6.4	5.4	22.7	15.4	47.2	5.8	2.6	1.1	0.0	19.4	0.1	42.1	0.0	4.2	24.7	10.7	5.1	30.2	6.2	28.0	13.1	38.4	30.8	11.8	25.8	2.5	21.0	0.1	18.9	20.5	16.9	27.6	18.1	19.3	20.8	28.9	11.5	14.6	51.2	27.9	18.5	15.6	24.6	16.9	10.9	18.0	6.7	11.4	16.5	7.5	19.5	6.3	18.0	16.0
IFIT3	"CIG-49, GARG-49, IFI60, IFIT4, IRG2, ISG60, RIG-G"	ENSG00000119917	"Interferon induced protein with tetratricopeptide repeats 3"	O14879	10	89327894-89340971	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 80.0"	"Group enriched"	"Detected in many"	4	"BJ hTERT+: 34.4;BJ hTERT+ SV40 Large T+: 80.5;BJ hTERT+ SV40 Large T+ RasG12V: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 80.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 80.0"					"Low region specificity"	"Detected in all"			HPA059914	Approved		Supported	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA059914: "	"unprognostic (2.81e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.25e-3)"	"unprognostic (3.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.99e-3)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (3.17e-4)"	"unprognostic (1.36e-1)"	"unprognostic (4.69e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.09e-2)"	50.5	15.7	14.9	11.3	17.3	22.1	10.6	6.9	17.0	6.8	9.7	7.6	4.1	14.5	8.8	16.8	6.2	10.9	15.1	8.9	14.2	12.9	19.3	17.0	25.9	10.0	13.5	12.4	11.3	4.3	3.8	5.5	22.9	23.0	9.7	5.4	9.2	19.6	8.1	8.1	5.0	11.3	11.1	18.4	26.0	7.2	5.1	12.1	14.3	14.9	5.5	2.9	11.0	5.9	1.6	2.5	80.0	18.4	0.3	2.6	3.2	6.2	0.4	0.1	1.7	7.3	7.9	0.0	4.0	34.4	80.5	93.5	0.3	9.1	0.5	1.7	6.4	5.6	0.1	0.8	5.9	0.9	0.0	2.4	1.8	0.2	4.2	0.7	2.0	4.9	0.1	7.0	0.5	0.4	0.1	1.4	2.0	0.0	1.5	1.9	0.1	2.0	1.5	0.5	0.4	2.3	3.0	0.0	0.0	0.7	0.1	15.8	0.2	0.8	0.6	1.3	0.2	2.2	1.0	2.2	1.8	0.1	1.8	3.0	1.3	15.2	7.5	26.6	0.7	16.0	0.1	1.6	1.1	0.5	2.5	1.4	0.7	0.8	80.0	0.3	18.4	0.5	2.6	3.2	14.9	17.3	6.9	17.0	14.2	12.9	13.5	12.4	23.0	12.1
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 120.0;BJ hTERT+ SV40 Large T+ RasG12V: 215.2;HMC-1: 66.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"									"HPA004810, CAB017615"	Enhanced		Supported	Cytosol				Cytosol		"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.2	0.1	52.2	4.2	3.8	13.4	0.3	11.1	51.9	120.0	215.2	0.1	43.5	0.1	8.3	11.6	14.8	1.6	1.1	2.4	13.2	2.7	6.4	4.0	0.4	34.6	9.3	66.4	25.1	0.0	1.3	0.1	0.2	22.7	52.7	0.0	0.9	4.6	17.9	14.8	1.6	1.2	0.1	1.2	32.1	0.0	0.0	0.0	5.8	0.6	10.6	2.1	0.8	0.3	0.1	0.1	0.0	0.0	3.7	2.0	0.3	0.1	14.0	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1
IFNA1	"IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA@, IFNA13"	ENSG00000197919	"Interferon alpha 1"	P01562	9	21440454-21441316	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 2.3;urinary bladder: 2.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.7;BJ: 1.0;HeLa: 6.6;NB-4: 1.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"cerebellum: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"	10000				"HPA047557: "		"unprognostic (3.14e-1)"				"unprognostic (1.55e-1)"							"unprognostic (9.75e-2)"			"unprognostic (5.88e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0
IFNA13		ENSG00000233816	"Interferon alpha 13"	P01562	9	21367424-21368962	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Antiviral defense"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 2.1;epididymis: 3.7"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;HeLa: 1.6;NB-4: 3.5;TIME: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA047557	Uncertain				"Secreted to blood"					"HPA047557: "																		0.0	0.0	1.1	0.0	2.1	0.0	0.0	0.4	0.6	0.0	0.0			0.0	0.1	3.7	0.0	0.1	0.0	0.0	1.5	0.6	0.4	0.0	0.2	0.2	0.8		0.1	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3			0.0		0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4										
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324477-33359862	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018015, HPA029226"	Uncertain						100000			"HPA018015: AB_1851433, HPA029226: "	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	27.2	16.4	18.5	16.8	18.7	14.8	15.9	18.1	22.9	14.2	16.8	15.1	10.0	12.3	15.7	10.9	15.8	13.5	16.2	14.5	16.9	15.8	17.5	56.4	16.6	15.0	19.7	13.8	16.6	18.3	30.6	17.9	23.2	18.3	14.7	12.2	12.1	17.6	12.6	17.3	10.6	15.8	13.7	22.2	29.8	18.8	10.3	16.7	26.9	21.4	9.1	13.1	18.7	18.1	20.5	17.8	64.5	23.1	7.3	12.1	10.7	13.1	12.0	5.1	5.8	16.9	17.3	5.9	14.2	15.2	6.5	6.7	12.9	15.1	10.2	11.5	9.7	7.9	4.8	8.3	7.0	11.5	9.6	15.1	11.6	7.6	7.2	11.1	10.8	14.3	7.4	10.8	6.5	12.5	17.3	49.9	10.7	10.9	8.2	4.5	5.5	7.7	8.1	18.0	17.3	7.2	17.3	6.1	5.5	14.2	10.2	9.0	15.6	8.2	19.8	13.2	7.2	17.3	7.9	33.4	45.8	11.7	17.7	15.7	14.1	18.9	16.8	9.7	8.0	19.7	7.5	18.5	10.6	9.0	11.3	20.5	12.1	9.4	64.5	7.3	23.1	17.8	12.0	10.7	18.5	18.7	18.1	22.9	16.9	15.8	19.7	13.8	18.3	16.7
IFNG		ENSG00000111537	"Interferon gamma"	P01579	12	68154768-68159747	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Antiviral defense, Growth regulation"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.4;lung: 14.5"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 2.2;U-698: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"gdT-cell: 7.3;memory CD4 T-cell: 3.3;memory CD8 T-cell: 8.6;naive CD8 T-cell: 5.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.6"					"Low region specificity"	"Detected in single"			CAB010344	Approved				"Secreted to blood"	400				"CAB010344: AB_2123447"	"unprognostic (2.16e-4)"	"unprognostic (1.93e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.04e-4)"	"unprognostic (5.14e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-4)"	"unprognostic (7.79e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.62e-9)"	"unprognostic (3.54e-2)"	"unprognostic (5.36e-1)"	"unprognostic (6.32e-2)"	"unprognostic (7.38e-3)"	2.4	0.9	0.3	4.5	0.3	14.4	0.5	0.1	1.0	1.4	0.9	0.5	0.0	0.2	0.6	1.4	1.3	0.2	0.6	1.0	0.3	0.3	0.7	4.1	14.5	8.5	1.5	0.4	0.4	0.2	0.0	0.5	0.8	0.6	1.2	0.4	1.1	1.4	0.2	1.7	0.3	0.7	0.7	1.3	4.1	0.8	0.2	0.0	0.8	1.3	3.1	4.7	2.2	0.6	0.5	0.0	0.2	0.0	1.2	8.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	3.3	8.6	0.0	0.5	0.8	5.2	0.2	1.2	0.0	0.0	0.2	1.1	0.3	0.3	0.1	1.0	0.3	0.3	1.5	0.4	0.6	0.0
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381464-65423072	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 5.0;AF22: 10.2;CAPAN-2: 8.9;EFO-21: 5.1;HSkMC: 5.7;NTERA-2: 7.6"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol			34000000	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	1.7	6.2	8.3	3.7	5.0	0.2	1.3	2.0	4.9	6.1	1.4	8.0	0.0	1.0	2.3	7.2	2.6	2.9	6.7	2.2	6.2	4.1	0.6	0.3	0.7	1.1	5.6	3.1	13.3	0.7	0.2	2.4	8.2	6.1	0.9	1.2	1.6	1.5	1.3	14.1	1.5	1.7	3.1	5.0	0.5	1.9	2.5	6.5	0.0	4.6	4.0	1.5	4.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	10.2	0.0	0.0	1.1	0.1	0.4	0.0	0.0	0.4	0.6	8.9	0.0	5.1	0.4	0.0	2.5	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.4	0.0	0.0	5.7	0.0	0.5	0.0	0.0	0.5	0.0	1.8	0.0	0.0	0.8	7.6	0.0	0.0	2.5	0.0	3.6	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	4.1	2.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	5.0	2.0	3.9	6.2	4.1	5.6	3.1	6.1	6.5
IGF1	"IGF-I, IGF1A, IGFI"	ENSG00000017427	"Insulin like growth factor 1"	P05019	12	102395874-102481744	"Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor"	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 21.3;HDLM-2: 27.7;K-562: 12.4;Karpas-707: 6.6;U-266/70: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 2.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	9	"B-cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA048946	Approved				"Secreted to blood"	175950000	410000000			"HPA048946: "	"unprognostic (1.25e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.04e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.26e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-3)"	33.4	3.6	0.8	10.7	1.4	0.3	23.0	0.6	2.1	46.6	6.7	0.6	20.6	2.2	35.0	58.3	16.1	8.1	8.8	17.4	1.5	1.0	3.9	32.8	7.6	13.3	0.9	0.4	17.6	3.2	1.2	1.2	13.5	1.9	57.2	2.8	3.7	5.4	32.0	11.9	3.2	3.5	29.4	1.0	4.9	5.9	19.0	0.2	1.5	29.3	11.6	2.2	21.2	15.3	4.5	0.2	0.5	0.1	0.2	0.1	0.8	0.2	0.0	0.0	0.0	21.3	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	6.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	2.4	0.1	0.1	0.0	4.5	0.1	0.1	0.5	0.2	0.1	0.2	0.0	0.8	0.8	1.4	0.6	2.1	1.5	1.0	0.9	0.4	1.9	0.2
IGF1R	"CD221, IGFIR, IGFR, JTK13, MGC18216"	ENSG00000140443	"Insulin like growth factor 1 receptor"	P08069	15	98648971-98964530	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 7.7;T-cells: 2.9"	"Low region specificity"	"Detected in all"							"CAB010268, HPA045563"	Approved		Approved	Vesicles			36000	Vesicles		"CAB010268: AB_671792, HPA045563: "	"unprognostic (1.30e-3)"	"unprognostic (5.81e-3)"	"unprognostic (1.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.29e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.87e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (3.75e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	8.4	12.7	11.5	5.9	13.5	16.3	18.5	23.0	15.7	15.3	13.4	10.4	22.7	4.2	15.3	16.3	9.2	18.9	7.7	11.6	11.7	7.3	17.0	2.0	11.0	4.9	8.0	11.8	23.2	22.5	4.7	13.8	17.5	9.5	21.7	7.2	16.7	12.5	23.2	9.1	13.0	7.5	18.1	8.0	7.3	10.7	12.0	11.5	10.7	16.1	7.0	5.6	12.8	21.6	1.0	0.4	7.7	0.6	1.0	2.9	0.7	3.3	16.5	11.6	0.2	5.8	4.2	7.7	3.7	7.4	1.2	1.1	7.1	8.8	0.8	10.7	7.2	15.8	5.1	15.0	1.0	0.0	5.2	12.5	18.5	14.2	5.1	6.6	1.3	6.6	7.1	2.1	10.2	4.1	0.6	2.9	5.7	23.4	2.5	4.4	10.8	0.9	4.0	9.0	3.0	3.5	20.3	3.9	17.3	26.7	1.5	14.4	8.1	3.1	11.3	1.1	15.0	3.0	5.8	1.0	4.4	2.7	2.2	4.9	2.8	4.0	0.6	1.8	0.9	0.6	0.6	0.4	0.8	0.3	0.4	1.0	2.9	1.0	7.7	1.0	0.5	0.3	0.0	0.7	11.5	13.5	23.0	15.7	11.7	7.3	8.0	11.8	9.5	11.5
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2149603	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 330.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 112.8;Hep G2: 77.4;LHCN-M2: 44.5;RH-30: 55.3;SH-SY5Y: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	609000000	1700000000	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: , HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favourable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	16.6	8.0	1.3	4.5	2.0	0.5	23.3	2.3	1.9	23.4	5.0	3.4	4.7	1.0	9.9	32.0	5.2	17.2	4.5	20.5	1.5	1.6	8.1	39.7	1.9	1.1	3.5	1.6	20.4	5.5	0.7	5.0	330.5	7.6	10.4	1.0	33.2	2.6	6.7	21.9	1.7	2.3	7.5	17.0	2.0	3.2	12.4	0.2	1.8	2.6	14.5	1.8	15.2	14.1	0.0	0.1	0.5	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	14.9	0.1	0.4	0.0	112.8	0.0	0.0	1.1	0.0	0.0	0.1	0.9	1.0	0.0	0.0	0.0	0.0	77.4	19.8	0.0	0.0	24.1	0.0	0.1	0.0	0.1	0.0	0.0	44.5	0.2	0.0	0.1	0.1	0.2	0.0	55.3	0.1	0.0	0.1	4.4	67.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	1.3	2.0	2.3	1.4	1.5	1.6	3.5	1.6	7.6	0.2
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB017126: , HPA035145: "	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavourable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.2	2.4	27.6	5.2	15.1	23.9	16.9	14.9	21.1	23.2	27.9	20.3	8.0	0.0	22.2	12.6	12.9	12.9	21.7	37.7	0.0	13.4	8.0	0.1	14.0	32.3	0.2	0.0	17.5	11.5	15.4	60.0	21.3	7.8	0.0	17.0	0.2	0.0	6.8	20.2	10.2	2.9	11.0	8.4	15.0	0.1	1.7	0.2	1.1	0.0	26.6	2.2	18.9	32.3	8.1	17.6	10.1	17.1	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969099-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 59.6;hTERT-HME1: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"			150000000	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavourable (3.01e-4)"	"prognostic unfavourable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (6.08e-4)"	28.0	22.2	6.8	13.5	8.1	16.7	39.4	6.4	8.2	14.9	17.3	9.5	13.0	9.4	19.6	16.0	16.7	13.1	17.9	27.9	6.7	6.2	20.6	26.6	32.6	44.7	12.3	3.6	18.0	19.6	23.5	13.6	15.5	10.0	14.1	13.3	13.9	18.2	13.5	62.0	15.9	15.4	16.5	7.6	30.2	14.4	13.8	9.0	37.9	18.5	17.3	14.1	16.3	26.9	0.4	2.9	13.3	2.0	1.0	3.6	0.9	7.7	7.0	12.4	17.4	45.3	25.0	16.8	12.2	26.4	10.1	17.4	10.6	12.2	3.2	13.7	13.4	10.4	9.3	59.6	17.0	16.8	6.6	1.4	12.2	19.1	26.8	7.4	12.1	19.9	19.1	21.0	60.7	6.5	13.9	17.4	15.9	5.7	3.4	7.4	5.5	7.5	8.0	8.5	16.3	14.3	7.8	4.1	9.1	16.5	14.8	16.5	6.2	21.0	9.8	9.8	10.3	21.1	22.3	10.3	14.4	3.3	18.9	10.2	15.1	0.1	2.0	1.1	3.6	0.8	1.4	0.3	1.2	1.7	0.3	0.4	1.0	2.4	13.3	1.0	1.4	2.9	0.7	0.9	6.8	8.1	6.4	8.2	6.7	6.2	12.3	3.6	10.0	9.0
IGFALS	ALS	ENSG00000099769	"Insulin like growth factor binding protein acid labile subunit"	P35858	16	1790413-1794971	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 107.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.2;T-47d: 2.1;U-266/70: 5.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040692, HPA040948"	Supported				"Secreted to blood"	14650000000	44000000000			"HPA040692: AB_10794067, HPA040948: AB_10794999"	"unprognostic (2.74e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.13e-2)"	"prognostic unfavourable (6.06e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-2)"	"prognostic favourable (5.97e-4)"	"unprognostic (5.54e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.51e-2)"	0.1	0.0	0.1	0.1	0.2	0.2	0.1	0.8	0.2	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.1	0.2	7.4	0.1	0.1	0.2	0.2	107.6	0.4	0.1	0.1	0.1	0.1	0.8	0.0	0.2	0.1	0.4	0.1	0.0	1.4	0.6	0.1	0.2	0.2	0.1	0.1	0.3	0.1	5.0	0.5	0.1	1.7	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	5.2	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.9	1.0	0.0	1.2	0.2	0.5	0.2	0.0	1.3	0.5	1.5	0.0	0.0	0.4	0.3	0.3	0.0	0.7	2.1	0.2	0.2	0.4	1.4	0.2	0.2	5.1	1.8	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.2	0.1	0.2	0.1	0.1	0.4	0.1
IGFBP1	"AFBP, hIGFBP-1, IBP1, IGF-BP25, PP12"	ENSG00000146678	"Insulin like growth factor binding protein 1"	P08833	7	45888357-45893668	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"liver: 157.6;placenta: 292.3"	"Group enriched"	"Detected in some"	8	"Hep G2: 17.6;U-2197: 28.8;U-87 MG: 49.8"	"Cancer enriched"	"Detected in many"	29	"liver cancer: 385.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004445, HPA046972, HPA050640"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	28130000	22000000	"Golgi apparatus"		"CAB004445: AB_627782, HPA046972: AB_2679884, HPA050640: AB_2681197"	"unprognostic (8.66e-3)"	"unprognostic (1.45e-1)"	"unprognostic (9.41e-2)"	"unprognostic (7.80e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.89e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.95e-2)"		"prognostic unfavourable (6.90e-11)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.43e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	10.7	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.2	157.6	0.1	0.0	0.1	0.0	9.3	0.0	0.0	0.2	292.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.5	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	17.6	0.1	0.3	0.0	0.0	0.2	3.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.8	0.0	0.0	0.0	0.0	49.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1
IGFBP2	IBP2	ENSG00000115457	"Insulin like growth factor binding protein 2"	P18065	2	216632828-216664436	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 165.3;pancreas: 228.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 138.4;HMC-1: 322.9;NB-4: 66.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077723			Approved	"Endoplasmic reticulum"	"Secreted to blood"	539805000	1000000000	"Endoplasmic reticulum"		"HPA077723: "	"unprognostic (2.58e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.32e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.36e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (5.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.22e-1)"	21.7	6.4	0.9	13.7	2.8	2.6	17.5	1.0	10.4	11.9	12.6	4.5	20.6	11.4	28.7	37.7	26.4	19.4	11.8	29.6	1.5	0.9	21.3	165.3	8.7	3.8	1.4	3.4	35.7	228.7	0.8	8.2	32.0	7.6	25.7	5.2	8.0	9.1	32.6	5.3	3.1	7.8	7.5	1.8	46.7	50.2	13.7	1.0	12.1	8.4	29.3	12.9	23.4	11.4	0.0	0.3	0.0	0.4	2.0	0.8	1.3	0.0	3.2	25.3	24.6	138.4	42.3	0.5	7.7	3.8	0.3	0.0	0.0	0.0	0.0	10.8	0.0	0.7	9.0	9.6	0.0	0.0	5.2	5.5	0.0	1.5	3.4	2.3	322.9	14.1	1.0	0.1	0.4	0.0	0.2	0.7	0.1	6.2	9.6	66.6	27.3	0.3	8.3	0.5	0.1	0.1	7.1	5.3	27.9	0.0	0.2	0.1	20.7	4.1	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.5	0.3	10.6	29.5	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	1.3	0.9	2.8	1.0	10.4	1.5	0.9	1.4	3.4	7.6	1.0
IGFBP3	"BP-53, IBP3"	ENSG00000146674	"Insulin like growth factor binding protein 3"	P17936	7	45912245-45921874	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis	"Growth factor binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 320.7"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 412.2;U-2197: 171.0;U-87 MG: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 28.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 28.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010360			Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	3247666667	5600000000	Vesicles	"Nucleoplasm, Cytosol"	"CAB010360: AB_2233528"	"unprognostic (4.46e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.54e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (8.14e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.67e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (5.07e-7)"	"unprognostic (2.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.63e-1)"	47.4	1.6	4.4	10.6	2.7	0.0	52.1	2.7	4.1	44.3	21.3	1.7	3.2	6.9	58.4	8.1	11.7	14.9	5.4	41.6	4.4	2.6	11.1	80.4	11.7	12.7	3.7	1.9	49.2	2.2	0.6	19.2	320.7	4.1	22.5	6.1	9.1	6.4	9.3	13.9	23.9	10.2	22.9	3.8	18.7	8.3	12.1	3.1	2.2	5.6	8.6	8.3	32.0	26.3	0.0	28.9	0.0	0.0	0.0	6.0	1.7	9.3	2.8	5.5	0.0	4.2	1.7	0.0	41.2	7.5	3.5	1.9	0.0	7.6	0.0	13.1	412.2	22.6	0.0	0.1	1.4	0.0	0.0	0.0	1.0	0.0	1.1	0.0	0.0	14.4	0.6	0.7	2.6	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.5	0.0	0.0	3.8	2.6	20.4	0.6	1.6	14.2	0.5	0.7	0.0	0.0	0.0	40.7	0.0	171.0	2.3	0.5	0.0	0.0	88.5	0.0	13.7	0.0	0.0	0.0	5.2	0.0	4.3	0.0	6.0	5.6	0.0	0.0	2.8	4.7	0.0	0.0	0.0	28.9	0.3	1.7	4.4	2.7	2.7	4.1	4.4	2.6	3.7	1.9	4.1	3.1
IGFBP4	"BP-4, HT29-IGFBP, IBP4, IGFBP-4"	ENSG00000141753	"Insulin like growth factor binding protein 4"	P22692	17	40443461-40457731	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 370.8"	"Cell line enhanced"	"Detected in many"		"A549: 109.4;ASC diff: 82.6;ASC TERT1: 81.0;BJ: 87.8;BJ hTERT+: 90.4;HSkMC: 172.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 12.6;NK-cell: 20.5"	"Group enriched"	"Detected in many"	5	"NK-cells: 20.5;T-cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066240	Supported				"Secreted to blood"	227300000	500000000			"HPA066240: "	"unprognostic (1.03e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.54e-4)"	"unprognostic (7.44e-3)"	"unprognostic (1.00e-1)"	"prognostic favourable (5.49e-4)"	"unprognostic (4.55e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.81e-2)"	79.7	23.3	2.5	36.8	5.2	0.0	198.7	1.8	3.1	115.0	57.1	3.2	41.1	9.9	88.8	126.5	67.7	67.4	117.5	119.1	2.2	1.8	72.3	255.6	88.2	101.4	3.7	2.3	370.8	21.5	6.5	19.4	99.8	5.1	66.7	17.0	46.2	24.4	38.6	36.3	22.3	36.8	80.4	6.4	68.1	38.7	53.2	2.3	4.2	81.0	50.4	22.5	89.9	123.9	3.6	0.1	0.0	0.0	20.5	12.6	0.9	0.0	109.4	5.6	0.0	82.6	81.0	0.1	87.8	90.4	16.8	13.1	4.8	1.4	0.0	47.6	41.7	0.9	1.8	0.5	7.6	0.3	0.1	0.3	8.0	7.2	51.8	0.2	0.0	172.1	0.3	22.5	3.2	29.1	1.7	0.0	24.1	3.3	0.0	20.2	3.1	14.8	5.4	0.1	0.1	0.7	3.4	1.5	4.4	39.7	0.1	1.3	40.5	2.0	43.8	23.4	1.2	73.9	0.0	0.0	0.0	0.1	13.9	0.8	6.0	0.0	0.0	0.0	1.8	0.0	12.6	0.4	3.3	4.4	0.0	3.6	0.2	0.4	0.0	20.5	0.0	0.1	0.0	0.9	2.5	5.2	1.8	3.1	2.2	1.8	3.7	2.3	5.1	2.3
IGFBP5		ENSG00000115461	"Insulin like growth factor binding protein 5"	P24593	2	216672105-216695525	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 245.3"	"Cell line enhanced"	"Detected in many"		"BJ: 77.9;BJ hTERT+: 207.2;T-47d: 50.4;U-138 MG: 68.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059827, HPA070407"		Supported	Approved	"Nuclear bodies,Golgi apparatus,Vesicles"	"Secreted to blood"	109650000	330000000	"Golgi apparatus, Vesicles"	"Nuclear bodies"	"HPA059827: , HPA070407: "	"unprognostic (7.69e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.78e-4)"	"unprognostic (4.58e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.91e-3)"	47.3	23.4	6.2	19.2	6.3	0.1	41.3	3.6	6.5	191.7	23.1	19.7	15.8	3.9	94.6	91.0	30.0	96.9	21.4	16.9	8.2	2.4	34.8	7.8	9.3	14.5	12.1	7.4	245.3	3.5	6.5	37.7	32.7	7.0	31.4	7.9	188.5	12.0	15.1	47.0	13.5	14.2	71.8	7.4	7.6	36.9	51.7	12.0	1.5	130.1	34.5	17.6	28.8	45.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	20.1	0.0	23.2	0.7	0.0	77.9	207.2	10.4	1.0	0.0	0.0	0.0	0.3	0.2	0.0	2.4	0.0	0.5	0.0	0.7	20.0	0.4	0.0	10.1	0.0	0.1	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.1	0.2	0.3	0.0	0.0	0.1	6.7	23.1	1.3	0.8	1.3	9.6	0.0	50.4	0.0	7.5	68.7	4.2	10.4	3.7	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	6.2	6.3	3.6	6.5	8.2	2.4	12.1	7.4	7.0	12.0
IGFBP6		ENSG00000167779	"Insulin like growth factor binding protein 6"	P24592	12	53097436-53102345	"Plasma proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.8;BJ: 74.4;fHDF/TERT166: 26.5;HaCaT: 44.2;U-87 MG: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 12.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.5;monocytes: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008005	Uncertain				"Secreted to blood"	199425000	320000000			"HPA008005: AB_1851499"	"unprognostic (4.93e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.62e-2)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (2.55e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.35e-1)"	60.2	15.9	0.9	6.7	1.4	1.2	61.0	0.3	4.7	70.2	15.2	0.8	34.9	5.2	20.7	78.5	47.0	37.6	14.7	27.5	0.7	0.8	6.4	2.6	12.5	3.3	5.9	2.9	37.5	3.9	1.7	19.6	12.5	6.1	29.4	3.6	41.5	6.1	23.5	18.3	6.5	8.9	52.6	26.1	8.0	12.6	36.0	0.0	0.2	15.1	55.8	7.6	58.0	90.5	0.0	0.7	12.5	7.1	0.0	1.7	0.4	15.5	9.8	0.0	6.2	8.4	27.8	0.0	74.4	17.3	2.9	2.0	0.9	12.9	0.0	7.7	26.5	44.2	0.0	1.7	0.4	0.0	0.2	0.1	1.7	1.5	4.2	0.0	0.0	11.2	0.0	1.9	0.2	0.8	0.0	0.1	0.8	0.0	0.5	0.1	0.4	21.2	0.1	0.5	0.2	0.1	0.0	0.0	0.7	22.9	0.0	0.6	0.3	0.0	17.6	3.6	4.6	6.5	1.3	0.4	0.3	0.0	31.0	0.2	1.9	0.0	0.0	12.5	0.1	2.1	0.8	0.0	0.3	1.0	0.7	0.0	0.1	1.7	0.0	0.0	7.1	0.0	0.0	0.4	0.9	1.4	0.3	1.7	0.7	0.8	5.9	2.9	6.1	0.0
IGFBP7	"FSTL2, IGFBP-7, MAC25, PSF"	ENSG00000163453	"Insulin like growth factor binding protein 7"	Q16270	4	57030773-57110385	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 82.3;BJ hTERT+: 77.0;EFO-21: 52.8;RPTEC TERT1: 82.7;TIME: 119.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 15.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002196, CAB020668"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	30300000	240000000	"Golgi apparatus"		"CAB020668: , HPA002196: AB_1079107"	"unprognostic (2.76e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.82e-2)"	"unprognostic (5.97e-3)"	"unprognostic (3.86e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	95.8	46.5	15.1	38.7	23.7	8.5	65.3	5.6	19.2	73.0	47.8	33.1	79.6	22.7	95.2	164.5	50.5	66.3	241.7	121.0	20.4	14.2	187.5	35.5	55.4	109.0	23.9	24.1	53.0	45.6	12.3	29.5	30.4	91.2	78.1	19.0	126.9	22.2	151.6	30.5	21.1	27.0	119.9	21.9	91.7	32.6	68.0	15.7	3.9	128.9	41.2	18.1	96.8	85.3	0.0	8.4	15.5	3.2	8.7	0.1	1.1	0.1	0.5	0.1	0.0	16.7	6.3	0.5	82.3	77.0	7.2	2.3	0.3	0.0	0.0	52.8	3.9	8.2	0.0	13.2	1.9	0.1	0.6	0.2	9.7	0.0	25.8	1.9	2.1	29.0	6.7	11.7	3.2	16.5	0.0	0.1	17.0	0.0	0.0	8.6	0.7	0.1	1.5	0.0	0.3	82.7	0.0	0.1	0.2	15.4	1.1	0.0	0.2	7.5	119.3	7.4	5.6	0.9	13.3	5.0	0.0	0.1	19.4	6.8	0.2	1.6	3.0	15.5	0.1	3.1	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.1	0.2	8.7	3.2	0.3	0.1	1.1	15.1	23.7	5.6	19.0	20.4	14.2	23.9	24.1	91.2	15.7
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580308	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"blood: 11.6;bone marrow: 37.7;lymphoid tissue: 29.4;testis: 20.8"	"Cell line enriched"	"Detected in some"	34	"REH: 126.8"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 11.6;naive B-cell: 9.8"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.6"									"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"		100000000000	"Endoplasmic reticulum"		"HPA051134: , HPA071406: "	"unprognostic (6.21e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.91e-6)"		"unprognostic (1.08e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.17e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.35e-2)"	"unprognostic (5.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.1	0.1	0.2	37.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	20.8	0.0	29.4	0.0	0.0	1.1	0.0	0.0	11.6	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	0.0	126.8	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog"	Q14623	2	219054420-219060467	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Developmental protein, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in some"	10	"CACO-2: 20.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"		13000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.1	0.1	20.2	0.1	0.0	0.1	0.3	0.2	4.5	33.1	0.1	0.7	10.7	14.3	10.3	0.7	0.7	19.1	0.1	0.1	0.2	3.7	3.4	3.3	0.1	0.1	0.1	0.7	0.1	0.0	0.6	0.2	0.1	2.3	11.4	8.2	0.1	1.1	0.1	0.1	42.8	0.5	0.1	0.1	11.6	0.3	0.1	0.1	1.1	0.1	0.1	0.9	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1
IKBKB	"IKK-beta, IKK2, IKKB, NFKBIKB"	ENSG00000104365	"Inhibitor of nuclear factor kappa B kinase subunit beta"	O14920	8	42271302-42332653	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001249, CAB004447"	Enhanced		Approved	Cytosol				Cytosol		"CAB004447: AB_627785, HPA001249: AB_1079126"	"unprognostic (1.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.20e-2)"	"unprognostic (3.02e-1)"	"prognostic favourable (1.46e-6)"	9.1	10.8	10.9	17.0	16.7	9.3	10.0	26.1	16.9	10.3	10.3	12.4	11.4	4.7	15.3	13.2	17.9	16.4	14.9	7.9	13.1	6.9	12.4	9.9	14.9	12.2	20.3	7.9	9.6	13.3	18.0	13.6	11.2	11.9	14.0	10.9	10.5	11.4	9.7	17.6	22.2	9.8	16.4	10.5	18.7	10.8	8.3	18.6	12.9	14.3	8.4	17.1	18.1	12.8	12.6	14.8	14.1	9.6	11.9	11.2	5.8	3.6	13.1	3.7	6.4	14.5	12.6	4.8	3.2	11.5	9.7	8.5	3.0	6.8	7.2	5.6	8.9	4.2	5.1	13.0	12.5	7.0	5.8	10.1	6.1	2.3	11.1	1.9	10.6	8.4	9.9	9.3	14.4	14.3	8.5	3.5	21.2	4.2	7.0	3.2	3.6	4.1	7.2	6.4	4.2	10.9	3.3	1.1	2.1	2.1	3.6	5.3	4.8	8.5	7.4	6.8	3.6	5.3	2.3	2.1	2.2	5.1	8.1	4.8	7.7	14.1	9.6	10.4	10.1	7.6	10.3	9.4	10.5	11.2	8.9	12.6	10.2	10.4	11.4	11.9	9.0	14.8	9.9	5.8	10.9	16.7	26.1	16.9	13.1	6.9	20.3	7.9	11.9	18.6
IL10	"CSIF, IL-10, IL10A, TGIF"	ENSG00000136634	"Interleukin 10"	P22301	1	206767602-206772494	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.3"	"Group enriched"	"Detected in some"	8	"HMC-1: 18.2;U-266/70: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 5.4;intermediate monocyte: 4.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB013120, HPA071391"	Approved				"Secreted to blood"	4757				"CAB013120: , HPA071391: "	"unprognostic (3.65e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (4.26e-1)"	"unprognostic (8.01e-2)"	"unprognostic (4.00e-1)"	"unprognostic (4.66e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-2)"	10.9	3.1	1.1	10.7	1.2	4.1	2.1	0.3	1.3	1.6	1.8	2.1	0.5	0.8	1.0	1.9	1.7	4.0	5.2	3.9	0.8	0.9	1.3	3.1	4.3	9.2	1.8	0.9	1.5	1.2	0.4	2.3	3.6	2.3	1.7	1.8	2.1	1.6	0.8	0.9	0.7	2.1	4.6	2.2	28.3	2.0	1.6	1.4	2.2	2.4	0.9	3.5	4.1	1.0	0.2	0.5	0.5	5.4	0.1	1.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.0	9.3	0.3	0.3	0.0	0.1	0.0	0.5	5.4	0.1	0.2	4.0	0.0	0.1	0.2	1.0	0.5	0.2	0.1	0.1	0.3	0.1	1.4	0.1	0.9	1.0	1.1	1.2	0.3	1.3	0.8	0.9	1.8	0.9	2.3	1.4
IL10RB	"CDW210B, CRF2-4, CRFB4, D21S58, D21S66, IL-10R2"	ENSG00000243646	"Interleukin 10 receptor subunit beta"	Q08334	21	33266358-33310187	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Antiviral defense"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB020670, HPA047550"	Approved		Approved	Cytosol			1300000	Cytosol		"CAB020670: , HPA047550: "	"unprognostic (8.43e-2)"	"unprognostic (6.50e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavourable (5.62e-9)"	"unprognostic (3.09e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.05e-1)"	17.6	11.0	5.4	19.6	7.3	8.9	21.5	3.6	4.4	15.2	29.2	10.3	10.6	19.6	17.5	9.6	22.7	13.2	14.8	12.3	5.6	5.4	11.6	27.5	19.3	36.1	6.6	3.1	18.2	23.2	5.5	9.7	47.4	9.3	17.7	20.8	11.7	26.0	9.7	12.4	13.8	53.6	12.2	8.0	31.7	17.6	8.4	7.3	34.0	14.3	15.3	26.2	15.1	22.6	13.8	19.4	57.9	34.7	14.0	19.5	20.4	10.2	7.9	1.5	6.4	32.2	23.6	11.3	7.9	22.3	8.7	12.5	7.5	12.7	2.9	9.1	13.7	12.8	4.2	5.4	5.7	9.5	5.9	8.0	6.0	5.6	22.4	10.2	19.3	23.7	10.2	15.1	8.9	11.5	7.1	24.0	12.0	10.7	6.8	9.8	1.1	4.2	6.3	3.6	12.1	7.8	6.1	2.0	2.9	16.2	12.0	13.7	8.0	38.4	10.4	8.7	8.5	14.8	4.3	12.7	14.2	1.7	15.4	14.6	5.6	22.3	30.1	24.8	8.8	34.4	9.6	13.6	11.1	10.6	17.8	13.8	10.5	10.4	57.9	14.0	34.7	19.4	19.5	20.4	5.4	7.3	3.6	4.4	5.6	5.4	6.6	3.1	9.3	7.3
IL12A	"CLMF, IL-12A, NFSK, NKSF1, p35"	ENSG00000168811	"Interleukin 12A"	P29459	3	159988750-159996019	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 10.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 7.4;HDLM-2: 11.2;SK-BR-3: 16.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 5.1"	"Group enriched"	"Detected in many"	7	"B-cells: 5.1;granulocytes: 1.3;T-cells: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 2.7"	"Low region specificity"	"Detected in some"			HPA001886	Uncertain				"Secreted to blood"					"HPA001886: AB_1079132"	"unprognostic (6.23e-2)"	"unprognostic (7.82e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.22e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.18e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.57e-10)"	"unprognostic (1.62e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.61e-2)"	0.7	1.4	3.4	1.6	6.2	3.3	2.0	2.6	5.6	0.5	1.6	1.0	0.0	1.5	1.2	0.8	10.1	5.7	0.6	1.4	3.1	2.2	1.2	0.6	5.2	2.9	3.2	1.7	1.6	1.1	0.1	1.0	0.4	5.4	0.9	1.3	0.2	2.1	1.1	0.4	0.2	1.5	0.8	2.7	2.8	1.2	0.9	4.1	0.0	0.5	0.5	2.1	0.9	1.1	5.1	0.1	1.3	0.3	0.0	1.6	0.3	2.7	0.3	0.4	2.3	0.0	0.1	0.2	3.1	1.9	3.5	7.4	1.2	0.1	0.0	0.2	0.5	0.3	0.8	0.5	3.3	11.2	3.9	0.1	0.1	0.8	2.5	0.6	5.2	0.6	0.9	6.3	2.4	1.1	0.0	1.9	2.2	0.0	0.1	0.0	0.3	1.6	2.2	0.0	0.4	0.4	0.2	0.1	1.1	0.0	16.8	0.4	0.8	1.2	0.8	0.9	0.8	2.1	5.7	1.2	0.0	0.0	1.4	5.1	0.7	0.0	0.1	1.3	0.9	0.3	1.4	1.3	0.4	1.6	0.1	5.1	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.3	3.4	6.2	2.6	5.6	3.1	2.2	3.2	1.7	5.4	4.1
IL12B	"CLMF, CLMF2, IL-12B, NKSF, NKSF2"	ENSG00000113302	"Interleukin 12B"	P29460	5	159314783-159330887	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 10.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;NB-4: 2.7;SCLC-21H: 3.6"	"Cancer enriched"	"Detected in single"	20	"testis cancer: 3.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040970	Supported				"Secreted to blood"	50000				"HPA040970: AB_10796234"	"unprognostic (5.96e-5)"	"unprognostic (4.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.40e-1)"		"unprognostic (9.13e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.58e-4)"	"unprognostic (6.69e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.15e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-2)"	0.2	0.2	0.2	0.7	0.2	1.4	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	0.4	0.2	0.7	0.2	0.2	0.2	0.6	0.3	0.9	1.8	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	0.2	0.6	0.2	0.7	0.2	0.2	1.3	0.5	0.2	0.2	1.8	0.9	0.5	0.2	10.8	0.4	0.2	0.9	0.3	0.2	1.1	0.3	2.9	0.5	1.0	0.2	0.0	0.3	0.4	0.6	0.7	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.5	0.9	0.5	0.1	0.1	0.3	0.1	0.1	0.0	0.5	0.8	0.1	1.4	0.2	0.1	0.4	1.1	0.3	0.3	0.1	0.0	0.1	0.2	2.9	0.0	0.2	0.5	2.7	0.6	0.4	0.5	0.7	1.8	0.0	0.2	3.6	0.2	0.3	0.3	0.0	0.3	0.3	0.4	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.7	0.5	0.2	1.7	0.5	0.2	0.2	0.1	0.1	1.1	0.2	0.1	0.1	0.3	0.2	0.2	2.9	1.0	0.1	0.3	0.1	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 20.7"	"Cell line enriched"	"Detected in single"	177	"HDLM-2: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042421			Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	33773		"Plasma membrane, Cytosol"		"HPA042421: AB_10795504"	"unprognostic (2.17e-1)"	"unprognostic (2.29e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.18e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (4.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.38e-1)"	0.3	0.0	0.1	0.8	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	3.0	0.0	0.0	0.1	0.0	0.0	1.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	20.7	0.0	2.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0
IL16	"FLJ16806, FLJ42735, HsT19289, IL-16, LCF, prIL-16"	ENSG00000172349	"Interleukin 16"	Q14005	15	81159575-81314058	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Chemotaxis, Host-virus interaction, Transcription, Transcription regulation"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 75.7;lymphoid tissue: 97.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.2;HEL: 12.9;HMC-1: 23.3;RPMI-8226: 22.1;U-266/70: 27.7;U-698: 11.4;U-937: 15.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 40.1"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"cerebellum: 61.1;hippocampal formation: 29.7"	"Region enriched"	"Detected in single"	38	"cerebellum: 96.7"	"CAB005247, HPA018467, HPA048861"	Enhanced		Supported	"Nuclear speckles,Plasma membrane,Midbody ring,Cytosol"	"Secreted to blood"	125370	14000	"Nuclear speckles"	"Plasma membrane, Midbody ring, Cytosol"	"CAB005247: AB_2124730, HPA018467: AB_1851642, HPA048861: "	"unprognostic (8.23e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.97e-2)"	"unprognostic (9.61e-4)"	"unprognostic (2.01e-1)"	"unprognostic (5.26e-4)"	"unprognostic (2.63e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.29e-1)"	8.8	2.4	4.1	48.0	5.8	19.5	7.8	40.1	4.3	4.7	4.8	4.6	0.9	3.8	5.4	2.9	3.4	9.7	5.6	5.1	4.9	2.1	2.5	3.9	14.7	58.0	5.8	2.3	3.7	1.7	0.7	1.4	3.0	6.7	3.5	5.9	3.4	13.5	1.5	1.8	6.1	19.2	3.3	7.8	38.2	5.0	2.2	5.5	97.9	3.7	2.4	54.8	8.7	5.4	43.3	37.1	75.7	35.0	49.3	60.5	66.5	0.0	0.0	0.0	0.0	8.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	12.9	0.0	0.0	0.4	9.1	23.3	0.4	0.0	0.0	0.2	0.1	1.3	4.9	0.0	0.0	0.7	9.7	0.0	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	2.0	0.1	0.1	0.1	0.4	0.0	27.7	2.3	11.4	0.8	15.5	0.7	52.7	27.4	75.7	43.1	35.0	48.6	43.3	45.1	47.1	37.1	39.9	60.5	48.6	69.1	49.3	33.7	28.0	47.0	66.5	4.1	5.8	40.1	4.3	4.9	2.1	5.8	2.3	6.7	5.5
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186387-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"lymphoid tissue: 7.6;tongue: 12.2;urinary bladder: 4.4"	"Group enriched"	"Detected in some"	37	"Karpas-707: 7.2;U-266/84: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	9915				"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.2	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.0	0.0	1.3	0.5	0.6	0.0	0.1	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.0	12.2	7.6	4.4	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
IL18	"IGIF, IL-18, IL-1g, IL1F4"	ENSG00000150782	"Interleukin 18"	Q14116	11	112143251-112164117	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.9;skin 1: 57.2"	"Cell line enhanced"	"Detected in many"		"A-431: 26.0;CAPAN-2: 41.2;HaCaT: 37.8;HBEC3-KT: 28.4;hTCEpi: 43.5;PC-3: 25.2;U-2 OS: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 17.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003980, CAB007772"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"	"Secreted to blood"	136427		"Nucleoplasm, Golgi apparatus"	Cytosol	"CAB007772: AB_562304, HPA003980: AB_1851670"	"unprognostic (2.31e-3)"	"unprognostic (3.25e-1)"	"prognostic favourable (2.78e-4)"	"unprognostic (3.41e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.13e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.15e-2)"	"unprognostic (9.01e-2)"	9.4	2.6	5.3	12.5	7.9	10.8	5.2	1.3	5.3	18.5	13.1	6.4	2.5	8.6	2.1	3.7	53.9	3.3	11.9	2.1	5.7	3.1	17.5	3.6	15.2	22.6	7.4	1.4	1.4	7.0	0.3	3.3	2.6	8.2	5.5	11.6	2.2	8.3	1.4	3.8	57.2	9.1	4.0	24.7	26.6	5.1	1.7	7.5	3.9	1.8	21.2	26.5	9.1	35.4	0.5	17.1	10.4	6.9	13.8	0.3	1.6	26.0	9.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	5.0	41.2	0.0	6.0	0.0	37.8	0.0	28.4	0.0	0.0	0.2	3.9	9.3	2.1	0.9	2.0	7.6	0.0	43.5	0.0	10.1	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	25.2	0.0	0.0	0.0	18.6	5.6	0.0	0.0	17.9	11.9	0.1	7.1	5.7	0.0	0.1	49.0	0.3	8.0	0.1	0.0	0.1	0.0	15.1	0.0	3.5	6.0	10.4	0.1	6.9	0.0	0.4	0.0	0.0	17.1	0.5	0.0	0.3	6.7	13.8	3.7	3.8	0.0	1.6	5.3	7.9	1.3	5.3	5.7	3.1	7.4	1.4	8.2	7.5
IL18R1	"CD218a, IL-1Rrp, IL1RRP"	ENSG00000115604	"Interleukin 18 receptor 1"	Q13478	2	102311529-102398775	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 13.5;HHSteC: 29.2;HMC-1: 19.6;U-937: 31.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 26.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA007615	Approved		Approved	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA007615: AB_1851675"	"unprognostic (3.60e-3)"	"unprognostic (9.75e-3)"	"unprognostic (1.12e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.34e-3)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.59e-1)"	"unprognostic (7.86e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.48e-2)"	17.8	2.6	1.4	8.3	1.7	12.5	11.2	0.8	1.3	8.2	8.1	0.7	6.6	5.1	4.2	5.7	4.5	4.5	14.1	10.5	1.7	1.9	7.4	8.8	39.3	29.6	2.0	0.1	3.3	2.6	0.8	4.6	10.7	1.6	6.3	3.4	5.0	3.0	28.4	2.8	3.2	10.7	7.9	1.9	19.5	4.6	2.4	0.4	2.5	3.2	3.2	6.6	8.2	12.9	0.1	6.8	5.5	0.1	26.8	10.6	1.1	0.8	0.2	0.0	0.0	0.7	0.7	1.6	0.0	0.5	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.8	0.0	13.5	0.7	2.4	0.6	0.1	29.2	5.1	19.6	6.7	1.1	2.1	3.5	4.9	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.4	0.6	0.4	2.3	0.4	0.0	0.0	0.0	0.1	31.3	2.3	5.5	0.0	2.4	4.2	0.1	10.6	0.1	2.4	3.0	2.0	0.1	0.4	0.8	4.1	26.8	0.0	6.8	2.4	1.1	1.4	1.7	0.8	1.3	1.7	1.9	2.0	0.1	1.6	0.4
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 84.8;hTCEpi: 41.9;hTERT-HME1: 55.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	11363					"unprognostic (3.41e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavourable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.1	0.0	10.2	0.0	0.6	0.0	84.8	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	41.9	0.7	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 92.5;HBEC3-KT: 42.0;HMC-1: 34.3;hTEC/SVTERT24-B: 46.3;U-87 MG: 84.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Low region specificity"	"Detected in some"												"Secreted to blood"	3370					"unprognostic (1.55e-3)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavourable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	0.4	1.0	0.0	0.0	0.0	2.6	0.0	2.1	0.0	42.0	5.7	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.3	0.1	1.3	46.3	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	3.5	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	84.5	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Cell line enriched"	"Detected in some"	19	"HDLM-2: 100.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	7132500	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.6	0.0	0.1	0.0	100.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1
IL1RAP	"C3orf13, IL-1RAcP, IL1R3"	ENSG00000196083	"Interleukin 1 receptor accessory protein"	Q9NPH3	3	190514051-190659750	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.5;liver: 91.8;placenta: 35.9"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 36.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035293	Uncertain		Approved	Vesicles,Cytosol	"Secreted to blood"		260000000	"Vesicles, Cytosol"		"HPA035293: AB_10671511"	"unprognostic (6.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.35e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.16e-7)"	"unprognostic (4.02e-3)"	"unprognostic (9.06e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (6.29e-4)"	3.4	1.7	3.7	5.2	4.5	7.8	2.8	0.8	6.0	2.9	1.8	3.4	0.7	1.1	2.6	1.7	9.1	3.2	5.7	3.3	7.4	2.9	1.9	91.8	6.3	12.6	3.5	2.5	2.2	2.0	1.0	1.4	35.9	5.5	2.1	1.4	1.6	4.7	2.0	1.2	5.8	1.5	3.1	6.3	7.1	2.3	1.0	2.9	2.3	2.2	3.8	3.4	3.3	4.4	0.9	1.4	36.5	2.2	0.1	1.3	0.5	3.8	1.0	1.6	0.2	2.8	2.3	3.0	1.7	3.5	4.0	3.9	1.6	8.6	0.6	17.9	4.7	10.0	0.8	16.7	5.6	0.7	1.0	0.8	1.7	4.1	6.0	5.7	2.8	3.1	6.9	5.8	18.5	1.7	0.1	0.0	1.8	1.8	0.4	2.6	2.5	1.8	2.7	2.5	1.3	1.5	4.1	0.3	0.0	7.8	4.4	71.2	2.8	4.1	2.3	3.1	3.2	9.5	7.8	1.4	0.0	0.1	5.2	5.1	18.2	3.5	1.5	8.5	0.7	1.7	1.3	0.9	0.8	0.9	1.4	0.9	0.8	0.5	36.5	0.1	2.2	0.2	0.8	0.5	3.7	4.5	0.8	6.0	7.4	2.9	3.5	2.5	5.5	2.9
IL1RAPL1	"IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2"	ENSG00000169306	"Interleukin 1 receptor accessory protein like 1"	Q9NZN1	X	28587399-29956723	"Disease related genes, Plasma proteins, Predicted membrane proteins"		Receptor	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 26.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 1.5;SK-MEL-30: 2.0;U-2 OS: 1.9;WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																		"unprognostic (2.51e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.74e-4)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.58e-3)"	1.5	1.0	12.9	1.0	21.8	0.9	1.5	6.9	17.2	1.2	1.5	15.0	0.0	1.1	1.2	1.5	1.7	1.0	1.5	2.7	10.9	3.3	1.1	1.8	1.1	1.1	21.7	10.1	2.3	1.2	1.0	1.5	1.6	12.3	2.1	1.5	0.0	1.2	2.1	2.2	0.9	1.7	1.2	9.9	0.9	1.4	1.6	26.7	0.0	1.7	0.0	1.0	2.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	0.6	0.4	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	1.0	0.1	0.0	0.3	0.0	1.1	0.1	0.0	1.5	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	21.8	6.9	17.2	10.9	3.3	21.7	10.1	12.3	26.7
IL1RL1	"DER4, FIT-1, IL33R, ST2, ST2L, ST2V, T1"	ENSG00000115602	"Interleukin 1 receptor like 1"	Q01638	2	102311502-102352037	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 49.7;lung: 77.2;placenta: 95.0"	"Group enriched"	"Detected in some"	6	"HHSteC: 54.1;HMC-1: 80.5;HUVEC TERT2: 39.3"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.9"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.4;cerebral cortex: 6.6;hippocampal formation: 5.6;midbrain: 3.8;pons and medulla: 14.6"	"Group enriched"	"Detected in some"	59	"basophil: 17.1;eosinophil: 17.0"	"Lineage enriched"	"Detected in single"	59	"granulocytes: 17.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007406, HPA007917"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"	"Secreted to blood"	19074133	1700000	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"HPA007406: AB_1079128, HPA007917: AB_1079129"	"unprognostic (7.25e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.60e-3)"	10.7	7.5	1.4	2.0	11.4	0.9	6.9	0.5	6.6	2.6	3.1	0.1	0.1	1.3	1.7	0.9	2.7	0.8	7.8	16.6	5.6	1.8	49.7	6.2	77.2	1.4	3.8	0.0	0.7	2.8	0.8	1.8	95.0	14.6	1.9	2.3	1.0	0.7	5.7	2.8	1.1	2.0	3.3	5.0	1.0	6.7	0.8	0.3	0.0	5.6	0.7	0.9	6.0	2.6	0.0	0.0	17.1	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	3.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.0	1.3	0.1	0.0	0.0	9.5	0.1	0.1	54.1	0.4	80.5	1.1	0.3	1.3	8.7	39.3	0.1	0.1	0.1	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.1	0.1	0.1	17.1	0.0	17.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	11.4	0.5	6.6	5.6	1.8	3.8	0.0	14.6	0.3
IL1RN	"ICIL-1RA, IL-1RN, IL1F3, IL1RA, IRAP, MGC10430"	ENSG00000136689	"Interleukin 1 receptor antagonist"	P18510	2	113107214-113134016	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 217.8;lymphoid tissue: 194.7;tongue: 123.7"	"Cell line enhanced"	"Detected in some"		"A-431: 20.6;HaCaT: 40.8;RT4: 39.8;THP-1: 11.5"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 92.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"classical monocyte: 17.1;myeloid DC: 17.1;neutrophil: 65.2"	"Group enriched"	"Detected in many"	332	"dendritic cells: 17.1;granulocytes: 65.2;monocytes: 17.1"	"Not detected"	"Not detected"							"HPA001482, CAB009633"	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted to blood"	421933		Nucleoplasm	"Centrosome, Cytosol"	"CAB009633: AB_2125576, HPA001482: AB_1078437"	"unprognostic (3.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (3.00e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.46e-2)"	"unprognostic (9.54e-2)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (5.59e-3)"	"prognostic unfavourable (2.66e-6)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.23e-4)"	"unprognostic (4.25e-2)"	"unprognostic (1.03e-1)"	17.3	0.2	0.2	7.2	0.3	32.9	1.1	0.2	0.5	27.2	3.8	0.6	1.4	1.1	1.5	0.7	217.8	0.2	4.1	0.5	0.2	0.0	0.5	23.5	2.9	1.9	0.3	0.2	0.4	0.4	0.1	0.3	3.1	0.6	1.6	0.3	0.4	30.9	1.3	0.5	14.4	3.7	0.7	0.2	3.6	5.7	1.4	0.2	1.0	0.7	123.7	194.7	3.3	42.2	0.0	17.1	65.2	17.1	0.0	0.0	4.9	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.2	0.1	0.1	0.0	40.8	0.0	1.1	0.0	0.0	0.0	0.1	0.0	6.9	0.0	0.1	7.7	0.0	5.3	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	0.0	0.3	0.0	0.0	11.5	0.1	0.5	0.0	0.3	0.0	0.3	0.0	0.0	3.9	4.6	0.1	0.0	17.1	0.3	0.0	7.6	0.0	0.0	0.0	0.0	17.1	0.0	0.0	0.0	65.2	0.0	3.4	0.1	0.0	4.9	0.2	0.3	0.2	0.5	0.2	0.0	0.3	0.2	0.6	0.2
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Cytokine, Growth factor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"	20467				"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	55657												"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
IL26	"AK155, IL-26"	ENSG00000111536	"Interleukin 26"	Q9NPH9	12	68201351-68225821	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.0;tongue: 5.4;urinary bladder: 4.4"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"MAIT T-cell: 2.2;memory CD4 T-cell: 1.5;memory CD8 T-cell: 1.1;T-reg: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.2"					"Low region specificity"	"Detected in all"								"Secreted to blood"	35743						"unprognostic (2.71e-1)"	"unprognostic (8.87e-2)"			"unprognostic (3.26e-5)"		"unprognostic (7.10e-2)"	"unprognostic (5.90e-2)"		"unprognostic (2.96e-1)"		"unprognostic (3.69e-5)"	"unprognostic (3.80e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.79e-2)"	0.1	0.0	0.5	6.0	0.2	0.0	0.0	0.7	0.1	0.1	1.0	0.0	0.0	0.2	0.0	0.0	1.4	0.1	0.5	0.3	1.0	0.2	0.1	0.1	0.5	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.3	0.0	0.0	0.5	1.4	0.0	0.1	1.1	0.3	0.3	0.0	0.5	0.1	5.4	3.5	4.4	0.3	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	1.5	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.1	0.5	0.2	0.7	0.1	1.0	0.2	0.1	0.0	0.0	0.0
IL2RA	"CD25, IDDM10, IL2R"	ENSG00000134460	"Interleukin 2 receptor subunit alpha"	P01589	10	6010689-6062370	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Immunity	Receptor	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 16.5;blood: 55.4;lymphoid tissue: 56.7"	"Cell line enriched"	"Detected in some"	59	"HDLM-2: 153.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.4"	"Group enriched"	"Detected in many"	6	"basophil: 30.3;T-reg: 55.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 30.3;T-cells: 55.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002419, HPA054622"	Enhanced						110000			"CAB002419: AB_563538, HPA054622: "	"unprognostic (2.82e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.08e-9)"	"unprognostic (2.10e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.10e-2)"	16.5	2.5	0.3	10.9	0.6	0.1	1.4	0.3	0.3	0.6	3.1	0.1	0.0	1.3	0.8	4.9	1.9	0.8	2.2	1.9	0.4	0.5	2.6	1.3	4.0	50.4	0.5	0.0	0.6	1.0	0.0	1.8	1.8	2.4	1.1	1.6	3.4	2.2	0.5	0.8	0.6	10.3	3.5	2.2	56.7	1.4	0.4	0.0	4.5	4.2	2.0	16.8	5.0	0.6	3.6	0.0	30.3	0.0	2.9	55.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	153.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	30.3	0.0	4.5	0.1	0.0	0.5	3.6	6.8	0.7	0.0	1.5	0.5	0.0	0.2	2.9	0.0	0.0	55.4	0.7	0.3	0.6	0.3	0.3	0.4	0.5	0.5	0.0	2.4	0.0
IL32	"NK4, TAIF, TAIFb, TAIFd"	ENSG00000008517	"Interleukin 32"	P24001	16	3065297-3082192	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 216.2;liver: 316.2;pancreas: 196.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 66.4;CAPAN-2: 45.1;HDLM-2: 94.6;Hep G2: 64.4;Karpas-707: 56.6;RH-30: 48.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 216.2"	"Lineage enriched"	"Detected in many"	9	"T-cells: 216.2"									"HPA029397, CAB030029"	Uncertain				"Secreted to blood"	46093				"CAB030029: AB_1089175, HPA029397: AB_10612120"	"unprognostic (2.00e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.33e-4)"	"unprognostic (2.95e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.16e-2)"	"unprognostic (4.29e-3)"	18.8	6.1	2.7	45.3	3.3	3.9	16.7	1.4	1.9	4.5	46.5	2.2	4.7	36.3	6.3	10.9	7.7	3.1	18.3	21.5	2.4	2.5	78.1	316.2	42.8	43.3	3.5	1.9	6.7	196.4	0.0	3.3	8.3	3.1	9.5	15.6	4.0	23.5	4.1	51.4	3.5	149.0	8.7	3.9	73.8	8.1	4.6	1.5	48.8	21.3	113.6	40.3	10.5	11.2	0.4	0.6	2.3	0.5	24.7	216.2	88.7	33.8	1.4	0.1	0.0	0.0	3.9	2.7	1.6	4.2	2.1	3.4	66.4	45.1	0.0	8.3	0.9	1.4	0.1	4.0	2.5	94.6	0.3	0.1	6.8	64.4	7.8	0.1	2.9	4.7	0.4	1.8	7.5	8.1	0.0	56.6	2.6	0.2	42.1	1.0	0.9	0.9	0.1	48.3	4.4	32.1	2.1	0.0	0.5	14.9	1.0	0.2	0.9	0.5	21.9	8.0	9.3	0.4	4.8	0.6	1.4	0.2	0.1	41.9	4.1	1.1	0.5	0.5	134.0	0.4	132.1	0.4	122.1	126.9	0.4	0.4	47.6	89.8	2.3	24.7	0.4	0.6	216.2	88.7	2.7	3.3	1.4	1.9	2.4	2.5	3.5	1.9	3.1	1.5
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682676	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	16	"blood: 73.8"	"Cell line enriched"	"Detected in some"	5	"MOLT-4: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	679	"basophil: 73.8"	"Lineage enriched"	"Detected in single"	679	"granulocytes: 73.8"					"Low region specificity"	"Detected in many"			HPA072995	Approved				"Secreted to blood"	7157				"HPA072995: "	"unprognostic (3.40e-2)"	"unprognostic (9.19e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.02e-1)"		"unprognostic (1.96e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.47e-10)"	"unprognostic (9.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.24e-2)"	0.4	1.2	0.3	1.1	0.3	0.9	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.0	1.1	0.3	0.7	0.8	0.8	0.3	0.3	0.1	0.5	0.3	4.6	1.1	0.3	0.3	0.3	0.3	3.7	1.4	0.3	0.3	0.4	0.0	0.3	0.4	0.3	0.3	1.6	1.0	0.3	0.3	0.7	0.2	1.0	0.3	1.3	0.8	0.3	0.3	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	73.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.3	0.3	0.3
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 35.8;HBEC3-KT: 34.4;U-698: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 34.4"	"Group enriched"	"Detected in all"	6	"B-cells: 34.4;granulocytes: 11.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"		49000	"Plasma membrane"	"Nucleoplasm, Centriolar satellite"	"CAB004451: AB_626889, HPA050124: , HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	20.7	14.8	8.7	31.6	10.6	36.9	12.0	4.4	7.7	20.8	30.3	5.9	11.5	10.9	18.0	12.8	24.7	13.6	25.1	12.3	6.7	4.4	13.3	39.1	40.9	44.8	10.8	1.7	14.7	11.3	3.8	5.5	16.1	10.1	18.8	15.1	12.3	7.7	11.5	7.2	9.9	18.6	39.6	13.6	31.8	21.1	10.4	9.8	9.1	8.6	13.7	38.4	31.6	15.4	34.4	1.6	11.9	2.6	3.3	4.0	1.8	11.3	3.0	1.9	3.9	0.9	4.5	4.1	7.2	8.3	2.9	2.3	6.1	31.4	35.8	9.0	11.3	12.1	2.1	34.4	2.5	31.0	1.0	6.7	1.8	9.3	13.0	1.8	19.1	6.9	13.9	13.2	7.9	15.4	2.9	3.0	4.6	5.0	0.1	5.4	2.4	2.6	0.1	14.9	2.9	13.3	13.0	0.6	0.3	1.0	6.9	1.5	2.6	6.9	23.0	6.5	2.9	5.8	5.0	1.8	0.5	33.3	0.7	6.0	0.0	0.5	2.6	4.7	1.7	1.1	1.3	7.7	2.6	1.7	1.6	34.4	4.0	1.9	11.9	3.3	0.6	1.6	1.8	1.8	8.7	10.6	4.4	7.7	6.7	4.4	10.8	1.7	10.1	9.8
IL5RA	"CD125, CDw125, IL5R"	ENSG00000091181	"Interleukin 5 receptor subunit alpha"	Q01344	3	3066326-3126613	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 70.1;fallopian tube: 18.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 41.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	196	"basophil: 31.4;eosinophil: 70.1"	"Lineage enriched"	"Detected in single"	308	"granulocytes: 70.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Intracellular and membrane"		92000				"unprognostic (1.38e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.79e-3)"	"unprognostic (8.42e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-4)"	"unprognostic (4.32e-3)"	"unprognostic (3.08e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.93e-2)"	0.5	0.2	6.7	0.6	6.2	0.7	1.3	0.2	0.3	1.8	0.9	1.8	0.0	2.2	0.6	8.2	0.6	18.6	2.0	2.4	2.3	2.1	0.6	1.3	7.9	1.2	0.1	0.0	3.8	0.5	0.1	7.5	0.1	11.8	2.6	1.4	0.5	2.2	0.1	0.3	0.4	2.1	0.6	0.6	4.6	1.3	1.6	0.7	1.1	0.4	1.1	1.9	4.2	0.4	0.1	0.0	70.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	31.4	0.0	70.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	6.7	6.2	0.2	0.3	2.3	2.1	0.1	0.0	11.8	0.7
IL6	"BSF2, HGF, HSF, IFNB2, IL-6"	ENSG00000136244	"Interleukin 6"	P05231	7	22725884-22732002	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.1;lymphoid tissue: 48.0"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 10.0;cerebral cortex: 4.4;hippocampal formation: 3.9;pons and medulla: 12.8"	"Group enriched"	"Detected in some"	70	"memory B-cell: 6.1;naive B-cell: 7.7"	"Lineage enriched"	"Detected in single"	77	"B-cells: 7.7"					"Not detected"	"Not detected"			"CAB023406, CAB072821"	Supported		Approved	Vesicles	"Secreted to blood"	6103		Vesicles		"CAB023406: AB_617317, CAB072821: "	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.07e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (1.10e-11)"	"unprognostic (2.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.31e-2)"	"unprognostic (7.80e-2)"	60.1	5.6	1.4	48.0	10.0	15.3	11.5	0.7	4.4	2.9	8.1	1.2	0.4	0.7	2.1	4.6	14.3	7.8	16.1	21.6	3.9	1.5	1.3	5.2	34.9	3.0	1.8	0.2	5.3	8.3	5.7	14.2	4.5	12.8	6.5	7.5	3.3	3.1	0.8	6.9	2.8	4.5	8.2	7.0	3.5	6.5	3.2	1.2	0.1	4.5	12.7	3.5	34.9	8.4	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.8	221.9	4.2	14.2	0.0	0.0	0.0	7.3	1.4	0.1	0.0	0.0	5.6	8.7	0.0	0.0	0.3	0.0	4.7	0.0	0.0	0.5	0.0	42.4	6.1	1.5	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	1.3	1.4	0.1	2.6	0.4	0.0	2.5	0.0	10.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	10.0	0.7	4.4	3.9	1.5	1.8	0.2	12.8	1.2
IL6R	CD126	ENSG00000160712	"Interleukin 6 receptor"	P08887	1	154405193-154469450	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.6"	"Cell line enhanced"	"Detected in many"		"THP-1: 54.6;U-266/84: 64.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		22000000				"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (7.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	8.4	4.0	4.7	14.8	5.1	9.0	6.5	1.4	6.3	6.1	16.9	4.8	1.2	9.6	6.3	4.7	5.2	7.9	6.9	5.0	5.2	2.9	8.9	38.1	20.8	15.4	7.2	2.2	5.7	5.3	0.0	7.7	3.7	7.8	4.5	6.0	3.6	5.4	1.7	59.6	4.7	12.6	5.3	5.0	11.3	6.6	3.7	5.0	4.2	2.5	6.1	13.3	6.3	4.8	0.6	14.3	35.0	11.7	0.5	8.0	5.5	0.8	1.4	0.1	0.1	0.9	1.3	0.1	0.8	0.6	0.5	0.2	0.1	0.9	0.0	1.9	1.0	0.4	0.2	4.4	0.4	14.7	0.4	0.2	0.6	3.3	0.1	2.3	1.3	0.7	2.7	0.4	6.6	0.6	0.1	6.1	0.1	0.3	0.0	3.8	0.4	3.3	0.0	0.0	12.7	2.7	1.1	0.1	0.0	0.2	9.0	14.8	0.8	54.6	0.6	0.9	0.9	0.8	0.5	10.4	64.3	0.1	1.1	14.8	1.4	2.8	11.7	10.4	0.2	7.1	0.6	0.6	6.4	0.7	14.3	0.2	6.4	2.2	35.0	0.5	3.0	5.1	8.0	5.5	4.7	5.1	1.4	6.3	5.2	2.9	7.2	2.2	7.8	5.0
IL6ST	"CD130, GP130"	ENSG00000134352	"Interleukin 6 signal transducer"	P40189	5	55935095-55994993	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 57.0;BJ hTERT+: 58.0;HHSteC: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 21.0"	"Lineage enriched"	"Detected in many"	5	"T-cells: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010558, CAB025784"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Secreted to blood"		100000000	"Plasma membrane"	"Golgi apparatus"	"CAB025784: , HPA010558: AB_1078439"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.95e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	44.8	34.2	24.7	25.5	23.4	8.8	76.9	15.9	22.9	38.1	23.9	15.0	29.0	8.7	26.1	24.9	22.7	23.1	31.1	31.9	21.9	19.7	37.2	71.2	36.3	70.0	25.8	14.7	42.1	16.4	35.8	36.2	97.0	22.5	31.9	17.1	20.0	26.3	33.0	27.1	12.5	20.6	36.6	33.8	35.5	19.7	13.7	20.3	19.4	37.6	12.5	18.7	33.7	51.1	0.7	2.1	0.9	3.8	0.8	21.0	4.0	9.4	11.8	3.8	9.1	27.3	57.0	15.8	28.2	58.0	15.2	22.7	16.5	9.0	0.3	21.1	17.4	4.1	3.0	8.4	31.2	0.8	3.0	2.2	9.7	13.6	64.9	0.2	4.5	49.9	4.6	33.0	16.1	34.7	1.6	39.8	17.5	1.6	0.4	0.4	0.6	3.9	0.5	10.7	5.4	8.3	5.6	2.0	3.4	11.4	3.8	11.6	19.0	1.5	55.7	5.9	6.7	23.8	14.8	9.8	4.2	0.3	15.8	0.4	15.3	0.2	3.8	0.1	0.8	3.5	0.4	0.7	4.9	0.8	2.1	0.6	21.0	5.9	0.9	0.8	0.6	1.8	3.4	4.0	24.7	23.4	15.9	22.9	21.9	19.7	25.8	14.7	22.5	20.3
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.5;lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.9;HEL: 13.7;HMC-1: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA019590	Approved				"Secreted to blood"	65993				"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	6.8	1.9	1.3	13.4	1.8	1.8	2.2	1.7	1.7	2.6	9.5	0.4	1.3	7.0	1.9	5.0	5.0	5.2	8.2	1.5	1.0	0.9	5.6	8.9	6.5	26.3	0.8	0.1	2.4	2.6	0.0	1.3	1.0	1.0	5.0	4.8	1.1	7.9	2.0	0.9	9.6	20.5	2.4	1.2	8.6	4.4	3.0	0.9	2.0	4.1	4.4	10.4	3.9	3.3	10.9	2.4	5.4	0.8	0.5	7.5	0.6	0.2	0.0	0.1	0.0	0.3	0.3	0.0	1.1	1.1	1.0	1.5	0.0	5.8	0.1	0.0	3.3	3.3	0.1	0.0	0.0	12.9	0.0	13.7	0.3	1.7	0.0	0.1	20.3	1.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	4.2	2.3	0.0	1.9	2.0	0.2	0.1	0.1	0.0	0.2	0.7	0.8	0.0	1.5	0.2	0.0	0.0	2.7	0.0	1.5	5.4	0.3	0.0	0.4	0.2	0.0	10.9	1.1	1.1	2.4	8.2	0.3	0.3	0.0	0.5	0.8	0.3	7.5	0.6	1.3	1.8	1.7	1.7	1.0	0.9	0.8	0.1	1.0	0.9
ILF2	NF45	ENSG00000143621	"Interleukin enhancer binding factor 2"	Q12905	1	153661788-153671048	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007484	Supported		Supported	Nucleoplasm			3800000	Nucleoplasm		"HPA007484: AB_1079137"	"unprognostic (1.97e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.15e-2)"	"unprognostic (8.75e-3)"	"unprognostic (9.70e-2)"	"prognostic unfavourable (5.71e-8)"	"unprognostic (2.64e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.94e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (5.57e-4)"	"unprognostic (2.61e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.09e-1)"	35.9	39.2	26.3	32.8	27.1	58.1	43.7	25.6	32.8	34.8	33.8	32.7	23.5	24.2	37.8	39.6	46.0	33.9	27.8	32.0	24.7	28.4	64.1	45.4	35.3	38.1	33.2	29.2	46.5	52.8	38.4	36.8	53.3	30.8	29.9	40.4	25.0	50.4	28.3	49.1	38.5	27.7	34.3	26.7	39.8	33.9	58.0	28.5	117.0	58.5	45.5	54.0	32.1	30.9	49.5	55.4	34.5	39.9	52.4	52.5	76.4	48.4	37.8	66.9	46.9	28.1	26.5	53.5	36.2	41.2	65.4	47.2	55.7	39.6	67.2	55.9	36.0	37.2	79.6	38.5	63.4	36.4	51.7	50.4	30.8	47.6	25.8	78.0	37.4	24.2	22.1	49.9	54.3	60.9	63.1	31.9	54.3	64.6	104.2	34.9	95.5	57.7	75.9	57.9	63.4	31.4	47.0	60.2	55.9	42.2	52.6	42.7	57.5	67.6	37.0	33.8	43.3	30.3	59.6	55.5	77.3	135.6	28.3	48.4	50.9	34.5	39.9	28.7	39.8	38.3	50.1	49.5	46.4	42.9	55.4	40.7	52.5	45.6	3.7	52.4	30.3	53.6	51.0	76.4	26.3	27.1	25.6	32.8	24.7	28.4	33.2	29.2	30.8	28.5
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Supported	Nucleoplasm,Nucleoli,Mitochondria			1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavourable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.4	37.0	60.0	54.9	13.0	17.9	34.9	29.1	24.7	48.9	38.3	42.4	26.4	56.8	29.0	26.1	40.8	64.8	39.3	44.1	36.3	57.7	73.7	32.7	39.5	18.7	53.0	36.8	16.9	17.6	38.8	43.5	41.7	62.9	44.7	28.4	37.4	87.9	85.3	72.0	40.7	64.8	57.2	39.3	19.4	48.3	66.3	48.2	37.5	29.8	21.6	25.2	34.1	33.4	40.1	38.2	41.5	57.4	38.4	52.4	69.0	22.4	56.7	43.2	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0
ILK		ENSG00000166333	"Integrin linked kinase"	Q13418	11	6603708-6610874	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004041, HPA048437"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Focal adhesion sites"			130000000	"Cell Junctions, Focal adhesion sites"	Nucleoplasm	"CAB004041: AB_2127050, HPA048437: "	"unprognostic (1.78e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.12e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.19e-3)"	"unprognostic (5.25e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (2.44e-4)"	"unprognostic (4.01e-3)"	"unprognostic (9.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.36e-3)"	20.9	17.6	11.0	22.3	11.9	7.5	37.0	9.4	14.6	40.2	75.1	14.7	41.9	13.5	75.4	25.2	35.7	33.2	41.1	35.1	11.1	9.2	21.6	15.1	21.9	18.9	11.5	14.0	24.2	22.3	20.4	10.9	22.2	11.5	39.9	24.6	19.3	19.4	89.9	18.5	12.4	22.2	103.5	10.6	20.2	33.2	14.2	11.0	8.2	17.5	14.1	13.6	60.8	25.9	19.5	45.9	76.5	49.4	45.3	25.8	63.7	23.8	18.4	29.1	10.0	44.9	31.9	13.2	35.1	69.4	41.6	50.8	19.2	28.1	9.0	9.3	57.4	19.2	16.2	29.7	41.8	15.7	14.8	12.9	17.6	14.9	30.1	10.3	14.8	30.6	14.0	28.1	21.5	39.6	11.8	10.7	54.2	17.9	9.1	17.7	18.3	21.6	9.6	15.2	9.5	30.5	19.1	5.0	11.4	16.6	23.0	19.3	16.0	11.8	45.8	52.2	23.6	21.6	17.0	7.8	4.8	12.6	38.7	15.6	24.3	48.3	49.4	76.5	25.8	47.9	25.1	19.5	23.3	24.4	45.9	17.1	14.7	18.5	31.7	45.3	44.4	18.5	25.7	63.7	11.0	11.9	9.4	14.6	11.1	9.2	11.5	14.0	11.5	11.0
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060955: , HPA061177: "	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.1	22.8	11.1	19.2	19.8	11.3	16.5	17.0	13.6	13.9	16.1	17.5	17.8	24.1	18.6	8.8	33.5	36.4	27.6	12.4	18.1	43.7	25.3	18.8	30.3	14.6	25.6	17.6	10.4	22.8	11.2	13.9	9.1	32.6	19.7	12.6	24.2	20.2	62.6	29.8	24.1	22.1	13.6	26.4	18.9	27.4	18.9	19.6	14.4	25.1	30.9	21.9	23.8	10.3	18.2	14.6	13.0	22.9	26.9	49.5	27.0	20.1	41.6	11.9	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3
IMPDH2		ENSG00000178035	"Inosine monophosphate dehydrogenase 2"	P12268	3	49024325-49029408	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"GMP biosynthesis, Purine biosynthesis"	"DNA-binding, Oxidoreductase, RNA-binding"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001400, CAB020717"	Approved		Enhanced	"Cytosol,Rods & Rings"			19000	Cytosol	"Rods & Rings"	"CAB020717: , HPA001400: AB_1079139"	"unprognostic (2.09e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.22e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.47e-2)"	25.0	21.5	16.1	25.7	15.4	23.9	47.0	9.7	21.1	34.7	24.9	15.1	19.1	18.9	29.5	19.8	40.1	51.9	33.3	29.3	13.0	11.2	21.4	29.4	19.9	52.5	18.1	13.0	89.0	88.8	19.1	16.6	23.2	15.6	33.2	31.7	10.8	22.1	22.2	61.4	40.7	17.8	34.1	15.2	23.7	22.2	15.3	15.4	31.2	29.8	51.3	33.4	30.3	32.1	31.6	18.8	6.2	16.8	21.6	34.8	16.0	39.6	22.9	31.8	32.8	47.6	86.9	30.9	27.5	44.6	66.4	56.6	39.8	35.8	72.4	19.7	33.1	27.7	65.6	55.9	58.2	19.0	21.9	53.6	33.8	36.4	40.8	56.8	22.1	77.2	61.6	63.4	115.3	46.6	32.0	41.0	53.4	32.2	48.0	39.5	41.2	46.3	21.0	33.5	71.0	37.8	25.7	20.6	20.3	29.9	33.8	49.7	41.9	25.3	23.4	29.1	54.0	70.7	70.5	39.8	28.7	34.7	33.6	63.4	28.4	6.2	10.1	4.0	17.0	16.8	31.7	31.6	23.3	19.6	18.8	31.1	34.8	28.6	4.4	21.6	13.9	14.5	15.5	16.0	16.1	15.4	9.7	21.1	13.0	11.2	18.1	13.0	15.6	15.4
INHBA		ENSG00000122641	"Inhibin beta A subunit"	P08476	7	41667168-41705834	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"placenta: 148.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.5;hTEC/SVTERT24-B: 59.6;hTERT-HME1: 24.7;TIME: 30.7;U-138 MG: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.8;non-classical monocyte: 1.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"		290000				"unprognostic (4.11e-3)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (4.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.18e-2)"	"prognostic unfavourable (4.34e-4)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.72e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (7.91e-8)"	"unprognostic (6.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.18e-3)"	1.7	1.0	1.2	3.6	3.7	6.6	1.3	0.7	3.5	1.7	1.5	0.8	1.3	0.3	13.6	4.2	3.8	1.6	17.3	9.3	1.9	1.6	2.0	7.9	26.4	0.6	1.2	0.7	5.2	1.2	0.0	0.8	148.2	4.8	2.4	0.2	1.4	4.3	3.8	1.2	2.9	0.8	3.8	8.7	0.4	1.5	3.9	1.3	0.4	1.5	2.6	0.7	4.8	1.8	0.2	0.7	1.8	1.3	0.0	0.0	0.3	1.0	0.0	0.1	0.0	0.8	1.9	0.0	4.7	0.5	2.6	0.8	0.0	0.1	0.0	0.3	1.7	3.9	0.0	19.5	2.5	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	1.8	1.1	59.6	24.7	2.1	0.1	0.0	5.9	0.0	0.0	0.1	0.4	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.8	0.1	0.0	0.0	0.0	30.7	46.4	13.4	4.9	4.8	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	1.8	0.0	1.3	0.0	0.0	0.3	1.2	3.7	0.7	1.3	1.9	1.6	1.2	0.7	4.8	1.3
INHBC		ENSG00000175189	"Inhibin beta C subunit"	P55103	12	57434760-57450828	"Plasma proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	256	"liver: 121.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 9.6;Karpas-707: 9.8;RH-30: 4.9;U-266/70: 5.0"	"Cancer enriched"	"Detected in single"	85	"liver cancer: 22.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"		11000000				"unprognostic (5.26e-2)"	"unprognostic (4.58e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.68e-4)"	"unprognostic (2.90e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-3)"	"unprognostic (5.05e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.1	0.0	0.2	0.2	0.1	0.1	1.5	0.1	0.5	0.0	9.6	0.0	0.4	0.1	0.3	0.0	0.0	0.6	0.0	0.1	9.8	0.0	0.2	0.1	0.0	0.0	0.1	0.3	4.9	0.7	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	5.0	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
INHBE	"activin, MGC4638"	ENSG00000139269	"Inhibin beta E subunit"	P58166	12	57452323-57459280	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Hormone"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	40	"liver: 127.6"	"Cell line enhanced"	"Detected in some"		"HHSteC: 14.8;Karpas-707: 22.3;U-266/70: 75.2"	"Cancer enriched"	"Detected in some"	27	"liver cancer: 34.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"HPA016843, CAB034017"	Enhanced		Supported	Vesicles	"Secreted to blood"		1400000	Vesicles		"CAB034017: AB_2233745, HPA016843: AB_1851796"	"unprognostic (7.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.69e-5)"	"unprognostic (2.61e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (5.66e-8)"	"unprognostic (4.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.52e-3)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	127.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	1.0	0.9	3.1	0.6	0.6	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.8	2.1	0.0	2.6	0.1	0.0	1.0	0.5	0.2	0.1	0.5	0.0	0.3	4.9	0.0	0.0	0.0	3.2	14.8	0.6	0.6	1.4	1.5	0.3	3.3	0.0	1.3	22.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	2.3	0.0	0.0	5.5	0.2	0.0	0.0	2.1	0.1	2.4	0.0	0.0	1.2	0.0	0.1	75.2	2.3	1.0	0.4	0.1	0.1	1.9	0.5	0.5	0.3	0.4	0.4	0.9	0.1	0.2	0.1	1.0	0.2	0.5	3.1	0.6	0.6	0.9	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0
INPP5D	"hp51CN, SHIP, SHIP1"	ENSG00000168918	"Inositol polyphosphate-5-phosphatase D"	Q92835	2	233059967-233207903	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in many"		"HEL: 31.2;HMC-1: 32.8;hTCEpi: 30.0;NB-4: 29.3;THP-1: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB016300, HPA070455"	Enhanced		Approved	Cytosol				Cytosol		"CAB016300: AB_628250, HPA070455: "	"unprognostic (5.29e-2)"	"unprognostic (2.05e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.10e-1)"	"prognostic favourable (2.03e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.82e-2)"	"unprognostic (6.58e-2)"	"unprognostic (6.54e-2)"	7.1	3.1	7.2	33.0	10.7	24.6	4.7	1.7	6.9	3.6	3.7	12.5	0.7	3.5	4.1	2.9	3.3	3.3	6.7	3.2	6.6	9.1	5.1	3.3	8.0	26.1	8.8	2.6	1.9	2.1	1.6	3.4	7.4	7.6	4.5	4.5	3.3	18.8	3.0	1.9	3.4	15.8	3.4	17.6	40.9	4.1	2.4	9.5	16.7	3.1	3.4	32.3	6.2	3.5	14.5	12.0	10.5	18.2	11.9	16.7	14.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.4	5.9	0.0	0.0	0.0	0.0	15.1	0.0	5.0	0.0	31.2	0.0	2.9	0.2	9.4	32.8	0.6	30.0	0.1	3.3	4.3	0.1	2.7	0.1	0.0	4.3	29.3	1.0	0.0	9.1	0.0	2.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	20.9	3.6	0.0	0.5	0.0	0.0	0.0	1.6	9.0	0.0	12.1	0.0	9.8	9.8	10.5	16.7	15.8	11.4	14.5	7.5	12.3	12.0	13.9	6.3	8.8	9.9	11.9	18.2	6.0	10.2	14.0	7.2	10.7	1.7	6.9	6.6	9.1	8.8	2.6	7.6	9.5
INS	"IDDM1, IDDM2"	ENSG00000254647	Insulin	P01308	11	2159779-2161341	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism"	Hormone	"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	193	"pancreas: 514.0"	"Group enriched"	"Detected in some"	9	"EFO-21: 52.5;U-2 OS: 68.8;U-698: 21.7"	"Cancer enriched"	"Detected in single"	7166	"pancreatic cancer: 1751.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Region enriched"	"Detected in single"	13	"midbrain: 1.7"	"CAB000048, HPA004932, CAB012098, CAB053843"	Enhanced				"Secreted to blood"	437220				"CAB000048: , CAB012098: AB_300968, CAB053843: AB_620123, HPA004932: AB_1851816"											"unprognostic (7.61e-2)"							0.4	0.1	0.1	0.1	0.1	1.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	1.4	0.1	0.1	0.1	0.1	0.1	0.1	514.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	2.6	0.1	0.1	0.1	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.8	0.0	5.2	0.0	2.4	21.7	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 81.4;liver: 143.2"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 152.5;RPMI-8226: 71.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 45.7;non-classical monocyte: 81.4"	"Lineage enriched"	"Detected in all"	6	"monocytes: 81.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Approved	Vesicles				Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (9.62e-4)"	"unprognostic (4.97e-2)"	18.4	9.2	8.5	8.3	8.8	9.7	14.1	10.1	14.3	6.0	7.4	21.8	7.5	12.5	5.2	8.3	15.6	4.6	8.0	5.6	10.8	11.6	6.4	143.2	18.5	6.9	8.6	8.3	16.4	27.2	4.6	5.2	17.5	23.9	15.9	6.7	11.9	31.4	3.1	2.4	10.5	14.2	5.1	19.2	4.5	13.4	8.2	8.3	10.7	3.3	6.1	6.9	11.2	5.6	10.0	13.6	10.7	81.4	4.0	12.7	12.5	18.9	3.5	9.4	5.9	25.0	33.4	5.2	1.5	21.6	4.5	30.1	2.1	27.5	12.4	4.4	11.7	10.3	6.4	11.2	5.4	3.8	18.9	3.3	6.5	0.0	12.3	5.7	56.0	20.8	6.2	34.9	3.2	6.0	6.2	152.5	5.8	9.8	28.0	15.1	9.8	2.2	5.2	0.0	71.5	35.7	9.4	7.0	5.6	5.0	3.6	7.9	3.5	19.3	6.8	5.0	1.5	9.5	3.9	37.2	6.5	11.0	22.2	22.5	4.6	3.1	4.9	2.1	8.7	45.7	4.4	7.7	6.0	7.4	13.6	10.0	5.9	6.7	10.7	4.0	81.4	7.7	12.7	12.5	8.5	8.8	10.1	14.3	10.8	11.6	8.6	8.3	23.9	8.3
INSR	CD220	ENSG00000171105	"Insulin receptor"	P06213	19	7112255-7294034	"CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Carbohydrate metabolism"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 64.5"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.6;U-266/70: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036302, HPA036303"	Uncertain		Approved	"Vesicles,Plasma membrane"			72000	Vesicles	"Plasma membrane"	"HPA036302: , HPA036303: "	"unprognostic (4.64e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.65e-3)"	"unprognostic (9.70e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.45e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.82e-2)"	13.9	14.7	7.1	3.5	8.2	4.5	12.0	12.0	8.2	10.3	15.2	11.7	10.6	8.4	15.5	6.1	4.7	13.1	7.7	17.7	6.4	5.8	18.7	32.5	5.3	2.2	10.1	4.9	28.3	64.5	11.6	11.6	26.2	8.0	10.5	8.9	11.0	12.0	10.6	15.1	7.3	16.0	10.6	6.8	47.3	8.7	6.9	9.7	2.2	17.1	5.0	3.2	11.3	16.0	1.1	8.8	5.1	10.5	0.8	0.7	1.3	3.7	2.1	1.9	2.9	10.6	3.7	6.4	2.1	1.9	1.2	1.2	5.3	4.3	4.7	5.3	3.8	1.0	4.6	0.9	0.7	0.0	3.7	0.0	1.5	11.5	4.6	2.2	3.8	5.7	2.4	0.1	2.8	2.1	5.7	30.6	0.9	1.7	1.6	3.8	1.8	3.3	16.3	1.1	4.1	0.1	15.5	3.7	2.8	3.8	2.0	2.1	0.9	10.8	2.0	2.2	1.4	4.7	2.8	22.6	12.3	10.9	2.6	3.8	0.0	2.0	8.2	5.1	0.2	7.8	0.3	0.8	0.3	0.1	8.8	1.1	0.7	0.1	1.7	0.8	10.5	7.4	0.0	1.3	7.1	8.2	12.0	8.2	6.4	5.8	10.1	4.9	8.0	9.7
INTS11	"CPSF3L, CPSF73L, FLJ20542, INT11, RC-68"	ENSG00000127054	"Integrator complex subunit 11"	Q5TA45	1	1311585-1324691	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028379, HPA029025"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA028379: AB_10599598, HPA029025: AB_10600425"	"unprognostic (7.54e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.34e-2)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.97e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.76e-3)"	"unprognostic (5.14e-2)"	"unprognostic (5.62e-3)"	21.4	22.5	22.8	25.4	24.9	23.2	26.9	50.8	30.4	26.5	31.2	32.1	24.1	29.1	33.1	39.8	25.3	39.1	24.8	29.8	23.7	19.8	23.5	26.7	19.7	25.7	25.9	25.8	34.1	33.5	24.1	26.9	25.8	21.0	29.5	19.9	20.4	33.8	28.0	52.8	28.6	25.4	34.0	20.0	27.3	27.9	57.8	25.9	28.5	23.3	23.5	22.5	27.5	25.7	24.6	37.7	22.0	42.2	28.4	35.2	32.4	21.1	21.9	12.4	23.7	21.3	17.3	13.4	11.7	19.7	27.2	20.2	19.7	26.9	23.7	17.0	23.8	15.6	18.4	26.2	12.1	22.2	24.0	18.2	29.8	26.5	32.8	14.4	20.1	29.2	14.3	24.7	37.2	28.4	21.6	21.6	13.4	19.1	28.4	19.6	15.0	23.6	22.4	11.7	34.1	19.1	10.8	17.5	16.2	11.8	31.9	33.2	17.2	21.1	20.4	16.9	15.4	19.2	14.9	33.9	36.3	30.8	23.7	25.6	8.3	22.0	32.3	20.8	31.7	37.2	33.8	24.6	28.1	29.3	37.7	20.3	26.5	24.9	15.3	28.4	42.2	24.5	35.2	32.4	22.8	24.9	50.8	30.4	23.7	19.8	25.9	25.8	21.0	25.9
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favourable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	25.5	15.3	13.6	14.2	17.1	8.8	22.2	18.4	18.3	19.5	13.7	14.2	17.4	10.4	19.9	13.9	18.6	16.1	16.4	20.0	15.2	13.4	18.5	16.9	12.8	14.2	14.9	13.7	18.6	14.4	23.9	20.9	24.4	17.1	15.9	13.7	13.2	14.8	16.6	19.0	14.0	12.3	17.0	14.4	26.3	13.7	30.9	13.3	18.8	21.7	15.7	15.0	19.8	24.4	4.2	3.6	12.2	5.6	18.0	5.3	3.2	11.7	11.1	10.3	15.9	8.4	11.4	14.0	12.7	9.7	13.3	15.0	12.4	9.3	20.2	10.2	12.9	9.7	21.3	14.8	21.1	7.6	11.2	9.4	11.4	11.1	6.1	10.6	5.4	8.1	8.6	16.0	17.2	50.4	17.7	6.6	13.3	11.1	11.2	13.8	13.2	6.8	13.7	15.2	18.3	8.3	11.6	11.0	6.4	11.1	8.8	9.0	11.3	7.4	22.7	8.0	8.9	8.9	11.6	5.2	8.5	14.0	10.0	14.8	9.6	12.2	2.1	1.8	3.5	3.4	4.2	3.1	3.7	3.6	3.6	4.2	5.3	3.8	2.1	18.0	5.6	2.3	2.3	3.2	13.6	17.1	18.4	18.3	15.2	13.4	14.9	13.7	17.1	13.3
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024297	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol			92000	"Nucleoplasm, Cytosol"		"CAB009110: AB_2264985, HPA040983: , HPA056548: "	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	26.3	13.8	16.5	14.5	18.3	13.0	23.5	16.3	20.2	20.2	19.7	15.9	13.5	9.6	21.1	13.4	19.4	18.9	12.4	23.9	15.7	12.7	18.9	23.2	14.1	16.0	20.8	15.9	33.5	60.7	12.5	13.0	14.3	15.3	19.1	16.6	11.0	13.9	20.2	65.0	13.5	11.3	25.5	24.3	14.9	18.9	79.5	19.4	23.3	23.0	24.1	21.1	21.8	23.9	8.0	11.0	1.1	7.3	10.3	12.3	6.1	28.2	19.1	35.8	32.8	24.4	62.1	22.0	41.6	32.8	58.7	41.8	39.1	21.8	81.8	14.6	50.0	24.6	74.4	28.5	81.2	20.6	23.4	44.5	36.2	30.6	17.4	48.0	15.9	34.8	18.8	47.6	40.1	33.4	30.7	11.0	50.1	7.7	36.2	13.0	36.0	22.9	46.6	40.7	24.2	14.1	18.6	26.6	21.7	21.4	25.0	15.6	18.9	26.5	23.4	39.7	20.0	19.8	37.8	14.8	18.2	25.5	41.0	30.5	27.1	0.5	4.4	1.1	7.1	7.3	12.3	8.0	8.3	8.8	11.0	7.6	11.6	9.6	0.6	10.3	5.1	5.4	8.5	6.1	16.5	18.3	16.3	20.2	15.7	12.7	20.8	15.9	15.3	19.4
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol			26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: "	"unprognostic (1.92e-1)"	"prognostic unfavourable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.3	29.2	34.4	27.3	34.9	45.1	27.6	45.5	29.3	33.7	36.5	25.3	34.4	35.1	16.6	35.0	29.4	48.8	35.3	56.3	16.7	40.3	29.0	33.2	25.3	21.8	44.3	22.1	28.8	38.3	22.1	52.2	39.7	43.4	21.1	43.8	15.2	26.7	21.7	33.9	34.0	28.1	54.2	15.8	27.8	35.3	13.7	26.9	20.3	40.3	32.8	18.5	22.3	31.1	41.5	28.6	42.7	48.6	6.1	23.4	24.2	27.2	23.9	22.5	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8
IPP	KLHL27	ENSG00000197429	"Intracisternal A particle-promoted polypeptide"	Q9Y573	1	45694324-45750650	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075545	Approved									"HPA075545: "	"unprognostic (8.45e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (9.11e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (5.84e-3)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (2.99e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.03e-2)"	"prognostic favourable (1.11e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.11e-1)"	6.6	8.7	7.2	5.1	10.1	3.5	7.9	5.8	11.3	6.8	7.1	13.8	7.6	6.1	15.0	7.2	8.2	8.7	7.6	8.6	7.7	7.4	9.4	8.7	5.3	7.8	7.8	8.3	10.2	8.5	16.5	12.7	5.5	10.7	10.1	7.4	10.5	10.7	8.8	17.7	7.2	8.4	11.4	9.2	4.5	7.2	14.8	6.7	16.0	12.7	5.8	9.3	8.9	6.6	4.7	1.0	5.1	1.2	5.0	7.5	3.5	8.1	7.8	7.1	10.3	9.0	16.6	5.7	8.8	6.2	6.1	6.3	4.8	6.0	4.5	9.3	10.7	6.1	7.7	6.5	8.8	10.3	4.9	6.3	7.0	5.9	9.1	1.7	5.7	14.0	7.4	13.2	7.2	5.9	7.7	9.1	10.7	5.4	6.1	0.5	4.4	4.5	2.6	13.0	3.7	5.0	8.9	10.4	6.7	16.7	9.0	8.2	8.8	1.6	7.0	6.7	8.4	4.6	6.7	7.6	8.6	8.2	10.8	2.7	10.4	4.5	0.9	5.1	7.5	0.6	5.6	4.7	4.6	6.0	1.0	4.4	5.8	6.7	4.2	5.0	1.2	1.0	6.8	3.5	7.2	10.1	5.8	11.3	7.7	7.4	7.8	8.3	10.7	6.7
IQGAP1	"HUMORFA01, KIAA0051, p195, SAR1"	ENSG00000140575	"IQ motif containing GTPase activating protein 1"	P46940	15	90388218-90502243	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013302, HPA014055"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			890000	"Plasma membrane, Cell Junctions"		"CAB013302: AB_2533146, HPA014055: AB_1851856"	"unprognostic (2.83e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.67e-5)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.25e-3)"	46.2	23.2	9.9	27.8	17.1	23.7	31.7	5.9	11.2	41.8	26.7	18.1	19.7	12.3	50.8	28.8	41.3	27.4	22.0	17.6	12.0	9.1	25.9	9.8	38.3	45.3	17.5	6.6	31.3	16.4	27.6	19.1	53.7	15.5	28.9	27.1	12.0	37.8	22.0	23.1	32.7	25.8	37.6	17.4	48.0	20.3	11.4	15.4	39.5	32.7	29.6	34.9	43.0	40.8	5.9	9.9	39.3	12.4	11.5	9.9	6.3	31.6	17.5	8.8	10.3	22.8	29.7	51.4	30.3	28.2	27.9	30.1	20.1	33.1	17.7	14.8	50.6	57.2	17.6	33.9	33.9	22.5	12.5	11.8	33.9	7.4	27.6	21.6	25.4	17.5	31.4	32.9	47.0	38.3	10.2	25.0	42.6	16.4	11.7	6.5	11.5	10.0	14.3	23.7	15.5	28.8	50.4	11.1	8.4	42.2	21.6	22.5	18.9	18.7	48.5	31.9	16.6	26.7	31.2	9.7	13.8	17.9	29.0	21.3	17.1	10.5	11.6	8.1	9.9	10.9	8.9	5.6	6.2	8.5	9.9	5.9	3.8	6.6	39.3	11.5	12.4	6.0	6.7	6.3	9.9	17.1	5.9	11.2	12.0	9.1	17.5	6.6	15.5	15.4
IQGAP2		ENSG00000145703	"IQ motif containing GTPase activating protein 2"	Q13576	5	76403249-76708132	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.5;Hep G2: 17.8;HMC-1: 63.8;RPMI-8226: 23.3;U-937: 16.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 34.4"	"Low region specificity"	"Detected in all"			"CAB004241, HPA037403, HPA037404"	Uncertain		Approved	"Vesicles,Plasma membrane"			8400000	"Vesicles, Plasma membrane"		"CAB004241: AB_2125909, HPA037403: , HPA037404: "	"unprognostic (9.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.03e-3)"	"unprognostic (8.85e-2)"	"prognostic favourable (5.65e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"prognostic favourable (9.44e-12)"	"unprognostic (3.29e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.27e-2)"	11.1	11.3	1.4	14.7	1.7	6.3	8.0	1.1	1.2	6.1	21.6	0.6	36.2	16.8	2.6	14.7	3.3	2.7	21.7	4.2	1.6	1.6	13.2	66.1	7.8	13.0	1.3	0.7	4.2	14.8	25.5	2.3	42.5	2.1	9.1	6.8	15.2	18.9	34.3	1.4	3.7	35.7	3.4	2.0	16.5	12.4	30.7	0.4	7.7	12.8	2.8	7.7	4.3	4.2	0.6	7.8	14.9	3.2	4.1	5.9	1.3	0.0	2.8	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.2	0.8	0.0	0.0	3.6	0.0	0.0	2.4	3.5	7.9	2.1	17.8	0.0	4.4	63.8	0.0	0.0	0.0	0.0	0.3	6.9	6.4	0.0	0.0	3.8	12.1	4.4	0.1	1.4	0.0	23.3	0.0	0.0	0.1	0.9	5.0	0.2	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	5.9	0.0	5.5	0.0	16.7	0.9	14.9	3.2	1.8	4.8	2.4	4.0	0.6	5.0	4.1	2.9	0.2	2.0	3.6	6.3	4.1	3.1	7.8	5.9	1.3	1.4	1.7	1.1	1.2	1.6	1.6	1.3	0.7	2.1	0.4
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.3	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.4	13.0	21.7	2.1	6.5	10.2	22.4	7.2	9.0	15.4	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.2	9.9	6.3	3.4	12.5	12.3	2.2	5.5	7.7	11.4	7.5	12.0	2.4	4.3	8.0	6.7	10.5	15.9	18.7	6.4	14.9	10.3	6.5	15.6	18.6	12.7	20.5	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3
IRAK3	IRAK-M	ENSG00000090376	"Interleukin 1 receptor associated kinase 3"	Q9Y616	12	66188879-66254622	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 14.7;ASC TERT1: 12.2;HEL: 12.6;HL-60: 16.7;NB-4: 13.3;THP-1: 20.2;U-937: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 5.6;classical monocyte: 13.1;intermediate monocyte: 13.2;myeloid DC: 6.2;neutrophil: 7.2;non-classical monocyte: 20.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 6.2;granulocytes: 7.2;monocytes: 20.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043097	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA043097: AB_10795612"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (8.52e-2)"	"prognostic unfavourable (6.23e-4)"	"unprognostic (5.58e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.23e-2)"	21.8	3.7	2.1	10.6	3.6	58.0	13.4	1.0	2.4	8.7	6.5	2.3	5.5	1.7	6.2	8.6	4.9	7.0	7.6	16.0	2.9	2.1	3.6	2.9	22.1	25.6	4.6	0.3	5.9	2.7	1.3	17.9	6.1	3.7	7.0	3.0	5.5	6.0	5.5	5.5	3.3	4.9	6.4	5.9	25.3	6.2	5.1	2.8	1.0	4.9	4.5	5.4	9.5	11.4	0.4	6.2	7.2	20.6	0.9	0.3	3.6	0.0	0.0	0.2	0.0	14.7	12.2	0.0	1.6	0.0	0.9	1.3	0.0	1.2	0.0	0.8	3.0	0.0	1.8	0.0	0.7	0.0	0.0	12.6	0.7	0.0	7.7	16.7	2.3	7.7	0.0	0.7	0.0	4.3	0.0	0.0	0.5	0.0	0.0	13.3	0.7	0.0	0.0	3.6	0.0	0.1	1.8	0.1	0.0	6.5	0.0	0.7	0.0	20.2	4.6	0.0	0.0	0.0	0.0	0.5	0.1	1.2	0.0	14.7	0.0	5.6	13.1	2.2	0.0	13.2	0.0	0.0	0.0	0.0	6.2	0.4	0.0	0.0	7.2	0.9	20.6	0.0	0.3	3.6	2.1	3.6	1.0	2.4	2.9	2.1	4.6	0.3	3.7	2.8
IRAK4	NY-REN-64	ENSG00000198001	"Interleukin 1 receptor associated kinase 4"	Q9NWZ3	12	43758944-43789543	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016685, CAB022077"	Uncertain		Approved	Nucleoli,Microtubules,Cytosol				Microtubules	"Nucleoli, Cytosol"	"CAB016685: AB_1618505, CAB022077: "	"unprognostic (2.76e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.47e-2)"	"prognostic favourable (3.46e-5)"	"unprognostic (6.15e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.44e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.44e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.00e-3)"	"unprognostic (6.29e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (4.42e-5)"	18.0	9.4	5.1	15.0	10.4	10.3	11.3	3.7	6.0	10.3	12.2	9.1	12.5	10.2	13.0	14.1	15.0	9.4	10.8	7.6	6.7	5.2	13.3	11.8	12.0	24.0	13.2	3.9	9.3	20.1	9.1	16.1	14.0	9.8	10.5	10.0	11.9	11.9	15.1	4.1	15.2	15.0	11.8	13.0	25.0	12.3	7.1	11.7	30.3	17.0	7.7	18.9	11.1	10.7	5.1	5.8	16.9	6.0	8.8	7.7	4.7	5.3	3.9	2.8	3.7	10.1	17.0	4.0	7.5	5.3	6.0	5.5	3.3	5.1	9.1	7.4	6.2	4.4	3.1	4.8	8.6	13.0	2.9	8.7	3.0	2.1	5.8	12.0	10.7	9.0	7.8	7.6	4.4	8.8	8.0	6.8	16.4	2.9	10.4	6.8	1.0	4.6	6.9	3.4	4.8	4.6	5.1	2.0	1.9	3.6	4.7	3.6	5.9	10.7	7.8	7.4	1.4	9.0	5.1	8.4	10.8	7.9	7.6	32.4	4.0	16.9	4.6	9.4	7.4	5.4	7.7	4.0	6.1	6.3	4.5	5.1	5.5	5.9	9.3	8.8	6.0	5.8	7.5	4.7	5.1	10.4	3.7	6.0	6.7	5.2	13.2	3.9	9.8	11.7
IREB2	IRP2	ENSG00000136381	"Iron responsive element binding protein 2"	P48200	15	78437431-78501456	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032885, HPA040371, HPA068982"	Uncertain		Approved	"Cell Junctions,Cytosol"				"Cell Junctions"	Cytosol	"CAB032885: AB_2126703, HPA040371: , HPA068982: "	"unprognostic (1.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.09e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.40e-2)"	18.9	42.4	12.0	16.2	22.0	22.6	18.3	22.3	24.9	19.0	16.2	14.8	14.3	16.6	20.4	17.9	19.7	17.6	14.4	13.6	10.7	11.8	18.2	21.1	22.4	31.1	10.3	16.7	23.1	17.0	20.3	23.6	23.2	21.7	16.5	19.7	19.2	17.1	15.8	27.3	18.6	25.3	15.5	13.7	25.5	15.7	18.0	12.3	39.6	27.8	14.0	20.3	17.8	18.4	7.1	9.5	7.1	7.8	7.2	8.8	3.4	7.4	13.2	20.6	12.9	18.2	12.0	13.9	12.7	9.9	11.6	10.6	13.0	13.0	27.6	8.7	10.6	14.5	47.9	12.9	10.3	8.7	16.6	23.9	13.9	9.1	9.5	25.7	25.8	12.6	8.8	8.9	10.9	13.6	25.0	9.9	9.9	11.2	15.7	13.1	26.9	4.8	18.5	20.6	7.8	12.7	20.6	12.4	18.6	17.3	12.2	13.3	11.4	22.6	11.0	12.0	8.2	6.5	11.0	12.3	27.0	15.8	8.6	23.9	8.5	7.1	5.8	4.4	6.0	7.8	7.7	6.5	6.6	5.9	8.0	7.1	6.5	8.8	6.8	7.2	6.0	9.5	5.3	3.4	12.0	22.0	22.3	24.9	10.7	11.8	10.3	16.7	21.7	12.3
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028699	"Plasma proteins, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	24.2	21.6	12.7	13.7	13.0	7.9	24.4	20.3	17.9	21.0	21.0	9.8	18.2	11.0	19.3	13.3	16.3	26.3	23.4	21.3	12.9	12.3	19.7	16.3	15.6	12.7	13.8	7.4	36.9	18.2	35.8	17.2	13.7	15.7	20.2	6.0	19.7	26.2	20.2	15.9	17.0	11.1	18.4	13.5	18.4	13.9	15.3	13.4	27.4	27.6	7.1	9.8	21.8	24.6	2.1	12.2	9.9	2.4	6.5	3.4	0.7	6.7	5.9	14.8	16.5	4.5	4.1	21.1	7.1	5.9	2.0	2.7	2.7	11.2	2.4	5.2	6.1	10.6	2.5	5.3	1.7	11.3	8.7	3.0	5.8	3.7	5.9	0.8	13.6	5.5	4.2	3.6	3.1	2.7	4.5	27.1	2.5	18.5	9.1	6.3	6.6	31.0	1.9	4.2	5.6	7.0	10.0	11.5	16.6	10.1	10.6	17.6	7.3	1.5	4.6	9.4	9.2	3.1	4.5	10.5	11.2	4.0	14.5	2.1	11.6	1.5	1.6	1.4	3.4	2.2	3.2	1.7	3.0	3.1	1.4	2.1	2.5	2.6	9.9	6.5	2.4	12.2	2.9	0.7	12.7	13.0	20.3	14.1	12.9	12.3	13.8	7.4	15.7	13.4
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85898803-85922609	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 197.4;lymphoid tissue: 64.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 34.7;THP-1: 58.7;U-698: 137.6;U-937: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 197.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 197.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	12.4	4.0	6.8	36.1	8.8	19.2	6.7	2.6	5.3	2.3	7.8	8.3	6.8	12.3	2.3	3.0	3.7	2.9	5.6	2.9	5.8	3.3	5.6	9.9	11.7	60.4	9.3	3.1	2.1	3.1	0.2	2.2	2.7	6.7	3.3	10.0	2.2	6.1	8.9	1.5	2.6	36.4	3.6	10.9	64.4	6.5	2.2	8.8	18.4	3.6	2.3	63.3	8.3	2.1	31.8	197.4	0.7	10.8	8.9	0.3	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	3.7	0.0	34.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.1	0.1	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.7	0.0	0.0	1.6	0.0	0.1	0.0	0.0	137.6	0.0	19.4	0.0	0.5	10.7	0.2	0.2	10.8	0.3	29.3	0.1	0.1	23.7	31.8	0.3	0.2	0.7	8.9	7.2	197.4	0.0	9.8	6.8	8.8	2.6	5.3	5.8	3.3	9.3	3.1	6.7	8.8
IRS1	HIRS-1	ENSG00000169047	"Insulin receptor substrate 1"	P35568	2	226731317-226799759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005261, HPA046433"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005261: AB_649615, HPA046433: "	"unprognostic (2.20e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.86e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.46e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.23e-2)"	"unprognostic (7.55e-3)"	7.0	9.9	3.1	5.0	2.7	0.6	11.7	9.6	5.4	13.3	14.2	1.4	3.9	4.0	17.2	5.0	3.8	13.9	11.5	6.3	3.9	2.2	5.2	12.0	5.0	2.5	2.3	2.6	21.9	7.1	3.4	2.5	9.1	4.2	9.8	2.9	5.5	3.3	7.5	23.3	5.1	6.5	11.7	2.6	3.3	5.8	2.4	1.7	17.1	23.4	5.6	2.5	14.6	15.8	1.2	0.4	0.0	0.2	0.0	0.3	0.2	3.2	14.7	10.8	0.4	14.9	8.9	0.0	8.8	7.0	11.9	7.7	8.4	8.2	1.3	1.5	6.0	5.6	0.7	8.5	6.8	3.2	0.6	0.0	0.9	3.9	7.4	0.3	0.0	12.3	4.7	9.3	8.5	0.0	1.6	13.1	8.0	12.6	2.7	3.7	4.3	8.2	0.6	14.0	0.1	5.4	10.7	1.9	0.3	2.8	2.0	4.7	7.9	0.1	0.7	15.7	14.4	12.1	8.5	6.1	2.5	1.9	15.5	0.3	4.6	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.1	0.1	0.1	1.2	0.2	0.1	0.0	0.0	0.0	0.4	0.3	0.2	3.1	2.7	9.6	5.4	3.9	2.2	2.3	2.6	4.2	1.7
IRS2		ENSG00000185950	"Insulin receptor substrate 2"	Q9Y4H2	13	109752698-109786568	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Transducer	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.1"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 18.0;SH-SY5Y: 18.9;THP-1: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016944, HPA054664"	Approved		Supported	Aggresome,Cytosol				Cytosol	Aggresome	"CAB016944: , HPA054664: "	"unprognostic (2.87e-3)"	"unprognostic (5.73e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.49e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.28e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.09e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.24e-1)"	38.9	24.3	27.6	10.9	25.2	70.1	33.5	19.6	30.6	13.5	10.9	13.0	6.7	8.7	14.4	12.2	7.1	7.7	8.4	13.5	23.6	14.6	7.7	24.6	11.6	5.3	24.2	22.1	27.1	7.9	6.1	23.0	13.6	19.5	20.0	7.5	9.3	11.5	12.2	20.9	15.3	9.7	9.7	25.1	9.0	8.3	6.3	21.3	2.0	10.7	4.7	5.3	8.4	17.8	0.5	0.1	6.9	1.4	0.2	0.5	0.2	2.6	3.0	1.9	0.0	16.5	3.3	1.0	2.9	3.4	1.7	1.5	0.2	3.2	0.0	1.8	2.0	1.2	1.0	2.6	2.2	1.0	13.6	1.2	4.3	0.0	16.7	4.7	1.5	6.9	13.9	0.5	18.0	0.6	0.8	0.0	17.0	1.3	0.0	13.9	2.1	0.6	5.9	1.8	1.2	4.9	0.7	2.9	18.9	1.5	0.0	11.6	0.3	28.3	0.0	3.7	0.0	0.2	3.8	0.0	1.3	0.9	2.7	4.6	6.3	2.7	1.4	1.9	0.2	0.3	0.3	0.1	0.4	0.1	0.1	0.5	0.5	0.4	6.9	0.2	0.4	0.1	0.5	0.2	27.6	25.2	19.6	30.6	23.6	14.6	24.2	22.1	19.5	21.3
IRX1	IRX-5	ENSG00000170549	"Iroquois homeobox 1"	P78414	5	3596054-3601403	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.1;breast: 36.0;salivary gland: 20.9"	"Group enriched"	"Detected in some"	4	"AF22: 7.0;REH: 28.3;U-251 MG: 11.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 5.6;glioma: 6.6;testis cancer: 15.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA043160	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA043160: AB_10794771"	"unprognostic (1.52e-2)"				"unprognostic (1.26e-2)"	"unprognostic (2.27e-1)"		"unprognostic (3.73e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.78e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.58e-2)"		5.3	0.4	2.6	0.4	2.1	1.4	36.0	6.6	1.5	0.4	0.4	2.0	6.0	0.4	0.4	1.7	0.8	0.4	0.4	1.0	3.1	3.2	13.9	0.4	8.0	0.6	4.2	1.0	0.4	0.7	0.4	0.7	0.4	16.1	0.5	0.4	2.8	20.9	1.5	0.4	6.8	0.4	0.4	5.1	0.4	0.4	0.5	1.6	3.0	0.5	0.5	0.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	1.3	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	28.3	0.0	0.0	2.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	6.6	0.2	3.1	3.2	4.2	1.0	16.1	1.6
IRX4		ENSG00000113430	"Iroquois homeobox 4"	P78413	5	1877413-1887236	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 11.2;heart muscle: 11.0;skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 30.3;HaCaT: 11.3;HBEC3-KT: 6.2;MCF7: 5.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	19	"pons and medulla: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	12	"pons and medulla: 1.9"	HPA064094			Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA064094: "	"unprognostic (1.00e-2)"	"unprognostic (1.00e-1)"			"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"		"unprognostic (1.35e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.52e-2)"		"unprognostic (7.54e-2)"	"unprognostic (4.26e-1)"		"unprognostic (1.70e-2)"	0.2	0.2	0.1	0.1	0.1	0.3	5.1	0.1	0.2	2.4	0.1	0.1	0.1	0.1	0.1	0.1	11.2	0.1	0.1	11.0	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.3	0.1	2.7	7.8	0.1	0.1	6.7	0.1	1.2	14.2	0.1	1.0	0.1	0.1	0.1	1.7	0.1	0.1	0.1	2.5	2.1	0.1	7.3	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.3	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	5.4	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.7	0.1
IST1	KIAA0174	ENSG00000182149	"IST1, ESCRT-III associated factor"	P53990	16	71845996-71931199	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041802, HPA054532"	Approved		Supported	Vesicles			45000	Vesicles		"HPA041802: AB_10794491, HPA054532: "	"unprognostic (2.15e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.11e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"prognostic favourable (4.55e-4)"	"unprognostic (1.64e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.43e-3)"	"prognostic favourable (8.88e-4)"	43.9	41.2	40.4	36.4	48.5	54.9	43.2	42.4	50.8	41.5	51.7	63.2	36.6	39.9	48.1	35.4	44.9	49.6	37.1	40.0	39.9	38.6	54.9	36.4	43.9	45.4	53.4	36.8	49.6	49.8	91.6	55.5	52.1	41.7	40.2	50.0	45.1	39.2	38.4	64.6	45.7	46.5	48.4	56.4	55.8	40.5	45.9	48.9	50.6	47.3	32.8	60.6	44.6	42.6	52.4	52.1	87.3	56.5	52.7	67.6	71.8	16.8	24.9	35.1	22.6	35.4	25.0	29.7	21.1	26.8	29.7	31.2	27.0	23.6	24.1	26.4	24.5	25.5	34.3	22.6	37.9	15.9	16.6	20.2	15.0	43.4	26.8	19.7	28.8	29.5	31.5	26.5	25.7	37.0	27.6	8.9	30.5	28.2	25.5	16.5	40.2	15.5	40.4	19.2	29.4	24.7	24.7	26.5	19.8	23.5	12.4	19.2	22.7	24.6	18.4	22.5	22.3	13.7	16.8	23.4	41.4	66.2	19.1	17.7	27.0	55.5	56.5	67.7	49.0	53.0	53.0	52.4	47.0	51.2	52.1	51.8	50.7	47.4	87.3	52.7	49.6	36.2	67.6	71.8	40.4	48.5	42.4	50.8	39.9	38.6	53.4	36.8	41.7	48.9
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787896-52959210	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 21.0;HHSteC: 25.8;WM-115: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain						2300000			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavourable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	22.6	20.2	2.3	12.7	2.7	0.0	12.4	1.2	2.9	10.9	28.2	1.5	13.6	5.3	15.9	12.5	22.3	9.2	13.9	11.1	2.5	2.2	17.9	40.4	28.8	10.2	3.1	1.4	9.6	3.3	11.5	3.0	24.8	3.3	26.1	8.2	5.9	2.9	18.2	9.7	2.4	13.5	52.8	2.7	66.0	16.8	4.1	1.6	0.6	10.7	3.5	2.2	42.7	17.8	0.0	0.1	1.2	0.3	0.0	1.8	0.1	0.0	0.0	2.0	0.0	5.8	1.7	1.2	2.7	7.2	1.6	4.8	3.7	0.3	0.0	0.9	21.0	1.4	0.4	2.3	1.5	0.0	1.5	0.0	3.4	2.7	25.8	0.0	0.0	3.9	0.2	1.9	0.7	0.3	0.0	0.0	2.4	0.0	0.8	0.0	1.1	0.7	0.0	1.9	0.0	3.1	0.0	0.1	9.1	2.7	0.6	0.6	0.0	0.0	2.1	4.4	0.4	0.1	1.4	0.0	0.0	0.0	2.8	0.0	19.1	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.1	2.3	2.7	1.2	2.9	2.5	2.2	3.1	1.4	3.3	1.6
ITGA10		ENSG00000143127	"Integrin subunit alpha 10"	O75578	1	145891208-145910189	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 19.4;HSkMC: 17.6;hTERT-HME1: 15.4;LHCN-M2: 26.7;TIME: 45.2"	"Cancer enhanced"	"Detected in many"		"melanoma: 6.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"prognostic favourable (7.18e-4)"	"unprognostic (4.53e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.32e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.37e-1)"	"unprognostic (5.72e-3)"	"unprognostic (6.48e-2)"	"unprognostic (5.79e-2)"	"unprognostic (2.58e-6)"	"unprognostic (2.77e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-5)"	"unprognostic (2.57e-2)"	3.7	2.9	2.7	1.8	6.0	0.7	9.7	5.1	7.1	12.6	4.4	3.3	0.0	3.2	6.7	5.0	2.5	3.0	3.4	7.2	2.2	1.5	2.5	1.3	13.1	2.1	9.7	4.1	4.9	1.4	2.8	4.8	4.3	10.2	3.7	1.8	12.2	4.2	2.4	16.0	3.3	4.0	4.5	15.5	1.7	3.4	3.4	3.7	0.0	4.4	4.2	2.1	6.8	2.5	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.5	0.1	0.1	0.4	19.4	0.0	0.2	5.2	0.0	0.2	0.0	0.2	0.1	0.3	0.1	0.1	0.1	0.4	0.1	0.2	0.0	0.1	0.0	0.2	3.5	0.0	0.2	17.6	1.0	0.7	15.4	8.6	0.0	0.0	26.7	0.1	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	45.2	8.3	0.1	0.1	0.1	0.1	0.2	0.0	0.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	1.1	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	6.0	5.1	7.1	2.2	1.5	9.7	4.1	10.2	3.7
ITGA2	CD49b	ENSG00000164171	"Integrin subunit alpha 2"	P17301	5	52989326-53094779	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.1;HaCaT: 30.4;HUVEC TERT2: 28.0;TIME: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB017690, HPA060991, HPA063556"	Enhanced		Approved	Nucleoplasm,Cytosol			46000000	Nucleoplasm	Cytosol	"CAB017690: AB_1124939, HPA060991: AB_2684405, HPA063556: AB_2685040"	"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-5)"	"unprognostic (4.27e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-1)"	1.9	14.0	2.9	4.7	13.4	0.4	7.9	1.8	6.8	7.1	6.5	22.5	12.1	7.6	5.1	10.4	16.7	2.8	9.3	2.5	5.4	3.6	15.1	1.8	17.2	1.4	18.3	4.5	1.8	2.7	16.1	2.5	4.8	10.7	8.5	6.0	0.8	15.8	16.8	1.2	16.9	17.0	2.5	8.4	9.1	7.4	1.3	13.0	1.5	2.5	7.4	10.0	7.5	11.1	0.5	1.5	1.7	0.6	0.2	0.6	0.3	19.5	5.0	0.4	0.2	1.3	2.4	1.5	19.8	30.1	0.7	1.2	9.4	13.8	0.0	3.4	8.4	30.4	1.6	22.2	2.9	0.0	1.5	1.4	1.3	5.6	4.6	0.2	0.4	1.0	3.9	19.9	3.5	28.0	0.0	0.0	0.5	3.6	0.2	0.0	1.2	10.1	0.0	0.1	0.0	6.3	10.4	0.2	1.1	1.0	1.3	2.0	3.2	0.0	23.9	3.6	2.1	0.5	3.9	0.0	0.0	0.0	21.8	0.0	15.9	1.7	0.6	0.2	0.6	0.2	0.4	0.4	0.5	0.5	0.1	0.5	0.5	0.6	0.8	0.2	0.1	1.5	0.4	0.3	2.9	13.4	1.8	6.8	5.4	3.6	18.3	4.5	10.7	13.0
ITGA2B	"CD41, CD41B, GP2B, PPP1R93"	ENSG00000005961	"Integrin subunit alpha 2b"	P08514	17	44372180-44389505	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8"	"Group enriched"	"Detected in some"	13	"HEL: 69.4;HMC-1: 118.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"basophil: 28.5"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 28.5"	"Low region specificity"	"Detected in single"							"CAB018611, HPA031168, HPA031169, HPA031170, HPA031171"	Enhanced		Approved	"Plasma membrane"			1100000000	"Plasma membrane"		"CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773"	"unprognostic (6.11e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.98e-3)"	"unprognostic (4.23e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.83e-9)"	"unprognostic (7.82e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.25e-1)"	0.7	0.2	1.4	0.4	1.0	15.2	0.6	3.8	2.4	1.2	0.9	0.4	0.4	0.1	1.1	25.2	0.7	1.9	1.4	10.6	0.9	1.6	1.0	0.4	6.5	0.5	0.7	0.8	2.1	2.5	0.1	2.5	1.9	1.1	0.6	0.3	0.6	0.4	1.6	0.8	0.1	0.6	0.4	0.8	22.8	0.2	3.0	0.4	0.4	5.2	1.0	0.6	0.7	1.9	0.0	0.5	28.5	0.2	0.0	0.2	11.1	0.0	0.1	0.7	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	69.4	0.0	0.6	0.0	0.0	118.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	7.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	28.5	0.2	2.1	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	11.1	1.4	1.0	3.8	2.4	0.9	1.6	0.7	0.8	1.1	0.4
ITGA4	CD49d	ENSG00000115232	"Integrin subunit alpha 4"	P13612	2	181457202-181536187	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 38.4;lymphoid tissue: 101.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.7;HEL: 61.5;MOLT-4: 71.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	7	"cerebellum: 26.0"	HPA074961			Approved	"Plasma membrane"	"Intracellular and membrane"		100000	"Plasma membrane"		"HPA074961: "	"unprognostic (5.31e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.76e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (2.26e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.57e-2)"	3.8	1.7	1.3	39.7	1.1	19.2	3.2	2.4	1.9	6.7	4.8	0.5	1.1	3.8	3.0	3.1	2.9	2.1	6.9	1.7	2.9	1.3	3.0	2.5	13.6	33.7	1.2	0.5	1.8	1.6	0.0	1.3	7.1	0.9	3.8	4.9	2.9	7.5	2.0	1.0	1.5	11.6	2.4	1.6	36.0	4.4	1.2	0.2	101.6	2.6	1.5	14.3	6.0	4.1	11.0	19.1	38.4	38.3	8.8	15.9	16.2	0.0	0.2	1.0	0.0	9.1	13.8	0.0	8.9	11.2	4.8	10.1	0.0	0.0	7.1	0.0	38.7	5.3	3.1	0.1	5.8	0.0	0.7	61.5	0.2	0.0	0.9	27.2	1.5	9.8	0.0	0.3	0.0	0.4	0.0	10.4	3.0	0.0	71.7	19.1	0.8	0.0	15.7	4.5	1.0	0.0	0.0	1.6	0.6	0.0	0.0	0.3	0.0	18.0	4.8	1.5	0.9	0.1	1.8	20.4	15.1	4.0	0.8	13.5	20.6	6.7	16.2	38.4	12.9	38.3	9.7	11.0	14.6	15.9	19.1	10.0	8.5	10.4	2.1	8.8	37.5	5.0	3.7	16.2	1.3	1.1	2.4	1.9	2.9	1.3	1.2	0.5	0.9	0.2
ITGA5	"CD49e, FNRA"	ENSG00000161638	"Integrin subunit alpha 5"	P08648	12	54395261-54419460	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 137.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 140.8;TIME: 134.1;U-87 MG: 66.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 31.5"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"basal ganglia: 9.3"	"Low region specificity"	"Detected in some"			"HPA002642, CAB009008"	Enhanced						23000000			"CAB009008: AB_647474, HPA002642: AB_1078469"	"unprognostic (7.51e-3)"	"prognostic unfavourable (4.07e-6)"	"prognostic unfavourable (8.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (8.51e-3)"	"prognostic unfavourable (2.91e-4)"	"prognostic unfavourable (2.23e-5)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (2.76e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.99e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavourable (1.32e-8)"	"unprognostic (2.11e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (8.89e-4)"	"unprognostic (2.18e-3)"	23.3	7.9	2.1	32.2	2.8	9.2	30.5	1.2	2.2	16.0	66.9	2.2	19.0	3.4	19.3	13.8	18.2	12.0	12.4	20.3	2.9	0.8	4.6	15.2	20.4	9.2	3.2	1.2	13.6	5.3	3.7	1.8	57.7	3.3	26.6	10.2	4.9	4.4	28.9	10.0	8.8	14.9	137.7	3.5	3.1	19.7	6.6	2.5	3.0	7.3	5.8	4.5	82.1	20.6	0.1	22.2	31.5	22.9	9.1	5.6	12.4	6.6	2.4	4.6	0.0	14.3	30.5	12.0	30.0	31.2	30.9	22.8	1.6	1.5	0.0	21.9	31.3	1.0	1.2	8.3	21.4	0.0	1.2	2.9	3.3	0.1	19.8	9.0	4.6	22.0	4.1	36.2	27.9	140.8	2.4	0.0	17.5	0.6	1.3	10.1	1.8	1.9	1.4	3.1	0.6	4.9	0.1	0.0	0.0	6.0	0.4	0.2	0.7	8.1	134.1	37.6	6.7	9.2	12.4	0.0	0.3	0.0	66.9	8.6	12.2	5.6	22.9	0.1	5.6	10.0	4.4	0.0	4.2	4.2	22.2	0.1	3.1	2.6	31.5	9.1	7.6	1.2	1.7	12.4	2.1	2.8	1.2	2.2	2.9	0.8	3.2	1.2	3.3	2.5
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506282	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 50.1;HaCaT: 55.2;HBEC3-KT: 108.5;hTCEpi: 47.3;hTERT-HME1: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced						45000000			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	28.0	3.1	9.8	19.1	10.5	1.6	30.1	3.0	8.4	27.0	34.9	9.4	42.3	28.5	28.2	11.3	17.0	11.1	23.8	21.7	9.7	8.2	22.0	4.9	29.0	14.9	9.8	5.1	7.6	31.3	7.4	4.9	38.7	12.6	14.3	25.2	17.6	37.1	32.4	13.5	17.5	44.2	15.2	9.6	14.9	25.0	12.4	6.9	15.1	11.5	35.2	13.2	24.1	17.3	0.3	0.1	16.2	0.2	5.5	10.0	3.3	11.4	9.8	4.3	7.7	0.2	0.1	23.6	50.1	5.4	5.1	3.2	5.5	22.0	0.1	14.1	13.3	55.2	2.8	108.5	9.3	0.1	2.6	0.2	10.5	9.1	0.7	3.1	0.3	1.0	47.3	0.3	48.1	32.8	0.0	0.8	6.4	0.5	0.8	2.7	7.8	8.4	0.1	12.8	0.2	7.8	16.1	0.1	0.5	9.2	0.0	10.7	2.0	0.2	14.7	7.2	6.5	13.2	8.6	0.7	0.5	0.3	0.2	1.1	28.9	2.6	0.2	16.2	4.2	0.0	8.5	0.2	5.4	5.0	0.1	0.3	10.0	4.6	0.5	5.5	0.0	0.0	5.7	3.3	9.8	10.5	3.0	8.4	9.7	8.2	9.8	5.1	12.6	6.9
ITGA8		ENSG00000077943	"Integrin subunit alpha 8"	P53708	10	15513949-15720125	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein, Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEK 293: 7.7;HMC-1: 18.5;HSkMC: 8.2;U-266/84: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA003432	Approved						110000			"HPA003432: AB_1851825"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.25e-2)"	"unprognostic (8.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.82e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.03e-2)"	7.1	7.8	2.3	2.4	1.9	0.1	3.1	1.4	3.7	36.1	5.5	1.5	4.1	4.8	17.9	22.8	12.4	7.1	10.7	10.3	3.0	1.6	7.4	0.8	22.1	3.7	1.7	2.6	17.0	0.8	0.7	3.3	0.2	2.9	28.3	4.6	18.8	3.0	22.9	3.3	3.1	4.9	21.2	1.5	17.0	19.4	12.1	1.2	0.0	5.3	5.5	4.3	21.3	10.8	0.2	0.2	0.6	0.4	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	7.7	2.3	0.0	0.0	0.0	0.0	18.5	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	8.4	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.2	0.4	0.2	0.2	0.3	0.3	0.0	0.2	0.5	0.5	0.5	0.2	0.4	0.2	0.8	0.0	2.3	1.9	1.4	3.7	3.0	1.6	1.7	2.6	2.9	1.2
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"			540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: , HPA069003: "	"unprognostic (3.07e-2)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	47.4	69.7	37.6	41.7	90.9	78.3	32.8	159.7	92.6	76.1	69.6	15.6	111.2	12.8	28.9	133.9	33.2	11.3	90.9	84.9	12.6	9.2	15.4	33.2	18.2	64.0	3.4	15.3	79.3	49.7	80.0	32.6	93.4	10.6	5.7	125.4	7.8	5.9	3.5	8.4	35.4	3.9	27.9	2.3	108.5	13.8	8.9	22.3	49.8	8.5	35.8	11.4	12.4	104.5	98.0	56.9	69.6	53.2	5.2	1.1	7.2	72.2	14.6	38.4	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6"	"Group enriched"	"Detected in some"	5	"THP-1: 114.8;U-937: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"			2500000	"Plasma membrane"	"Rods & Rings"	"HPA008877: AB_1846256, HPA016894: AB_1846257"	"unprognostic (1.94e-2)"	"unprognostic (7.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.73e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.42e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.83e-2)"	59.1	9.8	9.0	47.5	16.8	91.4	8.4	1.7	8.0	5.6	7.4	12.2	1.2	6.3	4.9	9.0	4.8	10.7	10.3	9.7	7.2	6.4	8.1	7.0	32.9	73.8	14.3	2.9	6.6	5.1	1.1	3.3	12.7	12.1	6.9	4.2	5.2	8.8	2.7	3.0	4.1	13.2	12.3	18.3	75.6	7.6	4.2	12.2	53.5	4.5	2.2	29.0	15.7	4.2	9.5	76.0	104.6	122.9	41.0	57.4	159.7	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	2.4	19.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	2.3	0.0	0.4	0.0	15.0	3.9	0.2	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.5	17.0	18.0	0.0	0.3	0.2	3.5	9.3	0.7	0.0	0.0	0.2	0.5	0.3	0.3	0.0	114.8	0.3	0.0	1.0	0.0	0.5	0.1	0.8	0.4	0.0	85.3	0.1	10.5	122.9	85.7	57.4	84.1	25.8	6.7	28.4	39.5	76.0	9.5	19.1	32.0	104.6	41.0	81.0	11.6	20.7	159.7	9.0	16.8	1.7	8.0	7.2	6.4	14.3	2.9	12.1	12.2
ITGB3	"CD61, GP3A, GPIIIa"	ENSG00000259207	"Integrin subunit beta 3"	P05106	17	47253846-47311816	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 36.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 45.5;HEL: 40.3;RPTEC TERT1: 26.2;U-87 MG: 20.6;WM-115: 65.7"	"Group enriched"	"Detected in many"	6	"melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	19	"basophil: 2.8;neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 2.8"									HPA027852	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"		710000000	"Plasma membrane"	Nucleoplasm	"HPA027852: AB_10601760"	"unprognostic (1.13e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.04e-3)"	"unprognostic (3.70e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.35e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-3)"	10.0	0.6	1.0	6.2	2.5	2.7	7.0	0.4	1.6	4.6	13.6	0.9	2.4	2.2	9.7	5.7	6.4	6.4	2.8	8.5	0.7	0.6	16.0	3.7	5.2	1.2	2.3	0.1	4.6	0.6	0.7	1.6	23.5	1.6	6.4	4.8	1.8	2.5	11.5	4.9	2.4	5.0	17.0	1.8	9.5	3.6	2.6	0.6	0.2	36.6	1.9	0.9	11.0	7.8	0.1	0.0	2.8	0.1	0.0	0.0	9.5	0.0	0.4	0.1	0.0	2.3	1.0	0.0	1.2	6.0	2.6	2.4	0.0	0.0	0.1	45.5	0.3	0.0	0.0	0.0	3.4	0.8	0.0	40.3	0.1	0.0	1.9	0.0	0.0	0.9	0.0	15.2	0.3	11.3	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0	1.0	0.0	26.2	0.0	0.0	0.1	1.5	0.0	8.2	0.0	0.0	12.3	0.5	0.6	0.3	2.8	0.0	0.0	0.2	20.6	0.0	65.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	9.5	1.0	2.5	0.4	1.6	0.7	0.6	2.3	0.1	1.6	0.6
ITGB4	CD104	ENSG00000132470	"Integrin subunit beta 4"	P16144	17	75721328-75757818	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 117.5;HaCaT: 45.0;HBEC3-KT: 100.3;hTCEpi: 34.3;RT4: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB002422, CAB005258, HPA036348, HPA036349"	Enhanced		Supported	"Plasma membrane,Cell Junctions"			79000	"Plasma membrane, Cell Junctions"		"CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078"	"unprognostic (3.17e-3)"	"unprognostic (3.52e-1)"	"unprognostic (4.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (7.18e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.14e-2)"	"prognostic unfavourable (6.39e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	6.3	3.4	9.7	10.9	9.7	1.4	13.7	4.7	7.7	14.3	32.1	15.6	10.0	35.3	9.7	8.8	24.0	13.7	47.8	4.3	9.4	7.9	4.8	1.5	7.4	3.7	10.1	9.1	4.7	6.7	3.1	5.7	50.0	17.2	19.7	10.4	9.8	52.3	13.2	2.4	47.0	58.5	7.4	10.7	17.0	41.0	3.9	9.8	1.8	3.2	22.1	15.9	17.2	20.5	2.4	8.2	1.3	0.7	0.0	2.2	0.8	21.8	19.3	0.0	0.2	0.0	0.1	26.6	0.1	0.0	0.0	0.1	2.0	117.5	0.0	4.2	0.0	45.0	0.1	100.3	0.0	0.1	0.0	0.1	4.9	2.1	0.1	0.0	0.2	0.1	34.3	0.0	21.4	0.7	0.0	2.0	0.0	12.2	0.2	0.2	0.1	16.8	0.3	0.5	0.2	26.8	33.0	0.0	0.2	0.6	2.0	0.3	8.4	0.2	2.2	0.6	1.0	0.0	0.2	0.7	0.2	0.0	0.2	0.1	0.3	0.0	0.4	0.0	0.7	0.7	2.2	1.4	0.3	1.0	0.1	2.4	0.9	0.6	1.3	0.0	0.0	8.2	1.4	0.8	9.7	9.7	4.7	7.7	9.4	7.9	10.1	9.1	17.2	9.8
ITGB5		ENSG00000082781	"Integrin subunit beta 5"	P18084	3	124761948-124901418	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 74.0;WM-115: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001820, CAB022050"	Approved		Approved	"Plasma membrane,Mitochondria"			95000	"Plasma membrane, Mitochondria"		"CAB022050: , HPA001820: AB_1079142"	"unprognostic (2.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.49e-3)"	"unprognostic (3.16e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.38e-3)"	72.5	13.8	9.7	9.7	10.0	0.8	50.1	5.7	8.2	34.2	18.8	14.8	28.0	12.9	31.7	17.2	25.6	13.9	29.1	32.9	9.4	5.1	19.6	22.1	20.4	3.5	12.0	6.2	17.4	12.1	8.9	8.4	36.4	13.0	23.0	10.1	27.1	18.6	23.1	15.9	33.3	16.1	25.1	9.0	18.7	12.4	17.0	8.7	2.8	18.8	16.2	10.9	24.4	27.1	0.1	1.1	0.4	0.6	0.9	2.1	5.8	29.6	74.0	5.3	13.4	50.2	14.6	27.5	31.8	19.7	5.9	9.6	14.7	38.8	0.1	15.5	54.0	23.8	4.8	16.5	5.2	0.3	3.2	10.5	11.4	15.5	8.8	0.0	19.3	8.7	3.8	14.9	7.8	19.8	9.3	15.9	20.3	30.2	0.1	0.1	23.8	8.2	0.0	8.5	11.2	16.8	6.5	0.1	11.1	23.6	35.1	26.8	19.8	0.6	51.0	22.4	33.8	19.4	16.4	2.7	2.8	0.2	23.4	0.1	77.2	0.4	0.6	0.2	2.1	0.2	0.0	0.0	0.2	0.0	1.1	0.1	0.3	0.4	0.4	0.9	0.4	0.1	0.0	5.8	9.7	10.0	5.7	8.2	9.4	5.1	12.0	6.2	13.0	8.7
ITGB6		ENSG00000115221	"Integrin subunit beta 6"	P18564	2	160099666-160200313	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Amelogenesis imperfecta, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 62.1"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 36.6;RPTEC TERT1: 73.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA023626, CAB073536"	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"				"Nucleoplasm, Cell Junctions"	Centrosome	"CAB073536: , HPA023626: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.22e-3)"	"unprognostic (3.61e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (5.03e-6)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.00e-1)"	0.3	0.3	0.3	3.1	0.3	0.0	8.7	0.3	0.3	4.1	8.3	0.1	4.5	3.5	2.1	2.5	18.7	1.2	12.0	0.7	0.3	0.3	62.1	0.3	28.8	0.1	0.3	0.1	1.5	3.8	7.0	2.2	18.7	0.2	7.5	3.0	0.1	3.8	4.8	31.5	1.9	11.7	2.0	0.3	0.3	7.9	0.6	0.1	0.1	4.9	6.8	5.9	12.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	36.6	0.0	0.2	0.0	7.5	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	73.2	12.1	0.0	0.0	0.0	11.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1
ITGB7		ENSG00000139626	"Integrin subunit beta 7"	P26010	12	53191318-53207307	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 31.3;lymphoid tissue: 37.6"	"Group enriched"	"Detected in some"	99	"Karpas-707: 288.3;RPMI-8226: 225.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA042277			Uncertain	"Plasma membrane,Cytosol"			42000	"Plasma membrane, Cytosol"		"HPA042277: AB_10793877"	"unprognostic (5.34e-2)"	"unprognostic (4.47e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (6.57e-4)"	"unprognostic (3.51e-5)"	"unprognostic (3.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.47e-4)"	1.8	1.4	1.4	29.1	1.8	7.5	1.5	0.6	1.2	1.8	8.7	2.9	0.8	6.7	2.3	2.8	6.6	2.0	5.6	1.4	1.5	1.0	5.4	5.1	4.9	26.4	1.9	1.0	1.1	1.3	0.7	1.7	1.8	2.4	2.7	5.6	2.1	10.7	2.2	1.0	6.4	15.1	1.5	2.0	26.7	4.3	0.9	2.0	7.8	3.6	4.4	37.6	4.6	3.0	10.1	15.4	31.3	1.9	7.5	23.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	288.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	225.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.2	0.2	0.1	0.0	22.6	1.9	31.3	19.3	0.5	14.3	10.1	19.4	23.0	15.4	8.3	16.3	17.1	0.5	7.5	0.1	4.2	22.7	5.2	1.4	1.8	0.6	1.2	1.5	1.0	1.9	1.0	2.4	2.0
ITIH1	"H1P, IATIH, ITIH"	ENSG00000055957	"Inter-alpha-trypsin inhibitor heavy chain 1"	P19827	3	52777592-52792068	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	95	"liver: 321.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.7;Hep G2: 3.2;HL-60: 2.5"	"Cancer enriched"	"Detected in some"	598	"liver cancer: 329.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 3.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA041639, HPA042049"	Approved		Approved	Vesicles	"Secreted to blood"	4490000	31000000000	Vesicles		"HPA041639: AB_10796349, HPA042049: AB_10797379"	"unprognostic (1.87e-4)"	"unprognostic (1.31e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.64e-3)"	"prognostic favourable (1.89e-5)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.45e-2)"	"unprognostic (4.53e-4)"	"unprognostic (4.02e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	321.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.3	0.8	0.0	0.9	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	2.5	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.7	0.0	0.0	3.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITIH2	H2P	ENSG00000151655	"Inter-alpha-trypsin inhibitor heavy chain 2"	P19823	10	7703269-7749520	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	202	"liver: 249.0"	"Cell line enriched"	"Detected in single"	1079	"Hep G2: 151.9"	"Cancer enriched"	"Detected in many"	279	"liver cancer: 626.9"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059150	Supported		Approved	"Golgi apparatus"	"Secreted to blood"		22000000000	"Golgi apparatus"		"HPA059150: "	"unprognostic (4.82e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	"prognostic favourable (1.48e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.10e-8)"	"unprognostic (9.91e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.46e-4)"	0.0	0.0	0.1	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	249.0	0.1	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.4	0.3	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.6	0.1	0.4	0.4	0.6	0.4	0.1	0.5	0.3	0.6	0.2	0.8	0.2	1.2	0.1	0.0	0.1	0.6	0.1	0.4	0.4	0.3	0.5	0.5	1.1	0.1
ITIH3	H3P	ENSG00000162267	"Inter-alpha-trypsin inhibitor heavy chain 3"	Q06033	3	52794768-52809009	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	233	"liver: 326.9"	"Cell line enriched"	"Detected in single"	24	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	247	"liver cancer: 273.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA017373	Approved				"Secreted to blood"		4500000000			"HPA017373: AB_1851954"	"unprognostic (2.07e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.30e-4)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.19e-1)"	"prognostic unfavourable (4.49e-8)"	"unprognostic (2.09e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.31e-2)"	0.9	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.8	0.3	0.1	0.3	0.0	0.5	0.5	0.3	0.3	0.5	0.2	0.1	0.0	0.2	326.9	0.4	0.3	0.2	0.1	0.6	0.0	0.0	0.1	0.3	0.2	0.2	0.1	0.2	0.2	0.4	0.3	0.1	0.1	0.1	0.1	1.4	0.1	0.4	0.1	0.1	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1
ITIH4	"H4P, IHRP, ITIHL1"	ENSG00000055955	"Inter-alpha-trypsin inhibitor heavy chain family member 4"	Q14624	3	52812975-52831479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 461.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.4;U-266/70: 6.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 7.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001835, HPA003948, CAB072872"	Enhanced		Approved	Vesicles	"Secreted to blood"	3056667	53000000000	Vesicles		"CAB072872: , HPA001835: AB_1079432, HPA003948: AB_1079433"	"unprognostic (6.08e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-14)"	"unprognostic (1.71e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.21e-5)"	0.5	1.8	0.1	0.1	0.1	1.0	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.1	0.1	1.3	0.2	0.1	0.1	0.6	0.1	0.0	0.2	461.4	0.2	0.1	0.1	0.2	0.2	22.8	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.2	4.1	0.1	0.1	0.2	0.1	0.5	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.3	0.3	0.6	0.6	2.6	0.8	0.0	0.0	0.4	1.0	2.1	1.1	0.0	0.4	0.1	0.0	0.0	0.2	0.3	0.2	1.3	0.0	0.5	1.1	0.0	0.0	0.5	5.4	0.2	2.2	0.0	2.9	0.9	2.5	0.2	0.3	0.4	0.0	0.1	0.0	0.6	1.8	0.0	0.2	0.5	0.7	1.0	0.0	1.8	1.0	0.0	0.8	0.7	0.1	1.0	0.7	0.0	0.4	1.1	0.7	0.2	0.0	0.9	1.0	0.0	6.6	3.1	0.5	0.1	0.7	1.2	0.0	0.6	0.0	0.1	0.1	0.1	0.3	0.7	0.0	0.0	0.2	0.0	0.8	0.6	2.6	0.1	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.2	0.1
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	294283333	160000000			"CAB012652: , HPA063275: , HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.3;HeLa: 25.0;HMC-1: 16.5;U-87 MG: 20.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles			37000	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.2	0.2	0.6	9.8	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.3	0.4	0.4	0.0	0.9	1.1	0.5	34.3	1.3	12.4	25.0	1.6	13.5	5.2	16.5	2.6	0.7	1.7	0.5	1.4	1.3	5.0	1.3	0.5	2.3	1.8	0.9	3.8	1.4	0.2	0.3	1.1	1.1	0.1	8.3	2.2	1.4	2.3	0.9	7.5	1.7	0.8	1.4	1.1	1.0	7.6	3.7	2.9	20.4	5.6	1.7	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3
ITPR2	"CFAP48, IP3R2"	ENSG00000123104	"Inositol 1,4,5-trisphosphate receptor type 2"	Q14571	12	26336515-26833198	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 47.1"	"Cell line enhanced"	"Detected in many"		"TIME: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059144, HPA062260"	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoplasm	"HPA059144: , HPA062260: "	"unprognostic (5.65e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.59e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.61e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.76e-1)"	8.8	20.6	12.8	14.5	13.8	6.1	18.5	9.3	15.0	7.9	9.9	7.8	3.7	6.0	7.2	7.8	12.0	7.3	8.0	7.1	14.2	6.0	14.4	47.1	6.5	8.1	12.8	4.6	8.0	9.2	17.4	9.9	11.9	13.0	6.6	7.8	4.8	17.6	3.8	4.7	13.3	8.9	5.4	20.3	12.5	5.9	3.4	15.3	35.3	5.3	6.6	10.7	5.5	8.1	4.3	9.0	17.3	5.2	3.6	3.1	0.7	2.6	1.1	1.6	2.6	4.9	5.0	1.7	2.5	3.4	1.7	1.8	0.1	1.4	9.2	1.6	3.3	2.9	8.6	5.2	2.3	2.2	2.8	7.4	2.4	14.8	4.5	6.6	3.3	4.7	0.7	3.7	6.8	16.3	3.2	2.9	2.2	2.2	4.6	8.8	7.1	0.8	1.5	3.8	5.8	4.0	4.2	0.5	2.6	11.2	2.0	6.2	4.2	3.3	35.6	3.5	1.3	3.4	3.1	2.7	2.1	17.2	3.2	3.0	2.2	17.3	5.2	7.1	2.4	2.2	2.0	4.2	2.1	1.9	1.0	4.3	2.5	2.2	13.5	3.6	3.0	9.0	3.1	0.7	12.8	13.8	9.3	15.0	14.2	6.0	12.8	4.6	13.0	15.3
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"basophil: 1.8;gdT-cell: 2.8;MAIT T-cell: 2.1;memory B-cell: 1.5;memory CD4 T-cell: 1.7;memory CD8 T-cell: 2.0;naive B-cell: 2.0;naive CD4 T-cell: 1.4;naive CD8 T-cell: 1.7;T-reg: 2.4"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;granulocytes: 1.8;T-cells: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles				Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	7.8	6.0	2.0	17.8	2.4	2.6	9.0	1.7	2.3	6.5	39.6	1.0	35.1	14.8	7.7	15.6	10.0	6.7	28.9	7.2	1.8	1.4	8.6	1.2	21.0	9.7	4.4	1.2	7.3	11.0	1.3	3.9	3.9	4.0	7.2	9.5	5.4	12.7	26.0	2.7	27.9	44.0	6.6	3.5	20.0	21.4	20.1	1.9	10.6	28.4	9.7	18.1	5.2	16.5	2.0	0.2	1.8	0.0	0.1	2.8	0.7	21.7	10.2	1.9	0.1	1.9	6.1	12.7	7.5	19.2	9.4	8.6	14.0	17.0	18.6	8.1	5.4	21.5	8.7	20.2	4.9	10.8	7.3	0.0	29.1	15.4	4.4	3.3	2.4	4.4	18.4	23.7	51.6	15.9	7.2	6.0	10.1	10.4	5.5	1.9	1.9	15.1	8.5	0.0	10.9	33.6	15.3	17.8	0.6	12.9	18.9	18.6	6.5	1.7	21.7	12.8	6.4	16.4	16.4	4.2	4.1	8.8	10.3	5.0	7.3	1.8	0.0	0.0	2.8	0.0	2.1	1.5	1.7	2.0	0.2	2.0	1.4	1.7	0.0	0.1	0.0	0.0	2.4	0.7	2.0	2.4	1.7	2.3	1.8	1.4	4.4	1.2	4.0	1.9
ITSN1	"ITSN, MGC134948, MGC134949, SH3D1A, SH3P17"	ENSG00000205726	"Intersectin 1"	Q15811	21	33642400-33899861	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 42.4;NTERA-2: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018007	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA018007: AB_1851836"	"unprognostic (2.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.91e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.02e-2)"	"unprognostic (5.64e-2)"	47.4	14.9	24.9	8.9	24.5	5.7	21.7	24.2	24.8	15.5	11.2	10.2	12.3	8.3	17.9	11.8	11.0	13.6	18.5	18.3	24.6	12.1	10.7	23.1	9.5	5.9	12.1	20.4	19.2	4.9	8.4	7.7	22.0	21.1	14.2	10.6	11.4	6.9	21.9	18.0	11.0	9.0	17.4	11.1	13.4	10.3	11.2	15.0	2.4	9.3	4.0	3.9	13.1	12.5	0.0	1.8	7.2	6.3	0.1	0.7	1.1	12.7	5.3	25.8	8.5	12.1	11.7	42.4	12.9	12.5	7.6	7.3	20.2	9.7	3.0	10.5	15.4	4.9	15.3	8.9	8.2	1.2	6.7	3.6	11.0	9.4	9.2	2.5	3.6	11.5	8.1	14.2	7.9	20.0	4.7	2.1	12.1	2.9	3.5	3.4	38.2	4.1	4.6	12.4	6.2	11.3	5.2	4.9	5.3	18.5	3.8	4.6	4.7	2.5	18.0	8.5	11.6	6.6	4.4	2.6	7.1	2.8	7.7	8.1	9.4	0.0	5.9	7.2	0.4	4.1	0.5	0.0	0.7	0.2	1.8	0.0	0.3	0.1	0.3	0.1	6.3	0.4	0.0	1.1	24.9	24.5	24.2	24.8	24.6	12.1	12.1	20.4	21.1	15.0
IVL		ENSG00000163207	Involucrin	P07476	1	152908545-152911886	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 97.1;tongue: 152.1"	"Group enriched"	"Detected in some"	25	"HaCaT: 77.0;RT4: 20.2;SK-BR-3: 23.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 44.0;head and neck cancer: 145.4;melanoma: 50.9;urothelial cancer: 47.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB002243, HPA055211"	Enhanced		Supported	"Nuclear bodies,Centrosome,Cytosol"			8000000	Cytosol	"Nuclear bodies, Centrosome"	"CAB002243: AB_563785, HPA055211: "	"unprognostic (3.29e-4)"	"unprognostic (1.91e-1)"		"unprognostic (2.92e-2)"		"unprognostic (2.31e-2)"		"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"		"unprognostic (4.82e-2)"	"unprognostic (3.11e-1)"		"unprognostic (3.66e-1)"		"unprognostic (1.22e-2)"	"unprognostic (1.32e-1)"	0.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	39.0	0.1	0.0	0.4	0.1	4.2	11.5	97.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	1.8	0.1	0.0	18.7	0.1	0.2	34.2	0.1	1.0	0.0	0.1	0.1	0.1	0.0	1.9	0.1	152.1	49.1	4.9	43.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	77.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	23.2	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
JAG1	"AGS, AHD, AWS, CD339, HJ1, JAGL1"	ENSG00000101384	"Jagged 1"	P78504	20	10637684-10673999	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"	"Developmental protein"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.8;hTERT-HME1: 34.5;U-251 MG: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010343, HPA021555"	Supported		Approved	"Golgi apparatus,Plasma membrane"			14000000	"Golgi apparatus, Plasma membrane"		"CAB010343: AB_649685, HPA021555: AB_1851969"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.42e-2)"	"unprognostic (4.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (4.10e-6)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.41e-3)"	27.7	5.6	6.8	14.5	5.4	9.7	56.5	2.9	6.7	34.2	20.1	4.3	17.4	7.2	26.1	22.8	33.9	16.7	23.1	18.8	5.4	5.1	12.9	3.8	22.0	12.4	5.4	4.0	14.7	22.2	21.7	6.0	36.3	6.0	19.2	12.7	21.4	11.2	23.4	16.8	34.8	11.7	21.4	13.0	14.2	13.4	9.1	3.8	1.5	14.5	24.6	16.1	18.7	31.4	0.0	0.9	2.4	2.0	0.4	0.1	0.4	1.0	5.2	16.4	20.1	3.1	3.0	0.6	0.6	3.0	0.8	0.4	4.6	2.8	0.1	15.4	0.6	21.9	2.4	55.8	0.7	0.0	1.1	1.7	0.5	21.9	1.5	7.0	0.1	1.2	16.6	2.7	34.5	5.4	0.0	2.2	1.5	0.0	0.0	5.0	4.7	5.2	1.3	1.0	3.2	7.8	6.4	0.7	0.5	1.6	1.1	6.6	0.1	0.8	20.4	3.7	2.6	3.0	46.9	0.9	0.1	0.2	2.4	2.5	2.9	0.0	2.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	1.6	0.4	0.3	0.9	0.0	0.4	6.8	5.4	2.9	6.7	5.4	5.1	5.4	4.0	6.0	3.8
JAK1	"JAK1A, JAK1B, JTK3"	ENSG00000162434	"Janus kinase 1"	P23458	1	64833229-64966504	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 69.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013088	Approved									"CAB013088: "	"prognostic favourable (9.63e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.88e-3)"	"unprognostic (1.66e-2)"	"unprognostic (8.84e-2)"	"prognostic favourable (2.67e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.51e-1)"	46.7	20.4	15.5	31.1	16.5	21.2	56.6	24.3	20.4	27.3	27.1	16.3	16.5	13.8	28.2	22.0	27.0	20.7	27.7	27.3	15.3	16.5	31.4	38.3	36.5	61.4	15.6	14.1	33.3	29.1	28.3	39.8	22.9	25.1	26.0	22.2	18.1	19.8	21.3	45.1	29.7	29.3	30.7	16.3	52.7	20.9	17.3	15.0	62.7	29.0	17.9	42.5	37.2	29.3	20.2	15.4	34.9	17.1	68.1	27.5	25.8	10.9	14.4	6.0	0.6	69.4	39.3	7.8	17.2	25.4	14.3	16.9	4.7	6.1	16.7	13.4	30.5	6.2	4.0	13.3	20.4	22.1	6.4	22.7	7.5	10.2	25.6	8.7	15.8	34.5	18.5	21.6	22.6	44.6	8.2	17.9	15.8	6.3	4.7	5.8	4.1	8.6	6.8	17.3	6.1	36.9	19.4	4.2	12.7	23.6	11.1	10.1	23.5	5.4	40.4	17.2	7.7	38.9	9.1	11.2	5.1	13.3	16.0	11.5	7.7	31.2	10.9	31.5	22.8	15.2	27.5	20.2	22.0	25.7	15.4	16.1	24.3	20.7	34.9	68.1	17.1	10.5	26.5	25.8	15.5	16.5	24.3	20.4	15.3	16.5	15.6	14.1	25.1	15.0
JAK2	JTK10	ENSG00000096968	"Janus kinase 2"	O60674	9	4984390-5128183	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"	"Chromatin regulator, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"ASC diff: 18.9;HDLM-2: 26.7;HEL: 54.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 40.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013089, HPA040820, HPA043870"	Approved		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"				Nucleoplasm	"Plasma membrane, Focal adhesion sites"	"CAB013089: AB_2533647, HPA040820: , HPA043870: "	"unprognostic (2.24e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.85e-1)"	"unprognostic (4.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.37e-3)"	19.8	8.8	11.5	19.0	10.5	19.0	17.7	14.7	14.4	17.8	10.6	7.0	10.3	7.2	14.8	13.6	12.4	13.4	14.6	27.6	10.3	6.7	7.7	5.6	16.1	19.4	7.0	10.5	15.9	6.7	10.1	7.5	12.0	10.0	12.0	7.4	9.4	7.2	7.4	14.4	19.0	12.3	10.4	11.7	21.5	14.1	10.1	9.0	13.6	8.6	6.5	13.5	13.9	15.6	2.1	9.6	40.8	7.5	3.4	2.1	2.5	2.5	1.4	1.4	2.5	18.9	4.9	0.4	3.4	2.9	2.6	1.7	0.1	0.8	0.1	0.8	2.0	0.8	1.5	2.1	1.9	26.7	0.5	54.8	2.9	0.7	3.9	3.7	2.8	4.0	0.9	1.1	1.8	2.4	3.9	6.4	4.7	0.9	0.9	5.2	1.3	1.7	1.9	2.7	0.7	2.0	1.3	1.6	0.9	1.0	1.5	1.0	0.7	6.5	5.0	4.0	1.3	4.1	2.4	1.2	2.2	0.5	5.2	1.8	2.0	40.8	7.5	13.4	2.1	7.3	1.7	2.1	1.6	1.2	9.6	1.9	0.9	1.1	7.1	3.4	5.8	3.6	1.6	2.5	11.5	10.5	14.7	14.4	10.3	6.7	7.0	10.5	10.0	9.0
JAKMIP2	"JAMIP2, KIAA0555"	ENSG00000176049	"Janus kinase and microtubule interacting protein 2"	Q96AA8	5	147585439-147782848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 44.0"	"Cell line enhanced"	"Detected in some"		"AF22: 10.9;Karpas-707: 25.8;RH-30: 26.1;SCLC-21H: 12.3;SH-SY5Y: 8.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 4.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 8.9;MAIT T-cell: 6.3;memory CD4 T-cell: 3.5;memory CD8 T-cell: 6.4;naive CD8 T-cell: 5.6;NK-cell: 7.4"	"Group enriched"	"Detected in many"	6	"NK-cells: 7.4;T-cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046929, HPA065023"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA046929: , HPA065023: "	"unprognostic (3.69e-2)"	"unprognostic (4.22e-3)"	"unprognostic (9.92e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.20e-8)"	"unprognostic (1.54e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	1.3	6.5	12.0	2.5	10.4	1.7	1.1	44.0	35.0	1.8	1.7	8.7	0.0	1.6	2.6	1.4	3.1	1.1	3.2	1.2	12.4	10.0	1.3	5.1	4.2	2.3	11.4	9.0	1.2	2.2	0.9	14.8	1.0	10.2	1.7	1.9	1.0	1.4	1.6	1.0	1.3	1.9	3.4	10.8	2.1	1.9	5.3	16.5	8.7	1.0	0.0	2.3	1.6	0.3	0.8	1.2	0.7	0.2	7.4	8.9	1.6	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.7	1.0	0.0	0.0	0.2	0.0	3.1	1.3	0.0	0.0	0.0	0.0	0.0	25.8	0.0	0.0	2.6	0.0	6.2	0.1	1.0	26.1	8.3	0.0	0.0	12.3	8.5	0.0	0.1	0.0	0.0	0.0	0.0	1.9	2.2	0.0	0.5	1.8	1.0	2.5	4.9	0.0	0.0	0.0	0.0	0.4	8.9	0.0	6.3	0.8	3.5	6.4	0.2	0.4	0.9	5.6	0.7	7.4	0.2	1.2	1.5	1.6	12.0	10.4	44.0	16.4	12.4	10.0	11.4	9.0	10.2	16.5
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246296-15522040	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 40.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: "	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	10.2	5.3	6.9	11.5	8.8	53.3	7.2	40.6	9.3	6.3	8.3	11.4	9.4	6.9	8.8	8.4	15.4	5.0	7.9	5.9	6.8	7.1	4.6	4.4	8.2	12.8	6.8	3.8	7.2	4.4	6.1	8.2	8.4	8.4	5.5	5.9	15.1	10.7	11.9	12.5	14.9	12.5	5.3	6.6	14.2	8.2	17.5	6.5	41.3	5.0	8.9	19.2	6.5	7.7	4.2	4.6	14.4	4.0	4.9	3.9	2.0	6.2	4.3	17.9	10.3	2.2	2.2	17.7	1.8	4.3	2.3	3.0	4.5	4.9	3.3	6.5	3.6	3.2	4.1	10.4	2.2	6.4	6.4	11.7	5.1	5.8	2.4	11.8	13.8	3.1	6.6	3.5	14.0	2.5	15.2	5.6	1.4	6.2	23.5	22.3	19.1	2.0	10.5	5.4	9.3	2.2	6.6	13.8	7.9	3.7	13.0	16.3	4.5	12.8	4.3	11.0	6.1	6.0	6.2	3.6	8.6	5.9	3.7	11.1	13.8	9.6	4.0	3.2	3.9	2.6	3.3	2.6	1.9	2.3	3.3	4.2	2.4	3.3	14.4	4.9	2.7	4.6	1.5	2.0	6.9	8.8	40.6	7.9	6.8	7.1	6.8	3.8	8.4	6.5
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 158.7;Karpas-707: 84.7;RPMI-8226: 168.2;U-266/70: 358.1;U-266/84: 139.0;U-698: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"		4200000000			"CAB034436: AB_2233368, HPA044132: "	"prognostic favourable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	158.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	84.7	0.0	0.0	0.2	0.5	0.1	0.0	0.2	0.1	168.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.2	358.1	139.0	206.4	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7
JPT1	"ARM2, HN1, HN1A"	ENSG00000189159	"Jupiter microtubule associated homolog 1"	Q9UK76	17	75135248-75168281	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 109.4;testis: 101.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 109.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059729	Approved		Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"				Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA059729: AB_2684114"	"unprognostic (1.13e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.31e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.71e-2)"	"unprognostic (2.51e-3)"	"prognostic unfavourable (1.58e-7)"	"unprognostic (3.58e-2)"	"unprognostic (1.37e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.25e-3)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.77e-7)"	"unprognostic (1.83e-1)"	"unprognostic (8.99e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.51e-1)"	8.0	18.5	15.6	25.9	22.2	23.0	8.1	30.7	25.4	9.4	43.3	4.6	7.7	37.5	6.1	5.4	52.8	4.3	23.7	6.1	17.9	19.6	15.5	12.8	13.9	26.3	11.1	15.0	5.6	6.5	1.2	6.6	29.2	13.7	7.0	23.7	3.3	15.9	17.6	23.7	9.3	51.3	7.3	8.3	26.2	42.5	101.3	4.9	32.6	5.8	28.9	28.7	17.9	17.0	15.4	14.5	109.4	28.4	10.2	28.7	14.6	91.6	91.4	48.1	47.7	10.2	10.5	38.4	48.3	14.4	47.5	36.6	74.8	55.0	25.8	31.0	38.6	54.8	44.9	60.1	35.8	25.8	56.4	41.5	36.3	74.0	24.0	31.1	40.1	16.0	28.8	38.6	39.8	86.2	23.4	53.2	43.4	66.4	99.7	30.4	28.0	120.5	63.7	57.5	40.0	50.7	57.6	59.8	48.6	69.1	36.6	25.7	98.1	19.1	49.6	27.2	76.9	38.1	56.0	20.8	33.5	38.6	23.7	29.2	31.0	27.5	18.5	51.6	12.4	26.6	8.9	15.4	17.2	14.9	14.5	8.0	8.2	12.0	109.4	10.2	28.4	9.6	28.7	14.6	15.6	22.2	30.7	25.4	17.9	19.6	11.1	15.0	13.7	4.9
JRKL	HHMJG	ENSG00000183340	"JRK like"	Q9Y4A0	11	96389989-96507574	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046184, HPA060341"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA046184: AB_10963576, HPA060341: "	"unprognostic (4.59e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	"unprognostic (4.94e-2)"	"unprognostic (7.55e-3)"	"unprognostic (6.12e-2)"	"unprognostic (3.99e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.57e-3)"	11.5	7.8	10.4	10.2	12.3	1.4	10.3	11.1	9.8	12.5	10.1	6.2	7.9	8.2	13.0	9.1	9.7	12.3	8.7	8.4	9.2	6.8	9.1	5.9	8.0	9.7	10.0	7.8	16.4	7.0	13.4	15.6	12.0	10.0	13.5	10.7	6.0	9.7	11.7	9.9	8.9	12.4	12.8	17.9	10.4	9.9	17.9	13.1	11.6	14.0	6.3	10.3	12.4	14.8	5.3	9.0	6.0	5.7	3.9	7.6	3.4	6.7	4.3	9.0	6.6	18.0	20.1	6.5	11.5	7.9	8.4	10.9	7.2	16.5	9.3	16.9	10.6	10.7	4.4	7.8	9.7	10.0	4.1	8.6	11.1	5.4	14.5	4.8	5.5	9.5	12.5	12.0	15.1	7.5	4.5	4.1	13.4	1.4	6.2	14.0	1.3	5.9	6.4	8.6	7.5	10.2	7.1	3.6	6.5	6.7	4.7	5.0	5.6	6.6	9.1	16.0	7.1	13.9	4.6	3.5	7.7	5.5	7.4	7.9	6.9	6.0	5.7	5.5	3.8	4.5	5.3	5.3	6.0	4.7	5.7	4.1	7.6	6.8	2.1	3.9	5.2	9.0	2.8	3.4	10.4	12.3	11.1	9.8	9.2	6.8	10.0	7.8	10.0	13.1
JTB	"hJT, PAR"	ENSG00000143543	"Jumping translocation breakpoint"	O76095	1	153974269-153977688	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006514	Approved		Approved	"Vesicles,Actin filaments"				Vesicles	"Actin filaments"	"HPA006514: AB_1079164"	"unprognostic (1.33e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.40e-1)"	"unprognostic (5.66e-3)"	"unprognostic (8.62e-3)"	"unprognostic (5.60e-2)"	"prognostic favourable (7.87e-4)"	"unprognostic (1.00e-3)"	"unprognostic (8.16e-2)"	"prognostic unfavourable (6.65e-9)"	"unprognostic (1.36e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.48e-2)"	"unprognostic (2.58e-3)"	23.9	30.2	28.5	23.0	32.7	43.2	32.6	30.7	32.3	31.8	36.0	23.6	51.3	35.9	25.1	41.0	30.4	26.1	37.1	36.2	25.4	23.9	34.2	81.1	27.7	34.7	27.7	19.8	26.9	106.8	24.8	49.8	30.0	24.4	33.4	36.0	24.9	100.6	45.9	42.1	23.4	45.6	21.6	20.5	35.9	42.4	15.3	25.2	30.5	58.5	32.0	34.0	25.2	33.0	47.4	54.1	60.7	43.0	30.4	46.4	30.2	39.5	27.4	11.8	21.6	38.8	24.1	33.3	28.9	28.2	19.3	19.5	26.3	32.9	37.8	41.0	33.4	36.2	29.8	22.2	15.8	35.6	59.6	21.9	32.6	26.6	40.7	42.2	33.8	22.9	42.0	20.3	24.1	22.8	32.5	27.8	13.5	68.8	30.4	54.2	25.3	48.3	32.2	16.1	75.9	24.4	21.7	32.4	32.8	22.9	66.5	38.7	41.8	61.4	17.8	9.6	16.5	28.9	36.8	41.5	46.3	41.0	23.6	40.6	20.6	32.6	43.0	60.7	29.4	30.3	35.5	47.4	41.1	46.4	33.4	45.2	42.4	33.7	39.9	30.4	33.4	54.1	33.6	30.2	28.5	32.7	30.7	32.3	25.4	23.9	27.7	19.8	24.4	25.2
JUNB		ENSG00000171223	"JunB proto-oncogene, AP-1 transcription factor subunit"	P17275	19	12791496-12793315	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.3;U-266/70: 44.7;U-266/84: 66.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 101.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 101.1;monocytes: 27.0"	"Group enriched"	"Detected in many"	5	"amygdala: 25.2;basal ganglia: 16.8;cerebral cortex: 31.3;hippocampal formation: 24.3;olfactory region: 15.1"	"Region enriched"	"Detected in single"	19	"cerebellum: 17.1"	"CAB004464, HPA019149"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB004464: AB_2130023, HPA019149: AB_1852053"	"unprognostic (1.03e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (7.20e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.02e-1)"	83.4	95.3	8.7	57.2	16.6	153.1	29.0	8.3	16.0	57.6	33.1	29.2	13.0	20.7	26.6	23.7	84.8	128.6	103.5	46.4	10.2	9.9	20.4	54.5	76.2	23.1	10.3	7.1	108.1	25.0	10.5	43.8	44.4	21.5	63.8	9.7	47.3	37.8	84.3	54.3	66.0	32.9	33.6	15.7	25.7	39.7	15.3	11.6	12.2	27.1	71.9	53.3	71.7	37.9	4.7	12.7	101.1	27.0	2.6	6.5	12.7	8.7	1.7	0.4	1.1	2.0	4.9	1.7	3.8	3.3	1.9	1.7	1.1	5.1	3.0	13.5	1.4	16.6	0.4	5.8	0.2	104.3	1.7	3.0	6.7	1.4	2.6	4.0	14.0	6.2	17.0	1.7	1.3	0.9	7.8	5.6	0.6	26.4	2.7	24.4	0.3	6.8	3.7	1.3	6.2	1.2	11.0	4.1	6.2	16.7	10.3	4.8	1.8	4.5	2.9	5.6	3.2	11.1	4.8	44.7	66.3	2.7	6.6	10.4	1.5	3.5	17.4	18.5	5.2	27.0	5.3	4.7	5.7	6.5	12.7	4.4	4.1	4.3	101.1	2.6	24.7	1.1	5.5	12.7	8.7	16.6	8.3	16.0	10.2	9.9	10.3	7.1	21.5	11.6
JUND	AP-1	ENSG00000130522	"JunD proto-oncogene, AP-1 transcription factor subunit"	P17535	19	18279760-18281622	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 204.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005268, HPA063029"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB005268: AB_2130177, HPA063029: "	"prognostic favourable (6.15e-5)"	"unprognostic (4.18e-3)"	"unprognostic (8.89e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.70e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.99e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.49e-1)"	75.7	52.7	35.4	38.9	32.4	204.7	51.5	34.7	56.5	42.4	49.5	42.6	21.1	35.7	43.4	31.0	31.7	55.7	43.5	35.9	31.5	32.1	26.9	66.5	55.7	17.2	21.6	22.6	78.1	64.3	21.7	47.8	80.3	27.0	45.5	21.0	35.2	39.0	33.3	29.2	44.5	61.8	34.4	31.5	39.3	46.2	34.9	19.2	32.0	27.2	33.7	23.1	41.7	30.8	8.6	10.7	19.0	7.8	4.5	6.3	1.7	22.0	9.3	9.3	10.5	7.4	8.3	41.2	9.2	11.1	5.2	7.1	10.1	19.9	11.4	10.9	9.4	12.0	2.2	2.1	2.7	22.6	20.2	16.8	7.6	21.8	16.5	7.8	22.0	8.0	9.4	5.6	7.3	4.2	22.9	33.3	1.4	29.3	23.1	24.5	19.3	13.4	8.5	5.8	23.9	7.6	3.4	50.7	20.8	11.4	12.6	30.0	10.5	11.8	14.4	3.2	15.2	20.3	5.6	46.6	18.5	9.2	11.3	11.9	7.4	8.0	6.4	5.8	4.9	7.8	3.8	7.4	6.3	4.4	4.6	8.6	4.7	4.9	19.0	4.5	7.4	10.7	5.1	1.7	35.4	32.4	34.7	56.5	31.5	32.1	21.6	22.6	27.0	19.2
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 126.0;hTCEpi: 63.6;RT4: 77.4;SK-BR-3: 76.5;T-47d: 63.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"			61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: "	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favourable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	30.2	25.1	2.5	2.1	0.0	0.0	39.3	1.7	10.4	0.7	0.6	37.9	33.5	0.6	18.7	1.1	126.0	3.6	28.0	0.1	0.0	8.9	1.3	20.0	8.3	4.2	0.8	13.4	0.0	63.6	0.1	5.2	11.2	11.1	11.0	0.0	38.8	0.2	10.9	4.9	4.2	35.4	0.0	22.7	19.4	77.4	6.2	4.6	3.9	76.5	0.2	63.8	0.9	17.6	0.0	1.8	0.8	0.5	0.9	3.4	0.6	0.1	1.4	0.3	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6
KANK1	"ANKRD15, KANK, KIAA0172"	ENSG00000107104	"KN motif and ankyrin repeat domains 1"	Q14678	9	470291-746106	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 7.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005539, HPA056090"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA005539: AB_1078164, HPA056090: "	"unprognostic (6.59e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	28.9	5.3	23.9	8.7	23.2	1.4	15.5	17.7	18.2	18.2	17.4	28.5	7.6	8.8	26.5	10.3	33.7	12.7	13.2	46.5	21.9	10.4	19.8	39.4	10.0	6.9	21.4	14.8	16.9	17.0	9.5	14.7	18.2	16.5	23.4	11.2	14.8	17.9	24.4	24.2	20.0	9.2	27.6	21.3	3.9	10.7	12.1	23.5	2.8	16.2	8.2	8.8	28.9	26.3	1.5	7.1	0.0	0.2	0.2	4.4	1.0	2.0	4.3	1.4	26.8	22.2	8.5	7.4	13.6	9.6	1.1	1.4	10.9	0.9	16.6	3.3	16.8	4.5	5.8	11.1	2.0	8.0	3.0	0.0	6.3	34.4	3.1	3.9	0.0	4.8	15.6	1.2	13.5	11.5	0.8	21.0	8.6	5.1	1.6	16.8	1.9	3.3	0.6	2.9	3.0	9.1	13.2	0.6	0.0	1.3	4.0	18.1	2.6	3.1	16.9	3.1	1.1	4.0	6.2	3.6	21.5	0.0	2.1	7.6	5.8	0.0	0.2	0.0	0.2	0.2	0.0	1.5	2.3	0.8	0.7	1.2	4.4	1.4	0.0	0.2	0.0	7.1	3.0	1.0	23.9	23.2	17.7	17.6	21.9	10.4	21.4	14.8	16.5	23.5
KAT8	"FLJ14040, hMOF, MOF, MYST1, ZC2HC8"	ENSG00000103510	"Lysine acetyltransferase 8"	Q9H7Z6	16	31115754-31131393	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 17.8;neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066324			Supported	Nucleoplasm				Nucleoplasm		"HPA066324: "	"unprognostic (8.58e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.22e-1)"	"prognostic favourable (6.34e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (9.77e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.00e-1)"	"unprognostic (1.41e-1)"	18.4	21.7	22.7	29.4	23.6	26.6	29.7	48.9	30.8	28.0	24.8	18.3	27.5	15.7	29.8	48.3	16.7	35.0	28.2	32.7	23.0	21.2	20.8	18.9	26.3	29.0	20.2	21.0	52.8	31.4	38.0	22.2	31.5	16.8	21.2	17.7	22.1	35.1	26.2	39.8	22.1	19.7	25.9	20.5	27.4	18.6	27.3	18.4	30.2	31.7	22.6	22.2	20.2	26.6	2.1	4.1	17.8	4.6	1.7	2.9	1.9	7.6	11.8	14.8	4.4	17.6	13.2	15.2	6.8	13.1	11.0	12.1	5.9	16.7	18.1	10.8	8.5	9.1	23.6	11.5	10.9	15.1	16.0	7.8	8.7	18.7	15.8	12.9	14.2	12.4	23.1	8.2	23.8	10.5	20.8	14.9	5.6	22.3	19.9	24.4	16.7	7.2	32.1	12.1	21.2	8.9	4.6	15.6	15.8	4.1	11.5	5.8	12.5	21.5	6.2	4.7	9.9	5.2	4.9	14.2	14.3	10.2	7.1	17.3	7.0	3.9	4.4	17.8	1.9	2.4	2.4	2.1	2.2	2.6	4.1	1.8	2.9	2.1	17.4	1.7	4.6	1.4	1.3	1.9	22.7	23.6	48.9	30.8	23.0	21.2	20.2	21.0	16.8	18.4
KBTBD11	"KIAA0711, KLHDC7C"	ENSG00000176595	"Kelch repeat and BTB domain containing 11"	O94819	8	1973878-2006936	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;NB-4: 7.4;SCLC-21H: 8.9;THP-1: 14.4;U-937: 20.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.6;monocytes: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051159	Uncertain		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA051159: "	"unprognostic (1.19e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (2.03e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.76e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-2)"	3.2	6.8	17.6	2.6	17.7	8.7	1.8	16.3	22.4	4.5	8.2	10.9	0.0	10.9	1.6	1.7	1.7	3.8	3.8	2.1	16.1	10.8	13.9	6.7	2.3	3.1	13.2	16.7	1.9	3.2	5.1	2.0	0.8	11.4	5.0	6.6	3.1	2.1	2.9	1.8	1.0	12.7	1.7	12.4	6.4	1.9	1.6	9.3	4.7	2.4	0.0	2.0	1.4	0.7	0.0	0.4	4.6	1.4	0.0	0.6	0.4	1.5	1.0	4.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.9	0.4	0.1	0.3	0.0	2.1	0.0	0.0	10.2	1.2	0.0	0.0	0.0	1.0	4.4	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	4.5	7.4	1.0	0.0	1.3	0.0	0.0	2.2	0.3	8.9	4.5	0.0	0.0	0.1	0.1	14.4	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.1	20.4	0.7	0.7	1.4	4.6	0.0	0.6	0.2	0.0	0.2	0.1	0.4	0.0	0.6	0.3	0.9	0.0	0.3	0.0	0.5	0.4	17.6	17.7	16.3	21.9	16.1	10.8	13.2	16.7	11.4	9.3
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009741-30017023	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease mutation, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 16.5;brain: 39.0"	"Cell line enhanced"	"Detected in some"		"U-2 OS: 1.6;WM-115: 2.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 39.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved									"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			2.2	16.5	9.8	0.6	39.0	0.6	0.6	0.2	12.2	0.6	0.6	0.8	1.8	0.7	1.1	0.9	0.6	0.8	0.6	5.9	6.1	2.7	1.2	0.6	2.4	0.6	1.6	6.2	0.6	0.6	0.6	2.8	1.2	10.5	0.6	0.6	0.0	0.6	1.7	0.6	0.8	0.6	0.8	0.6	0.6	1.0	0.7	5.9	0.0	0.6	0.0	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	39.0	0.2	12.2	6.1	2.7	1.6	6.2	10.5	5.9
KCNAB2	"AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B"	ENSG00000069424	"Potassium voltage-gated channel subfamily A regulatory beta subunit 2"	Q13303	1	5991466-6101193	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 57.5;brain: 54.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 67.1;U-937: 71.5"	"Cancer enriched"	"Detected in all"	7	"melanoma: 29.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001975	Enhanced									"CAB001975: "	"unprognostic (6.60e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.76e-2)"	"unprognostic (8.18e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.58e-2)"	"unprognostic (7.71e-3)"	"unprognostic (8.83e-3)"	"prognostic unfavourable (3.50e-5)"	"unprognostic (2.88e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.35e-1)"	"unprognostic (5.24e-2)"	6.9	4.8	37.8	21.5	34.7	57.5	2.7	13.5	54.3	2.7	4.2	4.2	0.5	3.7	3.4	2.1	4.1	6.2	8.1	8.1	44.6	13.1	10.9	3.8	13.9	31.2	16.1	24.7	3.2	2.2	1.3	6.1	4.5	28.7	2.7	4.1	10.8	3.1	2.5	4.0	9.0	7.4	5.0	5.8	21.9	5.3	3.1	4.7	13.9	2.4	0.5	17.0	9.0	1.7	6.8	19.6	11.4	21.1	9.2	19.8	22.8	2.5	7.0	0.6	0.8	0.3	1.2	2.3	1.3	8.5	1.4	1.7	2.5	1.1	14.9	4.3	0.9	0.9	0.5	0.1	0.8	17.3	2.3	18.2	7.0	4.2	1.3	67.1	0.5	1.3	0.3	0.9	1.7	1.1	0.5	28.2	0.7	2.2	12.9	28.9	0.4	3.1	2.6	2.1	17.6	0.2	0.0	4.3	1.5	1.0	1.2	22.1	1.0	25.9	0.2	0.3	2.5	2.5	1.4	21.4	25.0	21.1	2.6	71.5	0.5	2.1	21.1	11.4	19.8	17.6	18.7	6.0	13.0	19.1	19.6	6.8	13.8	14.5	9.0	9.2	15.4	8.1	13.6	22.8	37.8	34.7	13.5	54.3	44.6	13.1	16.1	24.7	28.7	4.7
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911937-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 36.9"	"Cell line enhanced"	"Detected in some"		"A549: 16.5;MCF7: 5.8;T-47d: 7.2"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1"	"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA014738: AB_1852114, HPA062278: "	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.9	0.9	11.5	1.0	25.5	0.8	1.2	0.8	36.9	0.9	1.2	2.4	0.0	1.2	1.9	0.8	1.6	1.1	1.0	1.1	13.1	4.7	1.1	0.9	1.0	1.0	3.1	10.5	0.9	2.2	0.8	0.2	0.9	3.6	1.0	1.2	0.0	0.8	1.4	0.8	0.8	1.1	1.0	1.0	1.5	1.1	1.0	3.1	0.5	0.8	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	16.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	2.5	1.7	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	7.2	0.8	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.5	25.5	0.8	28.5	13.1	4.7	3.1	10.5	3.6	3.1
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in some"	7	"K-562: 58.4;NB-4: 29.1;SH-SY5Y: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favourable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.9	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.5	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.4	0.0	0.0	0.3	0.5	29.1	0.4	0.0	0.0	0.0	3.0	0.0	0.0	1.2	24.5	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	1.7	0.0	0.6	0.0	3.6	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.4;SK-MEL-30: 3.6;U-266/70: 3.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced									"HPA078302: "	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.6	0.0	2.1	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.6	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.7	1.7	0.0	0.2	0.2	1.7	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell line enhanced"	"Detected in some"		"BJ: 5.3;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA024231	Uncertain									"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.3	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.5	0.1	0.0	0.4	0.2	0.3	1.7	3.3	0.1	0.5	0.2	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9
KCNK3	"K2p3.1, TASK, TASK-1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 69.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.6;EFO-21: 9.7;HeLa: 3.3;SCLC-21H: 23.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	2.4	69.2	1.3	1.9	4.0	0.6	8.3	4.7	6.2	3.5	4.0	0.8	5.7	1.3	2.4	5.6	1.9	2.0	2.3	10.3	1.0	4.0	1.8	0.7	10.0	0.6	1.5	1.5	4.6	24.7	0.7	3.6	16.6	13.4	8.2	1.1	1.9	0.6	7.7	0.6	0.6	2.6	4.7	1.1	0.9	2.2	0.9	0.0	0.0	2.1	0.0	0.5	3.2	2.3	0.7	0.5	2.5	0.4	1.2	0.4	0.0	0.0	0.6	0.2	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	23.0	2.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.3	0.2	0.7	0.4	0.4	2.5	1.2	0.2	0.5	0.2	0.0	1.3	4.0	4.7	6.2	1.0	4.0	1.5	1.5	13.4	0.0
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Group enriched"	"Detected in some"	5	"BJ: 14.7;NTERA-2: 5.6;SK-MEL-30: 10.4;THP-1: 18.3;U-937: 6.5"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	14.7	2.2	0.3	0.1	0.0	0.2	0.0	0.5	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.2	5.6	0.0	0.1	0.0	0.7	0.2	0.1	1.8	0.0	0.0	0.1	10.4	0.2	18.3	0.2	0.0	0.4	1.6	0.0	0.1	0.0	0.1	1.8	6.5	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849110	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.3;RPMI-8226: 15.0;U-266/70: 8.9;U-937: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553"	Enhanced									"CAB018656: AB_2131551, HPA048553: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favourable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	3.0	78.2	1.0	5.1	1.0	3.4	3.1	0.6	1.2	5.0	13.7	4.1	88.1	14.2	1.9	15.9	1.5	2.1	12.2	10.7	1.5	1.0	13.8	1.0	11.4	5.8	1.2	0.8	1.6	25.6	5.6	2.7	1.8	1.8	7.5	4.6	2.5	9.5	83.6	0.8	1.0	18.4	1.5	1.4	5.5	31.2	3.6	1.5	1.6	36.2	0.9	4.8	5.5	3.6	1.2	5.6	5.3	4.7	0.0	1.7	1.4	0.0	0.1	0.0	4.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.6	1.0	3.7	0.0	0.1	0.5	0.0	0.0	0.2	1.0	0.0	2.6	0.3	0.2	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.8	0.2	0.1	0.0	15.0	5.6	1.8	0.5	4.1	0.5	0.0	0.0	0.1	5.7	0.0	0.0	0.2	0.1	0.0	8.9	0.0	0.0	0.0	8.8	0.0	1.6	4.7	4.7	0.0	2.6	0.1	1.2	0.6	0.1	5.6	0.6	1.7	1.7	5.3	0.0	3.7	1.9	0.5	1.4	1.0	1.0	0.6	1.2	1.5	1.0	1.2	0.8	1.8	1.5
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Cell line enhanced"	"Detected in some"		"AF22: 8.3;AN3-CA: 13.7;NTERA-2: 7.6;SCLC-21H: 26.9;SH-SY5Y: 47.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: "	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.3	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	26.9	47.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2
KCTD12	"C13orf2, KIAA1778, PFET1"	ENSG00000178695	"Potassium channel tetramerization domain containing 12"	Q96CX2	13	76880166-76886390	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.2;HUVEC TERT2: 60.0;TIME: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 6.4;myeloid DC: 5.9"	"Group enriched"	"Detected in many"	17	"dendritic cells: 5.9;granulocytes: 1.6;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056987, HPA077376"		Supported	Approved	Mitochondria			19000000	Mitochondria		"HPA056987: , HPA077376: "	"unprognostic (6.42e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.13e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.82e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.83e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (1.14e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.25e-2)"	29.6	7.5	12.1	14.3	17.9	2.1	24.7	11.7	9.4	13.1	10.3	10.3	5.1	5.5	14.2	9.2	10.7	21.6	15.1	10.3	10.5	8.2	8.5	6.4	17.2	21.5	17.0	5.9	13.6	6.8	8.2	6.6	22.9	13.8	9.9	11.7	13.8	8.4	4.9	11.2	7.7	8.4	17.9	14.0	21.3	8.3	10.0	13.5	3.1	8.4	5.8	8.4	11.0	15.0	0.0	5.9	1.6	6.4	0.0	0.2	1.4	0.4	0.3	4.0	0.0	30.2	14.4	1.1	1.7	0.4	1.1	1.5	0.1	0.0	0.0	1.0	4.8	14.0	1.7	17.2	0.9	0.3	9.2	0.0	10.4	0.0	1.3	4.6	0.0	5.8	5.7	0.7	13.1	60.0	0.0	0.0	14.1	0.3	2.1	0.0	2.0	2.0	0.1	1.9	5.0	4.6	0.0	1.1	2.1	4.5	0.1	0.6	0.2	3.1	48.2	0.7	1.3	0.1	3.6	0.7	0.1	0.0	11.4	1.0	4.2	0.0	6.4	1.1	0.0	4.1	0.0	0.0	0.1	0.0	5.9	0.0	0.1	0.2	1.6	0.0	2.3	3.0	0.0	1.4	12.1	17.9	11.7	7.5	10.5	8.2	17.0	5.9	13.8	13.5
KCTD4	bA321C24.3	ENSG00000180332	"Potassium channel tetramerization domain containing 4"	Q8WVF5	13	45192853-45194717	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 45.5"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.7;RPTEC TERT1: 9.5;U-138 MG: 11.5;U-87 MG: 22.8"	"Group enriched"	"Detected in some"	5	"glioma: 1.2;renal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040734	Uncertain		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA040734: AB_10963227"	"unprognostic (1.36e-1)"		"unprognostic (1.02e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.19e-2)"		"unprognostic (1.70e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.98e-2)"			0.5	0.6	33.1	0.6	45.5	0.7	1.5	0.2	22.0	0.7	1.1	1.5	0.0	0.9	0.5	0.6	0.5	0.5	1.8	0.9	9.8	4.0	0.9	0.5	0.5	0.5	3.6	4.8	0.5	0.9	0.5	1.1	0.9	3.9	0.5	0.9	1.8	1.5	0.8	0.5	6.4	1.0	1.8	2.7	0.5	0.5	0.5	7.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	0.0	0.5	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	2.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.5	0.0	0.0	2.4	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.6	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	33.1	45.5	0.2	9.3	9.8	4.0	3.6	4.8	3.9	7.0
KDM2A	"CXXC8, DKFZP434M1735, FBL11, FBL7, FBXL11, FLJ00115, JHDM1A, KIAA1004, LILINA"	ENSG00000173120	"Lysine demethylase 2A"	Q9Y2K7	11	67119269-67258087	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012272, HPA044251"	Supported		Approved	Nucleoplasm				Nucleoplasm		"CAB012272: , HPA044251: "	"unprognostic (7.43e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.09e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.84e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.27e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.61e-2)"	"unprognostic (9.45e-3)"	19.6	14.6	18.6	25.3	23.9	38.1	21.0	36.5	22.8	20.0	21.9	17.8	20.7	15.3	32.0	18.6	32.7	20.2	19.3	18.8	17.4	12.7	16.8	20.3	24.3	30.1	17.9	14.9	27.4	15.3	26.1	21.1	26.0	17.5	23.3	17.1	21.0	22.2	20.5	32.8	28.7	24.1	25.0	14.6	29.0	19.8	27.6	18.6	32.2	19.9	20.3	37.3	24.9	25.9	7.2	1.9	5.0	1.9	4.6	5.2	2.8	25.0	15.1	9.2	14.3	9.2	13.3	6.9	11.0	12.8	19.7	13.6	23.6	13.2	19.3	19.3	15.5	24.5	15.2	10.9	16.0	32.4	6.8	14.2	18.0	5.9	9.7	12.1	19.7	11.0	13.3	19.3	13.5	14.3	13.1	27.3	9.5	16.7	15.6	8.8	18.6	13.0	19.9	15.5	10.8	8.3	15.8	12.5	10.0	35.2	20.3	20.9	30.5	12.3	19.2	13.3	8.9	18.2	9.4	15.2	16.7	12.3	11.6	8.7	9.1	0.6	1.9	0.5	4.8	1.5	5.2	6.4	3.6	4.2	1.2	7.2	3.8	3.5	5.0	4.6	1.0	1.9	4.3	2.8	18.6	23.9	36.5	22.8	17.4	12.7	17.9	14.9	17.5	18.6
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352596-138437028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA016610: AB_1852004, HPA057202: "	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favourable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	13.5	12.8	10.0	10.9	12.6	12.2	14.9	20.2	14.9	14.0	14.2	18.4	13.5	9.9	20.0	18.0	13.0	14.7	12.5	11.8	14.7	8.6	12.8	8.4	11.4	11.5	12.0	9.6	19.8	17.4	27.9	15.1	11.7	11.3	13.6	14.4	18.5	16.3	16.3	29.6	16.5	14.0	21.5	10.7	13.3	12.6	10.4	12.2	25.2	16.1	9.0	16.4	21.9	19.4	4.1	5.1	9.3	4.6	7.4	5.7	2.2	11.8	16.6	31.3	28.7	14.5	12.1	24.3	8.2	13.2	14.6	16.4	18.5	13.0	23.6	14.9	15.5	12.2	25.4	18.2	16.7	15.4	15.6	20.2	14.7	14.0	12.9	16.3	22.1	14.4	19.9	11.3	13.5	17.4	15.9	12.6	17.5	15.2	21.2	20.1	15.5	6.9	25.9	24.1	15.4	20.9	16.4	16.6	18.1	14.0	13.7	12.1	13.0	20.6	16.7	8.7	9.1	9.1	14.2	17.5	8.3	20.9	5.8	23.0	12.3	0.3	4.6	6.5	4.2	3.6	5.7	4.1	5.0	5.2	4.1	3.9	4.4	4.2	9.3	7.4	3.6	5.1	2.8	2.2	10.0	12.6	20.2	14.9	14.7	8.6	12.0	9.6	11.3	12.2
KDM4B	"JMJD2B, KIAA0876, TDRD14B"	ENSG00000127663	"Lysine demethylase 4B"	O94953	19	4969113-5153595	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 7.1;dendritic cells: 2.5;granulocytes: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062872			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA062872: "	"prognostic favourable (7.39e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.74e-4)"	"prognostic favourable (4.25e-7)"	"unprognostic (5.95e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (3.89e-2)"	"unprognostic (8.24e-3)"	"unprognostic (5.14e-3)"	"unprognostic (8.66e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.82e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.44e-2)"	13.3	16.0	14.8	15.1	13.4	22.0	20.0	26.1	18.7	19.4	12.6	18.3	24.3	12.1	24.2	18.1	15.9	18.4	12.0	12.6	13.3	9.2	10.4	18.2	11.8	19.2	13.8	12.9	18.5	19.0	12.1	17.9	29.4	11.2	24.8	6.0	18.8	16.5	22.6	38.0	21.1	12.9	16.2	13.3	21.2	12.0	19.9	13.8	14.6	28.9	8.8	13.7	13.3	21.9	7.1	2.5	6.9	0.9	1.3	0.8	0.5	8.8	3.1	7.3	8.7	4.2	4.2	14.7	4.4	3.3	3.9	4.9	5.2	2.5	12.3	4.7	5.0	5.0	4.4	5.2	2.4	5.5	11.2	4.1	5.3	4.3	7.9	4.1	9.6	6.5	5.6	3.2	2.7	5.2	10.1	7.6	3.5	4.5	4.7	6.3	6.4	7.7	8.0	5.5	10.2	3.9	5.8	13.6	10.4	5.7	6.4	7.0	34.9	10.9	7.5	5.8	3.3	7.1	4.4	20.9	8.6	9.5	11.5	8.3	3.3	1.6	0.9	2.6	0.5	0.3	0.3	6.1	0.4	0.4	0.4	7.1	0.6	0.8	6.9	1.3	0.4	2.5	0.5	0.5	14.8	13.4	26.1	18.7	13.3	9.2	13.8	12.9	11.2	13.8
KDM4C	"GASC1, JMJD2C, KIAA0780, TDRD14C"	ENSG00000107077	"Lysine demethylase 4C"	Q9H3R0	9	6720863-7175648	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 31.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069357			Approved	Nucleoplasm				Nucleoplasm		"HPA069357: "	"unprognostic (1.56e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.52e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.64e-3)"	12.1	12.1	13.3	21.5	15.0	27.5	12.7	51.2	14.3	12.4	14.9	18.0	14.6	14.2	14.7	13.9	12.5	12.0	11.9	10.0	11.1	11.9	9.9	12.2	16.1	21.1	15.1	10.5	13.5	18.9	26.0	24.0	10.6	13.7	11.5	18.5	15.3	15.1	13.9	9.7	16.9	16.6	15.4	13.8	15.2	16.2	10.4	16.0	29.0	14.9	7.9	25.7	13.5	14.2	13.8	8.4	13.0	11.1	10.8	11.8	6.9	9.3	5.6	2.4	3.5	8.1	9.0	6.7	4.3	5.8	5.1	5.0	6.5	5.3	11.0	2.6	5.9	2.9	5.1	7.4	6.6	31.6	3.7	15.3	7.9	8.8	7.7	5.8	10.5	7.8	5.1	4.0	8.6	6.1	2.4	7.5	5.4	4.9	9.5	22.8	4.0	2.1	5.7	2.0	6.7	7.5	5.5	8.1	4.8	3.9	7.7	3.7	3.7	10.0	6.5	5.0	2.3	5.8	4.0	5.6	4.1	11.0	4.9	5.6	1.8	7.2	6.4	13.0	9.8	6.9	10.8	11.9	10.9	10.7	8.4	13.8	11.8	8.8	1.5	10.8	11.1	3.4	9.2	6.9	13.3	15.0	51.2	14.3	11.1	11.9	15.1	10.5	13.7	16.0
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038244: , HPA046147: "	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	17.3	23.8	25.5	19.5	17.7	16.2	18.1	10.9	12.8	14.8	13.8	16.0	11.4	16.2	14.2	14.3	15.6	28.8	23.3	11.3	12.1	42.6	15.7	25.3	11.3	21.8	18.6	31.4	12.7	17.2	28.9	35.6	21.8	30.6	10.8	10.8	22.3	13.6	20.9	21.6	22.3	15.4	15.2	17.6	9.4	16.7	19.2	24.8	33.1	30.7	12.4	21.5	16.4	14.9	16.5	14.3	14.8	10.5	15.7	12.8	12.4	21.4	22.1	12.2	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2
KDM5D	"HY, HYA, JARID1D, KIAA0234, SMCY"	ENSG00000012817	"Lysine demethylase 5D"	Q9BY66	Y	19703865-19744939	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 26.8;U-698: 23.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049086			Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA049086: "			"unprognostic (8.38e-2)"		"unprognostic (2.20e-1)"	"prognostic favourable (3.58e-5)"	"unprognostic (6.08e-3)"	"unprognostic (1.50e-2)"	"unprognostic (3.10e-2)"		"unprognostic (4.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.80e-2)"	8.0	15.6	3.3	28.7	15.7	11.6	6.5	11.4	23.0	0.3	15.8	20.7	16.4	14.3	0.3	17.4	10.2	0.3	15.8	7.6	4.6	5.3	6.7	6.8	10.1	15.9	5.0	0.0	0.3	12.5	0.3	9.3	8.0	16.1	17.2	18.8	21.4	14.5	20.4	14.9	8.7	28.6	25.6	6.1	17.1	10.2	14.0	0.0	29.8	10.7	15.3	19.5	14.9	0.0	6.3	5.1	3.8	3.1	3.4	5.1	1.8	0.0	3.8	0.0	0.0	0.0	0.0	7.6	6.8	5.8	4.0	4.6	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.0	4.4	10.2	0.0	26.8	0.0	8.8	5.8	0.0	0.0	6.3	6.1	0.0	0.0	0.0	0.0	0.0	9.3	0.0	10.7	0.0	5.6	0.0	0.0	4.6	4.8	8.4	13.2	6.3	0.0	0.0	0.0	2.8	0.0	5.6	8.8	12.4	0.1	0.1	3.0	11.3	7.2	23.4	1.2	0.0	0.0	0.0	3.1	3.8	4.6	2.2	3.5	6.3	4.3	4.4	3.3	5.6	5.1	3.7	0.4	3.4	1.9	5.1	3.5	1.8	3.3	15.7	11.4	23.0	4.6	5.3	5.0	0.0	16.1	0.0
KDR	"CD309, FLK1, VEGFR, VEGFR2"	ENSG00000128052	"Kinase insert domain receptor"	P35968	4	55078259-55125595	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 31.8;TIME: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB004028	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"		7400000	"Plasma membrane"		"CAB004028: AB_2212507"	"unprognostic (1.61e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (7.26e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-1)"	19.7	6.2	1.8	4.4	3.1	0.4	20.5	1.1	2.2	11.4	6.0	1.8	11.5	2.3	28.8	10.2	5.2	9.5	6.2	12.1	2.3	1.7	7.8	10.4	13.2	14.1	3.1	2.9	6.0	8.1	8.0	6.8	34.5	3.9	9.5	1.4	27.6	7.1	10.3	5.3	3.0	3.8	7.7	2.6	4.4	4.2	5.3	1.2	0.5	20.0	5.3	3.0	4.4	12.0	0.1	0.1	0.7	0.0	0.2	0.2	0.1	0.0	0.0	1.7	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	3.7	0.0	0.0	0.3	0.0	0.0	0.2	31.8	0.0	0.0	0.2	0.0	0.0	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	1.8	3.1	1.1	2.2	2.3	1.7	3.1	2.9	3.9	1.2
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol			320000	Cytosol		"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413348-6424794	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm			740000	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: "	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	40.3	34.3	31.4	34.5	37.2	49.9	27.6	53.8	54.2	38.9	35.6	51.4	23.9	49.5	48.0	27.5	41.5	39.2	33.3	27.4	31.3	27.7	31.0	49.2	27.0	39.3	31.7	29.8	51.0	45.3	18.4	31.4	43.4	28.1	35.0	25.6	39.2	44.4	35.9	43.7	41.8	44.8	30.3	30.3	37.9	36.1	56.3	29.2	73.9	37.8	35.0	33.4	37.7	33.7	8.9	11.5	4.9	7.6	3.1	6.3	3.5	71.7	36.1	34.5	33.5	15.0	16.4	60.1	29.5	19.6	35.0	36.1	73.2	19.6	71.2	46.3	17.1	38.8	39.3	27.8	28.0	0.3	73.8	45.8	22.3	50.7	26.3	51.4	44.3	21.2	12.6	28.8	23.6	27.2	85.2	30.2	21.1	45.8	63.0	50.8	67.2	51.1	66.6	33.8	45.6	16.2	36.9	40.9	45.3	36.3	25.3	32.1	30.1	48.0	29.5	28.8	36.1	60.8	58.0	60.4	46.8	54.3	25.3	73.1	33.7	3.2	6.9	4.5	5.7	7.6	6.0	5.9	6.0	6.3	6.4	8.9	4.2	4.5	4.9	3.1	6.3	11.5	4.1	3.5	31.4	37.2	53.8	54.2	31.3	27.7	31.7	29.8	28.1	29.2
KIAA0141	DELE	ENSG00000081791	KIAA0141	Q14154	5	141923808-141942047	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036548, HPA061490"	Uncertain		Uncertain	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA036548: AB_10673356, HPA061490: "	"unprognostic (1.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.15e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.28e-3)"	26.2	35.7	17.9	28.5	21.0	31.0	27.4	39.6	26.8	24.8	27.2	28.1	33.5	27.3	32.9	29.0	23.5	26.1	29.4	66.5	17.9	16.2	27.0	35.2	28.9	35.6	21.7	25.8	26.2	28.4	25.2	25.2	28.2	22.0	26.2	28.6	23.1	22.1	38.8	40.9	20.1	24.6	27.5	23.2	43.0	26.0	19.0	21.2	19.9	26.9	26.5	24.8	27.6	24.9	10.2	26.2	8.8	28.8	10.9	12.3	10.7	10.0	13.6	19.9	29.2	15.8	20.9	13.3	13.2	21.4	23.0	25.6	19.4	23.6	23.7	15.1	14.2	15.6	11.9	27.5	12.8	13.5	10.5	14.3	15.7	15.0	20.0	20.3	28.4	25.4	13.8	20.2	16.6	24.0	9.0	32.3	11.8	13.1	5.4	11.2	7.6	21.1	18.5	13.2	26.3	16.6	14.9	11.2	14.2	15.2	24.0	31.0	31.0	18.3	19.2	17.6	10.8	9.2	11.6	9.1	9.6	14.4	14.4	16.4	19.3	7.7	20.3	6.5	10.4	26.4	9.8	10.2	8.4	10.2	26.2	9.4	7.2	9.2	8.8	10.9	28.8	10.6	12.3	10.7	17.9	21.0	39.6	26.8	17.9	16.2	21.7	25.8	22.0	21.2
KIAA0232		ENSG00000170871	KIAA0232	Q92628	4	6781375-6884170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 13.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036891, HPA036892, HPA061498"	Approved		Approved	Cytosol				Cytosol		"HPA036891: AB_10672272, HPA036892: , HPA061498: "	"unprognostic (6.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.78e-1)"	"prognostic favourable (3.91e-10)"	"unprognostic (1.21e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.18e-2)"	12.5	12.7	18.7	8.1	22.2	14.0	13.8	22.8	25.5	13.3	13.8	20.5	12.4	8.5	15.8	13.4	21.1	15.9	12.7	32.2	19.8	18.8	19.5	15.0	12.0	7.0	20.7	17.5	13.9	10.6	25.4	22.2	25.8	25.4	15.5	12.7	11.5	10.6	15.7	32.4	7.7	18.8	13.5	19.8	12.3	11.0	13.5	17.9	10.0	15.5	13.3	8.5	12.1	13.2	1.6	2.4	13.1	2.5	2.1	3.8	0.9	8.8	8.6	18.1	11.2	13.1	14.2	9.5	11.7	12.2	8.2	6.9	5.4	7.5	5.9	4.0	13.0	4.7	9.1	5.1	10.7	3.3	3.7	17.4	7.4	7.1	6.9	7.5	23.0	9.5	12.1	9.1	5.0	8.4	13.1	5.1	10.3	4.3	14.3	7.6	9.5	9.6	10.2	18.5	2.7	13.9	8.4	13.8	8.9	8.5	7.7	8.0	9.8	13.8	10.6	7.5	9.0	6.7	9.9	8.9	8.9	4.7	9.2	8.1	20.3	1.9	2.4	6.3	2.8	1.6	3.8	1.6	2.1	3.1	1.6	1.6	2.0	2.0	13.1	2.1	2.5	2.4	1.9	0.9	18.7	22.2	22.8	25.5	19.8	18.8	20.7	17.5	25.4	17.9
KIAA0355		ENSG00000166398	KIAA0355	O15063	19	34254537-34355586	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014570	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA014570: AB_1852307"	"unprognostic (1.88e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.05e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.98e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.73e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-1)"	19.8	7.2	9.3	10.8	14.7	4.4	19.5	16.3	15.0	12.3	8.5	22.1	9.3	7.5	16.6	9.4	11.3	11.8	13.1	14.0	9.0	8.9	10.2	8.8	14.9	11.7	15.6	11.1	12.5	14.5	18.9	21.8	31.0	15.7	11.2	8.1	16.6	9.4	9.7	17.4	12.2	9.8	12.3	16.2	20.7	8.2	22.2	13.5	8.4	14.1	5.4	12.7	10.7	12.1	6.3	2.0	4.4	3.4	2.6	5.8	1.4	2.3	7.0	6.3	3.2	4.4	4.2	8.3	5.2	4.3	4.0	6.1	5.5	2.8	5.2	11.7	4.8	1.6	4.6	2.5	4.5	7.5	4.1	3.2	2.7	4.2	5.5	1.4	2.6	4.8	4.4	5.3	7.9	16.5	9.6	2.6	4.3	1.2	0.9	1.3	4.8	2.6	2.3	4.4	2.7	3.4	2.6	7.3	6.0	6.0	23.8	7.7	1.9	2.6	13.6	14.0	5.2	3.5	5.5	4.6	6.3	1.6	2.7	0.5	6.7	0.0	1.2	0.0	1.8	2.7	2.7	4.7	3.8	1.6	1.5	6.3	3.2	2.0	4.4	2.6	3.4	2.0	5.8	1.4	9.3	14.7	16.3	15.0	9.0	8.9	15.6	11.1	15.7	13.5
KIAA1109	"FLJ21404, FSA, KIAA1371, Tweek"	ENSG00000138688	KIAA1109	Q2LD37	4	122152333-122362758	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038076	Approved		Approved	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA038076: AB_10670652"	"unprognostic (2.53e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (6.62e-2)"	"unprognostic (7.61e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.97e-2)"	"prognostic favourable (4.33e-8)"	"unprognostic (2.04e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.29e-2)"	18.4	17.1	25.6	18.0	34.1	42.9	26.1	33.4	34.2	22.9	18.7	24.1	17.9	15.6	20.9	25.4	12.3	16.8	16.4	15.3	25.5	22.0	24.0	17.4	19.5	14.8	26.4	26.2	34.3	16.6	68.2	33.1	14.3	33.6	19.1	18.8	22.6	16.6	21.5	40.1	23.1	20.8	18.6	29.3	20.0	15.2	20.4	24.2	15.3	25.4	12.6	13.6	18.0	18.5	3.1	2.3	7.7	3.6	1.7	3.5	0.7	16.7	5.5	12.8	8.4	21.4	27.9	6.7	7.6	14.3	7.9	8.7	4.0	8.9	8.8	4.4	18.0	6.3	7.9	9.4	12.8	6.6	5.0	9.7	10.0	7.6	11.1	9.1	5.4	16.0	11.3	9.4	13.0	16.7	6.3	10.7	16.1	5.6	7.8	7.1	4.2	6.1	4.5	17.8	2.2	13.8	12.7	7.5	6.7	4.8	5.5	10.7	6.0	7.5	22.3	9.8	9.7	8.0	7.7	10.4	6.7	6.4	10.4	8.0	7.1	3.3	1.4	7.7	3.3	3.6	3.5	2.5	2.3	2.3	1.4	3.1	2.0	2.3	6.6	1.7	1.7	2.3	2.9	0.7	25.6	34.1	33.4	34.2	25.5	22.0	26.4	26.2	33.6	24.2
KIAA1468	"FLJ33841, HsT3308, HsT885"	ENSG00000134444	KIAA1468	Q9P260	18	62187255-62310217	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039708, HPA040038"	Approved		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"				"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA039708: AB_10794753, HPA040038: AB_10793860"	"unprognostic (1.33e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.44e-2)"	"unprognostic (6.30e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.47e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.71e-2)"	11.7	13.3	14.8	15.7	31.6	18.3	17.8	25.7	25.9	14.3	16.5	14.3	16.6	13.8	13.9	18.3	36.5	11.8	13.9	10.3	12.5	14.4	14.8	11.5	11.8	15.8	13.7	16.0	12.8	12.6	20.2	20.0	11.9	22.8	18.5	21.7	13.5	18.8	14.1	11.8	29.6	15.5	11.1	11.4	17.1	18.0	8.0	16.8	18.3	14.4	16.6	22.0	15.5	21.7	3.7	3.5	6.0	3.5	4.0	4.7	1.9	7.7	7.0	8.6	8.2	9.2	10.8	9.2	13.9	11.6	12.4	13.8	3.6	7.2	5.3	7.2	12.2	16.1	12.2	8.3	15.4	4.8	7.6	4.4	7.9	8.2	8.2	8.5	6.3	8.0	10.2	10.6	6.5	8.5	3.3	5.4	13.1	4.5	5.2	7.3	5.0	6.0	6.5	10.8	6.2	14.2	15.5	12.3	6.5	8.3	12.3	7.1	6.3	9.3	10.8	13.4	4.2	5.8	6.9	16.0	2.9	5.2	9.4	9.2	10.6	5.0	3.5	4.1	4.1	3.0	3.3	3.0	3.8	3.9	3.5	3.7	4.1	4.7	6.0	4.0	2.5	2.4	4.4	1.9	14.8	31.6	25.7	25.9	12.5	14.4	13.7	16.0	22.8	16.8
KIF11	"Eg5, HKSP, KNSL1, TRIP5"	ENSG00000138160	"Kinesin family member 11"	P52732	10	92593286-92655395	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 74.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA006916, HPA010093, HPA010568, CAB017617"	Enhanced		Supported	"Mitotic spindle,Cytosol"				Cytosol	"Mitotic spindle"	"CAB017617: AB_2131098, HPA006916: AB_1848033, HPA010093: , HPA010568: AB_1848034"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (8.19e-7)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (6.59e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.35e-3)"	"unprognostic (7.23e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.01e-1)"	2.3	1.6	1.0	20.2	2.6	14.3	1.6	0.7	1.5	2.4	4.6	0.7	0.5	3.7	1.4	1.9	11.5	0.8	2.6	2.0	1.1	1.2	1.1	1.1	2.8	12.1	1.0	1.0	1.1	1.1	0.5	0.7	3.1	1.4	1.0	5.4	0.5	2.7	0.2	0.6	4.2	4.4	1.6	1.8	5.2	2.7	10.5	1.1	74.2	1.2	7.5	13.4	2.2	3.8	2.4	0.9	2.5	1.2	3.5	3.9	1.0	30.6	13.7	31.0	28.8	2.2	3.4	7.7	22.1	19.3	24.6	24.4	12.0	20.4	33.9	11.4	10.3	22.2	22.1	11.3	28.9	20.2	12.7	21.2	13.1	12.5	0.4	34.1	19.8	1.1	1.0	19.0	17.7	15.2	15.0	39.7	18.5	12.3	29.0	19.2	12.3	9.5	31.3	30.7	12.0	6.4	9.0	9.5	13.6	17.3	7.8	9.0	21.2	10.9	8.6	11.2	16.2	11.4	29.0	11.1	17.0	34.9	9.1	24.7	15.2	2.5	0.5	0.5	0.4	1.2	1.1	2.4	1.4	1.9	0.9	1.0	0.5	0.7	1.4	3.5	0.4	0.4	3.9	1.0	1.0	2.6	0.7	1.5	1.1	1.2	1.0	1.0	1.4	1.1
KIF13B	"GAKIN, KIAA0639"	ENSG00000197892	"Kinesin family member 13B"	Q9NQT8	8	29067279-29263124	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 40.5;parathyroid gland: 107.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025023, HPA049655"	Enhanced									"HPA025023: AB_1852471, HPA049655: AB_2732555"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-1)"	"prognostic favourable (8.92e-4)"	"unprognostic (1.35e-3)"	"unprognostic (2.27e-1)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavourable (4.77e-4)"	"unprognostic (9.76e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.27e-1)"	7.4	10.5	12.3	8.2	21.5	4.8	8.7	3.2	13.8	8.6	15.1	40.5	15.4	13.6	6.1	9.1	6.9	7.1	10.5	4.6	16.5	10.4	16.3	12.5	7.6	4.3	25.9	7.1	7.2	9.7	107.1	10.2	4.4	22.0	10.0	12.2	4.9	12.9	8.9	3.9	15.2	18.0	7.3	29.3	7.7	15.6	6.1	25.1	4.2	8.4	5.1	7.9	9.4	5.9	2.9	5.4	4.1	3.8	2.0	4.1	1.0	9.0	9.8	3.5	2.9	5.7	3.4	5.1	0.5	2.2	3.0	4.8	6.1	5.2	1.9	5.3	0.6	6.1	2.8	1.6	3.8	2.8	2.7	4.7	1.4	6.1	5.6	1.3	14.8	3.9	3.0	6.6	2.8	12.9	6.1	7.2	9.6	2.8	7.0	2.2	1.7	1.7	4.0	8.0	3.5	13.0	9.8	1.0	6.9	1.8	6.1	8.5	4.5	2.7	17.0	2.1	5.9	0.6	4.0	5.3	7.8	3.2	12.6	2.5	9.9	0.3	3.8	4.1	4.1	2.9	2.0	2.9	1.6	2.4	1.2	2.0	1.3	1.7	2.0	2.0	1.4	5.4	1.5	1.0	12.3	21.5	3.2	13.8	16.5	10.4	25.9	7.1	22.0	25.1
KIF14	KIAA0042	ENSG00000118193	"Kinesin family member 14"	Q15058	1	200551497-200620734	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Ciliopathy, Disease mutation, Meckel syndrome, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 9.0;lymphoid tissue: 34.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038061, HPA058220"	Uncertain		Supported	"Midbody ring,Cytosol"				Cytosol	"Midbody ring"	"HPA038061: AB_10669515, HPA058220: "	"unprognostic (1.84e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (8.47e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-5)"	"unprognostic (2.31e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.28e-3)"	"unprognostic (3.31e-1)"	"unprognostic (8.14e-2)"	"unprognostic (7.44e-2)"	0.4	0.6	0.2	2.7	0.4	9.0	2.6	0.3	0.3	0.7	2.0	0.4	0.2	1.8	0.4	0.5	3.8	0.2	0.2	0.5	0.3	0.3	0.4	0.8	1.2	4.7	0.2	0.2	0.3	0.3	0.0	0.2	2.8	0.6	0.6	1.8	0.4	0.9	0.2	0.2	1.4	2.4	0.8	0.6	2.0	1.1	4.5	0.2	34.4	0.3	0.6	4.9	0.8	1.3	0.5	0.1	2.4	0.2	0.7	1.9	0.2	15.5	9.2	14.6	8.1	0.4	1.7	8.1	10.7	6.3	10.3	9.3	5.5	8.1	9.4	3.8	5.1	12.4	11.6	7.1	14.8	11.5	6.1	15.1	13.1	5.4	0.0	23.6	8.6	0.3	0.3	11.4	9.8	7.2	22.6	12.3	12.7	6.3	13.8	7.4	12.3	8.1	12.7	19.3	12.0	3.4	4.4	6.9	7.7	15.1	5.2	6.2	7.0	6.1	5.9	8.1	9.7	8.8	18.6	4.5	4.5	13.8	4.7	12.7	16.5	2.4	0.1	0.1	0.1	0.2	0.1	0.5	0.5	0.4	0.0	0.4	0.2	0.1	0.5	0.7	0.1	0.1	1.9	0.2	0.2	0.4	0.3	0.3	0.3	0.3	0.2	0.2	0.6	0.2
KIF15	"HKLP2, KNSL7, NY-BR-62"	ENSG00000163808	"Kinesin family member 15"	Q9NS87	3	44761717-44873376	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 33.5;testis: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA035516, HPA035517"	Approved									"HPA035516: , HPA035517: AB_10671935"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.17e-3)"	"unprognostic (6.68e-7)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.14e-4)"	"unprognostic (2.72e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.58e-1)"	0.4	0.3	0.4	4.4	0.4	6.5	0.4	0.4	0.9	0.8	2.0	0.1	0.5	1.9	0.4	0.7	2.6	0.3	0.3	0.6	0.4	0.3	0.3	0.3	0.5	3.2	0.4	0.0	0.3	0.2	0.0	0.3	0.9	0.2	0.3	2.4	0.3	0.6	0.0	0.3	1.1	1.9	0.3	0.3	1.9	0.8	13.0	0.0	33.5	0.3	2.4	3.2	0.6	0.9	0.9	0.0	0.0	0.4	0.0	2.0	0.4	5.4	2.9	12.7	9.4	0.9	1.0	2.9	6.3	3.8	7.6	6.6	4.7	5.4	9.4	2.1	2.1	4.7	7.2	3.3	9.3	8.4	2.1	10.4	6.0	5.9	0.1	10.5	4.8	0.2	0.1	5.2	5.1	6.0	6.6	12.2	6.1	3.0	20.6	4.0	13.4	5.0	8.1	14.0	5.7	1.7	3.6	6.2	5.6	10.1	3.3	2.1	5.4	8.2	3.4	8.0	6.5	6.2	8.5	5.4	8.8	12.4	4.1	12.2	7.5	0.0	0.0	0.0	0.5	0.4	0.0	0.9	0.6	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.4	0.4	0.4	0.4	0.9	0.4	0.3	0.4	0.0	0.2	0.0
KIF17	"KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3"	ENSG00000117245	"Kinesin family member 17"	Q9P2E2	1	20664014-20718017	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;testis: 19.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 3.7;hTERT-HME1: 8.2;U-2 OS: 4.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA032085	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA032085: AB_10669917"	"unprognostic (4.15e-3)"	"unprognostic (8.60e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.34e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.20e-2)"	0.1	0.4	2.4	0.2	5.2	0.1	0.1	0.0	3.9	0.4	0.2	0.4	0.0	0.3	0.4	0.8	0.1	3.1	0.2	0.2	1.8	3.5	0.2	0.1	0.4	0.1	0.4	0.7	0.6	0.1	0.2	1.5	0.7	0.5	0.4	0.1	0.0	0.1	0.8	0.1	0.1	0.2	0.9	0.3	0.1	0.1	19.4	0.0	0.0	0.9	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	0.9	0.0	0.0	0.1	0.2	2.7	3.7	1.5	0.9	0.4	1.0	0.0	1.2	1.9	0.0	1.3	0.9	1.1	0.0	0.3	0.0	0.0	0.4	1.6	0.0	0.0	0.3	0.8	1.0	8.2	0.0	0.6	0.0	1.8	0.1	0.0	0.0	2.5	1.7	0.0	0.1	0.0	0.6	0.0	0.6	1.5	0.4	0.0	0.3	0.0	0.0	0.0	0.6	4.9	0.5	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	5.2	0.0	3.6	1.8	3.5	0.4	0.7	0.5	0.0
KIF1B	"CMT2, CMT2A, HMSNII, KIAA0591, KLP"	ENSG00000054523	"Kinesin family member 1B"	O60333	1	10210805-10381603	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Motor protein"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015177	Approved									"CAB015177: AB_2296564"	"unprognostic (1.30e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.82e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.20e-1)"	"prognostic favourable (2.91e-6)"	"unprognostic (1.51e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.33e-3)"	7.8	11.0	32.9	6.2	30.2	10.3	9.0	37.0	43.2	7.4	7.6	31.0	2.0	7.1	10.0	5.7	12.9	7.4	7.8	19.3	28.3	23.7	10.8	7.4	7.4	3.5	29.2	21.5	11.7	8.9	21.2	5.8	7.5	29.9	8.9	7.2	9.5	8.2	7.5	112.9	9.1	7.7	10.9	25.2	5.3	5.4	13.1	25.6	0.3	8.2	13.0	4.2	6.2	5.4	0.8	1.1	8.0	1.8	0.8	1.2	0.7	10.6	7.7	36.1	14.0	10.0	11.3	3.1	10.4	7.3	11.1	11.3	8.4	5.3	1.5	10.6	16.8	7.7	25.9	8.2	15.4	14.9	8.6	6.3	11.4	9.8	8.0	2.2	2.0	8.7	8.4	18.8	12.0	13.6	7.0	6.3	12.2	3.2	2.4	2.2	7.9	5.7	10.5	21.0	2.8	4.6	5.3	24.8	12.1	14.7	7.1	14.5	5.0	3.0	15.8	13.1	8.4	14.6	9.9	3.5	5.8	3.4	11.3	6.8	6.5	2.9	1.4	8.0	1.1	1.4	0.5	0.7	1.1	1.2	1.1	0.8	0.7	0.6	7.5	0.8	1.8	0.8	1.2	0.7	32.9	30.2	37.0	29.5	28.3	23.7	29.2	21.5	29.9	25.6
KIF1C	"SAX2, SPAX2, SPG58"	ENSG00000129250	"Kinesin family member 1C"	O43896	17	4997948-5028401	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 172.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024602, HPA045020"	Approved									"HPA024602: AB_1852480, HPA045020: "	"unprognostic (3.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.74e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.69e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.90e-3)"	"prognostic favourable (2.26e-9)"	"unprognostic (1.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.10e-3)"	18.8	6.3	34.1	9.2	33.6	2.9	43.9	8.0	18.9	10.6	16.4	25.2	9.9	19.3	10.3	8.6	27.7	7.8	14.8	60.1	37.3	25.5	14.8	14.8	17.0	7.4	44.4	8.7	7.4	18.7	18.7	2.6	7.4	17.1	12.2	12.7	7.8	12.8	14.8	172.0	13.2	18.3	15.6	53.7	9.5	15.8	6.0	22.0	2.1	15.8	32.0	7.4	11.8	37.8	1.8	1.1	4.6	1.9	1.1	1.2	0.5	27.8	26.8	9.0	19.4	21.4	12.9	14.3	22.3	17.9	17.8	10.9	19.2	6.8	4.5	13.2	34.8	29.0	16.2	29.5	12.7	10.8	19.0	3.2	34.1	15.4	14.6	1.3	9.7	13.2	30.9	23.9	16.5	24.2	12.1	7.9	17.4	16.6	3.9	2.1	7.0	17.6	4.0	15.2	4.6	15.8	19.7	2.2	4.3	31.5	17.6	9.9	17.3	4.0	50.9	24.1	18.3	17.4	26.9	3.0	2.5	2.4	17.8	5.7	11.9	1.7	1.9	2.4	0.9	1.7	0.9	1.4	0.9	1.1	1.1	1.8	0.9	1.0	4.6	1.1	0.9	0.9	1.2	0.5	34.1	33.6	8.0	18.9	37.3	25.5	44.4	8.7	17.1	22.0
KIF21B	"DKFZP434J212, KIAA0449"	ENSG00000116852	"Kinesin family member 21B"	O75037	1	200969390-201023700	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.3;brain: 20.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 16.4;HMC-1: 17.5;Karpas-707: 20.7;RPMI-8226: 17.6;U-266/70: 37.8;U-266/84: 17.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027249, HPA027274"	Approved		Approved	"Plasma membrane,Mitotic spindle,Cytosol"				"Plasma membrane"	"Mitotic spindle, Cytosol"	"HPA027249: AB_10602241, HPA027274: AB_1852483"	"unprognostic (3.49e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.92e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.41e-4)"	"unprognostic (5.98e-3)"	"unprognostic (2.64e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.81e-4)"	2.2	1.6	19.8	10.0	12.9	34.3	1.5	3.7	20.4	1.5	2.8	6.0	1.0	2.7	1.4	1.0	1.5	1.4	2.9	1.5	15.1	12.5	1.4	1.7	4.3	15.7	8.3	12.7	1.4	1.5	11.3	0.9	1.6	7.1	1.2	2.6	8.6	2.1	1.7	0.9	1.3	6.1	1.5	4.3	11.5	3.2	11.1	4.9	10.8	1.2	0.0	9.1	3.7	1.1	0.9	0.2	8.0	0.5	2.4	1.7	0.6	0.5	0.6	4.9	0.2	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.1	16.4	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	3.9	0.1	0.1	0.4	12.0	17.5	0.4	1.7	0.1	0.3	0.6	1.8	20.7	0.0	0.0	9.5	4.3	2.1	0.0	3.3	0.0	17.6	0.1	0.0	3.4	0.4	0.2	0.2	0.2	0.0	3.6	1.1	0.0	1.5	0.0	0.1	37.8	17.5	8.2	1.7	5.2	0.1	8.0	0.1	1.0	1.6	0.4	1.7	0.9	1.2	1.7	0.1	0.7	1.0	1.1	2.0	2.4	0.5	0.2	1.0	0.6	19.8	12.9	3.7	20.0	15.1	12.5	8.3	12.7	7.1	4.9
KIF22	"Kid, KNSL4, OBP-1, OBP-2"	ENSG00000079616	"Kinesin family member 22"	Q14807	16	29790719-29805385	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041076, HPA048213"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA041076: AB_10794540, HPA048213: "	"unprognostic (3.71e-2)"	"prognostic favourable (3.87e-8)"	"unprognostic (1.86e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.67e-1)"	5.6	4.3	8.5	21.7	11.2	38.9	7.0	6.4	10.9	5.1	12.5	8.8	3.0	8.4	5.1	10.1	13.6	6.5	6.0	5.6	6.2	5.9	7.2	4.5	5.8	16.1	6.3	6.2	5.8	3.9	18.6	5.7	22.1	5.8	13.2	10.7	8.9	6.3	9.6	4.0	16.7	9.6	4.1	5.8	11.6	5.9	17.9	5.9	78.2	16.8	13.1	19.0	6.5	7.6	13.6	6.6	19.7	9.1	13.3	25.0	17.1	21.5	23.1	30.5	22.0	2.1	3.1	26.8	16.3	13.1	31.4	29.4	22.2	25.8	31.4	15.3	8.4	22.5	29.8	16.8	14.7	20.5	23.9	17.4	25.1	28.1	0.7	18.9	19.3	1.7	4.5	17.4	13.1	16.9	25.4	26.3	16.4	43.8	41.3	47.6	25.7	14.3	57.8	27.1	30.0	11.3	10.1	25.5	16.5	11.9	23.8	8.3	21.4	25.7	7.4	16.4	17.3	14.5	17.6	24.6	24.3	33.9	10.7	31.3	20.9	19.7	6.4	17.0	23.6	9.1	17.6	13.6	23.7	25.0	6.6	11.3	19.5	18.5	2.8	13.3	7.7	4.2	24.0	17.1	8.5	11.2	6.4	10.9	6.2	5.9	6.3	6.2	5.8	5.9
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome			2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: , HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favourable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (5.45e-4)"	"prognostic unfavourable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.2	17.3	28.9	25.6	10.9	15.4	23.6	18.5	15.3	20.2	25.6	18.6	18.9	42.8	20.4	16.3	11.0	21.9	14.9	27.0	42.9	15.3	43.0	16.2	10.1	12.9	23.4	16.4	12.7	9.8	19.6	17.8	18.4	30.4	26.1	16.8	13.0	39.1	11.6	16.8	10.9	28.9	22.9	23.6	9.0	21.0	25.9	21.5	25.1	10.6	13.0	13.8	13.2	15.9	12.0	19.9	13.9	18.4	24.7	35.6	45.2	13.9	28.2	14.7	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4
KIF2C	"CT139, KNSL6, MCAK"	ENSG00000142945	"Kinesin family member 2C"	Q99661	1	44739818-44767767	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.9;testis: 61.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA006219			Supported	Nucleoplasm,Midbody,Centrosome				"Nucleoplasm, Centrosome"	Midbody	"HPA006219: "	"unprognostic (3.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (3.07e-7)"	"unprognostic (7.49e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (6.86e-4)"	"unprognostic (4.27e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (2.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.41e-1)"	1.1	0.7	0.4	8.7	0.4	12.7	0.8	0.5	0.5	1.2	2.4	0.4	0.2	2.1	1.3	1.4	4.6	0.6	0.7	0.9	0.6	0.5	0.7	0.6	1.6	6.7	0.4	0.2	0.7	0.4	0.3	0.6	2.2	0.6	0.6	3.2	0.4	1.1	0.2	0.4	2.3	2.2	1.1	0.4	3.3	1.4	61.4	0.2	39.9	0.8	4.7	12.0	0.9	1.7	1.3	1.5	0.0	0.2	3.9	5.8	1.0	28.7	11.2	25.0	20.0	1.3	2.9	16.8	21.6	15.4	44.2	38.6	18.9	20.8	33.1	10.4	10.6	13.7	25.4	14.5	40.5	21.4	10.9	39.2	19.8	15.7	0.1	28.9	18.2	0.7	1.4	31.5	15.4	14.2	30.9	28.4	27.9	11.2	30.4	17.5	24.4	14.1	24.4	37.8	20.8	7.4	10.4	17.2	12.3	28.7	20.5	18.1	11.8	22.0	8.4	16.1	31.9	17.4	37.8	15.1	15.3	47.8	10.3	28.2	30.9	0.0	0.0	0.0	1.9	0.0	0.1	1.3	3.4	2.6	0.3	0.2	0.7	0.5	0.0	3.9	0.2	1.5	5.8	1.0	0.4	0.4	0.5	0.5	0.6	0.5	0.4	0.2	0.6	0.2
KIF3B	"FLA8, KIAA0359, KLP-11"	ENSG00000101350	"Kinesin family member 3B"	O15066	20	32277664-32335011	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007119	Approved		Uncertain	"Nucleoplasm,Nucleoli,Golgi apparatus"				Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA007119: AB_1852498"	"unprognostic (1.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (9.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.44e-12)"	"unprognostic (2.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.42e-2)"	8.4	11.0	22.9	7.7	30.2	5.5	9.1	17.6	24.6	11.6	13.4	13.3	7.7	14.3	8.8	13.5	5.8	15.4	11.0	6.2	19.9	15.1	26.4	17.8	9.3	7.7	15.1	18.7	10.5	16.9	38.5	18.1	6.4	13.2	9.0	14.2	11.8	8.4	8.6	5.3	5.8	17.1	9.0	16.0	6.8	12.7	15.3	13.7	4.3	14.3	4.1	8.4	8.5	6.5	6.5	3.1	3.7	5.9	2.6	6.6	1.8	22.6	15.5	10.7	13.8	14.3	22.8	11.0	11.3	15.9	13.7	10.8	26.3	12.5	12.2	13.6	21.2	14.7	13.8	16.7	17.5	5.8	6.3	10.6	12.3	12.9	9.1	8.9	8.1	14.0	12.0	23.6	9.4	11.1	6.5	4.9	11.0	10.4	4.1	4.1	5.8	13.6	3.8	17.7	4.4	14.1	16.8	17.7	14.9	29.5	7.9	11.3	17.4	6.9	13.5	25.8	17.6	15.0	13.9	8.3	11.8	6.4	25.7	15.6	10.4	1.3	3.1	3.7	6.6	4.2	5.5	6.1	5.0	6.1	1.7	6.5	3.1	4.6	3.2	2.6	5.9	3.1	3.9	1.8	22.9	30.2	17.6	24.6	19.9	15.1	15.1	18.7	13.2	13.7
KIF3C		ENSG00000084731	"Kinesin family member 3C"	O14782	2	25926596-25982749	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 72.9"	"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 29.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035755			Approved	"Nuclear membrane,Nuclear bodies,Intermediate filaments"				"Nuclear bodies, Intermediate filaments"	"Nuclear membrane"	"HPA035755: AB_10602242"	"unprognostic (3.95e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.96e-4)"	"unprognostic (1.53e-2)"	"prognostic favourable (1.22e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.90e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.22e-1)"	3.0	7.3	22.8	2.9	21.2	2.2	2.6	22.7	72.9	3.6	2.4	3.8	0.0	2.1	3.9	2.6	3.0	3.3	4.1	3.0	21.6	18.9	2.0	1.6	2.6	2.0	17.5	20.3	7.3	2.3	4.5	4.8	2.8	22.8	3.3	2.6	1.9	1.9	4.6	2.4	2.3	2.7	4.8	6.2	2.2	2.0	3.0	5.2	0.5	2.5	0.0	2.0	3.5	1.5	0.1	0.3	2.4	0.2	0.7	2.0	1.3	13.0	19.8	10.6	8.1	6.2	7.2	8.5	6.8	3.4	4.1	4.7	3.5	2.0	0.0	5.7	6.2	1.4	8.0	4.1	2.8	2.2	3.8	4.7	1.5	7.1	3.7	1.2	4.1	5.2	1.2	12.9	2.6	13.6	1.7	1.7	4.3	0.9	3.3	1.6	10.8	5.8	5.3	5.2	0.8	9.4	3.2	12.9	29.1	2.7	1.2	14.3	0.4	1.6	10.7	7.2	7.4	3.2	6.6	0.4	2.3	1.5	16.3	6.4	6.1	0.0	0.2	0.0	0.4	0.0	1.1	0.0	1.6	1.5	0.3	0.1	0.5	0.6	2.4	0.7	0.0	0.2	2.0	1.3	22.8	21.2	22.7	40.0	21.6	18.9	17.5	20.3	22.8	5.2
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018132	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 9.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.4	0.1	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	0.5	0.1	0.0	0.1	0.7	0.0	0.4	1.0	0.4	0.0	0.4	0.7	0.0	0.3	0.2	0.0	1.1	0.2	2.4	0.4	0.0	0.8	0.5	0.5	0.5	0.7	1.1	1.0	0.0	0.7	0.5	0.5	1.3	0.2	0.3	0.5	0.5	0.2	0.7	1.2	0.7	1.2	0.4	0.6	0.5	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0										
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009010-32056431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"			260000	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	26.3	19.9	55.7	20.2	55.5	34.1	23.0	22.2	42.4	23.8	34.2	21.7	20.9	23.5	25.7	17.8	28.0	20.3	28.0	48.4	51.5	39.3	21.1	15.3	23.8	16.5	62.9	26.1	18.2	18.9	56.8	22.4	27.7	38.3	31.8	30.0	8.9	20.1	25.6	34.3	17.6	28.6	37.2	80.4	21.1	23.1	27.7	43.7	25.0	23.5	21.5	16.1	33.8	28.1	13.8	27.6	30.0	18.9	13.4	16.5	9.2	29.4	25.1	34.0	23.8	24.4	26.9	14.5	40.7	19.3	31.5	26.9	27.5	32.6	20.2	17.7	48.3	24.5	31.0	26.0	42.3	17.4	16.9	25.7	23.5	26.8	28.1	17.8	28.3	21.8	37.0	36.3	25.4	40.2	30.9	21.3	43.5	17.7	18.6	10.1	5.5	11.5	24.4	63.4	8.3	24.3	20.7	33.1	24.2	31.5	12.6	30.3	15.2	25.6	33.5	32.1	30.1	37.1	30.1	6.4	7.4	23.9	30.6	36.9	30.1	20.8	15.2	24.2	11.8	18.9	11.4	13.6	14.9	12.5	14.2	13.8	13.3	13.0	30.0	13.4	18.9	27.6	16.5	9.2	55.7	55.5	22.2	42.4	51.5	39.3	62.9	26.1	38.3	43.7
KIF5C		ENSG00000168280	"Kinesin family member 5C"	O60282	2	148875250-149026759	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport	"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 95.8"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 65.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.9"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035210, HPA062272"	Enhanced		Approved	Vesicles				Vesicles		"HPA035210: AB_10671931, HPA062272: "	"unprognostic (1.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.70e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.56e-1)"	"unprognostic (6.55e-6)"	"unprognostic (8.34e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.46e-2)"	1.8	10.5	32.0	2.3	31.8	1.3	1.6	33.8	95.8	2.2	2.5	21.7	0.0	1.6	1.8	11.0	1.4	1.6	1.7	1.6	25.4	13.7	1.6	1.2	1.5	1.8	15.8	25.5	3.3	2.5	1.5	12.6	1.3	27.1	21.9	3.2	0.4	1.4	7.5	1.3	1.4	2.3	2.0	20.1	1.6	2.4	13.5	18.3	0.0	3.6	0.0	1.7	2.4	1.0	0.8	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	12.6	2.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.1	0.6	0.0	0.1	0.0	7.3	0.0	1.4	3.7	1.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	12.7	3.9	0.0	0.1	0.0	0.0	2.7	65.3	15.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	1.1	0.0	1.8	1.2	0.2	0.0	4.6	0.2	0.4	0.0	0.0	0.0	0.3	0.0	5.9	0.5	1.1	1.4	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.7	0.0	32.0	31.8	33.8	40.3	25.4	13.7	15.8	25.5	27.1	18.3
KIFAP3	"FLA3, KAP-1, KAP3, SMAP"	ENSG00000075945	"Kinesin associated protein 3"	Q92845	1	169921326-170085208	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023738, HPA023742"	Supported									"HPA023738: AB_1857285, HPA023742: AB_1857286"	"unprognostic (5.72e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.89e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.17e-3)"	"unprognostic (7.74e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.00e-2)"	"unprognostic (3.08e-3)"	"unprognostic (4.39e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.22e-2)"	11.4	25.0	21.7	7.8	28.8	4.1	11.6	24.2	49.1	14.1	13.5	12.3	6.7	8.0	12.3	16.9	9.0	13.8	10.8	34.1	25.6	27.2	16.5	11.3	10.6	9.2	19.3	26.8	14.1	9.3	20.1	16.4	10.0	40.6	10.5	11.2	8.3	9.1	12.0	15.3	8.9	9.7	11.0	18.0	7.1	6.9	22.8	10.6	9.3	11.8	6.8	9.3	8.8	11.4	6.1	6.8	12.4	13.7	17.1	13.9	6.5	6.1	5.7	8.6	9.3	20.6	21.9	4.9	7.7	9.7	9.7	12.0	2.8	9.9	11.0	11.5	15.9	13.4	18.2	10.9	9.2	23.2	9.6	26.6	7.0	2.5	10.3	7.7	4.6	15.4	14.9	17.1	15.0	10.8	22.1	8.4	12.0	1.6	14.4	4.6	1.9	5.1	5.8	7.6	6.9	18.3	2.3	10.3	15.8	10.6	8.8	11.6	8.1	4.9	11.6	20.9	4.8	13.1	9.2	16.3	11.0	10.2	9.7	2.8	13.2	12.4	3.0	10.9	10.9	8.1	12.3	6.1	11.0	12.3	6.8	5.9	12.7	13.0	1.1	17.1	13.7	6.0	13.9	6.5	21.7	28.8	24.2	49.1	25.6	27.2	19.3	26.8	40.6	10.6
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391536-33409924	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 60.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome				Centrosome		"HPA055997: , HPA062674: "	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	0.9	0.8	0.0	18.0	0.3	9.6	1.5	0.0	0.5	1.7	5.7	0.1	0.3	3.0	0.9	1.6	10.1	0.5	2.2	0.8	0.0	0.0	0.7	0.7	2.2	6.3	0.1	0.2	1.5	0.3	0.2	0.2	3.6	0.4	0.6	2.5	0.6	1.7	0.1	0.4	3.3	4.2	0.7	0.4	4.7	2.5	9.7	0.2	60.9	0.4	7.4	14.6	0.6	2.8	0.8	0.3	0.0	0.1	0.2	1.4	0.7	10.6	1.8	10.2	10.7	0.2	0.4	6.2	7.7	1.9	6.1	5.2	3.7	4.7	7.0	3.0	1.6	5.8	2.6	3.6	6.7	4.1	5.8	5.7	8.6	5.4	0.0	4.6	6.3	0.0	0.9	5.1	1.5	0.5	1.7	17.4	4.6	2.7	2.7	9.3	4.7	2.2	7.0	5.7	2.4	0.9	2.4	9.3	4.1	2.8	5.9	1.4	6.2	4.8	1.4	3.2	10.0	5.4	11.4	5.7	10.9	6.8	0.0	6.9	5.7	0.0	0.1	0.0	0.4	0.0	0.6	0.8	0.3	1.4	0.3	0.8	0.3	0.3	0.0	0.2	0.0	0.1	0.6	0.7	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.2	0.4	0.2
KIRREL3	"KIAA1867, KIRRE, NEPH2"	ENSG00000149571	"Kirre like nephrin family adhesion molecule 3"	Q8IZU9	11	126423359-127003460	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 10.9;brain: 28.2"	"Cell line enhanced"	"Detected in some"		"BJ: 18.7;BJ hTERT+: 11.0;BJ hTERT+ SV40 Large T+: 7.0;BJ hTERT+ SV40 Large T+ RasG12V: 7.4;fHDF/TERT166: 13.4;U-138 MG: 8.6;U-251 MG: 10.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 10.9"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053324	Enhanced				"Intracellular and membrane"					"HPA053324: "	"unprognostic (1.92e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.23e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.05e-3)"	"unprognostic (3.81e-2)"	"unprognostic (4.06e-6)"	"unprognostic (9.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.92e-1)"	1.2	4.0	12.3	1.9	20.0	1.4	1.0	13.2	28.2	1.5	2.2	23.6	0.0	1.7	1.1	1.0	1.7	1.1	1.4	2.3	9.1	7.2	1.1	1.0	1.0	2.1	7.2	11.7	1.3	1.4	0.9	0.1	1.6	9.9	1.0	1.8	0.6	3.5	3.4	1.0	1.1	1.7	1.9	8.9	2.6	1.5	1.2	12.1	0.0	1.0	0.0	1.9	1.1	0.2	0.0	10.9	0.9	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.1	0.1	18.7	11.0	7.0	7.4	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	4.4	0.1	0.0	0.1	0.2	0.0	0.0	0.2	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.8	0.0	0.0	4.4	0.1	0.3	0.0	0.0	0.9	0.0	0.1	2.1	0.2	0.0	0.1	0.0	0.1	0.2	0.0	8.6	6.0	3.4	10.2	0.0	0.0	0.0	0.0	0.0	4.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.0	12.3	20.0	13.2	17.4	9.1	7.2	7.2	11.7	9.9	12.1
KIT	"C-Kit, CD117, PBT, SCFR"	ENSG00000157404	"KIT proto-oncogene receptor tyrosine kinase"	P10721	4	54657918-54740715	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 65.5"	"Group enriched"	"Detected in some"	13	"HEL: 47.7;HMC-1: 100.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7"	"Group enriched"	"Detected in many"	6	"granulocytes: 12.7;NK-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003288, HPA004471, CAB068253, CAB072867, HPA073252"	Enhanced	Supported	Supported	"Plasma membrane"			48000000	"Plasma membrane"		"CAB003288: AB_2335702, CAB068253: , CAB072867: , HPA004471: AB_1078431, HPA073252: "	"unprognostic (1.55e-2)"	"unprognostic (1.91e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.96e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	8.1	1.6	9.5	6.6	11.8	3.7	65.5	18.3	12.0	12.1	10.3	6.5	10.2	5.8	8.9	4.2	9.9	2.5	15.5	2.4	36.0	4.4	9.4	1.1	13.8	3.8	3.6	6.0	28.5	2.1	1.3	2.3	6.2	5.7	9.6	10.4	20.7	12.9	6.9	1.3	14.6	8.9	10.2	3.9	3.2	12.8	4.0	4.5	0.4	28.9	4.3	4.9	9.8	12.5	0.0	1.8	12.7	0.9	9.7	1.9	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.6	0.9	2.5	3.2	0.0	0.0	0.0	0.0	1.4	0.0	0.5	0.0	2.1	0.0	1.1	47.7	0.0	0.0	0.0	0.0	100.2	0.0	0.0	0.0	0.0	5.6	0.6	0.1	0.0	0.0	0.2	0.4	1.3	0.0	0.1	0.0	0.0	0.0	4.7	1.2	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	12.7	0.0	10.0	0.1	0.0	1.9	0.0	0.3	0.7	1.8	0.0	0.0	0.0	0.8	9.7	0.9	0.0	0.0	0.1	9.5	11.8	18.3	12.0	36.0	4.4	3.6	6.0	5.7	4.5
KITLG	"DFNA69, FPH2, Kitl, KL-1, MGF, SCF, SF, SLF"	ENSG00000049130	"KIT ligand"	P21583	12	88492793-88580851	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Cell adhesion"	"Growth factor"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 81.7;SK-BR-3: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070395	Approved		Approved	Vesicles	"Intracellular and membrane"		150000	Vesicles		"HPA070395: "	"unprognostic (7.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.61e-3)"	"unprognostic (7.89e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.03e-2)"	"prognostic favourable (5.81e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.54e-2)"	10.1	3.8	7.8	8.0	6.4	0.0	11.2	4.8	11.5	9.6	16.1	2.9	8.5	6.2	11.7	8.7	16.7	4.7	13.9	5.6	8.4	3.9	21.9	2.8	22.9	6.1	3.3	7.7	4.4	5.0	1.9	3.2	10.1	4.0	17.9	15.9	7.8	11.8	14.8	4.8	5.3	9.5	21.0	3.7	2.6	13.0	5.8	2.9	0.7	6.5	5.8	6.6	17.5	17.8	0.0	0.2	0.0	0.5	0.0	0.0	0.0	3.4	1.9	1.8	0.2	7.1	15.3	0.0	21.0	15.0	3.6	1.6	81.7	3.3	0.0	0.6	17.6	12.7	2.7	4.7	3.4	0.0	2.4	0.0	2.9	0.6	1.1	0.4	0.0	13.2	5.0	11.4	6.8	4.3	0.0	0.0	1.6	0.6	0.0	0.0	1.2	4.7	0.0	3.3	0.0	6.0	1.7	0.5	1.2	5.1	28.5	0.5	14.6	1.0	2.9	16.5	2.3	19.2	1.6	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.4	4.8	11.5	8.4	3.9	3.3	7.7	4.0	2.9
KLF13	"BTEB3, FKLF-2, NSLP1, RFLAT-1"	ENSG00000169926	"Kruppel like factor 13"	Q9Y2Y9	15	31326855-31435665	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.13e-2)"	"unprognostic (9.41e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.10e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.96e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.09e-1)"	"prognostic favourable (2.37e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.03e-2)"	26.2	13.5	18.0	13.5	22.1	53.5	12.5	39.4	29.3	12.1	16.0	29.0	12.1	16.5	12.4	10.4	12.5	14.9	12.6	20.5	21.3	11.0	16.7	14.3	22.9	18.0	24.7	15.6	10.6	46.2	17.2	8.1	6.0	14.4	6.7	15.3	7.5	12.2	13.3	23.6	30.2	18.9	22.2	19.6	21.9	14.4	5.4	27.2	58.7	20.2	13.7	19.1	10.6	13.6	17.5	13.1	5.6	3.2	0.9	14.0	2.7	4.4	0.4	6.4	2.6	15.3	8.2	0.5	4.4	7.1	2.5	3.0	3.7	3.1	0.8	9.4	8.4	6.9	1.8	5.4	1.9	21.0	1.5	10.6	11.6	2.9	21.9	9.5	14.4	4.8	37.3	2.0	14.0	0.1	4.5	2.3	1.2	1.3	13.2	11.6	1.2	9.0	7.7	6.4	7.2	4.9	1.9	7.3	15.9	5.6	9.4	0.0	1.4	5.8	9.5	1.9	5.2	7.2	0.0	14.1	7.4	2.9	1.6	14.5	2.2	1.0	3.2	4.1	8.5	1.4	9.3	17.5	5.2	8.2	0.8	12.7	4.5	14.0	5.6	0.9	1.2	13.1	12.3	2.7	18.0	22.1	39.4	29.3	21.3	11.0	24.7	15.6	14.4	27.2
KLF7	UKLF	ENSG00000118263	"Kruppel like factor 7"	O75840	2	207074137-207167267	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 24.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030490	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA030490: AB_10601922"	"unprognostic (5.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.85e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.75e-2)"	"unprognostic (8.78e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.47e-1)"	"prognostic favourable (4.26e-4)"	"unprognostic (3.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.47e-2)"	22.2	10.1	10.3	15.1	12.0	40.7	17.3	30.2	12.0	12.2	12.1	14.6	9.3	5.7	19.7	13.4	11.6	10.2	13.8	12.1	10.3	8.0	9.9	8.4	17.1	15.7	12.9	9.1	17.1	6.1	3.0	6.4	7.0	17.4	10.2	6.7	7.0	8.9	9.3	6.2	7.9	11.9	24.2	25.7	11.3	10.7	7.9	14.7	14.4	10.8	8.5	8.3	18.4	18.2	4.5	3.0	24.0	11.7	12.9	9.0	3.5	4.4	3.2	8.7	0.6	3.0	7.9	1.8	5.2	4.2	8.2	3.6	0.0	3.7	0.0	3.4	10.7	11.2	7.3	24.2	4.4	3.1	0.4	0.1	8.8	1.8	5.3	2.3	3.6	10.5	8.2	5.7	18.9	9.5	0.0	4.3	6.3	0.1	2.8	0.8	5.1	1.6	1.2	2.3	3.2	1.9	3.5	13.4	16.4	4.5	6.4	4.2	1.0	3.6	18.8	16.4	7.9	6.9	6.2	3.3	2.2	0.0	14.4	2.0	3.2	11.5	5.4	6.8	0.9	6.8	0.4	3.0	5.1	1.0	3.0	4.5	9.0	6.1	24.0	12.9	11.7	1.4	4.1	3.5	10.3	12.0	30.2	12.0	10.3	8.0	12.9	9.1	17.4	14.7
KLF8	"BKLF3, DXS741, ZNF741"	ENSG00000102349	"Kruppel like factor 8"	O95600	X	56232421-56287889	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 11.9;RT4: 10.4;SK-BR-3: 9.2;T-47d: 16.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071740			Supported	Nucleoplasm				Nucleoplasm		"HPA071740: "	"unprognostic (2.32e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.50e-8)"	"unprognostic (2.96e-1)"	"prognostic favourable (3.32e-4)"	"unprognostic (6.56e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-3)"	"unprognostic (3.15e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.60e-2)"	15.1	2.0	2.9	7.9	7.4	0.4	15.0	6.7	5.5	12.9	5.0	0.8	5.2	1.2	19.2	8.6	24.8	6.8	4.8	4.3	2.4	1.8	8.8	0.9	8.3	2.7	1.3	3.3	10.3	2.0	4.0	2.0	7.9	2.9	5.3	4.0	5.2	8.8	4.7	3.3	28.4	4.9	11.6	1.9	5.0	3.4	5.3	0.9	0.7	5.5	16.6	14.3	9.7	14.3	5.0	2.1	0.6	0.2	4.1	1.4	0.5	2.1	0.0	0.1	0.0	1.9	0.5	1.3	0.2	2.3	0.0	0.0	0.0	0.0	0.0	2.8	0.0	5.1	0.0	0.0	0.0	4.0	4.9	1.4	0.0	0.0	0.1	0.0	0.0	0.1	11.9	0.0	1.8	0.0	1.2	0.6	0.4	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.1	5.6	10.4	0.0	0.0	4.4	9.2	0.0	16.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.3	0.2	0.4	5.0	1.2	1.4	2.1	4.6	0.3	0.3	0.5	4.1	0.1	0.8	0.5	0.5	2.9	7.4	6.7	5.5	2.4	1.8	1.3	3.3	2.9	0.9
KLHL41	"KBTBD10, Krp1, SARCOSIN"	ENSG00000239474	"Kelch like family member 41"	O60662	2	169509702-169526262	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"skeletal muscle: 564.4;tongue: 157.3"	"Group enriched"	"Detected in some"	9	"HSkMC: 12.5;LHCN-M2: 19.8;RH-30: 31.8"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 10.8;prostate cancer: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA021165, HPA021753, HPA021760"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"HPA021165: AB_1852087, HPA021753: AB_1852089, HPA021760: AB_1852091"	"unprognostic (2.44e-2)"	"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.65e-4)"	"unprognostic (9.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.52e-1)"	12.0	0.1	0.2	0.1	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.0	0.0	0.1	0.1	17.8	9.8	0.2	0.6	10.2	0.2	0.3	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.5	0.1	0.0	3.9	0.1	0.0	6.6	0.1	564.4	0.2	0.1	2.3	0.2	0.1	0.2	0.5	0.0	0.0	2.0	157.3	5.0	2.1	0.1	0.2	0.5	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.1	0.0	12.5	0.2	0.1	0.0	0.0	0.0	0.0	19.8	0.0	0.0	0.0	0.0	0.1	0.0	31.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.0	0.0	0.0
KLHL5		ENSG00000109790	"Kelch like family member 5"	Q96PQ7	4	39045039-39126857	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 75.8;HHSteC: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013958	Approved									"HPA013958: AB_1852590"	"unprognostic (6.02e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.92e-1)"	"unprognostic (7.54e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.48e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.24e-3)"	24.6	15.0	31.9	21.2	27.6	5.1	33.1	10.4	20.9	11.9	29.5	20.7	15.6	8.1	12.7	9.2	21.3	6.7	15.1	10.1	31.5	25.2	16.4	35.2	14.0	19.6	33.4	11.9	12.5	7.3	7.3	6.4	33.1	18.1	24.4	10.9	6.5	8.1	44.5	6.1	4.6	9.8	32.3	34.2	14.3	10.9	6.9	20.7	6.9	14.0	4.6	23.9	25.7	14.3	7.4	4.1	5.6	5.2	1.8	2.6	1.3	12.8	18.2	9.7	7.1	5.5	14.3	14.1	10.3	75.8	8.7	8.5	14.9	9.4	19.8	12.6	10.5	0.7	11.9	26.2	11.2	2.0	2.3	8.4	17.2	10.6	47.9	2.4	2.8	18.1	14.7	13.2	33.1	17.3	6.3	4.0	20.5	5.4	2.5	4.4	3.0	17.8	4.7	12.7	0.5	7.5	5.3	0.6	7.1	5.8	1.9	5.0	4.5	5.2	21.9	23.3	16.0	6.0	12.3	4.6	4.1	18.3	18.9	6.5	5.4	5.6	3.9	0.8	1.4	5.2	2.1	7.4	2.6	1.5	4.1	5.9	2.1	1.0	4.3	1.8	2.3	1.5	0.5	1.3	31.9	27.6	10.4	15.8	31.5	25.2	33.4	11.9	18.1	20.7
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 56.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA013856: AB_1852594, HPA017762: "	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favourable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.3	6.9	5.6	8.1	3.0	12.0	10.0	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5.0	7.4	7.7	7.2	11.4	10.3	9.0	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8.0	6.9	5.5	4.2	6.5	7.0	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5.0	6.5	5.7	10.4	4.6	9.5	7.0	5.6	8.4	4.5	5.6	6.6	9.2	5.0	9.5	6.8	6.1	2.8	11.0	8.3	12.2	9.0	6.9	11.5	4.3	5.4	8.1	18.9	7.3	8.7	6.0	8.6	8.6	6.6	14.9	8.7	5.8	7.2	22.6	9.6	2.6	2.3	8.5	8.9	5.8	9.5	6.8	21.9	7.6	5.5	13.5	6.2	4.6	14.0	6.2	7.1	8.8	7.5	6.9	13.0	8.5	16.9	5.4	9.0	7.8	1.9	12.1	7.3	3.0	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9.0	2.7	0.9	5.0	6.9	8.1	10.0	10.7	7.7	7.2	6.3	5.6	7.3	6.5
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329671-21335380	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favourable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	17.8	15.1	16.4	12.4	15.6	9.3	20.8	18.0	19.5	19.7	14.4	19.4	12.7	8.7	19.5	18.7	14.8	16.8	12.6	13.6	15.8	19.9	17.8	15.1	13.6	13.2	16.9	11.9	25.3	20.4	18.1	16.9	22.6	15.7	20.0	15.1	15.3	16.2	14.8	9.3	10.1	15.6	17.6	16.9	17.3	16.1	9.9	13.2	23.0	19.9	11.6	13.5	15.7	16.5	3.4	5.0	16.7	7.2	6.0	8.3	4.5	5.9	7.3	16.6	9.0	21.6	21.5	3.6	11.3	11.5	8.6	9.7	2.7	4.8	2.7	7.3	16.4	3.3	9.7	11.0	10.7	14.9	7.0	0.0	13.8	7.1	15.0	4.7	3.3	21.0	11.9	6.7	10.9	13.0	0.0	3.6	19.5	3.8	9.8	16.5	6.8	6.3	0.0	7.3	3.2	10.6	7.5	5.3	10.1	6.5	5.9	6.9	10.6	0.0	15.5	0.0	6.1	4.8	6.5	3.9	5.3	2.8	0.0	5.0	5.8	7.5	6.2	16.7	5.5	6.9	6.2	3.4	6.7	5.0	5.0	2.6	8.3	5.6	2.0	6.0	7.2	3.7	4.6	4.5	16.4	15.6	18.0	19.5	15.8	19.9	16.9	11.9	15.7	13.2
KLK11	"PRSS20, TLSP"	ENSG00000167757	"Kallikrein related peptidase 11"	Q9UBX7	19	51022216-51028039	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.4;lymphoid tissue: 88.5;salivary gland: 96.5"	"Group enriched"	"Detected in some"	4	"EFO-21: 9.4;HaCaT: 29.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	11	"pons and medulla: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026340	Approved				"Secreted in other tissues"		320000			"CAB026340: "	"unprognostic (4.23e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (3.78e-4)"		"unprognostic (2.08e-2)"	"unprognostic (4.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (4.17e-4)"	"unprognostic (2.92e-2)"	"unprognostic (4.16e-6)"	"unprognostic (3.90e-2)"	"unprognostic (2.73e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.53e-1)"	5.5	0.0	0.2	1.1	0.2	0.0	4.9	0.2	0.6	24.5	1.7	2.0	0.4	0.0	5.1	2.7	103.4	9.7	61.8	0.4	0.9	0.0	0.2	0.6	12.3	0.2	0.2	0.2	2.3	25.0	0.0	2.1	0.4	10.7	18.8	0.0	5.1	96.5	1.6	0.3	49.8	0.6	0.3	0.2	0.2	18.7	7.7	0.2	0.9	0.2	65.2	88.5	0.7	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	9.4	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.9	0.0	0.2	0.2	10.7	0.2
KLK14	KLK-L6	ENSG00000129437	"Kallikrein related peptidase 14"	Q9P0G3	19	51077495-51084245	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 14.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;HEK 293: 3.9;U-266/84: 7.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB026228	Uncertain				"Secreted in other tissues"					"CAB026228: "	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.60e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.04e-8)"	"unprognostic (1.93e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.94e-2)"	"unprognostic (8.08e-2)"	0.2	0.0	0.4	0.2	1.2	0.1	2.7	2.1	0.9	3.8	0.6			1.8	0.4	0.9	1.2	0.8	0.3	1.1	0.6	0.5	0.1	0.1	0.5	0.4	0.3		0.9	0.4	0.0	0.3	0.0		0.7	0.4		1.1	0.7	0.3	14.2	1.0	0.0	0.3	0.4	0.8	0.7			0.1		0.6	0.2	3.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.7	0.7	0.1	0.9	0.6	0.6	0.7	0.2	0.0	0.0	0.2	1.7	2.1	0.8	0.6	0.3	13.7	0.2	0.3	0.0	0.5	3.9	0.3	1.0	0.0	0.2	0.3	0.3	0.4	0.4	0.5	0.6	0.2	0.3	0.5	0.0	1.2	0.2	0.8	0.8	1.5	0.2	0.1	0.8	0.0	0.7	0.1	0.0	0.3	1.2	0.4	0.6	0.0	0.0	0.2	0.6	0.9	0.2	3.6	7.1	0.5	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
KLK2		ENSG00000167751	"Kallikrein related peptidase 2"	P20151	19	50861568-50880567	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"prostate: 163.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 9.9"	"Cancer enriched"	"Detected in some"	1666	"prostate cancer: 989.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA000764	Supported				"Secreted in male reproductive system"					"HPA000764: AB_1079700"	"unprognostic (3.05e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.53e-2)"		"unprognostic (1.15e-1)"		"unprognostic (8.97e-2)"	"unprognostic (3.22e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.11e-3)"	"unprognostic (7.56e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.04e-1)"	0.0	0.1	0.0	0.1	0.0	1.1	0.2	0.0	0.6	0.0	0.0	0.0	0.6	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	163.5	0.0	0.1	2.3	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.2	0.0	2.2	1.9	5.7	2.2	1.6	1.3	0.5	1.7	1.1	0.6	1.6	0.0	0.8	4.9	0.5	0.3	0.2	0.2	0.6	0.7	1.8	0.2	0.0	2.0	0.2	0.0	0.3	1.7	1.1	0.0	1.3	0.4	0.0	0.3	3.1	0.4	0.3	0.3	0.4	0.0	1.4	1.9	0.3	1.8	1.2	9.9	1.1	0.0	0.9	0.0	2.8	0.0	1.6	0.9	1.5	0.3	1.3	1.3	1.2	0.4	0.8	1.3	1.9	4.8	1.6	1.8	3.2	0.8	1.9	1.7	1.4	0.9	2.2	1.6	1.2	1.0	1.0	1.0	0.8	1.0	0.5	2.2	0.8	1.3	5.7	1.6	0.8	1.9	0.4	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0
KLK3	"APS, PSA"	ENSG00000142515	"Kallikrein related peptidase 3"	P07288	19	50854915-50860764	"Cancer-related genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	115	"prostate: 447.4"	"Group enriched"	"Detected in some"	135	"BEWO: 21.9;NB-4: 18.5;RPMI-8226: 12.2;SH-SY5Y: 7.3;U-2197: 7.5"	"Cancer enriched"	"Detected in some"	3905	"prostate cancer: 4241.6"	"Region enriched"	"Detected in single"	8	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000070, HPA000764"	Enhanced				"Secreted in male reproductive system"					"CAB000070: , HPA000764: AB_1079700"	"unprognostic (5.06e-3)"	"unprognostic (5.60e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.90e-2)"		"unprognostic (1.09e-2)"				"unprognostic (1.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.13e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.15e-1)"		0.1	0.3	0.0	0.1	0.0	0.0	0.7	0.0	1.0	0.1	0.1	0.0	0.2	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	447.4	0.0	0.1	3.8	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0
KLK6	"Bssp, Klk7, neurosin, PRSS18, PRSS9"	ENSG00000167755	"Kallikrein related peptidase 6"	Q92876	19	50958631-50969673	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6;esophagus: 48.9"	"Group enriched"	"Detected in some"	14	"A-431: 68.4;CAPAN-2: 163.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 131.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"pons and medulla: 175.6"	"Group enriched"	"Detected in many"	8	"midbrain: 106.3;pons and medulla: 164.1;thalamus: 62.4"	HPA051837			Supported	"Nucleoplasm,Nuclear membrane,Cytokinetic bridge"	"Secreted in other tissues"		6800000	Nucleoplasm	"Nuclear membrane, Cytokinetic bridge"	"HPA051837: "	"unprognostic (7.30e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.38e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.31e-1)"		"prognostic unfavourable (8.85e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (7.82e-4)"	"unprognostic (4.45e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavourable (1.27e-4)"	0.9	0.9	9.7	0.9	23.5	0.9	6.5	3.3	42.2	10.0	1.0	82.0	0.0	1.1	2.0	1.2	48.9	24.6	3.8	0.9	20.1	11.8	9.0	0.9	0.9	0.9	46.1	14.9	0.9	0.9	0.9	0.2	0.9	44.3	1.0	0.9	0.0	5.9	2.8	0.9	2.9	0.9	1.0	97.6	5.1	1.0	1.5	32.6	0.0	0.9	15.7	28.1	0.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	163.7	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.1	5.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	23.5	3.3	23.1	20.1	11.8	46.1	14.9	44.3	32.6
KLK8	"HNP, neuropsin, ovasin, PRSS19, TADG14"	ENSG00000129455	"Kallikrein related peptidase 8"	O60259	19	50996007-51002711	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 43.6;skin 1: 40.4;tongue: 46.9"	"Group enriched"	"Detected in some"	7	"A-431: 31.5;CAPAN-2: 41.3;HaCaT: 30.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 29.9;ovarian cancer: 30.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hippocampal formation: 39.6"					"CAB019393, HPA035761"	Enhanced		Approved	Vesicles	"Secreted in other tissues"		950000	Vesicles		"CAB019393: , HPA035761: "	"unprognostic (4.27e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (2.31e-4)"		"unprognostic (5.46e-2)"		"prognostic unfavourable (5.72e-4)"	"unprognostic (2.95e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (1.10e-4)"			"unprognostic (4.29e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (6.17e-4)"	1.6	0.0	0.1	0.4	0.1	0.0	4.5	1.0	0.3	8.1	0.7	0.1	0.1	0.0	1.1	0.7	43.6	6.7	0.3	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	0.1	0.4	0.6	0.3	0.0	0.3	6.0	0.1	0.3	40.4	0.1	0.1	0.6	0.3	0.0	0.7	0.1	0.5	0.3	46.9	11.1	0.3	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.6	41.3	0.0	0.8	0.0	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.6	0.1
KLKB1	KLK3	ENSG00000164344	"Kallikrein B1"	P03952	4	186208979-186258471	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Inflammatory response"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 102.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 7.1;SCLC-21H: 4.9;SK-MEL-30: 2.1;U-937: 2.4"	"Cancer enriched"	"Detected in some"	17	"liver cancer: 27.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	7	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	28860000000	4900000000				"unprognostic (4.80e-2)"	"unprognostic (4.53e-3)"	"unprognostic (4.36e-2)"	"unprognostic (4.17e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-2)"	0.3	0.3	0.8	0.3	1.2	0.0	0.3	0.7	0.5	0.3	0.4	0.3	0.3	0.7	0.4	0.4	0.3	0.2	0.7	0.5	0.6	0.5	1.3	102.9	0.3	0.3	0.5	0.5	0.3	1.3	0.5	1.0	0.4	0.4	0.3	0.3	0.5	0.3	0.3	0.5	0.1	0.6	0.3	0.3	0.5	0.0	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	7.1	0.0	0.1	0.0	0.2	1.3	0.0	4.9	0.4	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.2	0.7	0.5	0.6	0.5	0.5	0.5	0.4	0.3
KMT2A	"ALL-1, CXXC7, HRX, HTRX1, MLL, MLL1A, TRX1"	ENSG00000118058	"Lysine methyltransferase 2A"	Q03164	11	118436490-118526832	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017794, CAB024270, HPA044910"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB017794: , CAB024270: , HPA044910: "	"unprognostic (6.80e-2)"	"unprognostic (8.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.72e-3)"	"unprognostic (4.52e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.90e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	14.4	11.3	17.7	17.0	19.2	28.6	16.8	43.8	21.2	17.3	14.6	19.8	18.1	8.5	21.8	17.1	10.6	15.7	14.1	10.2	17.3	13.4	13.1	9.3	15.3	19.6	16.6	18.7	35.6	16.8	28.9	21.8	10.2	15.4	15.6	12.4	14.4	14.2	19.2	11.1	16.8	14.2	15.2	12.1	15.7	12.3	7.9	23.4	16.6	16.6	7.8	19.4	18.8	24.6	6.7	3.5	8.3	2.0	6.5	5.3	0.8	11.9	5.5	14.9	11.2	9.1	10.9	4.4	5.4	7.8	5.7	6.6	11.1	8.7	14.7	11.1	7.9	10.4	15.8	5.9	11.3	16.2	6.1	28.8	5.1	6.0	5.1	17.2	5.6	5.2	6.1	12.4	16.7	8.8	18.7	12.6	7.1	9.3	11.4	10.1	9.0	8.2	8.7	14.3	4.9	8.4	9.0	12.3	8.0	13.5	4.4	2.8	7.6	5.8	13.0	9.8	8.8	7.1	9.6	3.7	2.8	9.9	3.7	12.7	5.8	8.3	2.0	4.6	5.3	1.3	4.3	6.2	4.8	4.6	0.8	6.7	4.9	4.8	1.3	6.5	1.4	3.5	3.9	0.8	17.7	19.2	43.8	21.2	17.3	13.4	16.6	18.7	15.4	23.4
KMT2C	"HALR, KIAA1506, MLL3"	ENSG00000055609	"Lysine methyltransferase 2C"	Q8NEZ4	7	152134922-152436005	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Chromatin regulator, DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074736			Approved	Nucleoplasm				Nucleoplasm		"HPA074736: "	"unprognostic (7.75e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (8.01e-6)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.64e-1)"	13.9	12.6	11.7	16.7	18.6	29.7	14.5	24.8	14.1	18.4	12.6	15.5	21.4	9.7	20.2	20.6	14.4	12.8	12.7	10.8	13.4	9.5	10.3	11.4	13.0	12.1	17.7	9.4	18.8	18.4	18.8	18.9	38.0	12.6	14.0	11.8	12.6	15.8	22.9	30.3	25.2	13.1	13.6	16.0	14.6	14.9	13.6	19.6	22.6	16.9	9.3	16.8	17.8	31.6	5.6	3.5	16.1	3.9	5.5	2.9	0.6	9.5	4.8	9.0	9.5	16.2	9.8	10.5	5.0	3.8	4.0	4.9	9.1	5.8	15.2	7.3	9.1	5.5	9.6	7.3	6.7	9.6	4.9	9.0	7.2	6.3	7.9	15.3	11.1	8.2	10.1	5.7	7.6	5.7	14.5	13.2	8.7	13.3	11.0	13.9	5.4	4.8	7.4	8.1	7.9	6.9	9.9	13.1	10.3	8.2	14.7	5.4	4.8	12.5	7.2	6.7	3.5	7.1	7.1	13.8	6.7	16.4	8.7	12.5	6.8	8.8	3.5	4.3	2.1	2.2	2.9	5.6	1.7	1.7	1.7	3.8	2.7	1.8	16.1	5.5	3.9	3.5	1.3	0.6	11.7	18.6	24.8	14.1	13.4	9.5	17.7	9.4	12.6	19.6
KMT5B	"CGI-85, SUV420H1"	ENSG00000110066	"Lysine methyltransferase 5B"	Q4FZB7	11	68154863-68213828	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063648			Supported	Nucleoplasm				Nucleoplasm		"HPA063648: "	"unprognostic (5.82e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.21e-2)"	"prognostic favourable (9.30e-4)"	17.6	19.1	20.9	23.4	22.5	23.7	27.3	38.8	26.7	22.4	21.2	19.9	32.3	21.8	26.2	22.7	19.7	20.4	18.2	15.1	23.8	15.3	19.1	21.5	17.4	16.9	18.6	22.2	27.4	24.0	27.4	28.1	26.6	17.0	24.9	21.5	15.4	25.2	30.4	18.8	20.8	24.0	23.4	18.4	19.6	19.7	19.1	23.6	38.0	30.9	17.5	19.1	20.5	22.5	4.5	5.5	16.0	5.2	8.9	5.9	2.7	10.1	7.7	15.8	10.2	3.7	9.3	17.1	7.3	5.1	9.1	5.4	24.2	16.3	8.3	12.8	10.0	5.4	10.9	8.5	13.5	9.3	6.3	7.9	9.1	10.0	13.4	11.0	10.9	9.1	17.6	11.0	11.6	9.0	11.6	9.7	7.8	21.0	7.7	11.6	16.9	5.8	12.9	12.3	22.3	6.8	9.9	13.8	16.5	11.3	11.5	51.5	14.6	7.3	9.5	12.4	16.5	9.5	7.4	12.5	5.4	17.6	7.8	7.0	13.2	7.8	3.7	16.0	4.7	5.2	3.3	3.4	5.1	5.7	3.6	4.5	5.9	5.2	11.3	8.9	4.8	5.5	4.0	2.7	20.9	22.5	38.8	26.7	23.8	15.3	18.6	22.2	17.0	23.6
KNG1	"BDK, BK, KNG"	ENSG00000113889	"Kininogen 1"	P01042	3	186717276-186744410	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis, Inflammatory response"	"Protease inhibitor, Thiol protease inhibitor, Vasoactive, Vasodilator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 323.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 4.4;HL-60: 2.4;RH-30: 3.9;SiHa: 2.6"	"Cancer enriched"	"Detected in some"	126	"liver cancer: 608.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA001616, HPA001645, CAB009809"	Enhanced				"Secreted to blood"	90000000000	64000000000			"CAB009809: AB_2134781, HPA001616: AB_1079216, HPA001645: AB_1079215"	"unprognostic (3.88e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (1.28e-6)"	"unprognostic (1.29e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.45e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (4.52e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	41.9	323.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.4	2.3	0.2	0.7	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	1.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.1	4.4	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.1	0.7	0.0	0.1	3.9	0.0	0.2	0.0	0.5	0.1	2.6	0.4	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.9	0.0	1.9	0.0	2.0	0.0	2.3	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.5	0.1	0.2	1.6	0.7	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 54.7;testis: 35.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: "	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.7	0.5	0.3	7.1	0.4	5.4	0.7	0.3	0.3	0.6	4.0	0.1	0.0	1.5	0.4	0.8	3.9	0.4	0.9	0.5	0.4	0.4	0.9	1.0	1.3	4.7	0.3	0.0	0.5	0.5	0.0	0.4	2.8	0.1	0.5	1.5	0.0	0.8	0.0	0.4	0.8	3.9	0.5	0.4	3.3	0.8	35.6	0.0	54.7	0.5	4.1	3.7	0.7	0.9	2.9	1.2	0.7	0.5	0.7	2.5	0.0	10.8	5.6	11.4	8.2	0.3	1.7	5.1	12.7	5.1	10.0	8.4	6.8	4.4	7.2	4.0	5.5	13.6	10.8	5.9	10.6	12.5	2.9	21.2	9.6	2.0	0.0	16.2	10.7	0.3	0.2	6.7	4.2	8.5	13.5	12.1	11.6	3.7	13.8	3.2	5.6	5.9	12.6	16.3	3.6	1.5	9.6	9.9	4.6	11.0	6.2	1.3	6.7	4.9	7.8	11.6	10.3	13.3	7.0	4.6	15.8	14.1	4.7	11.0	11.0	0.4	0.2	0.1	0.1	0.1	0.0	2.9	1.1	0.1	1.2	2.2	0.0	0.7	0.7	0.7	0.5	0.1	2.5	0.0	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.0	0.1	0.0
KNTC1	"KIAA0166, ROD"	ENSG00000184445	"Kinetochore associated 1"	P50748	12	122527246-122626396	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025241	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA025241: AB_1852629"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (9.34e-2)"	"prognostic favourable (8.69e-4)"	"prognostic unfavourable (4.79e-6)"	"unprognostic (4.04e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.59e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (7.89e-8)"	"unprognostic (2.17e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.74e-1)"	5.6	5.6	4.5	15.3	5.4	28.9	5.8	7.5	5.6	5.2	6.4	2.7	3.9	7.0	5.4	5.5	9.6	4.9	2.9	2.9	4.6	1.8	4.9	4.5	5.8	11.8	4.0	3.8	6.7	4.9	3.5	5.9	8.1	3.6	5.3	9.7	3.9	6.1	2.8	1.6	11.7	10.9	7.7	3.1	14.1	5.5	23.2	2.8	39.6	4.0	7.0	15.6	4.4	6.6	4.8	2.1	5.0	2.6	2.2	3.6	0.8	13.0	10.9	31.5	7.2	2.5	4.5	14.2	12.1	7.9	12.0	11.4	10.3	11.0	15.6	6.3	5.8	18.0	13.6	7.6	16.0	11.1	9.4	19.2	20.4	10.5	0.8	18.9	13.3	2.4	1.7	12.4	8.3	8.1	19.2	11.8	9.0	9.7	15.6	43.8	15.9	13.8	21.4	15.3	17.3	7.2	14.0	9.8	12.6	22.0	4.7	6.5	17.8	10.9	5.9	13.8	13.2	13.4	14.1	15.9	16.0	24.1	8.2	12.3	15.7	5.0	1.4	4.6	2.0	1.9	1.8	4.8	3.3	3.6	1.3	3.0	2.5	2.9	4.4	2.2	2.6	2.1	1.4	0.8	4.5	5.4	7.5	5.6	4.6	1.8	4.0	3.8	3.6	2.8
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol			38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: "	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavourable (2.12e-10)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavourable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	61.9	81.5	77.8	31.2	11.5	11.2	49.4	54.7	42.5	88.4	69.0	56.0	29.0	58.2	17.3	31.5	34.4	86.0	42.7	101.8	23.4	50.7	51.5	39.3	53.4	12.2	44.3	35.5	6.9	8.1	50.8	31.4	85.0	40.9	42.1	78.4	57.8	55.2	28.5	52.5	42.3	30.5	71.0	31.9	34.9	29.1	30.9	34.4	30.7	99.2	32.1	57.8	22.3	33.1	49.1	60.6	34.5	73.5	35.0	49.9	58.1	23.9	38.1	52.6	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol			11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.4	13.8	12.3	15.9	19.0	16.8	14.5	14.1	16.7	20.6	20.0	15.3	19.1	14.6	16.8	25.3	15.1	18.9	21.6	26.4	14.7	10.4	15.1	21.3	12.4	16.9	16.4	12.4	16.9	20.6	25.6	24.5	21.5	14.5	13.5	19.5	9.6	13.2	9.4	28.7	10.4	13.4	17.8	12.0	18.0	16.1	11.9	10.0	25.6	15.4	13.7	10.9	8.8	24.9	19.2	13.3	24.9	20.2	9.7	11.0	11.6	21.0	15.4	18.3	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"			5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: "	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavourable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.2	73.6	46.9	42.6	22.7	39.5	47.1	51.5	46.2	67.6	53.1	128.4	25.7	55.7	35.2	48.0	30.6	84.6	47.5	102.7	34.2	51.6	61.6	59.4	40.2	23.4	69.6	40.6	32.0	21.0	77.6	76.0	44.5	69.6	38.2	52.2	47.0	64.6	20.9	44.6	46.6	40.0	82.9	32.4	27.7	61.9	41.2	38.3	35.2	18.9	29.8	41.0	26.9	37.0	73.9	45.9	38.4	62.4	46.7	54.0	79.9	31.5	33.7	54.1	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA043433: AB_10960988, HPA051690: "	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.0	20.8	13.1	11.7	10.3	9.4	24.0	22.0	14.0	17.3	11.2	15.2	13.2	26.7	17.9	10.9	13.2	17.5	19.3	19.6	22.0	17.8	25.8	11.5	17.6	12.5	45.4	16.4	9.8	16.5	19.9	19.1	11.8	28.5	8.6	17.0	16.5	26.4	12.9	19.3	19.0	21.0	25.2	16.0	19.3	31.7	15.7	13.1	20.8	14.7	25.9	24.6	18.5	14.7	16.0	10.7	16.6	22.7	17.1	21.5	16.8	8.7	16.1	28.9	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 606.8"	"Group enriched"	"Detected in some"	37	"HaCaT: 43.9;hTCEpi: 18.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 313.8;melanoma: 478.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory CD4 T-cell: 5.8;memory CD8 T-cell: 2.1;naive CD4 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	59	"T-cells: 5.8"									"CAB002153, HPA017917, HPA062908"	Enhanced						65000000000			"CAB002153: AB_563790, HPA017917: AB_1852192, HPA062908: "	"unprognostic (8.05e-2)"	"unprognostic (8.49e-3)"	"unprognostic (5.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.24e-2)"	"unprognostic (6.63e-2)"	"unprognostic (3.23e-4)"	"unprognostic (1.58e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.09e-2)"	0.3	0.0	0.1	0.1	0.1	0.4	24.2	0.1	0.3	63.4	0.1	0.1	0.1	0.0	38.6	0.1	2.5	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.1	16.2	0.1	2.0	606.8	0.1	0.1	0.2	0.1	0.0	0.1	0.1	24.1	0.1	114.6	0.4	0.1	46.2	0.0	0.0	0.0	0.0	0.0	5.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	2.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1
KRT10	"CK10, K10, KPP"	ENSG00000186395	"Keratin 10"	P13645	17	40818117-40822595	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	20	"skin 1: 1236.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 129.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 562.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000132, HPA012014"	Enhanced				"Intracellular and membrane"		34000000000			"CAB000132: , HPA012014: AB_1852195"	"unprognostic (3.07e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (9.32e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.10e-2)"	4.1	4.4	5.3	3.7	6.0	3.9	41.4	7.2	6.4	37.3	3.7	1.4	8.2	4.0	14.9	5.4	7.4	3.0	3.7	9.3	6.4	2.9	5.9	7.6	3.0	5.3	5.2	3.2	3.3	9.2	2.6	8.1	5.7	4.9	5.6	2.9	2.4	17.4	8.3	12.2	1236.8	4.9	3.0	4.0	3.7	4.3	9.6	6.1	11.6	5.5	21.7	5.8	3.3	62.7	17.5	15.4	21.7	5.7	13.2	13.4	3.4	17.5	22.4	6.6	7.0	8.1	7.3	6.1	15.8	9.8	6.6	6.0	8.5	6.6	4.9	23.9	7.0	35.4	2.7	6.0	8.4	11.6	17.6	4.6	29.2	15.5	9.4	9.7	13.6	5.6	129.0	4.3	9.4	4.5	24.8	9.3	7.6	13.2	12.7	9.5	8.4	14.3	9.5	9.5	10.4	6.7	19.1	5.7	6.7	11.3	27.1	20.6	21.1	13.3	5.1	11.1	16.3	13.6	19.6	0.2	11.8	13.8	15.0	6.4	13.7	21.7	4.7	19.1	9.8	4.2	11.1	17.5	10.8	13.4	7.7	10.1	12.1	11.8	1.6	13.2	5.7	15.4	10.3	3.4	5.3	6.0	7.2	6.4	6.4	2.9	5.2	3.2	4.9	6.1
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867210	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;retina: 3.6;skin 1: 1.9"	"Cell line enriched"	"Detected in single"	6	"HeLa: 3.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055217, HPA055835"	Enhanced									"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.9	0.1	3.3	0.1	0.1	1.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	3.6	0.1	0.1	0.1	1.9	3.3	0.1	0.1	0.1	0.4	0.7	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Group enriched"	"Detected in some"	100	"A-431: 211.8;HaCaT: 141.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"			1100000000	"Intermediate filaments"		"CAB000133: , HPA030877: , HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavourable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavourable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	141.5	0.0	0.0	0.0	0.1	0.0	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 259.8;HBEC3-KT: 128.1;hTCEpi: 160.3;hTERT-HME1: 52.4;U-2197: 45.2"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"			2200000000	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favourable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	259.8	0.0	128.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	160.3	0.1	52.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KRT15	"CK15, K15, K1CO"	ENSG00000171346	"Keratin 15"	P19012	17	41513743-41522529	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 37.4;esophagus: 115.3;skin 1: 119.3;vagina: 38.6"	"Group enriched"	"Detected in some"	10	"HaCaT: 120.2;hTCEpi: 92.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 178.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023910, HPA024554"	Enhanced		Supported	"Nucleoplasm,Intermediate filaments"			580000000	"Intermediate filaments"	Nucleoplasm	"HPA023910: AB_1852205, HPA024554: AB_1852207"	"prognostic favourable (4.50e-4)"	"unprognostic (9.14e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.57e-2)"	"unprognostic (8.84e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.13e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.91e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-11)"	"unprognostic (6.91e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.33e-5)"	"unprognostic (5.35e-2)"	0.6	0.0	1.4	0.6	1.5	0.0	37.4	0.6	1.1	14.6	1.1	0.6	0.6	0.0	0.6	0.6	115.3	2.7	10.6	0.6	1.3	0.0	1.1	0.6	2.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	3.0	1.1	16.4	0.0	1.4	15.1	0.6	0.6	119.3	3.5	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6	1.9	6.2	0.8	38.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	5.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.6	2.1	0.0	0.2	0.0	120.2	0.0	4.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.4	0.0	92.9	0.2	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	10.2	0.3	0.7	0.2	0.0	0.1	1.7	0.1	2.3	0.0	2.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.4	1.5	0.6	1.1	1.3	0.0	0.6	0.6	1.1	0.6
KRT16	NEPPK	ENSG00000186832	"Keratin 16"	P08779	17	41609778-41615899	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"tongue: 503.5"	"Cell line enriched"	"Detected in some"	9	"hTCEpi: 134.9"	"Group enriched"	"Detected in many"	7	"cervical cancer: 713.1;head and neck cancer: 2720.5;melanoma: 712.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000136, HPA000539"	Approved		Approved	"Intermediate filaments"			2200000000	"Intermediate filaments"		"CAB000136: , HPA000539: "	"unprognostic (3.95e-3)"	"unprognostic (6.90e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.14e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (8.23e-2)"	"unprognostic (6.53e-8)"	"unprognostic (3.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.61e-2)"	1.6	0.2	0.2	0.2	0.2	0.0	2.1	0.2	0.2	32.4	0.2	0.2	0.2	0.0	1.1	0.2	112.4	0.1	0.6	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.2	0.7	0.0	0.3	15.5	9.9	0.4	41.4	0.2	0.2	0.2	0.2	0.1	0.6	0.2	3.0	0.2	503.5	26.4	0.6	50.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	3.9	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	134.9	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.3	0.1	0.9	0.0	0.0	9.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in some"	7	"hTCEpi: 638.7;SiHa: 265.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"			750000000	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: "	"prognostic favourable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	64.6	0.0	66.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	638.7	0.0	49.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	265.9	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 205.3;intestine: 184.9;placenta: 179.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 100.7;HBEC3-KT: 151.7;MCF7: 111.9;RT4: 161.1;SK-BR-3: 284.6;T-47d: 191.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.7"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"			330000000	"Intermediate filaments"		"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	9.8	1.6	0.7	22.8	0.9	0.0	50.1	2.9	0.8	37.4	126.7	1.0	38.0	37.8	9.9	53.0	102.1	19.5	205.3	2.3	0.8	0.2	35.0	2.1	50.6	0.7	0.8	0.8	16.7	7.5	1.2	2.6	179.4	1.3	39.2	40.1	1.8	103.0	46.3	0.7	15.8	184.9	11.7	0.6	0.6	69.1	6.4	0.7	33.3	4.9	21.2	89.2	77.0	35.4	0.0	0.0	0.0	0.0	2.7	0.6	0.2	0.1	17.6	0.0	0.3	0.0	0.0	61.6	21.2	0.0	0.6	0.1	50.6	100.7	0.0	20.8	10.1	53.9	0.0	151.7	0.1	0.0	0.5	0.0	11.4	34.6	1.6	0.0	4.3	0.0	27.6	0.4	0.0	1.3	7.3	0.1	0.0	111.9	0.2	0.1	0.9	25.6	0.1	0.0	0.3	69.5	161.1	2.1	0.0	0.1	284.6	0.0	191.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.7	0.9	2.9	0.8	0.8	0.2	0.8	0.8	1.3	0.7
KRT2	"KRT2A, KRTE"	ENSG00000172867	"Keratin 2"	P35908	12	52644558-52652164	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 289.9"	"Group enriched"	"Detected in some"	6	"HEL: 6.5;HMC-1: 2.8"	"Group enriched"	"Detected in some"	35	"head and neck cancer: 4.7;melanoma: 23.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 4.4;naive CD8 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Group enriched"	"Detected in some"	6	"amygdala: 1.8;hippocampal formation: 2.9"	"Low region specificity"	"Detected in single"			"HPA006299, CAB037321"	Enhanced		Approved	"Golgi apparatus,Intermediate filaments,Cytosol"			14000000000	"Intermediate filaments, Cytosol"	"Golgi apparatus"	"CAB037321: , HPA006299: AB_1079180"	"unprognostic (1.22e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.47e-3)"	"unprognostic (1.69e-2)"		"unprognostic (1.84e-1)"	"unprognostic (3.59e-1)"		"unprognostic (2.12e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.56e-7)"	"unprognostic (6.43e-2)"	"unprognostic (5.98e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.46e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	9.5	0.1	0.1	18.3	0.1	0.1	0.1	0.0	2.0	0.1	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.4	289.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	6.8	0.1	19.2	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	4.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	4.4	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875941-40885227	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 232.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.7"	"Low region specificity"	"Detected in all"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol			34000000	Cytosol		"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	0.2	0.1	0.2	38.0	0.2	0.0	0.2	0.2	0.2	0.2	75.5	0.2	0.2	40.4	0.2	0.2	0.3	0.3	3.9	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.3	45.0	0.2	0.3	0.2	0.2	0.2	232.0	2.7	0.2	0.2	13.6	0.2	0.2	0.2	0.2	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	2.8	0.0	7.2	0.4	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
KRT24	"FLJ20261, MGC138169, MGC138173"	ENSG00000167916	"Keratin 24"	Q2M2I5	17	40697991-40703750	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 62.1;lymphoid tissue: 68.9;placenta: 48.6"	"Cell line enriched"	"Detected in single"	14	"SK-BR-3: 12.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 15.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	24	"T-reg: 2.4"	"Lineage enriched"	"Detected in single"	24	"T-cells: 2.4"	"Region enriched"	"Detected in single"	18	"cerebellum: 1.1"	"Low region specificity"	"Detected in all"			HPA022978	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA022978: AB_1852230"	"unprognostic (2.74e-2)"	"unprognostic (1.05e-2)"		"unprognostic (1.45e-1)"		"unprognostic (3.16e-2)"		"unprognostic (2.47e-1)"			"unprognostic (3.75e-1)"	"unprognostic (2.74e-1)"		"unprognostic (2.95e-1)"			"unprognostic (3.37e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	9.2	4.1	0.0	0.0	0.0	0.7	9.3	62.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	48.6	0.0	0.1	3.1	0.0	1.2	0.8	0.1	0.1	0.2	3.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	1.4	68.9	0.6	3.4	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
KRT25	KRT25A	ENSG00000204897	"Keratin 25"	Q7Z3Z0	17	40748021-40755332	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 44.5"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 5.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 9.7"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 8.3;hippocampal formation: 6.1"	"HPA053977, HPA058943"	Enhanced		Approved	Vesicles				Vesicles		"HPA053977: AB_2682329, HPA058943: AB_2683859"						"unprognostic (8.19e-2)"							"unprognostic (5.89e-8)"		"unprognostic (1.79e-1)"			1.6	0.0	0.0	0.0	0.9	0.0	8.6	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.0	0.0	0.0	1.9	0.0
KRT27	KRT25C	ENSG00000171446	"Keratin 27"	Q7Z3Y8	17	40776808-40782534	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skin 1: 37.4"	"Group enriched"	"Detected in some"	6	"EFO-21: 5.5;SK-BR-3: 1.4"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.9"	"Region enriched"	"Detected in single"	9	"basal ganglia: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 104.2"	HPA055114	Enhanced									"HPA055114: "		"unprognostic (1.13e-1)"		"unprognostic (1.87e-1)"		"unprognostic (2.18e-1)"	"unprognostic (5.75e-4)"	"unprognostic (5.11e-2)"	"unprognostic (3.08e-2)"		"unprognostic (8.41e-2)"		"unprognostic (4.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.64e-3)"	1.1	0.0	0.1	0.1	1.2	0.0	4.9	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	37.4	0.2	0.1	0.1	0.1	0.0	1.0	0.1	2.8	0.5	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT3	"CK3, K3"	ENSG00000186442	"Keratin 3"	P12035	12	52789685-52796117	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 15.9;tongue: 58.7"	"Group enriched"	"Detected in some"	6	"HaCaT: 13.3;HMC-1: 8.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"										350000000				"unprognostic (1.03e-1)"	"unprognostic (2.68e-2)"		"unprognostic (2.42e-2)"		"unprognostic (2.75e-1)"		"unprognostic (9.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-2)"			"unprognostic (3.89e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.73e-2)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.9	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	58.7	0.9	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT31	"Ha-1, KRTHA1"	ENSG00000094796	"Keratin 31"	Q15323	17	41393724-41397592	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 21.2;skin 1: 72.1"	"Cell line enhanced"	"Detected in single"		"HBEC3-KT: 1.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	22	"cerebellum: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049550, HPA055194"	Enhanced						560000000			"HPA049550: , HPA055194: "	"unprognostic (3.92e-2)"	"unprognostic (3.50e-1)"		"unprognostic (3.30e-1)"	"unprognostic (5.51e-2)"	"unprognostic (7.71e-2)"		"unprognostic (4.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.84e-1)"			"unprognostic (4.07e-1)"			"unprognostic (4.26e-2)"	"unprognostic (1.65e-1)"	1.5	0.0	0.0	0.0	0.2	0.0	1.0	21.2	1.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.5	0.0	5.5	72.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	21.2	0.9	0.0	0.0	0.0	0.7	0.8	0.0
KRT33B	"Ha-3II, KRTHA3B"	ENSG00000131738	"Keratin 33B"	Q14525	17	41363494-41369800	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 40.6"	"Cell line enhanced"	"Detected in some"		"BJ: 8.8;BJ hTERT+ SV40 Large T+: 1.9;BJ hTERT+ SV40 Large T+ RasG12V: 2.1;hTEC/SVTERT24-B: 3.4;U-2197: 2.3"	"Cancer enhanced"	"Detected in single"		"urothelial cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA055194	Supported						460000000			"HPA055194: "		"unprognostic (3.34e-2)"				"unprognostic (5.19e-2)"		"unprognostic (3.04e-1)"					"unprognostic (1.55e-2)"				"unprognostic (6.28e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	2.7	0.0	7.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	8.8	0.7	1.9	2.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
KRT34	"Ha-4, KRTHA4"	ENSG00000131737	"Keratin 34"	O76011	17	41377650-41382403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 10.3;skin 1: 36.0;tongue: 18.2"	"Cell line enriched"	"Detected in some"	4	"BJ: 64.5"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA055194, HPA072208"	Enhanced		Approved	Nucleoplasm,Vesicles			170000000	"Nucleoplasm, Vesicles"		"HPA055194: , HPA072208: "		"unprognostic (2.52e-1)"		"unprognostic (2.14e-1)"		"unprognostic (9.03e-2)"		"unprognostic (2.94e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.86e-3)"		"unprognostic (5.12e-7)"				"unprognostic (3.84e-2)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	18.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	64.5	2.8	7.7	15.3	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	2.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	1.9	8.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT35	"Ha-5, KRTHA5"	ENSG00000197079	"Keratin 35"	Q92764	17	41476689-41481140	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"skin 1: 33.1"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"										270000000																					1.8	0.0	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	33.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT36	KRTHA6	ENSG00000126337	"Keratin 36"	O76013	17	41486136-41492546	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"tongue: 109.3"	"Cell line enriched"	"Detected in single"	15	"Karpas-707: 8.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;intermediate monocyte: 1.0"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"										150000000				"unprognostic (4.39e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.85e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.24e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.74e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.11e-2)"	0.3	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.3	0.1	1.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.6	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.5	0.1	0.1	5.6	0.3	0.1	0.1	1.6	0.0	0.6	0.1	1.9	0.1	109.3	5.1	0.1	1.4	0.0	0.8	0.0	2.3	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT38	KRTHA8	ENSG00000171360	"Keratin 38"	O76015	17	41436446-41440921	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 18.3"	"Cell line enhanced"	"Detected in some"		"BJ: 2.2;fHDF/TERT166: 1.3"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 1.1;urothelial cancer: 0.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																		170000000									"unprognostic (1.37e-1)"				"unprognostic (4.05e-1)"								0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0			0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		2.5	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0			0.0		2.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.6	0.1	0.4	0.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
KRT4	"CK4, CYK4, K4"	ENSG00000170477	"Keratin 4"	P19013	12	52806549-52814551	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 637.8;lymphoid tissue: 403.6;tongue: 174.6"	"Group enriched"	"Detected in some"	30	"HaCaT: 94.2;SK-BR-3: 38.2"	"Group enriched"	"Detected in many"	5	"cervical cancer: 94.3;head and neck cancer: 151.8;stomach cancer: 73.1;urothelial cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002154, HPA034881"	Enhanced		Supported	"Intermediate filaments"			540000000	"Intermediate filaments"		"CAB002154: AB_563803, HPA034881: "	"unprognostic (4.04e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.16e-3)"	"unprognostic (8.52e-3)"		"unprognostic (1.20e-1)"		"unprognostic (2.64e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (3.26e-4)"	"unprognostic (2.85e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.58e-11)"	"unprognostic (1.64e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (6.26e-4)"	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	25.5	0.1	0.0	0.0	0.1	2.5	0.1	637.8	0.3	0.1	0.2	0.0	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	48.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	174.6	403.6	0.2	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	94.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT5	"EBS2, KRT5A"	ENSG00000186081	"Keratin 5"	P13647	12	52514575-52520687	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 463.1;skin 1: 338.1;tongue: 522.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 118.0;HBEC3-KT: 211.3;hTCEpi: 483.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3340.4"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.7"	"Cell type enriched"	"Detected in single"	197	"plasmacytoid DC: 19.6"	"Lineage enriched"	"Detected in single"	197	"dendritic cells: 19.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000027, CAB000129, HPA059479"	Enhanced		Approved	"Intermediate filaments"			6500000000	"Intermediate filaments"		"CAB000027: AB_2281083, CAB000129: , HPA059479: "	"prognostic favourable (1.27e-4)"	"unprognostic (9.81e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.01e-7)"	"unprognostic (3.46e-2)"	"unprognostic (5.56e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.81e-3)"	0.3	0.0	0.1	0.3	0.2	0.2	15.9	0.1	0.2	74.2	0.2	0.3	6.2	0.0	4.9	6.4	463.1	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	4.4	1.7	5.8	0.0	0.4	46.9	7.8	0.5	338.1	0.1	0.3	0.1	0.1	0.1	0.7	0.1	31.7	0.1	522.3	128.9	4.0	96.8	0.0	19.6	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	118.0	0.0	211.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	483.0	0.0	42.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.2	1.7	0.1
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Cell line enriched"	"Detected in some"	4	"hTCEpi: 459.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"			7200000000	"Intermediate filaments"		"HPA045697: , HPA061168: "	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavourable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	52.7	0.0	111.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	459.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KRT6B	KRTL1	ENSG00000185479	"Keratin 6B"	P04259	12	52446651-52452126	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"esophagus: 135.3;tongue: 232.4"	"Group enriched"	"Detected in some"	6	"HBEC3-KT: 19.7;hTCEpi: 22.0;RPMI-8226: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 1424.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000130, HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"		"CAB000130: , HPA045697: , HPA061168: "	"prognostic favourable (9.44e-4)"	"unprognostic (3.27e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.21e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.77e-2)"		"unprognostic (9.63e-2)"		"unprognostic (3.29e-1)"	"prognostic unfavourable (9.52e-4)"	0.2	0.1	0.1	0.5	0.1	0.1	3.9	0.1	0.1	33.3	0.1	0.1	0.1	0.1	0.7	0.1	135.3	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	17.8	0.1	0.1	34.9	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1	232.4	15.4	0.1	26.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT6C	KRT6E	ENSG00000170465	"Keratin 6C"	P48668	12	52468516-52473785	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 109.4;esophagus: 125.8;tongue: 244.2"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 564.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045697, HPA061168"	Supported		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA045697: , HPA061168: "	"unprognostic (3.18e-2)"	"unprognostic (6.26e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-3)"		"unprognostic (6.97e-2)"		"prognostic unfavourable (1.23e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.24e-1)"		"unprognostic (2.84e-1)"			"unprognostic (4.50e-2)"	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.2	109.4	0.2	0.0	0.0	0.2	1.1	0.2	125.8	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.2	0.2	0.0	16.3	0.2	0.2	2.7	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.1	0.2	244.2	6.7	0.2	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT7	"CK7, K2C7, K7, SCL"	ENSG00000135480	"Keratin 7"	P08729	12	52232520-52252186	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 156.6;salivary gland: 142.6;thyroid gland: 199.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 117.7;HBEC3-KT: 262.1;RT4: 312.5;SiHa: 246.4;SK-BR-3: 143.9"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 560.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000028, HPA007272, HPA007315"	Enhanced		Supported	"Intermediate filaments"			350000000	"Intermediate filaments"		"CAB000028: AB_2134589, HPA007272: AB_1079181, HPA007315: "	"unprognostic (2.71e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.44e-3)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (9.42e-5)"	"prognostic unfavourable (7.78e-5)"	"unprognostic (4.54e-2)"	"prognostic favourable (2.77e-9)"	"unprognostic (2.82e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.98e-3)"	3.5	0.2	0.2	0.6	0.2	0.0	43.1	0.2	0.2	7.8	0.5	0.1	18.0	0.0	1.7	9.6	14.4	11.7	27.1	1.2	0.2	0.2	35.0	4.3	63.2	0.0	0.2	0.2	3.3	15.1	1.7	2.1	156.6	0.6	23.1	0.0	0.1	142.6	67.3	0.4	10.7	0.3	4.3	0.3	0.2	2.3	4.3	0.0	0.4	199.7	6.1	16.3	58.2	22.3	0.0	0.8	0.0	3.8	0.0	0.0	0.2	0.1	99.7	0.0	0.0	0.1	0.0	117.7	21.4	0.0	11.2	1.0	0.3	71.2	0.0	0.0	7.3	78.5	0.0	262.1	0.5	0.1	0.0	0.0	53.5	0.3	2.5	0.0	0.0	0.0	16.3	0.0	105.7	11.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	0.2	1.5	64.7	312.5	0.1	0.1	246.4	143.9	0.0	5.5	0.0	85.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0
KRT71	"K6IRS1, KRT6IRS, KRT6IRS1"	ENSG00000139648	"Keratin 71"	Q3SY84	12	52543909-52553147	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"epididymis: 10.8;skin 1: 42.7"	"Cell line enriched"	"Detected in single"	14	"CACO-2: 11.6"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049404	Enhanced						180000000			"HPA049404: "	"unprognostic (9.12e-2)"	"unprognostic (2.38e-1)"				"unprognostic (1.21e-1)"		"unprognostic (1.04e-1)"		"unprognostic (1.51e-1)"	"unprognostic (2.18e-1)"			"unprognostic (1.47e-1)"		"unprognostic (3.14e-1)"	"unprognostic (1.69e-2)"	1.4	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT72	"K6irs, K6IRS2, KRT6, KRT6IRS2"	ENSG00000170486	"Keratin 72"	Q14CN4	12	52585589-52601538	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 8.9;testis: 32.6"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"T-cells: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065523	Enhanced									"HPA065523: "	"unprognostic (3.36e-1)"	"unprognostic (7.20e-2)"				"unprognostic (3.41e-2)"		"unprognostic (1.02e-1)"			"unprognostic (6.97e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.82e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.16e-2)"		"unprognostic (1.19e-1)"	0.2	0.0	0.2	0.6	0.2	1.1	0.2	0.4	0.3	0.2	0.2	0.2	0.2	1.9	0.2	0.2	0.2	0.0	0.2	0.2	0.4	0.0	0.2	0.2	0.5	3.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	8.9	1.7	0.2	0.2	1.8	0.0	32.6	0.2	0.6	0.2	0.2	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.4	0.3	0.4	0.0	0.2	0.2	0.2	0.2
KRT73	"K6IRS3, KRT6IRS3"	ENSG00000186049	"Keratin 73"	Q86Y46	12	52607570-52618559	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 11.4;skin 1: 17.7"	"Cell line enhanced"	"Detected in some"		"HEL: 1.0;HMC-1: 2.3"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"naive CD4 T-cell: 11.4;naive CD8 T-cell: 3.9"	"Lineage enriched"	"Detected in single"	15	"T-cells: 11.4"	"Region enhanced"	"Detected in some"		"hippocampal formation: 5.3"	"Not detected"	"Not detected"			HPA044031	Enhanced									"HPA044031: AB_10963434"		"unprognostic (2.23e-3)"				"unprognostic (6.54e-2)"					"unprognostic (3.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.11e-3)"		"unprognostic (4.94e-1)"			0.5	0.0	0.0	0.8	0.0	1.5	0.4	0.0	0.0	0.0	0.0			0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.2	17.7	1.0	0.0	0.0	0.7	0.0	0.0			0.0		0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.7	11.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.0	0.0	11.4	3.9	0.0	0.7	0.0	0.0	0.0	1.5										
KRT75	K6HF	ENSG00000170454	"Keratin 75"	O95678	12	52424070-52434525	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skin 1: 22.9;tongue: 18.8"	"Group enriched"	"Detected in some"	6	"PC-3: 21.7;U-2 OS: 29.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 36.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 0.1"	"HPA019367, HPA076201"	Enhanced		Approved	"Plasma membrane,Cytosol"			2200000000	Cytosol	"Plasma membrane"	"HPA019367: AB_1852239, HPA076201: "	"unprognostic (2.83e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.85e-3)"	"unprognostic (2.67e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.60e-2)"	"unprognostic (9.20e-2)"	"unprognostic (5.19e-2)"		"unprognostic (2.45e-1)"	"unprognostic (8.98e-2)"		"unprognostic (1.94e-1)"	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	3.5	0.0	18.8	3.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
KRT76	"HUMCYT2A, KRT2B, KRT2P"	ENSG00000185069	"Keratin 76"	Q01546	12	52768155-52777345	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"tongue: 81.4"	"Cell line enhanced"	"Detected in single"		"HaCaT: 2.4"	"Cancer enriched"	"Detected in single"	12	"head and neck cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019696	Approved						430000000			"HPA019696: AB_1852243"		"unprognostic (2.00e-1)"				"unprognostic (1.89e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.4	7.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRT77	KRT1B	ENSG00000189182	"Keratin 77"	Q7Z794	12	52689626-52703463	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"skin 1: 77.7"	"Cell line enriched"	"Detected in single"	90	"HaCaT: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3"	"Not detected"	"Not detected"			HPA045934	Enhanced		Approved	"Nuclear membrane,Plasma membrane"			2100000000	"Nuclear membrane, Plasma membrane"		"HPA045934: AB_10960065"	"unprognostic (3.52e-2)"	"unprognostic (1.54e-1)"				"unprognostic (1.41e-1)"		"unprognostic (3.79e-1)"	"unprognostic (2.61e-1)"						"unprognostic (2.11e-1)"		"unprognostic (2.06e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	6.4	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	77.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT78	K5B	ENSG00000170423	"Keratin 78"	Q8N1N4	12	52837804-52849092	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 166.3;lymphoid tissue: 128.7;tongue: 53.1"	"Group enriched"	"Detected in some"	7	"EFO-21: 9.7;RT4: 2.7;SK-BR-3: 6.8;U-87 MG: 5.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 16.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 1.0"	"Lineage enriched"	"Detected in single"	11	"monocytes: 1.0"					"Not detected"	"Not detected"			HPA039724	Enhanced						71000000			"HPA039724: AB_10795255"		"unprognostic (5.36e-2)"		"unprognostic (5.89e-2)"		"unprognostic (2.95e-2)"		"unprognostic (3.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.01e-3)"		"unprognostic (8.88e-16)"	"unprognostic (3.50e-2)"	"unprognostic (6.92e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.25e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.1	26.8	0.1	0.1	0.1	0.0	0.6	0.1	166.3	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	18.3	0.1	0.3	15.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	53.1	128.7	0.2	25.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.7	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 102.9"	"Cell line enhanced"	"Detected in many"		"A549: 224.1;BEWO: 150.2;CACO-2: 278.9;CAPAN-2: 176.2;MCF7: 376.4;SK-BR-3: 191.3;T-47d: 160.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 13.7"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"			920000000	"Intermediate filaments"		"CAB000131: AB_2281144, CAB001696: , HPA049866: "	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	13.4	4.8	2.0	11.0	1.5	0.0	13.9	2.7	1.3	15.1	90.2	2.1	29.8	87.2	11.1	18.3	19.3	10.4	20.3	17.6	1.1	0.2	28.8	55.8	20.1	18.4	1.4	1.2	10.6	75.9	4.0	31.8	28.9	13.7	25.2	45.0	12.1	36.9	46.0	3.7	5.0	102.9	5.2	3.3	14.3	61.8	5.1	1.2	2.9	27.6	9.2	11.6	27.1	10.5	0.7	4.9	3.2	0.7	1.6	0.6	0.5	99.5	224.1	0.0	0.2	0.0	0.1	150.2	0.4	1.7	0.2	0.2	278.9	176.2	0.0	42.6	0.5	34.8	0.6	27.6	0.2	0.1	4.8	0.1	46.7	79.7	8.1	0.0	0.0	0.3	0.4	0.5	1.9	0.6	17.1	0.0	0.0	376.4	0.2	0.3	15.6	4.9	0.1	0.0	0.5	44.4	49.4	4.8	0.1	39.0	191.3	0.3	160.9	0.3	0.6	0.2	16.9	0.3	0.3	0.0	0.2	0.2	0.1	0.0	0.4	3.2	0.5	0.6	0.6	0.7	0.4	0.3	0.4	0.3	2.1	0.7	0.4	0.5	1.4	1.6	0.3	4.9	0.5	0.5	2.0	1.5	2.7	1.3	1.1	0.2	1.4	1.2	13.7	1.2
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell line enhanced"	"Detected in many"		"A-431: 44.0;MCF7: 62.9;SK-BR-3: 29.1;U-2 OS: 40.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"			290000000	"Intermediate filaments"		"HPA077836: , HPA077918: AB_2686871"	"prognostic unfavourable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.0	14.8	0.0	0.0	0.0	0.0	12.4	0.6	0.4	3.5	1.0	1.0	19.3	0.0	21.7	0.5	22.0	0.0	0.2	1.2	0.0	0.0	0.0	23.1	0.5	2.3	0.0	0.0	0.2	2.7	0.7	5.3	5.2	0.0	0.0	1.2	62.9	0.0	0.0	0.0	2.2	0.0	18.1	0.6	19.8	7.9	5.6	0.3	11.2	29.1	0.2	5.4	0.2	3.0	0.0	40.8	0.0	15.8	0.0	0.0	0.1	4.1	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
KRT81	"Hb-1, KRTHB1"	ENSG00000205426	"Keratin 81"	Q14533	12	52285913-52291534	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 43.2;skin 1: 53.9"	"Cell line enhanced"	"Detected in some"		"A-431: 210.7;A549: 160.7;MCF7: 48.0;PC-3: 77.3;U-251 MG: 148.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 46.1;cervical cancer: 49.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	43	"basophil: 43.2"	"Lineage enriched"	"Detected in many"	43	"granulocytes: 43.2"									HPA049778	Supported						220000000			"HPA049778: "	"unprognostic (1.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.90e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.10e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.64e-4)"	"unprognostic (5.98e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.31e-2)"	0.8	0.0	0.2	0.2	0.2	0.4	7.4	0.2	0.3	0.2	0.2	0.2	0.2	0.5	0.5	0.4	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.3	0.2	0.5	0.0	0.2	4.6	0.4	0.2	53.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.7	0.2	0.2	0.2	0.2	0.0	0.0	43.2	0.0	1.0	0.0	0.0	210.7	160.7	0.0	0.0	0.0	0.0	0.0	1.3	0.2	1.7	0.1	0.4	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.0	0.0	0.4	0.0	77.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	12.7	0.8	0.0	0.8	0.0	0.0	40.7	0.0	148.1	0.0	0.3	0.2	0.0	0.4	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
KRT82	"Hb-2, KRTHB2"	ENSG00000161850	"Keratin 82"	Q9NSB4	12	52393931-52406355	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 14.9"	"Cell line enriched"	"Detected in single"	5	"U-87 MG: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058715, HPA067230"	Enhanced						20000000			"HPA058715: AB_2683798, HPA067230: AB_2685807"		"unprognostic (3.04e-1)"				"unprognostic (3.59e-3)"												0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	1.6		0.0	0.0		0.3	0.0	0.0	14.9	0.0	0.0	0.0	0.2	0.0	0.7			0.0		0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT84	"Hb-4, KRTHB4"	ENSG00000161849	"Keratin 84"	Q9NSB2	12	52377812-52385652	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"tongue: 86.0"	"Cell line enhanced"	"Detected in some"		"A-431: 1.2;HaCaT: 1.6;U-251 MG: 1.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"gdT-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039714	Supported						79000000			"HPA039714: "		"unprognostic (1.08e-1)"				"unprognostic (1.65e-2)"		"unprognostic (1.65e-1)"	"unprognostic (3.47e-1)"					"unprognostic (1.59e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.4	0.0	86.0	3.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0
KRT85	"Hb-5, KRTHB5"	ENSG00000135443	"Keratin 85"	P78386	12	52360006-52367481	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Ectodermal dysplasia, Hypotrichosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"skin 1: 57.5;tongue: 16.1"	"Cell line enriched"	"Detected in some"	5	"A549: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"basophil: 2.0"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.0"					"Not detected"	"Not detected"			HPA049778	Supported						160000000			"HPA049778: "	"unprognostic (1.36e-2)"	"unprognostic (3.93e-1)"				"unprognostic (7.27e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.36e-1)"		"unprognostic (4.72e-2)"			"unprognostic (9.22e-4)"	"unprognostic (1.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.38e-1)"		2.1	0.1	0.1	0.1	0.1	0.2	2.1	0.1	0.1	0.7	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.5	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.7	0.3	0.1	0.0	0.1	0.1	0.4	0.2	57.5	0.1	0.1	0.1	0.1	0.0	2.9	0.1	0.3	1.1	16.1	0.1	0.1	0.1	0.0	0.0	2.0	0.0	0.2	0.0	0.0	1.3	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
KRT9	"CK-9, EPPK, K9"	ENSG00000171403	"Keratin 9"	P35527	17	41565841-41572058	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"lymphoid tissue: 25.7;skin 1: 7.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.6;HaCaT: 18.0;U-2197: 3.2;U-937: 5.6"	"Cancer enriched"	"Detected in some"	6	"melanoma: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA007261, CAB037322"	Supported						42000000000			"CAB037322: , HPA007261: AB_1079182"	"unprognostic (2.13e-2)"	"unprognostic (5.08e-2)"		"unprognostic (4.97e-2)"		"unprognostic (3.65e-2)"		"unprognostic (2.89e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.92e-7)"	"unprognostic (1.28e-1)"		"unprognostic (3.02e-2)"	"unprognostic (1.40e-1)"		"unprognostic (4.15e-2)"	0.1	1.7	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.9	0.1	7.6	0.5	0.2	0.1	0.1	0.0	0.7	0.1	25.7	0.1	0.1	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	7.6	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371391-30372257	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"intestine: 5.9;skin 1: 14.9;tongue: 19.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		1300000												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KRTDAP	"KDAP, UNQ467"	ENSG00000188508	"Keratinocyte differentiation associated protein"	P60985	19	35487324-35495558	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 110.5;skin 1: 326.3;tongue: 234.9"	"Cell line enriched"	"Detected in single"	55	"hTCEpi: 41.5"	"Group enriched"	"Detected in many"	7	"head and neck cancer: 486.4;melanoma: 207.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA063474	Enhanced				"Secreted in other tissues"		62000000			"HPA063474: "	"unprognostic (4.55e-2)"	"unprognostic (2.46e-1)"		"unprognostic (1.64e-1)"		"unprognostic (6.11e-2)"		"unprognostic (1.59e-1)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.16e-2)"	0.2	0.0	0.2	0.2	0.2	0.1	29.4	0.2	0.2	110.5	0.2	0.2	0.2	0.0	8.2	0.2	5.7	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.6	0.2	0.2	0.0	0.2	11.3	0.2	1.4	326.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	3.5	0.2	234.9	5.5	0.2	77.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
KSR2	FLJ25965	ENSG00000171435	"Kinase suppressor of ras 2"	Q6VAB6	12	117453012-117968983	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 27.4;pituitary gland: 24.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 7.2;SCLC-21H: 5.3;TIME: 10.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035536	Enhanced									"HPA035536: AB_10673485"	"unprognostic (1.74e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.29e-2)"	"unprognostic (9.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.14e-3)"	"unprognostic (5.74e-2)"	0.9	5.0	13.2	1.1	13.8	1.1	1.7	27.4	17.2	1.0	1.9	1.3	2.2	1.0	0.8	2.6	0.9	1.7	1.0	0.8	12.9	4.8	3.5	0.8	1.2	1.6	2.2	10.8	0.8	3.0	0.9	24.6	0.9	7.7	1.3	2.3	0.2	1.2	3.4	0.9	1.0	1.0	0.9	2.9	1.0	1.7	3.2	3.0	0.0	3.8	0.0	1.5	2.3	0.5	0.1	0.2	0.8	0.1	0.2	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.1	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	1.5	0.1	0.0	0.5	1.2	0.0	0.0	0.1	0.7	1.4	5.3	0.1	0.0	0.0	0.0	1.1	0.0	10.8	0.0	0.8	0.0	0.2	0.9	1.5	0.0	0.4	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.2	0.1	0.2	0.0	0.0	13.2	13.8	27.4	17.2	12.9	4.8	2.2	10.8	7.7	3.0
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (6.83e-5)"	"prognostic unfavourable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favourable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	26.5	27.5	30.8	18.9	37.3	9.5	44.2	30.8	35.2	22.7	28.8	15.8	23.4	13.0	18.8	30.8	26.1	16.8	18.1	36.1	32.2	25.3	33.1	31.8	21.2	16.9	39.3	24.5	23.1	22.8	48.3	54.7	21.3	49.5	26.9	28.7	13.1	21.4	24.0	101.9	41.4	20.1	40.5	51.9	22.1	18.9	40.9	42.0	14.5	33.3	37.9	17.9	32.7	39.7	35.6	58.3	27.0	15.5	19.6	24.0	4.8	40.2	27.9	20.9	22.7	28.8	27.6	30.3	32.9	26.5	20.7	18.4	18.6	50.2	31.1	47.1	33.8	75.5	25.5	28.7	35.0	52.2	14.0	22.0	46.2	35.2	27.3	32.2	17.8	25.7	26.3	25.5	44.3	33.9	21.4	18.2	39.7	31.5	27.6	19.1	16.1	41.6	22.0	54.9	14.8	51.9	63.4	25.7	21.5	52.2	24.0	28.9	24.9	20.6	47.8	42.3	54.3	21.7	30.9	8.3	11.1	23.2	49.5	18.9	23.4	27.0	14.8	14.6	19.6	13.1	18.7	28.3	23.2	22.1	14.2	35.6	24.0	20.6	9.4	19.6	15.5	58.3	14.8	4.8	30.8	37.3	30.8	35.2	32.2	25.3	39.3	24.5	49.5	42.0
KY	FLJ33207	ENSG00000174611	"Kyphoscoliosis peptidase"	Q8NBH2	3	134603138-134651636	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease"	"Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 19.5;tongue: 36.2"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.3;U-2197: 4.5;U-87 MG: 13.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036492, HPA036668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA036492: AB_10672222, HPA036668: "	"unprognostic (1.40e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.47e-1)"	0.3	5.7	3.5	0.4	2.3	0.5	1.4	2.5	4.6	2.2	1.7	2.1	1.7	0.9	3.9	2.3	3.1	3.7	0.9	4.8	4.9	2.1	0.7	0.2	0.3	0.2	1.7	6.9	1.7	0.2	8.5	6.8	0.2	3.2	3.6	0.6	3.3	1.7	2.8	19.5	12.6	0.5	7.4	2.0	0.3	1.7	0.7	3.6	0.5	5.2	36.2	1.1	1.3	1.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	13.6	0.7	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	3.5	2.3	2.5	4.6	4.9	2.1	1.7	6.9	3.2	3.6
KYNU		ENSG00000115919	Kynureninase	Q16719	2	142877498-143055832	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 35.9;liver: 41.1;placenta: 34.3"	"Cell line enhanced"	"Detected in some"		"A549: 40.1;HeLa: 44.8;Hep G2: 27.2;hTEC/SVTERT24-B: 23.5;SiHa: 22.2;U-87 MG: 70.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"classical monocyte: 28.7;intermediate monocyte: 35.9;memory B-cell: 19.7;myeloid DC: 28.4;naive B-cell: 12.7;non-classical monocyte: 29.2;plasmacytoid DC: 19.9"	"Group enriched"	"Detected in many"	21	"B-cells: 19.7;dendritic cells: 28.4;monocytes: 35.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA031686	Enhanced		Supported	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA031686: "	"unprognostic (2.58e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.04e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.58e-3)"	"unprognostic (4.88e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.64e-1)"	9.0	3.7	2.2	11.0	3.7	3.9	15.4	0.6	1.7	3.0	1.2	1.3	0.8	0.2	1.1	2.6	5.6	1.5	4.4	3.8	1.4	1.1	8.4	41.1	12.7	13.7	2.9	0.4	1.7	1.0	0.2	1.6	34.3	2.7	1.9	1.2	1.5	3.0	0.8	0.7	1.5	2.7	2.0	6.3	16.0	2.4	7.0	2.6	2.7	2.2	1.7	13.0	12.4	2.6	19.7	28.4	1.3	35.9	0.4	0.1	11.1	0.0	40.1	0.1	0.1	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.7	0.5	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.9	44.8	27.2	0.5	0.1	0.2	3.9	3.2	23.5	0.1	0.0	0.1	0.2	0.3	20.5	0.0	2.4	0.1	0.1	0.0	0.2	0.1	0.6	20.7	0.1	0.0	22.2	3.3	0.2	11.1	5.7	0.3	1.3	0.1	19.6	0.0	0.1	0.0	0.0	70.2	4.6	0.1	0.1	28.7	0.5	0.1	35.9	0.1	19.7	0.1	0.1	28.4	12.7	0.1	0.0	1.3	0.4	29.2	19.9	0.1	11.1	2.2	3.7	0.6	1.7	1.4	1.1	2.9	0.4	2.7	2.6
L1CAM	"CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1"	ENSG00000198910	"L1 cell adhesion molecule"	P32004	X	153861514-153886174	"CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 29.6;brain: 54.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 72.2;BJ hTERT+ SV40 Large T+ RasG12V: 39.7;HeLa: 52.1;RPTEC TERT1: 42.4"	"Cancer enhanced"	"Detected in many"		"melanoma: 34.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 1.0;naive B-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010896	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			59000000	Nucleoplasm	"Plasma membrane"	"CAB010896: AB_609903"	"unprognostic (1.33e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.51e-10)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (3.81e-4)"	"unprognostic (9.44e-2)"	"prognostic unfavourable (2.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.52e-3)"	"unprognostic (8.02e-2)"	"prognostic unfavourable (1.17e-4)"	"unprognostic (3.07e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-3)"	4.4	29.6	19.9	8.0	21.9	1.2	1.7	54.5	43.6	2.8	16.3	1.5	2.0	4.9	1.7	3.0	5.3	2.6	3.2	5.2	11.2	20.6	12.3	1.3	1.3	3.7	7.3	22.4	1.4	3.0	1.0	6.1	1.4	19.3	3.5	5.7	6.2	5.9	10.8	1.6	9.9	7.6	6.1	3.5	1.7	4.8	1.5	3.4	0.0	1.2	1.3	2.6	2.3	3.9	2.2	0.0	0.0	0.0	0.0	0.3	0.2	17.6	1.3	5.4	0.0	0.0	0.0	2.3	25.0	72.2	24.2	39.7	7.1	0.1	0.0	23.9	0.1	0.7	0.6	0.4	12.7	0.0	0.1	0.0	52.1	1.1	0.0	0.0	4.0	0.1	0.3	3.6	2.5	0.0	0.0	0.0	0.1	23.9	0.0	0.5	1.2	0.9	0.0	31.7	0.1	42.4	0.3	15.9	10.4	14.0	12.5	10.2	1.3	0.3	0.0	0.0	10.6	1.1	11.9	0.2	0.3	0.1	0.1	0.2	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.9	21.9	54.5	30.2	11.2	20.6	7.3	22.4	19.3	3.4
LACRT	LACRITIN	ENSG00000135413	Lacritin	Q9GZZ8	12	54630811-54634895	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	72	"salivary gland: 67.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	304	"breast cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to digestive system"		460000																					0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell line enhanced"	"Detected in some"		"A-431: 37.3;CAPAN-2: 33.1;HaCaT: 48.1;HBEC3-KT: 36.6;hTCEpi: 35.6;MCF7: 40.9;RT4: 35.1;SK-BR-3: 57.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"			"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.3	0.3	0.0	0.1	0.0	0.0	12.0	0.0	0.0	0.0	0.0	24.2	33.1	0.0	2.1	0.0	48.1	0.0	36.6	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	35.6	0.0	7.3	0.0	0.0	0.1	0.0	40.9	0.0	0.1	0.9	0.4	0.0	1.7	0.4	24.7	35.1	1.9	0.0	0.0	57.6	0.6	8.7	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3
LAMA1	LAMA	ENSG00000101680	"Laminin subunit alpha 1"	P25391	18	6941744-7117814	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.8;ASC diff: 13.3;BEWO: 63.6;hTEC/SVTERT24-B: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB010179	Enhanced				"Secreted to extracellular matrix"					"CAB010179: AB_2133741"	"unprognostic (2.75e-1)"	"unprognostic (3.66e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-2)"	"unprognostic (4.85e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.34e-3)"	3.2	0.4	2.2	0.9	4.4	0.4	4.2	0.7	3.3	2.7	0.5	7.3	0.6	0.4	2.8	4.0	0.5	0.7	0.6	0.6	5.2	1.7	5.5	0.5	0.9	0.4	3.6	1.9	4.4	1.4	0.4	3.4	0.8	5.4	0.7	0.6	0.2	3.6	2.0	0.4	0.7	0.4	1.3	5.7	0.7	0.4	20.9	4.7	0.0	6.7	0.0	0.4	1.4	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	13.3	12.0	63.6	0.6	3.1	3.1	6.9	7.5	0.0	0.0	0.1	1.0	0.0	0.0	2.3	1.3	0.0	1.0	0.0	3.5	0.0	1.5	0.0	0.0	10.1	0.3	13.2	7.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.0	0.0	12.4	0.0	0.0	0.0	2.4	6.6	1.3	0.0	0.0	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	4.4	0.7	2.4	5.2	1.7	3.6	1.9	5.4	4.7
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883141-129516569	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.7;placenta: 71.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 65.2;ASC TERT1: 47.5;HHSteC: 14.2;HSkMC: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	15	"NK-cells: 2.2;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"		38000000			"CAB040310: , CAB078182: "	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavourable (3.65e-5)"	35.3	7.4	1.7	3.5	8.1	0.9	38.9	6.4	3.8	22.0	10.4	1.7	6.3	2.0	13.3	12.8	17.1	17.7	13.6	65.7	2.1	1.5	3.6	3.8	17.1	8.8	4.7	3.3	33.0	5.4	2.1	7.0	71.2	6.2	8.2	4.2	3.5	9.4	7.5	26.1	8.2	7.2	26.8	6.9	7.3	10.2	16.7	5.4	0.0	9.6	9.2	1.4	18.5	22.1	0.1	0.1	0.0	0.0	2.2	2.2	0.1	0.0	0.0	0.7	0.0	65.2	47.5	0.0	6.4	2.3	0.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	39.9	0.0	3.3	0.0	0.0	0.0	0.2	10.8	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	1.8	0.0	2.2	0.0	1.0	1.1	0.1	0.1	0.0	0.5	0.0	2.2	0.0	0.0	0.5	0.1	1.7	8.1	6.4	3.8	2.1	1.5	4.7	3.3	6.2	5.4
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112108760-112254939	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 51.3;ASC TERT1: 78.1;HSkMC: 60.8;HUVEC TERT2: 64.1;TIME: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		350000	"Plasma membrane, Cytosol"		"CAB078156: , HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	42.3	3.6	5.8	20.7	5.4	0.0	21.7	3.7	4.6	28.7	28.6	4.7	12.9	6.3	41.0	24.8	29.7	29.6	23.3	13.8	5.1	4.1	4.6	1.8	27.9	8.8	5.5	2.1	19.9	1.6	3.6	5.6	25.4	5.0	21.3	13.2	18.4	22.9	15.7	5.7	6.8	13.1	53.6	3.6	0.4	15.6	9.4	2.5	1.1	9.1	15.2	6.6	35.6	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	51.3	78.1	0.0	12.8	7.7	1.3	0.2	0.0	4.8	0.0	8.5	22.2	0.0	0.5	0.0	0.2	0.0	6.6	0.0	6.4	0.0	10.5	0.0	0.0	60.8	0.0	9.3	0.0	64.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	21.0	0.3	0.0	0.3	1.9	0.0	9.9	0.0	0.0	58.6	21.1	1.1	23.6	4.3	0.0	0.0	0.0	5.3	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.4	3.7	4.6	5.1	4.1	5.5	2.1	5.0	2.5
LAMA5		ENSG00000130702	"Laminin subunit alpha 5"	O15230	20	62307955-62367312	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 30.3;CACO-2: 41.8;EFO-21: 31.2;TIME: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054609, CAB078157"	Enhanced		Supported	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"		1200000	Vesicles	Nucleoplasm	"CAB078157: , HPA054609: "	"unprognostic (8.01e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (9.90e-3)"	"unprognostic (4.01e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.98e-3)"	"unprognostic (4.04e-2)"	"unprognostic (9.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.33e-2)"	22.6	5.9	5.6	8.1	5.9	2.5	16.8	24.0	6.6	16.7	28.0	3.1	18.6	7.6	23.2	13.8	18.0	14.2	27.4	13.7	4.7	2.9	17.0	7.3	19.7	4.4	3.7	2.3	6.9	13.9	8.3	6.0	33.3	5.5	17.4	2.6	18.6	12.7	25.0	9.4	45.2	9.0	25.0	4.5	8.8	13.3	4.4	3.4	2.0	18.4	11.8	10.4	19.4	24.9	0.9	1.2	0.2	0.0	0.0	0.0	0.0	3.9	30.3	0.6	4.0	0.7	8.6	23.3	1.1	0.6	0.9	0.1	41.8	15.7	0.3	31.2	0.0	28.4	0.8	12.1	0.0	0.1	1.7	0.9	27.3	11.9	2.7	0.0	4.5	0.4	8.1	2.1	2.1	4.0	1.8	0.4	0.0	5.8	0.0	0.1	1.9	17.7	0.0	0.3	3.3	7.8	18.5	0.3	12.1	16.7	16.8	0.3	16.6	0.2	36.6	0.4	11.6	0.2	4.9	0.2	0.0	0.1	8.6	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	5.6	5.9	24.0	6.6	4.7	2.9	3.7	2.3	5.5	3.4
LAMB1	CLM	ENSG00000091136	"Laminin subunit beta 1"	P07942	7	107923799-108003255	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 81.0;ASC TERT1: 106.9;HSkMC: 104.6;TIME: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004056, HPA004132, CAB004256"	Enhanced				"Secreted to extracellular matrix"		140000000			"CAB004256: AB_627867, HPA004056: AB_1079226, HPA004132: AB_1079225"	"unprognostic (2.39e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.01e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.45e-3)"	"unprognostic (8.26e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.46e-1)"	47.3	9.9	5.4	11.8	9.9	0.0	36.4	7.0	5.7	20.3	29.4	1.9	9.3	13.2	31.8	16.8	20.5	18.5	21.2	36.2	2.5	1.4	36.9	6.8	39.4	18.2	3.1	3.9	16.5	20.1	3.3	10.9	57.5	6.9	25.1	17.8	20.4	10.4	13.4	15.8	13.8	24.2	27.0	4.6	28.5	20.3	13.3	2.6	6.7	31.8	7.8	5.5	28.2	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	17.7	10.7	0.5	81.0	106.9	42.2	14.8	22.4	8.3	9.0	37.2	21.7	0.0	21.4	24.2	5.4	3.0	17.9	6.6	0.0	3.2	0.7	7.3	15.6	54.6	0.0	0.8	104.6	6.8	21.3	24.6	56.4	2.2	0.0	17.7	4.4	0.0	0.0	6.3	12.8	0.1	7.5	0.0	44.2	12.6	3.8	21.6	10.4	14.7	10.0	4.9	0.1	77.4	23.9	6.9	8.1	17.6	0.0	0.0	0.0	12.2	0.0	44.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	9.9	7.0	5.7	2.5	1.4	3.1	3.9	6.9	2.6
LAMB2	"LAMS, NPHS5"	ENSG00000172037	"Laminin subunit beta 2"	P55268	3	49121114-49133118	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.0;fHDF/TERT166: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;myeloid DC: 2.0"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.0;monocytes: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000053, HPA001895, HPA050033, CAB078160"	Supported		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"		18000000	Vesicles	Cytosol	"CAB000053: AB_2313665, CAB078160: , HPA001895: AB_1079227, HPA050033: "	"unprognostic (1.12e-2)"	"unprognostic (4.40e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.08e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.24e-2)"	46.1	35.3	7.4	13.0	7.7	0.9	29.0	5.1	8.3	55.0	25.9	10.5	41.3	9.3	43.4	38.6	34.3	27.1	37.7	62.5	9.7	4.1	30.6	29.6	28.2	5.7	8.2	6.1	56.0	12.9	51.7	8.0	41.3	9.9	37.7	7.3	45.1	17.4	39.2	22.7	17.0	23.0	31.5	6.9	16.7	22.7	24.1	8.1	2.1	36.5	21.8	11.4	45.3	38.4	0.0	2.0	0.2	2.4	0.0	0.0	0.4	3.2	8.0	7.4	26.4	43.4	45.0	6.7	28.0	34.7	16.7	16.8	3.8	11.1	0.0	9.7	63.2	10.5	6.4	10.0	11.5	0.0	2.0	1.4	12.6	6.6	29.3	0.0	0.0	39.1	15.0	13.3	13.6	16.3	0.8	0.0	13.5	6.2	0.0	0.0	3.2	6.7	0.0	3.6	0.1	11.7	4.1	0.0	4.4	16.0	9.3	14.6	20.2	0.2	27.0	18.1	7.9	6.4	7.3	0.0	0.0	0.0	8.6	0.0	12.2	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	7.4	7.7	5.1	8.3	9.7	4.1	8.2	6.1	9.9	8.1
LAMB3	"BM600-125kDa, kalinin-140kDa, LAMNB1, nicein-125kDa"	ENSG00000196878	"Laminin subunit beta 3"	Q13751	1	209614870-209652466	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Amelogenesis imperfecta, Disease mutation, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.6;HaCaT: 64.5;HBEC3-KT: 157.5;hTCEpi: 50.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.9;neutrophil: 3.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;granulocytes: 3.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA007584, HPA008069, CAB078183"	Enhanced		Approved	Vesicles	"Secreted to extracellular matrix"		15000	Vesicles		"CAB078183: , HPA007584: , HPA008069: AB_1079228"	"prognostic favourable (8.43e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.62e-5)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.43e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.01e-2)"	"unprognostic (4.92e-3)"	24.5	8.4	1.2	5.5	1.7	3.3	11.7	0.8	4.1	10.2	9.9	0.9	3.2	12.1	7.0	3.1	22.1	6.3	8.4	8.9	1.1	0.8	4.7	4.7	11.0	1.6	1.2	2.2	1.4	2.1	0.0	1.1	16.1	1.1	11.9	6.3	0.8	19.1	10.3	1.9	17.9	22.8	2.7	1.4	2.1	28.7	1.7	0.8	4.9	1.1	35.8	30.2	16.2	13.3	0.1	1.9	3.4	0.5	0.4	0.4	0.1	20.6	3.1	0.0	0.0	2.2	1.4	0.1	0.6	1.8	0.7	1.1	8.1	42.6	0.0	1.8	0.4	64.5	0.0	157.5	1.1	1.5	0.1	0.1	11.0	0.1	0.3	0.1	0.1	0.3	50.4	2.3	31.4	0.7	0.2	0.8	0.2	0.0	0.0	0.1	0.0	8.9	0.0	2.1	18.9	8.7	12.9	0.0	0.0	8.8	1.0	1.8	0.2	1.1	16.5	3.6	7.6	0.1	12.3	0.2	0.3	0.0	5.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.4	0.0	1.9	0.1	0.4	0.0	3.4	0.4	0.0	0.0	0.0	0.1	1.2	1.7	0.8	4.1	1.1	0.8	1.2	2.2	1.1	0.8
LAMC1	LAMB2	ENSG00000135862	"Laminin subunit gamma 1"	P11047	1	183023460-183145592	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 167.8;ASC TERT1: 92.4;HSkMC: 104.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3"	"Group enriched"	"Detected in many"	15	"B-cells: 3.2;dendritic cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001908, HPA001909, CAB004486, CAB078163"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"	"Secreted to extracellular matrix"		90000000	"Endoplasmic reticulum, Plasma membrane"		"CAB004486: AB_627870, CAB078163: , HPA001908: AB_1079229, HPA001909: AB_1079230"	"unprognostic (1.46e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.30e-2)"	"unprognostic (8.84e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (8.85e-5)"	49.0	6.8	2.9	11.3	4.0	0.2	51.5	5.9	3.4	30.4	27.7	2.8	12.8	4.9	30.5	28.7	31.5	21.5	25.9	39.5	3.4	2.0	10.0	6.8	22.5	10.6	3.9	2.7	22.7	9.8	7.4	4.1	73.1	3.5	23.9	11.4	11.7	11.6	17.3	32.2	15.6	17.6	41.3	3.0	4.7	22.3	16.1	2.7	3.5	21.7	16.4	7.3	40.2	37.6	3.2	1.3	0.0	0.1	0.0	0.0	0.2	5.1	8.4	27.7	7.8	167.8	92.4	42.0	38.0	38.2	15.3	9.1	24.9	5.9	1.8	17.6	18.2	12.9	5.2	10.0	11.8	0.0	5.3	0.0	7.6	9.0	26.4	1.6	0.9	104.0	5.4	18.3	14.5	26.7	0.0	5.7	18.6	2.2	0.0	1.7	11.2	1.6	1.3	23.4	0.9	24.8	13.7	1.8	5.2	10.0	0.0	9.7	2.1	4.3	49.2	18.8	7.4	17.3	9.5	2.2	0.0	1.2	15.5	1.2	18.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	2.9	4.0	5.9	3.4	3.4	2.0	3.9	2.7	3.5	2.7
LAMC2	"BM600-100kDa, EBR2, EBR2A, kalinin-105kDa, LAMB2T, LAMNB2, nicein-100kDa"	ENSG00000058085	"Laminin subunit gamma 2"	Q13753	1	183186238-183244900	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 48.3;CAPAN-2: 43.7;HBEC3-KT: 216.9;hTERT-HME1: 133.9;RPTEC TERT1: 52.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 231.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004257, HPA024638, CAB078165"	Enhanced		Approved	Cytosol	"Secreted to extracellular matrix"			Cytosol		"CAB004257: AB_627873, CAB078165: , HPA024638: AB_1852689"	"unprognostic (7.27e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.20e-3)"	"unprognostic (9.43e-2)"	"unprognostic (4.94e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavourable (4.20e-6)"	"unprognostic (1.25e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (7.11e-5)"	"unprognostic (2.77e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	2.6	0.0	1.0	20.6	4.1	0.0	11.4	3.6	1.2	8.7	8.4	0.9	2.4	0.9	6.6	2.9	6.5	19.0	12.8	1.8	0.7	0.1	10.5	0.8	18.3	3.3	1.6	1.1	1.9	2.9	0.0	7.0	21.2	1.5	3.7	6.8	0.9	11.2	3.2	1.3	12.8	14.3	1.8	0.7	0.7	7.6	1.9	0.9	3.5	9.8	10.0	15.6	3.4	4.8	0.9	0.8	1.7	0.5	0.4	0.6	0.1	48.3	2.2	0.0	0.0	0.4	1.0	3.5	0.3	0.4	0.1	0.0	3.5	43.7	0.0	18.6	0.1	21.8	0.0	216.9	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.8	0.5	133.9	2.8	0.0	0.0	0.2	0.1	0.0	0.0	0.3	3.1	0.0	0.1	0.0	52.0	12.6	2.7	0.0	1.2	0.0	0.0	0.1	0.2	0.3	0.2	2.6	1.3	0.6	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.4	0.6	0.4	0.3	0.4	0.5	0.4	0.4	0.1	0.9	0.5	0.6	1.7	0.4	0.5	0.8	0.3	0.1	1.0	4.1	3.6	1.2	0.7	0.1	1.6	1.1	1.5	0.9
LAMC3	DKFZp434E202	ENSG00000050555	"Laminin subunit gamma 3"	Q9Y6N6	9	131009082-131094473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 50.8;testis: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;EFO-21: 20.1;Hep G2: 7.3;SiHa: 7.4;U-2 OS: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022814	Enhanced				"Secreted to extracellular matrix"		240000			"HPA022814: "	"unprognostic (9.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.55e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.28e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.83e-2)"	1.3	9.5	1.0	0.9	2.0	0.6	1.6	0.8	3.0	23.5	1.3	2.4	2.2	1.0	6.0	5.1	1.2	1.2	9.1	0.9	1.4	1.0	8.8	3.7	15.6	0.6	1.7	2.1	1.3	3.3	0.9	8.8	50.8	3.6	7.0	0.7	7.5	1.8	4.9	0.7	6.2	0.6	10.7	1.9	17.0	1.0	32.5	0.8	0.0	1.1	2.4	0.5	13.8	12.4	0.7	0.2	1.7	0.3	0.3	0.8	0.1	0.0	0.7	5.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	20.1	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.7	7.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	2.8	0.5	0.0	0.0	0.2	0.0	0.0	0.5	0.1	7.4	0.0	3.2	0.0	0.6	0.0	0.0	6.3	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.2	0.3	0.3	0.2	0.0	0.2	0.7	0.5	0.1	0.2	0.4	0.8	0.5	1.7	0.3	0.1	0.2	0.5	0.1	1.0	2.0	0.8	3.0	1.4	1.0	1.7	2.1	3.6	0.8
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297241-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported						460000000			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (3.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.04e-1)"	"prognostic favourable (4.15e-5)"	"unprognostic (2.06e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-1)"	61.3	41.9	34.6	36.7	44.7	28.5	70.7	17.6	50.6	50.4	39.0	77.9	46.7	49.9	55.7	73.4	50.6	38.1	60.8	45.0	38.0	30.7	61.2	83.3	74.6	78.1	64.3	42.3	44.4	79.5	38.2	43.7	68.6	42.1	47.0	31.3	30.1	60.6	47.8	26.6	72.0	46.7	43.3	67.6	46.2	43.6	41.6	57.3	34.9	59.5	43.1	37.0	47.6	48.1	3.1	7.6	12.2	7.0	5.4	6.5	2.7	43.5	15.2	15.8	43.1	88.8	33.5	29.8	51.5	54.3	32.1	43.1	29.6	81.5	10.3	23.6	52.3	56.0	15.4	32.7	22.0	21.5	25.5	17.0	30.1	27.8	46.0	51.9	39.9	40.8	44.7	29.7	19.5	38.7	14.1	15.2	39.4	17.5	10.4	25.4	11.9	16.6	15.5	13.7	15.5	29.1	33.0	14.5	15.2	30.3	45.0	29.7	43.4	37.0	58.5	33.0	35.9	43.5	22.9	28.6	28.2	11.0	55.1	51.9	38.2	3.8	7.0	12.2	5.9	5.3	5.0	3.1	4.6	6.5	3.5	3.0	5.2	4.3	9.2	5.4	5.8	7.6	4.6	2.7	34.6	44.7	17.6	50.6	38.0	30.7	64.3	42.3	42.1	57.3
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Approved	"Vesicles,Plasma membrane"			820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.8	11.7	8.6	11.1	113.5	38.8	23.9	20.5	35.8	20.0	37.4	9.7	21.2	8.4	18.1	35.6	20.0	12.5	15.5	32.6	9.4	8.9	6.6	13.0	13.0	37.8	29.0	18.4	42.0	31.2	26.6	17.6	27.2	7.6	30.0	32.3	21.9	8.0	14.8	6.7	10.4	6.2	14.6	15.0	29.2	8.8	2.9	4.6	22.0	22.4	43.8	13.3	32.4	28.1	28.7	13.9	36.9	55.3	15.1	14.4	5.5	27.4	35.1	68.7	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9
LAMTOR5	"HBXIP, MGC71071, XIP"	ENSG00000134248	"Late endosomal/lysosomal adaptor, MAPK and MTOR activator 5"	O43504	1	110401249-110407942	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA006812	Approved		Supported	Cytosol			270000	Cytosol		"HPA006812: AB_1079040"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (9.97e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (7.23e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.80e-3)"	"prognostic favourable (5.52e-4)"	"unprognostic (6.66e-2)"	29.0	32.1	38.9	21.0	35.2	60.9	30.1	25.2	35.8	23.6	29.8	24.4	28.9	23.7	21.6	47.3	30.4	26.7	31.0	63.8	33.2	34.8	118.7	54.3	26.7	28.1	41.5	28.5	29.7	34.8	28.9	35.2	46.3	35.8	28.0	31.6	31.0	32.9	29.6	64.0	21.5	34.2	22.9	36.4	30.7	28.6	24.0	29.5	22.6	37.8	56.7	32.3	27.8	24.7	62.0	59.0	86.1	42.6	25.4	32.4	42.1	46.4	38.9	35.3	21.1	59.2	45.2	35.3	39.5	31.2	33.5	31.9	33.9	23.0	37.0	42.2	38.2	18.9	35.8	33.0	41.3	39.6	40.2	27.1	46.9	68.5	45.3	38.8	33.8	39.4	51.2	34.6	22.1	40.0	31.9	34.9	48.5	75.6	35.2	47.0	25.0	64.8	24.4	63.8	28.0	77.2	52.3	26.1	34.1	35.1	51.3	85.5	19.8	55.1	38.0	25.4	33.0	63.8	37.0	36.8	41.1	47.1	83.2	38.9	58.2	47.1	42.6	86.1	25.2	41.2	22.1	62.0	29.5	27.0	34.7	54.6	25.9	27.3	65.6	25.4	39.0	59.0	32.4	42.1	38.9	35.2	25.2	35.8	33.2	34.8	41.5	28.5	35.8	29.5
LAP3	"LAP, LAPEP, PEPS"	ENSG00000002549	"Leucine aminopeptidase 3"	P28838	4	17577192-17607972	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029606, HPA029607"	Enhanced		Supported	Nucleoplasm,Midbody,Cytosol			4100000	Cytosol	"Nucleoplasm, Midbody"	"HPA029606: AB_10599288, HPA029607: AB_10611381"	"unprognostic (2.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.29e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.06e-1)"	"unprognostic (8.79e-2)"	42.5	29.7	23.2	43.9	38.5	18.1	30.7	8.5	23.5	13.3	21.0	23.5	12.3	27.5	17.2	20.8	19.3	18.7	24.3	25.4	24.4	17.0	71.7	70.3	39.4	54.2	33.7	16.1	13.5	14.7	23.5	13.2	25.0	34.9	15.3	22.7	15.0	23.0	12.1	33.3	20.9	30.6	26.9	35.0	54.9	20.8	19.3	30.7	19.9	29.4	21.7	32.1	24.4	23.7	7.5	45.7	9.5	46.1	11.8	12.9	25.3	10.8	9.5	9.1	8.6	18.1	22.1	0.1	17.1	19.3	62.3	75.7	17.3	20.7	42.7	11.4	13.1	6.7	34.2	12.1	23.7	16.3	9.8	23.7	10.5	22.6	21.1	21.3	15.2	22.4	7.7	20.4	10.7	21.6	22.9	30.5	14.6	11.7	18.9	29.2	19.0	18.2	29.4	8.7	21.6	16.2	12.7	13.5	11.1	15.7	9.7	33.5	8.2	8.2	14.0	15.8	10.7	16.6	29.7	28.1	42.9	36.9	21.4	35.5	15.3	8.4	43.4	9.5	8.0	46.1	7.4	7.5	7.5	8.5	45.7	5.2	6.5	6.8	6.2	11.8	31.9	25.9	12.9	25.3	23.2	38.5	8.5	23.5	24.4	17.0	33.7	16.1	34.9	30.7
LARP1	"KIAA0731, LARP, MGC19556"	ENSG00000155506	"La ribonucleoprotein domain family member 1"	Q6PKG0	5	154712902-154817607	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015222, HPA051397, HPA054819"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Endoplasmic reticulum, Cytosol"		"CAB015222: , HPA051397: , HPA054819: "	"unprognostic (1.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.95e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.34e-3)"	"unprognostic (4.12e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.83e-1)"	24.9	30.1	30.5	21.9	31.9	18.9	20.3	25.7	46.5	21.3	20.4	27.3	23.2	21.0	26.5	23.0	29.2	25.4	18.5	28.5	27.8	29.1	25.6	22.6	19.9	23.1	26.8	29.7	28.4	81.2	55.9	23.6	25.1	29.2	18.2	21.3	18.9	38.8	21.4	41.7	24.7	22.3	23.8	22.2	21.5	24.4	27.8	27.4	26.1	33.5	16.4	25.8	22.1	28.7	5.2	6.4	2.8	7.9	10.1	5.8	2.5	26.0	36.5	28.5	32.7	24.8	20.2	31.6	26.5	27.1	31.1	30.4	57.3	31.4	68.9	37.7	33.1	26.3	51.9	48.8	36.0	22.8	29.3	49.8	38.0	26.4	31.6	66.5	23.1	24.9	28.3	38.6	49.4	27.3	40.9	47.8	28.8	25.7	39.4	26.0	30.3	18.4	44.1	27.1	32.8	19.1	32.5	51.7	27.8	36.0	57.8	31.9	34.4	31.4	36.1	39.1	24.5	29.5	47.5	42.8	30.7	58.7	26.0	36.9	27.3	2.8	4.0	1.1	4.5	4.9	5.8	4.3	5.4	5.3	4.0	5.2	4.3	4.7	2.4	10.1	7.9	6.4	3.4	2.5	30.5	31.9	25.7	46.5	27.8	29.1	26.8	29.7	29.2	27.4
LARS	"FLJ10595, FLJ21788, HSPC192, LARS1, LEUS, RNTLS"	ENSG00000133706	"Leucyl-tRNA synthetase"	Q9P2J5	5	146113038-146182660	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036424, HPA040881"	Supported		Enhanced	"Nuclear bodies,Cytosol"			14000	"Nuclear bodies, Cytosol"		"HPA036424: AB_10670102, HPA040881: "	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (3.78e-5)"	"unprognostic (8.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (2.98e-4)"	"unprognostic (2.96e-2)"	32.2	30.1	27.0	25.8	31.2	17.8	38.6	31.8	33.7	25.5	25.3	30.1	23.9	16.8	35.8	31.3	28.5	26.8	16.4	29.0	24.2	22.2	26.5	18.4	20.0	24.8	27.3	26.1	32.0	40.8	35.0	43.0	20.6	31.6	26.3	29.9	19.5	39.9	24.8	55.5	24.1	21.5	32.5	30.9	25.2	24.9	20.5	30.5	25.6	30.8	22.8	28.9	30.9	29.2	21.3	28.0	5.8	18.3	19.0	21.8	11.2	20.4	24.2	28.0	45.9	23.2	30.3	43.6	23.9	17.7	24.2	35.1	25.2	22.4	31.1	14.8	31.4	17.5	47.3	39.3	42.4	26.7	27.8	35.5	30.6	14.6	32.2	50.4	23.5	23.8	39.6	39.6	68.8	33.0	39.4	58.3	26.0	16.9	38.9	30.9	43.4	26.8	30.1	35.3	31.0	18.5	18.5	27.6	34.8	26.0	28.7	60.4	32.6	43.5	32.2	28.3	18.8	25.6	35.7	30.3	44.7	50.9	30.8	53.2	33.0	2.5	13.5	5.8	14.8	18.3	19.8	21.1	16.4	13.6	18.6	21.3	21.8	18.0	1.2	19.0	13.6	28.0	14.8	11.2	27.0	31.2	31.8	33.7	24.2	22.2	27.3	26.1	31.6	30.5
LARS2	"KIAA0028, LEURS, MGC26121, mtLeuRS"	ENSG00000011376	"Leucyl-tRNA synthetase 2, mitochondrial"	Q15031	3	45388506-45549421	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035951, HPA045450, HPA066085"	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA035951: AB_10672997, HPA045450: , HPA066085: "	"unprognostic (3.89e-1)"	"unprognostic (3.89e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (3.02e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-3)"	"unprognostic (9.19e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.86e-1)"	"unprognostic (4.98e-1)"	"unprognostic (4.37e-2)"	"prognostic favourable (1.32e-11)"	"unprognostic (2.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (9.90e-2)"	"unprognostic (9.07e-2)"	9.6	14.3	18.8	9.6	21.8	6.7	8.1	11.9	17.9	9.2	14.8	13.1	8.3	9.6	9.8	8.9	10.4	11.2	8.4	14.2	14.6	13.6	18.9	17.2	7.0	10.3	15.7	9.5	10.2	8.2	20.0	14.0	10.6	12.3	10.8	15.3	10.0	8.7	9.8	14.1	7.8	8.8	11.0	8.8	10.0	8.9	7.3	11.8	16.1	10.5	8.3	12.8	11.3	7.8	5.1	5.9	2.4	3.3	8.4	6.0	3.7	6.2	7.9	9.2	8.7	8.4	9.5	9.9	9.8	10.1	18.3	13.7	14.0	8.8	13.0	8.4	11.4	6.8	34.2	20.5	13.9	11.4	8.6	14.1	12.8	13.5	8.8	20.4	5.2	12.3	12.7	17.5	9.2	11.4	21.9	7.4	11.4	6.9	14.6	7.5	23.0	14.6	8.3	9.2	14.5	16.3	15.2	7.3	9.1	15.6	8.8	8.1	14.0	12.0	10.0	11.2	8.3	9.3	11.7	5.8	10.6	13.9	13.2	13.9	9.9	0.6	2.8	2.4	6.0	3.3	5.8	5.1	4.4	5.4	5.9	4.0	4.8	5.4	1.2	8.4	3.0	4.5	3.9	3.7	18.8	21.8	11.9	17.9	14.6	13.6	15.7	9.5	12.3	11.8
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"			26000000	"Plasma membrane, Cytosol"	"Focal adhesion sites"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	34.8	72.7	21.3	18.8	31.3	34.0	36.7	43.9	42.9	46.3	34.0	21.7	38.0	15.9	36.7	67.8	55.6	9.6	33.4	40.5	11.6	5.2	7.6	21.0	37.7	29.7	17.5	23.1	30.1	11.7	39.2	11.1	31.0	12.9	5.3	64.3	11.5	20.8	27.0	10.6	18.2	11.8	11.3	20.1	56.8	30.7	3.2	7.8	26.1	27.4	22.7	43.3	21.4	54.1	27.8	40.5	32.4	26.6	13.7	18.1	12.3	29.3	15.8	33.4	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9
LAT	LAT1	ENSG00000213658	"Linker for activation of T cells"	O43561	16	28984826-28990783	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity, Mast cell degranulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"blood: 58.1;lymphoid tissue: 193.6"	"Cell line enhanced"	"Detected in some"		"HEL: 30.3;HMC-1: 128.1;MOLT-4: 43.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1"	"Group enriched"	"Detected in many"	134	"granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002223, HPA011157, CAB012978"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		75000	"Plasma membrane"	"Golgi apparatus"	"CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237"	"unprognostic (4.35e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.62e-1)"	"unprognostic (7.15e-5)"	"unprognostic (1.17e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.52e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.02e-8)"	"unprognostic (1.04e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.51e-4)"	4.8	1.8	1.6	27.6	3.0	8.5	2.5	6.6	2.3	3.9	10.8	2.0	2.0	4.9	7.7	3.1	4.3	4.2	5.8	3.1	1.9	1.9	6.0	3.3	7.8	33.2	1.7	1.7	3.0	2.7	1.4	6.0	2.8	1.8	8.5	2.8	3.1	12.2	5.4	2.0	5.8	9.0	3.1	1.9	13.9	5.1	2.3	1.7	193.6	7.3	4.6	50.3	6.4	5.4	0.2	0.2	38.2	0.2	15.7	58.1	26.8	0.1	0.3	0.2	0.3	0.6	0.3	0.7	0.8	0.2	0.2	0.3	0.3	0.4	0.1	1.1	0.3	0.4	0.4	0.2	0.1	0.2	0.5	30.3	0.7	0.5	0.1	0.9	128.1	0.3	0.6	0.2	0.1	0.1	0.3	3.6	0.1	0.8	43.6	6.0	0.5	0.4	0.4	0.1	3.8	0.3	0.2	0.8	0.1	0.1	0.3	0.3	0.4	5.0	0.5	0.6	2.9	0.6	0.2	1.2	1.0	0.4	7.7	0.4	0.5	38.2	0.2	0.1	47.9	0.2	33.5	0.2	46.9	47.9	0.1	0.2	44.6	42.6	2.3	15.7	0.1	0.2	58.1	26.8	1.6	3.0	6.6	2.3	1.9	1.9	1.7	1.7	1.8	1.7
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Group enriched"	"Detected in some"	10	"ASC diff: 12.1;HSkMC: 14.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	25011600000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (3.62e-12)"	"prognostic unfavourable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA049840: , HPA062236: "	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	24.7	9.7	32.9	14.6	13.8	8.6	16.6	6.5	8.2	13.6	14.7	19.5	42.7	51.0	14.6	6.8	18.9	23.5	6.9	20.7	29.7	24.4	12.7	9.5	16.6	8.6	55.1	22.5	7.5	4.5	12.4	11.0	17.3	38.5	34.7	9.1	3.4	50.5	31.1	29.7	3.3	34.1	30.0	47.5	15.6	11.6	8.8	11.7	11.1	8.2	5.4	11.3	36.4	11.3	3.8	19.7	10.5	23.4	12.5	17.0	57.0	5.1	24.9	12.8	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9
LCAT		ENSG00000213398	"Lecithin-cholesterol acyltransferase"	P04180	16	67939750-67944131	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"brain: 64.4;liver: 154.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 35.1;Hep G2: 27.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 64.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044767			Approved	Nucleoplasm	"Secreted to blood"	6470000000	9500000000	Nucleoplasm		"HPA044767: AB_2756312"	"unprognostic (3.34e-2)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (5.43e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.16e-1)"	"prognostic favourable (4.21e-8)"	"unprognostic (6.42e-2)"	"unprognostic (4.26e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.71e-4)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.90e-3)"	4.4	3.6	6.3	2.2	3.7	0.9	4.3	64.4	9.6	4.5	4.4	7.3	1.4	1.3	5.3	3.0	1.8	3.5	3.5	4.5	8.4	1.8	3.9	154.2	5.6	1.9	5.5	6.3	4.7	2.5	5.9	2.7	5.5	9.2	6.4	1.3	1.8	2.4	6.2	3.4	9.9	2.4	3.8	7.5	3.9	2.3	2.2	6.1	1.4	7.6	1.6	1.4	2.6	4.5	1.8	0.8	5.0	1.1	1.3	1.4	0.1	2.4	4.0	5.9	6.7	5.2	7.3	35.1	9.8	4.2	6.6	4.7	13.1	3.0	1.3	1.8	14.1	8.7	1.4	13.4	4.1	0.6	3.6	1.7	8.7	27.3	7.1	0.3	4.7	12.6	12.8	13.7	4.8	4.8	3.7	0.5	4.7	4.0	1.6	4.2	3.9	2.2	1.7	6.5	1.4	1.8	4.3	0.2	3.0	14.8	0.7	1.6	8.4	2.6	9.2	8.6	13.4	9.4	3.5	8.1	2.1	3.7	4.1	1.1	7.4	2.4	1.1	5.0	0.9	0.1	1.3	1.2	0.7	0.8	0.2	1.8	1.4	0.4	2.8	1.3	0.5	0.8	0.0	0.1	6.3	3.7	64.4	9.6	8.4	1.8	5.5	6.3	9.2	6.1
LCMT2	"KIAA0547, MGC9534, PPM2, TYW4"	ENSG00000168806	"Leucine carboxyl methyltransferase 2"	O60294	15	43323649-43330605	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039401, HPA048176"	Approved		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA039401: AB_10805478, HPA048176: "	"unprognostic (4.32e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (5.14e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.33e-3)"	"unprognostic (9.57e-2)"	"prognostic favourable (5.69e-9)"	"unprognostic (2.28e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	7.9	10.9	6.5	8.3	8.1	2.5	25.9	11.4	10.1	10.8	7.4	7.2	10.6	5.2	10.3	12.7	11.0	10.2	6.7	8.4	6.7	8.4	11.9	9.2	6.2	9.9	6.1	7.6	13.0	8.2	13.7	10.1	6.4	9.6	10.2	7.5	8.9	10.3	13.8	7.9	6.2	8.4	8.6	4.8	9.6	8.7	7.1	9.6	12.2	9.8	11.2	13.9	7.4	9.6	6.3	6.9	5.5	4.0	3.3	10.5	5.0	6.0	4.8	11.3	9.8	12.1	3.7	5.5	7.4	8.9	9.7	10.7	7.1	2.8	5.1	15.2	8.4	14.3	0.0	9.8	7.4	7.9	5.2	9.2	12.9	4.1	7.4	0.0	6.9	5.8	9.5	7.2	6.6	3.1	11.6	6.9	11.6	9.4	10.3	4.3	4.9	4.0	12.2	10.0	5.0	16.9	6.9	15.2	12.9	9.8	8.3	4.2	10.1	14.1	2.6	11.4	5.2	13.0	12.0	4.7	11.0	2.1	7.1	7.6	11.8	2.4	4.0	5.5	4.0	3.8	5.5	5.0	6.7	4.8	6.9	6.3	10.5	6.8	1.3	3.3	3.5	3.9	5.3	5.0	6.5	8.1	11.4	10.1	6.7	8.4	6.1	7.6	9.6	9.6
LCN1	"MGC71975, PMFA, TLC, TP, VEGP"	ENSG00000160349	"Lipocalin 1"	P31025	9	135521438-135526532	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Sensory transduction, Taste, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"tongue: 204.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;U-87 MG: 2.0"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.1"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in other tissues"		20000000				"unprognostic (5.50e-3)"		"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.08e-2)"		"unprognostic (1.11e-4)"	"unprognostic (1.22e-1)"	"unprognostic (7.84e-2)"	"unprognostic (9.47e-2)"		"unprognostic (3.94e-8)"	"unprognostic (2.07e-3)"	"unprognostic (3.03e-2)"		"unprognostic (5.83e-2)"	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	16.8	3.3	0.0	0.7	2.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	0.0	2.2	0.4	0.0	0.1	0.0	0.0	0.4	15.8	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	204.2	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.3	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	2.0	0.0	0.1	0.0	0.0	0.0
LCN2	"24p3, NGAL"	ENSG00000148346	"Lipocalin 2"	P80188	9	128149071-128153455	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Innate immunity, Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 199.7;gallbladder: 173.3;lymphoid tissue: 178.1;salivary gland: 168.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 271.0;EFO-21: 111.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"basophil: 5.4;neutrophil: 11.4;non-classical monocyte: 4.5"	"Group enriched"	"Detected in many"	72	"granulocytes: 11.4;monocytes: 4.5"									"HPA002695, CAB016549, CAB016550"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"		870000000	"Endoplasmic reticulum"		"CAB016549: , CAB016550: , HPA002695: AB_1852758"	"prognostic favourable (9.61e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.11e-2)"	0.3	0.5	0.2	24.6	0.3	199.7	2.7	0.2	0.5	78.7	19.4	1.0	0.5	2.4	7.9	9.1	77.0	4.0	173.3	20.4	0.2	0.2	12.7	12.8	32.6	0.2	0.2	0.1	6.7	17.4	0.0	5.4	7.1	0.8	17.0	10.5	1.0	168.7	0.9	1.0	3.1	17.0	0.7	0.2	8.1	35.1	5.8	0.1	5.0	3.8	142.0	178.1	68.9	48.5	0.0	0.0	11.4	4.5	0.0	0.1	9.6	8.5	2.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	271.0	0.0	111.0	0.0	17.7	0.0	0.5	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	4.9	0.0	0.6	0.1	0.0	0.2	1.2	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.0	4.5	0.0	0.0	9.6	0.2	0.3	0.2	0.5	0.2	0.2	0.2	0.1	0.8	0.1
LCP1	"CP64, L-PLASTIN, LC64P, PLS2"	ENSG00000136167	"Lymphocyte cytosolic protein 1"	P13796	13	46125920-46211871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 188.6;lymphoid tissue: 118.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 82.6;HDLM-2: 75.5;HL-60: 80.2;HMC-1: 85.1;THP-1: 74.8;U-698: 106.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019493, CAB020673"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"			2200000000	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB020673: , HPA019493: AB_1855457"	"unprognostic (2.79e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.19e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.99e-2)"	"unprognostic (6.70e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.92e-1)"	57.1	10.0	5.6	44.3	9.4	71.2	8.7	3.9	4.6	3.6	6.2	4.5	5.0	4.5	5.3	43.1	6.2	8.3	8.9	5.5	4.3	3.8	7.2	12.2	33.7	59.1	12.0	1.0	5.7	3.9	0.1	2.8	24.7	7.7	21.5	8.1	5.5	9.5	2.5	3.5	6.8	21.7	6.5	11.9	112.9	6.1	8.2	9.2	118.2	4.5	4.1	68.7	14.0	7.1	25.4	79.3	133.5	127.6	43.2	67.2	188.6	3.3	0.0	0.1	0.0	0.0	0.0	40.1	0.0	0.1	0.3	0.2	22.1	0.1	82.6	17.6	0.0	0.1	0.0	0.0	0.3	75.5	19.6	17.8	0.0	0.0	0.0	80.2	85.1	0.2	0.0	0.1	0.1	0.0	9.3	55.0	0.0	0.1	56.8	55.5	0.0	0.8	42.3	0.1	59.0	0.0	22.8	0.1	0.7	0.1	8.8	0.6	0.4	74.8	0.2	2.1	1.3	0.1	2.4	13.1	27.3	106.3	1.6	48.9	0.3	57.1	96.6	54.3	67.2	127.6	60.8	25.4	40.4	55.5	79.3	18.3	25.2	42.3	133.5	43.2	118.1	20.8	40.5	188.6	5.6	9.4	3.9	4.6	4.3	3.8	12.0	1.0	7.7	9.2
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 6.8;RPMI-8226: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"																"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.8	1.1	0.0	0.0	1.6	0.0	13.6	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0
LDB3	"CMD1C, KIAA0613, PDLIM6, ZASP"	ENSG00000122367	"LIM domain binding 3"	O75112	10	86668449-86736068	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	21	"heart muscle: 213.9;skeletal muscle: 329.7;tongue: 110.3"	"Cell line enhanced"	"Detected in some"		"HSkMC: 6.0;SCLC-21H: 9.7;SK-MEL-30: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"							HPA048955	Enhanced		Supported	"Nucleoplasm,Focal adhesion sites,Cytosol"			450000	"Focal adhesion sites, Cytosol"	Nucleoplasm	"HPA048955: "	"unprognostic (1.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.79e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.54e-3)"	"unprognostic (3.55e-2)"	"unprognostic (4.72e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-1)"	6.4	0.4	0.9	1.3	1.6	0.2	0.5	0.1	1.3	2.8	2.3	0.0	4.9	0.4	4.2	9.9	9.9	1.3	1.0	213.9	1.7	1.0	0.3	0.2	0.4	0.2	2.6	0.0	1.5	0.3	0.3	0.1	0.5	0.0	4.4	0.8	4.7	7.6	3.1	329.7	0.3	1.2	3.6	6.7	0.2	0.7	0.5	0.0	0.0	2.8	110.3	10.2	1.9	0.9	0.9	0.6	1.8	0.4	0.6	0.6	0.0	0.3	0.3	0.4	3.2	0.4	0.1	0.3	0.4	0.3	0.1	0.2	0.3	0.3	0.3	0.6	0.0	0.4	0.2	0.0	0.1	0.9	0.8	0.7	0.9	0.1	0.1	0.1	1.7	6.0	0.5	0.1	0.0	0.0	0.3	1.9	0.3	1.6	0.4	0.2	0.4	0.3	0.0	2.0	0.1	0.0	1.1	9.7	1.8	0.3	0.2	4.7	0.3	0.2	0.0	0.3	0.5	0.4	0.1	0.2	0.6	0.4	0.8	0.3	0.5	1.8	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.3	0.2	0.9	0.5	0.6	1.4	0.6	0.4	0.6	0.3	0.0	0.9	1.6	0.1	0.6	1.7	1.0	2.6	0.0	0.0	0.0
LDHA		ENSG00000134333	"Lactate dehydrogenase A"	P00338	11	18394388-18408425	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 249.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015336, CAB069404"	Uncertain		Supported	Vesicles,Cytosol			300000000	Cytosol	Vesicles	"CAB015336: AB_2134947, CAB069404: "	"unprognostic (8.83e-2)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (3.81e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-3)"	"unprognostic (4.66e-3)"	"prognostic unfavourable (3.26e-8)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.88e-2)"	"prognostic unfavourable (8.09e-6)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (9.69e-9)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-2)"	84.2	56.4	24.5	52.6	32.5	64.0	56.0	22.3	40.2	38.1	53.5	13.5	9.1	60.5	24.9	36.2	77.7	29.0	31.6	59.4	24.4	33.0	100.1	249.1	37.1	59.4	29.7	25.7	49.7	34.1	10.5	16.4	49.7	44.3	33.3	51.2	45.9	46.3	37.0	199.6	70.2	128.3	50.7	35.5	45.0	31.2	25.9	23.9	45.0	56.4	90.6	60.1	81.9	44.8	27.6	76.5	29.1	61.2	32.8	52.2	72.1	131.7	82.0	3.1	46.2	72.2	49.3	44.0	127.5	135.5	112.0	166.7	36.6	21.7	99.7	41.9	128.8	106.6	82.0	195.4	242.9	34.0	48.5	34.5	74.9	62.8	17.8	85.1	25.9	49.2	90.1	44.0	44.1	66.1	48.6	48.0	131.1	34.9	70.0	53.9	19.8	102.6	45.4	32.7	83.5	178.0	30.6	24.6	30.4	69.1	57.0	23.6	26.8	20.3	59.5	140.3	50.9	122.1	1.5	38.2	55.9	95.9	200.8	44.1	47.2	28.9	53.1	29.1	38.1	61.2	42.6	27.6	50.2	40.1	76.5	19.2	32.8	33.3	18.1	32.8	59.5	25.8	52.2	72.1	24.5	32.5	22.3	40.2	24.4	33.0	29.7	25.7	44.3	23.9
LDHAL6A	"LDH6A, MGC23940"	ENSG00000166800	"Lactate dehydrogenase A like 6A"	Q6ZMR3	11	18455824-18479600	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 18.9"	"Cell line enriched"	"Detected in some"	6	"HL-60: 15.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (1.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.95e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	0.2	0.7	0.6	0.4	0.6	1.4	0.2	2.4	1.9	0.1	0.2	0.4	0.0	0.9	0.2	0.4	0.4	0.2	0.3	1.1	0.4	0.5	0.4	0.2	0.2	0.6	0.3	0.7	0.7	0.4	0.0	0.4	0.2	2.2	0.2	0.1	1.9	0.3	0.3	0.2	1.5	0.8	0.0	0.3	0.4	0.4	18.9	0.0	0.1	0.8	0.0	0.1	0.2	0.2	1.3	0.7	3.5	0.5	1.6	1.9	0.2	0.2	0.4	1.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.5	0.5	0.8	0.2	0.0	0.6	0.1	0.3	0.4	0.7	0.9	0.6	0.8	0.5	0.0	15.3	0.7	0.1	0.2	0.0	0.2	0.0	0.4	1.2	0.1	0.2	0.4	1.1	0.3	0.7	0.7	0.4	1.5	0.1	1.1	0.6	0.5	0.5	0.3	0.2	0.4	2.2	0.8	0.5	0.2	1.0	0.3	2.7	0.5	0.2	0.3	0.6	0.3	2.1	0.4	0.4	1.9	0.3	0.3	0.9	0.5	0.5	0.7	1.3	1.1	1.0	3.5	1.6	0.5	0.5	1.3	0.2	0.6	0.6	2.4	1.9	0.4	0.5	0.3	0.7	2.2	0.0
LDHB		ENSG00000111716	"Lactate dehydrogenase B"	P07195	12	21635342-21757857	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 255.8;kidney: 233.1"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	4	"T-cells: 145.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004641, HPA019007"	Enhanced		Supported	Cytosol			780000000	Cytosol		"CAB004641: AB_425525, HPA019007: "	"unprognostic (2.93e-1)"	"unprognostic (9.20e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.39e-3)"	"unprognostic (1.36e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.91e-1)"	"unprognostic (6.41e-2)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.55e-1)"	"unprognostic (9.32e-2)"	70.9	60.2	79.5	33.3	79.6	40.8	33.4	52.4	80.1	24.9	31.8	30.6	13.2	11.8	38.7	27.3	25.6	34.4	32.3	255.8	58.8	69.9	233.1	9.8	27.7	52.3	91.6	62.3	68.0	54.8	41.8	19.4	40.1	84.9	34.9	39.4	26.8	21.8	42.2	29.7	8.6	18.0	42.9	52.9	23.8	47.5	16.4	47.6	59.1	48.5	56.3	58.7	49.7	21.8	28.1	32.9	33.0	15.3	33.7	145.1	93.2	32.7	88.0	77.4	50.9	55.5	61.8	90.0	45.8	45.8	64.1	63.5	139.3	0.1	116.1	30.1	30.8	16.5	106.4	84.9	81.7	29.7	74.1	119.5	84.1	0.1	53.1	111.5	51.7	70.6	30.4	56.1	76.4	73.1	65.3	17.5	70.5	0.1	94.7	135.0	223.2	38.2	85.6	108.0	93.6	318.2	146.3	24.9	57.7	21.0	32.6	79.0	0.2	87.5	28.4	43.2	56.7	30.7	86.3	15.5	20.9	152.5	47.9	53.4	51.2	33.0	15.3	1.8	28.5	9.4	47.5	28.1	110.7	59.4	28.3	17.7	145.1	92.2	2.5	33.7	6.7	32.9	105.4	93.2	79.5	79.6	52.4	80.1	58.8	69.9	91.6	62.3	84.9	47.6
LDLR	LDLCQ2	ENSG00000130164	"Low density lipoprotein receptor"	P01130	19	11089362-11133816	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol metabolism, Endocytosis, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 23.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009647, HPA013159"	Approved						12000000			"HPA009647: AB_1079243, HPA013159: AB_1852775"	"unprognostic (4.39e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.71e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (6.60e-5)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (3.43e-4)"	24.6	50.7	6.1	13.7	5.6	11.9	20.0	4.7	9.1	15.4	10.3	17.2	4.8	12.3	14.0	6.5	33.6	12.2	27.2	11.3	7.4	5.0	5.3	33.4	28.7	5.2	4.2	4.9	42.4	26.7	9.6	4.3	9.7	18.9	11.3	6.6	7.1	11.4	4.6	3.2	12.5	15.1	15.1	14.6	8.7	19.5	6.3	9.1	2.1	4.8	17.5	13.2	13.2	13.8	0.4	1.0	23.6	1.7	1.6	3.7	1.8	27.0	12.6	15.6	7.4	21.3	40.7	5.3	5.9	22.7	10.6	23.2	13.1	25.9	9.2	23.3	11.3	21.5	7.9	46.9	5.1	6.5	1.5	4.4	8.7	11.7	31.5	4.6	25.4	50.4	17.6	35.8	7.8	11.5	9.1	53.2	7.9	10.2	5.8	5.9	16.7	17.0	4.1	11.4	11.6	26.1	21.8	3.7	3.8	5.0	11.3	0.9	4.8	10.8	12.4	9.2	6.7	5.8	10.6	6.6	5.4	5.6	10.8	10.9	20.9	23.6	1.7	0.1	3.7	1.6	0.9	0.4	1.5	1.1	1.0	0.4	1.6	1.5	0.6	1.6	0.5	0.4	1.0	1.8	6.1	5.6	4.7	9.1	7.4	5.0	4.2	4.9	18.9	9.1
LEAP2	LEAP-2	ENSG00000164406	"Liver enriched antimicrobial peptide 2"	Q969E1	5	132872322-132875046	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 52.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	17	"liver cancer: 40.0"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"		1300000				"unprognostic (2.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.78e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.08e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (2.68e-4)"	0.1	0.1	0.0	0.2	0.1	0.0	0.2	1.5	0.0	0.2	0.3			1.5	0.1	0.1	0.3	0.2	0.4	0.2	0.1	0.0	1.4	52.4	0.2	0.3	0.1		0.2	0.5	0.5	0.2	0.0		0.7	0.5		0.3	0.1	0.9	0.4	2.6	0.0	0.1	0.7	0.5	0.1			0.6		0.5	1.8	0.4	1.6	0.9	4.2	1.3	0.9	2.0	0.3	0.4	2.3	2.3	4.8	2.6	1.3	1.7	1.0	0.2	0.7	1.6	2.3	2.8	2.0	0.4	0.2	4.1	3.8	1.1	0.5	3.5	1.6	1.6	5.7	1.6	0.7	0.9	1.2	1.1	1.9	0.6	1.3	0.7	1.4	4.8	0.7	1.2	1.6	3.8	1.4	1.1	1.4	1.5	1.5	1.0	2.0	1.6	1.1	1.0	1.0	0.8	1.5	1.2	0.4	2.7	1.5	1.2	0.6	5.7	4.3	1.6	0.7	2.7	1.1	4.2	1.3	0.2	1.3	0.9	1.4	1.5	0.9	0.6	0.9	1.6	1.1	1.2	3.2	0.9	0.5	0.8	2.0	0.3										
LECT2	"chm-II, chm2"	ENSG00000145826	"Leukocyte cell derived chemotaxin 2"	O14960	5	135922279-135955034	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 100.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	216	"liver cancer: 35.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043883	Enhanced				"Secreted to blood"	26543333	820000			"HPA043883: "							"prognostic favourable (4.16e-5)"						"unprognostic (2.57e-2)"		"unprognostic (3.52e-1)"			0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	100.7	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.5	2.5	1.2	0.1	0.8	0.3	1.0	1.2	1.5	2.5	0.6	2.2	2.3	0.5	0.2	0.0	0.0	0.9	1.4	2.4	1.9	1.0	1.5	0.2	0.7	0.2	0.9	3.2	2.4	3.3	4.1	1.0	3.0	0.5	0.8	0.7	1.1	1.1	1.1	0.9	2.0	2.0	1.5	1.2	1.3	1.7	1.9	1.6	1.4	0.7	1.6	2.7	1.0	1.9	0.0	0.6	0.1	0.3	1.6	2.5	0.9	1.5	1.3	0.4	3.6	1.7	1.0	1.1	2.8	2.4	2.4	1.2	0.4	0.7	0.8	0.5	1.3	0.8	0.8	0.2	1.0	0.7	0.5	2.5	0.1	0.6	0.5	0.7	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
LEF1	"TCF10, TCF1ALPHA, TCF7L3"	ENSG00000138795	"Lymphoid enhancer binding factor 1"	Q9UJU2	4	108047545-108168956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 231.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 103.2;REH: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 42.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 42.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002087, CAB019405"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"CAB019405: AB_823558, HPA002087: AB_1079245"	"unprognostic (1.03e-3)"	"unprognostic (7.36e-3)"	"unprognostic (2.97e-2)"	"prognostic favourable (1.37e-5)"	"unprognostic (9.08e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.47e-6)"	"unprognostic (1.12e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.88e-2)"	"unprognostic (8.91e-2)"	0.9	13.5	3.5	9.3	5.4	7.6	2.0	1.6	3.4	3.6	1.0	2.9	0.8	0.4	6.0	3.5	3.4	5.0	2.8	0.5	4.7	5.2	2.7	0.3	2.4	25.3	4.9	1.9	1.8	0.8	0.0	1.1	7.8	3.1	2.8	1.0	1.6	3.1	0.7	0.5	2.4	3.9	2.9	4.4	7.0	0.9	8.2	2.3	231.5	2.7	1.3	20.6	4.8	3.2	0.3	0.1	0.5	0.0	8.9	42.2	9.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.8	4.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	3.2	1.2	0.0	0.0	0.0	4.0	0.6	0.0	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.1	103.2	0.0	0.3	0.2	79.7	1.5	0.0	0.4	0.2	0.5	0.9	0.0	0.0	15.2	0.4	0.0	0.0	2.2	1.8	0.0	2.6	6.7	2.8	18.3	1.3	0.0	8.8	0.0	0.0	0.0	2.6	0.0	0.5	0.1	19.7	8.8	0.0	0.3	42.2	29.2	0.5	8.9	0.0	0.1	25.7	9.5	3.5	5.4	1.6	3.4	4.7	5.2	4.9	1.9	3.1	2.3
LEMD3	MAN1	ENSG00000174106	"LEM domain containing 3"	Q9Y2U8	12	65169571-65248327	"Disease related genes, Plasma proteins, Predicted membrane proteins"		DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025078, HPA076986"	Uncertain		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA025078: AB_10601908, HPA076986: "	"unprognostic (2.10e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (2.30e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.72e-1)"	13.7	11.9	21.9	15.3	27.3	24.8	15.3	36.0	26.3	13.3	14.4	10.9	11.4	13.4	18.0	13.1	14.5	14.3	10.0	11.1	19.4	12.5	14.2	13.3	13.9	17.2	15.8	16.9	17.8	16.4	25.7	15.2	10.4	16.9	14.0	14.6	12.1	14.8	11.9	14.9	13.3	14.8	12.1	15.8	16.2	13.5	28.6	19.6	23.2	15.3	8.4	16.7	13.1	15.8	4.8	5.0	3.1	2.1	3.8	5.3	1.6	11.5	6.5	10.5	10.5	7.4	8.7	7.2	13.5	7.3	6.8	5.9	8.1	7.5	31.6	8.7	8.3	15.7	11.2	9.7	9.9	7.5	13.1	12.9	6.3	6.2	5.7	19.5	9.3	6.2	10.5	8.1	11.0	8.0	16.8	15.1	9.5	6.8	10.2	10.2	14.4	6.7	24.0	10.4	15.7	8.5	12.8	11.0	6.8	13.5	13.9	8.1	13.8	15.5	10.9	8.3	9.0	7.8	9.3	10.8	10.2	19.4	7.0	9.6	10.2	2.3	1.8	3.1	3.9	1.6	5.0	4.5	5.2	5.2	2.4	4.8	5.0	5.3	2.1	3.8	2.1	5.0	4.1	1.6	21.9	27.3	36.0	26.3	19.4	12.5	15.8	16.9	16.9	19.6
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241284-128257628	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"adipose tissue: 85.2;breast: 63.7;placenta: 24.3"	"Group enriched"	"Detected in some"	9	"BEWO: 6.8;HSkMC: 2.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB010490	Approved				"Secreted to blood"		26000000			"CAB010490: AB_2296951"	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"	85.2	0.3	0.0	1.5	0.0	0.0	63.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.4	2.0	0.0	0.0	0.1	0.7	0.0	0.0	24.3	0.0	0.0	0.1	0.0	0.4	0.0	0.6	1.1	0.4	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	1.5	2.1	0.4	0.4	3.8	0.5	0.5	0.3	0.2	0.0	0.2	0.2	0.4	0.3	0.0	6.8	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.3	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.3	0.2	0.4	0.1	0.3	0.1	0.0	0.2	0.3	0.5	0.2	0.2	0.1	0.3	0.4	0.2	0.4	0.9	0.5	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.1	0.4	0.2	0.3	3.8	0.5	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LEPR	"CD295, OBR"	ENSG00000116678	"Leptin receptor"	P48357	1	65420652-65641559	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.8"	"Cell line enhanced"	"Detected in many"		"K-562: 46.1;RPTEC TERT1: 22.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 13.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA030899	Approved	Supported			"Secreted to blood"	8235000	8300000			"HPA030899: AB_10610003"	"unprognostic (1.59e-2)"	"unprognostic (1.09e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.73e-1)"	15.9	5.5	3.8	3.7	4.3	3.3	23.5	2.5	3.9	15.0	9.2	5.6	5.4	3.2	20.6	7.3	10.9	11.7	10.1	9.2	4.3	4.9	14.6	82.8	20.3	9.0	4.9	3.3	18.4	16.7	3.9	13.1	12.8	8.2	10.8	4.1	18.1	12.0	5.7	5.6	10.2	7.3	12.9	7.0	6.4	11.9	6.6	3.1	1.9	13.1	11.2	6.9	13.6	8.6	0.6	1.8	6.9	1.9	1.1	2.3	1.8	1.3	0.8	1.1	1.2	5.0	4.6	3.8	5.9	3.4	2.0	1.9	0.6	3.2	0.5	4.4	7.4	1.1	0.9	5.1	5.5	6.9	1.5	7.7	3.5	0.1	3.0	0.5	0.6	13.0	3.0	1.2	4.6	5.8	46.1	0.9	9.5	0.3	0.6	0.1	1.8	0.1	0.1	0.9	0.3	22.3	0.6	0.7	11.3	1.4	0.6	1.6	2.1	2.0	2.2	2.1	4.3	0.4	3.2	1.3	0.8	0.2	4.4	2.2	2.0	6.9	1.9	2.8	1.3	1.5	1.3	0.6	1.1	1.1	1.8	0.3	0.9	1.5	1.1	1.1	1.7	1.2	2.3	1.8	3.8	4.3	2.5	3.9	4.3	4.9	4.9	3.3	8.2	3.1
LGALS1	GBP	ENSG00000100097	"Galectin 1"	P09382	22	37675608-37679806	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000646, HPA000687, HPA001130, CAB002157"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"		19000000	Cytosol	Nucleoplasm	"CAB002157: AB_563734, HPA000646: AB_1078935, HPA000687: AB_2756309, HPA001130: AB_2756311"	"unprognostic (1.65e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.13e-2)"	"prognostic favourable (2.36e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.67e-3)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (3.22e-3)"	"unprognostic (4.91e-3)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-3)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (1.18e-10)"	"unprognostic (2.24e-2)"	"unprognostic (8.13e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavourable (5.10e-4)"	167.5	49.3	23.0	56.0	22.9	29.8	213.7	7.6	30.9	158.6	94.5	20.1	44.2	22.0	150.9	80.3	74.0	66.8	78.8	108.6	18.9	29.3	24.0	20.8	55.8	45.4	41.4	28.9	105.1	18.2	5.1	17.5	80.1	53.6	85.9	23.4	35.7	34.9	89.6	117.1	29.2	29.2	145.8	88.3	40.3	40.0	42.4	20.5	16.7	19.6	59.1	20.4	99.8	81.7	29.0	185.2	44.0	149.1	19.6	73.1	180.2	93.4	55.1	1.2	49.0	114.7	225.4	1.1	217.4	255.3	161.1	160.6	6.1	12.4	0.1	22.4	219.6	10.0	1.9	143.0	56.3	96.0	1.0	8.2	57.9	25.3	74.9	4.7	109.7	139.5	9.7	128.5	55.0	176.9	5.9	39.6	124.6	41.7	0.1	66.6	0.4	131.0	0.1	82.1	25.7	66.3	0.2	0.1	29.0	43.4	7.6	54.3	40.4	56.3	239.1	215.3	107.7	95.5	111.0	24.3	16.2	0.3	252.9	24.9	85.7	44.0	149.1	5.3	40.8	114.2	6.1	29.0	38.0	39.8	185.2	10.8	6.6	26.8	6.3	19.6	120.0	45.7	73.1	180.2	23.0	22.9	7.6	30.9	18.9	29.3	41.4	28.9	53.6	20.5
LGALS3	"GALIG, LGALS2, MAC-2"	ENSG00000131981	"Galectin 3"	P17931	14	55124110-55145413	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Immunity, Innate immunity, mRNA processing, mRNA splicing"	"IgE-binding protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.8;CAPAN-2: 74.5;SK-MEL-30: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 67.4;intermediate monocyte: 55.4;myeloid DC: 41.7;non-classical monocyte: 44.2;T-reg: 25.9"	"Group enriched"	"Detected in all"	12	"dendritic cells: 41.7;monocytes: 67.4;T-cells: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA003162, CAB005191"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		2300000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005191: AB_2136784, HPA003162: AB_1078937"	"unprognostic (1.42e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.65e-3)"	"unprognostic (7.60e-3)"	95.7	11.0	10.4	50.9	13.6	29.8	53.2	6.5	11.7	54.1	127.1	6.1	42.4	75.7	50.3	30.7	76.1	26.1	83.9	42.3	8.4	5.7	19.9	3.9	65.5	16.6	8.5	9.4	58.9	24.2	0.5	11.0	78.7	5.5	51.7	93.7	25.7	78.3	51.7	31.3	76.1	182.4	48.2	8.7	11.1	36.9	20.4	5.7	5.5	18.0	65.7	41.7	41.1	44.4	1.3	41.7	3.6	67.4	2.5	25.9	37.2	22.4	7.2	0.2	0.1	46.8	93.8	27.4	18.0	37.9	5.0	8.9	15.5	74.5	0.0	9.5	20.9	22.5	0.4	18.8	2.8	26.6	0.3	0.0	8.0	7.1	35.5	0.0	0.0	29.3	28.7	5.7	12.1	7.8	0.1	21.7	11.3	15.1	0.0	5.4	0.4	20.2	0.0	0.9	1.6	46.8	30.0	0.6	1.7	42.1	0.0	175.1	18.5	2.4	14.2	23.7	3.3	8.8	0.3	12.1	38.3	0.1	34.1	1.4	2.5	1.7	67.4	3.4	1.8	55.4	11.4	1.3	6.8	5.1	41.7	0.4	0.3	1.0	3.6	2.5	44.2	1.1	25.9	37.2	10.4	13.6	6.5	11.7	8.4	5.7	8.5	9.4	5.5	5.7
LGALS3BP	"90K, BTBD17B, CyCAP, gp90, M2BP, MAC-2-BP, TANGO10B"	ENSG00000108679	"Galectin 3 binding protein"	Q08380	17	78971238-78980109	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 75.9;SK-BR-3: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 30.2"	"Group enriched"	"Detected in all"	6	"monocytes: 10.6;T-cells: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000410, HPA000554"	Uncertain				"Secreted to blood"		11000000000			"HPA000410: , HPA000554: AB_1079246"	"unprognostic (1.23e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.07e-6)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	34.8	60.8	10.0	18.7	16.2	9.0	28.4	3.7	21.4	36.4	40.9	49.8	32.9	61.9	31.9	43.8	34.2	32.2	85.0	73.4	12.9	16.5	27.9	23.6	33.7	11.2	28.7	10.1	45.9	17.2	18.6	36.7	43.1	31.6	39.9	16.2	35.0	100.6	39.8	5.0	9.3	56.5	20.0	43.6	17.3	62.1	29.7	20.8	25.3	37.1	21.3	21.3	30.4	30.8	2.0	3.1	2.0	10.6	3.3	30.2	10.0	41.7	26.2	0.6	0.9	13.1	15.5	12.8	5.7	3.8	30.5	60.4	10.6	75.9	0.2	36.4	2.7	17.7	4.4	16.4	0.8	0.1	31.4	3.2	22.7	42.6	31.5	0.0	2.7	26.0	9.3	16.1	1.1	0.8	0.3	0.1	6.7	6.0	11.8	0.5	1.2	16.7	8.4	18.3	0.4	11.4	36.3	21.2	24.2	5.1	172.9	67.9	5.0	1.4	1.5	23.5	16.1	0.5	19.2	0.0	0.2	0.2	29.9	8.3	22.4	0.3	7.5	2.0	5.2	10.6	10.8	2.0	18.6	7.6	3.1	1.1	30.2	14.0	0.6	3.3	4.9	0.2	10.0	10.0	10.0	16.2	3.7	21.4	12.9	16.5	28.7	10.1	31.6	20.8
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38813364	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;NB-4: 2.6;RT4: 6.9;SH-SY5Y: 2.5"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"			92000	"Plasma membrane"		"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (3.21e-4)"	0.3	0.2	0.2	83.5	0.2	0.0	0.3	0.3	0.2	0.3	190.6	0.3	0.3	65.5	0.3	0.5	0.6	0.5	157.1	0.2	0.2	0.2	0.4	20.3	1.5	0.2	0.2	0.2	0.3	8.3	0.0	0.2	0.2	0.2	0.8	75.8	0.3	0.3	0.4	0.3	0.3	326.8	4.9	0.2	0.6	10.5	0.2	0.2	0.3	0.4	0.3	0.2	2.7	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.1	0.6	0.2	0.0	0.7	0.1	2.1	0.0	0.0	0.1	0.1	3.0	0.5	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.3	0.0	0.3	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.3	2.6	0.0	0.0	0.3	0.2	2.1	0.2	6.9	0.3	2.5	0.2	0.2	0.1	0.4	2.3	0.0	0.0	0.6	1.7	0.1	0.7	0.4	0.2	0.0	0.2	0.3	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2
LGALS7	"GAL7, LGALS7A, PIG1, TP53I1"	ENSG00000205076	"Galectin 7"	P47929	19	38770971-38773492	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 45.1;skin 1: 97.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 12.2"	"Group enriched"	"Detected in many"	7	"cervical cancer: 32.0;head and neck cancer: 64.8;melanoma: 27.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA001549, CAB032606"	Enhanced				"Intracellular and membrane"		3700000			"CAB032606: AB_640852, HPA001549: AB_1078938"	"unprognostic (1.56e-2)"	"unprognostic (1.30e-2)"		"unprognostic (1.18e-2)"		"unprognostic (4.86e-2)"		"unprognostic (2.39e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.01e-2)"		"unprognostic (3.37e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.09e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	8.3	0.0			0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		3.2	0.2	7.6	97.9	0.0	0.0	0.0	0.0	0.0	0.1			0.0		1.6	0.1	17.8	0.3	0.5	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.5	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.2	0.6	0.0										
LGALS7B	GAL7	ENSG00000178934	"Galectin 7B"	P47929	19	38789211-38791749	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skin 1: 260.5"	"Cell line enriched"	"Detected in single"	18	"HaCaT: 9.5"	"Group enriched"	"Detected in many"	7	"cervical cancer: 142.7;head and neck cancer: 185.0;melanoma: 42.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.3"	"Low lineage specificity"	"Detected in single"											"HPA001549, CAB025100"	Supported				"Intracellular and membrane"		3700000			"CAB025100: , HPA001549: AB_1078938"	"unprognostic (4.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.59e-4)"	"unprognostic (1.81e-1)"	"unprognostic (3.54e-2)"		"unprognostic (2.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.92e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.17e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.29e-3)"	0.3	0.1	0.3	0.3	0.3	0.2	10.3	0.3	0.3	20.7	0.3	0.3	0.3	0.1	1.6	0.6	61.8	0.2	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.1	0.3	6.7	0.3	11.6	260.5	0.3	0.3	0.3	0.5	0.1	0.3	0.3	0.8	0.3	21.4	2.1	0.3	33.4	0.1	0.7	0.0	0.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.7	0.1	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LGALSL	"GRP, HSPC159"	ENSG00000119862	"Galectin like"	Q3ZCW2	2	64453969-64461381	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 50.8;tongue: 90.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.4;HAP1: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 3.7;MAIT T-cell: 1.9;neutrophil: 4.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 4.1;T-cells: 1.9"					"Low region specificity"	"Detected in all"			HPA046079	Approved		Approved	Nucleoplasm			9700000	Nucleoplasm		"HPA046079: AB_10967075"	"unprognostic (1.34e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.25e-2)"	"unprognostic (8.43e-2)"	"unprognostic (3.57e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (9.19e-2)"	"unprognostic (2.77e-2)"	6.5	9.2	4.8	3.4	6.2	3.5	12.0	11.0	7.2	6.9	11.5	2.7	2.4	5.0	4.2	6.4	12.7	3.5	4.9	8.1	4.6	5.0	5.6	4.8	18.0	2.9	3.8	3.9	5.7	5.5	10.0	6.3	5.3	4.3	8.2	6.1	14.7	6.4	3.9	30.7	50.8	13.4	5.2	2.8	4.0	4.4	4.0	1.2	0.8	3.1	90.3	13.6	5.1	6.2	0.3	0.1	4.1	0.3	0.0	1.9	3.8	5.7	3.6	10.4	24.4	0.3	0.1	3.1	1.6	3.9	3.1	2.9	17.0	1.2	0.0	2.4	0.8	6.8	35.6	6.6	2.5	6.4	9.3	0.1	1.8	8.3	3.1	1.6	2.4	1.5	4.2	1.3	4.7	1.9	0.0	1.7	0.0	4.4	2.3	0.3	8.1	4.3	2.6	6.4	1.8	3.6	4.1	1.7	6.9	5.1	3.5	3.0	2.4	0.2	0.8	2.0	6.2	1.3	3.0	7.3	3.4	4.8	0.0	1.0	2.6	0.0	0.3	3.7	0.0	0.0	1.9	0.3	0.4	0.4	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	3.8	4.8	6.2	11.0	7.2	4.6	5.0	3.8	3.9	4.3	1.2
LGI2	"FLJ10675, KIAA1916"	ENSG00000153012	"Leucine rich repeat LGI family member 2"	Q8N0V4	4	24998847-25030879	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"parathyroid gland: 113.9"	"Cell line enhanced"	"Detected in some"		"AF22: 22.2;HAP1: 4.0;RPMI-8226: 10.2;SCLC-21H: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	10	"classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	10	"monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017140	Approved		Approved	Centrosome	"Secreted to blood"			Centrosome		"HPA017140: AB_1852833"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.20e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.38e-5)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.06e-4)"	"unprognostic (5.03e-3)"	2.5	1.6	2.8	6.7	3.3	0.8	2.3	7.9	7.8	3.7	4.0	0.0	1.0	1.1	8.9	4.9	4.1	11.4	4.2	3.7	2.4	3.9	3.0	0.9	1.4	2.0	7.2	0.4	9.1	2.6	113.9	0.5	2.6	18.7	1.0	1.6	6.0	0.9	1.4	0.9	0.9	2.6	7.1	2.9	1.2	2.4	2.0	0.9	0.6	1.8	0.6	4.6	1.8	1.1	0.0	0.1	0.0	1.3	0.0	0.0	0.2	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.6	0.0	0.0	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.6	0.7	0.0	0.9	10.2	0.4	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.6	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.3	7.9	7.8	2.4	3.9	7.2	0.4	18.7	0.9
LGI3		ENSG00000168481	"Leucine rich repeat LGI family member 3"	Q8N145	8	22146825-22157084	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 52.2;lung: 17.7;skin 1: 16.3;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;SCLC-21H: 4.5;SK-MEL-30: 4.5;U-2 OS: 2.5;WM-115: 2.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 14.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024826			Approved	Cytosol	"Secreted in brain"			Cytosol		"HPA024826: AB_10601131"	"unprognostic (4.41e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.26e-2)"	"unprognostic (5.59e-5)"	"unprognostic (1.36e-2)"	"unprognostic (9.41e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.14e-2)"	1.2	4.8	13.1	1.1	26.4	1.1	1.2	7.7	52.2	2.6	1.2	35.5	0.0	1.4	1.5	1.3	6.1	2.0	1.1	1.5	20.7	15.7	1.1	1.0	17.7	1.0	24.2	10.4	1.1	1.5	0.9	0.7	1.0	24.9	2.3	1.1	4.6	1.2	4.2	1.0	16.3	1.4	1.7	29.8	1.1	1.3	1.4	14.8	0.0	14.9	0.0	1.3	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.2	0.0	1.0	0.8	0.3	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	4.5	0.6	0.0	0.0	4.5	0.5	0.0	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	1.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	26.4	7.7	32.1	20.7	15.7	24.2	10.4	24.9	14.8
LGR6	FLJ14471	ENSG00000133067	"Leucine rich repeat containing G protein-coupled receptor 6"	Q9HBX8	1	202193901-202319781	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.6"	"Cell line enhanced"	"Detected in some"		"A549: 16.3;CAPAN-2: 14.5;HaCaT: 7.8;HeLa: 3.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	41	"T-cells: 14.3"	"Region enriched"	"Detected in some"	9	"olfactory region: 30.0"					HPA008556	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA008556: "	"unprognostic (4.72e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.13e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.54e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.83e-2)"	1.1	0.1	0.9	0.8	3.2	1.8	7.9	6.0	2.4	2.6	2.2	1.5	0.5	0.2	1.6	7.3	4.4	13.8	49.6	12.3	0.7	3.3	0.9	1.4	6.9	1.1	6.8	0.2	2.2	0.5	0.1	15.9	0.9	9.3	6.7	1.1	0.8	8.5	2.5	0.3	3.2	1.6	2.6	1.6	5.3	0.7	4.9	3.9	0.2	4.1	2.6	3.4	3.2	2.9	0.0	0.0	0.0	0.0	0.3	14.3	2.5	0.0	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.9	0.0	1.7	8.3	0.0	0.0	0.7	4.7	0.0	0.3	0.0	0.0	0.4	2.5	0.9	3.2	6.0	2.4	0.7	3.3	6.8	0.2	9.3	3.9
LIF	"CDF, DIA, HILDA"	ENSG00000128342	"LIF, interleukin 6 family cytokine"	P15018	22	30240447-30246851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 35.5;U-138 MG: 39.6;U-251 MG: 28.6;U-87 MG: 31.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"pons and medulla: 11.7"	"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.2"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.2"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA018844, CAB025985"	Uncertain		Supported	Cytosol	"Secreted in other tissues"			Cytosol		"CAB025985: , HPA018844: AB_1852814"	"unprognostic (1.28e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (8.79e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.36e-3)"	"unprognostic (4.18e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.10e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (6.78e-8)"	"unprognostic (2.02e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.99e-2)"	"unprognostic (4.71e-3)"	20.3	1.7	1.4	21.6	3.3	0.6	5.2	0.9	4.3	4.4	3.9	1.8	1.6	3.7	6.9	2.6	2.0	7.3	28.7	14.2	1.2	0.6	5.7	3.4	17.4	3.8	2.2	0.5	7.9	7.5	0.2	7.3	1.3	11.7	8.6	4.7	3.5	3.2	1.2	1.9	6.0	5.2	4.6	4.3	1.6	4.1	2.0	1.8	0.9	3.4	2.2	5.4	20.8	1.7	0.0	0.0	0.0	0.0	1.2	0.2	0.1	8.7	14.7	0.4	3.3	0.0	1.2	5.4	1.2	5.3	1.6	3.8	2.3	14.3	0.0	3.2	0.0	2.2	0.3	4.0	2.1	2.0	0.6	1.1	5.0	3.2	1.4	0.0	11.5	1.4	0.7	35.5	1.0	0.0	0.2	0.0	6.9	6.5	0.1	0.0	0.5	9.1	0.2	5.0	0.0	12.7	3.4	0.0	0.1	1.4	0.1	2.6	0.3	0.1	0.1	39.6	14.6	14.9	28.6	0.0	0.0	0.0	31.3	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.4	3.3	0.9	4.3	1.2	0.6	2.2	0.5	11.7	1.8
LIFR	CD118	ENSG00000113594	"LIF receptor alpha"	P42702	5	38474963-38608354	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 39.8;HHSteC: 17.0;SCLC-21H: 26.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004478, CAB010252"			Approved	"Nuclear speckles,Golgi apparatus"	"Intracellular and membrane"		74000	"Nuclear speckles"	"Golgi apparatus"	"CAB010252: AB_2128043, HPA004478: "	"unprognostic (6.00e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.80e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.78e-1)"	"unprognostic (9.80e-2)"	"unprognostic (2.73e-3)"	"unprognostic (1.06e-1)"	"prognostic favourable (1.40e-7)"	"unprognostic (3.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.65e-1)"	35.3	14.7	15.8	8.2	19.2	0.5	33.9	10.1	21.3	27.7	10.4	25.3	22.8	4.9	34.8	14.8	10.4	26.0	10.2	16.3	19.1	11.0	20.3	23.9	21.7	20.2	24.3	11.8	17.9	17.8	13.5	12.5	41.5	23.4	23.6	7.5	17.1	24.9	24.7	24.0	10.5	11.7	26.9	21.4	22.5	18.8	9.3	25.3	4.7	31.4	7.3	8.1	13.6	15.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.2	39.8	3.0	11.2	12.4	0.3	3.3	1.9	2.7	1.6	0.4	2.1	0.0	0.5	4.7	0.3	2.6	0.9	4.6	0.0	3.6	0.0	4.2	1.5	17.0	0.0	0.2	10.4	0.7	6.5	0.7	3.7	1.0	6.4	3.3	0.5	0.0	0.1	1.0	7.1	0.0	8.4	0.0	2.6	1.0	26.1	3.2	13.7	0.6	0.0	0.9	0.0	0.7	4.3	8.5	10.1	2.0	0.0	0.0	0.0	7.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	19.2	10.1	21.3	19.1	11.0	24.3	11.8	23.4	25.3
LIG1		ENSG00000105486	"DNA ligase 1"	P18858	19	48115445-48170603	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037015, HPA041431, HPA048071"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB037015: , HPA041431: , HPA048071: "	"unprognostic (1.83e-1)"	"unprognostic (1.48e-3)"	"unprognostic (6.45e-2)"	"unprognostic (9.76e-2)"	"unprognostic (9.47e-2)"	"unprognostic (9.24e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.03e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.10e-3)"	"prognostic unfavourable (5.75e-5)"	"unprognostic (3.59e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	4.1	5.6	8.1	25.2	10.4	37.8	6.4	17.2	10.6	6.5	9.2	6.5	8.7	12.0	6.8	6.1	11.0	7.8	6.9	2.6	6.3	5.3	6.0	6.2	5.9	18.6	7.7	7.4	10.8	10.3	9.1	9.7	11.7	8.1	7.5	6.0	4.6	7.2	7.9	6.1	12.5	12.8	3.6	7.1	11.2	6.7	15.1	11.5	34.7	10.7	12.1	16.9	6.6	8.6	10.4	1.3	2.0	5.6	10.9	11.5	4.8	15.7	20.3	21.7	14.0	0.9	1.1	15.7	9.1	6.8	14.8	16.3	11.5	15.5	28.5	5.6	3.8	10.6	8.9	9.0	6.4	15.4	15.4	17.6	14.3	14.8	0.3	21.8	14.6	2.0	0.7	7.9	1.2	7.9	14.9	10.7	7.4	12.6	34.9	32.5	12.3	4.7	30.1	17.0	14.1	4.5	24.1	13.8	13.7	11.0	12.9	3.1	8.3	16.8	7.7	11.8	19.9	9.9	14.2	10.6	16.7	29.0	4.8	12.3	13.0	0.0	1.4	2.0	7.6	5.6	6.8	10.3	8.4	7.6	1.3	10.4	11.5	8.0	1.1	10.9	2.7	1.2	8.9	4.8	8.1	10.4	17.2	10.6	6.3	5.3	7.7	7.4	8.1	11.5
LIG3	LIG2	ENSG00000005156	"DNA ligase 3"	P49916	17	34980494-35009743	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, DNA replication"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006723	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA006723: AB_1847781"	"unprognostic (6.05e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.39e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.71e-2)"	8.8	11.5	10.7	9.8	17.0	9.2	12.5	15.9	18.3	14.7	11.5	15.8	11.4	8.4	21.5	12.3	14.2	17.3	7.9	11.0	14.2	8.0	9.8	11.8	9.8	9.6	9.1	11.7	17.8	15.4	22.9	13.3	16.5	9.3	16.5	13.1	11.8	14.3	13.9	17.0	13.9	9.8	14.7	8.0	14.3	11.6	27.8	10.9	20.8	14.5	9.7	13.9	13.6	12.7	4.6	10.1	4.8	6.3	11.1	8.4	4.5	8.1	16.3	19.7	17.3	3.9	4.9	15.1	7.9	5.8	10.8	10.8	7.9	4.5	13.4	6.6	10.3	7.6	22.3	10.2	13.9	6.3	14.9	14.0	7.8	11.4	6.2	21.9	24.9	3.7	9.0	7.9	12.5	13.0	22.0	15.4	7.8	9.1	27.5	7.0	18.9	6.9	15.0	18.1	14.1	5.3	8.9	16.1	11.5	11.9	9.7	7.7	17.6	11.0	6.2	7.0	8.8	8.6	12.7	13.9	14.9	17.4	5.0	10.4	13.4	0.6	3.8	4.8	5.9	6.3	8.4	4.6	4.0	5.2	10.1	4.0	5.4	3.8	0.3	11.1	3.2	6.0	2.5	4.5	10.7	17.0	15.9	18.3	14.2	8.0	9.1	11.7	9.3	10.9
LILRA2	"CD85h, ILT1, LIR-7, LIR7"	ENSG00000239998	"Leukocyte immunoglobulin like receptor A2"	Q8N149	19	54572920-54590287	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 21.6;bone marrow: 21.7;lymphoid tissue: 39.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 2.5;REH: 2.9;THP-1: 5.9;U-937: 13.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.6"	"Group enriched"	"Detected in many"	7	"granulocytes: 21.6;monocytes: 7.1"														"Secreted to blood"		130000000				"unprognostic (2.04e-1)"	"unprognostic (7.72e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.53e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.30e-4)"	"unprognostic (4.21e-2)"	"unprognostic (6.59e-2)"	2.8	1.5	1.4	4.7	1.1	21.7	0.9	0.1	2.0	0.6	0.8	3.0	0.0	0.6	0.5	1.0	0.5	2.3	1.0	3.7	1.1	1.1	1.2	3.8	6.8	14.6	2.9	0.4	1.1	0.6	0.5	0.4	1.7	1.4	0.6	0.6	1.1	0.8	0.5	0.6	0.7	0.7	1.0	3.7	39.9	0.7	0.7	2.3	0.7	0.6	0.0	0.8	0.9	1.8	0.2	2.1	21.6	7.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.1	2.5	0.0	0.0	2.9	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	5.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	13.3	0.1	2.4	4.9	1.8	0.1	7.1	0.0	0.1	0.1	0.1	2.1	0.2	0.1	0.1	21.6	0.3	6.8	0.4	0.0	3.0	1.4	1.1	0.1	2.0	1.1	1.1	2.9	0.4	1.4	2.3
LILRB5	"CD85c, LIR-8, LIR8"	ENSG00000105609	"Leukocyte immunoglobulin like receptor B5"	O75023	19	54249431-54257301	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 31.0;lymphoid tissue: 35.1"	"Cell line enhanced"	"Detected in some"		"SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA012069	Approved						36000000			"HPA012069: AB_1852873"	"unprognostic (3.55e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-2)"	"unprognostic (8.86e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.02e-5)"	"unprognostic (6.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.73e-1)"	23.6	8.3	0.7	5.4	0.8	0.8	31.0	0.6	0.6	2.1	11.9	0.5	1.6	5.2	1.2	16.2	5.8	4.9	6.2	10.0	0.7	0.8	2.1	22.8	8.6	13.3	0.8	0.0	4.1	2.7	0.7	1.0	5.6	0.7	4.0	5.5	3.6	2.9	1.1	6.1	2.0	9.0	5.9	0.9	35.1	2.4	3.9	0.0	1.2	2.6	4.9	1.3	10.6	1.8	0.9	0.7	3.1	0.9	0.9	0.5	0.3	0.4	0.0	0.8	0.5	0.1	0.1	1.0	1.0	0.3	0.4	0.0	0.3	0.6	0.2	0.4	0.1	1.4	0.3	0.5	0.0	0.5	0.9	1.1	1.7	0.4	0.5	0.6	0.6	0.5	0.3	0.1	0.3	0.5	0.6	1.0	0.2	0.0	0.3	0.3	0.6	0.0	0.6	0.7	0.6	0.2	0.8	0.5	0.9	2.3	0.8	0.7	0.7	0.0	0.3	0.8	0.7	0.5	0.6	0.3	1.1	0.1	0.4	0.3	0.2	3.1	0.9	0.4	0.4	0.6	0.3	0.4	0.5	0.3	0.3	0.9	0.4	0.4	2.3	0.9	0.8	0.7	0.3	0.3	0.7	0.8	0.6	0.6	0.7	0.8	0.8	0.0	0.7	0.0
LIMD1		ENSG00000144791	"LIM domains containing 1"	Q9UGP4	3	45555394-45686338	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Repressor	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064220			Supported	"Nucleoplasm,Focal adhesion sites"				"Nucleoplasm, Focal adhesion sites"		"HPA064220: "	"unprognostic (2.77e-1)"	"unprognostic (3.22e-2)"	"unprognostic (5.43e-2)"	"unprognostic (7.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.88e-2)"	"unprognostic (2.11e-3)"	"prognostic favourable (6.73e-5)"	"unprognostic (8.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.61e-3)"	12.6	7.0	4.8	14.9	5.5	6.2	13.9	2.5	6.0	10.2	9.7	8.1	13.0	8.4	14.4	12.0	10.4	9.6	10.9	11.5	5.1	4.1	8.3	16.6	24.8	17.1	9.2	2.2	7.6	24.5	11.3	5.5	11.7	9.4	12.1	9.2	20.2	19.1	8.2	25.2	8.3	12.2	12.5	6.8	16.4	11.4	6.2	6.4	20.3	17.9	10.7	24.9	12.9	18.9	6.7	8.8	4.1	5.5	1.1	1.6	1.0	7.3	14.0	5.1	6.9	4.5	8.9	10.3	7.1	10.0	7.6	6.7	6.6	3.9	0.9	4.7	6.5	5.0	10.9	5.8	6.3	15.5	6.7	8.2	11.1	5.4	4.6	7.3	10.6	3.7	4.8	11.3	6.0	6.6	6.8	23.2	7.5	4.9	8.9	4.6	8.3	13.5	4.4	6.0	11.2	4.0	13.2	2.4	4.6	6.0	10.9	7.2	6.6	6.6	11.8	8.4	7.7	8.4	7.5	22.2	28.5	3.7	18.2	6.7	9.1	4.1	1.4	1.4	1.6	3.1	1.0	3.9	1.3	1.4	1.4	6.7	1.4	1.4	1.6	1.1	5.5	8.8	1.3	1.0	4.8	5.5	2.5	6.0	5.1	4.1	9.2	2.2	9.4	6.4
LIMK1	LIMK	ENSG00000106683	"LIM domain kinase 1"	P53667	7	74082933-74122525	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.2"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028064, HPA028516"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"HPA028064: AB_10600111, HPA028516: AB_10601751"	"unprognostic (1.45e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (4.95e-5)"	"unprognostic (2.77e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.35e-2)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (6.63e-8)"	"unprognostic (4.14e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.79e-2)"	8.8	8.6	31.6	18.2	18.6	6.3	7.4	14.3	44.1	11.5	6.6	7.1	6.6	6.9	7.3	5.3	6.4	6.0	10.8	6.3	26.8	32.9	5.2	2.6	12.5	22.0	33.4	22.2	12.1	8.1	4.0	7.2	8.0	45.2	6.1	4.7	4.8	18.1	9.6	10.9	6.8	7.2	7.6	10.8	18.4	7.8	10.4	6.5	4.3	7.5	3.7	18.1	14.1	7.2	4.6	8.6	3.8	7.7	6.9	2.4	3.1	17.2	13.5	10.3	17.1	13.6	18.5	7.5	10.7	10.3	8.7	9.7	7.8	17.0	10.7	4.8	13.1	10.4	3.8	6.6	3.3	18.5	6.7	7.9	4.6	8.9	15.6	6.0	29.0	18.2	5.9	7.0	3.7	12.9	5.3	3.4	10.8	15.1	5.1	10.8	19.5	8.4	7.5	16.0	6.7	9.6	3.7	4.1	9.4	6.9	16.5	8.6	5.2	5.4	15.3	13.9	12.9	35.7	17.1	3.9	4.3	19.5	51.4	4.4	9.4	0.1	6.5	3.8	2.4	7.7	1.8	4.6	0.6	1.5	8.6	2.4	0.2	0.7	0.7	6.9	4.7	0.8	0.4	3.1	31.6	18.6	14.3	44.1	26.8	32.9	33.4	22.2	45.2	6.5
LIMS1	"PINCH, PINCH1"	ENSG00000169756	"LIM zinc finger domain containing 1"	P48059	2	108534355-108687246	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA058455, HPA061230"	Approved		Supported	"Focal adhesion sites,Cytosol"			130000000	Cytosol	"Focal adhesion sites"	"HPA058455: , HPA061230: "	"unprognostic (1.79e-1)"	"unprognostic (8.82e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (7.51e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.11e-1)"	39.3	26.3	7.8	18.3	13.3	14.9	21.5	3.9	9.6	18.1	16.9	14.4	38.2	8.3	21.9	21.7	18.4	16.9	16.5	20.2	8.0	7.5	20.8	18.0	26.3	21.2	13.3	4.6	18.3	10.6	6.6	13.6	19.0	10.8	15.8	9.5	11.0	13.8	43.6	54.0	11.2	17.9	18.8	16.7	24.3	13.0	9.3	10.7	20.2	13.1	15.0	25.5	21.1	16.1	4.4	14.2	45.6	34.0	8.8	20.9	29.6	9.2	10.4	4.1	4.9	6.8	10.0	19.9	10.4	12.0	8.1	8.3	18.0	20.1	9.0	31.9	13.3	6.0	6.2	10.7	10.8	22.2	11.1	47.2	7.4	9.5	15.7	8.8	88.1	9.7	9.9	21.4	17.7	29.2	16.6	12.6	24.9	7.6	8.4	6.5	8.1	10.7	10.8	14.3	7.3	15.4	16.8	7.5	10.1	16.4	7.0	7.3	3.6	8.3	39.2	36.8	16.8	8.1	21.3	12.3	16.3	12.8	30.7	10.0	9.3	38.3	16.9	45.6	4.3	28.7	7.8	4.4	18.5	5.7	14.2	3.5	5.0	1.8	8.0	8.8	34.0	1.8	20.9	29.6	7.8	13.3	3.9	9.6	8.0	7.5	13.3	4.6	10.8	10.7
LIPG	EDL	ENSG00000101670	"Lipase G, endothelial type"	Q9Y5X9	18	49560699-49599182	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 37.0;placenta: 44.7;thyroid gland: 84.3"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 30.7;HaCaT: 47.1;RPTEC TERT1: 31.3;TIME: 61.1"	"Cancer enriched"	"Detected in many"	7	"thyroid cancer: 20.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 3.7;basal ganglia: 2.1;cerebral cortex: 2.9;hippocampal formation: 1.8;olfactory region: 1.9"	"Low region specificity"	"Detected in all"			HPA016966	Uncertain				"Secreted to blood"	656750000	170000			"HPA016966: AB_1852893"	"unprognostic (2.20e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.25e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.93e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.35e-1)"	1.5	0.4	0.8	4.7	0.7	0.1	0.8	2.0	0.7	0.4	5.6	3.9	15.0	1.9	0.4	3.1	1.0	0.5	4.3	1.2	1.1	0.9	5.2	37.0	4.4	0.7	1.1	0.1	0.5	1.0	0.0	0.6	44.7	1.4	1.0	2.2	8.3	0.6	24.6	2.6	1.1	7.6	2.2	1.4	0.4	1.4	5.8	0.4	0.3	84.3	2.1	0.5	2.0	0.6	1.2	0.6	2.1	0.6	1.7	0.8	0.1	0.5	0.0	13.5	30.7	0.1	0.0	0.2	0.1	1.4	0.0	0.0	13.3	4.8	0.0	7.5	0.0	47.1	2.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	1.4	10.8	4.8	9.4	7.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.7	31.3	3.6	0.2	0.0	0.2	0.3	0.0	0.0	0.0	61.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.4	0.7	0.4	0.4	0.8	0.5	0.5	0.2	1.2	0.8	0.7	2.1	1.7	0.4	0.6	0.4	0.1	0.8	0.7	2.0	0.5	1.1	0.9	1.1	0.1	1.4	0.4
LMNA	"CMD1A, HGPS, LGMD1B, LMN1, LMNL1, MADA, PRO1"	ENSG00000160789	"Lamin A/C"	P02545	1	156082573-156140089	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cardiomyopathy, Charcot-Marie-Tooth disease, Congenital muscular dystrophy, Disease mutation, Emery-Dreifuss muscular dystrophy, Limb-girdle muscular dystrophy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 10.4;memory CD4 T-cell: 8.9;myeloid DC: 34.8;T-reg: 35.4"	"Group enriched"	"Detected in all"	8	"dendritic cells: 34.8;granulocytes: 10.4;T-cells: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004022, HPA006660, HPA012078"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"			3200000	Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB004022: AB_2136278, HPA006660: AB_1079231, HPA012078: "	"unprognostic (2.22e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.75e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.47e-1)"	"unprognostic (5.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.90e-2)"	"unprognostic (5.10e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.44e-2)"	64.0	37.3	7.4	51.4	11.8	21.3	88.6	9.0	10.8	62.8	32.6	21.9	27.2	28.6	69.1	52.3	62.2	40.1	77.7	62.5	8.8	7.5	25.9	26.6	51.8	39.6	15.7	11.2	60.3	30.9	15.2	17.4	73.3	18.1	34.0	15.2	32.7	37.5	26.4	36.3	68.7	29.9	63.0	10.3	22.4	36.7	30.2	12.9	9.4	31.5	140.0	35.6	46.4	51.2	1.1	34.8	10.4	3.5	1.7	35.4	6.4	58.6	58.2	6.4	17.3	32.6	56.6	19.9	63.4	80.9	47.9	33.2	14.7	58.1	0.5	37.7	97.5	68.7	9.4	49.2	12.4	19.9	5.5	18.5	46.9	34.0	29.5	3.2	54.7	33.9	21.4	38.9	26.8	42.7	9.9	4.5	52.4	46.3	0.1	10.2	4.8	74.2	0.2	22.6	17.2	47.4	28.2	6.6	13.2	42.8	46.5	58.9	39.3	15.3	76.1	45.7	29.1	56.4	51.2	4.4	1.1	1.2	74.7	3.0	136.2	10.4	3.5	0.1	1.2	0.8	1.0	1.1	8.9	3.4	34.8	0.0	0.1	0.3	0.8	1.7	0.1	0.3	35.4	6.4	7.4	11.8	9.0	10.8	8.8	7.5	15.7	11.2	18.1	12.9
LMNB1		ENSG00000113368	"Lamin B1"	P20700	5	126776623-126837020	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 93.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"cerebellum: 23.4;pons and medulla: 6.3"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005269, HPA050524, CAB079757"	Supported		Enhanced	"Nuclear membrane"			3300000	"Nuclear membrane"		"CAB005269: AB_648156, CAB079757: , HPA050524: AB_2681156"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.96e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.65e-3)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (2.06e-2)"	"unprognostic (6.62e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (3.33e-16)"	"unprognostic (1.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	3.9	2.0	2.5	36.8	3.5	21.1	7.0	23.4	2.5	3.1	10.6	0.5	3.9	8.2	2.2	3.2	15.8	2.4	4.3	3.3	3.0	2.7	2.4	5.0	9.7	25.4	2.1	1.7	2.9	2.9	1.0	3.4	5.2	6.3	1.9	9.9	1.7	4.1	5.7	1.8	6.2	11.1	2.6	8.8	15.3	5.7	2.5	2.3	93.1	2.0	9.3	20.3	4.1	5.1	3.8	13.2	8.5	12.2	1.9	10.5	4.9	24.9	8.3	25.9	24.7	0.6	1.8	33.6	11.7	3.4	13.0	14.1	21.6	20.9	43.5	20.4	4.0	14.0	17.7	8.0	14.4	30.5	21.7	27.9	9.9	12.7	0.2	33.1	18.9	0.5	0.1	6.8	3.2	10.7	16.1	17.0	9.0	20.6	59.9	65.8	19.5	11.7	28.7	51.3	17.6	7.1	11.4	30.0	15.8	19.0	8.2	7.1	14.9	38.4	9.0	9.7	26.5	7.1	25.0	11.2	8.5	38.2	5.0	47.1	14.4	1.2	12.2	4.0	1.9	5.0	1.5	3.8	4.0	2.5	13.2	2.9	2.9	2.6	8.5	1.9	1.2	4.0	10.5	4.9	2.5	3.5	23.4	2.5	3.0	2.7	2.1	1.7	6.3	2.3
LMNB2	LMN2	ENSG00000176619	"Lamin B2"	Q03252	19	2427638-2456996	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022593, HPA047863, HPA062477"	Enhanced		Supported	"Nuclear membrane"			97000	"Nuclear membrane"		"CAB022593: , HPA047863: , HPA062477: "	"unprognostic (3.92e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.05e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (1.96e-1)"	"unprognostic (3.09e-3)"	"prognostic unfavourable (9.53e-5)"	"prognostic unfavourable (9.34e-5)"	"prognostic favourable (3.98e-4)"	"unprognostic (4.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.53e-2)"	5.6	5.0	4.6	11.5	6.0	11.8	8.6	8.9	5.9	3.7	8.2	4.3	5.1	8.7	10.1	3.6	7.9	5.1	5.9	5.4	4.3	5.0	4.2	4.4	5.7	9.3	5.3	5.4	7.0	5.1	2.3	5.4	11.6	5.2	5.0	4.8	4.5	5.3	4.1	10.1	7.7	9.6	4.1	3.4	6.0	7.5	7.4	4.4	18.4	5.4	12.4	8.7	4.1	11.3	1.6	7.3	1.6	4.0	1.6	3.5	1.2	45.3	29.2	21.1	27.5	4.6	7.3	28.3	30.7	15.0	31.0	23.5	38.5	19.5	21.1	12.6	14.2	47.8	18.8	21.8	15.9	25.7	22.5	16.8	10.3	30.0	5.6	23.5	17.1	6.6	5.6	16.6	13.1	15.8	29.2	13.6	14.6	26.5	26.8	13.0	40.4	25.7	37.8	26.9	17.7	8.8	22.9	31.4	18.2	25.6	17.2	10.2	17.2	24.2	21.8	29.9	31.2	45.9	45.8	12.2	10.3	21.4	24.2	22.5	38.4	0.0	1.4	1.6	2.3	1.3	3.5	0.9	2.5	2.2	1.7	1.6	2.6	2.9	0.1	1.6	4.0	7.3	0.7	1.2	4.6	6.0	8.9	5.9	4.3	5.0	5.3	5.4	5.2	4.4
LMO7	"FBX20, FBXO20, KIAA0858"	ENSG00000136153	"LIM domain 7"	Q8WWI1	13	75620434-75859870	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6"	"Cell line enhanced"	"Detected in many"		"BJ: 54.7;fHDF/TERT166: 90.2;LHCN-M2: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 14.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 32.9;basal ganglia: 46.3;cerebral cortex: 39.4;hippocampal formation: 54.2"	"HPA020923, HPA050184"	Approved		Supported	"Actin filaments,Cytosol"				"Actin filaments"	Cytosol	"HPA020923: AB_1852963, HPA050184: "	"unprognostic (2.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.14e-1)"	"prognostic favourable (7.75e-12)"	"unprognostic (2.49e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.33e-2)"	2.2	2.2	10.1	6.3	32.6	0.9	2.5	2.7	13.2	6.7	24.3	0.5	2.4	17.5	2.3	7.8	42.5	4.0	16.3	65.6	9.8	2.5	21.7	19.9	57.0	2.6	2.3	8.8	5.5	6.8	6.2	3.1	10.9	1.1	7.6	8.9	2.7	14.3	7.0	44.4	8.6	55.0	2.1	2.0	1.5	16.7	4.7	4.1	16.2	25.7	36.3	23.7	4.6	15.4	2.4	1.1	3.0	0.5	0.5	14.1	2.6	12.1	6.9	0.2	0.2	14.4	10.2	2.4	54.7	27.0	13.9	15.1	16.9	15.7	1.0	4.2	90.2	11.8	3.0	2.6	16.1	16.3	0.7	7.4	36.7	15.8	4.1	2.3	3.9	7.0	5.1	6.0	6.9	5.8	0.2	0.0	84.9	4.7	1.8	1.0	0.3	10.4	1.1	25.5	0.2	5.9	2.8	0.8	1.9	9.9	1.7	2.2	2.2	1.7	8.8	34.4	6.4	4.1	13.3	3.7	2.7	4.3	10.1	2.6	15.6	3.0	0.2	2.4	0.7	0.5	0.9	1.1	3.2	1.0	0.4	2.4	14.1	8.5	0.1	0.5	0.3	1.1	1.2	2.6	10.1	32.6	2.7	13.2	9.8	2.5	2.3	8.8	1.1	4.1
LMOD1	"1D, 64kD, D1"	ENSG00000163431	"Leiomodin 1"	P29536	1	201896452-201946588	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 199.7;urinary bladder: 165.5"	"Group enriched"	"Detected in some"	10	"ASC diff: 11.1;BJ: 14.3;BJ hTERT+: 23.3;fHDF/TERT166: 11.5;HSkMC: 10.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 43.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028325, HPA028435, HPA030097"	Enhanced		Approved	Cytosol				Cytosol		"HPA028325: AB_10600300, HPA028435: AB_10602180, HPA030097: AB_10601223"	"unprognostic (3.84e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.64e-1)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.27e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.15e-2)"	27.4	12.7	1.9	26.7	6.2	0.0	20.5	2.2	1.9	65.6	83.5	1.8	42.7	6.0	84.9	29.0	94.6	33.2	80.7	8.3	1.6	1.6	5.3	1.0	11.0	5.5	2.3	3.2	38.1	1.6	7.4	1.3	10.2	4.1	77.1	12.0	28.9	6.8	63.8	29.5	7.4	20.9	199.7	1.8	6.3	47.0	23.3	0.7	0.0	7.9	12.3	2.7	165.5	39.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	11.1	1.4	0.9	14.3	23.3	0.9	1.1	0.0	0.1	0.0	0.5	11.5	0.2	0.3	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	10.2	0.0	0.6	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.3	0.5	0.0	0.0	0.1	0.5	0.2	0.0	0.5	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.9	6.2	2.2	1.9	1.6	1.6	2.3	3.2	4.1	0.7
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: "	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.6	0.6	1.9	1.0	3.5	7.3	9.2	1.5	0.7	0.0	0.0	2.7	8.4	2.1	1.2	4.2	1.6	0.0	0.3	0.0	0.5	4.6	2.9	1.7	1.6	1.4	2.7	0.8	5.4	0.3	0.5	0.0	2.8	1.7	1.0	6.6	4.7	2.4	1.8	4.8	1.0	1.5	0.7	0.9	6.3	8.8	2.3	2.6	0.7	9.7	1.0	5.2	1.4	8.0	10.5	3.1	3.4	1.8	3.9	0.6	1.4	9.6	2.4	1.9	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0
LNX2	"MGC46315, PDZRN1"	ENSG00000139517	"Ligand of numb-protein X 2"	Q8N448	13	27545911-27620404	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040698	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"				Vesicles	"Plasma membrane, Cytosol"	"HPA040698: AB_10673138"	"unprognostic (4.97e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.79e-2)"	"prognostic favourable (7.09e-13)"	"unprognostic (4.18e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.84e-2)"	4.6	10.3	2.5	6.7	4.2	2.7	9.8	7.6	4.1	6.0	13.2	2.3	8.3	12.2	4.4	4.3	12.4	4.1	9.7	8.8	2.8	2.9	9.2	24.5	22.1	4.9	3.4	3.1	6.3	24.7	7.6	9.6	10.8	3.7	7.0	9.3	10.2	12.1	9.9	8.0	7.6	19.6	6.5	3.3	4.6	9.0	10.3	2.6	13.4	9.9	4.2	10.0	6.2	8.5	1.6	0.8	5.3	0.9	3.3	2.8	0.6	5.1	2.8	5.4	5.9	5.7	2.6	5.7	4.6	4.0	4.5	4.1	10.2	10.3	7.8	4.0	4.0	9.8	9.6	12.2	5.9	4.7	4.0	9.9	6.0	7.4	9.0	5.3	6.3	2.2	19.0	3.1	12.5	8.1	3.0	3.0	6.5	6.3	7.8	3.5	6.0	3.2	7.2	10.6	4.0	9.9	9.0	13.9	2.9	6.3	12.7	8.0	8.9	4.1	10.3	2.6	3.6	2.6	3.7	2.9	4.9	8.1	1.7	5.1	3.6	5.3	0.9	2.4	1.7	0.3	2.3	1.6	1.8	2.1	0.8	1.3	1.9	1.8	1.1	3.3	0.7	0.4	2.8	0.6	2.5	4.2	7.6	4.1	2.8	2.9	3.4	3.1	3.7	2.6
LOX		ENSG00000113083	"Lysyl oxidase"	P28300	5	122063195-122078360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		Oxidoreductase	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 103.5;fHDF/TERT166: 157.7;HSkMC: 38.5;U-138 MG: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043930			Supported	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		290000	"Endoplasmic reticulum"		"HPA043930: "	"unprognostic (5.10e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.99e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.06e-3)"	"unprognostic (8.92e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (3.93e-8)"	"unprognostic (1.11e-3)"	"unprognostic (9.92e-2)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (3.32e-4)"	33.8	1.8	1.0	7.2	1.2	0.0	37.4	0.9	0.9	16.1	11.7	0.1	4.1	3.8	6.3	20.1	11.1	7.6	12.8	21.4	1.2	1.3	6.5	2.4	20.6	4.3	0.9	1.1	15.7	6.0	0.8	1.5	14.8	1.6	11.2	3.0	3.2	3.4	3.5	12.7	11.3	4.5	9.5	1.5	7.7	4.0	10.6	0.1	0.7	10.8	4.2	2.7	36.9	10.4	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.1	0.0	0.2	0.1	18.0	21.3	0.0	103.5	21.8	8.0	28.2	0.1	0.0	0.0	2.4	157.7	0.0	0.4	0.2	17.2	0.0	0.3	0.0	2.0	0.8	22.8	0.0	0.0	38.5	0.4	13.3	0.5	10.0	0.0	0.0	9.3	0.0	0.0	0.0	0.7	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.5	7.3	0.0	0.6	0.0	0.0	0.8	52.4	3.5	31.0	1.4	0.0	0.0	0.0	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	1.0	1.2	0.9	0.9	1.2	1.3	0.9	1.1	1.6	0.1
LOXL1	"LOL, LOXL"	ENSG00000129038	"Lysyl oxidase like 1"	Q08397	15	73925989-73952137	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Oxidoreductase	Glaucoma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.4;BJ: 23.6;BJ hTERT+: 27.0;U-87 MG: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.5"	"Lineage enriched"	"Detected in single"	45	"T-cells: 6.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA042111, HPA063583"	Approved		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		120000	"Endoplasmic reticulum"		"HPA042111: AB_10794412, HPA063583: "	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (7.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.76e-2)"	9.4	2.5	2.4	6.7	1.2	0.9	5.0	0.4	1.8	19.3	7.0	1.6	7.0	2.3	12.3	8.4	9.9	6.9	12.4	19.1	2.4	1.6	7.9	1.3	7.0	13.6	1.3	1.6	9.6	3.0	3.8	7.4	16.1	4.4	14.8	1.7	26.7	5.7	15.5	4.2	4.7	5.3	26.6	2.1	2.8	6.5	3.7	1.3	1.2	3.9	10.5	10.4	16.9	11.7	0.1	0.0	0.0	0.0	0.0	6.5	0.6	1.1	0.0	0.3	0.0	16.9	20.4	0.8	23.6	27.0	10.0	17.8	0.4	0.6	0.0	4.4	17.3	7.0	0.1	0.0	2.4	0.0	1.5	0.1	0.7	0.1	2.3	0.0	0.0	16.7	0.0	7.5	0.0	0.3	0.0	0.1	11.9	0.8	0.1	0.4	2.2	16.1	0.0	14.0	0.2	0.9	4.2	2.0	0.0	0.7	0.1	0.0	0.1	0.0	1.7	19.7	17.5	15.4	8.9	0.0	0.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.9	0.1	2.9	1.5	0.0	0.1	0.7	0.8	0.0	0.0	0.0	0.0	6.5	0.6	2.4	1.2	0.4	1.8	2.4	1.6	1.3	1.6	4.4	1.3
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532414-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 26.7;U-138 MG: 47.1;WM-115: 101.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 11.1;non-classical monocyte: 8.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"		15000			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	7.9	7.1	6.3	8.5	5.0	15.9	9.7	2.9	6.5	6.6	8.4	13.1	2.2	5.1	10.2	7.5	4.1	5.8	8.0	10.8	4.5	5.0	3.2	2.0	6.8	8.0	5.7	6.7	4.2	3.3	2.3	3.9	18.8	7.4	4.4	4.8	7.8	3.6	5.5	1.6	2.1	4.9	10.2	9.7	12.3	3.7	3.5	4.8	0.6	3.0	3.4	2.9	6.1	6.0	0.1	3.4	2.7	11.1	0.0	0.0	2.5	0.2	0.0	3.8	0.6	3.2	4.1	0.7	13.1	26.7	6.4	6.1	4.4	0.2	0.0	0.1	13.4	0.1	0.4	0.3	3.8	19.8	0.0	3.1	0.2	0.0	1.0	0.1	3.2	4.2	0.0	16.9	0.7	0.1	0.1	0.3	1.1	0.6	0.0	1.1	2.1	0.1	0.3	0.4	0.0	0.0	0.1	1.8	2.4	0.0	0.1	2.7	0.3	0.2	0.0	47.1	1.6	0.2	0.1	0.1	0.1	0.0	17.7	1.2	101.0	0.1	5.6	0.3	0.0	11.1	0.0	0.1	0.0	0.0	3.4	0.1	0.0	0.0	2.7	0.0	8.7	0.3	0.0	2.5	6.3	5.0	2.9	6.5	4.5	5.0	5.7	6.7	7.4	4.8
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531483-160664259	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	71	"liver: 43.4"	"Cell line enriched"	"Detected in single"	6	"RT4: 4.6"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB016072, HPA060604"	Supported				"Secreted to blood"	78800000000	2900000000			"CAB016072: AB_2135240, HPA060604: "		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.2	43.4	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1
LPIN1	KIAA0188	ENSG00000134324	"Lipin 1"	Q14693	2	11677595-11827409	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 88.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024591, HPA038021"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA024591: , HPA038021: AB_10669514"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.60e-2)"	"unprognostic (4.02e-1)"	18.1	10.1	13.0	10.7	18.3	6.0	22.1	20.0	16.4	10.5	8.6	10.9	7.3	8.9	11.0	15.0	20.0	7.0	10.4	12.8	11.6	11.9	7.6	13.2	8.0	15.4	13.2	11.2	19.3	7.5	17.2	32.0	9.0	17.9	9.6	7.1	9.0	14.4	11.6	88.4	6.5	9.2	11.0	10.3	8.4	7.6	39.0	13.2	8.3	8.1	14.0	19.2	10.4	21.7	6.5	9.6	11.6	2.8	8.0	11.1	3.2	5.4	6.5	5.4	12.1	25.1	27.9	2.8	7.6	13.2	5.0	8.6	2.3	5.4	2.7	1.0	6.5	5.9	6.1	16.8	4.6	11.2	3.4	6.7	3.6	3.5	8.8	4.6	31.6	25.1	7.5	20.5	7.8	9.5	9.2	24.3	3.6	2.1	4.3	4.0	5.6	6.6	6.0	10.0	17.0	12.5	3.5	15.1	11.9	2.7	6.6	17.3	1.6	2.6	6.7	7.9	7.1	5.0	6.6	38.2	29.5	5.1	11.1	8.3	5.8	9.5	2.8	11.6	10.3	2.1	11.1	6.5	9.6	9.7	2.5	5.0	8.4	7.1	1.1	8.0	2.1	9.6	10.5	3.2	13.0	18.3	20.0	14.4	11.6	11.9	13.2	11.2	17.9	13.2
LPIN2	KIAA0249	ENSG00000101577	"Lipin 2"	Q92539	18	2916994-3013315	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation"	Hydrolase	"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 83.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"granulocytes: 20.8;NK-cells: 10.1;T-cells: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015223, HPA017857, HPA030550"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"				Cytosol	"Plasma membrane, Actin filaments"	"CAB015223: , HPA017857: AB_1852904, HPA030550: "	"unprognostic (7.03e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.20e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (9.85e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.44e-3)"	"unprognostic (3.19e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.15e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.11e-2)"	6.8	5.6	13.0	10.5	18.4	9.2	7.7	11.9	16.5	6.6	25.2	10.4	2.4	31.6	6.7	3.9	5.9	6.3	14.3	5.1	11.0	14.5	20.7	83.9	11.8	11.8	11.2	9.8	8.8	9.0	9.7	8.2	16.3	15.3	5.8	7.4	6.8	4.4	5.3	2.2	2.7	43.3	6.1	9.6	10.7	15.6	13.5	9.6	6.3	7.5	1.5	10.0	6.8	6.7	1.2	1.1	20.8	2.0	10.1	9.5	2.1	4.9	6.7	10.6	3.7	18.4	17.1	6.3	11.9	14.6	11.9	11.6	8.7	4.2	3.6	7.3	18.3	0.2	8.7	3.7	9.4	7.0	1.8	9.2	5.2	9.9	17.2	7.3	10.1	17.2	2.5	11.8	10.3	14.8	8.3	1.9	16.6	3.7	9.1	6.3	3.4	9.6	16.0	9.2	13.4	9.5	11.1	8.9	6.2	11.2	5.3	3.8	0.0	10.0	20.8	15.4	18.7	19.7	8.8	3.5	5.3	7.8	13.6	7.5	5.4	6.5	2.0	6.1	9.3	1.3	9.5	0.9	7.1	5.3	0.8	1.2	7.3	4.7	20.8	10.1	0.6	1.1	6.3	2.1	13.0	18.4	11.9	16.5	11.0	14.5	11.2	9.8	15.3	9.6
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967258	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease mutation, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 178.6;breast: 146.2;heart muscle: 121.4"	"Cell line enriched"	"Detected in some"	5	"AF22: 89.3"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.3"	"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 40.6"	"Region enriched"	"Detected in all"	4	"basal ganglia: 64.0"	HPA048749			Supported	Vesicles	"Secreted to blood"		880000	Vesicles		"HPA048749: "	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (6.07e-4)"	178.6	4.3	2.0	11.4	16.3	0.6	146.2	3.9	8.0	1.0	16.9	0.3	27.3	0.8	1.3	1.1	1.1	0.7	8.2	121.4	2.8	2.3	4.8	0.6	20.7	7.0	4.5	0.7	2.7	1.8	32.6	0.9	7.1	1.7	0.9	1.8	8.4	9.2	85.1	53.8	1.8	3.1	1.3	2.8	0.8	1.8	0.7	3.4	0.0	2.7	9.7	1.0	3.2	6.1	0.0	0.7	1.3	7.1	0.0	0.1	0.4	0.0	0.0	89.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	14.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.6	1.3	0.0	2.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	2.0	16.3	3.9	2.3	2.8	2.3	4.5	0.7	1.7	3.4
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 28.8;EFO-21: 35.8;U-698: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"			520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.5	7.0	5.1	3.4	11.1	11.4	5.5	4.9	6.3	3.6	2.4	12.6	3.6	28.8	35.8	11.2	3.2	1.5	3.3	9.1	3.1	1.7	1.4	5.4	3.3	4.7	0.6	1.7	8.1	4.7	8.1	7.0	6.1	0.0	0.6	6.3	2.4	1.4	0.6	2.0	2.3	1.8	3.8	0.1	4.0	8.0	0.3	0.0	10.6	3.5	6.0	2.7	2.4	13.1	8.4	6.5	6.0	12.2	0.0	1.1	59.7	4.2	1.3	7.6	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5
LRBA	"BGL, CDC4L, LAB300, LBA"	ENSG00000198589	"LPS responsive beige-like anchor protein"	P50851	4	150264531-151015727	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019366, HPA023597"	Approved		Approved	"Golgi apparatus,Cytosol"			190000	"Golgi apparatus"	Cytosol	"HPA019366: AB_2138441, HPA023597: AB_1853256"	"unprognostic (2.60e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.49e-3)"	"unprognostic (4.38e-1)"	"unprognostic (8.65e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.88e-2)"	"prognostic favourable (2.22e-16)"	"unprognostic (7.15e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.79e-1)"	"unprognostic (3.00e-1)"	7.6	15.8	7.1	14.7	10.9	7.2	16.5	14.4	8.3	11.3	12.2	7.3	17.9	9.8	12.9	11.8	21.4	11.9	12.7	10.5	6.4	4.3	18.4	10.2	10.1	14.2	7.4	5.6	10.1	13.8	33.0	32.1	8.8	7.7	14.3	13.0	8.3	18.2	15.1	10.5	20.5	14.7	7.9	8.3	11.3	12.8	10.1	7.8	26.5	15.2	11.0	17.9	14.0	12.4	5.7	2.6	5.9	0.8	3.8	7.9	2.3	15.3	7.9	7.2	6.2	7.7	10.6	9.0	3.3	8.8	6.2	6.1	17.0	19.5	17.8	4.1	4.9	7.9	12.0	19.2	9.4	13.3	8.6	12.5	12.2	9.1	4.5	16.8	10.0	8.3	11.5	9.2	14.2	18.7	13.0	12.7	7.3	10.2	12.3	2.1	6.1	5.9	10.0	7.5	6.5	20.1	20.3	18.6	7.5	8.7	17.8	4.3	17.6	3.2	9.9	9.0	6.6	4.9	6.3	11.8	11.5	12.1	14.0	6.9	4.6	5.9	0.7	1.6	7.9	0.3	4.7	5.7	5.3	6.9	1.5	3.5	3.7	5.6	0.2	3.8	0.8	2.6	5.9	2.3	7.1	10.9	14.4	8.3	6.4	4.3	7.4	5.6	7.7	7.8
LRG1	LRG	ENSG00000171236	"Leucine rich alpha-2-glycoprotein 1"	P02750	19	4536409-4540474	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 636.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.0;HMC-1: 8.2;SK-BR-3: 8.7;THP-1: 14.5;U-937: 26.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 160.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	19	"neutrophil: 58.9"	"Lineage enriched"	"Detected in many"	42	"granulocytes: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA001888, HPA001889"	Enhanced		Approved	Vesicles	"Secreted to blood"	21000000000	74000000000	Vesicles		"HPA001888: AB_1079276, HPA001889: AB_1079275"	"unprognostic (5.54e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (3.66e-6)"	"unprognostic (4.06e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.60e-2)"	1.7	0.9	0.2	3.3	0.4	5.4	0.9	0.2	0.3	1.7	1.3	0.2	2.2	1.1	0.3	1.1	4.5	1.9	3.0	0.9	0.4	0.2	3.5	636.5	2.2	5.7	0.7	0.1	1.5	8.1	0.0	0.7	0.4	0.4	1.1	0.8	0.3	4.1	3.0	0.5	0.8	0.6	0.2	0.3	4.3	2.3	0.5	0.3	0.3	0.9	1.7	3.4	1.4	1.3	0.1	0.3	58.9	1.4	0.0	0.2	0.4	5.8	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.6	4.3	2.1	7.5	0.0	0.8	0.0	0.9	0.0	7.6	0.2	0.1	0.1	8.0	0.0	0.2	8.2	2.3	0.0	0.0	0.0	0.0	5.3	0.1	0.0	0.3	0.0	5.8	0.1	0.0	0.0	0.1	6.1	0.5	1.1	0.0	0.0	0.0	8.7	0.1	2.5	14.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	26.8	0.0	0.5	1.4	3.0	0.0	0.4	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	58.9	0.0	0.2	0.0	0.2	0.4	0.2	0.4	0.2	0.3	0.4	0.2	0.7	0.1	0.4	0.3
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128493-57213351	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 82.6;ASC TERT1: 83.9;fHDF/TERT166: 36.0;HSkMC: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 7.6;intermediate monocyte: 4.0;myeloid DC: 2.8;non-classical monocyte: 3.7"	"Group enriched"	"Detected in many"	20	"dendritic cells: 2.8;monocytes: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"		88000000	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: , HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (1.29e-5)"	77.8	12.0	19.8	21.5	21.3	6.1	27.7	28.1	25.3	31.4	19.7	11.9	9.0	17.8	26.9	18.2	19.2	21.0	24.1	26.0	18.6	10.4	6.3	31.4	24.7	5.5	13.9	15.6	56.9	8.8	8.5	8.0	29.4	17.1	21.4	9.5	20.0	14.8	17.0	11.3	15.7	14.2	22.4	14.3	11.3	11.8	11.1	15.4	0.3	13.2	9.3	3.1	22.9	39.4	0.0	2.8	0.1	7.6	0.0	0.2	1.9	1.2	2.3	5.0	4.0	82.6	83.9	15.2	13.9	18.0	4.6	4.5	4.3	2.0	0.0	1.7	36.0	5.5	0.8	1.4	1.6	0.1	0.2	0.0	2.7	9.0	11.3	0.0	2.4	54.3	0.5	10.3	1.2	0.2	0.0	0.2	14.3	0.2	0.0	0.0	5.8	1.4	0.5	28.6	0.2	0.3	0.3	0.2	2.7	3.1	0.1	2.2	0.4	0.2	0.2	16.1	6.0	8.9	0.8	0.1	0.0	0.0	28.2	0.0	3.0	0.0	7.6	0.0	0.0	4.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	0.1	0.0	3.7	0.0	0.0	1.9	19.8	21.3	28.1	19.7	18.6	10.4	13.9	15.6	17.1	15.4
LRP1B	"LRP-DIT, LRPDIT"	ENSG00000168702	"LDL receptor related protein 1B"	Q9NZR2	2	140231423-142131701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7;thyroid gland: 14.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;HEK 293: 4.4;HeLa: 2.3;HSkMC: 2.1;U-138 MG: 4.9;U-87 MG: 2.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"myeloid DC: 1.4;plasmacytoid DC: 1.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Low region specificity"	"Detected in all"							"HPA069094, HPA074788"	Approved		Approved	Vesicles			63000	Vesicles		"HPA069094: , HPA074788: "	"unprognostic (5.31e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.36e-4)"	"unprognostic (5.19e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-3)"	"unprognostic (4.85e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.36e-1)"	4.8	4.5	17.6	1.3	14.1	1.2	2.6	23.2	25.7	1.4	1.3	6.5	0.0	1.2	1.3	6.8	1.3	1.9	1.4	1.6	18.3	9.3	2.2	1.6	1.4	1.2	10.8	16.7	3.0	1.2	1.1	12.7	1.2	12.8	3.5	1.3	0.1	2.5	3.8	10.5	1.7	1.3	1.3	8.2	1.2	1.5	1.9	10.6	0.0	14.9	0.0	1.3	1.2	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.2	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.9	0.2	0.2	0.6	4.4	0.0	2.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	17.6	14.1	23.2	21.3	18.3	9.3	10.8	16.7	12.8	10.6
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Group enriched"	"Detected in some"	12	"AF22: 21.4;CACO-2: 35.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: "	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0
LRP6	ADCAD2	ENSG00000070018	"LDL receptor related protein 6"	O75581	12	12116025-12267012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.7"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004490, HPA029925"	Enhanced						270000			"CAB004490: AB_627894, HPA029925: AB_10601768"	"unprognostic (1.80e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.47e-1)"	7.6	5.3	7.3	5.6	10.1	1.2	9.9	11.6	8.2	16.7	8.7	7.4	5.8	6.8	14.2	8.2	5.0	8.7	9.3	7.3	8.1	4.7	11.7	17.9	10.9	2.4	5.5	8.7	13.1	10.1	21.5	11.2	18.4	7.8	8.8	6.9	9.9	13.3	11.9	10.8	6.9	5.9	9.6	5.5	2.7	8.5	7.9	8.2	4.2	10.3	7.3	3.6	7.5	14.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	4.2	11.9	9.3	4.7	5.9	3.9	8.3	7.4	4.8	4.1	4.9	5.8	3.3	0.0	3.6	4.7	3.7	13.0	3.3	7.8	0.0	4.9	4.1	4.6	3.1	2.1	5.7	3.1	3.0	2.1	6.2	4.8	4.3	5.5	0.0	2.7	2.7	4.0	1.0	15.6	2.2	5.1	9.1	1.0	6.3	6.6	2.0	6.3	7.1	2.3	6.0	1.8	3.3	7.7	3.3	14.0	2.6	5.3	0.0	0.0	2.0	3.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.3	10.1	11.6	8.2	8.1	4.7	5.5	8.7	7.8	8.2
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355247-194369743	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 48.1"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 47.8;U-138 MG: 9.3;U-87 MG: 25.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"			1800000	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	3.3	0.5	0.5	3.1	0.6	0.0	5.3	0.5	0.5	4.6	2.1	0.2	0.0	0.4	3.5	0.3	1.0	1.3	2.0	1.8	0.5	0.5	0.5	0.5	2.5	0.8	0.5	0.0	3.1	0.8	0.0	0.5	48.1	0.3	0.6	4.2	0.7	1.6	0.0	1.0	9.1	0.8	0.7	0.5	1.3	1.9	0.9	0.0	1.1	1.8	7.7	7.7	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.1	0.0	0.0	0.4	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	1.5	1.2	0.0	0.0	0.0	0.0	25.8	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.5	0.5	0.5	0.5	0.0	0.3	0.0
LRRC3	C21orf102	ENSG00000160233	"Leucine rich repeat containing 3"	Q9BY71	21	44455486-44462196	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 35.3;liver: 19.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.1;U-2 OS: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017975	Uncertain									"HPA017975: AB_1853307"	"unprognostic (1.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.10e-4)"	"unprognostic (1.55e-1)"	"unprognostic (1.74e-2)"	"unprognostic (7.20e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.74e-5)"	"unprognostic (6.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (6.66e-3)"	3.7	2.7	1.1	2.5	1.6	1.0	3.9	0.3	1.0	4.5	7.6	1.1	2.5	3.1	2.1	3.3	3.7	1.9	35.3	2.8	1.2	1.4	1.1	19.1	3.8	3.7	0.5	0.2	5.7	2.3	0.1	2.0	1.8	0.9	4.1	1.6	2.1	2.6	1.3	1.0	3.3	3.0	5.2	0.8	1.9	5.4	5.4	0.0	2.2	1.0	2.2	1.6	4.5	5.8	0.9	0.5	2.1	0.8	0.5	1.1	0.1	0.7	0.5	4.5	3.7	0.0	0.0	11.1	1.8	0.0	0.2	0.0	1.6	1.5	0.0	3.3	0.9	0.2	2.1	0.0	0.1	0.3	4.8	0.0	0.5	4.9	0.8	0.0	2.9	1.4	1.8	0.0	0.0	1.8	0.4	5.7	0.0	1.5	0.7	0.2	1.2	1.8	2.3	0.0	1.8	0.1	0.2	3.6	4.0	1.7	0.3	0.7	1.0	2.3	3.4	0.0	8.3	0.0	0.0	3.2	6.2	0.0	0.0	2.0	0.6	1.8	0.8	0.2	0.3	0.7	1.1	0.6	0.5	0.2	0.3	0.9	0.4	0.4	2.1	0.5	0.6	0.5	0.2	0.1	1.1	1.6	0.3	1.0	1.2	1.4	0.5	0.2	0.9	0.0
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882112-128918039	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 49.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavourable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favourable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	25.8	10.6	24.3	14.2	26.8	13.4	17.8	28.5	50.4	13.8	14.0	18.5	10.9	9.0	18.8	7.4	37.9	12.4	21.1	14.5	22.6	21.0	11.6	16.4	20.3	7.7	27.2	19.5	11.4	19.0	21.3	7.4	21.8	21.1	18.4	8.2	12.1	16.2	24.8	8.0	16.0	9.5	25.8	13.0	10.5	16.7	9.2	22.6	8.4	13.5	12.0	14.3	20.9	18.7	2.5	2.8	3.2	1.9	6.1	7.4	1.7	10.3	16.3	9.9	8.4	23.2	9.0	12.5	12.0	8.0	7.4	5.3	7.2	22.3	3.8	13.5	13.0	49.6	6.1	26.5	3.5	3.8	4.9	3.4	10.5	8.6	15.8	4.0	6.3	7.0	18.8	13.2	15.8	25.7	7.5	3.8	9.7	8.9	4.5	3.8	29.4	17.8	6.3	11.4	6.1	11.7	5.2	5.9	12.3	13.4	8.4	4.7	6.1	3.0	45.0	21.8	9.4	9.2	17.4	4.4	10.4	4.6	12.0	3.0	12.6	1.2	1.4	3.2	7.4	1.9	3.4	2.5	3.7	4.7	1.8	2.0	3.7	3.6	2.6	6.1	0.5	2.8	6.1	1.7	24.3	26.8	28.5	32.6	22.6	21.0	27.2	19.5	21.1	22.6
LRRFIP1	"FLAP-1, FLIIAP1, GCF-2, HUFI-1, TRIP"	ENSG00000124831	"LRR binding FLII interacting protein 1"	Q32MZ4	2	237627576-237813682	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA006979	Approved		Supported	Cytosol			120000	Cytosol		"HPA006979: AB_1079282"	"unprognostic (2.07e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.09e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.99e-3)"	"unprognostic (8.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (8.07e-2)"	"unprognostic (7.64e-2)"	27.2	9.9	11.2	28.6	9.4	28.5	31.3	8.8	14.5	28.0	30.9	5.4	16.4	13.7	36.3	24.1	30.1	18.5	23.3	30.7	11.1	12.0	32.1	27.6	29.9	25.5	7.7	10.0	18.0	10.4	31.3	14.2	16.8	12.2	27.5	16.3	8.2	20.2	14.4	52.7	12.6	19.8	56.8	7.4	27.9	21.5	7.3	5.8	27.6	19.0	23.1	19.4	49.3	39.5	12.8	17.6	71.6	33.1	9.3	19.9	10.6	22.2	11.5	5.5	11.1	7.9	15.7	18.5	16.8	16.1	9.1	9.1	4.4	15.0	1.9	6.7	25.8	18.7	12.6	23.2	19.5	72.9	8.2	17.7	13.1	12.4	15.9	23.3	16.9	7.0	48.8	21.1	51.9	18.4	13.0	18.3	19.5	10.8	13.5	17.8	7.2	10.6	20.1	32.3	18.1	29.1	32.6	11.3	7.5	7.8	17.9	21.2	10.1	29.4	32.2	11.0	10.7	11.8	17.6	3.7	3.1	12.5	16.0	23.6	12.0	14.3	22.8	49.4	16.5	19.7	12.4	11.0	19.9	17.1	17.6	12.8	10.6	11.8	71.6	9.3	33.1	15.5	15.3	10.6	11.2	9.4	8.8	14.5	11.1	12.0	7.7	10.0	12.2	5.8
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system-associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell line enhanced"	"Detected in some"		"AF22: 6.8;SH-SY5Y: 13.9;WM-115: 33.8"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol			200000000	Cytosol		"HPA054051: , HPA076122: "	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	2.3	12.7	21.9	4.3	23.7	1.1	1.6	43.4	48.4	17.8	5.5	16.6	0.0	1.9	4.4	2.8	3.4	2.9	11.3	2.1	23.7	18.8	2.5	1.0	8.5	4.0	17.6	21.5	4.8	11.1	0.6	3.1	1.2	18.3	21.1	3.5	1.2	1.7	6.2	0.7	4.6	1.9	3.3	13.1	1.7	3.2	3.9	21.3	0.0	4.2	0.0	5.2	7.3	3.4	1.6	0.4	3.0	0.8	0.3	1.0	0.3	0.2	2.2	6.8	0.2	0.7	2.1	0.7	0.6	0.3	0.2	0.7	0.2	0.4	0.5	0.2	3.5	0.1	0.1	0.1	0.3	0.5	0.1	0.2	0.7	0.3	0.1	0.5	0.3	1.7	0.0	0.8	0.1	0.0	0.3	2.3	0.0	0.2	0.7	0.6	2.6	0.8	0.2	0.1	0.1	1.7	1.6	1.6	13.9	0.0	0.1	2.1	0.2	0.8	0.1	1.5	1.3	1.7	0.4	1.4	1.8	0.2	0.4	0.2	33.8	3.0	0.8	1.4	0.9	0.5	1.0	0.7	0.6	0.5	0.2	1.6	1.0	0.7	2.8	0.3	0.6	0.4	0.5	0.3	21.9	23.7	43.4	23.7	23.7	18.8	17.6	21.5	18.3	21.3
LSG1	FLJ11301	ENSG00000041802	"Large 60S subunit nuclear export GTPase 1"	Q9H089	3	194640788-194672477	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037704, HPA037705"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"	Nucleoplasm	"HPA037704: AB_10672912, HPA037705: AB_2675621"	"unprognostic (5.72e-3)"	"unprognostic (9.38e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (3.21e-7)"	"unprognostic (4.63e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-1)"	20.4	17.8	14.2	17.9	20.7	28.8	21.8	14.5	18.9	17.7	18.5	19.2	16.6	20.4	21.6	24.8	22.5	18.3	15.3	17.8	13.3	15.1	20.4	30.6	18.2	20.2	19.9	13.3	21.9	25.6	20.6	24.4	24.2	23.8	21.0	22.3	15.9	19.8	22.2	30.1	26.0	20.0	18.0	16.3	22.2	18.5	18.6	15.9	25.0	23.5	15.8	28.1	18.7	20.3	13.2	14.0	10.7	10.6	17.0	14.9	8.2	20.5	13.7	8.3	13.9	13.0	7.1	16.9	12.4	12.0	17.0	15.1	18.0	9.5	16.3	37.3	11.3	15.0	26.2	14.1	20.7	21.0	12.6	17.4	14.2	10.2	9.3	19.1	16.9	6.9	12.2	17.6	16.4	18.4	14.5	18.1	14.0	28.7	17.2	11.4	22.6	25.2	20.9	13.7	18.4	9.1	17.9	15.8	10.9	16.1	14.7	15.0	34.7	12.5	14.0	13.0	14.8	18.2	25.3	20.0	26.2	38.7	10.4	24.7	20.0	2.8	8.1	10.7	13.5	10.6	14.9	13.2	11.0	11.9	14.0	11.0	12.9	11.5	1.1	17.0	7.1	7.4	12.2	8.2	14.2	20.7	14.5	18.9	13.3	15.1	19.9	13.3	23.8	15.9
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806984	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm			26000	Nucleoplasm		"HPA052805: , HPA066718: "	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	20.3	17.4	15.7	21.7	19.4	21.0	18.7	14.4	17.7	21.1	19.5	14.0	11.8	17.9	23.6	15.2	21.8	21.5	20.7	17.5	14.4	12.8	17.5	15.1	18.0	33.5	20.7	17.5	19.4	20.3	9.6	15.1	17.9	20.3	19.7	21.3	10.8	12.8	14.0	19.5	17.1	15.3	21.5	26.7	22.1	16.7	16.5	19.4	51.8	23.4	19.5	26.9	21.8	20.9	18.2	10.8	8.7	5.7	12.3	15.3	10.1	10.0	4.9	8.7	11.2	4.9	6.8	9.1	6.3	4.1	9.1	8.1	5.6	3.8	10.7	8.8	5.2	4.1	11.4	10.7	8.2	11.3	14.6	12.3	3.0	5.7	6.1	12.2	4.4	5.1	5.0	8.4	8.7	9.5	16.1	7.0	6.4	7.3	14.7	28.0	8.0	10.7	9.1	6.9	15.7	7.5	3.0	8.7	7.6	6.8	6.1	12.3	6.7	9.8	4.9	5.4	9.5	6.2	10.2	7.3	12.4	13.7	2.8	14.6	8.4	8.7	5.7	3.6	9.4	5.2	12.4	18.2	10.1	10.6	9.5	16.1	9.7	11.9	1.2	12.3	4.4	10.8	15.3	10.1	15.7	19.4	14.4	17.7	14.4	12.8	20.7	17.5	20.3	19.4
LSM3	"SMX4, USS2, YLR438C"	ENSG00000170860	"LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated"	P62310	3	14178358-14201119	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044966	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA044966: "	"unprognostic (3.84e-3)"	"unprognostic (7.00e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-2)"	"unprognostic (8.07e-3)"	"unprognostic (4.93e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-3)"	14.1	13.6	18.2	12.5	17.1	18.9	15.5	13.2	17.3	11.5	15.6	11.8	7.6	15.0	11.6	13.4	19.1	10.3	11.3	20.1	15.1	12.5	27.6	26.7	10.1	14.2	14.2	13.5	12.4	15.6	7.3	12.4	16.5	14.4	14.2	13.9	12.3	13.3	11.0	31.9	12.1	17.6	15.8	15.0	16.3	12.5	21.5	13.9	24.4	19.7	21.4	13.9	12.9	11.1	21.3	23.1	27.2	18.3	17.1	17.7	18.7	14.4	11.7	12.6	13.0	5.9	6.9	32.2	12.0	8.0	15.3	14.7	13.2	11.4	15.9	10.0	8.2	6.8	14.2	11.6	15.2	15.0	17.6	16.9	16.9	12.6	3.0	18.8	12.3	5.1	8.4	15.3	6.6	7.8	18.1	12.8	11.3	16.6	19.9	25.7	21.8	15.9	11.0	15.6	17.5	14.3	14.9	7.1	11.5	13.7	19.2	11.1	22.1	24.0	7.1	9.8	15.7	11.9	20.4	9.1	26.4	30.0	12.5	18.5	14.0	27.2	15.9	23.3	12.8	18.3	15.0	21.3	15.0	14.9	14.6	17.1	16.5	17.3	15.2	17.1	15.3	23.1	17.7	18.7	18.2	17.1	13.2	17.3	15.1	12.5	14.2	13.5	14.4	13.9
LSM8	YJR022W	ENSG00000128534	"LSM8 homolog, U6 small nuclear RNA associated"	O95777	7	118184032-118192824	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020116	Uncertain		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA020116: AB_1853385"	"unprognostic (1.02e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.85e-4)"	"unprognostic (3.33e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (7.46e-6)"	"unprognostic (4.82e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.80e-2)"	"unprognostic (3.00e-3)"	27.5	20.8	16.8	30.8	19.7	39.7	27.1	33.1	25.9	18.5	20.1	12.8	18.8	20.6	23.0	25.4	26.2	19.3	16.2	25.1	19.1	10.1	20.2	19.9	23.1	34.1	19.8	17.2	22.9	27.0	13.2	28.3	16.8	20.1	22.3	22.8	13.6	24.5	21.2	21.4	21.9	26.2	23.6	28.3	33.8	22.3	21.0	20.2	30.0	24.6	23.2	38.2	22.1	21.6	29.8	40.6	22.0	28.2	18.2	35.3	16.2	14.4	9.7	22.1	16.8	8.1	13.1	9.0	15.7	13.7	10.9	14.2	7.8	15.2	30.0	32.9	8.2	10.3	13.2	10.2	11.5	15.5	14.2	20.0	20.2	15.6	17.9	26.0	23.2	11.7	12.4	13.4	12.4	11.1	20.8	29.9	13.5	6.6	45.8	65.5	20.0	14.7	14.5	13.1	20.8	11.4	9.7	13.1	16.8	14.0	35.7	30.2	7.4	29.2	9.1	17.5	9.9	20.5	19.6	25.6	18.2	34.7	12.8	31.9	22.2	22.0	21.0	19.1	29.0	28.2	28.1	29.8	32.2	35.3	22.4	26.5	31.2	31.7	7.0	18.2	26.6	40.6	31.4	16.2	16.8	19.7	33.1	25.9	19.1	10.1	19.8	17.2	20.1	20.2
LTA4H		ENSG00000111144	"Leukotriene A4 hydrolase"	P09960	12	96000828-96043520	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Leukotriene biosynthesis"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008399, CAB015221, HPA017017"	Supported		Approved	Nucleoplasm,Cytosol			85000000	"Nucleoplasm, Cytosol"		"CAB015221: , HPA008399: AB_1852816, HPA017017: AB_1852818"	"prognostic favourable (9.79e-4)"	"unprognostic (6.62e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.25e-3)"	"prognostic favourable (8.96e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.34e-1)"	27.9	33.2	11.2	21.5	16.7	55.7	19.0	24.1	15.6	27.2	29.1	13.1	16.7	27.6	27.6	14.1	53.4	22.7	14.5	19.2	10.6	12.2	27.2	19.4	68.0	33.4	12.3	11.3	49.9	28.2	21.2	31.8	11.3	13.3	29.6	17.8	20.7	21.1	16.1	20.6	23.6	41.2	21.5	13.3	44.3	22.1	13.7	11.5	29.2	38.8	22.3	43.1	30.1	25.2	20.6	35.3	6.1	84.2	14.2	9.0	54.6	23.5	25.4	35.7	21.3	31.0	34.7	15.6	9.9	29.3	19.6	22.8	18.6	20.5	52.9	12.4	14.7	31.1	29.2	40.3	26.8	18.1	28.3	19.4	16.3	22.5	18.3	10.2	11.8	33.0	34.0	27.0	33.1	38.7	11.8	9.3	28.2	16.2	26.8	31.5	41.6	34.5	25.2	26.6	30.5	35.9	30.1	18.5	21.9	20.0	23.4	21.4	29.0	12.5	13.8	8.3	14.0	11.8	10.7	12.6	21.8	24.5	5.9	18.6	6.5	0.4	76.0	2.2	4.5	84.2	8.4	15.1	6.3	5.8	35.3	20.6	9.0	6.7	6.1	14.2	73.2	8.7	6.3	54.6	11.2	16.7	24.1	15.6	10.6	12.2	12.3	11.3	13.3	11.5
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.1;lymphoid tissue: 81.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 19.4;HDLM-2: 10.9;NB-4: 12.6;REH: 11.9;U-698: 14.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048884	Approved		Approved	Centrosome				Centrosome		"HPA048884: "	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favourable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favourable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	1.0	0.2	0.2	35.9	0.2	3.4	0.5	0.1	0.1	0.2	1.5	0.0	0.0	1.3	0.2	0.3	2.7	0.4	0.7	1.9	0.2	0.1	4.2	1.3	4.2	27.8	0.2	0.0	0.5	0.8	0.0	0.2	0.3	0.1	0.7	0.6	0.5	6.1	0.3	0.1	0.6	18.0	0.3	0.3	69.7	2.0	0.2	0.0	81.5	1.1	0.8	41.6	1.6	0.5	44.1	15.6	17.8	3.6	5.2	39.3	10.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	19.4	0.2	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	12.6	0.0	0.0	11.9	0.0	2.7	4.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	2.5	0.4	17.8	3.7	2.0	26.8	42.5	39.3	17.3	0.6	44.1	33.5	14.2	14.5	5.2	3.6	15.6	22.2	10.7	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.0
LTBP1		ENSG00000049323	"Latent transforming growth factor beta binding protein 1"	Q14766	2	32946972-33399509	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 104.0;HSkMC: 33.5;HUVEC TERT2: 34.0;U-87 MG: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005707, CAB025428"	Approved		Approved	Cytosol	"Secreted to extracellular matrix"		200000000	Cytosol		"CAB025428: , HPA005707: AB_1853394"	"unprognostic (1.02e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.29e-2)"	"unprognostic (6.23e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-3)"	"unprognostic (5.67e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (7.79e-6)"	"unprognostic (4.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (1.62e-4)"	10.4	4.9	4.5	16.3	5.4	3.4	9.2	1.3	3.9	66.7	15.6	9.5	10.2	3.6	28.5	22.9	22.9	21.7	64.9	45.6	5.7	2.9	10.6	6.5	15.5	3.4	3.5	4.9	23.4	3.1	0.6	7.0	28.7	11.7	29.6	6.1	10.0	10.6	27.6	8.0	6.6	8.6	38.9	10.9	3.7	22.7	16.2	4.7	2.1	4.4	16.4	10.0	37.4	18.1	0.1	0.3	4.3	0.1	0.0	0.1	8.1	0.0	2.2	5.6	0.0	4.7	104.0	2.4	8.0	16.7	1.1	1.6	4.3	0.8	7.0	0.1	1.0	0.4	0.1	0.2	3.9	0.1	2.7	23.2	2.7	0.6	21.5	0.0	2.8	33.5	0.7	24.9	1.2	34.0	1.4	0.0	8.9	3.3	0.9	0.0	3.9	6.8	0.8	11.6	0.1	0.0	3.8	1.1	0.6	1.6	12.7	0.1	4.9	0.0	21.8	1.1	4.7	31.9	6.4	13.3	13.3	10.2	45.7	0.8	1.8	4.3	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	8.1	4.5	5.4	1.3	3.9	5.7	2.9	3.5	4.9	11.7	4.7
LTBP2	"C14orf141, LTBP3"	ENSG00000119681	"Latent transforming growth factor beta binding protein 2"	Q14767	14	74498170-74612378	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Heparin-binding"	"Disease mutation, Dwarfism, Glaucoma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 43.9;HUVEC TERT2: 23.9;LHCN-M2: 23.9;TIME: 105.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"cerebellum: 5.9;olfactory region: 3.0"	"Region enriched"	"Detected in many"	5	"olfactory region: 31.6"	HPA003415	Approved		Approved	Nucleoplasm	"Secreted to extracellular matrix"		13000000	Nucleoplasm		"HPA003415: AB_1079284"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.98e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.94e-4)"	25.0	1.7	0.8	8.0	1.3	0.0	21.5	1.0	1.0	50.3	5.0	1.2	4.8	1.2	18.0	11.8	16.2	6.2	20.1	20.3	0.8	0.8	2.4	1.4	29.5	4.8	1.6	1.9	32.1	3.9	0.4	4.2	19.0	3.1	15.7	0.9	51.8	13.6	9.7	20.5	6.0	3.2	8.6	2.6	2.5	4.3	12.2	0.4	2.2	44.8	14.4	6.0	14.7	11.6	0.4	1.7	0.3	0.2	0.0	1.2	0.2	0.5	0.8	0.2	0.0	7.0	13.0	0.0	8.8	3.0	1.7	1.1	0.0	3.2	0.0	2.7	43.9	0.9	0.0	3.2	0.7	0.0	0.1	0.1	0.3	0.3	1.7	0.0	0.1	13.4	1.4	9.4	5.5	23.9	0.0	0.0	23.9	0.1	0.0	0.0	0.0	0.8	0.1	0.2	0.0	2.1	1.2	0.2	0.6	6.3	0.0	0.2	0.2	0.0	105.6	0.6	10.6	3.3	3.2	0.1	0.1	0.0	2.4	0.0	0.3	0.1	0.1	0.1	1.2	0.1	1.0	0.2	0.6	0.2	0.2	0.4	0.7	0.6	0.3	0.0	0.2	1.7	0.0	0.2	0.8	1.3	1.0	1.0	0.8	0.8	1.6	1.9	3.1	0.4
LTBP4	"FLJ46318, FLJ90018, LTBP-4, LTBP-4L"	ENSG00000090006	"Latent transforming growth factor beta binding protein 4"	Q8N2S1	19	40592883-40629818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 42.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015194	Approved				"Secreted to extracellular matrix"		7300000			"CAB015194: AB_2139064"	"unprognostic (3.29e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.86e-3)"	"unprognostic (8.41e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (3.34e-2)"	"unprognostic (4.62e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.83e-2)"	16.9	10.0	2.7	22.8	4.0	1.0	16.2	1.3	2.8	86.1	30.3	4.3	29.2	12.3	54.8	41.7	43.7	28.3	51.1	52.1	2.6	3.4	9.9	7.9	51.2	14.1	7.8	2.5	47.6	6.6	3.1	11.0	7.4	6.9	78.0	8.1	31.1	12.1	36.8	14.6	9.8	28.9	62.0	13.5	15.1	15.7	37.1	5.3	6.1	25.2	44.5	20.0	46.4	50.6	4.0	5.5	0.4	2.7	2.9	10.2	2.2	6.7	7.6	15.2	20.4	5.6	6.0	2.4	2.7	9.0	2.8	2.3	2.2	15.4	7.1	12.6	4.6	9.4	3.8	9.5	0.9	20.7	1.3	2.5	17.4	0.8	17.9	0.9	8.4	7.3	7.8	5.6	10.2	1.7	15.1	42.9	0.6	6.8	1.0	0.5	1.7	9.2	17.8	0.4	13.3	1.3	0.6	0.6	6.2	10.0	7.8	2.6	4.0	4.0	6.7	0.5	30.6	1.0	5.7	9.6	8.0	2.3	12.9	9.7	7.0	0.0	1.6	0.4	10.2	2.7	6.6	4.0	9.4	7.7	3.0	2.6	3.9	4.1	0.4	2.9	1.4	5.5	6.1	2.2	2.7	4.0	1.3	2.8	2.6	3.4	7.8	2.5	6.9	5.3
LTBR	"D12S370, TNF-R-III, TNFCR, TNFR-RP, TNFR2-RP, TNFRSF3"	ENSG00000111321	"Lymphotoxin beta receptor"	P36941	12	6375045-6391571	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 75.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 24.6;intermediate monocyte: 22.9;myeloid DC: 17.6;neutrophil: 15.8;non-classical monocyte: 16.4"	"Group enriched"	"Detected in many"	32	"dendritic cells: 17.6;granulocytes: 15.8;monocytes: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026202, HPA061617"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB026202: , HPA061617: "	"unprognostic (2.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.24e-3)"	"prognostic unfavourable (5.13e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (3.66e-2)"	"unprognostic (9.84e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.86e-1)"	32.7	24.8	6.0	13.6	8.1	3.6	77.6	2.7	4.8	25.0	25.1	4.9	31.3	18.9	26.7	19.5	34.9	18.1	29.8	15.2	9.5	3.3	39.4	85.2	38.7	21.7	8.1	2.6	28.3	79.8	18.1	10.6	27.0	8.4	31.3	13.7	16.9	31.3	27.0	19.1	25.2	43.6	28.2	12.5	23.3	24.5	14.3	5.7	4.2	45.8	33.6	19.1	27.0	23.0	0.0	17.6	15.8	24.6	0.6	0.1	8.0	17.4	23.6	0.0	7.6	46.9	35.3	16.3	12.1	28.2	18.5	19.1	10.8	27.2	0.0	7.4	26.4	20.2	0.0	25.6	7.3	0.0	0.0	10.3	9.7	6.1	75.2	0.7	17.4	51.7	47.5	13.1	37.1	16.8	9.8	0.1	21.1	16.2	0.0	4.9	0.2	13.0	0.0	1.2	0.0	27.5	20.1	0.1	0.1	11.4	22.7	25.5	3.8	18.9	10.4	6.5	7.4	23.9	12.9	0.0	0.0	0.0	2.7	6.4	23.8	1.4	24.6	0.1	0.0	22.9	0.0	0.0	0.0	0.0	17.6	0.0	0.1	0.1	15.8	0.6	16.4	4.2	0.0	8.0	6.0	8.1	2.7	4.8	9.5	3.3	8.1	2.6	8.4	5.7
LTF	HLF2	ENSG00000012223	Lactotransferrin	P02788	3	46435645-46485234	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Ion transport, Iron transport, Osteogenesis, Transcription, Transcription regulation, Transport"	"Antibiotic, Antimicrobial, DNA-binding, Heparin-binding, Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 277.8;salivary gland: 181.9;seminal vesicle: 177.1"	"Group enriched"	"Detected in some"	10	"RPMI-8226: 29.1;TIME: 10.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	27	"neutrophil: 4.0;non-classical monocyte: 13.5"	"Group enriched"	"Detected in many"	27	"granulocytes: 4.0;monocytes: 13.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB008646, CAB016201, HPA057177, HPA059976"	Enhanced				"Secreted in other tissues"		600000000			"CAB008646: AB_1618695, CAB016201: AB_629860, HPA057177: , HPA059976: "	"unprognostic (7.24e-3)"	"unprognostic (2.43e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.41e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.45e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (6.30e-5)"	"unprognostic (1.66e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.09e-3)"	1.0	0.3	0.4	8.8	0.5	277.8	23.0	0.3	0.3	53.1	0.3	3.2	108.0	0.0	0.7	39.3	3.8	0.9	2.2	2.5	0.6	0.6	20.8	0.6	10.8	1.3	0.6	0.0	0.3	2.7	0.0	1.2	0.8	1.5	13.0	0.0	0.2	181.9	177.1	0.4	1.2	0.9	0.1	0.7	9.1	22.6	2.8	0.1	4.0	1.6	13.4	30.7	2.3	1.0	0.0	0.3	4.0	13.5	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.0	0.5	29.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	0.8	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	13.5	0.3	0.0	14.7	0.4	0.5	0.3	0.3	0.6	0.6	0.6	0.0	1.5	0.1
LUC7L2	"CGI-59, CGI-74, FLJ10657, H_NH0792N18.3, hLuc7B2, LUC7B2"	ENSG00000146963	"LUC7 like 2, pre-mRNA splicing factor"	Q9Y383	7	139340359-139423457	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051631	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA051631: "	"unprognostic (1.07e-3)"	"unprognostic (2.71e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (4.92e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.28e-3)"	27.2	24.7	32.2	34.7	35.0	59.3	41.3	35.6	33.9	35.1	34.7	41.6	28.0	22.6	35.7	36.8	33.1	32.7	29.3	35.0	33.3	30.4	29.7	33.3	26.6	39.0	33.2	30.5	41.3	34.7	47.7	29.0	31.6	33.8	39.8	31.4	27.3	29.5	40.1	58.4	41.8	27.5	35.2	37.3	32.0	29.0	37.0	32.4	66.3	53.3	23.6	44.8	34.0	33.7	14.3	11.3	15.0	13.7	13.5	20.8	10.6	18.6	10.8	22.4	21.0	15.6	12.9	17.3	21.4	20.4	20.4	21.6	12.0	17.7	30.8	13.1	16.8	13.5	27.3	21.2	29.2	14.5	27.0	26.4	16.3	11.8	13.2	42.1	22.2	11.1	27.2	19.3	23.8	16.4	33.5	16.4	22.2	17.4	50.1	38.4	18.4	15.5	30.5	22.9	27.8	23.4	20.7	19.9	19.4	23.5	23.7	20.6	16.6	16.6	16.1	16.2	9.7	18.1	19.7	25.7	23.9	67.4	17.7	40.7	21.6	8.0	8.1	15.0	16.7	12.5	18.7	14.3	16.3	17.5	11.1	13.1	20.8	17.4	8.2	13.5	13.7	11.3	16.3	10.6	32.2	35.0	35.6	33.9	33.3	30.4	33.2	30.5	33.8	32.4
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719544-50756213	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favourable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavourable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favourable (5.35e-5)"	24.1	42.2	57.2	39.6	66.9	24.0	28.7	137.4	62.6	37.6	36.7	22.3	36.4	37.0	55.0	35.0	23.7	31.5	24.3	27.5	54.5	31.3	25.4	20.4	27.8	45.9	72.2	51.8	60.1	27.3	34.1	71.9	29.3	51.3	34.7	29.1	21.6	32.8	35.2	50.6	39.1	35.9	38.2	78.4	41.8	30.5	20.7	70.9	29.1	37.2	27.5	32.1	30.2	39.2	28.8	30.6	22.7	15.9	10.3	18.8	5.2	35.8	23.3	47.5	30.4	20.0	19.4	22.5	33.7	13.1	16.4	19.7	44.5	27.8	43.8	36.6	13.5	31.3	31.3	14.1	28.6	45.2	49.4	51.8	81.3	35.4	10.9	45.3	29.0	18.2	20.0	17.7	10.5	16.8	40.2	40.0	20.9	19.9	44.5	44.2	30.9	17.6	48.3	44.6	45.4	22.5	22.9	33.6	35.2	20.1	25.8	34.9	41.6	33.6	23.7	37.0	31.4	15.5	34.6	35.3	37.7	53.7	23.0	31.3	25.7	18.3	15.9	14.5	16.3	11.3	14.3	27.5	17.6	13.5	9.9	28.8	18.8	15.4	22.7	10.3	8.8	30.6	13.3	5.2	57.2	66.9	137.4	62.6	54.5	31.3	72.2	51.8	51.3	70.9
LUM	"LDC, SLRR2D"	ENSG00000139329	Lumican	P51884	12	91102629-91111831	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 344.8"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 182.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	103	"basophil: 10.2"	"Lineage enriched"	"Detected in single"	103	"granulocytes: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001522, CAB025783"	Supported				"Secreted to extracellular matrix"		59000000000			"CAB025783: , HPA001522: AB_1079285"	"unprognostic (5.54e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.20e-2)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (5.25e-3)"	"unprognostic (2.27e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.06e-2)"	44.8	25.3	0.8	15.1	0.7	0.0	19.7	0.7	0.7	56.7	26.9	0.7	28.1	5.1	64.8	77.8	28.1	12.2	76.6	48.8	0.8	0.7	26.9	6.4	77.1	32.0	0.9	0.6	73.0	9.1	0.7	2.7	344.8	2.8	77.4	13.3	1.4	5.6	9.9	9.1	8.3	24.0	48.7	4.0	1.3	8.2	30.9	0.3	1.7	18.1	32.3	11.5	65.3	20.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	22.5	11.1	0.0	36.9	182.3	1.5	2.3	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	17.6	0.0	0.0	15.2	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	1.5	0.4	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.7	0.7	0.8	0.7	0.9	0.6	2.8	0.3
LY6D	E48	ENSG00000167656	"Lymphocyte antigen 6 family member D"	Q14210	8	142784880-142786592	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 236.9;skin 1: 111.6;tongue: 316.2"	"Cell line enriched"	"Detected in some"	20	"A-431: 55.8"	"Group enriched"	"Detected in many"	7	"cervical cancer: 409.8;head and neck cancer: 444.6;urothelial cancer: 242.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA024755, HPA064317"	Enhanced						92000			"HPA024755: AB_1853410, HPA064317: AB_2685244"	"unprognostic (2.13e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.08e-2)"		"unprognostic (8.97e-2)"		"unprognostic (1.51e-2)"	"unprognostic (3.84e-1)"	"unprognostic (5.11e-2)"	"prognostic unfavourable (1.94e-6)"	"unprognostic (8.68e-2)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.97e-1)"	"unprognostic (5.40e-4)"	"unprognostic (1.06e-1)"	0.2	3.7	0.2	0.2	0.2	0.1	3.7	0.2	0.2	23.0	0.2	0.2	0.2	0.1	2.1	0.2	236.9	0.1	0.5	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	1.3	0.2	1.2	0.1	0.2	18.1	0.2	0.4	111.6	0.2	0.9	0.2	0.2	2.0	0.2	0.2	0.9	0.2	316.2	61.8	6.3	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	1.5	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
LY6H	NMLY6	ENSG00000176956	"Lymphocyte antigen 6 family member H"	O94772	8	143157914-143160711	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 58.2"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 6.7;NTERA-2: 1.3;SCLC-21H: 3.8"	"Cancer enhanced"	"Detected in many"		"glioma: 9.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA077218	Enhanced				"Intracellular and membrane"					"HPA077218: "	"unprognostic (8.76e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.45e-4)"	"unprognostic (3.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.97e-2)"	"unprognostic (2.20e-5)"	"unprognostic (6.43e-3)"	"unprognostic (1.54e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.89e-3)"	1.4	1.4	46.7	1.6	26.3	1.3	1.3	0.0	42.8	1.3	2.8	3.2	0.0	5.6	1.5	1.4	1.5	2.6	1.4	1.2	58.2	53.4	1.3	1.2	1.4	1.4	10.9	32.5	1.2	1.3	1.2	8.4	1.3	7.1	1.3	1.3	0.0	1.3	1.4	1.4	1.2	2.2	1.8	4.0	1.2	4.3	2.3	1.9	0.0	1.3	0.0	1.2	1.4	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	6.7	0.0	1.3	0.0	0.0	0.0	0.7	0.0	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	46.7	26.3	0.0	36.9	58.2	53.4	10.9	32.5	7.1	1.9
LYPLA1	LPL1	ENSG00000120992	"Lysophospholipase I"	O75608	8	54046367-54102017	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid metabolism, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050941, HPA063151"	Enhanced		Approved	Nucleoplasm,Cytosol			1700000	"Nucleoplasm, Cytosol"		"HPA050941: , HPA063151: "	"unprognostic (2.62e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.42e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (2.34e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-3)"	14.1	17.7	7.2	12.2	8.9	13.4	16.4	10.8	15.2	10.7	14.6	6.9	4.7	15.4	8.0	11.1	30.4	8.0	11.9	27.1	6.8	6.8	31.1	37.3	13.6	23.4	7.3	4.9	12.3	24.3	9.0	7.4	51.1	12.0	15.3	15.2	17.0	23.3	7.1	26.4	22.1	17.6	10.4	6.3	14.0	14.9	64.8	4.1	21.3	13.3	19.3	19.7	24.6	17.3	29.1	37.1	42.7	40.4	27.1	29.2	35.1	30.3	17.2	22.4	20.1	8.1	13.3	28.3	18.2	10.5	16.8	15.9	12.4	29.5	53.3	21.3	11.8	20.4	31.5	30.3	23.6	19.3	17.2	37.1	11.0	19.9	13.4	22.7	50.3	11.6	26.7	13.1	29.5	43.6	37.6	16.2	23.4	8.0	34.5	17.3	33.3	7.9	20.9	11.8	24.4	26.0	41.2	11.8	20.1	12.8	23.9	27.9	34.9	20.3	20.9	10.2	14.9	17.6	16.8	22.6	34.0	48.1	13.8	24.1	19.9	31.4	33.1	42.7	19.1	31.1	19.0	29.1	18.2	18.4	37.1	23.9	18.4	17.8	19.5	27.1	40.4	23.8	29.2	35.1	7.2	8.9	10.8	15.2	6.8	6.8	7.3	4.9	12.0	4.1
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 87.6"	"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 42.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.0;neutrophil: 1.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025860, HPA042953"	Supported						3000000000			"CAB025860: , HPA042953: "	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavourable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	51.8	28.6	3.3	7.4	4.2	0.4	23.0	2.8	2.8	7.9	26.4	2.4	2.9	5.3	5.3	20.8	17.7	17.2	8.0	19.8	3.8	2.0	18.0	31.1	15.7	47.7	3.2	1.6	11.0	5.4	1.6	3.6	56.6	6.2	15.2	8.0	6.0	4.8	4.7	15.4	5.1	17.8	25.5	2.9	87.6	8.4	11.9	2.5	0.0	21.4	9.1	2.7	25.9	10.9	0.7	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	42.2	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.3	4.2	2.8	1.8	3.8	2.0	3.2	1.6	6.2	2.5
LYZ		ENSG00000090382	Lysozyme	P61626	12	69348341-69354234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase"	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 490.0;salivary gland: 1017.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 126.5;THP-1: 65.3;U-937: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 490.0;myeloid DC: 308.1"	"Group enriched"	"Detected in all"	18	"dendritic cells: 308.1;monocytes: 490.0"					"Not detected"	"Not detected"			"CAB000055, HPA048284, HPA066182"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Actin filaments"	"Secreted to blood"	1500000000	2600000000	"Golgi apparatus, Actin filaments"	Nucleoplasm	"CAB000055: AB_2341230, HPA048284: , HPA066182: "	"unprognostic (8.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.91e-2)"	"prognostic favourable (7.45e-4)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.65e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.62e-2)"	19.1	2.4	1.7	42.1	1.8	187.0	2.9	1.6	1.6	2.9	52.5	2.0	0.1	72.4	2.3	6.9	3.9	3.4	105.0	15.4	1.8	1.8	4.8	4.8	81.0	57.2	2.1	0.0	4.5	5.0	0.0	1.8	8.3	0.9	2.4	5.0	2.7	1017.8	2.8	1.8	2.1	95.0	1.8	2.5	34.2	212.1	1.6	0.5	24.5	2.4	207.7	75.7	6.6	2.4	1.6	308.1	21.9	490.0	2.3	1.1	407.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	0.8	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	0.1	126.5	0.0	14.8	7.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	14.4	0.3	0.0	0.2	0.2	2.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.3	0.3	0.1	0.3	0.1	0.1	0.0	70.7	0.0	7.5	490.0	5.9	0.7	102.3	1.1	1.6	0.4	0.5	308.1	0.4	0.4	0.4	21.9	2.3	17.6	6.5	0.6	407.9	1.7	1.8	1.6	1.6	1.8	1.8	2.1	0.0	0.9	0.5
LZTS1	FEZ1	ENSG00000061337	"Leucine zipper tumor suppressor 1"	Q9Y250	8	20246165-20303963	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 19.0;parathyroid gland: 64.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 35.9;U-698: 11.0;WM-115: 24.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 59.2"	"Group enriched"	"Detected in many"	5	"amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1"	"Group enriched"	"Detected in many"	10	"amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4"	"HPA006294, HPA022046"	Approved		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	Nucleoli	"HPA006294: AB_1079288, HPA022046: AB_1853455"	"unprognostic (7.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (6.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (9.06e-3)"	"unprognostic (6.81e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (9.28e-6)"	"unprognostic (3.35e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.82e-3)"	2.4	2.1	13.3	1.8	19.0	0.8	1.9	0.6	19.0	1.6	1.1	2.2	0.4	1.1	2.2	1.5	3.5	1.4	3.5	2.3	8.9	2.6	1.9	1.1	4.0	1.5	2.5	8.8	1.7	1.6	64.9	1.4	5.8	1.9	1.7	1.1	10.3	1.3	1.7	1.6	4.2	1.2	2.7	0.8	1.1	1.3	6.6	1.5	0.3	2.0	0.9	1.1	1.9	1.0	0.2	0.1	0.7	0.1	0.1	2.2	0.5	0.0	0.0	4.7	4.0	0.0	0.0	0.5	2.3	0.0	2.0	1.8	0.1	0.0	5.2	1.7	1.4	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.0	0.8	0.0	0.0	0.0	0.0	6.9	0.0	9.0	0.0	5.9	0.0	0.0	7.5	0.0	1.3	0.2	7.2	6.2	0.0	0.0	35.9	0.0	0.2	0.0	2.5	1.7	0.0	0.7	0.0	0.0	11.0	0.0	0.5	24.3	0.2	0.1	0.0	2.2	0.0	0.8	0.0	0.7	0.4	0.0	0.2	0.2	0.3	0.7	0.1	0.0	0.1	0.0	0.5	13.3	19.0	0.6	19.0	8.9	2.6	2.5	8.8	1.9	1.5
MAD2L1	"HSMAD2, MAD2"	ENSG00000164109	"Mitotic arrest deficient 2 like 1"	Q13257	4	120055608-120067074	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003348	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA003348: AB_10603014"	"unprognostic (4.08e-3)"	"unprognostic (7.31e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavourable (5.15e-5)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (6.74e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.87e-3)"	"prognostic unfavourable (3.07e-11)"	"unprognostic (3.06e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.70e-2)"	1.4	1.8	2.4	4.2	5.7	10.3	2.4	4.4	4.1	1.9	4.4	1.2	0.3	3.8	1.7	1.4	6.5	2.9	1.1	1.7	2.7	2.7	1.2	1.2	1.5	7.6	2.3	3.6	1.7	1.2	0.7	1.0	3.5	2.4	1.6	5.5	0.7	2.4	1.2	1.2	2.3	4.2	1.8	2.8	3.8	1.9	13.7	1.2	27.3	1.2	8.2	7.3	2.1	2.4	1.8	2.2	2.0	0.8	2.5	3.9	1.7	14.4	6.4	15.0	9.7	1.6	2.0	6.4	11.5	6.5	12.1	9.3	8.5	8.9	21.3	3.8	4.2	3.9	14.9	8.8	16.9	10.1	10.4	11.8	6.2	8.0	0.5	19.2	6.8	1.1	1.3	8.2	5.1	6.9	14.1	12.3	6.3	6.4	18.4	8.4	10.2	7.2	9.5	20.1	8.8	4.9	5.6	15.9	11.3	5.7	7.1	3.5	4.7	7.1	4.3	8.1	9.2	8.2	14.5	11.5	12.2	14.0	7.5	10.0	10.6	2.0	0.5	0.4	1.6	0.5	2.1	1.8	3.8	3.0	0.4	1.4	3.5	3.5	1.3	2.5	0.8	2.2	3.9	1.7	2.4	5.7	4.4	4.1	2.7	2.7	2.3	3.6	2.4	1.2
MAG	"GMA, S-MAG, SIGLEC-4A, SIGLEC4A"	ENSG00000105695	"Myelin associated glycoprotein"	P20916	19	35292125-35313804	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 113.6"	"Cell line enriched"	"Detected in some"	22	"WM-115: 28.1"	"Cancer enriched"	"Detected in some"	7	"glioma: 20.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009345, HPA012499"	Enhanced									"CAB009345: AB_670104, HPA012499: AB_1854238"	"unprognostic (2.70e-3)"	"unprognostic (2.70e-2)"		"unprognostic (8.06e-3)"	"unprognostic (1.23e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.18e-4)"	"unprognostic (6.29e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.66e-1)"	1.5	2.3	19.5	1.4	29.9	1.4	1.5	3.6	90.8	1.5	1.4	97.0	0.0	1.4	1.6	1.4	1.5	5.1	1.4	1.4	36.7	19.1	1.5	1.6	1.7	1.5	48.9	18.0	21.8	1.4	1.4	0.1	1.7	38.0	1.5	1.4	0.0	1.4	1.7	1.4	1.4	1.5	1.4	113.6	1.6	1.4	1.7	38.1	0.0	1.8	0.0	1.5	1.4	0.1	0.4	6.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	6.4	0.0	0.1	19.5	29.9	3.6	38.5	36.7	19.1	48.9	18.0	38.0	38.1
MAGEC1	"CT7, CT7.1, MAGE-C1, MGC39366"	ENSG00000155495	"MAGE family member C1"	O60732	X	141903894-141909388	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 23.5"	"Cell line enhanced"	"Detected in some"		"K-562: 22.3;Karpas-707: 22.4;U-2 OS: 15.1;U-2197: 28.5;U-266/70: 20.4;U-266/84: 18.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004622, CAB015452"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB015452: AB_784404, HPA004622: AB_1853495"	"unprognostic (5.63e-2)"				"unprognostic (1.59e-1)"		"unprognostic (1.68e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.47e-1)"					"unprognostic (8.56e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	15.1	28.5	0.0	20.4	18.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Supported		Enhanced	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.88e-4)"	"prognostic favourable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavourable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.5	10.3	61.7	18.8	29.4	40.0	11.4	23.1	41.2	18.3	32.6	10.2	14.2	7.7	60.6	46.4	7.6	17.5	17.4	13.2	13.8	14.5	16.1	12.2	20.0	25.2	4.1	12.4	52.4	7.3	18.6	9.4	34.8	3.9	9.5	35.0	15.4	9.1	6.9	22.8	12.3	6.1	22.1	11.0	25.1	4.2	9.7	25.1	9.2	10.7	53.4	44.0	7.0	29.9	15.6	24.4	23.3	6.5	6.1	5.1	5.6	22.8	10.8	79.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3
MAGEE1	"DAMAGE, KIAA1587"	ENSG00000198934	"MAGE family member E1"	Q9HCI5	X	76427724-76431353	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Tumor antigen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"B-cells: 1.0;NK-cells: 1.5;T-cells: 2.4"	"Low region specificity"	"Detected in all"							HPA003047	Approved		Approved	"Cytokinetic bridge,Cytosol"				Cytosol	"Cytokinetic bridge"	"HPA003047: AB_1079298"	"unprognostic (9.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (2.41e-3)"	"unprognostic (1.43e-1)"	"prognostic favourable (3.95e-4)"	"unprognostic (7.91e-2)"	"prognostic favourable (6.86e-6)"	"unprognostic (4.60e-3)"	"unprognostic (2.71e-1)"	"unprognostic (6.03e-3)"	"unprognostic (5.99e-3)"	2.6	5.8	13.8	3.0	23.5	1.1	3.3	18.7	33.9	4.7	1.9	3.2	0.5	1.5	5.4	3.5	2.3	4.8	2.3	3.9	18.9	20.3	4.1	1.1	2.6	4.1	10.2	22.0	8.4	4.1	15.1	5.1	0.8	19.8	5.9	2.1	2.3	3.4	7.4	2.2	3.3	2.0	4.8	5.4	4.5	2.6	1.3	4.9	1.1	4.0	0.1	3.6	2.4	1.8	1.0	0.0	0.0	0.0	1.5	2.4	0.4	0.2	4.7	4.8	9.2	3.4	2.0	4.3	3.5	3.5	3.0	1.7	1.0	0.7	1.0	1.8	3.1	3.6	7.1	6.6	2.5	2.3	0.1	0.0	0.0	3.0	0.7	1.8	0.6	1.5	3.0	0.8	0.8	1.1	0.3	0.0	4.5	0.6	5.1	0.2	5.8	7.1	4.0	3.6	0.0	3.9	0.0	0.0	2.5	0.0	0.5	0.7	2.2	0.1	0.6	4.5	5.8	4.8	0.0	0.0	0.0	0.8	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.8	0.8	1.1	2.3	0.0	1.0	1.4	1.3	0.0	1.5	0.0	0.0	0.0	0.4	13.8	23.5	18.7	33.9	18.9	20.3	10.2	22.0	19.8	4.9
MAGI1	"AIP3, BAIAP1, BAP1, MAGI-1, TNRC19, WWP3"	ENSG00000151276	"Membrane associated guanylate kinase, WW and PDZ domain containing 1"	Q96QZ7	3	65353525-66038834	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031851, HPA031852, HPA031853, HPA077002"	Supported		Supported	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"HPA031851: AB_10599289, HPA031852: , HPA031853: AB_10602095, HPA077002: "	"unprognostic (5.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.46e-3)"	"unprognostic (8.59e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.05e-3)"	"prognostic favourable (4.55e-8)"	"unprognostic (3.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-2)"	"unprognostic (8.03e-2)"	18.0	6.0	10.1	6.4	9.8	1.0	16.5	38.6	16.8	6.9	11.2	10.1	25.7	10.7	11.6	7.6	9.4	12.6	19.7	11.1	9.4	11.8	14.3	17.6	13.3	2.9	8.8	10.4	4.3	16.7	18.7	13.1	11.1	9.6	9.2	9.5	7.7	17.4	37.9	7.7	13.0	11.6	7.9	8.3	13.9	19.8	10.7	7.7	0.6	23.2	5.8	4.4	6.9	13.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	2.8	1.5	8.7	0.9	1.7	1.3	3.9	4.8	4.1	1.8	2.8	10.3	2.4	0.0	0.7	5.7	0.8	2.4	1.6	2.9	0.0	1.3	24.5	3.0	6.9	1.1	0.0	0.8	1.9	1.4	6.3	1.3	4.2	10.3	0.0	1.9	2.1	0.0	0.0	11.6	1.5	0.0	2.4	0.6	2.2	9.3	2.8	7.6	1.9	2.3	0.0	4.5	0.0	1.1	5.9	4.3	1.5	1.9	0.0	0.0	0.0	3.4	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	9.8	38.6	15.5	9.4	11.8	8.8	10.4	9.6	7.7
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838555	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 38.1;testis: 19.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	7	"pons and medulla: 10.6"	"Cell type enriched"	"Detected in single"	13	"neutrophil: 11.7"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"														"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.6	0.3	0.7	0.7	1.5	1.4	0.7	0.4	0.4	0.8	0.2	3.5	0.3	0.2	0.6	2.9	0.3	8.6	1.0	0.3	1.1	1.2	0.3	0.2	1.8	3.7	0.2	0.1	2.2	0.5	9.3	3.6	0.2	10.6	0.5	0.0	38.1	0.5	0.4	0.2	1.1	0.4	0.1	0.7	1.4	0.5	19.3	0.7	0.0	0.6	0.4	0.2	0.2	1.2	0.6	0.4	11.7	0.8	0.3	0.7	0.1	3.0	0.9	1.8	1.8	0.1	0.0	1.7	0.0	0.2	1.0	1.0	1.3	1.7	0.9	0.7	0.0	0.5	0.6	0.3	0.4	4.7	1.9	0.7	0.7	1.2	0.0	3.2	2.9	0.1	0.0	0.2	0.3	0.0	1.6	0.6	0.1	0.4	0.4	1.9	0.8	0.4	0.6	0.8	0.3	0.1	0.4	1.9	0.9	0.1	0.5	0.1	1.1	0.3	0.2	0.7	1.1	0.2	1.1	0.5	0.1	0.4	0.5	0.6	1.0	0.5	0.8	0.9	0.4	0.5	0.4	0.2	0.4	0.3	0.4	0.6	0.4	0.7	11.7	0.3	0.8	0.4	0.1	0.1	0.7	1.5	0.4	0.4	1.1	1.2	0.2	0.1	10.6	0.7
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177209-119349761	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 59.0;Hep G2: 41.4;Karpas-707: 46.2;U-266/70: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"			390000000	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: , HPA063561: "	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	41.8	19.8	5.8	10.5	17.4	8.1	32.2	1.5	7.9	12.3	23.3	3.2	3.6	17.4	11.3	12.0	10.6	9.5	22.0	10.4	5.0	3.3	23.4	74.2	16.4	16.8	2.8	5.7	10.3	22.0	3.4	6.4	26.1	3.7	14.7	9.9	10.5	41.0	5.3	7.1	9.6	36.3	19.7	3.5	20.9	10.0	8.7	3.7	8.8	15.2	10.3	9.1	21.2	36.4	1.4	5.5	6.0	1.1	1.9	4.7	0.6	0.0	0.0	0.7	0.0	59.0	26.1	1.4	1.4	8.6	1.0	2.6	4.0	0.5	8.8	0.0	5.4	0.1	1.5	0.0	1.3	13.0	4.0	7.3	0.8	41.4	5.9	0.0	3.7	17.8	1.1	8.8	5.4	0.7	25.5	46.2	8.3	1.2	0.3	0.0	0.4	2.1	2.4	0.9	13.3	2.8	7.3	3.0	4.4	0.0	0.1	0.0	2.1	0.9	5.1	3.6	3.3	6.7	3.2	62.4	8.8	17.4	10.7	0.1	2.1	6.0	0.6	2.0	2.4	1.1	4.7	1.4	1.3	1.3	0.6	0.9	0.8	1.9	3.8	1.9	0.9	5.5	1.4	0.6	5.8	17.4	1.5	7.9	5.0	3.3	2.8	5.7	3.7	3.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"			1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favourable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.1	6.2	10.6	9.1	14.0	16.9	34.1	11.8	18.5	5.3	5.0	4.7	8.2	10.6	21.9	15.1	8.5	4.9	10.0	12.1	13.3	7.4	6.3	8.7	5.2	8.5	9.9	14.5	11.3	10.8	8.1	7.1	15.8	10.1	16.4	11.1	27.6	6.0	3.1	5.4	6.5	5.4	23.1	7.2	7.3	19.4	5.8	8.5	11.7	12.6	9.3	6.2	6.3	15.0	12.1	9.9	8.5	12.0	11.2	7.6	7.2	15.9	7.9	28.5	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4
MAN1B1	"ERManI, MANA-ER, MRT15"	ENSG00000177239	"Mannosidase alpha class 1B member 1"	Q9UKM7	9	137086927-137109187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA051516	Approved		Uncertain	Vesicles			540000	Vesicles		"HPA051516: "	"unprognostic (1.21e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.25e-3)"	"unprognostic (4.67e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.44e-3)"	20.4	25.4	19.7	13.5	23.7	9.8	18.6	21.6	36.1	24.3	21.6	24.5	20.6	19.8	22.7	28.1	23.1	28.9	25.9	19.5	20.5	21.5	24.3	32.7	20.4	19.9	18.6	25.2	24.2	32.6	23.6	25.1	30.8	18.0	21.2	12.0	22.0	32.7	23.1	12.2	25.4	17.8	18.5	16.4	22.2	21.8	30.3	18.2	19.9	25.1	12.7	19.3	21.0	16.0	13.0	23.0	16.3	24.4	18.0	21.9	18.5	7.2	17.1	5.9	16.9	22.5	19.4	19.8	12.3	26.1	16.5	14.6	8.3	22.9	6.6	41.4	20.6	25.0	3.5	11.9	3.0	9.1	6.0	2.9	15.4	9.6	21.2	5.1	11.4	22.9	22.6	9.6	8.1	10.9	8.0	10.9	11.6	14.7	5.4	12.1	7.9	17.2	3.1	10.0	20.9	13.2	3.6	6.9	6.2	18.2	19.4	12.6	21.5	10.9	15.3	24.4	9.1	18.0	14.4	4.4	3.6	4.3	29.4	6.5	21.0	7.9	20.1	16.3	21.9	21.8	20.5	13.0	17.3	20.6	23.0	11.0	17.0	17.0	5.9	18.0	24.4	16.1	21.5	18.5	19.7	23.7	21.6	36.1	20.5	21.5	18.6	25.2	18.0	18.2
MAN2A1	"GOLIM7, MANA2"	ENSG00000112893	"Mannosidase alpha class 2A member 1"	Q16706	5	109689366-109869625	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022377, HPA026896"	Enhanced		Supported	"Golgi apparatus"			70000000	"Golgi apparatus"		"CAB022377: , HPA026896: AB_1853512"	"unprognostic (1.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.77e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.31e-3)"	7.6	17.5	10.9	7.7	21.8	5.7	7.4	1.9	13.2	8.4	11.2	46.8	2.4	17.2	9.2	1.8	7.7	6.2	10.6	4.2	11.7	4.8	9.5	20.7	8.5	7.8	29.9	10.4	7.5	16.7	20.1	3.4	8.7	19.8	4.7	11.9	5.6	9.0	6.0	8.7	7.0	14.4	11.2	23.1	6.9	8.9	7.5	30.6	15.0	9.0	1.8	7.8	10.9	6.2	3.3	2.7	5.8	6.7	0.9	5.5	1.6	7.2	6.7	8.4	3.6	16.1	14.2	31.4	16.1	26.6	9.2	16.6	7.9	11.7	5.2	10.4	20.9	8.6	4.5	16.7	20.1	5.6	3.4	10.6	5.0	7.2	9.1	4.8	5.8	12.1	6.9	14.7	19.5	18.1	2.8	30.5	21.6	3.6	9.0	1.3	6.0	2.4	3.5	13.1	23.0	7.3	11.5	1.2	1.1	7.6	6.8	4.6	6.7	4.2	19.3	18.2	8.0	9.8	10.4	16.3	21.1	4.4	14.0	6.2	10.1	5.8	2.9	0.9	3.0	3.8	1.9	3.3	4.5	4.9	2.7	2.9	5.5	4.8	2.1	0.9	6.7	2.5	4.1	1.6	10.9	21.8	1.9	13.2	11.7	4.8	29.9	10.4	19.8	30.6
MAN2A2	"HsT19662, MANA2X"	ENSG00000196547	"Mannosidase alpha class 2A member 2"	P49641	15	90902218-90922584	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.4;neutrophil: 10.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077930			Approved	"Cytoplasmic bodies"			30000000	"Cytoplasmic bodies"		"HPA077930: "	"unprognostic (5.17e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.09e-2)"	"prognostic unfavourable (8.95e-4)"	"unprognostic (7.55e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.33e-2)"	17.8	12.1	15.9	11.5	24.3	58.1	17.3	33.7	31.2	7.2	9.9	52.4	6.3	12.0	8.9	9.8	7.6	8.0	9.4	22.7	17.8	14.0	8.1	16.7	13.3	12.4	31.6	19.7	9.7	24.0	13.0	15.2	12.4	31.0	9.2	9.0	17.2	20.6	12.6	41.8	14.8	13.0	7.6	33.1	19.1	12.4	12.7	28.3	3.8	13.8	2.7	9.1	7.5	10.7	1.5	2.1	10.0	3.2	0.1	1.4	1.5	5.7	5.9	4.2	10.0	12.7	3.4	8.2	4.2	3.9	4.4	3.4	4.8	4.3	0.8	10.4	4.9	6.5	4.4	2.4	2.7	14.2	10.4	39.2	9.0	3.2	4.2	5.7	21.3	2.5	4.6	5.3	4.3	5.7	14.7	5.1	2.0	7.8	3.7	11.3	1.4	1.8	5.1	4.0	6.0	5.5	13.8	10.2	5.9	5.8	10.9	8.2	5.1	18.7	4.9	3.6	3.9	4.4	5.5	8.0	24.4	2.1	4.2	8.3	6.1	8.4	1.6	0.6	1.4	1.1	0.9	1.0	0.6	0.8	0.3	1.5	0.4	0.4	10.0	0.1	3.2	2.1	1.3	1.5	15.9	24.3	33.7	31.2	17.8	14.0	31.6	19.7	31.0	28.3
MAN2B1	"LAMAN, MANB"	ENSG00000104774	"Mannosidase alpha class 2B member 1"	O00754	19	12646511-12666742	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 42.1;intermediate monocyte: 39.4;myeloid DC: 35.2;non-classical monocyte: 28.4;plasmacytoid DC: 41.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 41.9;monocytes: 42.1"									"HPA041530, HPA053404"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"		3400000	"Nucleoplasm, Vesicles"		"HPA041530: AB_10795639, HPA053404: "	"unprognostic (6.63e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.48e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (4.00e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.51e-1)"	25.2	15.6	7.9	26.7	11.0	33.4	24.4	4.4	7.0	10.5	15.0	14.0	8.6	14.2	15.3	16.5	12.2	13.4	16.4	19.4	6.4	4.4	13.6	16.3	30.2	68.6	10.0	4.7	12.2	21.7	9.1	7.2	15.8	8.6	13.7	10.6	12.0	22.0	8.1	7.7	18.0	20.0	10.2	11.7	51.3	19.5	6.3	8.2	22.1	11.3	7.8	30.0	18.7	11.2	7.7	41.9	6.5	42.1	2.7	8.4	26.0	16.3	8.4	8.6	10.1	28.8	19.3	24.3	12.2	25.8	10.9	10.7	6.7	6.9	18.0	14.8	9.6	12.9	4.4	8.1	5.2	8.9	13.4	6.2	4.2	10.9	14.6	41.0	42.9	23.0	16.1	6.1	7.7	10.3	7.9	13.6	5.7	12.8	5.5	23.1	7.1	10.7	12.8	11.8	8.9	12.8	19.0	2.7	8.4	12.1	10.4	19.8	16.0	25.4	13.5	14.8	6.1	14.4	11.4	18.2	20.0	8.9	10.0	40.5	16.5	2.2	42.1	6.2	7.5	39.4	8.4	7.7	6.9	6.7	35.2	6.5	3.8	3.8	6.5	2.7	28.4	41.9	6.8	26.0	7.9	11.0	4.4	7.0	6.4	4.4	10.0	4.7	8.6	8.2
MAN2B2	KIAA0935	ENSG00000013288	"Mannosidase alpha class 2B member 2"	Q9Y2E5	4	6575175-6623362	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"								"Secreted to blood"		11000000				"unprognostic (1.30e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (7.59e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.18e-1)"	21.3	15.4	12.4	15.6	23.2	15.7	16.7	5.1	26.8	17.3	14.3	16.2	12.1	15.9	20.0	21.5	13.9	18.1	24.7	23.2	11.6	14.2	15.8	32.4	20.1	19.4	13.7	11.4	30.4	26.0	10.8	19.2	17.0	14.3	20.6	9.8	22.2	18.6	15.2	7.8	13.5	15.9	14.5	11.6	19.7	20.9	8.7	13.4	16.6	27.3	10.4	18.4	20.7	20.7	5.0	8.4	13.4	15.7	6.0	12.0	9.1	8.1	7.4	1.5	10.1	22.2	15.5	9.5	16.7	19.5	8.2	11.2	4.3	15.5	4.1	8.0	18.0	8.3	0.5	5.2	4.5	4.8	4.2	5.4	5.4	4.8	9.7	10.1	25.3	20.3	5.3	6.5	1.7	9.5	2.3	10.6	10.6	5.0	4.9	6.5	1.8	5.7	5.0	7.0	4.8	4.3	8.2	2.5	2.7	11.1	6.7	4.2	13.3	13.7	17.2	14.9	4.6	18.5	10.5	4.4	3.8	2.2	17.4	12.0	12.8	13.1	8.5	13.4	12.0	13.0	9.3	4.4	7.4	10.9	8.4	5.0	6.9	8.7	10.7	6.0	15.7	3.2	10.1	9.1	12.4	23.2	5.1	26.8	11.6	14.2	13.7	11.4	14.3	13.4
MANBA		ENSG00000109323	"Mannosidase beta"	O00462	4	102630770-102760994	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053478	Approved		Supported	Vesicles	"Intracellular and membrane"		12000000	Vesicles		"HPA053478: "	"unprognostic (2.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.56e-5)"	"unprognostic (4.11e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.13e-1)"	12.7	23.5	8.5	12.2	11.9	8.6	17.1	13.4	8.4	12.1	9.9	12.9	11.7	8.1	11.6	13.6	9.3	11.0	15.5	12.1	8.7	8.6	11.8	10.3	17.7	20.2	15.1	6.2	16.7	18.1	25.1	18.4	25.0	10.8	12.0	10.8	12.4	27.4	11.4	5.4	7.8	14.0	14.2	15.3	21.3	14.4	4.6	13.5	9.4	19.2	3.6	12.8	17.9	12.6	3.9	9.5	25.2	11.6	3.6	3.1	3.9	7.3	4.1	2.0	1.9	39.0	18.1	5.1	5.1	10.1	2.2	4.4	5.3	8.5	7.9	6.9	7.1	3.5	5.2	11.3	1.8	5.5	2.1	4.5	4.6	8.1	11.9	8.3	20.5	15.4	19.3	9.5	7.9	4.1	7.5	8.2	8.0	3.3	2.0	8.0	2.8	3.4	4.1	4.7	2.2	6.4	8.7	1.3	1.0	6.1	10.5	7.9	15.0	5.7	3.1	6.1	3.0	13.6	2.7	4.3	9.0	0.8	11.0	3.7	4.4	6.2	11.5	25.2	1.8	10.6	1.4	3.8	3.1	2.0	9.5	3.9	3.0	2.0	10.1	3.6	11.6	2.3	1.6	3.9	8.5	11.9	13.4	8.4	8.7	8.6	15.1	6.2	10.8	13.5
MANSC1	"FLJ10298, LOH12CR3"	ENSG00000111261	"MANSC domain containing 1"	Q9H8J5	12	12326056-12350541	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.9;RPTEC TERT1: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	24	"neutrophil: 37.5"	"Lineage enriched"	"Detected in many"	36	"granulocytes: 37.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007955, HPA007956"	Approved		Approved	"Golgi apparatus,Vesicles"			28000000	"Golgi apparatus, Vesicles"		"HPA007955: AB_1079306, HPA007956: AB_1079305"	"unprognostic (5.41e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.46e-3)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (3.30e-5)"	"unprognostic (1.15e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.03e-2)"	13.1	8.8	9.7	5.1	13.7	4.2	14.7	10.1	18.4	13.5	17.8	7.5	12.9	13.4	15.1	14.1	27.3	11.2	19.3	7.9	9.2	7.6	9.5	7.6	8.4	6.6	6.9	9.0	11.3	26.4	18.5	19.5	11.0	9.0	15.0	18.5	12.8	42.6	15.2	3.6	13.3	13.3	14.4	5.8	8.4	21.3	9.1	6.2	0.0	9.5	16.7	18.2	12.6	12.9	0.2	0.2	37.5	0.5	0.2	1.0	0.1	0.2	3.3	1.0	0.0	3.4	3.3	3.6	2.3	2.7	1.2	1.5	2.7	10.7	0.0	2.5	2.2	0.4	4.2	1.9	0.9	0.0	3.8	4.7	4.1	2.2	0.6	0.7	1.4	2.1	3.1	0.7	0.5	29.9	3.0	0.0	0.4	6.2	0.0	0.3	3.7	1.8	0.1	0.0	0.1	15.5	10.9	1.4	5.9	1.2	10.0	3.4	9.0	3.0	11.7	1.7	1.4	0.4	3.1	0.2	0.1	1.6	1.2	0.0	1.2	1.5	0.5	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.2	1.0	0.1	37.5	0.2	0.1	0.0	0.0	0.1	9.7	13.7	10.1	18.4	9.2	7.6	6.9	9.0	9.0	6.2
MAP1A	MAP1L	ENSG00000166963	"Microtubule associated protein 1A"	P78559	15	43510958-43531620	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 103.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.4;BJ hTERT+: 21.1;fHDF/TERT166: 31.5;hTEC/SVTERT24-B: 20.0;U-87 MG: 42.4"	"Cancer enhanced"	"Detected in many"		"glioma: 18.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 12.3"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039063, HPA039064, HPA066488"	Enhanced		Approved	Cytosol				Cytosol		"HPA039063: AB_2676327, HPA039064: AB_10673302, HPA066488: "	"unprognostic (1.60e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.86e-3)"	"unprognostic (4.45e-2)"	"unprognostic (3.58e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.13e-3)"	"unprognostic (8.36e-3)"	"unprognostic (3.45e-3)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (5.83e-2)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (1.09e-5)"	"prognostic unfavourable (1.66e-5)"	5.2	7.9	43.6	5.4	42.8	2.5	4.3	24.5	103.6	10.5	5.4	18.3	1.0	3.0	5.6	4.3	4.8	9.1	5.9	14.8	40.9	30.2	2.8	1.9	3.4	2.7	34.7	31.3	7.1	2.7	4.1	4.4	4.4	56.2	6.7	5.3	3.1	2.5	9.6	4.5	3.1	3.2	14.5	21.4	2.6	2.7	5.4	12.6	6.5	3.7	0.1	2.7	6.3	2.8	0.0	12.3	0.0	0.0	0.0	0.1	0.2	0.1	0.8	3.8	2.2	21.4	14.7	0.0	12.2	21.1	3.6	3.5	1.4	0.0	0.0	5.3	31.5	0.1	5.1	0.0	2.1	1.8	0.5	4.7	1.2	0.1	2.0	0.1	2.0	11.0	0.0	20.0	0.1	2.7	7.8	0.1	14.6	0.1	8.6	0.2	2.8	0.3	2.3	11.1	0.0	0.0	0.0	12.0	3.6	0.4	0.0	0.1	0.7	0.2	0.5	11.7	3.9	3.9	0.1	0.0	0.5	1.7	42.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.2	43.6	42.8	24.5	63.1	40.9	30.2	34.7	31.3	56.2	12.6
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209570	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 102.5"	"Cell line enhanced"	"Detected in many"		"TIME: 64.1"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol			140000	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (8.22e-5)"	20.3	18.1	27.5	10.2	39.6	1.6	9.3	52.3	101.9	15.3	6.1	21.6	3.5	3.2	9.2	9.8	12.8	7.7	10.7	17.1	37.6	40.7	4.4	3.3	3.7	3.2	42.4	42.5	7.8	4.5	3.0	7.0	9.5	102.5	19.0	6.2	9.4	7.6	24.0	3.6	10.2	3.9	22.9	45.7	2.4	7.2	11.0	11.3	0.0	5.7	0.1	2.6	13.4	5.9	0.2	0.4	0.6	0.0	0.0	0.3	2.1	0.3	12.1	30.5	11.0	19.0	33.3	0.0	6.5	5.0	6.6	7.9	0.1	0.4	0.0	15.7	24.1	0.1	16.6	0.6	10.0	0.0	2.4	1.3	4.3	3.9	10.1	0.0	1.0	33.4	2.1	26.6	9.9	20.6	1.9	0.0	11.2	0.1	0.0	0.0	8.2	3.9	0.1	3.6	0.0	0.5	0.0	19.7	13.6	6.4	0.0	3.3	0.0	1.2	64.1	21.0	9.9	15.3	29.4	1.4	0.0	0.0	22.7	0.0	16.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.6	0.0	0.0	0.4	0.2	2.1	27.5	39.6	52.3	59.1	37.6	40.7	42.4	42.5	102.5	11.3
MAP2	"MAP2A, MAP2B, MAP2C"	ENSG00000078018	"Microtubule associated protein 2"	P11137	2	209424058-209734118	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 122.3"	"Cell line enhanced"	"Detected in some"		"AF22: 74.6;NTERA-2: 26.7;SCLC-21H: 37.5;SH-SY5Y: 21.0"	"Cancer enhanced"	"Detected in many"		"glioma: 30.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"memory B-cell: 2.6;naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	15	"B-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001984, HPA008273, HPA012828"	Enhanced	Supported								"CAB001984: , HPA008273: AB_1853945, HPA012828: AB_1853946"	"unprognostic (2.47e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.58e-2)"	"prognostic unfavourable (1.98e-6)"	"unprognostic (2.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.10e-5)"	4.6	9.2	62.1	2.1	63.1	1.5	4.9	24.7	122.3	4.4	2.5	3.8	0.0	2.0	2.9	4.0	5.6	2.8	6.3	6.2	73.6	53.8	3.9	3.7	9.3	2.4	31.0	48.8	6.4	8.2	12.5	14.7	1.9	35.4	6.5	2.5	7.6	4.9	4.7	2.2	12.1	2.0	3.2	19.9	2.4	2.6	5.4	11.4	0.0	12.2	0.4	2.9	2.8	1.5	3.4	0.1	0.0	0.0	0.0	0.2	0.3	0.6	0.1	74.6	0.0	1.0	0.5	0.0	0.4	0.5	0.1	0.5	0.0	4.0	0.0	0.4	0.9	1.0	5.7	0.4	0.2	0.0	0.3	0.2	2.3	0.0	9.4	0.0	0.0	0.8	2.4	0.0	1.4	1.9	0.0	0.7	0.0	0.2	0.0	0.0	26.7	0.1	0.0	0.1	0.0	0.9	0.0	37.5	21.0	1.5	0.2	0.9	2.0	0.0	0.0	0.0	0.4	0.0	1.0	0.5	0.0	0.0	3.9	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	62.1	63.1	24.7	79.6	73.6	53.8	31.0	48.8	35.4	11.4
MAP2K4	"JNKK1, MEK4, MKK4, PRKMK4, SERK1"	ENSG00000065559	"Mitogen-activated protein kinase kinase 4"	P45985	17	12020824-12143830	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007751, HPA060074"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	"Cell Junctions"	"CAB007751: , HPA060074: "	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.53e-1)"	"unprognostic (2.76e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.32e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.79e-1)"	10.7	13.2	23.7	9.4	21.0	3.1	14.4	25.0	42.7	12.5	11.5	7.9	8.5	9.6	12.1	17.8	18.5	11.5	10.7	14.9	31.7	29.3	15.8	20.6	11.4	14.6	24.5	27.1	13.0	11.1	19.6	16.7	15.1	23.4	14.5	13.1	6.5	9.8	13.2	20.6	14.4	9.9	13.5	16.3	10.7	10.7	10.3	9.8	10.3	16.5	11.6	13.4	11.1	11.2	2.8	1.8	13.2	4.3	3.5	3.3	2.3	17.9	15.5	20.4	10.5	11.3	14.7	13.0	12.3	16.2	14.0	13.4	9.2	6.2	7.5	10.0	19.1	12.1	17.7	17.1	21.1	13.2	20.8	8.3	9.1	17.3	13.3	7.9	12.6	12.1	17.0	16.4	17.2	12.7	8.8	4.4	17.6	6.7	9.6	7.4	11.9	7.6	11.8	22.9	5.1	19.2	11.6	4.1	12.1	14.2	7.6	11.8	9.6	5.8	11.6	6.9	10.7	9.5	14.5	8.7	9.7	5.9	13.0	6.3	10.0	0.6	2.7	2.0	3.0	1.5	2.7	2.8	2.4	2.4	1.8	2.7	2.0	3.3	13.2	3.5	4.3	1.8	2.6	2.3	23.7	21.0	25.0	42.7	31.7	29.3	24.5	27.1	23.4	9.8
MAP2K7	"Jnkk2, MKK7, PRKMK7"	ENSG00000076984	"Mitogen-activated protein kinase kinase 7"	O14733	19	7903843-7914478	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA001633, CAB004262, HPA064711"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB004262: AB_627925, HPA001633: AB_1079516, HPA064711: "	"unprognostic (1.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.24e-2)"	"prognostic favourable (8.54e-5)"	"unprognostic (1.80e-3)"	"unprognostic (2.55e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.71e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.73e-2)"	"prognostic favourable (1.56e-4)"	16.3	14.9	13.5	16.4	16.4	23.8	13.6	28.7	21.5	14.3	15.6	23.2	15.1	19.3	19.1	9.9	13.6	13.1	14.3	15.8	14.6	11.9	12.8	15.9	12.5	15.9	17.2	13.9	18.4	22.3	13.9	17.0	16.4	16.2	14.4	7.9	14.2	23.0	13.4	61.6	21.3	18.7	14.1	12.5	19.4	14.8	21.5	16.5	9.8	13.7	17.3	12.8	15.4	15.2	3.0	2.6	4.8	2.7	3.3	2.5	1.0	12.7	7.3	6.4	10.4	5.1	5.0	11.9	8.4	4.1	5.7	6.0	10.5	7.8	15.2	13.6	4.4	11.7	5.5	6.4	2.2	12.1	27.4	10.7	9.7	7.8	6.6	9.9	13.6	5.7	8.4	4.5	5.2	5.2	15.6	20.0	3.3	6.7	14.2	24.2	11.2	16.5	14.1	6.9	15.4	5.1	10.7	11.7	11.8	5.7	10.1	11.7	10.8	11.4	7.7	17.5	10.0	12.3	11.3	29.0	13.4	14.3	8.7	14.7	7.0	0.0	2.7	1.9	2.3	2.5	1.5	2.1	1.9	2.0	1.3	3.0	1.7	2.5	4.8	3.3	1.5	2.6	0.7	1.0	13.5	16.4	28.7	21.5	14.6	11.9	17.2	13.9	16.2	16.5
MAP3K3	"MAPKKK3, MEKK3"	ENSG00000198909	"Mitogen-activated protein kinase kinase kinase 3"	Q99759	17	63622415-63696303	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007764, HPA035410, HPA035411"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"CAB007764: AB_562314, HPA035410: , HPA035411: "	"unprognostic (9.65e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.14e-2)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.79e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.08e-2)"	23.9	11.8	10.5	20.5	15.0	24.8	19.1	26.8	14.9	22.2	21.8	15.0	14.0	8.0	24.5	13.2	16.6	18.3	20.6	37.4	11.3	8.4	17.1	12.4	23.1	21.4	14.4	9.6	21.6	11.4	16.9	12.3	21.0	11.9	18.4	8.3	21.7	12.8	18.5	19.6	15.4	14.7	20.4	13.2	30.4	16.4	26.5	12.3	12.9	15.5	12.8	15.4	19.0	26.8	1.9	3.5	18.3	8.5	1.1	2.6	2.3	10.1	7.6	9.7	9.4	18.6	15.0	4.4	10.0	11.0	12.5	10.1	3.5	2.1	10.9	7.1	19.6	3.8	6.3	7.1	7.9	9.5	13.9	8.9	10.3	4.9	9.7	6.8	9.5	10.7	4.9	15.5	8.2	30.3	5.4	14.5	9.9	7.1	12.2	7.1	6.0	8.1	6.5	24.8	7.1	4.5	4.6	5.0	11.9	6.8	8.2	8.3	8.2	6.8	27.2	32.0	8.5	17.3	12.1	14.4	14.6	4.0	6.9	5.5	8.3	8.8	8.5	10.4	2.2	8.3	2.3	1.5	2.6	2.1	3.5	1.9	2.5	2.5	18.3	1.1	8.2	1.3	1.9	2.3	10.5	15.0	26.8	14.9	11.3	8.4	14.4	9.6	11.9	12.3
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557047-136792518	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol				Cytosol		"CAB007824: AB_598175, HPA063245: "	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	7.7	55.6	13.0	7.5	17.6	7.6	5.5	12.9	12.7	4.0	5.4	6.9	3.6	4.6	7.2	5.1	6.4	6.1	4.9	7.3	11.8	6.8	6.8	5.5	7.7	8.8	8.2	6.4	32.4	28.2	1.5	9.9	3.4	7.9	11.6	6.2	5.8	4.2	4.9	3.7	5.0	4.6	4.3	7.5	9.8	8.7	7.3	8.6	2.0	10.0	3.4	9.0	10.8	18.9	2.5	2.5	8.5	3.0	4.1	7.0	1.4	2.8	1.7	0.0	0.0	4.1	11.1	1.0	4.1	22.3	2.1	2.0	0.1	2.9	1.7	6.1	5.7	4.0	7.1	2.1	5.6	2.3	5.6	14.7	3.9	0.0	19.8	6.8	0.0	14.6	2.8	3.3	9.6	7.1	3.6	16.5	15.0	5.5	0.1	5.8	0.7	2.4	3.8	4.7	6.7	8.6	18.3	5.2	3.4	3.4	3.3	0.9	0.7	6.1	6.2	3.6	1.1	0.2	3.8	13.5	8.9	0.0	2.8	9.6	3.1	5.7	3.0	3.3	2.7	2.3	4.9	2.0	4.3	3.7	2.5	2.5	0.4	1.4	8.5	4.1	2.1	2.4	7.0	1.4	13.0	17.6	12.9	9.4	11.8	6.8	8.2	6.4	7.9	8.6
MAP3K6	"ASK2, MAPKKK6, MEKK6"	ENSG00000142733	"Mitogen-activated protein kinase kinase kinase 6"	O95382	1	27355184-27366892	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 63.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051192	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"				Nucleoplasm	"Plasma membrane, Actin filaments, Cytosol"	"HPA051192: "	"unprognostic (1.19e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (2.13e-4)"	"prognostic favourable (7.26e-4)"	"prognostic unfavourable (8.76e-4)"	"unprognostic (9.10e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.91e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.65e-3)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.50e-1)"	37.5	6.3	7.4	6.9	8.6	1.3	22.1	12.6	8.3	19.9	9.0	2.7	8.9	3.3	13.1	10.3	25.7	12.8	12.4	14.9	6.2	2.6	13.6	5.0	21.7	5.5	11.4	1.9	11.7	8.3	8.2	15.8	7.3	9.8	13.9	5.9	15.7	11.5	9.7	6.3	63.9	6.2	16.0	11.7	8.7	9.0	6.7	7.0	0.6	12.0	16.1	14.3	14.3	18.3	2.7	3.3	5.1	6.9	1.1	7.6	2.4	7.4	6.9	6.2	6.9	8.7	15.3	1.6	9.3	5.4	7.0	5.3	2.0	10.0	0.1	8.3	14.1	11.8	2.1	6.5	3.5	6.2	5.1	0.5	16.0	3.1	2.7	0.5	0.6	12.2	15.9	7.3	2.6	4.7	2.3	4.1	11.1	18.4	0.3	8.4	1.9	5.7	2.7	4.1	1.7	10.5	7.8	2.3	3.4	9.8	8.6	7.3	4.6	6.4	9.8	17.6	7.4	19.7	4.8	3.3	4.1	0.1	15.6	6.1	5.1	1.8	1.5	5.1	5.3	3.3	7.6	2.7	5.5	5.9	3.3	2.3	4.4	3.6	2.4	1.1	6.9	0.0	5.6	2.4	7.4	8.6	12.6	8.3	6.2	2.6	11.4	1.9	9.8	7.0
MAP3K8	"c-COT, COT, EST, ESTF, MEKK8, Tpl-2"	ENSG00000107968	"Mitogen-activated protein kinase kinase kinase 8"	P41279	10	30433937-30461833	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 104.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005120, HPA017962"	Supported		Supported	Cytosol				Cytosol		"CAB005120: AB_2140669, HPA017962: AB_1853776"	"unprognostic (1.91e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.07e-1)"	"unprognostic (9.29e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.41e-2)"	"unprognostic (8.04e-3)"	"unprognostic (8.23e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.76e-7)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.98e-3)"	28.0	7.6	3.6	15.6	4.1	104.6	26.1	1.5	2.6	8.2	8.4	2.7	11.3	3.4	11.5	16.5	13.8	19.5	15.3	20.1	4.3	2.9	6.3	7.6	29.0	33.7	4.3	2.0	9.8	3.6	2.8	4.1	27.5	8.3	7.9	6.8	9.4	6.1	18.4	8.6	15.3	9.6	23.4	9.7	25.6	10.7	6.7	3.6	2.4	7.0	13.2	17.2	13.2	15.6	19.6	13.8	23.7	16.8	12.4	7.8	4.0	7.9	7.1	1.9	4.1	10.3	8.7	9.1	2.0	11.9	4.4	5.3	4.9	18.5	5.2	5.1	4.2	14.9	4.5	1.9	1.6	12.0	2.3	9.7	12.1	15.7	8.7	3.0	24.0	10.8	1.1	4.4	0.8	1.9	4.3	7.8	0.7	4.5	0.1	11.6	0.7	2.5	0.6	1.6	3.0	4.4	16.1	0.2	0.8	7.1	6.1	0.9	2.0	6.4	0.1	2.7	2.3	9.7	0.3	11.9	11.1	1.5	3.9	13.2	0.1	17.9	7.0	23.7	7.8	12.0	4.3	9.6	1.7	4.9	6.6	19.6	0.1	3.0	16.7	12.4	16.8	13.8	0.4	4.0	3.6	4.1	1.5	2.6	4.3	2.9	4.3	2.0	8.3	3.6
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"			120000	"Plasma membrane, Microtubules, Cytosol"		"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	21.9	17.6	22.1	16.7	32.6	58.2	9.3	41.2	45.0	34.9	39.2	14.8	13.8	18.6	9.6	62.1	14.7	28.2	37.3	39.2	26.8	11.9	12.6	19.7	19.1	44.3	8.7	10.2	48.6	46.7	42.3	51.9	45.7	16.2	21.6	27.4	12.4	12.3	10.6	13.3	36.5	6.6	20.8	23.1	22.3	18.4	8.8	13.7	31.6	12.8	21.8	9.4	8.1	61.7	33.0	25.5	34.4	26.3	15.2	11.8	8.8	42.4	10.7	31.2	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8
MAP4K2	"BL44, GCK, RAB8IP"	ENSG00000168067	"Mitogen-activated protein kinase kinase kinase kinase 2"	Q12851	11	64784914-64803241	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007330	Enhanced		Approved	Vesicles				Vesicles		"HPA007330: AB_1079361"	"unprognostic (1.66e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.07e-3)"	"unprognostic (4.37e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavourable (3.10e-5)"	"unprognostic (4.51e-2)"	"unprognostic (3.65e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	6.9	6.2	9.4	15.2	10.0	19.1	5.8	12.1	15.6	5.2	5.8	10.1	6.9	4.9	6.2	4.0	4.3	4.4	6.3	5.5	9.4	9.2	6.2	3.1	12.0	22.3	8.3	7.3	4.2	7.2	5.2	8.0	12.3	12.5	6.1	4.7	6.7	9.0	8.9	3.4	5.0	9.9	5.6	6.7	22.6	7.1	5.5	6.6	11.5	8.7	3.9	18.8	6.1	5.1	10.8	5.0	8.2	14.8	2.3	9.6	7.1	6.1	5.5	3.6	6.6	3.3	2.0	8.6	4.6	4.3	5.6	3.9	2.4	2.9	10.7	8.6	5.2	1.8	4.4	4.5	3.3	13.9	2.1	18.8	7.7	5.1	4.0	9.9	7.1	2.0	2.3	4.3	2.8	13.6	1.6	1.0	1.7	7.6	5.8	9.9	2.4	7.5	12.2	0.4	12.3	3.1	3.1	4.4	6.3	4.0	5.2	4.1	10.5	15.2	10.5	4.7	10.5	4.3	1.9	1.2	2.4	11.6	4.1	15.0	3.4	2.2	4.2	5.6	5.2	12.2	5.3	10.8	7.0	4.7	4.4	7.6	8.6	6.3	8.2	2.3	14.8	5.0	9.6	7.1	9.4	10.0	12.1	15.6	9.4	9.2	8.3	7.3	12.5	6.6
MAP4K3	"GLK, MAPKKKK3, RAB8IPL1"	ENSG00000011566	"Mitogen-activated protein kinase kinase kinase kinase 3"	Q8IVH8	2	39249266-39437312	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 40.8;RT4: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030380	Approved		Approved	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA030380: AB_10601132"	"unprognostic (4.82e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.87e-3)"	"unprognostic (7.34e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.73e-2)"	"unprognostic (4.33e-3)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.08e-2)"	19.7	18.9	17.6	15.4	17.6	9.6	17.8	37.1	19.6	19.2	16.9	14.6	9.8	13.7	23.5	14.8	11.1	15.3	18.7	19.5	15.4	12.5	26.2	15.4	15.6	5.8	15.4	13.4	24.6	14.0	25.7	24.6	30.8	14.4	18.6	14.1	17.9	13.3	15.7	33.0	17.8	17.2	18.6	15.3	11.5	26.1	21.0	16.5	9.4	25.9	11.3	7.5	18.8	32.6	0.7	0.5	2.5	1.9	1.0	1.3	0.4	9.7	6.1	40.8	6.4	6.6	13.4	11.2	8.7	11.1	8.6	7.4	5.1	4.9	2.1	9.8	5.9	5.3	15.3	7.7	13.2	2.4	6.3	3.5	4.3	11.9	17.3	1.5	5.8	11.9	7.7	11.2	12.1	7.4	4.5	4.0	11.5	5.3	3.4	2.3	12.3	9.3	3.7	13.3	1.6	11.4	37.8	7.3	8.3	5.1	8.2	22.6	5.5	2.2	6.0	6.7	8.0	6.0	4.7	6.1	3.4	0.7	8.3	2.5	7.8	2.5	0.7	0.0	1.2	1.1	0.1	0.1	1.2	0.9	0.1	0.7	1.1	1.3	0.0	1.0	1.9	0.5	0.6	0.4	17.6	17.6	37.1	19.6	15.4	12.5	15.4	13.4	14.4	16.5
MAP4K4	"FLH21957, HGK, NIK"	ENSG00000071054	"Mitogen-activated protein kinase kinase kinase kinase 4"	O95819	2	101696850-101894689	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 81.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008476	Uncertain									"HPA008476: AB_1079362"	"unprognostic (6.40e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.57e-4)"	"unprognostic (4.29e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.22e-3)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (3.62e-6)"	"unprognostic (6.67e-3)"	"unprognostic (8.98e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.14e-3)"	27.0	5.0	68.3	21.1	56.3	32.1	35.2	14.5	50.4	13.2	7.8	47.5	2.1	5.4	14.6	6.7	18.5	8.6	18.0	22.2	70.5	40.5	6.3	16.8	13.2	25.8	65.3	21.5	12.6	8.3	9.5	4.3	25.1	40.2	7.6	9.6	6.1	7.7	5.7	16.1	8.7	6.5	14.8	81.2	11.7	11.0	20.3	49.1	13.2	8.3	6.6	29.6	13.5	16.3	4.6	6.3	14.4	3.4	1.1	3.7	1.5	18.8	14.3	30.7	14.6	29.1	52.3	38.6	24.0	19.8	21.5	17.8	23.7	25.1	27.5	20.9	35.9	7.8	9.7	21.1	21.5	36.8	6.6	20.6	10.8	61.8	24.6	9.8	0.9	46.9	9.7	53.0	23.7	55.8	13.3	0.0	56.4	10.3	22.7	6.1	15.6	22.8	27.5	21.0	0.1	14.3	6.6	12.0	20.0	16.5	0.0	17.9	3.9	17.8	70.1	42.7	18.3	12.3	28.5	0.0	0.0	16.7	27.5	12.5	31.2	6.9	3.3	0.0	2.4	3.4	1.8	3.5	3.3	1.7	1.1	4.6	2.5	2.7	14.4	1.1	3.0	6.3	3.7	1.5	68.3	56.3	14.5	38.9	70.5	40.5	65.3	21.5	40.2	49.1
MAPK1	"ERK, ERK2, MAPK2, p41mapk, PRKM1, PRKM2"	ENSG00000100030	"Mitogen-activated protein kinase 1"	P28482	22	21754500-21867680	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Kinase, Repressor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.3"	"Cell line enhanced"	"Detected in all"		"K-562: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003995, CAB004229, HPA005700, HPA030069"	Approved						250000			"CAB004229: AB_627547, HPA003995: AB_1078751, HPA005700: AB_1078750, HPA030069: AB_10602035"	"unprognostic (9.41e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.17e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.43e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.49e-2)"	16.1	21.1	32.9	18.3	80.3	20.2	13.6	31.0	54.5	18.6	18.5	23.2	9.6	13.7	17.4	10.6	25.7	16.9	14.9	22.8	32.4	23.4	21.7	16.4	19.9	16.6	18.4	23.6	16.0	19.8	27.4	10.9	17.2	27.6	16.4	19.9	14.2	15.8	17.8	28.2	17.5	15.1	22.8	20.4	19.8	17.2	24.2	21.5	19.5	23.0	11.1	21.4	17.7	15.3	2.5	3.2	13.5	4.9	7.0	13.7	2.5	19.3	12.2	15.7	9.0	18.7	18.9	6.0	21.4	20.0	19.2	18.6	9.7	10.3	10.7	10.6	28.6	18.4	18.5	17.1	25.1	43.1	17.3	19.4	11.5	11.4	15.4	27.3	20.1	14.0	13.7	23.2	21.5	26.2	79.5	12.2	23.4	7.9	17.6	6.0	5.9	12.1	19.4	39.0	2.9	11.0	15.9	12.9	7.1	23.1	14.0	12.5	10.5	9.2	22.9	16.1	21.0	18.4	13.6	11.7	14.3	16.7	15.2	13.3	17.4	1.0	4.0	5.8	13.7	4.6	3.9	2.0	2.9	4.9	3.2	2.5	2.8	5.1	13.5	7.0	4.9	3.2	2.7	2.5	32.9	80.3	31.0	54.5	32.4	23.4	18.4	23.6	27.6	21.5
MAPK4	"Erk3-related, Erk4, PRKM4"	ENSG00000141639	"Mitogen-activated protein kinase 4"	P31152	18	50560078-50731824	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 26.4;brain: 33.4;parathyroid gland: 43.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.0;HeLa: 4.4;NTERA-2: 3.0;SCLC-21H: 15.4;SH-SY5Y: 3.7"	"Group enriched"	"Detected in many"	5	"glioma: 15.2;melanoma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007461			Approved	"Nucleoplasm,Golgi apparatus,Midbody"				"Nucleoplasm, Golgi apparatus"	Midbody	"HPA007461: AB_1079308"	"unprognostic (4.12e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-3)"	"unprognostic (2.16e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.96e-4)"	"unprognostic (5.99e-4)"	"unprognostic (2.31e-2)"	"unprognostic (1.82e-1)"	1.9	26.4	16.9	1.1	33.4	0.9	1.8	15.9	23.9	1.4	2.6	9.5	3.8	1.6	1.8	4.5	3.5	1.5	3.0	16.9	13.0	14.3	4.5	7.0	3.5	0.9	17.1	9.1	4.2	2.5	43.5	8.3	3.7	20.5	5.3	1.8	4.1	1.8	12.4	1.7	1.0	1.9	5.2	11.8	1.1	1.3	3.5	12.4	1.7	7.8	0.0	0.9	2.2	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	1.5	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	15.4	3.7	0.0	1.1	2.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	33.4	15.9	14.5	13.0	14.3	17.1	9.1	20.5	12.4
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: "	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	4.1	6.5	5.4	4.2	27.1	11.3	6.3	5.6	5.2	7.8	7.2	7.5	0.7	2.5	4.6	9.7	4.6	6.3	5.1	4.9	4.3	4.8	1.2	4.7	3.3	11.7	1.1	4.2	11.9	3.6	11.8	4.2	5.7	2.2	0.9	7.7	2.7	8.3	4.4	6.2	4.3	4.5	7.9	1.7	2.6	2.3	2.4	7.2	5.7	0.5	2.9	3.5	1.4	3.2	8.4	6.2	9.2	3.8	1.6	2.4	0.6	9.7	1.0	5.0	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 38.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332"			Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA058921: , HPA070332: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favourable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	3.0	12.8	33.3	2.1	29.6	1.4	2.7	24.9	73.5	3.1	1.9	4.6	0.1	1.6	4.9	3.1	2.1	6.6	3.0	2.9	38.1	22.3	5.1	2.7	2.6	1.0	28.0	18.9	4.4	26.4	14.7	24.8	1.6	23.5	4.9	1.5	4.5	4.8	5.0	1.7	1.7	2.0	4.4	44.4	1.7	3.8	10.8	4.8	0.0	3.9	0.5	0.9	2.0	0.4	0.4	0.4	2.1	0.9	2.6	0.2	0.0	0.0	3.5	4.7	13.1	1.8	0.9	0.1	2.5	2.2	5.0	3.6	3.0	0.5	0.2	1.2	2.9	2.8	5.0	2.3	2.2	1.9	6.5	0.0	4.4	2.0	1.6	0.2	2.2	1.2	0.5	3.2	0.6	1.1	5.4	0.8	1.4	1.8	0.1	0.3	12.5	5.2	0.3	7.7	0.1	2.3	0.0	38.6	14.4	4.1	3.4	4.7	5.5	0.2	1.0	6.4	9.8	9.5	4.5	0.5	0.6	0.2	4.0	0.1	1.9	2.1	0.9	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.4	0.1	0.2	1.8	2.6	0.0	0.4	0.1	0.0	33.3	29.6	24.9	41.7	38.1	22.3	28.0	18.9	23.5	4.8
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819893-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"			17000000	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	35.4	23.4	30.9	30.9	28.7	77.5	27.2	12.3	25.3	26.1	39.3	34.0	25.9	18.3	40.0	29.8	30.0	28.4	27.4	31.7	26.9	25.0	33.6	14.2	30.3	31.9	36.6	17.5	29.5	22.1	19.7	20.0	35.2	27.9	29.1	28.1	24.7	22.0	35.3	20.4	19.3	25.8	42.5	37.1	38.5	29.1	31.7	24.1	48.4	35.2	26.1	31.0	39.1	30.0	19.7	25.7	66.8	41.4	27.3	30.3	42.1	30.5	28.1	31.5	18.0	17.1	15.5	44.9	30.0	18.7	46.8	34.6	81.2	28.5	46.7	30.2	26.9	28.1	37.6	33.5	51.4	15.7	14.6	89.9	19.6	43.4	18.1	32.3	40.0	16.7	16.8	38.2	25.6	29.1	40.4	26.7	41.0	19.0	44.2	28.3	22.7	26.1	29.8	55.9	25.0	25.5	21.2	19.7	20.7	53.8	23.9	30.8	34.5	24.1	25.7	52.8	28.5	26.3	38.6	23.6	32.4	50.3	28.0	74.1	29.3	55.1	33.6	66.8	28.1	39.3	29.1	19.7	26.9	25.9	25.7	18.9	27.3	30.3	36.8	27.3	41.4	23.6	27.0	42.1	30.9	28.7	12.3	25.3	26.9	25.0	36.6	17.5	27.9	24.1
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm			24000000	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	12.3	33.8	38.9	15.3	35.5	10.4	9.6	34.6	61.8	11.6	13.4	30.4	3.1	8.3	8.1	11.3	10.1	6.5	22.7	47.9	43.7	29.8	10.6	18.5	15.1	18.4	39.0	43.3	14.8	7.3	7.6	8.6	15.7	32.1	9.4	14.0	8.7	10.5	10.2	24.6	12.8	10.7	14.4	71.4	14.6	16.7	3.8	22.1	31.9	12.3	8.6	17.5	15.7	8.4	27.4	23.1	25.1	22.8	34.0	32.8	32.8	0.2	8.7	9.8	5.1	5.9	5.5	0.7	6.2	14.8	7.4	12.8	0.6	3.3	28.5	7.2	13.5	11.7	7.6	5.0	13.7	16.6	7.1	28.9	9.4	16.6	4.3	15.9	24.3	6.6	1.3	10.3	3.6	41.4	8.9	12.8	9.7	0.5	33.5	5.3	7.5	1.7	13.5	11.9	6.5	3.9	0.1	12.2	8.1	4.6	0.2	5.1	1.0	9.3	6.9	8.2	4.6	4.8	4.1	6.7	15.9	16.7	14.1	21.3	12.7	25.1	14.7	22.2	32.8	18.2	25.4	27.4	23.2	29.8	16.0	25.9	26.8	32.6	10.6	34.0	22.8	23.1	23.5	32.8	38.9	35.5	34.6	41.2	43.7	29.8	39.0	43.3	32.1	22.1
MAPT	"DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau"	ENSG00000186868	"Microtubule associated protein tau"	P10636	17	45894382-46028334	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 89.9;skeletal muscle: 43.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 27.3;SCLC-21H: 9.8;T-47d: 12.4"	"Group enriched"	"Detected in many"	11	"breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000151, HPA048895, HPA069524, HPA069570, CAB072344"	Enhanced		Supported	"Nuclear speckles,Plasma membrane"				"Plasma membrane"	"Nuclear speckles"	"CAB000151: , CAB072344: , HPA048895: , HPA069524: , HPA069570: "	"unprognostic (1.78e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (8.40e-5)"	"unprognostic (1.40e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.06e-5)"	"unprognostic (6.04e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.72e-3)"	"unprognostic (6.53e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.85e-2)"	"unprognostic (5.47e-2)"	3.8	7.1	28.9	2.4	31.2	2.1	8.8	40.1	89.9	2.4	2.7	21.4	1.7	2.5	2.6	2.3	6.4	2.5	2.8	6.5	28.7	29.7	15.3	2.2	2.4	2.3	22.6	35.2	2.3	2.8	8.5	8.8	5.2	29.1	5.1	2.5	2.2	8.1	5.3	43.7	4.6	2.8	2.5	13.6	2.2	2.3	6.5	27.7	0.0	2.3	3.1	2.3	3.2	0.8	0.0	0.0	0.3	0.1	0.5	1.7	0.1	0.8	0.3	0.2	2.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.1	0.0	27.3	1.4	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.2	1.3	0.0	4.1	0.5	0.1	0.0	1.1	0.0	2.2	2.7	0.0	3.5	9.8	4.6	1.0	0.0	0.9	12.4	0.0	0.0	0.2	0.3	0.6	0.1	0.5	0.1	0.0	0.2	0.5	0.3	0.0	0.1	0.3	0.8	0.0	0.6	0.0	0.4	1.2	0.0	0.0	0.9	0.9	0.0	0.5	0.1	0.0	1.7	0.1	28.9	31.2	40.1	46.3	28.7	29.7	22.6	35.2	29.1	27.7
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857362-113863471	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 74.3;TIME: 58.3"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 10.1;neutrophil: 15.0"	"Group enriched"	"Detected in many"	10	"B-cells: 3.9;granulocytes: 15.0;monocytes: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"			17000000	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: , HPA067595: , HPA069443: "	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	13.0	5.0	11.2	17.0	12.9	26.9	16.0	18.5	43.3	12.1	23.2	17.9	0.9	11.6	9.7	4.0	17.0	8.4	10.9	9.7	10.5		5.3	8.7	12.9	13.3	8.8	15.9	12.6	11.2	1.2	6.5	39.5	13.8	14.1	21.6	11.4	8.2	5.6	5.0	9.5	12.9	9.1	42.3	20.9	18.8	5.2	8.5	30.0	4.9	7.9	13.6	23.5	7.8	3.9	0.9	15.0	10.1	0.0	0.0	0.4	6.8	4.0	74.3	4.0	25.1	16.4	0.4	22.0	31.0	15.6	26.1	7.2	9.7	0.0	4.6	40.6	21.2	12.2	6.4	20.3	0.0	7.3	0.0	4.3	9.3	16.7	1.7	0.1	16.9	12.6	15.0	14.3	43.9	0.8	19.6	22.1	0.0	0.2	0.0	9.6	5.3	0.0	7.4	0.7	4.9	13.1	10.3	30.1	14.1	7.2	15.1	0.3	2.0	58.3	14.5	0.0	23.7	37.5	53.0	3.8	2.0	11.1	9.8	27.7	0.0	3.4	0.0	0.0	10.1	0.0	3.9	0.0	0.0	0.9	1.6	0.0	0.0	15.0	0.0	5.5	0.0	0.0	0.4										
MARCO	"SCARA2, SR-A6"	ENSG00000019169	"Macrophage receptor with collagenous structure"	Q9UEW3	2	118942166-118994660	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 66.3;lung: 65.6;lymphoid tissue: 58.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.9;THP-1: 5.6;U-2 OS: 6.0;U-266/70: 3.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 15.8;intermediate monocyte: 26.7"	"Lineage enriched"	"Detected in many"	5	"monocytes: 26.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063793	Enhanced		Approved	"Golgi apparatus,Vesicles"			24000000	"Golgi apparatus"	Vesicles	"HPA063793: "	"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.96e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.27e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.55e-2)"	22.8	11.7	0.8	29.6	1.1	0.9	3.3	2.3	1.3	0.3	2.8	0.9	0.0	0.6	0.3	12.9	5.2	13.8	0.8	10.8	0.6	0.4	1.6	66.3	65.6	29.3	1.3	3.1	4.7	0.4	0.2	0.8	2.3	2.7	4.5	0.7	1.0	2.9	0.8	6.8	1.1	1.3	9.6	1.7	58.7	2.2	2.8	0.6	0.0	3.0	0.5	0.4	8.8	1.1	0.0	5.0	0.3	26.7	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	3.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.6	0.0	0.0	6.0	0.9	0.0	3.6	0.0	0.2	0.0	1.3	0.0	0.0	15.8	0.0	0.0	26.7	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.3	0.0	3.2	0.4	0.0	3.4	0.8	1.1	2.3	1.3	0.6	0.4	1.3	3.1	2.7	0.6
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Group enriched"	"Detected in some"	8	"BJ: 26.5;BJ hTERT+: 101.0"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	8673000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favourable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	26.5	101.0	0.3	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7
MASP2	MASP1P1	ENSG00000009724	"Mannan binding lectin serine peptidase 2"	O00187	1	11026523-11047233	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	98	"liver: 185.1"	"Cell line enriched"	"Detected in many"	7	"Hep G2: 20.1"	"Cancer enriched"	"Detected in some"	71	"liver cancer: 41.9"	"Region enriched"	"Detected in single"	4	"cerebellum: 1.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	339700000	880000000	"Golgi apparatus"		"HPA029313: AB_10669654, HPA029314: AB_10670029"	"unprognostic (7.00e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.26e-3)"	"prognostic favourable (1.60e-4)"	"unprognostic (2.92e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.90e-3)"	"unprognostic (8.30e-4)"	"unprognostic (7.14e-2)"	"unprognostic (3.91e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-4)"	0.3	0.2	0.3	0.4	0.3	1.8	0.3	1.7	0.5	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.3	0.1	0.3	185.1	0.3	0.6	0.3	0.3	0.5	0.4	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.7	0.3	1.4	1.4	0.5	0.3	0.3	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.4	1.2	1.2	0.2	0.8	1.3	0.0	0.5	0.3	2.9	1.6	0.0	0.1	0.4	0.8	0.0	0.0	0.0	1.3	1.1	2.3	0.6	0.0	0.7	0.0	0.0	0.0	0.6	2.3	1.4	2.5	20.1	0.0	2.1	1.6	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	0.6	0.6	1.1	0.4	0.6	1.8	1.0	0.5	0.0	1.4	1.8	0.7	0.9	0.5	0.5	0.6	1.3	1.1	0.9	0.6	1.0	0.6	0.7	1.1	1.7	0.6	1.9	0.4	1.2	0.2	1.1	0.7	0.1	1.0	0.7	0.9	0.8	0.5	1.4	1.3	1.3	0.2	0.8	0.2	1.2	0.1	0.0	0.3	0.3	1.7	0.3	0.3	0.1	0.3	0.3	0.3	0.3
MAT1A	"MAT, MATA1, SAMS, SAMS1"	ENSG00000151224	"Methionine adenosyltransferase 1A"	Q00266	10	80271820-80289684	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"liver: 178.8"	"Cell line enriched"	"Detected in some"	15	"Hep G2: 44.8"	"Cancer enriched"	"Detected in many"	54	"liver cancer: 209.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA048627	Supported						530000			"HPA048627: "	"unprognostic (6.92e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.43e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.59e-3)"	"unprognostic (9.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (5.98e-2)"	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	12.5	0.1	0.2	0.2	0.1	0.0	0.0	0.3	178.8	0.1	0.1	0.1	0.0	0.7	9.9	0.0	0.6	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	44.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0
MAT2A	"MATA2, MATII, SAMS2"	ENSG00000168906	"Methionine adenosyltransferase 2A"	P31153	2	85539165-85545280	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 205.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009968, HPA043028"	Approved		Approved	Nucleoplasm,Cytosol			950000	Nucleoplasm	Cytosol	"CAB009968: AB_675710, HPA043028: AB_10960707"	"unprognostic (1.38e-3)"	"unprognostic (2.58e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (5.29e-5)"	"unprognostic (9.89e-3)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.87e-4)"	"prognostic favourable (8.94e-4)"	"prognostic unfavourable (5.94e-5)"	"unprognostic (4.07e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.77e-2)"	55.9	68.9	37.4	35.3	54.1	20.4	30.3	37.5	50.0	28.6	35.3	74.5	39.7	33.6	35.8	59.8	33.5	44.9	51.6	35.0	41.7	28.5	52.3	26.4	32.9	27.0	74.8	37.6	44.2	205.8	38.8	60.5	29.3	48.9	40.6	36.8	35.0	28.2	31.3	51.4	33.7	35.8	47.6	57.7	24.7	44.6	34.9	69.4	22.7	94.0	34.1	30.8	46.9	33.4	13.8	15.3	4.9	17.2	16.9	22.8	14.9	29.7	44.2	51.9	32.2	35.7	43.7	30.7	37.4	34.5	39.4	42.1	36.1	100.4	69.8	24.7	45.4	46.4	65.2	55.8	50.7	35.3	47.9	41.7	64.0	31.1	65.3	61.8	46.6	39.5	56.7	42.5	29.7	37.3	46.8	55.0	89.4	25.5	56.3	68.1	34.4	56.9	60.0	49.2	45.2	59.5	47.2	40.9	37.7	33.8	32.7	60.3	27.7	33.2	36.3	48.4	29.2	26.6	44.7	33.9	26.9	50.5	31.6	77.6	25.4	4.8	15.2	4.9	15.4	17.2	22.8	13.8	17.5	16.2	15.3	12.2	16.4	14.3	1.6	16.9	13.7	10.9	15.3	14.9	37.4	54.1	37.5	50.0	41.7	28.5	74.8	37.6	48.9	69.4
MATN4		ENSG00000124159	"Matrilin 4"	O95460	20	45293445-45308529	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 21.5;pancreas: 27.1;seminal vesicle: 17.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 6.9;SK-MEL-30: 2.2;U-937: 3.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (1.54e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.38e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.53e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.63e-6)"	"unprognostic (2.38e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.27e-1)"	"unprognostic (5.38e-2)"	0.6	0.0	0.1	0.0	0.2	0.1	2.4	0.0	0.2	1.4	0.0	0.0	21.5	0.0	0.6	0.6	0.2	0.1	0.1	1.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.3	0.0	0.1	0.2	0.0	1.9	1.5	17.7	0.0	4.1	0.0	0.0	0.3	0.0	0.4	1.6	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.1	0.4	0.4	3.1	0.3	0.1	0.3	0.0	0.0	0.0	1.0	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.3	1.0	0.0	0.1	0.0	0.3	0.2	0.5	0.0	0.1	0.3	2.2	0.1	0.6	0.0	0.2	0.9	0.0	0.1	0.1	0.6	0.2	0.2	3.5	0.7	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MATR3	"KIAA0723, MGC9105, MPD2, VCPDM"	ENSG00000015479	"Matrin 3"	P43243	5	139293648-139331677	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	RNA-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB033552, HPA036564, HPA036565"	Supported		Approved	Nucleoplasm	"Intracellular and membrane"		140000	Nucleoplasm		"CAB033552: AB_2281755, HPA036564: AB_10669907, HPA036565: AB_10673623"	"unprognostic (9.33e-2)"	"unprognostic (6.57e-2)"	"unprognostic (8.37e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.56e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.86e-2)"	"unprognostic (7.90e-2)"	32.9	39.7	62.4	25.8	77.3	82.2	49.0	103.4	81.6	46.9	32.2	35.3	27.1	22.4	50.6	38.6	31.4	40.5	34.6	36.1	61.5	62.0	46.3	33.3	34.0	42.0	50.1	58.5	62.6	30.2	61.7	61.0	36.1	59.0	40.7	32.6	28.8	28.4	43.3	44.3	23.7	27.5	43.5	51.3	35.0	25.5	32.7	36.8	64.8	58.0	23.9	48.5	36.7	30.4	36.6	28.3	45.5	30.4	45.4	44.8	42.9	37.0	34.7	104.7	47.9	36.7	40.7	53.0	31.6	55.6	56.3	65.7	49.5	38.6	62.4	44.3	44.2	24.7	69.1	49.2	75.9	49.4	33.8	42.3	41.1	51.7	35.0	46.0	32.6	42.0	37.9	45.7	42.5	54.4	38.1	31.5	57.7	33.6	87.4	51.5	56.5	33.2	54.1	78.3	39.0	52.2	57.8	52.3	65.9	45.5	33.1	46.5	36.2	45.5	35.1	51.6	33.7	33.7	44.3	32.0	52.1	76.1	36.0	40.4	49.6	45.5	20.9	33.9	36.3	25.1	44.8	36.6	38.2	40.9	28.3	30.7	42.3	38.8	10.4	45.4	30.4	15.7	40.8	42.9	62.4	77.3	103.4	81.6	61.5	62.0	50.1	58.5	59.0	36.8
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 61.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.4"	"Not detected"	"Not detected"							"CAB000060, HPA003123"	Enhanced						190000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	3.6	0.1	0.2	0.1	0.2	0.0	1.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.0	19.6	0.4	0.0	366.6	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.3	0.1	0.0	5.0	0.3	0.0	13.0	0.0	871.2	0.3	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0.0	4.4	0.7	0.0	0.6	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	6.3	0.0	0.2	0.0	0.8	0.3	0.1	2.6	0.0	2.2	0.5	0.0	6.5	61.5	0.0	13.7	0.0	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0
MBL2	"COLEC1, MBL"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52771700	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	825	"liver: 82.5"	"Cell line enriched"	"Detected in single"	10	"Hep G2: 6.9"	"Cancer enriched"	"Detected in single"	275	"liver cancer: 22.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 0.5"	"Region enriched"	"Detected in single"	35	"basal ganglia: 1.1"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	1219000000	1700000000			"CAB016782: , HPA002027: AB_1079324"							"unprognostic (1.72e-2)"		"unprognostic (3.03e-1)"									0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MBP		ENSG00000197971	"Myelin basic protein"	P02686	18	76978827-77133683	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autoimmune encephalomyelitis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	43	"brain: 1297.7"	"Cell line enhanced"	"Detected in many"		"HL-60: 28.4;SK-MEL-30: 59.1"	"Group enriched"	"Detected in all"	9	"glioma: 47.5;melanoma: 20.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002300, HPA049222, HPA064368"	Enhanced	Supported	Approved	"Plasma membrane"				"Plasma membrane"		"CAB002300: AB_563893, HPA049222: , HPA064368: "	"unprognostic (9.36e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (9.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.48e-12)"	"unprognostic (2.90e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	4.0	3.4	271.6	6.1	244.9	10.1	4.5	28.7	418.9	5.6	5.5	487.7	0.0	5.9	4.4	3.6	6.4	9.0	5.7	6.8	355.0	247.6	6.2	5.9	6.2	7.1	645.5	43.4	3.7	6.8	16.4	0.7	2.7	242.9	4.5	5.6	0.4	5.0	4.9	29.9	7.9	6.2	3.8	1297.7	7.6	5.1	2.9	224.3	0.0	6.8	0.0	7.7	6.0	0.6	3.4	6.8	23.7	4.7	15.4	17.1	5.6	7.4	6.5	0.0	0.2	11.0	16.4	2.6	0.1	0.2	0.2	0.1	0.9	11.5	4.6	1.3	0.5	14.7	1.1	6.5	0.2	17.8	1.6	2.9	1.1	1.5	6.9	28.4	19.8	2.3	5.5	5.9	9.1	1.9	0.0	1.0	0.0	0.9	1.1	14.6	0.6	5.2	0.4	0.1	10.2	10.4	10.1	0.5	0.1	0.9	0.0	59.1	0.2	17.4	0.0	0.0	0.1	0.0	0.8	0.0	0.1	4.9	1.7	18.0	0.7	11.0	4.7	17.8	13.2	4.6	8.0	3.4	9.4	17.1	5.3	3.3	5.7	10.5	23.7	15.4	4.4	6.8	7.9	5.6	271.6	244.9	28.7	127.7	355.0	247.6	645.5	43.4	242.9	224.3
MCAM	"CD146, MUC18"	ENSG00000076706	"Melanoma cell adhesion molecule"	P43121	11	119308529-119321521	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HUVEC TERT2: 125.3;TIME: 122.3;WM-115: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002147, HPA008848"	Enhanced		Approved	"Plasma membrane"			2600000000	"Plasma membrane"		"CAB002147: AB_563499, HPA008848: AB_1078445"	"unprognostic (6.45e-2)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.42e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.39e-2)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (8.75e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.79e-3)"	88.2	8.9	6.4	18.5	10.3	0.4	86.1	17.7	13.4	22.3	33.2	13.3	11.7	8.3	40.1	32.5	27.6	29.3	50.9	32.0	7.1	8.2	7.5	3.8	23.8	13.0	7.4	8.1	23.6	6.2	54.5	3.9	47.4	11.1	22.9	9.7	25.0	9.4	44.9	21.1	10.5	15.6	67.1	6.5	9.6	25.0	18.4	5.4	2.2	13.1	15.7	4.8	55.0	24.3	0.8	0.0	0.3	0.0	0.0	2.2	0.0	0.0	0.5	0.5	0.0	2.5	0.0	2.6	0.3	0.0	3.3	1.5	1.9	0.1	0.1	10.7	1.1	0.3	4.3	0.9	1.7	6.0	1.5	0.1	12.0	2.1	5.9	0.0	0.0	1.7	0.0	4.6	2.1	125.3	4.0	0.1	0.6	0.0	0.1	1.0	2.2	0.4	0.1	16.7	3.5	3.0	0.0	1.4	0.4	9.6	0.2	27.5	0.4	0.1	122.3	0.3	17.9	0.0	9.6	0.2	0.2	0.0	4.9	0.0	97.3	0.0	0.0	0.0	0.0	0.0	2.2	0.8	0.6	1.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	6.4	10.3	17.7	13.4	7.1	8.2	7.4	8.1	11.1	5.4
MCCC1	MCCA	ENSG00000078070	"Methylcrotonoyl-CoA carboxylase 1"	Q96RQ3	3	183015218-183116075	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008310	Approved		Supported	Mitochondria	"Intracellular and membrane"			Mitochondria		"HPA008310: AB_1853620"	"unprognostic (4.01e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.59e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.57e-3)"	"unprognostic (9.82e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.65e-2)"	"prognostic favourable (3.68e-4)"	"unprognostic (4.73e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.36e-1)"	25.1	26.0	14.1	10.4	16.4	9.0	24.6	23.1	20.6	9.0	12.6	15.1	10.1	12.6	11.0	11.4	15.8	9.5	11.6	24.4	12.2	10.1	42.4	41.1	13.8	8.0	17.0	14.4	12.8	32.3	10.2	15.8	5.5	13.4	11.4	13.7	9.9	14.2	15.6	19.4	11.5	10.1	11.3	10.5	8.3	17.7	8.9	16.4	8.9	14.0	8.5	13.2	23.2	9.5	13.1	19.4	17.1	11.3	18.9	11.6	7.6	14.1	5.4	3.4	3.6	15.0	6.8	6.9	6.5	9.1	7.2	8.2	7.4	5.7	15.6	10.6	5.7	7.3	5.2	4.3	9.2	5.2	5.8	13.3	6.2	7.8	9.9	8.9	7.6	7.7	4.9	3.4	7.7	9.6	7.3	8.2	8.0	11.6	8.6	4.4	3.8	5.9	7.2	7.7	20.0	10.5	22.5	7.7	5.6	24.9	34.4	7.0	52.6	12.5	4.6	5.5	4.4	4.4	9.6	8.4	15.4	15.8	6.0	12.8	5.1	8.5	9.7	17.1	8.3	11.3	9.4	13.1	10.8	9.0	19.4	11.1	11.6	10.4	1.6	18.9	11.2	12.7	6.8	7.6	14.1	16.4	23.1	20.6	12.2	10.1	17.0	14.4	13.4	16.4
MCF2	"ARHGEF21, DBL"	ENSG00000101977	"MCF.2 cell line derived transforming sequence"	P10911	X	139581770-139708227	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 30.7;brain: 23.1;seminal vesicle: 18.8;testis: 18.2"	"Cell line enriched"	"Detected in some"	11	"U-251 MG: 28.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.42e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.11e-4)"	"unprognostic (8.95e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.33e-3)"	"unprognostic (3.68e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.62e-4)"	"unprognostic (4.02e-2)"	0.7	30.7	5.2	0.8	8.1	1.0	0.5	3.3	12.4	0.5	0.5	0.9	12.5	0.5	0.5	13.4	0.5	1.2	1.1	1.4	7.1	11.3	2.0	0.6	0.5	1.0	8.9	5.7	11.5	0.7	0.5	3.3	0.5	23.1	1.8	0.5	2.8	1.3	18.8	0.6	0.6	0.5	0.5	6.3	1.3	0.6	18.2	2.4	0.0	1.6	0.0	0.6	0.6	0.1	0.1	0.3	0.6	0.1	1.0	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.4	0.0	0.4	0.4	1.9	0.0	0.1	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	28.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.6	1.0	0.0	0.3	0.0	0.0	5.2	8.1	3.3	12.4	7.1	11.3	8.9	5.7	23.1	2.4
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2"	Q8NI22	2	46901870-46941855	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB022410, HPA034593"	Supported				"Intracellular and membrane"		950000			"CAB022410: , HPA034593: "	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavourable (4.64e-4)"	16.3	56.2	16.8	10.9	19.6	10.5	18.0	15.3	19.0	17.7	12.3	12.0	48.1	10.3	18.8	16.0	15.0	15.7	14.9	15.8	15.8	20.5	19.5	69.7	15.4	15.3	14.6	14.2	28.2	60.2	13.9	18.0	32.9	15.7	18.2	8.9	19.4	82.1	46.9	32.5	8.6	14.3	17.3	14.1	14.1	13.8	11.9	10.1	15.3	39.8	12.2	13.5	14.4	13.2	11.0	14.4	22.1	17.7	7.5	12.3	10.2	26.4	15.8	14.2	11.3	29.1	41.6	21.6	45.6	46.9	24.4	22.2	21.2	20.2	17.6	56.0	53.5	15.0	12.4	23.2	39.9	11.8	12.5	18.5	16.4	32.9	45.1	17.1	30.1	31.0	14.6	38.7	33.8	39.0	35.2	10.7	49.8	8.7	10.1	12.2	12.1	15.8	12.4	25.0	19.3	15.1	10.7	4.6	11.8	17.0	8.8	21.0	6.2	14.7	62.3	56.8	25.0	18.3	29.8	8.0	7.8	14.2	60.6	16.2	18.7	18.8	16.8	22.1	8.2	17.7	10.5	10.1	9.5	8.6	14.4	11.0	12.3	8.4	9.9	7.5	13.4	13.4	7.4	10.2	16.8	19.6	15.3	19.0	15.8	20.5	14.6	14.2	15.7	10.1
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 328.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria				Mitochondria		"CAB002781: , CAB068195: , HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavourable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	9.8	5.0	9.4	5.6	19.1	20.2	12.9	12.1	12.4	12.7	10.3	6.3	8.1	12.5	7.1	8.6	13.2	7.1	14.4	12.8	10.3	4.9	5.1	8.1	7.2	15.1	8.6	11.6	11.0	16.6	12.4	24.2	13.9	11.4	18.2	16.6	10.8	4.2	6.6	17.4	8.9	6.5	7.6	6.5	14.0	7.1	7.3	9.9	8.6	11.7	15.5	7.4	13.3	17.1	8.1	8.5	5.1	15.1	23.3	27.3	328.0	13.9	6.8	10.6	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm			8600	Nucleoplasm		"CAB000303: AB_322519, HPA031495: AB_2673904, HPA031496: "	"unprognostic (2.43e-1)"	"prognostic favourable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	24.8	21.2	23.2	20.3	1.4	3.0	22.7	13.1	8.4	26.3	28.7	35.1	16.5	26.8	12.8	6.4	20.0	41.5	15.0	16.4	22.1	25.9	44.3	28.4	25.5	0.9	41.4	19.4	1.6	1.7	17.8	2.7	8.2	22.1	24.6	9.6	33.0	38.3	30.4	34.0	18.7	43.1	33.3	38.4	5.4	19.3	28.9	21.9	33.5	10.0	3.4	21.4	32.5	4.2	20.5	17.5	25.2	17.6	25.5	28.9	66.6	14.2	31.4	7.8	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264009-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 82.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Enhanced	Nucleoplasm			29000	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (3.13e-5)"	"unprognostic (1.34e-2)"	17.3	10.9	8.5	29.7	10.5	22.3	15.3	10.7	9.7	15.9	17.2	9.5	20.2	9.0	21.2	13.0	21.7	15.5	15.8	15.4	7.4	6.6	16.1	12.6	13.7	30.1	8.9	5.8	20.0	13.8	16.0	7.4	24.7	10.0	15.9	19.2	12.7	12.6	23.4	12.1	15.0	17.8	17.7	9.5	23.2	15.3	16.1	10.5	82.5	12.9	20.1	35.7	19.1	15.3	21.1	12.9	11.4	13.3	22.2	29.4	18.6	30.2	20.1	35.1	33.1	7.6	6.9	23.1	22.5	17.3	38.4	39.5	41.2	16.5	33.1	22.6	13.1	24.1	46.3	27.5	38.9	37.2	43.8	62.5	40.5	58.0	2.0	61.3	25.6	4.1	6.4	28.2	7.9	19.6	50.8	76.3	19.8	20.0	61.7	47.4	29.1	14.2	54.8	53.8	44.2	17.0	32.2	35.7	27.3	23.6	13.6	20.4	26.8	43.5	10.0	26.3	28.3	27.1	33.6	22.6	25.8	58.9	22.6	53.2	30.7	11.1	8.0	11.4	22.9	13.3	19.7	21.1	23.3	23.0	12.9	19.2	22.6	24.0	1.1	22.2	7.4	8.3	29.4	18.6	8.5	10.5	10.7	9.7	7.4	6.6	8.9	5.8	10.0	10.5
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: "	"unprognostic (6.71e-2)"	"prognostic favourable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.78e-4)"	"prognostic unfavourable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	38.9	28.3	22.4	22.8	2.1	4.4	19.6	26.0	13.8	38.9	37.0	18.8	19.4	25.8	15.1	13.2	19.4	22.3	20.6	12.5	20.8	41.0	36.8	28.4	37.5	0.7	75.9	33.3	2.4	1.9	23.2	6.3	17.2	22.7	38.6	14.7	32.1	61.8	25.3	29.7	16.8	70.0	31.7	32.5	7.7	22.6	17.3	18.4	35.8	14.4	8.0	15.0	29.0	10.1	39.3	29.9	24.4	26.8	21.5	26.4	48.5	25.4	28.7	30.0	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavourable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.0	14.2	31.0	19.7	6.7	8.7	12.2	16.8	12.8	19.6	21.9	29.0	17.7	40.4	12.4	12.2	13.7	31.3	15.4	21.0	20.7	21.6	40.1	21.1	9.1	3.1	48.1	17.9	5.1	2.0	14.3	4.4	13.3	28.6	34.2	14.4	23.6	58.7	35.4	27.9	14.3	29.1	37.1	37.0	9.8	20.4	19.5	16.6	22.2	10.6	10.6	12.2	30.3	6.5	13.7	11.4	14.7	12.7	20.5	33.4	53.2	19.1	36.8	16.2	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favourable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.5	28.4	31.3	23.6	3.0	4.0	16.0	14.9	18.1	41.7	44.5	21.6	25.9	41.6	14.3	10.6	19.4	45.9	21.7	35.3	21.3	39.3	26.5	15.9	14.9	1.6	44.9	17.2	2.8	4.1	30.6	18.4	15.8	50.6	34.1	21.1	52.4	76.3	18.4	27.4	20.5	41.1	45.9	50.7	8.1	14.9	20.5	31.2	23.6	21.9	7.4	10.1	18.8	6.7	15.8	28.6	30.8	29.6	14.3	24.3	74.8	10.9	36.1	28.1	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3
MCM8	"C20orf154, dJ967N21.5, MGC119522, MGC119523, MGC12866, MGC4816, REC"	ENSG00000125885	"Minichromosome maintenance 8 homologous recombination repair factor"	Q9UJA3	20	5950652-5998977	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045141, HPA066433"			Supported	Nucleoplasm				Nucleoplasm		"HPA045141: , HPA066433: "	"unprognostic (6.55e-2)"	"unprognostic (2.46e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (5.78e-2)"	"prognostic unfavourable (9.30e-8)"	"unprognostic (5.21e-2)"	"unprognostic (5.14e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (6.74e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.47e-1)"	4.9	5.4	7.3	11.0	7.6	11.2	9.3	17.9	12.7	5.4	6.2	3.1	12.0	5.4	5.9	3.9	6.6	4.3	2.7	11.3	4.8	2.2	4.3	3.1	6.3	9.6	10.6	5.1	5.0	5.6	5.1	4.8	5.4	7.1	5.9	6.0	3.5	5.1	7.2	11.2	6.1	6.1	7.0	8.3	6.1	5.6	21.9	7.7	8.8	4.4	7.0	9.5	6.0	6.1	1.8	1.7	3.3	0.7	1.9	3.0	0.4	18.9	14.8	12.8	12.9	3.4	4.1	11.3	15.6	6.3	12.2	14.7	16.2	12.0	19.4	4.7	5.2	20.4	21.2	12.3	22.1	5.3	8.7	21.4	7.1	15.7	0.5	22.5	3.3	1.9	2.0	20.6	8.5	5.7	21.8	19.1	12.5	5.3	11.6	11.8	17.1	8.7	14.2	21.7	7.8	3.1	7.6	9.5	10.1	15.9	17.7	9.5	11.4	8.0	3.8	21.7	18.1	11.7	22.6	8.2	20.5	32.9	4.4	14.6	17.8	3.3	0.5	1.7	1.8	0.5	3.0	1.8	1.1	2.1	0.1	1.7	1.1	1.7	2.1	1.9	0.7	1.7	2.0	0.4	7.3	7.6	17.9	12.7	4.8	2.2	10.6	5.1	7.1	7.7
MCRS1	"ICP22BP, INO80Q, MCRS2, MSP58, P78"	ENSG00000187778	"Microspherule protein 1"	Q96EZ8	12	49556544-49568153	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039057	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA039057: AB_10794085"	"unprognostic (2.60e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.60e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (2.26e-2)"	"unprognostic (2.83e-3)"	"unprognostic (6.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.70e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.26e-2)"	16.3	20.3	20.2	19.5	23.3	24.4	16.0	20.1	41.7	19.8	21.0	28.3	16.5	19.1	21.7	20.6	22.5	23.2	22.7	47.6	20.0	15.5	25.0	21.5	17.3	19.7	19.0	24.7	17.8	25.3	23.8	16.6	25.7	21.6	19.7	19.4	24.1	26.8	21.0	32.3	19.9	29.0	20.4	21.8	22.2	20.6	33.2	23.1	30.2	29.9	30.2	22.7	19.4	17.6	22.8	38.6	38.6	39.0	41.0	34.8	31.7	15.4	23.0	23.9	22.6	12.9	14.9	27.3	15.0	14.8	35.2	19.6	38.6	27.5	26.9	29.4	26.7	18.4	38.2	34.4	15.7	21.5	34.6	28.1	17.0	13.0	24.3	31.9	29.8	18.6	25.6	26.2	21.5	27.7	34.1	18.6	20.8	22.1	21.0	18.0	35.7	17.8	26.9	20.2	31.5	25.1	11.4	24.5	24.3	16.1	19.9	12.9	33.3	32.4	20.3	18.4	22.1	16.5	20.7	18.6	18.4	26.3	24.3	17.1	11.6	38.6	29.9	34.7	33.0	39.0	25.3	22.7	28.6	34.8	38.6	22.8	25.5	27.1	15.4	41.0	29.2	26.5	28.7	31.7	20.2	23.3	20.1	41.7	20.0	15.5	19.0	24.7	21.6	23.1
MDH1		ENSG00000014641	"Malate dehydrogenase 1"	P40925	2	63588609-63607197	"Cancer-related genes, Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 155.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027296, CAB047333, HPA054276"	Uncertain		Supported	Centrosome,Cytosol			63000000	"Centrosome, Cytosol"		"CAB047333: , HPA027296: AB_10611118, HPA054276: "	"unprognostic (1.01e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.61e-2)"	"prognostic unfavourable (7.13e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.26e-1)"	"unprognostic (8.80e-2)"	"prognostic favourable (9.95e-4)"	"unprognostic (6.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.05e-1)"	32.0	28.6	28.0	10.5	58.1	9.2	18.4	38.0	69.5	12.4	21.4	12.5	9.0	19.3	13.4	22.6	16.7	14.7	11.5	155.8	33.6	37.5	47.6	33.2	11.2	14.7	33.4	40.1	10.9	8.9	26.0	18.3	11.4	65.9	16.1	24.9	13.8	15.4	19.9	91.1	11.1	17.1	21.5	18.6	9.4	22.4	8.6	12.2	14.1	15.6	47.1	20.2	15.6	10.2	61.7	57.1	50.7	61.5	46.7	74.5	67.8	44.0	36.1	48.8	31.9	69.4	51.4	50.6	34.7	51.3	52.9	53.7	42.7	39.1	55.5	20.6	45.4	38.8	54.9	64.3	75.9	33.6	42.4	52.1	33.8	67.8	38.1	59.9	41.3	50.9	43.9	49.5	29.3	40.3	28.8	40.4	69.5	26.5	52.4	60.5	28.6	45.0	41.9	57.5	54.4	87.5	41.8	45.3	27.0	29.1	46.9	66.5	34.2	62.5	23.4	40.6	39.8	33.7	43.6	50.4	44.2	67.9	50.1	54.2	33.5	50.7	45.8	45.8	52.7	61.5	55.0	61.7	61.3	57.6	57.1	56.4	60.5	57.5	7.0	46.7	55.7	43.3	74.5	67.8	28.0	58.1	38.0	69.5	33.6	37.5	33.4	40.1	65.9	12.2
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria			47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favourable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	28.6	47.0	17.0	42.6	19.5	21.4	29.3	19.3	24.9	27.6	25.0	41.3	34.5	43.4	8.7	25.4	29.3	43.7	28.8	19.8	30.9	63.2	24.1	25.3	38.1	24.0	37.4	24.9	27.0	25.7	26.8	40.1	25.7	75.8	25.4	25.5	64.9	32.4	66.1	37.9	59.3	26.5	21.0	62.4	25.8	37.9	42.7	38.9	19.3	96.8	39.7	55.0	42.3	19.8	27.8	26.3	30.0	38.3	28.5	23.5	48.0	24.1	48.0	42.1	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642499-89819723	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 26.6;NTERA-2: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"				"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	10.0	8.8	8.6	10.1	18.2	16.1	14.9	19.2	18.7	9.1	7.5	14.8	8.6	5.9	14.1	10.0	9.2	10.2	6.4	8.6	9.4	9.6	9.4	15.1	7.3	10.9	13.1	12.4	22.3	10.7	19.0	10.9	5.9	15.9	8.1	8.6	9.4	9.3	8.3	16.2	19.6	8.8	9.2	12.7	9.0	8.2	14.0	13.7	8.4	12.8	8.2	12.7	7.5	7.8	3.8	8.9	6.7	1.0	3.3	4.2	0.3	4.5	4.5	4.7	4.4	7.7	7.4	4.7	3.1	2.3	3.6	4.4	10.3	1.7	13.7	3.6	3.2	4.0	12.1	4.2	6.4	5.3	8.1	14.9	5.8	6.7	3.0	19.2	3.7	4.5	3.6	9.5	8.8	6.3	26.6	3.3	3.5	5.5	3.0	7.3	25.9	4.0	6.0	8.9	3.4	3.1	6.5	8.6	3.8	4.4	2.7	2.8	1.9	8.5	8.0	2.4	4.4	3.2	7.2	3.8	4.2	6.7	3.3	11.0	4.1	6.7	1.0	1.9	2.4	0.8	2.1	3.0	3.3	2.6	0.6	3.8	4.2	3.3	0.2	3.3	1.0	8.9	1.3	0.3	8.6	18.2	19.2	18.7	9.4	9.6	13.1	12.4	15.9	13.7
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210389-83431071	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 15.6"	"Lineage enriched"	"Detected in many"	11	"T-cells: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"			3800000	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavourable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	30.7	35.3	16.3	4.6	17.7	0.8	27.1	5.5	13.1	5.9	6.7	5.4	39.2	18.1	3.8	7.4	24.5	4.2	13.5	21.3	10.5	14.0	3.6	12.4	7.7	6.0	16.8	11.8	10.0	3.3	30.0	11.1	2.9	16.3	7.9	10.1	9.3	7.8	30.2	25.7	10.1	8.7	18.7	17.2	6.3	20.0	13.4	7.2	1.4	6.3	20.9	4.5	13.7	14.9	0.0	0.0	0.0	1.4	0.0	15.6	0.5	9.5	19.8	0.4	0.0	16.9	15.8	0.0	6.2	15.9	6.6	12.9	46.4	8.4	0.0	16.2	14.5	10.1	14.7	5.5	7.3	0.0	8.3	0.0	12.7	0.0	21.7	4.6	17.4	17.2	11.1	13.3	9.1	10.3	6.6	0.0	8.9	10.7	0.0	5.3	0.0	7.8	0.0	16.7	9.2	19.6	4.6	2.0	5.1	10.5	15.6	0.3	0.0	11.4	10.9	4.1	4.9	1.3	0.0	3.7	4.2	0.0	0.0	0.0	12.1	0.0	1.4	0.0	0.8	0.3	15.6	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	16.3	17.7	5.5	13.1	10.5	14.0	16.8	11.8	16.3	7.2
ME2		ENSG00000082212	"Malic enzyme 2"	P23368	18	50878734-50954257	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008247, HPA008880"	Enhanced		Supported	Mitochondria			3400000	Mitochondria		"HPA008247: AB_1853704, HPA008880: AB_1853702"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (9.57e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (8.29e-8)"	"unprognostic (1.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.43e-2)"	"unprognostic (4.27e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.09e-1)"	12.6	18.1	17.1	18.4	16.2	11.6	10.7	13.2	16.0	9.4	26.4	14.3	16.8	30.2	10.5	7.7	10.6	9.3	10.5	34.6	15.8	17.8	12.1	12.1	10.3	24.1	18.7	14.0	11.1	16.7	20.6	20.2	10.5	47.7	11.8	26.6	9.4	8.8	23.1	29.5	7.1	44.8	16.9	18.9	36.6	20.3	15.3	8.7	24.3	9.0	7.8	17.3	14.2	15.7	4.9	9.6	14.3	17.4	6.7	6.0	4.5	12.9	13.0	17.4	20.2	7.9	8.8	8.0	10.8	8.1	14.2	12.0	5.9	7.1	46.2	4.3	9.6	10.8	25.8	10.9	16.3	19.1	4.0	11.8	8.2	6.9	23.4	39.2	14.2	5.4	13.5	17.8	29.0	18.1	12.5	11.3	9.6	2.7	28.3	3.9	11.6	5.3	18.6	8.6	13.3	15.4	2.8	21.5	11.4	10.1	6.2	10.8	4.7	19.0	11.1	10.1	11.3	5.2	14.3	21.1	8.5	22.7	10.2	28.0	10.7	5.0	11.6	14.3	5.0	13.1	4.1	4.9	3.3	6.0	9.6	4.9	2.9	3.5	13.3	6.7	17.4	3.2	3.1	4.5	17.1	16.2	13.2	16.0	15.8	17.8	18.7	14.0	47.7	8.7
ME3		ENSG00000151376	"Malic enzyme 3"	Q16798	11	86441108-86672636	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.9;HUVEC TERT2: 17.9;TIME: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038473	Approved									"HPA038473: AB_10672747"	"unprognostic (1.83e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.96e-2)"	"prognostic favourable (3.86e-4)"	17.2	15.9	16.0	6.3	27.7	5.8	13.1	15.7	26.1	19.3	14.3	4.8	7.3	7.8	15.8	7.6	5.0	9.0	12.9	21.9	12.2	13.1	12.6	3.9	8.1	4.3	12.5	18.1	22.1	16.7	28.5	15.4	5.4	20.2	13.0	15.0	11.5	13.6	10.3	21.2	3.0	7.1	15.6	5.5	7.3	20.8	8.8	8.4	2.8	8.2	6.3	2.9	10.3	10.2	0.0	5.0	0.0	0.9	2.2	3.1	1.0	0.0	9.0	2.5	0.0	4.1	8.5	0.0	3.1	4.7	6.4	8.1	6.8	26.9	0.0	2.7	2.8	0.1	0.0	0.0	2.9	4.7	0.0	4.6	7.4	0.0	6.1	0.5	0.0	5.9	1.4	5.1	0.0	17.9	0.1	0.0	4.2	0.9	1.2	0.0	0.6	3.7	3.9	0.0	0.3	5.7	10.5	3.1	0.0	1.9	0.0	0.0	0.4	0.7	19.8	0.8	0.6	13.3	0.4	0.0	1.6	0.0	0.7	8.3	0.8	0.0	0.9	0.0	1.9	0.1	0.0	0.0	1.9	3.1	5.0	0.0	2.3	2.7	0.0	2.2	0.3	0.6	0.0	1.0	16.0	27.7	15.7	26.1	12.2	13.1	12.5	18.1	20.2	8.4
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 109.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA017921	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	16.8	17.4	26.6	13.9	23.4	11.8	17.4	13.1	29.9	16.2	14.3	17.2	14.0	12.7	20.1	25.2	16.8	20.5	17.2	12.5	20.9	25.4	16.5	18.7	15.2	14.2	21.9	20.8	22.7	26.7	13.2	17.7	17.3	17.5	20.9	17.0	19.6	16.6	20.3	14.6	15.2	13.1	19.5	15.7	12.8	13.0	109.4	8.7	19.1	15.8	13.4	21.2	21.5	14.1	61.2	40.9	70.6	51.0	46.6	51.7	59.9	46.1	26.7	40.0	31.6	36.6	24.5	16.0	30.9	32.9	38.7	42.5	39.7	12.1	24.2	32.5	37.7	23.5	30.8	42.1	36.4	27.6	41.8	44.8	29.2	42.7	18.9	32.6	23.6	19.5	21.0	51.3	33.5	23.2	30.2	27.1	42.3	88.4	43.6	37.8	18.8	23.6	21.5	23.8	24.0	26.7	43.8	38.7	27.1	23.8	20.5	35.2	31.2	35.8	17.2	42.7	34.4	27.6	53.3	30.9	25.6	40.4	21.4	24.5	34.6	64.5	39.2	70.6	46.7	44.5	42.9	61.2	42.9	45.6	40.9	56.8	43.2	45.8	35.9	46.6	51.0	40.0	51.7	59.9	26.6	23.4	13.1	29.9	20.9	25.4	21.9	20.8	17.5	8.7
MED1	"CRSP1, CRSP200, DRIP230, PBP, PPARBP, PPARGBP, RB18A, TRAP220, TRIP2"	ENSG00000125686	"Mediator complex subunit 1"	Q15648	17	39404285-39451286	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 85.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017696, HPA052818"	Approved		Supported	Nucleoplasm			170000	Nucleoplasm		"CAB017696: AB_1128703, HPA052818: "	"unprognostic (1.77e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.50e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.94e-2)"	"unprognostic (9.40e-2)"	"unprognostic (5.79e-2)"	16.4	13.8	11.8	14.8	13.7	15.5	15.1	19.8	16.5	16.9	14.6	18.8	9.3	10.3	17.9	9.7	15.0	14.3	10.9	12.8	11.6	10.5	13.0	13.3	12.3	17.7	12.0	10.3	22.2	16.2	34.5	21.1	16.5	14.5	12.5	14.2	16.5	13.4	11.6	19.5	16.1	14.1	17.1	14.0	20.4	13.0	15.1	12.1	34.1	13.2	12.1	22.5	16.6	13.4	6.6	4.9	4.4	4.0	5.0	6.1	2.7	8.0	10.7	13.5	9.2	9.9	10.1	10.9	9.8	10.6	13.5	13.2	10.3	8.0	21.5	11.2	12.2	15.9	16.1	9.7	21.5	20.7	13.5	13.5	10.2	10.2	10.7	24.1	14.3	9.5	9.8	16.6	24.2	11.4	17.3	11.7	10.9	4.5	22.4	9.1	8.7	6.4	16.9	18.2	9.2	7.9	9.3	8.6	9.8	13.0	85.6	11.2	15.8	13.8	10.1	10.5	13.1	11.6	17.2	10.7	14.3	22.2	10.3	11.9	12.8	3.2	4.0	4.4	5.2	3.9	5.8	6.6	5.5	5.8	4.0	6.4	5.4	6.1	3.3	5.0	2.6	4.9	3.3	2.7	11.8	13.7	19.8	16.5	11.6	10.5	12.0	10.3	14.5	12.1
MED24	"CRSP100, CRSP4, DRIP100, KIAA0130, MED5, THRAP4, TRAP100"	ENSG00000008838	"Mediator complex subunit 24"	O75448	17	40019097-40061215	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 61.8;SK-BR-3: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.93e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.10e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.97e-1)"	18.5	21.1	27.0	18.7	26.1	25.8	18.9	41.9	34.5	26.1	19.2	26.2	14.5	22.9	25.3	17.1	21.1	25.5	15.3	25.2	22.9	17.8	20.8	21.3	26.7	19.7	19.3	18.0	26.8	16.6	28.1	27.3	21.0	21.0	18.2	20.4	24.7	23.1	16.3	48.8	26.0	22.0	20.2	16.2	21.9	21.2	31.8	23.1	36.5	19.5	15.4	24.8	16.5	19.2	7.1	9.7	8.1	8.5	5.0	8.7	6.1	7.8	15.9	14.7	15.2	10.2	9.6	11.5	10.5	8.3	14.7	13.1	15.8	10.7	16.1	18.6	11.6	18.4	22.8	61.8	11.8	14.7	37.5	8.4	14.9	20.7	8.5	20.7	16.3	11.8	11.7	14.5	8.8	19.1	23.8	10.7	9.8	10.4	22.7	13.6	9.6	18.5	17.6	11.6	13.5	7.6	9.1	20.7	14.9	11.1	72.8	8.3	15.9	18.7	11.4	8.1	6.8	8.9	13.2	10.1	9.8	12.3	14.7	10.5	10.8	1.0	6.1	8.1	7.9	8.5	6.6	7.1	5.7	8.7	9.7	6.6	5.3	6.3	0.7	5.0	5.6	3.8	5.5	6.1	27.0	26.1	41.9	34.5	22.9	17.8	19.3	18.0	21.0	23.1
MED8	"ARC32, MGC17544, MGC19641"	ENSG00000159479	"Mediator complex subunit 8"	Q96G25	1	43383917-43389808	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028377, HPA028438"	Approved		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA028377: AB_10600112, HPA028438: AB_10600057"	"unprognostic (1.23e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.41e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (2.04e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (1.11e-7)"	"unprognostic (7.08e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.36e-1)"	22.7	21.9	19.0	18.3	22.0	22.0	22.9	30.0	25.8	20.4	21.1	21.9	19.0	21.7	18.4	24.8	33.4	15.0	16.1	15.9	18.5	19.0	22.1	34.6	19.4	18.3	21.0	17.2	19.2	25.6	17.7	34.5	26.8	20.3	19.3	24.5	19.2	25.0	21.1	16.5	27.3	21.2	23.5	21.3	20.9	22.5	18.5	20.6	14.2	27.0	19.3	25.9	24.9	20.6	27.0	34.6	32.5	35.0	18.4	25.5	22.1	21.8	13.8	13.0	15.5	20.1	20.2	17.1	22.0	20.3	26.6	28.1	26.2	16.1	13.3	15.8	27.6	14.0	20.4	18.7	25.8	18.4	20.0	21.8	24.0	32.8	34.2	19.2	23.2	19.7	24.8	28.1	34.5	21.2	19.3	22.7	17.1	14.1	10.0	15.8	12.4	16.0	11.8	15.0	20.4	17.7	14.3	13.6	10.3	13.1	21.5	43.3	14.5	38.7	15.7	11.6	21.1	22.8	31.2	27.1	31.2	15.5	24.7	24.0	15.4	25.3	35.0	32.5	22.0	31.3	20.9	27.0	20.2	24.8	34.6	21.1	20.7	21.5	28.0	18.4	27.3	16.0	25.5	22.1	19.0	22.0	30.0	25.8	18.5	19.0	21.0	17.2	20.3	20.6
MEGF8	"C19orf49, EGFL4, FLJ22365, SBP1"	ENSG00000105429	"Multiple EGF like domains 8"	Q7Z7M0	19	42325609-42378769	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049248	Approved						370000000			"HPA049248: "	"unprognostic (5.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.25e-2)"	"unprognostic (8.58e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.64e-2)"	"prognostic favourable (6.03e-4)"	"unprognostic (4.33e-2)"	"prognostic favourable (2.17e-7)"	"unprognostic (1.18e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-1)"	15.7	10.6	17.0	5.6	22.5	3.0	8.1	22.9	31.3	8.3	7.7	13.6	8.6	6.5	9.2	9.9	6.3	8.5	6.9	13.1	15.8	16.3	11.6	5.2	6.1	5.0	12.8	15.2	12.1	6.9	28.8	8.4	8.2	11.7	10.9	6.2	9.1	9.9	11.7	12.0	8.1	6.7	9.1	8.4	8.3	5.9	6.0	12.2	3.2	8.5	6.1	4.6	7.0	9.2	2.0	1.5	1.7	2.1	2.2	1.1	0.6	6.8	12.1	12.7	3.1	28.7	13.6	4.7	6.0	8.4	3.5	5.4	2.4	6.5	5.9	12.9	8.2	3.7	9.2	7.7	3.4	7.0	8.2	4.2	5.8	3.8	11.0	6.0	5.4	16.4	7.9	4.1	6.4	11.7	6.2	2.7	6.4	4.4	1.4	3.7	6.5	2.0	5.7	11.4	1.4	9.4	9.0	6.7	16.6	7.3	4.0	7.8	4.0	13.4	17.4	7.2	7.2	2.3	8.0	6.3	3.4	3.3	7.9	3.6	17.1	1.7	1.7	1.4	1.1	2.1	1.1	1.0	0.8	0.5	1.5	2.0	0.8	0.8	1.1	2.2	2.0	1.3	0.9	0.6	17.0	22.5	22.9	30.3	15.8	16.3	12.8	15.2	11.7	12.2
MEGF9	EGFL5	ENSG00000106780	"Multiple EGF like domains 9"	Q9H1U4	9	120600813-120714470	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 19.1;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014319, HPA050238"	Approved		Approved	Nucleoplasm,Cytosol			32000000	Nucleoplasm	Cytosol	"HPA014319: AB_1848035, HPA050238: "	"unprognostic (1.18e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.97e-2)"	"prognostic favourable (5.48e-11)"	"unprognostic (1.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.41e-1)"	15.0	9.6	22.4	9.9	21.7	15.4	12.8	27.9	26.2	11.7	6.7	29.3	2.1	6.4	6.1	5.5	12.8	12.8	7.9	6.1	24.6	16.4	12.5	33.8	17.9	7.0	28.6	16.0	9.3	5.4	15.6	6.8	4.8	22.6	8.4	5.8	21.4	7.8	6.6	6.0	19.0	6.5	8.1	21.1	12.9	7.2	3.1	25.8	3.2	25.5	4.6	5.6	11.3	9.6	0.3	2.2	19.1	5.7	0.3	0.6	1.3	2.8	11.3	9.9	3.0	13.8	8.5	3.2	2.9	2.5	0.8	1.1	0.6	1.7	10.6	4.5	2.8	12.4	14.2	5.1	2.1	8.6	4.1	1.4	21.1	4.6	5.9	4.2	9.1	4.0	15.5	4.9	3.9	6.9	3.3	5.1	8.2	8.2	8.3	1.5	0.4	3.0	6.4	11.0	4.5	20.3	9.3	9.8	8.3	3.5	2.8	8.3	8.6	4.3	8.1	3.0	1.7	10.9	4.4	9.3	10.9	3.5	4.2	5.0	16.9	0.4	5.7	3.6	0.6	1.9	0.2	0.3	0.6	0.5	2.2	0.3	0.5	0.4	19.1	0.3	3.0	0.2	0.5	1.3	22.4	21.7	27.9	21.5	24.6	16.4	28.6	16.0	22.6	25.8
MELK	KIAA0175	ENSG00000165304	"Maternal embryonic leucine zipper kinase"	Q14680	9	36572862-36677683	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"T-reg: 4.8"	"Lineage enriched"	"Detected in many"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA017214	Uncertain									"HPA017214: AB_1853798"	"unprognostic (5.03e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.42e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (2.91e-7)"	"prognostic unfavourable (3.99e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavourable (4.58e-4)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (8.86e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.35e-1)"	1.5	1.1	0.3	11.4	0.6	7.7	2.6	0.2	0.8	2.1	5.9	0.3	0.1	4.5	1.2	1.5	12.2	0.4	1.6	1.3	0.5	0.4	1.2	1.3	2.0	8.3	0.4	0.1	0.7	0.8	0.0	0.3	6.3	0.5	0.7	7.8	0.4	2.3	0.1	0.9	2.8	4.6	1.9	1.0	5.2	2.9	11.3	0.4	42.4	0.5	7.2	12.6	1.5	3.3	0.1	0.6	1.0	0.1	0.4	4.8	0.5	35.4	18.2	24.6	14.5	3.4	5.9	14.3	26.3	18.6	36.9	45.6	14.0	14.0	11.9	8.5	12.9	12.2	21.4	16.5	40.8	32.3	8.5	9.3	21.7	13.9	1.3	14.4	11.8	2.1	3.0	28.5	16.2	18.6	11.9	19.0	30.2	11.8	17.9	6.8	19.6	14.3	16.6	16.6	7.6	11.3	12.0	16.7	12.4	14.0	13.5	8.5	11.3	6.9	9.1	19.9	25.2	16.8	23.9	3.7	13.5	17.8	12.6	10.7	27.0	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.8	1.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	0.6	4.8	0.5	0.3	0.6	0.2	0.8	0.5	0.4	0.4	0.1	0.5	0.4
MELTF	"CD228, FLJ38863, MAP97, MFI2, MGC4856, MTf, MTF1"	ENSG00000163975	Melanotransferrin	P08582	3	196988621-197029816	"CD markers, Plasma proteins, Predicted intracellular proteins"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"salivary gland: 65.7"	"Cell line enhanced"	"Detected in many"		"A-431: 46.1;SK-MEL-30: 57.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 32.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 3.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.9;monocytes: 2.1;T-cells: 3.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA004880	Approved				"Intracellular and membrane"		230000000			"HPA004880: AB_1853844"	"unprognostic (8.68e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.68e-3)"	"unprognostic (8.14e-2)"	"prognostic unfavourable (6.99e-11)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.09e-2)"	6.0	1.6	1.9	3.5	2.0	1.8	7.5	2.7	2.8	4.4	5.1	3.3	3.5	2.1	4.9	4.8	2.4	6.4	2.5	3.3	1.8	1.1	5.1	1.4	1.6	1.7	1.0	1.0	1.3	4.3	15.9	1.8	4.4	2.9	3.7	1.9	2.9	65.7	4.7	1.4	10.5	8.7	3.1	1.1	1.0	1.1	2.6	0.9	3.6	2.0	1.3	2.4	2.0	5.4	0.2	1.9	0.2	2.1	0.5	3.3	0.6	46.1	10.1	0.1	0.3	1.4	1.9	1.2	0.8	0.4	1.5	1.9	2.8	6.9	1.3	10.0	1.6	14.4	0.5	0.0	0.7	2.1	3.2	1.6	2.2	1.2	9.4	0.2	9.2	10.1	1.2	1.3	0.1	0.2	1.2	9.1	0.9	2.8	2.6	0.0	1.0	6.6	3.8	1.6	0.5	0.2	0.4	0.9	3.4	9.5	0.8	57.0	2.8	1.4	0.3	0.3	8.1	1.6	5.7	1.5	12.8	1.2	1.1	2.7	0.0	0.1	0.3	0.0	1.2	1.0	3.3	0.2	1.0	1.0	1.9	0.2	0.3	0.1	0.2	0.5	2.1	0.0	0.1	0.6	1.9	2.0	2.7	2.8	1.8	1.1	1.0	1.0	2.9	0.9
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 6.9;Hep G2: 1.8;NB-4: 3.0;RPMI-8226: 3.4;SH-SY5Y: 2.1;U-2197: 2.0"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced						990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
MERTK	"c-Eyk, mer, RP38, Tyro12"	ENSG00000153208	"MER proto-oncogene, tyrosine kinase"	Q12866	2	111898479-112029561	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Disease mutation, Proto-oncogene, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 20.8;Hep G2: 21.6;HUVEC TERT2: 21.5;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"intermediate monocyte: 10.3;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036196, HPA075622"	Approved		Approved	"Endoplasmic reticulum,Plasma membrane,Midbody,Cytosol"			29000000	"Plasma membrane"	"Endoplasmic reticulum, Midbody, Cytosol"	"HPA036196: AB_10670676, HPA075622: "	"unprognostic (2.17e-2)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.74e-4)"	"unprognostic (6.84e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.72e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (5.13e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.05e-2)"	20.1	55.1	13.1	12.5	17.8	1.9	31.8	6.2	13.8	10.8	13.8	6.8	27.7	11.5	11.3	25.4	8.4	12.8	11.7	7.1	16.5	6.3	14.2	18.9	12.7	30.3	8.1	10.1	12.9	9.0	23.9	14.3	18.4	18.6	14.1	7.9	20.4	6.8	24.9	6.4	6.4	12.8	13.6	12.2	38.4	12.3	17.3	9.8	1.7	9.9	2.0	8.4	14.1	26.6	0.0	0.2	0.1	10.3	0.0	0.0	0.3	0.5	0.9	4.3	9.7	0.2	0.1	6.9	0.0	0.1	0.5	1.0	20.8	1.3	0.1	4.6	0.0	0.1	5.7	0.0	0.8	0.8	3.0	3.7	0.0	21.6	0.1	0.1	0.8	0.2	0.0	5.0	0.3	21.5	1.1	2.0	1.6	0.9	0.0	4.9	2.7	3.4	1.4	1.2	1.6	10.9	12.9	0.1	4.1	0.1	0.3	1.7	0.0	0.2	3.2	0.6	2.0	0.0	0.0	1.7	2.5	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.4	0.1	0.0	0.3	13.1	17.8	6.2	13.8	16.5	6.3	8.1	10.1	18.6	9.8
MET	"DFNB97, HGFR, RCCP2"	ENSG00000105976	"MET proto-oncogene, receptor tyrosine kinase"	P08581	7	116672390-116798386	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 45.4;CAPAN-2: 49.6;EFO-21: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1"	"Low region specificity"	"Detected in many"			"CAB005282, CAB018577, HPA055607"	Approved		Supported	"Plasma membrane,Cytosol"	"Secreted to blood"	178550000	70000000	"Plasma membrane, Cytosol"		"CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: "	"unprognostic (1.60e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (6.75e-4)"	"unprognostic (1.68e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.53e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.20e-1)"	16.2	1.1	1.8	4.5	2.3	4.3	11.2	0.9	15.2	9.9	6.5	2.4	2.4	4.4	7.5	5.2	5.1	4.6	12.3	5.4	5.7	1.8	20.1	30.2	15.6	1.4	3.6	2.1	2.0	9.3	0.7	8.1	24.4	2.6	8.0	6.6	34.1	12.2	8.4	12.8	7.2	8.6	4.0	2.3	5.7	10.6	2.7	2.4	0.5	21.4	7.0	2.1	10.1	15.0	0.2	0.3	1.2	0.2	0.3	0.4	0.0	45.4	26.1	0.0	0.1	2.0	2.0	1.8	26.0	10.6	14.0	11.8	5.4	49.6	2.0	43.3	16.3	12.0	4.5	24.7	28.7	0.1	5.6	0.0	27.1	4.7	0.3	0.0	0.0	2.6	9.8	9.1	30.1	9.6	0.9	0.2	25.9	1.0	0.0	0.0	3.9	26.7	0.0	22.0	0.0	24.6	5.2	3.8	0.0	10.7	3.4	10.1	0.0	0.2	17.7	20.9	7.4	11.0	20.1	0.5	4.0	0.2	23.0	0.0	2.9	1.1	0.2	0.4	0.4	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	1.2	0.3	0.1	0.3	0.1	0.0	1.8	2.3	0.9	15.2	5.7	1.8	3.6	2.1	2.6	2.4
METAP1	"KIAA0094, MAP1A, MetAP1A"	ENSG00000164024	"Methionyl aminopeptidase 1"	P53582	4	98995620-99062813	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025485, HPA037997, HPA037998"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			11000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB025485: , HPA037997: , HPA037998: "	"unprognostic (1.79e-1)"	"unprognostic (3.39e-1)"	"prognostic favourable (7.22e-4)"	"unprognostic (1.58e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (3.08e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.28e-5)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.72e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.15e-3)"	"prognostic favourable (9.31e-4)"	12.1	8.3	10.0	16.0	10.1	11.8	18.6	9.2	13.8	16.0	17.9	7.0	22.9	13.4	24.1	25.9	37.2	14.0	12.3	27.9	9.5	7.1	14.3	13.7	10.7	12.6	7.9	9.8	11.3	13.0	7.8	14.4	9.2	9.9	19.1	19.3	7.5	19.0	21.5	27.2	16.4	15.2	27.8	10.1	13.9	11.6	46.8	8.1	27.0	10.8	21.8	19.1	36.6	22.6	12.7	11.7	10.4	11.1	12.5	19.2	10.8	21.7	21.5	18.9	20.2	15.0	24.1	21.0	31.2	20.1	26.7	25.5	24.1	32.5	32.2	12.5	25.2	21.9	33.1	31.2	37.1	22.5	15.8	28.8	15.7	25.8	16.3	38.9	24.1	17.3	22.7	22.6	24.1	21.9	22.5	19.5	28.5	16.5	34.0	18.6	23.2	17.5	22.4	29.5	17.2	42.8	28.2	25.9	15.3	10.4	32.3	12.3	12.4	14.9	17.8	21.6	27.5	19.7	27.1	14.1	19.9	25.5	18.6	19.9	21.4	10.4	9.4	4.2	14.9	11.1	19.2	12.7	15.4	14.5	11.7	10.1	15.1	13.5	2.3	12.5	10.7	5.8	13.4	10.8	10.0	10.1	9.2	13.8	9.5	7.1	7.9	9.8	9.9	8.1
METAP2	"MAP2, MNPEP, p67"	ENSG00000111142	"Methionyl aminopeptidase 2"	P50579	12	95473520-95515839	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013025, HPA019095"	Enhanced		Supported	"Plasma membrane,Cytosol"			22000	"Plasma membrane, Cytosol"		"CAB013025: AB_2533993, HPA019095: AB_1853823"	"unprognostic (1.91e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (4.51e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.03e-1)"	24.2	36.4	25.8	49.9	33.7	39.1	25.1	25.9	32.3	23.9	26.2	16.3	102.5	16.6	28.7	25.4	30.1	22.5	21.7	30.7	29.6	24.0	26.0	46.8	22.1	32.6	29.1	23.4	29.4	31.9	21.0	36.1	25.1	42.9	24.2	24.0	10.1	22.1	140.7	94.4	28.7	19.7	26.1	48.2	25.2	22.2	26.3	27.7	32.1	24.1	29.0	55.2	33.4	37.3	39.4	31.8	21.3	27.1	25.7	32.0	16.2	33.2	28.1	30.1	23.3	18.3	29.4	23.1	32.8	23.0	32.4	23.0	40.8	16.0	97.0	20.7	23.4	21.5	33.8	25.1	37.3	23.0	29.1	43.4	21.4	28.7	19.6	53.7	21.3	25.4	26.9	30.6	30.1	34.4	56.1	11.0	24.0	21.9	39.7	36.7	36.8	42.0	31.3	26.0	31.8	22.2	35.4	23.4	30.7	29.2	23.9	28.7	28.8	25.6	29.5	18.6	18.1	20.8	34.6	15.9	41.4	104.0	10.6	30.3	23.4	21.3	27.1	11.1	23.8	19.1	29.2	39.4	26.7	26.6	24.4	37.6	32.0	29.7	1.2	25.7	22.3	31.8	25.3	16.2	25.8	33.7	25.9	32.3	29.6	24.0	29.1	23.4	42.9	27.7
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"RH-30: 77.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA020914: AB_1853830, HPA050450: "	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	12.2	16.6	6.7	13.8	8.8	8.4	12.3	2.2	6.9	7.6	7.6	4.5	10.8	3.3	9.4	21.2	10.3	9.0	10.7	8.1	5.8	5.0	20.9	15.3	7.7	8.8	7.4	4.6	17.6	34.9	10.9	10.6	8.3	6.5	11.0	10.3	5.3	17.9	17.2	20.4	8.5	5.7	10.5	5.0	8.2	7.3	11.4	5.4	4.5	15.1	15.6	9.8	8.8	7.8	6.1	12.6	0.7	6.7	7.3	18.6	5.1	5.9	11.0	4.6	4.2	6.2	4.3	6.3	6.5	5.8	10.9	5.9	7.6	8.4	7.2	12.0	7.8	7.2	7.1	10.0	10.6	4.3	8.2	8.4	4.2	9.3	4.4	9.1	4.4	3.8	9.1	12.2	8.5	5.7	7.7	7.3	5.5	11.7	6.3	10.9	10.8	11.0	5.6	77.0	10.7	9.5	7.5	4.9	4.4	6.7	7.5	6.0	9.8	8.6	4.3	4.4	4.9	7.7	8.5	3.4	2.5	8.8	6.2	6.5	9.1	0.0	4.7	0.0	5.3	6.7	18.6	4.7	6.9	6.5	10.3	6.1	9.5	9.2	0.7	7.3	1.1	12.6	3.3	5.1	6.7	8.8	2.2	6.9	5.8	5.0	7.4	4.6	6.5	5.4
METTL2A	"FLJ12760, METTL2"	ENSG00000087995	"Methyltransferase like 2A"	Q96IZ6	17	62423867-62450822	"Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (2.31e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.51e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.33e-3)"	"unprognostic (6.86e-2)"	"unprognostic (9.77e-2)"	"unprognostic (2.00e-1)"	3.2	4.9	4.5	2.5	4.6	1.5	3.9	4.1	5.6	2.7	4.0			2.7	3.2	2.6	3.9	3.7	2.2	4.2	3.9	4.4	3.5	3.9	2.9	3.0	4.0		3.8	4.8	2.9	1.9	3.0		3.0	3.6		3.4	1.8	7.4	4.9	2.6	2.7	3.7	2.7	3.3	2.3			4.8		3.0	2.6	2.2	6.0	5.3	4.4	3.9	7.5	7.4	3.3	6.4	5.6	7.7	12.1	4.9	6.6	7.6	6.7	4.2	7.8	6.3	4.7	6.4	6.4	4.0	4.8	7.9	14.6	7.9	8.8	6.0	11.9	12.7	4.6	3.8	8.9	12.9	5.5	5.0	7.4	6.6	9.9	6.0	12.6	6.6	5.8	8.7	14.5	5.5	9.9	8.8	9.9	21.4	5.9	5.8	5.5	8.0	14.6	3.2	7.1	8.7	15.9	8.9	6.3	7.7	9.6	6.0	10.5	8.4	9.4	8.1	11.1	6.9	8.0	2.6	3.4	3.9	7.4	3.8	6.5	6.0	5.6	5.6	2.8	6.0	4.8	6.9	4.4	7.5	3.9	5.3	5.1	3.3										
METTL3	"M6A, MT-A70, Spo8"	ENSG00000165819	"Methyltransferase like 3"	Q86U44	14	21498133-21511375	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, Immunity, Innate immunity, Spermatogenesis"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.62e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.19e-5)"	"unprognostic (1.02e-3)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.78e-4)"	"prognostic favourable (2.72e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.98e-2)"	"unprognostic (7.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.22e-1)"	13.1	21.0	15.7	18.3	20.4	6.8	17.4	27.1	16.4	13.5	12.8	16.3	20.4	7.7	17.1	19.8	14.3	20.9	11.2	17.3	16.3	8.6	14.6	14.0	14.2	18.4	21.7	15.2	18.2	14.2	25.8	21.3	16.0	16.3	19.3	13.9	12.2	17.0	19.3	18.8	17.0	11.9	17.6	13.8	17.5	12.9	21.6	20.6	15.4	19.2	13.3	21.8	15.1	14.8	13.0	12.6	7.7	10.3	15.3	14.3	8.1	16.8	25.2	24.0	9.6	18.6	15.4	12.1	15.5	11.4	18.6	21.9	9.5	20.0	17.6	10.0	9.6	17.9	29.3	15.3	29.5	16.6	17.4	10.9	13.9	37.6	7.6	14.7	12.4	11.5	13.5	11.5	13.6	24.2	13.4	10.1	24.6	12.4	13.0	11.7	20.4	31.1	13.1	19.0	15.6	17.0	11.3	14.9	16.1	16.9	22.3	15.8	17.6	9.7	15.8	6.6	11.1	12.1	10.5	10.7	13.3	12.2	8.1	11.8	14.0	5.1	8.1	7.7	8.7	10.3	12.7	13.0	10.5	9.6	10.5	10.3	11.0	9.7	0.9	15.3	8.4	12.6	14.3	8.1	15.7	20.4	27.1	16.4	16.3	8.6	21.7	15.2	16.3	20.6
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387240	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 58.9;ASC TERT1: 90.0;fHDF/TERT166: 40.2;HHSteC: 41.2;HSkMC: 62.3;MOLT-4: 51.5;SH-SY5Y: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 2.3;intermediate monocyte: 4.0;non-classical monocyte: 4.2"	"Group enriched"	"Detected in many"	15	"granulocytes: 2.3;monocytes: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		140000000	"Endoplasmic reticulum"		"HPA054097: "	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favourable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (7.12e-4)"	41.5	10.0	1.3	37.3	4.1	0.0	34.9	1.3	3.7	62.5	44.8	5.1	18.1	12.1	64.3	58.7	64.2	32.2	150.2	46.9	1.8	1.3	15.9	12.0	106.1	10.7	2.4	5.8	57.6	8.5	0.0	15.8	43.3	6.8	102.4	17.2	102.5	16.3	16.6	18.7	25.9	43.8	88.9	3.2	7.6	31.4	26.2	1.3	8.4	20.3	55.3	39.0	79.2	73.7	0.0	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	58.9	90.0	0.1	6.4	23.0	0.6	0.4	0.0	0.0	0.0	0.0	40.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	41.2	1.9	0.0	62.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	51.5	4.7	1.0	0.0	3.6	3.6	0.0	0.0	0.0	5.2	51.3	0.0	0.0	0.0	0.0	11.6	0.0	7.5	0.5	0.3	0.0	0.0	0.0	0.0	7.2	2.1	0.0	0.0	0.3	2.3	0.0	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	1.3	4.1	1.3	3.7	1.8	1.3	2.4	5.8	6.8	1.3
MFAP5	"MAGP2, MP25"	ENSG00000197614	"Microfibril associated protein 5"	Q13361	12	8637346-8662888	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 128.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 52.2;BJ: 18.9;EFO-21: 45.8;HeLa: 17.3;LHCN-M2: 15.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010553	Enhanced				"Secreted to extracellular matrix"		3800000			"HPA010553: AB_1853843"	"unprognostic (1.80e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.79e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.05e-1)"	"unprognostic (4.41e-7)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (5.81e-4)"	44.3	3.2	0.6	3.3	0.7	0.3	21.8	0.5	0.5	71.5	11.2	0.5	18.2	1.4	78.4	34.0	31.3	9.0	6.8	16.5	0.7	0.6	1.9	3.0	3.3	3.3	0.6	0.4	4.7	1.4	0.2	1.7	128.1	0.7	7.6	11.0	0.9	6.0	13.5	19.6	13.0	9.0	37.0	3.4	1.0	7.9	12.3	0.3	1.0	13.1	35.0	4.5	46.3	21.1	1.1	1.2	5.3	2.4	0.6	1.2	0.8	0.4	1.6	0.4	0.8	9.0	3.8	52.2	18.9	0.3	0.2	0.3	0.6	0.3	0.1	45.8	5.8	2.7	0.1	3.9	0.0	0.1	0.1	0.4	17.3	0.5	0.1	0.3	0.2	2.6	1.3	2.2	0.0	0.0	0.7	1.1	15.8	0.2	0.5	0.2	0.9	0.8	0.3	0.4	1.8	1.9	0.7	0.2	0.2	0.5	0.2	0.3	7.2	0.2	0.6	3.3	6.6	13.8	0.8	0.6	0.5	0.6	1.8	0.2	0.0	5.3	2.4	2.0	0.7	1.9	1.2	0.4	0.4	0.4	1.2	1.1	1.2	0.5	3.1	0.6	1.4	1.0	0.1	0.8	0.6	0.7	0.5	0.5	0.7	0.6	0.6	0.4	0.7	0.3
MFNG		ENSG00000100060	"MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	O00587	22	37469063-37486401	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 72.7;lymphoid tissue: 42.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 32.2;HL-60: 40.5;HMC-1: 53.7;HUVEC TERT2: 43.3;U-698: 31.1;U-937: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048936, HPA056479"	Approved		Approved	Vesicles	"Intracellular and membrane"		28000	Vesicles		"HPA048936: , HPA056479: "	"unprognostic (1.21e-1)"	"unprognostic (4.17e-3)"	"prognostic unfavourable (5.12e-4)"	"prognostic favourable (1.65e-4)"	"unprognostic (6.41e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (2.67e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	10.0	4.5	2.6	16.6	5.1	14.4	13.4	1.0	3.3	6.0	6.5	3.0	2.0	3.7	6.5	3.5	4.4	7.1	6.3	6.7	2.8	2.6	6.1	5.6	14.9	42.1	5.6	1.2	3.6	3.7	0.8	2.2	14.0	8.3	5.6	3.7	4.4	5.7	2.5	3.4	3.0	14.1	5.1	4.4	37.6	4.1	2.6	3.6	33.9	6.3	4.5	19.3	8.8	4.2	24.1	40.5	72.7	40.8	40.9	53.3	53.2	1.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.6	32.2	0.1	0.0	2.3	9.4	1.8	0.0	12.7	0.2	24.8	0.1	0.3	0.1	40.5	53.7	0.0	0.5	0.3	0.7	43.3	0.1	15.3	0.0	0.1	4.6	0.5	0.1	0.1	11.9	0.4	24.2	0.1	0.0	19.4	0.1	0.1	0.0	0.0	0.2	2.8	24.1	0.0	1.2	4.8	0.1	0.0	0.1	31.1	0.2	36.4	0.5	36.8	40.1	72.7	41.3	38.8	45.1	21.8	48.0	43.3	40.5	24.1	52.9	45.5	25.5	40.9	40.8	10.1	53.3	53.2	2.6	5.1	1.0	3.3	2.8	2.6	5.6	1.2	8.3	3.6
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell line enhanced"	"Detected in some"		"A549: 3.6;BJ hTERT+: 3.2;HL-60: 5.3;U-937: 8.5;WM-115: 2.0"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced						68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.0	0.4	0.1	3.2	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.5	2.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1
MGAT1	"GLCNAC-TI, GLYT1, GNT-1, GnTI, MGAT"	ENSG00000131446	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase"	P26572	5	180784782-180815652	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017432	Approved						7200000			"HPA017432: AB_1853851"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.91e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.44e-2)"	"prognostic unfavourable (8.65e-4)"	"unprognostic (4.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.00e-2)"	67.7	20.9	14.9	30.8	20.1	25.5	53.3	15.6	19.3	22.3	29.0	14.6	22.4	24.8	26.1	26.8	31.2	26.4	19.8	26.4	16.1	10.6	20.8	55.6	42.7	50.5	25.6	10.3	27.2	37.1	8.5	20.8	84.9	17.7	26.6	15.3	24.1	28.4	21.8	18.5	22.9	35.1	20.7	31.1	45.7	24.5	19.2	21.9	27.0	32.1	16.9	29.8	38.2	39.1	13.2	40.8	37.7	54.9	16.5	24.9	47.2	14.1	14.2	7.8	16.7	41.5	18.9	27.4	33.8	41.6	21.2	26.5	20.3	11.7	12.1	19.0	32.6	17.0	4.2	50.4	12.6	65.1	11.7	10.6	8.2	15.7	20.2	9.7	34.9	21.9	24.2	17.1	17.1	18.3	6.1	21.8	18.9	20.1	9.1	13.9	7.6	18.4	11.1	11.5	15.9	8.1	16.9	6.7	8.1	14.1	14.6	27.9	11.2	17.4	19.6	25.9	11.6	11.0	15.2	41.3	34.1	10.6	21.1	19.7	13.0	19.5	54.9	25.3	22.4	45.9	24.9	13.2	16.4	18.7	40.8	12.1	14.4	16.0	37.7	16.5	35.1	38.9	18.8	47.2	14.9	20.1	15.6	19.3	16.1	10.6	25.6	10.3	17.7	21.9
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"		750000	Vesicles		"HPA055922: , HPA056816: "	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.8	9.0	14.0	21.3	44.5	22.4	23.5	17.0	25.5	18.9	22.5	9.3	12.3	9.7	16.3	19.3	20.3	14.9	15.7	19.4	16.8	9.3	13.4	9.3	14.5	40.8	23.0	16.3	20.5	15.1	18.0	31.9	19.7	17.2	23.9	14.2	7.1	17.9	14.9	15.5	12.9	12.2	38.0	23.5	9.7	11.8	15.2	16.0	17.5	15.9	14.2	17.0	15.1	14.3	12.8	9.8	21.6	18.1	27.3	17.3	12.2	16.0	11.1	16.8	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6
MICALL1	"KIAA1668, MICAL-L1, MIRAB13"	ENSG00000100139	"MICAL like 1"	Q8N3F8	22	37905657-37942822	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043480, HPA051956"	Uncertain		Supported	"Cell Junctions,Centriolar satellite,Cytosol"				"Cell Junctions, Centriolar satellite, Cytosol"		"HPA043480: AB_10793950, HPA051956: "	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.94e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (3.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.61e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.92e-2)"	8.0	4.8	5.3	10.1	10.3	6.3	12.6	5.9	7.3	19.1	25.2	21.4	17.6	6.1	21.3	11.0	32.3	11.1	14.4	6.0	7.5	5.5	6.4	5.7	11.8	9.2	17.4	5.1	6.8	14.2	19.2	4.3	29.6	12.5	15.3	7.5	8.7	13.4	25.2	8.5	24.4	9.2	43.5	18.7	5.9	28.5	7.4	11.1	5.3	9.4	15.5	13.5	21.4	17.5	2.8	3.3	2.3	1.6	4.1	2.6	1.6	10.7	6.0	6.5	7.0	6.5	5.6	26.0	15.3	8.7	15.0	11.3	8.2	5.8	4.7	4.7	10.1	28.0	5.0	29.9	10.9	8.0	13.2	1.9	6.3	8.0	10.7	5.3	5.4	4.7	46.8	17.9	37.2	10.3	3.3	4.5	13.1	5.1	1.3	2.4	2.3	4.5	7.1	12.4	2.5	3.9	29.9	4.5	8.0	9.5	8.4	8.1	5.0	5.1	14.2	25.2	20.8	16.7	12.4	4.6	1.5	3.0	22.8	2.4	12.2	0.4	1.1	0.6	1.8	1.6	2.3	2.5	1.4	2.2	1.7	2.8	2.6	1.3	2.3	4.1	0.6	3.3	0.9	1.6	5.3	10.3	5.9	7.3	7.5	5.5	17.4	5.1	12.5	11.1
MIF	"GIF, GLIF"	ENSG00000240972	"Macrophage migration inhibitory factor"	P14174	22	23894004-23895227	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Isomerase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 127.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003868, CAB005284"	Approved		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	13800000	14000000	Cytosol	Nucleoplasm	"CAB005284: AB_648587, HPA003868: AB_1079290"	"unprognostic (1.68e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.17e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	30.6	49.8	43.9	42.0	39.9	46.0	71.6	19.0	66.1	23.0	42.7	10.4	55.6	39.9	22.5	113.3	51.9	23.3	42.5	60.7	42.8	40.3	71.8	58.8	46.2	113.9	33.5	43.7	24.5	80.2	16.2	41.1	30.5	45.2	54.8	11.6	15.0	57.3	101.2	36.0	63.3	50.6	26.7	78.3	42.5	56.2	24.9	19.2	19.0	28.9	43.7	16.7	21.4	44.6	56.8	42.5	17.6	23.8	38.3	52.7	66.0	48.9	10.9	2.4	11.0	0.9	2.2	18.4	18.5	3.1	5.9	7.7	8.1	8.1	23.3	14.7	1.3	21.8	2.5	11.2	0.7	19.6	127.1	8.8	9.9	16.9	4.8	34.0	20.7	4.7	6.7	3.5	1.7	4.7	13.6	11.8	2.0	24.6	23.1	63.0	14.0	59.3	29.7	4.1	65.3	4.6	3.4	31.9	37.2	11.8	12.5	30.5	16.1	10.2	13.5	5.2	35.0	3.1	0.4	51.4	18.1	24.0	21.1	12.7	10.6	16.3	23.8	17.6	37.4	22.3	52.7	56.8	51.8	40.4	31.6	49.1	46.1	38.0	7.1	38.3	14.6	42.5	48.3	66.0	43.9	39.9	19.0	66.1	42.8	40.3	33.5	43.7	45.2	19.2
MINPP1	MIPP	ENSG00000107789	"Multiple inositol-polyphosphate phosphatase 1"	Q9UNW1	10	87504875-87553460	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026859	Approved				"Intracellular and membrane"		320000000			"HPA026859: AB_1853961"	"unprognostic (9.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (6.54e-2)"	"unprognostic (6.50e-3)"	"prognostic unfavourable (6.98e-5)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.01e-2)"	9.9	27.6	8.5	8.0	8.9	24.6	14.2	12.0	9.2	9.1	13.3	8.0	12.8	16.7	12.1	10.0	5.4	8.4	9.5	7.2	8.5	10.0	19.4	28.9	9.5	10.1	8.2	6.3	11.1	18.2	10.2	18.5	31.4	7.6	11.6	12.4	9.3	8.9	12.2	5.9	9.5	19.4	7.4	8.2	8.2	8.9	8.8	8.5	13.5	13.1	5.3	6.5	8.7	13.9	8.9	13.5	8.5	12.9	10.4	16.4	9.3	8.3	12.9	12.9	18.9	22.0	18.2	10.9	13.6	23.3	13.5	18.1	6.8	16.4	7.2	12.7	16.0	13.0	13.6	12.4	15.4	16.5	16.2	18.5	5.2	25.2	16.5	7.9	16.9	15.9	16.0	15.0	9.1	16.9	10.8	35.3	15.6	6.2	5.2	11.2	9.3	9.3	0.0	7.4	4.9	17.7	4.7	4.7	14.8	12.9	2.7	22.6	7.8	6.6	14.8	8.7	10.5	10.3	13.0	11.5	11.8	1.9	13.9	12.2	6.3	8.5	10.3	4.6	11.6	12.9	10.3	8.9	11.0	13.2	13.5	7.3	10.6	11.9	0.7	10.4	10.8	7.8	16.4	9.3	8.5	8.9	12.0	9.2	8.5	10.0	8.2	6.3	7.6	8.5
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria				Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favourable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	8.9	10.1	5.0	11.7	11.5	15.5	10.7	6.5	10.1	9.8	8.2	13.4	17.8	10.5	6.6	5.2	22.6	11.5	13.6	12.2	6.1	7.3	4.6	4.8	11.5	9.4	10.7	2.5	7.6	17.1	10.1	9.0	12.2	8.8	1.7	15.2	6.6	7.6	6.0	6.9	10.2	8.5	13.5	9.1	21.8	6.0	11.8	3.9	6.9	11.4	13.6	11.7	6.0	6.7	6.0	5.0	9.8	6.9	1.7	2.4	5.6	10.3	5.5	7.4	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9
MIPOL1	CCDC193	ENSG00000151338	"Mirror-image polydactyly 1"	Q8TD10	14	37197913-37552361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002893, HPA050179"	Enhanced		Approved	Cytosol				Cytosol		"HPA002893: AB_1079386, HPA050179: "	"unprognostic (3.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.61e-4)"	"unprognostic (2.37e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.54e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.78e-3)"	"unprognostic (3.41e-3)"	"unprognostic (1.85e-2)"	5.8	6.1	8.8	4.5	8.4	1.5	8.6	2.1	11.1	14.0	5.7	1.4	7.8	3.0	9.3	5.1	7.4	7.6	7.0	7.0	8.1	3.9	8.9	4.2	5.3	1.1	4.6	8.4	13.2	8.7	12.6	24.4	3.2	6.6	13.7	4.7	4.6	8.0	9.1	10.1	4.2	3.2	13.7	7.6	2.7	7.5	14.7	8.0	0.0	11.2	5.4	1.7	8.7	15.8	0.8	0.8	4.2	0.3	0.5	0.5	0.3	3.9	1.7	0.6	5.6	4.2	6.9	0.0	3.6	2.4	3.1	4.6	2.2	2.4	0.0	3.6	3.0	4.6	0.0	4.9	4.3	0.0	5.9	0.0	2.9	9.5	2.7	0.0	0.1	4.4	5.2	0.8	10.0	19.2	7.6	0.1	4.6	4.0	0.0	0.0	2.4	12.5	0.0	0.6	0.0	4.5	4.5	4.8	0.0	4.6	4.1	4.2	5.0	0.0	10.0	0.0	3.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	7.2	1.1	0.3	0.3	0.3	0.3	0.3	0.3	0.5	0.2	0.1	0.8	0.4	0.3	4.2	0.5	0.3	0.8	0.4	0.3	8.8	8.4	2.1	11.1	8.1	3.9	4.6	8.4	6.6	8.0
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"									"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB000058: AB_2142367, CAB068198: , HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	47.3	24.1	25.1	17.8	1.0	2.1	7.8	18.0	13.3	17.1	15.3	19.7	19.7	35.7	5.2	12.3	28.9	26.3	13.5	25.8	37.6	12.7	30.6	17.8	12.3	0.0	43.0	16.6	0.5	0.6	17.6	18.0	16.7	14.0	34.4	16.9	18.8	25.6	13.1	10.0	11.0	19.1	32.9	4.7	6.2	13.3	8.7	9.5	25.5	9.2	4.4	7.5	9.2	15.4	9.1	18.2	12.8	48.6	15.7	12.4	43.3	7.5	19.7	7.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2
MLEC	KIAA0152	ENSG00000110917	Malectin	Q14165	12	120686869-120701864	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										1300000				"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (9.60e-6)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.39e-1)"	"unprognostic (9.77e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.15e-2)"	"prognostic favourable (8.77e-4)"	"unprognostic (1.98e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	22.1	57.6	15.2	23.0	18.2	10.7	18.6	10.1	16.8	19.9	43.9	17.3	48.1	27.4	20.9	50.8	12.0	17.6	34.1	33.7	14.8	15.8	35.2	81.2	13.9	13.2	14.6	11.6	23.5	52.9	37.4	22.8	24.1	15.1	22.9	42.2	15.9	32.5	41.0	24.5	9.6	40.8	17.7	15.1	20.2	20.4	35.9	15.6	18.0	57.9	15.8	15.0	15.6	20.5	5.2	17.3	6.6	7.1	3.5	3.9	1.7	34.5	50.7	32.9	43.2	56.9	31.5	37.6	42.3	35.4	31.5	23.6	35.5	21.9	28.3	38.3	39.4	29.5	39.7	24.6	40.0	24.3	21.9	40.6	22.5	27.7	20.9	56.3	36.9	23.8	23.6	34.2	26.6	27.4	23.7	33.4	32.7	35.4	29.6	33.2	45.5	26.0	32.7	24.1	30.8	37.7	58.6	17.0	20.2	48.9	24.5	24.1	36.8	39.8	22.7	34.1	33.1	33.1	28.5	24.9	44.9	21.8	42.7	41.3	34.9	0.3	5.5	6.6	3.6	7.1	3.9	3.7	2.2	3.3	4.6	5.2	3.8	3.2	1.5	3.5	5.3	17.3	2.1	1.7	15.2	18.2	10.1	16.8	14.8	15.8	14.6	11.6	15.1	15.6
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993332-37050918	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: , HPA060714: "	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	16.3	20.7	18.2	19.4	21.4	24.4	18.7	19.7	19.6	15.3	17.3	28.8	19.6	12.4	18.7	23.6	15.1	16.2	14.4	32.0	17.3	17.7	18.8	20.5	17.8	22.8	19.9	16.0	17.6	18.1	26.0	29.4	17.3	19.2	18.5	17.7	16.7	15.6	18.1	46.4	14.2	14.1	21.1	21.6	20.7	16.5	27.6	21.5	29.0	22.2	19.5	24.5	16.9	21.4	12.0	12.9	13.2	23.2	6.7	13.4	9.0	14.0	22.2	27.8	0.0	12.4	15.5	12.4	21.0	16.8	24.5	26.1	16.7	15.7	34.9	10.4	17.0	9.7	23.8	17.7	26.2	15.8	12.3	24.4	20.5	23.4	13.7	29.9	17.0	11.5	12.6	22.8	28.4	15.1	31.2	16.7	24.8	11.3	31.1	12.3	20.3	12.2	3.1	33.9	14.7	15.5	15.2	5.9	14.0	21.3	22.6	14.0	32.7	21.3	11.9	19.2	20.8	18.9	24.6	13.2	36.1	32.6	14.9	28.3	17.2	10.9	11.7	13.2	13.4	19.5	9.7	12.0	8.4	10.7	12.9	10.3	9.6	9.7	3.4	6.7	23.2	6.1	12.5	9.0	18.2	21.4	19.7	19.6	17.3	17.7	19.9	16.0	19.2	21.5
MLH3		ENSG00000119684	"MutL homolog 3"	Q9UHC1	14	75013764-75051532	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060570			Approved	Nucleoplasm				Nucleoplasm		"HPA060570: "	"unprognostic (2.94e-1)"	"unprognostic (6.70e-3)"	"unprognostic (7.14e-3)"	"unprognostic (7.35e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.11e-2)"	13.6	15.6	10.3	9.0	14.4	3.3	13.4	15.2	18.6	13.7	11.8	17.3	17.0	8.4	13.1	12.9	9.4	10.9	10.7	11.0	11.2	10.6	12.8	11.7	8.6	10.3	18.5	15.4	13.3	9.4	24.6	33.6	10.3	16.6	13.4	11.0	8.4	9.2	19.4	13.6	8.0	13.3	12.0	15.6	9.9	7.9	10.7	18.5	7.7	19.2	5.7	12.6	12.0	9.6	8.1	4.1	4.6	3.8	9.8	7.0	8.3	10.3	10.3	7.3	1.3	8.2	13.8	7.8	3.3	3.2	6.1	5.5	8.0	12.3	11.9	3.1	3.9	7.6	0.1	3.8	8.7	11.4	0.1	7.3	6.7	5.0	6.7	3.3	5.0	5.5	7.7	6.1	0.4	9.9	7.4	9.3	13.3	7.8	4.7	3.2	6.7	5.8	9.2	4.9	2.3	13.3	10.8	11.9	9.1	11.1	8.0	0.6	10.8	6.7	5.3	2.5	4.8	3.5	3.6	11.0	10.8	11.6	9.1	0.3	11.3	4.6	3.8	2.4	7.0	2.9	5.8	4.8	4.1	6.4	4.1	8.1	6.4	5.1	1.9	9.8	2.0	3.5	4.5	8.3	10.3	14.4	15.2	18.6	11.2	10.6	18.5	15.4	16.6	18.5
MLPH	"exophilin-3, l(1)-3Rk, l1Rk3, ln, Slac-2a"	ENSG00000115648	Melanophilin	Q9BV36	2	237485428-237555318	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 79.5"	"Cell line enhanced"	"Detected in many"		"A549: 28.2;LHCN-M2: 30.6;MCF7: 52.8;SK-BR-3: 50.4;SK-MEL-30: 37.2;U-87 MG: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA014685	Approved									"HPA014685: AB_1853997"	"unprognostic (3.32e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (5.14e-6)"	"unprognostic (2.26e-4)"	"unprognostic (1.36e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (3.74e-3)"	"unprognostic (8.16e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.34e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-3)"	5.9	0.3	0.2	4.4	0.8	0.0	22.1	0.5	0.6	19.3	8.0	0.5	40.0	3.0	9.1	7.4	2.3	6.3	54.1	21.8	0.3	0.3	1.0	15.5	27.8	0.1	1.2	0.4	3.6	10.5	2.3	0.8	5.8	1.2	39.4	7.8	36.4	79.5	41.7	3.1	3.4	7.2	4.3	1.8	0.1	35.3	2.1	0.1	0.2	35.0	7.3	9.4	10.1	15.8	1.0	0.7	1.2	0.5	0.6	1.0	0.0	0.0	28.2	0.0	0.0	13.0	8.8	0.0	5.6	6.7	3.2	4.0	0.2	21.5	0.0	0.0	10.4	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	10.7	3.1	9.4	12.3	0.0	0.0	0.0	30.6	52.8	0.0	0.1	0.0	16.3	0.1	0.0	0.0	0.1	0.6	0.3	0.0	0.0	50.4	37.2	13.2	0.3	5.6	17.5	0.5	0.2	7.9	0.0	0.0	0.0	51.7	0.0	13.4	0.8	0.5	0.4	0.5	0.2	0.6	0.4	0.6	0.5	0.2	1.0	1.0	0.5	1.2	0.6	0.4	0.7	0.3	0.0	0.2	0.8	0.5	0.6	0.3	0.3	1.2	0.4	1.2	0.1
MLX	"bHLHd13, MAD7, MXD7, TCFL4"	ENSG00000108788	"MLX, MAX dimerization protein"	Q9UH92	17	42567068-42573239	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025329, HPA052766, HPA064438"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"CAB025329: , HPA052766: , HPA064438: "	"unprognostic (2.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (8.55e-3)"	"unprognostic (2.49e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.66e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.43e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.25e-1)"	21.3	19.2	10.4	12.6	11.9	8.3	22.5	10.3	14.3	12.3	32.2	10.8	15.4	27.5	11.0	15.1	18.8	10.5	19.2	38.1	9.8	9.8	23.5	34.7	19.0	18.6	11.3	6.6	10.4	36.8	8.5	13.0	13.7	9.4	13.4	23.1	11.6	18.5	14.8	43.3	15.6	42.5	12.1	10.2	18.7	20.6	7.4	8.9	20.3	23.5	24.9	19.7	16.5	13.1	14.6	26.3	34.7	33.5	12.8	18.2	23.0	16.0	18.6	14.6	14.8	22.3	25.8	10.1	24.2	21.5	26.1	23.7	16.8	16.7	19.4	17.0	20.5	24.3	26.6	15.6	23.0	15.3	25.0	20.0	13.4	18.6	26.3	26.8	28.9	22.3	17.5	20.9	19.2	19.2	21.8	17.4	29.7	21.4	37.6	13.2	10.3	16.9	17.0	30.4	20.7	21.1	19.9	22.8	11.3	10.7	13.9	27.1	28.6	31.8	13.6	23.3	15.1	25.4	35.6	17.7	20.0	18.2	26.0	17.2	27.3	14.2	25.0	34.7	14.3	30.8	15.8	14.6	14.8	14.3	26.3	11.8	13.1	13.1	32.3	12.8	33.5	14.1	18.2	23.0	10.4	11.9	10.3	14.3	9.8	9.8	11.3	6.6	9.4	8.9
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 103.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 29.5;K-562: 8.8;SCLC-21H: 15.9;T-47d: 7.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Region enhanced"	"Detected in many"		"cerebellum: 20.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA064640: "	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"	30.0	18.0	4.2	0.8	3.9	0.5	10.9	20.4	6.8	1.1	16.5	0.4	2.6	33.2	0.4	22.1	1.0	3.5	5.5	1.8	3.2	1.7	11.6	103.6	0.9	0.4	1.2	4.0	2.0	6.5	4.0	3.9	0.4	5.0	0.9	1.3	1.1	2.7	0.9	24.7	1.2	27.1	0.7	1.2	0.4	3.5	5.7	0.0	0.0	2.0	7.7	0.4	0.8	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.5	0.0	3.7	3.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.2	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	4.5	0.0	2.4	29.5	0.8	0.1	1.0	0.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	3.4	0.0	0.0	0.4	0.6	0.0	0.0	0.7	0.0	0.0	15.9	0.4	0.5	2.5	0.0	7.1	3.6	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.2	3.9	20.4	6.8	3.2	1.7	1.2	4.0	5.0	0.0
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 95.0;BJ hTERT+: 142.9;HSkMC: 92.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced						99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.6	95.0	0.2	21.2	142.9	10.8	28.1	0.0	0.0	23.4	0.0	18.8	0.0	0.7	0.8	26.1	0.0	0.1	0.0	0.0	0.0	30.9	0.0	0.0	92.1	0.1	5.8	41.6	8.2	0.0	0.0	17.3	0.1	0.0	0.1	0.9	0.1	38.8	18.2	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.1	0.0	0.0	23.3	46.7	0.1	15.9	3.7	0.0	0.0	30.8	5.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2
MMP1	CLG	ENSG00000196611	"Matrix metallopeptidase 1"	P03956	11	102789920-102798160	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation, Host-virus interaction"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 62.4;stomach 1: 27.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 88.1;HBF TERT88: 87.3;HUVEC TERT2: 229.4;WM-115: 113.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 344.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA004920			Approved	Vesicles	"Secreted to extracellular matrix"		430000	Vesicles		"HPA004920: "	"unprognostic (4.11e-3)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (4.20e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.46e-2)"	"unprognostic (6.50e-2)"	"prognostic unfavourable (4.22e-6)"	"unprognostic (7.83e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (9.86e-10)"	"unprognostic (1.67e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.11e-2)"	0.2	0.1	0.3	12.3	0.3	0.0	0.9	0.3	0.3	0.3	2.7	0.3	0.2	3.2	4.8	0.2	3.3	0.1	62.4	0.4	0.2	0.1	0.7	1.3	4.7	0.2	0.2	0.2	0.2	1.6	0.0	0.2	8.6	0.5	0.7	3.0	0.3	2.0	0.2	0.2	0.3	8.8	0.2	0.4	1.8	27.2	2.2	0.2	0.4	0.3	1.3	0.9	11.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	88.1	36.0	9.4	0.7	0.0	0.0	0.4	21.1	0.3	0.0	12.3	87.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	37.0	3.1	229.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	11.9	29.9	0.0	1.3	0.1	0.0	0.0	0.0	0.7	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.2	0.5	0.2
MMP13	CLG3	ENSG00000137745	"Matrix metallopeptidase 13"	P45452	11	102942995-102955734	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 12.6;vagina: 10.8"	"Group enriched"	"Detected in some"	5	"HaCaT: 19.1;PC-3: 7.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 70.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002742	Supported				"Secreted to extracellular matrix"					"CAB002742: "	"unprognostic (8.98e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-3)"		"unprognostic (1.32e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.55e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.73e-8)"	"unprognostic (2.12e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.33e-2)"	0.5	0.1	0.0	0.8	0.0	1.3	0.4	0.0	0.2	1.3	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	12.6	0.1	0.0	0.0	0.1	0.0	0.0	3.1	0.1	0.1	1.2	0.0	0.0	0.6	0.0	0.0	1.0	0.5	0.0	0.0	0.1	0.1	1.9	0.0	1.4	0.0	0.0	0.1	4.6	10.8	1.0	0.7	2.7	0.5	1.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	7.2	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.1	2.2	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.5	0.6	1.3	0.4	1.0	0.5	0.7	0.8	0.3	1.0	0.6	1.1	1.9	1.9	0.3	0.7	0.4	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836557-22849027	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 98.0;HHSteC: 92.7;HSkMC: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"			570000	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: "	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	60.9	10.5	2.4	16.6	4.7	0.2	64.2	2.2	3.2	56.3	35.0	8.2	12.7	12.0	53.1	24.1	47.0	21.9	39.6	17.5	3.4	1.8	16.8	9.0	29.8	16.9	5.8	2.9	39.3	11.2	34.4	4.7	73.5	16.4	39.1	11.3	27.1	24.4	16.7	20.4	37.0	22.9	28.5	20.7	22.5	18.2	26.3	4.6	5.4	22.3	14.6	16.7	52.5	53.9	0.1	0.7	0.0	0.7	0.0	0.0	0.1	7.9	0.1	2.4	0.1	98.0	62.3	45.0	25.1	50.6	7.6	13.6	2.3	29.9	0.1	14.0	26.4	20.3	0.0	26.1	9.8	0.1	0.1	3.7	0.1	0.5	92.7	0.0	0.1	94.2	15.8	31.7	27.2	46.0	0.1	0.2	17.9	0.1	0.0	9.0	1.5	4.3	0.3	8.6	0.0	6.9	13.7	0.0	0.0	16.4	0.0	54.4	0.1	8.1	40.7	61.9	5.3	18.0	28.6	0.1	0.1	0.1	37.7	0.0	35.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	4.7	2.2	3.2	3.4	1.8	5.8	2.9	16.4	4.6
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"CAB002611: , HPA040390: "	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.3	2.3	11.8	2.4	0.1	36.8	0.5	0.3	2.1	0.4	3.4	14.8	0.0	7.0	0.6	8.1	1.9	1.7	0.6	0.0	3.9	0.0	1.9	19.1	3.1	0.1	7.7	1.2	3.0	0.3	0.9	1.4	4.7	0.0	0.7	2.8	0.2	0.9	6.7	1.2	2.8	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.5	3.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1
MMP2	"CLG4, CLG4A, TBE-1"	ENSG00000087245	"Matrix metallopeptidase 2"	P08253	16	55389700-55506691	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 335.4;ASC TERT1: 97.7;HSkMC: 83.3;U-138 MG: 91.2;U-87 MG: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001939, CAB002788"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"		160000000	Vesicles		"CAB002788: , HPA001939: AB_1079395"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.36e-3)"	"unprognostic (4.81e-3)"	"unprognostic (3.79e-2)"	"unprognostic (4.59e-3)"	"unprognostic (6.12e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-2)"	"unprognostic (8.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (4.63e-2)"	197.5	9.0	1.2	13.2	1.6	0.0	136.4	0.8	1.4	74.3	74.4	2.4	36.9	5.6	85.0	123.0	52.3	25.7	115.4	54.0	0.9	0.5	9.4	3.5	38.9	3.9	1.5	1.1	71.0	6.5	0.7	2.2	58.9	2.2	66.8	18.7	36.4	18.6	20.4	68.6	68.2	22.6	57.1	1.8	12.4	20.5	57.0	1.1	1.3	20.6	31.8	9.1	84.1	105.3	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	0.2	11.1	0.1	335.4	97.7	18.2	28.7	65.9	5.8	4.6	0.0	0.1	0.0	23.1	50.5	3.1	0.0	0.2	3.3	0.0	0.0	0.0	0.7	0.1	31.7	0.0	0.8	83.3	0.0	29.8	0.2	37.4	0.0	0.1	19.3	0.0	0.0	0.4	8.8	0.0	0.0	2.6	0.0	0.9	0.4	0.1	20.2	5.3	0.0	0.1	0.0	2.0	52.7	91.2	8.7	17.5	3.7	0.0	0.0	0.1	106.8	1.5	16.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	1.2	1.6	0.8	1.4	0.9	0.5	1.5	1.1	2.2	1.1
MMP28	"EPILYSIN, MM28, MMP-25, MMP-28"	ENSG00000271447	"Matrix metallopeptidase 28"	Q9H239	17	35756249-35795707	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	9	"HaCaT: 28.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.2;naive CD8 T-cell: 5.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057288, HPA057890"			Approved	"Nucleoplasm,Focal adhesion sites"	"Secreted to extracellular matrix"			Nucleoplasm	"Focal adhesion sites"	"HPA057288: , HPA057890: "	"unprognostic (7.99e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (6.28e-6)"	"unprognostic (9.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.27e-3)"	8.0	1.6	1.8	2.7	3.7	0.5	4.3	0.0	5.1	1.7	7.3	1.6	1.4	3.0	3.2	4.8	4.3	1.5	12.3	0.5	2.8		0.8	0.2	10.3	0.4	0.0	2.9	0.1	1.3	0.5	0.0	0.7	1.3	2.9	4.1	2.7	0.1	2.1	0.6	4.5	9.3	4.3	0.2	0.6	7.2	13.4	0.2	0.0	4.2	4.4	2.5	5.5	2.2	1.1	1.5	0.1	0.2	1.3	7.2	0.9	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.1	0.7	0.0	28.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	2.5	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	2.0	1.1	0.4	1.7	0.1	0.9	7.2	5.9	0.1	1.3	0.2	1.5	0.0	0.9										
MMP3	"STMY, STMY1"	ENSG00000149968	"Matrix metallopeptidase 3"	P08254	11	102835801-102843803	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 177.5;salivary gland: 73.4"	"Group enriched"	"Detected in some"	17	"BJ: 98.9;BJ hTERT+: 269.1;fHDF/TERT166: 116.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 59.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			HPA007875	Uncertain		Supported	Vesicles	"Secreted to extracellular matrix"		170000	Vesicles		"HPA007875: AB_1079396"	"unprognostic (2.27e-1)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (1.63e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.11e-2)"	"unprognostic (5.26e-6)"	"unprognostic (3.46e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.09e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-15)"	"unprognostic (3.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.34e-1)"	19.1	0.0	0.2	14.4	0.3	0.0	6.9	0.2	0.5	0.2	1.5	0.3	0.2	1.8	28.3	177.5	0.2	0.0	1.4	0.2	0.2	0.0	0.3	0.5	0.4	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	1.2	1.7	0.2	73.4	1.5	7.3	12.6	0.7	5.9	0.2	0.2	2.8	1.4	0.2	0.2	0.6	1.5	0.9	7.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	269.1	1.7	0.5	0.0	0.0	0.0	0.0	116.5	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.2	0.8	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.0	0.2	0.2	0.2	0.2
MMP7	"MPSL1, PUMP-1"	ENSG00000137673	"Matrix metallopeptidase 7"	P09237	11	102520508-102530753	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.0;kidney: 129.5;salivary gland: 79.3"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CAPAN-2: 126.5;EFO-21: 30.0;RPTEC TERT1: 54.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 352.1"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025869, HPA051358"	Supported		Approved	Nucleoplasm,Vesicles	"Secreted to extracellular matrix"			"Nucleoplasm, Vesicles"		"CAB025869: , HPA051358: "	"unprognostic (1.06e-3)"	"unprognostic (9.51e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.70e-3)"	"unprognostic (7.28e-2)"	"prognostic unfavourable (2.53e-4)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (3.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.46e-1)"	6.8	0.2	0.2	1.2	0.2	0.0	28.8	0.2	0.2	5.2	0.2	0.2	2.1	0.0	17.2	12.3	3.3	16.4	93.0	0.2	0.2	0.2	129.5	1.4	5.0	0.9	0.2	0.2	3.9	23.5	0.0	0.7	2.7	1.3	42.0	0.0	0.2	79.3	6.7	0.2	7.8	0.3	0.5	0.2	0.2	0.9	9.4	0.2	1.2	0.3	1.4	4.5	19.9	0.8	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	126.5	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.3	0.2
MMP8	CLG1	ENSG00000118113	"Matrix metallopeptidase 8"	P22894	11	102711795-102727050	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 119.3"	"Cell line enriched"	"Detected in some"	8	"WM-115: 39.2"	"Cancer enriched"	"Detected in single"	17	"melanoma: 5.7"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Group enriched"	"Detected in some"	32	"neutrophil: 1.4;non-classical monocyte: 4.9"	"Group enriched"	"Detected in many"	32	"granulocytes: 1.4;monocytes: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA021221, HPA022935"	Enhanced				"Secreted to extracellular matrix"		83000			"HPA021221: AB_1854043, HPA022935: AB_1854044"	"unprognostic (3.03e-1)"	"unprognostic (8.49e-5)"	"unprognostic (1.08e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-2)"		"unprognostic (7.68e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.92e-2)"	"unprognostic (6.64e-3)"		"unprognostic (2.45e-6)"	"unprognostic (2.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (4.97e-1)"	"unprognostic (2.30e-2)"	1.9	0.1	0.2	0.2	0.4	119.3	0.3	0.1	1.7	0.1	0.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.1	9.0	0.2	0.3	0.4	0.8	12.6	2.6	0.3	0.0	0.9	0.9	0.1	0.6	1.4	0.2	0.1	0.1	0.1	0.3	0.1	0.6	0.3	0.1	0.2	0.3	18.7	0.2	0.1	0.1	5.2	1.9	0.0	0.1	0.2	7.6	0.0	0.0	1.4	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	0.0	0.0	1.7	0.2	0.4	0.1	1.7	0.2	0.3	0.3	0.0	0.2	0.1
MMP9	CLG4B	ENSG00000100985	"Matrix metallopeptidase 9"	P14780	20	46008908-46016561	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 64.0;blood: 63.2;bone marrow: 89.4;lymphoid tissue: 80.1"	"Cell line enriched"	"Detected in some"	12	"NB-4: 87.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	141	"neutrophil: 63.2"	"Lineage enriched"	"Detected in single"	339	"granulocytes: 63.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000348, HPA001238, HPA063909, CAB068199, CAB068200, CAB068201"	Enhanced		Approved	Cytosol	"Secreted to blood"		57000000	Cytosol		"CAB000348: , CAB068199: , CAB068200: , CAB068201: , HPA001238: AB_1079398, HPA063909: AB_2685150"	"unprognostic (4.62e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (6.65e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (7.19e-4)"	"unprognostic (1.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.21e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (4.05e-5)"	"unprognostic (4.65e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.17e-3)"	64.0	0.5	0.6	38.6	0.7	89.4	4.3	0.4	0.6	0.8	1.2	0.1	0.0	2.8	0.6	0.2	0.9	1.5	0.6	4.0	0.5	0.6	1.4	2.0	13.3	80.1	0.6	0.0	2.7	1.4	0.0	0.8	2.6	0.5	0.6	0.8	0.5	12.5	0.0	1.3	1.3	4.2	0.3	0.5	53.7	2.5	2.7	0.0	23.6	1.3	2.3	44.5	4.5	2.9	0.0	0.0	63.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	87.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	2.6	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	63.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.6	0.5	0.6	0.6	0.0	0.5	0.0
MMRN1	"ECM, EMILIN4, GPIa*, MMRN"	ENSG00000138722	"Multimerin 1"	Q13201	4	89879532-89954629	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"HUVEC TERT2: 164.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"NK-cell: 9.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.4;NK-cells: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035769	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"		300000000	"Endoplasmic reticulum"		"HPA035769: AB_10696511"	"unprognostic (1.15e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.11e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.71e-3)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (1.77e-4)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.23e-2)"	13.9	1.9	1.4	5.3	1.4	0.5	14.8	0.7	1.3	22.8	14.9	0.1	9.0	2.6	9.2	12.2	17.4	18.1	11.5	4.9	1.6	1.3	3.3	9.5	22.4	30.7	2.6	0.0	10.2	2.2	0.1	1.3	38.1	2.7	10.0	8.1	3.7	3.3	2.4	6.8	6.5	10.1	14.2	3.4	1.6	5.3	16.7	2.1	2.3	43.1	7.0	3.7	19.6	30.4	0.8	3.4	0.1	0.0	9.3	0.3	1.7	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.3	0.0	0.1	9.3	0.0	3.4	0.3	1.7	1.4	1.4	0.7	1.3	1.6	1.3	2.6	0.0	2.7	2.1
MMRN2	"EMILIN3, EndoGlyx-1, FLJ13465"	ENSG00000173269	"Multimerin 2"	Q9H8L6	10	86935540-86969481	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 24.1;HUVEC TERT2: 50.5;TIME: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA020741	Approved		Approved	Vesicles	"Secreted to extracellular matrix"		86000000	Vesicles		"HPA020741: AB_1848154"	"unprognostic (4.17e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.25e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.66e-1)"	61.0	8.0	5.4	5.7	6.5	0.4	63.6	4.1	6.8	17.2	10.1	3.5	9.5	5.0	19.0	12.0	12.5	12.5	10.2	51.0	8.2	4.9	11.1	11.1	26.1	7.5	5.9	2.5	12.2	5.4	6.7	5.2	41.9	7.4	13.1	4.4	13.8	12.8	15.2	20.2	19.5	8.1	13.9	6.3	30.8	7.5	10.5	6.0	2.0	16.2	17.6	6.2	23.4	42.2	0.5	0.1	0.1	0.3	0.0	3.1	0.1	2.9	0.8	0.1	0.0	0.3	1.8	1.9	1.1	3.0	1.3	1.9	1.7	24.1	0.0	10.4	2.0	5.8	0.0	1.4	1.7	2.1	0.0	0.6	2.3	0.0	0.2	0.0	1.2	0.4	7.2	1.5	10.6	50.5	0.5	9.6	0.5	1.8	0.1	1.1	0.5	1.3	0.0	0.0	0.0	0.5	4.6	1.3	0.0	0.8	1.0	0.3	4.0	0.3	60.3	0.5	3.1	0.5	0.0	0.7	1.0	0.0	1.6	0.0	0.6	0.1	0.3	0.0	0.3	0.0	3.1	0.5	0.9	0.7	0.1	0.2	0.3	0.1	0.1	0.0	0.1	0.0	0.9	0.1	5.4	6.5	4.1	6.8	8.2	4.9	5.9	2.5	7.4	6.0
MNX1	"HB9, HLXB9, HOXHB9, SCRA1"	ENSG00000130675	"Motor neuron and pancreas homeobox 1"	P50219	7	156994051-157010651	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 43.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;EFO-21: 11.1;HEK 293: 8.8;RPMI-8226: 24.2;SCLC-21H: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071717			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA071717: "	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.72e-3)"	"unprognostic (8.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.07e-2)"	"unprognostic (5.06e-2)"	"unprognostic (8.62e-4)"	"unprognostic (1.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.23e-5)"	"unprognostic (1.67e-3)"	"unprognostic (5.80e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	0.1	0.0	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.1	6.0	0.2	0.1	9.0	0.1	0.1	0.3	0.0	7.3	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	43.3	0.0	3.2	0.1	0.2	0.8	3.7	0.1	1.9	0.1	0.1	0.1	7.3	0.1	0.2	0.1	2.7	1.0	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	3.8	0.0	11.5	0.0	0.0	8.6	0.0	0.0	0.1	0.0	5.0	1.6	0.9	11.1	0.0	0.2	2.0	1.5	0.9	1.4	8.8	0.0	0.7	2.3	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	3.6	1.9	0.0	6.4	0.6	0.1	0.0	0.7	0.0	1.7	24.2	4.3	0.4	13.0	0.0	1.6	1.4	0.2	3.6	2.9	0.0	0.0	0.0	0.0	0.0	3.6	1.8	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
MOB1A	"C2orf6, FLJ10788, FLJ11595, Mats1, MOB1, Mob4B, MOBK1B, MOBKL1B"	ENSG00000114978	"MOB kinase activator 1A"	Q9H8S9	2	74152528-74178898	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047088, HPA071690"	Supported		Approved	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA047088: , HPA071690: "	"unprognostic (5.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.19e-2)"	"prognostic unfavourable (3.34e-4)"	"unprognostic (9.36e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.20e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.11e-3)"	32.2	18.0	12.2	41.5	16.3	36.6	36.2	10.8	11.3	24.5	21.5	12.6	16.1	19.7	27.1	19.8	28.9	22.0	19.9	20.9	11.0	10.4	34.7	21.4	28.4	65.1	14.7	6.9	28.4	12.6	13.8	11.5	20.9	15.9	21.0	20.7	14.3	18.1	18.8	12.8	22.9	30.2	31.6	21.8	51.1	18.7	17.9	12.8	57.0	25.4	16.9	42.4	29.2	24.6	22.3	22.2	32.3	42.8	20.6	15.9	25.2	20.7	11.9	15.0	16.1	24.7	27.0	17.7	16.7	22.5	21.8	21.6	16.2	15.1	42.6	14.3	20.9	17.4	19.1	19.1	33.2	29.9	11.4	38.4	8.2	17.1	19.7	33.2	62.1	22.8	18.7	17.4	14.8	22.8	16.4	15.8	21.1	11.2	41.6	28.3	13.9	9.8	28.7	51.5	22.6	18.7	26.0	7.6	9.9	23.7	17.6	15.2	14.0	15.8	21.6	28.4	15.0	19.8	26.4	11.8	10.4	32.7	19.1	28.4	15.1	30.8	24.0	32.3	14.8	39.0	15.9	22.3	13.3	15.7	22.2	17.2	12.3	14.6	24.0	20.6	42.8	15.5	13.4	25.2	12.2	16.3	10.8	11.3	11.0	10.4	14.7	6.9	15.9	12.8
MORF4L1	"Eaf3, HsT17725, MEAF3, MORFRG15, MRG15"	ENSG00000185787	"Mortality factor 4 like 1"	Q9UBU8	15	78810487-78898133	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042360, HPA062010"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA042360: AB_10794275, HPA062010: "	"unprognostic (5.36e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-3)"	"unprognostic (3.61e-3)"	"unprognostic (8.61e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-3)"	49.3	57.8	59.9	40.8	60.9	66.9	44.2	76.6	70.6	55.5	50.1	32.5	37.5	29.8	58.8	41.7	45.3	48.1	46.5	85.0	54.8	75.3	60.9	46.0	43.3	40.5	71.1	52.6	68.2	32.2	44.5	60.1	60.1	60.1	45.7	41.8	41.5	41.6	54.6	89.5	28.2	46.2	63.6	58.8	37.2	40.3	215.8	40.7	23.0	65.0	38.3	48.0	57.0	92.6	45.9	61.3	51.6	53.8	37.5	72.5	73.3	46.6	63.5	115.6	48.0	83.4	86.8	61.3	85.4	83.5	76.0	73.8	57.1	71.0	56.8	70.4	85.5	58.9	140.5	57.3	72.2	57.3	56.3	63.1	68.3	52.8	85.8	52.3	57.8	60.4	65.3	43.4	61.3	91.4	65.7	53.7	88.2	43.5	49.9	38.8	125.8	28.0	56.0	90.4	55.4	62.4	64.0	60.1	62.6	76.0	49.1	107.3	59.1	70.0	70.7	92.0	65.4	48.7	71.5	35.0	95.8	64.1	56.7	84.2	67.0	25.9	53.8	51.6	36.2	50.6	43.2	45.9	52.4	40.8	61.3	43.6	72.5	52.0	43.2	37.5	39.8	58.7	56.1	73.3	59.9	60.9	76.6	70.6	54.8	75.3	71.1	52.6	60.1	40.7
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA031872: , HPA054102: AB_2682379"	"prognostic unfavourable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	33.3	51.4	50.4	26.6	53.5	23.9	51.6	52.8	66.8	76.2	32.9	29.7	62.9	25.8	74.0	63.4	40.2	55.2	39.5	38.5	50.0	71.2	44.0	76.5	34.3	19.3	45.5	48.8	99.8	36.2	38.6	81.8	77.4	63.5	47.4	40.3	23.4	35.2	57.8	44.9	27.4	27.8	93.7	46.1	25.9	31.5	33.5	34.7	21.5	46.8	35.6	29.9	55.5	45.3	21.6	40.7	24.7	24.7	25.4	29.1	21.9	61.6	41.9	56.3	24.9	84.0	63.1	75.7	82.7	72.4	68.7	70.8	42.9	55.6	42.1	67.8	78.6	42.0	70.4	61.3	86.2	19.3	32.0	22.4	72.1	48.5	92.1	30.6	21.4	68.5	54.7	58.6	77.3	75.4	36.7	58.3	84.1	62.4	27.3	30.3	53.5	47.7	27.8	52.9	44.6	68.7	37.6	53.8	41.9	62.4	46.3	61.7	30.6	29.9	62.9	40.2	26.9	69.6	44.1	29.0	35.4	37.5	71.8	62.4	60.2	24.7	23.3	18.4	25.4	24.7	29.1	21.6	24.3	23.9	24.3	19.1	26.9	23.1	9.5	25.4	24.6	40.7	19.7	21.9	50.4	53.5	52.8	66.8	50.0	71.2	45.5	48.8	63.5	34.7
MOV10	"fSAP113, gb110, MGC2948"	ENSG00000155363	"Mov10 RISC complex RNA helicase"	Q9HCE1	1	112673141-112700746	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, RNA-mediated gene silencing, Transcription, Transcription regulation"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA031627			Approved	Cytosol				Cytosol		"HPA031627: "	"unprognostic (1.44e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.82e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (3.44e-4)"	"unprognostic (9.89e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.48e-11)"	"unprognostic (4.01e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.21e-3)"	12.5	17.0	6.2	12.6	6.9	3.5	15.0	1.9	6.3	11.4	23.1	9.3	12.3	18.8	16.4	12.6	15.8	12.2	15.3	5.8	8.6	5.1	13.3	19.4	9.7	7.7	5.9	5.1	14.5	12.9	13.1	14.1	20.2	8.2	14.0	9.3	13.8	13.5	16.5	3.1	23.2	33.8	9.4	6.3	12.9	10.4	17.7	6.0	14.5	12.1	6.9	10.9	11.0	12.5	1.9	5.6	0.9	9.5	9.9	10.8	5.9	11.8	7.3	4.4	16.8	3.5	10.2	16.5	8.1	19.4	24.1	34.5	13.5	13.1	0.0	5.6	11.2	12.6	16.5	19.6	8.4	13.0	10.0	8.2	10.6	15.2	15.3	3.4	8.1	17.2	6.0	14.6	4.6	20.4	10.8	4.1	7.4	22.0	12.9	2.6	9.8	7.5	23.3	11.0	0.5	11.1	13.0	1.8	6.3	16.9	11.4	13.2	8.9	7.8	12.2	7.5	13.5	5.2	7.2	4.7	1.3	0.0	14.8	7.1	21.4	0.7	2.8	0.5	10.7	8.4	10.8	1.9	9.7	9.7	5.6	1.4	9.4	7.1	0.9	9.9	9.5	0.9	8.2	5.9	6.2	6.9	1.9	6.3	8.6	5.1	5.9	5.1	8.2	6.0
MPDZ	MUPP1	ENSG00000107186	"Multiple PDZ domain crumbs cell polarity complex component"	O75970	9	13105704-13279590	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.7"	"Cell line enhanced"	"Detected in many"		"AF22: 26.4;HUVEC TERT2: 24.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013512, HPA020255, HPA026686"	Uncertain									"CAB013512: AB_2533517, HPA020255: AB_1854073, HPA026686: AB_1854074"	"unprognostic (1.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.09e-3)"	"unprognostic (1.68e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.03e-1)"	"prognostic favourable (8.68e-4)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.50e-1)"	"prognostic favourable (7.40e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.58e-1)"	"unprognostic (9.74e-2)"	17.6	9.2	16.7	5.1	14.4	1.0	18.7	20.4	18.8	13.4	12.5	12.8	8.0	3.1	15.1	13.3	6.9	15.4	10.2	23.6	14.7	12.8	16.0	68.7	9.5	3.5	14.5	12.4	22.3	4.5	11.4	21.7	20.0	14.8	16.9	5.2	9.6	5.4	20.3	14.7	3.2	5.3	21.0	18.6	9.2	7.3	9.5	17.0	0.0	10.2	6.5	2.3	12.1	24.3	0.0	0.8	0.0	0.0	0.0	0.3	0.0	6.9	9.4	26.4	11.6	18.1	16.7	5.4	7.1	7.3	6.3	6.0	0.0	0.0	0.0	2.1	17.4	0.1	7.7	3.8	10.3	0.0	4.5	4.6	9.6	1.6	9.4	0.0	2.5	12.1	1.6	4.4	2.9	24.0	0.1	0.0	5.4	1.8	0.0	0.1	11.3	3.9	0.0	6.4	0.0	6.3	3.9	3.3	12.2	5.5	1.2	6.8	3.5	0.0	19.1	6.4	1.2	2.1	5.4	0.0	0.0	0.0	3.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	16.7	14.4	20.4	15.1	14.7	12.8	14.5	12.4	14.8	17.0
MPO		ENSG00000005381	Myeloperoxidase	P05164	17	58269856-58280935	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"bone marrow: 315.2"	"Group enriched"	"Detected in some"	93	"HL-60: 212.9;NB-4: 279.1"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"classical monocyte: 7.6;intermediate monocyte: 3.8;myeloid DC: 3.2;neutrophil: 2.0"	"Group enriched"	"Detected in many"	30	"dendritic cells: 3.2;granulocytes: 2.0;monocytes: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000059, HPA021147, HPA061464"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"		15000000	Vesicles	Nucleoplasm	"CAB000059: AB_2335676, HPA021147: AB_1854083, HPA061464: AB_2684531"	"unprognostic (1.91e-1)"	"unprognostic (9.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.92e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.91e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.05e-2)"	0.2	0.1	0.5	0.1	0.8	315.2	0.1	0.4	1.0	0.1	0.1	1.4	0.0	0.1	0.2	0.2	0.1	0.1	0.1	21.5	0.6	0.8	0.1	1.4	6.9	0.8	0.6	0.0	0.6	0.1	0.1	1.0	2.9	0.4	0.2	0.1	0.2	6.3	0.1	0.7	0.5	0.1	0.1	0.4	17.8	0.1	0.4	0.2	19.7	0.6	0.0	0.5	0.1	0.0	0.0	3.2	2.0	7.6	0.0	0.1	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	212.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	279.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	3.8	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	2.0	0.0	0.8	0.0	0.1	7.2	0.5	0.8	0.4	1.0	0.6	0.8	0.6	0.0	0.4	0.2
MPP5	"FLJ12615, PALS1"	ENSG00000072415	"Membrane palmitoylated protein 5"	Q8N3R9	14	67241109-67335819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000993, HPA063890"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000993: AB_1079407, HPA063890: AB_2732707"	"unprognostic (3.65e-1)"	"unprognostic (3.82e-3)"	"unprognostic (4.56e-2)"	"unprognostic (9.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.93e-3)"	"unprognostic (9.89e-3)"	"prognostic favourable (1.71e-12)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.87e-2)"	7.1	9.2	14.8	6.8	29.2	7.0	10.1	9.4	18.0	9.0	12.5	15.9	13.7	18.5	6.9	20.8	14.4	7.2	9.0	7.3	16.4	17.0	28.8	17.2	11.5	4.5	30.6	10.2	6.4	8.6	22.9	11.4	27.9	20.5	15.8	11.6	7.6	15.9	18.6	14.6	8.6	18.7	11.9	23.3	6.2	9.7	8.2	25.4	6.8	24.1	6.9	5.8	9.1	9.1	3.6	2.4	3.7	2.8	6.7	4.4	1.2	53.7	8.6	8.7	7.0	5.1	4.6	7.7	16.4	8.6	12.1	8.1	8.5	16.5	4.6	7.8	13.3	11.3	5.0	9.4	18.5	2.2	3.4	4.2	9.1	5.8	5.9	1.6	3.2	4.8	3.6	7.0	8.9	6.7	4.4	2.0	19.2	7.2	5.1	1.9	2.9	5.9	4.6	13.9	5.5	10.9	13.4	4.9	3.5	10.2	10.0	5.6	10.3	3.3	10.3	15.4	32.7	5.4	7.2	3.2	2.8	7.0	10.2	3.7	5.3	0.4	2.2	3.7	1.7	2.8	1.4	3.6	2.0	1.9	2.4	1.9	4.4	2.4	0.8	6.7	2.3	2.4	1.1	1.2	14.8	29.2	9.4	18.0	16.4	17.0	30.6	10.2	20.5	25.4
MPST	"MST, TST2, TUM1"	ENSG00000128309	"Mercaptopyruvate sulfurtransferase"	P25325	22	37019635-37029822	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 106.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001240	Enhanced		Approved	Mitochondria,Cytosol			2800000	Mitochondria	Cytosol	"HPA001240: AB_1079408"	"unprognostic (7.18e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-3)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.98e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.52e-1)"	"prognostic favourable (5.89e-4)"	8.7	7.2	4.5	6.8	6.4	10.5	22.7	2.6	5.4	8.8	39.1	8.0	2.8	36.8	6.1	3.0	19.8	4.3	15.3	14.1	4.6	2.3	14.1	106.2	10.3	5.4	8.8	3.8	12.6	20.7	0.7	2.7	4.2	5.6	6.6	5.7	3.8	13.4	3.9	11.5	15.9	33.7	4.8	4.8	4.1	12.8	24.9	7.1	2.1	6.3	6.2	5.1	8.7	11.6	9.6	37.1	18.5	26.5	28.8	16.1	12.5	14.1	16.7	8.2	16.9	9.6	6.0	13.0	7.7	6.9	8.4	11.4	15.9	6.3	22.3	11.2	5.5	9.9	7.1	11.2	1.2	13.4	39.7	8.6	7.3	37.4	30.6	9.2	12.1	10.5	21.9	5.5	5.1	17.0	15.3	6.5	2.3	11.0	0.8	31.5	15.4	17.4	23.9	9.7	16.6	8.5	4.6	4.2	31.6	5.1	8.1	14.7	8.7	15.0	13.1	7.3	20.7	8.0	5.2	11.4	5.3	6.7	2.6	11.3	3.7	15.3	26.5	18.5	11.8	9.4	16.1	9.6	7.7	9.9	37.1	9.6	1.1	4.1	7.9	28.8	4.3	6.0	15.2	12.5	4.5	6.4	2.6	5.4	4.6	2.3	8.8	3.8	5.6	7.1
MRC1	"bA541I19.1, CD206, CLEC13D, CLEC13DL, MRC1L1"	ENSG00000260314	"Mannose receptor C-type 1"	P22897	10	17809344-17911170	"CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 44.8;lymphoid tissue: 37.8"	"Group enriched"	"Detected in some"	19	"MOLT-4: 17.2;TIME: 16.0"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	15	"myeloid DC: 8.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA004114, HPA045134, CAB068203"	Enhanced						130000000			"CAB068203: , HPA004114: AB_1846270, HPA045134: AB_2679228"	"unprognostic (2.20e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.62e-2)"	"unprognostic (4.30e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.05e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.02e-2)"	34.8	8.3	0.3	6.2	1.2	0.0	19.8	0.7	0.6	5.2	11.2	0.6	0.9	2.2	4.5	10.4	4.2	1.3	7.9	13.4	0.9		12.4	16.4	44.8	37.8	1.0	0.0	3.6	5.1	1.8	2.4	15.4	3.1	5.5	5.1	7.0	0.7	1.9	5.1	0.0	6.5	8.2	1.4	30.6	2.2	7.1	0.8	0.8	6.5	3.5	0.7	7.5	5.1	0.0	8.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.2										
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415578-94493908	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavourable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	14.7	11.0	10.7	15.2	12.5	24.0	16.6	21.2	12.0	17.5	11.0	10.8	13.9	8.0	17.4	11.2	13.9	13.2	8.9	9.4	8.7	6.5	8.8	8.9	11.4	13.8	13.3	7.9	16.7	15.5	8.2	12.8	14.2	9.8	12.7	14.1	10.4	14.1	10.8	9.3	18.3	12.8	12.8	13.5	17.2	11.8	9.9	13.0	25.3	12.7	7.4	18.4	14.3	13.3	8.7	14.8	7.9	13.1	10.3	11.8	7.9	10.0	10.3	19.3	2.4	6.5	9.2	11.0	14.1	9.2	12.8	15.2	18.6	20.7	26.3	23.0	7.3	19.3	16.3	10.6	16.9	17.4	9.7	22.9	14.7	10.7	3.0	15.0	16.6	6.4	6.6	16.5	10.4	11.1	16.0	17.1	10.1	7.2	15.2	14.3	6.2	11.3	13.6	17.3	13.2	8.3	14.1	6.8	9.7	19.5	12.3	3.8	21.1	9.1	8.1	19.2	14.0	16.5	10.1	4.3	15.2	25.8	5.1	24.0	15.2	5.4	11.1	7.9	11.2	13.1	11.0	8.5	8.4	11.8	14.8	8.7	7.1	11.5	4.8	10.3	9.8	10.5	10.9	7.9	10.7	12.5	21.2	12.0	8.7	6.5	13.3	7.9	9.8	13.0
MRGBP	"C20orf20, Eaf7, FLJ10914, MRG15BP"	ENSG00000101189	"MRG domain binding protein"	Q9NV56	20	62796453-62801738	"Plasma proteins, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 55.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017012	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA017012: AB_1845679"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavourable (2.33e-4)"	"unprognostic (8.56e-2)"	"unprognostic (1.80e-3)"	"prognostic unfavourable (3.80e-6)"	"unprognostic (2.02e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.01e-3)"	5.7	6.7	6.3	6.1	6.6	6.6	5.8	7.8	9.1	5.4	7.7	6.8	4.4	9.2	5.7	4.6	6.2	5.2	5.4	8.9	5.6	5.3	6.5	9.4	5.6	8.0	6.5	5.5	10.5	10.6	5.9	6.6	8.4	5.1	5.7	4.9	6.5	8.4	7.3	8.5	6.3	9.7	8.4	4.0	8.5	6.7	55.3	6.0	8.3	6.2	6.2	6.1	6.6	7.5	1.7	2.0	2.8	3.7	0.6	3.8	1.2	14.1	9.0	7.4	11.3	4.1	6.2	7.2	8.2	10.7	32.1	14.0	32.0	11.4	13.0	16.5	6.3	12.1	8.4	13.9	18.2	4.0	7.2	9.5	9.7	18.4	6.4	11.0	17.9	5.3	10.3	8.7	9.3	7.6	12.9	7.2	8.0	21.5	20.9	21.0	6.2	16.3	18.8	14.1	9.7	4.8	5.9	10.5	8.5	11.7	10.5	14.8	13.0	16.2	7.8	20.1	20.9	13.5	17.4	9.7	5.9	15.5	19.8	11.1	11.2	0.0	2.2	2.8	2.0	3.7	2.7	1.5	2.5	2.7	1.5	1.7	1.9	3.8	2.4	0.6	1.5	2.0	2.7	1.2	6.3	6.6	7.8	9.1	5.6	5.3	6.5	5.5	5.1	6.0
MRPL19	"KIAA0104, MRP-L15, RLX1, RPML15"	ENSG00000115364	"Mitochondrial ribosomal protein L19"	P49406	2	75646783-75690851	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046805, HPA056622"	Approved		Supported	Mitochondria				Mitochondria		"HPA046805: , HPA056622: "	"unprognostic (9.24e-2)"	"unprognostic (3.84e-2)"	"prognostic favourable (7.39e-4)"	"unprognostic (8.40e-2)"	"unprognostic (1.59e-2)"	"unprognostic (7.52e-3)"	"unprognostic (5.75e-2)"	"unprognostic (9.86e-2)"	"unprognostic (6.21e-3)"	"unprognostic (9.71e-3)"	"prognostic unfavourable (1.97e-5)"	"unprognostic (2.42e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.20e-1)"	21.3	33.9	22.5	13.0	25.2	8.8	21.1	15.9	26.7	23.0	19.5	24.1	12.1	16.8	19.1	19.6	25.7	13.9	15.6	24.4	21.3	20.4	40.8	44.9	13.0	13.5	26.0	21.2	17.3	17.8	30.9	20.6	18.4	26.6	16.4	23.0	13.2	17.7	19.6	47.3	17.2	16.3	21.1	27.7	18.1	16.3	12.0	24.4	19.2	27.3	22.0	17.3	15.1	15.9	18.5	23.7	9.6	17.1	15.5	18.0	11.1	36.0	21.0	20.0	17.9	21.9	26.4	28.3	23.2	21.0	29.6	23.5	32.4	15.0	20.4	23.4	25.3	25.5	31.0	35.1	44.6	22.6	26.6	27.8	16.5	40.9	23.4	29.5	16.7	17.4	27.1	29.9	27.5	31.0	30.5	12.0	29.1	22.0	26.8	23.3	26.0	23.5	33.8	43.6	26.8	50.1	22.6	22.1	19.1	22.8	26.4	25.8	22.6	11.9	20.8	25.9	28.6	22.9	34.2	12.5	18.7	16.9	20.4	29.3	22.5	9.6	14.1	9.2	16.0	17.1	18.0	18.5	16.5	16.9	19.9	16.1	14.7	18.0	0.9	15.5	15.4	23.7	17.4	11.1	22.5	25.2	15.9	26.7	21.3	20.4	26.0	21.2	26.6	24.4
MRPL27		ENSG00000108826	"Mitochondrial ribosomal protein L27"	Q9P0M9	17	50367857-50373214	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021416	Approved				"Intracellular and membrane"					"HPA021416: AB_1854103"	"unprognostic (2.09e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.61e-2)"	"unprognostic (3.14e-2)"	"unprognostic (7.76e-3)"	20.5	35.3	33.2	16.6	32.8	14.4	27.1	25.4	34.7	21.6	33.9	28.1	20.6	25.3	18.9	56.7	26.1	21.4	15.6	32.7	28.7	29.7	37.6	46.9	14.6	18.9	34.8	25.8	20.2	24.7	19.4	25.1	26.5	30.0	21.8	40.7	22.2	21.9	22.9	58.0	20.1	25.8	24.2	25.8	17.1	30.5	19.8	24.0	17.9	19.3	35.8	28.7	18.9	18.1	52.3	50.8	45.4	53.5	26.4	40.1	43.9	28.6	42.3	19.7	12.9	12.6	18.9	29.0	21.5	20.5	40.5	36.7	97.2	15.2	25.2	27.1	26.3	17.9	29.4	32.2	33.0	25.5	50.4	26.1	36.3	69.7	23.5	21.7	23.6	21.7	45.0	32.1	19.2	27.1	27.8	15.1	28.0	54.3	23.8	27.5	14.2	46.4	13.4	26.8	20.5	34.4	39.0	20.4	24.5	10.1	13.2	18.5	31.9	18.2	16.4	27.6	21.0	20.5	34.7	18.4	20.8	22.6	18.4	18.3	14.0	45.4	47.8	31.2	28.2	53.5	23.0	52.3	33.4	29.1	46.9	43.5	32.8	28.8	7.5	26.4	37.8	50.8	40.1	43.9	33.2	32.8	25.4	34.7	28.7	29.7	34.8	25.8	30.0	24.0
MRPL40	"MRP-L22, NLVCF"	ENSG00000185608	"Mitochondrial ribosomal protein L40"	Q9NQ50	22	19431902-19436075	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006181	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA006181: AB_1079411"	"unprognostic (4.12e-2)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.64e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.14e-2)"	4.0	6.6	5.5	2.5	6.6	1.3	3.9	5.1	5.4	4.3	2.6			2.9	3.0	5.0	3.7	5.0	2.9	11.8	4.6	4.7	6.1	10.3	2.2	3.0	5.1		4.7	7.0	6.4	4.9	2.5		4.6	2.2		8.7	4.2	14.8	3.6	2.3	2.4	5.0	2.7	3.1	2.8			8.2		2.8	3.7	2.5	28.1	21.6	10.3	15.1	10.9	16.4	16.6	13.2	9.2	2.2	8.4	13.7	12.7	7.0	10.0	11.6	14.1	17.6	10.8	7.7	11.6	10.4	11.0	13.1	13.9	15.9	11.8	11.7	21.2	10.5	6.5	13.3	20.2	14.9	7.0	13.1	15.4	10.3	18.5	9.4	42.4	11.0	13.6	10.1	7.8	8.9	3.6	12.5	7.3	14.5	5.3	16.7	5.5	7.6	7.0	15.3	12.9	19.1	11.4	8.7	11.7	18.8	17.3	7.4	9.6	10.6	14.2	16.9	12.2	10.2	13.5	5.9	13.8	10.3	13.0	15.1	14.0	28.1	13.2	13.5	15.0	25.5	16.4	14.3	1.6	10.9	12.0	21.6	15.0	16.6										
MRPL47	"CGI-204, NCM1"	ENSG00000136522	"Mitochondrial ribosomal protein L47"	Q9HD33	3	179588285-179604654	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037553, HPA047779"	Approved		Supported	Mitochondria				Mitochondria		"HPA037553: AB_10671375, HPA047779: "	"unprognostic (6.37e-2)"	"prognostic favourable (6.44e-4)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (1.53e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.29e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.84e-2)"	17.4	23.5	22.3	16.4	21.7	29.6	20.2	23.9	25.0	14.2	22.5	12.8	13.0	16.7	16.8	17.3	21.3	13.3	13.4	35.5	21.1	21.8	34.0	31.8	14.8	19.3	25.6	19.4	15.2	12.1	18.1	23.8	17.8	28.5	15.9	23.6	11.2	14.5	14.7	31.7	13.5	20.3	17.8	20.1	20.2	17.4	32.8	22.0	25.3	20.1	27.8	20.7	16.3	13.9	21.0	28.2	24.6	29.0	22.7	28.1	18.9	31.7	12.4	21.6	19.8	13.7	14.4	24.7	18.7	16.7	29.4	24.6	50.1	13.3	26.1	37.0	15.9	24.1	26.4	19.5	31.7	30.0	23.2	25.0	12.4	28.0	26.7	44.9	14.2	13.2	17.1	21.7	22.3	19.7	14.6	21.0	22.8	24.6	24.0	42.0	37.4	29.7	25.6	21.2	43.7	30.9	20.2	18.8	21.8	20.5	33.3	36.7	51.3	34.5	15.7	16.0	22.9	20.0	50.8	26.6	43.5	57.1	18.7	36.9	19.3	15.9	19.3	24.6	20.0	24.8	19.9	21.0	22.2	21.5	28.2	17.4	19.9	20.2	5.1	22.7	29.0	24.4	28.1	18.9	22.3	21.7	23.9	25.0	21.1	21.8	25.6	19.4	28.5	22.0
MRPL49	"C11orf4, L49mt, NOF, NOF1"	ENSG00000149792	"Mitochondrial ribosomal protein L49"	Q13405	11	65122183-65127371	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046778	Approved									"HPA046778: "	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.21e-1)"	"unprognostic (6.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.53e-1)"	"prognostic favourable (4.22e-15)"	"unprognostic (9.09e-3)"	"unprognostic (1.12e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.45e-3)"	17.3	61.0	17.8	17.0	20.1	14.3	23.1	14.4	20.7	21.2	23.9	16.0	28.1	16.9	20.3	26.9	27.8	27.3	18.5	21.0	17.9	16.1	37.3	41.3	17.4	17.2	17.0	18.4	28.4	21.9	20.9	25.3	29.0	15.5	25.7	22.5	24.5	23.5	27.2	23.3	26.3	20.3	19.5	12.0	19.8	18.9	17.8	13.6	20.2	39.1	16.2	27.6	26.4	18.5	29.7	18.8	39.0	19.0	33.3	33.0	32.7	22.0	20.8	15.7	14.5	13.6	9.2	16.2	15.9	24.4	33.6	24.4	25.7	31.0	22.6	24.3	19.1	23.0	32.3	23.2	26.7	18.8	10.8	21.0	15.2	19.8	23.1	21.1	17.6	15.3	20.7	28.0	41.5	20.7	26.4	12.8	19.7	30.9	25.7	22.4	26.1	28.7	23.3	15.5	29.9	27.0	17.0	23.6	16.2	24.8	32.3	30.1	57.5	16.4	9.9	14.1	21.1	20.5	15.0	25.1	33.6	44.9	19.1	14.6	23.7	39.0	14.7	26.4	26.6	14.3	30.5	29.7	29.7	33.0	18.8	29.0	32.8	28.6	11.9	33.3	19.0	18.4	26.6	32.7	17.8	20.1	14.4	20.7	17.9	16.1	17.0	18.4	15.5	13.6
MRPS17	"HSPC011, MRP-S17, RPMS17"	ENSG00000239789	"Mitochondrial ribosomal protein S17"	Q9Y2R5	7	55951819-55956501	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 63.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047159	Approved									"HPA047159: "	"unprognostic (3.38e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.92e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-3)"	"unprognostic (7.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.63e-1)"	10.5	13.3	14.3	9.0	14.8	10.3	13.6	13.6	18.1	8.3	12.3	7.8	9.9	10.8	12.3	11.6	13.0	12.6	9.2	19.2	15.2	13.0	13.8	20.4	7.3	9.9	10.1	18.5	12.1	18.5	5.6	8.5	7.8	11.8	11.0	12.0	5.9	10.6	13.4	36.4	9.0	8.7	18.8	10.8	10.2	11.0	10.2	9.5	8.4	12.0	18.5	10.7	10.4	8.9	13.6	11.1	2.6	8.5	9.4	14.6	6.5	63.0	8.2	5.7	12.2	5.9	5.8	7.5	6.8	6.6	8.3	9.5	10.0	8.6	16.0	10.2	5.4	14.5	12.8	12.9	10.0	6.7	9.9	4.7	11.4	10.4	8.4	11.9	4.9	6.5	10.5	8.3	13.8	8.6	18.4	6.4	7.3	7.0	9.4	16.6	12.6	14.2	7.6	5.5	12.6	13.3	7.7	8.6	7.5	7.8	25.7	8.8	16.9	9.4	6.0	2.7	14.0	20.4	15.7	5.6	10.8	27.1	2.9	6.0	12.7	2.6	7.5	2.2	9.5	8.5	11.1	13.6	12.7	13.4	11.1	11.8	14.6	12.8	2.2	9.4	8.4	10.9	12.5	6.5	14.3	14.8	13.6	18.1	15.2	13.0	10.1	18.5	11.8	9.5
MRPS2	CGI-91	ENSG00000122140	"Mitochondrial ribosomal protein S2"	Q9Y399	9	135499984-135504673	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029487, HPA057261"	Approved		Supported	Mitochondria				Mitochondria		"HPA029487: , HPA057261: "	"unprognostic (3.18e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.83e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.81e-2)"	"unprognostic (7.58e-2)"	"prognostic favourable (6.96e-9)"	"unprognostic (2.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.24e-1)"	18.5	31.7	15.6	14.8	18.4	17.7	32.1	17.9	28.9	15.2	19.6	12.6	31.3	20.9	19.7	15.7	20.7	33.3	20.6	43.6	15.0	15.5	24.5	48.6	17.8	32.7	15.4	15.1	25.6	37.1	21.7	15.5	16.5	14.1	18.3	16.2	15.0	25.7	29.3	43.0	19.7	16.0	22.0	12.8	18.4	20.6	12.3	10.6	18.5	22.5	28.4	18.2	18.5	15.7	20.6	16.2	7.3	15.8	14.5	22.3	13.7	16.2	27.0	9.9	13.5	11.3	12.7	17.1	12.0	10.9	20.3	15.1	40.6	15.4	20.7	16.4	11.0	37.0	24.9	28.1	7.9	12.7	39.1	10.2	27.4	27.2	19.8	20.7	12.6	16.9	21.9	22.1	15.9	18.9	33.6	15.3	11.8	50.1	20.2	36.2	22.7	43.7	22.2	16.3	43.5	16.8	13.9	30.0	15.8	16.3	31.3	17.2	26.0	16.5	11.7	14.9	16.8	25.6	21.5	16.9	33.0	22.9	15.3	18.9	13.7	4.8	15.8	7.3	18.0	14.9	20.4	20.6	18.1	19.2	16.2	20.3	19.7	19.6	1.3	14.5	12.2	13.9	22.3	13.7	15.6	18.4	17.9	28.9	15.0	15.5	15.4	15.1	14.1	10.6
MRPS31	IMOGN38	ENSG00000102738	"Mitochondrial ribosomal protein S31"	Q92665	13	40729135-40771173	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039083, HPA046344"	Uncertain		Supported	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"HPA039083: , HPA046344: "	"unprognostic (9.62e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.96e-3)"	"unprognostic (1.84e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-3)"	"unprognostic (3.92e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.54e-2)"	14.2	20.1	19.3	17.9	21.2	13.2	18.2	27.7	22.9	14.4	16.4	16.9	10.7	15.4	18.0	15.4	18.9	16.6	10.9	24.3	18.4	16.9	26.7	29.9	12.1	22.5	17.9	17.1	21.5	15.0	10.7	35.3	13.1	22.1	12.6	17.0	12.4	14.7	12.5	32.5	14.2	16.3	16.3	16.0	16.0	15.3	17.9	23.3	22.9	21.1	17.2	25.1	18.0	15.9	22.2	11.8	17.2	10.4	15.9	25.7	10.9	8.0	7.8	13.2	8.6	9.0	10.7	13.2	10.4	7.3	13.7	9.3	19.9	12.0	47.5	10.2	5.9	21.4	16.5	12.9	16.4	12.5	12.4	19.7	5.8	12.7	7.5	20.1	9.5	8.5	9.6	11.3	9.6	10.4	13.1	5.0	8.7	9.2	15.6	19.7	12.8	9.2	14.9	10.8	8.9	17.9	9.4	5.7	8.4	7.2	12.0	16.3	10.5	17.8	6.3	4.3	7.2	9.9	10.7	3.9	7.2	23.9	8.8	14.4	8.2	17.2	9.6	14.4	19.1	9.7	18.6	22.2	21.4	19.2	11.8	18.9	25.7	22.6	7.0	15.9	10.4	11.6	21.4	10.9	19.3	21.2	27.7	22.9	18.4	16.9	17.9	17.1	22.1	23.3
MRPS34	"MGC2616, MRP-S12"	ENSG00000074071	"Mitochondrial ribosomal protein S34"	P82930	16	1771890-1773155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042112	Supported		Supported	Mitochondria				Mitochondria		"HPA042112: AB_10796899"	"unprognostic (2.02e-1)"	"unprognostic (4.83e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.44e-2)"	26.8	30.5	15.6	14.1	18.3	21.1	17.8	20.2	26.8	11.5	28.0	14.7	19.2	28.4	15.1	13.6	24.7	13.7	17.9	21.9	14.0	13.1	22.5	27.7	12.9	14.8	14.0	13.1	12.6	42.0	13.0	15.5	12.6	16.3	21.2	7.0	12.5	46.6	19.4	89.8	21.9	23.6	10.8	13.6	25.8	36.5	8.8	15.1	21.5	21.0	28.1	21.1	14.7	15.7	55.5	54.6	27.2	50.8	41.0	51.9	45.5	14.0	15.6	2.2	5.4	1.8	2.2	18.0	15.4	3.0	5.3	4.1	10.6	8.2	17.7	24.7	1.8	16.5	3.1	7.4	0.7	12.5	74.4	12.4	13.9	11.2	4.1	22.6	13.2	2.0	3.6	3.2	1.4	4.1	20.7	3.7	1.5	22.6	12.3	40.4	20.9	47.9	27.7	10.6	38.6	2.0	3.9	27.6	20.7	17.2	8.6	14.8	11.1	9.2	10.3	5.7	18.4	7.7	12.6	32.1	22.2	28.1	4.4	12.9	7.2	15.7	50.8	27.2	41.0	44.0	43.4	50.5	45.8	43.5	54.6	55.5	43.7	39.2	11.0	41.0	37.4	51.0	51.9	45.5	15.6	18.3	20.2	26.8	14.0	13.1	14.0	13.1	16.3	15.1
MRPS9	"MRP-S9, RPMS9, S9mt"	ENSG00000135972	"Mitochondrial ribosomal protein S9"	P82933	2	105037983-105099960	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043476, HPA048479"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA043476: AB_2678498, HPA048479: AB_2680412"	"unprognostic (8.10e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.80e-3)"	"unprognostic (5.25e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.78e-1)"	"unprognostic (2.62e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-1)"	13.9	25.0	14.1	16.9	18.5	13.3	15.4	13.2	20.6	13.7	18.9	15.9	14.3	19.0	17.6	13.2	16.7	16.2	8.9	39.1	14.4	15.3	24.5	23.5	10.0	14.5	18.1	15.7	21.0	17.3	22.0	23.9	8.4	25.2	15.8	22.0	10.9	15.3	16.4	56.8	14.0	17.0	16.6	15.0	14.0	17.4	20.6	16.6	20.7	15.6	28.7	16.8	15.2	12.4	22.1	20.4	7.1	17.2	20.0	22.8	14.5	22.0	9.5	20.1	18.5	10.6	11.0	23.6	14.2	13.6	22.5	20.3	50.8	15.5	23.0	14.1	11.1	20.0	39.4	20.6	24.0	14.2	25.9	22.7	14.1	30.6	17.7	16.8	10.2	13.1	14.0	18.5	15.5	17.2	32.4	12.1	15.3	17.7	22.6	22.1	31.8	21.0	28.9	17.3	32.0	28.2	15.5	17.5	10.5	16.4	24.1	19.1	19.8	17.1	11.2	13.3	26.9	13.2	15.2	11.1	13.1	18.4	11.5	25.8	11.1	7.1	11.6	4.6	19.9	14.6	22.0	22.1	22.0	20.9	20.4	16.5	22.3	21.9	1.3	20.0	17.2	15.2	22.8	14.5	14.1	18.5	13.2	20.6	14.4	15.3	18.1	15.7	25.2	16.6
MSC	"ABF-1, bHLHa22"	ENSG00000178860	Musculin	O60682	8	71841549-71844468	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 56.3"	"Cell line enriched"	"Detected in some"	14	"HDLM-2: 129.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 18.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA062878			Supported	Nucleoplasm				Nucleoplasm		"HPA062878: "	"unprognostic (2.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavourable (5.21e-4)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (3.95e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.07e-13)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.40e-2)"	9.9	7.6	2.0	10.1	1.3	2.8	56.3	0.6	4.4	4.8	1.6	0.8	0.4	1.9	4.8	2.9	3.3	3.4	10.5	16.3	5.5	0.2	5.2	3.0	6.6	14.1	0.8	1.2	7.3	4.7	0.0	2.6	15.1	1.9	4.8	0.9	15.9	3.7	3.1	2.6	3.0	3.8	3.8	0.9	5.6	3.8	3.1	0.6	1.8	3.6	3.4	4.8	10.3	6.5	5.0	4.3	0.1	0.2	0.0	18.5	2.1	0.0	1.0	0.0	0.0	4.7	0.8	0.0	0.1	3.9	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.0	129.1	0.0	0.0	0.0	0.0	8.4	0.0	0.4	1.8	0.0	8.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.1	0.0	0.0	9.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.1	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.8	0.0	0.0	3.4	0.0	5.6	0.0	0.0	0.0	3.9	0.0	5.2	5.0	6.8	18.5	0.1	2.8	0.1	6.4	0.1	0.0	0.2	4.3	8.6	2.1	2.0	1.3	0.6	4.4	5.5	0.2	0.8	1.2	1.9	0.6
MSH2	"COCA1, HNPCC, HNPCC1"	ENSG00000095002	"MutS homolog 2"	P43246	2	47402969-47663146	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009572, HPA066845, CAB070867"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB009572: AB_2144828, CAB070867: , HPA066845: "	"unprognostic (2.35e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.89e-3)"	"prognostic unfavourable (4.44e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavourable (1.72e-9)"	"unprognostic (1.77e-1)"	"unprognostic (7.09e-3)"	"unprognostic (8.57e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (5.38e-2)"	"unprognostic (3.29e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.74e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.48e-1)"	7.3	9.8	14.2	12.2	25.5	11.4	14.1	22.6	18.1	9.4	11.6	7.6	5.6	6.5	10.5	13.3	10.8	11.1	4.9	8.4	13.0	14.0	7.3	5.5	7.1	19.7	12.5	17.0	7.9	8.4	15.3	9.1	9.9	18.5	7.9	13.8	12.3	9.4	7.3	6.7	10.3	8.0	7.8	13.8	9.4	6.7	13.4	13.5	37.0	13.9	6.6	21.4	8.5	7.6	7.4	2.9	3.9	4.2	12.2	12.6	6.2	28.0	9.6	26.3	14.1	1.9	5.5	15.9	16.7	8.3	20.8	20.1	18.0	12.1	34.5	22.6	5.9	11.9	19.6	9.5	31.4	17.8	14.6	24.9	11.1	16.3	2.0	24.3	8.8	3.1	2.8	17.7	4.8	11.4	41.4	8.0	15.8	11.2	28.1	18.3	49.4	11.4	37.7	46.9	20.2	9.0	14.9	21.8	23.6	14.8	11.5	11.8	11.5	9.5	4.6	13.8	18.1	14.2	18.6	5.1	18.3	48.4	8.4	18.0	8.5	2.8	1.0	3.9	7.9	4.2	8.6	6.3	7.4	9.5	2.3	7.4	12.6	11.9	0.7	12.2	3.2	2.9	10.1	6.2	14.2	25.5	22.6	18.1	13.0	14.0	12.5	17.0	18.5	13.5
MSH3	"DUP, MRP1"	ENSG00000113318	"MutS homolog 3"	P20585	5	80654648-80876460	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036081			Approved	"Nuclear bodies"	"Intracellular and membrane"			"Nuclear bodies"		"HPA036081: AB_10673229"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-2)"	"prognostic favourable (5.90e-5)"	"unprognostic (2.95e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.91e-1)"	"prognostic favourable (1.77e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	14.8	11.7	11.1	24.9	13.1	11.3	19.4	12.1	22.5	13.7	14.0	9.7	17.3	10.8	12.3	16.8	13.4	16.8	13.4	10.4	11.1	10.7	23.4	20.4	20.9	12.6	11.8	10.3	11.6	14.5	17.9	13.1	8.7	10.3	10.9	11.8	10.6	12.5	24.2	14.6	12.0	12.1	13.4	14.6	9.2	10.4	9.4	8.5	20.2	19.5	12.1	10.7	13.1	11.9	7.3	6.1	4.4	8.3	5.1	8.4	3.9	10.5	12.7	10.3	11.3	6.3	11.6	14.7	10.5	9.9	11.1	14.6	9.1	12.8	18.6	12.1	12.8	9.3	12.4	16.8	14.7	11.6	12.3	7.7	12.9	8.9	6.4	8.4	8.0	10.1	8.7	12.9	14.8	10.7	10.0	12.9	13.6	10.0	14.5	6.1	8.3	6.9	11.6	19.8	13.8	16.0	11.5	10.5	12.4	10.1	9.9	12.6	13.4	9.0	10.8	7.1	9.2	7.8	18.9	8.3	13.3	17.7	10.5	14.8	9.0	1.3	6.0	3.5	7.4	5.9	7.9	7.3	7.8	7.7	5.7	5.9	6.4	6.3	4.4	5.1	8.3	6.1	8.4	3.9	11.1	13.1	12.1	22.5	11.1	10.7	11.8	10.3	10.3	8.5
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739948-31762834	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.3"									HPA062688			Approved	"Endoplasmic reticulum,Vesicles"				Vesicles	"Endoplasmic reticulum"	"HPA062688: "	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	3.6	2.7	3.2	8.0	4.4	6.8	4.1	1.6	4.4	3.9	5.8	6.9	9.3	3.0	9.8	8.5	4.7	5.8	15.2	2.0	3.2	2.1	10.5	4.7	4.3	5.7	4.0	3.6	6.9	4.0	1.6	6.5	3.0	4.1	7.9	5.3	12.4	4.7	9.2	2.3	12.3	5.2	6.0	5.7	7.6	6.8	15.9	3.8	12.0	4.3	2.7	10.6	3.6	4.0	1.0	0.5	9.3	0.9	0.1	0.8	0.0	2.0	1.9	2.3	4.7	0.8	0.7	0.7	0.6	0.2	0.8	0.3	1.2	2.6	2.5	0.7	0.5	2.9	0.0	1.2	0.3	0.4	1.1	2.4	0.6	1.4	0.3	1.9	1.9	0.8	0.5	1.9	2.4	0.9	4.8	6.0	0.7	2.6	3.6	4.1	0.9	0.4	1.3	1.0	3.9	1.4	0.4	0.6	2.4	0.8	0.0	0.0	1.3	2.7	0.7	1.7	3.5	0.0	1.5	2.7	1.0	2.8	0.7	3.9	3.6	9.3	0.4	0.0	0.7	0.3	0.2	1.0	0.4	0.2	0.2	0.5	0.1	0.0	0.0	0.1	0.9	0.5	0.8	0.0	3.2	4.4	1.6	4.4	3.2	2.1	4.0	3.6	4.1	3.8
MSH6	GTBP	ENSG00000116062	"MutS homolog 6"	P52701	2	47695530-47810101	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	DNA-binding	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009091, HPA028376, HPA028446, CAB070870"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	"Golgi apparatus, Vesicles"	"CAB009091: AB_670083, CAB070870: AB_2144959, HPA028376: AB_10598909, HPA028446: AB_10602182"	"unprognostic (5.10e-2)"	"unprognostic (5.87e-3)"	"unprognostic (3.29e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (1.98e-1)"	"unprognostic (3.09e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.99e-2)"	"prognostic unfavourable (1.06e-7)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.48e-2)"	13.0	20.5	9.7	13.1	18.8	13.6	13.0	20.5	13.1	17.9	13.3	17.6	10.7	6.1	28.2	11.0	12.4	18.3	8.4	8.6	11.4	8.8	9.5	14.6	11.0	21.7	23.9	9.6	43.2	27.6	16.2	17.3	14.9	15.0	14.6	10.3	8.7	12.0	13.2	10.4	10.3	10.5	22.1	14.9	11.6	11.1	25.1	22.0	40.4	13.4	10.4	25.8	14.2	16.4	8.4	8.4	7.6	9.8	9.7	15.1	5.7	27.2	20.3	37.9	9.0	11.4	12.1	17.1	15.2	13.4	15.7	16.6	14.9	9.5	45.0	22.7	16.4	11.5	34.1	19.3	20.5	19.6	17.0	28.8	16.2	15.1	7.0	28.9	10.6	9.8	6.2	16.0	10.7	9.8	25.0	16.6	15.3	19.6	30.7	13.7	33.3	9.4	73.0	49.7	20.3	9.6	17.8	21.2	23.0	21.1	10.1	9.2	12.0	10.2	6.0	18.3	22.4	13.8	19.6	15.6	21.0	75.4	15.5	18.5	11.2	7.6	5.8	4.9	8.4	9.8	10.4	8.4	9.5	8.3	8.4	8.1	15.1	7.6	3.9	9.7	9.3	4.2	9.5	5.7	9.7	18.8	20.5	13.1	11.4	8.8	23.9	9.6	15.0	22.0
MSL3	MSL3L1	ENSG00000005302	"MSL complex subunit 3"	Q8N5Y2	X	11758159-11775753	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA034535, HPA034536"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA034535: AB_10603878, HPA034536: AB_10670973"	"unprognostic (2.58e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.36e-2)"	"prognostic favourable (3.28e-4)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.48e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.13e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (3.14e-9)"	"unprognostic (1.20e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.35e-1)"	"prognostic favourable (2.17e-4)"	11.4	8.1	11.7	23.4	13.3	19.0	10.7	11.9	18.8	7.8	9.3	10.0	6.4	8.6	9.6	7.5	11.9	9.4	10.9	7.7	11.1	11.2	9.9	9.2	14.4	32.5	11.8	10.5	8.6	7.5	7.0	7.9	12.3	15.7	9.7	10.5	4.6	9.9	8.9	24.0	13.7	16.2	10.1	11.3	34.1	9.5	10.5	10.0	49.1	10.1	9.4	30.2	13.9	15.5	25.7	27.1	39.0	33.4	24.5	37.1	30.9	11.3	12.4	16.4	14.4	13.6	18.9	7.0	14.6	13.2	16.0	19.3	7.6	11.6	16.4	15.1	13.9	9.5	19.5	11.9	19.5	10.5	13.7	8.7	14.1	3.9	12.4	13.2	16.9	11.6	15.4	19.3	8.4	27.3	15.8	10.3	16.0	11.6	10.6	15.0	13.4	20.4	7.7	16.7	19.8	11.2	14.2	10.8	13.0	15.8	6.8	9.5	11.5	8.7	26.1	15.5	10.9	25.2	13.4	8.2	9.8	18.9	11.3	7.5	12.8	26.7	31.1	22.4	24.2	27.5	23.0	25.7	28.6	27.8	24.0	25.3	37.1	34.5	39.0	24.5	33.4	27.1	33.6	30.9	11.7	13.3	11.9	18.8	11.1	11.2	11.8	10.5	15.7	10.0
MSLN	"CAK1, MPF"	ENSG00000102854	Mesothelin	Q13421	16	760762-768865	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 85.5;lung: 88.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 102.3;EFO-21: 15.8;HeLa: 31.2;hTCEpi: 22.7"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 343.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 9.0"	"Group enriched"	"Detected in many"	59	"dendritic cells: 9.0;monocytes: 2.6"	"Low region specificity"	"Detected in many"							"CAB002216, HPA017172"	Enhanced		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"		14000000	Vesicles	Nucleoplasm	"CAB002216: AB_563874, HPA017172: AB_1853819"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.46e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.57e-2)"	"unprognostic (4.69e-2)"	"prognostic unfavourable (6.66e-4)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.91e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.35e-2)"	36.5	0.0	0.4	6.7	0.5	0.7	0.3	0.1	0.4	5.4	5.4	0.8	26.8	2.1	4.8	18.9	3.1	85.5	9.6	4.3	0.4	0.3	2.6	0.2	88.5	0.4	0.6	0.0	22.3	0.4	0.0	0.6	13.7	0.9	1.9	1.2	0.2	14.4	33.1	0.0	0.5	0.7	1.0	0.8	0.1	3.7	2.1	0.0	0.1	0.1	0.6	7.8	1.4	1.3	0.0	9.0	0.0	2.6	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	1.5	1.8	0.4	1.4	102.3	0.0	15.8	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	31.2	1.1	0.9	0.0	0.0	0.0	22.7	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.4	0.4	0.5	0.1	0.4	0.4	0.3	0.6	0.0	0.9	0.0
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"			340000000	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	36.3	17.6	10.2	40.7	14.4	38.5	98.2	8.6	18.6	25.1	21.3	19.2	7.6	6.5	33.4	14.2	15.7	21.8	20.2	53.8	11.5	10.4	25.6	29.5	102.8	85.0	17.5	5.4	28.8	19.4	5.7	10.2	24.2	30.0	23.1	13.0	16.6	16.3	21.9	13.6	19.5	18.3	41.4	21.8	31.6	17.3	9.0	12.9	18.7	26.2	17.6	38.1	22.7	28.9	16.0	36.4	54.1	69.0	28.0	37.1	81.8	27.8	21.4	21.0	17.3	25.2	33.3	0.1	70.7	45.8	39.2	30.4	0.0	4.9	23.4	63.2	62.5	19.2	22.1	50.4	51.2	43.3	6.1	64.9	37.1	0.0	23.8	78.8	105.1	24.9	10.9	72.1	63.8	86.5	31.4	73.0	62.0	0.0	46.5	59.1	26.0	40.7	24.4	37.7	17.8	41.9	0.0	0.1	0.0	56.8	0.4	22.5	0.2	42.9	137.0	44.7	28.4	60.1	46.8	26.5	40.1	25.4	32.7	100.1	49.7	30.8	44.4	30.0	37.1	58.9	27.9	16.0	20.4	29.1	36.4	13.9	14.0	21.3	54.1	28.0	69.0	5.2	15.5	81.8	10.2	14.4	8.6	18.6	11.5	10.4	17.5	5.4	30.0	12.9
MSR1	"CD204, SCARA1, SR-A, SR-AI, SR-AII, SR-AIII"	ENSG00000038945	"Macrophage scavenger receptor 1"	P21757	8	16107878-16567490	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"adipose tissue: 88.1;lung: 70.4"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.1;REH: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 16.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 16.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA000272, CAB032491"	Enhanced						25000			"CAB032491: AB_672722, HPA000272: AB_1846269"	"unprognostic (8.19e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.85e-3)"	"unprognostic (2.89e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.16e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.85e-2)"	"unprognostic (4.69e-2)"	88.1	9.0	2.2	6.1	4.5	3.7	6.9	10.4	3.3	4.5	3.1	1.8	1.0	2.1	3.1	6.2	2.4	4.5	11.4	8.0	3.8	3.1	9.5	13.6	70.4	6.9	4.3	0.8	6.7	3.8	1.2	2.6	10.4	7.7	3.2	3.9	4.5	6.2	2.3	3.2	1.6	4.0	6.5	11.9	10.9	2.5	4.9	3.1	1.5	2.2	1.7	0.7	10.8	1.8	1.5	1.0	3.0	16.0	0.3	1.3	0.5	0.6	0.9	1.3	0.6	0.6	0.6	0.6	0.3	47.1	0.1	0.2	1.6	0.1	1.5	2.4	0.4	0.3	0.3	0.4	0.9	0.2	1.9	1.9	1.8	1.8	0.4	1.0	1.1	0.3	0.3	0.3	0.7	0.0	0.7	1.4	0.9	1.8	0.6	0.6	0.2	0.6	17.8	1.0	0.4	0.9	2.7	1.0	0.5	0.4	1.2	0.1	0.1	0.5	1.1	1.2	0.5	4.9	1.2	4.8	3.7	3.2	0.5	0.6	1.0	1.1	3.1	0.5	0.9	16.0	0.4	0.9	0.7	0.7	1.0	1.5	1.3	0.9	3.0	0.3	7.8	0.5	0.6	0.5	2.2	4.5	10.4	2.7	3.8	3.1	4.3	0.8	7.7	3.1
MSX2	"CRS2, FPP, HOX8, MSH, PFM, PFM1"	ENSG00000120149	"Msh homeobox 2"	P35548	5	174724533-174730893	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Osteogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.7;urinary bladder: 18.2"	"Cell line enriched"	"Detected in some"	6	"BEWO: 83.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"cerebellum: 6.9"	"Low region specificity"	"Detected in single"			HPA005652	Uncertain		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA005652: AB_1079418"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (8.43e-5)"	"unprognostic (2.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (6.93e-4)"	"unprognostic (2.08e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.36e-4)"	"unprognostic (7.64e-3)"	"unprognostic (5.06e-2)"	"unprognostic (2.12e-6)"	"unprognostic (1.43e-2)"	2.0	0.4	0.3	0.4	0.5	0.0	7.6	6.3	1.6	2.6	0.9	2.0	0.0	0.3	6.2	0.2	0.9	1.1	1.5	1.7	2.5	0.5	0.3	0.1	0.9	0.1	1.5	1.2	0.4	0.6	9.4	0.5	44.7	7.2	6.3	0.1	6.6	0.9	0.8	2.1	6.4	0.9	10.4	6.6	1.1	2.6	5.2	1.3	0.0	0.8	0.2	0.3	18.2	2.4	0.0	0.0	0.0	0.0	0.2	0.5	0.1	0.1	1.0	0.2	0.8	0.0	0.0	83.8	0.5	0.9	0.2	0.0	14.2	5.8	0.0	2.2	0.0	1.5	4.5	1.6	0.0	0.0	2.7	0.0	0.3	0.0	0.6	0.0	0.7	0.9	1.1	0.8	0.9	0.0	0.0	0.0	1.2	6.9	0.0	0.1	0.6	2.2	0.0	2.2	0.0	1.0	8.9	0.0	0.6	0.0	11.0	0.7	6.6	0.0	0.0	0.2	1.4	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.5	6.3	1.6	2.5	0.5	1.5	1.2	7.2	1.3
MT2A	MT2	ENSG00000125148	"Metallothionein 2A"	P02795	16	56608199-56609497	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 626.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 424.2;LHCN-M2: 170.7;U-87 MG: 140.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (1.14e-1)"	"unprognostic (8.90e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.74e-5)"	"unprognostic (5.69e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (8.59e-2)"	"prognostic unfavourable (2.92e-9)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.03e-2)"	177.1	215.4	27.7	49.6	66.6	16.3	58.2	10.3	41.7	23.1	48.1	20.8	12.4	26.0	10.7	37.5	35.8	33.6	48.0	30.8	31.6	23.4	74.6	626.9	53.0	38.7	51.0	13.9	23.3	129.1	2.9	11.4	21.8	95.2	30.4	20.2	15.9	19.5	10.8	184.6	29.6	62.8	21.2	63.4	29.7	30.6	7.6	26.5	0.6	69.6	29.8	15.6	24.6	20.5	3.8	13.1	25.3	26.3	10.5	33.6	18.0	13.9	5.8	0.1	4.9	40.4	59.2	0.8	117.3	60.8	23.0	21.0	0.0	24.7	2.1	16.4	9.4	15.1	5.2	424.2	9.5	22.6	3.5	2.6	5.9	2.1	19.2	17.0	1.7	36.8	19.8	53.3	20.8	28.9	0.1	0.2	170.7	10.0	1.8	22.5	11.2	55.3	2.0	6.9	0.1	108.8	0.1	2.7	0.6	28.8	10.2	7.8	1.6	2.1	36.9	119.2	46.3	19.5	33.5	0.1	0.2	0.1	140.4	20.9	7.2	25.3	16.3	21.3	31.9	24.8	21.2	3.8	18.7	33.6	13.1	2.2	13.0	25.8	9.6	10.5	26.3	2.1	30.4	18.0	27.7	66.6	10.3	41.7	31.6	23.4	51.0	13.9	95.2	26.5
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favourable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.1	10.5	19.6	19.5	7.5	12.9	17.4	10.5	8.0	10.4	10.1	13.6	17.8	25.8	11.0	7.6	18.2	14.2	10.0	7.1	16.9	23.9	13.4	9.5	13.9	16.6	16.8	10.4	14.4	12.7	7.4	17.0	14.8	15.2	11.3	5.4	23.6	30.3	33.4	28.3	22.3	28.7	11.9	8.4	8.3	10.3	31.7	33.0	14.1	16.5	15.0	14.8	16.1	10.6	8.5	9.0	13.9	10.9	23.0	11.1	16.4	10.5	11.4	14.7	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601840	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	26.3	20.4	16.6	28.0	17.9	28.7	20.5	21.6	24.8	23.9	22.0	31.5	15.6	17.1	23.8	16.9	45.1	19.9	23.7	18.8	15.8	12.4	19.0	23.6	21.8	35.5	19.7	12.7	35.0	13.7	22.5	19.8	22.3	20.9	21.9	27.3	21.2	22.3	22.1	12.7	41.1	23.5	25.0	23.8	39.4	19.9	25.7	18.9	64.6	19.3	20.3	49.1	21.7	27.8	12.9	12.0	8.4	13.2	10.4	17.3	4.4	24.5	21.5	34.3	44.8	15.4	14.5	23.7	20.8	29.3	41.8	30.7	20.3	21.5	35.0	22.5	27.3	33.1	46.2	57.5	35.6	34.6	23.2	37.3	23.2	20.4	24.0	42.0	48.0	16.1	32.4	29.4	43.9	38.7	41.1	27.9	29.9	47.6	53.3	53.6	29.6	25.1	51.2	24.4	40.9	29.6	36.9	27.4	25.1	21.7	31.1	17.6	36.4	28.8	27.0	23.5	21.7	26.5	23.9	20.9	27.0	49.5	17.2	30.8	22.6	5.6	6.4	8.4	17.3	11.0	14.6	12.9	14.4	12.5	10.2	9.8	13.7	13.5	2.9	10.4	13.2	12.0	11.6	4.4	16.6	17.9	21.6	24.8	15.8	12.4	19.7	12.7	20.9	18.9
MTA3	KIAA1266	ENSG00000057935	"Metastasis associated 1 family member 3"	Q9BTC8	2	42494569-42756947	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 74.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039433	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA039433: AB_10794747"	"unprognostic (5.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (5.28e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (4.69e-4)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.28e-2)"	8.8	35.0	19.2	16.7	21.0	1.6	14.6	11.4	23.7	14.5	12.5	10.2	16.8	9.0	17.2	25.0	16.7	14.1	11.3	11.1	18.3	14.0	14.5	7.6	8.3	11.5	12.3	14.6	33.3	15.0	18.3	15.8	16.1	12.5	15.0	14.1	12.6	10.6	20.8	9.8	15.4	8.7	14.3	10.4	6.4	12.5	21.0	9.3	74.3	13.0	7.7	15.0	13.5	13.4	2.9	3.2	7.7	1.9	3.3	8.8	3.3	7.7	8.1	12.1	7.3	9.7	13.6	24.0	4.8	8.7	10.9	9.3	10.2	13.4	25.3	8.4	10.5	4.8	25.6	11.5	16.0	9.3	8.7	4.5	4.7	16.0	10.5	2.7	15.5	14.3	12.9	7.4	7.9	14.6	8.2	2.9	11.9	11.4	17.6	8.5	43.2	4.9	10.2	10.6	0.0	10.9	6.3	6.4	20.9	7.5	23.5	9.9	12.7	3.5	9.1	5.2	8.6	3.9	4.7	6.1	2.8	37.1	6.9	2.8	6.7	7.7	1.9	0.0	4.1	0.7	5.7	2.5	4.4	6.2	3.2	2.9	8.8	5.9	0.3	3.3	1.2	1.0	2.2	3.3	19.2	21.0	11.4	23.7	18.3	14.0	12.3	14.6	12.5	9.3
MTAP	"c86fus, MSAP"	ENSG00000099810	"Methylthioadenosine phosphorylase"	Q13126	9	21802543-21937651	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Purine salvage"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046915			Approved	Cytosol			3100000	Cytosol		"HPA046915: "	"unprognostic (1.40e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.58e-3)"	"unprognostic (2.78e-1)"	"unprognostic (6.16e-2)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (9.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.63e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.27e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.85e-1)"	17.0	12.6	7.8	12.6	10.4	8.4	13.9	4.6	10.2	17.3	14.5	12.8	13.4	8.0	21.2	11.6	19.6	12.2	16.9	11.4	7.9	7.7	13.0	17.5	11.4	13.0	12.0	6.2	20.5	17.2	17.6	14.4	17.5	12.3	17.0	13.1	14.3	14.6	15.9	10.8	11.8	10.3	19.9	14.3	17.9	11.7	7.9	10.1	19.1	11.7	14.3	16.2	19.7	17.2	9.3	8.4	1.4	6.9	8.5	8.2	3.5	14.2	2.2	11.6	9.7	9.5	9.8	13.0	20.8	10.2	10.6	12.2	9.8	6.7	7.1	6.5	9.9	6.6	11.8	29.4	18.0	0.1	9.7	0.1	27.0	12.9	9.3	11.4	12.7	11.8	0.0	19.5	21.4	11.0	0.1	9.6	11.1	2.0	13.0	0.3	13.5	17.4	0.1	8.8	12.5	9.1	0.1	6.6	7.5	6.8	8.0	10.3	5.2	0.2	11.9	0.1	7.5	0.1	16.6	6.4	11.3	14.9	0.1	11.3	6.1	1.4	6.9	0.3	5.0	5.4	8.2	7.7	7.2	5.6	8.4	9.3	6.5	5.9	1.0	8.5	3.4	8.0	4.1	3.5	7.8	10.4	4.6	10.2	7.9	7.7	12.0	6.2	12.3	10.1
MTCL1	"CCDC165, KIAA0802, SOGA2"	ENSG00000168502	"Microtubule crosslinking factor 1"	Q9Y4B5	18	8705661-8832778	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 61.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"cerebellum: 61.5"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	HPA046245	Uncertain									"HPA046245: AB_10962580"	"unprognostic (2.64e-1)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.41e-4)"	"unprognostic (1.30e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (5.19e-4)"	"unprognostic (2.82e-1)"	"unprognostic (3.67e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.08e-2)"	1.4	1.2	1.8	3.2	3.4	0.4	1.4	61.5	10.0	5.5	8.5	2.4	4.1	2.3	3.4	2.0	3.8	1.3	12.5	3.8	1.7	2.4	1.4	1.3	1.4	0.9	2.4	3.8	1.3	3.4	4.8	2.7	3.0	5.2	1.7	2.3	8.4	1.5	4.4	2.4	1.6	2.7	7.0	3.3	1.1	4.9	8.2	1.2	1.4	1.1	1.1	0.6	9.9	4.8	0.6	1.1	0.0	0.0	0.0	0.0	0.0	8.8	19.0	9.5	5.5	4.3	8.0	0.3	12.4	9.2	10.3	7.4	5.5	3.1	5.5	7.1	8.6	1.3	3.0	5.0	4.7	1.1	2.4	2.7	5.0	4.9	6.1	0.1	4.0	4.7	3.8	5.8	4.0	8.0	0.6	9.7	4.7	2.6	0.3	1.3	4.3	8.3	7.4	6.9	2.0	14.7	16.0	21.8	4.9	5.7	1.6	1.5	0.5	0.3	15.2	18.9	9.9	15.1	12.7	1.9	1.4	2.7	4.7	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.8	3.4	61.5	10.0	1.7	2.4	2.4	3.8	5.2	1.2
MTERF1	MTERF	ENSG00000127989	"Mitochondrial transcription termination factor 1"	Q99551	7	91692008-91880720	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transcription termination"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA044894, HPA069560"	Uncertain		Supported	Mitochondria				Mitochondria		"HPA044894: AB_10966284, HPA069560: "	"unprognostic (5.57e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.46e-3)"	"unprognostic (7.62e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.22e-3)"	8.9	11.5	16.1	10.9	18.1	13.9	14.4	23.2	18.9	10.4	11.8	12.1	10.0	11.5	11.6	11.0	13.4	9.8	8.3	8.7	15.2	10.5	13.2	17.6	8.3	19.4	20.3	13.1	14.7	11.4	10.0	18.0	10.6	18.8	11.6	12.1	8.5	12.5	9.2	9.3	9.9	13.6	9.7	22.7	17.6	12.5	10.0	18.5	11.9	12.2	10.3	19.0	12.0	11.4	15.0	9.4	24.8	8.8	9.8	19.0	10.0	10.3	9.0	8.7	5.8	8.5	8.9	7.6	8.8	9.0	9.5	11.8	10.9	9.9	21.3	7.3	7.0	9.2	13.0	7.9	13.6	1.2	9.5	9.7	9.8	8.5	7.6	17.0	10.7	10.6	10.5	10.5	11.2	8.2	17.5	8.9	11.1	13.2	17.8	19.5	13.1	10.1	5.1	11.6	14.6	9.8	11.3	8.1	15.4	8.9	18.8	17.8	6.6	12.2	5.3	11.3	13.9	15.3	8.9	12.7	12.8	28.9	8.2	5.6	15.8	24.8	8.8	11.9	10.6	7.5	12.7	14.6	13.8	15.2	9.4	15.0	19.0	15.1	4.2	9.8	8.2	7.4	13.2	10.0	16.1	18.1	23.2	18.9	15.2	10.5	20.3	13.1	18.8	18.5
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.2;lymphoid tissue: 16.8;testis: 13.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles				Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavourable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	1.7	0.9	0.6	5.1	1.5	15.2	0.9	0.9	1.1	0.8	2.9	0.8	0.4	2.8	0.7	0.9	4.5	0.5	1.7	1.0	0.6	0.6	2.5	0.7	1.5	6.4	0.8	0.4	0.9	0.7	0.0	0.7	3.2	1.2	0.7	4.1	0.6	1.3	0.4	1.4	1.9	3.2	0.9	1.1	3.8	1.9	13.5	0.4	16.8	0.4	3.2	5.8	1.1	1.4	1.6	3.0	0.1	2.9	0.0	2.6	1.1	7.1	5.6	4.8	8.9	0.8	1.4	8.6	9.5	6.6	11.3	15.9	9.9	5.9	18.7	5.8	3.8	11.2	10.8	7.0	16.9	10.4	8.3	14.7	4.1	9.0	0.5	26.9	13.9	1.1	1.5	12.6	8.1	6.1	15.8	14.6	8.4	9.6	15.1	22.6	4.8	6.9	13.9	7.7	9.4	4.8	5.6	3.8	3.8	6.0	10.6	5.4	4.4	18.6	3.3	5.6	5.9	19.8	14.5	5.5	13.0	12.4	3.2	18.4	8.6	0.0	0.6	0.0	1.2	2.9	0.4	1.6	1.6	2.6	3.0	1.3	0.2	1.3	0.1	0.0	2.3	2.2	2.2	1.1	0.6	1.5	0.9	1.1	0.6	0.6	0.8	0.4	1.2	0.4
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol			250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: "	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavourable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.1	41.1	15.6	34.0	16.8	13.7	25.3	28.3	19.5	36.8	36.5	39.9	33.3	30.4	13.4	16.8	35.5	48.2	28.2	43.1	30.1	31.7	37.6	41.2	30.2	12.4	28.8	20.5	10.7	9.1	32.8	17.8	22.9	28.0	25.0	27.8	59.9	46.4	16.9	28.6	43.6	37.1	54.3	27.5	27.6	42.3	33.8	13.1	47.4	25.8	14.2	40.1	14.6	14.1	27.8	48.1	25.5	33.9	16.7	20.5	53.5	25.4	33.4	31.4	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4
MTM1		ENSG00000171100	"Myotubularin 1"	Q13496	X	150568619-150673322	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid metabolism, Protein transport, Transport"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010008, HPA010665"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA010008: AB_1079426, HPA010665: AB_1079425"	"unprognostic (3.66e-3)"	"unprognostic (8.43e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.74e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.59e-2)"	"prognostic favourable (7.40e-7)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.46e-1)"	10.7	17.9	15.0	10.2	16.4	11.1	9.2	10.6	10.8	9.1	21.5	12.5	12.7	12.8	10.9	10.9	11.1	11.1	8.0	9.0	14.3	12.0	17.9	19.9	12.2	12.4	17.3	9.3	13.8	7.5	21.4	11.9	21.5	12.9	9.5	21.6	8.3	10.2	12.9	11.2	10.2	21.0	8.0	17.2	15.3	8.6	12.1	16.4	14.5	12.7	8.3	13.9	8.5	9.1	6.9	7.9	18.4	7.2	10.1	7.7	4.6	8.5	3.9	5.5	2.0	5.0	5.0	3.5	4.1	5.6	4.7	5.2	3.0	4.7	13.8	7.3	5.2	6.1	4.0	7.9	5.8	3.7	3.5	3.7	3.7	9.1	3.8	15.3	12.5	3.0	9.5	3.8	8.1	6.1	2.3	12.8	5.7	2.8	4.2	15.8	2.8	5.1	5.1	3.1	2.7	8.1	4.8	1.4	1.5	3.5	7.4	5.2	2.6	22.3	5.3	3.1	1.9	8.1	4.2	2.6	5.9	13.1	4.0	9.4	5.1	17.6	6.3	18.4	1.5	7.2	4.9	5.5	6.8	5.2	7.9	6.9	6.5	3.9	8.5	10.1	6.2	5.1	7.7	4.6	15.0	16.4	10.6	10.8	14.3	12.0	17.3	9.3	12.9	16.4
MTMR1		ENSG00000063601	"Myotubularin related protein 1"	Q13613	X	150692971-150765103	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002977, HPA018502"	Approved		Approved	Centrosome				Centrosome		"HPA002977: , HPA018502: AB_1854185"	"unprognostic (2.37e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.40e-2)"	6.9	6.8	20.4	14.0	17.9	9.9	11.8	14.5	15.6	8.3	8.6	8.7	7.2	8.3	9.4	9.2	19.7	9.3	9.0	12.0	17.8	13.4	8.1	10.2	9.7	18.7	12.1	11.5	7.4	11.7	16.3	10.2	37.9	8.8	10.8	9.1	7.9	12.1	13.0	22.2	19.8	10.9	8.3	8.2	18.0	9.7	11.0	9.3	32.6	9.6	10.7	23.1	10.4	7.7	3.3	7.8	7.4	1.5	6.2	4.8	1.8	12.9	8.3	9.0	7.3	2.1	2.4	12.1	11.5	14.9	11.8	16.7	8.0	10.3	28.4	17.1	9.3	11.8	18.1	16.8	18.4	11.5	10.9	1.8	13.0	3.4	6.2	8.3	6.2	6.7	11.7	12.9	0.2	7.1	5.4	7.3	8.4	11.1	12.1	2.1	4.1	12.6	6.5	14.3	12.5	9.2	14.9	13.4	8.4	4.4	9.9	3.7	12.6	4.7	8.9	7.8	6.2	1.0	17.1	9.4	9.6	43.2	1.5	5.4	5.9	0.0	0.9	7.4	3.5	1.5	2.6	2.7	3.9	3.2	2.2	3.3	3.5	4.7	2.4	6.2	1.3	7.8	4.8	1.8	20.4	17.9	14.5	15.6	17.8	13.4	12.1	11.5	8.8	9.3
MTMR3	"FYVE-DSP1, KIAA0371, ZFYVE10"	ENSG00000100330	"Myotubularin related protein 3"	Q13615	22	29883155-30030866	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034515, HPA034516, HPA061399"	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA034515: AB_10669726, HPA034516: AB_10669727, HPA061399: "	"unprognostic (4.39e-3)"	"unprognostic (7.84e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.42e-1)"	"unprognostic (4.39e-1)"	"unprognostic (8.33e-4)"	"unprognostic (1.28e-1)"	"unprognostic (5.35e-4)"	"unprognostic (7.96e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.38e-2)"	15.8	17.2	15.7	12.6	20.6	66.7	16.0	24.2	18.0	13.7	12.6	18.9	14.8	10.6	18.8	13.5	20.1	16.7	13.0	14.4	13.0	11.7	12.4	9.9	18.3	12.6	14.7	11.4	20.3	15.8	22.1	20.6	20.6	15.8	15.1	12.9	18.1	15.9	14.7	30.7	22.5	13.1	16.0	17.0	20.7	14.1	23.7	14.6	14.0	16.6	11.9	14.9	14.0	19.3	2.6	3.9	16.5	6.6	3.9	4.1	3.5	8.4	6.6	11.4	12.1	11.5	8.4	8.4	7.5	11.4	10.3	11.9	6.1	5.1	6.4	5.0	14.4	10.4	12.0	9.5	10.4	12.7	10.0	11.6	6.6	6.6	10.6	9.8	29.5	8.9	15.8	10.0	18.2	10.2	7.1	11.5	6.3	10.5	6.6	7.2	4.2	4.9	7.8	15.5	6.5	9.7	15.7	12.7	8.7	14.3	13.0	7.7	7.3	9.9	10.9	16.9	11.4	3.4	5.3	10.0	6.7	6.0	7.3	4.9	7.7	6.4	6.6	10.0	3.1	4.6	4.1	2.2	2.5	3.4	3.9	2.6	3.1	2.7	16.5	3.9	4.7	1.5	2.7	3.5	15.7	20.6	24.2	18.0	13.0	11.7	14.7	11.4	15.8	14.6
MTMR6		ENSG00000139505	"Myotubularin related protein 6"	Q9Y217	13	25246201-25288009	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.91e-1)"	"unprognostic (9.19e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.30e-1)"	5.2	10.2	6.1	5.3	7.6	11.9	4.9	6.8	8.2	4.4	4.3			2.9	4.9	2.8	4.1	3.6	5.0	6.0	7.6	7.3	6.1	5.1	5.0	5.2	6.0		3.7	5.9	4.6	3.7	4.6		5.3	4.8		5.9	5.7	6.2	3.3	3.3	6.4	6.6	5.2	4.1	7.2			6.3		5.4	4.6	3.7	5.8	6.7	16.1	11.9	4.8	7.4	7.2	5.7	6.0	9.9	8.3	10.5	11.1	4.8	18.1	20.5	18.0	14.2	3.9	10.3	8.8	5.4	16.9	7.1	6.3	10.7	21.0	10.5	4.1	10.8	4.4	3.2	12.7	22.4	20.0	7.9	12.7	13.1	17.6	14.6	5.0	10.1	18.0	4.0	12.7	6.1	2.9	4.5	5.5	13.8	12.1	13.1	6.7	5.2	7.4	5.9	10.5	9.4	4.1	14.2	18.7	11.1	5.7	12.3	10.5	5.5	6.4	11.6	5.6	8.8	18.1	15.1	8.2	6.6	5.3	11.9	6.7	5.8	5.6	5.6	6.7	3.6	5.8	5.8	16.1	4.8	10.4	4.0	7.4	7.2										
MTMR9	"C8orf9, DKFZp434K171, LIP-STYX, MTMR8"	ENSG00000104643	"Myotubularin related protein 9"	Q96QG7	8	11284416-11328146	"Plasma proteins, Predicted intracellular proteins"	Endocytosis		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070944			Approved	"Actin filaments,Centrosome"				Centrosome	"Actin filaments"	"HPA070944: "	"unprognostic (1.97e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.43e-2)"	8.2	7.0	11.5	7.5	14.0	8.0	9.2	18.2	26.2	6.6	9.9	10.3	2.7	4.4	8.3	5.7	6.4	5.6	5.9	12.9	11.6	14.4	8.2	5.7	6.6	6.9	11.7	12.2	6.9	7.2	9.4	8.4	7.8	13.1	9.3	6.3	6.4	4.8	7.6	9.1	6.9	5.2	11.1	10.8	6.6	5.3	16.8	7.4	8.2	7.1	3.7	7.4	6.4	5.6	4.5	4.1	3.6	3.9	2.3	3.7	1.2	2.6	7.3	6.6	5.2	8.1	6.9	5.1	8.2	5.4	6.6	6.1	6.5	2.0	6.7	2.2	9.8	3.7	7.2	7.2	7.6	1.4	4.4	8.9	5.8	3.3	8.8	2.3	5.2	6.8	5.8	9.5	12.0	10.3	6.0	5.4	10.7	2.0	4.0	2.4	11.7	4.4	2.9	10.7	2.1	7.2	6.7	2.5	10.0	5.5	2.4	5.8	3.0	4.7	12.8	7.9	5.8	4.4	4.3	1.5	3.0	3.8	6.5	5.1	7.6	1.5	3.2	3.6	3.2	3.9	2.8	3.5	2.7	2.7	2.8	4.5	3.2	3.7	3.1	2.3	3.2	4.1	2.0	1.2	11.5	14.0	18.2	23.2	11.6	14.4	11.7	12.2	13.1	7.4
MTOR	"FLJ44809, FRAP, FRAP1, FRAP2, RAFT1, RAPT1"	ENSG00000198793	"Mechanistic target of rapamycin kinase"	P42345	1	11106535-11262507	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB069425, HPA071227"	Approved		Approved	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB069425: , HPA071227: "	"unprognostic (3.18e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.45e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.88e-1)"	"prognostic favourable (1.49e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.55e-2)"	11.3	13.9	18.7	13.0	22.5	12.3	14.9	25.2	25.2	11.3	14.5	18.2	10.4	11.2	13.8	23.6	13.1	10.5	15.7	14.2	14.5	13.6	15.8	19.4	10.8	14.3	14.0	14.4	10.7	16.6	26.5	16.0	12.5	15.5	15.2	17.1	14.4	14.2	15.2	24.6	16.5	13.6	15.2	10.4	15.4	13.1	38.6	13.1	16.6	13.2	9.9	15.7	11.7	10.2	3.9	4.0	3.0	6.4	2.6	5.6	2.3	15.2	13.8	18.7	14.1	22.6	10.8	9.3	12.9	12.4	17.2	17.0	14.2	14.1	16.9	11.1	15.2	18.2	25.2	19.7	22.3	13.5	18.4	22.5	28.6	17.9	14.2	21.9	16.8	13.8	15.0	24.6	25.0	21.8	25.1	14.6	12.0	17.4	15.1	16.7	14.1	13.1	15.2	22.0	11.3	15.2	13.8	18.9	13.8	27.6	14.9	16.9	12.1	13.0	23.2	15.1	13.7	11.5	17.2	14.4	13.4	33.3	10.9	23.7	15.8	0.7	2.9	3.0	5.2	6.4	4.3	3.9	3.0	2.7	4.0	3.4	3.6	3.1	2.0	2.6	3.3	3.1	5.6	2.3	18.7	22.5	25.2	25.2	14.5	13.6	14.0	14.4	15.5	13.1
MTPN	"GCDP, MYOTROPHIN, V-1"	ENSG00000105887	Myotrophin	P58546	7	135926761-135977353	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019735	Approved		Approved	"Plasma membrane,Cytosol"			48000000	"Plasma membrane, Cytosol"		"HPA019735: AB_1858710"	"unprognostic (5.97e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.52e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.06e-3)"	"unprognostic (3.30e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (9.00e-3)"	"unprognostic (4.86e-3)"	31.0	22.1	40.2	28.5	53.2	55.1	39.6	34.4	50.0	30.9	21.4	20.4	16.0	17.2	29.5	21.9	62.1	27.0	23.7	31.6	38.0	31.6	25.1	20.5	31.6	49.3	24.2	32.4	22.0	10.7	29.2	22.5	26.3	22.9	23.4	23.6	21.5	22.2	24.0	27.4	19.1	23.1	27.9	23.3	42.4	17.6	23.4	19.9	36.4	36.9	24.9	42.8	26.1	30.5	37.9	24.6	50.6	43.5	12.8	16.7	17.0	27.2	21.6	23.9	35.7	34.3	40.8	12.5	43.2	43.9	27.7	30.4	24.6	29.4	48.1	32.0	53.1	17.4	22.3	33.9	51.4	35.6	22.0	32.9	23.4	16.0	28.2	44.0	47.4	29.8	33.6	33.0	31.0	43.1	39.0	29.1	52.2	20.8	44.4	32.6	33.8	30.7	25.8	18.3	39.2	30.1	22.6	30.8	56.2	35.2	21.9	33.2	16.1	26.9	46.2	42.0	19.2	41.7	40.7	24.3	35.7	71.1	67.1	38.7	89.2	25.4	21.4	22.6	16.7	28.9	14.3	30.9	10.4	12.5	24.6	37.9	6.9	9.9	50.6	12.8	43.5	24.2	9.0	17.0	40.2	53.2	34.4	50.0	38.0	31.6	24.2	32.4	22.9	19.9
MTREX	"Dob1, fSAP118, KIAA0052, Mtr4, SKIV2L2"	ENSG00000039123	"Mtr4 exosome RNA helicase"	P42285	5	55307760-55425581	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037379	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037379: AB_10601713"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.08e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.05e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.11e-1)"	23.6	23.6	26.1	24.9	24.0	18.7	24.1	40.6	31.2	22.0	19.3	15.2	28.8	27.6	26.2	17.8	23.3	20.0	22.4	24.3	22.0	16.0	21.2	22.7	19.7	24.7	21.1	21.5	25.9	25.8	35.8	45.0	19.0	26.6	25.6	21.7	10.4	21.8	28.7	71.3	23.8	24.3	20.9	37.5	20.9	20.6	22.3	21.5	29.7	29.3	19.2	21.7	24.4	23.4	9.8	10.9	5.8	10.3	5.9	10.4	4.0	14.2	20.0	14.6	15.5	12.3	13.0	19.6	13.1	10.0	14.8	18.8	21.3	18.7	27.6	15.5	11.5	9.8	28.3	17.9	22.2	4.9	23.5	18.9	18.8	16.3	11.4	11.1	12.5	10.2	12.3	15.6	19.0	12.8	22.3	16.0	14.2	12.9	11.9	14.6	13.2	19.4	14.6	16.3	12.1	16.0	20.8	18.0	11.1	14.9	8.4	12.8	20.3	16.1	11.5	3.8	9.6	10.6	21.9	11.8	12.3	23.8	9.7	25.4	14.7	4.9	6.6	5.8	10.4	6.1	10.0	8.8	7.7	9.7	7.9	9.8	8.1	8.3	1.9	5.9	10.3	10.9	7.5	4.0	26.1	24.0	40.6	31.2	22.0	16.0	21.1	21.5	26.6	21.5
MTSS1	"KIAA0429, MIM, MIMA, MIMB"	ENSG00000170873	"MTSS1, I-BAR domain containing"	O43312	8	124550790-124728429	"Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 20.7;HDLM-2: 23.8;HEL: 81.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 44.8"	"Group enriched"	"Detected in many"	4	"B-cells: 16.1;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019613, HPA064003, HPA075540"	Approved	Supported	Uncertain	"Plasma membrane,Cytosol"			10000	"Plasma membrane, Cytosol"		"HPA019613: , HPA064003: , HPA075540: "	"unprognostic (1.70e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.48e-1)"	"prognostic favourable (2.11e-7)"	"unprognostic (6.74e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-3)"	18.7	27.3	14.0	9.2	16.3	8.5	12.4	36.0	19.1	8.1	8.2	32.1	1.7	5.0	5.6	15.8	32.4	8.9	7.0	13.4	13.5	13.6	18.2	51.5	12.0	12.1	18.1	10.3	8.2	21.0	2.6	10.5	25.3	16.9	7.9	7.0	19.8	10.2	5.3	16.5	21.3	5.0	7.2	20.9	23.9	9.0	15.8	20.0	8.2	4.1	12.1	12.2	9.7	13.7	16.1	3.3	0.6	44.8	0.6	6.9	6.8	0.9	0.2	12.9	0.3	20.7	10.7	0.0	0.5	3.5	0.2	0.1	1.2	0.1	0.4	1.3	0.0	0.2	0.1	7.1	0.2	23.8	0.4	81.4	0.2	6.4	4.7	0.0	8.7	17.0	16.5	3.9	10.3	7.8	0.1	0.1	1.4	0.6	0.2	1.0	0.5	0.1	0.1	0.0	0.1	2.9	2.8	9.3	0.8	2.0	1.9	6.6	0.3	0.2	4.0	0.7	0.4	0.0	0.2	0.2	0.2	1.4	7.5	0.2	2.7	0.6	3.9	0.0	6.9	25.6	0.8	13.2	1.5	2.6	3.3	16.1	0.7	2.1	0.6	0.6	44.8	0.0	0.1	6.8	14.0	16.3	36.0	16.7	13.5	13.6	18.1	10.3	16.9	20.0
MUC16	"CA125, FLJ14303"	ENSG00000181143	"Mucin 16, cell surface associated"	Q8WXI7	19	8848844-8981342	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 6.6;cervix, uterine: 19.3;fallopian tube: 6.7;salivary gland: 6.3"	"Cell line enhanced"	"Detected in some"		"A-431: 15.5;CAPAN-2: 5.5;HaCaT: 5.3;HeLa: 26.9"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB055172, HPA065600"	Enhanced				"Secreted in other tissues"					"CAB055172: AB_2148831, HPA065600: "	"unprognostic (8.66e-2)"	"unprognostic (3.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.83e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-8)"	"unprognostic (3.50e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.68e-3)"	6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.3	0.0			0.0	2.4	0.0	0.2	6.7	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0		0.0	0.0	0.0	0.0	0.3		0.0	0.0		6.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.4	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC5B	"MG1, MUC5"	ENSG00000117983	"Mucin 5B, oligomeric mucus/gel-forming"	Q9HC84	11	1223066-1262172	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 301.7;lymphoid tissue: 155.1;salivary gland: 192.8"	"Cell line enriched"	"Detected in some"	7	"PC-3: 51.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008246, CAB009396"	Enhanced		Supported	Vesicles	"Secreted in other tissues"		590000	Vesicles		"CAB009396: AB_2282256, HPA008246: AB_1854203"	"unprognostic (2.01e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.76e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.80e-3)"	"unprognostic (3.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.57e-7)"	"unprognostic (2.71e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.13e-2)"	0.1	0.1	0.1	0.7	0.1	0.0	0.2	0.1	0.1	67.4	8.4	0.0	0.0	0.0	1.9	0.0	11.6	0.2	301.7	0.1	0.1	0.1	0.1	0.6	2.0	0.0	0.1	0.0	0.1	2.2	0.0	0.1	0.0	0.0	0.1	4.6	0.0	192.8	0.0	0.7	0.1	0.3	0.1	0.1	0.1	1.5	0.1	0.0	0.0	0.1	31.6	155.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	51.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MUT		ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463191	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 96.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol			110000	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favourable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	10.7	14.3	10.9	5.7	13.4	4.1	9.7	10.0	12.1	8.9	12.7	8.6	9.0	13.6	8.7	8.6	13.2	8.4	7.5	16.6	10.1	10.0	25.5	96.5	7.8	5.7	11.8	9.5	13.1	15.7	15.8	13.5	7.5	12.0	11.2	11.2	8.0	9.3	9.2	13.7	9.0	14.7	11.8	9.7	6.4	10.9	9.1	9.9	8.2	11.2	9.1	5.8	12.8	8.1	9.4	8.9	14.0	15.2	14.2	12.0	6.7	13.2	4.7	14.3	16.6	28.5	27.1	7.9	11.9	15.7	12.6	18.7	5.4	6.9	12.3	9.5	12.7	7.6	15.9	8.4	17.8	10.5	11.5	6.5	10.8	14.2	20.8	8.3	6.3	16.4	12.6	12.8	15.0	12.1	11.9	14.8	14.8	8.3	9.7	8.3	6.1	3.5	8.8	17.9	17.0	14.6	12.8	13.3	9.2	13.1	9.4	19.7	8.2	13.4	8.7	11.8	8.7	15.9	16.0	5.9	6.6	10.6	16.6	9.9	10.2	14.0	7.5	12.5	7.9	9.9	9.9	9.4	9.5	9.9	8.9	8.3	12.0	9.0	4.3	14.2	15.2	6.3	11.9	6.7	10.9	13.4	10.0	12.1	10.1	10.0	11.8	9.5	12.0	9.9
MVD	MPD	ENSG00000167508	"Mevalonate diphosphate decarboxylase"	P53602	16	88651935-88663161	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041404, HPA048250"	Uncertain		Approved	"Cell Junctions,Cytosol"			30000	Cytosol	"Cell Junctions"	"HPA041404: , HPA048250: "	"unprognostic (1.67e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.42e-1)"	"prognostic favourable (2.17e-4)"	"unprognostic (1.89e-1)"	"unprognostic (9.56e-2)"	"unprognostic (9.26e-3)"	"unprognostic (8.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.00e-2)"	11.9	18.5	15.8	16.9	19.7	7.6	12.5	21.7	27.9	10.8	19.4	17.1	10.8	39.6	8.4	7.3	30.0	7.4	8.7	11.9	17.2	18.2	9.2	25.9	14.6	12.6	14.6	17.3	11.1	19.0	11.0	7.8	7.6	24.5	13.7	5.1	10.8	16.1	8.7	27.8	18.3	20.7	6.6	23.8	11.1	21.2	23.0	14.6	4.3	9.2	18.6	12.2	7.3	13.8	15.0	17.6	2.5	8.9	18.1	18.1	9.4	14.6	9.4	15.7	10.2	5.3	11.8	8.9	7.3	7.6	5.0	4.2	24.8	37.1	7.1	11.7	4.3	21.8	7.0	38.6	1.4	4.4	11.9	5.2	5.2	37.7	10.8	3.3	3.7	9.3	7.4	13.2	4.2	5.3	14.4	3.9	2.7	34.2	11.1	16.8	18.9	9.2	11.7	4.5	18.3	14.6	9.2	15.9	5.3	18.1	4.1	5.3	20.6	14.8	11.3	4.6	9.4	8.2	4.1	10.8	4.8	24.2	5.6	16.2	7.6	2.5	8.2	1.5	18.1	8.6	13.5	10.3	12.1	11.9	9.5	15.0	9.4	11.5	1.1	18.1	8.9	17.6	12.6	9.4	15.8	19.7	21.7	27.9	17.2	18.2	14.6	17.3	24.5	14.6
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.2;BJ hTERT+ SV40 Large T+ RasG12V: 41.2;MOLT-4: 26.3;U-266/84: 43.8;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain									"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	0.9	2.3	0.0	0.0	5.8	42.2	41.2	0.0	14.3	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.5	0.0	17.4	0.0	7.5	0.3	0.3	0.0	3.4	0.0	0.8	0.0	0.0	0.7	8.9	0.0	0.0	26.3	10.5	16.5	0.2	3.8	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.6	1.3	45.2	4.5	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1
MYBBP1A	"FLJ37886, P160, PAP2, Pol5"	ENSG00000132382	"MYB binding protein 1a"	Q9BQG0	17	4538897-4555631	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005466	Supported		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"HPA005466: AB_2667327"	"unprognostic (8.06e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (1.84e-1)"	"prognostic favourable (1.61e-4)"	"unprognostic (3.88e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (8.12e-4)"	"unprognostic (9.70e-2)"	14.1	11.6	13.8	16.5	14.6	13.2	16.2	15.0	21.5	11.3	10.2	14.9	11.1	12.9	15.4	11.7	17.1	15.8	12.4	11.5	11.7	9.2	8.7	21.5	11.6	16.0	15.2	11.1	15.3	23.7	10.5	13.1	7.2	13.0	17.0	7.2	12.7	24.5	15.3	30.8	25.0	12.8	10.9	7.3	15.0	12.9	9.3	12.6	14.6	11.7	18.2	17.6	15.4	13.2	5.3	4.9	0.4	4.9	4.3	5.9	3.8	19.4	31.2	4.1	18.8	5.3	6.2	14.0	13.5	6.0	13.7	10.6	23.0	8.0	26.6	15.8	8.0	24.7	17.0	20.4	6.4	13.3	45.8	12.8	19.3	20.3	8.5	15.0	11.7	9.0	11.7	20.1	10.0	9.1	20.9	12.3	5.8	16.9	17.5	5.9	18.8	16.3	22.7	6.9	17.6	3.2	15.7	8.7	16.7	13.8	9.7	9.1	9.3	6.1	11.7	11.9	10.7	11.1	38.7	11.1	7.5	10.8	11.3	17.6	15.2	0.0	2.8	0.4	5.1	2.7	5.9	5.3	4.2	5.5	4.9	3.3	4.5	4.6	0.1	4.3	4.9	3.5	1.8	3.8	13.8	14.6	15.0	21.5	11.7	9.2	15.2	11.1	13.0	12.6
MYBL1	"A-myb, AMYB"	ENSG00000185697	"MYB proto-oncogene like 1"	P10243	8	66562175-66614247	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 25.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.6;BJ hTERT+ SV40 Large T+ RasG12V: 24.2;Daudi: 29.1;HBF TERT88: 39.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.9;MAIT T-cell: 3.5"	"Group enriched"	"Detected in many"	32	"NK-cells: 1.4;T-cells: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008791	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA008791: AB_1078540"	"unprognostic (1.11e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.23e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.67e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-3)"	"prognostic unfavourable (2.03e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.87e-2)"	2.1	1.1	2.6	25.6	5.1	2.5	2.2	6.5	3.8	1.6	2.1	4.0	2.6	1.7	1.6	2.9	1.5	1.8	3.3	3.9	3.4	2.2	1.4	2.4	4.5	21.7	6.4	2.8	1.2	0.7	1.3	1.2	4.1	6.3	2.6	1.9	1.8	1.2	2.2	1.3	1.6	3.9	2.7	6.5	11.0	2.2	12.7	4.4	4.7	1.5	1.0	18.0	2.2	1.9	0.0	0.0	0.0	0.0	1.4	4.9	0.3	11.6	4.0	1.3	3.4	0.3	0.7	0.9	16.1	7.4	28.6	24.2	0.5	11.8	29.1	1.4	13.5	3.3	1.1	1.3	39.5	3.5	1.8	0.6	4.4	0.5	0.0	0.2	1.1	0.2	0.1	7.8	6.6	0.9	0.1	9.7	17.4	1.0	1.9	0.4	0.9	5.4	0.6	4.8	0.7	6.7	0.4	2.8	1.1	2.8	1.0	2.9	17.3	0.7	4.9	17.2	3.9	3.8	14.7	2.8	3.9	8.6	4.5	1.7	6.8	0.0	0.0	0.0	4.9	0.0	3.5	0.0	0.9	2.0	0.0	0.0	0.1	0.8	0.0	1.4	0.0	0.0	0.0	0.3	2.6	5.1	6.5	3.8	3.4	2.2	6.4	2.8	6.3	4.4
MYBPC3	"CMH4, FHC, MYBP-C"	ENSG00000134571	"Myosin binding protein C, cardiac"	Q14896	11	47331397-47352702	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	108	"heart muscle: 199.6"	"Cell line enriched"	"Detected in single"	17	"U-937: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.8"	"Region enriched"	"Detected in single"	33	"cerebellum: 38.5"	"Low region specificity"	"Detected in many"			"HPA040147, HPA043898"	Enhanced						44000			"HPA040147: AB_2676861, HPA043898: AB_2678720"	"unprognostic (1.06e-1)"	"unprognostic (1.47e-6)"	"unprognostic (2.17e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.40e-4)"	"unprognostic (7.47e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.21e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	199.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
MYD88		ENSG00000172936	"Myeloid differentiation primary response 88"	Q99836	3	38138478-38143022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 68.0"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009104	Approved		Supported	Vesicles,Mitochondria,Cytosol				Cytosol	"Vesicles, Mitochondria"	"CAB009104: AB_2146724"	"prognostic favourable (8.45e-4)"	"unprognostic (1.19e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.38e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.01e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.08e-2)"	25.0	11.3	5.9	19.5	6.9	18.1	14.7	5.2	4.6	10.0	13.4	5.8	5.0	15.1	9.5	12.3	25.5	9.8	12.4	10.4	5.3	3.2	15.1	47.9	25.6	40.1	6.2	3.5	13.3	10.3	5.4	10.4	17.8	6.7	11.3	14.3	8.8	13.9	5.4	3.9	12.5	30.4	10.7	7.0	39.0	12.5	5.8	5.1	28.5	10.4	17.5	30.8	13.9	13.7	7.8	34.7	49.0	68.0	8.3	14.3	34.6	8.1	12.0	1.8	10.7	8.5	11.1	3.7	8.0	13.1	22.6	24.0	7.5	9.9	17.4	4.8	14.3	10.2	14.2	8.0	7.6	13.5	2.9	9.4	6.1	11.4	7.0	11.9	24.6	12.7	8.5	12.8	4.8	12.8	4.1	7.1	11.8	8.2	19.6	3.8	7.6	12.0	8.5	2.3	7.5	11.6	19.0	0.8	3.9	11.3	54.5	7.1	8.5	13.5	11.9	4.4	2.7	20.4	7.6	10.5	11.7	12.9	8.6	20.9	9.6	38.3	37.6	48.1	12.2	56.5	10.4	7.8	11.0	12.2	34.7	6.7	7.7	10.9	49.0	8.3	68.0	16.6	14.3	34.6	5.9	6.9	5.2	4.6	5.3	3.2	6.2	3.5	6.7	5.1
MYDGF	"C19orf10, IL-25, IL-27, IL25, IL27, IL27w, R33729_1, SF20"	ENSG00000074842	"Myeloid derived growth factor"	Q969H8	19	4641374-4670370	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041872, HPA046744"	Approved				"Secreted to blood"	284533	3300000			"HPA041872: , HPA046744: "	"unprognostic (3.14e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-1)"	"prognostic favourable (6.50e-7)"	"unprognostic (4.14e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.11e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (4.99e-12)"	"unprognostic (4.42e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	20.7	26.1	12.1	25.4	13.2	24.7	31.2	7.0	17.1	27.4	25.1	10.9	51.7	23.9	21.7	40.5	18.1	19.3	28.7	22.9	11.6	13.5	24.6	108.0	25.3	41.5	15.5	11.2	21.4	115.5	6.4	36.9	55.2	14.5	23.7	21.3	10.7	58.7	43.8	11.3	16.0	26.9	16.8	12.6	35.0	29.1	19.3	12.4	11.1	30.4	19.5	20.3	17.5	28.5	24.6	80.4	23.0	42.8	27.1	30.6	35.9	30.5	15.1	9.7	24.5	30.4	25.5	17.1	55.1	48.7	27.5	34.7	24.6	20.0	17.8	26.5	57.7	15.5	11.4	20.1	16.0	16.6	19.0	10.7	27.1	31.1	47.3	38.2	26.2	21.2	24.4	20.1	38.5	29.9	18.7	135.7	25.0	16.7	10.0	21.5	12.2	52.2	9.8	16.3	85.2	21.8	14.4	14.7	15.1	18.8	24.5	27.2	14.4	46.2	33.7	21.5	17.6	58.3	40.4	65.4	26.7	15.0	52.9	50.6	33.5	23.0	41.7	14.8	30.0	42.8	30.6	24.6	24.2	24.1	49.8	19.1	20.7	22.1	2.6	27.1	36.7	80.4	17.6	35.9	12.1	13.2	7.0	17.1	11.6	13.5	15.5	11.2	14.5	12.4
MYH1	"MGC133384, MYHa, MyHC-2X/D, MYHSA1"	ENSG00000109061	"Myosin heavy chain 1"	P12882	17	10492307-10518543	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"skeletal muscle: 428.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;U-2 OS: 2.2"	"Cancer enriched"	"Detected in single"	45	"head and neck cancer: 8.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA001349, CAB010759"	Enhanced						49000000			"CAB010759: AB_477248, HPA001349: AB_1079437"	"unprognostic (2.87e-2)"					"unprognostic (3.27e-3)"		"unprognostic (1.91e-1)"	"unprognostic (8.95e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.31e-2)"		"unprognostic (5.63e-3)"	"unprognostic (9.85e-4)"	"unprognostic (1.92e-1)"		"unprognostic (4.58e-2)"	5.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	428.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 57.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"			130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: , HPA057198: "	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favourable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavourable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.6	9.0	57.2	19.1	7.5	9.0	25.7	11.4	10.4	13.8	14.9	24.2	2.1	0.1	7.6	11.3	1.3	28.4	13.7	15.6	0.3	23.1	15.8	5.8	21.0	17.5	1.3	1.1	12.8	5.0	17.9	6.9	22.3	21.9	0.0	8.6	5.4	16.7	0.4	26.9	2.0	26.8	17.0	0.0	15.7	5.7	4.7	25.7	17.9	0.9	18.3	4.8	0.9	0.7	13.0	9.6	0.1	9.8	2.2	2.6	3.4	0.0	1.3	29.2	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.5;NB-4: 3.8;U-698: 9.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Supported	"Plasma membrane,Cytosol"			130000000	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1854260, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favourable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.3	3.8	0.4	0.1	0.4	0.1	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.4	0.0	0.3	0.1	0.3	2.0	0.1	0.4	0.4	9.7	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2
MYH13	MyHC-eo	ENSG00000006788	"Myosin heavy chain 13"	Q9UKX3	17	10300865-10373130	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 1.9;skeletal muscle: 5.2;stomach 1: 4.8"	"Cell line enriched"	"Detected in some"	4	"U-2 OS: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"														"unprognostic (8.86e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.81e-2)"	"unprognostic (3.95e-1)"		"unprognostic (8.35e-2)"		"unprognostic (1.42e-2)"	"unprognostic (7.50e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.40e-9)"	"unprognostic (2.44e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.06e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	5.2	0.0	0.8	0.1	0.1	0.4	4.8	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310544	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;skeletal muscle: 53.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.0;CAPAN-2: 19.0;HaCaT: 37.8;MCF7: 18.4;RT4: 46.9;SK-BR-3: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm			59000000	Nucleoplasm		"HPA062391: , HPA067889: , HPA070260: "	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.97e-8)"	"prognostic favourable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	5.5	0.5	6.1	8.4	6.1	0.1	2.7	4.6	9.4	3.4	63.9	10.5	3.5	38.7	1.1	4.6	14.7	7.5	9.2	16.2	6.4	5.4	4.3	8.7	11.5	0.2	8.5	3.9	1.1	7.5	7.3	4.5	0.7	7.8	3.2	9.4	4.6	12.0	3.1	53.1	20.3	78.6	0.8	11.1	0.2	21.0	0.7	4.2	0.4	16.7	11.4	9.5	4.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	1.5	0.0	8.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.4	19.0	0.0	9.9	0.0	37.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	7.9	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	18.4	0.0	0.1	0.2	0.2	0.0	9.6	0.2	0.0	46.9	0.0	0.0	0.9	16.8	0.0	3.1	0.5	0.0	0.0	3.9	0.0	0.0	0.3	3.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.1	4.6	9.4	6.4	5.4	8.5	3.9	7.8	4.2
MYH2	"IBM3, MYH2A, MYHas8, MyHC-2A, MyHC-IIa, MYHSA2"	ENSG00000125414	"Myosin heavy chain 2"	Q9UKX2	17	10521148-10549957	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 559.4;tongue: 232.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 6.0;HSkMC: 2.9;NTERA-2: 12.8"	"Cancer enriched"	"Detected in single"	60	"head and neck cancer: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001349, CAB010760"	Enhanced						42000000			"CAB010760: AB_477190, HPA001349: AB_1079437"	"unprognostic (6.50e-2)"					"unprognostic (1.86e-2)"		"unprognostic (4.76e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.05e-4)"	"unprognostic (2.89e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"			10.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	11.6	0.1	559.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	232.5	11.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.1	12.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYH3	"HEMHC, MYHC-EMB, MYHSE1, SMHCE"	ENSG00000109063	"Myosin heavy chain 3"	P11055	17	10628526-10657309	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 21.1;prostate: 25.6;skeletal muscle: 18.5"	"Cell line enriched"	"Detected in some"	28	"HSkMC: 37.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.7"	"Low region specificity"	"Detected in some"			HPA021808	Enhanced						17000000			"HPA021808: AB_1854242"	"unprognostic (1.70e-2)"	"unprognostic (1.10e-3)"	"unprognostic (4.19e-4)"	"unprognostic (3.35e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.54e-1)"	"unprognostic (7.84e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.24e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.17e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.49e-1)"	1.0	0.5	0.7	0.8	1.0	0.6	0.8	1.9	0.8	2.2	4.1	0.6	3.5	0.9	1.9	13.2	21.1	1.0	0.6	0.6	0.9	0.6	0.8	1.8	0.6	1.0	0.9	0.6	1.4	1.3	0.5	0.7	1.1	0.6	25.6	0.9	0.6	0.7	16.2	18.5	1.5	1.4	16.5	1.2	1.6	0.8	2.8	0.6	1.8	2.3	1.7	2.0	8.5	2.6	1.0	0.1	0.0	0.1	0.9	0.7	0.0	0.1	0.6	0.4	0.6	0.6	0.2	0.6	0.4	0.2	0.3	0.3	0.6	0.1	0.4	0.2	0.2	0.6	0.3	0.1	0.6	0.4	0.5	0.5	0.1	0.9	0.2	0.3	0.8	37.0	0.2	0.4	0.4	0.0	0.2	0.0	0.1	0.4	0.5	1.3	0.5	0.4	0.5	0.5	0.1	0.2	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.1	0.0	0.8	0.6	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.7	0.0	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.9	0.0	0.1	0.6	0.0	0.7	1.0	1.9	0.8	0.9	0.6	0.9	0.6	0.6	0.6
MYH4	"MYH2B, MyHC-2B, MyHC-IIb"	ENSG00000264424	"Myosin heavy chain 4"	Q9Y623	17	10443290-10469559	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	29	"skeletal muscle: 15.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.5;U-2 OS: 1.4"	"Cancer enriched"	"Detected in single"	115	"liver cancer: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"amygdala: 0.9"	HPA001349	Supported						34000000			"HPA001349: AB_1079437"	"unprognostic (3.27e-2)"		"unprognostic (2.94e-2)"			"unprognostic (4.94e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.72e-1)"			"unprognostic (1.37e-1)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.52e-4)"		"unprognostic (9.97e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYH6		ENSG00000197616	"Myosin heavy chain 6"	P13533	14	23381990-23408277	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Atrial septal defect, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"heart muscle: 313.7"	"Cell line enriched"	"Detected in single"	23	"NTERA-2: 10.1"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001239, HPA001349, CAB075723, CAB075724, CAB075725"	Enhanced						20000000			"CAB075723: , CAB075724: , CAB075725: , HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (2.09e-2)"	"unprognostic (8.53e-4)"		"unprognostic (1.80e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.09e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.34e-3)"		"unprognostic (6.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.1	313.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.2	8.6	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.7	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
MYH7	"CMD1S, CMH1, MPD1"	ENSG00000092054	"Myosin heavy chain 7"	P12883	14	23412738-23435718	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"heart muscle: 644.7;skeletal muscle: 596.4"	"Cell line enriched"	"Detected in single"	32	"HSkMC: 16.0"	"Group enriched"	"Detected in some"	9	"head and neck cancer: 12.2;prostate cancer: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA001239, HPA001349, CAB015384"	Enhanced						31000000			"CAB015384: AB_2147279, HPA001239: AB_1079438, HPA001349: AB_1079437"	"unprognostic (6.49e-2)"	"unprognostic (8.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (3.04e-3)"	"unprognostic (4.30e-1)"	"unprognostic (7.33e-3)"		"unprognostic (8.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.38e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.28e-2)"	5.4	0.1	0.2	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	11.7	7.2	0.0	0.1	644.7	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.0	0.1	0.0	0.0	3.3	0.0	0.0	11.8	0.0	596.4	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	2.9	109.6	16.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.0
MYH8	"MyHC-peri, MyHC-pn"	ENSG00000133020	"Myosin heavy chain 8"	P13535	17	10390322-10421950	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 16.5;skeletal muscle: 18.3;tongue: 10.0"	"Cell line enriched"	"Detected in single"	14	"HSkMC: 12.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA001349, CAB016527"	Enhanced									"CAB016527: AB_2147291, HPA001349: AB_1079437"	"unprognostic (5.87e-2)"					"unprognostic (5.13e-3)"		"unprognostic (4.12e-2)"	"unprognostic (1.25e-2)"		"unprognostic (2.29e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.02e-3)"	"unprognostic (7.87e-2)"	"unprognostic (1.61e-1)"		"unprognostic (3.56e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.4	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.8	0.0	10.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MYH9	"DFNA17, EPSTS, FTNS, MHA, NMHC-II-A, NMMHCA"	ENSG00000100345	"Myosin heavy chain 9"	P35579	22	36281277-36388067	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Alport syndrome, Cancer-related genes, Cataract, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001644, CAB015386, HPA064783"	Enhanced		Supported	"Plasma membrane,Actin filaments,Cytosol"			3100000000	"Plasma membrane, Actin filaments"	Cytosol	"CAB015386: AB_784698, HPA001644: AB_1079439, HPA064783: AB_2732721"	"unprognostic (1.38e-1)"	"unprognostic (9.12e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.90e-2)"	"unprognostic (9.56e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.98e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.59e-2)"	115.5	26.1	11.9	43.7	12.9	55.6	59.0	9.3	16.8	67.1	44.6	18.0	26.4	26.9	120.8	39.7	48.3	45.6	66.9	39.2	11.0	8.1	45.0	42.8	74.4	57.7	15.1	9.2	56.4	43.9	19.0	15.4	65.7	17.9	47.6	23.6	32.4	66.2	27.2	36.9	40.3	49.8	46.7	13.5	91.5	37.1	25.8	11.9	76.0	42.5	38.4	65.0	56.0	53.7	6.9	8.2	28.5	11.5	4.2	16.6	19.3	60.6	28.2	9.0	7.6	16.8	21.1	45.7	40.7	52.7	58.2	43.7	30.4	17.5	15.7	24.2	68.1	42.1	13.1	79.7	60.0	35.4	12.4	30.3	30.3	25.9	51.5	34.4	48.6	24.9	24.6	78.6	66.8	47.9	6.6	21.3	46.5	16.1	12.2	20.3	5.3	17.4	23.3	27.9	14.6	32.9	59.1	13.5	5.5	57.2	22.5	26.2	16.8	17.8	137.0	129.1	39.2	24.7	73.5	14.1	11.1	13.3	48.9	17.4	37.4	26.8	10.4	28.5	16.6	9.6	14.7	6.9	12.0	13.2	8.2	6.4	9.6	10.1	19.7	4.2	11.5	3.8	12.6	19.3	11.9	12.9	9.3	16.8	11.0	8.1	15.1	9.2	17.9	11.9
MYL1		ENSG00000168530	"Myosin light chain 1"	P05976	2	210290150-210315190	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"skeletal muscle: 743.1;tongue: 350.7"	"Cell line enriched"	"Detected in some"	5	"HSkMC: 33.8"	"Group enriched"	"Detected in some"	18	"head and neck cancer: 36.0;prostate cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA046859, HPA063034, HPA073827"	Enhanced				"Intracellular and membrane"		20000000			"HPA046859: , HPA063034: , HPA073827: "						"prognostic unfavourable (6.59e-4)"									"unprognostic (1.88e-1)"			12.9	0.1	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	16.1	9.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	6.1	0.0	0.0	13.4	0.0	743.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	2.4	350.7	9.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	7.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYL12B	MRLC2	ENSG00000118680	"Myosin light chain 12B"	O14950	18	3261909-3278284	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039262, HPA045244, HPA059197"	Supported		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA039262: , HPA045244: , HPA059197: "	"unprognostic (2.55e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.69e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-2)"	"unprognostic (7.65e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.18e-1)"	"prognostic favourable (8.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.77e-1)"	"prognostic favourable (6.62e-6)"	"unprognostic (1.27e-2)"	64.1	82.2	38.7	46.1	38.2	41.9	66.1	27.0	48.9	63.9	84.8	21.4	58.7	67.6	52.9	86.8	106.9	49.6	65.2	53.0	37.8	34.0	150.0	105.3	85.9	68.7	36.0	31.9	53.4	48.9	48.4	37.5	139.8	46.8	56.8	75.0	37.1	69.8	52.8	71.8	59.6	129.4	54.7	30.9	62.2	52.8	42.8	26.0	65.1	107.2	89.8	61.1	58.6	61.5	46.7	83.6	151.5	78.1	47.6	77.7	109.0	48.0	25.5	22.6	21.8	65.9	56.3	39.0	73.4	64.6	68.6	70.8	53.4	38.6	24.1	32.4	99.7	24.4	37.4	84.4	70.5	14.1	15.8	24.3	28.9	42.8	68.0	54.4	38.3	48.4	81.0	45.6	29.2	102.7	20.8	23.7	89.0	97.5	31.1	39.3	15.1	21.9	15.5	28.5	19.3	144.6	89.2	18.6	19.4	72.9	44.4	44.2	38.0	32.6	123.6	66.8	99.7	58.2	88.8	13.2	12.6	29.4	40.5	22.1	51.9	123.3	51.4	151.5	72.2	68.0	61.4	46.7	70.7	77.7	60.9	37.8	58.0	66.8	120.5	47.6	78.1	83.6	75.2	109.0	38.7	38.2	27.0	48.9	37.8	34.0	36.0	31.9	46.8	26.0
MYL3	"CMH8, MLC1SB, MLC1V, VLC1"	ENSG00000160808	"Myosin light chain 3"	P08590	3	46857872-46882169	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"heart muscle: 398.1;skeletal muscle: 319.8"	"Cell line enriched"	"Detected in some"	5	"RPTEC TERT1: 27.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA016564, CAB018662, HPA046859, HPA063034"	Enhanced		Approved	Nucleoli,Mitochondria			15000000	"Nucleoli, Mitochondria"		"CAB018662: AB_627952, HPA016564: AB_1854244, HPA046859: , HPA063034: "	"unprognostic (3.11e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.67e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (1.22e-8)"	"unprognostic (1.16e-3)"	"unprognostic (9.45e-3)"	"unprognostic (7.18e-5)"	"unprognostic (2.53e-3)"	0.9	0.2	0.5	0.2	0.4	0.0	0.6	0.2	0.4	0.5	0.1	0.3	0.0	0.0	0.2	10.1	10.5	0.1	0.2	398.1	0.7	0.4	2.3	0.1	0.2	0.1	0.7	0.3	0.3	0.1	0.0	0.0	0.3	0.3	1.6	0.0	0.3	5.5	0.0	319.8	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.4	0.0	1.1	30.1	3.1	0.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.9	1.6	0.3	0.1	0.0	0.1	5.8	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.4	0.7	0.4	0.7	0.3	0.3	0.4
MYL4	"ALC1, AMLC, GT1, PRO1957"	ENSG00000198336	"Myosin light chain 4"	P12829	17	47200446-47223679	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"	"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"heart muscle: 712.3"	"Cell line enriched"	"Detected in some"	4	"HEL: 107.4"	"Group enriched"	"Detected in some"	7	"testis cancer: 2.4;thyroid cancer: 11.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 5.2"	"Group enriched"	"Detected in many"	6	"amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8"	"Low region specificity"	"Detected in all"			"HPA046859, HPA051884, HPA063034"	Enhanced		Approved	"Plasma membrane"			140000	"Plasma membrane"		"HPA046859: , HPA051884: , HPA063034: "	"unprognostic (2.43e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.25e-1)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.00e-6)"	"unprognostic (1.92e-4)"	"unprognostic (2.54e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.50e-1)"	0.1	0.0	0.0	0.1	0.0	10.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	712.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.8	3.3	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.0	0.1	0.6	4.6	0.1	0.1	0.2	0.2	5.2	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	107.4	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.2	25.4	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	5.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0
MYL6	"ESMLC, MLC1SM, MLC3NM"	ENSG00000092841	"Myosin light chain 6"	P60660	12	56158161-56163496	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046859, HPA063034"	Approved						160000000			"HPA046859: , HPA063034: "	"unprognostic (1.10e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.01e-1)"	103.6	74.0	39.9	123.8	48.9	78.2	114.5	34.4	45.6	96.2	269.3	31.2	173.9	53.0	156.8	132.8	131.0	105.4	149.2	58.6	39.0	37.2	83.7	59.0	94.5	74.0	47.3	47.3	61.5	83.4	44.8	40.0	71.8	66.1	103.9	127.6	53.3	65.5	162.6	67.3	53.0	92.4	400.4	57.3	79.4	118.0	41.8	41.5	30.7	72.8	71.3	69.3	159.9	158.4	85.0	163.2	402.2	194.0	64.3	127.7	368.3	87.6	80.5	150.6	44.8	93.4	91.3	82.3	185.8	183.5	255.9	150.9	126.4	79.5	33.3	108.0	244.6	56.7	92.0	129.3	168.9	63.6	30.9	59.2	123.3	70.7	68.7	40.7	108.1	109.0	87.7	150.9	55.9	223.3	31.1	98.7	200.5	93.7	56.7	62.3	75.8	82.7	46.0	58.5	41.4	240.0	109.9	54.9	41.1	205.1	64.3	33.6	100.6	108.0	237.1	70.5	48.4	98.9	125.5	29.8	49.8	39.2	93.3	52.9	72.9	295.3	140.5	402.2	107.3	152.9	80.5	85.0	97.3	99.9	150.3	73.8	70.0	88.4	271.2	64.3	194.0	163.2	127.7	368.3	39.9	48.9	34.4	45.6	39.0	37.2	47.3	47.3	66.1	41.5
MYL6B	MLC1SA	ENSG00000196465	"Myosin light chain 6B"	P14649	12	56152256-56159647	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Muscle protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.6"	"Group enriched"	"Detected in all"	5	"B-cells: 5.3;dendritic cells: 15.6;T-cells: 12.0"	"Low region specificity"	"Detected in all"							"HPA038887, HPA046859, HPA063034"	Enhanced		Approved	Vesicles				Vesicles		"HPA038887: AB_10674842, HPA046859: , HPA063034: "	"unprognostic (5.25e-2)"	"unprognostic (3.18e-1)"	"unprognostic (6.29e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (2.87e-4)"	"unprognostic (4.66e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-2)"	5.6	10.0	32.0	4.8	33.1	5.4	8.7	11.9	26.7	13.9	4.1	8.0	8.5	3.0	9.8	12.8	8.4	13.2	9.7	13.6	24.1	21.8	9.3	6.2	4.5	6.9	20.7	21.6	20.0	4.8	17.4	14.1	5.1	13.4	12.6	4.0	11.0	7.3	8.3	129.0	5.1	4.1	8.4	10.7	3.9	5.1	24.9	10.2	11.5	9.9	10.7	8.8	5.6	5.0	5.3	15.6	1.8	2.3	2.0	12.0	3.1	8.2	14.1	38.4	36.6	8.1	29.3	26.8	9.6	42.5	38.3	37.4	10.1	13.7	13.7	21.3	20.6	4.7	18.0	23.4	20.7	24.8	26.1	14.4	14.5	17.7	25.8	10.5	10.1	49.0	9.4	35.4	13.8	41.4	15.2	14.2	31.4	10.7	28.7	34.9	32.2	24.4	30.4	23.8	18.1	29.1	5.5	35.4	51.9	10.7	13.0	19.3	10.7	18.0	22.9	22.5	19.4	11.6	20.5	20.2	11.5	11.4	24.1	10.7	24.6	0.7	2.3	0.7	1.8	2.2	1.0	5.3	3.7	3.0	5.4	3.5	2.7	2.2	1.8	2.0	0.9	15.6	12.0	3.1	32.0	33.1	11.9	26.7	24.1	21.8	20.7	21.6	13.4	10.2
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	1.9	4.0	1.6	2.0	17.1	4.6	4.4	1.4	3.4	3.4	7.5	11.4	2.1	9.1	7.3	2.2	5.1	8.0	2.5	2.9	3.3	8.3	6.1	4.3	2.1	2.5	4.2	6.1	7.3	3.3	1.7	1.4	7.9	17.6	10.8	1.3	7.6	0.1	20.6	4.8	3.7	2.0	7.8	33.5	3.7	24.3	8.5	3.6	1.7	18.6	9.4	3.4	10.3	2.3	1.6	3.9	1.2	3.5	10.0	4.4	4.8	1.0	12.1	5.4	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.2;fHDF/TERT166: 45.0;HBF TERT88: 29.0;RPTEC TERT1: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"			3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: "	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavourable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.1	1.3	2.1	0.4	0.9	36.5	55.2	23.6	17.0	1.6	1.4	0.1	8.2	45.0	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	11.0	0.1	1.9	6.8	0.7	4.6	6.9	1.8	0.2	0.1	17.5	0.3	0.0	0.5	2.2	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0
MYLK2	"KMLC, MLCK2, skMLCK"	ENSG00000101306	"Myosin light chain kinase 2"	Q9H1R3	20	31819308-31834689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 176.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;RH-30: 13.2;RPMI-8226: 10.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059704, HPA059890"	Enhanced		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA059704: , HPA059890: "	"unprognostic (1.74e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.84e-2)"	"unprognostic (5.27e-2)"	"prognostic favourable (4.00e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.38e-7)"	"unprognostic (2.29e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.73e-2)"	"unprognostic (7.25e-11)"	"unprognostic (2.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.70e-2)"	1.4	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.4	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	176.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.1	18.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.5	0.1	0.0	0.4	0.1	0.3	0.3	0.6	0.4	0.0	0.1	0.1	0.0	0.2	0.2	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	1.0	0.2	5.2	0.1	0.8	0.7	0.4	0.6	0.4	0.7	13.2	10.7	0.1	0.1	0.7	0.6	3.4	0.1	0.0	0.1	0.1	2.6	0.2	1.0	0.6	2.9	0.1	0.9	0.2	0.2	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MYO10	KIAA0799	ENSG00000145555	"Myosin X"	Q9HD67	5	16661914-16936276	"Plasma proteins, Predicted intracellular proteins"	Transport	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 38.8;SK-MEL-30: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015224, HPA024223"	Enhanced		Supported	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"CAB015224: , HPA024223: AB_1854248"	"unprognostic (1.13e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (7.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.43e-2)"	"unprognostic (2.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (2.75e-4)"	"unprognostic (8.93e-2)"	"unprognostic (9.86e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.84e-1)"	10.5	3.4	28.1	5.1	30.1	3.0	8.0	8.9	39.7	6.3	15.3	17.3	6.6	19.5	5.7	4.3	7.7	3.8	7.7	3.7	26.2	10.9	13.3	7.1	14.5	1.6	14.6	15.3	12.1	22.0	10.4	16.2	22.0	10.6	5.4	15.8	19.7	9.8	7.4	6.6	13.4	14.6	4.3	11.1	10.9	24.2	12.4	18.5	0.5	28.6	3.3	2.3	6.6	7.1	0.9	0.5	1.1	6.0	0.5	0.6	0.3	13.1	20.9	8.7	4.1	6.4	3.5	8.0	23.6	16.7	6.6	5.4	13.2	2.2	0.4	16.2	10.7	7.0	38.8	15.5	12.3	0.0	3.9	0.0	34.9	3.7	23.6	0.1	0.4	7.1	6.8	15.9	19.0	22.0	0.0	1.3	6.4	2.6	0.0	0.1	22.5	7.6	5.3	2.2	13.9	6.6	10.2	1.1	0.6	5.1	2.6	45.3	1.7	2.1	26.6	16.0	5.9	0.2	12.9	0.2	0.1	0.1	7.9	2.5	15.9	1.0	0.6	0.5	0.3	1.5	0.4	0.3	0.4	0.3	0.5	0.9	0.6	0.6	1.1	0.5	6.0	0.4	0.3	0.3	28.1	30.1	8.9	20.7	26.2	10.9	14.6	15.3	10.6	18.5
MYO15A	"DFNB3, MYO15"	ENSG00000091536	"Myosin XVA"	Q9UKN7	17	18108706-18179806	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Hearing	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"pituitary gland: 46.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.6;EFO-21: 2.8;HSkMC: 2.2;RPMI-8226: 3.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	15	"hippocampal formation: 2.7"	HPA078501	Enhanced									"HPA078501: "	"unprognostic (2.48e-3)"	"unprognostic (5.31e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.92e-3)"	"unprognostic (2.33e-1)"	"unprognostic (8.32e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.66e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.18e-3)"	"unprognostic (5.69e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.21e-2)"	0.5	0.0	0.5	0.6	0.7	0.0	0.5	2.3	1.6	0.5	0.5	0.5	0.5	0.2	1.7	3.4	0.5	1.0	0.5	0.5	0.5	1.2	0.5	0.8	1.5	0.5	0.5	0.5	3.0	0.5	2.2	46.1	0.5	0.7	0.5	0.4	0.5	0.5	1.6	0.5	0.1	0.9	0.5	0.5	0.5	0.6	7.4	0.5	0.5	0.9	0.5	0.5	0.5	0.5	0.7	0.4	3.8	0.9	0.6	0.3	0.1	0.1	0.0	1.5	0.0	0.9	2.6	0.4	0.1	0.9	0.0	0.0	0.5	0.3	0.2	2.8	0.9	0.4	0.0	0.8	0.0	1.3	0.6	0.0	0.3	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.6	0.0	0.1	0.4	0.0	0.5	0.1	0.5	0.1	0.0	0.2	0.4	3.4	0.0	0.0	0.1	0.2	0.0	0.0	0.2	1.4	0.4	0.2	0.0	0.1	0.0	0.0	1.0	1.4	0.1	0.0	0.1	0.4	3.8	0.5	0.5	0.2	0.9	0.3	0.7	0.1	0.1	0.2	0.4	0.2	0.3	1.4	0.6	0.2	0.4	0.1	0.1	0.5	0.7	2.3	1.5	0.5	1.2	0.5	0.5	0.7	0.5
MYO18A	"KIAA0216, MysPDZ"	ENSG00000196535	"Myosin XVIIIA"	Q92614	17	29071124-29180412	"Plasma proteins, Predicted intracellular proteins"		"Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 179.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA019646	Supported						80000			"HPA019646: AB_1854249"	"unprognostic (2.54e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.70e-2)"	"prognostic unfavourable (3.28e-4)"	"unprognostic (1.94e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (3.18e-4)"	"unprognostic (6.94e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.95e-1)"	8.3	3.6	11.9	5.8	15.5	7.7	8.6	23.1	18.7	6.1	6.7	15.9	3.6	9.0	6.5	5.4	11.8	4.4	7.2	24.6	15.2	9.4	4.0	9.2	5.2	4.8	13.6	9.9	5.1	9.3	7.4	3.4	4.0	11.4	6.0	4.8	4.4	7.4	5.1	179.7	11.7	9.0	6.3	15.7	4.8	9.0	4.3	12.9	8.0	5.7	14.5	9.1	4.8	5.9	2.2	2.3	2.9	1.8	2.1	3.0	0.7	15.0	21.3	8.2	4.2	2.2	3.8	13.2	7.2	7.2	6.3	4.4	5.3	10.7	1.5	8.1	5.1	17.3	3.2	12.0	2.5	17.5	6.0	1.3	6.3	5.8	3.3	1.8	1.9	4.4	7.1	3.8	1.7	2.3	18.6	2.8	3.1	5.2	5.4	1.5	1.7	4.7	19.0	9.2	4.7	4.9	11.2	4.3	4.4	7.1	24.1	5.3	5.6	2.2	2.6	4.1	5.1	2.8	4.9	5.3	8.9	3.0	5.2	1.3	11.0	2.5	1.6	2.4	2.3	1.8	3.0	0.9	1.7	1.8	1.8	2.2	2.4	1.4	2.9	2.1	1.7	2.3	1.3	0.7	11.9	15.5	23.1	18.7	15.2	9.4	13.6	9.9	11.4	12.9
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA053490: "	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	11.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	7.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	2.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1
MYO1D	"KIAA0727, myr4, PPP1R108"	ENSG00000176658	"Myosin ID"	O94832	17	32492522-32877177	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9;CACO-2: 45.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 2.6"	"Group enriched"	"Detected in many"	5	"B-cells: 1.7;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054744	Uncertain		Approved	Cytosol				Cytosol		"HPA054744: "	"unprognostic (3.83e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.70e-3)"	"unprognostic (3.95e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	"prognostic favourable (5.01e-6)"	"unprognostic (1.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"prognostic unfavourable (4.53e-6)"	20.3	16.9	4.4	21.6	14.4	1.8	13.9	8.8	9.7	12.8	53.1	26.2	4.8	40.5	12.5	11.8	19.8	9.2	26.9	7.4	6.4	3.7	15.7	8.1	17.7	6.9	18.4	6.8	14.7	15.2	19.6	7.4	8.4	11.6	11.3	45.6	10.2	18.7	7.1	3.8	22.0	46.5	9.4	20.9	5.9	13.1	6.4	15.7	2.5	21.9	10.6	13.4	12.7	13.9	1.7	0.2	0.3	0.0	0.4	2.6	0.5	9.6	0.4	0.2	0.1	33.9	19.5	0.3	5.7	11.3	1.0	6.6	45.0	15.4	5.4	1.2	25.6	9.1	1.2	14.4	1.6	0.6	11.6	4.9	0.0	3.1	2.2	0.0	2.7	5.6	9.2	8.4	7.6	14.2	8.2	9.0	5.1	11.6	0.0	0.1	1.8	8.6	0.0	6.6	6.2	4.6	19.0	11.3	1.9	1.9	3.5	28.6	15.6	0.0	17.5	5.1	2.5	0.2	0.1	11.0	12.5	0.0	6.9	0.0	1.5	0.0	0.0	0.0	1.1	0.0	2.6	1.7	1.2	1.4	0.2	0.3	0.3	0.4	0.3	0.4	0.0	0.0	1.1	0.5	4.4	14.4	8.8	9.7	6.4	3.7	18.4	6.8	11.6	15.7
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.2;HL-60: 15.0;HMC-1: 26.5;NB-4: 59.1;THP-1: 44.0;U-937: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055242	Enhanced						8800			"HPA055242: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.0	15.2	0.0	10.9	0.0	0.0	0.0	15.0	26.5	0.1	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.0	59.1	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	44.0	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	24.3	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0
MYO3A	DFNB30	ENSG00000095777	"Myosin IIIA"	Q8NEV4	10	25934071-26212536	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Hearing, Sensory transduction, Vision"	"Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.1;testis: 12.5"	"Cell line enhanced"	"Detected in some"		"AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.6;SCLC-21H: 2.4;U-2 OS: 4.3;U-698: 10.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4"	"Cell type enriched"	"Detected in single"	12	"naive B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA048951, HPA051893"	Approved		Supported	"Plasma membrane,Actin filaments,Cytoplasmic bodies"				"Actin filaments, Cytoplasmic bodies"	"Plasma membrane"	"HPA048951: , HPA051893: "	"unprognostic (5.00e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.20e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.37e-2)"		"unprognostic (5.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.66e-3)"	"unprognostic (7.96e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.62e-2)"	"unprognostic (9.69e-2)"	0.8	0.7	0.4	0.3	5.0	0.5	1.5	0.3	1.9	2.1	0.6	0.1	0.7	0.4	0.3	3.2	0.9	1.1	0.3	0.3	0.5	1.3	0.9	0.2	1.0	0.3	0.2	0.0	0.5	2.1	0.2	8.1	0.2	5.4	0.5	1.1	3.8	0.2	0.6	0.3	2.2	0.6	1.0	0.4	0.3	0.9	12.5	0.8	0.0	1.3	1.4	0.9	0.5	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.0	0.0	1.2	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.3	1.9	0.5	1.3	0.2	0.0	5.4	0.8
MYO5A	"GS1, MYH12, MYO5, MYR12"	ENSG00000197535	"Myosin VA"	Q9Y4I1	15	52307283-52529050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.5;parathyroid gland: 47.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 58.9;RPMI-8226: 39.9"	"Cancer enhanced"	"Detected in all"		"melanoma: 25.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001356	Enhanced		Approved	"Focal adhesion sites,Centriolar satellite"				"Focal adhesion sites, Centriolar satellite"		"HPA001356: AB_1079441"	"unprognostic (1.54e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.74e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.63e-3)"	"unprognostic (3.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"prognostic unfavourable (4.22e-4)"	8.4	7.1	16.6	9.5	27.5	15.7	5.5	27.4	34.5	6.2	4.4	7.8	0.4	3.3	4.2	3.2	5.0	3.6	7.3	4.6	15.9	15.4	4.6	2.7	7.3	11.2	15.6	17.6	5.4	4.3	47.6	10.5	5.2	29.3	4.5	5.2	9.9	4.0	3.4	4.1	10.4	3.9	7.7	10.1	7.3	4.1	4.6	7.1	3.1	6.8	2.7	10.3	7.3	4.2	2.3	5.2	6.3	4.4	0.7	4.5	1.9	5.4	9.6	5.1	6.1	5.2	6.4	5.5	9.9	9.0	5.3	4.2	0.9	2.2	5.2	2.6	11.8	4.5	11.7	10.2	6.6	29.4	2.7	4.8	2.5	1.1	2.7	2.5	4.7	4.2	6.4	7.8	15.5	30.8	0.1	58.9	10.2	9.6	2.2	0.3	2.3	7.7	4.1	8.2	39.9	4.4	3.9	3.8	2.2	9.2	7.6	18.0	4.0	2.8	14.7	10.7	4.6	5.0	9.6	6.1	13.5	6.3	11.7	7.3	15.4	0.9	4.4	5.4	2.9	3.6	4.5	2.3	2.9	1.9	5.2	1.6	0.5	1.0	6.3	0.7	2.6	3.1	4.1	1.9	16.6	27.5	27.4	34.5	15.9	15.4	15.6	17.6	29.3	7.1
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.6;HaCaT: 32.6;RH-30: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: "	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	20.6	5.6	0.1	0.1	0.0	0.0	11.3	0.1	0.8	0.4	0.0	14.6	8.8	0.0	5.2	0.0	32.6	7.4	8.8	0.4	0.0	2.2	0.0	2.5	10.3	0.0	0.0	0.0	0.0	7.8	0.2	5.4	0.7	0.1	8.1	0.8	8.0	0.0	0.0	1.5	2.3	0.0	50.5	3.5	18.6	4.2	11.2	0.2	7.9	9.3	0.0	5.5	0.0	0.4	0.0	11.4	0.1	2.1	5.5	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RT4: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3"	"Group enriched"	"Detected in many"	20	"NK-cells: 3.3;T-cells: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: "	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	8.4	9.1	18.2	9.0	27.0	0.9	26.9	17.1	24.1	16.2	18.9	26.8	28.7	30.0	7.5	25.9	28.1	10.0	23.1	4.9	19.1	12.2	44.0	13.8	20.5	4.5	24.0	17.9	4.6	18.5	42.2	24.2	7.1	19.0	16.0	17.3	11.9	23.3	33.7	4.2	14.1	27.7	8.0	21.2	6.7	23.9	14.3	28.2	0.9	13.4	9.1	10.9	16.1	13.1	0.2	0.0	0.1	0.1	3.3	8.6	1.2	22.3	6.0	4.9	3.4	11.7	9.5	19.2	7.9	8.4	5.9	7.7	9.0	20.2	0.0	7.8	8.9	17.7	5.7	11.4	6.7	9.4	11.7	6.4	2.0	5.5	10.0	0.0	9.3	6.7	8.3	8.0	6.3	16.4	8.4	3.3	6.0	21.5	0.0	0.2	3.2	1.6	0.3	11.6	0.4	21.9	42.7	10.0	6.6	2.0	20.1	3.4	8.6	13.1	23.9	6.5	5.6	0.3	7.1	6.8	6.8	0.0	4.0	0.0	2.3	0.1	0.0	0.0	8.6	0.0	4.0	0.2	2.7	4.9	0.0	0.0	0.6	4.8	0.1	3.3	0.1	0.0	0.1	1.2	18.2	27.0	17.1	24.1	19.1	12.2	24.0	17.9	19.0	28.2
MYO9A	"FLJ11061, FLJ13244, MGC71859"	ENSG00000066933	"Myosin IXA"	B2RTY4	15	71822289-72118577	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, GTPase activation, Motor protein, Myosin"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039812, HPA040071"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA039812: AB_10961421, HPA040071: AB_10961117"	"unprognostic (7.53e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.14e-4)"	"unprognostic (3.44e-1)"	"unprognostic (4.41e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"	10.5	6.0	13.8	9.6	17.9	6.1	14.8	18.3	16.4	13.3	11.1	7.5	10.6	3.4	15.0	11.0	11.2	10.8	7.5	9.3	9.5	9.3	19.6	5.5	12.2	8.4	9.1	12.0	17.5	5.0	15.9	14.7	10.5	14.6	11.9	9.2	9.1	8.3	11.3	12.9	12.0	8.0	14.4	9.0	10.0	9.7	35.6	11.2	9.1	18.4	6.6	8.8	11.9	13.9	6.1	9.3	5.2	3.4	3.7	7.6	1.3	6.3	9.7	6.4	4.6	9.9	11.7	3.8	6.0	6.6	6.1	6.3	4.7	4.4	28.4	3.6	11.9	6.0	12.9	6.9	8.2	6.2	7.5	7.1	5.5	2.0	6.3	7.2	5.8	6.6	7.0	7.2	10.4	7.7	4.6	6.8	8.2	3.9	4.1	2.9	3.4	4.0	2.9	12.4	2.7	7.5	9.5	3.6	4.0	7.7	6.8	6.2	5.3	3.5	10.3	12.3	6.0	19.8	6.8	4.3	10.8	7.6	7.3	6.0	5.4	2.2	2.2	5.2	5.6	2.0	7.6	4.7	5.4	4.6	2.2	6.1	5.7	5.3	0.3	3.7	3.4	9.3	4.5	1.3	13.8	17.9	18.3	16.4	9.5	9.3	9.1	12.0	14.6	11.2
MYOC	"GLC1A, JOAG1, TIGR"	ENSG00000034971	Myocilin	Q99972	1	171635417-171652683	"Disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease mutation, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 100.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	6	"melanoma: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027364	Uncertain				"Secreted to extracellular matrix"		12000000			"HPA027364: AB_10602036"	"unprognostic (2.02e-2)"	"unprognostic (4.65e-2)"		"unprognostic (4.44e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.33e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.94e-4)"	"unprognostic (5.35e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.24e-1)"	26.9	0.8	0.0	0.5	0.0	0.0	8.4	0.0	0.0	5.4	6.0	0.0	5.3	2.4	8.1	7.6	40.7	7.4	8.3	12.6	0.1	0.0	0.2	0.1	3.7	0.0	0.0	0.0	3.9	2.1	0.2	0.1	0.1	0.2	9.0	2.5	100.8	10.5	4.8	21.7	2.4	2.6	39.4	0.3	0.1	29.9	2.8	0.0	0.6	14.9	28.2	5.0	26.1	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0
MYOCD	MYCD	ENSG00000141052	Myocardin	Q8IZQ8	17	12665890-12768949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"BJ: 6.8;BJ hTERT+: 6.8;HBF TERT88: 11.3;hTEC/SVTERT24-B: 12.5;REH: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"cerebellum: 6.4"	"CAB046485, HPA071528, HPA072582"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB046485: AB_10600720, HPA071528: , HPA072582: "	"unprognostic (2.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.79e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.15e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (2.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.91e-2)"	3.1	0.8	0.6	5.1	1.0	0.0	1.9	0.3	0.5	19.6	19.9	0.2	17.6	2.1	16.6	10.9	14.4	7.4	12.2	18.6	0.4	0.4	0.9	0.4	2.5	0.0	0.5	0.8	10.6	0.4	0.0	0.5	2.6	0.6	17.2	4.2	5.1	0.4	18.7	1.2	1.5	6.6	63.4	0.6	0.5	6.7	3.7	0.1	0.0	1.0	1.2	0.0	33.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.8	6.8	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.0	12.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	8.6	1.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.3	0.5	0.4	0.4	0.5	0.8	0.6	0.1
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482317	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 15.9;non-classical monocyte: 18.0"	"Group enriched"	"Detected in many"	65	"dendritic cells: 6.2;monocytes: 18.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"			14000	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	27.5	7.3	2.1	8.9	4.1	0.2	21.7	1.3	2.7	27.0	12.3	5.1	16.0	2.0	27.2	17.7	27.2	16.2	11.4	7.2	3.5	2.1	12.2	1.7	18.7	7.5	5.8	2.5	12.7	3.3	16.1	4.2	31.9	15.0	20.7	12.8	10.1	14.9	17.4	5.7	22.4	6.8	49.0	9.4	10.0	8.8	5.7	4.4	1.5	15.7	14.2	9.4	35.0	20.0	0.0	6.2	0.1	18.0	0.0	0.1	1.1	35.7	33.8	3.6	2.3	25.3	56.3	10.2	31.5	75.3	19.2	19.0	8.2	28.1	0.0	12.6	57.5	54.7	0.2	32.2	14.2	0.2	0.1	0.0	13.2	0.3	8.8	0.0	0.0	29.6	11.2	12.9	53.0	49.7	0.0	0.0	45.1	5.7	0.0	0.1	0.2	30.2	0.0	2.6	0.0	49.8	44.7	0.0	0.0	21.5	4.5	7.9	22.4	0.7	62.1	28.3	1.9	18.6	18.3	0.0	0.0	0.0	20.9	0.4	33.3	0.0	4.3	0.0	0.0	15.9	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.1	0.0	18.0	2.1	0.1	1.1	2.1	4.1	1.3	2.7	3.5	2.1	5.8	2.5	15.0	4.4
MYOG	"bHLHc3, MYF4"	ENSG00000122180	Myogenin	P15173	1	203083132-203086036	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 60.0"	"Group enriched"	"Detected in some"	200	"HSkMC: 17.6;RH-30: 33.6"	"Group enriched"	"Detected in some"	6	"head and neck cancer: 3.9;testis cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028336			Supported	Nucleoplasm				Nucleoplasm		"HPA028336: "	"unprognostic (1.71e-1)"				"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"				"unprognostic (2.22e-1)"			"unprognostic (2.79e-9)"	"unprognostic (3.96e-1)"	"unprognostic (2.56e-1)"			1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.3	0.0	0.0	2.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	1.7	13.3	1.7	0.0	0.0	0.8	0.8	2.3	1.3	1.8	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.8	0.4	0.7	1.0	0.8	0.5	0.6	0.3	0.6	0.9	1.0	1.4	1.8	1.3	0.8	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYRF	"C11orf9, MRF, Ndt80, pqn-47"	ENSG00000124920	"Myelin regulatory factor"	Q9Y2G1	11	61752642-61788518	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 96.7;stomach 1: 57.2"	"Cell line enhanced"	"Detected in some"		"A549: 18.3;CACO-2: 30.5;CAPAN-2: 17.6;EFO-21: 23.9;Hep G2: 12.9;HHSteC: 13.7;U-2 OS: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018310			Approved	Nucleoplasm,Cytosol			550000	Nucleoplasm	Cytosol	"HPA018310: AB_1845534"	"unprognostic (3.51e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (2.01e-4)"	"unprognostic (8.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	4.6	1.3	16.4	2.1	42.9	1.4	1.5	3.3	38.5	3.7	4.3	96.7	0.0	12.8	6.9	1.6	2.0	8.0	22.4	1.5	29.2	13.9	4.5	5.8	15.8	1.2	54.3	19.9	5.8	19.7	1.2	0.2	2.6	35.7	1.2	4.0	11.6	1.7	1.6	1.0	1.4	11.4	5.4	53.8	1.3	57.2	3.0	51.4	0.0	1.2	0.0	1.2	1.3	0.3	0.0	0.0	0.2	0.3	0.5	2.1	0.5	1.3	18.3	3.3	1.0	0.0	0.0	0.1	0.1	0.0	0.7	0.8	30.5	17.6	0.6	23.9	0.0	0.8	1.0	0.1	1.3	0.1	0.3	0.1	0.4	12.9	13.7	0.0	0.3	0.3	0.2	0.4	0.0	0.1	5.6	0.2	0.1	0.3	0.0	0.6	0.9	2.4	0.0	0.1	1.2	8.1	0.1	0.1	0.6	0.1	1.3	0.3	0.4	0.1	0.6	0.2	10.6	0.2	0.3	0.3	0.1	0.1	0.1	1.2	0.2	0.0	0.0	0.2	2.1	0.3	1.2	0.0	0.7	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.5	16.4	42.9	3.3	29.3	29.2	13.9	54.3	19.9	35.7	51.4
MYT1	"MTF1, MYTI, NZF2, PLPB1, ZC2H2C1, ZC2HC4A"	ENSG00000196132	"Myelin transcription factor 1"	Q01538	20	64102394-64242253	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 69.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.7;REH: 13.0;SCLC-21H: 16.2;SH-SY5Y: 4.2"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	13	"cerebellum: 69.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006303	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006303: AB_1079446"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.05e-7)"	"unprognostic (1.28e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.33e-3)"	"unprognostic (2.28e-2)"	"unprognostic (8.45e-4)"	"unprognostic (9.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.45e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.23e-1)"	0.4	7.4	4.3	0.5	5.0	2.4	0.4	69.5	11.0	0.3	0.7	2.7	0.0	0.9	0.4	0.5	0.3	0.6	0.5	0.8	4.2	5.3	0.6	0.4	0.4	0.4	3.7	2.2	0.4	4.7	0.4	3.7	0.4	5.1	0.6	0.6	3.7	0.3	0.4	0.3	0.4	0.6	0.4	2.0	0.5	1.0	2.1	4.8	0.0	1.4	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.6	0.0	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.4	0.0	0.7	0.2	13.0	0.0	0.0	0.0	0.0	16.2	4.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	4.3	5.0	69.5	3.1	4.2	5.3	3.7	2.2	5.1	4.8
MZF1	"MZF-1, MZF1B, Zfp98, ZNF42, ZSCAN6"	ENSG00000099326	"Myeloid zinc finger 1"	P28698	19	58561931-58573575	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 27.3;HeLa: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001757	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA001757: AB_1080718"	"unprognostic (8.25e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.12e-2)"	"unprognostic (5.16e-3)"	"unprognostic (7.15e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.62e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (7.97e-4)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (2.83e-8)"	"unprognostic (1.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.64e-2)"	"prognostic favourable (4.09e-5)"	7.8	14.2	16.9	10.9	17.4	9.4	8.1	20.3	18.8	12.5	9.4	12.4	24.8	19.6	13.6	13.4	8.7	16.6	13.5	6.7	15.4	9.7	11.7	9.8	12.5	9.9	13.9	14.8	15.9	15.2	17.5	26.0	6.8	13.7	13.8	7.8	12.4	16.7	21.5	9.7	11.6	17.0	9.6	9.6	11.7	14.7	9.0	16.1	8.3	18.1	5.2	9.4	11.0	9.8	3.5	2.3	2.3	1.2	6.6	9.0	3.4	4.6	12.1	5.0	3.2	2.9	2.6	6.0	4.2	2.2	0.7	1.5	2.5	5.7	3.3	2.1	1.2	5.2	1.3	3.0	0.4	5.8	27.3	3.5	20.9	1.4	1.8	2.7	6.1	1.7	7.8	1.1	3.4	2.6	2.9	4.3	1.1	5.2	1.5	1.4	1.8	4.8	4.1	1.2	6.0	2.7	10.2	4.7	6.7	2.0	4.1	2.6	4.2	3.5	2.9	8.0	2.5	1.4	2.1	7.3	8.3	2.8	6.4	2.9	1.9	0.0	1.2	0.6	3.3	0.9	4.9	3.2	5.4	3.8	2.3	3.5	9.0	5.6	2.3	6.6	0.9	0.6	3.2	3.4	16.9	17.4	20.3	18.8	15.4	9.7	13.9	14.8	13.7	16.1
NAA35	"bA379P1.1, FLJ21613, FLJ22643, MAK10"	ENSG00000135040	"N(alpha)-acetyltransferase 35, NatC auxiliary subunit"	Q5VZE5	9	85941146-86022298	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021547, HPA051586"	Approved		Supported	Vesicles				Vesicles		"HPA021547: AB_1853505, HPA051586: "	"unprognostic (5.87e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-3)"	"unprognostic (9.25e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.16e-7)"	"unprognostic (1.86e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.34e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-2)"	11.3	19.5	15.2	16.4	14.6	9.7	17.1	20.1	17.6	13.4	16.5	12.5	22.9	14.9	20.5	21.0	16.8	13.5	14.4	14.2	16.6	14.0	16.0	14.3	10.8	10.2	14.6	16.2	16.2	16.4	19.1	25.5	16.9	14.4	17.4	19.5	13.0	16.3	20.0	28.7	13.4	17.4	16.4	14.1	10.3	13.4	25.7	15.1	10.0	19.8	15.8	12.7	14.4	13.5	12.2	5.8	8.9	4.7	5.9	9.6	4.4	23.0	16.0	16.1	12.5	9.4	11.4	25.2	14.6	14.3	16.3	13.9	11.0	15.9	7.8	8.6	14.8	32.3	14.6	17.1	17.5	19.6	10.6	17.2	17.5	15.1	17.6	26.3	15.7	11.7	14.9	17.4	25.9	15.3	21.1	15.4	15.4	15.9	14.7	15.3	16.1	16.5	12.6	22.8	12.2	17.8	21.0	14.6	13.0	16.6	14.7	12.8	11.8	11.2	12.1	10.6	13.2	17.5	13.4	20.6	25.2	5.4	13.4	11.4	10.7	2.0	4.6	8.9	7.0	4.7	9.3	12.2	7.7	6.5	5.8	12.2	9.6	7.7	2.1	5.9	3.2	3.8	6.4	4.4	15.2	14.6	20.1	17.6	16.6	14.0	14.6	16.2	14.4	15.1
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.3;fHDF/TERT166: 6.7;HHSteC: 18.6;HSkMC: 12.2;SCLC-21H: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol				Cytosol		"HPA047123: "	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.4	5.3	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.1	3.0	18.6	0.0	0.0	12.2	0.0	2.4	0.0	3.2	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2
NAB2	MADER	ENSG00000166886	"NGFI-A binding protein 2"	Q15742	12	57088894-57095476	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004510, HPA027464"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB004510: AB_627982, HPA027464: AB_10601138"	"prognostic favourable (7.41e-4)"	"unprognostic (4.04e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavourable (9.38e-6)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (5.67e-3)"	"unprognostic (6.19e-3)"	9.5	12.6	11.7	9.9	14.2	4.8	7.9	33.3	20.4	18.7	13.7	5.3	9.6	8.2	22.8	18.9	10.5	15.6	14.5	9.6	8.6	6.8	8.4	18.7	12.8	9.1	4.4	14.6	29.2	8.5	14.5	17.0	13.4	6.8	15.0	4.4	8.5	5.6	14.5	7.1	18.6	7.1	14.5	4.1	8.0	8.2	11.8	7.0	12.4	9.8	7.7	8.6	14.5	26.5	4.2	1.2	0.9	5.4	0.9	2.5	1.2	5.5	3.5	18.7	17.1	16.8	22.0	2.0	16.6	15.0	10.5	8.8	5.7	3.2	3.5	6.8	16.3	10.0	6.4	12.2	5.6	1.4	1.7	4.1	2.7	5.8	12.8	3.3	10.0	24.5	13.5	12.5	4.3	2.8	9.4	3.6	12.2	25.7	5.0	16.1	3.8	6.2	3.7	24.6	1.8	4.5	2.1	2.1	4.9	8.0	4.7	34.9	10.5	7.3	3.1	15.5	13.0	11.0	4.8	8.6	2.1	1.8	15.1	2.2	9.3	0.0	2.3	0.3	1.2	5.3	1.4	2.1	2.0	1.5	1.2	4.2	2.5	2.5	0.9	0.9	5.4	0.0	1.9	1.2	11.7	14.2	33.3	20.4	8.6	6.8	4.4	14.6	6.8	7.0
NACA	NACA1	ENSG00000196531	"Nascent polypeptide-associated complex alpha subunit"	"E9PAV3, Q13765"	12	56712428-56731628	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transcription, Transcription regulation, Transport"	"Activator, Chaperone, DNA-binding"	Allergen	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA073152, HPA073648"			Approved	Cytosol				Cytosol		"HPA073152: , HPA073648: "	"unprognostic (3.35e-2)"	"unprognostic (9.98e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (4.58e-11)"	"unprognostic (9.47e-2)"	"unprognostic (6.28e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.79e-2)"	106.9	85.3	72.2	77.6	63.0	120.7	149.8	71.7	65.5	115.5	89.1	40.5	76.7	57.3	83.3	107.7	142.6	95.2	69.2	111.5	58.9	52.7	79.8	130.1	68.5	148.3	63.7	51.3	213.8	119.9	58.1	61.3	80.8	63.7	112.3	79.7	45.9	95.5	72.9	241.6	124.5	71.2	115.1	74.1	81.9	72.3	53.2	53.8	97.8	109.0	149.1	125.1	144.8	139.1	91.8	101.6	45.4	160.0	66.3	97.4	146.6	79.6	92.8	110.6	87.3	132.4	226.8	109.9	80.0	115.4	109.0	75.8	111.8	88.6	143.4	89.6	74.9	70.1	97.9	128.4	116.1	70.2	152.3	104.0	65.0	111.2	124.1	146.7	67.2	179.3	165.2	88.4	180.6	120.2	128.9	187.5	106.4	77.5	94.7	181.3	112.8	103.6	107.8	93.2	152.1	151.3	80.9	82.1	88.7	59.3	141.6	122.7	154.1	168.7	77.8	57.6	70.7	61.2	80.3	89.8	100.0	127.7	84.5	100.6	73.2	33.2	88.1	45.4	58.5	124.6	85.6	91.8	83.4	72.5	94.4	74.6	97.4	83.9	33.2	66.3	160.0	101.6	85.9	146.6	72.2	63.0	71.7	65.5	58.9	52.7	63.7	51.3	63.7	53.8
NAE1	"APP-BP1, APPBP1, ula-1"	ENSG00000159593	"NEDD8 activating enzyme E1 subunit 1"	Q13564	16	66802875-66873256	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041178, HPA042041"	Enhanced		Approved	Nucleoplasm,Microtubules,Centrosome			53000	Nucleoplasm	"Microtubules, Centrosome"	"HPA041178: AB_10964773, HPA042041: AB_10964772"	"unprognostic (3.22e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavourable (3.92e-8)"	"unprognostic (2.31e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.12e-3)"	"unprognostic (5.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.84e-1)"	"prognostic favourable (9.44e-5)"	"unprognostic (1.97e-1)"	23.6	27.4	25.3	20.2	31.8	27.2	27.3	36.7	41.7	26.0	25.8	24.4	23.7	26.2	27.9	31.0	27.5	23.9	20.2	23.6	25.4	29.0	24.3	25.9	18.3	27.0	27.7	31.9	31.0	26.6	38.8	42.2	26.4	34.9	24.9	30.0	22.1	24.3	23.5	33.2	26.9	27.6	25.4	25.3	18.4	22.2	36.9	25.9	28.9	27.9	28.0	24.9	24.7	22.4	9.4	6.4	6.7	3.2	8.6	19.4	9.4	22.6	17.5	31.2	30.7	12.5	17.8	25.9	17.3	17.6	25.7	31.2	21.2	17.6	25.1	19.9	13.0	23.0	23.4	20.8	36.5	9.2	26.7	17.8	12.1	32.9	14.4	33.1	22.4	14.4	15.5	20.4	18.0	17.9	42.1	8.9	19.7	7.9	34.6	37.9	43.2	31.6	37.2	37.2	33.5	19.8	20.0	33.6	24.7	51.8	11.1	19.9	11.9	22.4	13.9	18.0	18.0	18.7	20.0	16.8	25.9	90.5	16.2	22.0	21.7	1.3	3.1	6.7	15.4	3.0	19.4	9.4	16.4	16.6	4.2	7.9	17.8	17.7	1.4	8.6	3.2	6.4	14.0	9.4	25.3	31.8	36.7	41.7	25.4	29.0	27.7	31.9	34.9	25.9
NAGA	D22S674	ENSG00000198951	Alpha-N-acetylgalactosaminidase	P17050	22	42058354-42070842	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	8	"classical monocyte: 38.5;intermediate monocyte: 47.6;myeloid DC: 37.9;non-classical monocyte: 46.1;plasmacytoid DC: 23.2"	"Group enriched"	"Detected in all"	9	"dendritic cells: 37.9;monocytes: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000649	Enhanced				"Intracellular and membrane"		2300000			"HPA000649: AB_1079448"	"unprognostic (3.74e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.92e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.53e-1)"	23.7	13.5	12.1	20.3	14.5	11.3	12.5	11.8	10.3	16.3	18.3	15.0	10.7	13.2	18.9	16.1	14.5	17.3	16.5	15.8	10.1	8.6	17.9	28.2	19.9	32.6	12.6	7.3	18.1	9.5	27.8	13.1	45.3	11.5	15.2	18.0	19.8	16.6	14.5	9.2	9.9	25.6	18.7	11.4	22.0	14.1	9.3	13.2	12.0	15.0	11.4	17.9	17.3	14.5	2.1	37.9	4.9	47.6	3.4	3.4	19.2	9.0	4.6	7.4	13.1	12.9	14.8	5.4	7.5	15.4	12.9	13.5	10.3	13.4	4.4	4.6	16.2	6.4	5.6	9.1	7.7	10.1	7.1	10.9	7.1	6.9	7.5	9.0	65.2	10.1	8.0	11.6	4.9	21.3	4.0	18.9	10.2	10.5	3.3	3.7	1.9	6.2	7.5	3.7	7.8	10.0	10.8	2.3	2.6	9.9	9.1	9.8	13.6	16.7	11.4	9.1	11.1	5.8	6.7	10.5	10.5	3.5	9.7	17.3	11.2	4.9	38.5	4.6	2.8	47.6	2.8	2.1	2.9	2.6	37.9	1.5	1.9	1.8	1.9	3.4	46.1	23.2	3.4	19.2	12.1	14.5	11.8	10.3	10.1	8.6	12.6	7.3	11.5	13.2
NAGLU	NAG	ENSG00000108784	N-acetyl-alpha-glucosaminidase	P54802	17	42536172-42544449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Glycosidase, Hydrolase"	"Charcot-Marie-Tooth disease, Disease mutation, Mucopolysaccharidosis, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038815	Supported				"Intracellular and membrane"		300000000			"HPA038815: AB_10697398"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.48e-2)"	"prognostic favourable (4.17e-4)"	"prognostic unfavourable (6.59e-4)"	"unprognostic (1.46e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.68e-2)"	"prognostic favourable (6.90e-4)"	"unprognostic (8.07e-2)"	"prognostic favourable (2.58e-6)"	"unprognostic (2.25e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.62e-1)"	21.1	21.0	10.2	8.4	15.9	10.7	18.3	5.5	11.4	16.9	17.1	19.1	16.3	14.8	19.3	20.6	11.9	14.6	21.4	11.5	10.7	5.9	31.3	50.1	16.3	12.5	21.6	8.0	20.4	38.9	10.6	12.7	23.5	12.1	14.8	10.2	20.9	32.4	12.3	9.1	13.2	17.3	10.1	13.5	22.5	17.0	9.8	20.5	8.9	20.7	8.9	12.3	16.1	12.7	4.8	6.0	3.8	5.8	4.3	5.8	2.4	5.9	20.9	4.2	9.5	41.9	13.9	14.2	9.1	21.7	9.6	12.3	5.6	15.5	7.7	9.3	14.0	14.6	3.7	4.4	2.1	5.9	7.7	4.1	10.9	11.6	14.0	5.0	10.9	16.5	6.8	5.2	6.6	12.5	6.1	15.5	10.6	14.4	0.8	8.6	4.9	2.7	3.2	9.1	17.8	12.7	13.8	6.3	9.6	5.0	6.9	7.7	31.8	5.3	9.7	23.4	3.9	9.3	5.9	20.6	9.3	6.4	14.3	5.4	16.6	2.3	5.5	3.8	5.6	3.7	5.8	4.8	2.4	3.1	4.5	4.6	4.3	3.5	2.5	4.3	5.8	6.0	0.5	2.4	10.2	15.9	5.5	11.4	10.7	5.9	21.6	8.0	12.1	20.5
NAGPA	"APAA, UCE"	ENSG00000103174	"N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase"	Q9UK23	16	5024844-5034141	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064055	Approved						3600000			"HPA064055: "	"unprognostic (9.93e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.30e-3)"	"prognostic unfavourable (4.67e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (2.67e-5)"	"unprognostic (1.26e-1)"	"unprognostic (6.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.02e-1)"	8.3	6.3	9.9	9.0	20.1	8.7	4.7	4.7	25.0	6.8	8.5	4.6	5.8	11.4	6.2	4.7	6.1	4.8	5.6	5.0	15.3	5.3	7.2	7.6	7.6	9.1	5.0	9.5	4.2	7.3	7.6	4.9	6.8	6.6	4.9	5.1	4.0	6.0	6.2	6.7	8.5	9.2	5.5	4.4	10.9	12.4	2.7	5.5	4.3	5.1	2.6	5.6	6.0	4.4	9.5	26.5	5.1	20.9	5.1	9.9	9.7	1.5	5.9	1.0	6.4	2.5	3.3	6.7	4.4	7.9	5.8	7.3	4.9	12.3	0.6	5.6	6.0	4.6	2.7	4.9	1.7	7.2	8.3	2.1	3.8	31.8	8.2	5.3	9.3	5.0	5.1	3.8	1.7	9.0	6.8	8.8	3.5	6.7	2.4	14.2	3.1	6.3	6.4	2.4	11.6	3.7	2.3	2.6	3.5	3.5	8.8	9.0	6.0	6.5	6.6	6.4	4.6	14.8	3.3	4.8	3.7	1.4	3.0	8.1	5.3	1.2	20.9	5.1	9.9	18.2	7.9	9.5	9.8	8.8	26.5	8.3	8.1	7.4	0.6	5.1	11.7	6.8	8.7	9.7	9.9	20.1	4.7	25.0	15.3	5.3	5.0	9.5	6.6	5.5
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Biological rhythms, Pyridine nucleotide biosynthesis"	"Cytokine, Glycosyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	2140000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: , HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	18.9	12.6	4.6	7.6	19.4	22.6	7.5	6.0	34.0	12.2	21.6	7.4	11.5	15.9	14.4	6.7	15.0	8.4	18.1	26.8	9.4	9.1	6.4	5.4	5.8	72.5	12.4	11.9	21.6	20.7	21.8	25.5	38.8	13.4	60.9	14.5	9.9	12.3	5.2	8.8	10.2	5.9	6.5	34.9	11.6	17.8	9.3	5.1	8.4	18.5	21.4	5.9	3.6	33.0	18.2	14.1	26.1	11.0	42.0	23.8	22.8	108.1	14.1	26.9	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1
NAP1L1	"MGC23410, MGC8688, NAP1, NAP1L, NRP"	ENSG00000187109	"Nucleosome assembly protein 1 like 1"	P55209	12	76036587-76085033	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA028861	Approved		Uncertain	Microtubules			25000000	Microtubules		"HPA028861: AB_10603880"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.57e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.29e-9)"	"unprognostic (1.67e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.24e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.14e-13)"	"unprognostic (5.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.15e-1)"	55.9	73.9	48.7	65.8	54.5	70.1	59.1	33.2	55.4	64.1	49.2	41.0	47.2	18.7	65.9	44.4	56.3	45.4	53.7	59.2	50.1	42.5	36.1	27.3	64.6	99.6	58.1	43.4	154.7	33.5	33.0	51.6	48.3	57.3	60.0	31.2	33.0	45.4	54.8	79.2	34.5	36.1	79.8	78.0	63.7	35.9	33.2	53.1	100.3	50.1	45.3	90.2	92.5	93.7	39.5	34.6	26.7	103.7	22.6	41.9	30.8	73.6	56.2	107.0	67.9	69.2	111.7	60.5	47.5	65.4	73.2	54.3	61.1	27.8	174.1	53.1	59.2	49.4	62.8	75.3	91.7	55.0	61.9	64.7	41.6	62.5	98.1	102.9	63.7	77.4	81.9	50.6	86.3	89.0	94.7	38.2	116.7	35.4	131.3	84.2	121.6	53.1	103.8	106.0	72.0	64.8	41.5	46.1	66.4	39.6	58.7	111.2	86.6	75.4	69.7	57.5	65.8	40.7	66.9	47.9	57.0	109.3	35.0	54.0	37.1	0.9	17.2	26.7	15.5	51.4	31.4	39.5	35.7	25.1	34.6	32.7	41.9	33.3	4.4	22.6	103.7	25.4	36.2	30.8	48.7	54.5	33.2	55.4	50.1	42.5	58.1	43.4	57.3	53.1
NAP1L4	NAP2	ENSG00000205531	"Nucleosome assembly protein 1 like 4"	Q99733	11	2944431-2992377	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011567	Approved		Supported	Nucleoplasm			5700000	Nucleoplasm		"CAB011567: AB_776638"	"unprognostic (1.61e-1)"	"prognostic favourable (9.77e-4)"	"unprognostic (8.99e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.96e-3)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (1.68e-7)"	"unprognostic (1.80e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.55e-4)"	"unprognostic (1.54e-1)"	21.6	17.2	36.4	21.9	41.0	27.5	21.1	31.7	34.8	22.9	23.4	37.8	19.1	13.3	23.3	18.7	29.8	18.7	21.8	58.2	34.6	40.1	30.8	22.2	20.3	37.7	50.5	28.7	26.7	18.9	63.0	25.3	24.1	33.7	22.7	22.8	22.3	27.2	22.4	51.5	19.3	24.8	27.5	49.5	23.5	25.1	36.6	34.9	32.2	23.6	32.1	46.8	29.8	21.6	12.3	12.4	28.2	13.1	24.7	30.6	19.4	17.7	11.9	19.5	15.4	20.2	22.5	8.9	37.1	24.3	34.5	31.7	29.7	48.5	34.0	22.8	22.6	32.4	5.1	31.6	40.0	36.0	12.7	24.3	36.0	38.2	14.0	19.8	26.3	18.8	15.4	18.6	13.5	20.8	31.0	35.4	29.9	16.7	45.9	0.8	47.1	17.3	21.3	23.2	26.6	3.0	30.4	29.0	24.8	18.7	27.7	17.9	1.7	1.6	15.7	27.0	25.1	36.0	3.1	18.9	30.0	45.8	1.9	14.2	17.6	28.2	10.3	13.4	19.7	11.2	19.4	11.7	24.8	25.5	12.4	12.3	22.0	25.4	7.0	24.7	13.1	11.2	30.6	19.4	36.4	41.0	31.7	34.8	34.6	40.1	50.5	28.7	33.7	34.9
NAPSA	"KAP, Kdap, NAP1, NAPA"	ENSG00000131400	"Napsin A aspartic peptidase"	O96009	19	50358477-50365830	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"kidney: 47.5;lung: 153.3"	"Cell line enriched"	"Detected in some"	24	"U-698: 29.1"	"Cancer enriched"	"Detected in many"	18	"lung cancer: 249.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.5"	"Group enriched"	"Detected in many"	9	"B-cells: 5.1;dendritic cells: 10.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB009591, HPA045280, HPA047236, HPA047744"	Enhanced				"Secreted in other tissues"		380000			"CAB009591: , HPA045280: AB_2679283, HPA047236: AB_2679993, HPA047744: AB_2680143"	"unprognostic (5.36e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.30e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.67e-3)"	"prognostic favourable (1.21e-4)"	"unprognostic (4.08e-4)"	"unprognostic (3.29e-1)"	"unprognostic (9.83e-3)"	"unprognostic (7.26e-5)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	5.0	0.1	0.1	0.1	0.1	0.1	0.0	47.5	0.1	153.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	5.1	10.5	0.5	0.9	0.5	0.6	1.1	0.1	0.4	0.0	0.2	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.3	1.2	0.1	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.3	0.2	0.3	0.6	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.3	0.1	0.0	0.1	0.8	0.0	0.2	0.4	29.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.9	0.0	5.1	0.2	0.4	3.0	1.9	0.6	0.5	0.5	0.5	0.9	10.5	0.0	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1
NARS	NARS1	ENSG00000134440	"Asparaginyl-tRNA synthetase"	O43776	18	57600656-57622213	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034257, HPA040017"	Enhanced		Supported	Cytosol				Cytosol		"CAB034257: AB_2151043, HPA040017: "	"unprognostic (9.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (1.78e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.98e-1)"	"unprognostic (8.82e-2)"	"prognostic favourable (1.73e-7)"	"unprognostic (1.24e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.51e-1)"	30.9	36.9	35.0	28.8	42.6	19.5	31.6	47.1	51.4	28.1	49.7	24.8	31.1	42.5	30.8	31.6	40.2	27.4	26.8	40.6	40.5	36.5	66.0	41.9	26.0	23.0	39.5	39.2	29.4	29.4	52.0	35.7	25.6	49.5	33.1	46.1	18.5	33.7	30.9	76.6	26.9	35.2	29.9	40.6	25.7	36.0	14.9	36.3	25.0	44.5	31.9	29.2	34.6	35.3	20.0	26.6	15.6	40.8	15.8	23.4	23.7	35.9	23.8	22.4	32.7	28.8	22.1	34.9	50.3	26.3	29.7	36.9	17.1	16.9	45.4	24.2	34.8	41.0	35.2	31.1	43.6	22.0	12.2	34.7	18.3	26.9	48.7	71.9	35.9	23.4	54.5	40.7	39.0	24.6	42.6	33.9	33.3	13.4	27.8	17.4	32.9	19.1	22.1	26.4	38.3	55.6	40.6	24.6	27.0	24.4	31.5	52.8	17.6	40.0	26.9	33.2	22.2	14.0	37.2	76.1	94.1	44.1	30.5	47.3	38.6	15.6	40.8	14.2	16.4	35.1	20.2	20.0	17.3	17.4	26.6	18.8	23.4	21.2	12.7	15.8	26.6	25.1	17.2	23.7	35.0	42.6	47.1	51.4	40.5	36.5	39.5	39.2	49.5	36.3
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavourable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	20.7	15.2	19.3	33.4	32.0	64.0	21.2	20.1	24.0	22.8	21.9	30.2	26.4	15.9	22.3	19.8	20.1	23.0	12.5	18.1	22.4	17.3	17.5	21.0	17.6	39.0	40.2	17.8	28.3	17.4	21.9	22.9	28.5	24.2	18.9	24.7	12.6	17.8	21.8	14.3	16.1	20.5	21.3	30.3	31.7	17.5	35.8	40.2	49.1	17.7	28.2	43.0	18.5	19.6	16.9	11.8	8.1	9.7	7.3	17.5	6.9	24.2	14.4	69.1	24.5	11.7	6.1	32.6	19.7	14.7	30.7	38.6	26.5	17.6	45.9	13.9	8.5	23.6	46.1	21.0	39.4	20.9	29.2	59.3	25.9	41.6	4.1	61.9	25.0	7.1	5.1	33.8	11.8	20.9	49.8	27.1	20.8	16.6	70.4	56.7	100.5	12.2	89.1	60.6	44.1	15.2	24.6	26.5	32.1	32.5	18.6	20.1	13.4	48.5	11.3	14.2	43.6	27.2	32.1	16.7	31.4	79.6	14.5	39.5	14.1	4.9	7.3	8.1	12.3	9.7	14.2	13.5	13.9	14.0	11.5	16.9	12.3	11.8	3.1	7.3	5.7	11.8	17.5	6.9	19.3	32.0	20.1	24.0	22.4	17.3	40.2	17.8	24.2	40.2
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody				Nucleoli	Midbody	"CAB035546: , HPA057576: , HPA071628: "	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (1.07e-4)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.2	17.3	9.3	19.7	11.2	10.0	10.8	12.2	9.0	15.5	12.4	19.4	7.1	39.4	9.1	10.3	18.7	34.9	18.6	19.9	10.9	22.4	17.9	14.2	18.1	10.2	44.7	13.0	10.1	12.8	10.1	28.6	11.8	38.9	13.8	12.9	23.3	36.4	20.3	13.3	20.9	27.4	31.5	16.4	8.9	21.5	13.8	10.5	16.4	17.5	7.3	17.5	12.3	9.5	13.9	11.0	20.3	22.6	15.1	18.1	37.6	14.0	18.6	13.7	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9
NBEA	"BCL8B, FLJ10197, KIAA1544, LYST2"	ENSG00000172915	Neurobeachin	Q8NFP9	13	34942287-35673022	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 41.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039730, HPA040385"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Nucleoplasm, Nucleoli, Cytosol"	"HPA039730: AB_10794202, HPA040385: AB_10795523"	"unprognostic (1.80e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.95e-3)"	"unprognostic (5.01e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.45e-1)"	"prognostic favourable (7.86e-8)"	"unprognostic (2.28e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.46e-2)"	3.9	11.9	12.2	2.7	20.6	1.0	8.2	32.6	28.5	7.4	9.8	3.9	10.9	2.7	10.3	6.2	6.2	9.4	5.4	11.7	13.5	10.6	6.6	1.7	3.6	2.6	6.9	22.2	10.4	5.7	9.3	25.0	1.5	14.2	11.9	4.8	13.3	7.0	14.2	8.5	2.0	3.8	11.4	4.7	5.1	4.8	7.7	6.0	6.1	9.6	0.7	2.4	7.1	6.4	1.1	1.3	0.0	0.5	0.4	1.4	0.1	0.0	2.3	5.4	3.0	0.4	0.0	0.1	3.4	5.3	4.0	3.3	0.0	0.5	1.4	0.0	5.8	0.1	1.8	0.7	8.5	0.7	1.8	0.0	1.6	0.5	0.3	0.9	2.2	0.9	0.6	0.0	0.4	0.7	0.0	9.7	0.5	1.0	0.5	0.0	2.3	0.9	0.6	2.3	0.4	4.6	1.0	3.1	41.2	2.5	0.0	1.7	0.9	0.2	0.0	1.0	0.6	0.0	0.7	0.9	0.2	0.7	2.6	0.3	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.0	0.1	0.2	0.0	1.1	1.4	1.3	0.0	0.4	0.0	1.3	0.0	0.1	12.2	20.6	32.6	18.4	13.5	10.6	6.9	22.2	14.2	6.0
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Cell line enhanced"	"Detected in some"		"HEL: 19.1;RH-30: 43.1;SCLC-21H: 35.1;SH-SY5Y: 17.2;U-138 MG: 24.0;WM-115: 25.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"		2800000000	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: "	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.7	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	0.9	6.0	6.3	0.1	0.0	0.0	0.0	0.1	3.8	19.1	0.0	0.0	0.7	0.0	3.1	4.1	0.0	0.0	6.1	0.0	0.0	0.3	6.7	0.0	0.0	1.6	0.5	0.1	0.0	43.1	3.1	0.0	0.0	35.1	17.2	0.0	0.1	0.0	0.0	0.2	0.0	24.0	11.2	0.1	10.0	0.0	0.1	0.0	2.7	9.0	25.4	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2
NCAM2	"MGC51008, NCAM21"	ENSG00000154654	"Neural cell adhesion molecule 2"	O15394	21	20998315-21543329	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 15.9;brain: 52.7"	"Cell line enriched"	"Detected in some"	4	"T-47d: 44.1"	"Cancer enhanced"	"Detected in some"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030900, HPA030901"	Enhanced	Supported	Supported	"Nuclear bodies,Plasma membrane"			100000000	"Nuclear bodies, Plasma membrane"		"HPA030900: AB_10602037, HPA030901: "	"unprognostic (9.70e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.37e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.61e-1)"	"unprognostic (3.07e-4)"	"unprognostic (2.47e-4)"	"unprognostic (1.62e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.35e-3)"	2.0	15.9	25.8	2.0	22.3	1.1	3.1	7.0	52.7	3.3	2.1	14.7	0.0	1.3	2.3	1.8	1.7	1.8	2.6	3.1	18.7	13.9	1.3	9.1	4.4	1.2	21.6	19.4	1.4	1.3	1.1	1.0	1.7	17.9	2.2	2.4	0.5	1.8	2.3	1.5	2.0	1.9	2.7	17.3	2.0	1.3	8.3	26.6	0.0	1.5	0.0	1.3	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.6	0.0	1.1	0.0	0.0	5.6	0.0	1.7	0.0	0.0	5.1	1.1	0.1	7.1	0.1	0.0	0.2	0.0	0.5	0.0	2.1	0.0	0.0	0.0	2.6	0.0	0.3	0.3	44.1	3.3	0.0	0.6	0.4	0.0	0.0	0.3	0.0	0.0	1.2	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.8	22.3	7.0	22.4	18.7	13.9	21.6	19.4	17.9	26.6
NCAN	CSPG3	ENSG00000130287	Neurocan	O14594	19	19211973-19252233	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"brain: 88.4"	"Cell line enhanced"	"Detected in some"		"AF22: 2.9;SCLC-21H: 6.3;SH-SY5Y: 4.4"	"Cancer enriched"	"Detected in some"	57	"glioma: 71.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036814	Enhanced				"Secreted in brain"		340000			"HPA036814: AB_10673666"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.09e-6)"	"unprognostic (1.10e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.58e-2)"	1.1	1.2	21.2	1.1	23.2	1.1	1.1	5.4	88.4	1.1	1.1	12.9	0.0	1.1	1.1	1.1	1.1	1.1	1.1	1.1	16.8	8.3	1.1	1.2	1.1	1.1	7.8	15.2	1.1	1.1	1.1	0.1	1.1	12.3	1.1	1.1	0.0	1.2	1.1	1.1	1.1	1.1	1.1	4.0	1.1	1.1	1.8	5.6	0.0	1.1	0.0	1.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	6.3	4.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.1	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	23.2	5.4	22.8	16.8	8.3	7.8	15.2	12.3	5.6
NCAPD2	"CAP-D2, CNAP1, hCAP-D2, KIAA0159"	ENSG00000010292	"Non-SMC condensin I complex subunit D2"	Q15021	12	6493356-6531955	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 84.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012423, HPA036947, HPA037363"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"CAB012423: , HPA036947: AB_10671367, HPA037363: AB_10672483"	"unprognostic (1.51e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.03e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (1.79e-8)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.53e-1)"	"prognostic unfavourable (1.13e-7)"	"unprognostic (4.80e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.53e-1)"	"unprognostic (8.75e-2)"	6.8	8.8	6.5	24.6	12.7	16.7	7.7	7.7	9.0	8.0	11.3	16.2	7.0	10.6	11.5	8.8	17.7	8.1	6.5	6.2	7.5	5.4	7.0	5.1	7.7	20.4	16.5	6.2	7.7	7.2	9.6	6.3	13.9	8.7	8.2	12.4	8.1	10.5	8.3	7.0	14.8	13.0	8.2	12.7	16.4	9.9	17.2	11.4	84.1	11.4	12.4	24.3	10.9	9.5	5.0	4.8	7.2	2.8	7.8	7.4	3.2	21.9	20.4	21.9	15.8	5.7	6.0	25.6	15.1	12.2	24.6	19.9	18.3	23.3	23.1	4.5	9.9	19.4	36.0	17.7	47.0	41.8	20.2	21.1	23.3	10.4	2.4	26.2	15.3	3.8	6.6	19.2	19.6	16.2	13.4	9.4	21.7	10.9	29.6	17.2	34.2	15.9	25.3	49.8	12.2	8.2	12.3	9.0	9.5	22.6	10.7	8.1	4.7	16.5	10.1	16.2	26.6	10.9	29.4	7.4	9.9	32.9	9.5	15.2	20.0	7.2	2.0	3.6	6.3	2.8	5.6	5.0	6.2	7.3	3.0	3.8	7.4	7.2	1.9	7.8	1.9	4.8	7.2	3.2	6.5	12.7	7.7	9.0	7.5	5.4	16.5	6.2	8.7	11.4
NCAPD3	"CAP-D3, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056"	ENSG00000151503	"Non-SMC condensin II complex subunit D3"	P42695	11	134150119-134225454	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 82.1"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 50.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040286			Supported	Nucleoplasm				Nucleoplasm		"HPA040286: "	"unprognostic (4.27e-2)"	"unprognostic (6.05e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.32e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.48e-1)"	4.9	6.4	4.9	8.3	7.4	13.7	5.4	8.9	6.2	4.0	5.4	8.5	5.0	5.4	4.7	5.9	7.8	4.2	5.4	4.5	5.5	4.3	4.3	12.1	5.3	7.6	9.0	3.3	4.1	5.9	6.8	9.2	6.0	6.1	82.1	6.1	4.9	6.0	6.6	3.8	9.0	5.6	5.4	6.8	8.5	5.3	14.8	7.1	30.7	6.6	5.3	9.8	4.5	5.4	6.9	11.2	2.6	5.6	5.8	10.4	3.8	13.0	11.6	12.8	19.2	5.2	3.8	8.5	15.4	9.8	14.2	15.7	22.7	20.6	24.3	20.7	7.9	21.8	23.8	13.3	15.5	21.9	20.7	41.6	11.7	10.0	2.4	25.7	22.6	2.6	2.2	18.8	6.1	9.2	22.1	14.4	10.6	10.9	29.6	16.7	8.7	20.6	17.4	15.1	14.0	5.5	16.8	25.6	12.0	22.4	17.9	3.6	28.3	14.8	7.4	18.4	7.8	12.5	19.2	6.2	6.2	22.8	5.3	30.7	15.4	1.7	5.6	2.6	9.5	5.0	5.6	3.7	6.4	7.2	5.1	6.9	8.9	10.4	2.2	5.8	4.1	11.2	9.4	3.8	4.9	7.4	8.9	6.2	5.5	4.3	9.0	3.3	6.1	7.1
NCF2	"NOXA2, p67phox"	ENSG00000116701	"Neutrophil cytosolic factor 2"	P19878	1	183555563-183590876	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 125.2;bone marrow: 53.0;lung: 39.5;lymphoid tissue: 45.4"	"Cell line enhanced"	"Detected in many"		"A-431: 13.1;HMC-1: 11.4;hTERT-HME1: 27.4;U-2 OS: 26.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 125.2;neutrophil: 80.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002327, HPA006040, CAB022160"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB022160: , HPA002327: AB_1079550, HPA006040: AB_1854906"	"unprognostic (4.97e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.22e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.04e-2)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.29e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.36e-2)"	15.3	3.1	2.0	23.0	4.5	53.0	3.9	0.7	2.8	2.9	2.8	3.7	0.2	2.3	1.8	6.1	4.1	5.2	7.2	6.4	2.0	1.8	2.9	5.4	39.5	42.7	6.8	0.4	3.5	4.2	0.6	1.9	11.5	3.8	3.4	3.7	4.2	4.4	0.8	3.5	7.1	3.8	5.8	5.5	45.4	2.6	3.9	3.2	4.2	2.0	5.6	5.5	7.3	3.5	1.4	24.3	125.2	45.7	0.2	1.0	22.7	13.1	0.4	0.0	0.0	0.0	0.0	0.1	1.0	1.2	1.8	0.8	0.1	0.4	1.6	2.3	0.4	7.4	0.0	9.7	1.6	8.2	0.0	0.0	3.3	3.0	0.0	1.0	11.4	0.0	2.1	1.7	27.4	0.0	0.0	2.9	3.0	0.1	0.1	0.5	0.2	0.7	3.5	1.1	9.9	0.4	0.1	0.0	0.0	0.1	0.0	0.4	1.4	4.6	0.6	0.0	26.6	0.0	2.4	0.5	0.7	0.2	0.2	5.2	0.0	15.5	45.7	125.2	0.1	34.4	0.1	1.4	0.4	0.1	24.3	0.8	0.2	0.1	80.6	0.2	29.7	1.3	1.0	22.7	2.0	4.5	0.7	2.8	2.0	1.8	6.8	0.4	3.8	3.2
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell line enhanced"	"Detected in some"		"HEL: 18.2;HMC-1: 86.9;NB-4: 30.8;REH: 15.8;RPMI-8226: 30.6;THP-1: 29.0;U-937: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol				Cytosol		"CAB010146: AB_627989, HPA036156: , HPA057975: "	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.2	0.0	0.0	0.0	2.6	86.9	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.0	30.8	0.0	0.0	15.8	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	16.1	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4
NCK2	NCKbeta	ENSG00000071051	"NCK adaptor protein 2"	O43639	2	105744897-105894274	"Plasma proteins, Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 58.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016116, HPA031004"	Approved						64000			"CAB016116: AB_2150588, HPA031004: AB_10795571"	"unprognostic (2.39e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.85e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.21e-3)"	"unprognostic (4.22e-2)"	16.8	9.9	13.8	16.3	12.8	10.5	37.4	19.3	22.0	15.3	24.8	7.4	10.3	35.6	14.8	15.3	31.2	11.7	21.8	23.6	15.8	8.8	12.3	5.0	16.7	38.0	14.2	9.2	12.4	25.5	9.2	12.4	24.3	12.1	13.8	11.2	10.2	30.2	13.4	31.2	14.9	34.9	12.1	15.2	25.9	19.2	15.0	11.8	14.1	16.0	17.3	23.5	18.0	27.4	8.6	1.3	15.4	0.7	8.2	16.3	3.7	8.3	6.6	17.3	7.9	5.1	3.7	24.8	6.2	8.3	7.3	4.2	19.9	6.9	3.6	7.9	7.9	8.2	7.3	15.7	4.9	25.5	8.1	1.6	3.2	12.3	13.5	8.9	3.3	7.3	11.4	7.9	10.2	7.3	2.4	12.9	5.9	7.4	9.3	15.4	9.6	7.7	7.5	12.2	13.3	9.3	17.1	11.1	15.3	4.7	12.4	58.4	4.5	23.2	8.1	12.8	18.8	0.3	8.8	9.7	6.0	1.2	5.6	8.0	20.4	15.4	0.7	8.4	5.1	0.6	6.8	5.1	9.9	8.7	0.8	8.6	10.3	9.3	6.5	8.2	0.6	1.3	16.3	3.7	13.8	12.8	19.3	22.0	15.8	8.8	14.2	9.2	12.1	11.8
NCKAP1L	HEM1	ENSG00000123338	"NCK associated protein 1 like"	P55160	12	54497711-54548238	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 39.1;lymphoid tissue: 56.7"	"Cell line enhanced"	"Detected in some"		"HL-60: 32.9;HMC-1: 34.8;NB-4: 24.2;REH: 17.4;THP-1: 36.1;U-937: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039490, HPA040772"	Approved		Uncertain	"Plasma membrane,Cytosol"			52000	Cytosol	"Plasma membrane"	"HPA039490: , HPA040772: "	"unprognostic (4.54e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.80e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.54e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.63e-2)"	"unprognostic (4.74e-2)"	18.1	5.0	5.9	22.0	10.5	16.9	7.2	1.2	5.8	3.1	15.0	8.1	0.6	4.0	3.1	4.3	4.8	4.0	5.1	6.5	4.1	3.5	3.9	6.5	19.7	56.7	9.3	2.5	2.2	2.4	4.4	2.3	7.3	6.6	4.8	6.9	3.0	4.3	4.0	1.5	2.8	15.4	7.0	13.9	44.7	4.7	1.7	7.9	47.2	2.8	1.8	30.0	22.2	3.3	11.2	25.4	18.4	39.1	12.3	15.2	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.1	0.0	0.0	0.0	0.0	0.0	11.9	0.1	14.2	0.0	0.0	0.0	32.9	34.8	0.0	0.0	0.0	0.0	0.2	2.2	13.3	0.0	0.0	13.8	24.2	0.0	0.0	17.4	0.0	13.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.7	0.8	11.6	0.0	21.1	0.0	8.6	23.3	18.4	11.9	36.4	9.8	11.2	10.7	12.1	25.4	11.0	6.9	10.0	5.9	12.3	39.1	14.4	15.2	19.2	5.9	10.5	1.2	5.8	4.1	3.5	9.3	2.5	6.6	7.9
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	Nucleoplasm,Nucleoli			600000	"Nucleoplasm, Nucleoli"		"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	62.2	58.2	70.7	51.7	41.7	45.4	72.7	70.5	47.8	66.5	58.9	96.1	44.8	82.8	60.7	54.3	61.1	141.3	94.6	114.1	48.3	59.3	138.0	55.3	129.6	45.8	157.2	52.3	43.0	54.9	83.0	87.5	69.7	122.9	28.4	58.5	84.6	137.7	97.6	105.2	41.8	102.8	127.4	72.6	48.8	82.7	61.2	43.7	47.1	54.1	62.2	40.7	79.7	59.2	53.3	55.2	62.3	92.5	53.8	52.8	178.1	38.8	102.7	55.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4
NCOA3	"ACTR, AIB1, bHLHe42, CAGH16, KAT13B, p/CIP, RAC3, SRC-3, SRC3, TNRC16, TRAM-1"	ENSG00000124151	"Nuclear receptor coactivator 3"	Q9Y6Q9	20	47501902-47656877	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009800, HPA024210"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009800: AB_2251314, HPA024210: AB_10602011"	"unprognostic (7.26e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (8.09e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.22e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.04e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.63e-1)"	20.1	8.9	6.6	34.0	7.4	11.1	15.7	11.9	9.9	12.3	10.1	8.1	9.0	6.7	15.5	8.8	16.7	12.0	8.6	11.5	6.7	4.8	9.1	9.3	17.4	25.8	7.9	4.7	13.3	10.7	13.5	13.5	54.7	7.9	9.7	9.0	10.8	13.5	10.0	32.5	15.0	17.1	11.3	9.5	30.8	11.4	9.2	7.2	17.6	13.5	10.5	33.3	15.1	17.7	13.0	6.7	6.0	7.3	2.7	4.0	3.5	5.7	18.8	5.3	7.2	12.5	14.7	37.3	5.6	8.4	9.6	5.1	9.0	6.4	20.1	3.7	9.6	14.2	4.1	6.9	7.3	10.6	2.2	2.7	5.3	12.5	7.4	2.1	15.0	6.7	19.8	9.1	10.6	6.8	6.2	4.7	5.3	62.6	3.2	3.7	1.8	7.2	6.0	3.7	8.6	5.3	13.6	1.0	1.9	14.1	17.6	6.0	8.1	5.5	11.8	5.7	5.0	6.9	2.4	12.9	11.8	20.7	6.6	2.2	3.8	3.4	5.2	4.0	3.5	7.3	3.2	13.0	3.2	3.1	6.7	10.0	3.7	4.0	6.0	2.7	7.0	5.5	4.0	3.5	6.6	7.4	11.9	9.9	6.7	4.8	7.9	4.7	7.9	7.2
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB072830: , HPA043246: , HPA050288: , HPA051168: "	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favourable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	23.8	39.9	28.5	23.7	23.5	17.9	14.2	17.6	19.9	19.4	17.6	21.3	10.9	25.1	12.4	30.7	18.3	35.0	21.3	28.8	33.4	25.9	25.0	34.5	25.0	23.0	15.6	29.8	18.3	22.4	30.0	35.2	26.9	21.8	10.4	19.0	15.5	27.5	10.1	14.1	10.9	27.5	28.9	11.7	20.1	27.1	9.7	16.2	29.1	12.7	13.8	12.2	17.9	23.4	20.0	11.8	14.6	24.2	7.2	8.3	14.7	19.0	18.6	17.1	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4
NCOR2	"CTG26, SMRT, SMRTE, TNRC14, TRAC-1"	ENSG00000196498	"Nuclear receptor corepressor 2"	Q9Y618	12	124324415-124567589	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001928	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA001928: AB_1079454"	"unprognostic (9.51e-3)"	"unprognostic (7.37e-3)"	"unprognostic (4.66e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.19e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.90e-3)"	"unprognostic (6.42e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.86e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.90e-2)"	24.0	22.0	21.3	21.3	19.0	16.8	18.3	33.8	33.5	24.5	17.2	24.3	17.7	16.4	21.3	19.0	15.7	16.3	21.5	18.2	22.0	14.8	16.0	11.2	23.4	11.9	19.0	15.6	28.6	30.0	13.8	39.5	13.2	28.3	21.3	7.6	32.7	29.2	24.5	62.4	22.8	22.2	17.4	12.2	17.4	24.0	10.8	22.0	9.3	16.7	25.0	7.6	16.3	14.7	0.6	1.7	8.1	4.0	0.2	1.9	0.4	19.4	36.7	10.5	10.0	6.1	8.3	31.4	20.2	10.1	11.8	5.3	19.5	14.4	19.8	15.0	16.4	18.5	4.1	21.5	4.8	20.8	8.1	15.9	34.6	11.8	12.3	11.9	20.2	13.3	8.1	14.7	8.8	11.2	20.4	5.9	10.5	16.8	42.9	13.8	14.6	35.8	13.9	17.5	10.0	5.6	22.8	27.7	20.2	24.8	21.0	12.7	17.1	15.1	53.9	27.5	47.6	27.1	42.9	11.3	11.4	12.1	15.6	8.9	25.7	8.1	0.7	1.6	1.9	0.4	0.5	0.6	0.5	1.5	0.3	0.4	0.6	0.5	1.6	0.2	4.0	1.7	0.0	0.4	21.3	19.0	33.8	28.4	22.0	14.8	19.0	15.6	28.3	22.0
NDN	"HsT16328, PWCR"	ENSG00000182636	"Necdin, MAGE family member"	Q99608	15	23685400-23687330	"Plasma proteins, Predicted membrane proteins"	"Growth regulation, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 20.7;ASC diff: 20.4;HSkMC: 27.5;NTERA-2: 16.5;U-2 OS: 30.8;U-266/70: 19.5;U-266/84: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.5;plasmacytoid DC: 4.3"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074457			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA074457: "	"unprognostic (3.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.04e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (4.52e-4)"	"unprognostic (1.89e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.81e-2)"	29.9	35.5	19.2	7.7	39.1	1.3	25.0	2.6	28.2	32.7	12.9	12.9	8.1	8.0	29.9	17.7	12.3	21.4	19.1	20.3	18.1	40.3	6.9	3.0	10.3	8.9	14.8	17.6	50.7	7.1	2.1	23.2	22.4	19.0	18.8	8.1	16.5	9.2	29.3	9.2	4.7	8.4	23.5	11.8	11.8	8.6	16.4	7.3	7.1	8.4	8.7	4.9	13.1	17.3	0.0	4.3	0.0	0.8	0.4	0.0	0.0	0.0	0.0	20.7	0.0	20.4	7.8	0.0	13.1	0.0	0.3	3.6	0.0	0.0	0.0	0.0	3.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	12.0	27.5	0.0	3.8	0.0	0.0	0.4	0.0	6.7	0.0	9.8	0.0	16.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.1	0.0	3.5	0.0	0.0	1.0	30.8	0.0	0.0	19.5	18.1	0.0	2.1	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.6	4.3	0.0	0.0	19.2	39.1	2.6	28.2	18.1	40.3	14.8	17.6	19.0	7.3
NDRG1	"CAP43, DRG1, NDR1, RTP, TDD5"	ENSG00000104419	"N-myc downstream regulated 1"	Q92597	8	133237171-133302022	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Charcot-Marie-Tooth disease, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 69.0;hTERT-HME1: 139.1;U-87 MG: 93.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006881	Approved		Supported	Microtubules,Cytosol				Cytosol	Microtubules	"HPA006881: AB_1078392"	"unprognostic (6.96e-3)"	"unprognostic (3.31e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.47e-4)"	"unprognostic (3.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (7.27e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.28e-2)"	43.9	23.6	42.0	17.0	80.9	18.0	29.8	6.4	36.2	33.1	47.7	73.2	24.2	74.2	20.9	20.6	83.0	24.7	26.8	22.2	48.7	32.9	62.6	12.1	31.0	11.4	96.3	19.8	37.5	16.7	17.8	18.6	32.5	50.0	115.0	22.4	16.2	29.0	26.4	13.2	56.9	78.2	19.2	102.0	11.5	45.7	15.0	74.3	10.3	21.4	40.0	34.9	58.7	64.9	1.9	12.2	8.9	4.1	1.3	9.3	2.9	21.5	2.7	0.1	0.1	13.7	9.6	2.9	1.5	11.8	1.1	6.1	1.3	3.0	0.1	15.5	6.4	7.0	0.2	34.0	2.4	1.3	25.5	0.2	5.5	1.6	5.2	0.7	0.5	8.9	69.0	5.8	139.1	5.1	0.2	15.1	1.9	1.2	2.0	2.1	0.3	17.9	0.2	2.4	10.0	3.5	3.2	1.6	1.6	3.3	35.7	8.6	0.1	2.3	6.6	9.7	5.0	4.2	1.2	11.3	29.6	0.1	93.6	8.1	19.0	8.9	4.1	0.0	6.3	3.7	9.3	1.7	5.9	7.5	6.1	1.9	4.6	3.1	4.2	1.3	4.0	12.2	8.0	2.9	42.0	80.9	6.4	36.2	48.7	32.9	96.3	19.8	50.0	74.3
NDUFA11	B14.7	ENSG00000174886	"NADH:ubiquinone oxidoreductase subunit A11"	Q86Y39	19	5891276-5904006	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA072209			Uncertain	Mitochondria				Mitochondria		"HPA072209: "	"unprognostic (2.24e-1)"	"prognostic favourable (4.54e-5)"	"unprognostic (8.20e-3)"	"prognostic favourable (3.38e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.73e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.95e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.67e-3)"	"unprognostic (9.02e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.40e-2)"	"unprognostic (6.16e-3)"	32.3	70.8	50.2	40.9	41.3	43.4	49.3	29.9	75.2	35.3	45.1	25.8	41.2	41.6	35.9	36.9	53.1	38.4	41.4	149.3	41.9	45.8	44.1	59.8	37.9	51.9	48.3	45.8	38.4	70.9	13.5	33.8	32.5	35.9	35.1	19.6	35.9	76.3	41.1	106.0	32.4	39.5	45.2	40.2	31.5	38.8	21.2	27.0	37.3	37.8	72.1	30.5	38.3	37.2	63.3	90.2	54.3	87.4	44.8	73.7	121.4	49.1	38.1	28.4	46.1	23.3	37.9	31.8	34.0	39.3	62.4	57.7	45.4	26.2	48.7	53.8	32.4	32.6	19.5	39.7	15.1	41.9	73.4	20.0	36.6	72.6	60.9	29.7	29.7	51.8	36.1	35.4	16.8	40.7	42.1	54.2	31.4	37.5	77.0	53.0	42.9	95.8	53.4	35.5	69.6	38.5	32.9	41.1	43.7	26.5	43.5	59.9	33.5	63.4	36.4	34.8	33.5	69.3	55.6	82.5	71.5	63.0	58.8	71.3	44.7	54.3	87.4	47.7	53.5	68.0	54.8	63.3	59.6	54.0	74.9	54.6	56.7	49.5	39.2	44.8	57.7	90.2	73.7	121.4	50.2	41.3	29.9	75.2	41.9	45.8	48.3	45.8	35.9	27.0
NDUFA9	"CI-39k, NDUFS2L, SDR22E1"	ENSG00000139180	"NADH:ubiquinone oxidoreductase subunit A9"	Q16795	12	4649095-4694317	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA042268, HPA073212"	Supported		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA042268: AB_2677922, HPA073212: "	"unprognostic (2.26e-1)"	"unprognostic (7.85e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.58e-2)"	"unprognostic (9.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.57e-7)"	"unprognostic (7.80e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.93e-2)"	"prognostic favourable (5.75e-4)"	10.7	13.2	11.0	10.1	17.8	21.2	11.7	15.3	20.7	9.2	22.1	12.0	8.6	20.9	10.1	11.0	13.4	8.4	8.5	41.3	11.6	11.0	23.7	22.1	8.5	11.8	12.7	9.9	8.4	10.4	10.4	12.2	9.5	16.2	9.9	22.7	12.1	13.3	10.1	66.6	10.6	18.9	11.7	8.3	11.5	13.6	5.8	9.3	14.4	10.2	30.7	12.8	8.2	8.8	36.8	43.5	14.6	41.5	25.8	35.9	59.6	10.7	19.5	9.6	12.7	7.1	7.1	27.9	8.3	8.4	16.0	12.2	42.2	21.7	12.2	4.4	8.9	18.2	13.9	12.2	10.5	23.6	24.4	11.9	20.7	31.9	15.6	17.4	12.9	9.0	11.9	10.9	14.9	12.0	8.3	23.1	11.8	20.9	17.3	20.0	24.8	16.2	24.5	14.2	12.7	22.0	24.7	7.0	7.8	10.4	28.1	14.5	5.8	16.6	8.4	12.2	24.8	11.1	19.1	4.5	5.3	20.1	12.7	10.8	13.3	14.6	35.8	13.3	27.7	41.5	28.0	36.8	29.0	30.2	42.3	26.2	25.3	26.2	3.1	25.8	32.2	43.5	35.9	59.6	11.0	17.8	15.3	20.7	11.6	11.0	12.7	9.9	16.2	9.3
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003886	Supported		Approved	Mitochondria				Mitochondria		"HPA003886: AB_1079463"	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	35.2	39.8	86.7	27.0	67.4	35.6	26.1	39.3	81.5	25.4	37.7	23.8	23.1	38.8	24.7	42.3	36.8	28.8	28.2	110.0	70.6	62.8	50.4	50.6	19.8	28.1	63.9	54.1	27.7	36.3	31.5	31.4	19.9	49.9	26.6	36.2	25.7	39.7	34.5	88.5	24.3	33.8	41.5	38.9	22.1	31.5	12.0	41.4	18.3	28.3	49.2	27.8	25.2	21.5	76.6	88.6	62.2	74.4	60.5	105.9	129.7	41.8	70.6	38.2	67.7	28.9	28.1	42.2	28.6	62.2	44.0	47.7	95.7	48.8	44.4	25.8	32.0	50.2	28.5	46.5	35.0	29.1	72.9	31.2	59.9	77.4	39.2	63.7	53.8	34.6	42.0	43.9	59.2	48.1	32.4	28.2	37.8	50.8	61.4	80.2	25.5	65.9	42.9	41.7	58.5	51.5	47.9	26.4	37.1	21.0	40.2	41.5	59.7	57.1	32.2	25.2	28.5	26.8	50.0	51.2	46.5	55.1	50.0	67.5	28.0	35.1	74.4	62.2	59.0	72.9	69.5	76.6	73.6	67.8	80.4	64.1	79.8	76.7	17.1	60.5	61.4	88.6	105.9	129.7	86.7	67.4	39.3	81.5	70.6	62.8	63.9	54.1	49.9	41.4
NDUFC2	"B14.5b, HLC-1"	ENSG00000151366	"NADH:ubiquinone oxidoreductase subunit C2"	O95298	11	78068304-78080219	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA038873, HPA056195"	Approved		Supported	Mitochondria				Mitochondria		"HPA038873: AB_10673480, HPA056195: "	"unprognostic (7.32e-2)"	"unprognostic (5.91e-3)"	"unprognostic (4.00e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (3.32e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"prognostic favourable (5.00e-5)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.61e-3)"	55.0	70.8	40.8	23.3	44.4	32.3	46.2	51.4	58.4	22.5	41.1	31.2	68.0	63.4	31.8	32.8	41.8	35.6	31.9	60.4	41.0	44.5	37.5	89.6	30.1	36.4	43.2	47.0	27.3	48.4	25.3	34.7	31.8	40.8	27.3	20.3	29.7	79.5	59.0	122.8	29.0	55.3	23.7	41.1	24.5	36.6	28.6	23.2	26.9	63.5	43.7	23.3	31.9	24.1	50.3	78.2	70.3	73.2	44.5	46.3	81.2	36.1	45.2	24.6	15.5	23.4	14.8	30.3	44.3	26.6	35.2	25.1	121.1	40.7	21.7	81.3	20.9	38.2	18.5	26.0	13.5	41.1	52.3	23.3	46.9	95.3	40.0	50.9	23.2	20.4	24.2	27.0	10.2	23.9	45.9	36.6	19.6	62.4	33.2	91.8	27.7	57.1	29.1	46.8	73.3	26.6	54.5	34.8	30.8	31.5	65.0	22.8	51.5	42.3	31.2	34.3	42.3	81.7	37.9	33.7	66.1	49.9	19.5	30.6	32.8	65.8	73.2	70.3	39.4	58.2	36.2	50.3	45.6	41.5	77.2	45.5	39.6	41.3	21.0	44.5	48.0	78.2	46.3	81.2	40.8	44.4	51.4	58.4	41.0	44.5	43.2	47.0	40.8	23.2
NDUFS3	CI-30	ENSG00000213619	"NADH:ubiquinone oxidoreductase core subunit S3"	O75489	11	47565336-47584562	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004484	Approved		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA004484: AB_1079464"	"unprognostic (2.18e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.13e-2)"	"unprognostic (6.40e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.75e-3)"	"unprognostic (7.73e-2)"	"prognostic favourable (2.61e-6)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.17e-3)"	13.4	22.9	29.7	13.2	46.3	25.5	18.1	23.9	35.0	16.6	28.4	16.5	16.1	31.4	12.7	16.0	19.1	17.3	16.3	45.8	26.0	24.8	34.1	32.0	12.0	13.9	29.4	24.9	12.2	23.0	21.4	17.0	12.0	26.0	13.9	30.9	14.4	20.1	17.4	100.9	15.1	28.9	15.9	17.1	14.2	18.9	15.1	15.4	20.5	16.1	51.6	18.8	14.5	11.7	25.0	36.1	18.7	31.2	16.4	23.8	31.5	11.5	21.9	18.6	19.3	16.1	16.6	15.9	11.0	18.8	27.1	25.8	32.2	20.3	25.6	10.9	15.6	21.3	26.2	19.7	22.1	13.7	42.3	15.5	30.8	31.1	16.5	37.9	20.2	16.2	14.3	10.2	17.0	17.0	22.6	17.8	17.5	35.2	25.9	49.2	26.3	31.0	31.7	26.7	21.1	23.2	18.0	20.8	15.0	14.0	24.1	24.8	26.9	36.3	11.9	16.2	18.2	18.8	24.7	20.4	27.0	28.4	16.5	29.2	16.1	12.2	28.6	18.7	18.7	31.2	19.8	25.0	19.7	20.3	33.7	23.1	18.8	20.1	7.5	16.4	25.0	36.1	23.8	31.5	29.7	46.3	23.9	35.0	26.0	24.8	29.4	24.9	26.0	15.4
NDUFS6	CI-13kA	ENSG00000145494	"NADH:ubiquinone oxidoreductase subunit S6"	O75380	5	1801400-1816605	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 146.4"	"Cell line enhanced"	"Detected in all"		"HeLa: 102.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064221	Supported						27000			"HPA064221: "	"unprognostic (2.34e-1)"	"unprognostic (1.43e-3)"	"unprognostic (4.04e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.91e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.68e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.02e-1)"	25.0	20.6	19.8	18.9	20.9	23.7	23.9	13.3	26.8	10.6	26.2	11.5	13.6	34.2	13.6	14.4	20.3	10.9	18.8	59.8	17.6	16.5	28.1	43.1	13.5	26.2	19.9	12.9	13.0	29.7	10.5	13.6	17.1	16.1	15.4	12.6	14.7	22.3	19.0	146.4	13.0	27.1	17.8	16.5	16.4	25.4	13.3	9.3	25.5	14.7	36.6	14.1	15.5	12.7	38.7	55.7	35.8	52.8	32.4	40.2	36.7	20.4	28.2	13.8	20.9	5.0	4.5	37.8	17.5	6.2	9.4	8.2	31.0	20.0	28.3	48.3	7.2	20.4	10.3	13.9	5.1	32.0	34.1	21.8	102.7	26.2	10.2	25.6	19.3	6.4	8.9	9.0	6.4	9.1	26.7	21.7	10.1	34.1	36.6	46.9	18.3	39.7	27.3	18.0	33.2	9.7	22.8	17.1	17.2	56.6	36.4	21.8	24.3	30.5	18.4	15.0	34.8	15.4	28.3	26.3	40.2	36.2	18.9	37.4	16.9	31.4	46.5	35.8	35.1	52.8	34.9	38.7	37.2	35.5	55.7	31.0	31.5	35.2	20.2	32.4	45.7	54.5	40.2	36.7	19.8	20.9	13.3	26.8	17.6	16.5	19.9	12.9	16.1	9.3
NDUFS7	"CI-20, FLJ45860, FLJ46880, PSST"	ENSG00000115286	"NADH:ubiquinone oxidoreductase core subunit S7"	O75251	19	1383527-1395589	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"	Oxidoreductase	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 198.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (7.36e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (5.30e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.99e-3)"	"unprognostic (8.12e-2)"	"prognostic favourable (4.90e-7)"	"unprognostic (2.95e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-2)"	22.4	17.6	15.3	10.1	17.6	9.9	7.0	16.6	22.7	6.1	18.7	20.6	7.6	34.5	7.1	9.6	13.3	6.7	10.0	35.9	16.1	15.1	20.7	20.7	7.1	9.1	19.6	11.9	7.2	28.7	5.0	12.0	6.8	17.6	11.9	4.0	12.0	23.6	10.2	198.0	8.3	25.2	7.5	20.1	11.5	18.2	14.2	14.6	9.7	8.0	39.2	10.0	6.7	7.9	29.1	41.8	19.8	39.1	17.2	29.2	20.8	18.2	18.5	0.6	4.3	0.6	1.7	9.5	11.0	1.1	2.3	2.5	30.3	4.5	27.0	11.3	0.6	9.6	0.8	2.2	0.1	30.1	21.3	8.5	19.8	18.8	2.8	14.7	9.5	1.4	3.8	0.4	0.0	3.2	16.8	10.6	0.6	19.1	14.6	6.1	6.6	22.9	14.2	7.1	27.5	1.1	14.1	10.4	10.6	9.7	9.2	17.9	7.3	9.2	13.8	4.4	6.1	9.6	14.2	42.7	37.2	18.3	11.1	19.9	6.2	19.8	33.6	16.1	21.3	39.1	18.1	29.1	20.1	20.0	41.8	27.1	19.7	19.1	9.1	17.2	31.7	31.6	29.2	20.8	15.3	17.6	16.6	22.7	16.1	15.1	19.6	11.9	17.6	14.6
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria				Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.3	11.0	18.0	13.6	11.8	13.6	19.2	11.0	11.4	9.6	20.7	11.9	10.7	15.2	7.1	10.5	12.8	16.9	7.5	6.1	15.4	35.2	13.3	16.2	21.3	12.0	18.5	13.3	14.7	11.6	18.4	14.4	27.9	13.9	13.1	18.9	8.0	18.2	14.3	22.4	13.8	8.0	33.4	15.4	12.8	8.0	8.4	19.2	22.8	12.7	19.5	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.1	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3
NEB	"NEB177D, NEM2"	ENSG00000183091	Nebulin	P20929	2	151485336-151734487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Nemaline myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 505.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.7;RH-30: 26.6;U-266/70: 10.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 7.4;olfactory region: 4.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 25.3"	HPA016601	Enhanced									"HPA016601: AB_1854361"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-13)"	"unprognostic (6.80e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.06e-2)"	9.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.2	4.0	0.0	0.8	1.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	3.8	0.0	505.8	0.3	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	3.0	65.9	2.6	0.1	0.0	1.3	0.5	1.7	0.6	0.8	0.9	0.3	0.3	0.3	0.6	0.5	0.1	0.1	1.7	0.3	0.0	0.0	0.0	4.6	0.5	1.2	0.9	0.1	0.9	0.1	0.0	0.0	0.6	0.7	0.4	0.6	1.5	0.0	0.8	1.1	4.0	0.2	0.0	0.0	0.6	0.9	6.7	0.4	0.5	0.4	0.7	1.1	0.8	1.1	26.6	0.1	0.0	0.9	1.5	0.2	0.2	0.3	0.1	0.7	0.8	0.6	0.7	0.9	0.1	0.9	10.0	1.4	0.3	0.1	0.6	1.1	1.2	0.6	1.7	0.9	0.0	0.9	1.2	0.8	0.5	0.0	1.3	0.3	0.4	1.1	0.8	0.0	0.5	0.4	0.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0
NECTIN1	"CD111, CLPED1, ED4, HIgR, HVEC, OFC7, PRR, PRR1, PVRL1, PVRR1, SK-12"	ENSG00000110400	"Nectin cell adhesion molecule 1"	Q15223	11	119623408-119729084	"CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.3;skin 1: 73.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 58.1;hTCEpi: 36.2;RT4: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016135, HPA026846"	Approved				"Secreted in other tissues"		97000000			"CAB016135: AB_626865, HPA026846: AB_1846226"	"unprognostic (1.62e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.58e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.59e-3)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.62e-2)"	3.1	3.0	7.7	3.0	11.1	11.9	5.3	8.4	20.8	6.6	7.3	27.3	2.4	9.6	2.3	2.0	55.3	2.9	2.5	3.0	16.1	8.2	3.0	2.4	2.5	1.7	12.7	10.6	1.8	10.8	2.4	4.1	8.2	10.1	5.9	7.8	6.3	8.7	4.4	1.6	73.5	6.9	3.1	14.3	2.2	3.2	1.3	12.4	2.5	1.8	25.3	20.8	17.3	14.8	0.1	4.8	1.0	1.5	0.1	0.1	0.2	4.0	3.4	3.2	4.6	1.7	0.5	22.7	1.6	1.5	1.4	1.0	7.1	13.9	5.4	6.7	1.9	58.1	8.2	29.6	0.6	12.7	1.2	0.7	1.1	3.3	0.7	3.6	9.1	0.5	36.2	4.4	16.2	4.1	0.1	28.9	1.8	10.6	0.0	2.2	10.6	4.7	0.3	19.4	6.5	1.3	39.4	7.8	17.7	5.5	14.6	0.5	13.3	0.5	2.2	1.2	4.6	10.0	1.4	5.3	6.6	0.0	0.4	3.0	2.8	0.0	0.3	0.2	0.1	0.5	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	1.0	0.1	1.5	4.8	0.0	0.2	7.7	11.1	8.4	20.8	16.1	8.2	12.7	10.6	10.1	12.4
NECTIN2	"CD112, HVEB, PRR2, PVRL2, PVRR2"	ENSG00000130202	"Nectin cell adhesion molecule 2"	Q92692	19	44846175-44889228	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 11.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012759, CAB026138, HPA073459"	Enhanced		Approved	"Nucleoli fibrillar center,Cell Junctions"			3400000	"Nucleoli fibrillar center, Cell Junctions"		"CAB026138: , HPA012759: AB_1846227, HPA073459: "	"unprognostic (3.30e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (7.45e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.05e-1)"	29.5	28.2	7.9	15.6	7.7	5.6	38.0	4.5	9.0	24.2	34.0	9.3	22.3	24.2	23.2	27.4	33.6	16.7	54.1	21.9	10.5	8.1	29.0	53.7	39.6	23.0	8.2	6.8	25.5	20.6	22.5	15.9	45.8	11.2	25.8	14.8	22.9	24.4	28.9	14.6	18.3	42.9	13.8	8.4	31.4	26.2	38.7	5.8	3.8	32.2	19.2	24.1	21.6	31.4	0.0	3.3	11.5	2.6	0.0	0.3	0.7	17.8	21.4	27.7	32.7	14.0	8.5	32.2	15.3	18.9	27.1	31.3	44.1	39.3	0.1	20.7	17.7	24.5	24.5	12.6	21.6	0.7	12.8	10.8	7.4	28.5	33.7	0.1	29.0	14.9	5.1	12.9	10.5	35.0	17.6	0.1	13.5	32.5	0.1	1.2	23.0	6.4	1.0	9.4	0.7	32.1	22.1	1.3	3.7	19.0	28.9	6.5	22.5	10.6	34.9	7.4	26.3	5.5	11.2	2.2	6.4	0.1	13.6	2.3	19.3	1.5	2.6	11.5	0.0	0.9	0.3	0.0	0.1	0.0	3.3	0.0	0.0	0.0	2.4	0.0	0.5	0.3	0.0	0.7	7.9	7.7	4.5	9.0	10.5	8.1	8.2	6.8	11.2	5.8
NEDD8	Nedd-8	ENSG00000129559	"Neural precursor cell expressed, developmentally down-regulated 8"	Q15843	14	24216852-24232454	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol			5700000	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: , HPA060254: "	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	38.2	48.1	55.5	30.7	58.1	34.6	42.2	34.1	62.4	41.0	36.3	26.8	32.6	25.0	32.2	59.9	40.3	34.3	31.3	50.7	47.1	49.5	46.5	48.4	30.5	31.5	49.4	54.6	34.3	33.4	101.1	31.3	39.7	45.5	31.6	40.0	27.4	37.2	40.7	70.7	36.5	28.4	43.0	36.0	34.9	29.9	25.7	34.3	26.9	37.5	44.7	46.8	30.7	32.0	60.2	76.1	90.2	60.1	43.2	64.1	89.9	25.5	44.8	36.5	25.7	41.4	36.2	26.5	35.0	37.1	41.2	38.1	30.9	31.3	22.1	20.5	49.2	27.0	36.3	54.6	58.0	31.2	22.0	23.6	41.3	105.3	36.0	39.0	24.7	38.4	36.3	34.7	27.3	49.2	21.0	25.9	63.5	56.9	31.0	37.0	26.9	52.5	22.1	28.9	22.5	47.5	48.7	15.4	35.9	30.2	30.8	25.1	18.6	31.0	36.8	23.5	23.6	30.0	30.9	30.8	46.4	32.0	16.8	22.5	22.2	73.5	57.9	90.2	46.8	60.1	50.7	60.2	54.4	51.9	56.9	51.1	51.2	52.0	62.2	43.2	59.0	76.1	64.1	89.9	55.5	58.1	34.1	62.4	47.1	49.5	49.4	54.6	45.5	34.3
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 72.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 49.0;HSkMC: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009720, HPA038768, HPA039270"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB009720: , HPA038768: , HPA039270: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	72.8	4.7	4.5	14.9	5.6	3.3	35.7	2.2	5.9	14.0	16.6	5.1	14.2	7.1	17.3	21.7	10.3	11.5	15.3	17.3	4.6	4.1	34.6	9.5	58.4	15.0	4.9	3.9	11.1	7.9	4.2	6.1	32.6	6.6	13.4	14.7	12.8	15.4	15.4	22.4	12.3	17.9	12.4	5.3	25.7	10.9	12.2	4.3	18.8	15.8	6.8	18.6	17.6	9.9	5.8	6.0	34.8	19.8	5.1	8.3	6.3	1.5	10.0	9.3	0.1	6.4	0.8	9.8	2.3	2.8	4.3	8.0	3.2	0.6	3.1	49.0	5.0	4.3	12.5	4.7	5.6	1.4	0.3	0.3	1.5	21.1	3.0	3.3	0.1	24.5	1.4	2.8	0.4	7.3	0.0	2.6	9.7	0.4	1.9	1.3	1.4	1.0	0.5	0.2	1.8	2.1	13.7	0.2	1.7	0.4	11.0	19.0	0.8	2.6	18.6	2.9	5.2	0.3	5.6	2.8	11.3	3.9	0.0	2.7	12.7	9.1	5.5	15.4	8.3	12.2	6.8	5.0	5.6	8.0	6.0	5.8	3.0	4.7	34.8	5.1	19.8	3.7	5.0	6.3	4.5	5.6	2.2	5.9	4.6	4.1	4.9	3.9	6.6	4.3
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913012-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.7"	"Cell line enriched"	"Detected in some"	23	"HEK 293: 286.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	1.5	18.9	20.3	2.0	24.2	1.3	1.3	10.9	87.6	9.7	2.0	5.6	0.0	1.3	3.8	1.3	4.7	1.3	1.4	1.3	36.1	25.0	2.2	1.2	1.3	1.3	52.2	22.4	2.0	2.5	1.2	3.3	1.4	144.7	2.5	1.9	3.4	1.3	26.9	1.9	1.3	1.5	3.3	26.7	1.3	1.5	12.4	4.9	0.0	1.3	0.0	1.6	1.3	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	286.0	0.0	0.0	0.0	6.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	24.2	10.9	71.9	36.1	25.0	52.2	22.4	144.7	4.9
NEGR1	"IGLON4, KILON, MGC46680, Ntra"	ENSG00000172260	"Neuronal growth regulator 1"	Q7Z3B1	1	71395940-72282734	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 15.8;TIME: 16.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.1;plasmacytoid DC: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011894	Uncertain		Approved	"Vesicles,Actin filaments,Cytosol"			390000000	"Vesicles, Actin filaments, Cytosol"		"HPA011894: AB_1854363"	"unprognostic (2.60e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.72e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-5)"	"unprognostic (5.89e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.11e-4)"	17.5	7.8	18.1	7.6	16.3	2.2	7.3	24.1	41.5	8.0	14.7	2.6	2.4	3.8	7.1	5.9	13.6	5.9	13.5	10.7	11.2	14.8	8.8	1.1	5.4	2.4	8.7	26.3	8.4	6.0	1.5	4.6	4.1	5.9	9.9	10.3	3.2	3.6	7.6	5.9	5.5	6.3	25.5	10.2	1.5	7.6	4.4	3.0	0.3	3.8	1.5	1.6	20.1	9.1	0.5	3.3	1.1	0.4	0.4	0.4	0.1	0.2	0.1	0.4	0.2	15.8	12.5	0.1	11.0	4.1	6.1	7.4	0.1	0.1	0.2	0.1	12.1	0.3	0.0	0.0	13.2	0.2	0.1	0.1	2.2	0.1	1.3	0.2	0.3	6.0	0.0	5.1	0.9	7.1	0.1	0.5	11.2	0.1	0.1	0.2	1.8	6.3	7.6	11.8	0.2	1.0	0.2	0.8	1.0	3.8	0.1	0.1	0.1	0.2	16.1	1.3	13.4	0.6	13.6	0.3	0.2	0.1	3.0	7.3	4.7	1.1	0.4	0.3	0.4	0.2	0.3	0.3	0.3	0.3	3.1	0.5	0.3	0.3	0.8	0.4	0.4	3.3	0.2	0.1	18.1	16.3	24.1	31.8	11.2	14.8	8.7	26.3	5.9	3.0
NEIL1	"FLJ22402, FPG1, hFPG1, NEI1"	ENSG00000140398	"Nei like DNA glycosylase 1"	Q96FI4	15	75346955-75357114	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 4.7;memory B-cell: 4.0;naive B-cell: 6.5;NK-cell: 14.1"	"Group enriched"	"Detected in many"	12	"B-cells: 6.5;NK-cells: 14.1;T-cells: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054084	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA054084: "	"unprognostic (9.84e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.21e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.50e-3)"	"unprognostic (8.60e-2)"	"unprognostic (9.24e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.27e-3)"	7.1	14.8	12.9	28.2	14.5	6.8	9.3	24.4	15.4	10.8	8.3	4.9	23.2	10.1	8.4	11.6	6.4	10.0	10.2	5.3	12.8	5.7	7.9	9.1	9.3	9.8	6.0	9.8	11.0	10.8	9.1	9.0	4.6	8.0	10.4	2.4	7.1	25.0	24.2	13.6	11.7	9.5	4.3	5.9	6.8	9.9	3.8	7.0	15.4	8.2	5.2	13.3	7.5	8.5	6.5	0.2	0.7	0.5	14.1	4.7	1.0	2.1	3.6	2.4	1.5	0.7	0.8	4.5	1.3	0.0	0.5	0.1	0.6	4.0	11.4	2.1	0.2	6.3	1.4	0.4	0.0	5.6	9.3	1.9	9.9	1.8	0.9	2.2	2.7	0.3	1.8	0.6	0.0	1.4	1.2	3.4	0.4	2.9	0.4	6.2	2.1	0.8	2.1	1.4	0.5	2.1	2.4	1.4	2.8	2.2	1.0	3.1	4.2	3.3	6.2	1.3	2.5	1.9	1.1	5.3	5.2	9.3	1.2	9.3	1.2	0.0	0.5	0.0	4.7	0.1	1.3	4.0	0.8	1.0	0.2	6.5	1.4	1.4	0.7	14.1	0.1	0.2	0.2	1.0	12.9	14.5	24.4	15.4	12.8	5.7	6.0	9.8	8.0	7.0
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.5;HL-60: 28.8;Karpas-707: 37.9;MOLT-4: 29.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm				Nucleoplasm		"HPA065761: "	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.0	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.2	9.8	5.8	2.1	6.2	7.8	1.3	2.3	3.3	6.6	3.5	14.2	26.5	4.3	5.4	4.6	5.6	0.2	28.8	3.7	0.1	0.2	10.1	2.2	3.7	5.5	37.9	6.3	3.1	29.2	11.1	2.9	4.3	5.9	4.3	2.5	2.5	0.9	4.9	3.4	4.4	5.1	2.4	4.1	7.5	1.7	5.9	4.6	3.0	8.8	2.6	1.7	12.4	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3
NEK4	"NRK2, pp12301, STK2"	ENSG00000114904	"NIMA related kinase 4"	P51957	3	52708449-52770949	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015750, HPA058543"	Enhanced		Supported	Cytosol				Cytosol		"HPA015750: AB_1854367, HPA058543: "	"unprognostic (1.32e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (2.69e-5)"	"unprognostic (9.65e-3)"	"unprognostic (3.42e-1)"	"unprognostic (6.64e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.27e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.39e-2)"	7.2	10.7	15.5	9.1	15.7	7.3	11.0	20.2	16.1	10.6	8.4	10.6	9.6	7.6	10.3	10.7	8.1	15.8	7.5	7.4	12.5	14.2	11.6	12.4	7.7	8.8	12.7	8.6	15.8	10.2	13.4	17.6	8.7	11.9	9.4	9.7	9.1	8.5	11.3	10.8	5.3	6.6	9.5	10.7	7.9	11.0	47.7	12.4	11.1	15.5	5.0	10.4	9.3	10.7	5.1	6.4	12.4	11.8	4.6	5.2	5.5	12.8	10.0	13.7	10.8	12.6	9.1	14.9	9.1	12.3	17.1	17.3	8.7	9.6	13.2	4.3	8.9	6.0	16.7	10.7	23.0	13.1	7.0	10.3	12.2	11.1	7.8	25.1	10.4	5.6	9.9	21.9	14.6	6.4	12.8	10.7	10.7	10.9	13.5	9.2	11.9	9.9	11.9	12.0	9.7	9.6	18.5	10.1	6.1	19.1	11.8	9.0	11.0	15.2	5.8	11.5	11.7	18.3	16.8	12.0	17.5	13.0	13.1	11.9	12.4	12.4	11.8	5.8	4.6	7.3	5.2	3.6	4.0	4.8	6.4	5.1	4.9	4.2	1.8	4.6	4.8	3.2	3.1	5.5	15.5	15.7	20.2	16.1	12.5	14.2	12.7	8.6	11.9	12.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria			190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	16.9	19.5	26.8	17.3	16.5	11.6	8.1	7.9	10.1	8.9	17.4	0.1	11.3	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	10.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	6.1	17.5	19.4	9.0	6.1	12.4	7.3	18.7	13.3	6.4	12.7	15.8	14.8	15.2	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982714-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: , HPA043931: "	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavourable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	14.8	13.7	18.3	17.2	19.0	20.0	16.5	36.4	23.2	17.0	15.1	22.5	15.7	21.6	19.5	15.1	26.1	21.0	11.4	10.8	16.8	12.2	14.7	10.9	11.4	15.8	14.1	12.0	26.9	27.0	12.5	19.1	16.8	13.6	15.7	8.3	16.2	28.6	28.4	17.4	23.4	21.2	13.3	11.9	18.4	20.6	26.5	18.3	18.0	16.8	10.9	21.6	18.1	19.5	20.5	14.9	12.0	14.0	13.1	18.5	10.3	10.6	9.9	8.6	15.7	3.6	3.7	17.1	5.7	4.1	6.9	5.5	16.3	18.4	18.8	8.3	3.7	10.1	8.7	7.2	3.4	9.6	13.4	12.4	7.3	15.4	5.2	12.8	12.7	3.2	6.4	4.6	4.9	5.2	23.4	9.1	3.0	12.4	24.7	36.8	24.9	14.9	22.6	7.5	11.8	5.0	9.0	23.5	14.6	6.6	7.9	9.7	15.1	9.8	5.9	7.0	8.0	8.1	12.6	19.4	19.9	20.9	8.0	13.5	8.7	6.0	12.3	12.0	14.2	14.0	17.1	14.6	16.3	12.6	11.9	20.5	14.2	11.0	4.7	13.1	11.2	14.9	18.5	10.3	18.3	19.0	36.4	23.2	16.8	12.2	14.1	12.0	13.6	18.3
NELL2	NRP2	ENSG00000184613	"Neural EGFL like 2"	Q99435	12	44508275-44921848	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;brain: 73.3;fallopian tube: 35.1"	"Cell line enhanced"	"Detected in some"		"AF22: 40.9;NTERA-2: 16.1;SCLC-21H: 29.7;U-266/70: 10.9;U-266/84: 10.8;U-698: 14.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 33.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 24.5;naive CD8 T-cell: 36.8"	"Lineage enriched"	"Detected in many"	11	"T-cells: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035714, HPA035715"	Uncertain		Approved	Vesicles	"Secreted to blood"		4700000	Vesicles		"HPA035714: , HPA035715: AB_10669602"	"unprognostic (4.25e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.80e-1)"	"prognostic favourable (5.56e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-5)"	"unprognostic (8.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.60e-3)"	"unprognostic (3.75e-2)"	2.0	10.5	22.4	6.1	24.8	4.2	1.6	15.7	73.3	14.9	2.9	3.6	0.0	15.3	1.9	0.8	1.3	35.1	1.7	0.8	40.2	20.4	1.2	1.1	3.4	11.2	6.6	27.0	1.0	1.1	0.6	18.4	0.8	7.5	18.8	1.8	9.3	1.5	1.8	0.7	5.0	8.6	2.2	2.6	3.8	2.1	2.2	2.4	0.4	4.4	0.0	9.1	2.3	2.0	0.0	0.0	0.1	0.0	3.3	36.8	8.5	0.1	0.0	40.9	1.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.1	4.9	0.0	0.1	9.7	0.0	0.0	0.0	10.6	0.1	3.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	16.1	5.3	0.0	4.9	0.0	0.0	0.0	29.7	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.1	1.5	0.0	0.7	10.9	10.8	14.7	0.1	0.1	0.2	0.0	0.0	0.0	1.6	0.0	8.5	0.0	10.3	18.1	0.0	0.0	24.5	36.8	0.1	3.3	0.0	0.0	0.1	8.5	22.4	24.8	15.7	50.4	40.2	20.4	6.6	27.0	7.5	2.4
NEMF	"FLJ10051, NY-CO-1, SDCCAG1"	ENSG00000165525	"Nuclear export mediator factor"	O60524	14	49782083-49853203	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004160	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA004160: AB_1079884"	"unprognostic (9.92e-2)"	"unprognostic (6.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.15e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.12e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.81e-2)"	13.6	12.2	15.0	14.8	20.9	30.9	12.5	28.0	22.1	15.0	14.4	14.6	14.4	8.1	14.3	12.2	18.2	11.6	11.2	15.0	16.9	15.0	14.6	11.2	11.6	13.4	21.1	17.2	15.2	13.1	26.4	30.9	15.5	27.9	13.9	12.4	10.7	14.8	14.8	17.4	11.5	15.1	13.9	24.8	14.7	13.7	8.4	23.2	17.0	15.7	9.8	14.5	13.5	13.4	36.1	33.0	28.4	21.9	20.3	26.8	7.8	18.7	21.0	20.1	13.3	22.7	18.4	18.0	23.7	15.7	15.6	15.4	10.7	20.1	5.2	18.2	19.5	26.9	18.9	14.8	25.3	20.9	10.8	20.8	20.0	16.2	13.3	27.1	19.1	16.3	10.9	16.5	15.5	22.2	25.7	19.7	21.3	17.2	16.1	8.9	12.0	21.2	16.7	19.9	11.9	18.4	24.8	13.3	12.4	21.9	23.7	21.9	20.4	17.7	26.2	23.0	20.2	14.9	16.2	14.0	24.9	22.3	8.5	12.9	20.5	27.6	18.2	20.1	20.5	16.3	19.5	32.8	21.0	19.2	15.2	36.1	24.8	26.8	28.4	20.3	21.9	33.0	17.9	7.8	15.0	20.9	28.0	22.1	16.9	15.0	21.1	17.2	27.9	23.2
NENF	"CIR2, SCIRP10, SPUF"	ENSG00000117691	"Neudesin neurotrophic factor"	Q9UMX5	1	212432887-212446379	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026763, HPA028488"	Uncertain		Enhanced	Nucleoplasm	"Secreted - unknown location"		2400000	Nucleoplasm		"HPA026763: AB_1854379, HPA028488: "	"unprognostic (2.38e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.80e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-3)"	"unprognostic (4.99e-3)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (2.01e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.28e-1)"	"unprognostic (2.28e-2)"	21.9	19.9	33.5	10.1	47.7	12.8	44.4	16.2	30.6	41.9	23.9	45.2	24.0	12.7	24.1	42.2	19.4	27.6	19.6	50.6	31.3	31.4	32.0	25.8	18.0	20.4	38.3	21.3	38.3	43.4	21.0	47.1	17.9	23.6	26.7	23.9	19.8	22.1	36.1	53.6	16.5	12.2	29.7	49.5	13.2	16.8	9.6	24.5	6.5	23.6	26.0	16.2	19.3	19.9	7.2	13.3	1.9	6.7	0.8	9.2	2.5	22.6	11.9	6.5	29.3	47.9	36.2	11.6	11.4	28.2	20.5	20.2	14.0	14.5	8.7	8.9	27.3	14.7	16.1	16.7	16.8	13.3	32.2	5.6	7.7	4.0	18.1	5.6	20.3	25.9	24.6	14.2	11.9	13.2	17.3	11.8	17.9	9.3	12.9	26.4	11.3	37.6	11.5	11.7	14.6	20.9	4.0	13.0	22.7	11.8	27.0	20.5	20.6	21.8	2.5	16.1	14.9	22.3	21.1	11.0	17.7	6.7	17.6	7.9	12.2	1.0	4.8	1.9	4.1	6.7	7.3	7.2	4.9	9.2	7.7	5.1	6.5	6.5	0.5	0.8	4.5	13.3	5.7	2.5	33.5	47.7	16.2	30.6	31.3	31.4	38.3	21.3	23.6	24.5
NEO1	"HsT17534, IGDCC2, NGN, NTN1R2"	ENSG00000067141	"Neogenin 1"	Q92859	15	73051710-73305206	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009320, HPA027804, HPA027805, HPA027806"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"			280000000	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB009320: AB_2150998, HPA027804: AB_10600771, HPA027805: AB_10601755, HPA027806: AB_10601006"	"unprognostic (1.90e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.76e-2)"	"unprognostic (5.44e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.05e-2)"	"prognostic favourable (4.39e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.75e-1)"	7.3	5.8	19.2	6.2	22.4	1.2	11.4	12.7	23.9	13.4	30.0	44.5	14.8	17.9	14.2	7.2	8.0	15.4	13.4	6.8	20.1	14.1	16.2	5.9	10.7	2.7	27.1	15.7	17.5	11.5	44.4	6.9	1.5	19.3	23.1	36.9	16.0	11.5	25.5	17.9	24.6	19.0	16.0	22.3	3.6	15.1	9.0	22.5	2.1	12.5	3.8	4.7	10.1	9.5	0.0	0.3	1.4	0.3	0.8	3.1	0.3	3.7	18.2	21.8	14.4	13.2	3.9	5.4	1.4	1.7	3.6	0.7	2.7	18.4	1.0	2.1	4.0	0.8	15.2	8.3	1.5	6.6	11.2	12.2	0.2	2.5	3.8	0.3	0.4	9.5	15.5	0.7	7.1	0.0	0.0	23.4	0.8	11.2	4.3	0.2	20.8	1.5	10.0	11.7	2.4	6.9	10.0	9.9	14.0	17.1	7.6	9.0	8.0	2.2	0.0	16.8	9.0	5.4	3.9	10.0	18.5	2.6	3.6	3.5	4.7	0.0	0.3	0.4	1.8	0.0	3.1	0.0	1.1	1.4	0.0	0.0	0.6	0.5	1.4	0.8	0.0	0.3	0.0	0.3	19.2	22.4	12.7	23.9	20.1	14.1	27.1	15.7	19.3	22.5
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell line enhanced"	"Detected in many"		"AF22: 92.4;HUVEC TERT2: 46.7;LHCN-M2: 74.6;RH-30: 76.4;WM-115: 36.0"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: , HPA006286: , HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.4	19.7	0.2	5.0	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.4	4.3	0.0	0.8	0.0	46.7	0.6	0.0	74.6	0.6	0.0	0.0	15.0	12.8	0.1	76.4	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.1	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2
NET1	"ARHGEF8, NET1A"	ENSG00000173848	"Neuroepithelial cell transforming 1"	Q7Z628	10	5412551-5458463	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 11.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020068	Uncertain		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA020068: "	"unprognostic (1.77e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.37e-3)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (3.87e-5)"	"unprognostic (6.31e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (8.27e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.46e-1)"	19.4	4.8	14.2	25.8	16.7	15.0	39.8	11.8	15.2	30.2	39.3	21.0	32.1	24.1	19.4	25.7	38.2	20.7	25.9	8.4	16.5	12.7	21.3	19.0	9.5	10.5	19.0	9.4	15.2	19.4	2.9	6.6	51.8	20.8	23.0	38.9	20.3	43.0	23.2	16.7	21.8	54.7	33.4	19.9	3.9	33.5	11.8	10.9	14.8	18.1	26.8	20.2	28.0	31.8	1.8	5.9	2.7	1.2	1.0	11.5	2.4	27.9	16.6	11.6	12.9	6.8	3.1	63.7	16.9	9.3	13.7	13.1	9.1	53.3	10.3	7.1	10.3	45.8	14.0	25.6	16.5	9.6	10.1	18.6	5.6	20.3	1.8	5.3	8.1	4.6	15.3	13.5	3.2	7.9	32.8	16.3	7.5	13.3	17.9	7.4	15.6	12.7	11.3	21.4	8.0	8.4	14.0	9.9	5.5	14.9	27.7	5.0	9.2	15.9	7.2	5.2	8.2	8.0	13.7	10.0	5.4	13.5	4.7	8.1	10.8	2.7	0.8	1.8	0.9	1.2	0.0	1.8	1.6	0.5	5.9	0.9	11.5	2.1	0.1	1.0	0.6	2.5	5.1	2.4	14.2	16.7	11.8	15.2	16.5	12.7	19.0	9.4	20.8	10.9
NEUROG1	"AKA, bHLHa6, Math4C, NEUROD3, ngn1"	ENSG00000181965	"Neurogenin 1"	Q92886	5	135534282-135535949	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 2.1;retina: 7.7;testis: 2.3"	"Group enriched"	"Detected in some"	9	"AF22: 1.2;SCLC-21H: 1.1;THP-1: 2.4"	"Cancer enriched"	"Detected in single"	12	"testis cancer: 1.1"	"Region enhanced"	"Detected in single"		"midbrain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (3.04e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	2.1	0.0	0.4	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573238	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.5;intestine: 8.4"	"Cell line enriched"	"Detected in some"	5	"THP-1: 15.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Region enriched"	"Detected in single"	20	"hippocampal formation: 7.5"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;memory B-cell: 1.1"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA039785: AB_10795114"	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	7.6	0.0	0.0	8.0	0.0	0.0	0.9	0.0	1.8	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	7.5	0.1	0.1	0.0	0.0	0.0
NF1		ENSG00000196712	"Neurofibromin 1"	P21359	17	31094927-31382116	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.3;granulocytes: 6.5;T-cells: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045502	Uncertain		Approved	Mitochondria				Mitochondria		"HPA045502: "	"unprognostic (6.69e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.14e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-1)"	12.9	15.9	22.6	13.3	25.9	5.5	18.5	30.2	26.0	17.6	13.6	19.8	12.2	11.0	16.9	17.0	10.5	15.2	13.1	17.3	21.6	19.6	20.0	15.1	12.7	11.5	19.4	25.6	22.9	16.5	34.1	19.0	19.4	20.9	16.1	14.7	12.1	14.4	20.5	14.8	12.0	12.1	14.5	21.4	11.9	13.0	15.4	21.5	11.6	31.1	7.6	12.4	15.3	19.5	2.3	0.7	6.5	0.4	0.9	8.4	1.0	9.7	12.7	15.5	8.3	13.2	17.2	7.8	8.4	15.3	12.5	14.2	11.4	6.6	9.4	2.4	15.8	17.1	14.0	11.9	21.3	4.5	8.8	8.3	12.0	5.8	9.4	14.8	6.9	13.6	7.6	13.3	16.3	6.0	11.9	9.4	11.9	7.7	12.3	5.4	4.5	4.2	9.7	23.7	7.5	9.5	14.0	6.4	9.6	15.7	5.3	8.7	16.0	9.5	8.8	10.0	14.0	11.8	3.2	8.5	4.1	10.4	8.2	6.3	10.4	6.5	0.4	0.9	2.3	0.2	1.6	2.3	4.4	3.9	0.5	2.1	3.3	3.2	1.0	0.9	0.4	0.7	8.4	1.0	22.6	25.9	30.2	23.5	21.6	19.6	19.4	25.6	20.9	21.5
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favourable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	11.8	12.4	23.6	11.1	20.1	10.0	15.4	20.8	28.1	10.8	9.7	9.0	11.8	7.8	10.5	11.3	14.2	11.3	8.0	19.7	26.6	16.4	13.5	11.1	11.9	24.1	18.0	13.5	11.0	12.9	46.8	8.6	6.9	11.4	10.2	8.7	9.5	9.3	15.4	25.7	12.1	8.5	11.9	10.7	10.4	8.8	21.6	10.1	14.9	15.6	11.5	9.9	10.6	10.2	8.5	13.6	6.6	17.3	11.6	15.0	9.8	26.3	10.6	3.7	24.3	7.3	7.3	3.6	21.4	12.1	23.5	20.3	10.5	6.5	7.0	17.8	22.0	9.3	7.7	12.4	21.1	10.2	6.1	8.3	7.9	7.5	7.8	11.9	9.9	6.7	5.7	16.6	20.3	16.5	4.0	6.5	22.8	11.0	7.2	4.7	2.8	10.1	7.5	20.0	6.7	23.8	12.3	5.8	4.0	12.3	8.3	4.8	5.3	4.8	30.6	35.0	39.9	15.2	36.1	10.2	8.1	8.4	9.3	4.7	22.3	6.6	9.5	3.6	15.0	13.5	12.8	8.2	11.3	10.1	13.6	8.5	9.8	9.2	2.3	11.6	17.3	9.3	9.4	9.8	23.6	20.1	20.8	28.1	26.6	16.4	18.0	13.5	11.4	10.1
NFASC	"FLJ46866, KIAA0756, NF, NRCAML"	ENSG00000163531	Neurofascin	O94856	1	204828651-205022822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.6"	"Cell line enhanced"	"Detected in some"		"BJ: 13.2;BJ hTERT+ SV40 Large T+: 9.6;fHDF/TERT166: 23.9;SCLC-21H: 11.2;U-138 MG: 31.0;U-87 MG: 15.3"	"Cancer enhanced"	"Detected in many"		"glioma: 8.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008832	Enhanced						2100000			"HPA008832: AB_1854411"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.37e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.21e-5)"	"unprognostic (3.76e-1)"	"prognostic unfavourable (2.93e-5)"	"unprognostic (1.56e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.90e-2)"	"unprognostic (5.26e-3)"	4.9	8.7	21.1	3.9	25.9	0.6	3.8	22.3	37.3	4.6	7.8	49.6	1.1	5.1	9.1	10.4	11.3	12.0	6.6	17.4	19.5	10.8	10.7	2.4	5.7	2.6	27.9	25.2	11.9	6.4	1.6	11.7	11.2	28.7	8.7	6.8	8.1	2.6	18.4	3.3	4.2	5.6	15.3	17.5	6.8	5.3	2.0	34.0	0.0	3.0	0.2	3.4	8.9	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.2	0.4	0.0	13.2	0.0	9.6	2.9	0.0	0.0	0.0	0.0	23.9	6.3	0.2	0.3	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	6.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	1.0	0.0	0.0	0.0	11.2	0.6	0.0	0.6	0.0	0.1	0.0	0.0	31.0	6.7	0.0	0.0	0.0	0.0	0.0	15.3	0.0	7.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.1	25.9	22.3	35.0	19.5	10.8	27.9	25.2	28.7	34.0
NFE2L1	"FLJ00380, LCR-F1, NRF1, TCF11"	ENSG00000082641	"Nuclear factor, erythroid 2 like 1"	Q14494	17	48048329-48061487	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 194.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063384, HPA065424"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"			Nucleoplasm	Cytosol	"HPA063384: , HPA065424: "	"unprognostic (3.19e-1)"	"unprognostic (2.41e-1)"	"unprognostic (5.44e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (5.25e-2)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (5.20e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (5.79e-6)"	"unprognostic (2.20e-1)"	"unprognostic (4.09e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.01e-2)"	24.2	25.7	15.5	13.1	15.5	4.6	50.3	9.1	19.8	18.8	17.5	17.4	32.3	17.4	31.4	30.5	21.4	22.7	16.3	85.5	18.2	19.2	27.9	18.4	13.9	12.6	21.7	21.2	26.2	11.1	16.6	16.3	16.6	25.0	16.5	13.6	22.6	17.7	26.1	194.7	19.9	18.3	24.3	27.5	17.7	13.9	18.8	16.5	5.8	22.4	58.9	10.7	17.3	24.2	4.1	9.4	19.7	9.4	2.1	2.6	0.9	18.9	42.3	27.7	23.4	58.2	28.4	20.8	31.0	43.1	22.0	24.6	51.5	21.9	21.8	62.9	39.0	39.4	19.6	24.7	23.7	37.4	16.3	12.3	28.6	17.2	69.1	27.3	19.9	38.7	61.7	40.1	45.0	34.4	21.7	60.6	27.0	16.2	17.3	8.5	17.9	16.1	12.3	39.2	20.8	24.3	28.4	17.1	25.9	21.2	14.2	43.6	28.1	18.8	45.9	54.0	23.4	18.2	31.0	101.3	67.8	20.4	51.3	11.6	30.6	7.9	9.4	2.7	2.6	4.8	1.5	3.8	2.5	2.6	1.9	4.1	1.9	2.1	19.7	2.1	5.6	9.4	0.9	0.9	15.5	15.5	9.1	19.8	18.2	19.2	21.7	21.2	25.0	16.5
NFE2L3	Nrf3	ENSG00000050344	"Nuclear factor, erythroid 2 like 3"	Q9Y4A8	7	26152240-26187125	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 54.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 43.4;NTERA-2: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055889	Enhanced		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"			"Nucleoplasm, Vesicles"		"HPA055889: "	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-3)"	"unprognostic (5.37e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (7.29e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.12e-1)"	"unprognostic (9.88e-2)"	"prognostic unfavourable (6.62e-5)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (7.58e-12)"	"prognostic favourable (2.14e-4)"	"unprognostic (2.40e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.13e-3)"	3.5	2.5	0.8	7.8	1.2	1.6	4.1	6.2	1.6	1.8	6.7	4.0	2.4	6.2	1.9	1.7	3.1	2.4	7.1	3.6	1.3	1.1	4.2	2.3	5.8	6.9	2.5	0.8	1.7	7.5	0.0	2.1	54.9	2.1	3.7	4.0	2.1	7.7	0.4	3.4	8.2	7.1	0.8	3.7	10.4	5.6	2.5	1.5	11.2	1.6	1.5	8.9	3.1	2.1	1.4	2.8	0.8	1.1	1.1	2.6	0.4	12.5	1.1	0.5	1.3	0.0	0.0	43.4	2.5	4.9	4.9	9.0	8.3	22.0	0.9	16.6	0.2	2.6	1.9	4.2	11.2	8.6	2.7	1.7	1.8	6.1	3.4	1.5	16.8	0.4	0.5	2.0	0.7	11.3	2.6	22.3	0.9	1.7	1.0	2.7	36.4	4.4	1.5	0.1	6.2	6.6	12.4	3.9	4.7	0.0	1.0	0.3	0.6	0.9	23.5	0.4	0.7	0.2	10.1	13.6	21.6	1.0	0.0	5.4	16.8	0.0	1.1	0.0	0.5	1.1	1.6	1.0	2.1	1.0	2.8	1.4	1.2	0.7	0.8	1.1	0.3	0.9	2.6	0.4	0.8	1.2	6.2	1.6	1.3	1.1	2.5	0.8	2.1	1.5
NFKB1	"KBF1, NF-kappaB, NF-kB1, NFkappaB, NFKB-p50, p105, p50"	ENSG00000109320	"Nuclear factor kappa B subunit 1"	P19838	4	102501329-102617302	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004031, HPA027305"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB004031: AB_330564, HPA027305: AB_1854429"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.76e-4)"	"unprognostic (1.84e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.92e-3)"	19.8	14.7	8.2	37.7	12.0	44.5	26.6	12.4	10.3	18.2	17.1	10.4	10.4	10.7	17.5	11.2	20.5	16.4	20.3	14.5	7.5	5.1	13.2	15.8	26.9	46.0	11.4	4.8	17.5	14.3	10.2	8.7	13.7	10.0	18.8	14.6	10.8	17.7	13.5	17.1	19.6	16.7	16.0	10.1	30.0	14.6	9.3	12.5	37.5	14.7	16.3	26.7	18.4	22.7	5.8	10.4	5.5	7.1	14.3	10.6	3.5	16.9	9.5	5.1	7.8	16.0	14.4	6.3	9.7	28.8	12.1	12.4	10.5	24.3	27.7	8.8	15.3	13.5	10.2	17.0	16.7	25.0	6.0	11.8	7.7	11.3	15.0	21.0	25.1	11.9	12.0	11.8	16.4	15.2	11.4	20.4	8.7	11.9	1.8	11.5	3.1	8.8	14.8	12.2	12.5	11.3	23.9	3.5	5.8	17.9	25.0	9.8	5.1	15.7	19.4	16.5	8.6	8.9	13.6	9.0	6.2	26.9	10.5	10.8	23.3	5.2	5.4	4.9	3.4	7.1	6.0	5.6	8.4	5.6	10.4	5.8	10.6	8.9	5.5	14.3	5.9	7.4	4.5	3.5	8.2	12.0	12.4	10.3	7.5	5.1	11.4	4.8	10.0	12.5
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA056310: , HPA061382: , HPA073519: "	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favourable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.0	12.3	11.3	10.7	16.9	19.0	11.4	14.2	14.3	16.1	16.2	11.1	6.2	23.4	9.1	16.4	8.5	20.1	15.4	15.2	17.0	10.1	12.3	30.0	12.4	20.6	21.8	13.6	17.7	25.8	13.8	34.8	9.8	18.6	20.4	16.8	10.6	14.0	20.5	18.3	13.9	15.1	12.3	12.7	10.9	14.5	15.7	11.0	14.2	15.3	8.1	8.9	21.8	12.3	13.2	11.1	9.5	15.4	11.0	9.9	23.2	14.5	11.0	7.5	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0
NGF	NGFB	ENSG00000134259	"Nerve growth factor"	P01138	1	115285918-115338236	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 37.6;BJ hTERT+ SV40 Large T+: 13.4;BJ hTERT+ SV40 Large T+ RasG12V: 9.9;hTEC/SVTERT24-B: 13.0;U-2197: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (7.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-3)"	"unprognostic (8.85e-2)"	"unprognostic (4.12e-1)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.30e-2)"	"unprognostic (8.73e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (8.08e-7)"	"unprognostic (1.15e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.62e-4)"	9.1	2.3	1.3	2.8	1.6	0.2	6.5	0.6	2.8	7.5	3.4	0.6	2.3	0.3	11.4	5.9	1.5	10.6	6.6	16.5	3.2	0.6	3.4	2.7	1.4	1.5	2.3	1.6	17.8	0.7	0.3	2.1	2.0	1.7	3.7	1.2	7.0	3.8	2.0	1.8	0.6	1.4	7.0	2.1	3.8	1.6	3.2	1.1	0.0	2.9	3.0	0.3	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	37.6	4.3	13.4	9.9	0.0	0.0	0.0	0.8	8.9	1.5	0.0	0.2	6.0	0.0	0.1	0.0	0.2	0.0	5.6	0.0	0.0	0.0	0.2	13.0	9.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.5	0.0	0.5	0.0	0.0	0.0	0.5	0.1	0.7	0.2	0.0	0.0	0.0	0.3	0.8	1.6	26.2	1.5	0.0	0.0	0.0	1.6	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.6	0.6	2.8	3.2	0.6	2.3	1.6	1.7	1.1
NHS		ENSG00000188158	"NHS actin remodeling regulator"	Q6T4R5	X	17375420-17735994	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.9;RPTEC TERT1: 16.3;RT4: 10.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.1;neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031497, HPA076257"	Uncertain		Supported	"Cell Junctions"				"Cell Junctions"		"HPA031497: AB_10610144, HPA076257: "	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.27e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.21e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.83e-3)"	5.1	6.7	3.6	6.0	3.6	0.6	14.2	5.9	6.3	10.2	5.9	1.3	10.0	1.9	10.7	7.1	3.7	5.3	10.4	3.5	2.2	3.1	11.8	0.7	3.7	2.6	1.5	1.1	7.8	0.9	0.7	5.1	5.5	4.7	7.0	3.5	9.4	3.2	8.8	1.1	4.2	2.5	11.2	5.3	2.1	3.6	12.4	1.3	0.8	4.5	2.2	1.3	8.1	16.0	0.1	0.6	2.0	1.1	0.0	0.2	0.3	6.4	2.6	4.6	0.0	0.1	0.2	7.5	2.9	2.0	1.3	0.7	0.2	1.3	0.4	10.9	2.0	5.7	2.9	3.6	1.9	0.1	0.9	0.0	4.3	0.0	0.0	0.0	0.0	0.6	2.6	0.0	5.9	0.0	0.0	0.0	0.6	3.1	0.0	0.0	5.7	1.7	0.0	0.0	0.2	16.3	10.0	1.1	2.4	8.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	6.9	0.1	7.1	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	3.6	3.6	5.9	6.3	2.2	3.1	1.5	1.1	4.7	1.3
NID1	"entactin, NID"	ENSG00000116962	"Nidogen 1"	P14543	1	235975830-236065162	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 174.4;ASC TERT1: 81.5;HSkMC: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 5.4;intermediate monocyte: 11.3;myeloid DC: 4.5;non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	20	"dendritic cells: 4.5;monocytes: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB010044	Approved				"Secreted to extracellular matrix"		90000000			"CAB010044: AB_2153287"	"unprognostic (1.17e-1)"	"unprognostic (2.23e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.42e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (5.38e-8)"	"unprognostic (3.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.72e-3)"	49.4	12.7	1.6	14.7	4.0	0.7	80.5	1.7	2.2	38.8	29.3	1.9	10.4	6.9	29.4	25.5	23.8	27.4	24.3	40.5	1.6	1.1	18.3	36.7	18.8	24.5	3.3	1.4	29.4	6.3	4.6	3.6	74.6	3.8	19.2	7.3	19.9	6.3	15.3	18.3	7.9	18.5	36.1	3.9	31.0	23.0	19.6	1.7	1.4	12.2	6.2	3.8	41.9	30.0	0.0	4.5	0.3	11.3	0.1	0.0	1.8	0.1	0.5	5.9	0.0	174.4	81.5	11.4	13.5	11.2	8.4	5.5	3.2	4.2	0.0	2.6	20.2	0.4	3.9	0.0	5.0	0.0	6.4	0.8	0.6	4.8	32.9	0.0	0.0	68.8	0.5	4.1	0.1	17.7	0.0	0.0	2.8	0.0	0.0	0.0	6.1	0.7	0.0	0.0	0.0	0.0	1.7	0.0	5.0	0.1	0.0	1.0	0.0	5.4	15.2	7.4	4.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	11.3	0.2	5.4	0.0	0.0	11.3	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.1	7.1	0.0	0.0	1.8	1.6	4.0	1.7	2.0	1.6	1.1	3.3	1.4	3.8	1.7
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 52.1;BJ: 27.2;BJ hTERT+: 23.2;HHSteC: 28.9;HSkMC: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"		2500000	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavourable (2.78e-4)"	15.0	5.1	0.9	5.3	1.8	0.1	7.6	0.9	1.7	12.9	8.5	5.1	9.0	1.0	9.5	7.6	9.8	6.0	10.2	17.5	1.2	0.9	6.4	2.9	5.1	3.0	1.3	1.2	16.8	13.9	10.2	2.4	32.5	2.5	13.4	3.6	17.4	4.3	8.9	3.9	1.8	3.0	11.4	1.5	1.1	6.6	4.4	0.8	0.7	18.8	3.6	2.2	10.7	5.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	13.6	0.0	52.1	20.7	0.0	27.2	23.2	2.6	2.7	0.0	0.0	0.0	4.0	3.0	1.8	1.7	0.0	0.7	0.0	0.3	0.0	0.4	0.0	28.9	0.0	0.0	107.9	0.0	10.6	0.0	1.4	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.9	4.0	0.0	0.0	3.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	9.9	0.1	5.9	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.8	0.9	1.7	1.2	0.9	1.3	1.2	2.5	0.8
NIF3L1	"ALS2CR1, CALS-7, MDS015"	ENSG00000196290	"NGG1 interacting factor 3 like 1"	Q9GZT8	2	200889327-200903930	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036335, HPA036336, HPA061466"	Supported		Approved	Vesicles			8700000	Vesicles		"HPA036335: AB_10696654, HPA036336: AB_2675068, HPA061466: "	"unprognostic (6.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (9.52e-5)"	"unprognostic (2.48e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.53e-3)"	"unprognostic (6.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.83e-1)"	"unprognostic (6.04e-3)"	"unprognostic (8.61e-2)"	12.8	21.6	14.4	17.8	29.1	7.2	19.6	21.1	31.0	14.9	16.9	19.3	10.0	12.9	16.0	21.8	17.2	18.4	11.5	16.5	19.6	14.2	19.5	17.6	12.1	19.0	15.1	13.4	17.8	15.6	20.8	12.0	18.0	25.6	14.3	22.9	16.3	16.5	17.0	21.4	16.8	15.2	15.2	17.9	18.7	16.2	15.2	13.2	20.8	16.3	15.8	24.8	15.1	12.4	20.3	18.5	32.6	21.3	20.2	23.9	14.4	15.1	16.5	27.0	16.5	12.3	15.6	18.6	16.8	18.0	35.9	29.1	25.8	17.8	12.3	16.3	14.3	16.9	38.3	22.1	38.6	16.3	36.3	18.4	29.3	27.4	11.1	21.6	12.8	13.0	21.5	23.6	22.7	11.9	26.8	12.6	21.0	20.0	26.5	27.1	31.7	29.3	15.9	15.1	24.0	18.9	16.0	17.1	20.3	14.4	14.7	19.8	14.5	19.9	6.1	17.4	16.3	15.4	15.1	11.5	21.7	26.7	16.8	17.8	16.5	32.6	14.5	18.4	18.3	21.3	19.2	20.3	21.1	23.2	17.8	15.6	23.9	19.7	4.9	20.2	17.8	18.5	19.2	14.4	14.4	29.1	21.1	31.0	19.6	14.2	15.1	13.4	25.6	13.2
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome				Centrosome	"Nucleoplasm, Nucleoli"	"HPA005939: , HPA070691: "	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.2	8.7	18.1	15.4	7.0	11.2	7.6	10.5	9.1	8.9	7.5	5.6	6.5	28.8	7.2	14.1	12.9	14.5	6.6	18.7	13.9	4.5	10.6	5.3	5.3	4.1	18.4	30.6	7.7	5.3	15.5	6.4	14.1	2.6	11.8	13.4	13.4	13.9	7.4	2.5	9.6	15.8	33.5	2.0	8.0	13.9	8.4	9.5	13.2	4.0	11.3	7.5	16.4	20.5	22.6	31.4	8.6	11.6	9.5	4.8	19.9	5.9	15.0	12.2	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0
NIPBL	"DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, IDN3, Scc2"	ENSG00000164190	"NIPBL, cohesin loading factor"	Q6KC79	5	36876759-37066413	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Activator, Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040834, HPA058239"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA040834: AB_10796562, HPA058239: "	"unprognostic (4.92e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.10e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.34e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.40e-2)"	16.8	13.9	13.3	21.9	15.7	22.7	15.8	22.9	15.9	17.3	19.2	10.8	20.1	10.4	18.7	16.5	16.6	14.3	15.9	12.4	13.5	7.1	12.6	13.2	16.0	16.0	17.2	11.1	21.2	14.6	30.0	20.9	17.4	13.5	15.1	13.2	8.5	17.1	24.7	18.9	18.2	18.4	13.2	11.9	18.5	14.7	14.1	19.0	42.5	18.1	14.0	16.9	17.6	29.2	4.8	4.6	11.1	4.3	3.8	4.9	1.9	10.1	6.0	15.7	7.4	10.0	11.0	11.6	8.2	9.1	9.0	7.5	8.4	10.5	15.4	5.3	10.1	8.9	13.4	7.5	13.0	12.6	7.0	18.7	26.7	6.1	6.9	21.8	12.5	8.1	9.3	10.1	13.4	11.3	17.8	11.6	8.4	4.9	14.9	8.3	7.5	5.2	12.8	24.7	5.9	6.4	14.5	11.7	8.2	39.5	10.6	8.4	10.8	12.7	12.2	11.9	13.0	10.1	6.1	8.4	11.2	18.3	6.6	15.0	8.9	10.0	4.1	5.7	4.8	3.2	4.4	4.0	3.9	4.2	3.3	4.8	4.3	4.9	11.1	3.8	4.3	4.6	2.9	1.9	13.3	15.7	22.9	15.9	13.5	7.1	17.2	11.1	13.5	19.0
NIPSNAP1		ENSG00000184117	"Nipsnap homolog 1"	Q9BPW8	22	29554808-29581337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA059227	Uncertain									"HPA059227: "	"unprognostic (7.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (8.82e-6)"	"unprognostic (2.81e-2)"	"unprognostic (8.69e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.72e-1)"	3.5	17.1	14.3	7.8	21.3	4.6	10.7	16.3	22.2	7.7	12.2	7.4	12.8	21.9	6.7	8.8	9.1	9.2	8.9	8.6	14.0	16.4	38.0	94.5	6.0	12.7	13.6	13.8	11.3	9.8	20.1	13.5	5.9	16.7	8.4	13.0	10.5	8.5	16.4	1.5	6.8	15.7	6.2	8.1	6.4	9.5	5.4	5.6	9.7	11.2	6.1	9.0	8.5	6.3	14.9	10.3	7.2	8.4	17.6	21.1	10.0	15.5	18.8	39.1	48.5	7.0	14.4	7.3	9.1	16.5	12.7	16.4	12.6	21.1	11.1	18.3	13.1	15.8	20.4	23.2	15.4	22.3	21.5	3.8	9.0	39.1	10.6	8.1	5.5	14.4	12.0	10.3	13.0	17.1	7.0	18.6	11.4	35.2	13.2	11.2	33.0	15.9	26.5	12.2	32.0	30.2	13.7	48.4	42.7	10.6	19.6	21.0	32.2	13.2	8.0	5.5	19.5	6.8	7.2	25.4	12.4	10.4	14.8	13.1	9.2	5.2	4.6	7.2	17.8	8.4	21.1	14.9	17.7	18.4	10.3	14.1	17.2	20.6	6.7	17.6	5.0	5.3	20.8	10.0	14.3	21.3	16.3	22.2	14.0	16.4	13.6	13.8	16.7	5.6
NIT2		ENSG00000114021	"Nitrilase family member 2"	Q9NQR4	3	100334701-100361635	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 41.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036999	Approved		Supported	Centrosome,Cytosol			960000	Cytosol	Centrosome	"HPA036999: AB_10672105"	"unprognostic (3.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (6.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.60e-3)"	"unprognostic (2.21e-1)"	"unprognostic (6.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.47e-3)"	9.9	7.4	6.7	5.4	9.9	5.9	12.4	3.7	10.5	6.4	7.2	6.1	10.6	5.5	6.6	13.3	9.2	7.9	7.1	7.4	5.8	6.3	29.8	41.1	5.6	8.9	5.9	8.0	7.2	8.5	4.7	7.6	4.9	7.7	7.2	6.8	11.3	8.2	10.2	14.7	7.7	5.3	7.0	5.4	5.7	6.8	3.3	3.3	4.4	10.8	14.5	10.5	8.2	5.6	4.2	5.9	1.5	2.4	3.0	4.3	1.3	9.9	9.9	1.2	5.1	8.9	12.1	6.2	4.1	6.0	9.7	9.2	8.4	11.2	9.9	6.2	5.8	7.5	4.5	11.0	11.6	3.1	2.3	7.2	3.2	4.3	10.8	4.7	4.9	7.6	16.7	5.1	8.5	6.1	3.3	8.0	11.8	9.4	3.1	4.3	4.4	15.0	3.5	4.2	9.7	16.0	6.2	6.9	3.2	5.6	9.6	6.1	7.1	4.4	4.4	6.1	2.5	2.9	3.5	4.9	5.4	8.5	9.6	7.9	7.6	0.4	2.4	1.1	3.3	2.1	4.3	4.2	3.1	2.5	5.9	3.7	3.6	3.5	1.5	3.0	1.6	1.8	3.1	1.3	6.7	9.9	3.7	10.5	5.8	6.3	5.9	8.0	7.7	3.3
NKX2-8	"Nkx2-9, NKX2.8, NKX2H"	ENSG00000136327	"NK2 homeobox 8"	O15522	14	36580579-36582607	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 9.6;lung: 7.7;testis: 22.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.9;HaCaT: 9.7;HEK 293: 2.3;PC-3: 5.7;SiHa: 2.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 2.3"	"Low region specificity"	"Detected in some"			HPA062879	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA062879: "	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.37e-3)"	"unprognostic (2.27e-1)"	"unprognostic (3.45e-4)"		"unprognostic (2.36e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.11e-1)"		"unprognostic (8.39e-3)"	"unprognostic (4.60e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.13e-2)"	0.3	0.3	0.2	0.4	0.7	0.3	0.3	0.0	1.2	0.3	0.3	2.0	0.0	0.3	0.3	0.3	5.3	0.3	0.3	0.3	0.3	2.0	0.3	0.3	7.7	0.3	2.0	0.0	0.3	0.3	1.5	2.1	0.3	5.7	0.4	0.3	0.0	2.0	0.3	0.3	1.1	0.3	0.3	9.6	0.3	0.3	22.9	0.5	0.0	4.2	1.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	9.7	0.0	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.3	0.4	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	1.2	0.3	2.0	2.0	0.0	5.7	0.5
NLN	"AGTBP, KIAA1226"	ENSG00000123213	Neurolysin	Q9BYT8	5	65722196-65871725	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.7;intermediate monocyte: 5.9;myeloid DC: 4.1;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 4.1;monocytes: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031862	Approved		Approved	Mitochondria			53000	Mitochondria		"HPA031862: AB_10600827"	"unprognostic (5.91e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.58e-1)"	"prognostic unfavourable (7.51e-4)"	"unprognostic (1.27e-1)"	"prognostic favourable (5.58e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.18e-3)"	4.5	2.4	7.6	4.7	10.5	2.9	7.3	2.8	11.9	4.1	6.8	5.8	1.0	2.4	5.8	5.0	5.2	3.3	2.7	5.1	7.2	7.6	7.5	18.9	3.4	5.1	8.7	8.5	4.0	11.0	3.6	2.4	4.9	9.8	5.4	6.5	2.0	4.3	2.6	15.0	5.7	5.3	5.5	10.9	5.8	7.5	2.4	6.2	1.8	5.5	7.9	4.0	4.3	3.3	0.9	4.1	0.6	5.9	0.9	0.7	1.8	9.2	8.9	5.3	8.7	6.6	11.4	10.6	9.3	3.9	5.5	6.0	5.0	5.5	13.2	11.8	11.2	7.4	6.8	14.4	9.6	3.9	4.6	3.6	6.6	12.8	5.7	8.3	2.2	8.7	7.9	7.6	9.1	15.5	7.8	2.8	11.8	7.1	5.7	7.5	16.1	2.5	6.7	11.2	20.8	9.0	4.1	16.3	8.5	7.5	7.8	7.7	9.3	9.9	8.9	3.7	4.4	5.3	7.0	2.4	4.8	5.8	5.6	16.3	5.5	0.2	4.7	0.2	0.2	5.9	0.3	0.9	0.4	0.3	4.1	0.9	0.7	0.5	0.6	0.9	4.1	0.2	0.1	1.8	7.6	10.5	2.8	11.9	7.2	7.6	8.7	8.5	9.8	6.2
NLRC3	"CLR16.2, FLJ00348, NOD3"	ENSG00000167984	"NLR family CARD domain containing 3"	Q7RTR2	16	3539033-3577400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.0"	"Cell line enhanced"	"Detected in some"		"HEL: 6.2;HL-60: 12.9;HMC-1: 6.5;NB-4: 13.8;U-698: 19.9;U-937: 9.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA048062			Supported	"Vesicles,Centriolar satellite,Cytosol"				Cytosol	"Vesicles, Centriolar satellite"	"HPA048062: "	"unprognostic (4.93e-3)"	"unprognostic (3.84e-4)"	"unprognostic (7.61e-4)"	"unprognostic (4.94e-7)"	"unprognostic (9.56e-2)"	"unprognostic (3.76e-5)"	"unprognostic (1.86e-3)"	"unprognostic (6.70e-3)"	"unprognostic (2.66e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.15e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.08e-2)"	0.2	0.4	0.0	20.1	0.1	2.8	0.0	0.0	0.2	0.4	1.3	0.0	0.2	1.2	1.0	0.1	1.0	0.0	1.8	0.8	0.0		0.6	0.5	6.0	11.2	0.2	0.0	0.1	1.5	0.0	0.0	0.6	0.2	0.9	0.7	0.9	2.7	0.2	0.5	0.0	2.4	0.1	0.0	10.5	1.4	0.0	0.0	27.0	0.4	1.1	18.1	1.6	1.0	1.0	0.0	2.6	0.0	4.7	4.1	3.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	6.2	0.1	0.0	0.0	12.9	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	5.4	13.8	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	3.3	0.4	0.2	0.0	0.2	0.1	0.3	0.0	19.9	0.1	9.7	0.0	2.6	0.0	0.0	3.7	0.0	4.1	1.0	2.7	3.8	0.0	0.8	2.1	2.0	0.0	4.7	0.0	0.0	3.1	3.3										
NLRC4	"CARD12, CLAN, CLAN1, CLANA, CLANB, CLANC, CLAND, CLR2.1, ipaf"	ENSG00000091106	"NLR family CARD domain containing 4"	Q9NPP4	2	32224453-32265854	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Immunity, Inflammatory response, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.8;lymphoid tissue: 22.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 19.8;intermediate monocyte: 23.8;myeloid DC: 13.3;neutrophil: 9.7;non-classical monocyte: 17.6"	"Group enriched"	"Detected in many"	35	"dendritic cells: 13.3;granulocytes: 9.7;monocytes: 23.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA006592	Uncertain									"HPA006592: "	"unprognostic (7.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.88e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.33e-2)"	"unprognostic (6.33e-2)"	"unprognostic (6.03e-6)"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.63e-1)"	8.4	2.4	2.2	11.7	5.2	11.2	1.3	1.3	3.7	0.8	1.1	2.0	0.3	1.1	0.9	1.4	0.8	1.7	2.0	2.7	2.1	1.4	1.7	2.2	8.3	16.2	5.4	0.8	1.0	1.5	0.0	1.2	2.8	3.0	0.9	1.1	1.2	1.1	0.2	1.5	0.6	1.7	2.9	5.5	22.4	1.2	1.0	3.6	1.7	0.9	0.0	1.5	2.7	2.3	0.4	13.3	9.7	23.8	0.1	0.1	6.5	0.6	0.6	0.9	1.7	0.2	0.0	1.1	0.8	0.0	0.0	0.0	0.6	0.8	0.9	0.7	0.0	0.8	0.0	0.0	0.0	2.0	0.7	1.3	0.3	0.9	0.0	6.9	1.2	0.0	1.0	0.0	3.5	0.0	0.7	1.1	0.0	0.1	0.4	3.2	0.5	0.5	0.3	1.0	1.1	0.0	0.8	0.8	1.6	0.5	0.6	2.8	0.3	3.3	0.2	0.8	0.8	0.7	1.0	1.4	1.9	3.0	1.4	3.0	1.0	0.1	19.8	2.3	0.0	23.8	0.1	0.2	0.0	0.0	13.3	0.4	0.0	0.0	9.7	0.1	17.6	0.1	0.0	6.5	2.2	5.2	1.3	3.7	2.1	1.4	5.4	0.8	3.0	3.6
NLRP1	"CARD7, CLR17.1, DEFCAP, DKFZp586O1822, KIAA0926, NAC, NALP1, SLEV1, VAMAS1"	ENSG00000091592	"NLR family pyrin domain containing 1"	Q9C000	17	5499427-5619424	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Inflammatory response, Innate immunity"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.3;Karpas-707: 41.2;U-266/70: 20.6"	"Cancer enhanced"	"Detected in all"		"glioma: 20.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB009189, HPA064431"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009189: , HPA064431: "	"unprognostic (4.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (7.57e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (1.60e-5)"	"unprognostic (6.69e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.34e-2)"	19.5	2.5	2.4	39.9	3.1	15.1	16.4	0.9	2.8	19.1	6.1	5.3	5.6	4.0	16.2	10.2	12.4	7.6	15.5	8.6	4.9	1.8	6.3	3.4	19.1	31.2	4.2	1.9	4.5	2.3	2.2	2.9	8.3	5.2	10.2	5.7	6.3	8.1	11.3	17.8	35.2	18.3	13.1	6.8	34.4	4.4	6.9	3.2	15.9	13.7	11.9	30.8	17.5	16.8	5.3	4.6	16.8	7.5	3.8	7.0	3.7	6.2	0.0	0.0	0.0	3.3	4.6	0.7	2.6	2.5	1.0	2.2	0.1	2.4	2.2	9.7	2.5	2.8	0.0	10.1	1.6	23.3	0.0	0.6	2.0	0.2	3.1	0.0	0.7	2.8	6.4	8.5	6.2	10.8	5.4	41.2	5.0	0.0	0.0	1.8	0.0	0.1	2.4	1.6	9.7	0.0	2.0	0.2	0.0	0.0	0.1	0.2	0.0	0.2	10.5	2.1	1.3	1.3	0.4	20.6	6.6	1.6	3.5	0.2	0.1	13.8	6.3	4.4	6.0	4.5	6.6	4.4	4.9	6.1	4.6	5.3	5.5	5.0	16.8	3.8	7.5	0.4	7.0	3.7	2.4	3.1	0.9	2.8	4.9	1.8	4.2	1.9	5.2	3.2
NLRP10	"CLR11.1, NALP10, NOD8, PAN5, Pynod"	ENSG00000182261	"NLR family pyrin domain containing 10"	Q86W26	11	7959424-7965426	"Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"placenta: 13.2;skin 1: 10.5"	"Cell line enhanced"	"Detected in some"		"A-431: 17.6;BJ: 5.3;HBF TERT88: 7.6;LHCN-M2: 3.4"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"olfactory region: 2.6"					"HPA039498, HPA040101"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA039498: AB_10795679, HPA040101: AB_10795519"						"unprognostic (4.06e-1)"			"unprognostic (4.34e-1)"						"unprognostic (9.78e-3)"		"unprognostic (2.87e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	0.2	0.0	5.3	2.6	1.2	2.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0
NLRP14	"CLR11.2, GC-LRR, Nalp-iota, NALP14, NOD5, PAN8"	ENSG00000158077	"NLR family pyrin domain containing 14"	Q86W24	11	7020446-7071308	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 2.5;testis: 3.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HEK 293: 1.7;HUVEC TERT2: 4.1;U-698: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA039477	Approved		Uncertain	Cytosol				Cytosol		"HPA039477: AB_10794748"	"unprognostic (6.46e-3)"	"unprognostic (5.76e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.20e-4)"	"unprognostic (5.57e-2)"	"unprognostic (8.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.65e-2)"	"unprognostic (3.17e-3)"	"unprognostic (6.69e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.25e-1)"	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.1	0.8	0.1	0.2			0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.3	0.3	1.6	2.5	0.4	0.2	0.4		1.3	0.0	1.7	0.1	0.0		0.1	0.2		0.3	0.0	0.0	0.0	0.2	0.0	1.2	0.3	0.0	3.4			0.3		0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.2	0.2	0.9	0.5	0.6	0.0	0.4	1.6	0.0	0.1	0.0	0.0	0.1	0.6	0.0	1.7	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.1	4.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.0	2.1	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278365-285359	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 63.8"	"Group enriched"	"Detected in some"	4	"REH: 4.3;U-266/70: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA043681, HPA048500"	Supported									"HPA043681: , HPA048500: "	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favourable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.4	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.1	0.1	29.1	0.1	0.1	25.9	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.9	1.6	0.6	0.6	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	63.8	0.1	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.1	14.6	4.0	0.9	2.4	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.4	0.5	1.0	0.3	0.0	4.3	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	8.6	0.5	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.7	1.2	0.1	0.1	2.0	2.4	14.6	0.9	4.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 2.5;fallopian tube: 3.3;testis: 5.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;RPTEC TERT1: 1.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA026665			Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.1	0.0	0.6	0.0	2.5	0.0	0.4	0.0	0.8	0.5	0.0			0.0	0.2	0.3	0.6	3.3	0.0	0.0	0.5	1.6	0.2	0.0	0.2	0.0	0.6		0.3	0.0	0.0	0.0	0.1		0.0	0.0		0.2	0.6	0.0	0.0	0.0	0.2	0.8	0.1	0.2	5.1			0.4		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.9	0.9	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.5	0.0	0.4	0.0	0.2	1.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: "	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavourable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	47.6	95.2	32.9	45.9	13.8	22.1	55.3	37.2	25.8	77.1	58.5	74.9	28.9	83.9	38.8	34.4	25.6	62.8	63.2	66.0	40.7	84.6	55.0	73.9	103.9	28.0	60.2	25.2	21.0	39.8	58.0	54.3	46.4	81.1	27.9	45.6	80.7	71.5	69.3	39.4	86.8	43.9	64.9	77.2	59.2	33.3	45.7	52.6	19.5	53.4	34.6	55.6	40.8	29.2	49.8	45.2	30.9	76.3	36.0	83.0	98.8	30.1	51.1	37.8	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3
NME3	"DR-nm23, NDPKC, NM23-H3"	ENSG00000103024	"NME/NM23 nucleoside diphosphate kinase 3"	Q13232	16	1770286-1771730	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Nucleotide metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041113, HPA052733"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"		7900000	Nucleoplasm	Cytosol	"HPA041113: , HPA052733: "	"prognostic favourable (6.81e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.22e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.09e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (6.11e-3)"	20.6	45.6	18.0	12.9	19.8	6.6	20.0	21.9	18.2	16.6	18.0	11.0	31.6	25.7	14.4	19.1	12.9	14.3	21.5	11.8	17.5	16.1	17.7	11.2	17.3	11.3	18.4	15.9	22.1	26.8	15.1	24.1	9.7	14.4	26.9	6.4	13.8	34.3	41.4	15.2	9.2	24.6	14.6	14.1	20.4	17.5	7.2	14.6	5.1	24.1	11.7	8.8	11.5	17.9	19.3	34.1	15.5	25.6	20.1	24.4	20.0	0.7	11.6	0.2	9.5	2.7	1.4	1.1	6.8	2.0	1.2	0.9	0.0	13.8	0.1	18.9	0.9	9.8	0.6	3.8	0.1	13.5	30.8	0.0	5.4	5.5	5.1	2.3	4.3	6.3	3.4	1.2	0.6	2.4	4.6	1.9	1.1	16.8	0.2	4.5	12.3	9.4	6.4	0.1	18.0	2.0	0.5	13.5	10.4	20.4	15.4	1.6	14.7	5.6	8.5	2.5	9.6	8.1	4.6	4.9	1.5	1.0	3.5	0.4	5.8	4.9	25.6	15.5	17.5	22.9	17.1	19.3	24.4	16.4	22.0	16.3	21.4	16.8	5.3	20.1	24.5	34.1	21.8	20.0	18.0	19.8	21.9	18.2	17.5	16.1	18.4	15.9	14.4	14.6
NME4	"NDPKD, nm23-H4, NM23H4"	ENSG00000103202	"NME/NM23 nucleoside diphosphate kinase 4"	O00746	16	396725-410367	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Nucleotide metabolism, Transport"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045997, HPA072588"	Approved		Supported	Mitochondria				Mitochondria		"CAB045997: AB_11126630, HPA072588: "	"unprognostic (3.27e-1)"	"prognostic unfavourable (6.53e-4)"	"unprognostic (3.70e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.46e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.79e-3)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (3.78e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	34.5	34.4	21.5	13.9	17.6	46.8	34.6	10.4	13.6	25.6	44.6	12.8	40.7	9.7	21.7	33.7	25.1	20.0	39.9	26.9	16.6	16.5	20.2	61.2	13.5	27.5	16.9	11.3	31.9	19.2	22.0	17.3	19.4	11.7	46.9	10.6	32.2	44.4	44.0	13.7	7.5	15.3	83.9	12.4	17.8	27.1	13.3	10.9	19.6	21.0	14.2	14.5	64.1	27.5	13.1	28.6	18.2	6.3	1.2	13.7	5.2	0.1	49.5	44.0	60.4	17.6	31.0	9.8	23.3	28.0	35.3	30.3	33.0	28.8	0.4	17.6	37.1	0.6	23.8	25.0	10.4	19.9	35.5	24.0	6.7	44.0	33.3	17.4	8.8	39.9	13.2	21.6	2.1	22.6	24.8	4.3	26.2	40.5	15.2	22.0	44.8	11.0	76.9	9.8	12.5	24.4	0.2	12.9	69.6	5.9	0.4	21.6	29.4	41.0	28.1	25.2	36.7	16.8	5.8	0.5	0.3	13.1	11.0	3.2	29.0	4.1	6.3	18.2	7.5	5.6	6.5	12.3	7.7	8.3	8.7	13.1	13.7	7.1	2.2	1.2	4.8	28.6	0.4	5.2	21.5	17.6	10.4	13.6	16.6	16.5	16.9	11.3	11.7	10.9
NMI		ENSG00000123609	"N-myc and STAT interactor"	Q13287	2	151270465-151290057	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 75.1"	"Cell line enhanced"	"Detected in many"		"NB-4: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 75.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA008588	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA008588: AB_1079493"	"unprognostic (5.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.63e-2)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.57e-7)"	"unprognostic (1.91e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.57e-2)"	12.0	14.2	5.0	18.6	7.1	26.4	14.0	1.3	5.8	8.9	15.0	3.4	11.1	13.2	8.6	10.4	16.1	9.8	14.7	8.7	5.9	3.8	13.0	20.4	18.5	26.9	5.1	2.7	14.8	8.4	2.9	6.5	24.6	6.9	13.6	10.5	5.0	9.8	7.9	5.1	7.3	26.0	13.1	7.7	30.2	10.2	5.3	6.4	36.7	14.9	10.2	14.2	10.4	10.3	10.8	17.0	75.1	26.9	14.3	12.5	14.9	10.7	5.3	0.2	0.0	3.0	8.4	10.5	3.1	7.4	15.1	23.0	1.1	24.6	10.5	11.7	4.7	6.1	1.1	2.8	3.9	22.3	0.6	29.5	5.5	0.6	12.9	28.0	8.5	5.4	3.8	9.0	2.0	18.7	14.7	2.6	2.8	8.3	23.4	41.8	6.2	7.9	25.3	0.6	9.0	12.5	9.3	1.5	0.0	6.6	7.2	4.0	1.1	32.0	10.1	2.2	5.0	7.1	4.5	0.4	0.3	0.6	5.2	33.7	2.3	31.6	19.7	21.6	10.8	26.9	12.5	10.8	11.3	10.7	17.0	9.1	9.2	9.4	75.1	14.3	24.4	6.9	9.7	14.9	5.0	7.1	1.3	5.8	5.9	3.8	5.1	2.7	6.9	6.4
NNMT		ENSG00000166741	"Nicotinamide N-methyltransferase"	P40261	11	114257787-114313285	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 97.7"	"Cell line enhanced"	"Detected in many"		"HSkMC: 67.4;LHCN-M2: 40.0;RPTEC TERT1: 103.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059180	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"			15000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA059180: "	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (1.76e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-6)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-3)"	"unprognostic (2.77e-2)"	23.7	1.4	0.6	8.8	0.9	0.1	14.6	0.6	1.7	13.1	8.5	0.7	4.9	0.5	15.8	8.7	12.0	8.3	15.3	8.2	1.6	0.0	4.7	97.7	10.0	3.4	1.1	0.6	11.2	2.0	0.6	2.6	8.6	3.3	9.6	3.3	1.6	3.6	6.7	18.3	8.2	4.3	12.4	1.5	5.8	5.1	7.3	0.6	1.3	5.3	2.2	3.1	10.9	35.3	0.6	0.1	0.7	0.2	0.0	0.9	0.0	0.0	4.7	0.0	4.2	24.3	31.6	0.0	6.0	15.9	9.6	19.1	0.0	6.5	0.0	21.4	12.2	0.0	0.0	2.1	9.7	0.0	0.0	0.0	7.4	0.0	33.1	0.0	0.0	67.4	23.3	6.8	10.1	13.2	0.0	0.0	40.0	0.0	0.0	0.0	0.0	0.1	0.0	26.8	0.0	103.7	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	9.3	5.5	22.1	8.5	1.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.2	0.0	0.2	0.1	0.9	0.2	0.0	0.2	0.1	0.6	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.6	0.9	0.6	1.7	1.6	0.0	1.1	0.6	3.3	0.6
NNT		ENSG00000112992	"Nicotinamide nucleotide transhydrogenase"	Q13423	5	43602692-43707405	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004829, CAB004975, HPA066564"	Enhanced		Approved	Mitochondria			1100000	Mitochondria		"CAB004975: AB_425908, HPA004829: AB_1079495, HPA066564: "	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.33e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (8.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.58e-1)"	10.8	10.5	11.7	8.3	14.0	7.3	9.1	8.3	19.0	7.6	11.2	7.3	8.8	9.2	7.1	8.8	7.9	5.4	7.1	62.1	10.8	8.2	26.0	48.5	7.2	9.6	9.2	10.3	5.8	12.2	15.6	6.2	5.8	10.0	8.5	12.1	6.7	14.4	7.8	100.0	6.0	8.9	14.7	6.1	6.5	13.6	4.2	6.1	14.0	14.0	32.6	8.7	10.9	6.2	11.4	25.5	13.1	18.5	18.2	19.1	13.5	8.3	6.1	14.2	26.4	16.5	18.4	4.4	8.3	14.2	10.3	9.3	7.1	13.7	8.5	10.4	15.8	7.9	56.2	2.0	10.9	13.5	15.1	12.3	33.0	8.6	9.6	20.6	18.3	15.8	6.3	5.9	8.4	20.3	8.8	34.1	24.4	5.6	22.1	11.1	2.8	5.5	24.8	33.5	30.5	19.5	7.3	21.0	17.4	30.6	0.4	18.9	21.4	20.7	11.1	15.1	14.6	6.3	4.0	18.4	18.9	13.1	3.1	27.4	9.7	9.3	14.2	13.1	14.4	18.4	14.8	11.4	15.6	14.5	25.5	10.3	14.6	13.3	2.4	18.2	18.5	9.2	19.1	13.5	11.7	14.0	8.3	19.0	10.8	8.2	9.2	10.3	10.0	6.1
NOLC1	"KIAA0035, NOPP130, NOPP140, P130"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"			10000	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: "	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavourable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (8.25e-5)"	"unprognostic (7.68e-2)"	29.5	17.1	18.8	27.8	35.0	23.2	21.3	37.9	39.2	19.1	20.4	23.5	13.8	14.2	25.1	12.4	30.4	25.1	20.7	20.0	18.5	19.2	16.1	38.1	23.6	27.7	20.2	21.4	28.0	25.5	33.9	34.3	25.4	28.0	20.7	27.0	14.8	21.0	18.0	46.6	20.3	17.3	23.4	20.2	26.2	21.0	13.8	19.9	32.9	26.1	19.8	35.1	24.3	20.9	12.7	11.6	7.8	11.2	11.8	19.3	11.2	32.3	29.8	16.9	35.5	14.0	11.2	28.7	18.5	14.8	26.1	22.3	51.2	22.7	67.7	20.6	11.8	37.5	48.5	40.4	27.9	21.2	31.8	45.3	24.8	29.8	18.9	65.6	21.2	14.3	26.4	27.6	57.9	15.9	47.5	30.0	15.6	28.4	61.3	13.8	32.2	23.4	46.0	46.2	37.7	15.1	20.8	25.2	23.8	17.8	20.5	22.6	35.6	14.2	13.6	11.7	16.3	13.7	41.4	28.1	41.5	76.3	19.0	67.6	10.0	1.4	8.4	7.8	15.5	10.3	19.3	12.7	12.4	14.5	11.6	10.0	14.5	17.1	0.9	11.8	11.2	9.0	8.8	11.2	18.8	35.0	37.9	39.2	18.5	19.2	20.2	21.4	28.0	19.9
NOMO1	PM5	ENSG00000103512	"NODAL modulator 1"	Q15155	16	14833681-14896160	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 40.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.6;Hep G2: 36.6;RPMI-8226: 23.3;SiHa: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB025192, HPA046697, HPA061174"	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB025192: , HPA046697: , HPA061174: "	"unprognostic (5.33e-3)"	"unprognostic (1.60e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.18e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavourable (3.15e-4)"	4.2	3.3	4.4	10.1	11.1	0.8	4.6	7.9	10.2	2.4	3.7	5.4	1.5	1.4	6.1	3.6	3.4	8.3	2.8	12.9	5.2	6.4	11.3	8.9	4.1	3.4	4.6	10.6	11.7	40.0	1.2	3.3	9.1	6.6	5.9	10.3	2.7	4.1	5.9	12.2	6.9	7.0	9.0	3.5	1.8	5.9	15.0	2.8	1.5	9.9	1.5	2.4	2.6	1.9	1.2	3.8	5.2	4.0	1.4	1.0	1.0	0.3	12.5	15.7	20.6	0.0	1.5	10.2	1.3	3.1	3.8	3.9	0.2	0.9	1.3	0.9	2.8	0.2	2.8	0.1	3.9	1.9	0.0	1.2	16.7	36.6	13.6	1.8	0.9	0.2	0.2	2.0	2.2	2.9	7.1	0.8	17.7	0.0	0.4	0.0	0.0	0.0	0.8	1.4	23.3	0.0	0.7	0.3	11.6	42.3	0.0	0.2	17.2	0.1	0.4	0.5	0.0	1.8	14.5	0.0	0.6	1.5	0.9	0.7	0.5	5.2	0.6	0.6	0.3	1.2	0.7	0.2	0.3	0.9	0.5	1.2	0.5	0.8	1.6	1.4	4.0	3.8	1.0	1.0	4.4	11.1	7.9	10.2	5.2	6.4	4.6	10.6	6.6	2.8
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"			150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavourable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	58.5	64.8	89.7	49.2	36.6	37.8	49.1	48.0	44.7	65.0	57.4	51.4	43.5	66.6	53.5	44.2	43.8	133.8	41.7	71.6	50.7	89.4	54.6	68.0	51.1	31.0	76.6	48.0	40.0	29.8	65.7	44.1	53.3	69.6	69.9	59.9	52.0	99.0	69.8	111.6	52.6	89.1	94.0	57.1	49.8	51.8	62.3	77.3	62.2	40.6	55.1	38.2	49.6	48.9	42.1	63.2	58.8	55.5	40.3	76.3	75.8	31.4	89.1	60.1	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: "	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.1	13.7	8.2	16.9	11.0	12.6	14.4	14.9	10.6	15.6	12.9	17.9	17.1	45.8	10.6	12.1	11.2	22.6	19.4	16.8	8.7	21.6	36.4	13.0	16.2	14.6	39.5	15.9	12.7	17.5	17.6	16.1	13.1	32.9	16.3	11.7	11.6	41.6	29.8	21.3	22.6	27.0	12.4	15.2	7.8	26.1	17.0	10.0	12.4	9.2	11.6	17.6	15.6	16.2	13.1	7.6	15.9	27.4	12.2	19.7	39.5	13.6	29.3	13.5	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Supported	Nucleoli				Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavourable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.1	26.0	7.1	24.3	9.1	7.8	38.6	14.7	9.5	17.4	15.0	31.7	16.5	34.5	4.0	7.2	20.0	27.2	16.2	16.9	40.7	25.5	33.8	24.8	18.3	12.2	33.3	19.5	7.9	16.0	21.0	32.8	11.7	23.7	5.5	13.8	20.0	17.8	29.0	59.4	14.5	25.4	20.7	16.9	12.7	22.3	5.5	10.9	23.0	25.1	12.1	4.1	16.0	11.0	12.0	16.1	15.5	33.7	7.7	11.2	51.5	11.0	19.1	20.8	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652145-2658393	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB075757: , HPA049918: "	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	23.5	18.5	20.1	30.5	23.8	30.6	33.8	36.1	31.3	19.2	19.1	22.4	15.3	16.3	29.9	19.9	25.5	31.4	20.3	18.0	19.9	23.3	16.3	20.1	17.4	30.5	27.9	23.9	29.6	49.8	17.8	23.3	22.4	20.9	22.9	23.4	13.5	23.4	23.5	31.7	21.8	19.2	30.9	17.7	26.5	18.5	20.1	22.5	39.4	20.7	20.0	32.2	20.8	34.9	18.0	19.7	9.5	13.5	13.5	21.2	12.2	20.2	27.8	15.9	19.1	24.3	16.6	34.8	21.0	16.9	32.3	22.2	40.2	21.6	56.3	14.7	17.9	45.3	48.2	36.9	29.1	16.7	34.0	33.9	17.7	40.1	26.1	28.5	15.0	23.9	26.8	43.7	50.3	20.6	36.3	27.6	23.2	18.5	45.5	28.6	37.6	31.3	41.9	26.9	30.8	20.7	29.4	18.4	17.4	29.0	31.4	49.6	32.8	25.8	15.6	34.0	19.7	21.2	34.6	16.3	30.3	40.5	8.4	33.6	21.2	3.3	12.0	9.5	16.9	13.5	21.2	18.0	18.5	17.6	12.0	16.6	18.5	16.6	0.9	13.5	10.7	19.7	15.7	12.2	20.1	23.8	36.1	31.3	19.9	23.3	27.9	23.9	20.9	22.5
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.6	18.9	18.7	23.3	14.0	12.7	44.4	25.7	13.8	19.9	18.6	41.8	24.1	41.3	21.4	15.5	24.7	37.1	31.6	35.1	16.1	34.1	49.8	28.5	41.1	20.8	49.2	24.0	16.3	18.8	27.6	63.5	17.7	54.3	31.5	24.7	28.3	44.8	54.4	46.9	32.9	37.9	28.4	54.4	23.4	32.3	29.0	21.4	23.8	34.2	29.5	23.4	38.9	15.3	25.4	29.8	22.6	43.8	25.7	46.9	59.1	18.7	35.1	30.1	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8
NOP9	C14orf21	ENSG00000196943	"NOP9 nucleolar protein"	Q86U38	14	24299862-24309124	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000850			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA000850: AB_1078287"	"unprognostic (1.39e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.85e-1)"	"unprognostic (8.28e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.37e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.77e-2)"	"prognostic favourable (9.39e-6)"	"unprognostic (7.03e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.59e-2)"	12.0	12.9	11.3	11.4	11.4	14.4	10.0	13.3	17.5	11.3	14.4	16.8	9.6	16.5	11.1	10.1	16.6	10.3	13.8	19.4	10.9	10.6	9.7	14.2	9.5	15.1	13.7	10.0	13.3	13.3	20.1	8.9	11.6	10.9	10.8	12.3	13.0	12.5	11.5	29.7	13.5	12.4	12.3	12.3	18.8	10.9	13.0	10.7	11.8	11.2	18.3	14.9	12.1	9.4	1.6	2.1	1.8	5.2	0.4	1.6	1.4	5.1	10.2	8.3	10.4	7.2	6.2	8.3	9.1	6.8	10.8	8.5	7.6	9.0	13.1	5.2	8.3	13.3	16.4	11.3	11.3	8.3	6.2	9.6	14.1	17.5	5.8	22.0	11.0	6.2	8.9	7.9	7.4	10.0	8.1	6.5	7.5	8.8	10.1	8.3	3.7	13.1	12.8	5.0	8.4	6.6	11.7	8.4	6.4	12.8	15.0	2.8	6.3	5.8	10.2	7.3	6.0	6.0	8.6	9.2	8.1	9.9	4.0	10.1	5.7	1.4	2.3	1.8	1.5	2.4	1.6	1.2	1.4	0.7	2.1	1.6	1.0	1.0	0.5	0.4	5.2	1.1	1.2	1.4	11.3	11.4	13.3	17.5	10.9	10.6	13.7	10.0	10.9	10.7
NOS1	"nNOS, NOS"	ENSG00000089250	"Nitric oxide synthase 1"	P29475	12	117208142-117452170	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 13.4;skeletal muscle: 36.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.2;RH-30: 12.8;RPTEC TERT1: 8.0;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002167, HPA058312, HPA069509"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"CAB002167: AB_564073, HPA058312: , HPA069509: "	"unprognostic (1.63e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (6.64e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.12e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.97e-4)"	"unprognostic (1.87e-1)"	0.5	0.6	3.8	3.5	13.4	0.7	0.6	4.4	4.8	0.7	2.0	1.1	0.0	0.5	0.6	0.7	1.3	0.8	0.5	0.5	2.8	4.4	1.9	0.5	1.4	0.6	2.4	1.6	0.5	1.9	0.4	0.8	0.4	5.9	1.6	0.9	0.6	3.8	0.6	36.3	2.2	0.6	0.8	1.2	0.5	0.5	0.9	3.0	0.0	0.6	0.0	0.5	0.9	0.6	0.9	0.6	2.1	0.5	0.8	0.5	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	6.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	1.4	0.0	12.8	0.1	8.0	0.0	0.3	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	2.1	0.5	0.5	0.5	0.4	0.4	0.7	0.4	0.3	0.2	0.9	0.5	0.5	1.9	0.8	0.5	0.6	0.3	0.0	3.8	13.4	4.4	4.8	2.8	4.4	2.4	1.6	5.9	3.0
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800499	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.8;lymphoid tissue: 15.6"	"Group enriched"	"Detected in some"	8	"CACO-2: 16.6;SCLC-21H: 13.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB002014	Enhanced									"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	1.0	0.7	1.6	15.6	1.6	0.0	0.5	1.5	7.3	0.4	6.8	0.0	0.0	11.8	0.4	0.0	1.0	0.5	0.4	0.7	1.3	1.1	1.7	0.2	3.8	1.8	1.0	2.2	1.0	0.3	0.1	2.1	3.4	0.4	0.9	9.0	1.2	0.2	0.2	0.7	0.4	20.8	1.7	0.8	0.2	0.3	0.4	0.2	0.2	0.5	5.3	1.7	5.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	1.5	7.3	1.3	1.1	1.0	2.2	0.4	0.2
NOS3	"ECNOS, eNOS"	ENSG00000164867	"Nitric oxide synthase 3"	P29474	7	150990995-151014588	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Oxidoreductase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.2;HUVEC TERT2: 21.5;K-562: 7.6;TIME: 39.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 32.4;cerebral cortex: 12.4;hippocampal formation: 18.8;pons and medulla: 35.3"	"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	5	"T-cells: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002168	Enhanced									"CAB002168: AB_564072"	"unprognostic (6.53e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.56e-1)"	"unprognostic (9.40e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (1.25e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.01e-1)"	11.4	4.5	3.1	7.5	32.4	1.9	25.6	1.8	12.4	4.6	3.2	1.7	1.0	4.0	8.3	2.5	4.7	5.0	6.6	35.2	18.8	3.4	5.5	5.4	14.0	10.3	4.7	1.7	4.5	4.1	2.7	4.8	11.5	35.3	5.2	2.5	5.2	3.0	3.2	6.0	4.9	4.0	5.4	25.9	70.6	3.6	4.5	1.6	0.0	5.9	2.1	2.4	5.1	7.3	1.1	0.5	0.7	0.4	0.5	5.3	1.2	0.2	0.0	0.6	1.9	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	1.0	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	1.0	0.1	2.9	0.3	0.2	5.0	0.0	0.1	0.0	0.0	21.5	7.6	1.8	0.0	0.0	0.1	0.2	0.8	0.0	1.4	0.0	0.8	0.0	0.1	0.2	0.2	0.1	0.7	0.0	0.1	0.6	39.2	0.1	0.4	0.1	0.0	1.2	4.0	1.0	0.0	3.5	0.0	0.3	0.3	0.2	2.5	0.4	1.5	0.8	3.9	2.2	0.5	1.1	5.3	2.1	0.7	0.5	0.4	0.5	4.4	1.2	3.1	32.4	1.8	12.4	18.8	3.4	4.7	1.7	35.3	1.6
NOTCH1	TAN1	ENSG00000148400	"Notch 1"	P46531	9	136494433-136545786	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.5;HMC-1: 21.3;hTCEpi: 23.6;MOLT-4: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;NK-cells: 2.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm			8100000	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: "	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	20.0	4.0	10.0	14.5	10.4	14.6	12.8	3.8	18.8	12.8	14.2	19.9	8.2	9.8	11.2	5.1	13.3	9.6	13.1	9.6	10.7	5.8	9.4	7.2	17.4	13.7	11.6	7.5	9.2	17.8	3.7	5.6	8.5	9.3	12.1	5.7	10.4	14.2	11.8	8.2	32.3	10.8	7.7	6.6	20.7	8.6	4.1	9.9	34.8	9.4	10.2	10.9	12.3	22.2	0.6	1.1	8.8	1.0	2.7	1.3	0.9	4.4	7.3	6.1	3.0	0.2	0.5	7.6	2.2	0.6	1.3	0.4	1.0	0.5	5.9	4.6	1.7	24.5	2.0	10.0	0.2	13.5	1.1	3.3	3.0	0.4	3.4	3.5	21.3	0.3	23.6	1.7	3.7	7.8	1.4	1.1	0.8	7.9	37.4	5.7	5.1	3.4	7.7	4.9	11.0	0.9	3.7	0.0	0.4	3.2	3.4	1.4	2.1	5.6	11.5	3.2	4.7	3.1	2.4	1.2	1.0	2.4	2.2	2.5	16.5	0.7	1.0	2.8	1.3	0.4	0.8	0.4	0.6	1.0	0.6	0.6	0.4	1.1	8.8	2.7	0.4	1.1	0.4	0.9	10.0	10.4	3.8	11.7	10.7	5.8	11.6	7.5	9.3	9.9
NOTCH2		ENSG00000134250	"Notch 2"	Q04721	1	119911553-120069626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048743	Approved		Supported	"Nucleoplasm,Plasma membrane"			67000000	"Nucleoplasm, Plasma membrane"		"HPA048743: "	"unprognostic (1.33e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.32e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (5.24e-4)"	"prognostic unfavourable (9.48e-4)"	"unprognostic (3.86e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.35e-3)"	12.0	7.3	6.0	9.4	6.8	4.4	10.6	3.0	5.6	14.5	7.6	4.4	11.3	1.6	12.3	11.8	13.4	11.4	12.8	7.9	6.8	2.3	5.5	11.4	10.6	5.7	5.3	7.6	15.5	27.6	6.1	3.3	10.3	6.5	9.9	5.2	9.4	17.7	10.0	9.3	17.2	6.1	12.4	6.2	11.5	5.8	15.7	4.4	8.0	11.4	8.6	6.6	9.6	13.0	4.2	5.2	7.7	9.6	1.5	1.7	2.0	14.9	5.0	7.8	6.0	32.7	28.0	7.8	11.4	15.7	15.2	16.5	4.6	4.0	0.3	9.6	21.5	5.7	12.4	10.1	24.3	17.9	7.9	8.6	13.6	0.4	12.2	9.0	2.3	22.4	6.6	45.6	30.4	7.7	0.1	19.0	18.3	16.7	3.8	2.5	10.1	5.6	2.5	27.6	9.6	8.0	9.5	0.3	3.9	15.4	14.5	8.2	8.0	3.1	27.1	19.9	13.7	29.8	17.8	7.9	3.9	4.4	29.2	8.3	18.9	5.6	6.4	6.4	1.5	6.6	1.7	4.2	1.3	1.1	5.2	3.9	1.0	1.7	7.7	1.5	9.6	4.2	0.8	2.0	6.0	6.8	3.0	5.6	6.8	2.3	5.3	7.6	6.5	4.4
NOTCH3	"CADASIL, CASIL"	ENSG00000074181	"Notch 3"	Q9UM47	19	15159038-15200981	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 27.9;MCF7: 27.4;U-87 MG: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 2.4;granulocytes: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005393, HPA044392"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			18000000	"Nucleoplasm, Cytosol"	"Actin filaments"	"CAB005393: AB_2151246, HPA044392: "	"unprognostic (4.97e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.06e-3)"	"prognostic unfavourable (5.92e-4)"	"unprognostic (9.20e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.72e-1)"	"unprognostic (9.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.13e-1)"	"prognostic unfavourable (2.53e-7)"	"unprognostic (3.35e-2)"	"unprognostic (8.34e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-3)"	35.9	3.7	4.7	6.4	6.4	0.5	53.7	2.7	7.5	25.9	7.3	6.2	9.2	3.7	22.9	23.1	33.8	14.6	22.7	25.0	4.6	3.6	9.2	1.6	16.2	11.7	5.0	6.4	14.1	6.9	10.1	4.9	37.3	6.4	13.4	3.0	8.3	11.4	11.4	16.6	48.3	6.2	11.0	2.8	11.8	5.5	10.1	3.9	44.4	14.9	36.7	10.3	14.9	24.6	0.1	2.4	1.0	0.1	0.1	0.1	0.0	5.2	3.3	27.9	12.7	3.9	3.2	12.6	4.2	0.2	0.2	0.1	6.3	5.5	0.1	3.3	7.7	6.2	5.0	0.1	0.2	0.0	1.3	0.1	5.2	1.4	1.9	0.0	0.5	3.6	3.1	6.5	0.7	0.3	0.2	0.2	0.5	27.4	6.3	0.0	16.3	0.0	0.0	1.6	0.1	0.0	16.9	0.8	9.0	0.0	15.9	0.0	16.9	0.0	0.0	0.8	9.1	0.1	0.1	0.0	0.3	0.0	19.5	0.1	0.4	1.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	2.4	0.0	0.0	4.7	6.4	2.7	7.5	4.6	3.6	5.0	6.4	6.4	3.9
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Group enriched"	"Detected in many"	5	"BJ hTERT+: 43.0;U-2197: 44.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	269030000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	3.9	1.0	0.0	5.7	43.0	5.2	3.0	0.0	0.1	0.0	4.5	7.2	3.6	0.2	0.0	1.7	0.0	0.1	0.0	3.3	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	8.6	0.0	0.0	0.0	5.5	0.0	1.3	0.0	2.1	0.0	8.0	0.0	0.0	0.0	3.7	5.7	44.5	1.1	0.0	0.0	0.0	5.9	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 982.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 146.9"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000835	Enhanced				"Secreted to blood"		63000000			"HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavourable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favourable (6.55e-4)"	"unprognostic (1.42e-1)"	34.8	23.7	9.0	14.7	12.2	13.9	27.2	2.4	7.6	21.1	16.0	12.5	92.3	11.9	16.8	982.9	17.1	14.9	17.5	34.1	9.1	9.9	29.2	13.6	65.0	48.8	15.1	6.7	25.3	14.6	4.5	21.3	22.1	25.5	17.8	14.4	39.8	21.8	54.0	9.4	16.6	19.1	12.1	26.5	30.0	13.6	26.6	10.6	7.6	49.8	15.9	15.4	16.4	18.1	18.7	139.0	44.2	112.5	6.3	12.2	67.2	30.2	19.1	12.7	16.1	146.9	43.2	40.1	21.8	73.6	19.3	43.1	32.6	38.2	7.3	16.1	17.0	60.0	16.4	40.5	17.0	11.8	12.8	3.0	9.9	25.0	32.8	4.8	56.5	43.8	34.4	17.4	33.6	24.9	3.0	57.1	18.6	12.7	7.4	7.4	6.6	30.7	3.6	22.8	25.0	43.9	66.2	0.5	8.9	31.3	11.6	27.3	19.8	20.7	27.0	27.3	37.4	39.6	19.2	26.6	45.4	2.6	29.1	15.2	15.3	34.1	83.8	17.9	6.6	112.5	6.2	18.7	9.2	6.6	39.1	17.0	9.0	7.5	44.2	6.3	76.2	139.0	12.2	67.2	9.0	12.2	2.4	7.6	9.1	9.9	15.1	6.7	25.5	10.6
NPEPPS	"MP100, PSA"	ENSG00000141279	"Aminopeptidase puromycin sensitive"	P55786	17	47522942-47623276	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 80.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021453, HPA045649"	Uncertain		Supported	Cytosol			2100000	Cytosol		"HPA021453: , HPA045649: "	"unprognostic (1.63e-1)"	"unprognostic (3.15e-2)"	"prognostic favourable (3.39e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (3.84e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"	16.0	26.0	27.2	15.9	27.7	11.1	56.1	36.5	33.8	17.1	17.7	9.8	14.6	14.6	16.9	17.1	47.7	17.2	16.3	22.2	24.0	15.6	18.8	11.1	30.3	24.1	16.0	29.7	20.8	16.8	21.2	15.3	17.6	27.2	18.6	20.0	13.3	21.8	16.5	52.3	29.6	17.3	20.4	22.8	15.7	16.2	15.3	16.1	7.0	14.5	14.8	18.1	19.0	30.5	6.9	9.0	23.2	8.6	9.3	9.2	5.4	32.6	21.5	21.7	15.2	25.1	25.3	45.8	14.4	18.7	21.9	21.3	13.8	37.6	19.5	22.4	21.0	19.9	23.8	13.3	34.1	8.7	20.6	23.5	22.2	16.1	14.5	13.2	15.2	19.3	13.1	15.9	8.3	22.5	19.8	11.4	31.0	8.8	17.5	11.8	13.3	19.6	14.2	30.5	17.2	27.3	24.0	17.4	15.0	18.6	10.8	12.8	80.9	9.2	28.7	14.6	10.5	21.8	10.1	23.3	22.4	11.9	20.7	7.0	9.6	10.2	8.6	10.7	9.1	6.6	9.2	6.8	7.3	8.5	8.7	6.9	6.5	7.6	23.2	9.3	6.8	9.0	8.4	5.4	27.2	27.7	36.5	33.8	24.0	15.6	16.0	29.7	27.2	16.1
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1, nephrin"	O60500	19	35825964-35869287	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"kidney: 20.2;pancreas: 21.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 5.3"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 2.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced									"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	3.4	0.0		0.0	21.8	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4			0.0		1.9	0.0	0.0	0.1	0.1	2.4	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.8	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.4	0.1	0.0	0.1	0.0	0.0										
NPPA	"ANP, PND"	ENSG00000175206	"Natriuretic peptide A"	P01160	1	11845709-11848345	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hormone, Vasoactive"	"Atrial fibrillation, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	418	"heart muscle: 1267.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 12.2;SH-SY5Y: 11.7"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"olfactory region: 28.1"	"Region enriched"	"Detected in some"	5	"olfactory region: 21.2"	HPA058269	Enhanced				"Secreted to blood"		190000			"HPA058269: "	"unprognostic (1.27e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.93e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.70e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	1267.7	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.7	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.3	0.8	0.0	0.5	3.0	1.1	1.6	2.6	2.1	0.0	0.0	1.6	0.9	0.0	0.0	0.0	6.5	2.6	4.2	0.3	0.0	4.0	0.0	0.0	0.0	1.0	2.6	2.7	1.5	6.4	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	5.8	5.0	0.0	0.9	0.5	7.5	1.9	0.7	0.6	0.8	0.8	0.0	1.8	12.2	11.7	0.7	0.0	2.2	1.6	0.2	0.4	2.1	4.2	3.4	0.3	1.3	3.1	4.8	0.2	3.4	1.1	0.0	0.4	0.0	0.1	0.8	0.4	1.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	0.5	0.0	0.0	3.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
NPPB		ENSG00000120937	"Natriuretic peptide B"	P16860	1	11857464-11858931	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	296	"heart muscle: 348.6"	"Group enriched"	"Detected in some"	8	"BEWO: 33.4;CACO-2: 86.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to blood"	9675								"unprognostic (3.87e-1)"	"unprognostic (1.29e-2)"					"unprognostic (2.49e-1)"	"unprognostic (4.23e-1)"				"unprognostic (3.28e-2)"			0.1	0.0	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	348.6	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.9	0.5	0.4	0.7	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.5	0.2	86.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.8	0.4	1.0	1.0	0.6	1.0	0.5	0.5	1.1	1.1	0.0	0.7	0.3	0.9	0.7	0.9	0.1	0.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NPRL3	"C16orf35, CGTHBA, HS-40, MARE, NPR3, RMD11"	ENSG00000103148	"NPR3 like, GATOR1 complex subunit"	Q12980	16	84271-138860	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011741	Uncertain		Approved	Cytosol				Cytosol		"HPA011741: AB_1845577"	"unprognostic (1.34e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.87e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.50e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.85e-2)"	"unprognostic (9.07e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.73e-1)"	11.0	16.8	17.1	10.0	17.1	16.5	9.6	20.5	18.9	11.4	7.4	11.8	9.2	6.9	12.3	6.8	10.0	15.1	6.7	9.8	15.9	6.8	8.4	10.3	8.1	7.9	12.6	20.2	16.1	11.9	21.7	14.9	6.8	13.0	7.5	5.9	8.6	11.3	9.8	22.6	8.2	8.3	8.9	10.4	9.5	9.4	15.7	13.7	5.7	13.2	6.5	7.6	12.5	9.1	4.8	5.5	1.4	5.5	3.4	6.5	3.2	7.0	14.5	6.9	14.0	19.2	10.2	10.8	7.6	9.7	12.6	9.5	22.4	13.0	14.1	12.1	14.2	7.8	11.8	16.9	7.5	13.7	7.5	19.8	7.9	16.7	18.9	8.1	10.8	12.5	13.2	16.4	14.8	11.6	20.3	13.3	11.3	24.5	8.4	4.6	5.0	9.9	13.2	5.6	20.2	12.2	6.4	15.1	8.1	11.8	13.9	6.6	11.1	3.6	9.1	15.9	9.0	9.6	6.2	14.8	7.5	19.7	0.5	8.1	7.2	0.1	4.1	1.4	6.0	3.6	6.5	4.2	4.9	4.9	5.3	4.8	5.6	6.4	1.2	3.4	5.5	5.5	5.1	3.2	17.1	17.1	20.5	18.9	15.9	6.8	12.6	20.2	13.0	13.7
NPTXR		ENSG00000221890	"Neuronal pentraxin receptor"	O95502	22	38818452-38843982	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 73.6"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 14.8;SiHa: 11.0;U-87 MG: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA001079	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"		280000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA001079: AB_1078414"	"unprognostic (6.29e-2)"	"prognostic favourable (3.93e-4)"	"unprognostic (6.82e-3)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.55e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.49e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.77e-2)"	2.3	3.8	39.1	1.8	17.5	0.8	1.9	16.2	73.6	5.8	2.6	4.3	0.5	1.5	5.6	3.3	2.7	6.1	2.0	10.5	57.4	15.2	1.3	0.8	1.7	1.6	5.6	20.7	6.2	3.6	5.9	2.0	0.9	4.5	6.2	1.7	1.0	3.2	5.6	0.9	1.2	1.4	5.7	3.3	2.1	2.0	1.6	4.0	0.0	2.5	0.0	1.6	2.5	1.9	0.3	0.2	0.6	0.2	0.6	2.3	0.4	0.4	2.9	0.1	0.8	5.9	0.6	0.0	1.9	0.4	3.8	1.3	2.9	0.6	0.0	3.4	0.5	0.4	0.8	0.1	1.2	0.2	1.0	0.0	0.1	4.4	0.6	0.0	0.1	1.9	0.1	3.4	0.0	0.1	3.5	0.1	0.1	4.4	0.0	0.2	3.5	1.0	0.7	0.0	6.9	0.9	7.9	14.8	0.9	11.0	0.0	0.3	4.7	1.1	0.2	6.8	4.2	0.0	0.3	1.0	0.0	0.0	42.5	8.6	3.5	0.5	0.2	0.1	1.8	0.0	1.3	0.1	1.0	2.3	0.0	0.3	1.5	1.2	0.6	0.6	0.1	0.2	0.0	0.4	39.1	17.5	16.2	49.0	57.4	15.2	5.6	20.7	4.5	4.0
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 121.1"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	30733800		"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: , HPA056798: "			"unprognostic (2.00e-1)"	"prognostic unfavourable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	3.4	0.0	0.1	0.0	0.0	0.1	121.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3028869	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 62.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol			6500000	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavourable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	24.7	45.6	18.2	11.0	17.6	27.2	21.9	44.3	28.1	12.9	11.5	8.9	8.8	15.6	10.4	15.4	12.1	11.2	12.8	38.2	16.0	13.3	82.9	47.0	11.7	17.5	17.0	23.5	13.5	18.4	12.1	9.3	12.1	24.5	12.7	9.0	18.0	24.5	13.5	41.3	20.2	15.5	10.7	11.8	15.3	12.8	7.7	12.5	7.0	11.9	13.9	7.9	10.4	11.0	3.2	16.6	62.1	25.2	7.3	9.3	13.1	12.6	21.4	13.0	28.7	23.1	13.7	14.0	12.3	15.8	11.3	12.8	22.5	4.8	11.1	44.9	21.1	9.7	13.4	8.5	8.9	25.8	11.4	6.8	26.3	22.5	18.8	6.8	21.8	8.4	10.2	13.8	12.8	11.0	38.9	6.6	9.4	28.1	7.8	12.7	17.7	17.8	14.6	15.6	32.4	17.1	6.8	2.8	5.1	18.6	8.0	39.0	10.9	4.7	19.0	10.7	4.2	14.3	5.3	14.5	32.8	3.4	12.6	20.8	21.1	5.6	25.2	13.5	9.2	15.7	6.6	3.2	8.3	8.3	16.6	2.1	5.0	5.7	62.1	7.3	13.9	1.7	9.3	13.1	18.2	17.6	44.3	28.1	16.0	13.3	17.0	23.5	24.5	12.5
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Group enriched"	"Detected in some"	4	"A549: 34.3;RT4: 10.8"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"				"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: , HPA067207: "		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.3	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7
NR1H3	"LXR-a, RLD-1"	ENSG00000025434	"Nuclear receptor subfamily 1 group H member 3"	Q13133	11	47248300-47269032	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 22.5;HSkMC: 29.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 14.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036443, CAB037109"	Approved									"CAB037109: AB_1840991, HPA036443: AB_10966142"	"unprognostic (2.95e-3)"	"unprognostic (5.31e-3)"	"unprognostic (5.19e-2)"	"prognostic favourable (5.05e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.65e-2)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.40e-5)"	"unprognostic (3.56e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (3.40e-4)"	74.2	9.4	4.8	12.7	6.9	1.2	22.8	7.0	5.5	10.2	17.9	4.4	7.2	23.1	6.7	10.0	6.6	8.1	9.2	8.5	4.0	2.9	10.3	35.7	13.7	29.4	6.8	5.6	7.5	7.8	4.3	3.5	16.1	4.3	10.1	5.9	6.4	7.1	9.0	6.1	5.1	19.0	7.1	3.4	40.2	7.6	13.7	4.1	6.3	9.7	2.6	10.7	10.8	12.9	1.1	4.5	6.5	14.6	6.1	3.8	2.1	1.5	6.6	3.0	2.9	20.5	22.5	14.4	1.7	8.4	2.7	4.3	8.2	21.0	2.9	3.2	1.3	4.4	3.6	2.9	1.9	2.7	2.9	3.8	8.9	12.2	8.4	1.4	0.5	29.3	1.8	4.3	2.5	2.4	4.7	1.2	1.9	6.9	2.6	7.7	3.3	2.2	3.9	4.1	1.9	2.5	15.0	3.0	1.0	5.9	3.9	5.0	9.5	3.7	0.6	2.2	3.0	4.4	0.9	5.8	8.5	3.5	4.1	1.8	1.0	6.5	2.9	2.4	1.5	14.6	2.1	1.1	1.7	1.4	4.5	0.9	1.8	1.5	1.5	6.1	4.5	0.8	3.8	2.1	4.8	6.9	7.0	5.5	4.0	2.9	6.8	5.6	4.3	4.1
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.3"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA029309: , HPA055121: , HPA073926: "	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1										
NR2C1	"TR2, TR2-11"	ENSG00000120798	"Nuclear receptor subfamily 2 group C member 1"	P13056	12	95020229-95073703	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035040, HPA035041, HPA067767"	Supported		Supported	"Nucleoplasm,Cell Junctions,Cytosol"				Nucleoplasm	"Cell Junctions, Cytosol"	"HPA035040: , HPA035041: , HPA067767: "	"unprognostic (2.44e-1)"	"unprognostic (8.04e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.56e-3)"	"unprognostic (3.01e-2)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.83e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavourable (1.03e-6)"	"unprognostic (2.31e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (5.62e-5)"	11.6	15.8	15.9	11.8	14.7	15.5	12.4	38.3	23.9	12.5	11.2	12.5	12.9	11.2	17.6	20.2	8.3	15.5	11.1	14.8	14.6	9.3	10.3	14.0	14.2	9.9	11.7	15.2	16.3	12.5	16.4	15.4	11.2	13.7	10.7	12.7	14.6	8.0	17.4	19.6	11.0	11.2	15.7	14.2	14.3	10.5	22.2	14.9	12.3	18.0	9.0	10.2	12.3	10.7	4.5	6.2	3.5	4.2	3.5	9.0	3.9	8.0	10.0	15.9	7.4	3.7	6.6	22.6	7.9	5.7	7.9	7.4	8.8	4.5	9.7	2.8	5.2	8.6	7.8	6.1	6.0	4.2	16.6	11.8	8.0	10.5	8.4	7.9	5.2	7.6	5.0	5.4	6.7	8.4	9.0	3.8	9.2	5.3	8.5	18.3	10.7	17.5	8.2	11.1	5.8	8.8	9.3	8.2	6.5	12.6	5.4	5.8	9.5	5.0	7.9	6.4	6.3	7.8	4.4	5.6	9.1	9.4	1.6	9.2	3.0	0.5	4.1	3.5	7.1	4.2	9.0	3.7	5.7	6.0	6.2	4.5	7.2	5.0	2.6	3.5	3.7	6.2	3.7	3.9	15.9	14.7	38.3	23.9	14.6	9.3	11.7	15.2	13.7	14.9
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	13.2	13.1	22.5	17.0	17.5	17.1	16.1	30.5	26.4	11.9	14.0	12.8	14.1	18.5	17.8	11.0	13.6	12.6	12.3	14.5	18.3	12.0	12.4	12.6	18.7	16.9	12.6	20.4	18.8	14.2	18.0	23.2	11.9	13.1	12.3	12.2	13.7	13.0	21.5	31.5	19.6	18.1	15.7	13.5	18.8	14.7	29.2	13.3	26.0	19.4	9.0	15.5	15.5	17.8	5.1	4.2	6.2	3.4	2.7	4.9	1.5	10.0	11.4	13.1	10.1	9.3	11.2	30.1	14.6	11.8	11.9	12.3	7.3	9.9	15.6	7.6	13.0	10.1	12.1	7.5	12.4	20.5	17.1	20.4	24.4	6.6	7.9	14.9	15.8	8.8	10.0	14.9	7.8	13.3	14.4	10.7	10.4	8.9	22.8	11.8	8.7	11.8	18.4	15.6	10.4	5.7	15.3	8.4	20.9	13.3	11.1	13.4	11.1	14.9	17.2	18.4	21.9	16.7	19.9	16.4	21.2	16.9	13.3	14.3	16.1	6.2	2.5	1.9	4.9	3.4	4.4	2.3	2.7	2.9	2.6	5.1	3.9	3.5	3.5	2.7	3.0	4.2	2.5	1.5	22.5	17.5	30.5	26.4	18.3	12.0	12.6	20.4	13.1	13.3
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.0	20.5	1.5	0.0	13.5	15.1	1.8	15.8	18.9	13.6	15.8	1.5	13.5	8.9	7.2	23.1	9.6	0.1	12.4	16.9	5.0	7.0	2.3	27.8	4.4	12.7	9.2	7.1	10.9	16.1	22.4	21.9	5.1	3.3	34.0	12.0	3.6	5.4	6.6	4.1	4.3	1.9	14.3	18.9	4.0	0.7	2.7	2.1	27.6	4.0	6.6	1.8	13.3	12.1	33.2	6.6	15.8	11.9	6.9	6.2	14.0	17.4	9.5	11.5	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2
NRAP		ENSG00000197893	"Nebulin related anchoring protein"	Q86VF7	10	113588716-113664127	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 74.1;skeletal muscle: 268.1;tongue: 82.3"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Group enriched"	"Detected in some"	7	"head and neck cancer: 8.2;prostate cancer: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA037953, HPA037954"	Enhanced									"HPA037953: , HPA037954: AB_10672394"	"unprognostic (1.13e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.72e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.39e-4)"	"unprognostic (8.21e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.16e-1)"		5.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	9.4	5.8	0.0	0.0	74.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.0	4.2	0.0	268.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.8	82.3	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.8	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
NRCAM	"Bravo, KIAA0343"	ENSG00000091129	"Neuronal cell adhesion molecule"	Q92823	7	108147623-108456717	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.0"	"Cell line enhanced"	"Detected in some"		"A549: 26.0;AF22: 25.2;EFO-21: 47.1;HMC-1: 50.3;SH-SY5Y: 31.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 57.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"naive CD8 T-cell: 5.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012606	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"		70000000	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA012606: AB_1854636"	"unprognostic (2.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.10e-3)"	"unprognostic (4.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.42e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.28e-2)"	2.5	28.7	24.5	2.3	23.7	1.2	1.6	16.6	82.0	5.0	1.6	10.5	9.5	1.5	2.6	26.6	1.5	3.7	6.3	1.1	19.1	15.9	5.8	1.3	2.7	1.6	11.8	21.2	2.1	21.5	1.2	14.6	6.4	21.7	1.6	1.6	0.7	2.4	12.1	1.0	1.6	1.5	1.6	10.8	4.2	2.3	2.2	9.9	0.0	4.0	0.0	2.9	1.5	0.8	0.1	0.0	0.3	0.0	0.0	5.5	0.6	0.0	26.0	25.2	0.0	3.1	0.6	0.5	0.1	0.1	0.2	0.4	10.5	0.0	0.0	47.1	0.2	0.1	0.5	0.4	0.2	0.0	3.3	0.0	0.2	0.2	0.0	0.2	50.3	4.2	0.0	0.0	0.1	16.2	0.0	0.2	0.4	9.7	0.1	0.0	3.4	0.0	0.0	7.4	8.5	5.8	0.0	4.9	31.0	0.3	0.0	0.5	0.0	0.0	17.2	1.1	0.2	0.0	4.2	0.0	0.1	0.2	0.1	0.0	14.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.6	24.5	23.7	16.6	34.7	19.1	15.9	11.8	21.2	21.7	9.9
NRDC	"hNRD1, hNRD2, NRD1"	ENSG00000078618	"Nardilysin convertase"	O43847	1	51789191-51878937	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 96.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053661			Approved	Nucleoplasm				Nucleoplasm		"HPA053661: "	"unprognostic (1.22e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (5.49e-6)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (2.12e-9)"	"unprognostic (2.75e-1)"	"unprognostic (2.35e-2)"	"unprognostic (9.54e-2)"	"unprognostic (5.53e-3)"	16.4	15.9	13.4	15.8	17.5	14.5	11.7	14.7	16.9	12.2	13.7	11.0	9.9	11.2	11.8	12.1	14.4	10.9	10.9	25.7	13.1	13.3	12.4	28.5	12.0	13.6	16.2	10.6	11.7	15.9	19.3	21.4	14.2	15.7	13.8	12.1	9.8	11.9	11.3	96.4	19.1	10.3	13.3	14.0	13.6	11.9	32.3	14.5	19.4	11.7	21.5	15.1	13.0	16.0	13.8	18.5	36.3	19.1	15.8	15.1	16.2	47.6	26.8	26.9	38.7	28.3	43.9	31.4	48.1	41.6	35.0	37.2	18.8	18.8	31.4	25.8	36.2	27.8	39.6	37.3	44.4	37.2	19.5	37.5	36.5	16.3	29.1	32.7	28.6	34.9	28.6	51.1	47.5	36.4	49.4	21.1	43.8	17.4	29.6	11.3	47.8	28.9	29.0	32.2	34.6	25.9	27.7	25.9	19.5	43.9	35.3	26.0	23.6	39.9	30.2	30.8	28.6	33.5	40.9	31.5	47.6	29.4	36.4	41.3	35.3	19.3	18.1	26.0	13.7	19.1	13.7	13.8	12.7	15.1	18.5	9.3	12.5	13.4	36.3	15.8	14.5	15.0	14.4	16.2	13.4	17.5	14.7	16.9	13.1	13.3	16.2	10.6	15.7	14.5
NRDE2	"C14orf102, FLJ14051"	ENSG00000119720	"NRDE-2, necessary for RNA interference, domain containing"	Q9H7Z3	14	90267856-90332137	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047050, HPA050583"	Uncertain		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA047050: , HPA050583: "	"unprognostic (1.24e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.27e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-2)"	7.3	9.1	7.3	7.7	10.1	16.4	8.0	17.6	9.3	6.9	8.1	10.8	4.4	13.5	14.6	8.0	8.1	7.7	6.3	6.3	6.2	5.4	7.4	9.8	7.1	6.8	8.2	4.2	8.7	7.2	10.6	13.8	11.6	8.5	7.0	6.5	10.8	9.2	6.1	23.5	11.1	9.7	7.3	8.4	8.5	7.9	7.1	8.7	11.3	9.4	4.8	8.3	9.2	10.2	3.3	3.5	6.0	2.7	2.2	2.6	0.6	1.3	2.6	3.6	2.2	0.5	1.9	2.5	2.6	1.8	1.9	2.1	3.2	2.3	2.3	1.4	2.5	3.4	2.0	3.4	3.6	4.4	3.3	3.0	8.6	2.2	1.0	8.0	4.2	3.5	2.5	1.8	1.1	1.6	1.4	3.6	1.7	2.5	3.6	3.4	1.2	2.1	3.2	5.3	0.9	1.1	5.2	3.3	3.9	1.1	6.9	1.7	3.1	3.3	2.2	2.9	1.3	1.7	1.1	3.0	3.2	2.5	2.7	1.5	3.3	4.5	2.7	3.4	2.6	1.5	2.0	2.5	1.9	2.1	1.3	3.3	1.9	2.2	6.0	2.2	1.2	3.5	1.6	0.6	7.3	10.1	17.6	9.3	6.2	5.4	8.2	4.2	8.5	8.7
NRG1	"GGF, HGL, HRG, NDF, NRG1-IT2"	ENSG00000157168	"Neuregulin 1"	Q02297	8	31639386-32767959	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3"	"Cell line enhanced"	"Detected in many"		"A549: 38.9;BJ: 26.6;fHDF/TERT166: 29.8;HBF TERT88: 26.2;hTEC/SVTERT24-B: 27.9;hTERT-HME1: 29.3"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 4.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"classical monocyte: 22.8"	"Lineage enriched"	"Detected in many"	5	"monocytes: 22.8"	"Low region specificity"	"Detected in all"							HPA010964	Uncertain		Approved	Nucleoplasm	"Secreted to blood"			Nucleoplasm		"HPA010964: AB_1854641"	"unprognostic (5.76e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.96e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.94e-4)"	"unprognostic (4.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.98e-1)"	"unprognostic (5.65e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.40e-2)"	"unprognostic (7.83e-2)"	0.7	2.1	4.6	5.0	3.3	1.2	8.8	14.8	8.1	10.6	4.2	0.3	2.1	3.5	2.5	1.1	3.7	2.0	4.8	2.2	4.7	15.4	11.5	23.6	5.7	0.6	6.2	3.5	2.9	0.9	0.8	23.9	0.2	28.3	3.2	5.4	3.6	2.5	1.6	0.2	4.3	5.7	1.1	2.5	1.7	3.1	6.4	0.8	0.2	13.8	7.2	2.2	7.2	3.5	0.0	4.9	0.8	22.8	0.0	0.0	4.6	0.1	38.9	0.7	0.0	0.3	0.8	0.0	26.6	18.9	22.1	16.9	0.0	0.8	0.0	4.9	29.8	21.0	0.2	10.6	26.2	0.0	0.2	0.5	0.5	0.5	0.1	0.0	0.0	0.3	1.1	27.9	29.3	12.7	0.0	0.1	7.9	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	16.3	1.1	1.1	1.3	2.0	0.0	0.0	0.0	0.0	9.2	15.4	4.7	24.5	14.8	0.0	0.0	0.2	7.9	0.0	1.8	0.0	22.8	0.2	0.0	2.1	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.6	4.6	3.3	14.8	8.1	4.7	15.4	6.2	3.5	28.3	0.8
NRG3		ENSG00000185737	"Neuregulin 3"	P56975	10	81875314-82987179	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.6"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;HEK 293: 3.3;HUVEC TERT2: 1.6;SK-MEL-30: 7.2;U-2 OS: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA075789			Uncertain	Vesicles	"Secreted in brain"			Vesicles		"HPA075789: "	"unprognostic (6.15e-3)"		"unprognostic (2.43e-2)"	"unprognostic (1.65e-5)"	"unprognostic (1.89e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.85e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.31e-4)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.27e-4)"	0.9	1.5	15.6	1.2	8.2	0.6	2.8	1.9	30.6	0.8	0.9	4.8	0.0	0.8	0.7	0.7	0.9	8.0	5.3	0.9	14.5	6.2	1.2	1.5	1.6	0.8	4.9	8.0	0.7	0.9	0.7	1.6	1.2	6.5	0.9	0.9	3.1	5.0	1.1	0.7	0.8	0.9	0.9	5.6	0.8	0.8	3.3	6.0	0.0	0.9	0.0	0.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	8.2	1.9	12.8	14.5	6.2	4.9	8.0	6.5	6.0
NRIP1	RIP140	ENSG00000180530	"Nuclear receptor interacting protein 1"	P48552	21	14961235-15065936	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 40.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029785, HPA046571, HPA060036"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA029785: , HPA046571: , HPA060036: "	"unprognostic (5.60e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.20e-3)"	"unprognostic (4.64e-3)"	"unprognostic (7.98e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.94e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.80e-1)"	29.0	15.0	10.8	12.6	7.5	19.6	18.4	20.8	10.5	23.1	21.2	6.7	8.5	14.5	16.6	13.4	13.1	18.8	9.0	11.8	9.3	5.8	16.0	22.7	9.3	8.9	5.9	7.3	14.4	15.8	8.3	11.2	16.8	7.2	13.9	15.8	12.7	10.3	7.7	36.5	7.6	30.3	17.3	12.9	17.0	8.4	6.8	7.7	22.1	7.3	12.4	5.9	13.0	14.9	2.6	1.7	0.5	1.4	1.2	5.6	0.7	9.6	20.4	16.1	0.0	8.1	5.2	5.7	11.5	5.1	7.6	5.8	3.8	7.6	0.0	6.5	10.9	5.0	1.0	6.8	15.4	0.0	4.4	14.5	7.1	11.7	4.8	7.2	3.2	6.4	9.5	7.9	9.3	5.6	10.3	8.0	5.0	5.4	3.3	0.0	6.5	6.1	40.9	12.6	0.3	4.4	16.6	1.4	0.0	9.5	5.0	3.8	12.2	5.5	9.7	6.2	4.2	9.6	4.6	3.8	0.0	0.0	13.6	0.0	3.1	0.0	1.4	0.5	1.0	0.8	5.6	0.9	1.0	1.1	1.7	2.6	1.7	0.6	0.3	1.2	1.4	1.7	0.5	0.7	10.8	7.5	20.8	10.5	9.3	5.8	5.9	7.3	7.2	7.7
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 69.8;TIME: 58.0;U-87 MG: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"		720000000			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavourable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (3.87e-4)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	69.9	15.0	4.9	13.6	4.9	0.7	53.8	1.3	5.6	25.1	17.6	2.4	16.4	6.7	29.8	21.9	14.7	17.0	23.3	50.5	17.2	5.9	47.1	27.4	47.1	30.1	3.5	3.2	27.1	14.1	11.7	6.4	44.3	3.6	25.2	7.8	24.3	11.8	31.6	22.3	9.1	14.6	19.1	5.5	38.7	9.8	15.6	2.8	5.9	30.4	24.6	7.9	22.3	23.8	0.4	24.0	0.3	1.7	0.6	0.4	0.4	8.7	34.0	1.7	0.1	33.2	37.2	0.2	35.2	34.3	17.8	19.1	4.3	20.9	0.1	4.2	69.8	2.4	2.1	10.2	14.5	0.1	1.7	0.0	3.9	7.3	11.7	3.1	0.2	44.4	1.7	42.2	19.1	48.2	0.1	0.2	34.6	14.7	0.2	0.5	0.8	32.3	1.4	3.8	0.1	16.7	0.1	0.8	0.4	3.6	2.7	0.1	0.1	0.4	58.0	25.4	6.0	30.5	23.7	0.1	0.1	0.1	69.5	4.0	22.9	0.2	1.7	0.3	0.3	0.3	0.4	0.4	0.3	0.3	1.4	0.3	0.4	0.3	0.3	0.6	0.1	24.0	0.3	0.4	4.9	4.9	1.3	5.6	17.2	5.9	3.5	3.2	3.6	2.8
NRP2	VEGF165R2	ENSG00000118257	"Neuropilin 2"	O60462	2	205681990-205798133	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.2;HUVEC TERT2: 30.0;TIME: 28.6;U-251 MG: 58.5;U-87 MG: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA039980, HPA054974"	Enhanced		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"		15000000	"Vesicles, Plasma membrane"		"HPA039980: AB_10795517, HPA054974: "	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.12e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.57e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.56e-3)"	"unprognostic (4.17e-1)"	"prognostic unfavourable (7.68e-7)"	"unprognostic (2.22e-3)"	"unprognostic (5.45e-2)"	"unprognostic (6.41e-3)"	"prognostic unfavourable (7.80e-5)"	24.3	14.5	8.7	11.4	7.4	2.6	7.8	1.2	7.0	34.4	35.4	3.9	8.4	3.5	33.7	4.6	24.8	13.1	25.8	4.4	11.5	8.3	3.4	6.2	15.8	4.9	8.9	3.9	33.0	1.4	2.5	6.6	29.9	9.0	18.6	7.0	27.7	2.6	21.0	2.5	3.3	8.2	44.7	8.6	4.7	17.1	3.4	5.2	2.6	7.3	6.0	3.0	39.3	24.6	1.4	0.5	0.0	1.8	0.0	0.0	0.5	0.6	14.1	9.0	0.0	8.2	2.6	2.6	2.2	4.3	2.8	2.7	13.3	34.2	0.0	3.4	7.1	5.4	0.4	4.3	4.6	0.0	1.9	0.1	0.6	0.1	22.2	0.0	0.5	19.5	3.3	3.9	3.5	30.0	0.0	0.0	1.9	0.0	0.0	0.0	11.3	2.5	0.0	0.5	3.1	5.7	0.0	8.1	0.3	0.3	0.0	20.2	0.0	0.1	28.6	12.4	0.1	3.2	58.5	0.0	0.0	0.8	27.6	0.0	25.9	0.0	1.8	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	8.7	7.4	1.2	3.8	11.5	8.3	8.9	3.9	9.0	5.2
NRXN3	"C14orf60, KIAA0743"	ENSG00000021645	"Neurexin 3"	"Q9HDB5, Q9Y4C0"	14	78170373-79868290	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 8.2;RT4: 20.3;SK-BR-3: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.2"	"Low region specificity"	"Detected in all"							HPA002727	Approved						520000			"HPA002727: AB_1079468"	"unprognostic (7.96e-2)"	"unprognostic (5.70e-4)"	"unprognostic (8.18e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.31e-4)"	"unprognostic (9.56e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.12e-2)"	"unprognostic (7.91e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.83e-7)"	"unprognostic (4.81e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	1.8	7.5	15.1	4.1	24.7	1.1	2.8	75.3	36.9	6.3	12.3	2.6	7.3	3.6	4.7	2.8	6.7	3.9	3.9	2.3	12.7	9.4	2.3	1.3	4.0	1.3	11.9	20.2	1.4	4.5	1.7	9.2	2.3	14.7	9.5	6.0	7.8	4.1	15.7	1.1	2.9	5.6	25.5	8.6	7.4	6.9	7.5	4.3	0.0	1.2	0.0	1.2	8.1	2.1	0.5	0.3	2.2	0.4	0.4	0.2	0.1	0.0	0.0	6.3	0.0	0.1	0.2	0.0	2.5	1.8	8.2	6.2	2.1	0.0	0.1	0.0	0.2	2.4	0.0	0.2	5.7	2.3	5.1	0.0	0.2	0.0	0.6	0.0	0.0	1.5	0.2	3.6	1.2	2.1	0.0	0.1	0.1	0.0	0.2	0.2	1.4	0.0	0.2	0.0	0.0	4.4	20.3	1.0	0.0	0.0	7.9	0.4	0.0	0.0	0.0	0.1	5.4	0.0	2.6	0.0	0.0	0.0	1.5	0.3	4.5	2.2	0.4	0.5	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.5	0.2	0.2	1.6	0.4	0.2	0.3	0.1	0.1	15.1	24.7	75.3	36.9	12.7	9.4	11.9	20.2	14.7	4.3
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA043487	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA043487: "	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.3	11.1	13.8	18.5	8.6	15.8	21.0	14.6	7.6	9.3	7.4	18.4	20.0	16.5	31.1	8.0	12.6	10.8	16.1	13.2	11.2	16.8	8.6	21.7	21.1	8.0	14.9	20.2	10.4	15.2	12.4	9.2	7.7	8.5	13.9	9.9	15.4	25.1	37.6	9.1	9.7	18.0	16.1	31.0	11.7	22.5	14.8	19.3	8.8	17.1	39.3	16.0	42.6	8.9	7.1	21.7	13.5	41.8	13.9	18.5	26.9	18.0	26.5	10.7	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7
NSD1	"ARA267, FLJ22263, KMT3B, STO"	ENSG00000165671	"Nuclear receptor binding SET domain protein 1"	Q96L73	5	177133025-177300215	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048431, HPA070333, HPA073705"	Supported		Supported	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA048431: , HPA070333: , HPA073705: "	"unprognostic (3.48e-2)"	"unprognostic (7.46e-2)"	"unprognostic (7.14e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.68e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.77e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.32e-2)"	11.8	13.2	11.9	25.4	15.7	23.9	14.0	28.9	16.7	15.6	14.2	18.5	17.0	10.6	19.0	13.9	17.8	13.6	15.8	11.7	12.8	11.5	14.4	10.5	12.3	19.4	12.9	11.7	16.6	27.1	24.6	19.3	16.0	13.4	14.2	14.3	13.8	13.5	18.7	20.6	16.1	14.5	15.6	13.2	16.1	13.1	28.1	16.1	27.3	20.1	10.6	22.7	13.4	20.2	10.2	8.9	18.7	10.8	10.9	7.8	2.9	9.7	12.6	13.1	11.3	6.4	8.3	0.4	8.8	8.9	12.4	11.6	2.8	8.2	20.1	10.0	12.1	8.4	20.8	19.6	15.1	34.0	12.6	8.9	14.2	0.1	10.7	19.2	10.6	7.8	11.9	14.7	13.8	18.0	12.1	7.1	12.5	20.4	13.3	6.2	14.2	11.1	14.8	1.7	6.2	8.0	11.8	15.9	11.0	22.9	10.0	6.9	10.0	16.0	13.3	8.7	12.6	5.5	10.9	8.3	7.2	14.4	5.0	9.4	9.3	10.7	9.1	9.4	7.5	6.1	6.3	8.5	6.3	5.0	6.7	10.2	7.8	6.3	18.7	10.9	10.8	8.9	5.7	2.9	11.9	15.7	28.9	16.7	12.8	11.5	12.9	11.7	13.4	16.1
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			920000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	15.7	22.7	20.2	10.2	23.5	15.8	15.3	18.2	26.5	16.6	14.7	17.1	9.3	11.1	17.4	21.2	19.8	19.9	12.2	21.9	16.7	18.2	14.8	19.8	12.7	9.6	17.1	22.4	22.7	10.8	12.4	9.9	21.5	24.2	16.8	13.9	20.1	13.6	21.8	49.7	25.6	12.4	18.9	15.8	12.2	12.6	11.1	15.3	12.8	13.1	14.8	12.4	15.9	13.7	14.5	12.0	32.4	10.9	5.9	11.0	9.4	21.2	24.6	15.8	15.0	14.3	13.3	11.7	9.9	17.9	24.3	18.0	20.8	17.2	11.8	8.1	18.0	20.1	9.7	26.0	18.7	4.4	10.5	11.9	4.4	23.8	15.1	11.5	7.2	11.3	9.5	25.3	8.5	17.2	15.4	10.6	16.9	10.2	12.0	22.0	16.9	27.2	5.7	19.7	11.5	28.2	14.9	9.1	11.2	12.0	23.9	10.8	14.6	8.0	16.0	18.9	13.9	10.9	16.2	8.5	15.2	9.8	14.0	16.1	13.3	10.7	8.9	32.4	8.5	10.6	8.5	13.9	9.2	8.3	12.0	14.5	10.5	9.2	29.1	5.9	10.9	9.5	11.0	9.4	20.2	23.5	18.2	26.5	16.7	18.2	17.1	22.4	24.2	15.3
NT5C1B	"AIRP, CN-IB"	ENSG00000185013	"5'-nucleotidase, cytosolic IB"	Q96P26	2	18562872-18589572	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 52.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA056683	Uncertain									"HPA056683: "	"unprognostic (4.18e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.84e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.77e-1)"	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.3	0.7	0.0	0.4	0.3	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.5	52.6	0.1	0.1	0.5	0.1	0.1	0.5	0.1	1.2	3.7	0.0	0.1	0.7	2.6	0.4	3.2	0.7	0.3	0.0	0.0	0.0	0.5	2.5	0.0	0.0	0.0	0.0	3.5	1.6	0.5	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.9	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	1.1	0.2	0.0	2.9	0.1	0.2	0.7	1.7	0.3	0.7	0.8	0.1	3.0	2.5	1.2	2.6	0.4	1.5	0.8	0.7	1.7	1.5	1.0	2.9	0.5	1.0	0.7	2.0	2.5	0.0	1.2	0.0	0.1	0.0	1.3	0.0	2.3	0.1	1.3	1.3	0.3	1.2	2.6	2.2	0.0	0.7	0.1	3.7	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NT5C2	"cN-II, GMP, NT5B, PNT5, SPG65"	ENSG00000076685	"5'-nucleotidase, cytosolic II"	P49902	10	103088017-103193306	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Allosteric enzyme, Hydrolase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003751	Approved									"HPA003751: AB_1854664"	"unprognostic (8.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.87e-3)"	"unprognostic (2.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.41e-2)"	"unprognostic (9.59e-2)"	"unprognostic (2.93e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.40e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.50e-1)"	15.0	17.0	17.6	18.2	21.2	31.6	19.7	22.5	19.6	17.5	20.7	25.4	24.5	10.9	24.6	19.6	38.6	14.8	17.0	16.5	16.7	20.7	19.6	15.5	18.8	16.8	21.8	17.3	24.8	19.4	18.7	29.5	16.9	29.1	22.9	17.0	26.2	67.2	21.6	41.6	11.7	13.9	20.4	19.1	20.5	15.9	21.7	14.5	29.7	39.2	16.3	31.5	21.1	31.1	6.7	9.7	23.8	14.5	10.5	8.7	7.1	50.1	20.4	14.2	31.9	12.5	14.0	8.1	25.2	24.5	12.3	12.7	14.8	40.2	24.0	19.6	17.4	25.7	9.4	12.9	14.4	14.5	8.8	17.3	8.7	14.4	22.4	25.0	8.6	21.4	14.4	10.7	17.3	11.2	11.2	16.8	21.2	29.6	22.3	32.4	13.5	25.3	36.5	12.3	6.9	17.6	28.7	4.3	10.7	13.2	10.4	19.7	15.9	19.4	11.4	9.8	9.8	14.0	18.3	14.7	24.4	32.2	9.9	28.9	2.8	19.8	11.7	23.8	8.1	11.9	8.7	6.7	7.0	6.5	9.7	4.2	6.0	6.2	21.4	10.5	14.5	7.3	6.5	7.1	17.6	21.2	22.5	18.0	16.7	20.7	21.8	17.3	29.1	14.5
NT5C3A	"cN-III, hUMP1, NT5C3, p36, P5'N-1, PN-I, POMP, PSN1, UMPH, UMPH1"	ENSG00000122643	"5'-nucleotidase, cytosolic IIIA"	Q9H0P0	7	33014113-33062797	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010630, HPA029058"	Uncertain				"Intracellular and membrane"					"HPA010630: AB_2668319, HPA029058: AB_10601380"	"unprognostic (7.50e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.56e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (9.37e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.12e-3)"	"unprognostic (3.43e-3)"	12.3	12.1	9.9	17.0	9.9	15.4	11.4	16.2	12.2	12.0	27.5	7.4	8.1	20.9	14.7	11.6	12.0	9.0	12.9	11.6	9.8	10.3	11.7	10.5	11.6	15.0	10.3	9.8	10.3	19.1	5.5	10.9	10.6	8.4	9.6	27.2	8.5	9.0	8.9	53.3	15.0	19.7	7.5	9.9	18.4	14.5	6.3	8.9	15.4	9.8	28.8	22.8	12.0	11.6	21.4	6.8	36.6	11.4	8.6	18.9	13.3	14.1	10.3	9.6	8.5	7.3	6.4	7.8	15.5	10.1	10.5	14.4	6.4	40.0	35.5	9.0	9.0	21.5	10.4	10.2	15.7	5.5	13.3	16.1	12.2	9.3	7.7	19.2	13.4	7.1	9.1	11.5	23.1	6.9	13.9	9.5	12.9	9.6	7.1	30.1	9.9	9.1	9.5	8.8	21.0	33.6	14.9	10.4	12.9	10.1	19.1	24.2	12.7	10.7	6.0	9.0	8.1	15.3	20.2	19.0	21.6	17.4	7.4	11.9	14.0	26.9	8.0	29.8	9.0	10.2	10.2	21.4	12.1	11.0	6.8	20.5	12.4	10.6	36.6	8.6	11.4	6.4	18.9	13.3	9.9	9.9	16.2	12.2	9.8	10.3	10.3	9.8	8.4	8.9
NTM	"CEPU-1, HNT, IGLON2, NTRI"	ENSG00000182667	Neurotrimin	Q9P121	11	131370478-132336822	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 66.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 37.7;U-138 MG: 15.0;U-2 OS: 26.0;WM-115: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	157	"plasmacytoid DC: 15.6"	"Lineage enriched"	"Detected in single"	157	"dendritic cells: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB024875	Enhanced				"Intracellular and membrane"		58000000			"CAB024875: "	"unprognostic (1.52e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.99e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (4.60e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.31e-3)"	14.0	5.0	22.5	2.7	22.5	0.9	3.5	39.0	63.0	2.4	4.7	31.2	0.0	3.0	2.0	1.4	9.0	1.7	9.1	15.9	23.4	13.7	1.6	1.1	22.6	1.2	29.3	20.8	0.9	1.7	7.5	0.6	1.4	29.6	1.6	4.2	8.7	3.3	3.4	1.5	5.9	4.1	4.6	66.2	1.3	1.8	1.4	29.1	0.0	1.5	0.3	1.2	3.8	1.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.3	7.1	0.0	11.1	5.9	3.6	2.1	0.0	0.0	0.0	0.0	6.1	0.1	0.0	13.3	3.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	11.8	14.1	2.3	0.0	0.1	37.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	6.4	0.0	0.7	1.2	0.0	0.0	0.0	0.0	0.0	2.4	15.0	26.0	0.7	9.4	0.0	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	22.5	22.5	39.0	25.8	23.4	13.7	29.3	20.8	29.6	29.1
NTRK2	TRKB	ENSG00000148053	"Neurotrophic receptor tyrosine kinase 2"	Q16620	9	84668551-85027070	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, Epilepsy, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;thyroid gland: 63.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.4;HaCaT: 3.7;RPTEC TERT1: 11.6;SH-SY5Y: 13.3"	"Group enriched"	"Detected in many"	5	"glioma: 31.6;head and neck cancer: 8.0;lung cancer: 9.8;thyroid cancer: 26.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007637, CAB010346"	Enhanced		Approved	Cytosol			13000000	Cytosol		"CAB010346: AB_2155274, HPA007637: AB_1080385"	"unprognostic (2.75e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.39e-3)"	19.8	2.7	66.1	2.0	56.7	1.2	33.2	15.1	133.8	6.4	4.4	27.4	0.0	1.4	3.0	3.3	5.6	3.7	18.7	5.8	61.0	30.7	12.5	2.1	6.3	2.7	32.4	41.4	6.6	18.9	1.6	3.0	2.1	34.1	3.8	3.1	2.0	8.6	11.9	2.0	7.2	1.6	3.0	22.1	6.5	1.4	2.4	34.1	0.0	63.4	2.6	3.4	3.5	3.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.6	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.6	0.8	0.9	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	66.1	56.7	15.1	45.6	61.0	30.7	32.4	41.4	34.1	34.1
NTRK3	TRKC	ENSG00000140538	"Neurotrophic receptor tyrosine kinase 3"	Q16288	15	87859751-88256768	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8"	"Cell line enriched"	"Detected in some"	8	"U-138 MG: 47.4"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009233, HPA027484, HPA048065"	Approved		Supported	"Nuclear membrane,Nucleoli"			11000000	Nucleoli	"Nuclear membrane"	"CAB009233: AB_632555, HPA027484: , HPA048065: "	"unprognostic (1.27e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.91e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.49e-3)"	20.8	7.4	22.0	2.5	28.1	1.5	6.2	30.4	41.8	7.0	4.0	8.4	1.3	2.0	12.4	6.7	3.4	9.5	3.9	5.5	22.0	11.1	5.1	2.0	5.7	3.1	11.2	18.7	5.1	2.9	1.6	7.9	2.8	14.7	6.8	4.7	8.0	11.5	8.7	1.9	2.9	2.5	7.7	13.7	4.1	3.0	13.8	13.7	0.0	2.5	0.7	4.3	7.1	4.8	0.7	0.4	1.3	0.5	0.5	0.8	0.0	0.0	5.9	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.9	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.1	1.2	0.5	0.4	0.3	0.1	0.2	0.4	0.3	0.3	0.1	0.7	0.4	0.4	1.3	0.5	0.1	0.4	0.8	0.0	22.0	28.1	30.4	28.9	22.0	11.1	11.2	18.7	14.7	13.7
NUAK1	"ARK5, KIAA0537, NuaK1"	ENSG00000074590	"NUAK family kinase 1"	O60285	12	106063340-106140033	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, DNA damage"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.3;parathyroid gland: 18.6"	"Cell line enhanced"	"Detected in many"		"AF22: 23.0;EFO-21: 23.0;Karpas-707: 16.8;RH-30: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.4;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057143			Approved	"Nucleoplasm,Nucleoli fibrillar center,Microtubules"				"Nucleoli fibrillar center"	"Nucleoplasm, Microtubules"	"HPA057143: "	"unprognostic (4.20e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.71e-2)"	"prognostic unfavourable (9.83e-4)"	"unprognostic (4.13e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.80e-2)"	"unprognostic (9.91e-2)"	"unprognostic (4.06e-3)"	"unprognostic (3.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.93e-3)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.47e-2)"	8.2	1.8	4.2	2.0	13.0	0.0	5.5	9.9	20.1	4.6	1.7	24.3	1.1	1.0	5.8	1.6	1.9	3.6	2.7	11.3	5.1	3.3	2.5	2.4	4.9	1.5	8.7	8.4	3.2	1.2	18.6	1.9	2.5	7.6	3.6	2.2	2.3	1.8	3.7	9.4	11.6	1.5	6.3	5.5	1.1	1.5	1.3	9.3	1.1	1.8	1.1	1.4	3.4	3.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	4.9	3.4	23.0	0.2	9.2	1.0	10.6	5.7	3.9	4.4	3.3	1.7	0.8	0.0	23.0	10.3	4.8	4.8	4.6	2.0	0.0	1.3	0.0	3.6	1.8	1.9	0.0	0.0	4.7	3.1	2.5	0.8	8.3	0.0	16.8	3.1	0.5	0.1	0.2	4.5	1.4	0.0	33.0	4.0	2.5	5.9	2.7	0.1	2.6	0.7	0.2	1.2	0.1	6.2	3.8	12.8	1.4	6.8	0.0	0.0	0.3	1.1	0.0	3.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.0	9.9	17.5	5.1	3.3	8.7	8.4	7.6	9.3
NUCB1	"Calnuc, NUC"	ENSG00000104805	"Nucleobindin 1"	Q02818	19	48900050-48923372	"Plasma proteins, Predicted secreted proteins"		"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008176	Supported		Supported	"Golgi apparatus,Microtubules"	"Secreted to blood"		15000000	"Golgi apparatus"	Microtubules	"HPA008176: AB_1845923"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.36e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (8.14e-3)"	"unprognostic (2.34e-3)"	"unprognostic (9.89e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.41e-1)"	49.5	32.2	18.1	30.5	20.2	19.3	50.1	17.9	36.0	31.0	42.5	24.8	32.5	51.6	36.7	46.8	33.1	30.7	47.2	58.8	16.8	20.3	56.7	144.7	42.6	48.4	20.5	25.2	40.0	37.4	42.7	21.3	46.9	29.1	36.6	15.3	31.0	37.8	29.7	46.7	26.0	51.8	36.7	20.7	32.4	33.4	19.0	15.9	17.1	48.0	29.0	23.2	36.4	58.2	19.1	42.3	39.2	47.7	24.4	40.2	40.1	10.1	32.9	15.8	34.0	57.4	44.4	18.2	39.3	34.7	19.1	26.9	16.5	36.8	9.8	29.9	47.8	24.1	9.0	19.2	8.1	35.7	16.4	25.5	23.4	21.3	27.8	15.4	33.9	52.2	8.5	18.2	12.1	29.3	31.0	52.3	18.6	12.1	7.4	9.6	7.8	17.1	13.9	23.7	20.6	14.1	24.2	11.3	23.4	45.9	28.4	15.6	14.5	20.3	44.1	32.4	22.1	20.0	18.5	39.5	90.7	6.7	24.9	9.7	37.9	31.6	39.6	37.6	40.2	47.7	30.4	19.1	27.3	30.5	29.9	15.5	22.9	22.7	39.2	24.4	40.7	42.3	27.0	40.1	18.1	20.2	17.9	36.0	16.8	20.3	20.5	25.2	29.1	15.9
NUCKS1	NUCKS	ENSG00000069275	"Nuclear casein kinase and cyclin dependent kinase substrate 1"	Q9H1E3	1	205712819-205750276	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062351, HPA063843"	Supported		Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA062351: , HPA063843: "	"unprognostic (1.68e-1)"	"unprognostic (3.92e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.93e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.82e-3)"	"unprognostic (7.45e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.57e-2)"	25.6	25.3	46.9	17.3	55.5	12.1	31.3	45.0	49.2	33.0	24.2	38.3	18.8	12.5	36.5	27.8	25.3	32.1	22.5	40.6	43.8	35.6	30.9	43.9	20.6	29.4	43.6	47.6	49.1	17.4	50.3	21.0	20.8	32.8	31.9	21.1	21.9	19.0	32.7	43.1	21.7	14.6	42.9	49.1	22.6	17.9	14.2	38.9	35.3	42.5	20.6	24.8	32.0	22.6	7.8	7.4	4.5	4.9	10.7	11.8	4.0	40.6	25.0	67.4	26.6	18.7	25.9	31.8	29.3	30.3	41.2	33.3	13.7	46.9	45.1	17.0	28.5	30.1	51.2	24.6	47.4	21.5	25.6	29.3	22.1	14.9	13.8	46.0	10.5	20.5	22.3	24.5	42.7	32.2	47.0	14.5	32.1	47.0	41.7	23.2	68.8	18.7	43.6	83.1	25.9	23.1	25.1	28.1	51.9	43.3	34.7	23.5	53.0	34.8	32.1	31.7	28.2	36.1	51.8	13.3	15.7	36.4	21.7	26.0	42.6	4.5	3.4	3.7	9.9	4.9	9.6	5.8	9.2	8.6	4.7	7.8	11.5	11.8	0.6	10.7	4.0	7.4	5.5	4.0	46.9	55.5	45.0	36.6	43.8	35.6	43.6	47.6	32.8	38.9
NUDT5	"hYSAH1, YSA1H"	ENSG00000165609	"Nudix hydrolase 5"	Q9UKK9	10	12165325-12196144	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019827	Approved		Approved	Nucleoplasm,Vesicles,Centrosome			660000	Vesicles	"Nucleoplasm, Centrosome"	"HPA019827: AB_1854704"	"unprognostic (2.08e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.97e-2)"	"prognostic unfavourable (7.14e-12)"	"unprognostic (1.61e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (3.68e-2)"	19.6	22.0	17.4	18.6	21.2	13.5	20.2	15.4	21.4	16.7	20.4	16.1	15.2	17.3	10.0	16.5	25.8	16.3	12.1	10.0	16.2	14.3	26.0	57.1	16.8	22.7	21.7	12.8	12.5	16.9	19.1	35.7	19.9	18.5	13.4	24.2	13.2	16.7	19.7	5.1	20.6	15.9	11.6	17.9	22.4	14.1	8.0	21.5	28.2	19.1	16.5	29.5	16.2	18.6	22.4	45.9	50.1	19.5	16.2	37.0	20.4	37.3	27.6	33.0	30.7	32.0	31.6	29.3	27.7	17.7	32.7	35.1	39.6	35.7	37.4	24.1	22.4	37.6	46.0	42.9	30.0	30.6	45.0	31.1	33.9	58.1	33.4	20.6	21.9	33.2	25.6	35.6	18.2	41.6	41.6	25.6	29.7	34.3	38.6	24.2	28.7	17.2	35.3	12.0	43.4	30.5	12.9	15.9	23.9	33.6	25.9	38.5	44.4	21.3	26.0	13.9	26.7	38.8	33.8	21.6	37.9	50.3	29.3	26.9	10.3	8.1	19.1	33.5	22.8	19.5	26.2	22.4	24.6	26.8	27.0	18.3	17.0	23.0	50.1	16.2	14.8	45.9	37.0	20.4	17.4	21.2	15.4	21.4	16.2	14.3	21.7	12.8	18.5	21.5
NUF2	"CDCA1, CT106, NUF2R"	ENSG00000143228	"NUF2, NDC80 kinetochore complex component"	Q9BZD4	1	163266576-163355764	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 38.6;testis: 29.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059692, HPA076604"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA059692: , HPA076604: "	"unprognostic (9.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.32e-3)"	"unprognostic (6.20e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (1.04e-5)"	"prognostic unfavourable (9.16e-4)"	"prognostic unfavourable (4.83e-4)"	"unprognostic (8.45e-2)"	"prognostic unfavourable (9.75e-4)"	"unprognostic (3.70e-2)"	"unprognostic (0.00e+0)"	"unprognostic (9.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.96e-2)"	1.3	0.9	0.8	9.8	0.9	14.1	0.6	0.5	0.9	1.4	2.5	0.6	0.9	2.3	0.6	2.1	6.1	0.5	0.7	1.5	0.8	0.6	0.7	0.6	1.9	9.9	0.8	0.6	0.7	0.4	0.3	0.4	3.6	0.7	0.6	2.9	0.8	1.3	0.0	0.5	2.2	3.2	1.0	1.4	4.4	1.6	29.0	0.3	38.6	0.5	5.1	9.2	1.5	1.8	1.4	0.6	2.6	0.2	3.0	7.7	1.0	25.9	9.0	24.1	10.1	0.7	2.5	13.1	16.4	11.6	26.8	23.5	6.9	23.0	22.4	13.7	6.6	15.2	14.7	6.2	33.9	23.3	10.5	8.7	10.4	9.9	0.0	15.1	18.1	0.3	0.6	13.5	9.6	12.1	16.4	31.0	25.3	5.0	27.5	20.2	13.1	14.0	18.7	21.1	19.8	7.5	3.6	18.0	20.8	8.8	9.6	9.1	14.7	31.6	8.5	20.0	22.5	15.0	33.1	22.3	31.3	42.6	6.6	12.4	22.1	2.6	0.2	2.5	2.4	0.1	1.0	1.2	3.6	2.4	0.5	1.4	2.5	2.1	0.9	3.0	0.2	0.6	7.7	1.0	0.8	0.9	0.5	0.9	0.8	0.6	0.8	0.6	0.7	0.3
NUMA1		ENSG00000137497	"Nuclear mitotic apparatus protein 1"	Q14980	11	72002864-72080693	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019841, HPA019859, HPA029912"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA019841: AB_1854708, HPA019859: AB_1854709, HPA029912: AB_10602811"	"unprognostic (1.60e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.91e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"prognostic favourable (7.92e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.39e-1)"	29.7	33.5	23.6	20.6	28.1	26.8	33.1	38.4	31.8	51.9	37.7	55.6	40.1	25.5	58.3	30.9	34.1	37.8	31.2	21.2	21.6	19.4	23.0	13.1	28.3	23.3	37.6	24.8	51.4	30.0	70.7	29.5	26.0	28.3	50.3	24.2	41.2	35.3	40.1	43.7	41.9	30.2	45.3	29.5	23.0	31.2	25.9	39.5	39.4	32.6	22.5	31.8	50.5	37.2	10.3	12.9	4.9	5.7	7.0	9.7	6.6	18.5	23.6	29.6	19.9	26.3	27.5	15.1	25.1	29.1	26.2	22.9	24.5	34.4	25.3	22.0	30.7	39.9	27.0	25.4	24.0	26.0	12.7	31.0	37.1	18.6	21.2	23.4	22.6	29.0	16.8	25.6	25.9	22.1	18.2	30.6	17.8	35.8	30.2	13.1	18.4	17.0	37.1	51.6	19.5	19.6	29.1	35.8	50.8	40.0	37.1	37.3	49.9	13.7	30.4	27.8	21.7	39.2	16.6	19.8	19.6	35.6	18.6	11.1	15.8	4.9	5.6	2.5	9.7	3.5	7.4	5.2	6.0	7.5	4.9	10.3	7.5	5.2	4.6	7.0	5.7	12.9	7.2	6.6	23.6	28.1	38.4	31.8	21.6	19.4	37.6	24.8	28.3	39.5
NUMBL	"CAG3A, CTG3a, NUMB-R, NUMBLIKE, NUMBR, TNRC23"	ENSG00000105245	"NUMB like, endocytic adaptor protein"	Q9Y6R0	19	40665905-40690972	"Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 4.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058251, HPA058380"	Approved									"HPA058251: , HPA058380: "	"unprognostic (2.78e-2)"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.49e-4)"	"unprognostic (1.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.22e-1)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavourable (7.55e-15)"	"unprognostic (1.91e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.27e-2)"	"unprognostic (1.69e-3)"	21.4	11.9	18.0	9.1	25.2	3.4	10.7	17.3	44.3	19.5	11.0	4.3	4.9	9.7	20.9	7.8	8.6	16.3	13.3	9.0	12.9	11.5	4.2	4.6	8.2	4.4	6.6	21.8	18.0	7.9	4.7	26.2	6.8	10.0	14.1	4.9	8.8	11.8	17.7	6.0	10.7	10.3	14.8	6.8	7.8	10.3	11.3	4.5	1.0	10.0	6.6	3.8	19.0	13.8	1.0	0.9	0.9	2.3	0.3	4.0	0.7	8.6	24.1	5.1	13.5	12.3	12.2	2.8	10.5	9.2	6.2	7.5	9.0	6.5	3.2	10.5	15.2	8.5	3.7	4.5	3.3	8.5	6.2	3.4	23.6	1.2	13.1	1.7	4.1	11.6	3.1	10.2	4.3	8.8	10.0	3.7	4.3	7.9	5.4	1.6	6.0	5.6	4.6	14.1	6.4	1.8	2.4	10.2	18.2	11.5	6.8	10.2	6.9	2.9	16.5	11.3	13.1	17.9	13.0	4.9	5.8	1.9	18.3	5.5	6.4	0.1	0.4	0.1	4.0	0.3	0.3	0.4	0.6	1.2	0.0	1.0	0.4	1.7	0.9	0.3	2.3	0.9	0.1	0.7	18.0	25.2	17.3	44.3	12.9	11.5	6.6	21.8	10.0	4.5
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA059767: "	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.2	11.5	18.0	9.3	13.0	14.0	35.1	11.8	12.1	17.6	16.0	13.6	14.1	20.7	10.3	11.7	18.9	24.9	12.5	19.0	12.5	30.9	12.5	11.9	10.2	10.4	25.3	10.2	10.9	9.5	12.6	15.2	14.7	28.1	10.0	13.8	6.4	18.7	10.8	27.0	10.5	18.3	18.7	20.4	10.0	12.6	15.5	19.3	17.6	11.1	12.9	17.2	20.1	12.8	8.0	9.8	13.9	17.5	9.6	11.9	22.3	9.2	14.7	16.6	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.6	10.8	11.8	17.4	3.7	5.5	42.5	11.1	5.9	15.2	11.2	15.9	11.2	15.5	5.1	7.1	11.1	19.9	10.9	23.9	10.2	11.2	12.0	39.6	7.4	4.7	20.0	8.5	4.0	4.6	23.4	11.9	8.0	21.8	8.3	10.1	6.7	10.7	5.4	11.2	9.9	12.9	37.3	12.3	3.5	13.1	14.3	9.8	25.5	11.0	6.4	13.5	8.0	6.9	18.3	15.4	13.8	16.8	9.4	15.7	20.8	8.5	18.1	13.8	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557919-135648757	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	13.7	12.6	11.4	14.2	11.9	10.8	13.1	23.3	10.5	12.5	11.9	13.4	11.4	9.0	17.6	9.7	19.3	16.1	7.4	9.5	8.6	6.1	10.3	8.3	12.2	16.1	11.7	6.9	17.4	10.3	23.0	20.9	13.1	10.6	10.6	14.7	14.6	18.4	11.3	16.6	15.1	13.8	14.7	10.8	16.7	12.7	17.4	11.4	31.6	12.4	13.4	22.1	15.6	14.4	4.9	5.7	2.2	6.1	5.3	6.0	2.7	21.8	17.8	24.0	23.4	5.7	9.5	15.7	13.9	10.7	21.6	24.2	18.4	15.9	28.0	11.0	8.3	17.0	30.1	15.5	28.0	13.8	21.5	16.2	18.4	8.3	4.3	31.6	12.8	5.1	7.1	21.2	14.2	16.1	37.6	13.4	16.3	14.9	34.1	9.6	36.8	15.8	25.6	22.3	22.1	6.6	17.6	24.0	24.5	22.9	18.8	11.2	10.8	12.1	13.0	17.8	8.9	21.6	26.4	9.9	18.5	38.0	18.1	24.9	23.9	2.2	2.5	0.8	4.9	6.1	6.0	4.9	6.0	5.2	5.7	4.3	5.1	5.6	1.1	5.3	3.3	3.8	5.6	2.7	11.4	11.9	23.3	10.5	8.6	6.1	11.7	6.9	10.6	11.4
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell line enhanced"	"Detected in all"		"K-562: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"			100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: "	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.7	9.6	8.2	4.9	6.6	6.4	8.6	6.0	6.2	7.8	6.3	7.8	4.9	10.9	4.8	8.2	15.4	11.0	7.8	7.6	7.9	5.4	6.8	13.7	15.2	5.8	10.6	7.3	7.0	7.2	10.0	8.1	8.0	71.4	6.3	8.0	12.5	13.9	16.0	8.9	8.5	4.8	10.3	10.9	9.0	6.2	7.0	7.2	10.0	9.2	5.2	12.1	26.4	6.8	13.8	7.8	9.0	9.6	5.5	10.7	10.5	6.7	6.4	8.3	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163841-45188015	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	9.0	12.0	8.0	12.3	9.3	26.4	12.8	11.3	11.4	8.7	13.2	6.6	15.8	9.0	9.1	11.0	18.1	10.4	8.0	5.3	7.4	8.6	10.8	13.6	10.4	17.6	7.1	8.4	9.9	11.7	8.2	16.1	12.9	16.8	11.9	9.6	8.2	11.3	15.0	6.5	10.8	18.1	6.2	6.3	19.3	13.4	20.0	7.5	41.3	12.2	5.5	19.5	10.7	15.3	8.2	10.3	37.6	16.2	11.8	12.5	12.3	24.0	11.5	22.2	14.4	10.4	10.9	23.6	20.2	13.5	15.6	15.9	24.9	10.7	26.4	9.5	13.2	17.0	27.2	16.4	22.6	14.1	28.8	23.1	18.1	15.2	10.8	61.0	24.6	13.1	11.4	20.0	15.2	17.2	23.9	27.8	16.0	16.1	27.6	15.8	16.5	11.9	29.4	13.4	18.5	12.1	23.4	13.8	13.4	20.0	12.5	23.7	7.7	16.2	15.6	33.2	29.9	17.0	16.9	19.5	15.7	38.8	12.5	15.8	23.0	19.7	15.7	31.0	8.8	16.2	12.0	8.2	10.6	10.0	10.3	7.4	12.5	8.5	37.6	11.8	9.2	5.7	10.1	12.3	8.0	9.3	11.3	11.4	7.4	8.6	7.1	8.4	16.8	7.5
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148515	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035929: AB_10671236, HPA058122: "	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favourable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavourable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	23.7	14.5	13.5	18.2	15.2	28.4	25.7	26.0	17.2	23.1	20.0	14.6	17.9	15.3	22.9	18.2	21.4	22.5	15.1	17.0	12.2	10.8	16.4	20.3	17.8	22.8	20.5	13.1	25.3	19.3	13.3	16.8	22.8	14.9	19.8	19.7	12.2	20.0	24.1	17.8	21.2	18.4	24.7	14.7	23.6	19.2	19.6	20.0	36.1	19.8	18.1	22.1	24.1	21.8	10.0	11.4	7.7	10.0	21.6	16.5	7.5	16.8	6.6	21.4	15.4	18.3	17.5	18.9	17.1	24.7	25.4	26.1	15.7	24.2	25.6	14.4	17.0	11.4	23.0	19.1	31.8	16.8	13.4	15.5	8.4	14.9	17.3	29.9	18.7	16.0	13.8	20.1	21.3	21.7	26.4	16.1	18.3	14.7	31.4	14.0	34.3	6.0	24.7	33.8	9.8	15.0	16.2	13.0	10.8	15.8	18.8	13.7	8.0	18.4	14.5	20.4	18.2	24.3	20.8	10.5	3.8	24.4	14.6	17.6	17.9	6.5	7.5	7.7	12.2	9.0	16.5	9.0	12.9	11.7	11.4	10.0	13.8	13.0	3.5	21.6	10.0	8.4	12.5	7.5	13.5	15.2	26.0	17.2	12.2	10.8	20.5	13.1	14.9	20.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5420160	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	10.8	12.4	8.1	17.2	8.8	13.2	14.1	15.0	9.2	9.0	12.5	6.6	8.1	7.4	10.1	12.2	13.1	10.5	7.7	15.3	8.0	5.6	11.3	25.7	9.1	17.8	6.9	6.9	9.9	11.1	11.9	12.4	10.0	7.5	9.6	14.3	6.9	11.7	12.5	33.4	11.8	12.4	10.2	7.7	20.0	11.4	34.4	8.4	28.9	15.8	10.3	23.1	10.9	10.5	24.2	7.4	3.5	8.6	12.2	10.5	7.4	20.2	22.4	18.0	15.2	8.6	8.8	19.5	15.5	13.9	28.6	26.2	19.2	8.6	36.9	6.3	15.1	20.5	31.0	18.3	31.8	10.2	21.3	16.1	20.0	13.9	12.2	13.2	17.0	6.6	13.3	21.2	32.6	19.5	18.3	9.7	19.9	9.8	20.1	9.0	19.0	11.2	19.8	20.4	17.6	13.2	9.4	7.8	15.2	19.0	9.2	11.6	10.3	15.3	11.9	12.1	13.8	12.7	28.2	6.3	8.2	18.3	14.4	14.8	18.8	3.5	4.9	2.2	8.2	7.3	8.1	24.2	9.1	9.8	6.9	23.2	9.5	10.1	0.5	12.2	8.6	7.4	10.5	7.4	8.1	8.8	15.0	9.2	8.0	5.6	6.9	6.9	7.5	8.4
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730105-56850286	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain									"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	14.2	12.2	14.8	15.6	29.7	33.7	12.6	16.8	29.1	12.7	12.4	14.4	4.4	7.2	15.0	9.8	16.8	12.0	8.6	11.5	26.1	11.2	9.9	6.9	12.6	19.1	13.1	16.7	13.4	9.8	16.5	9.6	14.1	23.8	13.9	14.5	23.0	10.4	10.2	15.5	16.3	11.2	14.5	20.7	17.8	11.1	29.3	13.9	28.0	27.4	10.4	22.5	11.5	13.2	12.0	16.9	54.1	21.3	15.1	14.6	11.9	19.1	23.8	21.6	23.5	8.3	9.1	23.9	16.8	13.7	41.8	28.7	32.7	19.2	30.1	16.9	15.8	34.4	40.9	23.9	41.3	9.2	22.3	20.1	17.2	26.7	10.2	26.6	24.1	9.1	10.5	28.3	17.9	24.0	24.3	6.0	20.6	13.7	35.7	22.9	27.4	26.7	43.4	36.4	30.4	16.2	12.8	19.1	12.6	43.8	15.4	13.8	11.7	16.6	16.0	19.9	22.3	16.6	19.0	10.4	14.2	50.2	14.0	25.2	19.4	5.1	14.3	54.1	11.9	21.3	14.6	12.0	9.1	12.9	16.9	11.6	9.5	13.2	3.6	15.1	20.9	8.8	11.0	11.9	14.8	29.7	16.8	29.1	26.1	11.2	13.1	16.7	23.8	13.9
NUP98	NUP96	ENSG00000110713	"Nucleoporin 98"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074810			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA074810: "	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	20.2	13.5	8.7	23.5	11.7	40.8	23.5	14.2	13.2	18.0	15.3	14.6	17.8	11.2	19.2	17.5	18.6	17.3	17.1	18.2	7.8	8.0	12.8	20.1	20.7	17.4	11.4	8.7	25.5	19.0	25.7	23.6	20.7	12.7	18.6	15.2	17.8	17.4	25.0	35.2	18.5	15.7	20.8	10.4	18.3	16.0	57.0	10.6	27.5	20.9	15.0	26.6	22.6	19.3	8.9	9.9	24.9	10.0	6.1	13.2	8.7	29.8	23.4	19.3	21.3	21.4	17.6	17.0	21.3	24.9	29.3	26.4	25.7	37.1	29.2	10.1	25.5	32.2	33.9	21.0	40.0	20.7	24.5	31.3	19.2	17.6	18.0	39.9	26.4	20.0	14.5	16.1	29.4	22.7	38.9	23.5	31.1	12.2	40.1	13.0	24.4	18.0	24.5	23.5	14.0	16.7	23.6	17.8	11.9	30.9	25.1	14.2	15.4	15.7	16.6	23.5	20.4	25.6	19.4	14.2	24.2	31.0	15.9	17.2	24.7	19.1	7.9	15.5	11.0	10.0	11.0	8.9	10.7	9.7	9.9	7.8	12.2	10.5	24.9	6.1	6.3	2.7	13.2	8.7	8.7	11.7	14.2	13.2	7.8	8.0	11.4	8.7	12.7	10.6
NUTF2	"NTF2, PP15"	ENSG00000102898	"Nuclear transport factor 2"	P61970	16	67846732-67872567	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040915, HPA040956"	Supported		Approved	Microtubules			3000000	Microtubules		"HPA040915: AB_10794073, HPA040956: AB_10796233"	"unprognostic (1.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.56e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.17e-3)"	"unprognostic (9.80e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.45e-1)"	30.9	28.7	52.8	27.4	42.4	27.9	46.7	19.5	39.4	23.3	29.5	28.3	18.8	21.6	32.6	41.0	28.5	37.5	22.4	49.4	45.6	44.7	30.1	48.3	25.2	38.6	48.0	31.3	31.8	53.9	21.3	23.4	61.6	30.8	25.9	35.0	21.4	23.5	27.5	58.3	27.4	25.6	45.9	42.7	29.9	23.8	34.6	27.0	41.7	24.1	33.0	40.1	29.9	25.8	22.8	33.0	13.4	38.0	27.0	29.9	34.8	29.0	35.0	38.0	43.1	19.4	19.8	51.4	23.8	20.7	33.9	27.8	44.2	30.8	33.5	22.2	32.1	26.3	47.3	35.3	37.1	12.9	45.3	22.5	16.3	70.1	25.9	31.4	17.1	25.8	23.2	31.4	39.5	35.4	31.8	12.0	35.1	59.2	49.5	60.8	64.6	23.9	44.6	24.7	50.1	44.0	25.7	34.8	33.6	53.5	22.3	17.3	32.7	27.0	29.4	29.1	34.8	21.3	28.2	19.6	24.9	72.4	19.1	22.3	29.9	13.4	25.9	10.5	26.2	38.0	29.9	22.8	28.5	25.9	33.0	22.7	22.0	24.6	7.3	27.0	33.6	31.4	28.7	34.8	52.8	42.4	19.5	39.4	45.6	44.7	48.0	31.3	30.8	27.0
OAF	MGC52117	ENSG00000184232	"Out at first homolog"	Q86UD1	11	120210767-120230332	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 34.3;Hep G2: 53.7;NB-4: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.2;intermediate monocyte: 2.9;myeloid DC: 4.6"	"Group enriched"	"Detected in many"	12	"dendritic cells: 4.6;monocytes: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047412	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"		65000000	Nucleoplasm		"HPA047412: AB_10960631"	"unprognostic (1.59e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (5.71e-5)"	"unprognostic (2.11e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.09e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.95e-1)"	16.2	22.5	8.6	6.9	15.4	3.5	24.9	1.2	10.3	18.7	16.8	4.0	8.0	19.4	14.3	17.2	10.7	13.4	20.6	13.7	8.7	1.4	21.5	93.4	5.6	8.1	5.4	6.4	26.2	43.7	2.4	7.4	4.6	3.2	10.3	13.5	18.2	26.5	5.8	3.7	3.0	22.1	11.7	3.3	15.3	9.9	5.5	5.5	1.2	6.8	8.6	3.6	11.2	10.9	0.1	4.6	0.3	6.2	0.0	0.4	1.3	6.9	2.1	8.2	4.1	12.9	14.5	0.4	13.5	14.0	5.5	8.0	2.1	10.8	0.0	34.3	9.1	7.3	2.3	3.4	2.1	5.0	5.6	5.7	1.3	53.7	11.5	12.6	2.3	18.0	2.1	5.2	14.6	15.7	3.7	6.5	1.3	2.5	0.0	36.0	3.3	11.0	3.2	0.2	6.7	8.2	3.8	0.4	2.9	3.9	4.4	11.2	1.4	20.9	9.5	11.8	4.4	12.0	1.3	0.2	0.1	0.1	9.1	21.0	4.0	0.0	6.2	0.0	0.2	2.9	0.1	0.1	0.0	0.0	4.6	0.0	0.1	0.4	0.3	0.0	0.6	0.9	0.3	1.3	8.6	15.4	1.2	10.3	8.7	1.4	5.4	6.4	3.2	5.5
OAS2		ENSG00000111335	"2'-5'-oligoadenylate synthetase 2"	P29728	12	112978395-113011723	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	"Nucleotidyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 70.9;BJ hTERT+ SV40 Large T+ RasG12V: 57.8;SK-MEL-30: 27.7;U-266/70: 25.8;U-266/84: 22.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA003320, CAB024984"	Approved		Approved	Centrosome				Centrosome		"CAB024984: , HPA003320: "	"unprognostic (2.39e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.64e-3)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (4.31e-6)"	"unprognostic (1.12e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.94e-2)"	37.9	3.8	4.0	13.9	5.1	9.0	7.2	1.8	4.9	8.5	4.3	7.5	1.2	4.6	9.0	6.9	13.2	3.9	9.6	6.9	3.8	4.4	8.8	9.9	15.6	24.1	5.0	3.7	3.9	1.9	1.2	2.9	22.2	7.3	6.6	4.7	6.9	32.9	1.8	2.2	2.9	8.8	6.4	7.1	36.6	9.7	2.2	3.0	32.4	9.8	8.2	27.4	13.7	5.4	12.0	12.7	2.0	26.8	15.1	17.4	13.2	0.7	0.1	0.0	0.0	0.3	2.6	0.0	0.1	8.0	70.9	57.8	0.1	1.2	17.8	1.7	1.5	0.8	0.1	0.2	2.5	4.4	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	1.3	4.0	0.0	1.1	0.0	9.3	0.0	0.3	0.5	1.0	0.0	2.5	3.8	0.0	2.7	0.0	6.3	0.0	0.0	0.7	0.2	27.7	0.6	1.1	1.8	0.1	0.0	0.3	0.0	25.8	22.2	2.8	0.6	0.9	0.6	2.0	15.9	1.2	13.4	26.8	16.8	12.0	15.4	15.2	12.7	8.9	15.2	11.2	1.8	15.1	26.0	5.3	17.4	13.2	4.0	5.1	1.8	4.9	3.8	4.4	5.0	3.7	7.3	3.0
OAZ1	"AZI, MGC138338, OAZ"	ENSG00000104904	"Ornithine decarboxylase antizyme 1"	P54368	19	2269509-2273490	"Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009291	Uncertain		Approved	"Vesicles,Centriolar satellite"				Vesicles	"Centriolar satellite"	"HPA009291: AB_1079519"	"unprognostic (2.37e-1)"	"unprognostic (9.69e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (3.75e-2)"	"unprognostic (3.19e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (4.10e-5)"	"unprognostic (3.58e-2)"	"unprognostic (2.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.01e-2)"	50.7	56.5	73.3	47.5	68.2	84.6	67.4	41.5	68.6	27.2	37.8	22.9	31.1	47.8	32.7	33.7	38.6	40.1	34.0	73.7	67.2	53.3	31.8	45.7	50.3	71.4	60.4	52.3	31.2	86.0	11.9	34.6	53.5	39.9	32.1	24.0	27.1	65.6	33.7	137.4	30.4	55.3	37.3	37.0	66.0	41.4	25.0	29.4	31.8	43.8	59.3	40.1	37.2	45.3	69.7	83.1	150.4	136.3	24.4	54.4	160.8	72.9	15.2	11.7	20.0	24.6	39.4	30.5	52.2	36.3	26.4	36.3	21.6	23.7	49.9	28.2	24.2	21.3	11.5	15.7	17.5	66.3	39.8	38.5	15.1	34.0	25.2	53.7	61.0	26.2	27.5	9.9	15.1	29.9	37.3	58.0	29.7	26.7	44.5	56.1	38.5	27.7	37.0	23.4	65.8	24.0	21.2	27.7	29.4	34.3	31.3	57.3	26.1	114.2	38.0	18.8	23.2	80.9	54.7	56.6	23.3	60.9	85.6	84.4	28.4	109.3	116.3	134.1	36.1	117.5	36.0	69.7	39.5	38.3	83.1	66.6	36.9	36.4	150.4	24.4	136.3	56.0	54.4	160.8	73.3	68.2	41.5	68.6	67.2	53.3	60.4	52.3	39.9	29.4
OBSCN	"ARHGEF30, KIAA1556, KIAA1639, UNC89"	ENSG00000154358	"Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF"	Q5VST9	1	228208130-228378874	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Differentiation	"Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 180.2;tongue: 48.4"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA021186, HPA065801"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021186: AB_1854761, HPA065801: "	"unprognostic (8.47e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.99e-2)"	"prognostic unfavourable (1.64e-4)"	"unprognostic (5.30e-3)"	"unprognostic (6.36e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-2)"	2.5	0.9	0.5	0.9	4.4	0.6	0.7	3.1	0.6	0.6	0.8	0.5	0.5	0.6	0.8	4.4	2.4	1.0	0.6	21.2	0.5	0.7	1.6	0.5	1.0	1.0	0.5	0.5	1.7	1.4	0.4	2.4	0.5	0.9	1.7	0.3	5.2	2.6	1.1	180.2	1.1	0.8	0.5	0.6	1.4	0.5	0.7	0.6	0.5	2.2	48.4	3.5	0.6	0.7	1.0	1.1	0.1	0.4	0.6	3.2	0.7	2.9	2.8	8.0	4.5	0.2	0.1	5.6	1.5	0.5	1.0	0.9	2.0	2.1	5.7	8.1	0.5	1.0	0.4	1.1	0.2	2.1	5.1	1.9	16.0	0.0	2.0	1.3	6.1	3.0	1.0	0.4	0.2	0.4	5.3	1.3	0.3	5.0	2.0	1.6	8.8	1.7	8.1	0.1	1.3	4.6	1.5	3.0	9.0	0.2	2.9	1.1	8.0	3.7	0.7	0.0	9.3	0.2	0.1	4.7	0.9	1.4	0.0	0.8	2.1	0.1	0.4	0.0	0.9	0.1	0.9	0.5	0.9	0.7	0.9	1.0	3.2	0.5	0.1	0.6	0.1	1.1	0.8	0.7	0.5	4.4	3.1	0.6	0.5	0.7	0.5	0.5	0.9	0.6
ODC1	ODC	ENSG00000115758	"Ornithine decarboxylase 1"	P11926	2	10439968-10448504	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Polyamine biosynthesis"	"Decarboxylase, Lyase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001536, CAB035996"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"CAB035996: , HPA001536: AB_1079521"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.25e-3)"	"unprognostic (5.21e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.07e-5)"	"unprognostic (3.06e-2)"	"unprognostic (4.18e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.86e-2)"	13.2	8.2	11.6	33.5	11.1	41.8	9.1	7.2	11.8	11.7	17.4	11.5	33.8	8.6	22.9	21.6	16.5	16.5	30.0	33.8	9.7	10.6	31.5	48.7	14.2	42.3	11.3	6.5	29.2	48.7	13.4	35.4	6.9	11.2	26.3	20.7	18.2	11.0	27.2	64.2	9.6	14.9	26.2	10.2	20.4	19.2	54.6	6.3	31.0	16.4	19.8	39.6	16.1	14.6	13.4	10.8	2.4	2.4	1.2	4.4	3.0	18.6	15.0	20.9	24.7	3.7	11.2	48.5	27.0	13.4	25.6	11.9	79.7	8.7	98.9	13.6	16.5	3.4	63.9	30.7	31.2	37.6	26.7	45.1	25.8	48.6	30.4	76.2	10.8	7.5	8.3	57.9	72.7	20.5	75.0	32.2	14.2	12.3	75.4	30.0	38.1	49.0	53.8	65.7	66.6	15.5	13.7	29.2	24.9	33.9	10.4	13.7	7.0	34.2	14.3	20.8	42.9	26.8	58.0	15.0	45.4	89.9	18.7	50.5	12.8	0.0	1.3	2.4	2.7	2.4	3.2	13.4	3.8	4.4	3.0	11.0	2.7	4.3	0.5	1.2	1.5	10.8	3.8	3.0	11.6	11.1	7.2	11.8	9.7	10.6	11.3	6.5	11.2	6.3
OFD1	"71-7A, CXorf5, JBTS10, RP23"	ENSG00000046651	"OFD1, centriole and centriolar satellite protein"	O75665	X	13734745-13769353	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation, Joubert syndrome, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 31.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031102, HPA031103, HPA031104"	Approved		Supported	Microtubules				Microtubules		"HPA031102: AB_10670836, HPA031103: AB_10602188, HPA031104: AB_10669655"	"unprognostic (3.10e-3)"	"prognostic favourable (9.62e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.42e-3)"	"unprognostic (2.20e-3)"	"unprognostic (3.03e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (3.32e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.04e-2)"	"prognostic favourable (2.76e-7)"	7.8	8.0	10.1	20.1	12.3	16.6	18.0	18.7	10.9	19.3	15.0	13.3	16.6	12.5	18.9	15.6	13.5	13.0	15.2	8.3	12.5	9.0	14.9	8.7	11.9	21.2	13.6	8.5	16.1	15.1	27.8	27.2	10.3	12.6	14.9	10.3	9.2	18.4	15.8	7.1	14.2	22.0	9.7	14.6	18.4	14.6	11.7	16.1	16.5	17.7	9.3	19.7	15.0	13.6	8.0	31.5	2.9	1.4	6.7	7.4	2.1	10.0	4.6	6.7	11.9	5.6	8.8	5.0	3.2	7.3	3.7	4.8	8.1	11.4	14.7	8.3	3.7	9.9	4.8	8.7	6.1	7.2	12.2	6.8	13.6	6.8	4.2	9.0	12.5	7.0	6.0	8.5	8.4	4.1	10.2	13.3	4.2	7.9	6.2	10.8	7.0	6.6	15.6	7.8	29.1	5.8	8.6	6.9	11.0	14.9	12.1	7.4	11.4	8.2	3.7	6.7	3.5	7.9	4.0	9.9	9.3	17.2	5.5	4.0	5.4	2.0	0.8	2.9	6.1	1.0	7.1	6.6	5.4	7.4	1.8	8.0	4.5	6.6	2.4	6.7	1.4	31.5	4.1	2.1	10.1	12.3	18.7	10.9	12.5	9.0	13.6	8.5	12.6	16.1
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria			53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favourable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.4	17.0	16.6	19.4	16.9	20.8	22.5	47.8	20.2	24.7	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.2	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	26.2	16.7	14.3	20.4	15.3	17.7	10.3	12.6	25.8	17.0	9.6	53.7	22.2	32.4	23.4	11.2	24.6	34.1	10.6	20.2	18.0	20.6	14.0	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.7	10.9	6.8	10.7	12.3	20.1	7.5	7.7	11.5	13.8	10.3	5.7	35.0	5.0	9.5	5.6	6.4	8.2	4.9	12.4	9.2	17.4	17.3	14.7	11.3	6.7	11.2	12.2	10.5	19.9	8.5	14.2	5.5	5.7	10.9	10.7	5.4	6.7	5.7	15.4	4.0	7.3	11.4	6.4	2.9	4.9	8.6	9.6	7.8	5.8	12.4	11.5	9.2	11.7	12.4	9.1	12.2	5.7	8.1	18.0	9.4	19.5	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383967-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 68.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 18.2;HSkMC: 8.1;MOLT-4: 23.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"T-reg: 5.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"		190000000	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavourable (2.03e-4)"	35.6	3.9	0.7	7.1	1.3	0.0	14.7	2.0	2.2	47.8	15.2	0.7	11.7	1.5	25.2	19.8	11.7	12.9	47.5	27.6	0.9	0.7	1.9	1.0	7.8	1.3	2.8	1.6	26.1	1.9	68.7	7.1	9.7	2.9	27.7	5.7	10.7	2.9	4.9	2.4	1.6	5.9	31.1	6.0	0.8	9.4	10.7	0.8	1.3	5.9	7.0	1.5	32.0	10.0	0.6	0.3	0.0	0.0	0.4	5.1	0.2	0.0	0.0	0.0	0.0	3.9	18.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.5	0.3	0.6	0.1	0.1	0.0	0.4	0.0	0.1	5.1	0.2	0.7	1.3	2.0	2.2	0.9	0.7	2.8	1.6	2.9	0.8
OIT3	"FLJ39116, LZP"	ENSG00000138315	"Oncoprotein induced transcript 3"	Q8WWZ8	10	72893581-72933033	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 49.1"	"Group enriched"	"Detected in some"	6	"CACO-2: 5.6;Hep G2: 5.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"		150000000				"unprognostic (2.42e-2)"	"unprognostic (6.76e-2)"	"unprognostic (7.98e-4)"	"unprognostic (9.26e-2)"	"unprognostic (9.47e-4)"	"unprognostic (3.05e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.50e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.68e-3)"	"unprognostic (1.19e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.1	0.3	0.0	0.1	2.0	0.1	0.0	0.6	49.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.5	0.1	0.1	6.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	5.6	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.3	5.9	0.2	0.2	0.1	0.4	0.2	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.3	0.1
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248698	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol			3600000	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavourable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	28.5	23.1	39.3	18.0	40.6	23.0	29.1	39.4	52.4	18.5	23.5	14.7	12.2	24.9	17.9	20.6	29.9	19.8	20.0	27.9	35.4	34.3	28.4	33.3	14.7	26.1	28.8	27.9	17.1	31.1	19.7	23.8	20.7	45.3	21.5	27.3	15.1	18.9	18.2	50.1	25.9	24.0	18.8	27.0	18.7	19.2	23.1	16.5	36.1	31.9	27.2	25.6	21.9	18.4	12.7	24.5	9.6	16.3	16.7	16.6	13.9	39.9	19.0	31.2	51.8	16.6	36.5	56.2	32.3	32.7	45.2	34.5	44.9	23.8	55.1	32.4	25.8	31.9	37.8	37.3	53.4	25.0	32.2	51.4	18.4	46.5	32.1	58.0	21.0	32.0	46.7	47.8	51.0	39.8	55.9	18.9	39.0	25.8	52.5	60.3	36.6	62.2	40.0	50.4	37.8	56.5	43.3	50.7	29.0	21.9	32.6	45.5	23.2	49.3	28.8	29.8	37.7	29.6	46.9	17.7	44.2	41.9	29.2	40.2	26.3	9.6	16.3	4.6	11.5	16.0	16.6	12.7	13.4	14.6	24.5	11.1	15.8	15.1	1.4	16.7	12.4	15.0	16.6	13.9	39.3	40.6	39.4	52.4	35.4	34.3	28.8	27.9	45.3	16.5
OLFM1	"AMY, NOE1, NOELIN, OlfA"	ENSG00000130558	"Olfactomedin 1"	Q99784	9	135075422-135121179	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 159.5"	"Cell line enhanced"	"Detected in some"		"HeLa: 25.2;MCF7: 21.2;NTERA-2: 28.3;SCLC-21H: 40.8;SiHa: 33.8;T-47d: 52.4;U-2197: 22.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"classical monocyte: 3.4;intermediate monocyte: 5.0;myeloid DC: 5.1;non-classical monocyte: 1.3"	"Group enriched"	"Detected in many"	51	"dendritic cells: 5.1;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057444			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in brain"		130000000	Nucleoli	"Nucleoplasm, Cytosol"	"HPA057444: "	"unprognostic (6.77e-2)"	"prognostic favourable (7.14e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.08e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (9.46e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.20e-2)"	"unprognostic (7.53e-4)"	7.7	10.0	80.5	5.0	41.5	0.9	4.7	30.9	159.5	7.4	5.4	4.6	0.7	2.5	6.9	26.4	5.0	4.4	3.8	3.9	77.2	19.1	3.4	2.4	4.7	5.2	18.8	36.5	6.2	5.1	3.6	9.9	1.1	13.5	4.8	5.7	0.9	2.6	7.5	6.1	4.5	3.5	6.9	6.1	5.8	3.9	2.8	2.8	0.3	2.7	0.8	7.1	4.1	6.2	0.0	5.1	0.0	5.0	0.0	0.0	0.6	0.0	1.5	3.1	0.0	0.4	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.2	1.3	0.6	0.6	0.0	0.0	3.6	0.2	0.0	25.2	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	21.2	0.1	0.0	28.3	0.0	0.0	0.0	11.9	0.0	0.0	40.8	5.4	33.8	0.1	2.1	52.4	0.0	0.0	2.0	4.5	22.8	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.0	3.4	0.0	0.0	5.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	80.5	41.5	30.9	119.7	77.2	19.1	18.8	36.5	13.5	2.8
OLFM2	"NOE2, OlfC"	ENSG00000105088	"Olfactomedin 2"	O95897	19	9853718-9936552	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 51.4;skin 1: 60.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.4;ASC diff: 14.6;BJ hTERT+: 11.1;SH-SY5Y: 14.8;U-2 OS: 17.8;WM-115: 15.4"	"Cancer enhanced"	"Detected in all"		"glioma: 96.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 24.9"	"Group enriched"	"Detected in many"	27	"granulocytes: 24.9;T-cells: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049961, HPA057771"	Uncertain		Approved	Nucleoplasm	"Secreted in other tissues"		2300000	Nucleoplasm		"HPA049961: , HPA057771: "	"unprognostic (1.42e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.39e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.23e-1)"	20.9	12.2	37.2	2.7	39.7	0.8	5.8	9.1	51.4	4.5	1.9	11.6	0.3	2.1	7.9	3.8	3.9	6.6	4.9	3.9	26.2	21.6	1.8	23.5	3.2	5.0	19.6	17.9	3.5	7.9	1.1	4.4	5.2	15.4	5.2	1.4	3.2	7.1	10.3	1.7	60.2	2.0	5.1	9.0	2.2	1.4	5.2	4.6	16.0	8.4	1.1	3.7	2.6	3.2	0.0	0.0	24.9	0.0	0.6	8.9	1.7	0.0	2.2	1.8	15.4	14.6	9.0	1.0	3.3	11.1	0.7	0.9	0.1	1.4	0.0	1.4	2.5	0.9	5.9	1.0	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	2.6	4.7	0.9	0.1	0.1	0.0	0.1	0.2	0.0	4.8	0.1	0.1	9.6	0.0	0.0	0.0	0.0	0.0	0.5	0.1	14.8	0.5	0.0	3.0	0.5	0.0	0.1	6.5	17.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	15.4	9.6	0.0	24.9	3.5	0.0	3.8	0.0	4.1	3.1	0.0	0.0	8.0	5.1	0.3	0.6	0.0	0.0	8.9	1.7	37.2	39.7	9.1	38.0	26.2	21.6	19.6	17.9	15.4	4.6
OMG	OMGP	ENSG00000126861	"Oligodendrocyte myelin glycoprotein"	P23515	17	31272013-31297539	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	40	"brain: 89.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.5;U-87 MG: 1.4"	"Group enriched"	"Detected in some"	7	"endometrial cancer: 3.5;glioma: 9.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008206, HPA012693"	Enhanced				"Intracellular and membrane"					"HPA008206: AB_1854240, HPA012693: AB_1854239"	"unprognostic (8.05e-4)"	"unprognostic (2.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.81e-2)"	"unprognostic (9.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.96e-13)"	"unprognostic (7.80e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.24e-1)"	"unprognostic (2.42e-2)"	1.6	1.8	25.2	1.6	25.4	2.2	1.6	10.2	89.6	1.6	1.7	20.3	0.0	1.7	1.6	1.6	1.6	1.6	1.6	1.6	26.8	20.6	1.6	1.6	1.6	1.6	30.8	23.2	1.6	1.6	1.6	0.1	1.6	36.8	1.6	1.7	1.4	1.6	1.6	1.7	1.6	1.7	1.6	23.0	1.7	1.6	1.6	39.6	0.0	1.6	0.0	1.6	1.6	0.0	0.0	0.1	1.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.6	1.4	0.0	0.7	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	25.2	25.4	10.2	34.1	26.8	20.6	30.8	23.2	36.8	39.6
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria			13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: "	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favourable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	25.9	8.3	8.5	9.3	7.5	11.9	9.0	12.6	11.6	13.9	13.6	20.3	8.8	17.3	27.3	11.8	16.9	14.8	14.3	24.6	20.8	12.0	29.9	7.4	10.1	11.7	24.5	13.8	13.2	12.8	13.4	19.0	11.7	12.6	17.0	13.8	20.5	9.5	13.6	11.9	27.9	12.5	18.6	18.5	10.4	16.2	18.5	11.2	18.9	21.1	13.4	27.7	19.4	11.7	12.9	9.8	13.8	26.5	15.3	17.8	33.8	14.2	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8
OPCML	"IGLON1, OBCAM, OPCM"	ENSG00000183715	"Opioid binding protein/cell adhesion molecule like"	Q14982	11	132414977-133532519	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 49.9"	"Cell line enriched"	"Detected in some"	5	"BJ: 14.0"	"Group enriched"	"Detected in some"	10	"glioma: 3.7;renal cancer: 0.7;thyroid cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		6300000				"unprognostic (1.59e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.31e-4)"	"unprognostic (8.23e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.46e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.19e-1)"	1.2	1.5	10.5	1.1	22.3	0.9	1.0	31.4	49.9	1.6	1.1	3.9	0.0	1.1	1.7	1.1	1.5	1.6	1.3	1.4	14.7	8.9	2.9	1.0	1.0	1.0	4.2	21.2	1.3	1.0	7.0	1.1	0.9	4.0	1.1	1.2	4.8	1.2	1.8	1.0	1.1	1.1	1.7	2.6	1.8	1.2	1.5	6.6	0.0	1.2	0.0	1.0	1.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	14.0	0.1	2.1	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	2.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.5	22.3	31.4	35.6	14.7	8.9	4.2	21.2	4.0	6.6
OPHN1	"ARHGAP41, MRX60, OPN1"	ENSG00000079482	"Oligophrenin 1"	O60890	X	68042344-68433913	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Neurogenesis"	"GTPase activation"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002919	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA002919: AB_1079526"	"unprognostic (1.21e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.32e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.64e-3)"	5.8	8.2	21.9	2.4	22.6	3.6	7.1	12.3	21.6	9.9	4.9	10.7	3.2	3.5	9.7	4.8	6.1	5.3	4.5	4.1	19.5	9.7	7.0	1.7	6.6	2.0	9.6	12.2	7.1	4.0	6.6	4.8	20.7	9.1	16.2	5.1	7.9	7.2	8.0	7.8	8.6	4.1	6.3	6.2	2.9	5.9	2.9	12.4	0.1	7.2	2.0	2.3	3.9	6.2	2.7	3.3	4.1	1.7	1.7	1.2	0.3	15.1	3.8	2.4	5.9	5.5	5.7	3.9	2.8	3.9	5.3	6.4	2.4	3.1	0.7	10.8	3.4	4.1	2.1	1.2	8.2	0.4	1.5	3.2	4.3	2.4	1.8	0.8	3.8	3.2	3.9	4.9	4.8	4.3	2.1	1.4	3.1	7.8	0.5	0.8	4.6	3.2	0.4	4.8	0.7	6.9	5.8	0.9	2.3	5.5	7.0	12.4	4.7	1.3	4.7	3.6	5.8	12.7	3.6	2.1	2.5	0.5	2.7	1.9	2.6	1.1	1.7	0.6	1.2	0.9	1.0	1.3	1.0	0.8	0.7	2.7	1.1	1.2	4.1	1.7	1.2	3.3	0.7	0.3	21.9	22.6	12.3	18.6	19.5	9.7	9.6	12.2	9.1	12.4
OR12D2	hs6M1-20	ENSG00000280236	"Olfactory receptor family 12 subfamily D member 2 (gene/pseudogene)"	P58182	6	29395631-29398008	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.4			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR2Y1		ENSG00000174339	"Olfactory receptor family 2 subfamily Y member 1"	Q8NGV0	5	180739042-180740099	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"salivary gland: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.2		1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR3A2	"OLFRA04, OR17-228, OR228"	ENSG00000221882	"Olfactory receptor family 3 subfamily A member 2"	P47893	17	3276942-3386317	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 3.6;brain: 8.6;lymphoid tissue: 6.5;pituitary gland: 5.5;testis: 10.9"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 15.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (7.58e-2)"				"unprognostic (5.10e-2)"						"unprognostic (6.89e-2)"		"unprognostic (1.12e-1)"		"unprognostic (1.32e-1)"			0.5	0.5	2.2	0.5	8.6	0.5	0.6	0.4	2.8	0.6	0.4	1.2	0.0	0.4	0.5	1.5	0.4	0.3	0.2	0.4	2.5	1.2	0.5	0.3	0.8	6.5	1.4	0.6	1.0	0.4	0.2	5.5	1.0	2.7	0.7	0.4	1.3	0.3	0.5	0.8	0.6	0.5	0.4	1.9	0.9	0.4	10.9	2.1	2.3	0.3	0.0	0.7	0.6	0.4	3.0	3.4	3.6	0.6	0.7	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.6	0.7	0.9	0.3	1.6	3.0	1.2	0.3	0.8	0.8	1.2	1.8	1.6	0.7	0.4	3.4	0.5	0.8	2.2	8.6	0.4	2.8	2.5	1.2	1.4	0.6	2.7	2.1
OR4C16		ENSG00000279514	"Olfactory receptor family 4 subfamily C member 16 (gene/pseudogene)"	Q8NGL9	11	55572128-55573060	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"prostate: 42.1;retina: 14.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.2;BJ hTERT+: 3.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.7	0.2	0.2	5.0	0.2	0.1	1.7	0.1	0.5	0.6	8.2	0.0	0.5	0.2	1.6	1.3	0.6	0.6	0.3	1.1	0.2	0.2	0.4	0.1	0.1	0.0	0.2	0.0	1.1	0.2	0.1	0.2	5.1	0.4	42.1	2.2	14.6	0.2	2.4	0.5	0.3	0.9	2.0	0.2	0.1	0.5	0.7	0.0	0.0	0.2	0.4	0.0	1.6	0.3	1.6	0.9	2.2	0.6	0.8	1.2	0.4	0.1	0.0	0.1	0.1	0.7	6.2	0.3	0.0	3.4	0.0	0.2	0.2	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	1.2	1.2	0.3	0.0	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.5	0.1	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.0	0.5	0.4	0.7	0.3	0.0	0.5	0.0	0.1	0.4	0.0	0.0	1.5	0.6	0.5	1.2	0.5	0.8	0.8	0.8	0.6	0.3	1.6	0.8	1.1	2.2	0.8	0.5	0.9	0.4	0.4	0.2	0.2	0.1	0.5	0.2	0.2	0.2	0.0	0.4	0.0
OR51F2		ENSG00000176925	"Olfactory receptor family 51 subfamily F member 2"	Q8NH61	11	4821321-4822456	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																									"unprognostic (2.85e-2)"						0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR8J1		ENSG00000172487	"Olfactory receptor family 8 subfamily J member 1"	Q8NGP2	11	56354291-56361511	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
OR9Q1		ENSG00000186509	"Olfactory receptor family 9 subfamily Q member 1"	Q8NGQ5	11	58023881-58181616	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	5	"skeletal muscle: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (2.65e-3)"	"unprognostic (2.27e-1)"				0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.1		0.0	0.0		0.1	0.0	3.1	0.5	0.0	0.0	0.0	0.1	0.0	0.6			0.0		0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.4	0.3	0.7	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.2	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.3	0.2	0.2	0.1	0.1	0.1	0.8	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.0										
ORM1		ENSG00000229314	"Orosomucoid 1"	P02763	9	114323056-114326475	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 834.6"	"Cell line enriched"	"Detected in some"	11	"Hep G2: 157.9"	"Cancer enriched"	"Detected in many"	16	"liver cancer: 2506.9"					"Cell type enriched"	"Detected in some"	45	"neutrophil: 53.4"	"Lineage enriched"	"Detected in many"	45	"granulocytes: 53.4"									"CAB006265, HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	945333333333	120000000000	Vesicles	"Golgi apparatus"	"CAB006265: AB_425575, HPA046438: , HPA047725: , HPA057726: "	"unprognostic (3.85e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.16e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (2.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	0.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	834.6	0.3	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.6	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0			0.0		0.0	0.0	0.0	0.0	0.0	53.4	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	157.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	13.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.4	0.0	0.2	0.0	0.0	0.3										
ORM2	"AGP-B, AGP-B', AGP2"	ENSG00000228278	"Orosomucoid 2"	P19652	9	114329869-114333252	"Plasma proteins, Predicted secreted proteins"	"Acute phase, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	31	"liver: 404.1"	"Cell line enriched"	"Detected in single"	237	"Hep G2: 133.4"	"Cancer enriched"	"Detected in many"	34	"liver cancer: 873.1"					"Cell type enriched"	"Detected in single"	35	"neutrophil: 13.2"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 13.2"									"HPA046438, HPA047725, HPA057726"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	422277500	61000000000	Vesicles	"Golgi apparatus"	"HPA046438: , HPA047725: , HPA057726: "	"unprognostic (6.77e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-2)"	"unprognostic (5.76e-2)"	"prognostic unfavourable (1.23e-9)"	"unprognostic (3.23e-1)"	"unprognostic (6.80e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.15e-4)"	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	404.1	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	13.2	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.0	0.0	0.1										
OSBPL3	"KIAA0704, ORP-3, ORP3, OSBP3"	ENSG00000070882	"Oxysterol binding protein like 3"	Q9H4L5	7	24796539-24981634	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000691, HPA048401"	Enhanced		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA000691: AB_1854814, HPA048401: "	"unprognostic (3.57e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.11e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.05e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (2.34e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.06e-2)"	3.7	2.2	3.9	18.2	9.5	3.8	6.6	1.2	16.0	12.1	6.1	6.2	0.7	9.8	3.8	3.7	10.2	6.2	10.4	5.3	4.3	4.3	14.4	1.9	9.0	10.9	4.2	7.4	8.4	3.9	23.1	4.2	6.3	3.1	4.3	6.7	3.7	6.9	2.9	6.7	12.8	10.4	4.0	6.7	10.2	8.7	3.5	4.1	13.9	16.8	7.2	14.7	12.4	9.6	3.7	3.5	6.3	2.1	8.1	9.8	2.4	14.4	3.9	2.9	5.4	6.6	13.4	6.6	16.4	18.3	7.7	12.2	9.8	19.2	8.0	2.3	17.5	12.7	8.8	12.3	11.9	4.8	3.6	1.9	5.8	7.3	9.4	5.4	43.0	6.5	10.3	10.0	12.1	11.5	10.0	11.2	13.0	0.0	3.3	6.7	5.7	5.1	2.7	8.1	3.3	7.7	10.3	0.6	6.1	11.1	8.0	2.4	4.1	0.5	13.6	3.4	6.8	18.5	12.2	7.8	11.3	20.2	7.4	9.0	37.9	6.3	2.1	1.5	9.8	1.8	8.4	3.7	6.2	6.3	3.5	1.7	2.1	4.2	0.4	8.1	1.2	2.5	9.8	2.4	3.9	9.5	1.2	16.0	4.3	4.3	4.2	7.4	3.1	4.1
OSBPL5	"KIAA1534, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087116-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles				Vesicles		"HPA038335: , HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	17.6	7.0	4.2	10.3	6.2	17.8	20.7	4.4	8.8	24.7	15.6	7.5	24.0	9.0	17.1	15.9	8.1	12.6	13.8	10.0	4.6	6.5	8.1	2.7	12.9	10.5	6.9	6.4	9.6	8.4	2.4	6.5	7.8	9.8	15.9	5.2	9.0	17.1	17.5	28.0	17.8	9.6	20.1	11.9	20.3	10.2	4.4	6.3	36.5	9.3	9.6	3.8	14.3	17.7	0.0	2.7	1.0	10.1	10.0	9.3	3.9	1.7	2.7	3.2	3.7	9.7	4.5	0.0	8.8	4.3	3.5	2.5	0.0	5.1	0.0	2.7	4.9	6.5	0.6	2.4	0.5	1.7	2.5	7.3	8.7	0.0	7.9	6.5	1.1	7.0	2.9	1.2	1.3	2.4	2.5	0.0	1.7	4.9	14.2	36.3	2.3	5.7	7.4	4.4	1.0	1.4	1.6	5.4	0.6	3.6	12.9	3.3	5.3	17.3	8.0	4.5	6.1	10.6	1.5	1.8	0.0	0.2	4.7	12.3	5.6	0.2	3.1	1.0	9.3	4.4	1.2	0.0	1.0	3.4	2.7	0.0	0.6	3.6	0.4	10.0	10.1	1.2	0.1	3.9	4.2	6.2	4.4	8.8	4.6	6.5	6.9	6.4	9.8	6.3
OSBPL6	ORP6	ENSG00000079156	"Oxysterol binding protein like 6"	Q9BZF3	2	178194481-178402891	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 33.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.5;hTERT-HME1: 26.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 2.2;T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032131	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA032131: AB_10670963"	"unprognostic (6.22e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.95e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.03e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.15e-5)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.73e-4)"	"unprognostic (4.44e-6)"	2.4	2.8	9.2	1.9	10.5	0.8	3.2	10.2	18.4	1.9	1.7	3.2	0.2	1.6	1.8	1.7	4.1	2.1	2.2	5.9	7.5	6.3	4.5	8.7	6.3	2.0	4.9	8.0	2.8	2.3	1.2	15.1	1.4	11.3	5.3	2.1	2.5	2.9	2.9	33.4	11.6	5.6	2.6	4.3	2.0	1.7	2.4	4.3	0.0	4.1	6.3	1.7	1.5	2.3	0.2	0.1	2.2	0.0	0.2	1.4	0.6	0.0	0.5	4.3	8.7	3.6	4.0	3.3	7.1	3.7	6.3	7.7	0.7	0.1	0.0	0.3	6.5	0.1	10.1	5.8	10.7	0.1	5.2	24.5	1.5	0.0	2.3	4.0	0.1	2.7	9.2	13.8	26.8	3.0	0.4	3.0	8.2	3.5	0.0	0.0	5.2	5.2	0.0	8.8	1.5	0.4	0.0	3.3	1.9	3.2	0.9	7.0	1.2	0.0	5.8	7.2	4.5	4.8	8.2	16.7	6.5	0.0	8.6	0.0	3.3	0.5	0.0	0.0	0.0	0.0	1.2	0.0	0.6	0.8	0.0	0.2	1.4	0.1	2.2	0.2	0.0	0.1	0.0	0.6	9.2	10.5	10.2	18.4	7.5	6.3	4.9	8.0	11.3	4.3
OSBPL9		ENSG00000117859	"Oxysterol binding protein like 9"	Q96SU4	1	51577179-51798427	"Plasma proteins, Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027378, HPA027397"	Supported	Approved	Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA027378: AB_1854816, HPA027397: AB_1854817"	"unprognostic (5.99e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.11e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.36e-3)"	"unprognostic (8.61e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.37e-1)"	35.7	28.8	12.6	19.0	20.7	20.3	27.4	30.3	17.6	29.4	15.4	29.8	20.0	13.1	36.3	29.7	18.8	19.4	15.0	27.2	13.5	16.1	35.4	52.6	25.7	18.2	25.1	14.0	29.4	26.9	43.2	27.6	20.8	22.2	37.1	16.6	29.9	18.2	22.4	55.6	15.2	16.4	25.3	28.2	22.5	22.5	20.0	24.8	19.4	28.2	18.5	24.6	27.7	31.6	23.4	19.9	28.7	13.6	12.8	23.2	12.6	21.7	11.2	22.8	5.0	16.3	8.1	40.8	11.2	18.8	18.1	21.6	16.3	16.4	31.8	19.6	12.3	10.1	19.2	19.4	25.8	22.6	14.1	25.1	21.9	33.5	15.8	25.8	13.0	16.3	18.8	20.4	13.5	23.8	47.5	10.4	10.1	15.5	7.4	28.0	31.0	5.2	18.7	33.1	33.7	24.2	17.0	11.3	15.0	9.5	26.1	31.0	12.6	26.0	14.3	5.2	17.4	6.5	19.9	25.4	16.1	37.1	12.8	12.0	8.0	28.7	13.6	25.0	16.1	11.4	23.2	23.4	16.0	16.6	19.9	16.4	17.1	18.1	15.9	12.8	8.6	15.7	15.3	12.6	12.6	20.7	30.3	17.6	13.5	16.1	25.1	14.0	22.2	24.8
OSM	MGC20461	ENSG00000099985	"Oncostatin M"	P13725	22	30262829-30266840	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Growth regulation"	"Cytokine, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 24.9;bone marrow: 63.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.9;HL-60: 3.9;HMC-1: 11.7;Karpas-707: 3.6;NB-4: 6.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basophil: 24.9;neutrophil: 17.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 24.9"					"Not detected"	"Not detected"								"Secreted to blood"	39700					"unprognostic (5.15e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.02e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	5.3	2.6	0.9	8.5	2.5	63.0	3.7	0.7	1.7	1.6	1.0	5.3	0.4	0.6	1.2	1.9	0.8	3.8	4.1	2.2	3.8	1.7	1.9	1.8	11.4	9.4	2.0	0.0	3.0	1.0	1.0	2.5	6.4	5.9	1.2	0.7	1.8	1.4	0.5	1.7	0.4	1.0	2.1	7.8	6.9	1.4	2.3	1.2	0.6	1.1	0.5	2.2	6.8	0.9	0.1	0.4	24.9	0.2	1.9	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.3	0.0	0.0	0.0	3.9	11.7	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.5	6.7	0.0	0.0	0.6	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.4	0.0	24.9	0.2	0.9	1.0	0.1	3.4	0.0	2.5	1.3	0.4	0.1	0.5	1.2	17.5	1.9	0.0	0.1	0.7	0.8	0.9	2.5	0.7	1.7	3.8	1.7	2.0	0.0	5.9	1.2
OSMR	OSMRB	ENSG00000145623	"Oncostatin M receptor"	Q99650	5	38845858-38945596	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 38.9;HSkMC: 48.2;U-2197: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017278	Approved		Approved	Nucleoli	"Intracellular and membrane"		21000000	Nucleoli		"HPA017278: AB_1854818"	"unprognostic (6.34e-3)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.00e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.96e-6)"	"unprognostic (1.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.75e-2)"	41.1	18.0	7.3	18.7	9.4	0.3	31.0	3.1	9.4	14.1	13.7	2.8	4.6	4.4	14.4	12.9	14.7	14.5	22.4	22.4	5.4	3.5	19.7	23.6	25.7	31.7	9.0	1.3	33.6	10.1	6.6	10.5	40.1	13.3	20.8	8.6	9.2	17.2	11.1	13.0	12.5	8.0	32.5	15.6	23.5	11.5	10.8	6.9	3.6	17.5	10.4	11.3	40.4	43.6	0.6	0.6	1.6	0.4	0.7	0.6	0.1	7.5	9.8	1.6	4.2	18.1	38.9	5.7	12.4	19.7	12.2	16.4	0.0	20.6	0.0	5.9	13.1	10.5	2.1	15.2	19.7	0.0	1.2	0.5	7.7	7.4	20.6	0.0	0.1	48.2	9.1	27.3	23.5	1.8	0.0	0.0	7.7	2.0	0.0	0.0	0.2	3.2	0.0	0.5	0.0	24.5	2.2	0.0	0.0	27.9	0.0	0.0	8.6	0.0	2.9	29.8	11.3	38.5	6.5	0.0	0.0	0.0	23.9	0.0	6.4	1.6	0.4	0.4	0.5	0.3	0.2	0.3	0.3	0.1	0.1	0.6	0.4	0.6	1.0	0.7	0.1	0.6	0.2	0.1	7.3	9.4	3.1	9.4	5.4	3.5	9.0	1.3	13.3	6.9
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Arginine biosynthesis, Urea cycle"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria			1800000	Mitochondria		"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
OTOF	"DFNB6, DFNB9, FER1L2"	ENSG00000115155	Otoferlin	Q9HC10	2	26457203-26558698	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Hearing		"Deafness, Disease mutation, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"bone marrow: 13.8;brain: 26.8"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 26.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 26.8"	"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.4;memory CD8 T-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012410	Approved									"HPA012410: AB_1854836"	"unprognostic (4.01e-3)"	"unprognostic (7.85e-2)"	"unprognostic (8.95e-2)"	"unprognostic (7.20e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.97e-3)"	"unprognostic (4.85e-14)"	"unprognostic (1.33e-2)"	"unprognostic (5.19e-1)"	"unprognostic (9.65e-2)"	"unprognostic (8.96e-5)"	0.5	0.7	5.5	0.8	26.8	13.8	0.2	0.4	2.2	0.3	0.4	0.3	0.0	1.1	0.2	0.1	0.4	0.3	0.9	0.2	1.6	2.0	0.1	0.2	0.6	0.5	0.6	0.7	0.2	0.1	0.1	0.0	0.2	1.1	0.3	0.3	0.0	0.3	0.2	0.7	0.2	0.7	0.4	0.7	1.2	0.5	1.4	2.6	0.0	0.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	1.6	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.6	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	5.5	26.8	0.4	2.2	1.6	2.0	0.6	0.7	1.1	2.6
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol			630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.5	55.2	30.5	26.9	20.6	22.8	23.4	18.4	27.4	41.0	30.3	37.0	29.3	16.3	35.0	29.5	38.2	39.3	45.8	25.5	18.8	30.5	27.1	33.1	46.8	28.9	26.9	29.8	24.2	29.8	31.3	20.0	38.6	18.9	18.5	27.5	62.8	29.3	35.6	35.7	26.3	24.1	11.9	27.8	42.6	44.7	23.1	33.3	20.8	32.0	33.6	49.6	23.8	27.9	21.9	21.3	29.3	24.1	21.8	13.7	23.3	28.3	17.5	20.9	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2
OVGP1	"CHIT5, MUC9"	ENSG00000085465	"Oviductal glycoprotein 1"	Q12889	1	111414314-111427777	"Plasma proteins, Predicted intracellular proteins"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 240.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 7.8;SK-BR-3: 8.0"	"Group enriched"	"Detected in many"	13	"endometrial cancer: 58.7;ovarian cancer: 27.9"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"cerebellum: 6.6"	"Low region specificity"	"Detected in many"			HPA062205	Enhanced				"Intracellular and membrane"					"HPA062205: "	"unprognostic (1.52e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.35e-2)"	"prognostic favourable (1.36e-4)"	"unprognostic (8.39e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.34e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.35e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.86e-3)"	"prognostic favourable (3.93e-5)"	0.4	0.1	0.4	0.4	0.9	0.2	0.4	1.9	1.0	0.7	0.4	0.4	0.4	0.2	9.7	7.1	0.4	240.9	0.4	0.4	0.5	0.5	0.5	1.0	0.4	0.4	0.4	0.4	32.5	0.4	1.5	0.4	0.4	0.4	0.7	0.3	0.4	0.4	0.4	0.4	1.1	0.6	0.4	0.4	0.5	0.2	1.3	0.4	0.6	0.4	0.4	0.4	0.5	0.4	0.8	0.9	0.0	0.5	0.0	1.6	0.2	0.7	0.6	1.5	0.8	3.0	3.4	2.7	0.4	2.2	0.5	1.2	0.9	0.0	1.3	2.9	0.9	0.8	0.4	0.5	0.9	3.2	7.8	0.4	1.0	3.7	1.1	1.3	3.6	3.1	4.8	0.1	1.7	0.6	0.5	2.4	0.2	0.8	1.0	1.9	0.4	2.8	1.0	0.3	1.1	2.3	5.8	1.0	0.9	0.3	8.0	1.1	0.6	1.3	1.3	0.3	0.4	4.0	1.1	3.0	0.8	0.7	0.3	2.5	0.3	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.5	0.0	0.9	0.8	1.6	1.2	0.0	0.0	0.5	0.0	0.1	0.2	0.4	0.9	1.9	1.0	0.5	0.5	0.4	0.4	0.4	0.4
OXT	"OT, OT-NPI, OXT-NPI"	ENSG00000101405	"Oxytocin/neurophysin I prepropeptide"	P01178	20	3071620-3072517	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 232.0"	"Group enriched"	"Detected in some"	4	"CACO-2: 5.1;HL-60: 1.3;HMC-1: 3.7;PC-3: 2.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 12.1"	"Region enriched"	"Detected in some"	59	"hypothalamus: 232.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hypothalamus: 210.0"	"Group enriched"	"Detected in some"	878	"basal ganglia: 840.1;hypothalamus: 2453.1"	HPA071892	Supported	Supported			"Secreted to blood"	1501000				"HPA071892: "	"unprognostic (7.45e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.22e-2)"	"unprognostic (8.36e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.05e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.18e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.10e-1)"	5.0	0.2	0.0	0.1	3.9	0.2	0.2	0.0	0.3	0.1	0.0	0.4	0.0	2.6	0.0	3.8	0.0	0.0	0.0	0.0	0.1	232.0	1.6	24.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	1.8	0.6	0.2	0.2	0.0	0.0	0.4	0.2	0.2	0.2	2.4	0.0	0.0	0.2	0.2	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	1.5	6.3	0.4	0.4	3.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	6.3	0.8	0.4	1.0	3.7	1.7	1.1	0.9	3.6	3.2	3.6	1.1	0.4	0.0	1.5	2.4	0.9	0.0	3.9	0.0	0.3	0.1	232.0	0.0	0.0	0.2	0.0
P4HA1	"C-P4Halpha(I), P4HA"	ENSG00000122884	"Prolyl 4-hydroxylase subunit alpha 1"	P13674	10	73007217-73096974	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 105.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007599, HPA026593"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles,Mitochondria"	"Intracellular and membrane"			"Endoplasmic reticulum"	"Vesicles, Mitochondria"	"HPA007599: AB_1854891, HPA026593: AB_1854892"	"prognostic unfavourable (9.01e-4)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (2.76e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.19e-5)"	"unprognostic (2.30e-1)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.15e-2)"	"prognostic unfavourable (9.40e-9)"	"unprognostic (3.14e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.75e-2)"	16.8	14.4	16.5	10.4	20.2	7.0	47.6	9.9	18.2	18.5	10.9	11.3	7.4	5.6	14.8	12.2	11.6	22.4	14.1	23.9	17.0	10.9	19.0	39.9	18.1	7.5	33.5	4.9	22.3	13.1	11.1	8.6	33.5	25.4	17.9	9.4	8.6	8.5	10.4	63.5	10.3	7.8	15.1	45.8	9.7	11.1	9.7	30.9	4.1	19.4	7.5	7.3	34.4	105.7	6.9	14.8	10.2	17.3	3.4	7.3	6.1	17.3	4.5	13.0	25.3	40.2	30.9	10.9	51.0	46.2	19.7	47.4	7.4	13.5	5.9	19.5	50.4	19.7	8.2	18.6	43.3	7.5	3.1	5.0	4.3	8.8	16.7	9.2	3.5	18.7	10.9	16.8	22.3	9.3	7.8	3.1	17.0	4.6	3.6	8.9	4.6	19.8	3.4	8.7	10.6	11.1	7.5	1.2	7.3	10.4	30.8	12.1	4.7	8.7	8.8	24.2	10.0	6.7	11.8	17.7	6.4	2.8	43.4	13.5	11.7	0.8	13.5	10.2	5.2	16.4	6.7	6.0	6.2	6.0	14.8	6.9	4.6	4.7	7.4	3.4	17.3	11.8	7.3	6.1	16.5	20.2	9.9	18.2	17.0	10.9	33.5	4.9	25.4	30.9
P4HB	"DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PO4DB, PO4HB, PROHB"	ENSG00000185624	"Prolyl 4-hydroxylase subunit beta"	P07237	17	81843159-81860694	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Chaperone, Isomerase"	"Craniosynostosis, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 383.4;pancreas: 677.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012463, HPA018884"	Enhanced		Supported	"Endoplasmic reticulum"	"Secreted - unknown location"		140000000	"Endoplasmic reticulum"		"CAB012463: , HPA018884: AB_1854896"	"unprognostic (9.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.14e-3)"	"unprognostic (7.75e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (2.30e-11)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.19e-3)"	18.0	34.7	6.3	15.4	8.4	35.0	16.1	6.1	6.5	22.1	40.5	9.0	45.0	42.6	14.7	29.1	40.3	12.8	42.3	20.7	6.3	5.9	27.2	383.4	20.9	29.1	7.9	4.5	14.3	677.5	6.4	23.4	58.5	7.2	22.5	8.5	12.3	251.9	42.5	31.0	24.3	112.8	11.0	5.2	36.7	31.6	9.1	7.2	10.5	29.7	50.7	46.4	16.5	20.5	21.6	71.3	45.8	60.8	38.8	55.9	70.8	57.7	50.3	18.6	60.0	50.4	59.3	44.2	112.8	72.8	49.2	66.6	36.9	50.6	23.3	49.6	72.5	41.0	20.5	44.1	28.5	15.0	34.7	34.9	52.9	150.1	66.3	110.1	57.7	44.7	30.0	39.3	41.7	81.0	24.7	100.7	35.0	52.7	31.5	87.5	14.6	45.8	25.8	33.3	46.2	38.2	69.8	22.4	24.8	56.2	162.4	58.5	73.4	129.7	62.9	92.4	46.3	52.4	55.0	72.4	52.4	22.0	121.4	42.4	70.4	45.8	60.8	38.3	53.5	38.7	55.9	21.6	36.4	42.8	43.4	18.7	21.2	31.5	20.0	38.8	27.6	71.3	25.7	70.8	6.3	8.4	6.1	6.5	6.3	5.9	7.9	4.5	7.2	7.2
PA2G4		ENSG00000170515	"Proliferation-associated 2G4"	Q9UQ80	12	56104319-56113907	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011711, CAB012428, HPA016484"	Supported		Approved	Cytosol			1200000	Cytosol		"CAB011711: AB_732060, CAB012428: , HPA016484: AB_1854912"	"unprognostic (5.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.87e-1)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (6.31e-7)"	"unprognostic (4.25e-3)"	"unprognostic (2.77e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-2)"	"prognostic unfavourable (4.59e-7)"	"unprognostic (1.17e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.67e-2)"	41.1	32.1	26.6	41.4	29.8	52.5	38.5	35.1	38.8	33.7	39.2	31.0	27.1	34.4	36.1	22.4	69.4	31.2	31.9	55.6	26.6	25.5	36.1	51.6	32.6	43.3	26.7	28.0	43.3	44.3	42.8	20.5	39.0	28.2	40.3	44.2	23.6	34.6	33.4	77.3	53.0	31.7	39.4	32.3	46.7	34.4	27.9	23.9	70.8	39.7	57.2	54.0	45.5	39.6	25.5	27.1	13.5	25.1	37.4	48.9	36.0	53.3	47.4	32.6	35.8	15.1	22.9	65.4	56.5	27.1	69.6	38.8	57.9	39.7	106.8	38.1	26.7	44.0	74.2	63.1	68.0	30.3	63.6	82.1	32.3	49.4	29.5	111.3	30.4	23.1	32.3	60.2	54.5	42.2	99.6	49.7	38.1	47.3	86.5	58.2	53.4	58.3	71.3	58.9	72.4	35.2	40.1	48.9	29.6	37.2	58.9	34.5	63.5	43.3	33.8	34.0	48.0	39.1	62.4	30.5	41.9	104.6	30.7	67.1	44.0	7.8	23.0	13.5	36.6	25.1	48.9	25.5	38.9	39.4	27.1	22.2	37.6	37.3	3.7	37.4	20.0	26.3	43.3	36.0	26.6	29.8	35.1	38.8	26.6	25.5	26.7	28.0	28.2	23.9
PABPC1	"PAB1, PABP1, PABPC2, PABPL1"	ENSG00000070756	"Poly(A) binding protein cytoplasmic 1"	P11940	8	100685816-100722809	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB011536, HPA045423, HPA067156"	Supported		Supported	Cytosol			2700000	Cytosol		"CAB011536: AB_777008, HPA045423: , HPA067156: "	"unprognostic (5.00e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.18e-1)"	"unprognostic (4.50e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (5.80e-4)"	"unprognostic (2.51e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.21e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (5.70e-12)"	"unprognostic (6.22e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.98e-3)"	"unprognostic (1.40e-2)"	85.6	49.6	33.6	66.1	38.8	94.2	80.5	35.8	32.5	84.2	80.7	41.9	57.2	64.1	85.3	48.8	195.5	54.6	56.4	35.1	32.3	19.3	43.6	83.2	72.8	156.2	40.6	24.3	111.1	106.9	31.8	34.1	50.6	36.8	88.2	71.5	43.4	192.9	79.0	35.1	95.4	104.0	89.9	65.2	135.3	73.4	98.7	37.6	137.2	65.4	63.0	157.9	120.9	116.4	70.8	98.4	32.3	106.7	65.9	106.0	90.6	180.2	45.1	35.3	64.1	66.2	131.6	61.0	44.1	63.9	47.5	51.8	53.9	84.9	228.8	172.1	77.6	70.0	55.3	86.3	81.3	69.9	36.5	118.0	34.0	69.3	82.1	50.5	83.5	122.2	136.7	44.2	217.6	74.2	99.1	88.1	70.4	52.5	251.4	105.3	79.1	64.1	83.0	42.9	82.6	57.4	117.4	49.3	54.9	29.4	46.0	103.0	82.8	83.8	69.1	42.8	79.9	62.8	74.2	86.4	59.8	128.2	50.4	113.5	43.0	27.6	83.3	28.8	39.7	99.9	84.2	70.8	78.3	64.4	98.4	62.6	106.0	85.1	32.3	65.9	106.7	65.5	67.4	90.6	33.6	38.8	35.8	32.5	32.3	19.3	40.6	24.3	36.8	37.6
PABPN1	"OPMD, PAB2, PABP2"	ENSG00000100836	"Poly(A) binding protein nuclear 1"	Q86U42	14	23321289-23326185	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA000637	Supported		Approved	"Nucleoplasm,Nuclear speckles"				Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553"	"unprognostic (5.11e-3)"	"unprognostic (2.65e-2)"	"unprognostic (7.20e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-3)"	"prognostic favourable (9.66e-4)"	"unprognostic (5.88e-2)"	"prognostic unfavourable (2.41e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.25e-3)"	41.1	46.0	67.4	39.8	73.7	57.1	34.0	79.5	80.2	36.1	42.2	39.4	51.2	55.1	55.3	67.7	38.3	43.2	43.4	35.3	64.4	44.7	46.6	47.1	33.2	46.4	62.4	45.8	48.6	35.2	44.8	54.0	40.6	60.3	46.2	52.8	39.4	42.3	45.2	46.6	53.7	55.9	50.2	47.4	46.0	41.4	54.1	69.3	53.5	51.0	29.6	54.6	33.3	46.5	11.4	15.6	13.1	9.8	12.0	9.0	2.8	25.3	28.5	63.0	49.7	29.6	33.3	41.0	26.4	26.0	36.1	34.6	34.0	47.7	45.5	14.2	33.3	40.3	70.2	36.4	50.2	38.8	26.8	35.1	40.7	87.9	33.1	54.4	48.3	38.7	36.5	26.8	31.6	39.5	32.8	35.7	34.5	48.3	57.2	66.6	68.9	32.5	57.2	24.4	27.4	40.8	52.7	43.5	34.0	33.8	31.5	26.8	23.8	39.5	33.3	25.2	32.2	24.6	33.4	42.7	29.5	53.9	15.0	44.7	29.3	13.1	9.8	8.9	7.3	7.0	5.9	8.7	7.3	6.3	7.6	11.4	9.0	8.5	11.9	12.0	7.7	15.6	7.9	2.8	67.4	73.7	79.5	80.2	64.4	44.7	62.4	45.8	60.3	69.3
PACS1	"FLJ10209, KIAA1175"	ENSG00000175115	"Phosphofurin acidic cluster sorting protein 1"	Q6VY07	11	66070363-66244747	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038914	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038914: AB_10672831"	"unprognostic (7.03e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.35e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-3)"	"unprognostic (5.31e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.46e-1)"	20.0	14.6	18.0	33.7	23.1	17.7	25.5	33.6	25.5	17.7	16.6	12.5	12.8	10.5	17.4	16.9	19.6	18.1	19.8	33.1	17.3	15.0	17.7	7.4	20.7	42.3	12.8	19.0	26.2	16.7	19.9	16.9	14.6	12.8	21.3	8.5	19.0	66.8	18.8	15.2	16.2	15.1	23.5	11.7	24.0	16.0	28.4	13.6	33.9	21.6	15.6	33.7	21.9	17.7	7.2	1.9	11.2	3.7	2.9	5.8	3.6	16.7	17.8	8.3	5.5	15.9	19.0	9.7	22.8	16.8	16.9	10.5	10.9	13.9	10.6	15.4	40.2	11.0	6.2	17.3	21.5	16.9	7.0	17.1	15.6	15.7	19.3	2.4	14.2	19.4	8.1	15.3	19.2	15.8	6.4	20.9	18.2	31.8	18.2	6.6	3.9	8.5	12.2	8.5	18.7	11.8	16.9	11.9	13.6	23.8	14.2	11.8	15.9	3.3	20.8	21.7	9.5	28.9	9.8	10.6	6.8	2.8	18.3	4.0	10.6	5.2	2.0	3.9	5.2	1.5	3.5	4.6	4.9	4.5	1.9	7.2	5.6	5.0	11.2	2.9	3.7	1.2	5.8	3.6	18.0	23.1	33.6	25.5	17.3	15.0	12.8	19.0	12.8	13.6
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535231	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 81.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 9.7;RPMI-8226: 11.3;T-47d: 18.0;U-266/84: 13.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 15.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: "	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	1.5	2.1	42.5	2.4	33.8	2.0	1.4	29.3	81.7	1.5	1.7	2.1	0.0	1.8	1.9	1.5	1.4	2.0	1.7	4.7	32.8	21.9	1.6	1.4	1.5	4.4	14.6	32.9	1.7	6.1	1.4	1.2	1.4	31.6	1.8	1.6	5.5	1.6	1.7	1.5	1.4	1.8	1.5	3.7	2.5	2.4	1.9	4.1	0.0	1.4	0.0	3.4	2.0	0.0	0.0	15.0	0.0	0.0	3.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	3.7	0.7	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	9.7	0.5	0.0	2.4	0.0	0.1	0.0	11.3	0.0	0.3	3.6	0.2	0.0	1.8	0.0	18.0	1.9	0.0	0.0	0.3	0.0	0.0	3.0	13.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.1	0.0	15.0	0.0	0.1	42.5	33.8	29.3	56.3	32.8	21.9	14.6	32.9	31.6	4.1
PACSIN3	SDPIII	ENSG00000165912	"Protein kinase C and casein kinase substrate in neurons 3"	Q9UKS6	11	47177525-47186443	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6"	"Cell line enhanced"	"Detected in many"		"T-47d: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA039480, HPA043904"	Approved	Approved	Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA039480: AB_2676531, HPA043904: AB_2678725"	"unprognostic (1.75e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (2.09e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.75e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.76e-2)"	4.1	17.0	3.9	2.2	5.7	0.4	4.3	3.5	4.7	6.5	8.5	8.6	7.1	1.6	6.7	7.6	12.6	4.8	5.8	40.6	4.0	2.4	2.9	10.0	3.9	0.8	7.6	3.6	6.3	14.6	4.8	1.0	8.0	4.4	8.6	1.1	4.6	11.3	6.7	121.6	11.9	1.9	7.4	8.3	1.5	6.0	1.6	6.5	0.3	8.5	44.6	7.1	6.4	5.7	0.0	0.1	0.0	0.9	0.0	0.2	0.9	16.4	8.3	3.8	16.6	3.3	3.3	18.6	5.1	7.4	10.8	6.1	12.3	2.3	0.1	1.6	2.8	27.1	7.6	12.5	4.3	2.5	12.9	2.5	31.3	28.2	6.5	0.5	2.6	9.3	16.8	5.7	9.1	4.8	5.4	0.2	4.4	32.6	0.3	12.1	4.7	16.6	10.1	14.4	2.6	4.5	15.6	0.1	13.0	8.1	5.8	7.6	41.0	2.2	2.3	18.9	19.0	2.4	14.1	2.8	1.3	1.5	6.1	5.7	9.7	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.9	5.7	3.5	4.7	4.0	2.4	7.6	3.6	4.4	6.5
PADI4	"PAD, PADI5, PDI4, PDI5"	ENSG00000159339	"Peptidyl arginine deiminase 4"	Q9UM07	1	17308195-17364004	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 48.2;bone marrow: 54.8;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;HEL: 4.1;NB-4: 1.6;RPMI-8226: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"basophil: 17.0;classical monocyte: 18.6;eosinophil: 24.6;neutrophil: 48.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 48.2;monocytes: 18.6"	"Not detected"	"Not detected"							"HPA017007, HPA042825"	Enhanced						12000			"HPA017007: AB_1854921, HPA042825: AB_2678189"	"unprognostic (1.70e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-2)"	"unprognostic (8.49e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.66e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.80e-1)"	1.2	0.2	0.3	0.5	0.2	54.8	0.2	0.1	0.8	0.2	0.2	0.5	0.0	0.2	0.2	0.1	0.4	0.9	0.4	9.8	0.6	0.1	0.3	1.2	9.7	5.2	1.8	0.0	0.9	0.3	0.1	0.6	4.1	0.6	0.1	0.2	0.9	0.5	0.1	0.2	0.2	0.2	0.4	0.2	24.2	0.3	1.0	0.3	2.6	0.6	0.2	0.2	0.4	7.5	0.4	3.6	48.2	18.6	1.1	1.2	8.1	0.2	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	4.1	0.1	0.4	0.0	0.4	0.5	0.0	0.5	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.0	1.6	0.2	0.2	0.2	0.0	4.8	0.0	0.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.1	17.0	18.6	24.6	0.1	1.4	0.0	0.2	0.1	0.2	3.6	0.4	0.7	1.2	48.2	1.1	0.4	1.6	0.1	8.1	0.3	0.2	0.1	0.8	0.6	0.1	1.8	0.0	0.6	0.3
PAFAH1B1	"LIS1, MDCR, MDS, NudF, PAFAH"	ENSG00000007168	"Platelet activating factor acetylhydrolase 1b regulatory subunit 1"	P43034	17	2593210-2685615	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Lipid degradation, Lipid metabolism, Mitosis, Neurogenesis, Transport"	"Developmental protein"	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004489, HPA020036"	Approved		Supported	Centrosome			1100000	Centrosome		"CAB004489: AB_627889, HPA020036: AB_1854925"	"unprognostic (1.54e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.19e-3)"	"unprognostic (3.17e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.89e-3)"	"unprognostic (5.80e-2)"	"prognostic favourable (3.16e-4)"	"unprognostic (3.31e-1)"	"unprognostic (3.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (5.58e-2)"	20.1	20.4	35.6	17.0	40.8	10.0	20.8	57.1	63.7	22.3	21.5	24.2	13.8	19.2	23.8	21.1	21.9	20.1	19.6	28.8	33.7	38.3	24.7	17.2	23.0	18.2	34.3	47.0	22.4	16.4	37.5	26.2	20.2	46.5	20.9	20.9	14.8	17.6	24.1	41.6	27.2	21.9	27.2	29.9	17.9	19.3	37.2	28.0	25.9	26.9	17.3	22.8	18.6	25.5	7.5	3.5	9.3	5.3	8.7	13.3	3.9	22.1	21.1	32.6	12.1	25.7	30.4	17.0	30.8	27.0	26.9	27.8	25.7	10.3	25.0	25.7	38.0	23.1	28.5	23.0	33.7	20.9	18.1	20.3	21.5	9.8	26.6	14.1	35.7	26.5	29.3	27.1	32.3	23.5	15.0	28.2	33.1	9.1	22.2	10.5	14.6	10.3	15.9	25.2	12.9	23.6	12.4	14.7	24.1	26.7	13.3	24.3	14.2	11.0	33.2	29.5	14.2	23.1	26.5	12.0	18.5	19.6	23.8	13.1	28.4	7.8	3.4	6.5	7.7	4.3	9.7	7.5	10.1	8.3	3.5	5.2	9.5	8.1	9.3	8.7	5.3	2.7	13.3	3.9	35.6	40.8	57.1	46.2	33.7	38.3	34.3	47.0	46.5	28.0
PAICS	"ADE2H1, AIRC, PAIS"	ENSG00000128050	"Phosphoribosylaminoimidazole carboxylase and phosphoribosylaminoimidazolesuccinocarboxamide synthase"	P22234	4	56435741-56464579	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	"Decarboxylase, Ligase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035895, HPA041538"	Uncertain		Approved	Cytosol			340000	Cytosol		"HPA035895: AB_10669660, HPA041538: AB_2677540"	"unprognostic (2.59e-3)"	"unprognostic (7.90e-3)"	"unprognostic (3.84e-3)"	"unprognostic (2.88e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.82e-3)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (8.07e-3)"	"unprognostic (1.23e-2)"	"prognostic favourable (8.44e-4)"	"unprognostic (1.48e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (5.85e-5)"	"unprognostic (7.11e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (2.16e-1)"	15.5	27.1	21.6	20.4	17.4	21.4	29.3	15.8	20.6	17.5	22.5	18.5	18.4	17.2	19.6	12.6	29.0	19.6	11.4	13.4	16.7	22.6	26.5	63.7	11.3	25.6	26.4	19.2	23.3	27.7	26.2	17.9	24.3	29.8	17.5	30.5	13.1	15.7	16.8	23.8	20.0	16.1	19.4	23.5	19.8	12.8	18.3	15.9	44.9	17.8	26.8	33.1	18.7	18.9	13.7	12.8	3.2	6.4	10.9	14.4	6.7	33.9	25.5	52.8	32.6	11.3	25.6	45.5	29.5	21.4	42.3	41.8	40.5	40.5	78.8	34.3	19.7	21.0	83.2	42.8	72.7	15.7	29.3	42.8	39.1	44.8	21.7	76.0	19.1	21.6	31.1	44.9	34.0	34.7	73.8	29.4	36.4	22.7	87.3	38.1	60.4	32.0	70.9	22.6	51.8	40.1	23.9	56.7	33.9	29.0	40.6	17.8	26.8	24.4	18.6	33.6	43.9	33.0	60.2	20.8	17.8	82.9	35.4	55.7	36.9	3.2	3.7	0.3	4.1	6.4	11.8	13.7	11.5	7.3	11.4	8.9	14.4	12.1	0.9	10.9	4.8	12.8	8.3	6.7	21.6	17.4	15.8	20.6	16.7	22.6	26.4	19.2	29.8	15.9
PAK1		ENSG00000149269	"P21 (RAC1) activated kinase 1"	Q13153	11	77321707-77474635	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Exocytosis"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.0;brain: 71.4"	"Cell line enhanced"	"Detected in many"		"U-266/70: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4"	"Group enriched"	"Detected in all"	11	"dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003565, CAB005312"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			200000	"Plasma membrane, Cytosol"		"CAB005312: AB_2160720, HPA003565: AB_1854935"	"unprognostic (1.15e-2)"	"unprognostic (3.23e-2)"	"prognostic favourable (5.87e-4)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.62e-2)"	"unprognostic (8.19e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.52e-2)"	5.4	6.0	30.5	13.8	39.5	22.9	7.8	49.1	71.4	9.8	18.2	8.4	2.3	18.2	9.1	13.3	9.9	9.8	13.2	5.3	19.0	16.9	11.3	6.0	6.9	7.5	12.8	40.6	10.4	9.2	11.8	10.8	11.9	39.2	12.2	20.2	5.4	10.4	8.8	34.0	6.7	18.9	11.6	7.8	11.7	17.1	11.1	6.6	7.6	17.7	3.9	9.4	10.5	10.4	2.7	42.3	70.0	30.4	4.3	2.4	12.2	11.8	8.0	17.4	7.8	7.1	11.9	13.9	13.6	9.7	12.9	15.2	11.4	15.9	10.6	5.0	11.7	6.1	12.1	14.4	20.4	12.2	9.8	11.2	5.4	0.7	4.7	18.9	16.6	8.8	8.7	15.1	22.5	3.0	7.4	18.7	23.4	0.8	12.0	8.7	25.7	6.9	18.5	22.5	0.4	3.3	9.9	7.5	7.4	7.3	3.1	5.7	13.9	8.6	0.2	8.6	14.9	45.9	11.3	51.4	26.4	7.0	7.2	12.6	9.3	0.3	29.3	45.0	1.9	28.7	1.5	2.7	1.4	1.8	42.3	1.9	1.3	2.4	70.0	4.3	30.4	3.6	1.1	12.2	30.5	39.5	49.1	71.4	19.0	16.9	12.8	40.6	39.2	6.6
PAK2	"PAK65, PAKgamma"	ENSG00000180370	"P21 (RAC1) activated kinase 2"	Q13177	3	196739857-196832647	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Growth regulation, Host-virus interaction"	"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB007794	Approved		Approved	Nucleoplasm,Vesicles			590000	"Nucleoplasm, Vesicles"		"CAB007794: AB_562363"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.85e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.36e-4)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (1.30e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.39e-1)"	28.7	18.9	22.4	27.6	23.5	21.4	56.5	17.4	20.7	19.5	23.0	27.8	17.4	19.0	22.6	19.2	23.4	17.9	20.7	29.0	22.6	22.0	19.5	34.3	35.7	50.2	26.8	13.5	19.9	16.6	30.5	13.0	27.6	22.8	17.7	23.0	12.9	19.6	21.2	34.2	16.3	25.2	23.0	32.1	34.6	18.4	15.9	24.8	44.9	16.9	19.1	31.9	24.1	32.7	6.6	13.7	25.9	12.6	6.6	10.8	7.0	35.2	12.6	17.8	13.0	12.6	16.7	26.4	17.9	14.8	19.5	17.8	29.9	18.1	22.6	51.2	18.1	18.1	18.8	17.0	30.2	10.1	9.1	33.5	14.5	23.5	25.6	32.5	32.2	13.3	14.0	17.4	37.1	19.2	16.1	28.2	18.9	37.2	30.9	16.8	10.6	19.0	28.3	10.1	20.5	17.0	24.8	10.4	11.8	23.9	16.9	13.5	59.3	23.6	19.8	16.2	9.0	16.9	26.3	19.2	33.9	55.7	13.4	32.6	15.3	16.5	10.3	24.5	6.3	12.6	8.5	6.4	7.3	7.1	13.7	6.6	5.4	6.3	25.9	6.6	10.8	5.1	10.8	7.0	22.4	23.5	17.4	20.7	22.6	22.0	26.8	13.5	22.8	24.8
PAK5	"KIAA1264, PAK7"	ENSG00000101349	"P21 (RAC1) activated kinase 5"	Q9P286	20	9537389-9839041	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 30.3"	"Group enriched"	"Detected in some"	9	"SCLC-21H: 10.0;SH-SY5Y: 3.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020444	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA020444: AB_1854947"	"unprognostic (5.14e-5)"			"unprognostic (3.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.63e-2)"		"unprognostic (3.21e-1)"		"unprognostic (3.04e-1)"	"unprognostic (2.25e-4)"	"unprognostic (3.76e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (6.04e-2)"	"unprognostic (4.58e-1)"	0.5	5.2	5.7	0.6	11.7	0.5	1.6	30.3	19.6	0.8	0.6	0.8	0.0	0.7	1.0	2.2	1.0	0.7	3.4	0.6	4.0	3.3	1.0	2.3	0.7	0.6	1.6	8.8	0.6	3.5	0.5	2.0	0.6	5.3	1.6	0.6	0.6	1.2	1.6	0.6	1.6	0.6	0.6	1.2	0.6	1.2	1.0	1.7	0.0	0.6	0.0	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	10.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	5.7	11.7	30.3	13.6	4.0	3.3	1.6	8.8	5.3	1.7
PAK6	PAK5	ENSG00000137843	"P21 (RAC1) activated kinase 6"	Q9NQU5	15	40238759-40277487	"Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 22.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.5;HaCaT: 22.5;hTCEpi: 13.8;SK-BR-3: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA031124	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cell Junctions"				"Nucleoplasm, Nucleoli fibrillar center"	"Cell Junctions"	"HPA031124: AB_10601044"	"unprognostic (1.85e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.79e-3)"	"unprognostic (7.08e-3)"	"unprognostic (9.57e-2)"		"unprognostic (2.71e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.34e-2)"	"unprognostic (7.13e-3)"	"unprognostic (4.04e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.37e-3)"	"unprognostic (3.34e-2)"	0.3	5.3	14.7	0.8	18.4	0.8	2.3	11.3	20.1	3.0	1.3	1.6	2.5	1.4	1.0	1.1	15.8	4.3	1.4	7.9	11.6	5.2	3.4	0.4	2.6	1.0	3.0	10.9	0.6	7.4	12.9	6.4	8.1	2.1	3.6	1.2	0.3	3.4	7.5	3.5	22.2	1.4	0.8	1.2	1.0	3.6	12.8	2.2	0.0	7.4	8.5	5.1	3.0	5.1	1.4	0.7	2.9	0.7	2.0	5.5	1.2	2.6	0.0	0.2	0.1	0.0	0.0	4.3	0.0	0.1	0.6	0.4	14.5	2.0	0.1	2.3	0.0	22.5	3.2	4.8	0.2	0.1	0.7	0.0	1.9	0.1	0.0	0.1	0.3	0.0	13.8	0.2	3.2	0.0	1.1	0.2	0.0	3.1	0.0	0.3	0.4	2.0	0.2	0.1	1.8	1.1	5.9	5.2	1.3	1.8	7.6	0.2	0.8	7.0	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.0	0.5	0.3	0.1	2.1	0.7	2.9	5.5	0.3	2.1	1.4	0.5	4.2	0.7	0.5	0.3	1.2	1.3	2.0	0.2	0.5	0.1	1.2	14.7	18.4	11.3	20.1	11.6	5.2	3.0	10.9	2.1	2.2
PAM	"PAL, PHM"	ENSG00000145730	"Peptidylglycine alpha-amidating monooxygenase"	P19021	5	102753981-103031105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Lyase, Monooxygenase, Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 304.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 76.6;fHDF/TERT166: 98.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026119, HPA042260"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Secreted in other tissues"		59000000	"Golgi apparatus, Cytosol"		"CAB026119: , HPA042260: "	"unprognostic (4.30e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"prognostic favourable (1.63e-4)"	"unprognostic (4.23e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (7.58e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.71e-1)"	"unprognostic (9.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.79e-2)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	16.5	24.5	8.2	6.5	16.4	0.8	17.3	6.6	16.5	74.9	14.0	5.4	9.5	5.8	21.3	83.8	11.7	10.6	11.5	304.2	8.8	23.5	13.7	2.1	13.2	5.8	10.0	7.6	17.0	16.4	49.5	18.3	26.3	15.5	13.4	9.5	8.7	53.8	29.4	22.0	8.5	8.5	18.5	4.8	8.9	17.2	7.2	4.6	1.8	21.7	13.2	7.3	15.8	15.3	0.5	2.0	10.1	5.3	16.2	14.1	6.3	14.9	2.2	27.6	12.2	76.6	45.9	11.0	42.6	63.8	12.6	38.5	7.3	19.9	0.0	9.2	98.2	5.1	1.5	18.7	34.9	1.8	6.2	3.1	9.0	2.3	11.6	0.9	3.4	25.1	8.1	9.2	7.0	26.0	0.1	2.1	35.7	3.0	0.0	0.4	4.9	8.3	1.1	15.4	8.3	48.7	1.7	13.1	9.0	18.1	1.1	11.1	4.7	1.0	20.0	40.1	10.4	18.8	12.6	4.7	1.1	0.0	46.0	4.2	34.5	1.9	5.3	0.1	14.1	0.9	10.0	0.5	8.5	10.4	2.0	0.3	2.9	4.8	10.1	16.2	1.9	1.1	12.1	6.3	8.2	16.4	6.6	16.5	8.8	23.5	10.0	7.6	15.5	4.6
PANK2	"C20orf48, FLJ11729, HARP, HSS, NBIA1, PKAN"	ENSG00000125779	"Pantothenate kinase 2"	Q9BZ23	20	3888839-3929882	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Coenzyme A biosynthesis"	"Kinase, Transferase"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008440	Approved		Supported	Cytosol				Cytosol		"HPA008440: AB_1079559"	"unprognostic (4.50e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.75e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.81e-1)"	15.2	21.5	18.7	18.5	18.9	20.8	19.7	21.8	24.8	14.7	14.4	16.8	10.7	11.8	15.5	15.5	28.9	19.1	14.3	11.0	17.4	18.6	18.8	20.3	16.1	18.5	16.2	16.2	14.4	13.5	15.3	15.7	18.1	20.8	14.5	16.4	17.0	15.8	13.2	14.4	12.8	14.5	16.6	12.3	20.6	12.1	28.9	14.1	23.2	17.0	10.5	24.6	17.3	16.4	5.8	8.6	8.0	12.8	8.3	6.4	3.1	21.4	13.9	15.0	7.6	18.0	15.6	8.2	14.1	15.5	18.6	24.1	18.7	11.5	17.4	6.5	15.8	17.7	16.1	27.4	23.8	5.1	7.1	23.8	9.9	34.9	15.1	15.8	7.9	13.7	12.0	20.7	13.4	17.4	17.5	16.3	20.0	5.3	13.6	14.0	15.0	10.4	11.2	20.9	11.0	11.5	19.7	19.6	9.6	17.5	19.2	34.9	11.6	12.8	11.9	22.3	11.2	29.1	21.6	9.2	26.6	13.3	6.6	14.5	17.4	1.6	11.2	4.7	4.4	12.8	4.3	4.7	4.3	4.5	8.6	5.8	4.4	4.0	8.0	8.3	10.7	3.0	6.4	3.1	18.7	18.9	21.8	24.8	17.4	18.6	16.2	16.2	20.8	14.1
PAPD5	TRF4-2	ENSG00000121274	"Poly(A) RNA polymerase D5, non-canonical"	Q8NDF8	16	50152918-50235310	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, rRNA processing"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042968, HPA048225"	Uncertain									"HPA042968: , HPA048225: "	"unprognostic (1.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-2)"	"prognostic favourable (1.85e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.00e-2)"	9.4	9.9	5.9	8.8	8.6	19.2	12.6	14.9	10.8	15.9	10.0	4.5	8.8	11.1	13.1	6.3	7.4	10.8	6.3	8.0	7.7	6.9	10.0	11.9	8.5	11.2	6.4	8.0	10.5	7.9	18.5	13.4	9.2	7.5	10.0	6.4	6.7	7.6	9.8	9.9	8.1	9.4	9.7	6.1	6.0	8.0	12.3	8.0	6.8	7.5	6.0	6.6	13.1	30.8	3.5	4.9	4.6	2.9	7.2	5.6	1.2	11.3	8.7	7.1	12.7	11.2	9.5	9.1	10.2	10.4	12.3	5.7	12.0	8.1	13.7	12.2	12.4	8.6	13.3	7.6	16.2	8.0	8.7	8.2	4.7	15.5	12.6	6.8	12.7	5.7	9.4	10.1	12.8	8.5	8.4	4.8	11.3	4.9	9.5	10.2	9.2	9.4	12.8	14.2	17.9	3.5	4.2	9.1	5.4	10.3	13.3	7.0	4.4	5.0	7.3	11.4	10.0	9.9	5.8	9.6	7.4	18.1	6.8	6.3	8.1	4.6	2.6	1.3	4.0	2.9	3.5	2.9	4.3	4.8	2.0	3.5	4.8	5.6	4.0	7.2	2.1	4.9	3.7	1.2	5.9	8.6	14.9	10.8	7.7	6.9	6.4	8.0	7.5	8.0
PAPLN	MGC50452	ENSG00000100767	"Papilin, proteoglycan like sulfated glycoprotein"	O95428	14	73237497-73274640	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 12.9;HSkMC: 24.3;hTCEpi: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"neutrophil: 4.4;plasmacytoid DC: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 8.8;granulocytes: 4.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA048682, HPA053453"	Uncertain		Approved	Nucleoplasm	"Secreted - unknown location"		46000000	Nucleoplasm		"HPA048682: , HPA053453: "	"unprognostic (1.97e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.56e-3)"	"unprognostic (7.42e-2)"	"unprognostic (7.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.46e-3)"	"unprognostic (9.13e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.69e-2)"	"unprognostic (5.58e-2)"	9.3	6.1	13.6	11.8	14.8	2.9	11.0	4.1	11.1	10.8	7.0	6.0	3.8	4.1	14.2	19.5	4.6	12.1	8.0	4.8	15.7	3.0	24.9	1.9	7.8	23.3	4.1	9.7	10.9	2.7	1.0	11.1	5.2	5.7	8.1	6.2	14.9	4.7	10.2	1.8	16.2	10.3	8.6	6.0	17.6	7.4	6.5	8.9	5.1	15.3	2.2	16.5	6.8	5.6	1.1	8.8	4.4	0.8	0.5	0.5	0.2	2.0	1.9	0.8	0.3	1.5	1.8	4.6	0.4	0.0	0.1	0.1	2.5	0.6	0.4	2.1	0.0	3.3	2.0	1.5	0.2	2.3	3.1	0.9	3.2	0.3	12.9	0.3	1.7	24.3	9.0	0.4	1.3	0.4	0.6	0.3	0.0	1.0	0.2	2.2	0.5	0.6	0.3	0.3	2.1	1.8	0.4	0.2	0.4	4.8	5.4	0.9	0.1	3.6	0.4	0.6	1.8	0.2	0.2	1.0	0.1	0.2	1.1	1.0	0.5	1.1	0.8	0.6	0.4	0.5	0.2	0.7	0.3	0.5	0.2	1.1	0.5	0.5	4.4	0.5	0.4	8.8	0.5	0.2	13.6	14.8	4.1	11.1	15.7	3.0	4.1	9.7	5.7	8.9
PAPOLA	PAP	ENSG00000090060	"Poly(A) polymerase alpha"	P51003	14	96501433-96567111	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001788	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA001788: AB_1079564"	"unprognostic (3.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.10e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavourable (2.41e-5)"	"unprognostic (2.12e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.05e-1)"	35.8	43.4	49.1	45.7	51.6	54.5	39.7	61.2	60.5	41.0	45.1	25.2	45.6	34.9	43.8	48.3	42.0	38.7	35.6	71.8	46.3	39.6	40.0	50.2	37.1	44.7	48.1	39.7	58.2	52.9	50.2	68.7	54.5	45.6	45.1	45.8	24.0	39.2	45.5	46.4	35.5	45.5	38.9	41.9	50.9	40.4	53.0	55.7	53.0	54.8	34.8	49.6	44.9	119.5	26.4	23.0	39.0	23.5	25.2	23.4	19.8	32.0	31.0	39.9	40.0	28.9	32.7	90.8	29.4	31.8	35.0	33.7	35.8	33.2	43.5	33.9	34.4	27.8	13.0	40.5	62.8	35.9	21.1	35.1	23.5	35.1	29.9	45.9	35.6	29.8	35.5	39.1	35.0	39.1	32.9	39.9	33.7	46.7	35.9	23.3	27.2	35.3	38.4	48.6	25.2	34.9	51.2	41.0	27.2	39.2	30.8	28.6	43.7	40.4	31.1	24.7	19.7	27.8	35.8	31.5	47.1	38.4	40.0	35.2	41.4	39.0	19.7	32.7	15.5	23.5	20.4	23.8	19.6	22.6	23.0	26.4	23.4	21.8	27.4	25.2	22.6	15.2	18.7	19.8	49.1	51.6	61.2	60.5	46.3	39.6	48.1	39.7	45.6	55.7
PAPOLB	PAPT	ENSG00000218823	"Poly(A) polymerase beta"	Q9NRJ5	7	4857733-4861994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"testis: 33.0"	"Cell line enhanced"	"Detected in single"		"THP-1: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																						"unprognostic (7.58e-2)"					"unprognostic (1.25e-1)"				"unprognostic (1.68e-2)"	"unprognostic (1.78e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.5	0.1
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153804-116402322	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	86	"placenta: 484.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.0;ASC TERT1: 14.5;HSkMC: 52.2;U-138 MG: 13.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"midbrain: 10.4;olfactory region: 4.1;pons and medulla: 8.3;thalamus: 4.8"	"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"		41000			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.8	2.3	0.5	1.0	0.5	0.0	0.8	0.4	0.6	3.6	2.4	0.6	1.0	0.1	3.5	1.0	3.6	2.0	1.1	3.7	0.4	0.0	4.3	0.5	2.4	0.7	0.4	0.4	1.4	0.7	5.6	0.7	484.6	0.7	1.4	0.9	0.9	0.5	1.2	0.5	1.1	0.9	2.4	0.6	0.6	1.0	0.8	0.5	0.4	1.3	1.0	1.0	2.3	3.4	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	5.4	8.3	0.0	19.0	14.5	0.0	4.4	7.8	1.2	2.1	0.0	0.0	0.0	0.0	3.1	0.6	0.0	0.0	5.9	0.0	0.0	0.9	4.5	0.0	9.2	0.0	0.0	52.2	0.0	6.1	0.7	0.0	0.2	0.0	1.4	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	10.5	13.6	0.7	0.3	0.5	0.0	0.0	0.0	9.7	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.4	0.6	0.4	0.0	0.4	0.4	0.7	0.5
PARD3	"ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118"	ENSG00000148498	"Par-3 family cell polarity regulator"	Q8TEW0	10	34109560-34815325	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	25	"basophil: 9.0"	"Lineage enriched"	"Detected in single"	73	"granulocytes: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030443	Approved		Supported	"Cell Junctions,Cytoplasmic bodies"				"Cell Junctions"	"Cytoplasmic bodies"	"HPA030443: AB_10600926"	"unprognostic (9.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (1.73e-5)"	"unprognostic (3.48e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.20e-2)"	"prognostic unfavourable (4.41e-4)"	16.4	12.9	13.8	7.0	15.8	0.3	16.8	4.4	8.3	24.8	20.3	7.4	19.7	7.1	21.4	13.6	34.5	14.7	13.2	17.1	10.7	6.3	18.0	15.9	15.2	3.0	7.8	4.3	28.4	26.2	19.0	15.8	14.4	8.8	20.5	15.3	11.7	15.5	17.3	28.3	34.4	14.9	21.1	8.7	3.3	14.2	9.1	9.2	12.8	15.6	14.6	13.4	20.7	29.5	0.0	0.0	9.0	0.1	0.0	0.0	2.1	18.9	46.1	15.7	10.6	11.8	10.1	22.4	8.6	10.4	15.3	17.3	16.8	16.1	0.1	12.5	18.0	13.8	13.3	22.3	19.9	0.1	9.9	0.0	5.8	17.2	15.0	2.0	0.0	12.2	21.4	20.0	15.2	9.6	12.8	6.0	18.4	13.2	21.3	1.4	6.6	16.4	17.0	15.9	8.3	31.8	14.6	8.1	8.1	10.2	14.7	15.9	8.2	2.5	11.0	7.7	22.4	14.3	9.0	4.9	6.0	0.0	8.3	0.0	8.4	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.1	13.8	15.8	4.4	8.3	10.7	6.3	7.8	4.3	8.8	9.2
PARD3B	"ALS2CR19, PAR3beta, Par3L"	ENSG00000116117	"Par-3 family cell polarity regulator beta"	Q8TEW8	2	204545793-205620162	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.9;BJ hTERT+: 10.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035283	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA035283: AB_10671102"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (2.67e-10)"	"unprognostic (1.74e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.09e-2)"	13.9	4.3	6.7	6.9	6.5	0.0	8.6	2.1	4.6	11.9	17.5	8.3	11.3	5.3	15.1	8.9	7.1	10.3	11.8	6.7	7.9	5.3	10.8	5.0	8.2	2.9	7.5	4.3	12.6	12.3	13.5	3.6	6.3	7.7	11.7	8.5	14.7	5.0	8.5	4.5	7.1	14.1	26.1	6.7	4.4	7.2	5.4	7.5	0.8	8.6	7.3	3.7	9.6	22.7	0.0	0.0	0.0	0.1	0.0	1.0	0.1	2.2	1.8	5.4	1.9	16.9	8.0	3.1	3.4	10.7	2.8	3.2	5.0	1.5	0.0	4.1	6.7	0.2	0.7	0.8	3.0	0.1	2.7	7.4	4.4	0.0	1.7	0.0	0.4	3.1	1.5	1.0	4.8	4.2	0.2	0.1	4.0	0.8	0.0	0.0	0.8	0.5	0.0	2.6	1.8	3.5	2.3	0.6	1.8	1.8	1.7	1.4	2.6	0.0	9.4	2.3	1.6	4.8	1.6	0.0	0.0	0.0	2.3	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.1	0.0	0.0	0.1	6.7	6.5	2.1	4.6	7.9	5.3	7.5	4.3	7.7	7.5
PARD6A	"PAR-6, PAR-6A, PAR6alpha, TAX40, TIP-40"	ENSG00000102981	"Par-6 family cell polarity regulator alpha"	Q9NPB6	16	67660946-67662778	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.8;pancreas: 31.0"	"Cell line enhanced"	"Detected in many"		"REH: 17.6;RPMI-8226: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009733, HPA041551"	Approved		Supported	"Cell Junctions,Actin filaments,Cytosol"				"Cell Junctions, Actin filaments"	Cytosol	"CAB009733: AB_2159676, HPA041551: "	"prognostic favourable (5.40e-4)"	"unprognostic (6.18e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-3)"	"unprognostic (9.13e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (9.22e-3)"	"unprognostic (6.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-2)"	2.7	6.1	11.7	3.5	12.4	2.1	2.8	26.8	16.1	2.0	3.0	2.2	3.7	2.0	2.4	3.6	2.7	2.5	3.1	2.3	13.8	7.2	5.5	3.1	3.5	4.0	7.9	5.7	3.3	31.0	5.3	13.9	1.5	7.4	2.7	2.0	1.4	3.8	4.6	7.0	1.5	2.5	2.7	3.7	3.7	3.2	16.9	3.4	2.5	2.3	1.4	3.4	2.9	3.1	11.4	5.3	3.7	1.0	1.2	8.5	2.1	5.6	6.1	1.7	14.9	1.2	0.2	3.1	0.1	0.7	2.2	2.1	3.0	2.4	9.5	2.9	0.1	4.5	3.4	0.7	0.5	4.4	3.2	3.8	2.8	3.5	1.6	1.6	9.0	0.1	0.3	2.1	0.8	1.1	0.3	2.2	0.4	5.5	9.7	2.0	2.0	4.0	17.6	1.1	15.3	5.9	3.3	14.5	7.8	0.9	2.1	2.3	13.1	0.6	0.9	0.2	0.5	1.4	2.9	2.3	7.4	8.4	1.7	3.4	0.6	2.1	1.0	0.4	4.5	0.5	8.5	11.4	6.4	5.9	1.2	7.4	3.2	2.4	3.7	1.2	0.1	5.3	6.1	2.1	11.7	12.4	26.8	16.1	13.8	7.2	7.9	5.7	7.4	3.4
PARG		ENSG00000227345	"Poly(ADP-ribose) glycohydrolase"	Q86W56	10	49818279-49970203	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021819, HPA053007"	Enhanced		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA021819: AB_1854974, HPA053007: "	"unprognostic (5.77e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (5.57e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.06e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.13e-1)"	4.0	5.6	4.3	4.2	5.4	1.4	5.3	7.8	6.3	4.8	5.1			6.7	4.9	3.0	6.2	4.3	3.6	6.6	4.6	5.9	9.2	5.2	3.5	5.8	4.5		4.7	3.5	8.1	4.7	5.8		4.9	6.1		4.7	5.1	8.1	6.7	5.1	4.7	4.0	5.9	4.7	5.8			4.9		6.9	4.4	4.8	6.9	7.0	12.5	7.7	8.3	9.4	5.5	12.7	10.6	18.7	13.7	9.0	11.2	13.7	12.7	14.0	14.8	14.2	8.5	11.9	9.6	8.3	10.8	14.5	15.7	8.0	16.0	14.7	14.6	9.8	8.7	9.3	10.2	14.1	8.2	7.2	15.5	12.4	20.5	9.0	16.6	8.5	11.1	7.1	15.6	12.7	18.4	24.3	18.6	21.2	11.1	12.0	8.2	12.9	16.3	10.3	16.4	13.3	18.9	7.9	9.1	9.3	11.3	9.6	14.2	9.4	14.1	20.5	15.9	15.0	6.7	12.5	6.2	3.0	5.2	5.5	7.9	6.9	7.1	6.7	7.0	6.9	9.4	9.1	3.0	8.3	7.7	5.4	5.5	5.5										
PARK7	"DJ-1, DJ1, GATD2"	ENSG00000116288	"Parkinsonism associated deglycase"	Q99497	1	7954291-7985505	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Fertilization, Inflammatory response, Stress response"	"Chaperone, Hydrolase, Protease, RNA-binding"	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004190, CAB005870"	Supported		Supported	Nucleoplasm,Cytosol			69000000	"Nucleoplasm, Cytosol"		"CAB005870: AB_444361, HPA004190: AB_1079566"	"unprognostic (6.88e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.16e-2)"	"unprognostic (4.08e-2)"	"unprognostic (5.68e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.96e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.43e-2)"	44.6	67.9	69.3	38.1	64.9	33.7	45.4	57.2	62.7	34.0	36.4	33.4	43.2	27.3	35.8	56.6	40.9	39.0	41.6	71.7	56.9	57.2	60.5	77.1	28.6	46.1	61.6	57.2	45.9	60.4	66.6	48.4	44.6	41.2	44.7	39.5	38.6	46.5	39.4	128.7	19.8	27.5	48.1	52.5	37.5	37.2	38.2	32.2	38.8	71.6	43.3	46.5	41.3	43.4	49.5	141.8	38.8	61.0	52.8	87.2	90.6	68.2	61.5	61.3	70.4	66.0	63.5	30.1	63.6	59.6	62.6	50.6	56.0	74.8	84.7	71.9	68.2	49.0	66.1	85.0	81.4	75.3	71.4	91.0	91.9	83.1	57.0	86.8	56.1	59.8	36.3	63.8	76.7	65.6	88.3	63.1	86.8	63.9	60.4	110.3	50.0	63.5	46.5	82.3	116.1	98.2	35.1	71.7	60.2	63.6	98.3	99.2	54.8	64.7	62.1	57.8	46.1	53.3	69.7	61.3	98.3	120.5	76.2	132.9	81.8	22.7	61.0	38.8	52.6	55.4	49.7	49.5	52.7	62.2	73.9	38.6	45.6	52.4	21.0	52.8	44.1	141.8	87.2	90.6	69.3	64.9	57.2	62.7	56.9	57.2	61.6	57.2	41.2	32.2
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm			39000	Nucleoplasm		"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: , CAB075727: , HPA045168: "	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavourable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.5	15.3	42.6	30.1	11.2	9.2	24.3	18.9	16.9	25.8	21.2	24.3	14.0	83.2	28.3	11.5	21.5	58.5	18.6	22.7	34.9	81.7	32.2	20.4	15.9	6.7	53.4	15.6	9.1	7.4	20.7	14.7	20.0	51.2	42.5	13.3	13.6	17.1	19.3	78.4	30.4	51.8	73.0	76.9	12.1	20.4	42.9	37.6	24.6	27.6	15.5	23.2	33.5	15.2	13.7	22.7	18.5	35.4	17.3	29.0	71.5	11.4	18.1	30.7	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8
PARP12	"FLJ22693, PARP-12, ZC3H1, ZC3HDC1"	ENSG00000059378	"Poly(ADP-ribose) polymerase family member 12"	Q9H0J9	7	140023744-140063721	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 11.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA003584, HPA063872"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003584: AB_1079568, HPA063872: "	"unprognostic (1.46e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.86e-3)"	"unprognostic (7.51e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavourable (4.12e-7)"	"unprognostic (3.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.75e-2)"	"unprognostic (6.01e-2)"	3.1	1.8	1.0	3.7	0.9	6.1	2.5	0.1	0.7	2.1	2.2			4.2	2.8	4.2	2.1	2.5	3.1	1.7	1.0	1.0	3.1	3.0	5.2	3.8	1.0		3.2	2.7	2.5	3.3	3.4		2.8	3.9		4.3	1.4	0.9	8.6	4.4	1.5	1.3	6.0	2.3	5.7			3.2		2.7	1.9	3.1	1.0	1.3	3.4	2.0	2.3	3.3	2.4	3.7	2.3	0.0	0.4	1.1	0.4	3.8	0.6	0.5	4.6	7.8	2.7	3.5	1.7	2.8	1.1	3.7	1.5	4.3	1.3	4.6	4.6	1.4	1.3	1.7	2.0	0.4	1.4	1.5	2.5	2.0	4.2	4.9	4.1	2.3	0.0	2.9	4.4	11.9	0.2	6.8	2.0	0.0	0.0	2.0	2.3	1.4	0.0	2.4	1.1	3.4	0.6	0.9	9.4	1.5	2.1	0.5	3.4	0.1	0.1	0.4	0.9	5.8	0.8	0.7	2.0	2.2	2.9	1.7	1.1	0.3	1.9	2.9	1.3	1.0	0.6	1.9	3.4	2.3	1.9	0.7	3.3	2.4										
PARP14	"KIAA1268, pART8"	ENSG00000173193	"Poly(ADP-ribose) polymerase family member 14"	Q460N5	3	122680618-122730840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 29.2;BJ hTERT+ SV40 Large T+ RasG12V: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA008846, HPA012063"	Supported		Supported	Cytosol				Cytosol		"HPA008846: AB_1854982, HPA012063: AB_1854981"	"unprognostic (4.38e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.71e-2)"	21.6	10.3	5.6	15.8	7.2	11.7	9.3	2.3	6.0	11.6	13.3	5.9	6.4	11.4	10.6	12.7	11.7	7.2	10.0	6.5	5.2	4.8	13.7	21.5	26.0	16.7	7.3	5.2	10.0	6.7	7.2	6.8	17.5	6.3	12.3	6.7	7.5	8.5	5.5	5.2	5.7	22.3	11.9	6.8	29.7	7.6	4.6	4.9	18.7	20.4	6.4	18.9	12.8	12.4	15.9	4.2	20.8	10.5	7.4	7.0	2.8	5.9	4.9	3.1	3.3	4.4	10.6	0.0	2.3	15.5	29.2	45.1	2.6	11.7	0.0	9.7	5.1	4.6	4.6	4.7	6.0	9.0	0.5	5.4	2.3	4.0	10.8	2.4	2.7	6.4	2.4	5.1	2.0	12.6	2.5	8.8	1.0	3.0	9.1	1.6	0.4	4.2	12.7	3.2	1.6	7.1	6.1	0.2	0.0	5.9	1.3	6.6	2.2	4.3	8.6	1.5	3.9	0.9	2.1	3.4	0.6	1.0	4.7	5.7	2.7	8.3	8.2	4.0	6.9	10.5	6.0	10.2	3.8	4.5	4.2	15.9	3.2	3.4	20.8	7.4	9.3	0.6	7.0	2.8	5.6	7.2	2.3	6.0	5.2	4.8	7.3	5.2	6.3	4.9
PARP9	"BAL, BAL1"	ENSG00000138496	"Poly(ADP-ribose) polymerase family member 9"	Q8IXQ6	3	122527924-122564577	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 34.9;BJ hTERT+ SV40 Large T+ RasG12V: 41.8;SK-MEL-30: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066708			Supported	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Cytosol"	Mitochondria	"HPA066708: "	"unprognostic (3.06e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.55e-3)"	"unprognostic (6.70e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.39e-3)"	"unprognostic (1.31e-1)"	"prognostic favourable (6.65e-4)"	"unprognostic (1.00e-3)"	"unprognostic (5.63e-3)"	"unprognostic (1.56e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.70e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.56e-2)"	27.1	20.2	8.7	17.2	12.4	9.1	13.8	2.9	13.9	13.1	13.1	9.9	7.4	10.4	23.3	10.1	15.6	12.3	14.9	8.5	7.4	6.0	17.8	38.6	18.9	17.5	8.5	6.0	12.1	14.4	16.0	20.3	11.9	10.3	15.1	10.1	11.5	19.1	6.6	8.6	5.7	21.2	14.8	16.3	27.3	11.1	5.4	10.3	21.8	17.5	9.0	19.1	13.7	9.8	7.3	11.9	38.2	18.0	13.0	10.6	9.1	8.0	2.7	1.0	0.7	6.2	13.0	0.9	2.7	14.7	34.9	41.8	4.2	8.9	1.8	6.0	5.4	8.9	2.3	4.8	7.3	13.9	1.6	8.7	2.8	2.2	6.7	2.8	5.8	10.5	4.7	4.9	1.2	7.4	0.8	7.5	1.4	3.5	8.9	3.5	0.4	7.6	9.5	9.9	0.6	13.4	4.6	0.6	2.4	7.1	1.2	32.3	3.8	3.1	4.4	1.5	4.4	0.3	1.6	4.6	2.4	3.3	5.2	3.0	2.7	14.4	12.7	15.3	9.2	17.7	8.6	7.3	9.8	10.3	11.9	5.0	7.5	9.1	38.2	13.0	18.0	1.4	10.6	9.1	8.7	12.4	2.9	13.9	7.4	6.0	8.5	6.0	10.3	10.3
PARVB	CGI-56	ENSG00000188677	"Parvin beta"	Q9HBI1	22	43999211-44172949	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 43.7;RPMI-8226: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062601, HPA072217"	Enhanced		Approved	Cytosol			90000000	Cytosol		"HPA062601: , HPA072217: "	"unprognostic (2.41e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.10e-3)"	"unprognostic (7.65e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.28e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.87e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.19e-2)"	"unprognostic (7.05e-3)"	15.9	10.7	6.4	9.7	7.3	16.8	17.4	3.1	8.3	8.0	7.2	3.5	6.3	3.7	8.6	8.7	7.3	6.8	5.3	28.5	5.6	8.8	7.3	7.3	12.6	19.7	8.0	6.3	13.4	4.8	8.6	9.3	10.2	5.8	7.8	4.4	9.3	5.3	7.2	82.1	5.1	6.3	11.9	8.3	15.2	5.4	5.7	4.5	2.3	4.9	22.4	7.9	11.7	26.0	6.3	14.1	4.8	6.4	0.7	2.2	8.3	6.3	7.5	0.1	5.3	8.0	10.2	0.0	8.9	5.5	5.8	4.4	7.8	3.8	0.0	4.9	23.8	0.2	12.7	0.5	3.2	8.9	7.9	27.1	13.2	0.0	13.4	20.4	24.4	15.9	6.7	4.2	0.0	43.7	9.7	18.6	6.3	4.2	0.1	13.4	2.7	5.2	0.0	0.2	42.7	0.1	0.1	6.9	4.8	2.3	0.4	22.4	4.4	8.3	27.2	5.3	5.7	8.2	0.9	4.6	4.0	0.2	23.4	6.0	29.3	4.5	6.1	1.4	1.0	6.4	1.6	6.0	1.7	1.4	6.8	6.3	0.4	0.9	4.8	0.7	2.6	14.1	2.2	8.3	6.4	7.3	3.1	8.3	5.6	8.8	8.0	6.3	5.8	4.5
PAXBP1	"C21orf66, fSAP105, GCFC, GCFC1"	ENSG00000159086	"PAX3 and PAX7 binding protein 1"	Q9Y5B6	21	32733899-32771858	"Plasma proteins, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003757	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA003757: AB_10600796"	"unprognostic (8.21e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.38e-3)"	"unprognostic (2.54e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (9.43e-4)"	"prognostic unfavourable (1.50e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	8.9	10.6	11.9	16.6	19.6	42.0	11.6	25.7	20.0	13.5	14.1	11.3	10.1	15.8	16.3	12.4	10.3	11.6	10.1	8.3	11.2	9.7	11.3	10.3	10.1	13.7	22.7	10.0	19.8	12.3	11.6	19.3	13.2	14.7	11.2	12.6	6.9	10.2	10.5	15.2	12.6	12.8	10.8	19.0	11.2	9.5	12.9	19.7	18.5	11.3	5.0	12.3	11.2	18.9	2.2	1.6	0.3	1.3	0.7	3.1	0.4	7.3	6.1	12.3	9.6	4.8	3.9	17.5	5.5	3.5	7.2	5.3	12.8	6.7	8.8	4.3	3.1	7.6	12.3	5.1	7.6	7.1	10.1	15.1	10.0	9.3	2.3	17.0	9.0	2.1	7.7	8.4	3.7	4.7	17.6	8.1	5.3	6.5	11.6	9.9	34.7	6.2	10.8	11.7	12.8	5.6	6.8	10.1	5.7	7.9	9.1	6.2	5.8	9.5	4.2	5.4	7.4	6.2	8.5	8.0	10.0	16.3	3.9	15.5	5.4	0.0	1.3	0.3	2.2	0.6	3.1	1.6	2.5	1.9	1.6	2.2	2.7	2.6	0.0	0.7	0.8	1.1	1.4	0.4	11.9	19.6	25.7	20.0	11.2	9.7	22.7	10.0	14.7	19.7
PBK	"CT84, FLJ14385, Nori-3, SPK, TOPK"	ENSG00000168078	"PDZ binding kinase"	Q96KB5	8	27809620-27838095	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"lymphoid tissue: 19.4;testis: 67.9"	"Cell line enhanced"	"Detected in many"		"A-431: 60.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 1.6"	"Group enriched"	"Detected in many"	10	"NK-cells: 2.1;T-cells: 1.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005753, HPA050656"	Enhanced	Supported	Approved	Cytosol				Cytosol		"HPA005753: AB_1855018, HPA050656: AB_2681205"	"unprognostic (7.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.04e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.29e-5)"	"unprognostic (3.65e-3)"	"unprognostic (7.38e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (1.18e-12)"	"unprognostic (9.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.68e-2)"	0.6	0.8	0.2	7.7	0.3	3.3	1.3	0.3	0.4	1.1	3.8	0.3	0.2	3.7	0.4	0.6	6.2	0.3	0.8	3.3	0.3	0.2	0.7	0.9	1.2	5.4	0.3	0.2	0.4	0.4	0.0	0.2	2.2	0.3	0.4	4.6	0.2	1.1	0.2	0.4	1.9	3.6	0.9	0.6	1.7	1.7	67.9	0.2	19.4	0.3	4.7	5.3	0.7	1.9	0.1	0.0	0.0	0.0	2.1	1.6	0.5	60.7	19.8	19.5	12.3	1.9	3.4	8.2	27.9	13.3	28.8	24.3	6.9	11.3	32.4	9.9	10.7	16.1	18.7	9.4	31.6	7.9	10.2	7.8	14.1	10.0	0.1	5.0	11.6	0.9	7.7	13.3	7.1	14.5	11.4	21.8	33.9	6.9	19.2	5.9	3.5	17.2	12.0	27.2	8.7	10.8	9.4	7.7	12.1	10.4	12.2	15.6	12.9	7.7	8.4	18.9	45.6	23.9	29.6	3.1	8.6	15.0	11.5	8.9	40.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	1.6	0.5	0.2	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184741-32190186	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA061478: "	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavourable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favourable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	15.3	17.7	14.1	14.9	14.8	8.1	12.3	19.3	16.4	17.0	20.8	16.4	36.2	13.7	23.0	39.1	19.7	21.9	19.1	13.6	15.9	10.7	14.8	14.6	26.4	24.0	13.7	10.0	25.0	12.3	10.8	24.3	30.7	12.9	18.4	15.3	15.0	14.6	29.1	17.2	22.0	17.2	22.3	12.2	29.6	22.4	9.9	17.7	17.1	25.6	14.4	20.6	17.4	18.4	0.2	1.8	0.7	0.2	0.0	0.2	0.1	2.3	2.4	12.3	9.5	13.2	16.7	6.9	2.0	4.7	5.4	5.5	3.3	3.7	10.8	12.4	7.2	6.8	3.8	14.0	5.4	8.0	15.6	8.8	4.3	2.6	11.5	6.1	9.5	22.0	7.7	4.0	11.7	9.6	13.3	5.2	2.1	10.7	6.7	13.1	0.1	1.5	9.0	2.6	12.5	11.8	4.0	4.6	6.4	1.6	3.4	13.4	8.7	12.6	2.5	4.1	10.6	1.7	2.1	27.7	18.1	13.9	8.7	5.0	6.9	0.0	0.2	0.7	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	0.0	0.1	1.8	0.0	0.1	14.1	14.8	19.3	16.4	15.9	10.7	13.7	10.0	12.9	17.7
PBX4		ENSG00000105717	"PBX homeobox 4"	Q9BYU1	19	19561707-19618916	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"testis: 16.9;thyroid gland: 14.4"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;PC-3: 4.2;RT4: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"gdT-cell: 2.8;MAIT T-cell: 3.3;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.9;naive CD4 T-cell: 1.8;naive CD8 T-cell: 1.7;T-reg: 5.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 5.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA049859, HPA056469"	Enhanced		Approved	Vesicles				Vesicles		"HPA049859: , HPA056469: "	"unprognostic (5.36e-3)"	"prognostic favourable (8.69e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.44e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.89e-2)"	"prognostic favourable (5.94e-7)"	1.0	0.5	2.2	4.5	3.4	1.7	1.0	1.2	1.9	0.9	1.6	0.0	4.6	1.1	0.6	1.3	0.8	1.0	7.1	0.6	2.3	2.5	1.0	0.5	1.8	3.6	0.8	1.2	1.2	0.5	0.7	1.7	1.2	1.5	1.1	1.1	0.7	1.4	2.7	0.5	2.0	1.7	0.5	0.7	1.8	1.7	16.9	0.6	6.1	14.4	0.5	9.6	1.4	0.8	0.3	0.0	0.0	0.1	0.0	5.4	0.8	4.0	0.2	1.8	0.0	0.0	0.0	2.1	0.0	1.6	1.7	1.7	0.0	1.4	0.4	0.9	1.0	1.6	2.7	0.0	0.7	0.3	0.8	0.0	0.9	0.1	0.3	0.0	1.3	0.5	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.8	1.4	0.1	0.3	4.2	0.8	0.0	0.0	1.1	5.2	1.2	2.3	1.5	0.2	0.8	0.8	0.0	0.0	0.0	1.0	2.1	0.8	0.0	1.7	0.3	0.1	0.2	0.0	0.0	0.0	0.0	2.8	0.0	3.3	0.3	2.0	2.9	0.0	0.0	1.8	1.7	0.0	0.0	0.1	0.0	5.4	0.8	2.2	3.4	1.2	1.9	2.3	2.5	0.8	1.2	1.5	0.6
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell line enhanced"	"Detected in many"		"HeLa: 27.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria			96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavourable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	8.9	3.3	8.1	13.7	5.4	3.5	1.8	7.8	3.5	3.4	4.4	3.2	0.0	3.7	2.9	3.8	3.7	20.6	1.0	1.7	5.2	4.4	27.7	17.0	10.7	0.0	5.7	20.6	5.3	2.8	6.4	2.9	8.4	0.0	1.2	19.0	5.0	2.4	6.3	7.4	3.7	6.9	1.8	3.2	0.9	7.2	10.2	17.3	9.2	7.0	7.5	1.2	3.2	3.9	3.6	4.6	2.0	1.9	2.2	0.0	4.0	2.8	3.3	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087454-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Supported		Enhanced	"Nuclear speckles,Cytoplasmic bodies"			12000000	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: , HPA068497: "	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	52.7	57.6	34.4	49.7	36.7	79.5	149.6	33.3	39.9	38.8	47.2	32.4	45.7	41.1	54.1	39.3	55.6	39.3	45.4	55.1	34.0	31.2	41.6	69.5	46.3	77.8	43.5	29.8	42.3	88.3	42.8	30.5	52.7	37.5	36.3	31.2	29.6	47.9	42.0	149.0	41.5	39.6	59.7	39.1	52.0	43.2	31.6	42.1	91.0	43.8	59.9	48.4	49.6	148.0	15.1	29.2	49.6	32.1	31.6	30.3	28.9	61.4	63.5	54.9	42.8	59.3	45.4	88.5	46.1	42.7	45.8	38.6	73.5	41.4	84.6	23.8	52.3	55.1	64.4	67.2	47.0	60.3	49.7	67.6	38.9	112.2	66.9	55.9	65.1	39.5	43.9	37.7	52.7	58.1	69.1	62.7	57.4	76.4	72.0	84.1	55.4	42.0	58.3	60.1	84.8	62.2	63.7	52.2	42.0	37.9	77.8	54.5	46.2	50.9	53.3	43.1	54.1	36.4	58.1	83.6	85.8	85.9	45.6	77.7	52.9	12.6	30.8	45.5	30.3	32.1	27.8	15.1	23.7	26.0	29.2	14.4	24.2	26.9	49.6	31.6	26.7	21.0	27.7	28.9	34.4	36.7	33.3	39.9	34.0	31.2	43.5	29.8	37.5	42.1
PCBP2	"hnRNP-E2, HNRNPE2, HNRPE2"	ENSG00000197111	"Poly(rC) binding protein 2"	Q15366	12	53452102-53481162	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA038356	Uncertain		Supported	Nucleoplasm,Cytosol			2000000	Nucleoplasm	Cytosol	"HPA038356: AB_10697248"	"unprognostic (1.44e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.89e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.05e-2)"	"prognostic favourable (8.23e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.20e-2)"	105.3	106.7	110.8	85.7	93.4	158.1	180.8	136.5	131.5	84.1	67.2	50.5	75.7	69.2	101.7	84.5	75.3	89.5	71.0	112.1	105.0	53.1	112.6	108.3	83.8	118.8	94.5	88.9	124.5	148.2	98.1	88.7	62.4	93.2	61.7	71.0	65.0	88.3	61.2	96.5	94.4	71.3	90.8	115.4	73.0	86.2	98.7	104.2	106.8	91.2	57.1	93.5	76.8	132.5	20.9	31.5	17.2	18.5	12.4	28.8	13.7	57.4	89.5	87.5	70.4	127.5	98.7	67.1	61.2	84.0	100.5	72.0	104.1	86.6	103.1	59.9	91.7	56.5	96.4	83.4	96.2	63.8	69.5	103.6	69.9	102.1	128.6	101.1	68.4	113.5	70.0	84.9	136.7	96.3	88.4	185.2	89.7	156.3	94.9	113.9	111.8	62.9	76.4	79.5	120.8	79.4	90.0	86.4	75.9	83.8	75.5	59.8	105.7	88.1	70.2	52.1	71.5	47.5	62.1	103.1	71.0	95.3	61.2	64.9	56.6	8.3	18.1	13.1	15.9	18.5	26.1	20.9	24.5	20.5	22.5	20.9	28.8	23.6	17.2	12.4	17.0	31.5	27.4	13.7	110.8	93.4	136.5	131.5	105.0	53.1	94.5	88.9	93.2	104.2
PCBP3	"FLJ44028, PCBP3-OT1, PCBP3OT"	ENSG00000183570	"Poly(rC) binding protein 3"	P57721	21	45643694-45942454	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 14.5;HDLM-2: 26.6;HSkMC: 20.4;SH-SY5Y: 23.1;U-87 MG: 12.3;U-937: 14.8"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"cerebellum: 47.4;pons and medulla: 23.0"	"Cell type enhanced"	"Detected in many"		"eosinophil: 5.9"	"Group enriched"	"Detected in many"	6	"B-cells: 2.9;granulocytes: 5.9;T-cells: 1.6"	"Region enriched"	"Detected in all"	5	"olfactory region: 280.8"	"Region enhanced"	"Detected in all"		"olfactory region: 184.8"	HPA030247	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				"Nucleoplasm, Mitochondria"	Vesicles	"HPA030247: AB_10601244"	"unprognostic (3.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-4)"	"unprognostic (9.89e-4)"	"unprognostic (2.74e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.96e-6)"	"unprognostic (8.67e-2)"	"unprognostic (2.32e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.97e-2)"	6.5	11.7	6.0	11.2	6.7	12.3	6.3	47.4	12.6	3.8	7.9	7.0	2.2	3.1	9.3	12.4	1.4	3.2	4.4	2.7	6.5	7.3	2.2	1.1	1.8	5.0	6.9	3.7	3.4	3.5	0.6	14.8	2.3	23.0	1.5	3.0	20.2	1.7	1.9	1.1	1.6	4.8	12.3	7.3	11.6	3.4	20.5	6.1	22.6	0.8	0.0	4.6	2.3	1.8	2.9	0.0	5.9	0.4	0.6	1.6	0.5	0.0	0.0	0.2	0.0	6.7	14.5	0.0	0.8	0.2	1.5	0.6	0.0	0.0	0.0	0.3	3.9	0.0	0.8	0.0	0.2	26.6	0.0	0.0	0.0	0.0	6.9	0.0	0.0	20.4	0.1	0.2	0.4	0.0	0.0	0.1	0.9	0.3	7.6	1.5	0.4	1.3	0.0	0.0	1.1	0.0	0.0	2.5	23.1	0.5	0.0	0.0	0.0	4.1	0.0	0.0	0.0	6.0	0.0	0.3	1.4	0.0	12.3	14.8	0.5	4.4	0.4	5.9	1.6	0.3	0.3	2.9	0.9	0.0	0.0	1.9	1.5	0.2	1.4	0.6	0.2	0.0	0.8	0.5	6.0	6.7	47.4	6.0	6.5	7.3	6.9	3.7	23.0	6.1
PCCA		ENSG00000175198	"Propionyl-CoA carboxylase alpha subunit"	P05165	13	100089015-100530437	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 106.7"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 53.2;SCLC-21H: 29.5;U-937: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041716, HPA047792"	Enhanced		Supported	Mitochondria			120000	Mitochondria		"HPA041716: , HPA047792: "	"unprognostic (1.18e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.90e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.32e-2)"	15.6	26.2	9.7	11.3	11.1	3.2	12.0	24.0	10.7	12.0	17.5	12.0	14.3	6.7	16.4	106.7	8.8	8.4	7.6	12.4	9.5	7.5	51.3	44.3	8.1	4.0	11.2	8.2	9.7	12.7	5.5	12.4	10.5	12.6	13.1	13.7	11.7	12.2	10.4	10.7	7.7	7.8	17.0	12.0	8.2	16.1	4.7	10.9	4.2	11.9	5.0	6.9	10.8	8.8	3.7	13.0	1.6	10.8	7.3	6.1	4.7	3.2	5.8	9.6	3.1	9.2	8.0	5.4	3.2	4.8	3.0	2.8	7.2	4.4	0.2	4.9	3.2	3.7	2.8	4.5	5.0	5.3	3.2	7.5	4.1	15.4	5.1	0.3	3.7	7.4	4.8	2.8	4.7	6.2	3.0	4.3	5.5	3.5	0.8	16.9	5.9	2.6	6.6	4.1	5.2	53.2	6.4	29.5	3.5	2.2	12.3	5.4	8.9	13.4	4.5	3.1	2.6	2.1	2.2	4.2	3.8	0.1	6.0	41.0	2.2	1.5	8.5	1.6	4.6	10.3	6.1	3.7	3.0	4.3	13.0	2.6	4.1	5.1	1.3	7.3	10.8	1.1	6.0	4.7	9.7	11.1	24.0	10.7	9.5	7.5	11.2	8.2	12.6	10.9
PCCB		ENSG00000114054	"Propionyl-CoA carboxylase beta subunit"	P05166	3	136250306-136337896	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036939, HPA036940"	Enhanced				"Intracellular and membrane"		79000			"HPA036939: AB_10671366, HPA036940: AB_10669779"	"unprognostic (2.74e-1)"	"unprognostic (7.88e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.47e-7)"	"unprognostic (2.43e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.13e-1)"	13.0	46.0	14.3	7.7	16.3	12.7	11.8	7.8	19.2	8.1	17.5	21.0	11.6	15.3	7.1	6.4	11.8	8.1	12.5	36.7	14.1	12.6	36.0	80.2	7.7	8.7	18.9	16.4	6.8	20.8	16.2	9.6	10.0	22.3	10.2	17.6	10.0	10.9	10.6	30.5	8.0	11.1	14.1	18.6	7.9	11.5	17.6	15.5	6.3	15.7	12.4	8.1	9.6	6.6	12.4	24.6	3.9	16.6	12.8	14.9	11.5	20.2	14.5	13.9	20.8	10.6	11.7	24.6	10.7	11.6	16.2	23.0	21.5	14.3	25.3	29.9	15.0	11.3	16.3	14.4	24.7	15.0	13.8	44.3	17.1	32.4	22.6	34.0	19.7	13.8	13.8	10.3	23.6	18.2	32.2	13.6	12.4	38.6	33.6	20.0	11.7	13.1	9.3	11.5	36.1	29.8	22.2	27.8	20.7	27.0	16.0	24.5	31.9	20.2	13.6	8.2	8.7	22.9	9.4	25.9	21.3	21.1	11.6	13.2	9.5	2.8	16.2	3.9	13.2	16.6	14.9	12.4	8.8	13.6	24.6	10.2	9.0	11.1	1.4	12.8	14.6	21.2	7.9	11.5	14.3	16.3	7.8	19.2	14.1	12.6	18.9	16.4	22.3	15.5
PCDH1	pc42	ENSG00000156453	"Protocadherin 1"	Q08174	5	141853111-141879246	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.7;HaCaT: 37.1;HUVEC TERT2: 19.5;RT4: 25.4;TIME: 25.3;WM-115: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047720, HPA050538"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"			270000	"Nucleoplasm, Cell Junctions"	Nucleoli	"HPA047720: AB_2680130, HPA050538: "	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.16e-2)"	"prognostic unfavourable (4.96e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.43e-1)"	"prognostic favourable (7.55e-5)"	"unprognostic (2.05e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.91e-1)"	22.4	4.5	14.8	7.4	17.6	1.4	19.0	16.1	25.6	8.3	22.2	7.3	11.4	20.6	7.0	7.0	26.9	9.7	6.8	8.9	11.6	7.4	14.9	13.0	18.9	3.4	8.8	16.9	2.5	11.0	1.3	5.2	32.5	9.2	11.1	14.4	6.0	23.7	12.3	7.4	17.3	15.8	7.5	7.5	1.6	22.8	1.5	9.8	0.0	9.1	3.9	8.8	8.6	11.7	0.0	0.0	0.3	0.0	0.0	2.2	0.5	6.3	0.3	2.7	2.9	0.1	0.0	1.9	0.0	0.0	0.0	0.0	1.5	29.7	0.0	15.3	0.2	37.1	3.4	2.7	0.0	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.1	0.0	6.2	0.0	0.4	19.5	0.0	3.2	0.0	5.1	0.1	0.0	11.3	5.1	0.1	0.0	4.3	2.2	25.4	0.3	0.6	0.1	8.1	6.5	6.5	0.1	25.3	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.2	0.0	18.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.5	14.8	17.6	16.1	25.6	11.6	7.4	8.8	16.9	9.2	9.8
PCDH12	VE-cadherin-2	ENSG00000113555	"Protocadherin 12"	Q9NPG4	5	141943585-141969741	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Epilepsy, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.9"	"Group enriched"	"Detected in some"	4	"HUVEC TERT2: 13.8;Karpas-707: 34.3"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in some"	6	"non-classical monocyte: 7.0"	"Lineage enriched"	"Detected in single"	35	"monocytes: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051242	Uncertain				"Secreted to blood"		720000			"HPA051242: "	"unprognostic (6.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (3.25e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.37e-2)"	"unprognostic (9.33e-2)"	7.9	2.9	0.5	0.7	0.6	0.0	3.1	2.2	0.6	1.3	0.8			0.7	1.3	0.0	0.7	1.2	1.8	4.6	0.5	0.4	3.7	2.1	9.0	0.7	0.4		0.9	0.6	1.4	2.5	17.9		1.1	0.4		0.6	1.0	1.6	0.5	1.0	2.6	0.3	11.3	1.0	0.1			4.8		0.1	2.1	1.1	0.1	0.2	0.0	7.0	0.0	0.1	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	13.8	0.0	34.3	0.0	0.0	0.0	0.2	0.3	0.1	0.3	0.1	1.5	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.0	0.9	0.9	0.2	0.0	0.4	0.0	0.2	0.1	0.0	0.2	5.5	1.2	0.0	0.4	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.1	0.2										
PCDH15	"CDHR15, DFNB23, USH1F"	ENSG00000150275	"Protocadherin related 15"	Q96QU1	10	53802771-55627942	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Hearing"		"Deafness, Disease mutation, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 27.4;retina: 25.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.1;HUVEC TERT2: 1.7;U-2 OS: 2.7;U-266/70: 8.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074437		Supported			"Intracellular and membrane"					"HPA074437: "	"unprognostic (1.38e-1)"	"unprognostic (3.39e-1)"		"unprognostic (8.15e-5)"	"unprognostic (3.07e-3)"	"unprognostic (2.79e-1)"		"unprognostic (9.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.12e-3)"		"unprognostic (1.31e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (7.66e-3)"	0.7	27.4	9.7	0.9	7.4	0.6	0.5	4.3	10.9	0.7	0.7	5.6	0.0	0.8	0.6	1.1	0.6	0.6	0.6	0.9	10.5	5.8	11.0	0.5	3.7	1.8	6.0	3.2	0.5	0.5	0.4	6.9	0.7	8.7	0.7	0.5	25.1	0.6	0.5	0.4	0.5	0.8	0.5	5.7	1.3	0.9	4.4	7.9	0.0	0.6	0.0	1.2	1.5	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.7	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.1	0.0	0.0	1.5	2.7	0.0	0.0	8.1	0.8	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.7	7.4	4.3	7.1	10.5	5.8	6.0	3.2	8.7	7.9
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.4;RH-30: 46.0;RT4: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: "	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.5	7.6	11.5	11.2	0.0	1.4	0.0	0.7	0.3	0.7	9.9	0.0	0.0	0.0	5.7	0.4	14.4	1.3	0.0	16.4	0.0	10.4	0.0	11.9	0.2	0.0	6.7	3.4	0.3	4.1	2.8	0.0	0.0	3.4	0.0	0.0	0.0	3.3	1.5	0.0	46.0	0.0	0.3	24.2	0.3	0.1	0.1	0.4	0.5	0.7	2.5	0.0	9.3	2.4	2.5	0.0	0.0	0.0	0.0	7.2	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4
PCDH8	"ARCADLIN, PAPC"	ENSG00000136099	"Protocadherin 8"	O95206	13	52842889-52848641	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.6"	"Cell line enriched"	"Detected in some"	4	"AF22: 22.5"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010509	Uncertain		Uncertain	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA010509: AB_10601384"	"unprognostic (3.50e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.11e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.97e-2)"		"unprognostic (7.01e-2)"		"unprognostic (1.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.59e-1)"		"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"		0.8	0.9	11.5	1.1	18.6	0.8	0.8	0.4	20.6	0.9	1.0	1.1	0.0	0.9	1.0	0.8	0.8	0.8	0.8	0.8	18.2	4.8	0.8	0.8	0.9	0.8	3.6	8.4	0.8	0.8	0.8	1.4	0.8	0.8	1.7	0.9	0.8	0.8	0.8	1.4	0.8	1.1	0.9	0.9	0.8	1.2	2.3	2.5	0.0	1.4	0.0	0.8	0.9	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	1.6	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.6	0.4	20.6	18.2	4.8	3.6	8.4	0.8	2.5
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 16.5;brain: 47.0"	"Cell line enhanced"	"Detected in many"		"AF22: 12.4;LHCN-M2: 20.3;TIME: 23.6;U-698: 31.0"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"naive B-cell: 16.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome			1300000	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	4.5	3.2	18.4	1.1	24.7	4.1	1.5	6.7	47.0	1.8	1.3	7.8	0.0	0.9	1.0	2.1	1.0	1.1	2.4	5.7	15.0	10.0	3.5	2.3	2.3	1.4	21.4	11.0	1.4	2.0	0.7	1.3	0.7	16.6	2.5	1.3	0.0	1.0	5.6	2.0	0.9	1.0	1.2	11.0	1.6	1.7	1.6	18.9	0.7	1.8	0.0	1.4	1.1	0.6	16.5	1.0	2.5	0.0	0.7	0.1	0.2	0.0	9.3	12.4	0.0	3.3	2.6	0.0	1.8	0.1	1.3	0.5	0.0	0.0	2.7	0.0	1.4	0.0	1.0	0.3	0.6	0.0	4.9	0.1	0.1	0.0	3.2	0.3	0.1	6.1	0.3	1.5	2.5	1.0	0.3	0.1	20.3	0.7	5.6	0.0	0.1	1.2	8.5	0.4	0.0	0.2	0.0	1.6	0.6	0.0	0.1	0.1	0.0	0.0	23.6	0.7	0.6	2.9	0.9	3.6	0.0	31.0	5.3	0.0	2.4	2.5	0.0	0.1	0.0	0.0	0.0	3.7	0.0	0.0	0.0	16.5	0.1	0.1	0.1	0.7	0.0	1.0	0.0	0.2	18.4	24.7	6.7	24.6	15.0	10.0	21.4	11.0	16.6	18.9
PCDHA9	"KIAA0345, PCDH-ALPHA9"	ENSG00000204961	"Protocadherin alpha 9"	Q9Y5H5	5	140847463-141012344	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"blood: 1.8;brain: 3.1;pancreas: 3.4;testis: 3.5"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 11.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"																						"unprognostic (1.53e-3)"	"unprognostic (1.13e-1)"		"unprognostic (7.54e-4)"	"unprognostic (1.28e-2)"			"unprognostic (4.65e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.20e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (8.79e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-1)"		0.2	0.4	0.4	0.1	0.5	0.6	0.0	3.1	1.8	0.4	0.0			0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.4	0.4	0.0	0.0	0.0	0.1	0.3		0.2	3.4	0.2	0.3	0.0		0.0	0.0		0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.0	3.5			0.2		0.0	0.0	0.0	0.9	0.5	1.8	0.4	0.7	0.5	0.2	0.0	0.1	0.1	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	11.3	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.3	0.4	0.4	0.5	0.3	0.4	0.4	0.3	0.4	0.2	0.9	0.4	0.5	1.8	0.7	0.4	0.5	0.2	0.2										
PCDHB13	PCDH-BETA13	ENSG00000187372	"Protocadherin beta 13"	Q9Y5F0	5	141213919-141218979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 7.7;T-47d: 14.8;U-2197: 12.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.7"																				"unprognostic (9.91e-3)"	"unprognostic (3.34e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.55e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.61e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.80e-2)"	"unprognostic (3.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.93e-3)"	2.1	2.9	1.0	0.6	1.4	0.0	2.1	1.7	2.3	3.2	1.8			0.0	3.4	2.6	1.4	2.0	3.3	2.8	1.0	1.0	1.6	0.9	1.5	0.2	0.7		3.1	4.2	1.5	3.3	2.5		2.4	1.0		2.8	2.3	0.5	3.8	0.4	2.7	1.2	1.4	1.4	1.8			1.7		0.1	1.5	1.6	1.2	0.5	6.7	0.5	0.4	0.6	0.0	0.0	0.2	1.9	1.4	4.9	5.3	0.4	0.3	2.5	0.7	1.5	0.0	2.0	0.0	7.7	1.8	0.5	1.7	0.0	0.5	0.0	0.1	0.0	0.9	0.3	0.1	0.0	0.9	0.4	1.3	0.1	0.1	0.7	0.3	1.9	2.4	0.3	0.2	0.1	0.4	0.2	5.5	0.9	0.0	0.1	0.1	1.8	0.6	2.4	0.2	0.7	14.8	0.1	2.2	0.6	1.4	12.1	0.0	0.0	0.1	0.0	3.4	0.1	3.7	1.8	0.5	1.7	0.4	0.4	0.3	0.7	0.4	0.4	0.1	1.2	0.6	0.6	6.7	0.4	0.3	0.5	0.4	0.0										
PCDHB2	PCDH-BETA2	ENSG00000112852	"Protocadherin beta 2"	Q9Y5E7	5	141094578-141098703	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 13.4;AN3-CA: 28.8;EFO-21: 16.4;U-138 MG: 12.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007548	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA007548: "	"unprognostic (2.94e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.03e-3)"	"unprognostic (7.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (2.13e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (4.84e-4)"	7.3	3.0	3.4	1.6	8.6	0.8	5.5	5.7	13.3	3.9	4.4	7.0	0.0	2.1	6.7	2.1	4.0	2.8	4.4	4.3	4.1	1.9	2.9	0.8	6.2	1.0	3.2	5.1	4.3	2.7	0.9	5.3	2.4	4.8	5.9	2.8	4.0	3.8	1.7	1.9	4.3	2.6	4.3	8.4	1.6	1.9	12.1	5.0	0.0	2.8	1.2	0.9	4.4	2.6	0.2	0.2	0.8	0.1	0.5	0.4	0.3	0.2	1.9	13.4	28.8	3.7	1.8	6.2	0.5	2.1	0.0	0.0	0.3	0.1	0.5	16.4	0.9	0.0	0.6	0.1	0.0	0.1	0.4	0.0	0.0	3.8	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.3	0.4	0.4	4.0	0.1	3.7	0.0	5.9	3.8	0.0	9.9	0.1	1.5	0.0	7.4	2.0	0.0	1.8	4.2	8.2	2.4	1.5	12.7	3.9	5.9	1.9	0.2	0.0	0.1	2.8	0.1	7.5	0.5	0.1	0.0	0.4	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.1	0.2	0.8	0.5	0.1	0.2	0.0	0.3	3.4	8.6	5.7	11.0	4.1	1.9	3.2	5.1	4.8	5.0
PCDHB7	PCDH-BETA7	ENSG00000113212	"Protocadherin beta 7"	Q9Y5E2	5	141172619-141176383	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.3;EFO-21: 6.4;U-138 MG: 4.3;U-2197: 12.8;U-87 MG: 4.4;WM-115: 4.3"	"Cancer enhanced"	"Detected in many"		"glioma: 5.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA059271	Approved									"HPA059271: "	"unprognostic (2.13e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.69e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.57e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.78e-4)"	5.8	2.5	4.0	2.7	3.4	0.4	4.3	3.7	4.9	8.1	3.1	8.9	0.0	1.5	11.6	5.0	1.4	5.0	4.6	3.6	4.0	1.8	3.0	1.4	4.9	1.9	3.0	2.7	7.5	1.5	1.6	8.1	1.1	4.5	4.8	1.7	7.0	1.5	3.4	1.4	1.6	2.3	9.0	3.9	3.6	1.8	3.6	5.1	0.0	3.3	0.9	1.0	6.2	5.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.6	5.3	2.6	0.0	0.3	0.7	0.1	0.1	0.0	0.1	0.0	6.4	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	1.9	1.3	0.4	0.0	1.0	2.8	0.0	0.9	4.3	0.8	12.8	0.1	0.0	0.0	0.0	4.4	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	3.7	4.9	4.0	1.8	3.0	2.7	4.5	5.1
PCDHGA11	PCDH-GAMMA-A11	ENSG00000253873	"Protocadherin gamma subfamily A, 11"	Q9Y5H2	5	141421047-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.9;ASC TERT1: 16.1;HSkMC: 11.5;REH: 9.6;SK-MEL-30: 12.4;WM-115: 25.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.9"	"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.13e-2)"	"unprognostic (1.78e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.89e-1)"	3.4	2.5	7.4	2.8	9.4	0.5	2.1	4.1	8.5	2.4	2.5	8.5	0.0	1.2	2.6	1.7	3.1	2.1	2.1	3.4	11.6	1.9	1.9	1.2	2.3	1.8	4.5	5.2	3.8	2.3	1.3	1.9	8.3	5.0	2.5	1.5	3.3	2.8	3.4	2.8	6.6	1.2	3.3	4.9	1.6	1.8	2.2	7.1	0.1	3.4	0.6	1.7	1.7	2.2	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.4	14.9	16.1	0.5	3.2	6.2	2.5	4.0	0.0	0.1	0.3	5.4	3.2	2.1	0.1	0.3	4.0	0.1	1.4	0.0	0.0	0.0	2.5	0.2	0.0	11.5	0.1	4.4	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	9.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.3	1.8	4.5	0.5	0.1	0.4	0.0	0.0	0.2	0.0	0.1	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	7.4	9.4	4.1	8.5	11.6	1.9	4.5	5.2	5.0	7.1
PCDHGA12	"CDH21, FIB3, KIAA0588, PCDH-GAMMA-A12"	ENSG00000253159	"Protocadherin gamma subfamily A, 12"	O60330	5	141430589-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9"	"Cell line enhanced"	"Detected in some"		"BJ: 7.6;BJ hTERT+: 12.6;fHDF/TERT166: 18.7;HHSteC: 6.1;HSkMC: 14.0;TIME: 6.0"	"Cancer enhanced"	"Detected in many"		"melanoma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Low lineage specificity"	"Detected in many"											"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.17e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.01e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.65e-4)"	"unprognostic (2.98e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.28e-4)"	"unprognostic (8.30e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.85e-3)"	5.1	12.7	14.8	2.8	18.9	0.7	2.4	4.7	13.8	4.9	1.8	8.6	0.6	1.4	5.4	2.3	3.5	2.7	11.3	6.5	15.7	5.6	3.1	2.8	6.5	1.6	4.7	7.3	6.2	3.6	2.0	2.7	6.5	8.4	3.5	1.7	3.4	1.7	4.9	1.9	5.1	1.5	5.3	8.4	3.7	2.2	1.6	12.4	0.4	3.0	0.6	1.7	4.5	3.6	3.7	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.6	1.2	0.1	7.6	12.6	0.0	0.0	0.0	0.0	0.4	0.0	18.7	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.0	14.0	0.0	3.7	0.0	4.4	0.0	0.0	2.6	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	6.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	14.8	18.9	4.7	10.4	15.7	5.6	4.7	7.3	8.4	12.4
PCDHGA2	PCDH-GAMMA-A2	ENSG00000081853	"Protocadherin gamma subfamily A, 2"	Q9Y5H1	5	141338760-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.9;BJ: 5.4;fHDF/TERT166: 6.4;HSkMC: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA008755, HPA010580, HPA038625"	Approved		Approved	"Nucleoplasm,Nucleoli,Vesicles,Plasma membrane,Focal adhesion sites,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Nucleoli, Focal adhesion sites, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA038625: "	"unprognostic (2.43e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.01e-2)"	"unprognostic (4.32e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.68e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.23e-4)"	5.1	4.3	6.7	2.1	8.0	0.6	4.2	5.2	12.6	6.6	2.6	4.6	1.0	0.9	6.5	5.7	2.4	5.5	5.5	11.1	6.5	4.6	3.3	2.4	4.6	1.1	6.0	2.3	15.3	8.4	9.2	10.6	2.2	7.8	5.3	1.4	13.8	3.3	5.8	2.6	2.9	1.4	5.2	5.6	1.9	2.1	10.4	3.5	0.0	4.3	1.2	1.1	3.2	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	3.9	9.9	0.1	5.4	2.1	0.5	0.9	0.1	0.1	0.1	0.7	6.4	0.2	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	5.1	0.2	0.1	0.3	2.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	1.4	0.3	0.2	0.8	0.0	0.3	0.7	0.0	3.6	0.1	0.7	0.0	3.3	0.9	0.5	0.3	0.1	0.0	0.4	0.0	2.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	8.0	5.2	7.2	6.5	4.6	6.0	2.3	7.8	3.5
PCDHGA5	"CDH-GAMMA-A5, ME3, PCDH-GAMMA-A5"	ENSG00000253485	"Protocadherin gamma subfamily A, 5"	Q9Y5G8	5	141364232-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.1"	"Group enriched"	"Detected in some"	7	"ASC diff: 18.4;ASC TERT1: 7.3"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA008755, HPA010580"	Uncertain		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Vesicles, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA008755: AB_1079577, HPA010580: "	"unprognostic (3.61e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.83e-1)"	"unprognostic (6.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.90e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.38e-4)"	4.0	2.7	6.1	1.8	9.1	0.9	3.9	19.1	9.6	9.0	2.7	7.7	4.1	1.0	7.6	3.2	3.3	4.7	4.5	4.9	6.9	4.0	1.5	1.2	3.3	1.3	3.2	3.8	6.6	1.7	3.3	3.7	2.7	4.6	5.6	1.6	4.1	2.5	4.0	1.5	3.0	1.5	4.3	6.3	1.4	1.7	1.7	3.7	0.0	1.8	0.9	1.0	2.5	4.2	0.9	0.8	1.6	0.6	1.9	0.7	0.2	0.0	0.4	0.3	0.1	18.4	7.3	0.0	0.8	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.3	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	1.8	0.2	0.0	0.0	0.6	0.1	0.6	0.7	0.3	0.5	0.7	0.1	0.3	0.9	0.6	0.1	0.0	0.0	0.2	0.3	0.1	0.3	0.3	1.6	0.0	1.0	0.6	0.2	1.0	0.7	0.1	1.0	0.1	0.3	0.2	0.7	1.5	0.6	0.6	0.7	0.3	0.3	0.6	0.6	0.4	0.1	0.9	0.7	0.7	1.6	1.9	0.2	0.8	0.4	0.2	6.1	9.1	19.1	9.6	6.9	4.0	3.2	3.8	4.6	3.7
PCDHGB3	PCDH-GAMMA-B3	ENSG00000262209	"Protocadherin gamma subfamily B, 3"	Q9Y5G1	5	141370264-141512979	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.2;ASC TERT1: 10.7;TIME: 6.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA008755, HPA010580, HPA035822, HPA035823"	Uncertain		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Vesicles, Cytosol"	"HPA008755: AB_1079577, HPA010580: , HPA035822: , HPA035823: "	"unprognostic (6.93e-3)"	"unprognostic (9.10e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.62e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.80e-3)"	4.1	1.7	3.3	1.6	6.5	0.5	3.1	3.5	5.6	3.0	3.0	7.2	0.7	0.7	4.9	3.7	3.3	3.3	2.9	4.6	3.3	2.3	2.9	2.0	2.5	3.7	1.9	3.8	5.2	4.2	4.6	5.4	2.3	2.6	2.6	2.2	3.1	6.6	2.6	1.9	3.3	1.4	4.3	2.9	2.4	2.3	1.5	2.8	0.3	3.4	3.2	3.5	2.7	4.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.4	0.3	13.2	10.7	0.2	1.4	2.4	0.9	1.1	0.0	0.0	2.2	0.4	4.3	0.6	0.0	0.3	0.7	0.0	0.3	0.0	0.3	0.1	0.6	0.1	0.0	2.6	0.6	0.2	0.1	1.2	0.3	1.0	0.3	0.4	0.7	1.0	0.1	0.1	1.8	0.7	0.0	0.2	0.1	3.0	0.6	0.0	0.0	0.3	0.8	0.0	6.7	0.6	0.1	0.7	0.7	0.3	2.0	0.2	0.6	0.6	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	6.5	3.5	5.6	3.3	2.3	1.9	3.8	2.6	2.8
PCDHGC3	"PC-43, PC43, PCDH-GAMMA-C3, PCDH2"	ENSG00000240184	"Protocadherin gamma subfamily C, 3"	Q9UN70	5	141475947-141512979	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 99.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;ASC TERT1: 41.2;HSkMC: 40.4;U-138 MG: 51.8;WM-115: 77.2"	"Group enriched"	"Detected in all"	6	"glioma: 55.0;melanoma: 20.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"plasmacytoid DC: 15.2"	"Lineage enriched"	"Detected in single"	22	"dendritic cells: 15.2"									"HPA008755, HPA010580, HPA077289"	Approved		Approved	"Plasma membrane"			74000	"Plasma membrane"		"HPA008755: AB_1079577, HPA010580: , HPA077289: "	"unprognostic (2.52e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.44e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (6.19e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.22e-1)"	"prognostic unfavourable (8.18e-4)"	"unprognostic (3.72e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (6.00e-4)"	14.9	15.0	52.8	7.0	49.0	0.5	11.2	30.1	99.3	28.0	8.7	38.9	2.4	3.8	20.6	27.6	12.8	15.7	14.6	11.0	40.2	25.2	7.1	8.0	20.9	4.2	32.0	24.9	16.6	4.4	18.8	7.9	17.7	25.8	17.1	10.2	17.3	8.4	20.1	5.8	18.3	5.6	19.8	28.1	5.3	6.6	4.8	24.1	0.9	5.4	6.4	7.1	8.6	11.1	0.6	15.2	0.0	0.0	0.0	0.1	0.0	2.7	1.6	10.7	2.8	43.0	41.2	0.1	14.0	37.5	7.0	7.5	0.0	2.7	9.3	9.1	24.4	10.2	1.4	4.4	6.7	0.0	4.2	0.0	0.2	0.2	13.3	0.1	0.3	40.4	6.7	10.4	8.6	4.6	0.0	0.3	17.5	5.1	0.2	1.0	0.4	0.0	6.3	21.7	0.0	3.7	3.0	3.5	15.2	3.7	0.1	23.0	8.7	13.0	5.6	51.8	2.7	10.1	15.1	0.0	0.1	0.1	12.4	0.0	77.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	15.2	0.0	0.0	52.8	49.0	30.1	38.9	40.2	25.2	32.0	24.9	25.8	24.1
PCF11	KIAA0824	ENSG00000165494	"PCF11 cleavage and polyadenylation factor subunit"	O94913	11	83156988-83187451	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040779			Supported	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA040779: "	"unprognostic (1.53e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.24e-3)"	"prognostic favourable (1.34e-4)"	"unprognostic (3.74e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.12e-3)"	"unprognostic (9.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (2.03e-5)"	17.6	15.2	21.8	33.5	23.3	32.1	21.1	29.7	21.3	22.1	19.7	13.6	30.8	14.0	25.6	36.8	21.9	23.4	20.8	14.0	21.7	10.0	15.7	14.5	24.0	25.8	26.6	15.4	28.9	16.1	22.4	32.5	18.9	19.2	25.6	17.9	13.8	22.5	28.5	27.0	32.5	21.2	21.4	20.6	27.2	17.7	20.1	27.4	29.4	23.4	22.5	25.1	24.8	29.3	11.4	6.8	17.5	7.2	13.0	10.5	5.3	11.0	7.9	12.9	11.0	15.5	15.2	10.4	10.6	7.9	10.3	7.9	13.5	11.1	25.0	8.1	7.7	11.2	18.8	7.3	9.9	17.7	6.4	14.6	10.3	9.5	8.7	17.1	16.3	10.8	14.2	7.8	11.4	10.3	16.9	12.2	9.6	11.8	16.0	19.1	13.5	8.9	15.3	16.3	14.9	8.9	16.5	10.8	12.0	13.0	10.4	10.4	10.4	11.9	10.6	14.7	7.6	10.8	7.0	11.0	18.4	53.1	6.4	11.4	11.3	12.0	7.2	14.2	10.5	6.9	9.1	11.4	7.4	7.6	6.7	10.4	8.6	8.5	17.5	13.0	5.1	6.8	5.1	5.3	21.8	23.3	29.7	21.3	21.7	10.0	26.6	15.4	19.2	27.4
PCIF1	"bA465L10.1, C20orf67, PPP1R121"	ENSG00000100982	"PDX1 C-terminal inhibiting factor 1"	Q9H4Z3	20	45934628-45948023	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049517	Enhanced		Supported	"Nucleoplasm,Microtubules,Cytokinetic bridge"				Nucleoplasm	"Microtubules, Cytokinetic bridge"	"HPA049517: "	"unprognostic (5.42e-3)"	"unprognostic (7.76e-2)"	"unprognostic (7.69e-2)"	"prognostic unfavourable (8.86e-4)"	"unprognostic (1.39e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (1.50e-6)"	"unprognostic (1.01e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.24e-1)"	18.5	15.7	12.7	18.4	17.8	26.2	19.2	33.7	27.9	26.0	19.4	26.7	15.9	14.7	29.8	17.0	19.4	28.8	16.9	23.7	12.9	12.4	16.3	13.2	18.9	23.9	17.7	13.6	37.5	23.5	21.5	18.9	18.7	14.4	20.0	10.8	23.9	20.6	20.8	27.1	24.2	17.1	19.6	16.1	22.8	16.3	17.6	16.2	36.0	24.8	15.3	22.2	18.7	20.4	31.8	28.1	42.4	26.4	38.3	32.7	31.9	11.4	15.8	12.3	15.2	8.6	10.6	13.7	4.6	14.0	14.1	13.7	26.9	15.4	12.3	15.6	12.3	13.0	8.8	16.0	6.1	7.6	6.3	15.8	12.7	18.0	16.3	14.1	15.9	14.6	16.8	8.6	13.9	11.7	11.0	17.3	10.0	23.9	27.8	26.5	4.4	13.9	17.4	11.4	15.1	11.4	12.0	16.9	16.9	17.5	16.5	8.8	17.3	16.6	10.0	17.3	13.9	15.3	9.1	20.1	11.5	11.3	21.8	13.1	10.1	37.2	26.4	42.4	32.7	25.7	25.6	30.2	28.3	29.5	28.1	31.8	29.8	25.9	42.3	38.3	24.8	22.6	29.1	31.9	12.7	17.8	33.7	27.9	12.9	12.4	17.7	13.6	14.4	16.2
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria			3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.4	3.1	0.9	5.8	3.6	3.7	14.8	6.8	8.2	5.7	9.3	5.1	6.3	13.9	0.8	10.5	8.0	6.0	8.8	4.7	7.1	0.2	2.5	1.7	27.2	34.9	4.8	11.0	4.3	33.9	3.6	8.8	4.6	7.1	25.8	2.2	23.7	1.2	2.4	1.0	4.1	2.8	3.4	7.9	1.7	8.5	3.7	5.9	5.2	6.8	32.1	9.1	7.5	0.8	1.2	6.6	1.8	1.9	17.7	5.5	3.4	3.5	7.7	3.0	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3
PCLO	"ACZ, DKFZp779G1236, KIAA0559"	ENSG00000186472	"Piccolo presynaptic cytomatrix protein"	Q9Y6V0	7	82754013-83162930	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 50.3"	"Group enriched"	"Detected in some"	28	"REH: 61.0;U-2 OS: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA015858, HPA029579, CAB079012"	Approved	Supported	Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles, Plasma membrane"		"CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044"	"unprognostic (1.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.49e-3)"	"unprognostic (6.14e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.79e-6)"	"unprognostic (5.15e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.36e-5)"	"unprognostic (6.62e-5)"	3.1	7.9	8.8	0.8	26.3	0.4	4.7	50.3	19.4	3.2	3.9	1.6	0.4	2.9	1.0	7.3	2.3	2.0	1.9	2.2	9.8	5.7	8.2	0.6	1.8	0.6	4.6	12.6	1.9	4.0	11.4	19.2	1.0	9.1	4.9	3.5	3.6	2.5	5.0	0.6	2.6	2.4	0.7	5.3	1.1	2.9	4.5	4.4	0.0	8.4	0.0	0.8	1.0	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.1	1.3	0.5	0.5	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.4	0.0	2.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	1.1	61.0	1.0	0.0	0.4	0.2	1.1	0.8	0.0	0.6	0.1	0.7	0.1	0.0	0.0	70.0	0.3	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.8	26.3	50.3	19.4	9.8	5.7	4.6	12.6	9.1	4.4
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol			8200000	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavourable (4.02e-7)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (1.88e-4)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavourable (6.38e-4)"	19.1	18.4	35.7	13.0	43.0	28.5	19.3	33.5	58.3	20.2	16.9	19.2	12.4	14.7	16.0	22.2	17.9	15.8	11.0	43.9	35.0	38.8	21.3	29.5	15.1	14.6	35.1	46.0	16.2	14.6	16.4	15.5	17.2	57.4	22.1	18.1	11.6	17.2	21.4	69.5	14.7	13.6	19.6	28.6	12.0	12.7	29.1	19.2	18.1	19.3	15.9	17.9	14.4	13.7	31.6	53.0	51.2	58.0	30.0	37.4	51.6	21.4	17.0	17.4	21.8	37.5	31.0	19.4	35.3	20.2	28.1	35.5	49.3	16.4	27.2	30.0	29.8	26.8	29.9	35.2	40.6	18.9	43.3	41.5	32.0	48.2	25.1	49.4	51.1	15.4	26.1	32.0	34.6	26.5	59.3	26.7	33.5	63.9	24.0	37.7	14.2	19.1	19.9	22.6	19.5	27.3	15.8	33.2	12.8	26.8	42.8	22.9	25.9	35.2	19.7	16.6	21.0	31.4	38.3	16.9	26.2	27.8	26.1	33.0	32.8	40.0	58.0	51.2	30.2	53.6	30.1	31.6	30.6	32.7	53.0	24.2	28.5	32.5	30.8	30.0	52.2	23.9	37.4	51.6	35.7	43.0	33.5	58.3	35.0	38.8	35.1	46.0	57.4	19.2
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 115.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favourable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	13.9	21.4	11.1	31.8	15.8	87.2	13.7	17.2	14.6	13.7	23.1	15.6	13.7	18.9	15.7	13.7	36.0	12.7	17.5	13.6	11.6	9.8	21.7	14.9	17.8	41.6	18.8	10.8	14.4	14.3	14.0	13.9	24.0	14.3	10.8	26.1	18.7	17.7	15.6	11.0	16.5	20.5	12.8	16.1	24.5	15.7	40.5	17.4	115.8	18.1	40.7	38.7	17.3	17.2	16.9	16.0	8.7	11.6	19.6	24.4	16.9	73.2	57.7	58.6	25.2	13.9	13.0	41.1	48.3	28.5	45.5	64.7	45.0	58.6	74.5	15.7	17.2	55.1	34.6	58.2	41.7	22.1	38.2	52.3	22.2	104.8	5.9	71.6	23.5	9.4	13.8	38.7	9.2	25.9	46.5	63.0	44.3	26.5	136.8	79.2	43.8	32.0	75.6	51.5	60.1	20.6	42.8	50.3	34.2	33.8	52.3	33.1	36.9	36.5	17.3	32.9	37.8	46.2	55.1	32.0	91.3	126.2	14.8	68.2	42.1	2.4	11.6	8.7	19.2	10.9	23.8	16.9	24.4	19.3	16.0	13.6	22.4	20.1	3.8	19.6	11.4	14.7	23.3	16.9	11.1	15.8	17.2	14.6	11.6	9.8	18.8	10.8	14.3	17.4
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome				Centrosome		"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: "	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.2	7.3	11.3	6.9	5.7	5.8	7.1	7.2	5.0	7.2	6.4	8.8	6.0	9.3	4.6	8.2	6.7	9.1	6.2	5.0	27.0	12.8	24.6	13.6	6.8	1.9	12.4	10.2	3.1	4.7	9.6	4.8	5.5	12.4	14.0	9.8	15.4	12.2	12.8	11.2	5.0	15.2	4.6	8.1	5.6	10.0	13.9	6.2	15.5	9.7	4.7	9.2	9.7	7.5	12.9	6.5	7.3	11.4	12.1	10.1	10.0	8.0	12.2	6.9	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602177-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 83.4;BJ hTERT+: 62.1;HSkMC: 95.6;SH-SY5Y: 66.7;U-2197: 117.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"		1300000000	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: "	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	29.5	16.7	0.6	18.1	1.3	0.0	29.3	1.0	2.0	90.4	11.2	1.6	22.8	2.0	42.1	89.9	23.1	29.6	34.3	47.3	0.7	0.7	14.6	73.0	24.5	51.1	3.7	1.9	38.8	7.9	1.2	11.4	23.8	2.9	49.4	4.5	54.6	16.0	19.8	10.0	16.0	7.4	26.1	6.9	10.5	9.1	20.8	0.5	2.4	17.8	20.1	18.4	28.2	34.0	0.8	1.0	1.6	1.0	1.1	1.1	0.1	0.0	0.0	0.1	0.2	29.5	83.4	0.2	34.2	62.1	15.5	13.6	1.2	0.0	0.0	0.0	36.1	0.0	0.0	0.0	1.3	0.2	0.2	0.0	0.5	1.7	8.2	0.0	0.2	95.6	0.0	8.1	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.2	6.8	0.3	0.0	0.1	0.0	0.0	0.0	0.1	66.7	0.0	0.1	0.1	0.1	0.0	0.2	38.5	10.7	117.7	0.0	0.0	0.0	0.0	13.4	0.0	6.4	0.0	0.3	1.6	0.5	1.0	1.1	0.8	0.9	0.6	1.0	0.2	0.6	0.3	0.4	1.1	0.8	0.0	0.4	0.1	0.6	1.3	1.0	2.0	0.7	0.7	3.7	1.9	2.9	0.5
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Pregnancy	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.5;HaCaT: 21.8;RH-30: 14.4;RPTEC TERT1: 20.2;U-2 OS: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"		"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.5	2.1	0.2	0.1	0.0	8.2	0.9	0.3	0.6	0.2	21.8	1.1	0.6	0.1	0.2	1.9	2.8	1.6	0.7	0.4	0.8	1.3	2.9	0.2	0.5	0.2	4.5	3.2	1.0	1.5	5.1	3.2	4.9	10.6	0.9	0.6	14.4	0.8	20.2	1.2	0.2	0.2	3.3	0.7	0.2	1.2	3.5	3.5	0.7	31.5	1.8	0.9	0.2	0.1	0.4	2.4	1.2	12.0	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4
PCSK9	"FH3, HCHOLA3, NARC-1"	ENSG00000169174	"Proprotein convertase subtilisin/kexin type 9"	Q8NBP7	1	55039548-55064852	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Apoptosis, Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Hydrolase, Protease, Serine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 47.1;lung: 14.6"	"Cell line enhanced"	"Detected in some"		"A-431: 28.4;HaCaT: 38.1;HeLa: 33.2;RPTEC TERT1: 18.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"cerebellum: 6.9;pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	143000000	300000000				"unprognostic (1.28e-3)"	"unprognostic (6.93e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (7.30e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.09e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.45e-4)"	"unprognostic (1.49e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.40e-4)"	0.2	0.1	0.0	6.1	0.5	0.4	0.0	6.9	0.2	0.6	4.4	0.0	0.0	3.9	0.2	0.7	5.2	0.4	2.6	0.0	0.0	0.0	0.1	47.1	14.6	0.0	0.1	0.0	0.1	11.0	0.0	0.0	0.0	2.6	0.0	1.9	0.1	0.3	0.3	0.0	0.8	5.1	0.8	0.1	0.2	1.0	0.4	0.0	0.0	0.0	6.1	0.9	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.4	6.3	0.9	0.0	2.1	1.4	0.0	0.0	0.0	0.0	0.0	13.2	4.5	0.0	5.2	2.5	38.1	1.1	11.6	0.0	0.0	0.0	0.0	33.2	9.2	0.7	0.0	0.0	2.2	8.6	8.4	6.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	5.4	0.6	0.0	0.0	0.3	18.8	0.0	0.5	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.9	0.2	0.0	0.0	0.1	0.0	2.6	0.0
PCYOX1	"KIAA0908, PCL1"	ENSG00000116005	"Prenylcysteine oxidase 1"	Q9UHG3	2	70257386-70281191	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035193	Approved				"Intracellular and membrane"		480000000			"HPA035193: AB_10602017"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.28e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.38e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.54e-2)"	36.6	20.6	12.9	13.5	17.0	2.1	21.7	12.5	19.7	32.2	20.1	13.2	27.2	12.9	31.3	26.5	24.5	23.0	26.5	22.5	12.3	24.1	48.9	53.3	29.2	10.6	14.9	17.4	22.1	12.9	47.7	29.8	18.8	23.2	24.2	12.8	30.5	55.8	31.4	42.0	17.2	18.3	24.6	13.8	10.8	17.3	11.3	10.8	5.0	31.8	22.8	13.7	24.5	23.1	4.6	8.4	13.5	7.2	6.6	13.4	6.8	9.1	13.2	10.6	11.8	78.9	40.7	9.3	15.6	14.4	8.7	6.6	20.6	8.1	0.9	6.7	21.3	15.0	7.7	12.1	10.0	5.2	6.5	3.5	10.3	17.9	7.9	3.3	3.1	39.0	13.4	11.6	3.3	10.3	6.2	6.7	12.3	5.5	2.4	5.3	6.4	5.6	4.6	22.2	8.1	12.4	10.2	2.7	5.9	23.5	11.6	10.9	9.5	4.3	12.8	14.7	8.2	12.9	8.1	5.6	12.5	1.1	17.7	4.6	5.3	13.5	7.2	7.4	10.0	6.3	12.5	4.6	9.8	8.1	6.7	3.7	13.4	11.2	5.0	6.6	6.4	8.4	8.6	6.8	12.9	17.0	12.5	19.7	12.3	24.1	14.9	17.4	23.2	10.8
PCYT2	ET	ENSG00000185813	"Phosphate cytidylyltransferase 2, ethanolamine"	Q99447	17	81900965-81911464	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 70.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 62.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023033, HPA023034"	Enhanced		Supported	"Intermediate filaments,Centrosome"			7000	Centrosome	"Intermediate filaments"	"HPA023033: AB_1855094, HPA023034: AB_1855095"	"unprognostic (4.05e-3)"	"unprognostic (4.39e-3)"	"unprognostic (3.81e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"prognostic favourable (4.29e-6)"	"unprognostic (1.19e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.47e-2)"	13.6	5.5	13.3	5.7	12.7	5.3	10.4	12.2	17.0	6.5	16.2	13.4	6.4	30.7	5.8	8.6	7.6	12.2	8.0	17.7	14.0	11.8	21.7	46.5	7.2	6.3	13.4	16.0	7.8	11.5	8.2	4.6	6.0	15.9	10.1	8.5	5.8	10.8	6.6	13.5	4.5	26.5	5.0	14.3	4.1	11.5	70.8	11.0	5.6	6.7	6.8	5.8	7.5	4.4	7.3	6.6	2.1	3.5	4.7	8.4	4.0	12.1	7.0	5.6	15.8	28.2	14.9	8.3	8.7	18.8	12.3	14.6	27.4	12.7	4.2	4.8	9.1	10.0	8.5	16.2	7.1	1.2	6.9	9.2	9.6	62.6	30.2	9.2	7.7	12.2	9.4	11.1	8.6	11.3	17.0	8.8	9.1	10.3	10.9	11.4	4.5	7.5	7.2	6.0	15.0	14.7	23.0	7.2	6.6	6.6	36.4	8.5	10.1	21.9	7.6	9.1	6.0	6.8	7.2	5.7	2.4	4.1	9.4	12.4	8.9	2.1	3.5	1.2	7.1	3.4	4.6	6.0	8.4	7.2	6.6	7.3	7.0	7.2	1.0	4.7	3.0	6.5	5.0	4.0	13.3	12.7	12.2	17.0	14.0	11.8	13.4	16.0	15.9	11.0
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408829	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"			40000	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: , HPA060836: "	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	26.7	25.7	25.5	25.0	23.9	23.0	22.4	23.4	28.5	22.8	25.9	18.3	21.6	21.1	25.8	21.6	32.2	20.5	23.4	30.2	23.4	20.4	25.2	31.8	20.5	20.2	23.2	23.5	23.4	28.2	23.3	18.0	28.8	24.2	23.0	22.0	19.0	27.8	26.4	103.5	24.8	19.6	26.9	22.2	20.5	22.6	19.7	24.3	20.1	22.4	37.2	25.2	24.1	28.2	11.3	15.8	24.2	11.9	20.4	14.2	4.6	30.7	26.9	18.2	23.2	14.1	14.7	11.8	25.6	14.8	20.7	17.5	27.2	15.4	13.6	22.7	24.1	16.7	21.9	25.6	20.2	19.3	24.3	13.7	26.0	23.6	20.7	25.7	13.6	15.4	19.3	22.7	37.3	20.6	32.3	24.8	20.2	64.2	35.7	35.1	23.3	29.2	16.5	18.2	23.5	20.9	23.7	18.7	37.4	19.1	30.5	13.0	13.4	13.5	18.6	27.9	30.9	33.0	39.9	23.9	27.3	30.1	22.4	23.1	29.1	7.6	9.4	8.6	12.4	11.9	11.1	11.3	11.5	8.9	7.4	11.1	8.3	10.3	24.2	20.4	10.6	15.8	14.2	4.6	25.5	23.9	23.4	28.5	23.4	20.4	23.2	23.5	24.2	24.3
PDCD11	"ALG-4, KIAA0185, RRP5"	ENSG00000148843	"Programmed cell death 11"	Q14690	10	103396648-103446292	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017924, CAB026472"	Approved		Supported	Nucleoli,Vesicles				Nucleoli	Vesicles	"CAB026472: , HPA017924: AB_10601045"	"unprognostic (1.34e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.94e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.28e-2)"	"unprognostic (5.59e-2)"	11.3	11.8	11.6	13.9	12.5	9.6	13.8	12.6	12.0	11.0	10.4	10.6	8.9	8.5	17.3	10.6	17.3	14.3	9.9	10.3	10.5	7.0	11.0	14.0	11.3	14.7	9.9	8.6	16.5	17.2	17.7	14.4	10.9	10.5	12.1	12.0	9.2	11.3	13.0	42.8	22.3	11.1	13.6	9.5	14.7	10.8	22.8	12.4	20.7	10.9	13.8	17.0	11.2	16.8	5.6	5.4	1.4	4.4	3.4	9.1	3.5	10.1	15.1	10.5	29.6	9.2	8.3	11.8	11.2	7.9	11.3	9.3	20.5	10.0	28.0	8.0	8.0	18.2	27.0	14.1	12.8	12.9	18.2	16.3	9.6	16.4	11.0	32.4	11.2	8.6	13.0	17.4	39.8	12.1	26.1	12.6	10.9	11.5	16.2	18.5	21.6	14.6	16.4	15.1	12.7	7.1	10.0	7.1	13.3	7.5	8.9	12.4	8.8	9.2	13.1	8.4	10.6	11.2	20.9	16.1	22.4	26.6	7.4	31.4	6.2	0.1	4.4	1.4	5.7	4.3	9.1	5.6	5.4	4.6	4.7	4.1	4.8	5.6	0.6	3.4	3.6	5.4	3.8	3.5	11.6	12.5	12.6	12.0	10.5	7.0	9.9	8.6	10.5	12.4
PDCD5	"MGC9294, TFAR19"	ENSG00000105185	"Programmed cell death 5"	O14737	19	32581068-32587452	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018471	Enhanced		Approved	Nucleoplasm,Cytosol			31000	Cytosol	Nucleoplasm	"HPA018471: AB_1855108"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.60e-4)"	"unprognostic (2.02e-1)"	"unprognostic (8.64e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.49e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (6.00e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.54e-2)"	34.1	40.6	42.1	32.3	35.9	18.9	28.9	28.7	33.0	21.2	31.7	16.4	27.0	31.4	22.9	24.8	33.8	21.4	23.1	63.7	33.0	34.2	37.0	52.0	20.6	25.9	32.9	31.9	25.8	47.6	14.7	38.8	29.5	31.0	23.2	27.6	14.7	27.3	24.5	107.4	23.9	27.1	32.1	26.4	26.8	28.0	52.4	23.5	15.2	25.4	42.7	26.6	30.6	31.8	34.6	29.1	11.2	44.8	24.2	49.8	26.9	69.1	86.1	20.8	22.3	35.1	54.2	26.8	51.0	32.9	41.5	35.8	69.7	26.6	37.7	74.6	24.9	18.5	28.7	38.9	31.8	67.9	46.1	56.9	37.8	41.6	41.8	72.5	22.9	34.4	37.1	28.1	46.2	27.6	51.7	41.4	34.9	44.3	32.4	37.7	22.7	29.2	31.9	31.9	45.6	31.8	18.0	43.8	24.9	48.5	47.2	35.2	20.6	42.5	42.6	37.3	41.7	40.2	82.3	40.2	56.9	65.5	44.3	66.5	32.9	6.9	23.1	11.2	26.7	34.9	33.9	34.6	42.9	33.0	28.5	25.5	30.4	29.3	3.2	24.2	44.8	29.1	49.8	26.9	42.1	35.9	28.7	33.0	33.0	34.2	32.9	31.9	31.0	23.5
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-353856	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Approved	Cytosol			2100000	Cytosol		"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (2.19e-4)"	28.3	48.5	44.6	36.3	42.1	21.0	44.6	42.1	52.0	37.1	47.3	33.7	35.7	41.4	31.5	59.7	58.0	38.9	46.5	23.5	44.4	39.7	35.5	37.1	39.8	48.1	39.2	38.6	36.9	46.2	28.8	36.2	35.4	39.3	32.9	51.0	26.8	40.3	40.4	19.2	31.1	44.3	31.4	38.4	36.6	32.0	31.7	35.1	31.0	42.3	31.9	41.2	31.3	37.7	69.8	67.2	79.9	62.3	70.6	69.9	89.4	26.8	37.9	16.6	24.8	30.2	27.3	34.2	21.0	27.9	27.0	25.4	26.7	34.1	21.2	52.3	28.2	20.5	25.1	52.7	22.0	71.5	31.1	18.8	97.4	34.5	36.9	27.2	24.1	24.4	32.5	21.9	39.3	25.3	23.6	16.7	24.1	42.1	22.0	47.5	17.6	53.5	18.1	15.5	30.2	63.8	34.8	16.0	21.6	53.3	57.2	39.0	39.8	37.8	19.5	17.9	14.5	15.4	17.9	22.3	27.5	25.1	26.1	35.6	23.7	40.8	62.3	79.9	49.6	58.7	61.7	69.8	62.2	55.8	67.2	60.9	69.9	56.2	69.0	70.6	56.1	53.8	66.7	89.4	44.6	42.1	42.1	52.0	44.4	39.7	39.2	38.6	39.3	35.1
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798352-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011905, CAB016212, HPA051604"	Approved		Enhanced	Vesicles	"Intracellular and membrane"		6200000	Vesicles		"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favourable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	39.1	26.8	18.6	26.2	27.2	16.0	27.0	24.0	31.5	33.8	36.8	26.3	16.5	28.6	33.7	22.7	45.2	27.1	26.2	29.6	20.7	19.7	42.8	41.5	29.9	24.8	22.7	18.1	33.0	21.2	34.9	26.3	43.2	48.9	26.6	34.0	23.0	27.4	20.4	29.5	31.7	57.9	25.9	24.8	32.2	29.1	24.2	16.8	35.9	35.1	25.6	37.3	28.6	31.6	11.8	12.3	10.8	18.2	12.0	9.7	8.9	17.7	18.6	12.0	10.0	31.5	32.5	13.2	22.7	21.8	20.3	21.2	12.8	17.5	25.4	14.2	29.9	15.7	18.6	23.8	23.2	10.6	15.5	21.8	15.3	10.6	21.0	21.7	22.6	25.3	27.7	22.9	27.4	30.1	19.6	10.6	29.4	9.2	13.3	13.1	11.6	23.1	12.7	14.8	16.5	25.3	15.2	5.9	10.6	22.3	26.7	12.0	25.9	20.9	37.2	24.1	12.1	20.0	18.8	10.7	14.3	21.3	22.7	23.9	11.8	6.3	13.4	10.8	8.7	18.2	9.3	11.8	9.6	8.6	12.3	10.1	8.5	8.2	8.1	12.0	17.2	5.7	9.7	8.9	18.6	27.2	24.0	31.5	20.7	19.7	22.7	18.1	48.9	16.8
PDE1B	PDES1B	ENSG00000123360	"Phosphodiesterase 1B"	Q01064	12	54549350-54579239	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 11.3;HL-60: 6.3;HMC-1: 12.1;NB-4: 8.0;THP-1: 7.7;U-937: 6.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 52.6"	"Cell type enriched"	"Detected in single"	4	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.6"	"Region enriched"	"Detected in all"	6	"basal ganglia: 895.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 253.8"	HPA018492	Enhanced									"HPA018492: AB_1855119"	"unprognostic (2.90e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.67e-4)"	"unprognostic (5.63e-3)"	"unprognostic (7.02e-2)"	"unprognostic (7.51e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (4.77e-6)"	"unprognostic (6.64e-4)"	"unprognostic (2.14e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.83e-2)"	12.3	1.4	9.9	4.6	52.6	5.6	2.7	3.1	19.4	2.6	3.7	1.4	0.0	1.2	3.9	2.5	1.7	2.4	2.9	1.9	3.7	3.8	1.3	1.6	2.9	1.6	3.0	9.3	12.5	0.6	11.0	0.5	0.5	5.8	1.0	1.7	0.5	1.3	2.1	0.7	1.0	2.6	4.9	1.2	4.8	2.5	1.1	7.7	0.0	2.7	0.0	1.1	2.8	1.1	0.2	0.3	0.1	0.3	0.1	1.6	0.4	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.8	0.0	0.0	11.3	0.3	4.6	0.0	0.0	0.0	6.3	12.1	0.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.7	8.0	3.3	0.0	2.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	2.4	0.0	6.4	1.2	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.2	1.6	0.0	0.1	0.1	0.0	0.0	0.0	0.4	9.9	52.6	3.1	19.4	3.7	3.8	3.0	9.3	5.8	7.7
PDE3A	CGI-PDE	ENSG00000172572	"Phosphodiesterase 3A"	Q14432	12	20369245-20684381	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 62.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.7;HEL: 14.2;HeLa: 38.7;HUVEC TERT2: 6.9;SH-SY5Y: 14.5;U-138 MG: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 35.4"	"HPA014492, HPA074258"	Uncertain		Approved	"Plasma membrane"			23000	"Plasma membrane"		"HPA014492: AB_1855120, HPA074258: "	"unprognostic (2.59e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.25e-1)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (1.72e-6)"	"unprognostic (5.58e-2)"	"unprognostic (5.94e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.76e-4)"	7.1	1.0	1.7	4.7	2.0	0.0	3.8	3.5	1.4	7.8	15.9	1.0	2.0	2.1	7.8	3.5	9.1	4.9	5.5	62.2	1.6	1.4	3.7	1.8	3.9	3.3	1.9	1.1	7.1	6.5	1.0	2.8	13.8	2.7	6.3	9.0	12.0	7.8	4.2	2.0	1.4	21.4	6.0	1.8	2.1	5.5	2.3	0.7	0.0	2.8	1.9	0.9	4.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	7.7	0.0	1.8	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.2	38.7	0.2	0.6	0.0	0.0	1.8	0.0	0.4	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	2.1	0.0	0.1	14.5	0.0	0.0	0.0	0.0	0.0	0.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.7	2.0	3.5	1.4	1.6	1.4	1.9	1.1	2.7	0.7
PDE4B	DPDE4	ENSG00000184588	"Phosphodiesterase 4B"	Q07343	1	65792514-66374579	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 48.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.9;HUVEC TERT2: 35.9;NTERA-2: 21.8;SK-MEL-30: 21.6;TIME: 20.0;U-266/84: 18.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 36.6"	"Group enriched"	"Detected in all"	5	"B-cells: 16.1;granulocytes: 36.6;T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003005	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA003005: AB_1079587"	"unprognostic (7.86e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (6.10e-2)"	"unprognostic (8.78e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (2.89e-2)"	"unprognostic (3.54e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.33e-3)"	14.9	2.9	21.5	28.4	29.0	48.2	15.0	12.7	31.9	6.4	6.6	39.2	0.7	3.9	6.7	2.1	3.9	3.5	8.1	16.1	20.7	18.8	3.7	8.7	10.0	15.9	36.3	14.2	2.0	1.7	1.7	3.4	13.1	32.2	18.3	8.6	6.6	15.9	10.3	28.2	6.2	8.5	9.5	37.4	18.5	4.2	3.2	36.9	2.3	5.5	5.5	14.7	16.1	3.9	16.1	2.6	36.6	2.8	4.4	13.3	3.7	0.0	6.8	13.5	23.9	0.7	0.7	0.0	4.4	5.2	4.2	5.5	0.0	0.0	2.0	0.1	8.2	0.0	0.1	0.0	4.1	5.8	0.0	0.1	1.9	0.0	0.5	4.8	0.0	1.4	0.2	2.1	0.1	35.9	0.0	1.3	1.8	0.1	0.0	2.8	21.8	0.3	0.9	2.4	1.3	3.3	0.0	0.1	10.4	0.0	1.1	21.6	0.1	1.7	20.0	3.3	0.8	1.8	0.7	0.6	18.8	7.3	3.4	5.0	1.4	2.7	2.8	8.4	4.4	2.4	8.4	15.4	8.3	6.2	2.4	16.1	9.4	6.5	36.6	4.4	2.1	2.6	13.3	3.7	21.5	29.0	12.7	24.6	20.7	18.8	36.3	14.2	32.2	36.9
PDE6A	"PDEA, RP43"	ENSG00000132915	"Phosphodiesterase 6A"	P16499	5	149857955-149944793	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Hydrolase	"Disease mutation, FDA approved drug targets, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 153.4"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016970, HPA074677"	Enhanced									"HPA016970: AB_1855125, HPA074677: AB_2732264"	"unprognostic (6.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.39e-3)"	"unprognostic (8.83e-2)"	"unprognostic (6.54e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.57e-5)"	"unprognostic (9.93e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.26e-2)"	0.2	2.3	0.2	0.2	0.2	0.9	0.2	0.3	0.2	0.2	1.8	0.2	0.3	0.2	0.2	20.1	2.4	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	4.6	0.2	0.2	0.2	1.0	153.4	1.4	0.2	0.2	1.6	0.2	0.2	0.2	0.2	0.1	3.1	0.2	0.2	0.4	0.3	0.5	0.2	0.2	1.5	0.8	3.3	0.8	1.2	0.8	0.1	0.4	0.7	0.6	0.5	0.3	0.3	0.6	0.3	0.1	0.4	0.1	7.4	0.8	0.9	1.3	0.2	0.7	0.2	0.4	0.5	0.6	0.3	1.0	1.1	0.6	0.2	0.7	0.6	0.3	1.1	0.9	0.6	0.2	0.3	1.4	1.4	0.3	0.4	0.9	0.5	0.5	0.3	0.8	0.7	0.5	0.9	0.8	1.1	0.0	0.7	0.2	1.0	0.5	1.4	0.8	1.6	0.8	0.5	0.6	0.3	0.5	0.8	0.8	0.6	3.3	0.8	0.5	0.6	0.4	0.5	0.7	0.6	0.5	0.2	1.5	0.7	0.8	2.8	1.2	0.5	0.8	0.4	0.1	0.2	0.2	0.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PDGFB	"SIS, SSV"	ENSG00000100311	"Platelet derived growth factor subunit B"	P01127	22	39223359-39244751	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 29.1;HUVEC TERT2: 22.4;SK-BR-3: 22.2;TIME: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 10.8"	"Lineage enriched"	"Detected in single"	12	"T-cells: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011604, HPA011972, CAB018341"	Supported		Approved	Vesicles	"Secreted to blood"	324500	98000	Vesicles		"CAB011604: AB_2162180, CAB018341: AB_2162187, HPA011972: AB_1855134"	"unprognostic (4.96e-2)"	"unprognostic (8.94e-3)"	"unprognostic (8.41e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.46e-3)"	"unprognostic (4.34e-1)"	"prognostic unfavourable (3.67e-5)"	"unprognostic (3.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.84e-3)"	"unprognostic (5.12e-3)"	"unprognostic (7.47e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.03e-1)"	23.5	6.4	10.4	6.4	9.3	0.6	22.5	5.7	13.0	8.3	14.3	12.4	4.2	4.7	10.8	6.5	6.5	5.6	10.8	13.8	9.7	6.1	10.9	3.8	20.8	6.1	14.7	7.3	4.0	8.3	9.2	3.5	37.3	9.6	5.8	3.7	12.1	7.9	8.6	15.2	7.5	6.7	8.9	11.4	5.6	6.2	5.2	10.3	0.8	12.6	8.6	2.3	6.9	5.0	0.0	0.9	0.1	0.4	0.0	10.8	2.3	13.3	1.0	3.5	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	5.3	4.2	0.0	29.1	0.0	5.0	0.2	1.2	0.0	0.0	0.1	0.3	0.4	1.9	1.9	0.0	7.5	0.0	0.1	0.0	0.2	22.4	0.5	2.5	0.8	5.5	0.0	0.0	1.3	1.4	0.0	0.1	9.0	12.1	0.0	0.1	0.0	0.2	22.2	0.1	10.1	0.0	27.8	0.0	2.7	0.0	3.0	0.0	0.1	0.1	0.0	0.6	12.9	0.0	0.0	0.0	8.1	0.1	10.8	0.0	4.7	6.1	0.0	0.0	4.1	2.2	0.1	0.0	0.4	0.9	2.4	2.3	10.4	9.3	5.7	13.0	9.7	6.1	14.7	7.3	9.6	10.3
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229097-54298247	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 81.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.0;ASC TERT1: 37.9;BJ hTERT+: 47.0;fHDF/TERT166: 32.7;HHSteC: 27.4;HSkMC: 68.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"		150000	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: "	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favourable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavourable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	35.0	12.4	12.6	16.1	7.6	0.9	17.2	2.4	20.1	33.2	19.1	9.2	6.4	9.6	27.6	14.6	21.9	22.5	16.2	15.3	8.9	7.4	22.8	8.4	24.1	26.9	9.2	4.0	81.5	6.8	1.6	2.1	25.1	7.2	18.6	15.2	19.2	8.5	8.3	11.9	7.0	17.4	19.7	8.8	51.6	13.6	19.0	9.3	0.5	11.3	12.8	4.3	35.9	24.6	0.9	0.4	2.5	0.4	0.3	0.8	0.3	0.0	0.0	0.2	0.1	81.0	37.9	0.1	4.2	47.0	0.0	0.1	11.2	0.0	0.1	0.1	32.7	0.1	3.2	0.0	0.0	0.4	0.1	0.1	0.1	0.2	27.4	0.0	0.0	68.9	0.0	5.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.3	0.1	6.6	0.0	0.1	0.0	0.1	0.0	0.1	14.8	0.5	16.2	0.0	0.0	0.0	0.1	0.4	0.0	0.3	2.5	0.4	0.2	0.5	0.2	0.2	0.6	0.8	0.4	0.0	0.9	0.7	0.4	2.3	0.3	0.3	0.4	0.2	0.3	12.6	7.6	2.4	7.3	8.9	7.4	9.2	4.0	7.2	9.3
PDGFRB	"CD140b, JTK12, PDGFR, PDGFR1"	ENSG00000113721	"Platelet derived growth factor receptor beta"	P09619	5	150113837-150155872	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	Chemotaxis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"ASC diff: 169.0;ASC TERT1: 58.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.9;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	8	"monocytes: 4.1;T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003842, CAB018144, HPA028499"	Enhanced		Supported	"Golgi apparatus,Vesicles"			35000000	Vesicles	"Golgi apparatus"	"CAB003842: AB_562328, CAB018144: AB_2162497, HPA028499: AB_10602018"	"unprognostic (4.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.57e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (5.87e-8)"	"unprognostic (3.13e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (8.11e-4)"	61.8	10.4	8.3	11.0	9.1	0.5	66.1	4.6	10.4	73.1	15.7	6.7	6.9	5.1	44.3	17.3	21.7	26.1	51.7	24.2	8.2	3.9	17.0	4.6	28.9	21.5	7.9	8.1	46.5	7.5	10.4	7.7	46.4	7.7	24.2	6.3	22.9	11.2	19.3	29.8	20.3	11.2	29.8	5.0	19.6	9.2	21.5	6.7	1.4	21.4	16.0	7.3	23.6	35.1	0.4	0.1	0.0	4.1	0.0	2.9	0.6	0.0	0.0	1.0	0.0	169.0	58.5	0.3	5.9	24.5	4.1	7.0	0.6	0.0	0.0	0.7	16.9	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.4	24.0	0.0	0.0	26.3	0.0	5.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.1	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	6.7	2.2	2.8	0.3	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	2.9	0.6	0.0	0.4	0.1	0.8	0.1	0.1	0.0	1.3	0.0	0.0	4.1	0.0	0.0	0.6	8.3	9.1	4.6	10.4	8.2	3.9	7.9	8.1	7.7	6.7
PDHX	"DLDBP, E3BP, OPDX, PDX1, proX"	ENSG00000110435	"Pyruvate dehydrogenase complex component X"	O00330	11	34915829-35020591	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038484, HPA038485"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Mitochondria"				"Nucleoplasm, Plasma membrane"	Mitochondria	"HPA038484: AB_10669645, HPA038485: AB_10669540"	"unprognostic (1.60e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.41e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (1.83e-5)"	"unprognostic (2.24e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.82e-1)"	13.5	14.9	13.4	8.6	17.2	4.2	10.4	13.9	23.3	9.2	13.3	10.6	9.3	12.2	8.9	8.6	10.9	6.7	7.7	46.1	14.4	12.8	15.0	25.7	7.8	6.8	14.7	14.1	7.7	13.1	14.6	14.7	15.8	22.1	12.0	12.7	8.9	12.4	14.1	70.5	8.8	12.3	11.5	12.0	6.6	13.7	15.7	9.0	5.9	9.1	19.0	8.7	13.0	10.7	12.8	19.5	12.1	21.7	15.0	14.9	9.8	9.1	23.9	13.8	5.5	10.2	12.0	13.5	17.0	13.9	19.3	18.7	30.8	8.4	12.5	11.2	14.4	17.7	26.7	14.3	19.2	11.2	22.4	11.8	25.2	35.4	22.0	22.2	13.9	12.3	17.8	10.5	14.4	13.9	25.2	11.6	15.1	15.5	13.7	13.7	11.3	14.3	12.1	24.7	10.9	28.8	24.0	14.6	10.6	15.0	22.7	23.3	25.5	13.7	9.6	14.4	16.2	14.7	18.8	11.1	21.9	15.5	11.2	11.0	14.5	8.6	13.6	12.1	11.5	15.0	10.8	12.8	10.9	9.4	19.5	11.7	13.3	9.6	2.8	15.0	21.7	5.2	14.9	9.8	13.4	17.2	13.9	23.3	14.4	12.8	14.7	14.1	22.1	9.0
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: , HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favourable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavourable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.2	4.6	9.7	21.8	19.8	21.2	29.9	24.6	24.3	18.3	22.7	12.8	12.6	14.0	16.0	28.0	19.5	12.3	23.8	15.9	10.1	18.2	18.9	7.3	11.8	32.5	10.7	13.8	13.6	19.7	13.8	23.3	31.8	10.9	6.9	17.8	4.2	3.6	12.1	9.8	18.6	7.0	15.3	10.5	15.5	10.0	9.8	10.9	20.5	19.7	7.7	13.7	10.9	21.5	15.2	8.0	12.2	11.9	3.1	3.6	14.7	19.5	16.9	11.4	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3
PDIA4	"ERP70, ERP72"	ENSG00000155660	"Protein disulfide isomerase family A member 4"	P13667	7	149003062-149028641	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 164.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006139, HPA006140, CAB017368"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		12000000	"Endoplasmic reticulum"		"CAB017368: AB_10621725, HPA006139: AB_1848256, HPA006140: AB_1848257"	"unprognostic (1.98e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (9.69e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-3)"	"unprognostic (6.08e-3)"	"unprognostic (3.20e-2)"	"prognostic unfavourable (5.20e-9)"	"unprognostic (1.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.51e-1)"	17.6	13.0	7.7	25.6	11.9	7.4	27.4	5.1	7.9	25.5	20.9	12.1	28.8	18.2	19.4	46.3	15.2	20.8	28.1	16.9	7.3	8.0	27.7	164.3	19.1	29.1	11.6	6.2	19.4	76.3	7.0	19.1	24.7	12.0	18.0	21.9	7.8	36.4	26.5	5.8	10.1	21.3	17.8	13.9	27.9	23.7	11.5	11.3	19.2	89.8	11.9	24.3	17.4	22.6	26.6	63.3	16.2	21.2	21.5	35.9	34.5	32.6	31.1	33.8	94.5	30.9	22.1	49.0	46.0	30.8	26.4	43.1	25.8	88.4	23.5	103.3	37.8	21.4	22.8	43.6	23.2	16.7	13.4	11.3	9.0	56.5	41.5	25.7	31.9	21.7	19.6	28.9	23.2	53.5	18.4	64.2	23.1	35.7	24.4	29.3	50.4	18.1	16.1	26.2	57.0	30.8	25.7	10.8	28.4	41.7	30.1	16.0	17.1	19.8	29.2	20.8	11.8	50.5	32.3	48.9	22.0	16.6	48.6	30.4	70.8	16.2	20.1	12.1	34.3	21.2	35.9	26.6	22.6	26.7	19.4	15.1	21.5	22.7	2.7	21.5	21.0	63.3	16.6	34.5	7.7	11.9	5.1	7.9	7.3	8.0	11.6	6.2	12.0	11.3
PDIA6	"ERp5, P5, TXNDC7"	ENSG00000143870	"Protein disulfide isomerase family A member 6"	Q15084	2	10783391-10837977	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034347, HPA034652, HPA034653"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"	"Intracellular and membrane"		53000000	"Endoplasmic reticulum, Cytosol"		"CAB034347: AB_2299360, HPA034652: AB_2674263, HPA034653: AB_10601982"	"unprognostic (8.16e-2)"	"prognostic unfavourable (1.80e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.20e-4)"	"prognostic unfavourable (3.63e-5)"	"unprognostic (3.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.25e-3)"	"unprognostic (6.03e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (2.51e-6)"	"unprognostic (6.59e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.69e-3)"	26.9	32.7	16.7	25.0	29.9	19.9	28.7	11.3	16.8	33.4	26.1	13.9	53.7	20.4	30.4	76.1	27.1	25.5	22.4	32.7	14.2	13.9	42.1	118.4	30.4	36.3	17.8	12.7	26.5	141.6	24.9	23.3	39.5	19.0	22.6	30.1	14.6	53.4	45.0	15.7	16.1	28.4	26.5	14.3	35.1	30.9	12.4	19.5	18.1	97.9	20.1	29.7	21.9	30.6	45.2	61.0	52.0	46.2	51.5	52.2	59.7	33.9	36.9	52.9	82.9	68.1	58.9	94.0	82.7	76.8	43.4	58.5	52.3	67.1	55.2	58.2	80.8	27.9	39.7	69.2	46.7	43.2	31.3	44.7	28.9	84.9	73.7	45.8	33.6	42.5	53.2	42.0	75.8	97.8	38.4	119.1	42.8	40.2	17.6	47.5	44.1	29.2	42.3	53.9	99.9	61.8	41.1	33.9	67.9	32.6	47.8	46.4	16.9	77.7	48.0	40.8	52.1	36.7	47.8	112.4	69.3	35.8	55.1	57.6	57.0	52.0	44.4	20.5	47.5	46.2	52.2	45.2	37.7	44.7	48.6	33.1	18.4	31.0	8.1	51.5	33.9	61.0	37.7	59.7	16.7	29.9	11.3	16.8	14.2	13.9	17.8	12.7	19.0	19.5
PDK1		ENSG00000152256	"Pyruvate dehydrogenase kinase 1"	Q15118	2	172555373-172608669	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 31.3;U-87 MG: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 5.9;granulocytes: 16.0;T-cells: 15.8"	"Low region specificity"	"Detected in all"							"CAB017554, HPA027376, HPA059083"	Approved		Approved	Nucleoli,Mitochondria			22000	"Nucleoli, Mitochondria"		"CAB017554: AB_2161138, HPA027376: AB_1855139, HPA059083: "	"unprognostic (2.14e-1)"	"prognostic unfavourable (7.30e-5)"	"unprognostic (1.21e-1)"	"unprognostic (3.94e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.44e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.56e-2)"	"unprognostic (5.34e-2)"	9.9	16.2	6.8	11.0	10.5	13.4	16.7	7.1	15.6	7.3	15.3	3.3	2.9	15.5	5.4	8.0	11.2	4.4	5.8	27.6	6.9	5.2	6.8	14.2	6.1	21.4	7.2	5.2	19.5	7.2	3.4	7.5	7.9	7.2	6.5	13.1	7.6	14.1	7.6	9.6	24.7	8.4	5.2	10.7	14.2	12.5	11.0	6.7	10.3	5.1	5.0	20.8	18.0	9.8	5.9	2.3	16.0	2.2	1.4	15.8	6.2	14.1	0.6	3.7	9.1	1.5	2.3	5.2	12.5	10.1	6.3	13.4	3.6	3.0	13.5	6.9	3.8	6.2	2.5	7.8	20.1	2.7	5.0	16.4	3.3	4.2	2.7	8.1	6.1	2.9	2.8	4.3	7.3	3.3	3.4	9.3	8.3	1.4	5.1	10.2	8.9	3.9	5.4	6.0	21.7	3.2	4.6	6.9	7.9	3.2	3.8	4.7	2.4	3.4	3.8	10.0	3.2	5.2	3.3	31.3	18.1	11.1	32.0	5.9	2.0	12.2	2.2	16.0	2.5	1.5	3.0	4.7	4.2	2.8	2.3	5.9	15.8	9.6	8.5	1.4	1.9	0.4	8.0	6.2	6.8	10.5	7.1	15.6	6.9	5.2	7.2	5.2	7.2	6.7
PDLIM1	"CLIM1, CLP-36, CLP36, hCLIM1"	ENSG00000107438	"PDZ and LIM domain 1"	O00151	10	95237572-95291024	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 95.1;HHSteC: 92.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 39.1;memory B-cell: 49.1;naive B-cell: 44.9"	"Group enriched"	"Detected in many"	6	"B-cells: 49.1;granulocytes: 39.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017010, CAB072838, CAB072840"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"			210000000	"Actin filaments"	"Plasma membrane, Cell Junctions"	"CAB072838: , CAB072840: , HPA017010: AB_1855147"	"unprognostic (1.61e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.58e-2)"	"prognostic favourable (1.14e-5)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.82e-3)"	"unprognostic (5.77e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.21e-3)"	"unprognostic (1.11e-1)"	60.9	6.4	2.9	32.3	3.7	2.7	69.9	3.6	3.7	30.6	78.8	3.0	24.3	27.8	30.0	35.6	48.3	28.0	38.4	107.5	3.0	2.4	19.8	49.0	78.8	91.6	6.3	2.2	23.3	20.5	11.7	6.7	53.0	16.5	34.7	34.7	12.8	34.5	27.4	150.1	26.4	96.3	27.2	8.6	52.9	28.3	14.3	3.6	23.4	76.9	54.9	41.9	65.0	38.9	49.1	6.8	39.1	0.5	1.7	3.2	9.2	33.9	21.9	1.5	0.0	8.1	5.5	35.3	10.4	32.4	27.1	44.5	46.2	52.7	0.0	2.9	28.1	95.1	11.1	60.2	27.5	0.0	17.2	33.8	6.5	74.9	92.7	0.0	1.7	15.8	31.7	13.8	50.0	48.4	7.3	8.6	6.4	6.0	0.1	0.5	3.1	17.7	28.5	1.2	11.9	13.9	32.3	6.1	2.5	11.2	10.3	0.1	8.4	14.9	42.6	10.6	2.5	0.0	0.0	4.1	0.0	11.1	11.6	0.0	5.0	0.0	0.5	39.1	2.8	0.1	0.0	49.1	0.5	3.2	6.8	44.9	0.1	2.0	1.7	1.7	0.3	0.7	0.4	9.2	2.9	3.7	3.6	3.7	3.0	2.4	6.3	2.2	16.5	3.6
PDLIM3	ALP	ENSG00000154553	"PDZ and LIM domain 3"	Q53GG5	4	185500660-185535612	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 447.7"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 50.0;RH-30: 12.3;U-266/70: 40.2;U-266/84: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004749	Enhanced		Supported	Cytosol			270000	Cytosol		"HPA004749: AB_1855150"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.46e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.97e-7)"	"unprognostic (1.64e-3)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.13e-6)"	"unprognostic (2.78e-3)"	7.8	1.2	1.6	5.2	1.9	0.1	3.7	2.2	1.0	6.6	16.5	1.4	7.9	2.3	22.2	17.0	27.2	9.3	9.9	29.5	1.5	1.6	0.8	0.8	5.6	1.4	1.6	1.0	11.1	2.1	0.1	1.9	2.2	1.6	15.2	3.6	4.8	5.3	18.7	447.7	1.0	6.1	49.5	1.4	3.4	10.2	3.9	0.7	0.1	6.2	87.3	9.1	28.4	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.4	1.9	5.5	0.0	0.0	3.9	0.0	1.2	0.0	4.1	0.0	0.0	50.0	0.0	0.0	0.0	0.9	0.3	0.0	12.3	0.1	0.0	0.0	7.4	5.6	0.0	0.0	2.9	0.2	0.0	2.7	0.0	3.0	0.0	2.5	40.2	11.4	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.9	2.2	1.0	1.5	1.6	1.6	1.0	1.6	0.7
PDLIM5	"Enh, LIM"	ENSG00000163110	"PDZ and LIM domain 5"	Q96HC4	4	94451857-94668227	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 129.6;skeletal muscle: 173.0"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	8	"prostate cancer: 132.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"basophil: 51.1"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013511, HPA016740, HPA020026"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Focal adhesion sites"			2200000	"Nucleoplasm, Plasma membrane, Focal adhesion sites"		"CAB013511: AB_2533388, HPA016740: AB_1855153, HPA020026: AB_1855154"	"unprognostic (6.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	11.6	4.8	6.2	4.2	6.1	8.7	9.8	3.4	5.8	12.7	11.0	3.7	7.1	5.6	37.5	12.9	14.0	10.2	11.0	129.6	5.3	5.2	12.9	13.9	5.6	5.3	5.4	4.5	10.3	8.1	3.4	6.8	18.9	10.2	15.3	5.4	12.6	15.3	12.5	173.0	5.6	15.8	22.1	4.9	7.0	5.6	5.5	3.7	1.0	5.3	52.9	9.5	17.7	7.1	3.2	5.6	51.1	12.2	2.7	3.9	3.8	8.6	25.7	10.0	3.9	22.1	15.2	3.9	21.2	17.6	12.2	9.8	23.7	19.3	3.4	21.7	21.2	9.0	13.6	19.8	20.4	6.1	5.7	12.7	16.8	8.9	31.9	4.1	11.4	20.4	17.5	29.1	22.7	27.3	5.4	3.8	25.8	8.5	4.2	1.4	3.4	10.8	2.0	7.4	3.1	13.6	27.8	5.0	6.7	11.5	26.5	5.9	3.1	1.3	34.2	31.8	5.0	13.7	12.8	2.6	3.4	3.5	17.3	3.0	7.4	51.1	6.8	5.9	3.8	11.8	3.1	3.2	3.7	3.9	5.6	2.5	2.5	3.2	6.8	2.7	12.2	1.9	3.4	3.8	6.2	6.1	3.4	3.9	5.3	5.2	5.4	4.5	10.2	3.7
PDP1	"PDH, PDP, PPM2A, PPM2C"	ENSG00000164951	"Pyruvate dehyrogenase phosphatase catalytic subunit 1"	Q9P0J1	8	93857807-93926066	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 62.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;TIME: 33.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 38.9;cerebral cortex: 62.2;olfactory region: 32.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018483, HPA019081, HPA021152"	Uncertain		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA018483: AB_1855634, HPA019081: AB_1855633, HPA021152: AB_1855635"	"prognostic unfavourable (8.61e-5)"	"unprognostic (4.62e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavourable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.25e-1)"	"prognostic favourable (8.42e-9)"	"unprognostic (1.85e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.67e-1)"	5.1	32.3	11.0	4.6	38.9	5.9	7.9	7.5	62.2	7.5	4.3	4.7	1.6	3.3	7.7	8.6	8.0	6.1	9.6	22.9	10.1	8.0	6.3	2.2	6.0	5.6	5.1	32.5	9.7	9.3	20.6	4.2	6.6	4.4	5.2	6.2	4.4	6.6	4.7	31.8	3.2	5.5	5.5	3.4	5.8	5.5	12.9	4.8	4.1	9.3	7.0	5.8	7.7	5.1	11.0	12.7	7.8	21.5	2.8	19.5	8.8	8.9	4.4	9.6	4.0	8.0	14.6	3.2	7.0	7.8	8.3	9.8	4.6	33.2	5.0	23.7	11.2	19.9	4.1	5.9	12.3	0.5	2.0	2.3	5.5	1.6	9.1	1.1	3.3	9.4	11.8	14.1	22.6	18.7	0.8	8.2	10.1	2.1	6.9	3.6	4.4	5.7	1.7	5.7	0.9	5.7	6.2	0.8	4.2	4.6	0.5	21.6	1.5	1.4	33.2	10.1	6.5	23.6	8.3	4.6	1.9	4.2	12.9	4.2	8.9	3.1	15.4	7.8	5.6	14.3	5.3	9.3	9.1	7.2	12.7	11.0	5.5	4.8	1.8	2.8	21.5	2.1	19.5	8.8	11.0	38.9	7.5	62.2	10.1	8.0	5.1	32.5	4.4	4.8
PDPK1	PDK1	ENSG00000140992	"3-phosphoinositide dependent protein kinase 1"	O15530	16	2537964-2603188	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004272, HPA035199, HPA068961"	Supported		Approved	Vesicles				Vesicles		"CAB004272: AB_626657, HPA035199: , HPA068961: "	"unprognostic (2.67e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.69e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (1.29e-14)"	"unprognostic (2.04e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.16e-1)"	11.1	14.9	21.0	11.6	31.9	14.2	14.2	29.6	26.4	10.5	15.6	14.5	10.4	17.2	13.0	14.0	13.8	15.3	10.8	14.8	17.2	13.5	17.6	12.6	13.4	13.5	11.3	20.6	14.8	28.2	34.5	13.9	17.1	16.7	13.6	15.3	12.8	16.5	13.2	18.2	14.1	19.1	12.9	10.9	13.7	13.4	14.2	10.1	14.1	16.1	10.6	13.9	12.3	13.3	5.1	9.1	14.7	9.4	5.4	6.0	4.5	8.4	10.8	13.5	9.0	14.0	11.7	14.3	14.0	9.1	12.6	10.6	10.8	10.1	13.9	9.6	13.6	13.4	16.1	10.1	12.0	24.7	10.9	7.3	14.3	17.9	12.2	12.1	19.4	10.6	18.6	13.5	9.1	11.5	13.6	11.3	14.7	17.8	12.2	8.5	8.5	9.7	25.0	13.5	12.5	12.2	7.5	21.3	11.0	18.2	21.0	7.5	19.4	15.3	14.1	13.8	13.7	13.4	12.1	15.1	14.3	21.7	6.6	8.4	11.9	3.9	7.9	9.0	5.1	9.3	4.8	5.1	4.7	6.0	6.7	4.5	5.3	4.9	14.7	5.4	9.4	9.1	2.3	4.5	21.0	31.9	29.6	26.4	17.2	13.5	11.3	20.6	16.7	10.1
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 68.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm			870000	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	28.1	13.2	37.4	8.7	36.6	13.3	13.3	21.9	38.5	9.7	13.8	11.0	15.7	16.7	9.0	13.2	11.0	12.9	8.8	11.4	26.1	30.4	22.8	17.4	20.4	9.5	24.1	22.7	16.4	17.6	25.7	20.7	12.6	20.3	10.6	11.8	7.8	18.3	13.9	5.8	14.3	22.1	8.8	10.1	7.8	15.2	68.9	10.7	3.9	13.6	7.0	11.0	9.7	8.6	2.7	2.5	1.3	7.7	1.9	3.3	2.4	17.2	21.2	3.4	6.4	8.3	11.8	4.1	6.2	9.8	6.1	5.1	17.2	27.1	5.8	6.7	8.9	13.1	6.5	17.8	4.0	6.5	5.6	5.9	23.2	12.7	16.4	5.5	8.7	16.7	17.0	6.4	7.1	2.8	10.3	13.5	5.7	11.7	0.8	10.1	9.2	8.1	6.6	2.0	16.2	26.3	21.2	3.3	3.9	25.9	24.0	9.2	7.9	7.8	5.1	4.4	8.7	5.9	5.8	8.2	3.8	3.4	18.3	16.1	4.3	1.3	4.8	0.2	1.7	4.4	3.3	1.4	1.7	1.9	2.5	2.7	2.0	1.4	1.3	1.9	7.7	1.2	1.5	2.4	37.4	36.6	21.9	38.5	26.1	30.4	24.1	22.7	20.3	10.7
PEA15	"HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED, PED-PEA15, PED/PEA15"	ENSG00000162734	"Proliferation and apoptosis adaptor protein 15"	Q15121	1	160205337-160215376	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 199.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 30.6"	"Group enriched"	"Detected in all"	6	"B-cells: 7.6;dendritic cells: 22.1;monocytes: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028356, HPA070820"	Enhanced		Approved	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA028356: AB_10602814, HPA070820: "	"unprognostic (1.29e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.99e-3)"	"unprognostic (6.10e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavourable (6.53e-7)"	"unprognostic (2.60e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.24e-1)"	45.3	20.4	105.3	28.7	83.6	3.8	25.3	30.5	173.1	25.1	15.5	68.1	5.0	8.0	21.5	21.8	22.6	19.2	22.1	53.9	70.5	81.3	14.8	10.4	23.8	16.6	106.5	67.0	19.7	9.7	14.9	10.2	25.1	74.1	24.4	15.3	18.2	12.3	31.1	10.2	16.9	8.8	47.4	199.4	23.8	10.0	17.5	53.7	1.6	12.6	6.0	22.9	22.4	17.5	7.6	22.1	1.8	30.6	3.1	3.5	5.4	16.7	5.8	24.3	10.5	45.1	25.3	8.1	72.8	63.6	60.6	42.6	12.8	9.1	7.8	26.4	90.8	18.3	9.0	22.8	47.4	4.2	5.0	6.4	4.1	3.2	55.7	2.1	7.9	21.2	12.9	33.3	42.5	45.5	6.6	14.3	81.0	8.3	2.5	5.0	16.1	16.8	4.2	25.6	5.3	22.0	8.8	4.8	12.9	38.6	26.4	22.2	16.2	15.1	60.6	40.3	31.6	30.0	31.2	11.3	6.9	14.8	37.1	4.1	57.0	0.3	15.3	1.8	3.5	30.6	2.7	7.6	2.6	2.8	22.1	5.0	1.6	1.8	0.7	3.1	13.9	9.7	2.9	5.4	105.3	83.6	30.5	78.2	70.5	81.3	106.5	67.0	74.1	53.7
PEAR1	"FLJ00193, JEDI, MEGF12"	ENSG00000187800	"Platelet endothelial aggregation receptor 1"	Q5VY43	1	156893698-156916434	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.9;HBEC3-KT: 13.5;HHSteC: 10.2;HUVEC TERT2: 23.8;TIME: 38.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035217	Approved		Approved	"Nucleoplasm,Cell Junctions,Centrosome"			35000000	"Nucleoplasm, Cell Junctions"	Centrosome	"HPA035217: AB_10669902"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.62e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.99e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.20e-2)"	"unprognostic (3.37e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.64e-2)"	18.5	7.1	1.8	3.0	5.1	2.8	29.2	1.2	2.9	16.5	5.8	2.7	6.3	2.3	15.9	10.5	6.6	8.9	10.3	11.1	2.7	1.8	6.8	3.8	12.0	10.1	3.2	2.1	10.6	3.2	1.7	3.9	15.5	3.7	9.6	1.4	15.5	4.1	5.5	11.4	4.4	4.1	9.6	3.1	12.2	4.1	8.1	1.5	0.6	10.5	5.8	2.1	6.7	11.5	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.2	1.3	0.3	0.0	0.0	1.7	0.0	5.2	8.9	2.2	1.3	0.1	0.2	0.0	0.2	3.9	0.1	0.0	13.5	0.6	0.0	0.0	6.5	0.2	0.3	10.2	0.0	0.0	5.3	0.0	3.0	0.7	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	38.4	0.0	3.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.4	1.8	5.1	1.2	2.9	2.7	1.8	3.2	2.1	3.7	1.5
PEBP1	"HCNP, PBP, PEBP, RKIP"	ENSG00000089220	"Phosphatidylethanolamine binding protein 1"	P30086	12	118135858-118145584	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 260.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA008819, CAB013493, HPA063904"	Enhanced		Supported	"Plasma membrane"			62000000	"Plasma membrane"		"CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: "	"unprognostic (4.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.28e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.35e-3)"	"unprognostic (5.67e-2)"	"unprognostic (3.55e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (1.63e-1)"	"prognostic favourable (2.15e-13)"	"unprognostic (2.17e-1)"	"unprognostic (7.72e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.80e-2)"	26.8	207.3	83.0	15.2	82.3	13.5	32.3	63.3	102.7	35.5	50.4	58.0	18.9	75.3	22.9	52.8	24.3	28.5	22.6	57.6	77.6	69.7	132.7	260.7	22.1	16.0	77.8	71.5	43.5	46.2	139.2	30.8	16.5	59.1	35.4	25.4	41.2	43.6	33.1	65.1	20.9	75.4	23.4	79.1	15.3	20.6	22.7	43.5	8.7	94.9	26.1	19.7	20.2	17.8	45.2	37.3	3.0	12.1	20.9	45.3	36.4	31.7	27.1	38.5	40.0	60.7	29.8	59.9	25.3	29.6	40.0	20.6	16.2	11.0	51.2	25.5	37.9	22.9	56.9	23.5	31.3	12.8	54.4	25.7	30.6	112.6	35.1	46.5	11.3	29.4	39.1	23.6	16.5	18.6	42.6	19.1	40.0	37.6	25.3	94.2	37.3	32.9	50.1	28.7	93.4	49.0	31.0	46.1	35.8	52.6	36.6	49.5	52.5	31.7	20.1	30.8	17.5	30.0	25.4	18.7	33.2	26.4	36.1	34.8	33.2	0.7	11.0	3.0	26.9	12.1	42.4	45.2	45.3	33.3	33.3	32.5	43.9	35.3	1.2	20.9	10.3	37.3	41.2	36.4	83.0	82.3	63.3	102.7	77.6	69.7	77.8	71.5	59.1	43.5
PEBP4	"CORK1, hPEBP4, MGC22776"	ENSG00000134020	"Phosphatidylethanolamine binding protein 4"	Q96S96	8	22713251-23000000	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 85.8;skeletal muscle: 124.6"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 9.3"	"Group enriched"	"Detected in many"	13	"lung cancer: 11.4;prostate cancer: 23.7;thyroid cancer: 35.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7;neutrophil: 2.7;NK-cell: 2.6"	"Group enriched"	"Detected in many"	19	"B-cells: 2.7;granulocytes: 2.7;NK-cells: 2.6"									HPA025064	Uncertain				"Secreted in other tissues"		200000000			"HPA025064: AB_1855174"	"unprognostic (1.34e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.76e-3)"	"unprognostic (9.70e-8)"	"unprognostic (1.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.59e-1)"	2.7	0.9	2.2	0.2	4.9	0.2	0.9	1.0	1.9	0.3	0.2	2.4	0.8	0.1	0.3	85.8	1.6	0.5	0.6	43.8	2.2	5.1	0.6	0.7	31.8	0.3	10.8	0.8	0.4	7.4	0.4	4.7	0.2	7.8	10.4	0.2	18.9	12.3	0.8	124.6	0.3	0.2	0.2	1.0	0.2	1.7	1.4	2.5	0.0	22.3	16.6	2.3	0.2	0.0	2.7	0.1	2.7	0.0	2.6	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.7	0.1	0.0	0.7	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.9	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.3	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.4	0.0	0.0	2.7	2.6	0.0	0.1	0.0	0.0	2.2	4.9	1.0	1.9	2.2	5.1	10.8	0.8	7.8	2.5
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: "	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favourable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.9	5.5	0.0	3.1	4.6	0.1	0.7	2.5	0.5	0.0	0.1	0.4	0.1	2.6	1.5	0.5	4.2	0.0	0.2	1.3	1.5	4.7	8.5	0.0	2.6	0.7	20.7	2.9	0.2	0.0	0.0	1.0	3.5	0.1	0.6	0.0	23.2	0.2	9.0	0.7	11.4	0.3	1.0	2.2	9.3	10.9	0.0	0.5	0.0	6.1	0.0	3.8	0.3	1.6	2.8	0.5	2.6	0.4	0.0	0.6	2.9	3.2	1.6	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: , HPA062281: "	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favourable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	6.7	9.5	14.5	3.8	17.0	1.8	7.4	19.6	33.1	7.4	8.3	6.7	6.4	4.8	10.3	9.1	10.6	8.2	10.1	7.7	17.4	13.5	4.6	3.2	7.1	4.3	13.0	12.5	15.3	9.9	21.5	8.3	3.8	15.8	11.5	2.9	6.4	10.4	22.3	10.8	11.2	4.7	11.3	6.2	5.0	5.8	6.2	7.8	0.3	8.5	2.7	3.4	9.0	11.8	3.3	3.3	1.3	6.8	1.2	3.1	1.4	15.3	6.5	5.3	4.1	8.5	3.3	4.2	4.9	6.4	4.7	4.0	9.5	3.5	3.8	4.9	5.4	8.2	3.5	6.2	1.9	7.5	3.0	1.0	5.4	2.8	5.4	0.8	7.5	3.1	7.0	4.8	1.7	0.9	1.8	6.1	2.0	9.4	3.1	2.4	3.3	6.7	10.7	3.9	4.0	2.6	4.9	6.4	3.5	2.5	7.1	16.7	8.3	4.2	2.7	4.2	6.4	18.1	4.1	5.6	3.2	2.0	8.7	2.5	3.4	1.3	2.5	0.4	2.5	1.8	2.0	2.8	2.1	3.1	3.3	3.3	2.2	1.8	0.1	1.2	6.8	1.0	2.4	1.4	14.5	17.0	19.6	33.1	17.4	13.5	13.0	12.5	15.8	7.8
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.2;ASC TERT1: 9.7;BJ: 9.0;THP-1: 8.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in many"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"		35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.2	9.7	0.0	9.0	2.9	1.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Collagen degradation"	"Dipeptidase, Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm			1000000000	Nucleoplasm		"HPA015599: AB_1855192, HPA072045: "	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.2	35.9	10.6	17.0	45.2	17.4	24.5	11.7	24.1	15.0	17.1	31.2	11.6	5.4	17.6	29.5	3.4	15.2	9.6	12.4	15.2	15.0	34.3	7.3	31.7	30.9	9.9	41.6	21.4	9.1	13.7	8.5	20.0	6.5	15.6	16.3	16.1	7.6	3.3	14.6	14.6	15.0	14.4	14.9	13.0	34.9	13.0	33.4	21.9	10.8	17.7	7.5	10.8	16.7	14.5	15.7	18.8	13.6	14.3	21.2	4.7	15.5	14.4	20.6	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes				Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.6	6.3	10.3	17.4	6.5	5.6	9.3	3.8	5.0	4.5	6.5	3.8	6.1	8.5	8.6	4.3	5.8	7.8	6.8	7.2	8.7	6.9	4.0	6.7	4.7	4.5	7.2	4.6	6.1	6.2	6.8	9.2	7.0	14.9	12.1	7.1	10.7	14.4	7.1	7.1	5.9	10.2	11.5	10.5	6.4	8.4	7.6	12.3	8.8	24.4	7.5	5.0	3.1	5.8	4.4	5.9	16.5	3.9	13.6	10.7	11.7	4.1	4.3	6.9	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA049458: , HPA049755: "	"prognostic favourable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.6	18.7	20.5	6.2	19.9	5.6	16.3	7.6	24.6	9.8	9.2	23.1	6.6	10.1	7.6	13.6	10.6	11.4	8.3	12.9	17.8	15.5	12.0	12.1	8.3	7.6	19.2	13.5	13.0	19.4	12.5	12.2	10.2	16.0	15.4	7.0	11.4	17.4	12.3	22.1	10.8	9.0	6.6	21.3	8.9	10.1	17.3	12.6	6.0	10.5	11.8	9.0	8.1	6.8	7.4	11.5	2.2	10.7	4.5	6.4	4.8	12.0	10.1	7.8	8.7	5.7	6.6	7.3	6.4	7.4	10.6	7.7	16.0	18.2	6.3	16.9	8.4	9.4	7.1	11.8	5.0	10.2	13.8	4.8	10.3	31.9	11.0	8.5	2.6	6.5	6.2	7.8	10.7	9.0	5.8	7.9	9.3	15.7	7.9	4.0	6.7	20.2	6.5	8.1	13.1	11.4	4.2	12.3	9.4	7.5	11.4	20.7	9.9	3.4	8.7	9.7	4.3	14.9	8.5	11.5	4.7	5.7	11.2	6.6	7.7	1.9	6.9	2.2	5.2	10.7	6.0	7.4	4.5	6.4	11.5	6.9	5.2	3.9	1.6	4.5	8.7	9.8	2.5	4.8	20.5	19.9	7.6	24.6	17.8	15.5	19.2	13.5	16.0	12.6
PF4	"CXCL4, SCYB4"	ENSG00000163737	"Platelet factor 4"	P02776	4	73981077-73982124	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Cytokine, Heparin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 50.5;bone marrow: 46.8;heart muscle: 46.0;lymphoid tissue: 42.6"	"Cell line enriched"	"Detected in some"	10	"HEL: 29.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"basophil: 18.3;neutrophil: 16.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 18.3"									"CAB026008, HPA052485"	Enhanced				"Secreted to blood"	7700000				"CAB026008: , HPA052485: "		"unprognostic (4.14e-4)"	"unprognostic (1.00e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-4)"	"unprognostic (7.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.84e-2)"	"unprognostic (3.03e-2)"	"unprognostic (9.54e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.69e-2)"	"unprognostic (4.81e-2)"	0.7	0.4	0.2	0.7	0.9	46.8	0.8	0.2	0.3	0.3	1.1	0.0	0.0	0.1	0.2	0.4	0.2	0.5	0.8	46.0	0.8	0.3	0.5	1.7	9.1	3.3	2.6	0.3	3.0	0.4	0.1	0.4	4.8	1.9	0.2	0.9	1.0	0.4	0.2	1.0	0.2	0.3	0.2	0.9	42.6	0.9	0.6	0.0	0.0	1.8	0.9	0.1	1.0	3.0	0.3	1.9	18.3	1.4	0.0	0.3	50.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.7	0.0	0.0	1.5	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	1.4	0.4	0.3	0.3	0.3	0.0	0.0	0.0	0.5	0.3	0.2	0.1	16.5	0.0	1.1	1.9	0.2	50.5	0.2	0.9	0.2	0.3	0.8	0.3	2.6	0.3	1.9	0.0
PF4V1	"CXCL4L1, CXCL4V1, SCYB4V1"	ENSG00000109272	"Platelet factor 4 variant 1"	P10720	4	73853189-73854155	"Plasma proteins, Predicted secreted proteins"		"Cytokine, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 12.6;lymphoid tissue: 27.8"	"Cell line enhanced"	"Detected in some"		"BJ: 2.7;CAPAN-2: 3.5;EFO-21: 5.5;HHSteC: 2.2;HSkMC: 3.4;HUVEC TERT2: 1.8;RPTEC TERT1: 3.3;U-2197: 1.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 3.4"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	28	"basophil: 9.1;neutrophil: 11.2"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 11.2"									HPA052485	Supported				"Secreted to blood"		1400000000			"HPA052485: "		"unprognostic (4.95e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.16e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.68e-3)"		"unprognostic (2.66e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.39e-2)"			"unprognostic (2.11e-1)"	0.3	0.2	0.1	0.9	0.4	2.8	0.6	0.2	0.5	0.8	0.7	0.0	0.7	4.8	0.1	1.1	0.6	0.5	0.5	8.7	0.4	0.6	2.0	1.9	2.6	0.9	0.4	0.3	7.4	0.4	0.1	0.4	2.0	1.2	1.0	0.7	0.2	1.5	4.0	0.1	0.2	3.2	0.0	0.6	27.8	0.2	0.3	0.0	0.1	0.2	1.1	0.2	5.0	1.0	0.1	0.3	11.2	0.2	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.7	0.6	0.3	2.7	0.4	0.0	0.0	0.0	3.5	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	2.2	0.0	0.0	3.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.2	0.0	0.1	0.3	0.0	12.6	0.1	0.4	0.2	0.5	0.4	0.6	0.4	0.3	1.2	0.0
PFAS	"FGARAT, GATD8, KIAA0361, PURL"	ENSG00000178921	"Phosphoribosylformylglycinamidine synthase"	O15067	17	8247618-8270491	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Purine biosynthesis"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022140, HPA022886"	Enhanced		Approved	Vesicles			350000	Vesicles		"HPA022140: AB_1855232, HPA022886: AB_1855233"	"unprognostic (1.90e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavourable (9.19e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.08e-3)"	"unprognostic (9.51e-3)"	"unprognostic (3.63e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.88e-3)"	"unprognostic (3.85e-1)"	15.4	15.3	11.4	14.8	13.0	17.5	12.8	14.6	18.5	11.2	12.4	14.0	10.0	9.8	15.1	11.2	13.2	13.5	14.3	9.7	9.0	8.0	13.0	17.0	9.5	18.5	10.7	12.6	16.6	15.7	11.5	9.2	10.7	10.7	11.5	12.2	12.0	10.6	10.6	11.6	13.6	11.5	14.3	7.9	18.0	11.4	17.2	11.1	29.5	12.8	10.8	16.2	10.4	9.5	9.2	7.1	28.2	2.9	2.7	6.5	1.1	5.9	26.3	13.5	20.2	4.9	4.1	15.6	7.6	2.9	14.1	10.7	12.8	5.4	26.3	12.4	4.5	13.9	31.1	10.0	10.5	11.9	25.4	15.4	24.8	15.9	4.3	12.4	11.5	3.8	2.4	16.3	10.3	11.7	20.6	4.0	5.6	8.9	22.0	10.8	22.5	12.0	33.1	14.0	12.6	6.5	9.9	8.2	12.8	9.5	6.1	8.7	6.0	5.7	8.1	7.9	10.2	14.3	18.8	4.7	8.5	12.9	8.7	17.7	13.2	9.1	2.9	6.5	4.0	2.5	5.2	7.8	5.2	4.6	2.4	9.2	6.5	5.1	28.2	2.7	1.9	7.1	2.7	1.1	11.4	13.0	14.6	18.5	9.0	8.0	10.7	12.6	10.7	11.1
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118111	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol			60000	Cytosol		"HPA028700: AB_10603983, HPA058304: "	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	36.5	30.4	47.2	22.7	41.7	40.9	20.9	25.1	38.8	19.6	19.9	27.8	15.1	19.1	20.8	29.1	19.7	18.5	16.0	38.2	41.4	48.6	25.9	41.1	18.5	23.5	52.2	32.9	18.5	20.8	13.6	29.3	25.1	42.7	20.1	17.9	12.9	21.2	20.8	62.2	15.0	18.4	19.4	48.6	21.2	17.8	22.1	31.8	14.7	18.3	20.9	24.3	22.7	26.2	34.4	61.7	33.4	37.3	18.2	28.5	21.0	42.8	28.8	22.4	28.9	20.4	19.5	24.5	31.9	28.9	27.6	21.9	37.8	32.6	29.0	37.5	20.7	31.8	33.9	39.1	33.2	31.6	34.9	32.1	40.9	53.4	60.1	44.0	32.2	21.8	51.5	44.3	126.2	31.0	47.1	20.5	24.7	43.4	32.9	52.3	43.8	72.0	28.3	22.6	34.7	29.8	25.7	29.5	49.3	24.5	32.4	50.8	26.7	55.6	27.2	28.6	41.9	35.8	66.6	31.6	29.9	55.8	34.8	30.1	39.1	24.7	32.7	33.4	19.2	31.4	21.8	34.1	23.5	23.1	39.1	34.4	24.8	24.1	16.2	18.2	37.3	61.7	28.5	21.0	47.2	41.7	25.1	38.8	41.4	48.6	52.2	32.9	42.7	31.8
PFDN4	"C-1, C1, PFD4"	ENSG00000101132	"Prefoldin subunit 4"	Q9NQP4	20	54207847-54228052	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA024055	Approved									"HPA024055: AB_1855236"	"unprognostic (2.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.18e-3)"	"unprognostic (2.95e-2)"	"prognostic unfavourable (9.40e-4)"	"prognostic unfavourable (7.66e-5)"	"unprognostic (7.87e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.44e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (1.47e-10)"	"unprognostic (9.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.57e-2)"	8.1	9.6	24.1	6.9	17.1	6.7	8.8	11.9	22.5	10.0	7.6	7.0	4.6	3.4	12.9	8.8	10.2	7.5	8.8	19.7	19.9	24.1	9.7	6.3	6.0	9.2	21.7	10.4	12.4	5.8	9.4	7.9	10.7	17.8	8.9	6.6	4.6	6.2	8.6	12.6	6.6	5.1	9.8	15.7	8.7	5.2	12.1	6.4	7.5	10.6	8.2	6.9	10.8	8.2	6.3	8.7	2.6	5.8	6.9	11.9	4.5	4.6	1.7	5.6	1.7	3.9	8.9	6.0	4.5	3.2	9.9	4.5	7.7	4.6	3.5	14.6	4.7	4.0	5.9	5.5	16.6	3.3	5.4	3.0	7.3	22.0	4.8	5.8	3.2	5.0	7.5	4.4	7.8	6.1	5.3	3.8	8.6	23.3	5.8	13.3	6.8	8.3	4.8	2.2	6.0	8.2	5.9	6.6	6.8	5.9	14.1	14.2	4.3	11.4	3.2	7.4	9.0	10.1	9.2	2.6	3.9	4.7	7.4	4.9	6.3	2.6	5.5	2.4	4.9	5.8	6.7	6.3	6.5	5.6	7.7	5.4	6.4	6.1	1.0	6.9	5.0	8.7	11.9	4.5	24.1	17.1	11.9	22.5	19.9	24.1	21.7	10.4	17.8	6.4
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"			110000	"Nucleoplasm, Golgi apparatus"		"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favourable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	12.5	19.1	29.2	15.4	27.8	15.0	15.6	13.2	33.9	12.0	17.7	12.9	13.1	13.8	14.4	22.4	15.1	12.5	11.4	16.2	31.6	24.8	19.1	23.2	10.8	15.7	27.0	31.9	14.5	21.3	15.3	14.6	14.0	20.7	12.5	16.2	8.2	15.8	16.0	43.6	10.8	13.7	13.4	20.7	11.3	12.2	33.1	17.5	10.7	12.2	22.5	18.9	11.8	9.8	6.8	5.0	3.4	7.1	3.9	7.5	4.3	14.8	9.9	6.9	14.2	7.7	6.6	11.3	11.4	5.8	10.0	9.5	9.3	7.3	21.9	13.9	6.4	10.9	11.3	13.1	15.1	14.7	12.0	19.6	11.0	15.5	8.7	15.0	12.8	5.9	15.1	14.1	10.1	9.8	23.8	9.4	10.7	10.1	17.9	15.8	11.6	8.7	15.5	10.1	22.1	16.2	7.1	16.0	19.4	9.9	26.0	16.5	14.9	21.6	8.2	7.1	10.6	8.8	18.8	19.0	51.8	24.4	6.9	19.9	10.1	3.2	5.1	3.4	4.1	6.5	4.2	5.9	5.6	7.5	4.9	6.8	3.3	4.6	2.7	3.9	7.1	5.0	5.3	4.3	29.2	27.8	13.2	33.9	31.6	24.8	27.0	31.9	20.7	17.5
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell line enhanced"	"Detected in many"		"A549: 71.1;RPTEC TERT1: 44.9;T-47d: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: "	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.1	71.1	5.6	4.5	21.4	2.7	3.0	7.6	5.4	5.6	8.8	3.3	18.8	8.8	5.0	3.3	16.6	6.0	12.0	6.5	10.4	4.2	5.2	3.6	1.2	1.8	5.0	7.9	1.9	4.0	9.7	2.3	10.9	3.8	3.3	4.5	8.4	3.5	4.7	5.5	5.0	8.0	2.7	3.4	44.9	2.6	5.4	2.2	5.5	6.0	10.8	46.8	6.0	13.7	5.9	5.4	0.7	9.1	6.8	2.3	8.0	16.3	5.9	9.0	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8
PFKL		ENSG00000141959	"Phosphofructokinase, liver type"	P17858	21	44300051-44327376	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030047	Approved						1800000			"HPA030047: AB_10602815"	"unprognostic (6.21e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.98e-2)"	"unprognostic (9.75e-2)"	"prognostic unfavourable (4.41e-4)"	"unprognostic (5.69e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.99e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.01e-2)"	32.0	16.7	28.0	26.0	29.5	26.4	23.1	21.3	46.0	28.3	38.7	40.9	30.1	65.5	21.3	33.5	33.5	22.8	37.5	18.4	28.8	23.4	40.3	31.3	21.0	25.2	32.4	33.0	19.5	27.1	12.3	17.1	31.9	29.1	20.2	17.2	36.3	28.8	28.5	8.3	31.1	59.3	20.5	36.1	28.1	42.7	24.0	29.1	16.4	20.4	15.4	26.0	27.2	23.9	20.3	26.9	5.2	38.0	7.7	25.2	22.8	32.3	14.2	10.1	29.2	15.9	11.9	44.5	24.4	15.8	14.2	14.0	19.0	7.1	19.2	29.0	16.2	17.7	8.0	22.1	3.2	16.1	18.2	38.8	12.4	31.0	12.3	29.2	24.7	15.5	13.5	14.4	7.1	20.8	23.9	22.0	9.6	41.1	12.6	22.8	15.9	15.9	31.2	9.6	52.1	6.4	35.8	17.8	13.4	35.5	30.1	15.6	23.9	25.9	30.1	21.5	13.9	14.0	9.4	42.8	11.5	7.9	35.8	23.3	17.2	5.1	22.2	5.2	12.9	37.9	10.8	14.4	17.0	11.8	26.9	20.3	10.2	7.9	4.5	7.7	38.0	17.0	25.2	22.8	28.0	29.5	21.3	46.0	28.8	23.4	32.4	33.0	29.1	29.1
PFKP	"PFK-C, PFKF"	ENSG00000067057	"Phosphofructokinase, platelet"	Q01813	10	3066333-3137712	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018257, HPA056484"	Uncertain		Supported	Cytosol			4500000	Cytosol		"HPA018257: AB_10960391, HPA056484: "	"unprognostic (1.16e-1)"	"unprognostic (2.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.55e-4)"	"prognostic unfavourable (8.72e-6)"	"unprognostic (1.36e-3)"	"unprognostic (2.38e-1)"	"unprognostic (8.51e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.02e-3)"	"unprognostic (2.60e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.54e-3)"	14.6	7.9	29.6	22.0	28.9	9.2	8.1	34.2	61.4	9.7	20.5	11.5	7.9	26.8	19.2	11.0	36.0	12.8	19.8	62.0	29.3	32.9	20.0	2.8	9.2	18.2	22.2	29.8	9.3	8.8	1.5	16.8	8.8	21.3	20.3	19.4	14.7	13.4	36.5	24.4	16.5	31.1	34.3	21.1	11.3	20.7	71.8	14.8	9.6	19.3	11.7	13.3	26.9	15.6	8.9	12.5	16.2	4.7	14.3	20.4	8.9	47.4	66.8	4.5	0.1	4.5	9.4	58.3	29.6	10.6	30.0	36.1	70.4	50.6	5.7	23.6	21.3	38.6	22.8	46.1	31.5	16.0	17.6	20.5	32.2	3.8	10.6	8.3	34.6	4.3	10.4	31.4	15.7	57.7	5.7	0.2	33.2	37.1	28.1	8.9	7.3	23.4	22.1	7.4	22.9	32.5	18.7	12.3	10.6	21.0	17.8	26.2	14.7	13.0	69.4	20.5	11.0	61.7	32.2	32.5	29.3	20.4	52.5	15.9	12.5	16.2	4.7	1.6	15.9	2.3	12.6	8.2	15.9	14.8	8.0	8.9	6.0	9.5	0.7	14.3	0.9	12.5	20.4	8.9	29.6	28.9	34.2	51.7	29.3	32.9	22.2	29.8	21.3	14.8
PFN1		ENSG00000108518	"Profilin 1"	P07737	17	4945652-4949061	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 509.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB037134, CAB037140"	Enhanced		Supported	Cytosol			1100000000	Cytosol		"CAB037134: AB_1079599, CAB037140: AB_1079598"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.65e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.01e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (3.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.28e-1)"	65.2	48.2	24.0	125.4	36.7	118.0	61.3	15.6	25.9	63.8	102.3	33.1	46.7	66.4	97.4	52.9	96.6	67.5	87.8	40.7	22.0	19.6	80.5	137.3	70.5	159.4	37.4	17.3	53.7	37.2	18.3	27.5	82.8	28.5	62.0	68.2	39.3	46.0	52.6	51.6	51.2	96.4	119.4	33.3	138.7	70.4	27.2	30.5	199.3	46.6	65.3	116.3	97.9	54.4	154.4	263.4	356.5	322.9	223.0	288.9	509.4	138.1	166.6	62.6	50.2	32.3	40.3	93.9	118.1	77.6	102.6	77.8	64.5	48.8	100.4	102.7	99.8	87.3	55.8	120.4	82.7	174.6	109.7	102.8	85.3	83.7	88.7	64.8	244.6	47.8	52.9	79.5	79.3	92.0	56.7	73.3	122.9	68.7	123.4	139.7	97.3	102.3	123.7	84.0	64.6	99.4	73.9	25.7	76.3	79.3	49.8	72.3	46.6	55.0	112.5	89.7	83.3	67.3	171.6	52.3	53.0	80.9	77.4	77.8	136.3	168.7	216.8	356.5	286.3	278.7	190.1	154.4	236.8	270.9	263.4	135.2	154.8	221.1	255.4	223.0	322.9	212.4	288.9	509.4	24.0	36.7	15.6	25.9	22.0	19.6	37.4	17.3	28.5	30.5
PFN2		ENSG00000070087	"Profilin 2"	P35080	3	149964904-150050788	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 89.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035611, CAB037073"	Enhanced									"CAB037073: AB_1079600, HPA035611: AB_10672870"	"unprognostic (1.27e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.07e-3)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (3.42e-4)"	"prognostic unfavourable (2.19e-7)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.96e-3)"	"unprognostic (4.86e-3)"	"unprognostic (6.82e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.99e-1)"	9.2	13.9	59.1	6.7	49.6	1.3	12.8	35.1	89.7	14.5	10.3	22.8	11.6	8.8	21.4	54.1	9.0	33.8	12.5	15.4	64.8	39.9	39.8	8.7	6.6	2.6	36.1	44.6	21.8	11.7	15.7	12.9	7.4	33.6	23.4	10.0	11.7	15.8	23.9	75.0	2.9	11.7	20.5	30.5	5.5	8.5	9.4	15.9	2.3	34.4	9.1	3.7	15.2	6.8	2.7	0.3	1.5	0.3	1.6	9.7	3.1	76.8	26.8	64.6	26.4	14.4	49.4	17.3	24.7	37.6	39.1	45.5	10.0	62.2	0.0	52.3	54.0	0.8	26.8	35.1	56.8	2.4	15.9	0.9	14.6	28.6	19.3	4.3	1.2	31.0	29.8	38.3	50.0	22.7	0.2	3.1	40.5	28.5	3.7	0.2	28.2	35.6	4.3	48.0	0.3	28.8	39.3	35.2	36.3	12.2	5.9	33.2	9.4	0.6	16.4	18.6	26.2	31.0	31.8	4.1	0.3	2.0	40.4	0.2	22.7	1.2	0.3	0.5	2.9	0.1	6.0	2.7	6.3	5.3	0.1	1.5	9.7	5.7	1.5	1.6	0.1	0.3	1.6	3.1	59.1	49.6	35.1	87.5	64.8	39.9	36.1	44.6	33.6	15.9
PGAM1	"PGAM-B, PGAMA"	ENSG00000171314	"Phosphoglycerate mutase 1"	P18669	10	97426160-97433441	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042528, HPA060483"	Approved		Approved	Nucleoplasm			200000000	Nucleoplasm		"HPA042528: , HPA060483: "	"prognostic unfavourable (2.04e-4)"	"prognostic unfavourable (3.86e-4)"	"unprognostic (3.64e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.74e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.61e-3)"	26.5	46.1	42.8	28.9	50.3	30.2	19.0	32.6	90.0	26.5	27.6	24.9	14.2	29.8	24.3	20.6	63.5	17.7	21.2	54.1	47.4	44.9	32.7	35.7	18.5	29.5	45.7	61.1	22.9	14.3	27.8	23.2	30.8	72.4	21.9	29.2	30.4	24.5	33.7	8.4	30.0	27.4	35.6	25.7	21.7	20.3	26.1	21.0	26.6	17.4	27.0	43.7	31.0	31.9	22.5	49.7	88.0	65.3	22.8	41.2	72.8	120.6	57.4	39.7	75.6	37.6	34.7	54.1	77.4	101.2	91.0	127.0	62.3	36.1	64.0	53.1	65.7	75.8	69.0	112.5	110.4	59.2	65.9	41.3	45.1	69.6	27.8	59.1	55.3	33.9	46.1	60.4	45.1	65.8	27.0	36.3	95.5	49.9	52.8	73.0	60.8	68.9	40.2	36.4	50.7	70.3	45.8	8.6	40.6	41.6	24.9	39.7	67.7	49.9	49.4	48.8	42.9	43.0	88.8	54.7	60.3	58.4	113.4	99.0	22.5	30.4	65.3	88.0	37.0	57.2	32.7	22.5	31.8	36.6	49.7	18.8	20.7	28.9	50.3	22.8	62.8	17.6	41.2	72.8	42.8	50.3	32.6	90.0	47.4	44.9	45.7	61.1	72.4	21.0
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 38.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol			60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: , HPA060173: "																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.1	4.2	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1
PGBD2		ENSG00000185220	"PiggyBac transposable element derived 2"	Q6P3X8	1	248906196-248919946	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA029888, HPA029889, HPA029890"	Uncertain		Supported	Vesicles				Vesicles		"HPA029888: AB_10600088, HPA029889: AB_10611386, HPA029890: AB_10602002"	"unprognostic (1.06e-2)"	"unprognostic (8.05e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (6.08e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (7.86e-4)"	"unprognostic (2.41e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.25e-1)"	"prognostic favourable (2.05e-4)"	5.8	7.0	5.0	11.1	6.8	5.7	9.5	10.5	7.7	7.6	7.7	11.9	10.2	8.9	8.6	8.2	11.1	6.8	8.6	4.5	5.1	4.6	7.2	11.8	5.7	10.4	7.4	5.4	10.2	14.7	8.3	5.6	12.7	7.8	9.9	9.9	6.0	10.0	12.8	2.9	12.3	11.9	8.4	5.6	17.3	7.9	13.9	8.6	5.5	12.5	3.9	12.2	7.5	18.2	12.7	8.0	13.9	9.1	7.8	10.9	5.7	4.6	6.3	10.0	5.8	8.8	5.8	12.1	4.5	3.9	7.7	7.4	4.7	6.3	12.1	5.7	4.3	7.5	5.9	5.6	9.0	7.1	2.8	11.6	9.8	7.0	5.1	5.9	11.4	5.2	5.9	9.2	5.2	4.4	18.4	10.6	5.6	8.3	3.3	7.0	9.2	7.4	14.3	3.1	3.9	4.6	6.0	3.7	6.5	6.4	9.3	7.2	4.1	11.7	5.4	5.3	5.2	4.6	4.9	10.1	10.1	5.5	5.6	13.3	4.8	13.9	8.8	13.2	9.8	6.2	9.4	12.7	8.6	9.1	8.0	12.6	8.7	10.9	6.5	7.8	9.1	3.8	5.8	5.7	5.0	6.8	10.5	7.7	5.1	4.6	7.4	5.4	7.8	8.6
PGD		ENSG00000142657	"Phosphogluconate dehydrogenase"	P52209	1	10398592-10420144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Gluconate utilization, Pentose shunt"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 115.1;esophagus: 123.8"	"Cell line enhanced"	"Detected in all"		"A549: 177.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 98.6;classical monocyte: 32.0;eosinophil: 115.1;neutrophil: 38.4"	"Group enriched"	"Detected in all"	5	"granulocytes: 115.1;monocytes: 32.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031314, HPA031315"	Enhanced	Supported	Approved	"Intermediate filaments,Cytosol"			59000000	"Intermediate filaments, Cytosol"		"HPA031314: AB_10610278, HPA031315: AB_2673825"	"unprognostic (4.65e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.98e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.43e-3)"	"unprognostic (1.14e-1)"	29.8	12.7	10.9	14.2	11.8	85.5	23.7	8.0	19.1	16.0	14.1	13.8	8.1	22.9	6.3	12.5	123.8	8.4	24.9	14.3	10.3	12.1	15.4	23.2	25.6	34.9	12.4	11.4	14.3	8.3	16.2	10.8	17.0	19.3	7.9	12.9	19.7	31.8	6.8	8.5	10.6	25.3	9.5	12.6	27.6	13.4	27.0	7.4	16.8	21.2	68.8	49.9	14.8	26.1	3.9	15.9	115.1	32.0	2.0	3.0	19.0	22.6	177.4	44.2	47.5	67.3	41.7	9.6	15.3	27.2	21.2	29.1	26.0	26.1	22.2	18.9	15.7	19.2	32.3	27.5	14.3	15.3	28.2	30.0	31.9	54.6	20.5	49.6	33.4	29.7	13.8	33.5	8.3	50.1	40.1	19.7	27.2	25.7	40.9	24.8	26.6	15.6	31.8	40.6	40.9	29.7	12.2	23.8	20.8	13.1	20.8	18.1	22.9	42.6	46.9	11.2	20.0	13.3	16.9	14.9	27.3	39.9	24.5	53.9	10.1	98.6	32.0	115.1	2.6	15.3	3.0	3.9	2.5	2.4	15.9	2.3	2.4	2.6	38.4	2.0	10.9	11.4	2.4	19.0	10.9	11.8	8.0	19.1	10.3	12.1	12.4	11.4	19.3	7.4
PGF	"D12S1900, PGFL, PIGF, PLGF, PlGF-2, SHGC-10760"	ENSG00000119630	"Placental growth factor"	P49763	14	74941834-74955784	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 177.3"	"Group enriched"	"Detected in some"	6	"BEWO: 91.3;HUVEC TERT2: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041624			Approved	Nucleoplasm,Mitochondria,Cytosol	"Secreted to blood"	12380		Nucleoplasm	"Mitochondria, Cytosol"	"HPA041624: AB_10794522"	"unprognostic (1.67e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.34e-3)"	"unprognostic (8.67e-3)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-3)"	"prognostic unfavourable (1.33e-6)"	"unprognostic (2.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.14e-1)"	4.3	2.7	1.9	4.4	2.4	0.0	4.3	1.6	3.5	13.1	2.3	2.3	4.0	1.3	2.9	6.3	3.9	9.2	3.4	5.1	2.4	4.1	3.1	2.6	3.6	4.9	2.9	2.0	3.8	1.9	5.4	2.0	177.3	4.6	7.5	1.1	3.5	3.8	6.7	3.3	6.0	4.3	4.6	1.7	1.2	1.7	3.3	2.0	1.4	24.2	4.4	2.9	5.1	5.9	0.7	0.7	1.1	1.0	0.0	2.4	0.2	0.3	0.3	0.3	0.2	0.4	0.0	91.3	0.8	0.8	0.4	0.5	2.1	0.1	0.0	2.0	0.6	0.1	0.4	4.1	0.3	0.0	0.5	0.0	0.0	2.2	0.3	0.0	2.4	1.0	1.0	1.6	0.4	43.0	0.0	0.0	12.1	0.1	0.0	0.1	0.4	0.7	0.0	11.3	0.0	0.1	0.2	6.9	3.7	0.0	0.1	1.6	0.0	0.1	8.7	0.0	2.3	0.0	3.6	0.0	0.0	0.1	1.4	0.1	0.1	0.0	0.2	1.1	2.4	1.0	0.0	0.7	0.3	0.7	0.3	0.3	0.6	1.0	0.0	0.0	0.8	0.7	0.5	0.2	1.9	2.4	1.6	2.2	2.4	4.1	2.9	2.0	4.6	2.0
PGGT1B	"BGGI, GGTI"	ENSG00000164219	"Protein geranylgeranyltransferase type I subunit beta"	P53609	5	115204012-115262872	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030646	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Cytosol"				"Nucleoplasm, Endoplasmic reticulum"	Cytosol	"HPA030646: AB_10602019"	"unprognostic (2.73e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.92e-2)"	"unprognostic (7.34e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.93e-3)"	"unprognostic (1.15e-2)"	10.5	12.4	7.3	13.3	10.1	10.9	13.9	8.8	22.1	10.8	13.8	7.7	7.9	12.3	9.2	4.6	14.9	7.3	7.0	13.5	9.5	5.9	8.2	13.7	22.2	22.2	10.2	10.0	9.6	10.1	12.0	13.4	7.8	8.2	8.4	15.1	5.7	10.6	8.4	10.2	9.9	10.4	9.5	6.9	10.4	11.0	5.1	10.5	10.2	8.8	9.9	10.1	9.6	10.5	8.0	11.5	21.8	16.7	6.7	6.3	6.4	10.1	11.1	12.6	16.3	7.4	6.2	6.2	12.6	7.4	10.5	10.8	12.0	10.9	20.7	17.1	8.8	8.0	16.6	16.5	15.8	22.8	9.2	11.9	14.4	9.6	9.9	16.3	17.6	9.3	10.2	10.3	10.8	10.5	9.6	8.9	12.0	15.8	14.3	5.4	9.4	8.6	15.7	16.9	20.9	11.0	19.2	12.4	9.4	14.9	11.4	12.0	15.3	12.2	12.0	10.8	10.2	7.4	14.6	14.8	16.5	10.9	7.8	17.0	14.9	8.3	12.8	21.8	5.0	16.6	5.6	6.8	5.7	6.3	11.5	8.0	5.4	5.0	13.1	6.7	16.7	10.3	4.9	6.4	7.3	10.1	8.8	22.1	9.5	5.9	10.2	10.0	8.2	10.5
PGK1		ENSG00000102144	"Phosphoglycerate kinase 1"	P00558	X	77910739-78129296	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010065, HPA045385, HPA073644, HPA073656"	Approved						290000000			"CAB010065: AB_628116, HPA045385: , HPA073644: , HPA073656: "	"prognostic unfavourable (7.05e-8)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.21e-1)"	"unprognostic (8.30e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (2.65e-6)"	"prognostic unfavourable (2.74e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.66e-2)"	"prognostic unfavourable (8.34e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.99e-1)"	"unprognostic (8.99e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.57e-2)"	45.0	50.9	29.2	41.3	38.4	62.2	29.9	43.8	67.9	31.9	36.6	24.2	27.5	35.5	25.7	23.3	62.1	25.6	32.4	69.4	28.6	35.0	71.8	58.5	37.5	47.6	32.1	32.7	26.8	21.2	45.7	29.0	43.7	49.9	28.3	42.8	40.0	38.2	32.0	115.5	38.7	41.9	33.9	30.1	43.7	29.7	11.3	24.9	51.8	39.1	61.1	52.4	42.2	38.0	20.9	53.7	49.2	79.0	21.0	26.3	77.0	98.9	45.9	15.4	31.0	26.6	21.6	36.6	50.7	35.3	44.6	74.9	41.6	31.2	39.7	52.5	35.0	43.1	68.0	78.8	89.5	24.2	26.8	30.7	75.7	36.1	29.2	70.3	34.3	26.9	33.3	40.4	21.5	45.5	32.0	60.7	60.8	39.1	61.4	53.2	47.5	87.4	44.5	41.3	121.5	46.5	41.4	23.0	31.7	52.5	44.8	44.0	23.5	36.9	36.6	47.8	33.0	47.7	34.9	67.5	126.1	41.7	134.5	80.0	31.2	22.7	54.6	49.2	20.8	59.9	23.2	20.9	25.0	22.6	53.7	15.8	23.0	24.4	45.7	21.0	79.0	20.9	26.3	77.0	29.2	38.4	43.8	67.9	28.6	35.0	32.1	32.7	49.9	24.9
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785651-49787307	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"testis: 70.2"	"Cell line enhanced"	"Detected in some"		"RT4: 1.0;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported									"HPA045385: , HPA073644: , HPA073656: "					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	70.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.5	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGLS	6PGL	ENSG00000130313	6-phosphogluconolactonase	O95336	19	17511629-17521288	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040744, HPA042032"	Approved		Supported	Nucleoplasm,Cytosol			10000000	Nucleoplasm	Cytosol	"HPA040744: AB_2677111, HPA042032: AB_2677809"	"unprognostic (3.68e-2)"	"unprognostic (8.98e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.64e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.55e-3)"	"unprognostic (2.95e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.05e-2)"	"unprognostic (9.26e-3)"	27.3	31.5	15.6	23.6	13.9	29.3	33.7	9.0	20.1	23.8	29.5	16.0	17.9	21.9	16.6	18.7	38.0	25.9	27.8	18.5	13.9	11.6	25.9	42.7	27.5	60.0	14.3	11.8	32.0	42.1	19.1	16.4	26.5	10.9	23.5	13.5	16.8	31.5	20.7	10.9	27.2	30.8	13.3	16.8	31.4	20.8	15.8	12.2	46.6	26.7	19.2	27.6	18.5	21.6	17.6	46.4	45.8	44.5	17.4	14.9	22.4	18.6	16.8	10.6	7.2	16.2	27.0	20.3	12.8	20.9	12.9	16.6	8.0	28.3	20.7	14.4	20.0	12.9	5.9	20.0	3.9	10.3	23.2	9.7	7.8	14.3	27.9	10.3	10.8	31.7	27.7	7.7	23.2	17.3	11.0	5.1	15.8	20.5	22.6	29.0	14.1	70.6	15.3	6.8	13.1	17.4	15.1	13.5	16.2	8.2	9.1	18.0	13.2	18.7	16.2	13.4	3.7	26.7	7.2	9.0	6.3	8.8	19.1	26.5	13.1	15.2	40.8	45.8	14.9	44.5	12.1	16.4	13.2	13.2	46.4	17.6	12.5	12.6	39.6	17.4	41.5	34.4	14.0	22.4	15.6	13.9	9.0	20.1	13.9	11.6	14.3	11.8	10.9	12.2
PGLYRP1	"PGLYRP, PGRP, PGRP-S, PGRPS, TAG7, TNFSF3L"	ENSG00000008438	"Peptidoglycan recognition protein 1"	O75594	19	46019153-46023065	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 73.7;bone marrow: 130.1"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;HEK 293: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"eosinophil: 63.0;neutrophil: 73.7"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 73.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA045702	Enhanced				"Secreted to blood"		47000000			"HPA045702: AB_10960204"	"unprognostic (2.87e-2)"	"unprognostic (4.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.20e-1)"	"unprognostic (6.46e-2)"	"unprognostic (7.77e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.37e-3)"	0.7	0.1	0.2	0.5	0.4	130.1	0.2	0.4	0.2	0.1	0.3	0.3	0.0	0.2	0.1	0.1	0.2	0.4	0.1	10.9	0.2	0.2	0.2	1.5	10.9	1.0	0.2	0.0	0.7	0.2	0.1	1.4	4.1	0.1	0.1	0.1	0.5	0.7	0.1	1.3	0.3	0.2	0.1	0.1	26.9	0.2	0.9	0.0	7.5	1.3	0.0	0.5	0.1	5.5	0.0	0.0	73.7	0.3	0.0	0.0	0.4	0.6	7.1	1.1	0.7	0.0	0.0	1.9	0.6	0.0	0.0	0.0	1.1	0.6	1.9	0.2	0.0	2.6	0.0	0.0	0.0	1.8	4.0	0.8	3.4	0.2	0.0	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.5	0.4	2.2	0.4	2.7	1.5	0.2	0.1	0.0	2.6	0.8	0.1	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.3	0.7	1.1	1.5	1.3	0.8	1.1	1.6	0.1	0.0	0.0	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.3	0.0	0.0	0.4	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.0	0.1	0.0
PGLYRP2	"PGLYRPL, PGRP-L, PGRPL, tagL, tagL-alpha, tagl-beta, TAGL-like"	ENSG00000161031	"Peptidoglycan recognition protein 2"	Q96PD5	19	15468645-15498956	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 95.8"	"Group enriched"	"Detected in some"	6	"MCF7: 10.6;T-47d: 10.7"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 42.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"granulocytes: 3.6;monocytes: 7.1;T-cells: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB033468, HPA046311, HPA075237"	Supported		Approved	"Cell Junctions"	"Secreted to blood"		160000000000	"Cell Junctions"		"CAB033468: AB_1127187, HPA046311: , HPA075237: "	"unprognostic (7.39e-3)"	"unprognostic (1.52e-2)"	"unprognostic (5.22e-2)"	"unprognostic (8.79e-2)"	"unprognostic (3.97e-1)"	"unprognostic (4.88e-4)"	"unprognostic (5.93e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.66e-16)"	"unprognostic (6.35e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.81e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	95.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	3.6	7.1	0.6	3.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.7	0.0	0.0	0.2	0.0	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	3.6	0.7	0.3	2.6	2.4	2.5	0.3	1.6	1.3	0.2	0.0	3.6	3.7	2.5	0.6	7.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGM1		ENSG00000079739	"Phosphoglucomutase 1"	P36871	1	63593276-63660245	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Isomerase	"Congenital disorder of glycosylation, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 233.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004666, HPA024190, HPA024637, HPA046329"	Enhanced		Approved	Cytosol			20000000	Cytosol		"CAB004666: AB_425590, HPA024190: AB_1855266, HPA024637: AB_1855267, HPA046329: "	"unprognostic (2.50e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.42e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (8.74e-5)"	"unprognostic (7.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.74e-3)"	17.8	14.1	7.0	4.4	8.3	3.5	9.8	4.4	8.3	6.7	12.9	5.2	4.6	10.6	4.6	7.7	8.8	3.3	8.9	36.9	6.4	5.4	10.0	56.4	7.6	2.7	6.2	6.3	9.7	21.6	12.9	6.2	11.5	8.5	8.7	9.1	5.4	7.9	9.4	233.5	5.3	12.4	8.4	5.6	3.0	5.7	3.0	5.5	3.0	6.0	42.8	6.3	9.4	4.7	12.2	25.9	25.6	17.9	21.1	23.3	16.6	30.2	12.7	4.8	15.7	31.7	23.4	38.9	12.5	17.0	13.6	22.3	10.5	14.1	9.6	26.2	19.2	7.2	6.6	26.3	16.1	11.7	8.8	20.2	21.5	10.8	26.2	17.7	1.2	29.5	17.0	15.9	25.2	8.1	0.0	12.8	21.8	1.8	5.1	9.7	21.8	20.4	7.2	22.3	3.1	19.8	9.5	2.9	18.7	27.3	28.6	41.6	8.9	6.7	0.8	20.2	10.3	17.9	10.6	8.1	11.9	15.6	33.0	15.6	8.6	20.5	17.9	25.6	23.3	12.0	18.6	12.2	13.7	17.5	25.9	6.9	12.5	14.5	21.2	21.1	10.2	7.5	10.6	16.6	7.0	8.3	4.4	8.3	6.4	5.4	6.2	6.3	8.5	5.5
PHB	PHB1	ENSG00000167085	Prohibitin	P35232	17	49404049-49414905	"Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 189.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Vesicles,Mitochondria	"Intracellular and membrane"		3800000	Mitochondria	Vesicles	"HPA003280: AB_1855732"	"unprognostic (2.31e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.88e-3)"	"unprognostic (8.33e-2)"	"prognostic unfavourable (1.58e-4)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (5.81e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.36e-2)"	"prognostic favourable (3.77e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.09e-3)"	27.4	31.6	21.8	19.9	24.9	19.0	30.6	12.9	25.9	21.6	38.9	24.0	17.0	26.9	24.1	17.7	28.6	24.3	18.6	41.6	21.9	20.9	54.0	53.7	19.2	18.5	27.6	21.4	27.1	24.1	27.8	18.8	24.1	22.0	25.3	40.7	24.7	41.8	20.2	41.7	19.5	32.7	26.6	20.5	22.7	25.0	16.6	18.2	23.3	42.5	35.6	22.3	22.4	24.0	33.4	84.6	6.3	28.0	28.4	34.7	40.2	36.1	67.5	16.2	31.8	21.8	17.3	45.1	26.7	17.8	43.4	28.5	189.6	32.5	67.0	49.0	24.6	23.6	44.0	38.6	45.0	29.1	57.9	33.8	43.8	85.7	16.1	66.6	20.9	19.2	26.8	46.9	17.3	31.6	60.2	18.1	28.1	61.5	46.2	41.7	30.1	64.5	37.0	61.6	55.0	29.5	38.3	32.8	27.9	20.2	23.6	37.5	40.2	31.1	27.5	41.2	31.8	32.1	57.3	23.2	63.4	64.8	27.0	44.4	35.6	6.3	25.3	6.2	32.3	28.0	34.7	33.4	28.7	31.0	38.1	29.9	30.4	30.9	2.5	28.4	21.0	84.6	28.1	40.2	21.8	24.9	12.9	25.9	21.9	20.9	27.6	21.4	22.0	18.2
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970825	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria			780000	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	36.2	46.2	20.0	41.5	21.3	33.5	37.1	21.6	29.7	42.7	48.6	19.8	42.8	40.0	46.3	36.2	55.6	37.7	29.1	44.3	17.9	17.2	36.0	72.8	24.0	64.9	18.8	18.8	68.9	92.3	28.0	22.1	27.4	17.2	48.6	39.5	25.8	62.7	29.1	72.9	39.5	46.3	56.0	17.5	36.6	37.5	20.5	19.0	57.2	50.4	77.4	45.7	46.4	39.9	36.4	47.6	20.9	35.9	38.1	41.6	34.4	36.5	35.3	29.6	40.1	24.0	42.0	66.2	25.9	33.4	45.9	36.4	55.7	38.5	76.1	11.4	25.0	29.9	54.1	45.7	37.2	42.2	45.2	40.0	22.9	52.3	40.4	64.4	29.4	43.3	31.2	29.0	63.4	45.0	35.6	17.5	32.3	36.3	59.1	58.9	113.3	31.5	41.5	47.6	47.3	36.7	41.1	15.3	53.0	20.9	59.7	66.9	9.4	51.6	27.1	19.8	32.4	15.6	54.6	17.6	21.3	78.3	26.7	33.6	28.1	20.9	30.0	14.6	30.8	35.9	37.3	36.4	35.3	35.8	47.6	34.8	32.0	31.8	12.4	38.1	30.4	44.4	41.6	34.4	20.0	21.3	21.6	29.7	17.9	17.2	18.8	18.8	17.2	19.0
PHEX	"HPDR, HPDR1, HYP, HYP1, PEX, XLH"	ENSG00000102174	"Phosphate regulating endopeptidase homolog X-linked"	P78562	X	22032441-22251310	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	Biomineralization	"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 8.3;lung: 6.7"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 5.6;HUVEC TERT2: 4.3;PC-3: 4.7;TIME: 4.8;U-87 MG: 10.3;WM-115: 4.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 5.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	37	"plasmacytoid DC: 8.3"	"Lineage enriched"	"Detected in single"	37	"dendritic cells: 8.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"														"unprognostic (2.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-8)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (7.68e-2)"	0.3	0.0	1.8	1.9	1.1	0.0	1.7	0.9	1.1	0.8	0.9	0.8	0.3	1.2	5.0	0.3	0.4	0.1	2.0	0.3	1.5	1.8	0.3	0.3	6.7	3.4	2.0	0.3	3.9	0.3	0.0	0.3	0.3	5.0	1.3	0.0	0.3	2.8	0.9	0.3	0.1	1.4	3.9	3.8	3.4	0.0	0.3	0.3	1.3	4.8	0.3	4.3	0.5	0.6	0.1	8.3	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.2	0.1	0.1	0.4	0.0	0.0	0.1	0.1	0.3	1.3	0.1	0.1	1.3	0.1	0.1	0.0	5.6	0.3	0.0	0.1	0.1	0.5	0.0	0.1	0.1	0.2	2.2	1.1	1.1	3.3	4.3	0.0	0.4	0.5	0.0	0.0	0.2	0.0	4.7	0.0	1.0	0.0	0.6	0.2	0.1	0.2	0.4	2.4	0.8	2.8	0.0	4.8	1.0	0.1	0.6	0.8	0.0	0.0	0.0	10.3	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	1.8	1.1	0.9	1.1	1.5	1.8	2.0	0.3	5.0	0.3
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavourable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favourable (1.72e-4)"	10.7	10.2	12.0	15.5	15.2	23.5	29.0	14.2	12.5	29.7	14.6	9.4	26.4	11.0	18.2	30.7	10.0	16.3	18.3	15.4	13.2	13.3	13.0	10.5	19.7	16.7	16.9	12.0	31.5	24.9	21.1	26.6	7.7	14.6	16.9	6.2	14.6	17.6	28.5	12.9	7.7	12.1	18.9	12.3	18.8	12.7	26.7	12.8	5.0	22.4	9.3	21.3	20.7	29.2	1.5	0.5	3.2	0.4	1.1	4.6	0.9	1.7	2.4	5.4	3.5	2.4	1.4	10.9	3.7	5.9	2.8	3.2	3.3	1.6	0.6	2.3	8.9	0.5	1.1	1.9	0.7	2.2	1.2	5.1	4.0	1.4	0.4	2.9	12.7	2.8	2.6	5.6	5.0	1.8	2.0	4.4	2.2	1.3	0.9	1.8	1.9	1.7	2.2	0.7	1.8	0.3	2.3	3.6	3.8	1.9	2.0	3.0	1.5	3.6	3.5	5.6	1.6	3.3	4.0	3.0	4.8	5.9	4.1	3.2	3.3	0.2	0.3	0.7	1.4	0.4	4.6	1.2	2.8	3.5	0.5	1.5	3.3	1.7	3.2	1.1	0.4	0.3	0.9	0.9	12.0	15.2	14.2	12.5	13.2	13.3	16.9	12.0	14.6	12.8
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"				Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.6	7.7	13.5	19.9	9.8	11.3	12.6	11.0	10.5	11.1	9.7	22.4	7.3	16.1	10.0	14.6	6.0	12.4	15.3	13.6	7.2	5.3	30.0	14.7	8.3	9.9	14.3	11.7	8.8	21.6	11.7	18.1	12.1	12.2	10.4	12.7	5.7	14.5	8.4	6.7	9.6	10.6	20.0	9.5	8.8	6.7	12.3	10.0	19.6	22.8	10.1	18.0	10.7	16.9	24.6	5.6	12.7	11.2	9.6	11.4	11.8	18.2	10.5	12.6	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: , HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavourable (1.48e-4)"	"prognostic favourable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.5	5.5	14.5	34.9	8.3	11.0	27.1	12.3	22.2	17.6	29.2	28.7	2.4	0.0	5.3	32.9	18.3	26.9	25.6	12.4	0.1	24.5	4.3	19.5	19.8	17.3	27.4	0.1	15.8	42.8	16.8	20.0	12.6	7.8	32.5	7.7	53.3	18.3	8.4	36.3	42.3	16.1	25.2	2.3	1.1	16.2	15.7	14.3	9.0	6.0	98.9	12.2	46.8	0.1	2.9	15.3	17.9	13.7	26.8	6.7	27.4	35.6	38.3	22.6	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1
PHTF1	PHTF	ENSG00000116793	"Putative homeodomain transcription factor 1"	Q9UMS5	1	113696831-113759489	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059486			Approved	"Nucleoli,Nuclear bodies"				"Nuclear bodies"	Nucleoli	"HPA059486: "	"unprognostic (1.52e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.70e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.21e-6)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.25e-1)"	6.5	10.4	11.5	7.9	8.6	19.5	11.8	31.6	15.1	7.1	5.4	4.0	7.6	4.5	6.6	9.6	3.4	13.1	8.8	8.2	10.1	12.4	8.9	10.1	10.8	11.9	8.2	12.9	4.0	8.2	15.3	20.9	8.5	10.4	5.8	6.5	8.2	5.2	6.9	5.5	2.4	4.9	8.4	6.4	10.5	8.0	33.8	6.6	3.4	6.1	2.4	7.7	8.1	6.3	3.0	4.5	6.0	2.6	4.3	5.7	1.7	12.7	6.7	19.1	10.1	9.5	8.6	5.0	11.8	15.7	10.6	17.4	7.3	10.4	3.7	16.8	8.1	7.1	7.2	4.7	12.2	15.2	7.2	8.9	14.1	8.4	7.9	10.9	12.6	7.2	1.3	14.1	3.1	19.5	5.3	17.0	12.8	19.0	0.1	11.0	15.1	10.9	11.5	28.7	7.3	17.0	5.6	13.4	12.4	13.2	6.5	7.0	2.6	8.8	20.5	8.3	11.5	15.3	11.4	23.8	24.2	6.9	20.5	9.5	22.6	3.0	2.6	4.9	3.0	1.3	2.3	3.0	3.7	3.7	4.5	1.6	0.1	2.6	6.0	4.3	1.7	3.0	5.7	1.7	11.5	8.6	31.6	15.1	10.1	12.4	8.2	12.9	10.4	6.6
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 87.2"	"Group enriched"	"Detected in some"	4	"Daudi: 9.0;fHDF/TERT166: 8.3"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 29.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 29.9"	"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"midbrain: 6.0"	HPA076574	Approved				"Secreted to blood"		3600000000			"HPA076574: "	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	22.2	1.7	2.9	1.4	8.8	0.3	27.9	0.7	4.5	62.7	4.5	21.4	22.5	0.8	11.1	27.0	10.5	5.3	17.4	43.1	4.6	3.5	0.8	0.5	3.7	1.1	9.0	3.9	2.8	2.5	0.6	3.3	1.2	9.3	15.0	3.4	87.2	4.0	14.2	5.5	19.8	2.0	55.5	13.7	0.8	8.5	8.3	9.3	0.1	8.3	8.7	4.8	32.7	49.8	0.7	0.2	0.2	0.0	5.7	29.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	9.0	0.5	8.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.3	9.8	2.9	0.0	0.7	3.4	1.0	0.2	5.7	0.0	0.2	29.9	1.7	2.9	8.8	0.7	4.5	4.6	3.5	9.0	3.9	9.3	9.3
PI3	"cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14"	ENSG00000124102	"Peptidase inhibitor 3"	P19957	20	45174876-45176544	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6"	"Group enriched"	"Detected in some"	6	"EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 2666.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	1121	"neutrophil: 157.1"	"Lineage enriched"	"Detected in single"	1571	"granulocytes: 157.1"									"CAB009449, HPA017737"	Enhanced		Approved	"Plasma membrane"	"Secreted to blood"		2100000	"Plasma membrane"		"CAB009449: AB_2252354, HPA017737: AB_1848107"	"prognostic favourable (6.94e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.20e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.84e-6)"	"prognostic unfavourable (6.89e-4)"	"unprognostic (8.54e-3)"	"prognostic unfavourable (1.94e-8)"	"unprognostic (1.23e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.91e-3)"	0.4	0.0	0.2	8.8	0.2	0.0	0.7	0.2	0.2	85.3	9.3	0.2	0.4	0.1	7.7	0.2	200.8	0.3	4.8	0.6	0.2	0.0	0.3	0.6	3.1	0.8	0.2	0.2	0.3	0.4	0.0	0.2	0.6	0.3	1.0	3.7	0.3	35.6	0.4	0.2	6.4	3.2	0.6	0.2	1.4	0.7	5.1	0.2	23.4	0.2	468.6	173.5	1.6	118.7	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.9	0.6	0.4	27.0	0.0	32.8	0.0	6.7	0.0	0.3	0.0	0.1	2.0	0.2	0.0	0.2	0.0	0.0	6.4	5.3	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	55.7	0.0	0.3	0.0	6.4	0.1	0.0	0.0	4.6	0.6	0.0	0.0	0.0	0.2	0.3	3.2	0.0	0.2	0.1	0.4	0.1	4.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.3	0.2
PI4KA	"PI4K-ALPHA, pi4K230, PIK4CA"	ENSG00000241973	"Phosphatidylinositol 4-kinase alpha"	P42356	22	20707691-20859417	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 48.0"	"Cell line enhanced"	"Detected in all"		"K-562: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009092, HPA075515"	Approved		Approved	"Nucleoplasm,Plasma membrane"			18000	Nucleoplasm	"Plasma membrane"	"CAB009092: AB_2164033, HPA075515: "	"unprognostic (8.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.01e-3)"	"unprognostic (3.19e-2)"	"prognostic favourable (5.24e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.29e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.50e-1)"	7.7	9.2	28.8	10.5	34.2	12.5	6.5	14.1	48.0	9.7	8.8	10.1	4.9	9.1	9.7	6.1	8.3	8.4	8.0	8.5	30.4	19.2	9.0	12.6	9.0	11.2	19.0	25.9	10.2	8.6	25.6	12.5	10.4	19.3	9.8	8.9	10.8	6.8	10.6	7.1	6.6	10.0	13.2	6.8	10.2	9.9	13.1	8.2	17.9	9.9	2.9	10.2	8.4	4.8	5.0	12.5	7.6	5.5	9.1	7.7	2.9	9.7	8.2	7.3	10.9	20.8	12.6	10.4	8.9	13.5	13.1	12.8	6.4	4.2	18.4	5.3	17.8	8.6	13.8	8.5	8.0	15.6	21.2	18.9	11.2	7.3	10.4	18.7	15.2	11.2	5.4	11.1	6.2	10.6	51.5	15.6	10.1	13.5	16.3	6.4	5.7	8.5	16.4	15.9	3.4	7.3	15.6	17.9	13.1	11.6	13.5	9.2	11.4	8.6	10.7	23.9	12.4	8.8	7.4	12.0	12.2	14.6	15.8	13.5	9.9	3.1	5.5	7.3	5.1	5.4	4.9	4.6	5.6	6.1	3.6	5.0	5.7	7.7	7.6	9.1	4.6	12.5	5.8	2.9	28.8	34.2	14.1	48.0	30.4	19.2	19.0	25.9	19.3	8.2
PIBF1	"C13orf24, CEP90"	ENSG00000083535	"Progesterone immunomodulatory binding factor 1"	Q8WXW3	13	72782059-73016461	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity		"Ciliopathy, Disease mutation, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052269, HPA066120"	Approved		Supported	"Centriolar satellite"	"Secreted to blood"			"Centriolar satellite"		"HPA052269: , HPA066120: "	"unprognostic (1.54e-1)"	"unprognostic (4.17e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-1)"	14.3	12.1	8.6	17.5	11.3	11.6	15.9	17.3	12.7	20.0	15.3	6.7	14.1	8.9	15.0	14.6	13.2	14.3	10.8	12.7	8.5	8.2	14.5	12.0	13.4	11.5	9.0	8.9	19.0	9.8	10.1	43.9	16.6	11.6	17.4	11.4	6.6	13.7	16.7	12.1	10.8	13.8	13.1	14.8	19.2	10.8	17.2	11.9	30.8	22.7	10.6	10.3	18.6	14.9	7.9	6.5	8.2	4.7	11.0	12.3	3.4	8.5	2.7	11.5	6.6	10.1	17.7	4.4	7.8	10.6	8.1	9.8	3.7	14.6	7.7	9.4	8.9	7.5	6.0	7.9	13.0	7.8	5.8	5.4	7.4	4.4	13.0	19.9	5.1	11.4	6.5	8.6	21.4	10.4	7.5	4.0	10.8	2.4	9.7	12.2	6.0	2.6	7.8	8.3	8.0	16.5	4.6	6.5	10.5	6.1	4.2	10.5	7.1	14.6	7.7	4.1	4.3	6.4	4.7	6.6	4.7	3.9	12.4	11.4	8.8	8.2	4.5	7.5	8.3	4.7	8.9	7.6	8.9	8.7	3.9	7.9	12.3	10.0	4.4	11.0	4.4	6.5	6.7	3.4	8.6	11.3	17.3	12.7	8.5	8.2	9.0	8.9	11.6	11.9
PIGH	GPI-H	ENSG00000100564	"Phosphatidylinositol glycan anchor biosynthesis class H"	Q14442	14	67581955-67600287	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Autism spectrum disorder, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031624	Approved									"HPA031624: AB_10601046"	"unprognostic (1.59e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.47e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.69e-3)"	"unprognostic (3.26e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.73e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.39e-1)"	"prognostic favourable (2.68e-7)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.00e-2)"	"unprognostic (3.73e-1)"	9.7	22.7	15.1	8.8	15.9	18.6	18.5	21.5	18.8	21.8	10.1	11.9	11.5	10.3	10.6	30.6	10.2	9.2	15.6	12.5	14.0	17.2	28.0	18.3	9.1	11.0	19.5	11.3	16.7	21.4	56.0	9.4	17.9	17.8	24.1	9.8	21.0	19.9	17.2	19.5	12.7	12.7	13.1	19.2	11.1	12.2	23.6	14.5	13.5	31.5	7.4	10.5	10.8	10.7	31.8	14.4	24.4	20.4	23.5	29.9	16.8	13.9	9.2	8.8	18.3	19.7	7.6	7.5	7.7	9.5	10.9	10.7	14.7	4.9	9.7	7.8	5.3	10.3	15.5	11.1	12.2	14.4	20.6	10.0	7.8	15.0	15.6	7.4	12.2	11.0	14.3	8.3	12.7	6.9	22.5	6.9	7.9	12.2	10.7	12.2	1.6	24.9	3.6	8.9	5.7	11.6	11.7	11.1	13.3	5.9	11.4	18.9	13.1	7.4	3.5	11.1	14.0	14.3	9.2	13.2	8.5	6.6	8.6	15.7	15.2	17.9	12.6	24.4	23.1	16.6	29.9	29.6	24.4	21.5	12.3	31.8	25.7	24.0	6.0	23.5	20.4	14.4	22.3	16.8	15.1	15.9	21.5	18.8	14.0	17.2	19.5	11.3	17.8	14.5
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928518-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1"	"Cell line enriched"	"Detected in some"	5	"EFO-21: 28.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Intracellular and membrane"		1900000000			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favourable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	0.3	0.3	0.3	74.2	0.3	0.0	6.9	0.3	0.3	35.1	232.8	0.6	0.4	158.9	2.6	0.5	2.6	0.7	139.0	0.3	0.3	0.3	52.5	5.0	25.1	0.3	0.3	0.3	0.6	4.2	0.0	0.9	0.4	0.3	3.0	75.6	0.4	398.1	0.6	0.4	0.4	320.1	2.0	0.3	0.4	25.3	0.6	0.3	0.4	0.4	23.9	22.5	4.9	0.6	3.4	1.1	1.4	0.5	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.4	0.2	0.0	0.2	0.0	4.9	0.1	1.3	0.6	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.2	0.3	1.0	0.0	0.1	0.0	1.4	0.5	0.3	0.4	0.2	0.5	3.4	0.3	0.3	1.1	3.4	0.5	0.5	1.4	0.5	0.3	0.9	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
PIGS		ENSG00000087111	"Phosphatidylinositol glycan anchor biosynthesis class S"	Q96S52	17	28553383-28571872	"Plasma proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018149	Approved									"HPA018149: AB_1855373"	"unprognostic (2.29e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.82e-3)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (1.65e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.06e-3)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (5.31e-4)"	13.2	11.6	10.9	8.3	15.3	13.7	11.3	22.0	18.3	9.7	16.0	13.7	9.6	16.4	12.6	11.4	19.0	13.6	12.8	20.2	10.0	9.1	18.8	6.3	11.5	15.4	9.7	12.9	11.3	17.3	17.0	9.1	10.9	14.0	11.5	9.9	16.8	12.0	11.3	21.0	14.9	23.6	11.0	10.1	13.7	15.5	14.9	9.0	14.9	17.6	9.4	12.2	12.7	11.9	6.2	16.4	14.4	13.0	8.0	7.7	7.9	5.8	14.0	3.1	9.9	7.0	6.9	9.2	5.5	6.0	7.4	10.5	13.8	3.8	4.7	8.3	7.5	8.3	5.8	7.2	2.6	12.0	33.5	7.3	10.7	4.8	8.0	10.5	13.6	7.3	5.4	3.5	5.0	11.9	21.1	4.5	6.0	10.9	6.5	7.4	2.5	5.4	4.5	18.1	9.4	4.5	7.5	13.8	9.0	9.8	16.1	7.0	12.9	7.9	10.2	3.7	5.0	5.6	6.7	6.2	10.8	3.7	6.0	10.2	6.1	9.3	13.0	14.4	7.6	11.4	6.9	6.2	4.8	7.2	16.4	4.5	6.5	4.7	4.3	8.0	7.9	10.8	7.7	7.9	10.9	15.3	22.0	18.3	10.0	9.1	9.7	12.9	14.0	9.0
PIGT		ENSG00000124155	"Phosphatidylinositol glycan anchor biosynthesis class T"	Q969N2	20	45416067-45456934	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (6.06e-2)"	"unprognostic (4.60e-3)"	"unprognostic (7.63e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.18e-3)"	"unprognostic (6.68e-2)"	"unprognostic (7.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.32e-1)"	"prognostic favourable (2.51e-4)"	"unprognostic (5.48e-2)"	"unprognostic (7.60e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-2)"	35.8	36.6	14.8	20.8	27.0	34.8	33.0	18.2	42.8	40.6	43.0	58.4	24.9	27.6	46.7	52.0	24.8	35.5	36.1	63.8	19.0	21.0	36.5	44.4	27.9	22.1	39.7	20.4	34.2	51.9	53.1	32.7	40.0	33.6	28.1	46.2	34.7	33.6	34.1	38.0	29.1	35.2	40.9	33.2	25.6	35.7	34.5	30.0	20.7	32.6	27.2	26.7	33.2	28.9	11.0	36.1	23.8	31.8	20.5	23.4	27.9	15.8	21.4	7.3	27.6	46.0	33.3	14.7	19.0	35.3	26.6	20.9	40.6	25.2	9.5	24.9	28.9	29.5	9.4	26.2	16.2	5.3	12.5	9.6	20.1	21.5	21.7	19.2	39.0	25.2	24.8	22.0	23.1	25.1	12.9	34.5	22.8	36.5	8.4	14.5	6.2	38.7	6.9	22.6	33.0	21.7	11.1	12.1	15.6	36.7	36.0	18.2	31.6	34.6	20.7	63.0	29.3	11.7	26.4	18.2	27.8	6.0	40.3	14.8	28.4	16.9	30.0	23.8	23.4	31.8	17.2	11.0	16.6	21.5	36.1	10.2	14.7	16.9	11.6	20.5	28.4	27.4	22.2	27.9	14.8	27.0	18.2	42.8	19.0	21.0	39.7	20.4	33.6	30.0
PIK3C2B	"C2-PI3K, PI3K-C2beta"	ENSG00000133056	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta"	O00750	1	204422628-204494724	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.9;RT4: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030515, HPA050360"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA030515: AB_10670043, HPA050360: "	"unprognostic (5.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-3)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (3.35e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.75e-1)"	"prognostic favourable (1.16e-4)"	12.9	4.5	11.0	16.0	19.3	5.3	11.0	9.1	17.5	7.4	17.0	36.0	9.6	15.5	10.5	5.8	14.6	7.7	14.7	10.7	14.4	9.1	7.6	5.8	18.0	23.9	24.2	11.2	3.9	6.1	4.7	4.3	20.4	14.5	7.3	14.5	6.3	8.0	14.1	20.0	22.6	15.7	11.2	16.2	14.2	20.7	2.4	23.0	31.8	9.8	8.1	23.1	13.1	11.8	7.4	0.3	0.5	0.2	1.6	2.0	0.4	3.2	6.5	5.8	5.3	3.4	0.3	31.9	0.4	1.3	1.3	0.9	3.8	8.5	5.5	1.2	0.7	8.1	3.4	2.3	0.5	3.3	0.9	0.1	12.9	1.4	0.2	1.9	4.2	0.4	2.4	0.3	0.2	8.5	2.0	3.7	0.1	7.2	6.6	5.5	5.3	4.1	7.2	1.4	1.0	1.6	33.3	6.4	3.5	11.5	16.2	3.7	7.2	1.0	0.3	0.2	2.1	0.6	0.1	4.0	1.1	7.2	0.2	2.9	0.8	0.1	0.2	0.0	1.2	0.0	1.0	2.9	1.3	0.8	0.3	7.4	0.7	0.6	0.5	1.6	0.0	0.1	2.0	0.4	11.0	19.3	9.1	17.5	14.4	9.1	24.2	11.2	14.5	23.0
PIK3C2G		ENSG00000139144	"Phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 gamma"	O75747	12	18247614-18648416	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Chemotaxis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 54.2;epididymis: 30.7;seminal vesicle: 46.0"	"Group enriched"	"Detected in some"	5	"BEWO: 2.9;HaCaT: 4.6;hTERT-HME1: 8.5"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"														"unprognostic (1.29e-1)"	"unprognostic (1.61e-1)"		"unprognostic (6.21e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.46e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (3.50e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.98e-1)"		"unprognostic (2.37e-2)"	0.3	0.6	0.2	0.1	0.2	0.0	6.7	0.2	0.3	0.6	0.3	0.1	54.2	0.0	0.3	30.7	4.2	0.6	6.0	0.2	0.3	0.2	9.6	8.8	0.3	0.1	0.3	0.1	0.3	1.2	8.1	0.4	1.2	0.1	2.4	0.0	0.1	13.1	46.0	0.2	7.0	2.2	0.2	0.3	0.2	15.1	2.1	0.1	0.1	0.5	1.6	0.5	0.9	0.9	0.1	0.1	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	8.5	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.1	0.1	0.1
PIK3CB	PIK3C1	ENSG00000051382	"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta"	P42338	3	138652699-138834938	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Autophagy, Cell adhesion, Endocytosis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 41.2;HMC-1: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB031938, HPA042288, HPA064207"	Approved		Supported	Nucleoplasm,Nucleoli,Vesicles,Midbody				Nucleoplasm	"Nucleoli, Vesicles, Midbody"	"CAB031938: AB_2165408, HPA042288: , HPA064207: "	"unprognostic (4.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.97e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.42e-4)"	"unprognostic (3.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (3.99e-5)"	"unprognostic (2.15e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.59e-2)"	12.5	9.9	10.6	9.7	20.6	17.4	11.5	29.9	25.0	12.4	14.6	11.9	11.7	13.7	9.6	6.9	15.2	10.9	8.7	12.7	12.2	14.2	22.6	9.3	9.5	9.1	11.9	15.2	8.8	20.3	20.2	10.9	18.1	24.1	13.4	15.7	12.2	14.9	15.9	33.4	19.6	16.4	8.3	12.5	9.9	11.0	6.4	10.7	14.4	37.4	7.1	11.9	13.4	11.0	4.6	9.1	11.3	7.8	1.3	6.5	2.6	22.6	9.8	4.2	3.5	3.9	5.2	28.7	5.3	5.1	5.4	5.8	10.5	8.6	9.1	14.5	5.2	9.7	5.5	8.4	9.7	11.6	6.2	41.2	6.7	6.3	4.0	10.0	65.3	4.4	6.5	3.8	7.7	8.1	15.7	6.8	6.7	10.3	5.8	7.0	6.0	9.2	4.2	4.4	6.5	8.3	12.5	3.7	2.7	14.7	6.4	18.9	16.0	23.9	8.5	3.5	4.4	7.5	7.4	11.5	7.5	8.3	8.5	9.7	4.8	7.0	7.8	11.3	4.0	4.5	2.7	4.6	5.2	3.0	9.1	4.1	6.5	4.4	10.0	1.3	4.3	1.4	2.2	2.6	10.6	20.6	29.9	25.0	12.2	14.2	11.9	15.2	24.1	10.7
PIK3IP1	"HGFL, MGC17330"	ENSG00000100100	"Phosphoinositide-3-kinase interacting protein 1"	Q96FE7	22	31281593-31292534	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 82.0"	"Cell line enhanced"	"Detected in many"		"RT4: 14.0;SK-BR-3: 15.6;U-698: 19.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 82.0"	"Lineage enriched"	"Detected in many"	6	"T-cells: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										8600000				"unprognostic (1.02e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.84e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.61e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.65e-3)"	"unprognostic (4.42e-2)"	"unprognostic (8.68e-2)"	"prognostic favourable (3.80e-4)"	24.0	22.9	17.3	31.8	22.8	21.4	19.5	33.2	22.7	11.8	15.3	22.3	13.2	10.5	18.7	10.7	12.4	12.9	15.8	19.5	19.1	12.4	13.9	5.7	26.2	64.1	19.9	15.0	12.4	5.8	11.3	8.0	14.6	18.0	13.8	9.7	13.3	27.3	20.2	14.2	27.1	29.7	14.9	20.7	36.8	14.3	13.7	22.5	38.8	29.5	7.7	45.1	21.9	12.6	13.5	0.9	5.6	4.8	8.3	82.0	29.1	0.3	0.2	0.5	0.1	7.2	12.7	0.6	1.8	5.7	0.1	0.6	0.2	12.1	9.2	6.8	2.8	7.9	0.0	3.4	0.1	1.5	1.1	0.2	1.4	1.4	2.4	0.7	0.5	12.3	5.0	0.1	0.1	3.8	0.5	11.6	0.8	0.8	0.1	1.4	0.5	0.3	0.7	0.5	6.7	3.0	14.0	0.7	1.5	0.6	15.6	0.8	1.3	1.2	11.6	0.0	2.7	0.2	0.0	5.5	2.3	19.9	0.2	1.6	0.2	5.6	2.7	2.4	12.9	3.4	15.2	5.9	33.3	18.2	0.9	13.5	82.0	51.1	1.1	8.3	4.8	0.3	37.5	29.1	17.3	22.8	33.2	22.7	19.1	12.4	19.9	15.0	18.0	22.5
PIK3R1	"GRB1, p85, p85-ALPHA"	ENSG00000145675	"Phosphoinositide-3-kinase regulatory subunit 1"	P27986	5	68215720-68301821	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 71.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001216, CAB004268"	Approved		Approved	Cytosol				Cytosol		"CAB004268: AB_628126, HPA001216: AB_1079612"	"unprognostic (5.74e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"prognostic favourable (8.09e-4)"	"unprognostic (3.78e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.59e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.54e-1)"	26.2	13.4	26.0	13.0	24.3	51.6	42.3	15.3	50.3	27.1	20.3	12.8	12.8	8.1	41.3	22.1	20.8	33.0	18.1	33.9	24.0	13.4	17.9	46.5	16.3	12.0	22.0	40.8	25.8	6.8	22.3	9.4	15.0	18.2	15.2	10.8	8.7	54.6	16.2	48.9	19.1	16.1	36.3	17.6	18.8	13.1	7.6	23.6	16.2	12.8	8.5	10.8	25.2	24.4	2.2	2.1	10.6	4.1	8.2	14.8	4.0	1.0	2.1	6.3	18.7	71.7	21.0	2.7	6.0	2.8	2.3	2.5	5.2	1.9	5.5	10.3	8.2	2.6	1.7	12.1	2.9	23.0	2.3	6.6	1.7	4.2	24.1	6.7	5.3	22.1	27.6	4.2	22.5	3.0	1.0	4.2	2.1	2.8	16.4	2.6	1.8	1.1	15.4	3.0	4.3	3.0	12.3	1.2	5.7	0.9	1.6	3.9	9.0	4.8	3.6	2.7	2.8	4.5	3.7	4.7	7.0	6.4	2.9	8.5	2.0	10.6	1.2	5.9	9.2	1.7	12.7	1.2	11.5	8.4	2.1	2.2	14.8	10.8	1.5	8.2	4.1	0.9	8.5	4.0	26.0	24.3	15.3	50.3	24.0	13.4	22.0	40.8	18.2	23.6
PIK3R2	"p85, P85B"	ENSG00000105647	"Phosphoinositide-3-kinase regulatory subunit 2"	O00459	19	18153118-18170540	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Stress response, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA069291	Approved		Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA069291: "	"unprognostic (2.50e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.00e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.36e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.35e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.00e-2)"	6.4	20.9	27.5	7.2	30.1	10.1	7.2	14.4	36.6	14.5	13.5	11.4	6.7	21.7	13.9	12.0	19.0	17.8	17.2	12.5	33.2	11.5	10.3	10.3	8.4	6.3	10.1	18.1	20.2	13.0	24.3	16.7	10.2	7.9	11.6	10.1	11.4	14.5	11.9	10.9	26.2	16.5	11.1	7.4	7.1	15.9	9.8	11.0	11.3	9.0	9.4	10.4	13.9	11.6	2.5	1.9	3.1	1.8	1.9	3.2	0.8	18.8	9.7	13.3	17.7	17.7	17.9	20.1	15.1	19.0	11.4	8.4	9.9	9.2	14.9	23.9	21.0	14.2	8.0	16.5	6.3	12.2	29.1	5.7	13.1	23.6	14.2	12.9	7.0	22.3	16.3	7.6	11.7	2.8	16.2	5.4	14.0	29.4	8.8	11.0	15.5	21.7	9.3	18.5	11.4	16.3	14.0	29.9	33.9	14.3	13.8	13.1	8.8	7.1	5.7	20.3	10.5	25.1	13.4	10.2	13.0	6.7	16.2	18.9	12.8	0.7	1.7	3.1	3.2	1.8	2.0	2.5	1.7	1.5	1.9	2.3	1.6	1.8	1.0	1.9	1.0	1.4	0.3	0.8	27.5	30.1	14.4	36.6	33.2	11.5	10.1	18.1	7.9	11.0
PIM3		ENSG00000198355	"Pim-3 proto-oncogene, serine/threonine kinase"	Q86V86	22	49960513-49964080	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068758			Supported	Cytosol				Cytosol		"HPA068758: "	"unprognostic (3.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-1)"	"prognostic favourable (8.09e-4)"	"unprognostic (5.59e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.27e-3)"	32.5	15.5	6.8	19.9	16.7	62.4	50.5	7.6	11.9	16.4	22.6	11.3	20.9	15.9	14.4	17.6	25.0	15.9	37.8	23.6	7.5	7.9	29.1	25.7	38.3	29.4	21.1	4.9	13.9	36.4	4.8	14.9	31.4	15.1	28.4	7.6	9.7	27.6	22.7	39.9	31.3	20.9	12.2	10.1	25.4	33.6	13.0	13.5	9.7	19.1	19.9	19.0	25.6	18.3	6.1	5.7	16.9	4.0	1.2	4.5	1.9	7.2	4.8	3.2	6.1	2.5	1.9	18.5	4.6	7.4	5.4	3.9	8.0	6.2	12.9	5.8	1.2	6.2	6.2	3.4	1.9	9.7	25.7	5.3	11.5	9.6	12.0	11.5	10.3	3.6	11.5	3.3	5.7	17.6	7.3	45.7	1.6	16.2	5.8	20.6	6.8	7.7	27.2	5.4	15.3	2.9	5.5	11.6	8.1	8.9	40.6	28.4	5.3	15.3	4.6	3.4	14.8	5.6	7.4	23.5	14.9	11.0	8.6	6.5	9.2	0.0	3.1	0.1	1.9	3.2	2.3	3.4	4.4	3.8	2.5	6.1	4.1	1.7	16.9	1.2	4.0	5.7	4.5	1.9	6.8	16.7	7.6	11.9	7.5	7.9	21.1	4.9	15.1	13.5
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA054483: , HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favourable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favourable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.1	17.8	18.6	12.7	12.8	10.7	9.9	10.4	11.9	12.8	13.1	9.0	11.3	4.6	30.4	10.7	10.8	16.5	18.3	15.8	11.5	37.1	7.8	21.2	23.4	7.1	12.3	6.6	7.2	10.1	13.9	4.8	12.9	13.1	20.2	9.5	18.3	10.7	20.7	13.3	16.1	10.7	14.8	13.4	16.2	10.6	11.9	21.3	12.2	5.7	10.7	8.8	11.2	13.0	5.8	8.9	15.9	7.5	6.9	7.5	7.6	16.7	12.3	6.3	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9
PIP	"GCDFP-15, GCDFP15, GPIP4"	ENSG00000159763	"Prolactin induced protein"	P12273	7	143132077-143139746	"Plasma proteins, Predicted secreted proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"salivary gland: 1246.7;seminal vesicle: 651.3"	"Cell line enriched"	"Detected in single"	330	"T-47d: 123.4"	"Cancer enriched"	"Detected in many"	70	"breast cancer: 672.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 1.5;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 2.6"									"CAB002661, HPA009177"	Enhanced				"Secreted in other tissues"		89000000			"CAB002661: , HPA009177: AB_1845459"	"unprognostic (2.80e-1)"	"unprognostic (2.15e-1)"		"unprognostic (1.08e-3)"		"unprognostic (3.01e-2)"		"unprognostic (5.93e-2)"		"unprognostic (2.25e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.14e-1)"		"unprognostic (3.49e-2)"	"unprognostic (5.55e-1)"	0.4	0.1	0.1	0.0	0.2	0.0	144.4	0.2	0.1	0.2	0.1	0.0	219.3	0.0	0.1	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.6	0.0	0.2	0.0	0.1	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.0	1246.7	651.3	0.2	7.7	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	49.3	1.1	1.8	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	123.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.2	0.1	0.2	0.0	0.0	0.0
PIP4K2A	"PIP5K2A, PIP5KIIA, PIP5KIIalpha"	ENSG00000150867	"Phosphatidylinositol-5-phosphate 4-kinase type 2 alpha"	P48426	10	22534849-22714555	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 92.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065440, HPA068771"	Supported		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			8800000	"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA065440: , HPA068771: "	"unprognostic (1.11e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.56e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-3)"	13.0	7.3	43.8	20.3	63.8	17.3	6.9	6.6	41.4	13.2	7.8	75.5	1.0	5.9	9.9	5.6	9.2	7.2	15.1	5.9	56.0	31.7	7.6	8.3	11.5	33.4	65.7	22.9	4.3	4.9	29.5	4.2	10.5	36.5	4.4	9.0	5.7	3.9	6.3	2.6	4.0	8.1	14.4	92.0	26.6	8.4	5.4	59.8	10.1	5.9	1.0	38.5	11.5	5.8	14.7	12.0	26.3	16.6	38.4	46.7	39.3	8.7	8.7	10.1	3.2	16.3	22.2	7.7	16.4	17.5	8.9	11.0	8.1	14.2	18.5	6.0	32.9	3.1	8.8	4.6	9.0	40.9	9.1	34.7	6.4	17.9	28.9	6.6	27.3	11.1	4.1	12.1	11.7	13.1	19.3	36.1	16.4	3.6	26.6	6.0	4.1	6.2	10.7	14.5	25.1	13.2	1.7	1.8	4.3	5.2	2.7	26.1	2.3	11.6	15.8	6.9	10.1	12.7	10.0	23.0	13.0	13.5	18.6	20.2	5.3	16.1	8.8	26.3	34.5	15.6	46.7	14.7	27.5	40.0	11.6	8.6	18.6	34.9	10.9	38.4	16.6	12.0	19.6	39.3	43.8	63.8	6.6	30.3	56.0	31.7	65.7	22.9	36.5	59.8
PIPOX	LPIPOX	ENSG00000179761	"Pipecolic acid and sarcosine oxidase"	Q9P0Z9	17	28950513-29057220	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"kidney: 33.5;liver: 114.3"	"Group enriched"	"Detected in some"	6	"AF22: 12.2;Hep G2: 36.7;NTERA-2: 24.3;RH-30: 35.0"	"Group enriched"	"Detected in many"	13	"glioma: 15.5;liver cancer: 73.5"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"										390000				"unprognostic (8.02e-2)"	"unprognostic (3.50e-4)"	"unprognostic (3.03e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.45e-1)"	"prognostic favourable (1.49e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.58e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.22e-1)"	0.2	0.2	2.4	0.2	3.1	0.1	0.2	2.2	2.9	0.2	1.4	3.8	0.0	3.1	0.4	5.8	0.5	2.1	0.8	0.2	3.5	2.5	33.5	114.3	0.3	0.3	3.6	3.1	0.3	0.2	0.3	0.2	1.0	4.0	0.5	0.3	0.2	0.2	0.9	0.1	0.2	2.6	0.6	1.7	0.3	0.2	0.2	0.7	0.0	0.1	0.0	0.2	0.3	0.1	0.7	4.7	3.7	0.7	0.9	1.9	0.7	0.0	0.0	12.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.2	0.1	36.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	0.2	24.3	0.0	0.1	35.0	0.7	0.0	0.0	3.9	1.2	0.1	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	1.5	0.3	4.1	0.1	0.0	0.2	1.2	1.8	0.7	0.7	0.8	0.5	0.9	0.3	0.5	1.2	4.7	0.7	0.3	1.9	3.7	0.9	0.3	0.4	0.8	0.7	2.4	3.1	2.2	2.9	3.5	2.5	3.6	3.1	4.0	0.7
PIR		ENSG00000087842	Pirin	O00625	X	15384799-15493564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-MEL-30: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000697	Approved		Supported	Cytosol				Cytosol		"HPA000697: AB_1079621"	"unprognostic (3.46e-3)"	"prognostic favourable (2.78e-4)"	"unprognostic (4.26e-2)"	"unprognostic (5.62e-3)"	"unprognostic (4.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic favourable (4.94e-4)"	"unprognostic (3.78e-2)"	"unprognostic (1.92e-1)"	"prognostic unfavourable (6.11e-7)"	"unprognostic (1.99e-2)"	"unprognostic (8.90e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.44e-1)"	20.9	16.1	14.1	5.9	16.8	5.7	26.5	8.5	13.5	8.1	7.5	14.0	21.8	7.7	11.2	18.8	20.7	16.2	13.4	14.0	11.7	12.1	13.9	23.7	18.6	8.6	20.8	9.8	13.0	2.6	5.4	9.1	12.1	15.6	12.1	8.3	25.0	7.5	18.0	9.8	13.7	6.9	24.6	26.0	15.5	13.8	7.2	14.4	1.3	12.1	19.9	9.1	26.5	11.7	0.0	0.5	1.0	0.5	0.0	2.2	0.3	2.3	13.0	7.8	11.5	4.6	5.2	2.5	0.7	4.5	1.9	4.3	3.6	20.4	0.0	25.9	2.0	16.6	9.1	3.6	0.7	0.0	2.0	1.4	14.7	10.5	6.0	0.7	5.2	1.5	12.6	7.3	2.5	117.9	1.0	3.3	1.6	4.9	0.5	0.6	8.4	8.2	0.0	1.5	6.4	3.8	23.0	3.0	8.3	6.3	3.5	44.3	7.3	4.5	7.3	1.0	1.9	4.9	1.4	1.5	6.4	0.0	5.0	2.6	10.3	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.2	0.3	14.1	16.8	8.5	13.5	11.7	12.1	20.8	9.8	15.6	14.4
PISD	"dJ858B16.2, PSDC"	ENSG00000241878	"Phosphatidylserine decarboxylase"	Q9UG56	22	31618491-31662432	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA031090, HPA031091"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA031090: AB_10600114, HPA031091: AB_10600893"	"unprognostic (7.96e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.55e-3)"	"unprognostic (2.44e-3)"	"unprognostic (8.13e-3)"	"unprognostic (6.37e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.70e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.91e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.92e-2)"	"prognostic favourable (5.27e-5)"	38.3	12.3	9.5	15.1	10.9	20.9	18.5	34.5	12.3	5.9	7.3	6.2	7.4	11.4	9.6	14.4	7.0	10.0	9.5	6.9	6.4	6.9	11.9	8.4	12.9	14.6	8.3	10.1	7.5	10.9	6.0	11.7	38.1	8.6	8.2	3.3	7.7	7.9	7.9	6.4	10.2	8.0	6.2	5.8	16.5	9.7	17.8	7.7	4.2	10.6	5.3	9.8	6.2	7.0	6.9	11.0	28.6	12.9	5.7	6.8	7.9	10.4	9.6	2.9	2.9	8.9	3.4	6.7	8.5	6.8	6.0	6.5	13.9	3.3	6.3	9.1	4.3	11.8	3.9	7.6	1.0	6.9	8.4	6.6	5.9	11.4	18.5	13.7	17.3	6.4	4.3	10.7	4.6	5.3	19.0	3.7	3.4	39.0	5.9	5.9	2.8	4.0	8.4	3.2	6.3	3.8	9.2	7.2	4.2	4.9	16.0	5.5	13.2	7.5	10.3	7.6	9.0	4.8	7.9	4.5	6.2	7.8	7.2	9.2	6.0	9.9	12.9	9.3	6.8	9.5	6.5	6.9	4.9	5.7	11.0	6.3	6.7	5.5	28.6	5.7	5.0	5.4	4.7	7.9	9.5	10.9	34.5	12.3	6.4	6.9	8.3	10.1	8.6	7.7
PITPNM2	"NIR3, RDGB2, RDGBA2"	ENSG00000090975	"Phosphatidylinositol transfer protein membrane associated 2"	Q9BZ72	12	122983480-123150015	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"lymphoid tissue: 169.5"	"Cell line enhanced"	"Detected in many"		"HEL: 16.5;MOLT-4: 30.5;WM-115: 14.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.7"	"Group enriched"	"Detected in many"	4	"NK-cells: 4.7;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003414, HPA003978"	Approved		Supported	Vesicles				Vesicles		"HPA003414: AB_1855410, HPA003978: AB_1855411"	"unprognostic (2.43e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.50e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-2)"	"unprognostic (9.99e-2)"	3.4	5.9	3.3	3.2	7.9	3.5	3.1	9.3	8.0	3.9	3.5	2.4	3.2	3.5	3.6	5.2	3.7	2.5	2.2	4.6	2.8	2.2	3.7	4.3	5.1	6.1	2.4	2.6	14.0	2.5	5.3	4.2	3.0	2.3	2.7	1.6	3.7	2.7	3.1	3.3	3.0	3.6	4.5	2.5	3.3	2.7	14.8	2.2	169.5	2.3	2.2	4.3	4.7	2.7	0.8	0.0	0.1	0.1	4.7	2.3	1.6	2.5	5.0	1.6	2.3	1.2	2.2	9.8	0.4	0.6	1.3	0.7	2.2	2.1	0.0	2.2	0.8	7.3	1.3	1.2	0.5	0.1	1.6	16.5	2.9	5.9	0.8	0.6	3.5	1.1	2.2	1.7	1.4	2.6	3.7	0.2	1.6	1.6	30.5	3.4	1.9	2.2	8.8	0.1	6.3	2.4	2.7	1.5	0.5	3.6	3.0	2.4	0.6	1.8	7.6	1.9	2.2	3.1	2.8	0.5	0.5	11.7	4.8	1.2	14.7	0.0	0.0	0.1	2.3	0.0	0.2	0.4	0.6	1.7	0.0	0.8	1.5	1.4	0.0	4.7	0.1	0.0	1.1	1.6	3.3	7.9	9.3	8.0	2.8	2.2	2.4	2.6	2.3	2.2
PITRM1	"hMP1, KIAA1104, MP1, PreP"	ENSG00000107959	"Pitrilysin metallopeptidase 1"	Q5JRX3	10	3137728-3172841	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006753, HPA006754"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA006753: AB_1079624, HPA006754: AB_1079623"	"unprognostic (1.83e-3)"	"unprognostic (7.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.20e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.32e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.08e-2)"	26.7	39.4	22.7	20.4	34.4	31.0	21.5	29.7	47.8	21.6	23.4	29.8	19.1	19.1	27.6	27.2	25.0	21.3	23.7	41.0	22.1	19.3	28.8	47.1	23.6	21.2	22.9	25.6	35.3	25.7	31.2	26.0	17.8	38.8	27.2	22.4	29.2	25.1	23.8	62.0	28.0	25.3	26.3	19.1	18.9	21.6	41.6	20.4	48.6	28.7	33.0	26.8	26.0	22.4	11.5	13.7	6.0	13.9	12.4	13.9	9.1	25.4	20.6	8.2	11.1	23.3	25.3	9.4	37.8	17.6	30.2	16.5	18.6	15.6	12.8	13.2	23.6	19.7	13.1	29.2	22.8	22.1	18.7	18.1	16.9	13.9	13.3	7.0	21.6	20.8	21.7	33.0	18.9	31.4	18.3	16.9	39.9	22.0	17.6	7.3	5.6	25.1	8.7	11.4	18.2	24.0	19.5	10.5	6.4	28.6	21.0	15.9	24.4	8.4	38.5	23.9	6.7	58.4	18.1	13.6	14.2	13.3	36.5	12.9	11.7	6.0	9.4	4.9	13.1	12.0	12.9	11.5	11.3	12.2	13.7	6.8	12.1	13.9	1.4	12.4	13.9	7.6	13.8	9.1	22.7	34.4	29.7	47.8	22.1	19.3	22.9	25.6	38.8	20.4
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088710-2135898	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved						120000			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favourable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favourable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	4.5	4.6	2.6	2.3	3.6	1.5	1.4	45.3	7.9	2.8	5.1			1.8	5.4	0.7	2.6	3.4	1.8	7.1	3.5	4.2	0.7	0.6	2.2	1.3	1.9		6.8	3.3	1.2	11.3	1.7		3.7	0.4		4.3	5.4	18.0	7.8	2.8	3.3	1.5	2.7	2.6	2.2			1.0		0.3	3.1	1.8	0.1	0.1	0.0	0.1	0.0	0.4	0.7	3.0	6.5	3.6	8.2	6.3	6.8	7.1	10.5	4.4	3.0	3.1	5.8	2.3	4.6	6.7	5.4	7.7	1.0	1.6	1.1	5.3	5.2	2.8	16.6	2.3	12.5	3.9	5.9	6.3	5.3	5.7	3.5	2.3	4.0	4.6	1.9	4.9	5.5	11.8	3.2	4.9	15.6	5.9	6.8	1.5	2.1	15.1	16.9	9.5	6.4	6.5	5.2	13.3	5.4	9.7	7.9	7.2	7.6	6.8	3.0	5.1	5.4	3.6	6.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.7										
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Group enriched"	"Detected in some"	8	"T-47d: 6.3;U-266/70: 16.7;U-266/84: 6.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain									"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	6.3	0.0	0.0	0.0	0.9	0.0	0.0	16.7	6.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 36.5;BJ hTERT+: 55.4;fHDF/TERT166: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.8	12.2	6.2	28.2	18.9	3.6	36.5	55.4	17.1	17.1	0.5	3.4	1.0	8.0	43.9	2.4	2.1	5.4	15.0	5.5	1.9	1.7	5.5	1.1	15.7	4.1	3.5	15.6	2.4	13.4	7.2	7.7	0.2	2.9	14.9	3.7	2.9	2.0	6.3	1.8	5.6	7.2	1.5	15.2	4.5	2.4	5.5	6.7	0.3	8.6	2.6	3.1	11.8	16.2	3.5	4.5	4.9	2.3	0.7	1.1	9.6	0.6	14.8	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288154-100330486	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2;lymphoid tissue: 12.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.7;PC-3: 1.9;RT4: 1.0;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.7;U-937: 1.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			CAB022621	Uncertain									"CAB022621: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.3	0.3	0.4	0.6	3.7	1.3	1.4	0.1	6.2	0.1	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	2.0	0.3	0.5	2.7	4.0	2.3	0.5	4.0	0.2	0.2	0.0	0.2	0.7	1.3	0.4	2.2	1.0	0.3	0.0	0.1	0.1	0.8	0.0	1.5	12.0	0.1	2.3	0.0	0.3	0.1	0.0	2.9	0.4	0.1	0.2	0.3	0.6	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.7	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.7	0.0	0.0	1.3	0.0	0.0	2.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.6	0.0	2.3	0.0	0.0	0.4	0.4	3.7	0.1	6.2	2.0	0.3	0.5	4.0	1.3	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1, fibrocystin/polyductin"	P08F94	6	51615300-52087625	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"epididymis: 19.8;kidney: 49.4;pancreas: 32.9"	"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 15.4"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced									"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favourable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.1	0.0	5.6	0.0	0.1	19.8	0.1	0.1	6.3	0.1	0.1	0.1	49.4	2.5	0.1	0.0	0.1	0.0	0.1	32.9	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	1.2	0.1	0.4	0.1	0.1	0.1	0.1	0.5	1.4	0.0	0.0	0.1	0.0	0.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.5	15.4	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"			2900000	"Golgi apparatus, Cytosol"		"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: "	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol			540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavourable (1.30e-4)"	"prognostic unfavourable (2.74e-6)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.5	209.8	42.3	50.0	50.9	57.2	35.0	88.5	206.7	142.1	143.9	59.0	100.5	62.1	89.6	165.6	118.9	133.7	180.0	111.4	109.0	63.2	38.0	105.5	48.8	35.5	49.3	82.0	51.9	83.9	109.5	45.0	83.6	9.5	49.8	224.1	50.7	18.4	21.2	52.3	80.1	54.7	135.4	118.3	188.7	105.0	44.0	48.0	115.4	71.2	90.5	49.9	35.9	65.1	161.9	88.6	158.2	160.5	64.0	90.4	54.7	199.3	81.6	158.6	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"				"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: , HPA057913: "	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.3	9.2	18.2	10.9	12.2	13.9	11.8	13.8	12.8	15.6	16.2	9.7	16.8	9.2	16.5	13.1	18.4	17.7	10.5	21.3	3.3	12.9	6.8	19.0	8.3	10.7	6.7	2.0	11.4	11.0	12.2	14.8	17.7	11.3	6.7	16.7	4.7	7.7	5.8	9.1	10.7	7.4	27.7	3.8	13.8	46.0	8.8	5.8	20.7	12.0	17.8	8.9	6.1	16.5	13.2	11.9	16.9	14.4	3.7	3.2	6.3	5.5	6.6	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2
PKP1	B6P	ENSG00000081277	"Plakophilin 1"	Q13835	1	201283452-201332993	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Developmental protein"	"Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 80.1;skin 1: 137.6;tongue: 129.6"	"Group enriched"	"Detected in some"	5	"HaCaT: 44.0;HBEC3-KT: 26.9;hTCEpi: 96.0;hTERT-HME1: 25.5;PC-3: 36.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 295.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027221, CAB033130"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			2700000	"Nucleoplasm, Plasma membrane"		"CAB033130: AB_2164139, HPA027221: AB_10599737"	"unprognostic (3.55e-3)"	"unprognostic (7.63e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.49e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.67e-1)"	"unprognostic (9.17e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.59e-3)"	10.1	0.1	0.0	0.1	0.0	0.1	7.0	0.0	0.4	19.7	0.5	0.0	2.5	0.1	1.5	1.9	80.1	0.3	0.1	0.1	0.0	0.0	0.1	0.1	1.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	1.6	0.0	6.8	0.1	4.9	10.1	3.9	2.1	137.6	0.2	0.1	0.0	0.1	0.1	0.1	0.0	9.2	0.1	129.6	37.2	1.2	27.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	44.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.0	1.0	25.5	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 60.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favourable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	16.9	3.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	60.7	15.3	0.0	10.4	0.0	15.1	2.1	13.4	0.0	0.0	4.8	0.1	0.7	15.9	9.5	0.9	0.2	0.0	12.7	0.0	14.7	0.5	3.0	4.8	1.4	4.4	0.0	0.1	9.3	2.9	0.0	7.4	5.0	4.5	8.0	1.9	1.6	0.7	3.5	0.0	7.7	0.2	0.1	0.0	6.8	0.0	4.1	4.0	0.0	0.1	0.0	0.0	0.8	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell line enhanced"	"Detected in many"		"A-431: 37.0;CAPAN-2: 26.0;HaCaT: 50.0;hTCEpi: 32.7;MCF7: 23.3;SK-BR-3: 37.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: "	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavourable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.0	7.2	0.0	0.1	0.0	0.0	15.5	0.3	0.2	0.8	0.4	14.7	26.0	0.0	1.5	0.2	50.0	0.0	18.9	0.1	0.0	9.3	0.0	4.3	10.2	0.1	0.0	0.0	0.1	32.7	0.1	8.0	0.1	11.0	0.2	0.1	23.3	0.1	0.0	0.0	12.5	0.1	0.0	0.1	0.4	7.4	10.6	0.1	10.7	37.9	0.0	13.7	0.1	1.3	0.2	1.3	0.6	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"				"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: , HPA070648: "	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favourable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.5	9.2	12.7	14.4	5.9	6.4	12.1	13.8	7.4	20.8	18.1	30.9	15.7	10.6	10.3	16.0	13.4	16.4	13.8	34.9	15.9	8.4	10.0	10.4	25.2	9.9	15.8	2.2	2.8	13.3	14.3	21.9	10.5	13.6	16.9	15.8	18.3	6.9	6.8	13.5	7.0	9.2	19.0	9.1	30.8	12.0	22.2	3.9	9.6	14.4	11.3	17.1	14.5	4.8	12.5	14.0	9.2	17.3	9.7	8.1	7.8	7.3	8.7	12.1	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.8;Hep G2: 19.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"					"HPA057745: , HPA059562: "			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Asthma, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 57.0;lymphoid tissue: 32.9"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 3.8;PC-3: 7.7;RT4: 3.5;U-2 OS: 3.7"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 24.2"	"Group enriched"	"Detected in many"	56	"dendritic cells: 7.9;monocytes: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	7380000	170000000				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	57.0	2.1	2.8	14.0	5.8	1.1	2.9	2.0	2.7	1.5	4.4	2.0	0.4	2.3	2.9	1.6	0.8	1.4	3.6	2.0	2.1	1.7	1.0	4.3	19.0	22.2	3.2	1.8	4.0	0.9	0.1	3.1	15.8	2.3	8.5	6.6	2.8	2.5	1.6	0.9	2.3	3.7	1.5	7.1	32.9	1.4	0.7	2.0	6.4	13.1	0.6	6.0	7.2	0.8	0.1	7.9	0.2	24.2	0.0	0.2	6.1	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	1.5	0.0	0.1	0.0	0.2	1.9	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.3	3.8	7.7	0.0	0.0	0.1	0.0	3.5	0.1	0.5	0.0	0.0	0.0	1.0	1.0	0.0	0.0	3.7	0.1	0.8	0.1	0.0	0.0	0.0	0.2	1.3	0.0	24.2	0.1	0.0	5.0	0.2	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	6.1	2.8	5.8	2.0	2.7	2.1	1.7	3.2	1.8	2.3	2.0
PLAA	"DOA1, FLJ11281, FLJ12699, PLA2P, PLAP"	ENSG00000137055	"Phospholipase A2 activating protein"	Q9Y263	9	26904083-26947463	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005035, HPA020994, HPA020996"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			5300	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB005035: AB_562036, HPA020994: AB_1855444, HPA020996: AB_1855445"	"unprognostic (5.48e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.50e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.54e-2)"	"prognostic favourable (7.87e-4)"	"unprognostic (3.24e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.86e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.10e-1)"	13.6	20.1	9.4	12.4	13.1	29.6	11.9	12.9	18.0	13.4	12.3	11.1	13.5	10.5	15.6	12.8	16.2	10.8	13.6	26.2	10.1	10.2	15.0	19.6	14.4	16.4	9.6	10.9	12.3	12.9	15.0	10.0	17.4	13.4	12.1	13.1	9.5	13.4	11.6	52.6	13.5	12.3	16.1	10.0	16.1	12.0	15.7	7.9	27.0	13.0	18.2	14.6	14.9	12.7	13.2	12.2	19.2	17.9	13.5	16.5	8.6	27.2	16.2	20.5	20.7	13.9	17.8	15.4	25.7	14.7	19.7	19.3	5.7	13.1	24.7	21.5	19.6	11.0	20.3	20.3	21.8	32.5	8.6	15.3	26.6	10.9	14.2	12.3	20.9	15.8	12.2	24.0	17.6	19.6	9.3	25.1	21.1	11.4	23.7	12.0	29.7	14.1	16.9	12.9	14.6	15.3	16.4	13.2	22.5	13.8	16.3	8.0	11.3	9.5	23.7	0.0	24.4	12.7	20.7	8.3	17.9	25.7	13.9	17.6	10.2	19.2	11.9	18.7	11.2	16.8	12.5	13.2	11.6	11.3	12.2	11.5	10.7	12.2	11.2	13.5	17.9	6.3	16.5	8.6	9.4	13.1	12.9	18.0	10.1	10.2	9.6	10.9	13.4	7.9
PLAT		ENSG00000104368	"Plasminogen activator, tissue type"	P00750	8	42175233-42207724	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 132.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.8;HMC-1: 55.1;LHCN-M2: 55.6;U-2197: 58.0;WM-115: 115.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.6;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003412, CAB009335"	Supported		Approved	"Actin filaments"	"Secreted to blood"	9900000	12000	"Actin filaments"		"CAB009335: AB_2237146, HPA003412: AB_1858205"	"prognostic favourable (7.57e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.08e-1)"	"unprognostic (3.39e-1)"	"unprognostic (4.88e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.65e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (4.95e-4)"	"unprognostic (8.72e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.63e-2)"	"unprognostic (6.09e-2)"	19.3	14.9	5.2	12.9	6.8	0.4	13.3	2.2	6.2	24.5	17.1	9.1	19.0	11.2	35.5	28.1	18.1	19.1	18.5	7.3	6.0	5.9	67.6	2.8	15.9	1.9	8.2	3.6	18.4	5.8	132.2	5.1	15.5	9.4	27.4	12.2	39.4	6.1	12.7	5.8	2.0	31.7	23.0	7.0	1.0	14.6	12.2	3.8	0.6	11.2	14.7	7.4	47.9	13.7	0.3	0.1	1.6	0.0	0.0	2.3	0.3	0.5	0.2	4.2	1.0	7.7	10.5	0.1	18.0	32.0	7.7	6.6	0.2	85.8	0.0	0.6	2.3	1.4	0.0	4.0	15.9	7.8	1.4	0.1	0.1	0.1	37.9	0.0	55.1	10.5	0.0	18.8	0.7	14.4	0.5	0.1	55.6	0.0	0.0	0.0	5.6	7.6	0.0	15.6	0.0	2.5	0.0	0.0	0.9	0.0	0.1	24.5	0.1	0.0	27.5	1.5	5.7	58.0	1.8	0.0	0.1	0.0	1.2	0.0	115.3	1.6	0.0	0.0	0.3	0.0	1.0	0.3	2.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	2.3	0.3	5.2	6.8	2.2	6.2	6.0	5.9	8.2	3.6	9.4	3.8
PLAU	"UPA, URK"	ENSG00000122861	"Plasminogen activator, urokinase"	P00749	10	73909177-73917497	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Plasminogen activation"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 48.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.9;LHCN-M2: 66.5;RPTEC TERT1: 252.9;U-251 MG: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.4;neutrophil: 4.5;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"dendritic cells: 4.5;granulocytes: 4.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA008719	Approved				"Secreted to blood"	647333	58000			"HPA008719: AB_1858635"	"unprognostic (1.96e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (3.38e-4)"	"unprognostic (4.73e-2)"	"prognostic unfavourable (2.70e-4)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.58e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (3.51e-4)"	"unprognostic (2.83e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.77e-2)"	26.7	2.4	1.0	15.5	2.1	11.3	9.7	1.6	1.5	6.9	5.8	2.9	4.9	3.8	10.7	21.2	9.1	6.5	10.7	14.3	1.3	1.0	23.3	2.3	23.4	5.5	1.6	1.5	6.8	3.7	3.6	1.8	48.4	3.1	7.5	6.7	4.5	10.6	5.0	12.2	9.0	8.1	8.4	2.5	23.8	7.8	5.8	1.3	4.8	10.9	11.6	8.2	16.3	9.3	0.1	4.5	4.5	0.4	0.0	0.0	0.3	13.0	7.0	3.0	0.1	0.2	5.0	0.1	7.9	37.2	3.2	5.1	0.1	68.9	0.0	14.7	1.1	9.0	0.0	13.3	3.7	0.7	0.0	0.0	0.3	0.1	6.1	1.1	2.6	13.3	1.6	22.2	8.6	9.2	0.0	0.0	66.5	0.0	0.0	1.7	0.8	18.3	0.0	9.0	0.0	252.9	10.3	0.0	0.0	0.0	0.3	0.2	0.0	1.8	23.3	0.2	1.6	1.7	67.9	0.0	0.1	0.1	17.9	1.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	4.5	0.0	0.0	4.5	0.0	0.3	1.0	2.1	1.6	1.5	1.3	1.0	1.6	1.5	3.1	1.3
PLCB1	"KIAA0581, PLC-I, PLC154"	ENSG00000182621	"Phospholipase C beta 1"	Q9NQ66	20	8077251-8968360	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 56.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.6;Hep G2: 32.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004275, CAB005334, HPA034743, HPA057910"	Enhanced		Approved	"Plasma membrane"			5400	"Plasma membrane"		"CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: , HPA057910: "	"unprognostic (2.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.13e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.12e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.12e-1)"	5.6	7.0	13.8	4.4	27.7	3.4	5.9	7.5	31.1	6.5	9.9	2.1	20.6	5.5	8.0	10.3	4.5	7.4	6.6	8.6	15.7	9.1	10.0	3.1	4.0	1.6	9.3	14.5	3.2	10.8	56.7	4.6	14.2	5.5	10.4	3.6	1.3	19.7	22.2	9.8	2.3	4.5	12.3	4.0	2.9	5.5	2.6	8.0	4.1	3.1	1.9	1.1	8.6	6.3	0.5	0.8	2.8	3.3	2.4	5.2	0.4	0.0	0.6	2.3	0.1	4.3	8.1	3.1	9.7	6.4	2.5	1.5	21.6	2.4	1.0	4.1	1.8	0.0	1.7	0.0	1.9	0.0	2.1	0.4	1.6	32.5	1.1	0.5	0.3	0.5	0.4	3.4	0.0	5.1	3.3	12.6	0.0	2.9	0.4	1.5	7.3	3.5	6.9	0.0	5.7	1.9	8.0	8.3	3.6	0.0	2.0	0.4	9.6	3.1	0.9	8.3	3.7	0.6	6.0	9.5	11.0	16.3	4.2	5.9	14.3	0.8	3.3	2.8	3.6	0.7	5.2	0.2	1.0	1.3	0.4	0.5	0.5	1.1	2.1	2.4	0.4	0.8	0.2	0.4	13.8	27.7	7.5	30.8	15.7	9.1	9.3	14.5	5.5	8.0
PLCD1		ENSG00000187091	"Phospholipase C delta 1"	P51178	3	38007496-38029762	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 15.7;ASC TERT1: 14.0;fHDF/TERT166: 15.4;hTCEpi: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009913, HPA020107, HPA021677"	Approved		Approved	Microtubules				Microtubules		"CAB009913: AB_2163388, HPA020107: AB_1855318, HPA021677: AB_1855319"	"unprognostic (1.75e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.55e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.24e-1)"	"prognostic favourable (9.25e-11)"	"unprognostic (1.50e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.88e-2)"	10.9	11.3	11.2	5.6	12.1	5.1	8.0	6.0	11.2	11.6	19.3	15.2	7.3	6.6	9.1	7.6	21.9	8.6	8.5	8.0	13.0	6.9	7.8	5.8	9.4	9.3	10.5	11.4	12.8	6.2	4.7	7.3	6.9	15.9	10.6	12.7	8.3	10.9	12.6	4.5	17.0	6.5	12.3	15.5	6.3	6.5	37.3	8.7	7.7	6.6	21.2	12.2	14.6	23.1	1.0	2.6	8.6	2.4	3.7	13.2	5.4	0.6	1.7	5.6	1.5	15.7	14.0	1.7	1.7	6.7	2.6	4.0	0.6	1.3	0.4	0.9	15.4	9.0	2.9	1.7	0.8	2.5	0.7	0.2	0.9	2.8	9.2	0.0	1.0	11.3	19.2	7.8	1.0	4.9	9.4	0.8	5.7	0.7	1.3	0.6	1.5	1.7	0.5	0.8	2.1	3.1	3.0	0.0	1.6	0.5	7.5	1.8	1.6	0.7	2.8	1.6	4.0	4.1	0.0	3.4	1.3	0.3	4.0	0.0	0.8	8.6	1.9	0.1	10.2	2.4	11.6	1.0	13.2	9.8	2.6	0.5	7.8	6.1	6.9	3.7	1.4	1.5	11.8	5.4	11.2	12.1	6.0	10.7	13.0	6.9	10.5	11.4	15.9	8.7
PLCD3		ENSG00000161714	"Phospholipase C delta 3"	Q8N3E9	17	45108967-45133354	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 63.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025711, HPA053665"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA025711: AB_1855320, HPA053665: "	"unprognostic (3.58e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.14e-3)"	"unprognostic (8.13e-3)"	"prognostic unfavourable (2.89e-6)"	"unprognostic (2.96e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.62e-1)"	"prognostic favourable (4.28e-4)"	"unprognostic (3.34e-3)"	5.7	12.0	10.1	4.8	16.5	2.4	6.6	12.2	12.9	5.0	24.9	14.0	2.8	2.9	6.3	6.4	8.9	5.8	9.4	13.1	11.6	6.6	3.6	1.2	4.5	1.7	13.9	11.4	9.9	2.7	1.5	3.0	5.7	19.5	5.8	13.7	10.3	4.7	5.7	63.6	9.9	2.8	12.9	15.0	2.0	17.9	5.4	14.6	0.0	2.3	20.1	2.8	17.5	10.5	1.3	0.9	2.9	1.5	1.3	0.9	0.5	9.0	22.8	1.7	3.3	2.5	5.4	11.5	5.0	11.2	4.6	4.4	5.6	16.7	0.3	18.1	11.7	20.9	2.6	21.5	1.8	4.5	8.6	0.3	24.0	7.1	12.9	0.5	1.3	5.8	8.7	4.3	5.7	2.8	1.9	0.7	4.9	14.3	1.4	2.1	2.0	22.5	3.2	3.8	0.6	14.7	18.2	0.4	3.0	5.4	9.1	4.9	19.3	1.0	5.7	2.9	16.0	3.8	5.8	0.8	1.0	0.7	4.7	0.6	2.3	2.3	1.5	2.4	0.9	1.5	0.6	1.0	0.7	0.6	0.5	1.3	0.9	0.8	2.9	1.3	0.3	0.9	0.6	0.5	10.1	16.5	12.2	11.5	11.6	6.6	13.9	11.4	19.5	14.6
PLCE1	"KIAA1516, NPHS3, PLCE"	ENSG00000138193	"Phospholipase C epsilon 1"	Q9P212	10	94030812-94332823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Guanine-nucleotide releasing factor, Hydrolase, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 44.6"	"Cell line enhanced"	"Detected in many"		"RT4: 18.7;U-2 OS: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA015597, HPA015598"	Enhanced		Supported	Cytosol				Cytosol		"HPA015597: AB_1855321, HPA015598: AB_1855322"	"unprognostic (4.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.59e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.76e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.56e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.54e-2)"	"unprognostic (4.30e-2)"	3.2	2.4	4.1	9.1	5.5	0.0	2.2	1.8	7.9	9.2	13.8	3.1	1.6	5.0	11.4	4.6	4.5	4.2	3.8	12.8	4.1	2.6	6.3	0.7	7.2	0.4	2.4	6.8	3.2	12.8	0.1	5.2	3.1	6.4	3.3	12.6	44.6	2.1	7.7	4.3	0.7	4.6	5.8	2.4	5.8	8.7	1.7	2.3	0.0	15.1	7.3	1.1	7.9	5.4	3.2	1.2	0.8	0.9	1.1	2.3	0.5	6.0	8.3	1.8	1.0	1.0	5.9	2.3	3.7	1.0	0.8	1.2	5.4	1.5	0.7	1.9	3.0	2.6	4.2	1.0	1.3	0.4	2.1	0.4	4.6	0.5	0.1	0.8	0.3	2.4	0.0	2.2	0.0	0.0	0.4	0.3	7.2	0.2	0.7	0.8	0.6	8.7	0.1	5.7	0.2	0.2	18.7	0.8	1.5	4.4	6.0	0.5	5.1	0.5	0.6	3.9	11.2	2.3	4.9	0.5	0.2	0.3	3.1	1.0	3.5	0.4	0.5	0.1	1.5	0.9	1.3	2.6	1.6	1.1	0.6	3.2	2.3	1.8	0.8	1.1	0.8	1.2	0.6	0.5	4.1	5.5	1.8	7.9	4.1	2.6	2.4	6.8	6.4	2.3
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol				Cytosol		"CAB004277: AB_628119, HPA036681: , HPA036682: "	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.3	6.8	32.9	24.1	13.2	9.3	10.5	8.8	11.4	17.8	15.2	16.4	1.8	12.0	10.9	9.6	10.0	14.3	15.8	10.4	3.4	7.6	0.8	11.4	19.3	10.0	4.7	3.3	11.8	8.9	13.1	10.3	19.9	8.9	7.9	16.1	40.1	28.9	3.7	12.2	12.6	23.1	24.0	5.9	9.8	9.9	11.7	22.4	15.8	7.4	15.9	8.6	5.5	21.4	42.7	13.9	13.6	10.7	8.9	3.9	10.0	10.2	5.1	17.7	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9
PLCG2		ENSG00000197943	"Phospholipase C gamma 2"	P16885	16	81739097-81962693	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 55.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.6;HMC-1: 19.0;U-698: 87.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004280, HPA020099, HPA020100"	Enhanced		Approved	Vesicles			21000	Vesicles		"CAB004280: AB_628120, HPA020099: AB_1855324, HPA020100: AB_1855325"	"unprognostic (2.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"	"prognostic favourable (6.71e-4)"	"unprognostic (6.23e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	"prognostic favourable (4.88e-4)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.40e-3)"	8.4	3.8	3.3	55.8	4.9	14.1	10.7	1.0	2.4	5.6	10.3	5.3	3.1	8.7	11.2	12.2	6.0	4.7	10.1	4.4	3.3	2.8	20.6	8.8	10.7	35.5	5.2	1.8	2.0	3.6	1.0	1.8	4.1	4.5	4.3	3.6	4.6	8.8	2.8	2.0	4.1	17.6	4.6	8.6	33.6	4.2	2.3	4.2	6.3	5.3	2.6	44.6	7.5	7.7	18.8	3.9	26.8	12.2	14.0	1.1	2.3	0.3	0.7	0.1	0.6	0.0	0.0	0.9	0.0	0.0	0.5	0.2	0.2	1.7	39.6	6.8	0.0	0.9	0.8	0.1	0.3	0.3	0.4	4.7	0.0	0.0	0.2	4.7	19.0	0.0	0.4	0.3	0.2	0.9	0.5	3.3	0.0	1.2	0.5	11.9	0.7	0.2	16.1	0.0	5.0	0.1	0.8	0.3	0.0	1.1	0.3	0.3	0.7	14.6	0.2	0.0	0.7	0.1	0.1	7.9	12.9	87.9	0.0	6.5	0.3	2.8	4.4	26.8	0.7	5.7	0.3	18.8	0.2	1.1	3.9	17.3	0.3	0.8	24.8	14.0	12.2	2.6	0.1	2.3	3.3	4.9	1.0	2.4	3.3	2.8	5.2	1.8	4.5	4.2
PLD1		ENSG00000075651	"Phospholipase D1"	Q13393	3	171600405-171810950	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 52.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 29.9;SK-MEL-30: 16.7;TIME: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004527, HPA042396"	Enhanced									"CAB004527: AB_677324, HPA042396: "	"unprognostic (3.23e-1)"	"unprognostic (3.27e-1)"	"unprognostic (5.82e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.58e-1)"	"unprognostic (4.76e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.23e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (4.76e-6)"	7.0	26.6	5.3	6.1	20.4	4.5	6.3	1.4	10.8	8.6	19.7	31.4	1.8	27.7	6.9	4.9	25.0	4.9	52.1	14.7	7.7	4.7	7.5	20.2	4.4	5.2	25.3	7.2	17.1	13.9	0.9	2.7	6.6	18.8	3.5	9.4	8.5	13.2	4.2	2.0	17.6	29.5	3.4	16.8	9.9	5.3	3.5	21.8	0.9	4.1	10.7	8.5	4.3	11.5	0.1	0.9	10.2	2.6	3.0	4.1	0.8	2.3	3.7	1.9	0.7	5.9	6.7	4.1	1.2	5.2	1.8	2.3	0.5	3.3	0.0	9.3	0.5	7.8	0.3	1.0	3.0	1.9	1.6	2.2	5.9	13.0	2.7	3.8	10.4	2.6	5.7	2.2	1.0	29.9	1.4	0.0	0.4	0.6	0.0	3.2	0.4	2.7	0.1	0.8	0.0	4.7	0.9	0.0	0.0	4.1	2.5	16.7	4.6	5.0	26.0	0.8	3.2	2.1	1.3	5.0	4.0	0.0	3.6	4.5	1.0	10.2	2.6	3.2	0.5	1.6	4.1	0.0	0.4	1.0	0.9	0.1	0.0	0.1	1.5	3.0	0.5	0.0	1.2	0.8	5.3	20.4	1.4	10.8	7.7	4.7	25.3	7.2	18.8	21.8
PLEC	"EBS1, PCN, PLEC1, PLTN"	ENSG00000178209	Plectin	Q15149	8	143915147-143976734	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes, Disease mutation, Epidermolysis bullosa, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 144.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 72.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003847, HPA025967, HPA029906"	Enhanced		Enhanced	"Intermediate filaments,Focal adhesion sites,Cytosol"			7100000	"Intermediate filaments, Cytosol"	"Focal adhesion sites"	"CAB003847: AB_562198, HPA025967: AB_10601671, HPA029906: AB_10602279"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-3)"	"prognostic unfavourable (4.29e-4)"	"unprognostic (2.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.72e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.85e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (7.98e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.58e-2)"	"unprognostic (5.58e-3)"	20.9	11.0	15.9	16.5	13.3	27.9	13.1	15.0	20.7	20.7	17.7	14.6	16.7	13.1	20.2	16.8	25.1	18.2	29.0	23.4	18.9	10.7	11.2	10.9	16.6	15.0	9.9	13.0	18.0	14.0	8.8	12.0	24.2	13.2	17.5	9.8	13.0	17.8	14.8	144.9	36.4	24.1	24.7	11.0	16.9	21.4	6.7	12.7	16.3	9.2	44.2	24.5	20.2	19.2	1.5	3.4	0.8	4.1	0.7	2.9	3.2	16.3	51.2	3.3	4.1	6.0	13.4	11.7	24.0	10.7	6.4	3.6	7.1	17.1	1.6	18.7	35.1	19.4	2.2	33.6	2.5	12.2	1.8	6.2	52.0	5.8	9.5	2.0	5.2	15.4	6.6	17.2	33.6	7.4	3.0	5.3	7.4	28.7	1.2	3.4	2.2	72.1	0.3	9.4	4.4	10.7	30.3	3.4	3.4	40.9	8.7	3.9	10.7	2.4	23.8	24.8	44.9	21.8	28.4	0.8	0.6	1.2	23.6	2.6	35.2	0.0	4.1	0.2	1.4	3.8	2.8	1.4	2.7	2.0	3.4	1.5	2.0	1.1	0.8	0.7	2.7	2.8	2.9	3.2	15.9	13.3	15.0	17.3	18.9	10.7	9.9	13.0	13.2	12.7
PLEK	P47	ENSG00000115956	Pleckstrin	P08567	2	68365173-68397453	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 80.4;bone marrow: 120.1;lymphoid tissue: 51.0"	"Cell line enhanced"	"Detected in some"		"HEL: 91.5;HMC-1: 35.0;NB-4: 30.8;THP-1: 35.8;U-266/84: 23.8;U-698: 24.4;U-937: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031838, HPA057341"	Enhanced		Approved	Nucleoli			970000000	Nucleoli		"HPA031838: AB_10602146, HPA057341: "	"unprognostic (2.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.87e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.52e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.67e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavourable (1.95e-4)"	"unprognostic (3.57e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	27.8	3.6	3.0	21.7	7.7	120.1	4.6	1.0	3.0	1.8	4.2	7.0	0.4	2.4	2.4	7.5	3.5	5.5	4.9	4.9	2.6	2.4	3.8	6.5	17.0	36.6	6.4	0.8	4.3	2.8	0.7	2.0	8.5	5.0	4.0	4.5	2.7	3.5	0.8	2.3	1.7	8.0	5.0	8.6	51.0	3.2	5.7	3.7	8.2	3.8	2.7	25.7	7.3	2.0	22.9	66.9	80.4	50.8	33.2	44.7	65.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.5	0.0	0.0	0.0	20.6	35.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	30.8	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	0.0	0.0	0.0	0.0	0.0	1.3	23.8	24.4	0.0	56.8	0.0	24.8	39.7	57.2	44.7	49.2	23.5	22.9	8.2	32.2	32.1	13.5	2.3	25.3	80.4	33.2	50.8	66.9	0.8	65.9	3.0	7.7	1.0	3.0	2.6	2.4	6.4	0.8	5.0	3.7
PLEKHA5	"FLJ10667, KIAA1686, PEPP2"	ENSG00000052126	"Pleckstrin homology domain containing A5"	Q9HAU0	12	19129752-19376400	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 28.0;NTERA-2: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 14.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035923, HPA035924, HPA041455"	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA035923: AB_10673491, HPA035924: AB_10672994, HPA041455: "	"unprognostic (3.16e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.85e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (5.41e-5)"	"unprognostic (3.71e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.07e-2)"	7.7	52.3	13.8	7.8	22.0	2.9	11.9	13.0	22.4	23.5	9.8	7.2	19.4	10.0	23.1	25.7	16.0	16.0	16.7	25.2	11.2	11.5	32.2	12.1	9.9	2.4	10.7	16.3	26.1	11.3	27.2	14.4	10.2	15.0	17.6	10.8	22.2	11.4	22.7	2.0	13.2	10.0	23.1	23.7	2.8	13.7	14.8	13.0	6.1	11.5	5.9	4.3	18.1	18.1	0.4	2.7	14.8	0.4	1.7	6.4	0.4	11.0	5.4	20.0	0.2	6.8	9.2	7.1	4.7	10.3	2.9	4.6	8.1	10.0	0.2	1.6	5.2	4.7	13.4	8.8	6.0	28.0	4.8	6.5	12.1	3.9	6.3	0.2	0.9	5.3	9.2	8.2	15.7	3.0	2.8	0.4	3.0	3.4	4.3	0.8	28.6	2.8	0.1	9.3	0.1	20.1	13.1	1.8	4.1	4.6	2.7	16.9	3.3	1.5	4.6	1.9	7.9	0.5	0.2	0.3	0.2	0.2	4.4	0.1	3.6	14.8	0.4	0.3	2.7	0.3	6.4	0.2	2.5	2.3	1.8	0.4	0.4	1.9	1.0	1.7	0.2	2.7	2.1	0.4	13.8	22.0	13.0	22.4	11.2	11.5	10.7	16.3	15.0	13.0
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160753315	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 269.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 3.5;RH-30: 3.9;U-698: 2.0;U-937: 1.6"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	140000000000	41000000000			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: "		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favourable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	269.9	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	3.5	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.3	0.2	0.8	0.0	0.4	3.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	1.0	0.0	2.0	0.0	1.6	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PLIN1	PLIN	ENSG00000166819	"Perilipin 1"	O60240	15	89664365-89679427	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"adipose tissue: 187.5;breast: 62.6"	"Cell line enriched"	"Detected in single"	176	"ASC diff: 68.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA024299, CAB033821, CAB037333"	Enhanced		Uncertain	Peroxisomes			8900	Peroxisomes		"CAB033821: AB_2252681, CAB037333: , HPA024299: AB_1855467"	"unprognostic (4.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.62e-6)"	"unprognostic (5.56e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.85e-2)"	187.5	2.6	1.8	7.1	1.3	0.3	62.6	0.8	0.8	0.3	10.6	1.6	0.4	0.4	0.3	1.9	0.5	0.4	7.4	8.3	2.7	0.6	0.6	5.8	0.3	2.8	0.8	1.5	0.4	1.4	0.3	0.1	0.3	1.0	0.4	1.1	0.0	7.6	1.5	7.2	2.2	2.2	0.6	0.4	0.3	0.5	1.6	1.8	0.0	0.7	8.0	0.3	1.5	1.5	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	68.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.8	1.3	0.8	0.7	2.7	0.6	0.8	1.5	1.0	1.8
PLIN2	"ADFP, ADRP"	ENSG00000147872	"Perilipin 2"	Q99541	9	19108375-19149290	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 233.1;liver: 139.9"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.8;HHSteC: 171.3"	"Group enriched"	"Detected in all"	5	"liver cancer: 63.0;renal cancer: 136.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 83.5;eosinophil: 76.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 83.5;monocytes: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016607, CAB037331"	Supported		Supported	"Lipid droplets"				"Lipid droplets"		"CAB037331: , HPA016607: "	"unprognostic (2.02e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (4.92e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (3.14e-3)"	"unprognostic (7.89e-2)"	"prognostic favourable (2.16e-4)"	"unprognostic (1.77e-1)"	233.1	17.4	1.8	6.5	2.8	14.9	98.9	1.1	3.2	11.2	47.4	2.0	5.4	28.4	7.7	7.8	6.2	6.1	10.9	37.0	1.7	1.6	36.0	139.9	18.3	9.6	2.2	1.2	37.5	4.5	2.0	4.7	46.4	3.0	17.1	3.5	5.9	8.5	4.5	75.7	13.5	61.6	6.8	3.1	9.8	5.5	16.5	2.4	4.4	8.8	4.0	4.6	63.2	102.9	3.2	8.6	83.5	21.1	2.0	11.5	11.8	0.0	2.8	3.2	2.3	197.8	27.0	35.9	9.1	7.1	5.5	6.3	4.3	0.6	0.0	0.1	18.6	0.3	3.1	0.0	9.6	11.5	0.0	15.1	0.4	16.1	171.3	1.8	27.8	28.5	3.2	13.6	0.0	6.8	2.7	3.3	21.6	0.7	4.1	6.2	4.3	5.6	10.0	1.5	0.1	0.0	10.6	0.2	5.3	4.2	1.0	9.0	2.2	4.0	10.7	0.0	1.7	8.6	0.0	2.0	2.0	6.1	0.0	3.1	0.8	83.5	14.9	76.1	11.5	19.7	10.0	3.2	10.1	8.2	8.6	2.9	9.9	8.4	0.9	2.0	21.1	1.0	9.6	11.8	1.8	2.8	1.1	3.2	1.7	1.6	2.2	1.2	3.0	2.4
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"			9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: "	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favourable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (3.27e-5)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	27.7	16.4	11.5	10.4	12.7	41.4	5.0	40.5	37.8	32.7	30.3	10.7	25.4	14.4	9.2	50.9	12.7	5.2	22.8	19.3	16.4	7.5	15.6	9.3	19.6	9.1	11.1	23.8	32.3	9.5	23.2	5.0	17.0	23.7	6.4	39.6	11.4	15.8	15.0	8.6	26.7	27.2	15.5	8.1	27.8	6.4	0.5	5.4	12.6	11.5	9.9	14.6	25.2	25.3	17.4	17.2	69.6	20.8	9.0	11.5	9.9	52.4	15.8	20.0	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 75.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Supported	"Vesicles,Lipid droplets,Plasma membrane,Cytosol"			11000	"Lipid droplets, Plasma membrane"	"Vesicles, Cytosol"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavourable (8.31e-4)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	75.1	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.4	1.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8
PLOD1	"LH1, LLH, PLOD"	ENSG00000083444	"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1"	Q02809	1	11934205-11975538	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049137, HPA055799"	Uncertain		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"		2700000	Vesicles	Nucleoplasm	"HPA049137: AB_2680649, HPA055799: AB_2682924"	"unprognostic (1.00e-1)"	"unprognostic (2.69e-3)"	"unprognostic (9.21e-3)"	"unprognostic (5.43e-2)"	"unprognostic (7.53e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.15e-3)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (1.91e-12)"	"unprognostic (2.79e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.43e-4)"	29.0	19.5	14.9	16.8	24.0	7.1	32.1	12.1	17.6	35.8	21.7	17.0	17.7	19.1	34.2	21.1	16.5	24.7	21.3	31.2	17.6	14.8	27.5	51.3	22.2	19.7	24.5	9.9	31.8	30.3	18.2	16.3	41.5	20.8	21.1	12.0	25.1	39.3	22.0	18.3	13.3	20.8	39.0	13.2	21.1	18.6	10.0	22.4	1.7	34.8	11.1	8.2	19.5	69.7	1.6	16.3	17.7	19.4	2.6	9.1	9.3	17.6	15.1	8.3	38.9	56.9	31.9	6.7	52.5	69.7	27.7	47.1	17.2	11.6	10.2	55.5	57.9	14.9	12.1	18.3	19.1	10.6	12.9	5.5	24.3	21.8	35.3	3.4	26.8	38.7	9.6	33.4	13.4	49.0	15.4	5.0	28.8	11.4	0.8	9.2	3.7	22.5	4.1	16.9	22.1	15.9	4.0	3.2	13.2	22.9	15.7	26.4	7.9	8.8	48.4	31.7	23.8	39.6	25.7	11.7	19.1	6.1	70.2	12.1	51.6	0.0	19.4	0.9	9.1	17.2	1.6	1.0	1.6	4.4	16.3	1.6	0.6	3.4	17.7	2.6	15.0	2.4	1.0	9.3	14.9	24.0	12.1	17.6	17.6	14.8	24.5	9.9	20.8	22.4
PLPP3	"LPP3, PAP-2b, PPAP2B"	ENSG00000162407	"Phospholipid phosphatase 3"	O14495	1	56494747-56645301	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 102.8;ASC TERT1: 51.4;HSkMC: 63.5;U-2197: 93.3"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 168.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.4;naive B-cell: 4.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.4"									"HPA028892, HPA072751"	Uncertain		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA028892: AB_10602149, HPA072751: "	"unprognostic (2.50e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.22e-3)"	"unprognostic (5.86e-3)"	"unprognostic (7.25e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.75e-2)"	"unprognostic (3.91e-2)"	"unprognostic (3.08e-1)"	"prognostic favourable (4.59e-4)"	"unprognostic (3.16e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.09e-1)"	46.4	17.2	29.0	10.8	30.7	4.2	39.1	13.5	27.5	102.7	15.5	33.8	22.1	8.1	32.7	36.9	20.8	36.7	24.0	23.3	39.9	13.5	30.2	57.7	24.3	6.7	19.2	30.1	27.9	12.2	30.7	7.2	70.9	20.0	37.7	14.4	34.7	22.4	58.7	16.6	24.4	12.5	32.9	16.5	7.9	18.7	23.4	29.7	5.2	107.1	19.4	6.7	35.8	44.0	5.4	0.0	0.8	0.3	0.0	0.0	0.2	0.4	1.5	2.0	0.2	102.8	51.4	4.9	5.4	5.5	5.0	2.5	4.3	0.8	0.7	0.6	8.1	0.8	0.2	0.1	1.0	0.0	1.3	0.1	0.6	6.0	2.5	0.0	0.0	63.5	0.4	4.8	4.0	4.7	0.3	0.0	5.4	0.4	0.0	0.0	6.1	5.9	0.0	0.0	0.2	0.8	4.5	0.0	4.0	1.7	2.2	0.5	0.7	0.0	2.9	25.2	2.1	93.3	0.2	0.0	0.0	0.0	4.4	0.2	1.7	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.2	29.0	30.7	13.5	27.5	39.9	13.5	19.2	30.1	20.0	29.7
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"				"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: "	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.4	19.2	24.9	26.5	29.4	25.6	21.0	30.2	37.0	41.3	33.8	22.6	20.8	25.6	15.5	35.8	17.3	32.4	40.4	45.9	25.8	16.2	30.7	15.3	21.9	30.2	30.6	25.8	27.5	37.5	48.8	38.4	35.3	31.3	32.9	35.9	16.8	23.5	14.6	18.8	20.9	23.3	12.9	15.5	28.6	15.1	14.5	16.4	18.4	19.9	28.8	19.1	21.5	22.7	24.7	28.0	21.7	26.8	17.2	22.3	32.2	23.2	14.8	32.8	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9
PLS3	T-plastin	ENSG00000102024	"Plastin 3"	P13797	X	115561174-115650861	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"NK-cell: 4.2;plasmacytoid DC: 13.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 13.1;NK-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020433, HPA076083"	Approved		Approved	"Plasma membrane,Cytosol"			110000000	"Plasma membrane, Cytosol"		"HPA020433: , HPA076083: "	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.63e-2)"	"prognostic unfavourable (6.07e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (5.15e-2)"	"unprognostic (1.54e-1)"	"prognostic favourable (3.72e-4)"	"prognostic unfavourable (7.04e-4)"	41.9	11.0	11.8	9.8	12.5	0.2	24.6	3.6	16.7	43.8	14.3	13.9	24.1	6.0	37.4	27.6	54.4	21.5	23.6	18.8	12.2	8.2	40.7	100.5	64.7	6.0	14.7	13.7	44.4	8.9	2.7	4.6	21.9	22.7	21.6	9.2	10.6	16.6	31.4	17.7	38.4	8.2	34.6	14.5	31.6	13.3	14.9	13.0	5.1	64.8	34.7	12.5	38.7	29.0	0.0	13.1	0.4	0.1	4.2	1.5	0.2	27.8	28.7	25.1	7.3	25.4	23.8	38.3	29.1	32.9	27.9	33.8	31.1	23.2	0.1	84.2	23.9	35.9	26.6	47.3	45.4	0.4	33.3	2.7	35.6	13.0	23.0	0.0	1.3	15.0	22.8	43.2	30.4	60.4	0.0	0.0	26.6	8.1	0.0	0.3	33.3	34.4	0.0	16.8	0.6	33.3	15.1	0.0	5.2	61.1	15.2	12.2	8.4	0.4	66.0	45.3	7.7	46.1	58.1	1.1	4.0	0.5	19.8	0.1	18.7	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	0.1	4.2	0.0	13.1	1.5	0.2	11.8	12.5	3.6	16.7	12.2	8.2	14.7	13.7	22.7	13.0
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.8;ASC TERT1: 19.5;HUVEC TERT2: 20.0;TIME: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.8	19.5	0.1	4.4	6.0	2.0	4.3	0.4	4.8	0.0	4.8	8.2	0.5	0.9	0.4	1.1	0.0	0.0	1.9	3.0	0.5	11.3	0.0	0.5	11.8	0.6	4.1	1.2	20.0	0.1	0.3	2.9	0.1	0.0	0.0	0.8	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.5	0.0	1.4	0.3	0.2	41.2	4.2	1.0	9.2	0.8	0.1	0.0	0.0	1.0	0.0	3.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.0;BEWO: 37.9;HHSteC: 46.6;HSkMC: 60.7;U-87 MG: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 19.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB032873	Approved				"Secreted to blood"	9716666667	200000000			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavourable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	126.5	44.6	20.2	21.8	20.1	5.4	27.0	10.3	21.1	41.5	35.4	30.9	6.9	11.8	28.0	74.6	23.9	41.5	49.9	37.8	18.1	15.9	32.2	13.9	22.6	96.5	15.1	12.2	38.6	83.6	7.4	9.0	117.5	19.5	28.7	12.5	36.4	36.8	22.5	19.8	17.7	14.4	50.1	11.1	25.7	18.7	30.9	11.5	74.7	13.7	11.4	9.5	40.5	26.7	4.7	10.4	19.6	6.7	2.5	1.0	1.6	2.6	0.3	18.3	0.0	44.0	13.4	37.9	1.0	3.2	3.6	2.1	14.9	2.9	0.6	30.6	4.4	30.1	5.6	0.1	1.6	0.3	0.0	5.4	0.6	6.8	46.6	0.0	6.7	60.7	1.5	9.4	0.1	7.9	1.6	8.5	1.1	0.7	0.5	22.5	3.3	14.9	0.2	0.0	0.3	0.0	0.0	2.0	6.9	0.7	21.2	30.5	0.2	21.2	1.7	9.0	0.2	4.6	0.1	3.7	0.9	0.9	64.5	6.2	1.5	19.6	1.6	16.1	1.0	3.8	0.8	4.7	0.2	1.0	1.4	2.1	0.0	0.6	0.7	2.5	6.7	10.4	0.4	1.6	20.2	20.1	10.3	18.2	18.1	15.9	15.1	12.2	19.5	11.5
PLVAP	"FELS, gp68, PV-1, PV1"	ENSG00000130300	"Plasmalemma vesicle associated protein"	Q9BX97	19	17351448-17377350	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 128.3"	"Cell line enriched"	"Detected in some"	28	"EFO-21: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 22.1"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 22.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA002279	Supported		Approved	"Plasma membrane,Centrosome,Cytosol"			53000	Cytosol	"Plasma membrane, Centrosome"	"HPA002279: AB_1079636"	"unprognostic (3.19e-1)"	"unprognostic (8.22e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.49e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.96e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.70e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.17e-2)"	128.3	9.8	0.8	16.4	0.9	0.0	56.3	0.4	1.5	28.7	29.8	3.2	12.8	20.2	32.0	19.8	27.4	16.6	43.1	18.9	1.1	0.4	33.7	4.6	13.1	34.6	0.9	0.5	14.3	22.9	13.8	16.1	12.6	2.7	26.1	5.2	26.3	16.0	10.4	20.7	11.5	23.7	13.5	1.2	77.8	22.1	9.5	0.7	3.8	88.3	13.9	15.2	30.1	87.7	0.0	22.1	0.0	3.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	109.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	22.1	0.0	0.3	0.8	0.9	0.4	1.5	1.1	0.4	0.9	0.5	2.7	0.7
PLXNA3	"6.3, Plxn3, PLXN4, SEX, XAP-6"	ENSG00000130827	"Plexin A3"	P51805	X	154458281-154477779	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 19.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058989			Approved	"Nucleoplasm,Vesicles,Plasma membrane"			58000	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA058989: "	"unprognostic (2.79e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.04e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.33e-2)"	"unprognostic (5.73e-2)"	6.9	7.6	9.8	6.6	9.3	3.5	13.3	25.9	7.4	8.1	6.2	13.8	7.3	7.2	8.6	9.2	5.3	8.3	7.9	6.6	10.5	8.0	5.1	2.5	7.2	7.1	8.7	3.6	16.4	9.9	5.1	35.2	7.4	8.2	9.2	4.8	6.1	13.8	7.5	2.9	19.5	7.2	8.2	8.4	7.0	10.0	5.8	9.8	4.6	9.3	1.8	7.2	6.3	16.4	1.8	0.5	2.7	0.5	2.1	1.0	0.3	8.1	1.6	4.8	12.2	5.1	6.5	6.5	11.7	2.5	2.7	3.8	6.1	3.5	1.5	6.3	12.5	7.2	4.9	5.7	1.0	0.7	3.6	1.5	19.1	3.3	4.0	0.7	6.8	8.8	4.2	4.1	0.3	3.1	3.8	1.3	4.3	10.1	1.4	6.2	1.5	3.7	5.3	0.4	0.5	3.7	5.4	10.2	5.3	4.3	7.8	1.9	4.7	1.7	7.7	6.0	5.5	0.6	4.9	0.9	0.1	2.1	11.2	1.1	1.6	2.7	0.5	0.8	0.8	0.4	0.6	1.8	1.0	0.8	0.1	1.2	0.6	0.8	1.4	2.1	0.3	0.5	0.7	0.3	9.8	9.3	25.9	7.4	10.5	8.0	8.7	3.6	8.2	9.8
PLXNB1	"KIAA0407, PLXN5, SEP"	ENSG00000164050	"Plexin B1"	O43157	3	48403854-48430051	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040586	Enhanced				"Intracellular and membrane"		55000000			"HPA040586: AB_10794034"	"unprognostic (1.31e-3)"	"unprognostic (7.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.65e-1)"	"prognostic favourable (5.03e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.18e-2)"	"prognostic favourable (2.77e-5)"	"unprognostic (4.01e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.98e-2)"	"prognostic favourable (7.60e-4)"	5.8	3.6	23.1	3.7	34.0	1.4	7.5	11.5	25.6	8.4	9.0	47.4	7.2	10.6	10.8	6.7	14.3	25.0	11.3	7.8	26.3	7.4	17.1	14.8	10.8	2.0	48.7	19.3	11.1	24.9	9.1	9.9	7.6	28.9	12.5	6.2	8.8	11.5	18.7	1.0	21.0	9.9	8.5	22.6	6.3	10.1	3.2	34.7	1.4	19.9	3.6	3.0	11.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.9	9.1	5.4	3.4	2.7	18.7	2.5	1.4	1.4	0.9	6.0	11.2	0.0	9.1	1.7	8.8	1.9	19.8	0.3	5.0	0.4	0.0	9.5	11.3	5.0	3.9	1.7	4.9	17.4	0.3	4.1	2.3	0.7	0.4	1.4	5.0	0.7	3.4	16.2	1.1	4.4	1.9	0.6	8.6	13.1	4.7	10.1	3.1	18.9	2.8	10.1	3.3	4.5	1.5	4.4	2.1	2.8	0.1	0.0	0.1	0.3	1.1	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	34.0	11.5	25.6	26.3	7.4	48.7	19.3	28.9	34.7
PLXNB2	"KIAA0315, MM1, PLEXB2"	ENSG00000196576	"Plexin B2"	O15031	22	50274979-50307627	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"classical monocyte: 7.2;intermediate monocyte: 14.3;myeloid DC: 6.0;non-classical monocyte: 16.1;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	30	"dendritic cells: 6.0;monocytes: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003100	Uncertain						51000000			"HPA003100: AB_1079638"	"unprognostic (4.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.35e-3)"	"unprognostic (6.28e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (7.37e-4)"	"unprognostic (8.47e-3)"	"unprognostic (9.84e-2)"	"unprognostic (3.05e-2)"	"prognostic favourable (4.75e-4)"	"unprognostic (1.61e-2)"	"unprognostic (9.41e-3)"	"unprognostic (6.05e-2)"	14.1	27.0	10.8	13.9	9.6	5.5	14.4	43.5	12.8	23.1	19.6	15.0	39.8	22.2	25.9	28.0	27.8	26.7	56.2	12.0	11.9	5.8	31.6	20.3	21.0	18.6	8.3	9.3	32.2	23.3	10.5	19.6	29.6	11.6	27.7	7.7	26.5	26.7	31.0	5.0	24.7	23.6	22.5	9.5	33.6	39.5	19.3	9.5	3.4	45.9	19.6	20.2	23.2	21.9	0.1	6.0	0.3	16.1	0.1	0.3	4.5	17.6	27.4	13.8	19.5	7.7	9.2	24.0	26.1	12.5	8.3	8.3	18.2	24.8	12.7	29.3	17.7	34.5	2.1	17.3	1.8	2.6	11.6	2.2	44.0	13.7	20.3	0.4	12.6	15.7	25.3	8.4	6.3	7.3	3.5	3.6	7.9	29.2	0.2	5.0	3.8	6.8	14.8	23.7	4.5	9.2	49.0	6.5	12.4	23.8	82.0	6.4	30.6	17.6	14.5	18.9	28.5	9.4	8.9	1.8	0.2	2.3	15.3	0.7	25.5	0.0	7.2	0.0	0.0	14.3	0.1	0.1	0.0	0.0	6.0	0.0	0.0	0.1	0.3	0.1	16.1	5.6	0.3	4.5	10.8	9.6	43.5	12.8	11.9	5.8	8.3	9.3	11.6	9.5
PLXNB3	"PLEXB3, PLEXR, PLXN6"	ENSG00000198753	"Plexin B3"	Q9ULL4	X	153764196-153779346	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.3;salivary gland: 28.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 2.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA048046	Enhanced						17000			"HPA048046: "	"prognostic unfavourable (6.13e-4)"	"unprognostic (2.60e-1)"	"unprognostic (9.10e-4)"	"unprognostic (2.30e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.76e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.73e-3)"	"unprognostic (1.98e-2)"	3.7	17.4	15.5	2.9	34.9	1.5	4.5	16.1	46.3	3.5	14.8	45.8	1.8	3.3	8.1	5.3	6.4	3.8	6.1	3.1	19.9	9.4	1.3	1.3	2.1	1.4	39.7	17.3	1.3	5.6	1.1	0.6	1.4	18.4	9.0	3.2	2.8	28.9	10.7	1.4	11.3	3.4	8.9	25.6	1.3	4.4	7.2	40.2	0.0	1.3	0.2	1.2	6.8	3.8	0.1	2.7	0.0	0.0	0.7	0.0	0.7	4.8	0.5	0.6	0.4	0.6	0.4	0.3	4.5	0.9	0.6	1.6	0.0	0.1	0.0	2.9	1.2	0.5	0.0	3.8	0.5	0.1	0.0	3.0	5.4	3.4	1.3	0.0	0.3	1.0	2.8	2.8	1.8	1.8	0.2	1.7	1.2	3.9	0.0	0.7	0.1	7.5	1.4	0.5	0.0	0.7	2.2	1.3	4.1	0.2	4.2	10.1	5.6	0.0	7.9	4.7	2.4	3.7	5.6	1.6	0.4	0.1	10.2	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	2.7	0.0	0.7	15.5	34.9	16.1	20.8	19.9	9.4	39.7	17.3	18.4	40.2
PLXND1	KIAA0620	ENSG00000004399	"Plexin D1"	Q9Y4D7	3	129555175-129606818	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 70.5;HSkMC: 51.3;HUVEC TERT2: 60.0;TIME: 70.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 11.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"amygdala: 37.7;basal ganglia: 29.6;cerebral cortex: 27.0;hippocampal formation: 28.7"	"Low region specificity"	"Detected in many"			CAB020819	Approved						58000000			"CAB020819: "	"unprognostic (8.97e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.35e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (5.93e-7)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.00e-2)"	35.3	13.5	10.8	17.4	19.5	11.0	47.9	2.7	14.3	31.7	9.7	18.5	7.2	3.0	21.1	16.2	10.9	20.0	19.6	25.8	9.3	8.2	16.2	14.5	33.0	37.0	25.9	7.2	10.5	8.4	11.9	7.2	54.6	14.4	11.2	8.7	31.9	8.2	14.2	10.4	9.5	11.6	26.1	19.1	22.1	9.4	7.0	17.4	28.6	18.0	14.4	11.2	19.1	16.8	0.0	3.9	0.1	11.7	2.8	7.6	1.5	1.6	9.9	8.2	2.8	70.5	30.4	17.1	7.3	21.4	4.5	5.2	2.3	1.4	0.3	31.4	26.1	0.1	4.5	0.1	1.3	0.3	0.5	6.8	5.0	10.3	8.0	2.2	1.9	51.3	0.3	4.6	0.4	60.0	2.4	0.2	6.0	5.2	0.4	7.4	2.0	1.3	7.9	5.6	8.5	1.8	0.3	4.8	0.2	1.8	0.6	2.7	2.6	10.1	70.3	3.8	5.1	0.1	5.4	0.3	0.3	3.3	1.3	4.9	3.2	0.0	11.7	0.0	1.9	5.3	7.6	0.0	1.4	1.5	3.0	0.0	0.0	0.2	0.1	2.8	4.9	3.9	0.0	1.5	10.8	19.5	2.7	14.3	9.3	8.2	25.9	7.2	14.4	17.4
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"Promyelocytic leukemia"	P29590	15	73994673-74047812	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"				"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favourable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavourable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	46.2	15.4	13.5	29.9	13.0	30.0	50.0	11.4	17.2	24.7	21.9	8.3	22.1	16.9	29.4	22.1	19.3	23.0	25.6	17.6	10.7	7.5	20.5	12.9	37.2	27.3	11.9	12.4	21.2	11.0	9.6	15.0	22.4	16.1	21.2	8.7	14.6	38.0	27.7	18.7	24.2	19.6	20.1	14.3	25.9	21.4	8.7	13.1	25.3	25.9	23.3	23.0	20.7	35.6	11.8	12.9	19.1	18.2	12.7	13.2	7.8	13.8	5.2	4.6	4.4	13.2	18.7	15.9	7.2	12.8	22.3	25.8	5.5	25.0	6.2	25.4	12.9	25.5	6.3	14.4	3.2	21.7	9.7	13.4	8.2	6.0	15.3	12.7	12.3	35.1	10.4	15.1	7.9	15.5	11.3	11.1	13.1	6.5	10.4	19.9	5.0	9.6	8.1	5.5	11.6	24.9	23.1	4.0	4.4	11.5	6.3	17.1	4.9	10.7	25.8	22.6	6.2	11.2	14.3	11.6	7.3	3.0	15.6	16.2	7.2	5.4	12.7	19.1	12.4	18.0	9.6	11.8	9.9	13.2	12.9	9.8	8.1	8.2	11.0	12.7	18.2	8.3	12.9	7.8	13.5	13.0	11.4	17.2	10.7	7.5	11.9	12.4	16.1	13.1
PNLIP	PL	ENSG00000175535	"Pancreatic lipase"	P16233	10	116545931-116567855	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1895	"pancreas: 3207.8"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;HDLM-2: 2.7;U-2 OS: 4.5;U-251 MG: 1.0;U-266/84: 1.5"	"Cancer enriched"	"Detected in some"	4854	"pancreatic cancer: 2731.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.4"	"HPA062430, HPA062494"	Enhanced				"Secreted to digestive system"		13000000			"HPA062430: AB_2684761, HPA062494: AB_2684782"											"unprognostic (2.05e-2)"	"unprognostic (4.46e-2)"						0.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3207.8	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	1.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PNMT	PENT	ENSG00000141744	"Phenylethanolamine N-methyltransferase"	P11086	17	39667981-39670475	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 94.6;ductus deferens: 53.7;seminal vesicle: 40.7"	"Cell line enhanced"	"Detected in some"		"HEL: 4.7;K-562: 10.2;NB-4: 20.2;NTERA-2: 3.9;SCLC-21H: 5.5;SH-SY5Y: 5.0"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 27.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.0;T-cells: 2.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.3"	"Low region specificity"	"Detected in single"			"CAB017029, HPA043412, HPA051005"	Enhanced									"CAB017029: , HPA043412: AB_2630373, HPA051005: AB_2681306"	"unprognostic (1.50e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (3.95e-5)"	"unprognostic (4.27e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.75e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.87e-2)"	2.3	94.6	3.9	0.8	13.8	1.6	5.4	0.9	3.0	1.3	1.9	1.5	53.7	0.9	1.0	2.7	0.9	1.9	0.8	4.9	1.7	5.4	1.0	0.7	1.6	0.8	9.1	1.5	0.9	0.7	2.4	12.9	2.4	3.6	4.3	0.7	0.9	0.7	40.7	10.5	0.8	1.0	0.8	0.7	0.9	0.9	1.3	2.7	0.0	0.7	0.8	0.7	1.3	1.7	1.0	0.0	0.3	0.3	0.0	2.5	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.4	4.7	0.1	0.4	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	20.2	3.9	0.0	0.1	0.0	0.3	0.0	0.0	5.5	5.0	0.0	2.1	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	1.0	0.4	1.5	0.0	0.4	0.0	0.7	0.3	0.0	0.3	0.0	0.0	0.3	3.9	13.8	0.9	3.0	1.7	5.4	9.1	1.5	3.6	2.7
PNO1	"KHRBP1, RRP20"	ENSG00000115946	"Partner of NOB1 homolog"	Q9NRX1	2	68157844-68176238	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA056928			Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA056928: "	"unprognostic (1.81e-3)"	"unprognostic (4.83e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (5.88e-2)"	"unprognostic (1.66e-3)"	"prognostic unfavourable (3.04e-8)"	"unprognostic (5.82e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.13e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.74e-2)"	"unprognostic (7.66e-2)"	18.5	19.2	13.0	17.2	19.0	21.8	15.4	10.0	12.8	10.8	13.1	9.1	10.2	9.9	15.3	15.4	14.9	13.8	13.2	24.5	19.1	9.6	16.6	27.4	12.9	15.0	15.0	11.9	20.0	27.0	13.2	15.7	16.3	13.1	14.4	12.2	8.9	12.7	15.0	48.8	12.4	9.5	15.1	11.7	13.6	13.2	11.4	13.9	9.7	16.6	15.1	15.2	15.8	21.4	14.7	12.6	2.0	13.2	10.6	15.5	14.4	15.1	16.6	7.7	12.6	9.5	7.9	19.4	14.5	9.4	16.3	11.6	31.8	9.0	20.8	12.2	9.6	13.0	24.8	17.1	25.7	14.4	17.4	20.2	7.9	23.3	14.8	16.1	9.3	10.2	12.6	16.5	18.9	11.9	27.8	11.3	14.6	11.2	15.7	15.2	21.7	18.1	13.3	19.0	22.1	12.4	12.9	13.8	10.3	10.8	13.4	23.2	9.5	9.0	8.9	18.8	20.3	16.7	40.1	9.1	13.1	32.1	15.4	24.1	25.5	0.4	9.4	1.9	10.1	13.2	15.5	14.7	11.4	11.5	12.6	11.1	13.3	12.2	2.0	10.6	9.4	9.0	11.7	14.4	13.0	19.0	10.0	12.8	19.1	9.6	15.0	11.9	13.1	13.9
PNP	"NP, PUNP"	ENSG00000198805	"Purine nucleoside phosphorylase"	P00491	14	20468954-20477094	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 153.1"	"Cell line enhanced"	"Detected in many"		"HL-60: 81.4;U-937: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA001625	Enhanced		Supported	Cytosol			100000000	Cytosol		"HPA001625: AB_1854577"	"unprognostic (1.20e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.10e-1)"	"unprognostic (7.06e-2)"	"prognostic unfavourable (4.43e-4)"	"unprognostic (4.94e-3)"	"unprognostic (3.87e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-1)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.69e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.64e-3)"	24.7	7.6	9.5	15.0	14.0	69.4	15.7	13.9	11.8	9.5	19.1	6.2	25.2	29.4	5.9	153.1	34.0	7.8	15.7	12.1	11.5	8.4	49.7	24.2	18.3	13.2	13.5	3.4	3.6	11.0	8.7	8.4	45.3	17.7	6.0	16.1	3.8	9.2	7.9	3.3	10.6	32.0	9.8	16.3	18.0	17.0	4.5	12.5	7.0	7.1	21.7	19.1	7.5	14.7	13.1	20.7	4.1	12.4	15.7	33.7	12.1	13.2	17.9	3.8	8.6	4.3	3.5	11.7	13.6	6.4	11.1	11.0	10.3	12.2	35.4	15.8	7.2	14.3	20.1	25.6	14.8	11.4	17.7	29.6	15.3	17.0	4.0	81.4	15.4	2.3	9.3	33.5	14.8	47.3	14.5	22.1	13.9	12.3	23.9	48.0	10.8	29.9	20.2	5.7	13.7	39.4	12.6	16.6	3.7	26.0	33.2	2.1	12.2	14.5	37.9	7.6	10.1	17.1	23.0	10.2	17.0	40.1	6.5	92.8	0.7	4.0	12.4	4.1	18.1	11.5	33.7	11.2	20.3	20.0	20.7	13.1	12.9	16.3	1.6	15.7	10.6	11.7	6.9	12.1	9.5	14.0	13.9	11.8	11.5	8.4	13.5	3.4	17.7	12.5
PNPLA3	"adiponutrin, ADPN, C22orf20, dJ796I17.1, FLJ22012, iPLA2epsilon"	ENSG00000100344	"Patatin like phospholipase domain containing 3"	Q9NST1	22	43923739-43964488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Hydrolase, Transferase"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"liver: 31.1;retina: 39.3"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;LHCN-M2: 15.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA058058	Approved		Approved	Nucleoli,Mitochondria,Cytosol				Nucleoli	"Mitochondria, Cytosol"	"HPA058058: "	"unprognostic (4.74e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.52e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	2.8	0.4	0.5	0.7	1.0	0.3	4.0	0.3	2.4	0.8	1.3	0.4	0.0	1.0	0.5	1.9	0.4	1.1	0.5	0.9	0.8	0.6	4.6	31.1	1.4	0.4	0.3	1.8	0.5	0.2	0.6	0.2	0.4	2.2	0.2	0.2	39.3	0.9	0.2	2.2	5.3	0.6	0.2	0.5	0.6	0.3	0.5	0.3	0.0	0.2	0.0	0.3	0.2	0.4	1.2	0.7	1.8	0.6	0.9	0.8	0.0	3.9	1.2	13.3	5.4	3.8	4.2	0.4	2.4	1.4	3.3	7.1	3.8	7.0	0.0	2.0	4.0	3.3	8.3	3.9	2.7	0.0	0.7	0.2	3.1	7.1	6.1	0.0	0.2	4.8	3.0	10.4	0.5	0.4	0.0	0.0	15.0	0.6	0.2	0.0	9.1	0.0	0.0	7.2	0.1	1.4	0.2	1.2	0.1	2.7	1.0	3.7	4.2	4.5	0.4	1.3	4.0	0.1	0.1	0.0	0.0	0.0	11.4	0.0	4.7	1.5	0.6	0.4	0.5	0.4	0.3	0.7	0.4	0.3	0.2	1.2	0.6	0.8	1.8	0.9	0.3	0.7	0.2	0.0	0.5	1.0	0.3	2.4	0.8	0.6	0.3	1.8	2.2	0.3
PNPLA4	"DXS1283E, GS2, iPLA2eta"	ENSG00000006757	"Patatin like phospholipase domain containing 4"	P41247	X	7898247-7927739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA003656	Approved				"Intracellular and membrane"					"HPA003656: AB_1079033"	"unprognostic (2.97e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.17e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.29e-4)"	"prognostic unfavourable (5.37e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.42e-2)"	"unprognostic (6.30e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-1)"	"prognostic favourable (2.23e-12)"	"unprognostic (5.23e-2)"	"unprognostic (6.71e-3)"	"unprognostic (6.30e-2)"	"unprognostic (2.12e-1)"	11.3	18.1	12.6	6.0	18.8	4.7	13.9	5.0	11.5	8.9	8.9	8.5	13.3	11.2	9.2	11.4	13.2	15.0	6.2	24.0	10.9	11.9	26.5	39.8	5.8	6.3	12.0	8.7	14.0	21.0	13.3	17.0	4.7	12.2	8.0	7.5	13.1	18.9	10.7	40.9	10.8	10.5	7.4	11.2	5.4	11.5	7.8	10.6	7.2	23.6	21.1	8.9	6.6	9.5	13.2	18.3	7.6	10.4	9.0	10.3	8.4	18.6	7.6	1.2	19.3	0.4	0.2	5.2	5.8	0.6	10.1	6.2	7.7	6.9	5.9	0.0	1.9	11.0	0.0	19.5	17.3	0.2	13.7	4.2	14.8	16.1	12.8	7.3	6.2	13.2	20.0	5.1	12.1	7.0	16.4	0.2	0.1	4.9	0.1	7.2	20.4	16.3	0.1	0.1	6.5	13.3	8.5	11.1	5.6	17.6	7.3	9.9	11.3	5.5	4.0	0.1	5.1	15.5	0.1	8.9	0.1	11.1	0.1	0.1	1.6	5.2	9.8	7.6	5.4	10.4	6.2	12.3	7.8	5.9	18.3	13.2	10.3	9.8	0.7	9.0	9.7	13.5	4.8	8.4	12.6	18.8	5.0	11.5	10.9	11.9	12.0	8.7	12.2	10.6
PODXL	"Gp200, PC, PCLP"	ENSG00000128567	"Podocalyxin like"	O00592	7	131500262-131558217	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 36.0;NTERA-2: 48.7;TIME: 54.4;U-251 MG: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA002110, CAB016169, HPA045507, CAB062558, CAB068219, CAB068220"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"			43000000	"Plasma membrane, Centriolar satellite"	Vesicles	"CAB016169: AB_628165, CAB062558: , CAB068219: , CAB068220: , HPA002110: AB_1855512, HPA045507: AB_2679356"	"unprognostic (1.26e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.28e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.16e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.95e-3)"	"unprognostic (3.52e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.40e-1)"	"prognostic favourable (2.89e-4)"	"unprognostic (2.56e-1)"	"unprognostic (8.78e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.03e-1)"	8.8	4.9	8.2	3.8	8.9	0.8	7.6	4.8	13.5	11.7	5.0	4.6	16.0	2.8	14.5	2.7	4.4	22.1	7.9	19.3	6.7	6.7	30.6	3.0	14.7	2.6	7.2	5.9	6.1	20.4	7.5	4.0	12.5	15.2	4.5	3.7	15.5	9.1	27.8	5.7	3.8	4.8	12.8	8.1	2.9	4.6	3.5	6.6	0.0	14.0	5.2	2.5	6.1	8.3	1.1	0.3	2.2	0.3	0.4	0.8	0.3	5.0	2.4	4.1	1.8	0.1	0.0	0.3	0.6	0.5	1.8	0.7	12.3	7.9	0.0	11.8	36.0	3.6	4.0	0.0	1.2	0.6	2.0	0.0	15.0	0.2	0.1	0.4	0.4	0.0	0.0	6.5	0.0	14.5	1.2	0.2	1.5	1.4	0.0	0.0	48.7	4.9	2.0	7.3	1.5	0.2	2.2	3.7	0.9	4.4	0.5	0.0	0.4	0.1	54.4	0.7	2.9	7.4	21.6	0.3	0.5	0.1	2.8	2.0	4.3	0.7	0.3	2.2	0.6	0.2	0.5	0.3	0.5	0.8	0.0	1.1	0.4	0.4	1.1	0.4	0.2	0.3	0.4	0.3	8.2	8.9	4.8	13.5	6.7	6.7	7.2	5.9	15.2	6.6
POGZ	"KIAA0461, ZNF280E, ZNF635m"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459465	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavourable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (4.40e-4)"	11.6	15.2	18.3	15.6	20.1	23.5	18.2	40.6	24.8	16.1	17.8	22.2	21.9	10.0	24.2	39.0	11.0	23.9	17.7	12.4	15.4	13.5	16.9	14.4	13.9	12.7	18.7	20.7	37.4	13.2	33.0	26.8	10.4	17.3	17.8	14.5	17.1	15.4	17.6	15.4	24.1	13.0	19.3	20.3	16.7	13.1	21.2	21.8	20.3	21.6	7.4	13.9	15.0	17.6	5.2	4.0	7.8	2.6	2.9	5.6	1.8	9.8	13.0	32.6	18.4	14.6	14.2	11.2	8.7	8.0	10.0	10.5	14.5	10.4	20.9	15.2	11.0	8.7	18.8	9.3	13.1	17.7	10.5	12.7	17.7	8.3	10.8	17.6	13.1	12.5	7.7	11.0	13.3	15.9	11.9	20.2	9.8	25.4	19.4	11.5	23.1	7.8	19.0	15.6	10.7	10.8	16.3	17.8	18.2	14.7	12.5	14.5	16.3	23.1	13.2	12.1	14.6	10.0	12.6	14.7	12.6	40.5	8.7	9.4	10.2	7.8	2.5	5.5	4.2	2.1	3.6	5.0	4.2	5.6	2.2	5.2	4.3	4.2	4.8	2.9	2.6	4.0	2.9	1.8	18.3	20.1	40.6	24.8	15.4	13.5	18.7	20.7	17.3	21.8
POLB		ENSG00000070501	"DNA polymerase beta"	P06746	8	42338454-42371808	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Lyase, Nucleotidyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell line enhanced"	"Detected in all"		"HMC-1: 79.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011616, HPA049104"	Enhanced		Uncertain	Vesicles				Vesicles		"CAB011616: AB_731977, HPA049104: "	"unprognostic (1.67e-1)"	"unprognostic (2.68e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (1.46e-4)"	"unprognostic (8.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.57e-2)"	"unprognostic (4.77e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.22e-2)"	"prognostic favourable (5.65e-4)"	5.5	8.6	10.1	9.5	10.7	21.9	13.5	73.6	16.6	7.0	5.5	5.8	6.0	4.9	6.2	11.2	12.4	6.3	11.3	16.3	9.8	9.6	7.2	15.8	9.1	11.8	8.4	10.3	10.3	7.7	10.3	11.6	5.0	10.9	11.4	6.3	6.8	22.1	6.9	36.6	10.8	4.9	6.6	10.0	8.1	6.4	29.5	5.4	9.7	7.7	17.2	10.1	11.5	9.2	4.9	33.8	25.1	9.4	7.9	7.2	4.2	10.8	6.5	11.3	22.5	6.3	6.0	9.5	6.9	8.0	11.5	10.6	9.1	12.7	9.8	8.8	4.4	5.5	9.4	8.1	14.2	6.4	10.2	7.1	5.4	12.3	9.7	5.0	79.7	5.3	9.6	8.5	10.0	8.7	15.5	6.3	11.1	6.4	20.7	14.2	15.2	7.5	11.9	11.4	8.4	21.6	8.8	6.4	11.7	8.2	5.5	20.9	14.7	8.6	4.8	5.5	7.7	13.7	6.7	9.2	15.3	13.9	5.5	10.7	14.3	12.5	5.9	17.3	4.9	7.2	5.5	4.9	5.2	5.3	6.1	4.5	5.8	5.4	25.1	7.9	9.4	33.8	7.2	4.2	10.1	10.7	73.6	16.6	9.8	9.6	8.4	10.3	10.9	5.4
POLD1	"CDC2, POLD"	ENSG00000062822	"DNA polymerase delta 1, catalytic subunit"	P28340	19	50384204-50418016	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Exonuclease, Hydrolase, Nuclease, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004375, HPA046524"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB004375: AB_675487, HPA046524: "	"unprognostic (2.45e-1)"	"unprognostic (7.02e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavourable (2.87e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.08e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.01e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.70e-2)"	7.9	5.7	5.4	18.3	9.9	31.6	6.6	9.4	5.4	8.2	10.0	6.1	5.9	6.8	9.5	7.2	11.3	6.9	5.2	5.5	4.4	3.2	7.6	9.3	10.9	15.7	7.0	3.6	8.2	8.4	5.2	5.1	10.9	6.7	6.3	5.2	4.9	8.1	5.4	7.2	13.1	9.9	6.2	7.7	14.1	6.5	13.2	6.5	27.4	12.1	8.1	14.2	5.9	7.8	9.3	10.5	2.1	8.5	5.4	7.3	5.6	18.1	25.0	13.7	7.9	1.7	1.5	14.1	11.3	5.0	13.9	17.8	13.6	14.4	26.0	6.4	3.4	14.9	16.2	12.3	4.8	21.9	43.5	22.6	24.2	17.9	1.6	21.5	20.0	2.9	3.8	12.6	3.8	7.1	24.3	20.2	5.8	12.2	33.3	33.7	16.1	18.2	33.1	23.0	22.8	4.4	17.3	14.3	12.9	11.2	13.8	2.6	7.6	20.4	5.6	7.1	23.0	7.6	19.8	19.1	31.4	27.8	7.7	24.3	6.9	1.6	6.2	2.1	7.3	7.8	6.2	7.8	6.5	5.9	5.7	9.3	6.5	5.9	1.1	5.4	8.5	10.5	4.5	5.6	5.4	9.9	9.4	5.4	4.4	3.2	7.0	3.6	6.7	6.5
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114681-44124358	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	17.2	19.1	17.5	14.3	16.7	16.3	33.9	14.3	25.9	15.8	15.4	17.1	12.6	13.9	16.1	9.7	27.5	34.5	14.5	35.9	16.3	13.8	15.9	43.6	15.3	16.2	15.2	14.7	24.4	49.0	18.9	17.9	12.9	15.0	15.9	12.9	17.4	19.9	14.3	42.6	19.3	11.5	15.7	13.7	11.9	16.0	14.4	14.8	27.7	20.3	25.1	15.8	13.4	16.7	28.1	37.0	3.2	13.7	13.3	29.3	21.3	26.1	34.6	19.3	40.4	17.2	18.5	19.2	16.2	16.3	22.2	16.6	29.2	25.2	60.6	20.7	23.2	36.3	31.6	44.1	14.5	17.2	37.1	13.4	37.2	24.6	19.6	40.7	16.4	16.8	27.0	34.3	33.5	18.6	48.8	29.1	24.5	42.7	49.6	77.1	30.3	34.0	33.5	25.9	86.0	19.3	16.9	38.3	30.0	20.1	72.7	13.8	42.0	52.6	14.5	29.5	37.2	36.1	50.5	45.9	67.8	58.1	26.4	41.3	41.6	0.5	13.7	3.2	17.9	12.4	26.8	28.1	21.6	18.2	23.2	27.3	29.3	21.4	1.1	13.3	11.8	37.0	17.0	21.3	17.5	16.7	14.3	25.9	16.3	13.8	15.2	14.7	15.0	14.8
POLE	POLE1	ENSG00000177084	"DNA polymerase epsilon, catalytic subunit"	Q07864	12	132623753-132687365	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 34.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 4.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA058210, HPA067385"			Supported	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA058210: , HPA067385: "	"unprognostic (1.60e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.00e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"prognostic unfavourable (3.19e-8)"	"unprognostic (8.60e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.95e-2)"	6.1	3.4	6.7	10.2	4.4	29.3	6.2	34.8	14.4	7.0	6.6	2.0	7.6	7.3	6.1	4.4	7.5	6.2	6.5	4.7	5.6	1.6	3.8	8.6	5.4	8.2	3.3	4.3	8.7	6.8	3.6	3.1	6.5	5.1	6.8	7.7	4.3	8.7	7.4	8.9	17.9	8.5	6.8	3.7	16.7	7.8	25.6	4.4	29.8	5.1	6.0	10.3	6.7	8.7	0.5	1.7	0.8	0.8	4.8	0.7	0.5	11.1	14.9	22.1	10.6	4.7	3.6	19.7	11.4	5.2	13.7	10.0	18.0	6.6	12.8	4.8	6.2	15.5	15.4	7.7	8.4	5.9	19.5	20.2	19.2	8.8	0.9	15.8	11.6	2.8	3.0	14.2	4.7	4.8	22.6	7.2	6.7	18.1	25.9	28.9	17.2	8.9	21.5	12.5	5.8	4.3	18.3	18.5	10.6	13.3	10.9	2.5	16.1	9.8	4.3	12.5	12.8	9.4	11.5	9.6	6.5	20.1	6.8	21.9	8.8	0.0	0.3	0.8	0.5	0.1	0.7	0.5	0.3	0.4	0.7	0.3	0.5	0.3	0.1	4.8	0.8	1.7	0.6	0.5	6.7	4.4	34.8	14.4	5.6	1.6	3.3	4.3	5.1	4.4
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA012035: , HPA057303: , HPA068117: , HPA069375: "	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	14.7	12.7	10.1	8.6	12.9	6.3	13.4	17.0	13.4	18.1	10.7	8.8	13.6	6.3	21.3	12.1	11.7	10.5	9.5	11.4	14.1	10.5	12.6	12.3	12.2	9.2	14.1	12.9	15.5	11.1	18.5	23.9	15.2	17.2	13.9	8.1	6.5	10.2	10.5	15.2	10.3	9.2	15.4	16.9	13.1	9.0	9.8	12.4	12.1	18.8	9.3	8.9	12.7	10.2	7.0	7.5	6.0	13.3	4.6	4.5	2.5	6.4	6.6	4.1	5.2	5.4	10.9	3.5	12.3	8.7	9.6	10.0	4.2	5.2	6.6	10.1	8.1	2.5	3.8	4.2	11.5	7.3	4.4	6.0	5.8	1.9	10.4	3.8	4.9	5.0	5.2	7.7	5.3	8.0	5.3	3.9	9.0	0.5	7.5	3.1	1.5	3.9	3.2	10.5	4.6	5.8	2.2	4.2	4.6	9.2	2.5	3.3	3.6	3.7	10.0	7.0	3.6	3.3	7.0	4.5	4.1	5.9	4.7	6.1	12.0	5.7	7.1	3.4	3.3	7.9	2.9	7.0	3.7	4.0	6.1	5.4	4.5	3.0	6.0	4.6	13.3	7.5	4.1	2.5	10.1	12.9	17.0	13.4	14.1	10.5	14.1	12.9	17.2	12.4
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"				"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: , HPA049700: "	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.3	21.3	9.5	18.3	9.3	7.5	13.8	8.6	5.7	12.4	7.7	26.7	7.4	21.5	9.2	8.8	10.9	24.5	12.7	11.1	8.9	12.6	18.5	9.1	17.9	6.6	17.5	10.0	5.7	8.0	18.4	14.4	9.6	24.5	5.4	8.5	8.3	12.9	7.5	17.3	14.1	15.6	20.9	10.0	5.5	15.4	14.8	7.7	9.5	12.6	6.8	7.4	6.1	15.2	15.1	11.9	12.8	17.3	7.7	7.4	18.8	7.8	15.1	13.3	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9
POLR1B	"FLJ10816, FLJ21921, RPA2, Rpo1-2"	ENSG00000125630	"RNA polymerase I subunit B"	Q9H9Y6	2	112541915-112577150	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037528			Supported	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA037528: AB_10671627"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (2.71e-5)"	"unprognostic (2.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (5.52e-4)"	"unprognostic (6.12e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	8.8	11.0	6.4	10.6	6.8	4.9	15.7	8.0	8.2	7.6	7.0	7.7	8.6	5.8	9.3	7.4	12.8	9.2	9.2	6.1	5.7	6.1	11.3	20.5	8.0	11.3	6.8	3.7	11.3	25.2	20.7	11.5	7.2	5.2	7.7	8.5	7.3	10.0	8.3	14.7	9.2	8.0	7.9	4.8	11.4	8.1	15.7	5.0	9.6	15.7	11.5	14.6	8.9	11.8	9.4	11.0	2.5	6.3	10.2	17.1	7.3	9.4	9.9	6.3	13.0	6.8	6.6	11.8	7.1	5.4	12.0	10.5	22.2	5.6	22.7	10.6	4.7	13.3	26.4	14.5	13.9	10.2	13.3	13.1	9.9	16.7	7.2	20.9	9.1	6.2	10.5	12.5	19.3	9.3	23.7	8.2	6.3	8.3	9.4	13.6	30.6	19.7	14.2	10.4	24.1	8.3	9.0	15.9	14.8	6.5	16.5	9.0	7.6	7.4	8.4	7.4	10.9	6.8	10.4	11.1	18.3	19.6	5.6	13.4	6.2	0.2	6.0	2.5	8.3	6.3	17.1	9.4	8.4	8.9	11.0	9.3	10.3	10.4	0.4	10.2	4.8	2.6	11.3	7.3	6.4	6.8	8.0	8.2	5.7	6.1	6.8	3.7	5.2	5.0
POLR2B	RPB2	ENSG00000047315	"RNA polymerase II subunit B"	P30876	4	56977722-57031168	"Enzymes, Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037506	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037506: AB_10672597"	"unprognostic (9.88e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.83e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.21e-3)"	"unprognostic (1.24e-3)"	"unprognostic (3.51e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.95e-1)"	"prognostic favourable (7.17e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.35e-2)"	24.5	34.3	31.1	34.6	31.0	21.4	24.8	43.8	33.3	25.9	26.0	18.8	24.9	22.5	35.1	21.4	27.4	28.3	21.2	32.9	29.3	21.7	26.2	21.4	21.2	32.4	28.0	30.2	26.4	28.1	40.7	37.3	25.4	28.3	24.8	26.5	18.4	30.5	28.2	61.8	24.4	27.3	27.6	26.4	27.1	28.8	26.6	26.8	33.4	27.0	34.7	35.1	31.5	22.4	19.8	15.2	27.8	13.9	18.0	23.8	12.7	24.7	20.7	37.4	31.6	30.9	27.9	20.0	33.0	33.6	33.1	31.0	26.3	25.0	38.6	31.3	30.5	17.6	44.9	25.1	47.4	18.3	20.1	29.0	23.1	22.9	35.8	49.9	33.6	30.0	25.3	37.8	23.1	39.4	43.1	33.0	38.1	18.1	47.0	19.3	30.8	24.3	34.3	24.6	21.2	22.6	28.2	31.2	35.0	20.5	39.1	28.4	21.0	27.8	28.7	24.1	32.4	25.2	43.3	26.6	25.3	56.3	27.5	27.0	29.8	27.8	12.2	16.8	20.7	12.4	22.0	19.8	20.3	21.4	15.2	14.4	19.9	23.8	11.3	18.0	13.9	12.9	20.9	12.7	31.1	31.0	43.8	33.3	29.3	21.7	28.0	30.2	28.3	26.8
POLR2D	RBP4	ENSG00000144231	"RNA polymerase II subunit D"	O15514	2	127843551-127858157	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034694, HPA046092"	Approved		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA034694: , HPA046092: AB_10963049"	"unprognostic (3.57e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (8.91e-4)"	"unprognostic (2.51e-1)"	"unprognostic (7.95e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.66e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.38e-1)"	8.2	9.4	8.1	8.9	9.1	17.9	7.9	9.3	12.6	6.9	7.7	12.3	6.9	6.3	7.5	6.2	9.8	7.7	7.6	7.3	7.8	6.3	6.3	13.5	7.2	11.8	9.9	7.5	10.3	17.4	7.4	9.4	10.2	8.7	7.2	9.9	7.3	7.6	6.5	21.9	8.9	7.8	9.8	8.8	11.1	7.8	46.4	9.9	16.7	6.3	9.1	16.8	8.0	7.2	16.7	20.6	11.4	22.1	16.7	21.0	14.3	18.2	11.9	22.2	15.5	8.3	9.1	17.8	17.5	8.3	21.1	18.9	26.9	15.1	28.4	15.1	11.7	9.7	31.8	15.1	32.8	16.6	17.3	28.0	11.9	24.7	9.7	30.0	15.6	6.4	11.4	28.2	16.2	13.7	39.0	25.5	12.0	14.5	29.8	13.7	31.1	13.8	28.7	23.5	25.5	7.0	12.5	13.8	18.5	11.8	14.6	14.7	16.3	20.8	13.8	18.3	25.8	10.3	20.1	30.1	48.7	51.0	15.9	15.0	18.0	5.7	15.8	11.4	19.4	21.5	18.1	16.7	15.6	16.9	20.6	15.1	21.0	17.8	5.0	16.7	22.1	13.5	13.9	14.3	8.1	9.1	9.3	12.6	7.8	6.3	9.9	7.5	8.7	9.9
POLR2L	"hRPB7.6, hsRPB10b, RBP10, RPABC5, RPB10beta, RPB7.6"	ENSG00000177700	"RNA polymerase II subunit L"	P62875	11	837356-842545	"Plasma proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 85.8;PC-3: 109.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (2.65e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.49e-2)"	"unprognostic (3.46e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (6.17e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (6.77e-2)"	"prognostic favourable (5.56e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.73e-1)"	42.9	27.7	22.4	18.4	18.3	16.9	63.3	10.1	18.8	16.6	28.3	9.9	29.7	18.7	14.1	23.8	37.5	15.0	28.5	86.7	19.2	17.3	32.9	43.3	26.3	21.2	18.8	10.7	16.6	88.3	14.8	21.1	21.0	12.5	19.3	11.5	23.0	41.6	35.4	44.8	17.3	18.9	21.5	13.5	19.2	17.1	18.3	9.3	18.7	37.9	41.8	15.7	17.6	21.0	28.6	52.3	43.0	44.1	41.7	38.6	42.2	15.7	85.8	8.1	10.0	23.4	17.1	7.3	20.3	14.2	20.0	13.4	25.0	14.7	9.9	5.6	25.2	10.6	12.1	24.3	6.3	9.1	59.1	9.4	25.5	31.6	13.9	9.0	7.7	28.0	11.0	11.4	5.7	15.8	9.9	11.0	23.6	39.6	9.1	9.5	12.7	109.9	8.9	6.5	15.1	24.2	12.1	16.4	5.2	20.2	20.7	15.5	12.4	5.4	17.6	13.6	10.7	7.4	12.5	6.7	7.6	9.6	20.6	8.9	11.9	26.4	44.1	43.0	36.1	38.4	38.6	28.6	34.4	35.7	41.7	26.0	29.5	35.6	11.5	41.7	25.9	52.3	33.0	42.2	22.4	18.3	10.1	18.8	19.2	17.3	18.8	10.7	12.5	9.3
POLR3A	"hRPC155, RPC1, RPC155"	ENSG00000148606	"RNA polymerase III subunit A"	O14802	10	77969251-78029545	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	"Nucleotidyltransferase, Transferase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037926	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA037926: AB_10672400"	"unprognostic (6.83e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavourable (3.64e-6)"	"unprognostic (3.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.11e-2)"	7.1	10.2	10.3	8.3	21.7	5.9	10.6	22.2	29.7	9.2	8.1	12.8	7.4	8.6	9.4	13.3	8.6	8.5	7.4	7.4	9.4	9.6	9.3	9.3	6.8	8.7	8.1	11.0	11.5	10.7	13.8	17.3	10.1	20.4	10.2	10.7	10.4	8.6	8.2	17.6	11.2	7.8	9.7	6.6	8.9	8.2	11.7	9.8	12.6	9.6	4.4	13.4	7.9	8.0	7.5	5.4	8.0	6.4	6.5	8.8	3.6	7.3	8.8	9.3	15.4	6.1	7.9	6.2	8.4	11.0	10.9	10.8	11.5	5.3	9.1	5.2	7.3	8.6	16.1	9.2	13.3	6.7	11.8	7.3	7.0	14.2	5.8	12.5	6.2	6.7	6.6	19.3	18.0	9.5	13.6	5.7	10.5	5.4	9.4	8.0	10.1	40.0	9.0	5.9	5.9	5.4	4.8	8.5	10.8	8.1	15.1	8.6	11.2	6.6	10.4	7.0	6.8	7.6	16.6	8.9	9.3	11.1	12.5	13.2	3.4	8.0	5.2	2.9	7.8	6.4	7.6	5.6	6.0	7.2	4.8	7.5	5.7	6.6	3.3	6.5	5.4	5.4	8.8	3.6	10.3	21.7	22.2	29.7	9.4	9.6	8.1	11.0	20.4	9.8
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.4;RH-30: 1.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favourable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
PON3		ENSG00000105852	"Paraoxonase 3"	Q15166	7	95359944-95396368	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 148.0"	"Cell line enhanced"	"Detected in some"		"A549: 19.8;CACO-2: 6.4;CAPAN-2: 4.8;Hep G2: 21.9;T-47d: 12.3"	"Group enriched"	"Detected in many"	9	"liver cancer: 30.8;lung cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"NK-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014848, CAB025250"	Enhanced				"Secreted to blood"	1756666667	350000000			"CAB025250: , HPA014848: AB_1855540"	"unprognostic (2.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.28e-3)"	"unprognostic (5.52e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.30e-9)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.29e-2)"	"unprognostic (5.12e-2)"	0.4	0.7	0.3	0.1	0.6	0.0	6.9	0.2	0.5	0.9	1.0	0.3	2.3	1.5	0.2	1.2	0.2	0.4	0.7	0.4	0.7	0.3	0.7	148.0	4.0	0.0	0.4	0.2	2.4	7.1	0.0	15.5	0.2	0.5	0.2	0.4	0.8	21.4	5.5	0.1	1.8	1.7	0.1	0.3	0.2	0.5	3.6	0.4	0.4	1.5	0.0	1.1	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	2.1	19.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	4.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	12.3	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.5	0.7	0.3	0.4	0.2	0.5	0.4
POP1		ENSG00000104356	"POP1 homolog, ribonuclease P/MRP subunit"	Q99575	8	98117297-98159834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066194			Supported	Nucleoli				Nucleoli		"HPA066194: "	"prognostic unfavourable (2.54e-4)"	"unprognostic (9.42e-2)"	"unprognostic (5.96e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (1.26e-6)"	"prognostic unfavourable (9.88e-4)"	"unprognostic (4.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.39e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.96e-1)"	6.1	5.5	7.8	9.0	9.7	3.7	5.8	14.3	10.2	4.3	5.4	5.2	2.7	4.3	6.0	4.2	9.1	6.6	3.9	5.0	5.7	4.7	10.5	6.4	5.2	9.1	4.1	7.6	8.4	5.8	7.6	11.1	3.5	7.4	5.0	13.8	6.2	5.1	4.2	5.7	8.2	5.1	5.2	4.0	8.8	5.7	11.8	6.2	8.8	5.0	5.6	11.3	4.3	5.0	10.5	7.7	10.9	7.4	4.1	9.8	2.5	12.6	7.6	8.3	7.7	2.9	2.1	5.5	10.9	9.2	11.4	8.5	7.8	8.2	8.9	15.7	7.9	8.5	24.2	10.8	12.3	6.4	10.2	17.8	6.1	5.3	1.3	9.4	11.2	1.7	2.0	12.6	5.0	8.8	9.7	8.1	10.6	10.1	13.6	4.8	6.3	10.6	11.3	4.9	6.4	8.3	6.8	20.0	4.7	5.0	8.5	3.8	11.6	3.5	12.0	10.0	7.2	12.6	21.5	8.1	7.6	19.2	7.8	10.2	8.7	10.9	6.7	4.6	9.8	7.4	7.8	6.2	7.1	6.5	6.2	10.5	9.3	8.6	0.9	4.1	3.4	7.7	5.9	2.5	7.8	9.7	14.3	10.2	5.7	4.7	4.1	7.6	7.4	6.2
POR	"CYPOR, FLJ26468"	ENSG00000127948	"Cytochrome p450 oxidoreductase"	P16435	7	75899200-75986855	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Congenital adrenal hyperplasia, Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004372, HPA010136"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"CAB004372: AB_627391, HPA010136: AB_1079657"	"unprognostic (1.89e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.81e-3)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.65e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.94e-2)"	"unprognostic (9.89e-2)"	12.8	48.2	7.4	7.5	10.8	3.6	15.0	5.3	16.4	11.0	20.8	9.6	32.1	24.9	9.0	8.2	13.4	12.8	9.9	8.4	7.1	7.2	12.0	78.4	13.7	9.9	5.2	10.1	14.4	12.8	12.1	18.5	18.6	7.1	9.3	5.3	10.8	7.8	58.7	13.1	10.0	24.3	7.0	5.2	11.7	9.8	22.4	5.0	8.2	33.3	9.9	8.6	9.8	10.2	5.7	20.6	26.7	18.4	11.2	9.9	13.9	12.7	27.9	12.8	23.7	48.5	18.4	21.4	5.3	17.5	10.1	14.1	20.9	56.7	12.2	4.9	11.6	6.2	16.8	8.4	4.3	10.4	12.4	5.6	8.2	38.7	33.7	5.6	10.1	37.8	10.6	13.3	9.7	9.4	16.9	5.3	9.1	18.7	6.1	10.1	15.9	15.8	8.7	8.4	13.1	11.4	15.4	13.4	12.8	14.4	73.3	19.3	21.0	9.6	8.4	9.5	10.5	14.3	10.5	5.2	8.0	8.3	13.4	8.6	12.2	26.7	18.4	25.3	9.9	17.7	8.3	5.4	8.4	9.2	20.6	5.7	8.4	7.1	24.3	11.2	13.0	5.8	8.7	13.9	7.4	10.8	5.3	16.4	7.1	7.2	5.2	10.1	7.1	5.0
POSTN	"OSF-2, periostin, PN"	ENSG00000133110	Periostin	Q15063	13	37562583-37598844	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 77.4;U-138 MG: 98.9;U-2197: 67.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 231.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012306	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to extracellular matrix"		740000000	"Golgi apparatus"	Nucleoplasm	"HPA012306: AB_1854827"	"unprognostic (7.73e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.19e-3)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (3.05e-3)"	"unprognostic (7.10e-2)"	"unprognostic (1.32e-2)"	"unprognostic (5.93e-2)"	"prognostic unfavourable (1.83e-7)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.32e-3)"	60.9	2.0	5.3	12.7	4.0	0.0	26.9	0.5	2.7	17.6	14.1	0.6	11.7	0.6	29.0	20.0	16.5	20.3	14.5	34.1	6.2	0.5	47.5	3.0	28.4	19.5	0.5	1.1	21.0	3.1	8.2	1.7	17.3	2.5	12.4	19.7	0.8	10.8	10.2	14.2	46.1	9.6	14.5	1.7	0.7	37.3	21.5	0.1	3.1	8.0	5.5	1.7	23.5	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.2	13.7	8.3	0.0	3.5	0.0	0.8	0.1	0.0	0.2	0.0	0.0	2.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	14.6	0.0	77.4	0.3	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	98.9	0.0	67.3	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.0	0.5	2.7	6.2	0.5	0.5	1.1	2.5	0.1
POTEE	"A26C1, A26C1A, CT104.2, POTE-2, POTE2, POTE2gamma"	ENSG00000188219	"POTE ankyrin domain family member E"	Q6S8J3	2	131218067-131265278	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 2.4;prostate: 2.0;testis: 4.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.7;BEWO: 3.5;K-562: 3.6;U-2 OS: 6.8;U-266/84: 2.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA041264, HPA041271, HPA043260"	Uncertain									"HPA041264: , HPA041271: , HPA043260: "	"unprognostic (3.13e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.59e-3)"		"unprognostic (3.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.61e-3)"	"unprognostic (5.77e-2)"	"unprognostic (7.60e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.6		2.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.9			0.0		0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	2.4	0.1	0.0	0.2	2.7	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.1	0.7	2.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4										
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 associating factor 1"	Q16633	11	111352252-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.2;lymphoid tissue: 84.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 45.4;Karpas-707: 52.0;U-266/70: 50.7;U-266/84: 22.8;U-698: 93.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"memory B-cell: 19.9;naive B-cell: 14.2"	"Lineage enriched"	"Detected in many"	13	"B-cells: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011193	Enhanced									"CAB011193: AB_532299"	"prognostic favourable (1.68e-4)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	0.9	0.5	0.6	62.7	0.7	2.0	1.4	0.4	0.6	1.9	7.8	1.8	0.0	6.7	0.7	0.3	8.7	1.1	1.4	0.5	0.8	0.7	2.1	1.0	2.6	42.6	1.0	0.5	1.2	0.5	0.0	0.4	0.5	1.2	1.3	4.1	1.2	8.4	0.9	0.4	0.4	21.2	0.0	1.4	74.2	12.2	1.0	0.9	5.0	1.7	1.4	84.0	5.0	1.4	19.9	0.1	1.5	0.2	0.3	0.7	0.6	0.1	0.1	0.0	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	45.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.7	52.0	0.0	0.1	0.2	0.2	0.0	0.0	9.7	0.1	12.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.4	0.0	0.0	50.7	22.8	93.3	0.0	0.1	0.0	1.5	0.1	0.3	0.1	0.1	0.1	19.9	0.2	0.1	0.0	14.2	0.2	0.1	0.9	0.3	0.2	0.1	0.7	0.6	0.6	0.7	0.4	0.6	0.8	0.7	1.0	0.5	1.2	0.9
PPA2	FLJ20459	ENSG00000138777	"Pyrophosphatase (inorganic) 2"	Q9H2U2	4	105369077-105474081	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030888, HPA031671, HPA031672"	Supported		Approved	Nucleoplasm,Mitochondria			8300	Mitochondria	Nucleoplasm	"HPA030888: , HPA031671: AB_10603986, HPA031672: AB_2673988"	"prognostic unfavourable (2.98e-4)"	"unprognostic (5.64e-2)"	"prognostic favourable (6.60e-4)"	"unprognostic (9.26e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.54e-2)"	"prognostic favourable (1.27e-11)"	"unprognostic (3.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.10e-1)"	9.2	18.0	18.4	17.2	15.4	24.0	20.6	12.3	17.6	10.2	19.8	9.3	20.3	18.1	13.3	20.7	14.8	10.7	18.7	42.5	15.6	15.3	23.7	21.2	23.1	34.8	17.2	12.1	9.5	25.0	10.4	15.0	9.3	15.4	16.1	16.7	12.6	21.4	26.8	29.6	15.0	16.8	22.8	12.4	12.1	15.0	9.7	10.7	9.4	14.3	28.2	10.6	12.2	9.5	20.0	35.3	14.7	20.8	22.0	17.0	14.6	11.5	5.5	10.7	18.1	6.8	5.5	7.8	6.5	8.6	8.0	5.7	12.1	17.0	9.5	8.7	5.3	5.8	21.4	10.3	9.5	13.4	7.6	8.5	8.9	11.0	5.4	20.1	8.2	5.3	10.7	5.5	4.3	7.7	14.1	13.1	7.3	14.6	17.1	14.5	7.8	18.7	15.2	6.6	9.3	26.5	8.9	11.0	6.6	4.5	26.7	9.4	14.0	16.4	4.1	5.8	11.3	6.2	11.3	11.6	14.6	9.9	10.1	10.9	7.8	14.7	15.0	9.7	15.3	20.8	13.3	20.0	16.0	16.2	35.3	16.6	15.5	17.0	6.4	22.0	16.2	17.7	15.9	14.6	18.4	15.4	12.3	17.6	15.6	15.3	17.2	12.1	15.4	10.7
PPAN	"BXDC3, SSF, SSF1, SSF2"	ENSG00000130810	"Peter pan homolog (Drosophila)"	Q9NQ55	19	10106289-10111634	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043265	Approved									"HPA043265: AB_10793943"	"unprognostic (1.91e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.93e-2)"	"unprognostic (4.23e-2)"	"unprognostic (9.47e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (8.75e-3)"	"unprognostic (7.52e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.92e-3)"	18.9	17.5	15.9	26.0	23.2	19.2	17.8	21.5	21.7	14.9	15.1	15.3	8.8	20.8	18.7	14.4	24.6	17.3	13.1	14.9	15.0	12.2	13.0	22.3	13.5	29.3	15.0	15.7	22.1	25.3	16.9	13.2	14.0	14.8	17.8	11.3	13.5	19.5	15.1	27.4	27.2	17.2	15.5	10.8	24.7	16.4	19.7	19.6	23.3	14.8	17.5	25.3	15.0	17.5	13.8	6.0	4.2	6.4	5.6	12.0	2.8	13.6	11.5	4.4	9.7	3.1	3.3	9.9	7.7	3.5	9.5	7.4	15.2	5.2	15.9	14.0	4.6	11.7	11.8	13.0	4.2	8.7	31.8	29.2	12.7	15.1	7.9	17.9	17.3	5.1	10.2	10.3	13.2	4.7	20.9	14.5	4.9	20.2	21.6	67.5	21.0	32.1	15.9	5.7	21.7	5.3	11.8	9.4	11.5	6.7	11.7	10.4	6.4	9.5	5.8	12.7	7.0	14.0	19.2	32.0	15.1	16.6	8.7	15.6	11.1	1.6	6.4	3.1	7.0	4.7	9.2	13.8	8.9	11.6	6.0	13.2	12.0	6.3	4.2	5.6	3.3	4.5	8.0	2.8	15.9	23.2	21.5	21.7	15.0	12.2	15.0	15.7	14.8	19.6
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 47.4;ASC TERT1: 27.0;BEWO: 55.9;CAPAN-2: 25.0;HSkMC: 27.8;PC-3: 24.9;RT4: 34.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: , HPA063663: "	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavourable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favourable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favourable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.6	8.6	0.0	0.0	47.4	27.0	55.9	0.9	10.4	1.3	0.5	1.8	25.0	0.0	0.0	0.9	3.9	3.4	0.1	0.2	23.2	4.8	0.0	1.9	2.3	12.6	0.0	0.0	27.8	2.3	2.3	9.0	0.1	0.0	0.0	2.0	2.4	0.0	0.1	0.1	24.9	0.0	0.0	0.0	7.1	34.1	0.0	0.2	4.0	1.5	0.5	0.0	7.7	7.8	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6
PPBP	"b-TG1, Beta-TG, CTAP3, CTAPIII, CXCL7, LA-PF4, LDGF, MDGF, NAP-2, NAP-2-L1, PBP, SCYB7, TGB, TGB1, THBGB1"	ENSG00000163736	"Pro-platelet basic protein"	P02775	4	73987038-73988197	"Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Cytokine, Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 206.7;bone marrow: 67.0;lymphoid tissue: 60.0"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.0;HEL: 11.7;RPTEC TERT1: 2.7"	"Cancer enriched"	"Detected in many"	7	"colorectal cancer: 86.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"basophil: 30.0;neutrophil: 18.4"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 30.0"					"Low region specificity"	"Detected in all"			"HPA008354, CAB017624"	Supported				"Secreted to blood"	24540000	3500000000			"CAB017624: AB_1127132, HPA008354: AB_1847353"	"unprognostic (2.13e-1)"	"prognostic unfavourable (6.17e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.15e-3)"	"unprognostic (2.59e-2)"	1.4	0.6	0.4	0.6	1.7	67.0	0.6	0.2	0.4	0.5	0.2	0.1	0.0	0.1	0.3	0.5	0.5	0.8	0.9	35.7	0.3	0.3	0.5	1.9	13.3	0.1	1.6	0.0	6.0	0.4	0.1	0.5	8.7	1.3	0.6	0.2	0.4	0.5	0.1	1.0	0.3	0.2	0.2	1.3	60.0	0.3	0.5	0.0	0.0	2.2	0.9	0.1	1.7	11.0	0.3	2.6	30.0	1.8	0.2	0.5	206.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	30.0	1.8	1.1	0.2	0.6	0.3	0.1	0.1	0.0	1.0	0.3	0.5	0.1	18.4	0.2	0.5	2.6	0.2	206.7	0.4	1.7	0.2	0.4	0.3	0.3	1.6	0.0	1.3	0.0
PPEF1	"PPEF, PPP7CA"	ENSG00000086717	"Protein phosphatase with EF-hand domain 1"	O14829	X	18675909-18827921	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;testis: 20.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.5;HeLa: 5.1;SH-SY5Y: 2.9;SK-MEL-30: 1.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034577			Uncertain	"Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Cytokinetic bridge"	"HPA034577: AB_10602817"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.96e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.10e-11)"	"unprognostic (5.41e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.19e-2)"	0.1	0.5	3.1	0.2	6.4	1.4	3.9	0.2	10.6	0.2	0.2	0.1	0.0	0.1	0.3	0.9	0.2	0.2	0.3	0.3	1.9	1.0	0.3	0.1	0.4	0.3	1.7	6.9	0.2	0.2	0.1	0.7	1.0	0.2	0.5	0.1	0.0	0.3	0.6	0.1	0.7	0.1	0.2	10.5	0.3	0.1	20.2	0.0	0.1	0.4	0.0	0.3	0.4	0.1	0.2	1.3	0.0	0.9	0.0	0.0	0.2	0.0	3.5	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	1.2	0.0	5.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.3	2.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.1	6.4	0.2	10.6	1.9	1.0	1.7	6.9	0.2	0.0
PPFIA4		ENSG00000143847	"PTPRF interacting protein alpha 4"	O75335	1	203026498-203078740	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"brain: 72.6;heart muscle: 26.2;skeletal muscle: 20.4"	"Cell line enhanced"	"Detected in many"		"A-431: 7.7;LHCN-M2: 6.5;RH-30: 13.7;U-266/70: 8.6;U-87 MG: 12.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 72.6;cerebral cortex: 21.1"	"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053419, HPA054132"	Enhanced									"HPA053419: , HPA054132: "	"unprognostic (2.83e-1)"	"unprognostic (2.34e-3)"	"unprognostic (3.38e-5)"	"unprognostic (3.19e-1)"	"unprognostic (6.58e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.49e-8)"	"unprognostic (4.65e-1)"	"unprognostic (6.01e-4)"	"unprognostic (1.29e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.73e-8)"	"unprognostic (6.82e-3)"	"unprognostic (9.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.28e-2)"	0.6	1.3	9.2	1.0	10.9	1.6	0.9	72.6	21.1	1.8	1.0	1.4	0.0	1.1	1.7	3.5	1.3	1.2	2.6	26.2	6.6	5.0	1.9	0.6	1.2	0.8	3.0	10.8	0.9	0.6	1.3	0.7	3.9	11.4	1.5	0.8	0.6	1.4	1.3	20.4	2.9	1.3	2.0	2.0	2.2	0.8	3.3	2.3	0.0	0.9	0.4	0.8	0.9	0.9	0.0	1.4	1.3	0.9	0.0	0.6	0.0	7.7	0.0	0.1	1.9	0.0	0.3	0.4	0.4	0.9	0.7	3.3	0.4	0.3	0.4	1.6	1.7	0.9	0.6	1.5	1.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.0	2.5	0.1	0.4	0.0	0.0	0.1	0.3	6.5	1.1	0.5	1.0	0.9	0.3	1.3	13.7	2.2	0.0	0.0	2.6	3.3	0.8	0.2	1.1	0.2	0.6	0.0	4.9	3.0	0.1	0.0	8.6	0.2	0.1	12.6	0.7	0.5	0.0	0.9	1.3	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.6	0.0	9.2	10.9	72.6	21.1	6.6	5.0	3.0	10.8	11.4	2.3
PPFIBP1	"hSGT2, hSgt2p, L2, SGT2"	ENSG00000110841	"PPFIA binding protein 1"	Q86W92	12	27523431-27695564	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001924	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA001924: AB_1079665"	"unprognostic (5.27e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.10e-2)"	"prognostic unfavourable (6.29e-4)"	"unprognostic (4.73e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.11e-4)"	"unprognostic (7.33e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavourable (2.56e-4)"	"unprognostic (1.92e-2)"	"prognostic favourable (5.11e-7)"	"unprognostic (8.54e-2)"	"unprognostic (7.54e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.09e-2)"	21.3	17.1	15.5	8.0	16.8	2.2	22.6	4.9	25.0	18.3	15.4	13.3	13.0	7.1	28.1	9.3	17.1	16.5	12.2	43.3	17.1	9.0	23.8	15.7	25.0	7.8	13.1	16.4	53.1	13.7	12.7	22.2	34.5	15.3	15.3	11.1	8.1	14.2	18.4	13.7	17.8	10.0	20.5	11.2	16.6	15.1	7.1	13.3	6.2	23.9	14.9	6.2	17.2	18.4	7.0	2.0	1.5	0.6	0.3	1.8	0.6	4.5	9.2	7.5	6.4	12.5	34.9	13.4	16.6	18.7	9.8	14.2	24.2	13.9	3.4	19.4	33.6	11.4	4.0	15.2	17.7	7.8	2.2	7.6	7.0	3.5	5.4	2.3	4.3	27.1	10.6	28.5	29.3	33.5	4.0	3.5	34.8	3.5	2.1	0.6	13.4	7.1	3.5	18.7	1.3	14.5	10.1	0.6	3.1	8.3	4.4	23.1	5.7	3.5	32.5	27.7	9.3	15.1	16.9	0.0	0.0	0.2	30.7	3.3	43.6	1.5	0.6	0.3	0.7	0.2	1.4	0.7	1.3	0.7	0.6	7.0	1.3	1.3	1.5	0.3	0.2	2.0	1.8	0.6	15.5	16.8	4.9	25.0	17.1	9.0	13.1	16.4	15.3	13.3
PPFIBP2	Cclp1	ENSG00000166387	"PPFIA binding protein 2"	Q8ND30	11	7513298-7657127	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.7;RT4: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001935, HPA003911"	Enhanced		Approved	Mitochondria				Mitochondria		"HPA001935: AB_1079667, HPA003911: AB_1079666"	"unprognostic (4.14e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.20e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.08e-1)"	"prognostic favourable (2.32e-4)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.26e-5)"	"unprognostic (6.66e-3)"	"unprognostic (2.90e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (5.39e-8)"	"unprognostic (1.78e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.52e-2)"	"prognostic favourable (1.34e-5)"	6.9	6.0	9.2	11.6	13.3	3.1	8.5	6.6	12.9	7.0	13.7	21.4	38.7	12.2	5.7	17.3	17.7	8.4	14.0	6.3	10.0	6.3	17.2	22.1	5.9	6.5	24.0	4.0	8.4	6.0	56.2	3.3	10.0	10.2	12.0	13.3	15.3	34.9	55.9	12.4	20.3	15.4	7.0	10.8	8.0	20.2	18.7	19.3	0.8	17.7	10.2	15.9	20.0	15.3	12.1	7.0	5.4	11.8	2.0	6.1	4.5	0.6	12.6	2.2	1.4	3.0	0.1	31.7	2.9	6.5	1.9	1.8	10.2	1.8	3.5	1.4	1.9	5.9	9.1	0.9	1.6	1.7	0.9	0.0	0.0	6.5	4.1	7.5	3.4	5.0	2.9	0.0	2.3	0.6	0.3	10.7	1.5	6.9	0.0	7.0	14.8	0.0	1.1	0.0	5.8	0.0	43.9	0.5	4.9	0.4	11.6	8.3	1.7	5.7	0.1	0.7	1.1	2.4	0.2	5.2	3.8	3.1	0.9	1.7	5.0	2.0	7.9	5.4	2.8	9.4	2.1	12.1	4.4	2.0	7.0	7.1	6.1	4.5	3.8	2.0	11.8	0.5	0.8	4.5	9.2	13.3	6.6	12.9	10.0	6.3	24.0	4.0	10.2	19.3
PPIA	CYPA	ENSG00000196262	"Peptidylprolyl isomerase A"	P62937	7	44796680-44824564	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Host-virus interaction"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB004655, HPA058345"	Uncertain				"Secreted to blood"		420000000			"CAB004655: AB_425607, HPA058345: "	"unprognostic (3.10e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.86e-2)"	"unprognostic (9.27e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavourable (2.27e-6)"	"unprognostic (1.12e-3)"	"unprognostic (3.30e-2)"	"unprognostic (3.92e-2)"	"unprognostic (8.68e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.35e-3)"	"unprognostic (2.77e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.16e-1)"	92.0	90.3	147.0	80.4	124.3	105.9	169.0	88.9	148.0	111.3	143.5	81.6	52.9	73.9	74.8	125.1	176.5	76.3	80.4	60.2	132.0	121.9	149.2	214.3	95.4	137.1	123.2	88.3	74.2	103.2	93.1	58.3	96.2	142.5	83.0	149.1	68.1	84.7	102.3	68.4	114.7	105.1	113.9	120.8	137.0	73.1	62.4	59.8	228.2	130.2	123.4	191.2	94.3	93.1	129.8	158.5	35.0	83.1	76.0	117.7	180.3	85.8	115.3	146.5	106.3	122.8	186.7	48.3	125.9	197.8	241.9	237.4	127.9	131.7	194.2	64.9	160.3	117.5	188.3	241.1	223.2	111.0	137.3	78.4	132.9	121.8	99.6	158.9	81.9	136.6	165.6	171.4	188.4	245.6	161.1	157.1	248.7	122.3	174.1	281.4	167.2	159.0	125.1	88.7	247.0	328.0	121.5	109.7	90.9	106.1	304.4	82.7	163.2	217.0	109.1	124.7	120.3	83.4	165.0	114.7	226.4	327.7	108.7	180.9	188.0	23.4	74.5	35.0	94.9	83.1	102.0	129.8	97.0	97.1	134.8	103.9	80.3	88.2	9.2	76.0	77.7	158.5	117.7	180.3	147.0	124.3	88.9	148.0	132.0	121.9	123.2	88.3	142.5	59.8
PPIB	"CYPB, OI9"	ENSG00000166794	"Peptidylprolyl isomerase B"	P23284	15	64155812-64163205	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Isomerase, Rotamase"	"Disease mutation, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011487, HPA012720"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum"	"Secreted to blood"		120000000	"Endoplasmic reticulum"	Nucleoplasm	"CAB011487: AB_443295, HPA012720: AB_1847399"	"unprognostic (3.00e-3)"	"unprognostic (5.65e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (1.56e-5)"	"unprognostic (1.65e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.87e-1)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.02e-11)"	"unprognostic (7.05e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-2)"	56.9	64.3	23.9	49.3	26.9	54.9	48.1	15.1	32.1	75.3	44.1	35.4	102.8	42.0	64.2	106.9	48.0	54.8	58.1	44.5	23.8	27.3	89.5	285.9	57.2	63.8	29.7	19.6	67.5	193.7	26.7	71.8	120.2	27.5	51.0	47.7	36.2	123.3	95.4	19.5	33.1	57.5	54.3	30.7	78.0	47.7	27.2	29.5	53.7	154.3	45.7	69.1	49.2	51.7	63.5	191.6	41.0	51.1	44.9	71.6	87.1	39.3	49.5	44.7	101.6	156.7	91.0	39.3	94.0	123.5	74.4	88.5	71.2	73.1	37.6	76.4	145.5	64.2	81.7	63.1	38.4	23.8	30.8	53.0	54.7	93.1	164.3	52.9	48.0	83.8	68.1	43.4	105.8	89.8	37.0	131.0	56.4	62.8	16.1	81.1	39.0	31.8	30.9	47.5	191.8	77.2	61.4	25.3	39.9	43.0	74.0	68.4	44.2	161.8	55.2	74.4	61.7	41.6	63.4	71.2	68.9	39.5	69.5	85.2	74.2	41.0	51.1	33.9	71.6	39.2	71.5	63.5	50.5	58.1	67.4	38.0	33.0	44.2	25.5	44.9	25.2	191.6	40.1	87.1	23.9	26.9	15.1	32.1	23.8	27.3	29.7	19.6	27.5	29.5
PPID	CYP-40	ENSG00000171497	"Peptidylprolyl isomerase D"	Q08752	4	158709134-158723396	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Protein transport, Transport"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019520, HPA019692"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoli, Cytosol"	Nucleoplasm	"HPA019520: AB_1847400, HPA019692: AB_1847401"	"unprognostic (4.26e-2)"	"unprognostic (2.03e-2)"	"unprognostic (8.91e-3)"	"unprognostic (8.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.78e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.09e-1)"	16.8	25.8	20.1	15.5	21.4	14.9	22.3	26.7	26.8	12.6	16.8	14.4	18.2	33.4	14.6	13.6	16.5	15.4	13.0	28.8	19.4	22.1	21.5	45.3	11.0	17.4	22.6	18.9	14.6	17.5	11.3	30.3	14.5	26.0	16.1	14.2	9.1	15.4	13.7	53.3	24.0	29.2	13.1	22.7	16.5	15.5	16.9	23.4	22.7	21.7	16.0	16.8	15.4	55.0	15.6	17.2	33.4	22.2	23.9	24.4	17.1	15.3	14.3	14.4	19.7	21.4	16.1	21.8	15.2	8.3	14.0	10.6	18.5	10.5	16.2	6.8	14.1	11.8	43.6	17.4	17.1	53.7	15.2	29.0	12.9	25.5	16.6	18.2	21.8	10.1	14.2	12.0	17.9	15.2	36.2	29.0	15.5	14.7	26.0	16.5	19.8	19.1	11.8	7.1	13.9	15.4	7.7	24.4	16.3	11.4	23.7	21.6	10.9	17.4	14.7	14.0	15.8	15.4	20.0	16.7	34.6	20.7	17.8	19.7	14.0	33.4	15.3	33.2	21.2	22.2	24.4	14.6	20.7	19.6	16.7	15.6	21.5	22.0	20.9	23.9	22.0	17.2	22.4	17.1	20.1	21.4	26.7	26.8	19.4	22.1	22.6	18.9	26.0	23.4
PPIF	"Cyp-D, hCyP3"	ENSG00000108179	"Peptidylprolyl isomerase F"	P30405	10	79347469-79355337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Necrosis"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 32.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077416			Supported	Mitochondria			27000000	Mitochondria		"HPA077416: "	"unprognostic (2.21e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-3)"	"unprognostic (3.45e-1)"	"unprognostic (4.33e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.82e-1)"	"unprognostic (9.37e-3)"	"unprognostic (1.02e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.88e-2)"	16.5	76.2	12.1	15.7	18.8	52.0	16.9	7.1	21.3	8.3	18.1	27.1	13.2	13.3	5.2	7.6	21.0	8.8	10.0	36.5	13.0	14.5	21.0	73.1	9.4	19.4	23.3	16.6	7.2	42.0	12.0	6.2	11.3	25.2	6.6	19.9	7.5	12.7	21.9	44.4	22.5	11.1	9.9	28.0	19.6	34.0	20.8	18.0	8.8	10.0	73.9	19.8	12.5	11.0	8.0	18.6	32.8	14.9	3.6	5.0	6.5	35.1	15.0	10.5	20.7	9.8	12.8	13.5	20.5	27.0	45.2	42.8	35.0	17.1	36.6	11.4	14.4	21.1	32.6	19.1	70.5	11.6	30.7	57.3	14.7	61.6	16.7	39.4	13.6	30.0	13.8	44.8	44.9	7.9	55.7	45.2	15.3	18.1	10.2	33.0	8.8	83.4	17.6	16.3	18.7	17.5	32.9	21.0	15.6	10.5	42.7	15.8	18.7	30.5	7.1	19.8	18.0	23.3	39.5	21.0	21.3	29.6	19.6	51.4	5.3	5.1	14.9	7.3	4.7	11.4	5.0	8.0	4.2	4.3	18.6	3.9	3.8	3.7	32.8	3.6	4.1	2.3	4.2	6.5	12.1	18.8	7.1	21.3	13.0	14.5	23.3	16.6	25.2	18.0
PPIG	"CARS-Cyp, SCAF10, SRCyp"	ENSG00000138398	"Peptidylprolyl isomerase G"	Q13427	2	169584340-169641406	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021788, HPA057469"	Supported		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA021788: AB_1847408, HPA057469: "	"unprognostic (2.70e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.04e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.55e-3)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-3)"	"unprognostic (3.15e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (4.56e-4)"	"unprognostic (5.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.39e-2)"	26.2	25.3	28.5	23.8	45.3	39.2	26.7	45.0	40.7	33.1	27.1	14.6	26.0	25.3	27.1	28.1	29.4	24.3	21.2	24.2	30.0	20.3	26.0	41.1	25.5	30.4	27.7	35.9	29.5	22.8	39.4	56.7	26.0	38.0	29.3	23.9	13.8	28.6	28.8	27.8	24.5	30.8	31.9	39.7	29.7	24.1	19.8	33.7	24.1	28.4	22.6	29.9	37.4	27.6	36.4	23.7	41.7	24.7	18.7	29.6	13.3	19.1	9.1	25.8	14.1	14.3	17.6	24.3	21.9	16.5	16.2	16.8	24.9	22.1	33.1	20.2	15.8	18.5	20.2	18.0	24.0	23.0	16.3	49.8	13.6	30.3	13.8	46.8	22.2	14.8	20.4	22.0	24.7	17.8	48.0	27.6	18.5	15.5	34.5	28.7	37.0	9.3	31.8	25.8	32.3	20.1	28.9	22.6	14.9	23.6	17.6	23.8	16.4	27.1	20.4	21.2	16.2	14.1	18.0	16.1	23.1	46.2	15.6	25.1	19.4	20.7	20.0	29.9	20.3	20.1	23.2	27.6	27.0	23.8	14.9	36.4	29.6	23.7	41.7	18.7	24.7	23.7	22.9	13.3	28.5	45.3	45.0	40.7	30.0	20.3	27.7	35.9	38.0	33.7
PPIH	"CYP-20, CYPH, MGC5016, SnuCyp-20, USA-CYP"	ENSG00000171960	"Peptidylprolyl isomerase H"	O43447	1	42658425-42676758	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059019	Approved									"HPA059019: "	"unprognostic (7.93e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (1.55e-5)"	"unprognostic (1.09e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (1.78e-9)"	"unprognostic (6.59e-3)"	"unprognostic (4.93e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	17.5	19.7	20.4	35.7	19.6	40.7	21.4	23.9	23.3	19.5	24.0	20.9	14.7	18.0	29.8	24.2	29.6	19.2	14.4	21.2	18.0	16.1	17.5	13.6	17.8	31.0	15.8	19.9	22.0	17.7	7.0	15.2	24.6	17.2	17.1	26.5	19.2	24.4	18.8	18.4	20.9	20.7	20.8	15.0	27.2	18.0	21.1	18.6	39.7	26.9	28.1	36.8	15.3	20.3	20.0	14.9	16.8	12.3	18.5	26.3	14.0	18.9	12.2	15.5	21.7	5.1	9.7	20.9	12.9	9.2	24.2	22.2	19.3	21.7	31.4	16.3	9.6	15.5	28.2	19.8	25.5	26.4	22.7	29.8	22.6	17.9	4.4	57.1	17.5	6.3	10.5	22.6	17.6	11.2	36.9	17.9	11.9	15.9	44.3	80.5	38.1	14.7	24.8	28.9	27.9	11.6	12.4	12.2	22.1	11.4	18.9	14.2	10.4	83.7	9.3	10.7	27.4	14.6	30.9	11.6	26.9	57.1	11.9	53.5	17.5	12.6	8.8	16.8	21.0	12.3	19.8	20.0	21.7	23.9	11.7	19.2	22.3	26.3	1.8	18.5	11.2	14.9	20.2	14.0	20.4	19.6	23.9	23.3	18.0	16.1	15.8	19.9	17.2	18.6
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36875024	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062916			Approved	Nucleoli				Nucleoli		"HPA062916: "	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	9.0	17.2	15.9	11.1	23.1	7.3	12.3	16.6	18.7	11.1	10.2	13.0	5.7	8.7	13.7	11.7	13.1	17.5	7.5	29.7	13.2	19.8	17.6	34.3	7.5	13.4	15.0	15.5	13.2	36.7	10.6	19.4	16.0	15.3	11.2	13.2	11.0	12.0	12.5	11.7	5.6	8.2	17.4	15.8	10.3	8.5	14.0	11.0	10.2	23.5	13.4	17.4	12.2	8.1	7.7	6.6	1.1	4.4	5.0	15.0	6.9	14.1	11.2	29.6	19.7	4.0	8.4	16.0	14.4	9.6	21.7	18.1	19.6	9.4	21.7	18.3	10.1	11.5	35.0	24.0	24.9	18.1	29.2	25.8	7.3	25.9	13.2	22.0	10.8	6.3	11.4	16.7	31.3	19.4	48.3	10.6	15.7	13.4	26.1	10.1	19.6	15.2	21.1	25.9	19.5	12.9	10.0	31.5	16.6	9.6	10.3	18.9	15.0	18.7	11.8	16.8	15.5	12.8	24.0	11.6	30.3	39.7	5.3	40.8	31.9	1.1	3.2	0.8	11.2	4.4	15.0	7.7	9.3	10.7	6.6	6.2	10.5	12.3	0.9	5.0	2.1	5.6	6.8	6.9	15.9	23.1	16.6	18.7	13.2	19.8	15.0	15.5	15.3	11.0
PPL		ENSG00000118898	Periplakin	O60437	16	4882507-4960741	"Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 126.9;lymphoid tissue: 60.9;tongue: 57.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.6;HaCaT: 55.8;MCF7: 20.4;SiHa: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA042550, HPA059859"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"			310000	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA042550: , HPA059859: "	"unprognostic (2.12e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.90e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavourable (2.76e-4)"	"unprognostic (2.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	10.8	0.7	2.2	1.4	0.7	0.2	6.8	0.6	3.0	23.5	2.9	0.2	4.1	1.7	2.6	5.1	126.9	2.9	5.8	1.8	1.8	0.2	3.0	3.3	4.7	0.2	0.0	0.9	1.7	2.8	1.6	2.8	2.9	0.5	4.6	1.0	0.7	24.3	3.3	3.2	30.7	2.0	5.0	0.0	0.2	2.1	1.5	0.0	0.5	7.2	57.8	60.9	5.0	39.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.8	2.5	0.0	0.0	18.3	26.6	8.8	0.0	0.4	0.0	0.1	11.3	17.4	0.1	4.0	0.3	55.8	0.3	6.7	0.0	0.0	0.3	0.0	13.5	2.0	1.1	0.0	0.0	1.3	6.2	0.0	2.1	0.0	0.0	0.0	0.0	20.4	0.0	0.0	1.7	5.3	0.0	0.0	8.6	13.3	10.9	9.2	0.1	29.9	10.0	0.1	5.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	3.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.6	3.0	1.8	0.2	0.0	0.9	0.5	0.0
PPM1D	"PP2C-DELTA, Wip1"	ENSG00000170836	"Protein phosphatase, Mg2+/Mn2+ dependent 1D"	O15297	17	60600183-60666280	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022277	Approved		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA022277: AB_1858839"	"unprognostic (1.48e-1)"	"unprognostic (1.36e-2)"	"prognostic favourable (3.52e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (5.50e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.52e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.98e-1)"	12.2	7.0	6.1	5.7	9.2	13.6	11.9	30.8	6.6	11.1	10.0	10.6	7.8	7.6	12.0	8.3	8.6	11.1	8.3	5.8	7.7	4.4	7.4	7.4	9.2	7.9	10.3	4.6	17.3	12.3	8.1	8.9	18.5	8.8	9.3	9.4	8.2	8.1	6.8	9.7	8.1	8.1	8.2	7.3	9.2	7.3	16.2	12.5	15.5	8.7	6.9	7.0	7.8	11.3	7.3	13.1	20.5	13.2	6.8	8.3	6.8	2.7	5.4	6.1	5.2	4.1	2.5	7.9	4.3	2.8	2.8	4.0	5.5	1.6	7.8	3.5	2.9	2.9	3.9	1.8	3.8	1.4	8.7	5.6	5.4	6.4	3.4	2.2	4.3	2.2	2.9	4.1	2.4	6.3	4.1	3.3	3.0	26.5	6.1	3.4	2.6	4.2	7.4	7.8	4.7	2.5	3.4	8.4	6.1	5.7	1.9	1.3	2.3	3.0	4.6	3.6	10.0	2.8	2.3	5.3	5.6	5.9	1.4	2.3	2.8	8.2	13.2	14.1	6.7	10.2	5.9	7.3	5.6	6.1	13.1	5.9	6.1	6.2	20.5	6.8	6.1	5.8	8.3	6.8	6.1	9.2	30.8	6.6	7.7	4.4	10.3	4.6	8.8	12.5
PPM1F	"CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2"	ENSG00000100034	"Protein phosphatase, Mg2+/Mn2+ dependent 1F"	P49593	22	21919420-21952837	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030989, HPA030990"	Approved		Approved	"Nucleoplasm,Plasma membrane"			780000	Nucleoplasm	"Plasma membrane"	"HPA030989: AB_10669549, HPA030990: AB_10601249"	"unprognostic (6.26e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (6.03e-5)"	"unprognostic (6.44e-2)"	"unprognostic (3.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-2)"	25.0	15.6	14.0	21.8	14.3	24.3	18.4	16.9	16.3	18.1	13.2	7.6	12.5	9.6	17.6	9.7	23.6	12.3	13.1	17.0	13.9	14.9	13.2	8.5	21.6	15.1	11.6	10.1	14.4	10.7	8.3	7.7	28.1	14.5	15.6	4.9	11.2	11.2	16.5	15.8	15.5	11.1	15.4	15.5	31.4	10.5	6.7	10.9	6.2	10.9	15.1	10.2	15.8	37.6	0.7	5.5	17.7	13.9	1.7	1.4	2.8	9.1	9.8	6.3	6.1	3.5	6.2	7.9	10.4	6.2	9.2	6.3	4.4	3.7	5.5	13.0	7.3	11.0	2.7	6.4	3.3	7.8	8.8	21.3	4.5	4.2	5.8	7.8	5.8	5.8	1.9	9.0	4.2	35.8	54.2	2.3	11.8	8.4	4.6	6.1	2.6	10.7	7.0	16.2	1.6	3.1	3.9	2.5	9.8	9.9	3.3	8.5	4.1	5.5	30.1	11.1	11.3	10.1	9.9	4.6	3.7	6.1	11.2	15.0	21.2	0.0	7.7	3.3	1.0	12.9	0.7	0.7	0.7	0.6	5.5	0.6	0.7	0.8	17.7	1.7	13.9	1.4	1.4	2.8	14.0	14.3	16.9	16.3	13.9	14.9	11.6	10.1	14.5	10.9
PPP1CA	"PP-1A, PP1A, PP1alpha, PPP1A"	ENSG00000172531	"Protein phosphatase 1 catalytic subunit alpha"	P62136	11	67398183-67421183	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism, Host-virus interaction"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 177.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004545, HPA046833"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			8100000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB004545: AB_628177, HPA046833: "	"unprognostic (1.03e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.15e-3)"	"unprognostic (3.93e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.05e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.96e-2)"	"unprognostic (7.69e-2)"	"prognostic favourable (1.17e-4)"	"unprognostic (7.60e-2)"	28.4	35.4	24.2	42.0	32.3	42.1	25.1	19.6	33.4	23.9	39.6	22.1	29.9	33.9	19.6	25.8	59.7	22.8	28.6	33.0	21.8	17.1	43.7	55.0	27.6	49.3	19.9	19.9	20.1	53.3	23.1	21.6	44.0	19.3	27.2	33.2	23.2	49.7	31.1	39.0	34.4	47.3	20.5	21.3	53.7	35.1	15.7	19.4	77.7	38.5	40.5	63.9	25.5	25.7	78.8	76.6	126.2	118.0	68.2	113.9	177.2	46.2	53.4	31.7	46.6	15.8	19.4	32.3	22.9	26.9	46.3	35.2	76.3	55.9	39.8	39.1	34.8	40.5	36.6	47.7	28.5	41.8	24.8	38.2	25.2	40.0	34.5	48.5	49.4	21.8	31.6	39.4	23.2	46.4	35.5	33.0	37.4	105.5	61.5	95.4	52.5	42.3	43.7	43.9	34.5	45.4	38.3	24.8	41.2	26.6	47.8	70.7	57.2	33.6	33.0	35.7	36.6	42.1	29.6	33.1	30.6	45.2	42.8	33.4	37.6	81.4	80.1	126.2	88.6	100.5	69.3	78.8	79.8	90.5	76.6	77.0	49.1	69.2	93.3	68.2	118.0	54.4	113.9	177.2	24.2	32.3	19.6	33.4	21.8	17.1	19.9	19.9	19.3	19.4
PPP1CB	"PP-1B, PP1B, PP1beta"	ENSG00000213639	"Protein phosphatase 1 catalytic subunit beta"	P62140	2	28751640-28802940	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022558, HPA065425, CAB069426"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"			7700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB022558: , CAB069426: , HPA065425: "	"unprognostic (2.90e-1)"	"unprognostic (5.03e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.39e-1)"	"prognostic unfavourable (6.52e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.56e-1)"	"unprognostic (2.26e-2)"	28.5	22.6	30.0	20.5	37.6	29.5	32.4	19.1	29.8	51.1	39.3	21.1	30.7	24.4	58.0	31.8	86.0	37.0	33.3	67.1	27.8	27.9	32.0	20.0	35.3	22.3	27.4	24.4	39.7	21.9	48.9	28.7	42.3	22.0	46.4	27.7	25.2	36.5	38.6	99.6	25.1	30.0	100.8	27.5	25.2	31.4	25.5	21.4	28.1	27.5	32.9	25.3	82.1	50.5	15.6	25.4	41.5	42.7	23.5	28.3	17.9	36.4	23.0	80.2	24.8	27.5	25.6	46.7	19.6	22.4	19.1	18.9	20.4	21.6	29.2	24.7	20.3	22.6	22.8	26.2	22.8	46.3	11.8	22.0	28.2	22.0	59.9	24.9	10.4	19.6	37.3	20.6	43.2	23.1	20.0	29.0	25.0	18.3	26.4	21.6	26.3	18.2	26.0	71.1	22.2	62.2	44.1	22.0	27.2	30.5	33.9	26.6	16.4	14.0	27.6	25.6	28.2	18.3	23.6	20.7	32.5	59.8	27.2	26.9	18.9	22.5	24.8	32.1	16.8	37.8	21.3	15.6	25.5	19.6	25.4	13.4	22.7	25.5	41.5	23.5	42.7	19.6	28.3	17.9	30.0	37.6	19.1	29.8	27.8	27.9	27.4	24.4	22.0	21.4
PPP1CC	"PP1C, PP1gamma"	ENSG00000186298	"Protein phosphatase 1 catalytic subunit gamma"	P36873	12	110719680-110742939	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Carbohydrate metabolism, Cell cycle, Cell division, Glycogen metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022645	Uncertain						7600000			"CAB022645: "	"unprognostic (1.51e-1)"	"prognostic favourable (7.44e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavourable (2.75e-6)"	"unprognostic (6.55e-2)"	"unprognostic (4.11e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.96e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.92e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.18e-1)"	23.3	29.4	27.4	23.4	29.8	28.8	24.1	31.9	32.3	25.2	63.3	22.2	15.4	63.0	25.9	19.8	31.3	22.9	21.5	66.5	29.4	21.0	19.8	20.6	19.6	41.4	32.0	21.9	31.7	38.8	19.6	25.8	17.0	25.9	26.1	36.4	28.7	26.9	19.4	63.4	24.0	73.3	46.3	25.9	27.1	25.2	43.7	28.3	42.3	25.9	18.3	41.3	37.9	23.2	17.8	19.1	30.8	19.1	8.5	14.9	12.5	45.0	27.2	46.6	34.0	28.3	39.1	35.6	26.0	38.8	43.3	34.7	46.4	23.0	70.5	19.7	27.9	25.8	62.4	34.2	60.6	40.9	42.0	45.6	20.4	47.3	23.1	58.0	39.7	24.6	28.0	32.7	29.3	50.0	45.4	19.1	39.6	18.7	46.9	65.1	73.3	40.2	46.2	32.2	44.6	27.7	34.3	37.6	30.2	28.7	34.6	50.1	54.1	45.4	22.2	22.2	36.6	29.8	32.6	30.2	31.3	60.4	20.8	42.2	33.6	18.7	19.1	30.8	8.2	14.9	8.0	17.8	14.9	11.7	19.1	15.4	12.4	10.2	16.3	8.5	18.8	7.4	13.7	12.5	27.4	29.8	31.9	32.3	29.4	21.0	32.0	21.9	25.9	28.3
PPP1R12B	"MGC131980, MGC87886, MYPT2, PP1bp55"	ENSG00000077157	"Protein phosphatase 1 regulatory subunit 12B"	O60237	1	202348699-202592706	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 105.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 15.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024171, HPA024640"	Enhanced		Approved	"Plasma membrane,Actin filaments"				"Plasma membrane, Actin filaments"		"HPA024171: AB_1854266, HPA024640: AB_1854265"	"unprognostic (5.24e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.13e-3)"	"unprognostic (4.05e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.60e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	10.6	2.8	6.9	8.1	9.0	1.8	7.7	13.9	10.5	55.3	62.0	15.0	31.0	5.8	105.2	9.4	37.4	21.9	17.4	83.1	5.8	4.5	5.0	2.9	8.1	4.2	10.1	9.2	18.7	2.3	2.0	4.5	8.4	9.5	36.4	16.3	13.7	5.7	50.3	17.6	5.3	14.1	59.5	7.3	6.9	20.8	3.4	11.1	1.3	5.0	11.2	3.5	35.1	11.4	2.3	1.7	15.9	1.8	0.7	1.7	0.5	2.7	5.4	4.2	3.9	5.9	4.3	6.8	2.1	2.2	2.2	2.1	2.3	4.8	3.0	1.1	3.9	8.6	6.2	3.3	2.4	3.9	3.8	3.0	7.9	1.5	1.4	6.5	3.5	3.4	3.8	3.2	3.3	1.8	4.5	3.6	3.9	2.0	4.8	4.1	2.8	1.1	3.2	10.7	4.4	1.8	9.8	5.1	3.9	4.1	4.9	2.4	4.3	3.0	2.3	3.2	1.9	2.3	1.8	5.3	5.0	3.3	3.0	5.3	12.6	1.8	1.8	1.3	1.7	0.9	1.4	1.7	1.1	1.0	1.4	2.3	1.4	1.0	15.9	0.7	1.4	1.7	1.6	0.5	6.9	9.0	13.9	10.5	5.8	4.5	10.1	9.2	9.5	11.1
PPP1R13B	"ASPP1, KIAA0771, p53BP2-like, p85"	ENSG00000088808	"Protein phosphatase 1 regulatory subunit 13B"	Q96KQ4	14	103733752-103847590	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 16.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006394, CAB015454"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB015454: AB_2252775, HPA006394: AB_1079668"	"unprognostic (1.20e-1)"	"unprognostic (8.61e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.25e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (3.22e-3)"	"unprognostic (5.13e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.62e-3)"	"prognostic favourable (3.28e-11)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.23e-1)"	7.1	5.5	12.1	5.0	13.2	1.0	7.7	23.3	16.6	8.6	9.0	7.8	6.4	8.7	9.1	4.5	13.5	12.3	5.8	24.5	10.0	6.5	8.3	5.9	11.9	3.3	5.3	9.8	13.3	13.2	12.2	15.6	7.1	10.5	13.3	7.3	13.9	11.6	8.2	7.6	12.9	11.2	6.7	5.2	13.0	11.9	21.2	6.3	1.1	28.4	4.3	7.9	10.1	7.3	0.7	0.0	0.0	0.0	0.2	2.0	0.3	3.9	3.4	0.4	4.6	0.8	0.3	1.7	2.5	1.9	3.5	1.6	2.6	3.6	1.0	9.7	2.1	8.3	4.8	3.6	2.9	2.0	3.3	0.0	1.2	4.4	3.2	0.4	3.7	0.9	4.2	0.3	4.0	6.7	0.5	1.7	2.2	16.1	0.0	0.3	0.8	4.3	10.1	2.7	2.3	7.1	9.9	5.5	14.6	7.8	6.2	1.9	15.3	0.6	5.6	2.5	3.3	2.0	2.4	3.7	4.4	6.7	1.5	2.5	1.2	0.0	0.0	0.0	1.4	0.0	2.0	0.7	1.3	0.0	0.0	0.5	0.2	0.5	0.0	0.2	0.0	0.0	0.9	0.3	12.1	13.2	23.3	16.6	10.0	6.5	5.3	9.8	10.5	6.3
PPP1R14A	"CPI-17, PPP1INL"	ENSG00000167641	"Protein phosphatase 1 regulatory inhibitor subunit 14A"	Q96A00	19	38251237-38256591	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"A549: 39.7;EFO-21: 34.2;K-562: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"memory B-cell: 46.4;naive B-cell: 42.7;plasmacytoid DC: 39.3"	"Group enriched"	"Detected in many"	29	"B-cells: 46.4;dendritic cells: 39.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005044, CAB009803, HPA042097, HPA054534"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB005044: AB_562091, CAB009803: AB_2168720, HPA042097: , HPA054534: "	"unprognostic (5.40e-2)"	"unprognostic (4.00e-3)"	"unprognostic (4.02e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-1)"	"unprognostic (8.92e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (1.25e-5)"	"prognostic unfavourable (7.12e-4)"	"unprognostic (4.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.22e-2)"	45.4	34.9	22.5	15.1	28.7	2.6	20.1	4.4	37.9	21.1	56.1	60.9	16.6	13.9	39.6	10.8	32.6	20.1	31.7	13.0	34.4	19.0	8.9	4.0	21.1	2.8	43.6	19.2	22.7	17.1	1.7	1.6	24.2	28.4	29.7	10.0	4.4	10.4	70.3	13.9	3.5	16.5	79.9	76.0	31.1	22.9	18.7	38.2	0.0	3.3	3.4	2.1	51.6	15.6	46.4	39.3	1.1	0.1	1.4	0.1	3.7	0.0	39.7	0.1	0.0	0.2	0.0	1.7	3.7	0.0	0.0	0.0	3.1	0.0	0.0	34.2	0.2	0.1	3.4	0.0	0.0	0.5	0.0	7.1	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.4	0.0	0.0	16.5	0.1	0.0	0.2	0.0	0.1	1.3	0.0	0.0	1.0	0.1	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.0	46.4	0.0	0.0	6.8	42.7	0.1	0.0	0.3	1.4	0.0	39.3	0.0	3.7	22.5	28.7	4.4	29.7	34.4	19.0	43.6	19.2	28.4	38.2
PPP1R14B	"PHI-1, PLCB3N, PNG, SOM172"	ENSG00000173457	"Protein phosphatase 1 regulatory inhibitor subunit 14B"	Q96C90	11	64244480-64246941	"Plasma proteins, Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	74	"plasmacytoid DC: 73.9"	"Lineage enriched"	"Detected in single"	74	"dendritic cells: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053882	Approved						75000			"HPA053882: "	"unprognostic (1.36e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.74e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavourable (1.75e-6)"	"unprognostic (1.14e-1)"	"unprognostic (9.87e-2)"	"unprognostic (3.04e-3)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (6.86e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.43e-1)"	15.0	17.1	9.4	18.2	8.3	16.2	28.1	3.3	8.4	14.1	19.1	5.9	14.9	19.7	9.6	14.2	38.2	8.4	12.5	24.2	7.9	6.7	18.4	23.3	10.5	16.5	9.3	5.8	12.6	81.0	6.7	6.7	36.6	8.7	11.0	9.5	5.7	26.4	12.1	60.9	27.9	22.0	11.3	8.3	19.0	11.7	9.0	8.0	26.5	14.2	39.4	21.3	13.5	16.6	0.9	73.9	0.9	0.6	0.5	0.6	0.5	60.2	36.0	23.0	36.6	11.1	15.3	34.9	32.0	20.0	33.7	15.2	21.2	53.7	30.5	57.8	30.0	40.1	17.3	32.6	12.7	26.4	27.9	21.6	38.9	32.6	20.4	33.5	21.3	13.8	35.4	25.7	44.8	29.9	29.4	16.7	37.0	72.2	36.1	51.4	64.8	80.5	35.2	73.4	80.4	29.9	29.1	34.4	50.1	25.0	35.1	45.2	24.1	20.9	27.2	48.9	45.5	95.4	47.5	15.9	10.1	29.7	42.0	28.5	55.3	0.0	0.4	0.3	0.3	0.6	0.6	0.9	0.5	0.3	0.7	0.7	0.2	0.2	0.9	0.5	0.5	73.9	0.1	0.5	9.4	8.3	3.3	8.4	7.9	6.7	9.3	5.8	8.7	8.0
PPP1R3A	"GM, PPP1R3"	ENSG00000154415	"Protein phosphatase 1 regulatory subunit 3A"	Q16821	7	113876777-114075920	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Carbohydrate metabolism, Glycogen metabolism"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	20	"heart muscle: 24.1;skeletal muscle: 69.4;tongue: 75.4"	"Cell line enriched"	"Detected in single"	64	"THP-1: 17.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 1.2"	"Low region specificity"	"Detected in some"			"HPA070440, HPA073138"	Enhanced									"HPA070440: , HPA073138: "						"unprognostic (8.96e-3)"												1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.7	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	1.4	0.0	69.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	75.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PPP1R9A	"FLJ20068, KIAA1222, Neurabin-I"	ENSG00000158528	"Protein phosphatase 1 regulatory subunit 9A"	Q9ULJ8	7	94907202-95296415	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.3;RH-30: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 5.8;NK-cell: 10.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.8;NK-cells: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027726, HPA075591"	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA027726: AB_1855653, HPA075591: "	"unprognostic (1.05e-1)"	"unprognostic (6.59e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (7.17e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (8.63e-6)"	"unprognostic (2.74e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.47e-2)"	"unprognostic (8.79e-3)"	2.9	11.7	11.0	1.9	23.5	0.8	8.1	10.9	19.7	5.2	8.7	7.4	7.7	3.0	5.4	9.2	3.2	9.6	4.4	8.2	11.5	9.7	8.2	1.1	6.4	0.9	8.1	13.7	5.0	14.3	16.5	15.5	4.5	12.7	4.2	6.8	5.7	14.2	5.3	6.7	1.1	3.0	5.1	9.1	3.2	6.2	10.0	11.2	0.0	10.9	1.3	1.0	4.2	1.4	1.3	0.3	5.8	0.1	10.9	0.2	0.2	0.0	9.3	5.8	6.5	0.0	0.0	4.7	0.4	0.1	0.8	0.7	5.1	3.1	0.0	7.9	0.4	0.0	10.3	0.0	1.2	0.0	4.0	9.5	3.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.0	0.1	0.0	4.8	1.7	0.0	10.3	0.0	9.6	7.6	6.2	6.5	0.0	0.8	1.3	1.9	0.0	0.0	0.1	3.8	0.1	3.3	6.3	9.1	0.0	0.1	0.0	0.7	5.8	0.0	0.5	0.0	0.0	0.2	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	10.9	0.1	0.3	0.0	0.2	11.0	23.5	10.9	18.3	11.5	9.7	8.1	13.7	12.7	11.2
PPP2R1A	"PP2A-Aalpha, PP2AA, PR65A"	ENSG00000105568	"Protein phosphatase 2 scaffold subunit Aalpha"	P30153	19	52190039-52229533	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Chromosome partition"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018599			Approved	Cytosol			3400000	Cytosol		"CAB018599: AB_628178"	"unprognostic (1.78e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.87e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (1.76e-4)"	"prognostic unfavourable (2.50e-4)"	"unprognostic (4.30e-2)"	"unprognostic (3.06e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.28e-2)"	"prognostic favourable (1.20e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.19e-2)"	25.3	57.3	60.7	20.5	71.0	18.0	21.4	47.5	82.1	29.6	31.2	26.6	21.5	33.4	26.4	37.9	37.7	47.0	39.9	74.7	70.2	44.8	31.0	29.3	20.0	27.5	44.0	50.9	45.8	24.3	37.8	29.5	24.6	51.0	31.0	29.8	31.0	24.3	35.6	50.6	33.5	25.3	34.5	25.2	20.5	19.8	21.7	18.1	29.0	28.9	35.9	30.6	27.3	23.1	52.8	62.8	51.9	67.2	69.8	56.3	67.8	30.4	51.7	41.3	36.7	33.6	35.2	21.7	25.7	33.7	34.4	30.0	26.0	24.1	26.7	18.5	40.8	22.0	44.2	38.7	20.0	19.7	119.9	19.6	28.5	29.2	30.7	21.1	18.7	47.2	32.1	32.1	29.6	32.6	22.7	18.8	38.0	35.2	29.5	40.3	40.9	45.7	29.0	24.0	29.8	55.2	50.2	31.2	33.4	31.4	31.4	19.1	28.4	37.3	30.9	27.3	24.6	13.3	29.3	19.5	28.5	31.3	29.3	21.4	34.3	45.0	55.3	51.9	50.4	67.2	45.8	48.4	45.1	47.1	62.8	52.8	37.7	43.0	33.7	69.8	59.8	39.0	56.3	67.8	60.7	71.0	47.5	82.1	70.2	44.8	44.0	50.9	51.0	18.1
PPP2R5B	"B56B, B56beta, FLJ35411, PR61B"	ENSG00000068971	"Protein phosphatase 2 regulatory subunit B'beta"	Q15173	11	64917553-64934473	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036607	Approved									"HPA036607: AB_10670235"	"unprognostic (2.20e-2)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (3.24e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.37e-3)"	"unprognostic (8.00e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.12e-2)"	11.0	11.7	18.9	8.5	36.7	12.1	6.6	51.9	41.3	7.5	10.0	16.3	8.3	7.5	8.9	11.7	7.8	6.2	16.1	13.7	19.0	24.5	9.1	5.6	11.4	8.4	20.2	23.1	6.3	15.1	17.8	11.6	9.8	27.5	8.7	8.6	10.5	8.7	15.7	13.7	12.3	8.7	14.2	15.2	14.0	7.2	3.4	13.3	2.9	9.0	4.4	8.0	8.9	6.0	1.1	0.6	11.0	1.7	0.9	1.0	0.3	7.4	3.7	4.9	11.4	10.3	7.7	0.7	8.4	7.7	12.0	9.7	2.7	5.7	1.8	5.9	9.9	5.0	4.6	7.2	6.8	10.9	3.3	2.1	6.6	1.8	9.9	0.9	9.8	4.8	12.5	13.0	14.8	9.5	4.1	4.7	8.9	3.0	1.2	3.3	1.5	10.7	2.2	1.4	4.2	9.0	3.4	12.8	12.0	5.1	3.8	7.6	4.3	1.8	9.5	15.4	5.1	16.5	3.1	5.8	4.6	1.5	19.3	1.3	7.0	1.2	0.9	11.0	1.0	1.4	0.7	0.9	0.5	0.9	0.6	1.1	0.5	0.6	0.4	0.9	1.7	0.5	1.0	0.3	18.9	36.7	51.9	41.3	19.0	24.5	20.2	23.1	27.5	13.3
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell line specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol			35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.4	21.6	16.4	7.4	21.4	19.7	8.7	9.2	7.9	24.3	9.2	9.0	19.3	9.7	13.9	28.5	14.8	22.6	6.4	14.7	19.7	10.2	15.8	23.5	7.5	16.9	15.0	18.9	21.7	16.3	5.7	25.5	13.9	23.3	4.9	17.7	6.4	8.9	9.0	34.9	10.7	8.4	15.4	30.3	11.5	17.7	15.2	10.2	13.6	13.4	18.9	20.6	23.4	18.8	14.1	11.9	12.2	16.4	11.4	13.3	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0
PPP3CC	"CALNA3, PP2Bgamma"	ENSG00000120910	"Protein phosphatase 3 catalytic subunit gamma"	P48454	8	22440819-22541142	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023396, CAB024950"	Approved		Approved	Vesicles				Vesicles		"CAB024950: , HPA023396: AB_1855663"	"unprognostic (7.66e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.21e-2)"	"unprognostic (7.71e-2)"	"prognostic favourable (6.80e-5)"	"unprognostic (9.25e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.84e-2)"	"unprognostic (4.05e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.64e-2)"	18.0	8.3	6.9	13.7	8.1	15.2	21.1	11.9	12.0	10.3	10.2	10.9	3.7	6.1	13.4	7.8	11.6	9.0	10.7	27.5	7.6	7.3	8.9	8.2	16.5	22.3	7.7	4.9	10.1	9.9	13.7	15.1	12.7	9.9	11.1	7.1	20.7	15.5	6.0	52.4	9.1	9.8	13.5	7.9	14.1	9.5	41.6	6.9	6.8	11.5	13.2	20.0	14.7	11.0	15.5	4.0	6.6	2.9	11.9	16.0	3.9	5.4	4.0	3.6	4.4	9.6	11.9	5.3	7.6	13.5	11.4	12.6	2.3	3.4	20.8	9.4	11.8	3.9	8.3	7.6	14.6	11.9	4.4	4.4	4.6	6.7	13.0	3.2	7.4	7.2	10.6	7.6	7.9	9.8	8.7	27.8	12.7	2.5	7.5	5.2	2.6	5.6	24.5	8.5	6.9	10.6	5.2	2.5	6.0	5.7	3.4	7.8	2.3	5.4	10.5	17.7	3.8	26.8	5.9	13.9	16.7	21.8	9.4	4.2	11.7	3.4	1.6	6.6	11.4	2.0	8.7	15.5	12.9	16.0	3.2	13.9	12.4	10.1	0.4	11.9	2.9	4.0	10.1	3.9	6.9	8.1	11.9	12.0	7.6	7.3	7.7	4.9	9.9	6.9
PPP6R2	"dJ579N16.1, KIAA0685, SAP190, SAPS2"	ENSG00000100239	"Protein phosphatase 6 regulatory subunit 2"	O75170	22	50343304-50445090	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030656, CAB034919"	Uncertain		Supported	Vesicles,Cytosol				"Vesicles, Cytosol"		"CAB034919: AB_2183817, HPA030656: AB_10602926"	"unprognostic (1.24e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.70e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.79e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (7.51e-4)"	"unprognostic (6.89e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.77e-3)"	16.8	22.1	21.3	19.6	20.7	17.9	32.2	39.0	52.7	13.0	15.8	18.5	20.6	23.1	17.2	13.3	18.6	16.2	17.3	25.6	19.8	18.3	18.7	40.6	19.0	32.8	19.8	22.4	16.8	23.7	19.7	26.7	14.9	19.4	19.8	11.7	20.2	26.3	18.2	47.3	25.8	20.0	21.2	20.4	21.2	22.5	37.8	17.3	21.1	21.1	11.7	18.5	15.6	13.6	9.8	12.3	16.0	10.3	6.4	14.3	8.5	16.1	9.5	14.9	18.9	11.0	11.8	13.4	16.2	17.3	17.3	17.6	8.0	10.0	19.5	8.0	16.0	13.2	9.1	12.0	6.5	10.0	16.9	10.4	18.3	19.7	14.4	24.3	28.6	17.5	13.1	10.4	5.6	15.1	10.6	17.1	12.5	26.1	16.6	17.7	6.1	11.9	23.4	11.4	12.7	12.7	19.2	9.4	12.6	16.6	25.9	13.1	9.3	18.6	17.3	16.2	14.7	13.4	10.6	18.4	4.4	17.2	16.9	12.0	22.2	4.0	9.6	6.3	10.8	10.3	12.7	9.5	7.6	11.5	9.8	9.8	7.4	9.5	16.0	6.4	7.4	12.3	14.3	8.5	21.3	20.7	39.0	52.7	19.8	18.3	19.8	22.4	19.4	17.3
PRAME	"CT130, MAPE"	ENSG00000185686	"Preferentially expressed antigen in melanoma"	P78395	22	22547701-22559361	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"testis: 54.3"	"Cell line enriched"	"Detected in some"	5	"K-562: 139.9"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"HPA045153, HPA068562"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA045153: AB_10797259, HPA068562: "	"unprognostic (9.36e-3)"	"unprognostic (9.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.87e-2)"	"unprognostic (5.20e-2)"	"prognostic unfavourable (3.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.52e-3)"	"unprognostic (9.68e-3)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.48e-9)"	"unprognostic (1.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.26e-1)"	0.1	1.7	0.1	0.3	0.3	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.5	0.0	2.8	10.9	0.1	0.2	0.1	0.3	0.2	0.0	0.7	0.1	0.1	0.1	0.1	0.1	2.2	0.1	0.0	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.2	0.0	54.3	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	9.1	0.0	19.3	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	13.9	0.0	0.0	0.6	0.0	0.0	8.4	2.0	4.9	3.6	0.1	0.0	0.4	26.7	0.0	0.0	0.0	0.0	0.0	139.9	2.2	0.0	1.2	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.1	28.7	0.0	0.0	0.0	4.2	3.4	0.7	0.0	25.2	0.0	0.0	0.4	1.9	0.1	0.0	0.1	3.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.2	0.0	0.1	0.1	0.4	0.1
PRAMEF12		ENSG00000116726	"PRAME family member 12"	O95522	1	12774841-12777906	"Plasma proteins, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045286, HPA051704"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA045286: AB_10794782, HPA051704: "															"unprognostic (6.60e-2)"			0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.1	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.1	0.0		0.0	0.8		0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.1			0.0		0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0										
PRCC	RCCP1	ENSG00000143294	"Papillary renal cell carcinoma (translocation-associated)"	Q92733	1	156750610-156800817	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavourable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (1.02e-2)"	31.3	24.9	28.5	25.8	29.7	33.7	23.7	33.2	43.5	29.8	30.0	35.9	21.8	24.6	35.1	22.8	30.3	25.6	28.7	23.8	28.0	24.5	26.1	33.1	22.0	30.1	22.1	25.2	30.1	23.7	31.0	22.7	38.8	22.6	25.6	21.5	25.6	37.2	24.0	47.4	33.6	30.1	25.7	20.4	29.7	24.1	26.2	19.2	51.9	27.5	29.8	30.7	25.4	23.8	21.4	27.1	36.9	23.1	19.3	22.1	16.9	19.8	17.2	13.6	15.5	11.4	9.1	23.7	13.9	13.6	15.5	13.4	27.0	16.8	20.4	24.1	10.9	20.8	19.3	14.6	12.1	25.5	25.3	14.9	12.7	17.4	14.1	20.5	17.6	12.9	17.0	13.5	12.4	14.2	24.6	19.0	10.9	35.4	23.4	24.1	32.9	21.4	20.6	12.0	27.4	16.3	19.1	24.2	43.2	14.7	37.1	23.0	26.7	33.1	13.0	15.8	16.6	17.3	22.8	49.1	73.4	31.6	15.6	13.3	14.6	26.9	20.0	36.9	20.5	20.6	19.6	18.0	18.5	22.1	22.4	21.4	18.4	18.9	19.3	19.3	23.1	27.1	18.5	16.9	28.5	29.7	33.2	43.5	28.0	24.5	22.1	25.2	22.6	19.2
PRCP	"HUMPCP, PCP"	ENSG00000137509	Prolylcarboxypeptidase	P42785	11	82823502-82970584	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017065, HPA071115"	Approved		Supported	Vesicles	"Intracellular and membrane"		34000000	Vesicles		"HPA017065: AB_1855676, HPA071115: "	"unprognostic (3.24e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.33e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.88e-2)"	"prognostic favourable (2.65e-6)"	"unprognostic (7.16e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.49e-1)"	"unprognostic (4.07e-1)"	32.6	45.9	25.0	21.5	22.2	13.1	69.5	19.4	23.8	38.8	17.9	17.9	27.6	11.0	30.7	35.5	32.2	24.6	25.6	66.3	25.8	18.9	52.4	52.5	38.1	95.1	27.0	14.8	27.8	23.4	30.6	19.3	59.8	34.9	25.1	18.4	25.1	38.1	34.5	10.3	26.2	15.7	32.8	45.0	25.1	16.8	17.4	17.7	9.8	27.9	24.2	31.7	39.4	30.1	13.1	50.0	31.2	27.9	12.1	6.2	14.7	7.5	8.2	12.6	25.4	97.9	35.9	14.8	16.0	28.6	15.4	22.5	20.3	15.5	10.8	23.4	23.2	11.9	11.5	10.5	18.0	9.6	8.3	7.7	11.4	12.6	18.3	6.9	28.2	26.2	8.3	16.0	15.2	50.8	8.3	15.2	15.7	3.4	1.0	24.7	7.3	7.7	5.6	21.9	12.9	21.5	13.8	5.3	11.5	21.9	12.7	9.0	15.2	9.5	13.2	18.1	18.1	15.6	7.8	14.3	24.4	9.6	7.4	8.4	9.3	15.5	26.4	17.4	5.3	27.9	6.1	9.9	5.3	5.8	50.0	13.1	4.4	6.2	31.2	12.1	21.2	8.9	5.0	14.7	25.0	22.2	19.4	23.8	25.8	18.9	27.0	14.8	34.9	17.7
PRDM11	PFM8	ENSG00000019485	"PR/SET domain 11"	Q9NQV5	11	45095806-45235110	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA057072	Approved									"HPA057072: "	"unprognostic (3.32e-4)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.10e-4)"	"unprognostic (7.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.57e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.93e-6)"	"unprognostic (9.25e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.21e-1)"	7.5	5.1	9.7	6.2	7.3	3.6	5.2	11.3	11.4	12.9	10.6	8.2	5.6	3.3	14.4	11.3	10.4	13.4	10.2	11.8	9.4	5.9	4.7	3.2	7.9	13.6	5.6	9.4	14.7	8.0	5.3	8.8	6.3	5.4	9.2	3.7	10.0	6.2	12.8	7.5	4.9	4.9	14.2	4.2	5.4	7.2	5.6	6.1	3.7	12.9	2.7	4.0	8.8	9.8	1.1	1.3	0.6	0.6	1.1	1.8	0.2	3.6	10.4	2.6	1.3	4.4	3.7	0.6	1.9	4.2	6.5	4.2	9.5	1.4	4.1	4.4	2.7	4.5	5.1	2.3	2.1	1.3	4.0	3.1	14.7	1.8	6.9	3.6	4.1	4.7	8.5	0.4	6.8	6.3	1.4	0.0	3.1	1.8	0.0	4.8	3.1	6.9	4.7	9.7	0.1	3.5	3.4	3.3	4.1	4.3	0.6	4.8	16.0	1.9	3.4	14.0	6.7	3.4	4.2	3.3	3.6	3.8	0.6	0.8	3.8	0.0	0.0	0.6	0.5	0.3	1.8	0.9	0.4	0.7	0.4	1.1	0.7	0.3	0.0	1.1	0.6	1.3	0.1	0.2	9.7	7.3	11.3	11.4	9.4	5.9	5.6	9.4	5.4	6.1
PRDM15	"C21orf83, ZNF298"	ENSG00000141956	"PR/SET domain 15"	P57071	21	41798225-41879482	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 17.5;U-266/70: 16.1;U-698: 31.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024268, HPA029255, HPA029256"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA024268: AB_1855688, HPA029255: , HPA029256: "	"unprognostic (8.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.85e-4)"	"unprognostic (4.22e-4)"	"unprognostic (6.50e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.91e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.30e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.70e-1)"	"unprognostic (9.72e-2)"	"unprognostic (4.86e-3)"	4.8	4.7	9.0	8.1	7.0	4.6	5.5	10.4	7.5	4.8	5.4	7.3	8.4	7.9	5.4	4.5	6.7	5.9	4.9	4.4	4.3	3.4	3.9	5.1	4.7	17.0	8.0	4.8	6.7	5.9	5.6	6.4	3.3	6.0	6.3	5.0	4.3	7.6	7.3	9.3	8.3	7.7	5.1	6.6	9.4	5.4	6.2	7.8	10.8	6.1	6.9	16.8	4.8	7.7	3.0	1.5	1.2	2.5	0.1	1.3	1.3	1.3	2.9	2.5	3.2	0.7	1.3	2.6	1.1	0.9	1.3	1.0	1.9	1.7	17.5	1.2	1.3	2.9	2.2	1.4	1.2	1.7	2.3	3.2	6.7	2.1	0.7	2.7	2.1	0.7	1.7	1.4	1.2	1.7	2.9	1.0	1.6	3.6	2.6	2.0	2.7	1.9	4.5	1.7	2.0	1.3	2.3	4.1	2.5	5.3	2.1	1.0	2.1	1.5	2.2	2.0	0.7	1.3	2.0	16.1	1.9	31.9	1.6	3.3	2.7	0.0	1.4	1.2	1.3	2.5	0.1	3.0	0.2	1.1	1.5	1.0	0.8	1.2	0.0	0.1	0.6	0.7	0.8	1.3	9.0	7.0	10.4	7.5	4.3	3.4	8.0	4.8	6.0	7.8
PRDX1	"NKEFA, PAGA"	ENSG00000117450	"Peroxiredoxin 1"	Q06830	1	45511036-45523047	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004682, HPA007730"	Approved		Supported	Mitochondria			110000000	Mitochondria		"CAB004682: AB_437046, HPA007730: AB_1855204"	"unprognostic (1.28e-2)"	"unprognostic (4.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.39e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.89e-4)"	43.3	58.2	71.0	43.8	57.4	12.0	75.5	31.6	60.0	46.9	51.1	72.2	42.6	78.5	40.8	75.7	136.1	49.7	46.9	84.2	56.5	73.0	121.7	136.5	52.9	51.0	99.1	51.2	43.0	20.4	34.1	34.3	58.3	87.8	42.2	53.0	48.8	53.5	52.2	78.9	46.9	77.6	52.4	98.3	46.5	52.5	25.7	72.6	29.7	130.1	114.3	91.0	49.1	56.3	44.7	50.3	64.4	64.5	20.4	72.3	58.7	65.4	120.6	49.7	63.2	56.4	48.3	106.4	74.4	77.4	80.8	67.2	59.9	28.3	57.8	78.6	79.8	67.8	107.9	71.9	80.0	44.5	83.3	43.7	170.2	167.6	24.5	50.5	57.2	41.4	53.8	80.2	19.0	92.6	79.8	20.0	80.2	52.5	67.7	49.3	155.8	126.4	119.4	62.7	76.1	145.2	56.4	66.2	33.3	68.3	185.5	4.8	50.4	40.9	78.7	32.3	73.1	69.1	99.0	14.0	78.1	110.1	53.4	35.2	18.9	64.4	55.6	18.4	28.5	60.6	37.5	44.7	45.5	37.9	50.3	36.2	28.3	31.0	2.4	20.4	64.5	33.5	72.3	58.7	71.0	57.4	31.6	60.0	56.5	73.0	99.1	51.2	87.8	72.6
PRDX2	"MGC4104, NKEFB, PRP, PRX2, PRXII, TDPX1, TSA"	ENSG00000167815	"Peroxiredoxin 2"	P32119	19	12796820-12801859	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB008713	Approved						1100000000			"CAB008713: AB_1620974"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-3)"	"unprognostic (8.58e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.26e-2)"	"unprognostic (9.18e-2)"	"prognostic favourable (5.66e-11)"	"unprognostic (7.01e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.41e-1)"	39.8	95.1	54.7	17.9	55.6	119.1	27.7	52.1	80.8	22.5	39.9	27.8	42.2	53.6	28.1	33.8	49.9	31.5	36.4	142.0	49.2	54.4	44.5	79.4	15.9	22.7	62.2	41.6	40.0	43.0	32.8	49.4	20.9	70.9	30.6	30.8	35.9	42.3	41.5	136.8	44.3	44.9	27.6	27.5	18.1	31.5	13.7	23.5	38.9	36.8	69.9	29.5	31.5	24.6	42.1	24.6	9.5	20.6	23.3	76.8	72.3	44.8	0.1	62.0	80.2	9.0	6.2	45.7	20.8	20.7	28.4	16.1	47.2	11.3	13.2	48.7	20.0	42.9	39.1	33.7	8.2	56.5	61.8	23.9	63.6	70.4	24.3	0.0	0.1	26.6	15.5	21.3	10.4	26.2	51.0	20.8	10.8	81.4	52.8	20.3	45.7	86.9	52.3	0.0	63.6	37.7	48.7	76.8	60.7	49.3	50.6	16.4	45.3	34.4	11.5	21.3	17.9	59.1	45.0	25.5	24.9	60.6	20.2	8.0	4.8	2.8	20.6	9.5	53.6	14.3	56.2	42.1	73.5	54.8	24.6	29.2	74.9	58.5	2.7	23.3	15.4	14.4	76.8	72.3	54.7	55.6	52.1	80.8	49.2	54.4	62.2	41.6	70.9	23.5
PRDX3	"AOP-1, AOP1, MER5, SP-22"	ENSG00000165672	"Peroxiredoxin 3"	P30048	10	119167703-119178833	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008656, HPA041488"	Enhanced						14000000			"CAB008656: AB_1620979, HPA041488: "	"unprognostic (8.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.72e-3)"	"unprognostic (4.62e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.21e-1)"	34.0	100.7	28.8	18.8	28.3	14.4	29.1	16.1	28.9	23.0	27.1	20.7	25.1	28.1	25.5	26.3	30.6	24.8	21.8	55.8	26.7	28.2	78.8	114.8	16.3	20.0	29.9	23.2	19.2	34.1	25.2	24.6	29.9	33.6	27.4	29.6	21.2	40.5	29.3	80.9	10.3	34.6	26.8	24.1	27.4	24.6	14.0	24.6	24.3	48.9	46.1	20.5	25.9	17.9	30.9	65.7	41.4	74.9	20.9	34.2	73.0	53.0	60.9	37.2	42.1	39.3	42.6	23.2	38.2	65.1	58.2	61.3	46.7	53.3	62.4	33.5	44.9	24.3	61.4	46.1	65.8	61.0	64.6	28.1	26.5	82.5	41.2	52.4	34.0	49.9	29.7	46.5	43.4	42.1	34.5	13.0	53.2	21.2	39.6	44.4	34.7	36.1	42.1	54.1	43.0	98.3	25.5	16.4	23.8	40.5	54.7	50.0	28.3	63.2	29.6	19.0	28.8	27.1	49.4	20.4	29.7	50.1	29.9	77.9	16.8	19.5	74.9	40.8	20.3	61.8	25.9	30.9	27.1	24.5	65.7	24.3	28.3	25.2	41.4	20.9	53.2	36.8	34.2	73.0	28.8	28.3	16.1	28.9	26.7	28.2	29.9	23.2	33.6	24.6
PRDX5	"ACR1, AOEB166, B166, MGC117264, MGC142283, MGC142285, PLP, PMP20, PRDX6, PRXV, SBBI10"	ENSG00000126432	"Peroxiredoxin 5"	P30044	11	64318088-64321811	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase, Peroxidase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008661, HPA037915, HPA037916"	Enhanced		Enhanced	Mitochondria			19000000	Mitochondria		"CAB008661: AB_1620988, HPA037915: AB_2675735, HPA037916: AB_2675736"	"unprognostic (2.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.08e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.20e-1)"	"prognostic favourable (1.24e-5)"	"unprognostic (8.19e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.63e-2)"	"unprognostic (5.03e-2)"	28.7	69.7	70.3	38.6	60.3	57.0	35.5	69.3	73.9	47.2	79.3	31.9	49.0	49.5	26.6	54.8	69.6	94.9	44.8	102.4	56.7	74.2	57.3	54.2	50.3	25.0	68.6	70.2	42.2	72.0	36.0	53.7	49.1	71.4	30.7	71.2	33.9	77.5	62.6	104.7	27.0	51.2	30.9	44.1	27.3	64.5	35.0	29.3	25.1	82.0	64.8	33.5	34.4	50.4	55.2	69.2	115.0	66.9	48.4	40.5	75.3	26.0	53.2	32.3	53.3	34.8	52.3	37.3	32.7	52.4	24.0	30.0	38.7	53.6	38.3	57.2	52.2	59.7	30.1	69.4	15.3	53.1	23.7	38.6	83.8	44.1	71.4	14.6	32.9	53.0	90.7	40.3	40.9	36.5	21.7	91.0	33.8	66.2	25.5	63.5	48.9	68.2	24.6	33.1	135.2	90.0	51.8	27.4	52.0	27.3	60.7	93.2	44.4	33.3	35.1	34.4	32.0	39.7	14.4	46.6	55.4	45.0	41.6	29.5	26.8	79.8	66.9	85.4	37.7	59.6	32.7	53.8	35.0	30.8	52.4	55.2	34.8	35.0	115.0	48.4	52.5	69.2	40.5	75.3	70.3	60.3	69.3	73.9	56.7	74.2	68.6	70.2	71.4	29.3
PRDX6	"1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX"	ENSG00000117592	"Peroxiredoxin 6"	P30041	1	173477266-173488807	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006983, CAB008663"	Supported		Supported	"Plasma membrane,Cytosol"			180000000	"Plasma membrane, Cytosol"		"CAB008663: AB_1620994, HPA006983: AB_1079595"	"unprognostic (9.92e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (1.23e-5)"	"unprognostic (5.71e-3)"	"unprognostic (2.80e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.96e-3)"	"unprognostic (3.19e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (9.51e-4)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.73e-3)"	80.0	42.1	32.8	30.8	38.9	21.8	106.3	19.8	32.8	27.2	46.7	37.4	35.8	12.1	30.8	54.1	39.9	40.2	22.3	70.5	29.0	23.9	45.9	116.1	29.2	37.5	34.0	28.2	31.5	39.3	63.9	19.1	36.9	30.3	40.0	56.0	21.3	22.6	35.4	128.0	25.7	20.2	40.5	19.7	23.1	33.2	44.9	24.1	17.4	46.9	68.6	25.7	36.5	46.2	17.2	37.9	14.3	23.9	12.0	25.0	30.6	51.2	15.8	26.2	29.0	101.5	49.6	22.1	104.7	35.7	43.7	31.1	29.7	34.5	33.4	33.5	85.8	29.9	34.2	33.7	35.6	29.3	31.6	22.1	27.0	33.5	57.3	23.1	7.3	41.1	34.2	24.0	33.7	42.8	49.2	6.9	49.6	10.5	15.7	30.5	57.5	97.9	18.8	30.3	34.0	65.5	11.7	12.2	22.6	36.1	42.5	24.0	35.9	32.7	28.8	17.1	19.5	25.8	28.4	10.5	15.4	27.4	20.4	20.1	15.5	13.9	23.9	12.9	17.0	20.6	18.9	17.2	17.6	21.1	29.3	13.6	23.2	25.0	14.3	12.0	17.5	37.9	20.4	30.6	32.8	38.9	19.8	32.8	29.0	23.9	34.0	28.2	30.3	24.1
PRELID1	"CGI-106, PRELI, PX19"	ENSG00000169230	"PRELI domain containing 1"	Q9Y255	5	177303774-177306959	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005701	Approved		Supported	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA005701: AB_1079721"	"unprognostic (1.27e-1)"	"unprognostic (8.99e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavourable (5.46e-5)"	"unprognostic (7.63e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavourable (2.89e-7)"	"unprognostic (3.59e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.21e-1)"	18.9	25.0	21.9	33.9	20.3	30.3	21.6	12.0	31.1	16.9	44.6	14.8	15.4	43.5	18.3	15.5	35.6	17.4	20.6	16.8	19.3	18.6	46.1	62.3	18.9	43.0	20.2	14.7	20.3	91.6	12.3	17.7	29.4	21.0	19.8	35.0	18.9	40.1	16.4	11.9	26.2	70.6	19.0	14.8	43.5	24.6	12.9	13.5	25.2	29.3	27.2	33.7	18.0	18.9	27.1	77.4	111.7	94.2	30.4	26.4	49.2	31.8	30.0	18.3	48.7	16.4	17.8	60.8	22.8	15.9	33.3	32.2	67.1	36.6	27.1	26.9	21.4	18.1	32.5	60.9	22.8	116.1	45.0	23.4	31.1	44.6	17.3	36.8	33.0	16.0	21.9	26.3	22.5	41.2	25.8	39.3	32.4	82.8	23.6	53.9	37.2	49.6	7.6	36.9	48.7	21.7	26.7	29.2	36.7	21.3	42.5	39.6	27.4	45.3	22.7	30.5	26.7	25.0	54.5	22.0	37.7	39.4	26.3	49.7	31.7	31.5	75.7	111.7	26.4	94.2	25.8	27.1	21.9	26.2	77.4	21.1	19.3	21.1	55.2	30.4	90.3	28.3	23.3	49.2	21.9	20.3	12.0	31.1	19.3	18.6	20.2	14.7	21.0	13.5
PRELP	"prolargin, SLRR2A"	ENSG00000188783	"Proline and arginine rich end leucine rich repeat protein"	P51888	1	203475828-203491352	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 183.7"	"Group enriched"	"Detected in some"	9	"ASC diff: 18.5;BJ: 7.5;fHDF/TERT166: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"		280000				"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"prognostic unfavourable (9.70e-5)"	"unprognostic (2.83e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (5.62e-6)"	"unprognostic (2.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (1.02e-4)"	46.7	16.0	6.3	7.7	5.8	1.1	52.3	3.6	5.0	57.4	35.7	3.7	16.8	5.0	45.3	17.8	46.2	29.5	27.4	58.6	7.0	1.8	8.1	7.3	49.9	5.2	6.4	9.5	62.3	6.6	1.8	7.3	8.3	8.6	48.3	6.6	64.6	10.4	52.5	24.5	16.4	17.0	61.8	7.7	22.6	13.5	23.4	3.3	0.0	25.1	16.1	11.5	98.7	183.7	1.0	1.0	4.0	1.2	1.1	0.8	0.6	0.2	0.2	0.5	0.2	18.5	0.5	0.5	7.5	1.0	0.2	0.2	0.0	0.2	1.1	0.7	11.4	0.7	0.2	0.3	0.3	0.1	0.2	0.4	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.1	0.2	0.1	0.2	0.5	1.3	0.1	0.2	0.5	0.5	0.1	0.4	0.2	0.5	0.0	0.3	1.1	0.3	0.2	0.2	0.8	0.3	0.2	0.6	0.5	0.3	0.3	0.1	0.3	0.4	1.2	0.1	0.2	0.5	4.0	1.2	1.7	0.7	1.0	0.8	0.6	0.7	0.5	0.4	1.0	0.7	0.6	2.7	1.1	1.1	1.0	0.6	0.6	6.3	5.8	3.6	5.0	7.0	1.8	6.4	9.5	8.6	3.3
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105277565-105403084	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol			1400000	Cytosol		"CAB025414: , HPA031388: , HPA031389: , HPA031390: "	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	13.0	14.2	10.1	22.2	10.1	10.4	36.2	10.9	24.9	11.9	27.2	5.2	11.2	20.2	13.2	10.9	16.4	10.5	15.0	19.0	8.8	7.1	8.9	14.6	23.9	31.4	8.3	15.4	13.6	18.8	16.1	11.1	15.4	9.7	9.4	33.0	8.9	14.9	11.5	58.0	24.2	19.0	15.3	8.5	11.9	14.0	20.1	8.8	17.4	10.2	18.5	13.3	18.2	21.0	8.3	15.3	7.1	18.7	16.6	16.3	11.2	10.8	13.3	14.2	15.9	33.6	19.9	14.0	14.6	13.7	19.3	20.5	16.9	6.9	13.9	14.4	17.1	16.9	20.9	42.8	22.0	21.0	20.4	18.7	11.2	19.2	13.0	18.8	13.7	18.5	26.1	13.9	35.8	18.0	31.8	24.9	23.3	17.6	12.5	19.1	13.7	13.3	19.4	24.5	9.1	14.4	25.9	18.6	26.5	12.8	21.5	10.2	9.2	30.2	18.1	8.9	12.3	11.1	17.9	7.3	4.8	18.2	15.7	20.5	27.6	4.8	13.6	7.1	16.0	15.4	15.6	8.3	13.7	16.3	15.3	6.8	12.9	15.2	0.7	16.6	18.7	6.5	12.0	11.2	10.1	10.1	10.9	24.9	8.8	7.1	8.3	15.4	9.7	8.8
PREX2	"DEP.2, DEPDC2, FLJ12987, P-REX2, PPP1R129"	ENSG00000046889	"Phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2"	Q70Z35	8	67952118-68237030	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 12.7;HUVEC TERT2: 17.3;NTERA-2: 11.0;RH-30: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015234, HPA075956"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA015234: AB_1847604, HPA075956: "	"unprognostic (2.25e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (1.61e-7)"	"unprognostic (8.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (6.64e-2)"	18.8	3.0	14.1	3.3	17.9	1.0	8.5	11.4	16.4	10.8	4.4	13.1	3.0	4.3	6.2	4.5	4.4	12.4	7.6	7.6	15.5	8.1	4.1	3.2	9.1	2.4	12.4	10.0	5.2	3.1	3.7	4.4	17.5	17.2	6.3	4.4	2.6	3.0	5.7	4.9	4.4	4.0	6.1	12.7	3.5	4.1	2.7	16.2	0.0	12.1	3.9	2.9	5.9	15.8	1.1	0.3	0.8	0.1	0.2	0.4	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	2.6	0.0	11.0	0.0	0.0	5.0	0.0	0.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.1	0.1	0.4	0.1	0.2	0.5	0.2	0.2	0.0	1.1	0.2	0.3	0.5	0.2	0.1	0.3	0.0	0.0	14.1	17.9	11.4	13.6	15.5	8.1	12.4	10.0	17.2	16.2
PRG2	"BMPG, MBP, proMBP"	ENSG00000186652	"Proteoglycan 2, pro eosinophil major basic protein"	P13727	11	57386794-57390657	"Plasma proteins, Predicted intracellular proteins"	Immunity	"Antibiotic, Antimicrobial, Heparin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"placenta: 322.3"	"Group enriched"	"Detected in some"	63	"HL-60: 140.2;HMC-1: 222.9;NB-4: 443.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"basophil: 9.1"	"Lineage enriched"	"Detected in single"	92	"granulocytes: 9.1"	"Not detected"	"Not detected"							HPA038515	Supported				"Intracellular and membrane"		130000000			"HPA038515: AB_10675800"	"unprognostic (7.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.39e-2)"		"unprognostic (3.49e-1)"	"unprognostic (8.62e-4)"	"unprognostic (4.77e-3)"	"unprognostic (3.20e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.40e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.32e-1)"	1.5	0.0	0.1	0.1	0.1	16.9	0.9	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.6	0.0	0.2	0.3	0.1	0.0	0.1	2.8	2.2	0.1	0.1	0.1	0.1	0.3	0.0	0.4	322.3	0.1	0.1	0.0	0.1	0.5	0.1	0.3	1.8	0.1	0.1	0.1	6.8	0.1	0.1	0.1	1.6	0.4	0.1	0.2	0.1	0.2	0.0	0.0	9.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	140.2	222.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	443.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
PRG4	"bG174L6.2, CACP, FLJ32635, HAPO, JCAP, MSF, SZP"	ENSG00000116690	"Proteoglycan 4"	Q92954	1	186296279-186314562	"Disease related genes, Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 20.9;liver: 76.0"	"Cell line enriched"	"Detected in some"	7	"ASC diff: 79.8"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 28.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"T-reg: 4.0"	"Lineage enriched"	"Detected in single"	33	"T-cells: 4.0"	"Low region specificity"	"Detected in many"							HPA028523	Uncertain				"Secreted to extracellular matrix"		4300000000			"HPA028523: AB_10669642"	"unprognostic (8.67e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.87e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.91e-13)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.60e-3)"	"unprognostic (7.05e-3)"	20.9	0.7	0.1	1.0	0.1	0.2	5.1	0.2	0.3	0.2	2.8	0.4	0.1	0.1	0.2	1.7	0.9	6.8	0.3	11.0	0.1	0.3	0.2	76.0	7.2	0.3	0.3	0.1	0.7	1.1	0.1	0.3	0.1	0.3	0.3	0.2	2.6	1.0	0.2	13.8	1.6	0.2	0.7	0.1	0.3	0.2	1.1	0.1	0.2	0.7	1.9	0.3	0.7	0.1	0.1	0.0	0.0	0.0	0.0	4.0	0.1	0.0	0.0	0.0	0.0	79.8	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.3	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.6	0.2	0.0	0.0	0.0	0.0	4.0	0.1	0.1	0.1	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.1
PRICKLE2	DKFZp686D143	ENSG00000163637	"Prickle planar cell polarity protein 2"	Q7Z3G6	3	64092242-64445476	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.1;ASC TERT1: 11.3;HSkMC: 16.6;U-87 MG: 11.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.1;NK-cell: 1.1"	"Group enriched"	"Detected in many"	6	"B-cells: 2.1;NK-cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035493			Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA035493: AB_10696504"	"unprognostic (2.87e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.77e-1)"	26.5	4.9	15.2	6.9	14.2	1.3	19.8	2.6	23.0	24.4	20.4	5.2	13.8	3.9	24.8	13.7	11.2	14.3	12.6	7.8	15.7	8.4	6.0	4.9	13.2	1.8	7.0	13.2	12.7	5.5	13.3	8.7	8.1	8.9	11.0	7.1	8.7	6.1	19.9	2.6	5.3	7.4	22.8	6.2	2.7	11.4	2.9	5.5	0.0	9.9	3.6	2.2	14.9	18.2	2.1	0.0	0.2	0.0	1.1	0.1	0.1	0.0	3.4	0.9	0.0	18.1	11.3	0.0	2.5	3.2	2.1	3.1	5.9	0.1	0.0	0.3	2.4	0.1	0.0	2.3	2.1	2.3	0.1	0.0	0.3	0.0	5.1	0.0	0.0	16.6	2.9	6.0	2.6	1.2	0.0	1.3	2.8	3.2	0.0	0.0	2.2	0.0	0.0	0.1	0.1	3.3	8.3	0.9	0.1	0.0	0.6	0.1	1.2	0.1	0.1	8.9	4.1	2.1	4.9	2.7	0.0	0.5	11.5	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	1.1	0.0	0.0	0.0	0.1	15.2	14.2	2.6	21.6	15.7	8.4	7.0	13.2	8.9	5.5
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646849	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.7;prostate: 22.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm				Nucleoplasm		"HPA046566: "	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavourable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.00e-5)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavourable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	5.4	1.6	1.7	9.0	2.3	7.8	4.1	6.5	3.3	5.3	3.9	2.5	2.4	3.0	9.7	3.7	5.6	3.7	2.7	3.1	2.8		3.5	2.7	2.7	7.1	3.6	1.5	4.3	2.2	2.4	5.4	5.9	1.7	22.6	5.0	3.5	7.3	3.4	1.1	3.4	3.7	5.8	3.6	6.7	2.4	5.3	3.1	21.7	4.6	4.5	8.7	4.7	2.7	5.0	7.3	2.5	5.4	5.6	7.9	2.7	15.1	6.2	12.4	14.3	7.1	12.5	10.3	18.7	18.3	20.9	28.1	9.8	7.3	13.9	10.4	23.3	10.3	11.1	10.7	25.9	15.1	9.0	16.4	8.5	16.4	2.9	15.8	10.4	4.7	4.0	23.0	8.1	9.4	15.5	36.9	17.4	9.6	16.5	12.5	7.8	6.1	12.6	17.1	11.0	7.6	7.9	9.2	6.9	12.1	5.8	7.6	12.4	13.7	6.5	21.3	21.0	39.0	15.8	5.0	9.6	16.1	9.7	16.7	11.4	0.3	2.4	2.5	5.5	5.1	6.2	5.0	5.0	7.5	4.1	4.9	3.6	7.9	1.0	5.6	5.4	7.3	5.9	2.7										
PRKAG2	"AAKG, AAKG2, CMH6, H91620p, WPWS"	ENSG00000106617	"Protein kinase AMP-activated non-catalytic subunit gamma 2"	Q9UGJ0	7	151556111-151877125	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"		"Cardiomyopathy, Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004246, CAB018641"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"CAB018641: AB_2170355, HPA004246: AB_1078151"	"unprognostic (4.11e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.46e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.33e-3)"	"unprognostic (7.13e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.52e-1)"	12.8	5.5	15.3	8.7	28.8	6.3	9.7	31.1	19.2	8.8	11.5	7.5	9.4	16.7	10.4	10.9	10.8	8.6	12.0	77.2	15.1	13.5	15.4	18.5	8.6	7.7	12.3	14.3	6.8	6.2	6.7	5.1	20.0	18.3	17.5	13.5	7.8	11.9	14.8	21.5	6.9	17.8	32.8	8.5	12.8	13.8	9.7	9.5	2.3	12.6	5.2	7.1	22.4	12.4	7.9	7.8	18.4	6.0	3.1	6.1	3.5	18.2	5.3	3.6	4.2	16.4	14.0	6.4	8.4	7.6	9.1	8.9	3.4	23.4	0.0	13.9	11.2	5.9	2.2	9.8	14.8	4.4	2.5	4.9	0.6	0.4	24.4	3.6	4.7	6.8	21.0	9.1	9.7	15.6	1.6	2.3	27.5	6.9	1.9	2.6	3.7	15.5	1.8	2.6	3.8	17.3	4.4	16.1	2.5	4.9	9.2	3.7	2.9	4.9	20.8	2.1	1.8	1.0	5.3	1.6	1.9	0.0	25.9	11.3	20.4	18.4	6.0	10.5	5.1	5.4	3.7	7.9	4.5	4.5	4.3	3.8	4.2	6.1	13.6	3.1	5.4	7.8	2.4	3.5	15.3	28.8	31.1	19.2	15.1	13.5	12.3	14.3	18.3	9.5
PRKAR1A	"CNC1, PRKAR1, TSE1"	ENSG00000108946	"Protein kinase cAMP-dependent type I regulatory subunit alpha"	P10644	17	68511780-68551319	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Cushing syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019378, HPA049979"	Approved		Approved	Cytosol			11000000	Cytosol		"CAB019378: , HPA049979: "	"unprognostic (8.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (5.34e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-3)"	"unprognostic (6.26e-2)"	"unprognostic (6.92e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.11e-1)"	47.1	48.0	41.7	34.5	54.8	14.6	38.7	40.4	57.4	48.2	23.8	44.9	31.4	15.1	43.6	37.7	29.6	43.2	37.4	122.7	42.5	52.3	49.2	43.4	47.3	29.5	50.1	43.6	62.5	19.1	107.8	41.9	47.3	57.7	35.6	24.2	32.2	47.5	43.6	99.8	22.8	19.3	39.4	52.8	35.3	25.1	36.9	40.1	28.2	51.8	23.6	29.2	33.8	33.4	11.3	26.9	52.6	28.7	18.5	13.0	22.9	16.4	31.6	40.6	24.3	54.2	61.6	6.1	22.2	45.8	34.7	30.7	12.3	22.2	16.7	15.3	48.4	13.6	30.0	36.0	49.9	11.3	10.7	25.8	27.5	40.2	39.3	19.7	29.0	44.0	37.4	40.0	33.8	57.6	11.6	26.3	42.0	31.1	21.7	10.6	15.0	21.6	15.2	67.3	18.4	52.6	35.8	14.8	20.0	20.3	37.2	85.5	29.0	27.9	40.8	49.0	23.4	22.1	20.6	21.9	15.5	24.9	29.6	18.8	30.5	31.1	26.1	46.3	13.0	25.5	13.0	11.3	9.8	11.6	26.9	8.5	8.9	9.8	52.6	18.5	28.7	8.8	12.3	22.9	41.7	54.8	40.4	57.4	42.5	52.3	50.1	43.6	57.7	40.1
PRKAR2A	PRKAR2	ENSG00000114302	"Protein kinase cAMP-dependent type II regulatory subunit alpha"	P13861	3	48744597-48847846	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005023, HPA038268"	Uncertain						350000			"CAB005023: AB_562330, HPA038268: "	"unprognostic (2.81e-2)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.27e-5)"	"unprognostic (1.60e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.17e-3)"	"prognostic unfavourable (1.97e-4)"	"unprognostic (4.77e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"prognostic favourable (2.07e-4)"	"unprognostic (3.59e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-2)"	14.4	14.0	7.7	8.2	7.9	10.0	8.7	8.3	9.1	11.0	13.9	9.7	12.7	7.9	10.5	9.6	13.7	11.2	10.6	16.8	6.5	8.4	13.2	20.1	8.1	7.2	7.7	7.9	13.2	9.2	11.6	6.9	7.0	7.9	10.6	12.4	11.3	14.3	13.5	47.7	9.5	12.6	10.6	6.9	8.3	9.7	58.4	6.1	3.2	11.0	14.2	10.6	13.3	13.9	8.1	8.7	13.3	14.6	9.7	10.1	6.7	17.1	11.6	9.7	7.5	14.6	14.9	10.9	19.8	9.9	17.4	11.0	15.3	7.7	15.1	13.9	20.5	7.9	27.7	17.3	23.5	12.4	10.2	20.2	21.1	11.2	10.8	21.1	13.0	12.4	13.6	22.3	16.5	18.3	22.6	9.7	16.3	6.7	0.1	6.9	6.9	12.9	6.4	12.3	19.2	11.2	18.9	9.6	9.9	19.4	23.3	13.1	15.6	16.5	23.1	15.3	12.3	24.9	27.1	16.7	31.9	14.7	20.6	23.4	11.6	10.9	9.1	10.5	10.1	8.1	9.7	8.1	8.5	8.6	8.7	7.6	6.1	6.0	13.3	9.7	14.6	5.4	7.4	6.7	7.7	7.9	8.3	9.1	6.5	8.4	7.7	7.9	7.9	6.1
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"			1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.3	2.5	2.6	6.2	15.9	0.3	13.3	8.7	9.6	8.2	1.4	1.5	3.1	3.6	21.4	0.3	1.3	1.5	20.9	5.1	3.0	0.0	7.3	6.4	8.5	3.8	20.9	6.9	0.6	12.0	10.3	8.2	8.0	0.0	14.8	0.7	7.7	2.3	1.0	6.6	1.4	18.8	0.0	3.4	2.0	1.5	8.5	4.4	2.5	0.1	0.3	5.4	24.5	16.7	9.7	10.4	8.3	0.0	0.0	0.3	53.0	0.0	8.2	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4
PRKCB	"PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835946-24220611	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 57.2;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in some"		"HEL: 40.8;HMC-1: 40.9;K-562: 58.1;THP-1: 18.4;U-937: 16.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol			3400000	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: , HPA054203: "	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.0	1.9	13.9	20.8	55.6	20.4	1.8	14.1	57.2	4.1	4.7	4.4	0.6	4.9	3.5	1.2	3.2	2.6	3.9	1.5	23.4	7.8	1.8	3.7	5.4	31.0	11.0	20.4	1.2	1.4	0.9	1.4	2.5	8.3	6.2	4.4	3.5	1.9	8.4	1.2	4.6	9.1	5.8	7.3	31.2	3.8	6.4	6.4	24.1	3.9	0.0	27.7	7.6	1.7	23.6	18.5	21.8	14.6	20.1	19.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.8	40.8	1.9	0.0	0.0	5.9	40.9	0.0	0.1	0.0	0.0	0.0	58.1	0.1	0.0	0.0	12.9	12.9	0.3	0.0	12.3	0.1	2.3	0.1	3.6	7.1	0.0	0.0	0.0	0.6	0.0	18.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	16.4	0.0	17.5	7.6	14.4	14.5	10.7	6.7	23.6	9.5	17.2	6.2	22.1	7.8	19.0	21.8	20.1	14.6	18.5	6.7	7.5	13.9	55.6	14.1	57.2	23.4	7.8	11.0	20.4	8.3	6.4
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell line enhanced"	"Detected in some"		"HEL: 30.9;MOLT-4: 23.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"			200000	"Centriolar satellite"		"HPA065279: , HPA073098: "	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	1.8	3.3	0.0	0.0	2.1	30.9	0.0	0.2	0.4	1.5	0.3	0.1	2.0	0.1	0.1	0.3	6.7	0.0	0.0	0.0	23.2	4.3	3.2	0.0	4.5	0.7	0.0	6.5	1.6	0.2	1.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5
PRKCSH	"G19P1, GIIB, PCLD, PLD1, VASAP-60"	ENSG00000130175	"Protein kinase C substrate 80K-H"	P14314	19	11435288-11450968	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004465, HPA041940, HPA043560"	Supported		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"		62000000	"Endoplasmic reticulum"		"CAB004465: AB_626622, HPA041940: , HPA043560: "	"unprognostic (2.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.15e-2)"	"prognostic unfavourable (7.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.18e-1)"	46.9	37.4	26.9	32.5	28.5	50.9	45.0	37.8	39.4	46.8	42.6	36.3	50.1	43.6	50.1	48.4	41.2	50.2	50.2	31.5	27.7	27.3	41.2	85.6	39.9	53.2	29.6	32.1	72.6	77.7	52.9	40.3	72.7	27.0	48.8	38.4	43.9	58.8	53.1	31.3	43.8	41.8	40.1	38.6	42.5	37.9	42.8	29.8	51.6	60.1	32.7	41.9	44.6	44.9	26.2	44.1	32.8	29.8	19.5	28.5	19.4	48.6	34.2	38.0	63.6	65.1	84.4	39.5	52.4	71.6	61.5	58.1	49.9	54.8	31.3	85.0	72.1	48.5	39.1	57.1	49.8	33.6	25.1	27.2	42.9	43.2	48.7	42.4	40.0	77.0	42.7	57.7	45.6	42.1	31.4	71.0	53.1	71.8	33.0	49.0	79.9	44.2	35.3	34.7	79.7	42.8	42.6	24.1	47.5	45.8	47.7	42.9	49.0	47.0	42.4	74.7	35.3	70.8	61.4	87.4	103.9	21.8	57.1	44.6	50.9	15.9	29.8	23.8	24.9	22.2	28.5	23.9	21.0	23.8	22.6	26.2	20.3	21.3	32.8	19.5	24.4	44.1	22.0	19.4	26.9	28.5	37.8	39.4	27.7	27.3	29.6	32.1	27.0	29.8
PRKCZ	PKC2	ENSG00000067606	"Protein kinase C zeta"	Q05513	1	2050470-2185395	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.6;placenta: 93.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"eosinophil: 15.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021851	Enhanced		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA021851: AB_1855433"	"unprognostic (1.25e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	"prognostic favourable (1.64e-9)"	"unprognostic (3.57e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.85e-2)"	1.2	7.8	15.9	3.0	31.8	1.4	3.9	39.8	43.6	3.2	8.6	17.1	2.3	20.0	1.7	5.5	10.1	6.5	3.1	6.4	15.5	6.4	11.3	6.8	22.3	5.0	12.2	23.6	1.9	8.5	9.8	12.0	93.0	27.3	5.8	7.5	2.6	7.0	3.0	0.4	8.8	18.4	1.2	8.4	6.9	6.1	17.5	13.5	0.6	14.1	0.9	5.0	4.0	4.6	0.4	0.3	15.0	0.3	0.8	2.6	0.3	7.5	4.8	1.7	8.9	0.0	0.0	23.5	0.5	0.2	5.6	0.3	12.1	16.4	0.0	14.9	1.9	13.2	10.1	12.5	4.0	0.5	11.2	0.0	7.7	16.1	1.6	0.0	5.8	0.3	7.5	0.0	4.3	0.0	3.3	0.1	0.1	9.2	0.4	0.0	3.4	11.7	0.0	0.0	2.6	9.6	7.9	12.3	9.9	6.1	13.7	2.6	9.6	2.0	0.0	0.0	7.1	0.1	0.0	3.5	0.6	0.1	0.6	0.1	8.5	0.3	0.0	15.0	0.6	0.3	2.6	0.3	1.0	0.6	0.0	0.4	0.8	0.4	1.2	0.8	0.0	0.3	0.8	0.3	15.9	31.8	39.8	43.6	15.5	6.4	12.2	23.6	27.3	13.5
PRKD1	"PKC-mu, PKCM, PKD, PRKCM"	ENSG00000184304	"Protein kinase D1"	Q15139	14	29576479-30191898	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.8;fHDF/TERT166: 19.0;HSkMC: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018367, HPA029834"	Uncertain		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	Cytosol	"CAB018367: AB_2253119, HPA029834: AB_10602821"	"unprognostic (5.35e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.27e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.56e-1)"	"prognostic favourable (2.44e-5)"	"unprognostic (9.45e-4)"	"unprognostic (1.99e-1)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (3.89e-1)"	7.4	10.6	8.0	5.3	9.7	0.7	19.0	4.9	8.9	5.1	8.7	5.1	24.1	3.1	8.3	9.0	3.5	6.8	9.0	6.3	9.8	5.9	15.1	2.3	14.9	1.6	5.6	6.6	15.7	7.3	35.7	9.2	4.5	10.8	20.1	3.5	4.9	3.5	24.4	3.1	2.7	3.5	19.7	16.4	2.4	4.8	16.1	8.6	0.5	8.2	2.9	1.8	14.1	12.2	0.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.6	4.0	17.8	16.7	0.1	12.1	9.3	12.4	6.7	0.0	0.5	0.0	1.2	19.0	0.1	5.9	1.4	6.8	0.0	4.1	0.0	0.1	0.4	9.0	0.0	0.1	17.7	0.6	0.8	1.4	2.5	1.2	0.4	11.6	1.3	0.0	0.0	2.5	6.2	0.0	7.0	3.2	13.2	5.6	3.6	7.1	2.1	0.0	4.7	0.0	0.1	6.3	11.7	4.8	1.0	3.5	0.0	0.0	0.0	3.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	8.0	9.7	4.9	8.9	9.8	5.9	5.6	6.6	10.8	8.6
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm			1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: "	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.4	27.8	27.1	25.7	16.9	17.9	11.5	13.8	13.6	19.5	19.2	18.1	10.7	31.0	12.0	16.9	18.5	35.8	18.9	30.6	6.8	22.2	60.9	25.0	22.2	7.3	23.1	12.7	12.9	6.2	30.7	32.2	20.0	40.5	13.1	21.4	15.2	32.6	19.1	29.8	8.4	16.0	21.3	10.9	9.8	28.0	13.6	17.3	42.6	13.9	13.4	19.9	16.0	23.2	25.5	21.7	20.1	27.7	11.5	14.6	44.6	14.4	26.3	20.6	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9
PRKG1	"PGK, PKG, PRKG1B, PRKGR1B"	ENSG00000185532	"Protein kinase, cGMP-dependent, type I"	Q13976	10	50990891-52298350	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.3;BJ hTERT+: 15.5;fHDF/TERT166: 12.9;U-138 MG: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"basophil: 8.0"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007699, CAB009629"	Enhanced		Approved	Vesicles,Cytosol			33000	"Vesicles, Cytosol"		"CAB009629: AB_2170663, HPA007699: AB_1079677"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.94e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.40e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.78e-4)"	8.0	10.9	5.2	6.6	7.3	0.8	6.9	2.8	5.4	19.2	14.4	2.1	6.8	2.9	22.8	10.7	6.0	9.9	12.6	14.8	7.0	4.9	4.4	2.1	19.5	2.6	3.1	4.8	8.9	2.6	13.7	8.4	11.0	4.6	9.5	6.2	6.2	6.4	9.4	24.9	2.8	5.3	28.2	2.7	2.7	5.9	5.0	3.1	0.2	9.2	12.7	1.2	13.4	15.8	0.1	0.1	8.0	0.1	0.3	0.0	0.1	0.0	0.1	1.4	11.3	5.4	5.2	0.0	4.9	15.5	1.6	2.3	0.1	0.7	0.2	0.0	12.9	0.1	0.0	0.0	1.4	0.0	4.2	0.8	0.3	0.0	4.7	0.0	0.0	6.6	0.0	4.1	0.1	0.0	0.0	0.1	4.3	0.1	0.0	0.0	3.2	1.9	0.0	3.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.1	0.1	0.0	0.0	9.5	1.7	4.8	2.9	1.2	0.5	0.0	8.4	0.0	2.0	8.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.1	0.0	0.1	5.2	7.3	2.8	5.4	7.0	4.9	3.1	4.8	4.6	3.1
PRKX	PKX1	ENSG00000183943	"Protein kinase, X-linked"	P51817	X	3604370-3713608	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA015324	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA015324: AB_1855715"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.15e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.70e-2)"	4.3	1.3	12.3	7.5	15.8	5.4	11.2	4.4	12.3	6.9	5.2	5.4	11.5	4.1	7.3	8.4	13.6	16.5	3.9	4.0	14.0	7.4	14.2	2.0	8.4	9.5	27.9	5.6	4.8	4.1	3.2	2.3	6.6	22.7	3.7	5.2	3.1	6.5	5.3	1.6	9.9	6.0	3.0	17.6	10.0	3.1	6.1	22.7	6.1	28.8	3.2	8.0	3.7	11.2	2.5	2.8	12.2	4.1	3.3	3.8	1.7	4.5	4.2	11.6	8.6	2.2	3.0	10.6	2.7	1.0	1.3	1.8	6.2	3.1	0.4	2.7	2.1	3.1	10.8	8.1	2.3	5.0	7.5	5.0	3.2	0.1	2.3	6.4	38.9	2.0	8.7	1.4	5.4	13.1	5.8	6.5	4.4	3.9	7.3	5.8	7.7	4.8	13.7	11.1	8.5	10.7	3.8	7.8	5.0	2.8	1.8	2.7	1.4	5.1	7.1	1.2	2.0	1.9	1.8	0.1	0.3	5.8	0.7	5.8	3.0	12.2	3.1	1.8	3.5	3.3	3.8	2.5	3.7	3.3	2.3	2.4	3.1	3.3	0.8	3.3	4.1	2.8	2.5	1.7	12.3	15.8	4.4	12.3	14.0	7.4	27.9	5.6	22.7	22.7
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22297501	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"pituitary gland: 1739.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 17.6;SCLC-21H: 6.6;U-937: 3.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 1.2;non-classical monocyte: 1.0"	"Group enriched"	"Detected in many"	12	"monocytes: 1.0;T-cells: 1.2"					"Not detected"	"Not detected"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	75460000	3300000			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			0.2	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1739.5	21.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.2	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0
PRMT1	"ANM1, HCP1, HRMT1L2"	ENSG00000126457	"Protein arginine methyltransferase 1"	Q99873	19	49675786-49689029	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022550, HPA069769, HPA072136"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022550: , HPA069769: , HPA072136: "	"unprognostic (1.88e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (8.04e-5)"	"unprognostic (3.43e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.19e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.66e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.10e-2)"	21.3	31.5	27.4	28.1	29.7	21.8	22.0	29.4	35.9	31.8	25.5	26.9	27.8	21.4	36.0	22.5	28.9	45.4	24.5	56.4	25.2	28.6	23.4	20.8	22.0	34.9	32.0	23.8	43.4	35.0	20.0	31.7	27.9	25.6	33.3	18.4	34.1	20.9	31.5	83.8	21.9	19.8	38.3	20.9	33.3	20.3	24.9	28.0	25.0	32.9	31.3	32.0	29.8	23.8	51.9	41.2	9.2	23.6	38.7	35.5	31.8	37.9	86.9	60.3	72.7	16.4	18.6	31.8	24.4	42.7	70.6	60.8	64.8	30.3	62.5	18.2	28.6	28.1	50.8	51.6	30.9	48.5	87.2	45.6	23.9	70.3	40.1	54.8	32.8	26.0	25.7	39.5	56.9	41.7	47.9	44.4	27.4	57.4	70.7	67.8	63.6	56.6	50.3	48.7	57.0	39.7	80.2	67.3	52.4	28.1	29.2	14.9	22.1	32.3	25.9	41.6	40.4	19.0	58.1	42.8	64.4	61.7	25.5	39.7	43.5	5.8	20.2	9.2	28.6	23.6	35.5	51.9	26.6	30.5	34.2	41.9	29.9	29.1	3.9	38.7	17.1	41.2	24.2	31.8	27.4	29.7	29.4	35.9	25.2	28.6	32.0	23.8	25.6	28.0
PRMT5	"HRMT1L5, SKB1, SKB1Hs"	ENSG00000100462	"Protein arginine methyltransferase 5"	O14744	14	22920511-22929585	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005525, CAB012459, HPA064708"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB012459: , HPA005525: AB_1079679, HPA064708: "	"unprognostic (8.34e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.56e-3)"	"prognostic unfavourable (1.82e-4)"	"prognostic unfavourable (4.77e-5)"	"unprognostic (3.64e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (2.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.21e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (1.04e-4)"	17.0	21.6	18.3	17.8	22.8	12.0	21.2	18.4	24.9	20.3	25.0	18.1	24.9	16.1	24.9	19.6	33.1	28.0	16.6	22.3	15.3	13.2	25.7	22.2	15.8	15.6	17.2	15.2	30.2	30.9	30.8	17.4	24.3	15.9	21.1	22.6	16.9	19.0	21.7	42.0	21.7	14.5	22.2	13.4	17.9	19.5	22.1	17.3	22.7	30.9	19.6	22.1	20.8	22.0	17.6	23.8	4.3	17.6	9.8	15.6	15.5	40.0	38.7	28.0	27.7	13.3	15.2	30.5	27.6	20.5	42.9	36.4	35.4	37.3	39.1	22.6	20.3	32.0	55.4	46.4	49.6	25.1	26.8	24.3	26.1	54.4	25.6	51.0	21.2	15.0	24.8	33.2	60.6	20.3	34.4	21.4	22.1	36.2	36.4	22.8	25.0	49.0	43.1	34.0	28.4	20.8	27.5	30.2	19.8	30.1	32.4	14.1	21.8	19.3	19.0	18.2	26.0	25.9	35.1	29.4	62.6	52.0	11.5	24.8	28.4	1.7	16.8	0.2	8.2	17.6	13.4	17.6	11.3	13.5	23.8	15.5	15.6	12.5	4.3	9.8	13.2	14.1	9.4	15.5	18.3	22.8	18.4	24.9	15.3	13.2	17.2	15.2	15.9	17.3
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 114.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"		2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: "	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavourable (2.96e-4)"	"prognostic unfavourable (4.64e-4)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.2	20.0	4.6	7.1	37.3	22.8	4.1	40.2	57.9	19.5	19.9	6.6	18.8	4.4	9.3	78.3	56.5	5.0	54.7	36.6	3.6	4.3	0.0	2.3	20.6	45.9	7.9	1.8	20.6	78.9	83.4	65.2	16.7	2.3	15.8	22.4	5.4	3.1	4.8	3.7	29.8	3.8	12.2	4.0	9.8	4.3	5.4	0.8	11.4	16.0	57.1	3.3	4.1	25.1	31.8	14.6	17.7	32.6	7.3	14.7	14.8	25.6	5.8	114.4	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4
PROC		ENSG00000115718	"Protein C, inactivator of coagulation factors Va and VIIIa"	P04070	2	127418427-127429246	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 137.5"	"Cell line enriched"	"Detected in some"	16	"Hep G2: 57.5"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 118.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 29.2"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005550, CAB016721, CAB016792"	Supported				"Secreted to blood"		6400000000			"CAB016721: , CAB016792: , HPA005550: AB_1079687"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.13e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (2.56e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.60e-3)"	"unprognostic (8.06e-2)"	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.2	4.2	137.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.4	29.2	3.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.5	0.0	0.3	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.0	2.7	57.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	29.2	0.0	0.1	0.4	0.1	0.1	0.2	0.4	0.2	0.1	0.1	0.4	0.0
PROCR	"CCD41, CD201, EPCR"	ENSG00000101000	"Protein C receptor"	Q9UNN8	20	35172073-35216240	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 77.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.9;HUVEC TERT2: 101.2;TIME: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039461	Enhanced						1600000000			"HPA039461: AB_10673359"	"unprognostic (1.51e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.76e-2)"	"unprognostic (5.22e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (7.62e-6)"	"unprognostic (3.37e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.19e-2)"	51.0	11.9	2.3	10.1	3.2	4.4	24.6	2.9	2.3	16.8	25.0	3.1	14.1	8.7	27.7	44.5	19.4	17.3	13.4	27.4	2.7	2.4	11.7	3.8	10.6	30.3	3.1	2.1	19.3	11.5	2.7	4.7	77.8	7.4	15.5	12.3	16.4	4.2	14.0	17.7	10.4	14.0	20.0	5.8	22.1	10.4	9.1	2.0	0.6	12.1	13.0	3.9	25.8	14.9	1.6	7.3	4.1	1.7	3.4	14.6	2.0	2.4	14.5	0.0	1.5	16.0	13.1	3.4	3.4	14.9	5.6	11.0	18.7	12.7	0.4	10.7	3.4	8.0	3.3	21.7	4.7	0.1	4.5	5.3	3.5	0.7	3.9	0.2	64.9	11.1	8.1	26.6	22.2	101.2	1.8	0.7	5.8	0.8	0.1	0.2	2.0	15.0	0.1	2.8	0.0	9.6	0.9	0.4	0.2	1.8	3.9	3.0	1.3	0.8	59.8	14.6	7.4	5.5	5.7	0.0	0.1	0.1	16.8	5.4	3.0	4.1	1.5	0.9	8.3	1.7	14.6	1.0	2.6	5.2	7.3	1.6	0.7	6.3	4.1	3.4	1.4	1.2	2.0	2.0	2.3	3.2	2.9	2.3	2.7	2.4	3.1	2.1	7.4	2.0
PROKR2	"dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2"	ENSG00000101292	"Prokineticin receptor 2"	Q8NFJ6	20	5302040-5314369	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;brain: 5.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.6;NTERA-2: 3.2;SCLC-21H: 1.1;SH-SY5Y: 6.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory CD8 T-cell: 1.6;neutrophil: 1.1"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.1;T-cells: 1.6"	"Region enhanced"	"Detected in many"		"olfactory region: 20.9"	"Low region specificity"	"Detected in all"			HPA047281	Uncertain									"HPA047281: AB_10960057"										"unprognostic (1.36e-1)"					"unprognostic (1.69e-1)"			0.0	0.0	0.4	0.0	0.5	3.7	0.1	0.1	5.9	0.0	0.0			0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.5	0.4	0.0	0.0	0.0	1.8	0.1		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.5	1.4	0.1	0.0	0.1	0.0	0.3	0.3	0.0	0.7			0.0		0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0										
PROS1	PROS	ENSG00000184500	"Protein S"	P07225	3	93873033-93974066	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"		"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.5;ASC TERT1: 31.6;HSkMC: 28.6;SK-MEL-30: 45.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"pons and medulla: 24.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA007724, HPA023974"	Approved				"Secreted to blood"		3400000000			"HPA007724: AB_1079688, HPA023974: AB_1855738"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.21e-2)"	"unprognostic (8.03e-3)"	"unprognostic (3.35e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (4.42e-5)"	16.0	3.9	2.5	3.8	3.8	0.1	15.5	0.8	2.8	7.4	8.0	4.1	2.8	3.9	7.6	9.5	10.9	8.5	11.3	30.2	4.0	3.1	17.6	114.6	17.3	13.7	4.3	1.8	23.9	2.7	10.1	6.2	10.2	24.2	6.8	8.5	9.3	5.6	4.3	5.6	8.5	6.5	8.3	4.8	8.8	4.9	5.5	2.2	0.1	10.6	6.9	3.3	8.0	9.5	0.0	0.8	1.9	0.8	0.1	0.4	6.8	0.3	2.4	2.5	10.2	42.5	31.6	0.8	1.5	3.5	0.8	3.1	6.0	0.9	0.2	9.3	2.3	0.1	0.8	0.6	1.1	0.1	2.7	16.5	1.1	16.9	3.6	0.6	0.8	28.6	0.6	1.8	0.6	3.5	11.4	0.2	16.5	0.2	0.1	0.0	2.0	2.4	0.3	2.0	0.0	9.0	0.0	3.8	7.0	1.8	0.0	45.8	0.1	8.0	3.0	6.8	1.5	3.7	0.8	0.0	0.1	0.0	21.0	10.5	9.8	0.0	0.8	0.7	0.1	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	1.9	0.1	0.2	0.0	0.2	6.8	2.5	3.8	0.8	2.8	4.0	3.1	4.3	1.8	24.2	2.2
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 15.7;RH-30: 8.3;SH-SY5Y: 40.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000842, HPA001030"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000842: , HPA001030: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.5	0.3	0.0	15.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	1.8	2.7	0.0	0.2	0.0	0.2	0.0	0.8	0.7	0.0	8.3	1.2	0.1	0.2	1.2	40.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2
PROZ	PZ	ENSG00000126231	"Protein Z, vitamin K dependent plasma glycoprotein"	P22891	13	113158654-113172383	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 45.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;Hep G2: 7.6"	"Cancer enriched"	"Detected in single"	27	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 2.7;T-reg: 1.5"	"Group enriched"	"Detected in many"	12	"monocytes: 2.7;T-cells: 1.5"	"Not detected"	"Not detected"							HPA052006	Supported				"Secreted to blood"	1716566667	510000000			"HPA052006: AB_2681691"	"unprognostic (5.03e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (3.46e-4)"	"unprognostic (4.10e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.51e-4)"	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	9.3	45.0	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0	2.7	0.0	1.5	0.2	0.9	1.4	0.7	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	3.0	1.8	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.8	2.4	1.0	2.8	7.6	0.1	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	1.0	0.6	0.8	1.8	0.4	1.3	0.2	0.3	0.0	1.1	2.9	0.2	0.0	0.3	1.3	0.0	1.0	0.7	0.8	0.1	0.8	0.3	1.6	0.9	0.8	1.6	0.9	0.7	0.0	0.0	0.0	0.3	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.1	1.5	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890730-60906588	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	20.5	32.2	33.6	27.0	37.9	32.0	28.9	49.6	61.8	30.4	30.6	21.3	24.5	24.2	27.1	21.4	36.7	34.9	20.1	18.0	32.8	46.3	21.5	39.4	18.0	33.1	35.0	50.0	41.3	31.3	45.7	37.6	24.9	46.2	37.7	31.5	21.5	28.8	30.9	31.9	39.0	24.6	28.8	23.7	28.3	23.7	15.2	24.4	46.3	25.3	24.4	41.7	24.8	24.8	3.1	5.3	4.4	11.8	2.4	3.3	1.2	43.8	34.3	38.6	27.5	22.6	19.9	35.0	23.9	32.5	48.1	36.2	37.7	33.2	63.6	32.2	22.9	40.3	54.2	43.1	37.4	43.3	34.6	52.9	27.2	40.4	32.8	69.9	37.8	21.1	32.8	36.9	41.6	37.3	52.5	36.8	23.5	61.8	70.5	52.6	68.2	46.3	62.7	39.5	49.8	24.3	28.8	32.9	39.6	29.6	49.3	39.8	51.5	38.7	23.3	21.3	34.3	37.1	38.6	32.9	46.0	64.0	26.5	48.0	32.0	4.4	11.8	2.6	3.2	5.4	2.6	1.3	2.6	2.3	4.8	3.1	3.3	3.0	0.7	2.4	2.9	5.3	2.2	1.2	33.6	37.9	49.6	61.8	32.8	46.3	35.0	50.0	46.2	24.4
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321476-150353195	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027226: AB_1855770, HPA067116: "	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	21.9	18.6	22.1	28.6	24.0	38.4	23.3	37.8	27.5	21.2	20.0	25.6	27.8	16.7	35.7	27.9	18.6	21.5	17.4	17.3	18.9	12.3	17.6	19.7	20.9	26.2	19.6	19.5	32.7	17.4	22.5	41.9	23.5	17.0	22.0	20.3	27.7	18.9	23.2	19.2	21.6	20.1	22.5	23.6	26.8	16.2	18.9	24.0	27.6	27.7	18.1	27.3	20.7	20.9	13.2	9.3	12.4	19.1	9.9	15.6	7.7	16.5	17.9	18.2	11.6	12.3	13.3	24.8	17.3	12.1	26.8	18.6	13.7	15.5	21.9	11.6	14.1	19.6	32.9	12.1	24.2	10.9	15.2	18.9	26.0	13.0	12.2	23.2	12.2	9.7	16.9	22.8	19.8	16.2	22.4	13.3	19.0	24.6	19.0	20.2	26.1	16.2	27.7	14.8	14.4	11.0	10.0	15.7	13.9	14.5	17.0	13.1	20.3	55.9	12.9	16.9	13.0	14.2	28.4	12.8	22.8	24.6	11.2	21.0	17.5	6.9	8.6	12.4	15.6	11.4	15.0	13.2	11.3	10.1	9.3	10.2	11.7	12.1	5.2	9.9	19.1	7.5	8.5	7.7	22.1	24.0	37.8	27.5	18.9	12.3	19.6	19.5	17.0	24.0
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275343-113292905	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavourable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	16.4	20.9	13.8	23.8	17.4	18.4	21.7	19.4	23.2	15.2	15.7	14.4	20.0	13.4	18.9	28.6	22.9	17.8	17.6	16.8	15.3	13.9	21.5	24.3	15.2	19.6	12.4	19.2	24.3	22.7	19.1	19.6	17.2	19.0	20.6	17.6	13.9	16.8	19.7	26.1	21.8	14.7	21.1	14.4	18.7	15.9	16.6	12.6	21.8	16.5	18.2	23.1	18.0	24.6	16.5	19.9	18.1	21.7	17.0	17.9	13.7	12.8	22.1	14.7	16.2	10.4	10.8	15.0	20.2	10.1	22.3	16.4	21.5	12.0	26.8	11.9	10.9	29.7	30.8	17.7	25.2	19.0	11.6	13.6	19.3	15.7	9.5	23.9	12.5	7.8	12.2	23.2	22.5	10.6	23.3	14.9	19.0	20.0	22.3	17.1	23.4	24.3	20.8	35.3	18.4	9.7	10.5	19.4	13.1	29.5	16.0	9.3	25.0	12.5	10.4	18.2	13.8	23.4	25.6	19.2	51.9	26.3	14.0	15.4	23.3	18.1	15.8	15.1	15.2	19.3	17.9	16.5	15.2	13.8	19.9	16.4	15.5	15.3	5.3	17.0	21.7	13.1	13.6	13.7	13.8	17.4	19.4	23.2	15.3	13.9	12.4	19.2	19.0	12.6
PRPF40A	"FBP-11, FBP11, FLAF1, FLJ20585, FNBP3, HIP10, HYPA, NY-REN-6, Prp40"	ENSG00000196504	"Pre-mRNA processing factor 40 homolog A"	O75400	2	152651593-152717997	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038272, HPA038273"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA038272: , HPA038273: AB_10671526"	"unprognostic (1.81e-1)"	"unprognostic (2.91e-1)"	"unprognostic (4.31e-3)"	"unprognostic (4.49e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (4.62e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.05e-2)"	22.8	21.5	18.8	25.6	21.7	36.6	22.3	30.0	21.3	23.2	24.8	13.0	19.0	22.2	25.1	20.6	28.8	20.3	17.1	16.8	21.1	14.3	26.0	31.1	21.8	27.0	25.2	15.6	24.5	21.1	25.3	30.8	28.4	21.4	23.0	20.7	11.5	23.4	23.3	32.7	25.4	27.0	18.6	24.4	30.5	21.3	25.7	28.7	48.6	24.7	25.7	26.0	24.6	22.8	41.3	50.9	53.3	55.6	39.5	43.4	40.5	21.0	21.0	23.7	24.1	13.8	18.5	33.1	20.9	18.6	29.6	27.4	39.3	19.9	44.1	30.9	21.0	21.6	30.9	25.0	32.1	24.2	26.0	40.4	19.4	26.2	17.9	44.4	28.3	14.7	21.5	39.5	45.0	22.8	43.1	20.8	18.2	12.6	18.8	20.3	35.4	25.3	36.5	25.1	28.7	15.1	33.9	29.5	19.6	25.0	18.4	23.0	16.2	27.9	26.8	31.7	19.8	17.9	26.8	13.6	21.7	44.5	20.1	26.2	19.1	45.0	42.2	53.3	43.1	51.7	39.5	39.9	40.1	38.6	47.7	41.3	43.4	38.5	37.8	39.5	55.6	50.9	34.4	40.5	18.8	21.7	30.0	21.3	21.1	14.3	25.2	15.6	21.4	28.7
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favourable (6.82e-5)"	23.2	21.6	19.6	24.0	20.5	8.5	21.4	35.6	26.8	18.3	19.3	6.0	14.7	12.0	22.2	14.2	23.6	14.7	13.6	16.3	16.5	11.7	15.0	14.5	13.0	15.4	14.5	14.1	19.1	14.4	20.9	30.9	17.1	21.0	14.9	15.7	5.3	22.7	20.4	45.7	16.3	16.4	14.9	23.7	19.0	13.6	11.6	20.2	21.8	21.1	11.3	17.4	21.4	22.2	9.7	13.6	7.5	11.9	11.8	9.1	3.9	14.4	12.6	19.8	13.6	11.3	10.5	9.6	14.1	15.5	15.4	15.5	12.0	7.3	23.8	17.8	15.8	13.0	25.0	12.2	22.1	11.1	18.3	26.7	14.4	10.7	8.7	29.4	14.6	9.6	8.1	10.9	6.8	15.3	36.5	8.8	15.0	8.5	21.6	9.9	11.9	11.7	24.5	19.2	23.0	9.8	16.4	15.4	10.1	16.3	10.2	12.4	15.9	14.8	16.3	15.1	8.7	9.9	13.6	10.0	15.6	27.7	8.3	13.5	18.4	7.5	11.9	3.6	7.6	9.9	9.1	9.7	8.6	9.0	10.2	9.3	8.0	8.0	6.1	11.8	8.7	13.6	6.3	3.9	19.6	20.5	35.6	26.8	16.5	11.7	14.5	14.1	21.0	20.2
PRPF6	"ANT-1, bB152O15.1, C20orf14, hPrp6, Prp6, RP60, SNRNP102, TOM, U5-102K"	ENSG00000101161	"Pre-mRNA processing factor 6"	O94906	20	63981135-64033100	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047106	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA047106: AB_10963084"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-3)"	"unprognostic (7.02e-2)"	"unprognostic (9.36e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.16e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.19e-2)"	"unprognostic (5.39e-3)"	31.5	26.3	28.3	25.0	35.2	25.0	31.4	66.3	46.7	30.1	26.9	43.7	20.8	25.9	37.0	28.9	29.3	44.6	30.3	28.8	26.8	27.6	25.7	25.8	27.9	31.6	28.7	31.0	46.5	33.7	40.5	30.8	29.8	30.1	29.5	23.3	32.3	33.0	34.5	49.3	49.1	27.7	34.2	31.4	32.7	27.6	41.5	30.5	43.8	31.2	28.4	34.4	31.6	27.1	30.1	25.0	31.9	30.4	51.7	44.3	33.8	20.0	24.5	18.0	19.0	20.6	14.5	23.7	15.9	18.0	48.9	21.9	65.5	24.6	25.3	38.9	21.0	31.3	29.0	33.0	26.1	12.1	16.8	21.4	32.7	59.1	22.8	28.9	29.8	16.4	23.6	22.5	26.1	18.1	20.8	22.1	16.2	24.7	29.1	36.2	16.0	30.6	32.2	15.4	24.3	18.6	20.3	18.0	21.1	30.8	31.7	20.2	31.1	37.8	25.5	28.2	16.2	22.4	29.2	18.5	18.0	26.8	20.6	17.5	21.8	31.9	25.3	30.1	30.1	26.7	42.1	30.1	37.3	32.4	25.0	26.3	44.3	36.9	21.5	51.7	30.4	23.2	32.7	33.8	28.3	35.2	66.3	46.7	26.8	27.6	28.7	31.0	30.1	30.5
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684882	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm			240000	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	30.0	37.4	23.1	25.7	40.3	39.0	26.2	43.1	57.2	31.2	28.0	36.5	29.5	19.4	35.6	28.4	29.4	35.4	28.1	34.0	22.2	24.3	23.3	35.5	27.9	30.7	21.3	23.9	47.7	25.9	66.5	45.4	31.1	32.5	30.7	27.2	45.1	30.5	33.1	46.3	30.7	27.5	36.3	17.9	34.1	26.4	45.9	19.6	63.4	30.9	22.2	41.2	32.2	27.9	14.5	20.1	10.0	12.3	10.1	17.1	5.4	18.4	40.2	24.2	19.6	21.0	16.4	19.5	13.8	17.7	27.1	21.9	37.3	9.1	27.1	14.7	24.8	25.7	59.1	23.7	31.3	17.1	37.9	21.5	34.9	31.8	12.3	25.4	23.9	15.6	15.2	34.9	24.4	23.8	21.2	21.6	19.4	20.1	18.3	31.8	16.7	14.9	36.0	13.8	13.0	10.4	20.5	12.4	18.7	27.8	10.1	13.6	14.9	17.0	21.9	16.5	14.2	25.2	31.5	7.9	8.1	19.1	13.7	18.4	20.4	10.0	6.5	6.7	15.7	8.9	17.1	13.3	14.7	15.7	9.7	14.5	13.0	16.4	7.1	10.1	12.3	20.1	14.8	5.4	23.1	40.3	43.1	57.2	22.2	24.3	21.3	23.9	32.5	19.6
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696600-42722574	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 117.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.2;ASC TERT1: 4.8;fHDF/TERT166: 6.9;HHSteC: 10.8;HSkMC: 8.4;LHCN-M2: 4.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029458	Enhanced									"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.0	0.8	1.5	1.0	1.0	0.0	1.0	1.0	4.8	1.7	2.0	1.0	1.0	0.3	2.3	2.3	1.0	0.9	1.2	1.4	1.1	3.0	1.0	1.0	1.2	1.0	1.1	1.0	3.4	2.0	6.9	2.7	1.0	1.0	1.4	0.8	117.8	1.0	1.3	14.4	0.0	1.1	2.3	1.0	1.0	1.0	3.5	1.0	1.0	5.2	1.0	1.0	1.0	1.0	0.6	0.3	3.4	0.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	10.8	0.0	0.0	8.4	0.0	0.0	0.0	1.2	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.4	0.2	0.8	0.2	0.3	0.0	0.3	0.6	0.4	0.2	2.5	0.2	0.6	0.0	0.3	0.0	1.5	1.0	1.0	3.0	1.1	3.0	1.1	1.0	1.0	1.0
PRR4	"LPRP, PROL4"	ENSG00000111215	"Proline rich 4 (lacrimal)"	Q16378	12	10845849-10849475	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"salivary gland: 1184.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;HBEC3-KT: 1.3;Hep G2: 1.6;NB-4: 2.7;U-2 OS: 2.8;WM-115: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042133	Supported				"Secreted to digestive system"		25000000			"HPA042133: AB_10793979"	"unprognostic (1.34e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.03e-2)"	"unprognostic (3.01e-3)"	"unprognostic (3.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.57e-6)"	"unprognostic (2.81e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.15e-2)"	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1184.0	1.1	0.0	4.2	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	20.0	38.4	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.4	1.5	1.3	0.0	0.1	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	2.7	0.6	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620720-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 25.9;HEK 293: 47.2;U-266/70: 24.3;U-266/84: 25.8;U-698: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: , HPA066501: "	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	10.9	18.4	20.7	28.9	22.1	5.0	12.2	25.2	29.1	15.0	24.6	18.4	11.9	4.8	19.7	51.5	47.2	32.3	13.8	24.2	18.4	13.2	16.0	10.2	41.7	14.9	14.3	20.4	29.3	12.2	4.8	18.5	8.6	15.9	30.9	7.1	15.0	12.3	15.9	35.1	28.8	23.0	12.8	11.5	43.5	34.6	46.3	16.7	27.1	16.8	10.4	14.4	16.0	13.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	11.7	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	7.4	13.1	0.0	0.0	25.9	0.0	0.0	47.2	0.1	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	5.6	0.0	0.0	24.3	25.8	24.6	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	22.1	25.2	29.1	18.4	13.2	14.3	20.4	15.9	16.7
PRRC2B	"BAT2L, BAT2L1, KIAA0515, LQFBS-1, MGC10526"	ENSG00000130723	"Proline rich coiled-coil 2B"	Q5JSZ5	9	131373636-131500197	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021022, HPA064301"	Uncertain		Approved	"Nuclear bodies,Cytosol"				"Nuclear bodies, Cytosol"		"HPA021022: AB_1852324, HPA064301: "	"unprognostic (4.78e-3)"	"unprognostic (9.21e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.02e-1)"	"prognostic favourable (5.42e-9)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-2)"	27.4	29.1	43.3	30.3	44.1	30.3	22.1	54.6	56.3	29.4	26.3	32.7	27.3	18.9	33.8	19.7	35.7	36.1	27.5	28.0	39.0	34.1	24.7	18.1	22.5	31.8	26.8	36.8	51.4	30.2	42.0	35.5	23.6	28.9	28.2	15.1	31.8	23.0	29.9	29.4	42.4	23.0	27.2	21.4	27.4	22.2	21.9	26.9	28.1	29.9	18.3	28.1	26.0	29.5	10.3	6.9	4.1	4.5	5.8	7.4	3.0	17.5	34.1	36.5	25.2	27.9	28.8	36.5	17.8	17.5	20.8	17.3	32.0	15.0	30.5	21.1	20.4	42.4	36.4	15.2	15.8	31.3	19.7	19.0	60.1	14.0	18.8	25.1	25.1	28.2	20.2	22.5	26.3	24.0	34.4	22.8	18.7	36.9	21.0	16.2	26.5	14.0	40.8	37.2	29.3	15.1	27.6	49.3	31.0	43.2	26.4	17.9	53.4	15.6	34.7	46.7	21.7	20.6	23.3	10.1	25.0	41.0	16.4	13.6	23.1	4.1	4.5	2.7	7.4	1.9	5.5	5.5	4.4	6.6	2.3	10.3	7.2	6.3	3.2	5.8	1.1	6.9	3.6	3.0	43.3	44.1	54.6	54.7	39.0	34.1	26.8	36.8	28.9	26.9
PRSS1	TRY1	ENSG00000204983	"Serine protease 1"	P07477	7	142749468-142753076	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1708	"pancreas: 3057.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.5;HDLM-2: 1.7;RPMI-8226: 6.9;U-2 OS: 4.1;U-251 MG: 1.5;U-266/84: 2.5"	"Cancer enriched"	"Detected in many"	224	"pancreatic cancer: 1920.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7"	"Low lineage specificity"	"Detected in many"											"CAB025487, CAB025538, HPA062452, HPA063471"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"		26000000000	Vesicles	"Endoplasmic reticulum"	"CAB025487: , CAB025538: , HPA062452: , HPA063471: "	"unprognostic (6.55e-5)"	"unprognostic (5.28e-1)"	"unprognostic (7.58e-2)"	"prognostic unfavourable (6.41e-6)"				"unprognostic (8.26e-2)"		"prognostic favourable (7.05e-4)"	"unprognostic (1.35e-1)"			"unprognostic (3.93e-2)"	"unprognostic (1.96e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (3.12e-1)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.2	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	1.6	3057.4	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.4	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.0	0.0	1.7	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	1.5	0.0	2.5	0.6	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
PRSS12	"BSSP-3, MRT1"	ENSG00000164099	"Serine protease 12"	P56730	4	118280038-118353003	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.5;testis: 31.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 20.4;SH-SY5Y: 64.8;THP-1: 29.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 11.6;basal ganglia: 8.7;cerebral cortex: 26.5;hippocampal formation: 15.3;olfactory region: 11.0"	"Low region specificity"	"Detected in all"			HPA035054	Uncertain		Approved	"Nucleoplasm,Actin filaments"	"Secreted - unknown location"			"Actin filaments"	Nucleoplasm	"HPA035054: AB_10603990"	"unprognostic (4.30e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.41e-2)"	"prognostic favourable (2.66e-4)"	"prognostic favourable (1.03e-4)"	"unprognostic (4.21e-1)"	"unprognostic (3.48e-2)"	"unprognostic (7.83e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.09e-1)"	0.9	0.5	2.1	4.1	1.4	0.0	1.9	0.5	2.8	16.5	6.0	2.0	1.3	2.2	3.0	2.7	3.6	9.8	27.5	0.3	2.2	0.9	1.1	0.8	8.0	0.0	0.7	2.4	1.9	9.8	0.0	0.9	20.4	4.1	2.0	5.8	20.0	3.1	3.2	0.3	5.9	8.6	1.0	0.5	0.3	8.1	31.3	0.2	0.3	0.6	7.7	7.7	3.1	16.2	0.3	0.4	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.5	0.0	0.0	4.1	0.0	13.5	12.2	2.9	4.8	0.0	5.5	0.0	0.0	20.4	0.2	9.1	2.7	3.8	0.0	2.1	0.0	1.1	0.0	0.4	0.0	0.0	1.2	5.2	1.0	3.0	0.0	0.0	0.0	2.3	0.0	0.1	2.7	0.6	0.8	0.0	11.5	0.0	0.0	2.0	1.5	64.8	0.0	0.0	0.8	0.0	29.0	0.0	5.8	0.8	3.6	2.6	0.3	0.0	0.0	0.3	0.9	3.3	0.0	0.1	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.4	0.3	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.1	1.4	0.5	2.8	2.2	0.9	0.7	2.4	4.1	0.2
PRSS2	TRY2	ENSG00000275896	"Serine protease 2"	P07478	7	142760398-142774564	"Enzymes, Plasma proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	708	"pancreas: 6267.9"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 37.2"	"Cancer enriched"	"Detected in many"	72	"pancreatic cancer: 3463.4"					"Group enriched"	"Detected in some"	6	"basophil: 5.6;T-reg: 5.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 5.6;T-cells: 5.1"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"		27000000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: , HPA063471: "	"prognostic favourable (2.32e-4)"	"unprognostic (3.80e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-3)"		"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.36e-1)"		"unprognostic (4.62e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.58e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.18e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.6	6267.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	5.6	0.0	0.7	5.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.4	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.5	2.1	0.0	1.6	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.1	0.3										
PRSS21	"ESP-1, TEST1"	ENSG00000007038	"Serine protease 21"	Q9Y6M0	16	2817180-2826304	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 21.0;salivary gland: 20.9;testis: 37.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.2;HEL: 11.3;HeLa: 29.2;K-562: 13.4;U-698: 41.2"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 23.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basophil: 10.5;eosinophil: 21.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	27	"basal ganglia: 6.7"	HPA008477	Enhanced		Approved	Cytosol	"Intracellular and membrane"			Cytosol		"HPA008477: AB_1079697"	"unprognostic (4.35e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.21e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.07e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.99e-1)"	0.8	0.0	0.2	0.2	0.2	5.5	1.0	0.4	0.4	1.4	0.4	0.2	1.4	0.2	0.3	0.2	0.8	2.2	2.1	0.2	0.2	0.0	0.2	0.2	2.1	3.3	0.2	0.2	0.3	0.9	1.7	0.2	0.3	0.4	1.8	0.2	0.2	20.9	0.2	0.5	0.4	0.4	0.2	0.2	0.9	0.4	37.5	0.2	0.9	0.2	1.2	1.1	0.3	0.6	0.8	1.4	21.0	2.3	1.0	3.3	1.3	4.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	11.3	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	10.5	2.3	21.0	2.2	1.6	3.3	0.8	1.1	1.8	0.6	0.6	1.5	2.2	0.2	1.0	0.3	1.4	0.5	1.3	0.2	0.2	0.4	0.4	0.2	0.0	0.2	0.2	0.4	0.2
PRSS23	"SIG13, SPUVE"	ENSG00000150687	"Serine protease 23"	O95084	11	86791059-86952910	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 59.0;HUVEC TERT2: 73.6;TIME: 137.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 36.4"	"Group enriched"	"Detected in many"	30	"NK-cells: 10.2;T-cells: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA030591	Uncertain				"Secreted to blood"		290000			"HPA030591: AB_10602067"	"unprognostic (2.68e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.40e-3)"	"prognostic unfavourable (2.12e-4)"	"unprognostic (1.89e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.99e-3)"	"unprognostic (8.01e-2)"	19.5	8.7	2.3	10.8	4.1	0.4	40.7	1.2	2.6	89.0	33.8	2.1	37.2	5.1	44.9	27.4	14.5	9.6	45.6	17.2	5.0	3.0	17.5	10.4	36.2	15.9	3.7	4.4	16.2	14.3	9.6	6.3	30.2	12.5	36.7	14.4	15.2	17.6	37.3	19.1	7.2	12.4	100.2	4.9	7.3	22.0	19.5	1.4	3.8	15.3	10.5	5.8	68.6	31.1	0.0	0.0	0.5	0.7	10.2	36.4	10.9	7.3	18.5	19.9	0.1	8.9	21.9	0.0	32.5	29.9	36.3	29.1	42.9	59.0	0.0	25.9	49.8	15.3	0.3	24.8	8.8	0.0	1.5	2.5	9.5	0.1	4.5	0.0	0.1	17.4	3.3	17.7	20.2	73.6	0.1	0.0	27.3	10.1	0.0	0.0	1.2	2.0	0.0	0.0	0.0	13.6	9.9	0.1	0.1	7.2	0.5	2.2	0.7	0.0	137.4	21.7	0.2	43.3	18.4	0.1	0.1	0.0	15.5	0.0	21.4	0.0	0.0	0.0	36.4	0.0	0.0	0.0	6.6	20.5	0.0	0.0	1.8	18.5	0.5	10.2	0.7	0.0	0.0	10.9	2.3	4.1	1.2	2.6	5.0	3.0	3.7	4.4	12.5	1.4
PRSS3	"PRSS4, TRY3, TRY4"	ENSG00000010438	"Serine protease 3"	P35030	9	33750466-33799231	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Digestion	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"pancreas: 984.9"	"Cell line enriched"	"Detected in some"	8	"PC-3: 121.9"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 72.8;pancreatic cancer: 104.4;stomach cancer: 43.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	82	"basophil: 39.0"	"Lineage enriched"	"Detected in single"	82	"granulocytes: 39.0"									"HPA062452, HPA063471"	Supported		Approved	"Endoplasmic reticulum,Vesicles"	"Secreted to digestive system"		490000000	Vesicles	"Endoplasmic reticulum"	"HPA062452: , HPA063471: "	"unprognostic (6.90e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (4.30e-4)"	"unprognostic (3.18e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.94e-2)"	"unprognostic (7.75e-4)"	"unprognostic (5.46e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-1)"	0.3	0.3	1.6	1.7	1.5	0.2	0.2	2.8	4.2	0.9	8.2	0.0	0.0	2.8	0.2	0.2	2.9	0.2	4.8	0.4	1.2	0.7	0.3	0.4	0.2	0.2	0.3	1.6	0.7	984.9	0.2	0.1	0.2	2.3	0.2	2.3	0.0	0.6	0.2	0.2	2.0	23.9	0.3	0.2	0.2	0.8	0.3	0.0	0.0	0.2	6.6	3.5	0.2	1.3	0.0	0.1	39.0	0.4	0.1	0.3	0.1	1.7	2.0	0.1	0.0	0.0	0.9	0.0	4.8	1.1	0.5	0.2	4.7	0.4	0.0	0.0	2.1	2.1	0.0	4.4	1.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.5	15.9	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	121.9	0.0	0.0	0.0	0.0	0.2	0.0	12.3	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	39.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	1.6	1.5	2.8	4.2	1.2	0.7	0.3	1.6	2.3	0.0
PRTN3	"ACPA, AGP7, C-ANCA, MBT, P29, PR-3"	ENSG00000196415	"Proteinase 3"	P24158	19	840960-848175	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Collagen degradation"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 167.3"	"Cell line enriched"	"Detected in some"	5	"THP-1: 148.0"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA005938, CAB017558"	Enhanced				"Secreted to blood"		120000			"CAB017558: AB_2172317, HPA005938: AB_1855764"	"unprognostic (2.81e-2)"			"unprognostic (2.10e-1)"	"unprognostic (3.83e-3)"		"unprognostic (4.20e-1)"	"unprognostic (3.31e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.98e-3)"	"unprognostic (3.67e-2)"	"unprognostic (8.62e-6)"	"unprognostic (5.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.14e-2)"		0.3	0.2	0.9	0.2	1.0	167.3	0.2	0.0	2.3	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	31.0	0.3	0.6	0.2	1.7	8.1	3.5	0.1	0.1	0.4	0.2	0.2	0.8	4.2	0.8	0.2	0.2	0.3	0.3	0.2	0.5	0.3	0.2	0.2	0.0	25.5	0.2	0.2	0.1	35.0	0.9	0.0	0.2	0.2	0.0	0.0	0.0	1.9	0.1	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	148.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	6.8	0.9	1.0	0.0	2.3	0.3	0.6	0.1	0.1	0.8	0.1
PRX	KIAA1620	ENSG00000105227	Periaxin	Q9BXM0	19	40393768-40413366	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.1;lung: 31.7;retina: 20.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"midbrain: 42.1"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	21	"midbrain: 24.7"	HPA001868	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"				"Golgi apparatus, Vesicles, Plasma membrane"		"HPA001868: AB_2172440"	"unprognostic (1.29e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.72e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.03e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.97e-2)"	3.4	4.4	4.8	1.0	4.1	1.1	2.7	2.2	5.4	3.0	2.3	1.8	2.8	1.2	3.8	2.0	2.2	3.2	2.4	2.9	4.0	2.2	4.3	0.6	31.7	1.3	42.1	3.7	7.5	5.4	7.3	1.1	6.0	10.3	3.2	0.8	20.6	3.9	4.4	5.4	2.2	1.5	3.3	11.0	1.7	2.4	1.6	3.6	0.0	7.2	6.7	0.9	3.1	2.0	0.3	0.4	0.0	0.3	0.1	1.2	0.2	2.4	2.7	3.3	4.2	2.7	7.0	4.1	2.0	2.3	2.9	2.1	2.3	2.7	0.8	2.6	1.9	1.3	1.1	0.9	1.0	1.2	1.4	0.5	0.9	0.7	3.2	0.2	3.6	4.9	4.9	1.9	1.6	1.5	3.0	0.8	1.5	3.2	1.1	0.8	0.7	2.5	4.8	2.7	2.4	0.5	1.3	0.3	1.5	3.9	3.3	3.0	4.9	1.2	2.2	5.9	4.6	2.3	1.2	8.4	7.3	1.1	1.8	1.3	1.3	0.0	0.3	0.0	0.6	0.2	0.2	0.0	0.4	0.6	0.0	0.3	0.3	1.2	0.0	0.1	0.0	0.4	0.3	0.2	4.8	4.1	2.2	5.4	4.0	2.2	42.1	3.7	10.3	3.6
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 296.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	24.6	46.6	30.3	63.2	296.6	170.6	107.0	44.8	133.4	35.3	42.1	43.0	62.9	13.4	92.5	73.1	54.1	11.4	36.4	25.0	26.1	21.5	15.7	21.1	24.3	114.3	10.2	90.3	108.5	84.1	35.2	67.6	62.6	22.3	65.0	43.7	15.7	44.9	15.3	13.9	22.7	9.4	17.3	37.3	41.1	42.4	33.6	29.7	41.9	127.1	168.9	25.8	23.4	81.3	49.9	35.4	33.3	36.5	72.6	55.1	23.8	79.2	20.4	36.6	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 148.4;SK-MEL-30: 90.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol			1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: "	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.8	18.1	15.2	27.0	4.5	5.3	36.0	22.8	16.3	11.6	21.8	4.6	5.2	17.4	10.1	51.3	26.7	26.0	25.2	17.4	17.0	9.2	5.9	8.3	35.5	41.8	33.2	10.7	16.9	148.4	15.4	41.3	10.6	6.4	45.0	9.6	10.0	11.3	5.3	34.9	19.8	5.6	9.9	20.5	15.8	6.2	6.9	16.1	6.3	11.0	90.8	5.2	41.9	2.4	2.9	9.5	10.8	18.5	30.6	28.2	0.1	34.3	26.3	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0
PSG9	"PSG11, PSGII"	ENSG00000183668	"Pregnancy specific beta-1-glycoprotein 9"	Q00887	19	43211791-43269530	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	205	"placenta: 299.0"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;BJ hTERT+ SV40 Large T+: 5.4;HBF TERT88: 11.2;T-47d: 5.1;U-2197: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"									HPA046327	Supported				"Secreted in female reproductive system"					"HPA046327: "	"unprognostic (9.32e-2)"	"unprognostic (3.28e-1)"				"unprognostic (2.15e-1)"												0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.2	299.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	6.1	3.4	5.4	2.8	0.1	0.1	0.0	0.2	1.7	0.3	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.7	5.1	0.0	0.3	0.2	2.6	11.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15511019	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	15.1	20.3	42.7	20.8	48.8	24.9	12.2	65.3	49.4	22.6	16.1	19.0	11.5	10.8	27.9	18.2	12.9	20.0	14.9	16.0	38.7	42.7	16.1	10.5	15.6	35.4	34.1	30.2	43.6	8.1	18.8	24.9	18.7	32.4	18.3	15.3	12.3	9.0	21.1	16.3	12.3	14.2	21.3	37.7	24.6	12.5	37.2	29.3	70.4	18.1	6.5	31.9	17.0	16.1	11.4	2.6	8.5	4.3	8.0	16.4	1.9	17.6	11.7	40.0	29.2	8.6	10.5	8.9	21.3	15.2	19.2	22.8	4.9	9.2	37.6	4.9	11.2	4.9	24.8	11.5	27.8	24.7	15.0	130.0	30.7	9.1	10.5	15.1	14.4	8.8	3.4	16.0	11.8	16.7	21.4	20.9	12.4	6.4	31.3	37.7	62.0	18.2	29.3	21.8	7.6	10.7	6.2	25.4	28.0	19.0	8.4	9.9	8.5	20.4	11.8	14.0	14.1	10.4	20.1	9.0	12.6	33.9	11.1	15.3	8.0	8.5	2.1	4.2	5.5	1.6	6.7	8.4	11.0	7.6	2.4	11.4	16.4	10.1	7.2	8.0	4.3	2.6	9.8	1.9	42.7	48.8	65.3	46.6	38.7	42.7	34.1	30.2	32.4	29.3
PSMA2	"HC3, MU, PMSA2"	ENSG00000106588	"Proteasome subunit alpha 2"	P25787	7	42916857-42932223	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA008188	Uncertain						80000000			"HPA008188: AB_1855819"	"unprognostic (9.40e-3)"	"unprognostic (2.08e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.01e-2)"	"unprognostic (9.25e-2)"	"prognostic favourable (6.73e-5)"	"unprognostic (1.77e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.38e-2)"	"unprognostic (4.24e-2)"	24.7	32.2	25.3	24.6	29.5	29.7	29.4	19.6	22.0	19.2	25.6	13.4	26.0	29.8	22.6	26.2	31.1	19.4	20.5	35.8	22.3	16.6	33.3	90.9	23.2	27.4	27.2	17.6	20.8	28.8	12.0	18.8	33.7	29.2	24.5	26.0	10.1	21.7	19.6	57.2	22.4	33.1	22.0	21.4	26.6	27.8	18.6	23.5	42.2	29.9	44.6	29.9	22.8	20.2	46.2	54.1	81.7	47.4	36.7	56.7	75.0	31.9	34.3	40.3	48.6	21.5	24.2	30.1	28.2	33.1	45.7	49.0	51.0	52.6	59.4	50.5	25.0	44.7	41.5	39.2	52.7	42.9	33.0	30.2	46.5	53.8	23.0	51.3	32.8	22.2	28.6	35.2	21.0	42.9	60.9	36.5	36.5	37.4	45.7	100.9	79.7	42.6	44.7	39.2	58.3	43.9	44.1	32.8	33.3	30.7	70.6	30.9	51.4	60.1	30.6	27.1	49.4	29.0	55.6	47.6	72.1	97.2	46.1	65.2	76.5	59.0	45.7	81.7	35.2	45.2	40.4	46.2	43.4	40.5	48.5	40.7	39.0	41.3	23.3	36.7	47.4	54.1	56.7	75.0	25.3	29.5	19.6	22.0	22.3	16.6	27.2	17.6	29.2	23.5
PSMA3	HC8	ENSG00000100567	"Proteasome subunit alpha 3"	P25788	14	58244831-58272012	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000905	Approved						13000000			"HPA000905: AB_1079702"	"unprognostic (3.60e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.91e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.27e-1)"	"unprognostic (7.92e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.65e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (2.91e-4)"	"unprognostic (2.16e-1)"	26.6	41.5	21.3	27.7	25.0	24.3	28.7	16.2	25.1	23.3	26.5	17.5	34.3	27.7	25.4	46.3	33.5	23.4	21.1	55.8	24.2	22.6	51.2	59.6	28.0	31.9	23.2	20.3	23.5	25.1	20.0	30.8	50.6	28.3	24.7	28.9	17.5	25.0	27.7	68.6	18.1	34.4	27.0	22.4	33.9	26.9	15.9	15.8	32.5	37.6	50.6	31.2	32.0	20.5	36.1	50.7	31.2	40.3	38.0	45.9	36.1	66.5	41.5	41.3	33.9	32.5	30.5	53.2	35.2	39.5	49.4	49.7	61.3	55.4	56.1	65.5	31.8	45.9	47.0	37.6	58.1	49.2	28.8	38.4	31.4	69.1	61.7	61.8	33.0	26.0	27.2	34.3	32.7	58.0	36.3	33.2	39.6	75.8	53.9	59.8	28.0	63.0	45.8	53.6	41.5	71.2	65.9	39.0	19.5	31.3	49.8	34.3	51.9	46.4	37.1	28.9	56.4	32.5	47.0	13.4	25.0	57.9	41.6	48.6	34.8	31.2	34.3	20.6	32.4	40.3	40.6	36.1	39.7	38.1	37.9	25.6	32.4	37.2	20.1	38.0	33.7	50.7	45.9	36.1	21.3	25.0	16.2	25.1	24.2	22.6	23.2	20.3	28.3	15.8
PSMA4	"HC9, HsT17706"	ENSG00000041357	"Proteasome subunit alpha 4"	P25789	15	78540405-78552419	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004973, HPA055466, HPA060613"	Supported		Supported	Nucleoplasm,Vesicles,Cytosol			12000000	"Nucleoplasm, Cytosol"	Vesicles	"CAB004973: AB_425627, HPA055466: , HPA060613: "	"unprognostic (1.80e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.35e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.75e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (6.74e-10)"	"unprognostic (1.68e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.78e-3)"	"unprognostic (6.32e-3)"	41.2	38.8	24.9	36.7	25.8	33.4	33.0	25.3	37.5	32.4	38.0	17.9	23.7	39.4	35.3	32.5	49.9	27.1	24.4	37.7	29.8	27.6	55.7	76.3	37.4	45.1	25.5	26.9	31.2	24.4	20.2	25.9	55.4	33.8	35.3	41.3	19.1	26.0	25.0	60.3	26.3	49.1	36.6	28.1	45.5	31.5	36.5	21.4	61.6	42.6	75.0	44.8	41.3	28.3	29.4	61.9	31.4	75.6	37.7	40.0	61.4	40.1	58.2	50.4	44.4	31.8	30.1	39.5	37.8	30.4	46.6	50.0	60.5	58.7	87.7	55.9	34.8	55.0	101.6	41.0	45.1	35.9	70.8	73.6	43.6	48.7	51.6	74.8	45.5	24.3	25.7	39.2	39.1	50.2	78.9	34.4	38.0	57.8	50.4	70.2	47.4	34.2	43.9	66.7	29.4	47.2	70.4	44.5	32.5	60.6	44.3	46.1	40.9	61.6	39.9	34.8	46.5	38.3	64.3	31.5	74.2	82.7	32.6	112.5	38.3	18.8	47.4	31.4	27.8	75.6	28.5	29.4	29.2	29.0	61.9	22.9	23.3	28.3	21.7	37.7	69.7	35.3	40.0	61.4	24.9	25.8	25.3	37.5	29.8	27.6	25.5	26.9	33.8	21.4
PSMA5	ZETA	ENSG00000143106	"Proteasome subunit alpha 5"	P28066	1	109399031-109426427	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028392, HPA028398, HPA028441"	Approved		Supported	Cytosol			22000000	Cytosol		"HPA028392: AB_10600115, HPA028398: AB_10602310, HPA028441: AB_10602003"	"unprognostic (3.82e-2)"	"unprognostic (3.09e-3)"	"prognostic favourable (1.45e-5)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.52e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (5.95e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.20e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.07e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.34e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.05e-1)"	12.1	23.7	13.2	17.3	15.0	7.7	16.2	8.2	40.5	13.3	16.1	9.8	16.7	15.1	15.8	23.0	21.5	17.6	16.7	20.8	13.8	13.5	27.5	41.9	17.1	24.2	13.4	14.9	13.6	21.4	12.6	11.5	20.9	12.8	12.3	14.9	10.2	16.8	14.2	31.6	15.8	21.8	14.4	12.9	18.5	15.2	16.3	10.3	31.5	27.9	23.4	19.8	14.0	11.7	2.1	1.2	7.3	2.2	2.8	7.1	1.6	1.2	1.0	1.6	1.2	3.8	4.1	1.4	0.9	9.1	6.0	3.5	1.2	1.1	5.2	1.2	4.0	1.6	2.3	3.1	3.7	1.1	1.5	2.2	0.9	1.5	2.9	2.9	1.2	1.9	3.0	1.8	3.0	2.2	1.8	1.4	2.5	1.5	30.5	1.2	1.4	1.5	0.8	3.1	0.8	4.8	1.6	1.4	1.1	1.6	5.4	1.9	1.2	2.6	1.4	1.0	0.7	2.1	1.2	0.8	1.8	6.6	6.6	6.6	1.0	7.3	1.0	0.7	4.0	2.2	4.8	1.8	5.8	4.9	1.2	2.1	7.1	6.5	0.3	2.8	2.0	0.8	5.3	1.6	13.2	15.0	8.2	17.5	13.8	13.5	13.4	14.9	12.8	10.3
PSMA6	"IOTA, MGC22756, MGC2333, MGC23846, p27K, PROS27"	ENSG00000100902	"Proteasome subunit alpha 6"	P60900	14	35278633-35317493	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003049	Approved		Supported	Nucleoplasm			19000000	Nucleoplasm		"HPA003049: AB_1079703"	"unprognostic (9.68e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.07e-2)"	"unprognostic (3.42e-2)"	"unprognostic (4.11e-3)"	"unprognostic (7.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.27e-4)"	"unprognostic (1.29e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.45e-2)"	"unprognostic (3.49e-1)"	"unprognostic (5.08e-2)"	33.8	42.7	26.7	31.4	38.8	37.1	38.7	24.2	35.0	28.0	35.8	19.4	24.5	32.2	31.0	30.2	37.9	24.7	20.3	54.2	30.5	27.6	47.3	49.0	37.3	36.4	30.1	36.8	31.1	36.7	14.2	35.8	61.2	31.8	22.5	38.6	18.1	27.3	25.5	94.6	31.8	39.5	27.3	25.2	35.7	28.9	67.5	26.5	86.2	26.0	37.2	38.1	28.8	24.5	37.9	68.5	41.4	65.1	49.9	54.8	104.8	58.9	43.6	32.7	33.2	27.0	28.8	65.4	30.9	37.8	46.8	42.6	40.6	42.8	39.5	59.5	30.0	42.3	38.1	35.3	56.1	39.7	20.8	31.0	31.8	121.4	30.6	64.5	29.0	21.9	29.4	32.7	41.7	39.6	33.1	27.7	37.8	62.6	98.6	55.1	31.2	49.7	147.1	33.2	31.6	40.0	75.8	34.8	29.4	34.5	50.8	32.5	60.8	42.7	32.9	30.2	29.8	30.7	34.2	29.5	64.6	72.2	24.5	40.9	34.0	32.8	65.1	41.4	46.3	59.4	46.2	37.9	44.8	47.1	66.8	29.9	35.9	43.0	23.5	49.9	56.6	68.5	54.8	104.8	26.7	38.8	24.2	35.0	30.5	27.6	30.1	36.8	31.8	26.5
PSMA7	"C6, HSPC, RC6-1, XAPC7"	ENSG00000101182	"Proteasome subunit alpha 7"	O14818	20	62136735-62143440	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046007, CAB046008, HPA047266"	Approved						26000000			"CAB046007: AB_11128404, CAB046008: AB_2171861, HPA047266: "	"unprognostic (1.49e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.79e-2)"	"unprognostic (6.36e-1)"	"unprognostic (6.57e-3)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (8.82e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.21e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.98e-2)"	45.1	40.2	26.5	35.0	28.0	56.1	53.1	23.8	30.7	23.2	34.2	21.1	25.4	32.1	33.3	26.6	36.6	26.4	27.3	64.7	26.3	25.7	36.0	63.6	32.8	36.0	28.4	27.0	28.0	48.0	17.1	21.5	27.9	25.0	27.7	27.6	20.7	25.7	27.7	130.5	26.2	33.1	36.9	24.7	34.8	29.7	16.1	22.6	37.2	33.0	53.4	36.8	36.1	44.0	92.3	112.0	124.4	111.2	64.3	114.6	153.5	56.2	69.9	43.1	44.8	39.8	30.6	39.8	44.2	36.2	108.9	46.0	183.0	53.0	46.8	103.1	44.3	67.6	40.2	78.4	54.3	29.3	31.0	104.9	70.5	92.3	49.4	44.6	61.6	32.7	64.1	56.2	50.0	53.9	46.0	44.8	47.2	57.7	71.5	71.3	36.2	101.1	49.9	81.3	50.7	41.6	53.1	58.1	35.7	66.5	82.6	71.1	49.6	67.6	43.8	96.9	79.9	50.9	65.7	32.1	49.3	55.1	67.6	34.3	56.3	98.4	111.2	124.4	93.3	109.7	79.2	92.3	93.7	92.0	102.8	83.7	74.7	77.5	94.4	64.3	109.7	112.0	114.6	153.5	26.5	28.0	23.8	30.7	26.3	25.7	28.4	27.0	25.0	22.6
PSMA8	"MGC26605, PSMA7L"	ENSG00000154611	"Proteasome subunit alpha 8"	Q8TAA3	18	26133852-26193355	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 36.5"	"Group enriched"	"Detected in some"	95	"Daudi: 23.4;U-266/70: 14.5;U-266/84: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"														"unprognostic (5.39e-3)"	"unprognostic (7.45e-5)"			"unprognostic (2.94e-1)"	"unprognostic (3.04e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.30e-2)"		"unprognostic (7.54e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.56e-1)"		0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	1.1	0.0	36.5	0.2	0.7	0.1	0.0	2.2	0.1	0.0	4.0	1.9	0.2	0.1	1.2	5.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	15.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.1	2.2	4.0	2.1	3.9	0.3	3.1	2.4	5.8	0.2	1.2	0.1	1.9	4.3	1.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.7	0.2
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome subunit beta 1"	P20618	6	170535117-170553341	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm			14000000	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	60.8	59.3	38.5	40.4	53.7	53.2	55.0	31.4	46.4	40.5	48.6	37.9	49.9	45.1	56.8	90.6	51.7	49.8	43.1	71.9	40.9	40.1	56.4	93.2	46.9	66.7	40.8	41.1	43.7	67.3	35.4	48.4	80.6	48.4	40.6	52.7	43.8	43.6	50.0	109.3	56.1	46.0	59.7	44.9	51.4	46.9	47.1	38.1	47.1	47.9	75.2	60.4	50.1	42.0	71.0	98.1	51.9	81.9	71.6	79.3	104.1	42.5	40.0	57.1	73.6	51.1	40.2	60.8	40.8	60.0	68.0	69.6	87.5	36.8	62.3	53.2	54.5	43.1	63.3	64.8	71.0	63.4	71.2	53.2	40.6	109.7	60.0	62.4	47.5	45.8	39.9	65.6	42.6	58.0	105.0	53.5	62.0	114.6	46.7	87.1	52.1	55.1	45.2	45.3	79.0	70.5	25.6	57.1	46.6	39.2	60.9	31.2	41.7	90.4	44.1	27.7	44.5	67.3	75.3	45.8	60.6	77.4	64.7	70.7	59.4	40.1	81.9	51.9	53.2	75.8	62.1	71.0	62.2	57.7	98.1	53.4	59.2	57.2	47.5	71.6	67.6	55.8	79.3	104.1	38.5	53.7	31.4	46.4	40.9	40.1	40.8	41.1	48.4	38.1
PSMB10	"beta2i, LMP10, MECL1, MGC1665"	ENSG00000205220	"Proteasome subunit beta 10"	P40306	16	67934502-67937087	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 117.3"	"Cell line enhanced"	"Detected in many"		"REH: 36.0;U-266/70: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA030224, HPA030225, CAB034384"	Enhanced		Supported	Vesicles,Cytosol			1400000	Cytosol	Vesicles	"CAB034384: AB_2171876, HPA030224: , HPA030225: AB_10603231"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.60e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-2)"	"prognostic favourable (5.44e-4)"	11.5	13.0	9.1	24.9	11.8	23.9	11.4	4.0	7.8	8.0	21.6	5.6	8.5	42.4	9.3	9.5	10.6	12.4	16.6	12.0	6.9	4.9	16.9	17.2	19.5	38.3	9.5	5.6	8.7	61.5	0.9	6.9	11.2	8.5	13.5	6.3	5.8	27.9	11.6	6.9	7.0	35.6	7.7	6.5	49.7	23.8	2.5	7.8	39.2	13.1	10.4	20.5	13.2	8.4	50.8	75.2	100.0	98.1	69.1	68.8	117.3	5.9	5.3	0.4	0.8	0.4	3.5	21.0	2.0	8.5	6.9	9.8	2.7	29.1	21.6	3.7	2.7	8.7	0.1	1.9	0.5	9.6	0.5	7.7	1.8	3.0	12.0	14.3	23.6	5.3	1.2	3.0	0.0	4.0	0.7	8.3	1.9	7.4	28.1	14.7	0.3	2.0	36.0	2.2	29.5	4.7	10.4	0.3	0.4	6.7	11.8	2.6	2.4	31.0	6.7	4.4	1.2	1.9	2.3	40.3	7.2	14.4	10.9	18.7	9.5	57.1	89.4	67.1	68.8	98.1	50.2	50.8	54.0	57.3	74.6	49.1	45.3	50.1	100.0	69.1	71.4	75.2	60.8	117.3	9.1	11.8	4.0	7.8	6.9	4.9	9.5	5.6	8.5	7.8
PSMB2	HC7-I	ENSG00000126067	"Proteasome subunit beta 2"	P49721	1	35599544-35641844	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm			15000000	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavourable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.5	30.5	29.4	28.0	35.1	37.2	25.3	20.1	50.9	23.2	26.1	35.9	15.4	27.5	27.8	25.0	30.4	26.5	20.7	23.8	30.6	33.4	27.9	63.8	24.6	30.4	30.6	24.8	22.7	24.6	22.0	21.8	37.5	32.6	23.1	27.8	22.8	23.0	24.9	54.7	28.2	27.0	28.7	32.5	29.3	22.8	23.5	21.5	42.8	22.7	29.1	34.0	23.9	22.4	24.6	30.2	19.4	35.3	25.1	28.1	25.4	40.6	25.5	27.8	19.0	14.8	17.8	35.2	19.3	22.7	39.8	32.5	30.2	48.9	40.6	45.3	22.7	25.3	35.8	32.0	33.5	33.1	33.2	36.8	27.9	29.5	26.7	38.6	21.7	19.4	20.3	47.5	23.1	31.2	43.9	23.2	25.6	18.7	50.2	28.9	37.2	27.1	31.1	28.4	28.6	27.6	22.0	24.7	18.2	22.1	20.9	29.8	15.4	17.6	21.5	19.9	23.5	18.8	45.5	20.0	32.2	41.1	29.5	40.7	34.5	17.4	27.0	19.4	23.1	33.0	23.4	24.6	23.1	24.2	29.7	19.3	16.7	20.9	9.7	25.1	35.3	30.2	28.1	25.4	29.4	35.1	20.1	50.9	30.6	33.4	30.6	24.8	32.6	21.5
PSMB3	"HC10-II, MGC4147"	ENSG00000277791	"Proteasome subunit beta 3"	P49720	17	38752736-38764231	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 99.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA042775, HPA048147"	Approved						28000000			"HPA042775: , HPA048147: "	"unprognostic (1.86e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.14e-3)"	"unprognostic (5.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.75e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (1.71e-6)"	"unprognostic (4.44e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.42e-3)"	"unprognostic (6.03e-2)"	13.3	9.6	5.2	9.9	8.6	13.3	10.3	3.0	13.9	8.5	11.8	7.5	6.4	9.2	5.6	15.3	14.7	10.3	9.8	15.6	4.4		21.6	36.8	11.6	13.0	8.4	7.1	9.6	11.3	7.3	5.7	17.2	8.5	10.8	12.0	9.1	8.5	10.0	22.2	10.0	14.1	11.0	4.7	17.5	7.2	8.5	7.0	23.3	16.7	12.2	15.6	10.2	5.6	32.7	55.0	99.0	56.5	29.1	43.1	63.7	27.7	52.2	21.7	33.5	24.1	19.0	27.7	18.3	31.1	64.4	56.8	62.4	36.1	31.9	33.0	27.3	47.9	35.8	35.4	39.9	41.7	62.8	20.5	30.3	64.7	12.0	32.8	31.6	19.8	21.9	48.4	16.4	34.7	33.0	36.3	31.0	36.3	51.0	51.1	29.3	39.0	28.9	43.9	50.0	37.5	28.4	26.8	17.7	23.5	17.8	22.7	41.0	38.2	18.3	16.9	31.2	35.9	46.7	23.7	40.3	41.3	33.5	32.5	29.6	41.1	56.5	47.4	30.3	49.7	27.9	32.7	28.5	27.6	55.0	28.1	23.0	24.8	99.0	29.1	39.9	53.2	43.1	63.7										
PSMB4	"HN3, PROS26"	ENSG00000159377	"Proteasome subunit beta 4"	P28070	1	151399534-151401944	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006700	Approved						15000000			"HPA006700: AB_1079704"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.74e-2)"	"prognostic unfavourable (7.45e-4)"	"unprognostic (2.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (3.73e-1)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (2.90e-10)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.85e-2)"	45.7	64.5	47.4	40.4	49.5	40.2	56.3	39.6	84.0	44.4	44.3	28.5	58.8	41.2	53.5	65.3	55.7	51.2	37.8	66.6	47.0	50.7	57.3	71.9	43.6	81.1	49.2	61.0	52.4	87.0	40.0	45.4	50.9	48.4	42.6	47.5	37.8	46.7	56.1	68.7	45.7	39.7	66.4	55.1	46.6	43.4	31.8	36.3	51.1	46.8	63.3	62.2	58.6	37.7	68.5	106.5	58.6	81.4	72.5	89.0	78.3	51.2	53.8	45.8	54.9	51.9	49.5	63.0	30.2	66.1	88.3	62.0	71.9	69.3	46.7	91.8	50.6	51.5	46.4	56.9	50.5	65.1	47.0	32.3	40.3	53.8	56.1	44.9	44.4	54.0	54.4	83.0	34.1	61.6	52.1	91.4	62.2	137.3	53.9	52.9	117.2	69.7	51.7	33.5	82.4	72.2	41.9	50.9	60.5	35.2	76.9	101.2	69.5	71.2	39.0	38.8	41.3	41.2	66.4	91.1	104.3	90.0	57.3	40.0	81.6	54.6	81.4	49.5	63.9	75.2	75.9	68.5	74.9	72.5	96.4	60.8	65.8	68.0	58.6	72.5	56.9	106.5	89.0	78.3	47.4	49.5	39.6	84.0	47.0	50.7	49.2	61.0	48.4	36.3
PSMB5	"MB1, X"	ENSG00000100804	"Proteasome subunit beta 5"	P28074	14	23016543-23035230	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049518, HPA061796"	Approved		Supported	Nucleoplasm,Centrosome			8200000	"Nucleoplasm, Centrosome"		"HPA049518: , HPA061796: "	"unprognostic (3.03e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.35e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (2.85e-4)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (2.55e-2)"	"unprognostic (9.95e-2)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (4.73e-4)"	28.1	38.8	33.6	19.3	35.5	9.6	29.0	19.4	42.9	24.7	28.3	26.8	25.4	21.0	24.2	49.2	31.6	31.6	22.0	37.7	32.9	33.3	35.3	45.4	20.6	18.3	37.5	35.4	22.2	36.6	35.4	26.6	32.5	33.9	27.2	32.2	21.1	28.4	28.7	101.2	22.3	17.2	34.9	32.5	16.7	25.1	27.6	27.3	15.7	29.0	47.3	22.7	20.6	25.2	32.3	53.4	24.6	39.9	19.4	46.8	39.5	22.1	47.1	33.7	31.9	45.4	39.2	33.3	31.6	37.6	55.8	47.4	39.6	35.2	27.5	29.5	42.9	30.2	53.8	39.4	53.9	16.8	37.2	17.4	34.4	139.6	35.9	21.1	21.0	43.7	37.0	41.3	34.5	57.6	26.2	15.6	45.6	65.1	12.0	29.0	37.4	76.4	16.2	25.4	18.3	43.3	32.1	43.0	33.5	22.2	45.2	30.3	21.8	27.5	30.9	27.3	27.8	25.2	31.0	13.5	26.8	20.6	21.3	17.1	33.8	24.6	39.9	17.3	29.3	39.0	34.2	32.3	35.1	28.1	42.6	30.1	46.8	35.6	15.5	19.4	27.9	53.4	28.7	39.5	33.6	35.5	19.4	42.9	32.9	33.3	37.5	35.4	33.9	27.3
PSMB6	"DELTA, Y"	ENSG00000142507	"Proteasome subunit beta 6"	P28072	17	4796144-4798503	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023312, HPA063656"	Supported		Supported	Nucleoplasm,Cytosol			2800000	Nucleoplasm	Cytosol	"HPA023312: AB_1855828, HPA063656: "	"unprognostic (2.71e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.32e-3)"	"unprognostic (8.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.27e-2)"	"unprognostic (5.66e-2)"	28.6	35.0	33.7	23.2	36.4	31.7	34.0	24.2	41.5	29.6	31.7	26.7	26.8	22.6	33.4	47.1	41.9	30.3	24.2	72.0	30.4	30.5	41.4	67.1	25.7	35.3	33.4	34.0	25.3	41.8	40.8	26.6	49.6	35.9	26.4	36.1	23.5	30.6	36.6	97.4	33.6	23.2	40.5	29.7	29.0	31.2	27.0	28.0	35.8	34.6	53.8	39.6	27.9	26.0	93.9	96.3	51.1	95.3	60.4	81.2	107.9	46.0	80.6	43.5	37.1	37.1	33.4	50.2	24.4	51.1	74.7	58.6	59.9	37.6	35.8	48.5	58.4	46.7	66.1	68.4	72.9	46.6	69.7	21.2	53.0	69.6	42.8	21.9	33.9	31.5	52.5	65.2	62.1	72.5	32.4	54.5	57.2	54.8	38.7	36.6	36.9	56.0	43.4	30.9	47.4	56.0	31.1	25.5	31.3	35.0	27.4	25.1	33.4	24.6	34.5	36.9	27.9	49.5	59.0	22.8	30.3	21.8	52.8	40.1	44.3	51.1	95.3	50.5	57.1	87.5	57.8	93.9	62.3	62.6	96.3	79.8	53.7	56.1	32.9	60.4	78.0	89.7	81.2	107.9	33.7	36.4	24.2	41.5	30.4	30.5	33.4	34.0	35.9	28.0
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Supported	Nucleoplasm,Cytosol			2700000	Nucleoplasm	Cytosol	"HPA052408: , HPA054902: "	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	51.9	63.5	43.5	52.5	30.7	36.7	62.7	50.6	69.8	73.4	50.7	83.4	50.8	59.3	40.9	47.3	74.4	54.1	53.6	67.4	57.0	46.7	37.1	101.0	69.2	69.5	73.6	37.1	43.9	47.3	76.4	76.6	61.5	75.7	42.2	56.6	90.4	52.8	49.5	64.3	90.9	46.8	64.9	69.3	51.9	34.0	51.3	41.8	48.1	61.7	74.9	71.1	32.4	48.7	47.5	38.3	60.6	75.7	45.8	128.3	59.8	79.4	45.4	66.7	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome subunit beta 8"	P28062	6	32840717-32844703	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"			3300000	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favourable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favourable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	17.0	21.9	7.9	34.8	11.7	14.0	14.9	3.6	7.5	10.0	20.8	5.1	8.8	20.1	12.5	15.3	16.6	13.2	23.8	10.6	6.6	5.7	20.9	30.0	29.0	46.3	9.9	5.1	11.3	12.7	3.6	8.2	9.7	8.8	13.5	24.4	9.2	14.6	11.2	5.1	14.7	37.3	11.5	9.0	42.8	19.4	3.9	9.0	32.2	18.7	18.7	29.0	13.9	12.5	28.9	27.4	37.6	33.2	23.3	29.9	52.2	6.3	2.0	0.1	0.0	2.7	7.0	4.4	1.5	10.1	12.4	17.9	0.0	11.2	24.8	4.8	4.1	4.5	1.4	6.0	3.4	10.2	0.0	10.9	1.3	0.4	14.8	0.2	4.1	7.9	2.8	6.9	2.3	8.4	0.3	5.2	3.1	0.0	5.7	6.0	0.0	1.6	15.5	0.8	12.2	10.1	1.8	0.1	0.1	2.2	5.3	3.3	2.4	20.3	2.5	3.7	1.9	3.5	0.2	8.8	8.3	5.5	1.3	14.3	4.6	19.4	29.0	37.4	25.5	33.2	22.1	28.9	21.7	26.4	27.4	26.3	15.1	21.6	37.6	23.3	28.6	23.3	29.9	52.2	7.9	11.7	3.6	7.5	6.6	5.7	9.9	5.1	8.8	9.0
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome subunit beta 9"	P28065	6	32844136-32859585	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 69.1;lymphoid tissue: 54.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 29.1;REH: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol			420000	Cytosol		"CAB015180: AB_2172368, HPA042818: , HPA053280: "	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavourable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	13.3	9.7	5.0	30.0	7.9	10.7	11.6	1.6	5.3	7.6	16.5	6.0	3.4	15.7	8.8	7.1	10.8	7.4	10.8	8.9	5.1	4.7	12.2	12.2	17.7	32.7	7.3	3.7	9.2	5.4	1.2	4.5	5.5	6.3	12.5	5.8	7.7	9.0	3.5	6.2	7.6	36.1	5.7	9.8	54.9	11.2	3.0	6.7	35.4	14.4	9.3	35.2	15.9	8.8	31.8	17.2	69.1	30.5	23.4	31.1	45.7	0.0	1.4	0.0	0.1	1.1	2.9	2.0	0.2	3.2	4.2	9.7	0.0	9.1	29.1	0.4	2.6	5.9	0.4	6.2	0.5	16.4	0.0	17.7	0.5	1.1	15.7	3.1	1.3	1.3	0.2	2.6	0.4	1.5	0.7	5.4	1.4	0.4	13.4	4.1	0.0	0.9	21.5	0.0	6.9	2.8	0.5	0.0	0.0	2.7	1.7	1.9	2.3	6.5	1.5	4.5	0.4	8.5	2.5	10.1	15.3	9.3	4.6	11.8	3.8	21.9	22.4	39.3	28.7	30.5	23.8	31.8	23.3	27.5	17.2	23.4	17.5	22.9	69.1	23.4	29.4	12.7	31.1	45.7	5.0	7.9	1.6	5.3	5.1	4.7	7.3	3.7	6.3	6.7
PSMC3	"TBP-1, TBP1"	ENSG00000165916	"Proteasome 26S subunit, ATPase 3"	P17980	11	47418769-47426473	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 134.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006065	Approved		Supported	Nucleoplasm,Cytosol			180000	"Nucleoplasm, Cytosol"		"HPA006065: AB_1079706"	"unprognostic (2.01e-2)"	"unprognostic (5.08e-3)"	"unprognostic (9.43e-2)"	"unprognostic (8.12e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.71e-2)"	"unprognostic (8.99e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.24e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	27.9	25.9	37.3	24.1	49.3	31.8	26.2	25.6	39.7	25.1	28.2	24.9	21.1	20.3	27.2	26.0	29.4	25.0	21.8	45.7	32.8	28.0	30.7	60.2	21.5	22.8	36.1	27.3	21.0	25.2	31.0	16.8	39.8	28.2	22.6	24.0	21.3	32.1	29.8	134.7	34.8	20.9	30.8	24.3	25.7	24.9	24.0	22.9	33.5	27.1	38.3	28.8	25.5	25.3	39.2	45.1	32.6	54.7	45.0	51.1	61.3	39.0	44.5	42.8	31.5	20.6	22.2	41.7	32.6	48.5	82.1	58.3	39.6	22.9	31.7	20.3	41.0	39.3	37.5	42.7	37.1	47.2	48.4	30.5	54.5	38.2	26.6	35.5	32.6	24.7	23.1	33.3	37.6	46.0	43.1	30.0	50.0	87.1	44.7	45.2	41.9	53.8	47.3	84.2	27.8	38.2	29.5	31.3	27.1	26.7	37.7	20.5	46.5	37.1	32.5	47.1	59.6	66.6	83.5	32.5	37.5	36.7	48.6	35.6	58.8	24.4	43.5	32.6	47.9	53.1	43.7	39.2	40.4	43.8	45.1	32.8	35.6	36.2	9.8	45.0	54.7	45.1	51.1	61.3	37.3	49.3	25.6	39.7	32.8	28.0	36.1	27.3	28.2	22.9
PSMC4	"MGC13687, MGC23214, MGC8570, MIP224, S6, TBP-7, TBP7"	ENSG00000013275	"Proteasome 26S subunit, ATPase 4"	P43686	19	39971005-39981441	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002044, HPA005471"	Approved		Supported	Nucleoplasm,Cytosol			66000	"Nucleoplasm, Cytosol"		"HPA002044: AB_1079707, HPA005471: AB_1855838"	"unprognostic (1.66e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.83e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.32e-1)"	24.0	31.3	23.4	26.1	26.9	15.0	20.3	23.9	37.1	22.8	25.0	26.1	24.9	26.4	29.8	34.0	29.9	25.1	22.2	35.9	24.1	25.4	40.4	65.6	20.1	21.3	25.6	27.4	22.7	19.6	33.1	22.1	29.7	32.3	22.5	24.6	21.8	21.1	28.1	57.3	25.8	24.8	27.1	26.0	25.2	24.1	29.7	25.5	27.9	30.2	28.0	28.5	28.9	20.1	18.1	34.4	16.0	43.1	19.8	28.1	25.8	22.4	72.9	14.8	19.3	12.7	10.6	17.0	13.3	16.3	29.6	23.0	42.1	16.3	11.2	26.0	15.7	12.1	19.8	18.0	22.5	19.8	20.8	16.5	13.7	34.2	18.7	17.1	19.8	11.1	14.6	24.1	16.5	19.3	21.1	17.1	18.1	33.9	20.3	9.9	26.7	22.2	17.8	17.8	16.1	19.7	33.8	19.2	24.7	15.1	24.0	12.0	16.6	15.1	12.8	19.4	19.4	17.7	32.3	20.7	35.9	17.2	24.6	18.2	21.4	14.8	20.5	16.0	23.6	32.2	20.0	18.1	21.1	23.9	34.4	16.9	17.1	17.6	11.1	19.8	43.1	17.1	28.1	25.8	23.4	26.9	23.9	37.1	24.1	25.4	25.6	27.4	32.3	25.5
PSMC5	"p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1"	ENSG00000087191	"Proteasome 26S subunit, ATPase 5"	P62195	17	63827152-63832026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017871, HPA064293"	Enhanced		Supported	"Plasma membrane,Cytosol"			100000	"Plasma membrane, Cytosol"		"HPA017871: AB_1857638, HPA064293: AB_2685234"	"unprognostic (9.65e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.44e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.29e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (3.13e-6)"	"unprognostic (9.54e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.32e-1)"	36.8	43.1	44.8	35.8	42.6	26.7	30.3	47.7	48.3	29.5	36.5	30.3	40.8	26.2	32.0	42.4	46.0	32.2	42.0	41.7	38.6	42.9	52.3	48.7	26.3	33.5	50.1	42.2	28.2	36.7	77.0	32.6	42.9	41.8	32.7	36.7	26.7	36.0	41.7	94.2	45.2	28.9	41.8	39.3	33.4	33.2	32.7	35.7	33.0	37.8	60.4	43.9	33.3	32.4	30.4	31.2	30.9	40.9	34.2	57.7	40.5	41.6	62.8	43.9	28.4	30.8	32.6	36.2	42.5	30.5	51.5	40.9	67.5	26.1	28.1	29.3	42.4	31.1	44.1	39.4	73.9	25.2	46.6	61.9	51.5	55.0	30.8	61.9	41.4	32.5	29.6	52.7	48.8	46.4	46.4	36.1	47.7	73.1	45.7	23.4	38.6	54.3	42.9	87.1	40.8	36.3	49.1	36.9	50.3	29.1	51.4	24.0	50.7	30.0	43.5	63.2	59.4	29.1	85.2	38.3	59.1	45.5	37.9	44.6	40.1	22.8	25.6	30.9	37.8	37.2	51.4	30.4	44.8	40.4	31.2	24.4	37.7	42.2	8.1	34.2	40.9	22.4	57.7	40.5	44.8	42.6	47.7	48.3	38.6	42.9	50.1	42.2	41.8	35.7
PSMD1	"P112, Rpn2, S1"	ENSG00000173692	"Proteasome 26S subunit, non-ATPase 1"	Q99460	2	231056864-231172827	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB021092, HPA036736, HPA036737"	Enhanced		Approved	"Nucleoplasm,Actin filaments"			49000	Nucleoplasm	"Actin filaments"	"CAB021092: AB_10123242, HPA036736: AB_2675278, HPA036737: AB_2675279"	"unprognostic (9.32e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavourable (8.63e-12)"	"prognostic unfavourable (2.34e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.49e-1)"	"unprognostic (8.91e-3)"	"unprognostic (1.10e-2)"	"unprognostic (6.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.70e-3)"	21.9	25.5	21.5	19.0	27.8	14.4	18.4	22.3	29.0	17.3	20.6	16.2	15.3	21.7	24.3	17.6	25.3	16.1	13.0	34.9	31.8	22.1	20.9	27.8	16.8	16.3	20.3	27.2	16.4	10.9	73.9	24.6	28.5	34.0	18.7	23.7	15.0	16.7	21.1	75.5	20.2	17.9	27.2	17.5	18.7	17.4	16.8	17.8	20.6	17.3	23.7	22.3	17.8	16.4	14.3	21.2	23.5	26.7	25.6	21.6	15.4	28.8	31.5	35.5	27.7	37.0	26.7	34.4	38.5	40.1	39.0	39.7	38.2	28.9	22.7	36.3	42.9	27.8	49.3	35.9	53.3	34.3	26.4	41.9	25.9	43.8	19.1	36.9	36.4	23.0	17.8	41.9	22.3	45.9	57.9	17.2	46.2	28.1	28.8	21.2	45.7	25.2	24.5	54.5	21.7	28.7	30.0	23.7	21.3	30.8	27.9	18.8	22.1	21.8	42.8	31.1	32.8	37.5	36.5	14.9	21.9	40.4	48.0	28.5	35.5	23.5	19.2	14.6	19.2	25.9	19.0	14.3	18.3	16.9	21.2	12.0	14.9	16.8	10.8	25.6	26.7	12.1	21.6	15.4	21.5	27.8	22.3	27.6	31.8	22.1	20.3	27.2	34.0	17.8
PSMD11	"MGC3844, p44.5, Rpn6, S9"	ENSG00000108671	"Proteasome 26S subunit, non-ATPase 11"	O00231	17	32444261-32483318	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042275, HPA067433"	Approved		Approved	"Nucleoplasm,Golgi apparatus"			78000	"Nucleoplasm, Golgi apparatus"		"HPA042275: AB_10794793, HPA067433: "	"unprognostic (1.16e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (6.33e-6)"	"unprognostic (2.64e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.17e-3)"	"prognostic unfavourable (5.73e-6)"	"unprognostic (9.39e-3)"	"unprognostic (6.65e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.17e-2)"	26.0	22.4	20.7	19.9	22.3	19.9	17.4	22.2	27.1	16.3	19.2	23.8	14.9	19.2	24.2	17.2	28.5	17.6	16.5	24.7	18.3	18.7	21.7	38.2	19.1	19.5	24.4	16.9	19.1	25.8	30.1	19.1	27.5	28.1	18.6	23.7	17.3	19.2	16.7	69.0	25.3	18.8	25.4	19.1	20.0	18.3	22.8	19.8	27.7	19.5	26.9	26.8	18.9	18.9	24.4	30.8	22.8	28.0	30.1	33.1	26.8	35.7	39.7	29.0	31.2	19.7	14.7	31.0	20.4	26.5	45.4	36.9	40.0	32.8	28.1	32.6	22.1	41.6	33.0	28.4	44.7	14.1	22.5	22.7	20.1	30.9	19.2	26.9	24.4	13.1	15.0	39.4	27.4	31.8	43.0	33.0	26.6	22.2	40.2	15.9	39.8	20.0	25.0	37.6	38.0	22.3	26.8	25.7	17.4	25.9	18.8	20.6	45.5	12.9	21.8	25.4	29.6	31.3	47.1	18.4	28.7	37.2	36.8	21.1	42.6	22.8	27.4	16.7	28.3	27.1	31.0	24.4	27.7	28.4	30.8	23.7	24.9	26.0	12.6	30.1	28.0	25.1	33.1	26.8	20.7	22.3	22.2	27.1	18.3	18.7	24.4	16.9	28.1	19.8
PSMD14	"pad1, POH1, Rpn11"	ENSG00000115233	"Proteasome 26S subunit, non-ATPase 14"	O00487	2	161308038-161411717	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002114, HPA003828"	Approved		Supported	Nucleoplasm			9400	Nucleoplasm		"HPA002114: AB_1855850, HPA003828: "	"unprognostic (3.50e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.61e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.57e-1)"	"unprognostic (7.61e-3)"	"prognostic unfavourable (2.66e-8)"	"unprognostic (3.11e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-3)"	"unprognostic (9.84e-3)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (3.10e-6)"	"unprognostic (2.86e-2)"	"unprognostic (4.70e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.66e-1)"	18.2	26.3	24.8	19.9	25.0	16.8	19.8	21.0	36.9	14.7	17.9	13.5	11.0	15.0	15.6	16.3	23.7	14.4	12.2	22.3	24.8	26.1	23.5	33.7	16.2	24.9	26.2	16.1	11.8	15.0	18.6	24.3	21.5	27.9	16.8	21.9	13.0	15.1	16.7	60.8	16.7	14.3	20.6	26.0	20.2	13.6	19.0	15.3	22.1	18.2	21.6	25.6	15.2	13.1	22.9	27.2	13.1	24.6	23.6	29.6	24.7	35.2	30.7	34.6	30.3	25.2	21.5	42.3	37.2	35.8	53.2	43.4	45.1	30.1	41.9	56.7	27.0	27.2	37.6	39.3	53.3	43.6	28.3	41.8	24.9	50.6	31.0	40.5	24.9	16.4	29.8	60.1	56.2	39.5	45.3	30.2	44.2	33.7	29.8	30.6	48.0	46.6	25.8	33.6	40.9	46.8	30.3	30.1	22.1	25.2	28.5	34.3	19.4	26.1	31.2	35.7	33.6	24.2	40.5	18.1	48.8	39.4	38.3	27.0	39.2	13.1	17.9	8.8	25.3	24.6	26.5	22.9	27.4	27.0	27.2	19.1	22.2	26.5	1.9	23.6	19.1	26.7	29.6	24.7	24.8	25.0	21.0	36.9	24.8	26.1	26.2	16.1	27.9	15.3
PSMD2	"MGC14274, P97, Rpn1, S2, TRAP2"	ENSG00000175166	"Proteasome 26S subunit, non-ATPase 2"	Q13200	3	184298709-184309054	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045192	Approved						380000			"HPA045192: AB_10961324"	"unprognostic (1.06e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (9.98e-4)"	"prognostic unfavourable (6.63e-7)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (1.69e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.25e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.74e-3)"	21.6	33.7	31.7	20.8	28.7	23.2	16.3	22.2	31.5	19.4	20.4	17.9	20.6	16.5	22.6	16.8	25.3	18.8	15.7	39.2	27.1	21.2	22.9	28.5	18.3	18.6	23.8	29.7	16.5	16.4	28.2	18.9	25.2	25.0	18.8	22.2	15.7	19.0	22.2	107.0	22.9	16.4	26.2	15.1	19.0	19.2	34.1	17.7	20.1	19.2	28.4	25.2	18.1	24.8	28.3	53.2	37.0	40.4	34.7	35.3	42.7	109.9	29.0	23.3	39.6	28.3	16.0	28.5	62.5	42.8	69.1	40.1	40.3	19.6	29.0	92.4	46.0	31.6	34.7	61.0	87.9	50.5	26.7	31.3	27.5	25.0	15.7	21.2	27.9	18.3	19.1	66.0	41.6	41.6	22.0	27.1	56.9	36.3	22.2	13.0	36.4	48.2	26.1	33.1	30.5	29.7	29.3	20.0	17.3	44.6	38.5	22.3	54.8	19.0	51.9	43.1	54.4	34.4	130.8	30.4	66.3	54.3	55.6	26.8	30.7	20.3	40.4	37.0	31.1	36.1	30.7	28.3	30.6	35.3	53.2	23.4	30.5	30.3	12.3	34.7	37.2	22.7	29.8	42.7	31.7	28.7	22.2	31.5	27.1	21.2	23.8	29.7	25.0	17.7
PSMD5	"KIAA0072, S5B"	ENSG00000095261	"Proteasome 26S subunit, non-ATPase 5"	Q16401	9	120815496-120842984	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003216	Uncertain		Approved	Nucleoplasm,Cytosol			12000000	Cytosol	Nucleoplasm	"HPA003216: AB_1079709"	"unprognostic (7.72e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.02e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.04e-3)"	"unprognostic (4.39e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.87e-1)"	14.1	20.1	10.2	12.2	16.2	14.7	32.5	20.7	21.8	14.6	12.9	10.2	12.3	10.3	14.8	14.1	17.3	13.8	10.6	12.7	11.7	12.3	11.5	21.0	34.8	23.6	9.8	14.1	16.7	32.2	13.3	11.7	10.5	14.5	16.1	12.5	8.8	15.1	15.7	10.0	16.7	11.2	24.5	9.9	12.3	14.4	11.3	8.1	13.0	12.6	9.2	15.5	14.9	13.5	17.5	14.4	15.2	17.9	14.2	25.2	14.2	13.2	17.3	8.4	15.6	18.8	18.7	9.9	19.7	15.5	18.7	17.1	15.3	8.8	13.6	9.0	20.0	19.9	0.0	19.4	21.8	12.4	1.9	11.3	24.0	8.5	14.2	3.9	4.3	15.6	12.6	18.1	19.4	10.8	41.4	9.1	17.4	16.5	12.1	8.2	12.4	12.4	11.1	18.3	10.7	17.2	11.7	11.5	7.4	23.8	20.3	9.4	24.3	9.7	16.7	0.0	10.1	7.8	17.4	5.5	5.5	14.9	11.6	13.1	16.4	15.2	14.9	12.3	17.1	16.5	18.6	17.5	19.9	20.5	14.4	13.2	19.4	15.1	8.1	14.2	17.9	10.5	25.2	14.2	10.2	16.2	20.7	21.8	11.7	12.3	9.8	14.1	14.5	8.1
PSMD6	"KIAA0107, p44S10, Rpn7, S10"	ENSG00000163636	"Proteasome 26S subunit, non-ATPase 6"	Q15008	3	64010549-64024010	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"MCF7: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036921, HPA036922"	Uncertain		Supported	"Golgi apparatus,Vesicles"			8600	Vesicles	"Golgi apparatus"	"HPA036921: , HPA036922: AB_10670850"	"unprognostic (3.44e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (1.68e-4)"	"unprognostic (8.65e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.95e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.55e-2)"	"unprognostic (8.22e-3)"	17.1	27.4	16.1	16.3	19.3	33.8	18.4	15.8	24.2	14.5	16.0	13.2	21.4	12.1	17.9	23.1	23.5	14.5	18.7	31.4	16.2	16.8	24.5	29.1	14.2	20.0	18.4	17.7	13.6	100.6	21.9	16.3	22.2	21.1	15.8	16.2	12.3	20.3	20.1	55.9	20.3	12.9	18.0	16.2	17.0	17.4	41.7	16.2	23.5	14.9	32.4	21.8	15.9	15.1	54.1	53.5	62.3	58.1	47.2	59.6	65.6	12.2	12.7	18.9	13.2	13.3	11.9	16.0	16.9	17.0	29.8	22.0	23.7	10.5	16.7	7.5	17.2	8.4	21.9	19.0	28.1	17.1	13.0	22.3	10.3	15.8	19.6	25.3	14.6	12.8	13.5	24.6	10.8	18.6	22.4	11.3	20.9	176.8	17.4	16.0	23.6	9.0	14.6	12.9	16.6	23.5	17.7	6.8	11.0	12.6	11.2	16.8	9.8	16.1	15.5	13.3	14.1	18.9	27.7	13.7	20.4	25.5	19.5	24.1	15.2	41.0	51.7	60.2	48.8	58.0	51.0	54.1	55.8	53.1	53.5	49.4	56.2	54.3	62.3	47.2	58.1	37.3	59.6	65.6	16.1	19.3	15.8	24.2	16.2	16.8	18.4	17.7	21.1	16.2
PSMD8	"HIP6, HYPF, Nin1p, p31, Rpn12, S14"	ENSG00000099341	"Proteasome 26S subunit, non-ATPase 8"	P48556	19	38374536-38383824	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006702, CAB021101"	Supported		Approved	"Nuclear speckles,Cytosol"				Cytosol	"Nuclear speckles"	"CAB021101: AB_10061018, HPA006702: AB_1079710"	"unprognostic (9.50e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.70e-2)"	"prognostic unfavourable (3.84e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.54e-3)"	"unprognostic (1.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.61e-1)"	"unprognostic (8.79e-2)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.28e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.58e-3)"	"unprognostic (4.84e-2)"	53.0	35.1	30.0	23.9	35.6	32.9	43.0	28.1	49.4	26.5	31.8	25.8	30.1	31.5	30.9	40.9	39.1	32.5	28.0	75.3	32.2	29.3	40.9	71.1	28.8	28.8	27.1	37.0	24.4	48.2	30.6	29.2	56.6	30.0	33.6	32.9	24.6	32.6	29.7	157.1	42.2	33.2	34.5	25.0	27.6	28.9	55.8	21.4	38.1	35.4	50.1	33.9	28.3	27.1	40.4	60.8	32.0	68.1	38.8	65.6	68.7	61.1	97.6	38.5	43.9	62.8	50.6	20.2	44.6	60.9	68.7	71.9	66.9	36.9	43.2	46.6	59.3	21.3	64.3	55.4	62.1	71.1	42.4	46.9	32.2	41.2	81.2	47.2	41.7	50.9	55.4	59.1	78.8	53.9	58.4	48.6	75.4	60.9	44.5	26.6	29.9	53.3	46.5	61.9	34.3	48.6	51.0	40.3	41.0	46.2	59.9	43.2	31.3	44.6	39.6	52.6	48.6	55.0	65.2	49.2	56.8	57.6	79.1	48.6	58.3	32.0	55.2	29.2	46.1	59.9	39.1	40.4	40.4	44.2	60.8	37.0	33.6	32.6	20.8	38.8	68.1	42.3	65.6	68.7	30.0	35.6	28.1	49.4	32.2	29.3	27.1	37.0	30.0	21.4
PSMD9	"p27, Rpn4"	ENSG00000110801	"Proteasome 26S subunit, non-ATPase 9"	O00233	12	121888731-121918297	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA040512, HPA044220"	Enhanced		Supported	"Plasma membrane,Cytosol"			330000	Cytosol	"Plasma membrane"	"HPA040512: AB_2677014, HPA044220: AB_2678860"	"unprognostic (2.24e-1)"	"unprognostic (2.48e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (1.86e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.73e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.63e-2)"	25.6	10.7	11.5	12.9	12.1	27.8	18.7	15.3	12.0	9.6	22.1	9.2	14.8	19.5	14.4	13.6	12.3	10.7	12.5	13.9	10.6	11.2	19.2	19.8	12.3	14.8	10.6	9.0	13.0	28.6	4.9	8.3	8.7	12.7	9.5	4.8	9.4	15.3	14.2	28.6	12.4	16.3	15.7	11.6	14.8	24.7	13.6	8.7	13.8	10.9	17.1	9.2	8.2	11.8	24.5	36.7	29.6	26.3	14.9	25.9	27.3	20.5	31.6	2.6	4.8	4.4	4.5	5.5	21.0	6.8	10.5	6.0	23.0	2.5	15.3	17.8	10.8	8.4	7.5	11.0	6.3	29.6	16.6	12.5	14.7	11.4	11.0	8.8	8.9	8.0	5.2	11.8	4.5	6.3	11.2	2.2	6.6	24.1	17.5	6.6	5.5	24.7	13.4	7.2	9.4	5.1	20.7	5.5	7.7	21.1	3.1	11.3	9.1	4.4	16.6	10.1	11.6	19.7	14.6	12.0	25.9	22.3	18.1	11.5	9.2	20.3	26.3	29.6	20.9	25.4	16.7	24.5	20.1	18.9	22.2	19.5	15.8	13.6	24.1	14.9	22.0	36.7	25.9	27.3	11.5	12.1	15.3	12.0	10.6	11.2	10.6	9.0	12.7	8.7
PSME1	"IFI5111, PA28alpha"	ENSG00000092010	"Proteasome activator subunit 1"	Q06323	14	24136158-24138967	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006632	Approved		Approved	"Nuclear bodies,Cytosol"			8600000	Cytosol	"Nuclear bodies"	"HPA006632: AB_1079686"	"prognostic favourable (8.87e-5)"	"unprognostic (1.02e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.16e-1)"	"unprognostic (7.04e-2)"	"unprognostic (9.63e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.50e-1)"	"prognostic favourable (4.60e-4)"	"unprognostic (1.62e-3)"	37.6	59.1	19.1	64.4	23.0	37.2	59.7	9.9	16.9	34.8	53.9	15.3	47.4	48.2	40.3	50.4	45.4	39.4	53.4	59.1	19.6	17.2	67.7	70.3	61.7	114.2	24.8	17.4	46.7	47.2	26.4	30.6	42.7	21.3	39.2	44.8	28.4	38.0	57.0	38.0	33.7	82.3	45.0	20.4	82.8	38.9	14.5	22.5	70.5	58.4	54.3	52.0	35.8	40.4	68.2	72.2	112.1	93.3	81.2	87.8	132.3	17.4	14.6	11.1	21.3	24.2	28.0	17.0	11.2	36.5	35.9	51.6	9.3	42.7	45.1	8.4	18.6	25.4	15.8	23.2	24.1	37.6	9.7	20.0	7.2	51.5	53.3	25.5	25.6	24.4	14.9	16.2	14.3	27.1	3.1	40.3	14.0	44.4	65.5	31.1	1.0	25.2	52.1	22.8	32.4	45.3	46.4	7.1	12.6	14.2	37.1	21.6	24.3	25.1	15.2	9.9	11.7	11.2	16.6	37.7	38.7	21.3	13.4	22.8	15.9	53.2	74.4	89.4	87.0	93.3	87.0	68.2	82.0	82.6	72.2	61.6	59.4	72.7	112.1	81.2	89.4	68.5	87.8	132.3	19.1	23.0	9.9	16.9	19.6	17.2	24.8	17.4	21.3	22.5
PTBP1	"HNRNP-I, HNRPI, pPTB, PTB, PTB-1, PTB2, PTB3, PTB4"	ENSG00000011304	"Polypyrimidine tract binding protein 1"	P26599	19	797075-812327	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB013507	Supported		Supported	Nucleoplasm			3100000	Nucleoplasm		"CAB013507: AB_2533082"	"unprognostic (2.82e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavourable (2.71e-4)"	"unprognostic (4.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.28e-2)"	"unprognostic (8.31e-2)"	"unprognostic (3.72e-2)"	38.7	31.3	13.2	37.5	16.9	43.5	38.4	13.5	16.2	36.4	35.9	19.1	32.5	34.9	42.9	32.7	49.7	31.8	39.0	24.0	13.9	9.5	45.3	68.8	37.7	56.2	20.2	9.6	47.5	47.5	37.5	31.8	65.0	15.9	35.3	24.7	35.5	51.9	31.0	15.9	43.6	41.0	26.2	13.8	49.2	31.2	34.1	18.2	94.9	49.4	43.7	62.7	31.5	36.2	19.2	26.3	14.6	27.7	22.8	24.7	23.4	78.9	69.5	40.5	34.6	13.8	17.5	61.2	48.3	24.4	40.2	32.1	67.3	38.2	66.7	31.1	33.0	47.1	55.6	45.9	38.3	69.6	61.5	54.6	66.0	67.6	26.0	73.5	58.5	17.5	32.2	50.1	27.8	38.2	83.5	34.8	64.9	69.5	88.3	35.9	70.2	37.3	99.9	30.5	39.6	24.9	77.3	45.4	51.9	60.4	33.6	27.5	35.7	43.2	58.0	43.9	45.9	48.2	84.1	38.5	70.1	89.8	25.1	53.7	52.7	8.2	21.6	14.6	24.0	27.7	24.7	18.6	19.5	22.2	26.3	19.2	19.6	19.2	9.5	22.8	24.6	15.0	21.1	23.4	13.2	16.9	13.5	16.2	13.9	9.5	20.2	9.6	15.9	18.2
PTBP2	"brPTB, nPTB, PTB, PTBLP"	ENSG00000117569	"Polypyrimidine tract binding protein 2"	Q9UKA9	1	96721665-96823738	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047420	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047420: AB_10962353"	"unprognostic (2.14e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (7.80e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.41e-5)"	"unprognostic (2.26e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.31e-2)"	"unprognostic (5.48e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	12.5	10.5	17.1	9.9	21.2	34.4	15.3	22.0	25.8	16.7	26.6	20.0	11.3	7.6	23.6	11.2	12.8	11.9	10.7	7.8	18.8	18.4	12.0	8.1	7.3	9.8	17.9	18.9	14.6	7.3	6.1	22.0	8.1	21.7	16.3	13.0	9.0	7.4	17.3	15.4	8.3	11.0	28.1	18.6	10.3	11.6	35.4	19.9	16.6	14.7	6.8	8.4	21.1	12.8	3.6	1.6	1.4	1.8	4.1	4.2	0.7	3.5	1.9	16.4	8.7	3.9	4.8	9.2	3.1	3.4	5.4	5.0	2.4	3.4	12.0	3.6	2.1	2.3	9.8	2.5	7.9	2.0	3.0	6.6	5.5	3.1	2.2	3.4	3.4	2.7	1.6	6.8	2.9	2.7	4.8	3.3	7.1	1.2	10.8	10.9	10.0	4.3	6.4	39.0	1.7	5.5	2.0	9.5	9.8	4.0	2.6	4.7	2.6	6.9	2.5	3.8	7.4	3.1	4.0	2.6	1.9	14.0	1.8	5.5	1.6	0.9	1.4	0.9	2.7	1.7	2.0	3.5	3.5	2.5	0.8	3.6	4.2	2.9	1.4	4.1	1.8	1.6	3.2	0.7	17.1	21.2	22.0	24.7	18.8	18.4	17.9	18.9	21.7	19.9
PTGDS	"L-PGDS, PGDS"	ENSG00000107317	"Prostaglandin D2 synthase"	P41222	9	136975092-136981742	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism, Transport"	Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 286.6;retina: 331.2"	"Group enriched"	"Detected in some"	6	"HHSteC: 103.8;HSkMC: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	27	"plasmacytoid DC: 140.9"	"Lineage enriched"	"Detected in many"	27	"dendritic cells: 140.9"									"HPA004938, CAB009916"	Approved				"Secreted to blood"		4300000000			"CAB009916: AB_2174617, HPA004938: AB_1855745"	"unprognostic (2.79e-2)"	"unprognostic (3.96e-3)"	"unprognostic (9.70e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.19e-7)"	"unprognostic (8.49e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.21e-2)"	34.1	27.9	138.1	37.5	159.8	2.5	11.3	61.5	154.6	260.4	10.5	192.5	23.0	6.4	22.5	130.0	26.0	72.4	65.8	286.6	121.0	85.2	22.3	6.0	39.7	114.8	170.8	130.6	7.0	20.0	1.8	20.6	38.5	118.8	78.5	4.2	331.2	18.8	149.8	17.0	19.7	11.2	18.6	188.0	50.1	13.5	218.5	103.2	3.3	3.4	4.3	51.1	49.5	75.8	0.0	140.9	0.2	0.1	0.3	5.2	1.0	0.0	0.0	0.0	0.0	1.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	103.8	0.0	0.2	50.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.1	13.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	5.2	0.1	0.3	0.0	0.4	0.6	0.1	0.0	0.1	1.1	0.2	0.3	0.0	140.9	0.1	1.0	138.1	159.8	61.5	154.6	121.0	85.2	170.8	130.6	118.8	103.2
PTGES3	"cPGES, p23, TEBP"	ENSG00000110958	"Prostaglandin E synthase 3"	Q15185	12	56663341-56688408	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Chaperone, Isomerase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 358.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034319, HPA038672, HPA038673"	Enhanced		Approved	Nucleoplasm,Cytosol			580000	Cytosol	Nucleoplasm	"CAB034319: AB_2175206, HPA038672: AB_10697395, HPA038673: AB_10670786"	"prognostic unfavourable (2.15e-5)"	"unprognostic (2.60e-1)"	"unprognostic (8.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-3)"	"prognostic unfavourable (4.44e-6)"	"unprognostic (4.33e-3)"	"unprognostic (3.64e-2)"	"prognostic favourable (4.36e-4)"	"unprognostic (2.73e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.07e-1)"	44.7	41.4	56.0	41.2	55.7	39.6	175.0	44.2	51.7	49.0	51.9	38.1	49.5	46.4	57.7	52.0	52.6	69.8	36.0	46.0	54.6	57.2	52.1	67.1	46.4	62.0	67.0	41.4	82.3	55.1	43.2	49.2	50.3	57.0	60.7	55.3	24.0	36.6	49.4	64.2	37.0	46.7	64.7	72.5	42.7	36.6	39.7	65.1	53.5	72.5	36.7	55.1	72.7	358.9	40.6	36.9	27.3	74.8	29.2	42.5	60.5	79.9	69.8	56.6	33.7	41.7	37.9	86.3	52.4	40.1	67.5	50.5	59.1	84.4	88.7	79.7	44.7	51.6	106.1	68.5	85.6	65.1	70.6	69.2	44.1	68.2	30.6	82.2	50.3	27.4	50.1	51.0	61.9	69.4	111.0	85.0	65.9	49.9	81.6	78.1	96.7	81.5	71.4	53.4	119.0	59.4	62.6	73.4	42.9	53.5	77.2	45.4	88.9	69.1	41.6	40.6	47.2	48.7	72.4	35.8	98.6	71.3	44.2	67.9	73.0	27.3	37.5	23.2	32.0	59.0	42.0	40.6	42.5	38.1	36.9	28.5	42.3	36.4	14.8	29.2	74.8	31.3	42.5	60.5	56.0	55.7	44.2	51.7	54.6	57.2	67.0	41.4	57.0	65.1
PTGIS	"CYP8A1, PGIS"	ENSG00000124212	"Prostaglandin I2 synthase"	Q16647	20	49503874-49568146	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	Isomerase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 88.2"	"Group enriched"	"Detected in some"	4	"ASC diff: 17.4;ASC TERT1: 17.5;U-2197: 53.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB009517, HPA014193, HPA052244"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB009517: AB_2173209, HPA014193: AB_1855746, HPA052244: "	"unprognostic (7.68e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.09e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.22e-2)"	"prognostic unfavourable (4.74e-8)"	"unprognostic (2.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.89e-3)"	"prognostic unfavourable (9.99e-5)"	18.2	2.5	0.6	8.0	1.3	0.1	28.3	0.2	1.6	23.3	14.6	0.5	6.5	1.7	36.5	21.7	13.2	32.0	36.3	23.8	0.3	0.5	3.0	3.8	7.5	1.6	0.5	0.9	51.2	1.3	0.2	0.5	1.0	1.0	27.2	3.7	3.2	3.7	4.6	7.0	3.2	4.4	88.2	1.4	0.3	8.7	16.2	0.3	0.0	6.7	5.6	1.7	64.2	36.1	1.0	0.8	2.7	0.6	0.8	0.5	0.1	0.0	0.0	0.7	0.0	17.4	17.5	0.2	0.3	2.1	0.0	0.0	0.0	0.0	0.0	6.9	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	1.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	53.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.6	0.4	0.4	0.4	0.3	0.4	0.3	0.3	0.1	1.0	0.4	0.5	2.7	0.8	0.3	0.8	0.2	0.1	0.6	1.3	0.2	1.6	0.3	0.5	0.5	0.9	1.0	0.3
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced						940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	10.1	43.1	12.6	0.1	46.2	46.7	9.8	16.5	25.1	15.8	16.5	11.7	13.8	0.0	4.7	15.7	12.5	10.2	17.4	19.6	0.0	3.0	2.5	26.8	56.7	10.6	1.4	5.3	33.2	26.3	21.6	11.1	39.8	1.7	0.0	30.5	3.1	0.0	0.3	5.2	10.6	0.0	3.6	0.2	18.4	33.2	14.2	0.6	20.3	6.1	6.0	19.0	6.9	32.1	3.1	6.5	35.2	2.9	0.0	0.0	0.0	15.0	0.0	3.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4
PTH	PTH1	ENSG00000152266	"Parathyroid hormone"	P01270	11	13492055-13496181	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 963.9"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000072, CAB023409, CAB026363, HPA048540"	Enhanced				"Secreted to blood"	27980				"CAB000072: , CAB023409: AB_619175, CAB026363: , HPA048540: "																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	963.9	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	129.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTK2	"FADK, FAK, FAK1, PPP1R71"	ENSG00000169398	"Protein tyrosine kinase 2"	Q05397	8	140657900-141002216	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Angiogenesis	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001842, CAB004036, HPA029671"	Approved		Supported	"Vesicles,Focal adhesion sites,Cytosol"			32000	"Focal adhesion sites"	"Vesicles, Cytosol"	"CAB004036: AB_2269034, HPA001842: AB_1855891, HPA029671: AB_10610288"	"prognostic unfavourable (3.21e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-1)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.93e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.90e-2)"	22.6	20.4	36.0	14.4	42.3	3.1	19.3	20.5	40.8	24.9	17.9	55.7	23.5	14.5	20.2	29.9	14.6	18.7	18.4	20.0	43.5	23.9	22.3	17.0	21.5	13.0	41.4	31.4	19.4	18.2	33.1	13.0	42.1	30.0	19.2	20.7	11.0	21.9	25.5	17.9	13.5	16.3	21.9	38.0	12.2	17.5	21.2	46.1	2.8	22.5	10.2	14.0	22.2	17.8	8.6	7.2	1.8	3.9	5.2	5.7	4.1	14.6	23.4	32.5	11.7	13.7	14.7	21.0	14.5	20.2	13.6	13.4	10.2	12.2	8.9	33.0	18.6	17.4	19.1	33.3	20.6	0.1	8.9	19.7	12.9	14.0	18.7	0.0	9.4	10.0	16.4	17.0	24.0	40.1	19.8	0.2	18.2	25.5	0.2	0.2	12.6	26.2	13.1	17.8	0.4	28.7	33.5	12.9	16.1	22.7	7.3	14.7	17.2	0.3	24.2	13.4	25.3	15.8	16.3	0.0	0.1	0.9	17.4	0.1	18.1	1.8	3.9	0.0	0.3	1.6	0.0	6.8	0.8	0.1	5.3	8.6	5.7	2.0	1.7	5.2	0.9	7.2	0.2	4.1	36.0	42.3	20.5	40.8	43.5	23.9	41.4	31.4	30.0	46.1
PTK2B	"CADTK, CAKB, FAK2, PTK, PYK2, RAFTK"	ENSG00000120899	"Protein tyrosine kinase 2 beta"	Q14289	8	27311482-27459391	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Angiogenesis, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 46.7;brain: 65.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.0;REH: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5"	"Low region specificity"	"Detected in many"			"CAB003850, HPA026091, HPA026276"	Approved		Supported	"Plasma membrane,Cytosol"			84000	"Plasma membrane, Cytosol"		"CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234"	"unprognostic (2.36e-2)"	"prognostic favourable (3.32e-4)"	"unprognostic (1.06e-1)"	"unprognostic (7.36e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (5.11e-4)"	"unprognostic (3.33e-3)"	7.2	4.7	20.4	24.3	30.0	46.7	4.9	65.2	48.3	5.4	14.5	7.8	5.0	16.6	4.3	4.7	7.9	6.8	6.4	4.7	30.5	7.0	6.8	5.0	11.5	35.6	4.3	25.4	2.4	5.4	5.2	5.3	4.1	3.9	10.1	11.9	8.3	12.6	6.7	2.2	15.1	18.4	5.5	4.8	32.0	10.8	4.3	3.7	37.8	5.6	2.9	35.4	13.0	6.0	26.9	18.7	24.0	25.8	14.7	19.0	21.5	10.9	3.0	0.8	0.9	23.5	1.7	6.4	0.8	0.5	0.6	0.8	2.9	6.3	37.0	1.2	1.7	10.1	0.3	9.2	0.3	2.5	0.2	7.6	2.9	0.5	4.8	8.2	13.8	12.7	13.8	0.8	5.3	0.3	8.9	25.7	0.6	1.1	14.0	16.5	0.6	0.8	41.0	0.2	25.3	2.6	8.6	5.8	1.0	3.9	2.7	1.4	3.3	21.2	5.2	0.4	0.8	0.7	0.3	20.7	8.9	20.0	1.6	17.8	0.7	22.3	23.7	18.0	19.0	22.4	12.5	25.5	9.6	13.3	18.7	26.9	12.1	14.2	24.0	14.7	25.8	6.2	9.5	21.5	20.4	30.0	65.2	48.3	30.5	7.0	4.3	25.4	3.9	3.7
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076268-43161719	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	9	"plasmacytoid DC: 13.8"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"		10000000			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	5.4	1.8	1.4	3.5	3.4	0.8	12.2	3.5	4.9	30.9	4.8	3.4	8.9	2.1	37.7	36.9	11.7	14.3	14.5	3.5	2.2	3.9	10.1	0.8	18.7	4.3	1.3	2.7	42.6	16.3	9.0	9.0	20.9	4.2	18.2	3.3	13.9	15.0	10.9	0.4	13.6	3.4	16.4	3.2	12.4	4.6	14.9	1.4	28.7	19.3	8.1	6.2	9.5	17.6	0.0	13.8	0.3	0.0	0.7	1.5	0.8	2.1	0.6	21.1	35.1	22.7	23.3	30.0	22.6	36.5	19.8	25.4	19.0	7.6	0.0	17.9	26.3	24.5	9.4	21.5	12.6	0.1	11.7	2.0	4.3	25.5	34.5	0.0	0.1	33.3	19.5	26.1	8.3	2.5	1.3	0.0	9.0	1.6	7.6	3.0	9.8	1.7	7.7	30.0	0.0	15.3	10.5	12.1	23.0	3.6	0.3	11.7	12.9	4.6	1.6	21.2	13.4	0.1	12.2	0.1	0.2	0.7	4.9	0.0	3.5	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	1.5	0.2	0.7	0.0	13.8	0.0	0.8	1.4	3.4	3.5	4.9	2.2	3.9	1.3	2.7	4.2	1.4
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Supported	Nucleoplasm,Cytosol			610000	Nucleoplasm	Cytosol	"HPA047183: "	"unprognostic (1.49e-3)"	"prognostic favourable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	97.8	58.8	83.9	74.8	25.5	34.1	86.2	66.8	56.1	58.4	61.3	56.9	114.7	155.0	76.6	52.1	51.8	118.0	82.3	74.3	122.8	92.8	199.7	48.5	91.9	31.7	226.6	85.5	49.3	30.9	51.7	42.8	95.2	116.0	66.0	50.9	139.8	318.2	309.0	126.3	49.1	219.3	59.8	105.4	71.5	87.5	171.3	105.4	76.8	76.9	58.4	57.9	180.2	70.6	49.3	87.5	60.2	71.8	80.0	39.3	310.3	33.7	139.0	78.9	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol			4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favourable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.8	44.1	27.2	50.4	18.4	22.6	27.2	26.0	29.5	35.8	25.0	23.6	30.7	25.9	19.7	44.1	40.5	28.4	32.1	30.8	46.0	15.5	16.0	46.7	22.4	54.8	27.6	34.8	27.0	31.7	26.1	24.9	36.4	23.7	28.8	30.0	64.5	25.1	17.1	42.7	43.9	25.1	25.1	47.6	37.5	31.2	29.5	20.9	52.7	54.4	32.5	57.7	12.0	26.7	29.7	26.9	30.6	36.7	26.3	67.3	23.4	36.6	18.0	40.9	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6
PTPN11	"BPTP3, NS1, PTP2C, SH-PTP2, SHP-2, SHP2"	ENSG00000179295	"Protein tyrosine phosphatase, non-receptor type 11"	Q06124	12	112418351-112509913	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Hydrolase, Protein phosphatase"	"Cancer-related genes, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005377	Approved		Supported	"Nucleoplasm,Nucleoli,Actin filaments,Cytosol"			160000	Nucleoli	"Nucleoplasm, Actin filaments, Cytosol"	"CAB005377: AB_632401"	"unprognostic (2.18e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.80e-2)"	25.4	16.8	38.6	14.4	39.0	17.7	30.8	17.5	39.5	18.3	14.7	26.9	9.9	11.9	19.1	13.3	17.6	11.1	13.1	30.1	38.0	32.2	18.0	23.1	15.1	14.5	45.3	22.5	13.1	14.0	29.3	12.9	16.6	26.2	16.2	13.9	9.4	12.0	20.0	34.0	14.1	11.1	28.0	45.7	10.9	12.8	7.6	32.1	10.9	21.2	8.2	13.7	17.4	15.4	17.3	17.1	22.0	11.8	11.3	15.4	6.3	34.8	33.3	24.3	23.0	35.4	34.6	28.8	42.4	46.3	33.4	25.2	33.1	13.5	36.9	22.1	39.2	20.9	31.2	37.6	55.7	28.0	25.7	53.7	31.0	18.1	35.4	43.0	34.3	28.0	37.9	35.9	51.1	27.6	40.7	13.0	32.2	25.2	30.2	20.9	29.4	21.8	31.1	35.9	21.2	30.8	39.2	16.9	20.8	40.8	31.3	26.0	36.0	29.9	33.6	39.4	35.3	23.4	37.1	25.2	41.5	36.9	32.7	30.2	36.8	22.0	11.0	15.0	14.8	9.5	14.1	15.5	13.4	12.1	12.6	17.3	15.4	11.8	10.3	11.3	11.8	17.1	9.8	6.3	38.6	39.0	17.5	39.5	38.0	32.2	45.3	22.5	26.2	32.1
PTPN14	PEZ	ENSG00000152104	"Protein tyrosine phosphatase, non-receptor type 14"	Q15678	1	214348696-214552449	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB011469, HPA053864, CAB069441"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"CAB011469: AB_299202, CAB069441: , HPA053864: "	"unprognostic (1.54e-1)"	"unprognostic (8.19e-2)"	"unprognostic (5.42e-5)"	"unprognostic (1.42e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (7.43e-2)"	"unprognostic (8.34e-3)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.81e-3)"	13.6	10.0	3.0	6.5	2.4	0.2	15.0	0.8	3.7	13.6	8.5	2.6	11.0	1.0	15.4	8.0	8.6	9.2	9.7	7.0	3.5	1.9	11.2	2.0	12.2	6.6	2.4	1.3	11.8	5.0	6.3	4.0	13.2	4.9	10.6	2.9	7.2	9.2	23.4	21.6	18.8	3.5	9.4	4.3	5.3	5.7	8.3	2.4	1.4	8.1	6.9	3.7	12.4	17.7	1.0	0.5	1.9	0.4	1.0	0.6	0.1	8.7	3.9	3.2	4.6	5.6	9.5	9.4	9.9	9.3	7.6	6.4	7.9	4.6	0.0	11.1	23.1	7.8	4.3	11.1	13.1	0.1	3.3	0.8	11.1	1.4	10.1	0.1	0.4	7.1	11.6	13.2	21.3	14.7	0.0	0.1	18.4	0.9	0.1	0.1	7.0	4.2	0.1	16.0	0.0	13.7	4.4	0.0	0.7	12.3	8.1	5.0	8.0	0.3	26.2	17.9	7.0	6.4	14.1	0.5	0.0	0.0	9.6	0.1	14.9	1.3	0.4	0.3	0.5	0.3	0.6	0.5	0.5	0.4	0.1	1.0	0.5	0.6	1.9	1.0	0.4	0.5	0.6	0.1	3.0	2.4	0.8	3.7	3.5	1.9	2.4	1.3	4.9	2.4
PTPN22	"Lyp, Lyp1, Lyp2, PTPN8"	ENSG00000134242	"Protein tyrosine phosphatase, non-receptor type 22"	Q9Y2R2	1	113813811-113871759	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Immunity"	"Hydrolase, Protein phosphatase"	"Diabetes mellitus, Disease mutation, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.6;lymphoid tissue: 46.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 32.9;HL-60: 13.0;U-266/70: 14.2;U-698: 17.6;U-937: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"cerebellum: 5.9"	"Not detected"	"Not detected"			"HPA004912, CAB012209, HPA013350"	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"				Nucleoplasm	"Vesicles, Plasma membrane"	"CAB012209: , HPA004912: AB_10602069, HPA013350: AB_10601570"	"unprognostic (2.25e-2)"	"unprognostic (5.31e-3)"	"unprognostic (3.48e-1)"	"unprognostic (3.33e-4)"	"unprognostic (9.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (9.60e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.75e-6)"	"unprognostic (3.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.22e-2)"	4.2	1.4	0.5	17.1	0.8	23.6	1.9	1.0	0.5	2.4	3.3	0.3	1.0	4.1	2.0	2.2	2.0	1.7	3.2	2.5	0.6	0.7	3.4	1.8	9.0	14.9	0.7	0.4	1.5	2.4	0.0	0.9	0.9	1.0	1.7	2.8	1.3	2.7	3.0	0.6	1.0	9.9	0.9	2.1	19.0	3.1	1.1	0.4	46.0	1.5	2.4	12.8	4.8	1.7	7.2	6.2	17.2	3.5	7.5	14.9	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.2	0.0	0.3	0.0	0.2	32.9	0.0	0.1	0.0	0.0	0.0	0.2	3.1	0.0	4.6	0.0	0.0	0.1	13.0	10.3	2.9	0.0	1.4	0.1	5.1	0.0	7.5	5.0	0.1	9.2	7.4	0.0	0.0	0.5	3.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	2.3	7.8	0.1	0.1	0.2	14.2	3.0	17.6	5.4	13.4	0.0	10.2	3.5	17.2	12.8	0.9	14.9	7.2	6.5	10.1	6.2	4.7	3.9	9.4	1.7	7.5	0.4	3.7	10.0	4.6	0.5	0.8	1.0	0.5	0.6	0.7	0.7	0.4	1.0	0.4
PTPN3	PTPH1	ENSG00000070159	"Protein tyrosine phosphatase, non-receptor type 3"	P26045	9	109375466-109498313	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 15.4;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038343, HPA046728"	Approved									"HPA038343: AB_10671741, HPA046728: "	"prognostic unfavourable (6.71e-4)"	"unprognostic (3.48e-1)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.38e-2)"	"unprognostic (6.37e-2)"	"unprognostic (3.57e-2)"	"prognostic favourable (1.22e-15)"	"unprognostic (1.64e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.21e-2)"	2.7	1.9	3.4	4.8	5.0	0.0	4.8	2.1	11.1	4.4	9.4	2.0	10.7	7.6	3.2	13.4	10.3	6.4	6.3	12.1	3.1	2.8	28.8	21.1	4.9	0.5	1.2	3.9	1.5	17.0	10.6	4.9	14.5	4.5	4.7	6.5	3.8	13.1	13.6	38.1	18.8	18.8	0.8	0.9	0.9	5.9	2.1	0.0	1.1	9.4	7.2	9.5	4.1	5.5	0.6	0.3	2.8	0.6	0.3	0.3	0.1	6.4	8.0	0.3	2.1	0.0	0.0	12.7	1.4	0.0	1.7	1.9	4.2	10.5	0.0	1.5	0.1	15.4	2.2	9.0	1.8	3.5	4.9	0.0	3.8	4.3	0.0	0.0	0.1	0.1	9.7	2.2	4.7	0.0	0.0	0.1	0.1	8.1	11.0	1.9	1.0	6.0	0.0	2.6	0.1	20.7	12.4	5.2	1.1	3.5	13.1	0.0	7.5	1.0	0.0	0.6	5.1	0.8	0.0	6.3	10.3	0.0	6.8	0.0	4.6	0.4	0.6	0.8	0.2	0.4	0.2	0.4	0.2	0.2	0.3	0.6	0.3	0.3	2.8	0.3	0.6	0.3	0.1	0.1	3.4	5.0	2.1	11.1	3.1	2.8	1.2	3.9	4.5	0.0
PTPN4	PTPMEG	ENSG00000088179	"Protein tyrosine phosphatase, non-receptor type 4"	P29074	2	119759631-119983818	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	16	"NK-cells: 12.2;T-cells: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019351	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA019351: AB_1855928"	"unprognostic (1.45e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (5.16e-4)"	"unprognostic (3.31e-2)"	"unprognostic (3.34e-3)"	"unprognostic (3.13e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.81e-1)"	6.8	6.9	10.0	5.9	12.2	7.3	7.2	37.4	16.9	9.6	5.5	7.2	5.2	8.1	7.2	6.6	6.9	8.9	6.3	8.9	10.2	8.4	12.0	6.6	8.0	7.9	7.3	13.1	8.9	6.3	11.6	16.3	4.1	8.3	6.2	4.0	7.1	7.9	6.6	11.2	5.8	5.5	4.7	7.3	9.2	8.9	7.7	6.5	18.9	22.5	6.8	6.5	5.3	5.8	0.5	0.3	0.9	0.4	12.2	19.3	4.7	7.3	4.3	5.7	7.6	5.1	5.3	9.7	3.3	9.4	1.9	5.2	6.4	11.4	5.3	8.0	3.7	6.5	4.4	5.2	5.1	12.3	3.7	3.6	4.1	6.1	3.4	3.7	2.7	4.8	9.8	8.8	4.0	8.3	6.2	5.4	5.0	5.6	5.1	4.3	7.5	7.1	3.5	9.8	7.4	6.9	10.0	7.4	9.2	4.6	5.9	3.8	2.8	2.4	10.4	0.2	6.5	2.2	4.0	9.3	13.0	6.7	4.9	0.2	3.1	0.2	0.2	0.9	19.3	0.3	15.6	0.5	9.6	15.1	0.3	0.5	3.2	11.0	0.7	12.2	0.4	0.3	5.6	4.7	10.0	12.2	37.4	16.9	10.2	8.4	7.3	13.1	8.3	6.5
PTPN5	"PTPSTEP, STEP, STEP61"	ENSG00000110786	"Protein tyrosine phosphatase, non-receptor type 5"	P54829	11	18727928-18792721	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 70.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HMC-1: 3.6;NTERA-2: 5.7"	"Group enriched"	"Detected in some"	6	"glioma: 1.6;testis cancer: 2.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 70.0"	"Cell type enriched"	"Detected in single"	9	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031014, HPA072091"	Supported		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA031014: AB_10669550, HPA072091: "	"unprognostic (1.23e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.83e-3)"	"unprognostic (3.59e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.58e-1)"	"unprognostic (8.44e-4)"	"unprognostic (4.21e-3)"	"unprognostic (3.90e-2)"	"unprognostic (9.39e-2)"	"unprognostic (8.49e-2)"	2.5	1.6	16.3	1.1	70.0	1.1	1.2	0.9	47.5	1.5	1.1	0.4	0.0	1.1	1.2	1.0	1.3	1.7	1.4	4.3	9.1	8.6	1.1	0.9	2.7	1.1	3.5	16.0	2.5	1.2	1.5	0.5	0.9	6.1	1.6	1.4	0.0	1.3	1.7	1.8	1.0	1.4	1.4	2.1	1.3	1.3	3.4	9.3	0.0	1.2	0.0	1.0	1.5	0.3	0.1	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.0	0.0	3.6	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	5.7	0.3	0.0	0.1	0.1	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	1.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	70.0	0.9	25.1	9.1	8.6	3.5	16.0	6.1	9.3
PTPN6	"HCP, HCPH, PTP-1C, SHP-1, SHP1"	ENSG00000111679	"Protein tyrosine phosphatase, non-receptor type 6"	P29350	12	6946468-6961316	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.1;lymphoid tissue: 69.0"	"Cell line enhanced"	"Detected in many"		"HEL: 28.1;HL-60: 24.9;HMC-1: 110.1;THP-1: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001466, CAB004572, CAB072845"	Enhanced		Supported	Nucleoplasm,Nucleoli			7400000	Nucleoplasm	Nucleoli	"CAB004572: AB_628251, CAB072845: , HPA001466: AB_1855930"	"unprognostic (4.28e-3)"	"prognostic favourable (1.87e-4)"	"prognostic unfavourable (5.42e-4)"	"prognostic favourable (6.65e-4)"	"unprognostic (6.54e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.44e-2)"	"unprognostic (6.93e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.98e-3)"	"unprognostic (2.60e-2)"	"unprognostic (5.91e-2)"	"prognostic favourable (2.64e-8)"	6.6	8.8	2.4	42.9	4.4	27.7	4.6	1.2	2.7	2.8	7.0	5.1	4.7	7.5	3.7	8.8	7.0	5.0	9.8	2.9	3.1	2.3	7.0	6.8	25.4	58.1	5.2	1.8	2.3	6.7	2.7	5.6	7.7	3.9	5.6	5.2	3.6	10.6	7.0	1.3	6.1	21.0	2.6	4.9	69.0	6.6	1.5	3.3	31.4	6.3	4.1	50.7	8.5	4.2	63.9	38.0	107.1	103.2	22.2	28.2	63.2	2.8	5.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	2.9	6.4	2.0	1.5	0.0	3.3	0.0	3.8	0.0	1.2	1.1	28.1	0.6	2.4	0.0	24.9	110.1	0.0	2.8	0.0	1.2	0.0	0.0	0.2	0.0	6.0	9.0	14.6	1.5	0.9	8.2	0.0	14.2	3.0	5.4	0.5	0.0	0.9	4.5	0.0	1.4	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.9	0.1	54.4	35.9	107.1	28.2	71.3	18.2	62.3	13.7	21.0	38.0	63.9	15.8	19.9	66.7	22.2	103.2	10.0	14.4	63.2	2.4	4.4	1.2	2.7	3.1	2.3	5.2	1.8	3.9	3.3
PTPRA	"HLPR, HPTPA, LRP, PTPA, PTPRL2, RPTPA"	ENSG00000132670	"Protein tyrosine phosphatase, receptor type A"	P18433	20	2864184-3039076	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029412, CAB034366, HPA069480"	Approved		Approved	Nucleoplasm,Vesicles			21000	Vesicles	Nucleoplasm	"CAB034366: AB_2269058, HPA029412: AB_10602293, HPA069480: "	"unprognostic (1.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.58e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.43e-3)"	"unprognostic (5.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.24e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.16e-1)"	"prognostic favourable (3.29e-6)"	"unprognostic (1.25e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.19e-1)"	21.9	18.5	55.6	14.3	48.6	16.4	23.3	44.5	56.0	29.7	19.7	37.5	9.4	14.7	26.3	18.7	22.7	26.5	21.3	14.0	45.9	41.1	22.1	13.5	21.6	16.9	38.0	46.7	28.6	14.9	41.5	23.4	29.0	52.5	23.5	20.0	18.5	16.7	21.8	8.2	21.0	15.3	25.7	52.6	17.9	16.3	27.4	30.4	20.6	32.4	8.5	20.4	22.9	19.2	7.7	5.7	7.9	6.7	6.2	11.0	3.7	20.5	12.6	36.3	11.1	40.2	73.4	7.7	15.5	30.3	19.2	23.5	15.0	28.6	13.5	12.2	20.7	22.1	14.6	22.1	21.7	20.8	9.4	19.2	5.3	19.0	14.4	19.2	9.1	32.8	22.9	15.8	16.7	26.5	19.2	17.3	19.0	8.4	22.2	21.8	14.0	10.1	17.0	17.6	16.8	16.4	16.0	20.1	19.3	15.0	25.5	23.0	15.9	16.5	18.9	17.1	8.5	19.1	13.6	12.7	17.6	17.8	7.9	18.2	16.0	7.9	4.8	7.5	11.0	4.8	9.0	7.7	7.4	7.9	3.7	5.1	7.4	9.0	6.0	6.2	6.7	5.7	8.1	3.7	55.6	48.6	44.5	56.0	45.9	41.1	38.0	46.7	52.5	30.4
PTPRB	PTPB	ENSG00000127329	"Protein tyrosine phosphatase, receptor type B"	P23467	12	70515866-70637440	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 11.1;HUVEC TERT2: 27.5;TIME: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"memory B-cell: 3.5"	"Lineage enriched"	"Detected in single"	7	"B-cells: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004782, HPA067868"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"			6700000	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB004782: , HPA067868: "	"unprognostic (3.18e-1)"	"unprognostic (2.99e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (6.05e-4)"	"unprognostic (4.59e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.40e-1)"	"prognostic favourable (1.02e-4)"	"unprognostic (2.91e-2)"	"unprognostic (7.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.38e-1)"	23.5	7.0	4.5	5.5	7.0	0.1	22.9	3.6	6.1	11.3	8.0	4.3	7.1	5.3	17.1	8.5	5.8	8.2	11.4	17.6	6.2	5.1	18.7	12.0	39.9	3.3	6.9	4.6	5.5	4.4	4.9	5.7	23.3	7.8	6.1	8.2	16.0	3.6	7.1	11.8	4.7	7.4	13.3	7.3	22.9	5.2	3.7	4.3	0.7	14.0	12.2	2.6	6.5	14.7	3.5	0.1	0.2	0.0	0.4	0.3	0.2	1.9	0.1	0.8	0.1	0.0	0.0	0.4	0.4	1.9	1.0	2.4	0.0	1.5	0.7	11.1	0.3	6.8	0.1	0.3	3.5	0.5	0.3	0.1	0.7	0.4	0.1	0.3	0.0	0.0	0.3	2.7	0.0	27.5	1.5	0.4	0.6	0.0	0.0	0.0	1.0	0.4	0.0	0.7	0.3	5.1	0.7	0.0	0.4	0.7	0.0	1.6	0.0	0.6	40.2	0.4	0.4	0.1	2.3	0.5	0.3	0.3	0.2	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	3.5	0.0	0.3	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	4.5	7.0	3.6	6.1	6.2	5.1	6.9	4.6	7.8	4.3
PTPRD	"HPTP, PTPD"	ENSG00000153707	"Protein tyrosine phosphatase, receptor type D"	P23468	9	8314246-10612723	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 37.5"	"Cell line enhanced"	"Detected in some"		"AF22: 23.0;HAP1: 5.0;HSkMC: 7.8;NTERA-2: 5.6;RH-30: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054829	Uncertain		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"		2500000	Vesicles	Nucleoplasm	"HPA054829: "	"unprognostic (4.74e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.52e-3)"	"unprognostic (2.62e-1)"	"prognostic favourable (7.45e-6)"	"unprognostic (3.56e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.08e-3)"	2.6	1.7	19.7	1.5	19.2	1.1	1.1	27.9	32.1	5.6	5.4	21.7	0.2	4.0	3.6	1.8	1.5	3.6	2.6	3.0	18.0	13.5	11.4	4.2	3.4	0.9	17.9	22.3	12.7	1.7	37.5	4.4	9.4	15.1	3.3	5.3	1.9	1.1	2.0	1.0	1.2	4.6	2.8	29.7	1.4	1.7	2.5	18.5	0.0	3.2	0.0	1.0	2.7	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	23.0	0.0	0.3	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	2.6	4.7	0.6	0.0	0.0	0.0	0.2	7.8	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	2.7	0.0	5.6	1.4	2.8	8.5	0.0	2.1	0.0	3.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	19.7	19.2	27.9	32.1	18.0	13.5	17.9	22.3	15.1	18.5
PTPRF	LAR	ENSG00000142949	"Protein tyrosine phosphatase, receptor type F"	P10586	1	43525187-43623666	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 53.7;SK-BR-3: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012710	Uncertain		Approved	"Golgi apparatus"	"Intracellular and membrane"		95000000	"Golgi apparatus"		"HPA012710: AB_1855933"	"unprognostic (8.20e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (3.47e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.99e-2)"	"prognostic favourable (7.03e-4)"	"unprognostic (2.33e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.58e-1)"	37.1	5.5	22.4	10.4	18.1	0.9	30.7	6.8	19.5	14.2	34.3	16.8	34.4	30.7	12.3	33.4	41.4	32.2	20.0	6.3	17.2	15.0	12.0	45.6	15.7	5.8	17.2	18.5	10.4	25.3	17.5	10.3	38.1	16.1	30.9	23.1	5.9	41.9	23.6	2.9	46.8	35.5	16.8	11.2	2.0	21.8	4.3	15.8	4.6	12.5	11.7	14.9	21.4	21.3	0.9	0.0	0.2	0.0	0.0	0.0	0.7	30.4	14.6	9.6	11.3	2.2	0.1	53.7	17.5	7.0	14.5	12.4	15.5	41.5	0.0	4.9	7.6	23.9	11.1	38.5	17.6	0.3	13.9	0.1	10.0	14.1	6.8	0.2	0.2	2.2	22.2	20.8	34.6	21.5	4.7	1.4	5.3	17.6	0.2	0.2	14.5	4.0	10.6	17.0	0.7	5.6	46.1	14.3	5.3	17.4	61.4	2.3	17.7	3.2	16.9	0.3	23.2	1.4	23.3	0.6	0.5	0.0	1.4	0.7	45.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	22.4	18.1	6.8	19.5	17.2	15.0	17.2	18.5	16.1	15.8
PTPRG	"PTPG, RPTPG"	ENSG00000144724	"Protein tyrosine phosphatase, receptor type G"	P23470	3	61561569-62297613	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.5;HSkMC: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000546, HPA064237"	Uncertain		Approved	"Plasma membrane"			520000000	"Plasma membrane"		"HPA000546: , HPA064237: "	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.73e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (3.10e-6)"	"unprognostic (9.91e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	22.2	18.0	12.9	10.1	10.7	1.2	26.1	8.1	16.4	17.2	13.9	5.2	12.0	5.6	15.8	19.0	6.4	13.1	15.7	12.4	24.5	9.9	20.2	8.2	38.9	10.2	8.3	10.5	16.6	6.0	58.6	11.9	13.1	15.1	11.3	8.9	23.3	7.9	17.2	19.2	6.6	8.4	17.4	12.7	9.2	8.7	11.4	5.0	0.1	21.7	7.0	3.2	10.0	14.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	11.4	0.0	35.5	18.1	5.5	7.0	11.6	7.5	10.2	5.3	0.2	0.2	4.1	8.3	0.1	5.5	5.5	12.0	0.6	3.1	0.5	0.0	6.1	11.9	2.9	0.0	26.3	2.2	10.7	13.0	8.1	0.0	7.0	6.8	3.0	0.0	0.0	7.0	0.0	4.6	3.5	0.2	7.8	3.3	0.8	1.8	1.7	0.0	2.7	0.0	0.1	18.5	10.6	10.1	16.9	5.9	2.2	2.6	0.0	8.1	1.3	12.7	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	12.9	10.7	8.1	16.4	24.5	9.9	8.3	10.5	15.1	5.0
PTPRJ	"CD148, DEP1, HPTPeta"	ENSG00000149177	"Protein tyrosine phosphatase, receptor type J"	Q12913	11	47980558-48170841	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 25.3;RPTEC TERT1: 24.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in all"	4	"granulocytes: 12.2;monocytes: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006026	Approved				"Intracellular and membrane"		840000000			"HPA006026: AB_1078446"	"unprognostic (1.46e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.58e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.79e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.13e-5)"	"unprognostic (1.09e-2)"	"unprognostic (7.98e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.00e-1)"	5.6	3.7	10.4	17.7	13.9	22.6	5.6	4.9	9.5	6.1	9.0	8.8	12.3	8.4	3.9	7.6	2.9	5.0	6.7	5.2	9.5	9.2	13.3	12.2	12.2	22.6	10.8	9.4	3.0	9.1	21.1	14.5	20.3	8.3	7.8	8.1	12.9	12.9	9.0	4.6	4.3	13.4	5.5	6.7	33.0	13.8	3.1	9.9	6.7	18.8	0.9	9.7	6.0	3.9	1.0	1.8	12.2	5.3	1.2	2.1	0.9	3.5	13.4	5.9	3.2	0.9	2.1	2.0	3.6	2.6	6.3	4.7	0.8	19.8	3.3	25.3	9.1	2.7	9.2	0.9	7.7	21.7	2.5	0.9	16.6	1.2	5.8	1.2	20.6	1.5	0.3	1.7	0.4	3.8	1.2	2.1	2.2	7.6	0.0	7.4	4.6	2.1	0.7	0.7	1.7	24.6	5.2	4.0	1.2	10.0	5.7	9.0	6.3	9.1	12.4	5.0	5.2	10.0	10.9	0.5	0.7	5.5	5.7	3.8	18.1	0.9	1.5	3.4	2.1	2.5	1.4	1.0	1.2	1.5	1.0	0.7	1.0	1.3	12.2	1.2	5.3	1.8	1.1	0.9	10.4	13.9	4.9	9.4	9.5	9.2	10.8	9.4	8.3	9.9
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase, receptor type K"	Q15262	6	127968779-128520674	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 2.3;naive B-cell: 4.8;naive CD8 T-cell: 1.6"	"Group enriched"	"Detected in many"	7	"B-cells: 4.8;T-cells: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"			13000000	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: , HPA054822: "	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favourable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	12.0	5.2	18.6	10.7	20.3	1.2	20.9	4.7	24.4	12.2	21.9	25.6	11.2	25.7	12.1	10.3	9.1	13.2	29.6	11.4	17.2	12.6	13.3	23.6	17.4	5.7	20.5	19.3	15.6	25.7	11.4	12.2	17.4	14.9	16.3	23.4	3.9	18.3	17.5	9.1	13.5	27.4	14.6	17.1	6.4	24.6	2.7	23.7	15.3	10.1	6.5	7.6	18.4	15.1	4.8	0.0	0.0	0.0	0.4	1.6	0.2	4.4	4.8	2.9	0.2	6.1	8.2	2.9	12.1	23.5	5.0	4.6	8.0	3.7	0.0	3.7	11.1	12.7	3.0	9.6	7.1	13.4	4.9	0.1	7.4	11.1	7.5	0.0	0.4	6.0	8.9	10.5	14.4	13.7	0.0	0.2	12.3	9.0	6.8	0.0	3.0	6.2	24.5	6.2	0.8	12.4	9.2	15.3	0.0	12.5	14.0	0.7	3.8	0.3	23.1	7.9	5.5	15.3	10.9	0.1	1.6	0.0	10.1	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	4.8	0.4	1.6	0.0	0.4	0.0	0.0	0.1	0.2	18.6	20.3	4.7	24.4	17.2	12.6	20.5	19.3	14.9	23.7
PTPRM	"hR-PTPu, PTPRL1, RPTPU"	ENSG00000173482	"Protein tyrosine phosphatase, receptor type M"	P28827	18	7566782-8406861	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 7.2"	"Group enriched"	"Detected in many"	50	"dendritic cells: 2.7;T-cells: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003891, CAB022442, CAB022443"	Supported		Approved	"Plasma membrane"			76000000	"Plasma membrane"		"CAB022442: , CAB022443: , HPA003891: "	"unprognostic (2.59e-1)"	"prognostic unfavourable (8.65e-5)"	"unprognostic (4.89e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.41e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.41e-2)"	"unprognostic (2.63e-2)"	"prognostic favourable (1.07e-4)"	31.4	14.1	9.5	6.3	22.2	0.6	23.6	10.4	17.2	11.0	13.6	6.2	28.1	4.7	15.4	10.9	8.1	13.6	18.1	33.5	10.5	15.0	16.9	6.5	22.0	7.8	8.5	12.0	15.7	7.6	16.3	21.9	18.3	23.2	10.6	6.6	18.3	7.4	21.8	26.0	7.3	8.7	14.1	9.3	12.1	11.0	12.2	9.1	2.9	31.1	7.3	6.3	18.6	25.3	0.0	2.7	0.0	0.0	0.0	7.2	1.4	1.5	11.3	5.4	0.0	34.8	24.1	13.1	13.8	12.2	9.3	13.8	10.3	2.4	0.0	13.6	16.6	0.1	0.0	4.8	12.9	0.1	2.5	0.0	7.5	5.0	9.9	0.0	0.1	27.4	10.2	5.1	14.7	9.3	0.0	4.7	7.4	0.2	4.5	0.1	0.9	2.5	0.1	4.7	20.9	22.8	19.4	0.4	3.0	0.4	0.0	11.6	0.0	0.0	9.6	19.2	12.1	9.1	2.4	0.4	0.1	0.0	16.4	0.0	3.5	0.0	0.0	0.0	4.5	0.0	1.8	0.0	6.0	7.2	0.1	0.0	1.7	3.1	0.0	0.0	0.0	2.7	1.0	1.4	9.5	22.2	10.4	17.2	10.5	15.0	8.5	12.0	23.2	9.1
PTPRR	"EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ"	ENSG00000153233	"Protein tyrosine phosphatase, receptor type R"	Q15256	12	70638073-70920843	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 56.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 14.0;RT4: 26.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 56.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"cerebellum: 100.5"	"Low region specificity"	"Detected in all"			"CAB011461, HPA011851, HPA071067"	Uncertain		Supported	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"CAB011461: AB_298890, HPA011851: AB_1855939, HPA071067: "	"unprognostic (4.98e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.48e-5)"	"unprognostic (5.44e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (1.40e-5)"	0.4	3.8	18.8	1.6	11.3	0.3	0.4	56.1	20.9	0.5	11.2	0.1	0.0	5.1	8.4	0.3	0.4	0.5	1.9	0.4	8.6	4.9	0.4	0.4	0.4	0.4	1.3	13.2	0.4	0.6	0.3	0.9	0.7	3.3	0.5	7.8	0.8	0.4	2.1	0.4	0.4	11.3	4.9	3.1	0.4	4.4	0.4	1.4	0.0	0.4	0.0	0.3	4.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.3	0.0	0.5	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	26.7	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.8	11.3	56.1	20.9	8.6	4.9	1.3	13.2	3.3	1.4
PTPRS		ENSG00000105426	"Protein tyrosine phosphatase, receptor type S"	Q13332	19	5158495-5340803	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion"	"Heparin-binding, Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 40.7;HaCaT: 41.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	82	"plasmacytoid DC: 13.4"	"Lineage enriched"	"Detected in single"	82	"dendritic cells: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054747			Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"		92000000	"Plasma membrane, Cytosol"		"HPA054747: "	"unprognostic (8.14e-2)"	"unprognostic (4.59e-3)"	"unprognostic (2.57e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.86e-1)"	"prognostic favourable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (2.80e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-1)"	"unprognostic (3.46e-2)"	59.1	17.3	14.4	9.4	14.8	3.1	32.0	27.6	53.3	28.7	11.4	29.6	14.4	4.6	21.4	15.4	13.3	24.0	22.2	18.6	15.9	15.1	10.7	6.9	13.9	8.6	20.5	12.1	29.2	38.4	10.5	16.6	4.3	12.0	23.1	3.6	28.9	21.5	20.1	11.9	23.8	6.5	17.5	13.8	8.3	12.7	10.8	18.7	4.4	21.1	7.2	7.5	19.1	22.7	0.0	13.4	0.0	0.0	0.0	0.1	0.0	3.6	20.9	18.9	40.7	8.7	7.1	2.5	6.3	7.5	7.7	6.3	0.2	2.0	0.0	15.0	10.6	41.3	5.0	0.0	3.4	0.4	8.0	0.0	8.6	13.0	4.0	0.0	4.7	7.5	1.8	1.6	0.3	0.2	5.8	0.0	3.1	15.4	1.6	3.9	10.6	8.9	0.0	4.2	0.0	1.5	7.3	14.5	19.9	6.0	1.1	11.5	7.3	1.5	0.8	6.9	11.9	15.7	7.6	2.1	0.0	12.0	3.5	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	14.4	14.8	27.6	17.6	15.9	15.1	20.5	12.1	12.0	18.7
PTPRU	"FMI, hPTP-J, PCP-2, PTP, PTPRO"	ENSG00000060656	"Protein tyrosine phosphatase, receptor type U"	Q92729	1	29236516-29326813	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Differentiation"	"Hydrolase, Protein phosphatase, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB011476, HPA039832"	Approved									"CAB011476: AB_442989, HPA039832: AB_10793923"	"unprognostic (7.81e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-3)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (7.92e-4)"	"prognostic unfavourable (8.32e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.55e-3)"	"unprognostic (3.39e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.34e-1)"	"unprognostic (2.05e-1)"	6.0	3.2	3.1	1.7	5.8	0.6	16.0	6.7	12.7	24.8	3.7	2.6	6.1	1.3	9.5	4.7	3.9	14.5	7.0	8.9	4.5	5.1	3.9	7.0	11.4	1.2	5.2	5.3	12.2	12.0	12.1	8.1	14.3	21.4	11.0	2.3	18.7	11.3	17.9	14.7	7.3	1.7	6.5	6.6	2.4	4.5	4.4	0.9	0.3	4.9	2.1	2.0	12.2	17.6	0.4	0.0	0.0	0.5	0.0	0.2	0.0	3.1	4.3	0.2	0.6	12.1	0.4	39.7	3.4	3.0	0.1	0.2	3.7	14.1	0.5	6.7	0.6	17.1	15.7	11.0	0.0	0.2	7.9	0.6	4.8	15.7	5.1	0.0	0.7	5.6	5.9	0.0	1.0	0.1	0.1	0.5	3.1	5.2	0.2	0.1	6.5	2.0	0.0	4.6	0.2	4.8	15.8	13.4	17.4	3.4	10.8	2.3	6.4	0.7	2.8	0.6	3.9	1.0	0.4	0.3	0.4	0.0	7.8	0.7	0.8	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	5.8	6.7	12.7	4.5	5.1	5.2	5.3	21.4	0.9
PTPRZ1	"phosphacan, PTP18, PTPRZ, PTPZ, RPTPB"	ENSG00000106278	"Protein tyrosine phosphatase, receptor type Z1"	P23471	7	121873089-122062036	"Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 118.1"	"Group enriched"	"Detected in some"	9	"AF22: 92.1;NTERA-2: 25.6;WM-115: 40.3"	"Cancer enriched"	"Detected in many"	14	"glioma: 175.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015103	Enhanced		Approved	Vesicles,Cytosol	"Secreted in brain"		950000	Cytosol	Vesicles	"HPA015103: AB_1855946"	"unprognostic (8.49e-4)"	"unprognostic (3.96e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.18e-2)"	"unprognostic (2.41e-2)"	"unprognostic (8.30e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.17e-4)"	"unprognostic (1.83e-1)"	"unprognostic (8.72e-6)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.77e-2)"	"prognostic unfavourable (9.36e-4)"	2.0	2.5	33.1	2.3	44.1	1.5	4.0	15.4	118.1	2.4	2.2	19.3	0.0	1.9	1.6	2.0	7.0	1.7	1.9	2.0	39.6	15.9	1.6	1.6	2.1	1.5	18.6	17.8	2.0	3.3	1.5	1.6	1.6	67.6	2.1	2.3	0.8	2.4	2.0	1.5	19.3	1.9	2.4	76.6	2.1	9.8	1.7	23.6	0.0	1.5	1.8	3.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	1.1	0.0	0.1	0.0	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.1	44.1	15.4	39.6	39.6	15.9	18.6	17.8	67.6	23.6
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436789-157443628	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8"	"Cancer enhanced"	"Detected in many"		"glioma: 22.5"	"Group enriched"	"Detected in some"	6	"hippocampal formation: 1.1;pons and medulla: 3.6"	"Cell type enhanced"	"Detected in some"		"eosinophil: 3.2"	"Group enriched"	"Detected in many"	20	"dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Approved	"Plasma membrane"	"Secreted to blood"	1090000	310000	"Plasma membrane"		"HPA069320: "	"unprognostic (1.93e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (8.35e-9)"	"unprognostic (5.79e-3)"	"prognostic unfavourable (6.36e-4)"	"unprognostic (6.03e-3)"	"prognostic unfavourable (8.75e-6)"	"unprognostic (2.45e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.76e-9)"	"unprognostic (6.03e-3)"	"unprognostic (5.98e-2)"	"unprognostic (2.15e-4)"	"unprognostic (1.92e-3)"	61.7	3.4	0.3	16.7	0.2	31.6	35.3	0.2	0.7	0.8	13.2	0.3	0.6	0.5	0.5	0.8	2.0	6.5	3.5	14.7	1.1	0.0	3.0	0.6	22.5	7.0	0.3	0.1	6.8	18.0	0.3	1.0	4.9	3.6	2.5	1.2	5.2	1.8	0.4	67.7	6.0	1.9	6.4	0.9	9.6	4.9	0.9	0.2	0.3	2.7	0.4	0.4	77.0	2.5	0.0	1.3	3.2	1.2	0.0	0.0	0.1	0.0	0.0	51.0	0.0	84.6	122.6	0.0	8.8	80.5	3.8	4.1	0.0	0.5	0.0	31.4	10.3	0.0	0.0	0.0	7.5	0.0	0.0	0.1	0.0	0.0	157.4	0.1	0.0	163.9	0.0	86.6	29.5	17.8	0.0	0.0	25.4	0.0	0.0	0.1	0.7	0.3	0.0	0.0	0.0	0.3	3.5	0.4	0.0	0.5	0.0	0.0	0.0	0.1	116.7	17.3	0.8	108.8	1.5	0.0	0.0	0.0	3.6	0.4	4.9	0.0	1.2	3.2	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.3	0.2	0.2	0.2	1.1	0.0	0.3	0.1	3.6	0.2
PURA	"PUR-ALPHA, PUR1, PURALPHA"	ENSG00000185129	"Purine rich element binding protein A"	Q00577	5	140107777-140125619	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														150000				"unprognostic (2.69e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.28e-2)"	"prognostic favourable (4.77e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.09e-1)"	10.5	14.4	13.9	9.0	20.3	2.0	10.4	23.4	21.4	15.9	17.3	13.0	13.7	11.8	12.6	10.8	13.6	10.5	10.9	12.3	14.2	12.2	18.8	13.7	9.5	8.8	16.6	10.2	16.2	10.7	30.9	14.8	12.0	14.4	17.0	8.3	11.7	12.4	14.8	14.6	11.2	26.0	17.9	14.6	15.1	10.6	7.5	18.8	10.4	19.4	6.2	9.5	17.1	18.5	3.0	1.8	3.3	1.4	3.7	3.7	0.8	6.9	3.1	2.4	10.5	9.9	14.3	6.8	13.7	8.7	7.7	7.1	8.1	6.4	8.9	12.0	9.7	5.6	8.0	10.4	12.4	9.0	10.1	5.9	6.1	3.1	5.4	5.3	7.0	5.7	8.6	8.0	8.0	3.8	5.2	6.8	7.0	5.8	7.1	6.0	1.8	6.9	6.1	9.1	5.3	7.6	5.6	6.1	5.2	8.2	8.6	9.8	7.0	7.7	11.2	13.7	5.1	4.0	10.1	9.5	5.1	7.0	7.4	6.5	10.5	3.3	1.4	2.2	2.6	0.9	2.4	2.2	2.8	2.6	1.2	3.0	2.6	3.7	0.7	3.7	1.2	1.8	2.2	0.8	13.9	20.3	23.4	14.3	14.2	12.2	16.6	10.2	14.4	18.8
PVR	"CD155, HVED, Necl-5, NECL5, PVS, Tage4"	ENSG00000073008	"Poliovirus receptor"	P15151	19	44643798-44663583	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 65.6"	"Cell line enhanced"	"Detected in many"		"TIME: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 6.4;intermediate monocyte: 6.6;myeloid DC: 5.6;non-classical monocyte: 8.1"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;monocytes: 8.1"									HPA012568	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Secreted - unknown location"		940000000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA012568: AB_1846248"	"unprognostic (2.90e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.06e-2)"	"prognostic unfavourable (9.30e-4)"	"unprognostic (9.05e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.64e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.97e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-3)"	"prognostic unfavourable (2.75e-4)"	10.0	13.9	7.4	7.5	8.1	4.7	9.2	11.0	11.0	6.5	10.6	6.5	4.1	13.7	11.3	5.7	6.6	8.8	9.2	23.5	5.8	10.0	10.6	65.6	14.8	2.4	6.0	6.5	10.4	15.9	9.9	20.7	15.5	9.7	10.4	7.7	6.6	8.5	6.9	19.8	5.5	13.0	11.1	7.0	4.8	12.3	6.0	7.2	2.3	8.5	10.8	3.7	8.3	6.7	0.0	5.6	1.2	8.1	0.6	0.4	2.2	21.5	15.1	1.5	6.1	1.8	2.2	2.6	36.4	10.2	12.0	13.7	8.8	9.2	0.0	21.0	10.5	14.2	5.1	13.8	8.0	2.6	9.9	3.8	9.5	5.9	12.7	1.4	8.3	2.9	6.8	10.5	20.7	13.0	1.8	0.0	5.5	1.9	1.3	1.3	3.4	11.2	0.0	6.9	2.0	25.7	6.6	6.5	7.6	23.1	14.5	5.1	8.2	3.7	52.7	14.5	17.9	10.7	28.4	0.0	2.1	0.0	11.6	7.4	8.2	0.0	6.4	0.0	0.2	6.6	0.0	0.0	0.0	0.4	5.6	0.0	0.2	0.1	1.2	0.6	8.1	0.5	0.0	2.2	7.4	8.1	11.0	11.0	5.8	10.0	6.0	6.5	9.7	7.2
PXDN	"D2S448, D2S448E, KIAA0230, MG50, PRG2, PXN"	ENSG00000130508	Peroxidasin	Q92626	2	1631887-1744852	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Hydrogen peroxide"	"Oxidoreductase, Peroxidase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 60.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA012375	Approved				"Secreted to extracellular matrix"		4000000			"HPA012375: AB_1855965"	"unprognostic (4.37e-2)"	"prognostic unfavourable (6.28e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.34e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavourable (6.73e-4)"	"unprognostic (1.18e-1)"	"unprognostic (7.33e-3)"	"unprognostic (5.54e-3)"	36.4	3.2	2.6	13.1	2.0	0.5	60.8	0.3	3.7	15.5	17.7	2.7	5.1	4.3	20.4	8.9	7.4	9.7	12.9	16.2	2.0	2.6	5.8	6.9	14.3	8.5	1.8	1.4	19.2	2.1	1.5	6.5	18.3	3.6	15.2	5.0	7.6	7.3	6.8	8.4	3.7	8.4	41.0	2.6	13.7	7.8	5.8	1.2	4.3	5.9	4.8	3.4	26.3	20.1	0.5	2.0	0.0	0.0	0.0	1.1	0.1	6.7	2.4	12.7	0.0	36.0	33.1	9.7	40.2	32.0	17.6	19.3	0.0	0.1	0.0	57.8	39.7	1.4	0.0	24.7	22.5	0.1	0.4	0.0	25.2	0.0	35.8	0.1	0.0	36.4	7.3	19.9	15.0	43.3	0.0	0.0	25.0	4.0	1.1	1.3	10.3	9.2	2.2	44.5	0.1	20.7	0.0	0.0	23.5	0.0	13.0	0.0	4.7	0.1	42.0	29.2	14.4	1.1	31.0	0.0	33.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	2.0	0.0	0.1	2.6	2.0	0.3	2.7	2.0	2.6	1.8	1.4	3.6	1.2
PYGB		ENSG00000100994	"Glycogen phosphorylase B"	P11216	20	25248069-25298014	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 101.9"	"Cell line enhanced"	"Detected in all"		"PC-3: 70.3;SK-MEL-30: 88.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031067	Approved		Approved	Cytosol			16000000	Cytosol		"HPA031067: "	"unprognostic (6.13e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.37e-4)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (1.23e-3)"	"unprognostic (8.39e-3)"	"unprognostic (1.58e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.43e-4)"	19.0	11.3	24.2	12.1	22.9	6.1	28.4	38.3	34.8	14.3	47.0	21.5	19.0	12.5	15.9	13.8	49.6	14.1	21.1	72.5	21.1	21.3	13.5	4.4	14.8	8.1	22.9	24.7	11.9	9.7	8.0	18.2	6.2	28.0	42.2	33.8	11.0	58.4	52.0	5.0	23.9	13.1	101.9	17.8	8.2	24.1	14.5	17.4	9.5	21.1	8.4	10.3	56.7	14.8	4.5	11.2	5.2	16.8	8.1	10.6	16.0	5.2	37.6	6.8	6.6	17.4	32.8	5.0	10.6	13.9	8.9	7.5	8.4	6.5	6.2	12.5	14.1	21.1	7.6	28.2	4.9	3.5	4.7	5.0	3.1	14.4	20.6	7.3	7.0	19.0	26.5	22.7	33.6	11.4	2.7	15.8	12.5	14.5	7.3	5.7	6.1	70.3	5.6	12.3	8.2	48.9	9.6	10.2	6.3	7.2	12.8	88.2	8.9	4.7	25.0	10.6	6.4	11.3	21.5	6.1	9.5	2.4	11.9	5.8	57.6	2.6	10.2	5.2	8.5	15.5	8.3	4.5	6.8	7.5	11.2	4.2	8.8	10.6	2.5	8.1	16.8	5.5	7.5	16.0	24.2	22.9	38.3	34.8	21.1	21.3	22.9	24.7	28.0	17.4
PYGL		ENSG00000100504	"Glycogen phosphorylase L"	P06737	14	50857891-50944736	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 56.1;HMC-1: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 36.0;neutrophil: 41.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000962, HPA004119"	Enhanced		Supported	"Plasma membrane,Cytosol"			17000000	"Plasma membrane, Cytosol"		"HPA000962: AB_1079722, HPA004119: AB_1079723"	"unprognostic (2.70e-2)"	"unprognostic (8.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (8.55e-2)"	"unprognostic (9.41e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (2.63e-4)"	"unprognostic (4.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.95e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-3)"	47.6	9.9	4.9	9.7	6.8	40.0	28.1	1.3	3.9	17.2	10.1	3.0	23.7	1.7	10.9	7.3	24.8	7.8	5.5	15.0	3.9	3.4	6.8	58.8	19.6	25.6	6.5	1.6	15.4	4.1	12.5	3.7	23.3	5.3	11.4	10.3	17.8	11.8	55.2	7.1	15.3	3.5	11.2	8.7	38.8	4.5	6.8	5.4	2.4	7.1	9.1	7.3	18.4	24.3	0.0	7.3	41.4	13.8	0.1	0.0	5.5	28.3	8.0	2.1	13.2	9.8	11.8	23.0	5.7	4.8	15.7	24.0	21.1	3.6	0.0	11.1	33.8	56.1	21.4	28.8	27.3	0.1	9.0	5.4	12.8	16.4	17.6	20.6	62.0	25.1	11.8	21.3	9.0	13.9	2.2	0.1	11.1	28.3	0.0	28.4	7.9	29.7	0.5	7.3	1.1	21.8	19.0	0.9	0.9	25.8	9.0	0.3	4.2	40.4	0.6	6.1	10.2	11.4	18.3	0.2	0.0	0.0	5.6	21.3	3.2	11.3	13.8	36.0	0.0	6.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	41.4	0.1	3.9	0.3	0.0	5.5	4.9	6.8	1.3	3.9	3.9	3.4	6.5	1.6	5.3	5.4
PYGM		ENSG00000068976	"Glycogen phosphorylase, muscle associated"	P11217	11	64746389-64760297	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Allosteric enzyme, Glycosyltransferase, Transferase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	37	"skeletal muscle: 572.6;tongue: 172.6"	"Cell line enhanced"	"Detected in some"		"HSkMC: 8.2;NB-4: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"basophil: 9.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056003	Enhanced						12000000			"HPA056003: "	"unprognostic (3.33e-1)"	"unprognostic (6.03e-3)"	"unprognostic (3.87e-4)"	"unprognostic (1.95e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.64e-1)"	"unprognostic (6.33e-6)"	"unprognostic (3.37e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.68e-2)"	6.4	0.8	2.2	0.7	3.0	0.7	0.8	1.1	3.1	0.9	2.1	1.8	0.7	0.7	1.1	4.6	7.1	1.5	0.9	5.5	2.9	1.0	0.7	0.6	0.7	0.7	1.5	1.1	0.7	0.7	0.6	0.3	0.7	6.6	2.5	0.9	1.6	7.9	2.8	572.6	0.6	0.8	2.5	4.1	0.7	0.8	0.9	1.8	0.0	1.2	172.6	6.4	1.5	0.6	1.9	0.3	9.9	0.0	1.6	0.3	0.2	0.2	0.1	1.7	0.2	1.2	1.7	0.3	0.2	0.1	0.3	0.0	0.7	0.7	1.3	0.5	0.0	0.3	0.5	0.1	0.1	1.4	0.3	0.8	0.3	0.0	0.7	0.8	0.3	8.2	0.6	0.6	0.2	0.0	1.5	1.5	0.0	2.1	1.4	4.7	1.7	0.2	0.9	1.5	0.3	0.0	0.2	0.5	0.1	0.6	0.7	0.9	0.7	0.9	0.6	0.0	0.9	0.3	0.1	2.3	2.8	1.0	0.0	0.2	0.0	9.9	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.2	0.0	1.9	0.0	0.1	0.2	1.6	0.0	0.3	0.3	0.2	2.2	3.0	1.1	3.1	2.9	1.0	1.5	1.1	6.6	1.8
PZP	CPAMD6	ENSG00000126838	"PZP, alpha-2-macroglobulin like"	P20742	12	9148840-9208370	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 56.9"	"Group enriched"	"Detected in some"	8	"HeLa: 9.7;SiHa: 5.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"		13000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.0	0.9	0.6	0.0	56.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	3.5	0.0	0.7	0.9	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.6	0.0	0.0	1.4	0.6
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol			21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favourable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favourable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.6	19.0	31.6	45.3	40.8	44.4	32.6	20.7	47.4	41.2	40.5	23.9	24.2	57.6	13.3	34.3	23.7	44.9	34.1	29.6	16.4	35.9	45.4	30.4	41.8	21.5	36.9	28.0	46.7	29.9	31.7	27.0	44.9	20.2	25.6	30.1	10.0	26.6	33.1	27.2	29.6	17.5	26.6	42.5	27.6	27.8	11.6	32.4	18.4	46.7	28.6	38.7	43.1	25.9	18.8	26.6	30.9	23.1	22.1	37.6	32.3	19.2	33.3	11.9	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3
QDPR	"DHPR, PKU2, SDR33C1"	ENSG00000151552	"Quinoid dihydropteridine reductase"	P09417	4	17460261-17512234	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis"	Oxidoreductase	"Disease mutation, Phenylketonuria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 114.1;liver: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058951, HPA065649"	Enhanced		Approved	Mitochondria			1800000	Mitochondria		"HPA058951: AB_2683861, HPA065649: AB_2685526"	"unprognostic (1.30e-2)"	"unprognostic (4.29e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.07e-1)"	"prognostic favourable (7.84e-6)"	"unprognostic (1.58e-1)"	"unprognostic (2.60e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.19e-1)"	22.5	25.9	67.8	3.4	111.9	4.4	7.4	16.0	54.1	5.7	7.5	56.3	2.6	9.1	5.5	12.5	5.2	6.4	6.3	15.0	80.7	58.2	36.1	64.8	8.0	3.7	114.1	36.7	6.7	10.3	13.7	6.2	4.1	82.5	10.3	5.9	2.6	12.4	7.5	34.2	4.6	8.1	6.4	93.6	4.8	9.1	4.1	94.7	0.7	7.7	2.8	4.4	4.5	2.6	7.5	42.5	1.0	21.9	9.9	15.0	12.3	11.3	22.3	8.8	12.3	21.4	10.9	15.6	16.3	6.9	15.2	13.4	17.8	15.1	4.2	10.5	9.0	6.5	12.5	18.4	9.5	12.9	2.5	11.5	11.6	42.1	12.9	15.0	1.0	13.5	11.7	9.6	13.1	7.6	12.4	9.7	16.3	5.9	22.3	24.1	15.0	15.1	9.3	6.8	16.9	15.7	6.3	16.7	21.4	10.8	1.8	46.3	4.9	5.8	13.2	8.8	15.8	8.7	12.9	15.1	23.5	29.6	17.6	13.3	14.6	0.0	14.4	1.0	12.3	21.9	11.1	7.5	13.3	12.8	18.0	6.2	15.0	12.9	0.4	9.9	16.3	42.5	6.9	12.3	67.8	111.9	16.0	54.1	80.7	58.2	114.1	36.7	82.5	94.7
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;SCLC-21H: 23.8;SK-MEL-30: 80.0;U-266/84: 62.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	7.9	0.0	0.0	1.0	2.6	0.0	1.0	17.5	1.3	2.1	0.5	1.4	0.0	0.6	5.9	0.0	0.5	0.0	2.1	0.1	15.3	3.5	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.7	0.0	5.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.1	8.6	2.1	23.8	0.0	1.3	0.0	80.0	0.1	0.5	3.7	0.0	0.0	0.0	0.1	3.0	62.5	0.0	5.3	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5
QPRT	QPRTase	ENSG00000103485	"Quinolinate phosphoribosyltransferase"	Q15274	16	29679008-29698699	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 61.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 96.7;Hep G2: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.6;monocytes: 7.7"									HPA011887	Approved				"Intracellular and membrane"		230000			"HPA011887: AB_2668555"	"prognostic unfavourable (5.10e-5)"	"unprognostic (2.00e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.88e-1)"	"prognostic unfavourable (9.31e-4)"	"unprognostic (1.44e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.81e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.58e-2)"	3.2	36.4	6.1	3.0	5.2	1.1	2.4	1.6	5.8	17.9	10.8	4.4	43.3	20.0	12.7	44.3	1.3	14.9	4.9	11.3	4.9	7.5	40.1	61.2	4.7	2.9	7.9	7.5	15.3	22.9	6.1	2.6	24.3	10.0	4.4	5.2	12.6	15.0	19.4	1.5	1.6	24.1	4.7	6.4	5.3	2.7	3.1	2.6	3.7	2.2	0.3	2.1	5.9	5.1	0.1	4.6	1.2	7.7	0.5	1.4	2.2	0.1	0.2	9.2	10.1	1.5	3.8	22.6	0.9	0.9	1.5	1.8	23.1	16.5	0.4	96.7	1.8	0.1	3.1	0.1	0.8	0.1	2.1	4.7	0.3	40.3	8.8	0.6	1.9	12.0	0.2	0.8	0.0	0.0	11.8	0.5	0.0	22.5	3.0	16.4	28.1	0.0	13.0	2.8	9.1	8.4	0.7	7.4	15.1	0.0	26.3	19.3	19.6	21.1	0.1	0.4	3.8	0.1	0.0	0.3	0.7	3.0	0.7	1.7	1.5	0.0	3.7	0.4	1.3	4.7	1.4	0.1	0.9	1.0	4.6	0.1	0.1	0.7	1.2	0.5	7.7	2.6	0.8	2.2	6.1	5.2	1.6	5.8	4.9	7.5	7.9	7.5	10.0	2.6
QSOX1	QSCN6	ENSG00000116260	"Quiescin sulfhydryl oxidase 1"	O00391	1	180154834-180204030	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 172.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 194.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042127, HPA056243"	Uncertain		Supported	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"		3200000000	"Golgi apparatus"	Vesicles	"HPA042127: , HPA056243: "	"unprognostic (1.13e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.94e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.80e-3)"	"prognostic unfavourable (1.86e-5)"	"unprognostic (3.25e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	15.9	18.7	8.0	14.5	9.5	30.1	12.6	7.3	13.6	23.5	25.3	13.8	24.9	19.8	17.8	44.9	36.8	18.9	91.9	54.4	10.1	9.0	15.4	23.1	42.3	19.5	8.5	9.1	46.5	59.8	6.2	13.5	172.2	13.4	28.0	24.5	12.1	20.6	19.4	18.4	12.3	19.0	33.9	15.5	13.4	52.8	50.3	9.1	6.7	7.8	18.2	18.3	35.8	26.1	2.9	19.2	20.4	25.5	8.0	7.1	11.4	41.5	5.9	1.4	17.7	18.1	37.5	70.5	44.2	44.7	37.8	26.7	0.6	13.4	0.6	27.5	35.3	9.0	1.7	11.9	18.5	2.4	2.7	1.3	3.5	1.8	194.6	4.5	12.8	20.0	5.4	40.3	48.4	55.6	1.8	6.5	24.9	7.2	0.9	8.4	4.8	17.0	1.8	3.2	1.0	6.2	11.9	5.1	5.2	12.9	17.6	8.5	3.2	21.5	65.4	47.4	18.6	31.7	37.3	4.8	7.8	1.1	18.0	14.6	14.2	5.8	25.5	9.5	7.1	14.7	5.3	2.9	4.8	5.0	19.2	1.8	4.4	4.3	20.4	8.0	13.1	3.9	5.5	11.4	8.0	9.5	7.3	13.6	10.1	9.0	8.5	9.1	13.4	9.1
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell line enhanced"	"Detected in many"		"TIME: 25.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 2.6"					"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"				"Vesicles, Centriolar satellite"		"HPA036406: , HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.4	5.4	5.3	3.8	9.3	1.5	6.3	9.5	16.7	5.2	4.2	2.8	4.6	3.5	7.9	7.3	5.3	5.6	8.2	7.2	4.9	6.3	14.9	2.3	4.8	2.1	5.6	6.5	6.7	8.4	22.3	4.3	11.4	16.0	5.3	2.1	5.1	9.5	5.9	9.0	5.8	2.6	5.2	2.9	18.9	4.9	46.4	2.5	0.0	3.9	4.7	2.7	5.3	7.4	0.1	0.0	0.0	0.0	0.0	2.6	0.5	12.0	5.4	0.4	3.8	4.0	4.8	7.0	18.2	10.0	6.2	4.8	3.9	3.0	0.0	9.6	9.2	4.9	2.3	5.6	2.8	20.9	6.7	4.4	2.3	2.5	4.9	0.0	0.8	5.8	5.3	7.6	5.0	8.5	3.4	2.4	4.4	0.3	0.0	0.1	2.9	8.6	4.1	4.9	10.2	5.4	1.5	1.8	1.9	6.0	2.5	2.7	1.4	0.2	25.0	15.1	8.8	11.2	9.5	7.9	2.3	0.0	11.8	4.7	1.4	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	1.9	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.8	0.5	5.3	9.3	9.5	16.7	4.9	6.3	5.6	6.5	16.0	2.5
RAB14	"FBP, RAB-14"	ENSG00000119396	"RAB14, member RAS oncogene family"	P61106	9	121178137-121223014	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026419, CAB037066"	Approved		Supported	Vesicles			9900000	Vesicles		"CAB037066: AB_1841128, HPA026419: AB_1855996"	"unprognostic (1.30e-3)"	"unprognostic (3.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-3)"	"prognostic favourable (1.79e-8)"	"unprognostic (1.38e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	28.4	29.2	35.7	29.7	37.3	41.4	37.2	36.5	50.2	29.9	30.3	31.4	38.2	28.5	27.9	26.1	50.1	25.6	25.5	24.3	33.3	34.1	37.0	58.7	57.5	38.0	44.5	34.8	27.5	22.7	38.6	25.2	30.7	35.0	29.5	31.5	20.0	29.2	55.5	28.2	42.4	27.4	24.7	43.0	28.1	31.3	23.5	41.4	23.9	32.4	25.8	34.3	27.7	32.3	19.0	23.3	24.0	30.9	19.2	21.5	15.7	21.8	22.3	28.4	23.7	33.1	36.2	22.4	31.1	25.0	24.1	19.2	17.6	23.9	21.0	18.2	29.8	41.8	20.2	23.2	27.3	18.0	13.3	22.7	30.9	17.9	22.9	24.2	27.3	23.0	42.0	24.7	27.3	34.1	17.1	19.3	36.0	20.6	23.4	19.5	16.8	25.2	18.6	30.8	24.5	26.5	31.4	25.1	14.7	37.0	32.9	21.2	34.6	19.2	31.5	25.9	18.9	31.9	21.7	17.4	32.7	21.4	24.3	21.3	33.8	23.4	21.9	24.0	18.0	30.9	17.9	19.0	16.9	19.5	23.3	17.0	20.4	20.2	23.7	19.2	30.2	14.3	21.5	15.7	35.7	37.3	36.5	50.2	33.3	34.1	44.5	34.8	35.0	41.4
RAB1A	"RAB1, YPT1"	ENSG00000138069	"RAB1A, member RAS oncogene family"	P62820	2	65070701-65130106	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005331, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Cytosol"			19000000	"Endoplasmic reticulum, Cytosol"		"CAB005331: AB_632290, HPA056141: "	"unprognostic (4.78e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (4.19e-4)"	"unprognostic (1.55e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-1)"	"unprognostic (4.30e-3)"	"unprognostic (2.79e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.63e-2)"	53.0	57.6	54.6	34.8	58.4	80.8	54.0	47.7	63.2	49.2	50.3	24.8	53.8	52.7	46.7	75.8	58.8	40.7	40.9	49.9	48.1	52.8	77.8	75.4	48.2	40.7	44.0	55.3	37.1	53.5	38.5	59.7	108.6	47.3	40.5	52.2	34.0	68.7	57.1	43.8	35.5	51.6	47.6	49.6	34.5	53.2	30.9	42.4	21.5	56.9	53.1	34.9	52.2	45.1	19.1	33.2	45.0	37.1	24.4	25.1	22.2	39.2	29.1	35.8	20.8	86.6	51.0	56.4	58.4	39.7	25.9	27.5	50.2	26.0	15.9	33.6	57.6	25.2	32.5	51.9	41.0	19.6	19.5	20.1	23.2	73.6	55.0	20.8	18.3	45.0	53.0	33.9	30.3	50.8	28.6	18.5	50.8	35.1	12.2	25.1	28.2	26.2	12.5	33.9	25.3	50.0	44.0	25.8	23.0	26.8	43.9	49.2	27.3	19.6	48.7	33.4	42.6	35.2	32.6	28.9	17.8	38.3	44.4	32.2	32.3	35.3	37.1	32.2	19.5	36.8	21.5	19.1	21.1	21.0	33.2	13.9	20.5	20.4	45.0	24.4	31.6	27.6	25.1	22.2	54.6	58.4	47.7	63.2	48.1	52.8	44.0	55.3	47.3	42.4
RAB1B		ENSG00000174903	"RAB1B, member RAS oncogene family"	Q9H0U4	11	66268533-66277492	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010225, HPA056141"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"			26000000	"Golgi apparatus"	"Endoplasmic reticulum"	"CAB010225: AB_2284660, HPA056141: "	"unprognostic (6.07e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.00e-1)"	"prognostic favourable (1.09e-5)"	"unprognostic (2.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.42e-2)"	"unprognostic (5.85e-2)"	47.5	47.7	36.2	32.5	42.4	33.1	47.8	35.6	60.6	42.0	45.6	38.0	35.7	46.5	42.0	37.2	61.2	45.8	48.4	50.2	34.5	31.5	47.3	67.8	43.0	51.8	34.8	38.6	44.4	52.9	55.0	42.5	63.6	34.6	49.5	38.4	45.3	62.2	48.6	82.8	50.6	58.0	49.2	38.7	47.3	45.6	36.5	30.9	49.2	54.7	50.4	55.9	40.1	41.2	26.3	36.4	84.7	44.2	36.3	47.3	59.7	39.0	45.4	22.9	31.1	39.3	29.4	21.3	32.5	40.0	44.2	31.2	25.8	41.6	16.3	43.0	47.8	37.9	26.1	46.7	24.3	32.6	23.5	25.9	29.5	22.4	26.2	22.0	47.8	30.7	40.3	37.3	19.4	41.6	26.6	29.8	42.0	78.8	38.1	35.5	24.2	43.1	23.6	18.9	42.6	44.4	37.0	23.0	25.3	24.4	59.9	23.7	91.3	25.5	41.9	42.3	28.6	49.8	28.8	16.3	12.9	21.3	48.0	18.8	38.6	27.2	38.8	61.2	47.3	40.8	35.7	22.7	28.5	38.4	31.6	26.3	25.0	29.7	84.7	36.3	44.2	36.4	30.7	59.7	36.2	42.4	35.6	60.6	34.5	31.5	34.8	38.6	34.6	30.9
RAB20	FLJ20429	ENSG00000139832	"RAB20, member RAS oncogene family"	Q9NX57	13	110523066-110561733	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.5;SK-BR-3: 35.9;T-47d: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003621, HPA052111, HPA068647"	Uncertain		Enhanced	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"		"HPA003621: , HPA052111: , HPA068647: "	"unprognostic (5.59e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (8.57e-4)"	"unprognostic (6.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.28e-2)"	"prognostic favourable (4.48e-4)"	30.9	23.5	3.7	11.9	5.3	11.9	27.5	1.3	4.0	6.9	20.2	5.2	3.0	15.7	6.0	8.8	4.1	6.8	17.8	17.0	5.3	2.5	15.9	38.2	27.8	21.9	7.1	1.8	17.0	14.5	3.2	5.8	12.6	9.1	9.4	8.3	8.5	10.9	3.2	8.8	2.6	23.8	5.0	13.4	32.9	15.0	6.3	3.6	2.5	13.6	1.9	4.2	13.2	13.6	1.9	8.3	13.4	19.4	0.0	3.6	5.6	8.0	1.2	0.8	1.6	5.3	1.4	13.1	0.7	2.5	3.4	5.3	19.5	16.5	0.0	5.8	0.7	3.1	1.6	5.0	1.8	9.0	1.2	8.0	1.5	9.0	3.3	1.1	2.4	2.9	0.8	1.8	0.5	1.3	1.5	0.0	0.7	9.7	0.0	11.6	1.7	3.5	0.7	0.0	3.6	5.9	10.7	0.2	0.9	1.5	35.9	10.9	22.6	12.4	0.9	0.8	1.8	0.0	1.1	0.0	0.0	0.0	11.7	15.8	1.7	2.8	19.4	3.5	0.6	17.0	0.7	1.9	1.6	0.5	8.3	1.2	3.6	1.2	13.4	0.0	12.7	0.4	0.4	5.6	3.7	5.3	1.3	4.0	5.3	2.5	7.1	1.8	9.1	3.6
RAB21	KIAA0118	ENSG00000080371	"RAB21, member RAS oncogene family"	Q9UL25	12	71754874-71800285	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016988, CAB037048"	Approved						490000			"CAB037048: AB_1841130, HPA016988: AB_1855998"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.68e-2)"	"prognostic favourable (5.39e-8)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.91e-2)"	"unprognostic (6.31e-2)"	16.5	21.3	16.6	10.8	20.5	19.6	14.5	13.5	16.7	14.8	14.5	20.1	9.3	11.1	17.0	12.3	16.5	11.1	13.5	42.0	16.2	18.3	23.1	17.2	17.3	11.9	20.6	14.0	15.8	11.4	22.3	17.4	19.1	17.8	15.2	10.9	14.2	13.2	13.7	42.4	16.2	13.4	20.1	23.2	13.6	11.8	7.9	17.3	15.7	17.1	17.6	12.2	21.8	14.7	2.1	2.2	4.9	1.6	1.8	2.1	0.6	6.9	5.4	5.7	4.5	9.1	5.9	9.8	9.8	5.9	6.8	4.7	6.5	3.3	10.7	11.5	8.6	6.0	10.0	6.8	10.7	8.6	4.6	9.9	3.8	7.2	9.4	10.8	6.1	6.8	10.6	7.4	11.6	4.5	6.8	6.3	10.2	6.3	8.6	7.2	8.3	8.2	8.5	6.3	7.7	10.0	9.7	5.6	4.6	12.2	11.7	7.1	9.1	7.1	7.3	8.9	3.5	14.0	7.2	8.2	7.8	8.4	4.6	6.2	6.3	2.6	1.6	2.0	1.6	1.3	1.6	1.5	1.8	1.5	1.0	2.1	2.1	1.7	4.9	1.8	1.2	2.2	1.3	0.6	16.6	20.5	13.5	14.0	16.2	18.3	20.6	14.0	17.8	17.3
RAB27B		ENSG00000041353	"RAB27B, member RAS oncogene family"	O00194	18	54717860-54895516	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.0;stomach 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HEL: 20.5;hTCEpi: 15.6;hTERT-HME1: 19.0;U-87 MG: 55.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 4.6;NK-cell: 5.0"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.0;T-cells: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017712, HPA019849"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"			37000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB017712: , HPA019849: AB_1856000"	"unprognostic (1.59e-1)"	"unprognostic (5.20e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.51e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavourable (2.13e-4)"	"unprognostic (1.39e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.75e-1)"	"unprognostic (1.29e-1)"	1.1	2.4	13.8	2.3	11.3	1.0	10.8	0.8	30.0	4.5	4.4	0.3	0.0	4.5	1.1	0.7	17.0	1.3	9.8	0.9	12.0	7.9	0.8	1.4	6.2	0.7	4.6	18.4	0.7	5.3	1.3	3.6	2.4	8.6	18.0	4.8	0.0	12.8	3.3	0.6	13.2	4.3	1.1	2.1	1.8	36.6	4.8	0.4	0.1	0.7	13.9	5.9	6.8	7.1	0.0	0.0	1.1	0.0	5.0	4.6	3.4	2.5	7.3	0.2	0.0	0.5	6.7	0.0	0.5	4.4	0.6	0.4	0.0	2.8	0.4	0.0	1.2	4.8	0.0	2.9	0.1	0.0	0.1	20.5	1.7	0.0	0.8	1.1	2.2	5.3	15.6	8.6	19.0	0.2	0.0	1.3	5.4	2.5	0.0	2.4	0.1	4.9	0.0	0.0	0.1	1.3	9.4	0.0	3.5	0.7	4.4	0.0	2.7	0.1	0.1	6.4	0.2	3.3	0.6	0.1	0.0	0.0	55.6	11.6	0.3	1.1	0.0	0.2	4.6	0.0	1.1	0.0	1.5	2.3	0.0	0.0	0.6	2.3	0.5	5.0	0.0	0.0	0.0	3.4	13.8	11.3	0.8	30.0	12.0	7.9	4.6	18.4	8.6	0.4
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543693-146554965	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 26.5"	"Group enriched"	"Detected in many"	40	"dendritic cells: 16.0;granulocytes: 26.5;monocytes: 17.3"	"Low region specificity"	"Detected in all"							HPA025731	Approved		Approved	Cytosol			330000	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favourable (1.56e-4)"	"prognostic unfavourable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	18.4	9.0	5.2	11.0	4.9	57.8	29.9	1.1	4.4	8.4	14.6	6.6	6.3	6.7	14.8	12.8	10.2	10.2	11.2	15.3	5.2	3.0	10.7	23.0	16.5	26.4	6.2	3.5	11.0	7.4	1.5	2.8	5.9	7.4	12.5	14.9	11.3	10.1	6.9	6.3	10.2	9.0	28.2	7.5	29.4	10.6	20.8	5.5	10.4	5.8	7.0	5.6	15.6	15.2	0.0	16.0	26.5	17.3	0.5	0.0	4.9	12.0	6.4	7.5	12.5	11.3	19.4	0.0	23.4	26.1	32.2	53.6	3.9	6.0	0.0	8.6	24.6	16.0	0.4	15.1	43.5	0.0	5.8	15.3	16.1	14.1	49.6	21.0	22.7	17.1	25.4	18.4	26.2	20.8	2.9	0.0	17.5	2.8	9.5	11.5	0.9	12.3	0.0	8.0	0.1	12.6	8.4	0.0	9.9	27.4	3.3	40.5	6.4	17.1	16.6	9.8	13.4	25.7	28.5	0.0	1.7	0.0	22.5	15.9	13.2	26.5	17.3	2.9	0.0	7.7	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	6.3	0.5	5.3	0.8	0.0	4.9	5.2	4.9	1.1	4.4	5.2	3.0	6.2	3.5	7.4	5.5
RAB37		ENSG00000172794	"RAB37, member RAS oncogene family"	Q96AX2	17	74670578-74747335	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.0;brain: 52.1"	"Cell line enhanced"	"Detected in some"		"HEL: 22.3;HMC-1: 24.4;U-266/70: 35.6;U-937: 15.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 52.1"	"Cell type enhanced"	"Detected in many"		"basophil: 47.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"										1100000				"unprognostic (2.10e-2)"	"unprognostic (7.04e-4)"	"unprognostic (5.95e-2)"	"unprognostic (9.80e-4)"	"unprognostic (3.49e-1)"	"unprognostic (7.04e-5)"	"unprognostic (1.74e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.62e-3)"	"unprognostic (9.47e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (8.80e-6)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (7.80e-2)"	"unprognostic (4.01e-2)"	1.3	1.2	1.3	7.5	2.1	15.5	1.0	52.1	9.8	1.5	3.9	0.3	0.0	2.6	1.2	1.0	1.3	1.5	3.5	1.4	4.1	2.8	1.4	9.3	4.8	12.8	2.6	2.7	0.8	1.0	0.0	1.0	1.1	14.7	3.5	3.8	2.1	2.2	0.9	0.9	1.2	6.5	1.6	1.6	11.3	4.6	0.8	0.0	15.8	1.0	1.0	10.9	4.2	2.0	3.4	1.8	47.0	10.8	11.1	12.7	9.8	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.1	0.0	1.7	24.4	0.2	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	6.4	5.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.1	4.6	0.0	0.0	0.1	0.0	0.0	35.6	1.4	0.5	0.0	15.0	0.0	47.0	3.1	43.0	12.7	6.6	3.2	3.4	5.6	9.1	1.8	3.4	3.3	7.4	14.5	11.1	10.8	0.3	9.2	9.8	1.3	2.1	52.1	9.8	4.1	2.8	2.6	2.7	14.7	0.0
RAB39B	"MRX72, WSN"	ENSG00000155961	"RAB39B, member RAS oncogene family"	Q96DA2	X	155258241-155264589	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"		"Autism spectrum disorder, Disease mutation, Mental retardation, Parkinson disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.7;Karpas-707: 20.8;U-266/70: 20.9;U-266/84: 14.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001114, HPA042505"	Approved									"HPA001114: AB_1079732, HPA042505: "	"prognostic favourable (8.95e-4)"	"unprognostic (1.20e-3)"	"unprognostic (3.52e-2)"	"unprognostic (7.10e-5)"	"unprognostic (1.77e-1)"	"unprognostic (7.47e-4)"	"unprognostic (2.19e-1)"	"unprognostic (6.00e-4)"	"unprognostic (1.78e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.87e-4)"	"unprognostic (5.41e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.21e-2)"	"unprognostic (4.94e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.24e-1)"	0.9	3.8	9.4	4.8	12.1	1.7	1.7	14.2	21.5	1.3	1.7	5.8	1.8	1.5	1.0	11.6	1.1	1.4	1.6	1.1	10.4	11.0	1.8	1.0	1.5	8.5	10.1	9.6	1.2	4.7	7.7	10.8	0.9	11.9	3.9	1.6	1.0	1.2	2.8	0.6	0.6	2.0	0.9	9.5	5.3	2.6	2.0	7.3	4.5	4.6	0.0	9.9	2.4	0.7	4.9	5.4	3.3	0.5	3.5	8.7	3.8	0.0	0.2	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.7	0.0	0.0	0.0	0.1	0.0	6.6	0.3	1.3	0.0	0.0	1.0	0.0	2.8	0.1	0.0	0.2	4.6	0.0	0.0	20.8	0.1	1.1	5.7	0.0	4.0	0.3	0.0	0.0	1.2	0.0	0.0	7.9	6.1	0.0	0.0	3.6	0.2	0.1	0.0	0.4	1.3	0.0	0.6	20.9	14.5	3.6	3.7	0.0	0.0	1.0	0.4	2.5	5.7	0.3	5.9	4.9	7.7	7.4	5.4	3.4	8.1	8.7	3.3	3.5	0.5	1.4	5.6	3.8	9.4	12.1	14.2	15.8	10.4	11.0	10.1	9.6	11.9	7.3
RAB3D	"D2-2, GOV, RAB16, RAD3D"	ENSG00000105514	"RAB3D, member RAS oncogene family"	O95716	19	11322046-11346270	"Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.2;Karpas-707: 20.4;MCF7: 23.4;SK-BR-3: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 44.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB018067, HPA063283"	Approved		Approved	Vesicles				Vesicles		"CAB018067: AB_606903, HPA063283: "	"unprognostic (4.71e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.99e-3)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (4.17e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-1)"	"unprognostic (8.76e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.45e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.34e-1)"	6.3	3.8	6.4	4.6	8.2	13.2	10.8	7.1	11.9	13.5	7.7	5.0	12.0	7.2	7.9	7.7	30.2	8.0	10.3	9.0	8.1	6.4	10.6	21.6	7.9	8.3	5.3	6.7	7.4	54.7	5.1	5.4	6.4	6.1	15.0	7.8	9.9	22.8	11.0	5.2	42.4	5.7	7.9	4.3	9.2	16.6	5.6	4.1	5.4	14.4	12.0	9.4	8.1	13.3	0.6	9.3	44.6	22.5	0.4	1.5	5.9	0.6	6.2	1.9	7.9	3.2	5.6	0.4	0.5	1.6	1.1	1.1	2.2	0.2	0.2	7.2	3.7	8.5	3.3	5.2	1.0	3.3	0.5	2.4	2.8	2.5	2.0	1.3	6.0	2.4	21.2	0.9	2.3	9.1	0.9	20.4	0.3	23.4	0.9	3.0	1.6	6.4	0.9	0.0	6.9	9.8	6.2	2.2	4.2	1.8	30.6	3.9	18.3	15.2	3.4	1.1	0.3	5.1	0.1	7.0	8.8	1.4	3.8	8.2	1.1	26.0	22.5	23.9	0.9	13.5	1.5	0.6	0.9	0.7	9.3	0.6	0.6	0.7	44.6	0.4	9.9	0.2	1.5	5.9	6.4	8.2	7.1	11.9	8.1	6.4	5.3	6.7	6.1	4.1
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124976-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003426, HPA004167"	Approved		Enhanced	Endosomes			3600000	Endosomes		"HPA003426: AB_1079735, HPA004167: "	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	50.4	47.8	40.8	43.6	49.4	69.6	43.8	27.9	68.8	33.8	41.9	53.0	25.8	53.6	41.9	28.5	36.4	35.6	36.0	26.2	38.5	34.3	70.3	63.6	46.0	44.5	46.5	32.5	34.9	30.5	28.4	20.1	42.1	41.4	29.8	35.1	37.3	33.1	36.6	16.8	33.8	49.7	39.1	40.4	50.0	44.4	25.2	42.2	29.8	53.5	21.0	36.8	38.7	31.7	13.9	23.8	56.9	31.4	14.8	15.9	21.8	28.7	54.3	17.0	24.5	38.0	26.3	32.9	35.4	37.5	49.1	42.9	38.3	28.5	14.0	31.3	43.8	40.5	31.2	34.2	31.5	18.0	40.9	21.3	22.2	55.2	37.4	27.9	35.0	33.8	36.1	36.8	25.8	51.1	24.3	21.7	33.1	26.3	28.3	25.0	16.8	0.1	18.6	29.3	23.7	36.9	43.2	9.5	24.3	18.1	115.1	38.0	50.8	27.4	47.9	50.2	28.0	42.1	37.5	20.2	26.1	17.8	33.1	21.9	50.8	13.6	31.4	34.8	14.1	29.7	12.6	12.7	13.8	14.1	23.8	13.9	11.4	11.3	56.9	14.8	29.7	16.0	15.9	21.8	40.8	49.4	27.9	68.8	38.5	34.3	46.5	32.5	41.4	42.2
RAB7A	RAB7	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128726122-128814796	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes			9000000	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavourable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	61.5	57.0	64.6	43.8	59.9	41.7	49.5	44.8	67.1	43.5	55.4	69.5	29.4	45.1	49.8	60.7	63.2	44.2	43.1	73.5	62.9	60.2	58.4	69.6	51.7	42.7	66.9	53.6	51.3	34.1	44.0	52.7	64.2	66.2	39.2	50.8	60.9	47.0	41.6	146.3	54.2	45.9	48.9	69.0	52.3	40.7	26.3	61.9	37.7	52.0	51.0	50.7	42.8	47.7	27.7	60.7	102.8	58.7	31.7	33.8	52.9	72.8	24.8	32.2	18.6	73.0	41.2	34.8	70.4	51.3	39.5	41.7	43.5	42.0	33.6	46.2	46.3	38.4	35.7	48.1	44.8	43.3	25.2	73.6	24.1	42.7	60.2	72.7	46.4	48.6	51.4	36.8	43.2	35.1	33.6	32.7	51.6	53.8	45.2	54.9	31.2	34.0	33.4	36.8	35.7	44.1	70.6	24.2	33.6	45.0	41.1	73.9	42.1	49.3	62.3	44.2	27.3	82.9	32.4	46.5	51.0	56.7	66.2	49.3	55.8	38.2	54.1	59.1	27.5	58.7	26.1	27.7	28.5	27.3	60.7	25.1	27.2	26.5	102.8	31.7	54.6	23.6	33.8	52.9	64.6	59.9	44.8	60.8	62.9	60.2	66.9	53.6	66.2	61.9
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236909-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Vesicles			130000	"Nucleoplasm, Vesicles"		"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	100.5	72.1	32.2	92.0	32.8	74.9	185.3	45.0	34.3	102.3	85.7	36.2	66.0	43.0	86.0	82.9	128.1	98.3	81.8	102.5	29.8	29.2	80.6	113.7	95.7	223.3	38.2	27.6	189.2	330.4	48.8	68.3	72.3	31.8	102.6	61.2	57.8	119.7	66.9	133.8	115.5	72.1	92.8	37.6	107.8	70.5	52.9	32.4	197.4	115.4	117.0	141.8	99.7	113.5	92.9	69.4	19.2	50.8	47.1	81.4	138.7	66.0	56.4	85.7	107.1	131.7	242.1	86.6	59.6	162.6	140.0	141.4	121.0	58.7	134.8	78.1	103.4	45.7	97.8	331.2	103.6	134.1	105.5	46.0	62.4	60.2	164.8	105.8	46.7	231.6	178.6	105.2	146.6	142.3	60.9	99.1	107.4	102.5	104.5	68.0	59.7	51.1	81.6	53.1	112.5	147.8	63.4	71.3	84.1	30.5	101.7	150.0	69.4	92.3	75.0	48.6	44.3	42.7	90.0	74.4	107.0	84.1	46.6	82.7	49.5	19.2	50.8	16.3	45.9	43.6	69.5	91.9	70.3	53.8	69.4	92.9	81.4	65.2	7.8	47.1	37.1	53.3	68.6	138.7	32.2	32.8	45.0	34.3	29.8	29.2	38.2	27.6	31.8	32.4
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA006716: , HPA006724: , HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (3.73e-4)"	"prognostic unfavourable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.7	9.3	7.8	4.6	1.9	4.2	9.5	15.5	5.3	15.0	10.3	8.4	6.3	12.1	3.0	8.8	3.4	8.2	8.0	15.3	7.4	10.3	10.3	9.3	5.0	1.2	13.5	8.9	1.5	2.9	14.8	10.1	4.8	10.9	12.0	13.0	11.3	13.7	9.6	10.8	17.1	10.9	8.6	9.5	4.3	7.5	3.2	7.4	6.9	6.6	5.0	6.9	6.0	4.0	12.4	6.8	10.6	13.2	6.1	9.3	26.3	9.2	15.0	9.1	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332194	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol			8200000	"Nucleoplasm, Cytosol"		"CAB033868: AB_1128418, HPA029718: AB_10600116, HPA029720: AB_10601008"	"unprognostic (3.95e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.28e-2)"	"unprognostic (8.14e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavourable (2.58e-4)"	"unprognostic (2.94e-1)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.94e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	41.0	30.1	21.9	23.5	24.5	37.0	28.9	33.3	28.1	28.9	31.4	18.4	28.2	21.8	27.0	38.0	45.3	22.6	24.1	45.5	22.2	23.0	29.7	82.0	27.7	20.7	20.8	23.3	31.6	45.9	21.0	24.8	66.1	25.6	31.1	25.9	17.3	28.7	25.8	98.2	38.2	29.1	29.4	22.6	29.8	23.0	38.5	18.6	32.8	30.4	34.0	27.1	42.1	32.6	5.2	2.5	7.1	2.7	5.0	4.9	1.2	33.3	29.7	42.1	27.0	29.0	46.0	47.5	51.8	42.7	46.2	31.8	49.2	36.6	46.9	21.0	56.6	47.0	58.0	46.1	46.7	31.8	19.0	24.4	31.3	37.5	38.6	43.6	21.0	38.5	43.1	44.1	66.6	32.1	39.3	35.3	41.6	54.5	42.4	22.2	44.8	34.7	31.7	55.3	22.2	39.7	31.6	38.5	26.1	35.8	50.7	31.9	51.7	17.9	29.4	34.5	33.9	42.5	38.7	24.3	44.4	25.3	36.8	26.0	36.1	1.7	2.7	2.3	4.4	2.7	4.9	4.0	2.6	3.7	2.2	5.2	4.4	3.5	7.1	5.0	1.7	2.5	4.6	1.2	21.9	24.5	33.3	27.4	22.2	23.0	20.8	23.3	25.6	18.6
RAD50	"hRad50, RAD50-2"	ENSG00000113522	"RAD50 double strand break repair protein"	Q92878	5	132556019-132646344	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Host-virus interaction, Meiosis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB022103, CAB024979, HPA052291"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB022103: , CAB024979: , HPA052291: "	"unprognostic (3.46e-3)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (7.50e-3)"	"unprognostic (4.22e-3)"	"unprognostic (6.71e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.95e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.40e-1)"	11.3	8.4	10.2	8.7	11.2	10.4	11.7	8.2	11.9	8.4	11.2	4.1	8.6	6.7	13.0	20.6	15.0	8.2	7.6	11.9	8.3	5.0	11.0	12.4	11.2	6.0	9.1	9.7	11.8	10.8	14.9	16.2	11.2	10.7	9.7	8.4	3.6	11.4	11.4	13.5	19.8	11.7	8.0	7.6	10.1	8.8	12.8	9.9	11.4	13.9	7.2	6.5	9.6	12.8	6.9	3.6	6.7	4.9	9.8	8.0	3.1	5.2	14.7	1.4	8.3	10.0	9.7	4.5	3.6	6.5	3.8	6.6	13.9	9.9	13.7	2.2	6.1	7.6	6.7	8.3	5.8	4.6	8.9	5.2	9.2	8.7	8.4	6.8	5.4	7.7	16.4	7.3	17.1	2.9	8.3	2.4	6.1	5.2	5.0	9.4	6.7	6.2	3.5	1.9	5.0	6.3	9.7	7.3	9.9	7.8	3.3	1.2	7.1	4.6	3.6	2.5	3.8	8.1	5.3	4.0	4.7	15.6	6.3	8.7	3.9	6.7	4.6	0.5	5.9	4.3	8.0	6.9	7.5	5.8	3.6	6.1	6.5	6.6	0.2	9.8	4.9	3.2	3.5	3.1	10.2	11.2	8.2	11.8	8.3	5.0	9.1	9.7	10.7	9.9
RAD54B	RDH54	ENSG00000197275	"RAD54 homolog B (S. cerevisiae)"	Q9Y620	8	94371960-94475109	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 21.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"gdT-cell: 1.4;MAIT T-cell: 4.4;memory B-cell: 1.7;memory CD4 T-cell: 2.4;memory CD8 T-cell: 1.3;naive B-cell: 2.6;naive CD4 T-cell: 1.8;naive CD8 T-cell: 2.6;T-reg: 1.4"	"Group enriched"	"Detected in many"	14	"B-cells: 2.6;T-cells: 4.4"									HPA007087	Uncertain									"HPA007087: AB_1856040"	"unprognostic (1.68e-3)"	"unprognostic (2.51e-1)"	"unprognostic (2.31e-2)"	"unprognostic (8.84e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.56e-8)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.04e-12)"	"unprognostic (5.86e-2)"	"unprognostic (5.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.68e-5)"	2.7	3.9	3.9	7.7	8.6	4.6	4.7	11.8	9.1	6.1	4.7	3.8	4.4	3.8	4.0	4.7	5.4	7.7	2.3	3.5	7.7	3.5	3.5	4.3	2.6	6.3	5.4	4.2	5.2	4.1	5.0	6.6	3.7	7.2	5.2	4.8	3.1	3.7	5.7	1.9	4.2	3.4	3.1	9.4	3.2	4.2	10.5	6.7	21.2	3.6	5.0	6.7	6.7	3.8	2.6	0.2	0.0	0.2	0.2	4.4	0.9	14.1	9.8	13.9	7.5	1.1	1.5	7.6	10.7	5.7	15.1	14.4	5.0	9.7	10.2	16.2	3.0	7.7	12.3	5.3	16.5	11.7	7.3	15.5	5.6	4.0	1.3	5.8	5.5	1.3	0.7	7.6	9.3	5.5	11.5	6.7	15.3	6.6	19.7	3.8	9.6	8.7	4.7	15.2	5.8	6.3	6.8	8.9	6.2	7.6	1.8	5.7	9.6	3.3	4.3	10.3	5.5	11.4	11.7	3.5	7.5	5.3	5.5	10.4	10.3	0.0	0.0	0.0	1.4	0.0	4.4	1.7	2.4	1.3	0.2	2.6	1.8	2.6	0.0	0.2	0.2	0.1	1.4	0.9	3.9	8.6	11.8	9.1	7.7	3.5	5.4	4.2	7.2	6.7
RAE1	Mnrp41	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351010-57379211	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Uncertain	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA048795: "	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	9.2	10.0	9.4	11.1	15.2	28.6	12.0	18.1	18.3	9.5	9.7	11.5	9.3	8.0	13.0	13.9	14.0	12.2	7.9	8.1	9.8	11.0	9.2	10.7	7.1	12.5	8.1	12.6	12.1	9.1	12.3	13.7	13.5	10.4	9.2	11.4	9.4	8.9	11.0	9.6	14.8	8.8	11.3	7.3	12.1	8.6	64.8	8.3	19.4	11.7	11.5	17.3	10.0	11.5	17.0	16.6	39.1	21.5	11.8	20.2	17.8	12.6	15.6	15.6	8.9	9.4	8.6	14.1	10.3	14.5	50.6	19.6	49.6	10.2	20.3	14.4	14.8	16.8	29.2	25.2	41.7	6.1	13.2	13.9	14.0	22.0	17.7	16.7	12.5	12.7	22.7	21.7	24.4	15.3	24.3	9.8	15.9	34.1	24.8	14.6	9.9	27.6	13.9	15.1	13.4	11.8	13.3	17.0	14.0	17.5	39.8	18.0	21.6	14.5	8.8	21.6	19.4	12.7	17.0	10.7	23.0	23.2	15.1	10.4	10.8	9.1	21.5	39.1	15.6	18.1	18.9	17.0	15.2	15.5	16.6	16.3	20.2	18.4	19.4	11.8	17.9	12.6	12.9	17.8	9.4	15.2	18.1	18.3	9.8	11.0	8.1	12.6	10.4	8.3
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm		"HPA043939: "	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681473-17811453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA023898: AB_10971089, HPA054906: "	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	8.0	13.8	13.8	12.6	17.6	8.1	10.1	21.5	22.9	18.1	12.2	14.2	13.3	11.3	17.8	11.8	12.1	20.3	16.8	13.6	11.3	11.9	10.3	5.8	11.2	9.7	11.1	11.3	17.3	17.2	22.4	19.6	8.4	11.3	17.7	5.4	23.3	24.0	18.2	8.2	19.1	9.5	16.7	6.6	18.5	16.6	8.8	15.7	10.4	15.6	7.7	11.2	19.6	30.0	1.0	3.0	0.7	1.2	2.8	1.0	0.7	15.5	21.2	13.4	11.1	1.8	3.7	2.3	5.4	5.8	4.5	4.4	11.0	6.6	5.0	7.5	7.0	18.4	4.7	10.7	1.9	4.9	10.5	9.2	12.8	5.5	6.0	3.6	5.8	4.2	5.2	4.1	6.1	5.6	3.9	4.1	2.3	13.9	7.7	3.6	0.9	6.3	18.2	10.5	7.2	3.7	18.7	9.4	16.8	8.5	7.5	17.5	10.1	4.6	10.6	7.2	9.3	11.5	7.6	3.7	0.8	3.2	7.0	4.5	19.6	0.0	1.0	0.7	0.8	0.8	0.5	0.1	0.4	0.6	0.5	1.0	0.3	1.0	0.1	2.8	1.2	3.0	0.0	0.7	13.8	17.6	21.5	22.9	11.3	11.9	11.1	11.3	11.3	15.7
RALGAPB	"DKFZp781M2411, KIAA1219, RalGAPbeta"	ENSG00000170471	"Ral GTPase activating protein non-catalytic beta subunit"	Q86X10	20	38472816-38578861	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051454	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA051454: "	"unprognostic (1.06e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.28e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.51e-2)"	"prognostic favourable (7.25e-4)"	"unprognostic (3.03e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	18.0	19.4	13.9	16.9	22.2	14.3	21.6	28.1	25.4	17.5	16.6	21.2	14.9	15.6	25.3	17.6	18.7	15.3	14.3	15.3	14.3	15.2	19.7	11.6	15.6	14.6	15.5	13.5	17.4	15.5	39.2	34.9	21.5	19.9	19.7	17.8	18.6	17.1	17.9	21.3	19.7	22.3	17.2	13.6	18.5	16.5	25.4	16.2	32.1	24.0	12.3	22.9	22.4	15.5	3.3	3.6	6.1	3.4	5.6	4.8	1.5	13.0	12.3	12.9	9.4	12.4	14.4	13.7	10.7	12.6	13.5	13.3	22.1	9.9	12.3	10.3	12.5	15.5	12.0	16.3	19.1	7.0	5.1	18.8	11.1	12.6	11.8	15.2	10.0	10.2	21.2	15.9	17.5	17.5	13.7	12.3	12.9	8.6	17.4	6.4	9.4	16.1	10.0	18.4	8.2	9.0	24.6	13.6	15.0	23.8	32.2	20.0	18.7	7.8	20.7	27.3	10.9	15.4	10.8	14.4	17.6	11.2	19.8	7.5	12.0	3.1	2.3	6.1	3.3	1.8	4.6	3.3	4.8	4.3	3.6	3.0	4.1	3.5	4.6	5.6	3.4	2.4	1.9	1.5	13.9	22.2	28.1	25.4	14.3	15.2	15.5	13.5	19.9	16.2
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles			12000	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	37.7	23.4	26.3	39.9	30.7	65.2	55.4	22.4	33.9	35.0	43.7	37.6	35.1	41.9	36.4	31.0	41.6	35.2	38.9	51.9	27.3	24.4	39.3	30.3	40.9	53.9	33.0	23.4	38.3	38.5	21.9	20.7	41.9	26.5	34.9	34.9	32.0	38.7	32.7	62.0	39.8	48.8	41.7	40.9	40.4	36.0	56.8	28.9	76.0	76.7	43.6	42.6	33.5	49.7	30.8	40.9	61.6	54.1	54.1	48.4	40.4	36.3	25.2	40.8	31.1	18.3	19.5	33.1	25.5	21.2	34.3	29.6	67.8	33.1	28.7	37.6	21.2	41.1	19.2	39.8	19.5	18.8	19.9	68.0	14.8	67.7	25.4	35.0	34.7	20.7	24.3	25.3	26.0	33.2	28.1	49.2	21.8	35.3	87.1	56.6	21.1	48.7	51.6	55.8	39.0	20.9	23.1	38.9	43.6	42.6	40.8	57.9	41.6	37.3	26.0	70.9	42.9	34.4	31.8	49.3	41.3	51.1	35.6	26.6	32.5	32.9	32.4	61.6	44.3	39.9	33.1	30.8	40.1	48.4	40.9	30.7	35.6	33.6	52.9	54.1	54.1	33.8	42.0	40.4	26.3	30.7	22.4	33.9	27.3	24.4	33.0	23.4	26.5	28.9
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.0;EFO-21: 30.7;HUVEC TERT2: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles				Vesicles		"HPA052020: "	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	48.6	7.1	8.6	7.6	9.6	0.2	43.4	3.4	15.4	35.1	9.7	10.8	6.1	5.2	49.5	24.2	19.5	17.0	20.4	23.9	9.6	8.5	18.8	14.6	51.5	17.3	13.8	7.7	17.3	9.6	5.6	6.1	56.1	12.5	24.9	9.1	71.1	12.8	12.2	16.2	15.6	11.5	30.9	8.8	15.6	9.2	10.9	3.0	3.9	20.0	30.1	11.7	13.2	23.1	0.0	6.4	0.0	0.1	0.0	0.3	0.0	0.0	0.4	1.9	0.0	46.0	2.3	1.5	0.3	0.7	3.8	1.8	4.2	0.0	0.0	30.7	1.1	0.0	1.7	0.0	3.3	0.0	0.0	0.0	0.3	1.3	1.1	0.0	0.0	1.6	0.0	0.6	0.1	13.8	0.0	0.1	0.2	0.0	0.2	0.3	8.9	0.0	0.0	0.0	0.0	0.2	0.2	1.9	3.8	1.0	0.0	6.3	0.4	1.2	2.5	7.4	2.7	0.1	0.9	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.3	0.0	8.6	9.6	3.4	15.4	9.6	8.5	13.8	7.7	12.5	3.0
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130871879-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA063353			Uncertain	Nucleoplasm			2100000	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavourable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (7.86e-5)"	"prognostic unfavourable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	52.3	68.3	46.9	75.7	62.7	80.6	53.4	42.1	62.6	38.1	61.9	32.5	41.4	41.7	47.9	59.9	96.4	44.0	36.1	55.2	53.9	59.7	52.6	65.9	50.1	90.3	48.9	61.0	46.9	51.3	31.8	43.8	57.0	50.8	37.0	65.6	28.6	43.7	40.2	84.2	45.5	45.1	59.6	42.1	60.1	47.8	87.2	31.0	84.8	51.7	89.6	108.3	44.7	49.5	94.1	69.3	34.3	62.3	60.5	96.5	110.2	95.9	132.0	114.4	66.2	52.7	65.0	88.3	126.8	66.5	123.7	85.5	141.8	102.2	158.7	85.7	91.1	62.3	166.3	131.7	134.3	53.2	130.9	93.1	100.7	143.4	64.5	161.1	80.2	60.9	82.3	106.5	154.9	119.4	137.3	47.2	121.2	117.9	157.1	194.6	134.2	211.3	122.8	98.2	88.9	115.3	167.7	105.0	64.2	73.3	66.3	89.0	130.6	116.8	82.5	71.5	109.2	72.4	118.0	66.1	107.6	222.8	73.4	99.7	99.2	29.6	51.5	34.3	69.6	62.3	84.7	94.1	95.5	79.9	69.3	78.5	87.0	82.5	10.7	60.5	58.0	65.7	96.5	110.2	46.9	62.7	42.1	62.6	53.9	59.7	48.9	61.0	50.8	31.0
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127357	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 213.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol			910000	Cytosol		"HPA065868: , HPA065931: "	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavourable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	26.4	28.6	27.9	34.7	28.0	57.1	26.0	32.4	46.0	23.3	33.3	25.7	17.2	30.5	29.6	15.7	38.7	26.4	23.1	18.2	25.1	28.3	22.5	41.1	21.8	50.4	28.4	34.9	26.8	37.0	16.0	22.0	26.8	28.4	20.5	25.7	18.1	24.1	21.9	22.8	23.0	27.8	30.7	24.4	30.4	24.9	58.3	26.7	58.2	22.0	27.6	40.7	22.2	25.9	37.6	37.7	24.2	33.7	29.7	37.1	31.4	38.5	19.8	44.7	24.2	7.5	9.0	37.7	35.5	15.6	46.4	33.6	36.2	13.9	60.2	15.9	14.3	35.9	41.4	31.1	25.4	25.8	98.6	50.4	20.3	38.0	11.5	80.9	27.5	9.9	14.8	36.7	13.1	20.9	213.8	24.2	20.8	30.1	58.5	55.3	50.8	35.1	59.6	63.0	15.4	15.9	21.2	44.8	33.2	32.6	18.2	20.3	12.7	33.9	16.0	32.2	62.7	24.1	39.3	24.4	33.0	95.5	17.5	36.6	26.9	6.6	32.8	24.2	25.8	33.7	28.3	37.6	37.0	32.7	37.7	33.8	37.1	28.3	3.3	29.7	29.6	35.0	36.9	31.4	27.9	28.0	32.4	46.0	25.1	28.3	28.4	34.9	28.4	26.7
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Enhanced	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.2	11.2	16.1	14.6	18.8	16.9	15.6	16.5	13.1	13.6	12.0	27.8	8.8	28.8	12.8	17.1	15.4	27.5	17.1	19.9	17.5	13.3	30.0	13.9	19.6	11.0	35.0	10.1	14.1	13.1	21.3	16.6	20.8	32.1	16.0	18.0	10.1	15.5	14.3	20.3	13.4	14.6	24.8	13.9	12.1	22.9	23.5	10.8	14.6	12.6	16.0	8.0	16.1	24.8	14.3	18.9	10.0	18.4	13.3	19.6	26.2	11.1	15.8	11.0	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"				"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favourable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.7	30.9	20.1	21.0	10.9	9.0	24.5	51.0	27.9	51.4	27.0	37.5	19.4	31.7	41.1	37.3	54.7	36.6	40.1	31.1	25.6	56.8	26.8	30.1	29.2	13.6	43.3	20.2	8.7	19.1	36.6	32.5	26.9	34.4	22.6	29.2	50.4	25.2	35.2	22.0	36.8	31.0	19.9	33.4	20.1	33.7	18.3	12.2	36.2	32.1	18.6	18.9	17.5	41.6	39.4	37.8	21.7	41.8	16.8	22.4	30.2	27.5	30.8	22.7	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3
RAP1B	"DKFZp586H0723, K-REV, RAL1B"	ENSG00000127314	"RAP1B, member of RAS oncogene family"	P61224	12	68610839-68671901	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.20e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (8.08e-4)"	"unprognostic (1.08e-1)"	"unprognostic (8.86e-2)"	"unprognostic (7.86e-2)"	"unprognostic (3.22e-1)"	46.7	31.4	19.0	38.0	27.2	58.0	43.7	16.1	20.5	29.5	33.2	21.9	29.0	19.8	38.7	27.9	26.6	26.9	31.8	27.1	21.5	20.1	36.9	33.8	44.1	60.3	22.5	19.9	34.2	20.8	13.1	23.4	52.1	26.1	31.1	27.6	20.9	24.3	34.9	21.3	25.7	31.1	35.5	27.1	52.7	26.8	51.8	21.2	45.1	26.2	20.2	42.1	44.5	29.7	23.3	30.0	47.7	66.2	68.8	56.0	101.6	28.9	19.7	23.3	19.8	49.4	39.7	21.4	61.9	37.9	41.2	31.3	26.3	19.5	41.1	35.7	85.9	16.9	21.9	30.2	58.5	72.4	18.9	106.0	23.6	17.6	57.9	40.7	62.3	39.6	31.0	44.1	53.3	44.8	37.4	67.6	41.0	18.6	38.1	52.6	26.3	28.8	34.3	27.7	30.6	31.3	72.4	9.1	14.3	31.2	18.9	30.1	24.2	48.2	49.2	37.5	16.8	41.9	33.7	34.7	64.0	49.8	34.6	28.2	31.9	47.7	32.6	30.6	56.0	61.2	36.1	23.3	34.6	48.3	30.0	19.9	37.7	50.9	23.4	68.8	66.2	15.2	27.6	101.6	19.0	27.2	16.1	20.5	21.5	20.1	22.5	19.9	26.1	21.2
RAPGEF1	"C3G, GRF2"	ENSG00000107263	"Rap guanine nucleotide exchange factor 1"	Q13905	9	131576770-131740074	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 83.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006426, HPA075984"	Approved		Supported	Vesicles				Vesicles		"HPA006426: AB_1856070, HPA075984: "	"unprognostic (1.00e-1)"	"unprognostic (8.19e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.50e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (5.66e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.73e-2)"	16.2	10.8	18.4	21.5	28.0	19.7	18.5	21.8	19.5	9.6	11.5	13.7	6.0	10.1	11.1	6.9	10.3	11.4	10.2	21.5	17.4	16.0	9.4	9.7	16.9	21.7	13.1	10.2	7.4	24.1	9.0	7.3	28.5	13.5	9.0	10.3	16.8	8.5	10.0	83.3	9.2	13.7	13.2	13.0	16.7	12.0	6.8	11.6	12.4	9.9	8.8	25.9	11.3	12.0	9.2	2.9	5.3	3.9	2.0	6.5	2.3	10.4	12.2	12.4	12.5	12.7	13.8	47.6	9.0	18.5	10.5	7.6	15.1	6.9	19.0	11.4	18.2	19.2	14.2	12.6	5.3	44.0	5.8	5.6	20.5	7.9	10.7	23.0	25.7	10.5	23.3	13.7	16.4	19.0	14.9	37.7	13.6	10.9	16.2	8.1	12.5	11.1	16.1	29.0	26.4	4.8	12.7	10.5	10.5	13.2	12.6	13.2	12.0	19.4	20.0	28.4	11.9	17.9	13.7	12.7	11.0	37.5	13.5	9.9	6.8	5.3	2.0	2.6	6.5	3.8	3.7	9.2	4.2	4.2	2.4	5.3	1.1	2.9	2.3	2.0	3.9	2.9	3.0	2.3	18.4	28.0	21.8	18.5	17.4	16.0	13.1	10.2	13.5	11.6
RAPGEF5	"GFR, KIAA0277, MR-GEF"	ENSG00000136237	"Rap guanine nucleotide exchange factor 5"	Q92565	7	22118238-22357144	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 67.0;parathyroid gland: 258.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.6;HUVEC TERT2: 24.6;SCLC-21H: 19.0;TIME: 13.9;U-698: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057821, HPA076772"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			Nucleoplasm	"Nuclear bodies"	"HPA057821: , HPA076772: "	"unprognostic (1.00e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.17e-2)"	"prognostic unfavourable (9.44e-4)"	"unprognostic (5.22e-2)"	"prognostic favourable (3.52e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.76e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.26e-3)"	10.8	5.8	12.6	3.6	22.6	1.8	6.2	5.2	25.1	4.5	4.6	47.6	0.6	3.9	4.4	3.1	6.1	4.2	7.0	6.7	21.3	10.1	7.3	8.5	14.1	5.7	41.8	13.3	3.7	7.9	258.2	3.3	23.2	31.5	2.8	5.2	0.9	3.4	3.4	2.7	4.4	4.1	5.6	67.0	17.1	3.7	3.5	29.5	3.9	5.4	1.8	4.9	3.9	4.9	0.7	0.0	0.0	0.0	0.0	0.2	0.4	1.5	0.0	2.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.9	0.7	11.6	0.6	0.1	7.2	1.5	1.0	0.0	0.0	2.3	0.1	0.0	2.9	0.0	0.0	0.0	0.3	1.3	0.7	0.4	24.6	2.6	0.1	0.0	0.6	1.6	0.0	2.0	2.3	2.8	0.0	3.9	2.3	1.0	19.0	5.0	0.2	3.3	0.0	1.6	0.0	13.9	0.0	0.6	0.2	0.6	6.4	1.3	20.7	0.3	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	12.6	22.6	5.2	25.1	21.3	10.1	41.8	13.3	31.5	29.5
RARA	"NR1B1, RAR"	ENSG00000131759	"Retinoic acid receptor alpha"	P10276	17	40309192-40357643	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 63.1;SK-BR-3: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 26.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058282			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058282: "	"unprognostic (8.05e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.48e-3)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.67e-3)"	"unprognostic (4.87e-3)"	"unprognostic (2.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.59e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.09e-2)"	27.6	13.5	5.0	18.6	7.6	32.3	23.7	11.5	15.2	30.2	29.6	5.0	16.8	18.0	23.8	23.9	17.3	23.3	30.2	24.3	5.9	6.1	14.6	24.0	32.0	23.4	4.6	7.8	50.0	9.3	7.4	18.1	16.6	6.5	22.9	8.5	26.8	12.1	32.7	43.1	14.3	31.6	18.6	3.7	31.1	14.3	21.8	2.9	9.7	16.3	15.4	20.2	31.5	20.3	1.0	6.1	26.6	9.3	2.5	2.6	1.9	5.0	11.9	3.6	6.0	7.0	10.8	3.6	4.2	6.3	6.2	4.0	8.2	4.4	2.7	6.6	9.4	14.9	4.1	9.9	3.5	20.2	6.1	7.7	6.0	8.0	11.3	2.7	24.4	15.1	2.9	6.5	8.3	9.1	4.8	5.9	6.9	63.1	1.7	9.4	3.1	3.8	3.6	21.1	10.2	3.6	4.0	1.5	12.2	8.9	40.1	12.2	37.8	11.1	10.6	7.7	13.2	13.5	4.5	14.2	4.7	2.3	12.9	5.5	22.8	8.7	4.2	15.7	1.6	6.9	2.6	1.0	1.7	1.7	6.1	0.9	0.8	1.3	26.6	2.5	9.3	1.8	1.4	1.9	5.0	7.6	11.5	15.2	5.9	6.1	4.6	7.8	6.5	2.9
RARG	"NR1B3, RARC"	ENSG00000172819	"Retinoic acid receptor gamma"	P13631	12	53210567-53232980	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 49.4;skin 1: 52.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.2;MCF7: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 5.6;T-cells: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA053883	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA053883: AB_2682292"	"unprognostic (7.29e-2)"	"unprognostic (1.95e-2)"	"unprognostic (6.11e-2)"	"prognostic unfavourable (3.68e-6)"	"unprognostic (2.53e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.54e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.78e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (3.08e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.98e-2)"	"unprognostic (5.94e-3)"	"unprognostic (7.41e-2)"	4.8	5.0	2.7	7.0	3.6	1.3	10.8	6.3	3.8	26.8	6.3	1.8	7.3	1.0	14.6	6.0	49.4	10.6	8.6	6.9	3.0	1.4	3.7	1.9	7.4	6.7	2.4	2.3	12.6	2.7	4.2	2.8	4.4	1.6	11.3	3.4	10.3	9.5	10.6	2.6	52.1	3.0	9.7	1.5	4.7	6.0	3.9	1.7	2.3	7.3	30.6	26.8	10.9	19.8	1.8	5.6	1.5	2.5	1.7	17.0	2.9	7.2	8.0	1.8	16.9	18.8	16.2	0.5	7.6	16.6	10.0	7.8	2.7	33.2	0.1	4.1	30.5	24.4	6.1	14.6	2.5	1.9	3.1	1.0	6.1	2.3	7.9	0.0	3.0	11.9	21.4	9.5	2.1	4.2	0.2	3.2	3.9	35.0	0.4	0.3	5.4	14.1	2.3	0.6	5.8	2.9	12.0	1.5	7.6	15.4	16.7	10.1	14.5	0.4	4.5	12.0	5.6	7.9	0.4	1.5	0.8	0.5	14.7	1.2	16.9	1.5	2.5	0.7	6.6	0.8	17.0	1.8	5.7	4.8	5.6	0.6	4.8	4.1	0.0	1.7	0.0	0.4	1.5	2.9	2.7	3.6	6.3	3.8	3.0	1.4	2.4	2.3	1.6	1.7
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341674	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 145.8;liver: 184.8;pancreas: 145.4"	"Group enriched"	"Detected in some"	6	"AF22: 27.1;Hep G2: 39.3;HHSteC: 35.5;NTERA-2: 82.8"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 8.2"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	75000000	550000000				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	46.5	145.8	4.6	20.5	5.0	0.0	28.0	2.6	4.4	51.2	31.0	10.7	10.9	5.0	23.8	21.0	18.3	21.9	30.5	12.9	5.3	3.6	21.9	184.8	33.2	10.7	7.6	3.0	40.2	145.4	66.7	6.3	5.6	12.0	35.5	8.0	23.5	6.1	12.2	7.4	3.2	10.3	27.5	7.7	11.0	10.9	11.1	5.4	1.0	7.8	5.2	10.5	26.3	39.7	0.1	8.2	0.0	0.0	0.8	0.3	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.3	2.1	5.1	0.8	3.5	0.2	1.6	0.2	3.1	0.5	0.1	0.0	0.0	0.0	0.4	0.1	0.1	4.4	39.3	35.5	0.4	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.4	0.5	82.8	0.0	0.0	3.6	0.0	0.6	0.2	0.1	0.2	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	8.2	0.0	0.0	4.6	5.0	2.6	4.4	5.3	3.6	7.6	3.0	12.0	5.4
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (7.59e-5)"	"prognostic unfavourable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.1	32.2	23.9	26.4	33.1	37.9	41.1	40.0	34.4	41.7	48.8	54.7	29.6	28.9	32.8	38.0	26.4	31.2	53.8	54.4	30.0	21.5	19.4	29.4	34.3	28.7	45.7	20.7	29.1	28.8	45.4	21.8	33.3	28.9	14.7	44.6	25.1	19.0	18.3	39.2	22.0	8.4	34.8	27.4	37.1	31.0	22.8	28.0	30.6	35.4	41.2	32.1	19.2	33.0	30.2	27.8	23.3	46.6	14.6	26.8	29.6	32.9	32.7	28.7	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8
RASA1	"CM-AVM, GAP, p120, p120GAP, p120RASGAP, RASA"	ENSG00000145715	"RAS p21 protein activator 1"	P20936	5	87267888-87391931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	13	"placenta: 260.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007789, HPA036393, HPA064556"	Enhanced						7900			"CAB007789: AB_598183, HPA036393: , HPA064556: "	"unprognostic (1.57e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.38e-2)"	"unprognostic (6.88e-2)"	"unprognostic (8.38e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.12e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.30e-3)"	12.4	8.8	12.3	8.9	12.8	6.4	11.4	17.3	16.3	11.3	8.1	8.6	9.3	6.9	12.4	11.4	10.2	9.5	9.3	7.2	12.0	10.9	8.7	6.5	8.4	9.2	10.1	13.8	15.9	8.2	20.3	12.2	260.6	9.3	8.0	9.8	9.6	10.6	9.6	6.9	9.7	10.0	9.0	9.4	13.7	7.4	14.4	10.0	10.7	14.4	5.7	9.6	11.3	9.8	2.0	1.3	3.1	2.6	8.1	3.5	1.1	11.5	6.5	11.3	7.3	9.6	14.2	8.8	18.5	12.0	11.4	18.9	4.3	30.6	7.5	4.5	20.2	5.4	5.2	15.0	34.7	7.3	4.2	5.6	5.6	4.7	9.7	4.1	6.7	8.0	9.6	32.1	18.2	15.9	3.1	16.2	39.3	7.0	5.0	6.1	5.9	12.1	6.2	25.7	11.1	9.9	10.0	6.9	7.5	6.8	8.8	9.7	7.9	6.4	23.5	14.6	6.4	7.5	23.0	5.7	5.9	7.6	21.3	8.5	10.4	3.1	1.3	1.4	2.0	2.6	3.5	1.4	2.4	1.9	1.1	2.0	2.1	1.9	1.7	8.1	2.4	1.3	3.0	1.1	12.3	12.8	17.3	16.3	12.0	10.9	10.1	13.8	9.3	10.0
RASA3	"GAP1IP4BP, GAPIII"	ENSG00000185989	"RAS p21 protein activator 3"	Q14644	13	113977783-114132611	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046759	Uncertain						8100000			"HPA046759: AB_10959887"	"unprognostic (3.41e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-3)"	"unprognostic (4.01e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (1.99e-6)"	"unprognostic (8.98e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.08e-2)"	"unprognostic (4.11e-2)"	26.4	6.0	12.7	20.5	12.3	21.0	16.2	10.4	17.6	15.6	11.1	21.8	7.1	6.5	10.4	6.2	6.6	12.8	9.7	9.3	13.7	10.7	6.3	4.7	12.8	26.5	11.4	8.7	5.9	11.0	2.3	11.0	10.7	11.3	8.5	6.3	11.5	6.6	8.3	13.5	9.0	10.6	14.0	15.1	19.9	9.5	5.1	11.5	17.9	10.6	5.5	18.9	13.4	14.6	4.1	2.2	10.4	10.1	8.8	13.5	10.5	1.8	2.2	10.0	2.9	9.8	10.9	0.0	7.2	10.9	6.5	5.5	0.2	5.6	0.2	4.1	11.7	0.0	1.4	3.4	5.1	0.4	0.6	14.0	6.9	0.0	4.9	5.8	1.2	9.8	0.7	6.3	4.5	11.0	1.0	1.6	9.7	2.4	12.7	9.7	2.1	3.3	6.4	3.7	28.6	5.9	0.0	1.4	1.0	1.7	7.5	3.6	1.8	21.5	14.8	9.9	2.7	3.5	7.7	0.0	0.0	0.4	12.9	5.7	15.7	10.4	3.1	4.4	13.2	5.6	9.9	4.1	12.1	13.0	2.2	3.2	13.0	12.5	1.9	8.8	10.1	0.7	13.5	10.5	12.7	12.3	10.4	15.0	13.7	10.7	11.4	8.7	11.3	11.5
RASA4	"CAPRI, GAPL, KIAA0538"	ENSG00000105808	"RAS p21 protein activator 4"	O43374	7	102573807-102616757	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 58.0"	"Cell line enhanced"	"Detected in many"		"U-138 MG: 27.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043010	Uncertain		Uncertain	Vesicles				Vesicles		"HPA043010: "	"unprognostic (6.44e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.62e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.18e-2)"	5.5	2.3	4.2	2.5	2.6	1.6	4.4	2.7	4.7	4.9	4.0			3.6	6.3	1.8	1.9	3.6	1.9	1.5	3.6	3.0	3.3	0.2	2.7	3.6	1.9		4.1	2.1	6.8	3.7	4.0		3.3	1.6		2.0	5.6	58.0	5.4	4.3	3.2	1.2	4.1	2.2	0.6			2.2		2.4	3.9	4.7	3.6	11.3	2.2	9.4	1.5	3.7	3.1	0.7	1.2	9.1	1.8	1.6	4.7	0.3	9.3	4.7	3.1	3.3	3.7	2.7	7.1	6.9	14.1	9.1	0.4	0.1	2.3	1.3	2.4	2.0	3.6	0.9	1.8	1.3	2.7	4.3	1.1	0.8	0.4	1.6	3.1	10.5	0.7	3.6	7.1	4.9	0.7	4.7	9.7	2.0	10.2	0.3	3.4	8.9	18.6	1.7	2.1	1.2	1.8	3.6	2.3	27.3	13.3	3.1	2.3	16.6	10.2	6.1	3.4	3.0	3.3	0.4	8.4	0.3	1.9	9.4	3.7	2.8	3.2	2.2	11.3	3.6	3.4	2.4	2.2	1.5	1.2	9.8	3.5	3.1										
RASAL1	RASAL	ENSG00000111344	"RAS protein activator like 1"	O95294	12	113098819-113136239	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	Differentiation	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 64.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 8.3;EFO-21: 10.9;REH: 12.0;RPMI-8226: 26.8;RPTEC TERT1: 10.7;U-698: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 21.7;cerebral cortex: 20.9;hippocampal formation: 33.7"	HPA041650	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cytosol"	"Cell Junctions"	"HPA041650: "	"unprognostic (9.95e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavourable (3.26e-5)"	"unprognostic (1.27e-2)"	"unprognostic (7.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.02e-3)"	"unprognostic (3.16e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.64e-1)"	0.9	10.4	8.6	2.5	11.2	1.2	1.6	0.4	18.2	2.5	2.1	18.8	3.7	1.2	0.9	0.9	16.9	2.2	1.8	0.8	11.8	4.9	7.4	0.9	0.9	1.7	7.3	10.9	0.8	1.4	64.0	3.9	1.0	4.0	0.9	1.7	0.0	22.4	7.4	0.8	8.0	1.1	0.9	1.8	1.0	9.6	1.1	8.4	0.0	8.0	6.0	5.0	1.0	3.7	0.4	0.2	1.3	0.2	0.3	1.6	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.1	8.3	10.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.3	0.0	12.0	0.0	26.8	10.7	0.0	0.3	0.0	0.0	4.0	0.0	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	1.3	0.2	0.1	0.1	0.0	1.6	0.2	0.9	0.4	0.0	0.4	1.2	0.5	0.4	0.3	0.0	0.2	0.4	0.3	8.6	11.2	0.4	18.2	11.8	4.9	7.3	10.9	4.0	8.4
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094141-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"		"HPA018805: AB_1856085, HPA020453: AB_1856086"	"unprognostic (5.55e-3)"	"unprognostic (6.49e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.33e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (2.05e-4)"	13.5	3.8	4.2	2.8	5.1	0.4	7.1	2.7	8.5	9.5	4.2	3.7	4.2	2.4	10.9	5.5	24.4	5.8	9.0	15.5	3.8	5.9	7.1	2.7	9.2	1.5	4.0	6.5	6.3	5.0	6.1	6.7	21.2	5.6	5.0	4.3	10.7	9.6	4.5	8.3	7.5	3.3	7.1	3.8	2.9	3.7	9.0	2.7	0.0	5.0	13.1	4.8	5.6	13.2	2.1	0.5	1.4	0.6	0.3	0.1	0.0	16.1	5.3	7.0	2.3	4.7	6.4	9.7	8.1	7.9	6.9	5.2	8.5	8.6	0.0	13.5	7.9	13.6	5.6	12.9	6.4	0.0	3.1	0.0	5.6	3.3	5.6	2.3	0.3	20.1	2.5	8.2	29.6	6.2	0.5	0.0	9.5	1.6	0.0	1.9	5.2	1.0	0.1	2.8	0.0	3.7	2.1	5.4	2.6	6.3	4.9	4.9	5.7	2.6	11.7	9.2	9.3	9.5	10.8	3.5	0.0	0.0	7.2	1.2	6.5	1.4	0.4	0.1	0.1	0.3	0.0	0.6	0.0	0.0	0.2	2.1	0.1	0.1	0.8	0.3	0.6	0.5	0.0	0.0	4.2	5.1	2.7	7.1	3.8	5.9	4.0	6.5	5.6	2.7
RASGRP2	CALDAG-GEFI	ENSG00000068831	"RAS guanyl releasing protein 2"	Q7LDG7	11	64726911-64745456	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;bone marrow: 63.9;lymphoid tissue: 47.6"	"Cell line enhanced"	"Detected in some"		"HEL: 22.5;HL-60: 40.7;NB-4: 77.3;REH: 23.1;THP-1: 24.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015667	Approved						1900000			"HPA015667: AB_1856090"	"unprognostic (5.96e-2)"	"unprognostic (3.24e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.74e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.91e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.23e-1)"	7.6	4.2	4.6	26.8	26.4	63.9	4.5	4.3	8.2	5.6	9.9	3.2	4.5	3.6	8.8	4.9	4.5	8.9	4.7	13.7	5.5	4.7	5.5	3.1	8.5	47.6	4.7	5.7	2.7	1.2	0.7	1.5	8.1	4.1	6.9	3.2	5.3	7.4	10.4	5.8	1.5	25.6	8.1	2.7	43.9	5.4	3.1	8.2	9.7	2.9	2.5	30.1	7.0	4.8	51.6	29.1	24.5	32.2	16.7	32.8	22.2	0.0	0.0	0.7	0.0	0.0	0.0	2.0	0.3	0.0	0.3	0.2	0.3	0.0	14.0	0.6	0.0	0.1	1.2	0.2	0.0	0.0	0.4	22.5	0.0	0.0	0.0	40.7	8.3	0.0	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.3	9.6	77.3	0.5	0.0	23.1	0.0	0.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.1	24.2	0.1	0.0	0.4	0.3	0.0	0.1	0.0	12.9	0.0	12.9	0.0	16.5	11.8	19.1	24.4	28.6	13.2	51.6	25.3	19.3	11.6	32.0	32.8	29.0	24.5	16.7	32.2	29.1	29.9	22.2	4.6	26.4	4.3	8.2	5.5	4.7	4.7	5.7	4.1	8.2
RASSF7	"C11orf13, HRAS1, HRC1"	ENSG00000099849	"Ras association domain family member 7"	Q02833	11	560404-564021	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 31.8;HaCaT: 31.9;SK-BR-3: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA078015			Supported	"Centriolar satellite"				"Centriolar satellite"		"HPA078015: "	"unprognostic (1.11e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (6.09e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.58e-3)"	3.6	1.1	4.0	9.7	6.5	3.6	3.9	19.4	5.8	6.2	19.6	1.7	25.6	21.6	2.6	16.5	13.2	18.5	18.4	2.0	3.0	2.2	26.3	23.2	12.0	6.1	3.6	4.2	5.1	18.4	3.8	7.1	10.2	4.6	10.7	5.7	4.0	15.3	13.9	0.8	17.5	22.3	1.7	1.2	4.6	27.1	3.1	3.0	8.5	9.8	5.5	12.5	7.9	10.4	11.9	13.9	16.4	4.6	5.5	15.5	6.9	18.5	18.4	0.9	4.7	0.0	0.0	13.2	2.8	2.2	3.0	2.2	19.2	31.8	2.4	13.1	1.5	31.9	2.7	9.8	0.4	3.2	9.6	1.6	9.0	9.2	2.0	3.9	2.8	0.0	9.6	1.0	0.9	1.8	4.1	0.9	0.2	18.6	4.3	8.3	2.7	10.6	6.9	1.4	5.3	14.7	9.1	4.1	3.1	1.8	28.5	2.4	12.9	2.5	2.4	0.6	8.9	1.1	5.4	3.2	3.4	1.9	4.9	5.4	2.5	3.9	4.6	16.4	14.4	3.8	12.9	11.0	14.7	12.5	7.8	11.9	12.2	10.6	5.4	5.5	4.0	13.9	15.5	6.9	4.0	6.5	19.4	5.8	3.0	2.2	3.6	4.2	4.6	3.0
RASSF8	"C12orf2, HoJ-1"	ENSG00000123094	"Ras association domain family member 8"	Q8NHQ8	12	25959029-26079892	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038163, HPA038164"	Uncertain		Approved	Mitochondria,Cytosol				"Mitochondria, Cytosol"		"HPA038163: , HPA038164: AB_10672621"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.10e-3)"	"unprognostic (3.88e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.29e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.58e-2)"	9.8	14.1	14.6	6.4	14.0	1.3	14.6	8.0	10.4	20.9	12.7	10.3	7.0	2.5	23.9	10.5	6.7	10.0	14.6	11.9	16.0	8.5	19.7	5.2	12.5	2.2	15.1	8.0	26.3	5.2	4.3	16.1	10.6	14.8	14.2	4.6	14.7	4.4	12.7	12.0	3.3	4.4	17.3	19.9	5.0	7.0	44.7	13.6	0.3	9.7	5.2	2.2	10.1	18.8	0.6	4.1	0.9	0.3	1.4	0.6	0.1	3.2	2.6	11.5	1.4	18.0	20.4	16.1	17.9	26.2	7.6	8.4	5.7	1.0	0.2	14.2	19.3	1.3	2.5	2.1	9.7	1.2	3.3	0.5	6.5	0.3	9.0	2.0	0.1	12.1	2.1	16.8	11.3	9.0	0.6	2.3	8.7	4.4	2.3	0.4	11.5	24.8	3.0	11.2	0.1	4.6	4.9	0.5	8.3	9.4	0.1	8.8	1.7	1.7	10.6	15.0	7.8	38.0	13.4	1.0	0.6	0.3	13.9	0.2	21.0	0.7	0.3	0.2	0.6	0.1	0.2	0.3	0.2	0.2	0.0	0.6	0.3	0.2	0.9	1.4	0.1	4.1	0.1	0.1	14.6	14.0	8.0	10.4	16.0	8.5	15.1	8.0	14.8	13.6
RB1	"OSRC, PPP1R130, RB"	ENSG00000139687	"RB transcriptional corepressor 1"	P06400	13	48303726-48599436	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000095, CAB016687, HPA050082"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000095: , CAB016687: AB_1622010, HPA050082: "	"unprognostic (4.24e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.92e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.70e-1)"	19.6	21.5	14.9	23.2	18.4	14.7	28.1	25.6	19.4	18.0	13.2	11.5	19.0	12.3	16.8	19.5	27.9	12.7	15.3	19.5	15.4	15.3	18.1	12.1	25.4	30.1	17.0	11.8	15.2	11.6	12.8	17.2	21.5	16.0	15.5	15.3	11.6	20.0	17.4	27.9	20.3	14.3	16.8	23.6	29.4	13.7	14.4	15.3	39.1	19.9	15.8	25.3	17.4	23.6	20.5	10.3	13.2	12.2	3.6	4.6	4.0	9.0	4.9	13.4	14.4	6.6	7.7	6.1	17.9	14.9	18.9	16.1	4.2	16.1	11.7	4.1	11.9	12.6	17.4	14.4	28.9	16.4	6.6	21.6	10.1	7.1	7.1	18.5	20.5	4.3	8.9	12.2	15.7	13.0	7.1	9.7	21.6	4.3	57.9	9.3	6.5	5.4	24.9	13.4	13.5	19.6	8.8	0.6	13.7	17.7	8.9	14.6	9.7	24.2	10.1	11.7	7.7	14.3	16.1	4.3	1.2	0.1	6.2	11.6	15.8	11.0	9.7	5.0	4.6	12.2	3.7	17.4	3.8	4.6	9.3	20.5	3.2	3.8	13.2	3.6	12.1	10.3	4.5	4.0	14.9	18.4	25.6	19.4	15.4	15.3	17.0	11.8	16.0	15.3
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm			27000	Nucleoplasm		"CAB006264: AB_425651, HPA060710: , HPA060724: "	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favourable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavourable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavourable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	23.8	33.6	28.2	34.3	27.8	23.4	29.1	30.5	35.1	32.2	24.1	32.0	42.3	20.5	36.0	29.2	26.0	35.4	21.3	24.0	27.9	24.8	25.2	25.4	23.0	43.9	30.6	29.0	37.6	31.3	27.0	32.9	26.2	26.9	24.2	35.5	31.2	30.1	43.1	31.8	24.9	26.8	32.6	26.9	27.6	28.8	53.4	31.4	73.3	35.8	20.5	65.2	32.5	26.6	33.7	45.4	26.7	39.4	33.1	32.4	48.4	15.4	13.6	38.9	28.3	12.0	11.4	15.7	11.8	10.3	24.1	23.5	19.4	31.9	47.0	13.1	13.9	10.0	42.5	12.3	26.1	18.3	20.4	43.8	27.4	25.4	17.4	41.3	19.0	12.5	15.7	18.2	11.8	17.8	30.8	33.7	20.6	10.8	53.0	13.0	43.2	15.9	51.5	40.9	40.8	16.9	33.2	37.2	22.1	28.0	10.0	19.1	17.1	19.2	14.8	14.7	15.0	18.5	15.8	26.8	28.1	52.8	17.5	33.4	22.5	26.4	38.8	26.7	31.1	39.4	32.4	33.7	29.7	31.4	45.4	26.6	26.7	28.8	10.2	33.1	35.3	38.3	30.3	48.4	28.2	27.8	30.5	35.1	27.9	24.8	30.6	29.0	26.9	31.4
RBBP8	"COM1, CtIP, RIM, SCKL2"	ENSG00000101773	"RB binding protein 8, endonuclease"	Q99708	18	22798261-23026488	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA039890, HPA052946"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA039890: AB_10794756, HPA052946: "	"unprognostic (1.55e-3)"	"unprognostic (4.10e-3)"	"unprognostic (7.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (7.21e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.04e-2)"	"prognostic favourable (1.71e-5)"	"unprognostic (3.91e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.48e-1)"	9.0	6.2	6.0	10.8	6.4	9.4	19.4	4.2	5.9	16.4	13.4	4.1	22.5	5.4	13.1	18.6	17.1	17.6	8.7	8.3	4.9	6.8	49.6	12.3	17.0	7.8	6.6	3.6	12.2	14.3	17.4	29.2	11.5	11.5	13.4	8.0	5.3	14.8	29.1	3.8	17.4	14.0	10.3	4.5	9.8	7.8	16.7	3.8	24.2	14.7	10.8	10.0	10.4	13.0	4.3	5.1	7.8	21.0	5.0	2.8	2.2	9.4	7.3	10.9	12.5	5.6	6.0	8.5	13.1	9.2	12.2	17.3	13.4	10.8	27.7	6.1	8.2	20.0	12.3	26.6	24.0	19.7	9.9	12.1	9.9	12.7	6.9	43.5	13.3	4.3	25.8	18.4	32.2	4.9	7.1	20.8	12.4	14.1	32.2	14.6	10.3	12.4	16.6	19.9	17.1	35.3	10.2	25.5	12.1	21.9	6.7	11.3	38.7	11.5	3.5	32.8	15.1	15.8	22.7	28.2	30.2	30.4	15.0	21.1	17.5	7.8	4.0	2.3	0.8	14.8	0.3	4.3	1.1	1.4	5.1	3.3	0.6	1.0	1.5	5.0	21.0	5.1	2.8	2.2	6.0	6.4	4.2	5.9	4.9	6.8	6.6	3.6	11.5	3.8
RBCK1	"C20orf18, HOIL1, RBCK2, RNF54, UBCE7IP3, XAP4, ZRANB4"	ENSG00000125826	"RANBP2-type and C3HC4-type zinc finger containing 1"	Q9BYM8	20	407498-430966	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 63.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.94e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.15e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavourable (7.41e-9)"	"unprognostic (5.87e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.39e-3)"	24.6	36.4	18.8	30.7	23.9	24.2	26.0	40.2	18.8	21.4	34.0	25.4	22.5	31.9	25.7	29.7	27.6	23.5	31.4	23.2	18.6	15.1	28.1	53.0	31.3	29.8	27.2	19.1	28.9	28.7	22.9	28.9	30.5	19.1	28.0	17.5	18.2	39.7	30.4	21.7	27.1	43.3	20.9	20.9	34.6	25.0	18.2	24.3	44.4	26.2	18.5	19.4	23.4	23.3	17.5	26.6	50.3	30.1	18.5	23.2	18.4	18.3	22.1	5.4	9.6	10.0	13.3	14.6	11.6	13.7	14.1	18.6	12.8	18.4	9.2	14.8	16.7	16.6	6.6	37.1	4.8	6.7	9.4	8.1	5.1	35.1	45.7	8.0	6.0	19.7	63.6	10.2	44.3	13.6	7.8	14.1	9.3	8.4	15.1	21.4	5.4	22.5	11.5	7.0	10.4	18.2	13.8	11.2	11.4	8.3	29.7	36.1	17.2	16.0	9.3	13.1	7.6	9.0	13.0	12.7	15.5	9.9	7.1	16.0	9.6	17.3	18.9	30.1	23.2	24.8	16.8	17.5	18.3	23.1	16.3	16.0	15.2	17.6	50.3	18.5	30.1	26.6	19.5	18.4	18.8	23.9	40.2	18.8	18.6	15.1	27.2	19.1	19.1	24.3
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095995	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	5.0	4.3	4.9	12.3	7.1	20.4	4.8	16.6	7.8	5.1	5.6	5.5	5.9	4.0	8.1	3.0	7.7	4.4	3.6	4.0	4.0	3.6	3.3	3.0	4.5	11.1	6.5	2.2	7.8	6.0	5.9	5.9	8.3	5.7	4.4	6.1	5.3	4.8	2.7	10.2	5.3	5.9	5.9	7.1	6.9	4.6	8.2	5.5	19.6	5.3	6.1	11.4	4.7	7.1	5.0	5.1	2.2	1.9	3.6	7.4	1.6	12.0	7.9	9.9	6.6	2.5	3.3	6.3	14.1	6.3	12.2	12.7	8.3	6.8	13.5	4.1	5.8	11.9	8.8	9.1	20.5	4.7	4.7	13.3	9.3	7.0	1.5	17.1	9.3	1.6	1.2	16.1	5.7	6.8	9.7	13.1	6.9	5.1	15.9	5.7	2.9	7.7	10.4	29.4	10.2	2.8	6.0	2.3	5.9	15.4	8.9	4.1	5.7	12.4	4.5	21.7	8.3	19.8	12.2	4.4	7.7	13.7	15.5	12.1	10.6	1.4	1.2	2.2	5.0	1.4	4.2	5.0	5.6	4.5	2.2	3.9	6.0	4.8	0.6	3.6	1.9	5.1	7.4	1.6	4.9	7.1	16.6	7.8	4.0	3.6	6.5	2.2	5.7	5.5
RBL2	"p130, Rb2"	ENSG00000103479	"RB transcriptional corepressor like 2"	Q08999	16	53433977-53491649	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016547, HPA019703"	Supported		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"CAB016547: AB_785011, HPA019703: AB_1856106"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.12e-2)"	"prognostic favourable (3.57e-5)"	"unprognostic (9.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.70e-2)"	"unprognostic (7.51e-2)"	27.8	20.6	15.7	22.2	20.0	11.1	25.5	24.1	18.7	26.3	23.7	24.7	25.6	15.4	30.0	20.2	21.5	25.1	19.5	19.9	15.5	11.7	23.8	34.2	24.0	31.6	25.8	13.7	29.3	30.7	55.3	22.6	12.4	15.8	28.2	18.9	20.2	26.2	30.5	28.3	20.8	24.6	26.1	17.9	27.2	24.9	28.6	22.8	54.4	31.0	10.3	31.6	36.5	26.8	9.1	8.0	20.2	9.8	26.2	35.1	24.5	12.6	8.6	11.5	10.6	30.2	29.2	5.4	9.3	13.3	11.6	4.0	5.6	15.9	18.5	14.1	15.7	15.9	8.6	14.4	18.5	6.6	11.9	8.3	8.7	10.4	13.0	11.5	26.1	18.5	17.7	7.9	11.3	17.9	6.7	11.6	12.9	3.7	22.9	15.5	4.7	7.8	16.7	21.0	21.2	11.4	12.9	9.4	7.8	21.1	9.3	9.1	12.0	15.2	14.8	14.4	7.7	11.9	6.9	17.9	10.5	21.7	18.0	14.4	9.9	16.4	8.2	20.2	21.2	5.9	23.7	8.7	23.8	24.3	8.0	9.1	35.1	29.6	15.7	26.2	9.8	4.9	17.5	24.5	15.7	20.0	24.1	18.7	15.5	11.7	25.8	13.7	15.8	22.8
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: "	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavourable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (1.37e-4)"	"prognostic favourable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	8.5	7.6	6.3	12.2	7.6	48.7	7.9	18.6	8.3	6.6	8.8	7.6	8.3	7.3	8.5	7.2	8.0	7.3	6.6	8.8	5.2	4.3	6.3	11.0	10.5	13.7	8.3	6.0	8.6	7.5	7.1	8.1	7.1	5.9	5.7	5.7	8.1	7.4	6.4	17.2	7.2	11.3	5.5	5.0	12.5	8.3	14.0	7.9	21.8	7.0	5.3	13.4	6.5	8.6	10.5	4.8	9.8	6.9	5.0	9.9	5.5	7.0	7.7	6.9	7.1	4.4	4.6	10.9	3.7	4.9	5.9	7.8	9.4	6.5	13.3	6.0	4.2	10.0	10.8	9.4	8.8	13.8	10.0	10.8	11.7	6.8	6.2	11.7	11.5	4.2	6.6	8.2	7.7	6.3	15.2	23.4	5.9	7.2	10.5	9.2	14.8	4.3	12.5	10.5	9.1	4.8	7.1	8.4	4.2	8.2	10.3	7.9	7.2	14.1	4.3	5.7	10.2	6.1	6.8	18.0	9.1	28.9	8.5	11.8	7.0	8.2	6.9	9.4	7.0	6.0	9.9	10.5	7.7	6.0	4.8	10.0	6.8	8.2	9.8	5.0	6.4	4.7	7.5	5.5	6.3	7.6	18.6	8.3	5.2	4.3	8.3	6.0	5.9	7.9
RBM17	"MGC14439, SPF45"	ENSG00000134453	"RNA binding motif protein 17"	Q96I25	10	6088987-6117457	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037477, HPA037478"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA037477: AB_10671372, HPA037478: AB_2675494"	"unprognostic (8.55e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavourable (4.57e-8)"	"unprognostic (3.78e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.32e-2)"	"prognostic unfavourable (4.31e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.01e-2)"	36.5	28.0	36.2	40.7	43.1	67.9	52.5	37.2	35.8	31.4	31.9	38.2	25.2	36.4	40.0	29.9	31.3	32.7	30.5	28.9	35.5	24.6	28.5	25.8	44.9	46.0	37.0	29.2	34.1	37.1	30.2	23.4	42.6	35.1	25.2	38.5	24.7	30.2	28.7	50.5	25.9	40.3	37.4	39.2	47.6	30.2	35.7	41.0	49.3	38.2	20.5	46.8	29.9	53.3	47.9	33.6	41.4	34.0	31.4	41.2	22.8	41.3	24.4	31.7	27.4	17.2	15.8	39.0	27.9	12.4	28.4	31.0	39.9	33.4	49.4	19.8	20.2	41.3	28.0	30.0	30.9	48.7	27.8	42.5	24.5	33.8	21.4	23.1	21.0	16.1	22.9	29.2	16.1	34.5	44.7	25.0	18.2	47.6	41.0	14.4	19.8	17.0	44.5	17.5	25.6	20.7	26.0	13.2	17.5	26.5	24.6	20.6	32.3	23.6	20.9	17.4	34.6	37.2	29.3	24.8	28.3	83.1	16.1	30.1	11.1	28.2	34.0	41.4	33.4	33.4	34.1	43.7	33.0	33.0	29.4	47.9	33.7	31.5	17.5	31.4	24.6	33.6	41.2	22.8	36.2	43.1	37.2	35.8	35.5	24.6	37.0	29.2	35.1	41.0
RBM19	"DKFZp586F1023, KIAA0682, Mrd1"	ENSG00000122965	"RNA binding motif protein 19"	Q9Y4C8	12	113816738-113966371	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038860, HPA058732"	Supported		Supported	Nucleoli				Nucleoli		"HPA038860: AB_10697400, HPA058732: "	"unprognostic (2.10e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.14e-2)"	"prognostic unfavourable (5.87e-7)"	"unprognostic (9.32e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.43e-2)"	"unprognostic (3.53e-3)"	"unprognostic (8.37e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-2)"	15.4	18.4	19.9	23.5	26.1	23.8	17.1	25.0	26.7	13.7	15.4	27.5	16.0	14.7	17.7	15.1	15.7	15.1	13.0	14.3	19.4	12.6	16.5	15.7	15.2	22.1	22.4	16.2	25.5	21.3	22.0	16.6	16.9	19.4	19.0	15.8	16.0	16.1	16.2	20.0	16.3	16.5	19.6	14.5	19.1	16.7	17.3	26.3	16.8	26.7	14.4	21.5	17.1	21.7	8.1	6.7	1.4	11.9	7.9	9.1	4.8	7.0	14.2	8.5	16.6	8.6	6.9	13.0	12.8	10.1	14.5	10.7	19.0	10.0	12.7	8.0	10.8	10.1	20.0	12.3	11.5	22.9	11.7	27.2	14.0	18.2	6.5	20.5	13.0	8.5	8.2	17.7	6.5	10.5	29.2	5.2	8.9	10.6	11.5	15.5	18.6	12.2	15.4	8.2	11.0	9.9	13.8	10.2	8.2	11.4	16.7	7.8	18.3	5.9	11.9	9.6	11.8	8.2	7.8	9.5	7.1	12.7	12.9	14.7	12.1	0.0	4.9	1.4	9.1	8.8	6.9	8.1	6.4	7.4	6.7	7.0	5.2	7.1	0.3	7.9	11.9	4.6	5.5	4.8	19.9	26.1	25.0	26.7	19.4	12.6	22.4	16.2	19.4	26.3
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058436-73123898	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"			250000	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: "	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (8.09e-4)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	29.1	25.3	24.2	49.2	36.9	66.0	31.3	48.9	36.4	29.1	25.9	26.4	34.2	24.6	33.7	37.7	27.1	32.4	29.7	22.3	28.2	22.3	21.6	23.5	28.6	38.9	26.5	35.4	36.3	35.6	32.7	45.1	28.1	33.5	26.1	26.5	24.1	29.3	40.5	35.4	29.0	28.9	30.3	30.0	30.4	27.6	29.4	29.7	34.6	33.8	28.4	34.3	26.3	29.4	21.5	24.7	17.4	17.0	23.2	18.4	9.0	32.5	18.8	30.4	23.1	13.7	16.0	26.6	26.8	18.9	20.9	23.1	25.1	21.0	39.3	14.2	18.4	24.8	34.9	16.2	36.1	24.6	18.4	33.1	14.9	19.2	8.6	29.0	21.1	11.6	11.7	24.4	20.1	20.7	33.8	16.5	22.6	24.3	37.7	17.0	25.7	20.8	32.6	33.2	19.2	17.2	22.8	20.5	19.6	33.7	22.4	11.8	32.1	12.7	26.1	30.9	30.2	16.5	26.8	17.6	31.1	49.1	13.8	20.8	21.1	11.2	14.8	13.5	18.4	17.0	17.3	18.6	14.5	15.4	15.5	21.5	15.4	16.1	17.4	23.2	13.7	24.7	15.9	9.0	24.2	36.9	48.9	36.4	28.2	22.3	26.5	35.4	33.5	29.7
RBM26	"ARRS2, C13orf10, FLJ20957, PPP1R132, PRO1777, SE70-2, ZC3H17"	ENSG00000139746	"RNA binding motif protein 26"	Q5T8P6	13	79311824-79406477	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040252	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA040252: AB_10672895"	"unprognostic (5.55e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (3.46e-4)"	"prognostic unfavourable (5.87e-6)"	"unprognostic (8.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic favourable (8.20e-4)"	18.0	23.7	25.1	23.2	35.2	28.0	22.9	47.3	30.2	22.1	16.4	21.9	18.4	16.0	25.2	25.8	18.2	21.4	15.5	15.6	23.7	17.7	14.7	17.4	18.7	32.4	24.7	18.5	30.5	24.8	20.3	34.4	20.9	25.5	19.5	19.8	16.2	20.0	17.7	20.9	27.9	23.5	18.6	23.4	29.1	20.4	25.1	27.8	37.0	22.9	15.2	28.9	17.6	18.2	9.4	4.3	6.0	3.3	3.7	7.5	1.6	20.3	10.9	26.9	13.7	12.1	12.9	14.7	14.0	11.8	14.6	15.1	14.5	17.3	30.5	11.5	10.3	19.4	20.1	13.7	21.2	18.3	21.5	23.5	24.3	13.1	9.5	43.7	18.8	8.6	11.5	14.9	20.9	15.2	17.8	10.2	16.1	6.8	26.5	23.2	16.6	6.5	26.8	22.4	16.1	13.4	11.7	20.5	13.8	12.0	14.5	8.5	13.1	36.5	14.4	12.4	12.4	9.9	14.1	14.8	12.9	38.0	20.1	24.6	14.7	6.0	2.4	4.4	5.0	3.3	5.2	6.2	5.0	4.7	1.4	9.4	7.5	6.6	3.3	3.7	2.4	4.3	5.2	1.6	25.1	35.2	47.3	30.2	23.7	17.7	24.7	18.5	25.5	27.8
RBM39	"CAPER, CAPERalpha, CC1.3, fSAP59, HCC1, RNPC2"	ENSG00000131051	"RNA binding motif protein 39"	Q14498	20	35701347-35742312	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001591	Supported		Supported	"Nucleoplasm,Nuclear speckles,Microtubules,Centriolar satellite"				"Nucleoplasm, Nuclear speckles"	"Microtubules, Centriolar satellite"	"HPA001591: AB_1079749"	"unprognostic (1.37e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.56e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.04e-2)"	"unprognostic (7.65e-3)"	"prognostic unfavourable (2.78e-5)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.28e-3)"	41.4	44.1	37.5	41.5	41.4	120.8	38.5	57.5	41.8	43.4	35.0	30.7	46.3	29.5	51.9	34.3	42.8	35.3	40.7	40.2	35.8	29.9	39.2	32.4	40.4	41.8	41.1	31.4	52.3	35.6	40.9	71.5	45.2	37.4	39.2	27.0	28.9	37.1	46.0	44.1	32.1	30.6	40.2	43.0	38.4	33.5	22.9	46.4	52.4	40.7	28.2	40.5	39.9	46.1	27.6	32.5	88.9	25.1	24.2	22.5	16.8	28.7	26.7	27.8	24.6	21.9	24.9	30.3	38.6	19.3	25.2	23.8	38.6	26.7	39.7	30.1	14.9	27.2	41.2	24.4	29.1	26.6	29.5	52.8	27.0	44.6	24.8	48.6	33.0	10.1	42.4	21.1	24.0	23.5	54.4	35.4	21.6	24.9	56.5	35.0	33.5	32.0	34.5	44.1	29.9	22.9	20.8	27.1	23.5	30.2	38.5	33.7	25.9	34.3	27.0	32.8	28.1	30.4	34.6	22.8	46.3	58.3	22.5	39.1	24.0	41.2	25.1	38.2	22.5	22.1	22.1	25.3	19.8	20.7	22.4	27.6	18.9	18.0	88.9	24.2	19.4	32.5	22.1	16.8	37.5	41.4	57.5	41.8	35.8	29.9	41.1	31.4	37.4	46.4
RBM45	"DRB1, FLJ44612"	ENSG00000155636	"RNA binding motif protein 45"	Q8IUH3	2	178112424-178139011	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020448	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA020448: AB_1856133"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavourable (5.74e-9)"	"unprognostic (1.66e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (5.34e-9)"	"unprognostic (3.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.94e-1)"	9.5	13.7	15.7	12.4	18.1	7.3	17.3	15.3	15.4	12.2	16.2	10.4	19.7	11.8	13.9	19.3	12.3	14.7	10.3	10.5	14.8	13.1	13.4	15.6	11.0	14.4	15.2	16.2	12.2	16.1	16.2	24.0	6.9	14.6	12.1	19.1	11.1	17.0	14.1	11.2	16.1	13.2	12.0	11.9	16.5	12.4	13.4	16.3	21.6	14.0	7.0	18.7	11.1	10.2	10.8	8.1	4.4	9.5	11.8	11.5	5.6	8.9	9.6	15.2	6.3	13.7	15.4	9.1	11.8	13.7	12.2	13.6	10.0	7.4	14.9	8.2	14.0	8.0	12.6	16.0	15.6	11.7	10.7	11.6	6.9	14.5	14.0	13.9	11.1	12.2	13.6	12.9	10.8	13.2	10.5	12.4	16.3	14.2	14.0	9.4	10.8	12.0	10.9	10.9	14.8	18.1	20.6	9.4	10.0	8.8	8.7	11.2	12.4	13.0	11.3	9.2	8.6	10.5	11.6	11.7	13.1	18.5	8.9	11.0	12.4	4.4	5.6	1.8	6.9	8.5	8.4	10.8	7.5	7.5	7.5	8.4	6.7	8.2	1.2	11.8	9.5	8.1	11.5	5.6	15.7	18.1	15.3	15.4	14.8	13.1	15.2	16.2	14.6	16.3
RBM6	"3G2, DEF-3, DEF3, g16, NY-LU-12"	ENSG00000004534	"RNA binding motif protein 6"	P78332	3	49940007-50100045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026272, HPA027164"	Enhanced		Approved	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA026272: AB_1847592, HPA027164: AB_1847593"	"unprognostic (3.81e-3)"	"unprognostic (2.13e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.40e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.40e-2)"	"unprognostic (7.97e-3)"	"unprognostic (8.84e-3)"	"unprognostic (5.09e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (4.31e-2)"	"prognostic unfavourable (8.83e-4)"	"unprognostic (7.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (5.13e-5)"	24.4	30.2	30.2	51.3	37.1	30.0	25.1	49.4	41.1	31.2	31.0	28.9	38.5	30.3	51.4	34.3	21.8	28.8	32.6	25.3	32.1	19.8	29.2	30.6	26.8	39.8	38.1	26.0	42.6	35.9	41.9	36.9	21.9	30.5	40.1	29.8	25.6	28.1	38.3	25.3	35.9	32.4	36.7	40.9	42.6	28.0	29.7	38.0	24.9	32.6	21.9	35.9	25.1	36.6	12.8	9.9	14.7	8.6	7.3	15.6	5.9	9.6	6.1	25.1	16.7	25.7	14.1	8.9	16.3	14.2	14.4	15.2	10.6	10.9	49.5	9.6	16.2	8.0	21.4	14.4	18.3	19.8	8.0	22.9	14.1	13.7	14.6	24.1	23.8	13.1	17.8	16.3	18.4	18.1	18.8	12.5	13.7	9.1	22.6	35.8	20.1	11.2	8.7	10.8	12.6	14.3	18.8	9.9	17.9	14.9	10.8	10.2	8.4	19.0	16.8	14.4	17.2	11.7	16.5	17.2	40.7	29.8	8.3	20.2	14.1	14.7	8.6	5.0	15.6	4.7	12.1	12.8	10.2	8.5	8.8	11.9	10.5	11.5	6.1	7.3	7.7	9.9	6.7	5.9	30.2	37.1	49.4	41.1	32.1	19.8	38.1	26.0	30.5	38.0
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.2	42.0	38.4	30.5	13.8	13.6	47.2	31.4	21.3	45.2	33.3	55.4	39.0	47.1	49.7	21.6	35.3	40.8	34.3	37.2	41.7	38.9	36.3	31.8	40.9	19.6	60.5	31.9	14.9	25.9	40.4	43.4	33.5	54.5	44.7	34.7	141.6	60.8	48.0	65.9	73.3	54.0	33.5	46.8	28.9	49.5	39.4	48.3	46.8	24.1	42.6	45.1	73.7	34.5	36.5	46.6	35.8	85.8	50.5	79.6	69.1	32.7	36.5	31.4	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9										
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521929-56596196	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: AB_10963056, HPA058784: "	"unprognostic (1.35e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.09e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.15e-1)"	"prognostic favourable (3.22e-4)"	"unprognostic (2.67e-2)"	"unprognostic (4.73e-2)"	"unprognostic (4.06e-3)"	"unprognostic (2.63e-2)"	24.5	7.2	5.7	5.8	10.0	3.6	31.3	8.5	8.7	12.2	9.9	6.0	6.1	4.7	17.5	11.9	9.3	10.4	10.4	19.3	8.6	5.1	12.4	4.4	53.1	8.0	7.5	5.2	12.6	7.5	11.5	12.1	24.8	11.4	9.6	9.6	14.3	10.3	9.8	9.3	7.5	7.5	12.9	19.2	13.2	8.0	4.8	7.4	2.7	16.5	8.1	5.3	11.7	19.2	1.1	4.9	3.0	8.3	2.1	2.3	1.5	11.5	9.7	4.2	6.1	10.2	9.9	4.2	14.7	15.2	11.3	10.0	7.6	20.6	0.2	17.6	14.9	8.4	3.8	23.4	12.7	3.8	3.1	1.4	7.5	2.3	6.6	1.6	2.7	8.8	5.9	11.8	13.9	20.8	0.7	2.8	19.2	1.5	1.6	1.9	2.5	3.6	0.9	4.6	0.2	14.0	2.8	0.4	3.2	17.1	6.2	2.1	6.6	3.1	31.8	7.1	15.1	3.9	3.4	2.5	1.1	0.8	2.5	0.4	9.8	1.0	8.3	2.6	1.6	2.6	1.7	0.6	0.7	2.3	4.9	1.1	1.8	1.2	3.0	2.1	0.6	1.3	0.9	1.5	5.7	10.0	8.5	8.7	8.6	5.1	7.5	5.2	11.4	7.4
RBMX	"hnRNP-G, HNRNPG, RNMX"	ENSG00000147274	"RNA binding motif protein, X-linked"	P38159	X	136848004-136880764	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057707	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA057707: "	"unprognostic (1.53e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (5.59e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.64e-3)"	31.0	25.0	30.6	57.1	41.1	48.0	40.6	28.7	33.0	44.2	28.3	32.5	32.7	24.6	45.9	31.7	26.7	38.9	22.1	31.4	26.5	18.0	25.6	20.9	34.4	64.6	34.0	29.3	81.9	39.1	30.1	30.1	25.3	30.5	28.4	33.4	27.5	29.9	29.4	50.0	27.6	27.3	43.0	44.2	27.4	30.1	23.6	29.2	70.1	31.5	34.4	44.8	36.1	33.4	47.1	41.9	25.0	44.9	39.4	60.7	62.9	39.9	43.7	80.1	35.6	20.0	34.0	46.8	39.9	43.5	55.3	58.7	46.6	40.2	72.8	41.3	28.5	26.8	85.0	41.7	64.1	31.4	40.0	55.7	43.0	49.6	17.6	60.7	51.3	27.8	20.2	43.0	60.3	44.5	49.9	37.4	44.9	50.9	88.6	41.0	50.8	36.6	73.7	53.6	44.9	41.0	47.9	46.8	50.6	31.8	28.8	36.9	33.1	41.0	28.2	31.4	34.1	21.7	50.7	26.8	35.7	77.1	22.4	44.4	42.7	25.0	37.5	20.8	36.4	44.9	50.3	47.1	47.4	43.1	41.9	45.0	60.7	49.6	6.0	39.4	39.2	25.4	46.8	62.9	30.6	41.1	28.7	33.0	26.5	18.0	34.0	29.3	30.5	29.2
RBP4		ENSG00000138207	"Retinol binding protein 4"	P02753	10	93591687-93601744	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 897.1"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 151.8"	"Cancer enriched"	"Detected in all"	27	"liver cancer: 3135.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	14	"classical monocyte: 1.2;myeloid DC: 1.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.5;monocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001641, CAB004555"	Supported				"Secreted to blood"	46066666667	420000000000			"CAB004555: AB_670938, HPA001641: AB_1079795"	"unprognostic (9.42e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.69e-4)"	"prognostic favourable (1.74e-8)"	"unprognostic (2.39e-1)"	"unprognostic (5.76e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (7.14e-3)"	"unprognostic (9.88e-3)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.60e-2)"	39.0	2.0	1.4	2.4	3.1	0.3	27.0	0.0	2.1	0.3	1.8	0.0	0.1	0.5	0.4	0.4	0.3	0.4	2.1	1.2	1.4	2.2	7.9	897.1	1.5	1.0	0.2	1.1	0.5	4.7	0.3	28.3	1.8	0.4	0.9	0.6	5.6	1.8	0.5	0.4	0.4	0.6	0.3	0.1	0.3	0.7	0.4	0.0	0.0	0.3	0.5	0.2	0.6	1.6	0.0	1.5	0.0	1.2	0.0	0.0	0.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	36.6	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	151.8	0.0	1.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.2	17.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	3.1	0.0	2.1	1.4	2.2	0.2	1.1	0.4	0.0
RBP5	CRBPIII	ENSG00000139194	"Retinol binding protein 5"	P82980	12	7123684-7128942	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 99.9;liver: 74.2;lymphoid tissue: 54.3"	"Cell line enhanced"	"Detected in many"		"HEL: 6.8;Hep G2: 15.2;K-562: 31.3"	"Group enriched"	"Detected in all"	8	"liver cancer: 70.1;renal cancer: 126.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.5;T-reg: 2.4"	"Group enriched"	"Detected in many"	12	"granulocytes: 1.3;T-cells: 2.4"					"Low region specificity"	"Detected in all"			HPA038723	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA038723: "	"unprognostic (5.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (8.37e-4)"	"unprognostic (1.04e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.22e-1)"	"prognostic favourable (3.68e-4)"	1.5	2.6	0.3	18.2	0.3	0.7	1.3	0.6	0.3	2.8	1.7	0.1	2.3	1.4	5.3	13.3	2.3	1.5	3.6	2.3	0.3	0.3	99.9	74.2	3.6	54.3	0.2	0.0	3.5	1.3	0.2	1.6	0.1	0.1	2.6	1.6	0.7	5.9	3.3	0.4	0.7	4.4	1.8	0.2	44.3	1.2	1.2	0.0	6.2	2.0	0.7	10.1	2.3	1.4	0.1	0.0	1.3	0.0	0.0	2.4	0.1	1.8	3.1	0.0	1.0	0.0	0.0	0.7	1.1	0.0	0.0	0.2	1.7	1.9	1.1	0.5	0.0	2.2	0.1	0.0	0.0	2.7	0.0	6.8	4.9	15.2	0.0	0.4	2.0	0.3	0.1	0.0	0.0	0.0	31.3	1.4	0.0	0.0	0.1	0.4	0.4	0.1	0.4	0.0	0.1	0.1	2.6	0.1	0.3	2.7	1.1	0.0	0.6	1.1	1.1	1.3	1.3	3.7	0.5	0.6	0.2	0.2	0.9	1.4	0.2	1.3	0.0	0.0	0.4	0.0	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	2.4	0.1	0.3	0.3	0.6	0.3	0.3	0.3	0.2	0.0	0.1	0.0
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm				Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	24.1	27.9	41.6	22.2	35.3	37.6	32.9	28.0	35.7	23.0	22.7	27.4	15.8	18.4	19.4	43.7	27.6	21.2	16.6	39.2	38.3	37.4	34.2	28.3	23.6	28.1	40.4	22.3	18.5	15.6	12.3	19.5	54.1	32.4	20.3	23.9	22.1	21.3	20.8	46.5	21.8	23.0	23.2	45.2	26.4	21.4	16.4	24.8	31.7	31.1	37.4	34.4	19.5	19.4	33.4	60.7	32.2	41.5	23.9	38.5	62.6	33.1	19.0	35.9	17.8	25.5	30.5	20.2	26.7	24.6	40.3	35.7	30.7	16.0	29.1	18.1	26.2	19.0	34.0	30.6	42.7	33.8	54.2	18.0	27.8	37.4	21.9	43.9	23.4	25.2	24.8	29.1	21.1	34.1	21.2	29.6	35.5	40.6	26.4	50.7	19.7	20.0	34.7	24.9	36.6	46.0	21.5	16.9	11.0	23.5	23.6	23.9	20.3	30.3	22.6	24.6	25.4	20.6	25.4	25.2	23.1	43.1	30.8	22.4	27.3	32.2	37.2	29.9	24.7	37.0	23.1	33.4	30.9	26.0	37.6	29.4	27.0	29.2	12.6	23.9	41.5	60.7	38.5	62.6	41.6	35.3	28.0	35.7	38.3	37.4	40.4	22.3	32.4	24.8
RCC1	CHC1	ENSG00000180198	"Regulator of chromosome condensation 1"	P18754	1	28505943-28539300	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"DNA-binding, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015413, HPA027573, HPA027574"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	"Nuclear membrane"	"CAB015413: AB_831160, HPA027573: AB_10599303, HPA027574: AB_10601236"	"unprognostic (6.23e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.91e-5)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.79e-3)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (2.43e-11)"	"unprognostic (1.04e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.02e-1)"	"unprognostic (6.23e-2)"	12.3	11.2	7.5	21.1	10.9	32.0	13.9	5.8	10.4	11.6	17.9	5.0	8.0	17.5	12.1	10.1	30.1	12.6	8.6	6.9	8.0	4.6	9.5	23.0	15.3	22.7	14.8	4.0	16.3	21.0	4.7	12.4	17.0	9.8	10.2	19.0	6.0	20.6	7.8	13.6	11.7	14.7	12.7	17.7	23.0	11.8	46.7	10.2	34.2	47.9	28.4	34.2	16.4	16.7	8.4	16.0	4.6	8.7	6.2	11.5	6.9	47.7	20.7	18.0	21.3	12.9	16.7	20.2	18.7	11.4	30.5	23.9	20.6	38.5	61.4	11.5	18.0	28.8	58.7	29.8	24.0	24.8	35.0	54.2	25.3	27.0	9.7	59.0	32.5	21.1	19.9	29.4	24.2	20.8	40.4	19.0	12.3	25.9	47.0	21.4	38.7	20.3	46.7	31.8	29.9	11.3	22.4	29.0	14.8	20.3	32.3	15.6	13.6	18.5	15.9	15.7	31.1	19.2	36.4	11.5	16.3	46.9	15.3	87.3	16.9	4.6	8.7	3.2	6.2	8.7	11.5	8.4	9.2	9.6	16.0	7.7	8.3	9.1	1.9	6.2	6.2	9.1	8.4	6.9	7.5	10.9	5.8	10.4	8.0	4.6	14.8	4.0	9.8	10.2
RCL1	"RNAC, RPCL1"	ENSG00000120158	"RNA terminal phosphate cyclase like 1"	Q9Y2P8	9	4792869-4885917	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"liver: 108.1;pancreas: 37.5"	"Group enriched"	"Detected in all"	4	"HDLM-2: 34.3;HEL: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071308			Approved	Nucleoplasm				Nucleoplasm		"HPA071308: "	"prognostic favourable (5.48e-4)"	"unprognostic (7.60e-3)"	"unprognostic (7.55e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (8.02e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.59e-2)"	"prognostic favourable (2.40e-7)"	"unprognostic (1.01e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.66e-2)"	15.9	6.8	4.2	6.7	5.9	17.2	12.9	5.5	6.3	5.6	3.8	6.2	6.3	2.4	5.5	5.4	5.5	5.6	3.8	3.7	4.1	3.6	5.7	108.1	6.9	9.1	5.8	4.2	9.0	37.5	3.8	5.1	6.8	5.6	3.6	4.2	4.5	4.8	9.1	10.9	10.5	4.1	5.2	7.1	5.0	5.2	6.8	5.6	5.7	4.5	8.1	7.2	5.3	6.8	10.4	6.8	12.9	2.3	10.8	9.1	3.5	5.5	6.6	2.5	4.0	3.8	2.5	6.7	2.6	2.8	4.9	4.1	3.3	3.3	10.6	1.8	2.3	3.5	11.6	7.8	5.7	34.3	5.9	88.1	7.9	6.6	5.4	7.9	7.2	5.7	4.5	4.7	7.2	4.8	8.9	6.9	2.9	7.1	6.4	13.7	8.7	2.7	8.0	3.3	5.6	6.0	6.2	7.3	6.0	3.3	4.8	3.8	4.6	9.3	3.3	2.9	3.2	4.0	8.0	2.8	8.0	11.5	5.3	4.9	1.9	12.9	1.5	3.8	5.6	2.3	6.8	8.0	6.6	7.6	4.0	10.4	8.9	9.1	0.6	10.8	1.2	6.8	5.5	3.5	4.2	5.9	5.5	6.3	4.1	3.6	5.8	4.2	5.6	5.6
RCN3	RLP49	ENSG00000142552	"Reticulocalbin 3"	Q96D15	19	49527618-49546962	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.2;ASC TERT1: 36.1;BJ: 57.0;BJ hTERT+ SV40 Large T+ RasG12V: 33.0;fHDF/TERT166: 49.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 9.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA043134, HPA050402"	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"			"Endoplasmic reticulum, Vesicles"		"HPA043134: , HPA050402: "	"unprognostic (7.10e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.77e-3)"	"unprognostic (8.87e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.47e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.86e-2)"	"prognostic unfavourable (5.80e-12)"	"unprognostic (5.26e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.20e-3)"	19.6	10.9	3.7	18.2	5.3	3.2	15.6	7.2	6.6	36.3	10.7	2.0	9.6	22.2	28.2	33.9	11.4	10.7	26.2	18.2	3.4	3.5	12.6	18.6	12.6	4.4	3.3	2.8	29.5	5.1	2.1	9.0	18.0	6.0	19.4	7.0	10.7	6.2	8.2	10.6	8.2	23.7	16.8	2.9	21.3	7.8	17.3	4.2	1.8	9.9	9.8	7.9	21.5	21.6	0.6	0.5	3.9	0.4	2.3	9.7	1.6	0.5	0.8	0.5	30.3	52.2	36.1	0.3	57.0	14.8	21.5	33.0	0.7	0.2	0.2	3.4	49.8	0.0	1.4	0.1	10.3	0.0	0.4	3.2	0.2	1.6	18.3	0.0	7.5	20.3	0.0	15.0	0.0	8.2	1.4	0.1	17.5	0.6	0.0	0.3	0.2	3.9	0.1	0.7	0.9	0.2	0.0	0.3	1.9	0.0	0.2	0.0	0.2	2.0	19.2	0.3	9.6	24.9	0.0	2.8	8.3	0.5	1.4	1.8	2.4	0.0	0.3	2.2	0.9	0.0	1.0	0.6	2.5	0.9	0.5	0.4	9.7	3.2	3.9	2.3	0.4	0.4	1.9	1.6	3.7	5.3	7.2	6.6	3.4	3.5	3.3	2.8	6.0	4.2
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905621	"Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"retina: 208.6"	"Cell line enriched"	"Detected in some"	6	"WM-115: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015783, CAB022363"	Enhanced									"CAB022363: , HPA015783: "	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	1.4	0.0	1.1	0.8	1.4	0.9	0.2	1.5	2.7	0.5	0.3	0.2	0.1	0.7	0.5	0.2	0.1	0.3	0.5	0.8	1.0	0.7	0.1	0.1	0.4	0.2	0.3	0.1	0.3	0.1	0.0	0.1	0.1	0.7	0.1	0.1	208.6	0.1	0.3	0.1	0.7	0.4	0.6	0.2	0.8	0.6	0.3	0.1	0.2	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.4	1.5	2.7	1.0	0.7	0.3	0.1	0.7	0.1
RDH12	"FLJ30273, LCA13, RP53, SDR7C2"	ENSG00000139988	"Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)"	Q96NR8	14	67701886-67734452	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	Oxidoreductase	"Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 29.3"	"Cell line enhanced"	"Detected in some"		"K-562: 2.0;SK-MEL-30: 2.4;U-266/70: 1.7"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"						"unprognostic (4.25e-3)"	"unprognostic (4.50e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.72e-3)"	"unprognostic (7.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.42e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.92e-1)"	0.0	1.9	0.0	0.0	0.5	0.0	1.2	0.3	0.5	4.9	0.0			0.0	0.0	5.3	9.9	0.1	10.6	0.0	0.1	0.3	7.7	1.9	0.0	0.0	1.3		0.0	1.7	0.0	0.1	0.0		0.0	0.0		0.6	0.0	0.0	29.3	0.0	0.0	0.0	0.0	6.9	0.0			0.4		0.6	0.0	9.7	0.2	0.6	0.0	0.9	0.5	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.3	1.6	0.0	0.7	0.2	0.6	0.0	0.0	0.6	0.4	0.0	1.0	0.2	0.0	0.2	0.0	1.1	0.1	0.2	0.7	2.0	0.7	0.1	0.7	0.1	0.2	0.1	0.2	0.2	0.0	0.1	0.0	0.4	1.3	0.0	0.0	1.1	2.4	0.8	0.1	0.0	0.3	1.4	0.4	0.0	1.7	0.7	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.1	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.6	0.6	0.1										
REC8	"kleisin-alpha, REC8L1, Rec8p"	ENSG00000100918	"REC8 meiotic recombination protein"	O95072	14	24171853-24180257	"Plasma proteins, Predicted intracellular proteins"	"Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 30.4"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031727, HPA031729"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA031727: AB_10602920, HPA031729: AB_10669915"	"prognostic favourable (2.19e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (5.57e-4)"	"unprognostic (1.16e-1)"	"prognostic unfavourable (1.41e-7)"	"unprognostic (8.98e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.88e-2)"	"unprognostic (6.40e-3)"	2.8	4.6	3.1	2.9	4.6	8.2	1.5	20.3	6.1	3.0	2.7	5.2	9.9	2.0	3.3	3.0	1.5	17.4	30.4	1.6	3.8	3.8	6.3	1.7	3.6	4.0	3.8	5.4	2.2	1.7	0.9	21.4	1.0	10.8	3.2	0.9	8.0	2.1	10.3	1.3	1.4	2.2	3.7	5.1	4.2	8.5	13.3	3.4	22.3	2.0	0.0	4.4	1.7	1.7	2.1	6.2	10.7	6.3	3.3	6.9	1.3	0.0	0.1	7.0	0.0	0.2	0.3	0.4	0.3	0.3	0.6	0.5	0.1	0.7	0.1	0.0	0.0	0.3	0.2	0.0	0.4	0.6	0.1	0.2	0.3	0.0	5.9	0.1	0.9	3.2	0.3	0.2	0.0	1.2	0.0	1.0	0.0	0.1	7.1	1.1	2.2	0.1	0.1	0.0	0.0	0.2	0.2	0.1	31.4	0.0	0.0	0.2	0.1	0.3	0.2	0.0	0.1	0.2	0.1	1.1	0.3	0.1	0.0	0.1	0.1	2.6	0.1	10.7	6.1	1.2	6.9	2.1	2.2	3.3	3.8	1.6	1.0	3.1	0.1	3.3	6.3	6.2	3.5	1.3	3.1	4.6	20.3	6.1	3.8	3.8	3.8	5.4	10.8	3.4
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036433-36124451	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 54.0;ASC TERT1: 43.3;BJ: 16.8;BJ hTERT+: 24.2;HSkMC: 19.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"			37000000	"Plasma membrane"		"CAB025109: , HPA071729: "	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavourable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	15.9	8.9	6.9	6.3	8.2	1.5	31.7	9.1	7.8	18.9	10.2	8.5	6.2	4.3	18.4	7.5	13.7	12.0	15.6	11.3	8.4	4.9	6.9	6.7	16.7	6.1	8.3	4.9	17.2	3.9	3.7	7.8	12.7	8.3	12.3	7.6	10.5	7.8	8.9	5.7	8.7	7.7	17.3	7.9	8.1	9.8	7.9	8.5	8.4	10.5	9.8	6.2	17.8	16.8	3.5	3.7	1.2	5.5	3.6	8.9	3.1	0.3	0.6	2.1	1.1	54.0	43.3	0.0	16.8	24.2	1.2	2.9	0.0	0.0	0.6	1.6	14.8	0.1	0.4	0.3	1.7	1.0	0.9	0.6	0.7	0.0	4.3	0.0	2.9	19.3	0.4	1.8	0.7	3.8	0.0	0.5	3.1	0.0	1.6	0.2	0.7	0.5	1.7	1.6	0.0	0.8	0.0	0.2	1.1	0.3	0.2	0.6	0.0	2.2	11.4	2.3	0.8	1.5	0.9	0.7	0.8	0.7	1.4	2.2	1.5	1.2	3.3	0.9	5.4	3.5	6.1	1.7	7.1	5.7	3.7	3.5	8.9	6.4	0.5	3.6	5.5	2.1	3.2	3.1	6.9	8.2	9.1	7.8	8.4	4.9	8.3	4.9	8.3	8.5
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468911-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: "	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	32.7	15.8	10.0	22.0	12.7	10.8	18.2	10.9	11.2	18.0	16.3	9.4	11.0	7.5	19.8	14.4	18.7	14.6	14.1	17.9	11.2	7.2	19.6	18.0	19.5	25.7	15.3	7.6	16.0	11.9	8.0	14.8	17.1	12.0	14.0	12.7	6.7	13.1	12.4	15.0	12.4	15.5	20.5	19.5	34.0	12.9	10.8	13.0	27.4	17.4	14.3	25.0	22.6	13.0	19.3	15.2	11.3	20.7	23.1	28.0	13.8	17.5	17.8	13.5	10.0	27.4	34.5	15.7	34.0	28.7	21.9	25.6	19.5	14.7	21.1	13.1	23.1	12.9	14.4	16.9	31.3	35.3	9.6	25.7	19.8	8.2	10.6	17.8	19.5	19.2	8.7	31.1	22.9	24.6	9.0	10.3	28.8	8.5	19.5	20.8	22.5	12.1	16.1	54.9	16.3	8.4	12.1	3.6	10.8	25.3	6.8	17.8	17.3	11.4	33.1	30.9	20.1	27.0	31.5	4.2	12.4	46.3	26.1	10.5	22.7	9.3	11.8	11.3	21.9	20.7	21.3	19.3	20.5	21.0	15.2	16.0	13.6	18.8	5.5	23.1	18.8	11.6	28.0	13.8	10.0	12.7	10.9	11.2	11.2	7.2	15.3	7.6	12.0	13.0
RECQL5	"FLJ90603, RecQ5"	ENSG00000108469	"RecQ like helicase 5"	O94762	17	75626845-75667189	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, DNA replication"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029971			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA029971: AB_10611389"	"unprognostic (2.19e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (1.73e-6)"	"unprognostic (8.39e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.57e-3)"	"unprognostic (5.83e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.84e-2)"	"prognostic favourable (4.34e-4)"	"unprognostic (4.07e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.81e-2)"	7.4	12.9	12.6	11.7	16.0	10.0	9.8	11.4	17.7	9.4	10.6	24.4	17.4	22.9	10.5	13.2	20.4	11.8	12.4	6.7	12.9	8.6	14.9	15.8	8.4	16.8	14.5	11.0	14.3	10.8	17.6	21.9	32.3	14.3	12.2	9.8	13.2	15.6	14.0	6.8	21.1	23.2	9.6	13.2	16.6	23.8	21.0	17.0	12.1	21.4	6.2	16.0	12.1	12.8	5.2	16.4	6.0	3.9	3.8	4.2	3.2	11.0	20.5	8.3	11.7	11.6	7.8	19.1	8.2	6.9	10.7	9.5	9.0	11.8	13.1	8.9	7.2	10.5	8.6	9.8	10.2	7.0	16.1	23.9	24.8	13.0	11.6	7.7	11.9	11.0	12.1	10.6	12.8	13.9	12.0	11.7	7.9	9.8	15.8	10.5	5.4	15.9	12.8	19.4	13.2	9.0	13.2	10.0	9.7	8.9	16.1	11.0	28.9	6.2	7.0	13.8	15.9	7.5	8.4	16.7	9.5	12.6	11.3	7.7	9.9	6.0	3.1	4.4	4.2	3.9	2.7	3.6	2.7	3.1	3.8	5.2	4.1	2.9	2.1	3.8	1.9	16.4	2.2	3.2	12.6	16.0	11.4	17.7	12.9	8.6	14.5	11.0	14.3	17.0
REG1A	"PSP, PSPS, PSPS1, PTP, REG"	ENSG00000115386	"Regenerating family member 1 alpha"	P05451	2	79120362-79123419	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"pancreas: 1772.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.8;EFO-21: 11.7;HDLM-2: 9.3;NB-4: 6.7;RPMI-8226: 18.9;SH-SY5Y: 8.1;U-2 OS: 18.9;U-251 MG: 6.3;U-266/84: 6.3"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 313.8;pancreatic cancer: 1268.4;stomach cancer: 521.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB025138, HPA045549, HPA045579"	Enhanced				"Secreted to digestive system"		61000000			"CAB025138: , HPA045549: , HPA045579: "			"unprognostic (1.89e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.39e-1)"		"unprognostic (1.45e-1)"	"unprognostic (2.10e-1)"		"unprognostic (1.63e-1)"	"unprognostic (5.52e-2)"		"unprognostic (3.54e-3)"	"unprognostic (5.53e-2)"	"unprognostic (5.54e-2)"			0.3	0.1	0.3	2.8	0.4	0.0	0.3	0.3	0.3	0.3	37.9	0.3	0.3	129.0	0.3	0.3	0.3	0.1	1.3	0.3	0.3	0.0	14.6	0.3	0.3	0.3	0.3	0.3	0.3	1772.6	0.0	0.3	0.3	0.3	0.3	4.5	0.3	0.3	0.4	0.3	0.1	74.7	2.5	0.3	0.3	15.9	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.3	0.0	0.0	0.0	18.9	0.0	0.0	0.9	8.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.9	1.3	6.3	0.0	6.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;EFO-21: 11.5;HDLM-2: 10.6;NB-4: 11.9;RPMI-8226: 15.3;SH-SY5Y: 10.0;U-2 OS: 19.0;U-266/84: 10.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"		22000000	Cytosol		"HPA047894: , HPA048334: , HPA060705: "			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	15.3	0.0	0.0	1.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	3.7	7.1	0.0	10.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
RELB	REL-B	ENSG00000104856	"RELB proto-oncogene, NF-kB subunit"	Q01201	19	45001430-45038198	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.0;HDLM-2: 31.8;U-698: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007753, HPA040506"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB007753: AB_562340, HPA040506: "	"prognostic favourable (1.55e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.02e-3)"	"unprognostic (6.01e-2)"	"unprognostic (6.48e-2)"	"prognostic unfavourable (2.99e-6)"	"unprognostic (2.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.20e-2)"	8.0	6.8	2.2	27.6	3.6	27.8	6.8	1.2	3.1	4.9	12.2	2.1	1.6	8.8	8.5	4.7	6.4	5.2	10.9	11.9	1.8	1.6	10.1	7.4	12.8	18.2	3.6	0.9	7.8	12.3	1.9	2.1	4.7	2.8	9.9	3.4	3.6	7.3	4.8	8.1	8.3	13.0	8.4	3.9	17.2	8.3	3.7	1.7	17.7	5.6	7.2	24.8	8.8	6.1	8.2	3.9	14.5	5.0	2.1	2.2	1.7	8.7	5.3	0.5	2.3	1.1	3.9	1.8	1.6	11.4	2.5	4.0	1.8	9.7	25.0	4.6	2.6	4.0	0.2	3.6	2.1	31.8	0.8	0.9	0.3	1.0	10.2	1.9	14.9	6.4	1.5	5.1	6.0	1.6	0.2	16.3	0.9	2.1	0.4	5.9	0.8	0.9	1.9	1.3	3.0	4.1	13.6	0.0	0.8	1.6	4.7	4.5	1.6	4.8	5.1	6.0	3.0	2.2	5.8	20.6	12.1	26.8	6.6	0.7	3.3	0.0	5.0	2.1	1.4	3.2	2.1	8.2	2.2	2.0	3.6	7.9	1.8	0.9	14.5	2.1	2.6	3.9	1.1	1.7	2.2	3.6	1.2	3.1	1.8	1.6	3.6	0.9	2.8	1.7
RELN	"PRO1598, RL"	ENSG00000189056	Reelin	P78509	7	103471784-103989516	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"	"Developmental protein, Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 73.4;liver: 35.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 33.6;PC-3: 6.8;SCLC-21H: 8.2;SH-SY5Y: 8.9;TIME: 19.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Region enriched"	"Detected in many"	11	"cerebellum: 73.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046512			Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to extracellular matrix"		59000000	"Focal adhesion sites"	"Plasma membrane"	"HPA046512: "	"unprognostic (1.42e-1)"	"unprognostic (2.93e-3)"	"unprognostic (4.31e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.30e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.06e-2)"	2.7	5.9	5.7	1.2	5.3	0.5	6.3	73.4	6.7	2.9	2.1	0.8	0.0	1.1	1.0	3.0	1.7	4.4	1.9	3.2	5.7	5.3	1.2	35.8	1.6	7.9	1.8	2.5	1.3	1.0	0.3	0.8	0.4	5.1	1.2	2.1	10.6	1.1	2.1	0.4	1.1	1.9	2.4	3.2	1.1	0.8	1.5	0.0	0.0	2.6	1.7	0.9	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	1.2	0.0	0.1	0.0	0.0	2.4	0.0	33.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	0.0	8.2	8.9	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	5.3	73.4	6.7	5.7	5.3	1.8	2.5	5.1	0.0
REST	"NRSF, XBR"	ENSG00000084093	"RE1 silencing transcription factor"	Q13127	4	56907876-56966678	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006079, CAB068222"	Supported		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB068222: , HPA006079: AB_1079801"	"unprognostic (7.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (9.50e-5)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.79e-2)"	14.4	11.4	6.0	15.6	8.9	21.5	39.7	2.1	6.3	13.7	11.0	5.6	13.0	6.5	14.2	13.7	14.5	11.2	13.8	22.1	6.1	4.5	13.9	12.0	18.2	35.6	8.2	3.0	13.9	15.9	22.4	4.5	14.4	11.8	17.3	7.6	7.2	14.0	27.6	13.8	11.6	12.0	16.3	15.2	18.7	10.4	15.3	8.2	43.4	13.4	8.3	14.0	15.6	19.5	16.7	10.7	9.0	8.4	16.7	15.3	4.2	7.0	9.0	12.5	12.4	9.4	11.9	15.8	10.5	9.4	11.3	10.3	8.9	10.9	16.9	16.9	11.4	6.5	9.2	11.1	17.8	8.9	5.5	15.4	7.1	7.9	11.5	19.4	9.2	11.7	10.0	10.8	11.2	13.9	9.8	18.2	13.0	11.2	22.3	13.2	10.6	5.9	19.8	10.7	5.2	12.8	12.8	0.2	5.7	12.7	12.4	9.4	13.2	12.7	19.6	14.4	12.8	8.0	9.4	7.3	5.4	10.2	9.2	11.0	7.4	9.0	3.6	7.7	10.6	5.3	8.9	12.0	10.5	10.4	8.1	16.7	15.3	9.3	3.7	16.7	8.4	10.7	10.3	4.2	6.0	8.9	2.1	6.3	6.1	4.5	8.2	3.0	11.8	8.2
RET	"CDHF12, CDHR16, HSCR1, MEN2A, MEN2B, MTC1, PTC, RET51"	ENSG00000165731	"Ret proto-oncogene"	P07949	10	43077027-43130351	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Hirschsprung disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 63.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 17.6;NB-4: 11.6;SH-SY5Y: 89.7;THP-1: 26.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 11.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.1;monocytes: 6.7"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"midbrain: 95.5"	"CAB002581, HPA008356, HPA008495"	Approved	Supported	Approved	"Golgi apparatus,Plasma membrane,Cytosol"			260000	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB002581: AB_563673, HPA008356: AB_1847232, HPA008495: "	"unprognostic (7.94e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.49e-1)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (9.13e-4)"	"unprognostic (1.27e-2)"	"unprognostic (3.62e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (4.43e-1)"	"unprognostic (9.35e-5)"	"unprognostic (1.64e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.02e-2)"	1.8	15.2	1.1	1.8	1.3	0.7	1.2	4.1	9.0	1.9	3.1	0.9	1.1	1.5	0.9	0.6	1.2	0.7	1.0	1.2	1.5	5.8	1.0	11.7	0.7	0.8	17.5	1.2	0.8	1.3	63.9	6.3	0.8	16.8	2.2	1.5	2.8	13.6	2.0	4.5	1.1	2.6	1.1	2.8	0.6	2.1	2.0	0.0	0.1	0.8	5.1	0.6	1.9	1.4	0.2	2.1	0.0	6.7	0.0	0.3	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	11.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	89.7	0.0	0.0	0.0	1.2	26.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.7	2.1	0.3	0.4	1.1	1.3	4.1	9.0	1.5	5.8	17.5	1.2	16.8	0.0
RETN	"ADSF, FIZZ3, RETN1"	ENSG00000104918	Resistin	Q9HD89	19	7669044-7670454	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.5;bone marrow: 79.5;lymphoid tissue: 27.6"	"Group enriched"	"Detected in some"	11	"NB-4: 100.1;U-937: 46.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 4.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 45.5;myeloid DC: 30.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 30.3;monocytes: 45.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"	6440000	350000				"unprognostic (5.61e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (5.19e-4)"	"unprognostic (1.53e-4)"	"unprognostic (7.34e-2)"	"unprognostic (3.35e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.16e-5)"	"unprognostic (4.23e-2)"	"unprognostic (2.26e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.20e-1)"	1.3	0.4	0.0	1.9	0.6	79.5	0.6	0.4	0.9	0.1	0.2	0.1	0.7	2.3	0.3	0.1	0.2	1.3	0.2	21.9	0.0	0.0	0.9	1.6	17.3	7.5	1.3	0.0	0.8	1.6	0.1	0.4	1.1	0.2	0.2	0.1	0.7	0.7	0.1	0.6	0.2	0.3	1.5	0.4	27.6	0.4	0.4	0.5	2.7	0.8	0.0	0.4	0.2	2.3	0.0	30.3	3.4	45.5	0.0	2.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	100.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	45.5	0.0	0.1	21.7	0.3	0.0	0.5	0.4	30.3	0.0	1.1	2.4	3.4	0.0	11.1	1.2	0.0	14.0	0.0	0.6	0.4	0.9	0.0	0.0	1.3	0.0	0.2	0.5
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.4;ASC TERT1: 30.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA064853: , HPA069382: "	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	21.0	7.1	7.8	8.8	7.3	7.3	15.1	26.0	7.6	31.7	11.0	5.8	14.1	5.4	34.5	18.5	7.6	12.2	7.4	7.1	6.5	6.1	6.5	6.4	10.8	6.3	5.4	5.8	11.3	8.1	7.8	15.1	10.2	6.8	11.4	7.4	8.3	6.9	16.3	17.1	8.2	7.0	18.0	6.9	7.1	8.6	10.3	6.7	10.2	9.2	7.2	5.5	18.3	16.2	5.1	2.8	6.0	2.9	1.7	4.6	1.0	4.6	2.9	5.7	8.6	39.4	30.0	6.2	6.6	10.8	3.6	5.9	5.2	2.8	10.2	4.8	9.5	4.8	8.4	3.7	6.2	5.9	4.6	6.8	7.5	7.0	5.5	7.0	4.1	19.1	3.3	6.7	10.5	6.6	8.6	6.5	7.0	4.3	8.3	1.5	2.0	4.9	5.4	6.3	3.3	2.7	5.8	7.5	6.0	8.2	3.0	7.0	3.8	7.6	7.6	5.4	5.1	25.5	7.5	6.8	8.0	9.1	5.3	5.5	7.1	1.9	1.7	3.3	3.3	1.3	4.6	2.8	2.5	3.0	1.7	5.1	1.6	2.8	6.0	1.7	2.9	2.8	1.9	1.0	7.8	7.3	26.0	7.2	6.5	6.1	5.4	5.8	6.8	6.7
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB009520: AB_2178317, HPA046116: , HPA069306: "	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favourable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	18.7	24.0	20.2	22.5	24.9	26.8	21.2	19.9	22.7	23.8	17.8	17.1	20.3	12.5	20.7	19.0	19.4	15.8	11.9	15.4	17.9	14.6	23.4	24.9	17.2	26.3	29.0	22.7	26.2	34.1	41.3	30.7	17.6	23.5	20.1	14.5	10.5	17.4	18.9	13.5	17.8	16.0	21.0	32.7	21.6	17.1	12.4	28.9	33.6	22.3	14.6	27.3	25.3	17.4	15.3	13.0	6.4	8.1	10.8	13.5	4.7	15.5	7.1	20.1	16.4	9.7	12.4	10.3	18.1	16.5	18.5	22.1	13.7	15.9	38.5	12.2	12.1	7.6	18.4	15.7	29.9	6.9	12.6	17.2	13.5	12.5	11.8	24.0	11.5	9.4	12.7	18.7	21.0	14.4	16.9	8.2	14.0	6.3	35.2	15.5	12.3	9.0	28.1	36.7	12.1	8.0	10.9	14.1	13.7	10.6	4.2	13.7	11.1	13.6	10.9	15.3	18.9	14.1	22.8	11.6	15.8	36.6	12.6	25.2	15.2	6.4	8.1	3.2	13.2	6.2	9.6	12.4	11.4	11.2	6.2	15.3	13.5	11.9	3.7	10.8	7.4	13.0	9.9	4.7	20.2	24.9	19.9	22.7	17.9	14.6	29.0	22.7	23.5	28.9
RFC2	"A1, RFC40"	ENSG00000049541	"Replication factor C subunit 2"	P35250	7	74231499-74254458	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA replication"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029493	Approved		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA029493: AB_10603991"	"unprognostic (1.25e-1)"	"prognostic favourable (9.91e-4)"	"unprognostic (1.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavourable (2.09e-7)"	"unprognostic (2.22e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.59e-1)"	11.0	9.5	16.1	15.8	15.4	23.0	15.3	13.9	16.6	10.1	12.8	10.0	5.0	8.6	10.0	9.4	17.9	10.1	9.0	9.1	12.1	9.1	10.1	23.0	10.6	20.4	12.3	14.0	11.7	15.1	10.9	8.6	17.5	15.1	11.0	15.0	8.9	12.2	8.1	16.5	18.8	10.0	12.7	14.8	14.2	12.2	13.5	14.0	22.1	10.4	14.7	28.5	9.9	11.6	22.4	18.7	27.5	24.2	24.8	13.6	15.8	23.1	18.0	21.0	20.8	4.3	5.1	9.6	13.6	15.0	27.7	33.4	19.9	21.6	21.8	3.8	9.6	15.9	17.1	22.7	28.8	15.6	29.7	13.3	25.1	14.7	3.4	20.0	8.3	5.2	5.1	26.0	18.0	14.8	27.6	13.5	21.3	27.3	19.8	38.8	23.9	15.2	29.6	23.4	27.3	14.8	18.7	17.1	21.7	16.1	30.5	11.1	22.1	18.4	5.7	27.4	18.2	21.1	30.3	8.3	10.7	37.9	13.9	30.9	28.5	19.5	22.0	15.6	11.4	24.2	11.7	19.0	9.9	10.4	18.7	22.4	12.6	9.5	27.5	24.8	22.4	10.0	13.6	15.8	16.1	15.4	13.9	16.6	12.1	9.1	12.3	14.0	15.1	14.0
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favourable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavourable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.5	11.9	28.2	18.0	4.1	4.4	22.3	16.8	10.6	26.8	29.7	17.8	16.6	25.0	39.0	8.0	18.3	24.8	16.4	33.0	37.6	21.9	25.6	18.2	18.0	3.2	27.0	17.3	3.8	5.9	18.3	14.4	8.9	20.0	35.6	18.2	16.5	34.0	25.4	24.9	16.2	26.9	24.3	34.2	9.6	12.9	27.7	13.7	20.9	23.1	18.9	39.2	25.9	4.1	16.2	20.5	27.2	50.0	19.9	44.0	83.1	14.3	29.8	21.3	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8
RFC5	RFC36	ENSG00000111445	"Replication factor C subunit 5"	P40937	12	118013588-118033130	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041037	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA041037: AB_10805834"	"unprognostic (9.63e-2)"	"prognostic favourable (8.05e-5)"	"unprognostic (5.12e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.35e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.06e-1)"	9.4	9.3	9.8	15.1	10.7	30.3	11.7	14.4	12.5	11.4	11.0	10.2	12.6	10.2	12.9	10.8	14.3	12.2	8.4	6.7	15.2	6.5	9.3	13.9	8.4	16.0	7.0	10.1	18.7	12.3	7.3	11.4	9.1	11.0	8.7	14.5	8.5	9.9	12.6	7.3	11.2	11.5	9.0	9.3	11.1	9.8	16.4	9.3	33.4	12.0	11.2	17.0	12.6	10.8	12.9	8.8	14.2	10.4	9.1	14.1	7.9	19.3	21.2	20.8	11.6	5.1	6.1	22.7	14.6	10.0	28.4	21.3	21.7	8.4	22.9	10.3	7.6	18.6	28.6	14.4	26.8	16.0	23.8	17.9	16.6	14.3	3.1	28.0	13.7	3.2	4.8	21.4	6.9	11.8	23.8	8.3	13.3	21.1	35.2	21.2	15.7	19.5	26.4	25.5	21.7	12.3	17.6	27.9	12.2	25.3	7.0	9.0	26.0	10.8	5.5	15.3	17.1	20.7	27.5	14.2	18.3	28.0	14.7	20.2	25.9	14.2	6.2	3.9	11.2	10.4	10.0	12.9	13.7	9.8	8.8	11.1	10.7	9.3	6.1	9.1	5.8	7.6	14.1	7.9	9.8	10.7	14.4	12.5	15.2	6.5	7.0	10.1	11.0	9.3
RFNG		ENSG00000169733	"RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase"	Q9Y644	17	82047902-82051831	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 34.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011564, HPA031673"	Uncertain		Supported	Nucleoplasm			450000	Nucleoplasm		"HPA011564: AB_1079803, HPA031673: "	"unprognostic (4.17e-3)"	"unprognostic (7.60e-3)"	"unprognostic (2.87e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.86e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-1)"	"prognostic favourable (4.81e-4)"	"unprognostic (1.20e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (4.14e-2)"	19.5	13.0	13.8	9.3	13.3	11.7	43.8	14.3	13.8	11.4	11.8	9.0	22.7	14.9	13.5	20.9	13.4	16.3	17.0	12.2	11.6	8.7	12.5	34.5	16.7	10.1	11.2	8.0	19.7	26.6	4.1	10.7	8.2	9.9	11.8	4.8	10.6	27.3	20.4	32.6	13.3	12.7	12.9	8.5	8.9	13.2	12.8	10.6	5.7	12.6	10.5	7.6	12.4	12.8	3.4	3.4	4.3	5.0	0.4	6.3	1.5	9.3	9.3	2.7	9.4	7.0	6.2	12.1	8.7	5.1	4.2	3.3	5.7	6.7	2.2	6.3	13.8	5.2	1.9	7.5	0.8	2.8	9.8	3.2	2.2	23.1	34.7	1.2	6.9	11.2	5.1	7.2	12.3	7.8	4.0	8.2	3.3	11.5	6.9	3.3	2.7	9.8	4.8	3.3	4.9	4.7	5.7	4.8	12.2	3.3	5.7	25.7	15.7	6.7	2.9	6.6	9.0	6.3	4.7	11.0	2.1	2.3	8.3	2.0	5.7	2.3	5.0	4.3	4.1	1.4	1.5	2.5	2.8	4.3	3.4	3.4	2.8	1.9	2.0	0.4	1.5	2.7	6.3	1.5	13.8	13.3	14.3	13.8	11.6	8.7	11.2	8.0	9.9	10.6
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33299324	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA047039: , HPA053444: "	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	12.1	9.2	6.7	10.0	8.4	4.5	6.8	9.4	8.4	8.6	7.0	7.1	15.3	6.7	8.9	9.5	6.5	8.3	9.9	9.1	7.2	3.2	7.5	4.2	9.9	7.2	7.5	4.8	10.7	6.6	4.9	17.1	7.7	8.6	7.5	4.2	7.5	6.8	13.3	19.9	4.6	6.6	6.3	4.9	19.0	7.1	6.4	6.6	4.6	12.8	4.5	6.8	7.5	10.7	0.5	0.7	4.2	0.9	0.7	0.4	0.8	3.6	1.0	4.1	2.1	0.6	0.4	1.9	1.7	1.0	0.5	0.6	0.5	0.9	1.2	6.0	0.3	0.8	0.8	0.5	0.2	3.0	2.1	2.4	1.0	0.8	0.4	1.7	3.9	0.7	0.5	1.6	0.3	1.0	3.0	0.8	0.3	0.7	1.2	2.5	0.1	1.7	1.2	2.3	1.3	0.8	0.7	3.5	3.4	1.2	2.2	5.1	1.8	2.1	3.1	1.9	2.8	1.3	4.5	5.0	2.8	3.1	0.6	1.3	3.5	1.6	0.8	2.0	0.4	0.9	0.4	0.5	0.3	0.4	0.7	0.5	0.2	0.3	4.2	0.7	0.2	0.0	0.3	0.8	6.7	8.4	9.4	8.4	7.2	3.2	7.5	4.8	8.6	6.6
RGN	"RC, SMP30"	ENSG00000130988	Regucalcin	Q15493	X	47078355-47093314	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 51.0;liver: 118.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 16.1;fHDF/TERT166: 5.1;Hep G2: 24.1"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 47.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA029102, HPA029103"	Enhanced		Approved	Nucleoplasm			47000	Nucleoplasm		"HPA029102: AB_10599846, HPA029103: AB_10602097"	"unprognostic (1.80e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.56e-3)"	"unprognostic (8.22e-3)"	"unprognostic (1.32e-2)"	"prognostic favourable (7.55e-4)"	"unprognostic (2.60e-3)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.14e-2)"	"prognostic favourable (5.10e-10)"	"unprognostic (1.69e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.82e-2)"	"unprognostic (5.22e-2)"	2.6	51.0	6.7	0.6	6.5	0.4	1.5	8.4	6.2	2.8	1.9	6.2	2.5	4.5	2.3	6.1	1.5	1.7	2.0	4.5	6.1	4.2	17.6	118.8	4.9	0.7	5.9	4.5	7.5	12.7	6.2	2.5	4.2	5.0	4.8	1.1	8.4	7.5	6.3	3.8	0.6	4.6	4.9	4.4	1.1	2.9	1.5	5.2	0.0	6.5	1.6	0.6	2.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.3	0.6	0.0	0.0	16.1	0.0	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.1	0.8	0.1	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	6.7	6.5	8.4	6.2	6.1	4.2	5.9	4.5	5.0	5.2
RGS12		ENSG00000159788	"Regulator of G protein signaling 12"	O14924	4	3293028-3439913	"Plasma proteins, Predicted intracellular proteins"	Transcription	"GTPase activation, Repressor, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054646, HPA067421"			Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA054646: , HPA067421: "	"unprognostic (2.08e-1)"	"unprognostic (1.71e-3)"	"unprognostic (7.50e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (7.03e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.76e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (8.43e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.60e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.11e-2)"	4.7	4.4	20.7	4.1	22.0	2.3	4.4	10.2	37.2	5.4	2.9	10.2	1.5	5.3	6.4	5.6	13.5	7.5	4.4	4.7	13.4	5.6	4.4	6.7	6.5	3.4	12.3	16.3	8.9	3.1	3.1	6.1	4.1	9.4	6.8	2.2	3.1	6.5	5.7	6.8	20.6	4.6	3.0	18.9	4.1	3.2	5.5	9.9	4.3	3.8	3.4	3.6	5.5	7.9	1.0	1.5	1.6	3.9	0.4	1.3	0.7	3.9	5.0	10.1	7.3	3.4	2.7	4.2	4.3	3.4	4.4	3.3	4.0	2.4	0.9	2.7	3.7	3.9	2.0	13.6	1.4	0.1	1.6	0.4	2.8	9.8	3.1	0.3	5.6	2.3	9.3	2.3	3.1	9.7	4.6	0.2	4.0	3.4	0.7	10.6	4.8	4.8	10.0	3.9	3.2	2.3	11.8	11.4	11.8	2.7	1.9	9.0	4.6	6.7	7.3	8.6	5.6	1.7	4.5	5.0	3.9	2.2	5.1	5.9	6.1	1.0	1.2	0.3	0.9	3.9	0.3	0.2	0.8	0.5	1.5	1.0	1.3	0.5	1.6	0.4	3.7	0.8	0.6	0.7	20.7	22.0	10.2	37.2	13.4	5.6	12.3	16.3	9.4	9.9
RGS2	G0S8	ENSG00000116741	"Regulator of G protein signaling 2"	P41220	1	192809039-192812283	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Translation regulation"	"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 39.1;hTERT-HME1: 27.0;Karpas-707: 25.6;PC-3: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 135.8;neutrophil: 234.2"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 234.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013385			Supported	Cytosol				Cytosol		"HPA013385: "	"prognostic favourable (2.43e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.28e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.29e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.49e-2)"	"prognostic unfavourable (2.90e-5)"	"prognostic unfavourable (3.56e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.34e-3)"	"unprognostic (1.01e-3)"	22.7	62.0	8.1	39.2	20.1	84.9	23.3	6.0	10.0	20.7	57.5	4.5	50.6	23.2	43.3	34.2	45.5	27.4	35.0	14.2	8.2	13.2	9.4	10.8	24.3	32.6	8.9	6.6	25.1	84.3	1.9	52.6	16.7	16.9	99.8	19.1	44.0	5.0	54.5	4.4	6.4	33.9	135.0	19.0	50.6	22.5	13.0	7.9	3.9	4.2	5.7	6.2	72.1	28.5	0.3	6.2	234.2	26.6	0.1	1.8	12.2	0.0	5.3	7.0	0.6	13.8	2.1	0.4	2.6	3.3	0.8	0.9	4.7	3.2	0.4	0.7	2.4	2.6	4.5	4.7	0.8	0.6	3.3	1.2	3.5	0.1	6.1	3.1	0.7	2.2	39.1	1.8	27.0	6.5	1.1	25.6	2.7	0.0	1.7	4.4	9.3	61.8	1.7	1.6	1.3	4.5	4.3	2.5	13.1	1.8	0.1	2.9	0.2	1.6	1.8	1.3	1.2	1.4	1.3	15.3	0.4	1.3	18.8	0.6	4.7	135.8	26.6	38.0	0.8	10.5	1.8	0.3	0.5	0.5	6.2	0.1	0.3	0.3	234.2	0.1	17.7	0.8	0.3	12.2	8.1	20.1	6.0	10.0	8.2	13.2	8.9	6.6	16.9	7.9
RGS20	"RGSZ1, ZGAP1"	ENSG00000147509	"Regulator of G protein signaling 20"	O76081	8	53851808-53959303	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 20.0"	"Cell line enhanced"	"Detected in many"		"AF22: 12.5;SK-MEL-30: 19.0;U-87 MG: 18.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 12.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070193	Enhanced									"HPA070193: "	"unprognostic (2.14e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.91e-5)"	"unprognostic (5.03e-5)"	"unprognostic (2.15e-1)"	"unprognostic (1.57e-2)"	"unprognostic (8.86e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.75e-8)"	"unprognostic (3.71e-3)"	"unprognostic (9.78e-3)"	"unprognostic (8.32e-2)"	"unprognostic (1.69e-2)"	0.7	0.6	12.4	0.7	20.0	0.6	1.0	3.8	17.6	0.9	0.6	1.3	0.0	0.6	0.8	0.6	1.8	0.6	0.6	0.6	6.2	2.2	0.6	0.6	0.7	0.6	1.9	5.6	0.8	0.6	0.6	0.0	3.8	1.4	0.6	0.6	4.7	0.7	0.6	0.6	3.1	0.6	0.6	1.5	0.6	0.6	0.9	2.9	0.0	4.1	1.4	1.2	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	6.4	12.5	0.2	0.4	1.5	0.0	5.0	2.9	4.4	2.6	0.0	5.6	0.0	0.2	1.4	6.7	0.2	8.1	2.9	0.0	0.9	1.5	1.0	1.1	2.0	0.0	0.6	0.3	5.3	3.5	10.5	1.7	0.4	0.0	7.2	0.0	0.0	0.3	0.2	2.5	0.0	0.4	0.0	8.5	0.6	7.8	0.7	0.4	0.0	19.0	0.0	0.0	5.4	1.1	0.0	9.3	3.7	1.5	0.0	0.0	18.9	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.0	3.8	8.2	6.2	2.2	1.9	5.6	1.4	2.9
RGS3	"C2PA, FLJ20370, PDZ-RGS3"	ENSG00000138835	"Regulator of G protein signaling 3"	P49796	9	113444731-113597743	"Plasma proteins, Predicted intracellular proteins"		"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 52.5;HDLM-2: 84.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA044234			Supported	"Plasma membrane"				"Plasma membrane"		"HPA044234: "	"prognostic unfavourable (9.93e-4)"	"unprognostic (4.04e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (6.62e-4)"	"unprognostic (6.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.90e-1)"	25.2	17.8	7.6	10.7	18.3	4.7	34.0	4.2	13.8	9.8	13.0	27.9	5.1	9.9	11.4	8.0	11.3	8.4	25.0	52.2	9.7	10.1	31.9	20.1	24.9	12.5	18.4	8.5	7.2	17.5	6.3	8.1	18.9	18.1	14.5	9.6	12.9	5.6	6.6	24.6	7.0	10.8	17.9	16.8	16.2	12.3	14.8	17.1	4.0	13.2	10.7	8.3	18.3	8.1	1.4	3.8	10.6	4.1	22.4	15.0	7.8	0.9	3.5	8.5	7.8	2.6	3.9	0.6	8.6	52.5	7.0	6.0	8.4	3.2	3.6	6.4	6.9	2.2	0.1	3.3	4.1	84.3	0.0	0.3	2.8	5.1	5.4	0.0	1.1	7.1	3.5	19.5	2.8	26.4	0.0	3.6	12.7	3.8	0.2	0.3	2.2	2.9	0.2	4.2	0.5	14.5	1.7	6.7	0.9	0.8	6.7	5.1	4.6	0.7	12.7	23.7	2.5	1.0	16.2	1.8	0.3	0.5	27.3	0.8	10.8	3.4	3.5	2.1	15.0	4.1	10.1	1.4	3.5	12.1	3.8	1.2	1.4	6.6	10.6	22.4	3.1	0.1	2.0	7.8	7.6	18.3	4.2	13.8	9.7	10.1	18.4	8.5	18.1	17.1
RGS7		ENSG00000182901	"Regulator of G protein signaling 7"	P49802	1	240775515-241357230	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.5;brain: 38.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.0;HaCaT: 6.8;hTERT-HME1: 8.3;RH-30: 7.3;SH-SY5Y: 6.4;U-2 OS: 7.3;U-251 MG: 7.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017561	Enhanced		Supported	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB017561: AB_2285043"	"unprognostic (6.48e-2)"	"unprognostic (4.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.09e-2)"		"unprognostic (1.49e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.64e-2)"		"unprognostic (2.28e-1)"	0.7	11.5	9.1	0.8	18.3	0.7	0.9	27.6	38.1	0.9	0.8	1.6	1.7	1.0	1.0	0.8	0.9	0.7	1.3	0.7	11.5	8.3	4.2	0.8	0.9	1.1	3.6	8.9	1.3	1.4	0.7	2.8	0.7	4.7	0.8	0.9	1.3	0.7	1.4	0.7	0.9	0.9	0.7	1.4	1.0	4.6	7.8	1.8	0.0	0.7	0.0	1.0	0.7	0.1	0.7	3.6	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.3	0.9	0.0	2.7	5.2	7.0	0.5	0.0	0.0	0.0	0.4	3.6	6.8	0.0	0.1	3.5	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	8.3	0.5	0.0	0.0	2.2	0.0	0.0	0.0	3.8	0.2	0.0	7.3	0.0	0.0	0.0	5.9	6.4	0.4	0.3	0.3	0.0	0.0	2.8	0.0	7.3	0.4	7.9	0.0	4.2	0.0	1.1	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	9.1	18.3	27.6	20.7	11.5	8.3	3.6	8.9	4.7	1.8
RGS9	"MGC111763, MGC26458, PERRS, RGS9L"	ENSG00000108370	"Regulator of G protein signaling 9"	O75916	17	65100812-65227703	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Sensory transduction, Vision"	"Signal transduction inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Group enriched"	"Detected in some"	8	"HDLM-2: 22.9;HEL: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	6	"basal ganglia: 47.3"	"Group enriched"	"Detected in many"	6	"gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7"	"Group enriched"	"Detected in many"	74	"NK-cells: 3.7;T-cells: 11.0"	"Region enriched"	"Detected in many"	9	"basal ganglia: 222.4"	"Region enriched"	"Detected in many"	9	"basal ganglia: 79.8"	"HPA013550, HPA014137"	Enhanced	Supported	Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA013550: , HPA014137: "	"unprognostic (4.43e-3)"	"unprognostic (7.49e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.09e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.88e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.07e-2)"	"unprognostic (4.94e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.49e-1)"	1.1	1.9	3.3	4.4	47.3	1.0	2.3	4.1	8.9	3.4	5.2	7.2	2.7	3.3	4.2	7.2	4.1	9.5	3.9	1.3	5.4	7.4	2.0	5.0	5.9	5.3	3.5	3.7	6.7	3.7	7.3	7.9	3.0	4.5	8.6	3.4	24.1	3.2	9.2	1.6	1.5	3.6	4.0	3.4	4.3	3.7	1.7	6.6	0.4	4.2	0.5	7.5	5.1	2.4	0.0	0.0	0.0	0.0	3.7	11.0	1.4	0.2	0.0	1.0	0.1	0.1	0.2	0.0	0.0	2.1	0.0	0.2	0.1	0.0	0.7	1.6	0.0	0.1	0.0	0.1	0.2	22.9	0.5	9.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.0	0.0	2.8	0.0	1.0	7.4	0.0	0.0	0.0	3.6	0.0	3.7	0.0	0.0	0.0	1.4	3.3	47.3	4.1	4.5	5.4	7.4	3.5	3.7	4.5	6.6
RHOF	"ARHF, FLJ20247, RIF"	ENSG00000139725	"Ras homolog family member F, filopodia associated"	Q9HBH0	12	121777754-121803403	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 36.7;HDLM-2: 51.6;PC-3: 36.2;RPTEC TERT1: 29.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045912, HPA076019"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"			58000	"Nucleoplasm, Golgi apparatus"		"HPA045912: , HPA076019: "	"unprognostic (1.26e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.26e-5)"	"unprognostic (1.38e-3)"	"unprognostic (2.37e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.10e-4)"	"unprognostic (1.10e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.14e-1)"	5.0	13.8	13.3	19.2	15.6	29.3	5.8	53.2	19.3	16.5	17.8	8.9	15.9	24.7	12.7	17.5	13.7	10.9	10.3	13.5	13.8	9.8	16.4	6.9	18.7	28.6	20.2	8.7	8.8	7.5	9.1	14.7	4.7	14.2	8.3	14.1	12.4	9.6	12.1	8.5	7.3	26.5	9.9	11.2	28.4	20.9	9.0	18.9	27.2	18.3	6.2	24.4	14.2	10.2	17.4	24.2	13.4	21.0	18.5	32.9	13.6	16.1	18.7	3.5	4.1	1.2	1.9	1.6	1.6	1.5	0.7	1.3	7.5	36.7	1.6	12.5	1.6	2.3	6.2	9.6	0.5	51.6	2.0	8.6	12.7	7.1	2.8	9.6	7.2	2.5	2.0	1.5	0.8	4.9	1.4	2.6	0.3	10.3	13.4	14.5	2.9	36.2	7.1	0.2	2.9	29.3	1.4	2.9	2.4	9.7	1.2	0.7	5.5	4.2	6.0	1.2	11.2	3.5	0.4	3.7	1.9	4.9	1.4	11.0	0.7	6.2	3.5	13.4	32.9	11.1	31.0	17.4	26.0	28.1	10.9	14.8	20.1	24.5	7.7	18.5	21.0	24.2	27.3	13.6	13.3	15.6	53.2	19.3	13.8	9.8	20.2	8.7	14.2	18.9
RHOG	"ARHG, MGC125835, MGC125836, RhoG"	ENSG00000177105	"Ras homolog family member G"	P84095	11	3826978-3840983	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 112.3;bone marrow: 109.5"	"Cell line enhanced"	"Detected in all"		"HMC-1: 117.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA039871	Enhanced						2300000			"HPA039871: AB_10673428"	"unprognostic (2.39e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (2.26e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.27e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (9.49e-8)"	"unprognostic (9.38e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	22.9	14.0	14.5	36.6	24.4	109.5	22.0	4.9	21.4	14.6	15.9	49.7	9.2	21.0	17.8	10.1	28.2	15.8	16.5	12.6	19.8	13.5	13.7	17.3	30.2	65.1	34.8	11.6	15.6	12.2	8.8	9.9	22.3	23.3	13.2	14.0	9.3	14.4	14.9	17.9	17.3	27.0	18.6	44.5	63.8	15.1	9.4	26.5	38.6	11.0	15.9	30.4	19.6	18.6	9.6	35.3	112.3	58.4	10.3	22.6	31.4	13.1	18.0	3.6	6.3	14.2	16.1	4.0	8.8	11.0	13.8	14.6	11.1	14.4	13.4	4.7	16.1	15.6	5.7	12.4	8.9	11.8	13.8	30.5	8.8	10.2	14.4	26.6	117.6	15.6	11.4	8.6	8.3	15.8	17.8	15.0	11.2	15.4	22.2	36.8	5.8	14.5	11.4	3.9	7.9	9.8	9.2	1.9	5.0	6.2	14.4	7.0	7.6	20.1	12.2	16.7	8.4	17.7	10.2	8.4	11.4	7.5	15.3	24.3	9.3	40.8	38.9	80.1	14.0	51.7	12.2	9.6	15.3	15.4	35.3	9.2	10.9	12.5	112.3	10.3	58.4	8.8	22.6	31.4	14.5	24.4	4.9	21.4	19.8	13.5	34.8	11.6	23.3	26.5
RHPN1	"KIAA1929, ODF5, RHPN"	ENSG00000158106	"Rhophilin Rho GTPase binding protein 1"	Q8TCX5	8	143368887-143384220	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 16.7;MOLT-4: 15.1;RPMI-8226: 11.1;T-47d: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA024288, HPA024671"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA024288: AB_1856274, HPA024671: AB_1856275"	"unprognostic (2.04e-1)"	"unprognostic (3.71e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.38e-2)"	"unprognostic (2.07e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-2)"	3.3	3.2	17.9	3.6	11.9	5.9	4.0	2.5	14.3	5.7	2.6	10.8	6.2	1.2	1.1	6.2	1.9	8.0	3.7	1.3	19.4	9.7	9.7	0.9	4.0	4.0	9.0	9.4	0.8	7.8	10.3	14.8	1.4	10.9	3.2	1.3	2.0	6.6	7.2	0.8	5.3	1.9	1.7	8.3	5.6	5.2	2.7	14.1	15.4	14.9	0.5	2.5	2.4	1.2	0.0	0.1	0.0	0.0	0.0	1.0	0.0	1.7	3.0	0.7	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	1.2	0.1	6.0	0.0	0.7	0.0	0.0	0.0	0.3	2.7	0.0	1.8	0.1	0.2	0.1	1.9	0.0	0.5	0.0	0.0	0.6	0.6	3.6	0.0	16.7	15.1	1.5	1.1	8.1	4.1	0.0	11.1	2.7	2.8	4.5	1.7	0.9	5.0	1.0	27.2	0.0	0.0	0.0	3.2	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.3	0.3	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	17.9	11.9	2.5	12.7	19.4	9.7	9.0	9.4	10.9	14.1
RIDA	"HRSP12, P14.5, PSP, UK114"	ENSG00000132541	"Reactive intermediate imine deaminase A homolog"	P52758	8	98102344-98117241	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	9	"kidney: 81.4;liver: 248.6"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"liver cancer: 162.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022856, HPA023489"	Enhanced						5700000			"HPA022856: AB_1858253, HPA023489: AB_1858252"	"unprognostic (1.67e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.20e-2)"	"prognostic favourable (9.61e-6)"	"unprognostic (6.08e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.51e-2)"	8.3	9.4	16.8	2.5	18.8	1.6	4.2	5.6	11.6	2.6	4.7	4.5	2.7	5.8	2.1	4.8	2.8	2.2	4.3	5.2	11.7	12.5	81.4	248.6	2.2	2.1	19.1	9.5	4.6	5.2	3.5	1.8	2.4	11.8	4.0	4.8	2.3	3.2	2.7	6.8	2.3	4.2	2.5	7.9	1.8	4.6	3.3	9.5	0.6	3.2	3.5	2.6	3.2	1.8	12.1	10.0	5.0	8.3	8.4	12.8	7.1	17.1	14.9	12.1	14.7	27.3	21.3	13.2	15.9	11.2	10.6	12.8	20.2	11.5	24.4	20.4	11.6	12.2	26.4	22.5	21.5	8.5	11.4	17.7	10.1	21.6	12.5	6.5	2.8	18.4	7.8	14.9	16.4	13.7	31.5	5.3	14.2	22.3	13.8	17.8	19.0	27.3	16.0	8.8	7.0	25.6	12.4	13.1	6.5	10.1	7.0	11.0	17.9	8.6	8.3	8.3	5.2	13.9	6.3	12.7	17.4	12.0	14.4	13.8	5.3	0.1	8.3	5.0	6.5	7.0	8.3	12.1	9.4	9.5	10.0	9.5	12.2	12.8	1.5	8.4	7.0	7.6	12.3	7.1	16.8	18.8	5.6	11.6	11.7	12.5	19.1	9.5	11.8	9.5
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 83.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 4.8;EFO-21: 8.7;LHCN-M2: 9.6;RPTEC TERT1: 14.8;SH-SY5Y: 10.4;TIME: 5.1;U-138 MG: 5.0"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in all"	6	"cerebellum: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076565	Enhanced									"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.5	2.3	10.5	1.5	9.8	0.4	1.2	83.1	27.7	0.9	0.6	0.5	0.0	1.5	0.8	0.5	3.7	0.5	6.2	0.6	9.3	3.6	0.5	0.4	0.7	0.5	2.8	11.7	0.5	0.8	5.0	4.6	0.4	7.2	4.9	0.6	0.2	1.9	0.9	0.6	0.4	0.8	1.4	1.5	0.4	1.4	5.9	2.7	0.0	0.5	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.2	1.3	0.0	0.1	0.0	0.0	4.8	8.7	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.4	14.8	0.0	0.4	10.4	0.0	0.0	0.0	0.6	0.0	5.1	5.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	9.8	83.1	12.9	9.3	3.6	2.8	11.7	7.2	2.7
RIOK2	FLJ11159	ENSG00000058729	"RIO kinase 2"	Q9BVS4	5	97160867-97183260	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ribosome biogenesis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA005681	Uncertain		Approved	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA005681: AB_1856286"	"unprognostic (6.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.51e-2)"	"unprognostic (2.71e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.76e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.39e-2)"	22.2	20.1	14.8	17.1	17.5	24.4	19.7	26.3	18.6	19.1	17.0	8.9	14.0	17.3	17.5	17.1	17.0	15.0	10.7	19.6	15.7	13.4	21.0	23.6	13.3	17.6	20.0	11.1	20.7	21.5	15.1	37.5	15.8	19.7	19.5	17.3	10.3	18.7	16.6	24.9	13.3	20.2	16.3	20.7	22.5	16.4	14.8	18.6	25.8	21.7	20.7	17.4	20.7	21.0	15.2	17.8	9.4	18.7	17.8	24.1	13.5	8.8	10.4	9.7	18.8	12.8	14.0	15.5	22.3	13.8	15.8	21.0	14.2	15.6	19.6	25.4	10.0	10.5	16.5	13.0	21.7	13.8	9.1	9.8	20.1	19.8	11.5	18.6	13.8	9.2	10.2	19.3	19.6	12.8	14.8	12.7	18.1	14.8	21.7	22.2	11.5	11.2	24.5	18.9	28.8	12.4	8.1	12.1	9.0	13.5	14.0	15.3	14.7	17.7	13.7	20.3	14.1	16.1	24.2	12.5	16.2	44.0	12.1	19.1	18.4	7.0	16.0	9.4	16.3	18.7	22.3	15.2	20.7	17.8	17.8	11.0	22.5	24.1	3.2	17.8	13.4	17.8	18.5	13.5	14.8	17.5	26.3	18.6	15.7	13.4	20.0	11.1	19.7	18.6
RLF	"Zn-15L, ZNF292L"	ENSG00000117000	"Rearranged L-myc fusion"	Q13129	1	40161373-40240921	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054653, HPA057300"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"HPA054653: , HPA057300: "	"unprognostic (1.71e-1)"	"unprognostic (2.24e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.88e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (1.75e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.60e-2)"	"unprognostic (9.38e-2)"	"prognostic unfavourable (7.68e-6)"	"unprognostic (1.86e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.69e-2)"	14.8	8.1	12.6	11.3	12.6	44.5	13.9	20.8	17.1	12.4	11.1	11.6	7.1	8.6	14.1	8.6	12.4	9.9	11.2	12.3	11.0	8.3	8.7	12.7	12.8	11.8	12.8	11.8	14.6	9.4	12.5	15.1	11.9	15.4	13.2	9.2	10.2	9.4	9.9	13.4	17.7	9.9	14.3	14.1	10.1	9.3	15.9	11.8	14.9	10.0	8.4	13.5	18.1	14.8	4.1	3.5	10.1	4.1	4.1	4.9	2.4	12.3	4.7	9.4	9.8	8.4	6.9	11.2	4.6	7.0	8.0	10.7	9.7	6.6	12.4	6.1	5.9	11.7	11.9	8.2	14.7	5.8	8.0	10.2	5.8	5.9	6.7	8.4	6.2	6.8	8.7	8.6	9.7	5.5	15.4	7.6	7.3	3.9	7.1	5.1	12.6	5.5	5.5	15.5	7.2	5.1	12.6	6.7	9.4	8.7	11.7	8.3	5.5	30.6	4.6	9.5	10.2	7.8	8.6	7.0	6.5	11.6	8.2	7.9	5.9	10.1	2.8	5.5	3.7	3.9	4.9	4.1	3.7	3.8	3.5	4.1	4.8	4.0	6.3	4.1	4.1	1.6	3.3	2.4	12.6	12.6	20.8	17.1	11.0	8.3	12.8	11.8	15.4	11.8
RLN1	H1	ENSG00000107018	"Relaxin 1"	P04808	9	5334969-5339873	"Plasma proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"prostate: 25.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.1;HEL: 4.7;SK-BR-3: 1.0"	"Cancer enriched"	"Detected in some"	106	"prostate cancer: 67.0"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.1"	"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.6"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.6"														"Secreted to blood"						"unprognostic (7.12e-6)"	"unprognostic (2.32e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.04e-1)"		"unprognostic (4.32e-2)"	"unprognostic (3.44e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.08e-4)"	"unprognostic (8.15e-2)"	"unprognostic (2.89e-4)"	"unprognostic (8.82e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.53e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	2.1	0.0	0.0	0.0	0.0	0.0
RNASE1	"RAC1, RNS1"	ENSG00000129538	"Ribonuclease A family member 1, pancreatic"	P07998	14	20801228-20803278	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"pancreas: 809.6"	"Group enriched"	"Detected in some"	7	"HUVEC TERT2: 73.2;RT4: 28.7;TIME: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.0;myeloid DC: 16.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 16.1;monocytes: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001140	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"		1500000000	Vesicles	Nucleoplasm	"HPA001140: AB_1079816"	"unprognostic (2.32e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.51e-3)"	"unprognostic (7.77e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (6.59e-3)"	"unprognostic (4.69e-2)"	"unprognostic (7.92e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.67e-1)"	79.2	48.4	28.7	12.0	38.5	1.6	59.7	4.0	32.2	21.3	33.7	57.8	63.6	16.8	13.6	49.1	19.3	24.3	37.5	70.3	41.2	21.6	33.8	8.6	94.3	23.5	39.0	16.0	19.2	809.6	6.7	4.1	79.0	25.1	23.0	39.8	106.4	15.9	35.6	31.7	10.8	20.6	26.6	52.3	34.5	87.9	86.5	27.1	7.8	11.2	14.3	7.2	29.0	10.9	0.0	16.1	1.3	8.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	73.2	7.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	28.7	0.3	0.3	0.0	0.2	0.0	0.0	0.0	38.0	0.0	0.6	0.4	0.0	0.1	0.0	0.0	1.0	0.0	1.0	1.3	8.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	2.0	28.7	38.5	4.0	32.2	41.2	21.6	39.0	16.0	25.1	27.1
RNASE2	"EDN, RAF3, RNS2"	ENSG00000169385	"Ribonuclease A family member 2"	P10153	14	20955452-20956436	"Enzymes, Plasma proteins, Predicted secreted proteins"	Chemotaxis	"Endonuclease, Hydrolase, Lyase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 137.2;bone marrow: 236.7"	"Group enriched"	"Detected in some"	318	"HL-60: 53.6;NB-4: 53.6;THP-1: 143.6;U-937: 130.2"	"Cancer enriched"	"Detected in many"	7	"glioma: 14.1"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 37.8;eosinophil: 137.2"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 137.2"									HPA044983	Enhanced				"Secreted to blood"		300000000			"HPA044983: AB_10963689"	"unprognostic (6.66e-2)"	"unprognostic (3.00e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.94e-3)"	"unprognostic (6.77e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (3.28e-13)"	"unprognostic (2.27e-2)"	"unprognostic (7.14e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.50e-1)"	2.7	3.2	4.8	2.0	9.3	236.7	0.5	0.9	3.7	0.9	0.6	1.4	0.1	0.5	0.7	0.5	0.5	3.2	0.9	3.7	3.9	1.8	1.2	1.3	6.6	7.2	4.7	0.1	0.5	2.5	0.5	0.6	0.8	4.9	0.5	0.6	0.1	0.7	0.5	0.9	0.9	0.6	2.1	10.5	19.4	0.9	0.6	3.7	0.1	0.5	0.1	0.6	1.4	0.3	0.0	20.0	137.2	11.5	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	53.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	143.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	130.2	0.0	37.8	11.5	137.2	0.0	2.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	1.0	0.0	0.2	0.2	0.0	3.3	4.8	9.3	0.9	3.7	3.9	1.8	4.7	0.1	4.9	3.7
RNASE4	RAB1	ENSG00000258818	"Ribonuclease A family member 4"	P34096	14	20684100-20701215	"Plasma proteins, Predicted secreted proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 366.2"	"Group enriched"	"Detected in many"	4	"ASC diff: 30.8;ASC TERT1: 34.9;Hep G2: 43.4;HSkMC: 20.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 17.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"												"Secreted to blood"		27000000				"unprognostic (1.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.18e-4)"	"unprognostic (1.20e-1)"	"unprognostic (7.05e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (1.43e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.16e-2)"	"unprognostic (4.27e-2)"	29.6	1.7	1.5	5.7	1.8	0.2	28.7	1.0	1.2	25.2	16.3	2.5	12.3	4.9	19.2	18.4	14.7	15.7	23.4	10.3	2.3	1.0	18.9	366.2	12.8	5.2	3.0	1.4	30.8	16.3	3.8	3.0	4.4	2.7	30.4	15.0	10.5	35.0	14.2	7.1	10.6	13.6	17.4	3.8	3.2	19.2	13.2	1.9	0.3	8.4	10.5	7.3	25.1	26.3	4.0	9.7	0.5	17.0	0.4	2.5	5.0	0.8	4.1	0.8	0.0	30.8	34.9	0.2	3.3	7.6	0.5	1.4	1.0	1.1	0.0	0.8	7.7	0.8	0.4	0.8	0.6	5.3	0.4	0.0	0.9	43.4	3.4	0.4	0.1	20.8	1.9	0.5	3.5	4.0	0.0	3.7	2.2	0.5	0.2	0.0	0.1	3.3	0.1	0.6	1.1	0.7	0.7	0.0	0.1	1.2	0.6	0.8	0.9	0.1	4.1	0.9	0.5	1.2	0.1	0.7	0.9	0.1	1.4	0.3	0.8	0.1	17.0	0.0	0.6	0.9	0.8	4.0	1.1	0.4	9.7	2.2	0.2	0.4	0.5	0.4	0.1	2.3	2.5	5.0	1.5	1.8	1.0	1.2	2.3	1.0	3.0	1.4	2.7	1.9
RNASEL	"PRCA1, RNS4"	ENSG00000135828	"Ribonuclease L"	Q05823	1	182573634-182589256	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense"	"Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA002633, CAB010906"	Approved		Supported	Cytosol				Cytosol		"CAB010906: AB_477444, HPA002633: AB_1856314"	"unprognostic (3.46e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.81e-1)"	8.1	10.8	7.4	9.5	10.9	3.7	8.3	5.7	7.7	12.5	9.3	6.7	8.5	8.0	12.4	11.9	10.0	8.8	8.0	5.8	7.0	5.3	9.9	3.9	8.4	10.1	7.7	3.3	14.0	5.3	13.5	18.0	8.5	10.1	10.5	10.8	13.3	10.5	10.3	4.1	6.3	12.2	9.6	7.4	10.5	8.8	3.5	6.7	13.3	13.3	2.8	11.0	13.9	11.0	5.0	7.2	26.9	13.5	5.0	9.2	4.9	2.3	3.3	1.4	0.5	7.6	13.3	2.6	4.5	5.6	4.6	4.3	1.9	5.1	5.1	7.9	5.1	4.3	3.3	4.6	1.8	4.0	2.8	5.9	1.2	0.2	3.9	11.0	11.7	9.4	10.6	2.4	0.7	2.0	2.1	3.9	4.0	3.3	3.2	4.6	1.1	0.9	4.8	1.1	2.6	4.9	3.1	0.7	0.2	4.0	4.9	3.8	5.0	12.3	2.5	2.4	1.9	2.5	2.4	3.5	1.2	0.6	3.8	6.8	3.5	16.8	7.2	24.6	4.9	7.6	6.4	5.0	5.8	5.2	6.0	3.8	9.2	6.7	26.9	5.0	13.5	7.2	4.6	4.9	7.4	10.9	5.7	7.7	7.0	5.3	7.7	3.3	10.1	6.7
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008716	Approved		Supported	Cytosol				Cytosol		"HPA008716: AB_1856337"	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.5	21.0	14.8	29.0	26.6	27.9	9.9	25.8	14.4	18.2	20.2	17.4	14.7	22.2	30.3	26.5	6.9	18.8	25.4	16.3	16.7	16.2	14.1	11.0	7.9	29.3	15.5	12.6	20.9	22.4	24.1	30.4	22.5	17.1	31.1	37.2	15.0	15.0	4.9	6.2	24.0	9.9	16.4	24.1	25.0	21.8	16.3	13.3	22.6	41.5	43.9	28.9	12.1	23.2	24.2	7.8	11.4	24.4	19.6	22.8	20.4	20.7	19.0	29.8	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.6	11.1	4.2	6.2	14.7	11.6	9.5	21.7	17.8	14.1	10.0	13.9	16.3	22.7	10.9	20.6	17.0	11.8	17.6	23.5	21.7	7.4	24.7	9.4	11.9	23.1	25.8	26.1	10.9	34.4	15.8	33.9	14.1	9.5	0.0	21.8	11.3	14.4	15.1	3.4	7.8	11.5	16.4	8.9	17.4	16.7	7.7	4.7	11.6	21.3	20.6	8.1	25.4	18.4	12.2	7.4	16.3	15.5	5.8	5.4	13.6	11.1	14.8	15.9	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88610272-88963721	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	9.1	12.1	10.2	19.6	12.2	14.2	9.9	18.5	13.1	10.0	8.1	8.7	7.0	7.4	11.1	7.2	12.5	8.7	7.2	9.6	10.5	16.0	9.4	11.8	9.4	26.3	9.8	6.4	10.4	6.6	12.1	23.1	11.6	11.1	9.8	9.8	9.4	8.4	11.6	10.5	9.0	10.7	10.7	10.7	14.3	7.5	15.0	10.4	28.0	10.0	7.8	28.2	10.9	13.8	18.6	4.4	5.7	4.6	8.0	8.4	4.3	5.6	8.6	13.5	17.1	7.9	8.4	8.1	12.9	8.5	10.5	13.3	9.8	4.3	14.6	10.6	9.2	7.1	15.7	10.4	19.4	19.8	12.3	19.0	7.8	7.8	6.5	20.3	10.8	5.3	9.2	10.9	10.6	9.3	18.7	11.8	15.6	7.5	8.9	14.5	8.1	7.6	17.7	20.9	8.3	9.4	8.8	7.9	11.4	10.7	6.5	7.0	7.0	20.4	7.3	8.5	7.9	9.6	17.4	10.7	18.7	8.2	12.5	15.2	15.5	3.5	3.0	5.7	6.4	4.6	6.4	18.6	7.2	7.9	4.4	16.8	8.2	8.4	2.5	8.0	3.9	3.1	6.7	4.3	10.2	12.2	18.5	13.1	10.5	16.0	9.8	6.4	11.1	10.4
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol			27000000	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favourable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	39.8	35.7	18.5	27.6	25.7	40.8	57.9	14.7	33.1	34.9	27.8	43.0	25.9	27.3	36.6	34.2	51.4	30.5	32.8	49.5	20.4	16.5	32.6	46.2	36.1	36.6	37.1	25.3	36.2	32.4	25.7	21.1	35.1	24.3	30.7	8.7	25.6	37.5	33.2	41.6	60.7	26.0	37.7	31.7	29.8	25.3	37.9	29.6	17.1	41.4	41.9	25.8	35.5	38.6	12.9	47.8	10.3	53.3	9.8	12.1	35.3	21.1	30.1	3.3	11.2	18.3	26.1	12.4	19.9	13.8	18.1	15.7	16.8	25.9	11.7	15.4	37.8	19.9	5.7	19.9	2.8	14.9	27.4	7.9	8.3	15.4	61.8	10.4	25.4	22.2	29.6	10.5	13.1	12.3	10.3	19.9	10.3	21.1	8.0	19.7	5.5	30.7	10.2	7.3	15.0	11.1	7.7	9.6	6.6	11.9	17.3	19.8	12.4	32.8	22.0	31.1	9.1	11.2	13.3	12.7	13.5	8.6	33.9	23.6	20.4	5.7	44.4	10.3	10.4	53.3	12.1	12.9	11.2	10.4	47.8	9.5	10.5	9.3	3.2	9.8	48.7	13.9	10.7	35.3	18.5	25.7	14.7	33.1	20.4	16.5	37.1	25.3	24.3	29.6
RNPEP	APB	ENSG00000176393	"Arginyl aminopeptidase"	Q9H4A4	1	201982372-202006147	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 12.1;granulocytes: 12.3;monocytes: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036074, HPA036075, HPA061487"	Approved		Supported	"Nucleoplasm,Golgi apparatus"	"Secreted - unknown location"		6600000	"Golgi apparatus"	Nucleoplasm	"HPA036074: AB_2674926, HPA036075: AB_10672999, HPA061487: "	"unprognostic (8.57e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.93e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.68e-1)"	18.5	22.0	6.4	14.9	8.2	9.5	16.7	9.2	11.0	17.8	34.2	13.5	21.2	31.1	17.4	18.7	33.2	19.2	21.8	11.5	6.1	4.6	22.5	18.3	21.5	14.1	7.0	5.4	18.0	19.5	11.6	10.4	26.3	9.0	18.4	26.8	16.4	25.1	13.6	10.0	18.3	66.6	12.8	8.1	22.7	15.7	21.2	6.0	13.9	28.4	19.1	24.7	17.6	17.5	2.3	12.1	12.3	17.0	1.6	3.1	2.2	19.0	20.7	12.3	18.5	20.2	19.0	31.1	14.7	28.5	18.4	20.8	14.8	24.4	4.1	18.9	25.8	34.6	15.7	28.7	12.9	11.3	20.3	10.4	9.9	13.9	17.2	26.4	36.8	17.3	29.7	16.4	18.9	33.1	23.6	6.2	18.6	17.4	3.6	11.2	17.4	10.3	13.9	17.4	29.4	38.3	17.3	14.3	12.1	36.3	45.4	14.6	34.5	15.1	23.6	8.7	11.7	8.4	17.8	13.8	11.1	3.7	8.6	22.5	17.3	10.8	9.2	12.3	1.9	15.7	2.6	1.6	2.0	2.2	12.1	2.3	1.8	2.1	6.7	1.6	17.0	4.5	3.1	2.2	6.4	8.2	9.2	11.0	6.1	4.6	7.0	5.4	9.0	6.0
ROBO2	KIAA1568	ENSG00000185008	"Roundabout guidance receptor 2"	Q9HCK4	3	75906695-77649964	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Group enriched"	"Detected in some"	5	"BJ hTERT+: 14.9;HEL: 40.7"	"Cancer enhanced"	"Detected in many"		"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013371	Approved		Approved	"Nucleoplasm,Centriolar satellite"			660000	"Nucleoplasm, Centriolar satellite"		"HPA013371: AB_1856391"	"unprognostic (1.14e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.25e-3)"	"unprognostic (1.82e-2)"	"unprognostic (5.93e-3)"	"unprognostic (3.87e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.07e-2)"	"unprognostic (4.23e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.08e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (9.65e-3)"	1.1	3.3	6.4	0.8	13.8	0.3	1.1	19.0	26.1	3.6	1.3	2.2	0.0	0.9	2.9	0.8	6.2	0.4	3.1	1.0	6.3	6.5	2.5	1.8	12.3	1.8	9.6	5.5	9.4	2.2	6.8	2.1	6.4	9.9	1.9	0.8	4.8	2.1	7.8	0.4	3.0	1.2	1.9	7.8	3.6	1.1	4.5	3.6	3.6	0.4	4.2	3.0	2.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	3.9	4.2	0.0	0.1	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	4.8	40.7	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	2.6	4.6	0.0	0.0	0.5	6.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.8	19.0	11.3	6.3	6.5	9.6	5.5	9.9	3.6
ROBO3	"FLJ21044, HGPPS, HGPS, RBIG1"	ENSG00000154134	"Roundabout guidance receptor 3"	Q96MS0	11	124865386-124881470	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 20.1"	"Cell line enriched"	"Detected in some"	11	"AF22: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Low region specificity"	"Detected in all"			HPA071053			Approved	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"HPA071053: "	"unprognostic (1.30e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.95e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.84e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.95e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.75e-8)"	"unprognostic (7.27e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.91e-3)"	2.4	1.5	1.5	0.5	1.4	1.3	1.7	0.5	3.1	0.8	0.9	0.5	0.5	1.9	1.8	20.1	0.5	2.1	0.5	1.5	1.5	0.6	0.7	0.5	1.7	0.8	1.1	1.1	7.4	0.5	0.2	0.5	1.5	1.0	1.0	0.2	1.0	1.7	0.5	2.6	0.2	2.2	4.5	0.7	3.0	0.8	1.0	0.5	0.8	1.1	0.5	0.5	0.5	1.0	0.0	1.3	1.4	0.3	0.0	0.8	0.0	0.0	0.0	20.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.7	1.0	0.0	1.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.3	0.4	0.0	0.6	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.3	0.8	0.0	1.5	1.4	0.5	2.7	1.5	0.6	1.1	1.1	1.0	0.5
ROBO4	"ECSM4, FLJ20798, MRB"	ENSG00000154133	"Roundabout guidance receptor 4"	Q8WZ75	11	124883691-124898500	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 63.4;TIME: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065212			Approved	"Plasma membrane"			340000000	"Plasma membrane"		"HPA065212: "	"unprognostic (2.86e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.97e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (7.94e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.55e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.15e-2)"	33.3	4.5	4.0	5.6	4.5	0.6	21.6	2.0	5.5	11.1	4.4	4.3	3.7	2.8	10.8	7.8	5.3	7.7	8.5	15.5	4.9	3.0	10.6	6.5	24.9	5.8	4.7	2.8	5.9	3.5	3.8	3.8	23.6	5.5	6.0	1.8	9.2	2.9	4.5	12.5	4.5	4.7	8.4	3.6	33.3	4.3	3.9	3.3	1.0	11.6	9.8	2.5	6.2	5.9	0.0	1.2	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.7	63.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	4.0	4.5	2.0	5.5	4.9	3.0	4.7	2.8	5.5	3.3
ROCK1	p160ROCK	ENSG00000067900	"Rho associated coiled-coil containing protein kinase 1"	Q13464	18	20946906-21111851	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004562, HPA007567, HPA045639"	Approved						240000			"CAB004562: AB_628223, HPA007567: AB_1856393, HPA045639: "	"unprognostic (7.86e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.63e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.89e-3)"	"prognostic unfavourable (9.93e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.93e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.28e-1)"	19.3	9.7	9.7	16.3	9.7	40.0	15.1	18.3	11.0	13.9	12.6	7.1	14.4	10.1	16.0	14.9	13.3	14.4	11.7	11.9	10.3	5.6	10.5	9.2	17.0	20.5	10.1	6.0	13.7	9.5	11.2	12.2	11.5	10.3	14.2	9.4	9.5	9.4	9.8	7.9	8.5	11.6	27.7	10.7	17.3	12.0	6.6	12.4	24.8	10.9	9.6	11.2	17.9	21.0	5.4	5.3	17.9	5.0	2.6	5.1	2.0	6.4	4.0	4.0	3.9	7.6	8.2	6.6	9.0	4.4	4.0	4.4	6.7	2.8	8.0	6.5	10.6	5.3	3.6	5.2	8.1	11.3	4.2	6.4	7.4	2.9	3.9	17.5	10.0	5.9	4.8	6.0	4.9	6.1	3.6	8.3	4.7	4.1	8.2	3.8	3.4	6.8	11.7	4.7	3.1	3.9	6.0	4.7	3.7	7.2	4.9	3.6	4.8	6.7	10.1	8.1	6.7	7.3	7.3	11.4	5.1	9.2	6.1	7.5	5.0	2.8	5.0	6.3	5.1	3.1	4.1	3.7	3.8	3.9	4.0	5.4	3.7	3.6	17.9	2.6	3.6	5.3	3.2	2.0	9.7	9.7	18.3	11.0	10.3	5.6	10.1	6.0	10.3	12.4
ROCK2		ENSG00000134318	"Rho associated coiled-coil containing protein kinase 2"	O75116	2	11179761-11348330	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007459, CAB008666, HPA044109"	Approved		Supported	Cytosol			3700000	Cytosol		"CAB008666: AB_1622617, HPA007459: AB_1079828, HPA044109: AB_2678813"	"unprognostic (4.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.18e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (1.57e-5)"	"unprognostic (1.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-2)"	"unprognostic (3.47e-2)"	26.9	7.8	14.6	9.5	21.9	4.4	21.4	26.1	26.4	16.6	16.5	5.6	8.6	12.3	22.4	11.0	12.4	13.2	11.9	12.3	13.4	7.6	11.4	12.3	16.7	6.8	7.2	16.7	15.1	8.6	12.9	14.8	18.4	10.3	14.4	20.3	5.6	10.3	14.4	28.0	8.7	13.8	42.9	7.1	12.6	10.7	5.8	9.6	5.9	10.5	5.1	6.2	22.1	20.8	2.5	3.0	3.6	2.2	3.5	3.3	0.9	6.5	15.9	13.2	12.9	23.8	16.7	8.4	15.5	14.5	10.1	10.7	15.0	14.3	8.2	9.2	24.5	7.3	9.5	8.9	16.0	11.7	5.7	16.4	27.4	30.0	8.6	9.1	4.7	13.0	5.7	12.4	8.9	16.1	14.2	3.3	15.0	5.5	6.7	4.7	7.3	9.8	8.1	29.0	2.6	5.5	18.5	6.2	6.6	30.4	10.6	10.6	4.3	5.1	21.9	20.9	15.1	8.3	13.6	2.6	3.2	7.3	9.0	10.8	29.1	3.6	1.8	1.7	2.7	2.2	3.3	1.6	2.2	1.8	1.3	2.5	1.9	2.1	3.0	3.5	1.7	3.0	1.8	0.9	14.6	21.9	26.1	26.4	13.4	7.6	7.2	16.7	10.3	9.6
ROM1	"ROM, TSPAN23"	ENSG00000149489	"Retinal outer segment membrane protein 1"	Q03395	11	62611722-62615120	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Sensory transduction, Vision"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 108.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.8;U-266/84: 18.7"	"Cancer enriched"	"Detected in all"	6	"glioma: 14.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028910	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA028910: "	"unprognostic (1.54e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (2.20e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.87e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.50e-2)"	"prognostic unfavourable (2.85e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.24e-2)"	9.4	4.6	16.3	2.3	15.0	0.9	3.6	5.7	18.8	4.9	3.1	5.1	3.3	2.0	3.8	5.7	4.7	7.4	5.2	2.7	14.7	9.2	2.4	3.2	3.0	2.3	18.1	4.7	13.2	3.2	4.8	2.1	1.6	8.7	3.8	3.0	108.1	2.5	5.9	2.2	3.7	1.7	6.3	21.6	2.5	2.4	3.7	7.7	0.7	3.0	2.2	2.6	3.1	9.2	1.1	0.8	0.8	1.2	5.6	3.2	1.4	2.1	1.2	2.2	4.6	3.2	15.6	0.4	1.4	2.5	3.1	2.0	0.6	3.6	2.0	10.0	8.1	2.7	1.0	2.8	0.8	3.6	1.8	1.8	5.3	2.5	9.2	0.7	0.6	17.8	4.1	3.1	6.4	4.7	2.6	4.6	6.2	5.3	1.1	1.5	0.5	3.2	1.1	1.8	12.7	3.4	1.2	2.3	3.3	3.5	4.0	1.6	5.6	0.9	5.4	5.1	1.9	5.9	1.6	2.0	18.7	1.6	9.5	2.1	1.0	0.0	1.2	0.8	0.9	0.3	2.4	0.7	3.2	0.8	0.6	1.1	1.5	1.8	0.4	5.6	1.1	0.8	0.9	1.4	16.3	15.0	5.7	8.4	14.7	9.2	18.1	4.7	8.7	7.7
RORA	"NR1F1, ROR1, ROR2, ROR3, RZRA"	ENSG00000069667	"RAR related orphan receptor A"	P35398	15	60488284-61229319	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 64.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 34.3;U-266/70: 19.7;U-266/84: 27.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009861	Approved									"CAB009861: AB_2180141"	"unprognostic (1.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.34e-1)"	"prognostic favourable (5.42e-6)"	"unprognostic (6.94e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.62e-2)"	8.6	32.4	8.1	6.0	9.8	12.2	12.0	29.8	17.0	7.6	6.1	4.8	11.9	2.7	7.5	6.7	14.8	5.4	8.1	6.7	8.7	4.2	11.2	23.1	10.0	5.9	7.8	7.0	8.9	11.8	11.8	10.3	4.1	10.0	5.4	3.5	9.1	7.8	12.0	34.6	64.8	6.2	7.8	11.0	7.7	5.5	11.2	9.3	1.5	11.1	9.9	8.8	8.9	10.3	0.8	0.4	0.3	0.0	3.7	16.9	2.6	0.0	0.3	1.2	0.0	1.6	0.8	0.4	0.6	0.7	0.5	0.6	0.8	0.2	0.0	0.2	1.6	0.2	2.8	1.2	1.0	1.3	2.4	0.0	0.1	1.3	0.6	0.0	0.1	3.7	0.3	1.5	0.0	5.4	0.1	34.3	2.3	0.1	0.3	0.0	0.9	0.5	0.0	1.1	0.5	1.1	0.2	0.9	2.1	0.1	0.2	0.0	0.0	0.0	0.1	4.8	2.1	1.9	0.0	19.7	27.2	0.1	8.1	0.0	0.5	0.1	0.0	0.0	14.7	0.0	16.9	0.8	11.1	9.9	0.0	0.1	3.5	7.4	0.3	3.7	0.0	0.4	9.3	2.6	8.1	9.8	29.8	17.0	8.7	4.2	7.8	7.0	10.0	9.3
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: "	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavourable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	19.8	18.9	17.5	22.2	18.6	15.7	19.6	21.0	19.2	20.1	21.2	17.0	26.7	15.9	23.7	20.1	23.8	23.2	20.6	27.6	15.0	15.6	13.3	15.2	19.2	27.6	19.6	19.8	28.8	17.8	18.8	15.7	15.2	15.0	20.2	16.5	20.9	22.9	23.3	46.1	23.6	18.6	21.7	15.0	18.7	17.0	13.9	17.5	36.7	21.1	24.4	33.1	23.6	19.1	24.6	14.5	23.9	19.7	34.2	27.1	25.2	27.4	28.2	25.7	23.6	13.0	13.1	28.7	22.6	14.2	30.1	31.5	39.9	12.7	38.7	21.3	14.4	25.6	31.8	19.4	34.0	25.3	37.4	23.5	35.0	16.6	8.6	17.2	20.9	10.7	12.8	29.6	13.0	21.7	22.1	22.3	21.0	15.8	37.0	11.0	19.6	16.5	51.6	13.8	21.0	13.4	19.0	11.1	17.2	32.1	11.3	20.0	23.2	13.6	16.8	20.5	17.9	23.7	34.2	6.2	16.2	22.3	14.7	27.2	25.4	16.7	11.3	23.9	25.9	16.2	26.3	24.6	27.1	25.7	13.8	15.4	26.8	24.3	5.5	34.2	19.7	14.5	25.0	25.2	17.5	18.6	21.0	19.2	15.0	15.6	19.6	19.8	15.0	17.5
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favourable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	18.6	17.1	33.6	24.3	38.8	20.5	26.6	23.6	30.5	20.0	15.4	17.2	17.6	9.9	19.5	26.3	18.7	28.8	19.2	22.5	31.4	22.1	19.5	18.4	19.3	37.1	22.0	26.7	32.6	15.3	16.4	27.0	17.2	25.4	17.2	19.0	18.0	16.2	19.8	45.0	22.6	16.8	18.6	22.1	28.4	15.3	34.6	27.7	25.4	30.7	17.2	37.9	20.3	17.1	46.2	31.5	48.4	18.1	49.3	55.9	65.9	13.0	12.5	21.0	15.7	14.3	13.2	12.7	24.3	16.5	31.1	27.1	17.7	16.2	33.3	15.6	9.6	12.2	29.6	13.7	30.4	24.6	27.5	38.7	16.9	15.2	7.2	51.3	27.3	5.7	7.7	30.0	15.5	13.4	40.4	29.0	18.0	13.3	36.5	22.5	41.1	26.7	24.4	31.1	15.5	11.1	14.2	17.9	17.3	26.8	10.8	21.2	11.2	15.2	8.5	7.7	16.7	41.5	15.9	23.6	52.5	28.9	19.0	45.5	13.9	42.8	18.1	48.4	51.6	14.0	55.9	46.2	48.8	47.3	20.4	39.0	55.8	53.9	18.1	49.3	18.1	31.5	42.5	65.9	33.6	38.8	23.6	30.5	31.4	22.1	22.0	26.7	25.4	27.7
RPIA		ENSG00000153574	"Ribose 5-phosphate isomerase A"	P49247	2	88691644-88750935	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Isomerase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042620, HPA057954"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"			4100000	"Nucleoplasm, Vesicles, Plasma membrane"		"HPA042620: AB_10793980, HPA057954: "	"unprognostic (3.35e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.31e-1)"	"unprognostic (8.24e-2)"	"prognostic unfavourable (1.46e-5)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-3)"	"unprognostic (8.70e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavourable (8.53e-6)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-2)"	"unprognostic (8.79e-3)"	12.9	8.8	6.6	15.6	7.0	43.0	12.1	11.1	6.4	8.1	12.7	6.1	11.0	12.4	11.1	7.3	18.3	8.5	14.0	10.9	5.0	4.9	6.8	6.2	9.0	16.2	7.2	3.8	11.7	26.5	3.6	11.4	26.1	6.5	8.8	13.4	6.0	12.6	8.5	17.6	9.2	12.7	7.7	5.1	15.4	10.4	8.9	7.6	30.7	9.6	10.5	19.3	8.1	11.8	18.5	14.1	21.4	12.5	13.3	22.4	11.6	8.5	5.0	10.2	8.0	7.2	7.4	22.3	4.8	4.5	7.9	5.4	17.8	11.4	43.7	10.4	5.5	5.2	12.6	4.0	12.5	20.7	16.5	17.5	3.2	17.5	7.3	32.0	12.9	6.8	3.4	7.0	11.0	11.1	18.7	7.6	7.4	13.4	35.1	28.0	9.2	8.2	18.4	12.1	10.6	6.5	13.8	7.3	8.3	5.7	7.4	11.0	4.0	13.2	6.3	4.7	12.4	15.4	13.6	5.9	4.8	43.7	4.8	29.1	6.7	5.5	9.7	21.4	11.1	9.8	14.2	18.5	15.5	16.4	14.1	15.4	22.4	18.4	2.3	13.3	12.5	6.8	12.6	11.6	6.6	7.0	11.1	6.4	5.0	4.9	7.2	3.8	6.5	7.6
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavourable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	187.8	87.1	87.3	66.8	198.2	375.4	77.2	72.2	167.6	139.1	177.0	77.2	84.5	372.4	175.0	120.5	73.0	170.8	173.0	119.6	81.8	135.4	50.2	62.4	84.6	233.1	107.9	74.4	283.3	274.0	83.6	261.3	218.2	70.7	119.0	135.8	94.3	117.5	105.0	68.7	150.6	140.9	82.7	206.9	151.8	67.1	70.0	117.0	17.4	153.8	213.5	56.0	150.9	105.0	48.7	92.6	109.6	159.9	283.6	204.8	370.4	74.0	155.8	60.8	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468408-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			360000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: "	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	55.0	41.7	35.5	80.8	28.0	79.0	96.9	25.3	37.6	71.5	76.4	22.8	62.3	35.0	91.2	62.5	88.7	91.0	72.6	45.2	28.1	23.1	45.4	71.1	44.8	94.0	28.5	38.0	155.3	141.2	18.6	35.6	56.6	25.6	86.5	55.2	34.7	104.5	66.1	98.5	92.9	47.2	56.8	27.3	51.4	55.5	33.2	20.1	70.6	62.0	121.6	76.5	77.4	86.4	165.3	104.4	8.5	62.8	101.1	186.5	235.1	65.8	68.0	77.4	72.7	116.0	211.6	87.7	68.3	140.6	96.3	76.8	98.4	63.8	197.7	63.0	92.5	58.5	104.2	155.8	80.1	68.5	91.8	75.9	63.0	137.4	171.8	110.6	63.3	245.9	182.7	70.6	237.0	141.0	89.4	97.8	109.2	116.4	116.7	134.5	81.2	60.1	92.4	74.6	153.0	121.7	109.0	54.6	80.0	42.0	96.6	192.8	104.5	201.8	81.3	31.5	56.9	41.8	85.9	61.8	100.6	130.6	39.5	129.1	56.3	8.5	62.8	5.9	82.7	61.2	146.9	165.3	137.8	106.1	104.4	146.8	186.5	145.8	6.1	101.1	52.4	98.5	104.4	235.1	35.5	28.0	25.3	37.6	28.1	23.1	28.5	38.0	25.6	20.1
RPL11	L11	ENSG00000142676	"Ribosomal protein L11"	P62913	1	23691742-23696835	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA002734, HPA074839"	Approved		Approved	Vesicles			720000	Vesicles		"HPA002734: AB_1079838, HPA074839: "	"prognostic favourable (2.55e-4)"	"unprognostic (3.98e-2)"	"unprognostic (7.77e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.70e-2)"	"unprognostic (4.51e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavourable (5.93e-6)"	"unprognostic (8.65e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.41e-2)"	"unprognostic (1.90e-1)"	75.0	46.8	35.1	71.4	74.9	65.8	175.9	33.4	41.1	100.3	69.1	32.9	50.5	30.3	130.0	112.0	87.8	95.9	65.4	79.9	56.0	26.2	56.2	78.8	78.7	222.2	39.5	46.6	148.2	311.5	47.6	43.4	48.3	78.6	85.2	97.7	43.2	204.8	66.6	84.2	92.1	58.0	103.4	47.0	72.3	77.5	52.9	23.2	65.5	91.9	92.2	169.3	73.7	115.4	178.7	93.6	43.4	72.4	79.3	199.1	235.2	37.7	62.0	74.7	38.1	128.2	182.0	26.3	25.5	107.9	97.7	73.1	111.8	42.7	79.0	28.4	86.8	32.4	93.7	126.1	109.5	27.9	125.6	36.8	212.4	147.7	96.1	62.0	30.3	176.7	186.8	82.3	148.6	103.3	42.6	42.8	103.5	117.3	36.0	99.2	18.6	71.0	45.8	36.3	75.0	110.1	67.7	29.5	35.9	20.0	41.7	73.8	30.7	77.2	30.9	24.0	32.8	40.3	32.1	39.3	35.6	55.3	30.3	88.7	27.4	43.4	72.4	22.0	73.6	63.2	125.4	178.7	150.1	107.5	93.6	157.3	199.1	146.6	11.6	79.3	49.8	93.2	109.4	235.2	35.1	74.9	33.4	41.1	56.0	26.2	39.5	46.6	78.6	23.2
RPL12	L12	ENSG00000197958	"Ribosomal protein L12"	P30050	9	127447674-127451405	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003403	Approved		Approved	"Golgi apparatus"			520000	"Golgi apparatus"		"HPA003403: AB_1856432"	"unprognostic (5.89e-3)"	"unprognostic (3.27e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (5.66e-4)"	"unprognostic (4.98e-2)"	"unprognostic (3.05e-1)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (7.42e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.80e-2)"	68.0	44.4	34.5	55.7	38.5	81.6	103.5	23.4	35.9	80.3	56.3	26.3	48.3	35.0	54.4	82.8	71.4	79.4	59.0	40.1	28.9	22.1	54.2	68.9	48.6	108.3	29.2	26.8	118.6	174.8	16.1	34.3	40.0	28.7	57.2	49.7	34.1	88.8	68.4	116.2	88.3	54.0	63.7	38.8	82.7	52.3	35.6	38.7	63.9	58.4	102.4	82.0	83.6	77.0	173.9	97.8	17.7	60.5	76.2	152.2	157.1	64.7	59.9	66.3	132.9	127.7	286.9	102.2	58.1	158.6	104.6	82.1	128.9	67.8	124.0	79.2	98.8	78.4	83.8	135.3	71.9	62.4	76.9	72.5	81.5	116.9	271.6	110.9	78.4	311.4	270.7	73.3	279.4	141.2	97.7	106.0	129.9	223.3	104.4	171.3	96.9	112.2	89.3	127.3	134.1	153.6	65.6	58.5	85.2	43.7	147.3	180.4	120.9	153.9	78.9	39.4	70.6	67.6	114.2	55.2	67.7	126.7	41.0	106.4	60.0	17.7	58.0	16.5	67.8	60.5	125.9	173.9	127.1	92.4	97.8	171.9	152.2	126.5	7.5	76.2	58.0	89.5	109.6	157.1	34.5	38.5	23.4	35.9	28.9	22.1	29.2	26.8	28.7	38.7
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: "	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favourable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	66.8	74.4	52.9	85.7	95.2	158.6	110.8	42.3	91.7	88.4	35.9	112.3	103.8	94.1	87.4	71.7	93.1	62.8	111.2	44.1	26.3	174.3	32.0	41.5	148.9	203.8	38.9	39.1	192.1	237.1	56.6	142.9	92.1	97.8	53.7	67.9	209.5	106.4	305.2	108.1	79.1	158.7	56.0	132.2	107.3	56.2	74.6	109.1	58.6	76.5	126.9	150.5	231.1	53.7	57.1	61.7	50.3	57.9	81.4	76.5	96.0	74.6	137.3	60.0	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6
RPL13A	"L13A, TSTA1"	ENSG00000142541	"Ribosomal protein L13a"	P40429	19	49487554-49492308	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA038751	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA038751: AB_10962004"	"unprognostic (2.35e-3)"	"unprognostic (2.15e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.95e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (9.97e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.81e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.87e-1)"	85.4	87.0	45.7	114.3	46.9	132.5	106.4	38.9	41.2	103.8	145.5	38.8	89.2	84.1	129.4	80.7	117.7	83.5	119.9	112.5	37.2	31.2	65.4	113.9	71.8	265.3	41.5	37.0	203.8	334.9	21.8	54.2	76.7	44.1	114.3	46.8	65.4	169.0	95.4	216.0	122.9	77.0	121.1	44.2	121.4	87.8	54.5	27.8	124.0	119.8	147.0	115.0	112.7	196.5	284.6	144.9	40.5	81.3	148.0	268.3	354.3	119.8	147.3	70.1	204.6	133.7	211.9	83.5	104.9	129.9	75.6	82.1	124.9	92.1	304.0	84.4	78.4	79.5	87.4	151.7	44.8	85.1	205.9	153.4	95.9	178.0	163.0	230.4	122.0	245.0	253.4	53.6	182.2	121.9	132.1	114.7	87.0	104.2	161.0	234.1	135.5	132.6	156.6	160.0	132.5	102.7	203.6	120.2	158.1	54.8	244.2	231.7	107.7	265.9	150.1	95.5	103.1	59.2	138.0	116.1	157.4	137.2	59.7	158.0	87.6	40.5	81.3	20.7	132.2	70.3	194.3	284.6	226.2	180.3	126.7	264.8	268.3	212.3	13.6	148.0	60.4	144.9	165.3	354.3	45.7	46.9	38.9	41.2	37.2	31.2	41.5	37.0	44.1	27.8
RPL14	"CTG-B33, hRL14, L14, RL14"	ENSG00000188846	"Ribosomal protein L14"	P50914	3	40457292-40468587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 92.6;hTCEpi: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004136	Approved		Supported	"Endoplasmic reticulum,Cytosol"			210000	"Endoplasmic reticulum, Cytosol"		"HPA004136: AB_1079839"	"unprognostic (1.36e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.15e-1)"	49.9	33.5	28.3	57.4	43.8	47.2	134.4	28.7	57.6	85.4	68.2	21.4	48.0	29.8	87.0	30.9	66.0	61.0	56.7	46.7	40.8	22.8	42.5	69.8	44.6	61.7	24.7	22.2	151.9	117.3	48.4	34.4	60.8	40.6	81.8	42.0	36.2	162.9	73.6	72.3	66.7	39.0	59.1	24.7	69.6	52.4	23.8	11.7	42.9	63.3	100.2	58.5	48.7	77.0	26.6	16.0	4.6	11.6	14.3	38.3	47.9	9.5	5.3	32.5	11.5	26.3	92.6	18.9	14.7	49.3	55.5	42.1	11.1	3.8	41.9	12.4	14.5	2.9	16.5	25.7	32.7	14.2	18.2	20.1	9.2	10.6	40.3	28.5	10.8	44.8	96.7	15.8	33.5	50.8	23.6	5.9	38.4	9.2	9.4	26.0	9.3	17.3	4.4	12.3	20.3	41.1	7.1	10.1	16.3	7.7	7.5	22.3	11.7	15.7	16.9	11.3	8.2	14.3	18.6	18.3	22.0	22.9	5.0	21.5	10.4	3.7	11.6	4.6	21.1	11.6	35.5	26.6	31.7	27.7	16.0	24.1	38.3	34.9	1.8	14.3	9.9	14.6	24.9	47.9	28.3	43.8	28.7	57.6	40.8	22.8	24.7	22.2	40.6	11.7
RPL15	"EC45, L15, RPL10, RPLY10, RPYL10"	ENSG00000174748	"Ribosomal protein L15"	P61313	3	23916545-23924374	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																		56000				"unprognostic (8.73e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.76e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.17e-2)"	74.1	64.1	63.1	56.1	82.7	146.4	119.6	65.7	102.7	92.0	73.2	63.8	50.1	50.5	89.7	84.5	92.3	100.9	61.8	58.1	49.7	48.4	75.2	120.6	58.1	105.8	55.4	67.2	209.8	139.7	33.5	67.2	81.5	80.5	78.2	64.4	68.5	139.4	62.1	100.9	97.8	61.6	84.0	58.9	79.9	77.1	161.7	35.1	102.1	108.5	84.1	108.9	92.6	87.8	187.3	155.1	36.8	109.3	115.7	184.8	271.3	91.0	83.6	97.8	112.0	167.1	275.9	115.5	88.5	168.4	136.2	119.0	94.9	106.3	190.3	83.1	135.5	62.2	116.2	197.3	101.0	86.5	164.2	75.9	90.9	111.5	214.0	129.8	97.0	270.2	283.7	146.7	259.2	177.2	91.5	152.7	146.5	126.0	165.5	165.0	165.6	137.3	145.1	85.9	193.5	143.1	108.8	51.2	124.6	51.8	224.2	181.0	149.3	257.2	96.2	80.0	104.3	84.6	157.1	133.6	175.7	162.3	83.1	175.5	92.0	36.8	109.3	22.6	95.9	96.7	168.2	186.5	147.5	132.2	155.1	187.3	184.8	157.9	14.1	115.7	79.4	124.6	127.4	271.3	63.1	82.7	65.7	102.7	49.7	48.4	55.4	67.2	80.5	35.1
RPL17	"L17, rpL23"	ENSG00000265681	"Ribosomal protein L17"	P18621	18	49488453-49492523	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043724, HPA046385"	Supported		Supported	"Endoplasmic reticulum,Cytosol"			28000	"Endoplasmic reticulum, Cytosol"		"HPA043724: , HPA046385: "	"unprognostic (1.11e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavourable (3.60e-5)"	"unprognostic (2.69e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.72e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-3)"	59.6	60.0	40.5	57.8	58.1	101.1	127.2	41.7	42.9	66.7	64.4	26.3	67.8	40.9	64.1	65.5	84.9	76.7	79.7	49.5	32.2	31.1	99.4	184.2	48.0	106.0	42.9	32.3	177.4	203.2	21.7	72.5	77.1	43.6	60.7	53.1	39.8	83.3	83.8	67.6	76.3	69.7	43.7	38.1	78.5	66.8	92.7	32.9	66.6	81.7	146.2	75.2	58.2	70.4	140.6	102.8	22.2	59.2	95.1	158.9	142.2	98.1	62.5	91.1	107.5	150.7	308.0	86.8	110.5	128.7	104.8	79.5	84.0	47.9	170.4	76.3	109.2	117.9	123.5	198.2	112.3	70.6	127.7	89.9	74.3	114.4	131.4	291.6	72.3	293.3	224.7	109.1	258.9	143.1	87.9	125.1	130.0	79.8	105.2	187.3	92.7	51.4	104.6	118.7	219.3	141.9	117.7	69.8	84.2	40.8	85.1	170.8	80.5	191.1	113.6	77.8	66.2	38.1	115.9	112.9	105.2	157.8	74.4	177.7	74.0	22.2	59.2	15.2	82.8	53.2	158.9	140.6	134.5	109.0	93.7	117.9	150.4	127.9	12.7	95.1	43.8	102.8	104.8	142.2	40.5	58.1	41.7	42.9	32.2	31.1	42.9	32.3	43.6	32.9
RPL18	L18	ENSG00000063177	"Ribosomal protein L18"	Q07020	19	48615328-48619536	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"NB-4: 548.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046572	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA046572: "	"unprognostic (2.12e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.48e-3)"	"unprognostic (4.76e-2)"	"unprognostic (3.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.15e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.21e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.27e-2)"	56.2	57.3	50.3	79.1	40.8	122.4	84.9	35.2	51.1	89.8	76.6	44.8	60.8	66.1	100.6	56.1	129.6	78.2	99.2	43.4	38.3	33.1	56.4	101.9	62.1	194.1	40.3	27.0	206.5	260.5	19.8	57.1	74.8	26.8	100.5	39.6	54.6	136.7	62.3	78.8	108.6	60.5	69.1	39.7	88.7	64.0	45.8	28.6	114.9	115.8	116.5	122.2	91.2	90.5	137.1	84.5	19.0	57.5	71.1	144.1	148.6	57.1	89.2	32.9	57.0	33.5	66.1	48.0	26.3	43.8	54.5	45.9	80.4	53.2	83.7	27.6	25.1	47.4	29.8	59.7	20.8	35.6	103.8	30.3	41.7	76.8	67.8	42.1	47.3	77.9	87.7	29.2	39.4	53.6	42.7	73.7	34.2	72.6	66.2	548.2	52.3	44.5	69.4	26.4	75.8	44.1	70.7	46.7	60.9	23.7	83.6	79.3	47.1	82.1	30.5	40.5	45.0	25.0	60.2	61.3	71.4	49.9	25.4	65.1	47.6	19.0	57.5	12.2	65.7	47.6	115.3	130.3	116.4	88.1	79.2	137.1	144.1	113.9	8.6	71.1	37.3	84.5	89.6	148.6	50.3	40.8	35.2	51.1	38.3	33.1	40.3	27.0	26.8	28.6
RPL18A	L18A	ENSG00000105640	"Ribosomal protein L18a"	Q02543	19	17859876-17864153	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 430.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA055259	Approved		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA055259: "	"unprognostic (3.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.71e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.36e-1)"	48.8	33.8	24.9	42.2	43.0	85.7	53.6	27.8	61.1	49.9	46.0	26.5	28.1	40.4	47.8	36.4	65.5	56.5	38.9	31.5	22.6	16.2	50.0	85.9	34.8	83.7	22.3	26.1	109.2	106.6	9.3	30.5	46.9	30.9	41.8	26.8	30.4	99.8	31.6	157.7	90.1	43.3	36.6	21.9	57.6	50.1	67.3	17.6	59.5	65.3	107.9	54.0	45.0	57.1	395.8	193.6	24.8	110.7	126.0	278.4	430.5	126.2	98.4	65.8	92.7	98.8	162.8	166.6	77.5	98.6	102.7	97.9	135.8	127.2	191.2	179.9	66.7	95.2	77.5	165.1	35.9	97.7	208.8	89.3	94.7	154.6	171.1	128.4	97.8	203.2	217.7	56.8	122.4	112.2	113.4	124.0	64.8	197.0	173.7	169.6	154.7	151.8	156.3	69.8	226.6	93.7	120.2	95.3	143.0	27.5	192.2	240.0	91.2	249.6	86.0	63.6	74.1	127.0	130.0	166.3	151.2	123.4	83.6	205.6	78.9	24.8	110.4	16.5	134.8	110.7	234.6	368.3	232.2	167.1	166.6	395.8	278.4	212.5	11.3	126.0	85.6	193.6	195.9	430.5	24.9	43.0	27.8	61.1	22.6	16.2	22.3	26.1	30.9	17.6
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 937.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol			100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: "	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavourable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	47.0	64.0	46.4	56.3	85.0	107.5	48.1	44.3	90.4	91.7	73.8	69.7	44.5	115.2	78.0	63.2	80.0	69.8	91.6	47.3	46.7	122.5	41.1	47.8	90.7	132.6	100.6	56.9	119.7	100.6	70.6	127.9	79.1	71.4	67.4	63.3	46.4	133.2	140.6	47.5	47.7	79.0	66.1	115.1	82.7	59.0	56.5	62.8	26.6	937.7	138.3	90.8	128.1	46.5	35.9	48.5	54.6	81.4	89.0	88.1	84.7	48.7	76.8	46.1	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1
RPL22	"EAP, L22"	ENSG00000116251	"Ribosomal protein L22"	P35268	1	6181269-6209389	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Heparin-binding, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068294			Approved	Nucleoplasm,Nucleoli			320000	Nucleoli	Nucleoplasm	"HPA068294: "	"unprognostic (3.16e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.40e-2)"	"unprognostic (7.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-3)"	"unprognostic (3.83e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.98e-1)"	75.5	71.5	54.3	79.7	42.8	124.7	75.0	46.7	39.5	95.8	73.9	39.2	53.9	66.5	133.6	63.9	103.9	59.1	61.8	50.8	47.4	38.6	58.8	90.2	55.3	142.6	50.6	39.7	163.1	154.8	30.4	57.0	49.8	37.4	90.8	46.4	57.0	140.3	66.8	114.0	79.7	62.6	106.6	58.3	79.1	62.0	38.2	35.0	95.3	91.0	112.8	81.1	101.5	91.9	75.6	62.3	11.0	38.9	42.2	98.8	73.9	88.0	25.1	53.5	54.6	37.7	59.3	42.3	76.9	30.9	28.3	24.2	49.8	76.6	136.7	63.3	28.5	50.9	40.2	40.0	37.3	66.9	65.4	132.8	57.2	61.7	37.4	175.7	53.3	52.3	33.1	25.2	52.2	35.3	109.4	82.8	32.5	38.8	76.8	143.4	33.3	55.7	74.1	111.0	105.8	41.4	30.6	74.0	67.9	62.6	181.4	140.8	58.4	139.3	86.3	40.4	44.5	53.3	72.2	66.7	91.4	206.8	26.7	181.7	25.0	11.0	38.9	8.8	38.0	34.3	66.9	75.6	71.1	52.3	59.8	72.4	98.8	78.1	2.9	42.2	27.8	62.3	54.0	73.9	54.3	42.8	46.7	39.5	47.4	38.6	50.6	39.7	37.4	35.0
RPL23	"L23, rpL17"	ENSG00000125691	"Ribosomal protein L23"	P62829	17	38847865-38853843	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003373	Approved		Supported	Cytosol			76000	Cytosol		"HPA003373: AB_1856436"	"unprognostic (1.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.48e-2)"	"unprognostic (9.08e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (4.19e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.46e-3)"	"unprognostic (4.45e-1)"	103.1	79.0	47.1	86.5	56.3	125.2	175.1	35.2	54.6	117.2	86.6	26.4	106.1	48.7	93.4	115.8	132.6	92.1	119.4	163.9	58.9	39.5	79.6	107.5	112.3	239.3	52.1	51.0	240.1	329.6	33.8	55.3	68.4	73.2	99.9	76.1	52.5	114.5	101.3	150.0	119.8	69.5	192.7	72.8	95.5	80.1	49.2	42.6	89.3	95.2	117.3	132.0	152.4	207.2	160.0	168.4	29.0	94.3	87.5	176.7	163.2	90.9	91.6	121.0	102.4	216.4	284.5	84.9	91.4	138.5	115.3	86.8	132.0	81.4	202.8	91.1	100.4	161.1	104.8	177.3	141.6	70.1	156.6	74.5	120.1	187.8	162.6	205.1	78.4	266.6	221.1	100.0	209.9	122.0	117.8	102.9	148.0	81.6	179.8	219.7	88.3	55.8	122.6	177.5	199.0	161.0	116.0	82.4	122.5	49.1	84.9	184.0	140.4	258.1	85.2	53.2	81.8	83.1	151.5	66.7	102.4	158.8	81.5	123.3	68.4	29.0	94.3	19.6	82.3	76.6	101.9	160.0	130.7	100.1	134.8	149.7	176.7	145.4	15.2	87.5	65.5	168.4	95.4	163.2	47.1	56.3	35.2	54.6	58.9	39.5	52.1	51.0	73.2	42.6
RPL23A	L23A	ENSG00000198242	"Ribosomal protein L23a"	P62750	17	28719393-28724359	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 261.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051754, HPA077474"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"			15000	"Nucleoli fibrillar center, Endoplasmic reticulum, Cytosol"		"HPA051754: , HPA077474: "	"unprognostic (1.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.79e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (5.16e-6)"	"unprognostic (3.91e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.98e-3)"	"unprognostic (2.68e-1)"	49.1	38.5	48.6	43.3	62.1	67.9	87.0	40.6	75.5	63.8	47.0	27.3	48.5	34.8	53.2	44.0	56.5	64.1	35.1	48.8	56.6	28.7	39.5	93.2	62.3	108.0	42.6	39.6	142.1	63.3	21.4	45.3	51.0	40.5	44.9	48.8	27.6	61.3	41.7	64.9	70.5	44.6	39.8	63.4	59.1	47.8	108.1	35.7	56.1	44.4	78.8	84.9	51.1	61.0	261.4	139.2	30.6	75.3	142.1	254.7	206.1	58.8	120.4	72.8	90.3	96.5	155.5	71.0	55.4	97.1	93.8	79.3	122.4	57.2	133.3	52.2	76.8	80.6	95.9	123.5	97.3	70.5	265.1	63.7	118.3	130.3	87.9	132.2	66.7	151.2	159.1	74.6	118.0	101.5	82.6	90.5	93.8	97.4	147.6	174.4	69.3	73.4	87.5	131.6	157.5	101.6	120.5	75.3	87.8	39.3	285.5	123.9	141.9	155.4	60.1	51.6	73.6	60.1	97.8	112.9	104.2	77.9	81.8	73.2	56.9	30.6	66.3	19.4	156.5	75.3	232.3	261.4	227.4	203.4	108.7	227.4	254.7	229.5	9.4	142.1	59.6	139.2	154.0	206.1	48.6	62.1	40.6	75.5	56.6	28.7	42.6	39.6	40.5	35.7
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"			19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: "	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavourable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favourable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	163.5	54.4	83.4	92.0	91.5	164.0	126.3	94.3	105.4	127.5	93.5	108.2	72.5	180.5	117.0	72.1	87.1	96.6	116.8	127.8	96.7	96.9	107.0	47.2	80.9	89.9	120.3	56.7	159.1	149.9	80.2	143.3	107.9	97.9	90.1	117.2	109.3	128.2	184.3	150.1	118.2	113.1	82.3	172.4	130.1	73.0	178.7	83.1	49.1	88.3	209.1	107.9	221.4	78.8	55.6	103.2	30.4	114.6	79.2	101.1	315.6	74.5	127.4	93.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1
RPL3	L3	ENSG00000100316	"Ribosomal protein L3"	P39023	22	39312882-39320389	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003365, HPA055361"	Uncertain		Supported	Nucleoli,Cytosol			120000	"Nucleoli, Cytosol"		"HPA003365: AB_1079841, HPA055361: "	"unprognostic (9.79e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.44e-3)"	"unprognostic (1.72e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.87e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.32e-2)"	71.7	71.8	51.3	72.3	50.3	107.0	134.5	50.8	49.3	102.2	94.4	42.7	78.1	63.1	207.5	79.6	126.9	101.6	96.2	54.5	41.4	38.8	66.6	102.5	74.5	205.9	47.4	57.7	217.8	453.1	50.9	75.0	74.5	58.0	138.7	57.0	74.8	216.3	68.5	48.9	118.1	62.6	115.6	50.7	84.3	74.4	76.4	23.3	105.5	158.5	82.3	109.8	119.9	105.7	198.9	114.8	18.9	56.4	150.3	249.0	326.4	86.4	80.1	91.6	101.3	117.3	254.3	123.5	67.0	127.6	67.1	60.3	100.6	66.1	357.7	92.9	80.7	57.6	97.7	143.3	44.7	60.8	96.3	90.0	95.8	150.5	173.2	127.9	76.0	245.7	194.2	58.0	206.7	130.4	101.3	124.4	96.9	111.3	129.8	186.2	95.8	55.9	104.3	88.9	179.5	123.9	128.2	83.9	99.1	42.0	137.6	219.3	103.7	208.6	129.2	45.1	71.3	47.2	76.3	95.6	72.2	158.4	101.6	113.1	50.9	18.9	56.4	11.9	132.5	51.7	205.6	198.9	192.1	153.7	101.2	175.8	249.0	195.2	8.1	150.3	44.5	114.8	126.1	326.4	51.3	50.3	50.8	49.3	41.4	38.8	47.4	57.7	58.0	23.3
RPL30	L30	ENSG00000156482	"Ribosomal protein L30"	P62888	8	98024851-98046469	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA002651	Approved		Approved	"Endoplasmic reticulum,Cytosol"			52000	"Endoplasmic reticulum, Cytosol"		"HPA002651: AB_1079842"	"unprognostic (3.28e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.76e-2)"	"prognostic unfavourable (1.41e-9)"	"unprognostic (2.84e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.97e-3)"	146.2	68.8	77.6	75.4	56.2	153.1	195.1	54.3	62.0	158.8	123.2	64.1	96.3	57.5	146.1	120.3	164.9	126.6	113.5	147.3	64.5	53.1	75.7	140.6	121.2	383.2	78.6	46.4	284.8	344.3	44.6	62.1	97.5	49.3	154.7	96.3	66.2	172.7	131.4	191.2	144.8	90.1	164.3	85.2	146.6	96.3	79.5	58.7	168.1	170.4	102.5	176.5	153.6	197.4	180.4	94.5	42.1	70.0	94.2	238.2	179.6	146.7	100.8	108.6	104.1	156.6	290.4	104.6	86.7	151.6	146.4	128.6	111.2	138.8	192.1	227.0	123.7	96.3	135.2	161.0	152.5	75.8	112.9	167.3	100.9	145.7	230.5	89.1	83.7	246.3	255.8	108.4	311.0	150.2	119.4	127.5	124.2	195.2	207.8	167.2	97.1	146.4	112.6	82.7	176.7	119.4	136.4	157.0	134.5	50.2	125.5	197.9	165.2	212.1	83.4	57.3	61.7	85.5	103.7	134.5	108.9	157.3	80.5	182.3	83.7	42.1	70.0	31.6	104.4	63.1	154.1	180.4	181.2	138.9	94.5	171.7	238.2	186.0	26.3	94.2	55.6	94.0	117.8	179.6	77.6	56.2	54.3	62.0	64.5	53.1	78.6	46.4	49.3	58.7
RPL31	L31	ENSG00000071082	"Ribosomal protein L31"	P62899	2	101001715-101024032	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA072263	Approved						22000			"HPA072263: "	"unprognostic (4.82e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.86e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (3.94e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (8.08e-6)"	"unprognostic (1.81e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.51e-2)"	86.7	77.3	111.6	123.7	82.3	192.3	167.6	45.7	84.5	109.6	106.7	32.8	76.6	63.4	125.3	113.6	122.9	90.1	100.6	89.7	77.4	59.4	74.0	109.7	78.4	168.2	84.6	100.4	258.3	206.1	32.6	77.6	74.0	58.8	114.3	76.0	44.8	162.7	87.1	121.6	103.9	66.8	106.6	70.7	99.4	78.3	65.5	52.9	95.0	113.3	171.8	115.4	116.1	159.8	273.6	161.7	48.6	114.4	154.6	363.9	366.8	91.8	54.2	97.6	150.7	189.0	260.4	182.4	149.3	117.4	92.7	74.4	169.7	108.9	237.6	116.3	94.9	102.1	93.6	150.2	98.0	83.8	147.7	140.0	157.6	196.3	148.4	246.6	114.1	211.8	239.2	81.6	188.2	105.2	131.0	56.3	106.8	122.6	181.9	310.8	182.4	65.0	102.5	148.3	191.6	144.2	147.4	121.0	132.5	63.3	220.1	262.1	106.4	336.0	159.3	76.3	135.7	88.9	116.2	119.0	159.9	157.3	105.8	233.2	73.7	48.6	114.4	25.6	145.0	89.7	240.3	273.6	260.9	202.0	160.4	235.7	363.9	288.2	18.1	154.6	72.6	161.7	164.1	366.8	111.6	82.3	45.7	84.5	77.4	59.4	84.6	100.4	58.8	52.9
RPL32	L32	ENSG00000144713	"Ribosomal protein L32"	P62910	3	12834485-12841588	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 406.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047501, HPA051994"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"			140000	"Endoplasmic reticulum, Cytosol"		"HPA047501: AB_2680070, HPA051994: AB_2681686"	"unprognostic (6.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.58e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.44e-2)"	80.5	42.2	62.9	55.4	44.5	106.7	109.0	33.2	50.8	101.5	58.9	34.9	38.3	37.3	63.1	91.5	94.8	82.3	49.5	53.5	46.5	36.5	68.4	132.9	63.7	117.4	50.1	41.1	167.0	406.2	20.4	38.6	48.6	32.8	62.6	68.4	41.8	67.9	43.3	121.4	90.5	48.6	78.0	48.4	77.7	52.0	55.9	30.7	103.9	66.9	87.7	121.5	91.2	68.9	230.3	119.2	38.8	86.1	104.4	281.7	293.2	73.3	88.3	77.1	98.2	121.3	217.4	254.8	60.7	113.1	128.3	88.0	116.6	75.3	128.1	55.5	87.1	46.1	87.4	126.1	105.6	59.1	146.3	74.4	112.0	126.0	181.4	119.9	75.6	195.0	275.4	97.8	189.2	111.9	91.3	119.1	104.7	221.5	134.7	207.3	129.9	167.7	107.7	69.3	166.7	129.6	122.3	49.0	98.0	40.8	109.8	130.4	160.7	231.2	64.5	55.7	71.2	73.1	111.3	80.6	126.5	223.9	70.9	172.2	82.9	38.8	86.1	22.9	99.1	66.7	178.3	230.3	197.2	143.1	119.2	214.7	281.7	213.1	12.7	104.4	53.6	118.2	147.0	293.2	62.9	44.5	33.2	50.8	46.5	36.5	50.1	41.1	32.8	30.7
RPL4	L4	ENSG00000174444	"Ribosomal protein L4"	P36578	15	66498015-66524532	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA034600	Uncertain		Supported	"Nucleoli,Nuclear bodies,Endoplasmic reticulum,Cytosol"			830000	"Endoplasmic reticulum, Cytosol"	"Nucleoli, Nuclear bodies"	"HPA034600: AB_10601483"	"unprognostic (1.51e-2)"	"unprognostic (3.77e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.20e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.60e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.27e-1)"	63.6	33.4	37.0	59.0	40.4	70.6	88.2	34.5	42.2	73.6	60.5	33.5	42.3	18.8	67.3	49.8	81.3	65.7	39.4	38.8	31.7	26.4	53.2	84.5	46.1	103.9	35.1	26.3	139.1	159.9	33.1	42.0	52.0	34.1	67.6	50.9	35.9	66.2	51.0	87.2	77.1	36.4	67.3	47.9	60.3	46.3	42.8	20.0	81.3	66.1	91.7	102.8	74.2	55.9	72.5	58.7	5.9	40.9	45.0	97.0	135.7	44.2	89.4	37.8	63.7	170.4	309.9	66.8	54.1	111.7	83.8	65.1	98.8	77.7	175.4	61.7	128.8	80.6	270.2	209.1	92.7	48.4	162.0	107.5	80.1	82.0	240.2	112.6	53.9	304.0	272.6	91.0	363.9	133.9	98.4	69.0	125.2	73.0	75.0	50.1	82.7	64.0	84.1	86.3	170.2	115.1	87.9	67.3	70.4	33.3	94.9	133.6	70.1	162.8	78.4	43.8	66.2	40.7	85.9	67.9	105.2	117.3	53.9	151.6	49.3	3.5	40.9	5.9	38.2	36.2	71.1	72.5	74.6	53.7	58.7	60.5	97.0	75.7	2.7	45.0	33.5	37.4	57.0	135.7	37.0	40.4	34.5	42.2	31.7	26.4	35.1	26.3	34.1	20.0
RPL5	"L5, PPP1R135"	ENSG00000122406	"Ribosomal protein L5"	P46777	1	92831983-92841924	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"	"Cancer-related genes, Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA043717, HPA054444"	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			130000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043717: AB_10964719, HPA054444: "	"unprognostic (5.81e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.44e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (6.81e-5)"	"unprognostic (2.26e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.97e-1)"	119.4	80.3	50.0	70.0	50.1	113.8	140.5	46.9	46.8	158.6	111.4	45.0	75.1	61.7	135.2	114.6	159.4	100.5	73.1	73.0	43.5	43.1	99.7	114.9	89.9	148.2	54.5	36.2	296.8	306.5	40.8	90.3	90.2	44.3	175.4	78.8	64.3	121.5	73.2	109.1	97.8	95.3	153.4	61.9	130.1	90.0	68.8	45.7	156.6	210.0	97.7	118.9	191.2	146.6	104.5	85.2	12.8	45.9	72.4	143.0	142.1	116.8	50.2	89.5	75.5	116.4	235.3	143.6	69.9	93.6	87.1	62.4	133.0	51.1	220.5	112.3	78.5	74.7	102.6	131.0	111.3	69.8	140.4	114.4	83.6	122.4	139.7	175.1	48.2	192.4	206.7	77.3	170.2	120.2	141.6	116.3	99.7	66.3	139.4	198.6	138.2	94.9	128.1	173.4	142.4	105.6	97.3	76.3	91.3	45.5	127.1	203.3	70.0	240.9	73.0	44.0	80.4	83.1	126.0	72.0	68.3	149.2	29.8	151.0	29.8	12.8	45.9	7.2	60.9	44.8	122.1	104.5	111.5	91.6	85.2	88.4	143.0	123.9	4.4	72.4	38.3	71.1	83.2	142.1	50.0	50.1	46.9	46.8	43.5	43.1	54.5	36.2	44.3	45.7
RPL7	"humL7-1, L7"	ENSG00000147604	"Ribosomal protein L7"	P18124	8	73290267-73295789	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 536.3"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 627.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA058373	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"			170000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA058373: "	"unprognostic (3.75e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.31e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.31e-1)"	54.7	36.5	54.6	37.9	49.3	67.6	86.9	55.9	54.1	57.5	46.2	36.4	41.0	33.6	54.9	50.6	59.5	50.6	26.5	36.7	32.1	22.0	46.4	67.6	40.3	53.3	55.9	20.5	125.8	87.5	22.9	67.7	33.4	55.0	43.6	44.9	44.1	51.8	36.6	61.9	72.7	37.0	49.5	46.9	46.5	51.2	135.1	54.9	33.7	42.6	69.0	66.6	50.8	58.5	338.1	231.5	66.1	171.7	205.0	464.0	536.3	98.1	71.3	76.7	92.3	156.6	200.7	75.5	107.9	86.8	73.7	58.3	85.7	102.8	292.0	88.3	87.0	94.2	101.2	137.7	115.1	78.5	84.0	159.8	93.3	88.2	94.1	112.6	82.0	187.8	162.8	68.2	213.6	119.5	142.4	110.8	104.6	83.3	178.7	172.3	89.4	76.7	120.9	87.9	113.8	114.9	98.5	106.2	77.4	50.7	627.9	151.0	158.7	148.1	112.1	56.7	86.8	72.1	99.6	64.1	90.8	188.4	59.3	139.9	93.1	66.1	171.7	41.1	179.1	138.9	322.3	338.1	314.4	232.5	231.5	282.6	464.0	327.0	22.3	205.0	118.6	192.4	237.0	536.3	54.6	49.3	55.9	54.1	32.1	22.0	55.9	20.5	55.0	54.9
RPL7A	"L7A, SURF3, TRUP"	ENSG00000148303	"Ribosomal protein L7a"	P62424	9	133348214-133351426	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA046794			Approved	Nucleoli,Vesicles			160000	Nucleoli	Vesicles	"HPA046794: "	"unprognostic (5.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.07e-3)"	"unprognostic (4.17e-3)"	"unprognostic (7.95e-2)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (1.98e-1)"	"unprognostic (8.88e-2)"	"prognostic unfavourable (3.60e-5)"	"unprognostic (4.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.89e-2)"	58.8	72.8	34.9	64.0	39.6	78.6	96.3	33.1	43.2	70.1	66.6	27.6	66.9	38.9	137.4	81.5	96.0	94.8	74.4	48.2	29.5	25.7	51.0	59.3	48.1	159.6	32.7	45.2	164.9	193.1	29.1	50.6	42.4	34.1	90.1	67.6	47.3	204.8	70.0	85.2	91.9	48.6	91.0	35.5	68.1	61.4	78.2	24.0	80.5	77.9	70.1	93.2	75.1	109.7	79.7	56.4	12.1	35.8	50.2	80.4	94.0	45.2	69.0	78.9	78.5	138.7	230.3	75.3	57.1	116.9	103.0	57.6	104.8	59.8	142.1	35.3	99.6	111.1	116.5	137.2	83.2	60.3	65.9	50.0	102.6	101.9	92.0	118.3	59.3	231.6	205.4	74.5	129.3	130.7	95.6	75.0	118.2	153.8	91.7	123.8	85.7	68.1	80.7	98.9	180.8	132.7	58.1	74.1	65.4	46.7	120.5	72.9	131.3	125.4	71.4	68.1	49.0	61.2	67.7	29.3	58.3	87.3	53.1	82.7	52.8	12.1	35.8	7.7	52.2	33.6	77.3	79.7	71.2	64.3	56.4	71.8	80.4	73.5	5.5	50.2	29.3	56.1	54.6	94.0	34.9	39.6	33.1	43.2	29.5	25.7	32.7	45.2	34.1	24.0
RPL8	L8	ENSG00000161016	"Ribosomal protein L8"	P62917	8	144789765-144792587	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 322.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045095, HPA050165"	Enhanced		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			240000000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA045095: AB_2679213, HPA050165: AB_2681038"	"unprognostic (2.52e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.84e-2)"	"prognostic unfavourable (7.22e-4)"	"unprognostic (4.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.13e-2)"	65.9	45.5	32.1	53.7	34.7	120.1	115.2	31.0	61.9	63.9	78.4	26.4	51.1	95.2	106.4	57.1	76.0	51.2	68.9	78.7	27.2	23.6	48.2	62.6	54.5	169.4	29.0	28.8	125.7	349.6	11.8	45.2	38.4	28.8	61.3	15.7	45.6	174.7	57.3	202.1	89.0	82.8	84.9	29.2	79.7	96.4	48.9	17.0	61.2	73.2	103.2	72.8	64.7	100.0	174.8	117.5	31.1	82.7	77.9	136.8	251.3	120.4	142.3	10.2	44.2	11.4	26.0	97.8	87.3	16.5	26.7	19.0	124.2	65.2	162.1	126.4	10.3	73.0	13.3	30.4	4.9	70.4	161.9	96.2	109.6	87.5	28.6	63.0	52.5	28.0	34.7	12.0	20.6	19.6	129.5	37.6	11.3	322.1	89.9	85.4	95.0	161.3	88.2	58.9	152.4	14.2	91.4	62.3	104.0	83.8	45.7	119.9	105.8	61.0	78.4	35.5	135.2	74.1	104.9	68.8	58.7	140.2	70.7	104.8	48.6	24.1	80.3	31.1	70.5	82.7	117.9	166.8	119.3	86.9	117.5	174.8	136.8	105.0	9.8	77.9	78.5	64.5	113.8	251.3	32.1	34.7	31.0	61.9	27.2	23.6	29.0	28.8	28.8	17.0
RPL9	L9	ENSG00000163682	"Ribosomal protein L9"	P32969	4	39452521-39458949	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003372	Approved	Approved	Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"			24000	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA003372: AB_1079843"	"unprognostic (1.08e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.06e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.58e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.50e-2)"	"unprognostic (7.85e-2)"	"prognostic unfavourable (7.34e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.06e-2)"	52.6	35.2	42.2	73.9	44.4	179.1	202.3	35.7	51.6	63.0	59.8	34.5	42.2	69.8	50.4	226.8	49.9	48.1	69.7	58.2	42.3	27.6	47.4	73.2	35.8	48.7	34.7	51.7	158.5	126.2	37.4	44.7	38.7	42.5	47.8	59.1	31.7	93.7	71.4	66.3	62.9	38.8	49.5	34.0	45.2	46.5	56.9	25.9	36.0	63.2	70.1	59.0	46.0	56.6	118.3	72.5	26.2	41.4	63.0	145.0	148.9	3.2	2.8	122.4	2.8	6.6	9.0	4.7	57.6	87.0	71.9	54.6	8.0	65.4	142.9	6.6	57.9	65.1	5.4	6.2	78.7	52.0	115.0	4.5	24.1	7.8	8.5	9.3	37.8	11.9	180.9	4.4	82.7	5.4	109.2	66.7	5.0	4.3	77.5	9.8	109.2	3.8	71.6	122.7	4.9	89.4	3.7	4.6	48.8	1.9	47.3	7.3	104.4	6.7	4.1	3.0	4.6	83.7	7.9	102.5	143.9	124.1	83.1	86.9	3.3	26.2	41.4	12.3	52.1	40.1	101.2	118.3	102.2	71.4	57.2	103.8	145.0	111.7	6.9	63.0	31.2	72.5	77.0	148.9	42.2	44.4	35.7	51.6	42.3	27.6	34.7	51.7	42.5	25.9
RPLP0	"L10E, LP0, P0, PRLP0, RPP0"	ENSG00000089157	"Ribosomal protein lateral stalk subunit P0"	P05388	12	120196686-120201235	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 408.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003512, HPA073501"	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003512: AB_1079844, HPA073501: "	"unprognostic (2.39e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.35e-1)"	"prognostic unfavourable (7.66e-12)"	"unprognostic (2.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.47e-1)"	67.3	59.5	20.6	76.6	31.6	100.5	119.8	26.8	26.0	58.4	76.8	22.0	61.8	50.5	95.9	66.0	128.3	74.8	88.6	49.8	28.9	16.2	47.1	121.7	55.4	59.7	21.9	26.6	117.5	408.6	13.5	36.6	70.1	41.5	72.4	60.8	32.8	138.5	54.6	101.0	113.9	57.3	63.8	23.4	60.0	69.0	73.0	18.7	89.6	90.8	162.5	82.8	64.2	116.6	135.9	143.3	10.7	63.4	82.7	172.4	193.3	126.0	109.1	92.8	158.8	189.6	312.3	132.4	97.1	168.7	152.0	99.1	120.6	77.6	276.3	98.2	169.9	100.2	164.3	201.7	96.3	106.7	125.2	131.8	72.4	103.0	204.5	177.0	99.7	281.5	345.4	106.5	316.4	179.5	161.4	80.1	144.5	136.4	178.2	119.7	176.8	146.2	130.0	130.6	216.4	152.0	145.6	99.1	120.7	70.0	104.8	190.8	187.1	214.1	120.6	71.7	109.4	90.8	120.4	181.1	190.6	137.9	128.8	127.4	60.3	10.7	63.4	5.3	71.5	58.3	172.4	135.9	131.9	97.1	137.0	123.2	131.4	104.4	5.0	82.7	35.1	143.3	83.4	193.3	20.6	31.6	26.8	26.0	28.9	16.2	21.9	26.6	41.5	18.7
RPLP1	LP1	ENSG00000137818	"Ribosomal protein lateral stalk subunit P1"	P05386	15	69452784-69456194	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1030.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003368			Supported	"Endoplasmic reticulum,Cytosol"			1000000	"Endoplasmic reticulum, Cytosol"		"HPA003368: AB_1079845"	"unprognostic (5.04e-3)"	"unprognostic (2.26e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.79e-1)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (2.30e-9)"	"unprognostic (7.75e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.83e-2)"	59.6	57.2	47.5	76.8	42.9	171.7	451.2	68.8	103.3	70.1	79.0	20.8	57.9	87.5	73.5	76.3	100.7	65.7	80.6	341.6	35.5	29.7	55.8	69.9	290.9	1030.2	42.4	33.3	134.3	209.0	8.6	36.0	52.3	45.6	71.0	33.3	61.3	102.8	60.7	262.9	155.2	74.3	128.2	38.8	77.4	77.1	45.7	32.7	73.0	50.8	146.9	71.8	72.3	95.5	329.0	226.3	79.6	176.1	169.8	267.2	368.8	82.7	84.7	38.0	87.6	54.5	65.8	81.7	72.9	43.3	40.8	32.7	85.9	84.4	115.9	109.0	38.3	113.3	58.5	57.3	8.9	116.2	179.0	97.6	97.3	83.8	95.5	86.4	89.2	82.7	100.5	29.7	55.7	49.2	91.8	98.9	28.8	77.6	94.2	254.8	142.1	81.7	96.7	124.2	169.6	39.3	89.7	60.9	118.7	73.2	90.6	297.4	74.7	199.0	86.3	59.2	132.5	70.6	118.3	202.7	323.2	98.3	70.9	220.7	48.8	79.6	176.1	60.4	119.5	124.7	220.2	329.0	247.2	162.7	215.0	278.5	267.2	223.0	26.2	169.8	70.2	226.3	202.7	368.8	47.5	42.9	68.8	103.3	35.5	29.7	42.4	33.3	45.6	32.7
RPLP2	"D11S2243E, LP2, MGC71408, P2, RPP2"	ENSG00000177600	"Ribosomal protein lateral stalk subunit P2"	P05387	11	809647-812880	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 314.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053635	Approved		Approved	Mitochondria	"Intracellular and membrane"		730000	Mitochondria		"HPA053635: "	"unprognostic (6.98e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (9.14e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (2.19e-6)"	"unprognostic (6.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.31e-2)"	165.8	66.1	52.7	134.4	47.8	132.4	240.5	28.0	42.6	110.3	108.3	43.2	78.6	82.6	103.7	95.7	160.7	76.7	99.1	129.1	45.8	37.0	67.4	118.5	103.2	499.1	51.9	28.5	190.5	241.9	20.4	49.2	75.3	35.9	118.4	70.3	53.1	154.6	97.8	160.3	125.6	95.7	108.6	52.4	176.3	75.7	60.0	32.4	207.7	111.3	106.1	155.0	136.0	190.6	232.5	127.3	27.8	82.7	82.7	233.6	233.4	78.5	83.8	45.5	62.2	64.5	68.1	64.0	47.2	32.3	51.9	42.1	130.0	66.4	100.2	35.0	43.3	75.5	52.7	74.0	25.5	46.3	314.4	51.0	71.3	188.1	73.4	97.8	58.2	87.8	112.0	20.9	66.2	52.3	91.2	67.5	35.9	97.2	90.8	158.6	99.2	222.3	104.8	42.1	111.3	50.6	62.1	61.7	91.0	30.8	97.4	107.9	36.3	132.6	50.7	32.8	42.7	29.0	60.9	114.4	91.8	97.7	53.3	75.4	39.1	27.8	82.7	27.2	100.7	65.2	140.1	232.5	189.1	142.1	94.0	222.8	233.6	178.0	11.9	82.7	51.5	127.3	106.4	233.4	52.7	47.8	28.0	42.6	45.8	37.0	51.9	28.5	35.9	32.4
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum"			8200000	"Endoplasmic reticulum"		"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.8	33.2	27.7	51.0	75.1	50.3	62.8	52.5	69.0	69.8	81.3	68.7	57.3	38.1	49.5	75.7	61.3	44.7	46.7	68.3	27.3	28.7	67.2	24.7	56.4	82.8	54.4	35.4	41.7	54.7	45.9	67.9	54.4	27.6	51.1	45.7	55.6	30.2	59.8	35.1	30.4	33.0	37.3	91.6	48.3	36.6	42.7	24.6	43.1	44.7	53.1	47.8	56.4	35.4	36.1	28.2	52.7	38.9	55.2	43.4	40.7	59.2	40.6	52.0	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241623	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"			2800000	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavourable (2.44e-4)"	29.2	47.6	16.6	24.2	19.6	30.1	34.8	13.2	21.4	34.3	30.5	23.3	52.6	24.0	38.3	70.3	35.1	29.5	34.8	36.3	14.2	14.1	52.9	105.7	38.7	53.0	19.1	14.7	33.3	72.2	38.2	28.7	110.3	19.8	33.3	34.7	43.1	64.6	49.1	32.9	26.0	43.2	30.2	15.6	47.5	35.7	43.5	14.5	27.9	56.8	26.4	42.3	27.8	27.7	48.1	96.3	55.8	70.1	60.8	72.3	92.9	36.5	33.1	34.7	46.2	48.2	36.2	68.9	48.5	57.7	62.2	52.9	105.0	64.3	28.7	59.4	62.5	53.5	35.9	57.7	56.7	13.3	22.2	32.8	38.7	70.0	46.6	51.7	55.0	34.1	57.7	49.3	51.3	59.6	50.3	93.6	43.5	33.1	29.8	52.8	28.0	47.1	27.1	64.4	94.1	42.6	34.9	28.7	30.7	58.8	142.0	56.4	70.1	87.1	38.5	70.7	43.1	36.8	42.1	56.3	67.2	30.2	69.3	35.1	57.0	55.8	70.1	45.1	62.8	66.6	72.3	48.1	59.2	62.8	78.7	37.4	53.8	55.5	13.0	60.8	53.7	96.3	52.9	92.9	16.6	19.6	13.2	21.4	14.2	14.1	19.1	14.7	19.8	14.5
RPP30	TSG15	ENSG00000148688	"Ribonuclease P/MRP subunit p30"	P78346	10	90871716-90908553	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037578	Approved		Approved	"Nucleoplasm,Nucleoli,Microtubule ends,Cytosol"				"Nucleoplasm, Nucleoli"	"Microtubule ends, Cytosol"	"HPA037578: AB_10696939"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-1)"	"unprognostic (5.64e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.01e-6)"	"unprognostic (1.98e-1)"	"unprognostic (9.84e-3)"	"unprognostic (3.43e-2)"	"unprognostic (2.10e-2)"	24.2	19.0	20.9	16.8	20.3	27.2	22.3	26.0	24.0	18.9	19.0	16.2	16.3	11.5	25.2	18.6	23.8	19.2	16.0	26.6	19.8	16.8	20.6	18.4	17.1	23.2	18.5	20.4	23.9	17.7	37.7	23.6	23.6	19.3	18.8	19.3	18.7	19.2	16.5	35.9	23.5	16.4	20.6	19.2	21.3	19.2	32.0	21.6	31.2	18.1	24.0	26.3	21.7	18.9	19.4	22.2	16.2	19.5	14.2	20.3	16.2	28.0	18.7	19.6	23.6	12.8	13.8	6.9	20.1	18.1	33.7	35.4	31.6	22.6	16.6	15.4	12.8	19.7	26.1	17.8	34.7	26.6	18.0	11.1	12.0	24.9	12.1	22.5	14.1	11.3	11.6	25.3	28.8	19.1	22.1	15.2	22.2	17.3	26.1	30.7	12.1	21.3	14.6	16.7	17.4	12.7	13.3	10.6	10.7	11.7	8.5	23.6	23.0	14.3	10.8	16.8	16.8	9.5	41.4	10.3	26.3	35.6	21.1	12.2	12.9	4.3	19.5	16.2	17.1	18.7	18.6	19.4	19.6	18.7	22.2	16.7	17.0	18.5	2.2	14.2	15.3	20.7	20.3	16.2	20.9	20.3	26.0	24.0	19.8	16.8	18.5	20.4	19.3	21.6
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426125	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol			170000	Cytosol		"HPA047268: , HPA048084: "	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	84.5	76.6	68.1	142.7	49.5	158.8	142.0	35.9	54.3	130.3	132.7	48.2	97.2	65.1	149.8	103.9	169.7	113.6	74.7	84.9	51.3	44.1	80.7	122.5	96.3	180.1	54.8	31.9	189.4	323.2	20.3	59.1	88.0	39.5	129.7	64.5	59.4	248.9	75.5	153.2	131.9	76.4	105.6	49.4	132.5	85.3	66.7	41.0	110.5	151.0	158.8	127.4	127.1	169.7	150.1	105.0	31.6	61.5	83.1	176.2	227.6	99.0	64.2	66.8	151.4	115.1	169.8	110.5	81.7	113.1	135.1	97.8	155.7	50.6	191.5	84.7	90.5	74.8	124.6	139.8	81.4	80.3	222.1	85.7	70.8	147.5	159.3	135.4	92.2	187.6	243.7	94.6	179.7	117.8	146.0	97.1	100.9	154.6	110.1	203.5	100.7	94.7	104.4	78.2	180.6	101.5	109.6	111.7	68.4	58.7	99.1	226.2	128.8	347.0	80.8	60.9	78.0	69.3	132.7	80.4	179.0	160.5	33.2	176.1	109.3	31.6	61.5	18.8	78.9	50.6	116.3	150.1	136.2	111.1	88.7	147.7	176.2	136.7	13.6	83.1	47.2	105.0	90.2	227.6	68.1	49.5	35.9	54.3	51.3	44.1	54.8	31.9	39.5	41.0
RPS11	S11	ENSG00000142534	"Ribosomal protein S11"	P62280	19	49496365-49499689	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049719	Uncertain		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA049719: "	"unprognostic (1.49e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.50e-7)"	"unprognostic (5.19e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.71e-3)"	103.0	76.8	80.6	187.8	68.7	161.8	165.7	50.4	75.3	138.6	134.1	43.2	105.8	67.0	149.4	132.4	142.8	132.3	133.0	135.9	63.2	53.5	84.3	105.7	101.9	354.2	71.5	64.2	242.4	490.0	41.7	89.7	72.2	63.4	116.6	103.4	72.7	193.2	104.0	223.4	140.8	88.1	198.4	69.9	132.6	96.3	67.2	48.3	137.3	119.0	190.7	169.5	145.6	230.6	232.4	173.3	45.1	96.7	91.3	161.6	231.8	110.2	171.9	130.6	201.7	188.9	286.0	87.5	93.8	185.4	133.7	128.2	119.0	92.1	270.6	58.6	127.7	74.3	154.0	185.9	131.9	115.3	267.3	163.6	113.1	171.0	176.5	289.0	121.6	283.7	303.3	89.3	230.0	192.9	161.5	144.3	144.2	123.2	134.8	217.7	120.6	177.3	130.1	165.4	143.9	191.9	260.5	139.6	186.3	63.9	215.3	139.5	70.0	300.6	110.4	106.2	95.5	51.5	123.4	144.4	219.6	192.4	44.2	199.1	90.6	45.1	96.7	29.9	95.6	82.8	127.6	232.4	137.5	110.9	144.1	221.1	161.6	135.7	25.9	91.3	70.6	173.3	109.8	231.8	80.6	68.7	50.4	75.3	63.2	53.5	71.5	64.2	63.4	48.3
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814441-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"			280000	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: "	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	95.6	65.1	66.4	169.3	53.2	199.6	187.3	49.6	66.9	98.4	83.8	42.5	93.7	73.1	106.1	99.2	129.4	88.0	113.7	152.2	56.1	44.6	78.0	108.8	182.0	515.8	67.8	42.0	222.2	403.5	23.2	46.3	87.7	44.5	94.4	82.1	56.5	220.6	71.5	100.5	153.8	79.5	162.6	71.8	122.9	85.4	62.6	52.5	139.6	116.7	155.1	130.9	109.7	196.8	159.2	101.3	17.4	54.3	70.9	211.8	222.0	66.7	50.8	78.9	122.4	152.4	193.7	93.8	85.2	114.9	90.6	87.7	104.4	64.1	148.0	118.2	108.9	65.2	85.6	142.6	83.2	96.9	110.2	100.9	66.6	147.4	170.8	283.6	78.8	207.4	233.9	78.3	277.5	119.0	165.2	98.5	110.0	136.2	119.4	165.2	97.3	83.0	135.2	63.1	93.7	120.4	69.5	67.2	54.8	28.7	184.7	227.9	78.3	288.7	103.5	38.7	111.1	129.7	157.1	148.0	120.5	110.4	127.9	161.1	55.2	17.4	54.3	7.8	95.6	50.7	147.0	159.2	168.0	123.1	73.4	139.3	211.8	174.2	5.7	70.9	40.7	101.3	90.8	222.0	66.4	53.2	49.6	66.9	56.1	44.6	67.8	42.0	44.5	52.5
RPS13	S13	ENSG00000110700	"Ribosomal protein S13"	P62277	11	17074389-17077787	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005985	Uncertain		Approved	"Endoplasmic reticulum"			56000	"Endoplasmic reticulum"		"HPA005985: AB_10960703"	"unprognostic (7.74e-3)"	"unprognostic (2.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.81e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	119.9	51.1	49.0	80.4	40.3	120.2	120.6	36.0	38.8	129.2	91.3	49.0	52.0	54.5	74.1	70.7	143.1	74.2	83.1	70.5	43.4	38.8	84.9	133.7	97.3	151.2	55.4	26.2	190.8	234.2	29.2	47.8	98.5	34.9	117.2	66.3	57.4	101.7	67.9	203.5	102.6	91.0	90.2	60.3	115.0	75.8	82.1	39.3	146.2	118.0	132.0	127.4	135.4	87.4	166.8	139.3	20.7	103.6	72.0	204.5	216.1	106.7	76.3	76.2	63.9	130.8	198.8	85.7	74.6	92.3	104.8	85.0	119.3	132.3	156.3	52.7	79.8	78.6	105.2	113.5	104.5	67.3	226.6	70.0	79.8	123.9	158.5	143.8	73.4	153.9	183.7	45.0	178.3	120.6	100.6	87.7	99.9	98.5	113.9	189.8	89.3	150.4	109.3	109.6	97.0	100.4	116.1	62.9	108.8	36.4	138.3	167.6	62.3	214.6	81.1	50.6	88.3	117.6	93.2	63.6	129.7	121.2	58.7	115.7	67.1	20.7	103.6	15.3	64.2	77.2	126.1	166.8	135.3	93.8	132.8	152.0	204.5	151.5	10.6	72.0	60.9	139.3	94.0	216.1	49.0	40.3	36.0	38.8	43.4	38.8	55.4	26.2	34.9	39.3
RPS14	"EMTB, S14"	ENSG00000164587	"Ribosomal protein S14"	P62263	5	150442635-150449756	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 708.0;pancreas: 483.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018504	Approved		Supported	"Endoplasmic reticulum,Cytosol"			540000	"Endoplasmic reticulum, Cytosol"		"HPA018504: AB_1856463"	"unprognostic (5.70e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.17e-3)"	"unprognostic (7.51e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (7.73e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.26e-1)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (1.47e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.14e-2)"	60.9	43.2	50.1	64.3	39.1	92.8	111.6	22.6	37.2	85.1	70.3	28.0	50.6	33.6	59.6	86.4	79.4	91.7	57.2	59.2	35.7	30.3	53.6	74.7	57.0	96.6	39.8	32.5	115.1	483.0	17.4	38.9	62.0	35.3	69.7	61.5	41.1	61.8	50.8	93.4	95.0	60.6	67.0	37.0	68.4	58.3	48.5	33.8	84.5	93.9	71.2	83.6	87.1	65.2	360.5	205.3	51.0	166.0	157.4	465.9	708.0	87.6	160.8	83.7	170.4	128.2	241.2	137.4	67.4	113.0	110.0	100.4	219.1	113.1	199.0	99.3	127.2	70.3	125.2	299.6	74.8	92.3	151.2	72.3	149.2	164.5	182.4	206.4	74.9	183.1	117.3	112.0	264.2	152.8	95.4	78.8	139.2	236.7	89.1	174.1	86.2	136.6	87.5	96.4	213.1	143.9	161.3	92.3	105.1	48.8	244.4	193.4	107.7	226.5	94.7	59.5	50.0	50.3	90.6	107.0	150.4	130.7	74.2	202.4	39.2	51.0	166.0	36.7	186.2	114.2	261.9	360.5	313.3	226.8	181.1	299.4	465.9	319.4	25.7	157.4	97.0	205.3	196.8	708.0	50.1	39.1	22.6	37.2	35.7	30.3	39.8	32.5	35.3	33.8
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433207-39435948	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA064222	Approved		Supported	"Endoplasmic reticulum,Cytosol"			36000	"Endoplasmic reticulum, Cytosol"		"HPA064222: "	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	89.8	60.8	49.0	123.2	46.1	127.3	126.9	39.8	46.8	124.8	120.7	48.6	80.0	67.2	97.9	80.8	150.1	108.1	105.9	118.7	41.7	35.7	81.5	147.6	103.7	243.2	49.2	29.9	248.1	457.6	19.9	48.8	97.0	35.5	129.5	52.8	73.8	130.5	87.6	205.5	113.4	110.9	126.3	52.2	136.7	92.1	57.4	37.7	153.9	125.1	183.6	151.0	143.8	159.8	153.7	106.4	17.6	71.8	71.7	179.1	225.5	138.3	296.6	79.7	90.4	120.1	148.1	74.0	63.8	74.7	83.4	76.9	188.7	76.9	117.3	82.9	79.6	46.3	93.2	155.3	52.8	137.0	220.6	92.6	101.0	194.9	122.6	135.1	62.9	172.7	242.1	73.5	117.4	106.9	118.2	132.7	86.9	213.9	184.6	136.3	98.4	108.6	123.8	82.4	141.9	91.5	156.3	81.1	116.8	47.9	215.8	164.1	61.9	262.6	64.2	69.6	91.3	73.7	138.8	185.0	191.5	148.7	72.0	129.3	67.1	17.6	71.8	11.0	84.5	57.9	120.9	153.7	140.8	105.6	91.9	143.2	179.1	143.0	13.2	71.7	48.2	106.4	94.7	225.5	49.0	46.1	39.8	46.8	41.7	35.7	49.2	29.9	35.5	37.7
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272010-33276510	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 484.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA050159, HPA055007"	Approved		Supported	Cytosol			90000	Cytosol		"HPA050159: , HPA055007: "	"prognostic favourable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	67.0	49.1	43.4	126.4	32.2	109.6	132.5	20.9	37.7	99.8	105.5	17.8	48.6	44.6	83.1	109.2	120.3	66.7	92.9	71.5	31.2	26.1	48.1	69.1	69.1	263.7	34.5	35.4	154.5	484.7	8.9	33.0	56.3	26.6	95.9	65.2	37.0	168.4	53.7	107.6	140.4	56.9	99.6	35.8	89.9	56.8	40.2	32.3	94.1	94.3	155.9	90.6	101.6	114.8	98.8	55.7	7.8	30.3	49.6	92.4	130.1	51.4	29.8	39.6	103.9	67.9	134.5	63.8	51.6	75.2	67.9	51.4	75.1	30.1	169.7	55.6	54.7	37.9	62.1	81.7	53.4	53.2	97.6	63.3	35.6	98.8	132.5	109.3	33.8	145.3	161.9	51.8	154.9	64.4	84.0	53.3	59.9	86.2	55.1	121.7	54.5	43.1	65.9	64.0	113.6	62.4	66.7	45.5	67.1	20.1	103.4	162.3	70.9	190.5	53.2	32.0	37.4	33.9	67.5	64.0	129.8	130.0	17.9	119.2	38.9	7.8	30.3	3.9	42.7	27.4	72.8	98.8	83.0	60.9	55.7	80.2	92.4	78.5	3.1	49.6	20.2	50.6	61.4	130.1	43.4	32.2	20.9	37.7	31.2	26.1	34.5	35.4	26.6	32.3
RPS19	"DBA, S19"	ENSG00000105372	"Ribosomal protein S19"	P39019	19	41859918-41872926	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 546.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063217			Supported	Nucleoplasm			52000	Nucleoplasm		"HPA063217: "	"unprognostic (8.02e-3)"	"unprognostic (9.04e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.32e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.69e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.68e-2)"	"unprognostic (5.78e-2)"	"unprognostic (9.96e-2)"	"prognostic unfavourable (2.32e-8)"	"unprognostic (1.16e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-2)"	63.2	51.5	41.6	67.3	38.6	116.3	98.2	20.5	36.2	62.3	86.8	29.7	48.4	64.8	89.9	47.7	134.3	75.2	66.9	43.2	31.9	26.5	52.0	110.8	53.6	104.9	48.4	38.1	139.4	121.2	11.7	38.5	69.8	38.4	88.3	53.3	28.9	117.8	41.3	64.7	110.0	62.7	44.9	35.7	110.4	61.4	79.0	36.3	103.3	81.6	95.2	94.4	70.0	138.8	420.3	255.5	23.6	255.6	250.5	376.5	546.5	146.3	212.0	136.0	120.2	177.2	234.7	150.7	114.2	136.4	146.8	131.5	164.0	100.7	216.6	129.7	102.3	78.0	116.8	194.7	68.4	89.0	215.4	106.8	66.1	168.0	304.8	177.5	110.8	332.2	398.1	88.1	172.0	146.6	118.2	151.7	119.5	168.7	163.3	125.3	157.0	88.2	182.0	109.1	104.2	134.4	158.2	96.9	119.3	62.9	215.0	158.8	121.4	290.1	113.5	94.7	149.8	63.1	179.5	170.8	178.6	201.7	103.5	153.8	107.5	23.6	116.2	12.4	221.3	206.9	333.3	403.7	329.8	286.1	186.0	420.3	376.5	337.2	17.0	250.5	255.6	255.5	248.1	546.5	41.6	38.6	20.5	36.2	31.9	26.5	48.4	38.1	38.4	36.3
RPS2	"LLREP3, S2"	ENSG00000140988	"Ribosomal protein S2"	P15880	16	1962052-1964860	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 284.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA055133	Approved		Approved	"Endoplasmic reticulum,Cytosol"			140000	"Endoplasmic reticulum, Cytosol"		"HPA055133: "	"unprognostic (2.98e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.43e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavourable (7.70e-4)"	"unprognostic (7.43e-2)"	"unprognostic (3.17e-1)"	"unprognostic (7.23e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (3.04e-7)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.47e-1)"	46.1	41.0	28.0	101.8	40.4	97.6	65.9	34.7	30.7	48.2	47.0	22.2	28.8	39.9	45.7	27.1	100.7	61.7	55.7	38.2	19.5	16.0	34.2	107.4	71.1	104.2	36.6	18.6	112.6	284.3	9.6	32.2	45.4	30.1	43.6	32.5	18.3	53.6	28.9	67.3	78.3	47.5	25.8	22.4	131.9	47.8	18.9	28.1	115.2	50.3	114.5	78.3	51.6	77.6	137.5	69.0	18.2	44.9	53.6	125.4	54.7	81.0	117.7	68.2	219.3	99.1	244.6	120.8	55.7	133.9	146.3	103.9	209.6	56.8	155.5	89.2	96.2	101.9	98.5	186.8	55.0	98.1	194.8	52.4	131.3	187.7	242.1	123.0	86.5	326.4	267.9	122.2	203.4	141.8	107.1	88.4	100.8	376.2	154.3	215.6	216.7	106.4	189.2	110.5	185.9	133.5	77.2	122.3	111.1	54.5	171.3	132.0	115.5	216.0	64.7	78.9	104.0	18.9	116.4	34.4	56.6	197.9	42.5	106.6	99.0	4.9	37.6	18.2	50.7	44.9	84.6	137.5	99.9	78.4	68.7	117.9	125.4	93.8	7.6	53.6	36.0	69.0	68.1	54.7	28.0	40.4	34.7	30.7	19.5	16.0	36.6	18.6	30.1	28.1
RPS20	S20	ENSG00000008988	"Ribosomal protein S20"	P60866	8	56067295-56074581	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003570	Approved		Supported	"Endoplasmic reticulum,Cytosol"			100000	"Endoplasmic reticulum, Cytosol"		"HPA003570: AB_1856466"	"unprognostic (2.57e-2)"	"unprognostic (6.91e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (9.78e-2)"	"unprognostic (4.83e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (3.64e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-2)"	164.6	74.7	74.1	177.3	61.8	191.2	193.8	30.4	57.8	148.1	118.9	49.5	104.1	58.3	100.6	108.4	161.3	91.2	108.3	140.0	57.3	47.0	88.0	136.5	124.0	280.9	67.7	41.8	267.4	218.0	28.5	69.2	77.9	48.1	136.7	60.5	70.2	165.9	104.1	161.5	132.2	86.1	152.5	75.9	157.1	98.5	79.6	47.5	168.0	141.7	143.6	140.8	179.7	157.7	214.3	142.6	64.0	77.1	78.0	248.9	267.6	142.9	128.2	126.5	122.9	181.6	209.9	107.4	96.4	143.2	114.7	105.5	132.8	139.0	211.1	119.3	101.4	90.4	78.8	152.1	97.1	91.3	109.5	175.0	118.1	165.6	174.5	97.6	115.2	205.0	159.3	75.0	216.9	138.8	139.9	126.5	112.9	176.5	266.9	195.4	169.6	55.4	146.7	46.6	109.0	137.7	155.4	42.3	131.5	41.6	113.3	188.5	164.3	203.1	90.8	86.7	149.1	114.2	152.2	138.0	118.7	154.1	131.6	171.2	77.2	64.0	77.1	31.3	101.6	64.5	144.7	214.3	189.1	135.6	100.5	180.9	248.9	181.3	14.6	78.0	59.0	142.6	125.7	267.6	74.1	61.8	30.4	57.8	57.3	47.0	67.7	41.8	48.1	47.5
RPS21	S21	ENSG00000171858	"Ribosomal protein S21"	P63220	20	62387116-62388520	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003371	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"HPA003371: AB_1079846"	"unprognostic (1.92e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (8.46e-4)"	"unprognostic (6.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.60e-1)"	69.0	66.0	93.6	140.3	61.5	191.6	177.7	59.2	89.7	93.5	105.1	24.3	84.0	72.0	121.5	85.7	99.6	93.3	97.8	66.0	65.6	47.3	62.9	86.1	66.4	199.9	74.0	86.6	189.4	321.2	12.8	49.2	53.0	52.7	76.3	61.9	33.1	164.2	97.3	172.3	129.6	71.5	120.0	51.1	94.9	73.3	92.9	60.0	92.9	86.3	175.2	90.8	84.4	229.7	170.4	122.5	18.1	59.8	71.0	175.9	158.2	99.5	104.1	53.1	100.4	59.2	105.1	70.1	64.4	51.6	161.6	61.6	347.1	133.6	122.4	133.4	49.6	139.9	58.8	179.3	55.8	30.4	153.0	201.5	149.2	263.9	120.8	154.8	90.9	116.8	251.0	61.1	111.3	74.9	102.9	102.0	55.3	151.5	173.8	220.5	81.3	318.5	118.0	135.0	185.0	75.8	112.7	97.8	96.9	66.2	296.6	134.7	126.1	203.4	78.7	95.6	126.4	80.9	125.9	163.2	185.3	133.2	114.3	94.6	50.6	18.1	59.8	13.9	85.7	50.5	122.2	170.4	146.0	112.6	87.6	170.0	175.9	152.7	9.4	71.0	40.0	122.5	92.7	158.2	93.6	61.5	59.2	89.7	65.6	47.3	74.0	86.6	52.7	60.0
RPS24	S24	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033732-78056813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003364	Approved		Approved	"Nuclear bodies,Endoplasmic reticulum,Cytosol"			70000	"Endoplasmic reticulum, Cytosol"	"Nuclear bodies"	"HPA003364: AB_1079847"	"prognostic favourable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	171.6	122.0	127.7	80.8	79.0	186.2	231.3	56.2	68.4	242.4	201.1	37.9	112.4	86.2	159.2	148.8	277.8	125.1	128.5	123.9	90.4	83.8	134.4	176.6	147.0	263.8	100.6	70.2	369.4	279.3	49.1	86.1	139.3	64.6	251.6	130.0	49.8	176.0	139.5	320.4	192.3	148.9	182.4	111.7	175.8	85.3	87.9	79.5	197.1	221.4	130.0	123.5	271.7	237.7	171.5	180.5	49.6	123.2	156.4	187.3	213.6	110.2	43.1	108.6	169.5	134.6	237.7	97.9	118.6	163.4	125.4	110.3	62.0	77.9	229.3	65.2	102.6	86.0	125.0	152.8	115.0	76.3	141.7	93.4	28.7	59.1	152.7	223.1	53.2	225.2	229.1	88.6	322.0	148.8	126.7	45.9	135.1	44.9	119.0	368.0	76.1	403.5	80.9	130.0	110.2	160.0	51.8	54.9	107.5	59.7	200.8	146.5	113.2	248.1	126.1	38.0	90.6	51.5	156.9	60.5	122.2	176.7	46.9	311.1	31.1	49.6	123.2	46.5	102.4	118.3	167.4	171.5	140.6	129.8	180.5	145.4	187.3	168.2	16.9	156.4	91.0	155.4	112.3	213.6	127.7	79.0	56.2	68.4	90.4	83.8	100.6	70.2	64.6	79.5
RPS27	"MPS-1, MPS1, S27"	ENSG00000177954	"Ribosomal protein S27"	P42677	1	153990755-153992155	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 778.4;lymphoid tissue: 769.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA066851			Approved	"Nucleoli,Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA066851: "	"prognostic favourable (9.69e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (5.88e-3)"	"unprognostic (2.05e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (4.86e-7)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.81e-2)"	120.7	72.5	74.9	188.7	118.6	186.7	268.2	51.3	91.4	172.5	114.2	35.9	136.4	58.1	169.0	135.6	107.5	129.0	144.1	176.5	59.6	50.1	98.6	102.5	167.8	769.0	92.1	76.0	317.8	227.2	44.6	91.5	67.5	71.2	117.6	113.6	63.5	248.2	116.1	243.8	160.1	115.9	254.3	65.6	159.3	111.5	119.0	81.9	118.2	113.0	224.0	270.9	162.9	286.0	720.2	296.5	132.9	139.9	324.1	750.5	778.4	104.0	122.0	161.3	87.8	379.9	374.5	100.0	126.2	302.5	170.0	153.7	244.4	115.1	236.9	106.0	182.0	104.8	142.1	208.9	143.7	115.1	183.2	93.3	161.8	158.5	251.8	207.4	123.1	363.6	410.9	135.2	249.1	139.3	113.9	128.9	161.3	261.5	223.2	131.3	195.4	178.0	143.0	118.2	184.3	157.0	210.8	85.8	191.2	72.3	254.7	219.3	141.9	416.9	82.3	58.8	97.3	93.6	126.1	258.9	263.9	287.2	102.0	116.5	80.6	132.9	139.9	68.1	393.0	138.9	473.7	720.2	594.4	502.0	179.5	637.3	750.5	579.6	32.4	324.1	127.0	296.5	397.8	778.4	74.9	118.6	51.3	91.4	59.6	50.1	92.1	76.0	71.2	81.9
RPS3	"FLJ26283, FLJ27450, MGC87870, S3"	ENSG00000149273	"Ribosomal protein S3"	P23396	11	75399486-75422280	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Apoptosis, Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Lyase, Ribonucleoprotein, Ribosomal protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063339	Uncertain		Supported	"Endoplasmic reticulum,Cytosol"			430000	"Endoplasmic reticulum, Cytosol"		"HPA063339: "	"unprognostic (3.62e-2)"	"unprognostic (6.94e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (6.92e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.19e-1)"	72.2	52.7	36.6	108.4	41.2	122.2	136.6	32.1	33.8	105.1	102.0	32.5	65.2	65.8	102.4	84.7	136.5	92.2	107.7	58.5	29.7	26.5	52.9	78.1	71.0	218.6	47.6	30.6	224.7	288.7	13.8	51.3	75.9	35.0	105.7	65.7	47.6	151.0	61.8	86.9	117.6	78.0	110.6	42.1	121.4	75.4	54.1	36.5	126.5	119.4	134.7	130.1	110.3	118.9	104.5	69.7	22.6	44.5	64.6	144.2	213.9	85.5	53.1	75.5	83.1	95.5	170.4	97.7	82.1	105.8	109.0	71.1	153.1	102.5	299.4	100.6	73.7	124.1	97.4	152.7	100.5	79.2	76.1	122.6	53.0	67.6	142.6	197.9	80.4	199.9	208.7	74.5	207.1	142.9	122.1	85.3	97.9	94.0	118.7	95.2	94.8	63.0	112.8	264.9	218.1	107.0	71.6	65.0	92.2	60.5	143.9	83.5	146.9	151.7	114.4	52.7	87.8	71.8	74.1	78.3	96.5	331.7	31.6	111.1	53.2	22.6	44.5	14.7	94.2	31.6	129.1	104.5	123.0	99.4	69.7	95.6	144.2	111.8	11.2	64.6	30.1	60.8	78.2	213.9	36.6	41.2	32.1	33.8	29.7	26.5	47.6	30.6	35.0	36.5
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"			63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	79.4	58.5	111.6	109.6	143.6	281.1	113.9	84.8	130.9	120.2	74.4	113.0	116.2	360.7	42.4	92.4	52.8	113.1	141.5	114.2	79.4	109.4	77.9	72.3	130.5	166.3	184.8	80.8	208.5	292.1	73.9	196.6	142.5	125.2	188.9	142.6	118.7	199.5	219.6	104.7	45.3	146.2	108.9	120.6	139.1	96.6	107.3	106.2	38.1	139.5	186.6	93.3	224.7	86.5	58.8	77.8	64.8	93.2	146.9	236.3	220.8	75.5	135.0	69.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7
RPS4X	"CCG2, DXS306, FLJ40595, RPS4, S4, SCAR, SCR10"	ENSG00000198034	"Ribosomal protein S4, X-linked"	P62701	X	72255679-72277300	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA000857	Supported						160000			"HPA000857: AB_1079849"	"unprognostic (1.09e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.53e-3)"	"unprognostic (7.05e-3)"	"unprognostic (1.32e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.96e-2)"	"unprognostic (9.65e-2)"	"unprognostic (7.49e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (4.50e-6)"	"unprognostic (1.03e-2)"	"unprognostic (9.78e-3)"	"prognostic favourable (4.22e-4)"	"unprognostic (6.87e-2)"	50.3	35.5	34.9	39.4	42.8	72.1	96.8	23.8	38.5	74.6	51.6	25.0	45.1	40.1	66.9	103.2	77.8	81.0	30.5	35.1	33.3	26.3	86.6	92.2	35.3	64.1	29.6	35.0	141.5	109.1	25.7	165.3	54.5	34.5	45.1	45.7	32.1	64.8	42.4	71.5	83.0	60.2	49.0	33.7	47.8	47.6	23.9	25.9	57.8	52.9	122.6	67.9	56.5	73.7	125.7	88.3	15.8	52.0	74.7	149.4	194.2	55.2	50.7	68.6	50.1	96.7	155.3	50.1	38.4	102.4	89.7	71.6	83.2	39.3	176.6	94.3	36.0	32.1	66.6	82.2	94.3	36.3	154.9	30.5	65.4	60.8	124.5	74.0	76.6	163.6	96.4	38.3	123.1	75.4	49.7	109.8	86.9	80.7	87.9	120.3	68.2	59.7	53.7	96.2	140.1	57.0	74.4	64.2	77.9	63.2	144.0	115.7	28.8	116.1	40.1	21.0	59.1	43.3	36.7	41.8	39.2	55.6	36.6	138.2	43.2	15.8	52.0	9.6	73.0	45.5	114.9	125.7	120.1	94.3	77.2	107.2	149.4	120.1	4.9	74.7	41.7	88.3	93.4	194.2	34.9	42.8	23.8	38.5	33.3	26.3	29.6	35.0	34.5	25.9
RPS5	S5	ENSG00000083845	"Ribosomal protein S5"	P46782	19	58386400-58394806	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 495.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055878, HPA061979"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"			860000	"Endoplasmic reticulum, Cytosol"		"HPA055878: AB_2682954, HPA061979: AB_2684650"	"unprognostic (5.88e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (4.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.06e-1)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (2.79e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.01e-1)"	93.2	62.4	40.6	71.7	36.4	118.0	111.7	28.4	34.9	105.3	100.7	34.6	69.1	51.1	108.4	66.2	159.0	103.7	81.4	50.9	33.3	28.9	63.1	160.1	79.1	162.1	37.8	30.9	199.2	376.8	19.4	45.0	72.5	31.9	112.3	50.9	45.5	145.6	54.9	162.7	122.7	63.3	81.1	39.0	103.1	66.0	66.8	34.0	136.8	134.5	144.1	129.6	104.5	131.0	150.0	86.6	16.9	44.9	64.8	138.0	156.5	75.0	110.5	42.2	67.1	82.3	106.6	66.1	42.0	69.9	51.8	33.1	82.3	55.5	156.3	53.0	59.5	49.0	67.0	103.5	21.5	42.4	495.1	61.8	61.5	103.8	102.1	103.6	52.7	135.2	172.2	53.7	122.8	67.5	78.5	83.7	55.2	61.0	100.1	71.2	70.0	149.3	97.3	60.5	137.0	57.2	95.0	63.4	79.1	29.4	84.6	86.3	48.8	125.9	42.5	78.3	57.5	31.2	91.4	112.5	190.6	115.2	49.0	77.6	42.9	16.9	44.9	8.6	54.2	41.1	99.7	150.0	94.6	70.4	82.9	141.7	138.0	106.0	6.5	64.8	30.1	86.6	74.7	156.5	40.6	36.4	28.4	34.9	33.3	28.9	37.8	30.9	31.9	34.0
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.6;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favourable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.84e-4)"	"prognostic favourable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.7	3.4	2.8	3.7	0.1	0.0	3.7	0.8	1.5	4.2	4.0	4.0	8.1	18.3	4.5	0.5	11.5	6.3	22.7	3.0	15.1	4.1	20.1	8.5	7.0	1.3	23.7	29.6	0.7	8.3	3.8	6.9	1.8	3.4	6.7	0.2	5.4	0.8	23.3	7.2	11.0	12.6	3.6	8.0	12.0	2.7	4.1	1.6	6.9	6.6	3.2	4.2	20.3	1.2	0.2	5.3	0.7	3.3	4.1	4.9	10.0	2.5	31.8	4.0	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0
RPS6KA2	"HU-2, RSK, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.2;ASC TERT1: 39.0;HHSteC: 39.5;HSkMC: 35.1;hTERT-HME1: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"eosinophil: 17.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: , HPA054237: "	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavourable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	15.4	6.5	26.8	5.3	35.5	6.9	12.7	12.1	21.5	13.5	7.1	20.3	11.5	4.3	18.3	5.2	14.0	11.9	12.5	40.9	25.0	18.3	9.9	3.3	24.6	10.6	22.4	18.4	20.9	30.2	32.6	18.0	12.1	22.7	10.6	7.4	11.1	9.0	10.5	14.4	7.5	7.2	15.8	37.2	16.5	10.4	5.1	25.7	0.8	24.8	3.5	4.9	15.5	10.2	0.4	3.9	17.5	1.6	3.3	0.6	0.2	2.1	0.0	4.3	6.2	53.2	39.0	0.0	4.6	8.9	2.5	3.6	0.0	1.3	0.2	1.5	16.1	1.9	2.2	9.9	2.3	0.9	0.5	0.0	9.4	0.1	39.5	0.1	1.7	35.1	7.1	13.7	42.4	13.9	0.0	0.0	10.4	0.4	0.2	0.4	1.1	2.5	0.7	2.2	6.2	2.7	2.3	2.4	16.8	1.6	4.3	5.8	0.1	3.3	5.1	9.1	0.9	25.1	1.3	1.2	1.8	0.6	6.0	0.2	8.6	0.1	0.5	17.5	0.5	0.7	0.2	0.3	0.5	0.2	0.7	0.4	0.6	0.3	0.4	3.3	1.6	3.9	0.4	0.2	26.8	35.5	12.1	21.5	25.0	18.3	22.4	18.4	22.7	25.7
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavourable (8.17e-4)"	"prognostic unfavourable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	27.7	15.5	2.2	5.7	5.0	4.7	32.1	14.7	7.8	11.6	5.8	15.4	14.6	2.8	17.3	8.5	25.7	2.7	12.0	5.7	8.7	5.2	6.5	13.3	7.8	5.0	6.6	12.2	4.7	11.3	9.8	8.1	7.0	2.6	4.0	5.9	25.4	5.9	10.3	2.5	32.9	11.7	9.3	9.3	8.0	12.9	3.3	2.6	15.3	9.4	12.9	11.0	8.2	13.9	15.8	19.9	28.6	13.2	4.8	3.7	2.9	10.5	7.6	8.0	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5
RPS6KB1	"p70(S6K)-alpha, PS6K, S6K1, STK14A"	ENSG00000108443	"Ribosomal protein S6 kinase B1"	P23443	17	59893046-59950564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"MCF7: 74.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003838, CAB018346, HPA039442"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB003838: AB_562325, CAB018346: AB_632156, HPA039442: "	"unprognostic (2.25e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.35e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.76e-2)"	"prognostic unfavourable (5.09e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.52e-3)"	18.4	18.3	16.6	23.2	19.5	20.5	18.4	25.7	24.2	18.1	18.2	13.1	18.4	13.1	19.6	16.5	25.4	14.5	14.9	14.2	15.7	12.6	13.5	20.0	14.8	17.3	20.3	17.5	21.6	22.3	24.5	18.9	20.3	17.6	16.7	15.0	10.1	17.3	21.5	50.3	15.8	14.1	19.3	19.8	17.6	17.5	10.7	20.0	17.8	16.8	18.4	22.0	18.5	20.8	8.9	12.8	25.9	11.1	9.4	13.5	8.3	10.6	10.4	8.9	8.4	6.1	9.0	6.7	9.9	9.2	8.7	9.7	8.5	5.3	12.9	12.3	8.2	5.5	11.7	8.9	14.0	7.1	13.1	8.8	6.8	9.7	9.1	13.6	8.9	9.1	6.8	10.1	7.5	11.3	11.7	8.3	6.4	74.4	16.1	5.8	6.0	8.0	9.5	15.0	12.1	7.2	7.9	6.5	7.8	8.3	4.8	5.2	9.5	7.5	9.7	8.5	14.1	6.9	13.1	15.0	12.7	14.5	6.4	8.4	6.7	25.9	10.1	9.0	11.4	10.2	13.5	8.9	10.5	13.0	12.8	8.6	12.3	12.9	10.0	9.4	11.1	8.0	9.5	8.3	16.6	19.5	25.7	24.2	15.7	12.6	20.3	17.5	17.6	20.0
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"			52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	100.6	50.4	81.1	106.7	141.0	221.9	132.7	74.1	117.5	104.8	84.4	86.5	110.3	191.0	81.7	89.7	69.1	103.9	129.0	77.6	69.1	181.5	71.2	71.8	114.9	200.4	141.4	69.8	176.5	214.1	69.8	187.5	125.1	105.7	134.3	97.4	79.7	155.4	151.4	177.1	87.3	125.3	99.3	213.1	117.5	86.6	86.8	100.2	40.0	224.7	293.7	78.5	284.6	85.3	52.1	91.4	79.9	125.8	106.0	103.9	144.4	63.7	169.9	62.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0
RPS9	S9	ENSG00000170889	"Ribosomal protein S9"	P46781	19	54200742-54249003	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 90.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 90.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048746	Approved						1100000			"HPA048746: "	"prognostic favourable (9.23e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (5.08e-2)"	"unprognostic (3.14e-2)"	51.9	40.6	32.5	68.3	25.6	74.8	80.3	18.2	28.1	52.1	63.8	29.5	48.3	42.3	89.9	51.1	80.4	38.9	80.4	47.4	27.5	22.2	40.4	60.5	48.3	114.8	31.8	22.9	98.2	188.8	15.2	27.1	33.1	22.4	58.7	30.2	34.0	106.3	47.5	74.5	65.1	41.6	59.4	35.5	65.5	67.0	41.5	19.4	67.3	71.4	85.0	62.9	59.5	79.4	13.1	15.7	90.3	20.0	7.4	13.9	23.9	21.9	8.5	14.0	22.9	28.1	46.5	16.7	30.1	26.6	21.5	17.2	10.4	21.4	71.5	23.5	20.1	24.8	33.9	22.5	17.2	25.5	41.7	32.1	7.8	11.3	20.0	41.8	17.8	42.6	35.4	17.5	30.8	32.6	36.3	26.5	17.0	5.1	37.0	24.8	28.9	9.9	26.9	23.8	37.4	23.6	17.1	16.5	28.7	17.6	33.3	29.0	29.9	47.1	37.8	12.0	22.3	19.5	40.0	25.1	48.6	43.2	17.6	36.1	19.3	6.2	20.0	17.1	8.8	9.3	11.7	11.9	11.7	9.2	13.1	13.1	13.9	11.1	90.3	7.4	4.6	15.7	7.5	23.9	32.5	25.6	18.2	28.1	27.5	22.2	31.8	22.9	22.4	19.4
RPSA	"37LRP, LAMR1, LRP, p40, SA"	ENSG00000168028	"Ribosomal protein SA"	P08865	3	39406689-39412542	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB009561	Approved		Supported	"Plasma membrane,Cytosol"			710000	"Plasma membrane, Cytosol"		"CAB009561: AB_2182543"	"unprognostic (3.67e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.38e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.84e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.46e-1)"	47.5	42.9	48.8	88.4	56.9	107.0	76.7	26.3	56.2	50.9	63.6	29.1	65.6	48.4	73.5	50.1	93.4	82.4	52.2	67.3	43.2	33.7	44.1	63.8	67.5	300.2	41.7	37.7	145.1	264.7	35.7	42.2	45.0	43.5	58.9	71.5	31.4	148.1	50.2	60.4	70.5	53.0	73.9	48.1	76.8	58.4	60.2	26.8	83.5	72.8	105.2	112.4	53.8	80.4	92.4	64.0	6.9	24.8	61.5	101.2	114.8	92.6	84.9	73.9	121.8	65.0	148.4	116.2	66.2	107.5	151.0	88.5	92.9	80.8	209.9	40.7	130.3	37.1	159.7	152.9	130.2	75.7	83.6	95.0	80.7	90.1	126.0	133.4	89.6	164.7	254.9	116.1	186.3	155.4	98.6	101.8	109.0	64.8	154.9	99.8	247.1	146.1	73.2	105.9	154.0	105.6	42.9	53.5	109.2	36.1	279.0	114.8	81.4	185.7	61.2	46.4	85.6	77.1	161.0	78.7	119.6	125.2	74.4	130.0	61.3	6.9	20.6	4.8	53.8	24.8	93.5	92.4	89.8	71.4	58.1	89.5	101.2	88.4	3.0	61.5	20.4	64.0	66.1	114.8	48.8	56.9	26.3	56.2	43.2	33.7	41.7	37.7	43.5	26.8
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes				"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: "	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	13.6	12.3	10.5	11.1	14.5	10.2	9.3	17.5	21.0	12.6	13.1	19.0	9.6	12.2	15.0	9.3	14.2	12.5	8.0	15.5	10.8	10.5	8.3	12.9	11.0	9.0	12.2	9.9	12.8	9.8	14.3	14.1	9.7	12.7	12.0	7.4	15.2	10.4	13.9	23.7	12.3	11.0	13.6	9.5	11.6	11.1	10.3	12.7	16.7	10.2	11.1	11.9	14.3	10.5	2.1	1.9	3.1	2.4	1.7	3.8	1.2	9.6	19.3	4.6	8.2	6.6	5.7	8.6	7.3	6.7	11.6	8.7	15.1	8.6	8.1	5.8	8.9	5.9	7.4	9.8	6.6	2.9	12.0	12.5	10.7	13.6	6.7	11.2	8.9	8.4	6.7	11.9	6.9	11.5	15.5	3.3	6.5	5.3	10.7	4.7	4.9	15.5	5.1	8.4	6.6	3.4	11.0	9.1	9.2	8.9	14.3	8.1	9.3	8.2	5.2	24.5	10.4	7.7	9.3	5.2	1.9	8.0	14.9	5.9	14.9	3.1	0.9	0.0	3.8	2.4	2.5	2.1	1.6	1.8	1.9	1.1	2.3	2.2	0.0	1.7	1.3	1.1	3.6	1.2	10.5	14.5	17.5	21.0	10.8	10.5	12.2	9.9	12.7	12.7
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"			44000	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favourable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	31.0	22.2	6.7	14.9	30.8	33.3	35.1	48.8	41.1	20.7	28.1	49.3	29.4	12.0	16.5	46.0	31.4	7.1	39.6	16.9	5.6	5.5	13.9	6.4	50.9	44.2	5.1	17.5	44.0	11.9	33.4	19.8	20.3	5.8	11.7	30.9	14.1	2.0	11.7	7.8	21.5	3.6	17.7	41.3	17.4	10.6	3.4	2.5	27.7	65.9	20.0	11.5	7.8	36.4	44.2	16.5	22.9	16.0	21.6	16.3	3.9	16.7	5.6	22.4	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2
RRM1		ENSG00000167325	"Ribonucleotide reductase catalytic subunit M1"	P23921	11	4094707-4138876	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA replication"	"Allosteric enzyme, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022093, HPA057265, HPA064297"	Enhanced		Enhanced	Cytosol			13000	Cytosol		"CAB022093: , HPA057265: , HPA064297: "	"unprognostic (4.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.99e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.06e-3)"	"unprognostic (4.21e-2)"	"unprognostic (6.88e-3)"	"unprognostic (9.20e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.93e-3)"	13.9	25.3	8.0	15.2	12.2	18.5	14.4	18.0	12.6	15.7	15.9	11.1	11.5	11.9	13.0	9.8	25.4	10.7	8.7	11.9	7.9	9.0	9.2	13.1	11.0	20.2	9.0	10.3	13.6	10.7	24.2	11.2	22.7	18.4	14.0	18.9	12.0	15.4	10.7	28.3	26.8	12.5	17.5	10.7	12.4	13.8	10.5	9.1	78.6	9.8	28.0	27.1	17.5	18.5	5.6	4.3	3.3	8.3	5.7	24.3	6.0	45.4	24.7	40.5	23.5	6.2	12.4	15.7	41.9	20.8	47.7	49.2	22.2	34.6	49.2	10.2	20.9	36.6	37.5	30.1	56.5	24.2	39.8	25.0	37.1	17.3	2.5	42.8	18.4	5.8	8.1	26.1	18.8	22.8	32.6	23.3	39.7	20.6	50.3	9.3	25.6	25.1	40.8	31.7	17.6	13.1	12.9	34.7	19.0	36.9	22.3	6.7	22.0	15.0	13.0	44.9	23.5	44.4	30.7	15.2	21.1	53.8	24.9	28.7	27.8	3.3	2.5	2.6	7.7	6.5	13.3	5.6	14.2	10.7	4.3	3.5	11.3	9.2	0.0	5.7	8.3	2.7	24.3	6.0	8.0	12.2	18.0	12.6	7.9	9.0	9.0	10.3	18.4	9.1
RRM2		ENSG00000171848	"Ribonucleotide reductase regulatory subunit M2"	P31350	2	10120698-10131419	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 120.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 10.4"									HPA056994	Enhanced		Supported	Cytosol				Cytosol		"HPA056994: "	"unprognostic (2.10e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.40e-3)"	"unprognostic (4.42e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (1.04e-3)"	"unprognostic (6.67e-3)"	"unprognostic (4.53e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-2)"	4.7	2.2	0.4	32.6	0.4	29.0	4.2	0.4	0.9	3.5	9.3	0.4	0.4	5.2	2.1	1.7	21.6	0.7	5.0	3.3	0.4	0.5	2.0	3.9	5.7	16.4	0.6	0.1	0.9	2.9	0.0	0.7	5.4	0.3	1.0	10.6	0.1	2.9	0.0	0.5	2.8	11.3	3.2	0.8	19.8	5.4	8.0	0.0	120.9	0.8	22.3	33.1	3.8	5.2	1.4	0.3	0.6	0.2	1.8	10.4	2.6	29.1	17.7	25.0	17.1	2.2	4.1	24.8	47.7	23.6	34.1	37.1	29.5	14.0	26.8	6.6	14.9	14.3	40.5	24.6	41.8	60.0	15.6	51.6	17.0	26.0	0.1	38.2	24.8	1.4	0.5	41.7	3.5	27.5	21.6	79.5	42.4	22.0	42.2	20.5	20.2	20.7	31.8	54.6	18.4	16.7	22.2	24.8	20.4	39.2	27.9	4.8	15.0	6.9	9.6	26.1	38.0	19.5	66.8	51.6	40.5	54.7	18.5	32.4	37.5	0.3	0.1	0.1	3.7	0.0	0.0	1.4	2.6	2.9	0.2	0.4	0.2	1.2	0.6	1.8	0.2	0.3	10.4	2.6	0.4	0.4	0.4	0.9	0.4	0.5	0.6	0.1	0.3	0.0
RRN3	"DKFZp566E104, TIF-IA"	ENSG00000085721	"RRN3 homolog, RNA polymerase I transcription factor"	Q9NYV6	16	15060022-15094317	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049837	Supported		Supported	Nucleoli				Nucleoli		"HPA049837: "	"unprognostic (1.83e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.67e-2)"	"unprognostic (4.50e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.27e-1)"	7.8	6.0	4.3	4.0	5.7	10.0	7.2	9.2	6.3	4.9	5.1			5.0	6.3	5.4	4.5	5.9	4.7	5.5	3.9	5.0	5.5	10.1	4.3	5.9	3.7		8.4	5.8	8.9	5.8	4.9		6.6	6.5		4.6	4.8	15.2	5.3	5.0	5.1	3.9	6.2	5.3	4.9			6.2		6.3	6.6	4.9	10.7	8.2	12.3	7.0	10.0	14.2	9.5	7.6	10.2	8.0	6.8	9.5	8.2	5.8	9.7	6.5	9.5	9.1	9.4	11.2	13.5	15.5	8.6	7.5	14.9	9.9	13.8	10.8	10.1	29.6	13.6	18.0	13.8	11.0	34.6	8.5	13.7	13.4	15.2	6.7	8.2	11.7	13.1	12.0	10.6	14.1	9.0	8.5	23.3	11.1	14.9	7.9	10.0	16.9	11.9	10.4	12.3	10.7	15.9	9.9	6.8	11.3	5.3	7.9	9.8	9.4	13.4	19.0	6.7	13.3	14.5	12.3	6.4	5.9	11.2	6.6	13.3	10.7	9.8	11.0	8.2	7.7	14.2	11.0	1.0	10.0	7.0	5.2	9.4	9.5										
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.6	9.9	10.6	15.9	6.9	7.4	8.7	8.8	6.3	9.8	8.1	22.4	7.3	32.7	5.8	6.9	7.5	26.0	15.2	11.7	11.0	20.7	19.3	11.4	14.0	9.5	30.1	7.7	7.6	9.7	11.7	13.6	10.9	30.2	9.6	8.6	8.7	23.9	9.1	36.0	11.0	31.5	10.7	22.9	7.1	8.0	21.0	11.2	16.5	12.2	12.2	8.0	9.4	9.6	3.0	9.6	7.9	16.0	13.1	16.7	39.1	9.6	32.5	9.9	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6
RRP7A	"CGI-96, Rrp7"	ENSG00000189306	"Ribosomal RNA processing 7 homolog A"	Q9Y3A4	22	42509968-42519802	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001586, HPA046768"	Approved		Approved	"Nucleoplasm,Nucleoli,Cell Junctions"				"Nucleoplasm, Nucleoli"	"Cell Junctions"	"HPA001586: AB_1078506, HPA046768: "	"unprognostic (8.46e-2)"	"unprognostic (3.30e-3)"	"unprognostic (5.96e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.71e-3)"	"unprognostic (2.92e-1)"	"prognostic unfavourable (1.21e-5)"	"unprognostic (6.73e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.22e-2)"	"unprognostic (9.53e-3)"	"unprognostic (8.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.71e-2)"	10.4	12.9	19.9	15.4	26.6	16.5	13.5	18.5	20.9	12.8	12.2	15.1	9.4	10.2	12.0	47.3	15.1	18.9	12.0	11.1	17.5	14.8	14.0	18.1	11.3	21.5	14.8	9.3	21.2	12.0	16.6	10.3	17.7	17.4	17.8	10.8	12.6	15.2	14.6	13.5	14.9	13.3	11.9	11.7	15.6	12.0	11.2	18.6	17.4	11.6	8.7	16.4	10.7	11.0	26.2	30.5	17.4	27.5	15.2	18.4	20.3	12.8	18.1	10.0	11.7	6.4	4.3	20.2	11.0	6.6	14.2	12.1	23.1	7.4	21.4	5.6	7.8	14.3	11.4	15.2	6.1	5.4	23.4	11.7	12.7	12.4	6.1	27.9	10.1	5.4	7.7	19.2	9.8	8.6	16.4	6.2	8.4	26.1	26.8	11.4	8.3	13.2	46.7	10.2	9.5	7.4	15.8	5.4	3.9	8.0	23.2	10.6	9.5	12.6	6.4	10.9	14.0	8.3	11.1	9.5	7.1	25.3	9.0	10.7	15.5	10.0	23.5	17.4	18.4	26.4	17.7	20.5	16.1	16.8	18.1	26.2	17.7	16.5	4.7	15.2	27.5	30.5	13.5	20.3	19.9	26.6	18.5	20.9	17.5	14.8	14.8	9.3	17.4	18.6
RSRC1	"BM-011, MGC12197, SFRS21, SRrp53"	ENSG00000174891	"Arginine and serine rich coiled-coil 1"	Q96IZ7	3	158105855-158545730	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044792	Supported		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA044792: AB_10794502"	"unprognostic (1.06e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (7.40e-5)"	"unprognostic (5.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-3)"	"unprognostic (2.91e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.53e-3)"	"unprognostic (8.84e-2)"	"unprognostic (7.98e-3)"	"unprognostic (3.48e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.15e-1)"	26.2	24.4	23.8	16.6	25.6	18.7	23.0	43.0	32.3	22.6	17.3	17.7	12.2	12.3	19.4	19.2	18.2	14.6	14.7	20.1	23.8	27.0	22.1	23.1	13.2	17.9	26.5	22.5	18.8	21.5	22.8	28.2	16.5	31.9	19.3	20.7	12.5	16.7	21.5	22.8	15.4	14.3	20.7	33.7	19.5	16.4	14.8	23.2	24.0	24.1	13.3	19.9	19.6	16.2	24.5	33.8	17.6	21.6	9.4	15.7	6.6	30.9	14.9	11.8	15.1	27.9	19.5	15.4	15.6	13.6	17.8	19.8	20.6	23.8	29.8	29.1	19.0	13.9	21.8	14.0	26.6	45.1	18.6	30.8	13.1	16.8	4.4	26.1	19.9	14.1	13.5	13.9	12.4	8.3	17.9	22.4	13.5	25.3	20.3	17.5	9.8	14.4	23.9	20.1	36.2	13.1	10.3	20.3	23.1	17.2	11.9	19.2	27.1	22.7	9.2	22.3	13.4	28.8	30.6	18.9	20.2	32.0	22.7	35.6	27.3	17.6	19.8	10.3	14.8	21.6	15.6	24.5	15.7	14.8	11.9	24.1	14.9	15.7	13.7	9.4	19.9	33.8	12.5	6.6	23.8	25.6	43.0	32.3	23.8	27.0	26.5	22.5	31.9	23.2
RSU1	"FLJ31034, RSP-1"	ENSG00000148484	"Ras suppressor protein 1"	Q15404	10	16590611-16817528	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA025927	Uncertain		Approved	Vesicles			210000000	Vesicles		"HPA025927: AB_10610420"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.89e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.91e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.30e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (9.32e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.53e-2)"	34.3	11.9	11.3	18.5	11.0	18.1	27.3	11.2	9.9	24.6	26.9	13.0	11.7	8.9	33.5	15.9	29.3	21.3	17.3	19.5	11.3	12.4	29.4	19.5	20.4	16.0	13.7	7.4	27.2	36.9	9.2	6.4	48.1	10.2	22.5	18.3	13.0	15.1	21.7	12.7	15.1	15.9	37.2	13.7	30.3	18.3	9.7	11.8	19.6	17.1	16.0	20.3	31.9	20.8	12.2	23.7	17.4	17.7	20.4	23.6	29.8	9.3	6.5	5.3	31.6	28.8	29.8	6.6	23.4	10.1	16.5	17.8	6.0	8.7	9.4	3.8	31.6	8.3	6.4	12.3	17.7	13.9	5.3	29.5	4.2	5.7	12.7	4.5	17.1	14.7	13.0	15.5	4.9	16.8	4.7	6.5	22.0	6.0	10.2	8.0	5.6	3.7	6.8	7.2	6.3	15.5	3.5	2.1	4.2	11.6	7.7	11.5	2.7	11.8	20.7	13.9	4.9	17.4	11.9	5.7	6.9	8.1	18.4	12.8	6.0	17.4	14.7	15.0	18.2	17.7	20.3	11.6	20.8	19.4	23.7	12.2	15.5	19.3	10.4	20.4	16.4	17.7	23.6	29.8	11.3	11.0	11.2	9.4	11.3	12.4	13.7	7.4	10.2	11.8
RTEL1	"bK3184A7.3, C20orf41, DKFZP434C013, KIAA1088, NHL, RTEL"	ENSG00000258366	"Regulator of telomere elongation helicase 1"	Q9NZ71	20	63657810-63696253	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA020622, HPA067329, HPA078328"			Approved	"Nuclear speckles,Nuclear bodies"				"Nuclear speckles, Nuclear bodies"		"HPA020622: , HPA067329: , HPA078328: "	"unprognostic (3.63e-2)"	"unprognostic (8.08e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.27e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.30e-2)"	"unprognostic (9.05e-2)"	"unprognostic (4.09e-2)"	"unprognostic (9.50e-2)"	"unprognostic (8.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.84e-2)"	8.4	14.3	9.4	11.5	12.4	14.2	7.9	25.6	11.8	9.1	11.1	11.2	10.9	9.8	15.4	7.4	7.0	9.5	9.3	6.2	8.0	6.9	7.1	7.2	8.9	7.8	7.5	12.1	10.6	17.8	7.2	18.2	9.8	8.2	10.2	4.8	10.2	12.9	10.2	10.2	8.2	10.1	8.8	4.4	11.6	10.4	17.6	8.9	9.1	11.9	4.9	9.5	9.3	9.0	1.7	3.6	0.0	3.3	0.4	3.0	2.4	5.2	7.2	5.2	10.0	1.1	1.2	9.6	10.9	2.9	17.0	4.5	14.4	4.5	7.1	5.7	3.3	9.9	3.5	7.1	4.1	3.5	7.3	8.7	12.5	13.7	3.8	8.5	16.0	1.5	4.0	4.2	5.2	5.8	10.8	6.7	3.8	5.6	13.2	11.0	5.1	15.2	10.6	4.9	7.3	2.7	6.5	10.3	6.2	6.1	17.8	1.3	4.7	9.6	7.7	19.3	6.3	6.6	8.3	6.2	2.6	4.4	4.7	6.0	6.7	0.0	2.7	0.0	3.0	3.3	1.6	0.9	1.7	2.0	3.6	1.7	2.9	1.1	0.0	0.4	2.6	3.2	1.4	2.4	9.4	12.4	25.6	11.8	8.0	6.9	7.5	12.1	8.2	8.9
RTF2	"C20orf43, CDAO5, HSPC164, RTFDC1"	ENSG00000022277	"Replication termination factor 2"	Q9BY42	20	56468585-56519449	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053986	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA053986: "	"unprognostic (1.65e-1)"	"unprognostic (1.94e-3)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (6.35e-4)"	"unprognostic (3.54e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavourable (1.31e-4)"	"unprognostic (8.90e-2)"	"unprognostic (4.02e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"unprognostic (4.58e-1)"	"unprognostic (8.48e-3)"	33.4	34.2	43.5	29.1	43.9	52.6	28.9	27.4	48.7	28.8	29.4	53.0	20.1	28.0	31.4	24.1	30.5	31.6	23.2	38.7	40.6	35.6	31.8	30.3	24.2	29.7	49.6	35.7	35.2	27.5	26.0	29.3	30.5	46.6	28.5	26.0	26.0	25.8	31.7	74.6	27.9	29.8	34.1	59.7	30.2	25.3	29.1	45.2	31.4	29.1	28.9	34.4	29.0	23.9	20.0	35.1	91.6	31.8	29.4	23.0	33.2	28.5	20.5	20.8	20.3	26.0	23.3	19.4	44.6	33.7	64.4	37.0	41.9	27.8	24.5	52.9	36.1	32.1	20.8	34.3	44.6	11.4	16.1	30.6	22.4	32.3	29.9	43.5	42.3	20.6	35.7	28.7	25.0	27.6	23.6	25.6	31.5	54.5	36.4	37.1	15.4	39.1	25.0	56.7	32.2	26.8	18.8	21.5	23.3	46.8	79.4	41.9	36.8	41.6	29.5	55.1	35.7	29.9	36.0	21.4	24.6	34.8	43.4	29.6	30.0	39.2	31.8	84.1	20.9	29.6	17.6	18.6	18.0	20.3	35.1	20.0	20.5	18.8	91.6	29.4	28.8	29.9	23.0	33.2	43.5	43.9	27.4	48.7	40.6	35.6	49.6	35.7	46.6	45.2
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Group enriched"	"Detected in some"	4	"HEL: 22.7;SCLC-21H: 28.1;SH-SY5Y: 45.0"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"			140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: , HPA044249: "	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favourable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.3	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	22.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	28.1	45.0	5.5	0.0	0.0	0.0	0.0	0.0	3.8	1.1	0.0	2.0	0.0	0.0	0.0	7.5	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 157.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"			13000000	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: "	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavourable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	103.7	60.5	75.1	27.9	85.0	19.3	63.6	66.6	105.5	24.8	35.4	52.9	17.5	45.0	29.3	36.0	43.0	26.3	38.5	30.8	71.9	69.7	86.5	103.5	36.2	19.6	84.9	75.8	27.4	23.7	59.9	16.1	33.8	99.0	45.2	35.7	24.7	23.6	38.1	171.1	48.1	55.2	47.4	92.6	20.1	23.5	14.6	62.7	14.7	25.9	47.2	16.5	48.1	35.4	2.8	6.1	33.3	7.7	16.8	15.8	4.4	32.5	23.7	23.2	6.0	79.0	74.1	13.0	108.5	92.2	33.6	31.5	19.4	31.1	7.1	57.7	73.5	29.6	15.2	43.6	51.3	20.1	11.7	9.8	14.6	30.6	157.2	17.5	5.1	55.5	41.8	45.9	89.5	62.9	19.9	16.4	144.9	9.5	21.4	18.0	20.8	21.2	9.6	30.6	14.6	78.0	39.3	15.3	18.0	24.8	14.6	30.3	12.4	13.5	89.3	65.8	27.9	25.8	62.0	10.0	8.1	4.5	66.9	20.4	52.8	33.3	4.3	10.9	4.3	4.9	3.5	2.8	6.9	3.8	4.0	1.6	11.7	4.8	7.0	16.8	7.7	6.1	15.8	4.4	75.1	85.0	66.6	105.5	71.9	69.7	84.9	75.8	99.0	62.7
RTN4RL2	"NgR2, NGRH1"	ENSG00000186907	"Reticulon 4 receptor like 2"	Q86UN3	11	57460549-57477534	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 44.3;liver: 38.1;thyroid gland: 24.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.9;Karpas-707: 25.6;REH: 15.4;RPMI-8226: 49.3"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"amygdala: 17.7;basal ganglia: 17.9;cerebral cortex: 44.3;hippocampal formation: 12.4;olfactory region: 17.6"	"Group enriched"	"Detected in some"	4	"classical monocyte: 1.0;intermediate monocyte: 2.5;MAIT T-cell: 1.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	24	"dendritic cells: 3.4;monocytes: 2.5;T-cells: 1.1"	"Group enriched"	"Detected in many"	4	"amygdala: 23.2;basal ganglia: 10.6;cerebral cortex: 29.8;hippocampal formation: 23.6"	"Low region specificity"	"Detected in many"								"Intracellular and membrane"		25000000				"unprognostic (6.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.40e-2)"	"unprognostic (8.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (3.05e-7)"	"unprognostic (3.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.18e-2)"	2.7	0.9	17.7	0.9	17.9	1.4	2.4	1.6	44.3	1.5	1.0	1.0	0.0	1.8	1.5	0.8	1.2	1.2	3.8	2.1	12.4	1.5	2.0	38.1	1.9	1.0	2.0	17.6	1.0	2.8	5.4	2.5	2.7	1.0	1.9	0.7	1.9	2.8	1.0	2.3	5.3	1.2	1.4	0.7	1.3	1.9	1.5	0.1	1.0	24.9	0.5	1.0	1.3	1.2	0.0	3.4	0.0	2.5	0.0	1.1	0.0	2.6	3.8	2.9	4.9	1.2	1.7	0.3	0.0	1.0	0.1	1.0	0.5	0.5	0.1	0.1	0.1	0.0	4.5	0.0	0.0	0.6	1.8	0.7	0.3	2.6	1.7	0.6	16.9	4.6	0.5	0.4	0.4	0.0	0.6	25.6	0.0	0.5	0.1	1.9	5.0	2.9	15.4	2.0	49.3	0.0	0.0	5.4	0.4	0.4	0.2	2.8	3.2	0.7	0.0	0.2	8.9	1.2	0.9	1.5	3.2	0.5	6.4	2.7	2.1	0.0	1.0	0.0	0.2	2.5	1.1	0.0	0.3	0.0	3.4	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	17.7	17.9	1.6	44.3	12.4	1.5	2.0	17.6	1.0	0.1
RUFY1	"FLJ22251, RABIP4, ZFYVE12"	ENSG00000176783	"RUN and FYVE domain containing 1"	Q96T51	5	179550558-179610026	"Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038804	Approved		Supported	"Nuclear speckles,Vesicles,Cytosol"			9600	"Vesicles, Cytosol"	"Nuclear speckles"	"HPA038804: AB_10673290"	"unprognostic (3.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	20.9	27.9	19.7	24.7	22.4	21.1	36.9	22.4	18.9	18.2	20.2	16.9	27.9	16.9	22.5	16.9	25.9	18.8	20.7	14.8	19.7	14.8	23.9	17.5	20.8	23.1	18.8	17.1	19.4	19.8	22.6	21.5	17.3	19.7	20.9	15.5	16.4	21.2	18.3	26.7	24.2	18.8	17.5	14.7	27.9	18.6	12.2	20.5	20.1	27.3	14.1	20.1	20.7	34.3	3.2	3.4	7.9	4.5	1.2	2.9	21.5	7.1	11.8	6.3	8.3	12.2	10.1	7.2	12.7	9.1	7.5	8.8	11.4	16.7	11.6	7.2	15.4	6.6	11.5	16.6	8.9	36.6	8.7	20.2	9.0	8.2	12.5	11.2	11.1	10.2	9.2	5.1	14.6	8.2	8.2	11.1	6.7	21.6	11.9	7.8	6.7	5.5	10.7	4.5	10.7	12.6	11.7	6.3	9.0	18.6	12.0	6.6	9.6	13.8	9.8	10.0	3.3	5.3	9.9	6.9	10.6	20.8	9.2	20.3	9.1	7.4	3.4	7.9	1.7	3.6	1.0	2.7	2.0	1.7	3.0	3.2	1.4	1.8	5.9	1.2	4.5	3.4	2.9	21.5	19.7	22.4	22.4	18.9	19.7	14.8	18.8	17.1	19.7	20.5
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Cell line enhanced"	"Detected in many"		"HEL: 65.0;HMC-1: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: "	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavourable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	13.0	1.0	0.0	0.1	3.4	4.4	8.6	7.4	7.5	4.1	3.1	0.6	10.0	6.4	0.5	6.5	11.8	0.8	8.8	6.0	9.9	1.0	65.0	2.6	3.0	6.3	7.5	39.2	8.5	5.3	12.5	12.4	2.3	4.4	3.8	8.7	2.8	30.3	11.9	0.6	3.8	30.7	22.8	3.9	5.5	5.2	0.3	0.0	7.6	1.9	2.7	3.9	17.6	9.7	6.8	8.8	10.1	11.1	12.5	5.1	6.1	8.5	16.5	9.9	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6
RUVBL1	"ECP54, INO80H, NMP238, Pontin52, RVB1, TIH1, TIP49, TIP49a"	ENSG00000175792	"RuvB like AAA ATPase 1"	Q9Y265	3	128064778-128153914	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Growth regulation, Mitosis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019947, HPA019948"	Enhanced		Supported	Nucleoplasm,Cytosol			47000	"Nucleoplasm, Cytosol"		"HPA019947: AB_1856516, HPA019948: AB_1856514"	"unprognostic (7.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (1.21e-8)"	"unprognostic (2.43e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.27e-2)"	17.6	15.1	10.7	15.8	14.2	11.9	13.9	7.9	14.0	12.5	11.6	12.9	14.3	8.4	19.2	11.4	19.2	37.3	11.3	18.6	11.4	13.6	20.9	13.7	12.9	18.7	10.0	9.8	15.4	13.6	26.5	14.2	19.9	13.0	12.0	14.1	11.5	10.2	12.0	12.9	11.8	10.2	16.1	8.8	21.9	10.9	44.7	10.3	33.4	15.2	18.1	23.9	12.6	15.0	10.6	8.7	1.5	7.9	10.9	20.2	7.2	26.7	24.3	14.9	24.3	11.7	11.4	19.6	13.1	11.3	25.3	17.5	25.4	15.9	38.0	13.1	12.5	21.3	39.8	27.8	29.5	15.5	19.5	31.5	14.1	17.0	12.1	29.4	10.1	11.6	14.7	21.3	27.4	16.9	25.8	8.9	14.4	38.1	31.5	22.3	37.6	20.8	25.9	18.1	26.4	15.1	10.1	25.1	22.5	14.5	12.0	20.1	21.8	21.8	10.9	11.5	14.1	17.3	19.8	9.1	14.5	37.3	14.2	18.1	14.4	0.8	4.8	1.5	11.3	7.9	14.6	10.6	13.6	14.0	7.7	10.2	11.5	12.8	0.2	10.9	7.4	8.7	20.2	7.2	10.7	14.2	7.9	14.0	11.4	13.6	10.0	9.8	13.0	10.3
RUVBL2	"ECP51, INO80J, Reptin52, RVB2, TIH2, TIP48, TIP49b"	ENSG00000183207	"RuvB like AAA ATPase 2"	Q9Y230	19	48993448-49015995	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 59.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012432, HPA042880, HPA067966"	Enhanced		Supported	Nucleoplasm,Centrosome,Cytosol				"Nucleoplasm, Cytosol"	Centrosome	"CAB012432: , HPA042880: AB_2678210, HPA067966: AB_2685933"	"unprognostic (1.71e-1)"	"unprognostic (9.06e-3)"	"unprognostic (3.51e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavourable (9.28e-4)"	"unprognostic (7.06e-3)"	"unprognostic (6.25e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.13e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.21e-2)"	"unprognostic (7.61e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.58e-1)"	6.9	5.3	6.7	7.5	7.1	13.4	4.8	8.2	10.4	4.8	9.9	7.6	6.3	11.2	8.3	5.5	16.1	5.5	7.2	9.1	6.9	6.0	7.6	10.3	5.5	8.2	7.7	8.1	6.5	8.7	1.6	6.4	5.5	6.7	6.0	3.2	6.5	10.0	6.6	27.8	7.7	10.0	3.7	7.1	6.9	10.7	59.0	5.8	14.6	8.8	9.4	8.1	6.4	12.9	12.6	16.4	5.6	14.3	11.0	12.5	15.2	28.8	29.7	3.5	20.0	1.5	2.7	9.4	15.6	6.8	17.9	11.8	15.4	12.5	27.1	12.1	3.1	15.3	2.1	10.2	2.1	16.4	12.2	17.7	8.9	7.8	5.0	34.7	12.4	3.1	2.0	4.0	2.1	6.6	30.6	11.5	1.6	5.9	30.6	4.1	10.7	4.4	25.4	16.0	17.4	3.2	11.1	14.2	20.5	15.7	13.1	5.6	11.6	13.3	9.7	11.4	16.7	7.5	38.6	23.4	26.7	28.0	8.4	17.0	16.3	5.6	14.3	4.2	11.1	11.1	11.2	10.9	11.1	9.1	16.4	12.6	12.2	8.0	1.0	11.0	10.8	12.5	12.5	15.2	6.7	7.1	8.2	10.4	6.9	6.0	7.7	8.1	6.7	5.8
RXRG	NR2B3	ENSG00000143171	"Retinoid X receptor gamma"	P48443	1	165400917-165445355	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 14.9;pituitary gland: 29.8;retina: 13.5;skeletal muscle: 44.8"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 28.3"	"Group enriched"	"Detected in many"	13	"melanoma: 25.7;thyroid cancer: 34.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 89.8"	"Low region specificity"	"Detected in all"			"CAB002615, HPA012933"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB002615: , HPA012933: "	"unprognostic (2.29e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.29e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-2)"	"unprognostic (9.13e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.95e-2)"	"unprognostic (5.41e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.18e-1)"	"prognostic favourable (9.40e-5)"	"unprognostic (5.03e-2)"	1.9	3.9	5.4	1.0	14.9	0.6	1.0	0.3	5.9	4.0	2.5	5.3	0.6	1.3	1.8	1.3	1.7	3.6	1.2	5.8	7.5	8.9	0.7	0.8	3.4	0.8	4.1	4.3	1.7	2.7	0.8	29.8	1.3	14.1	1.1	2.7	13.5	1.9	2.1	44.8	2.9	2.0	1.8	8.9	1.0	1.1	1.5	5.4	0.0	1.1	2.5	0.6	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	14.9	0.3	5.9	7.5	8.9	4.1	4.3	14.1	5.4
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.7;RH-30: 11.3;SiHa: 22.3;U-2 OS: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"				"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: "	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.7	0.0	13.7	0.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.6	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	11.3	1.0	0.6	0.0	0.0	1.1	22.3	0.0	0.0	0.5	4.2	0.0	0.0	9.4	0.2	0.0	0.3	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 10.4;K-562: 3.2;NB-4: 2.7;NTERA-2: 3.9;U-937: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.3	0.5	0.0	0.0	7.7	10.4	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.2	0.2	0.0	0.0	0.0	2.7	3.9	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0
RYR3		ENSG00000198838	"Ryanodine receptor 3"	Q15413	15	33310945-33866121	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 28.8;skeletal muscle: 26.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;RH-30: 10.6;RPTEC TERT1: 5.0"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	31	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 4.0"	"Low region specificity"	"Detected in many"							HPA062004			Approved	Vesicles				Vesicles		"HPA062004: "	"unprognostic (5.85e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (8.03e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.10e-2)"	"unprognostic (8.25e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.91e-1)"	1.8	2.0	9.9	1.1	15.4	2.5	2.9	4.9	12.4	2.8	4.5	6.0	0.2	1.5	10.2	1.0	2.7	3.9	1.6	1.0	13.3	3.5	1.2	0.9	1.2	0.9	5.6	6.9	1.7	0.8	28.8	1.2	1.0	10.7	1.8	2.9	0.6	1.4	3.9	26.8	1.2	1.3	7.4	5.9	1.4	1.6	1.6	7.9	0.0	1.1	1.5	1.4	2.1	2.6	0.1	0.0	4.0	0.0	0.0	0.1	0.0	0.3	7.0	1.5	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.6	0.1	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.2	1.4	0.2	0.0	0.0	1.0	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.4	0.2	0.3	1.1	0.1	0.5	10.6	0.2	5.0	0.5	0.1	0.5	0.8	0.0	0.2	0.1	0.3	0.9	0.2	0.1	0.0	0.7	0.3	1.2	0.7	0.5	2.3	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	15.4	4.9	12.4	13.3	3.5	5.6	6.9	10.7	7.9
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Group enriched"	"Detected in some"	5	"Hep G2: 42.7;SK-MEL-30: 146.4"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced						240000			"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.5	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.1	0.0	1.1	0.0	0.0	0.0	0.4	0.4	1.0	0.6	42.7	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	3.4	0.5	0.0	1.2	0.1	0.5	0.2	0.3	3.0	0.4	1.0	0.8	1.6	0.7	0.2	0.3	1.3	146.4	4.4	2.2	0.3	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.7	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8
S100A11	S100C	ENSG00000163191	"S100 calcium binding protein A11"	P31949	1	152032506-152047907	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 485.8;esophagus: 373.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 485.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034320, HPA042745"	Enhanced						11000000			"CAB034320: AB_2183487, HPA042745: "	"unprognostic (1.85e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.61e-2)"	"prognostic unfavourable (3.64e-5)"	"unprognostic (3.34e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.92e-2)"	"prognostic unfavourable (3.24e-6)"	"unprognostic (2.91e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.43e-3)"	"unprognostic (8.86e-2)"	98.4	18.7	9.2	32.7	17.3	24.9	48.0	2.7	9.2	96.3	22.2	14.7	41.3	12.1	42.2	48.0	373.9	42.1	45.6	30.2	7.4	6.5	107.9	17.2	74.6	73.4	16.5	3.4	35.1	23.4	77.0	20.1	197.6	14.3	60.8	22.9	29.6	108.3	49.0	23.9	65.3	31.0	31.2	19.4	89.9	38.7	16.9	11.3	46.7	44.3	181.3	272.3	71.0	130.7	9.2	81.7	485.8	124.5	18.4	39.3	110.7	93.2	74.4	3.6	27.8	102.7	128.8	60.6	91.4	132.4	73.7	75.6	34.5	105.3	0.1	82.0	117.4	132.1	3.7	163.4	41.8	45.2	7.5	8.1	44.1	19.9	79.4	7.3	57.4	97.6	165.5	80.9	102.2	56.0	16.5	18.1	107.3	149.5	0.9	34.2	26.5	75.6	0.1	39.2	70.7	219.1	158.9	0.1	6.0	69.6	92.6	61.6	70.9	80.9	80.3	39.6	28.0	61.5	48.5	0.1	0.8	0.3	89.7	24.1	46.7	173.6	124.5	187.4	20.4	119.9	26.9	9.2	39.3	24.1	81.7	5.3	11.7	13.2	485.8	18.4	120.9	28.3	32.6	110.7	9.2	17.3	2.7	9.2	7.4	6.5	16.5	3.4	14.3	11.3
S100A12	"CAAF1, CAGC, CGRP, ENRAGE, MRP6, p6"	ENSG00000163221	"S100 calcium binding protein A12"	P80511	1	153373706-153375649	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 139.8;bone marrow: 329.6;lymphoid tissue: 94.7"	"Group enriched"	"Detected in some"	7	"hTCEpi: 6.4;SK-BR-3: 2.1;THP-1: 4.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 51.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"classical monocyte: 91.9;neutrophil: 139.8"	"Group enriched"	"Detected in many"	12	"granulocytes: 139.8;monocytes: 91.9"					"Not detected"	"Not detected"			"HPA002881, CAB025872"	Enhanced				"Secreted to blood"	26266667	6200000			"CAB025872: , HPA002881: AB_1848175"	"unprognostic (1.33e-1)"	"unprognostic (4.51e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (9.04e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (5.03e-4)"	"unprognostic (3.68e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.31e-2)"	"unprognostic (7.70e-2)"	6.7	0.5	0.9	8.9	1.7	329.6	0.8	0.3	1.0	3.5	1.1	0.2	0.0	0.6	0.5	0.4	9.2	3.3	1.1	41.2	0.7	0.8	1.6	4.0	34.4	27.4	3.3	0.0	1.5	5.0	0.4	0.7	3.9	2.8	0.8	0.4	0.7	1.9	0.4	1.3	0.8	0.5	4.4	0.8	94.7	1.4	3.4	0.5	3.9	4.5	15.3	4.9	1.7	36.0	0.2	9.6	139.8	91.9	0.0	0.1	59.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	2.1	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	91.9	0.3	0.1	3.3	0.0	0.2	0.0	0.1	9.6	0.0	0.0	0.0	139.8	0.0	0.7	0.6	0.1	59.2	0.9	1.7	0.3	1.0	0.7	0.8	3.3	0.0	2.8	0.5
S100A14	"BCMP84, S100A15"	ENSG00000189334	"S100 calcium binding protein A14"	Q9HCY8	1	153614255-153616986	"Plasma proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.0;tongue: 189.3"	"Group enriched"	"Detected in some"	10	"A-431: 62.5;HaCaT: 86.8;HBEC3-KT: 123.0;hTCEpi: 183.4;SK-BR-3: 129.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"plasmacytoid DC: 1.1"	"Lineage enriched"	"Detected in single"	11	"dendritic cells: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA027613	Enhanced		Approved	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytosol"			110000	"Nuclear bodies, Plasma membrane, Cell Junctions, Cytosol"		"HPA027613: AB_10602298"	"unprognostic (1.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.75e-3)"	"unprognostic (2.89e-1)"	"unprognostic (3.16e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.81e-2)"	"unprognostic (9.53e-2)"	0.6	0.0	0.6	4.3	0.6	0.0	6.4	0.6	0.6	38.0	19.2	0.6	3.9	21.4	5.7	2.6	256.0	1.2	7.9	0.6	0.6	0.0	2.4	1.2	7.5	0.6	0.6	0.6	0.7	4.6	6.6	0.8	1.4	0.7	1.9	19.6	0.7	41.8	3.1	0.6	41.4	23.8	1.0	0.6	0.6	9.4	0.9	0.6	8.9	9.6	189.3	71.0	2.2	79.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	7.8	11.4	0.0	0.1	0.0	86.8	0.0	123.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	183.4	0.0	1.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	4.1	0.0	0.0	0.1	129.6	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.7	0.6
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 419.2"	"Cell line enhanced"	"Detected in many"		"A549: 112.8;ASC diff: 146.4;BJ hTERT+: 281.6;fHDF/TERT166: 201.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Enhanced	"Plasma membrane"			13000000	"Plasma membrane"		"CAB002618: , CAB027387: , CAB058698: , CAB068227: , CAB068228: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favourable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	125.9	10.1	2.6	29.2	8.3	75.2	171.6	2.2	4.6	52.1	33.9	2.7	25.8	7.3	26.8	52.2	58.6	27.9	34.7	59.9	3.0	1.7	27.8	6.1	80.7	53.2	10.8	3.1	12.7	6.7	0.0	3.0	46.9	6.6	49.5	28.0	19.3	29.8	13.4	25.4	44.5	25.5	38.5	8.9	55.9	17.2	18.2	6.2	8.5	23.7	57.5	26.4	34.9	58.2	18.6	213.1	281.6	293.3	17.3	162.7	419.2	0.5	112.8	0.5	3.3	146.4	100.9	0.1	71.5	281.6	1.4	6.3	0.8	7.9	0.0	13.1	201.4	2.8	0.4	1.0	1.1	16.1	0.0	48.2	25.1	2.5	0.1	4.2	81.6	15.7	1.1	2.8	0.6	0.1	0.4	0.1	102.5	0.4	0.1	50.0	0.3	43.3	2.5	0.1	106.3	4.4	3.0	4.3	0.5	1.2	54.5	0.4	3.3	60.4	0.1	0.3	0.6	96.1	0.4	3.5	24.0	0.5	0.2	53.7	5.5	49.5	293.3	30.8	141.2	201.4	147.2	18.6	127.2	112.3	213.1	6.2	22.4	66.5	281.6	17.3	253.9	37.4	162.7	419.2	2.6	8.3	2.2	4.6	3.0	1.7	10.8	3.1	6.6	6.2
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 375.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"			5100000	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favourable (7.56e-4)"	126.4	32.6	14.8	104.9	29.9	73.8	223.6	13.3	14.6	95.4	176.8	10.1	51.2	70.2	65.0	135.5	126.5	42.2	264.5	112.3	13.0	22.5	103.4	6.0	151.9	61.5	45.6	7.9	38.1	13.5	0.5	17.7	100.1	27.3	85.1	85.5	28.5	58.7	55.2	59.1	45.1	98.1	88.9	35.5	27.5	69.9	29.6	17.8	4.9	76.9	183.0	36.2	150.9	145.0	30.7	130.1	303.7	180.7	9.1	69.2	201.7	77.6	86.9	0.0	7.2	146.3	189.8	0.2	95.2	237.8	48.3	63.4	6.0	162.4	0.1	30.2	141.3	33.7	1.5	136.7	22.8	31.9	0.0	16.2	58.1	5.3	55.4	0.7	11.2	88.5	113.7	51.7	89.5	107.1	0.0	0.1	120.3	11.7	0.2	6.6	0.1	143.0	0.0	10.8	28.1	375.0	72.1	22.4	3.9	129.5	131.9	97.9	18.1	25.2	156.4	46.7	12.2	95.3	154.5	0.2	0.2	0.2	181.3	17.4	99.6	139.8	180.7	74.1	62.0	96.8	67.3	30.7	58.5	60.3	130.1	17.2	37.3	49.5	303.7	9.1	86.9	68.3	69.2	201.7	14.8	29.9	13.3	14.6	13.0	22.5	45.6	7.9	27.3	17.8
S100A7	"PSOR1, S100A7c"	ENSG00000143556	"S100 calcium binding protein A7"	P31151	1	153457744-153460701	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 116.2;lymphoid tissue: 156.7;tongue: 409.9"	"Group enriched"	"Detected in some"	5	"HaCaT: 7.3;SK-BR-3: 16.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 458.9;head and neck cancer: 1201.5;melanoma: 638.4;urothelial cancer: 281.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB001453, HPA006997, CAB033766"	Enhanced		Uncertain	Cytosol	"Secreted in other tissues"		17000000	Cytosol		"CAB001453: AB_564004, CAB033766: AB_2269963, HPA006997: AB_1079860"	"unprognostic (3.28e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.94e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.00e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.99e-1)"	"unprognostic (5.41e-2)"		"unprognostic (1.21e-2)"	0.1	0.0	0.1	0.1	0.1	0.1	2.2	0.1	0.1	45.2	0.1	0.1	0.1	0.0	3.7	3.9	116.2	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	6.2	0.1	0.1	45.7	0.1	0.2	0.1	0.1	0.0	0.3	0.1	1.2	0.1	409.9	156.7	0.2	85.3	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	7.3	0.0	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.8	16.9	0.0	0.3	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100A8	"60B8AG, CAGA, CFAG, CGLA, MRP8, P8"	ENSG00000143546	"S100 calcium binding protein A8"	P05109	1	153390032-153391188	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	Antimicrobial	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 720.9;bone marrow: 718.8;esophagus: 532.3;tongue: 597.1"	"Group enriched"	"Detected in some"	28	"hTCEpi: 27.5;SK-BR-3: 100.9;THP-1: 53.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 2290.9;head and neck cancer: 2382.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"classical monocyte: 320.7;neutrophil: 720.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 720.9;monocytes: 320.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB002791, HPA024372"	Enhanced		Supported	"Intermediate filaments,Cytosol"	"Secreted to blood"	10876880	530000000	"Intermediate filaments"	Cytosol	"CAB002791: , HPA024372: AB_1856536"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.58e-2)"	"unprognostic (8.60e-3)"	"unprognostic (9.26e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (8.94e-7)"	"unprognostic (1.17e-1)"	"unprognostic (8.90e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.94e-3)"	14.0	0.8	0.8	30.5	2.6	718.8	1.1	0.5	1.6	123.0	2.8	0.7	0.4	0.4	12.0	1.2	532.3	5.5	2.1	36.7	1.5	0.5	1.4	4.3	26.2	37.3	3.3	0.4	2.1	2.7	0.1	0.9	4.7	3.3	1.4	0.4	1.3	92.4	0.3	2.5	6.2	1.0	9.0	1.8	72.4	2.0	1.9	0.9	2.6	4.6	597.1	257.6	5.0	224.1	0.6	63.7	720.9	320.7	0.3	0.6	244.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	1.6	0.0	2.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	27.5	0.0	0.9	0.0	1.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.4	100.9	0.0	0.6	53.6	1.4	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	1.6	0.0	8.2	320.7	38.9	0.4	26.5	0.6	0.6	0.3	0.2	63.7	0.3	0.3	0.3	720.9	0.3	6.4	2.5	0.4	244.7	0.8	2.6	0.5	1.6	1.5	0.5	3.3	0.4	3.3	0.9
S100A9	"60B8AG, CAGB, CFAG, CGLB, LIAG, MAC387, MIF, MRP14, NIF, P14"	ENSG00000163220	"S100 calcium binding protein A9"	P06702	1	153357854-153361027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Autophagy, Chemotaxis, Immunity, Inflammatory response, Innate immunity"	"Antimicrobial, Antioxidant"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 638.3;bone marrow: 820.1;esophagus: 642.6;tongue: 477.6"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 227.6"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 5468.0;head and neck cancer: 6692.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 381.5;neutrophil: 638.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 638.3;monocytes: 381.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004193, CAB009441"	Enhanced		Supported	"Nucleoplasm,Cell Junctions,Cytosol"	"Secreted to blood"	10597950	1400000000	"Nucleoplasm, Cell Junctions, Cytosol"		"CAB009441: AB_2184420, HPA004193: AB_1856537"	"unprognostic (1.72e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (5.45e-3)"	"prognostic unfavourable (1.13e-6)"	"unprognostic (1.10e-2)"	"unprognostic (4.31e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.59e-2)"	"prognostic unfavourable (8.10e-4)"	"unprognostic (1.48e-1)"	"unprognostic (7.52e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-2)"	19.5	2.1	1.3	41.9	4.2	820.1	4.1	0.9	2.1	143.6	4.4	0.7	0.4	0.7	4.9	4.0	642.6	9.9	4.4	51.2	2.5	0.4	2.8	4.8	29.2	169.0	5.3	0.6	3.4	4.4	0.1	0.9	10.4	5.2	2.2	0.7	2.0	109.6	0.5	3.4	7.5	1.4	13.1	2.1	103.2	3.5	2.9	1.4	3.8	6.7	477.6	228.0	24.3	237.0	0.5	87.5	638.3	381.5	0.3	1.0	323.2	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.8	35.7	0.0	2.1	0.0	14.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	12.4	0.0	0.8	0.0	0.6	0.3	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.4	7.5	0.0	9.2	0.1	0.0	0.3	227.6	0.1	3.6	28.9	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	6.5	0.0	5.3	381.5	46.4	0.5	31.6	1.0	0.4	0.4	0.3	87.5	0.5	0.3	0.3	638.3	0.3	15.0	2.9	0.5	323.2	1.3	4.2	0.9	2.1	2.5	0.4	5.3	0.6	5.2	1.4
S100P		ENSG00000163993	"S100 calcium binding protein P"	P25815	4	6693069-6697170	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 89.9;bone marrow: 42.8;stomach 1: 70.0;urinary bladder: 47.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 37.2;Hep G2: 39.1;hTCEpi: 43.6;RT4: 80.0;SK-BR-3: 44.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 564.7"					"Group enriched"	"Detected in some"	41	"basophil: 47.8;eosinophil: 24.8;neutrophil: 89.9"	"Lineage enriched"	"Detected in many"	68	"granulocytes: 89.9"									HPA019502	Enhanced		Supported	"Nuclear bodies"			1200000	"Nuclear bodies"		"HPA019502: AB_1856530"	"unprognostic (1.46e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavourable (2.00e-4)"	"unprognostic (3.87e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.24e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.12e-2)"	0.1	0.0	0.0	1.1	0.0	42.8	0.0	0.0	0.0	0.3	5.2			0.1	0.0	0.0	23.3	0.3	1.0	0.0	0.0	0.0	0.0	1.9	2.4	0.0	0.0		0.0	0.0	0.0	0.0	16.4		4.8	5.4		1.1	0.0	0.0	3.9	0.5	0.1	0.0	4.4	70.0	0.0			0.0		2.5	47.6	5.1	0.0	0.0	89.9	1.3	0.0	0.0	0.4	5.0	3.2	0.0	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.8	0.0	6.2	0.0	0.0	0.0	2.4	0.0	0.1	3.6	39.1	0.0	2.3	0.1	0.0	43.6	0.0	0.0	0.0	0.1	0.0	0.0	7.1	0.0	4.5	0.0	5.7	0.0	0.0	0.0	0.0	80.0	0.0	0.0	7.3	44.8	0.0	1.2	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	47.8	1.3	24.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	89.9	0.0	0.1	0.0	0.0	0.4										
SAA4	"C-SAA, CSAA"	ENSG00000148965	"Serum amyloid A4, constitutive"	P35542	11	18231349-18236893	"Plasma proteins, Predicted secreted proteins"	"Acute phase"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	132	"liver: 263.3"	"Cell line enriched"	"Detected in some"	18	"Hep G2: 22.1"	"Cancer enriched"	"Detected in many"	141	"liver cancer: 118.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 1.9"	"Lineage enriched"	"Detected in single"	20	"B-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB026061, HPA060139"	Supported				"Secreted to blood"	65000000000	72000000000			"CAB026061: , HPA060139: "	"unprognostic (4.70e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.83e-1)"	"unprognostic (4.15e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.94e-2)"		"unprognostic (2.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.35e-2)"	"unprognostic (2.54e-8)"	"unprognostic (2.49e-1)"			"unprognostic (6.46e-2)"	0.7	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	263.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	22.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SACS	"ARSACS, DKFZp686B15167, DNAJC29, KIAA0730, PPP1R138, SPAX6"	ENSG00000151835	"Sacsin molecular chaperone"	Q9NZJ4	13	23328826-23433740	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			CAB017714	Uncertain									"CAB017714: "	"unprognostic (1.22e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (9.04e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (6.21e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.06e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.65e-4)"	6.3	6.0	15.9	7.9	20.3	9.6	7.1	7.7	20.2	5.6	6.4	7.8	2.6	2.8	8.8	6.3	5.5	5.1	5.2	7.4	13.5	10.2	2.8	2.8	4.0	8.1	12.5	11.5	8.6	4.6	38.5	7.5	3.4	21.4	8.0	4.0	2.4	6.0	5.4	13.6	4.8	4.3	13.5	11.6	8.3	4.7	7.8	15.2	6.6	3.2	8.7	7.4	6.9	6.7	2.5	2.0	1.0	0.9	1.3	2.8	0.5	3.8	5.1	10.6	3.2	3.3	12.6	1.6	8.9	11.5	3.5	2.9	2.4	2.1	2.7	3.8	19.0	0.8	15.3	5.3	11.5	6.2	6.2	10.0	3.9	3.6	2.5	18.2	4.0	4.0	1.2	22.2	10.8	11.3	5.7	1.3	15.7	1.8	6.5	7.0	8.7	4.1	7.7	19.5	8.0	6.0	0.4	7.7	7.4	4.9	1.8	3.9	0.9	4.9	24.5	10.7	8.8	5.7	16.8	2.5	2.7	6.6	5.0	6.5	9.3	0.0	0.8	1.0	1.1	0.9	2.0	1.1	1.7	0.8	2.0	2.5	1.2	1.4	0.0	1.3	0.3	1.7	2.8	0.5	15.9	20.3	7.7	20.2	13.5	10.2	12.5	11.5	21.4	15.2
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favourable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favourable (1.70e-4)"	28.7	27.6	26.4	34.8	32.5	50.7	26.2	50.8	36.0	28.9	29.7	34.3	18.6	31.0	32.1	17.3	26.6	25.8	22.6	26.9	28.2	25.8	23.8	29.0	27.1	38.0	31.5	26.2	35.0	29.2	31.2	35.0	35.5	28.1	27.5	20.5	21.4	31.1	28.8	53.6	35.5	31.0	27.8	31.4	39.1	28.4	30.3	32.1	61.4	26.3	19.5	31.3	30.7	45.6	32.8	31.6	48.4	42.3	31.2	37.5	30.5	27.3	24.2	29.5	18.9	13.1	11.8	33.7	20.5	13.3	17.5	14.8	36.2	15.7	44.3	16.3	10.2	25.7	28.3	16.8	18.5	29.9	27.8	32.5	22.3	33.8	12.4	40.1	28.8	10.5	15.6	15.7	16.7	13.8	45.2	22.8	13.4	24.2	42.1	31.7	39.2	24.1	42.4	32.3	30.7	13.6	23.0	27.2	23.3	23.1	18.7	21.0	17.2	21.7	21.3	17.9	22.0	21.9	31.5	37.0	31.6	40.6	17.2	33.3	23.6	35.0	28.4	48.4	36.2	28.4	36.7	32.8	36.0	35.2	31.6	32.2	37.5	36.0	30.6	31.2	42.3	26.6	34.5	30.5	26.4	32.5	50.8	36.0	28.2	25.8	31.5	26.2	28.1	32.1
SAFB2	KIAA0138	ENSG00000130254	"Scaffold attachment factor B2"	Q14151	19	5586999-5624046	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050894	Approved		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"				Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA050894: "	"unprognostic (7.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (7.69e-3)"	"prognostic favourable (7.10e-4)"	"unprognostic (7.95e-2)"	"unprognostic (6.76e-3)"	"unprognostic (4.19e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.14e-2)"	"prognostic favourable (2.53e-4)"	"unprognostic (2.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.11e-2)"	"prognostic favourable (2.12e-4)"	25.7	29.6	31.0	29.6	33.7	35.4	17.4	50.8	46.2	27.4	21.6	28.4	23.1	25.8	30.2	27.4	15.7	26.8	19.4	21.0	30.3	24.6	32.2	20.0	18.2	26.8	30.5	26.5	42.8	24.2	31.0	38.4	17.3	28.6	28.4	20.9	21.3	23.6	34.8	38.1	18.9	25.7	24.8	43.4	29.4	20.1	23.4	34.3	23.5	26.9	11.1	25.2	24.1	32.7	11.4	9.3	24.3	9.5	6.4	13.3	5.6	17.8	23.3	17.0	12.5	16.6	10.7	19.8	17.0	9.2	10.6	10.1	29.6	12.9	34.1	15.5	8.5	16.4	20.6	10.6	17.6	23.7	22.1	25.9	23.7	22.9	9.7	21.6	24.5	10.6	11.3	15.6	12.1	10.4	24.8	17.3	12.5	19.9	25.8	20.7	29.0	24.7	32.8	14.7	19.0	12.0	30.5	16.0	14.9	22.5	10.3	13.7	15.3	13.3	16.4	13.2	13.8	16.5	23.1	23.0	20.4	24.8	13.5	18.8	21.5	24.3	9.5	15.8	11.9	8.2	13.3	10.3	10.5	9.2	8.3	11.4	11.7	9.1	18.3	6.4	8.5	9.3	9.5	5.6	31.0	33.7	50.8	46.2	30.3	24.6	30.5	26.5	28.6	34.3
SALL1	"Hsal1, TBS, ZNF794"	ENSG00000103449	"Spalt like transcription factor 1"	Q9NSC2	16	51135975-51151367	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	Deafness	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.9;kidney: 26.8;liver: 32.0"	"Cell line enhanced"	"Detected in some"		"AF22: 14.8;BJ hTERT+: 12.7;NTERA-2: 24.1;RPTEC TERT1: 20.4;U-87 MG: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"olfactory region: 64.6"	"Low region specificity"	"Detected in many"			"HPA049829, HPA074673"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear speckles,Cytosol"				Nucleoplasm	"Nucleoli, Nuclear speckles, Cytosol"	"HPA049829: , HPA074673: "	"unprognostic (9.91e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.82e-6)"	"prognostic favourable (1.28e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-1)"	"prognostic favourable (1.91e-7)"	"unprognostic (1.86e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.76e-1)"	0.8	0.7	12.2	1.2	14.5	0.7	0.9	1.7	18.9	16.1	3.1	31.9	0.0	1.6	17.8	1.5	0.8	10.4	1.1	1.2	13.6	5.5	26.8	32.0	0.6	0.6	21.8	9.1	5.2	1.6	0.9	4.3	4.3	17.6	1.3	3.2	0.0	0.9	2.3	0.6	0.7	1.4	9.4	19.7	0.7	3.0	2.2	19.4	0.0	23.7	0.0	0.6	2.2	4.8	1.0	1.9	2.3	3.1	0.1	1.1	1.1	0.0	0.8	14.8	0.1	0.4	0.3	0.0	4.9	12.7	0.3	0.7	0.0	0.0	0.0	5.7	6.9	0.0	9.2	0.0	0.4	0.0	5.6	0.0	0.0	8.9	0.3	0.0	4.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	1.8	0.9	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	23.5	0.0	4.9	0.6	3.1	2.3	0.7	2.0	0.7	1.0	1.0	0.9	1.9	0.8	0.6	0.6	1.8	0.1	1.5	1.9	1.1	1.1	12.2	14.5	1.7	10.3	13.6	5.5	21.8	9.1	17.6	19.4
SALL3	ZNF796	ENSG00000256463	"Spalt like transcription factor 3"	Q9BXA9	18	78980275-79002677	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.6;vagina: 6.6"	"Group enriched"	"Detected in some"	30	"HAP1: 6.7;HEK 293: 3.9;NTERA-2: 13.6"	"Cancer enriched"	"Detected in some"	6	"glioma: 6.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"olfactory region: 15.4"	"Low region specificity"	"Detected in many"			HPA016656	Uncertain									"HPA016656: AB_1856546"	"unprognostic (3.96e-2)"	"unprognostic (3.41e-3)"			"unprognostic (8.16e-2)"	"unprognostic (1.87e-2)"		"unprognostic (2.37e-1)"	"unprognostic (4.23e-1)"			"unprognostic (2.12e-1)"		"unprognostic (1.11e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.86e-3)"		0.7	0.7	7.3	0.7	7.6	0.7	0.7	0.3	11.6	0.9	0.7	8.3	0.0	0.7	0.7	2.1	0.7	0.7	0.7	1.2	7.1	5.4	4.4	0.7	0.7	0.7	5.7	3.3	0.7	0.7	0.7	1.1	0.8	6.8	6.0	0.7	0.2	0.7	1.2	0.7	0.7	0.7	0.7	8.8	0.7	0.7	2.4	4.6	0.0	0.9	0.0	0.7	0.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.6	0.3	6.6	7.1	5.4	5.7	3.3	6.8	4.6
SAMD9	"C7orf5, FLJ20073, KIAA2004"	ENSG00000205413	"Sterile alpha motif domain containing 9"	Q5K651	7	93099513-93118023	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 34.6;lymphoid tissue: 35.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA021318, HPA021319"	Approved		Enhanced	Vesicles,Cytosol				"Vesicles, Cytosol"		"HPA021318: AB_2183383, HPA021319: AB_1856554"	"unprognostic (3.66e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (8.96e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.48e-2)"	"prognostic unfavourable (2.93e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.37e-2)"	"prognostic unfavourable (8.31e-5)"	"unprognostic (6.00e-2)"	"prognostic unfavourable (8.40e-7)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.64e-1)"	9.6	4.0	2.3	9.2	2.4	5.2	2.6	1.0	1.6	9.3	6.8	0.6	0.9	4.3	2.8	3.0	34.6	2.7	4.3	2.5	1.3	1.5	6.3	3.5	7.8	10.8	2.5	1.1	6.3	2.3	0.1	6.4	11.3	3.1	5.3	7.0	0.7	5.7	1.6	2.4	1.5	12.7	2.2	2.5	21.7	6.3	2.5	1.7	35.4	3.3	9.9	9.5	4.8	9.7	5.5	3.0	15.6	9.8	7.4	7.6	2.6	12.2	1.6	0.4	0.1	5.5	7.0	0.1	4.8	20.1	23.0	30.5	0.1	13.6	5.1	7.6	11.8	14.5	0.0	4.4	7.8	17.4	0.6	7.4	8.2	0.0	2.5	8.3	10.4	3.1	6.4	7.6	2.1	3.4	0.5	12.8	4.8	0.0	12.3	6.8	0.0	3.5	4.1	4.1	5.8	0.1	1.5	2.0	0.2	3.7	1.4	3.9	0.4	4.1	14.8	5.4	1.9	16.1	2.6	7.6	1.4	4.7	5.6	4.9	5.3	15.6	3.6	12.7	7.6	7.0	7.3	5.0	5.9	6.5	3.0	5.5	6.3	5.7	15.5	7.4	9.8	2.1	7.2	2.6	2.3	2.4	1.0	1.6	1.3	1.5	2.5	1.1	3.1	1.7
SAMHD1	"AGS5, HDDC1, Mg11, MOP-5, SBBI88"	ENSG00000101347	"SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1"	Q9Y3Z3	20	36889773-36951901	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity"	"Allosteric enzyme, Hydrolase"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 57.2;BJ hTERT+ SV40 Large T+: 24.3;BJ hTERT+ SV40 Large T+ RasG12V: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 46.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047072	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			100000	Nucleoplasm	"Plasma membrane"	"HPA047072: "	"unprognostic (1.09e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.65e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.44e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.72e-2)"	54.3	18.6	8.7	31.8	13.0	9.9	35.9	4.9	9.7	14.5	21.2	9.0	8.7	15.8	13.5	20.2	24.1	33.4	15.3	25.4	8.7	6.0	12.5	12.4	25.7	48.3	14.5	4.9	22.1	18.1	4.9	22.4	13.7	10.2	14.0	13.2	11.6	14.7	9.7	9.2	11.4	20.6	21.3	13.7	40.7	19.2	15.1	15.0	9.7	14.9	10.7	18.5	23.2	50.2	0.4	46.7	2.8	23.4	6.0	10.9	19.1	3.8	1.5	0.7	1.5	57.2	10.9	0.7	2.3	4.2	24.3	26.0	4.8	1.3	8.2	3.3	1.5	3.0	6.0	2.8	5.1	2.4	2.0	0.4	2.1	2.5	5.0	4.7	1.4	13.3	0.1	8.5	0.2	3.1	1.5	1.9	0.5	1.2	0.0	1.7	0.7	3.2	0.2	3.9	3.1	0.9	0.6	2.9	0.4	3.0	1.1	2.9	1.4	7.5	0.8	1.9	2.1	2.0	3.4	1.1	3.0	3.4	1.6	0.4	0.6	0.2	19.4	0.6	6.1	23.4	5.6	0.4	6.9	6.4	46.7	0.4	8.5	6.3	2.8	6.0	20.4	11.0	10.9	19.1	8.7	13.0	4.9	9.7	8.7	6.0	14.5	4.9	10.2	15.0
SAR1A	"SAR1, Sara, SARA1"	ENSG00000079332	"Secretion associated Ras related GTPase 1A"	Q9NR31	10	70147289-70170523	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, CAB022545, HPA048368"	Supported		Supported	"Endoplasmic reticulum"			10000000	"Endoplasmic reticulum"		"CAB022545: , HPA006923: AB_1856577, HPA048368: "	"unprognostic (3.77e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.13e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavourable (7.00e-5)"	"prognostic unfavourable (4.04e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.76e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-2)"	"unprognostic (7.13e-2)"	52.7	40.0	26.7	24.5	31.9	91.1	37.8	27.8	35.7	32.6	26.9	28.6	38.3	17.3	35.7	34.6	30.8	28.2	30.4	34.6	25.6	27.0	31.7	48.8	38.2	27.0	26.6	27.8	36.5	29.8	30.0	37.0	51.6	30.3	28.5	25.3	29.5	39.6	40.5	35.9	27.5	25.1	36.0	28.3	31.8	28.6	18.4	23.5	24.9	34.8	28.9	25.5	36.4	28.8	18.7	22.9	27.7	30.4	40.2	40.1	32.6	21.7	14.5	20.7	35.7	71.1	43.1	15.2	34.7	43.4	33.2	40.1	42.6	19.5	19.5	17.2	42.2	23.8	26.7	19.9	32.7	25.3	12.7	14.3	17.0	20.7	32.8	22.3	14.7	44.4	19.5	21.1	36.9	17.4	18.8	26.6	30.5	14.8	18.7	18.5	17.6	40.8	18.3	23.1	11.3	24.8	16.8	11.7	19.9	26.2	37.1	18.5	17.6	15.2	24.2	17.1	23.9	23.7	23.7	17.7	30.5	27.1	22.8	29.8	13.0	25.4	24.7	27.7	36.3	30.4	40.1	18.7	29.3	36.1	22.9	15.0	29.0	38.1	27.4	40.2	26.6	17.8	20.0	32.6	26.7	31.9	27.8	35.7	25.6	27.0	26.6	27.8	30.3	23.5
SAR1B	SARA2	ENSG00000152700	"Secretion associated Ras related GTPase 1B"	Q9Y6B6	5	134601144-134649271	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006923, HPA048368"	Supported		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA006923: AB_1856577, HPA048368: "	"unprognostic (6.14e-2)"	"unprognostic (7.33e-2)"	"unprognostic (5.32e-2)"	"prognostic favourable (7.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (5.92e-2)"	"prognostic favourable (6.59e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.87e-2)"	15.0	24.4	14.4	9.2	16.4	9.0	15.0	11.2	17.4	11.7	20.9	23.2	20.5	26.7	8.2	15.8	19.0	7.7	11.6	17.9	15.1	12.7	23.2	78.8	9.6	9.4	26.7	12.1	9.7	17.5	27.9	27.3	11.6	19.7	16.0	15.3	10.9	19.1	16.8	68.6	8.5	45.1	10.8	26.5	11.4	16.6	23.9	20.1	8.6	13.8	30.2	12.9	12.2	10.4	22.0	28.9	23.9	33.2	14.5	33.4	29.3	16.9	14.8	11.1	25.3	35.1	17.1	15.0	28.6	24.6	25.8	39.9	25.0	24.1	9.3	24.3	29.3	15.8	19.1	27.7	33.6	21.7	11.1	9.9	25.3	23.9	28.8	8.4	13.7	19.1	17.8	30.0	25.6	19.3	12.9	21.8	26.4	25.1	11.1	12.8	3.7	10.4	9.9	19.2	20.6	18.8	28.5	11.2	5.1	20.2	11.0	20.7	22.5	10.5	15.5	22.6	13.6	20.4	21.4	27.7	60.8	17.0	17.4	16.5	24.7	9.8	32.0	23.9	20.5	31.1	25.1	22.0	23.7	23.6	28.9	13.3	21.1	20.7	11.7	14.5	33.2	19.7	33.4	29.3	14.4	16.4	11.2	17.4	15.1	12.7	26.7	12.1	19.7	20.1
SARDH	"DMGDHL1, SDH"	ENSG00000123453	"Sarcosine dehydrogenase"	Q9UL12	9	133663560-133739955	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 25.3;liver: 52.8;pancreas: 39.4"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.9;Hep G2: 18.4;MOLT-4: 13.3;RH-30: 11.4;RPMI-8226: 23.0;SH-SY5Y: 9.2"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory CD4 T-cell: 4.1;naive CD4 T-cell: 8.4;T-reg: 9.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057267, HPA058086"	Approved		Approved	Mitochondria			190000	Mitochondria		"HPA057267: , HPA058086: "	"unprognostic (3.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.38e-1)"	"prognostic unfavourable (4.62e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.78e-1)"	"unprognostic (3.48e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.30e-2)"	0.5	1.1	1.7	1.0	1.8	0.3	0.4	0.8	1.9	0.9	0.5	1.1	2.9	0.8	1.4	25.3	0.3	0.9	1.2	1.1	1.1	1.4	5.8	52.8	1.3	1.7	1.2	2.1	3.4	39.4	2.0	1.9	0.3	1.2	1.4	0.1	3.7	8.2	0.9	0.3	0.2	0.6	0.6	0.6	0.7	1.2	1.1	0.8	2.2	0.8	0.2	1.2	0.6	0.6	0.4	0.3	0.6	0.1	0.1	9.7	1.6	0.0	0.1	0.8	10.9	0.0	0.3	1.4	0.1	0.4	0.5	0.7	0.2	0.1	0.0	1.5	0.1	0.0	0.0	0.2	0.4	0.0	0.2	1.5	0.0	18.4	1.2	0.0	0.2	2.6	0.0	1.3	0.0	0.1	0.0	0.2	6.9	1.9	13.3	1.4	1.7	0.1	0.9	11.4	23.0	0.0	0.1	1.0	9.2	0.0	0.3	2.3	1.5	0.1	0.0	2.1	1.9	0.2	0.0	0.1	0.0	0.7	1.3	0.8	0.0	0.1	0.1	0.1	0.4	0.0	1.0	0.0	4.1	1.0	0.0	0.4	8.4	1.5	0.6	0.1	0.0	0.3	9.7	1.6	1.7	1.8	0.8	1.9	1.1	1.4	1.2	2.1	1.2	0.8
SARNP	"CIP29, Hcc-1, THO1"	ENSG00000205323	"SAP domain containing ribonucleoprotein"	P82979	12	55752463-55817756	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Translation regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA030902, HPA030903"	Supported		Supported	"Nuclear speckles"			120000	"Nuclear speckles"		"HPA030902: AB_10669872, HPA030903: AB_10964180"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.36e-4)"	"unprognostic (2.02e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.03e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.31e-6)"	"unprognostic (8.50e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.19e-1)"	24.3	31.5	32.3	22.8	32.6	40.2	30.8	34.8	29.6	28.8	29.2	22.3	19.9	16.0	26.0	30.8	30.4	22.7	18.2	39.5	27.1	33.5	30.9	25.1	26.3	31.3	35.9	23.6	28.0	31.1	19.4	27.4	28.4	29.4	26.0	28.9	19.8	20.5	26.6	44.4	20.3	25.7	27.9	31.3	30.6	22.1	26.4	28.9	34.6	25.8	20.8	41.8	31.4	23.4	39.7	50.1	68.1	50.2	40.6	53.1	43.7	26.9	23.6	59.7	25.1	27.6	39.9	28.3	38.7	29.3	46.5	39.1	33.1	29.9	43.9	26.0	30.2	15.3	52.3	36.4	50.3	34.4	30.1	44.2	39.0	28.2	39.5	36.9	33.2	29.4	27.0	30.5	22.9	49.0	31.6	32.4	46.4	21.6	45.8	58.1	52.0	21.0	42.2	31.1	35.9	62.4	29.8	25.4	20.8	32.1	20.6	32.1	31.3	49.2	33.9	18.8	18.8	24.1	29.3	20.6	27.5	60.1	22.6	37.7	23.5	63.7	46.2	68.1	38.2	50.2	34.7	39.7	40.7	40.7	50.1	34.6	32.6	36.5	35.7	40.6	42.3	48.0	53.1	43.7	32.3	32.6	34.8	29.6	27.1	33.5	35.9	23.6	29.4	28.9
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol			100000	Cytosol		"HPA016939: AB_1856585, HPA064668: "	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favourable (9.47e-4)"	"prognostic unfavourable (5.75e-4)"	"prognostic unfavourable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	32.7	12.9	24.8	37.3	37.3	33.9	42.7	34.5	35.8	30.0	37.5	24.9	10.1	35.4	17.9	48.7	18.0	38.6	48.8	35.0	25.0	23.5	13.7	16.0	18.0	75.0	17.2	15.4	41.6	85.5	35.4	77.0	35.7	31.3	44.4	29.2	31.4	19.1	8.8	10.3	30.5	15.8	31.7	15.8	22.8	17.5	34.5	18.3	16.5	26.7	93.6	15.1	20.6	28.1	17.9	22.6	25.4	24.1	33.9	13.7	29.0	56.5	18.9	60.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"SART1, U4/U6.U5 tri-snRNP-associated protein 1"	O43290	11	65961689-65979828	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"				"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	22.3	17.5	26.4	25.0	27.8	50.7	21.7	28.5	27.2	21.4	19.6	17.7	20.9	22.7	26.3	17.4	19.0	20.3	20.7	19.5	23.8	16.8	15.8	18.2	19.0	26.2	23.0	25.7	26.8	28.4	22.5	19.2	22.4	25.2	18.1	12.0	15.9	27.1	27.2	34.6	26.2	19.9	27.9	29.2	29.2	20.3	20.4	25.6	24.0	20.5	19.1	19.0	20.6	41.3	5.9	5.8	12.1	5.3	4.1	8.1	2.7	22.5	27.3	12.5	16.8	12.3	9.8	19.2	17.5	12.4	20.3	13.3	19.7	15.7	25.7	20.2	15.2	22.2	15.7	16.0	10.3	20.6	15.6	29.7	19.4	18.2	18.5	25.6	25.0	12.3	12.3	18.8	16.9	12.6	18.7	18.3	11.6	40.7	32.9	36.9	21.3	26.1	36.2	18.2	27.0	8.4	15.1	14.2	20.1	16.6	17.1	20.3	19.1	20.9	18.7	25.4	25.1	24.9	24.5	28.0	21.8	22.5	21.1	13.0	21.5	2.0	4.5	12.1	7.1	5.3	6.0	5.9	8.0	7.4	5.8	5.4	5.9	6.6	6.3	4.1	3.1	4.9	8.1	2.7	26.4	27.8	28.5	27.2	23.8	16.8	23.0	25.7	25.2	25.6
SART3	"KIAA0156, p110, RP11-13G14, TIP110"	ENSG00000075856	"Squamous cell carcinoma antigen recognized by T cells 3"	Q15020	12	108522580-108561400	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028840, HPA044322"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028840: , HPA044322: "	"unprognostic (1.72e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (6.32e-6)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (8.74e-4)"	"unprognostic (1.38e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.36e-2)"	18.0	19.0	29.3	30.0	27.6	25.9	19.6	35.7	27.9	22.8	19.1	19.1	19.4	14.7	24.7	19.5	23.7	22.5	19.1	16.2	21.5	19.3	16.1	19.8	18.6	28.7	16.3	26.1	30.2	17.2	28.9	25.8	20.2	19.6	21.6	21.0	19.0	18.6	28.7	43.9	23.3	19.6	20.2	15.7	25.9	18.7	20.5	20.1	36.2	25.5	15.5	30.5	20.9	20.5	11.7	13.0	14.3	10.4	11.4	15.0	9.2	12.3	23.4	20.7	21.5	12.2	9.8	16.5	12.1	16.5	22.9	17.9	20.6	8.6	21.1	7.1	12.1	11.9	33.7	16.5	21.3	22.5	18.1	28.9	15.6	20.3	18.9	27.6	15.6	13.7	14.9	16.0	23.8	14.2	30.9	13.0	13.7	16.3	24.4	23.8	31.6	24.8	23.8	17.4	18.8	12.1	23.5	21.5	14.9	16.9	6.6	10.9	18.0	20.6	9.2	13.6	8.6	10.4	10.8	16.5	22.8	28.9	13.9	16.7	17.7	14.3	9.3	10.4	13.5	7.8	15.0	11.7	9.1	12.0	13.0	11.3	14.0	11.2	3.1	11.4	10.4	8.8	13.6	9.2	29.3	27.6	35.7	27.9	21.5	19.3	16.3	26.1	19.6	20.1
SATB1		ENSG00000182568	"SATB homeobox 1"	Q01826	3	18345387-18445588	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"lymphoid tissue: 331.6"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 92.0;MOLT-4: 21.5;REH: 25.7;T-47d: 20.6;THP-1: 39.3;U-937: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 37.9"	"Group enriched"	"Detected in many"	6	"NK-cells: 18.6;T-cells: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051769, CAB056144"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB056144: AB_10584780, HPA051769: "	"unprognostic (2.16e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.58e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.90e-2)"	"unprognostic (6.14e-2)"	"prognostic favourable (8.97e-4)"	"unprognostic (1.66e-1)"	"prognostic favourable (1.96e-7)"	"unprognostic (1.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-3)"	6.7	5.3	11.8	11.7	11.0	16.4	5.9	10.1	22.7	5.6	15.1	3.6	16.1	6.8	5.9	11.1	5.3	8.0	7.7	10.9	10.8	8.1	5.4	7.2	7.6	25.9	10.0	15.6	6.2	14.8	22.4	12.9	1.8	6.6	10.1	8.2	5.9	17.9	26.2	35.7	9.2	11.3	12.1	8.1	11.5	10.4	2.9	4.5	331.6	11.3	4.6	11.8	18.7	11.0	4.7	1.2	4.7	0.6	18.6	37.9	7.9	0.4	0.0	2.6	0.0	3.7	3.6	0.3	0.7	2.5	0.6	2.1	0.1	4.7	0.9	0.0	0.8	0.0	9.6	1.1	1.2	92.0	5.8	0.0	0.2	0.0	0.5	5.3	0.8	1.6	0.8	0.0	0.1	0.6	0.1	5.1	0.4	0.0	21.5	6.8	3.9	0.3	25.7	1.3	0.9	1.0	3.2	1.2	7.3	0.0	0.8	0.0	20.6	39.3	0.3	2.7	1.7	1.2	0.7	0.2	0.0	2.0	2.2	20.7	1.2	4.7	0.5	1.3	14.3	0.6	25.8	0.5	9.7	7.4	1.0	4.7	37.9	22.6	1.2	18.6	0.3	1.2	1.7	7.9	11.8	11.0	10.1	22.7	10.8	8.1	10.0	15.6	6.6	4.5
SBDS	"CGI-97, FLJ10917, SDS, SWDS"	ENSG00000126524	"SBDS, ribosome maturation factor"	Q9Y3A5	7	66987677-66995601	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028891	Approved		Supported	Nucleoplasm,Cytosol			55000	"Nucleoplasm, Cytosol"		"HPA028891: AB_10601500"	"prognostic unfavourable (1.49e-4)"	"unprognostic (1.87e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.71e-3)"	"unprognostic (8.06e-3)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.99e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.59e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.06e-3)"	40.9	34.5	37.7	18.7	44.0	41.7	44.5	23.6	43.2	30.7	37.5	35.3	20.2	39.1	35.6	27.3	40.8	27.7	34.0	70.0	39.2	40.9	36.9	38.4	32.1	16.7	50.6	36.6	31.9	27.5	50.4	26.9	38.6	44.6	35.1	35.7	20.1	23.5	40.5	130.7	26.1	34.4	52.0	63.2	16.7	32.8	15.9	48.2	7.2	33.9	38.7	15.6	54.0	38.0	21.6	15.5	20.8	12.6	16.6	39.1	19.4	31.0	13.2	11.7	10.6	42.7	31.9	13.1	52.9	43.6	40.5	31.2	27.1	16.0	11.5	40.2	48.3	15.1	19.7	31.4	43.6	11.0	26.0	5.7	24.6	16.2	38.0	14.4	7.9	28.8	42.3	30.8	53.6	24.9	41.7	12.6	62.9	18.6	7.6	21.0	13.0	31.4	5.8	25.2	24.2	42.7	13.9	18.0	12.4	26.5	45.9	35.1	34.2	12.2	33.1	54.8	18.7	27.7	38.5	7.8	9.2	26.4	18.8	23.7	30.3	20.8	11.1	20.2	23.4	12.6	29.6	21.6	30.6	27.2	11.3	18.7	39.1	31.5	4.7	16.6	11.2	15.5	25.9	19.4	37.7	44.0	23.6	43.2	39.2	40.9	50.6	36.6	44.6	48.2
SBSN	"HLAR698, UNQ698"	ENSG00000189001	Suprabasin	Q6UWP8	19	35523367-35528351	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 105.1;skin 1: 241.3;tongue: 338.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 19.7;ASC TERT1: 34.4;HSkMC: 46.5;U-2197: 16.0;U-87 MG: 37.7"	"Group enriched"	"Detected in many"	9	"cervical cancer: 76.5;head and neck cancer: 355.2;melanoma: 153.1"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			"HPA062568, HPA067734"	Enhanced		Approved	Vesicles	"Secreted - unknown location"		62000000	Vesicles		"HPA062568: AB_2684794, HPA067734: AB_2685894"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.23e-3)"	"unprognostic (3.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (4.83e-4)"	"unprognostic (4.31e-4)"	"unprognostic (6.97e-2)"	"unprognostic (9.08e-14)"	"unprognostic (6.37e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.36e-3)"	0.3	0.0	0.2	0.2	1.6	0.1	11.2	0.2	0.2	65.1	0.2	0.2	0.2	0.0	3.5	0.2	105.1	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.0	0.2	26.8	0.2	1.3	241.3	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.2	338.1	51.7	0.4	51.4	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.7	34.4	0.0	1.5	2.2	0.7	0.2	0.0	0.0	0.0	0.3	1.4	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	46.5	2.5	9.3	2.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	5.8	1.2	16.0	0.4	0.1	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671033-31732075	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	18.8	14.9	15.1	32.7	16.3	19.0	18.4	24.0	21.4	19.9	23.2	20.3	12.9	19.4	21.6	17.6	22.3	16.8	22.3	15.4	13.2	11.5	14.0	22.5	19.0	27.1	15.3	11.9	23.9	18.5	23.7	18.1	20.3	14.3	17.6	16.8	17.1	18.4	19.3	23.3	24.2	21.9	16.1	13.3	23.7	17.9	25.6	14.6	44.2	16.5	12.8	26.4	18.9	20.4	14.1	12.0	12.7	13.2	9.6	12.8	8.4	13.8	9.2	18.6	13.4	10.1	7.7	12.7	10.4	10.9	10.9	10.3	17.6	10.1	28.4	6.2	10.0	8.6	20.1	10.0	12.1	12.7	12.0	22.6	7.1	14.6	11.6	24.1	9.5	8.6	11.4	14.6	12.6	9.6	29.8	14.9	9.0	18.6	25.5	17.6	23.8	8.0	25.3	20.7	9.3	7.6	10.9	12.8	13.8	15.8	12.3	8.9	9.4	16.2	11.0	11.4	11.0	10.9	10.4	9.6	8.9	32.8	8.2	19.4	10.6	8.2	9.4	12.7	12.8	13.2	12.8	14.1	7.5	12.1	12.0	14.0	8.8	9.5	5.0	9.6	11.4	8.4	6.6	8.4	15.1	16.3	24.0	21.4	13.2	11.5	15.3	11.9	14.3	14.6
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733325-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	27.9	19.1	17.4	32.0	19.1	36.1	27.5	28.1	22.2	30.0	23.4	18.2	20.8	14.2	28.3	21.6	18.5	25.1	21.9	19.3	16.9	13.4	19.8	17.6	19.6	23.5	16.2	15.1	32.6	20.0	33.6	24.1	23.8	14.8	24.4	20.7	17.9	21.9	30.1	28.5	26.9	21.2	23.8	14.3	21.7	19.9	25.4	20.2	42.6	24.7	20.1	22.8	26.1	32.9	5.4	3.3	3.8	6.7	6.1	7.5	2.6	8.4	8.2	24.4	14.7	16.5	17.0	15.0	13.8	19.5	18.3	18.7	12.9	8.6	26.4	11.3	15.9	11.5	21.5	18.2	24.7	11.5	10.8	23.7	8.9	15.7	19.2	21.8	15.9	18.2	19.4	16.0	25.1	15.6	27.4	16.1	16.8	15.3	23.3	14.8	17.0	6.2	22.4	13.3	14.3	15.5	15.5	15.1	17.7	14.4	19.0	10.5	12.4	25.4	14.2	10.5	12.8	13.5	13.9	15.1	11.1	29.3	13.1	13.6	16.2	1.2	2.8	3.5	6.0	3.9	5.8	4.8	6.2	5.9	3.3	5.4	6.3	5.6	3.8	6.1	6.7	3.2	7.5	2.6	17.4	19.1	28.1	22.2	16.9	13.4	16.2	15.1	14.8	20.2
SCAND1	"RAZ1, SDP1"	ENSG00000171222	"SCAN domain containing 1"	P57086	20	35953617-35959472	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047138			Supported	"Nucleoplasm,Actin filaments,Cytosol"				"Nucleoplasm, Actin filaments"	Cytosol	"HPA047138: "	"unprognostic (3.88e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.28e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.15e-3)"	"unprognostic (3.53e-1)"	"unprognostic (2.62e-1)"	"unprognostic (3.48e-2)"	38.7	31.8	23.5	25.4	22.0	50.3	21.6	13.7	37.7	18.1	30.3	12.3	22.4	45.3	19.3	32.8	21.0	17.0	27.1	19.8	21.6	22.7	30.7	39.6	18.0	26.5	21.0	18.4	19.8	30.7	8.8	21.2	16.9	14.5	26.8	7.2	19.1	36.2	27.8	50.7	19.5	35.4	15.4	16.5	31.9	40.6	23.8	13.4	34.8	26.8	26.2	15.9	14.8	17.3	42.0	60.9	70.6	61.6	30.4	47.2	43.2	13.0	9.7	3.8	7.3	2.0	2.4	24.4	9.1	3.6	4.0	4.7	8.9	9.7	10.1	23.6	1.5	12.2	0.8	4.3	0.4	3.6	21.7	24.9	5.3	19.0	7.0	7.8	10.3	4.2	3.4	3.3	0.7	6.4	10.8	8.1	2.4	13.1	21.8	55.4	12.8	38.3	16.6	11.8	16.5	3.8	5.2	18.8	27.8	15.0	24.0	20.2	16.3	14.8	12.8	13.4	12.0	12.9	8.9	24.3	11.9	14.2	15.6	8.4	10.4	70.6	61.6	57.3	35.1	40.9	27.7	36.6	35.0	30.9	45.8	42.0	29.7	29.0	53.3	30.4	39.6	60.9	47.2	43.2	23.5	22.0	13.7	37.7	21.6	22.7	21.0	18.4	14.5	13.4
SCEL	"FLJ21667, MGC22531"	ENSG00000136155	Sciellin	O95171	13	77535674-77645263	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 145.6;skin 1: 70.8;tongue: 62.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.9;HaCaT: 24.3;HBEC3-KT: 11.6;RPTEC TERT1: 47.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA039737, HPA040154"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA039737: AB_10805485, HPA040154: AB_10795359"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (4.07e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.54e-2)"		"unprognostic (6.62e-2)"	"unprognostic (3.51e-1)"	"unprognostic (8.08e-3)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (4.57e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.81e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (1.73e-5)"	0.4	0.0	0.1	0.2	0.4	0.0	4.9	0.1	0.2	15.2	0.2	0.2	0.1	0.0	0.8	0.2	145.6	0.0	0.3	0.1	0.1	0.0	0.4	0.1	27.8	0.1	0.1	0.1	0.2	0.1	0.0	0.1	3.7	0.2	0.1	0.4	0.1	11.8	0.1	0.3	70.8	0.2	0.1	0.2	0.1	0.0	0.5	0.1	0.4	0.5	62.2	35.1	0.4	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.8	0.0	24.3	0.0	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	47.3	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1
SCFD2	"FLJ39514, STXBP1L1"	ENSG00000184178	"Sec1 family domain containing 2"	Q8WU76	4	52872982-53366075	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036526, HPA036527"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA036526: AB_10673499, HPA036527: AB_2675175"	"unprognostic (1.50e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.22e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.08e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (3.81e-6)"	"unprognostic (9.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.51e-2)"	13.7	19.4	11.0	15.8	15.1	12.5	13.7	7.8	17.6	12.9	11.7	16.2	6.5	10.5	14.2	9.0	16.7	9.9	10.0	11.9	11.5	13.2	13.6	17.2	10.4	12.7	15.7	9.3	13.2	18.3	11.4	15.3	11.2	16.4	8.7	11.8	10.5	13.0	10.4	13.8	13.5	10.7	14.2	13.2	12.7	10.6	5.1	12.4	16.2	10.1	10.2	19.3	10.4	12.1	6.5	15.9	1.4	9.7	13.9	9.5	9.1	6.6	6.2	3.6	8.3	11.9	12.1	4.4	15.5	11.7	5.4	4.6	4.4	8.6	12.7	12.0	29.5	4.2	11.5	13.5	10.4	3.9	6.7	7.1	6.6	5.3	5.6	8.4	13.1	8.3	8.2	10.4	4.1	9.1	12.0	7.4	9.2	7.7	12.4	5.4	2.1	7.8	7.7	3.3	13.4	6.0	4.5	10.3	5.8	3.5	13.1	6.9	5.1	4.1	8.4	11.8	7.5	13.3	11.3	8.7	4.7	15.0	8.0	10.5	33.5	0.0	5.6	1.4	7.8	9.7	7.8	6.5	6.4	8.8	15.9	5.7	9.5	8.6	1.2	13.9	9.3	10.3	5.5	9.1	11.0	15.1	7.8	16.9	11.5	13.2	15.7	9.3	16.4	12.4
SCG2	"CHGC, SgII, SN"	ENSG00000171951	"Secretogranin II"	P13521	2	223596940-223602503	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 133.0;brain: 94.1;pituitary gland: 76.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 26.2;HSkMC: 22.4;SCLC-21H: 22.8;SH-SY5Y: 9.9;WM-115: 16.7"	"Group enriched"	"Detected in many"	8	"glioma: 70.0;pancreatic cancer: 52.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011893, HPA075062"	Enhanced	Supported	Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"		54000	"Golgi apparatus"	Vesicles	"HPA011893: AB_1856656, HPA075062: AB_2732277"	"unprognostic (2.93e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-3)"	"unprognostic (6.82e-4)"	"unprognostic (2.51e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.69e-2)"	"prognostic favourable (5.58e-4)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (7.01e-10)"	"unprognostic (2.47e-3)"	"unprognostic (4.02e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.90e-3)"	3.5	133.0	13.3	11.0	94.1	0.9	0.9	5.6	55.9	1.4	5.4	5.8	0.0	17.3	2.1	0.9	1.0	0.8	2.2	1.4	10.5	79.4	1.0	0.8	1.9	0.9	21.7	11.0	1.3	10.7	1.1	76.5	1.1	57.7	2.1	5.5	1.5	0.9	1.3	0.8	1.0	8.0	5.2	10.3	0.8	8.0	0.9	5.0	0.0	3.1	0.0	0.8	1.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.9	4.1	1.1	26.2	0.1	0.2	0.9	1.9	4.9	0.2	0.4	0.0	0.4	0.3	0.1	0.1	0.0	2.5	0.0	0.2	0.0	0.3	0.0	0.3	0.3	2.2	22.4	0.1	2.7	0.9	0.0	0.1	0.2	2.4	0.1	0.0	0.1	3.5	0.0	0.0	0.1	0.0	0.3	0.0	22.8	9.9	0.0	0.2	1.1	0.0	0.0	0.0	2.6	1.0	0.1	1.7	0.0	0.0	0.1	0.7	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	13.3	94.1	5.6	23.0	10.5	79.4	21.7	11.0	57.7	5.0
SCG3	"FLJ90833, SgIII"	ENSG00000104112	"Secretogranin III"	Q8WXD2	15	51681353-51721031	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 118.3"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.0;SCLC-21H: 47.9;SH-SY5Y: 22.6"	"Group enriched"	"Detected in many"	7	"glioma: 41.0;pancreatic cancer: 15.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006880, CAB033274, HPA053715"	Enhanced	Supported	Supported	Vesicles	"Secreted in brain"		4800000	Vesicles		"CAB033274: AB_2302033, HPA006880: AB_1079898, HPA053715: "	"unprognostic (1.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-5)"	"unprognostic (1.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.78e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	1.7	12.9	29.6	2.1	25.4	1.7	1.7	33.4	118.3	1.5	2.4	6.5	0.0	2.9	1.5	1.6	1.6	1.6	1.6	1.5	22.6	23.5	1.5	1.5	1.8	1.7	13.6	37.7	1.5	11.5	1.4	23.7	1.5	27.1	1.6	2.8	1.3	1.5	1.4	1.5	1.8	2.6	1.7	13.2	1.5	8.7	2.9	7.3	0.0	2.1	0.0	1.5	1.6	0.1	0.9	1.2	1.9	0.5	0.3	0.8	0.2	0.0	0.0	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	20.0	0.0	0.1	0.0	0.1	0.0	0.2	47.9	22.6	0.1	0.1	0.0	0.0	1.4	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.3	0.1	4.3	0.4	0.4	0.6	0.8	0.2	0.5	0.9	0.6	0.4	0.4	0.7	0.5	0.6	1.9	0.3	0.5	1.2	0.2	0.2	29.6	25.4	33.4	40.6	22.6	23.5	13.6	37.7	27.1	7.3
SCGB1A1	"CC10, CC16, CCSP, UGB"	ENSG00000149021	"Secretoglobin family 1A member 1"	P11684	11	62405103-62423195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Phospholipase A2 inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"lung: 508.4"	"Cell line enriched"	"Detected in some"	69	"HaCaT: 207.4"	"Cancer enriched"	"Detected in many"	8	"lung cancer: 215.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025686, HPA031828"	Enhanced				"Secreted in other tissues"		17000000			"CAB025686: , HPA031828: "		"unprognostic (2.40e-3)"		"unprognostic (1.55e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.70e-2)"		"unprognostic (4.69e-3)"		"unprognostic (2.12e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.31e-2)"		"unprognostic (2.63e-2)"	"unprognostic (1.63e-1)"		"unprognostic (2.40e-2)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	28.7	0.0	0.1	0.0	0.1	0.0	0.0	508.4	0.0	0.1	0.0	9.4	0.2	0.0	7.4	0.0	0.1	7.6	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.3	4.8	0.1	0.1	0.0	0.8	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	207.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0
SCGB3A1	"HIN-1, HIN1, LU105, PnSP-2, UGRP2"	ENSG00000161055	"Secretoglobin family 3A member 1"	Q96QR1	5	180590103-180591540	"Plasma proteins, Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 56.1;gallbladder: 113.1;lung: 176.2;salivary gland: 196.6"	"Cell line enhanced"	"Detected in some"		"NB-4: 6.2;T-47d: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"endometrial cancer: 114.2;lung cancer: 288.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 25.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"		8000000				"unprognostic (7.70e-3)"	"unprognostic (4.90e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.87e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.55e-2)"	"unprognostic (7.19e-2)"	"unprognostic (8.74e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-2)"	0.2	0.1	0.1	0.1	0.3	0.1	23.5	0.1	0.2	56.1	0.1	0.1	0.1	0.1	2.3	1.6	12.1	5.7	113.1	0.3	0.1	0.6	0.1	0.5	176.2	0.1	0.1	0.1	1.5	2.9	0.0	1.6	0.1	0.2	4.5	0.0	0.3	196.6	0.6	0.2	0.4	0.1	0.1	0.1	1.6	9.6	0.3	0.1	0.2	0.2	8.4	19.9	3.9	0.1	0.7	5.3	10.3	25.1	0.0	7.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	6.2	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.4	2.1	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.3	1.5	8.2	7.2	0.7	1.9	2.5	5.3	0.0	3.3	2.6	0.0	0.0	25.1	0.1	2.2	1.2	0.1	0.3	0.1	0.2	0.1	0.6	0.1	0.1	0.2	0.1
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.3;pancreas: 39.7;pituitary gland: 47.9"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 23.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2"	"Group enriched"	"Detected in many"	11	"cerebellum: 22.3;hippocampal formation: 6.2;hypothalamus: 22.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	16	"olfactory region: 100.5"	"Region enriched"	"Detected in some"	9	"olfactory region: 282.4"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"			Cytosol		"CAB004005: , CAB044060: , CAB062563: , CAB068232: , HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		1.5	2.1	0.7	6.0	0.8	0.1	2.0	22.3	1.5	0.4	10.5	0.5	0.9	7.2	0.1	0.3	0.3	0.0	0.5	5.0	6.2	22.0	3.8	2.5	0.4	0.1	0.5	1.2	0.2	39.7	0.0	47.9	1.8	1.4	1.1	11.7	1.8	3.7	3.0	0.1	0.3	8.0	0.7	1.0	0.1	12.5	0.6	0.1	0.5	1.1	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	23.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	22.3	1.5	6.2	22.0	0.5	1.2	1.4	0.1
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 37.7;SK-BR-3: 40.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.1	8.3	0.2	0.2	0.1	0.6	0.1	1.3	0.1	0.2	0.0	37.7	1.4	1.7	0.0	0.4	40.9	0.0	4.3	0.3	0.0	0.1	0.3	0.8	0.0	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4
SCML2		ENSG00000102098	"Scm polycomb group protein like 2"	Q9UQR0	X	18239314-18354727	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 20.0;REH: 17.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in single"	7	"dendritic cells: 7.0"					"Low region specificity"	"Detected in all"			"HPA001662, HPA064713"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"HPA001662: AB_1079879, HPA064713: "	"unprognostic (5.15e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.93e-2)"	"unprognostic (7.26e-5)"	"unprognostic (1.24e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.95e-5)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.15e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.35e-4)"	"unprognostic (3.30e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.31e-3)"	2.4	7.7	3.1	2.1	4.1	8.6	3.1	3.4	3.8	3.7	3.7	3.7	2.0	2.1	4.9	2.5	2.3	2.9	2.8	2.0	2.3	2.0	1.5	2.6	1.3	2.0	3.6	0.5	9.5	3.9	3.2	8.0	7.1	2.3	2.9	2.3	3.6	10.0	2.2	2.0	3.4	2.0	6.5	2.2	2.3	1.7	19.0	4.2	12.5	4.3	2.3	2.1	2.7	4.2	0.8	7.0	0.2	0.2	0.9	0.7	0.2	0.9	3.3	11.8	3.0	0.9	1.5	3.5	2.0	1.4	4.0	4.5	4.8	0.7	0.0	0.4	0.9	0.0	16.5	0.2	4.9	0.0	13.5	0.0	3.0	2.1	0.5	10.3	2.7	0.6	0.6	2.9	3.4	0.2	7.7	0.0	2.8	1.5	16.5	5.5	20.0	4.2	17.8	5.9	2.4	0.0	0.2	7.2	8.4	3.5	3.3	0.0	4.2	4.6	0.3	3.6	2.6	8.0	1.8	0.0	9.4	16.5	1.2	7.1	2.7	0.0	0.2	0.2	0.7	0.2	0.7	0.2	0.3	0.2	0.9	0.8	0.2	0.1	0.2	0.9	0.1	7.0	0.0	0.2	3.1	4.1	3.4	3.8	2.3	2.0	3.6	0.5	2.3	4.2
SCN10A	"hPN3, Nav1.8, PN3, SNS"	ENSG00000185313	"Sodium voltage-gated channel alpha subunit 10"	Q9Y5Y9	3	38696807-38816217	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"heart muscle: 1.5;testis: 2.0"	"Cell line enhanced"	"Detected in single"		"HUVEC TERT2: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (6.57e-2)"										"unprognostic (7.85e-2)"		"unprognostic (2.09e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.69e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.2	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SCN3A	Nav1.3	ENSG00000153253	"Sodium voltage-gated channel alpha subunit 3"	Q9NY46	2	165087522-165204067	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 13.6;brain: 28.5;pituitary gland: 13.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.5;MOLT-4: 24.1;RPTEC TERT1: 12.1;SH-SY5Y: 5.4"	"Cancer enriched"	"Detected in some"	6	"glioma: 3.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 8.4;naive B-cell: 13.6"	"Lineage enriched"	"Detected in single"	38	"B-cells: 13.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035396	Approved									"HPA035396: "	"unprognostic (1.80e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.50e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.96e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.21e-4)"	"unprognostic (4.55e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.88e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.93e-2)"	2.6	4.0	16.7	1.9	28.5	1.0	2.5	19.6	19.7	2.1	2.1	0.8	0.0	1.2	1.4	0.7	1.5	1.4	1.8	2.1	9.8	11.3	1.8	1.0	1.0	2.7	4.8	9.8	1.8	1.7	2.3	13.7	0.8	9.1	0.9	2.1	0.0	0.7	1.4	0.9	0.5	1.9	1.7	4.0	1.8	2.7	1.8	4.9	2.0	1.3	0.0	3.5	1.7	0.5	13.6	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	2.3	0.0	0.0	0.1	0.0	0.0	0.2	0.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.1	0.0	24.1	0.0	0.0	2.0	0.1	1.1	0.0	12.1	0.0	3.1	5.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.7	0.0	1.3	0.4	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	13.6	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.1	16.7	28.5	19.6	17.2	9.8	11.3	4.8	9.8	9.1	4.9
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Group enriched"	"Detected in some"	4	"LHCN-M2: 21.5;RH-30: 17.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"				"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.3	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.8	2.7	0.0	0.3	0.0	1.1	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	3.5	0.0	0.0	21.5	1.0	0.0	0.0	2.0	0.0	0.0	17.9	0.0	0.0	2.4	0.3	2.3	0.0	0.0	0.0	0.0	0.0	4.3	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166494326	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 51.9"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 2.8;SH-SY5Y: 1.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA072715	Approved									"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.9	6.0	1.0	10.4	0.7	0.0	2.9	0.3	0.7	16.2	23.3	0.0	13.0	2.0	24.6	8.1	28.1	7.8	6.8	16.0	0.7	3.6	1.8	1.3	51.9	1.6	3.6	0.5	33.3	3.1	0.3	1.1	8.1	2.6	18.4	6.1	14.0	4.9	11.3	3.7	1.5	6.2	10.5	4.3	5.5	6.4	6.9	0.1	0.5	1.3	4.9	0.2	9.7	7.6	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.1	0.1	0.8	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.0	0.7	0.3	0.7	0.7	3.6	3.6	0.5	2.6	0.1
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell line enhanced"	"Detected in many"		"AF22: 11.8;ASC TERT1: 12.4;BJ hTERT+: 11.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.3	1.0	11.8	0.1	1.6	12.4	0.2	6.7	11.0	7.7	7.2	1.9	1.3	0.3	1.5	8.7	0.0	1.9	0.0	9.1	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.1	1.1	8.2	0.1	0.1	4.8	0.8	1.9	0.1	4.0	3.8	0.0	0.6	0.0	0.0	0.4	4.7	1.9	3.4	1.7	0.2	0.3	0.1	2.2	7.5	5.0	2.7	4.2	0.1	0.1	0.0	1.5	1.6	10.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6
SCP2		ENSG00000116171	"Sterol carrier protein 2"	P22307	1	52927229-53051703	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Lipid transport, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027101, HPA027135, HPA027317"	Supported		Supported	Peroxisomes			370000	Peroxisomes		"HPA027101: AB_1856634, HPA027135: AB_1856633, HPA027317: AB_10610422"	"unprognostic (7.51e-2)"	"unprognostic (5.23e-2)"	"prognostic favourable (7.05e-5)"	"unprognostic (9.68e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.53e-2)"	"unprognostic (6.16e-2)"	"prognostic favourable (7.85e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.13e-2)"	29.1	26.2	21.8	19.9	21.2	14.0	30.3	12.0	19.7	24.4	51.9	15.9	28.1	49.2	19.0	28.8	32.2	18.1	32.1	29.3	20.0	20.0	54.2	168.3	21.8	14.0	25.6	17.8	22.8	24.6	16.7	24.1	17.1	21.9	25.5	40.5	18.9	21.8	23.3	22.0	18.8	80.1	20.6	27.1	20.9	33.9	16.7	19.4	23.0	28.2	28.6	17.6	22.3	20.5	36.4	57.1	67.8	50.7	40.8	49.2	61.2	25.9	14.3	19.3	35.3	63.3	54.1	20.9	31.0	46.6	20.4	29.6	12.8	28.2	24.7	33.6	45.4	18.3	13.2	29.0	31.2	36.0	19.2	26.6	20.5	26.3	42.2	38.3	44.9	43.9	39.6	24.2	12.1	57.7	23.6	12.9	41.2	15.0	42.5	33.3	21.1	28.1	22.4	33.9	33.8	56.5	44.2	16.0	19.2	27.1	55.0	25.9	28.1	43.8	44.6	27.8	14.4	48.4	24.7	21.6	27.4	28.9	36.0	38.1	25.7	55.4	48.7	67.8	49.2	50.7	39.9	36.4	39.2	48.6	57.1	29.8	33.2	47.1	7.5	40.8	46.8	37.1	47.1	61.2	21.8	21.2	12.0	19.7	20.0	20.0	25.6	17.8	21.9	19.4
SCRT1	"DKFZp547F072, ZNF898"	ENSG00000261678	"Scratch family transcriptional repressor 1"	Q9BWW7	8	144330565-144336281	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 20.3"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 10.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045265	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA045265: AB_10959521"	"unprognostic (7.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (6.88e-4)"	"unprognostic (2.43e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-4)"	"unprognostic (5.02e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.04e-1)"	0.3	2.3	2.1	0.3	6.6	0.3	0.3	5.7	20.3	0.3	0.3	0.0	0.0	0.4	0.3	0.3	0.3	0.3	0.3	0.3	2.2		0.3	0.3	0.3	0.3	0.0	3.8	0.4	0.7	0.3	0.0	0.3	4.2	0.3	0.3	0.0	0.3	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.3	1.2	2.0	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 60.9;hTCEpi: 56.3;U-251 MG: 58.0;U-266/70: 60.1;U-266/84: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Supported	"Focal adhesion sites"	"Secreted to blood"	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavourable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavourable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	30.8	17.3	5.5	13.8	1.5	0.2	17.3	8.6	8.3	8.1	6.8	3.6	18.8	0.0	3.2	6.1	30.4	2.4	60.9	5.4	0.1	1.6	0.0	1.6	18.5	1.3	1.3	0.1	0.8	56.3	7.2	17.3	0.8	0.7	12.1	4.3	18.4	0.0	0.3	4.9	33.5	0.6	2.0	23.3	10.3	46.3	1.6	12.8	6.5	43.9	1.9	4.3	0.3	1.3	32.1	10.3	1.1	58.0	60.1	126.7	0.1	9.6	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 99.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.4	22.4	23.9	12.4	89.4	77.1	10.5	14.9	53.2	21.6	28.5	8.9	30.3	0.0	24.0	19.9	6.0	12.9	17.1	26.8	2.6	11.0	21.7	19.9	7.1	99.4	5.5	35.4	52.6	23.2	21.7	65.3	51.8	10.7	12.7	49.0	3.8	12.2	6.5	14.9	6.4	5.9	7.3	2.8	34.4	15.2	10.4	18.9	15.9	6.8	73.0	6.2	15.2	44.5	20.9	9.0	24.6	9.5	3.8	5.1	8.7	53.2	0.0	18.7	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216908-1232031	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"		720000	"Golgi apparatus"		"CAB015227: , HPA011249: , HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	34.7	36.0	17.9	37.3	22.7	19.7	56.3	20.6	33.2	30.3	49.9	21.3	46.6	48.5	35.5	53.4	26.2	26.9	57.5	50.8	18.7	18.5	36.3	73.8	55.8	46.2	19.7	21.3	33.1	56.4	25.9	31.1	47.9	18.2	30.3	25.6	26.5	46.7	52.1	30.7	25.5	56.2	27.6	18.0	33.8	32.9	30.0	18.1	20.5	35.1	28.5	19.6	28.5	44.8	11.5	16.0	20.6	15.9	19.6	22.0	7.0	28.3	25.8	14.3	45.2	69.9	35.3	17.1	55.7	51.1	41.0	34.4	30.4	49.6	18.0	43.2	53.6	29.2	16.3	24.4	12.6	30.1	27.6	31.5	39.8	42.4	32.2	31.7	42.7	43.4	12.6	30.8	17.5	32.7	25.9	47.8	20.1	20.5	15.6	32.0	13.0	34.7	17.5	18.5	47.6	27.2	13.8	51.9	18.4	37.0	44.1	36.6	22.9	36.4	41.5	42.4	23.0	31.8	31.6	29.5	27.8	29.5	48.1	59.8	18.3	10.4	14.9	20.6	15.0	9.9	11.6	9.4	21.5	22.0	16.0	11.5	12.4	10.7	12.7	19.6	15.9	10.0	16.5	7.0	17.9	22.7	20.6	33.2	18.7	18.5	19.7	21.3	18.2	18.1
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria			780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavourable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.4	29.9	12.3	20.1	21.2	15.9	33.4	14.2	18.1	24.5	25.0	32.4	25.1	22.8	45.0	16.2	23.9	21.7	29.0	14.5	48.6	19.9	11.6	82.6	42.0	13.1	14.4	15.1	15.8	18.7	18.3	9.7	26.5	18.6	19.0	11.5	28.2	19.1	39.0	4.2	37.9	24.7	17.9	44.2	52.2	24.5	13.6	7.8	67.0	43.3	17.6	26.3	18.3	19.2	18.2	17.9	10.8	11.7	20.2	8.6	16.8	17.6	20.9	11.5	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054170	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"			Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: , CAB068234: , CAB068235: , HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favourable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	17.8	25.6	19.8	16.6	21.7	17.0	26.4	18.0	29.1	13.9	30.8	12.3	15.1	34.0	14.2	15.7	19.8	13.6	15.1	86.9	18.2	16.4	51.0	75.1	16.8	24.6	20.1	18.9	10.5	30.7	20.0	11.3	15.6	16.7	13.0	31.5	11.7	15.9	19.5	96.2	13.2	31.4	21.3	16.5	17.2	21.7	18.7	15.7	14.2	15.5	52.2	18.0	15.4	17.1	22.2	45.9	48.5	48.7	18.9	26.7	25.0	25.5	25.4	14.5	18.5	28.2	28.1	16.5	22.4	28.8	51.4	46.5	35.7	30.8	35.1	28.0	30.2	30.2	57.7	44.7	58.0	20.6	47.3	31.6	26.4	27.4	34.6	49.4	23.6	28.8	29.5	44.4	75.3	36.3	26.4	40.7	35.7	21.1	32.8	28.2	12.0	51.1	23.6	27.9	43.5	47.3	14.5	27.3	15.0	30.4	38.1	63.9	22.3	27.9	18.0	19.8	22.3	36.3	29.5	17.0	20.9	35.9	30.3	75.3	21.8	16.6	38.4	37.4	18.3	48.7	18.3	22.2	21.2	19.5	45.9	18.3	19.3	19.5	48.5	18.9	42.2	21.5	26.7	25.0	19.8	21.7	18.0	29.1	18.2	16.4	20.1	18.9	16.7	15.7
SDS	SDH	ENSG00000135094	"Serine dehydratase"	P20132	12	113392445-113426301	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Gluconeogenesis	Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 276.9"	"Cell line enhanced"	"Detected in some"		"HMC-1: 5.4;SK-BR-3: 3.3"	"Cancer enriched"	"Detected in all"	31	"liver cancer: 165.3"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"myeloid DC: 12.8"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.8"	"Low region specificity"	"Detected in single"							HPA039230	Uncertain		Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"HPA039230: AB_10674281"	"unprognostic (1.31e-1)"	"prognostic favourable (5.24e-4)"	"unprognostic (6.37e-3)"	"unprognostic (6.94e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.35e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.99e-2)"	0.9	0.9	2.2	1.4	5.9	0.5	0.4	0.6	2.1	0.5	0.9	0.8	0.0	0.7	0.4	0.2	0.2	0.2	1.4	0.2	1.7	2.5	0.2	276.9	0.6	0.6	4.2	0.7	0.3	0.4	0.1	0.0	1.0	2.8	0.3	0.8	1.3	0.3	0.2	0.2	0.2	0.7	0.3	1.3	0.5	0.9	0.3	0.8	0.1	0.3	0.0	0.3	0.8	0.0	0.0	12.8	0.6	0.8	0.2	0.0	0.3	0.0	0.4	0.2	1.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.2	0.4	2.3	0.0	0.4	0.0	0.0	0.0	0.5	0.5	1.3	0.6	0.6	0.1	0.8	5.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	1.4	0.1	0.4	0.8	0.9	0.0	0.8	0.1	0.2	0.5	0.1	0.1	1.6	3.3	0.7	1.2	1.7	0.6	0.0	0.9	1.1	0.3	0.7	0.4	0.2	1.1	0.8	0.3	0.1	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.6	0.2	0.1	1.3	0.0	0.3	2.2	5.9	0.6	1.6	1.7	2.5	4.2	0.7	2.8	0.8
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 90.8;TIME: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021463: , HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.7	8.6	15.2	23.3	6.4	7.9	5.4	10.7	9.2	12.6	10.9	11.4	7.7	31.4	21.5	14.7	4.5	6.7	10.4	16.4	5.8	6.1	16.4	6.6	14.8	10.8	3.3	7.7	11.1	4.2	10.5	11.0	90.8	10.0	26.5	17.7	5.9	5.7	4.4	5.5	7.8	4.4	24.4	23.3	21.4	4.7	11.7	9.1	11.8	6.2	6.6	5.2	3.6	56.7	14.3	13.5	7.8	7.6	15.2	11.9	16.5	6.2	3.4	4.2	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4
SEC23A		ENSG00000100934	"Sec23 homolog A, coat complex II component"	Q15436	14	39031919-39109646	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043806, HPA069974"	Uncertain		Approved	Nucleoplasm,Vesicles			54000	"Nucleoplasm, Vesicles"		"HPA043806: , HPA069974: "	"unprognostic (2.40e-1)"	"prognostic unfavourable (5.75e-4)"	"prognostic favourable (3.56e-4)"	"unprognostic (3.30e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.69e-4)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.41e-3)"	23.9	23.5	10.2	16.8	19.1	7.1	22.1	18.6	20.6	21.4	29.6	8.4	14.0	30.2	30.0	16.8	20.3	19.0	17.2	26.5	11.0	14.8	14.4	55.7	13.5	15.5	12.5	12.8	24.3	8.5	4.7	17.2	15.5	19.8	18.6	18.6	16.2	9.8	31.0	31.7	9.6	38.3	52.8	8.3	11.8	16.9	12.3	6.9	12.9	11.8	11.3	11.3	31.9	18.9	15.6	19.8	38.1	21.6	26.0	26.1	17.9	10.6	20.1	17.5	15.5	32.1	36.8	5.3	43.0	37.1	30.6	38.3	20.1	9.0	2.5	10.5	59.9	8.6	22.0	17.3	44.8	8.1	7.6	4.4	16.0	65.2	24.5	7.4	6.8	28.1	9.3	21.1	15.6	25.6	3.2	6.2	23.8	9.9	6.6	3.0	3.9	19.2	9.6	24.2	3.8	16.1	16.2	1.8	4.2	29.8	8.8	9.5	10.9	2.3	28.5	16.2	12.4	23.6	10.8	6.0	7.3	12.0	11.0	6.3	15.5	38.1	21.6	24.2	18.2	18.6	26.1	15.6	23.0	23.4	19.8	14.5	24.2	19.6	19.6	26.0	16.3	17.4	24.0	17.9	10.2	19.1	18.6	20.6	11.0	14.8	12.5	12.8	19.8	6.9
SEC23B	"CDA-II, CDAII, CDAN2, HEMPAS"	ENSG00000101310	"Sec23 homolog B, coat complex II component"	Q15437	20	18507482-18561415	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"		"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008216, HPA069974"	Uncertain		Supported	Vesicles				Vesicles		"HPA008216: AB_1079895, HPA069974: "	"unprognostic (4.47e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.52e-1)"	"prognostic favourable (8.25e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-2)"	"unprognostic (8.21e-2)"	11.8	32.9	16.5	16.5	19.0	17.2	21.3	13.5	20.0	21.8	16.9	28.8	40.9	12.8	11.2	29.2	24.0	17.4	14.3	8.2	16.2	14.8	27.1	32.8	17.4	15.3	22.3	12.3	13.2	43.1	32.8	31.8	13.1	18.0	19.4	18.9	15.6	69.5	46.3	4.4	14.9	14.9	10.8	22.0	19.7	20.5	23.4	18.3	19.2	34.3	12.7	20.8	12.8	12.5	27.5	44.1	50.8	38.4	32.9	34.1	36.6	24.7	27.9	15.8	14.6	10.7	12.0	35.5	21.0	14.4	26.4	22.7	24.2	22.9	11.5	13.9	16.1	26.7	27.7	38.5	28.5	13.8	12.6	18.7	11.1	36.2	21.8	26.0	23.8	9.0	22.9	38.2	49.0	16.2	21.6	25.4	17.9	25.6	17.8	13.8	14.6	30.1	18.5	24.1	35.9	24.4	25.1	25.1	17.9	24.6	56.6	23.0	24.8	27.6	13.3	16.5	9.0	18.5	25.7	32.1	44.2	17.6	14.1	14.0	23.0	50.8	38.4	42.1	24.7	38.4	34.1	27.5	25.3	26.4	44.1	22.2	23.0	24.1	19.6	32.9	35.9	33.4	29.1	36.6	16.5	19.0	13.5	20.0	16.2	14.8	22.3	12.3	18.0	18.3
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol			22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	24.8	11.3	32.7	23.1	58.3	72.7	23.8	46.4	52.0	26.1	32.4	19.5	32.0	32.3	20.4	92.5	11.9	32.2	30.7	36.2	32.9	12.8	19.7	19.4	51.1	58.0	21.0	25.1	69.5	39.0	39.9	45.9	42.3	29.9	32.1	46.4	21.8	27.7	17.0	22.4	10.3	20.7	17.7	23.9	42.1	14.4	21.1	23.5	18.4	32.1	29.9	25.0	23.8	43.2	34.4	17.9	30.1	29.0	24.1	10.3	44.4	34.4	25.4	39.5	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3
SELE	"CD62E, ELAM, ELAM1, ESEL"	ENSG00000007908	"Selectin E"	P16581	1	169722641-169764705	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 50.0"	"Cell line enriched"	"Detected in single"	5	"HUVEC TERT2: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"pons and medulla: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							CAB002143	Enhanced						640000000			"CAB002143: AB_563608"	"unprognostic (2.39e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.74e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.13e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.55e-1)"	14.9	2.7	0.9	30.4	1.2	0.2	8.3	0.3	1.0	13.7	2.7	1.9	4.4	0.4	18.1	3.2	6.7	20.1	7.4	4.4	0.9	0.9	2.5	4.9	10.6	2.0	1.2	0.0	9.8	1.4	21.0	3.1	0.9	5.4	21.2	1.9	4.3	2.0	4.6	2.2	3.7	2.4	13.1	4.8	0.2	3.4	5.6	0.5	0.9	9.0	50.0	15.5	16.4	4.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.9	1.2	0.3	1.0	0.9	0.9	1.2	0.0	5.4	0.5
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli			57000000	Nucleoli		"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.2	7.9	0.4	38.1	15.2	2.0	1.5	0.7	0.8	1.6	4.3	1.3	0.0	7.3	2.6	0.0	0.0	0.1	0.6	0.0	3.6	28.3	14.2	6.8	8.0	0.0	0.0	19.6	0.2	1.3	0.0	4.8	2.8	0.0	2.0	3.1	0.0	0.0	6.3	8.0	0.0	0.4	0.1	1.7	0.0	0.1	0.1	0.0	68.0	0.0	11.7	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0
SELENON	"MDRS1, RSMD1, RSS, SELN, SEPN1"	ENSG00000162430	"Selenoprotein N"	Q9NZV5	1	25800176-25818224	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Desmin-related myopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058076	Approved		Supported	Cytosol	"Intracellular and membrane"			Cytosol		"HPA058076: "	"unprognostic (2.65e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.11e-1)"	"prognostic favourable (2.23e-4)"	"unprognostic (1.93e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (3.40e-5)"	"unprognostic (1.94e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (6.01e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.56e-3)"	"unprognostic (5.89e-2)"	41.4	27.2	26.3	26.4	24.8	12.4	53.6	22.0	29.7	32.2	21.9	26.5	26.3	14.3	30.7	20.4	25.4	34.3	27.4	29.3	26.3	16.3	33.0	15.1	35.2	47.8	19.2	18.2	35.3	39.9	23.0	23.7	31.6	22.0	37.5	17.8	30.0	29.1	35.0	30.0	18.0	16.5	45.8	21.0	29.1	24.4	11.6	19.1	10.7	31.4	17.6	16.8	26.1	28.0	1.7	2.1	5.9	3.3	0.7	2.6	1.0	11.9	11.5	38.4	32.8	25.0	44.0	13.0	14.5	22.0	16.2	13.0	2.9	12.7	0.0	9.7	21.9	11.7	10.0	15.4	12.4	12.7	7.7	11.7	4.4	3.6	18.1	2.4	27.9	46.8	10.4	16.9	8.5	50.5	4.1	1.7	15.2	6.1	0.5	3.5	14.4	7.9	10.3	16.7	1.4	6.6	3.4	8.0	13.6	9.2	8.4	12.2	8.4	8.3	42.0	16.5	11.3	30.1	8.5	1.4	0.0	0.3	22.8	3.7	19.8	5.9	3.3	3.8	1.8	2.6	1.1	1.7	1.7	1.3	2.1	1.1	2.6	1.6	0.5	0.7	2.5	0.3	1.7	1.0	26.3	24.8	22.0	29.7	26.3	16.3	19.2	18.2	22.0	19.1
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Group enriched"	"Detected in many"	4	"Hep G2: 90.8;HSkMC: 79.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	2223100000	2300000000	"Nucleoplasm, Golgi apparatus"		"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.3	0.1	7.5	2.1	1.3	0.6	1.9	0.0	0.0	2.0	10.7	0.3	6.7	0.2	0.3	0.0	0.0	0.0	0.4	8.7	0.5	0.0	90.8	4.6	0.5	0.0	79.4	0.1	0.0	0.0	0.0	1.0	2.2	3.9	0.2	0.1	1.1	5.2	0.1	0.2	0.3	15.6	2.1	1.2	0.3	0.5	0.4	2.7	0.2	21.2	0.1	0.1	0.5	0.3	0.9	0.1	1.4	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690667-169711698	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 227.5;lymphoid tissue: 77.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.3;EFO-21: 7.1;MOLT-4: 13.4;U-266/70: 25.2;U-698: 11.7;U-937: 7.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol			8100000000	Cytosol		"CAB002144: AB_563862, HPA051972: "	"prognostic favourable (3.76e-4)"	"prognostic favourable (2.25e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.89e-2)"	"unprognostic (7.87e-3)"	"prognostic favourable (6.43e-4)"	"unprognostic (1.39e-3)"	"unprognostic (3.43e-1)"	"unprognostic (2.70e-3)"	"prognostic favourable (3.14e-4)"	"unprognostic (1.42e-1)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (4.96e-5)"	"unprognostic (4.76e-2)"	"unprognostic (8.71e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.01e-1)"	6.9	0.9	2.0	25.1	4.6	30.3	1.5	1.1	2.5	0.9	1.4	1.1	0.0	0.4	1.0	1.1	4.2	3.2	5.4	4.1	2.5	2.2	2.3	2.5	11.4	77.8	5.2	0.2	0.8	1.0	10.7	7.9	3.4	2.7	1.2	1.3	3.8	12.1	0.1	0.9	0.8	8.8	2.9	5.2	67.7	1.7	1.0	2.3	43.8	1.9	1.3	64.0	8.1	6.1	40.4	40.7	227.5	49.7	130.8	69.5	90.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.0	0.2	7.3	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	5.0	0.9	0.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.8	13.4	0.1	0.0	0.2	5.1	0.1	0.3	4.1	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	25.2	0.0	11.7	1.3	7.3	0.1	170.8	49.7	88.6	16.5	11.2	4.5	33.8	30.7	17.0	40.7	40.4	69.5	39.6	227.5	130.8	4.5	32.8	52.7	90.1	2.0	4.6	1.1	2.5	2.5	2.2	5.2	0.2	2.7	2.3
SELP	"CD62, CD62P, GMP140, GRMP, PADGEM, PSEL"	ENSG00000174175	"Selectin P"	P16109	1	169588849-169630193	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	37	"EFO-21: 24.7;HEL: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"basophil: 6.0;neutrophil: 2.4;T-reg: 8.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 6.0;T-cells: 8.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002145, HPA002655, HPA005990"	Enhanced						830000000			"CAB002145: AB_563984, HPA002655: AB_1078480, HPA005990: AB_1078479"	"unprognostic (3.37e-2)"	"unprognostic (2.98e-4)"	"unprognostic (4.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.26e-2)"	"prognostic favourable (3.12e-4)"	"unprognostic (5.30e-4)"	"unprognostic (4.14e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.93e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.24e-3)"	"unprognostic (1.74e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.66e-1)"	14.2	2.1	0.4	8.4	0.4	1.0	10.9	0.4	0.4	14.8	3.7	0.6	7.5	3.3	10.6	6.2	5.6	7.7	7.0	9.6	0.4	0.4	7.5	4.6	11.3	12.9	0.4	0.4	5.0	1.5	3.8	2.8	7.4	1.3	14.8	2.9	24.7	3.4	4.3	3.7	2.3	5.2	10.5	1.0	1.9	3.5	3.1	0.3	1.4	4.9	7.7	13.0	11.5	27.2	0.9	0.1	6.0	0.5	0.4	8.9	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.0	0.5	0.7	0.0	0.2	0.0	0.9	0.6	0.3	0.0	0.2	0.2	0.1	2.4	0.4	0.0	0.1	8.9	8.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	0.3
SELPLG	"CD162, PSGL-1"	ENSG00000110876	"Selectin P ligand"	Q14242	12	108622277-108633959	"Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 126.9;lymphoid tissue: 60.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 28.0;HMC-1: 27.2;Karpas-707: 42.6;RPMI-8226: 59.2;U-266/70: 69.5;U-266/84: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											CAB002431	Enhanced									"CAB002431: AB_563509"	"unprognostic (2.32e-2)"	"prognostic favourable (1.46e-4)"	"unprognostic (3.64e-3)"	"unprognostic (1.02e-2)"	"unprognostic (6.32e-2)"	"prognostic favourable (6.94e-4)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"prognostic favourable (2.92e-4)"	"unprognostic (2.26e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.24e-1)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (5.88e-2)"	"unprognostic (2.37e-2)"	"prognostic favourable (2.74e-4)"	"unprognostic (5.44e-2)"	10.6	5.5	11.3	25.3	8.9	10.7	4.2	2.2	12.5	5.8	5.4	27.2	0.1	5.0	2.9	4.1	5.0	6.8	9.6	5.9	12.1	9.6	4.6	3.9	23.3	46.8	16.2	5.4	2.1	2.9	1.3	3.1	7.3	11.5	3.0	5.2	3.4	5.2	2.5	1.8	2.7	10.3	6.7	19.6	60.5	6.0	2.1	13.5	26.0	3.1	2.8	18.0	14.8	3.0	2.2	50.9	126.9	68.4	28.1	63.2	77.1	0.1	0.0	0.3	0.1	0.1	0.3	0.1	1.0	1.0	0.3	0.3	0.0	0.4	0.1	0.3	1.5	0.0	0.0	0.0	0.3	28.0	0.0	9.9	0.0	0.0	0.0	7.0	27.2	0.3	0.1	0.5	0.1	0.0	0.1	42.6	1.3	0.0	5.6	4.0	0.0	0.3	0.0	0.1	59.2	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.0	8.9	0.3	0.5	0.1	0.7	0.2	69.5	43.3	1.2	0.3	14.9	0.4	126.9	28.1	88.8	43.8	49.5	35.8	2.0	41.8	37.4	29.4	2.2	32.4	34.1	125.8	28.1	68.4	50.9	63.2	77.1	11.3	8.9	2.2	12.5	12.1	9.6	16.2	5.4	11.5	13.5
SEMA3A	"coll-1, Hsema-I, SEMA1, SEMAD, SemD"	ENSG00000075213	"Semaphorin 3A"	Q14563	7	83955777-84492724	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 24.5"	"Cell line enhanced"	"Detected in many"		"AF22: 42.0;BJ: 32.6;fHDF/TERT166: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	15	"monocytes: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029447, HPA052235"	Approved		Approved	Nucleoplasm,Vesicles	"Secreted in other tissues"		1200000	Vesicles	Nucleoplasm	"HPA029447: AB_10602302, HPA052235: "	"unprognostic (1.20e-1)"	"prognostic unfavourable (2.69e-5)"	"unprognostic (1.51e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-2)"	"unprognostic (6.18e-12)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.47e-4)"	9.6	1.1	2.9	5.2	14.6	0.3	3.7	1.0	6.0	7.4	17.8	1.4	0.7	2.3	1.5	3.3	8.6	3.5	8.6	3.7	2.0	2.1	1.3	1.1	4.9	12.9	1.6	6.5	1.4	1.0	1.3	12.0	14.7	11.1	5.0	8.7	8.2	1.5	0.8	1.0	2.7	5.3	24.5	3.3	17.9	5.4	1.8	1.8	0.0	4.2	1.4	2.4	11.9	2.1	0.0	0.2	0.0	4.7	0.3	0.3	0.0	3.6	10.0	42.0	0.0	1.3	1.0	2.7	32.6	19.2	2.7	1.7	3.5	9.8	0.0	1.5	35.5	18.1	0.1	7.8	3.9	0.0	1.3	0.0	1.8	0.0	1.1	0.8	0.0	1.3	0.0	5.9	1.4	10.2	0.0	0.0	1.1	0.1	0.0	0.0	15.7	3.7	0.7	17.9	1.0	6.1	0.2	3.2	1.7	0.2	0.0	0.3	0.1	0.3	5.7	3.7	3.9	10.5	4.7	2.4	1.6	0.0	3.8	1.4	7.1	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	4.7	0.0	0.0	0.0	2.9	14.6	1.0	6.0	2.0	2.1	1.6	6.5	11.1	1.8
SEMA3F	"Sema4, SEMAK"	ENSG00000001617	"Semaphorin 3F"	Q13275	3	50155045-50189075	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 23.9;HUVEC TERT2: 41.7;RT4: 24.2;SK-BR-3: 38.8;TIME: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035008	Approved				"Secreted to blood"	1700000	4000000			"HPA035008: AB_10604091"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.71e-1)"	"prognostic unfavourable (5.15e-4)"	"unprognostic (1.71e-1)"	"unprognostic (9.05e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.19e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.88e-3)"	"unprognostic (6.87e-3)"	17.4	3.7	2.8	5.0	3.6	1.5	26.5	3.5	5.0	12.2	7.5	2.5	45.3	8.1	9.2	10.5	42.6	9.7	8.2	12.3	3.1	3.1	15.1	4.9	20.4	5.8	2.9	0.5	5.5	4.2	2.9	5.7	28.9	6.4	14.8	4.1	19.3	12.5	22.1	7.9	44.4	9.3	5.7	2.6	57.6	10.2	3.1	3.6	2.7	13.8	19.5	21.5	14.7	22.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.0	0.7	0.1	3.2	0.0	0.3	0.6	1.7	5.4	1.4	2.3	1.1	1.3	0.1	17.5	0.2	10.3	1.5	22.4	0.5	0.0	0.4	0.1	23.9	3.9	1.2	0.3	0.7	1.4	12.5	3.4	10.3	41.7	0.6	0.0	0.2	2.6	0.3	1.6	1.9	2.1	2.5	0.0	0.1	1.6	24.2	0.2	0.5	2.8	38.8	0.0	15.2	1.5	74.8	0.9	7.4	6.6	1.2	0.0	0.0	0.1	0.0	0.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.6	3.5	5.0	3.1	3.1	2.9	0.5	6.4	3.6
SEMA4D	"C9orf164, CD100, coll-4, FLJ39737, SEMAJ"	ENSG00000187764	"Semaphorin 4D"	Q92854	9	89360787-89498130	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.1;skeletal muscle: 43.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.9;HMC-1: 33.1;MOLT-4: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015662, HPA023277"	Approved		Supported	"Endoplasmic reticulum,Vesicles"			4100000	Vesicles	"Endoplasmic reticulum"	"HPA015662: AB_1856671, HPA023277: AB_1856672"	"unprognostic (2.94e-2)"	"prognostic favourable (4.17e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (4.06e-5)"	3.9	5.6	18.0	18.6	20.7	14.3	3.6	7.7	20.9	4.0	5.9	54.0	3.1	6.1	3.9	7.4	9.3	6.6	7.2	4.9	28.2	18.8	8.4	2.0	6.7	32.0	42.6	15.0	4.1	4.6	4.9	5.3	3.2	27.5	4.9	5.8	2.9	6.7	4.2	43.3	8.8	9.6	3.3	107.1	19.2	9.4	6.1	23.3	25.3	4.9	3.1	27.6	8.3	5.3	2.6	4.6	21.2	4.1	4.7	14.0	7.8	4.0	3.0	2.8	4.1	0.1	0.2	6.5	0.4	0.2	0.8	0.6	2.0	4.6	15.5	1.7	0.0	2.1	2.5	1.2	0.3	42.9	2.5	6.5	1.0	0.2	0.5	8.6	33.1	0.1	0.9	0.2	0.1	1.6	1.5	10.6	0.0	6.7	38.9	10.8	6.9	0.1	12.4	0.9	4.3	5.5	4.2	6.7	4.4	1.1	3.6	0.1	3.4	4.7	1.0	0.0	2.6	0.3	2.0	11.9	5.1	2.2	2.0	10.5	2.5	7.3	4.1	20.4	13.3	3.8	8.0	2.6	10.6	11.1	1.5	1.6	12.2	14.0	21.2	4.7	4.1	4.6	9.5	7.8	18.0	20.7	7.7	20.9	28.2	18.8	42.6	15.0	27.5	23.3
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;liver: 33.9"	"Group enriched"	"Detected in many"	4	"A549: 13.7;CACO-2: 13.1;Hep G2: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"		840000	"Vesicles, Lipid droplets"		"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	1.2	5.0	8.2	9.2	5.6	0.2	1.9	17.8	9.0	2.5	34.3	4.9	3.2	25.9	2.1	16.6	1.8	3.1	25.9	1.6	4.9	5.0	9.5	33.9	2.9	1.2	4.2	4.6	9.2	21.3	3.7	4.4	2.2	7.8	8.6	42.3	4.8	4.3	6.1	1.2	7.1	44.0	2.5	2.5	1.8	10.4	2.5	3.7	0.1	9.8	0.5	0.5	2.3	2.4	2.4	1.0	0.4	0.4	0.0	1.3	0.0	0.0	13.7	3.5	1.5	2.2	0.7	3.0	0.5	1.5	0.7	0.7	13.1	2.2	0.2	1.8	0.6	0.9	3.4	0.6	0.6	0.3	2.1	0.7	1.1	47.9	5.7	0.5	0.4	3.7	0.8	0.7	0.4	1.9	1.3	0.1	1.1	0.8	0.2	0.5	0.5	0.8	1.3	0.3	0.6	3.2	0.4	1.1	5.5	0.5	0.9	1.4	3.8	0.6	1.3	0.4	1.6	0.4	0.1	0.4	0.2	0.2	0.4	0.4	0.4	0.0	0.4	0.4	0.3	0.0	0.2	2.4	0.4	1.3	1.0	0.6	0.4	0.2	0.0	0.0	0.2	0.3	0.1	0.0	8.2	5.6	17.8	9.0	4.9	5.0	4.2	4.6	7.8	3.7
SEMA6A	"HT018, KIAA1368, SEMA, SEMA6A1, SEMAQ"	ENSG00000092421	"Semaphorin 6A"	Q9H2E6	5	116443616-116574934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.2"	"Cell line enhanced"	"Detected in some"		"AF22: 14.5;AN3-CA: 17.3;BEWO: 15.1;HAP1: 20.3;NTERA-2: 45.2;RT4: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031264, HPA031265, HPA031267"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Intermediate filaments"			180000	Nucleoplasm	"Nuclear bodies, Intermediate filaments"	"HPA031264: , HPA031265: AB_10610423, HPA031267: "	"unprognostic (3.79e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.77e-1)"	"prognostic unfavourable (4.39e-4)"	"unprognostic (1.64e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.92e-1)"	"unprognostic (6.21e-3)"	"unprognostic (7.32e-3)"	12.7	37.4	12.6	4.9	34.7	3.6	10.6	18.7	26.5	6.9	19.6	31.2	0.8	19.2	6.1	3.4	3.9	6.2	12.8	5.0	17.2	12.9	6.1	6.0	17.8	4.5	35.9	13.9	13.1	10.3	2.2	4.4	30.2	32.2	6.6	17.5	2.6	15.1	3.2	7.6	5.6	24.0	6.3	48.2	8.2	5.4	6.6	31.4	0.5	6.7	1.6	2.7	4.6	5.9	1.6	0.7	0.1	0.4	0.0	1.3	0.0	0.1	0.0	14.5	17.3	0.1	0.0	15.1	0.2	0.1	0.0	0.1	0.8	0.6	0.6	0.6	0.2	0.1	20.3	0.0	0.0	0.6	3.0	0.2	0.2	4.9	0.2	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	1.4	45.2	0.1	2.6	9.5	0.6	7.5	12.9	4.1	1.5	0.1	0.2	7.7	5.6	1.0	0.3	1.4	1.2	0.1	0.5	0.2	0.2	0.3	0.2	0.7	5.3	0.0	0.4	0.0	1.2	0.0	0.1	1.6	1.3	0.0	0.3	1.2	0.4	0.5	0.1	0.0	0.2	0.7	0.1	0.0	12.6	34.7	18.7	24.0	17.2	12.9	35.9	13.9	32.2	31.4
SEMA6B	"SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ"	ENSG00000167680	"Semaphorin 6B"	Q9H3T3	19	4542593-4559808	"Plasma proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 35.6;HMC-1: 58.8;HUVEC TERT2: 24.0;TIME: 30.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025157, HPA055778, HPA058523"	Enhanced						180000			"CAB025157: , HPA055778: , HPA058523: "	"unprognostic (4.03e-1)"	"unprognostic (9.69e-3)"	"unprognostic (6.38e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.34e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (3.29e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (1.45e-4)"	"unprognostic (9.55e-2)"	23.2	9.3	27.2	12.1	24.2	7.9	9.7	16.9	42.9	3.8	4.7	1.7	0.3	4.8	4.1	3.1	3.6	2.5	7.0	12.8	30.3	11.5	3.7	5.2	13.1	18.6	9.5	0.8	5.1	4.8	1.7	3.1	9.9	11.0	4.3	1.8	2.7	1.4	2.2	9.3	3.3	4.8	7.9	6.4	17.5	2.5	2.5	8.8	0.0	6.0	3.7	2.0	8.3	24.4	0.0	0.0	0.7	0.4	0.0	0.0	0.0	2.0	7.1	0.6	6.2	0.0	0.3	0.1	0.0	0.2	0.6	0.1	0.0	0.6	0.0	6.8	0.0	1.3	1.8	0.0	0.2	0.0	0.3	0.0	0.1	35.6	0.1	0.0	58.8	2.2	0.0	0.0	0.0	24.0	0.4	0.1	0.2	1.8	0.0	0.0	7.8	0.1	0.1	14.0	0.1	0.5	0.0	5.2	0.5	0.0	0.5	3.8	0.9	0.3	30.3	0.9	11.3	0.1	5.1	0.4	0.0	0.1	0.2	0.3	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	27.2	24.2	16.9	27.9	30.3	11.5	9.5	0.8	11.0	8.8
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"		480000	"Plasma membrane"	"Golgi apparatus"	"HPA043109: AB_10793941"	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.3	0.0	1.3	1.1	0.2	0.5	13.9	0.3	0.0	0.3	0.1	1.9	0.0	3.5	7.2	2.9	0.9	0.1	0.9	1.7	0.0	4.2	0.0	3.7	0.0	0.1	1.0	7.6	0.0	0.5	0.9	0.1	3.0	0.4	0.7	2.3	0.6	4.4	0.0	1.4	0.1	2.1	1.0	0.9	12.3	11.4	0.1	0.9	3.8	0.4	0.0	0.0	6.4	0.3	0.2	0.0	9.1	0.0	2.1	1.7	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0
SEMA7A	"CD108, H-Sema-L, SEMAL"	ENSG00000138623	"Semaphorin 7A (John Milton Hagen blood group)"	O75326	15	74409289-74433958	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Differentiation, Inflammatory response, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;lymphoid tissue: 34.7;placenta: 54.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 99.7;hTEC/SVTERT24-B: 39.1;U-251 MG: 57.5;U-87 MG: 33.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 8.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008210, HPA042273"	Uncertain		Uncertain	Vesicles			29000000	Vesicles		"HPA008210: , HPA042273: AB_10806234"	"unprognostic (2.00e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.02e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.54e-2)"	"unprognostic (4.18e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (2.45e-11)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.57e-2)"	2.2	1.9	5.4	10.4	13.8	12.8	1.4	22.9	27.3	1.3	1.8	19.9	1.4	2.7	4.3	1.8	3.2	1.2	3.3	1.4	10.8	5.7	1.4	1.5	4.4	19.0	28.5	5.7	5.9	0.9	6.4	1.9	54.0	28.6	1.4	1.8	7.8	1.7	3.5	1.4	4.7	6.0	2.0	36.4	34.7	3.7	23.6	15.4	9.0	1.1	0.4	19.7	4.6	1.7	1.4	1.8	8.9	0.0	0.8	0.2	0.0	5.7	0.0	1.7	0.5	2.2	7.4	14.3	26.5	10.7	5.6	8.6	2.2	9.4	0.0	1.5	12.0	1.7	0.5	1.7	5.8	0.4	0.3	10.3	0.0	2.8	0.5	0.3	99.7	5.2	0.0	39.1	2.2	0.0	5.9	3.6	18.1	0.4	1.4	3.4	1.8	4.0	0.2	1.1	1.5	2.3	2.4	0.1	0.1	0.2	4.8	2.1	0.3	2.1	1.0	10.5	7.0	5.0	57.5	0.6	0.4	0.1	33.6	1.2	0.5	3.9	0.0	8.9	0.2	0.0	0.2	1.4	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.8	0.0	1.8	0.0	0.0	5.4	13.8	22.9	27.3	10.8	5.7	28.5	5.7	28.6	15.4
SEMG1	"CT103, SEMG"	ENSG00000124233	"Semenogelin I"	P04279	20	45206997-45209772	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"ductus deferens: 2077.7;seminal vesicle: 1931.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.3;NB-4: 1.7;NTERA-2: 3.3;THP-1: 7.7"	"Cancer enriched"	"Detected in some"	14	"prostate cancer: 20.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	192	"eosinophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"									"HPA042476, HPA064892"	Enhanced				"Secreted in male reproductive system"		1700000			"HPA042476: AB_10794799, HPA064892: AB_2732724"			"unprognostic (3.71e-1)"								"unprognostic (2.92e-2)"	"unprognostic (1.44e-1)"		"unprognostic (3.32e-1)"			"unprognostic (1.11e-2)"	0.2	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.0	2077.7	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	76.5	0.0	0.0	0.2	1931.9	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	19.5	0.1	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SEMG2	SGII	ENSG00000124157	"Semenogelin II"	Q02383	20	45221300-45224458	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"ductus deferens: 1137.0;seminal vesicle: 1095.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	25	"prostate cancer: 9.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA042767, HPA042835"	Enhanced				"Secreted in male reproductive system"		920000			"HPA042767: AB_10959312, HPA042835: AB_10964060"												"unprognostic (1.39e-1)"		"unprognostic (2.17e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	1137.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	46.2	0.0	0.0	0.1	1095.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	8.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol				Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.2	3.1	7.6	8.6	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.2	13.5	6.4	8.1	15.8	5.8	13.3	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.7	8.7	5.1	6.2	6.2	6.6	11.8	7.7	7.6	6.9	9.1	28.1	5.3	8.2	10.4	13.7	4.9	5.1	7.9	8.8	5.9	13.2	11.0	18.1	11.0	3.9	6.0	6.5	10.9	11.2	13.6	16.2	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1
SENP3	"DKFZP586K0919, DKFZp762A152, SMT3IP1, SSP3, Ulp1"	ENSG00000161956	"SUMO1/sentrin/SMT3 specific peptidase 3"	Q9H4L4	17	7561875-7571969	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060290	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA060290: "	"unprognostic (5.68e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.82e-1)"	"unprognostic (7.37e-2)"	"unprognostic (3.72e-2)"	"prognostic favourable (6.22e-5)"	"unprognostic (2.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.56e-2)"	16.3	16.0	22.3	20.9	23.4	16.6	18.0	29.2	38.4	15.9	22.5	18.4	16.8	16.2	18.6	22.7	18.6	19.9	17.0	26.1	21.0	19.2	17.5	15.1	18.7	18.8	20.0	23.3	19.6	17.8	29.5	17.3	23.6	17.2	16.0	20.5	17.3	18.6	21.9	22.0	20.8	17.6	23.1	15.3	18.9	17.2	28.8	16.4	18.9	19.0	14.2	23.4	16.8	32.8	0.8	0.7	1.1	0.7	1.1	1.7	0.3	26.2	31.8	18.9	29.2	21.4	15.7	19.7	19.3	19.8	33.6	31.6	19.0	11.5	31.4	19.1	25.3	25.3	40.6	30.1	28.3	22.1	37.1	16.3	27.0	19.4	29.0	15.0	20.8	20.1	30.8	38.3	37.6	26.9	20.8	8.8	25.9	17.6	36.3	11.4	23.4	19.4	33.3	17.7	18.1	22.4	15.4	18.9	24.4	19.3	18.7	20.5	15.7	9.8	14.1	19.3	16.8	18.3	41.3	13.0	13.5	19.9	19.5	15.9	28.5	0.1	0.7	0.2	0.4	0.4	0.1	0.4	0.2	1.3	0.1	0.8	1.7	0.5	1.1	1.1	0.1	0.7	0.3	0.3	22.3	23.4	29.2	38.4	21.0	19.2	20.0	23.3	17.2	16.4
SEPHS1	"SPS, SPS1"	ENSG00000086475	"Selenophosphate synthetase 1"	P49903	10	13317424-13348298	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037645, HPA062118"	Enhanced		Uncertain	Nucleoplasm				Nucleoplasm		"HPA037645: AB_10671631, HPA062118: "	"unprognostic (8.18e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.99e-2)"	"prognostic unfavourable (2.16e-7)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.61e-2)"	"prognostic favourable (3.12e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.11e-2)"	15.1	21.9	19.8	11.4	18.0	11.5	33.2	17.3	16.2	14.4	16.0	14.6	10.4	11.9	17.5	20.2	15.4	19.1	15.1	16.1	18.3	15.4	30.5	39.1	20.0	24.3	16.3	11.2	19.8	37.3	23.2	16.6	14.2	17.3	14.4	17.6	15.1	20.6	14.0	20.5	11.8	13.0	17.7	16.6	17.9	15.1	13.7	16.1	44.7	29.8	22.2	17.2	14.1	17.0	8.1	13.2	8.7	19.6	12.7	10.9	6.6	28.0	20.5	42.0	40.4	14.0	10.7	19.8	12.5	9.7	26.8	22.8	23.2	26.5	27.4	15.6	14.6	18.0	44.5	20.7	28.1	41.2	18.4	15.0	15.3	29.4	14.5	20.2	9.5	9.3	14.9	15.6	9.2	21.6	19.7	22.4	19.0	37.2	49.9	8.6	69.4	9.3	39.0	20.5	16.4	14.5	11.4	14.9	27.8	38.4	17.0	17.2	21.5	21.5	14.4	11.9	22.8	15.5	26.1	16.5	30.5	50.8	9.6	15.1	9.5	8.7	9.7	7.1	7.1	14.5	8.6	8.1	7.3	8.0	11.6	6.3	9.4	8.7	1.5	12.7	19.6	13.2	10.9	6.6	19.8	18.0	17.3	16.2	18.3	15.4	16.3	11.2	17.3	16.1
SEPT11	FLJ10849	ENSG00000138758	"Septin 11"	Q9NVA2	4	76949703-77040384	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 89.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Approved		Approved	Cytosol			6500000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (1.69e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.39e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (1.70e-5)"	"unprognostic (1.79e-1)"	"unprognostic (6.04e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.58e-2)"	"unprognostic (5.85e-2)"	"prognostic favourable (2.40e-4)"	"unprognostic (5.70e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.57e-1)"	39.9	6.4	25.0	12.1	36.6	3.2	28.0	24.8	49.7	21.1	22.8	9.9	7.8	10.1	16.7	12.2	10.9	11.1	21.8	14.6	17.2	13.7	25.5	16.0	18.8	10.3	11.4	27.1	10.2	10.4	7.8	5.7	39.1	14.3	12.3	19.5	7.9	8.5	13.1	17.4	6.7	16.2	19.2	10.5	11.6	11.5	4.5	13.9	2.7	10.1	5.9	10.3	15.9	16.8	2.7	12.0	18.2	3.8	21.2	6.9	3.7	12.7	5.2	50.1	44.5	30.0	24.0	14.4	74.4	57.6	16.9	23.9	9.5	9.4	0.3	15.5	89.6	5.4	16.5	11.0	26.4	16.6	5.5	25.1	6.9	6.8	26.2	13.4	10.7	30.4	5.2	24.4	9.2	25.4	10.3	7.1	49.8	7.4	17.7	0.4	16.8	2.7	20.9	57.0	1.4	9.5	14.0	17.2	12.8	14.5	8.2	11.8	7.5	5.4	27.6	56.8	17.0	27.8	13.7	4.3	3.4	0.1	21.6	1.4	11.5	6.6	1.4	18.2	5.1	1.2	3.1	2.0	5.8	6.9	4.5	2.7	2.2	5.9	0.4	21.2	3.8	12.0	3.2	3.7	25.0	36.6	24.8	49.7	17.2	13.7	11.4	27.1	14.3	13.9
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"			8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavourable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	31.9	28.8	78.5	51.3	73.1	79.8	40.6	70.8	69.8	45.5	58.0	16.1	34.8	13.0	16.9	80.9	28.5	51.2	47.9	74.9	32.8	36.4	52.2	28.8	59.4	44.8	49.7	31.9	71.0	31.4	37.9	36.6	79.2	46.5	19.1	66.9	23.0	29.4	30.4	57.1	21.1	29.1	98.7	27.5	67.5	48.9	56.3	37.9	49.0	33.9	46.7	20.3	44.9	74.8	55.8	23.7	53.8	41.8	37.7	32.8	45.8	48.0	30.4	77.0	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2
SEPT6	"KIAA0128, MGC16619, MGC20339, SEP2, SEPT2"	ENSG00000125354	"Septin 6"	Q14141	X	119615724-119693370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Host-virus interaction, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 145.4"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 56.9;REH: 52.4;SH-SY5Y: 79.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003459, HPA005665"	Supported		Approved	Cytosol			10000000	Cytosol		"HPA003459: AB_1856696, HPA005665: AB_1079910"	"unprognostic (6.35e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.23e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.60e-2)"	5.1	39.1	6.9	34.0	6.5	20.6	5.6	23.6	13.1	6.1	22.5	3.8	5.6	5.4	6.7	7.2	9.5	7.3	9.9	8.8	6.7	17.2	8.2	9.8	7.0	42.9	9.5	6.9	6.0	2.2	3.4	5.5	14.1	13.3	6.5	7.3	8.4	12.4	16.7	2.3	3.8	17.6	9.3	5.4	31.8	9.5	24.7	3.3	145.4	4.3	4.5	43.8	9.8	5.3	24.3	22.6	13.0	12.9	27.5	38.5	16.8	1.2	2.0	7.6	13.7	0.7	1.6	10.8	3.7	8.3	6.3	10.9	0.6	2.8	25.3	2.9	4.7	0.7	11.9	2.4	4.4	15.4	2.7	11.2	4.1	4.4	1.8	12.6	5.9	2.8	0.5	5.0	0.1	9.2	8.2	13.6	3.7	0.9	56.9	7.1	8.0	6.1	52.4	6.3	20.5	6.7	1.3	3.4	79.9	9.7	3.5	4.1	4.8	6.5	5.7	1.7	3.5	5.5	0.9	6.8	2.7	33.5	0.1	13.4	1.2	9.8	5.6	13.0	22.3	9.4	23.3	24.3	28.4	25.6	12.0	22.9	30.5	26.0	4.4	27.5	12.9	22.6	38.5	16.8	6.9	6.5	23.6	13.1	6.7	17.2	9.5	6.9	13.3	3.3
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"			16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.6	17.7	45.1	29.6	50.8	52.6	23.1	47.3	43.7	40.4	34.8	27.4	28.5	34.7	32.2	48.1	27.9	31.8	31.5	57.7	23.7	16.7	27.9	24.7	14.8	29.7	33.6	30.9	34.1	24.7	31.7	31.3	42.1	21.9	27.5	65.5	17.1	33.9	56.5	48.3	25.0	35.1	42.9	19.9	39.1	27.4	24.2	42.5	33.0	42.6	28.3	31.4	37.3	35.5	40.8	48.4	25.0	52.0	32.4	29.5	87.6	26.1	56.3	86.1	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2
SEPT9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"			120000	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: "	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	25.5	33.3	23.2	53.3	16.4	28.2	38.6	42.9	28.3	39.4	45.7	19.8	29.0	34.4	50.7	29.3	36.3	35.0	61.3	18.7	20.2	19.8	27.1	40.8	29.6	75.1	19.3	23.9	36.4	14.9	32.3	24.3	30.8	21.0	35.8	20.8	31.7	28.7	41.5	24.5	27.7	49.9	56.2	26.2	54.6	38.0	35.8	15.0	137.8	19.7	27.4	61.9	47.0	37.9	10.2	20.4	13.9	27.1	8.4	17.1	10.2	36.3	49.6	35.3	29.0	40.4	66.6	18.6	27.6	33.1	18.2	13.6	39.0	36.1	49.1	24.2	57.4	21.8	14.4	53.4	13.9	1.2	9.1	18.6	25.5	72.5	32.3	12.2	33.3	34.6	19.9	24.6	20.8	24.6	20.5	6.7	16.9	38.0	89.4	11.0	31.4	40.8	41.3	29.0	16.4	30.0	60.1	25.7	49.1	30.9	57.0	34.8	38.8	10.8	35.9	27.0	22.3	31.5	19.7	1.6	2.8	82.1	37.3	10.8	54.7	2.2	9.1	13.9	12.4	24.0	10.7	8.8	16.1	14.5	8.8	10.2	17.1	14.4	3.4	8.4	27.1	20.4	16.2	10.2	23.2	16.4	42.9	28.3	20.2	19.8	19.3	23.9	21.0	15.0
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol			430000	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavourable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	38.3	30.4	22.5	35.7	30.0	33.8	36.9	25.4	27.7	35.4	32.8	25.5	28.6	30.9	36.4	35.2	68.4	25.9	39.4	32.6	22.3	19.1	30.6	48.4	27.5	47.9	29.7	18.6	33.5	56.1	52.2	21.8	28.7	25.0	34.8	27.1	23.2	41.8	28.5	87.5	50.5	29.9	42.0	26.8	31.9	31.5	35.8	28.7	48.9	42.6	54.1	41.3	36.0	40.7	34.3	35.4	16.8	30.2	46.7	44.4	33.9	58.5	35.8	38.5	38.2	34.3	31.5	57.0	61.8	24.3	43.0	36.5	69.0	26.2	113.4	46.4	33.4	45.2	60.3	57.9	46.7	50.6	72.5	104.4	67.2	61.1	30.0	84.5	40.1	32.1	39.1	55.2	50.4	46.6	116.3	40.0	34.3	40.8	63.6	51.3	133.8	47.3	73.5	84.5	56.7	33.3	48.9	65.0	45.6	48.0	52.3	56.0	28.6	51.7	48.5	39.5	48.1	56.9	83.1	37.3	47.7	101.8	32.5	80.3	44.1	9.8	27.4	16.8	35.0	30.2	44.4	34.3	35.2	35.3	35.4	33.4	41.4	37.4	9.0	46.7	27.4	32.3	41.7	33.9	22.5	30.0	25.4	27.7	22.3	19.1	29.7	18.6	25.0	28.7
SERHL2		ENSG00000183569	"Serine hydrolase like 2"	Q9H4I8	22	42553617-42574382	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"breast: 155.6"	"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 77.6"	"Group enriched"	"Detected in all"	5	"breast cancer: 8.0;prostate cancer: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"memory B-cell: 4.1;naive B-cell: 8.9;plasmacytoid DC: 4.5"	"Group enriched"	"Detected in many"	11	"B-cells: 8.9;dendritic cells: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.14e-1)"	"unprognostic (1.56e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.42e-1)"	1.4	1.8	2.4	1.1	11.9	1.3	155.6	1.1	10.9	2.2	1.4	5.0	10.5	0.9	1.8	14.0	1.6	2.5	1.3	2.3	4.5	3.4	1.5	3.1	1.3	1.8	13.9	2.2	9.5	0.9	2.6	0.7	1.0	8.7	7.3	1.2	0.9	3.9	6.1	1.2	10.9	1.4	1.5	4.3	1.3	1.8	1.9	14.1	0.0	1.7	0.6	1.2	2.3	4.4	8.9	4.5	0.5	0.1	0.2	0.4	0.3	0.0	0.0	0.4	0.7	1.0	2.4	0.1	0.5	0.5	0.6	0.7	0.0	0.1	0.3	0.3	1.5	0.3	0.4	0.2	0.3	0.1	0.1	0.2	0.0	0.7	0.5	0.2	0.5	2.5	0.4	0.3	0.0	0.1	2.9	0.0	0.5	1.0	7.1	0.3	0.0	0.0	3.4	0.0	0.1	0.2	0.1	0.1	0.1	0.1	77.6	0.0	0.2	0.4	0.5	0.2	0.0	0.2	0.0	0.2	0.0	3.2	0.3	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.2	4.1	0.1	0.4	0.1	8.9	0.0	0.1	0.0	0.2	0.1	4.5	0.0	0.3	2.4	11.9	1.1	10.9	4.5	3.4	13.9	2.2	8.7	14.1
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443354-122471822	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol				Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	49.0	62.0	72.0	21.6	74.5	31.4	39.6	67.3	96.4	40.4	25.1	61.5	17.0	23.9	36.7	27.8	23.8	27.0	31.6	39.1	75.5	78.4	48.7	58.1	38.9	20.6	91.6	57.7	42.7	24.4	56.4	32.9	47.0	109.2	36.0	25.2	29.7	22.5	37.8	37.4	20.5	27.2	35.4	120.6	28.4	23.1	15.6	57.5	12.9	50.8	13.0	18.7	33.2	22.8	10.0	12.6	44.1	20.4	17.7	20.7	17.4	7.3	9.1	23.1	21.1	87.8	48.2	12.3	38.9	48.8	21.3	33.1	10.6	20.0	4.9	30.6	43.8	14.7	13.6	16.8	32.0	15.8	16.1	14.0	15.5	19.3	39.3	14.0	28.0	50.0	33.0	26.5	36.7	18.4	13.9	28.3	44.0	8.5	6.3	9.3	7.5	11.6	7.7	11.4	11.9	45.9	13.0	12.1	21.9	17.2	19.2	26.3	13.2	19.7	37.4	25.7	11.2	21.0	20.1	21.5	24.0	6.6	34.0	11.4	30.0	44.1	15.0	31.4	16.8	18.8	18.1	10.0	17.6	16.2	12.6	8.7	20.7	17.9	38.9	17.7	20.4	9.9	18.6	17.4	72.0	74.5	67.3	86.9	75.5	78.4	91.6	57.7	109.2	57.5
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 318.5"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	1663100000000	210000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favourable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favourable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.6	40.1	0.1	1.1	0.0	0.1	0.0	0.8	0.0	4.9	0.0	0.2	0.1	318.5	0.0	1.1	0.1	0.2	0.4	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.1	1.1	0.1	21.5	0.2	0.0	0.0	0.4	0.1	0.1	18.9	0.1	0.1	0.1	5.0	0.1	0.6	0.2	0.1	0.4	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8
SERPINA10	"PZI, ZPI"	ENSG00000140093	"Serpin family A member 10"	Q9UK55	14	94280455-94293271	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	223	"liver: 169.5"	"Cell line enriched"	"Detected in many"	8	"Hep G2: 20.7"	"Cancer enriched"	"Detected in some"	51	"liver cancer: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA048739			Approved	Nucleoplasm,Cytosol	"Secreted to blood"	3955000000	5900000000	Nucleoplasm	Cytosol	"HPA048739: "	"unprognostic (7.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (9.00e-4)"	"unprognostic (6.11e-2)"		"unprognostic (2.81e-4)"	"unprognostic (2.31e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.93e-3)"	0.1	0.0	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	169.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.7	0.1	0.1	0.2	0.0	0.6	0.3	2.0	0.7	0.8	0.7	0.5	0.5	0.6	0.9	0.9	2.5	0.6	2.2	0.3	0.4	0.3	2.4	0.5	1.4	0.9	1.4	2.1	0.7	20.7	0.5	1.7	1.2	0.7	0.5	0.3	0.8	1.1	0.5	1.4	1.1	0.3	1.4	1.1	0.9	0.6	0.9	1.1	0.9	0.5	0.7	1.0	0.9	0.5	0.5	0.2	1.5	0.9	0.5	0.8	0.4	0.7	0.6	1.2	0.5	1.0	1.0	1.9	0.5	0.7	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SERPINA11		ENSG00000186910	"Serpin family A member 11"	Q86U17	14	94442464-94452790	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"liver: 189.6"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 19.1"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 94.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"		460000000				"unprognostic (2.50e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.00e-2)"	"prognostic favourable (6.30e-4)"		"unprognostic (7.44e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.44e-1)"		"unprognostic (5.14e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.64e-1)"				0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	189.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA3	"AACT, ACT"	ENSG00000196136	"Serpin family A member 3"	P01011	14	94612377-94624055	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 1244.8"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 96.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000893, HPA002560, CAB016647"	Enhanced				"Secreted to blood"		95000000000			"CAB016647: AB_1611882, HPA000893: AB_10794315, HPA002560: AB_1856717"	"prognostic favourable (8.92e-4)"	"unprognostic (3.33e-3)"	"unprognostic (9.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.74e-12)"	"unprognostic (6.47e-2)"	"unprognostic (1.33e-2)"		"unprognostic (2.02e-2)"	11.1	2.1	5.4	5.7	17.6	1.2	26.0	1.9	16.1	43.8	2.3	10.0	1.4	2.3	2.2	2.4	3.3	4.3	18.1	10.7	13.4	6.5	61.9	1244.8	4.9	53.0	16.3	0.8	8.3	182.4	1.0	14.0	2.7	34.2	18.3	2.6	10.2	62.1	7.9	6.8	1.5	2.3	10.2	47.2	8.2	9.7	9.5	7.4	0.0	3.5	0.5	1.7	7.6	11.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.1	1.0	0.0	0.2	0.0	0.9	0.0	0.5	0.0	0.2	0.0	96.2	13.1	0.4	0.1	11.9	14.3	0.0	0.5	0.0	0.0	0.0	0.0	3.6	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.8	0.0	0.0	0.0	0.4	0.5	14.0	0.5	0.0	0.1	0.0	1.8	0.0	4.1	0.2	0.3	0.4	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.4	17.6	1.9	9.6	13.4	6.5	16.3	0.8	34.2	7.4
SERPINA4	"KAL, kallistatin, KLST, KST, PI4"	ENSG00000100665	"Serpin family A member 4"	P29622	14	94561091-94569913	"Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 24.8;liver: 118.6;pancreas: 36.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 22.4"	"Group enriched"	"Detected in many"	8	"liver cancer: 94.8;pancreatic cancer: 21.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA003607	Approved				"Secreted to blood"	14517800000	22000000000			"HPA003607: AB_1079914"	"unprognostic (1.65e-3)"		"unprognostic (4.13e-2)"	"prognostic favourable (2.95e-4)"			"unprognostic (2.09e-3)"	"unprognostic (1.99e-3)"		"unprognostic (2.82e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (5.45e-2)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	3.2	0.3	0.1	7.9	0.1	0.1	24.8	0.1	0.0	0.0	1.4	118.6	0.0	0.0	0.0	0.0	0.1	36.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	8.2	0.0	0.1	0.1	0.0	0.0	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SERPINA5	"PAI3, PCI, PLANH3, PROCI"	ENSG00000188488	"Serpin family A member 5"	P05154	14	94561442-94593120	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Fertilization, Lipid transport, Transport"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 100.4;ductus deferens: 126.6;liver: 112.4;seminal vesicle: 106.7;testis: 146.5"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 74.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 121.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056919			Approved	Mitochondria	"Secreted to blood"		2300000000	Mitochondria		"HPA056919: "	"unprognostic (5.94e-3)"	"unprognostic (2.64e-4)"	"unprognostic (1.13e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (3.34e-3)"	"unprognostic (6.10e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-3)"	"unprognostic (5.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.87e-2)"	"unprognostic (8.39e-3)"	"unprognostic (3.38e-3)"	"unprognostic (9.92e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.23e-1)"	1.1	100.4	0.4	1.8	1.8	0.0	7.7	0.2	0.5	4.0	1.0	1.6	126.6	0.6	4.8	5.0	0.5	3.6	34.3	5.6	0.6	0.4	33.6	112.4	0.3	1.9	3.1	0.3	6.4	33.8	0.0	0.8	0.2	1.9	1.9	0.0	0.9	10.9	106.7	6.6	0.7	0.7	0.4	1.5	36.1	2.0	146.5	0.6	0.1	0.9	1.5	0.6	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.9	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	1.2	0.0	0.1	5.1	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.2	0.5	0.6	0.4	3.1	0.3	1.9	0.6
SERPINA6	CBG	ENSG00000170099	"Serpin family A member 6"	P08185	14	94304248-94323394	"Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 223.9"	"Cell line enriched"	"Detected in some"	11	"T-47d: 116.8"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 244.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA017864	Approved				"Secreted to blood"	60800000000	59000000000			"HPA017864: AB_1856721"	"unprognostic (2.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-3)"	"prognostic favourable (6.96e-5)"		"unprognostic (2.93e-3)"	"unprognostic (9.98e-3)"	"unprognostic (4.43e-2)"		"unprognostic (3.11e-1)"	"unprognostic (4.80e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.47e-2)"	"unprognostic (4.54e-2)"	"unprognostic (1.43e-1)"		"unprognostic (2.14e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.1	1.0	0.0	2.3	10.3	0.1	0.0	0.0	5.2	223.9	0.1	0.0	0.0	0.0	0.8	9.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINA7	TBG	ENSG00000123561	"Serpin family A member 7"	P05543	X	106032442-106038738	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	414	"liver: 101.8"	"Cell line enriched"	"Detected in single"	474	"Hep G2: 47.3"	"Cancer enriched"	"Detected in single"	203	"liver cancer: 82.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA002803	Approved				"Secreted to blood"	19450000000	49000000000			"HPA002803: AB_1079915"			"unprognostic (6.22e-2)"				"unprognostic (1.63e-3)"				"unprognostic (3.34e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.15e-3)"		"unprognostic (2.95e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	101.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2842006	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 119.2;lymphoid tissue: 108.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;U-937: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"			49000000	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	11.4	15.1	3.5	13.4	7.0	75.8	6.4	2.9	3.3	25.1	23.6	5.7	5.3	26.0	6.6	8.6	119.2	7.6	18.1	8.3	3.5	3.9	11.4	36.9	32.6	37.4	7.5	1.8	7.8	66.7	8.3	10.4	11.9	6.2	6.5	16.7	6.7	23.5	3.6	21.8	4.4	49.2	5.6	6.8	34.8	18.0	3.9	5.3	9.4	14.0	98.9	108.0	7.2	20.8	12.8	38.3	48.5	49.6	21.7	16.7	38.7	12.9	15.1	0.8	0.1	3.3	7.0	13.1	3.8	10.9	4.5	8.2	14.2	37.5	0.1	27.5	8.0	8.2	1.5	3.4	3.4	18.5	2.7	22.8	5.1	10.9	12.0	4.0	14.7	8.7	5.9	2.3	1.0	14.8	8.1	3.1	4.0	6.0	0.5	10.5	1.5	7.2	1.2	0.1	13.2	15.5	2.8	2.9	1.6	8.7	3.4	18.9	1.7	12.9	9.1	1.5	3.6	3.2	1.1	0.0	0.6	0.1	5.5	42.6	0.7	27.1	49.6	28.5	16.1	25.7	14.5	12.8	15.6	14.8	38.3	9.6	16.1	16.1	48.5	21.7	19.5	14.8	16.7	38.7	3.5	7.0	2.9	3.3	3.5	3.9	7.5	1.8	6.2	5.3
SERPINB10	"bomapin, PI10"	ENSG00000242550	"Serpin family B member 10"	P48595	18	63897174-63936111	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 43.9;tongue: 15.3"	"Cell line enriched"	"Detected in some"	7	"U-937: 47.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"classical monocyte: 4.2;eosinophil: 3.3;neutrophil: 1.8;plasmacytoid DC: 2.1"	"Group enriched"	"Detected in many"	9	"dendritic cells: 2.1;granulocytes: 3.3;monocytes: 4.2"					"Low region specificity"	"Detected in all"			"HPA015480, HPA059582"	Uncertain		Supported	Nucleoplasm,Cytosol			42000	Nucleoplasm	Cytosol	"HPA015480: AB_1855456, HPA059582: "	"unprognostic (4.66e-1)"	"unprognostic (5.11e-2)"			"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"		"unprognostic (9.56e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.59e-1)"	"unprognostic (1.10e-1)"			"unprognostic (3.64e-1)"			"unprognostic (1.25e-4)"	1.3	0.1	0.0	2.3	0.2	43.9	0.1	0.3	0.1	1.1	0.7	0.0	0.0	0.1	0.2	0.3	3.1	0.1	0.1	5.5	0.0	0.0	0.0	0.2	3.8	0.2	0.0	0.0	0.0	0.1	0.1	0.0	4.8	0.2	0.1	0.1	0.0	1.0	0.1	1.3	2.5	0.1	0.1	0.0	2.8	0.1	0.1	0.1	4.0	0.9	15.3	1.5	0.1	1.3	0.3	2.1	3.3	4.2	0.3	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.2	4.2	3.3	0.2	0.1	0.1	0.2	0.1	0.1	0.4	0.3	0.1	0.1	1.8	0.3	0.0	2.1	0.1	0.9	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.1
SERPINB11	EPIPIN	ENSG00000206072	"Serpin family B member 11 (gene/pseudogene)"	Q96P15	18	63647579-63726432	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 19.5;lymphoid tissue: 19.1;prostate: 23.7;tongue: 32.1"	"Cell line enhanced"	"Detected in some"		"A549: 1.2;BEWO: 2.0;hTCEpi: 1.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 6.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"															"unprognostic (5.04e-3)"				"unprognostic (4.76e-2)"		"unprognostic (4.05e-2)"				"unprognostic (3.44e-1)"					"unprognostic (2.62e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0		0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	23.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.1	19.1	2.0	2.4	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0										
SERPINB12	YUKOPIN	ENSG00000166634	"Serpin family B member 12"	Q96P63	18	63556160-63567011	"Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 9.3;skin 1: 38.8;vagina: 16.1"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.3;CAPAN-2: 1.0;hTCEpi: 2.4;U-266/70: 2.9"	"Group enriched"	"Detected in some"	14	"cervical cancer: 7.3;head and neck cancer: 2.1;lung cancer: 1.9;melanoma: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"										8500000					"unprognostic (7.35e-2)"				"prognostic favourable (1.76e-4)"		"unprognostic (1.57e-1)"	"unprognostic (2.00e-1)"						"unprognostic (8.10e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	9.3	0.0			0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.4	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.3			0.0		1.4	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5										
SERPINB2	"HsT1201, PAI2, PLANH2"	ENSG00000197632	"Serpin family B member 2"	P05120	18	63871692-63903890	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Plasminogen activation"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 70.6;placenta: 222.1"	"Group enriched"	"Detected in some"	5	"HaCaT: 79.8;U-138 MG: 95.5;U-2197: 145.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 26.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 16.3;eosinophil: 7.6"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 16.3"	"Region enriched"	"Detected in single"	14	"cerebellum: 2.9"	"Low region specificity"	"Detected in all"			HPA015480	Supported				"Intracellular and membrane"		110000			"HPA015480: AB_1855456"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.36e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.76e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.33e-6)"	"unprognostic (3.89e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.29e-1)"	"prognostic unfavourable (1.55e-5)"	6.0	0.0	0.1	2.9	0.2	8.7	2.6	0.2	0.1	6.4	0.8	0.1	0.1	0.0	0.7	0.4	70.6	3.1	0.1	0.4	0.1	0.0	0.1	0.1	0.9	0.1	0.1	0.1	0.6	0.3	0.0	0.1	222.1	0.2	0.3	0.0	0.1	11.3	0.2	0.3	25.7	0.2	0.3	0.1	0.3	0.1	0.2	0.1	0.9	0.2	49.0	37.7	1.1	13.8	0.0	0.2	16.3	3.9	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	19.4	20.6	0.7	1.5	0.1	0.0	0.0	0.0	0.6	79.8	0.0	16.4	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	9.5	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.5	95.5	0.0	145.1	0.0	0.0	0.0	0.0	2.5	0.2	11.1	16.3	3.9	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
SERPINB3	"HsT1196, SCC, SCCA1, T4-A"	ENSG00000057149	"Serpin family B member 3"	P29508	18	63655197-63661963	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.5;HaCaT: 8.9;SiHa: 5.5;U-2197: 11.3"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 186.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992"	Enhanced		Approved	"Plasma membrane,Cytosol"			11000000	Cytosol	"Plasma membrane"	"CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: , HPA049988: , HPA055992: "		"unprognostic (2.95e-3)"		"unprognostic (1.66e-1)"		"unprognostic (2.03e-1)"		"unprognostic (2.91e-2)"	"unprognostic (2.11e-1)"		"prognostic unfavourable (3.19e-4)"	"unprognostic (6.68e-2)"		"unprognostic (2.58e-1)"			"unprognostic (4.19e-3)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	50.7	0.2	0.2	0.2	0.0	3.8	0.2	140.0	0.0	0.2	0.2	0.2	0.0	0.2	0.2	5.4	0.2	0.2	0.2	0.2	0.2	0.0	2.4	0.2	0.2	1.1	0.0	0.2	13.0	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.0	0.2	0.2	1.4	0.2	21.3	3.1	13.1	80.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.1	8.9	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SERPINB4	"LEUPIN, PI11, SCCA-2, SCCA1, SCCA2"	ENSG00000206073	"Serpin family B member 4"	P48594	18	63637259-63644298	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 32.5;esophagus: 48.4;tongue: 18.4;vagina: 41.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.0;HSkMC: 2.0;SiHa: 3.1;U-2197: 10.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 104.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA048341, HPA049988, HPA055992"	Supported						5700000			"HPA048341: , HPA049988: , HPA055992: "		"unprognostic (8.81e-3)"				"unprognostic (9.43e-2)"		"unprognostic (8.96e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (5.48e-4)"	"unprognostic (2.46e-1)"		"unprognostic (4.37e-2)"			"unprognostic (1.27e-2)"	0.1	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.1	32.5	0.1	0.1	0.1	0.0	1.8	0.1	48.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	7.0	0.1	0.3	4.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.1	18.4	2.3	8.7	41.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	1.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SERPINB5	"maspin, PI5"	ENSG00000206075	"Serpin family B member 5"	P36952	18	63476761-63505085	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 99.3;skin 1: 60.7;tongue: 118.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 143.8;HBEC3-KT: 47.4;hTCEpi: 99.9;hTERT-HME1: 25.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 124.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009570, HPA019025, HPA019132, HPA020136"	Enhanced		Supported	Vesicles	"Intracellular and membrane"		660000	Vesicles		"CAB009570: AB_2186315, HPA019025: AB_1856726, HPA019132: AB_1856727, HPA020136: AB_1856728"	"unprognostic (2.84e-3)"	"unprognostic (1.05e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.04e-3)"		"unprognostic (2.09e-2)"		"prognostic unfavourable (1.54e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.47e-3)"	"prognostic unfavourable (5.71e-6)"	"unprognostic (1.28e-1)"	"unprognostic (1.84e-6)"	"unprognostic (2.57e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.38e-2)"	0.2	0.1	0.1	0.9	0.1	0.0	9.7	0.1	0.1	23.6	2.7	0.1	0.7	3.9	2.1	0.5	99.3	0.1	4.3	0.1	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.2	0.1	4.1	1.0	0.1	11.1	0.3	0.1	60.7	6.8	0.9	0.1	0.1	2.2	0.4	0.1	5.1	0.1	118.8	41.2	7.1	19.7	0.6	0.5	1.2	0.4	1.0	0.5	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.4	0.0	143.8	0.0	47.4	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	99.9	0.0	25.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	10.5	0.1	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.1	0.2	0.2	0.4	0.2	0.6	0.5	0.3	1.2	1.0	0.2	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome			5100000	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favourable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	31.6	38.8	21.1	23.5	34.8	17.3	29.6	13.4	20.8	31.8	44.6	35.2	38.1	54.9	30.3	30.3	36.0	35.9	42.4	58.7	21.1	21.3	32.4	20.1	36.2	45.3	33.7	20.4	45.3	85.3	26.5	23.7	38.5	28.5	37.8	30.9	32.6	23.4	32.6	51.0	12.0	85.5	36.6	32.4	41.4	29.9	55.5	28.9	5.9	32.6	34.2	23.7	31.7	24.5	8.4	30.8	34.2	31.3	23.6	18.6	24.0	30.3	19.9	6.6	27.3	17.9	39.9	20.4	28.4	34.5	22.6	26.4	7.0	22.0	0.2	32.8	32.2	46.1	18.2	28.9	21.2	39.9	8.2	17.9	23.8	11.8	31.3	0.3	10.9	22.9	20.3	21.5	5.6	53.4	23.1	0.5	40.1	21.6	0.2	0.3	3.8	38.4	1.9	12.3	25.5	28.4	7.4	0.4	16.8	23.3	3.5	31.5	15.4	14.6	38.2	23.1	8.5	51.2	19.2	0.6	0.1	0.5	17.7	17.9	23.6	13.9	31.3	34.2	16.8	30.4	8.3	8.4	9.5	11.1	30.8	6.9	11.3	18.6	2.8	23.6	24.6	3.1	1.3	24.0	21.1	34.8	13.4	20.8	21.1	21.3	33.7	20.4	28.5	28.9
SERPINB8	"CAP2, PI8"	ENSG00000166401	"Serpin family B member 8"	P50452	18	63969925-64019779	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 36.6"	"Cell line enhanced"	"Detected in many"		"HL-60: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB034300	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB034300: AB_2186486"	"unprognostic (8.49e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.71e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.98e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavourable (3.31e-5)"	"unprognostic (8.73e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-1)"	12.4	7.4	2.9	9.3	4.2	16.0	6.1	1.3	5.5	7.7	7.4	7.1	0.0	3.7	4.1	4.3	20.6	3.7	13.7	4.5	3.1	3.3	7.1	23.7	8.2	10.1	4.7	4.0	8.1	4.2	1.1	5.0	9.5	7.4	4.2	6.1	3.4	8.1	2.1	4.5	36.6	8.7	4.4	6.0	9.8	4.2	2.9	3.5	4.2	5.0	17.5	11.3	9.6	11.0	5.1	25.3	5.9	20.5	2.1	4.2	5.0	7.4	1.5	1.3	9.2	4.6	6.5	0.6	24.3	23.6	15.4	15.4	0.3	3.4	0.1	8.9	14.5	12.2	0.2	15.4	22.1	10.3	0.3	0.0	2.8	0.8	10.5	37.3	3.2	6.2	13.4	20.8	6.8	16.4	0.2	4.3	10.6	0.6	0.6	4.1	0.5	7.5	0.5	3.4	0.6	6.9	8.5	0.7	0.7	4.8	0.7	8.9	0.3	14.0	25.4	23.6	5.0	2.8	9.7	1.9	0.3	0.0	24.2	21.7	20.3	1.1	20.5	0.8	3.8	16.1	3.4	3.6	3.1	2.3	25.3	5.1	1.7	2.6	5.9	2.1	8.0	13.7	4.2	5.0	2.9	4.2	1.3	5.5	3.1	3.3	4.7	4.0	7.4	3.5
SERPINC1	"AT3, ATIII, MGC22579"	ENSG00000117601	"Serpin family C member 1"	P01008	1	173903804-173917378	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	203	"liver: 450.5"	"Cell line enriched"	"Detected in some"	35	"Hep G2: 41.6"	"Cancer enriched"	"Detected in some"	871	"liver cancer: 1504.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA001816, CAB016790, HPA024007"	Supported				"Secreted to blood"		210000000000			"CAB016790: , HPA001816: AB_1079926, HPA024007: AB_1856732"	"unprognostic (1.28e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.83e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.93e-2)"	"prognostic favourable (3.40e-5)"	"unprognostic (1.75e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.48e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.28e-3)"	"unprognostic (5.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.21e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	450.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	41.6	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SERPIND1	"D22S673, HC-II, HC2, HCF2, HLS2"	ENSG00000099937	"Serpin family D member 1"	P05546	22	20773879-20787720	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Chemotaxis, Hemostasis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease mutation, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"liver: 170.8"	"Cell line enriched"	"Detected in some"	10	"Hep G2: 62.7"	"Cancer enriched"	"Detected in many"	80	"liver cancer: 334.4"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008639, HPA055767"	Supported		Approved	Vesicles	"Secreted to blood"		94000000000	Vesicles		"CAB008639: AB_1618010, HPA055767: "	"unprognostic (1.68e-1)"	"unprognostic (8.27e-2)"	"unprognostic (4.40e-2)"	"prognostic favourable (4.09e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.94e-9)"	"unprognostic (2.01e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.46e-1)"	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.6	0.9	0.3	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	170.8	0.3	0.0	0.0	0.7	0.3	0.0	3.6	0.1	0.2	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	1.9	2.7	0.7	0.4	1.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	62.7	0.0	0.2	0.1	0.0	0.0	0.5	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	4.3	0.0	0.4	0.0	1.0	0.2	1.7	0.4	0.5	0.6	0.1	1.9	0.9	0.7	0.7	1.3	0.2	2.7	0.7	0.1	0.0	2.3	0.6	0.9	0.0	0.0	0.0	0.7	2.6	0.5
SERPINE1	"PAI, PAI1, PLANH1"	ENSG00000106366	"Serpin family E member 1"	P05121	7	101127089-101139266	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 253.6"	"Cell line enhanced"	"Detected in many"		"BJ: 140.2;HUVEC TERT2: 162.7;LHCN-M2: 157.1;TIME: 402.3;U-138 MG: 191.5;U-251 MG: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	20	"NK-cell: 10.8"	"Lineage enriched"	"Detected in single"	20	"NK-cells: 10.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA050039, CAB068501"	Uncertain		Approved	Cytosol	"Secreted to blood"		14000000	Cytosol		"CAB068501: AB_1642775, HPA050039: "	"unprognostic (5.02e-2)"	"prognostic unfavourable (5.01e-4)"	"prognostic unfavourable (2.82e-4)"	"unprognostic (2.10e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavourable (2.84e-5)"	"unprognostic (6.80e-3)"	"prognostic unfavourable (4.41e-6)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.88e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (5.88e-8)"	"prognostic unfavourable (3.27e-6)"	"unprognostic (1.05e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (5.51e-4)"	45.5	14.0	1.1	16.7	1.8	0.1	11.4	0.5	1.5	13.3	7.0	3.4	3.3	1.2	6.6	14.4	6.8	9.3	69.6	29.2	1.5	0.6	7.8	65.3	56.3	3.3	4.1	1.8	19.7	24.7	1.4	2.6	253.6	5.9	7.6	0.9	2.3	2.4	6.2	12.4	4.1	2.3	13.5	4.1	5.8	6.6	8.6	2.2	0.6	11.3	3.7	2.8	71.7	18.1	0.2	0.4	0.5	0.2	10.8	0.3	1.0	3.0	2.5	0.0	0.2	32.1	64.0	3.6	140.2	26.5	70.7	61.8	0.3	0.2	0.1	33.6	44.6	0.7	0.0	10.8	73.1	0.1	0.0	0.0	0.2	2.4	64.6	0.0	0.1	25.0	4.3	108.5	57.1	162.7	0.2	0.1	157.1	0.0	0.0	0.0	0.7	1.6	0.0	0.2	0.1	0.2	1.2	0.0	0.0	11.5	3.1	0.3	0.1	0.3	402.3	191.5	8.4	65.2	168.3	0.0	0.1	0.1	47.8	0.0	1.8	0.5	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.1	0.2	10.8	0.0	0.4	0.0	1.0	1.1	1.8	0.5	1.5	1.5	0.6	4.1	1.8	5.9	2.2
SERPINE2	"GDN, nexin, PI7, PN1, PNI"	ENSG00000135919	"Serpin family E member 2"	P07093	2	223975112-224039319	"Plasma proteins, Predicted secreted proteins"	"Differentiation, Neurogenesis"	"Developmental protein, Heparin-binding, Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 257.0"	"Cell line enhanced"	"Detected in many"		"BJ: 82.0;fHDF/TERT166: 350.3;SK-MEL-30: 156.2;WM-115: 120.4"	"Cancer enriched"	"Detected in all"	9	"melanoma: 271.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"naive CD4 T-cell: 10.5;naive CD8 T-cell: 5.3;NK-cell: 16.5"	"Group enriched"	"Detected in many"	13	"NK-cells: 16.5;T-cells: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in female reproductive system"		490000				"unprognostic (1.73e-1)"	"unprognostic (7.08e-3)"	"unprognostic (8.49e-2)"	"unprognostic (7.78e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.49e-2)"	"unprognostic (7.43e-3)"	"unprognostic (4.41e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.56e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (6.48e-5)"	8.0	5.8	34.7	18.0	30.6	2.2	4.8	14.9	35.2	8.6	6.1	13.0	0.1	7.4	5.1	4.4	9.7	6.0	11.9	24.5	21.9	25.3	10.6	3.3	3.2	7.7	33.0	14.4	38.4	2.9	1.3	2.0	257.0	25.2	6.6	6.2	4.9	3.1	2.8	3.2	3.5	6.0	28.1	23.0	7.8	2.7	14.2	11.9	1.6	6.2	3.2	10.8	18.3	6.9	1.0	0.1	0.3	0.0	16.5	10.5	2.2	0.1	4.4	1.6	1.7	67.4	25.4	0.2	82.0	47.0	6.6	6.4	0.2	0.3	0.0	1.8	350.3	0.2	0.1	5.6	5.7	0.0	1.4	0.8	2.9	1.2	3.3	0.6	0.0	7.3	3.8	19.0	28.6	0.5	0.0	0.0	22.8	0.2	0.1	0.2	3.1	4.9	0.5	1.4	3.3	61.5	5.1	2.3	0.4	15.6	0.0	156.2	0.0	0.3	57.8	39.3	5.4	11.9	3.8	0.3	0.6	0.0	25.1	0.6	120.4	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.4	0.5	0.0	1.0	10.5	5.3	0.3	16.5	0.0	0.1	0.5	2.2	34.7	30.6	14.9	29.8	21.9	25.3	33.0	14.4	25.2	11.9
SERPINF1	"EPC-1, PEDF, PIG35"	ENSG00000132386	"Serpin family F member 1"	P36955	17	1761959-1777574	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Dwarfism, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 360.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 121.4;ASC TERT1: 94.8;Hep G2: 55.4;HHSteC: 40.6;HSkMC: 128.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 105.5"	"Cell type enriched"	"Detected in some"	18	"plasmacytoid DC: 143.3"	"Lineage enriched"	"Detected in many"	119	"dendritic cells: 143.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005825	Uncertain				"Secreted to blood"	9293333333	85000000000			"HPA005825: AB_1079921"	"unprognostic (3.85e-1)"	"prognostic favourable (5.49e-4)"	"unprognostic (9.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.18e-2)"	"prognostic unfavourable (1.40e-8)"	"unprognostic (2.11e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.25e-3)"	70.0	7.5	2.3	15.1	4.5	1.1	61.6	0.7	13.9	84.1	16.4	20.8	14.8	5.0	48.9	71.9	24.3	75.3	66.8	50.3	11.6	1.9	6.9	190.1	20.1	30.6	1.9	5.9	68.1	54.7	0.6	11.0	38.6	105.5	53.2	6.5	360.1	17.8	14.2	51.4	21.5	15.7	27.6	2.4	21.2	17.8	86.3	1.4	6.0	27.4	38.5	14.6	32.1	37.9	0.8	143.3	0.1	1.2	0.1	0.5	1.3	0.0	0.4	0.2	0.2	121.4	94.8	2.0	5.6	4.7	0.0	0.0	0.9	0.0	0.2	0.2	6.7	0.3	8.0	0.4	0.0	0.0	4.3	0.1	0.0	55.4	40.6	0.1	0.1	128.9	0.7	0.1	0.1	0.0	11.4	0.0	5.9	0.0	0.7	0.6	3.2	0.1	0.3	22.3	0.1	0.0	0.6	0.1	4.1	0.0	0.0	5.7	0.7	17.1	0.2	0.0	1.8	1.4	0.1	0.0	0.2	2.9	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.0	0.8	0.0	0.1	7.9	0.4	0.2	0.5	0.1	0.1	0.0	143.3	0.0	1.3	2.3	4.5	0.7	13.9	11.6	1.9	1.9	5.9	105.5	1.4
SERPINF2	"A2AP, AAP, ALPHA-2-PI, API, PLI"	ENSG00000167711	"Serpin family F member 2"	P08697	17	1742836-1755268	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Acute phase"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"liver: 417.7"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 55.8"	"Cancer enriched"	"Detected in all"	6	"liver cancer: 450.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 19.8"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 19.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA001885, CAB024863"	Approved				"Secreted to blood"	11890	110000000000			"CAB024863: , HPA001885: AB_1079922"	"unprognostic (2.17e-3)"	"unprognostic (2.56e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.45e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.88e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.09e-3)"	"unprognostic (7.05e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.68e-3)"	"unprognostic (2.93e-1)"	0.9	0.0	0.2	0.6	0.2	0.0	1.8	0.2	0.2	0.6	0.3	0.2	6.6	0.0	0.7	17.2	0.2	2.1	0.2	0.3	0.2	0.0	10.2	417.7	1.3	3.4	0.2	0.2	0.7	0.8	0.0	0.2	0.2	0.8	2.1	0.0	1.8	0.5	9.0	0.2	0.4	1.0	0.2	0.2	0.6	0.2	1.7	0.2	0.2	0.7	0.2	0.5	0.6	0.4	0.2	19.8	0.5	0.7	0.4	0.0	0.4	0.3	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	55.8	0.4	0.1	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.2	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	19.8	0.0	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.8	0.2
SERPING1	"C1-INH, C1IN, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57614853	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 693.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 144.9;ASC TERT1: 75.1;HSkMC: 124.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.9;intermediate monocyte: 11.0;neutrophil: 32.1;plasmacytoid DC: 28.5"	"Group enriched"	"Detected in many"	143	"dendritic cells: 28.5;granulocytes: 32.1;monocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026161, HPA048738"	Supported				"Secreted to blood"		38000000000			"CAB026161: , HPA048738: "	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavourable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favourable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavourable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	88.8	16.3	3.6	18.2	5.4	1.6	75.0	3.8	6.3	62.7	37.8	7.3	16.7	6.2	63.4	58.8	58.3	63.4	61.6	55.5	3.4	3.0	53.4	693.2	73.8	22.4	5.7	4.1	116.4	38.1	8.0	18.4	33.1	14.9	70.3	11.9	82.6	20.7	33.2	36.5	23.1	20.3	38.7	17.3	42.7	30.3	39.2	3.6	1.8	41.5	24.4	16.8	68.7	122.2	0.0	28.5	32.1	11.0	0.1	0.0	2.8	0.0	0.0	5.5	0.0	144.9	75.1	0.9	9.2	6.5	1.9	3.5	0.3	0.0	0.0	11.1	4.7	0.0	0.0	0.6	1.2	0.0	0.0	4.5	0.0	0.2	19.2	0.2	0.9	124.5	1.8	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	5.6	0.0	0.7	0.4	0.0	0.8	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.4	0.0	0.3	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	8.9	0.1	0.0	11.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	32.1	0.1	4.4	28.5	0.0	2.8	3.6	5.4	3.8	6.3	3.4	3.0	5.7	4.1	14.9	3.6
SERPINH1	"CBP1, CBP2, colligen, HSP47, SERPINH2"	ENSG00000149257	"Serpin family H member 1"	P50454	11	75562056-75572783	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 165.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 117.6;HHSteC: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004441, HPA029198"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"		730000	"Endoplasmic reticulum"		"CAB004441: AB_627757, HPA029198: AB_10601712"	"unprognostic (3.80e-1)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (5.93e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.25e-2)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.72e-3)"	"unprognostic (2.35e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavourable (3.22e-15)"	"unprognostic (2.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	38.2	20.1	10.5	29.3	10.9	1.0	54.1	5.7	8.4	39.4	16.9	6.0	10.3	6.4	32.7	16.8	17.8	23.6	21.4	29.6	11.8	7.0	18.5	11.5	35.7	13.5	17.1	2.7	48.3	13.9	5.9	11.0	69.9	23.2	26.2	11.0	13.8	7.7	16.7	9.5	12.3	9.4	57.8	12.9	14.3	14.2	12.5	13.0	7.4	36.1	8.7	8.2	38.7	165.4	1.3	5.5	5.0	1.6	7.1	7.4	2.4	5.4	18.3	34.5	71.0	53.5	49.4	15.7	50.4	34.3	38.0	48.5	97.4	28.5	0.0	45.7	117.6	32.7	23.6	15.7	18.5	2.2	4.5	3.9	18.1	19.5	104.4	0.1	0.7	58.8	16.2	36.3	12.2	51.9	8.3	1.7	17.7	42.7	0.1	6.9	30.6	4.9	2.7	19.1	4.4	9.2	10.4	0.8	11.4	31.5	5.9	9.5	14.0	6.7	27.3	39.2	32.7	26.7	12.2	2.2	2.2	0.5	16.9	0.0	52.5	5.0	1.6	0.1	7.4	1.5	6.7	1.2	5.1	5.3	5.5	1.3	5.7	4.6	0.3	7.1	0.2	4.7	4.2	2.4	10.5	10.9	5.7	8.4	11.8	7.0	17.1	2.7	23.2	13.0
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"			880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: "	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavourable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	50.4	57.6	82.9	65.6	24.8	38.9	76.5	41.7	46.2	60.3	41.6	79.2	62.0	130.6	35.3	42.9	94.7	122.5	62.7	69.0	59.5	52.2	75.1	89.7	64.4	55.4	137.0	49.2	32.3	49.1	51.3	103.0	56.3	145.7	53.0	49.3	85.2	114.7	50.6	138.4	61.4	105.0	103.1	105.7	46.5	57.0	84.5	53.1	91.8	61.7	49.8	76.9	42.7	53.9	71.3	53.5	43.9	68.9	41.7	119.8	155.4	33.9	73.0	67.9	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6
SETD2	"FLJ23184, HIF-1, HYPB, KIAA1732, KMT3A"	ENSG00000181555	"SET domain containing 2"	Q9BYW2	3	47016429-47163967	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Differentiation, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Methyltransferase, Transferase"	"Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042451	Approved		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA042451: AB_10806239"	"unprognostic (2.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.19e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.84e-2)"	"prognostic favourable (7.99e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.79e-2)"	"unprognostic (5.43e-2)"	13.2	10.5	12.2	15.2	15.4	20.0	11.7	22.4	16.4	13.4	14.0	9.1	12.9	9.5	15.8	7.5	10.8	11.4	8.7	8.8	10.6	6.8	11.4	10.3	10.4	11.8	11.7	9.5	16.0	13.4	21.4	16.3	10.7	11.3	12.4	10.9	7.7	12.7	14.8	27.6	12.5	11.5	11.9	9.8	13.8	10.4	12.8	12.8	23.2	15.8	5.5	12.8	16.1	15.5	4.8	2.6	6.0	2.3	7.1	3.9	1.0	11.4	9.0	15.2	7.8	9.1	10.6	6.4	10.6	10.3	12.4	11.3	9.5	7.5	25.3	6.6	14.5	7.0	16.4	10.1	16.8	14.5	6.5	25.9	15.1	7.3	6.8	19.4	15.0	9.1	9.7	12.2	15.2	11.4	16.6	9.6	10.1	6.0	14.2	2.6	11.5	7.5	9.4	14.7	13.1	6.2	15.1	6.6	10.5	17.8	7.0	6.6	7.4	14.4	14.6	13.6	10.2	11.6	16.8	12.2	13.6	25.5	7.9	11.1	7.9	2.4	2.2	5.2	3.9	2.3	2.4	3.7	2.4	3.0	2.5	4.8	3.5	3.0	6.0	7.1	1.9	2.6	1.0	1.0	12.2	15.4	22.4	16.4	10.6	6.8	11.7	9.5	11.3	12.8
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	Nucleoli				Nucleoli		"HPA058111: "	"prognostic unfavourable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	8.9	11.5	4.4	2.6	26.1	22.5	9.7	21.2	22.0	10.8	9.2	6.8	12.2	20.8	8.4	35.6	4.5	14.6	16.7	17.7	10.2	10.3	2.9	15.0	0.2	12.9	9.9	4.4	19.5	19.6	17.2	18.4	13.7	1.7	32.3	13.8	14.9	6.5	1.5	2.1	7.6	6.1	15.3	11.9	10.5	8.2	17.2	5.7	14.1	20.9	5.0	8.3	9.1	22.2	19.2	13.6	22.9	17.5	28.0	26.8	13.2	22.1	10.0	9.2	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5
SETDB2	"C13orf4, CLLD8, CLLL8, KMT1F"	ENSG00000136169	"SET domain bifurcated 2"	Q96T68	13	49444374-49495003	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Chromatin regulator, Developmental protein, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 25.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012190, HPA071677"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB012190: AB_2186195, HPA071677: "	"unprognostic (1.77e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.74e-2)"	"unprognostic (3.44e-3)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.95e-2)"	"prognostic favourable (1.92e-7)"	"unprognostic (2.83e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.85e-1)"	10.2	14.5	9.8	20.5	10.8	9.5	14.1	14.4	12.3	13.0	12.4	8.3	13.6	7.8	13.1	11.6	9.8	9.9	9.7	12.7	8.2	6.9	12.4	11.0	16.3	19.0	7.2	11.1	21.0	15.0	10.8	15.8	7.8	9.5	13.6	11.9	13.5	11.7	10.9	5.5	9.6	11.4	11.3	8.4	19.0	10.7	18.1	8.7	17.3	14.6	3.7	16.6	11.9	10.3	8.4	7.4	4.7	5.4	7.8	10.2	4.5	2.0	1.3	4.2	4.3	6.0	6.7	2.1	5.8	7.3	5.2	4.9	8.5	4.9	25.1	1.1	3.7	4.2	4.4	3.9	5.1	5.7	3.9	8.7	3.8	5.1	8.4	13.3	5.0	5.2	7.2	4.0	13.1	4.4	3.8	3.5	4.7	1.7	5.0	9.9	2.2	3.4	9.8	5.3	5.3	4.8	1.9	2.1	2.5	2.5	3.6	12.4	3.0	11.5	2.6	5.0	1.8	6.6	2.3	4.3	5.8	13.3	1.5	10.8	2.3	4.1	4.1	4.7	6.9	5.4	5.8	8.4	7.1	7.1	7.4	8.1	10.2	7.6	1.4	7.8	4.3	5.2	9.4	4.5	9.8	10.8	14.4	12.3	8.2	6.9	7.2	11.1	9.5	8.7
SETX	"ALS4, AOA2, KIAA0625, SCAR1, Sen1"	ENSG00000107290	Senataxin	Q7Z333	9	132261356-132354985	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Differentiation, DNA damage, DNA recombination, DNA repair, Neurogenesis, Spermatogenesis"	"Helicase, Hydrolase"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024105, HPA057269"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"				Nucleoplasm	"Cytokinetic bridge"	"HPA024105: , HPA057269: "	"unprognostic (2.16e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.32e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.64e-3)"	"unprognostic (6.42e-2)"	20.3	12.3	13.0	23.5	15.0	14.0	16.1	16.7	14.8	14.7	16.0	11.2	14.5	9.9	18.3	15.2	13.2	17.5	12.3	13.8	13.0	8.3	12.5	15.8	18.5	23.5	19.8	12.6	15.8	11.0	24.0	24.6	13.4	16.9	13.8	12.6	8.6	16.2	16.1	18.4	15.2	19.4	16.9	20.6	25.7	13.2	34.5	18.1	26.3	31.6	10.8	24.0	18.8	16.3	8.0	5.5	16.9	5.0	5.3	6.5	2.3	9.2	12.3	14.3	15.4	18.5	22.4	8.6	12.3	13.8	10.0	9.4	13.0	10.5	15.7	6.0	22.8	18.9	14.3	10.6	11.0	14.9	6.2	16.4	13.9	11.2	17.3	25.2	20.0	15.7	16.8	17.0	15.2	16.0	19.0	12.7	11.5	13.3	15.5	9.6	15.3	9.7	14.8	20.8	10.4	11.1	12.1	8.9	13.7	20.2	9.0	11.2	12.4	13.0	18.2	21.0	9.1	14.0	11.7	7.8	13.1	24.4	9.6	10.1	11.2	7.7	4.9	4.8	6.1	4.5	6.5	6.2	4.6	4.6	3.6	8.0	5.0	4.3	16.9	5.3	5.0	5.5	3.4	2.3	13.0	15.0	16.7	14.8	13.0	8.3	19.8	12.6	16.9	18.1
SF1	"ZCCHC25, ZFM1, ZNF162"	ENSG00000168066	"Splicing factor 1"	Q15637	11	64764606-64778786	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018883	Supported		Supported	Nucleoplasm			52000	Nucleoplasm		"HPA018883: AB_1856763"	"unprognostic (1.24e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.35e-1)"	"prognostic unfavourable (4.85e-5)"	"unprognostic (3.72e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.78e-1)"	43.4	36.1	35.7	50.0	37.7	124.4	43.7	61.9	49.0	45.3	41.8	51.8	40.6	38.9	48.2	42.9	39.1	49.2	44.3	39.7	34.3	26.9	38.5	39.3	38.8	54.2	37.8	32.9	66.9	47.2	40.7	43.6	33.7	33.3	47.1	28.1	46.5	47.2	56.4	60.9	47.0	44.8	43.7	28.6	59.6	41.5	65.2	44.6	75.0	45.4	30.9	52.5	39.8	56.1	11.1	12.2	15.9	11.7	9.7	15.5	8.9	35.3	43.1	39.6	34.3	22.2	17.7	46.8	25.4	21.7	34.4	26.6	36.7	40.2	56.8	31.9	28.5	42.3	44.9	44.2	29.5	42.4	30.4	36.4	27.8	27.1	35.4	38.8	37.8	23.2	22.9	43.7	46.0	30.8	53.7	37.1	26.1	37.7	74.7	54.2	53.6	31.5	63.9	27.4	44.4	23.0	39.5	31.3	41.5	35.6	31.5	34.8	47.4	41.4	26.8	38.7	35.1	35.4	40.3	43.3	34.1	52.2	34.2	33.4	46.8	3.7	10.5	11.1	15.5	11.7	15.4	11.1	11.6	14.9	10.7	9.4	13.9	14.1	15.9	9.7	10.1	12.2	11.4	8.9	35.7	37.7	61.9	49.0	34.3	26.9	37.8	32.9	33.3	44.6
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356947	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nuclear speckles"			19000	"Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	32.6	30.2	23.3	37.3	25.6	44.6	35.0	33.6	37.3	29.2	26.4	24.8	27.7	26.1	36.3	23.0	32.2	29.4	30.7	26.2	21.5	16.6	24.9	29.7	28.5	48.2	23.5	26.1	45.7	31.4	44.4	27.2	25.9	19.6	27.2	24.5	29.7	31.8	33.1	45.5	36.3	29.5	27.6	18.7	34.6	29.1	78.4	25.7	50.9	32.9	26.6	34.9	32.7	42.6	13.2	10.6	16.2	13.7	12.1	16.6	8.3	26.1	18.4	25.4	24.6	15.1	13.5	30.3	20.8	13.3	22.6	16.9	24.4	17.5	32.7	14.3	14.7	25.3	32.0	22.1	24.9	29.7	28.1	30.6	22.8	19.9	13.6	61.3	34.1	13.5	15.7	28.6	23.4	16.2	33.8	34.3	16.5	15.0	29.8	13.9	41.9	15.4	42.6	31.8	26.6	12.9	29.1	26.3	24.1	26.4	16.1	24.0	19.7	20.2	22.7	29.1	25.9	20.7	38.3	26.6	32.1	33.1	22.4	22.8	29.9	7.6	9.8	15.0	13.5	11.3	13.7	12.8	13.5	14.4	10.6	13.2	15.3	13.7	16.2	12.1	13.7	6.4	16.6	8.3	23.3	25.6	33.6	37.3	21.5	16.6	23.5	26.1	19.6	25.7
SF3A2	"Prp11, PRPF11, SAP62, SF3a66"	ENSG00000104897	"Splicing factor 3a subunit 2"	Q15428	19	2236504-2248679	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042843, HPA049439"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA042843: AB_2678199, HPA049439: AB_2680766"	"unprognostic (5.29e-2)"	"prognostic favourable (7.16e-4)"	"prognostic unfavourable (8.64e-4)"	"unprognostic (3.09e-3)"	"unprognostic (9.19e-2)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (3.23e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.94e-2)"	"prognostic unfavourable (2.07e-4)"	"unprognostic (4.09e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.73e-2)"	21.1	12.0	12.1	27.1	16.6	35.7	21.3	25.7	22.3	29.2	19.7	20.5	13.2	29.7	32.5	18.2	22.4	23.7	19.5	13.8	10.9	9.0	15.7	13.5	17.4	28.7	13.5	13.1	39.3	25.1	7.5	17.7	24.9	12.1	22.9	7.0	18.4	29.9	21.6	24.8	36.0	26.0	22.8	12.8	27.9	21.0	45.3	14.6	54.2	19.6	20.3	27.0	30.3	24.2	3.4	4.2	9.3	4.3	2.1	5.5	2.8	25.8	11.4	15.7	15.7	4.6	6.9	27.3	9.0	8.3	14.5	13.9	16.6	9.1	28.2	10.6	7.3	20.8	15.3	11.6	3.1	21.6	23.3	18.0	11.3	13.6	12.3	22.5	23.4	9.6	10.4	12.5	9.8	14.2	21.3	26.7	5.3	14.1	29.2	21.8	31.0	9.6	49.4	8.9	24.5	6.2	7.6	19.3	32.0	13.7	10.6	11.5	14.8	25.8	14.0	15.1	16.6	31.3	28.5	29.8	29.4	28.2	11.0	17.5	14.9	1.2	2.9	9.3	5.1	4.3	3.5	2.8	3.9	5.5	2.9	3.4	3.5	3.1	2.9	2.1	2.8	4.2	4.6	2.8	12.1	16.6	25.7	19.6	10.9	9.0	13.5	13.1	12.1	14.6
SF3A3	"PRP9, PRPF9, SAP61, SF3a60"	ENSG00000183431	"Splicing factor 3a subunit 3"	Q12874	1	37956975-37990921	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032054, HPA032055"	Supported		Supported	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"HPA032054: AB_10602184, HPA032055: "	"unprognostic (1.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.08e-3)"	"unprognostic (6.19e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.68e-2)"	"prognostic unfavourable (2.11e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.74e-3)"	"unprognostic (9.18e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.68e-2)"	7.0	6.4	5.3	6.3	5.9	13.6	7.6	7.4	5.5	6.3	6.5			4.3	9.4	8.7	6.8	7.7	4.1	4.3	4.8	4.9	5.9	6.2	6.1	8.4	5.3		8.7	6.7	6.4	5.7	5.6		6.1	7.2		5.9	7.2	15.3	7.7	5.9	7.7	4.3	7.9	6.2	5.8			6.3		10.3	6.2	6.1	23.6	19.0	10.6	20.6	18.7	27.8	20.6	15.7	12.0	21.7	18.5	13.6	12.6	26.3	15.4	14.1	27.0	21.9	19.7	16.7	29.9	13.5	14.9	13.6	27.6	22.4	33.2	13.6	26.9	38.0	19.2	17.0	12.5	46.2	18.4	11.9	15.7	28.0	18.5	18.7	33.4	11.8	19.5	10.5	24.3	26.7	53.6	18.7	29.1	37.3	21.5	12.4	16.4	19.0	14.1	19.7	9.2	16.2	10.9	18.3	16.8	14.2	15.6	13.0	30.5	11.4	16.1	30.5	13.6	42.6	17.6	10.6	15.3	9.8	21.8	18.9	21.2	20.4	25.8	22.0	19.0	23.6	27.8	23.6	2.0	18.7	20.6	11.8	26.3	20.6										
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197389784-197435091	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"			840000	"Nuclear speckles"		"HPA050275: "	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	53.9	49.9	36.5	54.5	44.9	88.0	57.9	60.8	47.3	72.3	54.2	44.3	45.6	36.8	64.6	72.0	50.5	53.3	43.1	39.6	34.7	26.0	49.7	50.7	53.1	65.3	56.5	27.7	73.6	60.5	66.2	81.4	64.6	46.7	50.0	51.0	37.0	54.4	45.4	49.3	48.5	67.8	41.2	50.2	88.1	48.8	33.3	53.5	113.0	53.3	38.0	65.7	62.4	56.0	32.7	41.9	41.1	37.8	39.6	45.9	29.4	30.7	28.2	63.6	34.7	49.3	50.4	53.4	43.0	44.0	37.6	46.1	53.8	33.2	58.7	29.0	43.7	29.8	63.5	34.9	58.8	44.9	39.5	62.1	69.0	63.2	37.2	65.9	45.3	52.6	34.1	39.1	48.2	43.7	44.4	40.5	41.6	27.0	60.6	63.5	50.0	44.6	53.4	54.4	39.0	52.2	78.2	35.7	44.3	41.1	25.2	29.4	24.9	50.5	44.0	29.5	25.4	29.8	30.5	37.0	60.1	84.3	28.3	39.9	32.6	27.7	33.1	39.1	37.5	37.8	40.6	32.7	32.5	35.3	41.9	30.8	33.9	33.9	41.1	39.6	36.1	23.8	45.9	29.4	36.5	44.9	60.8	47.3	34.7	26.0	56.5	27.7	46.7	53.5
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"			57000	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	52.4	42.9	50.1	45.8	61.7	75.7	47.3	57.0	75.7	50.6	46.0	61.7	33.0	42.6	53.0	61.8	45.4	65.0	43.5	47.3	51.2	45.5	51.2	56.8	45.2	55.5	54.8	42.4	74.1	60.5	75.2	63.5	58.9	50.5	50.1	49.1	48.8	42.4	51.4	48.8	50.0	46.8	51.9	44.6	56.7	44.2	86.0	52.9	85.9	60.6	34.5	67.7	47.7	47.1	43.8	39.7	63.3	57.8	43.2	57.9	51.5	52.6	42.5	46.0	43.1	47.8	44.0	38.1	40.1	54.6	62.6	47.2	34.8	45.9	50.4	45.5	47.1	48.9	66.4	46.1	52.6	40.2	34.3	54.3	40.0	56.7	48.4	53.8	41.4	37.5	45.0	63.3	73.3	44.9	50.7	83.7	47.7	71.5	60.7	79.3	47.7	39.7	55.2	39.5	71.5	47.3	43.6	36.7	53.6	40.2	42.4	59.5	53.4	34.1	37.2	51.5	43.9	57.2	45.1	64.4	75.3	64.0	57.0	35.5	46.5	56.9	39.4	63.3	57.9	46.0	55.7	43.1	51.3	54.0	39.7	43.8	50.3	49.6	52.0	43.2	57.8	30.9	50.0	51.5	50.1	61.7	57.0	75.7	51.2	45.5	54.8	42.4	50.5	52.9
SF3B3	"KIAA0017, RSE1, SAP130, SF3b130"	ENSG00000189091	"Splicing factor 3b subunit 3"	Q15393	16	70523788-70577670	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041134, HPA042986"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA041134: , HPA042986: AB_10960386"	"unprognostic (3.39e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.47e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.76e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	23.8	21.1	11.8	22.1	23.2	24.7	22.4	24.9	26.9	23.4	20.6	20.9	15.6	17.1	27.5	13.9	31.8	22.1	15.6	20.1	14.0	12.8	17.0	19.0	18.4	28.5	16.9	15.0	33.3	22.5	34.0	26.8	19.9	16.5	18.4	16.4	20.2	22.6	17.3	30.9	28.9	18.8	20.1	15.4	21.0	17.9	15.5	15.9	47.7	25.1	17.2	31.9	23.7	25.0	23.2	21.4	16.4	18.8	21.0	25.9	19.7	18.4	19.4	25.2	17.6	12.5	11.6	19.0	17.5	15.0	22.9	18.6	19.8	14.8	24.8	14.2	13.7	21.8	26.5	15.0	37.0	8.0	18.6	19.3	15.9	20.9	8.5	27.1	22.8	11.0	10.9	25.5	18.9	13.7	26.3	8.9	18.2	22.8	23.8	13.4	23.1	11.2	42.1	19.6	27.8	7.4	25.5	21.9	16.2	57.1	9.1	8.8	19.6	13.5	14.0	17.0	18.6	13.1	18.4	10.0	21.9	66.5	11.3	17.4	15.8	11.5	15.8	16.4	23.1	18.8	25.4	18.6	21.8	24.2	21.4	23.2	25.9	22.0	5.4	21.0	17.9	12.0	24.0	19.7	11.8	23.2	24.9	26.9	14.0	12.8	16.9	15.0	16.5	15.9
SF3B4	"Hsh49, SAP49, SF3b49"	ENSG00000143368	"Splicing factor 3b subunit 4"	Q15427	1	149923317-149928344	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA028578, HPA064660"	Approved		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA028578: AB_10601601, HPA064660: "	"unprognostic (2.43e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (9.26e-3)"	"unprognostic (2.74e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavourable (1.54e-5)"	"unprognostic (3.11e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.60e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (1.74e-7)"	"unprognostic (9.63e-2)"	"unprognostic (6.54e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.91e-1)"	26.7	26.1	14.0	21.1	26.2	32.8	22.2	18.3	33.5	29.1	31.8	28.6	18.3	21.0	36.7	24.6	31.9	29.2	24.3	15.7	13.8	13.3	28.9	26.3	21.4	22.0	16.1	11.3	45.0	23.2	31.1	20.3	41.1	18.1	27.4	28.0	27.6	24.2	27.0	15.2	30.5	27.5	28.3	13.2	30.6	23.5	43.7	14.8	57.7	30.9	24.6	41.5	27.4	23.3	35.7	36.7	53.9	48.7	43.9	41.9	27.3	31.1	26.1	30.2	22.3	17.7	14.2	33.9	29.5	25.7	39.2	31.7	28.4	24.8	31.3	18.7	31.6	33.2	36.3	31.3	42.7	17.7	20.7	29.9	17.6	22.2	24.7	37.9	36.6	15.9	27.6	38.1	21.9	21.3	22.9	26.2	42.0	82.1	42.2	26.6	43.4	28.3	32.2	27.8	31.4	30.1	30.5	16.9	31.5	26.2	31.9	18.5	47.0	37.7	17.4	33.5	37.1	27.4	46.2	36.5	55.0	37.4	26.8	27.8	30.8	29.0	35.8	53.9	39.0	46.5	40.1	35.7	37.2	41.9	31.1	31.7	35.2	33.1	48.4	43.9	48.7	36.7	41.2	27.3	14.0	26.2	18.3	33.5	13.8	13.3	16.1	11.3	18.1	14.8
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094881-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054408	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054408: "	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	31.0	52.5	32.9	34.0	37.2	76.6	41.7	18.6	35.8	36.9	42.6	23.8	45.3	33.1	34.5	42.6	46.9	47.1	39.8	47.7	32.0	31.1	54.4	84.8	30.3	62.4	32.5	26.0	40.9	100.7	22.3	48.4	31.3	28.0	32.1	40.6	26.5	43.1	60.4	47.4	39.8	40.3	33.2	30.6	38.7	33.9	47.3	24.7	56.7	47.7	63.7	43.4	35.3	30.2	42.7	76.4	38.4	80.7	38.6	48.6	68.5	22.4	30.6	35.1	64.8	41.2	47.0	20.9	23.4	39.5	48.2	55.2	32.3	20.6	37.6	42.1	38.0	26.8	40.3	53.8	34.1	38.7	56.8	41.0	27.3	71.0	39.7	79.7	26.4	47.9	72.7	52.9	52.9	58.3	52.4	54.9	43.1	79.8	51.4	72.0	22.5	37.0	32.2	46.0	38.0	52.3	20.3	48.3	30.5	32.7	40.0	43.5	29.1	49.1	31.4	24.8	33.9	44.4	50.5	41.3	49.8	35.3	40.2	67.1	30.5	30.6	80.7	38.4	38.4	56.1	47.2	42.7	43.6	45.2	68.8	39.1	43.5	43.3	21.6	38.6	49.8	76.4	48.6	68.5	32.9	37.2	18.6	35.8	32.0	31.1	32.5	26.0	28.0	24.7
SF3B6	"CGI-110, Ht006, P14, SAP14a, SF3B14a"	ENSG00000115128	"Splicing factor 3b subunit 6"	Q9Y3B4	2	24067584-24076443	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034829, HPA034830"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA034829: AB_10673104, HPA034830: AB_10669680"	"unprognostic (6.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.35e-3)"	"prognostic unfavourable (5.57e-5)"	"unprognostic (1.74e-2)"	"unprognostic (8.75e-2)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.91e-1)"	39.4	43.5	39.5	31.0	35.9	72.5	57.1	24.2	35.5	43.7	49.7	30.8	34.6	39.5	41.3	58.6	62.9	36.5	35.4	38.8	35.5	31.5	60.3	64.5	33.1	37.1	35.3	29.2	41.5	43.1	26.4	41.4	49.3	30.8	41.8	45.5	27.1	46.4	36.3	40.8	33.4	62.1	46.0	40.4	42.5	35.8	42.2	34.7	56.9	57.1	63.3	47.3	49.6	42.2	54.1	49.9	71.1	45.6	44.0	62.4	47.4	49.1	23.8	38.3	31.8	30.4	47.5	23.6	37.4	40.0	45.2	46.7	50.8	31.2	36.8	21.2	34.4	29.3	39.2	47.0	54.9	36.1	47.1	38.9	30.6	44.1	54.8	48.0	24.3	43.9	56.4	45.9	52.8	45.3	44.0	28.0	47.1	37.1	36.1	72.6	30.8	47.1	26.6	52.6	36.5	53.6	27.7	34.3	51.6	20.9	41.4	82.3	20.2	49.7	27.0	25.0	34.6	26.1	61.2	28.1	36.1	99.6	34.1	80.3	34.3	56.6	43.9	64.9	36.8	45.6	40.5	54.1	46.9	43.9	49.9	40.7	46.4	49.1	71.1	44.0	40.2	45.6	62.4	47.4	39.5	35.9	24.2	35.5	35.5	31.5	35.3	29.2	30.8	34.7
SFN	YWHAS	ENSG00000175793	Stratifin	P31947	1	26863138-26864457	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 256.2;lymphoid tissue: 107.4;skin 1: 123.8;tongue: 256.0"	"Cell line enhanced"	"Detected in many"		"A-431: 68.6;HaCaT: 108.3;HBEC3-KT: 166.7;hTCEpi: 111.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 2526.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.1"	"Low region specificity"	"Detected in some"							"CAB006268, HPA011105, CAB040552, HPA061603"	Enhanced		Supported	Nucleoli,Cytosol	"Secreted in other tissues"		54000000	Cytosol	Nucleoli	"CAB006268: AB_425459, CAB040552: , HPA011105: AB_1844339, HPA061603: "	"unprognostic (5.70e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.92e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (5.68e-5)"	"unprognostic (1.71e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.96e-1)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (7.45e-6)"	"unprognostic (7.90e-3)"	"unprognostic (3.25e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.06e-2)"	0.4	0.0	0.5	3.1	0.5	0.0	3.8	0.4	0.7	37.5	10.7	0.5	0.5	5.9	3.3	0.7	256.2	0.0	6.0	0.3	0.6	0.1	1.2	0.5	8.2	0.3	0.4	0.3	0.3	0.3	0.0	0.3	3.4	0.8	5.9	4.0	0.3	25.5	0.4	0.4	123.8	13.2	0.5	0.7	0.3	6.6	0.4	0.4	3.1	0.4	256.0	107.4	9.1	47.7	0.0	0.0	7.1	0.0	0.0	0.6	0.0	68.6	11.6	0.0	0.1	0.0	0.0	3.4	0.0	0.0	0.0	0.0	4.2	36.2	0.6	3.0	0.0	108.3	0.0	166.7	0.0	16.4	0.5	0.0	11.6	12.2	0.0	0.0	0.1	0.0	111.9	0.0	29.3	0.0	0.1	0.4	0.0	14.6	0.0	0.0	0.2	19.3	0.0	0.0	3.8	25.9	15.8	0.0	0.0	16.6	2.9	0.1	7.7	0.1	0.0	0.0	31.7	0.0	0.4	0.1	0.5	0.3	0.1	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.5	0.5	0.4	0.7	0.6	0.1	0.4	0.3	0.8	0.4
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm			280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favourable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.1	30.2	52.8	29.8	13.0	19.6	49.6	19.8	20.2	33.9	24.8	32.9	26.2	66.1	27.6	22.9	33.1	57.4	38.8	46.3	35.2	38.1	49.7	32.6	39.0	17.6	51.6	29.6	15.6	15.1	29.4	14.3	29.5	56.1	31.6	32.9	31.5	60.4	44.3	62.9	29.3	61.4	35.9	43.0	32.7	44.0	38.1	42.4	28.6	22.3	28.7	26.1	36.8	31.3	27.2	40.0	17.8	42.4	36.2	30.7	67.3	19.4	34.2	38.6	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9
SFSWAP	"SFRS8, SWAP"	ENSG00000061936	"Splicing factor SWAP"	Q12872	12	131711081-131799737	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039362, HPA040063"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA039362: AB_10794089, HPA040063: AB_10795413"	"unprognostic (1.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.39e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.39e-3)"	"unprognostic (7.41e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (1.10e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (3.30e-2)"	"prognostic unfavourable (3.33e-8)"	"unprognostic (7.50e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	20.2	15.0	17.7	23.2	24.0	47.1	17.9	31.1	23.8	16.6	15.7	31.1	11.6	20.4	25.7	15.1	15.7	15.7	16.5	11.9	20.5	15.9	15.7	12.3	16.4	20.7	27.0	17.2	21.4	19.8	19.5	18.0	16.6	16.6	14.7	9.9	16.9	22.1	15.5	27.4	30.0	19.0	17.3	21.1	23.7	18.4	17.5	26.4	21.9	17.1	15.9	16.8	16.7	20.5	6.6	11.0	8.5	6.4	8.4	5.5	2.6	13.7	12.4	8.8	9.3	7.1	5.9	19.8	10.7	7.4	12.7	8.7	12.1	6.7	16.9	10.0	7.9	12.9	12.4	9.8	7.4	5.2	19.5	15.3	6.7	14.1	7.6	19.7	15.2	6.6	11.3	11.4	13.8	7.8	21.2	6.7	5.6	17.2	16.6	30.0	23.0	20.7	19.4	8.9	13.3	7.3	10.1	13.8	15.6	10.1	8.5	12.7	12.3	15.5	10.0	10.5	13.8	8.1	11.8	19.3	21.0	17.1	10.4	13.6	14.0	3.0	6.4	2.6	5.2	4.4	5.0	3.5	4.6	4.2	4.5	6.6	4.9	5.5	8.5	8.4	5.0	11.0	3.8	2.6	17.7	24.0	31.1	23.8	20.5	15.9	27.0	17.2	16.6	26.4
SFTPB	"SFTP3, SP-B"	ENSG00000168878	"Surfactant protein B"	P07988	2	85657314-85668741	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Gaseous exchange"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"lung: 757.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;NB-4: 5.5;U-2197: 11.2;U-266/70: 4.1"	"Group enriched"	"Detected in many"	149	"lung cancer: 1306.7;thyroid cancer: 270.2"	"Region enriched"	"Detected in single"	17	"pons and medulla: 2.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002440, HPA034820, HPA062148"	Enhanced				"Secreted in other tissues"		71000000			"CAB002440: AB_564142, HPA034820: , HPA062148: "	"unprognostic (6.46e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (1.71e-6)"	"unprognostic (2.25e-3)"	"unprognostic (4.57e-3)"	"unprognostic (8.57e-3)"	"unprognostic (6.45e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (2.99e-6)"	"unprognostic (2.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.90e-2)"	"unprognostic (4.38e-2)"	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	757.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	44.1	0.0	0.0	0.0	0.0	1.1	1.4	2.6	4.1	0.8	1.5	1.2	0.2	0.4	0.4	0.8	0.5	0.9	4.8	0.4	0.3	0.1	0.1	0.5	1.0	0.1	0.4	0.1	3.2	0.4	0.1	0.1	0.6	0.4	0.5	1.1	0.4	0.1	0.2	2.4	0.0	0.5	0.3	0.2	0.0	0.4	0.8	0.2	0.5	1.7	5.5	2.6	0.7	2.1	0.4	0.5	0.3	0.5	0.7	0.5	0.1	0.8	0.3	0.6	0.4	0.1	0.3	1.0	11.2	0.2	4.1	0.8	0.3	1.0	0.7	0.2	0.9	2.5	0.8	0.9	4.1	0.7	1.0	1.0	0.8	1.4	1.1	1.4	0.8	2.6	0.8	2.5	0.7	1.5	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0
SGCG	"A4, DAGA4, DMDA, DMDA1, LGMD2C, MAM, MGC130048, SCARMD2, SCG3, TYPE"	ENSG00000102683	"Sarcoglycan gamma"	Q13326	13	23180952-23325165	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 40.9;skeletal muscle: 53.3;tongue: 44.3"	"Cell line enriched"	"Detected in some"	5	"fHDF/TERT166: 37.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA007476	Enhanced									"HPA007476: AB_1079946"	"unprognostic (5.19e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-4)"	"unprognostic (3.00e-3)"	"unprognostic (3.61e-2)"		"unprognostic (8.14e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.49e-1)"	"unprognostic (6.05e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.07e-1)"	8.6	0.1	0.1	0.2	0.1	0.0	2.9	0.2	0.6	0.1	0.4	0.1	0.1	0.0	0.1	3.8	2.6	0.3	0.3	40.9	0.3	0.1	0.1	0.1	1.7	0.1	0.1	0.1	0.1	0.1	1.6	0.1	0.1	0.1	1.2	0.1	0.5	2.1	0.1	53.3	1.3	0.2	0.1	0.1	0.1	0.4	0.6	0.1	0.1	0.7	44.3	3.3	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	37.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	0.1	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.2	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.6	0.3	0.1	0.1	0.1	0.1	0.1
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: "	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.5	7.3	17.6	7.9	2.4	3.9	10.9	17.9	7.5	15.4	15.5	11.2	10.5	10.1	8.3	8.5	11.6	15.5	9.3	26.4	20.3	7.7	19.1	10.5	8.0	0.7	19.9	15.5	1.5	1.1	15.5	8.0	13.6	14.7	15.0	29.1	6.9	16.0	8.2	12.5	18.2	12.7	23.3	9.3	6.4	6.1	10.3	7.1	13.1	6.4	7.8	6.8	11.7	8.2	16.2	16.1	14.8	15.6	6.8	14.2	22.1	10.2	13.4	23.1	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3
SH2D1A	"DSHP, EBVS, IMD5, LYP, MTCP1, SAP, XLP, XLPD"	ENSG00000183918	"SH2 domain containing 1A"	O60880	X	124227868-124373197	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Innate immunity"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 163.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 23.7;Karpas-707: 53.2;MOLT-4: 63.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	53	"gdT-cell: 27.3;MAIT T-cell: 36.5;memory CD4 T-cell: 20.6;memory CD8 T-cell: 40.1;naive CD4 T-cell: 21.0;naive CD8 T-cell: 25.2;NK-cell: 31.7;T-reg: 25.3"	"Group enriched"	"Detected in many"	67	"NK-cells: 31.7;T-cells: 40.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"prognostic favourable (2.03e-4)"	"unprognostic (1.18e-3)"	"unprognostic (4.35e-3)"	"unprognostic (9.66e-5)"	"unprognostic (1.60e-1)"	"unprognostic (1.86e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (4.94e-6)"	"unprognostic (1.27e-1)"	"unprognostic (9.00e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.14e-3)"	2.5	0.5	0.4	5.8	0.6	2.5	1.0	0.2	0.3	0.8	1.0	0.4	0.5	0.6	0.7	0.8	0.9	0.6	2.6	0.6	0.5	0.4	1.1	1.7	4.1	21.3	0.6	0.2	0.6	0.3	0.0	0.4	0.4	0.3	1.0	0.7	0.7	1.9	0.3	0.3	0.4	4.0	0.3	1.0	12.2	1.3	0.4	0.3	163.1	1.3	0.7	10.2	4.2	1.1	0.2	0.1	0.5	0.2	31.7	40.1	17.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	63.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	27.3	0.1	36.5	0.2	20.6	40.1	0.1	0.0	21.0	25.2	0.5	31.7	0.2	0.1	25.3	17.2	0.4	0.6	0.2	0.3	0.5	0.4	0.6	0.2	0.3	0.3
SH3BGRL	MGC117402	ENSG00000131171	"SH3 domain binding glutamate rich protein like"	O75368	X	81201943-81298547	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051248	Approved		Approved	Vesicles			14000000	Vesicles		"HPA051248: "	"unprognostic (3.02e-3)"	"unprognostic (4.25e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavourable (4.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.73e-1)"	46.5	35.9	48.6	32.9	40.4	43.2	51.5	11.7	40.4	60.0	70.4	27.3	43.5	25.0	66.2	45.0	49.3	45.0	43.1	24.2	42.4	46.3	41.4	17.6	37.7	46.3	56.7	29.0	40.1	23.1	29.7	59.8	24.3	40.7	55.6	32.1	27.8	34.8	88.1	9.7	19.1	33.6	77.4	67.1	52.7	41.0	26.7	36.0	46.5	33.4	21.4	34.8	81.7	34.9	31.5	41.1	83.4	71.1	23.2	32.6	51.1	0.1	7.0	25.5	29.2	33.7	45.8	1.7	15.6	29.8	5.7	11.8	2.2	21.5	20.9	13.5	22.8	3.8	18.0	11.2	9.2	17.7	6.3	27.7	11.7	1.3	8.1	19.4	54.5	26.5	8.1	8.1	7.2	25.2	9.5	52.0	31.3	9.4	20.2	25.3	20.0	11.3	18.6	11.6	11.0	29.6	9.6	0.0	11.3	0.0	0.7	14.1	8.5	59.5	25.5	16.0	6.4	14.6	6.4	12.1	10.4	19.2	18.3	39.9	11.8	83.4	49.5	71.9	17.6	63.9	19.0	31.5	22.3	20.7	41.1	26.0	20.7	21.6	17.1	23.2	71.1	19.4	32.6	51.1	48.6	40.4	11.7	40.4	42.4	46.3	56.7	29.0	40.7	36.0
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631283-79703659	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 104.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 37.8;HEL: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 7.4;neutrophil: 2.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm			4700000	Nucleoplasm		"HPA047486: "	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	21.0	3.9	11.6	6.5	10.7	1.1	29.3	9.7	18.3	14.6	24.7	2.6	7.9	17.3	9.1	13.0	29.8	9.3	14.2	7.4	12.3	13.8	8.2	27.6	8.0	4.1	14.6	7.8	3.5	11.6	17.9	12.6	14.4	22.4	13.8	24.1	9.6	104.4	6.4	8.3	7.1	17.3	8.2	13.9	3.8	34.1	3.7	2.4	0.4	38.3	11.1	15.0	8.7	12.6	0.0	0.2	7.4	0.3	0.0	1.2	10.8	3.9	0.7	3.6	0.7	3.2	2.8	8.6	0.2	2.6	0.9	1.9	37.8	7.7	0.0	5.5	0.2	1.8	3.3	4.3	3.2	0.0	4.8	19.2	0.8	7.2	1.4	0.7	0.5	1.5	3.5	2.7	1.6	11.2	7.6	0.0	0.3	0.6	0.0	0.0	3.1	1.3	0.0	1.0	0.1	0.9	12.7	9.8	10.7	0.2	1.1	0.2	0.2	1.6	6.3	2.5	1.6	0.0	2.2	5.7	2.7	0.0	0.4	0.0	0.8	7.4	0.3	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.2	2.7	0.0	0.0	0.2	0.0	10.8	11.6	10.7	9.7	18.3	12.3	13.8	14.6	7.8	22.4	2.4
SH3BGRL3		ENSG00000142669	"SH3 domain binding glutamate rich protein like 3"	Q9H299	1	26279176-26281522	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 309.8"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030848, HPA076219"	Approved		Approved	"Nuclear bodies"			73000000	"Nuclear bodies"		"HPA030848: AB_10602398, HPA076219: AB_2686787"	"unprognostic (4.97e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.73e-3)"	"unprognostic (4.95e-2)"	"unprognostic (8.68e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.16e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.98e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (2.17e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.59e-1)"	"unprognostic (6.35e-2)"	"unprognostic (4.43e-2)"	97.7	26.9	37.3	82.0	37.2	80.9	33.5	11.3	43.2	33.6	65.8	32.3	19.1	31.9	22.9	124.4	84.0	22.9	42.9	31.3	34.6	32.3	36.6	35.1	58.7	98.4	40.5	19.9	26.8	33.6	7.5	22.2	39.9	31.1	23.9	78.2	21.6	36.3	18.3	16.2	51.8	41.3	34.8	32.6	101.4	40.8	13.7	19.3	80.5	26.6	66.0	95.0	41.1	41.5	75.1	184.4	237.0	211.4	68.2	155.1	309.8	28.4	11.0	11.8	15.6	37.3	93.0	1.8	48.8	58.0	43.6	28.8	8.3	25.8	5.9	18.0	91.3	10.6	5.4	46.5	32.9	10.1	4.0	50.3	10.5	8.6	28.4	15.7	86.1	38.4	27.1	45.1	35.9	52.2	5.2	25.3	79.3	12.8	11.0	25.5	13.0	72.5	19.5	13.2	9.1	35.4	9.7	7.1	11.2	17.9	20.0	21.6	3.7	26.3	78.4	62.1	22.3	90.5	23.8	8.0	12.3	5.6	133.1	41.7	30.9	107.5	211.4	188.4	143.1	191.7	106.2	75.1	127.2	140.7	184.4	66.0	55.5	108.8	237.0	68.2	180.6	96.8	155.1	309.8	37.3	37.2	11.3	43.2	34.6	32.3	40.5	19.9	31.1	19.3
SH3BP2	"CRBM, RES4-23"	ENSG00000087266	"SH3 domain binding protein 2"	P78314	4	2793023-2841098	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036790	Approved		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"		"HPA036790: AB_10671712"	"unprognostic (7.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (5.42e-6)"	"prognostic unfavourable (9.52e-4)"	"prognostic favourable (1.57e-5)"	"unprognostic (6.58e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.17e-2)"	"unprognostic (6.41e-3)"	"unprognostic (3.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.78e-2)"	"unprognostic (5.32e-1)"	"unprognostic (1.78e-1)"	"prognostic favourable (2.67e-4)"	17.5	7.0	9.7	20.4	14.5	30.2	13.1	6.1	10.1	9.0	11.6	9.8	7.5	8.9	7.9	18.7	10.8	8.7	9.5	9.9	9.3	8.8	26.3	18.3	20.2	18.5	12.0	3.5	8.8	10.1	3.6	7.6	20.8	15.4	8.4	7.4	11.6	9.3	7.8	11.0	31.2	14.2	8.9	14.5	46.8	10.8	5.0	12.2	5.2	8.0	6.9	17.4	11.6	10.9	4.4	8.6	16.7	21.9	3.8	7.0	5.4	5.2	3.2	3.7	5.1	3.1	7.7	3.5	8.3	6.9	6.5	5.8	2.3	16.3	8.2	9.6	6.9	2.5	0.2	5.5	3.9	4.2	3.3	19.3	6.5	2.7	10.1	7.9	13.7	14.6	5.2	3.7	3.3	14.2	1.1	19.2	7.7	4.2	1.2	9.5	5.9	6.2	0.3	3.3	3.6	11.0	8.2	11.1	8.2	6.1	5.8	4.1	8.8	13.3	17.9	6.3	4.8	2.2	6.2	8.1	3.8	1.7	7.3	21.5	6.7	1.8	10.5	6.7	7.0	18.6	4.4	1.4	1.9	4.6	8.6	4.4	1.0	2.7	16.7	3.8	21.9	3.5	3.5	5.4	9.7	14.5	6.1	10.1	9.3	8.8	12.0	3.5	15.4	12.2
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254853-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: "	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	38.6	72.5	12.7	20.0	13.4	29.9	35.7	34.8	22.3	30.5	12.7	20.7	42.0	7.5	33.9	20.4	11.9	32.2	29.0	9.6	17.2	11.2	19.6	9.9	38.8	25.1	13.0	18.9	49.6	7.1	30.0	14.7	19.5	15.1	13.5	4.9	12.4	22.4	45.1	61.7	10.1	10.3	21.0	19.0	14.8	7.2	17.0	10.8	9.3	20.8	7.7	18.9	25.3	44.3	13.3	4.8	8.0	3.9	13.0	28.9	9.5	7.2	3.6	1.7	3.4	15.7	13.3	92.0	4.0	2.7	2.2	2.7	2.3	3.3	6.1	1.7	10.5	0.9	0.8	3.4	1.9	4.7	3.4	4.1	16.5	0.4	6.0	1.1	2.1	10.6	2.5	10.0	2.1	30.7	4.5	2.0	3.0	26.0	14.4	6.8	3.6	5.5	0.2	8.2	27.5	2.6	12.2	4.1	2.2	5.5	5.0	5.8	4.5	3.0	23.6	5.9	8.2	5.6	3.1	0.8	1.7	4.2	11.2	4.0	7.9	3.5	3.9	4.5	28.9	1.3	9.1	10.9	13.7	19.9	4.8	13.3	7.5	9.8	8.0	13.0	2.1	2.2	5.7	9.5	12.7	13.4	34.8	19.2	17.2	11.2	13.0	18.9	15.1	10.8
SHANK1	"SPANK-1, SSTRIP, synamon"	ENSG00000161681	"SH3 and multiple ankyrin repeat domains 1"	Q9Y566	19	50661827-50719450	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 35.7"	"Cell line enhanced"	"Detected in some"		"REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							"HPA032129, HPA032130"	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"		"HPA032129: AB_10602796, HPA032130: "	"unprognostic (1.62e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.29e-3)"	0.9	2.6	27.9	0.9	10.0	1.2	0.9	13.6	35.7	1.3	0.9	1.1	0.0	0.9	1.3	1.0	0.9	2.2	1.1	0.9	25.6	12.3	0.9	0.8	0.8	0.9	6.0	11.1	0.9	0.9	2.1	2.8	1.0	4.1	1.0	0.8	0.2	0.9	1.0	1.0	1.2	0.9	1.1	2.2	0.9	0.8	1.4	3.5	0.4	0.9	0.0	0.9	0.9	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.5	0.0	1.2	1.2	0.1	0.1	0.0	0.0	0.0	1.9	0.7	0.0	0.2	0.0	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.1	0.1	0.8	1.2	0.1	7.3	0.0	0.7	0.0	0.0	0.0	3.5	0.0	0.0	1.1	0.0	3.1	2.2	4.1	10.4	0.0	0.0	0.0	0.0	0.0	3.9	4.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	27.9	10.0	13.6	23.0	25.6	12.3	6.0	11.1	4.1	3.5
SHANK2	"CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3"	ENSG00000162105	"SH3 and multiple ankyrin repeat domains 2"	Q9UPX8	11	70467856-71252577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.1"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 16.6;MCF7: 9.5;RT4: 15.4;T-47d: 11.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	13	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008174, HPA017220"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Vesicles"				"Nuclear speckles"	"Nucleoplasm, Vesicles"	"HPA008174: AB_1856822, HPA017220: "	"unprognostic (3.08e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.23e-5)"	"unprognostic (1.24e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.42e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.01e-1)"	"prognostic favourable (1.94e-6)"	"unprognostic (3.46e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.03e-2)"	"unprognostic (4.80e-2)"	2.1	1.7	16.8	0.8	22.6	0.0	7.3	6.1	24.1	2.8	3.1	2.3	1.9	2.4	1.8	3.1	5.1	7.9	1.1	0.2	12.2	8.1	7.0	4.7	5.5	0.3	3.6	12.9	0.2	11.3	0.0	7.3	2.7	8.7	4.6	2.8	1.4	12.7	3.3	0.1	1.2	2.0	0.6	1.5	1.5	4.7	1.2	3.7	0.0	8.5	0.0	0.5	2.3	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.4	7.7	4.2	0.0	0.4	0.7	3.1	0.6	0.3	0.0	0.0	8.1	2.9	5.1	1.5	0.0	0.8	0.0	2.9	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	1.7	0.2	1.5	0.0	0.0	0.0	0.0	16.6	1.6	9.5	0.0	0.0	3.3	0.3	0.0	7.6	7.5	3.9	15.4	2.5	1.0	0.0	6.2	0.0	11.8	0.0	0.0	0.1	1.2	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.8	22.6	6.1	24.1	12.2	8.1	3.6	12.9	8.7	3.7
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633383	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 14.2;liver: 51.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;Hep G2: 5.0;HSkMC: 7.5"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 0.4"										"Secreted to blood"		15000000000				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.5	0.9	1.0	0.0	1.3	0.1	0.2	0.4	0.8	0.6	2.7	0.4	0.0	3.5	0.3	0.6	0.2	0.5	0.4	0.9	0.9	0.5	2.3	51.1	0.3	0.1	0.8	0.7	0.5	0.8	0.3	1.4	0.3	1.1	0.3	0.2	1.1	0.3	0.3	0.5	0.0	14.2	0.2	1.1	0.2	0.2	8.0	1.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.2	4.1	3.8	0.6	7.7	3.6	0.2	1.0	1.6	1.7	0.8	1.6	0.6	0.0	0.9	1.4	0.6	0.2	0.3	0.9	0.2	0.6	0.0	1.0	5.0	2.5	0.0	0.1	7.5	0.6	2.9	1.4	0.1	0.4	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.1	0.3	0.5	0.6	0.5	0.2	0.6	3.1	0.0	0.4	0.6	0.0	1.3	0.8	0.0	0.0	0.3	0.6	0.6	0.3	1.9	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.8	0.9	0.5	0.8	0.7	1.1	1.0
SHC3	"N-Shc, NSHC, SHCC"	ENSG00000148082	"SHC adaptor protein 3"	Q92529	9	89005771-89178767	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.1"	"Cell line enhanced"	"Detected in some"		"AF22: 19.0;RT4: 7.0;SH-SY5Y: 7.0;U-87 MG: 10.6"	"Cancer enhanced"	"Detected in some"		"glioma: 5.1"	"Group enriched"	"Detected in many"	4	"amygdala: 15.7;basal ganglia: 20.8;cerebral cortex: 31.5;hippocampal formation: 14.2;olfactory region: 24.7"	"Cell type enriched"	"Detected in single"	14	"naive B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031427, HPA046656, HPA072448"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA031427: , HPA046656: , HPA072448: "	"unprognostic (6.22e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.07e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.72e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.53e-7)"	"unprognostic (8.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.01e-2)"	"unprognostic (9.84e-4)"	1.6	10.8	15.7	0.8	20.8	0.5	1.8	0.8	35.1	7.3	1.2	2.3	0.0	1.1	1.5	1.7	1.5	2.2	2.7	1.0	14.2	4.7	1.4	0.6	6.0	0.8	3.1	24.7	0.7	4.4	10.4	1.0	0.8	5.2	1.5	1.4	0.0	6.4	1.4	0.9	1.8	0.9	1.8	1.5	0.6	0.8	1.0	1.3	0.0	1.3	0.0	0.8	1.7	3.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	19.0	0.0	4.2	1.3	0.0	1.4	3.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.4	0.4	0.2	0.0	2.9	0.0	1.9	0.0	5.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	0.2	0.2	0.0	3.9	4.1	7.0	2.5	7.0	0.5	0.0	0.0	0.0	0.3	2.9	0.7	0.1	1.1	0.1	0.0	0.0	0.0	10.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	20.8	0.8	31.5	14.2	4.7	3.1	24.7	5.2	1.3
SHMT1	"CSHMT, MGC15229, MGC24556, SHMT"	ENSG00000176974	"Serine hydroxymethyltransferase 1"	P34896	17	18327860-18363563	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 57.8;liver: 108.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							HPA023314	Enhanced		Supported	Nucleoplasm,Cytosol			240000	"Nucleoplasm, Cytosol"		"HPA023314: AB_1856830"	"unprognostic (4.76e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.44e-3)"	"prognostic favourable (2.52e-4)"	"unprognostic (7.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.70e-1)"	"prognostic favourable (8.54e-6)"	"unprognostic (1.70e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.57e-3)"	"unprognostic (4.04e-2)"	10.9	3.2	2.2	4.9	4.1	2.1	10.4	6.5	3.0	4.6	15.2	5.3	7.3	12.3	2.8	7.4	16.3	3.9	4.0	2.0	2.6	1.8	57.8	108.3	4.3	3.8	3.5	1.9	4.1	3.5	30.1	1.6	2.8	3.6	3.4	3.5	7.2	9.8	8.0	5.7	6.2	15.1	2.3	2.9	8.6	3.9	6.3	3.8	11.1	10.9	10.8	8.7	4.3	6.3	8.6	6.7	6.2	10.6	13.0	18.7	7.9	23.7	24.1	7.6	12.0	19.5	12.2	28.3	5.0	6.2	16.9	18.7	23.9	10.6	18.5	15.0	4.3	23.5	16.0	20.2	9.6	11.0	23.3	8.3	18.9	18.0	4.9	5.5	9.0	10.1	8.0	13.1	5.9	11.6	7.0	4.2	6.0	17.5	27.4	7.6	9.6	7.9	22.5	30.3	15.7	26.9	16.2	10.5	5.5	34.2	6.5	8.6	26.6	7.8	2.7	3.3	9.8	29.9	15.8	8.6	8.2	7.4	6.4	13.0	7.8	6.0	8.2	6.2	10.1	10.6	17.1	8.6	12.3	12.8	6.7	6.9	12.3	13.0	0.1	13.0	7.5	3.1	18.7	7.9	2.2	4.1	6.5	3.0	2.6	1.8	3.5	1.9	3.6	3.8
SHMT2	SHMT	ENSG00000182199	"Serine hydroxymethyltransferase 2"	P34897	12	57229327-57234935	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 103.1"	"Cell line enhanced"	"Detected in all"		"RH-30: 208.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020543, HPA020549"	Enhanced		Enhanced	Microtubules,Mitochondria			160000	Mitochondria	Microtubules	"HPA020543: AB_1856833, HPA020549: AB_1856834"	"prognostic unfavourable (8.37e-5)"	"unprognostic (1.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (4.84e-8)"	"unprognostic (3.05e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.74e-2)"	13.0	13.5	5.9	15.0	7.1	12.6	9.5	9.6	9.5	10.5	11.5	6.1	5.0	13.4	10.2	8.5	22.1	8.6	10.3	11.0	6.5	5.4	15.5	103.1	11.8	18.7	8.7	4.6	17.9	38.9	4.5	8.1	16.8	6.5	10.3	9.4	7.1	44.6	5.7	16.5	13.7	11.5	9.9	7.6	23.5	13.4	5.4	6.3	26.1	13.2	19.0	25.6	11.2	13.8	33.6	14.5	6.5	11.7	9.7	48.7	12.3	24.6	11.4	11.6	30.6	9.1	14.0	23.0	13.4	21.8	17.9	16.5	16.4	11.9	45.7	22.2	16.5	15.8	20.9	21.7	9.7	25.5	18.6	18.8	7.0	11.6	67.4	31.1	16.7	17.9	31.6	14.4	48.2	17.8	19.7	43.5	13.6	16.2	24.7	17.0	9.9	18.6	16.7	208.3	42.3	9.0	11.4	24.9	11.9	7.0	16.5	48.4	22.4	38.3	11.2	7.3	14.8	9.4	18.1	58.3	31.9	38.8	15.7	29.0	13.0	6.5	9.8	5.9	6.9	11.7	8.0	33.6	12.1	7.4	14.5	32.4	5.3	5.4	0.5	9.7	7.5	4.8	48.7	12.3	5.9	7.1	9.6	9.5	6.5	5.4	8.7	4.6	6.5	6.3
SHOC2	"KIAA0862, SOC-2, SOC2, SUR-8, SUR8"	ENSG00000108061	"SHOC2, leucine rich repeat scaffold protein"	Q9UQ13	10	110919547-111013667	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009164, HPA048134"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA009164: AB_1079960, HPA048134: "	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.76e-2)"	"unprognostic (6.09e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.70e-3)"	"unprognostic (6.97e-3)"	"unprognostic (8.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.67e-1)"	22.9	13.2	22.3	17.2	32.4	31.2	18.0	24.9	25.2	19.3	16.7	8.9	12.1	12.5	17.3	17.4	19.1	14.1	15.8	14.6	19.0	24.8	20.9	18.2	16.8	20.9	22.3	20.1	21.9	15.7	26.5	33.4	17.9	17.7	18.1	17.0	9.8	13.9	14.4	21.7	15.8	24.2	25.0	23.3	23.2	13.9	26.7	17.7	29.4	21.5	9.4	23.3	23.7	17.1	16.4	11.3	34.6	13.7	9.8	9.6	11.2	11.2	7.1	9.1	15.2	20.9	21.4	5.9	13.8	20.7	12.9	15.7	6.4	10.2	24.6	6.9	24.7	9.6	11.0	9.9	18.9	13.4	6.5	11.2	11.0	6.2	15.2	19.0	20.1	23.6	15.7	14.9	28.1	13.0	6.9	17.6	18.3	6.0	9.3	15.3	5.6	7.4	13.4	18.2	6.9	13.6	7.7	4.8	9.5	12.0	6.0	13.5	30.8	16.2	13.1	10.4	9.3	13.1	9.4	16.3	16.6	39.4	12.4	19.7	7.4	20.9	12.0	16.7	7.0	13.7	8.4	16.4	8.3	8.1	11.3	13.0	8.8	8.5	34.6	9.8	13.5	8.1	9.6	11.2	22.3	32.4	24.9	25.2	19.0	24.8	22.3	20.1	17.7	17.7
SHROOM2	APXL	ENSG00000146950	"Shroom family member 2"	Q13796	X	9786456-9949443	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 12.4;RT4: 12.9;WM-115: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"							"HPA051646, HPA061435"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions"	Cytosol	"HPA051646: , HPA061435: "	"unprognostic (8.65e-3)"	"unprognostic (1.36e-3)"	"unprognostic (4.68e-2)"	"unprognostic (4.06e-2)"	"unprognostic (6.99e-3)"	"unprognostic (8.05e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.73e-2)"	"prognostic favourable (1.35e-7)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.67e-3)"	1.3	3.6	6.8	1.3	7.7	0.5	2.5	2.8	17.0	4.7	3.2	3.7	4.6	1.8	3.3	5.8	7.2	3.6	6.3	1.5	7.4	5.5	5.3	7.6	8.1	1.0	5.7	9.1	13.8	7.2	5.5	6.1	14.3	5.8	10.6	3.0	3.6	6.0	5.8	0.7	7.9	1.4	2.1	7.9	1.7	2.6	5.8	2.5	1.8	3.1	3.4	3.4	6.4	4.3	0.0	0.9	1.1	0.0	0.0	0.2	0.0	4.0	0.5	7.6	1.0	0.4	1.2	4.3	0.4	1.3	1.6	2.7	5.0	0.0	0.0	1.4	1.0	3.3	3.9	10.8	1.9	0.0	2.9	0.0	0.0	0.8	2.5	0.0	5.2	0.2	7.5	12.4	0.5	9.3	0.0	0.0	2.6	4.3	0.0	0.0	6.6	0.0	0.0	8.3	0.0	7.0	12.9	1.1	0.6	0.3	0.1	12.0	4.4	0.2	4.3	12.1	1.5	0.0	0.4	0.0	0.0	0.0	7.9	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	6.8	7.7	2.8	17.0	7.4	5.5	5.7	9.1	5.8	2.5
SHROOM3	"APXL3, KIAA1481, SHRM, ShrmL"	ENSG00000138771	"Shroom family member 3"	Q8TF72	4	76435100-76783253	"Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 47.0"	"Cell line enhanced"	"Detected in many"		"A-431: 19.4;AF22: 19.1;BJ hTERT+: 18.2;EFO-21: 20.2;fHDF/TERT166: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047784	Enhanced									"HPA047784: "	"unprognostic (1.96e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.57e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.64e-13)"	"unprognostic (2.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.87e-2)"	1.0	1.5	3.3	3.0	4.5	0.0	9.0	7.4	6.4	3.9	11.3	2.3	4.9	8.5	2.5	21.2	18.2	9.1	16.7	2.6	5.6	1.1	5.9	6.2	6.3	0.3	5.5	2.5	0.8	4.6	11.1	4.4	2.1	6.8	6.3	10.0	9.4	47.0	4.7	0.3	3.0	12.1	5.3	6.6	6.8	12.7	0.6	1.2	0.6	2.8	14.6	14.8	4.7	2.4	0.2	0.1	1.0	0.0	0.1	0.1	0.0	19.4	3.8	19.1	12.5	0.0	0.3	0.7	6.1	18.2	0.4	0.8	3.3	13.0	0.3	20.2	16.9	10.0	2.5	8.7	0.3	0.0	3.3	0.0	3.7	0.0	0.1	0.0	0.0	0.1	2.2	0.7	3.4	0.3	0.0	4.7	0.4	1.7	0.3	0.0	8.0	2.3	1.7	3.2	3.0	3.0	0.4	7.5	10.0	2.5	14.0	1.0	3.4	0.1	0.0	3.3	2.8	0.1	2.6	6.0	6.2	0.0	0.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.1	0.0	0.0	3.3	4.5	7.4	6.4	5.6	1.1	5.5	2.5	6.8	1.2
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase, Multifunctional enzyme"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 4.0;HeLa: 3.1;NB-4: 3.3;RPMI-8226: 4.8;SH-SY5Y: 2.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011897	Enhanced									"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.4	7.6	16.6	14.9	14.3	12.5	17.0	7.9	10.8	11.8	5.8	5.8	11.1	11.0	8.8	10.0	9.9	11.4	11.6	14.6	4.4	9.2	5.9	6.0	15.1	20.0	5.8	9.1	15.0	20.9	6.9	16.1	9.9	9.5	10.5	9.6	5.8	15.6	11.9	20.2	11.8	18.2	25.0	11.6	11.0	10.7	18.9	16.8	23.6	11.8	20.3	7.5	13.4	10.5	12.7	11.4	6.8	8.4	13.7	5.7	20.2	9.4	7.2	11.4	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: "	"prognostic favourable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.6	4.1	3.2	6.4	11.1	8.4	13.1	6.9	8.0	8.4	10.3	8.4	7.5	9.3	10.2	7.2	10.3	8.7	6.2	7.9	7.8	6.2	18.2	5.0	27.9	15.9	10.0	5.4	7.6	14.5	5.0	11.5	6.5	4.5	36.7	5.3	20.0	18.3	5.1	10.5	8.2	13.5	7.0	33.3	5.3	5.8	12.5	5.9	5.2	4.9	12.3	32.9	15.1	4.5	5.8	5.2	12.6	9.3	43.7	16.6	13.0	5.5	14.5	2.9	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6
SIGLEC11		ENSG00000161640	"Sialic acid binding Ig like lectin 11"	Q96RL6	19	49948985-49961172	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"lymphoid tissue: 11.3;ovary: 36.6"	"Cell line enriched"	"Detected in some"	15	"HEL: 15.0"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA052132, HPA060278"	Approved		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA052132: , HPA060278: "	"unprognostic (1.07e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.93e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.79e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.95e-3)"	"unprognostic (5.38e-2)"	0.4	3.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.1		36.6	1.1	0.0	0.0	0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.3	0.3	0.1	11.3	1.8	0.5			0.0		0.0	0.3	0.0	0.6	0.5	2.6	3.3	0.8	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.5	0.2	15.0	0.2	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.4	0.2	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.0	0.2	0.2	0.5	1.0	2.6	0.1	3.3	0.1	0.5	0.2	0.1	0.5	0.6	0.1	0.2	1.4	0.8	3.3	0.3	0.0	0.3										
SIGLEC14		ENSG00000254415	"Sialic acid binding Ig like lectin 14"	Q08ET2	19	51642553-51646801	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 46.4"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	6	"classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7"									HPA014377	Uncertain						18000000			"HPA014377: AB_2189277"	"unprognostic (3.05e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.77e-3)"	"unprognostic (9.28e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.28e-3)"	"unprognostic (8.38e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.89e-1)"	1.6	1.6	0.6	13.0	0.5	13.3	0.5	0.0	0.3	0.6	0.6			0.0	0.4	0.0	0.2	1.7	1.0	0.8	0.6	0.6	0.4	1.4	5.1	6.2	1.3		0.1	0.3	0.0	0.1	0.9		0.4	0.4		0.7	0.1	0.0	0.0	4.0	0.9	1.9	21.6	0.7	1.3			0.2		7.0	2.2	0.2	4.9	15.9	48.7	29.7	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.7	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	3.6	25.8	0.4	0.0	29.7	0.0	4.9	0.0	0.0	15.9	4.8	0.0	0.0	48.7	0.1	21.3	2.9	0.0	7.6										
SIGLEC8	"MGC59785, SAF2, SIGLEC-8, SIGLEC8L"	ENSG00000105366	"Sialic acid binding Ig like lectin 8"	Q9NYZ4	19	51450847-51458456	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 63.0"	"Cell line enriched"	"Detected in some"	45	"HMC-1: 57.4"	"Cancer enhanced"	"Detected in many"		"glioma: 7.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	42	"eosinophil: 63.0"	"Lineage enriched"	"Detected in single"	623	"granulocytes: 63.0"									HPA012556	Uncertain		Uncertain	Cytosol				Cytosol		"HPA012556: AB_1856869"	"unprognostic (1.27e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.28e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.84e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.19e-1)"	"unprognostic (8.62e-3)"	"unprognostic (7.18e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.28e-3)"	"unprognostic (3.29e-1)"	0.6	6.7	5.8	2.4	8.4	0.7	2.3	0.7	7.0	1.4	2.9	7.4	0.0	2.9	1.0	1.1	1.1	1.1	2.7	0.3	8.6	4.8	0.4	1.6	4.1	9.6	8.3	3.6	0.3	0.7	0.7	1.2	0.1	7.5	1.0	2.8	0.1	1.1	0.9	0.3	0.8	4.5	1.5	14.8	9.2	2.1	0.5	6.2	0.6	0.7	0.0	4.1	2.0	0.7	0.0	0.0	63.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	57.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.5	0.1	63.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.8	8.4	0.7	5.6	8.6	4.8	8.3	3.6	7.5	6.2
SIK1	"msk, SNF1LK"	ENSG00000142178	"Salt inducible kinase 1"	P57059	21	43414483-43427189	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Cell cycle, Differentiation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skin 1: 34.5"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 16.7;HeLa: 27.8;hTCEpi: 21.5;LHCN-M2: 21.6;U-266/84: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.0;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	10	"B-cells: 2.0;dendritic cells: 1.6"									"CAB023801, HPA038211, HPA078064"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB023801: , HPA038211: , HPA078064: "	"unprognostic (4.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.35e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.82e-1)"	8.8	2.3	3.0	3.6	3.0	5.9	7.5	3.0	3.0	13.5	3.0	3.0	3.0	0.0	3.0	3.0	12.9	5.5	10.7	7.1	3.0	0.8	3.0	12.3	5.4	3.0	3.0	3.0	13.7	7.3	3.5	5.7	8.2	3.0	3.9	0.1	3.0	4.6	9.8	5.0	34.5	3.0	3.3	3.0	4.0	5.3	3.0	3.0	3.0	3.9	3.0	3.0	10.5	6.1	2.0	1.6	0.0	0.1	0.0	0.1	0.1	0.5	1.7	2.0	0.0	0.1	0.8	0.7	0.9	0.3	1.6	1.3	2.4	0.0	2.4	0.7	0.2	11.1	1.6	16.7	1.0	0.1	0.5	0.7	27.8	0.9	2.3	0.7	0.1	1.0	21.5	0.4	5.1	0.3	0.1	0.5	21.6	0.1	0.4	1.7	0.8	1.5	0.0	0.3	2.5	1.9	6.3	0.0	0.0	10.9	1.8	0.4	1.1	0.3	3.7	0.4	2.0	0.1	0.0	4.3	15.7	0.4	4.6	2.0	0.4	0.0	0.1	0.0	0.1	0.0	0.1	2.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	3.0	3.0	3.0	3.0	3.0	0.8	3.0	3.0	3.0	3.0
SIM1	bHLHe14	ENSG00000112246	"Single-minded family bHLH transcription factor 1"	P81133	6	100385015-100464929	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 13.2;kidney: 21.6;seminal vesicle: 17.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 7.8;BJ: 12.5;BJ hTERT+: 18.3;RPTEC TERT1: 14.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Region enriched"	"Detected in single"	21	"hypothalamus: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"hypothalamus: 6.1"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.6;hypothalamus: 5.2"	HPA024385			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favourable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			5.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	13.2	0.0	0.0	8.1	0.0	0.1	0.0	0.0	0.0	2.2	21.6	0.5	0.0	0.0	0.1	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	17.5	4.7	0.8	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	7.8	0.0	12.5	18.3	5.6	5.2	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	4.8	5.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	21.0	15.4	14.0	19.4	18.5	31.6	20.4	26.3	15.5	26.3	20.2	19.9	15.3	11.8	26.6	16.8	17.7	22.1	15.9	13.4	14.2	11.8	13.6	13.9	17.4	20.7	13.0	14.2	27.6	19.8	23.4	16.8	17.2	13.0	22.9	14.3	23.0	17.6	20.5	18.2	23.5	17.9	24.5	12.8	20.3	16.8	28.5	15.1	48.7	24.0	12.8	26.9	26.0	19.0	9.8	6.5	9.3	8.3	9.7	12.7	6.3	12.7	26.4	23.6	15.5	11.8	12.5	13.7	9.6	14.9	14.1	15.2	14.6	17.3	27.8	10.0	14.1	22.8	34.2	14.4	15.5	22.4	17.7	26.2	20.1	11.4	8.9	24.8	22.4	15.1	11.1	16.4	17.2	12.6	20.6	31.0	11.4	14.8	24.3	15.9	23.0	11.1	24.6	31.3	17.1	10.1	23.4	18.7	18.7	23.6	10.6	13.2	16.1	19.7	11.0	17.5	23.7	11.5	14.1	21.3	33.4	29.5	10.4	25.4	9.7	3.3	4.8	6.9	8.5	4.8	12.7	9.3	10.8	10.7	6.5	9.8	11.1	9.5	9.3	9.7	8.3	4.4	9.5	6.3	14.0	18.5	26.3	15.5	14.2	11.8	13.0	14.2	13.0	15.1
SIPA1L2	KIAA1389	ENSG00000116991	"Signal induced proliferation associated 1 like 2"	Q9P2F8	1	232397965-232561558	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 33.4;NTERA-2: 26.7;WM-115: 22.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024181, HPA027224"	Approved		Approved	"Nuclear membrane,Nuclear bodies,Golgi apparatus"				"Nuclear bodies"	"Nuclear membrane, Golgi apparatus"	"HPA024181: AB_1856886, HPA027224: "	"unprognostic (2.34e-2)"	"unprognostic (9.67e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.98e-1)"	"unprognostic (5.68e-2)"	"unprognostic (5.57e-3)"	"unprognostic (7.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (8.15e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.75e-1)"	"unprognostic (5.84e-3)"	"unprognostic (3.45e-3)"	4.1	1.1	3.6	2.9	3.3	2.1	3.4	0.3	7.6	3.2	8.9			1.6	1.9	1.0	8.7	1.2	4.4	16.2	3.1	3.9	1.6	2.4	6.5	0.8	6.5		6.7	1.4	3.9	3.2	10.0		2.9	10.5		3.3	2.3	2.5	3.3	3.3	3.7	3.0	4.5	2.0	3.4			3.4		1.1	4.7	5.7	0.0	1.2	4.3	1.2	2.0	2.4	0.2	0.0	3.6	33.4	0.2	0.2	0.0	14.5	0.6	1.2	1.5	1.1	1.4	0.0	2.8	6.7	12.6	0.8	6.8	1.0	1.4	0.0	6.3	0.0	3.2	0.0	3.1	0.4	3.6	1.9	4.7	0.3	3.0	7.7	0.0	0.0	0.7	1.5	3.5	0.3	26.7	5.4	0.0	0.0	1.7	4.2	5.2	1.8	5.8	11.1	0.3	4.5	0.7	0.4	2.7	4.0	0.0	8.6	1.3	3.1	0.0	0.0	4.9	3.0	22.6	0.0	0.6	0.0	0.2	1.2	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	4.3	2.0	0.9	1.2	0.0	0.2										
SIRPA	"BIT, CD172a, MFR, MYD-1, P84, PTPNS1, SHPS-1, SHPS1, SIRP, SIRP-ALPHA-1, SIRPalpha, SIRPalpha2"	ENSG00000198053	"Signal regulatory protein alpha"	P78324	20	1894167-1940592	"CD markers, Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.2"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 42.3;RPTEC TERT1: 30.7;SK-MEL-30: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.1;eosinophil: 20.9;myeloid DC: 6.3;neutrophil: 23.5"	"Group enriched"	"Detected in many"	134	"dendritic cells: 6.3;granulocytes: 23.5;monocytes: 10.1"									"CAB002776, CAB015122, HPA054437, HPA058511"	Enhanced						170000000			"CAB002776: , CAB015122: AB_677430, HPA054437: AB_2682488, HPA058511: AB_2683738"	"unprognostic (9.78e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.19e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.84e-3)"	"unprognostic (3.69e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.79e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.24e-2)"	23.2	21.7	36.9	24.9	38.8	19.9	14.0	39.1	69.2	9.5	6.7	22.8	3.0	14.1	6.4	11.2	7.2	9.1	14.6	11.9	29.3	18.5	9.6	16.1	22.0	10.3	18.8	50.3	9.7	6.1	2.2	5.5	13.8	14.7	4.9	8.2	9.5	15.0	8.9	5.5	13.6	11.7	11.4	18.0	9.6	5.2	3.9	20.4	1.0	4.1	2.2	8.8	13.2	6.9	0.0	6.3	23.5	10.1	0.0	0.0	3.4	3.4	7.5	3.8	7.0	9.1	8.6	0.5	18.1	15.4	4.9	1.5	4.7	0.1	0.0	4.4	42.3	3.4	3.0	21.0	2.0	0.0	2.1	0.0	0.9	2.6	11.1	7.0	8.7	7.7	9.9	4.2	5.1	15.3	0.4	4.7	6.6	0.2	0.0	9.8	4.2	3.4	0.0	6.7	4.7	30.7	0.0	0.5	1.1	2.4	0.0	35.6	1.2	22.6	22.8	21.9	11.4	14.1	8.9	0.0	0.0	0.0	6.8	22.7	2.4	0.1	10.1	20.9	0.0	2.7	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	23.5	0.0	1.0	0.4	0.0	3.4	36.9	38.8	39.1	68.6	29.3	18.5	18.8	50.3	14.7	20.4
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1563521-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 137.6"	"Group enriched"	"Detected in some"	4	"HMC-1: 24.7;NB-4: 32.8;THP-1: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 137.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 137.6;monocytes: 43.6"									HPA047463	Uncertain		Uncertain	Vesicles			33000000	Vesicles		"HPA047463: "	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	23.7	1.8	2.3	18.7	5.4	31.9	1.8	2.7	3.2	1.1	1.4	1.9	0.1	1.0	1.0	0.5	0.9	2.5	7.6	7.2	2.3	1.6	1.5	7.5	19.4	19.5	6.6	0.7	1.9	0.9	0.1	1.5	3.8	3.7	1.2	1.2	1.7	1.8	0.6	0.9	0.9	2.6	2.1	7.2	28.7	1.2	1.2	3.9	2.5	0.9	0.4	2.9	4.1	1.9	0.2	15.2	137.6	43.6	0.7	1.0	19.2	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	24.7	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.0	32.8	0.1	1.5	0.0	0.0	0.0	4.9	0.1	0.0	0.1	0.1	0.0	0.2	0.0	25.4	0.7	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.5	6.0	0.1	0.5	43.6	72.5	0.6	36.3	0.9	0.2	0.6	0.5	15.2	0.2	0.8	0.5	137.6	0.7	29.5	14.5	1.0	19.2	2.3	5.4	2.7	3.2	2.3	1.6	6.6	0.7	3.7	3.9
SKI		ENSG00000157933	"SKI proto-oncogene"	P12755	1	2228695-2310119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Craniosynostosis, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 34.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010449, HPA066567"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB010449: AB_2187342, HPA066567: "	"unprognostic (3.99e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.66e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.69e-2)"	"unprognostic (5.24e-3)"	12.5	4.7	11.8	7.1	22.5	4.8	8.1	34.5	21.2	9.8	8.2	5.5	3.1	4.6	11.9	4.4	5.9	9.1	8.0	9.0	11.0	4.1	4.4	6.1	11.1	6.9	6.2	10.1	10.4	9.6	4.2	6.2	7.4	8.5	8.4	3.5	4.0	12.0	11.9	6.8	11.7	5.9	9.3	5.3	9.3	6.0	7.2	5.3	3.6	6.9	8.1	5.1	7.6	7.8	0.8	0.3	3.0	0.6	1.3	0.6	0.4	10.3	6.0	14.6	14.2	24.4	14.7	9.6	15.6	8.7	9.7	7.2	9.1	8.1	6.6	11.7	20.0	12.3	8.1	12.6	9.0	7.2	17.7	16.6	9.1	12.8	16.3	9.3	17.8	15.7	7.0	14.6	11.0	11.9	9.3	5.1	11.9	6.6	1.1	10.3	14.7	11.7	5.1	9.2	5.4	8.3	4.1	21.0	13.7	15.2	13.6	15.1	4.6	12.0	21.5	16.8	10.5	23.6	12.1	4.0	2.8	6.1	8.9	16.2	6.8	0.6	0.5	0.3	0.5	0.6	0.5	0.3	0.4	0.5	0.3	0.8	0.6	0.5	3.0	1.3	0.3	0.1	0.4	0.4	11.8	22.5	34.5	21.2	11.0	4.1	6.2	10.1	8.5	5.3
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959080-31969755	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA051959, HPA054419"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavourable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	14.5	32.8	12.4	19.4	15.2	19.0	11.3	15.4	20.2	11.6	12.6	16.0	10.6	36.7	12.5	37.4	14.8	11.7	10.3	12.3	10.7	8.2	12.6	27.8	17.9	13.9	12.3	10.1	13.6	13.1	3.8	21.6	11.3	12.7	17.2	11.1	14.6	11.5	14.3	17.1	14.3	15.7	17.8	10.6	21.7	22.7	10.7	13.7	17.4	14.9	7.5	15.0	13.6	10.7	2.2	2.3	1.1	4.3	0.4	3.2	1.2	0.3	8.0	7.1	0.6	2.1	4.0	8.2	5.7	3.4	4.3	7.5	0.4	0.1	0.3	12.4	8.5	5.7	0.0	9.9	3.5	8.2	15.7	0.0	0.5	0.7	0.0	0.3	0.4	10.1	8.7	0.1	0.1	0.0	0.1	7.1	0.0	0.5	0.5	0.7	10.0	0.1	1.1	0.1	0.5	2.2	0.1	0.3	0.4	9.2	0.1	4.9	0.4	7.7	6.6	8.5	2.9	10.2	0.2	15.8	19.0	3.4	12.2	0.4	0.3	1.0	1.3	0.3	2.4	4.3	1.6	1.5	2.2	1.6	2.3	2.2	3.2	2.6	1.1	0.4	2.9	0.6	0.2	1.2	12.4	15.2	15.4	20.2	10.7	8.2	12.3	10.1	12.7	13.7
SLA2	"C20orf156, FLJ21992, SLAP-2"	ENSG00000101082	"Src like adaptor 2"	Q9H6Q3	20	36612318-36646216	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.7;lymphoid tissue: 36.5"	"Cell line enriched"	"Detected in some"	8	"HEL: 43.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdT-cell: 13.9;MAIT T-cell: 11.7;memory CD4 T-cell: 11.5;memory CD8 T-cell: 12.9;naive CD4 T-cell: 10.8;naive CD8 T-cell: 14.5;NK-cell: 16.5;plasmacytoid DC: 21.7;T-reg: 14.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 21.7;NK-cells: 16.5;T-cells: 14.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA053746, HPA058217"			Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA053746: , HPA058217: "	"unprognostic (4.16e-3)"	"prognostic favourable (7.36e-4)"	"unprognostic (4.52e-4)"	"unprognostic (2.30e-6)"	"unprognostic (3.37e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (6.77e-8)"	"unprognostic (8.48e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.45e-3)"	2.3	0.8	0.7	15.1	0.8	11.3	1.3	1.5	0.5	1.5	3.9	0.2	2.3	2.8	2.0	1.1	1.7	1.4	4.8	1.6	0.7	0.7	1.5	1.9	6.9	17.1	0.7	0.0	1.6	0.8	0.0	1.1	1.6	0.8	1.5	1.8	1.8	6.3	0.4	0.9	0.7	7.5	1.5	1.1	15.9	2.5	1.0	0.3	36.5	1.5	1.1	18.4	3.8	1.3	0.2	21.7	2.3	0.3	16.5	14.9	11.6	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.2	1.7	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	5.1	3.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.6	0.0	0.8	0.2	1.6	13.9	0.3	11.7	0.2	11.5	12.9	0.1	0.1	10.8	14.5	2.3	16.5	0.0	21.7	14.9	11.6	0.7	0.8	1.5	0.5	0.7	0.7	0.7	0.0	0.8	0.3
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 88.6"	"Group enriched"	"Detected in some"	12	"BEWO: 10.1;HAP1: 5.6;HeLa: 11.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA028748	Enhanced									"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	88.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	14.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050376-1112035	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041652	Approved		Uncertain	Cytosol				Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavourable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favourable (3.16e-5)"	10.1	6.4	5.7	14.1	7.3	4.3	13.0	2.4	8.3	6.5	11.5	5.6	6.6	28.0	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10.0	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7.0	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	5.9	3.3	10.2	0.5	0.5	5.1	0.1	0.7	0.4	0.0	14.1	3.7	0.0	11.6	0.1	4.4	2.7	3.5	0.0	12.8	3.5	2.7	7.4	4.9	7.4	0.0	6.2	1.1	0.5	0.0	1.1	3.2	3.9	0.1	0.0	6.8	8.2	0.0	7.0	9.4	24.9	14.2	11.6	3.9	8.5	1.8	2.2	3.1	0.0	3.5	5.7	1.6	2.7	0.0	3.4	0.0	0.0	0.2	0.0	1.4	0.0	0.3	1.7	0.5	3.4	0.0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0.0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683686	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;kidney: 5.7"	"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.0"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	4	"basal ganglia: 17.9"	"Low region specificity"	"Detected in many"														"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.8	1.0	0.0	0.1	0.4	0.6	0.9	0.0	0.7	0.1	0.0			0.3	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	5.7	0.0	0.2	0.1	0.0		0.1	0.0	0.3	0.1	0.0		0.2	0.0		0.2	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.1	1.3			1.0		0.0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.3	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.4	0.3	0.7	0.2	0.1	0.3	0.0	0.0	0.1	0.4	0.2	0.4	0.6	0.0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.2	0.3	0.6	0.0	0.3	0.4	0.5	0.3	0.4	0.3	0.1	0.7	0.1	0.4	0.5	0.1	0.2	0.1	0.1	0.1	0.3	0.3	0.4	0.3	1.0	0.4	7.0	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1										
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell line enhanced"	"Detected in many"		"BJ: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"				"Plasma membrane"		"HPA072719: "	"prognostic unfavourable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavourable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavourable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.3	4.1	3.0	16.9	8.1	4.2	0.0	35.2	10.9	14.3	8.2	0.0	0.3	0.0	0.5	13.6	0.6	0.4	14.9	8.4	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.3	3.6	7.4	8.7	0.0	0.0	0.0	3.3	0.0	0.2	1.0	11.2	3.1	6.7	8.1	0.0	7.0	0.0	0.7	5.3	3.9	19.7	0.1	0.2	0.4	0.0	13.9	3.7	15.2	17.4	0.0	0.0	0.0	15.3	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.5"	"Cell line enriched"	"Detected in some"	13	"SK-MEL-30: 104.5"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles				Vesicles		"HPA054459: , HPA066328: "	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	7.8	3.4	3.0	6.6	6.3	8.1	6.2	3.7	6.2	2.2	0.8	3.1	9.8	0.9	2.8	32.5	12.4	1.5	1.6	1.4	3.2	4.2	0.9	1.4	9.7	4.6	4.7	1.4	1.8	1.2	0.4	2.4	2.4	6.9	0.8	1.0	13.0	3.5	11.0	10.3	4.2	1.2	0.9	2.7	6.3	1.1	2.2	0.9	1.5	3.3	6.6	7.9	3.7	3.3	0.6	2.7	8.5	4.7	1.1	2.9	1.2	0.4	0.3	0.1	0.1	0.1	0.1	3.0	0.1	3.8	0.3	0.2	0.1	0.5	3.4	0.3	0.0	0.1	0.5	0.0	0.1	1.0	0.2	0.2	0.4	4.4	0.6	1.1	0.2	0.1	0.0	0.2	0.2	0.1	0.2	0.7	0.0	3.8	1.6	0.7	0.0	0.1	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.1	2.0	104.5	3.0	0.7	0.5	1.2	0.2	0.1	0.3	0.8	3.0	3.2	7.9	0.9	0.5	1.1	4.7	0.3	2.9	4.4	1.5	0.6	1.2	2.3	2.7	0.3	0.8	1.6	8.5	1.1	2.2	0.6	2.6	1.2	3.0	6.3	3.7	6.2	3.2	4.2	4.7	1.4	6.9	0.9
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.9;SiHa: 6.4;T-47d: 7.7;U-266/70: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"				"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: "	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.3	0.7	1.1	0.2	0.0	0.0	5.9	0.5	0.0	0.0	0.0	1.2	3.5	0.4	1.7	0.0	0.8	0.0	0.0	0.0	0.0	1.8	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	3.9	0.0	0.0	1.4	0.1	2.0	0.0	0.0	0.0	4.4	1.9	0.3	6.4	0.3	0.9	7.7	0.2	0.0	0.0	3.5	0.3	0.0	11.3	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;CACO-2: 34.1;HaCaT: 25.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria				Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.2	1.8	2.1	5.9	13.5	0.0	0.0	0.8	1.8	34.1	1.7	0.0	10.3	0.3	25.8	6.2	2.8	0.9	0.3	12.7	0.0	0.1	0.0	0.4	0.4	0.1	10.9	12.8	5.2	2.1	0.0	0.0	0.1	3.6	0.0	0.0	0.0	2.5	2.1	0.0	0.1	0.0	0.0	1.3	1.8	0.0	2.1	6.2	0.3	0.0	1.0	0.0	1.9	3.1	0.0	7.5	0.0	0.0	0.0	8.6	14.3	4.8	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 71.3;U-266/70: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome				Centrosome		"HPA034963: , HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.6	2.8	1.6	8.6	3.7	2.4	2.3	7.0	3.4	2.9	5.0	0.7	0.5	12.0	1.6	10.9	10.6	3.3	0.8	3.0	4.8	1.3	6.2	3.4	7.3	7.9	10.4	5.8	1.1	18.4	3.9	6.1	1.8	4.8	30.3	2.0	3.2	8.8	6.9	1.1	3.4	3.2	0.4	29.7	1.2	1.8	7.3	3.5	4.3	4.0	71.3	4.7	11.5	0.4	4.0	4.8	7.8	4.2	33.3	16.4	29.1	5.9	20.9	21.2	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 34.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 34.6;monocytes: 22.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavourable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	39.3	5.7	3.4	16.0	5.4	16.2	45.0	0.9	3.0	20.7	15.8	5.0	50.4	4.9	14.3	33.7	33.9	18.1	31.2	10.0	4.5	2.2	23.7	4.1	23.4	17.7	8.2	0.9	33.3	24.6	0.2	9.1	25.8	4.9	35.2	13.8	5.2	99.0	55.7	6.9	18.6	12.1	23.1	5.3	19.8	17.9	21.7	6.1	14.9	6.5	28.4	25.9	48.3	44.9	7.0	34.6	0.9	22.4	6.9	5.6	7.4	24.2	44.9	10.8	16.3	28.2	24.0	25.6	34.7	39.7	26.1	37.9	40.7	27.5	26.6	17.0	86.1	39.2	31.5	41.2	19.5	17.6	28.5	44.2	17.2	38.1	73.0	30.7	26.1	39.0	103.2	30.6	77.6	13.8	46.6	70.6	13.9	41.3	14.0	82.7	18.9	19.8	16.0	12.2	37.9	14.6	53.1	16.7	12.2	17.1	46.8	37.2	26.9	40.6	10.3	15.7	25.1	12.2	28.2	43.8	42.3	22.2	29.5	38.4	38.4	0.0	11.5	0.9	5.3	19.9	4.4	7.0	3.1	3.7	17.8	2.5	0.7	2.3	0.3	6.9	22.4	34.6	5.6	7.4	3.4	5.4	0.9	3.0	4.5	2.2	8.2	0.9	4.9	6.1
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA026076	Enhanced									"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940251	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved						17000			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favourable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favourable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	11.8	17.5	17.8	11.9	20.8	10.3	11.7	18.2	34.3	11.1	15.7	16.3	10.3	17.3	12.4	10.1	18.9	16.1	14.3	82.1	19.8	17.7	24.2	22.6	10.6	13.3	19.5	16.3	12.1	15.3	16.0	12.3	13.3	18.7	12.0	13.7	22.2	16.8	15.6	100.8	16.9	14.6	13.0	13.8	12.8	12.3	5.2	9.6	17.4	14.6	42.4	14.0	15.1	10.5	26.9	50.1	39.3	53.9	42.7	32.4	51.4	16.4	44.5	22.7	22.1	22.3	13.9	16.0	18.6	19.2	32.7	27.2	27.8	8.2	25.5	25.3	18.1	32.9	29.5	33.7	13.0	32.2	37.4	28.0	24.6	24.1	22.9	12.0	34.1	19.9	21.9	28.8	24.5	22.6	12.3	24.9	27.6	29.6	38.6	11.9	11.9	29.8	35.1	14.0	23.1	25.2	17.2	20.3	21.1	23.4	26.5	21.3	24.6	19.1	15.2	14.7	9.6	19.8	35.5	13.3	8.0	9.6	28.9	20.4	36.1	32.7	53.9	39.3	32.4	53.0	30.0	26.9	25.1	28.9	50.1	23.0	25.3	27.5	35.1	42.7	47.8	33.3	29.1	51.4	17.8	20.8	18.2	34.3	19.8	17.7	19.5	16.3	18.7	9.6
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Approved		Supported	Mitochondria				Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.4	14.6	16.8	5.8	2.9	2.3	23.6	4.2	3.2	10.1	10.3	26.1	15.5	7.4	19.9	2.6	9.8	18.8	6.0	12.0	2.9	12.4	8.4	13.7	20.3	6.8	10.7	6.7	6.2	6.4	8.7	7.8	11.6	23.7	2.8	4.9	18.1	0.0	10.0	29.6	9.0	4.2	10.0	17.1	24.3	15.6	8.1	26.5	14.5	30.7	24.8	9.1	8.2	6.8	7.6	16.9	17.8	12.7	5.8	14.5	4.7	9.3	10.3	12.4	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes				Peroxisomes		"HPA052708: , HPA060972: "	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	9.7	15.0	10.2	10.2	10.9	3.3	16.8	12.9	14.1	11.8	7.2	12.2	7.5	6.4	22.4	22.6	8.7	13.7	7.4	5.5	10.4	13.4	18.6	19.7	9.0	11.8	10.3	7.7	26.5	12.4	14.3	13.0	14.9	11.9	12.6	8.7	9.5	11.4	10.3	4.6	10.9	7.1	12.1	11.4	8.8	8.9	12.1	9.5	12.6	14.7	10.4	11.2	7.1	8.7	10.2	6.8	5.9	4.9	10.3	11.7	6.4	13.2	7.3	12.4	10.8	7.9	9.5	10.1	12.1	13.2	19.2	21.2	10.6	5.0	15.7	7.4	11.8	10.6	18.0	9.9	19.7	16.1	24.2	17.6	11.4	11.0	11.1	20.2	9.4	9.5	13.3	17.0	10.9	11.7	25.3	7.5	15.6	11.4	12.2	13.1	10.5	12.1	13.3	19.3	22.8	15.8	11.3	8.6	7.8	24.8	15.3	14.7	12.7	6.0	6.8	10.8	14.8	9.6	10.9	8.3	16.1	14.9	11.8	10.2	11.8	5.9	4.4	5.1	7.0	4.9	9.2	10.2	8.1	7.5	5.7	9.5	11.7	9.3	1.8	10.3	3.9	6.8	10.8	6.4	10.2	10.9	12.9	14.1	10.4	13.4	10.3	7.7	11.9	9.5
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.6;BEWO: 12.7;REH: 4.1"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.4	0.9	3.3	0.6	5.6	0.0	12.7	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.0	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.6	0.1	0.7	2.8	2.1	4.1	1.2	0.0	0.1	0.6	1.1	0.5	0.4	0.6	1.0	3.6	1.4	0.2	0.2	0.5	0.3	0.4	1.3	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.2	15.1	8.9	7.9	3.7	6.8	8.4	11.1	9.4	12.4	7.9	14.9	16.0	7.0	8.4	9.3	20.6	9.8	13.4	2.8	13.1	17.9	6.4	7.4	9.1	16.1	10.3	10.8	6.8	8.1	9.4	10.1	5.7	13.0	11.0	5.5	14.1	10.7	9.7	19.2	23.2	12.7	4.8	16.5	7.4	3.9	43.9	19.7	6.4	15.4	7.9	7.4	5.2	5.5	13.9	9.3	6.4	10.4	9.7	5.6	8.9	16.7	9.2	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 25.8;hTCEpi: 14.6;U-698: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria				Mitochondria		"HPA069732: "	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favourable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.3	2.3	7.8	8.9	6.2	0.1	1.1	3.6	1.1	0.2	0.0	2.8	0.8	5.4	1.9	4.0	1.1	3.4	0.7	0.0	11.6	0.0	25.8	2.8	4.7	0.1	0.3	9.6	14.6	0.0	9.2	0.2	0.1	0.0	0.9	0.8	0.0	0.1	1.2	3.0	0.0	3.0	0.1	5.9	7.3	7.1	0.7	5.4	0.3	2.9	5.8	0.0	0.8	4.9	3.3	0.5	0.9	3.1	0.0	15.9	0.7	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria			5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favourable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	75.6	59.1	78.4	64.9	71.4	118.8	101.1	66.4	88.5	86.1	72.0	106.1	39.8	103.4	39.5	80.4	65.2	79.5	89.7	90.8	38.9	63.4	61.6	43.6	70.3	88.0	72.1	49.0	112.3	80.3	62.5	90.0	121.5	66.4	30.7	102.6	56.4	66.9	80.5	72.6	97.1	76.5	81.7	114.7	111.3	76.0	40.3	54.0	79.5	71.5	109.6	96.6	78.9	81.6	48.0	45.3	52.6	66.4	52.0	61.1	72.3	37.8	42.6	61.7	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7800000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.25e-2)"	"prognostic favourable (7.35e-4)"	"prognostic favourable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favourable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	81.9	78.8	30.9	53.1	19.8	29.2	57.4	30.6	33.4	64.7	58.0	65.5	52.0	104.1	41.3	29.4	57.7	75.7	64.0	59.2	27.5	73.0	35.1	47.6	46.6	25.1	95.2	58.0	31.7	72.0	66.6	42.5	67.1	28.1	43.1	35.3	182.5	84.2	96.7	65.0	127.1	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.2	62.1	33.1	48.2	27.9	30.6	44.3	68.2	109.9	50.6	62.9	83.3	33.9	97.4	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria			7200000	Mitochondria		"HPA046835: , HPA071684: "	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.0	48.3	34.3	35.0	23.8	46.4	37.1	33.8	32.4	24.9	24.8	63.8	27.0	81.9	27.3	22.2	14.3	23.0	40.3	7.9	20.5	73.1	44.8	33.1	72.8	55.8	32.2	54.7	76.5	74.3	19.5	28.7	37.0	31.2	19.3	24.4	46.9	59.6	61.7	43.5	65.0	30.1	28.4	63.5	30.4	55.4	56.0	88.0	22.8	69.4	96.1	38.5	66.4	42.2	25.5	14.3	49.7	33.6	50.1	8.0	55.3	3.8	31.1	13.8	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2										
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.0;HMC-1: 8.9;T-47d: 9.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041654	Uncertain		Approved	Microtubules				Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favourable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.2	0.0	1.7	0.2	0.4	4.1	1.9	0.1	0.0	0.0	4.4	2.5	0.7	2.2	0.0	1.3	0.1	0.0	0.0	2.5	0.9	3.3	3.0	13.0	0.2	2.1	8.9	0.6	0.2	0.1	0.0	0.3	3.4	0.0	0.3	2.8	1.3	3.5	1.0	7.0	7.1	0.0	0.3	0.7	5.0	0.2	1.3	0.5	0.2	1.2	9.0	1.4	2.1	4.7	0.9	4.7	1.3	6.8	3.1	1.2	1.6	4.3	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol				Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavourable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.4	5.0	7.3	8.1	22.9	11.5	6.2	7.4	9.8	14.5	15.5	9.6	4.2	6.4	2.6	6.3	6.0	6.7	6.9	4.2	4.8	6.7	5.8	14.3	18.5	16.6	2.8	9.1	15.6	24.6	9.8	7.1	4.4	4.5	7.4	3.5	5.3	5.3	14.6	10.3	9.8	2.7	2.7	7.8	10.6	4.4	1.8	3.5	9.7	12.0	13.9	6.2	10.4	3.6	6.2	5.2	8.4	16.9	8.7	9.1	2.9	5.3	10.9	15.7	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"			36000000	"Plasma membrane"		"CAB002759: , HPA031345: , HPA058494: "	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavourable (3.65e-8)"	"prognostic unfavourable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavourable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavourable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.6	15.3	12.7	3.2	1.5	0.5	44.2	7.0	15.2	8.6	12.8	71.8	29.7	4.0	21.0	2.1	9.9	2.8	16.3	3.8	2.4	2.6	6.6	8.9	49.0	4.4	3.6	1.9	1.8	12.6	5.4	5.9	1.4	14.8	0.9	3.9	18.9	1.6	2.5	8.1	3.9	1.6	4.1	5.6	7.9	5.2	6.7	4.7	8.2	26.0	3.0	1.1	4.6	3.2	7.9	5.7	1.4	15.8	0.7	1.5	2.4	15.6	2.5	6.4	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035107-9088478	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.7;intestine: 84.1"	"Group enriched"	"Detected in some"	5	"Daudi: 50.1;THP-1: 12.8;U-266/70: 40.4;U-698: 47.1;U-937: 18.1"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005449	Enhanced									"HPA005449: AB_1078985"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	5.2	2.2	10.3	4.1	15.0	36.7	3.7	1.1	9.9	2.4	50.4	9.2	0.7	44.8	0.8	4.9	2.5	1.5	0.6	1.4	8.6	6.0	16.2	0.6	0.9	8.1	14.1	2.4	1.6	0.6	0.5	1.9	2.1	10.4	6.7	1.6	0.8	1.8	2.4	25.1	3.1	84.1	1.9	17.8	3.1	0.7	30.2	15.4	0.0	0.8	3.7	7.3	1.8	2.5	19.7	0.7	3.0	2.1	0.6	0.3	0.8	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	50.1	0.0	0.1	0.1	0.4	0.0	0.1	6.5	0.0	0.0	0.9	0.0	0.1	0.8	0.5	0.7	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	2.8	0.0	0.0	1.3	0.0	1.5	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.0	12.8	0.0	0.8	0.2	0.1	0.0	40.4	0.0	47.1	0.0	18.1	0.1	3.0	2.1	0.2	0.2	0.5	0.1	3.4	0.2	0.2	0.7	19.7	0.3	0.2	2.2	0.6	0.1	0.4	0.1	0.8	10.3	15.0	1.1	9.9	8.6	6.0	14.1	2.4	10.4	15.4
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479611-45522807	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 47.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018178	Uncertain									"HPA018178: AB_1857087"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	3.7	2.9	6.2	4.5	11.3	1.6	4.1	6.7	8.1	3.7	8.8	7.0	2.3	8.5	4.3	4.1	5.6	3.4	3.1	3.0	5.2	3.8	5.5	3.6	2.9	3.6	6.9	4.9	3.9	2.8	6.8	3.0	4.6	5.1	47.7	4.4	3.1	2.7	3.5	2.4	3.6	19.9	4.7	4.5	4.0	3.0	15.8	9.0	1.0	6.2	1.8	4.5	3.1	4.4	7.1	0.5	2.6	0.3	2.4	4.3	1.0	2.0	2.5	0.7	5.5	10.1	7.1	0.5	5.3	4.8	3.3	4.6	0.3	1.8	7.9	1.8	5.4	1.5	2.3	2.5	3.0	1.9	2.2	0.2	2.5	0.2	6.5	0.2	4.2	6.0	4.0	4.3	1.1	3.7	1.1	4.5	6.0	0.9	2.7	0.4	0.2	0.5	4.1	4.7	1.2	2.6	0.5	1.8	2.7	3.5	4.0	0.9	3.5	0.3	7.0	4.9	2.8	5.8	1.8	8.5	6.1	2.0	2.1	0.3	3.6	2.6	0.3	0.3	4.3	0.2	3.9	3.8	2.9	2.4	0.3	7.1	2.9	4.2	1.1	2.4	0.3	0.5	0.4	1.0	6.2	11.3	6.7	8.1	5.2	3.8	6.9	4.9	5.1	9.0
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Group enriched"	"Detected in some"	12	"HEL: 6.6;U-937: 4.3"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"				"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: , HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.1	0.0	0.2	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81245000-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"			44000000	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favourable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	22.8	18.6	8.1	17.0	11.3	18.5	43.0	9.9	10.2	15.8	23.8	13.8	22.0	21.8	17.4	30.7	13.2	15.2	28.4	17.3	7.4	9.2	18.0	59.2	24.6	23.7	11.6	6.7	23.7	55.1	6.8	30.2	23.2	10.0	16.0	6.5	15.1	33.3	26.1	8.7	11.2	26.2	10.9	10.4	21.0	19.1	25.0	12.3	20.2	25.9	10.3	15.8	18.4	13.0	6.6	10.0	17.2	15.4	4.6	9.8	7.9	17.1	30.1	5.3	27.7	20.3	9.6	31.5	21.1	19.1	13.0	15.3	14.0	28.8	13.2	24.2	14.5	20.7	5.3	10.6	4.8	13.1	15.8	13.2	10.7	23.5	18.2	13.0	31.6	16.6	7.9	11.6	7.6	24.7	9.8	20.3	9.6	21.8	7.8	22.2	5.2	14.9	12.8	11.1	13.3	9.1	16.2	10.1	26.4	17.0	10.7	23.0	15.2	27.2	24.3	21.0	12.3	15.6	11.3	17.9	7.8	7.5	12.5	20.2	21.5	11.0	10.2	17.2	8.1	12.0	9.8	6.6	7.8	9.8	6.3	6.6	5.4	5.8	8.2	4.6	15.4	10.0	5.5	7.9	8.1	11.3	9.9	10.2	7.4	9.2	11.6	6.7	10.0	12.3
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 129.8;SiHa: 132.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			210000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB010455: AB_638288, HPA017980: "	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavourable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favourable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavourable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.1	68.1	6.9	21.6	8.4	6.8	64.4	28.1	10.8	14.8	13.0	65.1	30.6	17.8	31.2	16.5	56.0	12.7	55.1	7.9	32.3	12.0	12.7	49.6	28.7	78.4	14.9	18.6	14.8	129.8	18.0	55.0	8.6	24.6	39.4	9.0	77.8	15.3	19.0	11.6	23.0	15.9	10.5	34.7	10.3	9.0	11.9	5.7	132.3	49.6	95.4	17.8	19.6	15.7	15.0	22.4	22.0	19.8	49.0	54.3	56.4	14.7	23.5	42.8	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced						160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: "	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.4	1.4	1.7	0.6	0.7	1.0	0.2	0.4	0.3	0.8	1.3	3.2	0.7	0.6	0.3	1.4	0.5	0.5	1.0	1.3	1.3	1.6	1.5	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.2	4.7	3.4	0.4	0.6	0.9	3.5	0.9	0.5	2.5	0.7	1.8	0.3	0.8	2.2	1.0	1.3	1.4	0.5	2.5	1.8	1.0	2.3	2.0	1.4	1.4	1.0	2.3	1.1	1.6	2.1	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 35.2;Hep G2: 20.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favourable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favourable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.3	7.6	0.9	4.0	2.6	0.7	10.9	2.7	1.7	1.4	0.8	0.5	7.0	0.0	3.1	0.9	35.2	4.2	8.3	0.2	0.0	1.7	0.3	3.3	20.6	1.6	1.9	6.9	0.3	3.4	1.7	1.6	3.5	0.7	4.9	1.4	3.4	0.2	0.2	6.1	10.3	1.2	5.2	1.7	8.5	15.0	0.4	2.5	1.4	8.8	0.2	3.4	3.3	5.9	1.0	3.6	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360202-140375143	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;Karpas-707: 1.0;U-266/70: 1.2;U-698: 2.6"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Low region specificity"	"Detected in all"			HPA051307	Uncertain									"HPA051307: "	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	26.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.7	0.2	0.3	0.0	0.8	0.1	0.3	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.5	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.3	0.1	0.0	1.2	0.6	2.6	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.0
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.0;RT4: 6.3;SK-BR-3: 9.9;T-47d: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved									"HPA049391: , HPA059078: "	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favourable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.0	0.4	7.3	1.4	5.9	0.5	2.8	3.5	9.0	2.6	9.6	2.1	12.0	13.1	1.8	1.9	4.6	2.0	3.0	3.3	6.6	4.2	10.0	0.4	1.4	0.7	5.6	1.3	1.2	2.2	0.6	0.5	6.7	7.3	7.9	6.3	0.5	5.5	15.8	1.0	1.7	16.3	1.5	4.7	0.4	5.2	32.5	6.0	0.0	0.7	1.2	0.9	4.7	2.2	1.1	0.7	2.4	0.6	1.1	0.8	0.4	3.4	1.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.4	27.0	0.0	4.0	0.0	3.9	0.0	2.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	2.4	0.0	0.0	0.3	0.0	6.3	0.0	0.1	3.9	9.9	0.0	12.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.5	0.4	0.2	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	2.2	1.1	0.4	0.7	0.3	0.4	7.3	5.9	3.5	9.0	6.6	4.2	5.6	1.3	7.3	6.0
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Low region specificity"	"Detected in all"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"CAB015467: , HPA051805: , HPA055106: "	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favourable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.0	4.8	0.0	0.1	1.8	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Cell line enriched"	"Detected in some"	4	"BEWO: 15.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022364, HPA049055"	Enhanced									"CAB022364: , HPA049055: "	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	1.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.6	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell line enhanced"	"Detected in all"		"BEWO: 68.0;SK-BR-3: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Cell Junctions"				"Cell Junctions"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavourable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.4	17.0	10.9	14.3	10.1	3.7	68.0	6.0	4.1	9.1	6.3	25.1	5.9	11.4	9.1	3.2	9.2	23.3	6.9	6.4	8.8	13.7	20.2	7.3	38.4	12.0	25.9	10.6	12.7	5.9	11.2	8.7	8.2	29.5	4.7	5.8	33.8	8.8	12.6	31.4	6.2	14.8	12.8	16.5	5.2	15.8	9.2	13.6	6.5	73.1	8.6	16.2	5.6	3.7	10.1	13.8	6.1	16.0	7.9	18.0	18.1	5.5	18.2	14.1	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 104.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol				Cytosol	Mitochondria	"CAB078195: , HPA004057: AB_1080012, HPA076311: "	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.8	104.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported								"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153688099-153696593	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 42.0;SK-BR-3: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.6"																				"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (7.39e-4)"	"unprognostic (2.87e-1)"	17.6	19.5	26.3	5.8	39.0	19.3	7.3	23.9	31.9	6.1	26.8	36.6	7.6	32.4	11.2	9.1	20.0	10.6	20.2	53.1	29.3	16.1	27.3	1.9	3.1	1.9	55.6	22.0	5.1	8.3	17.0	7.2	22.6	25.8	12.8	20.2	20.9	31.8	24.9	76.4	28.0	48.3	13.5	28.2	5.1	11.0	16.7	38.9	4.6	2.8	11.0	5.0	40.4	10.1	0.5	0.0	2.6	0.2	0.0	0.0	0.1	39.8	1.7	12.3	42.0	3.9	2.7	2.9	6.0	9.9	7.8	9.7	5.1	0.5	0.0	4.6	7.2	14.9	24.5	20.6	4.8	0.7	23.4	0.1	13.9	15.2	13.6	0.2	2.8	5.8	4.4	7.7	28.2	3.9	9.7	0.6	4.3	2.3	0.2	0.9	12.6	17.6	1.9	1.4	0.5	8.4	7.8	15.9	17.7	8.7	43.6	28.3	8.4	6.1	3.8	12.9	20.5	16.5	17.6	1.5	0.7	0.4	28.8	1.2	12.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	26.3	39.0	23.9	30.4	29.3	16.1	55.6	22.0	25.8	38.9
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.5;hTCEpi: 41.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavourable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.2	5.4	2.7	6.9	4.3	1.4	6.1	5.8	15.6	9.4	11.7	1.8	2.8	0.1	0.6	15.9	23.5	4.1	4.6	1.9	0.0	0.7	6.4	12.8	2.1	19.8	1.4	0.3	4.4	41.1	4.6	11.0	0.2	4.9	18.5	0.4	4.0	1.0	0.0	2.0	7.2	0.8	0.0	8.2	0.9	0.8	1.7	1.6	2.9	13.4	2.6	3.5	3.8	0.1	1.0	4.4	0.9	3.0	20.4	14.0	1.6	3.5	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.0;TIME: 30.7;WM-115: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles				Vesicles		"HPA064215: "	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favourable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.5	6.1	4.7	1.3	1.7	1.6	7.5	5.2	1.7	3.9	1.5	5.7	3.1	9.8	26.0	2.2	3.2	6.4	7.2	5.8	0.6	2.2	12.8	3.4	20.2	5.6	2.1	4.0	28.0	4.8	21.6	21.2	2.9	8.0	8.9	1.2	0.7	0.5	1.2	3.9	0.9	2.0	3.5	1.0	6.4	2.5	0.5	3.2	0.9	11.5	1.4	12.1	30.7	2.2	6.3	3.3	5.9	6.8	3.1	3.1	3.8	3.1	45.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced									"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.4	0.1	12.2	6.6	5.1	0.6	0.4	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.1;CACO-2: 5.6;MCF7: 6.3;RT4: 14.2;SK-BR-3: 12.6;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: "	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	8.1	5.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	2.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.1	0.2	4.3	0.0	0.0	0.0	1.0	14.2	0.0	0.0	0.0	12.6	0.0	15.8	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 77.3;SK-BR-3: 63.1;T-47d: 122.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"			9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.7	11.3	5.6	5.8	3.4	2.5	25.5	3.3	3.1	8.5	8.3	35.4	8.2	3.0	3.4	7.0	19.7	9.7	6.4	4.0	3.6	9.3	22.6	30.6	47.1	7.0	14.7	15.3	2.0	3.6	6.7	2.9	7.0	7.1	16.2	13.0	77.3	34.7	33.1	5.0	6.7	3.8	6.3	13.6	11.7	9.8	4.9	6.4	3.4	63.1	7.1	122.1	11.8	2.3	2.6	7.7	6.1	5.4	28.2	12.7	5.5	4.3	19.7	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles				Vesicles		"HPA048938: , HPA075385: "	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (8.58e-4)"	"prognostic unfavourable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.3	5.6	0.8	2.4	0.9	5.6	3.2	7.0	8.7	4.2	3.4	5.7	7.9	16.1	2.2	11.1	3.4	5.4	7.9	7.7	8.4	2.9	1.6	2.2	2.3	3.5	0.8	13.3	3.5	1.0	11.9	7.9	5.9	0.1	0.3	5.7	11.0	1.8	0.9	3.9	6.7	7.1	0.3	0.2	3.2	8.2	6.1	0.7	3.6	5.4	1.5	7.1	0.3	0.3	9.0	3.0	1.4	4.1	1.7	0.4	8.1	12.8	0.1	2.9	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved									"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	9.0	14.0	7.6	11.4	13.9	29.8	8.9	10.3	15.1	8.4	9.1	14.0	7.7	9.7	12.2	10.6	16.0	8.6	9.4	6.8	7.3	7.8	8.4	16.2	9.5	10.6	6.6	8.0	7.2	13.5	11.7	12.4	7.2	11.9	9.1	9.0	15.4	13.7	7.9	19.5	7.3	9.8	9.0	8.1	13.9	12.8	19.6	5.8	13.6	11.9	8.4	18.6	11.4	7.6	2.2	1.4	7.1	1.7	0.8	2.5	1.4	4.2	7.7	3.5	3.5	4.4	2.8	8.8	4.4	6.0	8.4	4.0	5.5	9.6	5.1	5.7	6.2	9.5	3.7	4.4	4.3	4.4	2.0	2.5	4.9	2.7	6.2	4.5	6.2	5.3	5.1	4.4	9.0	3.5	4.8	5.3	5.1	4.6	4.1	3.1	2.9	3.7	3.1	4.1	3.6	5.0	4.6	3.5	3.0	7.3	27.2	5.5	8.8	7.3	5.3	11.5	6.4	5.5	4.2	8.2	3.5	3.7	15.7	6.0	4.7	2.8	1.4	3.6	2.3	1.1	2.5	1.6	1.7	2.0	1.4	2.2	1.8	1.1	7.1	0.8	1.7	0.7	1.2	1.4	7.6	13.9	10.3	15.1	7.3	7.8	6.6	8.0	11.9	5.8
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"				"Plasma membrane"		"HPA071152: "	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.1	0.5	0.8	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	3.0	1.7	0.1	2.1	0.1	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.5	1.1	0.0	0.3	0.2	0.0	1.4	0.1	0.1	0.1	3.5	1.4	0.0	2.1	0.3	0.1	13.7	0.1	0.1	0.2	9.5	0.0	2.1	1.9	2.3	0.0	0.2	0.2	2.7	0.7	0.0	0.0	1.4	0.7	0.3	20.5	8.2	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.6;A549: 2.1;HeLa: 3.3;NTERA-2: 3.0;RPMI-8226: 4.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA050892	Supported									"HPA050892: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.8	4.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	0.0	0.0	1.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853695-92172435	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 25.7;HaCaT: 38.8;HMC-1: 22.9;RPMI-8226: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved									"HPA066327: "	"unprognostic (1.05e-3)"	"prognostic favourable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavourable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.1	8.5	12.3	8.6	19.2	10.6	7.9	7.8	18.4	6.8	4.6	32.8	6.6	2.7	4.5	4.8	9.2	7.7	8.3	24.3	19.5	10.9	7.1	4.1	14.7	7.3	27.0	10.0	4.2	3.2	22.6	5.4	1.7	17.2	4.2	4.9	7.7	4.0	8.9	5.4	15.1	3.5	6.7	31.9	11.5	3.9	15.5	25.0	0.8	10.1	3.2	7.9	8.4	9.3	0.2	2.0	9.5	3.2	0.4	3.2	0.7	3.9	4.9	5.7	0.1	8.8	5.3	0.0	1.6	1.3	0.6	0.1	0.0	25.7	4.8	2.2	0.5	38.8	1.1	2.5	0.0	3.4	0.1	11.0	8.9	0.0	0.4	0.2	22.9	2.4	2.7	1.2	3.0	0.0	0.0	0.0	0.0	0.7	0.0	2.0	1.5	0.6	0.0	0.4	17.3	5.5	4.0	0.8	1.4	4.2	0.4	0.0	0.0	3.3	0.0	1.4	1.9	0.0	4.1	10.6	6.2	4.7	1.7	6.7	2.4	5.2	3.2	8.2	1.9	2.4	1.4	0.2	2.0	2.2	2.0	0.0	0.7	0.8	9.5	0.4	1.9	0.0	3.2	0.7	12.3	19.2	7.8	18.4	19.5	10.9	27.0	10.0	17.2	25.0
SLITRK1	"KIAA1910, LRRC12"	ENSG00000178235	"SLIT and NTRK like family member 1"	Q96PX8	13	83877205-83882393	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 30.6"	"Group enriched"	"Detected in some"	4	"A-431: 7.4;AF22: 3.1;LHCN-M2: 2.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012414	Enhanced				"Secreted in brain"		270000			"HPA012414: AB_1857229"	"unprognostic (2.29e-1)"				"unprognostic (4.32e-1)"					"unprognostic (4.71e-2)"	"unprognostic (1.01e-1)"			"unprognostic (1.65e-2)"	"unprognostic (7.95e-2)"			0.9	1.3	16.7	0.9	9.5	0.9	1.0	2.0	30.6	1.2	1.0	6.3	0.0	1.0	1.0	1.0	0.9	0.9	1.0	0.9	16.9	7.3	1.0	0.9	0.9	0.9	7.3	14.9	0.9	3.1	0.9	3.1	0.9	5.8	0.9	1.0	0.1	1.0	1.4	1.0	0.9	0.9	0.9	3.7	0.9	1.0	1.0	8.5	0.0	0.9	0.0	0.9	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	3.1	0.0	0.1	0.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	9.5	2.0	21.5	16.9	7.3	7.3	14.9	5.8	8.5
SLK	"KIAA0204, se20-9, STK2"	ENSG00000065613	"STE20 like kinase"	Q9H2G2	10	103967201-104029233	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015757	Approved		Approved	"Plasma membrane,Cytosol"			17000	"Plasma membrane, Cytosol"		"HPA015757: AB_1857236"	"unprognostic (1.89e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (8.67e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (2.77e-5)"	"unprognostic (1.95e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (8.48e-2)"	"unprognostic (3.95e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.07e-1)"	15.2	11.2	13.7	11.0	36.7	14.6	16.1	16.7	13.1	16.6	19.0	9.9	10.9	9.1	17.0	12.1	40.2	12.1	13.6	17.2	10.6	7.1	14.9	12.2	17.1	10.1	11.2	13.4	17.2	12.5	22.6	13.1	17.4	12.8	19.3	13.6	11.4	19.8	12.7	19.3	16.6	15.5	29.8	13.0	12.1	15.7	10.2	12.8	12.0	15.8	21.6	12.5	24.9	23.6	1.4	2.2	6.5	1.4	1.3	3.6	0.7	21.2	12.4	14.9	10.6	16.1	22.5	6.3	13.3	17.7	9.9	9.3	7.9	22.9	11.3	8.3	13.7	23.2	7.8	16.8	14.5	9.0	10.8	11.5	10.2	6.6	12.1	13.7	10.0	11.5	22.1	13.4	39.2	17.8	14.3	7.8	13.0	7.4	9.6	7.6	3.7	8.0	9.4	18.3	5.8	13.0	24.5	3.5	6.1	11.5	11.2	11.0	5.8	9.9	26.9	7.3	7.6	13.4	15.5	9.5	11.6	7.2	10.8	18.4	4.7	1.2	1.4	3.3	3.6	1.2	3.6	1.1	2.2	2.2	1.2	1.4	1.5	2.5	6.5	1.3	1.0	2.2	1.4	0.7	13.7	36.7	16.7	13.1	10.6	7.1	11.2	13.4	12.8	12.8
SLPI	"ALK1, ALP, BLPI, HUSI, HUSI-I, WAP4, WFDC4"	ENSG00000124107	"Secretory leukocyte peptidase inhibitor"	P03973	20	45252239-45254564	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial, Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"cervix, uterine: 934.9;ductus deferens: 268.3;salivary gland: 480.2;seminal vesicle: 548.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 155.4;hTCEpi: 182.5;SiHa: 54.7;THP-1: 46.2"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	11	"pons and medulla: 4.7"	"Cell type enriched"	"Detected in single"	90	"neutrophil: 68.8"	"Lineage enriched"	"Detected in single"	90	"granulocytes: 68.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002303, HPA027774"	Enhanced		Approved	"Golgi apparatus"	"Secreted to blood"	26402233	2600000	"Golgi apparatus"		"CAB002303: AB_564008, HPA027774: AB_10602405"	"unprognostic (2.31e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.10e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.83e-3)"	"unprognostic (4.01e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavourable (6.91e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.81e-2)"	"unprognostic (8.31e-2)"	9.2	0.4	0.0	2.4	0.0	10.0	10.0	0.1	0.2	934.9	3.4	0.1	268.3	0.2	11.9	5.5	51.3	23.3	19.6	3.5	0.0	0.0	17.3	20.1	81.5	1.3	0.3	0.4	5.5	5.4	0.1	25.9	1.4	4.7	13.4	3.6	2.0	480.2	548.7	41.3	9.6	0.7	3.9	0.9	0.7	5.2	7.1	0.0	2.3	2.0	86.2	53.0	17.7	24.0	0.0	0.1	68.8	0.7	0.0	0.0	1.1	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.1	0.0	155.4	0.0	11.6	0.0	5.6	0.0	0.7	0.0	0.0	20.8	0.0	30.0	0.0	0.0	0.8	182.5	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.6	0.0	0.0	0.0	31.6	1.2	0.0	0.0	54.7	11.7	0.1	0.2	46.2	0.0	0.0	0.7	0.1	0.0	0.1	0.7	0.4	0.0	2.8	0.0	0.5	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	68.8	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.4	4.7	0.0
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Group enriched"	"Detected in some"	4	"HaCaT: 3.3;hTCEpi: 2.2;MCF7: 3.8;RT4: 2.6;T-47d: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"		5400000			"HPA050967: "	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SMAD2	"JV18-1, MADH2, MADR2"	ENSG00000175387	"SMAD family member 2"	Q15796	18	47808957-47931146	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025507, HPA067203, CAB073546"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli, Cytosol"		"CAB025507: , CAB073546: , HPA067203: "	"unprognostic (1.55e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.43e-2)"	"unprognostic (9.82e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (9.44e-5)"	"unprognostic (1.91e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.46e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.13e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.28e-2)"	38.5	39.2	29.0	26.2	25.9	19.6	31.4	19.5	28.9	28.8	34.2	29.4	28.9	21.5	26.6	26.3	33.5	28.8	25.7	31.1	26.1	27.1	26.4	20.9	28.3	23.8	30.9	24.3	36.6	28.1	25.7	24.4	34.8	28.6	27.8	29.8	31.7	29.7	28.7	33.9	28.0	26.4	34.6	35.4	34.1	26.3	29.2	26.2	60.7	46.1	23.6	31.5	35.1	35.7	12.0	21.8	28.9	24.7	24.5	25.9	19.7	22.4	32.2	19.7	19.0	31.5	38.5	22.5	24.5	29.4	25.6	29.9	12.3	21.5	34.9	17.6	31.0	24.8	22.1	27.3	34.3	37.9	11.3	29.6	48.7	19.9	36.7	41.1	30.3	28.4	35.3	21.9	50.7	28.2	13.7	29.3	31.4	14.6	28.2	19.8	9.6	7.7	20.6	28.7	23.8	57.4	38.7	18.2	21.4	29.5	20.2	24.0	15.3	27.4	31.5	38.0	21.9	10.3	17.8	28.7	27.5	30.4	26.3	28.1	27.7	28.9	22.6	25.0	16.9	24.7	21.2	12.0	23.1	20.9	21.8	9.4	25.8	19.8	22.7	24.5	20.8	15.5	25.9	19.7	29.0	25.9	19.5	28.9	26.1	27.1	30.9	24.3	28.6	26.2
SMAD6	"HsT17432, MADH6, MADH7"	ENSG00000137834	"SMAD family member 6"	O43541	15	66702228-66782848	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 20.8;HaCaT: 12.3;HeLa: 17.1;U-2197: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061917			Supported	"Nucleoplasm,Nuclear bodies,Golgi apparatus"				Nucleoplasm	"Nuclear bodies, Golgi apparatus"	"HPA061917: "	"unprognostic (1.20e-1)"	"unprognostic (7.43e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.50e-3)"	"unprognostic (9.59e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.55e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.33e-1)"	"prognostic favourable (5.45e-5)"	9.8	1.9	2.5	3.1	4.6	0.6	5.1	0.8	2.8	6.3	4.7	2.6	2.1	3.8	5.2	1.9	3.1	4.4	11.6	21.6	3.0	2.0	6.1	6.2	37.1	1.2	3.6	2.3	5.1	3.1	2.3	2.8	13.8	4.5	9.7	2.5	18.5	1.6	22.1	1.8	1.6	3.8	3.1	2.9	3.2	8.0	1.7	2.0	0.0	16.7	0.6	0.8	6.8	7.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.8	6.9	1.1	2.4	4.3	1.1	6.5	4.9	0.1	0.8	0.0	1.3	3.1	0.5	20.8	4.1	12.3	1.5	0.0	0.1	1.5	5.7	10.7	17.1	1.1	0.5	0.0	0.8	1.4	0.0	0.0	0.0	0.9	0.9	0.7	0.3	1.3	0.1	2.9	2.1	2.6	0.0	1.2	1.4	2.3	5.4	2.5	1.1	2.6	2.9	0.5	1.0	1.9	4.2	3.0	3.9	12.1	0.9	0.3	1.2	0.2	2.1	3.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	4.6	0.8	2.8	3.0	2.0	3.6	2.3	4.5	2.0
SMARCA2	"BAF190, BRM, hBRM, hSNF2a, SNF2, SNF2L2, SNF2LA, Sth1p, SWI2"	ENSG00000080503	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2"	P51531	9	1980290-2193624	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Hypotrichosis, Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"HDLM-2: 176.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029981, CAB037276"	Enhanced		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"				"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB037276: AB_477083, HPA029981: AB_10602406"	"unprognostic (5.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.60e-3)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.26e-6)"	"unprognostic (3.09e-1)"	"unprognostic (2.81e-1)"	"unprognostic (8.32e-3)"	"unprognostic (8.50e-2)"	23.6	29.6	38.8	21.3	43.6	40.7	30.1	41.6	44.0	23.8	17.3	20.0	38.4	10.3	26.4	30.1	20.4	29.4	22.8	21.2	30.2	30.8	23.4	28.9	20.2	29.5	25.9	32.4	85.0	18.5	104.1	35.0	23.2	24.7	23.2	15.9	22.8	26.1	44.8	41.3	27.0	18.3	26.6	19.7	23.9	15.8	26.5	23.4	20.6	28.0	24.8	27.1	23.7	22.0	9.9	11.3	20.4	8.3	8.6	12.5	4.2	5.2	3.9	2.9	4.2	6.0	7.2	8.8	6.7	5.3	3.1	2.3	0.0	2.1	9.1	2.7	6.1	2.3	1.6	5.6	2.2	176.7	2.5	24.6	10.9	1.9	2.3	10.3	14.5	4.7	2.1	3.1	5.8	4.9	0.8	31.3	5.2	2.1	2.5	8.6	2.9	1.5	11.6	3.7	8.2	7.1	4.8	1.9	1.7	4.3	1.0	1.8	1.9	6.7	5.8	5.0	2.4	3.2	3.2	2.9	3.6	4.1	5.4	3.9	1.3	20.4	4.6	13.1	10.3	6.2	9.9	9.9	9.9	10.5	5.6	8.0	12.5	10.0	13.5	8.6	8.3	11.3	10.4	4.2	38.8	43.6	41.6	44.0	30.2	30.8	25.9	32.4	24.7	23.4
SMARCA4	"BAF190, BRG1, FLJ39786, hSNF2b, SNF2, SNF2-BETA, SNF2L4, SNF2LB, SWI2"	ENSG00000127616	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4"	P51532	19	10960825-11079426	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Helicase, Hydrolase, Repressor, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004208	Supported		Supported	Nucleoplasm			260000	Nucleoplasm		"CAB004208: AB_626762"	"unprognostic (2.68e-1)"	"unprognostic (4.85e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (7.19e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.80e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.29e-1)"	10.3	12.4	15.5	18.0	21.3	20.5	10.9	29.1	28.0	13.2	12.8	16.6	9.7	14.3	16.6	9.4	24.7	15.7	12.8	11.6	14.4	17.7	13.0	9.9	13.0	18.1	17.1	16.8	13.6	13.4	18.1	11.5	14.6	16.1	13.3	9.4	17.3	18.2	12.5	21.9	20.4	12.0	10.6	16.1	13.2	14.5	22.2	12.4	58.2	15.5	10.1	21.5	15.2	12.6	9.8	11.2	8.6	13.5	11.4	13.7	5.9	20.5	1.1	36.7	34.7	7.2	6.1	16.1	14.3	8.6	17.5	13.0	28.7	0.9	48.3	22.2	12.5	15.1	28.6	17.7	9.7	19.8	21.5	38.5	18.2	33.3	10.9	27.9	19.2	10.3	8.6	14.7	15.2	15.6	34.4	18.2	13.7	42.0	46.2	23.9	37.3	31.1	49.3	23.2	25.0	11.2	26.1	41.8	37.9	15.2	19.6	16.3	16.6	20.9	20.7	26.1	13.6	23.8	23.6	37.7	41.8	48.0	14.8	26.8	22.2	8.1	8.3	8.6	13.7	9.5	12.2	7.4	10.4	11.6	8.5	9.8	11.4	11.2	5.2	11.4	13.5	11.2	8.8	5.9	15.5	21.3	29.1	28.0	14.4	17.7	17.1	16.8	16.1	12.4
SMARCB1	"BAF47, hSNFS, Ini1, PPP1R144, RDT, Sfh1p, SNF5L1, Snr1"	ENSG00000099956	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1"	Q12824	22	23786931-23838008	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009196, HPA018248, HPA019127"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB009196: AB_2191983, HPA018248: AB_1851162, HPA019127: AB_1851165"	"unprognostic (2.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.63e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.52e-4)"	"unprognostic (4.10e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.43e-3)"	"prognostic favourable (1.14e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (7.04e-2)"	11.0	15.2	14.6	33.2	15.4	16.9	12.1	30.4	21.9	13.4	25.1	16.4	11.4	41.1	17.2	11.0	15.6	12.3	15.0	12.6	13.2	14.2	14.6	11.7	14.0	32.8	13.0	13.8	21.3	16.1	7.9	15.7	20.8	12.8	11.0	9.4	16.7	40.9	13.1	28.1	14.7	27.4	10.6	12.8	19.8	24.1	37.7	12.9	29.4	15.7	12.0	16.0	21.1	12.2	19.5	9.9	4.8	11.6	7.0	7.5	5.9	1.5	1.0	19.0	1.7	1.8	0.5	3.8	6.0	1.8	1.8	2.9	2.2	1.8	15.5	5.2	0.8	2.9	4.5	2.9	3.0	2.5	6.6	12.9	1.7	1.3	2.0	13.6	3.8	1.1	2.2	2.1	4.7	0.9	3.5	8.6	1.1	3.8	11.1	3.1	5.7	3.8	7.0	15.3	7.0	1.5	3.0	9.0	6.8	1.4	0.4	10.2	1.4	2.1	1.6	1.6	6.6	2.6	1.7	9.5	8.7	10.3	1.3	7.5	4.6	4.0	10.0	4.8	3.8	10.2	5.2	19.5	4.6	4.6	9.3	6.4	3.8	2.5	0.8	7.0	11.6	9.9	7.5	5.9	14.6	15.4	30.4	21.9	13.2	14.2	13.0	13.8	12.8	12.9
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585272-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favourable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavourable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	16.5	9.3	14.5	22.6	18.9	16.7	21.8	16.5	17.2	19.3	22.4	19.6	13.1	13.3	20.0	15.2	21.8	12.5	16.4	10.3	13.9	11.3	18.7	15.6	13.6	18.6	18.1	11.3	18.7	25.6	16.4	15.1	28.0	11.7	22.1	20.8	14.5	18.9	16.9	19.8	24.3	17.8	32.6	16.1	18.7	16.6	18.7	18.3	45.0	21.1	12.8	27.7	24.9	27.0	8.2	4.7	4.3	5.4	4.0	8.1	3.9	14.3	7.6	32.0	24.8	7.2	12.3	21.6	11.5	10.8	14.9	15.3	13.6	15.3	33.6	9.3	14.4	12.4	30.1	17.8	21.9	16.0	17.9	32.9	13.1	18.5	10.8	30.1	15.2	10.3	15.8	16.8	18.7	17.4	27.6	11.4	16.0	10.7	39.1	15.7	42.2	11.7	17.6	18.6	29.5	16.0	18.9	14.3	28.8	17.8	17.5	12.7	15.2	28.1	13.9	10.0	14.2	11.3	18.7	14.0	17.8	40.1	7.3	28.5	14.0	4.0	3.5	3.4	6.2	5.4	5.6	8.2	6.7	8.1	4.4	6.3	6.4	7.5	4.3	4.0	3.8	4.7	6.3	3.9	14.5	18.9	16.5	17.2	13.9	11.3	18.1	11.3	11.7	18.3
SMARCE1	BAF57	ENSG00000073584	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1"	Q969G3	17	40624962-40648864	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	Neurogenesis	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003916, CAB037318"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB037318: AB_476780, HPA003916: AB_1857279"	"unprognostic (7.91e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.55e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.93e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-2)"	25.1	20.2	14.4	17.2	18.8	18.4	20.2	17.0	16.7	37.6	25.1	18.0	12.6	18.4	42.8	19.5	31.0	21.1	20.6	19.6	13.3	12.0	23.0	22.6	20.1	22.3	16.5	14.3	39.5	16.9	13.3	20.4	34.8	15.2	32.4	19.2	17.9	20.6	21.9	32.0	21.3	22.6	33.4	15.8	30.3	19.1	22.0	17.5	53.9	23.8	18.9	25.1	31.2	21.0	40.3	32.0	34.0	30.3	47.2	44.0	39.2	20.5	34.3	42.1	31.3	22.3	32.1	20.7	25.9	35.8	30.5	23.0	22.4	17.9	32.7	37.5	35.0	28.1	26.0	27.4	36.7	30.6	33.8	23.4	18.5	39.4	22.5	42.6	23.8	27.8	21.7	24.3	35.5	32.8	34.0	13.0	29.1	23.1	78.0	8.8	23.5	17.0	43.8	47.4	24.8	36.8	35.3	33.7	32.6	23.0	66.9	21.5	40.1	26.8	26.8	24.8	27.4	22.4	31.9	24.4	28.4	48.9	25.3	19.6	38.2	31.8	26.0	34.0	39.1	26.8	40.5	38.4	35.8	40.9	31.3	40.3	30.2	34.9	11.0	47.2	30.3	32.0	44.0	39.2	14.4	18.8	17.0	16.7	13.3	12.0	16.5	14.3	15.2	17.5
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	20.6	14.1	14.6	24.2	28.2	24.6	16.2	33.6	21.7	19.9	18.2	22.0	10.5	16.2	27.5	10.0	22.4	21.7	12.5	16.2	16.8	10.8	19.2	23.5	15.4	30.2	25.2	13.0	21.8	17.2	31.0	18.4	19.5	18.0	13.4	17.3	12.5	16.8	12.9	24.3	16.2	19.7	21.7	21.3	20.1	17.5	10.4	25.8	38.3	16.8	11.1	25.7	22.0	21.3	14.3	15.5	13.7	18.7	15.6	17.8	10.6	28.2	31.7	25.2	21.5	9.3	10.3	14.1	17.1	11.3	21.7	17.6	18.8	16.5	27.6	14.7	11.4	21.6	44.9	24.7	24.3	23.6	52.3	24.1	36.8	13.1	3.8	34.0	34.6	5.8	6.4	24.3	14.8	18.7	35.4	17.8	16.9	17.1	30.6	10.3	37.4	16.9	32.9	43.5	25.5	9.2	18.6	26.8	22.6	44.7	22.1	9.4	23.7	13.9	10.5	18.5	19.6	18.3	16.6	11.7	19.7	25.6	10.6	38.7	18.1	6.1	13.8	13.7	17.8	18.7	17.0	12.2	12.0	15.6	15.5	14.3	14.2	10.9	9.4	15.6	17.4	12.9	8.8	10.6	14.6	28.2	33.6	21.7	16.8	10.8	25.2	13.0	18.0	25.8
SMC3	"BAM, bamacan, CSPG6, HCAP, SMC3L1"	ENSG00000108055	"Structural maintenance of chromosomes 3"	Q9UQE7	10	110567691-110604636	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037411, HPA043206"	Uncertain		Supported	Nucleoplasm			10000000	Nucleoplasm		"HPA037411: AB_10671753, HPA043206: "	"unprognostic (3.40e-1)"	"unprognostic (1.73e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.89e-3)"	"unprognostic (9.74e-3)"	"unprognostic (8.06e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.17e-2)"	"unprognostic (8.73e-3)"	"unprognostic (7.22e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (1.32e-1)"	17.1	13.4	16.8	15.4	22.9	32.7	21.3	37.8	18.0	19.2	15.1	9.9	10.7	13.3	20.1	14.3	19.7	15.6	9.9	11.9	16.7	11.2	16.6	17.2	12.6	23.7	18.6	15.4	26.5	18.4	22.2	36.6	22.9	17.7	14.6	15.1	8.8	15.3	14.3	18.4	18.4	18.8	19.6	22.2	18.1	13.5	32.0	23.2	47.4	19.4	11.4	20.8	20.7	19.7	13.2	11.0	19.1	10.5	15.1	17.7	7.4	26.8	16.8	36.6	26.0	12.2	10.5	15.8	21.8	21.8	20.2	19.9	21.2	22.7	35.1	9.6	14.6	21.5	26.2	13.2	30.9	28.6	22.5	28.3	21.2	19.0	12.2	40.2	21.9	8.3	10.8	22.3	35.2	14.8	22.5	27.2	17.4	14.1	30.9	21.4	25.2	13.5	26.3	66.3	19.0	12.5	12.0	20.9	23.9	23.5	6.8	17.9	10.9	19.7	15.2	16.3	25.8	18.3	31.4	15.8	14.1	38.0	14.5	38.8	13.3	19.1	7.7	18.6	13.0	10.5	16.1	13.2	15.1	14.0	8.4	13.1	15.5	15.1	8.4	15.1	8.9	11.0	17.7	7.4	16.8	22.9	37.8	18.0	16.7	11.2	18.6	15.4	17.7	23.2
SMC4	"CAP-C, hCAP-C, SMC4L1"	ENSG00000113810	"Structural maintenance of chromosomes 4"	Q9NTJ3	3	160399274-160434962	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA condensation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029449, CAB055509"	Approved		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles, Cytosol"		"CAB055509: , HPA029449: AB_10603891"	"unprognostic (2.63e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavourable (7.63e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.28e-2)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.47e-2)"	"prognostic unfavourable (4.20e-5)"	"prognostic unfavourable (9.00e-4)"	"prognostic unfavourable (8.05e-7)"	"unprognostic (3.03e-2)"	"unprognostic (4.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	4.8	5.5	3.0	25.4	4.4	15.1	4.0	3.1	3.2	5.3	10.1	1.7	5.3	6.5	5.2	4.9	19.3	4.6	7.0	5.7	2.4	1.7	4.4	6.3	7.9	16.5	3.1	1.3	4.7	4.2	1.7	10.8	7.4	2.6	4.4	6.9	2.7	5.7	6.9	5.9	4.6	7.0	6.2	3.1	13.1	5.7	20.7	3.2	70.2	5.1	7.6	14.3	7.8	6.3	8.8	6.1	30.5	7.6	7.8	15.8	4.8	62.1	11.5	26.2	12.1	5.0	5.1	12.1	31.0	14.7	35.9	31.2	14.5	35.8	39.4	18.1	12.7	36.0	29.8	15.0	57.8	52.2	20.8	38.1	19.7	4.7	2.8	25.2	31.2	2.6	2.2	19.0	15.5	15.2	21.9	45.8	21.4	11.2	30.9	6.2	15.4	27.1	31.4	41.2	28.6	6.7	7.7	15.8	16.4	23.7	21.9	10.8	26.3	18.9	14.4	23.0	19.2	20.9	56.5	30.6	31.3	71.9	16.4	25.9	25.5	30.5	3.2	12.1	6.7	4.7	6.5	8.8	10.5	8.0	3.5	7.2	6.7	6.0	5.7	7.8	7.6	6.1	15.8	4.8	3.0	4.4	3.1	3.2	2.4	1.7	3.1	1.3	2.6	3.2
SMG6	"C17orf31, EST1A, KIAA0732, SMG-6"	ENSG00000070366	"SMG6, nonsense mediated mRNA decay factor"	Q86US8	17	2059839-2303771	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042932	Approved		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA042932: AB_10964261"	"unprognostic (5.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.30e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.33e-1)"	"unprognostic (9.33e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.63e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (1.30e-6)"	"unprognostic (1.90e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.08e-2)"	12.7	16.6	18.1	18.9	17.6	11.9	10.9	19.1	18.4	15.0	10.6	15.1	13.2	9.0	26.2	11.9	16.1	22.2	16.7	16.4	12.8	15.9	11.5	7.3	11.5	10.7	13.4	16.1	38.7	9.3	16.2	17.2	10.1	14.5	14.5	9.5	18.6	10.4	13.3	14.0	15.3	10.3	18.9	12.8	9.0	9.7	39.2	11.5	22.3	11.6	8.4	16.8	12.7	12.4	2.0	3.3	4.8	3.6	4.6	4.3	1.5	8.4	13.0	18.8	12.1	20.3	16.5	9.7	13.7	15.1	15.6	13.3	15.8	4.3	8.9	4.9	20.1	12.4	13.7	11.7	16.4	8.9	8.6	8.7	6.9	7.7	11.6	4.6	6.3	23.3	8.6	12.6	11.2	14.2	7.1	10.9	11.6	6.7	11.6	3.7	6.0	6.8	12.1	12.0	3.5	9.0	7.8	3.2	9.6	14.3	4.2	5.9	6.5	3.4	18.6	14.4	7.9	15.2	14.3	9.5	5.7	4.2	11.5	5.2	8.3	4.8	1.8	2.0	3.7	0.8	3.7	1.2	3.1	3.5	1.0	2.0	4.3	2.9	1.4	4.6	3.6	3.3	1.8	1.5	18.1	17.6	19.1	18.4	12.8	15.9	13.4	16.1	14.5	11.5
SMG7	"C1orf16, EST1C, KIAA0250, SGA56M, SMG-7"	ENSG00000116698	"SMG7, nonsense mediated mRNA decay factor"	Q92540	1	183472216-183598246	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029350	Supported		Supported	"Intermediate filaments,Cytosol"				"Intermediate filaments, Cytosol"		"HPA029350: AB_10603031"	"unprognostic (6.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.44e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.17e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.40e-3)"	14.6	14.3	20.7	17.1	25.3	30.9	17.6	35.8	29.3	17.6	18.1	19.9	6.6	16.8	16.6	13.6	19.1	22.1	12.9	20.0	17.8	14.8	18.2	18.7	15.6	19.7	16.0	23.1	22.7	18.7	25.9	20.2	18.7	15.9	15.1	20.4	15.9	17.2	14.5	19.2	20.5	17.8	15.2	14.4	18.9	18.3	52.1	15.1	31.6	19.9	12.7	23.9	14.5	22.3	9.3	11.7	11.2	9.6	9.5	10.3	8.0	21.5	13.2	19.0	14.9	13.0	12.4	31.8	13.3	24.5	14.9	11.4	19.5	16.9	30.5	15.3	16.4	23.5	25.6	19.7	17.7	13.5	11.2	24.6	14.3	15.8	13.2	32.2	15.8	11.2	18.1	20.3	47.2	16.2	30.5	21.6	15.4	21.9	22.6	14.2	33.0	7.6	14.3	21.3	23.8	11.4	20.2	25.7	20.1	20.5	29.2	15.9	29.1	13.2	15.4	16.9	17.5	16.7	18.8	23.6	27.7	25.3	13.7	18.3	18.0	3.1	9.3	9.5	9.7	9.6	8.9	9.3	8.8	9.5	10.7	8.5	9.9	10.3	11.2	9.5	5.0	11.7	7.8	8.0	20.7	25.3	35.8	29.3	17.8	14.8	16.0	23.1	15.9	15.1
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188872-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 20.0;AN3-CA: 37.1;NTERA-2: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved									"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	4.0	4.1	4.2	3.8	4.8	0.5	7.4	5.3	4.6	18.2	5.8	5.1	9.2	2.5	20.9	18.7	10.3	11.4	10.0	5.2	8.4	3.7	10.6	13.7	2.4	2.0	4.3	4.5	23.0	7.1	14.4	13.5	2.6	9.0	18.4	2.2	17.2	9.4	12.8	3.5	16.6	3.5	9.8	7.0	2.0	4.2	7.9	3.4	5.3	9.2	6.8	4.6	6.3	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	7.8	20.0	37.1	0.5	0.1	6.3	2.2	2.9	4.4	2.6	6.0	0.1	0.0	6.1	4.4	12.2	12.0	0.6	1.7	0.0	9.8	3.9	0.0	9.6	2.5	0.1	0.0	7.3	4.9	1.4	0.0	2.5	0.6	0.0	1.3	0.0	10.2	0.0	28.4	2.2	14.8	8.5	0.0	2.3	0.0	0.6	13.4	0.0	0.0	5.2	4.9	2.5	0.0	0.3	6.4	7.7	4.2	0.4	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	5.3	4.6	8.4	3.7	4.3	4.5	9.0	3.4
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"			11000	Nucleoplasm	"Actin filaments"	"CAB001721: , HPA051778: , HPA058590: "	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	17.4	3.3	5.0	8.3	3.8	1.5	13.2	12.7	4.7	34.3	99.3	2.0	7.5	10.3	72.4	12.5	26.4	23.5	32.5	27.6	4.3	1.3	7.0	4.7	9.1	1.7	3.6	2.2	18.2	6.8	1.3	2.0	6.0	5.3	34.5	10.6	14.9	4.6	66.7	28.8	6.4	20.3	91.7	1.7	16.9	36.7	6.2	4.0	1.8	5.1	16.8	2.2	61.3	21.4	4.1	1.3	0.3	2.8	0.3	3.1	1.9	19.6	5.9	2.0	7.5	3.1	5.0	16.4	29.5	13.8	24.3	16.7	8.2	6.3	8.8	2.6	16.2	2.9	2.0	17.4	11.5	2.9	16.2	9.3	4.7	9.7	2.8	13.8	16.3	4.1	1.6	32.1	5.3	20.9	9.9	7.3	16.6	17.6	1.5	3.0	2.2	25.1	5.5	5.8	9.3	9.7	6.4	3.2	3.5	9.2	4.4	4.3	5.2	2.2	32.9	17.9	16.9	16.7	21.8	7.0	8.4	5.2	25.9	5.4	55.8	0.0	2.8	0.0	0.5	0.7	0.2	4.1	0.5	1.2	1.3	0.2	3.1	1.7	0.3	0.3	0.7	0.7	0.1	1.9	5.0	3.8	12.7	4.7	4.3	1.3	3.6	2.2	5.3	4.0
SNAPC3	"MGC132011, MGC33124, PTFbeta, SNAP50"	ENSG00000164975	"Small nuclear RNA activating complex polypeptide 3"	Q92966	9	15422704-15465953	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA053145, HPA066031"			Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA053145: , HPA066031: "	"unprognostic (2.62e-1)"	"unprognostic (4.26e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (4.93e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.15e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.36e-3)"	"unprognostic (3.07e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.09e-2)"	9.8	18.5	18.7	10.3	21.1	4.6	10.4	26.3	21.2	17.9	13.2	10.4	10.3	11.6	16.5	15.5	12.6	10.8	10.8	17.5	18.0	14.0	12.3	8.6	10.0	11.2	15.2	16.3	17.4	11.1	12.8	18.4	16.7	21.8	13.3	14.6	9.6	10.5	11.3	19.3	13.7	14.2	12.8	15.2	12.8	10.5	14.7	15.9	11.9	11.3	6.8	10.8	12.9	15.1	12.2	7.7	5.0	21.2	5.0	8.2	5.5	4.1	5.3	11.2	4.2	9.0	9.4	6.5	6.5	2.8	3.8	4.5	2.5	1.8	2.9	2.5	4.0	2.5	5.9	3.0	4.7	13.5	6.9	10.4	11.1	3.4	4.5	2.3	8.1	6.1	6.1	2.7	3.1	7.0	2.9	4.8	8.7	1.3	2.8	7.4	3.6	13.9	5.7	1.3	1.6	6.6	2.5	11.9	8.5	2.2	2.0	1.5	4.8	4.8	5.8	6.4	2.5	2.7	8.1	6.3	7.5	3.6	4.1	3.1	2.9	3.4	10.1	5.0	5.7	16.7	5.5	9.9	5.7	5.1	7.7	12.2	8.2	7.9	1.2	5.0	21.2	6.3	7.9	5.5	18.7	21.1	26.3	21.2	18.0	14.0	15.2	16.3	21.8	15.9
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Cell line enhanced"	"Detected in many"		"HEL: 43.3;HUVEC TERT2: 52.7;RT4: 27.8;SK-MEL-30: 51.7;TIME: 60.3"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"		23000000			"CAB010877: AB_261518, HPA005459: "	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.2	0.0	0.1	0.0	0.1	0.0	8.6	0.3	0.6	0.0	0.0	0.0	2.4	0.0	1.8	10.6	19.7	0.3	0.0	4.8	43.3	24.4	0.0	17.7	0.0	0.3	0.4	7.6	0.0	22.3	52.7	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.9	0.0	3.2	0.0	0.0	27.8	4.6	3.1	0.0	0.0	51.7	0.0	0.0	60.3	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.3	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652180-128092609	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol			1200000	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favourable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	21.5	29.8	25.3	25.3	19.8	22.5	45.4	28.1	28.1	33.3	20.0	13.0	57.7	21.3	36.1	38.4	24.8	26.7	25.3	28.3	20.9	16.6	17.3	39.6	38.8	64.2	20.2	19.0	39.7	130.3	22.2	30.3	33.7	27.6	24.5	20.2	13.9	37.5	66.7	20.5	21.5	19.2	41.0	40.1	24.9	30.8	37.0	18.0	22.3	26.6	13.5	24.9	26.5	24.2	28.1	34.9	16.1	30.0	21.0	30.9	28.5	27.9	25.4	19.5	35.3	29.5	30.9	26.7	33.0	39.0	30.2	34.0	32.8	24.3	37.2	16.7	40.4	23.5	27.4	35.8	29.6	20.3	23.2	20.5	30.4	31.4	53.8	31.7	20.2	45.5	39.9	25.8	43.3	37.5	22.7	37.4	30.1	20.9	34.5	23.8	21.8	31.7	24.1	17.4	83.2	23.7	19.8	24.5	26.5	23.9	111.1	38.2	13.9	22.6	37.2	24.6	16.1	44.6	25.6	46.1	17.3	39.1	49.4	27.4	44.5	16.1	30.0	5.9	26.1	28.1	30.9	28.1	19.8	21.0	32.3	16.2	14.3	15.8	2.2	21.0	22.8	34.9	15.8	28.5	25.3	19.8	28.1	28.1	20.9	16.6	20.2	19.0	27.6	18.0
SNRNP200	"ASCC3L1, BRR2, HELIC2, KIAA0788, RP33, U5-200KD"	ENSG00000144028	"Small nuclear ribonucleoprotein U5 subunit 200"	O75643	2	96274336-96305515	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029321	Approved		Supported	Nucleoplasm			6600	Nucleoplasm		"HPA029321: AB_10604096"	"unprognostic (2.63e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavourable (3.89e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	26.6	25.2	18.4	28.4	21.9	32.0	26.1	37.2	25.8	24.4	23.6	23.7	20.6	18.4	34.7	22.6	23.4	26.5	22.0	22.0	19.7	12.3	19.0	25.8	22.7	25.1	16.6	18.9	39.3	22.7	49.4	25.2	33.7	18.9	21.3	22.0	25.5	28.3	23.0	39.7	25.3	27.6	28.3	15.8	25.2	23.4	34.3	19.5	57.3	25.3	21.3	31.2	33.7	24.0	8.5	7.7	15.3	7.5	9.1	12.6	6.0	23.1	26.3	35.3	26.5	16.5	14.6	33.2	16.0	19.6	29.3	28.1	47.8	17.0	40.3	25.4	20.4	18.4	64.8	21.8	30.4	21.8	34.2	51.6	41.9	25.9	10.7	39.5	22.7	15.1	13.6	33.3	28.4	23.8	45.1	27.2	16.9	20.2	37.0	11.8	46.0	25.5	43.7	34.3	25.3	11.4	34.2	39.2	37.4	26.0	22.3	16.6	21.2	24.7	20.6	24.5	29.7	24.8	23.0	25.3	29.8	50.3	16.5	26.4	26.1	15.3	5.6	7.5	10.1	7.0	12.2	7.8	7.8	12.6	7.3	8.5	7.6	9.3	6.2	9.1	7.5	7.7	8.5	6.0	18.4	21.9	37.2	25.8	19.7	12.3	16.6	18.9	18.9	19.5
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm			30000	Nucleoplasm		"CAB001718: , HPA042050: , HPA043516: "	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favourable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavourable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favourable (5.35e-5)"	46.9	46.5	50.1	65.8	57.0	51.9	29.8	89.6	73.1	36.7	36.2	40.5	46.5	45.8	44.0	38.8	38.9	34.0	35.4	33.3	46.5	34.6	30.6	35.0	29.3	47.6	53.8	49.0	43.3	36.1	37.8	41.8	34.3	43.4	43.0	27.3	26.6	42.7	52.7	73.5	48.1	44.6	28.5	41.5	45.6	45.2	30.5	58.1	34.9	39.8	25.6	37.3	26.9	35.0	5.3	3.2	3.2	3.7	7.9	3.9	1.2	33.9	39.4	27.7	19.8	11.3	7.0	33.9	26.4	16.3	27.6	23.8	23.9	20.1	41.7	25.5	17.0	30.4	34.3	24.9	20.4	27.3	91.4	38.0	19.8	27.2	5.9	41.1	25.6	9.7	6.9	19.7	13.3	20.5	38.9	12.8	16.4	29.4	42.3	65.6	35.0	34.1	49.3	27.5	24.4	16.9	21.3	23.8	28.3	33.1	18.7	17.5	19.6	24.7	30.6	20.2	38.1	17.7	42.2	34.4	29.0	50.7	17.2	26.8	19.0	1.5	3.7	3.2	3.6	2.5	2.1	5.3	2.3	1.5	3.2	3.5	3.9	2.3	1.7	7.9	1.9	2.8	2.4	1.2	50.1	57.0	89.6	73.1	46.5	34.6	53.8	49.0	43.4	58.1
SNRPA	"Mud1, U1-A, U1A"	ENSG00000077312	"Small nuclear ribonucleoprotein polypeptide A"	P09012	19	40750637-40765389	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB004652, HPA046440, HPA054834"	Supported		Supported	Nucleoplasm			23000	Nucleoplasm		"CAB004652: AB_425687, HPA046440: , HPA054834: "	"unprognostic (3.53e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.30e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (1.03e-1)"	"unprognostic (8.04e-2)"	"unprognostic (9.08e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (2.96e-9)"	"unprognostic (2.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.80e-2)"	"unprognostic (7.01e-3)"	27.6	25.0	28.1	35.8	30.8	44.0	39.2	28.8	32.6	31.9	31.8	16.7	33.8	31.2	35.2	35.5	32.8	31.3	27.0	23.6	23.4	19.2	26.9	26.6	28.2	56.3	26.9	19.7	44.7	34.8	16.1	30.6	23.4	25.1	32.3	29.0	19.5	29.7	37.4	43.1	26.6	36.2	41.8	36.4	40.4	27.2	30.9	29.8	49.8	35.1	34.0	37.9	33.2	47.4	14.8	29.9	3.8	17.2	14.2	18.2	11.9	34.5	30.7	35.1	28.2	9.4	11.7	30.0	12.0	16.7	32.2	35.0	25.2	28.7	42.3	17.9	15.9	26.3	34.7	31.1	29.6	23.2	37.8	30.9	25.3	31.6	14.5	35.2	20.4	11.1	7.5	20.6	34.6	28.2	34.4	23.3	21.4	28.4	66.3	56.0	37.6	26.0	58.0	24.4	33.3	21.5	18.5	27.5	28.0	23.4	25.2	19.5	25.1	32.5	15.4	17.1	30.7	18.0	30.0	25.9	28.7	62.3	17.4	39.0	21.8	1.6	15.1	3.8	16.1	17.2	16.8	14.8	16.5	18.2	29.9	13.9	16.9	15.9	1.4	14.2	8.1	18.3	16.2	11.9	28.1	30.8	28.8	32.6	23.4	19.2	26.9	19.7	25.1	29.8
SNRPA1	Lea1	ENSG00000131876	"Small nuclear ribonucleoprotein polypeptide A'"	P09661	15	101281510-101295282	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045622, HPA048499"	Supported		Supported	"Nucleoplasm,Nuclear speckles,Nuclear bodies"				Nucleoplasm	"Nuclear speckles, Nuclear bodies"	"HPA045622: , HPA048499: "	"unprognostic (2.73e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (8.56e-5)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-3)"	"prognostic favourable (8.83e-5)"	"unprognostic (4.74e-2)"	"unprognostic (6.77e-3)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (3.06e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-2)"	11.9	13.3	12.4	26.1	19.6	35.2	17.7	9.7	17.2	9.9	18.0	10.2	10.4	14.6	14.3	21.1	24.6	12.4	11.8	17.3	17.9	9.8	16.1	19.7	14.1	29.2	11.2	12.2	10.8	16.3	9.1	10.7	29.3	14.1	10.3	19.3	11.3	17.2	9.1	13.4	12.1	22.5	11.7	9.4	26.4	15.9	24.3	7.0	33.4	11.6	18.1	30.0	12.3	12.2	21.7	23.5	8.4	18.2	18.3	26.9	15.3	31.2	21.9	21.1	10.7	6.0	4.9	20.8	29.1	13.5	26.2	20.0	46.7	28.0	34.8	16.7	19.7	18.7	31.5	20.8	28.1	17.6	48.7	27.3	35.6	24.6	4.6	31.2	19.6	4.0	15.6	16.7	21.1	16.8	37.9	32.8	16.0	34.6	31.4	33.2	27.0	18.6	31.4	22.8	35.0	19.1	82.2	16.5	17.3	17.7	20.3	21.9	19.6	24.7	12.1	14.0	26.6	16.3	29.0	27.1	80.2	67.6	11.3	29.5	16.5	1.4	15.0	8.4	24.6	18.2	24.1	21.7	25.4	24.2	23.5	19.1	21.2	26.3	2.9	18.3	16.6	22.3	26.9	15.3	12.4	19.6	9.7	17.2	17.9	9.8	11.2	12.2	14.1	7.0
SNRPB	"COD, Sm-B/B', SmB/SmB', snRNP-B, SNRPB1"	ENSG00000125835	"Small nuclear ribonucleoprotein polypeptides B and B1"	P14678	20	2461634-2470853	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003482, CAB009610, HPA067842"	Approved		Supported	Nucleoplasm				Nucleoplasm		"CAB009610: AB_2193859, HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (2.33e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.73e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.07e-5)"	"unprognostic (5.11e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.66e-2)"	"unprognostic (7.30e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (9.47e-2)"	26.6	28.5	14.8	41.1	16.4	78.9	29.0	20.8	17.7	26.3	33.6	10.6	26.8	27.1	34.4	30.2	46.7	26.8	29.6	29.2	10.9	9.9	26.2	36.4	29.3	39.5	18.3	16.5	29.5	34.4	14.7	20.7	35.7	16.6	23.9	23.4	16.0	29.6	21.2	43.8	37.9	27.9	23.4	12.3	39.5	26.9	30.3	15.6	60.1	29.3	51.0	39.6	24.7	28.1	57.9	65.0	36.8	56.9	41.7	63.8	63.7	79.2	108.7	39.2	36.0	8.8	15.8	44.5	35.0	26.7	72.2	58.8	125.9	57.7	59.7	22.4	20.4	58.7	37.8	64.5	36.6	24.5	67.4	40.9	21.9	117.1	31.0	56.6	25.2	18.1	25.0	58.9	26.0	40.1	56.3	43.3	29.4	54.8	88.9	90.7	86.9	52.8	54.1	40.3	72.1	27.0	42.1	42.5	46.6	42.8	58.2	49.9	54.1	62.5	27.7	43.1	36.3	37.8	78.1	36.2	90.8	89.3	14.5	62.9	43.6	36.8	47.1	35.3	59.4	56.9	49.9	57.6	53.0	52.4	62.4	57.9	43.5	50.5	24.4	41.7	56.4	65.0	63.8	63.7	14.8	16.4	20.8	17.7	10.9	9.9	18.3	16.5	16.6	15.6
SNRPB2	"Msl1, U2B''"	ENSG00000125870	"Small nuclear ribonucleoprotein polypeptide B2"	P08579	20	16729961-16742563	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 87.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050814, HPA076104"	Supported		Enhanced	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA050814: , HPA076104: "	"unprognostic (4.73e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (8.45e-2)"	"unprognostic (8.36e-2)"	"prognostic unfavourable (6.03e-7)"	"unprognostic (4.23e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.06e-1)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.77e-1)"	27.1	29.4	30.8	29.9	31.5	46.6	32.4	23.2	33.3	25.1	28.6	18.3	19.5	24.7	33.5	37.9	25.4	28.2	22.8	30.9	31.0	29.7	45.4	30.2	24.7	39.9	28.7	33.0	33.4	21.5	19.7	41.9	35.2	25.5	25.9	28.1	16.9	23.0	25.5	34.7	18.4	30.1	31.8	30.8	36.0	27.0	24.3	28.3	40.8	33.1	31.1	35.7	34.1	22.7	21.2	29.8	29.0	24.5	19.8	30.6	18.1	17.8	17.6	23.2	14.4	11.6	14.7	25.9	17.7	14.8	19.3	19.0	20.2	20.3	28.7	13.9	15.1	16.8	18.2	20.6	27.7	9.4	15.3	26.5	5.8	37.1	13.6	30.9	18.3	14.5	13.8	17.6	13.8	18.1	21.8	13.1	19.6	18.6	35.4	37.5	20.6	23.7	20.3	27.9	20.1	18.7	12.2	12.3	35.3	13.1	36.2	87.1	22.9	25.3	15.3	17.7	17.6	15.8	29.1	11.6	23.7	32.1	8.4	18.4	38.2	26.5	19.5	29.0	19.3	24.3	24.8	21.2	24.5	21.8	20.5	19.6	21.5	23.5	8.4	19.8	24.5	29.8	30.6	18.1	30.8	31.5	23.2	33.3	31.0	29.7	28.7	33.0	25.5	28.3
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757406-34773794	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB034338: AB_2295245, HPA042419: , HPA055490: "	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavourable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	20.9	24.6	28.3	25.5	29.5	56.2	23.5	19.0	26.7	20.3	28.2	19.0	26.9	26.6	28.5	33.7	28.1	32.1	31.6	56.8	24.4	22.4	26.7	34.9	25.3	36.3	27.4	28.3	26.3	62.5	18.5	19.5	27.1	23.8	22.9	24.3	19.7	30.6	26.5	54.9	20.7	27.3	25.0	29.3	28.6	25.5	66.6	26.3	39.8	36.9	47.2	33.7	24.1	21.0	58.6	53.4	32.6	56.7	38.4	58.3	55.5	47.2	29.2	38.5	50.2	20.9	20.4	29.7	27.1	29.8	54.3	46.0	50.4	18.7	53.1	36.3	33.7	22.8	58.0	40.5	44.3	35.4	61.1	41.0	24.9	69.3	36.3	52.1	26.1	25.2	39.6	55.1	39.3	34.4	65.8	31.0	39.1	39.6	62.3	86.2	41.9	35.7	43.2	32.5	51.1	35.0	20.2	47.7	34.3	24.3	25.1	59.4	38.5	78.9	22.8	33.4	39.2	27.1	65.9	34.5	89.6	74.8	15.1	91.2	56.6	26.8	43.8	32.6	35.3	50.1	40.4	58.6	43.5	40.4	50.3	51.0	47.4	43.0	7.9	38.4	56.7	53.4	58.3	55.5	28.3	29.5	19.0	26.7	24.4	22.4	27.4	28.3	23.8	26.3
SNRPD1	"HsT2456, Sm-D1, SNRPD"	ENSG00000167088	"Small nuclear ribonucleoprotein D1 polypeptide"	P62314	18	21612267-21633524	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040516	Supported						490000			"HPA040516: AB_10673236"	"unprognostic (1.83e-2)"	"unprognostic (1.81e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.61e-2)"	"prognostic unfavourable (1.82e-5)"	"unprognostic (5.59e-2)"	"unprognostic (2.15e-3)"	"prognostic favourable (7.90e-6)"	"unprognostic (1.87e-2)"	"unprognostic (7.39e-2)"	"unprognostic (3.87e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.83e-1)"	25.7	27.9	30.3	39.6	28.5	59.7	24.9	26.5	33.3	20.6	35.6	21.3	16.3	32.5	25.8	21.8	42.8	22.0	20.4	20.1	24.7	28.7	28.9	31.4	21.9	50.5	26.8	25.8	30.2	21.9	11.2	34.9	28.0	34.0	21.7	35.9	14.5	22.3	17.2	47.1	24.1	33.9	22.9	26.7	34.5	27.6	27.6	25.7	50.1	20.8	44.1	53.2	24.2	26.0	46.0	51.8	10.7	41.5	29.5	42.5	31.3	34.6	18.0	57.7	27.7	8.7	7.3	25.6	38.8	12.4	26.4	26.0	33.6	17.9	47.2	32.0	15.0	33.1	34.9	24.0	29.2	29.5	25.4	39.2	27.1	41.0	11.7	95.9	35.5	7.9	12.8	24.2	22.9	14.0	38.9	26.8	16.7	26.1	59.6	68.1	44.2	29.6	48.0	41.8	50.2	18.4	26.2	35.8	37.1	32.1	25.1	28.4	17.5	56.1	22.7	26.9	52.8	22.4	64.4	48.2	43.1	94.1	19.7	57.8	30.5	9.9	31.0	10.7	30.2	37.0	32.8	46.0	38.3	36.5	51.8	41.6	40.0	35.3	2.4	29.5	41.5	50.4	42.5	31.3	30.3	28.5	26.5	33.3	24.7	28.7	26.8	25.8	34.0	25.7
SNRPD3	"Sm-D3, SMD3"	ENSG00000100028	"Small nuclear ribonucleoprotein D3 polypeptide"	P62318	22	24555503-24609980	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001170	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			360000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA001170: AB_1080042"	"unprognostic (3.30e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.28e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.20e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	23.7	31.8	23.8	28.9	23.3	29.7	29.5	27.1	27.4	29.3	38.3	24.7	29.8	27.9	31.6	30.6	41.8	30.8	27.1	31.6	21.8	24.2	38.5	61.6	26.5	36.4	24.3	26.8	33.9	34.0	27.8	31.8	33.3	22.6	27.8	33.1	27.9	42.9	27.3	59.0	26.7	35.5	29.6	25.5	32.3	27.8	22.4	23.1	46.8	39.2	61.0	42.7	27.1	30.2	42.5	39.0	38.1	34.9	36.6	33.2	29.8	40.7	14.0	44.0	15.9	16.5	14.2	16.6	39.8	18.3	39.7	37.0	19.9	15.8	36.4	18.8	24.9	30.8	55.8	48.8	40.5	27.7	57.0	39.1	28.2	30.0	18.0	96.4	24.6	16.3	22.7	43.0	22.6	28.9	26.8	18.5	16.2	20.8	41.0	24.0	24.3	20.2	39.5	46.0	18.9	35.4	31.7	20.6	22.9	25.5	16.7	21.2	25.1	26.2	30.4	33.1	33.3	16.6	29.4	19.1	36.9	66.9	16.3	33.2	22.3	12.2	31.4	38.1	28.2	34.9	31.3	42.5	30.7	30.6	39.0	36.3	29.4	33.2	15.7	36.6	34.7	37.1	28.9	29.8	23.8	23.3	27.1	27.4	21.8	24.2	24.3	26.8	22.6	23.1
SNRPF	Sm-F	ENSG00000139343	"Small nuclear ribonucleoprotein polypeptide F"	P62306	12	95858928-95903828	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 93.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														26000				"unprognostic (6.86e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.08e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (2.11e-6)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-2)"	21.3	20.6	23.5	39.6	22.4	45.0	25.7	18.7	20.0	19.1	28.9	9.5	16.4	24.4	20.5	22.9	33.1	16.2	27.5	19.9	19.7	22.7	22.4	33.8	19.8	31.4	20.4	14.6	23.8	26.9	11.9	23.3	18.6	16.2	16.2	22.1	14.8	23.2	23.6	31.1	18.4	23.7	24.2	17.7	22.9	19.0	22.7	17.2	42.2	20.6	56.9	30.0	18.5	20.1	27.4	33.7	6.5	15.1	21.2	29.2	18.7	27.8	22.9	26.0	17.6	7.2	7.2	21.5	14.3	10.0	19.3	13.7	32.8	9.2	31.0	13.8	9.5	19.2	23.2	20.3	15.9	20.6	36.6	29.8	21.1	32.9	9.0	46.3	13.7	7.3	10.1	17.5	17.0	13.3	26.2	6.2	10.3	29.7	40.1	93.4	35.6	51.3	32.0	20.7	22.7	14.1	29.4	26.0	15.4	21.2	20.5	13.7	21.0	36.2	11.5	10.6	18.1	13.8	27.8	9.3	16.1	44.7	5.3	24.4	13.2	2.2	15.1	6.5	18.9	14.4	25.6	27.4	26.8	23.1	33.7	24.3	29.2	26.0	1.4	21.2	11.6	32.1	22.7	18.7	23.5	22.4	18.7	20.0	19.7	22.7	20.4	14.6	16.2	17.2
SNRPN	"HCERN3, PWCR, RT-LI, SM-D, SMN, SNRNP-N, SNURF-SNRPN"	ENSG00000128739	"Small nuclear ribonucleoprotein polypeptide N"	P63162	15	24823637-24978723	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 122.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003482, HPA067842"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA003482: AB_1857337, HPA067842: AB_2685909"	"unprognostic (9.91e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-2)"	"unprognostic (6.59e-2)"	"prognostic favourable (8.93e-8)"	"unprognostic (4.45e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.74e-2)"	7.9	35.1	62.2	7.8	73.4	5.6	13.0	65.6	74.7	21.4	9.4	18.4	14.2	6.5	11.6	64.8	8.0	22.8	25.9	84.7	55.9	68.3	35.8	12.4	13.0	14.9	51.3	47.4	28.4	20.3	49.8	42.8	6.5	51.6	33.0	6.4	17.3	22.4	29.1	34.9	6.3	7.9	10.9	31.9	13.3	10.3	9.6	21.3	9.9	55.5	6.8	14.1	12.9	7.8	48.6	71.0	23.6	9.6	36.3	73.7	67.3	0.1	22.3	40.9	28.0	24.2	11.0	0.1	7.3	15.2	4.9	9.0	20.6	10.6	0.0	14.6	17.8	4.2	0.0	21.7	2.8	12.2	0.0	13.5	14.3	22.2	28.7	16.1	12.2	20.8	9.3	10.7	12.7	14.6	3.6	0.0	27.9	0.0	32.2	0.2	122.2	9.5	16.8	15.4	0.0	26.4	33.6	24.2	23.2	0.1	0.5	26.1	14.4	41.4	9.7	12.3	12.6	0.0	4.4	34.5	18.5	21.1	10.4	11.0	9.2	23.6	9.3	13.7	44.6	9.5	49.9	48.6	55.2	50.6	8.7	45.1	73.7	60.6	2.5	36.3	9.6	71.0	55.4	67.3	62.2	73.4	65.6	74.7	55.9	68.3	51.3	47.4	51.6	21.3
SNTB1	"59-DAP, A1B, BSYN2, SNT2, SNT2B1, TIP-43"	ENSG00000172164	"Syntrophin beta 1"	Q13884	8	120535745-120813273	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 43.7;liver: 53.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 33.1;U-266/70: 34.7;U-937: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA024659	Uncertain				"Intracellular and membrane"		200000			"HPA024659: AB_1857713"	"unprognostic (1.32e-1)"	"unprognostic (2.77e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.76e-2)"	"unprognostic (6.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.72e-1)"	"unprognostic (2.00e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	6.9	43.7	4.7	4.9	5.1	8.1	12.4	2.1	3.0	4.9	4.1	5.0	1.1	2.8	2.8	2.1	7.7	2.9	5.4	2.2	5.9	3.8	6.2	53.4	14.5	5.0	4.5	2.9	2.4	22.4	0.2	2.3	3.8	6.8	3.3	3.1	6.9	27.4	1.7	12.7	5.9	3.2	4.3	3.3	10.8	11.3	4.2	4.9	3.6	33.8	7.8	4.6	4.8	4.9	1.5	1.6	6.8	1.6	3.1	5.4	1.5	0.0	0.8	0.2	0.0	4.3	8.9	0.0	2.5	14.0	0.7	1.2	5.6	0.6	0.0	5.0	2.7	0.0	0.8	0.0	0.5	2.7	2.8	0.0	0.3	33.1	0.4	6.2	0.0	4.4	0.0	4.5	0.0	0.1	0.0	12.8	2.1	1.5	0.0	4.9	0.9	3.8	0.0	17.3	0.0	13.0	0.9	0.0	0.2	1.0	4.6	11.3	0.5	11.2	0.0	9.7	0.7	0.0	0.8	34.7	13.6	14.3	7.6	18.9	11.1	4.3	1.6	6.8	5.4	0.8	1.3	1.5	1.1	2.8	1.6	0.7	3.0	3.0	0.5	3.1	0.6	0.1	0.0	1.5	4.7	5.1	2.1	3.0	5.9	3.8	4.5	2.9	6.8	4.9
SNTB2	"D16S2531E, EST25263, SNT2B2, SNT3, SNTL"	ENSG00000168807	"Syntrophin beta 2"	Q13425	16	69187129-69309052	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (4.86e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-3)"	"unprognostic (6.46e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.64e-2)"	"unprognostic (5.77e-3)"	"unprognostic (1.71e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.88e-1)"	20.7	8.4	5.8	10.2	7.9	3.8	13.4	5.3	9.4	22.9	12.2	4.5	13.3	5.5	17.8	10.9	16.1	13.0	10.4	8.6	4.8	3.2	14.1	5.8	12.7	7.2	4.8	4.8	13.9	6.6	31.9	7.2	7.4	5.3	16.7	7.8	26.0	8.3	8.4	8.8	12.7	9.6	15.7	5.0	8.6	9.3	10.5	4.0	6.4	22.8	6.8	7.5	18.3	20.2	1.0	0.6	3.0	1.0	2.6	3.7	0.9	4.0	6.1	4.3	3.3	15.7	21.2	5.2	7.8	11.0	6.2	6.9	6.0	3.7	5.0	4.8	9.1	7.3	5.7	3.8	8.1	2.2	3.1	2.2	6.0	5.1	5.2	0.1	3.4	15.1	2.8	10.2	4.1	18.5	1.3	7.9	7.5	4.5	1.6	0.7	2.9	4.9	10.0	3.8	9.4	3.3	6.1	1.6	3.5	24.1	3.5	2.4	4.1	0.3	14.3	11.7	5.6	8.2	7.2	1.8	2.7	5.7	7.5	0.7	5.3	1.1	1.0	1.0	3.2	1.0	3.3	1.0	1.6	1.8	0.6	0.8	1.0	3.7	3.0	2.6	1.0	0.4	1.6	0.9	5.8	7.9	5.3	9.4	4.8	3.2	4.8	4.8	5.3	4.0
SNTG1	"G1SYN, SYN4"	ENSG00000147481	"Syntrophin gamma 1"	Q9NSN8	8	49909789-50796691	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"brain: 22.7;lymphoid tissue: 7.8;pituitary gland: 10.4"	"Cell line enriched"	"Detected in some"	8	"RH-30: 10.6"	"Cancer enhanced"	"Detected in single"		"glioma: 2.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072282	Enhanced									"HPA072282: "					"unprognostic (4.60e-2)"		"unprognostic (1.72e-2)"		"unprognostic (2.47e-1)"		"unprognostic (1.05e-2)"			"unprognostic (6.94e-2)"	"unprognostic (2.03e-1)"		"unprognostic (1.16e-3)"	0.7	1.9	7.4	0.6	13.3	1.6	0.7	2.4	22.7	0.7	0.8	1.1	0.0	0.7	0.7	2.0	0.6	0.9	0.8	0.5	11.9	4.7	1.6	1.9	0.8	0.8	3.3	9.1	0.7	1.4	0.6	10.4	0.7	3.3	0.8	1.0	0.0	0.8	1.0	0.6	1.1	0.7	0.8	2.1	7.8	0.8	3.1	3.8	0.0	0.8	0.0	0.6	2.3	0.3	1.3	0.8	2.3	1.2	0.5	1.0	0.5	0.0	0.0	1.0	0.0	0.2	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.3	0.0	0.2	0.2	1.1	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.5	0.4	0.1	0.3	1.4	0.0	0.2	0.8	0.1	0.0	0.1	10.6	0.0	0.4	0.3	0.4	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.4	0.1	0.2	2.3	0.5	0.5	0.7	0.5	0.7	1.3	0.8	0.8	0.3	1.3	1.0	0.8	1.1	0.5	1.2	0.8	1.0	0.5	7.4	13.3	2.4	22.7	11.9	4.7	3.3	9.1	3.3	3.8
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Cytosol				Cytosol		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavourable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	23.4	25.9	19.9	16.0	21.9	16.6	26.7	25.2	30.1	20.1	23.3	16.1	17.8	17.7	23.8	37.0	17.1	17.8	17.4	17.4	19.5	24.2	33.2	41.0	23.8	17.7	21.6	18.0	17.9	27.7	27.2	35.5	29.6	30.8	21.1	22.2	19.9	17.7	20.2	9.6	17.1	31.0	15.8	20.7	24.6	26.8	49.1	17.1	16.1	26.1	11.2	18.2	22.6	15.1	8.9	16.4	20.0	24.1	13.4	13.3	8.9	14.9	9.1	15.0	22.0	34.4	25.2	15.8	19.2	26.5	15.1	23.4	16.5	25.3	19.7	23.8	24.7	20.3	10.3	19.8	23.9	17.4	6.0	21.5	12.7	24.7	28.4	20.1	22.4	22.0	15.0	17.6	17.9	26.8	21.7	17.1	32.8	17.4	1.2	38.5	6.0	10.3	8.1	30.6	9.4	36.8	27.8	6.6	15.1	11.7	26.0	17.8	16.1	36.1	23.9	12.0	7.5	14.9	19.9	17.2	27.3	7.3	24.6	23.8	24.1	18.1	13.6	20.0	13.3	20.3	10.0	8.9	9.0	11.9	16.4	8.8	8.2	10.3	6.3	13.4	24.1	4.8	10.2	8.9	19.9	21.9	25.2	30.1	19.5	24.2	21.6	18.0	30.8	17.1
SNX18	"SH3PX2, SH3PXD3B, SNAG1"	ENSG00000178996	"Sorting nexin 18"	Q96RF0	5	54517759-54546585	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037800	Approved		Approved	Cytosol				Cytosol		"HPA037800: AB_10672465"	"unprognostic (2.22e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.26e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.13e-2)"	"unprognostic (3.81e-3)"	"prognostic favourable (1.58e-4)"	"unprognostic (6.79e-3)"	"unprognostic (7.96e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	16.2	9.0	10.1	9.2	13.5	50.3	17.8	5.8	9.9	13.0	12.1	20.3	13.8	8.1	14.7	7.6	11.4	11.5	11.8	13.1	10.3	9.0	11.6	13.9	12.1	18.7	18.3	7.0	23.8	8.1	17.4	5.3	18.4	12.7	14.5	5.2	10.9	11.4	13.9	7.7	9.6	8.8	12.5	23.3	26.0	11.7	13.5	15.0	6.7	15.0	5.4	6.6	15.1	26.2	1.2	4.2	6.7	6.1	1.7	1.3	0.6	3.9	3.3	5.2	5.9	12.2	13.1	28.4	6.6	16.7	3.4	5.8	4.0	7.3	0.1	11.1	10.2	3.7	4.9	6.5	4.4	2.1	3.7	1.1	2.1	2.5	20.4	2.2	1.2	20.6	7.9	4.7	5.0	7.2	2.1	27.6	6.0	3.7	2.0	2.5	2.6	3.5	5.5	2.9	6.3	3.4	11.5	6.5	3.9	5.5	6.4	7.2	7.5	3.7	2.4	13.1	6.6	9.6	6.9	18.8	18.1	1.1	5.0	5.2	13.5	0.0	1.6	0.2	1.3	2.6	0.3	1.2	0.6	0.8	1.9	1.2	0.3	1.0	6.7	1.7	6.1	4.2	0.3	0.6	10.1	13.5	5.8	7.9	10.3	9.0	18.3	7.0	12.7	15.0
SNX19	"CHET8, KIAA0254"	ENSG00000120451	"Sorting nexin 19"	Q92543	11	130875436-130916509	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013447	Uncertain		Supported	Mitochondria				Mitochondria		"HPA013447: AB_1857347"	"unprognostic (8.79e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (9.19e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.97e-2)"	"prognostic favourable (3.56e-5)"	"unprognostic (1.05e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	22.3	23.1	24.0	16.9	30.6	10.0	17.2	18.0	38.0	17.1	23.8	35.6	25.3	17.1	22.9	32.5	17.9	19.8	20.4	22.6	22.8	22.2	24.1	25.6	17.5	15.3	31.0	15.3	20.6	26.6	32.9	28.5	18.5	28.0	21.7	22.2	23.7	23.1	27.2	26.4	19.0	17.8	26.0	30.8	18.5	22.3	36.2	28.2	24.6	31.1	12.1	18.1	23.0	16.4	5.9	5.4	11.3	6.6	3.6	6.2	5.2	6.7	7.4	9.6	13.4	28.9	20.4	6.3	18.0	21.4	9.1	9.5	8.4	13.0	6.4	12.6	19.8	12.3	1.4	12.9	11.7	10.3	5.8	11.6	7.4	0.0	21.0	0.0	9.1	23.2	16.0	9.3	10.2	11.1	10.2	0.0	19.4	4.9	9.4	7.7	2.9	9.5	7.2	9.1	3.7	9.9	12.2	9.4	8.7	7.7	12.4	6.1	22.0	7.3	14.7	12.8	9.5	10.4	10.5	2.2	0.0	0.0	5.3	7.7	14.6	11.3	6.0	4.4	4.8	6.4	6.2	5.9	4.7	5.7	5.3	4.4	5.6	4.4	3.6	3.6	6.6	5.4	4.1	5.2	24.0	30.6	18.0	38.0	22.8	22.2	31.0	15.3	28.0	28.2
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.8	8.7	9.3	11.7	14.7	10.9	20.7	3.2	6.6	5.6	6.0	7.1	7.8	5.6	6.9	5.1	7.3	11.9	6.4	7.1	7.9	4.5	8.9	5.1	7.9	9.8	10.6	6.1	8.6	4.8	6.4	7.4	6.3	5.4	34.5	7.3	10.5	6.3	7.3	16.4	5.6	6.6	9.0	7.2	8.7	8.9	9.3	8.0	8.5	15.9	6.1	10.2	9.0	8.3	8.0	5.4	8.3	6.6	7.2	7.3	11.3	9.5	6.9	8.9	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261260	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										730000				"prognostic unfavourable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavourable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	63.4	66.9	67.1	36.1	59.2	73.4	125.2	34.4	63.8	40.7	45.5	32.5	29.9	34.3	38.8	47.2	60.2	37.4	39.1	81.1	62.3	53.5	49.3	77.7	42.1	53.6	57.7	41.2	55.8	41.1	27.7	27.8	57.2	34.1	49.7	34.0	25.3	37.9	37.6	82.7	32.4	38.1	52.1	53.7	52.3	32.4	34.3	35.1	35.7	69.7	46.7	45.9	52.6	179.0	52.3	34.3	42.0	20.0	16.3	13.5	16.6	26.0	15.9	15.7	51.4	85.8	64.8	24.5	40.1	39.3	31.1	38.8	25.0	19.4	22.2	39.7	50.9	20.8	34.8	33.7	42.8	27.5	25.6	43.3	20.0	28.9	46.4	29.1	29.2	55.0	46.5	29.8	33.9	51.3	41.5	26.5	43.1	24.8	10.9	63.8	13.2	28.2	11.9	38.2	22.9	49.3	36.6	18.3	25.8	25.4	32.5	40.2	16.3	99.8	38.5	26.9	18.3	36.2	50.9	10.9	14.3	23.7	47.6	53.4	32.1	24.6	20.0	42.0	10.5	17.8	13.5	52.3	12.4	11.0	28.7	40.9	12.7	10.4	12.9	16.3	16.9	34.3	12.3	16.6	67.1	59.2	34.4	63.8	62.3	53.5	57.7	41.2	34.1	35.1
SNX4	ATG24B	ENSG00000114520	"Sorting nexin 4"	O95219	3	125446644-125520197	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005709	Uncertain									"HPA005709: AB_1080049"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.91e-2)"	"prognostic unfavourable (6.10e-4)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.33e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.99e-2)"	"prognostic favourable (5.01e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.05e-1)"	18.8	22.1	19.9	18.3	17.3	11.5	21.1	20.3	20.2	17.8	24.6	16.7	10.8	28.8	17.6	13.6	15.1	12.5	16.5	17.1	20.8	20.4	43.1	45.2	15.7	14.2	20.1	17.6	15.6	18.5	13.3	19.3	26.1	18.7	19.5	23.2	11.7	17.8	14.7	32.4	10.2	38.7	17.3	27.7	15.0	17.4	14.4	13.3	20.5	37.3	10.8	13.6	14.0	13.5	12.3	15.6	21.0	15.7	14.4	15.1	10.7	16.8	5.4	17.5	10.9	10.9	9.1	19.9	9.2	8.7	18.3	16.5	11.6	7.7	10.7	10.9	11.1	9.0	16.2	7.8	22.0	10.0	11.9	17.3	7.5	17.5	12.8	18.2	11.3	11.8	8.6	9.2	7.5	17.1	18.5	5.5	13.9	12.6	19.9	12.3	10.2	6.5	18.5	21.3	19.6	16.9	15.1	18.4	26.0	14.8	19.3	22.6	19.0	30.0	11.0	9.2	11.7	11.9	10.7	11.2	9.5	29.6	11.3	11.7	13.9	9.3	12.4	21.0	9.0	15.7	11.8	12.3	11.6	10.2	15.6	9.5	15.1	12.9	2.2	14.4	15.1	13.8	12.7	10.7	19.9	17.3	20.3	20.2	20.8	20.4	20.1	17.6	18.7	13.3
SNX6		ENSG00000129515	"Sorting nexin 6"	Q9UNH7	14	34561094-34630183	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049374	Approved		Supported	Endosomes,Lysosomes				"Endosomes, Lysosomes"		"HPA049374: "	"unprognostic (1.89e-1)"	"unprognostic (6.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-3)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.23e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.68e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.10e-2)"	35.7	27.0	26.7	23.0	23.2	16.3	29.4	19.0	21.5	20.8	28.1	30.7	17.7	37.0	37.9	18.0	24.9	16.3	21.6	19.0	28.3	22.0	30.4	18.6	17.6	33.5	33.7	18.1	20.7	15.5	61.1	19.1	46.2	26.7	22.3	24.3	14.7	20.1	18.6	20.3	18.3	38.4	23.2	50.9	33.6	20.8	23.1	23.3	28.5	21.5	19.6	21.9	28.5	22.5	30.5	29.4	56.0	43.1	29.8	43.9	45.2	31.7	18.0	21.0	13.6	32.7	67.4	29.5	31.4	34.8	32.4	28.4	17.3	39.7	20.6	26.3	41.2	22.5	22.2	23.2	56.7	25.2	8.9	12.4	11.0	31.6	28.1	21.8	15.5	43.3	25.6	22.1	32.2	44.0	13.3	17.1	43.3	18.3	19.6	10.7	11.4	21.6	21.0	24.3	20.8	41.3	24.3	16.5	17.8	25.3	22.0	26.3	28.4	14.2	43.2	23.3	16.6	22.5	20.1	15.8	25.7	23.4	12.7	12.0	25.9	26.7	32.8	39.5	32.3	43.1	41.7	30.5	43.9	37.4	29.4	27.0	33.6	36.0	56.0	29.8	39.7	19.3	42.7	45.2	26.7	23.2	19.0	21.5	28.3	22.0	33.7	18.1	26.7	23.3
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 44.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Enhanced	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA031410: AB_10603339, HPA057203: "	"unprognostic (1.63e-3)"	"prognostic unfavourable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavourable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favourable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	44.7	18.9	13.0	16.5	14.7	17.2	35.4	6.7	16.2	27.4	24.6	19.8	43.5	18.1	32.1	19.5	31.4	17.2	26.4	20.4	12.2	10.8	17.8	25.4	14.6	22.5	19.7	11.4	19.8	22.5	17.7	10.8	45.0	13.3	25.0	17.7	11.1	25.2	41.7	16.5	21.2	28.0	44.6	16.4	19.8	21.5	10.9	18.4	5.0	18.4	17.9	20.3	34.0	40.2	4.1	11.2	1.3	7.3	0.5	6.7	1.0	7.8	5.1	5.5	6.4	27.4	24.4	11.6	15.7	44.3	10.7	14.4	4.5	8.0	0.0	7.8	24.3	5.2	6.4	10.5	9.0	6.4	7.5	4.9	7.9	6.8	13.7	2.6	10.0	14.4	9.4	11.0	10.8	14.8	24.9	0.0	5.2	4.4	0.0	3.9	4.3	6.7	0.0	5.5	8.9	17.3	4.6	3.5	6.4	10.0	4.6	24.0	2.2	5.6	12.0	11.9	5.4	38.0	8.3	0.0	0.0	0.0	23.8	2.0	6.9	0.0	1.0	1.3	0.6	3.2	2.4	4.1	1.7	1.3	2.0	3.4	6.7	2.1	0.1	0.5	7.3	11.2	2.8	1.0	13.0	14.7	6.7	16.2	12.2	10.8	19.7	11.4	13.3	18.4
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	55.6	48.7	34.2	34.2	45.8	31.9	28.4	47.0	28.1	32.0	24.2	63.1	35.4	66.7	49.5	43.3	20.2	49.0	34.6	26.4	49.2	60.9	107.6	63.9	90.2	30.3	47.5	40.3	33.1	26.4	44.8	24.9	35.9	74.2	85.3	38.5	90.4	51.0	47.9	51.4	52.0	43.9	69.0	103.7	62.5	34.2	37.4	31.4	87.1	46.1	45.2	53.0	42.0	42.0	24.9	55.1	33.6	34.6	65.2	141.0	79.0	50.8	69.3	33.0	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8
SOD2		ENSG00000285441	"Superoxide dismutase 2"	P04179	6	159679119-159762529	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.2;bone marrow: 4.9;seminal vesicle: 3.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.0"									"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in single"																		140000000																					0.0	0.0	0.0	0.2	0.4	4.9	0.3	0.0	1.7	0.0	0.1	1.6	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0		0.3	1.0	0.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	1.6	0.5	0.2	1.0	0.1	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.7	0.0	0.0	0.0	0.2	0.0	0.0	3.2	0.4	0.9	0.4	0.2	0.8	0.2	0.0	0.3	0.4	0.4	1.4	1.3	0.5	0.1	2.0	0.8	1.4	0.5	0.2	0.1	0.4	0.4	0.3	1.0	1.8	0.5	0.2	0.0	0.2	0.4	0.7	0.6	0.1	0.1	1.0	1.4	1.6	0.0	0.1	0.2	0.6	0.4	0.0	0.7	0.1	0.1	0.0	0.5	0.3	0.4	0.4	0.0	0.7	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.3	0.0	0.6	0.6	0.2	0.2	0.2	0.1	0.6	0.4	0.4	0.7	0.2	0.1	3.2	0.6	0.4	0.4	0.9	0.8	0.4	0.9	0.2	0.4	0.2	0.5	0.2										
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 19.4;BJ: 10.8;PC-3: 15.6;RPTEC TERT1: 65.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	50375000	830000000			"HPA042110: "	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	90.0	9.9	3.7	13.8	5.0	0.8	31.9	1.6	8.3	46.4	24.7	14.7	8.0	10.4	34.4	21.1	52.1	39.5	55.1	61.9	6.4	1.9	40.4	3.9	40.1	6.7	3.4	6.2	36.1	41.0	1.6	4.6	30.4	24.3	40.0	8.1	45.0	13.7	15.5	16.1	19.9	13.7	53.6	5.4	8.4	25.4	25.9	2.1	4.4	68.0	25.2	17.7	61.1	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	5.1	0.5	10.8	4.7	0.6	0.4	0.1	0.0	0.0	3.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	4.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	2.3	15.6	0.0	0.0	0.1	65.8	0.2	0.0	0.0	0.0	0.3	0.0	9.8	0.0	0.0	2.5	0.3	0.4	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	5.0	1.6	8.3	6.4	1.9	3.4	6.2	24.3	2.1
SOGA1	"C20orf117, dJ132F21.1, FLJ44670, KIAA0889, SOGA"	ENSG00000149639	"Suppressor of glucose, autophagy associated 1"	O94964	20	36777442-36863686	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 55.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043992	Approved		Approved	Nucleoli,Cytosol	"Secreted to blood"			"Nucleoli, Cytosol"		"HPA043992: "	"unprognostic (2.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (8.28e-5)"	"unprognostic (1.09e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (4.49e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.45e-3)"	6.2	11.4	10.8	4.5	10.6	1.4	6.0	55.5	12.5	11.3	8.3	20.5	7.2	2.5	8.8	5.3	7.2	9.4	9.9	6.7	9.9	7.5	4.7	1.3	6.1	3.0	12.7	8.9	12.6	3.7	11.5	4.4	7.9	8.7	10.7	3.9	6.7	4.4	12.3	2.9	11.0	4.6	14.1	7.9	5.3	5.3	14.8	14.7	0.9	16.0	4.7	4.1	8.0	10.5	1.0	2.1	1.4	0.7	0.7	0.2	0.2	7.4	10.2	12.4	13.3	7.2	6.6	3.2	6.6	7.1	9.3	5.6	4.1	1.2	3.3	2.4	11.5	10.1	9.9	6.1	9.8	0.5	1.9	5.3	9.5	5.4	3.8	1.2	5.2	3.7	7.5	8.9	6.4	6.1	3.7	0.7	10.2	7.2	3.7	2.8	3.1	7.9	8.9	11.5	1.2	5.5	2.2	14.8	9.2	13.6	15.0	4.3	19.1	8.0	9.2	23.5	4.6	11.5	14.3	1.4	0.3	3.3	10.0	1.6	14.8	1.4	0.7	0.2	0.1	0.4	0.2	1.0	0.1	0.1	0.4	1.0	0.2	0.2	1.4	0.7	0.3	2.1	0.1	0.2	10.8	10.6	55.5	12.0	9.9	7.5	12.7	8.9	8.7	14.7
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: "	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.2	13.7	35.6	20.1	31.5	28.5	25.6	19.1	25.6	20.3	19.2	22.8	19.8	44.3	11.2	31.8	20.3	41.3	31.9	32.3	18.3	20.2	57.4	18.8	30.2	23.4	54.1	26.4	30.2	37.2	23.9	36.8	30.8	43.2	44.7	29.1	27.5	28.9	30.5	38.8	16.0	28.4	38.0	32.7	31.3	24.4	20.5	20.2	32.0	27.4	22.1	25.0	31.8	30.5	21.7	20.2	16.3	20.7	42.0	34.4	52.9	23.3	46.4	21.1	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4
SORBS3	"SCAM-1, SH3D4, vinexin"	ENSG00000120896	"Sorbin and SH3 domain containing 3"	O60504	8	22544986-22575788	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015849	Approved		Approved	"Focal adhesion sites,Cytosol"			6600	Cytosol	"Focal adhesion sites"	"HPA015849: AB_1857365"	"unprognostic (6.15e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.44e-2)"	"unprognostic (5.83e-3)"	"unprognostic (1.70e-1)"	"prognostic favourable (4.88e-4)"	"unprognostic (4.21e-2)"	"unprognostic (3.08e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavourable (1.53e-5)"	52.2	22.6	25.0	16.8	23.2	3.3	56.5	31.4	27.0	49.3	28.9	21.9	19.2	19.6	40.6	32.0	27.5	33.8	42.8	32.8	27.3	12.8	28.1	41.8	38.9	28.7	21.3	18.0	49.0	21.7	27.0	24.1	43.3	22.8	38.0	23.7	45.8	36.6	34.5	29.5	32.0	34.5	41.9	24.1	28.6	20.4	36.0	21.2	3.4	29.7	36.2	15.7	38.4	44.7	0.8	5.6	0.4	3.2	4.0	17.4	3.3	22.4	28.3	15.5	17.4	25.1	33.6	15.8	23.1	35.9	27.1	16.9	28.7	10.1	0.1	15.8	36.0	19.4	23.2	21.1	14.1	15.8	10.1	1.9	16.0	13.1	28.6	0.2	0.1	21.1	15.8	9.4	13.9	20.9	4.9	0.7	19.2	8.8	1.9	0.7	5.4	11.9	21.5	10.5	2.1	12.3	4.4	0.9	13.9	11.3	2.7	14.3	4.7	8.0	32.5	24.1	17.3	17.5	16.2	0.4	0.6	3.0	14.1	5.3	16.3	0.0	1.6	0.4	8.6	3.2	17.4	0.6	9.4	9.9	5.6	0.8	9.7	5.6	0.4	4.0	0.7	1.9	0.4	3.3	25.0	23.2	31.4	27.0	27.3	12.8	21.3	18.0	22.8	21.2
SORCS2	KIAA1329	ENSG00000184985	"Sortilin related VPS10 domain containing receptor 2"	Q96PQ0	4	7192538-7742836	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.1"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.5;HaCaT: 16.3;HMC-1: 12.3;RPMI-8226: 7.2;SiHa: 11.7;THP-1: 6.9;U-937: 7.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061916			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA061916: "	"unprognostic (1.38e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-3)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavourable (3.09e-4)"	"unprognostic (2.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.27e-3)"	4.9	2.6	12.0	6.4	16.6	3.3	1.8	4.8	22.4	13.8	4.0	32.1	3.2	3.1	6.0	8.2	4.7	3.5	7.1	3.2	10.7	6.9	7.4	5.2	8.3	2.0	9.9	11.2	7.4	1.7	0.8	2.7	0.9	11.2	7.5	2.6	7.5	2.6	5.3	2.4	1.9	4.2	11.5	11.2	1.3	1.9	3.4	11.3	0.8	6.2	2.2	2.7	5.2	3.7	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.9	1.1	0.2	0.1	0.0	0.0	0.1	0.0	1.4	0.4	0.1	0.5	0.0	6.5	4.1	16.3	0.0	0.0	0.2	0.0	0.0	0.0	2.4	0.2	0.1	0.0	12.3	0.2	3.6	5.1	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.3	0.7	0.0	1.3	7.2	0.2	0.0	0.7	0.6	11.7	0.0	0.0	0.0	6.9	0.0	4.2	1.2	0.0	0.1	0.0	0.0	0.0	1.4	7.1	0.2	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.1	12.0	16.6	4.8	17.7	10.7	6.9	9.9	11.2	11.2	11.3
SORD		ENSG00000140263	"Sorbitol dehydrogenase"	Q00796	15	45023104-45077185	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 66.3;liver: 98.4;thyroid gland: 116.3"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 72.5"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"eosinophil: 36.4"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 36.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040260, HPA040621"	Enhanced		Approved	Cytosol			430000	Cytosol		"HPA040260: AB_10794872, HPA040621: AB_10795384"	"unprognostic (8.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.90e-2)"	"prognostic favourable (6.14e-5)"	"unprognostic (3.33e-3)"	"unprognostic (1.67e-1)"	"unprognostic (4.95e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.56e-1)"	1.4	10.2	3.0	1.5	3.2	1.0	7.1	3.1	3.8	66.3	5.5	6.2	39.2	2.6	2.6	3.2	6.7	3.5	3.9	3.4	3.0	3.0	20.9	98.4	1.6	2.2	4.2	2.3	1.6	7.3	1.2	1.8	0.5	5.0	48.5	3.8	2.3	7.6	46.7	1.4	8.0	8.7	2.0	5.0	2.4	5.6	2.5	3.9	3.1	116.3	3.8	3.5	4.2	4.4	1.6	2.4	36.4	2.7	0.4	1.0	1.3	15.8	13.9	3.5	11.4	3.1	5.4	3.7	4.4	3.0	10.0	8.5	11.5	8.6	2.0	9.9	5.4	23.8	18.2	16.6	8.0	34.3	11.3	15.9	18.2	25.5	2.3	27.5	26.6	6.9	12.6	5.7	9.2	9.3	17.7	5.6	9.4	6.3	16.6	14.9	13.6	14.8	0.0	23.0	7.7	7.3	15.4	25.0	13.1	8.9	14.1	6.7	20.3	11.3	8.3	8.0	7.0	17.8	10.5	1.0	6.9	2.0	12.9	24.4	20.7	5.0	2.7	36.4	0.6	2.5	1.0	1.2	0.6	0.8	2.4	1.6	0.5	0.6	1.4	0.4	2.5	1.3	0.6	1.3	3.0	3.2	3.1	3.8	3.0	3.0	4.2	2.3	5.0	3.9
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452203-121633693	"Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 44.1;Daudi: 20.7;RT4: 31.2;U-698: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 43.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"					"CAB011500: AB_443414, HPA031321: "	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	5.6	5.0	17.3	17.0	24.9	30.7	10.5	28.3	40.8	34.8	12.7	36.0	9.9	8.6	4.5	7.2	5.7	29.4	5.8	3.0	22.4	18.7	15.0	41.4	10.0	14.8	28.6	21.9	7.3	6.1	19.9	17.7	2.1	24.0	16.0	12.7	6.4	14.7	20.0	1.5	3.9	13.0	3.8	27.8	21.3	7.9	4.1	23.4	11.1	10.3	0.2	16.3	15.8	6.7	2.0	5.6	43.8	5.4	6.7	10.8	6.1	0.4	2.4	2.3	0.3	0.0	0.0	2.3	0.1	0.7	0.1	0.0	3.6	44.1	20.7	2.7	0.5	14.6	2.8	2.1	0.0	0.0	0.8	0.0	3.3	5.0	0.0	8.8	0.0	0.0	2.4	0.0	8.2	0.0	0.0	0.2	0.0	2.9	2.1	4.5	2.7	3.3	2.3	0.1	0.4	4.9	31.2	1.6	0.4	4.6	6.7	0.0	6.5	2.8	0.1	0.0	1.6	0.3	0.0	0.0	0.0	43.0	0.0	11.8	0.1	13.0	5.4	19.1	8.0	2.3	10.8	0.7	9.0	7.2	2.2	2.0	8.6	7.6	43.8	6.7	2.8	5.6	6.3	6.1	17.3	24.9	28.3	40.8	22.4	18.7	28.6	21.9	24.0	23.4
SOS1	"GF1, GINGF, HGF"	ENSG00000115904	"SOS Ras/Rac guanine nucleotide exchange factor 1"	Q07889	2	38981396-39124345	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005396	Uncertain		Approved	Cytosol				Cytosol		"CAB005396: AB_2270724"	"unprognostic (6.68e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-3)"	"unprognostic (4.02e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.96e-3)"	"unprognostic (7.61e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.33e-2)"	25.9	13.2	19.2	18.8	18.1	12.0	26.1	33.3	18.6	18.6	21.9	12.1	15.3	18.3	19.1	14.6	17.4	17.0	18.1	16.4	17.9	14.1	14.6	15.2	19.9	19.9	18.2	14.0	28.1	13.0	33.5	21.7	21.5	17.8	18.4	16.8	14.6	15.9	18.1	26.2	15.0	23.1	22.3	14.6	16.2	20.1	12.7	20.1	23.1	19.4	12.9	21.8	25.1	22.0	3.2	1.4	3.2	2.0	6.2	4.6	0.9	9.7	6.0	9.4	6.7	12.7	15.2	9.8	6.2	7.6	4.9	4.7	6.5	5.9	14.2	4.2	8.0	5.8	11.0	5.6	9.2	14.2	4.9	22.0	5.2	8.9	5.2	7.0	55.8	9.3	9.0	6.7	6.5	7.7	9.3	6.7	6.3	5.3	7.5	6.5	5.8	4.3	8.4	8.5	4.1	5.2	7.9	9.1	9.1	7.3	13.2	7.6	4.2	3.7	8.6	8.2	6.7	6.4	6.1	7.9	8.0	7.5	6.6	6.9	4.9	0.0	1.2	3.2	3.2	1.8	4.6	3.2	3.3	3.3	1.0	2.4	3.7	3.4	1.4	6.2	2.0	1.4	1.9	0.9	19.2	18.1	33.3	18.6	17.9	14.1	18.2	14.0	17.8	20.1
SOS2		ENSG00000100485	"SOS Ras/Rho guanine nucleotide exchange factor 2"	Q07890	14	50117120-50231558	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004577, HPA047368, HPA052689"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB004577: AB_628270, HPA047368: , HPA052689: "	"unprognostic (7.99e-2)"	"unprognostic (6.17e-2)"	"unprognostic (7.80e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.81e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.99e-2)"	"unprognostic (8.21e-2)"	"prognostic favourable (8.48e-8)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.57e-2)"	16.0	12.9	16.9	10.5	17.8	25.2	13.4	15.8	14.5	12.9	20.1	19.8	23.4	15.5	14.9	17.3	12.7	11.2	11.4	15.3	17.7	13.4	18.4	9.4	12.5	15.6	19.9	9.8	11.8	11.6	38.6	20.5	30.1	15.1	13.0	13.0	11.1	14.3	14.7	37.1	13.0	26.7	18.3	23.1	17.0	12.1	19.2	16.8	14.7	18.7	14.6	10.3	15.3	15.0	1.2	2.1	8.5	2.8	2.4	1.8	0.6	9.5	7.1	14.4	9.6	11.1	12.1	6.8	8.6	9.5	6.5	8.2	3.1	12.7	10.0	7.8	10.9	8.8	7.7	6.5	11.7	16.8	2.8	10.1	5.5	5.3	12.2	11.8	10.8	12.5	16.1	6.1	14.2	14.0	7.7	25.3	15.6	7.9	9.7	9.4	4.4	6.2	10.6	20.0	7.5	10.6	9.1	10.4	12.2	9.5	11.4	11.2	12.6	14.5	15.3	18.0	11.8	8.1	5.6	17.8	19.3	12.5	4.7	6.6	10.6	8.5	1.8	4.1	1.8	1.4	1.5	0.9	1.1	1.3	1.2	1.2	1.3	1.2	7.2	2.4	2.8	2.1	0.1	0.6	16.9	17.8	15.8	14.5	17.7	13.4	19.9	9.8	15.1	16.8
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box 13"	Q9UN79	1	204073115-204127743	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.6;SK-BR-3: 49.4;T-47d: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 4.1;T-cells: 2.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA051790: , HPA054843: "	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	22.2	10.7	11.0	6.9	8.6	0.8	18.4	9.2	9.9	37.0	17.2	14.4	16.1	13.5	30.3	12.4	10.9	22.3	16.4	9.7	11.0	6.9	19.0	12.3	20.5	4.3	13.7	7.0	13.5	12.8	34.2	5.6	27.3	14.3	23.5	8.3	13.7	13.1	18.7	14.2	9.9	16.8	18.2	12.1	8.4	8.2	8.7	13.3	0.1	10.4	7.5	7.0	19.5	19.2	0.0	0.0	0.5	0.0	4.1	2.6	0.3	8.4	5.4	11.7	0.8	11.2	3.4	23.6	3.3	1.9	5.2	3.2	4.5	6.3	0.0	10.8	2.1	13.7	4.4	4.3	2.5	3.9	2.2	0.0	3.7	5.0	2.5	0.0	4.9	3.5	2.1	3.3	2.9	7.5	0.0	0.0	1.0	10.3	0.0	0.0	15.5	6.6	0.1	4.0	5.1	3.9	19.5	1.8	0.9	3.3	49.4	14.7	22.0	1.0	4.3	1.1	3.1	5.0	2.3	0.0	0.0	0.0	1.8	0.1	3.1	0.2	0.0	0.5	2.5	0.0	2.6	0.0	1.2	1.4	0.0	0.0	0.0	1.0	0.3	4.1	0.0	0.0	0.0	0.3	11.0	8.6	9.2	9.9	11.0	6.9	13.7	7.0	14.3	13.3
SP110	"IFI41, IFI75"	ENSG00000135899	"SP110 nuclear body protein"	Q9HB58	2	230167293-230225729	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 65.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 28.4;BJ hTERT+ SV40 Large T+ RasG12V: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA047036, HPA058554"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA047036: AB_10963065, HPA058554: "	"unprognostic (9.72e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.02e-2)"	"unprognostic (8.33e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (2.38e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.99e-3)"	"unprognostic (9.50e-3)"	21.4	8.9	6.5	29.9	12.1	17.6	12.3	3.1	7.5	10.2	8.9	11.6	3.2	7.6	13.5	8.0	11.1	8.1	11.7	8.6	6.0	5.7	10.0	10.4	14.6	43.4	10.7	4.6	12.7	10.0	8.9	13.0	11.2	8.9	12.2	9.4	9.3	10.3	5.4	8.0	7.9	18.6	9.5	12.7	45.2	9.2	4.0	10.3	32.7	8.4	5.7	35.1	14.3	13.2	36.0	21.3	65.9	31.7	13.2	16.5	10.4	3.1	1.7	1.0	1.8	5.7	9.5	3.4	6.0	12.1	28.4	40.7	0.0	5.0	13.6	5.6	6.1	2.0	3.8	9.2	10.7	12.2	2.3	5.7	2.6	3.4	5.9	8.3	6.9	13.4	4.6	8.3	11.9	9.8	2.0	4.9	8.0	1.9	12.4	16.2	3.5	2.0	7.8	10.1	5.1	22.8	4.3	0.2	2.3	2.2	4.9	12.1	3.7	7.1	7.2	5.2	3.2	1.2	2.9	5.3	1.8	6.8	5.7	7.9	4.2	18.6	12.0	29.1	14.7	20.4	12.6	36.0	14.1	12.9	10.6	34.5	14.6	15.2	65.9	13.2	31.7	21.3	16.5	10.4	6.5	12.1	3.1	7.5	6.0	5.7	10.7	4.6	8.9	10.3
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favourable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	18.8	15.0	16.9	21.9	20.5	19.1	21.0	28.5	23.4	17.3	16.3	26.9	12.5	16.9	20.5	16.2	19.9	18.3	14.9	20.2	13.8	11.8	17.2	13.3	17.4	22.3	14.1	13.0	20.5	19.7	31.0	14.5	21.4	18.5	16.2	15.8	26.9	18.7	18.2	30.2	19.2	20.8	16.6	17.6	22.2	16.5	23.2	16.3	31.9	21.7	16.0	28.3	18.9	18.0	8.3	6.3	14.3	9.3	12.7	11.5	7.8	16.3	18.9	13.0	11.0	6.4	6.0	12.4	9.6	7.1	10.0	9.1	20.6	8.3	14.2	8.7	12.6	12.6	9.0	8.4	10.6	20.6	12.7	14.4	12.7	10.6	6.0	12.8	17.1	8.7	9.9	11.8	11.1	9.5	15.5	24.2	9.6	22.2	31.6	8.1	5.9	12.6	14.4	17.8	8.9	7.0	26.5	13.0	15.6	8.4	8.9	9.5	12.9	12.2	15.5	17.6	9.4	12.3	14.8	21.6	23.8	12.7	9.6	8.7	14.2	14.3	8.0	12.1	11.5	9.3	10.1	7.0	8.8	10.7	6.3	8.3	10.2	10.3	14.3	12.7	8.1	6.1	8.8	7.8	16.9	20.5	28.5	23.4	13.8	11.8	14.1	13.0	18.5	16.3
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120865	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 6.3;neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"				"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: "	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavourable (8.10e-4)"	21.6	16.4	32.1	12.5	42.6	15.8	13.8	32.7	46.6	15.9	15.6	44.8	7.6	14.0	19.6	9.1	20.7	12.3	18.8	15.1	33.1	25.5	23.6	22.8	20.5	8.7	55.7	25.9	22.2	21.0	25.8	14.6	21.8	37.1	13.2	14.1	12.2	9.9	14.4	39.6	14.2	14.2	19.1	50.2	12.1	10.5	33.3	55.2	8.5	28.2	9.5	10.6	15.0	13.6	1.0	1.3	13.4	1.3	0.5	1.8	0.4	17.5	19.7	25.4	12.3	24.1	21.4	22.4	14.5	14.2	16.3	20.3	17.7	12.1	9.5	10.1	23.7	15.2	16.6	12.1	30.3	14.4	19.7	7.9	15.6	13.1	18.1	11.4	9.3	15.4	14.2	21.9	39.4	13.3	17.5	10.6	22.9	8.8	7.2	4.8	6.7	25.7	8.2	28.3	8.4	14.9	33.5	19.7	27.5	12.7	11.9	13.1	9.7	13.7	18.5	45.4	10.7	34.9	21.1	15.1	21.7	15.6	15.5	6.8	15.7	6.3	1.3	0.8	1.4	0.8	1.0	1.0	1.2	1.3	1.3	1.0	0.7	0.9	13.4	0.5	0.5	1.1	1.8	0.4	32.1	42.6	32.7	34.9	33.1	25.5	55.7	25.9	37.1	55.2
SPARC	ON	ENSG00000113140	"Secreted protein acidic and cysteine rich"	P09486	5	151661096-151687165	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 230.6;BJ: 188.2;fHDF/TERT166: 297.7;WM-115: 218.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 9.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 9.3;monocytes: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002306, HPA002989, HPA003020"	Supported		Approved	Vesicles	"Secreted to blood"		190000000	Vesicles		"CAB002306: AB_563919, HPA002989: AB_1079532, HPA003020: AB_1079531"	"unprognostic (3.34e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.97e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (3.53e-5)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.53e-1)"	"unprognostic (4.93e-3)"	178.3	58.3	50.2	47.4	93.3	3.4	68.6	33.8	131.3	115.6	42.8	92.3	22.9	13.2	89.0	65.9	36.9	38.5	177.8	65.5	68.3	100.3	46.3	25.0	66.8	25.4	124.7	18.0	55.1	14.1	36.7	16.8	249.1	153.5	46.3	22.4	47.5	15.8	45.3	31.2	40.2	20.6	144.0	202.0	43.8	20.4	75.2	68.8	7.4	38.6	39.4	14.8	104.6	35.9	0.0	0.8	9.3	3.0	0.0	0.3	40.6	0.2	0.2	55.7	2.6	230.6	78.2	5.2	188.2	62.0	78.0	80.4	0.2	0.1	0.0	44.7	297.7	2.5	7.0	14.3	26.9	0.2	2.6	2.5	0.0	5.1	69.0	0.1	0.2	122.1	20.6	57.4	8.0	107.0	2.3	2.0	44.3	0.0	0.2	1.6	25.7	0.2	0.1	55.3	0.1	0.0	0.0	2.1	4.2	0.1	0.0	25.0	0.2	6.1	126.4	36.4	56.3	16.4	59.1	0.1	0.2	0.2	31.8	0.1	218.8	2.2	3.0	0.9	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	9.3	0.0	0.0	0.7	0.0	40.6	50.2	93.3	33.8	24.6	68.3	100.3	124.7	18.0	153.5	68.8
SPARCL1	MAST9	ENSG00000152583	"SPARC like 1"	Q14515	4	87473335-87531061	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"AF22: 22.1;U-266/70: 8.7"	"Cancer enhanced"	"Detected in all"		"glioma: 528.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB026225	Enhanced				"Secreted in other tissues"		660000000			"CAB026225: "	"unprognostic (1.02e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.88e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.45e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.88e-3)"	"prognostic unfavourable (3.33e-4)"	102.2	21.9	110.3	18.8	139.9	0.9	52.1	42.9	212.1	123.2	58.0	17.9	23.8	19.7	148.7	74.6	56.4	92.8	74.7	80.9	98.8	40.9	13.2	4.5	58.7	14.6	67.5	106.4	45.2	13.0	15.8	38.3	48.8	69.7	97.0	30.4	7.9	31.5	166.0	35.2	13.1	27.4	185.6	82.5	23.9	40.8	29.2	53.9	1.2	38.8	24.4	15.6	103.9	50.3	0.0	0.3	0.1	0.1	0.0	0.8	0.0	0.6	0.0	22.1	0.3	0.2	0.1	2.2	0.1	0.1	0.0	0.0	0.0	0.1	0.4	1.8	0.0	1.3	2.4	0.0	0.0	1.8	0.0	0.3	1.1	0.4	1.0	0.3	1.3	3.5	0.0	0.0	0.0	0.0	0.4	3.2	0.0	0.5	0.1	3.3	0.6	0.0	0.3	0.3	1.0	0.0	0.1	0.7	1.8	0.2	0.2	0.1	0.3	0.4	0.0	0.2	0.3	1.3	0.1	8.7	1.2	0.5	3.4	0.4	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.3	0.0	0.0	110.3	139.9	42.9	136.4	98.8	40.9	67.5	106.4	69.7	53.9
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063547-32157637	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	12.7	9.6	18.4	14.8	16.4	13.4	9.8	21.1	21.9	14.7	12.7	15.1	12.5	11.5	12.3	8.7	11.1	10.4	10.2	6.2	20.2	18.5	9.4	14.6	9.7	18.9	20.6	10.0	15.1	10.9	11.8	12.3	11.5	17.5	10.3	12.0	6.8	9.3	13.7	15.4	11.5	17.6	11.6	27.0	15.5	9.7	14.4	14.6	21.5	13.4	6.2	13.8	11.3	10.1	5.0	7.1	9.5	9.0	6.6	7.6	4.3	10.6	7.7	12.6	12.4	8.0	9.4	11.4	5.9	8.7	6.2	5.6	10.4	9.3	18.6	5.5	8.2	7.6	12.4	6.0	7.7	12.5	7.5	20.5	4.2	12.7	7.3	14.2	14.4	5.2	7.9	7.9	7.6	13.7	16.6	6.3	6.8	4.5	22.8	12.0	13.1	4.5	12.1	17.8	12.1	8.4	6.6	18.0	19.3	10.0	8.5	9.8	5.5	9.8	11.8	6.9	10.6	6.1	6.9	9.5	17.7	15.1	7.5	12.3	8.2	3.4	6.3	6.7	3.6	9.0	5.2	5.0	5.8	5.6	7.1	3.9	5.9	6.0	9.5	6.6	6.3	3.2	7.6	4.3	18.4	16.4	21.1	15.8	20.2	18.5	20.6	10.0	17.5	14.6
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.4;HDLM-2: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favourable (1.16e-4)"	5.5	11.8	14.7	13.9	23.7	21.4	11.8	5.5	15.2	9.2	8.8	33.7	10.9	9.4	7.8	11.9	3.2	8.2	9.8	6.4	15.3	10.5	13.1	17.8	15.3	16.8	27.9	7.4	12.1	29.7	6.1	8.3	13.7	17.7	12.1	10.2	7.5	6.8	9.8	2.4	6.3	11.5	6.2	25.7	47.8	13.8	5.2	27.2	11.9	10.7	3.1	12.8	6.5	4.5	1.2	2.5	19.3	4.7	9.6	17.7	5.8	1.7	2.9	15.2	1.9	0.5	1.3	0.6	4.4	19.4	2.3	1.9	3.7	7.7	11.6	2.4	4.0	3.3	4.3	1.3	5.8	26.2	5.2	2.8	2.2	4.2	0.7	4.4	2.2	1.7	0.2	2.5	1.4	3.8	0.0	9.8	2.4	6.4	8.1	1.5	4.9	3.7	7.1	5.8	6.1	10.3	5.7	5.5	4.2	0.9	9.6	8.6	1.3	2.6	4.4	3.0	2.4	0.2	3.1	2.2	0.0	0.0	2.6	4.3	14.2	2.4	3.1	0.0	17.3	4.0	13.5	1.2	14.7	17.7	2.2	1.0	15.6	16.0	19.3	9.6	4.7	2.5	13.8	5.8	14.7	23.7	5.5	15.2	15.3	10.5	27.9	7.4	17.7	27.2
SPCS2	KIAA0102	ENSG00000118363	"Signal peptidase complex subunit 2"	Q15005	11	74949247-74979031	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013386	Approved		Approved	Nucleoplasm			220000	Nucleoplasm		"HPA013386: AB_1857426"	"unprognostic (2.43e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.65e-2)"	"unprognostic (7.09e-3)"	"unprognostic (9.30e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.04e-3)"	"unprognostic (9.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.62e-2)"	21.8	32.8	29.1	25.8	29.2	13.4	28.7	20.0	26.8	36.5	30.4	26.8	49.5	23.2	32.3	61.6	23.3	25.8	21.4	25.2	29.8	27.5	30.0	46.5	24.0	25.3	33.4	33.5	24.0	75.5	41.6	26.7	28.5	32.9	29.2	31.1	18.6	55.9	34.9	26.4	17.2	24.0	24.8	33.4	30.1	26.5	24.2	27.6	20.3	43.9	14.9	38.7	23.8	21.4	78.2	89.7	86.4	45.9	47.9	65.4	71.8	22.7	26.9	35.8	32.1	31.6	21.3	19.6	32.7	32.0	30.2	26.5	52.7	51.7	37.1	41.5	27.6	42.0	31.0	24.0	37.7	30.6	22.7	37.6	32.7	43.5	36.0	39.8	26.5	18.9	31.2	25.4	41.8	28.9	43.2	96.8	27.3	34.7	28.4	25.5	22.0	25.6	35.4	55.2	84.1	34.7	38.1	29.1	29.3	32.6	44.0	107.2	42.5	30.6	23.2	34.4	21.4	35.7	28.9	41.4	41.8	68.8	14.1	28.3	34.8	86.4	45.9	41.3	58.3	44.4	65.4	78.2	54.0	55.9	43.4	62.1	41.4	49.6	29.6	47.9	38.2	89.7	50.9	71.8	29.1	29.2	20.0	26.8	29.8	27.5	33.4	33.5	32.9	27.6
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15847864-15940460	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA015825: AB_1856823, HPA050257: "	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	18.2	11.2	18.2	18.2	22.2	27.2	17.3	38.2	25.9	18.5	13.4	20.7	17.7	11.9	19.0	12.7	16.7	19.4	11.8	13.5	17.6	11.5	14.4	13.2	17.8	16.6	23.4	17.5	31.2	23.9	35.1	17.5	16.2	19.0	14.9	13.3	11.6	16.2	16.2	24.0	22.8	16.0	15.1	22.0	16.5	13.7	13.6	23.3	18.3	20.1	8.7	18.0	17.1	41.9	5.0	2.7	7.7	2.4	1.3	1.7	0.6	12.5	10.7	13.4	10.0	13.4	8.2	7.2	6.5	8.6	7.1	6.0	9.6	9.8	17.8	7.8	12.8	18.2	12.5	11.6	11.5	15.9	34.7	22.3	9.4	6.1	6.1	18.3	10.7	6.0	8.4	10.6	15.4	8.0	23.1	18.3	5.7	7.0	15.1	7.2	6.0	8.2	14.6	13.0	11.0	4.0	11.3	10.3	10.4	18.3	9.0	7.8	3.2	9.0	14.5	6.5	8.1	12.6	9.3	11.1	7.2	20.3	6.4	14.7	9.1	7.7	1.5	0.9	1.6	2.4	1.3	1.8	1.7	1.4	0.7	5.0	0.9	1.3	4.2	1.3	1.2	2.7	1.1	0.6	18.2	22.2	38.2	25.9	17.6	11.5	23.4	17.5	19.0	23.3
SPIN1	"SPIN, TDRD24"	ENSG00000106723	"Spindlin 1"	Q9Y657	9	88388419-88478694	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Meiosis, Wnt signaling pathway"	"Chromatin regulator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000162, HPA068784"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA000162: AB_1080079, HPA068784: "	"unprognostic (1.53e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.96e-2)"	"unprognostic (8.78e-2)"	"unprognostic (8.32e-2)"	"prognostic favourable (8.69e-6)"	"unprognostic (4.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.56e-1)"	12.2	15.0	28.3	9.4	34.2	7.0	19.7	22.6	38.0	34.9	14.4	23.7	10.2	10.4	34.4	44.0	15.5	28.6	17.5	15.6	27.1	28.7	24.9	11.3	14.1	8.3	21.7	27.2	32.2	12.2	28.4	19.6	26.9	26.3	21.6	14.1	16.8	12.9	24.6	3.5	13.4	12.1	25.7	22.0	9.9	11.6	18.5	15.9	12.7	22.9	6.8	9.1	15.4	21.3	4.5	8.1	8.1	4.2	4.2	7.8	4.9	23.2	11.6	19.2	16.2	13.1	15.4	22.5	23.4	21.7	26.8	19.7	8.5	13.6	12.9	13.9	28.6	35.8	14.2	21.2	30.8	13.5	8.7	6.2	24.5	9.0	12.1	14.1	6.8	12.8	22.2	18.1	25.6	15.2	7.9	0.0	30.0	16.0	23.8	6.4	31.6	10.9	32.0	20.9	4.2	24.2	16.4	27.2	20.5	27.8	17.6	10.2	13.5	11.2	14.4	17.8	19.0	26.4	16.5	5.4	8.0	11.3	21.5	13.1	16.6	8.1	4.2	6.4	6.7	3.8	7.1	4.5	5.0	6.9	8.1	3.4	7.1	7.8	0.6	4.2	3.3	3.8	4.5	4.9	28.3	34.2	22.6	38.0	27.1	28.7	21.7	27.2	26.3	15.9
SPINK1	"PCTT, PSTI, Spink3, TATI"	ENSG00000164266	"Serine peptidase inhibitor, Kazal type 1"	P00995	5	147824568-147831786	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"pancreas: 1767.1"	"Group enriched"	"Detected in some"	8	"CACO-2: 43.1;RT4: 118.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 513.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB026366, HPA027498"	Enhanced				"Secreted to digestive system"		7900000			"CAB026366: , HPA027498: AB_10603115"	"unprognostic (1.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.96e-3)"	"unprognostic (3.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.79e-4)"	"unprognostic (8.34e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavourable (5.44e-7)"	"unprognostic (7.98e-2)"	"unprognostic (2.07e-1)"		"prognostic favourable (2.15e-5)"	0.3	0.0	0.3	1.6	0.3	0.0	0.3	0.3	0.3	0.3	6.0	0.3	0.3	6.3	0.3	0.3	0.3	0.0	1.5	0.3	0.3	0.0	2.0	13.3	0.4	0.3	0.3	0.3	0.3	1767.1	0.0	0.3	0.3	0.3	1.4	6.4	0.3	0.3	0.3	0.3	0.0	6.9	1.0	0.3	0.3	25.8	0.4	0.3	0.3	0.3	0.3	0.3	13.1	2.2	0.7	0.5	1.9	0.5	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	43.1	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	10.7	0.0	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	118.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.4	0.3	0.5	0.2	2.1	0.0	0.0	1.9	0.4	0.2	0.4	0.5	0.2	0.4	0.4	0.3	0.1	0.7	0.5	0.6	1.8	0.3	0.4	0.5	0.1	0.1	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 12.1;HeLa: 17.9;Karpas-707: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"		28000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	12.1	0.0	1.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.2	0.7	15.8	0.0	1.7	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	4.6	2.4	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.1	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"		3400000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA006903: AB_1079038, HPA031178: "	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	18.8	0.1	0.0	0.1	0.0	0.0	51.3	0.3	0.4	0.6	0.3	30.0	31.5	0.0	22.5	0.0	58.6	4.8	28.2	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	14.9	0.0	41.7	0.6	2.6	2.3	0.4	0.1	0.0	14.6	0.1	2.5	5.8	2.7	1.9	0.0	3.7	28.4	47.5	12.6	0.6	1.4	88.0	2.3	42.0	2.4	0.0	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.1	2.4	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7
SPINT2	"HAI-2, Kop"	ENSG00000167642	"Serine peptidase inhibitor, Kunitz type 2"	O43291	19	38244035-38292614	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 81.3;CAPAN-2: 120.0;hTCEpi: 66.8;RPTEC TERT1: 89.5;RT4: 69.4;SK-BR-3: 78.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA011101, CAB018969"	Approved		Uncertain	"Plasma membrane,Intermediate filaments,Cytosol"				"Plasma membrane, Intermediate filaments, Cytosol"		"CAB018969: , HPA011101: AB_1079039"	"unprognostic (5.13e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (3.41e-4)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.68e-2)"	1.5	7.2	11.9	15.1	14.0	10.7	29.2	14.3	20.8	24.0	46.3	4.7	63.2	38.3	7.1	44.9	60.6	30.4	51.8	3.3	10.4	22.9	47.5	2.8	25.6	10.3	9.3	14.6	15.3	78.7	30.2	82.7	77.3	11.0	29.6	40.3	15.3	143.1	61.6	0.7	41.7	82.3	13.1	5.6	9.4	34.1	87.0	2.8	15.0	95.6	32.0	37.5	27.1	25.0	23.1	73.9	70.7	17.9	2.6	13.2	17.6	81.3	59.1	0.3	0.3	0.0	0.0	38.7	1.5	0.1	0.1	0.2	41.8	120.0	0.6	6.6	0.4	27.0	4.2	57.9	0.1	0.7	4.9	15.3	1.5	0.0	0.1	0.1	0.0	0.0	66.8	0.0	28.3	0.2	0.3	0.0	0.1	63.0	2.4	0.2	5.9	16.6	8.3	0.0	36.6	89.5	69.4	22.3	0.3	24.2	78.7	0.2	35.1	10.1	0.0	0.1	0.4	0.3	0.3	5.5	7.0	4.5	0.1	1.0	0.1	57.2	17.9	70.7	0.5	12.5	1.1	20.0	6.5	3.2	41.7	23.1	13.2	11.9	7.8	2.6	8.4	73.9	2.5	17.6	11.9	14.0	14.3	20.8	10.4	22.9	9.3	14.6	11.0	2.8
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11, initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329759-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	142	"testis: 14.2"	"Group enriched"	"Detected in some"	19	"Daudi: 1.7;SiHa: 1.3;U-698: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPON1	"f-spondin, KIAA0762"	ENSG00000262655	"Spondin 1"	Q9HCB6	11	13962689-14267884	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.2"	"Group enriched"	"Detected in some"	35	"EFO-21: 41.0;RPTEC TERT1: 115.2"	"Cancer enhanced"	"Detected in all"		"ovarian cancer: 199.1"					"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 7.3"	"Lineage enriched"	"Detected in single"	74	"T-cells: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038584, HPA077546"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Actin filaments,Microtubule ends,Cytokinetic bridge"	"Secreted to blood"	11500000	27000000	"Nucleoli, Microtubule ends"	"Nucleoplasm, Actin filaments, Cytokinetic bridge"	"HPA038584: AB_10697394, HPA077546: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (3.12e-4)"	"unprognostic (7.22e-3)"	"unprognostic (7.89e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavourable (1.88e-4)"	16.8	5.1	8.3	5.2	12.5	0.0	3.3	4.8	10.7	15.7	9.7	7.6	0.0	9.6	12.0	4.6	5.3	20.3	40.2	4.9	7.2		5.4	0.1	8.1	0.7	5.1	8.8	12.0	0.8	0.0	2.0	12.3	7.5	7.2	15.0	8.5	0.9	2.5	0.0	1.6	12.4	15.7	3.2	1.8	3.9	0.8	5.7	0.0	0.8	0.6	0.0	15.6	9.9	0.0	0.0	0.0	0.0	0.0	7.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	115.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.3	0.0	1.3	0.7	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3										
SPON2	DIL1	ENSG00000159674	"Spondin 2"	Q9BUD6	4	1166932-1208962	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"HHSteC: 53.9;HSkMC: 95.0"	"Cancer enriched"	"Detected in all"	7	"prostate cancer: 243.7"	"Region enhanced"	"Detected in many"		"cerebellum: 10.7"	"Cell type enhanced"	"Detected in many"		"gdT-cell: 54.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 54.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040170, HPA066095"	Approved		Approved	Vesicles	"Secreted to blood"		1600000	Vesicles		"HPA040170: AB_2676868, HPA066095: "	"unprognostic (1.22e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-2)"	"prognostic favourable (2.03e-4)"	"unprognostic (7.64e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.28e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavourable (9.22e-4)"	18.5	10.2	0.9	11.7	4.2	7.2	27.9	10.7	3.4	63.7	18.0	1.0	6.4	8.5	46.7	25.7	13.9	11.6	26.6	14.4	1.8	0.0	19.3	35.7	13.9	1.6	0.5	1.5	24.2	4.8	0.1	3.2	44.9	1.9	39.4	3.2	3.4	6.3	7.6	8.9	9.1	14.2	23.1	0.6	6.7	9.6	10.6	0.9	1.1	3.5	21.0	3.0	20.1	22.8	0.2	8.7	2.1	0.4	10.0	54.2	22.7	0.0	0.1	0.0	0.0	1.7	12.9	0.5	1.1	0.6	0.1	0.2	0.0	0.0	0.3	1.8	4.4	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	53.9	0.0	0.2	95.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.8	2.4	0.6	0.1	0.1	0.6	1.3	0.0	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.1	3.9	0.0	0.2	0.4	0.1	0.0	1.3	0.0	0.8	0.1	0.1	54.2	0.2	1.1	0.1	7.6	22.3	0.1	0.2	3.4	22.0	2.1	10.0	0.4	8.7	0.0	22.7	0.9	4.2	10.7	3.4	1.8	0.0	0.5	1.5	1.9	0.9
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell line enhanced"	"Detected in some"		"EFO-21: 213.7;Hep G2: 105.2;RPTEC TERT1: 466.7"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"CAB002212, HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	180200000	54000000	"Golgi apparatus"		"CAB002212: AB_564074, HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavourable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.1	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	213.7	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	105.2	0.0	0.2	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.9	9.9	0.0	0.1	0.0	50.1	466.7	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	19.5	0.0	19.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9
SPP2	SPP24	ENSG00000072080	"Secreted phosphoprotein 2"	Q13103	2	234050679-234077134	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	879	"liver: 113.0"	"Cell line enhanced"	"Detected in some"		"HEL: 1.1;RH-30: 3.4;RPTEC TERT1: 1.0;U-698: 1.4"	"Cancer enriched"	"Detected in some"	112	"liver cancer: 65.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"								"Secreted to blood"		540000000										"prognostic favourable (2.33e-6)"	"unprognostic (7.02e-3)"		"unprognostic (9.62e-3)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.4	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765808	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles				Vesicles		"HPA036062: AB_10611670, HPA067304: "	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	20.5	23.5	6.9	18.0	8.6	15.0	23.3	6.2	8.1	16.4	29.3	10.8	15.3	24.9	14.5	17.9	18.7	13.0	14.9	37.6	7.8	5.3	23.3	44.8	19.2	23.9	8.3	6.1	13.2	32.7	61.0	11.8	32.2	14.4	14.7	26.9	14.9	21.7	15.5	63.1	15.8	39.2	20.5	8.5	21.2	18.3	10.2	7.4	21.6	15.6	17.4	17.7	19.7	13.9	9.8	19.4	24.0	27.3	11.9	15.4	22.4	15.2	26.5	10.3	13.7	40.9	24.4	16.3	24.6	41.3	22.6	32.3	30.7	17.7	9.5	18.4	48.1	23.0	12.4	14.9	25.3	19.4	7.6	18.0	18.2	15.9	33.8	11.1	29.4	21.2	27.5	18.7	30.3	22.2	13.5	37.4	29.8	35.2	5.2	4.3	4.5	6.0	6.5	16.1	20.8	31.1	35.5	8.3	9.4	14.8	28.6	16.6	20.3	22.1	27.0	36.6	14.7	23.4	28.9	15.2	26.0	10.5	16.5	18.8	24.9	21.2	26.9	24.0	15.4	24.6	9.7	9.8	12.6	13.9	19.4	9.3	7.2	11.5	19.4	11.9	27.3	17.1	15.4	22.4	6.9	8.6	6.2	8.1	7.8	5.3	8.3	6.1	14.4	7.4
SPR	SDR38C1	ENSG00000116096	"Sepiapterin reductase"	P35270	2	72887360-72892158	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 61.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 9.3;intermediate monocyte: 2.6;myeloid DC: 9.9"	"Group enriched"	"Detected in many"	13	"dendritic cells: 9.9;monocytes: 9.3"	"Low region specificity"	"Detected in all"							HPA039505	Uncertain		Supported	Nucleoplasm,Cytosol			52000	"Nucleoplasm, Cytosol"		"HPA039505: AB_10795466"	"unprognostic (4.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.50e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.95e-1)"	13.3	22.6	6.3	6.1	8.2	0.0	36.2	2.0	6.4	6.0	17.1	3.1	8.9	11.4	5.7	19.1	13.4	13.2	11.4	16.1	6.4	6.0	20.3	43.5	7.2	5.3	7.9	5.0	8.7	61.7	16.7	5.5	3.9	7.9	17.3	16.2	4.5	20.9	8.8	16.0	3.3	15.1	9.5	4.9	4.7	15.4	4.9	7.2	1.0	31.7	6.2	3.6	9.5	41.4	0.0	9.9	0.7	9.3	0.0	0.4	2.5	13.9	39.2	0.2	6.1	16.1	5.8	9.8	6.6	9.6	4.9	4.6	24.9	14.5	10.2	7.9	7.8	13.2	17.5	10.5	4.1	2.9	13.6	15.3	9.7	25.5	6.0	2.4	4.2	5.2	11.8	5.4	6.1	12.9	15.7	2.0	6.4	29.4	0.9	9.1	3.3	37.5	0.0	25.5	6.0	26.0	21.9	2.4	4.6	12.1	27.3	8.9	12.3	2.9	15.8	5.4	13.2	9.4	11.5	2.2	4.9	0.7	7.7	5.2	9.3	0.0	9.3	0.7	0.4	2.6	0.4	0.0	0.2	0.1	9.9	0.0	0.2	0.4	0.0	0.0	1.0	0.9	0.0	2.5	6.3	8.2	2.0	6.4	6.4	6.0	7.9	5.0	7.9	7.2
SPRED2	"FLJ21897, FLJ31917, Spred-2"	ENSG00000198369	"Sprouty related EVH1 domain containing 2"	Q7Z698	2	65310851-65432637	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NK-cell: 3.2;plasmacytoid DC: 7.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.7;NK-cells: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038256, HPA064394"	Approved		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038256: , HPA064394: "	"unprognostic (1.49e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.46e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.07e-2)"	"unprognostic (4.25e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.21e-3)"	"unprognostic (5.43e-2)"	25.1	13.5	21.0	19.3	17.8	6.7	26.2	26.2	28.9	16.9	18.9	9.0	5.8	17.2	20.1	12.3	12.8	13.8	18.3	17.5	19.0	14.3	16.1	28.1	22.0	14.8	15.3	19.0	18.3	20.6	29.5	15.1	18.1	20.5	15.1	18.7	15.1	17.9	13.6	9.6	13.6	20.7	13.7	16.5	11.0	22.6	8.1	12.9	40.3	22.1	10.4	17.1	21.2	30.5	0.1	7.7	1.2	1.2	3.2	1.2	1.5	26.6	14.1	15.4	15.6	20.0	20.1	11.1	8.0	11.8	5.2	7.1	18.5	7.6	20.5	4.2	9.9	9.0	8.7	17.9	10.5	23.5	6.4	4.2	3.7	19.9	10.1	13.0	8.7	16.0	10.6	18.3	17.6	3.2	18.2	8.0	8.3	18.0	10.1	12.2	7.6	16.5	8.1	13.9	10.6	16.0	22.5	6.6	23.4	8.4	7.2	21.3	6.8	11.1	5.0	13.1	17.6	11.6	12.7	15.9	6.4	33.6	21.2	12.6	25.2	0.0	0.4	0.0	1.2	1.2	0.1	0.0	0.2	1.0	0.8	0.1	0.2	0.3	1.2	3.2	0.6	7.7	0.0	1.5	21.0	17.8	26.2	26.7	19.0	14.3	15.3	19.0	20.5	12.9
SPRY2	hSPRY2	ENSG00000136158	"Sprouty RTK signaling antagonist 2"	O43597	13	80335976-80340951	"Disease related genes, Plasma proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 68.8;SK-MEL-30: 37.4;WM-115: 35.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037205, HPA042198"	Approved		Supported	"Actin filaments,Microtubules"				"Actin filaments, Microtubules"		"CAB037205: AB_261923, HPA042198: "	"unprognostic (9.37e-3)"	"unprognostic (3.71e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.80e-2)"	"unprognostic (8.99e-2)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.56e-2)"	"unprognostic (9.89e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.86e-2)"	44.5	20.4	23.2	9.8	21.9	20.8	45.0	41.2	29.3	26.5	22.7	18.6	10.5	14.3	17.1	15.5	16.9	23.8	25.4	28.2	22.7	15.0	15.0	22.3	21.8	9.2	20.8	22.7	14.4	22.1	7.1	10.2	11.5	33.9	16.2	23.0	19.0	28.0	16.8	25.4	14.4	18.1	19.7	30.4	23.6	14.5	6.0	20.2	3.7	15.6	13.1	5.3	16.7	20.5	0.6	1.8	3.9	0.0	7.5	1.7	0.4	0.4	1.9	21.8	68.8	28.9	19.0	1.5	17.5	8.0	4.0	4.8	8.7	2.6	0.0	3.0	7.2	1.6	1.2	3.5	4.5	0.0	3.9	3.0	1.1	2.2	6.6	15.6	1.2	8.4	3.8	6.8	16.7	7.7	1.0	0.0	9.0	0.3	2.1	7.1	8.6	5.0	6.3	29.0	0.0	7.5	2.9	0.2	12.1	1.4	0.8	37.4	1.6	14.0	11.2	3.7	1.4	7.8	3.3	0.0	0.0	0.0	25.6	6.0	35.0	0.0	0.0	3.9	0.8	0.0	0.3	0.6	0.0	1.7	1.8	0.0	0.1	0.3	0.1	7.5	0.0	0.3	0.0	0.4	23.2	21.9	41.2	29.3	22.7	15.0	20.8	22.7	33.9	20.2
SPTA1	EL2	ENSG00000163554	"Spectrin alpha, erythrocytic 1"	P02549	1	158610706-158686715	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"	"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 41.0"	"Cell line enriched"	"Detected in some"	4	"K-562: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB016193, HPA028048, HPA028253, CAB037246"	Enhanced						45000000			"CAB016193: AB_669050, CAB037246: AB_261445, HPA028048: AB_10603341, HPA028253: "	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.50e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.73e-8)"	"unprognostic (6.08e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.85e-3)"	0.6	0.0	0.0	1.1	0.0	41.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	8.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.6	4.6	0.0	2.2	0.0	0.3	0.9	0.0	0.0	0.0	2.8	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SPTB		ENSG00000070182	"Spectrin beta, erythrocytic"	P11277	14	64746283-64879907	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.2;brain: 25.2;skeletal muscle: 67.6"	"Group enriched"	"Detected in some"	5	"HEL: 23.0;K-562: 27.5;U-937: 8.3"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	5	"basal ganglia: 11.6;cerebellum: 25.2;cerebral cortex: 10.4;pons and medulla: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003394, HPA003398, CAB015169, CAB016232"	Enhanced		Approved	Cytosol			43000000	Cytosol		"CAB015169: AB_2194363, CAB016232: AB_785785, HPA003394: AB_1080076, HPA003398: AB_1080074"	"unprognostic (2.69e-1)"	"unprognostic (4.72e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-3)"	"unprognostic (2.66e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.18e-2)"	1.9	1.6	3.2	0.7	11.6	32.2	0.7	25.2	10.4	0.8	0.7	0.8	0.3	0.6	0.7	5.2	1.8	0.8	0.8	14.7	3.1	3.2	1.2	0.6	0.9	0.6	2.8	3.5	0.7	2.2	6.5	4.7	4.7	16.4	1.5	0.7	1.1	1.9	1.3	67.6	0.7	0.7	1.0	1.7	1.1	0.7	1.0	1.4	0.0	0.7	17.4	0.6	0.8	0.5	0.0	0.6	0.9	0.0	0.0	0.2	1.5	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.4	3.8	0.1	0.0	0.2	2.2	23.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	27.5	0.0	0.0	0.2	0.0	0.1	0.0	1.3	0.0	0.0	0.1	0.0	0.1	3.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.2	0.0	0.4	0.9	4.3	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	1.5	3.2	11.6	25.2	10.4	3.1	3.2	2.8	3.5	16.4	1.4
SPTBN1		ENSG00000115306	"Spectrin beta, non-erythrocytic 1"	Q01082	2	54456285-54671445	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012685, HPA013149"	Supported		Approved	"Golgi apparatus"			1900000	"Golgi apparatus"		"HPA012685: AB_1857433, HPA013149: AB_1857434"	"unprognostic (2.72e-1)"	"unprognostic (4.44e-3)"	"unprognostic (3.00e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.24e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.25e-2)"	"prognostic favourable (2.59e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.68e-3)"	"unprognostic (5.18e-3)"	81.1	37.1	75.7	16.1	76.4	16.1	63.3	33.8	62.9	27.4	29.0	41.8	44.2	16.6	31.8	27.5	21.3	28.3	33.8	58.9	67.4	48.6	32.8	43.8	60.7	13.4	61.4	44.1	35.9	22.4	103.7	15.7	44.5	42.1	23.2	26.0	31.5	26.8	43.9	23.9	18.9	23.0	27.3	47.8	27.5	26.9	16.0	33.2	6.3	34.2	21.9	14.6	23.7	59.8	6.1	2.1	3.8	0.6	8.2	8.5	4.0	23.4	36.7	13.5	14.0	62.3	37.0	19.6	8.9	17.8	14.0	13.8	25.1	17.0	0.0	27.7	31.6	28.1	18.9	32.3	14.7	0.1	9.0	9.5	27.7	42.9	25.8	13.4	6.3	16.2	17.0	44.3	30.6	35.7	11.3	15.6	21.1	5.4	24.6	3.8	17.2	17.8	27.3	21.6	9.2	25.8	29.3	8.5	28.2	27.5	10.3	22.2	4.9	2.5	55.4	21.3	20.0	25.6	13.2	16.3	9.3	8.1	24.1	4.4	37.9	3.2	0.6	3.8	6.3	0.0	6.5	6.1	5.8	5.8	2.1	5.7	8.5	5.9	1.0	8.2	0.0	1.8	4.8	4.0	75.7	76.4	33.8	59.2	67.4	48.6	61.4	44.1	42.1	33.2
SPTBN2	SCA5	ENSG00000173898	"Spectrin beta, non-erythrocytic 2"	O15020	11	66685248-66729226	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.7;skin 1: 36.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 19.9;NTERA-2: 23.1;SCLC-21H: 23.5;T-47d: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009844, HPA039293, HPA043529"	Enhanced		Supported	"Cell Junctions,Cytosol"			4800000	"Cell Junctions, Cytosol"		"CAB009844: AB_2194521, HPA039293: , HPA043529: "	"unprognostic (9.34e-2)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.41e-3)"	"unprognostic (4.91e-1)"	"unprognostic (6.05e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.67e-2)"	"prognostic unfavourable (3.14e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.00e-3)"	0.8	4.9	26.2	1.0	38.3	1.7	4.5	29.6	46.7	9.6	0.9	2.0	0.0	1.0	1.1	1.2	12.7	2.6	1.2	0.7	19.7	8.2	12.7	7.1	0.9	0.5	6.5	24.7	0.8	8.3	12.2	3.9	0.7	14.4	6.8	0.7	1.7	13.4	3.1	0.7	36.9	0.9	1.2	1.9	0.9	1.2	18.9	6.2	0.0	0.5	0.1	3.3	1.1	3.6	0.1	0.0	0.4	0.0	0.0	0.0	0.0	6.4	3.3	1.5	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.1	8.0	0.0	1.7	0.0	7.7	11.7	1.1	0.0	0.0	4.6	0.0	19.9	1.1	0.3	3.3	0.3	0.1	5.4	0.0	3.5	2.9	3.2	0.0	0.0	12.5	2.6	1.5	23.1	10.3	10.7	1.3	6.6	4.4	1.1	23.5	13.8	6.5	16.4	1.5	18.7	0.9	0.6	0.0	4.1	0.6	5.1	0.3	1.2	6.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	26.2	38.3	29.6	46.7	19.7	8.2	6.5	24.7	14.4	6.2
SPTBN4	"KIAA1642, SPTBN3"	ENSG00000160460	"Spectrin beta, non-erythrocytic 4"	Q9H254	19	40466241-40576464	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 36.3"	"Cell line enhanced"	"Detected in some"		"K-562: 3.5;Karpas-707: 5.0;SCLC-21H: 7.9;SH-SY5Y: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054481	Enhanced		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA054481: "	"unprognostic (1.97e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.65e-4)"	"unprognostic (3.72e-4)"	"unprognostic (7.79e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.50e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.55e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.02e-1)"	3.1	5.9	13.4	1.2	15.3	1.2	1.2	36.3	27.1	1.4	1.3	1.8	0.0	1.7	2.3	1.3	1.6	2.0	1.8	3.3	9.8	10.8	1.9	1.3	1.2	1.0	7.5	13.0	4.1	3.0	3.3	8.0	1.0	10.4	2.8	1.1	2.6	2.2	2.0	5.1	1.3	1.5	1.8	2.8	1.3	2.5	3.5	3.7	0.0	1.6	0.0	1.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.4	2.3	1.9	0.4	0.0	0.0	0.0	0.0	0.4	2.3	0.5	0.0	0.0	0.3	0.0	0.8	0.3	0.0	0.0	0.0	0.0	3.5	5.0	0.0	1.3	0.0	0.0	0.2	0.8	0.5	0.0	1.1	0.0	0.0	7.9	4.8	0.1	0.2	0.0	0.7	0.0	0.0	0.0	1.4	0.8	0.0	0.2	0.3	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.3	36.3	22.7	9.8	10.8	7.5	13.0	10.4	3.7
SPTBN5	"BSPECV, HUBSPECV, HUSPECV"	ENSG00000137877	"Spectrin beta, non-erythrocytic 5"	Q9NRC6	15	41848144-41894077	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.0"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 4.5;SCLC-21H: 6.2;TIME: 16.1;WM-115: 5.1"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"cerebellum: 10.0;midbrain: 6.8;pons and medulla: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA055283	Approved									"HPA055283: "	"unprognostic (5.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.84e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.84e-3)"	"unprognostic (6.40e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.11e-2)"	1.4	0.3	0.7	1.4	0.7	0.7	1.2	10.0	0.8	0.7	0.7	0.7	0.7	0.6	0.7	1.8	2.0	0.2	1.9	4.6	0.7	0.3	1.2	1.9	1.2	1.2	6.8	0.7	1.2	2.6	1.8	2.3	0.7	3.7	1.8	0.2	7.4	6.8	0.7	1.4	1.8	0.7	0.7	1.0	0.7	1.2	1.9	0.7	0.7	2.6	0.7	0.7	4.4	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.7	0.7	0.0	1.0	0.0	0.5	0.0	0.3	0.0	0.9	0.1	0.0	1.6	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.1	4.5	0.0	0.1	0.3	0.0	0.0	0.1	0.5	0.5	0.0	0.3	0.0	0.4	1.7	6.2	0.1	0.2	0.5	0.1	1.0	0.0	16.1	0.0	1.7	0.4	2.0	1.8	2.6	0.0	0.0	0.1	5.1	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.7	10.0	0.8	0.7	0.3	6.8	0.7	3.7	0.7
SPTLC1	"hLCB1, HSAN1, HSN1, LCB1, SPTI"	ENSG00000090054	"Serine palmitoyltransferase long chain base subunit 1"	O15269	9	92000087-92115384	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010860, CAB018747, HPA063907"	Supported		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB018747: AB_2195864, HPA010860: AB_1080086, HPA063907: "	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.03e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.37e-2)"	"prognostic favourable (1.36e-6)"	"unprognostic (1.13e-1)"	"unprognostic (2.41e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.49e-1)"	16.4	17.7	13.3	11.4	17.1	9.9	16.8	19.9	17.6	20.3	17.2	20.9	18.1	14.0	17.3	15.1	30.5	19.2	15.5	11.4	13.9	15.3	19.0	13.5	14.8	10.6	18.0	12.2	35.3	15.8	23.6	23.1	28.3	20.5	14.5	18.8	12.0	18.5	13.3	9.4	20.1	17.8	15.1	20.8	10.7	16.0	19.8	14.1	9.7	26.2	16.0	16.5	17.4	20.9	9.3	21.0	21.1	22.1	10.2	15.2	16.0	18.1	16.4	11.4	9.5	27.9	21.7	19.7	19.1	24.4	16.5	17.9	10.3	37.9	10.0	12.2	24.1	47.6	12.3	16.2	19.2	11.5	7.1	9.2	9.3	10.0	21.0	15.2	12.5	19.6	19.6	17.0	18.6	15.0	21.5	12.5	18.7	19.5	9.5	3.8	15.3	12.0	10.6	13.8	7.6	16.4	11.1	9.3	8.6	25.7	19.7	11.6	10.1	9.0	19.0	16.1	12.4	18.5	13.3	9.0	12.3	5.6	19.2	7.5	19.3	14.6	22.1	11.9	11.5	21.6	11.0	8.9	11.6	11.6	21.0	9.3	14.2	10.7	21.1	10.2	19.2	10.8	15.2	16.0	13.3	17.1	19.9	17.6	13.9	15.3	18.0	12.2	20.5	14.1
SPTLC2	"hLCB2a, KIAA0526, LCB2, LCB2A"	ENSG00000100596	"Serine palmitoyltransferase long chain base subunit 2"	O15270	14	77505997-77616773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027552			Approved	Mitochondria				Mitochondria		"HPA027552: AB_10601717"	"unprognostic (3.16e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.09e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (6.69e-8)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.32e-1)"	30.0	12.8	15.4	11.4	27.0	27.3	25.6	6.9	18.5	15.3	17.0	32.4	8.5	13.4	10.2	7.6	22.8	13.7	11.1	7.8	20.8	14.1	17.1	7.2	12.2	17.5	33.1	13.3	10.2	7.6	12.8	9.8	18.8	21.2	8.2	18.8	6.0	16.6	9.6	5.5	11.3	15.8	11.0	47.6	23.5	18.8	4.7	34.9	10.0	10.3	8.8	12.0	13.2	17.1	4.8	18.2	15.1	18.2	10.0	4.2	6.9	11.9	7.9	6.1	6.6	6.3	7.9	10.3	17.8	13.2	12.3	12.9	10.0	26.7	12.0	4.5	18.1	14.8	16.1	10.0	18.7	5.2	4.7	33.9	6.1	5.9	5.3	3.4	11.3	5.1	4.9	8.0	8.9	17.3	6.6	5.8	7.0	10.3	9.0	11.7	3.9	7.1	9.7	6.2	4.1	14.2	26.9	5.9	7.4	6.4	21.5	6.7	26.4	6.3	10.8	11.3	8.1	4.1	4.1	3.3	5.4	8.1	7.5	12.2	6.4	8.8	18.2	15.1	3.8	13.8	3.5	4.1	3.2	4.2	18.2	4.8	2.2	3.6	11.2	10.0	16.7	6.5	3.3	6.9	15.4	27.0	6.9	18.5	20.8	14.1	33.1	13.3	21.2	34.9
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 35.5;HBEC3-KT: 33.0;PC-3: 32.1;RT4: 34.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Plasma membrane,Cell Junctions,Cytosol"			20000000	"Plasma membrane, Cell Junctions"	Cytosol	"CAB004023: AB_2106059, HPA030875: "	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (1.63e-4)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.6	35.5	8.1	7.3	3.1	4.9	17.0	7.1	6.1	8.6	5.5	13.3	6.9	0.2	4.4	12.8	14.0	4.9	33.0	3.4	0.0	4.4	1.9	1.2	20.7	7.4	0.1	3.0	5.3	11.2	5.6	7.5	7.8	0.2	0.0	1.4	5.2	1.8	0.2	3.8	32.1	8.3	2.1	0.2	3.6	34.0	7.6	27.5	8.0	11.3	8.8	10.1	2.8	11.5	10.4	7.0	3.8	6.3	0.1	0.2	0.1	7.3	0.0	7.7	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8
SREBF1	"bHLHd1, SREBP-1c, SREBP1, SREBP1a"	ENSG00000072310	"Sterol regulatory element binding transcription factor 1"	P36956	17	17810399-17837002	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7;SK-BR-3: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005406, HPA043343, HPA043878"	Uncertain		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"CAB005406: AB_2194226, HPA043343: , HPA043878: "	"unprognostic (9.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-2)"	"prognostic favourable (2.66e-4)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.14e-2)"	"unprognostic (9.02e-3)"	"prognostic favourable (9.05e-4)"	"unprognostic (3.12e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.36e-3)"	34.0	78.2	16.4	9.3	17.9	14.8	15.5	5.8	22.3	15.7	13.8	31.9	30.4	28.9	8.6	23.4	20.5	15.7	17.6	10.2	13.5	10.3	9.0	49.9	11.9	14.4	20.3	16.7	20.5	7.7	9.6	12.5	16.0	11.8	18.0	6.4	15.1	72.7	33.0	16.8	14.5	27.4	7.1	13.1	7.3	13.6	16.8	16.2	15.2	9.5	13.6	13.8	11.9	15.0	0.6	0.4	4.7	0.8	0.4	2.2	0.5	13.7	32.5	4.0	25.0	8.2	15.2	7.0	5.1	16.2	4.4	10.8	6.6	26.9	8.6	4.8	4.0	39.3	4.6	13.6	1.1	5.3	2.0	4.7	27.0	6.9	10.3	0.6	9.1	11.8	5.8	6.2	3.8	5.0	9.1	31.1	1.0	34.0	11.4	7.9	5.4	6.5	8.1	2.9	49.7	3.6	7.2	4.8	19.9	6.0	48.2	14.3	16.3	9.1	5.7	2.4	12.0	5.7	3.2	9.1	0.8	3.9	14.0	6.8	12.4	0.0	0.8	0.4	1.8	0.5	0.4	0.6	0.8	0.3	0.4	0.4	1.6	2.2	4.7	0.4	0.6	0.3	0.2	0.5	16.4	17.9	5.8	22.3	13.5	10.3	20.3	16.7	11.8	16.2
SREBF2	"bHLHd2, SREBP2"	ENSG00000198911	"Sterol regulatory element binding transcription factor 2"	Q12772	22	41833079-41907308	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031962, HPA031963"	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum,Vesicles"				"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"HPA031962: AB_10601266, HPA031963: "	"unprognostic (6.53e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.41e-3)"	"unprognostic (9.08e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (9.85e-2)"	"prognostic favourable (1.37e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (7.93e-3)"	13.9	45.2	42.9	19.6	41.7	18.2	16.3	51.9	66.5	16.5	27.7	32.7	22.3	26.1	19.4	41.5	42.4	18.9	28.7	33.9	37.3	33.6	18.9	20.4	27.9	21.1	21.7	38.4	22.7	29.7	34.2	17.4	15.8	34.2	22.8	20.9	25.4	29.0	20.0	17.2	32.9	22.3	19.8	24.7	16.0	30.2	13.5	21.0	15.6	14.3	20.5	26.1	17.1	19.0	9.6	8.4	2.0	5.5	1.8	6.4	4.9	18.0	12.9	34.5	32.0	20.2	27.1	19.3	6.0	20.4	7.2	14.8	15.2	24.0	32.3	8.6	14.8	31.1	19.6	40.1	5.1	9.1	21.4	16.1	22.8	15.1	33.8	23.5	11.0	25.4	22.8	18.8	23.6	14.1	16.5	39.0	7.5	23.0	17.0	17.8	21.8	10.0	19.7	19.7	51.8	29.9	19.0	14.0	10.5	13.9	25.6	25.7	16.1	42.0	15.0	9.7	18.2	4.5	7.1	28.5	14.5	25.7	9.5	17.9	14.8	0.0	5.5	2.0	6.4	4.9	4.4	9.6	3.5	4.6	6.6	7.3	3.2	3.6	1.0	1.8	4.0	8.4	2.1	4.9	42.9	41.7	51.9	66.5	37.3	33.6	21.7	38.4	34.2	21.0
SRGN	"PPG, PRG, PRG1"	ENSG00000122862	Serglycin	P10124	10	69088106-69104811	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biomineralization"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 259.2;bone marrow: 657.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 229.4;NB-4: 133.3;THP-1: 229.8;TIME: 138.6;U-937: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 259.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 259.2"					"Low region specificity"	"Detected in many"			HPA000759	Enhanced		Supported	"Golgi apparatus"	"Intracellular and membrane"		50000000	"Golgi apparatus"		"HPA000759: AB_1079675"	"unprognostic (3.61e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.22e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.82e-2)"	"prognostic unfavourable (3.18e-5)"	"unprognostic (1.65e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.08e-2)"	51.3	12.3	11.0	74.4	18.7	657.4	27.0	5.7	11.8	11.6	13.8	9.7	3.4	8.1	11.6	10.5	13.3	19.6	31.6	31.9	21.0	14.0	29.1	23.2	107.8	87.1	18.4	3.0	11.9	7.4	6.5	13.2	33.0	32.9	12.7	12.6	15.7	8.4	6.8	15.1	3.7	16.8	21.1	42.4	129.8	11.7	10.7	12.6	28.2	15.2	6.5	31.1	46.1	16.2	3.3	28.4	259.2	46.1	40.8	22.7	53.1	0.2	2.1	0.0	0.0	42.8	41.9	0.0	5.0	3.3	12.6	15.4	0.0	0.9	0.4	6.3	0.2	0.0	0.0	1.0	43.7	27.2	0.0	4.4	1.8	0.0	17.5	229.4	50.2	17.0	0.0	34.9	2.1	65.3	4.0	22.6	66.3	0.0	0.9	133.3	0.0	4.3	0.1	0.1	23.0	0.0	0.3	0.0	0.0	0.1	0.0	0.8	0.1	229.8	138.6	10.4	0.6	0.2	1.0	26.5	25.5	2.9	6.2	185.8	0.0	82.5	46.1	116.7	22.7	34.3	14.8	3.3	11.0	16.9	26.1	1.6	6.2	13.2	259.2	40.8	29.7	28.4	17.1	53.1	11.0	18.7	5.7	11.8	21.0	14.0	18.4	3.0	32.9	12.6
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli			400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.7	31.1	75.4	56.3	56.5	51.3	36.8	45.7	48.5	39.7	40.8	55.9	21.2	20.8	47.6	55.4	40.2	59.9	47.5	37.6	49.7	42.8	49.7	99.3	65.4	43.3	44.2	40.6	53.2	54.4	32.8	40.3	66.6	51.9	38.3	63.4	37.6	65.2	52.1	41.1	56.4	44.8	34.4	35.0	85.5	74.0	55.0	49.0	46.1	45.8	29.9	62.9	82.0	57.3	46.2	31.4	43.5	33.3	31.2	87.0	51.6	44.9	48.2	42.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA048977: , HPA062044: "	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.3	22.0	21.1	19.8	21.8	22.5	25.4	29.2	26.6	30.2	38.8	26.5	22.9	29.7	29.8	27.8	21.5	28.9	23.0	43.9	29.5	14.5	24.0	21.0	62.1	33.9	25.6	24.3	18.8	22.7	22.2	39.6	30.4	21.2	32.5	31.4	33.8	27.4	14.4	16.2	21.4	21.9	25.8	23.7	36.0	31.1	20.1	21.6	20.9	27.2	26.6	36.1	17.8	23.0	18.4	19.8	21.9	20.1	28.2	37.8	37.2	13.1	16.5	21.9	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072653	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol				Cytosol		"HPA023303: AB_1857477, HPA055617: "	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (2.18e-4)"	"prognostic unfavourable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favourable (2.65e-4)"	"unprognostic (4.02e-3)"	23.2	23.8	39.8	20.3	41.1	17.5	22.9	35.4	44.1	25.4	28.1	16.6	26.3	18.4	25.7	34.4	37.6	26.0	16.4	25.5	32.4	24.9	24.9	28.9	21.8	22.1	23.8	32.2	32.3	43.1	33.4	29.1	32.0	34.5	24.4	25.0	16.6	27.6	25.8	71.7	35.4	19.7	30.8	30.3	22.6	25.2	18.4	32.4	20.6	32.0	20.4	34.5	25.6	27.3	17.5	20.4	20.2	16.4	26.3	24.5	10.5	38.1	33.8	20.9	21.8	29.8	24.1	37.8	27.9	20.5	33.4	26.2	28.5	21.3	30.2	14.4	28.3	26.0	39.3	29.6	50.0	12.6	43.7	28.1	27.3	41.8	35.3	33.0	21.9	21.2	33.1	29.3	25.8	38.8	40.0	28.5	28.0	23.3	31.8	20.5	19.3	35.7	27.0	55.9	30.9	27.9	33.7	25.7	25.2	25.6	41.5	30.7	37.0	30.1	24.8	36.5	27.9	16.8	37.2	28.2	12.8	34.1	26.4	24.6	27.1	3.7	16.4	20.2	15.2	15.0	16.5	17.5	21.5	23.3	20.4	14.6	24.5	18.2	2.6	26.3	14.8	15.8	18.8	10.5	39.8	41.1	35.4	44.1	32.4	24.9	23.8	32.2	34.5	32.4
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467336-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved									"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favourable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	28.7	26.4	18.5	23.1	27.0	37.3	29.8	24.1	33.5	27.0	22.7	17.3	31.3	17.1	30.2	22.7	32.1	24.3	20.2	21.6	17.2	20.9	26.6	52.5	24.9	33.4	20.5	23.6	32.7	43.8	26.7	32.5	40.9	32.1	21.8	25.3	13.0	49.6	30.1	34.4	33.3	23.2	27.1	22.6	34.4	24.1	15.9	18.8	41.8	32.9	34.8	31.9	28.7	25.4	25.7	37.4	16.8	32.4	25.9	31.5	23.9	26.5	20.5	25.9	25.0	16.5	23.8	25.1	39.4	31.6	33.2	26.6	22.6	30.3	41.3	27.2	32.8	15.3	32.0	33.4	39.4	10.8	18.6	35.9	24.2	21.0	30.3	68.9	29.9	22.4	45.1	35.3	63.0	29.5	52.0	39.8	31.6	20.5	40.6	17.9	22.4	21.5	36.5	20.9	31.0	22.8	25.3	16.1	26.9	25.0	49.1	21.7	19.5	25.1	35.6	27.6	37.2	28.2	40.8	28.6	13.5	45.3	29.7	36.8	33.3	14.6	30.0	16.8	24.8	32.4	31.5	25.7	25.1	24.5	37.4	22.8	25.0	24.5	3.8	25.9	24.5	28.1	26.8	23.9	18.5	27.0	24.1	33.5	17.2	20.9	20.5	23.6	32.1	18.8
SRPRA	"SR-alpha, Sralpha, SRP-alpha, SRPR"	ENSG00000182934	"SRP receptor alpha subunit"	P08240	11	126262919-126269144	"Plasma proteins, Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.23e-3)"	"unprognostic (6.87e-2)"	"unprognostic (6.11e-2)"	"prognostic favourable (8.56e-4)"	"unprognostic (1.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.64e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	19.7	28.5	10.2	20.1	15.1	19.6	24.4	11.6	20.0	25.7	16.0	14.8	47.1	14.3	24.4	42.1	19.8	19.8	22.4	22.2	9.6	11.0	23.5	75.3	23.4	26.8	12.5	11.7	21.2	122.1	24.5	32.5	21.0	15.3	23.9	17.5	22.2	78.4	56.8	29.5	18.5	18.7	19.2	10.7	24.5	30.3	15.1	11.1	18.8	25.3	18.5	26.6	20.7	17.2	25.0	37.6	44.1	36.0	28.4	46.3	38.2	14.4	14.3	13.8	20.8	37.9	29.6	18.4	41.7	38.5	20.3	24.1	26.2	37.2	27.2	43.4	41.0	28.7	20.8	24.0	20.4	29.9	16.5	49.8	11.8	26.1	53.1	43.7	32.5	25.2	30.7	31.1	57.3	27.6	16.6	65.4	28.3	19.4	20.9	17.3	9.1	31.1	13.9	19.0	28.3	20.0	29.7	19.9	18.7	28.5	34.7	21.2	45.6	26.2	26.1	35.9	16.1	20.3	29.7	28.7	18.3	16.7	20.0	39.9	46.2	29.9	29.4	44.1	46.3	31.8	40.7	25.0	32.5	37.3	28.5	21.3	29.6	33.9	31.1	28.4	36.0	37.6	24.9	38.2	10.2	15.1	11.6	20.0	9.6	11.0	12.5	11.7	15.3	11.1
SRPX	ETX1	ENSG00000101955	"Sushi repeat containing protein, X-linked"	P78539	X	38149336-38220924	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 82.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 278.5;ASC TERT1: 62.2;HSkMC: 93.6;HUVEC TERT2: 57.7"	"Group enriched"	"Detected in all"	6	"glioma: 64.2;melanoma: 70.1;pancreatic cancer: 14.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	56	"plasmacytoid DC: 10.5"	"Lineage enriched"	"Detected in single"	56	"dendritic cells: 10.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"		310000				"unprognostic (2.35e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.08e-3)"	"prognostic unfavourable (1.18e-4)"	"unprognostic (6.48e-2)"	"unprognostic (3.83e-3)"	"unprognostic (3.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (7.80e-13)"	"unprognostic (6.94e-3)"	"unprognostic (3.90e-2)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (3.36e-4)"	56.2	11.9	2.2	8.5	5.0	0.0	82.4	6.6	4.8	14.1	23.1	7.7	10.1	3.1	17.7	35.5	15.1	37.1	23.3	28.9	5.3	2.9	4.1	6.6	14.2	27.7	9.6	1.9	11.6	7.8	1.4	1.5	34.1	13.4	22.1	10.2	4.7	9.5	6.6	9.9	8.7	14.4	27.8	18.9	0.6	13.3	14.9	7.3	0.9	17.8	5.3	5.1	29.6	54.6	0.0	10.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	278.5	62.2	0.0	2.5	4.8	0.8	1.4	0.0	0.2	0.0	0.0	5.2	0.1	0.1	2.2	0.7	0.0	0.9	0.0	0.0	0.0	12.5	0.2	0.0	93.6	0.1	8.3	4.2	57.7	0.0	0.0	9.3	0.1	0.0	0.0	0.7	1.8	0.0	3.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	11.6	0.0	0.0	24.8	6.0	3.1	7.8	7.2	0.0	0.0	0.0	17.5	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.5	0.0	0.1	2.2	5.0	6.6	3.2	5.3	2.9	9.6	1.9	13.4	7.3
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"			12000	"Nuclear speckles"		"HPA049941: , HPA058612: "	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	16.9	13.7	27.2	24.3	15.3	15.8	26.7	19.9	13.2	19.9	22.9	15.0	28.5	38.0	12.6	16.8	21.3	27.0	19.5	26.2	13.0	18.7	29.1	26.5	17.8	10.7	33.5	19.3	10.8	12.3	16.1	23.8	17.2	28.2	20.9	20.4	14.7	30.3	22.5	44.7	9.3	27.2	21.7	18.5	17.4	17.7	16.5	14.9	21.4	17.4	14.8	15.6	16.4	19.0	17.5	18.2	23.7	19.9	18.7	14.3	46.9	18.9	39.5	19.3	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752329-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: "	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favourable (6.77e-4)"	"prognostic unfavourable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	41.4	50.2	50.1	73.1	69.8	105.5	48.0	85.3	77.1	53.1	51.7	61.5	57.9	56.1	60.4	44.5	53.1	56.8	60.7	43.7	51.0	28.2	47.2	56.0	48.7	53.3	70.3	38.2	70.8	74.8	88.1	49.1	43.8	48.8	52.5	48.2	45.6	80.8	63.0	91.7	67.4	63.4	46.7	52.9	63.2	61.7	37.8	69.8	48.7	58.9	38.3	46.2	52.0	69.5	9.0	11.6	36.4	8.9	23.9	4.7	0.9	22.9	29.4	46.8	32.3	33.0	32.3	27.7	26.1	14.7	23.4	20.9	24.3	26.7	40.9	20.0	28.8	33.0	37.3	33.1	24.8	29.7	38.7	35.1	54.7	41.9	15.0	36.7	50.9	32.9	32.1	34.2	40.7	24.0	39.3	40.3	21.4	40.8	34.6	59.1	43.9	16.3	60.8	19.0	31.8	30.1	24.6	30.8	27.3	34.6	35.5	20.3	32.2	30.2	34.1	33.2	34.0	21.6	32.6	35.8	27.3	89.1	11.5	26.6	22.2	36.4	8.9	4.3	3.2	3.9	3.0	5.2	4.0	3.0	2.0	9.0	3.5	4.7	18.3	23.9	3.5	11.6	2.0	0.9	50.1	69.8	85.3	77.1	51.0	28.2	70.3	38.2	48.8	69.8
SRSF1	"ASF, MGC5228, SF2, SF2p33, SFRS1, SRp30a"	ENSG00000136450	"Serine and arginine rich splicing factor 1"	Q07955	17	58003360-58007346	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013073, HPA061301"	Supported		Approved	Nucleoplasm			1100000	Nucleoplasm		"CAB013073: AB_2533079, HPA061301: "	"unprognostic (9.86e-2)"	"prognostic favourable (7.00e-4)"	"prognostic favourable (4.56e-5)"	"unprognostic (8.11e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.88e-3)"	"prognostic unfavourable (1.64e-6)"	"unprognostic (8.28e-2)"	"unprognostic (2.60e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (2.95e-5)"	"unprognostic (1.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (1.59e-2)"	27.0	30.0	25.4	41.0	31.7	19.1	29.9	58.3	32.9	43.8	41.1	26.3	41.7	32.2	44.9	29.3	28.6	43.2	30.2	24.0	23.9	15.8	29.0	30.9	31.4	47.1	34.6	21.6	73.1	28.5	40.8	52.3	28.5	30.1	44.9	32.4	28.7	32.9	31.7	40.7	24.7	38.9	42.2	27.4	38.4	29.2	26.0	32.1	57.0	44.7	30.7	50.7	32.1	44.1	19.8	41.8	16.5	36.1	24.8	23.2	22.3	52.2	46.8	56.4	34.1	15.7	15.9	39.6	48.8	24.6	50.2	45.5	54.5	40.9	89.5	29.9	31.7	42.2	65.0	51.9	54.3	53.0	44.9	71.2	56.5	51.2	20.2	70.4	38.6	15.4	19.4	47.2	33.4	32.4	77.1	31.0	33.6	42.5	83.6	41.9	55.9	42.3	81.8	55.5	49.5	31.3	44.1	46.6	44.0	39.2	28.6	26.2	40.5	41.2	42.1	36.4	43.2	27.1	59.3	27.5	53.9	86.0	36.0	60.5	45.4	9.8	27.3	16.5	23.2	36.1	23.1	19.8	17.8	21.8	41.8	14.6	19.5	19.5	12.7	24.8	23.8	21.3	19.2	22.3	25.4	31.7	58.3	32.9	23.9	15.8	34.6	21.6	30.1	32.1
SRSF11	"NET2, p54, SFRS11"	ENSG00000116754	"Serine and arginine rich splicing factor 11"	Q05519	1	70205682-70253052	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008762	Supported		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA008762: AB_1856782"	"unprognostic (7.82e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.30e-3)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.25e-3)"	"prognostic unfavourable (6.53e-6)"	"unprognostic (7.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.43e-2)"	36.1	42.7	38.3	36.9	41.3	80.1	42.2	68.2	43.6	38.6	32.6	34.8	38.4	30.7	41.4	51.2	31.2	39.0	31.6	25.9	33.4	26.6	30.7	42.5	33.9	47.6	47.7	34.4	51.1	42.5	39.0	53.4	38.4	39.9	37.1	32.4	32.3	34.4	41.8	31.3	51.8	40.6	36.8	37.8	45.9	34.5	35.1	41.7	46.6	44.6	25.5	43.3	32.8	36.7	34.7	42.1	45.4	29.7	36.0	36.4	22.2	24.6	12.5	33.0	21.0	17.0	22.9	45.4	30.5	15.8	24.9	22.7	22.0	18.6	42.0	20.9	15.3	21.1	41.6	16.7	34.1	28.1	32.5	42.5	28.2	26.3	20.3	58.4	17.7	18.3	21.2	23.0	23.5	22.1	41.8	26.6	24.5	9.6	34.9	43.4	53.0	21.2	41.6	36.5	26.6	29.0	17.8	27.8	23.0	25.8	28.0	36.4	22.4	26.3	26.1	27.6	19.8	19.8	27.4	30.8	24.6	46.2	19.8	43.5	24.1	39.6	29.7	45.4	32.6	23.1	36.4	34.7	32.9	31.4	30.1	34.1	36.1	33.4	15.0	36.0	27.1	42.1	35.5	22.2	38.3	41.3	68.2	43.6	33.4	26.6	47.7	34.4	39.9	41.7
SRSF2	"PR264, SC-35, SC35, SFRS2, SFRS2A"	ENSG00000161547	"Serine and arginine rich splicing factor 2"	Q01130	17	76734115-76737374	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049905	Supported		Approved	Nucleoplasm,Cytosol			140000	Nucleoplasm	Cytosol	"HPA049905: "	"unprognostic (2.50e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.73e-3)"	"prognostic unfavourable (8.73e-4)"	"unprognostic (1.75e-2)"	"unprognostic (4.19e-2)"	"prognostic unfavourable (3.53e-8)"	"unprognostic (1.19e-1)"	"unprognostic (7.79e-3)"	"unprognostic (7.03e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-3)"	"prognostic unfavourable (1.05e-7)"	"unprognostic (3.85e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"prognostic favourable (9.87e-4)"	35.4	40.2	20.6	56.6	30.3	73.1	35.3	33.3	36.2	42.1	37.7	34.0	19.5	41.8	37.0	33.6	51.1	35.1	34.8	32.4	19.9	22.6	36.9	66.7	37.3	64.3	21.6	24.0	47.1	34.2	29.1	33.8	51.2	29.5	31.3	36.5	35.5	35.6	40.5	44.9	41.1	46.6	25.5	23.9	52.5	35.6	29.2	18.9	105.3	41.1	41.3	64.5	30.6	35.7	11.1	30.2	4.2	23.5	15.6	12.7	12.2	47.7	38.5	45.7	31.9	11.2	9.5	47.5	30.9	22.9	35.9	33.3	40.4	33.5	73.6	22.6	29.0	43.3	45.3	35.7	36.1	30.8	79.0	55.2	37.3	46.9	12.7	61.0	33.1	10.5	8.1	29.7	8.6	28.0	56.1	32.5	28.0	38.2	66.9	66.6	53.5	55.0	67.8	49.2	54.3	24.0	34.4	39.0	55.7	35.2	30.3	16.6	37.1	44.6	29.2	33.1	42.7	22.0	49.9	42.8	32.2	85.2	29.8	48.5	27.3	1.0	17.5	4.2	12.3	23.5	12.6	11.1	8.5	12.7	30.2	9.8	9.8	9.0	2.1	15.6	14.7	22.4	10.6	12.2	20.6	30.3	33.3	36.2	19.9	22.6	21.6	24.0	29.5	18.9
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm			1600000	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: "	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favourable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavourable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (1.95e-4)"	"prognostic favourable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	45.3	27.4	37.4	42.1	38.3	69.5	43.5	42.6	39.1	36.4	41.7	32.9	34.0	25.5	37.2	31.8	42.9	40.8	27.4	37.5	33.0	28.1	34.3	36.9	32.3	51.8	35.8	27.0	53.9	31.3	22.4	47.2	37.4	38.1	40.1	46.6	30.1	30.2	33.0	29.2	36.2	35.8	43.1	31.9	36.4	35.2	27.2	36.7	67.5	35.9	46.7	67.0	49.6	38.6	28.0	73.9	12.9	38.0	37.6	37.6	53.9	51.7	34.6	61.1	46.6	23.6	18.5	37.7	37.1	31.1	62.5	48.2	40.6	37.2	87.1	26.7	40.5	41.1	80.1	59.0	66.8	40.6	49.3	52.2	27.5	45.7	28.9	70.1	44.2	16.4	20.1	40.7	45.5	47.4	62.9	36.9	45.3	40.4	86.1	66.4	64.3	36.4	76.8	58.5	52.1	44.2	43.1	47.2	44.7	41.2	40.4	56.0	41.0	75.4	30.9	32.0	46.7	32.0	55.6	36.5	53.9	119.3	27.4	65.2	44.3	12.9	38.0	11.5	32.9	36.2	37.1	28.0	31.1	34.5	73.9	24.0	31.4	32.3	3.7	37.6	24.4	43.7	37.6	53.9	37.4	38.3	42.6	39.1	33.0	28.1	35.8	27.0	38.1	36.7
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm			1400000	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavourable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	42.2	32.2	32.8	51.1	37.3	76.7	39.2	34.7	38.9	26.8	37.2	21.4	34.8	20.4	34.1	27.3	50.2	36.9	25.9	29.8	26.9	24.6	25.1	34.9	34.3	45.5	37.5	23.8	31.7	38.2	20.4	50.4	34.3	32.8	27.4	37.2	25.0	32.8	32.4	31.7	26.2	37.7	36.6	33.4	34.8	38.8	35.9	33.0	44.1	26.1	38.6	59.2	28.2	40.7	20.9	47.6	8.8	33.4	20.8	22.9	22.3	43.8	38.2	51.3	33.0	15.8	12.5	36.3	37.6	16.2	37.9	30.5	45.0	33.8	71.7	25.8	24.4	24.8	64.5	46.0	45.7	44.6	40.3	43.2	27.4	45.9	13.4	53.0	31.5	7.4	15.7	26.0	50.4	31.4	62.4	28.7	32.0	48.8	67.1	47.0	56.0	35.0	59.6	43.1	40.6	28.1	42.7	35.3	34.2	35.9	31.8	25.2	29.0	48.5	27.1	23.0	36.0	19.7	52.3	31.7	47.4	107.2	27.3	55.6	31.6	6.4	23.1	8.8	21.3	33.4	22.9	20.9	16.4	21.0	47.6	14.1	18.6	21.1	2.3	20.8	19.6	28.6	17.4	22.3	32.8	37.3	34.7	38.9	26.9	24.6	37.5	23.8	32.8	33.0
SSFA2	"CS-1, KIAA1927, KRAP, SPAG13"	ENSG00000138434	"Sperm specific antigen 2"	P28290	2	181891833-181930738	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 85.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"dendritic cells: 3.8;granulocytes: 8.1;monocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034665, HPA039989"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA034665: , HPA039989: "	"unprognostic (1.68e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavourable (8.19e-4)"	"unprognostic (6.95e-2)"	"prognostic favourable (2.91e-5)"	"unprognostic (3.39e-1)"	"unprognostic (5.54e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavourable (5.79e-5)"	14.2	10.1	23.3	11.8	27.0	16.1	21.6	25.8	22.5	17.7	24.4	26.2	9.4	17.5	13.0	8.9	12.0	10.7	18.7	13.6	23.7	19.1	22.8	36.0	23.0	11.2	31.3	17.7	7.2	85.5	10.5	10.2	40.9	24.8	18.1	24.1	22.3	29.2	10.0	16.6	50.6	19.5	14.2	27.8	14.7	26.0	16.7	23.8	9.3	19.6	12.2	7.9	14.3	23.5	1.2	3.8	8.1	6.4	1.0	1.4	1.8	16.1	8.1	23.6	4.0	20.6	17.1	6.7	28.7	27.9	10.1	13.4	8.3	18.7	0.3	9.3	20.2	14.0	5.7	13.8	19.6	7.4	6.4	16.3	34.7	6.7	15.2	8.3	15.3	10.1	20.3	17.4	23.7	52.8	7.3	9.0	28.1	8.1	7.3	11.7	1.6	19.1	5.5	9.5	5.6	28.6	4.9	4.1	3.6	16.8	6.0	25.7	4.3	18.3	21.0	24.0	11.6	8.6	14.9	6.2	2.7	6.5	11.2	5.0	17.8	8.1	3.9	5.7	1.4	3.9	0.9	0.6	1.0	0.9	3.8	1.2	1.3	1.1	6.6	1.0	6.4	3.1	0.6	1.8	23.3	27.0	25.8	22.5	23.7	19.1	31.3	17.7	24.8	23.8
SSR4	TRAPD	ENSG00000180879	"Signal sequence receptor subunit 4"	P51571	X	153793516-153798505	"Disease related genes, Plasma proteins, Predicted membrane proteins"			"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 699.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045209	Enhanced						600000			"HPA045209: AB_10961407"	"unprognostic (3.56e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	"prognostic favourable (1.76e-4)"	"unprognostic (8.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (7.99e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.10e-1)"	"unprognostic (5.04e-3)"	"unprognostic (5.74e-3)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (5.51e-6)"	"unprognostic (8.18e-2)"	"unprognostic (2.24e-1)"	"unprognostic (6.01e-2)"	"unprognostic (5.33e-2)"	17.4	30.0	13.2	29.5	22.6	37.5	46.0	12.2	20.6	30.4	31.7	9.0	152.0	30.7	19.1	81.4	21.4	18.3	30.2	40.7	23.0	17.7	21.8	48.0	42.1	136.9	14.5	11.6	18.4	699.0	7.2	67.7	30.3	26.0	24.0	24.0	11.7	83.7	192.6	12.1	16.9	24.1	19.5	26.3	37.9	43.6	19.6	8.2	15.3	22.6	21.0	29.4	27.7	20.0	67.1	171.0	50.7	58.6	62.0	78.7	108.1	34.3	44.2	15.0	84.2	80.9	43.1	31.4	29.4	43.5	30.6	41.7	54.9	30.4	48.9	77.8	44.5	34.0	26.1	27.3	11.1	19.9	22.3	13.8	41.4	43.0	70.1	37.8	36.7	53.6	38.0	26.3	35.9	32.8	15.1	104.0	23.7	61.4	21.5	56.4	9.1	72.1	24.2	19.5	90.6	38.6	41.0	29.3	24.2	17.4	30.1	31.8	19.5	81.7	27.2	18.0	19.9	34.7	38.1	154.4	75.5	57.3	38.3	64.7	30.1	50.7	58.6	26.1	63.6	44.4	78.7	67.1	65.5	62.9	58.5	56.6	57.0	58.4	9.3	62.0	35.5	171.0	47.9	108.1	13.2	22.6	12.2	20.6	23.0	17.7	14.5	11.6	26.0	8.2
SSRP1	FACT80	ENSG00000149136	"Structure specific recognition protein 1"	Q08945	11	57325985-57335877	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002697	Approved		Approved	Nucleoplasm,Cytosol			8300	Cytosol	Nucleoplasm	"HPA002697: AB_1857509"	"unprognostic (1.67e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.96e-2)"	"unprognostic (3.54e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.52e-2)"	"prognostic unfavourable (4.03e-7)"	"unprognostic (3.22e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (5.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.52e-2)"	25.3	23.2	23.5	37.7	25.1	32.0	38.4	28.5	27.6	27.2	30.5	19.4	28.8	23.0	34.9	28.2	34.6	34.4	33.1	28.4	22.7	20.3	22.6	27.8	26.5	33.7	21.6	20.7	41.8	39.3	39.7	31.2	34.8	22.0	26.6	33.0	17.2	32.8	27.5	47.7	32.9	26.2	28.9	17.1	28.3	29.3	28.3	25.2	44.0	45.9	37.0	42.5	28.7	51.7	10.2	10.3	4.5	5.2	6.9	12.0	4.7	57.1	55.2	52.4	38.3	16.5	18.5	25.6	31.5	30.4	55.0	39.5	37.9	42.7	69.5	33.7	27.6	44.2	83.1	49.0	69.5	48.4	46.6	44.3	40.7	40.7	26.1	73.4	33.3	18.5	30.0	56.5	78.8	35.9	60.2	35.2	37.4	38.7	74.3	65.0	68.8	34.0	62.8	88.6	67.5	25.7	41.3	54.9	46.5	44.6	38.3	46.4	46.4	29.0	27.0	37.6	49.7	50.6	53.8	41.1	40.6	71.8	31.8	41.5	49.5	0.8	4.3	4.5	9.4	5.2	9.1	8.7	8.1	10.2	6.1	10.2	8.9	12.0	1.2	6.9	5.0	10.3	9.6	4.7	23.5	25.1	28.5	27.6	22.7	20.3	21.6	20.7	22.0	25.2
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.2;U-2 OS: 28.3;U-251 MG: 4.7;U-698: 5.9"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	0.3	4.7	0.0	1.6	5.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6
SSTR5		ENSG00000162009	"Somatostatin receptor 5"	P35346	16	1078781-1080142	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0"	"Group enriched"	"Detected in some"	15	"Hep G2: 9.2;PC-3: 34.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basal ganglia: 4.2;hypothalamus: 2.7"	"Low region specificity"	"Detected in many"			HPA066503			Supported	"Plasma membrane"				"Plasma membrane"		"HPA066503: "		"unprognostic (2.16e-2)"	"unprognostic (7.31e-2)"		"unprognostic (3.69e-2)"	"unprognostic (2.39e-2)"		"unprognostic (2.14e-1)"			"unprognostic (9.89e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-1)"		"unprognostic (4.09e-2)"	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.4	0.0	0.7	0.6	0.9	0.5	0.0	8.2	2.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	9.0	0.0	0.0	1.1	0.0	0.0	1.1	0.9	0.1	0.1	0.8	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	5.2	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	1.3	0.3	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13, Hsp70 interacting protein"	P50502	22	40824535-40857022	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol				Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favourable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	43.0	46.0	36.8	26.2	32.0	20.9	39.9	32.2	35.3	45.0	36.4	41.3	33.0	23.9	57.1	37.9	32.9	46.5	32.7	44.0	33.8	33.6	63.2	72.0	23.7	25.0	40.8	28.8	141.6	31.8	38.6	38.1	35.9	36.6	45.1	27.6	30.4	34.8	37.8	75.3	28.3	25.9	42.4	52.0	25.6	31.9	29.3	40.5	38.7	50.3	38.5	30.2	49.4	76.7	41.3	29.4	23.3	36.6	28.2	62.1	39.0	45.4	36.7	55.5	48.3	51.6	80.2	50.5	43.1	55.2	53.6	46.9	65.9	27.2	65.6	37.4	43.1	33.3	72.9	42.3	63.7	41.8	46.6	47.1	73.6	74.6	47.1	68.0	38.1	71.2	44.8	48.2	32.8	55.1	56.2	28.7	51.0	34.1	59.5	32.4	31.5	24.2	68.7	47.3	51.6	54.3	69.0	18.5	18.7	49.8	40.1	61.6	38.9	43.0	41.4	44.8	43.7	37.5	34.9	33.2	65.3	61.5	61.3	31.9	43.1	23.3	21.4	22.5	24.9	29.3	37.8	41.3	39.1	29.6	29.4	36.6	62.1	46.7	7.4	28.2	36.6	20.7	32.7	39.0	36.8	32.0	32.2	33.8	33.8	33.6	40.8	28.8	36.6	40.5
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease mutation, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047014			Approved	Nucleoplasm,Vesicles			220000	"Nucleoplasm, Vesicles"		"HPA047014: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favourable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.2	0.0	0.0	0.1	0.0	0.0	14.3	0.0	0.0	0.0	0.0	35.7	72.1	26.0	2.7	0.0	50.5	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.2	0.1	0.0	0.0	47.3	4.7	21.5	2.9	0.0	0.2	33.4	0.0	50.5	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.4	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5
STAB2	"DKFZP434E0321, FEEL-2, FELL, HARE, SCARH1, STAB-2"	ENSG00000136011	"Stabilin 2"	Q8WWQ8	12	103587273-103766727	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 71.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;HaCaT: 4.3;RH-30: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA026871	Enhanced		Supported	Cytosol			210000	Cytosol		"HPA026871: AB_1857536"	"unprognostic (5.66e-3)"	"unprognostic (7.51e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.84e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.72e-4)"	"unprognostic (1.37e-2)"	"unprognostic (5.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.06e-1)"	0.6	0.2	0.1	0.5	0.1	0.4	0.5	0.1	0.1	0.7	1.4	0.1	0.1	0.1	1.1	1.1	2.5	0.9	0.6	0.4	0.1	0.1	0.1	11.7	0.5	19.9	0.1	0.1	0.4	0.2	0.0	0.2	0.4	0.2	0.5	0.2	0.1	2.1	0.3	0.1	0.2	0.3	0.2	0.1	71.3	0.3	1.5	0.1	0.2	0.7	0.5	0.4	0.3	0.4	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.7	0.2	0.0	0.0	15.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	4.3	0.0	0.0	0.0	0.0	1.1	0.4	0.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.7	0.5	0.1	2.5	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.1	0.3	0.1	0.6	0.8	0.4	0.0	1.1	0.2	0.2	0.0	0.3	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336233-136752403	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA035015: AB_10603117, HPA058653: "	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	26.0	10.9	13.3	12.9	15.6	12.9	17.9	46.5	14.3	24.8	14.9	11.2	12.0	9.1	21.3	10.8	12.8	16.8	10.5	12.3	12.9	7.4	12.0	10.2	13.3	12.9	14.0	7.2	22.6	13.8	17.3	20.4	20.5	14.3	16.3	14.3	13.0	14.5	14.0	20.8	17.2	12.7	16.8	9.5	14.5	12.2	9.5	18.9	29.7	15.6	11.7	18.6	17.0	29.0	8.9	6.7	13.2	4.8	8.0	7.4	2.9	17.3	9.0	15.3	13.1	11.5	20.0	8.2	19.5	25.1	18.4	17.5	15.3	7.7	13.6	12.4	20.2	12.1	16.4	8.9	25.2	16.6	7.7	14.5	13.1	8.4	8.8	25.2	14.6	12.6	10.1	13.5	15.2	14.2	9.2	27.5	11.6	14.8	16.6	8.2	9.9	7.2	14.9	16.6	18.1	10.1	12.5	7.5	12.0	20.9	8.4	8.8	11.9	10.7	11.9	21.3	15.5	18.9	17.2	20.6	14.1	30.9	13.1	8.6	13.5	4.8	4.4	6.5	7.0	4.6	7.4	8.9	5.9	6.3	4.1	7.3	6.7	5.2	13.2	8.0	4.8	6.7	6.9	2.9	13.3	15.6	46.5	14.3	12.9	7.4	14.0	7.2	14.3	18.9
STAG2	"SA-2, SA2, SCC3B"	ENSG00000101972	"Stromal antigen 2"	Q8N3U4	X	123960212-124422664	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002857	Supported									"HPA002857: AB_1079861"	"unprognostic (1.62e-1)"	"unprognostic (1.01e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.67e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.97e-1)"	24.0	18.8	21.5	23.9	23.7	39.7	30.1	35.4	23.5	28.1	25.1	16.4	25.2	14.9	24.3	21.0	24.3	20.0	16.3	15.7	21.4	17.9	22.2	18.1	23.4	26.2	24.9	17.5	31.1	19.7	46.1	27.6	25.5	20.6	25.9	18.3	14.2	20.7	27.8	27.6	18.9	21.9	25.9	30.6	26.7	17.6	9.3	26.4	69.3	32.0	19.7	27.1	37.7	37.8	12.8	12.5	30.3	14.4	12.1	15.5	6.7	17.2	16.3	24.5	15.4	10.5	15.9	15.8	16.4	17.7	17.0	21.5	15.1	18.5	31.9	23.2	14.7	15.8	50.1	13.9	24.2	22.6	21.4	29.5	32.6	9.9	10.9	38.5	23.2	12.5	13.8	20.1	32.6	14.2	28.7	34.0	12.5	18.8	49.2	17.4	12.8	24.2	34.9	32.4	26.6	13.2	33.0	22.1	17.7	37.0	13.8	19.4	8.2	17.7	17.3	0.1	9.1	20.0	18.6	14.7	22.1	40.1	10.7	23.7	17.1	16.8	10.2	18.1	10.8	13.1	12.6	10.0	11.2	10.1	12.5	12.8	15.5	12.4	30.3	12.1	14.4	11.2	8.7	6.7	21.5	23.7	35.4	23.5	21.4	17.9	24.9	17.5	20.6	26.4
STARD13	"ARHGAP37, DLC2, GT650, LINC00464"	ENSG00000133121	"StAR related lipid transfer domain containing 13"	Q9Y3M8	13	33103135-33350630	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 25.9;WM-115: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.3;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	8	"dendritic cells: 3.4;monocytes: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039535, HPA058867"	Supported									"HPA039535: AB_10965929, HPA058867: "	"unprognostic (7.42e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.13e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.66e-2)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.29e-2)"	18.7	13.3	10.0	7.5	17.8	1.0	13.6	6.4	18.2	16.4	30.0	11.5	12.2	6.3	19.1	9.4	9.6	10.7	13.8	12.5	12.7	5.6	9.0	7.9	14.1	3.3	15.7	11.4	9.9	13.6	9.5	5.5	30.0	15.2	11.1	9.1	9.1	7.8	15.3	7.6	6.3	8.3	23.3	9.7	9.1	13.9	3.9	16.3	0.0	25.8	6.6	2.3	14.7	15.7	0.0	3.4	0.0	1.3	0.0	0.3	0.3	5.6	0.8	1.8	1.2	3.6	8.6	0.3	10.8	13.5	9.1	5.7	0.4	2.0	0.0	1.4	5.2	5.3	0.7	3.8	11.6	4.9	1.9	2.6	1.9	2.6	3.0	0.0	2.4	7.1	2.2	10.3	12.6	8.8	0.0	0.9	25.9	1.6	0.0	0.0	1.1	2.9	0.1	8.7	0.0	5.5	1.6	0.0	2.9	1.6	4.2	1.3	9.6	2.3	18.4	4.5	4.9	11.5	5.5	1.5	0.0	0.0	3.7	0.0	20.9	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.3	10.0	17.8	6.4	18.2	12.7	5.6	15.7	11.4	15.2	16.3
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 88.9;BJ hTERT+ SV40 Large T+ RasG12V: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol			22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favourable (1.75e-4)"	"prognostic unfavourable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.8	9.4	4.4	7.4	19.5	26.4	14.4	13.4	41.1	88.9	100.1	14.9	10.2	3.6	8.5	28.7	7.5	5.0	10.7	17.6	30.1	4.1	16.3	7.4	8.7	13.6	8.4	10.2	17.5	6.8	16.4	5.8	10.7	8.9	21.6	16.3	7.2	6.3	10.6	6.2	15.5	5.3	12.1	4.4	11.7	11.0	6.2	6.0	15.8	6.0	41.2	6.3	10.4	9.4	17.7	10.4	15.3	8.6	36.8	53.8	3.4	13.5	7.2	8.1	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4
STAT3	APRF	ENSG00000168610	"Signal transducer and activator of transcription 3"	P40763	17	42313324-42388568	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Diabetes mellitus, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001671, CAB003859, HPA058603, CAB068241, CAB068242"	Supported		Supported	Nucleoplasm,Cytosol			220000	"Nucleoplasm, Cytosol"		"CAB003859: AB_347629, CAB068241: , CAB068242: , HPA001671: AB_1080102, HPA058603: "	"unprognostic (1.83e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.59e-3)"	"unprognostic (1.78e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.47e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.61e-1)"	44.6	30.7	23.2	34.4	27.5	35.3	49.3	15.7	23.5	25.1	31.5	18.4	21.7	20.5	33.2	27.4	36.4	32.7	34.0	82.9	20.1	14.7	34.5	90.0	45.7	45.5	26.0	11.1	40.6	32.1	18.6	27.9	24.6	27.6	28.9	21.8	24.3	29.3	22.9	53.4	28.4	28.6	49.7	25.1	41.4	29.4	15.4	25.7	16.8	38.0	31.2	28.8	40.4	53.1	10.8	13.7	69.7	20.2	13.9	21.7	26.7	16.6	31.7	14.0	13.8	30.0	28.6	10.2	19.6	24.9	17.0	16.6	8.3	16.2	5.2	19.4	19.4	25.5	12.7	20.0	13.9	43.0	8.7	36.2	19.3	17.1	22.2	8.8	23.6	44.6	19.7	13.5	19.6	23.0	22.2	16.6	11.2	11.8	32.6	8.8	8.1	0.0	7.2	37.4	7.7	26.9	21.7	12.9	8.4	22.6	53.6	8.1	28.1	13.3	19.4	26.3	13.5	15.6	16.0	25.7	20.0	4.4	16.3	9.4	11.6	26.2	19.4	24.9	21.7	20.2	17.3	10.8	16.0	16.8	13.7	10.4	16.6	15.8	69.7	13.9	18.7	7.5	12.0	26.7	23.2	27.5	15.7	23.5	20.1	14.7	26.0	11.1	27.6	25.7
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.3;HEL: 38.3;HMC-1: 22.3;K-562: 63.7;MOLT-4: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Approved		Enhanced	Nucleoplasm,Cytosol			140000	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: , HPA049883: , HPA051156: "	"prognostic favourable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	44.0	21.5	3.6	16.5	8.1	30.0	24.1	3.4	4.0	12.6	12.8	6.3	10.5	5.1	11.0	11.4	11.6	9.6	15.3	9.8	3.9	4.7	8.9	5.5	12.8	26.7	9.1	3.2	15.6	8.3	1.9	7.0	11.3	6.1	13.9	5.8	11.9	11.9	11.7	18.3	9.7	11.6	13.6	7.4	17.3	7.9	8.5	6.1	21.9	8.6	9.1	17.0	19.9	20.2	7.2	15.0	15.2	18.5	14.3	16.2	8.8	1.0	1.2	0.1	0.0	9.1	4.4	0.0	0.5	2.0	1.0	0.6	0.1	1.0	0.0	2.3	2.0	0.0	0.2	0.0	0.2	25.3	0.0	38.3	2.9	0.3	3.7	3.2	22.3	10.2	0.7	0.3	0.5	3.0	63.7	0.0	0.5	0.1	46.2	18.2	0.3	0.0	1.1	0.3	3.3	0.3	0.7	0.1	0.0	2.3	1.1	4.2	0.7	4.1	1.7	2.3	0.6	1.1	0.0	0.0	0.0	0.0	0.2	6.2	0.5	6.8	11.8	5.9	9.1	15.1	12.8	7.2	15.8	13.2	15.0	6.7	16.2	13.0	15.2	14.3	18.5	5.7	11.2	8.8	3.6	8.1	3.4	4.0	3.9	4.7	9.1	3.2	6.1	6.1
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell line enhanced"	"Detected in single"		"HHSteC: 1.5"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892"	Approved		Supported	Cytosol				Cytosol		"CAB020839: , HPA049892: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavourable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	30.8	34.2	33.3	32.6	30.8	34.9	59.4	28.7	38.3	28.7	35.7	31.4	24.3	34.3	34.1	25.2	31.1	43.2	31.2	37.4	30.0	27.1	55.7	77.1	30.9	26.9	33.9	28.8	31.2	44.4	58.1	20.9	31.1	39.7	30.9	30.7	26.0	31.3	31.5	51.0	30.1	38.8	34.8	45.4	25.3	33.1	28.6	28.8	39.1	48.6	20.6	28.6	45.6	36.7	14.0	13.1	29.9	15.0	11.1	17.4	9.9	25.8	19.8	21.6	9.5	22.0	27.4	24.1	19.7	23.7	59.1	26.9	67.5	28.6	17.7	34.1	24.6	28.5	28.8	35.2	49.8	6.9	16.6	14.5	15.4	53.6	18.6	11.7	14.3	21.9	30.3	24.0	28.2	28.9	25.2	11.1	22.3	16.5	20.4	19.5	17.7	27.8	15.7	28.5	17.1	24.2	22.8	25.1	22.3	49.0	47.3	28.5	30.1	16.9	26.3	35.8	31.1	22.0	23.3	10.0	11.5	20.2	26.2	12.6	20.6	19.6	15.0	14.6	14.9	12.5	16.7	14.0	16.0	15.8	13.1	13.0	14.8	13.9	29.9	11.1	14.5	12.5	17.4	9.9	33.3	30.8	28.7	38.3	30.0	27.1	33.9	28.8	39.7	28.8
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 14.7;Karpas-707: 30.9;U-266/70: 19.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Supported	Cytosol				Cytosol		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.7	1.8	0.2	2.4	5.2	1.4	3.3	4.1	2.5	1.6	1.9	1.7	4.4	0.0	3.3	2.7	2.3	0.7	0.9	0.6	14.7	1.0	0.2	2.2	2.2	0.7	2.1	2.7	0.8	2.6	1.3	0.6	0.0	0.1	30.9	2.8	2.4	0.2	1.7	0.4	2.0	0.0	0.8	2.5	0.9	1.8	0.8	4.3	3.2	4.1	0.0	1.1	0.7	0.7	3.1	2.0	7.3	2.3	19.9	3.6	0.0	4.3	1.3	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4										
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"			4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.7	19.2	6.0	10.4	28.5	24.8	8.3	13.3	13.5	9.5	11.7	8.6	4.9	15.7	13.8	18.3	27.0	7.6	7.8	7.9	12.8	11.4	25.2	7.3	12.9	23.3	20.3	14.6	28.2	19.4	13.8	33.9	12.3	15.2	29.9	9.7	3.4	19.1	7.4	2.4	6.8	4.8	8.5	14.7	15.0	8.7	1.2	5.5	18.9	12.1	7.1	4.5	11.5	12.6	17.4	5.8	17.0	9.1	32.3	24.3	8.0	14.5	8.5	9.9	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857678-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 71.5;U-698: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported									"CAB037196: AB_1841195, HPA036933: , HPA057511: "	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavourable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favourable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	13.5	11.0	15.2	23.3	19.9	15.1	16.0	12.0	16.8	12.3	11.9	12.6	10.2	18.0	13.4	20.3	7.6	12.7	22.3	9.6	14.9	8.8	16.9	12.2	17.9	25.1	12.5	13.1	20.7	14.3	10.2	17.3	9.4	18.8	14.7	14.4	25.2	14.8	7.1	8.2	16.0	19.7	9.8	10.2	24.0	14.8	8.7	12.6	19.2	14.6	6.5	23.5	15.9	10.3	7.9	7.3	11.0	7.5	2.7	6.8	1.8	4.4	5.8	5.5	8.8	5.1	3.7	5.7	8.3	3.0	5.7	5.7	4.3	12.3	18.1	4.6	3.4	4.1	4.0	10.8	5.7	4.3	6.9	5.3	8.9	3.8	4.0	9.6	4.6	4.2	4.9	6.7	3.1	5.7	4.6	3.6	10.7	4.8	7.5	9.5	5.9	8.0	71.5	10.4	4.1	4.0	9.6	11.0	3.9	6.6	4.7	2.4	2.5	7.0	6.2	7.7	4.1	5.1	6.6	8.7	8.2	33.3	7.7	9.5	10.9	11.0	2.5	1.7	6.0	2.0	3.8	6.0	6.5	5.0	1.7	7.9	6.8	5.9	4.0	2.7	7.5	7.3	3.3	1.8	15.2	19.9	12.0	16.8	14.9	8.8	12.5	13.1	18.8	12.6
STIP1	"HOP, STI1"	ENSG00000168439	"Stress induced phosphoprotein 1"	P31948	11	64185272-64204543	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 168.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017448, HPA039291, HPA044062"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			3700000	"Nucleoplasm, Plasma membrane"	Cytosol	"CAB017448: AB_10618972, HPA039291: AB_2676428, HPA044062: AB_2678795"	"unprognostic (2.49e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.23e-4)"	"prognostic unfavourable (6.18e-8)"	"unprognostic (2.16e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.04e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.72e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.99e-2)"	27.3	49.7	32.2	32.0	40.5	25.8	41.5	45.3	41.9	28.3	25.5	29.2	20.6	19.2	30.1	25.2	31.5	36.2	21.6	34.4	32.2	42.8	24.7	27.8	25.4	31.9	47.7	22.5	34.1	24.1	39.1	38.3	37.0	40.7	30.1	28.5	20.3	22.6	29.5	51.9	27.6	20.7	33.2	39.7	26.5	24.4	56.4	49.0	29.8	46.1	23.4	41.2	26.0	168.2	32.2	26.8	20.9	39.6	39.5	35.9	39.5	49.0	76.6	48.4	40.3	27.0	18.0	43.6	44.6	24.0	64.8	37.8	56.1	42.1	58.7	52.5	35.3	52.1	121.3	44.7	71.3	46.1	49.5	82.7	51.5	51.5	23.5	43.6	52.3	18.2	28.1	53.6	40.5	45.6	81.6	33.8	37.2	71.8	65.6	59.5	58.3	64.8	64.5	46.1	59.5	45.2	43.5	39.5	35.1	50.9	53.9	41.4	57.2	30.2	40.9	41.2	51.0	53.8	60.0	30.8	66.5	62.0	53.4	43.9	59.3	19.0	25.3	20.9	35.9	36.2	35.7	32.2	27.2	32.0	26.8	26.0	30.5	33.8	7.7	39.5	39.6	22.2	24.0	39.5	32.2	40.5	45.3	41.9	32.2	42.8	47.7	22.5	40.7	49.0
STK10	"LOK, PRO2729"	ENSG00000072786	"Serine/threonine kinase 10"	O94804	5	172042073-172188386	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in all"		"WM-115: 51.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 27.5"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015083, CAB020840"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			24000	"Nucleoplasm, Plasma membrane"		"CAB020840: , HPA015083: "	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"prognostic favourable (2.76e-4)"	"unprognostic (2.88e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.25e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.84e-1)"	15.0	4.7	2.6	25.8	4.4	38.3	13.5	27.5	3.0	3.6	5.0	4.8	3.4	4.7	4.4	4.4	3.6	4.2	11.0	9.0	2.4	2.5	5.3	4.5	15.4	40.9	5.4	1.9	3.5	4.1	2.5	3.7	16.2	4.5	4.3	4.0	5.6	7.8	2.5	3.1	9.0	12.2	5.7	4.6	33.0	6.2	13.1	3.5	20.6	4.6	3.1	23.7	9.5	11.3	5.0	10.3	22.3	30.8	7.4	18.0	15.6	7.7	7.2	4.5	6.7	5.2	6.5	11.5	10.1	8.4	7.3	6.8	3.7	10.2	9.3	5.4	12.4	9.0	2.0	12.3	4.8	12.2	3.3	11.2	3.0	2.1	7.5	11.3	13.3	6.4	2.6	9.9	8.3	6.3	1.0	13.1	5.1	12.4	8.1	25.5	1.8	5.7	13.4	3.5	6.2	3.0	9.8	3.0	3.7	5.8	8.1	27.6	2.9	24.0	8.7	8.2	4.1	5.7	5.4	11.1	16.3	5.9	10.8	17.5	51.5	7.1	10.8	10.0	18.0	21.4	13.3	5.0	9.4	12.8	10.3	4.4	5.6	9.6	22.3	7.4	30.8	3.2	12.2	15.6	2.6	4.4	27.5	3.0	2.4	2.5	5.4	1.9	4.5	3.5
STK17A	DRAK1	ENSG00000164543	"Serine/threonine kinase 17a"	Q9UEE5	7	43582758-43626786	"Enzymes, Plasma proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											"HPA018138, HPA037979"	Uncertain		Approved	"Nuclear speckles,Plasma membrane"				"Nuclear speckles"	"Plasma membrane"	"HPA018138: , HPA037979: AB_10795247"	"unprognostic (1.81e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.41e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.03e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.07e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-3)"	"unprognostic (3.66e-1)"	7.1	10.1	6.1	43.3	8.2	20.2	8.4	7.9	7.2	4.8	9.3	3.7	2.0	6.1	5.3	4.2	10.1	4.7	8.6	17.7	5.7	5.6	6.7	8.1	15.2	36.6	6.6	2.6	7.3	14.3	1.5	6.3	37.2	5.7	6.2	5.3	3.6	8.6	3.4	10.7	4.8	12.3	5.8	5.3	27.8	11.0	9.0	2.8	30.1	7.3	6.8	37.7	10.3	8.1	10.8	1.4	11.5	0.9	12.7	11.4	2.9	4.5	5.7	5.2	3.5	6.5	8.6	2.1	16.5	17.8	9.0	9.2	4.9	3.3	7.3	26.0	13.7	9.4	3.9	21.9	12.6	18.0	4.4	6.5	4.3	6.1	4.8	11.2	4.4	7.0	25.8	11.9	10.9	16.8	7.6	25.2	10.3	2.1	18.2	5.2	8.0	18.7	6.3	3.3	14.5	15.7	3.4	2.8	6.3	7.4	3.4	4.8	4.0	5.7	16.8	19.6	7.5	11.6	18.4	15.3	7.6	10.6	19.9	9.9	31.2	0.7	0.4	11.5	5.8	0.2	5.8	10.8	6.1	9.7	0.3	10.1	11.4	10.2	6.4	12.7	0.9	1.4	3.2	2.9	6.1	8.2	7.9	5.9	5.7	5.6	6.6	2.6	5.7	2.8
STK17B	DRAK2	ENSG00000081320	"Serine/threonine kinase 17b"	O94768	2	196133566-196176503	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 35.5;HMC-1: 36.0;Karpas-707: 33.4;U-698: 38.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"cerebellum: 71.1"	"Low region specificity"	"Detected in all"			HPA034858	Enhanced		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA034858: AB_10670981"	"unprognostic (2.14e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.43e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.72e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.80e-2)"	21.0	4.1	3.2	42.8	3.8	103.4	10.1	3.2	3.3	8.2	18.8	1.1	3.8	8.5	3.4	3.9	8.9	6.3	8.6	5.7	3.3	2.2	7.2	2.9	26.2	53.7	2.3	1.8	3.1	5.0	0.7	3.8	6.5	1.7	6.8	5.7	3.5	16.7	6.1	3.4	10.9	31.8	5.3	2.7	59.3	6.0	4.6	1.4	72.2	7.5	7.0	56.2	11.3	6.0	16.9	13.6	62.0	27.0	10.3	28.4	19.0	3.1	2.2	3.3	1.2	14.7	5.6	3.7	7.6	11.4	8.3	8.7	6.6	1.1	35.5	7.0	4.3	2.2	1.4	3.2	10.2	6.2	3.8	3.3	2.8	0.6	4.4	13.4	36.0	7.1	3.2	10.3	5.4	3.4	2.6	33.4	20.6	1.7	17.4	30.4	1.9	5.1	2.9	20.3	10.7	4.9	7.5	1.2	1.3	1.9	1.9	1.6	1.3	7.0	4.1	8.1	4.0	5.8	4.2	13.7	22.2	38.7	6.1	4.6	3.6	35.9	19.7	40.2	12.0	20.7	15.3	13.3	21.5	14.5	13.6	16.9	28.4	23.1	62.0	10.3	27.0	9.7	18.5	19.0	3.2	3.8	3.2	3.3	3.3	2.2	2.3	1.8	1.7	1.4
STK25	"SOK1, YSK1"	ENSG00000115694	"Serine/threonine kinase 25"	O00506	2	241492674-241509730	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 164.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047147	Uncertain									"HPA047147: AB_10966137"	"unprognostic (1.75e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavourable (6.03e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (3.91e-8)"	"unprognostic (6.16e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.58e-1)"	17.8	13.6	22.3	14.2	26.0	16.3	12.9	22.3	35.3	16.4	17.1	17.0	13.0	14.6	17.7	15.9	19.3	15.4	16.7	19.0	19.4	20.0	17.3	13.5	13.4	13.5	16.3	20.4	17.5	19.2	18.9	17.1	15.6	16.4	15.1	12.9	13.5	14.2	17.6	164.2	15.3	14.2	17.3	12.6	15.8	16.1	16.8	14.4	15.2	20.0	24.6	12.6	14.6	16.6	15.0	13.6	13.7	16.4	21.5	19.9	10.6	18.3	11.7	23.4	29.0	28.8	20.1	36.0	30.7	20.7	23.4	26.8	13.0	16.2	7.0	8.7	40.9	15.7	32.9	33.4	28.5	26.2	34.5	19.6	24.8	33.6	26.1	11.9	15.1	28.9	24.0	22.6	18.2	52.8	30.2	6.2	42.8	19.3	17.6	18.5	32.6	16.8	29.7	29.8	10.4	20.6	15.6	39.3	18.0	14.9	11.3	19.2	9.0	21.1	61.5	17.7	21.7	20.3	21.7	12.9	2.9	11.9	17.1	9.8	20.0	13.7	14.8	11.5	16.9	13.4	15.5	14.5	15.5	17.5	13.6	15.0	12.0	11.6	5.5	21.5	16.4	10.7	19.9	10.6	22.3	26.0	22.3	35.3	19.4	20.0	16.3	20.4	16.4	14.4
STK3	"KRS1, MST2"	ENSG00000104375	"Serine/threonine kinase 3"	Q13188	8	98401403-98942827	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.3;granulocytes: 9.0;monocytes: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007120, CAB025316"	Uncertain		Approved	"Intermediate filaments,Rods & Rings"				"Intermediate filaments, Rods & Rings"		"CAB025316: , HPA007120: AB_10601664"	"unprognostic (7.88e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.12e-3)"	"unprognostic (9.68e-3)"	"prognostic unfavourable (4.25e-4)"	"unprognostic (6.71e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavourable (9.21e-5)"	"unprognostic (9.16e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (9.72e-2)"	16.5	16.6	6.5	8.1	12.4	2.5	20.5	2.6	10.6	17.2	13.1	10.5	14.2	4.6	22.2	13.1	9.0	16.0	12.6	10.0	7.4	4.1	14.7	12.0	16.2	10.8	12.8	3.6	22.8	10.7	15.1	18.9	53.1	9.9	15.0	6.0	8.2	10.8	16.4	11.6	10.0	10.8	23.5	12.9	8.2	9.5	10.1	11.4	3.4	10.6	7.9	5.9	16.4	24.3	1.9	8.3	9.0	8.7	1.8	1.8	2.9	37.6	7.1	7.5	9.9	24.4	12.2	7.5	13.1	11.8	12.3	10.7	5.2	16.0	0.0	11.4	13.0	15.3	5.2	11.3	19.9	9.0	6.7	10.1	3.5	3.5	8.3	3.3	8.8	8.1	19.5	6.3	17.2	5.2	4.2	5.5	8.9	4.7	8.4	4.0	2.2	2.8	7.4	6.5	3.2	14.0	4.7	1.9	4.4	8.3	9.6	8.1	7.9	5.5	3.9	8.3	5.3	12.5	7.2	4.4	6.5	2.7	7.4	4.2	13.1	2.1	8.6	4.5	1.3	8.7	1.4	1.9	0.8	1.8	8.3	1.3	1.1	0.7	9.0	1.8	5.4	3.4	0.1	2.9	6.5	12.4	2.6	10.6	7.4	4.1	12.8	3.6	9.9	11.4
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 104.0;hTCEpi: 85.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"			140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.4	9.7	0.8	4.4	104.0	29.9	0.0	25.9	25.7	7.3	11.5	1.2	1.9	11.8	6.4	32.2	2.5	5.4	24.0	13.0	7.2	2.2	27.4	21.3	3.7	56.4	10.1	5.8	49.5	85.0	11.4	15.2	26.0	5.9	15.8	15.8	7.7	0.3	7.7	11.8	3.0	1.4	0.0	25.6	5.7	0.2	1.0	0.1	21.6	19.2	11.1	6.5	8.4	33.0	16.9	5.3	16.8	2.4	6.7	7.3	0.7	6.5	10.2	9.0	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3
STON2	"STN2, STNB2"	ENSG00000140022	"Stonin 2"	Q8WXE9	14	81260656-81436465	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 42.8;HMC-1: 24.3;Karpas-707: 22.0;RT4: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 3.6"	"Lineage enriched"	"Detected in single"	4	"monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA003086	Enhanced		Supported	Nucleoli,Cytosol			9800	Cytosol	Nucleoli	"HPA003086: AB_2302748"	"unprognostic (5.28e-2)"	"unprognostic (9.83e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.96e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.30e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.19e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.37e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.44e-1)"	6.1	1.2	26.8	1.5	23.5	5.6	11.5	2.0	22.4	4.3	5.3	18.1	1.6	4.7	1.8	6.7	11.3	13.6	7.1	4.0	26.1	11.6	17.5	3.7	5.0	1.3	10.3	11.5	3.7	1.3	0.6	7.9	4.3	9.6	2.6	6.1	7.9	4.6	3.8	9.5	9.2	4.9	2.2	4.5	18.7	6.8	4.0	15.9	0.3	13.1	4.9	3.4	6.8	6.6	0.0	0.5	0.8	3.6	0.0	0.1	3.2	1.7	1.3	4.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	4.2	1.5	0.0	2.2	0.0	11.8	6.5	14.7	0.0	0.2	2.3	42.8	7.9	1.6	0.0	0.0	24.3	0.6	13.0	0.0	4.4	0.0	15.7	22.0	0.4	2.6	2.1	0.0	4.7	1.1	0.0	6.9	1.3	3.1	17.7	11.5	0.7	5.2	0.2	0.0	0.6	0.1	0.1	0.9	3.6	3.9	1.0	2.5	4.5	0.0	3.2	0.1	1.1	0.0	2.4	0.0	0.1	3.6	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.8	0.0	1.2	0.0	0.0	3.2	26.8	23.5	2.0	17.5	26.1	11.6	10.3	11.5	9.6	15.9
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882391-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol			290000	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavourable (9.07e-4)"	"prognostic unfavourable (5.10e-4)"	36.7	39.8	43.5	28.1	43.2	24.1	46.4	38.1	55.3	30.5	29.4	19.3	29.2	24.7	31.8	29.1	33.7	24.7	25.8	54.0	55.7	44.9	46.4	42.9	27.7	30.4	35.8	48.3	25.5	38.7	40.4	36.7	34.4	47.1	27.8	29.5	20.5	26.0	32.2	109.2	25.3	23.6	37.4	51.5	20.7	28.9	32.9	27.5	27.9	42.6	36.6	29.4	28.6	29.8	36.9	44.6	30.8	41.8	29.2	43.4	38.5	32.6	38.5	36.8	31.3	32.6	32.6	49.1	39.2	27.3	35.4	33.1	55.0	28.8	36.4	19.5	39.8	23.8	43.9	43.0	52.3	48.6	35.6	36.8	30.6	24.1	53.5	42.6	17.9	31.3	36.7	39.0	44.0	41.1	28.2	11.1	46.0	22.8	35.4	20.4	129.7	25.2	27.3	50.6	21.0	41.0	33.7	23.7	40.4	31.6	21.9	42.7	40.8	22.9	34.4	26.5	31.5	28.0	48.0	12.8	17.3	59.8	32.6	23.7	33.4	26.8	36.7	30.8	34.6	41.8	38.9	36.9	36.0	33.3	44.6	30.8	35.4	37.3	17.0	29.2	35.9	27.4	43.4	38.5	43.5	43.2	38.1	55.3	55.7	44.9	35.8	48.3	47.1	27.5
STRN3	"PPP2R6B, S/G2NA, SG2NA"	ENSG00000196792	"Striatin 3"	Q13033	14	30893799-31026401	"Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003392, HPA004636, CAB069925"	Approved		Supported	"Nucleoplasm,Actin filaments,Cytosol"			15000	Cytosol	"Nucleoplasm, Actin filaments"	"CAB069925: AB_1146988, HPA003392: AB_1079942, HPA004636: AB_1079940"	"unprognostic (4.08e-1)"	"unprognostic (8.66e-2)"	"unprognostic (8.08e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.06e-2)"	"unprognostic (7.74e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"prognostic favourable (9.66e-4)"	"unprognostic (8.74e-2)"	"unprognostic (7.85e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.01e-2)"	18.5	14.3	15.9	12.1	16.2	10.9	13.5	23.4	17.7	15.8	17.4	11.5	16.5	8.8	14.7	14.8	16.5	10.8	14.0	21.5	14.4	12.1	15.2	22.7	11.6	7.2	12.9	10.1	12.6	13.1	18.0	20.2	14.1	13.9	16.2	14.0	11.4	12.6	17.2	52.0	12.6	11.3	22.0	11.8	11.9	12.9	22.4	14.6	9.3	14.9	13.5	9.7	25.1	20.5	7.0	10.5	8.5	7.9	7.4	10.0	2.4	17.7	15.3	17.1	12.3	14.6	11.1	14.2	16.9	12.5	14.2	14.4	20.4	12.0	10.3	12.4	12.3	9.8	19.0	10.8	21.1	8.9	6.4	10.2	10.5	39.4	15.8	8.7	11.4	11.7	11.4	11.3	13.8	11.4	12.3	9.8	13.7	12.1	11.3	8.5	8.4	14.2	8.3	20.1	2.7	21.3	25.5	10.8	8.9	18.8	13.8	9.2	15.8	7.5	13.7	14.0	12.5	8.8	6.7	9.3	10.7	10.2	6.9	6.4	11.1	6.3	7.1	8.3	6.8	7.9	8.9	7.0	8.5	7.7	5.8	6.9	8.6	10.0	8.5	7.4	6.2	10.5	6.4	2.4	15.9	16.2	23.4	17.7	14.4	12.1	12.9	10.1	13.9	14.6
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 73.7;pituitary gland: 26.9"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 49.9;U-87 MG: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.5"	"Group enriched"	"Detected in many"	5	"amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5"	"Group enriched"	"Detected in all"	8	"amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3"	"CAB008372, HPA069176"	Enhanced				"Intracellular and membrane"					"CAB008372: AB_592786, HPA069176: "	"unprognostic (5.12e-3)"	"prognostic unfavourable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	1.4	5.6	27.4	2.4	20.9	7.6	1.4	33.7	73.7	1.7	2.6	1.3	0.8	3.7	2.8	1.8	1.7	2.3	5.5	1.2	22.0	8.3	1.1	1.2	1.8	1.4	4.0	28.0	2.2	5.7	1.5	26.9	2.2	2.6	1.9	2.1	0.1	1.9	1.8	1.1	1.9	3.5	2.6	1.3	1.3	6.2	2.0	0.7	0.0	1.6	0.0	1.1	2.8	1.1	0.4	0.0	0.1	0.2	0.0	2.5	2.7	1.5	7.3	1.2	3.5	1.6	4.2	0.8	5.0	3.3	2.1	1.4	2.5	4.3	1.9	0.7	3.5	1.3	1.7	3.1	1.6	3.4	1.3	0.6	2.6	1.4	1.8	0.8	1.8	2.5	1.4	14.6	5.1	3.6	1.6	2.3	3.9	3.7	0.6	7.1	0.9	16.7	0.0	0.8	1.9	1.7	1.3	49.9	7.9	1.5	4.2	1.0	1.4	0.6	13.6	10.3	3.4	7.9	13.3	1.3	0.8	0.9	33.2	0.7	12.1	0.0	0.2	0.0	2.5	0.0	0.9	0.4	0.4	0.6	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	2.4	2.7	27.4	20.9	33.7	49.9	22.0	8.3	4.0	28.0	2.6	0.7
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavourable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	20.2	12.3	7.1	13.3	14.2	9.1	9.0	17.1	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	15.6	8.7	16.6	13.9	7.3	12.9	10.2	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 13.0;classical monocyte: 16.5;eosinophil: 15.0;intermediate monocyte: 18.0;memory B-cell: 26.9;myeloid DC: 19.5;naive B-cell: 35.1;neutrophil: 26.4;non-classical monocyte: 18.2;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes			850000	Lysosomes		"CAB062564: , HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	28.9	14.3	27.8	26.4	24.3	13.0	21.1	27.2	29.4	17.3	21.8	25.0	11.8	25.1	22.2	14.1	23.8	16.0	23.2	23.8	24.9	23.6	35.0	12.6	22.6	47.8	28.3	22.2	22.7	13.0	12.5	13.4	31.9	31.2	18.6	20.5	16.3	20.2	19.3	16.3	17.8	26.7	20.6	42.1	29.0	19.2	8.2	27.7	9.0	21.9	15.2	46.5	21.2	19.9	35.1	23.5	26.4	18.2	2.9	3.9	8.5	7.1	7.2	12.3	8.7	24.7	22.1	9.6	14.2	14.7	14.8	21.4	12.6	12.0	35.7	14.0	17.2	9.4	10.8	13.1	20.0	12.3	12.8	13.6	6.4	13.3	19.8	9.1	10.3	12.6	12.4	15.1	13.8	16.1	14.5	12.9	16.8	10.0	4.2	7.5	4.7	8.5	10.0	9.5	10.2	24.7	8.4	10.1	3.1	6.4	10.6	38.2	7.2	8.8	27.7	8.6	8.8	18.7	15.0	12.4	7.2	15.4	12.1	7.4	9.6	13.0	16.5	15.0	3.7	18.0	1.5	26.9	2.7	2.5	19.5	35.1	2.0	2.4	26.4	2.9	18.2	23.5	3.9	8.5	27.8	24.3	27.2	29.4	24.9	23.6	28.3	22.2	31.2	27.7
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 127.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 47.1;SK-MEL-30: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol			6400	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavourable (1.47e-4)"	"prognostic unfavourable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favourable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	14.1	16.0	32.4	4.7	42.2	1.5	5.1	86.8	127.4	8.1	4.6	6.5	1.9	3.7	13.2	4.7	6.3	17.9	6.7	12.7	35.0	31.5	7.1	2.7	16.8	3.7	24.6	55.5	14.3	13.2	8.1	22.3	7.9	61.9	6.5	5.3	12.6	8.1	6.6	5.0	5.6	4.6	11.7	13.3	5.9	5.2	5.4	5.3	0.0	10.7	0.9	4.3	5.7	7.6	0.0	0.5	0.0	0.4	0.0	3.4	0.6	4.0	8.5	8.2	9.2	18.6	16.0	7.4	14.3	7.3	8.6	7.6	0.4	4.8	4.0	8.0	9.3	1.4	7.2	8.8	10.6	9.2	4.8	5.4	23.1	1.5	9.4	0.5	4.7	12.1	4.9	22.6	11.0	10.2	5.4	6.2	14.5	7.5	3.8	1.7	7.0	11.8	2.3	3.9	9.7	7.1	0.2	47.1	22.9	24.1	11.9	40.8	1.8	1.7	15.2	9.8	5.0	19.2	5.3	13.4	22.1	5.4	19.2	5.8	9.0	0.0	0.4	0.0	0.8	0.1	0.3	0.0	2.2	3.4	0.5	0.0	1.4	1.7	0.0	0.0	0.1	0.3	0.3	0.6	32.4	42.2	86.8	87.7	35.0	31.5	24.6	55.5	61.9	5.3
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.5;lymphoid tissue: 101.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 55.2;U-937: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol			53000000	Cytosol		"HPA015564: AB_1857626, HPA063868: "	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favourable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavourable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favourable (7.68e-4)"	"prognostic favourable (5.13e-6)"	7.2	7.9	5.5	17.9	9.9	49.5	9.9	2.0	5.8	6.5	17.7	5.4	15.9	19.0	3.0	10.4	23.4	9.6	14.3	18.4	5.2	2.0	20.2	19.0	46.4	61.5	12.2	1.3	4.6	28.0	10.9	9.8	24.9	5.8	16.4	10.5	8.7	24.6	9.7	1.5	15.3	32.0	3.7	16.9	101.5	20.6	22.5	8.0	73.4	19.5	5.4	17.8	11.4	18.0	6.7	30.2	45.6	101.5	9.0	9.9	31.9	24.0	8.5	0.2	0.1	0.0	0.2	16.9	3.1	0.3	0.6	1.6	20.1	15.3	6.4	12.4	2.4	16.6	0.9	14.7	0.6	26.5	10.3	27.5	10.2	11.8	14.7	17.7	55.2	1.0	15.1	3.0	8.6	12.9	17.1	21.9	0.0	15.2	8.6	41.1	6.3	15.1	8.9	0.0	24.4	12.3	27.9	2.6	0.1	7.4	11.0	0.5	13.7	45.8	13.5	0.1	5.0	0.3	0.1	24.4	12.0	8.2	0.2	48.4	0.6	25.5	58.1	35.5	9.6	73.1	7.7	6.3	7.3	8.6	30.2	6.7	5.2	6.2	45.6	9.0	101.5	11.5	9.9	31.9	5.5	9.9	2.0	5.8	5.2	2.0	12.2	1.3	5.8	8.0
STXBP3	UNC-18C	ENSG00000116266	"Syntaxin binding protein 3"	O00186	1	108746674-108809526	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027225	Approved		Approved	Nucleoplasm,Cytosol			160000	Nucleoplasm	Cytosol	"HPA027225: AB_1857627"	"unprognostic (3.14e-3)"	"unprognostic (4.33e-2)"	"unprognostic (7.18e-3)"	"unprognostic (4.88e-2)"	"unprognostic (6.54e-2)"	"unprognostic (9.78e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.55e-2)"	18.3	18.4	29.8	18.7	42.1	15.2	20.9	21.9	27.1	19.4	20.5	26.3	15.6	18.7	20.3	19.9	18.8	16.0	20.8	14.3	30.4	22.1	30.2	17.8	16.8	18.2	48.0	28.0	16.2	20.5	31.9	18.0	20.3	31.4	18.1	21.9	9.8	17.5	21.3	15.4	19.7	23.8	18.4	56.6	19.8	18.0	11.3	42.5	20.0	27.8	14.6	17.8	20.2	18.3	5.9	8.3	26.2	11.6	8.7	10.2	5.9	21.9	8.7	15.0	7.9	18.3	17.8	21.2	20.4	18.9	13.8	14.1	8.0	8.9	19.5	13.9	16.5	13.2	10.1	12.0	19.4	21.7	14.0	16.1	11.9	10.4	14.5	25.1	27.7	13.8	17.1	15.4	16.9	17.0	11.9	19.3	19.1	14.9	15.8	20.2	16.0	13.8	13.3	21.9	10.7	22.4	18.4	9.0	8.3	25.1	24.3	29.7	9.7	23.9	19.1	18.1	10.6	25.0	17.5	12.9	11.2	16.2	32.5	19.3	27.4	26.2	8.8	20.8	7.8	10.6	9.9	5.9	9.2	7.8	8.3	5.4	7.9	7.5	24.3	8.7	11.6	3.9	10.2	5.9	29.8	42.1	21.9	27.1	30.4	22.1	48.0	28.0	31.4	42.5
SUB1	"p14, p15, PC4"	ENSG00000113387	"SUB1 homolog, transcriptional regulator"	P53999	5	32531633-32604079	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 162.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001311, CAB015351"	Supported		Supported	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"CAB015351: AB_2197157, HPA001311: AB_1080123"	"unprognostic (5.19e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.87e-2)"	"prognostic unfavourable (5.25e-6)"	"unprognostic (8.31e-2)"	"prognostic unfavourable (2.79e-4)"	"unprognostic (3.46e-3)"	"unprognostic (5.04e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.45e-1)"	54.4	40.8	64.1	50.9	69.8	87.6	52.3	28.2	82.4	48.9	44.4	21.5	23.2	36.2	36.8	36.3	52.7	27.4	31.3	46.9	79.3	53.5	54.7	60.7	36.3	58.4	45.8	57.5	30.7	26.9	26.5	49.0	47.0	51.6	34.5	46.0	17.4	32.3	29.1	39.6	26.8	47.5	33.2	39.6	67.2	38.7	28.1	29.8	72.4	42.2	54.2	54.6	39.8	29.7	61.1	69.4	92.0	24.6	25.9	59.5	49.2	21.6	18.0	35.8	33.4	21.8	38.7	22.5	38.0	27.7	34.4	31.8	26.0	34.4	11.0	26.5	26.2	14.8	30.0	31.1	46.4	45.9	27.5	37.0	43.9	49.2	30.9	64.3	50.7	27.1	26.9	36.5	26.1	25.7	42.9	162.4	30.3	19.3	60.7	102.8	23.5	36.8	27.0	46.7	70.3	34.2	19.7	19.4	16.1	58.8	27.7	26.9	30.7	59.9	26.5	37.3	40.5	31.4	28.5	63.5	109.5	19.2	34.3	69.9	22.7	92.0	23.9	54.9	31.5	24.6	28.4	61.1	41.4	41.2	46.8	35.1	32.9	37.6	29.2	25.9	21.9	69.4	59.5	49.2	64.1	69.8	28.2	82.4	79.3	53.5	45.8	57.5	51.6	29.8
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria			6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavourable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	17.2	20.0	25.4	15.2	29.1	22.0	15.3	26.4	29.6	27.5	18.7	35.5	19.6	24.2	20.2	25.8	24.0	33.5	25.1	34.9	23.1	28.7	27.2	19.0	23.0	20.3	27.5	15.9	20.7	29.6	18.7	22.1	20.2	18.3	8.8	27.3	11.9	28.3	31.5	26.3	25.6	24.1	23.2	18.7	39.7	16.7	14.1	16.8	22.0	20.4	15.5	18.1	24.4	15.4	15.3	9.9	21.7	18.3	9.1	14.2	28.2	9.5	20.1	22.4	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4
SUCLG1		ENSG00000163541	"Succinate-CoA ligase alpha subunit"	P53597	2	84423523-84460045	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 125.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036683, HPA036684"	Enhanced		Supported	"Plasma membrane,Mitochondria"	"Intracellular and membrane"		330000	Mitochondria	"Plasma membrane"	"HPA036683: AB_10671708, HPA036684: AB_2675248"	"unprognostic (6.84e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.58e-3)"	"prognostic unfavourable (5.23e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.24e-2)"	"prognostic favourable (2.21e-8)"	"unprognostic (4.94e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.23e-1)"	26.1	23.3	18.0	15.0	18.9	10.6	23.8	18.9	19.5	14.1	50.1	17.7	23.2	53.9	13.9	19.6	25.0	13.5	14.0	57.7	17.4	17.3	125.6	44.1	12.8	13.3	19.2	17.0	12.7	33.9	36.2	16.3	13.8	17.3	17.1	39.4	16.9	39.3	24.9	57.6	15.6	71.6	26.5	17.1	12.1	21.9	13.3	16.0	16.9	28.8	42.8	15.2	24.3	16.3	26.6	43.5	31.6	40.3	35.2	39.1	46.8	23.5	25.9	20.5	25.0	38.6	26.0	35.5	26.9	23.0	34.6	25.3	59.3	19.5	32.4	18.6	32.1	34.4	42.1	31.6	41.2	31.3	38.3	28.1	22.4	33.7	32.6	28.6	23.0	30.9	26.0	29.1	39.8	30.8	28.5	26.7	31.5	36.0	40.6	26.2	10.7	46.4	25.8	47.5	35.5	46.4	28.6	24.9	13.9	21.4	44.5	42.7	27.1	22.6	24.8	27.2	26.3	33.3	32.9	23.5	33.3	28.0	31.7	39.7	23.9	31.6	34.4	28.7	31.4	40.3	34.6	26.6	29.2	35.1	43.5	20.2	32.4	34.2	18.5	35.2	40.0	23.7	39.1	46.8	18.0	18.9	18.9	19.5	17.4	17.3	19.2	17.0	17.3	16.0
SUCLG2		ENSG00000172340	"Succinate-CoA ligase GDP-forming beta subunit"	Q96I99	3	67360460-67654614	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 90.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046705, HPA051998"	Enhanced		Supported	"Plasma membrane,Mitochondria"			290000	"Plasma membrane, Mitochondria"		"HPA046705: AB_2679762, HPA051998: AB_2681687"	"unprognostic (1.69e-1)"	"unprognostic (2.31e-1)"	"prognostic favourable (1.08e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.26e-2)"	"unprognostic (4.61e-3)"	"unprognostic (5.59e-2)"	"prognostic favourable (2.79e-10)"	"unprognostic (3.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	17.0	19.3	8.8	26.5	10.0	3.4	12.4	2.4	7.2	15.3	38.9	9.5	16.4	31.4	11.5	18.3	18.6	9.9	27.9	23.6	6.6	6.2	38.3	90.9	14.6	21.1	9.8	6.5	16.5	20.9	5.9	8.5	8.5	7.6	14.0	34.5	9.6	21.0	17.3	57.0	9.3	42.4	23.5	8.6	24.7	25.4	6.5	8.1	9.6	16.4	27.0	16.7	19.9	13.2	19.2	10.2	5.8	18.2	27.1	31.1	18.9	13.8	12.1	12.0	14.6	20.2	35.1	14.7	16.6	24.4	19.6	21.9	13.4	31.0	17.7	5.4	23.4	7.1	9.3	23.0	25.5	7.5	6.4	16.1	11.0	20.8	26.1	21.1	11.3	26.2	20.0	15.3	35.3	20.8	12.2	16.3	42.6	9.7	7.9	6.7	11.2	7.5	5.5	18.6	26.5	33.2	21.6	2.3	8.2	26.4	30.6	22.0	23.5	13.6	18.1	19.5	12.8	21.4	19.7	11.1	16.2	12.5	28.6	16.5	22.9	5.8	15.3	5.2	13.8	18.2	16.7	19.2	20.0	17.4	10.2	16.7	31.1	23.7	0.7	27.1	14.8	4.0	18.5	18.9	8.8	10.0	2.4	7.2	6.6	6.2	9.8	6.5	7.6	8.1
SUGT1	SGT1	ENSG00000165416	"SGT1 homolog, MIS12 kinetochore complex assembly cochaperone"	Q9Y2Z0	13	52652709-52700909	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015942, HPA043949"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB015942: , HPA043949: "	"unprognostic (3.66e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavourable (8.69e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.96e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.83e-2)"	"unprognostic (2.82e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.56e-1)"	22.7	29.9	40.0	23.1	44.8	26.2	27.9	39.7	42.7	17.9	24.0	23.0	14.9	25.8	19.4	20.6	27.1	19.2	18.9	33.8	34.0	28.8	30.8	34.3	19.8	23.5	35.9	28.9	20.8	28.6	14.0	39.8	24.4	36.0	18.1	26.5	14.2	22.5	16.8	26.1	23.1	24.8	21.4	31.1	21.3	23.1	31.2	43.5	15.2	21.6	19.5	27.4	21.8	48.3	17.5	23.4	29.0	19.1	17.5	25.3	13.6	15.2	16.7	24.8	18.8	24.6	20.1	23.8	33.7	22.3	21.1	16.9	36.4	38.5	33.6	9.6	20.8	26.5	30.5	19.3	31.1	27.8	12.7	31.2	21.9	27.5	17.9	24.2	23.5	13.9	17.6	21.8	16.6	35.3	29.1	11.1	32.2	10.8	22.5	44.5	29.0	16.1	26.0	14.4	14.5	36.6	17.2	8.2	10.5	17.4	14.3	15.8	14.7	23.1	25.3	17.7	20.7	20.3	28.7	8.7	12.3	30.0	10.6	19.5	25.3	29.0	16.8	26.8	14.9	19.1	14.6	17.5	19.4	20.0	18.6	16.3	14.9	16.5	2.3	17.5	18.2	23.4	25.3	13.6	40.0	44.8	39.7	42.7	34.0	28.8	35.9	28.9	36.0	43.5
SULF2	"HSULF-2, KIAA1247, SULF-2"	ENSG00000196562	"Sulfatase 2"	Q8IWU5	20	47656348-47786616	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 47.4;HaCaT: 31.4;HBEC3-KT: 35.4;hTCEpi: 114.1;MCF7: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"basophil: 12.7;classical monocyte: 11.0;intermediate monocyte: 9.2;myeloid DC: 11.5;neutrophil: 17.2;non-classical monocyte: 4.4;plasmacytoid DC: 14.7"	"Group enriched"	"Detected in many"	88	"dendritic cells: 14.7;granulocytes: 17.2;monocytes: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA002325	Approved				"Intracellular and membrane"		200000			"HPA002325: AB_1080126"	"unprognostic (4.06e-2)"	"prognostic unfavourable (6.43e-5)"	"unprognostic (4.39e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.85e-1)"	"prognostic unfavourable (4.02e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.14e-3)"	16.2	3.9	13.3	15.1	11.2	3.7	13.6	7.4	22.4	42.5	17.8	10.8	3.7	11.1	51.8	13.7	30.2	24.4	24.8	15.1	16.8	11.5	21.9	14.2	5.1	24.9	13.0	9.9	58.7	3.4	2.1	17.1	12.4	28.2	10.4	17.3	19.4	11.6	9.1	14.1	9.8	8.2	33.6	6.3	5.4	6.9	13.9	9.3	2.5	13.9	7.9	14.1	16.1	19.4	0.1	14.7	17.2	11.0	0.0	0.1	3.1	0.0	2.8	13.0	0.0	2.7	0.3	1.2	2.2	0.0	0.2	0.4	4.9	6.6	0.5	47.4	2.3	31.4	3.7	35.4	0.1	0.0	2.7	0.0	3.5	11.0	2.5	0.0	0.7	14.8	114.1	0.2	1.5	2.5	0.0	21.0	0.2	92.8	0.0	0.1	2.6	28.8	0.0	0.0	5.2	27.5	0.1	1.1	0.3	4.5	0.0	0.0	0.1	0.3	2.4	0.0	0.2	0.0	3.0	0.7	0.2	0.1	0.0	0.0	0.3	12.7	11.0	1.0	0.0	9.2	0.1	0.1	0.0	0.0	11.5	0.1	0.0	0.0	17.2	0.0	4.4	14.7	0.0	3.1	13.3	11.2	7.4	11.0	16.8	11.5	13.0	9.9	28.2	9.3
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Lipid metabolism, Steroid metabolism"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA002107: "	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.5	0.3	0.4	0.5	0.0	0.1	0.3	0.6	0.4	0.5	0.4	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	47.5	0.2	1.1	0.4	0.3	0.3	0.5	0.4	0.2	0.2	1.6	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.7	0.3	15.4	0.4	0.8	13.7	0.3	0.8	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7
SULT1C2	"ST1C1, SULT1C1"	ENSG00000198203	"Sulfotransferase family 1C member 2"	O00338	2	108288639-108309915	"Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.2;kidney: 58.4;stomach 1: 59.2"	"Group enriched"	"Detected in some"	6	"RPTEC TERT1: 23.5;RT4: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007190	Approved									"HPA007190: AB_1857647"	"unprognostic (3.31e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.19e-2)"	"unprognostic (9.27e-2)"	"unprognostic (6.28e-2)"	"unprognostic (4.63e-2)"	"unprognostic (9.96e-5)"	0.5	0.1	0.2	2.2	0.2	0.0	0.4	0.1	0.2	0.8	1.5	1.0	0.5	10.6	0.8	13.3	0.4	1.0	69.2	0.5	0.2	0.2	58.4	1.5	2.5	0.6	0.4	0.3	0.3	3.2	0.2	4.6	0.6	2.2	0.3	1.9	18.6	3.5	4.9	0.1	0.2	1.8	0.6	0.6	0.4	59.2	0.4	0.0	0.4	10.3	0.4	0.3	0.6	0.4	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.2	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	23.5	6.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.2	0.2	0.4	0.3	2.2	0.0
SUMF2	DKFZp566I1024	ENSG00000129103	"Sulfatase modifying factor 2"	Q8NBJ7	7	56064002-56080670	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024040, CAB025743, HPA074892"	Enhanced		Uncertain	"Vesicles,Plasma membrane"	"Intracellular and membrane"		730000	"Vesicles, Plasma membrane"		"CAB025743: , HPA024040: AB_1857651, HPA074892: "	"unprognostic (2.93e-1)"	"prognostic unfavourable (6.58e-6)"	"unprognostic (2.42e-2)"	"prognostic favourable (3.96e-4)"	"unprognostic (3.87e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.99e-3)"	"prognostic unfavourable (7.71e-4)"	26.8	38.3	13.0	17.7	17.0	15.4	26.2	10.9	28.2	35.0	31.9	24.8	35.4	31.1	32.2	32.3	23.8	37.8	51.2	16.8	12.8	11.6	36.0	40.4	30.2	25.9	19.8	18.0	28.6	91.0	34.7	18.3	37.5	20.7	29.5	25.0	25.0	39.7	37.1	14.0	23.6	35.1	27.2	19.6	27.0	32.9	16.2	17.6	29.8	33.3	15.1	25.1	29.1	23.1	21.0	43.1	17.1	28.5	15.7	33.4	28.5	63.9	19.4	8.4	39.1	41.8	28.9	13.1	21.0	29.4	17.7	22.0	10.5	52.0	10.1	18.2	30.0	32.5	5.1	24.3	11.8	16.4	8.1	6.5	12.7	9.8	27.1	15.7	20.7	22.9	23.8	15.9	27.7	26.0	20.4	45.1	28.4	14.1	13.4	18.5	11.6	9.9	10.8	8.6	64.5	24.1	7.1	10.0	12.2	26.3	55.8	25.7	55.9	26.3	21.4	16.4	23.5	40.1	17.9	30.7	23.3	15.0	26.9	29.9	52.3	17.1	21.0	7.5	26.2	27.4	33.4	21.0	25.6	26.2	24.8	18.7	28.5	27.7	1.3	15.7	28.5	43.1	26.8	28.5	13.0	17.0	10.9	28.2	12.8	11.6	19.8	18.0	20.7	17.6
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin-like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: , HPA048064: "	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavourable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	32.2	23.8	37.4	17.7	43.8	50.0	25.0	31.6	43.4	26.9	28.0	17.5	19.4	24.0	21.7	23.9	23.4	22.1	21.9	36.6	27.6	38.7	24.4	29.2	26.2	32.0	30.8	29.0	26.3	26.2	14.6	15.6	21.7	26.6	21.8	15.5	30.6	28.3	30.2	62.4	18.9	28.9	17.4	19.7	28.2	27.7	17.3	17.3	23.9	26.1	18.4	20.8	22.5	20.3	23.8	46.0	14.0	35.7	18.5	27.6	38.4	45.5	18.4	17.3	7.1	20.2	23.3	18.2	31.8	34.9	45.1	36.2	27.4	18.2	16.1	50.4	29.6	9.0	14.9	24.7	11.1	22.4	22.5	66.1	13.2	21.7	22.0	37.3	32.7	26.3	23.5	26.3	15.0	18.2	37.8	26.9	18.0	58.6	31.7	25.9	41.3	36.9	37.0	1.5	36.0	11.8	17.7	17.0	32.7	28.5	20.9	22.0	28.2	26.8	35.9	13.5	29.6	28.7	32.7	33.3	46.6	40.8	12.1	51.1	18.6	0.6	34.6	14.0	23.5	35.7	23.9	23.8	22.8	22.8	37.5	21.5	27.6	24.8	4.1	18.5	32.0	46.0	24.7	38.4	37.4	43.8	31.6	43.4	27.6	38.7	30.8	29.0	26.6	17.3
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	59.3	22.9	28.7	41.7	58.7	84.6	66.9	17.6	43.8	33.7	33.6	57.5	24.2	29.0	47.3	23.3	41.4	42.5	25.3	32.3	37.8	19.3	24.4	47.1	37.7	56.8	73.6	25.4	44.8	44.1	10.5	14.8	22.7	42.5	31.2	16.3	14.9	39.1	35.0	48.6	31.0	31.6	35.3	37.1	46.3	35.2	30.2	68.0	42.6	26.9	20.1	36.0	47.0	35.9	6.4	6.0	14.0	13.9	13.3	25.5	11.8	24.6	11.5	11.5	12.8	35.0	8.7	15.0	17.0	19.9	20.2	17.2	10.3	28.0	7.8	20.8	24.1	18.5	3.8	12.6	8.3	27.0	15.5	5.1	12.4	9.3	21.3	17.1	53.3	7.3	10.7	9.7	9.1	16.0	6.3	44.2	10.9	7.9	9.5	14.8	1.1	7.4	15.8	16.1	23.4	5.0	12.1	10.2	3.8	18.9	21.1	10.0	14.1	32.1	26.8	14.7	12.9	12.9	22.0	32.7	10.2	8.2	27.3	20.6	24.6	14.0	7.4	9.7	25.5	8.8	16.5	6.3	16.2	20.6	6.0	6.4	17.1	20.1	8.0	13.3	13.9	3.7	11.0	11.8	28.7	58.7	17.6	43.8	37.8	19.3	73.6	25.4	42.5	68.0
SUPT16H	"CDC68, FACT, FACTP140, FLJ10857, FLJ14010, SPT16/CDC68"	ENSG00000092201	"SPT16 homolog, facilitates chromatin remodeling subunit"	Q9Y5B9	14	21351472-21384266	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022551, HPA049787"	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"				Nucleoplasm	"Nucleoli fibrillar center"	"CAB022551: , HPA049787: "	"unprognostic (1.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.58e-3)"	"unprognostic (9.05e-2)"	"unprognostic (5.87e-3)"	21.6	18.3	16.3	21.6	26.2	21.5	21.3	39.1	27.9	22.8	21.3	14.4	20.7	13.5	31.5	18.5	20.9	23.7	14.5	15.9	17.9	16.2	17.7	14.1	17.1	28.0	18.8	22.8	29.0	15.7	40.3	24.0	18.9	28.6	18.8	21.5	11.3	19.3	20.5	21.4	22.1	19.9	27.4	18.9	22.6	19.1	24.9	19.0	32.7	20.3	17.0	29.5	24.6	20.7	23.3	17.1	21.1	20.4	23.2	26.8	16.7	29.9	28.3	39.3	28.8	17.8	17.8	28.0	27.1	21.7	33.2	31.3	27.4	27.1	63.7	10.4	19.7	32.1	49.7	24.5	50.3	20.2	21.2	38.6	25.9	38.4	18.2	54.5	28.8	15.6	15.1	27.6	31.3	22.4	31.7	27.4	27.4	19.4	50.9	16.6	43.8	28.1	55.1	44.9	34.4	13.3	33.2	39.4	33.6	43.9	26.4	16.5	14.6	25.9	18.9	29.1	24.3	18.0	29.3	27.4	45.7	64.2	10.7	32.2	22.0	21.1	13.1	19.6	22.8	17.3	26.8	23.3	21.8	25.3	17.1	21.3	25.0	25.1	11.0	23.2	20.4	16.1	20.3	16.7	16.3	26.2	39.1	27.9	17.9	16.2	18.8	22.8	28.6	19.0
SUPT6H	"KIAA0162, SPT6H"	ENSG00000109111	"SPT6 homolog, histone chaperone"	Q7KZ85	17	28662091-28702684	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012416, HPA036382"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB012416: , HPA036382: "	"unprognostic (8.18e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.23e-2)"	"prognostic unfavourable (3.68e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"prognostic favourable (4.36e-5)"	"unprognostic (4.75e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-2)"	27.6	30.0	30.0	24.1	32.8	56.3	25.6	31.9	35.7	28.0	30.1	28.5	23.2	19.9	38.6	28.4	24.4	24.1	25.0	23.8	25.7	22.0	24.1	32.6	26.3	26.0	25.7	32.8	33.1	28.8	40.7	34.5	31.9	24.3	26.9	21.8	33.2	28.2	29.2	50.1	38.6	28.7	40.0	29.8	33.1	28.5	23.4	29.0	27.2	27.6	18.4	29.4	30.7	27.1	5.7	8.2	14.4	6.1	5.4	5.6	3.4	17.7	37.2	18.7	21.3	22.8	15.3	14.4	24.4	26.1	28.8	25.9	34.5	7.9	18.9	12.8	24.3	21.2	27.3	17.7	29.9	35.1	24.3	26.4	30.0	21.3	19.1	27.6	29.5	21.0	10.7	30.6	20.4	18.9	25.8	22.4	20.5	21.2	27.3	11.8	14.5	12.1	14.0	34.4	15.4	14.2	35.2	14.3	18.9	28.6	45.2	15.5	27.7	19.6	29.7	22.8	18.8	21.6	31.0	28.5	21.8	27.7	25.7	12.5	18.8	14.4	5.9	5.4	5.2	3.9	5.5	5.6	4.3	5.6	4.8	5.7	4.4	3.8	9.0	5.4	6.1	8.2	3.8	3.4	30.0	32.8	31.9	35.7	25.7	22.0	25.7	32.8	24.3	29.0
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA023608: AB_1857671, HPA074622: "	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favourable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.6	5.1	7.6	3.2	2.9	8.4	6.7	3.9	6.0	3.7	10.3	7.2	12.2	5.2	3.7	12.7	6.5	7.0	2.2	8.1	7.4	8.4	7.5	6.1	5.8	14.1	7.3	4.2	6.3	6.3	5.8	3.1	18.2	6.6	5.3	10.9	11.4	11.6	14.8	11.9	12.1	7.1	12.3	5.2	4.0	10.7	9.1	6.5	10.8	5.8	9.4	8.0	6.3	13.7	7.2	6.9	9.0	4.9	6.9	15.8	5.1	9.7	8.0	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8
SUZ12	"CHET9, JJAZ1, KIAA0160"	ENSG00000178691	"SUZ12 polycomb repressive complex 2 subunit"	Q15022	17	31937018-32001045	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057436	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli, Nuclear bodies"		"HPA057436: "	"unprognostic (1.23e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.65e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.66e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.31e-1)"	10.1	10.8	13.4	15.4	10.4	25.5	33.5	16.0	13.8	11.2	11.4	7.5	13.6	10.1	12.5	8.1	12.3	9.8	7.7	9.7	9.1	7.6	10.9	11.5	10.6	19.9	9.3	9.9	10.0	10.1	15.5	10.4	15.3	9.5	10.7	10.9	6.9	10.1	9.6	8.7	9.9	12.2	9.6	7.7	15.2	10.7	17.1	12.5	31.8	12.0	6.5	18.9	10.8	19.5	5.5	4.6	4.1	2.6	4.4	5.5	1.2	14.0	12.5	11.8	13.5	6.8	8.8	12.1	13.7	12.1	16.9	20.5	9.4	7.9	30.8	10.6	8.5	12.5	17.5	7.9	27.5	10.8	17.0	21.3	10.6	6.8	8.0	33.5	21.9	6.1	8.9	16.8	12.9	10.3	20.5	42.8	14.5	4.9	39.8	19.5	6.7	7.6	23.8	30.2	24.9	9.9	13.8	15.1	11.8	22.1	7.2	13.2	20.8	28.0	7.6	13.4	12.2	16.1	21.1	23.4	29.1	38.1	9.8	20.7	12.1	1.4	1.9	3.8	3.8	2.6	3.0	5.5	4.1	4.0	1.4	4.4	3.9	5.5	4.1	4.4	1.8	4.6	4.2	1.2	13.4	10.4	16.0	13.8	9.1	7.6	9.3	9.9	9.5	12.5
SVIL		ENSG00000197321	Supervillin	O95425	10	29457338-29736781	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 235.1;tongue: 93.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.1;U-2197: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 15.2;monocytes: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010878, HPA020095, HPA020138"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane"	"Actin filaments, Cytosol"	"CAB010878: AB_476685, HPA020095: AB_1857680, HPA020138: AB_1857681"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.26e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.28e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.38e-3)"	"unprognostic (7.11e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (5.70e-5)"	11.9	2.1	0.7	10.5	1.1	3.7	4.5	0.6	0.9	18.7	42.3	0.6	10.7	1.7	34.3	13.3	18.2	8.9	15.5	25.5	0.5	0.6	2.8	2.0	3.8	2.3	0.8	0.7	13.9	2.4	5.1	4.1	2.9	1.7	12.6	5.3	10.0	10.6	15.3	235.1	4.7	9.1	36.4	1.3	1.5	14.2	5.5	0.5	4.6	6.9	93.5	11.6	28.6	9.9	0.1	0.7	15.2	4.2	1.2	1.7	0.6	17.3	7.5	3.4	1.2	9.9	26.6	5.5	2.8	6.7	1.1	1.1	8.8	17.2	0.0	12.3	1.1	40.1	1.9	6.6	1.1	0.2	3.7	0.0	9.5	5.7	6.0	1.5	0.3	24.4	6.5	12.4	4.5	19.9	0.0	0.1	1.7	5.4	1.4	0.8	1.7	2.7	3.2	10.1	0.1	11.8	5.8	4.1	3.4	2.5	0.3	8.8	3.1	1.8	12.8	5.7	5.9	28.1	8.4	0.1	0.0	0.0	22.0	3.4	19.5	2.9	1.1	5.2	1.2	1.9	1.5	0.0	1.1	0.6	0.7	0.1	1.7	1.1	15.2	1.2	4.2	0.2	0.1	0.6	0.7	1.1	0.6	0.9	0.5	0.6	0.8	0.7	1.7	0.5
SYCP1	"CT8, HOM-TES-14, SCP1"	ENSG00000198765	"Synaptonemal complex protein 1"	Q15431	1	114854803-114995370	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	51	"testis: 30.6"	"Cell line enriched"	"Detected in single"	93	"THP-1: 19.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	51	"cerebellum: 16.5"	"Low region specificity"	"Detected in some"			HPA021083	Enhanced									"HPA021083: AB_1857685"	"unprognostic (2.91e-1)"									"unprognostic (6.89e-3)"				"unprognostic (4.87e-1)"	"unprognostic (8.74e-3)"			0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYMPK	"SPK, SYM"	ENSG00000125755	Symplekin	Q92797	19	45815410-45863290	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041756, HPA042449"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"HPA041756: AB_10963544, HPA042449: "	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.33e-3)"	"unprognostic (9.93e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.16e-3)"	"unprognostic (1.67e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.38e-2)"	14.7	15.9	15.3	23.7	24.2	20.7	15.2	25.1	32.2	17.1	18.2	25.3	20.3	18.6	22.6	18.9	17.4	19.3	17.6	14.6	17.3	18.0	15.0	21.6	15.6	27.2	19.3	16.8	21.6	16.3	20.5	24.0	34.8	19.9	17.4	12.2	16.1	21.5	17.5	33.4	21.1	18.0	13.9	18.7	23.0	19.4	38.0	22.0	28.5	20.5	11.6	23.4	16.8	16.7	7.9	9.2	6.5	7.1	4.2	5.2	2.7	19.2	34.1	14.0	10.6	13.7	17.6	23.6	15.5	10.8	15.8	18.0	15.1	17.7	34.1	10.6	17.3	15.9	18.8	16.8	14.2	26.4	21.1	19.7	23.4	15.9	15.8	21.6	23.2	12.8	10.3	16.9	19.4	16.3	25.9	22.3	13.7	18.1	19.9	22.8	11.9	7.9	21.5	16.3	21.1	11.3	35.0	16.0	20.3	18.9	12.3	12.4	16.9	29.9	18.0	13.1	21.1	10.1	22.5	29.6	55.9	27.6	15.0	14.5	21.5	2.1	5.1	2.2	3.4	3.8	3.2	4.7	3.0	5.2	4.2	7.9	2.6	2.4	6.5	4.2	7.1	9.2	2.3	2.7	15.3	24.2	25.1	32.2	17.3	18.0	19.3	16.8	19.9	22.0
SYN1		ENSG00000008056	"Synapsin I"	P17600	X	47571898-47619943	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 127.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HHSteC: 6.4;NTERA-2: 13.5;SCLC-21H: 23.6;SH-SY5Y: 6.1"	"Cancer enhanced"	"Detected in many"		"glioma: 11.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000397, CAB021929"	Enhanced									"CAB021929: , HPA000397: AB_1080146"	"unprognostic (1.22e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.05e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-1)"	"unprognostic (3.49e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-4)"	"unprognostic (2.73e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.95e-3)"	"unprognostic (5.27e-2)"	1.7	7.1	31.8	2.9	33.3	2.0	1.3	34.4	127.0	1.7	1.9	2.1	0.0	1.4	1.6	1.9	1.5	2.1	2.5	7.6	33.6	24.9	1.4	1.8	1.7	1.3	13.3	27.1	2.5	2.0	2.1	6.1	3.4	24.0	2.0	2.1	0.9	1.3	2.0	1.5	1.7	2.0	2.0	3.7	1.3	1.9	2.4	2.1	0.0	1.2	0.0	1.5	1.9	0.1	0.0	0.8	0.0	0.6	0.0	0.9	0.0	0.0	0.0	3.8	0.5	0.1	0.8	0.0	0.6	0.1	1.1	0.3	0.0	0.0	0.0	1.2	0.1	6.9	0.3	0.0	0.3	0.5	0.1	0.3	0.0	0.0	6.4	0.0	1.7	1.5	0.0	1.1	0.3	0.0	0.4	0.2	0.2	0.2	0.2	0.2	13.5	0.1	0.0	0.0	0.2	0.0	0.0	23.6	6.1	0.0	0.0	0.1	1.7	0.0	0.2	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.9	0.0	0.0	0.6	0.8	0.0	0.0	31.8	33.3	34.4	56.9	33.6	24.9	13.3	27.1	24.0	2.1
SYN3		ENSG00000185666	"Synapsin III"	O14994	22	32512552-33058372	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 8.1;Hep G2: 4.6;NTERA-2: 5.5;SCLC-21H: 10.8;WM-115: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	29	"naive B-cell: 7.2"	"Lineage enriched"	"Detected in single"	29	"B-cells: 7.2"	"Low region specificity"	"Detected in all"							HPA034566	Uncertain									"HPA034566: AB_10603120"	"unprognostic (1.15e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.34e-1)"	"unprognostic (9.39e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.77e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.52e-1)"	1.2	2.1	23.9	1.0	13.8	3.6	2.1	4.9	20.2	0.8	1.5	0.3	0.0	1.1	1.2	1.3	1.2	1.6	2.3	1.4	7.9	5.6	1.5	1.1	1.8	2.4	3.8	12.3	1.2	2.1	0.6	3.9	6.2	15.3	1.5	1.4	0.4	1.4	1.3	0.8	3.0	1.8	1.3	3.6	3.4	1.6	8.7	3.3	0.0	2.0	0.0	1.4	0.9	0.8	7.2	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.3	0.4	2.8	0.3	1.0	0.5	0.6	0.2	0.1	0.4	1.6	0.2	0.8	0.2	0.1	0.7	8.1	0.0	0.0	0.2	1.4	0.5	0.9	4.6	0.0	0.8	0.5	0.3	1.9	0.1	0.0	0.3	0.7	0.5	0.2	0.0	0.6	0.6	5.5	0.0	0.3	1.0	0.6	0.0	1.4	10.8	1.0	0.2	0.1	1.7	0.1	0.3	0.0	0.2	1.0	0.6	0.2	0.6	0.8	0.2	0.5	0.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	23.9	13.8	4.9	20.2	7.9	5.6	3.8	12.3	15.3	3.3
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607785-85643792	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275"	Supported		Supported	Nucleoplasm,Cytosol			77000	Nucleoplasm	Cytosol	"CAB010895: AB_261964, HPA041275: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavourable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favourable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	29.1	28.3	27.9	31.3	36.2	30.4	28.4	35.6	37.9	32.9	29.4	19.2	31.8	20.4	32.7	18.9	48.8	24.5	21.9	31.3	29.3	19.0	25.2	31.3	25.7	35.0	31.9	23.1	26.2	34.9	37.5	27.9	31.3	28.2	23.1	29.6	17.3	31.4	32.8	41.4	27.2	23.7	53.5	28.1	24.7	25.4	19.8	30.1	38.1	42.0	29.8	41.7	31.2	39.4	13.2	20.9	4.6	20.0	18.1	18.6	12.6	31.9	24.0	40.0	23.3	26.3	31.4	25.4	47.4	39.1	43.0	42.7	39.2	21.0	75.5	34.6	45.6	31.0	58.5	47.1	75.5	25.9	26.8	67.3	28.9	26.9	22.2	82.1	29.0	25.7	27.1	49.2	50.7	45.3	67.4	35.6	49.7	35.2	38.4	35.0	38.3	25.5	57.7	64.0	32.0	35.2	51.2	37.7	30.6	33.0	27.9	19.4	24.2	51.2	41.5	29.2	23.9	30.5	56.6	22.3	43.9	49.8	26.8	49.7	40.6	1.0	13.0	4.6	17.7	18.6	18.6	13.2	16.8	15.9	20.9	11.9	15.3	16.6	1.6	18.1	20.0	15.5	16.7	12.6	27.9	36.2	35.6	37.9	29.3	19.0	31.9	23.1	28.2	30.1
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease mutation, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"eosinophil: 33.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.8"									HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	12.7	11.5	18.2	9.1	30.2	41.7	9.0	62.0	25.0	16.8	7.3	9.8	12.4	2.7	15.2	18.4	6.2	12.9	7.9	22.7	21.0	17.5	18.4	11.2	16.1	13.7	13.2	15.1	27.7	10.6	37.3	37.0	4.7	19.7	10.1	6.3	10.5	3.6	12.5	22.0	16.9	5.3	19.1	9.7	15.5	9.0	8.3	11.6	9.0	20.6	9.5	12.1	10.0	12.3	3.2	0.8	33.8	1.5	4.7	6.4	1.4	0.1	3.9	2.8	3.2	3.9	8.6	1.0	8.8	4.6	2.3	4.2	0.8	0.1	8.3	0.5	4.8	0.2	1.0	2.3	2.4	10.0	2.7	3.5	2.6	2.7	9.0	0.6	1.6	5.5	0.5	5.0	10.3	4.4	0.0	9.5	6.2	0.4	1.4	0.1	0.6	1.5	1.9	5.5	2.3	8.9	0.1	1.7	2.6	1.4	0.5	6.1	0.5	0.3	5.9	10.7	14.5	3.7	4.8	18.9	8.0	13.3	5.9	1.9	3.1	3.0	1.1	33.8	6.4	0.7	4.1	2.9	4.2	6.1	0.8	3.2	4.0	5.1	1.1	4.7	1.5	0.7	5.1	1.4	18.2	30.2	62.0	25.0	21.0	17.5	13.2	15.1	19.7	11.6
SYNE2	"DKFZP434H2235, KIAA1011, Nesp2, Nesprin-2, NUA, NUANCE, SYNE-2"	ENSG00000054654	"Spectrin repeat containing nuclear envelope protein 2"	Q8WXH0	14	63852983-64226433	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Actin-binding	"Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 111.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 43.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"cerebellum: 15.8;pons and medulla: 16.3"	"Cell type enhanced"	"Detected in many"		"eosinophil: 30.3"	"Group enriched"	"Detected in many"	10	"granulocytes: 30.3;T-cells: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003435, HPA050204"	Enhanced		Supported	"Nuclear membrane,Intermediate filaments"				"Nuclear membrane, Intermediate filaments"		"HPA003435: AB_1080162, HPA050204: AB_2681051"	"unprognostic (1.93e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.97e-3)"	"unprognostic (9.04e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.24e-1)"	"prognostic favourable (3.56e-9)"	"unprognostic (5.05e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.80e-2)"	30.8	4.5	2.3	18.0	2.8	5.5	29.7	15.8	3.3	16.1	13.4	1.9	7.7	3.6	18.8	13.6	17.2	7.1	8.6	27.3	2.3	2.4	35.6	13.0	15.2	11.0	2.7	2.1	22.8	22.4	60.1	17.6	14.1	16.3	13.7	4.8	13.0	9.8	9.2	111.4	24.1	10.6	10.2	2.3	16.0	6.9	14.3	1.9	16.9	30.9	29.7	15.8	11.1	26.4	2.3	1.1	30.3	0.1	1.5	16.3	1.3	17.3	5.9	8.7	2.8	8.7	2.6	11.5	1.2	1.2	2.0	3.5	1.9	3.6	43.5	1.8	1.1	8.4	5.7	2.2	2.5	6.6	2.2	0.2	4.3	0.5	1.7	0.7	0.2	3.7	8.2	2.5	2.3	4.5	0.2	3.5	1.4	9.7	4.6	0.2	3.9	1.8	5.4	8.2	1.4	13.2	8.3	8.1	6.0	13.8	3.3	3.7	3.8	0.1	3.9	3.2	5.2	1.0	3.6	4.8	2.1	16.5	0.9	0.0	4.6	0.2	0.0	30.3	16.3	0.1	11.0	2.1	10.0	10.8	0.0	2.3	4.9	7.4	13.3	1.5	0.1	1.1	11.1	1.3	2.3	2.8	15.8	2.6	2.3	2.4	2.7	2.1	16.3	1.9
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33457541	"Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell line enhanced"	"Detected in many"		"AF22: 20.7;HMC-1: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.9"	"Group enriched"	"Detected in many"	6	"B-cells: 1.5;T-cells: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favourable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavourable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	4.5	5.0	29.7	11.9	28.6	6.2	4.3	27.2	33.7	7.8	5.9	5.5	2.4	6.0	13.0	5.3	4.2	11.9	6.1	4.4	37.9	7.6	4.0	2.2	5.9	10.3	4.1	38.9	12.8	3.5	10.0	26.1	6.2	7.9	6.3	4.7	3.2	3.7	7.1	2.3	6.2	5.7	11.1	8.7	9.7	4.9	8.7	9.3	8.9	5.6	0.2	7.0	6.9	6.4	1.5	0.1	0.1	0.2	0.0	1.9	0.0	2.0	0.9	20.7	7.7	4.3	4.5	2.6	5.0	3.2	2.8	2.2	8.6	0.8	5.8	1.3	2.4	3.0	2.6	2.9	2.0	3.3	1.6	14.5	2.3	0.5	2.9	2.2	17.0	3.1	0.9	5.2	2.5	2.0	4.5	2.7	2.0	4.3	3.5	3.4	10.4	2.2	13.6	0.5	2.4	2.1	1.5	5.0	4.0	1.9	3.6	1.6	7.9	2.1	0.6	5.9	5.8	2.3	0.9	3.2	1.1	4.3	3.4	2.6	1.4	0.0	0.2	0.1	0.3	0.0	0.8	0.1	1.9	0.9	0.0	1.5	0.9	0.2	0.1	0.0	0.1	0.1	0.1	0.0	29.7	28.6	27.2	33.7	37.9	7.6	4.1	38.9	7.9	9.3
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.5;HSkMC: 6.0;RH-30: 5.8;SK-BR-3: 6.1"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"				"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: , HPA057142: "	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.2	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.5	0.7	0.3	0.5	0.9	0.1	0.1	0.0	0.4	0.1	0.2	0.3	0.6	0.4	0.6	0.2	0.2	6.0	0.1	1.2	0.1	0.0	0.3	0.3	0.3	0.3	0.2	1.8	0.2	0.7	0.2	5.8	0.2	0.0	0.6	0.3	0.4	0.1	6.1	0.1	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0
SYT6		ENSG00000134207	"Synaptotagmin 6"	Q5T7P8	1	114089291-114153919	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 14.9;kidney: 3.7;pancreas: 11.1"	"Group enriched"	"Detected in some"	7	"NTERA-2: 20.6;WM-115: 14.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basal ganglia: 27.9;olfactory region: 87.2"	"Low region specificity"	"Detected in many"			HPA058362			Approved	Vesicles				Vesicles		"HPA058362: "	"unprognostic (7.12e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.11e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.71e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	0.3	2.2	2.6	0.8	6.5	0.3	2.1	0.2	10.4	0.4	0.3	5.1	0.0	0.9	0.4	0.2	0.2	0.3	0.5	0.3	2.3	14.9	3.7	0.3	0.4	0.3	2.8	1.3	2.3	11.1	0.7	0.3	1.4	3.9	1.5	0.6	0.9	1.1	0.2	0.4	0.4	0.5	0.3	4.2	0.3	0.3	0.9	3.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.3	0.1	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.6	6.5	0.2	9.3	2.3	14.9	2.8	1.3	3.9	3.3
SYTL1	"exophilin-7, FLJ14996, JFC1, SLP1"	ENSG00000142765	"Synaptotagmin like 1"	Q8IYJ3	1	27342020-27353937	"Plasma proteins, Predicted intracellular proteins"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.9;CAPAN-2: 22.8;NB-4: 32.4;U-266/70: 18.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 8.8;cerebellum: 30.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA037825	Enhanced									"HPA037825: AB_10671635"	"unprognostic (4.23e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.40e-1)"	"prognostic favourable (6.83e-7)"	"unprognostic (7.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.18e-3)"	"unprognostic (4.41e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (1.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-3)"	0.6	0.1	8.8	20.8	0.5	19.2	5.6	30.2	0.7	9.1	3.7	0.4	15.7	3.4	2.5	5.1	38.1	7.2	15.3	0.9	1.1	0.4	1.7	0.7	8.6	13.5	0.7	0.7	2.3	50.8	2.5	7.2	3.6	1.8	20.6	1.4	0.9	42.6	20.5	0.4	26.2	5.7	3.0	0.4	14.5	15.4	0.7	0.5	20.3	4.7	26.4	47.4	12.5	15.7	14.5	15.9	52.3	28.9	14.5	21.6	11.2	4.5	0.0	0.0	0.1	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.4	22.8	3.4	4.6	0.0	14.2	0.0	8.5	0.0	0.0	0.8	0.4	0.3	5.9	0.3	8.7	0.0	0.0	15.7	0.0	3.2	0.0	0.3	3.9	0.0	5.8	5.1	32.4	0.2	2.2	6.0	0.0	15.8	3.5	3.7	6.7	0.3	0.0	6.6	0.2	16.8	9.4	0.0	0.0	2.2	0.0	0.0	18.5	4.5	3.0	0.6	11.1	0.0	11.8	6.0	52.3	21.6	14.8	19.4	14.5	17.1	17.5	15.9	11.2	10.4	12.4	10.7	14.5	28.9	0.9	19.2	11.2	8.8	0.5	30.2	0.7	1.1	0.4	0.7	0.7	1.8	0.5
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 65.2"	"Cell line enhanced"	"Detected in many"		"MCF7: 26.3;RH-30: 53.0;RPTEC TERT1: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.5;MAIT T-cell: 17.9"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.9"	"Low region specificity"	"Detected in many"							HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favourable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favourable (9.07e-4)"	12.8	5.5	27.6	11.8	13.9	1.8	9.7	6.8	32.0	6.5	26.3	6.8	2.1	11.4	7.6	11.8	9.6	6.3	15.0	5.7	13.8	9.0	14.5	3.9	8.1	5.7	8.4	21.5	3.7	2.5	7.2	5.5	9.8	12.4	9.9	39.8	5.7	8.4	5.8	3.7	4.6	17.7	7.8	12.8	5.4	65.2	3.2	5.1	5.8	4.2	5.0	3.8	17.2	11.3	0.1	0.7	0.0	0.0	3.0	17.9	1.7	1.0	2.3	3.6	0.3	0.8	4.8	0.0	8.9	11.7	7.9	18.1	10.1	1.3	0.2	3.3	6.2	6.6	0.2	0.8	10.5	0.6	0.0	0.0	0.0	0.1	0.5	0.7	0.1	6.0	1.1	17.1	0.2	0.0	0.1	0.1	10.0	26.3	0.0	0.2	6.1	4.0	0.3	53.0	0.0	37.9	13.7	0.1	0.1	1.9	1.6	0.8	0.2	0.1	0.0	12.5	4.8	7.8	0.4	0.0	0.0	4.7	12.8	0.1	7.6	0.0	0.0	0.0	10.5	0.0	17.9	0.0	2.1	6.3	0.0	0.1	1.7	3.1	0.0	3.0	0.0	0.7	0.8	1.7	27.6	13.9	6.8	32.0	13.8	9.0	8.4	21.5	12.4	5.1
SYTL5		ENSG00000147041	"Synaptotagmin like 5"	Q8TDW5	X	38006582-38128819	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 17.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.8;MCF7: 6.3;SK-MEL-30: 16.4;U-2 OS: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	19	"non-classical monocyte: 1.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA026074	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol				Nucleoplasm	"Microtubules, Cytosol"	"HPA026074: AB_1857697"	"unprognostic (3.60e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	0.5	6.0	10.5	3.4	11.0	0.0	2.9	0.5	2.5	7.0	7.3	0.5	0.5	2.3	2.6	1.0	12.2	0.2	2.9	0.9	9.2	8.9	1.0	6.1	2.4	0.5	2.4	0.5	0.5	6.4	0.0	1.1	17.0	0.5	2.0	3.5	1.5	7.1	1.7	0.5	0.0	14.3	3.9	1.3	0.8	13.8	0.7	0.5	0.7	0.9	1.2	5.9	1.3	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.2	0.3	6.3	0.0	0.0	2.9	0.0	0.0	2.3	0.0	0.0	0.4	3.6	0.1	0.3	1.4	16.4	0.0	0.0	0.0	0.2	5.5	0.0	3.6	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	10.5	11.0	0.5	2.5	9.2	8.9	2.4	0.5	0.5	0.5
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399741-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Enhanced	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB032328: AB_2281637, HPA039988: , HPA057104: "	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	12.2	14.9	18.3	13.6	20.8	13.6	12.5	24.7	28.1	16.9	16.2	32.0	10.9	16.9	18.8	10.7	13.6	17.9	19.2	18.9	17.9	15.7	12.4	14.8	13.7	15.8	22.7	18.8	26.7	19.5	16.3	12.5	13.8	15.9	16.9	9.1	19.6	21.6	19.1	27.8	17.3	15.7	14.3	17.2	17.2	14.4	11.9	20.6	13.0	13.3	10.9	13.0	16.8	14.3	5.9	8.2	6.1	8.7	5.2	7.6	6.3	12.0	12.5	12.8	14.6	13.6	11.5	11.3	10.1	12.6	15.6	14.8	11.5	8.7	18.3	8.0	9.8	14.8	12.9	14.8	6.2	14.1	20.7	8.0	15.4	11.3	11.9	15.0	15.4	11.6	13.2	11.7	12.8	11.3	14.6	12.6	7.7	7.8	11.5	12.5	8.9	12.8	20.9	18.2	18.2	12.0	12.9	11.4	8.4	14.4	17.9	12.6	14.6	16.6	9.7	10.9	17.3	8.3	8.2	19.9	12.8	13.3	12.8	10.7	10.6	1.4	8.7	6.1	7.6	7.2	6.2	5.9	4.6	6.1	8.2	5.9	7.5	6.7	1.3	5.2	6.7	3.8	4.6	6.3	18.3	20.8	24.7	28.1	17.9	15.7	22.7	18.8	15.9	20.6
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA052059: , HPA063647: "	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	14.0	12.9	12.7	15.3	16.2	13.9	11.0	13.7	14.1	10.5	11.7	15.0	13.2	12.7	10.2	11.0	12.6	8.0	11.5	13.1	11.8		9.8	15.0	8.9	19.4	14.7	8.3	10.7	11.3	14.6	18.1	11.1	11.1	11.4	10.1	9.2	9.8	15.3	26.9	14.7	13.4	17.5	15.9	12.7	11.0	11.3	15.5	21.1	9.4	12.8	15.8	12.0	9.8	3.7	3.2	3.8	3.6	4.7	7.2	2.2	28.7	47.3	25.3	24.5	20.3	11.5	16.6	32.9	11.2	15.0	14.7	31.6	20.8	57.2	23.7	21.3	30.6	33.6	33.1	21.7	16.1	43.9	32.9	34.4	33.1	20.0	53.1	22.1	18.3	17.4	22.7	35.7	20.2	30.8	23.7	16.9	34.3	57.9	12.9	15.6	13.6	34.6	37.6	21.4	19.0	51.7	19.2	18.9	41.0	12.4	13.0	29.0	18.3	27.3	11.6	25.3	16.7	39.5	22.4	27.3	41.7	22.9	26.2	19.0	3.8	3.5	3.5	4.9	3.4	7.2	3.0	3.5	3.8	2.5	3.7	3.3	3.7	2.0	4.7	3.6	3.2	3.9	2.2										
TAF1L		ENSG00000122728	"TATA-box binding protein associated factor 1 like"	Q8IZX4	9	32629454-32635669	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"testis: 6.2"	"Cell line enriched"	"Detected in single"	11	"U-87 MG: 4.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA056605	Uncertain									"HPA056605: "	"unprognostic (7.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.79e-2)"		"unprognostic (4.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.13e-2)"		"unprognostic (1.60e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.68e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.86e-2)"	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2			0.0		0.0	0.0	0.0	0.3	0.3	1.2	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	4.4	0.1	0.0	1.0	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.2	0.0	0.3	0.2	0.4	1.2	0.4	0.1	0.3	0.1	0.1										
TAF5	"TAF2D, TAFII100"	ENSG00000148835	"TATA-box binding protein associated factor 5"	Q15542	10	103367967-103389065	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006195, HPA006474"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA006195: AB_1080188, HPA006474: AB_1080185"	"unprognostic (3.09e-2)"	"unprognostic (2.44e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.36e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (1.36e-9)"	"prognostic favourable (7.39e-5)"	"unprognostic (2.79e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	5.3	3.6	4.0	5.8	5.9	7.9	6.3	13.8	7.7	5.3	5.8	3.8	3.7	5.5	5.2	3.5	5.0	4.1	3.2	3.4	5.2	3.5	3.5	5.0	3.9	7.6	3.8	3.9	6.1	7.9	3.4	7.5	6.6	6.3	4.2	6.1	2.1	4.4	4.5	5.5	4.7	4.7	4.4	5.4	6.2	4.3	25.5	5.6	14.0	4.4	2.5	7.9	4.1	7.3	3.2	1.3	2.5	1.8	1.1	3.4	0.6	6.5	3.1	7.6	13.6	4.3	3.6	8.9	4.7	5.4	6.9	8.7	6.0	3.5	15.8	2.7	2.5	6.7	12.7	2.5	8.8	5.8	11.0	7.2	3.5	5.9	2.0	14.0	7.9	1.6	1.9	4.0	4.4	5.1	10.3	7.9	4.6	4.3	11.3	18.3	9.2	4.0	9.7	9.2	4.8	1.9	1.9	5.3	5.9	3.0	2.2	2.7	2.6	5.8	3.0	4.0	5.1	4.5	8.3	4.5	5.4	9.7	2.2	16.7	2.5	0.6	1.8	2.5	1.5	0.6	1.3	0.4	1.4	2.8	1.0	3.2	3.4	2.0	0.3	1.1	1.1	1.3	3.4	0.6	4.0	5.9	13.8	7.7	5.2	3.5	3.8	3.9	6.3	5.6
TAF5L	PAF65B	ENSG00000135801	"TATA-box binding protein associated factor 5 like"	O75529	1	229593111-229626047	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067941			Supported	"Nuclear speckles,Cytoplasmic bodies"				"Nuclear speckles"	"Cytoplasmic bodies"	"HPA067941: "	"unprognostic (3.41e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.17e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.91e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.99e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.11e-1)"	19.5	8.3	13.0	14.4	12.8	23.0	25.6	13.5	14.7	12.1	15.3	14.7	9.9	12.7	15.8	10.6	15.0	14.1	16.3	12.9	10.5	9.0	9.5	18.6	13.6	15.7	12.1	8.0	12.2	10.4	12.7	11.6	25.0	12.9	15.7	15.8	9.2	13.3	12.3	24.9	10.1	17.0	16.5	12.8	15.6	13.8	8.5	10.5	15.9	13.5	11.9	15.3	17.1	13.2	1.1	1.6	0.2	1.3	2.1	2.6	0.8	16.7	9.7	14.0	11.6	9.7	10.2	36.3	11.4	13.7	14.3	13.4	13.0	13.8	18.9	12.2	12.3	14.4	15.4	14.0	13.8	14.1	22.1	14.8	9.9	8.3	10.9	19.6	17.2	11.2	13.6	14.1	12.1	13.9	19.7	17.6	13.4	8.1	22.1	10.6	19.8	7.7	19.7	15.7	19.5	10.0	15.6	14.1	17.2	9.8	13.5	15.7	16.0	20.5	12.0	11.9	14.6	15.8	24.0	9.4	7.1	21.7	9.1	11.9	18.7	0.0	1.1	0.2	2.1	1.2	2.6	1.1	2.2	1.7	1.6	1.0	2.2	1.9	0.2	2.1	1.3	0.7	1.9	0.8	13.0	12.8	13.5	14.7	10.5	9.0	12.1	8.0	12.9	10.5
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA028930: , HPA053429: , HPA058961: , HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavourable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	11.3	7.2	6.8	5.5	8.4	16.6	8.8	6.5	9.5	6.7	8.0	4.0	6.3	6.3	5.9	10.0	10.9	5.1	5.7	9.2	5.6		11.5	18.0	6.5	8.2	6.8	6.2	7.3	7.4	4.4	10.8	8.6	9.4	7.1	9.1	4.4	5.2	5.2	11.0	5.3	9.7	6.9	5.7	8.7	6.1	30.1	6.8	10.2	9.8	9.8	9.8	7.8	5.0	24.9	21.8	29.8	28.8	14.9	25.0	31.2	17.7	18.7	11.9	20.0	19.1	25.1	31.3	17.7	26.7	29.8	39.9	19.8	21.9	24.1	13.3	25.4	13.2	15.9	35.7	39.2	11.0	19.7	19.8	31.2	25.0	46.8	19.4	28.7	29.7	23.6	20.6	46.2	24.1	19.8	19.3	28.1	24.5	22.0	30.5	14.2	14.7	14.2	19.9	27.3	25.3	19.6	19.9	14.1	16.8	10.3	30.7	16.3	28.7	16.8	11.6	17.7	12.2	29.2	17.9	21.5	30.4	16.9	23.6	13.3	28.4	28.8	29.8	14.9	26.1	22.4	24.9	22.2	18.3	21.8	19.7	25.0	21.4	4.5	14.9	20.6	13.5	23.2	31.2										
TAGLN	"DKFZp686P11128, SM22, SMCC, TAGLN1, WS3-10"	ENSG00000149591	Transgelin	Q01995	11	117199321-117204782	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 136.3;BJ hTERT+ SV40 Large T+: 129.6;CACO-2: 122.3;EFO-21: 162.6;fHDF/TERT166: 138.9;LHCN-M2: 95.9;U-138 MG: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"intermediate monocyte: 19.0;non-classical monocyte: 26.6"	"Lineage enriched"	"Detected in many"	10	"monocytes: 26.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"midbrain: 176.0"	"CAB001447, HPA019467"	Enhanced		Approved	Microtubules,Mitochondria,Cytosol			8000000	"Microtubules, Mitochondria"	Cytosol	"CAB001447: AB_564012, HPA019467: AB_1857245"	"unprognostic (1.36e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.16e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.76e-1)"	"prognostic unfavourable (2.12e-7)"	"unprognostic (9.58e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.52e-3)"	73.3	22.6	2.3	67.6	5.9	0.2	60.8	2.1	7.7	278.3	328.7	6.1	156.2	22.3	399.7	156.8	337.9	133.3	227.5	48.7	3.1	3.0	49.5	12.9	44.1	38.6	7.1	11.8	159.2	9.3	1.5	8.0	36.2	14.9	237.5	51.6	39.1	24.1	347.5	36.6	17.9	81.0	481.9	9.1	26.0	114.7	65.1	2.1	1.1	47.3	30.0	11.2	473.0	78.1	2.6	1.4	0.8	26.6	0.0	0.3	0.9	1.2	0.3	21.4	0.5	10.0	9.0	18.0	136.3	59.1	129.6	48.5	122.3	1.9	0.2	162.6	138.9	3.2	0.3	1.1	36.9	0.4	0.2	0.3	4.5	8.3	55.7	0.1	0.3	23.7	4.6	18.9	2.4	0.2	0.2	0.4	95.9	0.2	0.1	1.0	6.5	0.1	0.1	1.6	0.6	0.2	1.7	0.1	0.5	2.1	0.7	0.1	0.6	0.3	14.6	126.3	21.3	0.9	5.8	0.6	0.4	1.0	0.7	0.4	0.3	0.8	1.1	0.0	0.1	19.0	0.2	1.6	0.0	0.0	1.4	2.6	0.1	0.0	0.1	0.0	26.6	0.7	0.3	0.9	2.3	5.9	2.1	7.7	3.1	3.0	7.1	11.8	14.9	2.1
TAGLN2	"HA1756, KIAA0120"	ENSG00000158710	"Transgelin 2"	P37802	1	159918107-159925732	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA001925	Approved		Approved	"Actin filaments,Cytosol"	"Intracellular and membrane"		540000000	Cytosol	"Actin filaments"	"HPA001925: AB_1857756"	"prognostic unfavourable (2.06e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (7.07e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.21e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.92e-10)"	"unprognostic (1.81e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.50e-2)"	80.6	26.4	19.7	57.5	25.6	47.9	62.8	7.9	18.3	49.1	45.9	16.6	54.5	43.3	39.2	49.4	96.3	36.3	63.6	57.3	15.9	18.5	68.0	178.2	107.7	65.0	24.3	9.8	45.7	51.2	8.8	18.1	122.2	24.8	43.8	43.0	24.7	67.2	62.9	35.3	62.6	74.6	36.2	20.0	95.8	96.8	46.4	20.2	60.5	37.7	150.7	76.5	57.2	62.0	53.0	114.4	220.7	42.4	44.0	41.7	106.7	109.5	59.2	1.8	0.6	21.2	52.7	68.4	61.7	71.0	134.4	65.4	61.4	86.0	68.1	52.6	73.3	86.0	30.3	76.9	82.9	77.6	24.6	90.7	57.5	3.6	25.0	63.7	102.2	52.3	59.8	79.1	41.0	80.9	38.8	47.9	45.8	41.7	28.8	40.2	51.1	101.1	0.2	31.6	101.7	27.8	43.0	28.4	26.9	72.4	118.6	31.8	62.6	62.8	92.8	80.5	93.6	72.9	166.2	19.3	8.6	39.9	104.1	40.9	49.5	66.9	42.4	177.0	34.7	25.2	30.6	53.0	38.6	33.4	68.5	39.7	20.4	22.4	220.7	44.0	18.9	114.4	41.7	106.7	19.7	25.6	7.9	18.3	15.9	18.5	24.3	9.8	24.8	20.2
TAGLN3	"NP22, NP25"	ENSG00000144834	"Transgelin 3"	Q9UI15	3	111998664-112013887	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 139.0"	"Group enriched"	"Detected in some"	5	"AF22: 38.5;RPTEC TERT1: 15.7;SCLC-21H: 21.0;SH-SY5Y: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062620	Enhanced									"HPA062620: "	"unprognostic (1.55e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.36e-3)"	"unprognostic (4.28e-1)"	"unprognostic (4.07e-1)"		"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.51e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.67e-3)"	1.7	21.9	47.3	2.4	40.6	1.5	1.6	40.2	139.0	1.5	2.7	4.6	0.0	1.9	1.6	1.5	1.6	1.6	1.7	1.7	32.9	37.9	4.2	1.5	1.8	1.6	30.5	33.2	1.6	4.6	1.6	13.5	1.5	29.8	1.7	2.9	2.3	1.5	1.7	1.5	1.6	2.2	2.2	8.3	1.5	3.7	1.6	2.7	0.0	1.8	0.0	1.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	2.7	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	1.4	3.4	5.3	1.0	0.0	15.7	0.0	21.0	35.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	40.6	40.2	65.7	32.9	37.9	30.5	33.2	29.8	2.7
TALDO1		ENSG00000177156	"Transaldolase 1"	P37837	11	747329-765024	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Pentose shunt"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 204.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 148.6;neutrophil: 204.6"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048089			Approved	Nucleoplasm,Cytosol			39000000	Nucleoplasm	Cytosol	"HPA048089: AB_2680260"	"unprognostic (5.29e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (9.78e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.97e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.16e-3)"	39.0	24.2	26.6	34.8	31.3	117.4	44.2	20.6	38.3	27.7	28.5	51.2	18.8	34.2	20.4	20.7	90.0	23.2	33.2	37.5	29.2	23.6	45.8	48.4	37.9	60.0	46.5	26.6	23.4	31.9	14.6	15.8	34.3	30.7	28.3	23.7	15.5	38.3	19.5	31.2	38.4	29.4	40.4	47.5	45.6	35.8	14.8	33.0	34.1	42.2	82.4	43.1	51.4	37.5	8.5	36.1	204.6	60.8	5.9	10.4	45.3	41.9	53.1	15.4	29.1	31.9	18.6	45.4	31.9	41.1	31.6	26.1	22.6	91.6	23.4	43.4	41.8	45.4	24.3	34.4	16.5	30.6	49.3	40.5	20.6	78.8	34.1	64.7	60.5	15.2	27.8	21.2	17.2	43.4	52.5	39.2	29.3	40.1	37.6	76.8	24.2	43.1	31.4	18.1	83.9	57.4	24.5	38.0	13.3	29.7	61.5	30.9	29.2	49.3	57.6	14.5	13.6	11.4	29.9	16.6	16.1	27.8	32.1	56.6	58.4	64.7	60.8	148.6	5.6	23.2	6.1	8.5	7.5	6.8	36.1	6.8	6.1	5.7	204.6	5.9	23.2	14.8	10.4	45.3	26.6	31.3	20.6	38.3	29.2	23.6	46.5	26.6	30.7	33.0
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Supported	"Endoplasmic reticulum,Centriolar satellite"			110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: "	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favourable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavourable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.6	1.5	3.4	6.9	9.4	0.1	3.0	5.9	3.9	1.1	5.5	1.1	2.4	0.4	10.1	1.5	6.6	1.3	2.3	4.3	0.0	2.4	1.3	2.1	1.9	1.2	1.7	0.4	5.6	0.8	1.7	1.1	13.1	0.0	1.9	5.9	1.2	3.9	8.9	0.5	0.0	0.3	1.6	4.2	5.7	3.8	11.8	0.9	2.6	1.0	6.3	0.0	7.5	10.4	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007066	Approved						1100000			"HPA007066: AB_1857769"	"prognostic favourable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favourable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	31.8	24.5	10.5	28.0	12.4	19.3	14.1	13.2	13.6	15.8	41.3	10.1	17.1	44.2	13.2	21.2	23.8	15.0	22.4	22.4	10.5	8.5	26.7	48.7	34.8	20.9	8.9	8.3	17.9	16.5	27.3	13.6	28.8	9.2	21.8	11.0	13.9	20.9	16.6	18.5	16.2	46.6	20.6	7.4	46.8	23.2	10.0	8.6	55.2	40.2	17.8	34.6	19.6	13.8	15.7	15.7	26.9	23.6	25.1	24.0	29.1	0.8	0.5	1.7	3.5	3.8	4.8	17.1	8.1	19.9	10.1	12.0	0.0	30.9	7.0	8.4	11.3	0.8	0.0	6.8	2.0	18.9	2.3	6.1	3.8	4.8	0.0	7.7	9.9	12.2	5.8	0.2	1.5	0.1	0.5	19.0	2.0	3.1	6.9	5.9	0.0	2.2	1.1	0.1	0.5	3.6	0.4	3.0	0.2	0.2	0.7	3.0	0.5	0.1	14.1	17.5	4.1	0.5	0.6	23.4	15.8	8.9	11.9	7.8	11.9	21.4	14.0	26.9	24.0	15.7	22.5	15.7	18.1	22.6	15.7	10.1	12.7	16.1	22.2	25.1	23.6	14.9	12.5	29.1	10.5	12.4	13.2	13.6	10.5	8.5	8.9	8.3	9.2	8.6
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11026420	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm			13000	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favourable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavourable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	36.1	38.1	52.3	43.3	62.9	31.7	42.8	86.2	61.8	38.7	39.8	47.6	37.5	39.8	45.8	47.2	47.8	37.9	32.4	40.8	49.5	36.7	39.3	48.3	40.2	52.8	59.0	45.2	53.0	39.1	60.2	68.1	44.2	46.5	43.3	52.9	38.4	41.7	45.3	57.1	43.0	43.4	50.5	44.7	46.1	38.1	34.5	62.6	52.2	46.7	38.0	63.5	38.1	47.9	29.4	31.7	16.5	24.8	33.6	31.1	17.0	52.0	35.7	61.3	31.4	33.3	28.0	36.2	35.8	31.6	58.9	44.1	42.2	38.5	69.4	26.3	39.7	37.3	74.4	41.6	77.6	37.2	35.9	52.5	59.4	56.1	27.3	63.0	35.0	22.8	47.3	41.3	33.9	41.7	67.5	39.1	49.8	42.0	46.0	51.1	48.9	32.0	54.6	49.2	44.1	42.4	38.6	41.9	34.6	48.7	38.6	27.6	38.7	44.5	38.0	39.6	46.4	32.5	51.4	29.2	36.1	73.4	25.9	63.3	41.9	16.3	19.6	16.5	25.4	24.8	31.1	29.4	26.0	24.6	31.7	21.2	25.9	27.7	7.9	33.6	23.6	22.2	26.8	17.0	52.3	62.9	86.2	61.8	49.5	36.7	59.0	45.2	46.5	62.6
TARS		ENSG00000113407	"Threonyl-tRNA synthetase"	P26639	5	33440696-33469539	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037425	Approved		Supported	"Actin filaments,Cytosol"			170000	Cytosol	"Actin filaments"	"HPA037425: AB_10672279"	"prognostic unfavourable (6.14e-5)"	"unprognostic (5.13e-2)"	"unprognostic (9.04e-2)"	"prognostic unfavourable (5.17e-4)"	"unprognostic (9.10e-2)"	"unprognostic (1.07e-3)"	"prognostic unfavourable (9.88e-7)"	"unprognostic (1.43e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (9.63e-4)"	"unprognostic (1.37e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-2)"	17.4	25.6	10.2	16.0	13.1	19.2	17.7	14.4	17.2	12.7	22.1	12.3	18.7	11.6	18.3	19.7	31.0	12.2	11.9	19.1	10.3	10.9	19.2	57.0	17.2	12.7	17.5	7.8	21.3	27.6	21.3	27.0	18.5	16.8	13.9	24.7	10.8	42.1	15.8	25.1	11.7	21.7	21.2	19.5	18.3	21.2	9.6	15.4	17.6	22.8	27.3	21.2	21.8	21.9	13.1	16.0	14.2	12.6	24.0	15.0	9.7	29.4	24.7	20.7	29.2	13.7	25.9	30.1	33.1	28.1	25.1	28.4	30.1	18.4	11.7	12.1	27.3	21.0	44.1	32.7	51.7	17.3	16.0	17.0	63.3	17.2	42.6	27.3	18.2	24.7	52.7	34.5	44.7	26.8	33.3	31.6	32.0	16.3	21.3	9.4	22.0	18.3	18.1	36.7	17.2	28.5	23.6	12.1	13.8	30.7	22.5	21.9	11.8	24.4	14.1	19.7	29.4	15.5	23.2	18.6	36.6	18.3	22.0	36.1	21.3	14.2	11.6	10.5	15.0	12.6	14.1	13.1	12.7	15.0	16.0	11.5	11.6	14.7	1.5	24.0	10.1	8.8	12.1	9.7	10.2	13.1	14.4	17.2	10.3	10.9	17.5	7.8	16.8	15.4
TAT		ENSG00000198650	"Tyrosine aminotransferase"	P17735	16	71565660-71577130	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Phenylalanine catabolism, Tyrosine catabolism"	"Aminotransferase, Transferase"	"Disease mutation, Mental retardation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 387.0"	"Group enriched"	"Detected in some"	5	"Daudi: 2.3;Hep G2: 7.1"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 152.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.66e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic favourable (6.51e-4)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	387.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.9	2.6	1.5	0.4	0.2	0.5	0.2	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.2	7.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.2	0.4	0.1	0.0	0.7	0.9	0.0	0.1	0.3	0.1	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.5	0.2	0.5	0.0	0.3	0.2	1.5	0.4	0.2	0.3	0.1	0.4	1.2	0.5	0.4	0.2	1.9	0.5	0.5	1.5	0.2	0.1	2.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
TBC1D14	KIAA1322	ENSG00000132405	"TBC1 domain family member 14"	Q9P2M4	4	6909242-7033118	"Plasma proteins, Predicted intracellular proteins"	Autophagy	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 62.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036930, HPA067398"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA036930: AB_10670155, HPA067398: "	"unprognostic (3.05e-2)"	"unprognostic (7.48e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.90e-1)"	"prognostic favourable (5.28e-10)"	"unprognostic (1.56e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.13e-3)"	"unprognostic (4.12e-2)"	20.0	31.2	31.9	24.4	33.8	10.6	22.0	18.1	32.8	16.0	20.2	22.5	17.0	17.3	16.2	21.9	24.3	18.8	15.0	22.9	28.6	27.5	32.1	21.6	20.7	48.4	28.8	20.5	23.3	19.3	23.6	20.7	18.0	29.0	19.6	20.7	26.1	23.2	16.7	35.1	37.3	20.0	17.8	37.3	26.2	35.8	22.4	29.3	24.0	14.9	17.9	19.9	16.7	15.4	5.3	7.5	26.4	8.2	5.5	8.9	6.0	10.3	11.3	12.7	14.2	10.6	8.9	7.7	8.3	9.1	7.8	6.7	11.7	21.7	16.7	4.9	9.9	7.5	21.3	19.1	9.6	4.6	6.9	27.9	7.4	12.2	7.3	12.6	62.9	6.8	27.1	7.4	12.2	7.3	26.4	6.0	9.4	6.7	19.3	12.8	17.2	12.7	24.3	16.8	18.0	11.6	7.3	19.5	13.9	6.9	7.5	25.6	10.4	12.0	7.3	8.6	6.5	7.5	12.2	11.6	26.8	17.1	8.1	16.2	8.3	1.7	8.2	3.5	5.9	5.3	8.9	5.2	6.4	6.3	6.9	5.3	4.9	4.5	26.4	5.5	2.4	7.5	7.5	6.0	31.9	33.8	18.1	28.0	28.6	27.5	28.8	20.5	29.0	29.3
TBC1D19	FLJ11082	ENSG00000109680	"TBC1 domain family member 19"	Q8N5T2	4	26576437-26755351	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 40.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039592	Approved		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA039592: AB_10671043"	"unprognostic (2.64e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.94e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.28e-2)"	"prognostic favourable (1.21e-7)"	"unprognostic (1.04e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (3.51e-1)"	6.1	13.9	8.6	5.4	10.2	2.8	6.8	11.5	11.2	11.8	8.8	8.7	7.7	3.1	22.4	11.0	4.8	11.9	11.8	10.7	6.6	9.0	24.9	4.6	6.6	3.5	9.3	7.7	13.9	7.7	21.9	23.4	6.1	14.8	8.7	5.1	8.4	5.8	10.4	5.7	4.2	3.8	13.5	8.6	4.4	6.9	10.0	7.1	33.3	12.1	2.9	4.2	8.3	7.0	4.1	2.4	2.3	0.9	6.6	8.7	1.8	1.3	1.2	4.6	2.8	6.7	10.4	1.4	5.8	4.5	2.7	2.9	2.1	3.3	3.2	5.2	8.2	0.6	2.5	3.2	2.6	0.9	1.3	0.7	3.7	0.6	3.5	1.6	0.7	5.0	2.5	5.3	3.0	3.7	2.5	0.0	40.3	0.0	3.3	1.8	2.0	4.9	2.4	4.7	0.3	10.4	1.3	4.6	1.9	2.8	0.6	2.8	1.1	0.7	3.3	3.4	1.0	2.6	1.4	0.8	1.7	1.4	12.0	0.9	3.5	1.6	0.9	2.3	8.1	0.9	8.7	3.2	6.2	8.3	1.4	4.1	4.9	5.1	0.1	6.6	0.8	2.4	3.0	1.8	8.6	10.2	11.5	11.2	6.6	9.0	9.3	7.7	14.8	7.1
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744481-42746096	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 54.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035073, HPA035074"	Approved		Supported	Cytosol				Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	5.8	6.1	8.6	9.4	8.0	19.0	6.2	10.9	15.7	7.6	7.6	7.9	6.9	7.4	8.7	7.1	6.4	8.5	8.5	8.0	6.6	7.1	7.0	5.6	5.9	14.1	7.7	8.4	8.0	7.8	3.0	7.3	7.2	10.9	6.9	5.0	6.0	7.4	6.8	13.5	8.7	7.9	5.5	6.6	8.5	7.4	8.4	6.6	9.4	7.8	4.1	10.0	7.7	6.6	31.6	46.3	54.8	30.2	52.1	48.8	49.5	17.1	5.7	8.8	16.3	12.7	8.6	11.6	11.9	13.4	13.2	14.5	8.8	6.8	15.6	9.6	11.5	15.1	11.8	11.8	7.4	8.4	12.9	8.1	8.4	14.8	14.5	8.8	13.3	14.0	14.4	10.2	8.5	10.4	18.5	14.2	11.7	21.1	7.2	17.0	8.2	15.7	7.3	10.6	10.1	12.5	9.4	33.9	14.7	7.7	13.4	20.3	14.6	30.1	11.1	12.7	11.4	10.2	16.2	18.9	21.1	26.2	6.2	12.1	12.1	37.6	30.2	54.8	37.2	25.3	37.7	31.6	39.4	40.3	27.3	30.7	46.1	42.6	53.4	52.1	22.6	46.3	48.8	49.5	8.6	8.0	10.9	15.7	6.6	7.1	7.7	8.4	10.9	6.6
TBL1X	"EBI, TBL1"	ENSG00000101849	"Transducin beta like 1 X-linked"	O60907	X	9463295-9741037	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Activator	Deafness	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 17.3"									"CAB005363, HPA067703"	Approved		Approved	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB005363: AB_2240272, HPA067703: "	"prognostic unfavourable (8.50e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-1)"	"prognostic favourable (1.32e-4)"	"unprognostic (2.66e-1)"	"prognostic favourable (4.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.53e-1)"	6.5	7.1	10.1	6.0	12.3	4.5	8.1	3.3	8.1	21.4	7.9	13.2	18.0	2.1	33.0	26.4	8.3	12.4	6.7	5.2	8.6	9.0	12.5	11.0	5.2	9.5	7.6	6.0	13.8	11.3	21.0	24.3	14.5	7.5	24.7	4.1	9.8	5.5	33.0	4.9	5.8	4.2	22.4	9.0	5.7	7.0	9.9	8.5	14.7	9.4	3.4	7.1	15.3	24.5	3.2	3.1	17.3	4.2	0.3	3.1	1.7	0.0	13.5	8.6	23.0	8.0	8.4	8.5	5.2	11.6	10.0	10.5	10.1	9.3	14.4	0.3	10.3	3.1	18.8	4.1	14.7	5.9	9.3	9.0	16.5	11.9	11.4	3.2	32.5	7.5	4.7	10.4	5.5	9.2	15.8	25.1	5.7	11.4	7.8	12.2	17.1	14.6	17.6	6.8	17.6	13.6	7.7	11.1	5.0	12.5	3.1	7.5	6.1	7.1	13.3	3.5	8.7	0.3	2.0	15.3	11.9	11.4	12.9	7.9	3.3	4.4	4.2	4.9	2.1	2.6	1.7	2.0	1.6	1.9	3.1	3.2	3.1	2.8	17.3	0.3	1.7	0.3	2.5	1.7	10.1	12.3	3.3	8.1	8.6	9.0	7.6	6.0	7.5	8.5
TBL1XR1	"C21, DC42, FLJ12894, IRA1, TBLR1"	ENSG00000177565	"Transducin beta like 1 X-linked receptor 1"	Q9BZK7	3	177019340-177228000	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019182	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA019182: AB_1857800"	"unprognostic (4.11e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.27e-3)"	"prognostic favourable (5.16e-5)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (1.08e-7)"	"unprognostic (3.75e-1)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.13e-3)"	"unprognostic (2.50e-1)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	20.7	26.0	27.4	24.3	26.8	27.3	20.3	27.5	28.1	28.9	29.9	22.6	15.4	24.0	23.9	20.5	23.8	21.9	22.7	30.3	26.2	20.7	19.9	21.8	30.8	27.8	21.4	25.9	26.5	19.9	30.6	11.3	24.0	19.7	24.4	23.2	24.7	21.3	17.7	21.1	17.8	24.3	21.9	19.6	24.7	21.3	17.4	22.3	28.4	45.6	14.9	32.1	29.1	25.5	7.4	13.3	12.9	4.6	6.8	8.3	4.1	23.4	12.0	15.6	8.8	13.3	14.5	9.3	7.4	11.5	6.4	8.9	13.8	19.4	24.0	35.1	10.6	14.5	11.7	15.5	13.0	25.2	3.7	13.5	20.6	8.2	11.4	21.4	8.0	21.3	8.0	9.5	23.6	10.0	10.1	42.6	8.3	8.4	20.0	2.9	9.9	8.2	11.5	19.9	25.6	5.8	33.2	5.6	9.0	10.0	7.9	9.3	28.6	16.4	15.3	10.6	8.9	5.9	16.0	23.3	29.8	69.5	7.1	16.0	12.0	11.4	3.0	3.8	5.8	4.6	5.1	7.3	5.7	6.6	4.0	7.4	5.0	6.4	12.9	6.8	3.9	13.3	8.3	4.1	27.4	26.8	27.5	28.1	26.2	20.7	21.4	25.9	19.7	22.3
TBX3	"TBX3-ISO, UMS, XHL"	ENSG00000135111	"T-box 3"	O15119	12	114670254-114684164	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 117.7"	"Cell line enhanced"	"Detected in many"		"BJ: 33.8;BJ hTERT+: 32.2;RT4: 42.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA005799, HPA075876"			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA005799: AB_1857817, HPA075876: "	"unprognostic (3.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.40e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-3)"	"unprognostic (1.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.28e-4)"	4.3	60.5	0.9	3.3	1.9	0.0	19.9	0.7	2.3	18.2	12.2	1.7	69.6	14.2	13.1	18.7	1.9	7.5	5.0	6.2	1.2	1.5	4.1	15.1	12.6	0.8	1.2	0.5	15.6	1.1	0.3	5.3	67.8	1.6	32.3	1.5	2.6	7.3	117.7	4.2	4.8	19.4	9.7	1.4	2.6	2.2	3.5	1.2	0.5	36.3	7.3	3.5	24.6	25.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	5.9	0.0	0.0	8.9	12.3	13.4	33.8	32.2	13.1	13.0	5.3	1.4	0.0	0.5	5.8	1.5	2.8	1.2	16.2	0.0	4.0	0.0	1.5	15.4	2.9	0.0	0.0	5.4	0.8	4.4	9.1	0.1	1.2	0.0	1.1	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.8	0.0	42.2	2.2	6.5	4.8	2.2	1.1	1.6	0.0	0.0	4.0	2.6	2.2	10.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.7	2.3	1.2	1.5	1.2	0.5	1.6	1.2
TBX6		ENSG00000149922	"T-box 6"	O95947	16	30085793-30091887	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"esophagus: 22.8;lymphoid tissue: 16.3;pancreas: 19.8"	"Cell line enhanced"	"Detected in many"		"RT4: 10.0;U-266/70: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA062498			Approved	Nucleoplasm				Nucleoplasm		"HPA062498: "	"unprognostic (2.47e-1)"	"unprognostic (1.32e-3)"	"unprognostic (5.62e-5)"	"unprognostic (1.49e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.35e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.21e-2)"	"unprognostic (5.05e-3)"	"unprognostic (4.26e-2)"	1.2	1.4	1.4	1.0	1.5	0.6	0.9	0.9	1.5	2.7	1.2	0.9	0.9	1.8	0.9	1.0	22.8	1.6	1.3	0.9	1.5	1.0	1.8	1.2	1.2	1.2	1.7	0.9	1.9	19.8	3.2	2.3	0.9	2.1	3.2	0.3	2.3	3.9	2.2	2.8	5.0	1.7	0.9	1.5	1.8	7.8	2.4	1.2	1.6	2.3	5.1	16.3	5.5	8.6	4.4	1.3	3.3	2.6	1.3	1.9	1.1	0.9	1.1	0.6	1.2	1.5	0.8	0.8	0.3	0.2	0.0	0.2	1.3	4.3	1.9	2.3	0.2	1.3	0.5	0.9	0.0	1.4	0.8	1.2	1.7	1.0	1.1	0.2	2.6	0.3	1.2	0.3	0.5	0.6	0.1	4.3	0.1	3.7	0.7	0.5	0.9	0.9	2.8	0.1	3.2	0.0	10.0	1.4	2.1	0.2	0.9	1.2	1.8	1.7	0.5	1.2	0.7	0.6	0.0	10.5	2.4	0.3	1.2	1.8	0.4	3.1	2.6	0.8	1.8	2.3	1.2	1.3	0.9	1.3	1.3	4.4	1.9	1.7	3.3	1.3	0.8	1.1	1.8	1.1	1.4	1.5	0.9	1.4	1.5	1.0	1.7	0.9	2.1	1.2
TBXAS1	"CYP5, CYP5A1, THAS, TS, TXAS, TXS"	ENSG00000059377	"Thromboxane A synthase 1"	P24557	7	139777051-140020325	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Prostaglandin biosynthesis, Prostaglandin metabolism"	"Isomerase, Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 67.1;lymphoid tissue: 51.7"	"Cell line enhanced"	"Detected in some"		"NB-4: 34.7;PC-3: 11.1;RPTEC TERT1: 9.9;U-937: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"basophil: 38.1;classical monocyte: 44.5;eosinophil: 45.2;intermediate monocyte: 67.1;myeloid DC: 18.7;neutrophil: 38.8;non-classical monocyte: 56.4"	"Group enriched"	"Detected in all"	20	"dendritic cells: 18.7;granulocytes: 45.2;monocytes: 67.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031257, HPA031258, HPA031259"	Enhanced						32000000			"HPA031257: , HPA031258: AB_2673813, HPA031259: AB_2673814"	"unprognostic (4.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (9.41e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (1.14e-4)"	"unprognostic (1.52e-1)"	"unprognostic (5.00e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.34e-2)"	13.5	7.7	6.6	17.6	8.9	13.8	5.4	1.5	5.6	3.7	6.3	13.9	0.8	6.5	3.2	4.1	3.4	5.0	13.9	3.7	7.6	5.7	6.1	8.1	20.3	43.9	12.6	2.0	2.5	3.1	1.4	3.5	9.0	9.0	5.2	8.6	4.4	8.2	2.6	1.6	1.9	9.3	7.9	19.3	51.7	7.1	2.0	12.7	7.5	2.4	2.2	6.1	9.3	2.5	1.3	18.7	45.2	67.1	1.5	2.2	25.1	0.1	3.0	0.1	0.0	0.6	1.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	4.5	0.3	8.2	0.0	0.0	0.8	2.7	7.3	1.0	0.0	0.0	0.4	1.0	0.2	1.0	0.3	0.0	1.0	34.7	0.1	11.1	1.3	0.0	0.5	9.9	0.0	0.1	0.5	0.1	0.0	0.3	0.0	6.6	0.9	0.2	0.1	0.6	0.5	2.3	0.4	0.1	0.2	28.2	0.8	38.1	44.5	45.2	1.1	67.1	1.7	1.3	2.2	0.6	18.7	0.5	0.3	0.2	38.8	1.5	56.4	3.3	2.0	25.1	6.6	8.9	1.5	5.6	7.6	5.7	12.6	2.0	9.0	12.7
TC2N	"C14orf47, C2CD1, FLJ36557, MTAC2D1, Tac2-N"	ENSG00000165929	"Tandem C2 domains, nuclear"	Q8N9U0	14	91779751-91867536	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 100.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;MCF7: 9.2;RT4: 21.0;SK-BR-3: 25.4;T-47d: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 32.2"	"Group enriched"	"Detected in many"	46	"NK-cells: 12.9;T-cells: 32.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA027549	Approved		Approved	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA027549: AB_10603346"	"unprognostic (5.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.44e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (9.86e-4)"	"unprognostic (3.00e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (6.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.09e-2)"	6.6	1.5	0.9	15.8	0.9	1.9	12.3	0.4	1.9	8.9	10.2	0.6	16.7	5.4	7.6	7.0	11.6	5.4	24.9	4.7	0.9	1.0	3.7	6.8	13.5	11.3	0.8	0.5	5.5	100.1	12.4	8.4	13.1	1.6	9.3	7.0	6.6	29.8	20.1	2.1	6.9	11.7	3.2	1.1	12.3	10.8	4.9	0.1	8.7	10.3	5.8	27.9	8.3	9.5	0.2	0.0	0.4	0.0	12.9	32.2	7.7	5.1	0.8	0.0	0.0	1.0	0.0	7.2	0.0	0.1	0.0	0.0	3.7	11.1	3.4	0.2	0.0	0.6	5.1	5.2	0.0	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	5.3	0.0	0.2	0.0	0.1	2.7	0.0	9.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.5	21.0	3.9	0.0	0.4	25.4	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	32.2	0.2	16.2	18.6	0.0	0.1	13.3	11.0	0.4	12.9	0.0	0.0	5.2	7.7	0.9	0.9	0.4	1.9	0.9	1.0	0.8	0.5	1.6	0.1
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA064854: , HPA069752: , HPA069808: "	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavourable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavourable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	15.7	12.1	16.8	20.9	28.1	34.2	16.7	36.3	22.7	14.2	15.3	13.7	10.1	15.3	19.6	13.9	18.6	17.5	14.8	14.5	16.3	12.7	10.7	10.0	14.7	23.8	12.4	19.1	20.5	12.6	14.4	18.5	17.8	17.2	15.0	16.4	13.0	16.1	19.0	34.9	19.0	15.2	17.5	12.7	16.6	16.8	19.5	14.9	21.9	14.7	14.9	23.9	18.7	16.5	6.5	10.5	2.6	11.6	10.5	8.3	5.8	19.4	14.4	22.4	15.3	6.2	9.8	28.3	14.8	12.0	16.5	19.5	23.3	20.7	33.6	11.1	12.0	17.4	27.1	18.5	25.3	19.8	21.7	22.2	16.3	14.1	6.6	32.6	17.4	6.8	11.0	15.8	17.4	14.5	25.8	12.4	12.6	13.9	28.4	18.4	22.2	16.4	27.9	26.4	22.3	10.3	15.3	14.6	18.0	16.4	17.5	10.7	18.6	16.5	16.1	14.4	16.9	12.2	22.8	12.9	14.2	45.2	13.5	28.0	16.1	1.0	6.4	2.6	6.7	9.6	7.9	6.5	7.8	8.3	10.5	6.0	8.2	8.1	0.5	10.5	11.6	5.4	6.9	5.8	16.8	28.1	36.3	22.7	16.3	12.7	12.4	19.1	17.2	14.9
TCF20	"AR1, SPBP"	ENSG00000100207	"Transcription factor 20"	Q9UGU0	22	42160013-42343616	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"CAB017849, HPA036786"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"CAB017849: , HPA036786: "	"unprognostic (2.17e-1)"	"unprognostic (2.12e-2)"	"prognostic favourable (1.88e-4)"	"unprognostic (2.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavourable (4.89e-4)"	"unprognostic (1.77e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.30e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.07e-3)"	"unprognostic (4.94e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.92e-1)"	4.1	4.3	10.2	5.5	16.4	5.4	4.6	6.6	17.1	5.4	5.6	22.6	4.4	5.7	6.1	4.3	10.9	5.6	4.2	2.7	7.3	5.4	4.9	4.6	4.7	6.5	14.7	14.6	5.7	6.7	6.9	10.2	4.3	10.5	4.4	6.1	9.9	6.5	4.2	3.1	8.5	6.4	4.6	5.8	5.5	6.0	9.3	12.2	3.5	9.2	2.3	7.5	5.5	6.8	0.3	0.3	0.9	0.3	0.0	0.5	0.0	6.3	3.6	5.5	4.9	2.9	2.6	5.6	2.9	3.5	3.4	4.5	5.3	2.6	10.7	2.7	2.5	6.4	5.3	5.9	4.3	7.6	4.2	3.0	3.9	3.6	3.1	7.0	4.1	2.3	5.9	3.8	7.6	2.6	4.5	5.6	1.9	5.7	7.1	3.8	4.0	3.0	4.0	3.1	5.6	3.4	5.9	5.4	2.2	5.0	4.8	4.9	2.6	4.3	3.2	4.3	7.0	2.6	3.3	4.6	5.6	5.4	2.7	4.4	2.9	0.0	0.1	0.0	0.4	0.0	0.4	0.2	0.5	0.1	0.0	0.3	0.5	0.4	0.9	0.0	0.3	0.3	0.3	0.0	10.2	16.4	6.6	17.1	7.3	5.4	14.7	14.6	10.5	12.2
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652605	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 95.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"CAB018351: AB_675504, HPA049808: , HPA062476: "	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavourable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	13.0	8.8	12.8	31.6	9.8	33.2	17.4	8.3	11.9	15.5	16.2	11.9	9.4	18.1	16.6	11.3	16.7	12.1	19.0	9.4	11.2	6.2	11.9	8.9	13.2	42.0	10.7	6.0	18.2	13.5	6.3	13.9	10.8	11.0	17.1	9.7	12.4	13.6	6.9	11.2	16.7	23.0	8.8	10.4	33.1	14.9	36.0	11.2	63.2	15.9	11.6	38.0	15.2	13.9	11.3	12.1	2.9	2.8	2.3	4.2	1.6	15.7	8.1	22.3	19.9	3.2	8.5	9.9	9.8	7.7	11.2	10.0	15.9	12.4	75.4	11.1	8.0	16.3	13.6	10.6	6.6	45.6	9.0	7.1	10.2	17.4	7.3	17.3	10.0	5.4	12.3	8.8	6.8	13.5	29.1	26.1	7.1	27.7	47.8	16.9	30.9	8.5	75.0	10.2	17.0	7.5	13.8	21.2	29.8	9.2	9.2	11.3	11.6	30.9	16.2	14.8	17.5	18.2	16.6	63.8	31.1	95.0	9.6	22.1	13.2	2.9	1.3	0.9	3.5	1.4	3.7	10.8	2.2	3.2	2.7	11.3	3.2	4.2	0.4	2.3	2.8	12.1	2.1	1.6	12.8	9.8	8.3	11.9	11.2	6.2	10.7	6.0	11.0	11.2
TCHH	THH	ENSG00000159450	Trichohyalin	Q07283	1	152106317-152115454	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Keratinization			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skin 1: 28.8;tongue: 40.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 8.0;THP-1: 4.3"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA028375	Uncertain									"HPA028375: AB_10601722"	"unprognostic (7.70e-3)"	"unprognostic (3.84e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (7.12e-5)"	"unprognostic (2.03e-1)"	"unprognostic (6.55e-2)"	"unprognostic (5.90e-6)"	"unprognostic (5.58e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.71e-2)"	"unprognostic (9.28e-7)"	0.7	0.4	0.2	0.2	0.2	0.0	1.7	0.2	0.6	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.3	0.2	0.6	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	3.5	0.2	0.2	0.0	0.2	0.7	0.2	0.2	28.8	0.3	0.2	0.2	4.7	0.0	1.9	0.2	0.6	0.2	40.9	0.2	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.4	1.4	0.6	0.0	1.6	0.1	8.0	0.0	0.1	0.0	0.4	0.2	0.4	0.0	0.0	0.0	0.6	2.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.2	2.1	0.2	0.3	2.0	0.4	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.4	0.7	0.0	0.6	4.3	0.1	0.2	2.0	0.4	0.2	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	0.2
TCN1	"TC1, TCI"	ENSG00000134827	"Transcobalamin 1"	P20061	11	59852800-59866575	"Plasma proteins, Predicted secreted proteins"	"Cobalt transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 152.9;salivary gland: 172.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.1;HaCaT: 6.8;PC-3: 9.1;SiHa: 9.5;THP-1: 3.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 124.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	95	"basophil: 152.9"	"Lineage enriched"	"Detected in single"	1202	"granulocytes: 152.9"					"Low region specificity"	"Detected in all"								"Secreted to blood"		3300000				"prognostic favourable (1.90e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.89e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.49e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.52e-3)"	"unprognostic (3.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.07e-3)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.56e-8)"	"unprognostic (2.50e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.76e-2)"	0.2	0.1	0.1	0.1	0.1	27.6	2.1	0.1	0.2	5.5	0.2	0.1	0.0	1.3	1.5	0.0	4.6	0.2	26.7	1.1	0.1	0.1	0.7	0.4	1.8	0.0	0.2	0.0	0.2	3.8	0.1	0.4	0.2	0.1	0.4	0.0	0.1	172.4	0.3	0.2	0.3	0.2	0.1	0.2	1.0	12.7	0.2	0.0	0.3	0.2	28.4	10.0	3.8	1.9	0.0	0.0	152.9	0.1	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.7	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.0	0.0	9.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	9.5	0.0	2.3	0.0	3.5	0.1	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.2	152.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.0
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357639-150400308	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavourable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	15.9	11.7	15.0	21.2	17.5	17.8	13.1	16.6	23.6	12.6	18.1	12.5	10.3	10.7	18.3	13.6	16.8	14.4	12.9	18.0	14.3	12.0	11.7	9.6	12.4	24.2	20.3	17.7	16.7	14.5	16.4	13.9	15.0	17.0	15.2	13.3	10.2	15.0	17.0	19.1	18.6	14.4	17.4	12.6	19.4	14.0	14.7	18.1	25.8	13.6	12.0	23.1	18.0	15.5	5.9	3.0	1.9	2.8	11.5	7.0	3.7	21.4	24.0	12.3	23.2	4.8	6.4	33.4	16.9	6.8	23.0	23.4	59.3	17.0	31.5	15.5	6.2	25.2	26.8	30.3	16.9	16.5	28.9	15.4	15.9	22.4	5.1	25.3	11.9	5.3	7.1	27.3	21.0	10.2	22.0	9.5	7.9	19.6	27.5	18.7	37.3	23.1	25.0	19.5	18.3	5.6	15.3	16.9	17.4	19.6	32.0	15.4	14.3	10.1	9.9	17.4	21.6	20.8	31.7	11.8	14.7	34.6	13.7	21.9	15.5	1.8	2.8	1.4	5.6	2.7	7.0	5.8	5.1	5.3	2.7	5.9	4.3	4.6	1.9	11.5	2.7	3.0	3.3	3.7	15.0	17.5	16.6	23.6	14.3	12.0	20.3	17.7	17.0	18.1
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789749	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved						3900000			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavourable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavourable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	51.6	37.4	40.5	34.8	38.2	61.4	58.9	40.6	43.6	32.7	40.9	34.7	31.7	28.3	40.4	35.4	41.7	38.8	28.6	49.1	39.6	40.7	46.3	57.1	33.3	40.4	45.5	30.4	52.3	42.9	45.9	29.5	41.3	43.4	35.4	45.3	26.1	48.0	31.3	63.2	38.7	35.7	42.7	46.5	32.9	35.0	65.9	39.9	50.7	36.7	60.4	49.8	41.9	108.6	38.6	35.9	35.6	48.6	38.4	46.5	39.4	30.6	37.8	39.5	55.6	36.6	29.7	61.9	45.6	23.1	58.2	44.6	74.7	23.0	75.9	32.0	36.7	45.4	107.5	46.7	83.7	38.9	50.3	78.3	42.0	70.5	28.1	64.1	42.1	28.6	29.7	57.1	54.8	51.4	110.4	35.9	54.5	25.6	79.2	75.8	43.8	41.2	59.1	29.7	62.6	47.1	22.5	50.2	32.5	42.6	62.9	20.7	28.8	62.2	34.7	28.7	42.9	63.7	95.1	32.4	66.8	84.0	40.7	75.3	45.0	28.8	28.9	35.6	35.8	38.9	46.5	38.6	39.9	38.7	35.9	29.5	41.3	40.1	13.8	38.4	48.6	22.3	40.7	39.4	40.5	38.2	40.6	43.6	39.6	40.7	45.5	30.4	43.4	39.9
TDRD1	CT41.1	ENSG00000095627	"Tudor domain containing 1"	Q9BXT4	10	114179270-114232304	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 35.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 33.0"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 4.1"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA037729	Enhanced									"HPA037729: AB_10670527"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.96e-2)"	"unprognostic (3.15e-2)"		"unprognostic (6.13e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.60e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.68e-1)"	0.3	0.2	0.2	0.3	0.2	0.0	0.4	0.2	2.1	0.2	0.3	0.0	0.0	0.2	0.6	0.7	0.3	0.2	0.6	0.8	0.3	0.2	2.8	0.7	0.2	0.2	0.2	0.4	0.5	0.6	0.0	0.3	0.0	0.4	2.9	0.1	0.0	0.3	0.2	0.4	0.2	0.3	0.2	0.7	1.6	0.3	35.3	0.0	0.0	0.2	1.0	0.2	0.2	0.2	0.8	4.5	0.2	0.2	0.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.2	0.1	0.1	0.5	0.2	0.8	0.8	0.0	0.2	0.4	0.0	4.5	0.2	0.0	0.2	0.2	0.2	2.1	0.3	0.2	0.2	0.4	0.4	0.0
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 37.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.6;HeLa: 3.9;hTCEpi: 2.2;PC-3: 3.3;SCLC-21H: 1.6"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Region enriched"	"Detected in many"	6	"cerebellum: 8.2"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;intermediate monocyte: 1.4"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA075923	Enhanced									"HPA075923: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.4	0.7	2.6	1.3	0.0	0.7	8.2	1.3	0.7	0.7	0.7	0.7	0.3	0.7	2.9	0.7	0.3	1.7	0.7	1.0	0.8	0.7	1.3	0.7	3.0	1.1	0.7	0.7	0.7	0.4	1.8	1.1	0.7	1.6	0.0	0.9	0.9	0.7	1.5	2.9	0.7	0.7	0.9	1.9	0.3	37.9	0.7	0.7	5.2	0.7	0.7	1.6	0.7	0.0	0.7	0.1	2.4	0.0	0.0	0.4	0.0	0.0	0.2	1.5	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.0	0.0	0.0	1.6	0.0	3.9	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.3	0.0	0.0	0.0	0.9	0.6	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.7	0.0	2.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.7	1.3	8.2	0.9	1.0	0.8	1.1	0.7	0.7	0.7
TDRKH	TDRD2	ENSG00000182134	"Tudor and KH domain containing"	Q9Y2W6	1	151770107-151791416	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, RNA-mediated gene silencing, Spermatogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 46.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016419, HPA019625"	Approved		Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA016419: AB_1857870, HPA019625: AB_1857871"	"unprognostic (2.27e-3)"	"unprognostic (2.89e-1)"	"unprognostic (8.60e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.14e-1)"	2.7	3.5	8.8	4.2	10.9	1.6	4.6	18.0	9.9	2.6	3.3	6.3	7.5	2.5	2.0	6.2	2.1	2.4	2.3	3.6	8.8	8.9	3.1	3.7	4.4	5.4	8.1	7.8	1.4	3.5	46.5	5.5	3.7	15.9	6.2	4.3	2.9	6.4	6.7	4.5	2.5	2.5	3.1	7.6	5.9	3.1	19.3	4.9	8.0	7.3	1.0	5.2	3.7	2.0	3.8	5.3	5.3	7.0	7.3	13.1	4.2	6.3	5.5	4.9	11.4	0.3	0.5	4.8	1.1	0.6	3.4	2.3	3.6	9.2	7.4	10.1	0.4	3.9	7.2	7.5	5.3	19.2	5.1	7.4	1.6	2.5	2.2	1.4	1.2	0.6	3.0	7.3	3.1	3.6	5.7	6.7	1.0	17.2	11.7	2.2	3.8	9.6	1.4	3.1	15.4	6.0	3.1	7.2	11.8	8.0	6.4	7.4	14.0	5.6	1.4	1.6	2.9	5.0	6.1	13.8	16.9	8.3	7.4	6.0	2.2	5.3	0.9	1.9	8.8	4.3	13.1	3.8	8.2	8.8	2.0	3.6	6.0	7.5	0.7	7.3	7.0	5.3	9.4	4.2	8.8	10.9	18.0	9.9	8.8	8.9	8.1	7.8	15.9	4.9
TEC	PSCTK4	ENSG00000135605	"Tec protein tyrosine kinase"	P42680	4	48135783-48269864	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 10.4;HMC-1: 16.4;U-266/70: 16.3;U-266/84: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 13.3;eosinophil: 11.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005733, HPA024657"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"HPA005733: AB_1857878, HPA024657: "	"unprognostic (7.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-2)"	"prognostic favourable (7.12e-4)"	"unprognostic (7.46e-3)"	"unprognostic (7.83e-2)"	"unprognostic (1.01e-4)"	"unprognostic (4.24e-2)"	"unprognostic (2.16e-1)"	"unprognostic (7.39e-2)"	"unprognostic (4.96e-3)"	3.9	4.5	0.8	7.2	1.1	9.8	5.1	0.6	2.0	3.4	4.8	0.5	8.4	2.8	3.0	21.6	9.5	3.6	2.1	3.3	0.9	0.9	4.0	5.7	6.4	7.0	1.5	0.3	2.9	2.9	2.6	6.4	2.0	3.2	2.0	2.5	3.0	6.8	4.7	2.1	8.1	6.5	3.0	1.2	6.7	2.2	5.5	0.6	4.4	4.4	5.8	11.1	3.2	6.5	0.9	1.3	13.3	0.6	2.9	0.4	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.4	1.8	1.0	2.2	0.0	1.7	1.5	1.6	0.0	0.5	0.9	0.0	1.5	0.1	0.7	10.4	0.7	0.1	0.0	1.7	16.4	0.0	0.2	1.4	0.0	0.0	5.7	0.4	3.2	0.7	1.0	3.7	0.3	0.7	2.4	2.2	0.0	2.8	0.7	0.0	0.2	0.5	0.2	0.4	0.6	3.3	0.0	0.0	0.0	2.2	0.0	16.3	11.6	2.1	0.0	2.3	0.1	13.3	0.5	11.0	0.1	0.6	0.3	0.9	0.1	0.4	1.3	0.6	0.4	0.4	0.4	2.9	0.1	0.1	0.0	0.3	0.8	1.1	0.6	2.0	0.9	0.9	1.5	0.3	3.2	0.6
TEF	KIAA1655	ENSG00000167074	"TEF, PAR bZIP transcription factor"	Q10587	22	41367333-41399326	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.75e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-3)"	"unprognostic (7.87e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.12e-2)"	"unprognostic (7.17e-3)"	"prognostic favourable (3.47e-11)"	"unprognostic (7.54e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.55e-2)"	11.0	10.9	21.0	4.2	33.5	1.0	10.1	45.0	39.2	16.7	10.4	13.9	14.5	6.5	14.9	8.8	12.2	15.8	10.6	25.0	19.9	14.2	15.6	10.6	11.7	5.4	10.7	25.0	29.8	18.3	30.3	12.6	3.7	13.4	10.6	9.2	20.1	21.9	20.8	30.4	18.2	8.9	8.2	8.6	8.3	7.5	9.2	13.9	1.7	23.1	13.8	6.6	9.3	7.0	1.7	3.1	2.6	2.7	0.3	3.3	1.1	3.6	1.8	5.8	6.7	9.8	5.8	4.2	2.7	13.4	3.9	5.5	4.8	9.2	10.3	4.0	13.6	7.8	1.7	6.5	4.5	4.6	2.7	2.1	3.7	3.1	4.4	3.1	3.0	8.1	10.6	5.1	11.9	2.6	0.9	8.9	1.9	8.4	2.6	2.2	3.4	4.3	7.5	3.7	4.4	3.0	8.1	5.5	2.8	12.4	2.8	5.5	4.6	3.6	4.0	10.8	11.8	4.3	4.3	9.3	6.7	6.6	10.5	2.8	11.4	0.0	1.0	2.6	2.2	2.7	3.3	1.7	2.4	2.2	0.9	0.7	2.8	1.8	1.5	0.3	1.4	3.1	1.9	1.1	21.0	33.5	45.0	39.2	19.9	14.2	10.7	25.0	13.4	13.9
TEK	"CD202b, TIE-2, TIE2, VMCM, VMCM1"	ENSG00000120156	"TEK receptor tyrosine kinase"	Q02763	9	27109141-27230175	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 35.8;NTERA-2: 17.8;TIME: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010359, HPA073265"	Approved		Supported	"Plasma membrane,Centriolar satellite"	"Secreted to blood"	7750000	8300000	"Plasma membrane"	"Centriolar satellite"	"CAB010359: AB_2203226, HPA073265: "	"unprognostic (2.24e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.26e-3)"	"prognostic favourable (2.31e-5)"	"unprognostic (7.48e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.72e-1)"	"prognostic favourable (7.81e-4)"	"unprognostic (7.50e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.83e-1)"	"unprognostic (5.24e-3)"	28.6	7.8	8.1	4.6	5.9	0.4	17.9	3.4	5.4	10.8	4.7	4.6	3.4	3.2	14.5	5.3	6.7	5.9	9.1	13.0	7.1	6.1	25.4	8.7	27.8	2.9	6.9	3.4	6.1	4.5	3.5	4.0	36.3	6.9	5.4	4.7	12.4	3.4	5.5	7.8	3.0	5.3	10.6	5.3	23.4	4.0	3.7	3.5	0.3	9.7	8.4	2.4	6.4	12.4	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.2	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.0	0.0	0.6	0.0	0.0	0.7	0.0	0.8	0.3	35.8	0.0	0.0	0.3	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	8.1	5.9	3.4	5.4	7.1	6.1	6.9	3.4	6.9	3.5
TEP1	"p240, TLP1, TP1, TROVE1, VAULT2"	ENSG00000129566	"Telomerase associated protein 1"	Q99973	14	20365667-20413429	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029206			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA029206: AB_10601271"	"unprognostic (4.53e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (9.58e-4)"	"unprognostic (2.27e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.18e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.00e-1)"	14.7	10.4	5.4	22.0	8.7	4.5	11.4	5.8	6.6	8.9	24.1	11.2	7.7	27.7	12.9	11.3	9.4	7.9	15.7	9.3	6.3	3.5	9.4	9.2	14.1	15.0	7.7	3.0	9.2	8.7	28.2	11.7	7.0	7.3	10.8	18.1	8.1	11.4	8.3	13.4	10.0	38.3	10.9	12.2	19.5	11.1	3.6	8.7	14.2	11.2	6.6	20.8	9.7	10.9	4.2	8.3	7.8	4.4	0.9	1.8	0.5	7.3	2.9	3.4	3.6	20.7	8.6	5.8	4.9	4.6	3.0	4.2	6.3	7.7	5.7	3.4	14.0	7.2	2.7	9.9	5.3	7.2	2.8	6.9	6.4	4.2	6.2	5.7	12.6	12.0	9.4	6.2	4.8	14.0	2.4	4.6	11.0	4.4	4.3	4.0	1.3	2.7	9.5	8.1	2.0	10.2	10.5	1.0	1.4	3.9	10.1	3.2	5.5	3.9	14.3	12.0	8.5	4.4	1.4	10.3	5.9	3.7	2.8	5.4	4.4	4.1	4.0	0.2	1.8	4.4	1.7	2.9	0.8	1.6	1.3	4.2	0.9	1.1	7.8	0.9	4.4	8.3	1.3	0.5	5.4	8.7	5.8	6.6	6.3	3.5	7.7	3.0	7.3	8.7
TESK1		ENSG00000107140	"Testis-specific kinase 1"	Q15569	9	35605305-35610041	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (5.17e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.18e-2)"	"unprognostic (2.04e-2)"	"unprognostic (8.76e-2)"	"prognostic unfavourable (9.68e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-3)"	30.9	19.4	13.5	10.8	20.5	5.6	25.4	13.4	26.4	14.3	15.2	15.0	9.7	13.7	15.3	13.4	11.0	12.0	13.0	12.8	13.7	13.1	10.5	10.0	11.5	10.7	14.1	10.3	17.0	16.0	13.1	15.7	12.3	12.6	15.1	8.8	14.2	14.6	21.0	47.2	13.7	12.7	16.9	7.3	11.0	12.9	28.4	12.9	9.2	13.0	12.3	9.0	16.6	20.9	1.0	2.3	0.3	1.8	2.1	4.9	1.5	9.9	9.3	6.4	10.6	25.7	10.7	7.3	11.4	10.2	10.6	6.8	5.4	2.8	18.1	6.5	11.4	3.4	4.0	8.2	2.0	11.6	5.4	2.6	8.8	4.7	15.0	2.2	8.7	10.4	13.0	8.3	11.4	7.4	3.0	6.5	10.5	11.0	5.0	11.0	3.9	10.9	7.8	3.9	4.2	7.8	4.6	5.2	6.4	6.5	7.9	4.8	9.4	3.3	6.4	23.6	10.1	16.9	6.8	4.0	5.6	6.7	17.1	2.6	5.3	0.0	1.8	0.3	3.4	0.4	3.0	0.8	1.4	4.9	2.1	1.0	1.5	1.6	0.0	2.1	0.8	2.3	0.3	1.5	13.5	20.5	13.4	26.4	13.7	13.1	14.1	10.3	12.6	12.9
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.0;RT4: 12.7;SK-MEL-30: 12.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA027257: AB_10602477, HPA063869: "	"unprognostic (2.95e-1)"	"prognostic favourable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.0	0.6	4.3	1.9	3.2	3.6	1.5	5.2	0.6	1.5	2.0	3.4	2.7	1.5	3.7	4.3	3.5	1.8	2.7	1.7	1.2	9.8	1.8	2.9	2.1	3.0	1.5	0.6	10.9	1.2	0.6	3.0	2.4	3.4	1.5	4.4	0.1	1.4	1.7	12.7	0.3	1.4	3.3	6.4	12.1	9.9	1.5	0.0	0.2	2.0	1.6	1.1	7.1	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8
TEX264	"FLJ13935, ZSIG11"	ENSG00000164081	"Testis expressed 264"	Q9Y6I9	3	51662693-51704323	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005002, HPA017739"	Enhanced		Approved	Nucleoli,Cytosol	"Secreted - unknown location"			"Nucleoli, Cytosol"		"CAB005002: AB_425976, HPA017739: AB_1857910"	"unprognostic (2.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.79e-3)"	"unprognostic (8.11e-2)"	"unprognostic (8.26e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.06e-3)"	"unprognostic (2.30e-1)"	"unprognostic (5.19e-2)"	"prognostic favourable (5.67e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (7.95e-9)"	"unprognostic (4.99e-2)"	"unprognostic (3.65e-1)"	"unprognostic (3.17e-1)"	"unprognostic (4.67e-2)"	15.7	34.6	15.1	15.3	18.7	9.0	20.0	8.6	22.8	17.5	21.3	15.0	36.0	18.7	20.1	25.5	17.7	21.9	24.8	19.0	14.6	15.6	35.9	30.7	17.0	22.6	15.7	17.9	15.8	29.0	29.9	12.3	24.5	12.2	20.3	16.7	22.6	43.6	44.3	16.3	29.5	20.8	16.6	15.8	18.6	19.0	90.8	11.5	16.6	33.9	18.5	15.9	16.7	16.3	33.1	34.5	24.7	36.7	22.8	50.7	41.1	11.7	21.6	3.8	19.9	40.4	19.7	7.9	10.1	24.0	16.9	17.1	11.6	28.0	17.0	7.4	14.5	11.5	11.0	20.5	8.2	13.6	17.5	16.2	13.5	15.3	36.1	10.2	18.2	25.9	32.7	19.1	19.6	12.3	8.5	29.6	17.3	13.6	16.2	23.6	4.2	24.3	7.9	5.1	32.0	26.6	16.4	5.6	9.1	12.4	34.3	15.6	16.7	21.5	9.0	17.0	7.1	17.8	13.4	20.7	22.3	8.3	20.9	21.4	16.9	24.7	36.7	21.7	41.9	36.7	41.9	32.2	43.5	39.7	34.5	33.1	36.5	37.0	7.7	22.8	34.7	30.5	50.7	41.1	15.1	18.7	8.6	22.8	14.6	15.6	15.7	17.9	12.2	11.5
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133745956-133796640	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 711.5"	"Cell line enriched"	"Detected in some"	48	"Hep G2: 129.1"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	2500000000000	120000000000			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favourable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavourable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	7.8	1.3	6.7	1.2	26.7	1.3	1.9	3.7	20.4	1.4	1.3	57.2	0.0	1.2	1.3	1.3	1.8	1.3	1.3	2.4	11.3	7.4	1.5	711.5	1.3	1.3	50.8	12.3	1.4	1.6	1.4	0.8	1.3	40.2	1.5	1.3	14.0	4.0	1.3	1.3	1.3	1.2	1.3	46.9	1.3	1.3	2.4	39.9	0.0	1.4	0.0	1.4	1.3	0.6	1.1	1.0	2.6	1.1	0.9	0.8	0.4	0.3	0.2	0.3	0.2	0.9	0.6	0.1	0.3	0.3	0.1	0.1	0.5	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.2	0.1	0.1	2.7	0.4	129.1	0.2	0.7	0.4	0.4	0.6	0.1	0.2	0.3	1.0	0.3	0.4	0.2	0.1	0.2	0.2	0.3	0.2	0.5	0.1	0.1	0.5	0.3	0.2	0.3	0.4	1.0	0.3	0.2	0.4	0.4	0.2	0.2	0.1	0.3	0.4	0.2	0.3	0.2	0.2	2.6	1.1	0.7	0.6	0.7	0.6	0.6	0.6	0.6	0.6	1.1	0.8	0.8	2.4	0.9	0.7	1.0	0.4	0.4	6.7	26.7	3.7	19.6	11.3	7.4	50.8	12.3	40.2	39.9
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847613	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"epididymis: 65.5"	"Group enriched"	"Detected in some"	4	"AF22: 31.7;SH-SY5Y: 59.0"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in some"	41	"cerebellum: 4.7;pons and medulla: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 11.2"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA034683: AB_10670966, HPA062942: "	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.2	3.0	0.0	0.0	0.0	0.0	9.4	4.7	0.0	0.2	0.2	0.0	8.8	0.0	0.0	65.5	5.8	0.0	0.0	0.1	0.0	0.1	6.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	6.3	0.1	0.0	12.2	7.0	0.6	0.0	6.3	0.0	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	59.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.1	0.0	6.3	0.0
TFF1	"BCEI, D21S21, HP1.A, HPS2, pNR-2, pS2"	ENSG00000160182	"Trefoil factor 1"	P04155	21	42362282-42366594	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	34	"gallbladder: 247.7;stomach 1: 375.3"	"Cell line enriched"	"Detected in some"	58	"MCF7: 484.6"	"Group enriched"	"Detected in many"	10	"breast cancer: 402.1;colorectal cancer: 268.3;pancreatic cancer: 805.7;stomach cancer: 744.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB002170, HPA003425"	Enhanced				"Secreted to digestive system"		990000			"CAB002170: AB_563985, HPA003425: AB_1848260"	"prognostic favourable (5.00e-4)"	"unprognostic (8.81e-3)"	"unprognostic (9.82e-2)"	"prognostic favourable (5.67e-4)"		"unprognostic (2.42e-1)"	"unprognostic (1.72e-3)"	"unprognostic (8.14e-2)"		"unprognostic (2.45e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.62e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	1.0	0.2	0.0	3.5	0.1	0.1	0.5	4.9	1.4	0.1	1.4	0.1	0.1	1.1	0.1	247.7	0.1	0.1	0.0	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.9	0.0	0.1	0.1	0.1	1.9	4.7	0.1	5.0	0.2	0.1	0.0	5.6	0.1	0.1	0.1	375.3	0.1	0.1	0.1	0.2	1.1	9.2	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	484.6	0.1	0.0	0.2	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TFIP11	"DKFZP434B194, Spp382, TIP39"	ENSG00000100109	"Tuftelin interacting protein 11"	Q9UBB9	22	26491225-26512505	"Plasma proteins, Predicted intracellular proteins"	"Biomineralization, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027085			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027085: AB_1857964"	"unprognostic (1.53e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.87e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.86e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.01e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.62e-1)"	11.8	13.5	12.7	12.7	13.8	43.9	10.9	13.8	15.4	9.4	9.5	13.1	8.9	9.9	11.8	8.9	14.5	10.7	10.3	11.8	13.2	9.6	12.3	24.7	11.0	17.7	15.5	12.0	10.3	16.3	11.1	12.0	11.5	12.2	10.5	9.8	11.9	10.9	8.7	34.2	16.3	12.7	10.2	10.6	17.8	11.1	40.6	12.3	23.8	15.4	11.0	19.0	11.1	11.5	23.8	15.5	35.4	23.8	19.6	25.5	17.8	10.9	12.9	11.2	12.6	18.0	10.9	11.3	13.5	17.2	21.1	20.0	9.8	8.0	21.4	8.4	16.7	16.3	16.0	13.0	15.7	15.6	15.2	13.1	8.3	9.9	16.5	30.4	16.9	13.9	17.6	20.0	15.8	16.1	17.7	20.5	14.1	13.4	13.8	16.7	10.8	10.8	21.0	17.3	18.9	12.2	11.1	8.5	12.3	16.1	11.6	15.8	9.4	14.5	15.8	17.8	29.2	11.2	12.3	15.1	19.3	42.4	14.1	12.3	13.2	35.4	16.9	28.6	23.8	18.2	22.1	22.9	21.1	22.2	15.5	23.8	20.2	18.4	26.8	19.6	23.8	9.7	25.5	17.8	12.7	13.8	13.8	15.4	13.2	9.6	15.5	12.0	12.2	12.3
TFPI	"EPI, LACI, TFI, TFPI1"	ENSG00000003436	"Tissue factor pathway inhibitor"	P10646	2	187464230-187565760	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.2;placenta: 192.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 55.2;HUVEC TERT2: 103.8;LHCN-M2: 63.6;TIME: 62.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.5;plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA005575, CAB020842"	Supported		Approved	"Intermediate filaments,Cytosol"	"Secreted to blood"		95000000	Cytosol	"Intermediate filaments"	"CAB020842: , HPA005575: AB_1080290"	"unprognostic (8.75e-2)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (7.95e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.86e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.39e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (5.81e-2)"	52.8	5.0	1.3	5.2	2.2	1.6	18.5	1.9	2.4	22.8	32.1	0.3	7.2	12.8	13.3	14.8	25.9	12.5	15.0	14.0	1.2	1.1	35.6	98.2	89.7	40.2	2.4	1.0	17.3	7.7	0.9	4.9	192.3	2.3	18.2	6.9	3.8	6.0	3.8	15.8	6.6	37.0	13.6	5.4	16.5	7.7	13.7	1.6	3.4	22.6	10.4	4.0	30.0	14.7	1.5	5.1	5.5	0.6	1.0	0.6	4.9	5.0	3.5	4.1	0.1	32.1	38.5	0.0	9.1	21.7	5.9	9.2	3.2	27.0	0.0	3.6	7.1	0.3	1.2	0.4	15.5	0.2	1.0	1.6	10.9	27.4	55.2	0.1	0.0	17.6	0.7	32.1	8.6	103.8	4.0	0.1	63.6	4.7	0.6	0.1	2.5	8.8	0.0	5.7	0.0	10.1	0.2	0.0	0.0	7.4	0.2	0.4	0.1	0.0	62.1	4.3	4.0	8.5	1.7	0.0	0.1	0.0	34.6	0.0	4.9	5.5	0.6	0.5	0.5	0.3	0.2	0.9	0.4	0.2	0.5	1.5	0.5	0.6	2.6	1.0	0.3	5.1	0.2	4.9	1.3	2.2	1.9	2.4	1.2	1.1	2.4	1.0	2.3	1.6
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Group enriched"	"Detected in some"	11	"HEL: 27.8;HMC-1: 38.6;K-562: 25.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011937, CAB016255"	Enhanced									"CAB016255: AB_628395, HPA011937: AB_1858243"	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favourable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	2.8	0.0	0.6	38.6	0.0	0.0	0.0	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavourable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	21.9	20.0	9.2	18.6	20.4	11.8	57.5	31.4	23.9	22.1	36.7	48.7	20.2	22.5	59.6	11.6	33.9	31.5	10.4	27.1	107.6	10.7	85.3	17.0	22.6	16.1	69.9	17.3	13.3	10.3	19.0	17.2	7.3	35.5	21.6	17.2	20.3	22.9	14.8	28.0	41.0	12.2	13.7	27.0	19.8	55.6	21.0	8.7	30.3	79.7	7.1	77.4	14.6	9.4	26.3	21.4	23.0	47.0	6.1	47.5	35.2	30.8	19.0	15.9	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1
TG	"AITD3, TGN"	ENSG00000042832	Thyroglobulin	P01266	8	132866958-133134903	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Thyroid hormones biosynthesis"	"Hormone, Thyroid hormone"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	247	"thyroid gland: 994.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;HSkMC: 4.2;Karpas-707: 9.7;PC-3: 4.8;U-266/70: 3.5"	"Cancer enriched"	"Detected in some"	1672	"thyroid cancer: 3072.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 1.3"	"Low region specificity"	"Detected in many"			"CAB000077, HPA002740, CAB056155"	Enhanced				"Secreted in other tissues"		1000000			"CAB000077: , CAB056155: , HPA002740: AB_1080277"	"unprognostic (1.18e-1)"	"unprognostic (6.86e-2)"	"unprognostic (7.40e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.77e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.64e-2)"	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.4	0.6	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	994.3	0.1	0.1	0.1	0.1	0.3	1.2	4.0	0.6	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.9	1.4	0.6	0.0	1.7	0.0	0.1	0.9	0.0	0.0	0.2	0.4	0.5	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	4.2	2.9	1.1	0.0	0.0	0.0	9.7	0.2	0.0	0.1	0.0	0.0	4.8	0.1	0.0	0.3	0.2	2.8	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.6	0.0	3.5	2.9	0.0	0.2	1.2	0.0	0.0	0.6	0.7	0.2	0.0	0.9	0.0	0.4	0.0	0.0	0.3	0.3	0.2	4.0	0.0	0.3	1.2	0.4	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TGFA		ENSG00000163235	"Transforming growth factor alpha"	P01135	2	70447280-70554193	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"		"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 23.9;CAPAN-2: 29.5;EFO-21: 15.2;HBEC3-KT: 25.7;RPTEC TERT1: 25.9;U-87 MG: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 6.3;eosinophil: 14.0;neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042297	Approved		Approved	Vesicles	"Secreted to blood"	57867		Vesicles		"HPA042297: AB_10793878"	"unprognostic (1.23e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.57e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.49e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.00e-3)"	"unprognostic (6.69e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (7.74e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.21e-2)"	"prognostic favourable (1.52e-4)"	"unprognostic (9.19e-2)"	2.0	0.5	8.4	4.3	10.7	1.2	6.2	3.5	7.9	5.7	9.4	21.4	0.3	7.4	1.2	2.8	23.8	5.7	14.6	0.8	10.7	6.9	12.4	4.0	3.5	4.2	10.9	5.2	0.5	12.0	1.0	0.8	1.7	9.4	2.2	7.3	9.7	6.3	1.2	0.4	10.8	13.7	1.3	22.5	5.1	7.6	2.3	12.8	0.2	7.4	17.4	12.1	5.4	10.8	0.0	0.6	14.7	0.4	0.2	2.7	0.4	23.9	3.8	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	29.5	0.0	15.2	0.1	12.8	0.2	25.7	0.0	0.0	0.5	0.0	0.6	2.0	0.0	0.3	0.0	0.0	10.3	0.0	10.1	0.0	0.0	0.1	0.0	0.9	0.0	0.5	0.4	7.3	0.0	0.1	6.3	25.9	9.3	0.2	0.0	1.9	0.0	0.0	3.3	0.2	0.2	0.1	1.7	0.0	5.2	0.1	0.1	0.0	24.5	0.8	8.8	6.3	0.4	14.0	1.0	0.1	2.7	0.0	0.6	0.6	0.6	0.0	0.3	0.2	14.7	0.2	0.0	0.0	0.0	0.4	8.4	10.7	3.5	7.9	10.7	6.9	10.9	5.2	9.4	12.8
TGFB1	"CED, DPD1, TGFB, TGFbeta"	ENSG00000105329	"Transforming growth factor beta 1"	P01137	19	41301587-41353911	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Mitogen"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000361, HPA073356"	Approved		Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	1288167	38000000	"Golgi apparatus"	Cytosol	"CAB000361: AB_2201910, HPA073356: "	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.29e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.75e-3)"	"prognostic unfavourable (3.38e-4)"	"unprognostic (8.51e-3)"	"unprognostic (5.63e-3)"	"unprognostic (2.47e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (1.19e-8)"	"unprognostic (1.65e-3)"	"unprognostic (2.79e-2)"	"unprognostic (6.39e-2)"	"unprognostic (4.86e-3)"	24.3	14.4	7.7	29.8	11.9	53.1	19.0	2.2	8.2	27.8	15.3	14.3	11.5	11.4	24.1	12.8	24.5	13.0	15.6	17.6	8.8	6.5	19.2	10.4	32.4	33.3	12.0	4.1	15.3	8.2	6.9	9.7	54.7	11.7	17.2	5.8	10.3	10.9	15.9	8.7	14.0	17.6	14.6	12.8	55.8	12.8	9.5	12.3	30.6	10.3	9.1	30.6	28.7	24.6	0.7	1.4	7.5	2.2	0.5	1.7	1.3	14.5	22.9	1.2	0.1	10.6	9.4	2.9	21.1	19.0	6.8	4.6	9.7	9.0	14.4	22.7	28.6	7.9	4.1	13.5	2.4	19.1	4.5	48.5	5.5	12.3	13.7	13.3	33.1	12.2	4.3	13.1	8.4	34.1	26.0	36.3	6.2	10.7	11.4	19.5	2.5	13.7	12.3	3.2	21.6	12.1	6.3	0.2	1.6	5.8	0.3	4.1	0.5	11.9	43.1	26.7	20.9	5.6	22.9	20.1	7.8	9.4	26.1	26.7	4.7	1.5	1.9	7.5	1.7	2.2	1.3	0.4	0.9	0.9	1.4	0.7	0.7	0.9	4.7	0.5	2.0	1.4	0.5	1.3	7.7	11.9	2.2	7.6	8.8	6.5	12.0	4.1	11.7	12.3
TGFBI	"BIGH3, CDB1, CDGG1, CSD1, CSD2, CSD3, LCD1"	ENSG00000120708	"Transforming growth factor beta induced"	Q15582	5	136028895-136063818	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Sensory transduction, Vision"		"Amyloidosis, Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 157.4;HSkMC: 164.3;hTCEpi: 114.3;LHCN-M2: 130.6;U-2197: 114.2;U-87 MG: 218.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"pons and medulla: 19.7"	"Group enriched"	"Detected in many"	30	"classical monocyte: 41.9;intermediate monocyte: 27.0;myeloid DC: 28.6;non-classical monocyte: 20.6;plasmacytoid DC: 61.2"	"Group enriched"	"Detected in many"	43	"dendritic cells: 61.2;monocytes: 41.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA008612, HPA017019"	Enhanced				"Secreted to blood"		1400000000			"HPA008612: AB_1857970, HPA017019: AB_2669511"	"unprognostic (1.05e-1)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (4.38e-3)"	"prognostic favourable (1.17e-4)"	"unprognostic (5.21e-3)"	"unprognostic (5.53e-3)"	"unprognostic (4.60e-2)"	"unprognostic (8.71e-3)"	"unprognostic (5.45e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (1.42e-3)"	"unprognostic (2.26e-1)"	"prognostic unfavourable (7.82e-10)"	"unprognostic (8.81e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-3)"	51.3	16.6	1.8	30.4	3.9	4.3	32.2	1.1	6.5	14.1	24.2	5.2	16.2	9.2	30.2	71.9	21.1	15.2	94.9	53.0	4.1	2.9	21.7	47.5	42.5	65.1	3.7	2.4	27.0	10.5	3.3	23.7	90.0	19.7	27.0	16.9	21.8	21.1	13.1	24.1	63.8	22.4	56.5	10.1	41.6	21.2	18.2	2.1	21.2	12.0	40.1	18.8	46.3	24.4	0.2	61.2	0.9	41.9	1.2	0.3	15.1	5.7	23.5	0.0	0.2	66.5	21.9	0.0	17.6	2.2	12.1	7.3	10.6	74.0	0.0	10.7	157.4	28.4	0.0	56.6	10.8	0.1	0.0	0.0	28.2	28.5	44.5	0.0	0.2	164.3	114.3	4.5	5.1	10.3	0.0	0.2	130.6	0.2	0.0	0.0	0.7	0.0	0.0	1.2	0.1	5.7	0.5	0.0	0.0	27.7	0.9	0.2	0.2	6.3	43.3	82.3	3.5	114.2	62.7	0.0	0.0	0.0	218.6	0.0	62.7	0.2	41.9	0.1	0.1	27.0	0.2	0.2	0.2	0.3	28.6	0.0	0.0	0.2	0.9	1.2	20.6	61.2	0.1	15.1	1.8	3.9	1.1	3.0	4.1	2.9	3.7	2.4	19.7	2.1
TGFBR2	"MFS2, TBR-ii, TBRII"	ENSG00000163513	"Transforming growth factor beta receptor 2"	P37173	3	30606502-30694142	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Apoptosis, Differentiation, Growth regulation"	"Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB073537			Supported	"Plasma membrane"			560000	"Plasma membrane"		"CAB073537: "	"unprognostic (1.74e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.81e-2)"	"unprognostic (8.02e-2)"	91.8	24.6	6.7	24.6	10.3	7.3	88.3	3.6	7.3	36.5	42.6	9.8	18.6	13.2	42.6	23.3	36.2	28.4	42.6	73.5	6.9	5.2	32.6	21.9	52.6	75.7	12.6	3.7	22.2	26.0	17.4	10.3	24.2	9.9	35.2	17.5	27.9	22.5	19.5	34.9	17.0	31.3	37.2	12.0	68.7	26.8	15.4	8.2	19.3	40.9	16.8	26.9	48.0	82.0	5.3	6.8	20.0	6.6	1.4	19.7	3.9	2.4	14.4	0.9	0.0	53.4	80.5	2.4	12.5	17.6	4.3	4.3	3.2	13.3	0.3	45.3	16.8	5.0	0.6	18.3	7.2	1.0	1.3	1.4	1.6	16.2	22.8	2.2	11.8	69.5	16.3	18.6	18.0	46.7	0.2	0.0	65.8	0.2	2.3	1.6	0.4	5.8	2.0	5.8	0.3	23.2	5.8	0.0	0.9	3.7	1.0	3.5	0.0	2.4	60.3	21.2	5.2	9.6	4.7	0.4	0.0	2.0	12.7	2.5	8.5	6.9	2.9	20.0	3.5	3.0	3.2	4.0	5.4	4.2	2.6	5.3	19.7	9.1	12.6	1.4	6.6	6.8	1.2	3.9	6.7	10.3	3.6	7.3	6.9	5.2	12.6	3.7	9.9	8.2
TGFBR3	"betaglycan, BGCAN"	ENSG00000069702	"Transforming growth factor beta receptor 3"	Q03167	1	91680343-91906335	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.7;ASC TERT1: 32.0;U-2197: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 21.3;MAIT T-cell: 11.6;memory CD4 T-cell: 5.4;memory CD8 T-cell: 11.4;naive CD8 T-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	22	"NK-cells: 9.0;T-cells: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008257, CAB018971"	Supported		Approved	Cytosol	"Secreted to blood"		29000000	Cytosol		"CAB018971: , HPA008257: AB_1080258"	"unprognostic (7.57e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (9.39e-3)"	"prognostic favourable (4.84e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.99e-4)"	"unprognostic (2.46e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (1.08e-2)"	40.1	15.9	3.2	6.8	3.1	1.6	63.5	1.8	4.4	30.1	15.2	3.5	30.0	3.4	17.6	21.0	22.2	17.6	23.3	16.3	3.9	1.9	12.5	11.9	18.4	18.1	2.6	2.0	62.4	8.9	4.4	4.4	25.1	4.5	21.7	5.6	8.8	14.7	46.5	19.2	13.4	9.8	34.4	4.1	27.1	11.1	14.0	3.0	1.1	7.5	6.5	3.1	39.2	42.1	0.0	0.6	0.6	0.6	9.0	21.3	3.9	2.7	2.6	4.0	0.6	65.7	32.0	12.7	2.0	10.0	2.3	2.8	1.2	0.4	0.0	0.5	3.6	0.4	1.0	0.2	1.8	9.3	2.1	0.0	3.3	11.1	1.4	0.1	0.0	7.7	1.3	5.1	1.1	1.1	6.4	0.2	0.6	0.0	0.0	0.0	1.6	0.9	0.1	1.3	0.5	0.9	16.0	0.1	0.0	0.9	0.0	5.5	0.3	1.0	3.6	3.9	1.0	22.3	0.4	9.9	0.9	0.0	0.8	0.5	0.4	0.6	0.0	0.0	21.3	0.1	11.6	0.0	5.4	11.4	0.0	0.0	1.7	8.0	0.3	9.0	0.6	0.6	2.4	3.9	3.2	3.1	1.8	4.4	3.9	1.9	2.6	2.0	4.5	3.0
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA053786: , HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	6.9	1.7	20.0	22.6	2.9	2.7	7.3	4.0	4.6	9.6	7.2	10.2	8.9	18.7	10.6	3.9	7.2	16.2	10.4	9.4	8.8	5.9	23.4	4.0	13.5	4.6	9.9	5.7	4.2	6.9	2.0	7.4	9.4	11.2	11.5	4.6	9.9	16.8	18.9	16.7	5.0	14.4	23.9	10.2	6.3	4.6	6.0	17.8	1.2	10.6	10.0	12.7	22.1	6.8	1.5	6.3	0.1	7.5	13.2	4.9	17.6	0.1	11.9	7.5	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8
TGM1	"ICR2, LI, LI1, TGASE, TGK"	ENSG00000092295	"Transglutaminase 1"	P22735	14	24249114-24264432	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.8;HaCaT: 17.6;HeLa: 11.5;MCF7: 12.6;SK-BR-3: 15.7"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 78.3"	"Region enriched"	"Detected in single"	11	"cerebellum: 3.0"	"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB015159, HPA040171"	Enhanced						430000			"CAB015159: AB_2202870, HPA040171: "	"unprognostic (2.95e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.72e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.94e-7)"	"unprognostic (7.11e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.86e-2)"	2.9	0.2	0.2	0.4	0.2	0.2	0.7	3.0	0.3	10.1	1.0	0.2	0.2	0.3	0.5	2.0	106.0	1.3	0.2	0.6	0.2	0.0	0.6	0.3	0.9	0.4	0.2	0.2	0.7	1.3	0.2	0.2	0.9	0.2	0.5	0.3	0.4	12.8	1.4	0.7	9.3	0.3	0.2	0.2	0.4	0.2	0.4	0.2	0.5	0.4	86.8	70.0	0.4	17.2	0.4	0.5	0.0	0.5	0.0	1.1	0.2	0.8	1.5	0.8	0.7	0.0	0.6	12.8	0.3	0.2	0.7	1.2	0.9	1.3	0.7	1.7	0.9	17.6	2.1	1.4	0.5	1.4	2.4	1.0	11.5	4.0	0.6	0.6	1.1	1.1	7.0	0.4	1.5	0.5	0.7	0.7	0.5	12.6	0.5	1.3	0.2	1.6	0.8	0.1	0.8	0.5	1.5	0.9	1.1	0.2	15.7	0.0	1.1	0.8	0.6	0.8	3.7	1.5	0.6	1.1	1.2	0.2	0.3	1.5	0.9	0.0	0.5	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.2	0.2	3.0	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TGM3	TGE	ENSG00000125780	"Transglutaminase 3"	Q08188	20	2296001-2341078	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Keratinization	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"esophagus: 195.0;lymphoid tissue: 152.6;tongue: 206.5"	"Cell line enriched"	"Detected in some"	6	"EFO-21: 11.6"	"Cancer enriched"	"Detected in many"	9	"head and neck cancer: 81.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	205	"neutrophil: 20.4"	"Lineage enriched"	"Detected in single"	205	"granulocytes: 20.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA004728	Enhanced						14000000			"HPA004728: AB_1080360"	"unprognostic (7.14e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.23e-3)"	"unprognostic (4.27e-2)"	"unprognostic (4.20e-2)"	"unprognostic (8.62e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.78e-8)"	"unprognostic (1.56e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.45e-2)"	"unprognostic (9.67e-2)"	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	4.9	0.1	0.0	0.0	0.0	0.1	0.1	195.0	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	24.5	0.0	0.1	7.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	206.5	152.6	0.0	2.8	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TGM4	TGP	ENSG00000163810	"Transglutaminase 4"	P49221	3	44874608-44914990	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"prostate: 107.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.5;hTERT-HME1: 2.6;NB-4: 5.1;RPMI-8226: 3.6;SH-SY5Y: 2.8"	"Cancer enriched"	"Detected in single"	312	"prostate cancer: 75.4"	"Region enriched"	"Detected in single"	254	"cerebral cortex: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA032072, CAB033571"	Enhanced									"CAB033571: AB_2287329, HPA032072: AB_10603350"	"unprognostic (4.40e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.56e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.44e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.41e-2)"	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	25.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	107.8	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.6	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.1	2.6	0.3	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	3.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.7	0.7	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0
TGM7	TGMZ	ENSG00000159495	"Transglutaminase 7"	Q96PF1	15	43276280-43302255	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 5.9;testis: 2.9"	"Cell line enriched"	"Detected in single"	78	"EFO-21: 8.9"	"Cancer enriched"	"Detected in single"	13	"endometrial cancer: 2.1"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (2.45e-2)"		"unprognostic (2.04e-1)"		"unprognostic (2.82e-2)"				"unprognostic (1.71e-2)"		"unprognostic (1.07e-1)"			"unprognostic (2.01e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0			0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.3	0.0		0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9			0.0		5.9	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0										
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328425	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"			9800000	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	40.0	40.7	34.3	38.4	38.0	55.6	36.5	51.7	43.1	33.3	50.0	38.7	31.5	53.2	41.2	31.1	23.9	33.3	44.9	43.2	31.9	34.4	59.6	66.2	44.1	37.4	35.4	36.7	36.1	34.4	39.5	21.8	50.4	35.8	34.0	50.1	26.9	38.9	36.5	23.7	23.7	63.1	36.0	40.3	47.1	36.8	22.3	33.2	31.8	44.8	17.0	37.7	39.9	32.9	9.4	14.9	34.2	34.1	8.6	12.3	22.7	11.2	29.1	12.4	16.3	29.9	31.4	28.9	34.2	39.9	23.3	18.7	24.3	34.1	14.1	27.1	47.3	18.4	8.9	16.7	38.7	23.1	8.9	20.2	10.3	26.0	16.3	39.1	46.9	23.2	10.7	30.1	18.2	33.6	11.6	23.2	34.3	10.2	12.6	19.9	10.9	11.8	13.3	45.5	10.4	25.0	17.7	11.7	9.7	29.9	22.5	19.8	12.6	17.6	35.6	50.0	18.6	37.7	40.9	15.2	19.5	13.8	37.0	30.4	32.5	17.6	27.5	23.5	12.3	26.9	9.6	9.4	9.2	8.3	14.9	9.1	9.6	9.1	34.2	8.6	34.1	5.6	7.2	22.7	34.3	38.0	51.7	43.1	31.9	34.4	35.4	36.7	35.8	33.2
THAP12	"DAP4, P52rIPK, PRKRIR, THAP0"	ENSG00000137492	"THAP domain containing 12"	O43422	11	76349956-76380971	"Plasma proteins, Predicted membrane proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA008758	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA008758: AB_1855714"	"unprognostic (2.79e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.23e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.08e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.79e-2)"	17.0	15.4	19.4	15.5	16.9	17.1	26.4	28.8	15.5	14.6	14.5	7.1	7.2	11.9	17.9	13.7	12.5	14.9	10.2	20.6	13.6	11.2	17.0	25.3	13.2	18.5	11.7	8.7	15.2	32.3	10.4	16.2	20.1	14.2	12.8	16.3	8.2	12.4	12.6	20.6	9.3	14.5	13.8	12.7	21.9	13.8	14.4	13.4	43.2	16.3	11.6	17.2	11.9	23.3	5.1	2.9	2.0	2.1	7.5	7.7	2.4	10.6	8.5	16.3	9.2	11.2	16.0	9.9	11.0	11.5	14.0	12.4	17.1	11.5	29.1	17.0	10.5	10.6	20.0	13.1	22.5	21.8	6.3	20.8	6.1	7.9	12.4	26.2	10.3	11.4	17.4	12.4	23.3	12.0	24.0	16.5	12.5	11.5	22.6	14.8	6.7	9.4	17.0	37.4	30.1	8.1	11.3	16.0	10.6	10.7	12.0	5.8	12.0	10.4	10.7	16.8	27.5	34.0	9.6	14.7	15.5	70.6	4.0	14.7	9.0	1.1	2.1	2.0	6.6	2.1	7.7	4.9	6.9	7.2	2.9	5.1	5.1	6.6	0.6	7.5	2.0	1.3	6.3	2.4	19.4	16.9	28.8	15.5	13.6	11.2	11.7	8.7	14.2	13.4
THAP2	DKFZP564I0422	ENSG00000173451	"THAP domain containing 2"	Q9H0W7	12	71663009-71680639	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039790	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA039790: AB_10795157"	"unprognostic (5.62e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.51e-4)"	"unprognostic (1.24e-4)"	"unprognostic (7.00e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.13e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.80e-2)"	19.8	31.3	10.9	9.9	13.3	14.2	6.1	24.1	14.1	7.7	6.4	7.3	6.2	6.6	7.1	20.0	10.0	6.9	10.2	7.9	11.6	8.1	6.7	5.9	6.8	7.9	16.3	10.4	9.9	6.1	5.5	20.6	7.9	12.6	8.4	6.8	2.5	5.4	5.5	5.7	6.5	6.3	5.3	18.2	7.4	8.2	21.0	16.0	7.0	8.0	4.2	7.7	7.8	11.6	6.5	3.8	2.8	4.1	8.4	11.4	3.1	3.8	4.9	11.5	8.7	8.6	7.1	5.7	6.1	5.5	5.9	5.0	4.7	5.0	2.6	4.2	4.0	6.9	11.0	3.4	7.7	11.3	6.0	7.5	8.3	7.7	7.6	4.5	3.5	5.3	14.7	5.7	12.4	9.1	5.5	5.6	7.8	1.2	3.7	4.5	5.7	8.1	5.3	3.8	12.9	6.8	6.0	8.0	12.7	6.4	3.9	5.3	7.2	4.7	4.0	6.1	2.9	5.2	4.0	7.1	8.8	6.1	3.5	5.3	3.7	2.0	2.8	2.8	5.0	3.9	8.2	5.7	7.0	4.8	3.8	6.5	11.4	7.6	2.5	8.4	4.1	1.9	6.8	3.1	10.9	13.3	24.1	14.1	11.6	8.1	16.3	10.4	12.6	16.0
THBS1	"THBS, THBS-1, TSP, TSP-1, TSP1"	ENSG00000137801	"Thrombospondin 1"	P07996	15	39581079-39599466	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, Unfolded protein response"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 162.1;HUVEC TERT2: 157.6;LHCN-M2: 117.7;TIME: 229.8"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.4;pons and medulla: 8.1"	"Cell type enhanced"	"Detected in some"		"eosinophil: 14.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB033678, HPA059756"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"		1600000000	"Plasma membrane"		"CAB033678: AB_793044, HPA059756: "	"unprognostic (1.72e-2)"	"unprognostic (9.55e-3)"	"unprognostic (7.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.03e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavourable (8.47e-5)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (1.00e-1)"	"unprognostic (9.25e-3)"	"unprognostic (1.48e-3)"	79.6	15.2	0.9	81.4	3.4	19.3	41.0	0.7	1.3	25.7	42.7	2.5	6.6	5.0	72.8	30.5	22.7	40.8	57.7	49.0	1.0	1.0	23.4	27.2	118.4	38.8	1.1	0.8	60.9	14.0	1.3	7.7	38.1	8.1	31.9	18.3	8.4	38.0	13.2	22.6	9.2	23.0	63.5	4.5	58.0	46.5	27.5	0.2	0.6	14.0	21.4	18.4	111.8	78.9	0.0	0.5	14.1	7.4	7.5	2.6	8.6	11.5	3.9	3.1	1.1	13.1	15.4	0.0	67.0	54.8	18.4	12.1	11.4	8.7	0.0	25.3	162.1	41.2	0.1	32.7	9.3	3.0	0.0	2.9	2.3	2.9	2.9	0.0	0.8	34.5	2.4	15.3	34.5	157.6	0.0	0.1	117.7	0.8	0.0	0.2	0.5	1.4	0.0	8.1	0.0	27.6	29.4	0.0	0.0	19.0	1.0	1.1	11.7	0.2	229.8	64.5	15.3	75.9	76.9	0.1	0.1	0.1	2.1	0.0	68.9	0.2	7.4	14.1	0.8	0.8	2.6	0.0	0.4	0.5	0.5	0.0	0.1	0.1	1.4	7.5	0.1	0.3	0.0	8.6	0.9	3.4	0.7	1.0	1.0	1.0	1.1	0.8	8.1	0.2
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254044	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 84.6;urinary bladder: 67.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 81.9;ASC TERT1: 56.2;BJ hTERT+ SV40 Large T+ RasG12V: 27.2;HSkMC: 30.3;hTEC/SVTERT24-B: 29.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"		22000000	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: "	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	43.5	4.0	4.3	10.1	7.8	0.4	84.6	1.1	9.0	24.3	17.0	6.3	3.3	1.9	26.1	16.1	9.8	14.8	43.0	21.9	5.5	3.6	4.6	5.9	8.4	3.8	8.1	1.4	26.2	5.9	1.5	4.4	2.0	14.8	10.5	3.4	0.7	3.9	2.8	14.6	22.7	3.8	22.0	16.0	2.8	2.6	12.5	5.2	0.0	13.2	10.6	4.8	67.4	29.4	0.4	0.7	0.2	0.8	0.1	0.3	0.0	0.0	0.0	0.5	0.3	81.9	56.2	0.0	15.6	21.4	21.6	27.2	0.1	0.0	0.0	0.0	18.6	0.0	0.6	0.8	12.4	0.0	0.0	0.0	0.0	0.0	22.9	0.0	0.0	30.3	0.0	29.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.8	3.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	9.9	0.1	22.0	1.8	0.0	0.3	0.0	6.1	0.1	0.5	0.0	0.8	0.2	0.2	0.5	0.0	0.4	0.1	0.0	0.2	0.3	0.1	0.3	0.0	0.1	0.5	0.7	0.2	0.0	4.3	7.8	1.1	3.1	5.5	3.6	8.1	1.4	14.8	5.2
THBS3		ENSG00000169231	"Thrombospondin 3"	P49746	1	155195588-155209051	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006293, HPA073242"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"		4100000	Vesicles		"HPA006293: AB_10602898, HPA073242: "	"unprognostic (2.57e-1)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (2.43e-4)"	"prognostic unfavourable (1.44e-4)"	"unprognostic (2.63e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-2)"	"unprognostic (4.23e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.38e-12)"	"unprognostic (2.06e-2)"	"unprognostic (9.41e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.26e-1)"	10.5	5.5	6.2	12.2	19.5	5.4	15.4	4.7	10.0	20.7	12.6	8.5	8.2	3.4	34.4	24.7	15.1	13.8	19.2	14.4	5.8	3.3	10.1	8.1	8.5	3.2	9.5	6.1	17.5	11.4	12.8	9.5	8.6	7.0	11.4	7.5	8.1	7.5	11.4	5.7	12.9	8.0	24.5	6.1	6.4	8.1	8.3	4.2	1.1	14.3	23.5	7.4	14.4	11.4	1.7	3.5	2.2	4.1	0.9	4.3	2.0	1.7	4.1	15.5	15.7	8.5	9.9	0.9	7.1	10.6	3.3	6.1	0.5	12.9	1.1	8.1	15.7	4.2	0.4	2.6	2.5	2.8	1.0	1.0	4.6	0.6	9.1	0.8	2.1	17.0	9.4	4.9	6.7	6.0	0.8	2.5	3.0	6.2	0.6	1.6	3.5	2.1	13.7	0.6	2.7	6.9	4.4	23.0	13.1	1.8	3.5	3.6	10.4	2.1	4.5	11.1	2.6	2.0	2.4	6.1	0.7	0.3	10.1	0.9	0.9	0.0	4.1	1.6	1.8	2.2	1.1	1.7	2.7	2.2	3.5	0.9	3.0	1.0	2.2	0.9	0.7	0.5	4.3	2.0	6.2	19.5	4.7	10.0	5.8	3.3	9.5	6.1	7.0	4.2
THBS4		ENSG00000113296	"Thrombospondin 4"	P35443	5	79991311-80083287	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Tissue remodeling, Unfolded protein response"	"Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 69.8;heart muscle: 59.0;skeletal muscle: 61.7;smooth muscle: 94.0"	"Cell line enhanced"	"Detected in some"		"AF22: 5.0;THP-1: 10.7;U-2 OS: 4.6;U-266/70: 4.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	51	"eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"CAB004597, HPA042426"	Approved		Approved	Vesicles	"Secreted to extracellular matrix"		420000000	Vesicles		"CAB004597: AB_628352, HPA042426: "	"unprognostic (1.41e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.64e-2)"	"unprognostic (9.94e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.64e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.96e-3)"	"unprognostic (2.74e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.76e-3)"	"prognostic unfavourable (3.33e-4)"	69.8	1.0	7.6	2.1	8.3	3.7	9.7	0.8	4.6	1.1	21.4	2.6	1.2	1.3	12.2	13.6	6.5	1.4	4.1	59.0	6.4	6.4	0.8	0.6	1.0	0.9	8.5	1.9	2.1	23.0	5.5	7.8	0.6	10.7	3.7	3.7	4.9	19.8	2.6	61.7	1.5	1.4	94.0	11.5	0.6	4.0	5.5	2.6	2.0	9.9	39.3	4.1	3.4	2.7	0.1	0.0	8.0	0.0	0.0	0.1	0.0	0.2	0.0	5.0	0.3	0.4	2.2	0.5	0.1	0.2	1.5	0.5	0.1	0.6	0.2	0.2	0.4	0.2	0.2	0.6	1.3	0.2	0.7	0.5	0.0	0.3	2.7	0.0	0.1	1.5	0.3	0.1	0.3	0.0	0.0	0.3	0.3	0.7	0.1	0.0	3.9	0.1	0.0	1.5	0.0	0.3	0.1	4.0	1.2	0.1	0.0	0.4	0.0	10.7	0.0	0.1	4.6	0.3	0.3	4.1	0.1	0.7	1.8	3.4	0.9	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.6	8.3	0.8	4.6	6.4	6.4	8.5	1.9	10.7	2.6
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favourable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favourable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavourable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favourable (9.62e-4)"	11.9	9.1	11.8	12.5	14.5	10.7	7.7	19.0	12.5	10.5	10.7	12.3	10.9	10.4	15.5	8.1	13.4	8.2	7.7	8.5	10.9	9.9	11.6	16.5	7.1	17.6	18.1	7.6	9.9	8.1	11.1	23.3	9.6	11.5	8.4	8.7	8.9	10.4	7.6	12.1	9.1	9.4	10.8	14.2	12.8	9.6	26.3	17.7	16.2	9.2	7.8	17.8	14.6	7.8	11.7	11.0	9.1	9.7	9.7	14.2	6.4	12.8	6.9	16.2	13.5	10.3	7.4	20.0	7.0	7.1	15.3	16.0	14.2	8.3	18.3	6.0	9.8	8.4	20.8	11.7	18.9	5.8	9.0	11.0	9.1	9.6	8.1	25.0	10.2	4.9	7.2	16.3	10.6	16.3	24.9	8.7	13.2	9.6	18.2	14.2	16.0	10.2	25.6	15.5	16.6	8.5	12.6	10.9	8.2	19.7	10.2	11.7	7.0	17.8	8.3	13.7	14.8	10.9	23.2	7.1	12.3	26.7	11.6	17.3	11.7	9.1	6.7	5.7	9.5	9.7	14.2	11.7	11.6	12.0	11.0	9.5	13.6	13.3	0.7	9.7	7.8	6.5	11.4	6.4	11.8	14.5	19.0	12.5	10.9	9.9	18.1	7.6	11.5	17.7
THOC2	"CXorf3, dJ506G2.1, MRX12, MRX35, THO2"	ENSG00000125676	"THO complex 2"	Q8NI27	X	123600561-123733056	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047921	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA047921: AB_10960388"	"unprognostic (2.12e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.08e-1)"	"prognostic unfavourable (5.77e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.24e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.29e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.43e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	25.9	22.7	25.2	23.3	28.2	21.6	26.6	36.0	29.8	30.1	22.5	17.8	24.8	22.5	27.4	39.8	24.7	21.6	19.9	17.7	25.2	19.2	28.0	20.3	24.0	29.4	28.9	21.9	30.1	23.6	28.3	45.4	22.8	24.9	26.3	23.4	17.2	18.9	24.6	20.6	29.0	31.1	27.0	31.7	27.4	20.0	15.2	29.7	45.3	26.2	20.7	26.3	27.0	21.2	13.5	15.2	9.7	12.7	11.7	16.0	8.2	21.1	17.7	22.8	24.5	16.8	16.1	12.2	14.5	14.3	16.0	21.5	12.4	21.8	21.7	16.7	15.8	16.2	27.5	10.8	27.3	20.7	24.9	30.4	24.9	16.8	15.6	35.1	21.8	31.9	13.6	18.3	21.2	14.8	45.4	19.8	16.2	22.3	30.2	34.5	12.6	17.6	30.8	14.2	17.9	25.1	24.0	17.6	15.6	40.6	11.2	13.5	11.2	21.6	15.2	14.5	7.5	20.6	24.3	13.7	20.1	18.7	12.9	31.5	15.8	9.6	9.2	9.7	13.4	12.4	15.6	12.3	14.6	14.4	8.9	13.5	16.0	15.4	5.6	11.7	12.7	15.2	11.1	8.2	25.2	28.2	36.0	29.8	25.2	19.2	28.9	21.9	24.9	29.7
THOP1		ENSG00000172009	"Thimet oligopeptidase 1"	P52888	19	2785460-2815807	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025497, HPA035262"	Uncertain		Supported	Cytosol			1400000	Cytosol		"CAB025497: , HPA035262: "	"unprognostic (1.52e-2)"	"unprognostic (1.73e-3)"	"unprognostic (7.94e-2)"	"prognostic favourable (2.35e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.39e-1)"	"prognostic favourable (5.90e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.37e-2)"	8.2	9.4	19.1	12.3	19.8	18.4	6.2	21.7	26.1	5.2	11.8	14.1	5.8	24.6	7.5	8.4	11.0	8.4	6.7	11.6	18.5	15.4	7.1	30.4	6.2	11.9	14.1	15.2	11.1	7.8	7.0	12.7	22.3	13.1	18.1	8.2	11.9	13.7	6.8	29.1	11.9	20.0	7.1	10.7	9.8	7.8	27.3	10.9	17.0	7.5	11.5	11.3	5.8	6.8	7.5	9.8	8.0	7.5	3.9	9.5	3.2	29.2	21.8	8.5	18.2	4.4	4.3	30.4	18.3	6.8	18.2	14.8	25.6	9.4	26.4	9.0	7.1	23.8	12.6	15.0	7.7	0.1	26.5	9.3	24.0	30.2	4.7	18.0	14.6	4.8	5.4	15.1	6.8	10.3	21.7	12.9	7.7	22.7	20.0	33.8	25.1	30.1	16.7	11.3	25.0	7.6	17.0	23.1	18.5	16.0	14.4	8.9	14.0	17.5	11.7	14.0	12.1	29.8	30.9	22.7	19.0	17.8	15.6	30.3	16.6	8.0	3.5	1.6	5.5	3.9	4.5	5.6	4.0	7.4	4.9	7.5	5.1	4.3	1.7	3.9	7.5	9.8	9.5	3.2	19.1	19.8	21.7	26.1	18.5	15.4	14.1	15.2	13.1	10.9
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224416-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"			22000	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: "	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favourable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	33.9	30.5	19.8	27.2	28.5	26.8	27.0	30.7	33.7	25.5	26.6	28.4	24.8	20.2	30.2	23.6	29.7	25.1	21.5	28.1	19.7	20.2	25.2	37.1	24.6	32.4	21.2	20.1	29.6	24.8	38.6	32.6	35.6	28.5	32.1	24.1	26.3	27.4	23.7	79.1	27.0	29.3	27.6	20.7	32.6	26.5	23.8	22.2	57.4	29.0	28.6	38.8	27.4	26.1	36.2	23.1	49.3	24.0	25.2	29.8	22.2	30.9	20.1	34.7	29.5	27.7	22.5	29.0	33.4	33.8	33.7	34.8	23.5	28.6	57.9	12.6	34.4	28.8	38.6	32.5	42.2	29.8	21.7	48.0	31.0	24.8	30.2	48.6	32.3	34.6	20.5	34.2	29.1	37.0	39.7	30.1	24.1	17.6	52.4	27.0	41.0	15.8	50.1	41.1	30.8	24.2	44.0	22.0	26.2	38.2	24.8	27.7	22.8	20.9	39.0	28.1	32.6	26.1	35.0	18.0	31.7	52.6	26.4	33.3	29.2	36.6	20.1	36.7	29.8	24.0	25.2	32.2	25.3	26.0	22.7	36.2	26.8	23.3	49.3	25.2	23.8	23.1	21.3	22.2	19.8	28.5	30.7	33.7	19.7	20.2	21.2	20.1	28.5	22.2
THY1	CD90	ENSG00000154096	"Thy-1 cell surface antigen"	P04216	11	119417378-119424985	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.7;smooth muscle: 91.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 52.6;BJ: 82.2;BJ hTERT+: 92.1;fHDF/TERT166: 144.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003733, CAB068243, CAB068244"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"			9800000	Nucleoplasm	"Plasma membrane"	"CAB068243: , CAB068244: , HPA003733: AB_1846340"	"unprognostic (9.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (6.87e-4)"	"unprognostic (7.43e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavourable (2.40e-6)"	"unprognostic (1.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.14e-2)"	28.7	5.9	42.0	23.2	72.4	0.4	7.0	17.6	97.7	26.9	9.0	7.2	2.1	3.5	20.3	13.9	9.8	7.5	31.6	4.3	63.4	41.1	46.6	2.6	6.5	10.9	29.8	34.8	3.2	5.0	7.3	5.5	19.1	53.8	4.6	13.6	8.5	2.9	15.7	1.4	4.2	4.6	91.5	9.3	6.7	5.7	4.0	6.9	3.1	12.0	1.0	10.8	36.9	7.2	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.3	12.3	0.0	52.6	38.1	0.0	82.2	92.1	29.5	32.7	0.0	0.0	0.0	0.0	144.0	0.0	0.4	0.1	22.6	7.0	0.0	4.4	1.5	0.0	16.3	0.0	0.0	28.2	0.0	37.4	1.3	0.0	0.0	0.0	22.7	0.0	0.0	0.0	19.7	0.1	0.0	5.8	0.0	0.0	0.0	2.1	5.6	0.0	0.0	0.0	0.1	0.2	0.0	42.4	14.1	12.2	12.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	42.0	72.4	17.6	97.7	63.4	41.1	29.8	34.8	53.8	6.9
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 18.9;HEL: 18.3;HMC-1: 16.0;RT4: 19.0;SCLC-21H: 17.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	11.9	0.7	0.2	2.8	18.9	0.0	0.0	1.4	0.5	0.1	2.1	4.0	0.8	0.3	2.8	1.4	2.4	2.4	0.3	6.5	18.3	0.3	0.1	0.3	0.0	16.0	1.2	0.8	8.1	3.2	0.0	0.0	6.0	6.0	7.7	2.8	0.1	3.8	5.1	3.6	3.7	0.0	1.8	19.0	17.9	4.4	0.8	6.2	0.7	2.5	0.0	0.1	1.7	6.9	0.0	0.8	6.7	5.0	3.6	4.0	1.4	13.1	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1
TIE1	"JTK14, TIE"	ENSG00000066056	"Tyrosine kinase with immunoglobulin like and EGF like domains 1"	P35590	1	43300993-43323108	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Angiogenesis	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"EFO-21: 27.9;HUVEC TERT2: 61.6;TIME: 53.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 3.4;NK-cell: 5.4"	"Group enriched"	"Detected in many"	22	"granulocytes: 3.4;NK-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		75000000				"unprognostic (1.88e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.35e-2)"	39.4	5.4	3.9	6.6	6.0	1.0	43.6	2.5	6.0	10.8	8.4	4.5	4.2	4.5	18.6	10.9	7.8	10.2	11.1	15.1	4.9	4.2	9.4	10.8	22.0	13.1	6.4	3.1	7.0	3.0	2.7	5.1	39.9	5.5	8.6	3.0	6.9	6.0	6.9	17.8	4.2	5.8	12.1	5.3	14.8	5.1	5.1	3.8	1.1	13.9	10.2	3.1	9.0	14.7	0.0	0.2	3.4	0.0	5.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	61.6	0.0	0.0	0.0	0.0	0.0	5.1	0.3	0.0	2.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	3.9	6.0	2.5	6.0	4.9	4.2	6.4	3.1	5.5	3.8
TIMD4		ENSG00000145850	"T cell immunoglobulin and mucin domain containing 4"	Q96H15	5	156919282-156963255	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 32.0;lymphoid tissue: 83.9;testis: 58.9"	"Group enriched"	"Detected in some"	18	"U-266/70: 45.7;U-266/84: 12.4"	"Cancer enriched"	"Detected in some"	10	"renal cancer: 6.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 2.3;memory CD8 T-cell: 4.5;naive CD4 T-cell: 3.0;naive CD8 T-cell: 3.0;T-reg: 6.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 6.4"									"HPA015625, CAB026027"	Approved						18000000			"CAB026027: , HPA015625: AB_1858018"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.90e-2)"	"prognostic favourable (3.37e-4)"	"unprognostic (1.31e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.08e-2)"	6.7	0.4	0.4	3.5	0.4	5.3	0.5	0.4	0.4	0.4	1.3	0.0	0.0	0.0	0.4	1.0	1.5	0.4	0.3	0.8	0.4	0.4	1.7	32.0	0.6	83.9	0.5	0.0	0.4	0.4	0.0	0.4	2.8	0.0	1.1	0.1	0.0	6.5	0.0	0.7	0.4	1.1	0.2	0.5	12.5	0.4	58.9	0.0	21.7	0.8	0.2	8.5	5.3	0.4	0.4	0.0	0.0	0.0	0.0	6.4	1.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	45.7	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	2.3	4.5	0.0	0.0	3.0	3.0	0.0	0.0	0.0	0.0	6.4	1.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.0
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943920	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043052	Supported		Enhanced	Mitochondria				Mitochondria		"HPA043052: AB_10795713"	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	12.8	15.3	11.8	13.0	12.4	7.5	12.7	16.2	17.2	10.8	15.3	8.5	14.1	16.1	12.1	11.8	19.4	10.8	12.6	39.2	12.9	10.3	13.5	19.7	9.0	9.2	11.7	7.7	13.8	20.2	7.4	10.3	8.9	12.3	10.8	6.3	8.5	17.3	21.4	48.8	12.6	10.5	17.7	9.0	12.2	12.2	9.4	11.6	5.8	12.5	26.6	8.8	13.0	9.4	9.0	16.2	10.1	12.2	9.6	12.1	8.4	18.2	10.7	5.7	10.0	10.0	9.3	8.4	11.0	9.0	15.3	13.9	23.6	3.9	26.8	12.8	9.2	12.8	23.5	12.4	3.9	12.5	35.8	13.5	9.1	19.8	24.5	16.1	5.6	10.8	15.9	13.0	16.2	9.7	24.7	9.6	6.6	18.6	14.0	10.6	16.6	45.4	14.8	8.2	12.6	6.7	11.8	13.7	7.1	9.8	13.4	31.3	8.2	15.7	5.1	7.3	11.5	18.5	20.8	18.8	23.7	26.1	5.2	23.5	12.3	10.1	11.7	3.7	12.1	12.2	10.7	8.7	11.1	11.2	16.2	9.0	10.7	10.4	0.6	9.6	7.2	13.2	9.4	8.4	11.8	12.4	16.2	17.2	12.9	10.3	11.7	7.7	12.3	11.6
TIMP1	"CLGI, EPO, TIMP"	ENSG00000102265	"TIMP metallopeptidase inhibitor 1"	P01033	X	47582313-47586789	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor, Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 293.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 161.3;ASC TERT1: 216.0;HSkMC: 148.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB022360, HPA053417"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	116666667	750000000	"Golgi apparatus"		"CAB022360: , HPA053417: "	"unprognostic (5.86e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.07e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.24e-3)"	"unprognostic (9.12e-3)"	"unprognostic (9.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (2.90e-11)"	"unprognostic (1.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.66e-1)"	80.2	82.3	6.3	154.0	12.8	9.2	31.8	3.3	8.4	63.5	29.1	6.5	27.2	6.1	48.9	109.6	34.9	53.5	110.9	105.7	9.2	5.5	71.2	115.9	144.8	293.3	8.4	4.8	149.3	22.2	41.8	48.7	125.5	29.5	62.9	19.0	33.4	45.9	42.0	26.1	11.6	13.2	64.5	14.6	69.3	19.3	71.9	4.6	8.8	98.6	14.6	34.8	121.0	46.8	2.3	56.8	57.1	91.5	9.4	26.4	39.7	9.4	15.8	7.7	91.3	161.3	216.0	1.9	102.5	84.8	32.0	25.9	6.2	17.8	0.1	13.5	131.9	9.4	4.2	43.5	20.7	19.1	10.0	9.7	11.5	9.6	107.4	6.5	124.3	148.0	11.1	97.4	20.7	14.3	15.0	7.2	52.9	18.4	0.1	25.0	8.6	33.2	0.1	15.9	8.4	51.5	6.6	0.1	0.4	60.8	0.4	12.9	0.8	12.6	13.8	47.9	50.5	56.5	10.0	3.0	6.4	0.3	139.3	15.7	31.1	29.5	54.6	0.8	16.2	91.5	16.0	2.3	26.4	14.3	56.8	1.2	8.6	7.7	57.1	9.4	83.6	1.6	10.7	39.7	6.3	12.8	3.3	5.3	9.2	5.5	8.4	4.8	29.5	4.6
TIMP2	CSC-21K	ENSG00000035862	"TIMP metallopeptidase inhibitor 2"	P16035	17	78852977-78925387	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 269.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8;ASC TERT1: 153.5;BJ hTERT+: 87.2;fHDF/TERT166: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 13.3;monocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010203	Approved				"Secreted to extracellular matrix"		83000000			"CAB010203: AB_2204966"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.24e-2)"	"unprognostic (3.05e-1)"	"unprognostic (4.31e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.77e-3)"	75.2	35.1	30.9	17.7	18.9	3.4	45.6	4.6	25.8	95.8	40.5	36.8	28.2	12.9	87.9	41.5	37.4	39.8	72.3	38.5	23.2	29.6	21.1	12.2	38.4	15.4	25.3	23.2	182.4	14.4	15.8	17.2	269.8	34.0	44.6	20.3	49.7	16.9	51.6	24.5	38.4	22.0	70.7	32.6	37.9	24.2	51.7	26.1	28.4	25.3	24.0	11.3	60.2	58.1	0.2	2.1	13.3	5.0	0.2	0.3	0.8	14.8	7.5	8.5	16.2	124.8	153.5	4.6	52.6	87.2	25.8	20.5	2.7	26.0	0.0	18.6	95.6	2.9	2.6	2.2	27.1	0.3	1.5	0.0	15.2	4.2	37.0	0.2	0.1	60.3	1.1	25.4	4.1	34.1	0.0	0.0	26.5	1.7	15.3	2.6	1.5	11.1	10.3	19.5	6.3	16.4	0.2	4.3	26.8	32.9	15.6	67.1	7.9	3.7	40.4	69.2	13.3	40.1	9.0	7.7	6.4	0.1	15.8	2.8	33.3	0.0	5.0	6.8	0.0	3.3	0.0	0.1	0.1	0.0	2.1	0.2	0.3	0.3	13.3	0.2	3.8	1.4	0.1	0.8	30.9	18.9	4.6	25.8	23.2	29.6	25.3	23.2	34.0	26.1
TIMP4		ENSG00000157150	"TIMP metallopeptidase inhibitor 4"	Q99727	3	12153051-12159351	"Plasma proteins, Predicted secreted proteins"		"Metalloenzyme inhibitor, Metalloprotease inhibitor, Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 72.2;breast: 97.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 53.4;ASC TERT1: 13.3;HSkMC: 23.2;NTERA-2: 13.3;U-87 MG: 13.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 66.4"	"Region enriched"	"Detected in all"	5	"cerebellum: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"cerebellum: 118.9"	"Region enriched"	"Detected in all"	6	"cerebellum: 100.1"						"Secreted to extracellular matrix"						"unprognostic (2.99e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.97e-4)"	"unprognostic (9.33e-3)"	"unprognostic (4.26e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.81e-2)"	"unprognostic (4.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.66e-5)"	"unprognostic (2.86e-1)"	72.2	4.3	1.9	2.2	1.6	0.7	97.5	17.8	11.2	2.6	11.7	2.4	0.7	1.1	1.9	0.9	3.2	1.6	2.9	10.9	1.7	1.5	1.9	0.8	2.6	6.0	3.1	1.5	1.2	1.5	1.2	3.2	4.6	3.8	2.9	2.4	2.4	3.1	1.6	7.7	1.7	2.4	2.4	2.9	0.8	2.3	1.8	1.2	0.1	6.1	3.8	0.6	3.7	9.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	5.9	0.2	0.0	53.4	13.3	6.6	0.2	2.1	0.2	0.3	0.1	0.0	0.0	0.5	0.2	0.2	0.0	0.1	0.1	0.2	0.0	0.0	3.4	0.2	8.3	0.0	0.0	23.2	0.5	1.4	0.0	0.0	0.1	4.3	0.0	0.1	0.0	0.0	13.3	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.6	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.6	17.8	1.3	1.7	1.5	3.1	1.5	3.8	1.2
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"			790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: "	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favourable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.2	1.7	4.2	4.7	20.1	19.7	23.2	8.1	5.9	12.9	7.0	6.4	19.4	7.6	8.1	4.5	32.7	6.9	17.0	14.7	27.2	5.0	7.4	4.6	32.8	5.6	3.0	14.0	15.3	12.3	10.1	6.0	27.1	4.4	5.2	6.7	7.4	1.1	0.4	10.4	11.6	3.9	6.1	0.8	33.3	35.5	1.9	3.3	2.9	20.7	0.6	6.7	1.6	38.8	9.7	10.5	7.5	8.2	5.3	1.1	0.1	11.1	4.3	3.5	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1
TK1		ENSG00000167900	"Thymidine kinase 1"	P04183	17	78174075-78187233	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA synthesis"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 32.8;lymphoid tissue: 41.8;tongue: 33.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 21.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			CAB004683	Enhanced									"CAB004683: AB_437067"	"unprognostic (7.09e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.22e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavourable (6.87e-4)"	"prognostic unfavourable (3.03e-5)"	"unprognostic (4.05e-2)"	"unprognostic (3.18e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (6.50e-11)"	"unprognostic (5.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.94e-2)"	5.3	2.0	2.1	21.4	4.5	32.8	4.8	1.1	1.9	3.7	11.4	2.2	1.9	8.5	2.4	4.8	18.9	2.2	7.0	4.3	1.6	0.7	7.9	6.2	9.3	15.7	3.1	1.6	2.1	3.6	0.1	1.3	8.6	2.1	2.3	7.9	0.5	4.6	2.0	2.0	6.2	8.5	4.4	1.7	9.0	9.4	3.6	1.6	41.8	1.3	33.0	20.5	3.1	5.8	4.0	2.1	1.1	1.2	6.2	21.2	3.5	65.1	54.2	10.8	13.6	1.0	4.3	7.1	32.4	17.0	48.2	66.9	47.8	27.5	21.2	11.4	19.4	29.7	9.8	28.9	25.0	7.3	36.2	37.4	19.4	31.3	0.3	15.8	24.2	2.1	0.9	25.1	3.4	19.6	23.0	47.0	18.5	48.7	7.9	8.9	5.6	37.8	21.4	43.8	47.3	12.8	21.2	4.9	14.3	24.8	68.2	9.1	46.0	21.3	9.0	47.4	46.6	33.8	41.6	19.8	10.3	27.3	23.3	10.7	21.3	0.0	0.7	0.0	1.1	1.2	0.5	4.0	5.3	2.7	2.1	1.2	0.3	1.4	1.1	6.2	1.0	0.7	21.2	3.5	2.1	4.5	1.1	1.9	1.6	0.7	3.1	1.6	2.1	1.6
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell line enhanced"	"Detected in all"		"A549: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm			190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavourable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.8	161.2	23.1	25.6	51.5	63.0	47.1	21.6	37.5	37.4	35.8	44.5	82.0	40.1	10.4	31.5	46.2	40.0	81.3	11.1	13.3	22.2	26.7	112.8	66.8	63.0	32.6	18.1	45.5	46.8	44.8	23.1	47.1	19.0	17.5	15.2	38.9	34.0	36.5	78.3	38.9	20.6	10.5	74.5	58.5	54.2	15.0	11.1	40.2	64.4	38.8	20.0	45.2	35.2	11.6	17.9	34.1	41.2	10.1	18.9	24.0	25.3	33.0	21.5	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3
TLDC1	KIAA1609	ENSG00000140950	"TBC/LysM-associated domain containing 1"	Q6P9B6	16	84476421-84554033	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041020	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol				Cytosol	"Nucleoplasm, Nucleoli"	"HPA041020: AB_10794184"	"unprognostic (8.35e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-3)"	"unprognostic (5.97e-4)"	"prognostic unfavourable (1.03e-5)"	"unprognostic (3.94e-1)"	"unprognostic (2.85e-2)"	"prognostic unfavourable (7.05e-5)"	"unprognostic (2.92e-2)"	"unprognostic (6.78e-3)"	"unprognostic (9.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-2)"	5.5	4.9	7.6	7.1	10.7	1.8	7.3	8.1	11.5	8.1	7.1	6.3	5.2	6.0	14.0	8.8	24.4	6.9	6.5	4.7	6.3	4.5	7.6	5.1	6.4	6.1	5.0	9.4	8.7	5.2	11.3	4.4	15.8	10.7	7.8	7.8	12.9	7.7	6.1	4.5	11.0	9.3	10.7	4.0	5.4	6.8	8.1	3.4	8.3	7.6	6.5	10.0	10.4	12.1	3.3	2.7	13.6	3.5	3.1	8.7	2.6	14.4	10.2	9.0	4.8	4.1	7.2	4.2	10.7	9.6	11.0	3.2	5.8	17.5	2.0	5.8	20.6	16.1	2.5	28.7	14.6	1.0	2.1	1.6	5.0	5.0	5.1	1.2	5.0	5.0	12.5	10.3	13.6	4.6	2.6	2.5	7.4	3.4	1.1	1.2	2.7	3.5	4.5	2.3	0.6	9.8	8.1	2.9	2.1	9.7	6.9	4.8	10.0	1.9	11.2	7.8	3.5	4.1	4.4	2.0	3.4	5.3	4.6	0.6	2.6	13.6	3.1	4.4	3.8	2.7	3.7	3.3	6.8	5.5	2.7	2.7	7.6	4.7	3.1	3.1	3.5	0.8	8.7	2.6	7.6	10.7	8.1	11.5	6.3	4.5	5.0	9.4	10.7	3.4
TLK2	"MGC44450, PKU-ALPHA"	ENSG00000146872	"Tousled like kinase 2"	Q86UE8	17	62458658-62615481	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 47.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.53e-3)"	"unprognostic (6.57e-2)"	"prognostic unfavourable (9.40e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.78e-2)"	"unprognostic (5.32e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.88e-1)"	"unprognostic (7.30e-2)"	7.4	6.4	8.3	7.3	7.2	12.0	12.5	7.8	14.0	5.8	7.8	4.0	3.1	7.4	9.0	3.1	9.0	6.2	9.9	17.8	7.7	7.4	5.7	5.0	6.9	8.7	7.7	7.3	8.5	8.9	5.6	6.9	9.0	10.4	6.6	5.3	7.5	8.6	8.7	11.7	8.7	10.1	6.5	8.6	8.9	6.7	47.9	5.7	4.1	11.7	3.1	10.0	8.5	7.2	4.6	3.6	8.6	2.8	6.6	4.9	1.5	15.5	14.3	24.8	26.2	8.1	10.5	14.4	17.2	13.4	20.4	18.7	14.9	14.0	30.5	8.8	11.2	10.6	17.5	7.3	19.5	16.1	13.9	20.7	13.5	15.0	14.5	21.8	13.2	9.0	10.0	13.7	16.6	10.1	20.5	13.9	10.9	33.9	31.1	7.8	15.7	12.0	21.3	32.6	9.7	9.6	15.7	26.7	36.2	14.7	10.0	22.1	17.0	19.6	13.6	28.6	27.2	12.9	19.4	16.1	20.1	28.0	11.8	11.2	14.9	3.7	2.8	8.6	2.5	2.2	2.6	4.5	4.4	3.1	2.5	4.6	3.5	4.6	5.5	6.6	2.4	3.6	4.9	1.5	8.3	7.2	7.8	14.0	7.7	7.4	7.7	7.3	10.4	5.7
TLL1		ENSG00000038295	"Tolloid like 1"	O43897	4	165873258-166103895	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	Differentiation	"Developmental protein, Hydrolase, Metalloprotease, Protease"	"Atrial septal defect, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.6"	"Group enriched"	"Detected in some"	4	"HeLa: 8.5;Karpas-707: 13.3;PC-3: 4.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 40.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	10	"cerebellum: 132.6"	HPA060767			Approved	Vesicles	"Secreted to extracellular matrix"			Vesicles		"HPA060767: "	"unprognostic (2.17e-1)"	"unprognostic (6.45e-4)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-5)"	"unprognostic (9.85e-2)"	"unprognostic (2.51e-4)"	"unprognostic (3.37e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.07e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.13e-3)"	"unprognostic (7.76e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.21e-5)"	10.1	1.3	1.2	2.6	2.8	0.0	7.9	40.6	2.9	5.0	5.4	0.2	4.2	1.4	3.0	2.7	2.5	2.4	5.4	2.4	2.2	1.7	3.3	0.5	3.1	3.0	1.1	0.6	1.6	4.6	1.1	2.2	13.8	8.5	3.1	2.2	3.3	1.9	1.9	1.6	2.7	4.4	3.3	0.9	0.4	1.7	1.5	0.1	0.0	3.2	1.4	1.6	3.6	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	1.4	0.0	13.3	0.0	0.0	0.0	0.2	1.2	4.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.8	40.6	2.9	2.2	1.7	1.1	0.6	8.5	0.1
TLN1	"ILWEQ, TLN"	ENSG00000137076	"Talin 1"	Q9Y490	9	35696948-35732395	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002006, HPA004748"	Supported		Supported	"Plasma membrane,Focal adhesion sites,Centriolar satellite,Cytosol"			3600000000	"Focal adhesion sites, Cytosol"	"Plasma membrane, Centriolar satellite"	"CAB002006: , HPA004748: AB_1857760"	"unprognostic (9.71e-2)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (5.56e-4)"	"unprognostic (1.96e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (7.21e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (7.83e-2)"	"unprognostic (8.83e-3)"	47.4	23.7	10.9	29.3	16.6	25.1	38.1	9.6	11.8	34.7	64.0	18.8	22.8	13.0	57.4	20.6	41.2	38.3	48.4	30.3	11.1	7.1	30.5	36.1	33.0	26.0	17.9	7.3	39.0	12.8	19.6	14.6	30.4	14.4	39.5	15.5	22.8	14.9	43.6	24.5	16.5	27.6	87.0	12.4	54.1	38.2	17.3	14.1	33.4	20.7	12.5	20.7	72.5	49.6	3.3	6.8	12.7	9.2	4.8	7.1	7.1	11.3	19.0	11.8	16.2	40.6	30.9	13.5	31.7	34.9	30.8	27.9	15.7	5.1	13.8	10.5	58.5	6.2	13.8	19.7	22.6	31.1	8.9	31.3	24.7	13.9	25.2	18.9	52.4	37.3	9.4	45.3	21.5	47.2	10.7	14.2	40.6	5.0	12.7	4.9	9.6	14.7	17.1	6.9	8.0	15.4	9.1	2.6	11.3	15.4	8.6	10.1	7.3	13.1	56.9	49.2	19.1	15.0	25.5	4.9	4.8	9.6	38.1	10.2	44.3	6.7	7.0	8.4	7.1	7.8	5.9	3.3	4.2	5.4	5.3	3.2	2.0	4.2	12.7	4.8	9.2	6.8	2.8	7.1	10.9	16.6	9.6	11.8	11.1	7.1	17.9	7.3	14.4	14.1
TLN2	"ILWEQ, KIAA0320"	ENSG00000171914	"Talin 2"	Q9Y4G6	15	62390526-62844631	"Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 36.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 29.4;hTERT-HME1: 23.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017194, HPA051828, HPA054787"	Enhanced		Supported	"Focal adhesion sites,Cytosol"			81000000	"Focal adhesion sites, Cytosol"		"CAB017194: , HPA051828: , HPA054787: "	"prognostic favourable (6.53e-4)"	"unprognostic (2.61e-1)"	"unprognostic (9.47e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.24e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.91e-1)"	"prognostic favourable (1.81e-6)"	"prognostic favourable (7.74e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.30e-1)"	12.5	3.1	7.0	12.1	7.0	2.3	5.3	5.4	18.9	5.6	24.3	4.0	1.7	3.3	6.5	4.2	3.4	3.2	6.3	8.5	6.8	6.0	36.9	1.8	1.9	1.3	6.2	4.2	7.0	3.3	2.3	3.0	2.4	4.5	3.1	5.4	5.5	5.4	1.6	16.9	1.6	16.6	6.9	9.6	0.8	4.1	3.5	1.3	0.9	29.0	4.5	1.3	4.3	7.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.8	2.6	3.9	4.5	29.4	2.8	4.3	6.5	5.1	6.0	6.0	7.1	0.9	2.2	3.0	11.3	1.1	4.9	1.0	5.3	7.0	0.5	0.2	10.7	4.7	1.0	0.7	0.2	5.1	2.7	8.0	23.9	0.2	0.2	0.1	10.0	3.4	0.3	0.3	6.8	1.9	2.7	9.8	2.7	3.1	5.4	0.9	4.5	5.0	0.5	1.7	1.4	1.7	1.8	10.9	14.8	17.5	16.5	0.1	0.4	1.4	4.9	1.6	13.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	7.0	7.0	5.4	12.9	6.8	6.0	6.2	4.2	4.5	1.3
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Inflammatory response, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Centrosome	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved									"HPA017378: "	"prognostic unfavourable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favourable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	73.3	78.3	57.3	33.4	60.1	34.9	54.9	31.5	56.7	57.1	68.5	84.0	73.0	60.2	46.0	86.7	70.5	57.1	57.5	36.7	47.0	46.1	146.2	245.5	62.2	36.1	56.9	38.2	52.8	88.9	54.6	29.3	69.2	55.1	51.6	65.0	55.1	131.6	59.5	41.3	37.0	123.7	38.4	65.4	53.5	68.0	45.2	50.8	52.5	117.0	42.6	55.8	54.7	42.1	47.1	65.7	139.2	80.5	49.1	69.8	158.0	56.3	49.1	40.1	36.6	116.3	64.6	49.9	42.7	81.9	55.7	51.1	78.9	163.0	35.6	73.0	83.4	62.0	34.8	62.7	60.8	51.1	37.4	56.5	37.6	38.5	70.6	64.6	93.7	65.3	147.0	62.2	91.0	46.1	50.9	147.4	63.6	54.9	33.0	39.2	41.6	37.7	28.1	40.1	60.1	84.6	86.1	31.0	20.4	57.3	75.9	48.1	95.3	68.7	43.3	51.4	39.1	34.4	37.1	63.6	64.2	30.4	71.7	30.4	24.9	79.0	80.5	85.6	66.5	80.1	69.8	47.1	60.6	65.9	65.4	41.4	54.0	61.2	139.2	49.1	79.7	65.7	59.1	158.0	57.3	60.1	31.5	56.7	47.0	46.1	56.9	38.2	55.1	50.8
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584531-123598577	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles				Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavourable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	31.3	31.9	15.7	21.8	21.2	23.5	32.0	13.2	21.5	38.5	31.6	20.4	41.1	27.6	33.4	49.0	41.3	27.4	28.9	41.7	15.7	17.1	32.6	120.1	28.1	29.4	18.2	16.7	37.4	135.4	18.1	36.3	40.0	18.9	33.3	32.8	23.8	90.2	38.0	46.3	27.4	34.2	30.5	22.5	25.6	32.4	17.8	15.0	24.0	49.2	23.8	30.0	34.0	27.8	32.4	69.3	58.9	40.9	39.5	61.2	36.2	41.8	37.3	24.8	42.9	56.6	50.2	59.1	72.8	58.8	46.4	36.8	37.2	36.5	35.9	39.1	72.5	41.9	33.5	39.2	48.8	26.9	28.9	38.7	22.7	48.0	107.6	52.7	33.4	42.2	65.5	39.8	54.1	43.3	39.0	24.6	47.3	31.1	27.9	43.3	35.8	33.6	29.1	40.5	41.7	56.6	63.5	30.9	26.8	48.7	49.0	48.2	83.1	42.8	41.0	39.6	25.0	38.2	40.7	54.5	50.5	30.5	46.7	34.9	46.7	58.9	39.8	39.6	46.8	40.9	61.2	32.4	42.4	44.1	44.2	27.2	34.6	40.3	31.5	39.5	37.8	69.3	38.3	36.2	15.7	21.2	13.2	21.5	15.7	17.1	18.2	16.7	18.9	15.0
TMEM115	PL6	ENSG00000126062	"Transmembrane protein 115"	Q12893	3	50354749-50359610	"Plasma proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006319, HPA015497"	Supported		Supported	"Golgi apparatus"				"Golgi apparatus"		"CAB006319: AB_425880, HPA015497: AB_1858076"	"unprognostic (1.62e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (3.73e-5)"	"unprognostic (7.00e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.75e-3)"	"unprognostic (2.65e-2)"	"prognostic favourable (1.04e-7)"	"unprognostic (4.88e-3)"	"unprognostic (3.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.75e-1)"	20.8	23.8	15.1	11.3	15.2	10.1	19.7	19.4	24.3	20.2	23.5	18.7	21.5	23.1	24.5	21.3	20.6	21.3	23.9	19.8	12.5	12.8	22.4	24.1	18.5	15.7	13.6	13.3	24.9	24.0	25.7	14.8	37.3	16.2	22.4	13.0	22.4	26.3	22.5	18.2	28.1	25.5	17.3	10.6	17.6	20.7	18.6	11.8	20.4	42.2	16.9	15.9	19.0	17.3	13.2	17.2	28.4	18.4	17.2	18.3	14.5	11.0	13.5	8.8	14.4	25.2	20.2	11.4	17.1	25.4	21.8	16.8	10.0	13.0	5.4	14.5	22.3	11.8	10.6	13.9	6.2	9.9	18.4	8.1	12.1	13.6	35.5	8.8	11.8	30.3	18.0	18.0	13.1	16.5	8.7	9.3	16.2	10.1	6.0	14.0	15.7	21.4	3.0	7.1	11.8	16.5	10.4	9.9	21.2	10.4	11.6	14.1	9.6	9.4	17.1	19.9	10.1	20.8	17.9	13.9	8.0	3.0	18.2	9.7	13.0	28.4	18.4	25.6	18.3	16.5	12.1	12.6	12.3	14.8	15.3	13.2	13.6	13.0	25.3	17.2	14.8	17.2	15.3	14.5	15.1	15.2	19.4	24.3	12.5	12.8	13.6	13.3	16.2	11.8
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500090	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: "	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favourable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	14.6	25.6	26.6	11.2	32.0	13.9	9.8	24.4	32.7	11.7	16.7	30.3	8.2	15.4	13.0	8.5	14.5	27.4	13.7	21.1	21.7	13.3	14.0	9.6	17.0	10.6	24.0	23.0	17.1	13.9	17.2	18.6	18.6	21.9	12.5	11.5	25.4	11.8	12.5	40.4	16.2	15.2	9.4	15.9	14.3	14.8	16.5	23.4	10.7	18.4	9.6	9.2	13.7	7.1	4.6	6.2	5.5	4.6	4.3	7.1	4.5	7.5	19.7	16.3	25.6	8.2	9.3	23.4	4.5	10.0	7.7	7.9	6.6	11.8	10.6	15.1	7.9	9.9	7.8	12.5	4.3	9.5	11.1	10.8	8.8	9.9	11.1	12.0	23.5	16.1	7.0	7.7	6.7	14.0	11.2	12.4	10.1	8.8	24.8	7.5	6.8	7.7	17.6	19.3	9.8	7.6	19.9	14.5	15.4	5.4	23.5	13.5	14.5	14.3	8.1	7.7	9.8	8.0	6.4	27.0	7.7	5.8	9.1	11.1	10.5	0.2	4.6	5.5	7.1	2.9	5.4	2.0	3.3	4.7	4.6	4.6	2.8	4.4	1.2	4.3	2.7	6.2	4.1	4.5	26.6	32.0	24.4	32.7	21.7	13.3	24.0	23.0	21.9	23.4
TMF1	"ARA160, TMF"	ENSG00000144747	"TATA element modulatory factor 1"	P82094	3	69019827-69052339	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008729	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"		"HPA008729: AB_1080310"	"unprognostic (2.71e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.02e-3)"	"unprognostic (7.19e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.75e-3)"	"unprognostic (6.73e-3)"	"unprognostic (1.79e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-1)"	17.4	14.2	12.8	15.2	14.2	26.2	20.8	20.8	15.6	18.8	21.1	9.5	26.6	14.8	18.3	24.2	14.9	17.7	16.8	16.7	11.9	12.1	17.5	17.2	19.0	16.8	13.5	11.1	20.2	23.0	22.3	36.1	28.9	17.2	19.0	16.9	9.5	24.3	28.9	21.3	13.3	22.9	13.8	13.6	16.3	15.9	20.9	16.0	20.3	24.7	11.1	16.4	23.2	18.6	6.6	4.6	10.0	5.9	5.0	6.4	3.1	12.5	5.5	5.3	5.3	14.3	18.5	11.9	16.3	15.8	11.0	13.3	7.8	9.4	4.8	2.6	16.5	7.0	6.8	7.2	18.1	9.2	5.2	9.4	7.3	9.2	13.0	10.5	13.4	10.8	11.6	14.5	13.2	11.7	5.6	7.9	14.2	7.2	6.0	9.1	4.6	2.9	5.0	6.7	6.9	14.2	10.2	3.7	5.6	13.4	9.5	10.1	7.2	12.7	15.2	10.8	4.6	18.9	9.7	8.9	8.5	4.7	16.5	10.9	8.5	7.6	4.5	9.1	6.4	3.7	4.3	5.2	5.7	5.4	4.0	6.6	5.9	5.4	10.0	5.0	5.9	4.6	5.8	3.1	12.8	14.2	20.8	15.6	11.9	12.1	13.5	11.1	17.2	16.0
TMOD3	UTMOD	ENSG00000138594	"Tropomodulin 3"	Q9NYL9	15	51829628-51947295	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001849	Approved		Approved	"Actin filaments,Cytosol"			21000000	Cytosol	"Actin filaments"	"HPA001849: AB_1080313"	"unprognostic (6.31e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (2.39e-1)"	"unprognostic (7.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (3.38e-5)"	"unprognostic (7.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.58e-3)"	23.0	9.6	7.3	14.2	9.7	7.7	14.1	7.5	7.7	16.4	16.0	4.6	32.4	13.3	13.4	11.8	53.1	12.0	12.0	10.5	7.7	6.3	16.6	14.6	25.4	10.3	8.1	4.2	12.7	9.3	8.0	9.2	20.2	8.5	11.0	13.9	6.9	20.8	21.4	5.9	15.4	21.7	11.1	8.7	20.5	14.4	6.6	8.0	19.6	11.4	21.9	22.7	16.5	27.2	14.4	17.6	28.3	21.9	10.7	15.1	9.4	23.1	23.3	9.4	2.4	9.3	15.7	10.7	10.8	14.8	11.3	10.2	9.0	17.6	5.6	8.8	11.5	34.1	8.6	24.3	14.5	9.4	3.8	8.4	25.7	7.2	10.4	10.7	9.2	10.5	23.7	9.1	28.3	19.9	8.8	8.7	13.6	17.2	7.1	7.2	5.2	3.8	8.5	11.1	14.6	18.4	16.0	2.3	6.1	18.0	12.1	6.4	8.2	8.6	21.7	14.5	9.6	11.7	12.5	5.2	15.2	6.3	9.3	19.6	8.5	22.7	17.7	24.0	14.8	20.9	13.1	12.0	12.8	12.9	12.4	14.4	11.1	10.3	28.3	10.7	21.9	17.6	15.1	9.4	7.3	9.7	7.5	7.7	7.7	6.3	8.1	4.2	8.5	8.0
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515512-98550379	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 130.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235"	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavourable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	10.8	9.5	8.1	25.0	9.5	36.8	12.7	19.1	11.0	16.9	22.9	10.7	8.7	15.9	18.4	17.1	23.0	15.4	10.3	9.6	8.5	8.3	15.8	20.5	13.8	34.0	9.0	11.2	34.7	21.6	9.9	9.9	13.6	7.6	15.6	17.6	12.5	14.0	9.7	9.4	11.7	22.6	10.7	9.4	29.1	16.8	11.4	10.3	130.9	13.2	12.2	35.4	13.0	17.9	14.1	10.9	18.1	33.1	9.7	15.6	13.3	30.3	20.0	49.4	25.1	4.1	5.5	29.3	25.0	13.2	33.9	24.6	21.8	15.2	53.0	15.4	14.5	19.5	41.4	18.8	31.1	37.0	25.7	45.4	18.3	14.4	3.7	52.4	30.3	3.1	6.2	20.0	10.8	19.3	38.2	20.6	21.0	19.1	85.4	41.3	29.7	18.8	71.7	32.8	36.7	12.0	28.4	39.1	23.4	42.7	26.9	13.4	30.3	25.2	10.3	19.7	17.2	13.4	25.5	22.4	38.2	59.3	5.6	30.4	26.1	18.1	14.4	6.1	9.5	25.0	10.2	10.9	11.1	10.8	10.9	14.1	15.6	11.7	1.1	9.7	33.1	6.1	13.3	13.3	8.1	9.5	19.1	11.0	8.5	8.3	9.0	11.2	7.6	10.3
TMPRSS13	"MSPL, TMPRSS11"	ENSG00000137747	"Transmembrane serine protease 13"	Q9BYE2	11	117900643-117929459	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 22.1;salivary gland: 16.6;skin 1: 26.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.3;BEWO: 17.5;MCF7: 14.7;SK-BR-3: 25.3;T-47d: 25.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.08e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.16e-6)"	"unprognostic (2.05e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.44e-1)"	0.2	0.3	0.2	0.6	0.2	0.3	6.2	0.2	0.2	5.8	0.2	0.2	0.2	0.2	0.9	0.7	14.8	0.1	0.2	0.2	0.4	0.0	0.7	0.2	4.0	0.7	0.2	0.2	0.3	5.7	0.0	0.5	22.1	0.2	0.9	0.2	0.6	16.6	0.2	0.2	26.0	0.5	0.2	0.2	1.0	0.1	0.3	0.2	0.4	9.5	13.7	10.6	0.3	5.6	1.0	2.6	1.0	0.7	1.9	1.2	0.8	7.3	0.0	0.0	0.0	0.0	0.0	17.5	0.0	0.0	0.0	0.0	5.6	0.1	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.4	0.0	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.0	0.2	0.0	0.0	25.3	0.3	25.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.0	0.6	0.0	0.9	0.7	0.0	1.0	0.1	1.2	1.8	0.5	0.4	0.1	0.0	1.9	0.5	2.6	0.7	0.8	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2
TMPRSS4	"MT-SP2, TMPRSS3"	ENSG00000137648	"Transmembrane serine protease 4"	Q9NRS4	11	118077012-118121890	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 60.9;gallbladder: 45.4;lymphoid tissue: 41.0;urinary bladder: 43.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 44.9;HaCaT: 19.2;RPTEC TERT1: 31.5;RT4: 39.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 4.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA006238	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA006238: AB_1080316"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (5.50e-2)"	"unprognostic (8.17e-3)"	"unprognostic (1.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.62e-2)"	"prognostic unfavourable (3.14e-4)"	"unprognostic (2.87e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-2)"	"unprognostic (9.96e-3)"	0.3	0.3	0.2	14.2	0.3	0.0	0.3	0.3	0.2	11.4	23.5	0.1	0.0	16.1	3.1	2.8	60.9	0.6	45.4	0.3	0.3	0.3	17.7	0.3	3.2	0.0	0.2	0.0	0.3	0.4	0.0	0.3	0.8	0.1	9.9	26.2	0.2	4.0	0.0	0.3	2.4	27.4	4.2	0.2	0.3	13.7	0.7	0.0	0.6	0.3	13.7	41.0	43.9	22.3	0.5	0.1	4.5	0.7	0.2	0.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	44.9	0.0	1.7	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	31.5	39.3	0.0	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.5	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.1	0.9	0.2	0.7	0.1	0.1	0.0	0.2	0.3	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.0
TMPRSS6	FLJ30744	ENSG00000187045	"Transmembrane serine protease 6"	Q8IU80	22	37065436-37109563	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 59.3"	"Group enriched"	"Detected in some"	4	"Hep G2: 7.5;SCLC-21H: 12.9"	"Group enriched"	"Detected in many"	14	"liver cancer: 51.3;thyroid cancer: 14.1"	"Region enriched"	"Detected in single"	10	"basal ganglia: 1.8"	"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	5	"basal ganglia: 2.2"												"unprognostic (3.93e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.29e-5)"	"unprognostic (7.95e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (8.16e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.15e-7)"	"unprognostic (2.38e-1)"	"unprognostic (9.15e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.86e-5)"	0.1	0.0	0.1	0.1	1.8	0.0	0.8	0.1	0.1	0.1	0.3	0.1	0.1	1.1	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.1	59.3	1.9	0.1	0.1	0.1	0.5	0.9	0.0	5.3	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	1.1	0.6	0.1	0.1	0.1	2.3	2.6	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.0	0.1	0.0	1.3	0.0	0.2	0.8	0.2	0.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.8	2.3	0.3	0.1	7.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.3	0.0	0.0	0.3	0.1	0.4	0.2	0.3	0.0	0.0	12.9	0.4	0.2	1.0	0.0	0.1	0.0	0.6	0.5	1.6	0.1	0.0	1.5	0.4	0.1	0.4	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.5	0.2	1.3	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TMSB10	TB10	ENSG00000034510	"Thymosin beta 10"	P63313	2	84905625-84906675	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 764.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"										4500000				"unprognostic (3.60e-1)"	"unprognostic (4.52e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.19e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.17e-3)"	"unprognostic (3.26e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.20e-3)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (8.49e-7)"	"unprognostic (1.28e-1)"	"unprognostic (2.83e-1)"	"prognostic favourable (4.97e-5)"	"unprognostic (3.16e-2)"	159.1	50.6	179.7	148.7	112.1	122.4	142.6	20.5	128.4	129.3	199.6	30.9	44.9	71.1	86.5	244.1	128.4	62.6	120.8	78.5	110.3	87.6	115.8	49.1	166.0	197.1	78.4	135.1	203.5	76.5	8.8	45.6	129.1	66.1	67.0	183.0	53.2	97.0	44.0	68.3	68.2	131.5	114.6	68.3	170.4	79.5	104.5	51.1	154.3	69.9	101.7	163.8	111.4	116.9	320.3	387.6	206.4	346.8	142.7	452.9	764.0	110.1	127.9	119.0	66.4	156.2	322.6	62.3	166.6	231.6	185.0	222.9	101.5	171.0	56.1	122.2	335.4	42.5	33.5	384.0	199.2	191.4	31.9	25.5	87.7	83.7	98.1	24.0	24.0	281.5	191.0	226.6	122.1	280.1	9.4	96.6	305.1	85.4	84.6	100.3	42.1	132.0	64.4	183.8	45.8	275.8	20.8	63.4	58.0	112.0	97.6	138.3	29.3	42.7	272.5	150.3	107.5	137.1	168.9	19.4	31.0	50.6	252.0	103.0	118.3	169.1	346.8	206.4	191.8	299.9	118.1	294.6	291.0	201.6	387.6	320.3	304.3	256.5	50.2	142.7	252.7	231.6	452.9	764.0	179.7	112.1	20.5	128.4	110.3	87.6	78.4	135.1	66.1	51.1
TMSB4X	"TB4X, TMSB4"	ENSG00000205542	"Thymosin beta 4, X-linked"	P62328	X	12975108-12977227	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 1074.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB033806	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			400000000	"Nucleoplasm, Vesicles, Cytosol"		"CAB033806: AB_2256019"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.71e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (6.20e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.98e-1)"	122.3	97.5	79.8	105.4	76.4	169.0	87.1	33.2	74.8	92.3	93.3	62.0	59.7	38.5	83.7	67.2	62.7	53.0	92.5	54.9	90.8	67.8	69.6	50.8	134.4	205.2	111.4	84.0	61.9	51.0	4.4	23.4	53.4	74.3	46.6	86.6	31.2	42.3	100.4	28.9	39.6	71.5	75.1	195.6	205.7	98.9	26.4	63.8	96.8	34.4	48.6	154.5	112.2	62.1	296.5	495.3	775.0	554.0	272.7	521.9	1074.5	141.5	118.6	233.1	367.2	285.8	313.3	0.5	75.1	196.5	58.3	100.5	24.4	119.2	33.9	72.6	227.8	62.4	34.5	50.3	78.5	198.2	1.9	42.2	70.3	0.3	66.6	164.9	350.9	145.8	72.2	69.0	60.4	350.3	5.3	0.5	206.3	50.4	196.0	357.9	83.8	81.8	151.1	82.5	138.5	347.1	41.5	24.8	10.5	108.8	5.1	13.8	136.7	167.5	281.7	85.2	42.2	482.6	74.5	110.6	80.3	65.8	130.3	68.4	61.3	544.9	512.5	775.0	364.8	524.7	309.6	296.5	407.3	391.0	495.3	275.6	345.8	349.0	576.0	272.7	554.0	204.1	521.9	1074.5	79.8	76.4	33.2	74.8	90.8	67.8	111.4	84.0	74.3	63.8
TNC	"DFNA56, HXB, MGC167029, TN"	ENSG00000041982	"Tenascin C"	P24821	9	115019578-115118257	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 111.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 83.7;hTEC/SVTERT24-B: 68.4;U-138 MG: 57.6;U-87 MG: 76.7;WM-115: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB004592, HPA004823"	Approved				"Secreted to extracellular matrix"		760000000			"CAB004592: AB_628342, HPA004823: AB_1080243"	"unprognostic (5.46e-2)"	"unprognostic (3.76e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.97e-3)"	20.6	2.5	1.4	50.9	11.4	0.5	12.6	0.4	6.4	19.4	63.6	18.6	24.1	5.3	42.4	23.9	18.5	12.0	16.9	13.6	3.4	2.8	16.4	2.6	21.0	66.3	4.3	3.3	10.6	1.8	0.6	3.3	3.2	14.7	13.0	9.3	0.0	8.5	10.8	10.8	10.3	21.2	111.4	5.7	26.9	31.3	5.4	6.8	4.7	5.5	15.4	16.1	20.4	6.6	0.3	0.3	1.9	0.3	0.2	0.3	0.1	2.5	0.6	0.7	0.1	4.1	1.1	0.0	21.5	83.7	45.6	22.5	0.5	5.8	0.0	3.4	30.4	9.0	0.0	1.2	27.4	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.4	0.6	0.1	68.4	31.9	0.0	0.0	0.5	1.2	0.0	0.0	0.0	7.1	9.2	0.0	48.4	0.0	41.5	0.0	0.0	0.6	9.0	0.0	2.1	0.0	0.1	0.0	57.6	9.5	9.9	50.5	1.5	0.0	0.0	76.7	0.0	131.3	0.1	0.3	0.1	0.3	0.1	0.1	0.2	0.2	0.1	0.3	0.3	0.1	0.2	1.9	0.2	0.0	0.2	0.0	0.1	1.4	11.4	0.4	3.9	3.4	2.8	4.3	3.3	14.7	6.8
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575567-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.6;lymphoid tissue: 28.0"	"Group enriched"	"Detected in some"	5	"HDLM-2: 10.0;HMC-1: 9.6;NB-4: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 10.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.5;monocytes: 10.8;T-cells: 6.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	10140					"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	2.3	1.2	0.6	15.6	1.0	14.6	1.2	0.4	1.8	1.7	1.3	3.7	0.3	1.3	1.1	0.4	1.5	0.9	2.3	2.0	0.5	0.3	2.6	1.9	9.5	8.0	0.8	0.0	0.6	0.7	0.5	0.5	3.2	2.0	0.7	0.7	0.4	2.2	0.8	0.4	2.7	4.1	0.7	1.0	28.0	1.0	0.4	0.5	2.1	0.6	5.3	14.7	1.2	0.4	1.3	1.2	3.5	10.8	0.5	6.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.8	0.0	0.0	0.0	0.8	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	1.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.7	0.0	4.1	6.5	6.6	1.3	3.1	2.4	1.2	1.3	0.9	1.0	3.5	0.5	10.8	0.7	2.2	2.1	0.6	1.0	0.4	1.8	0.5	0.3	0.8	0.0	2.0	0.5
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"RT4: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: "	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (4.10e-4)"	"prognostic favourable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favourable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.4	26.9	0.1	0.1	1.7	7.7	9.0	1.6	6.9	4.3	1.5	0.2	24.4	0.0	20.1	7.8	17.4	1.9	0.0	2.1	0.9	0.1	2.4	18.8	0.1	3.3	1.2	3.4	2.9	0.2	1.4	0.0	2.2	2.4	5.9	0.6	0.5	0.0	1.9	1.6	2.2	1.0	3.1	3.9	13.8	126.5	0.2	0.3	24.7	8.6	0.3	13.9	8.0	4.6	0.9	2.3	5.0	5.0	5.3	0.3	0.1	6.5	5.5	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867188-137883312	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 48.4;REH: 42.0;U-266/84: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA002116, HPA067479"	Approved		Supported	Vesicles				Vesicles		"HPA002116: AB_1858162, HPA067479: "	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	27.4	6.0	1.5	58.6	1.8	112.4	17.2	0.4	1.5	7.7	15.7	3.2	2.6	5.1	9.7	7.3	12.7	12.1	17.0	11.7	2.1	1.3	6.8	8.1	45.1	38.8	2.1	2.6	37.5	7.2	2.1	3.7	14.5	4.6	13.8	6.3	7.2	8.2	3.5	10.7	20.5	17.2	8.2	3.8	25.9	8.0	9.3	2.1	38.6	5.7	9.2	31.4	23.3	9.5	7.1	18.6	10.0	9.7	7.5	20.5	9.0	8.9	1.5	0.5	0.8	3.0	5.1	2.1	5.1	20.0	1.4	1.8	9.9	3.0	2.0	13.2	5.9	6.8	0.3	14.8	2.6	14.6	0.5	2.0	5.2	5.8	3.3	2.7	3.7	4.7	2.1	16.9	16.1	0.8	4.1	48.4	2.4	0.5	14.7	11.5	0.3	0.4	42.0	10.4	1.4	4.4	4.3	0.2	0.0	1.0	1.5	4.4	1.0	3.4	4.0	14.5	1.7	12.9	2.9	15.6	36.1	4.1	5.3	3.5	1.8	5.6	9.7	5.5	14.8	7.1	20.5	6.2	15.1	13.3	10.3	7.1	10.0	7.4	10.0	7.5	3.7	18.6	14.7	9.0	1.5	1.8	0.4	1.5	2.1	1.3	2.1	2.6	4.6	2.1
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380048	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.4;HHSteC: 18.9;hTEC/SVTERT24-B: 25.1;SH-SY5Y: 9.9;U-2197: 20.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Approved				"Secreted to blood"		15000			"CAB032719: AB_2204650, HPA050884: "	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (9.16e-5)"	14.0	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2.0	4.0	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1.0	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0.0	0.0	50.9	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	7.3	0.0	1.1	30.4	1.1	5.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	18.9	0.0	0.0	9.1	0.0	25.1	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	7.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	1.0	2.1	20.2	0.3	0.0	0.0	0.0	2.2	0.3	1.5	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.5	0.0	0.0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8
TNFRSF10B	"CD262, DR5, KILLER, TRAIL-R2, TRAILR2, TRICK2A, TRICKB"	ENSG00000120889	"TNF receptor superfamily member 10b"	O14763	8	23020133-23069179	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA023625	Approved									"HPA023625: AB_1847860"	"unprognostic (8.43e-3)"	"unprognostic (7.43e-3)"	"unprognostic (3.04e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.51e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.96e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (4.01e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.52e-2)"	29.6	18.5	5.2	16.4	7.3	7.6	19.6	2.3	5.8	11.5	23.1	7.5	13.3	14.1	10.4	13.9	12.1	11.4	22.1	13.2	6.4	3.2	14.3	36.1	21.3	11.6	7.9	2.6	16.2	20.0	14.8	6.1	8.5	8.2	15.1	14.3	7.9	11.5	14.5	15.5	6.1	31.2	10.5	8.6	17.4	11.2	7.8	6.4	4.1	17.7	13.0	15.2	17.9	9.9	3.1	12.1	2.8	12.9	0.8	4.0	5.2	8.5	22.7	33.3	10.1	15.6	20.4	32.6	20.6	26.5	11.2	17.5	9.4	8.6	5.1	14.0	11.2	8.3	8.7	39.0	20.0	5.1	7.3	0.0	8.9	17.6	52.3	1.9	8.6	30.3	35.0	24.9	26.6	35.5	3.6	0.0	22.0	2.8	0.2	2.8	8.3	8.2	4.6	12.1	3.2	21.7	13.5	0.0	5.6	10.3	2.9	10.9	5.0	2.4	31.4	16.4	8.5	5.2	14.8	6.6	1.1	2.4	16.7	3.7	23.4	2.8	12.9	0.4	1.6	9.3	2.7	3.1	1.9	1.6	12.1	1.6	4.0	1.6	2.6	0.8	11.9	0.0	1.3	5.2	5.2	7.3	2.3	5.8	6.4	3.2	7.9	2.6	8.2	6.4
TNFRSF11B	"OCIF, OPG, TR1"	ENSG00000164761	"TNF receptor superfamily member 11b"	O00300	8	118923557-118952200	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 18.6;thyroid gland: 52.8"	"Group enriched"	"Detected in some"	4	"BJ: 49.7;BJ hTERT+: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	66	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in single"	66	"dendritic cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034939	Approved				"Secreted in other tissues"					"CAB034939: "	"unprognostic (1.39e-2)"	"prognostic unfavourable (6.22e-4)"	"unprognostic (5.27e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.21e-3)"	"unprognostic (5.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.43e-1)"	"prognostic favourable (6.79e-4)"	"unprognostic (1.32e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavourable (3.88e-4)"	3.0	3.0	2.2	2.8	2.8	0.2	4.4	2.9	5.2	1.2	1.5	0.7	0.5	0.9	5.5	4.1	1.0	1.7	3.2	7.3	2.8	1.4	18.6	7.6	8.1	5.3	1.7	0.8	0.5	2.8	0.3	1.9	4.0	12.0	1.1	2.0	1.8	1.4	0.8	0.6	0.7	1.4	1.5	7.9	1.5	0.8	0.3	2.7	0.9	52.8	0.8	1.7	1.7	1.1	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.6	0.5	0.0	49.7	184.9	2.4	0.6	0.5	0.1	0.0	13.4	27.5	0.5	0.0	0.0	1.2	0.0	0.0	0.0	2.3	0.0	0.3	0.0	0.0	0.2	0.0	2.4	0.0	0.0	0.0	0.0	6.9	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.5	0.8	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	2.2	2.8	2.9	5.2	2.8	1.4	1.7	0.8	12.0	2.7
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 60.5;skin 1: 47.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 16.1;BJ hTERT+: 26.3;fHDF/TERT166: 20.0;Hep G2: 27.3;SK-MEL-30: 45.6;WM-115: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"naive B-cell: 1.9;T-reg: 4.0"	"Group enriched"	"Detected in many"	4	"B-cells: 1.9;T-cells: 4.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favourable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favourable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.3	1.3	1.0	0.4	1.4	0.6	4.6	0.8	2.0	3.4	1.5	3.0	17.1	0.7	5.3	7.3	5.1	14.3	2.3	14.7	1.5	1.5	7.1	0.5	7.9	0.6	3.0	1.3	3.4	2.2	0.1	8.0	3.8	2.8	12.7	0.8	11.4	60.5	13.0	1.2	47.9	0.9	4.1	1.9	2.5	2.4	2.7	1.1	0.8	5.7	8.0	3.7	2.7	4.0	1.9	0.7	0.7	0.0	0.6	4.0	0.2	0.0	1.0	1.1	0.0	1.6	16.1	1.1	1.2	26.3	0.6	0.9	7.6	0.0	0.0	0.0	20.0	0.0	1.0	0.9	1.2	0.0	0.9	0.2	0.8	27.3	0.7	0.0	0.3	7.7	0.2	7.6	0.1	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.7	1.6	0.0	4.5	0.0	2.7	0.1	10.5	1.8	0.0	0.0	45.6	0.0	0.1	0.0	3.8	0.2	0.0	1.1	0.0	0.0	0.0	1.5	0.0	28.4	0.0	0.0	0.7	0.0	0.0	0.4	0.7	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.0	0.7	4.0	0.2	1.0	1.4	0.8	2.0	1.5	1.5	3.0	1.3	2.8	1.1
TNFRSF1A	"CD120a, TNF-R, TNF-R-I, TNF-R55, TNFAR, TNFR1, TNFR60"	ENSG00000067182	"TNF receptor superfamily member 1A"	P19438	12	6328757-6342114	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Apoptosis, Host-virus interaction"	Receptor	"Amyloidosis, Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 86.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004102, CAB010309"	Approved				"Secreted to blood"		170000			"CAB010309: AB_2206639, HPA004102: AB_1846232"	"unprognostic (2.19e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.14e-2)"	"prognostic favourable (8.22e-4)"	"unprognostic (3.07e-2)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.00e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavourable (2.70e-7)"	"unprognostic (1.43e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.74e-1)"	55.1	43.9	16.8	28.9	16.8	13.7	40.6	7.2	15.6	40.3	41.5	14.1	22.6	39.2	38.2	27.5	39.4	34.2	37.1	26.8	14.0	7.5	49.3	61.6	40.9	37.2	19.2	6.4	59.5	21.4	20.3	19.9	45.3	18.3	37.0	23.0	31.1	25.7	22.2	34.2	30.9	81.7	38.8	25.1	43.6	28.2	21.8	15.7	31.6	42.7	25.4	22.3	49.1	58.5	0.0	20.8	86.5	27.1	1.8	11.6	15.9	7.4	57.8	8.1	11.5	56.0	57.3	15.3	15.9	27.5	21.3	18.6	6.9	29.7	0.6	5.5	34.3	20.8	2.5	18.6	14.8	0.1	4.8	4.1	16.0	15.3	49.7	19.3	13.0	59.0	18.7	17.7	26.1	26.0	6.2	5.7	24.5	10.6	6.1	18.2	19.7	16.9	5.3	12.9	5.7	16.5	13.5	0.0	0.4	22.5	11.8	11.8	3.2	21.1	28.3	16.8	14.4	12.6	14.7	0.0	1.8	2.4	20.1	18.0	20.8	2.2	27.1	15.0	11.6	21.8	11.1	0.0	4.9	9.5	20.8	0.0	4.5	6.6	86.5	1.8	17.5	6.0	4.8	15.9	16.8	16.8	7.2	15.6	14.0	7.5	19.2	6.4	18.3	15.7
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.1;K-562: 20.9;THP-1: 24.5;U-87 MG: 16.8;U-937: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	3226667	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.0	0.0	5.5	7.5	4.3	0.5	1.0	2.0	2.2	0.8	17.1	0.1	0.3	1.8	0.0	0.4	0.0	1.1	6.8	0.0	0.0	0.1	0.0	12.9	0.1	1.8	7.4	0.0	6.8	0.0	10.4	20.9	3.1	0.9	0.0	0.0	3.9	0.1	0.6	0.5	0.2	12.0	0.0	0.4	0.0	0.0	0.3	0.1	0.6	0.0	24.5	3.6	3.0	0.1	13.0	0.0	0.9	0.0	0.0	16.8	17.7	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.4"	"Cell line enhanced"	"Detected in many"		"RT4: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	35	"plasmacytoid DC: 31.6"	"Lineage enriched"	"Detected in single"	309	"dendritic cells: 31.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"			1300000	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favourable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	25.9	3.7	9.7	8.7	13.6	5.9	7.8	7.4	20.8	9.6	19.3	26.9	1.0	6.4	9.1	3.0	21.8	9.9	18.7	4.1	13.8	16.0	26.2	4.6	9.5	11.5	26.8	7.9	5.0	17.9	35.6	4.4	17.0	29.5	10.2	18.5	3.0	15.2	2.4	3.5	2.7	10.2	8.2	63.4	11.6	30.4	5.8	10.1	11.5	2.9	19.2	16.5	41.2	11.6	0.0	31.6	0.1	0.0	0.0	0.0	0.2	29.9	9.7	9.5	3.0	26.1	7.7	10.8	3.5	6.9	1.1	0.4	16.8	21.2	2.2	14.2	2.5	18.1	1.4	12.9	0.6	0.0	2.9	0.0	1.2	16.9	15.3	0.4	0.1	13.7	15.5	0.6	11.8	5.1	0.7	0.0	0.3	5.9	2.6	0.2	7.4	10.1	5.6	2.9	3.2	18.1	102.3	6.8	1.5	3.0	2.8	2.4	2.2	2.1	1.0	2.8	2.6	0.1	3.2	0.0	0.0	3.1	4.7	2.1	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.0	0.2	9.7	13.6	7.4	20.8	13.8	16.0	26.8	7.9	29.5	10.1
TNFRSF8	"CD30, D1S166E, KI-1"	ENSG00000120949	"TNF receptor superfamily member 8"	P28908	1	12063377-12144207	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.3"	"Cell line enriched"	"Detected in some"	21	"HDLM-2: 109.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 9.3"	"Region enriched"	"Detected in single"	14	"basal ganglia: 13.1"	"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 21.7;non-classical monocyte: 33.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 33.3"					"Low region specificity"	"Detected in many"			"CAB000016, HPA014823, HPA032081, HPA032082"	Approved		Supported	"Plasma membrane"				"Plasma membrane"		"CAB000016: AB_563546, HPA014823: , HPA032081: , HPA032082: "	"unprognostic (1.07e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.17e-8)"	"unprognostic (3.31e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.31e-2)"	10.7	0.2	0.1	7.2	13.1	1.4	5.8	0.2	0.4	1.1	0.8	0.0	1.5	0.2	1.7	1.3	0.9	2.1	1.4	3.8	0.1	0.2	0.9	0.2	3.9	2.9	0.5	0.5	1.2	0.4	0.0	0.1	6.2	0.5	1.0	0.5	0.0	0.7	0.3	3.1	1.6	1.3	1.3	1.4	2.9	6.4	2.5	0.9	3.0	0.7	2.7	5.3	2.6	3.8	0.0	3.2	6.8	33.3	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.4	0.0	0.0	0.0	0.0	0.0	109.9	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	5.1	0.3	0.0	0.0	0.2	0.0	4.4	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	21.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	6.8	0.0	33.3	0.8	0.3	2.7	0.1	13.1	0.2	0.4	0.1	0.2	0.5	0.5	0.5	0.9
TNFSF13	"APRIL, CD256"	ENSG00000161955	"TNF superfamily member 13"	O75888	17	7558292-7561608	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 102.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 18.4;RPTEC TERT1: 46.5;U-937: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.5;eosinophil: 22.8;intermediate monocyte: 62.7;myeloid DC: 43.0;non-classical monocyte: 37.3;plasmacytoid DC: 19.8"	"Group enriched"	"Detected in many"	10	"dendritic cells: 43.0;granulocytes: 22.8;monocytes: 63.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004863	Uncertain				"Secreted to blood"	6766927	29000			"HPA004863: AB_1078187"	"unprognostic (2.46e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.42e-1)"	"unprognostic (6.53e-2)"	"prognostic unfavourable (9.73e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (1.30e-9)"	"unprognostic (4.69e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.38e-2)"	12.1	14.4	18.7	15.4	24.2	18.3	12.9	5.7	15.3	15.7	20.4	8.7	27.4	32.0	7.7	12.8	6.1	14.4	29.1	9.5	11.1	10.7	34.1	11.9	43.0	39.0	14.3	9.4	14.0	20.7	5.7	10.8	6.4	31.6	13.7	18.7	22.0	102.8	69.4	3.0	5.3	18.5	10.9	13.1	16.2	23.4	5.0	9.0	3.3	14.1	8.2	11.5	10.4	8.4	4.1	43.0	22.8	63.5	1.3	0.4	30.6	8.3	3.4	1.1	2.3	1.3	0.7	1.4	1.5	1.0	0.6	0.5	1.8	5.2	3.7	18.4	1.5	5.3	0.0	1.5	0.6	6.5	2.9	2.3	7.5	3.9	2.8	2.0	2.4	1.5	1.4	0.4	2.4	1.9	1.8	1.4	0.5	1.2	0.9	6.6	1.1	2.5	6.6	1.4	15.8	46.5	5.5	2.1	2.0	2.9	7.8	1.0	10.4	5.0	1.0	2.0	2.4	0.9	3.2	0.3	1.1	0.9	0.8	17.8	3.9	9.0	63.5	22.8	0.1	62.7	0.1	2.0	0.0	0.1	43.0	4.1	0.4	0.2	8.6	1.3	37.3	19.8	0.1	30.6	18.7	24.2	5.7	15.3	11.1	10.7	14.3	9.4	31.6	9.0
TNFSF13B	"BAFF, BLYS, CD257, TALL-1, TALL1, THANK, TNFSF20"	ENSG00000102524	"TNF superfamily member 13b"	Q9Y275	13	108251240-108308484	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	Immunity	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 76.5;lymphoid tissue: 39.6"	"Cell line enriched"	"Detected in some"	7	"U-937: 59.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 76.5"	"Group enriched"	"Detected in many"	10	"dendritic cells: 31.0;granulocytes: 76.5;monocytes: 53.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB009188	Enhanced				"Secreted to blood"	393384	530000			"CAB009188: "	"unprognostic (6.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (2.53e-11)"	"unprognostic (1.23e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.25e-1)"	7.2	8.2	3.0	18.5	8.2	13.2	3.4	1.4	5.2	1.6	4.2	2.1	1.0	7.8	1.2	6.5	3.5	2.9	9.4	9.4	5.7	2.9	3.1	5.0	13.2	39.6	7.2	2.6	2.9	2.7	0.5	2.1	6.4	5.7	3.7	6.4	2.6	5.4	1.8	1.6	1.6	6.8	3.5	11.6	23.5	3.4	1.0	4.9	7.2	5.1	1.7	12.7	8.5	3.8	1.0	31.0	76.5	53.7	0.6	5.3	20.8	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.3	0.2	0.7	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.0	0.1	0.0	7.9	0.0	0.1	0.0	0.0	0.1	3.7	0.1	0.0	3.8	59.5	0.6	1.2	53.7	14.4	0.8	39.8	5.3	0.6	3.5	0.7	31.0	1.0	1.7	0.5	76.5	0.6	31.7	11.5	2.8	20.8	3.0	8.2	1.4	5.2	5.7	2.9	7.2	2.6	5.7	4.9
TNFSF9	4-1BB-L	ENSG00000125657	"TNF superfamily member 9"	P41273	19	6530999-6535928	"Plasma proteins, Predicted intracellular proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 3.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA059857			Approved	"Golgi apparatus"				"Golgi apparatus"		"HPA059857: "	"unprognostic (2.21e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.41e-3)"	"unprognostic (4.88e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-3)"	3.2	2.3	3.9	5.6	7.7	10.7	1.3	4.8	7.4	11.7	3.8	7.2	0.3	1.5	1.0	1.4	11.2	2.5	3.7	1.6	4.8	4.9	1.3	1.5	14.3	3.4	6.2	1.7	1.0	1.4	0.5	0.5	3.2	5.5	1.5	6.4	0.1	2.3	0.8	1.7	1.9	1.6	1.9	4.9	2.4	1.4	5.9	5.5	0.8	0.7	7.7	7.1	3.0	10.2	2.0	0.9	0.1	0.0	0.1	3.4	0.0	4.7	6.1	0.1	2.2	1.2	2.8	0.2	0.7	2.2	1.7	8.1	0.1	8.2	5.1	3.2	1.3	8.7	2.4	1.0	0.4	0.0	1.2	0.8	8.5	2.0	0.1	0.1	40.1	0.4	4.7	9.3	2.6	0.2	4.8	0.0	0.6	0.6	0.4	0.8	0.8	4.3	0.5	0.0	1.2	10.6	0.1	0.0	0.0	13.6	0.8	2.1	0.5	7.3	2.8	0.0	4.5	12.1	0.0	12.5	4.4	9.3	4.8	2.6	2.7	0.1	0.0	0.0	0.5	0.0	0.3	2.0	0.1	3.4	0.3	0.4	0.2	0.3	0.0	0.1	0.0	0.9	0.0	0.0	3.9	7.7	4.8	7.4	4.8	4.9	6.2	1.7	5.5	5.5
TNK2	"ACK, ACK1, p21cdc42Hs"	ENSG00000061938	"Tyrosine kinase non receptor 2"	Q07912	3	195863364-195911945	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	Endocytosis	"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041954	Approved		Approved	Cytosol				Cytosol		"HPA041954: AB_10794164"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.15e-3)"	"prognostic unfavourable (8.96e-4)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.89e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.92e-3)"	"unprognostic (4.49e-2)"	"prognostic unfavourable (1.30e-4)"	"unprognostic (6.82e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (1.00e-4)"	9.2	7.6	36.3	16.2	27.6	38.9	8.5	20.7	43.7	6.0	6.3	17.6	3.8	6.6	8.0	6.6	13.0	10.7	6.5	10.6	28.4	21.8	4.1	7.2	9.3	18.1	21.6	31.8	8.6	7.8	5.1	19.3	8.4	20.0	10.8	3.9	5.3	16.8	8.2	30.5	37.1	6.9	7.6	10.3	17.0	12.1	7.7	21.8	3.4	4.6	9.8	12.8	7.7	12.3	6.1	3.1	6.3	3.2	0.9	1.9	1.2	31.3	3.0	5.1	5.4	7.1	4.5	30.5	6.0	5.8	3.6	3.3	4.8	24.3	9.1	21.2	8.2	11.2	4.4	7.5	1.1	21.4	5.6	8.2	10.2	3.5	3.2	4.2	4.1	3.3	11.9	5.0	6.0	4.6	3.3	12.7	3.4	23.1	1.8	15.4	4.8	11.3	5.3	6.1	9.2	3.2	15.2	6.2	6.3	3.9	15.9	7.8	26.0	5.3	7.5	8.4	4.9	4.4	16.8	27.6	3.0	5.6	7.5	13.8	6.2	2.0	2.4	0.9	1.9	3.2	1.1	2.7	1.8	1.0	1.1	6.1	1.4	1.3	6.3	0.9	2.8	3.1	0.2	1.2	36.3	27.6	20.7	33.3	28.4	21.8	21.6	31.8	20.0	21.8
TNKS2	"PARP-5b, PARP-5c, PARP5B, PARP5C, pART6, TANK2, TNKL"	ENSG00000107854	"Tankyrase 2"	Q9H2K2	10	91798312-91865276	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036606			Approved	Microtubules				Microtubules		"HPA036606: AB_10673470"	"unprognostic (1.12e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.53e-1)"	17.6	16.3	16.7	23.0	18.6	26.9	18.4	27.9	20.0	18.8	13.9	18.3	18.3	11.9	18.9	18.8	24.7	16.7	17.2	12.2	16.6	14.9	14.6	16.8	17.0	22.9	20.3	14.9	26.0	19.3	20.8	26.7	47.5	16.1	16.7	14.3	16.1	21.4	16.0	39.7	23.9	16.5	18.9	18.0	22.8	15.8	9.5	17.9	42.9	24.5	21.0	23.8	18.6	18.9	3.6	5.2	3.8	2.5	3.3	3.5	1.4	14.3	12.3	25.3	21.4	17.9	16.4	28.3	15.5	28.4	19.0	23.4	10.9	11.8	13.6	7.5	20.2	15.6	15.8	12.0	26.9	13.7	15.3	11.2	11.8	12.1	17.5	21.6	16.8	16.6	15.9	19.2	34.3	17.8	8.3	15.1	19.7	7.7	18.6	14.8	12.7	8.3	17.5	15.8	10.3	13.0	15.6	6.6	11.9	15.6	6.9	19.3	16.7	15.1	19.1	10.3	8.7	13.5	14.7	19.1	15.6	17.7	13.5	16.3	9.1	1.0	2.5	3.8	3.5	2.3	3.0	3.5	3.3	3.2	3.4	3.6	2.8	2.4	2.5	3.3	2.2	5.2	1.7	1.4	16.7	18.6	27.9	20.0	16.6	14.9	20.3	14.9	16.1	17.9
TNN		ENSG00000120332	"Tenascin N"	Q9UQP3	1	175067858-175148066	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.2;gallbladder: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.5;NB-4: 4.6;THP-1: 14.0;U-266/70: 3.6;U-937: 2.6"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB010907, HPA026726, HPA026764"	Uncertain				"Secreted to extracellular matrix"		11000000			"CAB010907: AB_477565, HPA026726: AB_10601771, HPA026764: AB_10601859"	"unprognostic (1.16e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.25e-3)"	"unprognostic (1.01e-2)"	"unprognostic (4.69e-1)"	"unprognostic (5.07e-1)"	"unprognostic (1.08e-3)"	"unprognostic (1.76e-2)"	"unprognostic (9.38e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.02e-2)"	15.2	0.2	0.1	1.5	0.2	0.0	7.9	0.4	0.8	0.3	0.8	0.1	0.1	1.0	0.1	0.5	0.3	0.0	14.2	0.6	0.1	0.0	0.4	1.8	1.8	0.1	0.1	0.9	0.1	0.3	1.8	3.7	0.1	0.6	0.1	0.1	4.8	6.4	0.1	0.1	5.3	1.0	0.8	0.7	0.6	0.5	0.1	0.3	0.3	2.6	7.5	0.3	0.1	0.2	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	3.6	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	0.7	0.1	0.0	0.1	0.9	0.6	0.3
TNNC1	TNNC	ENSG00000114854	"Troponin C1, slow skeletal and cardiac type"	P63316	3	52451102-52454070	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Muscle protein"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"heart muscle: 431.6;skeletal muscle: 765.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 23.8;EFO-21: 23.9;HeLa: 15.7;Hep G2: 15.9;HSkMC: 24.8;U-2 OS: 36.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Lineage enriched"	"Detected in single"	7	"T-cells: 4.0"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 88.3"	"Region enriched"	"Detected in single"	7	"midbrain: 8.5"	"CAB002450, HPA044848, HPA056897"	Enhanced		Approved	"Nucleoplasm,Actin filaments,Mitochondria"			260000	"Nucleoplasm, Actin filaments, Mitochondria"		"CAB002450: AB_564152, HPA044848: AB_2679110, HPA056897: AB_2683269"	"unprognostic (2.18e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.15e-2)"	"unprognostic (4.86e-1)"	2.0	0.3	0.1	0.0	0.1	0.0	0.7	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.1	17.8	12.8	0.1	0.0	431.6	0.1	0.1	0.6	0.1	2.6	0.0	0.1	0.0	0.1	0.2	0.0	0.6	0.2	0.5	5.5	0.1	0.7	10.4	0.0	765.7	0.4	0.1	0.1	0.7	0.1	0.1	0.7	0.0	0.0	3.0	86.9	8.7	0.4	0.2	0.2	0.6	0.0	0.0	0.0	4.0	0.5	0.2	1.8	1.3	0.2	0.0	0.2	2.9	0.1	0.1	0.1	0.1	23.8	11.9	0.2	23.9	3.4	0.1	0.0	0.1	0.0	0.4	0.5	0.1	15.7	15.9	0.1	0.1	0.0	24.8	0.4	0.0	0.2	0.0	0.0	1.8	0.7	0.0	0.0	0.2	0.1	0.2	0.0	1.0	0.8	1.1	4.5	0.0	0.0	0.1	2.4	0.0	9.6	0.2	0.0	0.0	36.7	0.3	0.0	1.0	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.7	0.0	4.0	0.2	0.9	0.5	0.0	0.1	1.4	0.5	0.0	0.0	0.0	0.6	2.5	0.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.5	0.0
TNNI3	"CMD2A, CMH7, TNNC1"	ENSG00000129991	"Troponin I3, cardiac type"	P19429	19	55151767-55157773	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	367	"heart muscle: 419.3"	"Cell line enhanced"	"Detected in some"		"HEK 293: 8.6;HMC-1: 14.4;K-562: 26.2;THP-1: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"thalamus: 1.0"	"CAB009349, HPA046428"	Enhanced		Approved	Vesicles,Cytosol			1700000	Cytosol	Vesicles	"CAB009349: AB_793465, HPA046428: "	"unprognostic (2.12e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.62e-3)"	"unprognostic (9.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.02e-3)"	"unprognostic (8.89e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.82e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	1.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	419.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.7	0.8	0.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.3	0.0	0.2	1.1	4.5	0.0	0.6	0.9	0.2	0.0	0.0	8.6	2.0	0.0	1.2	0.4	0.0	14.4	0.0	0.4	0.0	0.2	0.0	26.2	0.5	0.0	0.4	0.1	0.0	0.5	0.3	1.1	0.3	0.0	1.3	0.0	0.0	1.5	0.0	0.0	0.2	2.0	6.6	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"			47000	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavourable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.9	29.3	20.1	26.2	24.5	20.7	52.3	18.5	21.9	18.5	21.6	15.7	32.3	16.4	25.4	25.4	26.5	17.9	22.8	21.9	22.5	16.5	26.2	20.8	24.2	22.4	22.9	16.4	22.5	28.9	54.1	36.5	34.9	27.0	21.2	24.4	19.4	26.1	35.3	38.0	15.9	19.9	32.0	31.2	21.7	25.3	30.9	20.8	25.2	32.6	18.0	23.6	27.5	30.8	11.1	10.7	8.9	13.3	14.1	18.3	10.6	21.6	28.6	41.6	24.9	31.0	38.5	24.6	25.7	35.0	25.6	26.4	24.3	18.6	25.3	17.6	40.3	15.8	28.3	22.9	37.1	14.7	15.7	15.6	38.0	12.3	21.0	17.2	11.5	27.8	16.6	34.2	48.8	62.1	23.3	13.5	72.7	10.3	15.7	6.6	22.3	21.9	19.0	37.5	15.9	15.8	29.0	21.6	22.3	41.3	13.2	30.3	16.3	14.2	58.8	21.7	25.6	32.7	28.7	12.4	19.4	33.8	17.3	17.7	39.8	7.3	8.3	6.9	13.4	11.5	18.3	11.1	12.2	10.0	10.7	11.0	13.4	13.4	8.9	14.1	13.3	5.0	8.1	10.6	20.1	24.5	18.5	21.9	22.5	16.5	22.9	16.4	27.0	20.8
TNRC6A	"CAGH26, GW182, KIAA1460, TNRC6"	ENSG00000090905	"Trinucleotide repeat containing 6A"	Q8NDV7	16	24610209-24827632	"Plasma proteins, Predicted intracellular proteins"	"RNA-mediated gene silencing, Translation regulation"	RNA-binding	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015305, HPA017869"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA015305: AB_1850454, HPA017869: AB_1850456"	"unprognostic (2.64e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-3)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.63e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.18e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.35e-2)"	17.3	23.6	14.7	23.2	15.1	10.2	17.0	25.0	19.3	20.8	17.0	15.6	17.2	10.5	26.6	23.1	12.5	20.2	12.6	13.4	11.3	9.4	13.0	17.0	14.0	16.7	14.5	10.9	26.7	20.1	42.6	25.4	12.6	16.2	16.4	12.8	17.8	16.6	18.6	26.5	16.5	16.0	27.5	19.4	14.2	15.8	11.4	14.7	15.9	19.6	14.9	13.8	16.4	16.4	5.4	5.2	2.3	2.7	3.3	3.9	1.3	11.5	16.1	19.1	10.3	16.6	22.0	10.9	19.8	16.1	14.5	15.9	11.8	9.7	11.7	8.6	19.8	13.1	23.7	16.6	21.8	11.8	12.3	11.7	17.8	16.2	14.3	11.9	8.2	22.1	8.7	18.9	12.5	19.8	17.7	7.5	18.6	13.6	9.9	7.9	27.4	8.1	19.6	14.8	10.5	11.0	10.8	9.4	13.0	13.9	8.6	7.6	9.9	7.9	18.1	18.6	12.7	9.1	13.8	16.5	12.9	19.5	17.3	7.5	13.3	2.3	2.7	1.9	3.0	1.6	2.5	5.2	2.9	2.7	1.0	5.4	3.9	2.7	1.5	3.3	1.6	5.2	2.9	1.3	14.7	15.1	25.0	19.3	11.3	9.4	14.5	10.9	16.2	14.7
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 46.3;ASC TERT1: 25.2;fHDF/TERT166: 21.9;REH: 24.1;TIME: 21.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"				"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavourable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.3	25.2	0.3	7.8	2.6	0.4	0.3	3.4	0.0	0.0	4.5	21.9	0.5	0.3	0.4	0.2	3.1	0.2	6.6	1.9	0.9	3.4	0.0	0.8	12.0	0.0	8.3	0.0	10.9	0.2	0.7	6.5	0.9	0.0	0.4	0.3	0.1	24.1	5.8	0.3	1.6	0.0	0.7	3.5	1.3	3.3	0.8	1.1	2.4	21.4	5.7	10.3	5.7	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041154-32115334	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease mutation, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 11.1;ASC TERT1: 18.1;U-2197: 14.6;U-87 MG: 7.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 7.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted to extracellular matrix"		1100000000				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	45.1	66.2	1.0	12.2	1.8	3.8	61.5	7.7	1.5	28.3	14.5	0.6	17.6	4.2	31.6	38.0	25.7	7.5	33.3	39.3	1.0	1.4	3.3	5.4	22.3	8.7	2.2	0.4	41.0	3.1	1.5	1.8	7.6	1.4	9.0	2.7	3.0	7.1	7.9	17.9	8.4	10.2	49.2	4.4	7.9	5.4	11.4	0.3	0.4	6.7	36.6	4.5	33.0	32.2	0.0	0.0	0.1	0.1	0.0	0.2	1.7	0.1	0.2	0.2	0.1	11.1	18.1	0.2	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.4	1.0	0.1	0.0	0.0	0.0	0.3	0.9	0.1	0.5	0.0	2.5	0.0	0.2	0.2	0.1	0.4	0.0	0.0	0.6	0.3	0.0	0.1	0.0	0.1	0.3	3.3	0.2	0.0	0.2	0.0	0.1	0.1	0.2	1.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	14.6	0.0	0.4	0.3	0.2	7.2	0.1	0.3	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	1.0	1.8	7.7	1.5	1.0	1.4	2.2	0.4	1.4	0.3
TOLLIP	IL-1RAcPIP	ENSG00000078902	"Toll interacting protein"	Q9H0E2	11	1274371-1309654	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038621, HPA038622"	Enhanced		Approved	"Plasma membrane,Cytosol"			34000	"Plasma membrane, Cytosol"		"HPA038621: AB_10673177, HPA038622: AB_10675946"	"unprognostic (8.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.18e-2)"	"unprognostic (6.08e-2)"	"prognostic unfavourable (5.45e-4)"	"unprognostic (8.89e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.74e-1)"	"prognostic favourable (1.11e-16)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-2)"	15.3	16.7	31.2	8.8	32.5	9.0	11.9	28.3	63.0	10.7	12.7	12.9	8.6	18.6	8.3	10.3	29.4	10.7	13.7	15.8	28.0	20.3	20.9	37.1	12.3	9.6	18.1	32.1	12.8	41.8	13.7	18.7	9.9	17.4	15.6	6.6	12.9	15.9	16.8	23.4	24.0	15.7	9.0	13.5	13.2	15.1	24.5	11.8	5.9	12.6	11.8	10.9	14.6	14.8	13.9	26.9	49.0	34.8	11.1	12.6	18.3	15.6	16.6	8.5	9.6	18.1	11.4	7.4	13.9	12.7	16.4	14.6	18.0	10.0	7.3	13.5	12.8	14.2	7.6	17.1	4.5	15.0	15.5	6.0	3.6	26.9	25.9	11.3	15.2	17.1	20.1	9.7	9.4	10.2	9.8	20.0	13.4	13.1	14.3	13.9	10.3	22.1	10.9	8.7	7.2	10.8	21.0	22.8	13.4	12.5	15.2	15.3	12.0	12.9	18.6	17.8	7.6	7.5	8.0	20.3	18.0	8.9	28.1	7.5	13.9	9.5	34.8	35.9	9.6	30.0	8.0	10.9	10.3	8.9	26.9	13.9	8.1	7.6	49.0	11.1	27.5	14.1	12.6	18.3	31.2	32.5	28.3	63.0	28.0	20.3	18.1	32.1	17.4	11.8
TOP2A	TOP2	ENSG00000131747	"DNA topoisomerase II alpha"	P11388	17	40388516-40417950	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	"DNA-binding, Isomerase, Topoisomerase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 146.3;testis: 36.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002448, HPA006458, HPA026773"	Enhanced	Approved	Supported	Nucleoplasm,Nucleoli				Nucleoplasm	Nucleoli	"CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.42e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (5.92e-6)"	"prognostic unfavourable (4.99e-4)"	"unprognostic (6.21e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavourable (3.83e-5)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	2.7	2.0	0.4	20.0	0.5	14.6	4.1	0.4	0.5	3.0	6.9	0.5	0.5	7.0	2.0	3.4	18.2	0.7	2.4	2.3	0.6	0.5	1.4	1.9	5.5	15.4	0.6	0.4	1.2	1.1	0.0	0.4	10.7	0.6	1.2	8.0	0.6	3.2	0.3	0.6	5.9	9.2	2.6	1.8	7.3	4.5	36.8	0.3	146.3	0.9	11.8	16.7	3.2	5.7	1.3	0.3	0.3	0.3	3.2	5.7	1.1	33.7	44.9	57.2	26.1	2.8	5.8	12.7	46.4	25.0	42.7	37.9	21.0	25.9	54.5	23.6	15.7	53.8	43.9	18.5	57.4	29.1	29.3	36.0	28.7	35.1	0.2	50.4	38.3	1.2	1.5	30.0	30.6	22.4	38.9	37.4	46.1	11.7	58.4	33.9	23.7	17.9	49.6	88.8	22.6	10.3	21.6	33.8	24.3	37.4	46.7	14.7	39.2	23.2	14.7	28.2	39.7	32.5	44.5	21.5	24.3	47.6	15.9	34.8	46.9	0.3	0.0	0.0	0.6	0.0	0.0	1.3	0.9	0.9	0.3	0.4	0.2	0.1	0.3	3.2	0.3	0.0	5.7	1.1	0.4	0.5	0.4	0.5	0.6	0.5	0.6	0.4	0.6	0.3
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 104.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favourable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.5	10.9	24.1	29.5	8.0	10.2	9.6	10.2	13.1	9.5	10.4	5.5	8.4	32.6	7.1	14.7	9.0	20.0	11.3	16.0	15.6	10.7	49.5	13.6	9.3	5.6	38.7	26.5	7.3	5.7	10.6	9.3	15.4	16.6	16.1	12.2	11.7	25.0	9.6	18.3	8.3	104.7	13.6	15.1	8.5	37.2	12.2	21.1	15.2	10.9	9.3	11.3	34.6	14.7	13.2	10.3	10.5	10.9	24.9	14.1	34.7	8.7	29.0	8.8	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7
TOP3B		ENSG00000100038	"DNA topoisomerase III beta"	O95985	22	21957025-21982816	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 48.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072114			Approved	Nucleoplasm				Nucleoplasm		"HPA072114: "	"unprognostic (1.03e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.37e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.93e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.11e-4)"	10.4	11.7	12.1	16.1	17.4	20.8	10.9	17.2	17.1	12.5	11.0	16.9	14.9	15.4	16.1	11.0	14.2	11.0	11.2	10.1	12.7	5.5	13.4	15.3	12.7	17.0	18.7	6.5	20.2	12.1	13.5	21.0	12.1	16.2	15.6	14.9	14.1	13.3	13.3	13.4	17.5	16.1	14.5	17.4	23.6	11.8	11.1	16.9	13.1	14.2	5.7	18.9	10.5	14.3	9.0	8.8	2.7	6.8	6.1	9.3	5.2	9.5	9.1	18.7	7.4	6.9	5.8	11.7	6.4	7.9	14.7	13.1	9.9	4.1	13.1	4.8	6.6	17.5	8.4	11.2	11.9	6.7	20.2	10.3	11.8	10.2	9.4	14.0	6.8	2.8	17.3	12.1	5.9	12.2	48.2	7.2	6.9	9.7	8.8	10.9	7.7	8.8	13.8	12.4	2.0	7.3	12.8	12.2	8.9	7.8	6.9	5.9	5.4	9.0	8.9	6.1	12.7	5.7	7.7	10.6	8.6	12.4	4.7	8.6	6.2	2.5	6.7	2.7	9.3	6.8	6.5	7.5	5.8	6.5	7.4	9.0	5.9	5.7	2.3	6.1	3.8	8.8	6.7	5.2	12.1	17.4	17.2	17.1	12.7	5.5	18.7	6.5	16.2	16.9
TOR1AIP1	"FLJ13142, LAP1B"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179925000	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546"	Enhanced		Enhanced	"Nuclear membrane"			17000	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167"	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	29.3	26.4	27.1	25.1	28.1	52.2	25.4	28.6	30.5	33.2	40.0	24.6	38.2	11.6	33.6	33.0	30.1	27.6	27.2	29.3	28.3	20.8	27.2	27.1	25.5	28.2	31.7	23.6	42.5	24.6	31.1	30.5	20.3	27.3	33.6	17.0	27.0	21.9	42.9	44.7	17.8	21.6	46.9	26.1	27.8	30.9	23.5	32.2	24.9	34.5	28.8	21.8	40.7	30.5	19.0	27.9	61.0	35.9	21.4	29.4	29.9	12.9	13.0	9.0	11.5	40.9	27.5	17.4	17.6	21.0	16.5	17.0	10.2	24.6	3.4	19.5	17.9	22.8	8.4	14.1	19.4	22.0	8.5	9.3	12.4	9.9	18.8	31.4	28.8	22.2	11.0	20.1	19.0	14.7	13.4	17.2	17.2	11.5	12.8	9.8	13.0	5.1	7.9	14.2	8.9	16.0	25.3	7.7	10.7	21.7	20.9	29.3	16.4	32.4	15.1	23.3	9.8	15.2	20.6	19.5	25.6	6.9	8.8	17.4	35.1	45.8	26.4	61.0	24.9	29.1	29.4	17.7	23.0	24.9	27.9	19.0	23.8	24.4	41.0	21.4	35.9	20.2	24.2	29.9	27.1	28.1	28.6	30.5	28.3	20.8	31.7	23.6	27.3	32.2
TOX4	"C14orf92, KIAA0737, LCP1"	ENSG00000092203	"TOX high mobility group box family member 4"	O94842	14	21476597-21499175	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017880, HPA027551"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles				Nucleoplasm	"Nucleoli, Vesicles"	"HPA017880: AB_1845573, HPA027551: AB_10601701"	"unprognostic (9.56e-2)"	"unprognostic (2.54e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.46e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.23e-1)"	"prognostic unfavourable (3.46e-4)"	"unprognostic (8.05e-3)"	"unprognostic (2.58e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.94e-1)"	"prognostic favourable (8.38e-5)"	"unprognostic (1.84e-1)"	"unprognostic (2.48e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.48e-3)"	16.5	15.1	18.0	13.4	24.7	18.8	16.9	19.9	29.8	19.8	17.3	21.0	10.9	12.7	18.9	16.2	21.8	15.6	14.7	19.2	17.0	18.4	14.3	15.8	15.8	13.7	19.3	15.9	17.0	17.0	23.2	15.5	21.3	25.3	15.6	15.9	16.0	19.7	19.2	46.0	20.2	20.0	20.5	17.3	14.7	16.9	18.0	13.3	19.5	17.7	16.6	21.6	18.2	14.4	18.4	23.7	34.1	19.9	19.1	21.4	17.6	12.9	13.8	11.5	10.9	16.7	16.1	15.4	12.6	24.9	26.9	26.0	13.3	15.8	7.9	8.9	20.7	15.8	18.8	19.4	34.5	13.9	7.6	8.8	9.4	18.4	21.7	16.2	14.5	20.9	20.1	21.0	20.3	19.0	10.8	13.6	19.1	11.1	16.0	9.0	6.5	21.8	14.4	11.9	9.1	12.5	16.5	10.7	10.9	12.4	13.3	10.9	12.6	6.2	12.4	13.6	12.9	12.2	11.0	17.9	19.4	17.7	6.6	7.9	14.4	25.2	19.6	27.0	17.3	19.9	18.6	17.0	15.3	16.2	17.7	18.4	16.4	17.9	34.1	19.1	17.7	23.7	21.4	17.6	18.0	24.7	19.9	29.8	17.0	18.4	19.3	15.9	25.3	13.3
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: , HPA051244: , HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favourable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.2	35.6	19.4	14.0	9.1	10.8	20.6	6.9	15.6	19.2	24.3	1.0	9.9	45.3	31.5	13.6	42.5	28.2	19.1	18.0	10.1	18.9	18.3	20.0	16.9	27.4	0.4	9.5	13.7	22.2	9.3	25.7	18.8	0.9	1.7	9.8	34.2	30.7	22.4	19.6	0.7	59.7	13.7	15.7	14.3	21.3	11.6	20.0	22.8	15.4	5.9	26.7	1.7	24.3	23.0	7.6	0.3	11.6	11.9	8.7	19.5	6.0	2.3	19.4	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in some"	5	"HaCaT: 23.3;HBEC3-KT: 44.6;hTCEpi: 33.8;hTERT-HME1: 32.3;RT4: 49.0"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favourable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	23.3	0.0	44.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	33.8	0.0	32.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	49.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0
TP73	P73	ENSG00000078900	"Tumor protein p73"	O15350	1	3652520-3736201	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 11.2;SCLC-21H: 14.3;U-698: 14.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"cerebellum: 25.7"	"Cell type enhanced"	"Detected in some"		"eosinophil: 1.2;memory B-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002514, CAB003022, HPA027314, HPA044516"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB002514: AB_563940, CAB003022: , HPA027314: , HPA044516: "	"unprognostic (5.71e-3)"	"prognostic favourable (2.98e-4)"	"unprognostic (2.71e-1)"	"prognostic favourable (1.82e-4)"	"unprognostic (5.58e-2)"	"prognostic favourable (9.50e-4)"	"unprognostic (5.25e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.26e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.65e-1)"	0.5	0.3	1.1	3.4	2.3	1.0	1.1	25.7	0.4	1.5	0.7	2.4	1.3	0.3	0.4	6.2	4.8	12.8	1.4	0.3	1.9	1.2	0.2	2.1	3.8	2.0	0.5	0.0	2.6	1.5	0.3	0.7	1.7	3.2	3.6	0.4	0.4	5.5	1.4	0.4	11.9	0.5	0.3	0.9	4.2	0.8	9.8	0.3	2.5	0.4	0.8	7.1	0.6	3.9	1.4	0.1	1.2	0.1	0.0	0.6	0.1	1.9	0.1	0.2	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.4	3.2	2.0	1.6	0.0	3.3	2.1	0.7	0.0	0.6	6.8	0.1	3.2	1.9	0.0	0.0	2.3	0.0	1.4	0.0	0.1	0.0	4.2	0.0	0.6	1.5	11.2	1.5	0.4	0.1	0.0	9.2	0.1	0.2	2.9	14.3	6.7	0.3	0.0	0.6	8.6	7.0	0.0	2.3	6.1	0.0	4.5	2.7	0.5	14.4	0.4	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.5	1.4	0.4	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	1.1	2.3	25.7	0.3	1.9	1.2	0.5	0.0	3.2	0.3
TPD52L1	"D53, hD53"	ENSG00000111907	"Tumor protein D52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 95.2;salivary gland: 104.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 51.4;hTCEpi: 45.3;MCF7: 67.2;RPTEC TERT1: 52.1;SK-BR-3: 36.3;T-47d: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"				"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favourable (3.97e-4)"	"prognostic unfavourable (5.34e-4)"	10.3	95.2	31.5	4.3	47.5	1.0	25.7	2.6	32.9	10.5	8.5	9.2	31.0	4.3	6.2	27.6	43.3	13.9	10.8	26.0	21.4	9.5	11.7	22.0	4.7	2.9	15.4	12.8	9.0	18.0	10.3	8.7	4.0	16.1	16.6	5.8	13.0	104.6	32.7	34.4	11.8	4.6	27.1	5.5	1.4	10.3	2.6	18.2	0.0	23.5	20.1	11.0	18.1	14.6	1.1	0.9	5.9	1.2	5.3	1.7	1.0	6.9	7.9	0.0	51.4	0.4	0.1	12.2	1.1	1.1	0.0	0.1	12.5	8.9	0.0	26.4	5.8	15.9	1.5	11.0	0.0	0.1	11.0	0.1	11.0	0.1	1.1	0.0	0.0	1.4	45.3	0.0	5.9	0.0	5.5	0.1	0.9	67.2	0.0	0.1	0.8	4.3	0.0	0.0	0.0	52.1	1.8	1.7	0.0	13.3	36.3	0.8	31.0	0.1	0.0	0.3	1.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	2.7	1.2	0.8	0.8	0.6	0.8	0.8	1.3	0.6	0.5	1.1	1.7	1.2	5.9	5.3	0.3	0.9	0.4	1.0	31.5	47.5	2.6	32.9	21.4	9.5	15.4	12.8	16.1	18.2
TPD52L2	"D54, hD54"	ENSG00000101150	"Tumor protein D52 like 2"	O43399	20	63865228-63891545	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047489	Approved		Approved	Vesicles,Cytosol			1500000	Vesicles	Cytosol	"HPA047489: "	"unprognostic (1.17e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavourable (1.39e-5)"	"unprognostic (3.63e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.69e-2)"	"prognostic unfavourable (1.74e-8)"	"unprognostic (2.79e-1)"	"unprognostic (7.07e-2)"	"unprognostic (3.33e-2)"	"unprognostic (3.15e-3)"	48.6	40.9	28.1	33.5	33.6	55.4	43.3	33.4	40.2	40.1	35.8	35.0	34.6	25.3	38.4	29.7	52.2	33.9	32.2	45.3	27.6	30.0	31.0	24.7	30.3	38.3	26.6	34.1	33.4	30.1	20.5	30.6	42.9	33.8	33.8	24.2	29.0	27.4	43.7	32.3	33.9	25.0	48.0	27.4	36.5	28.1	35.0	24.7	19.4	40.9	32.8	31.8	40.9	55.6	13.0	17.6	50.5	25.4	16.7	14.4	23.1	32.7	17.0	10.6	12.9	24.5	39.2	15.8	37.9	33.5	67.6	28.7	62.7	37.6	13.3	42.0	38.1	32.4	21.5	51.6	39.4	7.4	9.0	12.6	22.4	37.9	26.1	16.1	13.1	28.1	58.2	27.1	43.8	30.9	26.2	19.6	26.5	18.2	15.4	20.4	15.3	60.3	21.4	11.7	21.2	26.6	14.7	16.2	18.3	44.7	34.6	30.8	23.5	32.5	32.7	54.4	15.6	31.5	27.6	12.6	19.8	16.1	51.0	15.0	16.7	18.8	25.4	16.7	11.6	19.9	14.4	13.0	12.7	13.1	17.6	11.9	13.0	11.7	50.5	16.7	16.5	8.8	13.8	23.1	28.1	33.6	33.4	40.2	27.6	30.0	26.6	34.1	33.8	24.7
TPI1		ENSG00000111669	"Triosephosphate isomerase 1"	P60174	12	6867119-6870948	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Glycolysis"	"Isomerase, Lyase"	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 234.8;skeletal muscle: 211.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050924, HPA053568"	Uncertain		Approved	Nucleoplasm,Vesicles			270000000	Nucleoplasm	Vesicles	"HPA050924: AB_2681276, HPA053568: AB_2682193"	"unprognostic (2.85e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.62e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (4.14e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (6.54e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.11e-2)"	20.2	41.2	41.2	24.3	46.9	27.4	83.4	93.2	196.1	27.1	39.1	12.8	18.6	40.1	17.2	22.6	51.0	22.1	33.3	94.9	36.7	33.1	43.1	40.8	48.8	140.2	34.0	34.6	19.9	87.0	32.1	16.8	27.1	70.7	19.0	43.5	21.1	26.0	28.7	211.0	25.8	37.8	29.4	20.8	20.1	21.6	15.7	19.4	14.2	20.2	38.4	38.0	23.0	28.0	55.4	170.3	145.5	148.2	81.2	67.1	234.8	119.2	106.9	56.6	87.6	55.5	58.6	100.1	86.3	95.3	163.1	197.9	110.3	65.6	70.0	17.4	85.1	59.4	134.6	144.2	181.0	92.3	100.3	90.7	78.3	72.7	41.4	103.2	74.5	63.6	60.2	125.8	108.4	99.1	46.9	26.9	125.2	87.8	54.2	87.2	139.7	68.1	31.9	93.2	71.8	102.1	85.1	40.3	67.1	75.3	78.4	41.8	17.9	77.6	61.2	87.5	75.0	56.6	126.5	52.6	21.6	104.6	175.6	64.2	62.7	87.7	146.1	145.5	56.1	148.2	57.0	55.4	56.5	54.5	170.3	44.3	39.9	49.3	61.1	81.2	127.8	30.7	67.1	234.8	41.2	46.9	93.2	196.1	36.7	33.1	34.0	34.6	70.7	19.4
TPM1	"C15orf13, CMH3"	ENSG00000140416	"Tropomyosin 1"	P09493	15	63042632-63071915	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 544.2;skeletal muscle: 589.5"	"Cell line enhanced"	"Detected in many"		"BJ: 123.0;fHDF/TERT166: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 23.8"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 23.8;monocytes: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, CAB017698, HPA047089, HPA053624"	Supported		Approved	"Actin filaments,Cytosol"			280000000	"Actin filaments"	Cytosol	"CAB017698: AB_2272017, HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: "	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.53e-2)"	"prognostic unfavourable (7.30e-4)"	17.9	5.7	5.5	32.4	5.2	1.2	15.2	5.6	5.1	48.1	119.7	2.4	84.2	14.6	72.4	38.3	121.6	36.2	75.3	544.2	4.1	2.6	14.5	4.4	10.5	3.3	3.3	7.0	27.0	29.3	1.9	3.2	17.7	4.1	72.5	28.0	19.1	12.9	81.3	589.5	6.5	39.5	245.2	2.7	6.5	51.7	9.6	2.3	0.4	7.7	121.7	5.9	193.8	38.7	2.7	8.4	23.8	11.6	1.2	3.4	9.9	43.6	28.8	34.8	1.7	12.2	7.7	114.6	123.0	45.3	75.7	56.3	20.2	8.7	0.1	56.5	122.9	24.2	29.5	19.7	50.4	1.1	4.1	6.4	31.0	9.8	34.2	0.2	1.4	10.7	11.4	62.2	16.6	19.8	0.6	1.5	57.8	22.5	1.9	0.5	41.5	5.0	0.7	12.3	1.2	108.1	24.1	8.3	5.7	14.7	23.3	5.2	17.0	1.2	91.2	100.1	49.2	14.9	87.2	0.4	0.3	0.5	28.3	1.7	69.3	23.8	6.1	2.9	2.5	11.6	2.0	2.7	2.4	2.7	8.4	2.6	2.6	2.3	6.7	1.2	7.9	1.7	3.4	9.9	5.5	5.2	5.6	5.1	4.1	2.6	3.3	7.0	4.1	2.3
TPM2	"AMCD1, DA1, NEM4"	ENSG00000198467	"Tropomyosin 2"	P07951	9	35681992-35690121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 1091.5;tongue: 332.2"	"Cell line enhanced"	"Detected in many"		"BJ: 197.7;fHDF/TERT166: 107.9;HSkMC: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	727	"plasmacytoid DC: 76.4"	"Lineage enriched"	"Detected in single"	727	"dendritic cells: 76.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047089, HPA053624"	Approved						290000000			"HPA047089: , HPA053624: "	"unprognostic (5.56e-2)"	"unprognostic (5.37e-2)"	"prognostic unfavourable (2.64e-4)"	"unprognostic (3.34e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.18e-3)"	"unprognostic (6.56e-3)"	"unprognostic (2.58e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (8.51e-10)"	"unprognostic (1.43e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-2)"	14.5	8.2	1.8	24.5	1.6	0.7	9.1	3.7	1.7	47.5	101.0	1.4	76.0	8.4	86.6	51.1	166.5	26.8	100.3	34.6	1.9	1.4	9.5	1.1	10.0	5.3	1.5	3.1	29.2	2.2	1.1	2.6	8.6	3.4	72.2	9.6	15.0	21.0	81.0	1091.5	4.2	27.4	231.7	1.6	4.7	48.7	13.4	0.6	0.2	9.3	332.2	22.0	190.7	38.6	0.0	76.4	0.1	0.0	0.0	0.0	0.4	29.9	22.9	16.1	2.6	30.4	81.4	9.9	197.7	80.6	83.7	56.9	0.9	1.9	0.0	17.7	107.9	0.6	0.2	24.4	38.8	55.2	0.7	0.7	81.8	0.9	48.5	0.1	8.1	94.9	3.8	62.7	0.0	19.6	0.3	0.0	84.2	1.1	0.1	2.0	20.4	1.3	1.3	29.8	0.2	2.6	0.5	0.2	1.0	37.6	0.6	1.3	0.5	2.1	2.3	1.2	45.7	0.9	56.3	0.0	0.1	0.2	2.8	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	76.4	0.0	0.4	1.8	1.6	3.7	1.7	1.9	1.4	1.5	3.1	3.4	0.6
TPM3	"NEM1, TRK"	ENSG00000143549	"Tropomyosin 3"	P06753	1	154155304-154194648	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes, Disease mutation, Nemaline myopathy, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 738.4;tongue: 203.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA000261, HPA009066, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"			410000000	"Actin filaments"	Cytosol	"HPA000261: AB_1080339, HPA009066: AB_1080342, HPA047089: , HPA053624: "	"unprognostic (1.64e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.69e-3)"	"prognostic unfavourable (6.73e-6)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (2.80e-1)"	"prognostic favourable (2.39e-5)"	"prognostic unfavourable (3.65e-4)"	"unprognostic (3.31e-2)"	"prognostic unfavourable (3.12e-5)"	"unprognostic (3.52e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.00e-2)"	10.1	7.3	10.8	10.8	10.5	26.5	6.2	6.4	11.2	4.6	9.6	3.9	3.2	7.9	4.1	27.9	18.3	4.4	6.7	29.7	7.7	8.1	7.2	6.8	9.6	12.9	8.9	5.8	4.8	23.2	3.6	3.2	6.7	5.0	5.7	10.7	4.4	20.5	2.5	738.4	5.9	8.2	5.2	7.7	11.7	6.9	5.4	4.4	6.7	9.3	203.6	28.6	6.8	4.9	38.9	72.6	154.8	95.9	35.4	54.4	146.1	67.5	33.7	43.2	28.3	36.6	47.8	43.5	58.1	53.7	77.1	58.2	62.8	63.4	50.9	47.3	65.5	62.6	42.8	61.1	82.2	35.2	23.3	62.6	32.9	42.2	29.1	91.6	83.2	36.0	33.5	67.9	52.3	118.6	47.0	54.7	95.1	40.5	71.3	94.6	97.2	73.3	61.1	30.0	72.1	55.6	51.6	30.3	56.9	44.1	58.8	57.6	82.0	109.5	88.6	67.5	48.9	64.7	91.0	46.6	76.5	68.0	61.0	69.0	106.6	70.8	64.7	154.8	54.4	87.8	48.6	38.9	48.5	51.1	72.6	30.1	36.6	47.3	74.9	35.4	95.9	36.0	52.1	146.1	10.8	10.5	6.4	11.2	7.7	8.1	8.9	5.8	5.0	4.4
TPM4		ENSG00000167460	"Tropomyosin 4"	P67936	19	16067021-16103005	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 225.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004685, HPA047089, HPA053624"	Approved		Approved	"Actin filaments,Cytosol"			950000000	"Actin filaments"	Cytosol	"CAB004685: AB_425723, HPA047089: , HPA053624: "	"unprognostic (1.27e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.62e-3)"	"unprognostic (7.38e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.61e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.26e-10)"	"unprognostic (3.85e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.78e-1)"	66.2	17.9	13.3	60.0	13.7	10.8	47.4	46.2	11.5	90.2	40.5	14.6	56.4	17.4	87.1	63.3	149.3	49.4	108.4	39.2	14.5	12.4	32.4	12.2	69.7	27.1	16.0	10.5	102.4	15.4	8.4	16.2	65.0	19.7	84.1	31.8	18.6	47.6	64.6	29.9	39.0	25.2	127.2	22.5	99.7	37.5	30.6	11.7	11.5	20.0	92.2	60.1	177.3	70.5	22.2	35.0	40.7	32.7	24.7	52.5	48.6	58.7	23.3	45.1	27.5	104.9	156.3	56.6	82.3	99.9	69.8	72.0	24.2	61.4	2.7	64.3	102.7	31.7	18.8	47.2	91.3	38.7	10.8	29.6	33.5	19.4	57.7	5.3	70.8	96.7	15.3	57.0	65.6	79.7	3.4	37.3	96.3	20.0	15.9	18.6	23.6	28.4	21.8	38.8	12.7	16.1	50.4	8.2	25.8	55.3	24.8	29.2	0.5	8.2	93.4	121.6	15.4	225.9	76.1	6.5	15.3	13.1	84.3	15.6	41.1	40.7	30.1	2.2	34.8	32.7	26.3	22.2	26.9	31.2	35.0	18.8	7.8	18.3	35.2	24.7	16.2	27.4	52.5	48.6	13.3	13.7	46.2	11.5	14.5	12.4	16.0	10.5	19.7	11.7
TPP1	"CLN2, SCAR7"	ENSG00000166340	"Tripeptidyl peptidase 1"	O14773	11	6612763-6619485	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"	"Disease mutation, Epilepsy, Neurodegeneration, Neuronal ceroid lipofuscinosis, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037709, HPA044868"	Enhanced				"Intracellular and membrane"		13000000			"HPA037709: AB_10672913, HPA044868: AB_2679122"	"unprognostic (8.27e-3)"	"unprognostic (5.85e-2)"	"unprognostic (7.12e-3)"	"unprognostic (3.34e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (4.31e-4)"	"prognostic unfavourable (1.11e-4)"	"unprognostic (6.32e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.23e-2)"	"prognostic unfavourable (4.46e-4)"	"unprognostic (3.87e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.12e-2)"	37.4	64.6	32.2	28.8	36.2	43.0	23.1	15.1	33.3	24.0	26.8	41.7	13.2	28.0	32.0	22.3	20.3	18.0	26.9	25.6	24.5	25.1	36.0	45.1	35.9	42.3	31.0	29.3	22.0	14.8	35.1	30.0	56.4	25.4	19.4	28.2	43.4	18.4	29.1	15.4	15.5	31.4	42.4	32.8	69.0	19.8	17.9	24.7	21.7	24.0	9.1	26.9	25.6	29.4	9.4	43.5	12.8	38.9	7.0	15.3	26.2	4.9	10.1	5.1	9.6	59.4	32.9	3.9	9.8	46.5	7.6	13.3	4.2	21.3	7.2	6.5	24.7	14.9	10.0	13.7	11.6	7.1	5.7	5.8	5.2	11.2	44.9	8.3	35.3	49.3	22.4	8.9	19.8	32.5	11.0	21.6	22.2	6.1	2.6	10.3	3.6	12.2	6.5	4.3	14.0	13.5	7.8	0.6	3.9	10.5	7.8	18.3	5.2	15.9	37.1	22.0	6.3	19.8	3.5	18.3	17.9	2.5	28.0	19.6	11.5	12.8	37.7	8.9	10.7	38.9	8.7	9.4	8.5	11.0	43.5	8.5	5.8	7.6	6.9	7.0	26.4	24.2	15.3	26.2	32.2	36.2	15.1	33.3	24.5	25.1	31.0	29.3	25.4	24.7
TPP2	TPPII	ENSG00000134900	"Tripeptidyl peptidase 2"	P29144	13	102597003-102679958	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021069, HPA049630"	Approved		Supported	"Nuclear bodies,Cytosol"			410000	"Nuclear bodies, Cytosol"		"HPA021069: AB_1858344, HPA049630: "	"unprognostic (4.75e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.45e-2)"	"unprognostic (8.33e-3)"	"unprognostic (5.02e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.26e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.95e-2)"	"unprognostic (3.43e-3)"	19.9	12.4	10.8	21.4	14.5	24.7	18.1	23.1	18.4	16.8	14.7	12.2	50.3	13.1	20.0	21.8	14.4	16.7	13.5	17.0	11.7	9.7	12.9	22.8	18.4	32.8	11.7	13.8	21.6	16.3	15.7	15.7	19.2	15.3	13.9	21.0	12.9	15.6	34.5	35.7	14.1	17.4	19.2	13.4	20.7	15.4	34.5	14.0	23.8	21.9	16.0	19.7	17.0	16.0	6.0	5.8	9.2	6.9	10.9	12.1	4.7	15.9	6.4	18.5	15.7	12.5	17.3	13.2	16.3	11.9	10.5	13.2	13.5	21.5	17.5	5.6	13.1	15.7	14.3	11.5	19.0	12.2	12.7	33.3	16.8	10.8	10.6	37.6	20.3	13.4	5.2	11.8	15.8	15.0	19.8	19.6	14.8	5.0	17.3	28.2	15.0	8.9	19.2	14.0	15.8	13.6	13.2	17.2	14.1	10.2	17.1	7.3	9.8	42.2	12.0	10.0	7.3	6.4	13.5	19.3	23.3	15.3	16.7	27.2	12.9	9.2	6.0	4.0	9.1	6.9	10.7	6.0	10.3	10.1	5.8	5.5	12.1	11.5	1.3	10.9	5.7	4.6	10.9	4.7	10.8	14.5	23.1	18.4	11.7	9.7	11.7	13.8	15.3	14.0
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"				"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favourable (4.71e-4)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	22.0	19.1	28.7	16.6	23.0	20.6	30.2	25.4	17.0	18.0	16.8	28.7	18.9	25.9	19.7	17.2	29.0	21.6	17.4	22.2	19.4	23.6	34.5	30.9	20.1	12.4	36.8	22.6	15.7	10.6	27.1	21.1	21.2	41.5	23.4	19.1	19.1	18.2	9.8	31.6	6.7	21.7	22.5	22.4	14.7	26.6	15.6	24.8	29.6	19.7	15.9	21.9	23.5	29.7	18.0	17.1	19.8	30.7	25.7	30.0	23.7	11.5	18.8	16.1	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8
TPT1	"fortilin, TCTP"	ENSG00000133112	"Tumor protein, translationally-controlled 1"	P13693	13	45333471-45341370	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB008364, HPA039437"	Approved		Supported	Cytosol			3000000	Cytosol		"CAB008364: AB_591904, HPA039437: "	"prognostic favourable (5.90e-5)"	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (2.35e-4)"	"unprognostic (3.25e-1)"	"unprognostic (3.57e-2)"	"unprognostic (8.71e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.56e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.54e-5)"	"unprognostic (1.47e-1)"	"unprognostic (8.48e-2)"	"prognostic favourable (4.31e-5)"	"unprognostic (6.51e-2)"	197.3	108.4	81.7	126.7	74.3	156.7	185.4	35.2	41.3	173.3	229.7	66.5	131.7	101.9	197.9	162.6	234.4	97.1	168.2	292.9	74.4	58.0	141.0	317.4	179.5	286.0	85.1	27.1	273.2	671.6	32.3	97.4	188.3	46.3	203.4	91.6	77.5	460.5	124.6	772.2	98.5	178.1	169.1	101.1	180.2	107.7	95.9	52.1	211.5	306.1	322.2	178.4	211.5	356.3	106.0	111.8	76.0	91.7	110.6	165.2	205.6	58.1	52.8	89.4	58.4	264.1	368.4	106.3	124.0	193.3	79.2	83.2	118.5	151.5	124.1	104.7	128.7	101.5	72.1	182.0	109.8	57.3	63.1	99.4	48.0	131.5	266.9	135.2	155.8	302.0	370.5	50.4	305.1	163.5	73.6	34.3	161.5	106.2	163.7	323.1	101.9	56.3	103.3	84.8	92.7	203.0	122.3	38.1	102.1	41.1	131.8	189.2	75.6	394.4	106.5	36.6	52.1	59.3	76.0	84.7	85.6	117.3	97.6	108.1	28.4	76.0	91.7	44.6	82.3	71.6	149.6	106.0	154.6	111.3	87.2	84.4	165.2	133.5	42.2	110.6	65.9	111.8	134.7	205.6	81.7	74.3	35.2	41.3	74.4	58.0	85.1	27.1	46.3	52.1
TPTE	"CT44, PTEN2"	ENSG00000274391	"Transmembrane phosphatase with tensin homology"	P56180	21	10521553-10606140	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	69	"testis: 78.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;K-562: 8.7;Karpas-707: 7.1;MCF7: 5.2;PC-3: 5.3;RPMI-8226: 9.6;U-2 OS: 4.7;U-266/70: 8.6"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA049690, HPA068342"	Enhanced		Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA049690: , HPA068342: "															"unprognostic (3.63e-2)"			0.1	0.0	0.0	0.7	0.2	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0		0.1	0.8	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.0	0.2	0.7	0.3	0.0	0.0	0.2	0.4	0.0	0.9	0.0	78.6	0.0	0.4	0.1	0.4	0.8	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	7.1	0.0	5.2	0.0	0.0	1.2	5.3	0.0	0.0	9.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	4.7	2.4	0.0	8.6	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0										
TPTE2	TPIP	ENSG00000132958	"Transmembrane phosphoinositide 3-phosphatase and tensin homolog 2"	Q6XPS3	13	19422877-19536762	"Enzymes, Plasma proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 12.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 9.9;Karpas-707: 2.9"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068342			Approved	"Endoplasmic reticulum,Cytosol"				Cytosol	"Endoplasmic reticulum"	"HPA068342: "	"unprognostic (2.50e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.25e-2)"	"unprognostic (5.33e-3)"		"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.05e-12)"	"unprognostic (1.04e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.00e-3)"	0.0	0.1	0.4	0.2	1.0	0.0	0.1	0.7	0.8	0.0	0.1			0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.4		0.0	0.0	0.0	0.1	0.1		0.0	0.1		0.2	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.2	12.3			0.0		0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.9	0.0	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.3	0.3	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.4	0.0	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0										
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol			40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: , HPA064972: "	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favourable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.3	13.0	32.6	16.6	9.5	7.5	17.9	25.5	16.4	28.2	22.3	20.8	16.6	30.4	30.7	13.0	20.5	35.6	24.8	33.1	25.5	22.6	28.4	11.7	27.6	12.7	30.1	23.0	7.2	12.3	16.6	16.1	21.5	27.1	19.4	21.5	16.5	74.5	43.7	48.5	20.2	45.2	26.3	35.5	27.3	13.7	24.2	24.1	16.8	23.7	30.0	23.9	33.4	12.2	19.1	25.0	15.9	38.2	35.8	87.2	56.7	19.6	35.0	30.0	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1
TRABD	PP2447	ENSG00000170638	"TraB domain containing"	Q9H4I3	22	50185915-50199598	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000822	Approved		Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA000822: AB_10959384"	"unprognostic (9.37e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (1.19e-5)"	"unprognostic (2.80e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.27e-2)"	"prognostic unfavourable (1.85e-4)"	"unprognostic (1.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.98e-3)"	8.9	10.3	8.3	28.8	13.4	45.5	12.0	15.3	11.4	10.6	14.7	7.4	19.9	15.9	9.3	15.6	19.9	9.2	18.1	10.0	9.0	4.9	13.4	20.0	13.1	25.6	12.4	6.1	10.2	42.9	5.9	12.0	9.6	9.5	14.8	6.0	8.4	24.6	19.5	14.0	13.0	18.3	9.3	9.6	19.5	16.5	9.7	11.8	21.0	13.2	13.2	33.1	11.5	13.1	6.9	33.0	23.0	14.2	14.7	13.6	9.2	22.4	14.9	5.4	8.8	2.9	3.4	13.5	7.8	5.1	6.6	5.6	9.4	10.8	13.9	7.7	3.6	14.1	6.9	13.8	1.3	9.7	32.2	8.0	23.0	15.9	11.6	16.2	16.0	5.5	8.5	4.8	6.5	6.4	9.8	22.8	2.8	24.8	11.2	18.4	7.9	14.2	31.4	7.3	29.3	5.0	21.8	6.3	10.6	6.7	24.3	11.1	10.4	16.4	7.1	5.5	13.7	7.1	8.7	27.8	4.9	16.6	6.8	11.3	8.6	7.0	14.2	23.0	10.9	12.5	10.2	6.9	9.8	9.8	15.4	3.6	6.7	7.7	19.5	14.7	7.6	33.0	13.6	9.2	8.3	13.4	15.3	11.4	9.0	4.9	12.4	6.1	9.5	11.8
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavourable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.4	8.8	4.9	12.9	8.8	20.3	19.3	13.3	11.5	5.5	28.1	12.2	14.4	5.3	20.2	9.9	10.0	29.7	12.6	3.7	9.8	10.4	3.0	4.4	10.5	6.0	6.0	16.8	15.2	5.7	15.5	15.9	14.1	14.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.8	10.0	18.5	11.6	6.8	16.9	10.9	11.0	14.7	6.3	10.3	13.2	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4
TRAF4	"CART1, MLN62, RNF83"	ENSG00000076604	"TNF receptor associated factor 4"	Q9BUZ4	17	28743984-28750958	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 27.7"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052377	Enhanced									"HPA052377: "	"unprognostic (1.77e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.76e-1)"	"unprognostic (7.38e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.77e-2)"	"unprognostic (5.58e-3)"	5.0	8.1	13.8	13.1	14.5	19.9	15.9	6.3	12.4	7.9	22.2	24.7	14.0	32.8	6.8	5.7	15.4	9.5	17.1	2.8	12.7	7.6	20.7	30.1	13.5	12.5	17.9	7.7	7.2	33.8	3.1	8.1	11.8	12.4	16.7	16.0	6.0	32.2	10.4	0.9	7.5	31.4	5.1	10.9	10.2	21.7	7.4	16.4	5.9	16.4	7.1	16.5	15.9	6.0	5.3	27.7	2.7	0.6	0.8	1.4	0.9	11.3	18.2	25.1	12.2	3.6	4.2	39.0	7.7	6.7	8.4	11.1	14.4	14.6	17.8	11.4	8.6	17.3	11.4	17.7	3.4	5.6	16.0	6.3	30.1	16.4	14.0	3.0	7.1	8.0	17.5	9.9	11.8	6.5	16.6	1.6	7.6	19.1	9.6	6.4	19.4	4.2	14.2	11.4	8.7	23.8	33.5	15.8	18.2	12.2	53.7	23.2	20.4	4.9	4.3	5.3	11.1	6.0	10.8	2.4	5.7	22.2	4.2	5.1	24.0	2.7	0.2	0.9	0.6	0.6	1.4	5.3	1.0	1.0	1.5	5.3	0.7	0.7	0.1	0.8	0.4	27.7	0.5	0.9	13.8	14.5	6.3	12.4	12.7	7.6	17.9	7.7	12.4	16.4
TRAM1	"TRAM, TRAMP"	ENSG00000067167	"Translocation associated membrane protein 1"	Q15629	8	70573442-70608387	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023929	Approved									"HPA023929: AB_1858239"	"unprognostic (3.85e-2)"	"prognostic unfavourable (2.06e-4)"	"unprognostic (8.34e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.61e-2)"	"prognostic unfavourable (7.79e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.85e-2)"	38.0	31.3	14.6	22.8	15.5	20.8	33.4	10.3	13.0	36.6	36.0	18.5	37.7	21.6	32.9	37.7	26.6	28.7	28.7	30.7	15.7	15.0	59.4	123.7	58.6	31.9	19.0	10.4	32.9	89.0	23.6	30.9	45.9	14.6	32.2	19.4	23.5	84.4	45.1	16.1	19.2	40.0	23.2	24.0	46.8	24.9	26.9	16.0	49.1	60.9	19.0	31.5	33.0	30.6	34.2	59.3	35.4	33.2	40.0	51.0	63.5	26.5	26.2	11.5	7.0	55.8	58.8	16.5	47.8	46.4	36.1	43.9	16.5	42.2	25.5	10.4	39.5	34.2	10.4	39.7	34.8	17.3	11.7	18.5	9.3	18.7	82.0	13.9	10.5	69.9	38.7	17.8	65.2	30.0	11.8	66.7	44.2	7.0	31.1	9.7	7.5	12.9	15.4	8.8	16.7	94.9	24.3	8.4	9.1	30.7	61.0	26.7	22.8	15.1	30.6	22.1	19.5	25.3	15.5	54.6	21.8	13.1	25.2	14.2	16.3	35.4	30.4	19.5	39.8	32.7	51.0	34.2	43.3	44.8	36.5	27.0	41.0	41.8	8.7	40.0	33.2	59.3	44.1	63.5	14.6	15.5	10.3	13.0	15.7	15.0	19.0	10.4	14.6	16.0
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717597	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria			1100000	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	19.1	20.3	19.1	15.9	29.7	14.2	17.5	21.1	38.5	16.8	23.0	18.1	13.1	18.6	17.1	14.2	34.4	28.5	20.8	40.0	22.1	20.4	24.6	62.6	12.3	20.6	17.1	30.7	23.5	54.7	18.3	13.6	15.5	23.2	15.4	17.8	16.4	19.7	13.7	80.3	31.2	14.1	20.9	12.3	15.2	19.7	20.0	15.1	16.4	16.0	39.8	21.2	17.2	18.2	20.0	24.6	1.3	17.0	12.7	22.3	13.8	18.9	47.7	9.9	26.2	11.0	11.3	29.4	11.5	10.5	26.8	16.9	59.2	27.1	61.1	21.9	11.1	35.7	38.6	28.8	11.8	23.4	42.2	17.8	40.9	41.4	18.9	31.9	12.3	13.3	20.1	21.2	33.3	18.3	55.9	22.3	8.7	62.0	22.9	23.7	18.4	24.3	52.7	20.8	84.3	19.8	14.1	47.3	18.0	12.0	44.4	23.1	32.1	23.2	10.3	11.3	20.2	19.7	16.8	23.8	26.2	48.1	7.0	25.8	15.3	0.0	10.8	0.3	11.7	17.0	22.3	20.0	17.1	14.8	24.6	13.9	20.3	17.1	1.3	12.7	12.3	3.6	14.2	13.8	19.1	29.7	21.1	38.5	22.1	20.4	17.1	30.7	23.2	15.1
TRAPPC10	"EHOC-1, TMEM1, TRS130"	ENSG00000160218	"Trafficking protein particle complex 10"	P48553	21	44012319-44106552	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"basophil: 9.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.5"									HPA050423	Supported									"HPA050423: "	"unprognostic (1.82e-2)"	"unprognostic (4.89e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.93e-1)"	"unprognostic (4.00e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.76e-1)"	13.5	13.2	15.5	16.7	25.8	34.2	21.8	16.6	24.7	13.4	16.7	28.0	10.3	12.9	14.3	19.8	15.4	13.6	13.6	11.4	18.5	14.7	17.8	17.2	14.7	21.9	28.9	16.5	11.8	13.7	22.3	14.5	14.5	21.6	10.7	18.4	11.6	14.4	12.4	15.5	13.7	20.4	13.4	21.3	23.9	16.2	20.9	23.1	25.6	17.2	8.7	27.0	14.0	12.0	1.0	1.2	9.5	1.0	0.5	1.2	0.3	10.4	5.1	7.9	5.4	14.6	7.5	7.9	9.6	9.6	9.9	10.5	11.2	6.1	13.2	3.3	9.2	5.0	7.6	10.4	14.7	8.4	7.3	18.1	5.6	4.2	6.7	12.1	11.0	5.8	11.3	12.7	10.1	11.0	13.2	14.1	16.5	7.5	6.9	5.8	9.1	7.9	7.7	5.2	10.8	5.7	7.3	11.3	6.6	8.7	9.7	8.7	5.3	10.5	11.4	10.3	7.0	11.5	9.2	13.5	12.1	9.7	6.4	11.7	7.8	9.5	0.7	1.4	1.0	0.9	0.2	0.5	1.2	1.0	0.5	1.0	0.5	0.9	1.3	0.5	1.0	1.2	0.1	0.3	15.5	25.8	16.6	24.7	18.5	14.7	28.9	16.5	21.6	23.1
TRAPPC12	"CGI-87, TTC-15, TTC15"	ENSG00000171853	"Trafficking protein particle complex 12"	Q8WVT3	2	3379675-3485094	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034799, HPA043196"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"		"HPA034799: AB_10600920, HPA043196: "	"prognostic favourable (1.80e-5)"	"unprognostic (9.21e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.27e-1)"	"prognostic favourable (9.15e-4)"	"unprognostic (3.23e-2)"	"prognostic unfavourable (2.44e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.18e-2)"	18.2	17.3	15.2	19.7	19.7	14.6	12.8	18.3	25.3	20.3	16.4	21.1	15.2	15.8	19.7	14.4	16.7	14.8	17.9	26.8	16.0	15.6	16.1	29.2	16.8	22.0	15.4	15.6	19.3	16.4	16.5	20.4	12.8	20.6	18.5	8.3	16.3	24.4	16.9	40.7	41.3	17.6	16.4	13.1	19.9	17.1	50.8	12.2	23.2	16.8	17.3	18.6	16.9	14.1	1.0	7.5	6.0	5.5	1.4	3.9	1.2	8.4	14.7	4.8	5.5	10.9	13.6	12.8	13.9	3.4	4.1	2.2	9.1	7.1	9.6	15.4	4.7	10.8	5.6	6.2	1.6	11.6	20.9	8.3	4.2	31.1	4.9	10.4	14.9	9.9	4.8	4.5	11.5	3.5	12.8	5.3	7.1	11.7	10.4	17.8	11.8	20.8	7.9	6.6	7.7	4.4	7.0	12.4	20.2	5.5	6.3	9.1	7.3	8.4	8.9	10.1	5.7	10.0	12.2	15.2	11.2	7.6	11.7	8.2	5.5	1.2	1.8	6.0	1.4	4.1	3.6	0.9	2.3	3.8	2.4	1.0	1.6	1.9	1.7	1.4	5.5	7.5	3.9	1.2	15.2	19.7	18.3	25.3	16.0	15.6	15.4	15.6	20.6	12.2
TRAPPC4	"PTD009, SBDN, TRS23"	ENSG00000196655	"Trafficking protein particle complex 4"	Q9Y296	11	119018432-119025454	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039752, HPA041371"	Approved		Approved	Cytosol				Cytosol		"HPA039752: AB_2676664, HPA041371: "	"unprognostic (5.26e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.18e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavourable (2.03e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.32e-1)"	20.4	26.8	17.1	11.8	21.2	16.3	14.8	15.6	20.1	16.1	20.4	16.1	33.7	20.4	13.6	20.4	16.3	14.3	19.4	15.4	16.1	20.1	30.1	20.3	16.3	15.3	17.5	16.2	16.4	19.4	11.9	21.1	16.2	16.5	20.2	13.8	16.2	14.4	24.8	26.4	12.7	23.8	14.5	17.1	15.5	18.1	19.6	12.1	16.4	18.2	10.0	18.1	18.1	10.6	29.9	28.6	39.7	28.0	26.3	47.2	29.4	7.7	7.9	9.0	9.3	11.0	7.7	4.2	30.8	17.0	18.9	15.1	18.3	3.1	8.9	21.9	11.5	7.3	13.8	11.3	14.5	16.0	8.3	14.9	7.7	20.1	15.9	12.0	7.5	11.2	10.2	18.1	13.7	16.4	16.7	3.5	10.8	17.5	13.6	11.5	7.1	21.7	12.3	7.0	10.7	13.1	10.1	3.5	8.4	6.0	6.8	7.4	27.7	10.8	12.1	5.2	10.1	6.5	9.9	4.8	9.3	22.2	5.7	9.6	8.5	29.8	20.8	39.7	28.9	22.9	29.3	29.9	33.7	32.9	20.0	26.7	31.4	34.0	17.9	26.3	28.0	28.6	47.2	29.4	17.1	21.2	15.6	20.1	16.1	20.1	17.5	16.2	16.5	12.1
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.5;K-562: 1.8;MCF7: 6.0;SCLC-21H: 1.2;SK-BR-3: 1.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: "	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 23.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"									HPA005563	Uncertain				"Intracellular and membrane"					"HPA005563: AB_1858259"	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 37.9;bone marrow: 10.5;heart muscle: 10.0;lymphoid tissue: 26.7"	"Cell line enriched"	"Detected in single"	166	"HEL: 37.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 19.2"	"Lineage enriched"	"Detected in single"	31	"granulocytes: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced						94000000			"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	1.2	1.2	2.1	3.7	1.2	10.5	0.6	0.5	1.3	0.4	0.3	0.3	0.3	0.0	0.3	0.6	0.3	0.6	1.3	10.0	2.1	1.6	0.3	0.3	2.9	7.7	3.3	0.3	1.9	0.5	0.2	0.6	1.7	1.2	0.3	1.3	0.6	1.3	0.3	0.8	0.3	0.4	0.3	4.3	26.7	0.2	0.8	0.3	1.4	0.6	0.3	7.1	1.1	0.3	0.1	0.3	19.2	0.6	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	37.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.6	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	3.9	0.0	0.1	0.3	0.0	37.9	2.1	1.2	0.5	0.7	2.1	1.6	3.3	0.3	1.2	0.3
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41190277-41201194	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.8;bone marrow: 13.6;placenta: 54.3"	"Cell line enhanced"	"Detected in some"		"HEL: 24.4;HL-60: 5.7;U-698: 6.9;U-937: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 16.1;neutrophil: 20.8"	"Group enriched"	"Detected in many"	15	"B-cells: 16.1;dendritic cells: 5.5;granulocytes: 20.8"					"Low region specificity"	"Detected in some"										2300000				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.2	0.2	6.3	0.2	13.6	0.2	0.2	0.2	0.2	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.9	0.3	0.5	0.2	0.2	0.3	0.4	1.5	9.2	0.2	0.1	0.2	0.2	0.0	0.2	54.3	0.3	0.2	0.0	0.1	1.5	0.1	0.2	0.2	1.9	0.1	0.3	12.3	0.4	5.9	0.2	4.9	0.3	0.1	7.5	0.8	0.2	16.1	5.5	20.8	0.8	0.4	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.3	1.8	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.1	4.5	0.0	1.4	0.3	7.7	0.2	0.7	0.3	3.6	0.6	0.1	1.3	16.1	0.9	0.2	20.8	0.4	0.8	5.5	0.4	1.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.2
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: "	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.8	13.2	7.1	9.7	5.3	4.4	33.5	9.1	6.1	10.6	8.5	16.0	12.1	10.4	10.2	6.1	22.6	8.5	8.7	4.5	11.6	20.5	8.6	12.2	8.6	14.5	10.9	13.2	5.9	14.0	10.9	5.5	5.2	19.7	13.5	5.4	9.0	13.1	17.2	18.1	11.7	12.9	6.4	12.6	6.9	17.0	11.8	21.7	7.6	21.6	12.0	15.2	18.2	5.8	6.7	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.7	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8
TRIM21	"RNF81, Ro/SSA, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393696	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004566, HPA005673"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favourable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favourable (2.26e-6)"	"unprognostic (9.12e-3)"	18.2	12.1	4.9	13.7	6.5	15.0	9.8	2.5	6.4	15.0	11.7	6.4	6.0	12.5	11.6	10.3	14.6	10.4	10.8	8.5	5.0	5.3	12.9	14.9	14.6	21.4	6.8	4.0	17.4	10.7	4.3	9.9	19.9	8.6	18.0	12.0	8.5	11.9	8.6	4.5	6.9	21.8	12.0	4.7	28.3	13.5	6.0	4.7	21.5	19.1	6.8	17.0	11.6	13.5	10.9	22.0	72.4	27.5	14.5	19.5	28.6	5.9	7.0	3.5	3.3	7.3	11.0	4.9	7.6	14.4	30.2	33.5	3.2	17.2	9.1	3.5	11.2	8.5	6.2	11.6	9.4	15.2	6.9	14.0	4.0	2.8	16.2	16.5	13.9	10.7	7.0	6.1	4.2	18.4	4.4	10.0	10.0	5.2	8.6	12.1	3.0	3.6	6.1	4.6	5.0	11.9	5.5	0.0	1.5	6.2	7.0	8.4	2.4	11.3	16.5	7.4	5.8	3.8	2.8	5.3	4.1	5.8	6.6	13.1	5.2	18.8	26.9	60.1	19.3	27.5	16.8	10.5	16.6	17.1	22.0	10.9	14.9	15.7	72.4	14.5	24.4	7.4	19.5	28.6	4.9	6.5	2.5	6.4	5.0	5.3	6.8	4.0	8.6	4.7
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 42.7;HMC-1: 57.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavourable (9.94e-4)"	"prognostic favourable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.1	5.1	42.7	12.3	2.9	2.6	3.3	3.9	4.1	3.0	3.0	8.1	3.9	8.0	3.9	3.7	2.2	20.7	3.2	4.5	6.1	5.1	17.7	3.8	24.9	3.9	13.7	57.8	2.3	3.4	2.5	4.1	7.2	20.0	4.9	3.6	8.1	23.4	12.5	16.3	4.6	18.6	5.0	6.8	6.8	12.5	8.9	20.2	7.3	6.5	2.1	4.5	9.1	3.0	3.5	2.9	6.2	5.3	4.6	4.9	13.7	5.9	9.1	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.8	14.3	3.5	11.9	26.7	22.6	0.0	11.4	23.1	27.3	23.6	13.9	15.9	28.2	23.7	10.9	17.2	17.2	15.3	15.3	24.0	13.6	18.2	11.1	15.4	23.0	21.7	13.1	10.1	25.8	14.2	30.3	18.1	4.4	17.3	13.8	19.3	24.2	15.7	2.2	27.8	17.4	11.9	17.7	15.9	22.8	6.9	6.4	9.0	14.5	26.5	19.6	17.7	12.0	12.8	9.2	19.6	11.8	9.8	18.7	4.7	12.4	15.0	5.0	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544091-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 217.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"		140000	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: "	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	24.2	26.4	17.9	40.1	20.6	52.2	30.6	34.5	26.3	46.7	36.5	26.2	26.2	26.8	43.3	30.0	34.1	34.5	38.5	28.4	18.5	16.4	27.3	42.3	29.5	38.1	29.2	22.7	69.3	47.0	30.7	25.7	45.6	22.8	37.6	18.5	21.5	31.8	32.4	56.5	41.2	27.5	38.4	17.9	34.9	32.9	48.1	23.1	119.9	50.6	33.5	33.5	34.0	46.4	13.7	14.6	5.0	7.6	16.0	16.9	6.3	35.8	77.2	41.5	30.6	18.1	13.9	46.3	23.6	21.4	23.0	17.6	53.8	30.2	39.5	15.6	20.3	24.6	46.9	33.9	15.1	20.2	217.0	67.9	35.0	42.7	19.3	43.0	43.7	18.8	18.9	29.4	23.1	21.5	33.0	22.3	21.2	53.1	60.1	53.1	29.1	49.8	57.1	25.1	42.4	20.6	59.6	41.6	32.6	24.6	32.0	13.1	22.0	41.9	19.8	54.2	21.5	11.8	42.2	28.7	46.8	44.1	24.5	32.2	34.3	1.3	7.1	5.0	8.9	7.6	11.6	11.5	12.8	12.3	9.0	13.7	16.9	15.1	3.8	16.0	4.9	14.6	8.2	6.3	17.9	20.6	34.5	26.3	18.5	16.4	29.2	22.7	22.8	23.1
TRIOBP	"DFNB28, HRIHFB2122, KIAA1662, TAP68, Tara"	ENSG00000100106	"TRIO and F-actin binding protein"	Q9H2D6	22	37696988-37776556	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003747, HPA019769"	Enhanced									"HPA003747: AB_1858328, HPA019769: AB_1858329"	"unprognostic (2.94e-1)"	"prognostic favourable (4.29e-4)"	"unprognostic (2.79e-1)"	"unprognostic (4.57e-2)"	"unprognostic (8.22e-2)"	"unprognostic (7.44e-3)"	"unprognostic (3.77e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.81e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.67e-2)"	19.0	17.6	8.6	17.3	9.5	10.5	47.4	3.5	7.1	31.5	22.6	8.0	9.8	11.0	27.4	17.6	29.0	24.9	28.1	36.8	7.6	3.7	15.1	15.3	27.8	18.7	9.8	6.4	31.3	13.2	9.8	6.5	32.1	10.7	23.0	7.9	20.2	16.9	17.2	10.5	10.9	13.7	34.9	6.7	24.3	21.8	14.3	7.1	9.9	17.9	15.0	19.2	25.4	23.1	1.7	3.4	15.1	9.5	1.6	2.0	1.6	19.7	16.1	10.4	8.1	22.8	37.0	14.5	34.0	34.9	18.4	13.8	3.6	13.7	7.5	9.3	20.9	15.9	2.9	19.5	5.6	11.7	9.2	2.0	11.5	6.5	23.5	9.5	9.0	14.8	9.1	16.2	8.0	22.8	1.9	10.7	14.0	11.6	4.2	6.8	6.2	19.4	7.4	7.4	5.1	12.7	15.5	5.1	8.1	15.3	14.6	17.7	7.9	6.8	45.4	27.1	12.2	18.5	8.1	9.4	2.6	4.7	26.2	3.9	31.3	5.3	6.3	9.8	1.6	6.2	0.5	1.1	1.3	1.6	3.4	1.7	1.1	1.6	15.1	1.6	9.5	1.5	2.0	1.6	8.6	9.5	3.5	7.1	7.6	3.7	9.8	6.4	10.7	7.1
TRIP10	"CIP4, HSTP, STOT, STP"	ENSG00000125733	"Thyroid hormone receptor interactor 10"	Q15642	19	6737925-6751526	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 103.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"plasmacytoid DC: 19.4"	"Lineage enriched"	"Detected in many"	12	"dendritic cells: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041934, HPA072625, HPA073886"	Approved		Supported	Nucleoplasm,Vesicles			15000	Vesicles	Nucleoplasm	"HPA041934: , HPA072625: , HPA073886: "	"unprognostic (5.75e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (3.61e-4)"	"unprognostic (2.19e-2)"	"unprognostic (6.57e-2)"	"prognostic favourable (1.76e-4)"	"unprognostic (6.73e-3)"	"unprognostic (1.10e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.28e-1)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.93e-2)"	"unprognostic (8.83e-2)"	19.7	10.7	6.0	9.2	7.2	2.3	16.8	3.7	5.4	25.6	19.1	4.5	20.6	9.7	17.8	16.7	44.8	12.0	17.6	18.1	6.5	1.9	14.0	4.5	19.5	5.4	6.7	3.5	22.4	12.9	7.0	4.8	25.4	7.0	19.2	6.6	20.2	16.1	18.3	103.7	10.4	10.1	20.9	6.7	7.1	11.3	8.7	5.4	2.8	31.7	21.6	21.7	24.3	26.5	1.5	19.4	0.1	0.7	1.6	0.9	0.4	26.6	16.2	5.7	8.6	22.4	23.5	20.5	17.2	19.9	19.7	17.3	21.9	15.4	0.5	23.4	14.5	19.9	12.8	25.1	11.8	16.8	5.1	8.7	15.3	16.7	18.4	0.4	2.7	27.1	17.1	17.5	13.5	20.2	12.7	7.3	14.4	9.0	2.3	6.0	12.1	13.8	3.9	11.7	7.8	16.6	13.3	0.0	6.6	22.7	10.2	6.4	10.7	4.7	39.4	13.3	23.9	34.7	18.1	7.7	4.2	2.6	21.5	2.5	8.7	0.0	0.7	0.0	0.5	0.1	0.7	1.2	0.2	0.9	3.8	1.5	0.3	0.2	0.1	1.6	0.1	19.4	0.0	0.4	6.0	7.2	3.7	5.4	6.5	1.9	6.7	3.5	7.0	5.4
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: "	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favourable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	13.0	15.0	10.5	10.8	12.5	7.7	12.1	18.5	14.1	17.4	13.0	8.8	15.2	11.1	13.3	12.7	14.7	11.4	11.2	12.9	9.2	6.7	15.5	16.1	10.6	9.4	12.2	11.1	16.0	27.1	27.1	34.9	24.4	15.2	14.5	11.0	9.4	15.1	15.3	24.0	12.4	15.9	11.2	10.7	15.2	16.2	14.0	13.5	16.4	18.4	11.1	11.9	15.8	12.5	20.0	12.7	17.0	13.0	12.1	14.1	3.9	12.4	12.6	8.2	8.6	14.5	22.5	12.5	19.8	15.2	9.8	11.3	7.6	20.3	8.7	14.6	17.4	16.4	10.8	9.6	21.5	13.2	3.3	9.8	11.4	7.2	11.1	11.5	9.8	8.6	11.8	17.3	14.9	15.6	6.4	10.1	15.3	17.4	6.5	2.8	3.7	9.0	8.1	15.7	4.3	8.8	20.4	6.0	5.4	16.0	9.4	6.1	20.5	5.8	20.6	11.4	8.1	11.9	8.9	9.0	13.8	7.8	13.4	6.5	14.3	8.2	8.8	17.0	13.3	8.0	12.8	11.8	14.1	12.1	6.9	20.0	13.5	14.1	8.7	12.1	13.0	12.7	12.2	3.9	10.5	12.5	18.5	14.1	9.2	6.7	12.2	11.1	15.2	13.5
TRIP12	KIAA0045	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763838-229923239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA036835: , HPA045893: "	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	29.6	28.1	23.6	25.4	26.9	26.9	23.1	20.5	26.2	24.0	23.1	26.2	24.3	14.3	25.3	26.3	30.6	19.9	20.7	35.9	19.0	19.3	26.2	24.9	26.2	26.5	23.1	20.5	24.3	18.8	32.4	33.1	27.2	24.8	25.8	21.3	22.3	25.5	22.0	62.7	23.6	22.0	26.2	23.3	32.5	23.4	77.1	24.0	42.2	28.0	21.5	31.5	26.5	27.4	7.0	9.1	25.8	12.0	9.1	12.7	6.1	23.8	26.9	24.7	20.7	23.6	28.7	23.0	36.8	25.0	26.7	29.8	21.5	19.2	9.3	27.0	32.8	18.7	36.0	26.2	39.2	38.2	13.1	64.8	22.6	19.0	20.4	48.7	42.4	24.8	20.2	44.4	28.5	34.8	47.8	10.0	30.5	18.1	27.2	16.8	19.3	12.3	24.8	48.8	8.2	19.8	41.0	25.1	17.9	0.5	12.4	25.3	12.5	29.8	48.3	34.6	24.6	22.5	28.4	17.4	19.9	30.5	26.4	19.2	29.0	18.8	9.9	15.7	9.5	11.3	9.7	7.0	8.8	9.2	9.1	6.8	7.3	7.0	25.8	9.1	12.0	9.0	12.7	6.1	23.6	26.9	20.5	26.2	19.0	19.3	23.1	20.5	24.8	24.0
TRMT1	"FLJ20244, TRM1"	ENSG00000104907	"TRNA methyltransferase 1"	Q9NXH9	19	13104902-13117567	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041130, HPA041380"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041130: AB_10803995, HPA041380: AB_10793873"	"unprognostic (2.10e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.91e-2)"	"unprognostic (8.74e-3)"	"prognostic unfavourable (9.87e-7)"	"unprognostic (1.19e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-2)"	15.5	15.0	19.1	19.8	23.5	23.1	16.6	19.5	22.6	15.0	16.3	17.3	15.5	14.9	19.2	19.0	17.6	19.6	19.4	13.2	15.7	13.4	14.4	17.3	13.5	26.8	22.1	14.7	29.1	23.8	16.3	14.4	14.4	21.9	18.1	14.5	10.9	14.9	15.6	21.4	22.1	16.1	16.5	12.4	25.0	16.3	16.8	20.1	12.2	15.6	12.1	19.6	17.3	18.8	11.2	14.9	3.1	15.7	4.3	10.2	8.5	15.3	10.4	11.3	19.1	11.5	14.7	16.2	17.3	8.7	19.1	16.6	11.1	12.7	19.3	22.7	9.3	14.3	18.8	15.2	8.9	12.6	26.3	15.3	26.7	18.6	20.8	30.7	18.1	20.8	20.5	19.9	18.7	14.0	33.2	6.2	11.8	17.0	12.4	33.2	26.7	24.4	21.0	14.5	26.6	11.9	15.7	26.8	12.2	10.8	22.5	18.0	8.7	17.2	15.6	27.6	10.7	16.6	30.3	10.7	20.7	17.8	12.9	32.5	14.3	1.2	15.7	0.5	8.1	11.9	7.7	10.4	8.6	7.7	14.9	11.2	10.2	7.7	3.1	4.3	7.5	8.8	5.6	8.5	19.1	23.5	19.5	22.6	15.7	13.4	22.1	14.7	21.9	20.1
TRMT2A	HTF9C	ENSG00000099899	"TRNA methyltransferase 2 homolog A"	Q8IZ69	22	20111866-20117392	"Plasma proteins, Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 37.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001077	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA001077: AB_1079092"	"unprognostic (5.01e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.19e-3)"	"unprognostic (5.93e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (2.99e-8)"	"unprognostic (4.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.14e-3)"	14.3	22.5	12.6	18.8	13.6	14.3	13.4	16.3	19.7	13.9	16.6	17.4	15.4	18.2	13.1	15.6	16.1	15.3	17.1	12.8	13.1	11.4	13.2	22.8	11.1	22.8	12.4	14.4	15.2	23.6	10.8	18.5	15.8	11.2	16.8	6.1	14.2	36.5	16.1	14.8	18.4	16.2	12.4	12.7	23.2	16.7	16.9	13.4	26.8	15.6	12.7	18.3	13.1	11.0	9.7	14.0	7.0	14.9	9.5	15.2	11.5	6.3	7.4	2.8	4.6	2.9	2.1	9.8	5.7	2.9	4.6	4.1	8.7	5.5	8.8	4.9	2.6	10.0	2.1	3.2	0.6	9.1	24.0	10.1	9.8	7.9	7.9	15.8	10.2	3.8	4.3	4.8	1.8	4.7	37.9	6.1	3.1	10.1	8.9	10.0	5.4	9.4	10.4	4.9	3.6	2.6	7.2	7.6	5.8	3.5	9.1	9.1	6.3	13.5	4.4	5.6	7.5	4.3	4.9	21.9	9.7	6.7	7.5	6.7	5.6	6.6	11.5	7.0	10.5	14.9	15.2	9.7	10.9	12.1	14.0	6.8	12.2	11.5	1.5	9.5	12.0	12.4	8.5	11.5	12.6	13.6	16.3	19.7	13.1	11.4	12.4	14.4	11.2	13.4
TRO	"KIAA1114, MAGE-D3, MAGED3"	ENSG00000067445	Trophinin	Q12816	X	54920462-54931431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 32.1"	"Cell line enhanced"	"Detected in many"		"AF22: 20.9;HEK 293: 12.9;HSkMC: 13.1;SCLC-21H: 14.0;SH-SY5Y: 18.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA053358			Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA053358: "	"unprognostic (6.18e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (9.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.18e-1)"	"prognostic favourable (1.93e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.67e-4)"	"unprognostic (6.33e-2)"	"unprognostic (3.27e-2)"	"unprognostic (6.86e-2)"	4.5	4.2	21.7	2.1	15.5	1.6	3.7	11.3	23.8	8.0	2.5	7.9	1.4	1.7	16.3	8.6	2.4	7.1	5.6	2.9	17.9	15.6	5.3	13.2	2.5	2.3	10.5	13.2	21.7	5.7	7.6	20.2	5.5	22.3	7.4	3.2	5.0	1.5	6.9	32.1	1.5	1.8	10.9	8.9	1.4	2.0	3.6	14.2	4.2	9.2	0.1	2.4	3.6	5.0	0.7	2.6	0.0	0.2	5.2	1.2	0.4	0.0	0.2	20.9	0.0	4.1	5.7	0.0	1.1	7.2	1.1	0.4	0.0	0.0	0.0	3.0	7.5	0.1	0.1	0.3	0.6	0.0	12.9	9.6	0.0	0.8	1.5	0.0	0.1	13.1	0.0	6.7	0.0	0.5	0.0	0.1	7.7	0.0	0.1	0.0	10.7	0.0	6.1	9.1	0.1	2.0	0.1	14.0	18.8	0.0	0.3	1.8	0.0	1.2	0.0	8.8	9.2	0.1	1.1	3.3	0.4	0.0	1.3	0.0	7.6	0.0	0.0	0.0	1.2	0.0	0.7	0.7	0.1	0.4	0.0	0.5	0.3	0.7	0.0	5.2	0.2	2.6	0.0	0.4	21.7	15.5	11.3	23.8	17.9	15.6	10.5	13.2	22.3	14.2
TROVE2	"Ro60, SSA2"	ENSG00000116747	"TROVE domain family member 2"	P10155	1	193059422-193091777	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002835, HPA005142"	Uncertain		Approved	Nucleoplasm,Cytosol			28000	Cytosol	Nucleoplasm	"HPA002835: AB_1857490, HPA005142: "	"unprognostic (1.91e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.94e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (5.62e-2)"	21.2	13.7	13.3	11.4	16.2	29.7	18.5	13.7	16.5	16.9	12.3	13.2	11.7	8.4	15.3	10.9	16.8	11.3	10.9	18.0	13.9	7.7	14.3	13.6	15.0	13.0	19.6	11.8	19.8	12.1	16.8	13.0	13.6	15.1	17.3	9.4	11.4	14.8	14.7	23.4	16.5	11.6	22.7	20.4	14.7	10.9	24.3	17.0	15.1	14.9	8.7	12.9	19.9	19.8	19.1	13.9	38.3	14.6	19.6	24.3	14.5	8.8	15.9	18.4	17.1	15.9	14.7	11.2	13.5	12.6	9.5	12.7	8.1	12.1	18.4	12.5	15.1	13.7	14.4	10.3	16.7	22.7	11.0	22.2	15.2	10.8	14.6	25.8	16.3	13.7	12.2	17.3	19.3	15.3	24.1	24.7	16.2	14.5	15.4	6.8	13.8	5.2	12.9	15.8	20.9	9.2	18.4	6.5	12.9	16.6	20.2	17.4	16.7	8.9	20.4	18.0	6.6	16.9	17.2	14.5	14.8	17.4	9.7	12.9	27.7	38.3	13.9	17.4	24.3	13.1	23.4	19.1	17.9	20.3	13.9	17.2	19.0	21.2	22.7	19.6	14.6	12.2	17.9	14.5	13.3	16.2	13.7	16.0	13.9	7.7	19.6	11.8	15.1	17.0
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Cell line enhanced"	"Detected in some"		"AF22: 7.0;BJ: 16.4;BJ hTERT+ SV40 Large T+: 7.0;fHDF/TERT166: 15.6;U-2197: 7.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	1.1	2.3	0.0	16.4	2.2	7.0	3.8	0.0	0.2	0.0	0.0	15.6	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.3	0.0	2.7	0.0	0.0	1.0	0.0	2.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.1	7.4	1.4	3.9	0.9	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;ASC diff: 8.6;BJ hTERT+: 4.6;HEL: 4.3;RPTEC TERT1: 20.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved						140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.6	0.2	0.0	8.6	2.1	0.0	3.0	4.6	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	4.3	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.9"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.7;NB-4: 23.7;THP-1: 29.2;U-937: 27.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.3;plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 14.5;monocytes: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030976, HPA035260"	Enhanced		Approved	"Nuclear membrane"				"Nuclear membrane"		"HPA030976: , HPA035260: "	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favourable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favourable (7.59e-4)"	5.4	4.5	7.4	8.6	7.8	29.9	3.9	14.5	16.3	2.9	4.5	6.9	0.0	4.4	1.9	1.5	2.1	2.6	5.7	1.8	7.8	8.9	2.1	2.0	3.8	8.2	8.5	10.4	1.5	2.4	2.1	2.1	7.1	11.7	1.9	3.0	2.6	2.9	1.3	1.3	2.3	5.1	3.2	9.7	8.1	3.1	1.9	7.3	2.0	1.7	0.0	4.8	4.9	1.7	1.4	14.5	0.4	7.3	0.5	1.1	1.8	8.3	3.1	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.2	0.1	0.0	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	16.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	23.7	0.0	9.8	0.9	3.0	3.2	0.0	0.0	6.1	0.0	0.0	9.8	0.0	11.6	29.2	0.0	0.5	8.9	0.0	0.3	0.1	12.4	0.0	0.0	27.6	0.0	0.0	7.3	0.0	1.0	2.6	0.6	0.3	0.3	0.4	2.5	1.4	0.3	0.4	0.4	0.5	2.0	14.5	1.1	1.8	7.4	7.8	14.5	16.3	7.8	8.9	8.5	10.4	11.7	7.3
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HeLa: 4.4;Karpas-707: 2.5;RT4: 7.2;U-266/70: 2.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.0	1.6	0.2	0.2	0.0	0.0	7.5	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.4	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.2	0.0	2.5	0.1	0.9	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0	7.2	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.7	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Cell line enhanced"	"Detected in all"		"U-2197: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"				"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: "	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.3	8.3	7.0	7.7	20.2	15.2	8.5	10.6	14.7	6.7	8.9	11.4	4.6	18.2	5.2	12.2	14.1	9.3	7.8	9.7	10.1	5.6	14.5	12.8	6.0	18.4	15.0	11.3	14.1	9.2	7.6	14.4	5.4	16.4	14.0	12.2	13.1	9.6	7.3	5.3	5.1	10.6	9.7	8.9	9.4	19.8	5.8	7.4	7.3	11.6	14.2	7.3	16.3	8.2	10.7	5.1	49.9	12.1	9.5	21.0	17.5	11.7	30.7	9.9	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0
TRRAP	"PAF400, TR-AP, Tra1"	ENSG00000196367	"Transformation/transcription domain associated protein"	Q9Y4A5	7	98877933-99050831	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054376			Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA054376: "	"unprognostic (2.10e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (8.77e-4)"	"unprognostic (1.40e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.96e-1)"	9.6	14.2	10.7	18.4	13.4	18.8	14.9	22.8	14.4	14.1	11.3	15.4	10.0	10.6	15.1	10.1	11.3	17.1	11.4	11.4	10.7	9.5	10.8	11.0	13.1	17.1	12.4	9.4	22.4	16.2	26.7	29.9	12.2	9.6	11.8	10.2	13.7	11.8	16.7	11.7	16.9	13.3	16.9	14.2	14.5	11.5	19.3	12.1	37.1	16.6	7.7	19.3	12.8	11.5	2.7	3.1	5.7	0.9	1.3	2.7	0.3	12.1	14.3	14.8	12.5	7.3	7.6	7.4	5.4	7.2	8.5	8.2	11.1	5.4	17.0	8.6	10.0	6.4	15.3	7.4	9.4	9.8	15.0	10.4	10.4	6.4	5.4	18.6	7.7	7.0	4.4	13.9	11.9	10.9	17.7	32.3	7.9	23.5	22.7	7.4	11.3	8.8	16.8	8.5	13.0	4.4	13.6	11.7	14.6	13.7	9.0	4.6	4.5	8.4	11.4	11.4	16.7	15.1	12.5	13.3	15.1	25.2	8.1	9.6	11.3	5.7	0.9	0.6	1.5	0.6	2.7	2.0	2.7	1.3	0.9	2.7	1.9	1.8	2.9	1.3	0.9	3.1	2.0	0.3	10.7	13.4	22.8	14.4	10.7	9.5	12.4	9.4	9.6	12.1
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol				Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: "	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.1	7.3	10.0	8.2	10.3	9.8	18.8	8.3	13.4	8.7	8.6	12.4	7.2	14.4	3.6	15.8	16.0	11.7	8.4	8.9	6.9	6.2	4.6	14.5	10.1	12.3	6.7	6.2	10.5	6.4	11.1	13.6	10.0	8.0	7.9	9.9	11.4	6.0	5.8	13.7	6.1	7.3	18.9	8.1	3.9	8.1	5.0	7.7	9.7	6.1	4.8	11.0	4.0	10.3	14.3	8.6	8.5	5.6	4.4	9.8	14.0	8.1	4.0	6.3	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047465-2089487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol				Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: "	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favourable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	13.9	11.9	16.9	12.4	20.0	10.9	13.2	35.1	26.9	20.5	17.0	19.4	17.9	14.0	20.1	12.2	13.0	18.6	15.0	14.0	13.3	8.8	11.8	9.8	12.7	10.1	13.8	14.7	21.1	16.1	20.0	18.1	10.6	14.6	13.8	10.8	16.7	22.9	19.6	31.7	14.5	13.2	13.5	11.4	12.9	16.6	21.4	12.9	14.1	20.1	11.3	10.9	18.0	14.0	4.7	5.6	7.7	4.9	3.6	7.0	3.7	7.2	11.6	16.1	18.2	19.2	16.2	13.6	17.4	11.9	13.1	11.2	13.9	13.8	10.9	15.5	14.3	12.0	9.6	12.6	9.8	8.3	15.8	10.3	22.5	5.7	13.2	12.8	12.5	19.1	8.0	10.6	7.9	12.3	10.0	9.8	11.6	14.4	15.2	3.8	16.7	11.4	24.2	17.6	13.9	5.3	6.5	12.2	23.1	24.8	16.4	8.8	15.0	9.5	19.4	13.8	9.4	12.3	8.8	21.9	21.8	21.8	5.7	5.2	16.3	6.2	4.9	5.4	7.0	4.7	6.7	4.4	4.4	4.1	5.6	4.7	3.1	4.8	7.7	3.6	3.7	1.5	3.2	3.7	16.9	20.0	35.1	26.9	13.3	8.8	13.8	14.7	14.6	12.9
TSG101	"TSG10, VPS23"	ENSG00000074319	"Tumor susceptibility 101"	Q99816	11	18468336-18527232	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004283, HPA006161"	Approved		Supported	"Nucleoli,Plasma membrane,Cytosol"			14000	Cytosol	"Nucleoli, Plasma membrane"	"CAB004283: AB_671392, HPA006161: AB_1080408"	"unprognostic (1.42e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.72e-3)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (5.67e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.00e-2)"	"unprognostic (4.15e-3)"	"unprognostic (4.27e-2)"	"prognostic favourable (5.52e-6)"	"unprognostic (1.92e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	24.7	30.5	18.4	14.2	25.5	23.5	27.6	22.7	25.9	22.5	23.1	23.7	21.6	20.5	25.8	27.7	34.3	23.9	18.4	31.8	17.7	20.6	33.4	29.0	20.1	23.4	21.6	21.4	23.2	39.5	33.2	23.5	38.5	24.6	21.9	28.4	19.4	25.4	22.4	44.5	27.3	25.7	23.1	21.7	20.5	23.0	33.7	20.2	27.5	32.3	37.1	25.5	24.2	25.5	20.5	18.2	42.3	29.2	14.3	22.0	22.2	14.3	23.7	21.0	14.6	24.9	26.0	19.5	22.3	30.1	27.3	27.0	16.2	7.6	19.4	13.7	24.8	22.0	20.9	20.2	30.4	27.2	25.5	12.0	12.5	23.8	32.0	18.0	20.8	22.4	41.1	14.2	38.8	22.4	19.5	16.5	33.0	25.9	11.4	19.6	12.9	24.0	10.3	21.2	16.1	18.3	20.5	15.0	26.9	21.4	18.0	28.5	17.9	18.1	12.0	18.3	11.2	38.2	16.5	10.6	20.4	15.4	18.9	10.0	23.4	42.3	19.5	40.7	14.9	21.7	15.0	20.5	14.4	15.9	18.2	18.0	15.4	16.4	34.5	14.3	29.2	15.4	22.0	22.2	18.4	25.5	22.7	25.9	17.7	20.6	21.6	21.4	24.6	20.2
TSN	"BCLF-1, REHF-1, TRSLN"	ENSG00000211460	Translin	Q15631	2	121737103-121767853	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, Endonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059561	Uncertain		Supported	"Nucleoplasm,Endoplasmic reticulum"			320000	"Nucleoplasm, Endoplasmic reticulum"		"HPA059561: "	"unprognostic (3.15e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (7.13e-3)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (2.32e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.42e-2)"	"unprognostic (3.18e-1)"	14.9	18.7	23.1	13.0	24.6	43.0	25.6	17.8	27.7	18.6	23.1	23.7	11.8	17.2	17.9	19.1	18.2	15.2	16.3	18.7	20.6	23.0	24.7	22.0	15.0	22.6	22.8	20.1	17.5	20.7	19.3	17.9	13.8	23.3	15.0	18.9	16.5	16.3	18.2	29.4	18.9	16.4	14.3	22.0	17.5	15.4	33.9	17.6	28.3	17.2	18.7	17.4	13.9	14.2	22.1	22.7	22.0	24.4	19.6	23.1	20.7	21.4	9.7	14.4	12.1	13.3	10.6	8.0	18.4	16.7	19.3	19.1	27.1	11.8	29.9	21.7	16.5	10.0	21.0	16.9	26.8	16.6	17.2	17.6	14.0	24.2	14.9	24.6	12.6	9.0	18.7	21.9	14.5	15.8	26.6	14.3	17.4	11.0	14.9	27.6	17.5	18.5	25.2	16.1	22.0	23.3	14.2	18.9	11.8	12.0	17.3	20.6	11.5	18.4	11.8	13.9	23.7	9.2	17.3	13.3	37.7	33.5	16.1	16.7	16.8	17.2	24.4	22.0	19.6	22.2	22.7	22.1	20.4	17.0	22.7	18.0	23.1	20.1	7.9	19.6	19.0	16.5	20.2	20.7	23.1	24.6	17.8	27.7	20.6	23.0	22.8	20.1	23.3	17.6
TSPOAP1	"BZRAP1, KIAA0612, PRAX-1, RIM-BP1, RIMBP1"	ENSG00000005379	"TSPO associated protein 1"	O95153	17	58301228-58328760	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 83.7"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 52.9;HL-60: 19.2;NB-4: 19.6;REH: 39.0;THP-1: 13.6;U-266/70: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 5.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 2.7;T-cells: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024662, HPA025244"	Enhanced									"HPA024662: AB_2066340, HPA025244: AB_1845509"	"unprognostic (2.03e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.23e-4)"	"unprognostic (1.24e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (9.15e-7)"	"unprognostic (1.62e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.22e-2)"	2.3	9.7	76.9	5.2	59.1	26.1	6.4	46.5	83.7	8.0	6.7	10.2	0.7	3.4	16.0	6.2	5.2	21.6	5.7	6.1	65.3	13.0	5.9	2.8	8.2	8.1	12.0	47.9	22.0	11.1	13.9	15.9	1.5	18.6	13.5	3.3	1.5	17.9	16.6	7.1	5.0	4.4	6.9	14.3	8.5	7.4	1.1	23.2	10.3	10.0	0.6	4.2	4.8	4.8	0.0	0.0	0.5	0.0	2.7	5.4	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	1.2	1.3	0.3	0.1	0.0	0.0	0.0	52.9	0.4	0.2	0.5	0.0	0.0	19.2	2.0	0.0	0.2	0.0	0.0	0.0	0.6	3.5	0.0	0.0	6.5	19.6	0.3	0.0	39.0	0.0	5.5	0.2	0.0	2.9	2.1	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.5	0.0	0.0	13.8	2.6	3.4	0.0	0.6	0.0	0.5	0.0	0.1	5.4	0.0	2.2	0.0	0.5	1.2	0.0	0.0	0.5	1.2	0.0	2.7	0.0	0.0	0.1	1.0	76.9	59.1	46.5	83.7	65.3	13.0	12.0	47.9	18.6	23.2
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: "	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.4	7.6	35.7	6.7	34.5	50.2	12.4	23.6	29.4	10.7	14.5	10.1	10.8	18.5	8.2	39.5	7.0	10.7	14.5	15.1	19.6	7.7	37.4	11.5	13.1	12.6	20.8	12.1	25.9	9.0	10.8	9.7	15.8	22.5	21.8	20.0	16.6	20.2	5.4	10.1	13.0	27.1	17.1	9.7	12.4	16.6	27.3	20.8	29.3	16.8	15.2	19.0	8.2	20.5	15.3	6.1	18.7	8.8	21.9	15.7	18.5	25.2	20.9	11.5	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"				"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.8	7.5	8.8	4.5	14.3	7.3	7.8	13.6	6.8	17.7	10.7	9.3	2.8	18.3	7.3	9.1	5.7	19.8	13.4	17.9	15.5	15.6	17.6	3.4	5.3	12.6	13.3	4.3	6.5	13.7	25.8	15.8	7.2	18.8	2.3	9.6	4.7	11.8	8.0	18.6	14.3	10.9	18.8	8.3	8.7	2.8	5.8	4.1	11.6	6.1	11.4	5.6	7.3	7.0	8.7	9.6	8.7	18.3	6.6	11.6	14.5	11.1	15.2	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0
TTF2	"HuF2, ZGRF6"	ENSG00000116830	"Transcription termination factor 2"	Q9UNY4	1	117060303-117107453	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005776, HPA070762"	Approved		Supported	Cytosol				Cytosol		"HPA005776: AB_1080416, HPA070762: "	"unprognostic (1.82e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.01e-3)"	"unprognostic (4.90e-2)"	"unprognostic (3.41e-3)"	"unprognostic (5.27e-4)"	"unprognostic (7.96e-2)"	"unprognostic (1.92e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.34e-3)"	"unprognostic (1.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.50e-1)"	"unprognostic (3.65e-2)"	5.7	9.4	5.4	8.5	8.4	6.6	6.0	0.9	5.2	5.9	7.0	8.4	2.6	6.0	5.9	2.3	9.8	4.5	3.9	5.8	4.6	3.8	3.9	3.1	4.7	11.5	12.0	2.1	5.5	5.5	6.7	10.7	4.9	7.2	5.0	8.1	4.2	6.5	3.6	8.4	6.9	5.7	6.8	7.7	6.8	5.4	6.3	8.0	25.1	5.2	7.8	17.8	6.4	6.5	3.7	5.9	3.2	6.3	5.3	6.1	2.5	12.5	4.6	9.4	13.2	3.7	3.3	11.7	6.7	3.2	9.9	8.8	6.5	2.2	15.3	10.5	4.4	13.1	16.5	8.7	15.4	11.7	11.7	13.0	9.0	8.2	2.7	19.0	15.0	3.7	3.3	7.3	13.7	6.7	10.0	14.0	7.5	19.2	12.6	11.8	14.6	9.4	18.2	34.6	6.7	6.0	5.7	8.0	3.3	10.1	10.1	3.8	5.5	7.8	6.8	6.3	13.4	14.7	14.6	6.4	5.5	18.8	4.2	14.4	25.2	1.8	5.2	3.2	3.0	6.3	2.9	3.7	3.5	4.7	5.9	3.5	3.6	4.1	0.9	5.3	3.6	3.3	6.1	2.5	5.4	8.4	0.9	5.2	4.6	3.8	12.0	2.1	7.2	8.0
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 58.3;testis: 31.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 4.0"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol				"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavourable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavourable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	1.1	1.4	0.3	3.2	0.4	13.9	1.0	0.3	0.4	1.0	2.7	0.2	0.2	2.2	0.5	1.0	6.5	0.3	0.4	1.5	0.4	0.3	0.9	0.6	1.2	4.6	0.4	0.2	0.4	0.5	0.0	0.3	3.0	0.6	0.6	3.6	0.3	1.2	0.6	0.3	2.0	2.8	0.7	0.8	2.1	1.8	31.7	0.2	58.3	0.5	2.6	5.4	0.8	1.8	1.7	0.0	1.1	0.0	1.1	4.0	0.8	13.3	8.0	24.0	19.7	1.1	3.5	13.6	15.5	9.6	22.7	27.8	10.9	10.2	19.8	12.1	6.6	17.4	21.2	9.5	31.7	18.0	17.1	18.3	10.7	8.9	0.0	21.5	12.0	0.4	1.0	15.9	10.2	12.8	20.0	20.5	19.3	9.9	12.3	15.6	14.2	9.7	11.0	43.9	8.2	5.7	8.6	16.6	9.7	9.1	9.9	5.6	9.3	16.4	5.3	10.2	10.2	6.6	24.8	4.6	15.5	11.0	3.6	20.1	8.7	0.0	0.0	1.1	0.6	0.0	0.6	0.9	1.0	1.6	0.0	1.7	0.3	0.5	0.3	1.1	0.0	0.0	4.0	0.8	0.3	0.4	0.3	0.4	0.4	0.3	0.4	0.2	0.6	0.2
TTLL12	KIAA0153	ENSG00000100304	"Tubulin tyrosine ligase like 12"	Q14166	22	43166622-43187133	"Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003054, CAB046029"	Approved		Approved	"Plasma membrane,Cytosol"			2100000	Cytosol	"Plasma membrane"	"CAB046029: AB_11128395, HPA003054: "	"unprognostic (2.45e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.37e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavourable (2.84e-4)"	"unprognostic (5.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.81e-2)"	7.3	13.8	7.2	14.7	8.3	14.0	11.2	13.6	12.3	10.9	21.5	5.5	8.9	15.0	7.1	8.7	46.3	9.0	36.0	6.9	7.3	7.1	8.4	19.4	5.3	9.2	6.5	5.9	16.5	29.8	4.4	7.0	6.8	7.1	9.4	12.1	7.0	13.5	7.9	5.5	16.4	13.9	5.9	4.0	9.7	20.7	18.3	5.3	10.7	7.6	23.7	23.5	8.3	15.2	3.5	3.8	1.3	4.7	4.3	5.6	3.3	31.5	13.3	5.4	13.3	8.3	5.7	17.5	10.4	3.7	10.0	5.2	21.6	18.0	30.4	12.6	8.6	22.5	22.4	19.0	2.5	3.8	35.6	7.4	21.4	18.5	13.0	33.4	7.7	9.0	23.2	11.9	12.8	10.5	45.8	7.2	4.6	29.3	23.2	18.1	19.6	13.3	23.6	18.6	43.7	8.4	10.4	16.5	6.8	22.1	32.4	11.7	12.7	14.9	10.0	6.7	9.4	12.8	14.4	12.2	15.0	22.5	7.6	17.2	9.0	0.0	4.7	0.7	5.6	2.4	5.5	3.5	5.5	4.1	3.8	2.7	5.5	3.7	1.3	4.3	3.1	3.3	3.5	3.3	7.2	8.3	13.6	12.3	7.3	7.1	6.5	5.9	7.1	5.3
TTN	"CMD1G, CMH9, CMPD4, FLJ32040, LGMD2J, MYLK5, TMD"	ENSG00000155657	Titin	Q8WZ42	2	178525989-178830802	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 136.5;skeletal muscle: 713.8;tongue: 227.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 4.8"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA007042, CAB022682, HPA030048"	Enhanced						25000000			"CAB022682: , HPA007042: AB_1080292, HPA030048: "	"unprognostic (1.00e-2)"	"unprognostic (3.92e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.11e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.49e-4)"	"unprognostic (1.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-2)"	23.7	0.3	0.2	0.3	0.3	0.9	0.3	0.2	0.4	0.2	0.2	0.0	0.0	0.2	0.2	21.3	8.3	0.2	0.3	136.5	0.2	0.2	0.2	0.2	0.4	0.4	0.2	0.0	0.3	0.4	0.2	0.3	0.3	0.0	0.7	0.2	0.0	11.6	0.2	713.8	0.3	0.2	0.2	0.3	0.3	0.2	0.4	0.0	0.0	5.6	227.0	15.8	0.3	0.2	7.0	0.3	1.9	0.3	5.0	7.3	0.1	0.7	0.3	1.9	1.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	1.8	0.3	2.4	0.6	0.0	1.7	0.0	0.0	0.0	2.3	2.0	3.7	2.6	1.0	0.0	0.3	0.8	2.4	0.0	0.0	0.0	1.4	2.1	1.2	0.4	0.4	1.6	2.5	0.4	1.8	1.3	4.8	1.3	0.0	0.6	1.0	1.7	0.4	1.3	0.0	0.7	2.4	1.6	0.0	0.0	0.9	0.4	3.5	0.4	3.5	0.1	1.1	0.9	1.9	0.3	0.7	0.5	0.2	0.2	6.9	1.2	0.9	0.2	7.0	2.7	3.5	1.3	5.0	0.2	0.3	7.3	0.1	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TTPA	AVED	ENSG00000137561	"Alpha tocopherol transfer protein"	P49638	8	63048553-63086053	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"liver: 74.1"	"Cell line enhanced"	"Detected in some"		"SK-BR-3: 10.2;T-47d: 3.8;U-2 OS: 5.3;U-2197: 6.3"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 21.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"																		"unprognostic (1.48e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.30e-7)"	"unprognostic (1.78e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.50e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.57e-2)"	"unprognostic (5.46e-3)"	"unprognostic (6.16e-3)"	0.9	0.4	2.4	0.4	3.3	0.3	2.5	3.5	2.0	0.3	1.6	2.1	0.0	0.4	0.3	0.3	0.3	0.3	0.4	0.3	3.9	1.1	1.4	74.1	0.6	0.3	2.4	1.8	0.3	0.8	0.4	0.3	1.0	3.8	0.3	2.3	0.0	0.3	0.3	0.3	0.4	0.4	0.4	3.1	0.3	0.4	0.4	2.4	0.0	0.3	0.0	0.3	0.3	0.2	0.9	0.3	2.0	0.5	0.3	0.4	0.0	0.1	1.5	1.0	0.2	0.5	0.0	0.0	0.1	0.0	0.4	0.1	0.2	2.4	0.0	0.1	0.0	0.0	2.7	0.2	0.5	0.0	0.1	0.1	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.1	0.2	0.4	1.2	0.1	0.2	1.0	0.7	0.1	0.0	0.0	0.0	0.7	0.4	0.1	1.0	10.2	1.0	3.8	0.4	0.3	0.1	5.3	6.3	1.1	0.4	0.0	0.1	2.3	0.1	1.9	2.0	0.5	0.3	0.4	0.1	0.3	0.4	0.3	0.2	0.2	0.9	0.3	0.3	1.6	0.3	0.2	0.3	0.2	0.0	2.4	3.3	3.5	2.0	3.9	1.1	2.4	1.8	3.8	2.4
TTPAL	"C20orf121, dJ179M20.3"	ENSG00000124120	"Alpha tocopherol transfer protein like"	Q9BTX7	20	44475886-44494603	"Plasma proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 39.6;HSkMC: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046957, HPA066532"	Uncertain		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA046957: AB_10959741, HPA066532: "	"unprognostic (8.71e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (3.47e-5)"	"unprognostic (1.69e-1)"	"prognostic unfavourable (2.94e-4)"	"unprognostic (1.54e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.50e-2)"	"unprognostic (9.55e-2)"	"prognostic unfavourable (8.09e-5)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.93e-2)"	9.5	6.2	6.3	7.2	8.3	9.1	7.6	6.5	13.1	8.2	4.6	4.8	5.1	4.3	6.3	9.2	7.0	6.9	5.3	4.2	5.8	7.9	5.7	32.0	4.0	9.7	5.9	11.5	6.6	7.6	11.1	12.8	5.0	9.8	6.4	5.0	6.4	6.2	7.3	3.8	14.7	5.3	6.6	3.6	5.7	5.5	6.4	3.0	5.8	9.3	5.5	9.2	5.9	7.9	5.9	3.1	4.2	3.5	7.9	7.6	3.4	8.5	4.5	3.5	6.1	39.6	15.4	3.4	9.3	13.0	9.0	7.8	16.5	5.2	5.3	8.0	8.6	8.5	4.4	14.6	9.8	5.5	2.0	2.5	4.6	4.8	11.0	3.7	6.0	34.1	9.6	8.9	15.0	3.0	3.2	5.6	7.2	9.8	3.6	2.4	4.1	7.5	1.1	3.7	2.9	3.5	6.2	7.7	3.6	12.9	5.7	5.7	6.2	2.4	3.1	20.3	8.1	6.0	8.0	8.4	5.7	5.8	9.8	2.7	5.9	0.7	1.6	2.6	6.7	3.2	7.1	5.9	5.7	6.7	1.7	5.8	5.1	7.6	4.2	7.9	3.5	3.1	5.7	3.4	6.3	8.3	6.5	13.1	5.8	7.9	5.9	11.5	9.8	3.0
TTR	"CTS, CTS1, HsT2651, PALB"	ENSG00000118271	Transthyretin	P02766	18	31591726-31599021	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	Transport	"Hormone, Thyroid hormone"	"Amyloidosis, Cancer-related genes, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 1008.0;liver: 680.8;retina: 332.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.7;EFO-21: 10.8;Hep G2: 47.1;U-2 OS: 14.2"	"Group enriched"	"Detected in many"	28	"liver cancer: 928.2;pancreatic cancer: 666.0"	"Region enriched"	"Detected in many"	9	"pons and medulla: 1008.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"basal ganglia: 1513.1;hippocampal formation: 5269.0;pons and medulla: 5831.5;thalamus: 3501.9"	"Region enhanced"	"Detected in many"		"pons and medulla: 1006.9"	"CAB002517, HPA002550, CAB062567, CAB073406"	Supported		Approved	"Golgi apparatus"	"Secreted to blood"	345350000000	180000000000	"Golgi apparatus"		"CAB002517: AB_563965, CAB062567: , CAB073406: , HPA002550: AB_1080419"	"unprognostic (6.79e-3)"		"unprognostic (3.38e-2)"	"unprognostic (4.10e-1)"	"unprognostic (1.74e-1)"		"unprognostic (1.84e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.74e-2)"		"unprognostic (9.66e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.23e-2)"	"unprognostic (8.35e-3)"	"unprognostic (5.26e-1)"		"unprognostic (3.52e-2)"	0.5	0.4	3.6	0.4	3.0	0.6	0.4	5.8	60.8	0.4	0.6	361.3	0.0	0.9	0.4	0.4	0.4	0.4	3.3	0.4	115.6	4.4	1.0	680.8	0.4	0.4	7.1	0.0	0.4	62.3	1.6	0.5	0.4	1008.0	0.4	0.5	332.4	0.4	0.4	0.4	1.0	0.6	0.4	4.9	0.5	2.0	0.4	0.6	0.0	0.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.6	10.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.1	0.0	47.1	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	14.2	0.0	1.0	0.0	0.6	4.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.0	5.8	60.8	115.6	4.4	7.1	0.0	1008.0	0.6
TUBA1C	"bcm948, MGC10851, MGC14580, TUBA6"	ENSG00000167553	"Tubulin alpha 1c"	Q9BQE3	12	49188736-49274603	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 35.4"	"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA039247, HPA043684, HPA063394"	Supported		Supported	Microtubules				Microtubules		"HPA039247: , HPA043684: , HPA063394: "	"prognostic unfavourable (2.90e-4)"	"unprognostic (1.15e-2)"	"prognostic favourable (7.37e-5)"	"unprognostic (3.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.88e-2)"	"prognostic unfavourable (8.48e-8)"	"prognostic unfavourable (6.85e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (5.64e-6)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.26e-7)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.45e-3)"	40.4	17.0	4.6	22.2	6.7	25.4	22.5	3.5	5.2	39.1	40.8	7.3	20.0	22.2	21.9	27.9	125.5	15.0	40.3	17.6	5.4	4.4	73.2	74.8	24.9	38.9	8.4	1.2	25.2	19.4	5.1	9.4	62.1	22.8	15.1	34.2	28.6	40.9	26.3	18.6	37.5	77.1	27.1	9.3	24.6	25.7	16.7	5.2	52.6	32.7	129.7	82.9	26.7	41.9	4.6	12.1	35.4	7.7	5.4	8.8	7.9	100.2	78.3	17.1	29.3	18.4	31.0	66.6	80.6	90.7	142.3	76.4	76.1	75.9	45.3	86.2	94.6	46.3	100.0	112.7	94.9	43.8	35.8	55.0	34.1	73.3	13.7	42.4	40.7	22.4	54.0	120.9	51.0	91.5	78.7	24.8	122.4	63.2	23.2	41.5	51.6	155.7	26.7	33.6	25.1	62.5	47.7	13.7	0.7	69.9	46.4	30.3	45.2	33.4	66.5	67.5	74.8	66.7	133.9	8.2	23.0	44.0	35.5	42.0	58.2	35.4	6.1	13.2	5.8	7.7	8.8	4.6	6.1	5.3	12.1	3.2	3.0	3.4	5.6	5.4	5.7	9.4	7.6	7.9	4.6	6.7	3.5	5.2	5.4	4.4	8.4	1.2	22.8	5.2
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249711-219278170	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules			500000000	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: , HPA043684: , HPA063394: "	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	5.0	9.4	22.4	13.4	30.5	37.7	7.5	23.2	63.3	7.4	13.8	4.5	5.2	8.1	3.4	5.2	27.1	6.1	6.1	23.5	24.9	23.6	13.2	10.5	7.2	20.9	20.4	21.9	6.1	8.0	18.1	6.5	2.9	43.1	7.9	12.4	5.7	15.6	10.7	124.1	63.5	9.5	6.2	6.2	15.7	10.1	8.2	3.3	6.2	3.7	34.8	25.0	9.1	13.9	25.8	4.2	66.8	13.0	14.8	32.0	49.2	19.0	15.9	0.0	0.0	1.7	1.3	0.0	2.9	9.2	0.5	0.3	3.5	20.0	25.1	32.7	2.0	48.3	8.9	78.8	0.7	14.6	0.1	31.5	29.7	2.6	1.4	10.5	11.3	1.2	29.2	4.3	9.3	3.2	3.5	17.2	18.9	0.7	0.0	18.9	6.1	19.0	1.1	25.9	15.3	24.3	1.3	16.1	0.2	37.5	3.3	0.1	1.4	8.9	2.2	9.5	5.1	11.0	10.2	7.0	8.5	30.2	34.8	20.0	0.4	22.1	12.5	32.4	22.5	8.6	23.2	25.8	32.0	30.2	4.2	17.7	30.4	29.5	66.8	14.8	13.0	0.7	27.5	49.2	22.4	30.5	23.2	63.3	24.9	23.6	20.4	21.9	43.1	3.3
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30720201-30725426	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 198.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	Microtubules			510000000	Microtubules		"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: , HPA046280: "	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavourable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavourable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	51.6	27.7	30.0	31.8	33.2	78.8	30.0	30.9	57.2	43.3	37.0	24.3	18.7	10.8	58.5	39.7	39.9	41.0	29.6	33.1	23.7	48.2	31.4	74.1	32.7	62.1	27.8	24.0	81.5	27.0	15.3	16.3	41.1	39.9	32.2	34.2	30.6	27.9	24.3	29.6	37.6	24.3	37.6	27.4	47.7	29.1	19.7	14.4	198.7	26.9	36.8	91.5	39.7	34.3	15.4	17.5	8.6	15.4	12.3	18.2	19.8	41.9	15.5	60.6	26.3	17.1	29.7	0.5	0.0	0.0	0.0	0.0	29.6	16.1	21.0	26.0	19.4	14.5	48.9	44.0	0.0	11.8	30.9	0.5	0.0	16.9	8.2	57.2	28.2	22.0	10.3	0.0	0.5	21.3	16.5	0.0	26.6	30.3	41.3	0.2	0.0	18.3	0.0	0.6	12.3	35.4	23.9	10.5	35.4	22.8	10.1	0.4	26.4	5.2	13.1	63.8	28.4	0.0	0.2	19.6	37.6	48.6	12.6	56.9	80.6	4.9	7.7	8.6	15.5	12.2	18.2	15.4	12.1	17.6	6.2	10.0	12.3	12.2	4.3	12.3	15.4	17.5	14.2	19.8	30.0	33.2	30.9	57.2	23.7	48.2	27.8	24.0	39.9	14.4
TUBB1	dJ543J19.4	ENSG00000101162	"Tubulin beta 1 class VI"	Q9H4B7	20	59019254-59026654	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 58.6;lymphoid tissue: 28.2"	"Cell line enriched"	"Detected in some"	19	"HEL: 24.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"basophil: 8.7;neutrophil: 6.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB004286, HPA043640, HPA046280"	Approved						480000000			"CAB004286: AB_2288090, HPA043640: , HPA046280: "	"unprognostic (3.76e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.10e-4)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (7.51e-4)"	"unprognostic (1.90e-2)"	"unprognostic (2.63e-1)"	"unprognostic (6.80e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-1)"	0.6	0.3	0.2	0.4	0.6	12.2	0.2	0.7	0.7	0.2	0.2	0.1	0.0	0.2	0.2	0.9	0.2	0.5	0.6	10.8	0.2	0.2	0.2	1.0	8.3	0.4	0.2	0.4	0.8	0.4	0.0	0.7	3.2	0.6	0.3	0.0	0.5	0.2	0.6	0.6	0.2	0.5	0.0	0.6	28.2	0.3	1.8	0.0	0.0	0.5	0.3	0.2	0.4	1.8	0.1	0.6	8.7	0.5	0.0	0.1	58.6	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	24.4	0.6	1.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.3	0.2	0.0	0.3	0.2	0.1	0.2	0.0	0.2	0.3	0.2	0.1	0.5	0.1	0.1	0.1	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.1	0.2	0.3	8.7	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	6.5	0.0	0.0	0.6	0.1	58.6	0.2	0.6	0.7	0.7	0.2	0.2	0.2	0.4	0.6	0.0
TUBB3	"beta-4, CFEOM3, CFEOM3A, FEOM3"	ENSG00000258947	"Tubulin beta 3 class III"	Q13509	16	89921392-89938761	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 85.1"	"Cell line enhanced"	"Detected in many"		"A549: 65.2;SCLC-21H: 66.4;SH-SY5Y: 67.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved						250000000			"HPA043640: , HPA046280: "	"unprognostic (7.08e-2)"	"unprognostic (3.37e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.91e-2)"	5.1	19.4	23.9	8.9	23.3	3.2	1.2	24.1	85.1	2.4	4.1	7.8	0.0	3.6	7.9	1.1	2.2	1.0	7.3	1.8	25.0	66.5	1.1	1.1	1.6	5.7	44.5	15.9	1.1	2.5	1.0	9.9	2.2	60.9	1.6	2.8	5.5	1.9	1.3	1.0	4.1	4.8	9.3	12.9	1.1	2.5	11.2	3.3	0.0	1.0	1.7	4.4	5.3	0.6	5.2	0.7	0.2	0.3	0.0	0.2	0.2	4.5	65.2	24.3	27.6	2.9	28.0	1.0	27.9	4.8	16.9	7.7	8.8	8.4	13.8	14.6	21.1	17.2	23.4	4.1	4.3	3.4	2.3	0.1	5.5	57.7	0.9	0.0	10.8	16.0	1.2	25.8	2.2	13.8	1.4	0.4	19.2	43.4	0.1	4.6	42.6	35.8	0.0	8.5	1.4	20.9	1.3	66.4	67.0	39.2	0.7	19.0	2.1	0.2	17.4	23.1	24.9	30.9	28.2	0.2	2.8	5.2	23.9	1.7	40.8	0.2	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.2	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.2	23.9	23.3	24.1	51.0	25.0	66.5	44.5	15.9	60.9	3.3
TUBB4A	"beta-5, DYT4, TUBB4"	ENSG00000104833	"Tubulin beta 4A class IVa"	P04350	19	6494319-6502848	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 62.6;brain: 197.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 35.5;HAP1: 20.4;HEL: 29.8;PC-3: 14.8;REH: 14.7"	"Group enriched"	"Detected in many"	9	"glioma: 50.1;melanoma: 83.2;testis cancer: 49.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"B-cells: 5.3;T-cells: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010768, HPA043640, HPA046280"	Approved		Supported	Microtubules			360000000	Microtubules		"CAB010768: AB_261775, HPA043640: , HPA046280: "	"unprognostic (4.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (8.42e-7)"	"unprognostic (3.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.08e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.30e-1)"	2.3	62.6	41.3	2.9	52.4	2.2	2.3	115.3	197.8	2.2	2.9	115.2	0.0	2.7	2.3	2.3	2.5	2.3	2.4	2.3	56.8	36.9	2.8	2.2	2.3	2.6	73.7	34.5	2.6	2.8	2.1	0.2	2.5	72.0	2.2	2.5	2.7	2.7	2.3	3.9	4.6	3.2	2.5	73.2	4.8	2.2	31.3	43.0	0.0	2.1	0.0	2.4	2.3	0.1	5.3	0.1	0.2	0.0	0.4	6.5	1.6	0.0	10.5	0.0	35.5	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.4	0.1	0.0	10.4	0.0	0.3	20.4	0.0	0.2	0.0	3.4	29.8	0.7	0.3	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	2.8	0.2	0.0	1.0	5.9	1.3	2.6	14.8	14.7	0.0	7.0	3.8	0.0	0.1	11.8	0.1	0.1	10.4	0.3	0.7	0.0	0.0	4.4	0.0	0.1	0.8	0.5	4.0	0.4	0.0	0.2	0.0	0.0	0.0	6.3	0.0	4.6	5.3	1.0	6.5	0.0	1.6	2.2	4.7	0.2	0.4	0.0	0.1	0.0	1.6	41.3	52.4	115.3	79.7	56.8	36.9	73.7	34.5	72.0	43.0
TUBB4B	"Beta2, TUBB2C"	ENSG00000188229	"Tubulin beta 4B class IVb"	P68371	9	137241213-137243707	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Deafness, Disease mutation, FDA approved drug targets, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 207.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010880, HPA043640, HPA046280"	Enhanced		Supported	Microtubules				Microtubules		"CAB010880: AB_609915, HPA043640: , HPA046280: "	"unprognostic (2.24e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.50e-1)"	"prognostic favourable (4.91e-4)"	"unprognostic (1.29e-2)"	"unprognostic (8.93e-2)"	"prognostic unfavourable (9.98e-4)"	"unprognostic (9.92e-3)"	"unprognostic (2.90e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.47e-3)"	"unprognostic (6.37e-2)"	"unprognostic (1.36e-2)"	"prognostic favourable (6.36e-6)"	"unprognostic (1.69e-1)"	31.1	22.1	33.0	22.1	32.7	87.5	24.4	22.3	67.2	23.0	44.0	35.9	25.2	33.4	22.7	52.7	65.7	122.5	32.1	66.4	35.2	55.5	46.6	49.7	28.4	21.0	33.8	46.6	33.7	33.0	13.4	25.3	31.9	48.4	29.8	27.3	40.9	41.8	31.8	37.1	55.9	38.9	28.4	21.5	21.0	30.5	207.7	12.2	61.1	40.1	56.7	40.1	21.8	25.7	17.2	18.3	37.0	14.6	11.2	21.7	14.4	59.3	89.1	38.1	27.5	19.2	20.3	53.2	55.8	47.0	77.3	53.4	94.1	73.2	36.5	42.8	54.2	113.2	47.1	89.9	29.5	25.9	39.9	26.4	71.0	73.9	12.2	31.1	29.4	13.0	25.5	59.0	16.2	55.1	36.8	21.0	63.6	163.4	28.1	42.3	40.2	155.5	35.9	72.8	33.7	58.0	55.6	26.7	28.7	74.0	42.6	14.8	61.3	33.9	42.8	55.2	61.6	62.5	73.4	8.2	22.5	40.2	45.0	24.3	47.9	37.0	14.1	20.5	21.4	14.6	20.6	17.2	16.7	18.2	17.5	14.1	10.7	14.3	28.6	11.2	14.6	18.3	21.7	14.4	33.0	32.7	22.3	67.2	35.2	55.5	33.8	46.6	48.4	12.2
TUBB6	"HsT1601, MGC4083"	ENSG00000176014	"Tubulin beta 6 class V"	Q9BUF5	18	12307669-12344320	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 46.7"	"Group enriched"	"Detected in many"	5	"B-cells: 14.8;dendritic cells: 46.7"	"Region enriched"	"Detected in single"	10	"olfactory region: 24.5"	"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Approved						150000000			"HPA043640: , HPA046280: "	"unprognostic (4.40e-2)"	"unprognostic (8.28e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.20e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.74e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"prognostic unfavourable (1.22e-7)"	"unprognostic (5.83e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (9.69e-4)"	63.0	7.2	4.2	24.0	7.6	7.9	46.6	3.2	3.9	47.4	38.7	5.6	14.7	8.9	62.8	36.3	83.3	28.6	35.9	39.5	5.1	5.5	13.6	8.2	23.6	28.4	6.1	2.5	42.3	18.0	0.9	7.3	27.3	11.9	34.7	8.3	15.6	14.9	27.1	17.4	21.6	16.2	84.4	7.1	15.3	22.0	15.0	4.7	4.2	14.5	47.4	32.8	62.1	26.1	14.8	46.7	0.5	5.8	0.3	0.1	3.5	22.9	15.7	16.8	8.7	17.3	24.1	12.0	71.3	47.5	55.1	51.4	11.8	7.5	0.1	33.1	47.4	11.1	9.1	70.4	42.3	0.2	4.9	3.6	18.1	7.9	17.5	0.3	6.8	25.1	16.3	47.1	25.4	40.0	17.1	0.3	46.8	23.2	0.0	17.3	8.9	7.6	0.1	29.2	0.2	10.8	0.6	2.2	3.1	41.4	4.1	12.2	8.7	22.9	92.6	70.6	58.0	65.1	66.1	1.3	0.4	0.4	54.3	5.1	25.1	0.5	5.8	0.0	0.1	2.2	0.1	11.7	0.0	0.0	7.6	14.8	0.0	0.1	0.1	0.3	2.0	46.7	0.0	3.5	4.2	7.6	3.2	3.9	5.1	5.5	6.1	2.5	11.9	4.7
TUBB8	bA631M21.2	ENSG00000261456	"Tubulin beta 8 class VIII"	Q3ZCM7	10	46892-74163	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.2;parathyroid gland: 2.3;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.8;MCF7: 5.3;NTERA-2: 1.8"	"Cancer enriched"	"Detected in single"	5	"testis cancer: 1.0"					"Cell type enhanced"	"Detected in some"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in many"											"HPA043640, HPA046280"	Uncertain									"HPA043640: , HPA046280: "	"unprognostic (4.75e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.74e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.50e-1)"	"unprognostic (4.15e-3)"	"unprognostic (7.17e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.33e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.86e-3)"	0.0	0.0		0.5		0.0	1.1		0.1	0.0	0.0			0.0	0.4	0.1	0.0	1.2	0.0	0.1			0.1	0.0	0.0	0.4			0.0	0.0	2.3		0.4		0.0	0.0		0.0	0.0	0.0	0.1	0.1	0.0		0.0	0.0	2.5			0.3		0.1	0.5		1.0	0.1	2.2	0.3	0.2	0.5	0.1	0.5	0.0	0.0	0.3	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.3	1.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	5.3	0.1	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.6	0.1	0.6	0.2	1.0	0.4	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.4	0.1	0.0	0.0	0.2	0.1	2.2	0.5	0.2	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1										
TUBG1	"TUBG, TUBGCP1"	ENSG00000131462	"Tubulin gamma 1"	P23258	17	42609676-42615234	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 102.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							CAB004608	Enhanced									"CAB004608: AB_628417"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.79e-2)"	"prognostic favourable (8.99e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (1.08e-8)"	"unprognostic (2.62e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (6.48e-5)"	"unprognostic (2.64e-1)"	"unprognostic (3.52e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.97e-2)"	11.7	14.1	8.8	10.7	11.2	23.9	13.0	12.4	19.3	7.5	9.8	6.9	7.8	9.6	9.7	7.8	15.4	7.7	10.4	18.3	13.2	12.6	16.2	20.5	8.6	9.2	8.7	12.0	8.8	30.1	13.1	9.5	14.2	12.2	9.6	8.6	8.3	9.2	11.1	24.3	15.9	7.7	14.1	6.8	10.3	12.8	102.4	5.2	14.6	9.7	11.8	10.8	10.8	9.5	9.7	26.2	1.8	15.4	6.8	8.3	6.3	23.2	61.7	23.9	26.1	15.6	10.8	21.6	26.8	18.5	44.0	34.2	37.3	16.3	16.8	19.8	22.0	37.4	25.8	37.6	32.0	44.0	32.9	13.5	41.0	62.0	7.6	14.7	19.2	8.4	11.7	54.0	16.4	27.7	24.6	17.1	32.5	68.6	36.0	15.6	12.4	30.8	17.4	35.5	26.8	19.0	28.9	34.2	16.6	16.8	15.9	13.0	49.4	14.4	17.7	44.0	28.3	36.1	41.6	24.8	30.4	25.0	23.2	14.6	30.6	1.3	8.4	1.8	7.3	15.4	7.6	9.7	6.7	7.5	9.7	8.3	7.1	7.3	0.4	6.8	15.2	26.2	8.3	6.3	8.8	11.2	12.4	19.3	13.2	12.6	8.7	12.0	12.2	5.2
TUBGCP2	"GCP2, SPBC97, Spc97p"	ENSG00000130640	"Tubulin gamma complex associated protein 2"	Q9BSJ2	10	133278630-133312337	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037885	Approved		Supported	Nucleoplasm,Centrosome				"Nucleoplasm, Centrosome"		"HPA037885: AB_10672397"	"unprognostic (3.57e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.72e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (4.24e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.89e-2)"	20.3	26.7	16.7	17.3	25.6	29.4	21.4	28.6	33.4	20.3	19.3	22.5	25.2	19.2	23.2	18.9	19.8	35.1	21.7	18.6	21.9	17.2	24.4	22.2	22.8	27.7	16.3	26.5	28.3	30.9	31.9	23.0	17.0	22.3	20.8	16.0	19.0	26.8	22.3	30.4	24.1	19.7	17.6	16.7	25.6	20.1	33.5	15.4	25.6	23.0	18.3	19.5	19.3	18.2	6.1	14.3	17.3	11.9	12.1	10.4	8.7	18.2	25.4	9.4	9.5	10.0	10.9	12.0	14.3	23.3	17.7	17.9	26.4	12.8	13.8	8.1	16.3	12.3	12.5	11.7	7.8	12.9	24.0	8.8	12.5	14.5	12.6	18.8	16.3	11.3	10.3	16.4	20.4	11.6	10.7	11.2	14.2	25.0	10.3	20.9	8.2	20.2	8.2	10.9	6.0	11.6	9.5	6.4	12.7	10.2	11.5	11.5	8.3	9.7	14.0	8.6	7.8	11.3	12.7	11.2	7.6	16.1	34.7	8.5	5.5	5.0	11.9	11.9	7.6	11.2	8.5	6.0	7.6	8.0	14.3	6.1	8.7	9.0	17.3	12.1	11.8	6.5	10.4	8.7	16.7	25.6	28.6	33.4	21.9	17.2	16.3	26.5	22.3	15.4
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria			2800000	Mitochondria		"CAB075730: , CAB075731: , CAB075732: , HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.1	55.4	17.8	37.1	25.8	23.7	36.5	21.4	24.9	34.1	32.4	59.7	32.3	65.6	39.5	21.4	57.2	42.1	41.4	20.5	26.1	64.4	25.0	44.8	72.2	30.7	44.8	23.3	30.2	32.8	36.9	36.7	40.6	56.1	25.9	24.8	59.4	42.9	43.8	39.8	34.4	59.5	32.3	95.4	29.5	28.6	31.2	38.1	18.7	66.7	29.2	39.7	36.5	25.8	20.4	23.8	25.3	32.6	39.6	40.9	28.5	26.1	56.3	26.7	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"Tubby like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved									"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.2	2.8	8.1	2.0	13.7	0.7	4.4	8.1	16.1	2.9	2.4	2.7	3.0	4.5	3.8	3.2	3.0	2.3	2.3	7.2	8.6	6.9	3.5	1.6	2.7	3.0	8.5	8.3	2.7	9.2	8.8	3.7	2.7	9.0	2.7	2.1	1.2	3.2	6.9	6.3	7.1	4.7	2.5	9.4	2.9	3.3	4.3	3.0	1.2	5.5	2.2	3.2	2.6	2.1	4.2	6.1	0.6	3.7	2.5	5.4	2.8	2.7	5.9	4.4	9.6	7.8	5.0	9.1	2.7	3.9	2.6	3.1	8.7	1.7	7.6	2.6	5.5	4.9	5.1	6.7	4.7	4.8	2.8	3.7	4.1	8.8	5.7	3.4	4.2	3.8	7.7	4.2	8.8	6.5	5.8	11.9	7.1	4.2	3.5	4.0	2.9	2.7	7.5	10.4	4.7	4.2	4.5	8.4	10.4	7.7	11.7	8.3	6.8	4.6	10.3	6.6	8.0	9.7	10.3	8.2	9.9	6.6	6.4	2.7	8.1	0.6	2.7	0.0	3.8	3.0	5.1	3.8	4.4	5.0	1.7	4.2	3.2	3.7	0.2	2.5	3.7	6.1	5.4	2.8	8.1	13.7	8.1	16.1	8.6	6.9	8.5	8.3	9.0	3.0
TUSC3	"MGC13453, MRT7, N33, OST3A"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved									"HPA049851: , HPA049974: "	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favourable (7.86e-4)"	"unprognostic (1.55e-1)"	10.5	35.3	10.5	4.0	23.0	0.1	19.7	21.5	19.8	12.1	6.2	5.4	5.1	4.5	16.0	50.5	6.1	27.0	8.1	16.1	10.4	21.4	11.6	3.2	8.5	3.3	6.0	15.6	35.5	15.8	24.8	50.6	127.8	13.4	23.9	7.1	11.6	5.7	14.1	2.8	3.8	4.1	14.4	4.3	3.6	5.2	10.2	3.3	2.9	4.7	3.6	2.4	15.0	9.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	13.1	9.5	26.4	24.5	30.8	35.7	0.0	18.7	40.2	20.7	34.7	0.0	0.0	0.1	6.6	24.9	10.1	9.2	18.0	30.1	0.0	12.6	0.0	7.8	1.5	13.3	0.0	1.3	28.3	5.7	29.0	10.8	1.7	17.4	4.0	31.4	9.5	4.8	0.1	13.1	8.3	5.9	21.9	0.1	28.6	32.8	10.5	20.2	0.0	10.7	14.6	12.5	0.0	8.1	19.1	18.9	7.9	9.3	0.0	2.3	0.0	0.3	0.0	26.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	23.0	21.5	19.8	10.4	21.4	6.0	15.6	13.4	3.3
TWF2	"A6r, A6RP, PTK9L"	ENSG00000247596	"Twinfilin actin binding protein 2"	Q6IBS0	3	52228610-52239260	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053874	Uncertain		Supported	"Plasma membrane"			14000000	"Plasma membrane"		"HPA053874: "	"unprognostic (4.24e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.70e-2)"	"unprognostic (3.51e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.58e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.31e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.07e-2)"	25.0	13.0	10.4	21.0	10.9	17.0	22.3	17.5	21.1	13.8	15.2	7.7	10.4	12.1	14.3	13.1	17.2	11.4	18.7	38.8	13.2	9.4	13.9	11.7	16.5	39.4	9.2	13.2	14.4	10.9	5.4	7.5	11.0	9.1	13.4	7.1	10.4	18.2	13.5	81.7	11.9	13.5	13.5	8.4	23.3	13.4	7.9	7.3	34.5	9.4	15.4	19.5	18.7	14.3	32.3	46.8	72.5	50.1	26.9	40.9	38.7	6.5	16.9	5.9	10.3	19.3	23.6	10.5	15.5	25.1	18.6	16.7	8.8	18.1	23.6	10.3	18.2	11.6	7.4	21.7	4.2	14.9	9.7	24.2	12.7	21.2	16.7	14.6	40.8	21.9	10.4	22.0	7.5	28.2	5.6	12.3	13.9	5.7	20.1	33.6	9.2	47.9	7.8	6.1	24.7	14.6	10.6	4.6	17.7	5.5	23.4	30.7	5.3	15.9	29.0	18.2	19.9	14.1	13.3	11.1	9.8	11.5	35.9	41.4	21.9	26.8	50.1	39.6	33.7	48.9	30.6	32.3	35.9	35.8	46.8	25.4	28.9	35.6	72.5	26.9	49.5	42.3	40.9	38.7	10.4	10.9	17.5	21.1	13.2	9.4	9.2	13.2	9.1	7.3
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favourable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	61.9	85.2	23.1	25.5	58.3	76.0	34.0	75.5	70.5	52.6	40.1	55.3	74.8	55.3	32.5	69.7	140.2	32.9	100.6	51.7	81.9	73.0	27.7	79.9	95.6	66.7	68.7	84.6	53.9	66.4	77.0	58.3	46.2	46.5	53.3	71.9	50.2	57.2	103.1	49.1	104.0	24.0	78.3	64.4	67.3	44.0	50.3	18.0	81.4	66.2	51.2	63.5	47.6	55.4	54.3	35.1	101.8	93.5	27.0	76.2	47.0	78.8	60.0	75.3	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0
TXNDC12	"AGR1, ERP18, ERP19, hAG-1, PDIA16, TLP19"	ENSG00000117862	"Thioredoxin domain containing 12"	O95881	1	52020131-52056171	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"		95000				"unprognostic (6.54e-2)"	"unprognostic (5.46e-2)"	"prognostic favourable (4.44e-4)"	"unprognostic (2.33e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (2.61e-4)"	"prognostic unfavourable (1.28e-5)"	"unprognostic (1.25e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavourable (1.40e-12)"	"unprognostic (2.13e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.17e-1)"	30.5	24.6	20.4	19.8	20.1	19.5	22.7	19.2	20.4	23.1	25.6	15.3	20.9	20.4	18.6	28.5	18.9	25.1	20.2	21.6	18.2	22.1	30.7	60.3	24.5	20.6	23.5	12.5	28.0	51.9	14.0	29.4	32.4	18.5	19.7	29.1	15.4	30.3	22.0	15.5	17.2	35.0	17.7	21.0	35.1	24.3	16.7	18.3	31.8	38.6	18.3	26.6	20.8	21.6	24.2	28.6	62.8	36.4	22.3	33.3	36.7	17.9	16.6	18.7	26.6	31.0	16.5	14.9	27.8	27.3	25.2	29.1	18.5	14.9	14.0	18.3	21.8	24.2	26.0	21.1	33.8	18.4	23.6	17.9	15.3	29.5	37.4	32.9	35.9	24.1	28.8	26.0	42.0	25.2	15.9	10.7	20.7	16.5	18.3	42.9	41.3	16.2	18.8	27.7	38.5	33.4	15.6	14.9	19.4	27.3	24.2	26.3	13.6	43.3	16.1	18.2	20.0	20.8	31.2	21.8	32.8	15.8	26.3	30.9	20.5	46.7	36.4	54.6	23.2	33.2	29.0	24.2	28.5	24.8	26.9	20.9	27.4	26.3	62.8	22.3	34.4	28.6	33.3	36.7	20.4	20.1	19.2	20.4	18.2	22.1	23.5	12.5	18.5	18.3
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910814	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 158.5;U-266/84: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.6;plasmacytoid DC: 17.5"	"Group enriched"	"Detected in many"	21	"B-cells: 9.6;dendritic cells: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"		14000000	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavourable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	20.2	15.7	3.7	42.1	6.3	6.0	61.9	4.6	6.8	28.8	69.8	7.5	18.3	35.0	28.3	20.9	25.3	21.5	30.2	28.6	4.4	5.2	23.2	96.2	24.5	117.9	5.9	4.3	26.1	63.3	7.9	10.6	22.4	7.2	17.6	29.0	10.9	71.5	29.1	10.1	9.9	33.6	16.3	7.5	84.2	36.8	12.3	5.2	6.4	18.0	19.8	48.2	35.8	21.7	9.6	17.5	0.0	0.5	0.0	0.6	0.3	9.3	9.1	6.4	21.5	55.5	23.7	10.4	21.0	20.5	14.6	15.9	13.7	6.9	9.9	37.1	32.2	7.4	11.3	10.3	16.7	8.4	9.7	15.1	8.0	24.7	16.3	17.1	15.2	16.2	15.2	14.0	15.4	78.5	9.4	72.2	10.0	8.3	4.0	10.3	8.4	20.0	7.2	9.3	158.5	11.8	8.5	10.0	5.3	27.0	16.5	11.8	8.4	7.6	21.5	16.8	11.7	14.4	22.1	84.2	336.3	17.4	8.6	10.8	23.0	0.0	0.2	0.0	0.6	0.5	0.5	9.6	0.1	0.4	0.7	3.3	0.1	0.3	0.0	0.0	0.0	17.5	0.5	0.3	3.7	6.3	4.6	6.8	4.4	5.2	5.9	4.3	7.2	5.2
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol			1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavourable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favourable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.5	33.3	34.2	28.9	42.4	23.6	29.7	30.5	38.3	32.5	21.8	24.5	27.0	26.5	32.2	31.0	31.4	26.8	39.7	27.5	14.4	37.0	20.5	40.7	33.9	53.8	24.2	32.1	27.8	36.0	33.1	30.8	27.0	45.4	38.7	23.8	31.1	35.2	24.1	26.4	25.5	22.4	46.9	44.7	38.8	27.6	25.2	16.8	23.7	28.0	25.8	28.9	24.4	40.3	21.3	14.0	28.8	44.1	47.2	42.2	26.3	41.3	29.4	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1
TXNRD1	"GRIM-12, Trxr1, TXNR"	ENSG00000198431	"Thioredoxin reductase 1"	Q16881	12	104215779-104350305	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"	Oxidoreductase	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001395, CAB004607, CAB015834, HPA043871"	Approved		Supported	Nucleoplasm			5900000	Nucleoplasm		"CAB004607: AB_628405, CAB015834: , HPA001395: AB_1858377, HPA043871: "	"unprognostic (2.52e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavourable (1.12e-5)"	"unprognostic (5.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.80e-2)"	19.1	79.2	14.1	15.6	16.9	22.6	18.5	11.1	13.7	13.0	21.8	9.7	19.7	23.5	23.5	14.7	16.7	19.0	23.2	32.4	11.0	11.7	25.3	19.6	29.3	18.1	12.0	10.9	16.4	7.9	10.5	16.2	30.8	16.4	25.3	19.1	18.1	10.6	26.5	30.0	5.7	17.0	99.6	10.9	14.9	24.2	14.8	8.9	15.6	16.5	16.9	13.2	73.2	72.0	8.1	14.2	37.6	16.2	8.3	10.2	8.7	22.0	102.6	11.9	11.2	57.5	32.2	41.6	41.0	26.0	18.5	19.2	10.8	32.9	16.5	19.1	143.4	7.7	23.5	15.7	22.0	8.0	10.2	13.9	80.6	45.6	92.3	21.7	15.2	18.3	16.2	40.9	13.1	63.4	19.1	7.8	27.7	10.6	22.2	9.9	11.5	105.8	22.0	8.3	14.3	21.5	12.1	18.6	11.2	33.1	52.4	32.7	12.4	12.8	84.7	9.1	18.9	20.3	33.5	8.6	16.8	24.8	19.1	12.0	53.9	33.0	10.6	24.7	9.1	14.0	10.2	8.1	8.4	9.0	14.2	5.2	7.6	6.6	37.6	8.3	16.2	9.2	7.1	8.7	14.1	16.9	11.1	11.2	11.0	11.7	12.0	10.9	16.4	8.9
TXNRD2	"TR, TR3, TRXR2"	ENSG00000184470	"Thioredoxin reductase 2"	Q9NNW7	22	19875517-19941992	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2 OS: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002007, HPA003323"	Supported		Supported	Mitochondria,Cytosol			410000	Mitochondria	Cytosol	"CAB002007: , HPA003323: AB_1080396"	"unprognostic (3.17e-2)"	"unprognostic (8.72e-2)"	"unprognostic (4.30e-1)"	"unprognostic (9.71e-3)"	"unprognostic (7.25e-2)"	"unprognostic (6.35e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.94e-3)"	"unprognostic (2.49e-1)"	"prognostic favourable (1.10e-7)"	"unprognostic (2.47e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.10e-1)"	9.8	30.2	8.5	8.3	10.1	11.6	7.4	19.0	15.0	8.3	10.3	9.0	7.6	9.2	11.9	12.3	8.8	8.4	13.0	22.6	8.3	7.5	13.9	40.9	10.8	8.4	7.8	9.7	11.9	13.0	9.9	9.9	14.0	7.1	17.9	4.5	10.0	15.2	8.8	16.5	6.0	10.2	5.4	5.6	11.2	14.6	10.5	6.8	4.9	12.6	9.2	10.5	7.5	7.9	4.8	9.1	5.8	12.1	4.8	4.9	4.9	6.3	13.2	1.2	5.1	2.4	3.4	3.0	6.1	7.2	11.1	8.2	12.2	6.6	3.5	14.9	6.4	11.3	6.1	8.4	4.2	6.7	15.1	5.9	10.5	7.2	4.6	6.6	2.9	3.3	6.4	5.7	4.8	31.4	32.8	6.0	8.6	15.4	2.2	9.9	6.1	9.4	3.4	29.3	3.2	6.7	6.9	6.5	5.7	10.5	13.8	7.0	11.2	9.0	17.4	8.1	48.8	6.7	12.8	6.0	4.4	2.2	7.8	5.1	10.2	3.2	12.1	5.8	4.3	9.2	3.3	4.8	3.8	3.9	9.1	3.6	4.9	4.0	1.3	4.8	8.7	3.4	2.4	4.9	8.5	10.1	19.0	15.0	8.3	7.5	7.8	9.7	7.1	6.8
TYMP	"ECGF1, MNGIE"	ENSG00000025708	"Thymidine phosphorylase"	P19971	22	50525752-50530056	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Chemotaxis, Differentiation"	"Developmental protein, Glycosyltransferase, Growth factor, Transferase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 57.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.9;HHSteC: 39.3;Karpas-707: 38.0;U-266/70: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"classical monocyte: 23.0;eosinophil: 18.2;intermediate monocyte: 22.4;myeloid DC: 12.2;neutrophil: 6.7;non-classical monocyte: 15.9"	"Group enriched"	"Detected in many"	18	"dendritic cells: 12.2;granulocytes: 18.2;monocytes: 23.0"	"Low region specificity"	"Detected in some"							"HPA000530, HPA001072, CAB002518"	Enhanced		Approved	"Nuclear bodies,Golgi apparatus"			16000000	"Nuclear bodies"	"Golgi apparatus"	"CAB002518: AB_563953, HPA000530: , HPA001072: AB_1080274"	"unprognostic (7.02e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (4.34e-5)"	"unprognostic (7.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (3.50e-8)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	25.2	7.9	2.8	41.6	8.4	12.1	19.0	1.5	4.4	10.7	10.7	3.8	2.3	10.4	4.4	15.7	22.0	13.7	9.6	15.0	7.0	2.6	18.6	38.1	28.8	57.8	6.5	0.4	7.5	5.8	1.7	3.9	11.5	9.1	7.9	4.9	5.4	16.5	3.8	10.0	8.8	13.9	7.3	15.2	43.9	12.4	3.0	5.0	13.3	12.5	25.5	28.8	12.4	9.4	0.9	12.2	18.2	23.0	0.8	0.9	2.6	6.5	0.7	0.0	0.1	0.9	1.2	0.6	1.1	0.1	2.4	5.3	0.0	15.9	0.5	0.8	2.7	5.8	0.2	0.2	0.0	2.8	1.4	0.3	1.1	0.4	39.3	0.1	7.6	2.4	2.4	3.2	0.0	0.0	0.2	38.0	0.2	0.1	0.0	1.0	0.0	2.1	0.2	0.0	7.6	0.0	0.0	0.0	1.4	6.1	8.3	0.5	0.6	4.8	1.5	0.0	0.6	0.1	0.2	18.2	3.7	0.4	0.2	0.1	0.2	2.5	23.0	18.2	0.3	22.4	0.2	0.8	0.3	0.2	12.2	0.9	0.2	0.1	6.7	0.8	15.9	1.1	0.9	2.6	2.8	8.4	1.5	4.4	7.0	2.6	6.5	0.4	9.1	5.0
TYMS	"HsT422, TMS, TS, Tsase"	ENSG00000176890	"Thymidylate synthetase"	P04818	18	657604-673578	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Nucleotide biosynthesis"	"Methyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.9;lymphoid tissue: 75.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.8"	"Group enriched"	"Detected in many"	6	"NK-cells: 6.8;T-cells: 13.8"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"cerebellum: 6.7;olfactory region: 8.8"	CAB002784	Enhanced									"CAB002784: "	"unprognostic (7.58e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.31e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavourable (5.10e-6)"	"unprognostic (1.62e-3)"	"unprognostic (1.68e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.23e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (2.47e-1)"	3.0	2.6	4.6	15.5	5.8	34.9	2.8	1.2	6.3	3.4	10.1	10.2	1.5	4.8	2.5	3.6	12.3	2.4	4.6	2.0	5.8	2.9	4.8	5.1	4.2	15.4	3.4	4.5	2.0	3.1	1.1	1.3	14.3	3.4	3.0	12.9	1.1	3.4	0.8	0.7	3.6	6.9	5.5	4.6	8.9	4.2	21.5	5.3	75.5	1.7	10.9	19.3	4.8	4.3	1.2	1.8	1.0	0.1	6.8	13.8	2.5	13.7	21.2	44.3	21.4	4.9	8.2	22.5	32.5	19.4	35.1	42.1	17.9	11.0	21.4	12.7	17.5	6.2	30.9	12.2	30.4	20.1	34.3	36.3	19.9	30.7	1.1	74.5	39.8	7.3	2.9	22.1	6.9	29.3	29.1	34.4	44.1	15.8	89.7	41.3	15.9	15.9	59.4	39.9	25.8	13.2	12.2	15.1	24.5	27.4	12.7	8.2	8.7	34.0	11.6	40.6	80.2	37.1	63.3	42.7	52.5	48.9	10.7	32.3	46.4	0.0	0.0	1.0	1.1	0.1	0.0	1.2	2.9	2.2	1.8	0.0	0.0	0.7	0.6	6.8	0.1	0.3	13.8	2.5	4.6	5.8	1.2	6.3	5.8	2.9	3.4	4.5	3.4	5.3
TYRO3	"Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif"	ENSG00000092445	"TYRO3 protein tyrosine kinase"	Q06418	15	41557675-41583586	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.2;ovary: 48.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071245	Approved						6400000			"HPA071245: "	"unprognostic (1.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.56e-3)"	"unprognostic (5.41e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-10)"	"unprognostic (7.59e-2)"	"unprognostic (5.22e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.84e-2)"	18.3	4.1	18.7	2.1	16.6	1.5	7.7	27.3	39.2	2.3	1.8	25.6	1.2	2.3	5.0	4.2	12.7	11.7	3.1	2.5	15.1	7.8	6.4	1.6	3.2	1.9	19.6	18.2	48.2	9.5	1.3	0.8	5.9	14.0	3.3	1.7	1.7	2.4	6.7	1.4	13.0	2.9	4.8	23.1	5.4	3.6	17.9	16.6	0.0	1.8	2.2	4.1	2.9	2.8	1.2	1.0	5.0	0.9	1.0	0.8	0.2	4.7	3.1	9.9	10.8	9.3	6.4	33.5	6.9	4.4	6.9	6.4	17.6	1.6	0.1	8.9	5.6	11.2	11.1	1.7	3.2	2.7	7.4	1.4	10.0	8.3	6.6	2.4	0.2	2.0	3.5	5.2	1.8	5.1	8.7	2.0	3.7	4.5	1.1	0.4	22.9	3.2	14.7	9.0	1.7	0.6	9.2	11.9	3.4	6.5	10.3	7.7	8.5	2.8	3.9	13.7	6.0	10.1	10.4	0.8	1.6	1.4	8.3	15.8	8.2	2.6	0.9	0.8	0.6	0.5	0.6	0.7	0.6	0.8	0.3	1.2	0.7	0.7	5.0	1.0	0.5	1.0	0.5	0.2	18.7	16.6	27.3	32.7	15.1	7.8	19.6	18.2	14.0	16.6
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107587	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA044833: AB_10960990, HPA052083: "	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	20.0	15.1	20.8	19.2	21.1	48.5	61.0	25.6	20.8	16.1	21.5	9.7	12.3	17.6	28.8	26.5	19.3	27.6	17.1	19.5	19.7	15.8	14.6	17.1	35.2	33.5	25.7	2.9	22.1	48.3	15.3	27.8	21.2	20.8	23.9	13.7	9.6	44.5	19.8	33.0	16.6	20.4	38.7	23.9	21.0	17.5	33.9	22.7	20.6	27.3	26.5	20.0	22.9	31.7	58.4	82.8	81.2	54.1	33.1	55.5	53.8	25.0	27.5	15.0	11.3	8.8	6.3	35.1	21.8	15.1	17.8	15.9	63.9	9.2	42.9	11.9	14.1	12.3	31.3	23.1	9.2	33.6	70.7	69.4	14.1	24.0	21.5	29.8	17.1	8.7	14.3	28.8	18.4	14.7	38.0	19.4	12.4	47.1	24.7	33.1	31.8	31.7	40.8	14.4	21.6	11.8	10.6	22.8	17.4	23.4	14.1	11.5	17.2	17.4	18.3	14.8	20.2	13.4	22.7	26.0	30.6	35.5	14.2	55.0	22.8	48.4	52.6	50.9	42.2	52.5	41.4	55.9	46.4	42.1	54.1	58.4	46.4	44.8	81.2	33.1	54.1	82.8	55.5	53.8	20.8	21.1	25.6	20.8	19.7	15.8	25.7	2.9	20.8	22.7
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674715	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: , HPA043562: "	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	32.1	39.3	40.0	51.9	40.0	68.2	34.1	53.4	44.1	39.6	43.7	41.2	37.0	46.2	45.0	32.5	47.9	43.6	35.4	33.8	35.0	29.4	36.5	39.1	35.6	59.6	41.1	33.7	51.4	38.3	37.7	48.1	42.9	31.5	36.8	29.7	35.9	36.4	39.5	33.3	42.7	43.0	34.7	32.4	58.1	37.4	104.4	41.4	68.4	42.0	34.0	50.4	36.3	42.9	3.0	4.1	5.5	4.0	1.4	3.0	1.7	43.9	72.1	44.1	36.2	20.9	21.3	47.7	35.7	33.5	61.3	59.7	41.9	41.8	53.2	29.0	30.1	36.1	54.8	49.6	27.3	40.0	91.6	44.5	32.3	38.4	34.0	50.6	51.1	28.9	30.1	45.8	30.3	35.2	53.1	34.3	31.0	41.3	70.2	44.5	48.6	57.4	76.7	28.5	42.5	33.6	51.5	52.5	40.8	39.1	37.0	22.5	36.1	53.6	30.1	54.0	39.2	24.8	75.3	31.3	42.3	63.1	24.0	50.2	45.9	0.2	2.6	2.2	3.0	4.0	2.6	2.1	2.7	2.4	2.4	3.0	2.2	2.0	5.5	1.4	2.6	4.1	2.9	1.7	40.0	40.0	53.4	44.1	35.0	29.4	41.1	33.7	31.5	41.4
UAP1	"AgX, AGX1, SPAG2"	ENSG00000117143	"UDP-N-acetylglucosamine pyrophosphorylase 1"	Q16222	1	162561506-162599842	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 105.7;U-251 MG: 68.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014659	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"			19000	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA014659: AB_1857409"	"unprognostic (2.32e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.59e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.51e-1)"	"unprognostic (3.45e-2)"	38.4	18.5	7.0	17.4	9.8	17.2	24.8	9.0	13.4	16.1	26.9	5.7	45.7	17.2	10.9	19.4	23.6	15.7	18.3	22.5	7.7	7.8	11.0	67.1	16.0	7.4	6.6	8.9	20.4	31.4	5.1	16.0	21.5	9.1	13.9	26.9	7.8	43.9	62.5	19.4	12.4	33.4	28.8	7.1	8.1	23.0	37.7	3.7	5.6	12.4	13.5	15.3	24.4	16.7	8.3	5.6	8.1	1.6	6.2	16.1	4.8	29.9	2.1	6.0	4.8	29.2	23.4	4.1	44.1	16.2	34.0	27.8	5.7	14.1	1.1	9.9	33.8	5.2	6.7	12.8	56.1	4.7	10.1	5.3	6.9	11.1	13.7	9.0	3.6	10.8	6.1	37.3	105.7	20.8	29.9	12.4	45.4	5.5	5.2	5.8	4.4	9.8	4.7	11.7	14.6	5.3	3.5	6.4	6.7	19.2	12.0	10.2	5.9	10.3	35.3	17.2	15.8	43.2	68.8	20.8	7.3	9.9	9.8	4.2	10.8	1.0	1.6	8.1	13.0	1.6	16.1	8.3	7.9	13.3	3.4	6.5	7.6	9.5	1.6	6.2	0.8	5.6	3.9	4.8	7.0	9.8	9.0	13.4	7.7	7.8	6.6	8.9	9.1	3.7
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Enhanced	Nucleoplasm			16000000	Nucleoplasm		"CAB019435: AB_2211440, CAB073410: , HPA000289: AB_1080443, HPA001506: AB_2756305"	"unprognostic (7.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.40e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (7.22e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.43e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.17e-3)"	"unprognostic (1.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.38e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (1.21e-2)"	45.6	63.0	56.0	47.2	50.6	42.0	38.3	58.1	75.7	48.0	39.3	55.9	44.9	36.3	52.9	34.1	59.4	56.0	39.9	48.7	49.5	39.9	51.1	60.0	42.0	48.2	47.7	62.3	57.6	34.9	78.8	55.5	39.1	47.6	40.2	35.5	41.0	47.5	45.7	77.7	56.1	37.9	59.4	35.5	53.4	38.7	36.0	48.6	52.7	65.0	43.9	54.0	39.2	52.7	28.9	30.6	32.6	36.0	25.6	29.0	24.1	45.8	47.6	54.5	82.8	37.3	34.0	24.1	30.5	32.5	43.9	35.8	37.8	35.0	34.2	20.3	61.0	44.3	68.3	64.9	32.3	28.3	69.4	21.4	52.8	30.3	26.3	36.0	46.2	31.9	34.0	63.8	49.8	57.5	23.2	30.8	43.5	58.1	33.9	31.9	58.0	74.4	39.5	38.0	58.2	35.1	49.4	35.3	26.5	90.9	44.2	20.2	61.5	22.5	42.0	33.0	38.3	47.5	28.4	21.1	21.9	48.8	33.9	25.8	39.4	17.4	27.0	27.4	29.0	36.0	25.4	28.9	24.0	25.9	30.6	22.0	19.1	23.4	32.6	25.6	32.8	20.8	28.2	24.1	56.0	50.6	58.1	75.7	49.5	39.9	47.7	62.3	47.6	48.6
UBA7	"D8, UBA1B, UBE1L, UBE2"	ENSG00000182179	"Ubiquitin like modifier activating enzyme 7"	P41226	3	49805207-49813946	"Plasma proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 22.3;HEL: 20.8;HMC-1: 40.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB015444, HPA058182"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol			1400000	"Nucleoplasm, Vesicles"	Cytosol	"CAB015444: AB_793598, HPA058182: "	"prognostic favourable (1.55e-4)"	"unprognostic (7.07e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.61e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (1.04e-5)"	"unprognostic (9.11e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (1.48e-4)"	11.3	12.1	6.8	22.0	7.5	16.0	11.5	2.0	6.7	10.8	12.7	14.4	25.4	19.6	17.2	31.6	17.7	12.9	33.1	9.1	6.7	3.9	15.9	11.9	18.8	28.2	6.0	6.2	19.1	9.5	1.4	8.4	8.9	9.4	18.5	12.1	14.2	24.5	34.2	3.3	9.0	25.5	11.3	7.7	35.9	13.2	3.4	5.9	20.4	17.8	18.4	23.5	12.6	13.1	12.4	14.3	24.8	21.7	11.1	11.8	13.0	4.3	0.0	0.3	0.1	12.0	12.7	1.3	2.3	10.4	16.7	22.3	0.0	9.1	0.1	1.8	8.5	2.4	0.0	4.1	1.4	11.1	0.0	20.8	0.2	1.3	8.9	1.9	40.6	19.5	0.2	6.5	0.4	8.3	0.0	1.3	3.8	0.1	4.2	5.1	0.0	0.4	5.4	0.4	0.7	3.4	8.4	0.0	0.3	2.8	4.1	1.4	0.4	13.8	3.7	3.3	0.4	1.4	0.9	0.0	0.0	0.1	9.1	7.4	0.7	13.9	14.7	24.8	11.8	21.7	10.3	12.3	10.8	10.5	14.3	12.4	9.9	8.9	4.6	11.1	17.2	5.2	10.6	13.0	6.8	7.5	2.0	6.7	6.7	3.9	6.0	6.2	9.4	5.9
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favourable (5.09e-5)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	36.5	24.4	42.8	29.9	28.9	37.1	27.4	38.7	36.2	45.6	53.4	62.8	34.8	52.3	51.0	39.9	23.2	42.0	65.2	61.1	33.7	24.5	29.6	27.0	36.0	56.6	28.9	26.4	29.1	33.7	45.2	67.7	48.6	25.6	44.8	42.2	36.7	44.6	41.2	23.5	26.6	34.0	44.5	37.8	47.9	43.3	39.0	25.8	33.8	43.5	61.4	27.2	25.7	31.8	34.8	19.4	28.9	47.2	32.2	52.3	73.3	24.9	47.7	27.7	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3
UBE2G1	"UBC7, UBE2G"	ENSG00000132388	"Ubiquitin conjugating enzyme E2 G1"	P62253	17	4269259-4366628	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045681, HPA050551"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA045681: , HPA050551: "	"unprognostic (1.57e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.80e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.58e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.50e-2)"	10.8	11.1	12.6	17.8	13.5	14.3	11.2	11.6	15.3	13.0	19.4	17.8	8.9	11.9	13.3	8.5	27.4	9.2	9.7	26.9	13.5	11.2	14.6	17.7	8.9	18.7	15.2	9.7	9.1	17.1	12.0	6.0	11.4	14.5	14.0	13.3	8.8	11.9	12.0	95.6	14.1	16.6	14.6	19.4	15.0	11.9	11.8	13.6	21.3	12.5	20.7	23.3	17.7	16.5	23.7	13.1	24.4	11.5	20.5	20.6	13.1	21.2	23.0	21.5	15.7	17.6	18.7	30.7	20.7	16.7	19.8	17.4	15.8	10.9	33.3	21.8	20.3	23.0	26.7	19.2	31.9	17.5	21.8	12.4	12.2	18.0	17.3	18.0	23.6	15.9	28.8	18.7	27.3	26.4	21.8	36.1	16.2	9.5	22.9	16.6	23.7	12.0	29.8	11.4	30.4	23.0	14.0	9.3	17.4	19.5	17.0	16.1	16.7	11.8	19.8	19.9	15.2	23.2	23.1	14.0	16.4	47.1	15.3	16.9	15.2	8.1	10.3	24.4	15.4	10.8	20.6	23.7	20.1	20.1	13.1	15.5	20.2	20.5	18.6	20.5	11.5	9.6	18.3	13.1	12.6	13.5	11.6	15.3	13.5	11.2	15.2	9.7	14.5	13.6
UBE2G2	UBC7	ENSG00000184787	"Ubiquitin conjugating enzyme E2 G2"	P60604	21	44768580-44802019	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003332	Approved									"HPA003332: AB_1858525"	"unprognostic (7.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.67e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.79e-3)"	"unprognostic (6.93e-3)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.98e-3)"	"prognostic unfavourable (7.02e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.55e-2)"	30.9	20.7	18.9	22.8	20.9	25.8	21.1	21.0	21.6	18.9	22.7	20.5	19.8	14.9	22.2	18.4	19.3	20.5	18.0	37.1	18.3	17.1	26.2	27.3	19.7	19.7	19.0	17.0	18.1	30.2	22.1	26.0	17.0	18.9	18.3	16.5	18.6	15.4	28.3	50.8	15.6	16.9	28.5	17.8	23.8	20.2	14.0	18.8	18.4	20.6	18.7	21.6	20.9	18.9	11.9	17.5	5.9	13.0	14.0	17.3	12.1	15.6	3.2	10.8	13.9	14.8	6.5	9.9	11.1	8.6	9.7	10.6	12.4	2.1	20.3	10.6	11.0	6.3	15.8	13.4	8.8	19.0	16.3	33.0	2.3	10.0	11.7	24.3	5.7	10.4	15.9	13.0	12.7	15.2	30.6	14.2	13.3	7.0	26.9	2.9	28.1	14.0	22.1	10.0	18.1	12.7	8.4	12.6	22.4	15.6	5.1	16.0	4.9	21.2	10.8	9.4	6.7	8.7	17.9	22.3	43.8	20.1	9.4	28.8	11.0	2.3	11.6	5.9	16.0	11.8	17.3	11.8	14.7	16.2	12.5	11.9	15.7	16.6	3.6	14.0	13.0	17.5	14.6	12.1	18.9	20.9	21.0	19.3	18.3	17.1	19.0	17.0	18.9	18.8
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021"	Approved						120000			"CAB009021: AB_2210610, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favourable (5.68e-4)"	"unprognostic (1.15e-3)"	34.3	43.1	28.8	36.3	36.9	48.4	45.2	45.6	48.5	38.1	32.0	28.6	28.1	28.9	55.4	32.9	43.4	35.6	30.3	41.8	27.4	28.4	29.4	26.6	29.1	44.2	22.7	32.9	62.5	35.5	33.4	36.2	47.2	21.4	40.7	31.0	34.1	37.8	32.2	31.6	35.8	32.2	40.0	23.2	43.7	29.4	43.6	21.6	78.0	42.5	31.8	53.9	38.7	38.8	82.2	58.0	85.4	67.4	50.9	57.8	60.0	24.9	34.5	58.2	34.3	25.0	30.3	25.2	36.0	26.0	33.5	33.5	40.8	41.1	43.5	30.0	31.1	30.5	41.6	33.8	43.3	31.3	29.4	27.2	31.9	39.4	39.6	40.3	32.5	28.0	22.0	32.8	39.3	36.2	38.9	27.4	31.6	53.3	71.2	40.6	47.4	25.5	90.4	36.9	49.5	31.2	23.0	33.0	34.8	31.6	35.9	35.9	36.5	48.9	29.8	33.3	38.2	29.2	32.5	29.0	34.3	88.8	18.7	30.0	35.2	63.9	59.3	85.4	48.0	67.4	57.8	82.2	49.0	48.7	58.0	61.8	44.1	44.2	41.3	50.9	62.3	50.1	50.9	60.0	28.8	36.9	45.6	48.5	27.4	28.4	22.7	32.9	21.4	21.6
UBE2L3	UBCH7	ENSG00000185651	"Ubiquitin conjugating enzyme E2 L3"	P68036	22	21549447-21624034	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 107.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA045609, HPA062415"	Approved		Approved	Nucleoplasm,Cytosol			8800000	"Nucleoplasm, Cytosol"		"HPA045609: AB_10961322, HPA062415: "	"unprognostic (4.90e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.74e-2)"	"unprognostic (9.99e-3)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.65e-2)"	"prognostic favourable (3.82e-6)"	"unprognostic (3.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.15e-3)"	27.8	34.9	34.8	23.5	29.6	31.3	24.9	25.5	36.9	25.9	27.7	38.4	22.8	26.4	25.6	29.2	38.0	26.9	23.0	33.0	30.7	30.8	27.4	36.0	23.5	32.5	34.3	33.1	24.3	23.9	24.3	21.7	30.1	36.9	27.5	31.7	29.3	30.6	26.7	43.5	23.9	34.4	33.1	36.2	28.5	25.1	35.7	22.6	25.3	25.0	32.4	33.9	28.4	22.2	34.7	49.9	46.1	45.8	34.6	46.9	54.9	24.4	14.1	20.7	16.1	22.6	20.2	11.9	20.6	23.6	26.6	25.3	16.0	11.8	23.1	10.4	27.3	21.0	27.5	22.4	26.5	23.0	29.7	26.7	13.8	19.1	15.1	38.1	19.3	17.8	19.6	19.2	14.0	29.8	107.9	12.4	28.6	18.0	19.8	27.6	15.2	14.9	16.2	31.1	6.3	24.9	19.7	18.6	13.8	16.4	20.7	18.9	12.9	21.1	21.3	18.8	24.2	15.9	21.0	12.1	19.5	21.1	25.5	17.7	17.8	30.8	40.4	46.1	41.4	45.8	38.8	34.7	39.6	44.2	49.9	31.2	34.5	41.6	34.2	34.6	37.6	48.4	46.9	54.9	34.8	29.6	25.5	36.9	30.7	30.8	34.3	33.1	36.9	22.6
UBE2N	"MGC8489, UBC13, UbcH-ben"	ENSG00000177889	"Ubiquitin conjugating enzyme E2 N"	P61088	12	93405673-93442262	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA044976	Enhanced		Supported	"Nucleoplasm,Nucleoli fibrillar center"			4600000	Nucleoplasm	"Nucleoli fibrillar center"	"HPA044976: "	"unprognostic (1.74e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (8.49e-3)"	"unprognostic (2.72e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.07e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.30e-3)"	24.7	25.0	29.0	28.7	39.1	29.0	21.2	29.2	44.3	18.4	26.6	15.6	15.1	20.7	23.2	20.0	30.4	19.7	17.0	27.7	31.0	33.7	25.4	22.3	19.3	36.1	27.6	34.5	17.4	17.6	13.9	18.2	24.2	34.9	23.4	22.6	13.7	18.0	18.5	35.7	19.1	20.4	21.3	24.6	21.5	19.3	83.7	17.4	32.2	15.5	16.8	35.1	22.7	18.8	53.8	35.5	29.9	39.2	29.5	57.3	51.9	35.8	26.0	43.9	28.1	17.0	16.9	30.6	50.2	26.8	40.3	33.8	46.2	15.6	73.0	11.4	29.3	28.6	48.4	36.8	38.4	60.7	25.1	49.1	14.3	40.7	21.7	58.6	32.8	17.7	15.2	24.0	30.0	31.0	54.5	11.4	41.8	29.5	57.8	54.5	57.1	36.4	45.0	35.6	35.7	33.5	54.3	42.9	39.1	26.5	31.2	24.5	40.8	36.1	32.0	27.3	22.8	24.6	36.1	19.7	53.3	62.0	10.7	31.3	33.3	29.9	27.1	28.9	31.7	35.4	36.9	53.8	40.2	39.2	35.5	38.6	36.0	34.4	8.2	29.5	39.2	26.7	57.3	51.9	29.0	39.1	29.2	44.3	31.0	33.7	27.6	34.5	34.9	17.4
UBE4B	"E4, KIAA0684, UBOX3, UFD2"	ENSG00000130939	"Ubiquitination factor E4B"	O95155	1	10032832-10181239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019219	Approved									"HPA019219: AB_1858554"	"unprognostic (5.32e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.46e-2)"	"unprognostic (7.19e-2)"	"unprognostic (4.39e-2)"	"prognostic unfavourable (3.69e-5)"	"unprognostic (2.53e-1)"	"unprognostic (9.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.26e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-3)"	11.8	18.6	16.4	11.5	20.2	16.5	12.7	27.1	24.2	17.5	19.3	26.5	12.6	15.1	16.7	12.8	20.4	14.1	11.3	22.5	18.9	17.3	13.0	13.9	10.5	11.3	18.5	15.0	22.8	20.4	24.3	15.3	18.3	23.6	14.5	12.8	18.2	12.0	12.7	43.5	24.3	14.5	16.6	16.3	13.0	15.1	8.6	21.4	15.7	19.7	11.2	13.6	16.8	12.0	6.0	6.7	9.4	7.9	2.9	9.8	5.3	21.6	13.9	17.1	18.8	22.7	30.0	13.5	14.3	18.1	14.0	14.4	15.0	25.4	18.7	17.4	25.4	16.0	21.4	16.5	16.7	19.1	12.0	20.1	24.3	17.6	17.2	21.0	14.3	24.7	15.0	18.9	16.1	20.6	34.5	24.9	13.0	11.3	13.5	10.3	22.8	11.5	13.3	17.0	20.1	14.2	9.9	20.9	16.1	22.5	16.1	29.7	12.3	15.5	17.8	12.6	19.4	15.5	11.6	11.4	15.4	21.6	18.5	24.4	15.9	4.2	7.9	3.6	5.3	6.0	8.8	6.0	8.8	8.5	6.7	5.6	8.0	6.5	9.4	2.9	4.4	3.2	9.8	5.3	16.4	20.2	27.1	24.2	18.9	17.3	18.5	15.0	23.6	21.4
UBQLN1	"DA41, DSK2, PLIC-1, XDRP1"	ENSG00000135018	"Ubiquilin 1"	Q9UMX0	9	83659963-83708203	"Plasma proteins, Predicted intracellular proteins"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037256, HPA054143"	Supported		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB037256: AB_1858556, HPA054143: "	"unprognostic (4.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.07e-5)"	"unprognostic (3.11e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-3)"	"unprognostic (2.29e-2)"	26.8	33.9	27.2	26.2	38.7	41.1	38.1	35.0	42.2	24.9	24.4	21.2	27.8	21.9	29.1	22.2	30.5	21.4	21.0	34.5	28.9	32.1	31.6	40.8	23.3	25.8	30.0	27.8	21.5	28.1	36.0	29.5	30.4	37.2	26.5	23.7	15.2	23.8	28.9	79.1	27.8	27.6	26.9	33.9	28.6	23.1	22.9	23.3	59.8	25.7	16.2	34.8	24.8	27.3	16.0	19.2	23.4	25.0	24.7	18.8	14.9	43.5	40.3	29.6	22.9	24.7	26.3	49.1	40.7	36.1	43.3	32.9	16.5	31.1	43.3	26.3	34.0	50.1	41.0	28.9	45.1	22.8	19.1	26.5	31.0	25.6	32.6	32.1	29.2	21.8	36.4	36.5	50.8	32.3	28.6	31.0	35.3	25.8	44.9	17.8	38.8	37.0	33.4	33.2	22.6	28.2	19.0	26.8	29.9	37.6	37.9	29.1	18.9	23.4	32.0	27.7	25.9	45.8	40.7	43.5	61.4	21.2	41.2	23.7	33.5	23.4	17.1	17.6	16.6	25.0	16.2	16.0	14.5	15.2	19.2	15.5	14.7	16.0	18.5	24.7	23.1	8.2	18.8	14.9	27.2	38.7	35.0	38.7	28.9	32.1	30.0	27.8	37.2	23.3
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"			200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.8	14.1	14.1	16.5	32.5	20.8	8.9	15.3	18.2	11.5	12.8	7.8	8.9	14.5	16.7	18.0	11.1	26.9	17.0	13.9	22.3	16.2	5.8	19.4	8.3	17.1	11.4	12.9	19.3	21.7	15.4	13.6	10.0	6.8	16.0	18.1	8.8	14.6	10.0	11.7	16.8	13.2	18.3	13.6	23.2	14.8	17.5	16.4	22.0	9.8	8.9	16.4	8.5	11.2	12.2	12.5	17.6	9.2	6.1	7.4	10.0	13.7	12.1	10.3	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038838	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA038838: AB_10673120"	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	4.9	7.2	8.3	6.7	13.2	10.2	7.9	12.1	13.4	10.7	13.9	9.1	3.9	5.8	7.2	12.4	8.6	11.9	10.6	12.8	11.9	5.8	22.9	14.4	4.4	9.2	16.1	11.0	11.0	6.0	13.1	10.7	12.0	13.0	8.8	13.3	2.8	8.7	4.8	4.7	7.4	11.4	11.4	5.0	10.8	11.7	8.4	7.5	15.9	8.4	5.6	8.1	8.4	16.5	13.2	8.2	11.7	12.2	10.4	17.6	16.7	9.0	10.2	11.9	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	15.7	8.0	9.3	14.6	19.2	18.5	12.6	12.2	13.2	10.8	11.3	11.5	6.5	10.9	9.7	13.1	16.0	13.4	10.4	13.8	14.6	9.4	17.2	11.9	14.9	15.6	16.6	11.9	13.0	11.4	10.7	11.8	12.2	20.1	13.8	10.4	12.8	13.0	14.7	8.5	7.8	11.6	13.9	16.2	12.4	13.8	11.1	8.8	12.3	11.9	11.9	11.6	16.1	17.6	9.9	7.7	12.0	8.8	12.8	11.3	16.8	5.2	12.5	6.0	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.8	7.5	8.0	10.6	16.0	12.7	6.8	16.0	9.3	9.3	7.5	11.5	5.6	10.0	13.9	12.4	11.7	9.5	8.1	11.6	10.4	8.2	36.6	8.0	12.2	8.0	12.1	11.9	7.6	7.6	12.1	8.1	9.1	19.0	10.9	15.7	8.3	7.8	5.9	6.3	6.3	7.5	13.2	10.6	6.7	12.5	15.8	8.6	11.2	10.4	6.5	6.8	6.8	11.5	14.0	5.7	10.9	10.0	8.9	6.9	9.2	11.5	7.1	7.7	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor, RNA polymerase I"	P17480	17	44205033-44221626	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	21.9	25.4	27.8	33.0	29.4	32.8	25.1	43.6	37.1	28.0	29.2	31.7	34.8	22.8	35.3	29.4	27.2	28.2	30.5	25.3	24.4	21.0	22.9	22.9	22.2	42.7	23.3	28.5	30.9	32.3	35.9	24.8	20.5	18.8	27.9	20.0	26.5	25.5	46.2	37.9	32.9	26.8	26.6	23.3	34.0	22.4	13.7	26.0	69.6	33.0	21.1	36.4	27.3	27.7	14.0	11.9	9.2	9.6	13.4	16.4	9.4	17.8	28.0	21.0	25.5	13.9	16.1	19.3	18.5	12.6	19.3	14.4	13.5	14.8	65.7	18.5	17.5	16.9	26.9	15.9	16.0	38.2	29.1	26.2	19.6	21.9	9.3	49.6	23.2	16.2	14.7	12.2	18.2	16.1	30.1	20.7	16.1	30.6	48.6	19.8	19.9	22.1	48.3	28.5	29.6	11.3	14.5	32.9	25.1	18.5	16.9	14.8	24.6	32.3	19.6	30.3	36.8	17.7	24.8	18.1	15.6	40.4	18.1	22.9	27.0	7.5	5.2	5.3	15.1	5.8	16.4	11.1	10.7	15.8	6.1	14.0	12.5	13.0	9.2	13.4	9.6	11.9	8.7	9.4	27.8	29.4	43.6	37.1	24.4	21.0	23.3	28.5	18.8	26.0
UBXN6	"UBXD1, UBXDC2"	ENSG00000167671	"UBX domain protein 6"	Q9BZV1	19	4444999-4457822	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040906, HPA041313, HPA061872"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"HPA040906: AB_10794997, HPA041313: AB_10795004, HPA061872: "	"unprognostic (1.53e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.50e-2)"	"prognostic favourable (5.68e-5)"	"unprognostic (1.67e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.48e-1)"	"prognostic favourable (6.95e-4)"	"unprognostic (3.93e-2)"	"prognostic favourable (2.78e-5)"	"unprognostic (4.61e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.79e-1)"	29.1	47.7	29.0	20.0	38.0	38.4	22.9	30.5	45.9	21.0	21.8	12.4	42.3	26.2	23.3	45.9	26.3	24.9	35.6	35.1	29.7	21.8	29.2	37.6	23.4	26.6	25.4	30.5	35.1	45.3	18.9	35.6	22.9	23.3	23.7	8.1	20.8	42.1	46.7	72.0	25.4	28.9	30.3	21.7	22.2	22.8	41.5	18.4	11.9	38.8	42.2	12.0	26.9	22.5	7.4	13.6	12.9	10.3	3.6	8.7	6.1	21.0	14.9	7.1	15.4	18.1	22.6	10.8	21.6	25.8	15.8	16.8	9.2	17.8	9.4	19.7	21.2	12.3	5.5	16.5	5.8	16.5	11.9	7.9	15.8	12.1	29.8	9.8	15.8	20.5	21.9	12.3	12.0	19.2	16.1	25.7	11.6	13.3	19.5	16.7	11.5	13.0	9.0	10.2	22.2	14.9	13.2	20.8	30.2	12.1	12.5	35.0	14.8	16.1	23.0	21.0	16.2	44.6	14.1	57.7	22.7	9.4	40.2	18.5	18.6	8.5	9.2	12.9	5.5	10.3	8.7	6.8	6.5	7.3	8.9	7.4	7.7	6.1	9.1	3.6	6.0	13.6	6.9	6.1	29.0	38.0	30.5	45.9	29.7	21.8	25.4	30.5	23.3	18.4
UCHL1	"PARK5, PGP9.5, Uch-L1"	ENSG00000154277	"Ubiquitin C-terminal hydrolase L1"	P09936	4	41256413-41268455	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 225.8"	"Cell line enhanced"	"Detected in many"		"EFO-21: 97.1;SCLC-21H: 96.9;U-251 MG: 88.7;U-266/84: 85.5;U-87 MG: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 3.6"	"Lineage enriched"	"Detected in single"	37	"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002580, HPA005993, CAB079024"	Enhanced	Supported	Supported	Nucleoplasm,Cytosol			440000	Cytosol	Nucleoplasm	"CAB002580: AB_563981, CAB079024: , HPA005993: AB_1858560"	"unprognostic (1.54e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.08e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.09e-2)"	"unprognostic (4.31e-2)"	"unprognostic (8.77e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.70e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.12e-3)"	"unprognostic (2.10e-2)"	"prognostic unfavourable (1.93e-4)"	8.2	40.2	52.4	8.9	65.1	2.0	3.1	17.5	225.8	4.5	6.3	11.5	0.0	5.5	6.0	1.8	2.7	5.7	6.5	5.4	53.4	97.4	14.0	2.0	2.7	6.5	62.0	57.1	15.4	6.3	1.8	30.5	2.7	100.6	5.3	4.7	6.0	3.0	4.4	7.5	2.7	8.6	5.2	38.6	2.3	2.8	8.0	8.3	0.0	3.9	0.0	4.5	5.6	2.8	3.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	55.0	11.4	0.0	1.5	1.9	0.0	57.6	29.7	20.4	20.6	11.1	0.0	0.0	97.1	29.3	0.1	21.0	0.0	8.3	0.1	8.6	0.0	0.3	0.0	44.0	0.0	0.0	10.6	0.2	16.3	0.0	0.1	0.0	0.2	10.8	0.0	0.0	0.9	32.9	62.2	0.0	24.4	0.0	30.8	0.0	96.9	60.9	0.3	0.2	0.1	0.0	0.4	0.3	1.3	0.4	0.0	88.7	45.5	85.5	0.2	94.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	52.4	65.1	17.5	92.6	53.4	97.4	62.0	57.1	100.6	8.3
UCHL5	"CGI-70, INO80R, UCH37"	ENSG00000116750	"Ubiquitin C-terminal hydrolase L5"	Q9Y5K5	1	193012250-193060080	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005908, HPA075383"	Approved		Supported	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"		"HPA005908: AB_1858585, HPA075383: "	"unprognostic (3.66e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.17e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.44e-3)"	"unprognostic (6.92e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (7.10e-5)"	"unprognostic (4.33e-2)"	15.7	18.3	20.1	16.1	26.2	16.0	18.2	30.1	34.8	10.9	17.7	11.5	12.6	19.0	12.5	14.7	26.1	10.7	11.9	22.0	21.6	20.6	21.6	28.3	12.4	19.9	21.3	29.4	13.4	24.8	15.6	16.2	17.8	33.3	17.8	18.8	10.3	19.3	12.9	29.1	16.7	18.0	13.9	20.1	17.3	14.0	9.9	17.5	20.0	15.1	19.1	23.0	14.8	14.8	22.5	20.8	23.8	21.1	35.6	30.9	20.9	33.2	18.5	16.0	16.4	9.3	9.5	19.1	19.6	10.0	18.8	16.3	17.4	22.6	26.1	18.9	10.8	20.7	21.3	25.3	24.9	26.9	15.3	30.9	23.9	23.1	15.0	48.5	17.4	8.7	11.3	26.9	23.9	18.5	67.7	21.3	15.9	26.8	35.7	18.0	14.8	11.7	20.7	18.0	50.7	17.5	19.5	16.3	20.1	17.6	25.5	27.2	20.7	24.5	12.0	17.6	5.4	17.8	31.1	16.6	25.6	29.4	10.5	30.3	29.9	23.8	16.5	19.0	28.3	19.5	30.9	22.5	25.9	26.9	19.4	18.0	28.2	30.5	10.0	35.6	21.1	20.8	24.8	20.9	20.1	26.2	30.1	34.8	21.6	20.6	21.3	29.4	33.3	17.5
UFM1	"bA131P10.1, C13orf20"	ENSG00000120686	"Ubiquitin fold modifier 1"	P61960	13	38349849-38363619	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039758	Approved						160000			"HPA039758: AB_10697555"	"unprognostic (8.08e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (1.08e-4)"	"unprognostic (9.67e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.03e-2)"	"unprognostic (4.90e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.99e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.90e-1)"	35.8	28.3	39.8	28.0	31.0	52.9	29.1	28.1	37.4	31.0	26.0	31.1	33.9	29.5	37.4	42.2	27.2	26.4	27.9	23.0	39.1	35.6	40.7	64.4	27.7	30.2	36.4	27.5	39.3	52.6	14.7	57.7	52.7	38.7	31.9	33.1	16.8	35.3	32.6	17.5	26.7	38.6	25.6	43.4	29.6	31.5	14.7	33.3	20.9	35.2	22.7	29.4	31.5	27.5	26.7	28.6	36.9	27.2	25.6	26.6	21.6	11.0	7.1	16.8	16.5	29.2	35.1	15.9	33.0	25.1	16.7	17.8	21.6	22.5	17.7	10.8	27.5	18.3	15.4	19.7	23.9	26.1	10.2	14.6	12.0	18.7	38.2	21.6	21.2	29.0	29.1	16.1	45.2	16.3	9.9	24.2	23.6	14.2	14.8	17.7	17.3	17.2	16.8	31.2	17.5	20.7	15.2	6.6	15.0	11.4	19.8	27.5	14.3	18.0	20.0	20.1	12.8	32.0	18.7	23.2	15.2	24.0	42.6	11.4	29.9	36.9	20.4	26.5	21.8	27.2	26.6	26.7	22.6	20.5	17.5	23.6	22.4	22.9	10.4	25.6	25.6	28.6	20.7	21.6	39.8	31.0	28.1	37.4	39.1	35.6	36.4	27.5	38.7	33.3
UGDH		ENSG00000109814	"UDP-glucose 6-dehydrogenase"	O60701	4	39498755-39528311	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Carbohydrate metabolism"	"Allosteric enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 125.8"	"Cell line enhanced"	"Detected in all"		"A549: 84.2;Hep G2: 97.5;U-2197: 60.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034444, HPA036656, HPA036657"	Enhanced		Supported	Nucleoplasm			42000	Nucleoplasm		"CAB034444: AB_2019602, HPA036656: AB_10671706, HPA036657: AB_10672360"	"unprognostic (1.22e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.96e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.81e-3)"	"unprognostic (6.86e-2)"	"prognostic unfavourable (5.51e-10)"	"unprognostic (2.48e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.97e-2)"	25.9	11.3	4.4	24.7	3.2	0.2	12.7	4.0	3.1	13.0	29.3	3.8	10.2	13.7	11.5	9.7	22.9	9.9	12.9	10.1	3.6	3.5	28.2	125.8	13.5	4.7	4.0	2.2	20.6	24.9	5.1	4.7	26.8	5.3	13.2	23.3	7.5	8.2	7.3	7.5	5.5	24.2	17.7	3.7	3.3	14.1	5.0	3.8	1.7	16.7	12.7	7.1	30.2	24.1	12.0	12.3	17.1	12.0	21.8	22.4	10.2	4.8	84.2	9.3	12.1	30.4	33.8	7.8	16.0	19.1	15.9	14.6	11.8	18.2	3.1	10.1	22.2	5.0	9.6	4.5	16.7	3.9	1.7	3.4	10.9	97.5	12.0	4.2	3.5	11.3	2.5	27.1	8.5	10.1	4.5	2.6	10.9	14.3	4.1	4.6	7.5	6.2	7.1	14.4	3.1	8.7	19.3	4.7	6.9	9.9	5.8	6.7	3.2	3.5	11.8	16.3	7.6	60.6	7.6	5.9	4.3	3.1	13.7	3.6	8.5	17.1	12.0	10.9	14.3	10.6	22.4	10.9	11.4	14.8	10.7	12.0	9.8	12.0	2.3	21.8	6.1	12.3	7.3	10.2	4.4	3.2	4.0	3.0	3.6	3.5	4.0	2.2	5.3	3.8
UGGT1	"HUGT1, UGCGL1"	ENSG00000136731	"UDP-glucose glycoprotein glucosyltransferase 1"	Q9NYU2	2	128091200-128195677	"Plasma proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012761, HPA015127"	Enhanced		Uncertain	Cytosol			3800000	Cytosol		"HPA012761: AB_1858597, HPA015127: AB_1858596"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.45e-2)"	"unprognostic (7.03e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.05e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (3.86e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.38e-3)"	13.7	14.7	7.6	16.4	10.2	23.8	11.3	10.7	10.8	12.7	15.2	10.0	21.1	11.4	12.3	26.3	13.1	10.6	11.3	13.0	7.7	7.9	13.7	33.4	13.9	14.6	11.0	5.7	10.4	44.1	13.4	11.2	22.1	9.1	11.7	13.5	9.7	15.5	20.5	19.3	11.1	17.4	8.9	9.0	16.1	13.0	9.9	9.5	24.3	13.8	6.4	15.7	11.4	11.0	6.3	7.4	8.8	6.2	4.7	5.9	2.8	16.2	5.7	10.9	23.4	14.4	11.5	16.6	18.8	8.2	6.3	5.7	12.6	12.1	23.1	7.5	13.8	12.1	8.3	8.2	12.9	14.6	4.0	20.3	7.5	38.4	14.3	27.1	12.8	8.4	6.5	12.7	11.6	14.6	13.0	12.6	13.3	11.4	10.9	15.6	19.3	5.9	9.0	10.4	9.8	11.7	12.1	5.7	8.6	13.0	17.8	11.0	7.0	19.2	20.1	17.4	11.9	9.9	13.4	13.2	18.3	10.7	14.8	14.9	16.0	7.1	6.2	5.4	5.9	6.0	5.8	4.0	4.8	5.3	4.5	6.3	4.1	5.9	8.8	4.7	5.7	7.4	3.8	2.8	7.6	10.2	10.7	10.8	7.7	7.9	11.0	5.7	9.1	9.5
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.2;HaCaT: 11.0;PC-3: 5.0;RT4: 26.1"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																				"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.0	0.0	4.2	0.3	0.1	2.0	0.0	11.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	1.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.2	0.4	5.0	0.1	0.1	0.4	0.0	26.1	0.2	0.3	2.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.6	0.3	0.2	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
ULK1	"ATG1, ATG1A"	ENSG00000177169	"Unc-51 like autophagy activating kinase 1"	O75385	12	131894651-131923167	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Autophagy	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 6.9;plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063990			Approved	Cytosol				Cytosol		"HPA063990: "	"unprognostic (1.53e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.52e-3)"	"unprognostic (2.21e-3)"	"unprognostic (8.01e-3)"	"unprognostic (5.48e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.03e-2)"	"unprognostic (9.09e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.16e-1)"	10.9	18.6	14.6	9.2	49.6	33.2	8.9	24.0	24.4	14.4	11.8	6.9	13.3	11.7	16.5	10.7	9.8	10.6	16.2	17.4	11.5	8.3	9.0	15.8	9.0	8.3	7.9	12.0	18.2	59.6	13.8	23.8	17.2	11.6	13.4	4.0	13.9	18.1	13.4	33.4	24.3	11.5	10.2	5.4	16.5	11.4	11.4	11.4	13.8	10.7	9.6	6.5	12.1	10.9	0.6	6.4	6.9	1.7	0.2	0.8	0.6	5.1	16.6	7.7	9.6	3.5	2.8	10.5	8.2	5.9	3.5	2.8	3.6	5.3	1.4	8.6	5.7	5.1	1.7	3.2	1.0	5.5	10.0	3.4	13.6	4.8	6.5	2.5	7.6	5.2	9.0	3.9	1.6	4.3	4.5	4.1	2.3	11.7	15.3	14.5	8.5	15.9	11.6	2.8	6.8	2.0	6.4	19.6	10.8	8.7	9.0	4.5	13.7	16.8	8.2	8.4	5.0	14.6	3.7	18.3	6.6	1.8	14.2	4.3	9.6	0.2	1.7	2.3	0.8	0.7	0.2	0.1	0.7	0.7	0.3	0.6	0.5	0.5	6.9	0.2	0.7	6.4	0.5	0.6	14.6	49.6	24.0	24.4	11.5	8.3	7.9	12.0	11.6	11.4
UMOD		ENSG00000169344	Uromodulin	P07911	16	20333052-20356301	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"			"Ciliopathy, Disease mutation, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	417	"kidney: 237.4"	"Cell line enriched"	"Detected in single"	32	"EFO-21: 3.8"	"Cancer enriched"	"Detected in single"	39	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009446, HPA043420, HPA054721"	Enhanced				"Secreted in other tissues"		83000000			"CAB009446: AB_2212378, HPA043420: AB_2678474, HPA054721: AB_2682585"	"unprognostic (2.51e-2)"										"unprognostic (1.33e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.43e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	237.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
UNC13D	Munc13-4	ENSG00000092929	"Unc-13 homolog D"	Q70J99	17	75827225-75844717	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Exocytosis		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 67.1"	"Cell line enhanced"	"Detected in many"		"HEL: 55.1;HMC-1: 57.1;SK-BR-3: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in single"	6	"cerebellum: 5.6"	"Low region specificity"	"Detected in many"			"HPA067117, HPA073525"	Enhanced		Supported	Vesicles,Cytosol			14000000	Cytosol	Vesicles	"HPA067117: , HPA073525: "	"unprognostic (6.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (3.62e-4)"	"unprognostic (2.98e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (5.28e-12)"	"unprognostic (3.27e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.59e-2)"	4.5	3.3	2.9	17.1	5.2	31.3	4.5	4.1	3.1	5.2	5.2	2.8	1.4	4.5	3.8	1.8	11.5	5.2	8.7	13.0	1.8	1.6	2.6	4.9	30.1	24.9	4.5	1.6	8.7	5.5	0.3	5.3	67.1	3.2	3.1	2.6	2.6	8.0	3.9	3.2	3.0	7.6	2.8	3.7	33.8	7.2	2.2	3.3	23.6	2.4	9.3	24.7	7.0	8.2	4.0	6.9	24.8	13.6	8.2	11.5	7.9	8.3	3.2	0.0	0.0	0.1	0.2	10.4	0.0	0.0	0.0	0.0	8.0	18.8	0.7	10.0	0.0	2.9	0.0	0.5	0.0	0.1	0.1	55.1	24.4	5.1	0.9	20.9	57.1	0.1	0.4	0.1	0.5	3.7	19.0	0.2	0.0	14.2	22.1	10.5	0.2	0.4	7.1	0.2	0.3	0.3	3.3	0.0	15.3	3.6	39.1	0.2	10.5	11.9	10.4	0.1	14.8	0.1	0.0	0.3	1.3	0.8	0.1	6.7	0.0	24.8	8.0	16.4	11.5	9.4	10.4	4.0	6.7	8.1	6.9	2.2	5.3	6.9	22.4	8.2	13.6	4.0	6.0	7.9	2.9	5.2	4.1	3.1	1.8	1.6	4.5	1.6	3.2	3.3
UNC5B	"p53RDL1, UNC5H2"	ENSG00000107731	"Unc-5 netrin receptor B"	Q8IZJ1	10	71212570-71302864	"Plasma proteins, Predicted membrane proteins"	"Angiogenesis, Apoptosis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 43.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 46.0;hTCEpi: 40.6;SH-SY5Y: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.5"	"Lineage enriched"	"Detected in single"	6	"monocytes: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA076687	Approved									"HPA076687: "	"unprognostic (3.98e-2)"	"unprognostic (3.14e-2)"	"unprognostic (9.28e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (3.01e-5)"	"unprognostic (8.82e-3)"	"unprognostic (6.79e-3)"	"prognostic unfavourable (3.80e-5)"	"unprognostic (7.70e-3)"	"unprognostic (6.67e-2)"	"prognostic unfavourable (1.54e-4)"	"unprognostic (4.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.25e-1)"	3.8	12.4	9.1	4.6	19.8	0.5	2.3	23.1	12.5	5.7	8.3	29.5	33.6	3.2	5.4	7.5	14.2	9.1	10.5	13.8	12.2	6.8	6.6	2.1	9.3	3.9	27.1	9.7	4.5	5.2	1.5	5.3	6.0	15.0	10.1	6.0	7.1	4.5	43.7	3.0	5.9	4.5	5.5	17.5	8.5	9.9	6.0	20.4	2.2	4.6	5.2	3.6	9.6	8.9	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.2	1.1	3.6	5.9	0.1	2.0	5.8	0.0	0.1	1.1	5.4	0.0	2.0	12.4	14.0	0.4	0.8	0.0	0.0	1.3	3.1	0.2	0.0	46.0	0.0	0.3	5.1	40.6	0.5	2.6	0.8	0.1	0.0	0.0	0.4	0.0	0.0	3.1	0.1	0.0	1.4	0.0	0.0	6.1	6.2	38.1	0.4	0.4	0.3	0.6	0.1	2.4	0.4	1.8	0.7	0.8	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	9.1	19.8	23.1	12.5	12.2	6.8	27.1	9.7	15.0	20.4
UNC5C		ENSG00000182168	"Unc-5 netrin receptor C"	O95185	4	95162504-95549206	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.3"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 41.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										230000				"unprognostic (1.55e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.48e-1)"	"unprognostic (3.40e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.70e-5)"	"unprognostic (1.25e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.62e-4)"	3.2	17.4	13.5	2.4	16.2	0.7	3.2	4.7	14.2	4.2	5.9	31.3	1.8	3.0	5.1	4.1	1.9	4.3	4.4	5.8	10.7	7.3	2.9	2.6	5.0	1.5	13.7	10.8	6.2	1.3	1.0	2.6	3.8	19.6	7.2	7.0	6.4	11.4	8.3	0.8	1.0	4.0	5.1	13.1	7.9	4.4	5.3	19.9	0.0	22.7	0.0	1.3	4.7	7.9	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.2	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.1	0.1	6.2	0.0	0.0	0.6	0.0	3.8	0.0	0.0	0.0	0.0	4.4	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	13.5	16.2	4.7	14.2	10.7	7.3	13.7	10.8	19.6	19.9
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235457-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6"	"Group enriched"	"Detected in some"	4	"HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain									"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.3	3.9	8.4	0.4	13.5	0.3	0.4	2.8	15.4	5.0	0.9	0.5	0.1	11.7	3.8	0.5	0.4	0.6	0.3	0.3	3.6	9.4	5.0	0.3	0.5	0.3	1.3	8.1	0.3	0.6	0.4	14.2	0.3	4.7	10.6	1.5	3.3	0.4	0.8	0.3	0.4	3.9	2.4	0.8	0.4	0.6	1.6	0.8	0.0	2.1	0.0	0.3	0.3	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	8.4	13.5	2.8	15.4	3.6	9.4	1.3	8.1	4.7	0.8
UPF1	"HUPF1, KIAA0221, NORF1, pNORF1, RENT1, smg-2"	ENSG00000005007	"UPF1, RNA helicase and ATPase"	Q92900	19	18831938-18868236	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Nonsense-mediated mRNA decay"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019587, HPA020857"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA019587: AB_1856174, HPA020857: AB_1856175"	"unprognostic (1.03e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.77e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.98e-2)"	"prognostic unfavourable (2.72e-4)"	"unprognostic (2.94e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.71e-3)"	"prognostic favourable (2.97e-6)"	"unprognostic (4.48e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.01e-2)"	22.5	22.4	18.0	22.4	19.9	23.2	20.4	40.9	25.4	21.5	20.0	24.5	27.8	21.9	24.9	16.7	23.4	19.6	27.0	19.2	14.6	13.5	17.3	20.8	20.5	23.4	20.3	19.3	23.6	42.7	38.1	21.1	28.7	17.7	22.4	11.4	17.9	36.3	25.3	27.9	26.4	20.3	20.1	15.9	23.7	23.7	46.9	20.8	24.9	25.9	13.0	22.9	25.4	24.4	0.9	1.3	4.7	2.3	2.6	1.1	0.8	23.6	15.8	11.1	13.2	17.3	11.4	36.6	20.2	12.5	19.6	15.4	30.3	21.6	21.4	26.8	12.6	23.9	15.6	22.0	7.5	11.3	30.8	23.4	14.3	19.4	14.9	26.0	14.2	12.6	16.0	15.2	16.6	12.4	29.4	20.8	10.3	25.9	30.1	16.3	18.5	38.7	24.2	18.0	20.0	8.6	21.5	23.6	18.2	18.5	21.1	10.9	12.7	16.7	17.4	17.5	12.2	21.4	22.5	13.5	10.4	33.0	12.4	25.1	19.3	0.0	1.7	3.0	0.8	0.9	0.7	0.4	1.1	0.2	1.3	0.9	0.7	0.5	4.7	2.6	2.3	0.6	0.5	0.8	18.0	19.9	40.9	25.4	14.6	13.5	20.3	19.3	17.7	20.8
UPF2	"DKFZP434D222, KIAA1408, RENT2, smg-3"	ENSG00000151461	"UPF2, regulator of nonsense mediated mRNA decay"	Q9HAU5	10	11920022-12043170	"Plasma proteins, Predicted intracellular proteins"	"Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA067008			Supported	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA067008: "	"unprognostic (1.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (5.48e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.27e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.01e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.48e-2)"	15.8	8.7	12.9	18.9	18.1	19.2	13.4	19.7	14.2	22.5	25.5	8.1	14.6	10.2	15.8	14.2	17.2	11.7	9.2	12.7	13.8	11.9	14.5	20.2	12.8	17.8	13.6	10.0	17.8	14.1	20.1	22.3	18.1	13.4	24.5	13.8	7.4	12.2	20.0	33.5	14.5	19.2	19.8	19.3	20.1	12.0	19.4	17.5	28.8	23.0	16.0	17.7	25.5	13.5	7.9	8.4	21.8	3.2	3.7	4.2	1.2	19.0	12.1	10.4	12.9	7.9	10.2	11.8	14.9	6.9	10.7	12.9	11.3	15.6	27.4	5.1	12.4	16.0	14.9	13.5	15.4	17.2	8.6	32.8	9.9	10.3	9.0	14.7	22.2	7.6	10.6	13.5	9.2	13.0	19.4	14.1	12.2	9.3	18.2	8.7	9.9	6.5	16.1	12.5	13.5	10.2	7.7	6.8	7.3	11.8	12.7	12.8	15.4	19.9	13.8	8.4	17.7	17.2	11.3	13.0	10.2	22.7	13.5	14.4	6.6	8.3	3.2	7.1	3.3	3.0	3.2	7.3	3.8	3.4	2.1	7.9	4.2	3.4	21.8	3.7	2.0	8.4	2.7	1.2	12.9	18.1	19.7	14.2	13.8	11.9	13.6	10.0	13.4	17.5
UQCC1	"BFZB, C20orf44, CBP3, FLJ10850, UQCC"	ENSG00000101019	"Ubiquinol-cytochrome c reductase complex assembly factor 1"	Q9NVA1	20	35302566-35412141	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034875	Approved		Approved	"Nucleoplasm,Plasma membrane,Actin filaments"				"Plasma membrane"	"Nucleoplasm, Actin filaments"	"HPA034875: AB_10603226"	"unprognostic (9.66e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.45e-1)"	"unprognostic (8.72e-3)"	"unprognostic (4.01e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.82e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (6.72e-3)"	"unprognostic (3.23e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.34e-2)"	12.6	19.2	13.7	10.6	24.5	2.5	10.1	19.6	23.9	10.9	13.3	15.7	12.1	13.0	14.2	14.2	10.5	11.7	8.4	34.3	13.5	15.9	20.0	17.2	8.7	10.9	16.6	18.2	11.9	10.8	19.8	17.0	10.1	20.1	11.9	17.5	15.8	12.1	12.9	70.2	9.2	11.3	15.5	15.5	11.2	12.2	13.2	13.4	8.9	14.2	17.1	13.8	11.0	9.9	13.5	13.5	16.3	11.9	19.7	15.2	9.6	6.8	9.9	11.2	10.3	11.4	12.5	1.6	13.0	14.1	23.3	16.2	32.1	13.5	21.8	24.6	8.1	18.1	19.7	22.5	17.7	6.5	7.8	29.3	13.2	25.7	7.2	17.5	8.7	12.2	23.0	12.4	15.6	7.9	12.6	7.2	16.2	8.9	20.0	6.3	9.4	20.4	11.0	17.5	12.0	21.4	7.7	15.8	10.6	11.0	53.0	11.4	7.9	11.2	7.4	15.9	10.1	8.3	11.8	11.2	12.1	9.1	28.4	10.2	12.8	16.3	7.7	11.0	12.7	11.9	15.2	10.3	12.1	12.5	13.5	13.5	14.6	13.2	0.3	19.7	7.7	11.5	11.2	9.6	13.7	24.5	19.6	23.9	13.5	15.9	16.6	18.2	20.1	13.4
URB1	"C21orf108, KIAA0539, NPA1"	ENSG00000142207	"URB1 ribosome biogenesis 1 homolog (S. cerevisiae)"	O60287	21	32311018-32393026	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018334	Supported		Supported	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA018334: AB_1856088"	"unprognostic (1.58e-1)"	"unprognostic (2.28e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-3)"	"prognostic unfavourable (4.93e-4)"	"unprognostic (3.04e-1)"	"unprognostic (4.57e-1)"	"unprognostic (4.65e-3)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.95e-3)"	"unprognostic (2.78e-2)"	10.7	14.7	8.5	9.5	13.0	7.4	11.3	10.4	16.2	13.1	8.4	12.6	20.1	6.1	22.2	11.0	13.3	16.5	8.7	10.7	9.2	8.8	8.7	14.9	7.7	9.5	11.7	8.7	17.6	14.1	13.0	15.3	8.6	17.4	19.4	7.5	6.4	15.7	24.9	16.0	16.6	6.7	13.9	10.0	8.7	8.6	14.9	10.9	9.6	10.6	10.2	13.8	16.1	12.4	2.5	1.3	2.5	1.2	3.2	3.5	1.1	7.8	10.0	4.5	9.3	9.3	7.4	7.3	8.1	4.1	6.2	4.8	13.8	4.5	7.9	4.5	7.9	4.9	12.6	19.2	6.4	6.0	7.6	26.9	9.1	7.3	6.7	14.9	6.0	12.0	6.7	14.0	15.4	6.6	24.0	7.8	9.0	7.9	9.6	5.3	14.9	9.3	11.5	10.6	9.5	4.2	7.5	10.2	9.1	9.5	8.0	8.8	7.0	5.8	7.6	15.3	9.2	6.3	9.1	11.0	10.6	12.6	7.0	13.7	7.8	2.5	1.2	0.1	1.8	1.1	3.5	2.5	2.0	2.3	1.3	2.1	2.7	2.5	1.4	3.2	0.7	1.2	2.0	1.1	8.5	13.0	10.4	16.2	9.2	8.8	11.7	8.7	17.4	10.9
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli				Nucleoli		"HPA008902: AB_2213805, HPA046788: "	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.0	7.2	9.6	4.5	3.8	22.0	5.8	3.6	9.1	6.9	10.9	5.8	15.2	6.8	4.1	10.1	17.8	7.1	8.3	7.4	16.9	9.4	9.3	6.4	4.3	13.8	8.2	3.7	5.2	9.0	7.0	4.3	20.0	7.1	5.6	5.8	15.3	6.8	24.1	7.3	17.2	10.2	15.2	4.0	9.3	10.8	13.2	6.9	7.2	5.8	8.1	7.9	4.7	7.5	9.4	9.4	16.6	7.9	7.6	22.8	4.0	10.4	13.5	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2
UROC1	"FLJ31300, HMFN0320"	ENSG00000159650	"Urocanate hydratase 1"	Q96N76	3	126481281-126517773	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Histidine metabolism"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"liver: 50.7"	"Cell line enriched"	"Detected in some"	8	"NB-4: 9.3"	"Cancer enriched"	"Detected in single"	100	"liver cancer: 12.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA069863	Enhanced						510000			"HPA069863: "	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.23e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.71e-2)"	"unprognostic (9.97e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.65e-5)"	"unprognostic (3.97e-2)"	"unprognostic (2.66e-1)"		"unprognostic (5.52e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	50.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UROD		ENSG00000126088	"Uroporphyrinogen decarboxylase"	P06132	1	45012147-45015575	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	"Decarboxylase, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027468, HPA028668, HPA030350"	Uncertain		Supported	Nucleoplasm,Cytosol			5200000	"Nucleoplasm, Cytosol"		"HPA027468: AB_1858654, HPA028668: AB_10603458, HPA030350: "	"unprognostic (5.90e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.61e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavourable (2.48e-4)"	"unprognostic (2.31e-2)"	"unprognostic (4.76e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.73e-2)"	"unprognostic (8.12e-2)"	20.7	50.2	23.1	12.2	26.2	67.5	20.7	14.2	28.6	17.7	24.2	16.5	25.9	11.2	27.8	22.6	17.8	20.8	17.4	34.0	21.1	20.3	29.6	58.1	14.3	14.8	21.6	22.9	27.4	18.4	35.9	17.6	25.8	16.2	19.2	12.3	24.3	45.6	19.2	28.8	12.1	13.2	22.9	18.9	16.6	15.0	16.3	11.5	17.2	26.3	23.6	16.0	15.0	13.0	25.7	48.6	20.6	36.3	26.0	27.4	35.6	12.5	8.2	13.2	17.3	22.8	21.5	6.4	15.3	39.6	32.3	24.9	11.8	6.6	8.9	16.2	23.2	6.5	25.1	29.9	22.5	7.9	26.4	46.0	19.0	39.1	26.6	14.0	8.6	22.3	19.0	30.8	25.0	41.4	79.8	9.8	30.8	10.5	9.5	12.1	20.5	29.1	14.4	19.6	12.9	28.1	10.6	14.1	11.1	16.8	12.6	25.9	9.9	14.7	26.8	18.4	14.4	6.3	24.7	10.2	10.9	7.5	28.8	21.3	9.2	17.6	36.3	20.6	19.7	25.8	20.0	25.7	23.8	19.2	48.6	23.7	22.3	20.3	6.6	26.0	15.5	32.4	27.4	35.6	23.1	26.2	14.2	28.6	21.1	20.3	21.6	22.9	16.2	11.5
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB001480: AB_2213986, HPA036233: , HPA036535: "	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favourable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavourable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favourable (1.95e-5)"	15.4	17.0	21.6	16.9	24.4	14.3	13.8	31.0	27.6	15.2	17.6	15.6	15.6	17.7	15.1	15.5	12.6	17.1	16.2	17.4	21.6	22.1	15.2	19.1	16.7	23.8	19.7	19.4	17.2	9.8	19.0	12.3	17.3	17.1	14.4	18.0	14.7	13.8	19.0	27.4	14.6	17.8	18.0	18.3	26.7	13.7	8.5	18.7	21.9	16.1	13.5	30.3	18.5	13.8	3.9	5.7	8.6	4.7	2.0	4.0	2.0	8.2	12.5	15.0	17.4	20.3	11.6	20.2	6.9	15.0	21.6	16.9	8.7	10.4	10.7	14.7	11.5	10.3	17.6	11.0	12.2	9.9	10.4	9.1	10.5	9.1	11.9	12.7	12.9	9.4	11.0	15.6	12.8	20.2	15.0	11.5	13.5	9.6	19.6	13.9	30.9	16.4	17.1	11.7	12.9	10.7	13.2	8.5	16.3	12.6	16.4	8.7	13.7	41.5	11.8	10.9	6.9	6.6	11.1	9.7	12.3	16.9	9.3	12.5	8.2	4.7	4.7	2.7	4.0	4.5	2.4	3.4	2.5	2.9	5.4	3.9	2.7	2.6	8.6	2.0	4.2	5.7	2.7	2.0	21.6	24.4	31.0	27.6	21.6	22.1	19.7	19.4	17.1	18.7
USP1		ENSG00000162607	"Ubiquitin specific peptidase 1"	O94782	1	62436297-62451804	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 70.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028387, HPA028440"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA028387: , HPA028440: AB_10603000"	"unprognostic (1.22e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.78e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavourable (5.81e-5)"	"unprognostic (6.72e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.33e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.61e-3)"	"unprognostic (5.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.71e-1)"	11.6	9.0	11.3	17.2	10.7	29.3	15.9	20.6	14.2	19.2	13.3	7.8	8.0	10.8	15.1	12.0	15.6	13.8	8.9	9.0	11.5	9.6	11.8	9.3	11.7	19.2	14.2	9.6	26.7	12.7	14.8	18.4	13.6	10.9	14.8	13.9	7.6	12.7	13.5	11.7	12.3	13.3	15.8	15.5	18.1	11.6	31.6	11.8	70.6	15.0	13.3	20.1	16.5	16.5	14.7	11.8	23.4	12.4	15.5	16.3	9.2	22.0	6.5	27.4	14.8	6.2	7.4	15.2	21.2	14.5	26.4	29.0	11.0	10.8	39.9	15.4	11.9	12.8	22.5	14.6	37.0	19.9	16.2	32.7	22.6	11.5	6.7	35.0	16.5	3.9	9.6	23.9	18.0	12.4	23.7	34.9	18.6	9.8	35.9	13.5	24.1	13.5	34.1	46.5	24.7	9.9	16.5	28.4	15.9	24.0	19.6	23.2	11.2	21.4	8.6	20.4	22.2	29.8	29.7	13.9	19.3	45.8	13.8	28.0	18.2	17.4	9.5	23.4	12.6	9.6	16.3	14.7	15.0	12.7	11.4	10.7	14.3	11.9	16.9	15.5	12.4	11.8	13.6	9.2	11.3	10.7	20.6	14.2	11.5	9.6	14.2	9.6	10.9	11.8
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, DNA damage, DNA repair, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.6	18.9	18.4	22.8	6.8	11.6	24.9	13.5	14.3	22.9	12.6	26.6	11.9	23.7	15.7	14.1	15.7	25.5	21.5	30.5	9.6	13.4	13.6	8.9	17.6	9.0	20.2	8.3	7.3	16.6	23.9	27.7	17.5	37.1	5.2	15.8	28.6	20.9	9.8	22.1	12.8	27.2	10.1	11.2	14.4	11.1	17.2	10.1	32.3	10.5	9.1	24.1	12.9	12.8	15.9	12.7	8.0	12.8	8.7	12.1	60.1	10.3	13.0	16.3	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2
USP11	UHX1	ENSG00000102226	"Ubiquitin specific peptidase 11"	P51784	X	47232690-47248328	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 74.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003103, HPA037536"	Enhanced	Supported	Supported	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA003103: AB_10671088, HPA037536: AB_10672904"	"unprognostic (1.60e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.84e-2)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (3.08e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.11e-3)"	"unprognostic (9.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.52e-1)"	"unprognostic (3.29e-3)"	"unprognostic (3.74e-2)"	"prognostic favourable (4.13e-5)"	"unprognostic (3.14e-2)"	"unprognostic (9.23e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.11e-2)"	11.5	17.3	32.9	11.5	55.0	4.9	9.4	35.7	74.0	17.5	9.1	19.9	5.8	6.0	22.6	12.7	9.7	26.6	12.8	20.6	27.0	44.0	13.6	6.7	12.5	13.8	23.1	47.4	38.2	13.8	28.4	32.3	12.6	27.8	15.7	7.6	17.9	9.3	21.3	13.7	7.8	7.3	19.1	17.0	13.5	9.1	19.2	14.6	19.0	27.2	4.3	14.3	11.0	9.8	21.0	20.6	22.8	8.7	19.8	31.7	16.4	14.3	22.6	38.9	26.5	14.7	9.9	10.8	11.0	17.3	21.9	24.5	21.5	11.8	9.5	8.7	19.8	17.1	31.5	7.7	19.5	14.7	23.9	11.1	17.9	19.1	17.1	12.4	23.2	14.2	3.2	23.1	9.9	8.7	8.3	1.3	17.0	21.8	24.1	13.3	28.9	20.2	27.2	38.1	7.9	10.7	19.8	22.0	37.8	20.1	4.1	11.9	8.5	7.2	9.1	18.5	19.5	26.0	12.5	17.7	11.1	16.6	11.4	15.5	16.4	22.8	3.5	7.4	22.6	7.4	19.9	20.1	10.2	22.1	4.6	21.0	15.4	31.7	2.2	19.8	8.7	20.6	12.7	16.4	32.9	55.0	35.7	74.0	27.0	44.0	23.1	47.4	27.8	14.6
USP13	IsoT-3	ENSG00000058056	"Ubiquitin specific peptidase 13"	Q92995	3	179652755-179789401	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 34.8;skeletal muscle: 90.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"MAIT T-cell: 15.4"	"Lineage enriched"	"Detected in many"	8	"T-cells: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004827	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA004827: AB_1080497"	"unprognostic (1.00e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.14e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.22e-2)"	"prognostic unfavourable (3.46e-6)"	"unprognostic (4.93e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavourable (3.06e-4)"	6.4	7.5	2.0	2.3	2.8	0.8	3.5	2.9	4.1	2.7	2.1	4.6	1.5	0.7	3.2	3.8	2.6	2.5	2.5	34.8	2.0	2.3	2.3	3.4	6.0	2.5	2.1	2.1	7.2	3.0	3.3	9.8	1.9	3.0	3.0	1.8	3.1	3.3	2.1	90.3	1.8	1.7	3.7	2.5	1.6	1.6	5.6	1.3	1.7	5.5	17.1	3.2	2.6	1.9	2.0	1.9	0.0	0.4	0.0	15.4	0.7	12.3	5.3	10.1	7.7	4.6	6.4	4.9	7.3	8.4	10.8	9.1	7.8	4.4	15.3	8.2	8.8	0.9	11.3	4.4	12.9	36.2	4.8	4.0	8.0	7.3	3.3	11.2	0.0	6.8	1.6	8.4	10.7	8.6	1.9	19.8	8.9	8.1	6.8	2.0	7.8	4.8	11.7	10.0	12.5	7.3	3.5	5.7	7.4	7.0	9.4	4.2	16.2	8.1	9.3	13.0	10.4	11.1	28.1	9.6	8.0	31.4	6.0	7.6	12.1	0.0	0.2	0.0	1.3	0.4	15.4	2.0	1.3	2.9	1.5	0.6	1.0	1.0	0.0	0.0	0.4	1.9	0.6	0.7	2.0	2.8	2.9	4.1	2.0	2.3	2.1	2.1	3.0	1.3
USP14	TGT	ENSG00000101557	"Ubiquitin specific peptidase 14"	P54578	18	158383-214629	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001308	Approved		Supported	Cytosol			1400000	Cytosol		"HPA001308: AB_1080499"	"unprognostic (2.21e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.59e-3)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (7.81e-5)"	"prognostic unfavourable (4.30e-5)"	"unprognostic (5.14e-2)"	"unprognostic (5.00e-2)"	"prognostic favourable (7.91e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.76e-2)"	24.8	24.2	25.9	20.7	32.1	19.4	21.7	21.7	28.4	16.5	17.1	17.9	19.1	13.4	19.4	24.3	25.3	14.7	14.4	23.3	22.1	27.6	23.2	24.4	15.8	21.9	22.6	28.8	16.2	16.2	22.3	18.0	25.1	29.2	29.9	19.4	14.5	16.7	20.5	53.3	15.7	12.9	23.9	22.1	15.4	15.6	17.2	16.5	19.5	20.1	25.4	28.6	17.8	17.8	13.1	15.2	7.7	15.2	23.0	21.2	11.0	26.8	22.1	18.8	19.1	18.7	18.7	33.7	35.3	19.4	36.0	33.6	28.7	14.4	39.9	27.0	28.9	15.1	37.1	27.0	41.1	11.3	18.3	22.5	14.8	22.5	18.7	55.2	21.6	14.9	20.9	36.7	21.1	27.6	31.0	29.7	35.4	21.8	30.8	15.1	18.4	26.0	25.7	24.7	29.1	26.6	23.3	22.0	18.5	36.6	17.7	15.0	17.3	14.9	31.2	42.3	32.0	38.8	50.0	19.6	35.6	39.7	24.4	23.0	26.3	5.0	10.7	7.7	17.8	15.2	21.2	13.1	17.7	18.4	15.2	10.1	17.5	16.9	0.8	23.0	11.4	11.1	16.7	11.0	25.9	32.1	21.7	27.1	22.1	27.6	22.6	28.8	29.2	16.5
USP15	"KIAA0529, UNPH4"	ENSG00000135655	"Ubiquitin specific peptidase 15"	Q9Y4E8	12	62260338-62417431	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 68.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 68.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006237, HPA006428, HPA071014"	Approved		Enhanced	Cytosol			280000	Cytosol		"HPA006237: AB_1080502, HPA006428: , HPA071014: "	"unprognostic (8.18e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.75e-1)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (6.59e-2)"	"unprognostic (7.70e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.51e-2)"	"prognostic unfavourable (1.58e-5)"	"unprognostic (9.28e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.26e-1)"	23.1	16.8	11.5	22.5	11.9	88.9	17.8	21.1	15.7	14.5	14.5	5.2	11.9	11.4	12.7	12.4	16.1	14.1	11.2	15.2	9.6	6.2	13.8	20.4	23.8	26.2	11.6	9.4	22.5	15.8	18.9	22.5	31.0	14.9	12.4	13.8	7.6	16.2	10.7	28.5	23.0	19.7	16.3	16.2	35.6	14.3	20.0	11.0	33.1	14.1	15.4	18.9	18.4	17.9	5.7	6.0	68.5	14.2	3.3	12.1	4.8	9.3	8.8	8.8	7.6	13.9	16.3	15.7	15.2	13.5	13.5	12.1	8.8	9.4	10.0	8.7	13.0	10.2	11.7	13.2	15.8	11.0	7.2	13.7	7.5	6.7	13.5	21.7	33.4	11.8	13.8	15.9	14.2	15.9	44.4	19.4	12.4	10.4	12.9	11.0	12.9	13.0	8.3	9.3	16.1	12.5	10.8	11.1	5.3	17.6	11.2	8.6	14.7	13.0	19.0	10.5	10.5	16.3	9.4	9.2	10.2	11.4	12.0	17.7	11.8	27.2	14.2	13.8	3.4	7.3	3.5	5.7	4.6	3.2	4.9	4.7	5.9	3.5	68.5	3.3	5.8	6.0	12.1	4.8	11.5	11.9	21.1	15.7	9.6	6.2	11.6	9.4	14.9	11.0
USP16	Ubp-M	ENSG00000156256	"Ubiquitin specific peptidase 16"	Q9Y5T5	21	29024629-29054488	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021140	Supported		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021140: AB_1858668"	"unprognostic (6.06e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.78e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.73e-2)"	"unprognostic (8.65e-2)"	"unprognostic (6.68e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	25.4	21.7	24.4	27.4	24.2	20.4	22.8	32.4	23.1	24.2	24.3	13.5	23.6	20.4	22.6	28.2	27.1	19.4	17.0	23.8	23.8	22.6	28.4	34.0	16.8	20.7	25.8	19.5	27.3	23.6	31.6	41.6	45.9	25.3	26.0	22.3	13.3	20.6	28.8	35.8	16.1	33.2	26.2	28.6	29.1	20.8	20.1	25.3	37.6	28.4	25.6	25.5	30.8	17.1	30.9	23.5	21.2	20.5	19.9	26.2	10.1	21.8	8.7	13.9	12.5	9.9	16.3	13.1	21.3	14.2	14.8	14.1	10.9	14.2	22.3	6.5	20.4	10.0	17.2	15.5	19.4	21.3	18.3	29.7	10.6	12.1	14.7	29.1	16.5	13.9	16.4	19.3	17.8	14.2	24.4	39.4	17.1	10.0	17.9	10.6	14.8	11.3	12.0	34.3	25.5	12.2	15.8	15.1	16.1	13.8	22.1	18.7	15.2	20.0	14.2	17.3	21.6	15.9	21.9	33.7	46.2	23.4	18.1	21.2	17.2	21.2	16.2	20.9	25.4	16.1	19.8	26.4	23.9	22.8	14.9	30.9	26.2	24.8	15.5	19.9	20.5	23.5	24.5	10.1	24.4	24.2	32.4	23.1	23.8	22.6	25.8	19.5	25.3	25.3
USP19	"KIAA0891, ZMYND9"	ENSG00000172046	"Ubiquitin specific peptidase 19"	O94966	3	49108046-49120938	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.23e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.90e-3)"	"unprognostic (2.99e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.69e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (7.05e-9)"	"unprognostic (2.99e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.72e-3)"	"unprognostic (7.54e-2)"	13.9	19.5	10.3	14.6	12.2	16.2	14.9	19.4	37.1	17.0	16.3	12.5	19.6	14.6	18.7	17.9	14.3	17.2	19.9	17.9	10.3	9.4	14.8	16.5	14.7	13.8	11.9	9.5	17.2	15.2	22.4	13.2	17.6	11.4	14.2	10.9	14.9	24.7	26.0	57.3	18.4	16.1	13.9	8.5	17.5	15.1	14.9	11.7	23.0	17.7	15.2	12.6	17.4	14.1	5.1	6.7	12.3	5.7	4.3	8.4	5.3	8.1	11.8	14.1	19.9	17.4	11.9	18.0	9.2	12.3	17.2	13.1	11.8	12.5	17.6	9.4	11.5	10.9	17.8	13.4	7.2	13.8	13.8	17.1	23.6	10.8	18.0	19.4	18.1	16.9	10.4	16.2	11.8	11.3	13.4	13.3	8.6	10.6	18.4	20.1	26.7	17.3	8.9	10.4	20.4	10.6	15.6	7.8	22.2	13.6	17.9	16.0	12.1	25.8	8.9	11.5	14.0	17.0	13.9	33.7	32.6	15.6	14.8	15.4	14.3	12.3	4.9	7.5	7.2	5.3	6.8	4.6	5.8	8.4	6.7	5.1	5.7	6.2	8.8	4.3	5.7	3.0	4.1	5.3	10.3	12.2	19.4	37.1	10.3	9.4	11.9	9.5	11.4	11.7
USP25	USP21	ENSG00000155313	"Ubiquitin specific peptidase 25"	Q9UHP3	21	15730025-15880069	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018297, HPA024142"	Approved		Supported	Cytosol				Cytosol		"HPA018297: AB_1858672, HPA024142: AB_1858673"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.90e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.34e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.32e-2)"	14.9	8.5	11.0	14.2	15.5	12.4	28.7	11.3	11.1	17.5	11.8	6.6	17.8	6.5	20.7	14.5	12.6	10.6	10.1	17.8	9.9	5.8	12.9	10.4	22.1	14.8	7.6	7.1	14.5	8.2	8.1	8.4	17.7	7.7	12.9	8.6	7.8	11.4	13.6	56.3	8.3	12.3	19.2	7.3	11.6	9.0	26.1	7.5	16.5	10.5	14.6	9.6	13.8	18.1	3.1	2.8	5.8	2.9	2.3	7.2	1.6	13.0	9.9	9.4	1.4	17.3	25.9	11.0	9.4	9.4	7.0	8.9	8.6	7.5	14.1	13.9	14.8	7.0	7.2	12.4	9.7	14.0	8.2	11.5	10.5	6.6	28.8	15.2	5.3	16.8	15.2	11.3	32.7	24.5	14.8	26.6	12.6	5.4	17.3	2.9	11.5	8.8	13.2	8.7	10.7	19.0	3.5	2.0	5.6	13.4	11.4	8.7	6.1	8.9	23.3	10.9	7.1	11.4	5.2	7.8	4.7	11.2	7.1	6.8	8.0	0.0	2.9	3.6	4.0	2.8	4.4	3.1	3.4	7.2	2.5	2.2	3.2	4.8	5.8	2.3	2.5	2.8	4.4	1.6	11.0	15.5	11.3	11.1	9.9	5.8	7.6	7.1	7.7	7.5
USP26		ENSG00000134588	"Ubiquitin specific peptidase 26"	Q9BXU7	X	133024631-133097109	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	7	"testis: 3.8"	"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"														"unprognostic (7.92e-4)"		"unprognostic (3.59e-2)"											"unprognostic (1.99e-2)"	"unprognostic (2.08e-1)"			0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.1	0.1	3.8	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.0	0.0	0.5	0.4	0.5	0.4	0.1	0.1	0.2	0.2	0.7	0.1	0.2	0.1	0.7	0.1	0.1	0.1	0.7	0.1	0.2	0.3	1.0	0.3	1.0	0.3	0.1	0.1	0.0	1.5	0.6	0.4	0.1	0.1	0.4	0.4	0.2	0.2	0.1	0.7	0.4	0.3	0.4	0.1	0.0	0.9	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.7	0.3	0.9	0.1	0.3	0.4	0.9	0.3	0.1	0.2	0.4	0.3	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
USP29		ENSG00000131864	"Ubiquitin specific peptidase 29"	Q9HBJ7	19	57119138-57131926	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 4.1;bone marrow: 2.7;pancreas: 2.1;skin 1: 2.3;testis: 8.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.3;HEK 293: 3.2"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Not detected"	"Not detected"			HPA076515	Enhanced									"HPA076515: "															"unprognostic (1.32e-1)"			0.1	0.1	0.2	0.0	0.2	2.7	0.1	0.1	0.4	0.1	0.1			0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.3	0.1		0.2	2.1	0.0	0.1	0.0		0.1	0.0		0.7	0.0	0.2	2.3	0.1	0.0	0.1	0.1	0.4	8.4			0.4		0.0	0.7	0.1	1.1	1.9	4.1	1.1	1.2	0.8	0.6	0.1	0.7	0.8	0.3	0.0	0.0	3.3	0.0	0.0	0.1	0.1	1.7	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	1.0	3.2	0.8	0.0	0.0	1.1	0.0	1.9	0.9	1.0	1.4	0.0	0.0	0.3	0.9	0.0	0.7	0.0	1.2	0.0	1.0	0.9	0.0	1.0	0.0	2.1	2.0	0.7	0.6	0.4	0.2	0.8	1.3	1.5	1.2	0.5	0.0	0.0	1.6	0.5	1.5	0.5	0.8	0.0	3.1	1.1	1.1	0.8	0.7	0.6	0.5	0.7	0.3	0.3	1.1	0.7	0.7	4.1	1.2	0.4	1.9	0.5	0.6										
USP32	"NY-REN-60, USP10"	ENSG00000170832	"Ubiquitin specific peptidase 32"	Q8NFA0	17	60179094-60422470	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 58.4"	"Cell line enhanced"	"Detected in all"		"MCF7: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 28.4"	"Group enriched"	"Detected in many"	10	"dendritic cells: 28.4;granulocytes: 13.5"									HPA044365	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	Cytosol	"HPA044365: "	"unprognostic (4.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (2.15e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.16e-2)"	9.5	13.9	17.3	10.8	19.5	20.6	10.9	14.6	20.3	8.0	8.5	18.9	7.9	7.2	8.2	5.4	13.1	7.4	9.1	11.1	14.7	12.2	15.5	19.7	12.5	8.6	18.8	14.3	7.4	8.5	17.3	11.4	9.8	19.2	8.7	8.9	11.6	8.2	9.0	23.0	12.2	7.2	9.8	16.5	12.1	8.1	58.4	18.1	7.3	15.6	7.9	8.5	8.8	8.5	1.4	28.4	13.5	2.1	0.6	1.1	0.9	10.9	12.5	6.6	10.6	16.8	15.8	6.3	9.0	13.5	11.7	15.1	6.5	7.1	6.8	7.5	16.5	5.8	11.3	12.4	20.7	5.1	5.0	13.5	9.9	7.1	16.8	10.7	12.4	14.8	9.1	15.8	14.6	12.8	13.7	5.6	14.5	60.4	10.8	7.6	7.8	6.0	5.2	17.6	4.1	12.3	8.0	4.7	7.0	7.4	2.2	11.5	9.2	14.9	10.8	17.9	18.7	11.2	8.3	5.8	11.0	6.3	8.9	8.4	11.6	4.3	2.1	7.2	1.0	1.8	0.7	1.4	0.7	0.8	4.1	1.1	0.5	1.0	13.5	0.6	2.0	28.4	1.1	0.9	17.3	19.5	14.6	20.3	14.7	12.2	18.8	14.3	19.2	18.1
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nuclear speckles"				Nucleoli	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: "	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	15.7	19.1	5.6	10.4	12.1	13.5	10.8	13.0	13.2	12.5	8.4	18.5	8.0	20.2	6.6	11.5	11.6	13.2	9.6	22.4	4.8	20.0	18.4	27.8	19.2	12.4	20.1	10.1	11.7	16.0	17.8	39.9	10.8	14.6	21.3	10.3	12.1	18.3	20.4	8.7	15.3	14.1	12.3	13.5	7.9	16.6	16.6	10.1	9.3	43.5	23.6	11.2	12.8	9.2	29.5	13.7	17.1	22.9	15.8	6.2	24.8	11.6	15.8	9.2	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7
USP37	KIAA1594	ENSG00000135913	"Ubiquitin specific peptidase 37"	Q86T82	2	218450251-218568361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045160	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA045160: AB_10795620"	"unprognostic (7.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.83e-2)"	"unprognostic (9.19e-4)"	"unprognostic (1.83e-1)"	"prognostic favourable (2.85e-4)"	"unprognostic (2.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.66e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.82e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-1)"	"unprognostic (6.69e-2)"	"unprognostic (6.41e-3)"	10.4	8.4	9.2	9.7	10.5	19.2	9.0	16.2	10.0	8.3	6.6	10.4	8.0	5.8	9.6	15.8	8.2	7.8	7.0	6.9	7.4	5.5	6.1	7.4	8.1	10.5	8.7	7.8	15.3	6.9	10.7	17.1	8.5	8.7	7.3	7.0	7.4	9.7	9.6	11.1	9.9	7.2	8.1	10.2	7.0	6.6	22.2	10.5	13.4	9.8	5.4	9.4	10.5	9.1	7.4	6.1	7.4	4.8	5.9	9.0	2.5	7.3	5.4	11.4	8.8	3.0	3.7	9.7	5.6	4.1	9.9	11.1	10.2	5.9	6.7	6.2	4.4	7.1	12.5	6.3	10.9	9.2	6.6	18.2	10.9	6.7	3.4	11.8	9.1	2.0	3.8	10.3	7.5	4.2	13.1	13.0	6.2	5.5	15.2	8.1	9.8	4.7	12.3	17.1	6.2	3.4	8.8	12.5	6.8	9.0	4.5	5.7	5.2	8.4	5.3	11.1	9.8	6.2	7.4	8.9	7.8	13.8	6.0	8.8	7.5	6.5	4.2	7.4	7.0	4.8	7.3	5.4	5.8	5.9	4.4	7.4	9.0	5.7	3.5	5.9	4.4	6.1	7.3	2.5	9.2	10.5	16.2	10.0	7.4	5.5	8.7	7.8	8.7	10.5
USP42	FLJ12697	ENSG00000106346	"Ubiquitin specific peptidase 42"	Q9H9J4	7	6104884-6161564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064800			Approved	Nucleoplasm				Nucleoplasm		"HPA064800: "	"unprognostic (1.48e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.82e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.47e-2)"	"unprognostic (3.17e-3)"	"unprognostic (3.14e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.66e-1)"	6.7	5.6	5.7	5.7	9.5	19.8	7.2	14.1	10.6	8.5	7.4	10.4	5.5	8.1	14.1	7.0	6.9	8.1	6.5	5.4	5.8	6.0	7.4	7.1	7.3	6.5	6.7	4.9	10.6	11.7	10.5	10.9	8.2	6.2	7.4	6.5	8.9	6.6	6.3	7.4	9.2	9.2	8.7	9.9	7.8	6.7	25.2	8.1	14.3	7.7	6.2	8.3	7.6	6.9	1.9	2.2	3.3	2.4	1.9	4.3	0.8	8.3	6.2	11.3	11.0	6.5	5.0	7.7	4.5	5.8	5.4	5.3	4.4	4.4	9.9	3.0	5.6	7.8	9.4	5.0	5.8	2.4	7.3	4.6	5.3	4.5	5.5	10.6	5.3	5.8	5.9	5.7	7.4	6.5	17.6	6.7	3.5	7.4	6.4	12.0	12.7	4.8	12.2	8.8	6.8	5.0	4.4	8.6	15.3	5.8	12.0	3.6	5.5	5.5	5.5	4.8	17.8	6.0	5.4	6.0	5.0	8.6	4.0	6.5	9.4	2.3	1.1	3.3	2.1	2.4	3.0	1.9	2.6	1.3	1.1	1.1	1.7	4.3	1.4	1.9	1.2	2.2	1.8	0.8	5.7	9.5	14.1	10.6	5.8	6.0	6.7	4.9	6.2	8.1
USP46	FLJ12552	ENSG00000109189	"Ubiquitin specific peptidase 46"	P62068	4	52590972-52659335	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Behavior, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA007288, CAB076369, CAB076370"	Uncertain		Approved	Nucleoli				Nucleoli		"CAB076369: , CAB076370: , HPA007288: AB_1080531"	"unprognostic (1.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.95e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.28e-1)"	4.7	9.5	26.0	3.5	20.9	2.8	7.0	23.7	29.4	8.9	4.2	12.8	5.2	4.8	7.2	6.2	12.4	7.8	5.8	28.9	21.9	19.0	10.8	3.1	4.4	3.7	19.1	13.9	12.3	5.6	12.2	5.3	10.6	12.7	7.7	4.6	5.3	8.0	7.8	13.7	8.0	4.5	5.5	18.9	3.5	6.3	12.2	15.0	1.0	10.0	4.3	5.8	7.3	5.7	1.4	4.4	2.0	1.4	1.2	3.9	1.0	5.3	3.8	12.3	9.1	13.5	16.9	13.6	8.8	7.1	6.5	5.5	7.6	4.2	3.5	10.4	8.7	3.1	21.4	10.2	12.0	3.1	7.5	5.5	3.6	8.5	13.5	7.3	6.5	14.4	9.6	6.7	6.3	9.6	5.4	5.0	13.8	4.9	3.1	3.8	9.1	4.6	7.9	9.0	0.7	14.0	9.9	7.4	8.9	4.3	14.7	8.5	5.4	5.5	8.9	6.4	14.0	7.5	13.2	5.2	2.4	2.8	9.9	4.4	7.9	2.0	1.4	0.3	2.3	1.2	1.7	1.4	3.9	2.0	2.8	1.2	0.9	0.8	0.3	1.2	0.9	4.4	1.2	1.0	26.0	20.9	23.7	24.3	21.9	19.0	19.1	13.9	12.7	15.0
USP48	"FLJ11328, FLJ20103, FLJ23054, FLJ23277, MGC14879, USP31"	ENSG00000090686	"Ubiquitin specific peptidase 48"	Q86UV5	1	21678298-21783606	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030045, HPA030046"	Approved		Supported	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA030045: AB_10670833, HPA030046: AB_10603325"	"unprognostic (1.35e-1)"	"unprognostic (3.72e-1)"	"unprognostic (5.46e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.00e-3)"	"prognostic unfavourable (6.09e-8)"	"unprognostic (1.04e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.80e-2)"	20.1	38.8	18.6	28.9	30.9	30.9	22.1	48.2	27.5	19.9	18.4	25.6	15.4	17.6	21.3	17.6	19.0	17.4	20.5	17.8	16.9	15.8	15.5	18.3	18.3	26.2	26.6	22.5	27.0	19.8	24.6	35.4	23.1	26.8	21.6	22.0	22.1	24.5	16.3	17.0	23.9	22.2	22.2	19.7	29.1	26.2	15.8	23.6	25.8	23.9	14.0	29.0	19.8	21.0	13.7	10.5	33.7	9.6	5.6	11.2	5.6	14.6	7.0	16.5	11.9	14.3	17.7	16.3	18.5	12.6	12.4	16.5	6.4	15.0	16.5	12.5	16.7	13.6	20.3	14.9	18.9	16.0	13.9	35.3	26.1	11.6	12.8	17.7	18.9	14.3	12.9	12.6	14.1	36.6	27.7	46.8	15.2	7.3	14.6	23.0	10.4	12.6	20.6	16.6	19.3	14.3	12.4	20.1	12.5	17.4	16.0	41.8	8.2	21.4	25.9	13.4	11.1	16.4	10.7	37.5	26.6	16.4	12.9	22.0	19.7	33.7	9.6	16.7	6.4	4.6	7.6	13.7	9.5	9.5	10.5	12.8	11.2	7.0	8.9	5.6	5.0	7.7	10.1	5.6	18.6	30.9	48.2	27.5	16.9	15.8	26.6	22.5	26.8	23.6
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 23.4;U-698: 33.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 8.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain									"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.4	2.4	7.6	3.5	6.0	7.3	2.7	12.7	9.3	2.3	1.9	2.0	4.3	2.2	4.0	2.3	1.8	2.2	2.1	3.5	7.6	4.2	1.6	1.7	2.4	3.7	3.0	5.8	4.0	3.2	2.6	4.8	1.8	4.2	2.4	2.1	3.7	2.7	2.4	3.8	4.1	2.2	3.2	3.2	3.5	2.2	7.4	3.2	7.3	7.7	0.6	3.4	2.8	2.0	1.2	0.7	8.5	1.8	0.8	0.9	0.4	3.0	0.9	12.3	6.0	1.5	1.6	5.1	1.1	1.1	1.8	2.2	3.9	0.7	12.4	1.3	1.5	1.3	7.6	1.1	2.7	3.0	5.6	4.4	4.6	1.3	1.0	3.4	2.7	1.6	0.9	2.6	1.7	1.1	9.2	3.4	1.4	1.7	13.1	5.2	3.4	1.1	23.4	6.0	2.7	0.7	2.1	8.3	3.4	1.6	0.6	0.6	1.8	3.1	3.1	4.3	4.2	1.4	1.5	6.4	5.6	33.3	0.5	3.5	0.8	8.5	1.3	1.4	0.8	1.5	0.4	1.2	0.4	0.8	0.5	0.9	0.9	0.7	2.4	0.8	1.8	0.7	0.4	0.4	7.6	6.0	12.7	9.3	7.6	4.2	3.0	5.8	4.2	3.2
USP5	IsoT	ENSG00000111667	"Ubiquitin specific peptidase 5"	P45974	12	6852128-6866632	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006756	Uncertain		Approved	Nucleoplasm,Cytosol			820000	"Nucleoplasm, Cytosol"		"HPA006756: AB_1080534"	"unprognostic (2.19e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.21e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.71e-2)"	"unprognostic (8.90e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.02e-3)"	18.6	28.7	23.1	17.8	32.6	13.6	12.9	24.6	50.9	15.9	21.5	26.8	13.8	17.6	22.3	12.8	27.7	19.1	14.7	22.4	23.9	28.6	14.9	24.8	14.4	18.6	23.6	33.2	14.4	13.2	29.7	19.6	21.7	36.8	19.5	16.1	11.6	14.1	22.7	41.2	33.5	18.1	25.3	23.6	14.1	15.9	30.9	18.7	22.8	19.2	20.4	19.9	21.3	16.0	10.8	18.6	5.3	16.6	10.8	17.1	16.6	25.3	39.7	26.7	30.2	18.2	16.8	34.1	27.6	21.2	33.0	24.1	37.5	25.2	30.7	14.5	28.6	22.4	29.3	27.4	21.2	57.5	24.8	28.1	31.9	20.3	14.2	25.4	29.6	16.9	15.9	28.5	19.8	28.2	24.1	12.3	27.2	27.8	38.1	12.6	52.0	16.8	30.0	34.8	21.2	18.8	24.7	14.7	29.7	18.8	28.7	12.0	11.5	20.8	27.3	28.0	33.9	21.3	34.3	14.9	34.2	46.7	31.2	16.2	27.2	2.3	12.3	5.3	17.1	16.6	16.1	10.8	15.2	14.4	18.6	10.0	14.6	14.8	0.9	10.8	14.7	13.6	12.9	16.6	23.1	32.6	24.6	50.9	23.9	28.6	23.6	33.2	36.8	18.7
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 57.2;TIME: 52.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"			6000000	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favourable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	34.5	14.1	11.6	34.5	23.5	22.9	25.4	3.1	11.3	32.6	15.3	6.8	21.9	7.7	28.8	21.5	17.7	21.4	15.8	13.8	9.2	12.8	15.5	11.8	35.2	30.9	12.7	8.8	22.7	23.8	53.1	13.0	21.1	16.0	23.4	15.2	17.3	18.4	24.8	11.7	16.7	14.8	19.8	16.6	45.8	13.3	45.0	8.5	27.4	32.4	20.0	25.7	20.7	23.4	11.7	15.0	10.6	48.0	10.3	12.6	3.7	6.8	5.8	10.3	13.3	17.9	16.5	6.2	10.1	9.8	8.2	12.1	22.1	2.5	2.1	8.9	22.7	4.0	57.2	8.5	11.9	22.8	6.6	8.1	6.3	13.1	7.1	9.0	0.1	9.5	1.8	12.2	6.4	40.8	0.5	6.0	11.5	4.5	7.1	3.9	4.1	6.2	6.5	18.6	0.1	9.5	0.1	13.1	0.2	15.7	2.2	6.2	8.7	12.3	52.5	7.9	9.9	4.0	9.6	4.6	6.2	0.3	4.8	5.5	12.9	9.8	12.3	6.6	12.6	36.3	9.0	7.4	8.0	10.2	5.1	11.7	7.0	7.3	10.6	10.3	48.0	15.0	6.4	3.7	11.6	23.5	3.1	11.3	9.2	12.8	12.7	8.8	16.0	8.5
UXT	"ART-27, STAP1"	ENSG00000126756	"Ubiquitously expressed prefoldin like chaperone"	Q9UBK9	X	47651798-47659161	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Activator, Chaperone, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050499, HPA058400"	Approved		Supported	"Nucleoplasm,Centriolar satellite"				"Centriolar satellite"	Nucleoplasm	"HPA050499: , HPA058400: "	"unprognostic (1.12e-1)"	"unprognostic (3.85e-3)"	"unprognostic (9.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.09e-3)"	30.9	37.4	21.7	33.7	23.6	54.4	38.9	20.0	27.3	26.7	31.9	24.8	33.5	23.2	26.8	39.8	30.1	32.4	31.3	47.3	20.9	16.5	34.7	66.8	24.9	46.1	23.6	24.9	50.5	54.1	21.4	29.6	39.0	26.0	30.0	31.1	19.5	46.5	30.5	42.1	36.2	29.1	21.1	27.6	37.1	31.9	24.7	22.6	50.4	37.0	33.2	41.6	24.5	32.5	58.2	60.2	26.2	35.8	36.0	73.5	52.0	44.8	49.8	21.2	28.2	48.6	58.7	37.3	29.1	42.6	50.0	47.5	42.7	42.8	51.5	21.2	41.5	36.4	30.1	39.8	35.7	33.6	59.8	25.9	56.7	42.2	56.7	57.1	51.0	41.2	51.1	42.1	45.3	40.2	28.2	49.8	42.3	49.4	38.9	79.5	30.5	56.9	34.7	43.1	70.7	40.2	33.1	20.2	26.4	32.3	35.3	45.0	41.4	52.9	29.3	35.0	38.2	48.1	31.9	39.4	34.7	46.2	44.6	63.5	35.3	18.7	35.8	26.2	40.2	35.5	54.1	58.2	57.7	43.2	47.4	56.7	73.5	60.2	23.0	36.0	32.4	60.2	52.9	52.0	21.7	23.6	20.0	27.3	20.9	16.5	23.6	24.9	26.0	22.6
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"			5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favourable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	18.5	11.3	13.7	8.9	16.1	17.5	19.1	23.1	19.2	21.0	23.1	15.1	18.5	18.3	21.6	20.1	13.0	13.2	22.0	24.1	11.3	16.6	29.9	12.1	23.3	38.3	40.3	57.3	16.4	22.3	19.9	23.7	21.2	30.0	19.2	18.4	10.0	30.9	23.4	8.8	18.0	16.2	18.6	24.8	20.5	18.8	19.3	10.5	26.7	16.3	16.6	15.2	20.9	22.6	34.3	25.5	35.5	28.0	34.4	27.9	21.9	19.4	17.4	23.5	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 24.8;U-266/84: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol			23000	Cytosol		"HPA046710: "	"unprognostic (1.86e-2)"	"prognostic unfavourable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.86e-4)"	"prognostic unfavourable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.1	6.3	3.5	2.8	8.5	8.6	2.6	6.5	3.9	2.6	1.4	7.6	10.7	5.4	2.4	10.0	6.6	3.9	5.5	14.2	3.7	5.1	6.0	4.6	15.0	12.4	4.2	2.4	2.6	6.0	3.2	10.4	10.3	4.2	3.4	6.8	0.7	6.0	4.2	8.8	1.6	24.8	5.0	2.8	3.9	1.4	0.7	8.5	3.7	5.2	6.0	1.1	4.5	4.2	6.0	14.2	14.8	25.4	6.2	3.3	3.0	5.0	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5
VASN	SLITL2	ENSG00000168140	Vasorin	Q6EMK4	16	4371848-4383528	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	12	"U-2197: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011246, HPA016992"	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted - unknown location"		2400000000	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA011246: AB_1858720, HPA016992: "	"unprognostic (2.20e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavourable (6.24e-5)"	"unprognostic (2.35e-3)"	"unprognostic (8.91e-3)"	"unprognostic (3.15e-3)"	"unprognostic (5.92e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.82e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.95e-3)"	"unprognostic (5.27e-2)"	22.4	10.2	4.9	7.7	6.7	3.8	28.6	1.6	6.5	19.9	5.1	5.6	6.4	5.1	14.3	13.6	16.2	9.9	10.2	12.9	4.4	1.8	21.6	14.1	17.2	5.2	2.7	2.9	21.0	9.8	1.7	5.9	30.2	4.8	12.9	2.0	33.6	7.9	13.1	7.0	16.0	4.0	9.4	3.6	7.9	6.5	14.7	3.5	0.0	15.2	5.5	8.2	16.6	19.0	0.3	0.2	0.4	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	2.7	3.1	1.1	5.2	5.1	1.6	2.6	0.3	0.5	0.0	1.9	3.4	0.0	0.0	0.1	0.2	1.1	0.1	0.1	1.4	1.6	9.9	0.0	0.0	3.2	0.0	3.9	0.1	0.0	0.2	0.0	0.2	1.8	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.1	0.9	2.4	4.1	0.0	0.9	0.2	0.0	4.8	1.2	123.8	0.6	0.0	0.0	0.0	1.4	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.9	6.7	1.6	6.5	4.4	1.8	2.7	2.9	4.8	3.5
VASP		ENSG00000125753	"Vasodilator stimulated phosphoprotein"	P50552	19	45506579-45526983	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 23.6"	"Group enriched"	"Detected in all"	6	"granulocytes: 23.6;monocytes: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004612, HPA005724"	Enhanced		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites"			110000000	"Plasma membrane, Cell Junctions, Focal adhesion sites"		"CAB004612: AB_2213431, HPA005724: AB_1858721"	"unprognostic (3.07e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.85e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (3.49e-5)"	"unprognostic (1.66e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavourable (5.91e-7)"	"unprognostic (1.15e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-2)"	29.1	10.3	4.9	33.3	5.9	40.3	19.0	3.9	4.7	22.6	38.2	5.3	15.4	28.8	37.5	13.3	34.3	23.8	32.2	21.1	5.2	4.3	17.9	21.1	30.5	44.5	7.7	2.2	22.5	10.5	2.9	7.5	31.5	6.2	26.8	9.8	8.9	12.9	20.3	10.4	13.0	43.7	36.7	4.8	69.2	33.4	14.4	6.6	28.3	11.7	12.8	33.2	39.2	17.5	1.8	2.6	23.6	10.4	2.0	2.1	2.2	15.3	16.1	4.7	8.1	2.4	4.1	12.1	15.8	12.2	10.9	9.5	7.3	32.2	7.1	13.4	12.6	14.3	1.4	15.6	3.7	20.8	3.7	40.7	8.0	12.3	13.4	14.9	63.9	6.3	8.8	10.2	6.6	16.3	24.3	15.5	6.7	12.8	6.8	12.8	8.3	11.1	5.1	2.9	2.6	9.3	49.1	5.6	3.9	18.8	9.6	11.1	10.4	25.5	24.1	17.5	17.7	5.6	24.9	8.3	9.9	12.1	12.2	18.1	21.0	5.6	4.0	23.6	2.1	6.5	1.5	1.8	1.7	2.0	2.6	1.7	1.1	1.3	17.1	2.0	10.4	1.0	1.2	2.2	4.9	5.9	3.9	4.7	5.2	4.3	7.7	2.2	6.2	6.6
VAT1	"FLJ20230, VATI"	ENSG00000108828	"Vesicle amine transport 1"	Q99536	17	43014605-43025123	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 37.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045170	Uncertain						1000000			"HPA045170: AB_10964166"	"unprognostic (2.22e-2)"	"unprognostic (4.41e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (1.16e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.38e-1)"	"prognostic favourable (5.89e-4)"	"unprognostic (1.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-2)"	78.7	66.6	9.9	17.0	14.6	25.3	119.8	5.6	18.3	36.4	23.7	18.5	14.8	8.6	33.2	33.8	45.6	24.2	30.9	38.9	10.9	35.0	26.5	20.3	67.1	16.8	25.1	9.0	66.6	22.5	16.6	27.6	27.8	19.5	32.9	11.3	41.3	22.6	18.8	14.3	46.8	18.4	40.6	23.0	14.3	14.4	34.3	15.2	37.2	22.6	28.5	14.8	40.5	44.0	9.2	3.5	37.4	6.8	4.3	8.4	6.7	5.2	31.3	7.5	16.5	80.0	63.3	10.6	13.1	39.3	12.6	23.7	19.2	11.5	1.0	18.3	54.0	8.1	13.0	11.2	11.7	1.9	17.7	4.9	15.7	37.6	51.6	23.8	38.6	33.7	16.7	21.6	10.1	59.6	10.2	1.7	31.5	5.0	34.9	10.2	9.5	14.7	5.0	9.3	2.6	14.3	10.6	7.1	13.4	7.0	4.1	92.6	11.6	13.5	59.7	28.7	13.5	31.9	3.1	2.7	4.0	1.9	29.1	18.0	4.3	37.4	6.8	10.0	5.9	3.3	6.9	9.2	8.4	6.1	3.5	9.2	7.9	4.8	2.2	4.3	3.6	1.7	5.5	6.7	9.9	14.6	5.6	18.3	10.9	35.0	25.1	9.0	19.5	15.2
VAT1L	KIAA1576	ENSG00000171724	"Vesicle amine transport 1 like"	Q9HCJ6	16	77788530-77980107	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.3;brain: 47.1;retina: 32.1"	"Cell line enhanced"	"Detected in some"		"AF22: 9.2;BJ hTERT+: 27.1;fHDF/TERT166: 14.8;NTERA-2: 31.9;U-87 MG: 33.5"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.1"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044061, CAB046032, HPA061138"	Enhanced		Approved	Cytosol				Cytosol		"CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: "	"unprognostic (1.49e-2)"	"unprognostic (8.74e-3)"	"unprognostic (8.80e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.46e-1)"	"prognostic unfavourable (3.01e-6)"	"unprognostic (2.50e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.96e-2)"	1.1	57.3	7.9	3.0	41.3	1.2	1.0	28.4	20.1	1.3	3.4	5.7	0.0	2.4	1.8	6.3	2.0	1.4	3.8	12.7	3.8	47.1	5.3	1.4	0.9	1.0	8.4	12.7	0.9	2.1	0.6	1.5	2.0	27.2	0.8	5.2	32.1	0.9	1.0	0.6	0.6	3.1	2.6	15.4	0.7	1.7	2.1	5.8	0.0	2.0	0.0	2.4	1.4	0.4	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	3.2	0.0	0.0	1.1	27.1	0.3	0.2	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	31.9	0.0	0.7	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.4	0.0	0.0	7.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	41.3	28.4	9.1	3.8	47.1	8.4	12.7	27.2	5.8
VAV1	VAV	ENSG00000141968	"Vav guanine nucleotide exchange factor 1"	P15498	19	6772714-6857366	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 25.7;bone marrow: 25.7;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 30.9;Karpas-707: 35.3;MOLT-4: 33.5;REH: 22.2;THP-1: 26.0;U-266/84: 25.6;U-937: 28.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001864	Enhanced		Approved	Cytosol			30000	Cytosol		"HPA001864: AB_1858722"	"unprognostic (2.93e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.56e-2)"	"unprognostic (8.58e-2)"	"prognostic unfavourable (1.48e-4)"	"unprognostic (9.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.57e-2)"	"unprognostic (3.28e-1)"	5.1	3.0	3.1	19.0	5.6	25.7	2.3	0.7	2.2	1.7	3.5	4.0	0.3	2.8	1.9	2.6	2.6	2.6	3.1	3.3	2.5	3.0	2.7	2.6	8.5	25.1	5.3	1.2	2.0	1.5	5.2	1.8	4.4	3.5	3.2	3.7	2.3	5.8	1.1	0.8	1.4	10.7	2.6	8.7	37.1	2.5	1.5	4.8	43.1	2.0	1.2	20.0	6.1	2.4	9.3	10.5	25.7	22.8	11.5	14.7	10.5	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.8	15.2	4.6	0.0	0.0	0.0	0.0	0.0	6.4	0.5	18.3	0.0	0.0	0.0	17.8	30.9	0.0	0.0	0.0	0.0	0.0	0.6	35.3	0.0	2.5	33.5	10.2	0.0	0.0	22.2	0.0	12.0	0.6	0.0	0.0	0.0	0.0	5.1	0.0	2.2	26.0	0.0	0.0	0.4	0.0	0.0	21.2	25.6	17.2	0.0	28.1	0.0	0.9	11.5	11.9	14.7	18.8	10.5	9.3	10.7	12.7	10.5	9.2	11.8	10.6	25.7	11.5	22.8	9.0	8.5	10.5	3.1	5.6	0.7	2.2	2.5	3.0	5.3	1.2	3.5	4.8
VAV2		ENSG00000160293	"Vav guanine nucleotide exchange factor 2"	P52735	9	133761894-133992604	"Plasma proteins, Predicted intracellular proteins"	Angiogenesis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.4"	"Group enriched"	"Detected in many"	36	"B-cells: 6.4;dendritic cells: 2.0;monocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003224	Uncertain		Approved	Vesicles				Vesicles		"HPA003224: AB_1080554"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.83e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.16e-2)"	"prognostic favourable (7.39e-7)"	"unprognostic (8.64e-3)"	"unprognostic (3.00e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (3.97e-2)"	6.3	19.2	6.8	13.3	5.6	1.9	8.1	2.8	7.3	7.7	16.6	5.8	9.3	15.5	9.8	9.2	5.4	9.5	21.3	5.7	5.4	6.9	16.0	30.3	17.2	12.5	7.7	5.5	6.1	44.1	8.8	6.5	9.6	9.6	7.8	7.3	9.4	12.1	11.0	1.7	4.6	28.1	7.6	4.7	13.8	7.0	3.5	4.0	3.1	11.6	3.9	13.3	8.6	17.3	6.4	2.0	0.0	3.6	0.0	0.1	0.7	4.8	8.5	13.4	5.4	3.7	6.3	34.6	9.7	5.4	8.2	5.0	12.8	7.5	1.4	7.9	9.6	28.7	12.5	20.9	4.2	8.2	2.9	1.6	10.7	14.3	13.8	3.9	0.6	6.2	13.5	7.2	10.3	9.1	2.8	2.4	5.6	24.5	0.3	1.9	6.5	8.1	13.1	11.3	4.6	18.6	8.7	14.9	10.1	25.5	17.1	3.4	10.4	5.6	7.3	11.7	6.5	11.5	13.3	0.1	0.1	2.6	7.7	3.4	7.1	0.0	1.4	0.0	0.1	3.6	0.0	6.4	0.0	0.1	2.0	4.5	0.0	0.0	0.0	0.0	2.4	1.2	0.0	0.7	6.8	5.6	2.8	7.3	5.4	6.9	7.7	5.5	9.6	4.0
VAX2	DRES93	ENSG00000116035	"Ventral anterior homeobox 2"	Q9UIW0	2	70900590-70965373	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.4;retina: 21.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.5;MCF7: 7.4;RH-30: 6.4;SCLC-21H: 6.4;SH-SY5Y: 7.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 2.1;hypothalamus: 4.7"	HPA009708			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA009708: "	"unprognostic (1.56e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (7.23e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.74e-3)"	"unprognostic (6.63e-3)"	"unprognostic (4.65e-1)"	"unprognostic (6.67e-3)"	"unprognostic (2.18e-2)"	2.7	2.6	4.4	1.4	1.9	0.4	2.1	16.4	7.9	1.9	0.8	1.1	0.0	0.5	3.6	0.8	1.8	1.1	0.6	1.5	2.5	4.1	0.6	0.3	0.9	0.6	1.4	1.1	2.3	6.9	0.9	2.2	1.2	0.8	2.3	0.6	21.2	4.5	0.6	2.0	1.5	0.5	1.9	1.6	0.4	0.4	0.8	1.0	0.0	0.7	1.2	0.4	1.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	4.9	1.2	6.5	1.8	1.0	3.6	1.2	0.5	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.3	2.5	0.0	0.2	0.0	4.0	0.0	0.1	2.7	0.8	0.0	0.0	1.8	0.0	0.3	0.0	0.6	0.0	0.0	2.4	7.4	0.0	0.1	2.8	0.1	0.0	6.4	0.0	2.0	1.6	6.4	7.7	5.0	0.0	2.7	2.8	0.2	1.2	3.1	0.7	1.5	1.3	0.0	0.0	0.0	1.5	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.9	16.4	2.7	2.5	4.1	1.4	1.1	0.8	1.0
VCAM1	CD106	ENSG00000162692	"Vascular cell adhesion molecule 1"	P19320	1	100719742-100739045	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"kidney: 69.6;lymphoid tissue: 129.2"	"Group enriched"	"Detected in some"	5	"HHSteC: 56.9;HSkMC: 38.0"	"Cancer enriched"	"Detected in all"	8	"renal cancer: 89.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"gdT-cell: 1.3;memory CD8 T-cell: 2.9;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000154, HPA034796, HPA069867"	Enhanced		Approved	"Cell Junctions"			960000000	"Cell Junctions"		"CAB000154: , HPA034796: , HPA069867: "	"unprognostic (2.96e-1)"	"prognostic favourable (3.82e-4)"	"unprognostic (1.31e-1)"	"unprognostic (7.49e-3)"	"unprognostic (1.04e-1)"	"prognostic favourable (7.19e-5)"	"unprognostic (1.60e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.95e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.55e-2)"	10.9	18.1	1.5	20.2	3.2	1.3	5.2	0.9	1.1	3.7	5.0	3.3	1.4	3.3	4.9	4.5	5.3	4.9	6.8	7.2	1.7	2.3	69.6	11.8	9.8	26.8	2.8	1.7	11.1	6.6	10.6	3.5	10.9	4.2	8.3	5.5	15.3	4.9	1.1	4.7	1.8	6.3	4.2	3.7	129.2	3.0	2.5	1.6	13.3	3.5	2.8	20.9	8.2	2.8	0.0	0.1	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.2	0.1	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	8.2	0.0	0.0	0.0	0.0	56.9	0.0	0.0	38.0	0.0	10.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	3.2	0.9	1.1	1.7	2.3	2.8	1.7	4.2	1.6
VCAN	"CSPG2, PG-M"	ENSG00000038427	Versican	P13611	5	83471465-83582303	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			Cataract	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 58.1;HSkMC: 39.6;RPTEC TERT1: 73.9;U-2197: 32.6;U-251 MG: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 55.5;myeloid DC: 21.3"	"Group enriched"	"Detected in many"	31	"dendritic cells: 21.3;monocytes: 55.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004726, CAB008979"	Supported		Supported	Vesicles	"Secreted to blood"		5200000	Vesicles		"CAB008979: , HPA004726: AB_1080561"	"unprognostic (7.90e-2)"	"unprognostic (9.03e-3)"	"unprognostic (7.09e-2)"	"unprognostic (6.06e-3)"	"unprognostic (1.87e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (7.59e-4)"	"unprognostic (4.36e-3)"	"unprognostic (2.68e-3)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (5.17e-4)"	"prognostic unfavourable (1.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.30e-3)"	33.3	18.3	14.8	53.2	10.3	20.1	12.3	4.8	16.2	25.2	8.4	17.9	1.7	3.6	14.5	23.5	9.0	7.6	23.2	35.7	19.8	8.9	8.5	3.1	25.8	21.2	13.9	9.8	5.3	3.2	3.7	2.0	52.0	14.4	8.9	8.9	3.3	6.5	4.1	9.0	9.3	4.7	33.9	18.2	18.4	6.2	8.7	19.4	1.1	5.7	6.5	2.3	24.4	9.8	0.0	21.3	1.2	55.5	0.1	0.1	17.7	0.0	1.0	58.1	0.0	23.7	16.3	0.0	0.4	1.1	0.4	0.3	0.5	0.0	0.0	9.0	21.0	0.0	0.0	0.0	0.3	0.0	1.8	0.4	0.0	0.4	1.1	0.0	0.0	39.6	0.0	24.7	0.2	0.0	0.0	0.0	12.3	0.0	0.1	0.0	9.8	1.9	0.0	12.2	0.0	73.9	0.0	0.7	3.0	0.0	0.0	0.0	0.0	0.1	22.4	17.7	0.1	32.6	33.4	0.0	0.0	0.0	8.1	0.0	3.1	1.2	55.5	0.1	0.1	7.7	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.9	0.1	0.8	0.4	0.0	17.7	14.8	10.3	4.8	9.8	19.8	8.9	13.9	9.8	14.4	19.4
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"			1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavourable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	23.6	16.2	29.4	20.7	36.8	42.9	16.2	31.2	94.8	21.4	24.3	14.5	20.6	1.0	26.1	54.4	30.3	19.3	15.7	22.6	2.0	8.2	11.2	15.8	6.0	20.2	2.2	17.2	35.4	4.2	28.9	26.4	28.5	8.1	2.4	35.5	4.0	0.3	2.6	13.9	57.3	3.9	15.3	3.0	30.6	30.6	1.1	4.4	17.3	19.7	8.9	9.1	3.4	38.1	23.4	9.8	11.3	29.2	0.4	0.9	4.6	27.3	6.4	6.6	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol			110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favourable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favourable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	17.4	42.3	40.1	43.6	30.7	24.5	19.9	38.9	37.6	26.6	22.3	26.6	27.6	27.0	43.5	19.5	54.3	20.6	20.8	40.1	25.4	21.8	53.7	37.0	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	18.5	15.9	44.4	20.2	26.1	17.9	29.4	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2
VCPIP1	"DUBA3, FLJ23132, KIAA1850, VCIP135"	ENSG00000175073	"Valosin containing protein interacting protein 1"	Q96JH7	8	66628487-66667217	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023932	Uncertain		Approved	"Plasma membrane,Centrosome"				"Plasma membrane"	Centrosome	"HPA023932: "	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.23e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.96e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-2)"	"unprognostic (8.58e-3)"	9.5	8.7	15.7	12.6	14.5	30.9	8.9	14.4	15.1	7.5	8.4	7.0	3.8	7.0	7.8	8.7	8.1	6.9	7.0	6.7	10.2	9.2	8.3	12.3	10.5	13.6	10.3	13.7	7.8	9.0	14.0	5.9	8.0	12.3	7.0	7.8	6.0	9.0	7.1	14.8	7.3	10.0	6.3	9.6	14.7	8.0	10.8	11.7	11.6	8.0	2.8	13.3	7.9	7.0	2.6	3.4	11.3	8.8	2.8	4.3	1.7	8.8	8.0	4.2	5.5	12.7	9.0	4.0	7.1	7.2	5.5	6.3	4.7	8.4	11.9	2.1	9.5	7.9	6.7	5.9	7.9	8.9	4.8	13.3	7.9	5.9	7.7	4.4	14.3	9.7	8.8	5.9	10.8	5.9	8.9	11.6	8.0	4.3	9.5	7.6	7.9	5.6	6.1	6.5	6.0	7.9	7.0	2.4	4.7	5.5	8.4	6.1	8.6	7.3	11.8	7.2	5.4	6.3	4.7	10.3	5.0	12.8	7.2	6.4	5.4	9.2	3.2	6.7	4.3	5.2	3.6	2.0	2.7	3.1	3.4	2.6	2.2	2.9	11.3	2.8	8.8	1.3	3.3	1.7	15.7	14.5	14.4	15.1	10.2	9.2	10.3	13.7	12.3	11.7
VDAC1	"MGC111064, PORIN"	ENSG00000213585	"Voltage dependent anion channel 1"	P21796	5	133971915-134005133	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 189.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005885, HPA030780, CAB072343"	Supported		Uncertain	Vesicles			4800000	Vesicles		"CAB005885: AB_2214787, CAB072343: , HPA030780: "	"prognostic unfavourable (5.30e-4)"	"unprognostic (7.63e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.01e-1)"	"unprognostic (5.11e-3)"	"prognostic unfavourable (4.90e-4)"	"prognostic unfavourable (8.49e-4)"	"prognostic unfavourable (2.87e-5)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	22.4	27.0	32.2	18.9	36.6	9.8	22.6	24.4	46.4	13.8	31.3	15.6	20.4	54.0	12.1	42.8	35.2	13.3	25.8	79.0	31.0	32.3	44.9	52.5	16.3	17.3	30.6	29.5	14.6	27.5	31.6	14.1	22.8	41.8	17.9	35.3	23.3	26.6	17.9	189.4	21.9	39.9	18.9	20.7	18.3	32.5	8.3	14.7	16.3	17.3	66.6	25.5	18.9	21.3	18.9	44.7	9.2	36.5	26.5	23.3	20.0	55.7	49.6	45.5	47.1	45.7	64.0	64.2	62.8	46.5	62.5	64.4	101.4	44.9	77.1	47.3	65.5	44.0	64.1	110.6	78.5	45.5	52.8	44.4	53.1	81.1	46.6	40.7	44.1	58.2	59.4	48.5	54.2	60.5	39.5	31.6	81.5	62.2	49.5	40.6	31.8	42.1	45.7	45.5	73.3	97.1	70.6	50.9	28.8	40.0	48.9	62.6	23.5	40.0	49.0	58.9	39.3	53.9	82.1	42.4	41.9	48.4	87.4	54.7	66.9	6.4	26.2	9.2	18.5	36.5	20.4	18.9	19.1	19.3	44.7	13.4	13.7	15.1	2.2	26.5	31.2	13.1	23.3	20.0	32.2	36.6	24.4	46.4	31.0	32.3	30.6	29.5	41.8	14.7
VDAC3	HD-VDAC3	ENSG00000078668	"Voltage dependent anion channel 3"	Q9Y277	8	42391624-42405897	"Plasma proteins, Predicted intracellular proteins"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 187.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026864	Uncertain		Supported	Mitochondria			9300000	Mitochondria		"HPA026864: AB_1858733"	"unprognostic (2.55e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.88e-3)"	"unprognostic (4.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.78e-3)"	"unprognostic (6.94e-3)"	19.9	18.8	26.0	13.7	29.8	18.6	17.3	38.3	39.1	16.0	23.7	14.5	12.3	19.1	19.1	17.7	26.8	21.5	13.9	85.8	28.2	35.3	27.9	22.1	12.5	14.6	32.5	24.6	18.1	15.0	17.5	16.5	15.4	44.3	17.6	26.2	16.0	22.2	20.8	187.5	13.0	22.7	22.1	19.6	17.3	16.6	27.4	13.0	20.5	21.6	39.7	18.4	23.1	13.3	34.4	59.4	47.5	44.4	31.4	52.4	81.9	48.2	48.6	38.3	40.7	32.3	28.1	19.0	38.6	33.0	49.7	45.5	37.5	41.3	49.6	37.1	32.7	30.9	51.6	41.4	54.8	25.1	42.6	75.4	32.5	53.3	23.1	36.3	42.1	21.8	31.5	37.6	17.6	60.3	59.1	34.6	50.6	26.7	77.4	41.7	45.4	31.7	41.0	70.5	35.1	53.4	43.0	33.8	29.0	24.4	29.0	24.3	61.3	27.7	32.2	19.4	33.8	48.2	37.4	32.2	53.7	56.5	26.0	51.3	32.6	31.1	44.4	47.5	42.1	43.8	42.4	34.4	45.1	41.7	59.4	24.2	45.1	43.3	22.0	31.4	38.5	43.8	52.4	81.9	26.0	29.8	38.3	39.1	28.2	35.3	32.5	24.6	44.3	13.0
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 49.7;hTERT-HME1: 49.5;U-87 MG: 108.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.2;eosinophil: 1.9"	"Group enriched"	"Detected in many"	9	"granulocytes: 1.9;monocytes: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	214485				"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: "	"unprognostic (1.12e-1)"	"prognostic unfavourable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favourable (2.73e-4)"	35.0	17.5	16.6	11.4	20.1	12.8	39.5	6.5	32.3	11.8	25.9	8.7	15.0	16.0	54.1	9.4	19.4	10.4	27.5	57.0	13.4	5.4	25.8	58.6	30.0	2.9	15.8	3.7	16.4	25.1	20.6	7.3	16.7	19.8	40.5	7.2	24.4	15.1	23.8	52.9	11.9	26.3	19.2	35.1	19.0	20.5	4.5	15.4	0.3	87.9	19.6	13.6	47.5	15.7	0.0	0.1	1.9	1.2	0.0	0.0	0.0	12.4	2.2	2.1	12.2	3.6	5.8	14.4	7.6	13.7	5.1	10.1	7.1	1.6	4.1	6.1	4.6	5.1	5.7	15.4	9.0	4.5	1.8	3.1	2.9	4.8	38.7	3.3	6.9	10.1	30.7	49.7	49.5	1.3	5.7	20.7	18.5	5.1	0.3	4.6	1.3	3.5	0.3	2.0	9.8	19.7	10.4	3.8	8.0	11.0	7.5	26.4	2.9	12.5	1.7	21.2	5.7	30.6	12.5	11.8	6.9	8.0	108.8	7.9	7.3	0.0	1.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	16.6	20.1	6.5	32.3	13.4	5.4	15.8	3.7	19.8	15.4
VEGFD	"FIGF, VEGF-D"	ENSG00000165197	"Vascular endothelial growth factor D"	O43915	X	15345591-15384376	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 39.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.1;ASC TERT1: 5.9;EFO-21: 2.6;HSkMC: 5.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA027342	Uncertain				"Secreted to blood"	592125	340000			"HPA027342: AB_1848597"	"unprognostic (5.90e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.06e-3)"	"unprognostic (5.57e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.59e-5)"	"unprognostic (3.08e-2)"	"unprognostic (2.03e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.75e-2)"	9.5	7.4	0.6	1.8	1.0	0.1	19.5	1.1	0.7	10.5	7.6	0.2	4.1	1.1	10.1	12.9	15.4	2.7	3.5	27.8	0.6	1.1	1.0	1.3	39.0	0.7	0.8	0.2	7.3	2.6	0.2	4.4	0.2	0.8	22.2	1.9	0.2	1.5	1.8	12.0	0.5	4.3	9.8	0.6	2.3	3.4	14.9	0.1	0.0	2.0	17.5	1.2	12.3	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.1	1.8	7.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	2.6	0.0	0.5	0.5	0.0	0.0	0.0	0.1	0.0	1.5	0.6	0.4	0.0	0.8	5.9	0.7	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.5	0.5	0.4	0.3	0.1	0.6	0.0	0.7	0.3	0.0	0.1	0.3	0.3	0.4	1.1	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.1	0.7	0.6	1.1	0.8	0.2	0.8	0.1
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 35.9;SK-MEL-30: 96.8;U-2 OS: 17.6;WM-115: 29.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Secreted to blood"	1273770	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavourable (4.25e-4)"	"prognostic unfavourable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	1.9	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	4.6	0.0	0.4	3.6	0.4	0.1	0.0	0.0	0.0	0.0	2.9	35.9	0.0	0.1	96.8	0.0	0.0	0.0	0.0	17.6	0.0	0.4	0.0	0.1	0.9	2.8	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419092-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 129.3"	"Group enriched"	"Detected in some"	106	"CACO-2: 122.1;Hep G2: 57.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"			41000000	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.3	0.2	0.6	5.7	0.8	0.0	0.3	0.7	0.4	0.3	36.6	0.3	0.3	68.9	0.3	1.2	0.3	0.2	22.6	0.3	0.5	0.5	4.6	6.1	0.3	0.3	0.5	0.3	0.3	7.2	0.0	0.4	0.3	0.3	0.3	32.6	0.3	0.5	0.3	0.3	0.3	129.3	1.2	0.5	0.4	0.9	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	2.5	0.1	0.1	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	122.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.1	0.0	0.4	0.0	7.8	0.6	0.8	0.7	0.4	0.5	0.5	0.5	0.3	0.3	0.3
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.3;stomach 1: 52.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035675	Enhanced									"HPA035675: AB_10671223"	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (1.35e-4)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	2.7	2.1	7.1	12.3	7.2	6.3	3.4	4.7	5.3	5.3	28.0	1.7	3.9	33.2	6.2	3.2	3.8	4.1	21.8	3.3	5.3	4.1	2.8	0.6	7.0	7.3	2.9	4.6	3.9	2.2	0.6	3.4	3.6	2.9	8.5	14.8	4.5	3.8	4.8	1.0	5.1	46.3	3.8	3.4	6.3	52.5	3.5	3.5	12.1	4.5	3.1	9.6	15.0	3.8	5.4	4.6	0.1	3.9	4.0	9.2	4.8	6.4	0.0	0.2	0.3	2.3	1.9	0.7	1.8	1.5	1.9	1.8	4.8	20.1	3.1	2.9	1.2	1.5	1.4	0.2	0.4	0.6	0.0	5.7	0.0	0.4	2.9	5.9	7.8	2.8	1.9	1.8	0.0	3.7	5.6	1.8	2.1	0.0	9.5	6.8	0.1	0.0	3.7	0.0	1.5	0.6	7.8	0.1	0.2	0.0	0.4	1.3	0.5	9.8	2.2	0.8	0.3	2.5	0.0	1.2	2.3	0.9	0.5	8.6	4.0	0.0	3.9	0.0	8.7	2.4	9.2	4.4	5.8	4.9	2.6	5.4	7.4	5.4	0.1	4.0	1.6	4.6	6.8	4.8	7.1	7.2	4.7	5.3	5.3	4.1	2.9	4.6	2.9	3.5
VIM		ENSG00000026025	Vimentin	P08670	10	17228259-17237593	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 558.9;fHDF/TERT166: 290.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000080, HPA001762, CAB058687"	Enhanced		Supported	"Intermediate filaments"			19000000	"Intermediate filaments"		"CAB000080: AB_2304493, CAB058687: , HPA001762: AB_1080568"	"unprognostic (1.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.87e-2)"	"prognostic favourable (9.75e-6)"	"unprognostic (3.81e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (8.69e-8)"	"unprognostic (1.87e-3)"	"unprognostic (7.32e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.47e-3)"	254.1	29.2	29.3	51.3	36.2	93.6	285.0	7.5	21.1	137.6	58.0	29.9	46.0	15.8	92.6	100.0	78.4	80.7	71.3	94.8	30.5	14.5	38.7	15.5	100.5	171.0	37.6	26.1	302.9	27.1	32.1	46.2	95.0	38.3	90.5	30.6	161.6	42.6	43.4	52.3	76.2	43.1	101.6	50.7	93.0	38.3	69.8	20.1	56.8	142.0	74.6	73.1	99.2	139.1	24.3	112.1	68.9	90.4	12.2	60.8	61.0	0.5	32.3	58.5	93.3	194.1	558.9	0.0	152.0	101.2	114.7	102.5	0.2	2.0	0.0	8.1	290.4	0.2	8.2	4.2	112.0	100.8	11.3	16.0	16.5	0.0	59.8	8.4	6.6	204.4	0.1	169.2	96.2	186.0	24.8	46.3	203.0	0.1	20.5	25.7	18.6	40.8	16.0	81.2	2.6	114.9	0.0	0.2	28.1	0.0	0.2	152.7	0.2	9.7	157.8	114.4	49.5	95.8	180.1	52.1	26.3	3.7	172.8	0.8	108.7	68.9	90.4	26.5	30.0	59.5	38.6	24.3	49.6	39.1	112.1	14.9	30.8	30.0	53.5	12.2	55.9	44.9	60.8	61.0	29.3	36.2	7.5	20.7	30.5	14.5	37.6	26.1	38.3	20.1
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132681590-132714049	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 131.9;liver: 112.2"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;CAPAN-2: 4.2;EFO-21: 14.8;HBEC3-KT: 3.9;LHCN-M2: 4.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 13.4"	"Group enriched"	"Detected in many"	71	"dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064145	Uncertain				"Intracellular and membrane"		1100000000			"HPA064145: "	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	1.8	0.4	0.3	0.6	0.3	2.4	0.7	0.2	0.3	0.4	128.6	0.1	0.0	40.6	2.5	0.2	0.6	1.7	27.0	1.1	0.3	0.3	6.5	112.2	7.9	2.4	0.4	0.1	0.4	0.9	0.0	0.3	1.0	0.5	0.4	0.3	0.2	1.5	0.1	0.4	0.5	131.9	0.0	0.5	5.6	0.8	0.5	0.1	0.2	0.4	0.0	0.4	0.4	0.9	0.1	4.9	8.0	13.4	0.0	0.0	3.6	4.0	0.0	0.5	0.1	0.1	1.3	0.9	0.3	0.3	0.0	0.0	0.1	4.2	0.2	14.8	0.0	0.1	0.0	3.9	1.0	0.1	0.0	0.2	0.2	2.3	2.3	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.2	0.0	0.6	0.1	0.2	0.1	0.2	1.7	0.9	0.3	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.6	1.0	0.1	0.4	0.2	0.4	0.0	0.1	0.4	0.1	0.6	2.3	13.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	8.0	0.0	10.2	0.2	0.0	3.6	0.3	0.3	0.2	0.3	0.3	0.3	0.4	0.1	0.5	0.1
VPS13B	"CHS1, COH1"	ENSG00000132549	"Vacuolar protein sorting 13 homolog B"	Q7Z7G8	8	99013266-99877580	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043865			Approved	"Cell Junctions"				"Cell Junctions"		"HPA043865: "	"unprognostic (4.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.65e-3)"	"unprognostic (8.60e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.90e-1)"	11.3	10.5	9.6	13.8	10.4	22.1	10.3	13.4	11.8	12.4	9.3	6.6	10.8	4.8	22.4	8.0	10.4	11.6	8.8	7.9	8.7	4.7	7.9	6.2	12.3	12.5	9.9	7.4	16.5	8.1	18.3	21.2	7.9	8.5	10.0	7.5	6.5	9.9	9.6	8.4	11.0	9.6	18.4	11.0	9.8	8.8	10.7	8.4	15.6	9.5	4.9	10.7	12.5	11.8	5.0	1.0	9.8	3.3	1.0	2.9	0.8	8.0	5.8	7.0	5.2	13.2	16.0	3.5	5.2	9.5	5.2	6.9	3.4	4.1	4.4	6.8	8.8	3.7	4.8	4.8	9.5	7.2	4.4	9.7	6.1	2.6	4.3	4.6	7.2	10.3	4.5	8.3	12.0	7.4	7.3	12.0	5.9	4.9	9.6	2.7	2.2	2.1	7.8	5.0	8.4	3.5	7.6	2.1	5.8	8.0	3.9	3.9	6.9	5.3	10.2	7.8	7.3	6.9	4.4	4.9	5.5	12.1	5.9	7.6	5.4	3.5	1.9	4.3	2.1	1.7	1.9	5.0	1.8	1.6	0.8	2.9	2.9	1.9	9.8	1.0	3.3	1.0	2.1	0.8	9.6	10.4	13.4	11.8	8.7	4.7	9.9	7.4	8.5	8.4
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69172861	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes			19000	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: , HPA057498: "	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavourable (1.72e-4)"	"prognostic unfavourable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavourable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	30.7	25.8	31.8	18.8	37.1	25.2	29.6	42.6	37.2	23.3	27.5	14.5	15.1	21.4	24.5	20.7	37.1	20.7	20.9	40.7	33.3	21.1	34.3	26.5	23.9	17.7	26.5	25.4	24.1	19.3	31.4	24.5	36.4	29.9	23.9	28.8	15.3	25.7	20.3	29.3	33.8	28.0	22.9	35.4	24.7	22.7	34.2	29.1	21.8	27.8	23.6	22.8	30.8	27.3	16.9	28.1	28.2	29.4	34.7	28.1	25.3	33.1	12.7	15.6	28.0	27.6	25.1	13.8	20.3	33.0	24.9	28.4	29.8	32.6	10.3	16.5	22.2	23.0	23.4	20.3	34.6	9.3	12.7	15.5	11.8	16.6	35.7	23.4	12.5	22.7	31.9	24.8	55.3	26.1	29.7	14.7	39.5	10.5	10.5	26.5	10.5	32.3	13.1	25.9	12.4	29.0	19.7	9.6	14.3	27.6	38.1	36.9	15.0	20.1	29.9	16.9	21.7	27.4	26.4	8.8	21.3	16.9	23.2	38.2	8.8	28.2	25.4	22.9	27.9	29.4	25.3	16.9	21.6	28.1	28.1	13.7	19.2	26.6	23.0	34.7	24.2	11.5	24.1	25.3	31.8	37.1	42.6	37.2	33.3	21.1	26.5	25.4	29.9	29.1
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria				Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favourable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	23.5	29.1	14.2	15.9	17.4	16.5	17.0	17.1	19.4	16.2	23.4	20.8	12.1	25.5	17.8	13.8	20.6	15.4	17.6	21.3	17.1	11.9	29.2	28.6	19.9	18.1	18.3	16.9	16.8	23.9	14.5	14.7	20.9	15.6	15.9	23.7	22.1	17.3	15.3	30.8	16.8	31.2	19.7	17.4	24.6	21.5	7.4	17.8	21.3	16.7	13.3	20.6	23.0	16.1	19.6	24.2	40.3	30.2	24.9	26.9	24.5	12.2	5.8	12.8	10.8	23.6	21.2	14.2	12.3	27.3	11.3	16.6	8.0	13.4	8.8	4.6	28.2	6.1	13.6	13.2	10.9	21.0	9.8	14.9	5.9	7.7	20.6	11.0	10.1	18.4	13.0	13.0	21.1	21.0	9.3	19.6	21.5	5.8	18.8	9.4	14.2	5.6	17.5	6.1	12.8	13.8	9.5	10.3	13.9	8.4	16.5	26.0	15.7	8.9	16.6	12.9	4.5	13.6	7.1	30.2	30.4	12.2	20.3	18.8	14.1	23.5	24.5	40.3	26.9	30.2	25.0	19.6	23.2	24.4	24.2	14.7	21.5	22.6	25.4	24.9	26.3	9.6	26.7	24.5	14.2	17.4	17.1	19.4	17.1	11.9	18.3	16.9	15.6	17.8
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29, retromer complex component"	Q9UBQ0	12	110491097-110502117	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol			140000	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favourable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	39.2	34.9	35.6	28.5	38.5	44.4	32.6	23.0	46.6	30.3	38.0	24.4	29.5	33.6	31.5	50.4	51.2	29.0	27.5	35.9	31.5	30.9	62.2	51.2	31.3	33.1	32.8	27.8	27.6	31.4	18.3	31.4	34.5	46.6	41.6	43.5	27.3	34.1	40.6	64.0	25.2	36.2	47.3	28.9	43.1	34.9	17.0	23.8	29.8	38.3	32.9	38.0	51.5	27.4	40.5	67.4	52.7	79.9	41.7	46.0	72.1	31.2	30.7	29.2	20.8	32.9	32.7	23.1	29.7	31.1	30.0	27.2	30.7	27.4	29.0	31.3	29.4	29.9	38.6	27.5	31.5	34.3	30.9	35.4	38.7	25.2	28.7	42.2	31.1	21.5	23.5	25.4	28.1	52.4	33.8	27.2	53.7	15.7	33.0	60.0	16.7	39.5	22.1	29.9	40.7	49.9	46.6	31.5	16.7	33.7	30.0	37.2	40.7	32.7	29.4	26.1	17.2	36.0	34.6	18.6	25.9	34.1	30.4	40.4	27.7	43.9	57.6	52.7	31.9	73.2	35.1	40.5	40.7	37.3	67.4	31.4	37.4	36.8	38.5	41.7	79.9	45.3	46.0	72.1	35.6	38.5	23.0	46.6	31.5	30.9	32.8	27.8	46.6	23.8
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35, retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes			320000	"Endosomes, Lysosomes"		"HPA040802: "	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favourable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavourable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favourable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	14.1	12.6	15.1	11.8	21.1	18.3	15.7	13.1	23.6	14.3	15.2	11.9	10.0	11.7	13.0	19.3	16.4	14.8	11.2	14.0	15.1	18.6	13.4	9.2	14.4	11.6	20.4	17.0	16.2	11.7	22.8	18.0	15.3	31.7	14.5	12.2	8.4	12.3	12.7	11.9	19.5	21.9	12.7	16.5	14.0	12.3	12.1	10.9	14.0	12.2	11.8	13.0	17.1	11.6	2.4	2.9	3.1	9.2	1.7	3.2	2.0	8.5	8.7	10.0	6.3	12.1	16.6	5.4	8.2	10.2	11.7	6.2	8.5	6.0	9.1	8.7	10.0	8.4	10.2	12.3	13.5	2.5	11.6	6.7	4.9	6.5	11.3	9.5	6.7	11.0	13.8	10.1	5.9	11.6	6.4	2.5	12.4	6.1	10.9	9.1	3.0	11.4	11.3	14.3	16.6	11.3	7.2	7.2	8.3	8.1	9.1	7.4	3.8	8.8	11.6	8.9	2.9	9.2	9.7	5.5	5.6	9.3	15.4	12.3	4.9	2.2	2.7	2.6	1.6	4.5	1.7	2.4	1.9	2.1	2.9	2.4	3.2	2.4	3.1	1.7	9.2	1.7	2.7	2.0	15.1	21.1	13.1	23.6	15.1	18.6	20.4	17.0	31.7	10.9
VPS39	"KIAA0770, VAM6"	ENSG00000166887	"VPS39, HOPS complex subunit"	Q96JC1	15	42158701-42208316	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (4.39e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.28e-2)"	"prognostic favourable (3.21e-7)"	"unprognostic (9.85e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.51e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.04e-2)"	21.4	28.7	24.9	18.1	35.0	19.5	18.9	26.2	39.4	23.7	20.4	29.5	22.0	16.9	24.9	24.2	19.3	24.5	19.1	25.5	19.8	22.4	21.4	12.6	22.6	19.3	22.0	25.3	20.9	24.5	40.1	27.5	20.7	26.8	23.6	18.9	22.0	26.9	26.0	32.5	27.0	21.0	25.9	17.6	25.0	22.0	18.8	18.7	24.9	25.2	12.8	23.9	22.6	17.6	14.1	13.4	26.3	14.2	16.6	14.6	14.8	7.6	10.8	15.8	17.8	29.0	28.1	10.0	13.8	24.9	16.8	17.7	9.2	6.6	6.9	14.0	25.1	18.2	12.2	13.8	15.5	21.4	7.0	16.6	17.6	8.6	20.0	15.0	12.9	24.5	19.9	15.7	16.3	17.4	12.2	19.1	18.5	6.8	11.5	8.4	9.7	9.4	8.8	14.7	10.8	12.3	18.0	14.0	20.5	11.3	10.9	7.2	17.6	19.6	18.9	14.6	6.2	17.4	10.1	16.3	21.8	10.1	17.7	13.7	11.8	26.3	12.7	15.0	13.8	14.2	13.9	14.1	12.3	14.6	13.4	11.3	12.5	12.0	14.4	16.6	12.4	5.8	10.8	14.8	24.9	35.0	26.2	39.4	19.8	22.4	22.0	25.3	26.8	18.7
VPS41	HVSP41	ENSG00000006715	"VPS41, HOPS complex subunit"	P49754	7	38722963-38932394	"Plasma proteins, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020080, HPA020299"	Approved									"HPA020080: AB_1858768, HPA020299: AB_1858769"	"unprognostic (9.20e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.63e-2)"	"prognostic favourable (3.40e-8)"	"unprognostic (1.62e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.28e-1)"	18.7	16.6	26.0	13.3	34.4	7.6	15.7	13.9	42.4	20.0	17.1	18.0	11.3	11.8	21.2	13.0	17.2	17.0	25.4	17.0	23.2	26.0	22.0	18.0	17.1	15.7	27.8	27.4	23.1	16.0	25.8	34.6	15.8	32.0	16.9	14.1	18.8	12.3	18.8	8.4	13.1	12.8	17.7	33.0	15.2	14.4	10.6	19.2	14.2	21.8	7.3	17.1	16.4	13.3	18.6	19.6	22.6	21.5	18.7	13.5	10.8	11.7	15.7	16.2	17.2	24.0	22.6	8.2	12.3	22.8	10.3	16.9	9.5	17.6	11.8	36.7	16.5	14.9	23.4	15.7	17.8	15.7	11.3	11.4	9.7	7.6	19.1	13.8	22.9	16.5	13.1	14.2	13.9	18.6	16.9	24.9	18.8	10.7	14.0	7.8	17.5	10.6	15.2	14.7	12.2	19.3	29.3	13.9	24.4	12.2	19.4	11.5	21.8	17.6	19.6	11.7	11.9	15.6	12.7	25.4	45.7	22.1	25.2	12.2	39.6	16.8	16.2	22.6	13.5	16.2	11.3	14.2	10.3	12.3	19.6	18.6	10.9	11.9	19.3	18.7	21.5	11.8	11.1	10.8	26.0	34.4	13.9	40.5	23.2	26.0	27.8	27.4	32.0	19.2
VPS45	"h-vps45, H1, VPS45A, VPS45B"	ENSG00000136631	"Vacuolar protein sorting 45 homolog"	Q9NRW7	1	150067279-150145329	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027425, HPA027441"	Uncertain		Approved	Microtubules				Microtubules		"HPA027425: AB_10599415, HPA027441: AB_10602284"	"unprognostic (1.57e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.36e-3)"	"prognostic unfavourable (6.57e-6)"	"unprognostic (4.76e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (1.05e-4)"	"unprognostic (1.49e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.32e-2)"	15.5	22.1	26.4	9.8	29.6	4.9	15.9	40.7	25.9	19.1	15.4	12.2	13.8	10.5	16.0	21.0	14.9	13.5	12.1	32.4	19.6	16.7	18.9	10.6	13.3	10.4	17.4	21.8	13.0	8.7	20.0	26.5	14.9	17.6	17.3	15.5	13.5	11.7	18.7	14.3	12.4	13.8	22.3	19.8	12.6	13.8	9.0	20.1	12.3	17.7	9.3	12.8	15.5	12.4	11.1	18.6	12.7	20.1	9.3	12.3	12.4	15.8	12.4	21.8	14.1	20.3	16.2	10.0	23.1	12.5	24.3	20.2	9.1	13.9	9.8	14.1	19.3	13.6	22.3	14.2	26.6	19.2	16.3	12.4	17.7	8.4	13.5	8.9	16.2	14.1	13.3	23.2	12.3	19.6	17.3	14.8	21.2	26.9	17.4	8.8	15.0	20.2	12.1	22.2	13.9	16.8	15.3	15.1	32.0	18.1	16.0	23.8	25.9	23.8	17.1	11.2	13.2	10.0	16.1	11.1	24.0	9.5	16.7	12.7	15.9	12.7	19.0	3.2	12.3	20.1	11.5	11.1	10.7	11.6	18.6	8.6	10.2	10.8	1.9	9.3	13.3	10.2	11.8	12.4	26.4	29.6	40.7	25.9	19.6	16.7	17.4	21.8	17.6	20.1
VPS4B	"SKD1, SKD1B, VPS4-2"	ENSG00000119541	"Vacuolar protein sorting 4 homolog B"	O75351	18	63389190-63422483	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040393, CAB046445, HPA057649"	Approved		Approved	"Vesicles,Intermediate filaments"			34000	Vesicles	"Intermediate filaments"	"CAB046445: AB_10603252, HPA040393: , HPA057649: "	"unprognostic (8.54e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.85e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.67e-1)"	"prognostic favourable (1.23e-4)"	"unprognostic (4.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.21e-1)"	16.8	13.0	14.3	14.3	17.2	28.0	17.2	15.4	19.1	19.8	24.0	21.8	15.5	20.0	16.7	12.1	55.0	13.1	15.1	9.9	13.7	16.0	15.6	20.5	14.3	21.6	17.0	14.7	11.9	14.0	17.5	17.4	27.4	23.4	14.3	22.2	9.3	21.8	15.0	9.9	22.1	28.7	15.2	20.2	17.3	18.7	9.0	14.6	27.8	17.0	17.6	31.8	18.6	24.7	20.7	13.6	56.4	20.6	19.1	18.9	15.4	18.4	6.8	7.6	8.3	11.8	16.7	13.2	16.2	15.3	12.4	13.6	5.0	13.2	17.8	10.6	11.8	40.1	9.1	17.7	16.5	12.9	7.3	8.9	9.6	7.7	16.9	30.6	19.5	15.1	27.6	10.9	19.5	11.5	4.4	16.7	17.6	6.4	19.1	9.6	7.9	10.7	16.0	16.2	17.1	15.6	21.7	13.0	11.5	12.2	12.0	18.1	11.5	16.7	17.6	19.2	9.4	7.2	10.6	56.1	26.9	22.9	11.0	14.5	14.2	39.4	16.8	36.0	16.5	16.6	15.4	18.9	17.4	17.0	13.6	20.7	15.8	16.6	56.4	19.1	20.6	13.6	18.9	15.4	14.3	17.2	15.4	19.1	13.7	16.0	17.0	14.7	23.4	14.6
VRK1		ENSG00000100749	"Vaccinia related kinase 1"	Q99986	14	96797304-96931722	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000660, HPA017929"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA000660: AB_1080579, HPA017929: AB_1858770"	"unprognostic (1.03e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (4.20e-2)"	"unprognostic (2.11e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.58e-1)"	6.0	4.4	7.1	9.8	17.1	39.0	8.7	8.6	10.2	6.1	7.8	4.4	4.1	5.2	5.9	5.7	9.4	6.9	3.3	6.0	7.4	6.5	6.2	4.3	4.5	18.3	6.9	6.1	5.9	3.7	3.8	5.1	7.1	6.7	5.3	9.1	4.1	4.8	4.1	4.3	6.4	6.9	5.4	6.1	15.7	6.7	33.3	6.9	33.0	4.9	6.1	18.4	5.9	5.7	20.8	13.5	20.1	9.5	28.5	22.3	12.5	15.7	9.1	22.5	10.0	2.7	5.0	14.0	11.9	9.3	19.1	19.0	10.8	15.6	40.1	8.1	7.0	17.5	21.0	15.5	26.3	22.8	11.3	25.0	6.0	11.1	2.9	48.0	15.7	2.7	2.8	14.4	10.6	13.2	21.2	25.4	16.4	18.0	38.1	20.7	14.4	17.3	35.7	39.4	13.6	8.7	16.2	15.9	9.0	10.5	10.8	8.0	12.3	19.0	7.1	8.7	7.8	15.0	11.9	13.3	15.7	38.8	13.6	21.0	10.3	20.1	7.6	14.5	15.1	9.3	18.4	20.3	17.6	18.5	9.9	20.8	19.1	19.3	4.5	28.5	9.5	13.5	22.3	12.5	7.1	17.1	8.6	10.2	7.4	6.5	6.9	6.1	6.7	6.9
VRK3		ENSG00000105053	"Vaccinia related kinase 3"	Q8IV63	19	49976467-50025946	"Enzymes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 77.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056489	Approved		Supported	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA056489: "	"unprognostic (2.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.78e-2)"	"unprognostic (3.47e-1)"	"unprognostic (8.79e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.43e-1)"	"prognostic favourable (1.83e-4)"	"unprognostic (9.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (5.66e-4)"	9.7	11.9	9.2	9.4	12.7	10.7	8.3	12.0	14.1	8.9	13.4	11.9	9.3	13.4	15.7	10.8	8.4	18.0	12.2	7.4	9.3	11.1	16.7	16.2	8.5	13.4	10.4	9.9	11.2	11.5	7.1	11.8	10.7	9.8	9.4	11.7	14.2	14.3	8.5	11.8	7.7	17.3	7.5	11.0	12.8	10.9	77.2	9.1	24.7	14.1	6.0	12.9	9.9	8.0	24.5	19.7	47.3	20.9	33.5	30.1	18.1	16.3	16.9	12.4	13.4	16.5	15.3	12.9	11.8	14.1	17.5	19.3	9.0	18.3	19.7	8.4	11.4	12.2	11.5	10.0	14.2	17.2	23.7	15.3	10.2	15.6	12.4	19.1	27.0	13.7	15.1	10.1	10.7	14.4	18.6	29.4	12.6	6.9	25.8	12.9	6.7	14.6	20.8	13.1	25.1	15.0	17.3	14.0	6.8	11.5	14.2	12.8	13.1	20.4	10.9	18.0	10.5	7.2	9.1	19.1	24.3	10.3	14.4	11.8	12.3	37.0	17.8	32.4	23.8	18.8	19.1	24.5	21.7	22.7	19.7	21.9	22.1	20.4	47.3	33.5	20.9	18.8	30.1	18.1	9.2	12.7	12.0	14.1	9.3	11.1	10.4	9.9	9.8	9.1
VSIG4	Z39IG	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;HMC-1: 1.1;NB-4: 3.1;SH-SY5Y: 1.0;U-937: 2.7"	"Cancer enhanced"	"Detected in all"		"glioma: 88.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 13.9;intermediate monocyte: 8.1;myeloid DC: 13.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 13.1;monocytes: 13.9"					"Low region specificity"	"Detected in many"			"HPA003903, CAB026000"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			41000000	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: AB_1858776"	"unprognostic (6.87e-3)"	"unprognostic (4.79e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.37e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.37e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"prognostic unfavourable (1.95e-6)"	"unprognostic (3.70e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.47e-2)"	67.1	28.1	15.9	17.6	16.6	2.6	19.0	1.8	10.4	6.3	18.0	5.6	1.0	9.2	6.1	14.2	9.3	28.7	15.5	15.9	11.5	3.5	18.5	22.9	61.4	37.0	17.9	3.4	8.2	8.2	3.7	7.9	52.4	12.0	10.9	12.6	8.1	11.3	4.0	10.5	4.0	14.6	39.9	16.7	28.5	9.4	13.5	17.8	0.0	10.7	1.7	1.8	14.4	9.0	0.1	13.1	0.4	13.9	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.1	3.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.3	0.0	0.4	0.0	0.0	0.8	2.7	0.0	0.0	13.9	0.0	0.0	8.1	0.0	0.0	0.0	0.2	13.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	3.3	15.9	16.6	1.8	10.1	11.5	3.5	17.9	3.4	12.0	17.8
VSTM2A	"MGC33530, VSTM2"	ENSG00000170419	"V-set and transmembrane domain containing 2A"	Q8TAG5	7	54542325-54571080	"Plasma proteins, Predicted secreted proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.7;brain: 51.7;prostate: 13.7"	"Group enriched"	"Detected in some"	6	"Karpas-707: 3.3;SCLC-21H: 10.2;SH-SY5Y: 7.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (1.15e-1)"		"unprognostic (1.02e-1)"		"unprognostic (1.89e-1)"						"unprognostic (1.14e-2)"	"unprognostic (4.66e-1)"	"prognostic favourable (5.34e-4)"	"unprognostic (4.34e-2)"	"unprognostic (6.79e-2)"		"unprognostic (7.15e-2)"	0.7	13.7	18.4	0.7	22.7	0.7	1.1	0.5	51.7	0.7	6.0	1.4	0.0	2.4	0.7	0.7	0.7	0.7	0.9	0.7	9.4	15.5	0.8	0.7	0.8	0.7	4.4	13.6	0.7	1.8	0.7	0.4	0.7	6.7	13.7	5.8	1.1	0.7	0.7	0.8	0.7	1.1	0.8	3.2	0.7	7.2	1.2	3.0	0.0	0.7	0.0	0.7	0.9	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	10.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	22.7	0.5	51.7	9.4	15.5	4.4	13.6	6.7	3.0
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224689	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol			22000	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavourable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavourable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	18.8	19.5	20.5	15.5	28.2	17.2	20.6	25.0	39.3	17.2	22.0	18.5	9.6	24.2	16.0	17.1	31.4	17.9	14.9	21.2	19.8	20.3	24.9	29.9	13.5	19.3	20.1	20.7	15.3	15.6	16.3	21.7	30.5	30.7	16.8	26.3	11.2	19.4	13.5	48.6	20.9	32.7	17.0	24.0	20.8	14.6	12.9	18.2	33.6	18.0	24.3	24.0	18.4	19.7	29.0	30.9	58.6	38.1	30.9	30.1	36.1	18.1	15.6	25.5	39.0	22.5	24.8	17.6	41.1	24.6	37.7	36.1	26.3	14.2	29.6	27.9	36.8	23.2	27.1	28.1	52.3	20.0	23.8	32.1	16.7	31.4	16.6	49.7	18.6	20.4	32.9	37.6	24.4	24.1	29.7	14.9	31.5	26.4	32.2	25.9	19.1	17.9	29.7	20.4	18.0	29.0	20.1	26.7	20.8	23.1	17.8	20.6	19.3	33.9	17.4	17.0	23.7	28.4	29.5	14.7	25.4	33.7	11.1	27.8	25.8	58.6	31.0	49.5	23.5	38.1	30.1	29.0	26.8	27.4	30.9	26.6	29.8	29.9	19.1	30.9	37.4	19.0	25.7	36.1	20.5	28.2	25.0	39.3	19.8	20.3	20.1	20.7	30.7	18.2
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367276-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	42	"liver: 321.7"	"Cell line enriched"	"Detected in some"	11	"CACO-2: 164.9"	"Cancer enriched"	"Detected in many"	85	"liver cancer: 2216.6"					"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016695, CAB016765, HPA060933"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	224300000000	32000000000	"Endoplasmic reticulum, Vesicles"		"CAB016695: AB_1624536, CAB016765: , HPA060933: "	"unprognostic (1.19e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.29e-2)"	"unprognostic (6.13e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.42e-2)"	"prognostic favourable (3.74e-4)"	"unprognostic (6.20e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.95e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (4.10e-11)"	"unprognostic (8.82e-3)"	"unprognostic (2.27e-1)"	"unprognostic (4.86e-3)"	"unprognostic (7.09e-2)"	0.2	7.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	3.6	2.2	0.0	0.0	0.0	321.7	0.0	0.0	0.0		0.0	0.6	0.0	0.0	2.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4			0.0		0.0	0.0	0.0	0.3	0.2	0.6	0.2	0.7	2.1	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.1	0.0	164.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	8.5	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	15.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	1.0	0.0	0.9	0.0	0.9	0.9	0.1	0.3	0.6	2.1	0.6	0.7	0.0	0.2	0.0	0.1										
VWF	F8VWF	ENSG00000110799	"Von Willebrand factor"	P04275	12	5948874-6124770	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Cell adhesion, Hemostasis"		"Cancer-related genes, Disease mutation, FDA approved drug targets, von Willebrand disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 91.7"	"Cell line enriched"	"Detected in some"	57	"HUVEC TERT2: 111.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001694, HPA001815, HPA002082, CAB072874, CAB072875"	Supported				"Secreted to blood"	351500000	6400000000			"CAB001694: , CAB072874: , CAB072875: , HPA001815: AB_1080574, HPA002082: AB_1080575"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (7.09e-2)"	"unprognostic (4.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.73e-3)"	91.7	3.1	6.1	9.7	8.1	0.8	41.5	3.7	8.6	19.7	13.9	7.3	6.8	6.6	21.5	16.7	14.4	15.1	15.3	38.7	7.4	5.0	4.6	1.5	41.2	9.9	9.4	7.1	13.6	5.8	17.7	2.6	36.4	10.2	18.7	5.1	26.3	7.2	10.5	28.9	8.1	11.8	22.1	7.4	19.0	9.6	12.7	5.9	1.8	18.6	13.2	6.5	18.9	35.0	0.0	0.0	1.3	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	111.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.8	6.1	8.1	3.7	8.6	7.4	5.0	9.4	7.1	10.2	5.9
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell line enhanced"	"Detected in all"		"HHSteC: 116.6;SK-MEL-30: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol			53000000	Cytosol		"HPA005573: , HPA018944: "	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavourable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	10.9	10.4	6.8	39.9	9.9	14.1	11.0	14.1	27.3	30.5	38.4	6.8	9.8	11.9	13.2	33.7	18.6	19.9	16.1	19.6	18.8	5.7	7.6	7.9	8.3	116.6	21.8	12.6	16.0	23.2	17.7	36.8	27.2	24.0	31.5	13.0	20.9	7.5	10.2	6.9	18.9	6.2	10.8	7.6	14.8	9.6	18.4	10.7	8.4	7.3	140.8	18.8	27.6	18.0	3.3	7.3	33.3	7.4	61.5	31.2	22.1	36.7	16.9	29.7	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: , HPA070916: "	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavourable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	21.7	28.1	16.7	17.3	25.1	18.5	20.1	17.1	23.7	18.7	18.2	38.0	13.0	17.9	22.2	16.5	19.6	15.8	18.0	17.1	16.9	15.2	23.2	18.2	16.8	23.0	22.8	16.4	16.5	17.1	25.9	26.4	22.0	28.7	18.3	20.7	17.9	22.6	17.3	23.1	18.6	16.8	20.7	24.5	19.6	18.3	9.3	22.5	25.0	23.9	17.8	20.6	20.4	16.0	8.4	16.0	9.7	21.5	13.5	13.5	9.6	15.5	18.4	10.1	12.4	23.1	24.8	6.7	16.8	25.9	17.9	19.0	6.8	16.9	14.0	12.0	21.8	12.2	16.5	15.3	23.5	18.4	9.2	18.8	11.4	8.9	22.5	5.7	19.1	24.6	10.2	14.7	12.8	20.4	10.8	14.5	21.6	34.1	17.1	4.6	9.7	18.8	11.6	9.1	14.3	13.6	19.6	5.3	10.7	19.6	44.4	15.5	19.1	10.0	17.7	9.7	21.6	16.1	14.9	13.0	11.9	12.6	25.8	10.9	13.5	7.7	13.7	9.7	11.8	16.8	12.5	8.4	11.3	11.9	16.0	8.1	9.1	12.5	4.8	13.5	21.5	5.8	13.5	9.6	16.7	25.1	17.1	23.7	16.9	15.2	22.8	16.4	28.7	22.5
WASL	"N-WASP, NWASP, WASPB"	ENSG00000106299	"Wiskott-Aldrich syndrome like"	O00401	7	123681935-123749067	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 44.3;U-2197: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005399, HPA005750"	Supported		Approved	Nucleoli,Cytosol				Cytosol	Nucleoli	"CAB005399: AB_2288632, HPA005750: AB_1854729"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.20e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (5.30e-5)"	"unprognostic (7.32e-2)"	"prognostic favourable (4.51e-8)"	"unprognostic (9.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.14e-1)"	17.9	19.3	25.6	11.6	29.5	3.8	20.7	21.0	39.3	23.7	31.2	17.0	8.9	27.4	21.0	14.6	22.5	14.8	21.7	15.4	35.2	22.5	33.3	34.5	15.3	5.5	18.8	23.0	27.8	21.9	36.7	16.9	25.4	28.6	19.9	28.8	18.0	16.9	19.5	21.6	14.4	30.2	18.2	16.6	12.1	22.0	17.3	15.0	10.0	26.7	12.0	9.7	23.7	21.1	4.6	4.5	4.9	6.2	6.2	4.3	1.5	10.7	7.9	8.8	7.5	13.8	14.4	11.4	7.5	12.5	5.5	7.2	6.5	13.6	1.1	6.0	11.3	8.1	16.2	8.2	8.6	1.8	6.4	0.9	6.6	7.0	15.1	1.4	0.9	11.5	15.5	8.2	14.0	9.5	4.8	2.1	13.2	6.5	1.8	1.9	16.4	7.3	1.1	7.1	2.4	11.7	44.3	10.8	15.9	10.3	31.1	20.1	6.0	1.4	10.8	14.9	4.2	42.0	7.3	2.4	0.8	2.4	12.9	1.2	11.9	4.9	4.1	1.8	4.3	4.1	3.6	4.6	2.8	2.6	3.5	3.2	3.6	3.8	1.8	6.2	6.2	4.5	1.4	1.5	25.6	29.5	21.0	39.3	35.2	22.5	18.8	23.0	28.6	15.0
WDR1		ENSG00000071127	"WD repeat domain 1"	O75083	4	10074339-10116949	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020804, HPA036434, HPA070293"	Approved		Supported	"Plasma membrane,Cell Junctions"			280000000	"Plasma membrane, Cell Junctions"		"CAB020804: , HPA036434: , HPA070293: "	"unprognostic (1.35e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.63e-3)"	"unprognostic (6.83e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.52e-2)"	"unprognostic (2.61e-1)"	"prognostic favourable (1.73e-5)"	"unprognostic (1.11e-1)"	"unprognostic (3.56e-1)"	"unprognostic (3.46e-2)"	"unprognostic (4.83e-3)"	40.2	23.7	19.0	49.4	18.1	33.5	35.0	8.1	22.6	53.5	53.3	25.8	38.4	39.2	80.9	54.2	59.6	54.9	57.6	49.5	19.6	20.5	55.4	41.3	41.7	57.4	22.1	17.1	51.5	22.2	19.5	18.6	40.4	26.8	47.1	38.3	37.6	38.5	49.1	32.1	31.6	54.5	88.0	19.5	46.9	41.1	38.0	16.0	74.5	49.9	36.4	50.2	69.6	41.5	22.9	40.2	54.2	61.2	32.5	55.6	64.1	30.2	30.3	27.2	22.8	20.6	34.3	43.0	76.4	70.5	69.1	54.3	36.2	38.2	21.0	24.9	91.2	19.8	29.5	55.9	73.9	32.8	10.1	60.0	31.1	25.7	48.4	19.0	69.6	32.9	28.7	70.1	35.1	74.2	17.9	35.0	66.9	17.3	83.8	26.8	32.2	30.5	39.6	24.9	17.8	43.1	48.2	9.2	10.0	32.6	18.1	31.4	15.2	20.7	111.6	53.3	22.4	44.1	66.9	22.1	35.4	27.6	56.4	28.9	66.1	37.1	29.0	54.2	48.3	51.7	37.4	22.9	40.6	48.2	37.8	16.9	41.7	44.4	54.1	32.5	61.2	40.2	55.6	64.1	19.0	18.1	8.1	22.6	19.6	20.5	22.1	17.1	26.8	16.0
WDR11	"BRWD2, DR11, FLJ10506, HH14, KIAA1351, SRI1, WDR15"	ENSG00000120008	"WD repeat domain 11"	Q9BZH6	10	120851175-120909524	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038980	Approved		Approved	Microtubules,Cytosol				"Microtubules, Cytosol"		"HPA038980: AB_10675955"	"unprognostic (8.98e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.98e-3)"	"unprognostic (2.84e-1)"	"unprognostic (3.84e-1)"	"unprognostic (8.31e-2)"	"unprognostic (1.80e-3)"	"prognostic favourable (5.04e-4)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.38e-2)"	18.6	21.9	10.6	17.4	17.2	6.2	16.4	17.1	18.9	17.3	15.5	21.5	18.0	14.5	22.6	15.9	19.6	21.0	15.7	10.6	11.5	12.7	25.2	19.8	14.9	17.0	13.9	10.6	19.4	16.1	33.9	17.7	18.4	26.0	16.5	17.3	19.0	20.3	21.5	8.5	14.8	19.9	17.5	20.0	19.7	18.9	12.8	12.9	20.6	24.0	11.7	19.8	22.0	17.3	6.4	6.8	15.5	16.3	3.9	3.3	3.4	11.9	11.8	11.6	19.1	16.3	20.8	8.1	11.6	23.2	12.9	16.4	6.6	13.4	8.7	6.0	17.1	11.8	13.4	16.0	16.0	11.8	11.5	9.4	9.5	6.3	15.4	13.0	10.9	17.0	12.8	11.7	19.1	24.3	7.4	10.9	13.7	5.1	8.1	5.1	5.6	7.5	3.3	19.6	7.5	15.0	10.0	5.8	10.3	10.0	11.2	30.6	8.2	8.4	17.9	8.9	5.4	1.3	10.7	5.5	3.4	10.8	12.7	10.8	4.6	15.5	5.9	2.5	3.3	8.0	2.6	6.4	2.3	3.1	6.8	3.8	2.4	2.5	0.5	3.9	16.3	1.6	2.9	3.4	10.6	17.2	17.1	18.9	11.5	12.7	13.9	10.6	26.0	12.9
WDR12	"FLJ10881, YTM1"	ENSG00000138442	"WD repeat domain 12"	Q9GZL7	2	202874782-203014798	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036389	Uncertain		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoli	"HPA036389: AB_10670716"	"unprognostic (1.08e-2)"	"unprognostic (3.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.24e-2)"	"unprognostic (9.40e-3)"	"prognostic unfavourable (2.57e-6)"	"unprognostic (1.52e-1)"	"unprognostic (6.14e-2)"	"unprognostic (4.78e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.48e-2)"	5.8	9.7	7.2	5.5	16.1	6.7	7.6	11.5	15.2	5.9	6.2	6.5	3.7	8.9	7.1	7.0	8.0	6.7	5.0	8.4	6.8	8.6	11.1	8.7	4.2	6.4	7.4	8.9	7.3	5.7	6.7	8.0	6.6	12.6	4.9	8.7	6.7	5.4	5.2	11.0	7.7	6.0	7.4	6.2	5.3	5.6	17.1	8.2	9.6	7.1	5.1	7.5	5.8	5.6	5.4	6.9	3.6	5.0	3.6	5.9	3.0	4.3	4.6	5.3	10.0	10.0	8.6	9.7	6.6	5.3	8.2	8.0	11.6	6.1	7.9	6.1	5.3	5.5	14.3	10.6	13.2	4.0	8.9	13.4	7.4	13.7	6.5	17.4	8.2	7.8	7.7	9.7	19.4	8.5	20.9	5.2	9.0	5.0	11.9	10.2	12.1	11.7	8.7	8.3	12.4	9.0	5.2	9.3	8.2	5.2	6.8	8.1	4.0	11.5	6.8	7.4	6.0	6.1	7.3	6.8	10.3	13.3	7.3	11.9	7.3	3.6	4.7	2.0	4.2	5.0	5.9	5.3	4.0	4.3	6.0	5.4	5.2	5.0	2.1	3.6	4.5	6.9	4.3	3.0	7.2	16.1	11.5	15.2	6.8	8.6	7.4	8.9	12.6	8.2
WDR18	Ipi3	ENSG00000065268	"WD repeat domain 18"	Q9BV38	19	984271-998438	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050193, HPA050200"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA050193: AB_2681047, HPA050200: AB_2681049"	"unprognostic (7.94e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.13e-3)"	"unprognostic (8.58e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.88e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.43e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	13.1	16.5	13.4	16.7	14.5	14.0	11.1	24.0	20.5	10.9	14.3	14.4	12.2	16.9	11.4	17.4	18.8	11.5	11.7	14.9	12.0	11.6	17.9	23.4	11.0	18.7	12.4	8.2	16.1	32.2	10.5	14.6	15.1	10.3	14.4	6.8	14.3	19.5	15.1	28.7	16.9	15.5	10.6	9.8	14.0	17.0	15.2	9.2	22.7	13.1	20.9	16.8	11.0	10.8	22.9	40.7	6.2	28.1	18.4	21.3	22.3	18.9	18.6	5.9	9.9	5.7	5.2	23.0	8.5	5.1	10.9	8.2	20.6	6.7	22.4	10.1	13.0	15.6	16.1	18.6	4.3	11.7	24.9	10.8	11.2	25.6	13.3	23.3	10.3	6.8	9.9	6.5	15.3	9.8	23.9	8.9	4.0	20.0	17.3	32.8	33.0	11.8	32.6	13.4	35.0	6.9	12.1	21.9	20.4	8.1	7.0	8.3	16.4	14.1	9.5	12.0	14.4	23.4	13.4	28.1	23.9	10.9	10.4	14.6	12.7	4.0	27.4	6.2	19.7	28.1	19.2	19.9	19.9	21.1	40.7	22.9	20.0	18.2	1.2	18.4	22.1	25.5	21.3	22.3	13.4	14.5	24.0	20.5	12.0	11.6	12.4	8.2	10.3	9.2
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028539: AB_10669752, HPA061094: "	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavourable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.8	12.9	14.7	21.1	6.6	10.5	9.9	18.6	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: , HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavourable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavourable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.0	9.6	9.6	14.5	10.4	8.6	11.1	10.5	6.9	12.3	10.8	10.0	5.0	17.8	14.5	7.8	10.1	23.7	12.1	19.6	14.6	12.3	16.7	10.2	8.1	8.6	31.3	8.9	8.4	8.7	15.5	23.6	11.7	20.3	8.8	10.7	8.7	14.9	7.2	34.4	15.3	14.2	33.2	13.5	6.1	10.0	14.8	13.5	12.0	14.9	17.0	5.9	13.1	10.3	9.2	14.7	16.8	23.5	12.9	15.1	27.9	13.5	20.2	23.8	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9
WDR44	"DKFZp686L20145, RAB11BP, RPH11, SYM-4"	ENSG00000131725	"WD repeat domain 44"	Q5JSH3	X	118346073-118449961	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038084, HPA046719"	Approved		Supported	"Golgi apparatus"			1500000	"Golgi apparatus"		"HPA038084: AB_10675626, HPA046719: "	"unprognostic (1.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.52e-2)"	14.3	14.9	17.7	13.3	25.0	9.2	12.6	19.9	19.5	15.2	13.5	20.4	13.1	14.0	16.0	12.2	19.8	12.9	20.4	13.9	16.3	15.0	10.8	21.5	13.4	15.4	21.8	16.6	15.2	11.6	25.9	19.9	12.4	17.0	13.6	11.0	9.9	12.8	19.3	17.1	9.8	14.2	22.5	18.0	13.2	15.1	16.3	22.7	17.6	12.3	9.9	15.2	15.9	14.8	5.9	7.7	10.7	7.7	10.7	10.6	5.9	11.0	6.5	7.1	4.0	12.1	10.0	3.9	17.5	12.3	12.8	18.1	4.4	12.8	3.2	10.3	12.5	8.7	13.8	8.3	14.7	12.5	6.1	12.6	17.1	2.8	8.4	7.8	8.8	5.8	9.0	12.1	8.1	11.3	9.9	11.1	12.1	5.4	6.1	4.7	12.8	10.6	4.9	6.1	4.8	10.4	7.1	3.0	4.8	16.6	5.9	5.4	5.2	5.7	14.2	9.5	3.7	12.8	9.8	4.2	6.6	4.5	8.0	9.4	6.3	9.5	4.9	10.7	8.8	7.4	8.9	5.9	7.3	8.7	7.7	5.2	8.5	9.2	3.0	10.7	7.7	5.6	10.6	5.9	17.7	25.0	19.9	19.5	16.3	15.0	21.8	16.6	17.0	22.7
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289527	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"BEWO: 16.6;HMC-1: 16.5;U-698: 36.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043004	Uncertain									"HPA043004: AB_10967417"	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavourable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	10.5	12.5	9.9	10.8	9.6	13.0	10.6	6.3	9.5	19.2	13.7	5.8	10.6	24.9	14.6	50.6	11.0	10.2	11.8	7.9	6.3	5.4	15.7	16.9	8.4	5.8	7.0	8.3	14.1	19.3	3.5	11.9	10.4	7.0	9.8	23.1	6.0	10.9	11.8	14.2	13.3	8.2	13.3	4.3	13.2	9.3	15.2	7.8	9.4	10.6	12.3	38.1	14.9	10.8	3.3	7.9	4.3	15.4	6.1	6.5	4.4	0.0	0.0	0.0	0.3	0.0	0.0	16.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	36.2	0.0	0.1	0.0	4.3	4.7	2.1	5.7	9.6	4.1	3.3	4.4	6.5	7.9	3.0	3.7	5.9	0.0	6.1	15.4	2.4	2.9	4.4	9.9	9.6	6.3	9.5	6.3	5.4	7.0	8.3	7.0	7.8
WDR7	"KIAA0541, TRAG"	ENSG00000091157	"WD repeat domain 7"	Q9Y4E6	18	56651343-57036606	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042074, HPA051057"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA042074: , HPA051057: "	"unprognostic (1.03e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.70e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (1.13e-5)"	"unprognostic (4.80e-2)"	"unprognostic (4.52e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.23e-2)"	8.0	11.3	14.2	7.9	21.2	9.1	6.8	16.7	34.0	7.5	7.7	11.9	6.1	6.0	7.1	8.1	6.6	6.4	7.7	8.8	17.3	17.9	7.9	10.4	7.2	9.5	14.4	16.4	6.6	6.2	15.6	19.0	6.9	21.1	11.1	7.4	7.9	6.1	8.8	10.5	5.7	6.1	8.3	12.5	8.3	6.9	6.2	12.1	13.2	13.1	4.0	8.2	7.4	6.3	4.5	6.3	9.2	8.7	7.4	9.0	3.2	3.8	6.5	7.5	4.1	11.8	6.9	1.9	7.7	6.6	6.4	7.6	2.6	2.4	10.7	3.1	6.9	4.2	7.5	6.1	8.0	12.4	4.6	10.1	5.3	2.3	7.1	15.2	12.9	5.8	5.1	8.5	5.7	7.9	4.8	14.9	7.8	3.8	10.5	4.5	3.2	4.3	4.7	5.7	5.2	4.9	7.0	9.7	4.8	5.5	2.7	3.6	4.1	4.3	6.9	9.1	4.6	2.7	4.1	15.0	11.1	11.8	7.5	7.7	6.1	7.2	5.0	9.2	6.6	7.6	8.2	4.4	7.5	6.7	6.3	4.5	7.9	7.2	4.6	7.4	8.7	3.0	9.0	3.2	14.2	21.2	16.7	23.7	17.3	17.9	14.4	16.4	21.1	12.1
WDSUB1	"FLJ36175, UBOX6, WDSAM1"	ENSG00000196151	"WD repeat, sterile alpha motif and U-box domain containing 1"	Q8N9V3	2	159235793-159286799	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036840, HPA058172"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA036840: AB_10670926, HPA058172: "	"unprognostic (1.37e-2)"	"prognostic favourable (3.35e-4)"	"unprognostic (2.56e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavourable (2.67e-4)"	"unprognostic (2.76e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.46e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.87e-2)"	10.3	14.2	9.7	6.6	12.7	10.9	14.8	18.9	14.0	10.3	8.5	8.9	10.6	5.8	9.8	22.1	11.1	11.8	9.9	11.5	9.7	10.6	27.7	8.2	10.7	16.1	11.5	7.0	16.4	15.5	19.4	23.8	15.7	9.2	11.3	9.2	16.0	11.8	8.7	7.7	8.2	7.7	9.9	9.5	10.5	9.0	7.7	10.2	8.5	22.2	6.1	9.2	10.0	15.0	9.8	10.3	2.8	9.3	16.2	13.0	6.2	6.6	4.9	4.5	7.1	8.2	9.5	15.3	5.2	10.2	9.5	16.7	10.7	10.8	8.8	5.5	7.8	4.0	12.6	4.7	13.4	3.4	10.5	9.1	5.7	10.7	10.0	7.7	12.6	5.5	17.6	11.6	9.6	7.8	12.0	6.7	8.9	6.8	5.5	14.2	6.1	10.7	8.7	6.6	4.8	10.9	9.5	8.4	5.5	5.4	7.0	12.0	5.4	13.5	3.2	6.7	5.0	9.4	4.9	3.4	5.7	8.1	11.9	9.6	4.2	2.7	9.3	2.8	13.0	7.0	9.8	9.8	5.2	8.1	10.3	8.9	6.3	7.4	0.6	16.2	6.3	9.7	2.6	6.2	9.7	12.7	18.9	14.0	9.7	10.6	11.5	7.0	9.2	10.2
WDTC1	"ADP, DCAF9, KIAA1037"	ENSG00000142784	"WD and tetratricopeptide repeats 1"	Q8N5D0	1	27234516-27308633	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028177, HPA028180, HPA028182"	Uncertain		Supported	"Golgi apparatus,Vesicles"				Vesicles	"Golgi apparatus"	"HPA028177: AB_10600419, HPA028180: AB_10601676, HPA028182: AB_10602204"	"unprognostic (3.18e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.69e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.25e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.41e-3)"	"unprognostic (1.73e-1)"	"prognostic favourable (8.84e-8)"	"unprognostic (1.28e-1)"	"unprognostic (9.33e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.51e-2)"	14.7	17.5	20.2	11.1	22.0	13.2	12.1	21.8	28.4	15.0	15.3	20.7	14.1	13.3	14.5	9.1	12.4	21.1	11.0	29.1	18.0	15.0	13.6	13.0	14.3	13.3	15.8	16.1	15.8	22.3	49.3	12.3	10.9	19.7	14.3	10.1	29.6	20.6	16.5	51.1	20.9	14.2	12.8	15.1	13.2	15.2	28.3	16.5	21.0	19.4	12.1	14.0	15.0	12.3	1.3	1.5	5.6	0.8	0.8	3.3	1.2	13.0	5.7	9.3	0.9	13.3	11.1	3.9	8.1	13.6	8.7	10.6	1.9	13.1	11.0	9.8	16.0	6.8	8.7	12.3	7.5	15.3	14.9	11.5	6.5	5.2	12.0	5.9	15.6	10.5	20.1	10.8	9.9	11.8	11.7	11.9	9.1	7.2	9.6	14.4	4.4	12.4	4.8	6.9	12.3	10.2	2.9	13.7	11.8	10.5	4.5	9.5	6.7	10.4	10.0	7.1	4.4	10.0	3.9	17.2	9.2	5.4	14.6	11.4	8.5	0.3	0.5	5.6	3.3	0.8	1.3	1.3	0.8	1.4	1.5	0.8	0.6	1.5	4.8	0.8	0.6	1.0	0.9	1.2	20.2	22.0	21.8	28.4	18.0	15.0	15.8	16.1	19.7	16.5
WEE1	WEE1A	ENSG00000166483	"WEE1 G2 checkpoint kinase"	P30291	11	9573681-9593457	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004619, HPA068845"	Approved		Approved	Nucleoli				Nucleoli		"CAB004619: AB_628447, HPA068845: "	"unprognostic (6.04e-2)"	"unprognostic (1.90e-3)"	"unprognostic (1.09e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.79e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (3.73e-1)"	"prognostic unfavourable (5.19e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	6.9	3.5	2.0	26.1	2.1	6.6	27.4	5.3	1.6	12.8	18.0	2.5	15.4	3.7	21.9	14.3	22.1	12.4	20.2	23.0	2.0	2.2	6.8	19.3	10.2	10.9	1.8	1.2	11.1	4.4	4.9	6.1	42.7	4.7	17.0	4.7	5.9	12.8	17.8	12.0	33.3	10.4	22.9	2.4	8.0	12.5	28.3	2.0	35.9	12.0	26.8	26.4	19.8	14.7	8.5	0.1	6.4	0.0	2.1	7.8	0.6	14.2	5.5	21.2	11.7	18.6	9.3	42.0	17.6	13.6	9.9	9.8	10.1	17.5	33.4	6.6	7.7	17.3	14.5	6.8	12.7	11.9	11.9	13.1	8.9	6.7	2.0	19.8	13.1	3.1	7.4	4.6	16.4	6.1	21.3	23.3	17.2	3.4	20.2	10.7	31.9	6.3	19.5	16.6	7.2	7.8	30.1	7.9	10.5	11.9	14.1	8.6	8.9	9.5	7.0	17.8	12.5	7.2	14.1	5.5	16.3	44.2	7.6	10.9	12.5	0.0	0.0	6.4	2.0	0.0	0.2	8.5	2.0	3.3	0.1	3.6	0.1	1.6	0.1	2.1	0.0	0.1	7.8	0.6	2.0	2.1	5.3	1.6	2.0	2.2	1.8	1.2	4.7	2.0
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved									"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favourable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavourable (3.13e-4)"	"unprognostic (3.64e-2)"	28.5	13.3	17.9	7.0	52.5	1.5	16.5	9.4	24.2	22.3	15.5	13.2	21.9	12.0	31.2	15.1	12.1	28.9	24.0	27.8	19.4	12.2	7.1	7.6	30.2	7.4	13.5	16.5	51.0	12.4	8.8	20.7	25.4	13.6	22.6	4.5	16.6	12.1	39.0	10.3	10.0	11.1	28.1	14.2	16.9	12.5	18.3	14.9	1.3	23.4	4.4	3.2	24.2	12.2	4.4	0.6	0.0	1.6	2.5	6.9	2.4	5.3	10.9	3.7	13.3	15.2	4.0	40.1	9.5	12.5	6.5	5.7	9.4	14.6	2.4	14.0	10.2	2.4	2.7	5.3	2.7	2.1	5.5	0.0	4.8	29.0	13.6	0.0	0.4	13.5	7.5	5.6	5.3	10.0	0.1	9.8	3.8	9.9	0.4	0.1	5.2	15.5	1.2	3.7	2.7	2.6	23.2	2.3	6.2	5.5	6.8	5.1	11.9	0.1	8.2	7.5	9.7	7.3	5.7	10.8	3.5	0.0	9.5	0.0	7.5	0.0	1.0	0.0	4.9	1.6	6.9	4.4	2.6	3.5	0.3	2.3	2.3	2.8	0.0	2.5	1.6	0.6	1.3	2.4	17.9	52.5	9.4	24.2	19.4	12.2	13.5	16.5	13.6	14.9
WISP2	"CCN5, CT58, CTGF-L"	ENSG00000064205	"WNT1 inducible signaling pathway protein 2"	O76076	20	44714844-44728509	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 109.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.8;ASC TERT1: 26.3;HeLa: 14.7;HSkMC: 10.6;U-2197: 83.9"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.8"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB019273	Approved				"Secreted to extracellular matrix"		400000			"CAB019273: "	"unprognostic (1.87e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.53e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.76e-10)"	"unprognostic (1.55e-3)"	"unprognostic (7.21e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.28e-1)"	57.0	6.5	0.2	2.0	2.2	0.4	32.7	0.1	0.5	109.7	4.7	0.6	8.6	0.6	7.0	12.4	47.1	5.5	8.4	29.7	0.3	0.0	0.5	0.9	25.6	0.9	0.1	1.4	48.4	1.8	0.7	0.0	0.9	0.2	20.1	0.9	0.5	4.3	8.9	18.0	30.6	1.4	22.0	0.2	0.5	1.4	37.7	0.4	0.0	2.5	3.7	0.6	18.2	18.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	9.8	26.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	83.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.2	0.1	0.5	0.3	0.0	0.1	1.4	0.2	0.4
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: "	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.2	13.3	16.9	19.2	7.9	10.8	14.2	6.9	11.8	8.2	8.1	25.3	11.2	23.3	12.8	11.5	7.3	9.9	2.9	8.7	12.5	8.2	7.2	6.4	12.2	9.4	12.2	13.9	13.1	8.5	9.3	10.6	12.7	9.7	8.0	27.4	17.0	8.7	18.0	22.1	15.9	6.1	11.3	7.7	10.5	18.2	23.1	12.4	11.3	9.1	12.4	8.9	17.1	27.1	10.8	21.3	18.0	14.3	8.5	12.1	11.3	11.3	18.2	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8
WNK1	"HSAN2, HSN2, PPP1R167, PRKWNK1"	ENSG00000060237	"WNK lysine deficient protein kinase 1"	Q9H4A3	12	752593-911452	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Protein kinase inhibitor, Serine/threonine-protein kinase, Transferase"	"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046541, HPA059157"	Enhanced		Supported	Cytosol				Cytosol		"HPA046541: , HPA059157: "	"unprognostic (1.40e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (9.67e-4)"	"unprognostic (1.84e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.38e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.30e-2)"	30.0	12.4	49.3	19.1	47.5	28.9	45.4	22.5	36.7	21.2	12.6	42.6	10.6	8.5	15.9	19.4	45.5	16.9	16.5	38.5	53.7	36.4	45.6	18.0	33.0	34.3	62.3	27.1	18.5	11.3	29.1	12.7	20.3	41.4	17.1	14.3	12.0	15.4	20.3	43.4	31.3	10.3	22.3	82.8	16.9	15.7	23.8	38.8	23.9	16.7	17.4	24.5	18.9	26.5	3.7	2.6	10.9	7.1	2.1	5.2	1.9	14.2	27.0	35.7	3.3	25.8	24.8	13.6	14.2	17.1	15.4	14.4	15.2	16.3	20.1	5.0	30.5	10.8	24.1	16.4	21.7	34.8	14.4	44.9	35.9	13.1	18.9	24.2	19.6	19.2	25.0	25.5	45.8	20.8	20.4	48.6	23.3	13.1	43.5	4.1	29.1	6.5	20.8	39.6	5.4	22.2	30.9	10.4	12.2	33.2	21.5	9.6	23.7	24.9	23.0	19.1	22.2	26.8	20.9	7.4	12.3	30.5	18.2	12.8	15.5	0.9	2.7	2.6	3.8	4.0	5.2	3.0	4.3	3.6	2.6	3.7	2.3	4.1	10.9	2.1	7.1	1.7	4.9	1.9	49.3	47.5	22.5	36.7	53.7	36.4	62.3	27.1	41.4	38.8
WNK2	"KIAA1760, NY-CO-43, PRKWNK2, SDCCAG43"	ENSG00000165238	"WNK lysine deficient protein kinase 2"	Q9Y3S1	9	93184916-93320572	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 21.9;pancreas: 18.3;salivary gland: 19.5;skeletal muscle: 23.7"	"Cell line enhanced"	"Detected in many"		"Daudi: 11.2;Hep G2: 18.4;SCLC-21H: 23.4"	"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015555, HPA016519, CAB017813"	Enhanced		Approved	Cytosol				Cytosol		"CAB017813: , HPA015555: AB_2669218, HPA016519: AB_2669380"	"unprognostic (5.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.38e-4)"	"unprognostic (1.62e-1)"	0.0	0.7	3.9	0.9	3.8	0.0	1.2	9.5	7.2	0.7	7.5			7.4	1.3	1.5	2.1	6.6	0.1	21.9	4.0	4.2	0.0	0.0	0.0	0.0	2.6		0.0	18.3	0.8	7.5	0.9		4.9	4.8		19.5	5.5	23.7	3.0	6.2	1.6	1.1	0.5	3.0	1.5			0.0		0.0	1.0	0.1	0.0	0.0	1.9	0.0	0.0	0.3	0.0	4.4	4.0	2.8	8.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	1.6	0.1	11.2	1.5	0.0	0.2	6.4	0.0	0.0	0.0	7.4	0.0	3.5	18.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	5.8	0.1	0.1	7.1	0.2	0.0	0.0	9.1	0.0	0.6	23.4	9.2	1.4	6.3	0.6	0.8	1.3	0.1	0.0	3.1	0.1	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0										
WNK4	PRKWNK4	ENSG00000126562	"WNK lysine deficient protein kinase 4"	Q96J92	17	42780678-42796936	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.1;ovary: 14.6"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 19.4;K-562: 21.7;TIME: 21.0;WM-115: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016500	Approved									"HPA016500: AB_10962984"	"unprognostic (6.34e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.08e-3)"	"unprognostic (4.33e-3)"	"unprognostic (7.70e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.99e-2)"	1.1	0.0	0.8	5.8	0.2	0.0	2.6	0.6	0.3	0.7	12.9	0.4	0.4	2.1	0.2	2.8	8.7	0.5	1.0	0.2	2.6	0.0	28.1	0.2	0.4	0.1	0.1	0.3	14.6	1.0	0.0	2.4	0.0	1.7	11.1	11.7	12.2	1.4	1.2	0.0	0.5	3.3	0.4	0.8	0.1	2.6	0.4	0.2	0.0	0.0	0.2	2.0	0.3	0.4	0.4	0.0	0.0	0.3	0.0	1.0	0.0	1.2	0.6	0.2	0.0	0.2	0.1	2.9	7.2	2.8	2.7	0.8	0.4	0.5	0.2	4.3	19.4	0.0	0.1	0.2	4.7	0.4	0.9	0.0	0.0	2.8	4.6	0.0	0.4	2.5	0.4	3.9	1.2	0.2	21.7	0.7	0.0	0.6	0.0	0.5	0.2	4.9	0.3	0.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.9	1.4	1.5	21.0	0.2	1.9	0.2	0.1	3.5	3.0	0.6	0.0	1.2	14.1	0.0	0.3	0.0	0.0	0.0	0.7	0.4	1.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.6	0.3	2.6	0.0	0.1	0.3	1.7	0.2
WNT5A	hWNT5A	ENSG00000114251	"Wnt family member 5A"	P41221	3	55465715-55490539	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell line enhanced"	"Detected in many"		"BJ: 42.1;BJ hTERT+: 58.0;HeLa: 44.3;SiHa: 65.7;U-87 MG: 47.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.34e-3)"	"unprognostic (1.35e-1)"	"prognostic favourable (2.94e-5)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.58e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.42e-3)"	"unprognostic (3.63e-2)"	2.1	0.8	3.4	3.8	2.0	0.0	3.4	2.5	3.8	6.1	2.3	1.6	6.8	2.2	19.6	2.8	15.8	4.8	5.0	2.3	2.6	2.0	2.7	1.6	3.6	4.6	2.3	1.3	8.2	5.3	0.1	1.9	25.6	2.0	5.0	2.1	1.0	26.8	18.2	1.1	2.3	2.5	4.2	4.8	2.5	2.2	1.6	2.5	1.9	2.7	13.1	6.8	21.0	10.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.0	7.2	0.0	42.1	58.0	8.6	15.2	0.2	0.0	1.2	0.1	23.9	0.0	1.8	0.0	9.0	0.0	1.1	1.1	44.3	0.0	6.7	0.0	0.0	4.7	1.1	26.0	1.4	0.0	0.0	20.6	20.8	0.0	0.0	0.0	2.1	2.5	0.0	2.6	0.1	1.1	1.4	0.0	0.2	65.7	8.0	0.0	0.0	0.0	0.0	14.6	2.6	13.2	3.3	4.9	0.0	0.4	47.2	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.0	2.5	3.8	2.6	2.0	2.3	1.3	2.0	2.5
WNT7A		ENSG00000154764	"Wnt family member 7A"	O00755	3	13816258-13880121	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.5;gallbladder: 8.7;placenta: 19.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 24.7;EFO-21: 23.2;PC-3: 8.1;RPTEC TERT1: 41.2"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 4.4;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	45	"T-cells: 4.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA015719, CAB025894"	Approved				"Secreted to extracellular matrix"					"CAB025894: , HPA015719: AB_1858856"	"unprognostic (1.26e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavourable (2.96e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.32e-4)"	"unprognostic (2.20e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.03e-6)"	"unprognostic (7.89e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.49e-4)"	"unprognostic (1.90e-1)"	"unprognostic (3.74e-1)"	"unprognostic (8.88e-3)"	0.4	0.4	7.8	0.6	6.1	0.7	0.4	1.2	11.5	1.1	0.4	2.1	0.0	0.4	3.4	1.0	1.6	0.7	8.7	0.4	3.3	2.8	0.7	0.5	5.7	1.4	3.1	3.2	0.4	0.8	0.4	0.2	19.4	3.9	0.5	0.4	0.0	0.5	1.4	0.4	2.8	0.4	0.5	4.4	3.1	0.4	2.3	2.3	0.0	0.4	0.0	0.7	0.9	0.5	0.0	0.0	0.0	0.0	0.0	4.4	0.5	3.4	0.0	0.3	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.0	0.0	3.1	0.0	23.2	0.0	4.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.6	41.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.6	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.5	7.8	6.1	1.2	7.2	3.3	2.8	3.1	3.2	3.9	2.3
WNT9A	WNT14	ENSG00000143816	"Wnt family member 9A"	O14904	1	227918656-227947898	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 12.9;PC-3: 8.7;RH-30: 13.3;SCLC-21H: 12.1;SiHa: 11.7;U-2197: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to extracellular matrix"						"unprognostic (2.27e-2)"	"unprognostic (3.24e-1)"	"unprognostic (3.77e-3)"	"unprognostic (4.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.23e-1)"	"prognostic unfavourable (1.06e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.70e-2)"	"unprognostic (3.72e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.93e-2)"	2.4	1.4	1.0	13.1	0.5	0.2	2.6	1.4	1.0	4.0	14.1	2.6	2.2	1.9	6.3	4.7	9.5	5.4	15.3	14.6	0.7	0.9	0.8	0.4	9.2	2.1	0.8	0.1	8.9	7.5	0.8	4.3	4.3	3.1	4.7	1.6	4.9	4.9	4.2	20.2	1.0	6.8	8.3	0.6	1.2	5.7	1.8	1.0	0.6	1.8	10.6	4.0	7.1	3.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.7	2.6	0.3	0.1	0.3	0.6	6.6	0.9	0.7	0.1	0.0	0.0	7.0	0.0	3.8	1.1	12.9	0.3	0.6	0.0	1.2	0.5	0.0	4.3	0.2	0.3	0.0	0.4	0.1	3.2	0.1	0.1	0.8	0.0	0.0	1.4	1.7	0.0	0.0	0.8	8.7	0.2	13.3	1.3	3.7	0.8	12.1	0.0	11.7	5.3	0.0	6.7	1.4	0.5	1.7	1.1	8.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.5	1.4	0.7	0.7	0.9	0.8	0.1	3.1	1.0
WRN	"RECQ3, RECQL2"	ENSG00000165392	"Werner syndrome RecQ like helicase"	Q14191	8	31033801-31173769	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Exonuclease, Helicase, Hydrolase, Multifunctional enzyme, Nuclease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028661	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA028661: AB_10602255"	"unprognostic (8.73e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.21e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.53e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.66e-1)"	10.1	9.2	5.6	8.5	6.6	15.6	11.1	10.7	7.3	14.2	8.0	7.7	7.7	5.5	24.4	8.8	7.6	9.7	6.9	7.0	5.9	4.0	5.1	7.7	7.2	6.7	8.2	5.3	12.0	9.9	7.8	28.1	8.5	7.0	8.6	7.8	8.3	10.8	7.8	7.7	10.2	7.0	12.1	14.9	8.9	8.3	10.4	7.3	11.8	7.9	6.3	9.3	10.8	8.7	3.9	2.7	1.3	1.9	2.9	6.2	1.6	6.4	6.3	13.1	8.3	7.8	12.5	8.3	7.3	7.1	8.9	9.3	4.0	3.9	15.1	6.7	7.3	3.3	8.1	5.2	13.4	4.2	6.9	15.4	6.0	3.3	9.8	9.1	5.7	9.1	5.8	8.5	10.2	8.6	24.3	9.6	8.2	4.1	18.9	4.4	11.2	4.6	10.9	9.9	6.0	3.7	7.0	2.8	7.5	8.8	5.0	6.9	3.5	4.5	13.7	9.7	6.0	5.0	6.1	2.5	2.7	19.0	7.2	7.2	6.6	1.2	1.9	1.3	3.3	1.9	6.2	3.9	3.8	3.3	2.7	3.5	2.5	3.2	0.5	2.9	0.8	2.0	2.8	1.6	5.6	6.6	10.7	7.3	5.9	4.0	8.2	5.3	7.0	7.3
WRNIP1	"bA420G6.2, FLJ22526, WHIP"	ENSG00000124535	"Werner helicase interacting protein 1"	Q96S55	6	2765414-2786952	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	15.4	23.1	29.9	19.8	32.1	31.2	22.4	42.5	33.5	22.2	21.9	23.3	25.7	17.7	19.8	29.7	32.8	28.0	24.7	28.8	30.9	30.1	23.3	25.8	21.2	23.4	27.4	26.2	23.2	37.4	39.2	31.2	32.3	21.3	22.5	22.6	23.9	34.6	22.0	29.0	27.8	19.6	18.5	20.2	20.7	19.3	24.6	24.2	34.1	31.6	36.0	25.3	18.8	29.2	3.4	4.2	9.1	2.8	3.7	6.5	2.3	31.0	15.6	15.9	26.1	16.9	14.6	21.2	14.3	20.1	26.3	26.3	24.6	14.5	27.9	38.9	18.4	24.2	26.0	28.7	25.8	27.8	28.6	29.1	17.7	38.4	19.3	18.3	20.2	14.8	23.5	24.1	26.3	33.2	22.2	10.1	19.1	30.3	27.0	33.2	13.6	19.4	21.6	23.3	28.2	27.9	19.2	48.1	13.7	16.8	17.2	33.2	22.1	20.6	18.0	19.8	14.9	17.1	34.4	13.0	22.7	21.6	7.7	19.9	26.7	9.1	2.6	3.4	6.5	2.8	2.1	3.4	4.7	4.8	2.1	2.4	5.5	5.2	1.1	3.7	1.4	4.2	6.5	2.3	29.9	32.1	42.5	33.5	30.9	30.1	27.4	26.2	21.3	24.2
WSB1	"DKFZp564A122, DKFZp564B0482, SWIP1"	ENSG00000109046	"WD repeat and SOCS box containing 1"	Q9Y6I7	17	27294076-27315926	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003293	Approved		Approved	Mitochondria				Mitochondria		"HPA003293: AB_1858863"	"unprognostic (1.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (4.07e-5)"	"unprognostic (2.59e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavourable (1.02e-7)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.74e-2)"	32.9	18.7	19.1	36.3	45.0	36.4	26.1	15.4	28.7	37.9	26.5	59.6	17.6	23.8	47.1	34.6	21.7	34.8	45.8	28.7	23.4	20.7	31.5	15.0	48.4	26.9	56.2	29.6	38.4	21.0	18.0	25.8	61.9	39.5	26.9	27.1	37.6	17.7	29.1	17.0	18.3	23.2	38.1	57.4	55.7	26.0	18.1	48.0	17.9	22.0	12.9	28.8	29.5	30.9	10.6	26.3	27.9	31.1	8.2	12.1	9.0	12.1	8.6	27.1	15.5	17.2	21.3	29.1	10.9	15.4	8.6	16.6	12.9	4.9	12.2	12.4	14.8	11.6	16.3	8.0	13.0	33.8	13.3	19.5	15.5	13.0	32.4	13.3	28.8	25.6	10.9	12.5	7.6	34.1	19.5	11.7	15.2	7.5	17.2	15.3	8.0	7.1	14.1	14.7	7.3	12.8	9.9	8.7	11.9	11.3	11.3	14.7	9.1	17.8	18.9	10.6	8.1	14.4	10.3	5.3	13.4	12.5	10.0	10.7	9.4	21.4	16.2	27.9	9.4	28.1	11.2	9.1	7.8	10.2	26.3	10.6	7.5	8.5	15.2	8.2	31.1	8.6	12.1	9.0	19.1	45.0	15.4	28.7	23.4	20.7	56.2	29.6	39.5	48.0
XAB2	"HCNP, HCRN, NTC90, SYF1"	ENSG00000076924	"XPA binding protein 2"	Q9HCS7	19	7619525-7629565	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048751			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA048751: "	"unprognostic (1.13e-1)"	"prognostic favourable (4.04e-4)"	"unprognostic (1.99e-3)"	"prognostic favourable (4.96e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.95e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (2.69e-1)"	"unprognostic (7.43e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.80e-3)"	13.5	18.4	12.2	13.3	17.8	35.7	17.8	22.9	22.6	16.3	12.1	19.2	12.1	16.3	15.5	12.1	17.8	18.9	12.7	17.5	11.9	10.3	20.1	24.6	13.0	17.0	16.8	11.4	29.6	34.3	11.9	12.2	14.6	13.3	15.2	5.3	13.6	28.7	18.1	18.0	19.5	13.8	13.7	13.4	18.8	22.8	30.2	15.8	24.8	21.4	13.2	15.9	18.6	15.6	15.2	9.0	9.9	14.1	8.9	16.7	13.8	15.4	14.2	8.6	11.2	9.1	6.8	16.8	9.1	10.7	16.2	16.5	18.3	10.2	10.5	18.1	8.4	13.6	12.2	13.2	4.1	18.3	15.7	13.9	12.0	16.0	11.8	18.4	12.6	12.0	11.0	11.4	8.3	9.8	12.4	27.9	5.0	17.1	17.2	28.7	19.6	28.1	19.2	10.9	18.3	6.4	12.2	12.3	14.1	10.3	10.2	8.9	12.9	16.3	9.6	7.4	12.2	16.8	15.3	48.2	28.4	15.2	12.7	15.7	11.0	8.3	12.2	9.9	14.8	11.6	13.6	12.3	13.8	11.0	9.0	15.2	16.7	12.6	7.3	8.9	14.1	7.8	15.8	13.8	12.2	17.8	22.9	22.6	11.9	10.3	16.8	11.4	13.3	15.8
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;HBEC3-KT: 15.0;hTERT-HME1: 23.9;U-251 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoli	"HPA062641: , HPA069323: "	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.1	3.5	0.7	1.1	0.2	1.7	0.0	1.2	0.2	3.2	0.0	15.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.9	23.9	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.0	1.1	3.3	4.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	1.9	0.1	6.5	1.9	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
XIRP2	CMYA3	ENSG00000163092	"Xin actin binding repeat containing 2"	A4UGR9	2	166888487-167259753	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Actin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 292.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2;HEL: 1.5;HUVEC TERT2: 8.5;U-2197: 6.0"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034813, HPA074599"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA034813: AB_10602588, HPA074599: "					"unprognostic (5.27e-4)"	"unprognostic (5.96e-3)"		"unprognostic (7.42e-2)"	"unprognostic (2.42e-1)"					"unprognostic (1.74e-1)"	"unprognostic (2.56e-1)"			7.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.3	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	4.3	0.0	292.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	2.3	51.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.5	0.0	0.2	0.2	0.0	0.0	0.9	0.0	0.2	0.7	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178783	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: , HPA069673: "	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favourable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favourable (2.46e-4)"	20.2	17.1	14.2	24.0	30.2	8.4	21.4	16.1	19.3	22.3	18.9	20.8	27.5	18.0	24.6	18.3	16.9	24.9	25.1	12.4	16.2	14.4	24.6	23.4	19.9	21.1	33.4	15.2	35.0	20.9	35.4	26.7	28.0	22.1	20.9	15.9	16.7	17.6	30.3	22.4	30.5	23.6	17.7	22.6	23.3	15.9	12.9	30.6	18.5	25.7	12.4	20.8	22.4	22.3	10.9	7.0	34.6	8.8	8.8	12.2	6.1	4.4	11.5	13.0	8.3	19.5	13.5	44.0	11.1	32.0	10.8	8.4	4.2	5.4	15.0	4.9	13.5	5.6	8.5	17.8	8.9	6.0	7.3	7.9	12.2	7.7	17.3	5.9	15.1	19.1	21.1	14.3	28.8	12.8	10.9	8.1	12.0	9.4	4.9	5.7	7.7	7.8	6.2	5.9	12.0	13.6	13.4	2.8	10.1	12.1	10.1	8.0	10.6	4.8	20.0	4.2	11.4	6.3	5.1	18.7	13.6	8.9	10.0	7.0	15.1	12.0	8.2	9.4	9.8	6.3	9.6	10.7	11.2	9.6	7.0	10.9	12.2	8.7	34.6	8.8	8.8	6.7	9.2	6.1	14.2	30.2	16.1	19.3	16.2	14.4	33.4	15.2	22.1	30.6
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"			170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: "	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavourable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	38.8	34.7	47.1	35.3	21.4	28.7	34.7	43.0	27.7	45.2	38.8	46.1	29.2	57.0	30.1	29.4	33.0	71.8	29.8	66.7	34.8	26.4	56.1	35.8	28.8	15.5	56.5	38.4	16.2	22.3	35.7	39.0	36.9	64.7	33.3	41.6	20.4	47.0	24.8	54.8	26.6	42.1	53.8	34.6	20.6	29.5	37.7	20.0	41.8	35.4	20.9	28.9	27.9	24.6	42.5	48.3	34.6	42.2	27.0	44.6	82.7	26.4	48.5	38.3	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA053768: "	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.6	5.0	8.3	7.9	4.0	7.1	8.6	7.6	5.6	9.0	7.5	10.2	8.4	14.7	4.1	7.3	11.0	19.1	10.3	16.8	10.0	5.5	23.3	6.3	6.9	6.1	20.4	7.6	6.9	6.5	9.1	17.3	10.8	11.0	4.9	8.5	5.5	9.7	9.0	9.4	4.7	10.8	13.7	6.1	6.3	8.1	9.5	6.6	6.5	9.5	7.8	5.6	11.2	8.9	6.4	5.0	7.8	10.8	3.2	4.8	12.2	3.1	13.1	9.5	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm			140000	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: "	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavourable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	53.7	47.6	35.2	47.0	56.8	47.0	56.6	47.0	59.7	51.2	44.3	45.2	39.5	39.5	62.9	43.8	61.1	51.7	41.2	43.7	38.6	36.4	62.4	67.1	43.8	56.2	41.8	45.2	58.7	46.7	63.0	56.1	54.3	58.3	46.0	53.5	36.1	49.4	47.9	65.0	54.7	46.5	49.7	44.2	60.5	47.9	36.9	38.0	112.4	64.2	55.6	65.5	56.5	47.7	38.6	51.5	60.9	61.3	50.4	54.0	82.3	38.4	32.7	73.5	39.3	32.7	37.5	44.4	45.9	47.5	53.1	57.3	70.2	38.4	37.3	37.5	40.1	34.5	72.2	55.6	81.9	35.5	49.7	80.9	51.7	65.6	40.5	72.0	39.6	34.1	29.7	62.3	27.3	62.5	51.0	34.1	69.1	37.1	80.4	36.3	85.3	29.2	70.8	65.0	30.8	57.1	43.9	64.4	54.4	36.9	27.4	33.1	33.6	54.1	45.0	50.0	42.1	32.6	51.9	41.3	50.1	83.3	38.9	56.6	49.0	60.9	51.5	51.8	50.2	54.0	54.0	38.6	49.1	50.9	51.5	37.5	49.9	49.8	59.4	50.4	61.3	31.4	49.3	82.3	35.2	56.8	47.0	59.7	38.6	36.4	41.8	45.2	58.3	38.0
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621119-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm			24000	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	49.2	67.9	44.4	47.8	54.3	62.3	49.7	44.5	57.5	51.2	51.3	39.5	44.1	44.7	59.9	41.0	68.6	52.4	35.2	63.0	59.3	39.2	50.1	61.6	48.1	66.9	37.2	50.6	61.5	44.0	48.4	53.1	63.5	51.5	46.1	56.4	39.7	59.2	52.1	100.9	58.6	46.9	58.2	68.4	54.4	50.8	113.6	34.2	83.8	49.5	59.2	70.9	51.4	50.1	51.9	63.7	42.7	57.0	46.6	62.6	96.7	64.2	46.4	64.6	56.2	39.4	35.1	50.9	46.9	56.4	98.6	81.3	68.1	40.8	103.7	39.4	56.8	48.4	89.2	58.7	99.5	57.6	112.0	55.6	56.8	67.5	35.7	131.2	64.4	31.8	40.5	61.5	34.0	61.2	54.2	44.0	63.4	70.7	68.2	49.0	59.3	55.0	78.1	68.0	82.3	55.7	48.2	30.1	21.5	76.2	40.7	54.1	46.7	53.1	43.2	49.3	68.6	43.3	61.5	43.7	76.3	105.7	46.2	52.1	58.2	24.5	50.1	42.7	51.1	57.0	53.5	51.9	56.8	55.8	63.7	48.2	62.6	55.8	13.5	46.6	55.5	37.7	61.8	96.7	44.4	54.3	44.5	57.5	59.3	39.2	37.2	50.6	51.5	34.2
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol			230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavourable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.3	14.8	15.7	37.7	19.5	22.5	16.7	29.4	24.3	24.1	30.8	17.6	19.6	51.7	11.7	30.5	16.7	47.7	34.6	38.2	21.7	18.9	47.3	22.5	16.6	64.2	37.3	28.7	22.2	43.0	38.1	97.1	24.4	52.2	54.8	20.7	14.7	41.8	20.5	28.5	20.6	36.7	15.0	43.5	17.3	14.2	30.3	18.6	16.0	18.8	54.1	18.8	40.7	19.8	14.7	26.2	29.8	24.2	44.3	47.1	48.3	36.7	52.1	40.3	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0
YARS2	"CGI-04, FLJ13995, mt-TyrRS"	ENSG00000139131	"Tyrosyl-tRNA synthetase 2"	Q9Y2Z4	12	32727490-32755902	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038721, HPA057610, HPA074097"	Uncertain		Supported	"Nuclear bodies,Mitochondria"				Mitochondria	"Nuclear bodies"	"HPA038721: AB_10674837, HPA057610: , HPA074097: "	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.12e-1)"	"unprognostic (5.99e-3)"	"prognostic unfavourable (3.19e-5)"	"unprognostic (1.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.39e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.09e-1)"	12.6	15.8	11.0	12.6	15.3	13.9	13.8	11.6	14.9	13.1	11.8	11.5	18.4	9.8	13.3	12.9	17.5	11.3	9.1	12.1	11.9	9.7	12.4	16.3	9.2	15.5	10.8	11.7	13.3	21.0	11.0	16.6	15.9	13.5	12.9	13.7	11.3	17.4	10.0	15.9	12.0	10.8	11.1	12.6	13.3	12.3	12.5	12.6	17.5	12.3	16.0	16.4	13.3	11.8	11.8	9.5	9.4	9.9	12.9	12.7	5.2	9.5	11.5	6.7	8.0	7.4	8.7	21.3	7.3	7.5	9.1	8.9	28.8	12.3	17.3	12.0	7.4	12.4	13.4	19.3	10.3	7.5	20.9	11.4	8.7	16.0	10.7	12.1	6.7	8.1	12.4	8.5	15.6	14.3	16.1	8.0	9.6	7.8	9.0	14.7	37.1	14.2	10.2	14.4	10.2	11.5	13.7	10.4	5.0	11.2	9.8	7.2	18.3	11.0	9.6	8.6	9.2	14.0	12.3	4.8	5.1	18.0	8.0	9.1	7.1	9.4	7.0	4.1	10.1	8.9	10.6	8.8	10.7	10.4	9.5	11.8	11.2	12.7	1.4	12.9	9.9	9.3	9.3	5.2	11.0	15.3	11.6	14.9	11.9	9.7	10.8	11.7	13.5	12.6
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: "	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavourable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavourable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	91.5	54.0	86.5	86.7	84.3	76.3	77.1	67.6	63.0	94.0	73.8	74.0	85.6	116.2	70.9	67.8	55.5	97.4	102.6	93.4	62.0	90.3	118.6	107.3	94.9	68.0	159.2	88.9	70.2	88.4	93.8	116.2	77.7	123.3	50.7	87.5	57.7	179.8	155.0	195.0	73.0	108.8	155.5	125.6	93.1	67.8	119.7	84.4	66.3	89.8	126.2	29.9	317.1	60.6	66.8	114.0	90.5	137.5	74.3	93.1	132.3	63.2	119.4	70.8	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9
YES1	"c-yes, HsT441, Yes"	ENSG00000176105	"YES proto-oncogene 1, Src family tyrosine kinase"	P07947	18	721588-812546	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 14.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004370, HPA026480"	Approved		Supported	"Plasma membrane,Cytosol"			4300000	"Plasma membrane, Cytosol"		"CAB004370: AB_627370, HPA026480: AB_1858921"	"unprognostic (3.28e-1)"	"unprognostic (1.62e-2)"	"unprognostic (5.87e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.85e-3)"	"prognostic unfavourable (2.46e-4)"	"unprognostic (2.14e-1)"	"unprognostic (8.12e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.11e-1)"	26.2	13.1	17.0	9.4	15.6	2.6	47.2	6.7	12.8	15.8	23.8	8.9	13.7	18.2	13.1	17.4	22.0	10.7	14.9	17.9	14.8	12.4	22.6	43.2	23.6	13.7	15.8	6.6	13.2	21.4	16.7	10.7	31.3	16.8	12.2	17.3	6.5	23.7	21.0	10.6	12.3	24.8	18.8	16.8	34.5	15.5	13.6	12.0	8.1	16.8	15.6	7.1	21.9	17.5	0.1	0.1	14.7	0.0	1.0	2.5	0.6	14.2	7.1	22.4	17.5	13.5	16.7	26.4	9.5	19.4	11.2	15.4	16.8	10.5	0.0	10.1	16.1	8.3	20.9	16.8	22.0	0.0	7.1	4.2	7.0	11.7	11.0	3.2	7.6	12.7	18.1	16.9	18.9	37.8	18.4	6.3	15.9	9.8	1.9	4.2	14.2	9.1	2.4	17.6	1.2	16.3	16.9	4.6	5.3	19.6	14.9	12.4	10.3	6.8	32.5	27.7	30.7	20.8	25.5	5.5	2.7	0.8	10.5	4.7	16.4	14.7	0.0	0.9	2.5	0.0	1.6	0.1	0.5	1.4	0.0	0.0	1.2	1.9	0.0	1.0	0.0	0.1	0.1	0.6	17.0	15.6	6.7	12.8	14.8	12.4	15.8	6.6	16.8	12.0
YLPM1	"C14orf170, PPP1R169, ZAP"	ENSG00000119596	"YLP motif containing 1"	P49750	14	74763366-74859435	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048070, HPA061123"	Uncertain		Supported	"Nucleoplasm,Nuclear speckles"				"Nucleoplasm, Nuclear speckles"		"HPA048070: , HPA061123: AB_2684435"	"unprognostic (2.17e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.95e-1)"	"unprognostic (2.98e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.64e-2)"	"unprognostic (3.22e-3)"	"unprognostic (8.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (7.83e-3)"	"unprognostic (6.63e-2)"	"prognostic favourable (6.08e-7)"	"unprognostic (1.09e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.60e-1)"	17.2	19.0	28.9	21.7	33.4	26.1	21.0	51.4	32.6	18.6	15.4	24.9	18.8	13.1	23.8	20.6	17.4	20.6	15.9	15.8	24.2	18.2	15.7	14.0	16.4	20.8	24.1	24.8	31.3	21.0	30.9	30.5	19.8	22.5	20.0	17.2	18.8	20.6	22.8	20.7	23.0	16.5	17.7	21.2	18.9	16.2	28.8	27.6	24.7	22.5	8.7	20.6	22.4	18.7	5.5	7.8	3.3	3.9	5.4	4.6	3.0	18.9	21.1	23.1	4.4	16.6	16.2	12.5	13.2	13.5	13.4	13.5	18.5	13.7	28.5	9.9	14.8	17.2	20.0	13.7	21.3	17.1	11.5	20.6	13.4	12.6	9.0	15.7	15.7	14.2	9.1	15.1	11.4	18.2	16.3	13.6	16.5	19.5	18.1	12.7	13.8	17.7	27.3	23.0	9.9	10.7	27.4	17.0	16.7	21.2	13.1	5.0	15.6	10.4	27.3	16.2	20.8	11.6	16.5	16.7	16.0	31.4	14.1	11.5	12.1	0.7	3.4	3.3	3.8	3.9	4.2	4.4	3.2	3.2	3.1	5.5	4.6	4.6	2.7	5.4	3.1	7.8	2.7	3.0	28.9	33.4	51.4	32.6	24.2	18.2	24.1	24.8	22.5	27.6
YTHDC1	"KIAA1966, YT521, YT521-B"	ENSG00000083896	"YTH domain containing 1"	Q96MU7	4	68310387-68350089	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036462	Supported		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA036462: AB_10669793"	"unprognostic (1.02e-1)"	"unprognostic (8.44e-3)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.05e-1)"	"prognostic favourable (7.29e-5)"	22.1	16.6	25.1	28.8	33.2	101.8	24.3	38.4	25.8	30.3	20.8	24.4	24.0	16.7	29.2	25.1	25.4	20.2	17.6	18.5	23.5	19.6	19.8	19.5	21.1	26.8	26.1	23.4	39.7	24.2	27.6	32.4	33.2	22.8	25.2	21.3	13.8	22.7	30.2	32.9	26.1	21.2	27.6	25.4	23.6	20.6	17.7	35.1	30.2	23.8	20.2	26.7	34.8	30.3	18.0	15.1	41.6	9.3	7.5	11.1	3.2	17.4	10.5	21.5	12.9	12.9	11.3	17.8	19.2	12.2	12.1	12.7	12.9	16.1	28.6	15.8	9.8	13.2	20.1	16.9	19.7	21.2	12.2	21.8	15.0	14.3	13.3	23.0	16.9	10.6	18.4	10.8	25.9	13.0	20.6	16.8	17.6	13.3	26.8	20.8	16.1	10.4	23.5	24.3	12.7	18.9	20.3	18.6	14.6	16.8	18.2	13.9	14.2	16.1	13.8	13.9	14.7	9.5	12.7	17.6	11.8	29.9	9.4	15.0	12.7	20.2	8.3	14.7	9.9	5.0	7.7	12.7	8.0	7.9	4.6	18.0	11.1	9.2	41.6	7.5	9.3	15.1	7.3	3.2	25.1	33.2	38.4	25.8	23.5	19.6	26.1	23.4	22.8	35.1
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"				Cytosol	"Cytoplasmic bodies"	"HPA030063: , HPA054080: , HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	31.1	33.0	18.2	27.0	19.9	42.0	52.4	21.5	28.3	23.7	23.6	20.4	31.5	22.1	26.6	35.1	36.0	26.1	21.7	23.3	18.5	19.4	26.8	35.8	30.0	42.5	18.1	21.3	25.5	37.2	29.7	18.4	32.6	20.2	21.7	26.2	22.1	34.4	31.3	39.6	36.5	24.4	25.1	15.1	29.8	24.8	28.0	17.0	44.2	26.4	30.4	31.7	24.7	31.0	36.5	42.2	33.3	39.9	39.0	40.4	41.8	21.5	15.1	33.0	31.9	25.7	19.8	37.9	21.0	26.3	26.3	26.8	13.7	25.5	37.0	21.0	27.0	20.2	38.1	34.2	31.5	23.2	27.7	31.1	20.7	25.1	30.4	32.7	24.6	26.6	35.4	28.3	40.6	32.2	31.2	18.5	29.5	16.9	34.6	25.8	53.0	19.3	30.0	24.4	30.5	36.9	31.0	28.2	30.0	21.9	33.8	56.8	22.3	30.9	21.9	18.6	19.2	17.3	29.7	22.2	14.2	42.5	21.3	25.9	29.5	33.3	32.4	32.6	28.9	39.9	40.0	36.5	33.9	36.4	42.2	25.5	36.1	34.1	11.5	39.0	38.0	25.9	40.4	41.8	18.2	19.9	21.5	28.3	18.5	19.4	18.1	21.3	20.2	17.0
YWHAB	YWHAA	ENSG00000166913	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta"	P31946	20	44885676-44908532	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003759, HPA007925, HPA011212, HPA061603"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol			210000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB003759: AB_289588, HPA007925: AB_1844340, HPA011212: AB_1844334, HPA061603: "	"prognostic unfavourable (9.18e-4)"	"unprognostic (1.48e-1)"	"unprognostic (9.06e-2)"	"prognostic unfavourable (5.46e-4)"	"unprognostic (3.80e-1)"	"prognostic unfavourable (6.14e-4)"	"prognostic unfavourable (1.91e-6)"	"prognostic unfavourable (6.01e-4)"	"unprognostic (8.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (2.52e-5)"	"unprognostic (6.72e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.60e-3)"	"unprognostic (8.59e-2)"	39.3	38.6	65.5	39.4	79.2	28.6	33.0	60.1	87.9	34.0	47.5	27.7	28.7	37.9	35.2	26.4	48.1	30.2	29.6	40.3	68.7	63.4	47.3	36.5	37.4	46.8	49.8	76.2	25.8	18.9	41.1	18.4	36.7	50.1	31.4	53.4	22.9	30.7	43.2	28.3	38.4	39.3	43.3	38.4	53.7	36.7	16.8	33.6	48.2	36.1	31.8	60.2	41.2	34.9	30.9	41.9	37.3	58.4	26.8	43.5	26.6	51.8	39.3	31.7	30.4	52.8	46.7	43.0	47.2	46.0	58.2	51.1	81.8	58.8	55.4	49.5	62.3	55.2	44.7	87.8	69.6	21.2	27.3	41.2	34.6	48.5	35.0	66.7	39.9	36.5	65.7	45.6	58.9	58.2	44.4	26.8	59.7	61.3	52.0	55.0	29.9	61.2	40.9	46.0	43.0	62.3	58.0	33.9	36.1	80.0	85.6	55.1	62.3	64.2	66.0	90.5	46.5	51.0	48.0	17.9	32.6	50.8	66.1	44.7	46.0	34.8	40.1	34.4	29.7	52.2	30.2	30.9	37.7	36.3	41.9	28.6	30.8	36.6	37.3	26.8	58.4	26.5	43.5	26.6	65.5	79.2	60.1	87.9	68.7	63.4	49.8	76.2	50.1	33.6
YWHAE	FLJ45465	ENSG00000108953	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon"	P62258	17	1344272-1400378	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008445, CAB016200, CAB021109, CAB047350, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB016200: AB_626619, CAB021109: AB_10060396, CAB047350: , HPA008445: AB_1844336, HPA061603: "	"unprognostic (1.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.99e-2)"	"prognostic favourable (6.48e-6)"	"unprognostic (1.59e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.77e-3)"	"unprognostic (4.53e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.92e-3)"	"unprognostic (8.33e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.94e-2)"	55.2	54.3	107.5	35.3	87.1	32.7	37.3	71.5	118.4	28.4	40.2	60.9	23.8	40.2	35.9	54.1	43.1	44.2	23.4	57.7	92.3	81.9	64.5	50.9	32.8	25.4	94.1	77.9	40.2	40.2	41.0	37.9	45.1	73.7	35.0	42.5	27.9	42.4	27.7	135.9	36.8	36.2	32.2	101.1	26.2	38.5	46.0	53.6	30.9	47.5	36.5	37.2	31.6	32.1	19.2	41.5	17.2	36.2	15.0	23.3	31.5	77.8	58.2	70.5	59.3	31.2	36.1	67.8	50.4	29.7	45.0	34.9	104.0	32.0	52.9	59.2	41.7	54.1	59.7	50.9	63.8	36.5	111.3	36.9	48.6	44.5	37.3	35.3	37.8	32.7	37.6	45.0	69.0	54.1	42.3	38.2	57.8	37.9	46.7	28.2	64.6	37.8	56.8	33.3	37.5	45.8	45.1	39.3	59.7	60.6	24.9	39.4	47.2	32.7	51.1	43.7	37.1	55.1	88.9	24.0	44.3	44.4	52.4	42.3	63.1	17.2	31.8	8.6	12.4	36.2	15.6	19.2	18.7	13.9	41.5	16.1	17.0	14.3	10.8	15.0	30.9	28.8	23.3	31.5	107.5	87.1	71.5	90.2	92.3	81.9	94.1	77.9	73.7	53.6
YWHAG	PPP1R170	ENSG00000170027	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma"	P61981	7	76326794-76359031	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 117.8;skeletal muscle: 91.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB013274, CAB018389, HPA026918, HPA061603"	Approved	Approved	Supported	Nucleoplasm,Nucleoli,Cytosol			160000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB013274: , CAB018389: AB_2217962, HPA026918: AB_10610566, HPA061603: "	"unprognostic (3.71e-2)"	"prognostic unfavourable (4.53e-4)"	"unprognostic (3.88e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.28e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.98e-3)"	"prognostic unfavourable (5.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.44e-4)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (4.01e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.70e-1)"	52.4	31.2	46.3	17.7	54.6	7.3	17.2	36.2	117.8	13.4	14.2	13.3	4.6	14.4	15.0	7.0	18.6	9.0	17.0	33.1	50.2	56.2	15.9	22.0	12.9	12.1	45.9	49.8	13.3	18.0	14.8	7.8	16.6	74.6	14.7	14.0	8.6	10.0	13.3	91.8	11.7	12.5	20.2	22.8	12.7	11.2	8.9	13.5	6.8	8.8	13.8	14.3	14.7	13.2	3.1	5.9	3.2	5.0	1.1	3.3	1.7	37.1	46.7	41.4	52.5	42.4	24.5	18.7	43.2	21.4	26.8	29.2	29.3	40.0	52.4	14.9	38.3	34.8	51.8	47.7	37.8	35.5	22.6	49.6	32.0	32.5	38.7	60.5	48.6	26.8	45.8	31.3	64.9	42.6	68.1	59.3	40.0	35.0	43.2	44.7	45.9	32.8	50.7	41.9	57.9	42.1	25.4	22.2	61.7	47.9	61.4	30.6	42.7	36.7	44.9	52.4	30.5	46.4	57.7	19.7	36.9	80.7	47.1	57.3	55.8	3.2	5.0	1.1	2.1	4.6	3.3	3.1	2.4	2.6	5.2	1.8	1.8	2.0	1.1	1.1	3.8	5.9	2.0	1.7	46.3	54.6	36.2	88.9	50.2	56.2	45.9	49.8	74.6	13.5
YWHAH	YWHA1	ENSG00000128245	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta"	Q04917	22	31944461-31957603	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 154.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025918, HPA061603"	Uncertain		Approved	Nucleoli,Cytosol			130000000	Cytosol	Nucleoli	"CAB025918: , HPA061603: "	"unprognostic (3.77e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavourable (1.59e-5)"	"unprognostic (8.62e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.51e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.60e-2)"	"unprognostic (7.00e-2)"	"unprognostic (6.81e-2)"	21.5	18.6	87.9	20.6	47.4	16.3	19.3	41.9	154.3	13.7	24.4	10.0	4.3	17.2	13.1	14.1	14.0	16.4	18.6	15.2	78.8	59.1	11.7	11.5	25.0	13.5	35.5	101.6	10.0	16.7	5.2	10.4	22.4	49.5	12.3	20.1	6.8	9.9	15.6	13.9	9.9	17.4	25.9	19.4	12.8	26.9	3.7	9.1	6.3	10.5	5.5	15.1	18.5	10.6	8.1	16.6	14.9	14.4	17.7	12.8	9.6	67.9	27.2	30.4	17.7	18.5	17.1	19.3	66.1	32.7	38.1	43.6	28.8	23.7	40.1	16.1	60.6	32.9	36.4	36.3	36.0	35.5	31.7	23.7	21.4	25.7	18.7	76.3	26.5	15.5	19.4	32.1	22.9	31.1	32.7	29.4	29.0	27.4	23.1	35.1	36.2	29.8	33.2	41.9	21.3	24.0	29.4	65.4	21.5	37.6	26.3	23.5	15.0	18.9	49.7	38.5	38.5	28.2	41.9	16.4	25.3	50.2	27.9	30.8	33.8	7.8	14.4	14.9	5.7	11.8	8.1	8.1	7.0	8.1	16.6	7.6	2.8	3.6	8.7	17.7	12.2	4.5	12.8	9.6	87.9	47.4	41.9	126.3	78.8	59.1	35.5	101.6	49.5	9.1
YWHAQ	"14-3-3, HS1"	ENSG00000134308	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta"	P27348	2	9583972-9631014	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA007925, CAB010286, HPA061603"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol			120000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB010286: AB_2218221, HPA007925: AB_1844340, HPA061603: "	"unprognostic (2.65e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.78e-2)"	"prognostic unfavourable (8.20e-4)"	"unprognostic (1.53e-1)"	"unprognostic (5.78e-3)"	"prognostic unfavourable (9.83e-6)"	"unprognostic (4.90e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.51e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.74e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.39e-3)"	40.5	47.3	77.8	32.1	60.8	48.0	50.8	88.5	82.5	52.2	44.0	82.5	25.0	37.9	60.5	48.2	57.6	45.3	40.0	68.5	73.7	76.2	45.9	37.2	35.0	38.2	74.3	54.8	55.9	64.4	39.2	39.0	39.3	69.8	54.2	44.1	31.2	38.9	48.8	17.6	33.3	36.5	57.9	72.2	29.8	36.9	44.3	63.5	58.8	45.4	56.7	43.3	47.7	46.3	31.5	30.9	24.8	28.9	51.4	58.4	60.9	42.7	64.5	58.5	56.5	46.1	63.8	55.0	58.8	57.9	61.8	51.9	48.5	37.7	55.4	30.7	84.2	40.3	64.9	64.1	79.8	136.3	52.8	51.8	42.1	51.8	35.3	49.8	31.4	43.1	37.7	67.4	44.0	69.3	50.8	33.5	75.9	29.8	88.2	50.9	99.3	74.4	64.6	75.9	67.8	68.0	38.3	55.7	94.4	53.5	55.5	42.5	34.5	25.7	63.1	77.7	55.1	67.2	89.6	34.2	46.8	73.1	66.4	52.1	64.4	17.1	22.2	24.8	47.8	28.9	58.4	31.5	45.1	50.8	30.9	28.8	24.7	39.9	6.8	51.4	27.2	15.7	43.1	60.9	77.8	60.8	88.5	69.0	73.7	76.2	74.3	54.8	69.8	63.5
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916525-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005065, HPA061603"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol			760000000	Cytosol	"Nucleoplasm, Nucleoli"	"CAB005065: AB_2218378, HPA061603: "	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavourable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavourable (2.28e-5)"	"prognostic unfavourable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	54.6	40.9	89.9	51.8	104.6	70.8	39.6	55.8	117.7	52.4	69.6	38.7	25.3	47.4	43.5	37.6	141.8	38.3	51.9	29.1	81.7	67.0	44.1	32.9	40.7	60.0	50.1	66.7	46.4	27.5	37.8	25.2	69.0	78.2	42.5	70.3	31.7	55.2	47.2	19.7	63.0	71.4	53.5	43.8	56.3	51.5	34.1	31.5	89.4	46.0	74.9	83.2	53.6	70.2	58.6	57.2	129.4	77.9	57.0	78.4	104.9	138.9	67.6	129.0	37.0	32.1	40.8	63.9	65.3	85.0	88.5	86.2	47.0	91.2	62.5	70.9	103.7	60.5	81.1	93.1	134.8	55.3	32.0	59.0	51.2	30.4	42.3	24.6	67.7	37.8	126.9	73.1	116.5	79.4	67.0	61.3	75.6	50.5	101.6	43.7	43.6	70.9	43.3	37.6	42.9	85.1	78.5	72.2	51.5	49.7	49.3	103.4	71.4	29.1	64.6	44.9	65.9	54.1	58.5	39.1	46.4	76.7	74.3	46.5	183.7	129.4	45.0	81.2	69.1	66.5	70.3	58.6	59.0	66.5	57.2	48.0	44.8	56.4	74.6	57.0	77.9	35.4	78.4	104.9	89.9	104.6	55.8	117.7	81.7	67.0	50.1	66.7	78.2	31.5
YY1	"DELTA, INO80S, NF-E1, UCRBP, YIN-YANG-1"	ENSG00000100811	"YY1 transcription factor"	P25490	14	100238298-100282792	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, DNA damage, DNA recombination, DNA repair, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001119, CAB009392"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Vesicles"				Nucleoplasm	"Nucleoli fibrillar center, Vesicles"	"CAB009392: AB_2218501, HPA001119: AB_1858930"	"unprognostic (7.67e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (6.13e-4)"	"unprognostic (6.75e-3)"	"unprognostic (8.31e-3)"	"prognostic unfavourable (3.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-1)"	32.7	28.8	26.3	27.0	25.8	45.3	33.8	33.6	26.4	28.1	37.6	24.9	34.6	26.4	29.5	33.7	34.1	24.4	27.4	38.3	27.6	21.9	31.4	42.8	31.8	30.6	26.5	21.1	26.9	27.7	32.5	23.6	35.2	24.1	29.3	28.2	21.5	25.6	23.1	39.9	27.2	31.0	25.9	26.5	30.6	25.3	22.6	25.8	60.2	40.9	23.3	35.2	29.7	47.0	8.2	6.3	14.2	7.0	12.0	9.0	3.0	23.7	12.5	25.8	20.5	20.6	25.8	28.0	23.6	21.3	25.7	26.0	15.1	39.9	36.3	33.6	20.5	24.9	28.1	24.3	35.1	28.2	22.7	33.8	14.6	19.4	19.1	40.3	29.5	15.6	29.2	17.7	24.4	24.3	26.2	25.4	24.2	29.5	43.8	22.0	27.0	21.6	35.8	35.9	19.7	28.8	23.5	27.5	20.4	31.5	22.7	31.9	35.0	37.0	22.1	16.0	20.0	38.8	20.6	26.6	27.0	50.3	22.2	26.1	20.6	5.1	7.0	14.2	5.5	5.9	7.0	6.3	7.6	7.7	6.1	8.2	7.1	6.8	12.2	12.0	4.5	6.3	9.0	3.0	26.3	25.8	33.6	26.4	27.6	21.9	26.5	21.1	24.1	25.8
ZAP70	"SRK, STD, ZAP-70"	ENSG00000115085	"Zeta chain of T cell receptor associated protein kinase 70"	P43403	2	97713560-97739862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 37.4;lymphoid tissue: 107.1"	"Cell line enriched"	"Detected in some"	13	"MOLT-4: 61.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	41	"gdT-cell: 37.4;MAIT T-cell: 25.4;memory CD4 T-cell: 19.6;memory CD8 T-cell: 29.2;naive CD4 T-cell: 14.3;naive CD8 T-cell: 21.9;NK-cell: 26.4;T-reg: 19.9"	"Group enriched"	"Detected in many"	53	"NK-cells: 26.4;T-cells: 37.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB002625, HPA003134"	Enhanced									"CAB002625: , HPA003134: AB_1080629"	"unprognostic (4.11e-3)"	"prognostic favourable (6.89e-5)"	"unprognostic (3.82e-3)"	"prognostic favourable (9.66e-8)"	"unprognostic (5.78e-2)"	"prognostic favourable (3.93e-6)"	"unprognostic (2.30e-3)"	"unprognostic (1.09e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.23e-3)"	"unprognostic (2.70e-1)"	"prognostic unfavourable (3.02e-8)"	"unprognostic (1.29e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.40e-2)"	"unprognostic (5.83e-3)"	2.2	0.5	0.3	18.1	0.6	11.2	1.5	0.7	0.6	1.2	3.7	0.7	0.3	2.9	1.2	1.1	1.7	1.5	2.8	0.9	0.4	0.8	2.2	2.3	5.8	28.1	0.8	0.6	0.9	1.3	0.0	0.7	0.9	0.6	2.1	0.6	1.0	5.5	1.0	0.7	1.0	12.3	0.7	0.7	24.8	3.2	1.4	0.6	107.1	2.5	1.1	20.8	3.0	1.7	0.4	0.2	0.5	0.2	26.4	37.4	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	61.5	0.1	0.0	0.0	2.4	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	37.4	0.1	25.4	0.0	19.6	29.2	0.0	0.4	14.3	21.9	0.5	26.4	0.2	0.2	19.9	14.3	0.3	0.6	0.7	0.6	0.4	0.8	0.8	0.6	0.6	0.6
ZAR1	Z3CXXC6	ENSG00000182223	"Zygote arrest 1"	Q86SH2	4	48490252-48494389	"Plasma proteins, Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 2.0;brain: 2.7;salivary gland: 1.3;testis: 4.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.2;HeLa: 1.5;K-562: 1.2;SCLC-21H: 2.4;SH-SY5Y: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	7	"basal ganglia: 1.7;hypothalamus: 1.1;midbrain: 2.7;pons and medulla: 0.5"													"unprognostic (9.71e-2)"	"unprognostic (2.58e-1)"		"unprognostic (4.59e-3)"	"unprognostic (2.47e-2)"		"unprognostic (6.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.54e-1)"				"unprognostic (1.08e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.32e-5)"	"unprognostic (4.51e-1)"	0.0	0.0	0.0	0.0	0.8	2.0	0.0	0.0	0.4	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.7		0.4	0.0	0.0	0.5	0.0		0.0	0.0		1.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	4.2			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.0	0.4	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.2	1.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.4	3.1	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZBED4	KIAA0637	ENSG00000100426	"Zinc finger BED-type containing 4"	O75132	22	49853842-49890078	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045341	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA045341: "	"unprognostic (3.82e-2)"	"unprognostic (6.39e-2)"	"unprognostic (7.22e-3)"	"unprognostic (4.43e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.53e-2)"	"unprognostic (5.20e-2)"	5.5	4.6	5.9	11.3	7.5	15.0	7.3	11.7	7.5	5.8	9.1	8.9	2.8	8.5	6.7	6.4	11.5	6.0	7.1	4.8	5.1	4.7	7.2	8.0	8.0	11.4	5.4	3.8	6.8	16.5	5.6	6.4	6.6	4.9	6.1	8.0	5.8	11.1	3.7	8.5	8.0	8.5	5.2	6.5	9.5	7.2	8.8	5.3	29.7	6.2	5.4	10.9	6.9	5.9	1.6	2.5	1.6	1.4	6.7	4.1	1.5	9.2	8.3	15.9	12.6	4.9	5.4	9.9	5.5	4.5	6.1	5.6	8.5	4.1	18.3	3.9	5.8	10.6	11.2	7.0	6.5	7.2	13.6	10.5	8.3	8.0	7.1	22.2	15.1	5.1	10.8	6.6	10.1	8.1	11.2	8.8	7.1	7.4	18.4	10.6	8.6	5.8	22.1	14.4	11.1	6.5	9.4	8.4	16.7	5.4	16.1	10.9	7.6	12.7	9.3	8.3	13.2	4.9	7.7	8.8	5.4	16.8	5.0	10.0	9.7	0.7	0.9	1.6	2.2	1.4	4.1	1.6	2.2	2.3	2.4	1.1	2.7	2.1	0.6	6.7	1.4	2.5	1.6	1.5	5.9	7.5	11.7	7.5	5.1	4.7	5.4	3.8	4.9	5.3
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA024655: AB_1859171, HPA031757: , HPA031758: "	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	13.1	41.0	11.0	6.8	12.9	39.2	11.8	11.5	14.4	10.3	7.5	8.3	7.4	4.9	15.4	9.2	8.0	11.4	13.8	9.4	9.6	7.3	8.0	19.6	10.3	5.8	8.3	6.2	19.6	10.7	20.9	11.7	18.3	8.8	9.6	6.2	6.8	8.5	8.6	5.3	13.8	7.6	9.9	8.9	8.7	8.9	13.1	10.4	10.1	12.1	6.4	7.1	10.7	14.5	4.9	5.0	5.0	6.2	1.3	5.9	2.4	6.4	5.2	5.1	5.7	7.2	5.6	4.9	6.0	8.7	5.8	8.9	6.1	3.2	11.5	2.7	6.0	4.9	7.3	4.2	9.4	6.0	7.3	1.3	5.2	3.7	5.5	4.4	2.8	3.2	9.1	8.1	10.7	3.2	7.5	20.0	4.1	9.4	12.0	2.2	5.0	6.4	5.1	5.7	13.4	2.5	5.2	7.2	4.2	8.3	12.6	5.8	4.5	2.1	3.6	8.6	4.8	5.9	5.9	32.1	28.0	10.8	11.3	7.5	5.5	0.2	4.9	2.4	3.7	6.0	4.2	4.9	4.0	2.9	5.0	4.5	5.9	4.3	5.0	1.3	6.2	4.3	2.6	2.4	11.0	12.9	11.5	14.4	9.6	7.3	8.3	6.2	8.8	10.4
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA054699: "	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	12.1	12.0	16.5	18.4	19.2	14.6	18.1	17.1	15.2	12.3	12.6	13.9	7.7	8.1	13.3	18.8	8.3	14.6	11.9	20.0	13.0	10.8	10.1	12.4	12.5	28.0	15.4	12.9	16.3	12.9	18.1	18.6	9.5	14.7	12.9	11.3	13.2	9.0	12.8	19.2	15.9	14.1	13.2	18.5	17.0	11.1	11.5	18.1	31.8	19.2	7.8	22.7	20.0	14.0	6.4	2.9	2.8	2.4	6.3	11.5	6.3	14.9	6.6	4.4	4.4	6.4	8.0	8.7	2.6	4.6	4.3	5.6	3.1	10.5	11.2	3.0	4.3	13.9	4.3	4.3	5.2	11.5	1.4	2.6	9.9	1.4	7.3	1.8	5.9	10.1	4.3	4.2	8.3	3.9	1.5	18.4	5.1	6.4	6.3	2.6	2.3	6.9	4.9	4.8	4.7	4.9	7.1	4.3	4.7	5.5	4.2	3.4	5.3	1.3	4.2	5.9	8.9	2.7	3.9	16.3	3.8	5.1	8.8	2.2	4.4	2.8	2.4	1.5	6.9	1.6	9.0	6.4	9.7	6.6	1.6	4.3	11.5	11.2	2.6	6.3	1.3	2.9	8.3	6.3	16.5	19.2	17.1	15.2	13.0	10.8	15.4	12.9	14.7	18.1
ZBTB40	"KIAA0478, ZNF923"	ENSG00000184677	"Zinc finger and BTB domain containing 40"	Q9NUA8	1	22451851-22531157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042386			Approved	Nucleoplasm				Nucleoplasm		"HPA042386: AB_10794649"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.91e-2)"	"prognostic favourable (2.01e-4)"	"prognostic unfavourable (7.78e-8)"	"unprognostic (8.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.44e-2)"	"prognostic favourable (4.12e-5)"	"unprognostic (1.52e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.34e-2)"	14.1	21.0	8.3	13.5	12.3	11.2	10.8	18.0	12.6	13.9	11.7	14.1	10.9	10.6	21.5	10.5	8.8	13.1	11.9	8.4	9.6	6.4	11.7	8.2	11.5	17.8	12.9	7.3	15.3	15.5	19.0	31.6	8.5	11.6	13.6	11.6	13.5	14.6	10.6	12.7	11.5	18.1	14.4	12.8	23.2	12.5	9.2	13.0	16.6	14.4	6.8	19.5	12.9	14.8	2.5	1.7	1.6	2.1	7.6	3.0	0.8	6.8	7.9	13.1	13.8	9.8	8.2	11.8	6.0	6.6	9.3	10.1	7.1	8.5	8.1	7.2	7.2	9.0	13.3	6.4	11.1	10.7	11.1	17.2	14.9	8.4	8.5	10.0	16.7	6.9	9.6	12.3	9.5	8.0	18.2	0.1	7.6	5.1	6.8	12.8	7.9	6.6	11.6	10.2	9.1	4.6	7.5	11.0	9.1	11.4	8.4	4.9	15.9	8.5	9.8	11.4	9.5	11.8	6.0	5.6	7.4	8.2	6.9	12.6	8.2	1.6	1.0	0.6	2.4	2.1	3.0	1.8	1.9	2.0	1.7	2.5	1.9	2.3	0.4	7.6	1.0	1.1	2.7	0.8	8.3	12.3	18.0	12.6	9.6	6.4	12.9	7.3	11.6	13.0
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"				Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: "	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavourable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favourable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.7	18.0	8.6	13.0	10.0	22.7	23.4	10.1	14.9	10.1	12.2	20.7	13.0	15.8	15.4	12.9	17.9	5.9	20.0	14.4	12.5	10.8	23.2	18.6	18.3	9.9	25.8	5.8	16.9	16.9	11.3	9.7	10.8	19.1	27.1	8.0	8.6	22.7	7.1	9.7	15.6	14.5	3.6	7.5	20.0	14.1	17.3	8.2	14.5	21.2	4.8	7.1	13.2	10.7	8.7	9.1	23.7	10.9	21.7	11.4	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9
ZDHHC15	"DHHC15, FLJ31812, MRX91"	ENSG00000102383	"Zinc finger DHHC-type containing 15"	Q96MV8	X	75368427-75523502	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.6;K-562: 3.5;LHCN-M2: 3.9;MOLT-4: 4.1;NTERA-2: 3.7;RH-30: 5.7;RPTEC TERT1: 3.1;SH-SY5Y: 4.7"	"Cancer enhanced"	"Detected in some"		"glioma: 2.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003618	Uncertain		Approved	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA003618: AB_2217686"	"unprognostic (8.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.62e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.19e-1)"	"unprognostic (8.70e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.78e-13)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.67e-4)"	3.0	5.4	4.9	1.5	6.8	1.1	5.3	6.2	9.9	5.8	3.4	3.9	2.4	1.3	6.5	3.7	3.2	4.5	3.3	5.4	5.9	8.7	5.3	1.2	4.1	1.6	4.8	5.3	8.5	4.7	5.0	8.7	0.7	7.0	4.0	2.3	5.4	12.7	6.9	1.6	2.8	1.8	5.2	6.4	2.9	2.1	2.6	3.1	2.0	6.6	2.1	1.5	2.6	3.1	0.3	0.4	0.7	0.2	0.5	1.6	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	3.9	0.0	4.1	0.1	3.7	0.0	0.0	5.7	0.0	3.1	0.0	1.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.1	0.0	0.1	0.3	0.6	0.0	0.0	0.2	1.6	1.1	0.7	0.5	0.1	0.4	0.0	0.3	4.9	6.8	6.2	9.6	5.9	8.7	4.8	5.3	7.0	3.1
ZDHHC5	"DHHC5, KIAA1748, ZNF375"	ENSG00000156599	"Zinc finger DHHC-type containing 5"	Q9C0B5	11	57667747-57701187	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014670	Approved		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA014670: AB_2257442"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.74e-3)"	"unprognostic (4.36e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavourable (6.74e-5)"	"unprognostic (1.76e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.16e-1)"	"unprognostic (6.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.74e-3)"	19.6	18.2	6.9	14.2	16.1	13.0	17.3	12.4	19.2	20.0	18.7	14.1	20.9	14.6	19.8	15.9	45.8	16.0	19.1	18.2	8.2	8.1	27.8	24.8	18.7	18.0	8.5	8.2	16.2	21.3	31.4	13.9	31.4	12.8	15.5	18.2	19.1	29.3	18.4	31.3	33.2	25.9	15.2	8.7	21.5	16.3	35.7	7.8	26.4	25.5	23.9	39.1	23.3	26.0	9.4	13.4	15.5	11.3	6.9	13.1	9.0	27.9	31.1	12.2	12.4	27.0	20.8	23.0	26.3	31.6	22.1	16.5	18.8	34.5	18.9	34.2	31.1	39.6	19.0	31.2	19.7	23.2	8.6	16.0	14.3	16.7	30.3	30.0	27.2	29.3	28.2	32.6	33.1	24.8	21.1	23.9	27.8	16.8	16.9	8.4	14.8	18.7	16.8	24.7	23.3	25.2	41.6	8.9	11.4	24.5	27.7	25.7	29.7	17.2	29.1	28.6	14.9	30.0	18.3	17.4	21.5	16.3	21.3	15.5	24.8	15.5	8.1	9.8	11.1	10.1	13.1	9.0	10.9	9.4	8.0	9.4	11.0	11.1	10.2	6.9	11.3	13.4	9.8	9.0	6.9	16.1	12.4	19.2	8.2	8.1	8.5	8.2	12.8	7.8
ZFHX2	"KIAA1056, KIAA1762, ZFH-5, ZNF409"	ENSG00000136367	"Zinc finger homeobox 2"	Q9C0A1	14	23520855-23556192	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.5;testis: 17.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000720, HPA005146"	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoli fibrillar center"	Nucleoplasm	"HPA000720: AB_10603462, HPA005146: AB_1859250"	"unprognostic (7.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.94e-2)"	"unprognostic (3.71e-2)"	"unprognostic (5.08e-4)"	"unprognostic (2.39e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.75e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.90e-2)"	1.7	2.6	5.1	1.9	5.8	0.9	1.7	15.5	12.4	1.7	1.6	3.9	1.2	1.1	1.9	2.0	1.2	6.6	1.9	1.2	6.8	4.9	3.0	1.1	2.1	1.5	4.5	6.3	2.0	1.9	7.4	8.1	1.2	5.4	2.0	1.2	1.6	1.8	4.0	2.3	2.1	1.2	2.4	3.2	1.1	1.8	17.9	6.1	0.0	2.1	0.0	1.4	1.8	0.7	0.3	0.5	2.3	0.4	0.0	0.9	0.0	0.2	5.3	4.2	8.4	2.9	0.4	0.3	1.2	0.4	0.6	2.1	0.5	0.4	0.4	0.5	0.1	0.1	2.2	0.3	0.9	3.7	1.3	4.3	0.0	1.0	0.5	0.7	3.0	0.6	0.2	0.9	0.3	0.6	0.6	0.7	0.1	1.4	0.5	0.5	5.1	1.2	2.3	0.1	0.0	2.3	2.0	4.6	3.0	0.7	1.1	0.3	1.7	1.1	0.1	0.0	2.1	1.3	0.5	0.5	1.7	0.2	0.1	0.3	0.2	0.0	0.4	0.0	0.1	0.3	0.9	0.0	0.0	0.2	0.5	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	5.1	5.8	15.5	12.4	6.8	4.9	4.5	6.3	5.4	6.1
ZFHX3	"ATBF1, ZNF927"	ENSG00000140836	"Zinc finger homeobox 3"	Q15911	16	72782885-73891871	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059353	Uncertain									"HPA059353: "	"prognostic unfavourable (1.55e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.36e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.16e-2)"	"prognostic favourable (1.37e-5)"	"unprognostic (6.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.15e-2)"	7.9	6.0	2.5	2.3	4.6	1.1	11.3	1.5	4.1	7.5	7.7	5.4	14.5	2.0	7.4	7.3	4.5	4.9	18.2	4.9	4.3	4.8	4.4	6.5	6.1	1.4	4.0	2.6	4.4	5.7	23.8	6.3	8.1	5.5	12.0	3.5	10.5	5.0	19.5	16.9	3.6	3.6	15.5	9.7	3.9	5.0	2.3	5.2	0.5	10.8	4.0	1.0	16.7	14.7	0.8	1.0	0.2	1.6	2.5	0.1	0.2	4.4	7.8	12.7	10.5	4.7	6.0	13.1	3.4	3.7	2.1	2.4	8.8	2.5	1.9	5.9	6.3	3.1	8.0	4.0	3.0	7.7	1.9	0.3	10.6	12.6	4.4	1.3	3.2	2.2	2.4	6.3	5.7	4.0	0.9	0.5	5.4	9.1	0.4	2.6	2.2	1.3	5.8	3.4	0.6	3.5	7.4	9.5	3.4	5.9	1.8	4.2	2.6	0.6	8.7	5.3	6.3	5.6	4.4	4.9	1.6	1.3	2.5	1.2	4.0	0.2	1.6	0.2	0.1	0.9	0.1	0.5	0.0	0.0	0.7	0.8	0.0	0.1	0.2	2.5	1.1	1.0	0.1	0.2	2.5	4.6	1.5	4.1	4.3	4.8	4.0	2.6	5.5	5.2
ZFP36L1	"Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B"	ENSG00000185650	"ZFP36 ring finger protein like 1"	Q07352	14	68787660-68796253	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA transport, Transport"	"Developmental protein, DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 212.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 212.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001301	Uncertain									"HPA001301: AB_1080644"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.68e-2)"	59.0	22.4	40.2	42.4	35.0	14.2	89.9	16.3	31.0	91.5	60.2	49.6	24.8	26.0	90.6	37.5	66.8	59.9	36.5	36.2	45.1	15.3	34.6	46.0	45.6	39.0	32.7	16.7	121.7	47.1	63.4	14.8	62.7	44.9	65.3	21.9	29.9	60.3	43.7	31.6	90.2	28.5	91.2	47.3	33.9	42.2	26.9	39.4	22.1	43.3	22.7	57.1	81.2	93.2	37.0	8.7	212.7	17.7	10.4	16.1	14.4	38.8	37.3	15.5	22.4	39.3	31.6	34.3	16.5	27.4	9.6	12.1	16.3	25.8	9.4	10.0	28.4	18.0	1.4	51.0	11.8	4.4	2.2	3.4	18.7	11.5	22.4	0.5	4.3	26.6	65.5	11.7	76.7	19.3	9.6	18.5	51.1	9.2	1.4	1.7	12.9	5.4	24.9	20.8	2.8	35.3	28.0	0.1	0.4	18.6	26.8	13.8	24.6	0.4	44.1	28.6	21.0	22.6	15.7	10.4	5.2	6.5	35.5	0.2	10.8	14.2	17.7	0.2	16.1	17.2	15.0	19.7	12.9	11.2	8.7	37.0	14.1	12.4	212.7	10.4	11.4	1.1	12.0	14.4	40.2	35.0	16.3	31.0	45.1	15.3	32.7	16.7	44.9	39.4
ZFPM1	"FOG, FOG1, ZC2HC11A, ZNF89A"	ENSG00000179588	"Zinc finger protein, FOG family member 1"	Q8IX07	16	88453317-88537016	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 30.4"	"Cell line enhanced"	"Detected in many"		"HEL: 14.3;K-562: 21.2"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 12.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046603	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA046603: "	"unprognostic (1.29e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.58e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.49e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.89e-2)"	"prognostic favourable (4.24e-4)"	4.3	3.7	3.7	7.9	2.9	12.0	2.2	6.8	3.3	2.9	11.2	1.6	4.7	18.5	3.8	4.5	2.8	3.7	30.4	4.7	3.9	3.0	2.7	15.2	5.4	5.5	2.7	1.9	7.3	24.5	1.5	5.6	1.8	2.1	7.0	1.7	7.7	6.9	7.3	2.2	3.8	15.4	1.5	2.1	12.7	21.5	12.7	0.8	15.7	3.8	1.4	9.4	4.8	2.2	0.3	0.6	1.5	0.3	0.6	1.3	0.3	1.1	2.8	2.1	4.5	0.4	0.1	9.2	3.0	0.4	1.0	0.3	9.1	1.1	4.4	2.3	0.4	7.1	0.1	2.5	0.2	3.4	1.9	14.3	5.6	7.9	1.7	0.8	4.8	1.0	1.6	1.0	0.3	1.0	21.2	0.3	0.8	5.4	5.0	5.2	1.4	2.5	1.4	1.0	2.1	1.0	3.6	6.0	9.9	3.7	0.2	2.9	2.3	2.3	3.6	3.8	2.5	1.7	0.6	1.0	0.7	0.4	1.1	1.7	3.7	0.0	0.1	1.5	0.9	0.2	0.2	0.1	0.4	1.3	0.2	0.3	0.3	0.5	0.9	0.6	0.3	0.6	0.1	0.3	3.7	2.9	6.8	3.3	3.9	3.0	2.7	1.9	2.1	0.8
ZFYVE28	KIAA1643	ENSG00000159733	"Zinc finger FYVE-type containing 28"	Q9HCC9	4	2269582-2418663	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"brain: 63.6"	"Cell line enhanced"	"Detected in many"		"HMC-1: 11.0;NB-4: 11.9;U-266/70: 12.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 63.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038175, HPA057587"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA038175: AB_10697244, HPA057587: "	"unprognostic (1.59e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.08e-3)"	"unprognostic (9.89e-3)"	"unprognostic (3.79e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-3)"	"unprognostic (2.56e-2)"	"unprognostic (3.64e-2)"	"prognostic favourable (1.35e-6)"	"unprognostic (6.05e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.41e-2)"	4.5	8.6	7.7	5.1	15.8	3.1	3.7	63.6	15.1	3.7	7.4	4.6	1.8	10.4	4.1	3.1	3.4	4.3	5.9	2.4	7.1	5.5	5.7	4.2	4.4	6.1	7.9	8.0	3.4	7.3	7.9	7.5	1.8	9.9	2.9	5.1	5.8	9.5	5.4	4.3	5.7	11.9	2.8	9.4	7.0	7.5	7.9	6.7	1.2	5.3	3.1	4.0	4.5	3.2	3.1	0.7	0.9	0.4	0.3	4.4	1.3	0.8	1.0	0.2	3.7	2.1	0.7	0.1	1.8	3.1	1.0	0.3	0.1	6.6	0.0	1.9	3.2	3.8	1.2	0.3	0.6	9.5	1.3	0.2	4.2	0.3	4.3	0.7	11.0	3.0	0.6	1.1	0.1	3.0	1.8	8.1	0.9	2.2	0.1	11.9	0.1	8.1	0.0	0.0	3.9	1.5	0.5	5.8	0.4	1.8	0.1	1.0	2.4	0.3	0.5	1.7	0.0	5.4	0.1	12.6	9.1	0.1	5.3	2.3	1.8	0.9	0.4	0.1	4.4	0.0	1.9	0.9	2.3	3.2	0.7	3.1	3.2	3.2	0.1	0.3	0.3	0.2	4.0	1.3	7.7	15.8	63.6	15.1	7.1	5.5	7.9	8.0	9.9	6.7
ZG16B	"HRPE773, JCLN2, PRO1567"	ENSG00000162078	"Zymogen granule protein 16B"	Q96DA0	16	2830169-2839585	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"salivary gland: 1069.4"	"Cell line enhanced"	"Detected in some"		"MCF7: 18.8;SK-BR-3: 17.4;T-47d: 15.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 47.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 6.7;intermediate monocyte: 11.4;non-classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	7	"monocytes: 11.4"									"HPA041125, HPA053549"	Enhanced		Approved	Nucleoplasm,Vesicles	"Secreted to digestive system"		1200000	Vesicles	Nucleoplasm	"HPA041125: AB_10794264, HPA053549: AB_2682184"	"unprognostic (5.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (4.37e-2)"	"prognostic favourable (3.48e-6)"	"unprognostic (1.39e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.33e-2)"	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.0	0.7	0.2	0.0	0.2	0.1	0.1	0.1	0.5	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.0	0.6	0.0	0.0	0.0	1.6	0.3	0.0	1069.4	0.2	0.1	0.8	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	78.5	3.7	0.2	0.2	0.0	1.1	1.7	11.4	1.1	0.4	1.7	0.0	0.8	0.0	0.0	0.2	1.4	0.1	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.2	0.0	1.5	0.0	3.1	0.0	0.0	0.0	6.3	1.8	1.6	1.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.1	2.6	0.2	18.8	0.0	0.3	0.1	3.6	0.0	0.0	5.9	0.1	4.4	0.0	0.0	0.0	17.4	0.0	15.9	0.0	2.2	0.0	0.4	1.3	0.0	0.0	0.3	0.2	0.2	4.5	0.2	1.7	6.7	0.0	0.0	11.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	1.1	7.3	0.0	0.4	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781394-122974512	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.7;REH: 25.4;U-698: 24.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.3	12.4	14.6	26.2	14.8	7.1	12.7	11.1	16.2	15.1	8.2	22.2	9.8	6.0	15.8	10.6	10.8	17.7	13.9	16.3	16.0	9.8	9.7	15.9	13.2	26.8	19.3	10.3	31.5	20.3	10.1	13.5	7.1	12.4	16.9	7.7	12.7	13.4	15.2	31.1	9.3	11.7	13.6	14.3	15.9	8.3	5.2	20.0	17.9	15.3	10.9	24.7	17.7	11.3	12.2	5.4	9.6	1.9	6.9	7.5	3.2	2.6	1.3	7.5	1.5	3.7	1.2	0.0	1.6	5.0	1.8	2.3	0.3	8.7	23.7	6.5	5.2	2.2	5.0	3.0	1.9	10.6	3.4	10.9	1.6	8.4	4.0	2.6	3.4	3.2	3.6	1.6	8.9	2.0	0.4	8.4	2.1	7.5	2.5	2.3	4.2	1.8	25.4	4.1	1.9	8.3	6.7	3.2	1.8	6.4	18.9	3.1	3.2	5.9	3.4	1.4	3.7	1.7	3.3	2.1	0.0	24.3	1.3	2.1	2.3	9.6	1.0	5.2	6.9	1.3	7.2	12.2	5.0	6.7	1.2	11.0	7.5	5.9	5.1	6.9	1.9	5.4	5.1	3.2	14.6	14.8	11.1	12.8	16.0	9.8	19.3	10.3	12.4	20.0
ZHX3	"KIAA0395, TIX1"	ENSG00000174306	"Zinc fingers and homeoboxes 3"	Q9H4I2	20	41178448-41317672	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046498			Supported	Nucleoplasm				Nucleoplasm		"HPA046498: "	"unprognostic (6.26e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.53e-5)"	"unprognostic (3.06e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (7.52e-4)"	"prognostic unfavourable (1.84e-5)"	15.7	18.6	19.8	7.9	24.7	4.1	19.3	26.8	27.6	13.7	13.9	18.2	7.0	10.6	13.1	7.8	16.8	12.1	10.6	12.8	21.1	13.9	33.2	13.2	11.3	8.0	17.0	16.9	20.4	14.4	22.7	10.5	6.4	15.8	11.1	10.3	13.7	6.1	15.6	29.7	11.4	10.5	20.1	17.7	5.1	13.1	26.6	20.3	4.4	23.2	7.8	6.1	15.7	17.4	3.1	0.9	1.6	0.9	2.3	1.8	0.5	9.2	2.6	2.8	6.0	23.1	25.0	3.2	13.1	15.0	12.2	8.3	4.7	1.2	6.4	6.4	24.5	2.9	3.3	16.5	13.1	1.7	3.0	2.7	3.6	3.6	9.5	3.1	3.4	15.3	8.1	9.1	11.9	5.2	2.5	4.5	16.3	18.6	4.8	1.8	1.2	9.8	2.3	8.0	2.5	16.7	2.8	9.9	3.5	8.7	5.1	3.1	4.9	4.3	8.3	30.6	4.6	10.7	6.4	5.2	3.2	2.9	12.6	4.6	4.8	0.3	0.7	1.6	1.2	0.4	1.7	2.4	0.9	0.8	0.9	3.1	1.8	1.7	0.5	2.3	0.9	0.6	1.1	0.5	19.8	24.7	26.8	21.9	21.1	13.9	17.0	16.9	15.8	20.3
ZIC2	HPE5	ENSG00000043355	"Zic family member 2"	O95409	13	99981772-99986773	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Disease mutation, Holoprosencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 63.0"	"Cell line enhanced"	"Detected in many"		"AF22: 27.0;HDLM-2: 13.0;HEK 293: 20.5;NTERA-2: 25.2;SCLC-21H: 56.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 214.5"	HPA055031			Supported	"Nuclear bodies"				"Nuclear bodies"		"HPA055031: "	"unprognostic (6.43e-6)"	"prognostic favourable (2.64e-4)"	"unprognostic (5.73e-2)"	"unprognostic (1.99e-2)"	"unprognostic (4.39e-1)"	"unprognostic (3.12e-2)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.36e-3)"	"unprognostic (7.42e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.26e-1)"	"unprognostic (2.11e-1)"		"unprognostic (5.36e-3)"	0.6	0.5	3.9	0.5	2.9	0.5	0.7	63.0	14.7	0.5	0.8	7.7	0.0	0.6	0.8	0.5	0.8	0.5	0.5	0.5	6.1	2.1	0.6	0.5	0.7	0.6	1.7	7.4	0.5	0.6	0.5	0.5	0.5	13.4	0.6	0.6	3.8	0.5	0.5	0.5	0.8	0.5	0.6	2.2	0.5	0.6	2.5	1.0	0.0	0.5	0.0	0.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.5	27.0	1.7	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	1.7	0.0	2.3	0.0	0.0	1.2	0.0	0.0	13.0	20.5	1.9	1.2	1.3	0.0	0.0	1.3	0.0	1.9	0.0	1.2	0.0	1.9	0.0	0.0	0.8	0.1	10.3	25.2	0.6	5.9	1.0	0.0	0.1	0.6	56.7	0.0	0.8	0.1	0.0	1.3	10.1	0.0	6.4	0.0	1.1	1.7	0.2	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	2.9	63.0	7.1	6.1	2.1	1.7	7.4	13.4	1.0
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003211: AB_1080661, HPA075255: "	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	7.3	23.7	22.5	7.9	20.6	6.2	7.9	16.6	22.7	10.8	10.4	13.6	10.3	7.0	14.0	19.2	8.0	19.8	11.3	9.3	19.5	14.6	10.6	9.6	10.8	10.9	16.8	20.6	36.8	8.2	15.3	14.4	7.8	14.0	14.3	8.0	10.5	11.2	18.0	9.5	11.1	8.8	14.8	14.1	12.1	9.0	15.9	17.3	13.9	12.6	6.4	10.4	11.9	10.0	9.4	13.5	6.8	7.3	6.0	6.8	5.0	7.2	13.3	32.3	17.1	9.4	9.5	8.2	6.7	10.0	14.6	13.7	14.7	11.0	18.3	16.8	12.0	6.8	27.6	10.1	11.0	6.1	14.8	15.9	11.8	13.0	4.4	14.8	9.9	11.2	5.9	10.6	6.6	12.2	18.3	10.1	10.6	11.9	17.8	19.0	32.1	11.7	22.3	9.9	13.5	10.8	8.8	15.5	10.6	11.4	7.2	6.6	10.5	9.7	9.3	7.2	13.4	10.5	6.0	9.3	5.5	15.6	8.7	20.3	7.9	6.8	7.3	5.6	6.1	6.3	6.8	9.4	6.8	5.6	6.4	9.0	6.0	5.9	0.5	6.0	5.1	13.5	6.3	5.0	22.5	20.6	16.6	22.7	19.5	14.6	16.8	20.6	14.0	17.3
ZMYND10	"BLU, CILD22"	ENSG00000004838	"Zinc finger MYND-type containing 10"	O75800	3	50341110-50346852	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"fallopian tube: 55.7;testis: 99.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.4;U-87 MG: 7.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035255			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA035255: AB_10601928"	"unprognostic (2.93e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.85e-3)"	"unprognostic (4.44e-1)"	"unprognostic (7.78e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (6.75e-5)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-1)"	0.1	0.1	1.9	0.2	4.8	0.3	0.6	0.3	0.8	1.6	0.1	5.5	0.2	0.2	0.9	4.6	0.2	55.7	0.3	0.1	2.6	3.1	0.5	0.2	4.7	0.2	0.2	0.3	4.2	0.2	1.4	1.6	0.1	10.2	0.1	0.1	0.3	0.2	0.2	0.2	0.2	0.1	0.3	0.5	0.2	0.1	99.4	1.2	0.1	0.8	0.1	0.1	0.1	0.0	0.4	1.1	0.8	0.7	3.8	2.5	0.5	2.7	1.0	0.4	0.8	1.0	1.6	0.8	0.4	1.7	2.9	0.9	0.2	1.4	1.0	1.1	1.7	0.6	2.4	0.1	0.3	1.1	1.1	2.5	3.5	0.1	0.1	0.7	1.2	0.1	0.3	3.7	0.2	0.2	0.6	0.6	0.4	1.4	0.5	3.4	0.0	1.1	1.0	0.1	0.8	3.6	0.1	2.9	1.1	0.3	0.8	0.2	10.4	0.9	0.0	0.8	0.7	1.8	0.2	1.3	0.6	0.3	7.3	3.3	0.2	0.3	0.4	0.3	2.5	0.4	1.0	0.1	0.2	0.4	1.1	0.4	0.1	0.5	0.8	3.8	0.7	0.4	0.1	0.5	1.9	4.8	0.3	0.8	2.6	3.1	0.2	0.3	10.2	1.2
ZMYND11	BS69	ENSG00000015171	"Zinc finger MYND-type containing 11"	Q15326	10	134465-254637	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Mental retardation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015816			Supported	Nucleoplasm				Nucleoplasm		"HPA015816: AB_1845427"	"unprognostic (1.96e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (4.76e-7)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.42e-1)"	19.9	19.6	35.7	12.8	35.0	5.1	23.9	38.0	32.5	26.4	26.9	27.3	18.5	15.4	28.8	24.8	23.0	21.8	18.5	28.7	34.1	27.7	26.9	17.8	19.7	12.0	33.3	26.2	30.0	24.2	63.6	24.0	17.6	27.5	28.0	17.9	17.0	21.6	30.2	29.1	16.2	15.4	49.2	38.0	15.5	19.5	15.9	28.9	7.1	46.0	13.4	12.4	31.3	29.6	4.4	4.0	16.2	2.8	12.3	10.7	4.3	23.7	25.2	20.6	16.4	23.3	22.6	12.4	24.2	14.1	17.2	16.2	15.1	23.9	0.0	7.8	30.3	14.3	11.2	17.4	22.1	9.3	9.1	26.1	13.8	16.2	25.3	7.0	14.7	15.7	22.6	16.7	15.5	21.3	6.9	17.3	28.4	29.0	10.9	9.5	6.5	4.3	10.4	13.3	12.4	21.7	27.9	9.2	16.9	26.9	31.9	12.5	28.7	13.8	27.5	17.3	6.0	33.8	18.2	13.9	17.6	1.7	17.2	13.3	11.5	9.8	2.0	16.2	10.7	2.8	9.5	4.4	7.7	10.7	3.1	3.0	8.3	8.3	0.9	12.3	1.2	4.0	7.2	4.3	35.7	35.0	38.0	31.4	34.1	27.7	33.3	26.2	27.5	28.9
ZMYND15	DKFZp434N127	ENSG00000141497	"Zinc finger MYND-type containing 15"	Q9H091	17	4740015-4746119	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Cell line enhanced"	"Detected in some"		"A-431: 5.0;CAPAN-2: 4.7;HaCaT: 3.9;T-47d: 3.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.1;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	11	"granulocytes: 1.1;monocytes: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA023286			Uncertain	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"HPA023286: AB_1859076"	"unprognostic (2.30e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.62e-2)"	"unprognostic (7.86e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.49e-1)"	"unprognostic (6.72e-3)"	"unprognostic (4.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.07e-1)"	3.6	1.6	2.3	2.9	2.0	0.9	2.0	0.7	2.7	1.3	1.0	5.1	1.4	5.2	1.8	4.5	1.2	1.5	3.8	3.8	3.6	1.8	2.4	3.5	6.1	4.9	3.7	1.7	0.9	4.7	12.5	1.8	1.5	3.4	1.9	1.0	4.2	3.8	2.7	0.4	1.8	3.9	1.2	4.8	6.2	2.4	25.6	2.9	0.7	1.4	0.7	0.8	1.6	0.9	0.0	0.1	1.1	1.5	0.0	0.0	0.2	5.0	0.8	0.0	2.4	0.0	0.2	0.4	0.1	1.4	1.3	3.0	2.3	4.7	0.0	0.1	0.0	3.9	0.9	0.4	0.1	0.5	1.7	0.0	0.5	1.2	0.8	0.0	1.4	0.2	0.6	0.2	0.2	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.6	0.0	0.1	1.4	1.6	2.3	3.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	1.5	0.0	0.0	0.2	2.3	2.0	0.7	2.7	3.6	1.8	3.7	1.7	3.4	2.9
ZNF106	"SH3BP3, ZFP106, ZNF474"	ENSG00000103994	"Zinc finger protein 106"	Q9H2Y7	15	42412823-42491123	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 64.8;skeletal muscle: 111.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 48.5"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054267	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	"Nucleoplasm, Cytosol"	"HPA054267: "	"unprognostic (2.15e-2)"	"unprognostic (3.31e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.32e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.76e-3)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.09e-3)"	14.9	5.4	8.8	6.6	10.4	9.0	10.3	6.3	9.1	7.1	7.8	4.5	4.5	3.9	7.4	6.3	12.7	5.4	6.1	64.8	9.2	6.3	6.4	3.7	7.8	6.0	7.6	6.4	6.6	4.4	8.4	7.1	5.0	11.9	7.8	5.6	11.3	6.0	5.7	111.1	4.3	5.9	10.9	8.0	6.3	6.0	5.7	7.2	3.4	5.7	46.9	6.8	7.0	17.7	8.3	10.8	48.5	19.6	3.9	5.1	4.5	14.1	8.2	14.4	15.9	36.4	32.1	8.8	11.5	11.0	10.1	10.8	19.3	4.1	9.5	10.3	14.1	16.2	14.9	11.8	15.5	15.4	7.2	18.2	19.2	6.9	10.5	21.8	10.9	24.1	7.9	15.3	17.1	16.2	21.6	1.3	16.4	5.6	8.3	5.3	6.1	8.4	8.0	26.2	5.2	5.3	16.0	9.2	4.9	23.3	11.0	13.0	10.1	14.2	24.4	10.9	16.8	14.4	16.8	7.9	15.2	35.6	9.7	17.4	18.8	19.9	19.6	7.6	5.1	15.9	4.5	6.7	4.2	4.2	10.5	8.3	3.8	3.4	48.5	3.9	18.5	10.8	3.8	4.5	8.8	10.4	6.3	9.1	9.2	6.3	7.6	6.4	11.9	7.2
ZNF148	"BERF-1, BFCOL1, HT-BETA, pHZ-52, ZBP-89, ZFP148"	ENSG00000163848	"Zinc finger protein 148"	Q9UQR1	3	125225561-125375354	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001656, CAB017486"	Supported		Supported	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"CAB017486: AB_794260, HPA001656: AB_1079995"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.94e-2)"	"unprognostic (5.94e-3)"	"unprognostic (5.66e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-2)"	"prognostic unfavourable (2.88e-4)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.72e-1)"	10.5	9.2	12.5	13.4	17.4	5.3	9.4	18.4	17.7	10.7	8.9	4.1	3.3	5.7	11.2	8.3	8.9	10.2	8.6	11.7	11.2	7.2	10.6	9.0	8.8	8.8	11.9	11.8	14.5	7.7	15.7	18.2	7.6	10.5	9.1	9.2	6.7	10.3	12.2	12.2	7.6	8.0	11.0	7.6	8.6	7.4	9.5	10.9	25.4	24.4	3.2	10.8	10.7	9.8	13.9	7.3	29.7	12.1	18.8	17.3	10.2	18.1	12.0	13.1	11.6	11.7	12.7	9.9	16.5	19.4	18.6	17.8	11.3	10.1	14.6	11.6	24.4	14.9	14.3	12.5	26.6	6.5	5.5	18.0	14.5	5.8	8.7	12.3	18.2	10.2	13.1	17.5	18.5	12.7	8.8	12.5	13.7	14.2	15.2	4.5	8.4	10.3	11.1	14.4	8.2	10.7	20.3	11.4	9.5	22.1	11.2	18.4	13.9	12.4	16.4	14.2	15.3	17.7	10.5	10.9	12.4	22.3	10.6	7.9	13.0	2.5	8.7	17.4	13.4	8.4	13.8	13.8	11.8	12.5	7.3	13.9	17.3	13.5	29.7	18.8	12.1	6.5	10.8	10.2	12.5	17.4	18.4	17.7	11.2	7.2	11.9	11.8	10.5	10.9
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA003226: AB_2218705, HPA064793: "	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favourable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	5.8	5.3	9.9	6.0	12.5	11.3	8.5	10.8	23.4	10.2	6.7	8.6	3.4	5.1	8.5	6.6	6.4	7.1	6.2	4.7	11.8	6.0	10.7	5.2	6.1	8.7	11.5	14.1	9.9	6.0	11.7	9.2	4.5	8.7	7.0	7.1	3.4	7.0	7.1	6.4	8.7	6.0	6.9	10.9	7.4	6.5	13.3	9.9	14.1	8.9	3.7	9.7	7.7	6.8	7.7	4.2	8.1	3.8	7.2	12.0	4.1	4.1	1.3	7.3	13.2	5.3	3.9	2.4	4.1	5.5	4.8	7.4	2.3	2.4	7.6	7.0	2.6	2.6	6.4	2.6	7.0	7.3	4.0	9.1	4.7	3.3	2.8	10.8	6.6	2.8	4.0	3.5	3.7	5.2	6.9	14.2	8.0	2.1	17.3	9.2	4.2	3.0	22.9	10.2	11.3	3.3	3.9	12.5	6.0	4.6	4.0	6.0	4.7	9.4	3.5	7.4	4.9	3.3	4.7	6.5	10.9	14.3	1.6	12.7	7.3	2.2	2.8	8.1	8.9	3.8	12.0	7.7	9.4	8.5	4.2	6.6	7.1	9.0	1.5	7.2	2.9	2.6	10.5	4.1	9.9	12.5	10.8	23.4	11.8	6.0	11.5	14.1	8.7	9.9
ZNF185	SCELL	ENSG00000147394	"Zinc finger protein 185 with LIM domain"	O15231	X	152914442-152973480	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 93.5;esophagus: 67.6"	"Cell line enhanced"	"Detected in many"		"A-431: 31.0;EFO-21: 36.9;HBEC3-KT: 25.6;PC-3: 22.7;TIME: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 21.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.6;monocytes: 13.9"					"Low region specificity"	"Detected in all"			"HPA000400, HPA016438"	Enhanced		Supported	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"			5400	"Plasma membrane, Cytosol"	"Actin filaments, Focal adhesion sites"	"HPA000400: AB_1080685, HPA016438: AB_1859109"	"unprognostic (1.34e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.43e-2)"	"unprognostic (9.75e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.49e-2)"	"prognostic unfavourable (1.50e-4)"	"unprognostic (7.94e-2)"	"unprognostic (6.28e-2)"	"prognostic unfavourable (3.30e-5)"	"unprognostic (5.18e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	3.9	1.7	1.8	2.0	3.2	0.8	1.8	2.7	2.0	14.3	1.8	1.4	10.7	0.0	3.8	93.5	67.6	3.1	2.0	1.9	1.7	0.8	2.0	1.1	3.3	3.1	2.1	1.1	1.2	0.9	0.1	2.3	4.0	1.7	4.2	0.3	1.3	10.1	28.1	1.5	9.9	1.2	1.4	1.2	3.7	0.8	1.9	2.0	1.2	3.9	1.4	6.6	2.1	22.8	0.4	3.8	21.6	13.9	0.2	0.6	10.2	31.0	6.6	0.6	0.4	0.8	1.0	1.4	1.5	0.1	3.9	0.5	0.2	9.4	0.4	36.9	2.3	4.4	0.9	25.6	15.9	0.3	0.6	2.0	2.7	1.0	1.8	0.1	0.1	0.7	18.4	0.4	15.1	19.7	0.1	0.3	0.1	7.3	0.1	0.1	0.4	22.7	0.1	0.1	0.2	2.0	2.9	0.2	2.1	0.0	5.9	0.9	6.0	0.6	60.4	0.2	13.4	0.7	1.1	0.3	0.2	0.2	0.4	2.2	0.4	21.6	13.9	5.7	0.5	12.9	0.3	0.4	0.4	0.6	3.8	0.3	0.6	0.3	9.5	0.2	10.2	2.5	0.5	10.2	1.8	3.2	2.7	2.0	1.7	0.8	2.1	1.1	1.7	2.0
ZNF197	"D3S1363E, P18, ZKSCAN9, ZNF166, ZSCAN41"	ENSG00000186448	"Zinc finger protein 197"	O14709	3	44584888-44648471	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA054567	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA054567: "	"unprognostic (1.06e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavourable (6.78e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.14e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.85e-2)"	9.9	9.9	14.0	12.4	16.1	4.2	12.7	23.7	15.4	13.5	10.9	8.6	18.3	8.9	13.6	13.4	8.3	11.0	9.2	9.8	13.2	12.4	10.2	12.8	9.4	9.7	15.0	14.0	18.4	10.2	17.8	23.5	11.1	16.0	13.7	11.1	9.2	9.0	19.8	18.2	10.8	8.8	17.6	18.3	10.1	9.2	10.1	16.2	11.8	15.9	8.9	9.6	12.0	15.7	2.7	3.2	0.9	8.4	2.5	1.7	0.7	3.0	1.4	13.8	4.5	7.8	8.5	0.4	6.1	7.8	5.3	5.8	2.9	2.6	3.0	3.7	5.1	2.1	7.0	5.3	6.0	0.7	1.7	12.5	5.2	2.1	7.5	10.1	3.2	8.9	8.0	5.7	9.7	3.8	7.8	5.0	8.6	0.7	5.7	6.6	9.1	4.4	1.9	10.0	3.6	5.6	3.7	5.9	10.0	5.7	2.7	8.3	7.7	8.6	4.3	5.9	4.3	8.3	5.1	6.4	7.4	1.9	4.6	3.1	5.8	0.6	1.4	0.9	1.5	0.6	1.5	1.1	1.4	1.4	1.9	2.7	1.7	1.0	0.9	2.5	8.4	3.2	1.5	0.7	14.0	16.1	23.7	14.7	13.2	12.4	15.0	14.0	16.0	16.2
ZNF205	"Zfp13, ZNF210"	ENSG00000122386	"Zinc finger protein 205"	O95201	16	3112560-3120517	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001791	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA001791: AB_1080688"	"unprognostic (8.46e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.72e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.71e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.17e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.43e-2)"	"unprognostic (9.19e-3)"	10.7	10.6	11.4	7.0	13.6	3.5	9.8	16.4	16.8	11.8	11.1	14.2	17.2	13.9	13.0	9.3	10.6	14.2	14.9	12.9	11.5	10.1	13.6	12.4	10.3	5.3	13.0	12.1	17.2	18.3	16.5	10.9	11.0	12.0	12.9	6.1	10.2	15.4	14.8	30.6	19.0	11.1	9.7	9.0	9.0	11.5	5.6	14.3	1.4	14.4	9.0	4.6	8.2	12.4	0.6	0.3	1.5	0.5	2.7	2.4	0.6	7.5	9.1	8.7	14.0	3.4	4.6	12.0	6.3	6.6	8.3	10.3	4.9	7.2	0.3	8.3	3.9	11.7	7.7	6.5	4.0	2.0	15.3	3.2	12.7	6.1	7.8	0.3	1.8	5.1	10.3	8.0	5.4	9.5	6.7	5.8	4.1	12.7	0.1	0.3	9.2	7.5	0.4	10.9	6.9	4.9	4.3	12.4	10.8	6.6	14.2	9.2	10.0	2.7	5.5	8.4	9.7	8.1	9.0	0.1	5.7	0.3	3.7	0.4	7.0	0.0	0.5	1.5	2.1	0.4	1.8	0.4	0.7	1.9	0.3	0.6	1.8	2.4	0.2	2.7	0.0	0.2	1.1	0.6	11.4	13.6	16.4	16.8	11.5	10.1	13.0	12.1	12.0	14.3
ZNF207		ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350117-32381886	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	41.0	36.7	29.7	42.6	29.9	101.0	37.1	51.0	35.2	40.1	33.2	39.1	31.0	26.9	44.3	37.5	61.0	35.4	29.5	32.5	25.8	24.4	33.3	33.7	40.3	45.6	35.4	25.5	43.9	31.3	38.4	53.1	52.5	28.4	32.5	41.3	37.7	42.1	31.4	42.4	39.7	34.9	39.0	41.4	41.8	34.7	32.7	33.8	74.9	35.6	46.5	60.4	42.0	43.1	28.3	45.7	39.6	39.1	36.9	38.8	35.6	37.3	46.0	49.8	28.0	26.7	28.9	40.0	37.5	52.9	53.4	48.1	43.8	35.8	51.5	29.0	46.0	38.7	64.3	45.4	60.4	26.5	43.0	52.8	42.1	44.9	28.0	66.8	48.6	33.4	27.4	37.4	20.9	49.2	53.5	39.8	51.1	34.1	53.4	31.4	43.0	26.2	48.1	44.7	48.0	44.0	73.1	35.0	39.0	35.2	26.0	33.1	46.9	39.8	34.8	30.2	36.0	30.5	50.6	34.0	50.4	82.3	25.8	31.7	46.7	39.6	34.2	34.3	33.0	38.4	34.1	28.3	30.4	30.3	45.7	22.1	25.7	29.3	17.7	36.9	39.1	21.6	38.8	35.6	29.7	29.9	51.0	35.2	25.8	24.4	35.4	25.5	28.4	33.8
ZNF213	"CR53, ZKSCAN21, ZSCAN53"	ENSG00000085644	"Zinc finger protein 213"	O14771	16	3129777-3142805	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035000, HPA056750"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"				"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA035000: AB_10669997, HPA056750: "	"unprognostic (1.94e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.05e-3)"	"prognostic unfavourable (6.74e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.57e-1)"	5.7	8.2	9.0	6.0	10.3	6.0	5.7	10.8	16.7	5.0	6.2	14.6	4.7	9.3	7.5	5.1	8.4	6.8	6.0	9.1	9.5	7.7	4.4	2.4	6.3	8.8	7.1	9.3	10.3	12.1	8.7	7.3	4.1	9.1	6.5	2.5	6.8	17.4	5.9	11.1	16.9	11.2	6.8	7.6	7.5	6.9	20.1	8.0	7.5	9.2	4.7	5.4	7.1	5.8	4.8	3.2	3.5	2.5	4.0	4.7	1.8	3.3	10.6	4.7	11.2	4.6	3.8	5.9	6.2	2.5	3.3	3.8	3.4	7.0	4.1	6.1	4.0	8.2	2.2	6.8	1.3	8.5	8.2	2.9	11.7	6.6	8.8	7.0	7.6	3.7	8.5	4.6	1.7	2.4	7.4	9.2	2.1	14.5	6.5	8.6	8.1	8.1	8.8	5.5	7.5	2.6	2.3	9.8	8.5	9.3	5.6	4.4	7.3	12.1	6.0	6.7	6.1	7.5	4.3	5.2	4.8	6.3	2.7	9.3	5.1	0.0	1.6	3.4	3.7	2.5	3.2	2.7	3.6	2.4	1.6	4.8	4.7	3.4	3.5	4.0	1.9	3.2	2.0	1.8	9.0	10.3	10.8	16.7	9.5	7.7	7.1	9.3	9.1	8.0
ZNF224	"BMZF-2, KOX22, ZNF255, ZNF27"	ENSG00000267680	"Zinc finger protein 224"	Q9NZL3	19	44094339-44109886	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA054045	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	Nucleoplasm	"HPA054045: "	"unprognostic (1.01e-3)"	"unprognostic (4.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.40e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.25e-4)"	"unprognostic (9.61e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.64e-2)"	"prognostic unfavourable (5.32e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (1.53e-7)"	13.5	13.3	12.4	13.6	17.7	6.9	14.4	29.2	20.2	13.6	11.0	10.8	17.7	14.8	14.9	20.3	10.0	13.5	11.6	9.0	16.4	7.8	12.7	13.3	14.6	17.1	20.3	11.0	18.6	13.1	16.6	25.0	12.1	15.4	15.0	18.1	11.6	13.8	13.9	6.6	20.2	19.4	15.0	12.3	23.6	13.1	5.4	15.8	14.9	18.0	8.7	18.3	12.1	11.3	11.6	6.5	25.0	8.1	10.0	14.5	6.7	6.1	10.3	11.1	9.1	11.1	11.7	9.1	7.8	11.7	5.4	12.5	5.1	4.9	7.5	8.7	10.2	7.0	6.1	6.7	7.3	7.6	12.3	14.3	17.1	5.3	5.9	10.3	16.8	14.4	12.2	6.7	10.0	9.7	4.3	9.1	9.0	1.6	9.0	12.5	4.8	7.2	5.3	12.1	4.5	8.2	19.9	5.7	13.1	10.7	4.6	3.6	4.6	13.5	10.2	12.1	7.8	5.4	5.4	12.3	11.4	4.2	6.5	8.0	5.5	25.0	6.1	14.1	13.3	4.1	14.5	11.2	11.2	13.1	6.5	11.6	14.1	10.9	4.5	10.0	8.1	5.8	12.5	6.7	12.4	17.7	29.2	20.2	16.4	7.8	20.3	11.0	15.4	15.8
ZNF227		ENSG00000131115	"Zinc finger protein 227"	Q86WZ6	19	44207547-44237268	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA030573	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"		"HPA030573: AB_10610702"	"unprognostic (3.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (7.14e-2)"	"unprognostic (2.77e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-2)"	"unprognostic (8.05e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.68e-3)"	"unprognostic (1.94e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.21e-2)"	"unprognostic (9.91e-2)"	"prognostic favourable (2.64e-4)"	10.4	11.5	13.6	8.3	13.3	6.3	12.7	24.7	14.4	12.9	10.3	13.0	8.7	8.0	15.4	12.1	10.1	12.6	9.0	8.9	12.3	11.7	10.0	11.0	9.4	14.0	13.5	12.5	17.6	9.9	18.5	28.0	11.4	15.7	13.3	9.0	9.6	9.3	11.2	10.0	9.6	8.9	12.8	15.3	13.4	12.6	10.7	17.6	20.8	12.7	4.3	16.2	12.3	13.2	12.1	5.8	13.0	4.5	10.6	13.1	4.9	5.1	7.4	8.9	11.1	7.3	6.4	4.2	5.1	7.4	5.0	9.7	3.6	4.1	9.1	7.9	4.7	3.0	10.1	5.4	6.7	11.8	12.8	15.9	8.0	4.4	5.2	13.8	7.0	5.7	6.0	4.8	9.2	7.3	1.5	0.2	5.3	2.8	13.0	3.7	14.3	3.9	7.8	9.0	7.7	5.1	9.5	15.2	15.6	11.4	5.2	4.0	4.3	7.5	6.2	5.5	9.1	4.1	6.5	21.3	28.2	20.0	3.6	5.8	7.3	13.0	4.5	8.6	10.7	3.2	11.7	11.4	10.0	10.3	5.4	12.1	13.1	11.1	4.1	10.6	2.9	5.8	11.8	4.9	13.6	13.3	24.7	14.4	12.3	11.7	13.5	12.5	15.7	17.6
ZNF232	ZSCAN11	ENSG00000167840	"Zinc finger protein 232"	Q9UNY5	17	5105541-5123116	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA027309, HPA028611"	Uncertain		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA027309: AB_10603464, HPA028611: "	"unprognostic (4.20e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.69e-1)"	"unprognostic (5.59e-3)"	"unprognostic (5.21e-2)"	"unprognostic (5.90e-3)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (3.12e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.49e-2)"	"prognostic favourable (6.55e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.49e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.61e-3)"	6.7	5.2	6.5	6.7	9.5	2.0	7.4	14.3	11.1	6.6	8.2	11.1	7.8	4.5	8.9	10.1	5.5	9.9	5.5	5.9	7.3	5.4	6.6	6.3	6.3	7.0	9.8	5.7	14.3	10.0	3.8	8.7	6.2	8.7	7.6	5.9	6.5	8.8	6.4	7.7	5.5	6.3	8.5	6.2	6.9	7.2	7.5	10.7	6.4	8.0	5.4	6.1	6.3	6.2	11.8	7.4	1.9	2.1	5.4	7.8	3.9	5.5	4.2	6.9	7.0	2.5	1.1	3.7	2.7	1.4	2.7	3.8	6.5	1.4	11.2	3.4	1.0	3.8	4.8	2.8	1.6	4.4	7.3	1.9	9.7	5.8	3.6	0.0	3.4	2.0	3.0	2.9	2.6	1.9	9.4	4.2	3.3	2.7	9.5	3.9	13.5	4.6	8.2	4.4	7.5	2.3	0.8	7.2	4.7	5.4	2.2	4.4	1.1	2.8	3.2	2.7	4.6	2.1	5.3	5.6	8.8	2.8	7.0	0.3	4.5	1.4	2.1	1.9	4.7	1.9	5.5	11.8	5.2	6.2	4.0	11.0	7.8	7.2	0.1	5.4	1.2	7.4	4.2	3.9	6.5	9.5	14.3	11.1	7.3	5.4	9.8	5.7	8.7	10.7
ZNF236		ENSG00000130856	"Zinc finger protein 236"	Q9UL36	18	76822607-76970727	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008600	Uncertain		Approved	"Nucleoplasm,Cell Junctions,Cytosol"				"Cell Junctions"	"Nucleoplasm, Cytosol"	"HPA008600: AB_1080696"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.88e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.95e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	5.7	5.2	7.0	9.1	11.2	10.8	10.0	15.3	11.0	7.2	5.8	7.3	6.7	5.0	7.6	7.1	5.6	7.6	6.3	5.1	8.3	5.7	4.7	4.3	6.4	6.2	8.3	3.5	11.3	7.1	12.2	8.9	5.6	7.3	6.2	4.1	5.4	6.6	12.6	5.7	9.9	5.5	5.8	6.5	5.5	5.8	16.6	10.6	10.4	6.5	1.9	10.0	6.2	12.7	9.0	4.6	5.9	3.4	3.0	5.4	1.2	4.3	5.8	8.2	6.0	6.3	6.1	3.7	3.4	4.7	5.4	4.3	4.1	4.1	6.2	1.7	4.4	8.0	5.7	4.8	4.6	6.5	5.7	5.9	6.7	4.8	3.9	9.4	6.8	6.0	5.2	5.1	7.9	5.4	5.6	5.2	5.4	4.1	11.4	5.2	4.5	4.6	7.3	8.5	4.1	4.0	6.8	4.7	4.9	6.1	3.7	4.2	4.4	6.6	5.6	9.3	3.7	2.5	5.0	3.5	4.9	8.0	6.2	5.2	6.9	1.1	3.4	5.9	5.4	2.9	5.2	9.0	4.0	3.7	2.2	8.1	4.6	4.8	3.7	3.0	2.7	4.6	3.9	1.2	7.0	11.2	15.3	11.0	8.3	5.7	8.3	3.5	7.3	10.6
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87264196	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: "	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	11.8	10.2	15.2	16.7	16.8	31.1	14.5	31.1	19.7	15.0	13.9	10.3	11.4	11.2	16.4	15.1	11.1	11.1	9.8	11.6	13.6	9.0	9.8	10.8	9.7	14.8	18.2	9.8	20.6	12.5	14.6	20.7	12.3	15.3	14.0	10.2	12.0	15.0	11.2	9.3	14.0	15.7	12.3	18.6	12.2	11.6	8.7	19.6	25.6	14.1	5.7	16.5	22.6	22.9	16.7	10.4	35.8	7.6	4.3	8.3	3.0	6.2	3.7	12.6	11.1	7.3	6.6	13.2	4.9	6.3	5.8	8.1	6.3	4.4	9.7	7.2	6.4	6.5	7.8	7.4	12.7	21.9	5.9	13.1	4.8	5.1	5.4	10.4	6.0	6.5	7.3	5.7	7.5	5.3	9.5	15.0	6.3	3.5	6.0	9.4	6.3	3.4	12.7	12.6	3.7	5.2	13.6	9.4	13.3	6.2	4.2	4.7	4.2	12.6	6.0	7.8	5.5	5.7	7.7	13.9	9.0	6.6	8.6	9.1	5.6	18.0	7.6	7.9	6.9	2.2	6.5	16.6	7.4	7.5	3.2	16.7	8.3	7.1	35.8	4.3	2.3	10.4	7.1	3.0	15.2	16.8	31.1	19.7	13.6	9.0	18.2	9.8	15.3	19.6
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"											"HPA028975, HPA051777"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"				"Nucleoplasm, Nucleoli"	"Nuclear bodies"	"HPA028975: , HPA051777: "	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavourable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	2.5	0.0	9.6	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	6.3	0.0	9.1	3.6	0.0	0.0	0.8	16.5	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1
ZNF333	KIAA1806	ENSG00000160961	"Zinc finger protein 333"	Q96JL9	19	14689801-14733746	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043973, HPA054680"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA043973: AB_10961277, HPA054680: "	"unprognostic (8.16e-2)"	"unprognostic (2.80e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.87e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.32e-5)"	"unprognostic (4.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.62e-1)"	"unprognostic (7.06e-3)"	10.7	8.1	8.8	7.8	11.3	12.2	9.4	16.2	12.1	11.4	9.9	14.3	7.0	4.5	16.5	11.0	5.3	10.8	6.6	6.3	8.6	6.9	5.8	4.9	8.7	7.3	16.8	9.8	15.3	9.1	8.2	7.5	7.4	10.3	8.8	5.9	10.3	5.7	8.5	14.5	7.7	6.5	11.6	9.6	13.0	6.7	8.8	12.8	6.7	6.9	4.3	6.6	9.5	8.8	2.7	4.9	7.9	5.0	13.5	5.4	2.4	1.5	0.9	5.7	7.7	8.3	7.8	2.2	3.5	4.8	3.0	4.4	0.4	1.4	2.4	3.9	4.5	1.4	2.0	1.4	4.6	5.5	1.5	9.8	2.1	2.4	6.8	3.9	5.6	7.1	3.8	2.8	8.0	4.4	2.0	4.7	3.8	0.8	2.5	9.4	2.3	1.7	3.6	3.2	2.3	3.0	2.0	3.1	6.1	3.1	0.4	5.6	1.5	6.6	7.1	5.2	2.4	8.3	3.6	2.2	1.0	2.4	5.4	6.8	6.1	7.9	4.0	6.0	4.0	5.0	5.4	2.6	3.6	3.0	4.9	2.7	4.1	3.6	7.0	13.5	4.3	2.4	3.0	2.4	8.8	11.3	16.2	12.1	8.6	6.9	16.8	9.8	10.3	12.8
ZNF33A	"FLJ23404, KIAA0065, KOX31, KOX5, ZNF11A, ZNF33, ZZAPK"	ENSG00000189180	"Zinc finger protein 33A"	Q06730	10	38010650-38065088	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA005538, HPA056638"	Approved		Approved	"Nucleoli fibrillar center,Endoplasmic reticulum,Vesicles"				"Nucleoli fibrillar center, Endoplasmic reticulum"	Vesicles	"HPA005538: , HPA056638: "	"unprognostic (1.85e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.69e-3)"	"unprognostic (7.96e-3)"	"unprognostic (4.89e-3)"	"unprognostic (6.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (6.83e-2)"	"unprognostic (7.39e-3)"	11.7	13.9	10.6	18.5	13.2	10.9	19.4	34.6	15.9	17.1	14.4	8.9	31.3	13.7	16.1	17.9	14.1	16.2	12.4	11.5	13.5	10.9	16.8	16.9	12.0	14.2	18.2	13.5	16.3	21.8	24.1	49.7	12.0	18.8	17.7	17.0	9.7	18.9	27.7	16.7	14.4	16.9	17.8	17.3	17.4	17.1	6.4	16.4	12.8	18.9	11.0	16.7	16.1	15.9	7.0	6.8	17.2	6.5	4.8	6.8	3.2	10.8	6.1	11.5	9.6	5.5	7.3	8.9	4.9	4.9	6.4	7.1	6.6	9.9	21.2	5.4	6.6	7.2	13.6	8.7	6.0	12.7	15.1	16.8	12.1	8.9	5.7	23.7	14.1	6.2	15.9	4.7	7.3	5.4	8.8	11.4	6.4	7.0	9.8	5.5	11.5	7.2	8.5	7.7	9.8	9.1	10.1	8.7	13.8	7.6	8.5	4.4	10.4	6.4	4.9	5.6	8.3	6.2	3.9	9.0	11.0	12.8	5.2	13.3	2.6	9.6	3.8	6.3	6.2	5.4	5.5	7.0	5.5	4.1	3.6	7.0	6.8	5.3	17.2	4.8	6.5	6.8	3.7	3.2	10.6	13.2	34.6	15.9	13.5	10.9	18.2	13.5	18.8	16.4
ZNF343	MGC10715	ENSG00000088876	"Zinc finger protein 343"	Q6P1L6	20	2481817-2524702	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA030587, HPA052438"	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA030587: AB_10603246, HPA052438: "	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.38e-6)"	"unprognostic (9.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.88e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavourable (4.53e-5)"	"unprognostic (1.65e-1)"	"unprognostic (3.71e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.53e-2)"	11.6	8.6	10.4	8.0	11.9	3.9	12.4	20.6	15.0	10.6	12.3	10.7	8.5	5.1	13.9	18.0	8.9	10.6	8.1	7.8	10.0	7.1	9.3	8.0	9.4	9.9	9.1	7.6	12.7	12.8	17.2	10.9	9.4	10.4	10.2	10.1	9.0	8.7	10.4	13.8	11.3	7.5	13.0	9.1	8.2	8.9	7.5	9.5	5.4	11.4	6.6	9.8	11.3	12.9	8.9	5.3	4.5	3.9	1.8	7.6	3.0	9.4	10.2	6.9	7.6	8.0	8.3	2.4	6.6	7.4	8.2	8.5	5.3	5.6	12.2	2.5	6.6	9.0	10.6	12.1	10.6	3.2	5.2	7.9	4.5	10.5	7.1	4.7	2.9	7.5	12.1	9.9	15.9	8.1	10.1	6.2	7.8	3.3	10.1	3.1	7.0	10.9	8.3	9.3	7.2	4.1	2.5	8.0	12.8	8.3	13.7	7.8	4.8	4.0	5.2	11.3	5.2	8.2	7.5	12.7	20.1	6.3	3.0	6.5	6.6	0.6	3.9	4.5	5.1	3.8	5.4	7.0	6.3	4.4	3.9	8.9	5.8	7.6	3.3	1.8	3.4	5.3	5.7	3.0	10.4	11.9	20.6	15.0	10.0	7.1	9.1	7.6	10.4	9.5
ZNF410	"APA-1, APA1"	ENSG00000119725	"Zinc finger protein 410"	Q86VK4	14	73886617-73932511	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002871			Approved	"Nuclear bodies"				"Nuclear bodies"		"HPA002871: AB_1080712"	"unprognostic (5.84e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (5.86e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.83e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.29e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.19e-1)"	24.2	22.6	14.2	12.9	18.6	37.9	22.3	21.5	20.8	20.2	20.2	21.8	19.2	14.3	28.8	33.8	24.0	19.4	17.7	15.4	13.7	12.8	22.7	20.7	19.5	17.3	15.7	12.5	30.9	19.1	17.2	27.0	32.7	16.6	21.7	18.5	20.2	18.0	21.7	14.5	26.4	20.8	21.7	14.5	20.6	18.6	37.2	15.9	28.3	26.0	17.2	30.5	20.4	20.5	26.5	27.3	43.5	28.2	34.0	33.2	30.5	18.4	14.7	17.9	19.5	19.4	17.0	21.9	21.4	24.0	37.6	34.5	15.9	16.5	15.4	9.3	26.5	17.2	17.5	21.5	35.2	22.4	11.0	14.6	14.0	11.8	28.9	12.0	19.8	15.7	30.4	18.4	35.6	19.8	15.3	13.7	18.0	35.2	18.1	20.3	6.4	17.6	16.3	20.6	9.8	23.5	17.9	16.9	21.7	23.5	21.9	21.9	20.7	21.2	13.8	26.9	25.4	15.4	18.9	19.0	33.8	19.5	17.0	13.8	22.3	35.1	27.6	43.5	31.4	25.7	33.2	23.6	32.1	31.0	27.3	26.5	28.3	28.8	21.2	34.0	28.2	18.2	27.1	30.5	14.2	18.6	21.5	20.8	13.7	12.8	15.7	12.5	16.6	15.9
ZNF445	"ZKSCAN15, ZNF168, ZSCAN47"	ENSG00000185219	"Zinc finger protein 445"	P59923	3	44431720-44477670	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006678	Uncertain		Approved	Nucleoplasm,Mitochondria,Cytosol				Nucleoplasm	"Mitochondria, Cytosol"	"HPA006678: AB_10603329"	"unprognostic (7.72e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.79e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.48e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.05e-1)"	6.8	6.4	8.3	6.4	10.9	4.5	7.5	16.5	10.9	8.6	7.1	11.7	8.0	5.1	13.6	7.7	5.2	8.3	6.1	6.3	7.7	7.0	6.3	7.5	6.7	6.6	11.3	10.5	13.0	7.6	16.1	13.9	7.1	7.9	8.6	6.6	9.9	8.1	8.2	11.2	8.2	5.7	12.3	6.6	7.0	7.3	6.5	8.9	14.2	6.9	4.8	8.1	6.7	8.2	1.1	1.1	4.1	2.5	1.9	1.5	0.5	2.5	2.9	9.1	7.1	5.1	5.2	4.1	3.5	2.9	5.3	5.3	4.4	2.2	4.5	2.2	3.5	2.1	6.1	2.3	6.4	4.9	2.3	8.3	5.9	4.3	3.2	10.4	7.0	3.6	3.0	5.9	3.7	3.7	6.4	3.4	4.2	1.6	9.9	7.1	6.1	2.6	4.4	5.7	2.2	2.8	5.2	4.5	5.6	5.4	2.8	1.4	5.2	4.6	4.4	7.5	6.6	4.5	4.4	2.7	2.0	3.8	2.7	5.2	4.5	2.7	1.3	2.3	1.2	0.8	1.1	0.7	0.9	0.9	0.9	1.1	1.5	1.1	4.1	1.9	2.5	1.1	0.4	0.5	8.3	10.9	16.5	10.9	7.7	7.0	11.3	10.5	7.9	8.9
ZNF45	ZNF13	ENSG00000124459	"Zinc finger protein 45"	Q02386	19	43912629-43935278	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038611, HPA075124"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA038611: AB_10669544, HPA075124: "	"unprognostic (1.67e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.31e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.91e-1)"	"unprognostic (7.68e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.17e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.82e-2)"	11.8	12.0	7.5	7.8	9.0	8.2	10.9	17.9	10.0	12.9	9.3	12.2	7.2	8.4	12.1	8.8	8.2	10.5	8.0	7.3	11.3	7.2	9.8	8.7	8.9	10.9	9.7	5.4	14.4	7.7	18.3	13.7	8.9	10.3	11.4	9.5	11.1	9.9	16.8	8.8	8.8	9.8	10.0	7.4	14.8	8.5	6.1	11.4	22.1	14.9	6.6	11.5	10.7	8.8	8.4	6.6	7.4	5.7	8.4	11.9	5.4	6.1	8.3	11.9	10.6	5.7	5.1	4.2	8.0	8.8	8.5	12.9	4.0	2.6	9.0	5.0	5.0	3.6	9.0	5.9	10.7	7.5	9.5	13.3	7.1	3.6	5.4	13.0	9.0	5.1	5.9	6.2	5.5	6.7	4.1	3.6	9.0	2.8	7.7	3.3	13.9	3.5	6.4	11.8	3.2	5.2	13.8	8.2	13.5	11.3	4.6	3.9	4.8	8.6	6.9	9.4	13.8	3.9	7.3	14.9	24.1	10.0	4.0	5.1	10.9	3.8	5.0	7.4	8.0	4.6	11.9	8.4	7.7	8.4	6.6	6.3	10.8	7.3	1.5	8.4	5.7	4.4	8.1	5.4	7.5	9.0	17.9	10.0	11.3	7.2	9.7	5.4	10.3	11.4
ZNF462	"DKFZP762N2316, KIAA1803, Zfp462"	ENSG00000148143	"Zinc finger protein 462"	Q96JM2	9	106863097-107013634	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022283	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA022283: AB_2220602"	"unprognostic (4.22e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (6.04e-2)"	"prognostic favourable (6.19e-4)"	"unprognostic (2.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-2)"	4.8	11.9	10.4	5.0	11.0	0.8	6.4	25.4	9.5	10.4	6.5	13.2	7.7	2.3	13.3	5.1	10.7	9.1	6.0	8.6	10.6	6.6	5.6	2.9	5.3	1.8	8.1	7.8	11.5	2.1	18.1	10.0	5.6	10.0	11.4	6.4	8.1	12.6	11.9	22.1	11.2	3.3	10.8	9.7	4.8	3.3	9.1	9.8	1.5	11.7	5.4	2.5	5.6	9.3	0.4	0.5	1.1	0.6	1.8	1.7	0.3	3.2	7.6	15.1	10.3	5.1	3.8	2.2	2.0	2.9	2.0	2.2	9.3	3.3	0.0	5.7	2.1	5.1	9.8	9.0	2.5	0.1	1.3	0.0	2.5	0.0	2.0	1.6	0.3	3.5	4.1	4.5	12.4	1.0	0.0	4.2	5.5	5.7	1.8	0.1	11.6	7.4	0.0	10.2	0.2	5.8	2.8	7.0	7.9	3.8	0.1	3.3	7.8	0.0	1.0	2.6	8.9	5.9	6.3	0.0	0.1	0.1	4.3	0.2	9.3	1.1	0.2	0.3	0.7	0.4	1.2	0.3	0.7	0.3	0.3	0.4	1.7	0.5	0.7	1.8	0.6	0.5	0.3	0.3	10.4	11.0	25.4	7.7	10.6	6.6	8.1	7.8	10.0	9.8
ZNF479	KR19	ENSG00000185177	"Zinc finger protein 479"	Q96JC4	7	57119614-57139864	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	6	"testis: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																																				"unprognostic (1.54e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	1.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.5	0.2	0.3	0.4	0.3	0.3	0.2	0.5	0.8	0.8	0.2	1.2	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF483	"KIAA1962, ZKSCAN16, ZSCAN48"	ENSG00000173258	"Zinc finger protein 483"	Q8TF39	9	111525159-111577844	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3;pituitary gland: 40.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 11.5;SCLC-21H: 6.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055041			Approved	Nucleoli				Nucleoli		"HPA055041: "	"unprognostic (4.33e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.95e-3)"	"unprognostic (9.18e-5)"	"unprognostic (2.02e-1)"	"unprognostic (9.50e-2)"	"unprognostic (4.44e-3)"	"unprognostic (5.49e-2)"	"unprognostic (5.19e-4)"	"unprognostic (7.19e-3)"	"unprognostic (1.74e-1)"	"unprognostic (4.30e-2)"	"unprognostic (6.17e-2)"	3.2	10.1	13.9	2.1	30.5	7.7	5.6	35.9	36.3	6.1	4.0	8.6	2.9	2.0	10.0	11.9	2.4	7.0	4.9	4.7	18.1	7.3	5.1	2.5	3.9	3.4	9.5	23.0	12.6	4.3	13.6	40.4	1.8	24.4	7.2	2.4	5.9	3.2	7.7	2.3	3.5	2.9	5.5	9.8	4.8	3.9	11.8	10.3	0.0	12.5	0.0	3.1	4.7	4.8	2.5	1.0	4.6	1.0	2.1	6.5	1.5	0.3	3.2	3.1	4.7	0.4	0.6	1.0	0.4	1.5	3.1	2.9	0.3	1.5	0.5	0.5	1.3	0.9	1.5	1.6	1.9	0.2	1.8	1.6	4.4	2.5	0.9	0.6	0.4	1.2	0.6	1.7	0.9	2.9	1.3	0.8	0.7	3.0	0.2	0.8	11.5	1.1	0.3	4.8	0.4	1.2	1.3	6.7	3.2	1.2	0.6	0.8	1.9	0.4	0.5	0.9	1.6	1.4	2.2	0.7	1.9	0.4	1.0	0.5	0.7	4.6	1.0	0.6	4.8	0.5	2.7	1.5	3.3	2.3	0.3	2.5	5.9	6.5	3.4	2.1	0.7	1.0	1.6	1.5	13.9	30.5	35.9	36.3	18.1	7.3	9.5	23.0	24.4	10.3
ZNF496	"MGC15548, ZKSCAN17, ZSCAN49"	ENSG00000162714	"Zinc finger protein 496"	Q96IT1	1	247297412-247331846	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055834			Uncertain	"Golgi apparatus"				"Golgi apparatus"		"HPA055834: "	"unprognostic (1.88e-3)"	"unprognostic (3.31e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-3)"	"unprognostic (8.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.55e-1)"	10.1	6.2	6.9	6.4	8.2	6.3	8.7	11.4	13.5	17.8	10.8	15.1	4.7	4.1	16.1	11.4	7.2	16.8	8.7	9.6	6.3	5.8	8.1	4.7	8.7	6.8	6.3	6.2	21.7	20.4	12.7	7.0	10.6	7.3	10.1	6.3	14.5	8.1	12.3	16.6	5.9	6.7	13.0	7.1	9.6	9.2	21.1	7.8	22.4	14.1	7.0	7.5	12.8	8.5	1.5	2.7	0.3	1.0	2.7	5.5	1.8	11.9	11.0	11.7	14.2	4.6	11.9	14.7	5.6	14.1	12.7	11.5	6.0	11.2	3.4	9.8	9.2	10.3	12.0	10.8	12.7	9.2	2.8	11.1	7.8	6.8	12.6	13.5	5.7	12.6	11.5	9.8	23.8	15.0	19.7	8.7	7.8	7.7	13.3	9.3	23.5	16.5	12.7	12.8	4.6	7.8	14.6	10.0	22.1	7.5	8.6	11.3	8.9	16.8	10.2	9.2	13.1	4.1	17.5	9.7	7.7	9.9	3.9	0.9	10.0	0.0	1.0	0.3	2.1	0.7	3.4	0.8	0.9	2.3	2.7	1.5	1.9	5.5	0.3	2.7	1.0	1.6	0.3	1.8	6.9	8.2	11.4	13.5	6.3	5.8	6.3	6.2	7.3	7.8
ZNF502	"FLJ12515, FLJ14855"	ENSG00000196653	"Zinc finger protein 502"	Q8TBZ5	3	44712643-44723831	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA024761, HPA029557"	Uncertain									"HPA024761: AB_10599830, HPA029557: AB_10601448"	"unprognostic (1.80e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.72e-3)"	"unprognostic (5.49e-2)"	"prognostic favourable (4.51e-5)"	"unprognostic (1.88e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.97e-1)"	"prognostic favourable (2.06e-4)"	8.2	5.1	6.4	3.9	11.7	2.5	9.5	12.9	7.3	8.7	6.0	4.3	5.7	3.0	8.4	8.6	5.6	7.3	3.6	4.9	6.0	3.9	5.3	3.3	4.3	3.7	3.1	8.3	10.6	6.7	5.1	14.5	6.0	5.8	10.0	5.5	8.3	6.1	7.9	6.6	8.2	4.2	10.5	4.7	5.8	5.1	8.3	4.7	2.7	9.9	4.8	3.9	6.7	5.8	4.1	1.5	1.3	1.0	3.4	4.9	1.1	0.0	1.2	3.3	0.0	3.8	5.5	0.0	2.9	0.7	3.5	2.0	0.2	1.5	0.0	0.8	2.7	1.7	0.0	4.1	3.0	0.0	1.6	0.0	0.1	0.0	4.2	0.0	1.6	4.2	1.8	3.6	0.0	2.2	0.0	0.0	3.3	0.0	0.0	0.9	5.1	0.0	0.0	2.0	0.0	3.7	3.8	3.0	4.4	1.6	2.7	0.0	0.0	0.0	2.8	0.0	2.7	5.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.6	1.3	1.8	1.0	3.3	2.6	3.2	2.5	1.5	4.1	4.9	3.5	0.0	3.4	1.0	0.8	0.6	1.1	6.4	11.7	12.9	7.3	6.0	3.9	3.1	8.3	5.8	4.7
ZNF507	KIAA1084	ENSG00000168813	"Zinc finger protein 507"	Q8TCN5	19	32345594-32387667	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030964, HPA049728"	Uncertain		Supported	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA030964: AB_10670562, HPA049728: "	"unprognostic (3.39e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.28e-3)"	"unprognostic (7.24e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.46e-2)"	10.9	8.7	11.3	16.0	13.1	13.5	12.0	18.4	16.4	12.0	11.4	9.0	10.2	10.0	12.4	9.8	9.6	12.2	10.3	10.1	9.4	8.1	9.0	11.1	8.2	10.5	12.3	10.3	18.6	10.9	13.6	15.7	16.9	11.1	10.7	9.9	6.8	11.0	9.6	21.0	8.6	14.7	11.9	12.9	9.6	9.7	28.3	13.0	17.1	18.7	10.0	10.5	11.0	20.1	4.0	0.4	2.3	1.4	2.0	4.7	1.4	9.1	18.2	13.6	8.4	8.9	14.0	11.0	8.2	8.1	7.6	8.5	10.5	7.2	13.6	10.2	7.9	5.3	19.8	10.2	14.7	10.5	17.9	13.9	8.8	7.1	10.7	11.6	7.6	8.8	7.8	9.7	15.8	10.2	20.5	11.0	8.0	5.7	12.4	3.8	14.6	5.8	13.0	15.8	5.5	4.6	10.2	11.2	9.7	10.9	7.4	9.0	5.8	8.4	10.8	12.2	13.1	7.1	10.6	10.7	12.4	14.1	8.6	8.6	11.0	0.4	0.1	2.3	4.1	0.0	4.7	2.5	3.1	2.8	0.0	4.0	4.2	3.4	2.0	2.0	1.4	0.4	2.4	1.4	11.3	13.1	18.4	16.4	9.4	8.1	12.3	10.3	11.1	13.0
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956702-63969865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006688	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA006688: AB_10963053"	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	7.5	8.2	11.0	6.3	13.3	6.2	5.6	14.3	16.7	7.4	3.6	9.9	6.1	5.3	9.3	9.0	10.1	8.5	7.5	8.3	11.0	8.5	9.6	18.5	7.1	7.0	8.8	10.5	11.3	14.4	13.6	10.3	10.4	8.4	8.5	1.7	9.9	15.5	10.5	11.2	14.3	5.8	7.8	6.4	9.3	8.5	8.8	6.5	6.2	10.7	5.8	8.8	6.2	6.7	0.6	0.4	0.0	0.1	1.4	1.1	0.3	5.3	9.1	10.3	10.9	4.6	3.4	9.4	7.8	6.2	23.6	7.7	17.8	9.1	3.5	19.3	6.8	6.9	7.7	11.6	5.7	5.8	11.1	8.7	12.8	16.9	7.3	4.7	10.5	7.1	9.6	8.1	4.7	7.3	12.1	5.4	4.6	12.9	22.8	10.2	7.1	12.0	10.5	0.9	10.7	4.2	9.1	15.1	8.8	6.4	10.7	5.2	22.5	11.4	10.1	22.7	3.5	5.7	6.7	13.1	6.2	9.9	8.1	0.0	9.6	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.0	0.1	0.4	0.6	1.1	1.0	0.0	1.4	0.0	0.4	0.0	0.3	11.0	13.3	14.3	16.7	11.0	8.5	8.8	10.5	8.4	6.5
ZNF566	"FLJ14779, MGC12515"	ENSG00000186017	"Zinc finger protein 566"	Q969W8	19	36445119-36489902	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023456	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA023456: AB_2221143"	"unprognostic (1.68e-1)"	"unprognostic (6.34e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (3.89e-3)"	"unprognostic (5.71e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.56e-2)"	"unprognostic (8.19e-4)"	"unprognostic (7.51e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.48e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.47e-3)"	8.2	8.2	10.4	7.2	11.4	5.9	9.0	22.7	14.2	8.7	7.0	9.4	5.8	6.7	12.1	10.3	6.1	9.7	6.2	8.1	10.9	11.7	8.8	8.4	7.9	9.1	11.6	11.8	14.3	6.3	10.4	14.0	5.5	12.7	8.1	5.9	11.6	6.3	7.2	7.3	8.5	6.4	9.1	10.7	7.6	6.0	5.1	13.8	5.1	10.3	5.3	8.9	8.4	6.1	8.1	2.8	5.6	1.6	4.6	8.6	3.2	3.5	8.5	9.9	10.9	7.5	7.6	6.9	6.9	5.8	8.7	9.2	3.5	1.5	6.7	7.5	4.4	2.5	8.9	2.5	10.1	10.8	6.7	6.8	5.9	3.1	5.5	7.2	8.1	6.5	3.6	4.6	7.3	3.3	9.8	0.2	5.9	5.6	9.4	3.7	11.9	3.7	6.2	7.9	4.5	2.6	6.8	9.3	14.0	8.3	4.8	6.5	4.2	9.9	3.7	7.6	10.4	3.2	6.5	2.8	7.6	9.2	0.4	4.8	9.9	5.6	1.5	1.9	5.3	1.4	8.6	8.1	6.5	6.5	2.8	6.1	7.9	8.0	1.4	4.6	1.6	2.0	6.7	3.2	10.4	11.4	22.7	14.2	10.9	11.7	11.6	11.8	12.7	13.8
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: "	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favourable (8.73e-5)"	20.7	19.1	22.4	14.9	26.0	18.7	19.8	51.3	25.5	19.8	19.7	23.4	13.0	11.3	26.0	14.8	17.3	20.1	14.3	16.0	20.1	11.9	18.7	22.9	16.4	16.9	25.4	19.9	31.1	15.4	28.9	46.7	16.9	23.9	17.2	14.7	14.1	20.6	15.5	33.2	16.9	15.8	18.4	22.7	16.0	17.3	21.0	29.7	26.0	22.5	11.2	16.1	26.6	17.8	14.8	10.2	32.4	12.8	11.8	14.1	6.0	14.8	21.4	32.9	15.3	19.4	21.4	25.4	17.0	19.7	14.5	13.0	20.4	14.6	24.4	15.8	15.5	12.6	30.5	17.4	21.1	24.8	17.0	32.1	23.4	18.5	16.8	29.2	21.8	13.5	17.0	15.5	29.0	22.2	32.0	14.4	21.0	14.9	20.6	21.7	28.5	13.8	17.7	49.9	17.0	15.5	22.7	25.4	16.7	20.9	14.7	21.4	13.7	18.1	22.7	18.0	26.2	13.3	17.0	11.8	18.2	24.2	15.1	19.2	19.4	32.4	10.1	18.7	11.4	9.5	10.6	14.5	10.6	10.4	7.9	14.8	14.1	10.3	17.1	11.8	12.8	10.2	8.9	6.0	22.4	26.0	51.3	25.5	20.1	11.9	25.4	19.9	23.9	29.7
ZNF780A	ZNF780	ENSG00000197782	"Zinc finger protein 780A"	O75290	19	40069152-40090938	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA003311	Uncertain		Approved	Nucleoplasm,Centrosome				Nucleoplasm	Centrosome	"HPA003311: AB_1080757"	"unprognostic (1.92e-1)"	"unprognostic (9.25e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.53e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.13e-1)"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-2)"	"prognostic favourable (9.30e-4)"	6.9	9.2	11.1	8.6	8.5	4.1	7.7	12.8	10.8	8.7	6.6	5.8	13.9	5.7	8.2	10.8	10.4	7.8	7.8	6.7	7.1	6.1	7.9	11.8	7.0	11.3	10.5	8.9	8.6	11.0	15.8	14.1	7.0	6.8	7.9	6.0	6.8	10.0	11.4	4.5	8.0	9.1	6.0	10.4	12.0	8.2	7.9	9.7	7.8	11.2	5.3	11.3	8.8	7.9	3.9	4.6	8.4	7.7	3.3	5.9	2.5	4.8	9.2	6.0	5.6	5.5	5.0	4.3	5.6	4.5	4.6	7.1	6.0	3.3	4.3	3.7	2.7	4.1	3.8	3.2	5.1	7.4	5.2	6.8	7.6	5.7	4.9	7.0	5.6	5.2	3.6	4.7	3.9	4.7	7.6	7.3	3.9	2.8	2.8	2.4	4.8	2.9	2.3	10.6	2.5	3.8	10.0	3.7	7.1	8.4	3.2	3.7	4.0	8.5	3.5	5.7	7.6	5.1	4.5	7.2	6.3	4.3	3.6	4.9	3.8	2.7	5.4	8.4	3.9	4.9	5.1	3.7	4.2	3.5	4.6	3.9	5.9	5.1	4.7	3.3	7.7	3.6	4.5	2.5	11.1	8.5	12.8	10.8	7.1	6.1	10.5	8.9	6.8	9.7
ZNFX1	"FLJ11277, KIAA1404"	ENSG00000124201	"Zinc finger NFX1-type containing 1"	Q9P2E3	20	49237946-49278426	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046629	Approved		Approved	Mitochondria				Mitochondria		"HPA046629: AB_2616451"	"unprognostic (1.03e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (8.71e-3)"	"unprognostic (7.40e-2)"	"unprognostic (7.86e-2)"	27.2	14.9	13.2	21.5	15.1	32.8	19.3	14.4	19.7	16.6	16.0	20.1	12.1	14.5	21.3	17.4	13.1	17.2	19.2	16.5	12.3	12.0	16.5	13.4	28.2	20.5	13.4	13.8	18.3	12.2	23.8	14.6	17.4	17.1	15.5	14.4	21.1	14.4	13.7	23.0	17.6	20.6	18.3	14.4	25.9	16.2	23.9	14.6	18.6	21.4	14.4	22.7	16.8	15.0	5.7	5.1	30.0	14.0	5.6	8.3	5.4	5.7	9.0	2.1	3.0	11.9	9.4	3.7	7.9	18.6	49.5	20.7	10.2	4.8	4.8	10.2	15.6	11.2	4.0	10.7	17.2	4.5	1.3	5.7	6.5	4.5	10.3	4.6	7.0	9.9	10.0	11.0	8.2	7.4	4.3	6.0	12.3	2.4	4.9	3.1	2.0	7.5	3.1	7.3	1.3	8.1	8.0	2.2	1.6	11.6	22.7	8.1	5.8	3.9	18.5	24.3	6.9	8.8	7.6	4.0	1.4	2.6	9.8	3.1	5.3	8.8	6.7	10.8	8.3	8.8	7.3	5.7	8.3	7.8	5.1	4.6	8.0	6.1	30.0	5.6	14.0	3.0	6.0	5.4	13.2	15.1	14.4	19.7	12.3	12.0	13.4	13.8	17.1	14.6
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081297	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"HPA053960: , HPA061949: , HPA063298: "	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavourable (5.70e-4)"	"prognostic unfavourable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	26.4	27.4	39.8	31.1	42.2	35.1	34.4	54.1	48.6	39.3	28.8	19.6	33.3	23.4	48.3	45.6	20.2	30.6	20.3	27.5	33.5	30.6	20.1	19.5	26.7	37.8	34.1	40.5	39.5	23.9	23.1	77.5	24.6	32.0	30.5	29.3	17.5	25.1	33.2	54.4	27.9	24.9	35.1	42.2	26.2	23.6	31.6	38.0	40.0	32.8	24.3	30.9	32.8	25.6	31.4	34.0	32.1	16.3	20.9	30.8	13.8	23.3	8.5	34.9	20.1	13.7	23.6	20.0	28.6	15.8	25.1	32.1	15.9	15.1	48.4	25.3	17.6	14.8	29.6	17.8	37.8	34.2	21.3	42.0	33.2	13.2	20.3	45.8	17.2	17.8	22.3	24.5	21.1	21.1	43.9	26.0	19.2	7.9	37.4	14.9	35.6	16.6	42.7	26.1	28.4	16.2	20.0	26.1	16.5	24.3	16.4	24.4	20.1	20.1	28.3	18.6	17.8	14.5	28.2	21.4	26.6	53.3	27.5	42.8	26.1	32.1	16.3	14.2	22.2	15.0	25.1	30.6	23.6	21.3	12.4	31.4	30.8	24.2	14.6	20.9	14.8	34.0	22.0	13.8	39.8	42.2	54.1	48.6	33.5	30.6	34.1	40.5	32.0	38.0
ZSCAN10	ZNF206	ENSG00000130182	"Zinc finger and SCAN domain containing 10"	Q96SZ4	16	3088890-3099317	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 2.8;testis: 3.9"	"Cell line enriched"	"Detected in single"	86	"NTERA-2: 35.5"	"Cancer enriched"	"Detected in single"	207	"testis cancer: 19.5"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.7"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (4.37e-2)"	"unprognostic (5.13e-2)"		"unprognostic (9.15e-2)"	"unprognostic (6.65e-3)"	"unprognostic (6.24e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.24e-2)"		"unprognostic (1.15e-1)"		"unprognostic (1.72e-1)"	"unprognostic (1.85e-11)"	"unprognostic (5.98e-2)"	"unprognostic (2.92e-2)"		"unprognostic (1.79e-2)"	0.2	0.2	0.3	0.2	0.2	1.3	0.2	2.7	1.4	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.5	0.2	1.3	0.9	0.3	0.2	0.2	0.1	0.2	0.2	0.2	1.1	2.8	0.3	0.2	0.2	0.6	1.2	3.9	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.8	0.7	2.4	0.8	0.6	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	35.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	2.4	0.8	0.8	0.4	0.6	1.1	0.8	0.2	1.0	0.4	0.8	0.5	0.6	1.3	0.6	0.7	0.7	0.1	0.2	0.3	0.2	2.7	0.3	0.3	0.2	0.2	0.2	0.2	0.2
ZSWIM2	"MEX, MGC33890, ZZZ2"	ENSG00000163012	"Zinc finger SWIM-type containing 2"	Q8NEG5	2	186827835-186849208	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 17.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.1;U-138 MG: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.00e-1)"													0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.4	0.0	0.0	0.3	0.0
ZSWIM4	FLJ12221	ENSG00000132003	"Zinc finger SWIM-type containing 4"	Q9H7M6	19	13795460-13832230	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042084	Uncertain									"HPA042084: AB_10795392"	"unprognostic (3.29e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.78e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.25e-3)"	"unprognostic (6.14e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (7.85e-5)"	"unprognostic (3.47e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.63e-2)"	6.2	7.5	4.7	9.4	5.0	4.6	6.3	4.1	8.9	6.2	3.5	4.8	6.7	5.2	7.6	3.5	19.7	4.0	7.1	5.3	5.2	4.0	6.7	3.1	8.2	5.4	6.1	2.5	5.0	9.3	4.1	8.6	9.3	6.5	6.5	1.9	9.2	18.5	7.7	3.8	9.9	3.8	4.5	5.7	6.2	7.3	2.3	4.9	11.3	7.6	4.9	14.2	5.7	8.8	1.2	0.5	2.8	0.4	0.8	1.5	0.2	7.2	4.2	8.4	4.2	1.1	0.9	8.0	3.1	6.8	2.8	3.0	1.5	4.0	2.6	5.0	2.7	3.1	1.4	2.8	2.0	9.2	2.6	0.4	4.7	0.9	6.9	0.7	2.1	4.5	0.8	3.2	1.2	6.8	2.3	5.7	0.8	4.0	4.1	5.7	9.7	4.3	9.0	7.9	4.2	3.9	3.4	2.4	16.1	5.4	13.4	5.6	2.0	4.9	7.8	8.5	3.1	2.4	10.7	7.0	4.2	1.7	5.4	3.0	5.9	0.0	0.3	0.3	0.4	0.4	1.5	0.3	0.4	0.4	0.4	1.2	0.5	0.2	2.8	0.8	0.1	0.5	0.0	0.2	4.7	5.0	4.1	8.9	5.2	4.0	6.1	2.5	6.5	4.9
ZW10	KNTC1AP	ENSG00000086827	"Zw10 kinetochore protein"	O43264	11	113733187-113773811	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, ER-Golgi transport, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011565, HPA051253, HPA055410"	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"		"CAB011565: AB_779030, HPA051253: AB_2681408, HPA055410: AB_2682809"	"unprognostic (4.33e-3)"	"unprognostic (6.65e-2)"	"prognostic favourable (2.70e-4)"	"unprognostic (3.12e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.52e-2)"	"prognostic unfavourable (8.57e-4)"	"unprognostic (7.44e-2)"	"unprognostic (8.01e-3)"	"unprognostic (5.91e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.57e-3)"	"unprognostic (6.00e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.17e-3)"	11.8	11.4	9.0	10.4	13.5	10.7	15.2	19.8	15.2	12.5	11.4	11.2	8.6	7.8	14.0	10.5	17.2	8.9	8.0	10.3	9.9	7.6	12.2	19.6	9.6	11.7	10.3	9.9	11.9	16.8	14.9	14.4	10.4	17.0	11.4	14.3	7.9	15.2	11.0	24.1	22.9	10.7	12.2	12.5	11.7	12.0	25.0	10.9	18.6	9.4	12.4	15.8	11.8	13.1	8.3	12.3	8.6	13.2	7.3	11.8	7.2	12.0	7.7	15.8	11.1	10.3	10.7	9.2	13.6	11.5	17.2	17.5	19.9	22.3	15.1	17.9	13.6	16.9	19.9	17.0	24.6	10.4	8.2	16.0	6.8	12.2	10.9	15.5	9.8	9.1	11.1	18.3	14.9	17.7	18.3	5.6	18.0	6.2	14.9	10.7	10.0	15.3	14.0	16.5	17.0	11.4	11.6	6.3	7.5	15.4	12.8	5.7	23.6	9.1	9.9	14.4	23.1	7.9	15.0	3.3	5.5	16.0	4.7	20.0	16.7	7.4	9.5	8.6	8.8	13.2	11.8	8.3	8.3	7.6	12.3	7.2	7.9	9.4	2.7	7.3	11.1	3.6	7.3	7.2	9.0	13.5	19.8	15.2	9.9	7.6	10.3	9.9	17.0	10.9
ZYX		ENSG00000159840	Zyxin	Q15942	7	143381080-143391111	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.5;granulocytes: 47.5;monocytes: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004835, CAB009321, HPA073497, CAB075747"	Approved		Enhanced	"Focal adhesion sites"			420000000	"Focal adhesion sites"		"CAB009321: AB_2221290, CAB075747: , HPA004835: AB_1080771, HPA073497: "	"unprognostic (1.96e-2)"	"unprognostic (5.35e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.60e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (7.92e-5)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.72e-2)"	52.7	11.7	7.7	39.3	8.8	46.1	34.3	17.5	22.2	61.1	56.8	10.7	20.5	13.6	103.6	38.6	52.3	48.9	58.1	22.7	7.4	7.7	24.7	21.2	52.8	63.0	8.8	8.3	58.1	15.9	63.8	9.1	32.4	15.5	43.8	10.8	17.9	18.8	40.7	28.3	21.1	26.6	74.7	8.5	57.1	28.3	37.4	7.1	24.4	18.9	19.1	26.0	93.7	35.7	0.9	16.5	47.5	22.1	4.1	6.7	9.0	12.6	7.7	10.2	14.2	19.3	43.1	12.1	26.9	31.7	29.5	24.9	26.2	8.2	0.8	10.5	32.9	10.3	6.3	27.2	13.8	13.5	3.3	19.7	9.0	9.1	33.9	15.9	31.5	45.8	12.1	32.3	10.9	37.3	4.8	8.6	31.5	14.2	0.2	32.0	21.3	49.8	3.0	5.5	1.1	22.4	6.7	0.5	7.7	21.2	19.8	11.1	2.3	15.9	65.5	35.3	14.5	37.5	28.3	2.8	3.6	2.1	31.4	16.7	23.4	4.9	18.2	12.5	5.9	19.2	4.7	0.9	5.5	6.7	16.5	0.5	3.5	4.0	47.5	4.1	22.1	4.2	5.0	9.0	7.7	8.8	17.5	22.2	7.4	7.7	8.8	8.3	15.5	7.1